PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Janowski, M; Kunert, P				Janowski, Miroslaw; Kunert, Przemyslaw			Intravenous Fluid Administration May Improve Post-Operative Course of Patients with Chronic Subdural Hematoma: A Retrospective Study	PLOS ONE			English	Article							BURR-HOLE CRANIOSTOMY; INDEPENDENT PREDICTORS; BLOOD-VOLUME; RECURRENCE	Background: The treatment of chronic subdural hematoma (cSDH) is still charged of significant risk of hematoma recurrence. Patient-related predictors and the surgical procedures themselves have been addressed in many studies. In contrast, postoperative management has infrequently been subjected to detailed analysis. Moreover variable intravenous fluid administration (IFA) was not reported in literature till now in the context of cSDH treatment. Methodology/Principal Findings: A total of 45 patients with cSDH were operated in our department via two burr hole craniostomy within one calendar year. Downward drainage was routinely left in hematoma cavity for a one day. Independent variables selected for the analysis were related to various aspects of patient management, including IFA. Two dependent variables were chosen as measure of clinical course: the rate of hematoma recurrence (RHR) and neurological status at discharge from hospital expressed in points of Glasgow Outcome Scale (GOS). Univariate and multivariate regression analyses were performed. Hematoma recurrence with subsequent evacuation occurred in 7 (15%) patients. Univariate regression analysis revealed that length of IFA after surgery influenced both dependent variables: RHR (p = 0.045) and GOS (p = 0.023). Multivariate regression performed by backward elimination method confirmed that IFA is a sole independent factor influencing RHR. Post hoc dichotomous division of patients revealed that those receiving at least 2000 ml/day over 3 day period revealed lower RHR than the group with less intensive IFA. (p = 0.031). Conclusions/Significance: IFA has been found to be a sole factor influencing both: RHR and GOS. Based on those results we may recommend administration of at least 2000 ml per 3 days post-operatively to decrease the risk of hematoma recurrence.	[Janowski, Miroslaw; Kunert, Przemyslaw] Med Univ Warsaw, Dept Neurosurg, Warsaw, Poland; [Janowski, Miroslaw] Polish Acad Sci, NeuroRepair Dept, Mossakowski Med Res Ctr, Warsaw, Poland	Medical University of Warsaw; Polish Academy of Sciences; Mossakowski Medical Research Institute of the Polish Academy of Sciences	Janowski, M (corresponding author), Med Univ Warsaw, Dept Neurosurg, Warsaw, Poland.	mjanows1@jhmi.edu		Kunert, Przemyslaw/0000-0002-0583-9505; Janowski, Miroslaw/0000-0001-5261-7975				Abouzari M, 2007, NEUROSURGERY, V61, P794, DOI 10.1227/01.NEU.0000298908.94129.67; Gastone P, 2004, NEUROL INDIA, V52, P475; Han HJ, 2009, J KOREAN NEUROSURG S, V46, P87, DOI 10.3340/jkns.2009.46.2.87; Hoff R, 2009, STROKE, V40, P2575, DOI 10.1161/STROKEAHA.108.538116; Horn EM, 2006, SURG NEUROL, V65, P150, DOI 10.1016/j.surneu.2005.05.030; Ishfaq A, 2009, JCPSP-J COLL PHYSICI, V19, P492, DOI 08.2009/JCPSP.492495; Kasuya H, 2003, STROKE, V34, P956, DOI 10.1161/01.STR.0000064321.10700.63; Ko BS, 2008, J KOREAN NEUROSURG S, V43, P11, DOI 10.3340/jkns.2008.43.1.11; Komotar RJ, 2010, NEUROSURGERY, V66, pN15, DOI 10.1227/01.neu.0000367840.82764.3a; Kurabe S, 2010, ACTA NEUROCHIR WIEN; Lee JY, 2004, SURG NEUROL, V61, P523, DOI 10.1016/j.surneu.2003.10.026; Lega BC, 2009, J NEUROSURG; Mondorf Y, 2009, BRIT J NEUROSURG, V23, P612, DOI 10.3109/02688690903370297; Moskala M, 2007, MICROSC MICROANAL, V13, P211, DOI 10.1017/S1431927607070286; Santarius T, 2008, BRIT J NEUROSURG, V22, P529, DOI 10.1080/02688690802195381; Stanisic M, 2005, ACTA NEUROCHIR, V147, P1249, DOI 10.1007/s00701-005-0616-1; Taussky P, 2008, BRIT J NEUROSURG, V22, P279, DOI 10.1080/02688690701818885; Torihashi K, 2008, NEUROSURGERY, V63, P1125, DOI 10.1227/01.NEU.0000335782.60059.17; Weigel R, 2003, J NEUROL NEUROSUR PS, V74, P937, DOI 10.1136/jnnp.74.7.937; Yamamoto H, 2003, J NEUROSURG, V98, P1217, DOI 10.3171/jns.2003.98.6.1217	20	9	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2012	7	4							e35634	10.1371/journal.pone.0035634	http://dx.doi.org/10.1371/journal.pone.0035634			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UD	22532865	Green Submitted, gold, Green Published			2022-12-25	WOS:000305339200089
J	Orgiazzi, A; Lumini, E; Nilsson, RH; Girlanda, M; Vizzini, A; Bonfante, P; Bianciotto, V				Orgiazzi, Alberto; Lumini, Erica; Nilsson, R. Henrik; Girlanda, Mariangela; Vizzini, Alfredo; Bonfante, Paola; Bianciotto, Valeria			Unravelling Soil Fungal Communities from Different Mediterranean Land-Use Backgrounds	PLOS ONE			English	Article							DNA BARCODE; BIODIVERSITY; DIVERSITY; IDENTIFICATION; INDICATOR; GRADIENT; DATABASE; ECOLOGY; REVEAL; YEASTS	Background: Fungi strongly influence ecosystem structure and functioning, playing a key role in many ecological services as decomposers, plant mutualists and pathogens. The Mediterranean area is a biodiversity hotspot that is increasingly threatened by intense land use. Therefore, to achieve a balance between conservation and human development, a better understanding of the impact of land use on the underlying fungal communities is needed. Methodology/Principal Findings: We used parallel pyrosequencing of the nuclear ribosomal ITS regions to characterize the fungal communities in five soils subjected to different anthropogenic impact in a typical Mediterranean landscape: a natural cork-oak forest, a pasture, a managed meadow, and two vineyards. Marked differences in the distribution of taxon assemblages among the different sites and communities were found. Data analyses consistently indicated a sharp distinction of the fungal community of the cork oak forest soil from those described in the other soils. Each soil showed features of the fungal assemblages retrieved which can be easily related to the above-ground settings: ectomycorrhizal phylotypes were numerous in natural sites covered by trees, but were nearly completely missing from the anthropogenic and grass-covered sites; similarly, coprophilous fungi were common in grazed sites. Conclusions/Significance: Data suggest that investigation on the below-ground fungal community may provide useful elements on the above-ground features such as vegetation coverage and agronomic procedures, allowing to assess the cost of anthropogenic land use to hidden diversity in soil. Datasets provided in this study may contribute to future searches for fungal bio-indicators as biodiversity markers of a specific site or a land-use degree.	[Orgiazzi, Alberto; Lumini, Erica; Bonfante, Paola; Bianciotto, Valeria] Natl Res Council CNR, Plant Protect Inst Turin UOS, Turin, Italy; [Orgiazzi, Alberto; Girlanda, Mariangela; Vizzini, Alfredo; Bonfante, Paola] Univ Turin, Dept Life Sci & Syst Biol, Turin, Italy; [Nilsson, R. Henrik] Univ Gothenburg, Dept Biol & Environm Sci, Gothenburg, Sweden	University of Turin; University of Gothenburg	Bianciotto, V (corresponding author), Natl Res Council CNR, Plant Protect Inst Turin UOS, Turin, Italy.	v.bianciotto@ipp.cnr.it	Bonfante, Paola/ABE-6733-2020; Nilsson, R. Henrik/A-6062-2009; LUMINI, Erica/AAR-7802-2021; LUMINI, Erica/F-8901-2013	Nilsson, R. Henrik/0000-0002-8052-0107; LUMINI, Erica/0000-0001-5864-8561; LUMINI, Erica/0000-0001-5864-8561; Vizzini, Alfredo/0000-0001-8390-6446; Bonfante, Paola/0000-0003-3576-8530; BIANCIOTTO, VALERIA/0000-0002-7409-5538	ENDURE (European Network for the Durable Exploitation of Crop Protection Strategies); IPP-CNR (Plant Protection Institute - National Research Council); SOILSINK Project (Fondo Integrativo Speciale Ricerca - FISR); FORMAS [215-2011-498]; Ministero dell'Istruzione, dell'Universita della Ricerca (MIUR); IPP-CNR	ENDURE (European Network for the Durable Exploitation of Crop Protection Strategies); IPP-CNR (Plant Protection Institute - National Research Council); SOILSINK Project (Fondo Integrativo Speciale Ricerca - FISR); FORMAS(Swedish Research Council Formas); Ministero dell'Istruzione, dell'Universita della Ricerca (MIUR)(Ministry of Education, Universities and Research (MIUR)); IPP-CNR	VB's research was funded by ENDURE (European Network for the Durable Exploitation of Crop Protection Strategies) Project and IPP-CNR (Plant Protection Institute - National Research Council) (Biodiversity Projects-Torino). PB's research was funded by the SOILSINK Project (Fondo Integrativo Speciale Ricerca - FISR). Financial support to RHN from FORMAS (grant no. 215-2011-498) is gratefully acknowledged. AO was supported by Ministero dell'Istruzione, dell'Universita della Ricerca (MIUR) and IPP-CNR grants. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abarenkov K, 2010, NEW PHYTOL, V186, P281, DOI 10.1111/j.1469-8137.2009.03160.x; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; [Anonymous], 1994, BIODIVERSITY UK ACTI; Arnolds E, 2010, FUNGAL ECOL, V3, P81, DOI 10.1016/j.funeco.2009.05.005; BACCHETTA, 2004, FITOSOCIOLOGIA, V41, P29; Barrios E, 2007, ECOL ECON, V64, P269, DOI 10.1016/j.ecolecon.2007.03.004; Bellemain E, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-189; Benson DA, 2007, NUCLEIC ACIDS RES, V35, pD21, DOI [10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkp1024, 10.1093/nar/gkw1070, 10.1093/nar/gkx1094, 10.1093/nar/gks1195, 10.1093/nar/gkr1202, 10.1093/nar/gkn723]; Blaalid R, 2012, MOL ECOL, V21, P1897, DOI 10.1111/j.1365-294X.2011.05214.x; Blaxter M, 2005, PHILOS T R SOC B, V360, P1935, DOI 10.1098/rstb.2005.1725; Boddy L., 2007, ECOLOGY SAPROTROPHIC; Brooks TM, 2006, SCIENCE, V313, P58, DOI 10.1126/science.1127609; Buee M, 2009, NEW PHYTOL, V184, P449, DOI 10.1111/j.1469-8137.2009.03003.x; Coleman M, 2010, ANOTHER KINGDOM AMAZ; Council of Europe, 2001, O J EUR COMM; Council of Europe, 1992, O J EUR COMM; Cox RL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014508; Curtis TP, 2005, SCIENCE, V309, P1331, DOI 10.1126/science.1118176; Dance A, 2008, NATURE, V455, P724, DOI 10.1038/455724a; Dumbrell AJ, 2011, NEW PHYTOL, V190, P794, DOI 10.1111/j.1469-8137.2010.03636.x; Egli S, 2011, ANN FOREST SCI, V68, P81, DOI 10.1007/s13595-010-0009-3; FELLNER R, 1990, AGR ECOSYST ENVIRON, V28, P115, DOI 10.1016/0167-8809(90)90025-9; GARDES M, 1993, MOL ECOL, V2, P113, DOI 10.1111/j.1365-294X.1993.tb00005.x; Hartmann M, 2010, J MICROBIOL METH, V83, P250, DOI 10.1016/j.mimet.2010.08.008; Hawksworth DL, 2001, MYCOL RES, V105, P1422, DOI 10.1017/S0953756201004725; Hibbett David S., 2011, Fungal Biology Reviews, V25, P38, DOI 10.1016/j.fbr.2011.01.001; Hibbett DS, 2009, NEW PHYTOL, V184, P279, DOI 10.1111/j.1469-8137.2009.03042.x; Hooper DU, 2005, ECOL MONOGR, V75, P3, DOI 10.1890/04-0922; Huse SM, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r143; Jolly N. P., 2006, SOUTH AFRICAN JOURNAL OF ENOLOGY AND VITICULTURE, V27, P15; Jonsson BG, 1999, BIODIVERS CONSERV, V8, P1417, DOI 10.1023/A:1008900309571; Jumpponen A, 2010, MOL ECOL, V19, P41, DOI 10.1111/j.1365-294X.2009.04483.x; Kirk PM, 2008, DICT FUNGI; Lagomarsino A, 2011, BIOL FERT SOILS, V47, P283, DOI 10.1007/s00374-010-0530-4; Lilleskov EA, 2001, ECOL APPL, V11, P397, DOI 10.1890/1051-0761(2001)011[0397:EFACCO]2.0.CO;2; Loureiro V, 2003, INT J FOOD MICROBIOL, V86, P23, DOI 10.1016/S0168-1605(03)00246-0; Lumini E, 2010, ENVIRON MICROBIOL, V12, P2165, DOI 10.1111/j.1462-2920.2009.02099.x; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Martin F, 2011, NEW PHYTOL, V190, P818, DOI 10.1111/j.1469-8137.2011.03688.x; Medail F, 1999, CONSERV BIOL, V13, P1510, DOI 10.1046/j.1523-1739.1999.98467.x; Mello A, 2011, MYCOLOGIA, V103, P1184, DOI 10.3852/11-027; Mueller GM, 2007, BIODIVERS CONSERV, V16, P1, DOI 10.1007/s10531-006-9117-7; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Nacke H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017000; Newton AC, 2003, BIOL CONSERV, V111, P11, DOI 10.1016/S0006-3207(02)00243-4; Nilsson RH, 2010, FUNGAL ECOL, V3, P284, DOI 10.1016/j.funeco.2010.05.002; Novacek MJ, 2001, P NATL ACAD SCI USA, V98, P5466, DOI 10.1073/pnas.091093698; O'Brien HE, 2005, APPL ENVIRON MICROB, V71, P5544, DOI 10.1128/AEM.71.9.5544-5550.2005; Parmasto E, 2001, BR MYCOL SY, V22, P81, DOI 10.1017/CBO9780511565168.006; Pastorelli R, 2009, AGROCHIMICA, V53, P386; Podani J., 2001, SYNTAX 2000 COMPUTER; Rotheroe M, 2001, BR MYCOL SY, V22, P120, DOI 10.1017/CBO9780511565168.011; Schwarze F.W.M.R., 2004, FUNGAL STRATEGIES WO; Smith S.E., 2008, MYCORRHIZAL SYMBIOSI, V3rd ed; Tedersoo L, 2010, NEW PHYTOL, V188, P291, DOI 10.1111/j.1469-8137.2010.03373.x; Ter Braak C. J. F., 2012, CANOCO REFERENCE MAN; Unterseher M, 2011, MOL ECOL, V20, P275, DOI 10.1111/j.1365-294X.2010.04948.x; Wang Z, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019039; White T., 1990, PCR PROTOCOLS GUIDE, P315; Xu LH, 2012, SOIL BIOL BIOCHEM, V46, P26, DOI 10.1016/j.soilbio.2011.11.010	60	129	137	8	91	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2012	7	4							e34847	10.1371/journal.pone.0034847	http://dx.doi.org/10.1371/journal.pone.0034847			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UD	22536336	Green Submitted, Green Published, gold			2022-12-25	WOS:000305339200024
J	Ouna, BA; Nyambega, B; Manful, T; Helbig, C; Males, M; Fadda, A; Clayton, C				Ouna, Benard A.; Nyambega, Benson; Manful, Theresa; Helbig, Claudia; Males, Matilda; Fadda, Abeer; Clayton, Christine			Depletion of Trypanosome CTR9 Leads to Gene Expression Defects	PLOS ONE			English	Article							RNA-POLYMERASE-I; PAF1 COMPLEX; MESSENGER-RNA; TRANSCRIPTION ELONGATION; H2B UBIQUITYLATION; TUMOR-SUPPRESSOR; HISTONE H3; POLYADENYLATION; IDENTIFICATION; BRUCEI	The Paf complex of Opisthokonts and plants contains at least five subunits: Paf1, Cdc73, Rtf1, Ctr9, and Leo1. Mutations in, or loss of Paf complex subunits have been shown to cause defects in histone modification, mRNA polyadenylation, and transcription by RNA polymerase I and RNA polymerase II. We here investigated trypanosome CTR9, which is essential for trypanosome survival. The results of tandem affinity purification suggested that trypanosome CTR9 associates with homologues of Leo1 and Cdc73; genes encoding homologues of Rtf1 and Paf1 were not found. RNAi targeting CTR9 resulted in at least ten-fold decreases in 131 essential mRNAs: they included several that are required for gene expression and its control, such as those encoding subunits of RNA polymerases, exoribonucleases that target mRNA, RNA helicases and RNA-binding proteins. Simultaneously, some genes from regions subject to chromatin silencing were derepressed, possibly as a secondary effect of the loss of two proteins that are required for silencing, ISWI and NLP1.	[Ouna, Benard A.; Nyambega, Benson; Manful, Theresa; Helbig, Claudia; Males, Matilda; Fadda, Abeer; Clayton, Christine] Heidelberg Univ, Zentrum Mol Biol, DKFZ ZMBH Alliance, D-6900 Heidelberg, Germany	Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg	Clayton, C (corresponding author), Heidelberg Univ, Zentrum Mol Biol, DKFZ ZMBH Alliance, D-6900 Heidelberg, Germany.	cclayon@zmbh.uni-heidelberg.de	Nyambega, Benson/GOH-3417-2022; Clayton, Christine/K-7700-2019	Nyambega, Benson/0000-0002-0947-0354; Clayton, Christine/0000-0002-6384-0731; Fadda, Abeer/0000-0002-8489-1335	Deutsche Forschungsgemeinschaft (German Research Foundation) [SFB544, Cl112/9]; Bundesministerium fur Bildung und Forschung (BMBF, Federal Ministry of Education and Research); Deutsches Akademisches Austauschdienst (German Academic Exchange Service)	Deutsche Forschungsgemeinschaft (German Research Foundation)(German Research Foundation (DFG)); Bundesministerium fur Bildung und Forschung (BMBF, Federal Ministry of Education and Research)(Federal Ministry of Education & Research (BMBF)); Deutsches Akademisches Austauschdienst (German Academic Exchange Service)	This work was supported by Deutsche Forschungsgemeinschaft (German Research Foundation), SFB544 and Cl112/9; Bundesministerium fur Bildung und Forschung (BMBF, Federal Ministry of Education and Research), Sysmo project "The silicon trypanosome"; and Deutsches Akademisches Austauschdienst (German Academic Exchange Service). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alibu VP, 2005, MOL BIOCHEM PARASIT, V139, P75, DOI 10.1016/j.molbiopara.2004.10.002; Alsford S, 2011, GENOME RES, V21, P915, DOI 10.1101/gr.115089.110; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Biebinger S, 1996, NUCLEIC ACIDS RES, V24, P1202, DOI 10.1093/nar/24.7.1202; Colasante C, 2006, EUKARYOT CELL, V5, P1194, DOI 10.1128/EC.00096-06; Crisucci EM, 2011, EUKARYOT CELL, V10, P712, DOI 10.1128/EC.05013-11; Das A, 2005, MOL CELL BIOL, V25, P7314, DOI 10.1128/MCB.25.16.7314-7322.2005; Das A, 2008, EUKARYOT CELL, V7, P429, DOI 10.1128/EC.00297-07; Das A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006959; Dermody JL, 2010, J BIOL CHEM, V285, P33671, DOI 10.1074/jbc.M110.140764; Estevez AM, 2003, J BIOL CHEM, V278, P34943, DOI 10.1074/jbc.M305333200; Estevez AM, 2001, EMBO J, V20, P3831, DOI 10.1093/emboj/20.14.3831; Fernandez-Moya SM, 2010, WIRES RNA, V1, P34, DOI 10.1002/wrna.6; Gunzl A, 2003, EUKARYOT CELL, V2, P542, DOI 10.1128/EC.2.3.542-551.2003; Haanstra JR, 2011, MOL MICROBIOL, V79, P94, DOI 10.1111/j.1365-2958.2010.07435.x; Ip JY, 2011, GENOME RES, V21, P390, DOI 10.1101/gr.111070.110; Jaehning JA, 2010, BBA-GENE REGUL MECH, V1799, P379, DOI 10.1016/j.bbagrm.2010.01.001; Kim J, 2011, METHODS, V54, P331, DOI 10.1016/j.ymeth.2011.03.009; Kim J, 2010, CELL, V140, P491, DOI 10.1016/j.cell.2009.12.050; Kolev NG, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001090; Kramer S, 2011, TRENDS PARASITOL, V27, P23, DOI 10.1016/j.pt.2010.06.011; Langenbacher AD, 2011, DEV BIOL, V353, P19, DOI 10.1016/j.ydbio.2011.02.011; Lee JH, 2010, MOL CELL BIOL, V30, P5502, DOI 10.1128/MCB.00966-10; Manful T, 2011, RNA, V17, P2039, DOI 10.1261/rna.2837311; MATTHEWS KR, 1994, GENE DEV, V8, P491, DOI 10.1101/gad.8.4.491; Mayer A, 2010, NAT STRUCT MOL BIOL, V17, P1272, DOI 10.1038/nsmb.1903; Michaeli S, 2011, FUTURE MICROBIOL, V6, P459, DOI [10.2217/fmb.11.20, 10.2217/FMB.11.20]; Mueller CL, 2002, MOL CELL BIOL, V22, P1971, DOI 10.1128/MCB.22.7.1971-1980.2002; Mueller JE, 2006, GENETICS, V173, P557, DOI 10.1534/genetics.106.055400; Narayanan MS, 2011, NUCLEIC ACIDS RES, V39, P2018, DOI 10.1093/nar/gkq950; Nguyen CT, 2010, DEV BIOL, V341, P167, DOI 10.1016/j.ydbio.2010.02.020; Nordick K, 2008, EUKARYOT CELL, V7, P1158, DOI 10.1128/EC.00434-07; Oesterreich FC, 2011, TRENDS CELL BIOL, V21, P328, DOI 10.1016/j.tcb.2011.03.002; Oh S, 2004, PLANT CELL, V16, P2940, DOI 10.1105/tpc.104.026062; Panicker LM, 2010, ENDOCR-RELAT CANCER, V17, P513, DOI 10.1677/ERC-09-0272; Park SH, 2012, MOL BIOCHEM PARASIT, V181, P29, DOI 10.1016/j.molbiopara.2011.09.009; Penheiter KL, 2005, MOL CELL, V20, P213, DOI 10.1016/j.molcel.2005.08.023; Peterson ML, 2011, WIRES RNA, V2, P92, DOI 10.1002/wrna.36; Pinto PAB, 2011, EMBO J, V30, P2431, DOI 10.1038/emboj.2011.156; Puig O, 2001, METHODS, V24, P218, DOI 10.1006/meth.2001.1183; Rigbolt KTG, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001570; Rozenblatt-Rosen O, 2009, P NATL ACAD SCI USA, V106, P755, DOI 10.1073/pnas.0812023106; Rudenko G, 2010, ESSAYS BIOCHEM, V48, P201, DOI [10.1042/BSE0480201, 10.1042/bse0480201]; Schwede A, 2009, NUCLEIC ACIDS RES, V37, P5511, DOI 10.1093/nar/gkp571; Siegel TN, 2009, GENE DEV, V23, P1063, DOI 10.1101/gad.1790409; Siegel TN, 2010, NUCLEIC ACIDS RES, V38, P4946, DOI 10.1093/nar/gkq237; Solnoki K, 2011, MOL BIOCH P IN PRESS; Squazzo SL, 2002, EMBO J, V21, P1764, DOI 10.1093/emboj/21.7.1764; Stanne TM, 2011, EUKARYOT CELL, V10, P964, DOI 10.1128/EC.05048-11; Tomson BN, 2011, GENETICS, V188, P273, DOI 10.1534/genetics.111.128645; ULLU E, 1993, MOL CELL BIOL, V13, P720, DOI 10.1128/MCB.13.1.720; Warner MH, 2007, MOL CELL BIOL, V27, P6103, DOI 10.1128/MCB.00772-07; Wurst M, 2012, MOL MICROBI IN PRESS; Yang YJ, 2010, NUCLEIC ACIDS RES, V38, P382, DOI 10.1093/nar/gkp991; Zeiner GM, 2003, EUKARYOT CELL, V2, P222, DOI 10.1128/EC.2.2.222-230.2003; Zhang YF, 2010, J BIOL CHEM, V285, P14152, DOI 10.1074/jbc.M110.115220; Zhang YF, 2009, P NATL ACAD SCI USA, V106, P2153, DOI 10.1073/pnas.0812939106	57	16	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2012	7	4							e34256	10.1371/journal.pone.0034256	http://dx.doi.org/10.1371/journal.pone.0034256			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UD	22532828	gold, Green Published, Green Submitted			2022-12-25	WOS:000305339200011
J	Monk, J; Ierodiaconou, D; Harvey, E; Rattray, A; Versace, VL				Monk, Jacquomo; Ierodiaconou, Daniel; Harvey, Euan; Rattray, Alex; Versace, Vincent L.			Are We Predicting the Actual or Apparent Distribution of Temperate Marine Fishes?	PLOS ONE			English	Article							SPECIES DISTRIBUTION MODELS; UNDERWATER VIDEO STATIONS; HABITAT-SUITABILITY; RELATIVE DENSITY; REEF FISHES; PERFORMANCE; BIODIVERSITY; BEHAVIOR; SYSTEM; DETECTABILITY	Planning for resilience is the focus of many marine conservation programs and initiatives. These efforts aim to inform conservation strategies for marine regions to ensure they have inbuilt capacity to retain biological diversity and ecological function in the face of global environmental change - particularly changes in climate and resource exploitation. In the absence of direct biological and ecological information for many marine species, scientists are increasingly using spatially-explicit, predictive-modeling approaches. Through the improved access to multibeam sonar and underwater video technology these models provide spatial predictions of the most suitable regions for an organism at resolutions previously not possible. However, sensible-looking, well-performing models can provide very different predictions of distribution depending on which occurrence dataset is used. To examine this, we construct species distribution models for nine temperate marine sedentary fishes for a 25.7 km(2) study region off the coast of southeastern Australia. We use generalized linear model (GLM), generalized additive model (GAM) and maximum entropy (MAXENT) to build models based on co-located occurrence datasets derived from two underwater video methods (i.e. baited and towed video) and fine-scale multibeam sonar based seafloor habitat variables. Overall, this study found that the choice of modeling approach did not considerably influence the prediction of distributions based on the same occurrence dataset. However, greater dissimilarity between model predictions was observed across the nine fish taxa when the two occurrence datasets were compared (relative to models based on the same dataset). Based on these results it is difficult to draw any general trends in regards to which video method provides more reliable occurrence datasets. Nonetheless, we suggest predictions reflecting the species apparent distribution (i.e. a combination of species distribution and the probability of detecting it). Consequently, we also encourage researchers and marine managers to carefully interpret model predictions.	[Monk, Jacquomo; Ierodiaconou, Daniel; Rattray, Alex] Deakin Univ, Fac Sci & Technol, Sch Life & Environm Sci, Warrnambool, Vic, Australia; [Harvey, Euan] Univ Western Australia, Sch Plant Biol, Oceans Inst M470, Crawley, WA, Australia; [Versace, Vincent L.] Deakin Univ, Sch Informat Syst, Fac Business & Law, Warrnambool, Vic, Australia	Deakin University; University of Western Australia; Deakin University	Monk, J (corresponding author), Deakin Univ, Fac Sci & Technol, Sch Life & Environm Sci, Warrnambool, Vic, Australia.	jacquomo.monk@deakin.edu.au	Ierodiaconou, Daniel A/B-9915-2008; Rattray, Alex J/I-8172-2012; Harvey, Euan/B-2896-2011; Monk, Jacquomo/C-6856-2011; Versace, Vincent/AAL-6418-2021	Harvey, Euan/0000-0002-9069-4581; Monk, Jacquomo/0000-0002-1874-0619; Versace, Vincent/0000-0002-8514-1763; Ierodiaconou, Daniel/0000-0002-7832-4801; Rattray, Alex/0000-0002-8591-6688	National Heritage Trust/Caring for our Country and Parks Victoria as part of the Victorian Marine Habitat Mapping Project	National Heritage Trust/Caring for our Country and Parks Victoria as part of the Victorian Marine Habitat Mapping Project	This work was supported by the National Heritage Trust/Caring for our Country and Parks Victoria as part of the Victorian Marine Habitat Mapping Project. The funders had no role in data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Aswani S, 2006, ENVIRON CONSERV, V33, P263, DOI 10.1017/S0376892906003183; Austin M, 2007, ECOL MODEL, V200, P1, DOI 10.1016/j.ecolmodel.2006.07.005; BARRETT NS, 1995, MAR FRESHWATER RES, V46, P853, DOI 10.1071/MF9950853; Bozec YM, 2011, MAR BIOL, V158, P969, DOI 10.1007/s00227-011-1623-9; Breiman L, 2001, STAT SCI, V16, P199, DOI 10.1214/ss/1009213726; Cappo M, 2004, J EXP MAR BIOL ECOL, V302, P123, DOI 10.1016/j.jembe.2003.10.006; Cappo M, 2001, USE BAITED REMOTE UN, P63; Colton MA, 2010, MAR ECOL PROG SER, V400, P19, DOI 10.3354/meps08377; Dormann CF, 2007, GLOBAL ECOL BIOGEOGR, V16, P774, DOI 10.1111/j.1466-8238.2007.00344.x; Edgar G, 2000, AUSTR MARINE LIFE PL; Elith J, 2008, J ANIM ECOL, V77, P802, DOI 10.1111/j.1365-2656.2008.01390.x; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Engler R, 2004, J APPL ECOL, V41, P263, DOI 10.1111/j.0021-8901.2004.00881.x; Fielding AH, 1997, ENVIRON CONSERV, V24, P38, DOI 10.1017/S0376892997000088; Gibson L, 2007, DIVERS DISTRIB, V13, P704, DOI 10.1111/j.1472-4642.2007.00365.x; Godo OR, 1997, ICES J MAR SCI, V54, P273, DOI 10.1006/jmsc.1996.0167; Gomon M., 2008, FISHES AUSTR S COAST; Guisan A, 2000, ECOL MODEL, V135, P147, DOI 10.1016/S0304-3800(00)00354-9; Harris PT, 2009, OCEAN COAST MANAGE, V52, P22, DOI 10.1016/j.ocecoaman.2008.09.009; Harvey E, 1995, MAR TECHNOL SOC J, V29, P10; Harvey ES, 1998, MAR TECHNOL SOC J, V32, P3; Harvey ES, 2007, MAR ECOL PROG SER, V350, P245, DOI 10.3354/meps07192; HASTIE T, 2008, GAM GEN ADDITIVE MOD; Hirzel AH, 2001, ECOL MODEL, V145, P111, DOI 10.1016/S0304-3800(01)00396-9; Ierodiaconou D, 2007, J SPAT SCI, V52, P93, DOI 10.1080/14498596.2007.9635105; Jackson JBC, 2001, SCIENCE, V293, P629, DOI 10.1126/science.1059199; Jordan A, 2005, AQUAT CONSERV, V15, P51, DOI 10.1002/aqc.657; Kadmon R, 2003, ECOL APPL, V13, P853, DOI 10.1890/1051-0761(2003)013[0853:ASAOFA]2.0.CO;2; Kery M, 2008, COMMUNITY ECOL, V9, P207, DOI 10.1556/ComEc.9.2008.2.10; Kery M, 2010, J BIOGEOGR, V37, P1851, DOI 10.1111/j.1365-2699.2010.02345.x; Kulbicki M, 1999, AQUAT LIVING RESOUR, V12, P315, DOI 10.1016/S0990-7440(99)00116-3; Langlois TJ, 2012, GLOBAL ECOL BIOGEOGR, V21, P886, DOI 10.1111/j.1466-8238.2011.00734.x; Leathwick JR, 2006, ECOL MODEL, V199, P188, DOI 10.1016/j.ecolmodel.2006.05.022; Lobo JM, 2008, GLOBAL ECOL BIOGEOGR, V17, P145, DOI 10.1111/j.1466-8238.2007.00358.x; MacKenzie DI, 2002, ECOLOGY, V83, P2248, DOI 10.1890/0012-9658(2002)083[2248:ESORWD]2.0.CO;2; MacNeill MA, 2008, MAR ECOL PROG SER, V367, P249, DOI 10.3354/meps07580; Moisen GG, 2002, ECOL MODEL, V157, P209, DOI 10.1016/S0304-3800(02)00197-7; Monk J, 2011, CONT SHELF RES, V31, pS17, DOI 10.1016/j.csr.2010.02.012; Monk J, 2010, MAR ECOL PROG SER, V420, P157, DOI 10.3354/meps08858; Moore CH, 2010, MAR BIOL, V157, P2717, DOI 10.1007/s00227-010-1531-4; Moore CH, 2009, ICES J MAR SCI, V66, P2068, DOI 10.1093/icesjms/fsp205; Murphy HM, 2010, MAR FRESHWATER RES, V61, P236, DOI 10.1071/MF09068; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Peterson AT, 2008, ECOL MODEL, V213, P63, DOI 10.1016/j.ecolmodel.2007.11.008; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Pittman SJ, 2009, J COASTAL RES, V25, P27, DOI [10.2112/SI53-004.1, 10.2112/S153-004.1]; Popper AN, 2009, J FISH BIOL, V75, P455, DOI 10.1111/j.1095-8649.2009.02319.x; R Core Development Team, 2008, R LANG ENV STAT COMP; Ready J, 2010, ECOL MODEL, V221, P467, DOI 10.1016/j.ecolmodel.2009.10.025; Roubicek AJ, 2010, ECOL MODEL, V221, P2280, DOI 10.1016/j.ecolmodel.2010.06.021; Sara G, 2007, MAR ECOL PROG SER, V331, P243, DOI 10.3354/meps331243; Segurado P, 2004, J BIOGEOGR, V31, P1555, DOI 10.1111/j.1365-2699.2004.01076.x; Sergio C, 2007, BIOL CONSERV, V135, P341, DOI 10.1016/j.biocon.2006.10.018; Stoner AW, 2008, CAN J FISH AQUAT SCI, V65, P1230, DOI 10.1139/F08-032; Stoner AW, 2007, J SEA RES, V57, P137, DOI 10.1016/j.seares.2006.08.005; Thomsen Bjarti, 2010, P143, DOI 10.1002/9780813810966.ch6; Tsoar A, 2007, DIVERS DISTRIB, V13, P397, DOI 10.1111/j.1472-4642.2007.00346.x; Tyre AJ, 2003, ECOL APPL, V13, P1790, DOI 10.1890/02-5078; Vanderklift M. A., 2000, Pacific Conservation Biology, V6, P152; VanDerWal J, 2009, ECOL MODEL, V220, P589, DOI 10.1016/j.ecolmodel.2008.11.010; Ward G, 2009, BIOMETRICS, V65, P554, DOI 10.1111/j.1541-0420.2008.01116.x; Ward TJ, 1999, ECOL APPL, V9, P691; Warren DL, 2008, EVOLUTION, V62, P2868, DOI 10.1111/j.1558-5646.2008.00482.x; Watson D.L, 2006, THESIS U W AUSTR; Watson DL, 2010, MAR BIOL, V157, P1237, DOI 10.1007/s00227-010-1404-x; Watson DL, 2005, MAR BIOL, V148, P415, DOI 10.1007/s00227-005-0090-6; Willis TJ, 2000, MAR FRESHWATER RES, V51, P755, DOI 10.1071/MF00010; Willis TJ, 2006, J EXP MAR BIOL ECOL, V331, P108, DOI 10.1016/j.jembe.2005.10.003; Willis TJ, 2000, MAR ECOL PROG SER, V198, P249, DOI 10.3354/meps198249; Wilson MFJ, 2007, MAR GEOD, V30, P3, DOI 10.1080/01490410701295962; Wintle BA, 2005, J WILDLIFE MANAGE, V69, P905, DOI 10.2193/0022-541X(2005)069[0905:EADWDI]2.0.CO;2; Wisz Mary S., 2009, BMC Ecology, V9, P8, DOI 10.1186/1472-6785-9-8; Zacharias MA, 2005, CONSERV BIOL, V19, P86, DOI 10.1111/j.1523-1739.2005.00148.x	74	33	33	0	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2012	7	4							e34558	10.1371/journal.pone.0034558	http://dx.doi.org/10.1371/journal.pone.0034558			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TL	22536325	Green Published, Green Submitted, gold			2022-12-25	WOS:000305336200007
J	Perry, LE; Pannell, JR; Dorken, ME				Perry, Laura E.; Pannell, John R.; Dorken, Marcel E.			Two's Company, Three's a Crowd: Experimental Evaluation of the Evolutionary Maintenance of Trioecy in Mercurialis annua (Euphorbiaceae)	PLOS ONE			English	Article							PACHYCEREUS-PRINGLEI CACTACEAE; INBREEDING DEPRESSION; POLLEN LIMITATION; SEXUAL SYSTEMS; ANNUAL PLANT; ANDRODIOECY; DIOECY; POPULATION; GYNODIOECY; ALLOCATION	Trioecy is an uncommon sexual system in which males, females, and hermaphrodites co-occur as three clearly different gender classes. The evolutionary stability of trioecy is unclear, but would depend on factors such as hermaphroditic sex allocation and rates of outcrossing vs. selfing. Here, trioecious populations of Mercurialis annua are described for the first time. We examined the frequencies of females, males and hermaphrodites across ten natural populations and evaluated the association between the frequency of females and plant densities. Previous studies have shown that selfing rates in this species are density-dependent and are reduced in the presence of males, which produce substantially more pollen than hermaphrodites. Accordingly, we examined the evolutionary stability of trioecy using an experiment in which we (a) indirectly manipulated selfing rates by altering plant densities and the frequency of males in a fully factorial manner across 20 experimental plots and (b) examined the effect of these manipulations on the frequency of the three sex phenotypes in the next generation of plants. In the parental generation, we measured the seed and pollen allocations of hermaphrodites and compared them with allocations by unisexual plants. In natural populations, females occurred at higher frequencies in denser patches, a finding consistent with our expectations. Under our experimental conditions, however, no combination of plant densities and male frequencies was associated with increased frequencies of females. Our results suggest that the factors that regulate female frequencies in trioecious populations of M. annua are independent of those regulating male frequencies (density), and that the stable co-existence of all three sex phenotypes within populations is unlikely.	[Perry, Laura E.; Dorken, Marcel E.] Trent Univ, Dept Biol, Peterborough, ON K9J 7B8, Canada; [Pannell, John R.] Univ Oxford, Dept Plant Sci, Oxford, England; [Pannell, John R.] Univ Lausanne, Dept Ecol & Evolut, Lausanne, Switzerland	Trent University; University of Oxford; University of Lausanne	Perry, LE (corresponding author), Trent Univ, Dept Biol, Peterborough, ON K9J 7B8, Canada.	marceldorken@trentu.ca		Pannell, John/0000-0002-0098-7074	Natural Sciences and Engineering Research Council of Canada (NSERC)	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	The work was funded by the Natural Sciences and Engineering Research Council of Canada (NSERC) through a Discovery Grant to MED. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashman T. L., 2006, ECOLOGY EVOLUTION FL, P204; Bailey MF, 2007, OIKOS, V116, P1609, DOI 10.1111/j.0030-1299.2007.15315.x; Bates D., 2011, PACKAGE LME4 LINEAR, V1; CHARLESWORTH B, 1978, AM NAT, V112, P975, DOI 10.1086/283342; Charlesworth D, 2002, HEREDITY, V88, P94, DOI 10.1038/sj.hdy.6800016; Charlesworth D., 1999, GENDER SEXUAL DIMORP, P33, DOI [10.1007/978-3-662-03908-3_2, DOI 10.1007/978-3-662-03908-3_2]; CHARNOV E L, 1982; Crawley MJ., 2007, R BOOK; Darwin C, 1877, EFFECTS CROSS SELF F; DELPH LF, 1990, ECOLOGY, V71, P1342, DOI 10.2307/1938271; Delph LF, 2007, TRENDS ECOL EVOL, V22, P17, DOI 10.1016/j.tree.2006.09.013; Dorken ME, 2008, AM NAT, V171, P824, DOI 10.1086/587524; Dorken ME, 2008, EVOLUTION, V62, P971, DOI 10.1111/j.1558-5646.2008.00336.x; Dorken ME, 2009, CURR BIOL, V19, P620, DOI 10.1016/j.cub.2009.03.042; Durand B, 1963, ANN SCI NAT BOT BIOL, V12, P579, DOI DOI 10.1080/01811797.1992.10824974; Eppley SM, 2009, HEREDITY, V102, P600, DOI 10.1038/hdy.2009.21; Eppley SM, 2007, EVOLUTION, V61, P2349, DOI 10.1111/j.1558-5646.2007.00195.x; Fleming TH, 1998, EVOL ECOL, V12, P279, DOI 10.1023/A:1006548132606; FLEMING TH, 1994, AM J BOT, V81, P858, DOI 10.2307/2445767; Hesse E, 2011, J ECOL, V99, P1531, DOI 10.1111/j.1365-2745.2011.01880.x; LLOYD DG, 1975, GENETICA, V45, P325, DOI 10.1007/BF01508307; LLOYD DG, 1974, HEREDITY, V32, P11, DOI 10.1038/hdy.1974.2; Lopez S, 2003, J EVOLUTION BIOL, V16, P1177, DOI 10.1046/j.1420-9101.2003.00622.x; MAURICE S, 1995, OIKOS, V74, P55, DOI 10.2307/3545674; Obbard DJ, 2006, AM NAT, V167, P354, DOI 10.1086/499546; Pannell J, 1997, BIOL J LINN SOC, V61, P95, DOI 10.1006/bijl.1996.0117; Pannell J, 1997, HEREDITY, V78, P50, DOI 10.1038/hdy.1997.6; Pannell J, 1997, J ECOL, V85, P57, DOI 10.2307/2960627; Pannell JR, 2008, GENET RES, V90, P73, DOI 10.1017/S0016672307008981; Pannell JR, 2008, INT J PLANT SCI, V169, P129, DOI 10.1086/523360; Pannell JR, 2002, ANNU REV ECOL SYST, V33, P397, DOI 10.1146/annurev.ecolsys.33.010802.150419; Pannell JR, 2004, BIOL J LINN SOC, V82, P547, DOI 10.1111/j.1095-8312.2004.00340.x; Pannell JR, 2000, PHILOS T R SOC B, V355, P1851, DOI 10.1098/rstb.2000.0740; PINHEIRO JC, 2011, NLME LINEAR NONLINEA, V3, P1, DOI DOI 10.1371/J0URNAL.P0NE.0018860; Pujol B, 2009, P NATL ACAD SCI USA, V106, P15379, DOI 10.1073/pnas.0902257106; R Development Core Team, 2009, R FDN STAT COMP; RENNER SS, 1995, AM J BOT, V82, P596, DOI 10.2307/2445418; Sokal RR, 1995, BIOMETRY; Tutin T.G., 1968, FLORA EUROPAEA, V2, P368; Venables W.N., 2002, MODERN APPL STAT S, V4th ed, DOI DOI 10.1007/978-0-387-21706-2; Webb C.J., 1999, GENDER SEXUAL DIMORP, P61, DOI DOI 10.1007/978-3-662-03908-3_3; Weiblen GD, 2000, AM NAT, V155, P46, DOI 10.1086/303303; Whitlock MC, 1997, GENETICS, V146, P427; Wolf DE, 2004, AM NAT, V163, P122, DOI 10.1086/380493; Wright S, 1940, AM NAT, V74, P232, DOI 10.1086/280891	45	7	7	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2012	7	4							e35597	10.1371/journal.pone.0035597	http://dx.doi.org/10.1371/journal.pone.0035597			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TL	22532862	gold, Green Published, Green Submitted			2022-12-25	WOS:000305336200061
J	Emmert-Streib, F				Emmert-Streib, Frank			Limitations of Gene Duplication Models: Evolution of Modules in Protein Interaction Networks	PLOS ONE			English	Article							TRANSCRIPTIONAL REGULATORY NETWORK; COMMUNITY STRUCTURE; GENOME DUPLICATION; MODULARITY; DYNAMICS; BIOLOGY; IDENTIFICATION; COMPLEXITY; EMERGENCE; ALGORITHM	It has been generally acknowledged that the module structure of protein interaction networks plays a crucial role with respect to the functional understanding of these networks. In this paper, we study evolutionary aspects of the module structure of protein interaction networks, which forms a mesoscopic level of description with respect to the architectural principles of networks. The purpose of this paper is to investigate limitations of well known gene duplication models by showing that these models are lacking crucial structural features present in protein interaction networks on a mesoscopic scale. This observation reveals our incomplete understanding of the structural evolution of protein networks on the module level.	Queens Univ Belfast, Sch Med Dent & Biomed Sci, Computat Biol & Machine Learning Lab, Ctr Canc Res & Cell Biol, Belfast, Antrim, North Ireland	Queens University Belfast	Emmert-Streib, F (corresponding author), Queens Univ Belfast, Sch Med Dent & Biomed Sci, Computat Biol & Machine Learning Lab, Ctr Canc Res & Cell Biol, Belfast, Antrim, North Ireland.	v@bio-complexity.com	Emmert-Streib, Frank/G-8099-2011; Emmert-Streib, Frank/AAF-2878-2020	Emmert-Streib, Frank/0000-0003-0745-5641; Emmert-Streib, Frank/0000-0003-0745-5641	Department for Employment and Learning through its "Strengthening the all-Island Research Base" initiative	Department for Employment and Learning through its "Strengthening the all-Island Research Base" initiative	Parts of this project are supported by the Department for Employment and Learning through its "Strengthening the all-Island Research Base" initiative. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; [Anonymous], ANAL COMPLEX NETWORK; [Anonymous], HDB GRAPHS NETWORKS; [Anonymous], TAXONOMY NETWORKS AR; [Anonymous], [No title captured]; [Anonymous], NUCL ACIDS RES; [Anonymous], MULTIVARIATE ANAL; Babu MM, 2004, CURR OPIN STRUC BIOL, V14, P283, DOI 10.1016/j.sbi.2004.05.004; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Berg J, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-51; Breitkreutz BJ, 2008, NUCLEIC ACIDS RES, V36, pD637, DOI 10.1093/nar/gkm1001; Cerami E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008918; Chung F, 2003, J COMPUT BIOL, V10, P677, DOI 10.1089/106652703322539024; Ciliberti S, 2007, PLOS COMPUT BIOL, V3, P164, DOI 10.1371/journal.pcbi.0030015; Csardi G, 2008, IGRAPH PACKAGE; Danon L, 2005, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2005/09/P09008; Dehal P, 2005, PLOS BIOL, V3, P1700, DOI 10.1371/journal.pbio.0030314; Dehmer M, 2011, INFORM SCIENCES, V181, P57, DOI 10.1016/j.ins.2010.08.041; Dehmer M, 2009, J CHEM INF MODEL, V49, P1655, DOI 10.1021/ci900060x; del Sol A, 2007, PLOS COMPUT BIOL, V3, P2446, DOI 10.1371/journal.pcbi.0030239; Dobzhansky T., 1937; Durrett R, 2006, RANDOM GRAPH DYNAMIC; Emmert-Streib F, 2006, J COMPUT BIOL, V13, P1503, DOI 10.1089/cmb.2006.13.1503; Emmert-Streib F, 2011, WIRES SYST BIOL MED, V3, P379, DOI 10.1002/wsbm.134; Emmert-Streib F, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-35; Emmert-Streib F, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-237; Evlampiev K, 2007, BMC SYST BIOL, V1, DOI 10.1186/1752-0509-1-49; Felsenstein J., 2004, INFERRING PHYLOGENIE; Fernandez E, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.27; Fortunato S, 2010, PHYS REP, V486, P75, DOI 10.1016/j.physrep.2009.11.002; Futuyma D. J., 2005, EVOLUTION; Gould SJ, 2002, STRUCTURE EVOLUTIONA; Hallinan J, 2004, BIOSYSTEMS, V74, P51, DOI 10.1016/j.biosystems.2004.02.004; HIGGINS DG, 1988, GENE, V73, P237, DOI 10.1016/0378-1119(88)90330-7; Hoaglin D.C., 1983, UNDERSTANDING ROBUST; Holm L, 1996, SCIENCE, V273, P595, DOI 10.1126/science.273.5275.595; Ispolatov I, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.061911; Ispolatov I, 2006, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2006/09/P09014; Izenman AJ, 2008, SPRINGER TEXTS STAT, P1, DOI 10.1007/978-0-387-78189-1_1; Kim WK, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000232; Klebanov L, 2007, BIOL DIRECT, V2, DOI 10.1186/1745-6150-2-9; Koonin EV, 2006, CURR OPIN BIOTECH, V17, P481, DOI 10.1016/j.copbio.2006.08.003; Koonin EV., 2003, SEQUENCE EVOLUTION F; Lancichinetti A, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.046110; Lehman E. L., 2005, TESTING STAT HYPOTHE, V3rd; Levy ED, 2008, CURR OPIN STRUC BIOL, V18, P349, DOI 10.1016/j.sbi.2008.03.003; Lozano S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001892; Lynch M, 2001, GENETICS, V159, P1789; Lynch M, 2007, ORIGINS GENOME ARCHI; Ma HW, 2004, NUCLEIC ACIDS RES, V32, P6643, DOI 10.1093/nar/gkh1009; Mayr E, 1976, EVOLUTION DIVERSITY; MCQUITTY LL, 1966, EDUC PSYCHOL MEAS, V26, P825, DOI 10.1177/001316446602600402; Middendorf M., 2005, P NATL ACAD SCI USA, V102, p3192 3197, DOI DOI 10.1073/pnas.0409515102; MOWSHOWITZ A, 1968, B MATH BIOPHYS, V30, P175, DOI 10.1007/BF02476948; MOWSHOWITZ A, 1968, B MATH BIOPHYS, V30, P225, DOI 10.1007/BF02476692; MUSHEGIAN A, 2007, FDN COMP GENOMICS; Newman MEJ, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.036104; Newman MEJ, 2006, P NATL ACAD SCI USA, V103, P8577, DOI 10.1073/pnas.0601602103; Newman MEJ, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.066133; Newman MEJ, 2001, P NATL ACAD SCI USA, V98, P404, DOI 10.1073/pnas.021544898; Otto SP, 2000, ANNU REV GENET, V34, P401, DOI 10.1146/annurev.genet.34.1.401; Palla G, 2005, NATURE, V435, P814, DOI 10.1038/nature03607; Plachetzki DC, 2007, INTEGR COMP BIOL, V47, P759, DOI 10.1093/icb/icm050; Popper, 1959, LOGIC SCI DISCOVERY; Przulj N, 2004, BIOINFORMATICS, V20, P3508, DOI 10.1093/bioinformatics/bth436; R Core Team, 2022, R LANG ENV STAT COMP; Ratmann O, 2009, HFSP J, V3, P290, DOI 10.2976/1.3167215; Rosvall M, 2007, P NATL ACAD SCI USA, V104, P7327, DOI 10.1073/pnas.0611034104; Shannon C., 1964, MATH THEORY COMMUNIC; Shen-Orr SS, 2002, NAT GENET, V31, P64, DOI 10.1038/ng881; Sole RV, 2008, J R SOC INTERFACE, V5, P129, DOI 10.1098/rsif.2007.1108; SOLOMONOFF RAY, 1951, BULL MATH BIOPHYS, V13, P107, DOI 10.1007/BF02478357; Stouffer DB, 2011, P NATL ACAD SCI USA, V108, P3648, DOI 10.1073/pnas.1014353108; Thorne T, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-467; Todeschini R., 2002, HDB MOL DESCRIPTORS; Vazquez Alexei, 2003, ComPlexUs, V1, P38, DOI 10.1159/000067642; Wagner A, 2003, P ROY SOC B-BIOL SCI, V270, P457, DOI 10.1098/rspb.2002.2269; Wagner A, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-231; Wagner GP., 2005, ROBUSTNESS EVOLVABIL; Wagner GP, 2007, NAT REV GENET, V8, P921, DOI 10.1038/nrg2267; Wang XW, 2008, CURR OPIN BIOTECH, V19, P482, DOI 10.1016/j.copbio.2008.07.011; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Yoon J, 2006, BIOINFORMATICS, V22, P3106, DOI 10.1093/bioinformatics/btl533; Yu HY, 2008, SCIENCE, V322, P104, DOI 10.1126/science.1158684; Ziv E, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.046117	86	2	2	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2012	7	4							e35531	10.1371/journal.pone.0035531	http://dx.doi.org/10.1371/journal.pone.0035531			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959XD	22530042	Green Published, Green Submitted, gold			2022-12-25	WOS:000305350600095
J	Kabgani, N; Grigoleit, T; Schulte, K; Sechi, A; Sauer-Lehnen, S; Tag, C; Boor, P; Kuppe, C; Warsow, G; Schordan, S; Mostertz, J; Chilukoti, RK; Homuth, G; Endlich, N; Tacke, F; Weiskirchen, R; Fuellen, G; Endlich, K; Floege, J; Smeets, B; Moeller, MJ				Kabgani, Nazanin; Grigoleit, Tamara; Schulte, Kevin; Sechi, Antonio; Sauer-Lehnen, Sibille; Tag, Carmen; Boor, Peter; Kuppe, Christoph; Warsow, Gregor; Schordan, Sandra; Mostertz, Joerg; Chilukoti, Ravi Kumar; Homuth, Georg; Endlich, Nicole; Tacke, Frank; Weiskirchen, Ralf; Fuellen, Georg; Endlich, Karlhans; Floege, Juergen; Smeets, Bart; Moeller, Marcus J.			Primary Cultures of Glomerular Parietal Epithelial Cells or Podocytes with Proven Origin	PLOS ONE			English	Article							FOCAL SEGMENTAL GLOMERULOSCLEROSIS; TRANSGENIC MICE; MURINE MODEL; EXPRESSION; GLOMERULONEPHRITIS; CRESCENTS; MOUSE; RATS	Parietal epithelial cells (PECs) are crucially involved in the pathogenesis of rapidly progressive glomerulonephritis (RPGN) as well as in focal and segmental glomerulosclerosis (FSGS). In this study, transgenic mouse lines were used to isolate pure, genetically tagged primary cultures of PECs or podocytes using FACsorting. By this approach, the morphology of primary glomerular epithelial cells in culture could be resolved: Primary podocytes formed either large cells with intracytoplasmatic extensions or smaller spindle shaped cells, depending on specific culture conditions. Primary PECs were small and exhibited a spindle-shaped or polygonal morphology. In the very early phases of primary culture, rapid changes in gene expression (e. g. of WT-1 and Pax-2) were observed. However, after prolonged culture primary PECs and podocytes still segregated clearly in a transcriptome analysis - demonstrating that the origin of primary cell cultures is important. Of the classical markers, synaptopodin and podoplanin expression were differentially regulated the most in primary PEC and podocyte cultures. However, no expression of any endogenous gene allowed to differentiate between the two cell types in culture. Finally, we show that the transcription factor WT1 is also expressed by PECs. In summary, genetic tagging of PECs and podocytes is a novel and necessary tool to derive pure primary cultures with proven origin. These cultures will be a powerful tool for the emerging field of parietal epithelial cell biology.	[Kabgani, Nazanin; Grigoleit, Tamara; Schulte, Kevin; Kuppe, Christoph; Floege, Juergen; Smeets, Bart; Moeller, Marcus J.] Aachen Univ Technol RWTH, Univ Hosp, Div Nephrol & Immunol, Aachen, Germany; [Sechi, Antonio] Aachen Univ Technol RWTH, Univ Hosp, Dept Cell Biol, Aachen, Germany; [Sauer-Lehnen, Sibille; Tag, Carmen; Tacke, Frank] Aachen Univ Technol RWTH, Univ Hosp, Div Gastroenterol, Aachen, Germany; [Sauer-Lehnen, Sibille; Tag, Carmen; Weiskirchen, Ralf] Comenius Univ, Inst Clin Chem & Pathobiochem, Bratislava, Slovakia; [Boor, Peter] Comenius Univ, Inst Pathol, Bratislava, Slovakia; [Boor, Peter] Comenius Univ, Inst Mol Biomed, Bratislava, Slovakia; [Warsow, Gregor; Fuellen, Georg] Univ Rostock, Inst Biostat & Informat Med & Ageing Res, Rostock, Germany; [Warsow, Gregor] Ernst Moritz Arndt Univ Greifswald, Dept Math & Informat, Greifswald, Germany; [Warsow, Gregor; Schordan, Sandra; Endlich, Nicole; Endlich, Karlhans] Univ Med Greifswald, Dept Anat & Cell Biol, Greifswald, Germany; [Mostertz, Joerg; Chilukoti, Ravi Kumar; Homuth, Georg] Ernst Moritz Arndt Univ Greifswald, Dept Funct Genom, Interfac Inst Genet, Greifswald, Germany	RWTH Aachen University; RWTH Aachen University Hospital; RWTH Aachen University; RWTH Aachen University Hospital; RWTH Aachen University; RWTH Aachen University Hospital; Comenius University Bratislava; Comenius University Bratislava; Comenius University Bratislava; University of Rostock; Ernst Moritz Arndt Universitat Greifswald; Greifswald Medical School; Ernst Moritz Arndt Universitat Greifswald	Kabgani, N (corresponding author), Aachen Univ Technol RWTH, Univ Hosp, Div Nephrol & Immunol, Aachen, Germany.	mmoeller@ukaachen.de	Smeets, Bart/D-5179-2014; Boor, Peter/C-7707-2011; Endlich, Karlhans/G-5485-2013; Kuppe, Christoph/ABF-8873-2020; Weiskirchen, Ralf/O-1734-2018; Tacke, Frank/ABF-2212-2020; Sechi, Antonio S/A-5595-2009; Moeller, Marcus J/L-1836-2015; Kuppe, Christoph/ABD-4882-2021	Smeets, Bart/0000-0002-8466-3367; Boor, Peter/0000-0001-9921-4284; Kuppe, Christoph/0000-0003-4597-9833; Weiskirchen, Ralf/0000-0003-3888-0931; Sechi, Antonio S/0000-0002-1374-1794; Endlich, Karlhans/0000-0001-6052-6061	German Research Foundation (DFG) [TP17, SFB/Transregio 57]; German Ministry for Science and Education (BMBF) [01 GN 0805, 01 GN 0901, 01 GN 0804]; Genzyme Renal Innovation Program (GRIP); Netherlands Organization for Scientific Research (NWO) [2007/09196/ALW]; NephCure Foundation [F001]	German Research Foundation (DFG)(German Research Foundation (DFG)); German Ministry for Science and Education (BMBF)(Federal Ministry of Education & Research (BMBF)); Genzyme Renal Innovation Program (GRIP); Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); NephCure Foundation	This work was supported by TP17 and the Q3 central platform SFB/Transregio 57 of the German Research Foundation (DFG to MJM, FT, RW), the German Ministry for Science and Education (BMBF, 01 GN 0805, 01 GN 0901 and 01 GN 0804 to KE, GF and MJM), the Genzyme Renal Innovation Program (GRIP, to BS), and the Netherlands Organization for Scientific Research (NWO) (2007/09196/ALW, to BS). Furthermore, this work received support from the NephCure Foundation (F001 to MJM and BS). FT, RW, JF, MJM are members of the SFB/Transregio 57 DFG consortium "Mechanisms of organ fibrosis.'' The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Appel D, 2009, J AM SOC NEPHROL, V20, P333, DOI 10.1681/ASN.2008070795; Brinkkoetter PT, 2010, CELL CYCLE, V9, P1729, DOI 10.4161/cc.9.9.11471; Chittiprol S, 2011, AM J PHYSL RENAL PHY; Dijkman H, 2005, KIDNEY INT, V68, P1562, DOI 10.1111/j.1523-1755.2005.00568.x; Ding M, 2006, NAT MED, V12, P1081, DOI 10.1038/nm1460; KRIZ W, 1995, KIDNEY INT, V48, P1435, DOI 10.1038/ki.1995.433; Krtil J, 2007, KIDNEY BLOOD PRESS R, V30, P162, DOI 10.1159/000102520; Le Hir M, 2003, KIDNEY INT, V63, P591, DOI 10.1046/j.1523-1755.2003.00782.x; Matsusaka T, 2005, J AM SOC NEPHROL, V16, P1013, DOI 10.1681/ASN.2004080720; Moeller MJ, 2004, J AM SOC NEPHROL, V15, P61, DOI 10.1097/01.ASN.0000102468.37809.C6; Moeller MJ, 2003, GENESIS, V35, P39, DOI 10.1002/gene.10164; Moeller MJ, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000015614.68893.0B; Mundel P, 1997, J AM SOC NEPHROL, V8, P697; Ohse T, 2008, J AM SOC NEPHROL, V19, P1879, DOI 10.1681/ASN.2007101087; PABST R, 1983, KIDNEY INT, V24, P626, DOI 10.1038/ki.1983.203; Reidy KJ, 2009, SEMIN NEPHROL, V29, P321, DOI 10.1016/j.semnephrol.2009.03.009; Ronconi E, 2009, J AM SOC NEPHROL, V20, P322, DOI 10.1681/ASN.2008070709; Saleem MA, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V133630; Sasaki Tamaki, 1994, Medical Electron Microscopy, V27, P49, DOI 10.1007/BF02348228; Shigehara T, 2003, J AM SOC NEPHROL, V14, P1998, DOI 10.1681/ASN.V1481998; Smeets B, 2011, J AM SOC NEPHROL, V22, P1262, DOI 10.1681/ASN.2010090970; Smeets B, 2009, J AM SOC NEPHROL, V20, P2604, DOI 10.1681/ASN.2009010122; Thorner PS, 2008, J AM SOC NEPHROL, V19, P495, DOI 10.1681/ASN.2006101115; Tumbar T, 2004, SCIENCE, V303, P359, DOI 10.1126/science.1092436; Uhlen M, 2010, NAT BIOTECHNOL, V28, P1248, DOI 10.1038/nbt1210-1248; WEINSTEIN T, 1992, J AM SOC NEPHROL, V3, P1279; Yaoita E, 2002, MICROSC RES TECHNIQ, V57, P212, DOI 10.1002/jemt.10075; Yaoita E, 2001, CELL TISSUE RES, V304, P339; Yu DH, 2005, J AM SOC NEPHROL, V16, P1733, DOI 10.1681/ASN.2005020159	29	46	50	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2012	7	4							e34907	10.1371/journal.pone.0034907	http://dx.doi.org/10.1371/journal.pone.0034907			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959XD	22529955	Green Published, gold, Green Submitted			2022-12-25	WOS:000305350600041
J	Muller, P; Chikkaballi, D; Hensel, M				Muller, Petra; Chikkaballi, Deepak; Hensel, Michael			Functional Dissection of SseF, a Membrane-Integral Effector Protein of Intracellular Salmonella enterica	PLOS ONE			English	Article							III SECRETION SYSTEM; HOST-CELLS; EPITHELIAL-CELLS; PATHOGENICITY ISLAND-2; FILAMENTOUS STRUCTURES; CONTAINING VACUOLES; VIRULENCE; TYPHIMURIUM; IDENTIFICATION; SIFA	During intracellular life, the bacterial pathogen Salmonella enterica translocates a complex cocktail of effector proteins by means of the SPI2-encoded type III secretions system. The effectors jointly modify the endosomal system and vesicular transport in host cells. SseF and SseG are two effectors encoded by genes within Salmonella Pathogenicity Island 2 and both effector associate with endosomal membranes and microtubules and are involved in the formation of Salmonella-induced filaments. Our previous deletional analyses identified protein domains of SseF required for the effector function. Here we present a detailed mutational analysis that identifies a short hydrophobic motif as functionally essential. We demonstrate that SseF and SseG are still functional if translocated as a single fusion protein, but also mediate effector function if translocated in cells co-infected with sseF and sseG strains. SseF has characteristics of an integral membrane protein after translocation into host cells.	[Muller, Petra; Chikkaballi, Deepak; Hensel, Michael] Univ Klinikum Erlangen, Inst Mikrobiol, Erlangen, Germany; [Chikkaballi, Deepak; Hensel, Michael] Univ Osnabruck, Abt Mikrobiol, Osnabruck, Germany	University of Erlangen Nuremberg; University Osnabruck	Muller, P (corresponding author), Univ Klinikum Erlangen, Inst Mikrobiol, Erlangen, Germany.	Michael.Hensel@biologie.uni-osnabrueck.de	Chikkaballi, Deepak/AAB-2775-2021	Hensel, Michael/0000-0001-6604-6253; C A, Deepak/0000-0001-7835-5790	DFG [SPP1150]; DFG collaborative research center [SFB796, C1]	DFG(German Research Foundation (DFG)); DFG collaborative research center(German Research Foundation (DFG))	This work was supported by the DFG through priority program SPP1150 'Signaling pathways to the cytoskeleton and bacterial pathogenesis' and the DFG collaborative research center SFB796, project C1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahams GL, 2006, TRAFFIC, V7, P950, DOI 10.1111/j.1600-0854.2006.00454.x; Abrahams GL, 2006, CELL MICROBIOL, V8, P728, DOI 10.1111/j.1462-5822.2006.00706.x; Aleman A, 2009, FEMS MICROBIOL LETT, V296, P167, DOI 10.1111/j.1574-6968.2009.01630.x; Betts HJ, 2004, TRENDS MICROBIOL, V12, P476, DOI 10.1016/j.tim.2004.09.010; Beuzon CR, 2000, EMBO J, V19, P3235, DOI 10.1093/emboj/19.13.3235; Boucrot E, 2003, J BIOL CHEM, V278, P14196, DOI 10.1074/jbc.M207901200; Brumell JH, 2002, TRAFFIC, V3, P407, DOI 10.1034/j.1600-0854.2002.30604.x; Dai SP, 2004, J BACTERIOL, V186, P5078, DOI 10.1128/jb.186.15.5078-5086.2004; Deiwick J, 2006, INFECT IMMUN, V74, P6965, DOI 10.1128/IAI.00648-06; Drecktrah D, 2008, TRAFFIC, V9, P2117, DOI 10.1111/j.1600-0854.2008.00830.x; GARCIADELPORTILLO F, 1993, P NATL ACAD SCI USA, V90, P10544, DOI 10.1073/pnas.90.22.10544; Halici S, 2008, INFECT IMMUN, V76, P4924, DOI 10.1128/IAI.00531-08; Haraga A, 2008, NAT REV MICROBIOL, V6, P53, DOI 10.1038/nrmicro1788; Henry T, 2006, CELL MICROBIOL, V8, P23, DOI 10.1111/j.1462-5822.2005.00649.x; Henry T, 2006, P NATL ACAD SCI USA, V103, P13497, DOI 10.1073/pnas.0605443103; Hensel M, 1998, MOL MICROBIOL, V30, P163, DOI 10.1046/j.1365-2958.1998.01047.x; HOFMANN K, 1993, BIOL CHEM HOPPESEYLE, V374, P166, DOI DOI 10.1515/BCHM3.1993.374.1-6.143; Husseiny MI, 2007, VACCINE, V25, P185, DOI 10.1016/j.vaccine.2005.11.020; Ibarra JA, 2009, CELL MICROBIOL, V11, P1579, DOI 10.1111/j.1462-5822.2009.01368.x; Jordan M, 2004, METHODS, V33, P136, DOI 10.1016/j.ymeth.2003.11.011; Knodler LA, 2005, MOL BIOL CELL, V16, P4108, DOI 10.1091/mbc.e05-04-0367; Kuhle V, 2004, CELL MOL LIFE SCI, V61, P2812, DOI 10.1007/s00018-004-4248-z; Kuhle V, 2004, TRAFFIC, V5, P356, DOI 10.1111/j.1398-9219.2004.00179.x; Kuhle V, 2002, CELL MICROBIOL, V4, P813, DOI 10.1046/j.1462-5822.2002.00234.x; Marcus SL, 2002, CELL MICROBIOL, V4, P435, DOI 10.1046/j.1462-5822.2002.00202.x; Miao EA, 2000, P NATL ACAD SCI USA, V97, P7539, DOI 10.1073/pnas.97.13.7539; PLUTNER H, 1992, J CELL BIOL, V119, P1097, DOI 10.1083/jcb.119.5.1097; Rajashekar R, 2008, TRAFFIC, V9, P2100, DOI 10.1111/j.1600-0854.2008.00821.x; Ramsden AE, 2007, TRENDS MICROBIOL, V15, P516, DOI 10.1016/j.tim.2007.10.002; Ramsden AE, 2007, CELL MICROBIOL, V9, P2517, DOI 10.1111/j.1462-5822.2007.00977.x; Salcedo SP, 2003, EMBO J, V22, P5003, DOI 10.1093/emboj/cdg517; SCHMIEGER H, 1972, MOL GEN GENET, V119, P75, DOI 10.1007/BF00270447; Shea JE, 1996, P NATL ACAD SCI USA, V93, P2593, DOI 10.1073/pnas.93.6.2593; Stein MA, 1996, MOL MICROBIOL, V20, P151, DOI 10.1111/j.1365-2958.1996.tb02497.x; Tan YP, 2005, MICROBIOL-SGM, V151, P2301, DOI 10.1099/mic.0.28005-0; Ustun S, 2012, NEW PHYTOL IN PRESS; Zhao YX, 2004, ANAL CHEM, V76, P1817, DOI 10.1021/ac0354037	37	12	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2012	7	4							e35004	10.1371/journal.pone.0035004	http://dx.doi.org/10.1371/journal.pone.0035004			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959XD	22529968	Green Submitted, gold, Green Published			2022-12-25	WOS:000305350600051
J	Psouni, E; Janke, A; Garwicz, M				Psouni, Elia; Janke, Axel; Garwicz, Martin			Impact of Carnivory on Human Development and Evolution Revealed by a New Unifying Model of Weaning in Mammals	PLOS ONE			English	Article							LIFE-HISTORY; PROTEIN EVOLUTION; BRAIN-DEVELOPMENT; HYPOTHESIS; PATTERNS; WEIGHT; SPAN; TIME; APES	Our large brain, long life span and high fertility are key elements of human evolutionary success and are often thought to have evolved in interplay with tool use, carnivory and hunting. However, the specific impact of carnivory on human evolution, life history and development remains controversial. Here we show in quantitative terms that dietary profile is a key factor influencing time to weaning across a wide taxonomic range of mammals, including humans. In a model encompassing a total of 67 species and genera from 12 mammalian orders, adult brain mass and two dichotomous variables reflecting species differences regarding limb biomechanics and dietary profile, accounted for 75.5%, 10.3% and 3.4% of variance in time to weaning, respectively, together capturing 89.2% of total variance. Crucially, carnivory predicted the time point of early weaning in humans with remarkable precision, yielding a prediction error of less than 5% with a sample of forty-six human natural fertility societies as reference. Hence, carnivory appears to provide both a necessary and sufficient explanation as to why humans wean so much earlier than the great apes. While early weaning is regarded as essentially differentiating the genus Homo from the great apes, its timing seems to be determined by the same limited set of factors in humans as in mammals in general, despite some 90 million years of evolution. Our analysis emphasizes the high degree of similarity of relative time scales in mammalian development and life history across 67 genera from 12 mammalian orders and shows that the impact of carnivory on time to weaning in humans is quantifiable, and critical. Since early weaning yields shorter interbirth intervals and higher rates of reproduction, with profound effects on population dynamics, our findings highlight the emergence of carnivory as a process fundamentally determining human evolution.	[Psouni, Elia] Lund Univ, Dept Psychol, Lund, Sweden; [Psouni, Elia] Kristianstad Univ, Ctr Psychol, Kristianstad, Sweden; [Janke, Axel] LOEWE Biodivers & Climate Res Ctr BiK F, Frankfurt, Germany; [Janke, Axel] Goethe Univ, Inst Ecol Evolut & Divers, Frankfurt, Germany; [Garwicz, Martin] Lund Univ, Neuronano Res Ctr, BMC F10, Lund, Sweden	Lund University; Kristianstad University; Goethe University Frankfurt; Lund University	Psouni, E (corresponding author), Lund Univ, Dept Psychol, Lund, Sweden.	Elia.Psouni@med.lu.se	Janke, Axel/M-2135-2013	Janke, Axel/0000-0002-9394-1904; Garwicz-Psouni, Elia/0000-0003-2758-5785	Swedish Research Council [2009-1273, 14015, 60012701]; Knut and Alice Wallenberg Foundation [KAW 2004.0119]	Swedish Research Council(Swedish Research CouncilEuropean Commission); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation)	EP was supported by the Swedish Research Council (2009-1273). MG was supported by the Swedish Research Council, projects 14015 and 60012701 (a Linnaeus Grant to the Neuronano Research Center) and the Knut and Alice Wallenberg Foundation (project number: KAW 2004.0119). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; AIELLO LC, 1995, CURR ANTHROPOL, V36, P199, DOI 10.1086/204350; AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; ALLMAN J, 1993, P NATL ACAD SCI USA, V90, P118, DOI 10.1073/pnas.90.1.118; Ardrey R, AFRICAN GENESIS PERS; Arnason U, 2002, P NATL ACAD SCI USA, V99, P8151, DOI 10.1073/pnas.102164299; Benton Michael J., 2009, P35; Binford L.R., 1981, BONES ANCIENT MEN MO; Bunn HT, 2001, MEAT EATING HUMAN EV, P350; Cao Y, 1998, J MOL EVOL, V47, P307, DOI 10.1007/PL00006389; Carmody RN, 2009, J HUM EVOL, V57, P379, DOI 10.1016/j.jhevol.2009.02.011; Charnov Eric L., 1993, Evolutionary Anthropology, V1, P191, DOI 10.1002/evan.1360010604; Clancy B, 2001, NEUROSCIENCE, V105, P7, DOI 10.1016/S0306-4522(01)00171-3; Clancy B, 2007, NEUROTOXICOLOGY, V28, P931, DOI 10.1016/j.neuro.2007.01.014; de Magalhaes JP, 2009, J EVOLUTION BIOL, V22, P1770, DOI 10.1111/j.1420-9101.2009.01783.x; Deaner Robert O., 2003, P233; Dettwyler Katherine A., 1995, BREASTFEEDING, P39, DOI [10.4324/9781315081984-2, DOI 10.4324/9781315081984-2]; Ernest SKM, 2003, ECOLOGY, V84, P3402, DOI 10.1890/02-9002; FELSENSTEIN J, 1985, AM NAT, V125, P1, DOI 10.1086/284325; Finch CE, 2010, P NATL ACAD SCI USA, V107, P1718, DOI 10.1073/pnas.0909606106; FINLAY BL, 1995, SCIENCE, V268, P1578, DOI 10.1126/science.7777856; Foley Robert, 2001, P305; GALDIKAS BMF, 1990, AM J PHYS ANTHROPOL, V83, P185, DOI 10.1002/ajpa.1330830207; Garwicz M, 2009, P NATL ACAD SCI USA, V106, P21889, DOI 10.1073/pnas.0905777106; Hallstrom BM, 2010, MOL BIOL EVOL, V27, P2804, DOI 10.1093/molbev/msq166; HARVEY PH, 1985, EVOLUTION, V39, P559, DOI 10.1111/j.1558-5646.1985.tb00395.x; Hawkes K, 2006, SCH AM RES, P95; Hawkes K, 2006, SCH AM RES, P45; Hutchins M, 2003, GRZIMEKS ANIMAL LIFE, V13- 16; Isler K, 2009, J HUM EVOL, V57, P392, DOI 10.1016/j.jhevol.2009.04.009; Jobb G, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-18; Kennedy GE, 2005, J HUM EVOL, V48, P123, DOI 10.1016/j.jhevol.2004.09.005; Lefebvre L, 2006, BRAIN BEHAV EVOLUT, V68, P218, DOI 10.1159/000094359; Maddison D.R., 2007, MESQUITE 2 MODULAR S; Martin R.D., 1983, HUMAN BRAIN EVOLUTIO; Martin RD, 2007, YEARB PHYS ANTHROPOL, V50, P59, DOI 10.1002/ajpa.20734; MAYR E, 1961, SCIENCE, V134, P1501, DOI 10.1126/science.134.3489.1501; Midford P. E., 2008, PDAP PDTREE PACKAGE; Milton K, 1999, EVOL ANTHROPOL, V8, P11, DOI 10.1002/(SICI)1520-6505(1999)8:1<11::AID-EVAN6>3.3.CO;2-D; PASSINGHAM RE, 1985, BRAIN BEHAV EVOLUT, V26, P167, DOI 10.1159/000118773; Robson SL, 2008, J ANAT, V212, P394, DOI 10.1111/j.1469-7580.2008.00867.x; Robson SL, 2006, SCH AM RES, P17; SACHER GA, 1974, AM NAT, V108, P593, DOI 10.1086/282938; Sellen DW, 2009, ADV EXP MED BIOL, V639, P253, DOI 10.1007/978-1-4020-8749-3_18; Sellen DW, 2001, J NUTR, V131, P2707, DOI 10.1093/jn/131.10.2707; SHERMAN PW, 1988, ANIM BEHAV, V36, P616, DOI 10.1016/S0003-3472(88)80039-3; Smith BH, 1992, EVOL ANTHROPOL, V1, P134, DOI DOI 10.1002/EVAN.1360010406; Stanford Craig B., 2001, P122; Taylor HW, 1999, J BIOSOC SCI, V31, P289, DOI 10.1017/S0021932099002898; van Schaik CP, 2006, SCH AM RES, P127; Yang ZH, 1998, MOL BIOL EVOL, V15, P1600, DOI 10.1093/oxfordjournals.molbev.a025888	51	10	10	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2012	7	4							e32452	10.1371/journal.pone.0032452	http://dx.doi.org/10.1371/journal.pone.0032452			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959XD	22536316	Green Published, gold			2022-12-25	WOS:000305350600003
J	Yeang, CH; Ma, GC; Shih, JC; Yang, YS; Chen, CP; Chang, SP; Wu, SH; Liu, CS; Kuo, SJ; Chou, HC; Hwu, WL; Cameron, AD; Ginsberg, NA; Lin, YS; Chen, M				Yeang, Chen-Hsiang; Ma, Gwo-Chin; Shih, Jin-Chung; Yang, Yu-Shih; Chen, Chih-Ping; Chang, Shun-Ping; Wu, Sheng-Hai; Liu, Chin-San; Kuo, Shou-Jen; Chou, Hung-Chieh; Hwu, Wuh-Liang; Cameron, Alan D.; Ginsberg, Norman A.; Lin, Yi-Shing; Chen, Ming			Genome-Wide Gene Expression Analysis Implicates the Immune Response and Lymphangiogenesis in the Pathogenesis of Fetal Chylothorax	PLOS ONE			English	Article							PLEURAL EFFUSION; HUMAN FETUSES; OK-432	Fetal chylothorax (FC) is a rare condition characterized by lymphocyte-rich pleural effusion. Although its pathogenesis remains elusive, it may involve inflammation, since there are increased concentrations of proinflammatory mediators in pleural fluids. Only a few hereditary lymphedema-associated gene loci, e. g. VEGFR3, ITGA9 and PTPN11, were detected in human fetuses with this condition; these cases had a poorer prognosis, due to defective lymphangiogenesis. In the present study, genome-wide gene expression analysis was conducted, comparing pleural and ascitic fluids in three hydropic fetuses, one with and two without the ITGA9 mutation. One fetus (the index case), from a dizygotic pregnancy (the cotwin was unaffected), received antenatal OK-432 pleurodesis and survived beyond the neonatal stage, despite having the ITGA9 mutation. Genes and pathways involved in the immune response were universally up-regulated in fetal pleural fluids compared to those in ascitic fluids. Furthermore, genes involved in the lymphangiogenesis pathway were down-regulated in fetal pleural fluids (compared to ascitic fluid), but following OK-432 pleurodesis, they were up-regulated. Expression of ITGA9 was concordant with overall trends of lymphangiogenesis. In conclusion, we inferred that both the immune response and lymphangiogenesis were implicated in the pathogenesis of fetal chylothorax. Furthermore, genome-wide gene expression microarray analysis may facilitate personalized medicine by selecting the most appropriate treatment, according to the specific circumstances of the patient, for this rare, but heterogeneous disease.	[Yeang, Chen-Hsiang] Acad Sinica, Inst Stat Sci, Taipei 11529, Taiwan; [Ma, Gwo-Chin; Chang, Shun-Ping; Chen, Ming] Changhua Christian Hosp, Dept Genom Med, Changhua, Taiwan; [Ma, Gwo-Chin; Chang, Shun-Ping; Chen, Ming] Changhua Christian Hosp, Ctr Med Genet, Changhua, Taiwan; [Ma, Gwo-Chin] Chung Shan Med Univ, Inst Biochem & Biotechnol, Taichung, Taiwan; [Shih, Jin-Chung; Yang, Yu-Shih; Chen, Ming] Natl Taiwan Univ, Dept Obstet & Gynecol, Taipei 10764, Taiwan; [Chen, Chih-Ping] Mackay Mem Hosp, Dept Obstet & Gynecol, Taipei, Taiwan; [Chen, Chih-Ping] Mackay Mem Hosp, Dept Med Res, Taipei, Taiwan; [Chang, Shun-Ping; Wu, Sheng-Hai; Chen, Ming] Natl Chung Hsing Univ, Dept Life Sci, Taichung 40227, Taiwan; [Liu, Chin-San] Changhua Christian Hosp, Dept Med Res, Vasc & Genom Ctr, Changhua, Taiwan; [Kuo, Shou-Jen] Changhua Christian Hosp, Dept Surg, Changhua, Taiwan; [Chou, Hung-Chieh; Hwu, Wuh-Liang; Chen, Ming] Natl Taiwan Univ, Coll Med & Hosp, Dept Pediat, Taipei 10764, Taiwan; [Chou, Hung-Chieh; Hwu, Wuh-Liang; Chen, Ming] Natl Taiwan Univ, Coll Med & Hosp, Dept Med Genet, Taipei 10764, Taiwan; [Cameron, Alan D.] So Gen Hosp, Ian Donald Foetal Med Unit, Glasgow G51 4TF, Lanark, Scotland; [Cameron, Alan D.] Univ Glasgow, Glasgow, Lanark, Scotland; [Ginsberg, Norman A.] Northwestern Univ, Feinberg Sch Med, Dept Obstet & Gynecol, Chicago, IL 60611 USA; [Lin, Yi-Shing] Welgene Biotechnol Co, Taipei, Taiwan; [Chen, Ming] Tunghai Univ, Dept Life Sci, Taichung 40704, Taiwan; [Chen, Ming] Chung Shan Med Univ, Coll Med, Taichung, Taiwan	Academia Sinica - Taiwan; Changhua Christian Hospital; Changhua Christian Hospital; Chung Shan Medical University; National Taiwan University; Mackay Memorial Hospital; Mackay Memorial Hospital; National Chung Hsing University; Changhua Christian Hospital; Changhua Christian Hospital; National Taiwan University; National Taiwan University; University of Glasgow; University of Glasgow; Northwestern University; Feinberg School of Medicine; Tunghai University; Chung Shan Medical University	Yeang, CH (corresponding author), Acad Sinica, Inst Stat Sci, Taipei 11529, Taiwan.	mchen_cch@yahoo.com	Yeang, Chen-Hsiang/AAP-2962-2021; Chou, Hung-Chieh/AGZ-5161-2022; SHIH, JIN-CHUNG/AAQ-8651-2021	SHIH, JIN-CHUNG/0000-0002-0296-4327; YANG, YU-SHIH/0000-0002-8633-0873; Chen, Ming/0000-0001-5076-2917; HWU, WUH-LIANG/0000-0001-6690-4879; CHOU, HUNG-CHIEH/0000-0002-8932-9472	National Science Council, Taiwan [NSC-99-2314-B371-001-MY2]; Changhua Christian Hospital [100-CCH-ICO04]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); Changhua Christian Hospital	This research was funded by grants from the National Science Council, Taiwan (NSC-99-2314-B371-001-MY2) to Ming Chen and Wuh-Liang Hwu, and from Changhua Christian Hospital (100-CCH-ICO04) to Ming Chen. The funders had no role in study design, data collection and analysis, decision to publish, or manuscript preparation.	Bazigou E, 2009, DEV CELL, V17, P175, DOI 10.1016/j.devcel.2009.06.017; Bennet L, 2010, AM J PHYSIOL-REG I, V299, pR664, DOI 10.1152/ajpregu.00116.2010; Chao AS, 2010, EUR J OBSTET GYN R B, V151, P112, DOI 10.1016/j.ejogrb.2010.03.027; Chen CH, 2009, LYMPHOLOGY, V42, P134; Chen M, 2005, ULTRASOUND OBST GYN, V26, P791, DOI 10.1002/uog.2634; Chen M, 2007, PRENATAL DIAG, V27, P435, DOI 10.1002/pd.1704; Cowie RV, 2009, FETAL DIAGN THER, V25, P304, DOI 10.1159/000235876; Deurloo KL, 2007, PRENATAL DIAG, V27, P893, DOI 10.1002/pd.1808; Huang XZ, 2000, MOL CELL BIOL, V20, P5208, DOI 10.1128/MCB.20.14.5208-5215.2000; Joshi-Tope G, 2005, NUCLEIC ACIDS RES, V33, pD428, DOI 10.1093/nar/gki072; Ma GC, 2010, AM J MED GENET A, V152A, P784, DOI 10.1002/ajmg.a.33157; Ma GC, 2008, PRENATAL DIAG, V28, P1057, DOI 10.1002/pd.2130; Matsukuma Eiji, 2009, J Pediatr Surg, V44, pe37, DOI 10.1016/j.jpedsurg.2008.12.008; Nygaard U, 2007, OBSTET GYNECOL, V109, P1088, DOI 10.1097/01.AOG.0000259907.91973.69; Ono S, 2010, J PEDIATR SURG, V45, pE7, DOI 10.1016/j.jpedsurg.2010.06.010; PEMBLE SE, 1992, BIOCHEM J, V287, P957, DOI 10.1042/bj2870957; Ruano R, 2011, PRENATAL DIAG, V31, P496, DOI 10.1002/pd.2726; Saharinen P, 2004, TRENDS IMMUNOL, V25, P387, DOI 10.1016/j.it.2004.05.003; Samuel M, 2000, FETAL DIAGN THER, V15, P93, DOI 10.1159/000020983; Schaefer CF, 2009, NUCLEIC ACIDS RES, V37, pD674, DOI 10.1093/nar/gkn653; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tammela T, 2010, CELL, V140, P460, DOI 10.1016/j.cell.2010.01.045; Tartaglia M, 2002, AM J HUM GENET, V70, P1555, DOI 10.1086/340847; Yang YS, 2012, ULTRASOUND OBST GYN, V39, P56, DOI 10.1002/uog.9048; Yinon Y, 2008, BEST PRACT RES CL OB, V22, P77, DOI 10.1016/j.bpobgyn.2007.09.004; Zheng DY, 2007, GENOME RES, V17, P839, DOI 10.1101/gr.5586307	26	5	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2012	7	4							e34901	10.1371/journal.pone.0034901	http://dx.doi.org/10.1371/journal.pone.0034901			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959XD	22529953	Green Published, gold, Green Submitted			2022-12-25	WOS:000305350600040
J	Sabiiti, W; May, RC				Sabiiti, Wilber; May, Robin C.			Capsule Independent Uptake of the Fungal Pathogen Cryptococcus neoformans into Brain Microvascular Endothelial Cells	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; IN-VITRO; MOUSE-BRAIN; MENINGITIS; BARRIER; DISSEMINATION; AIDS; PHAGOCYTOSIS; MACROPHAGES; EXPRESSION	Cryptococcosis is a life-threatening fungal disease with a high rate of mortality among HIV/AIDS patients across the world. The ability to penetrate the blood-brain barrier (BBB) is central to the pathogenesis of cryptococcosis, but the way in which this occurs remains unclear. Here we use both mouse and human brain derived endothelial cells (bEnd3 and hCMEC/D3) to accurately quantify fungal uptake and survival within brain endothelial cells. Our data indicate that the adherence and internalisation of cryptococci by brain microvascular endothelial cells is an infrequent event involving small numbers of cryptococcal yeast cells. Interestingly, this process requires neither active signalling from the fungus nor the presence of the fungal capsule. Thus entry into brain microvascular endothelial cells is most likely a passive event that occurs following 'trapping' within capillary beds of the BBB.	[Sabiiti, Wilber; May, Robin C.] Univ Birmingham, Coll Life & Environm Sci, Sch Biosci, Inst Microbiol & Infect, Birmingham, W Midlands, England	University of Birmingham	Sabiiti, W (corresponding author), Univ Birmingham, Coll Life & Environm Sci, Sch Biosci, Inst Microbiol & Infect, Birmingham, W Midlands, England.	r.c.may@bham.ac.uk	May, Robin Charles/ABA-9266-2021; Sabiiti, Wilber/AAH-7921-2021	May, Robin Charles/0000-0001-5364-1838; Sabiiti, Wilber/0000-0002-4742-2791	Wellcome Trust [088148MF]; Lister Institute of Preventive Medicine	Wellcome Trust(Wellcome TrustEuropean Commission); Lister Institute of Preventive Medicine	The work was funded by the Wellcome Trust (http://www.wellcome.ac.uk) grant (088148MF), the Lister Institute of Preventive Medicine (http://www.lister-institute.org.uk/) to Dr. May, and Darwin Trust doctoral scholarship to Dr. Sabiiti. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bicanic T, 2005, BRIT MED BULL, V72, P99, DOI 10.1093/bmb/ldh043; BOLANOS B, 1989, J LEUKOCYTE BIOL, V46, P521, DOI 10.1002/jlb.46.6.521; Boulware DR, 2010, J INFECT DIS, V202, P962, DOI 10.1086/655785; Brown RC, 2007, BRAIN RES, V1130, P17, DOI 10.1016/j.brainres.2006.10.083; Byrnes Edmond J, 2009, F1000 Biol Rep, V1, DOI 10.3410/B1-62; Byrnes EJ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000850; Byrnes EJ, 2009, J INFECT DIS, V199, P1081, DOI 10.1086/597306; Casadevall A, 1998, CRYPTOCOCCUS NEOFORM; Chang YC, 2004, INFECT IMMUN, V72, P4985, DOI 10.1128/IAI.72.9.4985-4995.2004; Charlier C, 2005, AM J PATHOL, V166, P421, DOI 10.1016/S0002-9440(10)62265-1; Charlier C, 2009, INFECT IMMUN, V77, P120, DOI 10.1128/IAI.01065-08; Chen SHM, 2003, J MED MICROBIOL, V52, P961, DOI 10.1099/jmm.0.05230-0; Correale J, 2009, NEUROCHEM RES; Datta K, 2009, EMERG INFECT DIS, V15, P1185, DOI 10.3201/eid1508.081384; De Jesus M, 2010, EUKARYOT CELL, V9, P1018, DOI 10.1128/EC.00268-09; Eisenman Helene C, 2007, Curr Infect Dis Rep, V9, P457, DOI 10.1007/s11908-007-0070-8; Fries BC, 2001, J CLIN INVEST, V108, P1639, DOI 10.1172/JCI13407; Goldman DL, 2001, PEDIATRICS, V107, DOI 10.1542/peds.107.5.e66; Guerrero A, 2006, MICROBIOL-SGM, V152, P3, DOI 10.1099/mic.0.28451-0; Heitman J., CRYPTOCOCCUS HUMAN P; Huang SH, 2011, J BIOL CHEM, V286, P34761, DOI 10.1074/jbc.M111.219378; Huffnagle GB, 1999, J NEUROVIROL, V5, P76, DOI 10.3109/13550289909029748; IBRAHIM AS, 1995, INFECT IMMUN, V63, P4368, DOI 10.1128/IAI.63.11.4368-4374.1995; Jain N, 2006, FEMS YEAST RES, V6, P480, DOI 10.1111/j.1567-1364.2006.00039.x; Jong AY, 2001, INFECT IMMUN, V69, P4536, DOI 10.1128/IAI.69.7.4536-4544.2001; Kambugu A, 2008, CLIN INFECT DIS, V46, P1694, DOI 10.1086/587667; Kidd SE, 2004, P NATL ACAD SCI USA, V101, P17258, DOI 10.1073/pnas.0402981101; Kim KS, 2008, NAT REV MICROBIOL, V6, P625, DOI 10.1038/nrmicro1952; Lin XR, 2009, INFECT GENET EVOL, V9, P401, DOI 10.1016/j.meegid.2009.01.013; Lortholary O, 2007, CLIN INFECT DIS, V45, P81, DOI 10.1086/518583; Ma HS, 2009, ADV APPL MICROBIOL, V67, P131, DOI 10.1016/S0065-2164(08)01005-8; MITCHELL TG, 1995, CLIN MICROBIOL REV, V8, P515, DOI 10.1128/CMR.8.4.515; MUKHERJEE S, 1995, INFECT IMMUN, V63, P573, DOI 10.1128/IAI.63.2.573-579.1995; Mwaba P, 2001, POSTGRAD MED J, V77, P769, DOI 10.1136/pmj.77.914.769; Neofytos D, 2010, TRANSPL INFECT DIS, V12, P220, DOI 10.1111/j.1399-3062.2010.00492.x; Nussbaum JC, 2010, CLIN INFECT DIS, V50, P338, DOI 10.1086/649861; Park BJ, 2009, AIDS, V23, P525, DOI 10.1097/QAD.0b013e328322ffac; Santangelo R, 2004, INFECT IMMUN, V72, P2229, DOI 10.1128/IAI.72.4.2229-2239.2004; Shi MQ, 2010, J CLIN INVEST, V120, P1683, DOI 10.1172/JCI41963; Syme RM, 1999, INFECT IMMUN, V67, P4620, DOI 10.1128/IAI.67.9.4620-4627.1999; Vecchiarelli A, 2002, IMMUNOLOGY, V106, P267, DOI 10.1046/j.1365-2567.2002.01419.x; Zaragoza O, 2008, CELL MICROBIOL, V10, P2043, DOI 10.1111/j.1462-5822.2008.01186.x	42	23	26	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2012	7	4							e35455	10.1371/journal.pone.0035455	http://dx.doi.org/10.1371/journal.pone.0035455			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WC	22530025	gold, Green Submitted, Green Published, Green Accepted			2022-12-25	WOS:000305347400052
J	Wu, MZ; Nissen, JC; Chen, EI; Tsirka, SE				Wu, Muzhou; Nissen, Jillian C.; Chen, Emily I.; Tsirka, Stella E.			Tuftsin Promotes an Anti-Inflammatory Switch and Attenuates Symptoms in Experimental Autoimmune Encephalomyelitis	PLOS ONE			English	Article							EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS; TISSUE-PLASMINOGEN ACTIVATOR; CENTRAL-NERVOUS-SYSTEM; MYELIN OLIGODENDROCYTE GLYCOPROTEIN; REGULATORY T-CELLS; SPINAL-CORD-INJURY; MULTIPLE-SCLEROSIS; ANIMAL-MODELS; CUTTING EDGE; MICROGLIA	Multiple sclerosis (MS) is a demyelinating autoimmune disease mediated by infiltration of T cells into the central nervous system after compromise of the blood-brain barrier. We have previously shown that administration of tuftsin, a macrophage/microglial activator, dramatically improves the clinical course of experimental autoimmune encephalomyelitis (EAE), a well-established animal model for MS. Tuftsin administration correlates with upregulation of the immunosuppressive Helper-2 Tcell (Th2) cytokine transcription factor GATA-3. We now show that tuftsin-mediated microglial activation results in shifting microglia to an anti-inflammatory phenotype. Moreover, the T cell phenotype is shifted towards immunoprotection after exposure to tuftsin-treated activated microglia; specifically, downregulation of pro-inflammatory Th1 responses is triggered in conjunction with upregulation of Th2-specific responses and expansion of immunosuppressive regulatory T cells (Tregs). Finally, tuftsin-shifted T cells, delivered into animals via adoptive transfer, reverse the pathology observed in mice with established EAE. Taken together, our findings demonstrate that tuftsin decreases the proinflammatory environment of EAE and may represent a therapeutic opportunity for treatment of MS.	[Wu, Muzhou; Nissen, Jillian C.; Chen, Emily I.; Tsirka, Stella E.] SUNY Stony Brook, Sch Med, Dept Pharmacol Sci, Stony Brook, NY 11794 USA; [Wu, Muzhou; Tsirka, Stella E.] SUNY Stony Brook, Sch Med, Program Neurosci, Stony Brook, NY 11794 USA; [Nissen, Jillian C.; Tsirka, Stella E.] SUNY Stony Brook, Sch Med, Program Mol & Cellular Pharmacol, Stony Brook, NY 11794 USA; [Chen, Emily I.] SUNY Stony Brook, Sch Med, Prote Ctr, Stony Brook, NY 11794 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Wu, MZ (corresponding author), SUNY Stony Brook, Sch Med, Dept Pharmacol Sci, Stony Brook, NY 11794 USA.	stella@pharm.stonybrook.edu	Tsirka, Stella/AAD-4018-2019		National Institutes of Health (NIH) [R01NS42168]; National Multiple Sclerosis Society (NMSS) [CA1044A1]; National Science Foundation (NSF) 3MT IGERT; NIH/NCRR [1 S10 RR023680-1]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR023680] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007518] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS042168] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Multiple Sclerosis Society (NMSS)(National Multiple Sclerosis Society); National Science Foundation (NSF) 3MT IGERT(National Science Foundation (NSF)); NIH/NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health (NIH) R01NS42168, National Multiple Sclerosis Society (NMSS) CA1044A1 and National Science Foundation (NSF) 3MT IGERT. The mass spectrometer used in this study was funded by the shared instrument grant (NIH/NCRR 1 S10 RR023680-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe Y, 2003, J NEUROTRAUM, V20, P43, DOI 10.1089/08977150360517173; Benveniste EN, 1997, J MOL MED-JMM, V75, P165, DOI 10.1007/s001090050101; Bernard CCA, 1997, J MOL MED-JMM, V75, P77, DOI 10.1007/s001090050092; Bhasin M, 2007, BMC IMMUNOL, V8, DOI 10.1186/1471-2172-8-10; Bonecchi R, 1998, J EXP MED, V187, P129, DOI 10.1084/jem.187.1.129; Bukhari N, 2011, J NEUROSCI, V31, P14931, DOI 10.1523/JNEUROSCI.3339-11.2011; Carvalho PC, 2008, GENET MOL RES, V7, P342, DOI 10.4238/vol7-2gmr426; CHAO CC, 1992, J IMMUNOL, V149, P2736; Crawford HC, 2009, CURR PHARM DESIGN, V15, P2288, DOI 10.2174/138161209788682442; Diemel LT, 1998, NEUROCHEM RES, V23, P341, DOI 10.1023/A:1022405516630; Elias JE, 2007, NAT METHODS, V4, P207, DOI 10.1038/nmeth1019; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; Ferber IA, 1996, J IMMUNOL, V156, P5; FRIDKIN M, 1989, CRIT REV BIOCHEM MOL, V24, P1, DOI 10.3109/10409238909082550; Funderburg N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001915; Gavazzi I, 2001, CELL TISSUE RES, V305, P275, DOI 10.1007/s004410100365; Gordon S, 2010, IMMUNITY, V32, P593, DOI 10.1016/j.immuni.2010.05.007; HERMAN ZS, 1981, EXPERIENTIA, V37, P76, DOI 10.1007/BF01965580; Hjelmstrom P, 1998, J IMMUNOL, V161, P4480; Jee Y, 2001, J NEUROIMMUNOL, V114, P40, DOI 10.1016/S0165-5728(00)00446-X; Kersey PJ, 2004, PROTEOMICS, V4, P1985, DOI 10.1002/pmic.200300721; Kigerl K, 2009, J NEUROSCI; Kim S, 2007, J NEUROCHEM, V103, P2640, DOI 10.1111/j.1471-4159.2007.04995.x; Kohm AP, 2002, J IMMUNOL, V169, P4712, DOI 10.4049/jimmunol.169.9.4712; Kreutzberg GW, 1996, TRENDS NEUROSCI, V19, P312, DOI 10.1016/0166-2236(96)10049-7; Lai AY, 2008, GLIA, V56, P259, DOI 10.1002/glia.20610; Langrish CL, 2005, J EXP MED, V201, P233, DOI 10.1084/jem.20041257; Liu HB, 2004, ANAL CHEM, V76, P4193, DOI 10.1021/ac0498563; Liu YW, 2006, NAT MED, V12, P518, DOI 10.1038/nm1402; Lloyd CM, 2000, J EXP MED, V191, P265, DOI 10.1084/jem.191.2.265; Lock C, 2002, NAT MED, V8, P500, DOI 10.1038/nm0502-500; Lohr J, 2006, J EXP MED, V203, P2785, DOI 10.1084/jem.20061341; Lu WQ, 2002, J NEUROSCI, V22, P10781; McGeachy MJ, 2005, J IMMUNOL, V175, P3025, DOI 10.4049/jimmunol.175.5.3025; Michelucci A, 2009, J NEUROIMMUNOL, V210, P3, DOI 10.1016/j.jneuroim.2009.02.003; MIKITA J, 2010, MULT SCLER; MOSMANN TR, 1989, ANNU REV IMMUNOL, V7, P145, DOI 10.1146/annurev.immunol.7.1.145; Nieuwenhuis EES, 2002, P NATL ACAD SCI USA, V99, P16951, DOI 10.1073/pnas.252648899; NISHIOKA K, 1973, BIOCHIM BIOPHYS ACTA, V310, P230, DOI 10.1016/0005-2795(73)90025-1; Olah M, 2012, GLIA, V60, P306, DOI 10.1002/glia.21266; Olivares-Villagomez D, 1998, J EXP MED, V188, P1883, DOI 10.1084/jem.188.10.1883; Paul C, 2000, J NEUROSCI METH, V98, P83, DOI 10.1016/S0165-0270(00)00201-6; Pitt D, 2000, NAT MED, V6, P67, DOI 10.1038/71555; Rabchevsky AG, 1998, MENT RETARD DEV D R, V4, P187, DOI 10.1002/(SICI)1098-2779(1998)4:3<187::AID-MRDD6>3.0.CO;2-L; Raivich G, 2004, BRAIN RES REV, V46, P261, DOI 10.1016/j.brainresrev.2004.06.006; Rogove AD, 1998, CURR BIOL, V8, P19, DOI 10.1016/S0960-9822(98)70016-8; ROTT O, 1994, EUR J IMMUNOL, V24, P1434, DOI 10.1002/eji.1830240629; Siao CJ, 2002, J NEUROSCI, V22, P3352; Siddiq MM, 2004, MOL CELL NEUROSCI, V25, P162, DOI 10.1016/j.mcn.2003.10.007; Siemion IZ, 1999, PEPTIDES, V20, P645, DOI 10.1016/S0196-9781(99)00019-4; Smith T, 2000, NAT MED, V6, P62, DOI 10.1038/71548; Stanislaus Romesh, 2005, J Autoimmune Dis, V2, P4, DOI 10.1186/1740-2557-2-4; STEVENS DB, 1994, J NEUROIMMUNOL, V51, P77, DOI 10.1016/0165-5728(94)90131-7; SWANBORG RH, 1995, CLIN IMMUNOL IMMUNOP, V77, P4, DOI 10.1016/0090-1229(95)90130-2; THANOS S, 1993, J NEUROSCI, V13, P455; Tordjman R, 2002, NAT IMMUNOL, V3, P477, DOI 10.1038/ni789; Veeravalli KK, 2009, NEUROCHEM RES, V34, P1183, DOI 10.1007/s11064-008-9894-3; von Wronski MA, 2006, J BIOL CHEM, V281, P5702, DOI 10.1074/jbc.M511941200; Wang L, 2003, J BIOL CHEM, V278, P48848, DOI 10.1074/jbc.M310047200; Wei JC, 2007, INT ELECTRON J ALGEB, V2, P1; Wilson NJ, 2007, NAT IMMUNOL, V8, P950, DOI 10.1038/ni1497; Wu M, 2009, GLIA; Yao Y, 2010, J BIOL CHEM, V285, P31509, DOI 10.1074/jbc.M110.124891; Ye BH, 1997, NAT GENET, V16, P161, DOI 10.1038/ng0697-161; Zhai HY, 2011, GLIA, V59, P472, DOI 10.1002/glia.21117	65	29	32	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2012	7	4							e34933	10.1371/journal.pone.0034933	http://dx.doi.org/10.1371/journal.pone.0034933			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WC	22529957	Green Published, gold, Green Submitted			2022-12-25	WOS:000305347400026
J	Cromie, GL; Chapple, DG				Cromie, Gillian L.; Chapple, David G.			Impact of Tail Loss on the Behaviour and Locomotor Performance of Two Sympatric Lampropholis Skink Species	PLOS ONE			English	Article							CAUDAL AUTOTOMY; RUNNING SPEED; ROCK-LIZARDS; MOVEMENT PATTERNS; VIVIPAROUS SKINK; METALLIC SKINK; SPRINT SPEED; COSTS; REGENERATION; SQUAMATA	Caudal autotomy is an anti-predator behaviour that is used by many lizard species. Although there is an immediate survival benefit, the subsequent absence of the tail may inhibit locomotor performance, alter activity and habitat use, and increase the individuals' susceptibility to future predation attempts. We used laboratory experiments to examine the impact of tail autotomy on locomotor performance, activity and basking site selection in two lizard species, the delicate skink (Lampropholis delicata) and garden skink (L. guichenoti), that occur sympatrically throughout southeastern Australia and are exposed to an identical suite of potential predators. Post-autotomy tail movement did not differ between the two Lampropholis species, although a positive relationship between the shed tail length and distance moved, but not the duration of movement, was observed. Tail autotomy resulted in a substantial decrease in sprint speed in both species (28-39%), although this impact was limited to the optimal performance temperature (30 degrees C). Although L. delicata was more active than L. guichenoti, tail autotomy resulted in decreased activity in both species. Sheltered basking sites were preferred over open sites by both Lampropholis species, although this preference was stronger in L. delicata. Caudal autotomy did not alter the basking site preferences of either species. Thus, both Lampropholis species had similar behavioural responses to autotomy. Our study also indicates that the impact of tail loss on locomotor performance may be temperature-dependent and highlights that future studies should be conducted over a broad thermal range.	[Cromie, Gillian L.; Chapple, David G.] Monash Univ, Sch Biol Sci, Clayton, Vic, Australia	Monash University	Cromie, GL (corresponding author), Monash Univ, Sch Biol Sci, Clayton, Vic, Australia.	David.Chapple@monash.edu	Chapple, David/B-9073-2008	Chapple, David/0000-0002-7720-6280	Australian Research Council [DP0771913]; Hermon Slade Foundation [HSF09/02]; National Geographic Society [CRE8085-06]	Australian Research Council(Australian Research Council); Hermon Slade Foundation; National Geographic Society(National Geographic Society)	This research was funded by grants from the Australian Research Council (DP0771913), Hermon Slade Foundation (HSF09/02), and National Geographic Society (CRE8085-06) (to DGC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angilletta MJ, 2002, J THERM BIOL, V27, P199, DOI 10.1016/S0306-4565(01)00084-5; [Anonymous], 2010, COMPLETE GUIDE REPTI; Arnold E.N., 1988, Biology of Reptilia, V16, P235; BALLINGER RE, 1979, HERPETOLOGICA, V35, P114; Bateman PW, 2009, J ZOOL, V277, P1, DOI 10.1111/j.1469-7998.2008.00484.x; Bellairs A.D., 1985, Biology of Reptilia, V15, P301; Chapple DG, 2011, ECOL EVOL, V1, P278, DOI 10.1002/ece3.22; Chapple DG, 2012, TRENDS ECOL EVOL, V27, P57, DOI 10.1016/j.tree.2011.09.010; Chapple DG, 2012, TRENDS ECOL EVOL, V27, P68, DOI 10.1016/j.tree.2011.11.008; Chapple DG, 2004, J ZOOL, V264, P411, DOI 10.1017/s0952836904005941; Chapple DG, 2004, AMPHIBIA-REPTILIA, V25, P326; Chapple DG, 2004, J HERPETOL, V38, P137, DOI 10.1670/128-03N; Chapple DG, 2002, FUNCT ECOL, V16, P817, DOI 10.1046/j.1365-2435.2002.00687.x; Chapple DG, 2002, AUSTRAL ECOL, V27, P565, DOI 10.1046/j.1442-9993.2002.01217.x; Clause AR, 2006, J EXP ZOOL PART A, V305A, P965, DOI 10.1002/jez.a.346; Cooper WE, 2003, BEHAV ECOL SOCIOBIOL, V54, P179, DOI 10.1007/s00265-003-0619-y; Cooper WE, 2008, BEHAVIOUR, V145, P1085; Cooper WE, 2009, CAN J ZOOL, V87, P400, DOI 10.1139/Z09-024; DIAL BE, 1983, SCIENCE, V219, P391, DOI 10.1126/science.219.4583.391; Doughty P, 2003, COMP BIOCHEM PHYS A, V135, P215, DOI 10.1016/S1095-6433(03)00087-4; Downes S, 2001, ECOLOGY, V82, P1293, DOI 10.1890/0012-9658(2001)082[1293:WDTLIA]2.0.CO;2; FORMANOWICZ DR, 1990, ANIM BEHAV, V40, P782, DOI 10.1016/S0003-3472(05)80710-9; Goodman RM, 2006, J HERPETOL, V40, P99, DOI 10.1670/09-05N.1; HAMLEY T, 1990, Memoirs of the Queensland Museum, V28, P153; Higham TE, 2010, BIOL LETTERS, V6, P70, DOI 10.1098/rsbl.2009.0577; JOSS JMP, 1985, AUST J ZOOL, V33, P699, DOI 10.1071/ZO9850699; Kraus Fred, 2009, V4, P1; Kutt Alex, 1993, P187; Lever C., 2003, NATURALIZED REPTILES; Lin ZH, 2006, COMP BIOCHEM PHYS A, V143, P508, DOI 10.1016/j.cbpa.2006.01.018; Lin ZH, 2005, J COMP PHYSIOL B, V175, P567, DOI 10.1007/s00360-005-0017-z; Losos JB, 2002, J ZOOL, V258, P57, DOI 10.1017/S0952836902001206; Maginnis TL, 2006, BEHAV ECOL, V17, P857, DOI 10.1093/beheco/arl010; MARTIN J, 1993, BEHAVIOUR, V124, P123, DOI 10.1163/156853993X00533; Martin J, 1997, HERPETOLOGICA, V53, P117; MARTIN J, 1992, OIKOS, V65, P328, DOI 10.2307/3545026; Martin J, 1995, COPEIA, P984; Martin J, 1998, FUNCT ECOL, V12, P794, DOI 10.1046/j.1365-2435.1998.00247.x; Ottoni EB, 2000, BEHAV RES METH INS C, V32, P446, DOI 10.3758/BF03200814; Pafilis P, 2008, NATURWISSENSCHAFTEN, V95, P217, DOI 10.1007/s00114-007-0320-5; Prosser C, 2006, J HERPETOL, V40, P151, DOI 10.1670/38-05A.1; PUNZO F, 1982, J HERPETOL, V16, P329, DOI 10.2307/1563731; R Development Core Team, 2010, R VERS 2 10 1 FDN ST; Shine R, 2003, FUNCT ECOL, V17, P526, DOI 10.1046/j.1365-2435.2003.00756.x	44	43	44	1	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2012	7	4							e34732	10.1371/journal.pone.0034732	http://dx.doi.org/10.1371/journal.pone.0034732			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VO	22523555	Green Submitted, Green Published, gold			2022-12-25	WOS:000305345000026
J	Klick, B; Nishiura, H; Cowling, BJ				Klick, Brendan; Nishiura, Hiroshi; Cowling, Benjamin J.			Optimal Design of Intervention Studies to Prevent Influenza in Healthy Cohorts	PLOS ONE			English	Article							RANDOMIZED CLINICAL-TRIAL; SEASONAL INFLUENZA; DOUBLE-BLIND; RESPIRATORY-INFECTIONS; VIRUS-INFECTION; FIELD TRIAL; HAND HYGIENE; YOUNG-ADULTS; EFFICACY; VACCINE	Background: Influenza cohort studies, in which participants are monitored for infection over an epidemic period, are invaluable in assessing the effectiveness of control measures such as vaccination, antiviral prophylaxis and non-pharmaceutical interventions (NPIs). Influenza infections and illnesses can be identified through a number of approaches with different costs and logistical requirements. Methodology and Principal Findings: In the context of a randomized controlled trial of an NPI with a constrained budget, we used a simulation approach to examine which approaches to measuring outcomes could provide greater statistical power to identify an effective intervention against confirmed influenza. We found that for a short epidemic season, the optimal design was to collect respiratory specimens at biweekly intervals, as well as following report of acute respiratory illness (ARI), for virologic testing by reverse transcription polymerase chain reaction (RT-PCR). Collection of respiratory specimens only from individuals reporting ARI was also an efficient design particularly for studies in settings with longer periods of influenza activity. Collection of specimens only from individuals reporting a febrile ARI was less efficient. Collection and testing of sera before and after influenza activity appeared to be inferior to collection of respiratory specimens for RT-PCR confirmation of acute infections. The performance of RT-PCR was robust to uncertainty in the costs and diagnostic performance of RT-PCR and serological tests. Conclusions and Significance: Our results suggest that unless the sensitivity or specificity of serology can be increased RTPCR will remain as the preferable outcome measure in NPI studies. Routine collection of specimens for RT-PCR testing even when study participants do not report acute respiratory illness appears to be the most cost efficient design under most scenarios.	[Klick, Brendan; Nishiura, Hiroshi; Cowling, Benjamin J.] Univ Hong Kong, Li Ka Shing Fac Med, Sch Publ Hlth, Infect Dis Epidemiol Grp, Pokfulam, Hong Kong, Peoples R China; [Nishiura, Hiroshi] Japan Sci & Technol Agcy, PRESTO, Saitama, Japan	University of Hong Kong; Japan Science & Technology Agency (JST)	Klick, B (corresponding author), Univ Hong Kong, Li Ka Shing Fac Med, Sch Publ Hlth, Infect Dis Epidemiol Grp, Pokfulam, Hong Kong, Peoples R China.	bcowling@hku.hk	Cowling, Benjamin John/C-4263-2009	Cowling, Benjamin John/0000-0002-6297-7154; Nishiura, Hiroshi/0000-0003-0941-8537	Harvard Center for Communicable Disease Dynamics from the National Institute of General Medical Sciences [U54 GM088558]; Hong Kong University Grants Committee [AoE/M-12/06]; Research Grants Council, Hong Kong; JST PRESTO; MedImmune Inc.; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM088558] Funding Source: NIH RePORTER	Harvard Center for Communicable Disease Dynamics from the National Institute of General Medical Sciences; Hong Kong University Grants Committee; Research Grants Council, Hong Kong(Hong Kong Research Grants Council); JST PRESTO(Japan Science & Technology Agency (JST)); MedImmune Inc.(AstraZenecaMedimmune); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work received financial support from the Harvard Center for Communicable Disease Dynamics from the National Institute of General Medical Sciences (grant no. U54 GM088558) and the Area of Excellence Scheme of the Hong Kong University Grants Committee (grant no. AoE/M-12/06). BK is supported by a Hong Kong PhD Fellowship from the Research Grants Council, Hong Kong. HN is supported by the JST PRESTO program. The funding bodies were not involved in the collection, analysis and interpretation of data, the writing of the manuscript, or the decision to submit for publication. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of General Medical Sciences or the National Institutes of Health.; BJC has received study funding from MedImmune Inc., a manufacturer of influenza vaccines. The authors report no other potential conflicts of interest. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Aiello AE, 2010, J INFECT DIS, V201, P491, DOI 10.1086/650396; Allwinn R, 2002, MED MICROBIOL IMMUN, V191, P157, DOI 10.1007/s00430-002-0137-y; Bellei N, 2008, J MED VIROL, V80, P1824, DOI 10.1002/jmv.21295; Belshe RB, 2000, J PEDIATR-US, V136, P168, DOI 10.1016/S0022-3476(00)70097-7; Belshe RB, 1998, NEW ENGL J MED, V338, P1405, DOI 10.1056/NEJM199805143382002; Beran J, 2009, J INFECT DIS, V200, P1861, DOI 10.1086/648406; Beran J, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-2; Call SA, 2005, JAMA-J AM MED ASSOC, V293, P987, DOI 10.1001/jama.293.8.987; CALLMANDER E, 1968, J CLIN PHARMACOL N D, V8, P186, DOI 10.1002/j.1552-4604.1968.tb00269.x; Carrat F, 2008, AM J EPIDEMIOL, V167, P775, DOI 10.1093/aje/kwm375; Carter NJ, 2011, DRUGS, V71, P1591, DOI 10.2165/11206860-000000000-00000; Cheng CKY, 2009, DIAGN MICR INFEC DIS, V65, P35, DOI 10.1016/j.diagmicrobio.2009.05.003; Cheng PKC, 2010, J CLIN VIROL, V47, P182, DOI 10.1016/j.jcv.2009.11.022; Cowling BJ, 2010, CLIN INFECT DIS, V51, P1370, DOI 10.1086/657311; Cowling BJ, 2010, NEW ENGL J MED, V362, P2175, DOI 10.1056/NEJMoa0911530; Cowling BJ, 2009, ANN INTERN MED, V151, P437, DOI 10.7326/0003-4819-151-7-200910060-00142; DAWKINS AT, 1968, J AMER MED ASSOC, V203, P1095, DOI 10.1001/jama.203.13.1095; DOLIN R, 1982, NEW ENGL J MED, V307, P580, DOI 10.1056/NEJM198209023071002; Ellis JS, 2002, REV MED VIROL, V12, P375, DOI 10.1002/rmv.370; FINKLEA JF, 1967, AM J EPIDEMIOL, V85, P403, DOI 10.1093/oxfordjournals.aje.a120702; Gravenstein Stefan, 2005, J Am Med Dir Assoc, V6, P359, DOI 10.1016/j.jamda.2005.08.006; HAMMOND GW, 1980, J INFECT DIS, V141, P644, DOI 10.1093/infdis/141.5.644; Hayden FG, 1999, JAMA-J AM MED ASSOC, V282, P1240, DOI 10.1001/jama.282.13.1240; HIGGINS PG, 1974, J HYG-CAMBRIDGE, V72, P425, DOI 10.1017/S0022172400023664; Killingley B, 2011, LANCET INFECT DIS, V11, P879, DOI 10.1016/S1473-3099(11)70142-6; Klick B, 2011, EPIDEMIOL INFECT, P1; Larson EL, 2010, PUBLIC HEALTH REP, V125, P178, DOI 10.1177/003335491012500206; Lau LLH, 2010, J INFECT DIS, V201, P1509, DOI 10.1086/652241; Lehmann E.L., 2006, TESTING STAT HYPOTHE, V3rd ed; Loeb M, 2010, JAMA-J AM MED ASSOC, V303, P943, DOI 10.1001/jama.2010.250; Loeb M, 2009, JAMA-J AM MED ASSOC, V302, P1865, DOI 10.1001/jama.2009.1466; LONGINI IM, 1988, AM J EPIDEMIOL, V128, P639, DOI 10.1093/oxfordjournals.aje.a115011; MacIntyre CR, 2011, INFLUENZA OTHER RESP, V5, P170, DOI 10.1111/j.1750-2659.2011.00198.x; Maclntyre CR, 2009, EMERG INFECT DIS, V15, P233, DOI 10.3201/eid1502.081167; Madhi SA, 2011, CLIN INFECT DIS, V52, P128, DOI 10.1093/cid/ciq004; McClellan K, 2001, DRUGS, V61, P263, DOI 10.2165/00003495-200161020-00011; Miller AE, 1997, NEUROLOGY, V48, P312, DOI 10.1212/WNL.48.2.312; Monto AS, 2004, INT CONGR SER, V1263, P3, DOI 10.1016/j.ics.2004.02.049; Monto AS, 1999, JAMA-J AM MED ASSOC, V282, P31, DOI 10.1001/jama.282.1.31; MONTO AS, 1969, B WORLD HEALTH ORGAN, V41, P537; MONTO AS, 1985, AM J EPIDEMIOL, V121, P811, DOI 10.1093/oxfordjournals.aje.a114052; NAFTA I, 1970, B WORLD HEALTH ORGAN, V42, P423; Osterholm MT, 2011, LANCET INFECT DIS; Petrie JG, 2011, J INFECT DIS, V203, P1309, DOI 10.1093/infdis/jir015; PETTERSSON RF, 1980, J INFECT DIS, V142, P377, DOI 10.1093/infdis/142.3.377; Rabie T, 2006, TROP MED INT HEALTH, V11, P258, DOI 10.1111/j.1365-3156.2006.01568.x; Sandora TJ, 2008, PEDIATRICS, V121, pE1555, DOI 10.1542/peds.2007-2597; Sattar SA, 2000, INFECT CONT HOSP EP, V21, P516, DOI 10.1086/501796; Suntarattiwong P, 2009, PEDIAT INFECT DIS J; Turner RB, 2010, ANTIMICROB AGENTS CH, V54, P1363, DOI 10.1128/AAC.01498-09; Watanabe A, 2010, J MED VIROL, V82, P2110, DOI 10.1002/jmv.21914; Wilde JA, 1999, JAMA-J AM MED ASSOC, V281, P908, DOI 10.1001/jama.281.10.908; Zambon M, 2001, ARCH INTERN MED, V161, P2116, DOI 10.1001/archinte.161.17.2116	53	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2012	7	4							e35166	10.1371/journal.pone.0035166	http://dx.doi.org/10.1371/journal.pone.0035166			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UT	22514718	Green Published, gold			2022-12-25	WOS:000305341600124
J	Villalon, A; Sepulveda, M; Guerrero, N; Meynard, MM; Palma, K; Concha, ML				Villalon, Aldo; Sepulveda, Mauricio; Guerrero, Nestor; Meynard, Margarita M.; Palma, Karina; Concha, Miguel L.			Evolutionary Plasticity of Habenular Asymmetry with a Conserved Efferent Connectivity Pattern	PLOS ONE			English	Article							BRAIN ASYMMETRY; CEREBRAL LATERALIZATION; PINEAL COMPLEX; CICHLID FISH; ZEBRAFISH; NUCLEI; DIENCEPHALON; FOREBRAIN; BEHAVIOR; ORGANIZATION	The vertebrate habenulae (Hb) is an evolutionary conserved dorsal diencephalic nuclear complex that relays information from limbic and striatal forebrain regions to the ventral midbrain. One key feature of this bilateral nucleus is the presence of left-right differences in size, cytoarchitecture, connectivity, neurochemistry and/or gene expression. In teleosts, habenular asymmetry has been associated with preferential innervation of left-right habenular efferents into dorso-ventral domains of the midbrain interpeduncular nucleus (IPN). However, the degree of conservation of this trait and its relation to the structural asymmetries of the Hb are currently unknown. To address these questions, we performed the first systematic comparative analysis of structural and connectional asymmetries of the Hb in teleosts. We found striking inter-species variability in the overall shape and cytoarchitecture of the Hb, and in the frequency, strength and to a lesser degree, laterality of habenular volume at the population level. Directional asymmetry of the Hb was either to the left in D. rerio, E. bicolor, O. latipes, P. reticulata, B. splendens, or to the right in F. gardneri females. In contrast, asymmetry was absent in P. scalare and F. gardneri males at the population level, although in these species the Hb displayed volumetric asymmetries at the individual level. Inter-species variability was more pronounced across orders than within a single order, and coexisted with an overall conserved laterotopic representation of left-right habenular efferents into dorso-ventral domains of the IPN. These results suggest that the circuit design involving the Hb of teleosts promotes structural flexibility depending on developmental, cognitive and/or behavioural pressures, without affecting the main midbrain connectivity output, thus unveiling a key conserved role of this connectivity trait in the function of the circuit. We propose that ontogenic plasticity in habenular morphogenesis underlies the observed inter-species variations in habenular asymmetric morphology.	[Villalon, Aldo; Sepulveda, Mauricio; Guerrero, Nestor; Meynard, Margarita M.; Palma, Karina; Concha, Miguel L.] BNI, Santiago, Chile; [Villalon, Aldo; Sepulveda, Mauricio; Guerrero, Nestor; Meynard, Margarita M.; Palma, Karina; Concha, Miguel L.] Univ Chile, Fac Med, Anat & Dev Biol Program, Inst Biomed Sci, Santiago 7, Chile; [Villalon, Aldo] Univ Diego Portales, Fac Med, Santiago, Chile	Universidad de Chile; University Diego Portales	Villalon, A (corresponding author), BNI, Santiago, Chile.	mconcha@med.uchile.cl	Palma, Karina/AAL-7009-2021; Concha, Miguel/I-2551-2013	Palma, Karina/0000-0001-6105-6436; Concha, Miguel/0000-0003-3353-9398	FONDECYT [1090242]; Millennium Initiative [P07-048-F, P09-015-F]; Howard Hughes Medical Institute [INTNL 55005940]; Commission of the European Communities [FP6-2004-NEST-PATH EDCBNL]	FONDECYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Millennium Initiative; Howard Hughes Medical Institute(Howard Hughes Medical Institute); Commission of the European Communities(European Commission)	This work was funded by FONDECYT (1090242), the Millennium Initiative (P07-048-F and P09-015-F), Howard Hughes Medical Institute (INTNL 55005940), and the Commission of the European Communities (FP6-2004-NEST-PATH EDCBNL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agetsuma M, 2010, NAT NEUROSCI, V13, P1354, DOI 10.1038/nn.2654; Aizawa H, 2005, CURR BIOL, V15, P238, DOI 10.1016/j.cub.2005.01.014; Aizawa H, 2007, DEV CELL, V12, P87, DOI 10.1016/j.devcel.2006.10.004; Aizawa H, 2011, FRONT NEUROSCI-SWITZ, V5, DOI 10.3389/fnins.2011.00138; Amo R, 2010, J NEUROSCI, V30, P1566, DOI 10.1523/JNEUROSCI.3690-09.2010; Andres KH, 1999, J COMP NEUROL, V407, P130, DOI 10.1002/(SICI)1096-9861(19990428)407:1<130::AID-CNE10>3.0.CO;2-8; Bianco IH, 2009, PHILOS T R SOC B, V364, P1005, DOI 10.1098/rstb.2008.0213; Bianco IH, 2008, NEURAL DEV, V3, DOI 10.1186/1749-8104-3-9; Bianki V. L., 2001, SEX DIFFERENCES LATE; Bisazza A, 2000, LATERALITY, V5, P269, DOI 10.1080/135765000406111; Bolker JA, 2000, AM ZOOL, V40, P770, DOI 10.1668/0003-1569(2000)040[0770:MIDAWI]2.0.CO;2; BRAITENBERG V, 1970, Journal of Comparative Neurology, V138, P137, DOI 10.1002/cne.901380203; Cerda-Reverter JM, 2001, J MORPHOL, V247, P229, DOI 10.1002/1097-4687(200103)247:3<229::AID-JMOR1014>3.0.CO;2-K; Clotfelter ED, 2007, BRAIN BEHAV EVOLUT, V69, P169, DOI 10.1159/000096985; Concha ML, 2009, SEMIN CELL DEV BIOL, V20, P498, DOI 10.1016/j.semcdb.2008.11.007; Concha ML, 2003, NEURON, V39, P423, DOI 10.1016/S0896-6273(03)00437-9; Concha ML, 2001, J ANAT, V199, P63, DOI 10.1046/j.1469-7580.2001.19910063.x; Concha ML, 2000, NEURON, V28, P399, DOI 10.1016/S0896-6273(00)00120-3; Diaz E, 2011, J COMP NEUROL, V519, P3727, DOI 10.1002/cne.22687; ENGBRETSON GA, 1981, J COMP NEUROL, V198, P155, DOI 10.1002/cne.901980113; EWING AW, 1975, BEHAVIOUR, V52, P172, DOI 10.1163/156853975X00029; Gamse JT, 2003, DEVELOPMENT, V130, P1059, DOI 10.1242/dev.00270; GOMEZSEGADE P, 1988, J MORPHOL, V197, P71, DOI 10.1002/jmor.1051970107; Guglielmotti V, 2006, BRAIN RES BULL, V69, P475, DOI 10.1016/j.brainresbull.2006.03.010; GURUSINGHE CJ, 1985, CELL TISSUE RES, V240, P149; Gutierrez-Ibanez C, 2011, BEHAV BRAIN RES, V221, P189, DOI 10.1016/j.bbr.2011.03.001; Hikosaka O, 2010, NAT REV NEUROSCI, V11, P503, DOI 10.1038/nrn2866; HOLMGREN N, 1920, ACTA ZOOLOGICA, V1, P137; Jones EG, 2006, THALAMUS, P1315; KEMALI M, 1990, BRAIN RES, V517, P251, DOI 10.1016/0006-8993(90)91034-E; Kuan YS, 2007, J EXP ZOOL PART B, V308B, P669, DOI 10.1002/jez.b.21184; Lee A, 2010, CURR BIOL, V20, P2211, DOI 10.1016/j.cub.2010.11.025; Miller RN, 1940, J COMP NEUROL, V73, P345, DOI 10.1002/cne.900730302; NELSON JS, 2006, FISHES WORLD, pR19; Nieuwenhuys R, 1977, Ann N Y Acad Sci, V299, P97, DOI 10.1111/j.1749-6632.1977.tb41902.x; Nissl F., 1892, ALLG Z PSYCHIAT, V48, P197; Okamoto H, 2011, DEV NEUROBIOL; Reddon AR, 2008, BIOL LETTERS, V4, P338, DOI 10.1098/rsbl.2008.0206; Reddon AR, 2009, BEHAV BRAIN RES, V201, P223, DOI 10.1016/j.bbr.2009.02.015; SCHNITZLEIN HN, 1962, J COMP NEUROL, V118, P225, DOI 10.1002/cne.901180208; Shanklin WM, 1935, PHILOS T R SOC B, V516, P361; Signore IA, 2009, PHILOS T R SOC B, V364, P991, DOI 10.1098/rstb.2008.0260; Stephenson-Jones M, 2011, P NATL ACAD SCI US; STEYN W, 1960, ANAT REC, V136, P79, DOI 10.1002/ar.1091360202; Wagner GP, 2007, NAT REV GENET, V8, P921, DOI 10.1038/nrg2267; Winther RG, 2001, J EXP ZOOL, V291, P116, DOI 10.1002/jez.1064; Wolf M, 2007, NATURE, V447, P581, DOI 10.1038/nature05835; WREE A, 1981, ANAT EMBRYOL, V161, P419, DOI 10.1007/BF00316052; Zilles K, 1976, J Hirnforsch, V17, P1	49	22	23	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2012	7	4							e35329	10.1371/journal.pone.0035329	http://dx.doi.org/10.1371/journal.pone.0035329			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UT	22514727	Green Submitted, Green Published, gold			2022-12-25	WOS:000305341600132
J	Moller, AP; Bonisoli-Alquati, A; Rudolfsen, G; Mousseau, TA				Moller, Anders Pape; Bonisoli-Alquati, Andrea; Rudolfsen, Geir; Mousseau, Timothy A.			Elevated Mortality among Birds in Chernobyl as Judged from Skewed Age and Sex Ratios	PLOS ONE			English	Article							BARN SWALLOWS; RADIATION; ANTIOXIDANTS; ABUNDANCE	Background: Radiation has negative effects on survival of animals including humans, although the generality of this claim is poorly documented under low-dose field conditions. Because females may suffer disproportionately from the effects of radiation on survival due to differences in sex roles during reproduction, radiation-induced mortality may result in male-skewed adult sex ratios. Methodology/Principal Finding: We estimated the effects of low-dose radiation on adult survival rates in birds by determining age ratios of adults captured in mist nets during the breeding season in relation to background radiation levels around Chernobyl and in nearby uncontaminated control areas. Age ratios were skewed towards yearlings, especially in the most contaminated areas, implying that adult survival rates were reduced in contaminated areas, and that populations in such areas could only be maintained through immigration from nearby uncontaminated areas. Differential mortality in females resulted in a strongly male-skewed sex ratio in the most contaminated areas. In addition, males sang disproportionately commonly in the most contaminated areas where the sex ratio was male skewed presumably because males had difficulty finding and acquiring mates when females were rare. The results were not caused by permanent emigration by females from the most contaminated areas because none of the recaptured birds had changed breeding site, and the proportion of individuals with morphological abnormalities did not differ significantly between the sexes for areas with normal and higher levels of contamination. Conclusions/Significance: These findings are consistent with the hypothesis that the adult survival rate of female birds is particularly susceptible to the effects of low-dose radiation, resulting in male skewed sex ratios at high levels of radiation. Such skewed age ratios towards yearlings in contaminated areas are consistent with the hypothesis that an area exceeding 30,000 km(2) in Chernobyl's surroundings constitutes an ecological trap that causes dramatic excess mortality.	[Moller, Anders Pape] Univ Paris 11, CNRS, UMR 8079, Lab Ecol Systemat & Evolut, F-91405 Orsay, France; [Bonisoli-Alquati, Andrea; Mousseau, Timothy A.] Univ S Carolina, Dept Biol Sci, Columbia, SC 29208 USA; [Rudolfsen, Geir] Fram Ctr, Dept Environm Radioact, NRPA, Tromso, Norway	AgroParisTech; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Universite Paris Saclay; University of South Carolina; University of South Carolina System; University of South Carolina Columbia	Moller, AP (corresponding author), Univ Paris 11, CNRS, UMR 8079, Lab Ecol Systemat & Evolut, Batiment 362, F-91405 Orsay, France.	anders.moller@u-psud.fr	Moller, Anders/O-6665-2016; Alquati, Andrea Bonisoli/S-2082-2017; Rudolfsen, Geir/ABD-7777-2020; Mousseau, Timothy A/A-1253-2011	Moller, Anders/0000-0003-3739-4675; Alquati, Andrea Bonisoli/0000-0002-9255-7556; Mousseau, Timothy/0000-0002-2235-4868; Rudolfsen, Geir/0000-0001-7984-8458	US National Science Foundation; University of South Carolina School of the Environment; CNRS; National Geographic Society; NATO; Samuel Freeman Charitable Trust	US National Science Foundation(National Science Foundation (NSF)); University of South Carolina School of the Environment; CNRS(Centre National de la Recherche Scientifique (CNRS)); National Geographic Society(National Geographic Society); NATO(NATO (North Atlantic Treaty Organisation)); Samuel Freeman Charitable Trust	We gratefully acknowledge support from the US National Science Foundation, the University of South Carolina School of the Environment, the CNRS, the National Geographic Society, the NATO Collaborative Linkage Grant program, and the Samuel Freeman Charitable Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bibby CJ, 2005, BIRD CENSUS TECHNIQU; Blount JD, 2000, TRENDS ECOL EVOL, V15, P47, DOI 10.1016/S0169-5347(99)01774-7; Bonisoli-Alquati A, 2010, COMP BIOCHEM PHYS A, V155, P205, DOI 10.1016/j.cbpa.2009.10.041; Bromet EJ, 2011, CLIN ONCOL-UK, V23, P297, DOI 10.1016/j.clon.2011.01.501; Burnham K.P., 2002, MODEL SELECTION MULT, DOI 10.1007/b97636; Catchpole CK, 2008, BIRD SONG: BIOLOGICAL THEMES AND VARIATIONS, 2ND EDITION, P1, DOI 10.1017/CBO9780511754791; Chernobyl Forum, 2005, CHERN TRUE SCAL ACC; Chernobyl Forum Expert Group `Environment', 2006, ENV CONS CHERN ACC T; Cramp S, 1988, BIRDS W PALEARCTIC, V1-9; Dunn Erica H., 2004, Studies in Avian Biology, P1; European Union, 1998, 16733 EUR EUR UN, P16733; Garamszegi LZ, 2007, BEHAV ECOL, V18, P86, DOI 10.1093/beheco/arl047; Gaschak S. P., 2008, Radiatsionnaya Biologiya Radioekologiya, V48, P28; Moller AP, 2007, BIOLOGY LETT, V3, P483, DOI 10.1098/rsbl.2007.0226; Moller AP, 2007, J APPL ECOL, V44, P909, DOI 10.1111/j.1365-2664.2007.01353.x; Moller AP, 2007, BIOL LETTERS, V3, P414, DOI 10.1098/rsbl.2007.0136; Moller AP, 2006, ECOL APPL, V16, P1696, DOI 10.1890/1051-0761(2006)016[1696:CAAPSF]2.0.CO;2; Moller AP, 2011, BIOL CONSERV, V144, P2787, DOI 10.1016/j.biocon.2011.08.009; Moller AP, 2008, J COMP PHYSIOL B, V178, P735, DOI 10.1007/s00360-008-0262-z; Moller AP, 2011, ECOL INDIC, V11, P424, DOI 10.1016/j.ecolind.2010.06.013; Moller AP, 2009, J ORNITHOL, V150, P239, DOI 10.1007/s10336-008-0343-5; Moller AP, 2005, J ANIM ECOL, V74, P1102, DOI 10.1111/j.1365-2656.2005.01009.x; Moller AP, 2005, P ROY SOC B-BIOL SCI, V272, P247, DOI 10.1098/rspb.2004.2914; Moller AP, 2001, OIKOS, V92, P27, DOI 10.1034/j.1600-0706.2001.920104.x; Moller AP., 1994, SEXUAL SELECTION BAR; Moller AP, 1983, METHODS MONITORING B; Nesterenko AV, 2009, ANN NY ACAD SCI, V1181, P1, DOI 10.1111/j.1749-6632.2009.04819.x; Rahu M, 2003, EUR J CANCER, V39, P295, DOI 10.1016/S0959-8049(02)00764-5; Rankin DJ, 2007, OIKOS, V116, P335, DOI [10.1111/j.2006.0030-1299.15451.x, 10.1111/j.0030-1299.2007.15451.x]; Ricklefs RE, 1997, ECOL MONOGR, V67, P23, DOI 10.1890/0012-9615(1997)067[0023:CDONWP]2.0.CO;2; Robertson BA, 2006, ECOLOGY, V87, P1075, DOI 10.1890/0012-9658(2006)87[1075:AFFUET]2.0.CO;2; SAS Institute Inc, 2000, JMP; Shestopalov V. M., 1996, ATLAS CHERNOBYL EXCL; SNOW D. W., 1956, BRIT BIRDS, V49, P174; Svensson L.A., 2006, IDENTIFICATION GUIDE; Vorisek P, 2010, BEST PRACTICE GUIDE	36	29	29	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2012	7	4							e35223	10.1371/journal.pone.0035223	http://dx.doi.org/10.1371/journal.pone.0035223			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TP	22514722	gold, Green Published, Green Submitted			2022-12-25	WOS:000305336600094
J	Chan, SC; Li, YM; Dehm, SM				Chan, Siu Chiu; Li, Yingming; Dehm, Scott M.			Androgen Receptor Splice Variants Activate Androgen Receptor Target Genes and Support Aberrant Prostate Cancer Cell Growth Independent of Canonical Androgen Receptor Nuclear Localization Signal	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STEROID-RECEPTORS; STRUCTURAL BASIS; DNA-BINDING; IN-VIVO; RESISTANT; DOMAIN; TRANSACTIVATION; IDENTIFICATION; ABIRATERONE; EXPRESSION	Synthesis of truncated androgen receptor (AR) splice variants has emerged as an important mechanism of prostate cancer (PCa) resistance to AR-targeted therapy and progression to a lethal castration-resistant phenotype. However, the precise role of these factors at this stage of the disease is not clear due to loss of multiple COOH-terminal AR protein domains, including the canonical nuclear localization signal (NLS) in the AR hinge region. Despite loss of this NLS, we show that diverse truncated AR variant species have a basal level of nuclear localization sufficient for ligand-independent transcriptional activity. Whereas full-length AR requires Hsp90 and importin-beta for active nuclear translocation, basal nuclear localization of truncated AR variants is independent of these classical signals. For a subset of truncated AR variants, this basal level of nuclear import can be augmented by unique COOH-terminal sequences that reconstitute classical AR NLS activity. However, this property is separable from ligand-independent transcriptional activity. Therefore, the AR splice variant core consisting of the AR NH2-terminal domain and DNA binding domain is sufficient for nuclear localization and androgen-independent transcriptional activation of endogenous AR target genes. Indeed, we show that truncated AR variants with nuclear as well as nuclear/cytoplasmic localization patterns can drive androgen-independent growth of PCa cells. Together, our data demonstrate that diverse truncated AR species with varying efficiencies of nuclear localization can contribute to castration-resistant PCa pathology by driving persistent ligand-independent AR transcriptional activity.	[Chan, Siu Chiu; Li, Yingming; Dehm, Scott M.] Univ Minnesota, Masonic Canc Ctr, Minneapolis, MN 55455 USA; [Dehm, Scott M.] Univ Minnesota, Dept Lab Med & Pathol, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Dehm, SM (corresponding author), Univ Minnesota, Masonic Canc Ctr, Mayo Mail Code 806,420 Delaware St SE, Minneapolis, MN 55455 USA.	dehm@umn.edu			National Institutes of Health (NCI) [CA141011]; Prostate Cancer Foundation; American Cancer Society [RSG-12-031-01]; Department of Defense [PC094384]; NATIONAL CANCER INSTITUTE [R21CA141011] Funding Source: NIH RePORTER	National Institutes of Health (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Prostate Cancer Foundation; American Cancer Society(American Cancer Society); Department of Defense(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA141011 (NCI; to S. M. D.). This work was also supported by a Prostate Cancer Foundation Young Investigator Award (to S. M. D.), an American Cancer Society Research Scholar Grant (RSG-12-031-01 (to S. M. D.), and a Department of Defense Prostate Cancer Research Program New Investigator Award (PC094384 (to S. M. D.)).	Andersen RJ, 2010, CANCER CELL, V17, P535, DOI 10.1016/j.ccr.2010.04.027; Black BE, 2004, TRENDS ENDOCRIN MET, V15, P411, DOI 10.1016/j.tem.2004.09.006; BONNEKOH B, 1989, ARCH DERMATOL RES, V281, P487, DOI 10.1007/BF00510085; Cai CM, 2011, CANCER CELL, V20, P457, DOI 10.1016/j.ccr.2011.09.001; Callewaert L, 2006, CANCER RES, V66, P543, DOI 10.1158/0008-5472.CAN-05-2389; CATELLI MG, 1985, EMBO J, V4, P3131, DOI 10.1002/j.1460-2075.1985.tb04055.x; Cintron NS, 2006, J BIOL CHEM, V281, P26235, DOI 10.1074/jbc.M605417200; Cutress ML, 2008, J CELL SCI, V121, P957, DOI 10.1242/jcs.022103; De Bono JS, 2011, NEW ENGL J MED, V364, P1995, DOI 10.1056/NEJMoa1014618; Dehm SM, 2008, CANCER RES, V68, P5469, DOI 10.1158/0008-5472.CAN-08-0594; Dehm SM, 2007, MOL ENDOCRINOL, V21, P2855, DOI 10.1210/me.2007-0223; Dehm SM, 2007, CANCER RES, V67, P10067, DOI 10.1158/0008-5472.CAN-07-1267; Dehm SM, 2006, J BIOL CHEM, V281, P27882, DOI 10.1074/jbc.M605002200; Dehm SM, 2011, ENDOCR-RELAT CANCER, V18, pR183, DOI 10.1530/ERC-11-0141; DELAUNOIT Y, 1991, CANCER RES, V51, P5165; Dull T, 1998, J VIROL, V72, P8463, DOI 10.1128/JVI.72.11.8463-8471.1998; Fang YF, 1996, J BIOL CHEM, V271, P28697, DOI 10.1074/jbc.271.45.28697; Fu MF, 2002, MOL CELL BIOL, V22, P3373, DOI 10.1128/MCB.22.10.3373-3388.2002; Fu MF, 2000, J BIOL CHEM, V275, P20853, DOI 10.1074/jbc.M000660200; Garraway LA, 2006, NAT REV CANCER, V6, P593, DOI 10.1038/nrc1947; Guo ZY, 2009, CANCER RES, V69, P2305, DOI 10.1158/0008-5472.CAN-08-3795; Haelens A, 2007, CANCER RES, V67, P4514, DOI 10.1158/0008-5472.CAN-06-1701; Hernandez MP, 2002, J BIOL CHEM, V277, P11873, DOI 10.1074/jbc.M111445200; Hofman K, 2001, BIOCHEM BIOPH RES CO, V283, P97, DOI 10.1006/bbrc.2001.4738; Hornberg E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019059; Hu R, 2011, PROSTATE, V71, P1656, DOI 10.1002/pros.21382; Hu R, 2009, CANCER RES, V69, P16, DOI 10.1158/0008-5472.CAN-08-2764; Isken O, 2008, NAT REV GENET, V9, P699, DOI 10.1038/nrg2402; JENSTER G, 1995, J BIOL CHEM, V270, P7341, DOI 10.1074/jbc.270.13.7341; Kaku N, 2008, ENDOCRINOLOGY, V149, P3960, DOI 10.1210/en.2008-0137; Knudsen KE, 2009, CLIN CANCER RES, V15, P4792, DOI 10.1158/1078-0432.CCR-08-2660; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Li Y, 2012, ONCOGENE IN PRESS; Li YM, 2011, CANCER RES, V71, P2108, DOI 10.1158/0008-5472.CAN-10-1998; Mostaghel EA, 2011, CLIN CANCER RES, V17, P5913, DOI 10.1158/1078-0432.CCR-11-0728; Ripple MO, 1997, JNCI-J NATL CANCER I, V89, P40, DOI 10.1093/jnci/89.1.40; Saporita AJ, 2003, J BIOL CHEM, V278, P41998, DOI 10.1074/jbc.M302460200; Shaffer PL, 2004, P NATL ACAD SCI USA, V101, P4758, DOI 10.1073/pnas.0401123101; Smith DF, 2008, MOL ENDOCRINOL, V22, P2229, DOI 10.1210/me.2008-0089; Stewart M, 1998, J MOL BIOL, V284, P1517, DOI 10.1006/jmbi.1998.2204; Sun SH, 2010, J CLIN INVEST, V120, P2715, DOI 10.1172/JCI41824; Tanner TM, 2010, CELL MOL LIFE SCI, V67, P1919, DOI 10.1007/s00018-010-0302-1; Wang QB, 2009, CELL, V138, P245, DOI 10.1016/j.cell.2009.04.056; Watson PA, 2010, P NATL ACAD SCI USA, V107, P16759, DOI 10.1073/pnas.1012443107; ZHOU ZX, 1994, J BIOL CHEM, V269, P13115; Zufferey R, 1997, NAT BIOTECHNOL, V15, P871, DOI 10.1038/nbt0997-871	46	169	173	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 1	2012	287	23					19736	19749		10.1074/jbc.M112.352930	http://dx.doi.org/10.1074/jbc.M112.352930			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974EF	22532567	Green Published, hybrid			2022-12-25	WOS:000306411900083
J	Ramilo, DW; Diaz, S; da Fonseca, IP; Delecolle, JC; Wilson, A; Meireles, J; Lucientes, J; Ribeiro, R; Boinas, F				Ramilo, David W.; Diaz, Suraya; da Fonseca, Isabel Pereira; Delecolle, Jean-Claude; Wilson, Anthony; Meireles, Jose; Lucientes, Javier; Ribeiro, Rita; Boinas, Fernando			First Report of 13 Species of Culicoides (Diptera: Ceratopogonidae) in Mainland Portugal and Azores by Morphological and Molecular Characterization	PLOS ONE			English	Article							AFRICAN HORSE SICKNESS; BITING MIDGES; BLUETONGUE; EPIDEMIOLOGY; VECTORS	The genus Culicoides (Diptera: Ceratopogonidae) contains important vectors of animal and human diseases, including bluetongue, African horse sickness and filariosis. A major outbreak of bluetongue occurred in mainland Portugal in 2004, forty eight years after the last recorded case. A national Entomological Surveillance Plan was initiated in mainland Portugal, Azores and the Madeira archipelagos in 2005 in order to better understand the disease and facilitate policy decisions. During the survey, the most prevalent Culicoides species in mainland Portugal was C. imicola (75.3%) and species belonging to the Obsoletus group (6.5%). The latter were the most prevalent in Azores archipelago, accounting for 96.7% of the total species identified. The Obsoletus group was further characterized by multiplex Polymerase Chain Reaction to species level showing that only two species of this group were present: C. obsoletus sensu strictu (69.6%) and C. scoticus (30.4%). Nine species of Culicoides were detected for the first time in mainland Portugal: C. alazanicus, C. bahrainensis, C. deltus, C. lupicaris, C. picturatus, C. santonicus, C. semimaculatus, C. simulator and C. subfagineus. In the Azores, C. newsteadi and C. circumscriptus were identified for the first time from some islands, and bluetongue vectors belonging to the Obsoletus group (C. obsoletus and C. scoticus) were found to be widespread.	[Ramilo, David W.; Diaz, Suraya; da Fonseca, Isabel Pereira; Meireles, Jose; Ribeiro, Rita; Boinas, Fernando] Univ Tecn Lisboa, Fac Vet Med, Interdisciplinary Ctr Res Anim Hlth CIISA, Lisbon, Portugal; [Delecolle, Jean-Claude] Fac Med, Inst Parasitol & Trop Pathol, Entomol Lab, Strasbourg, France; [Wilson, Anthony] AFRC, Inst Anim Hlth, Pirbright Lab, Woking GU24 0NF, Surrey, England; [Lucientes, Javier] Univ Zaragoza, Fac Vet, Dept Anim Pathol Anim Hlth, Zaragoza, Spain	Universidade de Lisboa; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute; Pirbright Institute; University of Zaragoza	Ramilo, DW (corresponding author), Univ Tecn Lisboa, Fac Vet Med, Interdisciplinary Ctr Res Anim Hlth CIISA, Lisbon, Portugal.	ifonseca@fmv.utl.pt	Boinas, Fernando/AAD-9779-2022; Pereira da Fonseca, I/AAR-2441-2021; da Fonseca, Isabel Pereira/AAY-1828-2021	Boinas, Fernando/0000-0001-6259-4404; Pereira da Fonseca, I/0000-0002-6632-1224; Wilson, Anthony/0000-0002-2000-2914; Ramilo, David/0000-0003-4096-2581; Meireles, Jose/0000-0002-3001-2809; Ribeiro, Rita/0000-0002-9976-3731	Direccao-Geral de Veterinaria of Portugal; Faculty of Veterinary Medicine of the Technical University of Lisbon; Biotechnology and Biological Sciences Research Council [BBS/E/I/00001409] Funding Source: researchfish; BBSRC [BBS/E/I/00001409] Funding Source: UKRI	Direccao-Geral de Veterinaria of Portugal; Faculty of Veterinary Medicine of the Technical University of Lisbon; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Sources of funding include Direccao-Geral de Veterinaria of Portugal and Faculty of Veterinary Medicine of the Technical University of Lisbon. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alahmed A. M., 2010, Journal of Entomology, V7, P227; Barros SC, 2007, VET MICROBIOL, V124, P25, DOI 10.1016/j.vetmic.2007.04.014; Borkent A, 2011, NUMBERS EXTANT FOSSI; Capela R, 2003, MED VET ENTOMOL, V17, P165, DOI 10.1046/j.1365-2915.2003.00419.x; da Silva VNRB, 2008, SURVEILLANCE VECTOR; Delecolle J-C, 1985, NOUVELLE CONTRIBUITI; Diaz S., 2005, LIST TERRESTRIAL FAU; Guis H, 2007, GEOMATIQUE EPIDEMIOL; Haubruge E., 2008, ECOLOGY CULICOIDES B; LINLEY JR, 1983, J MED ENTOMOL, V20, P347, DOI 10.1093/jmedent/20.4.347; Mathieu B, 2010, INTERACTIVE IDENTIFI, P201; Mellor PS, 2000, ANNU REV ENTOMOL, V45, P307, DOI 10.1146/annurev.ento.45.1.307; Nolan DV, 2007, VET MICROBIOL, V124, P82, DOI 10.1016/j.vetmic.2007.03.019; Pages N, 2009, CULICOIDES SPECIES S; Pena I, 2003, CONTRIBUICAO ESTUDO; Portas M, 1999, EPIDEMIOL INFECT, V123, P337, DOI 10.1017/S0950268899002897; Purse BV, 2005, NAT REV MICROBIOL, V3, P171, DOI 10.1038/nrmicro1090; Rawlings Peter, 1996, Graellsia, V52, P57; Saegerman C, 2008, EMERG INFECT DIS, V14, P539, DOI 10.3201/eid1404.071441; Venter GJ, 2009, VET PARASITOL, V166, P299, DOI 10.1016/j.vetpar.2009.08.020; Vila-Vicosa MJM, 2009, GENERO CULICOIDES LA; Wilson A, 2008, PARASITOL RES, V103, pS69, DOI 10.1007/s00436-008-1053-x	22	16	18	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2012	7	4							e34896	10.1371/journal.pone.0034896	http://dx.doi.org/10.1371/journal.pone.0034896			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TL	22536340	Green Published, Green Submitted, gold			2022-12-25	WOS:000305336200012
J	Sinha, S; Redfield, RJ				Sinha, Sunita; Redfield, Rosemary J.			Natural DNA Uptake by Escherichia coli	PLOS ONE			English	Article							COMPETENCE GENE HOMOLOGS; HAEMOPHILUS-INFLUENZAE; VIBRIO-CHOLERAE; PLASMID TRANSFORMATION; BINDING; PROTEIN; STRAINS; K-12; CELLS; IDENTIFICATION	Escherichia coli has homologues of the competence genes other species use for DNA uptake and processing, but natural competence and transformation have never been detected. Although we previously showed that these genes are induced by the competence regulator Sxy as in other gamma-proteobacteria, no conditions are known that naturally induce sxy expression. We have now tested whether the competence gene homologues encode a functional DNA uptake machinery and whether DNA uptake leads to recombination, by investigating the effects of plasmid-borne sxy expression on natural competence in a wide variety of E. coli strains. High-and low-level sxy expression alone did not induce transformation in any of the strains tested, despite varying the transforming DNA, its concentration, and the incubation conditions used. Direct measurements of uptake of radiolabelled DNA were below the limit of detection, however transformants were readily detected when recombination functions were provided by the lambda Red recombinase. This is the first demonstration that E. coli sxy expression can induce natural DNA uptake and that E. coli's competence genes do encode a functional uptake machinery. However, the amount of transformation cells undergo is limited both by low levels of DNA uptake and by inefficient DNA processing/recombination.	[Sinha, Sunita; Redfield, Rosemary J.] Univ British Columbia, Dept Zool, Vancouver, BC, Canada	University of British Columbia	Sinha, S (corresponding author), Univ British Columbia, Dept Zool, Vancouver, BC, Canada.	sinha@zoology.ubc.ca	Redfield, Rosemary/K-5633-2012	Redfield, Rosemary/0000-0001-8940-587X	Canadian Institute of Health Research	Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR))	This study was funded by a research grant from the Canadian Institute of Health Research to RJR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	APPLEYARD RK, 1954, GENETICS, V39, P440; Archer CT, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-9; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; BACHMANN BJ, 1972, BACTERIOL REV, V36, P525, DOI 10.1128/MMBR.36.4.525-557.1972; BARTOLOME B, 1991, GENE, V102, P75, DOI 10.1016/0378-1119(91)90541-I; Bauer F, 1999, SYST APPL MICROBIOL, V22, P161, DOI 10.1016/S0723-2020(99)80061-7; Baur B, 1996, APPL ENVIRON MICROB, V62, P3673, DOI 10.1128/AEM.62.10.3673-3678.1996; BERGMANS HEN, 1981, J BACTERIOL, V146, P564, DOI 10.1128/JB.146.2.564-570.1981; Blokesch M, 2012, ENV MICROBIOL; Bosse JT, 2009, FEMS MICROBIOL LETT, V298, P124, DOI 10.1111/j.1574-6968.2009.01706.x; BUKAU B, 1985, J BACTERIOL, V163, P61, DOI 10.1128/JB.163.1.61-68.1985; Cameron ADS, 2008, NUCLEIC ACIDS RES, V36, P10, DOI 10.1093/nar/gkm915; Cameron ADS, 2006, NUCLEIC ACIDS RES, V34, P6001, DOI 10.1093/nar/gkl734; Chen SF, 2001, J MOL BIOL, V314, P75, DOI 10.1006/jmbi.2001.5090; COSLOY SD, 1973, P NATL ACAD SCI USA, V70, P84, DOI 10.1073/pnas.70.1.84; DAGERT M, 1979, GENE, V6, P23, DOI 10.1016/0378-1119(79)90082-9; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Dubnau D, 1999, ANNU REV MICROBIOL, V53, P217, DOI 10.1146/annurev.micro.53.1.217; Etchuuya R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016355; Finkel SE, 2001, J BACTERIOL, V183, P6288, DOI 10.1128/JB.183.21.6288-6293.2001; Grainger DC, 2005, P NATL ACAD SCI USA, V102, P17693, DOI 10.1073/pnas.0506687102; GUTTERSON NI, 1983, P NATL ACAD SCI-BIOL, V80, P4894, DOI 10.1073/pnas.80.16.4894; HANAHAN D, 1983, J MOL BIOL, V166, P557, DOI 10.1016/S0022-2836(83)80284-8; INOUE H, 1990, GENE, V96, P23, DOI 10.1016/0378-1119(90)90336-P; Kitagawa M, 2005, DNA RES, V12, P291, DOI 10.1093/dnares/dsi012; KOOISTRA J, 1976, J BACTERIOL, V128, P549, DOI 10.1128/JB.128.2.549-556.1976; Lawson CL, 2004, CURR OPIN STRUC BIOL, V14, P10, DOI 10.1016/j.sbi.2004.01.012; Maeda S, 2006, FEMS MICROBIOL LETT, V255, P115, DOI 10.1111/j.1574-6968.2005.00072.x; Maeda S, 2004, FEMS MICROBIOL LETT, V236, P61, DOI 10.1111/j.1574-6968.2004.tb09627.x; Marvig RL, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-155; Maughan H, 2009, EVOLUTION, V63, P1852, DOI 10.1111/j.1558-5646.2009.00658.x; Meibom KL, 2005, SCIENCE, V310, P1824, DOI 10.1126/science.1120096; OCHMAN H, 1984, J BACTERIOL, V157, P690, DOI 10.1128/JB.157.2.690-693.1984; Palchevskiy V, 2006, J BACTERIOL, V188, P3902, DOI 10.1128/JB.01974-05; Pollack-Berti A, 2010, ENVIRON MICROBIOL, DOI [10.1111/j.1462-2920.2011.02689.x, DOI 10.1111/J.1462-2920.2011.02689.X]; REDFIELD RJ, 1991, J BACTERIOL, V173, P5612, DOI 10.1128/jb.173.18.5612-5618.1991; Redfield RJ, 2005, J MOL BIOL, V347, P735, DOI 10.1016/j.jmb.2005.01.012; SABELNIKOV AG, 1979, MOL GEN GENET, V172, P313, DOI 10.1007/BF00271731; SABELNIKOV AG, 1975, MOL GEN GENET, V138, P351, DOI 10.1007/BF00264805; Sauvonnet N, 2000, EMBO J, V19, P2221, DOI 10.1093/emboj/19.10.2221; Sauvonnet N, 2000, J BACTERIOL, V182, P848, DOI 10.1128/JB.182.3.848-854.2000; Sinha S, 2009, J BACTERIOL, V191, P5180, DOI 10.1128/JB.00476-09; Sobue R, 2011, FEBS LETT, V585, P2223, DOI 10.1016/j.febslet.2011.05.040; Suckow G, 2011, J BACTERIOL, V193, P4914, DOI 10.1128/JB.05396-11; Sun DC, 2006, FEMS MICROBIOL LETT, V265, P249, DOI 10.1111/j.1574-6968.2006.00503.x; Sun DC, 2009, J BACTERIOL, V191, P713, DOI 10.1128/JB.01130-08; Tarry M, 2011, J MOL BIOL, V409, P642, DOI 10.1016/j.jmb.2011.04.034; Tracy E, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-101; Tsen SD, 2002, J BIOMED SCI, V9, P246, DOI 10.1159/000059425; VANDIE IM, 1983, J GEN MICROBIOL, V129, P663; VanWagoner TM, 2004, J BACTERIOL, V186, P6409, DOI 10.1128/JB.186.19.6409-6421.2004; WACKERNAGEL W, 1973, BIOCHEM BIOPH RES CO, V51, P306, DOI 10.1016/0006-291X(73)91257-6; Warming S, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni035; WESTON A, 1981, J BACTERIOL, V145, P780, DOI 10.1128/JB.145.2.780-787.1981; WILCOX KW, 1975, J BACTERIOL, V122, P443, DOI 10.1128/JB.122.2.443-453.1975; Woegerbauer M, 2002, APPL ENVIRON MICROB, V68, P440, DOI 10.1128/AEM.68.1.440-443.2002; Yamamoto S, 2011, J BACTERIOL, V193, P1953, DOI 10.1128/JB.01340-10; Yamamoto S, 2010, GENE, V457, P42, DOI 10.1016/j.gene.2010.03.003; Yu DG, 2000, P NATL ACAD SCI USA, V97, P5978, DOI 10.1073/pnas.100127597; ZULTY JJ, 1995, P NATL ACAD SCI USA, V92, P3616, DOI 10.1073/pnas.92.8.3616	60	29	31	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2012	7	4							e35620	10.1371/journal.pone.0035620	http://dx.doi.org/10.1371/journal.pone.0035620			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TL	22532864	Green Submitted, Green Published, gold			2022-12-25	WOS:000305336200063
J	de Biase, D; Visani, M; Morandi, L; Marucci, G; Taccioli, C; Cerasoli, S; Baruzzi, A; Pession, A				de Biase, Dario; Visani, Michela; Morandi, Luca; Marucci, Gianluca; Taccioli, Cristian; Cerasoli, Serenella; Baruzzi, Agostino; Pession, Annalisa		PERNO Study Grp	miRNAs Expression Analysis in Paired Fresh/Frozen and Dissected Formalin Fixed and Paraffin Embedded Glioblastoma Using Real-Time PCR	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; MICRORNA EXPRESSION; PATHOLOGY ARCHIVES; CANCER; PROLIFERATION; FROZEN; CELLS; GLIOMA	miRNAs are small molecules involved in gene regulation. Each tissue shows a characteristic miRNAs epression profile that could be altered during neoplastic transformation. Glioblastoma is the most aggressive brain tumour of the adult with a high rate of mortality. Recognizing a specific pattern of miRNAs for GBM could provide further boost for target therapy. The availability of fresh tissue for brain specimens is often limited and for this reason the possibility of starting from formalin fixed and paraffin embedded tissue (FFPE) could very helpful even in miRNAs expression analysis. We analysed a panel of 19 miRNAs in 30 paired samples starting both from FFPE and Fresh/Frozen material. Our data revealed that there is a good correlation in results obtained from FFPE in comparison with those obtained analysing miRNAs extracted from Fresh/Frozen specimen. In the few cases with a not good correlation value we noticed that the discrepancy could be due to dissection performed in FFPE samples. To the best of our knowledge this is the first paper demonstrating that the results obtained in miRNAs analysis using Real-Time PCR starting from FFPE specimens of glioblastoma are comparable with those obtained in Fresh/Frozen samples.	[de Biase, Dario; Visani, Michela; Pession, Annalisa] Univ Bologna, Dept Patol Sperimentale, Bologna, Italy; [de Biase, Dario; Morandi, Luca; Marucci, Gianluca] Univ Bologna, Dept Ematol & Sci Oncol, Bologna, Italy; [Taccioli, Cristian] UCL, Paul OGorman Canc Inst, Dept Canc Biol, London, England; [Cerasoli, Serenella] Anat Pathol Bufalini Hosp, Cesena, Italy; [Baruzzi, Agostino] Univ Bologna, IRCCS, Ist Sci Neurol Bologna, Bologna, Italy; [Baruzzi, Agostino] Univ Bologna, Dept Biomed & Neuromotor Sci, Bologna, Italy	University of Bologna; University of Bologna; University of London; University College London; IRCCS Istituto delle Scienze Neurologiche di Bologna (ISNB); University of Bologna; University of Bologna	de Biase, D (corresponding author), Univ Bologna, Dept Patol Sperimentale, Bologna, Italy.	dario.debiase@unibo.it	Meletti, Stefano/O-3622-2015; Immovilli, Paolo/AAC-8360-2021; Taccioli, Cristian/ABC-3379-2020; SILINI, ENRICO MARIA/AAB-8747-2019; bertolini, francesco/AAC-9780-2019; Franceschi, Claudio/L-4484-2017; Marucci, Gianluca/F-1426-2019; Rizzi, Romana/R-7051-2016; Morandi, Luca/A-3191-2016; fiorica, francesco/K-8036-2016; Leonardi, Marco/B-2961-2013; Baldin, Elisa/AAC-1311-2020; Nichelli, Paolo/F-7336-2015; Visani, Michela/K-5597-2016; Taccioli, Cristian/F-8801-2010; Iaccarino, Corrado/L-3190-2013; cenni, patrizia/AAL-3588-2020; pisanello, anna/AAM-4486-2020; de Biase, Dario/B-9274-2012; Servadei, Franco/ABX-4656-2022; Rinaldi, Rita/K-7004-2016	Meletti, Stefano/0000-0003-0334-539X; Immovilli, Paolo/0000-0001-9417-3903; Taccioli, Cristian/0000-0003-2995-5612; SILINI, ENRICO MARIA/0000-0003-2578-3059; bertolini, francesco/0000-0001-5660-3255; Franceschi, Claudio/0000-0001-9841-6386; Marucci, Gianluca/0000-0003-4508-3359; Rizzi, Romana/0000-0002-0875-8575; Morandi, Luca/0000-0002-3810-9760; fiorica, francesco/0000-0002-9404-3655; Baldin, Elisa/0000-0002-3277-5623; Nichelli, Paolo/0000-0001-9756-6796; Visani, Michela/0000-0002-9051-2231; Taccioli, Cristian/0000-0003-2995-5612; Iaccarino, Corrado/0000-0002-5133-6327; cenni, patrizia/0000-0001-7911-8500; de Biase, Dario/0000-0002-0609-8817; CARELLI, VALERIO/0000-0003-4923-6404; Pasini, Elena/0000-0001-6298-455X; Brandes, Alba/0000-0002-2503-9089; Bisulli, Francesca/0000-0002-1109-7296; Michelucci, Roberto/0000-0002-9655-7940; Dall'Agata, Monia/0000-0002-2270-5269; Granieri, Enrico/0000-0003-4038-3192; Bonora, Elena/0000-0001-6132-7734; tinuper, paolo/0000-0002-0588-3063; Servadei, Franco/0000-0002-3595-3464; Bigliardi, Guido/0000-0001-5312-7206; morelli, nicola/0000-0003-3787-2243; Palandri, Giorgio/0000-0002-9306-0242; Pession, Annalisa/0000-0001-9035-9698; /0000-0001-9734-8035; Giorgi, Carlotta/0000-0002-2494-7405; Rinaldi, Rita/0000-0002-4564-7284; Casmiro, Mario/0000-0003-0283-5987; franceschi, enrico/0000-0001-9332-4677; Mostacci, Barbara/0000-0002-6994-0821	Progetto Emiliano-Romagnolo di Neuro-Oncologia (PERNO); C.I.R.C. (Centro Interdipartimentale di Ricerche sul Cancro 'G.Prodi', University of Bologna)	Progetto Emiliano-Romagnolo di Neuro-Oncologia (PERNO); C.I.R.C. (Centro Interdipartimentale di Ricerche sul Cancro 'G.Prodi', University of Bologna)	This study was funded by Progetto Emiliano-Romagnolo di Neuro-Oncologia (PERNO) (Emilia-Romagna region project). Dr. de Biase was funded by C.I.R.C. (Centro Interdipartimentale di Ricerche sul Cancro 'G.Prodi', University of Bologna). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Carlsson J, 2011, CANCER CELL INT, V11, DOI 10.1186/1475-2867-11-14; Chen Y, 2008, CANCER LETT, V272, P197, DOI 10.1016/j.canlet.2008.06.034; Ciafre SA, 2005, BIOCHEM BIOPH RES CO, V334, P1351, DOI 10.1016/j.bbrc.2005.07.030; Conti A, 2009, J NEURO-ONCOL, V93, P325, DOI 10.1007/s11060-009-9797-4; Dalmay T, 2008, J INTERN MED, V263, P366, DOI 10.1111/j.1365-2796.2008.01926.x; Gabriely G, 2011, CANCER RES, V71, P3563, DOI 10.1158/0008-5472.CAN-10-3568; Glud M, 2009, J INVEST DERMATOL, V129, P1219, DOI 10.1038/jid.2008.347; Godlewski J, 2008, CANCER RES, V68, P9125, DOI 10.1158/0008-5472.CAN-08-2629; Hasemeier B, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-90; Henriksson R, 2011, J NEURO-ONCOL, V104, P639, DOI 10.1007/s11060-011-0565-x; Hoefig KP, 2008, ANTICANCER RES, V28, P119; Hui ABY, 2009, LAB INVEST, V89, P597, DOI 10.1038/labinvest.2009.12; Huse JT, 2009, GENE DEV, V23, P1327, DOI 10.1101/gad.1777409; Iorio MV, 2005, CANCER RES, V65, P7065, DOI 10.1158/0008-5472.CAN-05-1783; Kefas B, 2008, CANCER RES, V68, P3566, DOI 10.1158/0008-5472.CAN-07-6639; Lawrie CH, 2007, EXPERT OPIN BIOL TH, V7, P1363, DOI 10.1517/14712598.7.9.1363; Leite KRM, 2011, UROL ONCOL-SEMIN ORI, V29, P533, DOI 10.1016/j.urolonc.2009.05.008; Li JH, 2007, BMC BIOTECHNOL, V7, DOI 10.1186/1472-6750-7-36; Li WB, 2011, CANCER BIOL THER, V12, P477, DOI 10.4161/cbt.12.6.16300; Li YQ, 2009, CANCER RES, V69, P7569, DOI 10.1158/0008-5472.CAN-09-0529; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lukiw WJ, 2009, J NEURO-ONCOL, V91, P27, DOI 10.1007/s11060-009-0077-0; Malzkorn B, 2010, BRAIN PATHOL, V20, P539, DOI 10.1111/j.1750-3639.2009.00328.x; Michael MZ, 2003, MOL CANCER RES, V1, P882; Nass D, 2009, BRAIN PATHOL, V19, P375, DOI 10.1111/j.1750-3639.2008.00184.x; Nelson PT, 2004, NAT METHODS, V1, P155, DOI 10.1038/NMETH717; Nonn L, 2010, EXP MOL PATHOL, V88, P45, DOI 10.1016/j.yexmp.2009.10.005; Pang JCS, 2009, ACTA NEUROPATHOL, V117, P599, DOI 10.1007/s00401-009-0525-0; Quintavalle C, 2011, ONCOGENE; Roa W, 2010, CLIN INVEST MED, V33, pE124; Siebolts U, 2009, J CLIN PATHOL, V62, P84, DOI 10.1136/jcp.2008.058339; Silber J, 2008, BMC MED, V6, DOI 10.1186/1741-7015-6-14; Skalsky RL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024248; Smits M, 2010, ONCOTARGET, V1, P710, DOI 10.18632/oncotarget.205; Sozzi G, 2011, CELL CYCLE, V10, P2045, DOI 10.4161/cc.10.13.15712; The WHO, 2020, CLASSIFICATION TUMOU; Ujifuku K, 2010, CANCER LETT, V296, P241, DOI 10.1016/j.canlet.2010.04.013; Wang H, 2007, RNA, V13, P151, DOI 10.1261/rna.234507; Webster RJ, 2009, J BIOL CHEM, V284, P5731, DOI 10.1074/jbc.M804280200; Weng LH, 2010, J PATHOL, V222, P41, DOI 10.1002/path.2736; Xi YG, 2007, RNA, V13, P1668, DOI 10.1261/rna.642907; Zhang X, 2008, J MOL DIAGN, V10, P513, DOI 10.2353/jmoldx.2008.080077	43	27	28	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2012	7	4							e35596	10.1371/journal.pone.0035596	http://dx.doi.org/10.1371/journal.pone.0035596			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959XD	22530056	Green Published, gold, Green Submitted			2022-12-25	WOS:000305350600102
J	de Cima, S; Gil-Ortiz, F; Crabeel, M; Fita, I; Rubio, V				de Cima, Sergio; Gil-Ortiz, Fernando; Crabeel, Marjolaine; Fita, Ignacio; Rubio, Vicente			Insight on an Arginine Synthesis Metabolon from the Tetrameric Structure of Yeast Acetylglutamate Kinase	PLOS ONE			English	Article							L-GLUTAMATE KINASE; N-ACETYLGLUTAMATE; CRYSTAL-STRUCTURE; THERMOTOGA-MARITIMA; P-II; BIOSYNTHESIS; SYNTHASE; COMPLEX; PURIFICATION; ACETYLTRANSFERASES	N-acetyl-L-glutamate kinase (NAGK) catalyzes the second, generally controlling, step of arginine biosynthesis. In yeasts, NAGK exists either alone or forming a metabolon with N-acetyl-L-glutamate synthase (NAGS), which catalyzes the first step and exists only within the metabolon. Yeast NAGK (yNAGK) has, in addition to the amino acid kinase (AAK) domain found in other NAGKs, a similar to 150-residue C-terminal domain of unclear significance belonging to the DUF619 domain family. We deleted this domain, proving that it stabilizes yNAGK, slows catalysis and modulates feed-back inhibition by arginine. We determined the crystal structures of both the DUF619 domain-lacking yNAGK, ligand-free as well as complexed with acetylglutamate or acetylglutamate and arginine, and of complete mature yNAGK. While all other known arginine-inhibitable NAGKs are doughnut-like hexameric trimers of dimers of AAK domains, yNAGK has as central structure a flat tetramer formed by two dimers of AAK domains. These dimers differ from canonical AAK dimers in the -110 degrees rotation of one subunit with respect to the other. In the hexameric enzymes, an N-terminal extension, found in all arginine-inhibitable NAGKs, forms a protruding helix that interlaces the dimers. In yNAGK, however, it conforms a two-helix platform that mediates interdimeric interactions. Arginine appears to freeze an open inactive AAK domain conformation. In the complete yNAGK structure, two pairs of DUF619 domains flank the AAK domain tetramer, providing a mechanism for the DUF619 domain modulatory functions. The DUF619 domain exhibits the histone acetyltransferase fold, resembling the catalytic domain of bacterial NAGS. However, the putative acetyl CoA site is blocked, explaining the lack of NAGS activity of yNAGK. We conclude that the tetrameric architecture is an adaptation to metabolon formation and propose an organization for this metabolon, suggesting that yNAGK may be a good model also for yeast and human NAGSs.	[de Cima, Sergio; Gil-Ortiz, Fernando; Rubio, Vicente] Ctr Invest Biomed Red Enfermedades Rasas CIBERER, Inst Biomed Valencia Consejo Super Invest Cientif, Valencia, Spain; [Crabeel, Marjolaine] Vrije Univ, Dept Genet & Microbiol Emeritus, Brussels, Belgium; [Fita, Ignacio] Inst Res Biomed IRB Barcelona, Inst Biol Mol Barcelona IBMB CSIC, Barcelona, Spain	CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Biomedicina de Valencia (IBV); Vrije Universiteit Brussel; Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Biologia Molecular de Barcelona (IBMB)	de Cima, S (corresponding author), Ctr Invest Biomed Red Enfermedades Rasas CIBERER, Inst Biomed Valencia Consejo Super Invest Cientif, Valencia, Spain.	ifrcri@ibmb.csic.es; rubio@ibv.csic.es	Fita, Ignasi/R-4515-2019; de Cima, Sergio/K-7982-2014; Rubio, Vicente/K-7919-2014	Fita, Ignasi/0000-0002-7521-2679; de Cima, Sergio/0000-0001-9341-5042; Rubio, Vicente/0000-0001-8124-1196; Gil-Ortiz, Fernando/0000-0001-5897-2724	Spanish Ministry for Science (MICINN) [BFU2008-05021]; Valencian Government [Prometeo/2009/051]; CIBERER-ISCIII; Valencian Government; CIBERER; EU (European Union); EMBL (European Molecular Biology Laboratory)	Spanish Ministry for Science (MICINN)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Valencian Government; CIBERER-ISCIII(Instituto de Salud Carlos III); Valencian Government; CIBERER; EU (European Union)(European Commission); EMBL (European Molecular Biology Laboratory)	This work was supported by the Spanish Ministry for Science (MICINN) (http://www.micinn.es/) [grant number BFU2008-05021], the Valencian Government (http://www.gva.es/) [grant number Prometeo/2009/051], and CIBERER-ISCIII (http://www.ciberer.es/). Dr. de Cima had postdoctoral contracts of the Valencian Government and CIBERER. Dr. Gil-Ortiz was a CSIC-JAE-Doc fellow (http://www.csic.es/web/guest/programa-jae). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the ESRF synchrotron staff for assisting in the data collection, the EU (European Union) and the EMBL (European Molecular Biology Laboratory) for funding synchrotron visits, Nadine Gougeard (CIBERER) for technical help, Drs. A. Abadjieva and K. Pauwels for discussions and for sending plasmid pYB3, Clara Marco for initial expression and crystallization trials, Mariano Polo (IBV-CSIC) for yNAGK crystal 1 data collection, Helen Warburton for English correction, and the crystallization service at the IBV (Dr. F. Gallego) for robotized crystallization trials.	Abadjieva A, 2001, J BIOL CHEM, V276, P42869, DOI 10.1074/jbc.M103732200; BACHMANN C, 1982, BIOCHEM J, V205, P123, DOI 10.1042/bj2050123; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BOONCHIRD C, 1991, EUR J BIOCHEM, V199, P325, DOI 10.1111/j.1432-1033.1991.tb16128.x; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Caldovic L, 2003, BIOCHEM J, V372, P279, DOI 10.1042/BJ20030002; Caldovic L, 2002, BIOCHEM BIOPH RES CO, V299, P581, DOI 10.1016/S0006-291X(02)02696-7; Caldovic L, 2010, MOL GENET METAB, V100, pS13, DOI 10.1016/j.ymgme.2010.02.018; Cowtan K, JOINT CCP4 ESF EACBM, V31, P34; CUNIN R, 1986, MICROBIOL REV, V50, P314, DOI 10.1128/MMBR.50.3.314-352.1986; Dixon M., 1979, ENZYMES, Vthird; Doublie Sylvie, 2007, Methods Mol Biol, V363, P91, DOI 10.1007/978-1-59745-209-0_5; Dyda F, 2000, ANNU REV BIOPH BIOM, V29, P81, DOI 10.1146/annurev.biophys.29.1.81; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Errey JC, 2005, J BACTERIOL, V187, P3039, DOI 10.1128/JB.187.9.3039-3044.2005; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Fernandez-Murga ML, 2004, J BACTERIOL, V186, P6142, DOI 10.1128/JB.186.18.6142-6149.2004; Forchhammer K, 2008, TRENDS MICROBIOL, V16, P65, DOI 10.1016/j.tim.2007.11.004; FRENCH S, 1978, ACTA CRYSTALLOGR A, V34, P517, DOI 10.1107/S0567739478001114; Gil-Ortiz F, 2003, J MOL BIOL, V331, P231, DOI 10.1016/S0022-2836(03)00716-2; Gil-Ortiz F, 2010, J MOL BIOL, V399, P476, DOI 10.1016/j.jmb.2010.04.025; HAAS D, 1975, EUR J BIOCHEM, V52, P365, DOI 10.1111/j.1432-1033.1975.tb04004.x; Haberle J, 2003, HUM MUTAT, V21, P593, DOI 10.1002/humu.10216; Hayward S, 2002, J MOL GRAPH MODEL, V21, P181, DOI 10.1016/S1093-3263(02)00140-7; JANCARIK J, 1991, J APPL CRYSTALLOGR, V24, P409, DOI 10.1107/S0021889891004430; KABSCH W, 1976, ACTA CRYSTALLOGR A, V32, P922, DOI 10.1107/S0567739476001873; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Leslie AGW, 2007, NATO SCI SER II-MATH, V245, P41, DOI 10.1007/978-1-4020-6316-9_4; Llacer JL, 2007, P NATL ACAD SCI USA, V104, P17644, DOI 10.1073/pnas.0705987104; Llacer JL, 2008, CURR OPIN STRUC BIOL, V18, P673, DOI 10.1016/j.sbi.2008.11.002; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Min L, 2009, J BIOL CHEM, V284, P4873, DOI 10.1074/jbc.M805348200; Mizuno Y, 2007, J BIOL CHEM, V282, P35733, DOI 10.1074/jbc.M707127200; Neuwald AF, 1997, TRENDS BIOCHEM SCI, V22, P154, DOI 10.1016/S0968-0004(97)01034-7; Painter J, 2006, J APPL CRYSTALLOGR, V39, P109, DOI 10.1107/S0021889805038987; Parra-Gessert L, 1998, J BIOL CHEM, V273, P7972, DOI 10.1074/jbc.273.14.7972; Pauwels K, 2003, EUR J BIOCHEM, V270, P1014, DOI 10.1046/j.1432-1033.2003.03477.x; Qu Qiuhao, 2007, BMC Biochemistry, V8, DOI 10.1186/1471-2091-8-4; Ramon-Maiques S, 2006, J MOL BIOL, V356, P695, DOI 10.1016/j.jmb.2005.11.079; Ramon-Maiques S, 2002, STRUCTURE, V10, P329, DOI 10.1016/S0969-2126(02)00721-9; REGLERO A, 1977, FEBS LETT, V81, P13, DOI 10.1016/0014-5793(77)80917-4; Sancho-Vaello E, 2009, FEBS LETT, V583, P202, DOI 10.1016/j.febslet.2008.12.001; Sheldrick GM, 2010, ACTA CRYSTALLOGR D, V66, P479, DOI 10.1107/S0907444909038360; Shi D, 2008, J BIOL CHEM, V283, P7176, DOI 10.1074/jbc.M707678200; SONODA T, 1983, J BIOL CHEM, V258, P9839; Strong M, 2006, P NATL ACAD SCI USA, V103, P8060, DOI 10.1073/pnas.0602606103; Vagin AA, 2004, ACTA CRYSTALLOGR D, V60, P2184, DOI 10.1107/S0907444904023510; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Vedadi M, 2006, P NATL ACAD SCI USA, V103, P15835, DOI 10.1073/pnas.0605224103; Walter TS, 2006, STRUCTURE, V14, P1617, DOI 10.1016/j.str.2006.09.005; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736; Xu Y, 2007, MICROBIOL MOL BIOL R, V71, P36, DOI 10.1128/MMBR.00032-06	54	14	14	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2012	7	4							e34734	10.1371/journal.pone.0034734	http://dx.doi.org/10.1371/journal.pone.0034734			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959XD	22529931	Green Published, gold, Green Submitted			2022-12-25	WOS:000305350600024
J	Greenwald, JW; Greenwald, CJ; Philmus, BJ; Begley, TP; Gross, DC				Greenwald, Jessica W.; Greenwald, Charles J.; Philmus, Benjamin J.; Begley, Tadhg P.; Gross, Dennis C.			RNA-seq Analysis Reveals That an ECF sigma Factor, AcsS, Regulates Achromobactin Biosynthesis in Pseudomonas syringae pv. syringae B728a	PLOS ONE			English	Article							OUTER-MEMBRANE; EPIPHYTIC FITNESS; EFFLUX PUMPS; IRON; IDENTIFICATION; VIRULENCE; FLAGELLAR; GENES; SIDEROPHORES; BIOGENESIS	Iron is an essential micronutrient for Pseudomonas syringae pv. syringae strain B728a and many other microorganisms; therefore, B728a has evolved methods of iron acquirement including the use of iron-chelating siderophores. In this study an extracytoplasmic function (ECF) sigma factor, AcsS, encoded within the achromobactin gene cluster is shown to be a major regulator of genes involved in the biosynthesis and secretion of this siderophore. However, production of achromobactin was not completely abrogated in the deletion mutant, implying that other regulators may be involved such as PvdS, the sigma factor that regulates pyoverdine biosynthesis. RNA-seq analysis identified 287 genes that are differentially expressed between the AcsS deletion mutant and the wild type strain. These genes are involved in iron response, secretion, extracellular polysaccharide production, and cell motility. Thus, the transcriptome analysis supports a role for AcsS in the regulation of achromobactin production and the potential activity of both AcsS and achromobactin in the plant-associated lifestyle of strain B728a.	[Greenwald, Jessica W.; Greenwald, Charles J.; Gross, Dennis C.] Texas A&M Univ, Dept Plant Pathol & Microbiol, College Stn, TX 77843 USA; [Philmus, Benjamin J.; Begley, Tadhg P.] Texas A&M Univ, Dept Chem, College Stn, TX 77843 USA	Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station	Greenwald, JW (corresponding author), Texas A&M Univ, Dept Plant Pathol & Microbiol, College Stn, TX 77843 USA.	d-gross@tamu.edu	Begley, Tadhg/B-5801-2015	Philmus, Benjamin/0000-0003-2085-0873	Texas A&M AgriLife Research project [H-8832]	Texas A&M AgriLife Research project	This work was supported by Texas A&M AgriLife Research project no. H-8832. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen C, 2003, REV PHYSIOL BIOCH P, V147, P122, DOI 10.1007/s10254-003-0008-y; Arrebola E, 2007, MOL PLANT MICROBE IN, V20, P500, DOI 10.1094/MPMI-20-5-0500; Arrebola E, 2009, INT MICROBIOL, V12, P87, DOI 10.2436/20.1501.01.85; Banin E, 2005, P NATL ACAD SCI USA, V102, P11076, DOI 10.1073/pnas.0504266102; BERNARD P, 1992, J MOL BIOL, V226, P735, DOI 10.1016/0022-2836(92)90629-X; Berti AD, 2007, J BACTERIOL, V189, P6312, DOI 10.1128/JB.00725-07; Berti AD, 2009, J BACTERIOL, V191, P4594, DOI 10.1128/JB.00457-09; Blair JMA, 2009, CURR OPIN MICROBIOL, V12, P512, DOI 10.1016/j.mib.2009.07.003; Bleuel C, 2005, J BACTERIOL, V187, P6701, DOI 10.1128/JB.187.19.6701-6707.2005; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Cornelis P, 2009, ENV MICROBIOL REP, V1, P256, DOI 10.1111/j.1758-2229.2009.00041.x; Croucher NJ, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp811; Dasgupta N, 2003, MOL MICROBIOL, V50, P809, DOI 10.1046/j.1365-2958.2003.03740.x; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Feil H, 2005, P NATL ACAD SCI USA, V102, P11064, DOI 10.1073/pnas.0504930102; Filiatrault MJ, 2010, J BACTERIOL, V192, P2359, DOI 10.1128/JB.01445-09; Franza T, 2005, MOL MICROBIOL, V55, P261, DOI 10.1111/j.1365-2958.2004.04383.x; Friedman L, 2004, J BACTERIOL, V186, P4457, DOI 10.1128/JB.186.14.4457-4465.2004; Goel AK, 2002, J BACTERIOL, V184, P3539, DOI 10.1128/JB.184.13.3539-3548.2002; GRANT SGN, 1990, P NATL ACAD SCI USA, V87, P4645, DOI 10.1073/pnas.87.12.4645; GROSS DC, 1985, J APPL BACTERIOL, V58, P167, DOI 10.1111/j.1365-2672.1985.tb01444.x; GUERINOT ML, 1994, ANNU REV MICROBIOL, V48, P743, DOI 10.1146/annurev.mi.48.100194.003523; HIRANO SS, 1990, ANNU REV PHYTOPATHOL, V28, P155, DOI 10.1146/annurev.py.28.090190.001103; HUYNH TV, 1989, SCIENCE, V245, P1374, DOI 10.1126/science.2781284; Jackson KD, 2004, J BACTERIOL, V186, P4466, DOI 10.1128/JB.186.14.4466-4475.2004; Jahn CE, 2008, J MICROBIOL METH, V75, P318, DOI 10.1016/j.mimet.2008.07.004; Jones AM, 2011, J BACTERIOL, V193, P2767, DOI 10.1128/JB.00069-10; Joyner DC, 2000, MICROBIOL-UK, V146, P2435, DOI 10.1099/00221287-146-10-2435; KADURUGAMUWA JL, 1987, J CLIN MICROBIOL, V25, P849, DOI 10.1128/JCM.25.5.849-855.1987; Kang HJ, 2005, APPL ENVIRON MICROB, V71, P5056, DOI 10.1128/AEM.71.9.5056-5065.2005; Kendziorski C, 2005, P NATL ACAD SCI USA, V102, P4252, DOI 10.1073/pnas.0500607102; KING EO, 1954, J LAB CLIN MED, V44, P301; Koorts A. M., 2007, Archives of Physiology and Biochemistry, V113, P30, DOI 10.1080/13813450701318583; LANDY A, 1989, ANNU REV BIOCHEM, V58, P913, DOI 10.1146/annurev.biochem.58.1.913; LEONG SA, 1982, J BIOL CHEM, V257, P8724; Liu F, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-153; Liu RY, 2007, P NATL ACAD SCI USA, V104, P7116, DOI 10.1073/pnas.0700266104; LOPER JE, 1987, PHYTOPATHOLOGY, V77, P1449, DOI 10.1094/Phyto-77-1449; Lu SE, 2005, MOL PLANT MICROBE IN, V18, P324, DOI 10.1094/MPMI-18-0324; Ma LY, 2007, J BACTERIOL, V189, P8353, DOI 10.1128/JB.00620-07; Marioni JC, 2008, GENOME RES, V18, P1509, DOI 10.1101/gr.079558.108; Miethke M, 2007, MICROBIOL MOL BIOL R, V71, P413, DOI 10.1128/MMBR.00012-07; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Mossialos D, 2007, FUTURE MICROBIOL, V2, P387, DOI 10.2217/17460913.2.4.387; O'Toole GA, 1998, MOL MICROBIOL, V30, P295, DOI 10.1046/j.1365-2958.1998.01062.x; Owen JG, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-218; Peng XJ, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-26; Perkins TT, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000569; Piddock LJV, 2006, NAT REV MICROBIOL, V4, P629, DOI 10.1038/nrmicro1464; Records AR, 2010, J BACTERIOL, V192, P3584, DOI 10.1128/JB.00114-10; Sambrook J., 1989, MOL CLONING LAB MANU, V2; SAWAHEL W, 1993, BIOTECHNOL TECH, V7, P261, DOI 10.1007/BF00150895; Sorek R, 2010, NAT REV GENET, V11, P9, DOI 10.1038/nrg2695; Visca P, 2007, TRENDS MICROBIOL, V15, P22, DOI 10.1016/j.tim.2006.11.004; Wang LK, 2010, BIOINFORMATICS, V26, P136, DOI 10.1093/bioinformatics/btp612; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Weber KA, 2006, NAT REV MICROBIOL, V4, P752, DOI 10.1038/nrmicro1490; Wensing A, 2010, APPL ENVIRON MICROB, V76, P2704, DOI 10.1128/AEM.02979-09; Yang CH, 2002, MOL PLANT MICROBE IN, V15, P472, DOI 10.1094/MPMI.2002.15.5.472	59	14	14	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2012	7	4							e34804	10.1371/journal.pone.0034804	http://dx.doi.org/10.1371/journal.pone.0034804			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959XD	22529937	Green Published, Green Submitted, gold			2022-12-25	WOS:000305350600029
J	Hayashino, Y; Utsugi-Ozaki, M; Feldman, MD; Fukuhara, S				Hayashino, Yasuaki; Utsugi-Ozaki, Makiko; Feldman, Mitchell D.; Fukuhara, Shunichi			Hope Modified the Association between Distress and Incidence of Self-Perceived Medical Errors among Practicing Physicians: Prospective Cohort Study	PLOS ONE			English	Article							ADVERSE DRUG EVENTS; HOSPITALIZED-PATIENTS; CANCER-PATIENTS; INTENSIVE-CARE; EXCESS LENGTH; DEPRESSION; PERFORMANCE; SAFETY; SATISFACTION; SURGERY	The presence of hope has been found to influence an individual's ability to cope with stressful situations. The objective of this study is to evaluate the relationship between medical errors, hope and burnout among practicing physicians using validated metrics. Prospective cohort study was conducted among hospital based physicians practicing in Japan (N = 836). Measures included the validated Burnout Scale, self-assessment of medical errors and Herth Hope Index (HHI). The main outcome measure was the frequency of self-perceived medical errors, and Poisson regression analysis was used to evaluate the association between hope and medical error. A total of 361 errors were reported in 836 physician-years. We observed a significant association between hope and self-report of medical errors. Compared with the lowest tertile category of HHI, incidence rate ratios (IRRs) of self-perceived medical errors of physicians in the highest category were 0.44 (95% CI, 0.34 to 0.58) and 0.54 (95% CI, 0.42 to 0.70) respectively, for the 2nd and 3rd tertile. In stratified analysis by hope score, among physicians with a low hope score, those who experienced higher burnout reported higher incidence of errors; physicians with high hope scores did not report high incidences of errors, even if they experienced high burnout. Self-perceived medical errors showed a strong association with physicians' hope, and hope modified the association between physicians' burnout and self-perceived medical errors.	[Hayashino, Yasuaki; Fukuhara, Shunichi] Kyoto Univ, Grad Sch Med & Publ Hlth, Dept Epidemiol & Healthcare Res, Kyoto, Japan; [Feldman, Mitchell D.] Univ Calif San Francisco, Dept Med, San Francisco, CA USA; [Utsugi-Ozaki, Makiko] Horikawa Hosp, Kyoto, Japan	Kyoto University; University of California System; University of California San Francisco	Hayashino, Y (corresponding author), Kyoto Univ, Grad Sch Med & Publ Hlth, Dept Epidemiol & Healthcare Res, Kyoto, Japan.	hayasino-y@umin.net	Hayashino, Yasuaki/AAA-8637-2022	Hayashino, Yasuaki/0000-0002-2932-8478	Ministry of Education, Science and Culture of Japan [21790580]; Fulbright Research Fellowship	Ministry of Education, Science and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Fulbright Research Fellowship	This study was funded by research grants from the Ministry of Education, Science and Culture of Japan (No. 21790580). MDF was supported by a Fulbright Research Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apatira L, 2008, ANN INTERN MED, V149, P861, DOI 10.7326/0003-4819-149-12-200812160-00005; Awata S, 2007, PSYCHIAT CLIN NEUROS, V61, P112, DOI 10.1111/j.1440-1819.2007.01619.x; Baker GR, 2004, CAN MED ASSOC J, V170, P1678, DOI 10.1503/cmaj.1040498; Bates DW, 1997, JAMA-J AM MED ASSOC, V277, P307, DOI 10.1001/jama.277.4.307; Bech P, 2003, INT J METH PSYCH RES, V12, P85, DOI 10.1002/mpr.145; Bumpus Lisa, 2003, J Cardiovasc Manag, V14, P11; Chen ML, 2003, CANCER NURS, V26, P61, DOI 10.1097/00002820-200302000-00009; Chi GCHL, 2007, ONCOL NURS FORUM, V34, P415, DOI 10.1188/07.ONF.415-424; Classen DC, 1997, JAMA-J AM MED ASSOC, V277, P301, DOI 10.1001/jama.277.4.301; Davison SN, 2006, BRIT MED J, V333, P886, DOI 10.1136/bmj.38965.626250.55; DUFAULT K, 1985, NURS CLIN N AM, V20, P379; Duggleby W, 2009, J ADV NURS, V65, P2376, DOI 10.1111/j.1365-2648.2009.05094.x; Fahrenkopf AM, 2008, BRIT MED J, V336, P488, DOI 10.1136/bmj.39469.763218.BE; Greenberg CC, 2008, ANN SURG, V248, P337, DOI 10.1097/SLA.0b013e318181c9a3; Groopman Jerome., 2004, ANATOMY HOPE; Henkel V, 2004, GEN HOSP PSYCHIAT, V26, P190, DOI 10.1016/j.genhosppsych.2004.02.003; Henkel V, 2003, BRIT MED J, V326, P200, DOI 10.1136/bmj.326.7382.200; Herth K, 1991, Sch Inq Nurs Pract, V5, P39; HERTH K, 1992, J ADV NURS, V17, P1251, DOI 10.1111/j.1365-2648.1992.tb01843.x; Kalish R L, 1995, Am J Med Qual, V10, P48, DOI 10.1177/0885713X9501000108; Kataoka M, 2008, JAPANESE SOC NURSING, V31, P67; Kazandjian VA, 2004, QUAL SAF HEALTH CARE, V13, P9, DOI 10.1136/qshc.2003.008698; Kleinbaum D, 1988, APPL REGRESSION ANAL; Kohn L.T., 2000, ERR IS HUMAN BUILDIN, VVolume 600; Koizumi M, 1999, ANN GUNMA HLTH SCI, V20, P103; Kubo M., 2007, Journal of Science of Labour, V83, P39; Kubo M, 2004, PSYCHOL BURNOUT; LEAPE LL, 1991, NEW ENGL J MED, V324, P377, DOI 10.1056/NEJM199102073240605; Leimkuhler AMM, 2007, J AFFECT DISORDERS, V98, P65, DOI 10.1016/j.jad.2006.07.007; Lin CC, 2003, J PAIN SYMPTOM MANAG, V25, P29, DOI 10.1016/S0885-3924(02)00542-0; Lynch W. F., 1974, IMAGES HOPE IMAGINAT; Makary MA, 2006, ANN SURG, V243, P628, DOI 10.1097/01.sla.0000216410.74062.0f; Makary MA, 2007, J AM COLL SURGEONS, V204, P236, DOI 10.1016/j.jamcollsurg.2006.10.018; Matsuda S, 1997, JAPANESE J HLTH PSYC, V10, P44; McClement SE, 2008, EUR J CANCER, V44, P1169, DOI 10.1016/j.ejca.2008.02.031; Mitsumoto H, 2007, JAMA-J AM MED ASSOC, V298, P207, DOI 10.1001/jama.298.2.207; Morimoto T, 2011, J GEN INTERN MED, V26, P148, DOI 10.1007/s11606-010-1518-3; Mutter Michael, 2003, Jt Comm J Qual Saf, V29, P279; Rothschild JM, 2005, CRIT CARE MED, V33, P1694, DOI 10.1097/01.CCM.0000171609.91035.BD; Rustoen T, 2004, HEART LUNG, V33, P111, DOI 10.1016/j.hrtlng.2003.12.003; Rustoen T, 2010, CANCER NURS, V33, P258, DOI 10.1097/NCC.0b013e3181d6fb61; Sand L, 2009, J PAIN SYMPTOM MANAG, V37, P13, DOI 10.1016/j.jpainsymman.2008.01.013; Shively EH, 2004, ANN SURG, V239, P752, DOI 10.1097/01.sla.0000128301.67780.d7; SHORTELL SM, 1994, MED CARE, V32, P508, DOI 10.1097/00005650-199405000-00009; Tao M, 1996, THEORY RES BURNOUT B, P129; Thomas NK, 2004, JAMA-J AM MED ASSOC, V292, P2880, DOI 10.1001/jama.292.23.2880; Ueno T, 1996, JPN J HLTH PSYCHOL, V9, P9; West CP, 2006, JAMA-J AM MED ASSOC, V296, P1071, DOI 10.1001/jama.296.9.1071; West CP, 2009, JAMA-J AM MED ASSOC, V302, P1294, DOI 10.1001/jama.2009.1389; Wonghongkul T, 2000, CANCER NURS, V23, P422, DOI 10.1097/00002820-200012000-00004; Zhan CL, 2003, JAMA-J AM MED ASSOC, V290, P1868, DOI 10.1001/jama.290.14.1868	51	37	39	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2012	7	4							e35585	10.1371/journal.pone.0035585	http://dx.doi.org/10.1371/journal.pone.0035585			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959XD	22530055	Green Submitted, Green Published, gold			2022-12-25	WOS:000305350600101
J	Arocena, GM; Zorreguieta, A; Sieira, R				Arocena, Gaston M.; Zorreguieta, Angeles; Sieira, Rodrigo			Expression of VjbR under Nutrient Limitation Conditions Is Regulated at the Post-Transcriptional Level by Specific Acidic pH Values and Urocanic Acid	PLOS ONE			English	Article							IV SECRETION SYSTEM; PATHOGEN BRUCELLA-MELITENSIS; INTRACELLULAR SURVIVAL; ENDOPLASMIC-RETICULUM; VIRB OPERON; ABORTUS; SUIS; IDENTIFICATION; MACROPHAGES; HOMOLOG	VjbR is a LuxR homolog that regulates transcription of many genes including important virulence determinants of the facultative intracellular pathogen Brucella abortus. This transcription factor belongs to a family of regulators that participate in a cell-cell communication process called quorum sensing, which enables bacteria to respond to changes in cell population density by monitoring concentration of self produced autoinducer molecules. Unlike almost all other LuxR-type proteins, VjbR binds to DNA and activates transcription in the absence of any autoinducer signal. To investigate the mechanisms by which Brucella induces VjbR-mediated transcriptional activation, and to determine how inappropriate spatio-temporal expression of the VjbR target genes is prevented, we focused on the study of expression of vjbR itself. By assaying different parameters related to the intracellular lifestyle of Brucella, we identified a restricted set of conditions that triggers VjbR protein expression. Such conditions required the convergence of two signals of different nature: a specific pH value of 5.5 and the presence of urocanic acid, a metabolite involved in the connection between virulence and metabolism of Brucella. In addition, we also observed an urocanic acid, pH-dependent expression of RibH2 and VirB7, two additional intracellular survival-related proteins of Brucella. Analysis of promoter activities and determination of mRNA levels demonstrated that the urocanic acid-dependent mechanisms that induced expression of VjbR, RibH2, and VirB7 act at the post-transcriptional level. Taken together, our findings support a model whereby Brucella induces VjbR-mediated transcription by modulating expression of VjbR in response to specific signals related to the changing environment encountered within the host.	[Arocena, Gaston M.; Zorreguieta, Angeles; Sieira, Rodrigo] Consejo Nacl Invest Cient & Tecn, IBBA, Fdn Inst Leloir, RA-1033 Buenos Aires, DF, Argentina; [Zorreguieta, Angeles] Univ Buenos Aires, Fac Ciencias Exactas & Nat, Dept Quim Biol, Buenos Aires, DF, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Leloir Institute; University of Buenos Aires	Arocena, GM (corresponding author), Consejo Nacl Invest Cient & Tecn, IBBA, Fdn Inst Leloir, RA-1033 Buenos Aires, DF, Argentina.	rsieira@leloir.org.ar			Argentinian Council of Research (CONICET) [PIP2011-00336]; University of Buenos Aires, Argentina [UBACyT X240]	Argentinian Council of Research (CONICET); University of Buenos Aires, Argentina(University of Buenos Aires)	This work was supported by grant PIP2011-00336 to Rodrigo Sieira from the Argentinian Council of Research (CONICET) (http://www.conicet.gov.ar/web/conicet/inicio), and grant UBACyT X240 (http://secinves.com.ar/guias/ubacyt) to Angeles Zorreguieta from the University of Buenos Aires, Argentina. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arocena GM, 2010, J BACTERIOL, V192, P3434, DOI 10.1128/JB.00232-10; BECKER A, 1995, GENE, V162, P37, DOI 10.1016/0378-1119(95)00313-U; Boschiroli ML, 2002, P NATL ACAD SCI USA, V99, P1544, DOI 10.1073/pnas.032514299; Broughton ES, 1997, VET MICROBIOL, V57, P253, DOI 10.1016/S0378-1135(97)00135-1; Celli J, 2003, J EXP MED, V198, P545, DOI 10.1084/jem.20030088; Corbel MJ, 1997, EMERG INFECT DIS, V3, P213, DOI 10.3201/eid0302.970219; de Barsy M, 2011, CELL MICROBIOL, V13, P1044, DOI 10.1111/j.1462-5822.2011.01601.x; de Jong MF, 2008, MOL MICROBIOL, V70, P1378, DOI 10.1111/j.1365-2958.2008.06487.x; Delrue RM, 2005, CELL MICROBIOL, V7, P1151, DOI 10.1111/j.1462-5822.2005.00543.x; Dorrell N, 1999, MICROB PATHOGENESIS, V27, P1, DOI 10.1006/mpat.1999.0278; Marchesini MI, 2011, CELL MICROBIOL, V13, P1261, DOI 10.1111/j.1462-5822.2011.01618.x; Kohler S, 2002, P NATL ACAD SCI USA, V99, P15711, DOI 10.1073/pnas.232454299; Martinez-Nunez C, 2010, J BACTERIOL, V192, P5603, DOI 10.1128/JB.00567-10; McAnulla C, 2007, MICROBIOL-SGM, V153, P2074, DOI 10.1099/mic.0.2007/007153-0; O'Callaghan D, 1999, MOL MICROBIOL, V33, P1210, DOI 10.1046/j.1365-2958.1999.01569.x; Patankar AV, 2009, FEMS MICROBIOL REV, V33, P739, DOI 10.1111/j.1574-6976.2009.00163.x; Patey G, 2006, INFECT IMMUN, V74, P4945, DOI 10.1128/IAI.00584-06; Pizarro-Cerda J, 1998, INFECT IMMUN, V66, P5711; Porte F, 1999, INFECT IMMUN, V67, P4041, DOI 10.1128/IAI.67.8.4041-4047.1999; Rambow-Larsen AA, 2009, TRENDS MICROBIOL, V17, P371, DOI 10.1016/j.tim.2009.05.006; Rarnbow-Larsen AA, 2008, J BACTERIOL, V190, P3274, DOI 10.1128/JB.01915-07; Rouot B, 2003, INFECT IMMUN, V71, P1075, DOI 10.1128/IAI.71.3.1075-1082.2003; Bonomi HR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009435; Sambrook J., MOL CLONING LAB MANU; SCHAFER A, 1994, GENE, V145, P69, DOI 10.1016/0378-1119(94)90324-7; Sieira R, 2004, MOL MICROBIOL, V54, P808, DOI 10.1111/j.1365-2958.2004.04316.x; Sieira R, 2010, J BACTERIOL, V192, P217, DOI 10.1128/JB.01124-09; Starr T, 2008, TRAFFIC, V9, P678, DOI 10.1111/j.1600-0854.2008.00718.x; Taminiau B, 2002, INFECT IMMUN, V70, P3004, DOI 10.1128/IAI.70.6.3004-3011.2002; Tsai CS, 2010, MOL MICROBIOL, V77, P1072, DOI 10.1111/j.1365-2958.2010.07279.x; Uzureau S, 2007, J BACTERIOL, V189, P6035, DOI 10.1128/JB.00265-07; Uzureau S, 2010, J PROTEOME RES, V9, P3200, DOI 10.1021/pr100068p; Weeks JN, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-167; Yang MH, 2009, J BACTERIOL, V191, P434, DOI 10.1128/JB.01247-08; Zhang XX, 2007, GENETICS, V176, P2165, DOI 10.1534/genetics.107.075713	35	16	19	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2012	7	4							e35394	10.1371/journal.pone.0035394	http://dx.doi.org/10.1371/journal.pone.0035394			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WC	22530016	Green Published, Green Submitted, gold			2022-12-25	WOS:000305347400048
J	Hippert, C; Ibanes, S; Serratrice, N; Court, F; Malecaze, F; Kremer, EJ; Kalatzis, V				Hippert, Claire; Ibanes, Sandy; Serratrice, Nicolas; Court, Franck; Malecaze, Francois; Kremer, Eric J.; Kalatzis, Vasiliki			Corneal Transduction by Intra-Stromal Injection of AAV Vectors In Vivo in the Mouse and Ex Vivo in Human Explants	PLOS ONE			English	Article							LEBERS CONGENITAL AMAUROSIS; GENE-THERAPY; ADENOASSOCIATED VIRUS; IGF2 GENE; EXPRESSION; CELLS; TISSUE; KERATOCYTES; CYSTINOSIS; DELIVERY	The cornea is a transparent, avascular tissue that acts as the major refractive surface of the eye. Corneal transparency, assured by the inner stroma, is vital for this role. Disruption in stromal transparency can occur in some inherited or acquired diseases. As a consequence, light entering the eye is blocked or distorted, leading to decreased visual acuity. Possible treatment for restoring transparency could be via viral-based gene therapy. The stroma is particularly amenable to this strategy due to its immunoprivileged nature and low turnover rate. We assayed the potential of AAV vectors to transduce keratocytes following intra-stromal injection in vivo in the mouse cornea and ex vivo in human explants. In murine and human corneas, we transduced the entire stroma using a single injection, preferentially targeted keratocytes and achieved long-term gene transfer (up to 17 months in vivo in mice). Of the serotypes tested, AAV2/8 was the most promising for gene transfer in both mouse and man. Furthermore, transgene expression could be transiently increased following aggression to the cornea.	[Hippert, Claire; Ibanes, Sandy; Serratrice, Nicolas; Court, Franck; Kremer, Eric J.; Kalatzis, Vasiliki] CNRS, Inst Genet Mol Montpellier, Montpellier, France; [Hippert, Claire; Ibanes, Sandy; Serratrice, Nicolas; Court, Franck; Kremer, Eric J.; Kalatzis, Vasiliki] Univ Montpellier I, Montpellier, France; [Hippert, Claire; Ibanes, Sandy; Serratrice, Nicolas; Court, Franck; Kremer, Eric J.; Kalatzis, Vasiliki] Univ Montpellier 2, Montpellier, France; [Malecaze, Francois] Fac Med Toulouse, INSERM, U563, F-31073 Toulouse, France; [Malecaze, Francois] Hop Purpan, Dept Ophtalmol, Toulouse, France	Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier; Universite de Montpellier; Universite de Montpellier; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); CHU de Toulouse	Hippert, C (corresponding author), Inst Ophthalmol, Div Mol Therapy, London, England.	vasiliki.kalatzis@inserm.fr	Kremer, Eric J/D-3734-2013; Kremer, EJ/P-9838-2019; Kalatzis, Vasiliki/F-6170-2019	Kremer, EJ/0000-0001-6114-7530; Kalatzis, Vasiliki/0000-0002-9626-8807; court, franck/0000-0003-0327-9708; Serratrice, Nicolas/0000-0002-9419-1463	Cystinosis Research Foundation (CRF; Irvine, CA); Cystinosis Research Network (CRN; Lake Forest, IL); Association Francaise contre les Myopathies (Paris, France) [11960]; Region Languedoc Roussillon-CTP (Communaute de travail des Pyrenees) [115277]; CRN	Cystinosis Research Foundation (CRF; Irvine, CA); Cystinosis Research Network (CRN; Lake Forest, IL); Association Francaise contre les Myopathies (Paris, France)(Association Francaise contre les Myopathies); Region Languedoc Roussillon-CTP (Communaute de travail des Pyrenees)(Region Occitanie); CRN	This work was funded by the Cystinosis Research Foundation (CRF; Irvine, CA; http://www.natalieswish.org/), the Cystinosis Research Network (CRN; Lake Forest, IL; http://www.cystinosis.org/), the Association Francaise contre les Myopathies (Paris, France; http://www.afm-telethon.fr/; grant number 11960) and the Region Languedoc Roussillon-CTP (Communaute de travail des Pyrenees; http://www.transferts-lr.org/transferts_lr/europe/; grant number 115277). C. H. was a CRF fellow. S. I. was supported by the CRN. V. K. and E.J.K. are Inserm fellows. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDER IE, 1994, J VIROL, V68, P8282, DOI 10.1128/JVI.68.12.8282-8287.1994; Bainbridge JWB, 2008, NEW ENGL J MED, V358, P2231, DOI 10.1056/NEJMoa0802268; Beck M, 2007, HUM GENET, V121, P1, DOI 10.1007/s00439-006-0280-4; Bemelmans AP, 2009, GENE THER, V16, P933, DOI 10.1038/gt.2009.41; Borras T, 1996, INVEST OPHTH VIS SCI, V37, P1282; Brissette-Storkus CS, 2002, INVEST OPHTH VIS SCI, V43, P2264; Carlson EC, 2004, INVEST OPHTH VIS SCI, V45, P2194, DOI 10.1167/iovs.03-1224; Chintakuntlawar AV, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000841; Du YD, 2005, STEM CELLS, V23, P1266, DOI 10.1634/stemcells.2004-0256; Du YQ, 2009, STEM CELLS, V27, P1635, DOI 10.1002/stem.91; Duan DS, 1998, J VIROL, V72, P8568, DOI 10.1128/JVI.72.11.8568-8577.1998; Espana EM, 2004, INVEST OPHTH VIS SCI, V45, P2985, DOI 10.1167/iovs.04-0201; Fini ME, 2005, CORNEA, V24, pS2, DOI 10.1097/01.ico.0000178743.06340.2c; Galiacy SD, 2011, GENE THER, V18, P462, DOI 10.1038/gt.2010.159; George AJT, 2000, AM J RESP CRIT CARE, V162, pS194, DOI 10.1164/ajrccm.162.supplement_3.15tac11; Hagege H, 2006, CYTOGENET GENOME RES, V113, P230, DOI 10.1159/000090837; Hao J, 2010, BRAIN RES BULL, V81, P256, DOI 10.1016/j.brainresbull.2009.06.011; Jhanji V, 2010, CURR OPIN OPHTHALMOL, V21, P301, DOI 10.1097/ICU.0b013e32833a8dd3; Johnson JS, 2009, J VIROL, V83, P2632, DOI 10.1128/JVI.02309-08; Joseph A, 2003, INVEST OPHTH VIS SCI, V44, P4689, DOI 10.1167/iovs.02-0999; Kalatzis V, 2001, EMBO J, V20, P5940, DOI 10.1093/emboj/20.21.5940; Kalatzis V, 2007, PEDIATR RES, V62, P156, DOI 10.1203/PDR.0b013e31809fda89; Kamata Y, 2001, MOL THER, V4, P307, DOI 10.1006/mthe.2001.0461; Klausner EA, 2007, J CONTROL RELEASE, V124, P107, DOI 10.1016/j.jconrel.2007.05.041; Kremer EJ, 2000, J VIROL, V74, P505, DOI 10.1128/JVI.74.1.505-512.2000; Lai LJ, 2007, J BIOMED SCI, V14, P313, DOI 10.1007/s11373-007-9153-7; Liu J, 2008, MOL VIS, V14, P2087; Lutfalla G, 2006, METHOD ENZYMOL, V410, P386, DOI 10.1016/S0076-6879(06)10019-1; Maguire AM, 2008, NEW ENGL J MED, V358, P2240, DOI 10.1056/NEJMoa0802315; Mohan RR, 2005, PROG RETIN EYE RES, V24, P537, DOI 10.1016/j.preteyeres.2005.04.001; Mohan RR, 2003, EXP EYE RES, V76, P373, DOI 10.1016/S0014-4835(02)00275-0; Nesterova G, 2008, PEDIATR NEPHROL, V23, P863, DOI 10.1007/s00467-007-0650-8; NEUFELD EF, 1991, ANNU REV BIOCHEM, V60, P257, DOI 10.1146/annurev.biochem.60.1.257; Nilsson EC, 2011, NAT MED, V17, P105, DOI 10.1038/nm.2267; Prydal JI, 1998, EYE, V12, P337, DOI 10.1038/eye.1998.82; Saika S, 2005, AM J PATHOL, V166, P1405, DOI 10.1016/S0002-9440(10)62358-9; Sharma A, 2010, EXP EYE RES, V91, P440, DOI 10.1016/j.exer.2010.06.020; Smith RH, 2008, GENE THER, V15, P817, DOI 10.1038/gt.2008.55; Sosnova M, 2005, STEM CELLS, V23, P507, DOI 10.1634/stemcells.2004-0291; Stieger K, 2009, MOL THER, V17, P516, DOI 10.1038/mt.2008.283; Toti P, 2002, OPHTHALMOLOGY, V109, P1167, DOI 10.1016/S0161-6420(02)01042-4; Tsai ML, 2002, INVEST OPHTH VIS SCI, V43, P751; Weber M, 2001, MECH DEVELOP, V101, P133, DOI 10.1016/S0925-4773(00)00573-6; Weber ML, 2003, ANAL BIOCHEM, V320, P252, DOI 10.1016/S0003-2697(03)00396-8; West-Mays JA, 2006, INT J BIOCHEM CELL B, V38, P1625, DOI 10.1016/j.biocel.2006.03.010; Williams KA, 2010, CLIN EXP OPHTHALMOL, V38, P93, DOI 10.1111/j.1442-9071.2009.02179.x; Yu H, 2007, BIOCHEM BIOPH RES CO, V361, P946, DOI 10.1016/j.bbrc.2007.07.114	47	29	29	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2012	7	4							e35318	10.1371/journal.pone.0035318	http://dx.doi.org/10.1371/journal.pone.0035318			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VO	22523585	Green Published, Green Submitted, gold			2022-12-25	WOS:000305345000057
J	Paul, G; Ozen, I; Christophersen, NS; Reinbothe, T; Bengzon, J; Visse, E; Jansson, K; Dannaeus, K; Henriques-Oliveira, C; Roybon, L; Anisimov, SV; Renstrom, E; Svensson, M; Haegerstrand, A; Brundin, P				Paul, Gesine; Ozen, Ilknur; Christophersen, Nicolaj S.; Reinbothe, Thomas; Bengzon, Johan; Visse, Edward; Jansson, Katarina; Dannaeus, Karin; Henriques-Oliveira, Catarina; Roybon, Laurent; Anisimov, Sergey V.; Renstrom, Erik; Svensson, Mikael; Haegerstrand, Anders; Brundin, Patrik			The Adult Human Brain Harbors Multipotent Perivascular Mesenchymal Stem Cells	PLOS ONE			English	Article							MARROW STROMAL CELLS; NEURAL PROGENITOR CELLS; IN-VITRO; MICROVASCULAR PERICYTES; DIFFERENTIATE; EXPRESSION; MUSCLE; MOUSE; TISSUES; NICHES	Blood vessels and adjacent cells form perivascular stem cell niches in adult tissues. In this perivascular niche, a stem cell with mesenchymal characteristics was recently identified in some adult somatic tissues. These cells are pericytes that line the microvasculature, express mesenchymal markers and differentiate into mesodermal lineages but might even have the capacity to generate tissue-specific cell types. Here, we isolated, purified and characterized a previously unrecognized progenitor population from two different regions in the adult human brain, the ventricular wall and the neocortex. We show that these cells co-express markers for mesenchymal stem cells and pericytes in vivo and in vitro, but do not express glial, neuronal progenitor, hematopoietic, endothelial or microglial markers in their native state. Furthermore, we demonstrate at a clonal level that these progenitors have true multilineage potential towards both, the mesodermal and neuroectodermal phenotype. They can be epigenetically induced in vitro into adipocytes, chondroblasts and osteoblasts but also into glial cells and immature neurons. This progenitor population exhibits long-term proliferation, karyotype stability and retention of phenotype and multipotency following extensive propagation. Thus, we provide evidence that the vascular niche in the adult human brain harbors a novel progenitor with multilineage capacity that appears to represent mesenchymal stem cells and is different from any previously described human neural stem cell. Future studies will elucidate whether these cells may play a role for disease or may represent a reservoir that can be exploited in efforts to repair the diseased human brain.	[Paul, Gesine; Ozen, Ilknur; Christophersen, Nicolaj S.; Henriques-Oliveira, Catarina; Roybon, Laurent; Anisimov, Sergey V.; Brundin, Patrik] Lund Univ, Wallenberg Neurosci Ctr, Dept Expt Med Sci, Neuronal Survival Unit, Lund, Sweden; [Paul, Gesine] Scania Univ Hosp, Dept Neurol, Lund, Sweden; [Reinbothe, Thomas; Renstrom, Erik] Lund Univ, Ctr Diabet, Scania Univ Hosp, Malmo, Sweden; [Bengzon, Johan] Lund Univ, Lund Stem Cell Ctr, Lund, Sweden; [Bengzon, Johan] Scania Univ Hosp, Dept Neurosurg, Lund, Sweden; [Visse, Edward] Lund Univ, Dept Clin Med, Rausing Lab, Lund, Sweden; [Jansson, Katarina; Dannaeus, Karin; Haegerstrand, Anders] NeuroNova AB, Stockholm, Sweden; [Svensson, Mikael] Karolinska Hosp, Dept Neurosurg, S-10401 Stockholm, Sweden; [Paul, Gesine; Ozen, Ilknur] Lund Univ, Wallenberg Neurosci Ctr, Dept Clin Sci, Translat Neurol Grp, Lund, Sweden; [Brundin, Patrik] Van Andel Res Inst, Ctr Neurodegenerat Sci, Grand Rapids, MI USA	Lund University; Lund University; Lund University; Lund University; Karolinska Institutet; Karolinska University Hospital; Lund University; Van Andel Institute	Paul, G (corresponding author), Lund Univ, Wallenberg Neurosci Ctr, Dept Expt Med Sci, Neuronal Survival Unit, Lund, Sweden.	gesine.paul@med.lu.se	Svensson, Mikael/F-8662-2012; Reinbothe, Thomas M./N-1532-2014	Svensson, Mikael/0000-0003-1179-7003; Reinbothe, Thomas M./0000-0002-8934-6109; Bengzon, Johan/0000-0001-6536-2107	Swedish Research Council; EuroStemCell (EU Framework 6 project) [LHSB-CT-2003-503005]; EU FP6 project STEMS [LHSB-CT-2006-037328]; Lundbeckfonden [R7-A686]	Swedish Research Council(Swedish Research CouncilEuropean Commission); EuroStemCell (EU Framework 6 project); EU FP6 project STEMS; Lundbeckfonden(Lundbeckfonden)	This study was supported by the Swedish Research Council, the EuroStemCell (EU Framework 6 project LHSB-CT-2003-503005), the EU FP6 project STEMS (LHSB-CT-2006-037328). G. P. is supported by a grant according to the "Agreement on doctor's training and research''. L. R. and I.O. are supported by the EU (FP6 project STEMS (LHSB-CT-2006-037328) and Multipark. N.S.C. was sponsored by a grant from Lundbeckfonden (#R7-A686). The funding agencies had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alliot F, 1999, J NEUROSCI RES, V58, P367; Alvarez-Buylla A, 2004, NEURON, V41, P683, DOI 10.1016/S0896-6273(04)00111-4; Armulik A, 2005, CIRC RES, V97, P512, DOI 10.1161/01.RES.0000182903.16652.d7; Bianco P, 2008, CELL STEM CELL, V2, P313, DOI 10.1016/j.stem.2008.03.002; Bondjers C, 2003, AM J PATHOL, V162, P721, DOI 10.1016/S0002-9440(10)63868-0; Bondjers C, 2006, FASEB J, V20, P1703, DOI 10.1096/fj.05-4944fje; Brachvogel B, 2005, DEVELOPMENT, V132, P2657, DOI 10.1242/dev.01846; Canfield AE, 1996, J CELL SCI, V109, P343; CAPLAN AI, 1991, J ORTHOP RES, V9, P641, DOI 10.1002/jor.1100090504; Caplan AI, 2008, CELL STEM CELL, V3, P229, DOI 10.1016/j.stem.2008.08.008; Conti L, 2010, NAT REV NEUROSCI, V11, P176, DOI 10.1038/nrn2761; Covas DT, 2008, EXP HEMATOL, V36, P642, DOI 10.1016/j.exphem.2007.12.015; Crisan M, 2008, CELL STEM CELL, V3, P301, DOI 10.1016/j.stem.2008.07.003; Meirelles LDS, 2006, J CELL SCI, V119, P2204, DOI 10.1242/jcs.02932; Davidoff MS, 2004, J CELL BIOL, V167, P935, DOI 10.1083/jcb.200409107; Dellavalle A, 2007, NAT CELL BIOL, V9, P255, DOI 10.1038/ncb1542; Dezawa M, 2004, J CLIN INVEST, V113, P1701, DOI 10.1172/JCI200420935; Doherty MJ, 1998, J BONE MINER RES, V13, P828, DOI 10.1359/jbmr.1998.13.5.828; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Dore-Duffy P, 2006, J CEREBR BLOOD F MET, V26, P613, DOI 10.1038/sj.jcbfm.9600272; EHLER E, 1995, CELL TISSUE RES, V279, P393, DOI 10.1007/BF00318497; Farrington-Rock C, 2004, CIRCULATION, V110, P2226, DOI 10.1161/01.CIR.0000144457.55518.E5; Fox LE, 2010, STEM CELLS DEV; Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433; Gerhardt H, 2003, CELL TISSUE RES, V314, P15, DOI 10.1007/s00441-003-0745-x; Goritz C, 2011, SCIENCE, V333, P238, DOI 10.1126/science.1203165; Gould E, 2007, NAT REV NEUROSCI, V8, P481, DOI 10.1038/nrn2147; Hayase M, 2009, J CEREBR BLOOD F MET, V29, P1409, DOI 10.1038/jcbfm.2009.62; Hermann A, 2004, J CELL SCI, V117, P4411, DOI 10.1242/jcs.01307; Huang FJ, 2010, DEV BIOL, V344, P1035, DOI 10.1016/j.ydbio.2010.06.023; Johansson CB, 1999, EXP CELL RES, V253, P733, DOI 10.1006/excr.1999.4678; Kriegstein A, 2009, ANNU REV NEUROSCI, V32, P149, DOI 10.1146/annurev.neuro.051508.135600; Lindahl P, 1997, SCIENCE, V277, P242, DOI 10.1126/science.277.5323.242; Lotharius J, 2002, J BIOL CHEM, V277, P38884, DOI 10.1074/jbc.M205518200; Meirelles LD, 2008, STEM CELLS, V26, P2287, DOI 10.1634/stemcells.2007-1122; Miller FD, 2009, CELL STEM CELL, V4, P507, DOI 10.1016/j.stem.2009.05.008; Nunes MC, 2003, NAT MED, V9, P439, DOI 10.1038/nm837; Ozerdem U, 2002, MICROVASC RES, V63, P129, DOI 10.1006/mvre.2001.2376; Palmer TD, 2001, NATURE, V411, P42, DOI 10.1038/35075141; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; RICHARDSON RL, 1982, ACTA ANAT, V114, P41; Sanchez-Ramos J, 2000, EXP NEUROL, V164, P247, DOI 10.1006/exnr.2000.7389; SIMS DE, 1991, CAN J CARDIOL, V7, P431; Walton NM, 2006, DEVELOPMENT, V133, P3671, DOI 10.1242/dev.02541; Winkler EA, 2010, MOL NEURODEGENER, V5, DOI 10.1186/1750-1326-5-32; Woodbury D, 2000, J NEUROSCI RES, V61, P364, DOI 10.1002/1097-4547(20000815)61:4<364::AID-JNR2>3.0.CO;2-C; Yamashima T, 2004, HIPPOCAMPUS, V14, P861, DOI 10.1002/hipo.20001	47	158	161	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2012	7	4							e35577	10.1371/journal.pone.0035577	http://dx.doi.org/10.1371/journal.pone.0035577			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VO	22523602	Green Published, Green Submitted, gold			2022-12-25	WOS:000305345000076
J	Stein, M; Pilli, M; Bernauer, S; Habermann, BH; Zerial, M; Wade, RC				Stein, Matthias; Pilli, Manohar; Bernauer, Sabine; Habermann, Bianca H.; Zerial, Marino; Wade, Rebecca C.			The Interaction Properties of the Human Rab GTPase Family - A Comparative Analysis Reveals Determinants of Molecular Binding Selectivity	PLOS ONE			English	Article							PROTEIN-INTERACTION; STRUCTURAL BASIS; KINETIC-PARAMETERS; DOMAIN; LOCALIZATION; SPECIFICITY; PHYLOGENIES; EVOLUTION; REGIONS; SWITCH	Background: Rab GTPases constitute the largest subfamily of the Ras protein superfamily. Rab proteins regulate organelle biogenesis and transport, and display distinct binding preferences for effector and activator proteins, many of which have not been elucidated yet. The underlying molecular recognition motifs, binding partner preferences and selectivities are not well understood. Methodology/Principal Findings: Comparative analysis of the amino acid sequences and the three-dimensional electrostatic and hydrophobic molecular interaction fields of 62 human Rab proteins revealed a wide range of binding properties with large differences between some Rab proteins. This analysis assists the functional annotation of Rab proteins 12, 14, 26, 37 and 41 and provided an explanation for the shared function of Rab3 and 27. Rab7a and 7b have very different electrostatic potentials, indicating that they may bind to different effector proteins and thus, exert different functions. The subfamily V Rab GTPases which are associated with endosome differ subtly in the interaction properties of their switch regions, and this may explain exchange factor specificity and exchange kinetics. Conclusions/Significance: We have analysed conservation of sequence and of molecular interaction fields to cluster and annotate the human Rab proteins. The analysis of three dimensional molecular interaction fields provides detailed insight that is not available from a sequence-based approach alone. Based on our results, we predict novel functions for some Rab proteins and provide insights into their divergent functions and the determinants of their binding partner selectivity.	[Stein, Matthias; Pilli, Manohar; Wade, Rebecca C.] HITS, Mol & Cellular Modeling Grp, Heidelberg, Germany; [Stein, Matthias] Max Planck Inst Dynam Complex Tech Syst, Magdeburg, Germany; [Bernauer, Sabine; Habermann, Bianca H.; Zerial, Marino] Max Planck Inst Mol Cell Biol & Genet, Dresden, Germany; [Habermann, Bianca H.] Max Planck Inst Biol Ageing, Cologne, Germany	Max Planck Society; Max Planck Society; Max Planck Society	Stein, M (corresponding author), HITS, Mol & Cellular Modeling Grp, Heidelberg, Germany.	matthias.stein@mpi-magdeburg.mpg.de; rebecca.wade@h-its.org	Habermann, Bianca/N-4886-2016; Pilli, Manohar/G-6568-2015; Stein, Matthias/A-2865-2011; Wade, Rebecca/L-1489-2019	Habermann, Bianca/0000-0002-2457-7504; Pilli, Manohar/0000-0002-3084-8788; Stein, Matthias/0000-0001-7793-0052; Wade, Rebecca/0000-0001-5951-8670	BMBF HepatoSys Competence Network Systems Biology of Hepatocytes [0313076, 0313078C]; Virtual Liver Network [0315749]; Klaus Tschira Foundation	BMBF HepatoSys Competence Network Systems Biology of Hepatocytes(Federal Ministry of Education & Research (BMBF)); Virtual Liver Network; Klaus Tschira Foundation	Financial support from the BMBF HepatoSys Competence Network Systems Biology of Hepatocytes (grant nos. 0313076 and 0313078C) and Virtual Liver Network (grant 0315749), as well as the Klaus Tschira Foundation is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali BR, 2004, J CELL SCI, V117, P6401, DOI 10.1242/jcs.01542; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Blomberg N, 1999, PROTEINS, V37, P379, DOI 10.1002/(SICI)1097-0134(19991115)37:3<379::AID-PROT6>3.0.CO;2-K; Bock JB, 2001, NATURE, V409, P839, DOI 10.1038/35057024; Burguete AS, 2008, CELL, V132, P286, DOI 10.1016/j.cell.2007.11.048; CHAVRIER P, 1990, CELL, V62, P317, DOI 10.1016/0092-8674(90)90369-P; Colicelli John, 2004, Sci STKE, V2004, pRE13, DOI 10.1126/stke.2502004re13; Collins RN, 2005, METHOD ENZYMOL, V403, P19, DOI 10.1016/S0076-6879(05)03003-X; De Rienzo F, 2000, PROTEIN SCI, V9, P1439, DOI 10.1110/ps.9.8.1439; Delprato A, 2004, CELL, V118, P607, DOI 10.1016/j.cell.2004.08.009; Delprato A, 2007, NAT STRUCT MOL BIOL, V14, P406, DOI 10.1038/nsmb1232; Dlugosz M, 2008, J CHEM PHYS, V129, DOI 10.1063/1.2948414; Do CB, 2005, GENOME RES, V15, P330, DOI 10.1101/gr.2821705; Felsenstein J., 1989, CLADISTICS, V5, P164, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Gabdoulline RR, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-373; GOODFORD PJ, 1985, J MED CHEM, V28, P849, DOI 10.1021/jm00145a002; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Guo Z, 2005, BIOCHEMISTRY-US, V44, P15423, DOI 10.1021/bi0518601; HODGKIN EE, 1987, INT J QUANTUM CHEM, P105; Iida H, 2005, MOL REPROD DEV, V71, P178, DOI 10.1002/mrd.20294; Kieslich CA, 2011, BIOTECHNOL PROGR, V27, P316, DOI 10.1002/btpr.541; Mackiewicz P, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-101; MADURA JD, 1995, COMPUT PHYS COMMUN, V91, P57, DOI 10.1016/0010-4655(95)00043-F; Marti-Renom MA, 2000, ANNU REV BIOPH BIOM, V29, P291, DOI 10.1146/annurev.biophys.29.1.291; MATTHEW JB, 1985, ANNU REV BIOPHYS BIO, V14, P387; Merithew E, 2001, J BIOL CHEM, V276, P13982, DOI 10.1074/jbc.M009771200; MOORE I, 1995, TRENDS BIOCHEM SCI, V20, P10, DOI 10.1016/S0968-0004(00)88939-2; Nussbaum M, 2005, METHOD ENZYMOL, V403, P10, DOI 10.1016/S0076-6879(05)03002-8; OLKKONEN VM, 1993, J CELL SCI, V106, P1249; Ostermeier C, 1999, CELL, V96, P363, DOI 10.1016/S0092-8674(00)80549-8; Pereira-Leal JB, 2001, J MOL BIOL, V313, P889, DOI 10.1006/jmbi.2001.5072; Pereira-Leal JB, 2003, BIOCHEM BIOPH RES CO, V301, P92, DOI 10.1016/S0006-291X(02)02963-7; Pereira-Leal JB, 2000, J MOL BIOL, V301, P1077, DOI 10.1006/jmbi.2000.4010; Recacha R, 2009, STRUCTURE, V17, P21, DOI 10.1016/j.str.2008.10.014; Regazzi R, 2007, MOL MECH EXOCYTOSIS, P28; Richter S, 2008, NUCLEIC ACIDS RES, V36, pW276, DOI 10.1093/nar/gkn181; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Schleinkofer K, 2004, J MOL BIOL, V344, P865, DOI 10.1016/j.jmb.2004.09.063; Schwartz SL, 2007, J CELL SCI, V120, P3905, DOI 10.1242/jcs.015909; Stein M, 2008, BIOCHEM SOC T, V36, P51, DOI 10.1042/BST0360051; Stein M, 2010, MOL BIOSYST, V6, P162, DOI 10.1039/b912398a; Stenmark H, 2001, GENOME BIOL, V2; Stenmark H, 2009, NAT REV MOL CELL BIO, V10, P513, DOI 10.1038/nrm2728; Talavera G, 2007, SYST BIOL, V56, P564, DOI 10.1080/10635150701472164; Terzyan S, 2004, ACTA CRYSTALLOGR D, V60, P54, DOI 10.1107/S0907444903021632; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Vetter IR, 2001, SCIENCE, V294, P1299, DOI 10.1126/science.1062023; Wade RC, 2001, INT J QUANTUM CHEM, V83, P122, DOI 10.1002/qua.1204; WARSHEL A, 1991, ANNU REV BIOPHYS BIO, V20, P267, DOI 10.1146/annurev.biophys.20.1.267; Weidemann A, 2008, BIOINFORMATICS, V24, P1463, DOI 10.1093/bioinformatics/btn207; Winn PJ, 2007, FRONT BIOSCI-LANDMRK, V12, P3419, DOI 10.2741/2323; Winn PJ, 2004, STRUCTURE, V12, P1563, DOI 10.1016/j.str.2004.06.017; Yang MJ, 2004, BIOCHEM BIOPH RES CO, V318, P792, DOI 10.1016/j.bbrc.2004.04.115; Yoshimura S, 2007, J CELL BIOL, V178, P363, DOI 10.1083/jcb.200703047; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055	56	29	29	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2012	7	4							e34870	10.1371/journal.pone.0034870	http://dx.doi.org/10.1371/journal.pone.0034870			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VO	22523562	Green Published, gold, Green Submitted			2022-12-25	WOS:000305345000034
J	Terada, M; Kawano, F; Ohira, T; Nakai, N; Nishimoto, N; Ohira, Y				Terada, Masahiro; Kawano, Fuminori; Ohira, Takashi; Nakai, Naoya; Nishimoto, Norihiro; Ohira, Yoshinobu			Effects of Mechanical Over-Loading on the Properties of Soleus Muscle Fibers, with or without Damage, in Wild Type and Mdx Mice	PLOS ONE			English	Article							SKELETAL-MUSCLE; SATELLITE CELLS; COMPENSATORY ADAPTATIONS; MUSCULAR-DYSTROPHY; FAST-TWITCH; HYPERTROPHY; INJURY; PATHOGENESIS; DIVISION; GROWTH	Effects of mechanical over-loading on the characteristics of regenerating or normal soleus muscle fibers were studied in dystrophin-deficient (mdx) and wild type (WT) mice. Damage was also induced in WT mice by injection of cardiotoxin (CTX) into soleus muscle. Over-loading was applied for 14 days to the left soleus muscle in mdx and intact and CTX-injected WT mouse muscles by ablation of the distal tendons of plantaris and gastrocnemius muscles. All of the myonuclei in normal muscle of WT mice were distributed at the peripheral region. But, central myonuclei were noted in all fibers of WT mice regenerating from CTX-injection-related injury. Further, many fibers of mdx mice possessed central myonuclei and the distribution of such fibers was increased in response to over-loading, suggesting a shift of myonuclei from peripheral to central region. Approximately 1.4% branched fibers were seen in the intact muscle of mdx mice, although these fibers were not detected in WT mice. The percentage of these fibers in mdx, not in WT, mice was increased by over-loading (similar to 51.2%). The fiber CSA in normal WT mice was increased by over-loading (p<0.05), but not in mdx and CTX-injected WT mice. It was suggested that compensatory hypertrophy is induced in normal muscle fibers of WT mice following functional over-loading. But, it was also indicated that muscle fibers in mdx mice are susceptible to mechanical over-loading and fiber splitting and shift of myonuclei from peripheral to central region are induced.	[Terada, Masahiro; Ohira, Takashi; Ohira, Yoshinobu] Osaka Univ, Grad Sch Frontier Biosci, Toyonaka, Osaka 560, Japan; [Kawano, Fuminori; Nakai, Naoya; Ohira, Yoshinobu] Osaka Univ, Grad Sch Med, Toyonaka, Osaka 560, Japan; [Nishimoto, Norihiro] Wakayama Med Univ, Lab Immune Regulat, Ibaragi City, Osaka, Japan	Osaka University; Osaka University	Terada, M (corresponding author), Osaka Univ, Grad Sch Frontier Biosci, Toyonaka, Osaka 560, Japan.	ohira@space.hss.osaka-u.ac.jp			Japan Society for the Promotion of Science [19-6885, B-23700856, S-19100009, 20650104]; Ministry of Health, Labor and Welfare of Japan [H23-Immunology-003]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Health, Labor and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan)	This study was supported by the Grant-in-Aid for Research Activity Start-up from Japan Society for the Promotion of Science (19-6885, Dr. Terada), Grant-in-Aid for Young Scientists (B-23700856, Dr. Terada), the Grant-in-Aid for Scientific Research (S-19100009, Dr. Ohira, http://www.jsps.go.jp/j-grantsinaid/index.html) and for Exploratory Research (20650104, Dr. Ohira) from Japan Society for the Promotion of Science, and the grant from the Ministry of Health, Labor and Welfare of Japan (H23-Immunology-003, Dr. Nishmoto). The funders had no roles in study design, data collection and analyses, decision to publish, or preparation of the manuscript.	Allen DG, 2004, CLIN EXP PHARMACOL P, V31, P485, DOI 10.1111/j.1440-1681.2004.04032.x; Bigard AX, 2001, AM J PHYSIOL-CELL PH, V281, pC1686, DOI 10.1152/ajpcell.2001.281.5.C1686; Bigard XA, 1996, J APPL PHYSIOL, V81, P2658, DOI 10.1152/jappl.1996.81.6.2658; BINKHORST RA, 1973, PFLUG ARCH EUR J PHY, V342, P145, DOI 10.1007/BF00587845; Chan S, 2011, EXP PHYSIOL, V96, P564, DOI 10.1113/expphysiol.2010.056713; Crisona NJ, 1998, J MUSCLE RES CELL M, V19, P43; DALBIS A, 1988, EUR J BIOCHEM, V174, P103, DOI 10.1111/j.1432-1033.1988.tb14068.x; Deconinck N, 2007, PEDIATR NEUROL, V36, P1, DOI 10.1016/j.pediatrneurol.2006.09.016; DONOVAN CM, 1986, J APPL PHYSIOL, V61, P288, DOI 10.1152/jappl.1986.61.1.288; HALLCRAGGS EC, 1970, Z ZELLFORSCH MIK ANA, V109, P481, DOI 10.1007/BF00343963; HALLCRAGGS EC, 1972, J NEUROL SCI, V15, P27, DOI 10.1016/0022-510X(72)90119-0; Haslett JN, 2005, MAMM GENOME, V16, P739, DOI 10.1007/s00335-005-0053-8; Hosaka Y, 2002, J CELL BIOL, V158, P1097, DOI 10.1083/jcb.200204076; HUBBARD RW, 1975, GROWTH, V39, P85; IANUZZO CD, 1976, LIFE SCI, V19, P1517, DOI 10.1016/0024-3205(76)90096-5; IRINTCHEV A, 1987, CELL TISSUE RES, V249, P509; Iwata Y, 2007, AM J PATHOL, V171, P1576, DOI 10.2353/ajpath.2007.070452; JAMES NT, 1979, J ANAT, V129, P769; KANDARIAN SC, 1992, J APPL PHYSIOL, V72, P1934, DOI 10.1152/jappl.1992.72.5.1934; Kawano F, 2007, AM J PHYSIOL-CELL PH, V293, pC35, DOI 10.1152/ajpcell.00297.2006; Kawano F, 2008, AM J PHYSIOL-CELL PH, V295, pC458, DOI 10.1152/ajpcell.00497.2007; Lepper C, 2011, DEVELOPMENT, V138, P3639, DOI 10.1242/dev.067595; McCarter GC, 2000, J MEMBRANE BIOL, V176, P169, DOI 10.1007/s002320001086; McCarthy JJ, 2011, DEVELOPMENT, V138, P3657, DOI 10.1242/dev.068858; Mokhtarian A, 1999, J APPL PHYSIOL, V86, P924, DOI 10.1152/jappl.1999.86.3.924; Murphy MM, 2011, DEVELOPMENT, V138, P3625, DOI 10.1242/dev.064162; Ohira T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021044; Ohira Y, 2001, AM J PHYSIOL-CELL PH, V280, pC1008, DOI 10.1152/ajpcell.2001.280.4.C1008; Richard-Bulteau H, 2008, AM J PHYSIOL-CELL PH, V294, pC467, DOI 10.1152/ajpcell.00355.2007; ROY RR, 1985, J APPL PHYSIOL, V59, P639, DOI 10.1152/jappl.1985.59.2.639; SAITO K, 1981, BRAIN DEV-JPN, V3, P65, DOI 10.1016/S0387-7604(81)80008-3; Sambasivan R, 2011, DEVELOPMENT, V138, P3647, DOI 10.1242/dev.067587; Schafer R, 2005, NEUROMUSCULAR DISORD, V15, P57, DOI 10.1016/j.nmd.2004.09.011; SOLA OM, 1973, EXP NEUROL, V41, P76, DOI 10.1016/0014-4886(73)90182-9; SWOAP SJ, 1994, J APPL PHYSIOL, V77, P621, DOI 10.1152/jappl.1994.77.2.621; Terada M, 2010, CELLS TISSUES ORGANS, V191, P248, DOI 10.1159/000240245; TSIKA RW, 1987, J APPL PHYSIOL, V62, P2180, DOI 10.1152/jappl.1987.62.6.2180; VAUGHAN HS, 1979, J ANAT, V129, P293; Wang XD, 2006, AM J PHYSIOL-CELL PH, V290, pC981, DOI 10.1152/ajpcell.00298.2005; Wang YX, 2012, NAT REV MOL CELL BIO, V13, P127, DOI 10.1038/nrm3265; WILLIAMS DA, 1993, J PHYSIOL-LONDON, V460, P51, DOI 10.1113/jphysiol.1993.sp019458; Yablonka-Reuveni Z, 2006, DEV DYNAM, V235, P203, DOI 10.1002/dvdy.20602	42	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2012	7	4							e34557	10.1371/journal.pone.0034557	http://dx.doi.org/10.1371/journal.pone.0034557			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VO	22523551	gold, Green Published, Green Submitted			2022-12-25	WOS:000305345000021
J	Liu, AD; Fang, HS; Dirsch, O; Jin, H; Dahmen, U				Liu, Anding; Fang, Haoshu; Dirsch, Olaf; Jin, Hao; Dahmen, Uta			Oxidation of HMGB1 Causes Attenuation of Its Pro-Inflammatory Activity and Occurs during Liver Ischemia and Reperfusion	PLOS ONE			English	Article							MOBILITY GROUP BOX-1; CHROMATIN PROTEIN HMGB1; ISCHEMIA/REPERFUSION INJURY; SUBCELLULAR-LOCALIZATION; CELLS; RAT; TRANSPLANTATION; RELEASE; DANGER; ACTIVATION	High mobility group box 1 (HMGB1) is a nuclear transcription factor. Once HMGB1 is released by damaged cells or activated immune cells, it acts as danger molecule and triggers the inflammatory signaling cascade. Currently, evidence is accumulating that posttranslational modifications such as oxidation may modulate the pro-inflammatory potential of danger signals. We hypothesized that oxidation of HMGB1 may reduce its pro-inflammatory potential and could take place during prolonged ischemia and upon reperfusion. Liver grafts were cold preserved for 24 h and flushed with saline in hourly intervals to collect the effluent. Liver grafts, cold-preserved for 6 h, were transplanted into syngeneic recipients to obtain serum and liver samples 24 h after initiation of reperfusion. Addition of the effluent to a macrophage culture induced the synthesis of tumor necrosis factor-alpha (TNF-alpha) and interleukin (IL)-6. The stimulatory activity of graft effluent was reduced after depletion of HMGB1 via immunoprecipitation. Oxidation of the effluent HMGB1 using H2O2 attenuated its stimulatory activity as well. Liver transplantation of cold preserved grafts caused HMGB1 translocation and release as determined by immunohistochemistry and ELISA-assay, respectively. Using Western blot with non-reducing conditions revealed the presence of oxidized HMGB1 in liver samples obtained after 12 h and in effluent samples after 16 h of cold preservation as well as in liver and serum samples obtained 24 h after reperfusion. These observations confirm that posttranslational oxidation of HMGB1 attenuates its pro-inflammatory activity. Oxidation of HMGB1 as induced during prolonged ischemia and by reoxygenation during reperfusion in vivo might also attenuate its pro-inflammatory activity. Our findings also call for future studies to investigate the mechanism of the inhibitory effect of oxidized HMGB1 on the pro-inflammatory potential.	[Liu, Anding; Fang, Haoshu; Jin, Hao; Dahmen, Uta] Univ Jena, Dept Gen Visceral & Vasc Surg, Jena, Germany; [Liu, Anding] Shaoxing Univ, Affiliated Hosp 1, Shaoxing Peoples Hosp, Ctr Mol Med, Shaoxing, Peoples R China; [Liu, Anding; Fang, Haoshu; Jin, Hao; Dahmen, Uta] Univ Duisburg & Essen, Univ Hosp Essen, Dept Gen Visceral & Transplantat Surg, Essen, Germany; [Dirsch, Olaf] Univ Hosp Jena, Inst Pathol, Jena, Germany	Friedrich Schiller University of Jena; Shaoxing University; University of Duisburg Essen; Friedrich Schiller University of Jena	Liu, AD (corresponding author), Univ Jena, Dept Gen Visceral & Vasc Surg, Jena, Germany.	uta.dahmen@med.uni-jena.de	Liu, Anding/AAU-2477-2020		DFG grant "Klinische Forschergruppe 117 - Optimierung der Leberlebendspende'' [Da251/4-3, Da251/4-4, Da251/5-3, Da251/5-4, KFO117]; German Federal Ministry for Education and Research (BMBF) Virtual Liver Network	DFG grant "Klinische Forschergruppe 117 - Optimierung der Leberlebendspende''; German Federal Ministry for Education and Research (BMBF) Virtual Liver Network(Federal Ministry of Education & Research (BMBF))	This research is supported partially by the DFG grant "Klinische Forschergruppe 117 - Optimierung der Leberlebendspende'' (grant number: Da251/4-3&4, 5-3&4, KFO117) and the German Federal Ministry for Education and Research (BMBF) Virtual Liver Network. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Abraham E, 2000, J IMMUNOL, V165, P2950, DOI 10.4049/jimmunol.165.6.2950; Abu-Amara M, 2010, LIVER TRANSPLANT, V16, P1016, DOI 10.1002/lt.22117; Andrassy M, 2008, CIRCULATION, V117, P3216, DOI 10.1161/CIRCULATIONAHA.108.769331; Bell CW, 2006, AM J PHYSIOL-CELL PH, V291, pC1318, DOI 10.1152/ajpcell.00616.2005; Bianchi ME, 2007, IMMUNOL REV, V220, P35, DOI 10.1111/j.1600-065X.2007.00574.x; BIANCHI ME, 1989, SCIENCE, V243, P1056, DOI 10.1126/science.2922595; Bonaldi T, 2003, EMBO J, V22, P5551, DOI 10.1093/emboj/cdg516; Bustin M, 1996, PROG NUCLEIC ACID RE, V54, P35, DOI 10.1016/S0079-6603(08)60360-8; Colletti LM, 1996, HEPATOLOGY, V23, P506; Hoppe G, 2006, EXP CELL RES, V312, P3526, DOI 10.1016/j.yexcr.2006.07.020; Ilmakunnas M, 2008, LIVER TRANSPLANT, V14, P1517, DOI 10.1002/lt.21573; Ito I, 2007, J BIOL CHEM, V282, P16336, DOI 10.1074/jbc.M608467200; Jin H., 2011, J SUPERCOMPUT, P1; KAMADA N, 1979, TRANSPLANTATION, V28, P47, DOI 10.1097/00007890-197907000-00011; Kazama H, 2008, IMMUNITY, V29, P21, DOI 10.1016/j.immuni.2008.05.013; Kim JB, 2008, J NEUROSCI RES, V86, P1125, DOI 10.1002/jnr.21555; Klune JR, 2008, MOL MED, V14, P476, DOI 10.2119/2008-00034.Klune; Kono H, 2008, NAT REV IMMUNOL, V8, P279, DOI 10.1038/nri2215; Liu AD, 2012, CYTOKINE, V57, P150, DOI 10.1016/j.cyto.2011.11.009; Liu AD, 2011, EXP MOL PATHOL, V91, P502, DOI 10.1016/j.yexmp.2011.05.005; Liu AD, 2011, HISTOCHEM CELL BIOL, V135, P443, DOI 10.1007/s00418-011-0802-6; Liu AD, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/436145; Lotze MT, 2005, NAT REV IMMUNOL, V5, P331, DOI 10.1038/nri1594; Muller S, 2004, J INTERN MED, V255, P332, DOI 10.1111/j.1365-2796.2003.01296.x; Muller S, 2001, EMBO J, V20, P4337, DOI 10.1093/emboj/20.16.4337; Peralta C, 2001, TRANSPLANTATION, V71, P529, DOI 10.1097/00007890-200102270-00008; Peter ME, 2008, IMMUNITY, V29, P1, DOI 10.1016/j.immuni.2008.06.006; Piratvisuth T, 1995, Liver Transpl Surg, V1, P296, DOI 10.1002/lt.500010505; Rovere-Querini P, 2004, EMBO REP, V5, P825, DOI 10.1038/sj.embor.7400205; Sahu D, 2008, FEBS LETT, V582, P3973, DOI 10.1016/j.febslet.2008.09.061; STEININGER R, 1994, TRANSPLANTATION, V58, P179, DOI 10.1097/00007890-199407270-00008; Tsung A, 2005, J EXP MED, V201, P1135, DOI 10.1084/jem.20042614; Vardanian AJ, 2008, MOL MED, V14, P337, DOI 10.2119/2007-00134.Vardanian; Wang HC, 1999, SCIENCE, V285, P248, DOI 10.1126/science.285.5425.248; Wu HL, 2007, J CLIN INVEST, V117, P2847, DOI 10.1172/JCI31008; Yang HA, 2010, P NATL ACAD SCI USA, V107, P11942, DOI 10.1073/pnas.1003893107; Yang H, 2010, BBA-GENE REGUL MECH, V1799, P149, DOI 10.1016/j.bbagrm.2009.11.019; Youn JH, 2006, J IMMUNOL, V177, P7889, DOI 10.4049/jimmunol.177.11.7889	38	31	33	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2012	7	4							e35379	10.1371/journal.pone.0035379	http://dx.doi.org/10.1371/journal.pone.0035379			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UT	22514737	gold, Green Published, Green Submitted			2022-12-25	WOS:000305341600142
J	Kim, SH; Lee, PC				Kim, Se Hyeuk; Lee, Pyung Cheon			Functional Expression and Extension of Staphylococcal Staphyloxanthin Biosynthetic Pathway in Escherichia coli	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AUREUS; VIRULENCE	The biosynthetic pathway for staphyloxanthin, a C-30 carotenoid biosynthesized by Staphylococcus aureus, has previously been proposed to consist of five enzymes (CrtO, CrtP, CrtQ, CrtM, and CrtN). Here, we report a missing sixth enzyme, 4,4'-diaponeurosporen-aldehyde dehydrogenase (AldH), in the staphyloxanthin biosynthetic pathway and describe the functional expression of the complete staphyloxanthin biosynthetic pathway in Escherichia coli. When we expressed the five known pathway enzymes through artificial synthetic operons and the wild-type operon (crtOPQMN) in E. coli, carotenoid aldehyde intermediates such as 4,4'-diaponeurosporen-4-al accumulated without being converted into staphyloxanthin or other intermediates. We identified an aldH gene located 670 kilobase pairs from the known staphyloxanthin gene cluster in the S. aureus genome and an aldH gene in the non-staphyloxanthin-producing Staphylococcus carnosus genome. These two putative enzymes catalyzed the missing oxidation reaction to convert 4,4'-diaponeurosporen-4-al into 4,4'-diaponeurosporenoic acid in E. coli. Deletion of the aldH gene in S. aureus abolished staphyloxanthin biosynthesis and caused accumulation of 4,4'-diaponeurosporen-4-al, confirming the role of AldH in staphyloxanthin biosynthesis. When the complete staphyloxanthin biosynthetic pathway was expressed using an artificial synthetic operon in E. coli, staphyloxanthin-like compounds, which contained altered fatty acid acyl chains, and novel carotenoid compounds were produced, indicating functional expression and coordination of the six staphyloxanthin pathway enzymes.	[Lee, Pyung Cheon] Ajou Univ, Dept Mol Sci & Technol, Suwon 443749, South Korea; Ajou Univ, Dept Biotechnol, Suwon 443749, South Korea	Ajou University; Ajou University	Lee, PC (corresponding author), Ajou Univ, Dept Mol Sci & Technol, Suwon 443749, South Korea.	pclee@ajou.ac.kr	Lee, Pyung Cheon/AAR-1021-2021; Kim, Hyeuk/O-9911-2015	Kim, Hyeuk/0000-0003-4543-4622; Lee, Pyung Cheon/0000-0003-2014-6587	National Research Foundation of Korea [2011-0018057, 2011-0003535]; Korean Government; Ministry of Education, Science, and Technology; Priority Research Center Program through National Research Foundation of Korea [2011-0022978]	National Research Foundation of Korea(National Research Foundation of Korea); Korean Government(Korean Government); Ministry of Education, Science, and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); Priority Research Center Program through National Research Foundation of Korea(National Research Foundation of Korea)	This work was supported by National Research Foundation of Korea Grants 2011-0018057 and 2011-0003535 funded by the Korean Government and by Priority Research Centers Program Grant 2011-0022978 through the National Research Foundation of Korea funded by the Ministry of Education, Science, and Technology.	Albrecht M, 2000, NAT BIOTECHNOL, V18, P843, DOI 10.1038/78443; AUGUSTIN J, 1990, FEMS MICROBIOL LETT, V66, P203, DOI 10.1016/0378-1097(90)90283-V; Bowles B. L., 1996, J RAPID METH AUT MIC, V4, P235; Cahoon EB, 1996, J BACTERIOL, V178, P936, DOI 10.1128/jb.178.3.936-939.1996; Clauditz A, 2006, INFECT IMMUN, V74, P4950, DOI 10.1128/IAI.00204-06; Daum RS, 2008, NEW ENGL J MED, V359, P85, DOI 10.1056/NEJMcibr0803278; Fischer CR, 2010, APPL MICROBIOL BIOT, V88, P265, DOI 10.1007/s00253-010-2749-2; Holt NE, 2005, SCIENCE, V307, P433, DOI 10.1126/science.1105833; Horinouchi S, 2009, CURR OPIN CHEM BIOL, V13, P197, DOI 10.1016/j.cbpa.2009.02.004; Johnson ET, 2008, TRENDS BIOTECHNOL, V26, P682, DOI 10.1016/j.tibtech.2008.09.002; Kim SH, 2010, APPL ENVIRON MICROB, V76, P5199, DOI 10.1128/AEM.00263-10; Klein-Marcuschamer D, 2007, TRENDS BIOTECHNOL, V25, P417, DOI 10.1016/j.tibtech.2007.07.006; KOVACH ME, 1995, GENE, V166, P175, DOI 10.1016/0378-1119(95)00584-1; Lee PC, 2003, CHEM BIOL, V10, P453, DOI 10.1016/S1074-5521(03)00103-0; Lee PC, 2010, APPL ENVIRON MICROB, V76, P7328, DOI 10.1128/AEM.01606-10; Liu CI, 2008, SCIENCE, V319, P1391, DOI 10.1126/science.1153018; MARSHALL JH, 1981, J BACTERIOL, V147, P914, DOI 10.1128/JB.147.3.914-919.1981; Mijts BN, 2005, CHEM BIOL, V12, P453, DOI 10.1016/j.chembiol.2005.02.010; Mijts BN, 2004, METHOD ENZYMOL, V388, P315; Na D, 2010, CURR OPIN MICROBIOL, V13, P363, DOI 10.1016/j.mib.2010.02.004; Pelz A, 2005, J BIOL CHEM, V280, P32493, DOI 10.1074/jbc.M505070200; Schmidt-Dannert C, 2000, NAT BIOTECHNOL, V18, P750, DOI 10.1038/77319; Smirnova N, 2001, J IND MICROBIOL BIOT, V27, P246, DOI 10.1038/sj.jim.7000185; Tao L, 2005, APPL ENVIRON MICROB, V71, P3294, DOI 10.1128/AEM.71.6.3294-3301.2005; Walsh CT, 2008, ANGEW CHEM INT EDIT, V47, P5700, DOI 10.1002/anie.200801801; Wyatt MA, 2010, SCIENCE, V329, P294, DOI 10.1126/science.1188888; Yadav VG, 2010, CURR OPIN MICROBIOL, V13, P371, DOI 10.1016/j.mib.2010.04.002	27	37	40	0	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 22	2012	287	26					21575	21583		10.1074/jbc.M112.343020	http://dx.doi.org/10.1074/jbc.M112.343020			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974GH	22535955	hybrid, Green Published			2022-12-25	WOS:000306418600002
J	Kulaeva, OI; Zheng, GH; Polikanov, YS; Colasanti, AV; Clauvelin, N; Mukhopadhyay, S; Sengupta, AM; Studitsky, VM; Olson, WK				Kulaeva, Olga I.; Zheng, Guohui; Polikanov, Yury S.; Colasanti, Andrew V.; Clauvelin, Nicolas; Mukhopadhyay, Swagatam; Sengupta, Anirvan M.; Studitsky, Vasily M.; Olson, Wilma K.			Internucleosomal Interactions Mediated by Histone Tails Allow Distant Communication in Chromatin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IN-VITRO; NUCLEOSOME CORE; ENHANCER ACTION; H4-K16 ACETYLATION; DNA FLEXIBILITY; RNA-POLYMERASES; GENE-EXPRESSION; FIBER STRUCTURE; RING-CLOSURE; MODEL	Action across long distances on chromatin is a hallmark of eukaryotic transcriptional regulation. Although chromatin structure per se can support long-range interactions, the mechanisms of efficient communication between widely spaced DNA modules in chromatin remain a mystery. The molecular simulations described herein suggest that transient binary internucleosomal interactions can mediate distant communication in chromatin. Electrostatic interactions between the N-terminal tails of the core histones and DNA enhance the computed probability of juxtaposition of sites that lie far apart along the DNA sequence. Experimental analysis of the rates of communication in chromatin constructs confirms that long-distance communication occurs efficiently and independently of distance on tail-containing, but not on tailless, chromatin. Taken together, our data suggest that internucleosomal interactions involving the histone tails are essential for highly efficient, long-range communication between regulatory elements and their targets in eukaryotic genomes.	[Kulaeva, Olga I.; Polikanov, Yury S.; Studitsky, Vasily M.] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Pharmacol, Piscataway, NJ 08854 USA; [Studitsky, Vasily M.] Moscow MV Lomonosov State Univ, Sch Biol, Moscow, Russia; [Zheng, Guohui; Colasanti, Andrew V.; Clauvelin, Nicolas; Olson, Wilma K.] Rutgers State Univ, Dept Chem & Chem Biol, BioMaPS Inst Quantitat Biol, Piscataway, NJ 08854 USA; [Mukhopadhyay, Swagatam; Sengupta, Anirvan M.] Rutgers State Univ, Dept Phys & Astron, BioMaPS Inst Quantitat Biol, Piscataway, NJ 08854 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; Lomonosov Moscow State University; Rutgers State University New Brunswick; Rutgers State University New Brunswick	Studitsky, VM (corresponding author), Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Pharmacol, 675 Hoes La W, Piscataway, NJ 08854 USA.	studitvm@umdnj.edu; wilma.olson@rutgers.edu	Clauvelin, Nicolas/B-4287-2009; Sengupta, Anirvan/G-2508-2012; Studitskaia, Olga/D-8551-2014; Polikanov, Yury/B-4322-2016	Studitskaia, Olga/0000-0001-5417-9964; Polikanov, Yury/0000-0002-5064-0327	National Institutes of Health [GM34809, HG03470, RR022375]; National Science Foundation [7046342]; Government of the Russian Federation [220]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR022375] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG003470] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM034809] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Government of the Russian Federation; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM34809 (to W. K. O.) and HG03470 (to A. M. S.) and National Institutes of Health Instrumentation Award RR022375 (to A. M. S. and W. K. O.). This work was also supported by National Science Foundation Grant 7046342 and a Government of the Russian Federation (Order 220) research grant (to V. M. S.).	Angelov D, 2001, P NATL ACAD SCI USA, V98, P6599, DOI 10.1073/pnas.121171498; Arya G, 2006, P NATL ACAD SCI USA, V103, P16236, DOI 10.1073/pnas.0604817103; Arya G, 2009, J PHYS CHEM A, V113, P4045, DOI 10.1021/jp810375d; Baneres JL, 1997, J MOL BIOL, V273, P503, DOI 10.1006/jmbi.1997.1297; Bannister AJ, 2011, CELL RES, V21, P381, DOI 10.1038/cr.2011.22; Bell O, 2010, NAT STRUCT MOL BIOL, V17, P894, DOI 10.1038/nsmb.1825; Bellomy G R, 1990, Prog Nucleic Acid Res Mol Biol, V39, P81, DOI 10.1016/S0079-6603(08)60624-8; Ben-Haim E, 2001, PHYS REV E, V64, DOI 10.1103/PhysRevE.64.051921; Bondarenko V, 2003, METHOD ENZYMOL, V370, P324; Bondarenko VA, 2003, BIOCHEM CELL BIOL, V81, P241, DOI 10.1139/o03-051; Bondarenko VA, 2003, EMBO J, V22, P4728, DOI 10.1093/emboj/cdg468; Chodaparambil JV, 2007, NAT STRUCT MOL BIOL, V14, P1105, DOI 10.1038/nsmb1334; Czapla L, 2008, J MOL BIOL, V382, P353, DOI 10.1016/j.jmb.2008.05.088; Czapla L, 2006, J CHEM THEORY COMPUT, V2, P685, DOI 10.1021/ct060025+; Davey CA, 2002, J MOL BIOL, V319, P1097, DOI 10.1016/S0022-2836(02)00386-8; de Laat W, 2008, CURR TOP DEV BIOL, V82, P117, DOI 10.1016/S0070-2153(07)00005-1; Diesinger PM, 2010, BIOPHYS J, V99, P2995, DOI 10.1016/j.bpj.2010.08.039; Dorigo B, 2004, SCIENCE, V306, P1571, DOI 10.1126/science.1103124; Huang J, 2001, P NATL ACAD SCI USA, V98, P968, DOI 10.1073/pnas.98.3.968; JACKSON V, 1990, BIOCHEMISTRY-US, V29, P719, DOI 10.1021/bi00455a019; JACOBSON H, 1950, J CHEM PHYS, V18, P1600, DOI 10.1063/1.1747547; Katritch V, 2000, J MOL BIOL, V295, P29, DOI 10.1006/jmbi.1999.3021; Langowski J, 2006, EUR PHYS J E, V19, P241, DOI 10.1140/epje/i2005-10067-9; LAYBOURN PJ, 1992, SCIENCE, V257, P1682, DOI 10.1126/science.1388287; Lee KM, 1997, P NATL ACAD SCI USA, V94, P8959, DOI 10.1073/pnas.94.17.8959; Lee SY, 2003, GENE DEV, V17, P2552, DOI 10.1101/gad.1125603; Liu Y, 2001, P NATL ACAD SCI USA, V98, P14883, DOI 10.1073/pnas.261477898; Lowary PT, 1998, J MOL BIOL, V276, P19, DOI 10.1006/jmbi.1997.1494; Mergell B, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.011915; Murakami KS, 2003, CURR OPIN STRUC BIOL, V13, P31, DOI 10.1016/S0959-440X(02)00005-2; Perisic O, 2010, J MOL BIOL, V403, P777, DOI 10.1016/j.jmb.2010.07.057; Poirier MG, 2008, J MOL BIOL, V379, P772, DOI 10.1016/j.jmb.2008.04.025; Poirier MG, 2009, NAT STRUCT MOL BIOL, V16, P938, DOI 10.1038/nsmb.1650; Polach KJ, 2000, J MOL BIOL, V298, P211, DOI 10.1006/jmbi.2000.3644; Polikanov YS, 2007, METHODS, V41, P250, DOI 10.1016/j.ymeth.2006.11.003; Polikanov YS, 2009, METHODS MOL BIOL, V543, P563, DOI 10.1007/978-1-60327-015-1_33; Ramakrishnan V, 1997, ANNU REV BIOPH BIOM, V26, P83, DOI 10.1146/annurev.biophys.26.1.83; Ringrose L, 1999, EMBO J, V18, P6630, DOI 10.1093/emboj/18.23.6630; Robinson PJJ, 2008, J MOL BIOL, V381, P816, DOI 10.1016/j.jmb.2008.04.050; Robinson PJJ, 2006, P NATL ACAD SCI USA, V103, P6506, DOI 10.1073/pnas.0601212103; Rosa A, 2010, BIOPHYS J, V98, P2410, DOI 10.1016/j.bpj.2010.01.054; Routh A, 2008, P NATL ACAD SCI USA, V105, P8872, DOI 10.1073/pnas.0802336105; Rubtsov MA, 2006, P NATL ACAD SCI USA, V103, P17690, DOI 10.1073/pnas.0603819103; Schalch T, 2005, NATURE, V436, P138, DOI 10.1038/nature03686; Schiessel H, 2001, BIOPHYS J, V80, P1940, DOI 10.1016/S0006-3495(01)76164-4; Schoenfelder S, 2010, CURR OPIN GENET DEV, V20, P127, DOI 10.1016/j.gde.2010.02.002; Shogren-Knaak M, 2006, SCIENCE, V311, P844, DOI 10.1126/science.1124000; SHORE D, 1983, J MOL BIOL, V170, P957, DOI 10.1016/S0022-2836(83)80198-3; Staynov DZ, 2008, CHROMOSOMA, V117, P67, DOI 10.1007/s00412-007-0127-3; Stein A, 2002, NUCLEIC ACIDS RES, V30, P5103, DOI 10.1093/nar/gkf671; TAYLOR WH, 1990, J MOL BIOL, V212, P363, DOI 10.1016/0022-2836(90)90131-5; Vologodskii A, 1996, BIOPHYS J, V70, P2548, DOI 10.1016/S0006-3495(96)79826-0; Walter W, 2004, METHOD ENZYMOL, V377, P445; Wedemann G, 2002, BIOPHYS J, V82, P2847, DOI 10.1016/S0006-3495(02)75627-0; Widom J, 2001, Q REV BIOPHYS, V34, P269, DOI 10.1017/S0033583501003699; WOODCOCK CL, 1993, P NATL ACAD SCI USA, V90, P9021, DOI 10.1073/pnas.90.19.9021; Yang Y, 2009, BIOPHYS J, V96, P2082, DOI 10.1016/j.bpj.2008.10.073; Zheng CY, 2003, J BIOL CHEM, V278, P24217, DOI 10.1074/jbc.M302817200; Zheng GH, 2010, PHYS CHEM CHEM PHYS, V12, P1399, DOI 10.1039/b916183j; Zhou JS, 2007, NAT STRUCT MOL BIOL, V14, P1070, DOI 10.1038/nsmb1323	60	35	38	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 8	2012	287	24					20248	20257		10.1074/jbc.M111.333104	http://dx.doi.org/10.1074/jbc.M111.333104			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974FB	22518845	Green Published, hybrid			2022-12-25	WOS:000306414500045
J	Liu, Y; Song, R; Gao, Y; Li, Y; Wang, S; Liu, HY; Wang, Y; Hu, YH; Shu, HB				Liu, Yu; Song, Ren; Gao, Yan; Li, Yi; Wang, Shuai; Liu, Hai-Yun; Wang, Yan; Hu, Yun-Hong; Shu, Hong-Bing			Protein Kinase C-delta Negatively Regulates T Cell Receptor-induced NF-kappa B Activation by Inhibiting the Assembly of CARMA1 Signalosome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PKC-THETA; LYMPHOCYTES; PHOSPHORYLATION; MALT1; BCL10; LYMPHOMA; PATHWAY; COMPLEX; BETA; TCR	T-cell receptor (TCR)-induced T-cell activation is a critical event in adaptive immune responses. The engagement of TCR complex by antigen along with the activation of the costimulatory receptors trigger a cascade of intracellular signaling, in which caspase recruitment domain-containing membrane-associated guanylate kinase 1 (CARMA1) is a crucial scaffold protein. Upon stimulation, CARMA1 recruits downstream molecules including B-cell CLL/lymphoma 10 (Bcl10), mucosa-associated lymphoid tissue lymphoma translocation gene 1 (MALT1), and TRAF6 to assemble a specific TCR-induced signalosome that triggers NF-kappa B and JNK activation. In this report, we identified protein kinase C delta (PKC delta) as a CARMA1-associated protein by a biochemical affinity purification approach. PKC delta interacted with CARMA1 in TCR stimulation-dependent manner in Jurkat T cells. Overexpression of PKC delta inhibited CARMA1-mediated NF-kappa B activation, whereas knockdown of PKC delta potentiated TCR-triggered NF-kappa B activation and IL-2 secretion in Jurkat T cells. Reconstitution experiments with PKC delta kinase-dead mutant indicated that the kinase activity of PKC delta was dispensable for its ability to inhibit TCR-triggered NF-kappa B activation. Furthermore, we found that PKC delta inhibited the interaction between MALT1 and TRAF6, but not the association of CARMA1 with PKC theta, Bcl10, or MALT1. These observations suggest that PKC delta is a negative regulator in T cell activation through inhibiting the assembly of CARMA1 signalosome.	[Liu, Yu; Song, Ren; Gao, Yan; Li, Yi; Wang, Shuai; Liu, Hai-Yun; Wang, Yan; Hu, Yun-Hong; Shu, Hong-Bing] Wuhan Univ, Coll Life Sci, Wuhan 430072, Peoples R China	Wuhan University	Liu, Y (corresponding author), Wuhan Univ, Coll Life Sci, Wuhan 430072, Peoples R China.	yuliu@whu.edu.cn; shuh@whu.edu.cn	Liu, Haiyun/T-1047-2016; Wang, Shuai/Y-6634-2019	Wang, Shuai/0000-0002-5432-4970; Song, Ren/0000-0002-0620-4958	National Natural Science Foundation of China [30700417, 30972719, 30921001]; Ministry of Science and Technology of China [2012CB910201]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China)	This work was supported by grants from the National Natural Science Foundation of China (30700417, 30972719, and 30921001), and the Ministry of Science and Technology of China (2012CB910201).	Bidere N, 2009, NATURE, V458, P92, DOI 10.1038/nature07613; Blonska M, 2009, IMMUNOL REV, V228, P199, DOI 10.1111/j.1600-065X.2008.00749.x; Brenner D, 2009, P NATL ACAD SCI USA, V106, P14508, DOI 10.1073/pnas.0900457106; D'Costa AM, 2005, CELL DEATH DIFFER, V12, P224, DOI 10.1038/sj.cdd.4401558; Gorelik G, 2007, J IMMUNOL, V179, P5553, DOI 10.4049/jimmunol.179.8.5553; Gruber T, 2005, IMMUNOL LETT, V96, P291, DOI 10.1016/j.imlet.2004.08.011; Gruber T, 2008, MOL IMMUNOL, V45, P117, DOI 10.1016/j.molimm.2007.05.003; Ishiguro K, 2006, MOL CELL BIOL, V26, P5497, DOI 10.1128/MCB.02469-05; Jun JE, 2003, NAT IMMUNOL, V4, P1057, DOI 10.1038/ni1001; Kojo S, 2009, P NATL ACAD SCI USA, V106, P17847, DOI 10.1073/pnas.0904078106; Lee KY, 2005, SCIENCE, V308, P114, DOI 10.1126/science.1107107; Letschka T, 2008, BLOOD, V112, P4617, DOI 10.1182/blood-2007-11-121111; Lucas PC, 2001, J BIOL CHEM, V276, P19012, DOI 10.1074/jbc.M009984200; Ma JSY, 2008, J IMMUNOL, V181, P4716, DOI 10.4049/jimmunol.181.7.4716; Matsumoto R, 2005, IMMUNITY, V23, P575, DOI 10.1016/j.immuni.2005.10.007; Miyamoto A, 2002, NATURE, V416, P865, DOI 10.1038/416865a; Monks CRF, 1998, NATURE, V395, P82, DOI 10.1038/25764; Monks CRF, 1997, NATURE, V385, P83, DOI 10.1038/385083a0; Oeckinghaus A, 2007, EMBO J, V26, P4634, DOI 10.1038/sj.emboj.7601897; Rawlings DJ, 2006, NAT REV IMMUNOL, V6, P799, DOI 10.1038/nri1944; Rueda D, 2005, IMMUNITY, V23, P551, DOI 10.1016/j.immuni.2005.11.007; Ruland J, 2003, IMMUNITY, V19, P749, DOI 10.1016/S1074-7613(03)00293-0; Shinohara H, 2007, J EXP MED, V204, P3285, DOI 10.1084/jem.20070379; Sommer K, 2005, IMMUNITY, V23, P561, DOI 10.1016/j.immuni.2005.09.014; Spitaler M, 2004, NAT IMMUNOL, V5, P785, DOI 10.1038/ni1097; Sun LJ, 2004, MOL CELL, V14, P289, DOI 10.1016/S1097-2765(04)00236-9; Szamel M, 1998, J IMMUNOL, V160, P2207; Thome M, 2004, NAT REV IMMUNOL, V4, P348, DOI 10.1038/nri1352; Trushin SA, 2003, MOL CELL BIOL, V23, P7068, DOI 10.1128/MCB.23.19.7068-7081.2003; van Oers NSC, 2005, SCIENCE, V308, P65, DOI 10.1126/science.1110902; Wang DH, 2004, MOL CELL BIOL, V24, P164, DOI 10.1128/MCB.24.1.164-171.2003	31	14	14	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 8	2012	287	24					20081	20087		10.1074/jbc.M111.335463	http://dx.doi.org/10.1074/jbc.M111.335463			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974FB	22528498	Green Published, hybrid			2022-12-25	WOS:000306414500029
J	Breitman, M; Kook, S; Gimenez, LE; Lizama, BN; Palazzo, MC; Gurevich, EV; Gurevich, VV				Breitman, Maya; Kook, Seunghyi; Gimenez, Luis E.; Lizama, Britney N.; Palazzo, Maria C.; Gurevich, Eugenia V.; Gurevich, Vsevolod V.			Silent Scaffolds INHIBITION OF c-Jun N-TERMINAL KINASE 3 ACTIVITY IN CELL BY DOMINANT-NEGATIVE ARRESTIN-3 MUTANT	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTORS; NUCLEAR EXPORT SIGNAL; BETA-ARRESTIN; CRYSTAL-STRUCTURE; NONVISUAL ARRESTINS; PHYSIOLOGICAL FUNCTIONS; CLATHRIN ADAPTER; CONE ARRESTIN; MAP KINASES; ACTIVATION	We established a new in vivo arrestin-3-JNK3 interaction assay based on bioluminescence resonance energy transfer (BRET) between JNK3-luciferase and Venus-arrestins. We tested the ability of WT arrestin-3 and its 3A mutant that readily binds beta 2-adrenergic receptors as well as two mutants impaired in receptor binding, Delta 7 and KNC, to directly bind JNK3 and to promote JNK3 phosphorylation in cells. Both receptor binding-deficient mutants interact with JNK3 significantly better than WT and 3A arrestin-3. WT arrestin-3 and Delta 7 mutant robustly promoted JNK3 activation, whereas 3A and KNC mutants did not. Thus, receptor binding, JNK3 interaction, and JNK3 activation are three distinct arrestin functions. We found that the KNC mutant, which tightly binds ASK1, MKK4, and JNK3 without facilitating JNK3 phosphorylation, has a dominant-negative effect, competitively decreasing JNK activation by WT arrestin-3. Thus, KNC is a silent scaffold, a novel type of molecular tool for the suppression of MAPK signaling in living cells.	[Breitman, Maya; Kook, Seunghyi; Gimenez, Luis E.; Lizama, Britney N.; Palazzo, Maria C.; Gurevich, Eugenia V.; Gurevich, Vsevolod V.] Vanderbilt Univ, Dept Pharmacol, Nashville, TN 37232 USA	Vanderbilt University	Gurevich, VV (corresponding author), Vanderbilt Univ, Dept Pharmacol, Nashville, TN 37232 USA.	vsevolod.gurevich@vanderbilt.edu	Lizama, Britney/E-2260-2012; Gurevich, Vsevolod/A-3236-2008	Lizama, Britney/0000-0001-5970-3913; Gurevich, Vsevolod/0000-0002-3950-5351; Diaz Gimenez, Luis Eduardo/0000-0002-0110-2135	National Institutes of Health [GM081756, GM077561, EY011500, NS065868]; NATIONAL EYE INSTITUTE [R01EY011500] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081756, R25GM062459, R01GM077561, T34GM008718] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS065868] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM081756, GM077561, and EY011500 (to V. V. G.) and NS065868 (to E V. G.).	Azzi M, 2003, P NATL ACAD SCI USA, V100, P11406, DOI 10.1073/pnas.1936664100; Bruchas MR, 2006, J BIOL CHEM, V281, P18081, DOI 10.1074/jbc.M513640200; Burack WR, 2000, CURR OPIN CELL BIOL, V12, P211, DOI 10.1016/S0955-0674(99)00078-2; Carman CV, 1998, CURR OPIN NEUROBIOL, V8, P335, DOI 10.1016/S0959-4388(98)80058-5; Carter JM, 2005, J MOL BIOL, V351, P865, DOI 10.1016/j.jmb.2005.06.048; Celver J, 2002, J BIOL CHEM, V277, P9043, DOI 10.1074/jbc.M107400200; Coffa S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028723; Coffa S, 2011, BIOCHEMISTRY-US, V50, P6951, DOI 10.1021/bi200745k; Dacres H, 2010, ANAL CHEM, V82, P432, DOI 10.1021/ac9022956; Davis RJ, 2000, CELL, V103, P239, DOI 10.1016/S0092-8674(00)00116-1; DeWire SM, 2007, ANNU REV PHYSIOL, V69, P483, DOI 10.1146/annurev.physiol.69.022405.154749; Dhanasekaran DN, 2007, ONCOGENE, V26, P3185, DOI 10.1038/sj.onc.1210411; Gimenez LE, 2012, J BIOL CHEM, V287, P9028, DOI 10.1074/jbc.M111.311803; Goodman OB, 1996, NATURE, V383, P447, DOI 10.1038/383447a0; Guo C, 2008, J BIOL CHEM, V283, P15903, DOI 10.1074/jbc.M710006200; Guo W, 2008, EMBO J, V27, P2293, DOI 10.1038/emboj.2008.153; Gupta S, 1996, EMBO J, V15, P2760, DOI 10.1002/j.1460-2075.1996.tb00636.x; Gurevich EV, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-9-236; Gurevich VV, 2006, PHARMACOL THERAPEUT, V110, P465, DOI 10.1016/j.pharmthera.2005.09.008; Gurevich VV, 2010, EXPERT REV MOL MED, V12, DOI 10.1017/S1462399410001444; Gurevich VV, 2004, TRENDS PHARMACOL SCI, V25, P105, DOI 10.1016/j.tips.2003.12.008; Hamdan FF, 2007, J BIOL CHEM, V282, P29089, DOI 10.1074/jbc.M700577200; Han M, 2001, STRUCTURE, V9, P869, DOI 10.1016/S0969-2126(01)00644-X; Hanson SM, 2006, P NATL ACAD SCI USA, V103, P4900, DOI 10.1073/pnas.0600733103; Hanson SM, 2007, J MOL BIOL, V368, P375, DOI 10.1016/j.jmb.2007.02.053; Hirsch JA, 1999, CELL, V97, P257, DOI 10.1016/S0092-8674(00)80735-7; James JR, 2006, NAT METHODS, V3, P1001, DOI 10.1038/nmeth978; Laporte SA, 1999, P NATL ACAD SCI USA, V96, P3712, DOI 10.1073/pnas.96.7.3712; Loening AM, 2006, PROTEIN ENG DES SEL, V19, P391, DOI 10.1093/protein/gzl023; Lohse MJ, 2007, CURR OPIN PHARMACOL, V7, P547, DOI 10.1016/j.coph.2007.08.007; Luttrell LM, 2001, P NATL ACAD SCI USA, V98, P2449, DOI 10.1073/pnas.041604898; McDonald PH, 2000, SCIENCE, V290, P1574, DOI 10.1126/science.290.5496.1574; Miller WE, 2001, J BIOL CHEM, V276, P27770, DOI 10.1074/jbc.M102264200; Namkung Y, 2009, J BIOL CHEM, V284, P15038, DOI 10.1074/jbc.M900388200; Pan L, 2003, J BIOL CHEM, V278, P11623, DOI 10.1074/jbc.M209532200; Pearson G, 2001, ENDOCR REV, V22, P153, DOI 10.1210/er.22.2.153; Scott MGH, 2002, J BIOL CHEM, V277, P37693, DOI 10.1074/jbc.M207552200; Seo J, 2011, J BIOL CHEM, V286, P27894, DOI 10.1074/jbc.M111.260448; Song XF, 2006, J BIOL CHEM, V281, P21491, DOI 10.1074/jbc.M603659200; Song X, 2007, J NEUROCHEM, V103, P1053, DOI 10.1111/j.1471-4159.2007.04842.x; Song X, 2009, CURR BIOL, V19, P700, DOI 10.1016/j.cub.2009.02.065; Song XF, 2009, J BIOL CHEM, V284, P685, DOI 10.1074/jbc.M806124200; STERNEMARR R, 1993, J BIOL CHEM, V268, P15640; Stork PJS, 2002, TRENDS CELL BIOL, V12, P258, DOI 10.1016/S0962-8924(02)02294-8; Sutton RB, 2005, J MOL BIOL, V354, P1069, DOI 10.1016/j.jmb.2005.10.023; Turjanski AG, 2007, ONCOGENE, V26, P3240, DOI 10.1038/sj.onc.1210415; Vishnivetskiy SA, 2002, J BIOL CHEM, V277, P43961, DOI 10.1074/jbc.M206951200; Vishnivetskiy SA, 2000, J BIOL CHEM, V275, P41049, DOI 10.1074/jbc.M007159200; Vishnivetskiy SA, 2011, J BIOL CHEM, V286, P24288, DOI 10.1074/jbc.M110.213835; Vishnivetskiy SA, 2010, J MOL BIOL, V395, P42, DOI 10.1016/j.jmb.2009.10.058; WACKER WB, 1977, J IMMUNOL, V119, P1949; Walther C, 2010, J BIOL CHEM, V285, P41578, DOI 10.1074/jbc.M110.162156; Wang P, 2003, J BIOL CHEM, V278, P11648, DOI 10.1074/jbc.M208109200; Winter-Vann AM, 2007, J CELL BIOCHEM, V102, P848, DOI 10.1002/jcb.21522; Zhan XZ, 2011, BIOCHEMISTRY-US, V50, P10520, DOI 10.1021/bi201506g; Zhan XZ, 2011, J MOL BIOL, V406, P467, DOI 10.1016/j.jmb.2010.12.034	57	56	56	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 1	2012	287	23					19653	19664		10.1074/jbc.M112.358192	http://dx.doi.org/10.1074/jbc.M112.358192			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974EF	22523077	Green Published, hybrid			2022-12-25	WOS:000306411900076
J	Ramasamy, S; Wahab, NA; Abidin, NZ; Manickam, S; Zakaria, Z				Ramasamy, Sujatha; Wahab, Norhanom Abdul; Abidin, Nurhayati Zainal; Manickam, Sugumaran; Zakaria, Zubaidah			Growth Inhibition of Human Gynecologic and Colon Cancer Cells by Phyllanthus watsonii through Apoptosis Induction	PLOS ONE			English	Article							ELLAGIC ACID; BETULINIC ACID; CYCLE ARREST; IN-VITRO; PHENOLIC-COMPOUNDS; PROLIFERATION; ANTITUMOR; AMARUS; LUNG; CHEMOPREVENTION	Phyllanthus watsonii Airy Shaw is an endemic plant found in Peninsular Malaysia. Although there are numerous reports on the anti cancer properties of other Phyllanthus species, published information on the cytotoxicity of P. watsonii are very limited. The present study was carried out with bioassay-guided fractionation approach to evaluate the cytotoxicity and apoptosis induction capability of the P. watsonii extracts and fractions on human gynecologic (SKOV-3 and Ca Ski) and colon (HT-29) cancer cells. P. watsonii extracts exhibited strong cytotoxicity on all the cancer cells studied with IC50 values of <= 20.0 mu g/mL. Hexane extract of P. watsonii was further subjected to bioassay-guided fractionation and yielded 10 fractions (PW-1 -> PW-10). PW-4 -> PW-8 portrayed stronger cytotoxic activity and was further subjected to bioassay-guided fractionation and resulted with 8 sub-fractions (PPWH-1 -> PPWH-8). PPWH-7 possessed greatest cytotoxicity (IC50 values ranged from 0.66 - 0.83 mu g/mL) and was selective on the cancer cells studied. LC-MS/MS analysis of PPWH-7 revealed the presence of ellagic acid, geranic acid, glochidone, betulin, phyllanthin and sterol glucoside. Marked morphological changes, ladder-like appearance of DNA and increment in caspase-3 activity indicating apoptosis were clearly observed in both human gynecologic and colon cancer cells treated with P. watsonii especially with PPWH-7. The study also indicated that P. watsonii extracts arrested cell cycle at different growth phases in SKOV-3, Ca Ski and HT-29 cells. Cytotoxic and apoptotic potential of the endemic P. watsonii was investigated for the first time by bioassay-guided approach. These results demonstrated that P. watsonii selectively inhibits the growth of SKOV-3, Ca Ski and HT-29 cells through apoptosis induction and cell cycle modulation. Hence, P. watsonii has the potential to be further exploited for the discovery and development of new anti cancer drugs.	[Ramasamy, Sujatha; Abidin, Nurhayati Zainal; Manickam, Sugumaran] Univ Malaya, Fac Sci, Inst Biol Sci, Kuala Lumpur, Malaysia; [Wahab, Norhanom Abdul] Univ Malaya, Ctr Fdn Studies Sci, Kuala Lumpur, Malaysia; [Zakaria, Zubaidah] Inst Med Res, Canc Res Ctr, Hematol Unit, Kuala Lumpur 50588, Malaysia	Universiti Malaya; Universiti Malaya; Kementerian Kesihatan Malaysia	Ramasamy, S (corresponding author), Univ Malaya, Fac Sci, Inst Biol Sci, Kuala Lumpur, Malaysia.	sujatha@um.edu.my	ABIDIN, NURHAYATI ZAINAL/B-9429-2010; Manickam, Sugumaran/B-5268-2010; RAMASAMY, SUJATHA/B-9854-2010; ABDUL WAHAB, NORHANOM/B-5207-2010	Manickam, Sugumaran/0000-0003-3125-767X; 	Postgraduate Research Fund (PPP) [UM 524 PS130/2008A, UM PS307/2010A]; University of Malaya	Postgraduate Research Fund (PPP); University of Malaya(Universiti Malaya)	This study was supported by Postgraduate Research Fund (PPP) Grants UM 524 PS130/2008A and UM PS307/2010A, funded by University of Malaya. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaby K, 2007, J AGR FOOD CHEM, V55, P4395, DOI 10.1021/jf0702592; Abu Bakal MF, 2010, FOOD CHEM TOXICOL, V48, P1688, DOI 10.1016/j.fct.2010.03.046; Aggarwal BB, 2006, BIOCHEM PHARMACOL, V71, P1397, DOI 10.1016/j.bcp.2006.02.009; AVATO P, 1995, PHYTOCHEMISTRY, V40, P141, DOI 10.1016/0031-9422(95)00183-8; Balunas MJ, 2005, LIFE SCI, V78, P431, DOI 10.1016/j.lfs.2005.09.012; Bardon S, 2002, CANCER LETT, V181, P187, DOI 10.1016/S0304-3835(02)00047-2; Besson A, 2008, DEV CELL, V14, P159, DOI 10.1016/j.devcel.2008.01.013; Boik J., 2001, NATURAL COMPOUNDS CA; BORENFREUND E, 1985, TOXICOL LETT, V24, P119, DOI 10.1016/0378-4274(85)90046-3; Boyle P, 2008, 1260 INT AG RES CANC, P1; BURKILL I. H., 1966, A Dictionary of the Economic Products of the Malay Peninsula., V2; Cain K, 1999, J BIOL CHEM, V274, P22686, DOI 10.1074/jbc.274.32.22686; Cheng YL, 2004, LIFE SCI, V75, P1579, DOI 10.1016/j.lfs.2004.03.009; Chien SC, 2007, TETRAHEDRON LETT, V48, P1567, DOI 10.1016/j.tetlet.2007.01.011; Cragg GM, 2005, J ETHNOPHARMACOL, V100, P72, DOI 10.1016/j.jep.2005.05.011; Darison GWH, 1988, ENDAU ROMPIN MALAYSI; DAS M, 1985, CARCINOGENESIS, V6, P1409, DOI 10.1093/carcin/6.10.1409; Fjaeraa C, 2009, BIOMED PHARMACOTHER, V63, P254, DOI 10.1016/j.biopha.2008.07.093; GERAN RI, 1972, CANC CHEMOTHER REP, V3, P1; Gosslau A, 2004, NUTRITION, V20, P95, DOI 10.1016/j.nut.2003.09.017; Gurib-Fakim A., 2006, MOL ASPECTS MED, V27, P1, DOI DOI 10.1016/J.MAM.2005.07.008; Hail N, 2008, FREE RADICAL BIO MED, V45, P97, DOI 10.1016/j.freeradbiomed.2008.04.004; Hansakul P., 2009, Songklanakarin Journal of Science and Technology, V31, P273; Harada H, 2002, ANTICANCER RES, V22, P2587; Hu XL, 2010, BIOCHEM BIOPH RES CO, V398, P62, DOI 10.1016/j.bbrc.2010.06.033; Hu YW, 2009, J ETHNOPHARMACOL, V123, P293, DOI 10.1016/j.jep.2009.03.016; Huang ST, 2006, INT IMMUNOPHARMACOL, V6, P870, DOI 10.1016/j.intimp.2005.12.010; Huang ST, 2003, LIFE SCI, V72, P1705, DOI 10.1016/S0024-3205(03)00016-X; Jeena KJ, 1999, CANCER LETT, V136, P11, DOI 10.1016/S0304-3835(98)00294-8; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Kajdzanoska M, 2010, MACED J CHEM CHEM EN, V29, P181; Kiemer AK, 2003, J HEPATOL, V38, P289, DOI 10.1016/S0168-8278(02)00417-8; Kluck RM, 1997, SCIENCE, V275, P1132, DOI 10.1126/science.275.5303.1132; Krithika R, 2009, CHEM-BIOL INTERACT, V181, P351, DOI 10.1016/j.cbi.2009.06.014; Lai CS, 2008, J ETHNOPHARMACOL, V118, P14, DOI 10.1016/j.jep.2008.02.034; Le NTV, 2002, BBA-REV CANCER, V1603, P31, DOI 10.1016/S0304-419X(02)00068-9; Liu J, 2006, CANCER LETT, V242, P133, DOI 10.1016/j.canlet.2005.11.023; Losso JN, 2004, J NUTR BIOCHEM, V15, P672, DOI 10.1016/j.jnutbio.2004.06.004; Mahavorasirikul W, 2010, BMC COMPLEM ALTERN M, V10, DOI 10.1186/1472-6882-10-55; Maia LF, 2000, J NAT PROD, V63, P1427, DOI 10.1021/np9906323; Malek SNA, 2009, MOLECULES, V14, P1713, DOI 10.3390/molecules14051713; Marston A, 2007, PHYTOCHEMISTRY, V68, P2786, DOI 10.1016/j.phytochem.2007.08.004; MATSUNAGA S, 1993, PHYTOCHEMISTRY, V32, P165, DOI 10.1016/0031-9422(92)80125-X; MILLS JJ, 1995, CANCER RES, V55, P979; Moongkarndi P, 2004, J ETHNOPHARMACOL, V90, P161, DOI 10.1016/j.jep.2003.09.048; Narayanan BA, 1999, CANCER LETT, V136, P215, DOI 10.1016/S0304-3835(98)00323-1; Nayak PS, 2010, B LATINOAM CARIBE PL, V9, P353; Nhan TQ, 2006, AM J PATHOL, V169, P729, DOI 10.2353/ajpath.2006.060105; Nieves-Neira W, 1999, INT J CANCER, V82, P396, DOI 10.1002/(SICI)1097-0215(19990730)82:3<396::AID-IJC13>3.0.CO;2-Z; Panchal RG, 1998, BIOCHEM PHARMACOL, V55, P247, DOI 10.1016/S0006-2952(97)00240-2; PERCHELLET JP, 1992, BASIC LIFE SCI, V59, P783; Popov B, 2005, BIOCHEM BIOPH RES CO, V336, P762, DOI 10.1016/j.bbrc.2005.08.163; Prasanna R, 2009, CELL BIOL INT, V33, P127, DOI 10.1016/j.cellbi.2008.10.006; Rajkapoor B, 2007, BIOSCI BIOTECH BIOCH, V71, P2177, DOI 10.1271/bbb.70149; Ramasamy S, 2011, J MED PLANTS RES, V5, P2267; Reddy BS, 1997, CANCER RES, V57, P420; Santafe G, 2002, J NAT PROD, V65, P1161, DOI 10.1021/np0200459; Schmidt ML, 1997, EUR J CANCER, V33, P2007, DOI 10.1016/S0959-8049(97)00294-3; Schwartz GK, 2005, J CLIN ONCOL, V23, P9408, DOI 10.1200/JCO.2005.01.5594; Shakya R, 2008, J AGR FOOD CHEM, V56, P6949, DOI 10.1021/jf8006618; Sherr CJ, 2000, CANCER RES, V60, P3689; Sheu JH, 2000, J NAT PROD, V63, P149, DOI 10.1021/np9903954; STARK MJ, 1995, CANCER LETT, V96, P15, DOI 10.1016/0304-3835(95)03912-G; Stoner GD, 1997, CANCER LETT, V114, P113, DOI 10.1016/S0304-3835(97)04639-9; Su NW, 2005, J AGR FOOD CHEM, V53, P1949, DOI 10.1021/jf048310e; Sun J, 2006, CANCER LETT, V241, P124, DOI 10.1016/j.canlet.2005.10.027; Tanaka R, 1998, PHYTOCHEMISTRY, V21, P3563; Tang YQ, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0012644, 10.1371/journal.pone.0015631]; Taraphdar AK, 2001, CURR SCI INDIA, V80, P1387; TEEL RW, 1986, CANCER LETT, V30, P329, DOI 10.1016/0304-3835(86)90058-3; Thornberry NA, 1998, SCIENCE, V281, P1312, DOI 10.1126/science.281.5381.1312; Tokarska-Schlattner M, 2006, CR BIOL, V329, P657, DOI 10.1016/j.crvi.2005.08.007; Wang W, 2009, PROG NEUROBIOL, V89, P1, DOI 10.1016/j.pneurobio.2009.01.007; Wang ZB, 2005, CELL BIOL INT, V29, P489, DOI 10.1016/j.cellbi.2005.04.001; Wick W, 1999, J PHARMACOL EXP THER, V289, P1306; WYLLIE AH, 1984, J PATHOL, V142, P67, DOI 10.1002/path.1711420112; Yang Y, 2010, MOLECULES, V15, P7075, DOI 10.3390/molecules15107075; Zhang JH, 2002, TRENDS CELL BIOL, V12, P84, DOI 10.1016/S0962-8924(01)02206-1; Zhang YJ, 2004, BIOL PHARM BULL, V27, P251, DOI 10.1248/bpb.27.251; Zuco V, 2002, CANCER LETT, V175, P17, DOI 10.1016/S0304-3835(01)00718-2	80	27	29	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2012	7	4							e34793	10.1371/journal.pone.0034793	http://dx.doi.org/10.1371/journal.pone.0034793			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UD	22536331	gold, Green Published			2022-12-25	WOS:000305339200020
J	Jin, MY; Kumar, A; Kumar, S				Jin, Mengyao; Kumar, Anil; Kumar, Santosh			Ethanol-Mediated Regulation of Cytochrome P450 2A6 Expression in Monocytes: Role of Oxidative Stress-Mediated PKC/MEK/Nrf2 Pathway	PLOS ONE			English	Article							DRUG-METABOLISM; PHENETHYL ISOTHIOCYANATE; ANTIOXIDANT RESPONSE; SMOKING-BEHAVIOR; HUMAN CYP2A6; ACTIVATION; INDUCTION; NICOTINE; ALCOHOL; ENZYMES	Cytochrome P450 2A6 (CYP2A6) is known to metabolize nicotine, the major constituent of tobacco, leading to the production of toxic metabolites and induction of oxidative stress that result in liver damage and lung cancer. Recently, we have shown that CYP2A6 is induced by ethanol and metabolizes nicotine into cotinine and other metabolites leading to generation of reactive oxygen species (ROS) in U937 monocytes. However, the mechanism by which CYP2A6 is induced by ethanol is unknown. In this study, we have examined the role of the PKC/Nrf2 pathway (protein kinase C-mediated phosphorylation and translocation of nuclear erythroid 2-related factor 2 to the nucleus) in ethanol-mediated CYP2A6 induction. Our results showed that 100 mM ethanol significantly induced CYP2A6 mRNA and protein (similar to 150%) and increased ROS formation, and induction of gene expression and ROS were both completely blocked by treatment with either a CYP2E1 inhibitor (diallyl sulfide) or an antioxidant (vitamin C). The results suggest the role of oxidative stress in the regulation of CYP2A6 expression. Subsequently, we investigated the role of Nrf2 pathway in oxidative stress-mediated regulation of CYP2A6 expression in U937 monocytes. Our results showed that butylated hydroxyanisole, a stabilizer of nuclear Nrf2, increased CYP2A6 levels >200%. Staurosporine, an inhibitor of PKC, completely abolished ethanol-induced CYP2A6 expression. Furthermore, our results showed that a specific inhibitor of mitogen-activated protein kinase kinase (MEK) (U0126) completely abolished ethanol-mediated CYP2A6 induction and Nrf2 translocation. Overall, these results suggest that CYP2E1-mediated oxidative stress produced as a result of ethanol metabolism translocates Nrf2 into the nucleus through PKC/MEK pathway, resulting in the induction of CYP2A6 in monocytes. An increased level of CYP2A6 in monocytes is expected to further increase oxidative stress in smokers through CYP2A6-mediated nicotine metabolism. Thus, this study has clinical relevance because of the high incidence of alcohol use among smokers, especially in HIV-infected individuals.	[Jin, Mengyao; Kumar, Anil; Kumar, Santosh] Univ Missouri, Sch Pharm, Div Pharmacol & Toxicol, Kansas City, MO 64110 USA	University of Missouri System; University of Missouri Kansas City	Jin, MY (corresponding author), Univ Missouri, Sch Pharm, Div Pharmacol & Toxicol, Kansas City, MO 64110 USA.	kumarsa@umkc.edu	Boothapati, Anil Kumar/HHS-1813-2022; KUMAR, ANIL/ACD-8340-2022		National Institutes of Health [DA031616-01, AA015045]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA015045] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R21DA031616] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	The work was supported by National Institutes of Health grants (DA031616-01) to Santosh Kumar and (AA015045) to Anil Kumar. The funders provided salary support and costs for supplies to carry out this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABBUD RA, 1995, J INFECT DIS, V172, P859, DOI 10.1093/infdis/172.3.859; Achur RN, 2010, J NEUROIMMUNE PHARM, V5, P83, DOI 10.1007/s11481-009-9185-z; Andrieux L, 2004, MOL PHARMACOL, V65, P934, DOI 10.1124/mol.65.4.934; Bloom DA, 2003, J BIOL CHEM, V278, P44675, DOI 10.1074/jbc.M307633200; Boelaert JR, 1996, INFECT AGENT DIS, V5, P36; Boelaert JR, 1996, J INFECT DIS, V173, P1045, DOI 10.1093/infdis/173.4.1045a; BRADY JF, 1991, CHEM RES TOXICOL, V4, P642, DOI 10.1021/tx00024a008; Buckner CM, 2011, CELL IMMUNOL, V267, P109, DOI 10.1016/j.cellimm.2010.12.004; Burkhalter JE, 2005, NICOTINE TOB RES, V7, P511, DOI 10.1080/14622200500186064; Carayol N, 2006, J BIOL CHEM, V281, P31142, DOI 10.1074/jbc.M603417200; Cassol E, 2006, J LEUKOCYTE BIOL, V80, P1018, DOI 10.1189/jlb.0306150; Coleman CM, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-51; Correa F, 2011, GLIA, V59, P785, DOI 10.1002/glia.21151; Di YM, 2009, CURR DRUG METAB, V10, P754, DOI 10.2174/138920009789895507; Ferguson CS, 2011, DRUG METAB DISPOS, V39, P2233, DOI 10.1124/dmd.111.040378; Gescher A, 1998, GEN PHARMACOL, V31, P721, DOI 10.1016/S0306-3623(98)00069-X; Gilmore WJ, 2003, TOXICOLOGY, V184, P211, DOI 10.1016/S0300-483X(02)00581-4; Guo XQ, 2011, TOXICOL IND HEALTH, V27, P341, DOI 10.1177/0748233710387007; Haorah J, 2008, FREE RADICAL BIO MED, V45, P1542, DOI 10.1016/j.freeradbiomed.2008.08.030; Hennig M, 2009, J SURG RES, V154, P187, DOI 10.1016/j.jss.2008.11.836; Howard LA, 2003, BRIT J PHARMACOL, V138, P1376, DOI 10.1038/sj.bjp.0705146; HUANG K-P, 1990, Biofactors, V2, P171; Itoh M, 2006, J PHARMACOL EXP THER, V319, P693, DOI 10.1124/jpet.106.107573; Jin MY, 2012, J NEUROIMMUNE PHARM, V7, P289, DOI 10.1007/s11481-011-9283-6; Jin MY, 2011, ALCOHOL CLIN EXP RES, V35, P132, DOI 10.1111/j.1530-0277.2010.01330.x; Keum YS, 2006, PHARM RES, V23, P2586, DOI 10.1007/s11095-006-9094-2; Kim KC, 2010, INT J BIOCHEM CELL B, V42, P297, DOI 10.1016/j.biocel.2009.11.009; Kirby GM, 2011, CURR DRUG METAB, V12, P186; Kong SY, 2009, PHARMACOGENOMICS, V10, P1147, DOI 10.2217/PGS.09.48; Lamle J, 2008, GASTROENTEROLOGY, V134, P1159, DOI 10.1053/j.gastro.2008.01.011; Lee SE, 2011, J CELL BIOCHEM, V112, P2352, DOI 10.1002/jcb.23158; Lu YK, 2011, DRUG METAB DISPOS, V39, P330, DOI 10.1124/dmd.110.035691; Maicas N, 2011, ANTIOXID REDOX SIGN, V15, P889, DOI 10.1089/ars.2010.3835; Manda VK, 2010, J NEUROCHEM, V115, P1495, DOI 10.1111/j.1471-4159.2010.07054.x; Meyer RP, 2007, CURR DRUG METAB, V8, P297, DOI 10.2174/138920007780655478; Moon HJ, 2011, MOL CELL BIOCHEM, V349, P179, DOI 10.1007/s11010-010-0672-6; Morris CR, 2004, NUTR CANCER, V48, P54, DOI 10.1207/s15327914nc4801_8; Nakajima M, 2007, CURR OPIN MOL THER, V9, P538; Narasimhan M, 2011, MOL PHARMACOL, V80, P988, DOI 10.1124/mol.111.073262; Nguyen T, 2009, J BIOL CHEM, V284, P13291, DOI 10.1074/jbc.R900010200; Nitti M, 2008, MOL ASPECTS MED, V29, P36, DOI 10.1016/j.mam.2007.09.001; Niture SK, 2010, TOXICOL APPL PHARM, V244, P37, DOI 10.1016/j.taap.2009.06.009; Orlicky DJ, 2011, ALCOHOL CLIN EXP RES, V35, P1020, DOI 10.1111/j.1530-0277.2011.01434.x; Peterhans E, 1997, J NUTR, V127, pS962, DOI 10.1093/jn/127.5.962S; Pichette V, 2003, CURR DRUG METAB, V4, P91, DOI 10.2174/1389200033489532; Prandota Joseph, 2005, Am J Ther, V12, P254; PROCHASKA HJ, 1988, CANCER RES, V48, P4776; Rock RB, 2008, J NEUROIMMUNE PHARM, V3, P143, DOI 10.1007/s11481-007-9098-7; Schlaepfer Isabel R, 2008, Curr Drug Abuse Rev, V1, P124; Sellers EM, 2003, DRUG DISCOV TODAY, V8, P487, DOI 10.1016/S1359-6446(03)02704-1; Solodova E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018543; Sonoda J, 2003, CURR DRUG METAB, V4, P59, DOI 10.2174/1389200033336739; Tang W, 2005, CURR DRUG METAB, V6, P503, DOI 10.2174/138920005774330602; Tkachev VO, 2011, BIOCHEMISTRY-MOSCOW+, V76, P407, DOI 10.1134/S0006297911040031; Venugopal SK, 2007, J BIOL CHEM, V282, P31900, DOI 10.1074/jbc.M703729200; Villeneuve NF, 2010, ANTIOXID REDOX SIGN, V13, P1699, DOI 10.1089/ars.2010.3211; von Weymarn LB, 2006, CARCINOGENESIS, V27, P782, DOI 10.1093/carcin/bgi301; Williams J F, 1991, J Fla Med Assoc, V78, P517; YAMAZAKI H, 1992, CARCINOGENESIS, V13, P1789, DOI 10.1093/carcin/13.10.1789; Yokota S, 2011, BIOCHEM PHARMACOL, V81, P289, DOI 10.1016/j.bcp.2010.09.020; Zhang JY, 2006, CURR DRUG METAB, V7, P939, DOI 10.2174/138920006779010575	61	37	40	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2012	7	4							e35505	10.1371/journal.pone.0035505	http://dx.doi.org/10.1371/journal.pone.0035505			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959XD	22530035	Green Published, gold, Green Submitted			2022-12-25	WOS:000305350600090
J	Lakshmanan, LN; Gruber, J; Halliwell, B; Gunawan, R				Lakshmanan, Lakshmi Narayanan; Gruber, Jan; Halliwell, Barry; Gunawan, Rudiyanto			Role of Direct Repeat and Stem-Loop Motifs in mtDNA Deletions: Cause or Coincidence?	PLOS ONE			English	Article							MITOCHONDRIAL-DNA DELETIONS; SUBSTANTIA-NIGRA NEURONS; SKELETAL-MUSCLE FIBERS; RHESUS-MONKEYS; LIFE-SPAN; MUTATIONS; REGIONS; REPLICATION; SEQUENCES; MODEL	Deletion mutations within mitochondrial DNA (mtDNA) have been implicated in degenerative and aging related conditions, such as sarcopenia and neuro-degeneration. While the precise molecular mechanism of deletion formation in mtDNA is still not completely understood, genome motifs such as direct repeat (DR) and stem-loop (SL) have been observed in the neighborhood of deletion breakpoints and thus have been postulated to take part in mutagenesis. In this study, we have analyzed the mitochondrial genomes from four different mammals: human, rhesus monkey, mouse and rat, and compared them to randomly generated sequences to further elucidate the role of direct repeat and stem-loop motifs in aging associated mtDNA deletions. Our analysis revealed that in the four species, DR and SL structures are abundant and that their distributions in mtDNA are not statistically different from randomized sequences. However, the average distance between the reported age associated mtDNA breakpoints and their respective nearest DR motifs is significantly shorter than what is expected of random chance in human (p < 10(-4)) and rhesus monkey (p = 0.0034), but not in mouse (p = 0.0719) and rat (p = 0.0437), indicating the existence of species specific difference in the relationship between DR motifs and deletion breakpoints. In addition, the frequencies of large DRs (> 10 bp) tend to decrease with increasing lifespan among the four mammals studied here, further suggesting an evolutionary selection against stable mtDNA misalignments associated with long DRs in long-living animals. In contrast to the results on DR, the probability of finding SL motifs near a deletion breakpoint does not differ from random in any of the four mtDNA sequences considered. Taken together, the findings in this study give support for the importance of stable mtDNA misalignments, aided by long DRs, as a major mechanism of deletion formation in long-living, but not in short-living mammals.	[Lakshmanan, Lakshmi Narayanan; Gunawan, Rudiyanto] Swiss Fed Inst Technol, Inst Chem & Bioengn, Zurich, Switzerland; [Lakshmanan, Lakshmi Narayanan] Natl Univ Singapore, Dept Chem & Biomol Engn, Singapore 117548, Singapore; [Gruber, Jan; Halliwell, Barry] Natl Univ Singapore, Ctr Life Sci CeLS, Dept Biochem Neurobiol & Ageing Program, Singapore 117548, Singapore	Swiss Federal Institutes of Technology Domain; ETH Zurich; National University of Singapore; National University of Singapore	Lakshmanan, LN (corresponding author), Swiss Fed Inst Technol, Inst Chem & Bioengn, Zurich, Switzerland.	rudi.gunawan@chem.ethz.ch	Gunawan, Rudiyanto/D-4650-2009; Halliwell, Barry/C-8318-2009	Gunawan, Rudiyanto/0000-0002-6480-7976; Halliwell, Barry/0000-0002-3560-7123; Lakshmanan, Lakshmi Narayanan/0000-0002-2892-1931	ETH Zurich; Ministry of Education Singapore [MOE2010-T2-2-048]	ETH Zurich(ETH Zurich); Ministry of Education Singapore(Ministry of Education, Singapore)	LNL and RG were supported by funding from ETH Zurich. JG and BH were supported by funding from the Ministry of Education Singapore under grant MOE2010-T2-2-048. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBERTINI AM, 1982, CELL, V29, P319, DOI 10.1016/0092-8674(82)90148-9; BAUMER A, 1994, AM J HUM GENET, V54, P618; Bender A, 2006, NAT GENET, V38, P515, DOI 10.1038/ng1769; Bua E, 2006, AM J HUM GENET, V79, P469, DOI 10.1086/507132; Cao ZJ, 2001, NUCLEIC ACIDS RES, V29, P4502, DOI 10.1093/nar/29.21.4502; Chung SS, 1996, AGE, V19, P117, DOI 10.1007/BF02434081; CLAYTON DA, 1982, CELL, V28, P693, DOI 10.1016/0092-8674(82)90049-6; EDRIS W, 1994, MUTAT RES-DNAGING G, V316, P69, DOI 10.1016/0921-8734(94)90009-4; Eimon PM, 1996, DEV GENET, V18, P107, DOI 10.1002/(SICI)1520-6408(1996)18:2&lt;107::AID-DVG3&gt;3.0.CO;2-D; GLICKMAN BW, 1984, P NATL ACAD SCI-BIOL, V81, P512, DOI 10.1073/pnas.81.2.512; Gokey NG, 2004, AGING CELL, V3, P319, DOI 10.1111/j.1474-9728.2004.00122.x; Gruber J, 2008, FRONT BIOSCI-LANDMRK, V13, P6554, DOI 10.2741/3174; Guo XH, 2010, TRENDS GENET, V26, P340, DOI 10.1016/j.tig.2010.05.006; Herbst A, 2007, J GERONTOL A-BIOL, V62, P235, DOI 10.1093/gerona/62.3.235; Kraytsberg Y, 2006, NAT GENET, V38, P518, DOI 10.1038/ng1778; Krishnan KJ, 2008, NAT GENET, V40, P275, DOI 10.1038/ng.f.94; LEE CM, 1994, MECH AGEING DEV, V75, P69, DOI 10.1016/0047-6374(94)90029-9; Markham Nicholas R., 2008, V453, P3, DOI 10.1007/978-1-60327-429-6_1; McKiernan SH, 2009, EXP GERONTOL, V44, P170, DOI 10.1016/j.exger.2008.09.014; Mita S, 1998, MUSCLE NERVE, V21, P490, DOI 10.1002/(SICI)1097-4598(199804)21:4<490::AID-MUS7>3.0.CO;2-4; Reeve AK, 2008, AM J HUM GENET, V82, P228, DOI 10.1016/j.ajhg.2007.09.018; Sadikovic B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015687; Samuels DC, 2005, MECH AGEING DEV, V126, P1123, DOI 10.1016/j.mad.2005.05.003; Samuels DC, 2004, TRENDS GENET, V20, P393, DOI 10.1016/j.tig.2004.07.003; Samuels DC, 2004, TRENDS GENET, V20, P226, DOI 10.1016/j.tig.2004.03.003; SHOFFNER JM, 1989, P NATL ACAD SCI USA, V86, P7952, DOI 10.1073/pnas.86.20.7952; Solano A, 2003, J MED GENET, V40, DOI 10.1136/jmg.40.7.e86; VanTuyle GC, 1996, MUTAT RES-FUND MOL M, V349, P95, DOI 10.1016/0027-5107(95)00165-4	28	18	19	4	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2012	7	4							e35271	10.1371/journal.pone.0035271	http://dx.doi.org/10.1371/journal.pone.0035271			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959XD	22529999	Green Published, Green Submitted, gold			2022-12-25	WOS:000305350600071
J	Bai, YL; Yang, J; Zhou, X; Ding, XX; Eisele, LE; Bai, GC				Bai, Yinlan; Yang, Jun; Zhou, Xin; Ding, Xinxin; Eisele, Leslie E.; Bai, Guangchun			Mycobacterium tuberculosis Rv3586 (DacA) Is a Diadenylate Cyclase That Converts ATP or ADP into c-di-AMP	PLOS ONE			English	Article							DNA-BINDING PROTEIN; CYCLIC-AMP; ADENYLYL CYCLASES; GMP; BACTERIA; CAMP; BCG; PHOSPHODIESTERASE; BIOCHEMISTRY; DIGUANYLATE	Cyclic diguanosine monophosphate (c-di-GMP) and cyclic diadenosine monophosphate (c-di-AMP) are recently identified signaling molecules. c-di-GMP has been shown to play important roles in bacterial pathogenesis, whereas information about c-di-AMP remains very limited. Mycobacterium tuberculosis Rv3586 (DacA), which is an ortholog of Bacillus subtilis DisA, is a putative diadenylate cyclase. In this study, we determined the enzymatic activity of DacA in vitro using high-performance liquid chromatography (HPLC), mass spectrometry (MS) and thin layer chromatography (TLC). Our results showed that DacA was mainly a diadenylate cyclase, which resembles DisA. In addition, DacA also exhibited residual ATPase and ADPase in vitro. Among the potential substrates tested, DacA was able to utilize both ATP and ADP, but not AMP, pApA, c-di-AMP or GTP. By using gel filtration and analytical ultracentrifugation, we further demonstrated that DacA existed as an octamer, with the N-terminal domain contributing to tetramerization and the C-terminal domain providing additional dimerization. Both the N-terminal and the C-terminal domains were essential for the DacA's enzymatically active conformation. The diadenylate cyclase activity of DacA was dependent on divalent metal ions such as Mg2+, Mn2+ or Co2+. DacA was more active at a basic pH rather than at an acidic pH. The conserved RHR motif in DacA was essential for interacting with ATP, and mutation of this motif to AAA completely abolished DacA's diadenylate cyclase activity. These results provide the molecular basis for designating DacA as a diadenylate cyclase. Our future studies will explore the biological function of this enzyme in M. tuberculosis.	[Bai, Yinlan; Yang, Jun; Bai, Guangchun] Albany Med Coll, Ctr Immunol & Microbial Dis, Albany, NY 12208 USA; [Zhou, Xin; Ding, Xinxin; Eisele, Leslie E.] New York State Dept Hlth, Wadsworth Ctr, Albany, NY USA; [Zhou, Xin; Ding, Xinxin] SUNY Albany, Sch Publ Hlth, Albany, NY USA	Albany Medical College; State University of New York (SUNY) System; Wadsworth Center; State University of New York (SUNY) System; State University of New York (SUNY) Albany	Bai, YL (corresponding author), Albany Med Coll, Ctr Immunol & Microbial Dis, Albany, NY 12208 USA.	baig@mail.amc.edu		Bai, Guangchun/0000-0002-2086-4020	Potts Memorial Foundation; National Cancer Institute, National Institutes of Health [CA092596]; NATIONAL CANCER INSTITUTE [R01CA092596] Funding Source: NIH RePORTER	Potts Memorial Foundation; National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by the Potts Memorial Foundation (to GB) and by grant CA092596 from the National Cancer Institute, National Institutes of Health (to XD) (http://www.cancer.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal N, 2009, NATURE, V460, P98, DOI 10.1038/nature08123; Aziz MA, 2005, CLIN INFECT DIS, V41, pS258, DOI 10.1086/430786; Bai GC, 2005, J BACTERIOL, V187, P7795, DOI 10.1128/JB.187.22.7795-7804.2005; Bai GC, 2007, INFECT IMMUN, V75, P5509, DOI 10.1128/IAI.00658-07; Bai G, 2011, MOL MICROBIOL, V82, P180, DOI 10.1111/j.1365-2958.2011.07806.x; Bai G, 2011, CELL MICROBIOL, V13, P349, DOI 10.1111/j.1462-5822.2010.01562.x; Bai GC, 2009, FEMS IMMUNOL MED MIC, V55, P68, DOI 10.1111/j.1574-695X.2008.00500.x; BOTSFORD JL, 1992, MICROBIOL REV, V56, P100, DOI 10.1128/MMBR.56.1.100-122.1992; Camilli A, 2006, SCIENCE, V311, P1113, DOI 10.1126/science.1121357; Christen M, 2005, J BIOL CHEM, V280, P30829, DOI 10.1074/jbc.M504429200; Corbett EL, 2003, ARCH INTERN MED, V163, P1009, DOI 10.1001/archinte.163.9.1009; Corrigan RM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002217; Cotter PA, 2007, CURR OPIN MICROBIOL, V10, P17, DOI 10.1016/j.mib.2006.12.006; Dam J, 2004, METHOD ENZYMOL, V384, P185; Ebensen T, 2011, VACCINE, V29, P5210, DOI 10.1016/j.vaccine.2011.05.026; Eisele LE, 2006, BBA-PROTEINS PROTEOM, V1764, P1479, DOI 10.1016/j.bbapap.2006.06.008; Espinal MA, 2003, TUBERCULOSIS, V83, P44, DOI 10.1016/S1472-9792(02)00058-6; FINE PEM, 1995, LANCET, V346, P1339, DOI 10.1016/S0140-6736(95)92348-9; Florczyk MA, 2003, INFECT IMMUN, V71, P5332, DOI 10.1128/IAI.71.9.5332-5343.2003; Gomelsky M, 2011, MOL MICROBIOL, V79, P562, DOI 10.1111/j.1365-2958.2010.07514.x; Guo YL, 2001, EMBO J, V20, P3667, DOI 10.1093/emboj/20.14.3667; Hengge R, 2009, NAT REV MICROBIOL, V7, P263, DOI 10.1038/nrmicro2109; Jenal U, 2006, ANNU REV GENET, V40, P385, DOI 10.1146/annurev.genet.40.110405.090423; Jin L, 2011, J IMMUNOL, V187, P2595, DOI 10.4049/jimmunol.1100088; Kamegaya T, 2011, NAGOYA J MED SCI, V73, P49; Keppetipola Niroshika, 2008, J Biol Chem, V283, P30942, DOI 10.1074/jbc.M805064200; Linder JU, 2002, J BIOL CHEM, V277, P15271, DOI 10.1074/jbc.M200235200; LOWRIE DB, 1975, NATURE, V254, P600, DOI 10.1038/254600a0; McCue LA, 2000, GENOME RES, V10, P204, DOI 10.1101/gr.10.2.204; Oppenheimer-Shaanan Y, 2011, EMBO REP, V12, P594, DOI 10.1038/embor.2011.77; Pesavento C, 2009, CURR OPIN MICROBIOL, V12, P170, DOI 10.1016/j.mib.2009.01.007; Rao F, 2010, J BIOL CHEM, V285, P473, DOI 10.1074/jbc.M109.040238; Romling U, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.133pe39; Ryjenkov DA, 2005, J BACTERIOL, V187, P1792, DOI 10.1128/JB.187.5.1792-1798.2005; Sauer JD, 2011, INFECT IMMUN, V79, P688, DOI 10.1128/IAI.00999-10; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Shenoy AR, 2005, BIOCHEMISTRY-US, V44, P15695, DOI 10.1021/bi0512391; Shenoy AR, 2006, FEBS LETT, V580, P3344, DOI 10.1016/j.febslet.2006.05.034; Shenoy AR, 2006, TRENDS MICROBIOL, V14, P543, DOI 10.1016/j.tim.2006.10.005; Tamayo R, 2007, ANNU REV MICROBIOL, V61, P131, DOI 10.1146/annurev.micro.61.080706.093426; Witte G, 2008, MOL CELL, V30, P167, DOI 10.1016/j.molcel.2008.02.020; Woodward JJ, 2010, SCIENCE, V328, P1703, DOI 10.1126/science.1189801	42	55	68	2	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2012	7	4							e35206	10.1371/journal.pone.0035206	http://dx.doi.org/10.1371/journal.pone.0035206			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WC	22529992	Green Published, gold, Green Submitted			2022-12-25	WOS:000305347400036
J	Laillou, A; Pham, TV; Tran, NT; Le, HP; Wieringa, F; Rohner, F; Fortin, S; Le, MB; Tran, DT; Moench-Pfanner, R; Berger, J				Laillou, Arnaud; Thuy Van Pham; Nga Thuy Tran; Hop Thi Le; Wieringa, Frank; Rohner, Fabian; Fortin, Sonia; Mai Bach Le; Do Thanh Tran; Moench-Pfanner, Regina; Berger, Jacques			Micronutrient Deficits Are Still Public Health Issues among Women and Young Children in Vietnam	PLOS ONE			English	Article							FOLIC-ACID SUPPLEMENTATION; FORTIFIED FISH SAUCE; IRON-DEFICIENCY; VITAMIN-B-12 STATUS; REPRODUCTIVE AGE; ZINC STATUS; MALNUTRITION; POPULATION; INDICATORS; ANEMIA	Background: The 2000 Vietnamese National Nutrition Survey showed that the population's dietary intake had improved since 1987. However, inequalities were found in food consumption between socioeconomic groups. As no national data exist on the prevalence of micronutrient deficiencies, a survey was conducted in 2010 to assess the micronutrient status of randomly selected 1526 women of reproductive age and 586 children aged 6-75 mo. Principal Findings: In women, according to international thresholds, prevalence of zinc deficiency (ZnD, 67.2 +/- 2.6%) and vitamin B12 deficiency (11.7 +/- 1.7%) represented public health problems, whereas prevalence of anemia (11.6 +/- 1.0%) and iron deficiency (ID, 13.7 +/- 1.1%) were considered low, and folate (<3%) and vitamin A (VAD, <2%) deficiencies were considered negligible. However, many women had marginal folate (25.1%) and vitamin A status (13.6%). Moreover, overweight (BMI >= 23 kg/m(2) for Asian population) or underweight occurred in 20% of women respectively highlighting the double burden of malnutrition. In children, a similar pattern was observed for ZnD (51.9 +/- 3.5%), anemia (9.1 +/- 1.4%) and ID (12.9 +/- 1.5%) whereas prevalence of marginal vitamin A status was also high (47.3 +/- 2.2%). There was a significant effect of age on anemia and ID prevalence, with the youngest age group (6-17 mo) having the highest risk for anemia, ID, ZnD and marginal vitamin A status as compared to other groups. Moreover, the poorest groups of population had a higher risk for zinc, anemia and ID. Conclusion: The prevalence of anemia and ID in Vietnam has been markedly reduced over the last decade, but a large part of the population is still at risk for other deficiencies such as zinc, vitamin A, folate and vitamin B12 especially the youngest children aged 6-17 mo. Consequently specific interventions to improve food diversity and quality should be implemented, among them food fortification of staple foods and condiments and improvement of complementary feeding.	[Laillou, Arnaud; Rohner, Fabian; Moench-Pfanner, Regina] GAIN, Geneva, Switzerland; [Thuy Van Pham; Nga Thuy Tran; Hop Thi Le; Mai Bach Le; Do Thanh Tran] NIN, Hanoi, Vietnam; [Wieringa, Frank; Fortin, Sonia; Berger, Jacques] IRD, UMR Nutripass IRD UM2 UM1, Montpellier, France	Institut de Recherche pour le Developpement (IRD); Universite de Montpellier	Laillou, A (corresponding author), GAIN, Geneva, Switzerland.	alaillou@gainhealth.org	Wieringa, Frank Tammo/K-7565-2017; Rohner, Fabian/I-5088-2019	Wieringa, Frank Tammo/0000-0002-6010-355X; Rohner, Fabian/0000-0003-0579-6952	Bill and Melinda Gates Foundation	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation)	The survey was funded by the Bill and Melinda Gates Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aekplakorn Wichai, 2004, Journal of the Medical Association of Thailand, V87, P685; Allen L, 2006, GUIDELINES FOOD FORT; Allen LH, 2005, AM J CLIN NUTR, V81, p1206S; [Anonymous], SAS STAT INTR SURV S; AOAC International, 1995, OFF METH AN AOAC INT, P95; Barba C, 2004, LANCET, V363, P157, DOI 10.1016/S0140-6736(03)15268-3; Barton-Wright EC, 1952, PRACTICAL METHODS MI; Berger J, 2005, NUTR REV, V63, pS95, DOI 10.1301/nr.2005.dec.S95-S108; Berger Jacques, 2002, Sante, V12, P22; Black RE, 2008, LANCET, V371, P243, DOI 10.1016/S0140-6736(07)61690-0; Bui MH, 1999, INT J VITAM NUTR RES, V69, P362, DOI 10.1024/0300-9831.69.5.362; Casey GJ, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-261; de Benoist B, 2007, FOOD NUTR BULL, V28, pS480, DOI 10.1177/15648265070283S306; de Onis M, 2006, PUBLIC HEALTH NUTR, V9, P942, DOI 10.1017/PHN20062005; de Pee S, 2002, J NUTR, V132, p2895S, DOI 10.1093/jn/132.9.2895S; Dien LN, 2004, ASIA PAC J CLIN NUTR, V13, P40; Do TKL, 2009, ASIA PAC J CLIN NUTR, V18, P326; Ecker O, 2011, 10 USAID; European Committee for Standardization (CEN), 2003, FOODST DET FOL MICR; FerroLuzzi A, 1995, WHO TECH REP SER, V854, P1; FSS, 2010, DAT FOOD AGR ORG UN; Gibson RS, 2008, BRIT J NUTR, V99, pS14, DOI 10.1017/S0007114508006818; Gibson RS, 2006, P NUTR SOC, V65, P51, DOI 10.1079/PNS2005474; GSO, 2008, SUMM RES VIETN HOUS; GSO, 2010, RES SURV HOUS LIV ST; Ha do TP, 2011, BMC PUBLIC HEALTH, V11, P62; Hess SY, 2007, FOOD NUTR BULL, V28, pS403, DOI 10.1177/15648265070283S303; Hoang LV, 2009, ANAL CALORIE MICRONU; Hop LT, 2005, J NUTR, V135, p660S, DOI 10.1093/jn/135.3.660S; Hop LT, 2003, J NUTR, V133, p4006S, DOI 10.1093/jn/133.11.4006S; Hotz C, 2004, FOOD NUTR BULL, V25, pS189; Hung Le Q., 2005, Southeast Asian Journal of Tropical Medicine and Public Health, V36, P816; Huy ND, 2009, FOOD NUTR BULL, V30, pS506, DOI 10.1177/15648265090304S405; International Zinc Nutrition Consultative Group (IZiNCG), 2004, Food Nutr Bull, V25, pS99; IVACG, 1982, BIOCH METH ASS VIT S; Jones KM, 2007, J NUTR, V137, P1307, DOI 10.1093/jn/137.5.1307; Khan NC, 2008, ASIA PAC J CLIN NUTR, V17, P116; Khan NC, 2007, ASIA PAC J CLIN NUTR, V16, P274; Khoury C., 2008, Sight and Life Magazine, P40; Kim Y, 2004, OBES RES, V12, P445, DOI 10.1038/oby.2004.50; KIRKE PN, 1993, Q J MED, V86, P703; Ko GTC, 2001, ANN ACAD MED SINGAP, V30, P393; Le HT, 2007, BRIT J NUTR, V97, P955, DOI 10.1017/S0007114507659029; Le HT, 2007, FOOD NUTR BULL, V28, P291, DOI 10.1177/156482650702800305; Mai TT, 2003, ASIA PAC J CLIN NUTR, V12, P178; McLean E, 2008, FOOD NUTR BULL, V29, pS38, DOI 10.1177/15648265080292S107; MOH/ NIN, 2000, NAT PLAN ACT NUTR NP; Molloy AM, 2009, PEDIATRICS, V123, P917, DOI 10.1542/peds.2008-1173; National Institute of Nutrition, 2001, REP NAT SUBCL VIT A; Nguyen MD, 2007, PUBLIC HEALTH NUTR, V10, P115, DOI 10.1017/S1368980007224085; NIN NIoN, 2010, PREV UND CHIILDR 5 Y; Ninh N, 2001, MICRONUTRIENT DEFICI, P24; Oanh THT, 2009, ASIA PAC J CLIN NUTR, V18, P226; Organization WH, 1996, IND ASS VIT DEF THEI; PEREIRA SM, 1969, AM J CLIN NUTR, V22, P858; Perlas Leah A., 1996, Southeast Asian Journal of Tropical Medicine and Public Health, V27, P785; Pham VP, 2010, J NUTR, V140, P2241, DOI 10.3945/jn.110.123711; Nguyen PH, 2011, ASIA PAC J CLIN NUTR, V20, P359; Rustein SO, 2004, DHS COMPERATIVE REPO; Rutstein S.O., DHS WEALTH INDEX APP; Solomons NW, 2008, ASIA PAC J CLIN NUTR, V17, P20; Tagny CT, 2008, ANN BIOL CLIN-PARIS, V66, P90, DOI 10.1684/abc.2008.0195; Thurnham DI, 2010, AM J CLIN NUTR, V92, P546, DOI 10.3945/ajcn.2010.29284; Thurnham DI, 2003, LANCET, V362, P2052, DOI 10.1016/S0140-6736(03)15099-4; Thuy PV, 2003, AM J CLIN NUTR, V78, P284, DOI 10.1093/ajcn/78.2.284; Tran TN, 2009, J NUTR, V139, P1013, DOI 10.3945/jn.108.099754; Van Thuy P, 2005, J NUTR, V135, P2596, DOI 10.1093/jn/135.11.2596; Vietnam Academy of Social Science, 2006, VIETN POV UPD POV PO; Viteri FE, 2005, NUTR REV, V63, pS65, DOI 10.1301/nr.2005.dec.S65-S76; Vu TTH, 2009, PUBLIC HEALTH NUTR, V12, P941, DOI 10.1017/S1368980008003479; Wang Y, 2007, INT J OBESITY, V31, P177, DOI 10.1038/sj.ijo.0803354; WDI, 2010, DAT WORLD BANK; WHO, 2001, IRON DEFICIENCY ANAE; Wiss O, 1950, HYG, P225; World Health Organization, 2000, COMPL FEED FAM FOODS	75	61	62	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2012	7	4							e34906	10.1371/journal.pone.0034906	http://dx.doi.org/10.1371/journal.pone.0034906			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WC	22529954	gold, Green Published, Green Submitted			2022-12-25	WOS:000305347400024
J	Wang, CC; Lin, SY; Lai, YH; Liu, YJ; Hsu, YL; Chen, JJW				Wang, Chi-Chung; Lin, Sheng-Yi; Lai, Yi-Hua; Liu, Ya-Jung; Hsu, Yuan-Lin; Chen, Jeremy J. W.			Dimethyl Sulfoxide Promotes the Multiple Functions of the Tumor Suppressor HLJ1 through Activator Protein-1 Activation in NSCLC Cells	PLOS ONE			English	Article							FREE-RADICAL SCAVENGERS; LUNG-CARCINOMA CELLS; COMPLEX NAMI-A; FACTOR-KAPPA-B; INTERSTITIAL CYSTITIS; GENE-EXPRESSION; INDUCED APOPTOSIS; UP-REGULATION; DIMETHYLSULFOXIDE; CANCER	Background: Dimethyl sulfoxide (DMSO) is an amphipathic molecule that displays a diversity of antitumor activities. Previous studies have demonstrated that DMSO can modulate AP-1 activity and lead to cell cycle arrest at the G1 phase. HLJ1 is a newly identified tumor and invasion suppressor that inhibits tumorigenesis and cancer metastasis. Its transcriptional activity is regulated by the transcription factor AP-1. However, the effects of DMSO on HLJ1 are still unknown. In the present study, we investigate the antitumor effects of DMSO through HLJ1 induction and demonstrate the mechanisms involved. Methods and Findings: Low-HLJ1-expressing highly invasive CL1-5 lung adenocarcinoma cells were treated with various concentrations of DMSO. We found that DMSO can significantly inhibit cancer cell invasion, migration, proliferation, and colony formation capabilities through upregulation of HLJ1 in a concentration-dependent manner, whereas ethanol has no effect. In addition, the HLJ1 promoter and enhancer reporter assay revealed that DMSO transcriptionally upregulates HLJ1 expression through an AP-1 site within the HLJ1 enhancer. The AP-1 subfamily members JunD and JunB were significantly upregulated by DMSO in a concentration-dependent manner. Furthermore, pretreatment with DMSO led to a significant increase in the percentage of UV-induced apoptotic cells. Conclusions: Our results suggest that DMSO may be an important stimulator of the tumor suppressor protein HLJ1 through AP-1 activation in highly invasive lung adenocarcinoma cells. Targeted induction of HLJ1 represents a promising approach for cancer therapy, which also implied that DMSO may serve as a potential lead compound or coordinated ligand for the development of novel anticancer drugs.	[Wang, Chi-Chung; Liu, Ya-Jung; Hsu, Yuan-Lin] Fu Jen Cathol Univ, Grad Inst Basic Med, Taipei, Taiwan; [Lin, Sheng-Yi; Lai, Yi-Hua; Chen, Jeremy J. W.] Natl Chung Hsing Univ, Inst Biomed Sci, Taichung 40227, Taiwan; [Lin, Sheng-Yi; Lai, Yi-Hua; Chen, Jeremy J. W.] Natl Chung Hsing Univ, Inst Mol Biol, Taichung 40227, Taiwan	Fu Jen Catholic University; National Chung Hsing University; National Chung Hsing University	Wang, CC (corresponding author), Fu Jen Cathol Univ, Grad Inst Basic Med, Taipei, Taiwan.	075006@mail.fju.edu.tw; jwchen@dragon.nchu.edu.tw		Chen, Jeremy J.W./0000-0003-1049-3825	National Science Council (NSC), Taiwan, R.O.C. [NSC 97-2314-B-039-028-MY2, NSC 100-2325-B-005-001]; Ministry of Education, Taiwan, R.O.C. under the ATU; Fu Jen Catholic University, Taiwan, R.O.C. [9991A08, 9991A01-409931034019]	National Science Council (NSC), Taiwan, R.O.C.(Ministry of Science and Technology, Taiwan); Ministry of Education, Taiwan, R.O.C. under the ATU; Fu Jen Catholic University, Taiwan, R.O.C.	This study was supported by grants from the National Science Council (NSC), Taiwan, R.O.C. (NSC 97-2314-B-039-028-MY2 and NSC 100-2325-B-005-001 to Dr. Wang and Dr. Chen), as well as in part by the Ministry of Education, Taiwan, R.O.C. under the ATU plan (to Dr. Chen) and in part by grants from the Fu Jen Catholic University, Taiwan, R.O.C. (9991A08 and 9991A01-409931034019 to Dr. Wang). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albini A, 2006, J NATL CANCER I, V98, P825; Antonarakis ES, 2010, CANCER CHEMOTH PHARM, V66, P1, DOI 10.1007/s00280-010-1293-1; Bacac M, 2004, J INORG BIOCHEM, V98, P402, DOI 10.1016/j.jinorgbio.2003.12.003; BERTELLI G, 1995, J CLIN ONCOL, V13, P2851, DOI 10.1200/JCO.1995.13.11.2851; Bouma M, 2002, INT J PHARMACEUT, V248, P239, DOI 10.1016/S0378-5173(02)00460-X; Camici GG, 2006, CIRCULATION, V114, P1512, DOI 10.1161/CIRCULATIONAHA.106.638460; CEROSALETTI KM, 1990, CELL IMMUNOL, V127, P299, DOI 10.1016/0008-8749(90)90134-D; Chang CK, 2001, J SURG RES, V95, P181, DOI 10.1006/jsre.2000.6033; Chen HW, 2008, CANCER RES, V68, P7428, DOI 10.1158/0008-5472.CAN-07-6734; Chen JJW, 2003, CLIN CANCER RES, V9, P729; Chen JJW, 2001, CANCER RES, V61, P5223; Chu YW, 1997, AM J RESP CELL MOL, V17, P353, DOI 10.1165/ajrcmb.17.3.2837; COLLINS SJ, 1978, P NATL ACAD SCI USA, V75, P2458, DOI 10.1073/pnas.75.5.2458; Curado MP, 2007, CANC INCIDENCE 5 CON, VIX; Eter N, 2002, BRIT J OPHTHALMOL, V86, P1303, DOI 10.1136/bjo.86.11.1303; Goto I, 1996, BRIT J CANCER, V74, P546, DOI 10.1038/bjc.1996.399; Hanslick JL, 2009, NEUROBIOL DIS, V34, P1, DOI 10.1016/j.nbd.2008.11.006; IKEDA Y, 1990, ACT NEUR S, V51, P74; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Kami D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002407; Koizumi K, 2003, BIOL PHARM BULL, V26, P1295; Lee YR, 2005, LEUKEMIA RES, V29, P401, DOI 10.1016/j.leukres.2004.09.010; Lin SY, 2010, NUCLEIC ACIDS RES, V38, P6148, DOI 10.1093/nar/gkq412; Liu J, 2001, INT IMMUNOPHARMACOL, V1, P63, DOI 10.1016/S1567-5769(00)00016-3; Mastronarde JG, 1998, J INFECT DIS, V177, P1275, DOI 10.1086/515279; Metts JF, 2001, AM FAM PHYSICIAN, V64, P1199; Moldwin RM, 2002, CLIN OBSTET GYNECOL, V45, P259, DOI 10.1097/00003081-200203000-00027; Morassi P, 1989, Minerva Med, V80, P65; Murav'ev Iu V, 1986, Ter Arkh, V58, P104; Parkin J, 1997, UROLOGY, V49, P105, DOI 10.1016/S0090-4295(97)00181-7; Pegg David E, 2007, Methods Mol Biol, V368, P39; Reddy SPM, 2002, AM J PHYSIOL-LUNG C, V283, pL1161, DOI 10.1152/ajplung.00140.2002; Rosenstein ED, 1999, RHEUM DIS CLIN N AM, V25, P899, DOI 10.1016/S0889-857X(05)70109-5; SALIM AS, 1992, J LAB CLIN MED, V119, P710; SALIM AS, 1991, INTENS CARE MED, V17, P455, DOI 10.1007/BF01690766; Santos NC, 2005, LEUKEMIA RES, V29, P361, DOI 10.1016/j.leukres.2004.09.009; Santos NC, 2003, BIOCHEM PHARMACOL, V65, P1035, DOI 10.1016/S0006-2952(03)00002-9; SHIRLEY S W, 1978, Urology, V11, P215, DOI 10.1016/0090-4295(78)90118-8; SMITH RS, 1992, MED HYPOTHESES, V39, P248, DOI 10.1016/0306-9877(92)90117-U; TAKASE K, 1992, CELL GROWTH DIFFER, V3, P515; TAKENAGA K, 1984, CANCER RES, V44, P1122; Teraoka H, 1996, EXP CELL RES, V222, P218, DOI 10.1006/excr.1996.0027; Tsai MF, 2006, JNCI-J NATL CANCER I, V98, P825, DOI 10.1093/jnci/djj229; Vondracek J, 2006, LEUKEMIA RES, V30, P81, DOI 10.1016/j.leukres.2005.05.016; Wang CC, 2005, ONCOGENE, V24, P4081, DOI 10.1038/sj.onc.1208573; Wang CC, 2007, CANCER RES, V67, P4816, DOI 10.1158/0008-5472.CAN-07-0504	46	21	23	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2012	7	4							e33772	10.1371/journal.pone.0033772	http://dx.doi.org/10.1371/journal.pone.0033772			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WC	22529897	Green Submitted, gold, Green Published			2022-12-25	WOS:000305347400004
J	Yang, M; Wang, XY; Chen, DY; Wang, YA; Zhang, AY; Zhou, H				Yang, Mu; Wang, Xinyan; Chen, Danyan; Wang, Yanan; Zhang, Anying; Zhou, Hong			TGF-beta 1 Exerts Opposing Effects on Grass Carp Leukocytes: Implication in Teleost Immunity, Receptor Signaling and Potential Self-Regulatory Mechanisms	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; TGF-BETA; FUNCTIONAL-CHARACTERIZATION; RAINBOW-TROUT; GENES; CELLS; EXPRESSION; KIDNEY	In fish immunity, the regulatory role of transforming growth factor-beta 1 (TGF-beta 1) has not been fully characterized. Here we examined the immunoregulatory effects of TGF-beta 1 in grass carp peripheral blood leukocytes (PBL) and head kidney leukocytes (HKL). It is interesting that TGF-beta 1 consistently stimulated the cell viability and the mRNA levels of pro-inflammatory cytokines (Tnf alpha and Ifn gamma) and T/B cell markers [Cd4-like (Cd4l), Cd8 alpha, Cd8 beta and Ig mu] in PBL, which contrasted with its inhibitory tone in HKL. Further studies showed that grass carp TGF-beta 1 type I receptor, activin receptor-like kinase 5 (ALK5), was indispensable for the immunoregulatory effects of TGF-beta 1 in PBL and HKL. Notably, TGF-beta 1 persistently attenuated ALK5 expression, whereas immunoneutralization of endogenous grass carp TGF-beta 1 could increase ALK5 mRNA and protein levels. It is consistent with the observation that TGF-beta 1 decreased the number of ALK5(+) leukocytes in PBL and HKL, revealing a negative regulation of TGF-beta 1 signaling at the receptor level. Moreover, transient treatment with TGF-beta 1 for 24 h was sufficient to induce similar cellular responses compared with the continuous treatment. This indicated a possible mechanism by which TGF-beta 1 triggered the down-regulation of ALK5 mRNA and protein, leading to the desensitization of grass carp leukocytes toward TGF-beta 1. Accordingly, our data revealed a dual role of TGF-beta 1 in teleost immunity in which it can serve as a positive or negative control device and provided additional mechanistic insights as to how TGF-beta 1 controls its signaling in vertebrate leukocytes.	[Yang, Mu; Wang, Xinyan; Chen, Danyan; Wang, Yanan; Zhang, Anying; Zhou, Hong] Univ Elect Sci & Technol China, Sch Life Sci & Technol, Chengdu 610054, Peoples R China	University of Electronic Science & Technology of China	Yang, M (corresponding author), Univ Elect Sci & Technol China, Sch Life Sci & Technol, Chengdu 610054, Peoples R China.	zhouhongzh@uestc.edu.cn	Wang, Xinyan/N-7406-2019; Zhang, An/GRS-5852-2022; WANG, Xinyan/A-4819-2015		National Natural Science Foundation of China [30972280]; Science and Technology Committee of Sichuan Province [2011FZ0007]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Committee of Sichuan Province	This work was supported by grants 30972280 from the National Natural Science Foundation of China and 2011FZ0007 from the Science and Technology Committee of Sichuan Province. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arts JAJ, 2010, FISH SHELLFISH IMMUN, V29, P793, DOI 10.1016/j.fsi.2010.07.010; Boschi I, 2011, FISH SHELLFISH IMMUN, V31, P655, DOI 10.1016/j.fsi.2010.10.001; BRANDES ME, 1991, J BIOL CHEM, V266, P19697; Cai ZH, 2010, FISH SHELLFISH IMMUN, V28, P695, DOI 10.1016/j.fsi.2010.01.011; de Caestecker MP, 2000, JNCI-J NATL CANCER I, V92, P1388, DOI 10.1093/jnci/92.17.1388; Dijkstra JM, 2006, MOL IMMUNOL, V43, P410, DOI 10.1016/j.molimm.2005.03.005; Ebisawa T, 2001, J BIOL CHEM, V276, P12477, DOI 10.1074/jbc.C100008200; Fischer U, 2003, DEV COMP IMMUNOL, V27, P323, DOI 10.1016/S0145-305X(02)00100-3; Grayfer L, 2008, DEV COMP IMMUNOL, V32, P532, DOI 10.1016/j.dci.2007.09.009; Grayfer L, 2011, MOL IMMUNOL, V48, P563, DOI 10.1016/j.molimm.2010.10.013; Grayfer L, 2010, J BIOL CHEM, V285, P23537, DOI 10.1074/jbc.M109.096925; Haddad G, 2008, DEV COMP IMMUNOL, V32, P654, DOI 10.1016/j.dci.2007.10.003; Hetland DL, 2010, FISH SHELLFISH IMMUN, V28, P30, DOI 10.1016/j.fsi.2009.09.011; Kadowaki T, 2009, ANTICANCER RES, V29, P4871; Li B, 2006, IMMUNOL REV, V212, P99, DOI 10.1111/j.0105-2896.2006.00405.x; Li MO, 2008, CELL, V134, P392, DOI 10.1016/j.cell.2008.07.025; Li MO, 2006, ANNU REV IMMUNOL, V24, P99, DOI 10.1146/annurev.immunol.24.021605.090737; Liu YZ, 2008, NAT IMMUNOL, V9, P632, DOI 10.1038/ni.1607; Lopez-Munoz A, 2009, J IMMUNOL, V182, P3440, DOI 10.4049/jimmunol.0802528; Massague J, 1998, ANNU REV BIOCHEM, V67, P753, DOI 10.1146/annurev.biochem.67.1.753; Mitchell H, 2004, MOL BIOL CELL, V15, P4166, DOI 10.1091/mbc.E04-03-0245; Miyazono K, 2000, ADV IMMUNOL, V75, P115, DOI 10.1016/S0065-2776(00)75003-6; Pettersen EF, 2000, FISH SHELLFISH IMMUN, V10, P695, DOI 10.1006/fsim.2000.0284; Picchietti S, 2009, FISH SHELLFISH IMMUN, V27, P50, DOI 10.1016/j.fsi.2009.04.003; Rodrigues PNS, 1995, DEV COMP IMMUNOL, V19, P483, DOI 10.1016/0145-305X(95)00033-P; Ronneseth A, 2007, FISH SHELLFISH IMMUN, V23, P493, DOI 10.1016/j.fsi.2006.08.017; Saeij JPJ, 2003, DEV COMP IMMUNOL, V27, P29, DOI 10.1016/S0145-305X(02)00064-2; Saxena V, 2008, J IMMUNOL, V180, P1903, DOI 10.4049/jimmunol.180.3.1903; Scapigliati G, 2010, FISH SHELLFISH IMMUN, V28, P303, DOI 10.1016/j.fsi.2009.11.008; Sepulcre MP, 2002, CELL TISSUE RES, V308, P97, DOI 10.1007/s00441-002-0531-1; Stolte EH, 2008, DEV COMP IMMUNOL, V32, P1467, DOI 10.1016/j.dci.2008.06.012; Sun XF, 2007, FISH SHELLFISH IMMUN, V23, P1242, DOI 10.1016/j.fsi.2007.06.004; VERBURGVANKEMENADE BML, 1994, J EXP BIOL, V187, P143; Wan YY, 2007, IMMUNOL REV, V220, P199, DOI 10.1111/j.1600-065X.2007.00565.x; Wang XY, 2010, FISH SHELLFISH IMMUN, V29, P998, DOI 10.1016/j.fsi.2010.08.010; Xiao FS, 2010, FISH SHELLFISH IMMUN, V29, P594, DOI 10.1016/j.fsi.2010.06.004; Yang M, 2010, FISH SHELLFISH IMMUN, V28, P289, DOI 10.1016/j.fsi.2009.11.007; Zhang LJ, 2006, AUTOIMMUNITY, V39, P269, DOI 10.1080/08916930600753903; Zhao T, 2012, DOMEST ANIM IN PRESS; Zou J, 2003, DEV COMP IMMUNOL, V27, P813, DOI 10.1016/S0145-305X(03)00077-6; Zwollo P, 2005, J IMMUNOL, V174, P6608, DOI 10.4049/jimmunol.174.11.6608	41	19	25	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2012	7	4							e35011	10.1371/journal.pone.0035011	http://dx.doi.org/10.1371/journal.pone.0035011			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WC	22529969	Green Published, Green Submitted, gold			2022-12-25	WOS:000305347400029
J	Cascone, A; Bruelle, C; Lindholm, D; Bernardi, P; Eriksson, O				Cascone, Annunziata; Bruelle, Celine; Lindholm, Dan; Bernardi, Paolo; Eriksson, Ove			Destabilization of the Outer and Inner Mitochondrial Membranes by Core and Linker Histones	PLOS ONE			English	Article							CHROMATIN-STRUCTURE; APOPTOSIS; PROTEIN; ACTIVATION; P53; BINDING; ORIGIN; KINASE; H1.2; BAX	Background: Extensive DNA damage leads to apoptosis. Histones play a central role in DNA damage sensing and may mediate signals of genotoxic damage to cytosolic effectors including mitochondria. Methodology/Principal Findings: We have investigated the effects of histones on mitochondrial function and membrane integrity. We demonstrate that both linker histone H1 and core histones H2A, H2B, H3, and H4 bind strongly to isolated mitochondria. All histones caused a rapid and massive release of the pro-apoptotic intermembrane space proteins cytochrome c and Smac/Diablo, indicating that they permeabilize the outer mitochondrial membrane. In addition, linker histone H1, but not core histones, permeabilized the inner membrane with a collapse of the membrane potential, release of pyridine nucleotides, and mitochondrial fragmentation. Conclusions: We conclude that histones destabilize the mitochondrial membranes, a mechanism that may convey genotoxic signals to mitochondria and promote apoptosis following DNA damage.	[Cascone, Annunziata; Eriksson, Ove] Univ Helsinki, Res Program Unit, Helsinki, Finland; [Cascone, Annunziata; Bruelle, Celine; Lindholm, Dan; Eriksson, Ove] Univ Helsinki, Inst Biomed, Helsinki, Finland; [Bruelle, Celine; Lindholm, Dan] Minerva Med Res Inst, Helsinki, Finland; [Bernardi, Paolo] Univ Padua, Dipartimento Sci Biomed Sperimentali, Padua, Italy	University of Helsinki; University of Helsinki; University of Padua	Cascone, A (corresponding author), Univ Helsinki, Res Program Unit, Helsinki, Finland.	ove.eriksson@helsinki.fi	Bernardi, Paolo/C-3656-2008; Eriksson-Rosenberg, Ove/GVU-6692-2022; Lindholm, Dan/B-3777-2014	Bernardi, Paolo/0000-0001-9187-3736; 	Magnus Ehrnrooth Foundation; K. Albin Johansson Foundation; Swedish Culture Foundation; Italian Ministry of Education, Universities and Research (MIUR)	Magnus Ehrnrooth Foundation; K. Albin Johansson Foundation; Swedish Culture Foundation; Italian Ministry of Education, Universities and Research (MIUR)(Ministry of Education, Universities and Research (MIUR))	This study was supported by grants from the Magnus Ehrnrooth Foundation, the K. Albin Johansson Foundation, the Swedish Culture Foundation, and the Italian Ministry of Education, Universities and Research (MIUR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARENTS G, 1995, P NATL ACAD SCI USA, V92, P11170, DOI 10.1073/pnas.92.24.11170; Chen YR, 1996, J BIOL CHEM, V271, P631, DOI 10.1074/jbc.271.2.631; Chipuk JE, 2004, SCIENCE, V303, P1010, DOI 10.1126/science.1092734; Chubb JE, 2010, SUBCELL BIOCHEM, V50, P17, DOI 10.1007/978-90-481-3471-7_2; Ciccia A, 2010, MOL CELL, V40, P179, DOI 10.1016/j.molcel.2010.09.019; Cipolat S, 2006, CELL, V126, P163, DOI 10.1016/j.cell.2006.06.021; Cook PJ, 2009, NATURE, V458, P591, DOI 10.1038/nature07849; Du CY, 2000, CELL, V102, P33, DOI 10.1016/S0092-8674(00)00008-8; Fontaine E, 1998, J BIOL CHEM, V273, P12662, DOI 10.1074/jbc.273.20.12662; Happel N, 2009, GENE, V431, P1, DOI 10.1016/j.gene.2008.11.003; Hegde R, 2002, J BIOL CHEM, V277, P432, DOI 10.1074/jbc.M109721200; Jeong SY, 2008, BMB REP, V41, P11, DOI 10.1146/annurev-genet-102108-134850; Jourdain A, 2009, INT J BIOCHEM CELL B, V41, P1884, DOI 10.1016/j.biocel.2009.05.001; Joza N, 2001, NATURE, V410, P549, DOI 10.1038/35069004; Kasinsky HE, 2001, FASEB J, V15, P34, DOI 10.1096/fj.00-0237rev; Kim MY, 2004, CELL, V119, P803, DOI 10.1016/j.cell.2004.11.002; Koh DW, 2005, PHARMACOL RES, V52, P5, DOI 10.1016/j.phrs.2005.02.011; Konishi A, 2003, CELL, V114, P673, DOI 10.1016/S0092-8674(03)00719-0; Kuwana T, 2002, CELL, V111, P331, DOI 10.1016/S0092-8674(02)01036-X; Li LY, 2001, NATURE, V412, P95, DOI 10.1038/35083620; Lindholm D, 2004, BIOCHEM BIOPH RES CO, V321, P753, DOI 10.1016/j.bbrc.2004.06.138; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Mihara M, 2003, MOL CELL, V11, P577, DOI 10.1016/S1097-2765(03)00050-9; MILNE DM, 1995, J BIOL CHEM, V270, P5511, DOI 10.1074/jbc.270.10.5511; Okamura H, 2008, J CELL BIOCHEM, V103, P1488, DOI 10.1002/jcb.21537; Polianskyte Z, 2009, P NATL ACAD SCI USA, V106, P18960, DOI 10.1073/pnas.0906734106; Postberg J, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-259; Rasola A, 2010, FEBS LETT, V584, P1989, DOI 10.1016/j.febslet.2010.02.022; Roque A, 2007, BIOPHYS J, V93, P2170, DOI 10.1529/biophysj.107.104513; Schug ZT, 2009, BBA-BIOMEMBRANES, V1788, P2022, DOI 10.1016/j.bbamem.2009.05.004; Shechter D, 2007, NAT PROTOC, V2, P1445, DOI 10.1038/nprot.2007.202; Slesarev AI, 1998, NUCLEIC ACIDS RES, V26, P427, DOI 10.1093/nar/26.2.427; Speer O, 2003, J BIOL CHEM, V278, P34757, DOI 10.1074/jbc.M301990200; Sun MG, 2007, NAT CELL BIOL, V9, P1057, DOI 10.1038/ncb1630; Talbert PB, 2010, NAT REV MOL CELL BIO, V11, P264, DOI 10.1038/nrm2861; Taylor RC, 2008, NAT REV MOL CELL BIO, V9, P231, DOI 10.1038/nrm2312; Van Loo G, 2002, CELL DEATH DIFFER, V9, P301, DOI 10.1038/sj.cdd.4400966; Verhagen AM, 2000, CELL, V102, P43, DOI 10.1016/S0092-8674(00)00009-X; Verreault A, 2000, GENE DEV, V14, P1430; Wang HC, 2008, P NATL ACAD SCI USA, V105, P20758, DOI 10.1073/pnas.0811233106; Yu SW, 2002, SCIENCE, V297, P259, DOI 10.1126/science.1072221	41	20	21	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2012	7	4							e35357	10.1371/journal.pone.0035357	http://dx.doi.org/10.1371/journal.pone.0035357			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VO	22523586	Green Published, gold, Green Submitted			2022-12-25	WOS:000305345000058
J	Yoshino, S; Hara, T; Weng, JS; Takahashi, Y; Seiki, M; Sakamoto, T				Yoshino, Seiko; Hara, Toshiro; Weng, Jane S.; Takahashi, Yuka; Seiki, Motoharu; Sakamoto, Takeharu			Genetic Screening of New Genes Responsible for Cellular Adaptation to Hypoxia Using a Genome-Wide shRNA Library	PLOS ONE			English	Article							METABOLISM; EXPRESSION; PREVENTION; CANCERS; KINASE; RBSP3; BCL-2	Oxygen is a vital requirement for multi-cellular organisms to generate energy and cells have developed multiple compensatory mechanisms to adapt to stressful hypoxic conditions. Such adaptive mechanisms are intricately interconnected with other signaling pathways that regulate cellular functions such as cell growth. However, our understanding of the overall system governing the cellular response to the availability of oxygen remains limited. To identify new genes involved in the response to hypoxic stress, we have performed a genome-wide gene knockdown analysis in human lung carcinoma PC8 cells using an shRNA library carried by a lentiviral vector. The knockdown analysis was performed under both normoxic and hypoxic conditions to identify shRNA sequences enriched or lost in the resulting selected cell populations. Consequently, we identified 56 candidate genes that might contribute to the cellular response to hypoxia. Subsequent individual knockdown of each gene demonstrated that 13 of these have a significant effect upon oxygen-sensitive cell growth. The identification of BCL2L1, which encodes a Bcl-2 family protein that plays a role in cell survival by preventing apoptosis, validates the successful design of our screen. The other selected genes have not previously been directly implicated in the cellular response to hypoxia. Interestingly, hypoxia did not directly enhance the expression of any of the identified genes, suggesting that we have identified a new class of genes that have been missed by conventional gene expression analyses to identify hypoxia response genes. Thus, our genetic screening method using a genome-wide shRNA library and the newly-identified genes represent useful tools to analyze the cellular systems that respond to hypoxic stress.	[Yoshino, Seiko; Hara, Toshiro; Weng, Jane S.; Takahashi, Yuka; Seiki, Motoharu; Sakamoto, Takeharu] Univ Tokyo, Inst Med Sci, Div Canc Cell Res, Minato Ku, Tokyo, Japan	University of Tokyo	Yoshino, S (corresponding author), Univ Tokyo, Inst Med Sci, Div Canc Cell Res, Minato Ku, Tokyo, Japan.	mseiki@ims.u-tokyo.ac.jp	Seiki, Motoharu/K-9443-2015; Sakamoto, Takeharu/Y-6062-2019	Sakamoto, Takeharu/0000-0002-1225-1902	Ministry of Education, Culture, Sports, Science and Technology of Japan [22790846, 23112505, 22220014]	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a Grant-in-Aid for Young Scientists (B) (No. 22790846) and Grant-in-Aid for Scientific Research on Innovative Areas (No. 23112505) from the Ministry of Education, Culture, Sports, Science and Technology of Japan to T. S. and by a Grant-in-Aid for Scientific Research (S) (No. 22220014) from the Ministry of Education, Culture, Sports, Science and Technology of Japan to M. S. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson P, 2009, NAT REV MOL CELL BIO, V10, P430, DOI 10.1038/nrm2694; Arif A, 2009, MOL CELL, V35, P164, DOI 10.1016/j.molcel.2009.05.028; Cairns RA, 2011, NAT REV CANCER, V11, P85, DOI 10.1038/nrc2981; Denko NC, 2008, NAT REV CANCER, V8, P705, DOI 10.1038/nrc2468; Gatenby RA, 2004, NAT REV CANCER, V4, P891, DOI 10.1038/nrc1478; Ghosh A, 2010, CANCER SCI, V101, P1511, DOI 10.1111/j.1349-7006.2010.01551.x; Hu CJ, 2003, MOL CELL BIOL, V23, P9361, DOI 10.1128/MCB.23.24.9361-9374.2003; Huang JH, 2002, J BIOL CHEM, V277, P39792, DOI 10.1074/jbc.M206955200; Huang WC, 2008, CURR BIOL, V18, P781, DOI 10.1016/j.cub.2008.04.049; Kaelin WG, 2008, MOL CELL, V30, P393, DOI 10.1016/j.molcel.2008.04.009; Kashuba VI, 2004, P NATL ACAD SCI USA, V101, P4906, DOI 10.1073/pnas.0401238101; Kim JW, 2006, CELL METAB, V3, P177, DOI 10.1016/j.cmet.2006.02.002; Kroemer G, 2008, CANCER CELL, V13, P472, DOI 10.1016/j.ccr.2008.05.005; Kunz M, 2003, J BIOL CHEM, V278, P45651, DOI 10.1074/jbc.M301373200; Ludwig MG, 2003, NATURE, V425, P93, DOI 10.1038/nature01905; Luo WB, 2011, CELL, V145, P732, DOI 10.1016/j.cell.2011.03.054; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Martelange V, 2000, CANCER RES, V60, P3848; Papandreou I, 2006, CELL METAB, V3, P187, DOI 10.1016/j.cmet.2006.01.012; Parker R, 2007, MOL CELL, V25, P635, DOI 10.1016/j.molcel.2007.02.011; Sakamoto T, 2011, J BIOL CHEM, V286, P14691, DOI 10.1074/jbc.M110.188714; Sakamoto T, 2010, J BIOL CHEM, V285, P29951, DOI 10.1074/jbc.M110.132704; Sakamoto T, 2009, J BIOL CHEM, V284, P30350, DOI 10.1074/jbc.M109.019216; Semenza GL, 2010, CURR OPIN GENET DEV, V20, P51, DOI 10.1016/j.gde.2009.10.009; Senchenko VN, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-75; Shimizu S, 1996, CANCER RES, V56, P2161; SHIMIZU S, 1995, NATURE, V374, P811, DOI 10.1038/374811a0; SHINMOTO H, 1990, CYTOTECHNOLOGY, V4, P121, DOI 10.1007/BF00365092; Spriggs KA, 2010, MOL CELL, V40, P228, DOI 10.1016/j.molcel.2010.09.028; Van Dijk EL, 2007, RNA, V13, P1027, DOI 10.1261/rna.575107; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Wouters BG, 2008, NAT REV CANCER, V8, P851, DOI 10.1038/nrc2501; Zhang L, 2004, CANCER RES, V64, P4180, DOI 10.1158/0008-5472.CAN-03-3038; Zhou J, 2006, CANCER LETT, V237, P10, DOI 10.1016/j.canlet.2005.05.028	34	12	12	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2012	7	4							e35590	10.1371/journal.pone.0035590	http://dx.doi.org/10.1371/journal.pone.0035590			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VO	22523603	Green Submitted, gold, Green Published			2022-12-25	WOS:000305345000077
J	Moshitzky, S; Asher, C; Garty, H				Moshitzky, Shiri; Asher, Carol; Garty, Haim			Intracellular Trafficking of FXYD1 (Phospholemman) and FXYD7 Proteins in Xenopus Oocytes and Mammalian Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARDIAC NA+/CA2+ EXCHANGER; O-GLYCOSYLATION; PLASMA-MEMBRANE; KINASE-C; FUNCTIONAL INTERACTIONS; CHANNEL ACTIVITY; ALPHA-SUBUNIT; GAMMA-SUBUNIT; ION-TRANSPORT; PUMP FUNCTION	FXYD proteins are a group of short single-span transmembrane proteins that interact with the Na+/K+ ATPase and modulate its kinetic properties. This study characterizes intracellular trafficking of two FXYD family members, FXYD1 (phospholemman (PLM)) and FXYD7. Surface expression of PLM in Xenopus oocytes requires coexpression with the Na+/K+ ATPase. On the other hand, the Na+/Ca2+ exchanger, another PLM-interacting protein could not drive it to the cell surface. The Na+/K+ ATPase-dependent surface expression of PLM could be facilitated by either a phosphorylation-mimicking mutation at Thr-69 or a truncation of three terminal arginine residues. Unlike PLM, FXYD7 could translocate to the cell surface of Xenopus oocytes independently of the coexpression of alpha 1 beta 1 Na+/K+ ATPase. The Na+/K+ ATPase-independent membrane translocation of FXYD7 requires O-glycosylation of at least two of three conserved threonines in its ectodomain. Subsequent experiments in mammalian cells confirmed the role of conserved extracellular threonine residues and demonstrated that FXYD7 protein, in which these have been mutated to alanine, is trapped in the endoplasmic reticulum and Golgi apparatus.	[Moshitzky, Shiri; Asher, Carol; Garty, Haim] Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel	Weizmann Institute of Science	Garty, H (corresponding author), Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel.	h.garty@weizmann.ac.il			Israel Science Foundation [688/11]	Israel Science Foundation(Israel Science Foundation)	This study was supported by Israel Science Foundation Research Grant 688/11.	Ahlers BA, 2005, J BIOL CHEM, V280, P19875, DOI 10.1074/jbc.M414703200; ATTALI B, 1995, P NATL ACAD SCI USA, V92, P6092, DOI 10.1073/pnas.92.13.6092; Beguin P, 2002, EMBO J, V21, P3264, DOI 10.1093/emboj/cdf330; Bibert S, 2008, J BIOL CHEM, V283, P476, DOI 10.1074/jbc.M705830200; Bossuyt J, 2006, J BIOL CHEM, V281, P32765, DOI 10.1074/jbc.M606254200; Chen LSK, 1997, GENOMICS, V41, P435, DOI 10.1006/geno.1997.4665; Cheung JY, 2008, AM J PHYSIOL-HEART C, V294, pH584, DOI 10.1152/ajpheart.91430.2007; Crambert G, 2004, J BIOL CHEM, V279, P30888, DOI 10.1074/jbc.M313494200; Crambert G, 2003, ANN NY ACAD SCI, V986, P444, DOI 10.1111/j.1749-6632.2003.tb07227.x; Crambert G, 2002, P NATL ACAD SCI USA, V99, P11476, DOI 10.1073/pnas.182267299; Despa S, 2005, CIRC RES, V97, P252, DOI 10.1161/01.RES.0000176532.97731.e5; Fuller W, 2009, AM J PHYSIOL-CELL PH, V296, pC1346, DOI 10.1152/ajpcell.00523.2008; Fuzesi M, 2005, J BIOL CHEM, V280, P18291, DOI 10.1074/jbc.M500080200; Garty H, 2006, ANNU REV PHYSIOL, V68, P431, DOI 10.1146/annurev.physiol.68.040104.131852; Geering K, 1996, J CELL BIOL, V133, P1193, DOI 10.1083/jcb.133.6.1193; Geering K, 2006, AM J PHYSIOL-RENAL, V290, pF241, DOI 10.1152/ajprenal.00126.2005; Guo K, 2010, AM J PHYSIOL-CELL PH, V299, pC1203, DOI 10.1152/ajpcell.00149.2010; Han F, 2006, CIRC RES, V99, P1376, DOI 10.1161/01.RES.0000251667.73461.fb; Hanisch FA, 2001, BIOL CHEM, V382, P143, DOI 10.1515/BC.2001.022; Hennebicq-Reig S, 1998, BIOCHEM J, V334, P283, DOI 10.1042/bj3340283; Ino Y, 2002, P NATL ACAD SCI USA, V99, P365, DOI 10.1073/pnas.012425299; Kanno E, 2008, J NEUROSCI RES, V86, P1036, DOI 10.1002/jnr.21568; Kucik DF, 1999, BIOPHYS J, V76, P314, DOI 10.1016/S0006-3495(99)77198-5; Lansbery KL, 2006, AM J PHYSIOL-CELL PH, V290, pC1275, DOI 10.1152/ajpcell.00110.2005; Lee MCS, 2004, ANNU REV CELL DEV BI, V20, P87, DOI 10.1146/annurev.cellbio.20.010403.105307; Li CM, 2005, J BIOL CHEM, V280, P42738, DOI 10.1074/jbc.M508451200; Lifshitz Y, 2007, BIOCHEMISTRY-US, V46, P14937, DOI 10.1021/bi701812c; LIMAN ER, 1992, NEURON, V9, P861, DOI 10.1016/0896-6273(92)90239-A; Lubarski I, 2007, AM J PHYSIOL-RENAL, V293, pF1818, DOI 10.1152/ajprenal.00367.2007; Lubarski I, 2011, AM J PHYSIOL-RENAL, V301, pF1270, DOI 10.1152/ajprenal.00142.2011; Madhani M, 2010, AM J PHYSIOL-HEART C, V299, pH827, DOI 10.1152/ajpheart.00129.2010; Maryon EB, 2007, J BIOL CHEM, V282, P20376, DOI 10.1074/jbc.M701806200; Miller TJ, 2008, AM J PHYSIOL-LUNG C, V294, pL654, DOI 10.1152/ajplung.00430.2007; Minor NT, 1998, P NATL ACAD SCI USA, V95, P6521, DOI 10.1073/pnas.95.11.6521; Mishra NK, 2011, J BIOL CHEM, V286, P9699, DOI 10.1074/jbc.M110.184234; Mohler PJ, 2005, PLOS BIOL, V3, P2158, DOI 10.1371/journal.pbio.0030423; MOORMAN JR, 1992, J BIOL CHEM, V267, P14551; MORRISON BW, 1995, J BIOL CHEM, V270, P2176, DOI 10.1074/jbc.270.5.2176; Mounsey JP, 1999, BBA-MOL CELL RES, V1451, P305, DOI 10.1016/S0167-4889(99)00102-0; Nam JS, 2007, CANCER LETT, V255, P161, DOI 10.1016/j.canlet.2007.02.018; PALMER CJ, 1991, J BIOL CHEM, V266, P11126; Potter BA, 2006, AM J PHYSIOL-CELL PH, V290, pC1, DOI 10.1152/ajpcell.00333.2005; Shinoda T, 2009, NATURE, V459, P446, DOI 10.1038/nature07939; Sigal A, 2007, NAT PROTOC, V2, P1515, DOI 10.1038/nprot.2007.197; Silverman BD, 2005, CARDIOVASC RES, V65, P93, DOI 10.1016/j.cardiores.2004.09.005; Song JL, 2012, AM J PHYSIOL-HEART C, V302, pH770, DOI 10.1152/ajpheart.00733.2011; Song JL, 2005, AM J PHYSIOL-HEART C, V288, pH2342, DOI 10.1152/ajpheart.01133.2004; STOOS BA, 1991, KIDNEY INT, V39, P1168, DOI 10.1038/ki.1991.148; Sweadner KJ, 2000, GENOMICS, V68, P41, DOI 10.1006/geno.2000.6274; Wang JF, 2006, J BIOL CHEM, V281, P32004, DOI 10.1074/jbc.M606876200; Wang JF, 2011, AM J PHYSIOL-HEART C, V300, pH859, DOI 10.1152/ajpheart.00894.2010; WILCHEK M, 1986, BIOCHEM BIOPH RES CO, V138, P872, DOI 10.1016/S0006-291X(86)80577-0; Zhang XQ, 2006, J BIOL CHEM, V281, P7784, DOI 10.1074/jbc.M512092200; Zhang XQ, 2003, AM J PHYSIOL-HEART C, V284, pH225, DOI 10.1152/ajpheart.00698.2002; Zhang XQ, 2009, AM J PHYSIOL-CELL PH, V296, pC911, DOI 10.1152/ajpcell.00196.2008; Zhu WJ, 2001, EMBO J, V20, P5999, DOI 10.1093/emboj/20.21.5999	56	8	8	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 15	2012	287	25					21130	21141		10.1074/jbc.M112.347807	http://dx.doi.org/10.1074/jbc.M112.347807			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974FQ	22535957	hybrid, Green Published			2022-12-25	WOS:000306416800034
J	Moskovich, O; Herzog, LO; Ehrlich, M; Fishelson, Z				Moskovich, Oren; Herzog, Lee-Or; Ehrlich, Marcelo; Fishelson, Zvi			Caveolin-1 and Dynamin-2 Are Essential for Removal of the Complement C5b-9 Complex via Endocytosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEMBRANE ATTACK COMPLEX; CLATHRIN-INDEPENDENT ENDOCYTOSIS; PROTEIN-KINASE-C; PLASMA-MEMBRANE; HUMAN-NEUTROPHILS; MEDIATED LYSIS; GOLGI-COMPLEX; UP-REGULATION; CELL-DEATH; RESISTANCE	The complement system, an important element of both innate and adaptive immunity, is executing complement-dependent cytotoxicity (CDC) with its C5b-9 protein complex that is assembled on cell surfaces and transmits to the cell death signals. In turn, cells, and in particular cancer cells, protect themselves from CDC in various ways. Thus, cells actively remove the C5b-9 complexes from their plasma membrane by endocytosis. Inhibition of clathrin by transfection with shRNA or of EPS-15 with a dominant negative plasmid had no effect on C5b-9 endocytosis and on cell death. In contrast, inhibition of caveolin-1 (Cav-1) by transfection with an shRNA or a dominant negative plasmid sensitized cells to CDC and inhibited C5b-9 endocytosis. Similarly, both inhibition of dynamin-2 by transfection with a dominant negative plasmid or by treatment with Dynasore reduced C5b-9 endocytosis and enhanced CDC. C5b-9 endocytosis was also disrupted by pretreatment of the cells with methyl-beta-cyclodextrin or Filipin III, hence implicating membrane cholesterol in the process. Analyses by confocal microscopy demonstrated co-localization of Cav-1-EGFP with C5b-9 at the plasma membrane, in early endosomes, at the endocytic recycling compartment and in secreted vesicles. Further investigation of the process of C5b-9 removal by exo-vesiculation demonstrated that inhibition of Cav-1 and cholesterol depletion abrogated C5b-9 exo-vesiculation, whereas, over-expression of Cav-1 increased C5b-9 exo-vesiculation. Our results show that Cav-1 and dynamin-2 (but not clathrin) support cell resistance to CDC, probably by facilitating purging of the C5b-9 complexes by endocytosis and exo-vesiculation.	[Moskovich, Oren; Herzog, Lee-Or; Fishelson, Zvi] Tel Aviv Univ, Sackler Sch Med, Dept Cell & Dev Biol, IL-69978 Tel Aviv, Israel; [Ehrlich, Marcelo] Tel Aviv Univ, George S Wise Fac Life Sci, IL-69978 Tel Aviv, Israel	Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv University	Fishelson, Z (corresponding author), Tel Aviv Univ, Sackler Sch Med, Dept Cell & Dev Biol, IL-69978 Tel Aviv, Israel.	lifish@post.tau.ac.il		Ehrlich, Marcelo/0000-0002-2352-1808	Israel Science Foundation; Israel Cancer Association	Israel Science Foundation(Israel Science Foundation); Israel Cancer Association	This research was in part supported by grants from the Israel Science Foundation and the Israel Cancer Association.	Bashkirov PV, 2008, CELL, V135, P1276, DOI 10.1016/j.cell.2008.11.028; Bauer M, 2006, FEBS LETT, V580, P5559, DOI 10.1016/j.febslet.2006.08.077; Benmerah A, 1998, J CELL BIOL, V140, P1055, DOI 10.1083/jcb.140.5.1055; BHAKDI S, 1985, INFECT IMMUN, V47, P52; Boll W, 2004, EUR J CELL BIOL, V83, P281, DOI 10.1078/0171-9335-00373; CARNEY DF, 1985, J IMMUNOL, V134, P1804; Chetrit D, 2009, BIOCHEM J, V418, P701, DOI 10.1042/BJ20081288; DAMKE H, 1995, METHOD ENZYMOL, V257, P209; Donin N, 2003, CLIN EXP IMMUNOL, V131, P254, DOI 10.1046/j.1365-2249.2003.02066.x; Fishelson Z, 2001, MOL IMMUNOL, V38, P207, DOI 10.1016/S0161-5890(01)00055-4; Gancz D, 2009, MOL IMMUNOL, V47, P310, DOI 10.1016/j.molimm.2009.09.016; Hansen CG, 2009, J CELL SCI, V122, P1713, DOI 10.1242/jcs.033951; Hayer A, 2010, J CELL BIOL, V191, P615, DOI 10.1083/jcb.201003086; Henley JR, 1998, J CELL BIOL, V141, P85, DOI 10.1083/jcb.141.1.85; Ho CC, 2008, LUNG CANCER, V59, P105, DOI 10.1016/j.lungcan.2007.07.024; Jiao JD, 2008, HYPERTENSION, V52, P499, DOI 10.1161/HYPERTENSIONAHA.108.110817; Jurianz K, 2001, INT J CANCER, V93, P848, DOI 10.1002/ijc.1406; KERJASCHKI D, 1989, J IMMUNOL, V143, P546; Kirchhausen T, 2008, METHOD ENZYMOL, V438, P77, DOI 10.1016/S0076-6879(07)38006-3; Kraus S, 2000, EUR J IMMUNOL, V30, P1272; Lajoie P, 2010, INT REV CEL MOL BIO, V282, P135, DOI 10.1016/S1937-6448(10)82003-9; Lavie Y, 1998, J BIOL CHEM, V273, P32380, DOI 10.1074/jbc.273.49.32380; Massol RH, 2004, MOL BIOL CELL, V15, P3631, DOI 10.1091/mbc.E04-04-0283; Mayor S, 2007, NAT REV MOL CELL BIO, V8, P603, DOI 10.1038/nrm2216; Mora R, 1999, J BIOL CHEM, V274, P25708, DOI 10.1074/jbc.274.36.25708; MORGAN BP, 1986, J IMMUNOL, V136, P3402; MORGAN BP, 1987, J IMMUNOL, V138, P246; Moskovich O, 2007, J BIOL CHEM, V282, P29977, DOI 10.1074/jbc.M703742200; Mukherjee S, 1997, PHYSIOL REV, V77, P759, DOI 10.1152/physrev.1997.77.3.759; MULLEREBERHARD HJ, 1986, ANNU REV IMMUNOL, V4, P503, DOI 10.1146/annurev.iy.04.040186.002443; Oh P, 1998, J CELL BIOL, V141, P101, DOI 10.1083/jcb.141.1.101; PAPADIMITRIOU JC, 1994, VIRCHOWS ARCH, V424, P677, DOI 10.1007/BF01069750; Parolini I, 1999, J BIOL CHEM, V274, P25718, DOI 10.1074/jbc.274.36.25718; Parton RG, 2007, NAT REV MOL CELL BIO, V8, P185, DOI 10.1038/nrm2122; Pelkmans L, 2005, NATURE, V436, P128, DOI 10.1038/nature03866; Pilzer D, 2005, INT IMMUNOL, V17, P1239, DOI 10.1093/intimm/dxh300; Pilzer D, 2010, INT J CANCER, V126, P1428, DOI 10.1002/ijc.24888; REITER Y, 1992, EUR J IMMUNOL, V22, P1207, DOI 10.1002/eji.1830220515; Ricklin D, 2010, NAT IMMUNOL, V11, P785, DOI 10.1038/ni.1923; ROTHBERG KG, 1992, CELL, V68, P673, DOI 10.1016/0092-8674(92)90143-Z; SCHLESINGER M, 1990, CLIN EXP IMMUNOL, V81, P423; Schmid EM, 2007, NATURE, V448, P883, DOI 10.1038/nature06031; SCOLDING NJ, 1989, NATURE, V339, P620, DOI 10.1038/339620a0; SIMS PJ, 1986, BLOOD, V68, P556; STEIN JM, 1991, BIOCHEM J, V274, P381, DOI 10.1042/bj2740381; Tirado OM, 2010, INT J CANCER, V126, P426, DOI 10.1002/ijc.24754; TSCHOPP J, 1985, J IMMUNOL, V134, P495; Varsano S, 1996, AM J RESP CELL MOL, V15, P731, DOI 10.1165/ajrcmb.15.6.8969267; Walport MJ, 2001, NEW ENGL J MED, V344, P1140, DOI 10.1056/NEJM200104123441506; Williams TM, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-3-214; Yang CPH, 1998, FEBS LETT, V439, P368, DOI 10.1016/S0014-5793(98)01354-4; Ziporen L, 2009, J IMMUNOL, V182, P515, DOI 10.4049/jimmunol.182.1.515	52	31	31	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 8	2012	287	24					19904	19915		10.1074/jbc.M111.333039	http://dx.doi.org/10.1074/jbc.M111.333039			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974FB	22528500	Green Published, hybrid			2022-12-25	WOS:000306414500013
J	Fujisawa, T; Rubin, B; Suzuki, A; Patel, PS; Gahl, WA; Joshi, BH; Puri, RK				Fujisawa, Toshio; Rubin, Benjamin; Suzuki, Akiko; Patel, Prabhudas S.; Gahl, William A.; Joshi, Bharat H.; Puri, Raj K.			Cysteamine Suppresses Invasion, Metastasis and Prolongs Survival by Inhibiting Matrix Metalloproteinases in a Mouse Model of Human Pancreatic Cancer	PLOS ONE			English	Article							INTERLEUKIN-13 RECEPTOR ALPHA-2; NEPHROPATHIC CYSTINOSIS; CELL-LINES; IN-VITRO; CHILDREN; CARCINOMA; GROWTH; RATS; ANGIOGENESIS; PROGRESSION	Background: Cysteamine, an anti-oxidant aminothiol, is the treatment of choice for nephropathic cystinosis, a rare lysosomal storage disease. Cysteamine is a chemo-sensitization and radioprotection agent and its antitumor effects have been investigated in various tumor cell lines and chemical induced carcinogenesis. Here, we investigated whether cysteamine has anti-tumor and anti-metastatic effects in transplantable human pancreatic cancer, an aggressive metastatic disease. Methodology/Principal Findings: Cysteamine's anti-invasion effects were studied by matrigel invasion and cell migration assays in 10 pancreatic cancer cell lines. To study mechanism of action, we examined cell viability and matrix metalloproteinases (MMPs) activity in the cysteamine-treated cells. We also examined cysteamine's anti-metastasis effect in two orthotopic murine models of human pancreatic cancer by measuring peritoneal metastasis and survival of animals. Cysteamine inhibited both migration and invasion of all ten pancreatic cancer cell lines at concentrations (<25 mM) that caused no toxicity to cells. It significantly decreased MMPs activity (IC50 38-460 mu M) and zymographic gelatinase activity in a dose dependent manner in vitro and in vivo; while mRNA and protein levels of MMP-9, MMP-12 and MMP-14 were slightly increased using the highest cysteamine concentration. In vivo, cysteamine significantly decreased metastasis in two established pancreatic tumor models, although it did not affect the size of primary tumors. Additionally, cysteamine prolonged survival of mice in a dose-dependent manner without causing any toxicity. Similar to the in vitro results, MMP activity was significantly decreased in animal tumors treated with cysteamine. Cysteamine had no clinical or preclinical adverse effects in the host even at the highest dose. Conclusions/Significance: Our results suggest that cysteamine, an agent with a proven safety profile, may be useful for inhibition of metastasis and prolonging the survival of a host with pancreatic cancer.	[Fujisawa, Toshio; Suzuki, Akiko; Patel, Prabhudas S.; Joshi, Bharat H.; Puri, Raj K.] Ctr Biol Evaluat & Res Food & Drug Adm, Tumor Vaccines & Biotechnol Branch, Div Cellular & Gene Therapies, Bethesda, MD USA; [Rubin, Benjamin] Johns Hopkins Sch Med, Suburban Hosp, Dept Ophthalmol, Bethesda, MD USA; [Gahl, William A.] NHGRI, Sect Human Biochem Genet, Med Genet Branch, NIH, Bethesda, MD 20892 USA	US Food & Drug Administration (FDA); Johns Hopkins University; Johns Hopkins Medicine; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI)	Puri, RK (corresponding author), Ctr Biol Evaluat & Res Food & Drug Adm, Tumor Vaccines & Biotechnol Branch, Div Cellular & Gene Therapies, Bethesda, MD USA.	raj.puri@fda.hhs.gov	Fujisawa, Toshio/AAN-2884-2021	Fujisawa, Toshio/0000-0001-7367-0767; Patel, Prabhudas/0000-0003-1004-7024	NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG000215] Funding Source: NIH RePORTER	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Anderson IC, 1996, CANCER RES, V56, P715; APFFEL CA, 1975, CANCER RES, V35, P429; Basset P, 1997, MATRIX BIOL, V15, P535, DOI 10.1016/S0945-053X(97)90028-7; Besouw M, 2011, PEDIATR NEPHROL, V26, P639, DOI 10.1007/s00467-010-1680-1; Bramhall S R, 1998, J Hepatobiliary Pancreat Surg, V5, P392, DOI 10.1007/s005340050063; Brown PD, 2000, EXPERT OPIN INV DRUG, V9, P2167, DOI 10.1517/13543784.9.9.2167; Chang C, 2001, TRENDS CELL BIOL, V11, pS37, DOI 10.1016/S0962-8924(01)82222-4; D'Angelo M, 2001, J BIOL CHEM, V276, P11347, DOI 10.1074/jbc.M009725200; Dohil R, 2003, J PEDIATR-US, V143, P224, DOI 10.1067/S0022-3476(03)00281-6; Dohil R, 2006, J PEDIATR-US, V148, P764, DOI 10.1016/j.jpeds.2006.01.050; Dohil R, 2010, J PEDIATR-US, V156, P823, DOI 10.1016/j.jpeds.2009.11.059; Eccles SA, 1996, CANCER RES, V56, P2815; Fujisawa T, 2011, INT J CANCER, V128, P1221, DOI 10.1002/ijc.25437; Fujisawa T, 2009, CANCER RES, V69, P8678, DOI 10.1158/0008-5472.CAN-09-2100; Gangoiti JA, 2010, BRIT J CLIN PHARMACO, V70, P376, DOI 10.1111/j.1365-2125.2010.03721.x; Inano H, 2000, RADIAT RES, V153, P68, DOI 10.1667/0033-7587(2000)153[0068:IEOWAC]2.0.CO;2; Jeitner TM, 1996, CANCER LETT, V103, P85, DOI 10.1016/0304-3835(96)04200-0; JEITNER TM, 1990, J ENDOCRINOL, V127, P119, DOI 10.1677/joe.0.1270119; JONAS AJ, 1982, J PEDIATR-US, V100, P321, DOI 10.1016/S0022-3476(82)80665-3; Kilian M, 2006, PROSTAG LEUKOTR ESS, V75, P429, DOI 10.1016/j.plefa.2006.08.004; Kleta R, 2004, EXPERT OPIN PHARMACO, V5, P2255, DOI 10.1517/14656566.5.11.2255; MARKELLO TC, 1993, NEW ENGL J MED, V328, P1157, DOI 10.1056/NEJM199304223281604; MOLLENHAUER J, 1987, Pancreas, V2, P14, DOI 10.1097/00006676-198701000-00003; Nakashima H, 2010, J TRANSL MED, V8, DOI 10.1186/1479-5876-8-116; Schmalfeldt B, 2001, CLIN CANCER RES, V7, P2396; Shimamura T, 2010, CLIN CANCER RES, V16, P577, DOI 10.1158/1078-0432.CCR-09-2015; Shinoda K, 2003, INT J ONCOL, V22, P281; SMOLIN LA, 1988, PEDIATR RES, V23, P616, DOI 10.1203/00006450-198806000-00018; Sparano JA, 2004, J CLIN ONCOL, V22, P4683, DOI 10.1200/JCO.2004.08.054; Steward WP, 1999, CANCER CHEMOTH PHARM, V43, pS56, DOI 10.1007/s002800051099; Tamahashi U, 2008, VIRCHOWS ARCH, V453, P79, DOI 10.1007/s00428-008-0617-6; TATSUTA M, 1988, INT J CANCER, V41, P423, DOI 10.1002/ijc.2910410318; Unak G, 2012, COLLOID SURFACE B, V90, P217, DOI 10.1016/j.colsurfb.2011.10.027; Wan XM, 2011, INT J CANCER, V129, P1087, DOI 10.1002/ijc.25771; Wang HC, 2010, J AGR FOOD CHEM, V58, P11913, DOI 10.1021/jf1022065; WATANABE H, 1988, ACTA PATHOL JAPON, V38, P1285; Wenner WJ, 1997, PEDIATR NEPHROL, V11, P600, DOI 10.1007/s004670050345; Wu C, 2011, NANOMEDICINE NANOTEC; YAMADA I, 1991, BRIT J CANCER, V63, P187, DOI 10.1038/bjc.1991.46	39	33	36	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2012	7	4							e34437	10.1371/journal.pone.0034437	http://dx.doi.org/10.1371/journal.pone.0034437			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UD	22532830	Green Published, gold, Green Submitted			2022-12-25	WOS:000305339200014
J	Seibel, BA; Maas, AE; Dierssen, HM				Seibel, Brad A.; Maas, Amy E.; Dierssen, Heidi M.			Energetic Plasticity Underlies a Variable Response to Ocean Acidification in the Pteropod, Limacina helicina antarctica	PLOS ONE			English	Article							PERSPECTIVES; TEMPERATURES; METABOLISM; ANIMALS; IMPACTS; RATES; FOOD; SEA	Ocean acidification, caused by elevated seawater carbon dioxide levels, may have a deleterious impact on energetic processes in animals. Here we show that high PCO2 can suppress metabolism, measured as oxygen consumption, in the pteropod, L. helicina forma antarctica, by similar to 20%. The rates measured at 180-380 mu atm (MO2 = 1.25 M-0.25, p = 0.007) were significantly higher (ANCOVA, p = 0.004) than those measured at elevated target CO2 levels in 2007 (789-1000 mu atm, = 0.78 M-0.32, p = 0.0008; Fig. 1). However, we further demonstrate metabolic plasticity in response to regional phytoplankton concentration and that the response to CO2 is dependent on the baseline level of metabolism. We hypothesize that reduced regional Chl a levels in 2008 suppressed metabolism and masked the effect of ocean acidification. This effect of food limitation was not, we postulate, merely a result of gut clearance and specific dynamic action, but rather represents a sustained metabolic response to regional conditions. Thus, pteropod populations may be compromised by climate change, both directly via CO2-induced metabolic suppression, and indirectly via quantitative and qualitative changes to the phytoplankton community. Without the context provided by long-term observations (four seasons) and a multi-faceted laboratory analysis of the parameters affecting energetics, the complex response of polar pteropods to ocean acidification may be masked or misinterpreted.	[Seibel, Brad A.; Maas, Amy E.] Univ Rhode Isl, Kingston, RI 02881 USA; [Dierssen, Heidi M.] Univ Connecticut, Groton, CT USA	University of Rhode Island; University of Connecticut	Seibel, BA (corresponding author), Univ Rhode Isl, Kingston, RI 02881 USA.	seibel@uri.edu	Maas, Amy/AAC-1181-2022	Maas, Amy/0000-0002-3730-2876	National Science Foundation Office of Polar Programs [0538479]	National Science Foundation Office of Polar Programs(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	This work was funded by a grant from the National Science Foundation Office of Polar Programs (0538479). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brockington S, 2001, J EXP MAR BIOL ECOL, V258, P87, DOI 10.1016/S0022-0981(00)00347-6; Cohen AL, 2009, OCEANOGRAPHY, V22, P118, DOI 10.5670/oceanog.2009.102; Comeau S, 2010, MAR BIOL, V157, P2341, DOI 10.1007/s00227-010-1493-6; Comeau S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011362; Cummings V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016069; Dierssen HM, 2010, P NATL ACAD SCI USA, V107, P17073, DOI 10.1073/pnas.0913800107; Dymowska A, J EXP BIOL IN PRESS; Falk-Petersen S, 2001, POLAR BIOL, V24, P163, DOI 10.1007/s003000000190; Feely RA, 2004, SCIENCE, V305, P362, DOI 10.1126/science.1097329; Feldman GC, 2009, OCEAN COLOR WEB SEAW; Guppy M, 1999, BIOL REV, V74, P1, DOI 10.1017/S0006323198005258; Hendriks LE, 2010, SCIENCE, V86, P157; Hofmann GE, 2010, ANNU REV ECOL EVOL S, V41, P127, DOI 10.1146/annurev.ecolsys.110308.120227; Hunt BPV, 2008, PROG OCEANOGR, V78, P193, DOI 10.1016/j.pocean.2008.06.001; Hunt BM, 2003, ANTARCT SCI, V15, P333, DOI 10.1017/S0954102003001342; Hunt BPV, 2010, PLOS ONE, V5, P1; Lischka S, 2011, BIOGEOSCIENCES, V8, P919, DOI 10.5194/bg-8-919-2011; Maas AE, 2011, MAR ECOL PROG SER, V441, P129, DOI 10.3354/meps09358; McCue MD, 2006, COMP BIOCHEM PHYS A, V144, P381, DOI 10.1016/j.cbpa.2006.03.011; McNeil B, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL044597; McNeil BI, 2008, P NATL ACAD SCI USA, V105, P18860, DOI 10.1073/pnas.0806318105; Melzner F, 2009, BIOGEOSCIENCES, V6, P2313, DOI 10.5194/bg-6-2313-2009; Montes-Hugo MA, 2008, DEEP-SEA RES PT II, V55, P2106, DOI 10.1016/j.dsr2.2008.04.036; Orr JC, 2005, NATURE, V437, P681, DOI 10.1038/nature04095; Pierrot DEL, 2010, ORNLCDIAC105 US DEP; Portner HO, 1998, J EXP BIOL, V201, P43; Riebesell U., 2010, GUIDE BEST PRACTICES, DOI 10.2777/58454; Ries JB, 2009, GEOLOGY, V37, P1131, DOI 10.1130/G30210A.1; Rosenthal JJC, 2009, P NATL ACAD SCI USA, V106, P6192, DOI 10.1073/pnas.0901321106; Schofield O, 2010, SCIENCE, V328, P1520, DOI 10.1126/science.1185779; Seibel BA, 2003, BIOL BULL-US, V205, P93, DOI 10.2307/1543229; Seibel BA, 2003, ADV APPL BIODIVERSIT, V4, P59; Seibel BA, 2007, INTEGR COMP BIOL, V47, P880, DOI 10.1093/icb/icm089; Seibel BA, 2011, J EXP BIOL, V214, P326, DOI 10.1242/jeb.049171; Smith WO, 2011, PROG OCEANOGR, V88, P28, DOI 10.1016/j.pocean.2010.08.002; Stumpp M, 2011, COMP BIOCHEM PHYS A, V160, P331, DOI 10.1016/j.cbpa.2011.06.022; Tortell PD, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2007GL032583; Wood HL, 2008, P ROY SOC B-BIOL SCI, V275, P1767, DOI 10.1098/rspb.2008.0343	38	78	81	1	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2012	7	4							e30464	10.1371/journal.pone.0030464	http://dx.doi.org/10.1371/journal.pone.0030464			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UD	22536312	Green Published, gold			2022-12-25	WOS:000305339200002
J	Wang, L; Hurley, DG; Watkins, W; Araki, H; Tamada, Y; Muthukaruppan, A; Ranjard, L; Derkac, E; Imoto, S; Miyano, S; Crampin, EJ; Print, CG				Wang, Li; Hurley, Daniel G.; Watkins, Wendy; Araki, Hiromitsu; Tamada, Yoshinori; Muthukaruppan, Anita; Ranjard, Louis; Derkac, Eliane; Imoto, Seiya; Miyano, Satoru; Crampin, Edmund J.; Print, Cristin G.			Cell Cycle Gene Networks Are Associated with Melanoma Prognosis	PLOS ONE			English	Article							EXPRESSION SIGNATURES; TRANSCRIPTION FACTOR; MALIGNANT-MELANOMA; CUTANEOUS MELANOMA; SIGNALING PATHWAYS; TUMOR PROGRESSION; CLINICAL ACTIVITY; MITF; BRAF; MUTATIONS	Background: Our understanding of the molecular pathways that underlie melanoma remains incomplete. Although several published microarray studies of clinical melanomas have provided valuable information, we found only limited concordance between these studies. Therefore, we took an in vitro functional genomics approach to understand melanoma molecular pathways. Methodology/Principal Findings: Affymetrix microarray data were generated from A375 melanoma cells treated in vitro with siRNAs against 45 transcription factors and signaling molecules. Analysis of this data using unsupervised hierarchical clustering and Bayesian gene networks identified proliferation-association RNA clusters, which were co-ordinately expressed across the A375 cells and also across melanomas from patients. The abundance in metastatic melanomas of these cellular proliferation clusters and their putative upstream regulators was significantly associated with patient prognosis. An 8-gene classifier derived from gene network hub genes correctly classified the prognosis of 23/26 metastatic melanoma patients in a cross-validation study. Unlike the RNA clusters associated with cellular proliferation described above, co-ordinately expressed RNA clusters associated with immune response were clearly identified across melanoma tumours from patients but not across the siRNA-treated A375 cells, in which immune responses are not active. Three uncharacterised genes, which the gene networks predicted to be upstream of apoptosis-or cellular proliferation-associated RNAs, were found to significantly alter apoptosis and cell number when over-expressed in vitro. Conclusions/Significance: This analysis identified co-expression of RNAs that encode functionally-related proteins, in particular, proliferation-associated RNA clusters that are linked to melanoma patient prognosis. Our analysis suggests that A375 cells in vitro may be valid models in which to study the gene expression modules that underlie some melanoma biological processes (e. g., proliferation) but not others (e. g., immune response). The gene expression modules identified here, and the RNAs predicted by Bayesian network inference to be upstream of these modules, are potential prognostic biomarkers and drug targets.	[Wang, Li; Hurley, Daniel G.; Watkins, Wendy; Araki, Hiromitsu; Muthukaruppan, Anita; Print, Cristin G.] Univ Auckland, Fac Med & Hlth Sci, Sch Med Sci, Dept Mol Med & Pathol, Auckland 1, New Zealand; [Hurley, Daniel G.; Crampin, Edmund J.] Univ Auckland, Auckland Bioengn Inst, Auckland 1, New Zealand; [Tamada, Yoshinori; Imoto, Seiya; Miyano, Satoru] Univ Tokyo, Ctr Human Genome, Inst Med Sci, Lab DNA Informat Anal, Tokyo, Japan; [Araki, Hiromitsu; Tamada, Yoshinori] GNI Ltd, Shinjuku Ku, Tokyo, Japan; [Ranjard, Louis; Derkac, Eliane; Print, Cristin G.] Univ Auckland, Bioinformat Inst, Auckland 1, New Zealand; [Crampin, Edmund J.] Univ Auckland, Dept Engn Sci, Auckland 1, New Zealand	University of Auckland; University of Auckland; University of Tokyo; University of Auckland; University of Auckland	Print, CG (corresponding author), Univ Auckland, Fac Med & Hlth Sci, Sch Med Sci, Dept Mol Med & Pathol, Auckland 1, New Zealand.	c.print@auckland.ac.nz	Tamada, Yoshinori/AAY-4542-2020; Ranjard, Louis/M-4525-2015	Tamada, Yoshinori/0000-0003-3483-9712; Ranjard, Louis/0000-0002-7622-4823; Print, Cristin/0000-0001-8345-7812; Miyano, Satoru/0000-0002-1753-6616; Hurley, Daniel Glyn/0000-0003-0171-1982; Muthukaruppan, Anitadevi/0000-0002-6330-1594	University of Auckland [23285]; Maurice Wilkins Centre for BioDiscovery Scholarship; Health Research Council of New Zealand [06/581]; Marsden Fund [06-UoA182]; University of Auckland FMHS (Faculty of Medical and Health Sciences) [8303460]	University of Auckland; Maurice Wilkins Centre for BioDiscovery Scholarship; Health Research Council of New Zealand(Health Research Council of New Zealand); Marsden Fund(Royal Society of New ZealandMarsden Fund (NZ)); University of Auckland FMHS (Faculty of Medical and Health Sciences)	GNI Ltd, who provided a subset of the siRNA reagents used for this study, were shown the manuscript before submission as a matter of courtesy but played no role in its preparation. Funding for this research included University of Auckland Doctorate scholarships for DGH and LW, a Maurice Wilkins Centre for BioDiscovery Scholarship for DGH, Health Research Council of New Zealand (06/581), The Marsden Fund (06-UoA182), University of Auckland FMHS (Faculty of Medical and Health Sciences) Development Fund (8303460), and University of Auckland VCDF (Vice Chancellor Development Fund) (23285). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akslen LA, 2005, J INVEST DERMATOL, V125, P312, DOI 10.1111/j.0022-202X.2005.23788.x; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Avril MF, 2004, J CLIN ONCOL, V22, P1118, DOI 10.1200/JCO.2004.04.165; Balch CM, 2009, J CLIN ONCOL, V27, P6199, DOI 10.1200/JCO.2009.23.4799; Bansal M, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100120; BATAILLE V, 1995, BRIT J DERMATOL, V132, P134, DOI 10.1111/j.1365-2133.1995.tb08639.x; Benjamini Y, 2001, BEHAV BRAIN RES, V125, P279, DOI 10.1016/S0166-4328(01)00297-2; Berd D, 2004, J CLIN ONCOL, V22, P403, DOI 10.1200/JCO.2004.06.043; Bild AH, 2006, NATURE, V439, P353, DOI 10.1038/nature04296; Bilican B, 2006, EXP CELL RES, V312, P2358, DOI 10.1016/j.yexcr.2006.03.033; Bittner M, 2000, NATURE, V406, P536, DOI 10.1038/35020115; Bogunovic D, 2009, P NATL ACAD SCI USA, V106, P20429, DOI 10.1073/pnas.0905139106; Bollag G, 2010, NATURE, V467, P596, DOI 10.1038/nature09454; Bondurand N, 2000, HUM MOL GENET, V9, P1907, DOI 10.1093/hmg/9.13.1907; Brahmer JR, 2010, J CLIN ONCOL, V28, P3167, DOI 10.1200/JCO.2009.26.7609; Butte AJ, 2000, P NATL ACAD SCI USA, V97, P12182, DOI 10.1073/pnas.220392197; Carreira S, 2005, NATURE, V433, P764, DOI 10.1038/nature03269; Ch'ng S, 2009, FRONT BIOSCI-LANDMRK, V14, P918, DOI 10.2741/3286; Chang JT, 2006, BIOINFORMATICS, V22, P2926, DOI 10.1093/bioinformatics/btl483; Cheli Y, 2011, ONCOGENE, V30, P2307, DOI 10.1038/onc.2010.598; Chowdhery R, 2011, IMMUNOTHERAPY-UK, V3, P17, DOI 10.2217/IMT.10.89; Dai DL, 2005, J CLIN ONCOL, V23, P1473, DOI 10.1200/JCO.2005.07.168; Dhomen N, 2009, HEMATOL ONCOL CLIN N, V23, P529, DOI 10.1016/j.hoc.2009.04.001; Dong JL, 2003, CANCER RES, V63, P3883; Du JY, 2004, CANCER CELL, V6, P565, DOI 10.1016/j.ccr.2004.10.014; Firoz EF, 2009, CLIN CANCER RES, V15, P2573, DOI 10.1158/1078-0432.CCR-08-2678; Gajewski TF, 2010, CANCER J, V16, P399, DOI 10.1097/PPO.0b013e3181eacbd8; Garraway LA, 2005, NATURE, V436, P117, DOI 10.1038/nature03664; GIARD DJ, 1973, J NATL CANCER I, V51, P1417, DOI 10.1093/jnci/51.5.1417; Goldstein AM, 2007, J MED GENET, V44, P99, DOI 10.1136/jmg.2006.043802; Goldstein AM, 2000, J NATL CANCER I, V92, P1006, DOI 10.1093/jnci/92.12.1006; Goodall J, 2008, CANCER RES, V68, P7788, DOI 10.1158/0008-5472.CAN-08-1053; Halaban R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004563; Haqq C, 2005, P NATL ACAD SCI USA, V102, P6092, DOI 10.1073/pnas.0501564102; Hatanaka Yosuke, 2008, Genome Inform, V20, P212; Hodi FS, 2010, NEW ENGL J MED, V363, P711, DOI 10.1056/NEJMoa1003466; Hoek K, 2004, CANCER RES, V64, P5270, DOI 10.1158/0008-5472.CAN-04-0731; Hoek KS, 2009, GIORN ITAL DERMAT V, V144, P39; Hoek KS, 2006, PIGM CELL RES, V19, P290, DOI 10.1111/j.1600-0749.2006.00322.x; Imoto Seiya, 2006, Pac Symp Biocomput, P559; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Jaeger J, 2007, CLIN CANCER RES, V13, P806, DOI 10.1158/1078-0432.CCR-06-1820; Jeffs AR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008461; John T, 2008, CLIN CANCER RES, V14, P5173, DOI 10.1158/1078-0432.CCR-07-4170; Jung CR, 2006, NAT MED, V12, P809, DOI 10.1038/nm1440; Kanehisa M, 2010, NUCLEIC ACIDS RES, V38, pD355, DOI 10.1093/nar/gkp896; Kanehisa M, 2006, NUCLEIC ACIDS RES, V34, pD354, DOI 10.1093/nar/gkj102; Kaufman L., 1990, FINDING GROUPS DATA, DOI 10.1002/9780470316801; Klebanov L, 2007, BIOL DIRECT, V2, DOI 10.1186/1745-6150-2-28; Kunz M, 2008, SEMIN CUTAN MED SURG, V27, P16, DOI 10.1016/j.sder.2007.12.004; Lamb J, 2006, SCIENCE, V313, P1929, DOI 10.1126/science.1132939; Lee HK, 2004, GENOME RES, V14, P1085, DOI 10.1101/gr.1910904; Lopez-Bergami P, 2007, CANCER CELL, V11, P447, DOI 10.1016/j.ccr.2007.03.009; Mandruzzato S, 2006, J TRANSL MED, V4, DOI 10.1186/1479-5876-4-50; Marot G, 2009, BIOINFORMATICS, V25, P2692, DOI 10.1093/bioinformatics/btp444; Matys V, 2003, NUCLEIC ACIDS RES, V31, P374, DOI 10.1093/nar/gkg108; Meyle KD, 2009, HUM GENET, V126, P499, DOI 10.1007/s00439-009-0715-9; Nambiar S, 2008, CURR MOL MED, V8, P235, DOI 10.2174/156652408784221333; Neagu M, 2010, EXPERT REV MOL DIAGN, V10, P897, DOI [10.1586/erm.10.81, 10.1586/ERM.10.81]; New Zealand Ministry of Health, 2010, CANC NEW REG DEATHS; Obayashi T, 2011, NUCLEIC ACIDS RES, V39, pD1016, DOI 10.1093/nar/gkq1147; Obayashi T, 2009, DNA RES, V16, P249, DOI 10.1093/dnares/dsp016; Okoniewski MJ, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-276; Parman C, 2006, AFFYQCREPORT PACKAGE; Ren Suping, 2008, Cancer Control, V15, P202; Ribas A, 2010, J TRANSL MED, V8, DOI 10.1186/1479-5876-8-89; Riker AI, 2008, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-13; RYAN RF, 1988, J SURG ONCOL, V38, P250, DOI 10.1002/jso.2930380409; Salti GI, 2000, CANCER RES, V60, P5012; Smith AP, 2005, CANCER BIOL THER, V4, P1018, DOI 10.4161/cbt.4.9.2165; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Song S, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-502; Stambolic V, 1998, CELL, V95, P29, DOI 10.1016/S0092-8674(00)81780-8; Stuart JM, 2003, SCIENCE, V302, P249, DOI 10.1126/science.1087447; Talantov D, 2005, CLIN CANCER RES, V11, P7234, DOI 10.1158/1078-0432.CCR-05-0683; Tamada Y, 2011, IEEE ACM T COMPUT BI, V8, P683, DOI 10.1109/TCBB.2010.68; Tibshirani R, 2002, P NATL ACAD SCI USA, V99, P6567, DOI 10.1073/pnas.082099299; Timar J, 2010, CLIN EXP METASTAS, V27, P371, DOI 10.1007/s10585-010-9307-2; vanElsas A, 1996, AM J PATHOL, V149, P883; Viswanathan GA, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.0040016; Winnepenninckx VR, 2006, JNCI-J NATL CANCER I, V98, P472, DOI 10.1093/jnci/djj103; Wu H, 2003, ONCOGENE, V22, P3113, DOI 10.1038/sj.onc.1206451; Xu L, 2008, MOL CANCER RES, V6, P760, DOI 10.1158/1541-7786.MCR-07-0344	83	24	26	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2012	7	4							e34247	10.1371/journal.pone.0034247	http://dx.doi.org/10.1371/journal.pone.0034247			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UD	22536322	Green Published, gold			2022-12-25	WOS:000305339200010
J	Liu, JY; Zhang, DY; Luo, WJ; Yu, JX; Li, JX; Yu, YH; Zhang, XH; Chen, JY; Wu, XR; Huang, CS				Liu, Jinyi; Zhang, Dongyun; Luo, Wenjing; Yu, Jianxiu; Li, Jingxia; Yu, Yonghui; Zhang, Xinhai; Chen, Jingyuan; Wu, Xue-Ru; Huang, Chuanshu			E3 Ligase Activity of XIAP RING Domain Is Required for XIAP-Mediated Cancer Cell Migration, but Not for Its RhoGDI Binding Activity	PLOS ONE			English	Article							X-LINKED INHIBITOR; GDP-DISSOCIATION INHIBITOR; APOPTOSIS PROTEIN XIAP; IAP FAMILY PROTEINS; EXPRESSION; MOTILITY; METASTASIS; SURVIVIN; CLEAVAGE; GROWTH	Although an increased expression level of XIAP is associated with cancer cell metastasis, the underlying molecular mechanisms remain largely unexplored. To verify the specific structural basis of XIAP for regulation of cancer cell migration, we introduced different XIAP domains into XIAP(-/-) HCT116 cells, and found that reconstitutive expression of full length HA-XIAP and HA-XIAP Delta BIR, both of which have intact RING domain, restored beta-Actin expression, actin polymerization and cancer cell motility. Whereas introduction of HA-XIAP Delta RING or H467A mutant, which abolished its E3 ligase function, did not show obvious restoration, demonstrating that E3 ligase activity of XIAP RING domain played a crucial role of XIAP in regulation of cancer cell motility. Moreover, RING domain rather than BIR domain was required for interaction with RhoGDI independent on its E3 ligase activity. To sum up, our present studies found that role of XIAP in regulating cellular motility was uncoupled from its caspase-inhibitory properties, but related to physical interaction between RhoGDI and its RING domain. Although E3 ligase activity of RING domain contributed to cell migration, it was not involved in RhoGDI binding nor its ubiquitinational modification.	[Liu, Jinyi; Zhang, Dongyun; Yu, Jianxiu; Li, Jingxia; Yu, Yonghui; Zhang, Xinhai; Huang, Chuanshu] NYU, Sch Med, Nelson Inst Environm Med, Tuxedo Pk, NY USA; [Luo, Wenjing; Chen, Jingyuan] Fourth Mil Med Univ, Dept Occupat & Environm Hlth Sci, Xian, Shanxi, Peoples R China; [Wu, Xue-Ru] NYU, Sch Med, Dept Urol & Pathol, Tuxedo Pk, NY USA	New York University; Air Force Military Medical University; New York University	Liu, JY (corresponding author), NYU, Sch Med, Nelson Inst Environm Med, Tuxedo Pk, NY USA.	chuanshu.huang@nyumc.org	Yu, Yonghui/AAZ-4093-2021	Huang, Chuanshu/0000-0003-4133-5096; Wu, Xue-Ru/0000-0001-6058-6291	United States National Institutes of Health/NCI [CA112557, CA119028-05S110]; NIH/NIEHS [ES012451, ES010344]; NATIONAL CANCER INSTITUTE [R01CA119028, R01CA112557] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES012451, P42ES010344] Funding Source: NIH RePORTER	United States National Institutes of Health/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH/NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	Funding was provided by United States National Institutes of Health/NCI CA112557 and CA119028-05S110, NIH/NIEHS ES012451, and ES010344. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adra CN, 1997, P NATL ACAD SCI USA, V94, P4279, DOI 10.1073/pnas.94.9.4279; Akyurek N, 2006, CANCER-AM CANCER SOC, V107, P1844, DOI 10.1002/cncr.22219; Burstein E, 2004, EMBO J, V23, P244, DOI 10.1038/sj.emboj.7600031; Chan AY, 1998, J CELL SCI, V111, P199; Cummins JM, 2004, CANCER RES, V64, P3006, DOI 10.1158/0008-5472.CAN-04-0046; del Peso L, 1997, ONCOGENE, V15, P3047; DerMardirossian C, 2005, TRENDS CELL BIOL, V15, P356, DOI 10.1016/j.tcb.2005.05.001; Deveraux QL, 1999, GENE DEV, V13, P239, DOI 10.1101/gad.13.3.239; Dogan T, 2008, NAT CELL BIOL, V10, P1447, DOI 10.1038/ncb1804; Dovas A, 2005, BIOCHEM J, V390, P1, DOI 10.1042/BJ20050104; Duckett CS, 1996, EMBO J, V15, P2685, DOI 10.1002/j.1460-2075.1996.tb00629.x; FIDLER IJ, 1990, CANCER RES, V50, P6130; Fong WG, 2000, GENOMICS, V70, P113, DOI 10.1006/geno.2000.6364; Harlin H, 2001, MOL CELL BIOL, V21, P3604, DOI 10.1128/MCB.21.10.3604-3608.2001; Jost PJ, 2009, NATURE, V460, P1035, DOI 10.1038/nature08229; Kaur S, 2005, J BIOL CHEM, V280, P38599, DOI 10.1074/jbc.M505671200; Kjoller L, 1999, EXP CELL RES, V253, P166, DOI 10.1006/excr.1999.4674; Kleinberg L, 2007, AM J CLIN PATHOL, V128, P389, DOI 10.1309/E899BG1282M5D505; Kleinberg L, 2007, CANCER, V109, P228, DOI 10.1002/cncr.22426; Kluger HM, 2007, J TRANSL MED, V5, DOI 10.1186/1479-5876-5-6; LEFFERS H, 1993, EXP CELL RES, V209, P165, DOI 10.1006/excr.1993.1298; Levkau B, 2001, CIRC RES, V88, P282, DOI 10.1161/01.RES.88.3.282; Lewis J, 2004, J BIOL CHEM, V279, P9023, DOI 10.1074/jbc.M312891200; Li M, 2007, CHINESE MED J-PEKING, V120, P469, DOI 10.1097/00029330-200703020-00007; Lin M, 2004, BREAST CANCER RES TR, V84, P49, DOI 10.1023/B:BREA.0000018424.43445.f3; Liston P, 1996, NATURE, V379, P349, DOI 10.1038/379349a0; Liu JY, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.176982; Mehrotra S, 2010, CANCER CELL, V17, P53, DOI 10.1016/j.ccr.2009.11.021; MIURA Y, 1993, J BIOL CHEM, V268, P510; Nagi C, 2007, ANN DIAGN PATHOL, V11, P402, DOI 10.1016/j.anndiagpath.2006.12.012; Nemoto T, 2004, EXP MOL PATHOL, V76, P253, DOI 10.1016/j.yexmp.2004.01.001; Ouyang WM, 2009, J CELL PHYSIOL, V218, P205, DOI 10.1002/jcp.21590; Schile AJ, 2008, GENE DEV, V22, P2256, DOI 10.1101/gad.1663108; Schimmer AD, 2006, CELL DEATH DIFFER, V13, P179, DOI 10.1038/sj.cdd.4401826; Schimmer AD, 2005, HEMATOL-AM SOC HEMAT, V2005, P215, DOI DOI 10.1182/asheducation.V2005.1.215.215; Shan DD, 2005, P NATL ACAD SCI USA, V102, P3772, DOI 10.1073/pnas.0500658102; Srinivasula SM, 2008, MOL CELL, V30, P123, DOI 10.1016/j.molcel.2008.03.008; Staiger CJ, 2006, CURR OPIN PLANT BIOL, V9, P554, DOI 10.1016/j.pbi.2006.09.013; Taniuchi S, 1999, PEDIATR INT, V41, P37; Wittmann T, 2001, J CELL SCI, V114, P3795; Yang L, 2003, CANCER RES, V63, P6815; Yang YL, 2000, CELL RES, V10, P169, DOI 10.1038/sj.cr.7290046; Zhang BL, 2005, CANCER RES, V65, P6054, DOI 10.1158/0008-5472.CAN-05-0175	43	32	33	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2012	7	4							e35682	10.1371/journal.pone.0035682	http://dx.doi.org/10.1371/journal.pone.0035682			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TL	22532870	Green Published, gold, Green Submitted			2022-12-25	WOS:000305336200066
J	Bermudez, V; Pacheco, M; Rojas, J; Cordova, E; Velazquez, R; Carrillo, D; Parra, MG; Toledo, A; Anez, R; Fonseca, E; Marcano, RP; Cano, C; Miranda, JL				Bermudez, Valmore; Pacheco, Maikol; Rojas, Joselyn; Cordova, Evelyn; Velazquez, Rossibel; Carrillo, Daniela; Parra, Maria G.; Toledo, Alexandra; Anez, Roberto; Fonseca, Eneida; Paris Marcano, Rafael; Cano, Climaco; Lopez Miranda, Jose			Epidemiologic Behavior of Obesity in the Maracaibo City Metabolic Syndrome Prevalence Study	PLOS ONE			English	Article							WAIST CIRCUMFERENCE CUTOFFS; INSULIN-RESISTANCE; BODY-COMPOSITION; LATIN-AMERICA; WEIGHT-GAIN; CARDIOVASCULAR-DISEASE; NATIONAL-HEALTH; US ADULTS; OVERWEIGHT; POVERTY	Introduction: Obesity is a worldwide public health issue. Since the epidemiological behaviour of this disease is not well established in our country, the purpose of this study was to determinate its prevalence in the Maracaibo City, Zulia State-Venezuela. Materials and Methods: A cross-sectional study was undertaken using the data set from the Maracaibo City Metabolic Syndrome Prevalence Study. The sample consists of 2108 individuals from both genders and randomly selected: 1119 (53.09%) women and 989 (46.91%) men. The participants were interrogated for a complete clinical history and anthropometric measurements. To classify obesity, the WHO criteria for Body Mass Index (BMI), and Waist Circumference (WC) from the IDF/NHLBI/AHA/WHF/IAS/IASO-2009 (IDF-2009) and ATPIII statements were applied. Results: For BMI, obesity had an overall prevalence of 33.3% (n = 701), and according to gender women had 32.4% (n = 363) and men had 34.2% (n = 338). Overweight had a prevalence of 34.8% (n = 733), Normal weight had 29.8% (n = 629), and Underweight had 2.1% (n = 45). Adding Obesity and Overweight results, the prevalence of elevated BMI (>25 Kg/m(2)) was 68.1%. Using the IDF-2009 WC's cut-off, Obesity had 74.2% prevalence, compared to 51.7% using the ATPIII parameters. Conclusions: These results show a high prevalence of abdominal obesity in our locality defined by the WHO, IDF-2009 and ATPIII criteria, which were not designed for Latin-American populations. We suggest further investigation to estimate the proper values according to ethnicity, genetic background and sociocultural aspects.	[Bermudez, Valmore; Pacheco, Maikol; Rojas, Joselyn; Velazquez, Rossibel; Carrillo, Daniela; Parra, Maria G.; Toledo, Alexandra; Anez, Roberto; Fonseca, Eneida; Paris Marcano, Rafael; Cano, Climaco] Univ Zulia, Fac Med, Endocrine & Metab Dis Res Ctr, Maracaibo 4011, Venezuela; [Cordova, Evelyn] Univ Zulia, Sch Econ, Quantitat Methods Dept, Maracaibo 4011, Venezuela; [Lopez Miranda, Jose] Univ Cordoba, Dept Med, Reina Sofia Univ Hosp, Lipid & Atherosclerosis Unit,IMIBIC, Cordoba, Spain; [Lopez Miranda, Jose] Inst Salud Carlos III, CIBER Fisiopatol Obesidad & Nutr CIBEROBN, Cordoba, Spain	Universidad de Cordoba; CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; Instituto de Salud Carlos III	Bermudez, V (corresponding author), Univ Zulia, Fac Med, Endocrine & Metab Dis Res Ctr, Maracaibo 4011, Venezuela.	valmore@gmail.com	Bermudez, Valmore/E-3517-2018; Bermudez, Valmore/K-4721-2019; Anez, Roberto/E-1049-2018	Bermudez, Valmore/0000-0003-1880-8887; Bermudez, Valmore/0000-0003-1880-8887; Rojas-Quintero, Joselyn Joanna/0000-0003-4994-075X; Anez, Roberto/0000-0001-6363-2767	Endocrine and Metabolic Diseases Research Center, The University of Zulia, Medicine Faculty, Maracaibo, Venezuela	Endocrine and Metabolic Diseases Research Center, The University of Zulia, Medicine Faculty, Maracaibo, Venezuela	The funds for the research were provided by the Endocrine and Metabolic Diseases Research Center, The University of Zulia, Medicine Faculty, Maracaibo, Venezuela. The money comes from the Clinical Practice and Clinical Laboratory income. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ades PA, 2001, NEW ENGL J MED, V345, P892, DOI 10.1056/NEJMra001529; Alberti KGMM, 2009, CIRCULATION, V120, P1640, DOI 10.1161/CIRCULATIONAHA.109.192644; Banerji MA, 1999, J CLIN ENDOCR METAB, V84, P137, DOI 10.1210/jc.84.1.137; BAUMGARTNER RN, 1995, J GERONTOL A-BIOL, V50, pM307, DOI 10.1093/gerona/50A.6.M307; Bemstein A, 2008, REV PANAM SALUD PUBL, V24, P71; Bermudez Odilia I., 2003, Cad. Saúde Pública, V19, pS87, DOI 10.1590/S0102-311X2003000700010; Bermudez V, 2010, AM J THER, V17, P288, DOI 10.1097/MJT.0b013e3181c121bc; Burkhauser RV, 2008, J HEALTH ECON, V27, P519, DOI 10.1016/j.jhealeco.2007.05.005; Campos Gilberto, 2003, Invest. clín, V44, P5; Centers for Disease Control Fact Sheet, 2003, CTR DIS CONTR FACT S; Diaz J, 2005, HABITOS ALIMENTARIOS; Drewnowski A, 2004, AM J CLIN NUTR, V79, P6; Espinoza M, 2009, REV MED CHILE, V137, P1179, DOI /S0034-98872009000900006; Flegal KM, 2010, JAMA-J AM MED ASSOC, V303, P235, DOI 10.1001/jama.2009.2014; Gigante DP, 2009, REV SAUDE PUBL, V43, P83, DOI 10.1590/S0034-89102009000900011; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Health Statistics, 1996, NHANES 3 REF MAN REP; IBÁÑEZ A LUIS, 2007, Rev Chil Cir, V59, P399, DOI 10.4067/S0718-40262007000600001; Instituto Brasileiro de Geografia e Estatistica, 2004, PESQ ORC FAM 2002 20; Kain Juliana, 2003, Cad. Saúde Pública, V19, pS77, DOI 10.1590/S0102-311X2003000700009; KUCZMARSKI RJ, 1994, JAMA-J AM MED ASSOC, V272, P205, DOI 10.1001/jama.272.3.205; MALINA RM, 1995, INT J OBESITY, V19, P793; McLaren L, 2007, EPIDEMIOL REV, V29, P29, DOI 10.1093/epirev/mxm001; Mendez-Castellano H., 1986, VENEZUELAN ARCH CHIL, V49, P93; Misra A, 2005, NUTRITION, V21, P969, DOI 10.1016/j.nut.2005.01.007; Neufeld LM, 2008, OBESITY, V16, P714, DOI 10.1038/oby.2007.119; Novotny R, 2007, OBESITY, V15, P1565, DOI 10.1038/oby.2007.185; Núñez Roberto, 2006, AVFT, V25, P64; Okosun IS, 2000, J CLIN EPIDEMIOL, V53, P401, DOI 10.1016/S0895-4356(99)00217-6; Okosun IS, 2000, ANN EPIDEMIOL, V10, P263, DOI 10.1016/S1047-2797(00)00045-4; Omran AR, 1996, EPIDEMIOLOGIC TRANSI; Pena M, 2000, PAHO, Vxi, P3; Perez B, EFECTOS URBANIZACION; Pi-Sunyer FX, 1998, OBES RES, V6, p51S; Raji A, 2001, J CLIN ENDOCR METAB, V86, P5366, DOI 10.1210/jc.86.11.5366; Raymond SU, 2006, CURR OPIN CLIN NUTR, V9, P111, DOI 10.1097/01.mco.0000214568.52192.91; Rojas R, 2010, SALUD PUBLICA MEXICO, V52, pS11, DOI 10.1590/s0036-36342010000700004; Rosenberg L, 2003, OBES RES, V11, P1526, DOI 10.1038/oby.2003.204; Rosengren A, 1999, EUR HEART J, V20, P269, DOI 10.1053/euhj.1998.1235; Roubenoff R, 2000, J GERONTOL A-BIOL, V55, pM716, DOI 10.1093/gerona/55.12.M716; Ruiz-Fernández Nelina, 2009, Rev. salud pública, V11, P383, DOI 10.1590/S0124-00642009000300007; Ryder Elena, 2007, Invest. clín, V48, P45; Salzano FM, 2004, REV BIOL TROP, V52, P405; Sans M, 2000, HUM BIOL, V72, P155; Seidell JC, 1997, BRIT MED BULL, V53, P238, DOI 10.1093/oxfordjournals.bmb.a011611; Tanumihardjo SA, 2007, J AM DIET ASSOC, V107, P1966, DOI 10.1016/j.jada.2007.08.007; Uauy R, 2001, J NUTR, V131, p893S, DOI 10.1093/jn/131.3.893S; Velasco-Martinez RM, 2009, NUTR HOSP, V24, P187; Villareal DT, 2004, OBES RES, V12, P913, DOI 10.1038/oby.2004.111; Wannamethee SG, 2003, AM J CLIN NUTR, V77, P1312, DOI 10.1093/ajcn/77.5.1312; *WHO, WORLD HLTH REP 2003; Wildman RP, 2004, AM J CLIN NUTR, V80, P1129, DOI 10.1093/ajcn/80.5.1129; WILLIAMSON DF, 1991, NEW ENGL J MED, V324, P739, DOI 10.1056/NEJM199103143241106; Zhu SK, 2005, AM J CLIN NUTR, V81, P409	54	19	24	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2012	7	4							e35392	10.1371/journal.pone.0035392	http://dx.doi.org/10.1371/journal.pone.0035392			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959XD	22530014	gold, Green Published			2022-12-25	WOS:000305350600079
J	Lee, YK; Lee, KH; Kim, SG; Melhem, R; Moon, CS; Liu, SC; Greenhalgh, DG; Cho, KH				Lee, Young-Kwan; Lee, Kang-Hoon; Kim, Seon-Gyu; Melhem, Ramzi; Moon, Chang-Suk; Liu, Sicong; Greenhalgh, David G.; Cho, Kiho			Unique Profile of Ordered Arrangements of Repetitive Elements in the C57BL/6J Mouse Genome Implicating Their Functional Roles	PLOS ONE			English	Article							DNA REPEATS; PROTEIN; SEQUENCES; GENES; ONCOGENE; FAMILY	The entirety of all protein coding sequences is reported to represent a small fraction (similar to 2%) of the mouse and human genomes; the vast majority of the rest of the genome is presumed to be repetitive elements (REs). In this study, the C57BL/6J mouse reference genome was subjected to an unbiased RE mining to establish a whole-genome profile of RE occurrence and arrangement. The C57BL/6J mouse genome was fragmented into an initial set of 5,321 units of 0.5 Mb, and surveyed for REs using unbiased self-alignment and dot-matrix protocols. The survey revealed that individual chromosomes had unique profiles of RE arrangement structures, named RE arrays. The RE populations in certain genomic regions were arranged into various forms of complexly organized structures using combinations of direct and/or inverse repeats. Some of these RE arrays spanned stretches of over 2 Mb, which may contribute to the structural configuration of the respective genomic regions. There were substantial differences in RE density among the 21 chromosomes, with chromosome Y being the most densely populated. In addition, the RE array population in the mouse chromosomes X and Y was substantially different from those of the reference human chromosomes. Conversion of the dot-matrix data pertaining to a tandem 13-repeat structure within the Ch7.032 genome unit into a line map of known REs revealed a repeat unit of similar to 11.3 Kb as a mosaic of six different RE types. The data obtained from this study allowed for a comprehensive RE profiling, including the establishment of a library of RE arrays, of the reference mouse genome. Some of these RE arrays may participate in a spectrum of normal and disease biology that are specific for mice.	[Lee, Young-Kwan; Lee, Kang-Hoon; Kim, Seon-Gyu; Melhem, Ramzi; Moon, Chang-Suk; Liu, Sicong; Greenhalgh, David G.; Cho, Kiho] Univ Calif Davis, Shriners Hosp Children No Calif, Dept Surg, Sacramento, CA 95817 USA	University of California System; University of California Davis	Lee, YK (corresponding author), Univ Calif Davis, Shriners Hosp Children No Calif, Dept Surg, Sacramento, CA 95817 USA.	kcho@ucdavis.edu			Shriners of North America [86800, 84308, 84302]; National Institutes of Health [R01 GM071360]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071360] Funding Source: NIH RePORTER	Shriners of North America; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported, in part, by grants from Shriners of North America (No. 86800 to KC, No. 84308 to Dr. Y. Lee [postdoctoral fellowship], and No. 84302 to Dr. K. Lee [postdoctoral fellowship]) and the National Institutes of Health (R01 GM071360 to Dr. Cho). No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Batzoglou S, 2000, GENOME RES, V10, P950, DOI 10.1101/gr.10.7.950; Benson DA, 2007, NUCLEIC ACIDS RES, V35, pD21, DOI [10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkp1024, 10.1093/nar/gkw1070, 10.1093/nar/gkx1094, 10.1093/nar/gks1195, 10.1093/nar/gkr1202, 10.1093/nar/gkn723]; Bernal A, 2001, NUCLEIC ACIDS RES, V29, P126, DOI 10.1093/nar/29.1.126; Church DM, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000112; Collins FS, 2004, NATURE, V431, P931, DOI 10.1038/nature03001; Collins FS, 2003, NATURE, V422, P835, DOI 10.1038/nature01626; DUNNICK W, 1983, P NATL ACAD SCI-BIOL, V80, P7269, DOI 10.1073/pnas.80.23.7269; FEHON RG, 1990, CELL, V61, P523, DOI 10.1016/0092-8674(90)90534-L; Fondon JW, 2004, P NATL ACAD SCI USA, V101, P18058, DOI 10.1073/pnas.0408118101; GERONDAKIS S, 1984, CELL, V36, P973, DOI 10.1016/0092-8674(84)90047-3; Greenbaum D, 2001, GENOME RES, V11, P1463, DOI 10.1101/gr.207401; Janeway CA, 2001, IMMUNOBIOLOGY; Jin P, 2000, HUM MOL GENET, V9, P901, DOI 10.1093/hmg/9.6.901; Kim HM, 2010, FEBS LETT, V584, P605, DOI 10.1016/j.febslet.2009.12.005; KOOP BF, 1994, NAT GENET, V7, P48, DOI 10.1038/ng0594-48; Lage K, 2007, NAT BIOTECHNOL, V25, P309, DOI 10.1038/nbt1295; LAMERDIN JE, 1995, GENOMICS, V25, P547, DOI 10.1016/0888-7543(95)80056-R; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lee HS, 2010, FASEB J, V24, P2314, DOI 10.1096/fj.09-147314; Lee KH, 2011, EXP MOL PATHOL, V90, P300, DOI 10.1016/j.yexmp.2011.02.007; Makalowski W, 1996, GENOME RES, V6, P846, DOI 10.1101/gr.6.9.846; Makalowski W, 1998, P NATL ACAD SCI USA, V95, P9407, DOI 10.1073/pnas.95.16.9407; Mirkin SM, 2007, NATURE, V447, P932, DOI 10.1038/nature05977; Nadeau JH, 2001, SCIENCE, V291, P1251, DOI 10.1126/science.1058244; Pennisi E, 2007, SCIENCE, V316, P1556, DOI 10.1126/science.316.5831.1556; Pruitt KD, 2009, NUCLEIC ACIDS RES, V37, pD32, DOI 10.1093/nar/gkn721; Rajkovic A, 2002, GENOMICS, V79, P711, DOI 10.1006/geno.2002.6759; Richard GF, 2008, MICROBIOL MOL BIOL R, V72, P686, DOI 10.1128/MMBR.00011-08; Smit AFA, GREEN P REPEATMASKER; Tatusova TA, 1999, FEMS MICROBIOL LETT, V174, P247, DOI 10.1016/S0378-1097(99)00149-4; Thomas M, 1999, MOL CELL BIOL, V19, P1092; Wang YH, 1996, J MOL BIOL, V263, P511, DOI 10.1006/jmbi.1996.0593; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262	33	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2012	7	4							e35156	10.1371/journal.pone.0035156	http://dx.doi.org/10.1371/journal.pone.0035156			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959XD	22529984	Green Submitted, gold, Green Published			2022-12-25	WOS:000305350600062
J	Wallhausser-Franke, E; Brade, J; Balkenhol, T; D'Amelio, R; Seegmuller, A; Delb, W				Wallhaeusser-Franke, Elisabeth; Brade, Joachim; Balkenhol, Tobias; D'Amelio, Roberto; Seegmueller, Andrea; Delb, Wolfgang			Tinnitus: Distinguishing between Subjectively Perceived Loudness and Tinnitus-Related Distress	PLOS ONE			English	Article							RETRAINING THERAPY; HEARING-LOSS; SEVERITY; DEPRESSION	Objectives: Overall success of current tinnitus therapies is low, which may be due to the heterogeneity of tinnitus patients. Therefore, subclassification of tinnitus patients is expected to improve therapeutic allocation, which, in turn, is hoped to improve therapeutic success for the individual patient. The present study aims to define factors that differentially influence subjectively perceived tinnitus loudness and tinnitus-related distress. Methods: In a questionnaire-based cross-sectional survey, the data of 4705 individuals with tinnitus were analyzed. The self-report questionnaire contained items about subjective tinnitus loudness, type of onset, awareness and localization of the tinnitus, hearing impairment, chronic comorbidities, sleep quality, and psychometrically validated questionnaires addressing tinnitus-related distress, depressivity, anxiety, and somatic symptom severity. In a binary step-wise logistic regression model, we tested the predictive power of these variables on subjective tinnitus loudness and tinnitus-related distress. Results: The present data contribute to the distinction between subjective tinnitus loudness and tinnitus-related distress. Whereas subjective loudness was associated with permanent awareness and binaural localization of the tinnitus, tinnitus-related distress was associated with depressivity, anxiety, and somatic symptom severity. Conclusions: Subjective tinnitus loudness and the potential presence of severe depressivity, anxiety, and somatic symptom severity should be assessed separately from tinnitus-related distress. If loud tinnitus is the major complaint together with mild or moderate tinnitus-related distress, therapies should focus on auditory perception. If levels of depressivity, anxiety or somatic symptom severity are severe, therapies and further diagnosis should focus on these symptoms at first.	[Wallhaeusser-Franke, Elisabeth; Balkenhol, Tobias; D'Amelio, Roberto; Seegmueller, Andrea; Delb, Wolfgang] Heidelberg Univ, Med Fac Mannheim, Dept Phoniatr & Audiol, D-6800 Mannheim, Germany; [Brade, Joachim] Heidelberg Univ, Med Fac Mannheim, Dept Med Stat & Biomathemat, D-6800 Mannheim, Germany; [D'Amelio, Roberto] Univ Saarland, Univ Clin, Dept Internal Med 4, D-6650 Homburg, Germany; [D'Amelio, Roberto] Univ Saarland, Univ Clin, Neuroctr, D-6650 Homburg, Germany	Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Saarland University; Universitatsklinikum des Saarlandes; Saarland University; Universitatsklinikum des Saarlandes	Wallhausser-Franke, E (corresponding author), Heidelberg Univ, Med Fac Mannheim, Dept Phoniatr & Audiol, D-6800 Mannheim, Germany.	elisabeth.wallhaeusser@medma.uni-heidelberg.de			auric Horsysteme; Schaaf und Maier Horgerate	auric Horsysteme; Schaaf und Maier Horgerate	This work was partly supported by auric Horsysteme and Schaaf und Maier Horgerate. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AXELSSON A, 1989, British Journal of Audiology, V23, P53, DOI 10.3109/03005368909077819; D'Amelio R, 2004, HNO, V52, P599, DOI 10.1007/s00106-003-0944-5; DAUMAN R, 1992, TINNITUS 91, P225; Del Bo L, 2007, PROG BRAIN RES, V166, P341, DOI 10.1016/S0079-6123(07)66032-4; Delb W, 2002, HNO, V50, P997, DOI 10.1007/s00106-002-0645-5; Delb W, 1999, P 6 INT TINN SEM, P446; Dobie RA, 2003, OTOLARYNG CLIN N AM, V36, P383, DOI 10.1016/S0030-6665(02)00168-8; Frank E, 2012, J NEUROL, V259, P327, DOI 10.1007/s00415-011-6189-4; HALLAM RS, 1988, BRIT J CLIN PSYCHOL, V27, P213, DOI 10.1111/j.2044-8260.1988.tb00778.x; Henry J A, 2000, J Am Acad Audiol, V11, P138; Henry James A, 2008, Trends Amplif, V12, P188, DOI 10.1177/1084713808321184; Hiller W, 1997, J PSYCHOSOM RES, V43, P613, DOI 10.1016/S0022-3999(97)00188-8; Hiller W, 2005, BEHAV RES THER, V43, P595, DOI 10.1016/j.brat.2004.03.012; Hiller W, 2007, AUDIOL NEURO-OTOL, V12, P391, DOI 10.1159/000106482; Hiller W, 2006, ARCH OTOLARYNGOL, V132, P1323, DOI 10.1001/archotol.132.12.1323; Holgers KM, 2005, INT J AUDIOL, V44, P584, DOI 10.1080/14992020500190235; Jastreboff PJ, 2006, ORL-J OTO-RHIN-LARYN, V68, P23, DOI 10.1159/000090487; Jastreboff PJ, 1996, AM J OTOL, V17, P236; Kroenke K, 2002, PSYCHOSOM MED, V64, P258, DOI 10.1097/00006842-200203000-00008; Kroenke K, 2010, GEN HOSP PSYCHIAT, V32, P345, DOI 10.1016/j.genhosppsych.2010.03.006; Krog NH, 2010, J PSYCHOSOM RES, V69, P289, DOI 10.1016/j.jpsychores.2010.03.008; Langenbach M, 2005, GEN HOSP PSYCHIAT, V27, P73, DOI 10.1016/j.genhosppsych.2004.08.008; Langguth B, 2011, WORLD J BIOL PSYCHIA, P1; Lowe B, 2008, GEN HOSP PSYCHIAT, V30, P191, DOI 10.1016/j.genhosppsych.2008.01.001; Martinez Devesa P, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005233.pub2; Mazurek B, 2010, INT J ENV RES PUB HE, V7, P3071, DOI 10.3390/ijerph7083071; McKenna L, 1998, TINNITUS TREATMENT R, P140; Meikle Mary B, 2008, Trends Amplif, V12, P223, DOI 10.1177/1084713808319943; Newman C W, 1997, J Am Acad Audiol, V8, P143; Nondahl DM, 2011, INT J AUDIOL, V50, P313, DOI 10.3109/14992027.2010.551220; Olze H, 2012, AUDIOL NEURO-OTOL, V17, P2, DOI 10.1159/000323847; Ooms E, 2011, OTOLARYNG HEAD NECK, V145, P276, DOI 10.1177/0194599811403381; Savastano M, 2008, EUR ARCH OTO-RHINO-L, V265, P1295, DOI 10.1007/s00405-008-0630-z; Schlee W, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027379; Shargorodsky J, 2010, AM J MED, V123, P711, DOI 10.1016/j.amjmed.2010.02.015; Sindhusake D, 2003, EAR HEARING, V24, P501, DOI 10.1097/01.AUD.0000100204.08771.3D; STOUFFER JL, 1990, J SPEECH HEAR DISORD, V55, P439, DOI 10.1044/jshd.5503.439; Stouffer JL, 1990, HEAR INSTR, V41, P17; VONWEDEL H, 1989, LARYNGO RHINO OTOL, V68, P259, DOI 10.1055/s-2007-998330; Wiltink J, 2011, J AFFECT DISORDERS, V130, P429, DOI 10.1016/j.jad.2010.10.041; Zoger S, 2006, PSYCHOSOMATICS, V47, P282, DOI 10.1176/appi.psy.47.4.282	41	51	53	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2012	7	4							e34583	10.1371/journal.pone.0034583	http://dx.doi.org/10.1371/journal.pone.0034583			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959XD	22529921	Green Submitted, Green Published, gold			2022-12-25	WOS:000305350600018
J	Walther, B; Hermes, J; Cuny, C; Wieler, LH; Vincze, S; Elnaga, Y; Stamm, I; Kopp, PA; Kohn, B; Witte, W; Jansen, A; Conraths, FJ; Semmler, T; Eckmanns, T; Lubke-Becker, A				Walther, Birgit; Hermes, Julia; Cuny, Christiane; Wieler, Lothar H.; Vincze, Szilvia; Abou Elnaga, Yassmin; Stamm, Ivonne; Kopp, Peter A.; Kohn, Barbara; Witte, Wolfgang; Jansen, Andreas; Conraths, Franz J.; Semmler, Torsten; Eckmanns, Tim; Luebke-Becker, Antina			Sharing More than Friendship - Nasal Colonization with Coagulase-Positive Staphylococci (CPS) and Co-Habitation Aspects of Dogs and Their Owners	PLOS ONE			English	Article							METHICILLIN-RESISTANT; MULTIDRUG-RESISTANT; COMPANION ANIMALS; AUREUS MRSA; PET DOG; PSEUDINTERMEDIUS; INTERMEDIUS; PREVALENCE; EMERGENCE; CARRIAGE	Background: Since the relationship between dogs and their owners has changed, and dogs moved from being working dogs to family members in post-industrial countries, we hypothesized that zoonotic transmission of opportunistic pathogens like coagulase positive staphylococci (CPS) is likely between dogs and their owners. Methodology/Principal Findings: CPS- nasal carriage, different aspects of human-to-dog relationship as well as potential interspecies transmission risk factors were investigated by offering nasal swabs and a questionnaire to dog owners (108) and their dogs (108) at a dog show in 2009. S. aureus was found in swabs of 20 (18.5%) humans and two dogs (1.8%), and spa types which correspond to well known human S. aureus lineages dominated (e.g. CC45, CC30 and CC22). Multilocus sequence typing (MLST) of the two canine strains revealed ST72 and ST2065 (single locus variant of ST34). Fifteen dogs (13.9%) and six owners (5.6%) harboured S. pseudintermedius, including one mecA-positive human isolate (MRSP). Pulsed field gel electrophoresis (PFGE) revealed that one dog/owner pair harboured indistinguishable S. pseudintermedius- isolates of ST33. Ten (48%) of the 21 S. pseudintermedius-isolates showed resistance towards more than one antimicrobial class. 88.9% of the dog owners reported to allow at least one dog into the house, 68.5% allow the dog(s) to rest on the sofa, 39.8% allow their dogs to come onto the bed, 93.5% let them lick their hands and 52.8% let them lick their face. Bivariate analysis of putative risk factors revealed that dog owners who keep more than two dogs have a significantly higher chance of being colonized with S. pseudintermedius than those who keep 1-2 dogs (p < 0.05). Conclusions/Recommendations: In conclusion, CPS transmission between dog owners and their dogs is possible. Further investigation regarding interspecies transmission and the diverse adaptive pathways influencing the epidemiology of CPS (including MRSA and MRSP) in different hosts is needed.	[Walther, Birgit; Wieler, Lothar H.; Vincze, Szilvia; Abou Elnaga, Yassmin; Semmler, Torsten; Luebke-Becker, Antina] Free Univ Berlin, Fac Vet, Inst Microbiol & Epizoot, Berlin, Germany; [Hermes, Julia; Jansen, Andreas; Eckmanns, Tim] Robert Koch Inst, Dept Infect Dis Epidemiol, Berlin, Germany; [Cuny, Christiane; Witte, Wolfgang] Robert Koch Inst, Natl Reference Ctr Staphylococci, Wernigerode Branch, Wernigerode, Germany; [Stamm, Ivonne; Kopp, Peter A.] Vet Med Lab GmbH, Div IDEXX Labs, Ludwigsburg, Germany; [Kohn, Barbara] Free Univ Berlin, Fac Vet, Clin Small Anim, Berlin, Germany; [Conraths, Franz J.] Fed Res Inst Anim Hlth, Friedrich Loeffler Inst, Inst Epidemiol, Wusterhausen, Germany	Free University of Berlin; Robert Koch Institute; Robert Koch Institute; Free University of Berlin; Friedrich Loeffler Institute	Walther, B (corresponding author), Free Univ Berlin, Fac Vet, Inst Microbiol & Epizoot, Berlin, Germany.	walther.birgit@vetmed.fu-berlin.de	Semmler, Torsten/Q-7716-2018; Semmler, Torsten/O-9540-2019	Semmler, Torsten/0000-0002-2225-7267; Semmler, Torsten/0000-0002-2225-7267; Wieler, Lothar H./0000-0003-4365-3717; Conraths, Franz/0000-0002-7400-9409; Walther, Birgit/0000-0003-3112-5722	BMBF-founded interdisciplinary expert network project on zoonotic Staphylococcus aureus [MedVet- Staph: IP8, 01KI1014F]; Federal Ministry of Education and Research [01KI1014F, 01KI1012A]	BMBF-founded interdisciplinary expert network project on zoonotic Staphylococcus aureus; Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF))	S. Vincze is financed by the BMBF-founded interdisciplinary expert network project on zoonotic Staphylococcus aureus (MedVet- Staph: IP8, 01KI1014F:). S. Vincze and Torsten Semmler were supported by the Federal Ministry of Education and Research (MedVet- Staph, Grant no. 01KI1014F) and (FBI-Zoo, Grant no. 01KI1012A). No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bannoehr J, 2007, J BACTERIOL, V189, P8685, DOI 10.1128/JB.01150-07; Bannoehr J, 2009, J CLIN MICROBIOL, V47, P469, DOI 10.1128/JCM.01915-08; Becker K., 2011, MANUAL CLIN MICROBIO; Black CC, 2009, VET MICROBIOL, V139, P333, DOI 10.1016/j.vetmic.2009.06.029; Blouin DD, 2008, THESIS INDIANA U US; Chuang CY, 2010, J CLIN MICROBIOL, V48, P1497, DOI 10.1128/JCM.02033-09; Cohn LA, 2010, J VET EMERG CRIT CAR, V20, P31, DOI 10.1111/j.1476-4431.2009.00497.x; Cuny C, 2010, INT J MED MICROBIOL, V300, P109, DOI 10.1016/j.ijmm.2009.11.002; de Sousa MA, 2003, J CLIN MICROBIOL, V41, P159, DOI [10.1128/JCM.41.1.159-163.2002, 10.1128/JCM.41.1.159-163.2003]; Engemann JJ, 2003, CLIN INFECT DIS, V36, P592, DOI 10.1086/367653; Enright MC, 2000, J CLIN MICROBIOL, V38, P1008, DOI 10.1128/JCM.38.3.1008-1015.2000; Epley N, 2008, SOC COGNITION, V26, P143, DOI 10.1521/soco.2008.26.2.143; Fazakerley J, 2009, VET DERMATOL, V20, P179, DOI 10.1111/j.1365-3164.2009.00745.x; Frank LA, 2009, VET DERMATOL, V20, P496, DOI 10.1111/j.1365-3164.2009.00826.x; Franklin A., 1999, ANIMALS MODERN CULTU, DOI DOI 10.4135/9781446217764.N2; Futagawa-Saito K, 2004, J CLIN MICROBIOL, V42, P5324, DOI 10.1128/JCM.42.11.5324-5326.2004; Futagawa-Saito K, 2009, FEMS MICROBIOL LETT, V301, P176, DOI 10.1111/j.1574-6968.2009.01823.x; Hanselman BA, 2009, CAN VET J, V50, P954; Harmsen D, 2003, J CLIN MICROBIOL, V41, P5442, DOI 10.1128/JCM.41.12.5442-5448.2003; Ishihara K, 2010, APPL ENVIRON MICROB, V76, P5165, DOI 10.1128/AEM.02780-09; Iyori K, 2010, FEMS MICROBIOL LETT, V312, P169, DOI 10.1111/j.1574-6968.2010.02113.x; Kempker R, 2009, AM J MED SCI, V338, P425, DOI 10.1097/MAJ.0b013e3181b0baa9; Lina G, 1999, CLIN INFECT DIS, V29, P1128, DOI 10.1086/313461; Loeffler A, 2010, J HOSP INFECT; Lozano C, 2011, INT J MED MICROBIOL, V301, P500, DOI 10.1016/j.ijmm.2011.02.004; Mahoudeau I, 1997, J CLIN MICROBIOL, V35, P2153, DOI 10.1128/JCM.35.8.2153-2154.1997; Manian FA, 2003, CLIN INFECT DIS, V36, pE26, DOI 10.1086/344772; Merlino J, 2002, J ANTIMICROB CHEMOTH, V49, P793, DOI 10.1093/jac/dkf021; Nienhoff U, 2009, J ANTIMICROB CHEMOTH, V64, P660, DOI 10.1093/jac/dkp243; Paul NC, 2011, SMALL ANIMAL VET IND; Perreten V, 2010, J ANTIMICROB CHEMOTH, V65, P1145, DOI 10.1093/jac/dkq078; Rubin JE, 2010, VET MICROBIOL, V143, P440, DOI 10.1016/j.vetmic.2009.11.012; Ruscher C, 2010, VET MICROBIOL, V144, P340, DOI 10.1016/j.vetmic.2010.01.008; Ruscher C, 2009, VET MICROBIOL, V136, P197, DOI 10.1016/j.vetmic.2008.10.023; Soedarmanto I, 2011, RES VET SCI; van Duijkeren E, 2011, VET MICROBIOL; Van Hoovels L, 2006, J CLIN MICROBIOL, V44, P4609, DOI 10.1128/JCM.01308-06; Vincze S, 2010, BERL MUNCH TIERARZTL, V123, P353, DOI 10.2376/0005-9366-123-353; Walther B, 2009, BERL MUNCH TIERARZTL, V122, P178, DOI 10.2376/0005-9366-122-178; Walther B, 2009, J CLIN MICROBIOL, V47, P704, DOI 10.1128/JCM.01626-08; Weese JS, 2006, J VET INTERN MED, V20, P182, DOI 10.1892/0891-6640(2006)20[182:MSAIHA]2.0.CO;2; Wertheim HFL, 2005, LANCET INFECT DIS, V5, P751, DOI 10.1016/S1473-3099(05)70295-4; Wieler LH, 2011, INT J MED MICROBIOL, V301, P635, DOI 10.1016/j.ijmm.2011.09.009	43	84	86	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2012	7	4							e35197	10.1371/journal.pone.0035197	http://dx.doi.org/10.1371/journal.pone.0035197			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959XD	22529990	Green Published, Green Submitted, gold			2022-12-25	WOS:000305350600066
J	Zhang, LL; Hou, R; Su, HL; Hu, XL; Wang, S; Bao, ZM				Zhang, Lingling; Hou, Rui; Su, Hailin; Hu, Xiaoli; Wang, Shi; Bao, Zhenmin			Network Analysis of Oyster Transcriptome Revealed a Cascade of Cellular Responses during Recovery after Heat Shock	PLOS ONE			English	Article							CRASSOSTREA-GIGAS; PACIFIC OYSTER; INDUCED APOPTOSIS; MOLECULAR CHARACTERIZATION; INDUCED THERMOTOLERANCE; LIPID-COMPOSITION; LEAF SENESCENCE; GENE-EXPRESSION; STRESS-RESPONSE; THERMAL-STRESS	Oysters, as a major group of marine bivalves, can tolerate a wide range of natural and anthropogenic stressors including heat stress. Recent studies have shown that oysters pretreated with heat shock can result in induced heat tolerance. A systematic study of cellular recovery from heat shock may provide insights into the mechanism of acquired thermal tolerance. In this study, we performed the first network analysis of oyster transcriptome by reanalyzing microarray data from a previous study. Network analysis revealed a cascade of cellular responses during oyster recovery after heat shock and identified responsive gene modules and key genes. Our study demonstrates the power of network analysis in a non-model organism with poor gene annotations, which can lead to new discoveries that go beyond the focus on individual genes.	[Zhang, Lingling; Hou, Rui; Su, Hailin; Hu, Xiaoli; Wang, Shi; Bao, Zhenmin] Ocean Univ China, Coll Marine Life Sci, Key Lab Marine Genet & Breeding, Qingdao, Peoples R China	Ocean University of China	Zhang, LL (corresponding author), Ocean Univ China, Coll Marine Life Sci, Key Lab Marine Genet & Breeding, Qingdao, Peoples R China.	swang@ouc.edu.cn; zmbao@ouc.edu.cn	zhang, lingling/HDM-2189-2022; Su, Hailin/D-1352-2017	Su, Hailin/0000-0002-0284-2071	National Natural Science Foundation of China [31172384]; National High Technology Research and Development Program of China [2012AA10A401]; Public Science and Technology Research Funds Projects of Ocean [201205031]; Program for New Century Excellent Talents in University [NCET-10-0761]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); Public Science and Technology Research Funds Projects of Ocean; Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET))	Financial support for this work was provided by National Natural Science Foundation of China (31172384), National High Technology Research and Development Program of China (2012AA10A401), Public Science and Technology Research Funds Projects of Ocean (201205031), and Program for New Century Excellent Talents in University (NCET-10-0761). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beere HM, 2004, J CELL SCI, V117, P2641, DOI 10.1242/jcs.01284; Berndt C, 2008, BBA-MOL CELL RES, V1783, P641, DOI 10.1016/j.bbamcr.2008.02.003; Boss K.J., 1982, P945; Chatterjee MT, 2000, MICROBIOL-UK, V146, P877, DOI 10.1099/00221287-146-4-877; Chen GH, 2002, PLANT CELL PHYSIOL, V43, P984, DOI 10.1093/pcp/pcf125; Clegg JS, 1998, MOL MAR BIOL BIOTECH, V7, P21; Dong Z, 2002, BIOCHEM J, V364, P413, DOI 10.1042/BJ20011431; Farcy E, 2009, CELL STRESS CHAPERON, V14, P371, DOI 10.1007/s12192-008-0091-8; Fulda S, 2006, RECENT PAT ANTI-CANC, V1, P81, DOI 10.2174/157489206775246539; Guerzoni ME, 1997, CAN J MICROBIOL, V43, P569, DOI 10.1139/m97-080; Guerzoni ME, 2001, MICROBIOL-SGM, V147, P2255, DOI 10.1099/00221287-147-8-2255; Hamdoun AM, 2003, BIOL BULL-US, V205, P160, DOI 10.2307/1543236; Havasi A, 2008, J BIOL CHEM, V283, P12305, DOI 10.1074/jbc.M801291200; HIDVEGI EJ, 1980, ONCOLOGY-BASEL, V37, P360, DOI 10.1159/000225470; Ivanina AV, 2009, AQUAT TOXICOL, V91, P245, DOI 10.1016/j.aquatox.2008.11.016; Jenny MJ, 2007, MAR BIOTECHNOL, V9, P577, DOI 10.1007/s10126-007-9041-1; Kamradt MC, 2005, J BIOL CHEM, V280, P11059, DOI 10.1074/jbc.M413382200; Kinne O, 1963, J TEMP OCEANOGR MAR, V1, P301; Lang RP, 2009, MAR BIOTECHNOL, V11, P650, DOI 10.1007/s10126-009-9181-6; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Lee I, 2004, SCIENCE, V306, P1555, DOI 10.1126/science.1099511; Lee WP, 2009, BRIEF BIOINFORM, V10, P408, DOI 10.1093/bib/bbp028; LIU LF, 1987, P NATL ACAD SCI USA, V84, P7024, DOI 10.1073/pnas.84.20.7024; [刘涛 LIU Tao], 2010, [临床心血管病杂志, Journal of Clinical Cardiology], V26, P212; Liu WJ, 2008, CARCINOGENESIS, V29, P263, DOI 10.1093/carcin/bgm251; Meistertzheim AL, 2007, FEBS J, V274, P6392, DOI 10.1111/j.1742-4658.2007.06156.x; Oldham MC, 2008, NAT NEUROSCI, V11, P1271, DOI 10.1038/nn.2207; Pasupuleti N, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.3; Ponomarev I, 2012, J NEUROSCI, V32, P1884, DOI 10.1523/JNEUROSCI.3136-11.2012; Rebbaa A, 2003, ONCOGENE, V22, P2805, DOI 10.1038/sj.onc.1206366; Shamseldin AA, 1997, J SHELLFISH RES, V16, P487; Smoot ME, 2011, BIOINFORMATICS, V27, P431, DOI 10.1093/bioinformatics/btq675; Storey JD, 2002, J ROY STAT SOC B, V64, P479, DOI 10.1111/1467-9868.00346; TseDinh YC, 1997, TRENDS MICROBIOL, V5, P323, DOI 10.1016/S0966-842X(97)01080-9; Wang WX, 2004, TRENDS PLANT SCI, V9, P244, DOI 10.1016/j.tplants.2004.03.006; Wille A, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-11-r92; Yap MN, 2003, PLANT MOL BIOL, V51, P471, DOI 10.1023/A:1022334820332; Zhang B, 2005, STAT APPL GENET MOL, V4, DOI 10.2202/1544-6115.1128	38	18	19	2	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2012	7	4							e35484	10.1371/journal.pone.0035484	http://dx.doi.org/10.1371/journal.pone.0035484			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959XD	22530030	Green Submitted, gold, Green Published			2022-12-25	WOS:000305350600086
J	Keihaninejad, S; Heckemann, RA; Gousias, IS; Hajnal, JV; Duncan, JS; Aljabar, P; Rueckert, D; Hammers, A				Keihaninejad, Shiva; Heckemann, Rolf A.; Gousias, Ioannis S.; Hajnal, Joseph V.; Duncan, John S.; Aljabar, Paul; Rueckert, Daniel; Hammers, Alexander			Classification and Lateralization of Temporal Lobe Epilepsies with and without Hippocampal Atrophy Based on Whole-Brain Automatic MRI Segmentation	PLOS ONE			English	Article							VOXEL-BASED MORPHOMETRY; MAGNETIC-RESONANCE-SPECTROSCOPY; POSITRON-EMISSION-TOMOGRAPHY; RECEPTOR-BINDING; BASAL GANGLIA; WHITE-MATTER; SURGERY; AMYGDALA; IMAGES; PET	Brain images contain information suitable for automatically sorting subjects into categories such as healthy controls and patients. We sought to identify morphometric criteria for distinguishing controls (n = 28) from patients with unilateral temporal lobe epilepsy (TLE), 60 with and 20 without hippocampal atrophy (TLE-HA and TLE-N, respectively), and for determining the presumed side of seizure onset. The framework employs multi-atlas segmentation to estimate the volumes of 83 brain structures. A kernel-based separability criterion was then used to identify structures whose volumes discriminate between the groups. Next, we applied support vector machines (SVM) to the selected set for classification on the basis of volumes. We also computed pairwise similarities between all subjects and used spectral analysis to convert these into per-subject features. SVM was again applied to these feature data. After training on a subgroup, all TLE-HA patients were correctly distinguished from controls, achieving an accuracy of 96 +/- 2% in both classification schemes. For TLE-N patients, the accuracy was 86 +/- 2% based on structural volumes and 91 +/- 3% using spectral analysis. Structures discriminating between patients and controls were mainly localized ipsilaterally to the presumed seizure focus. For the TLE-HA group, they were mainly in the temporal lobe; for the TLE-N group they included orbitofrontal regions, as well as the ipsilateral substantia nigra. Correct lateralization of the presumed seizure onset zone was achieved using hippocampi and parahippocampal gyri in all TLE-HA patients using either classification scheme; in the TLE-N patients, lateralization was accurate based on structural volumes in 86 +/- 4%, and in 94 +/- 4% with the spectral analysis approach. Unilateral TLE has imaging features that can be identified automatically, even when they are invisible to human experts. Such morphometric image features may serve as classification and lateralization criteria. The technique also detects unsuspected distinguishing features like the substantia nigra, warranting further study.	[Keihaninejad, Shiva; Heckemann, Rolf A.; Gousias, Ioannis S.; Hammers, Alexander] Univ London Imperial Coll Sci Technol & Med, Fac Med, Ctr Neurosci, Div Expt Med, London SW7 2AZ, England; [Heckemann, Rolf A.; Hammers, Alexander] CERMEP Imagerie Vivant, Neurodis Fdn, Lyon, France; [Gousias, Ioannis S.; Hajnal, Joseph V.] Univ London Imperial Coll Sci Technol & Med, MRC Clin Sci Ctr, Imaging Sci Dept, London SW7 2AZ, England; [Duncan, John S.] UCL Inst Neurol, Dept Clin & Expt Epilepsy, London, England; [Duncan, John S.] Natl Soc Epilepsy MRI Unit, Gerrards Cross, England; [Aljabar, Paul; Rueckert, Daniel] Univ London Imperial Coll Sci Technol & Med, Dept Comp, London SW7 2AZ, England	Imperial College London; Imperial College London; University of London; University College London; Imperial College London	Keihaninejad, S (corresponding author), UCL Inst Neurol, Dementia Res Ctr, London, England.	alexander.hammers@fondation-neurodis.org	Rueckert, Daniel/C-4393-2008; Hammers, Alexander/D-9982-2015; Heckemann, Rolf Andreas/H-9022-2019; Hajnal, Joseph/P-6251-2018	Hammers, Alexander/0000-0001-9530-4848; Heckemann, Rolf Andreas/0000-0003-3582-3683; Hajnal, Joseph/0000-0002-2690-5495; Duncan, John S/0000-0002-1373-0681; Rueckert, Daniel/0000-0002-5683-5889	Medical Research Council [G108/585]; MRC Clinical Sciences Centre; Dunhill Medical Trust; National Institute for Health Research (NIHR) Biomedical Research Centre; Medical Research Council [MR/K006355/1, MC_U120061309] Funding Source: researchfish; National Institute for Health Research [NF-SI-0509-10161] Funding Source: researchfish; MRC [G108/585, MR/K006355/1, MC_U120061309] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC Clinical Sciences Centre(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Dunhill Medical Trust(Dunhill Medical Trust); National Institute for Health Research (NIHR) Biomedical Research Centre(National Institute for Health Research (NIHR)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	SK and AH were supported by the Medical Research Council (grant number G108/585 and core funding from MRC Clinical Sciences Centre). RH was supported by a research grant from the Dunhill Medical Trust. Authors affiliated with Imperial are grateful for support from the National Institute for Health Research (NIHR) Biomedical Research Centre Funding Scheme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhondi-Asl A, 2011, NEUROIMAGE, V54, pS218, DOI 10.1016/j.neuroimage.2010.03.066; Aljabar P, 2008, NEUROIMAGE, V43, P225, DOI 10.1016/j.neuroimage.2008.07.055; Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Avants BB, 2010, NEUROIMAGE, V49, P2457, DOI 10.1016/j.neuroimage.2009.09.062; Barnes J, 2007, NEUROBIOL AGING, V28, P1657, DOI 10.1016/j.neurobiolaging.2006.07.008; Belkin M, 2003, NEURAL COMPUT, V15, P1373, DOI 10.1162/089976603321780317; Bernasconi A, 2000, NEUROIMAGE, V12, P739, DOI 10.1006/nimg.2000.0724; Bernasconi N, 2004, NEUROIMAGE, V23, P717, DOI 10.1016/j.neuroimage.2004.06.015; Bernasconi N, 2003, BRAIN, V126, P462, DOI 10.1093/brain/awg034; Bonilha L, 2005, NEUROIMAGE, V25, P1016, DOI 10.1016/j.neuroimage.2004.11.050; Bonilha L, 2009, EPILEPSIA, V50, P228, DOI 10.1111/j.1528-1167.2008.01768.x; Bouilleret V, 2008, NEUROLOGY, V70, P177, DOI 10.1212/01.wnl.0000297514.47695.48; Carne RP, 2007, BMC NEUROL, V7, DOI 10.1186/1471-2377-7-16; Carne RP, 2004, BRAIN, V127, P2276, DOI 10.1093/brain/awh257; CASCINO GD, 1991, ANN NEUROL, V30, P31, DOI 10.1002/ana.410300107; CENDES F, 1993, NEUROLOGY, V43, P719, DOI 10.1212/WNL.43.4.719; Chupin M, 2009, NEUROIMAGE, V46, P749, DOI 10.1016/j.neuroimage.2009.02.013; Chupin M, 2007, NEUROIMAGE, V34, P996, DOI 10.1016/j.neuroimage.2006.10.035; Ciumas C, 2008, NEUROLOGY, V71, P788, DOI 10.1212/01.wnl.0000316120.70504.d5; Ciumas C, 2010, NEUROIMAGE, V51, P606, DOI 10.1016/j.neuroimage.2010.02.051; Connelly A, 1998, NEUROLOGY, V51, P61, DOI 10.1212/WNL.51.1.61; de Tisi J, 2011, LANCET, V378, P1388, DOI 10.1016/S0140-6736(11)60890-8; Debets RMC, 1997, J NEUROL NEUROSUR PS, V62, P141, DOI 10.1136/jnnp.62.2.141; DeCarli C, 1998, ANN NEUROL, V43, P41, DOI 10.1002/ana.410430110; Deransart C, 1998, EPILEPSY RES, V32, P213, DOI 10.1016/S0920-1211(98)00053-9; Didelot A, 2008, BRAIN, V131, P2751, DOI 10.1093/brain/awn220; Dreifuss S, 2001, NEUROLOGY, V57, P1636, DOI 10.1212/WNL.57.9.1636; Duchesne S, 2006, NEUROIMAGE, V29, P557, DOI 10.1016/j.neuroimage.2005.07.052; Duchesne S, 2008, IEEE T MED IMAGING, V27, P509, DOI 10.1109/TMI.2007.908685; Duncan JS, 2011, EPILEPSY BEHAV, V20, P230, DOI 10.1016/j.yebeh.2010.06.040; Duzel E, 2004, EUR J NEUROL, V11, P195, DOI 10.1046/j.1351-5101.2003.00737.x; Engel J, 1996, NEW ENGL J MED, V334, P647, DOI 10.1056/NEJM199603073341008; Eriksson SH, 2009, HUM BRAIN MAPP, V30, P3351, DOI 10.1002/hbm.20757; Fan Y, 2005, LECT NOTES COMPUT SC, V3749, P1; Fedi M, 2008, NEUROLOGY, V71, P795, DOI 10.1212/01.wnl.0000316192.52731.77; Focke NK, 2011, NEUROIMAGE IN PRESS; FREE SL, 1995, AM J NEURORADIOL, V16, P637; Freeborough PA, 1997, COMPUT METH PROG BIO, V53, P15, DOI 10.1016/S0169-2607(97)01803-8; Fukunaga K., 1972, INTRO STAT PATTERN R, V2nd; Gousias IS, 2008, NEUROIMAGE, V40, P672, DOI 10.1016/j.neuroimage.2007.11.034; HAJNAL JV, 1992, J COMPUT ASSIST TOMO, V16, P841, DOI 10.1097/00004728-199211000-00001; Hamer HM, 2002, NEUROLOGY, V58, P97, DOI 10.1212/WNL.58.1.97; Hammers A, 2004, NEUROIMAG CLIN N AM, V14, P537, DOI 10.1016/j.nic.2004.04.012; Hammers A, 2002, BRAIN, V125, P2257, DOI 10.1093/brain/awf233; Hammers A, 2002, HUM BRAIN MAPP, V15, P165, DOI 10.1002/hbm.10016; Hammers A, 2003, HUM BRAIN MAPP, V19, P224, DOI 10.1002/hbm.10123; Hammers A, 2007, NEUROIMAGE, V36, P38, DOI 10.1016/j.neuroimage.2007.02.031; Heckemann RA, 2006, NEUROIMAGE, V33, P115, DOI 10.1016/j.neuroimage.2006.05.061; Heckemann RA, 2011, NEUROIMAGE, V56, P2024, DOI 10.1016/j.neuroimage.2011.03.014; Heckemann RA, 2010, NEUROIMAGE, V51, P221, DOI 10.1016/j.neuroimage.2010.01.072; Hua JP, 2005, BIOINFORMATICS, V21, P1509, DOI 10.1093/bioinformatics/bti171; Jutila L, 2001, AM J NEURORADIOL, V22, P1490; Keihaninejad S, 2010, NEUROIMAGE, V50, P1427, DOI 10.1016/j.neuroimage.2010.01.064; Kelemen A, 1999, IEEE T MED IMAGING, V18, P828, DOI 10.1109/42.811260; Keller SS, 2002, NEUROIMAGE, V16, P23, DOI 10.1006/nimg.2001.1072; Kittler J, 1998, IEEE T PATTERN ANAL, V20, P226, DOI 10.1109/34.667881; Kloppel S, 2008, BRAIN, V131, P681, DOI 10.1093/brain/awm319; Kobayashi E, 2003, NEUROLOGY, V60, P405, DOI 10.1212/WNL.60.3.405; Korja M, 2007, EPILEPSIA, V48, P1768, DOI 10.1111/j.1528-1167.2007.01118.x; Labate A, 2008, NEUROLOGY, V71, P1094, DOI 10.1212/01.wnl.0000326898.05099.04; Landvogt C, 2010, EPILEPSIA, V51, P1699, DOI 10.1111/j.1528-1167.2010.02569.x; Leung KK, 2010, NEUROIMAGE, V51, P1345, DOI 10.1016/j.neuroimage.2010.03.018; MARGERISON JH, 1966, BRAIN, V89, P499, DOI 10.1093/brain/89.3.499; McDonald CR, 2008, EPILEPSY RES, V79, P130, DOI 10.1016/j.eplepsyres.2008.01.006; Mehta S, 2003, NEUROIMAGE, V20, P1438, DOI 10.1016/S1053-8119(03)00377-X; Moran NF, 2001, BRAIN, V124, P167, DOI 10.1093/brain/124.1.167; Morra JH, 2010, IEEE T MED IMAGING, V29, P30, DOI 10.1109/TMI.2009.2021941; Natsume J, 2003, NEUROLOGY, V60, P1296, DOI 10.1212/01.WNL.0000058764.34968.C2; Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058; Prechelt L, 1998, NEURAL NETWORKS, V11, P761, DOI 10.1016/S0893-6080(98)00010-0; Rohlfing T, 2004, NEUROIMAGE, V21, P1428, DOI 10.1016/j.neuroimage.2003.11.010; Rueckert D, 1999, IEEE T MED IMAGING, V18, P712, DOI 10.1109/42.796284; Shen DG, 2002, NEUROIMAGE, V15, P422, DOI 10.1006/nimg.2001.0987; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Uijl SG, 2007, EPILEPSIA, V48, P2121, DOI 10.1111/j.1528-1167.2007.01197.x; van der Lijn F, 2008, NEUROIMAGE, V43, P708, DOI 10.1016/j.neuroimage.2008.07.058; VanPaesschen W, 1997, ANN NEUROL, V42, P756, DOI 10.1002/ana.410420512; Vapnik VN, 1999, IEEE T NEURAL NETWOR, V10, P988, DOI 10.1109/72.788640; von Luxburg U, 2007, STAT COMPUT, V17, P395, DOI 10.1007/s11222-007-9033-z; Wang L, 2008, IEEE T PATTERN ANAL, V30, P1534, DOI 10.1109/TPAMI.2007.70799; Wang Y, 2010, NEUROIMAGE, V50, P1519, DOI 10.1016/j.neuroimage.2009.12.092; Webb J, 1999, MAGN RESON IMAGING, V17, P1149, DOI 10.1016/S0730-725X(99)00044-2; Wiebe S, 2001, NEW ENGL J MED, V345, P311, DOI 10.1056/NEJM200108023450501; Wieshmann UC, 1996, J NEUROL NEUROSUR PS, V61, P357, DOI 10.1136/jnnp.61.4.357; Woermann FG, 1999, ANN NEUROL, V45, P369, DOI 10.1002/1531-8249(199903)45:3<369::AID-ANA13>3.0.CO;2-Q; Woermann FG, 1999, BRAIN, V122, P2101, DOI 10.1093/brain/122.11.2101; Woermann FG, 1999, NEUROIMAGE, V10, P373, DOI 10.1006/nimg.1999.0481; Wolz R, 2010, NEUROIMAGE, V49, P1316, DOI 10.1016/j.neuroimage.2009.09.069; Yakushev IY, 2010, EPILEPSIA, V51, P415, DOI 10.1111/j.1528-1167.2009.02272.x	89	46	49	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2012	7	4							e33096	10.1371/journal.pone.0033096	http://dx.doi.org/10.1371/journal.pone.0033096			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VO	22523539	Green Published, gold, Green Submitted			2022-12-25	WOS:000305345000008
J	Zaidi, S; McLaughlin, M; Bhide, SA; Eccles, SA; Workman, P; Nutting, CM; Huddart, RA; Harrington, KJ				Zaidi, Shane; McLaughlin, Martin; Bhide, Shreerang A.; Eccles, Suzanne A.; Workman, Paul; Nutting, Christopher M.; Huddart, Robert A.; Harrington, Kevin J.			The HSP90 Inhibitor NVP-AUY922 Radiosensitizes by Abrogation of Homologous Recombination Resulting in Mitotic Entry with Unresolved DNA Damage	PLOS ONE			English	Article							HEAT-SHOCK-PROTEIN; PHASE-II TRIAL; TUMOR-CELLS; MOLECULAR CHAPERONE; ANTITUMOR-ACTIVITY; MULTITARGET APPROACH; GENOTOXIC STRESSES; RADIATION RESPONSE; MULTIPLE-MYELOMA; CARCINOMA CELLS	Background: Heat shock protein 90 (HSP90) is a molecular chaperone responsible for the conformational maintenance of a number of client proteins that play key roles in cell cycle arrest, DNA damage repair and apoptosis following radiation. HSP90 inhibitors exhibit antitumor activity by modulating the stabilisation and activation of HSP90 client proteins. We sought to evaluate NVP-AUY922, the most potent HSP90 inhibitor yet reported, in preclinical radiosensitization studies. Principal Findings: NVP-AUY922 potently radiosensitized cells in vitro at low nanomolar concentrations with a concurrent depletion of radioresistance-linked client proteins. Radiosensitization by NVP-AUY922 was verified for the first time in vivo in a human head and neck squamous cell carcinoma xenograft model in athymic mice, as measured by delayed tumor growth and increased surrogate end-point survival (p =< 0.0001). NVP-AUY922 was shown to ubiquitously inhibit resolution of dsDNA damage repair correlating to delayed Rad51 foci formation in all cell lines tested. Additionally, NVP-AUY922 induced a stalled mitotic phenotype, in a cell line-dependent manner, in HeLa and HN5 cell lines irrespective of radiation exposure. Cell cycle analysis indicated that NVP-AUY922 induced aberrant mitotic entry in all cell lines tested in the presence of radiation-induced DNA damage due to ubiquitous CHK1 depletion, but resultant downstream cell cycle effects were cell line dependent. Conclusions: These results identify NVP-AUY922 as the most potent HSP90-mediated radiosensitizer yet reported in vitro, and for the first time validate it in a clinically relevant in vivo model. Mechanistic analysis at clinically achievable concentrations demonstrated that radiosensitization is mediated by the combinatorial inhibition of cell growth and survival pathways, ubiquitous delay in Rad51-mediated homologous recombination and CHK1-mediated G(2)/M arrest, but that the contribution of cell cycle perturbation to radiosensitization may be cell line specific.	[Zaidi, Shane; McLaughlin, Martin; Bhide, Shreerang A.; Harrington, Kevin J.] Inst Canc Res, Chester Beatty Labs, Targeted Therapy Team, London, England; [Eccles, Suzanne A.] Inst Canc Res, Haddow Labs, Canc Res UK Canc Therapeut Unit, Tumour Biol & Metastasis Team, Sutton, Surrey, England; [Workman, Paul] Inst Canc Res, Haddow Labs, Canc Res UK Canc Therapeut Unit, Signal Transduct & Mol Pharmacol Team, Sutton, Surrey, England; [Nutting, Christopher M.; Harrington, Kevin J.] Royal Marsden Hosp, London SW3 6JJ, England; [Huddart, Robert A.] Royal Marsden Hosp, Sutton, Surrey, England	Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; Cancer Research UK; University of London; Institute of Cancer Research - UK; Cancer Research UK; University of London; Institute of Cancer Research - UK; Royal Marsden NHS Foundation Trust; Royal Marsden NHS Foundation Trust	Zaidi, S (corresponding author), Inst Canc Res, Chester Beatty Labs, Targeted Therapy Team, London, England.	Martin.McLaughlin@icr.ac.uk		huddart, robert/0000-0003-3604-1990; Harrington, Kevin/0000-0002-6014-348X; McLaughlin, Martin/0000-0002-9739-7133	Cancer Research UK [C46/A10588, CA309/A2187, C309/A82741]; NHS; Cancer Research UK [10588, 11566, 13407] Funding Source: researchfish	Cancer Research UK(Cancer Research UK); NHS; Cancer Research UK(Cancer Research UK)	SZ and MM were funded by Cancer Research UK Programme Grant C46/A10588. SAE and PW were funded by Cancer Research UK Programme Grants CA309/A2187 and C309/A82741. PW is a Cancer Research UK Life Fellow. The authors acknowledge NHS funding to the NIHR Biomedical Research Centre. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; SZ, MM, SAB, SAE, PW and KJH are or have been employees or students of The Institute of Cancer Research. Intellectual property from the research collaboration with Vernalis Ltd. on HSP90 inhibitors was licensed from The Institute of Cancer Research to Vernalis Ltd. and Novartis. The Institute of Cancer Research has benefited from this and requires its employees to declare this potential conflict of interest. SAE: consultant, Vernalis Ltd. PW: commercial research grant, Vernalis Ltd. (not used for the funding of this study); consultant, Novartis. CMN and RAH declare no conflicts of interest. There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials, as detailed online in the guidelines for authors.	Arlander SJH, 2006, J BIOL CHEM, V281, P2989, DOI 10.1074/jbc.M508687200; Arlander SJH, 2003, J BIOL CHEM, V278, P52572, DOI 10.1074/jbc.M309054200; Banerji U, 2005, J CLIN ONCOL, V23, P4152, DOI 10.1200/JCO.2005.00.612; Banerji U, 2005, CLIN CANCER RES, V11, P7023, DOI 10.1158/1078-0432.CCR-05-0518; Bisht KS, 2003, CANCER RES, V63, P8984; Brough PA, 2008, J MED CHEM, V51, P196, DOI 10.1021/jm701018h; Bull EEA, 2004, CLIN CANCER RES, V10, P8077, DOI 10.1158/1078-0432.CCR-04-1212; Camphausen K, 2007, CLIN CANCER RES, V13, P4326, DOI 10.1158/1078-0432.CCR-07-0632; Castedo M, 2004, ONCOGENE, V23, P4362, DOI 10.1038/sj.onc.1207572; Castedo M, 2004, ONCOGENE, V23, P2825, DOI 10.1038/sj.onc.1207528; Deckbar D, 2007, J CELL BIOL, V176, P749, DOI 10.1083/jcb.200612047; Dote H, 2005, CANCER RES, V65, P6967, DOI 10.1158/0008-5472.CAN-05-1304; Dungey FA, 2009, MOL CANCER THER, V8, P2243, DOI 10.1158/1535-7163.MCT-09-0201; Eccles SA, 2008, CANCER RES, V68, P2850, DOI 10.1158/0008-5472.CAN-07-5256; Gabai VL, 2010, ONCOGENE, V29, P1952, DOI 10.1038/onc.2009.480; Gabai VL, 2008, CANCER RES, V68, P1834, DOI 10.1158/0008-5472.CAN-07-5656; Gaspar N, 2010, MOL CANCER THER, V9, P1219, DOI 10.1158/1535-7163.MCT-09-0683; Ha K, 2011, MOL CANC THER; Heath EI, 2008, CLIN CANCER RES, V14, P7940, DOI 10.1158/1078-0432.CCR-08-0221; Jensen MR, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr1996; Kabakov AE, 2008, INT J RADIAT ONCOL, V71, P858, DOI 10.1016/j.ijrobp.2008.02.034; Koll TT, 2008, MOL CANCER THER, V7, P1985, DOI 10.1158/1535-7163.MCT-07-2104; Lobrich M, 2007, NAT REV CANCER, V7, P861, DOI 10.1038/nrc2248; Machida H, 2005, CANCER SCI, V96, P911, DOI 10.1111/j.1349-7006.2005.00125.x; Machida H, 2003, INT J RADIAT BIOL, V79, P973, DOI 10.1080/09553000310001626135; Massey AJ, 2010, MOL CANCER THER, V9, P906, DOI 10.1158/1535-7163.MCT-10-0055; Matsumoto Y, 2005, J RADIAT RES, V46, P215, DOI 10.1269/jrr.46.215; Merwald H, 2006, CELL STRESS CHAPERON, V11, P81, DOI 10.1379/CSC-89R.1; Moran DM, 2008, ONCOGENE, V27, P5567, DOI 10.1038/onc.2008.172; Munnink THO, 2010, EUR J CANCER, V46, P678, DOI 10.1016/j.ejca.2009.12.009; Nagengast WB, 2010, J NUCL MED; Noguchi M, 2006, BIOCHEM BIOPH RES CO, V351, P658, DOI 10.1016/j.bbrc.2006.10.094; Oda T, 2007, BLOOD, V109, P5016, DOI 10.1182/blood-2006-08-038638; Pacey S, 2012, INVEST NEW DRUG, V30, P341, DOI 10.1007/s10637-010-9493-4; Pacey S, 2011, CLIN CANCER RES, V17, P1561, DOI 10.1158/1078-0432.CCR-10-1927; Pearl LH, 2008, BIOCHEM J, V410, P439, DOI 10.1042/BJ20071640; Pearl LH, 2006, ANNU REV BIOCHEM, V75, P271, DOI 10.1146/annurev.biochem.75.103004.142738; Richardson PG, 2010, BRIT J HAEMATOL, V150, P438, DOI 10.1111/j.1365-2141.2010.08265.x; Ronnen EA, 2006, INVEST NEW DRUG, V24, P543, DOI 10.1007/s10637-006-9208-z; Russell JS, 2003, CLIN CANCER RES, V9, P3749; Schwock J, 2008, CANCER CHEMOTH PHARM, V61, P669, DOI 10.1007/s00280-007-0522-8; Stingl L, 2010, BRIT J CANCER, V102, P1578, DOI 10.1038/sj.bjc.6605683; Stuhmer T, 2008, LEUKEMIA, V22, P1604, DOI 10.1038/leu.2008.111; Sydor JR, 2006, P NATL ACAD SCI USA, V103, P17408, DOI 10.1073/pnas.0608372103; Tao YG, 2009, CELL CYCLE, V8, P3172, DOI 10.4161/cc.8.19.9729; Trepel J, 2010, NAT REV CANCER, V10, P537, DOI 10.1038/nrc2887; Weigel BJ, 2007, CLIN CANCER RES, V13, P1789, DOI 10.1158/1078-0432.CCR-06-2270; Workman P, 2010, BRIT J CANCER, V102, P1555, DOI 10.1038/sj.bjc.6605642; Workman P, 2007, ANN NY ACAD SCI, V1113, P202, DOI 10.1196/annals.1391.012; Yao Q, 2007, CLIN CANCER RES, V13, P1591, DOI 10.1158/1078-0432.CCR-06-1750; Yin XY, 2010, INT J CANCER, V126, P1216, DOI 10.1002/ijc.24815	51	44	44	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2012	7	4							e35436	10.1371/journal.pone.0035436	http://dx.doi.org/10.1371/journal.pone.0035436			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VO	22523597	Green Submitted, gold, Green Published			2022-12-25	WOS:000305345000070
J	Stolting, M; Wiesner, C; van Vliet, V; Butt, E; Pavenstadt, H; Linder, S; Kremerskothen, J				Stoelting, Miriam; Wiesner, Christiane; van Vliet, Vanessa; Butt, Elke; Pavenstaedt, Hermann; Linder, Stefan; Kremerskothen, Joachim			Lasp-1 Regulates Podosome Function	PLOS ONE			English	Article							SMOOTH-MUSCLE-CELLS; DEPENDENT PROTEIN-KINASE; CAMP SIGNALING PATHWAY; DISCRETE MICRODOMAINS; ACTIN CYTOSKELETON; ENDOTHELIAL-CELLS; EPITHELIAL-CELLS; CANCER CELLS; PHOSPHORYLATION; INVADOPODIA	Eukaryotic cells form a variety of adhesive structures to connect with their environment and to regulate cell motility. In contrast to classical focal adhesions, podosomes, highly dynamic structures of different cell types, are actively engaged in matrix remodelling and degradation. Podosomes are composed of an actin-rich core region surrounded by a ring-like structure containing signalling molecules, motor proteins as well as cytoskeleton-associated proteins. Lasp-1 is a ubiquitously expressed, actin-binding protein that is known to regulate cytoskeleton architecture and cell migration. This multidomain protein is predominantely present at focal adhesions, however, a second pool of Lasp-1 molecules is also found at lamellipodia and vesicle-like microdomains in the cytosol. In this report, we show that Lasp-1 is a novel component and regulator of podosomes. Immunofluorescence studies reveal a localization of Lasp-1 in the podosome ring structure, where it colocalizes with zyxin and vinculin. Life cell imaging experiments demonstrate that Lasp-1 is recruited in early steps of podosome assembly. A siRNA-mediated Lasp-1 knockdown in human macrophages affects podosome dynamics as well as their matrix degradation capacity. In summary, our data indicate that Lasp-1 is a novel component of podosomes and is involved in the regulation of podosomal function.	[Stoelting, Miriam; Pavenstaedt, Hermann; Kremerskothen, Joachim] Univ Klinikum Munster, Abt Mol Nephrol, Med Klin D, Munster, Germany; [Wiesner, Christiane; van Vliet, Vanessa; Linder, Stefan] Univ Klinikum Eppendorf, Inst Med Mikrobiol Virol & Hyg, Hamburg, Germany; [Butt, Elke] Univ Wurzburg, Inst Klin Biochem, Wurzburg, Germany	University of Munster; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Wurzburg	Stolting, M (corresponding author), Univ Klinikum Munster, Abt Mol Nephrol, Med Klin D, Munster, Germany.	kremers@uni-muenster.de			"Innovative Medizinische Forschung'' (University Clinic Munster) [IMF110904]; Wilhelm Sander Stiftung [2007.20.2]	"Innovative Medizinische Forschung'' (University Clinic Munster); Wilhelm Sander Stiftung	This work was supported by "Innovative Medizinische Forschung'' (University Clinic Munster, IMF110904 to JK) and "Wilhelm Sander Stiftung'' (2007.20.2 to SL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Buccione R, 2004, NAT REV MOL CELL BIO, V5, P647, DOI 10.1038/nrm1436; Burgstaller G, 2005, AM J PHYSIOL-HEART C, V288, pH3001, DOI 10.1152/ajpheart.01002.2004; Burgstaller G, 2004, J CELL SCI, V117, P223, DOI 10.1242/jcs.00839; Butt E, 2003, J BIOL CHEM, V278, P15601, DOI 10.1074/jbc.M209009200; Chew CS, 2008, AM J PHYSIOL-GASTR L, V295, pG37, DOI 10.1152/ajpgi.90247.2008; Chew CS, 2000, J CELL SCI, V113, P2035; Chew CS, 2002, J CELL SCI, V115, P4787, DOI 10.1242/jcs.00174; Chew CS, 1998, AM J PHYSIOL-CELL PH, V275, pC56, DOI 10.1152/ajpcell.1998.275.1.C56; Endlich N, 2009, KIDNEY INT, V75, P214, DOI 10.1038/ki.2008.486; Fultz ME, 2000, J MUSCLE RES CELL M, V21, P775, DOI 10.1023/A:1010396429297; Gimona M, 2003, MOL BIOL CELL, V14, P2482, DOI 10.1091/mbc.E02-11-0743; Gimona M, 2008, CURR OPIN CELL BIOL, V20, P235, DOI 10.1016/j.ceb.2008.01.005; Gimona M, 2006, INT J BIOCHEM CELL B, V38, P1875, DOI 10.1016/j.biocel.2006.05.003; Goicoechea SM, 2008, EUR J CELL BIOL, V87, P517, DOI 10.1016/j.ejcb.2008.01.010; Grunewald TGP, 2006, EXP CELL RES, V312, P974, DOI 10.1016/j.yexcr.2005.12.016; Grunewald TGP, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-31; Grunewald TGP, 2007, BMC CANCER, V7, P1, DOI 10.1186/1471-2407-7-198; Hai CM, 2002, EXP CELL RES, V280, P64, DOI 10.1006/excr.2002.5592; Kaverina I, 2003, J CELL SCI, V116, P4915, DOI 10.1242/jcs.00818; Keicher C, 2004, BIOCHEM BIOPH RES CO, V324, P308, DOI 10.1016/j.bbrc.2004.08.235; Kocher HM, 2009, GUT, V58, P271, DOI 10.1136/gut.2008.159871; Lee S, 2008, MECH DEVELOP, V125, P768, DOI 10.1016/j.mod.2008.06.012; Li B, 2004, J BIOL CHEM, V279, P20401, DOI 10.1074/jbc.M310304200; Lin YH, 2004, J CELL BIOL, V165, P421, DOI 10.1083/jcb.200311045; Linder S, 2005, J CELL SCI, V118, P2079, DOI 10.1242/jcs.02390; Linder S, 2003, TRENDS CELL BIOL, V13, P376, DOI 10.1016/S0962-8924(03)00128-4; Linder S, 2007, TRENDS CELL BIOL, V17, P107, DOI 10.1016/j.tcb.2007.01.002; Moreau V, 2003, MOL CELL BIOL, V23, P6809, DOI 10.1128/MCB.23.19.6809-6822.2003; Murphy DA, 2011, NAT REV MOL CELL BIO, V12, P413, DOI 10.1038/nrm3141; Osiak AE, 2005, EXP CELL RES, V307, P342, DOI 10.1016/j.yexcr.2005.03.035; Panaviene Z, 2007, CELL TISSUE RES, V327, P353, DOI 10.1007/s00441-006-0305-2; Rachlin AS, 2006, J CELL SCI, V119, P995, DOI 10.1242/jcs.02825; Schreiber VR, 1998, MOL MED, V4, P675, DOI 10.1007/BF03401929; Spinardi L, 2004, EXP CELL RES, V295, P360, DOI 10.1016/j.yexcr.2004.01.007; Stoelting M, 2009, BIOCHEM BIOPH RES CO, V379, P81, DOI 10.1016/j.bbrc.2008.12.008; Webb BA, 2006, ARCH BIOCHEM BIOPHYS, V456, P183, DOI 10.1016/j.abb.2006.06.011; Wiesner C, BLOOD, V116, P1559; Wiesner C, BLOOD; Xiao H, 2009, J CELL PHYSIOL, V218, P366, DOI 10.1002/jcp.21609; Zhou ST, 2006, AM J PHYSIOL-CELL PH, V290, pC463, DOI 10.1152/ajpcell.00350.2005	40	30	31	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2012	7	4							e35340	10.1371/journal.pone.0035340	http://dx.doi.org/10.1371/journal.pone.0035340			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UT	22514729	Green Published, Green Submitted, gold			2022-12-25	WOS:000305341600134
J	Twumasi-Boateng, K; Shapira, M				Twumasi-Boateng, Kwame; Shapira, Michael			Dissociation of Immune Responses from Pathogen Colonization Supports Pattern Recognition in C. elegans	PLOS ONE			English	Article							TOLL-LIKE RECEPTOR; CAENORHABDITIS-ELEGANS; PSEUDOMONAS-AERUGINOSA; INNATE IMMUNITY	Caenorhabditis elegans has been used for over a decade to characterize signaling cascades controlling innate immune responses. However, what initiates these responses in the worm has remained elusive. To gain a better understanding of the initiating events we delineated genome-wide immune responses to the bacterial pathogen Pseudomonas aeruginosa in worms heavily-colonized by the pathogen versus worms visibly not colonized. We found that infection responses in both groups were identical, suggesting that immune responses were not correlated with colonization and its associated damage. Quantitative RT-PCR measurements further showed that pathogen secreted factors were not able to induce an immune response, but exposure to a non-pathogenic Pseudomonas species was. These findings raise the possibility that the C. elegans immune response is initiated by recognition of microbe-associated molecular patterns. In the absence of orthologs of known pattern recognition receptors, C. elegans may rely on novel mechanisms, thus holding the potential to advance our understanding of evolutionarily conserved strategies for pathogen recognition.	[Twumasi-Boateng, Kwame; Shapira, Michael] Univ Calif Berkeley, Grad Grp Microbiol, Berkeley, CA 94720 USA; [Shapira, Michael] Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley	Twumasi-Boateng, K (corresponding author), Univ Calif Berkeley, Grad Grp Microbiol, Berkeley, CA 94720 USA.	mshapira@berkeley.edu			Ellison Medical Foundation; NSERC Postgraduate Scholarship	Ellison Medical Foundation(Lawrence Ellison Foundation); NSERC Postgraduate Scholarship(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by the Ellison Medical Foundation. KTB was additionally supported by an NSERC Postgraduate Scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Branicky R, 2006, TRENDS GENET, V22, P571, DOI 10.1016/j.tig.2006.08.006; Chen GY, 2010, NAT REV IMMUNOL, V10, P826, DOI 10.1038/nri2873; Gallagher LA, 2001, J BACTERIOL, V183, P6207, DOI 10.1128/JB.183.21.6207-6214.2001; Irazoqui JE, 2010, NAT REV IMMUNOL, V10, P47, DOI 10.1038/nri2689; Kanzok SM, 2004, J MOL EVOL, V58, P442, DOI 10.1007/s00239-003-2565-8; Kumar H, 2011, INT REV IMMUNOL, V30, P16, DOI 10.3109/08830185.2010.529976; Lau GW, 2005, TRENDS MICROBIOL, V13, P389, DOI 10.1016/j.tim.2005.05.011; Lemaitre B, 1996, CELL, V86, P973, DOI 10.1016/S0092-8674(00)80172-5; Lu R, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000286; Powell JR, 2009, P NATL ACAD SCI USA, V106, P2782, DOI 10.1073/pnas.0813048106; Pujol N, 2001, CURR BIOL, V11, P809, DOI 10.1016/S0960-9822(01)00241-X; ROSETTO M, 1995, BIOCHEM BIOPH RES CO, V209, P111, DOI 10.1006/bbrc.1995.1477; Shapira M, 2006, P NATL ACAD SCI USA, V103, P14086, DOI 10.1073/pnas.0603424103; Tan MW, 1999, P NATL ACAD SCI USA, V96, P2408, DOI 10.1073/pnas.96.5.2408; Tan MW, 1999, P NATL ACAD SCI USA, V96, P715, DOI 10.1073/pnas.96.2.715; Tenor JL, 2008, EMBO REP, V9, P103, DOI 10.1038/sj.embor.7401104; Ting JPY, 2008, NAT REV IMMUNOL, V8, P372, DOI 10.1038/nri2296; Troemel ER, 2006, PLOS GENET, V2, P1725, DOI 10.1371/journal.pgen.0020183; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Wong D, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-9-r194	20	18	18	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2012	7	4							e35400	10.1371/journal.pone.0035400	http://dx.doi.org/10.1371/journal.pone.0035400			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UT	22514739	gold, Green Published, Green Submitted			2022-12-25	WOS:000305341600144
J	Tsiang, M; Jones, GS; Niedziela-Majka, A; Kan, E; Lansdon, EB; Huang, WN; Hung, M; Samuel, D; Novikov, N; Xu, YL; Mitchell, M; Guo, HY; Babaoglu, K; Liu, XH; Geleziunas, R; Sakowicz, R				Tsiang, Manuel; Jones, Gregg S.; Niedziela-Majka, Anita; Kan, Elaine; Lansdon, Eric B.; Huang, Wayne; Hung, Magdeleine; Samuel, Dharmaraj; Novikov, Nikolai; Xu, Yili; Mitchell, Michael; Guo, Hongyan; Babaoglu, Kerim; Liu, Xiaohong; Geleziunas, Romas; Sakowicz, Roman			New Class of HIV-1 Integrase (IN) Inhibitors with a Dual Mode of Action	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VIRUS TYPE-1 INTEGRASE; SMALL-MOLECULE INHIBITORS; DNA-BINDING DOMAIN; PEPTIDE INHIBITORS; VIRAL-DNA; IN-VITRO; LEDGF/P75; DISCOVERY; REVEALS; PROTEIN	tert-Butoxy-(4-phenyl-quinolin-3-yl)-acetic acids (tBPQA) are a new class of HIV-1 integrase (IN) inhibitors that are structurally distinct from IN strand transfer inhibitors but analogous to LEDGINs. LEDGINs are a class of potent antiviral compounds that interacts with the lens epithelium-derived growth factor (LEDGF) binding pocket on IN and were identified through competition binding against LEDGF.LEDGF tethers IN to the host chromatin and enables targeted integration of viral DNA. The prevailing understanding of the antiviral mechanism of LEDGINs is that they inhibit LEDGF binding to IN, which prevents targeted integration of HIV-1. We showed that in addition to the properties already known for LEDGINs, the binding of tBPQAs to the IN dimer interface inhibits IN enzymatic activity in a LEDGF-independent manner. Using the analysis of two long terminal repeat junctions in HIV-infected cells, we showed that the inhibition by tBPQAs occurs at or prior to the viral DNA 3'-processing step. Biochemical studies revealed that this inhibition operates by compound-induced conformational changes in the IN dimer that prevent proper assembly of IN onto viral DNA. For the first time, tBPQAs were demonstrated to be allosteric inhibitors of HIV-1 IN displaying a dual mode of action: inhibition of IN-viral DNA assembly and inhibition of IN-LEDGF interaction.	[Tsiang, Manuel; Jones, Gregg S.; Niedziela-Majka, Anita; Kan, Elaine; Lansdon, Eric B.; Huang, Wayne; Hung, Magdeleine; Samuel, Dharmaraj; Novikov, Nikolai; Xu, Yili; Mitchell, Michael; Guo, Hongyan; Babaoglu, Kerim; Liu, Xiaohong; Geleziunas, Romas; Sakowicz, Roman] Gilead Sci Inc, Foster City, CA 94404 USA	Gilead Sciences	Tsiang, M (corresponding author), Gilead Sci Inc, 353 Lakeside Dr, Foster City, CA 94404 USA.	mtsiang@gilead.com						Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Al-Mawsawi LQ, 2008, EXPERT OPIN EMERG DR, V13, P213, DOI [10.1517/14728214.13.2.213, 10.1517/14728214.13.2.213 ]; Al-Mawsawi LQ, 2006, P NATL ACAD SCI USA, V103, P10080, DOI 10.1073/pnas.0511254103; Al-Mawsawi LQ, 2011, CHEMMEDCHEM, V6, P228, DOI 10.1002/cmdc.201000443; BUSHMAN FD, 1991, P NATL ACAD SCI USA, V88, P1339, DOI 10.1073/pnas.88.4.1339; Cai ML, 1997, NAT STRUCT BIOL, V4, P567, DOI 10.1038/nsb0797-567; Carayon K, 2010, NUCLEIC ACIDS RES, V38, P3692, DOI 10.1093/nar/gkq087; Cherepanov P, 2005, P NATL ACAD SCI USA, V102, P17308, DOI 10.1073/pnas.0506924102; Cherepanov P, 2005, NAT STRUCT MOL BIOL, V12, P526, DOI 10.1038/nsmb937; Cherepanov P, 2004, J BIOL CHEM, V279, P48883, DOI 10.1074/jbc.M406307200; Cherepanov P, 2003, J BIOL CHEM, V278, P372, DOI 10.1074/jbc.M209278200; Christ F, 2010, NAT CHEM BIOL, V6, P442, DOI 10.1038/nchembio.370; Ciuffi A, 2005, NAT MED, V11, P1287, DOI 10.1038/nm1329; Cooper D.A., 2008, 15 C RETR OPP INF BO, P357; CRAIGIE R, 1991, NUCLEIC ACIDS RES, V19, P2729, DOI 10.1093/nar/19.10.2729; De Luca L, 2009, CHEMMEDCHEM, V4, P1311, DOI 10.1002/cmdc.200900070; De Rijck J, 2006, J VIROL, V80, P11498, DOI 10.1128/JVI.00801-06; DeJesus E., 2007, 4 INT AIDS SOC C HIV; Du L, 2008, ACTA PHARMACOL SIN, V29, P1261, DOI 10.1111/j.1745-7254.2008.00863.x; Du L, 2008, BIOCHEM BIOPH RES CO, V375, P139, DOI 10.1016/j.bbrc.2008.07.139; Du L, 2008, CHEMMEDCHEM, V3, P173, DOI 10.1002/cmdc.200700223; Emiliani S, 2005, J BIOL CHEM, V280, P25517, DOI 10.1074/jbc.M501378200; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; ENGELMAN A, 1995, J VIROL, V69, P2729, DOI 10.1128/JVI.69.5.2729-2736.1995; HAZUDA DJ, 1994, NUCLEIC ACIDS RES, V22, P1121, DOI 10.1093/nar/22.6.1121; Hombrouck A, 2007, PLOS PATHOG, V3, DOI 10.1371/journal.ppat.0030047; Hou Y, 2008, J BIOMOL SCREEN, V13, P406, DOI 10.1177/1087057108317060; Jones GS, 2009, ANTIMICROB AGENTS CH, V53, P1194, DOI 10.1128/AAC.00984-08; Kessl JJ, 2012, J BIOL CHEM, V287, P16801, DOI 10.1074/jbc.M112.354373; Kessl JJ, 2011, NUCLEIC ACIDS RES, V39, P9009, DOI 10.1093/nar/gkr581; Kessl JJ, 2009, MOL PHARMACOL, V76, P824, DOI 10.1124/mol.109.058883; Kobayashi M, 2011, ANTIMICROB AGENTS CH, V55, P813, DOI 10.1128/AAC.01209-10; Lataillade M, 2007, ANTIVIR THER, V12, P563; Li HY, 2006, J MED CHEM, V49, P4477, DOI 10.1021/jm060307u; Llano M, 2006, SCIENCE, V314, P461, DOI 10.1126/science.1132319; LODI PJ, 1995, BIOCHEMISTRY-US, V34, P9826, DOI 10.1021/bi00031a002; LUTZKE RAP, 1994, NUCLEIC ACIDS RES, V22, P4125, DOI 10.1093/nar/22.20.4125; Maertens G, 2003, J BIOL CHEM, V278, P33528, DOI 10.1074/jbc.M303594200; Malet I, 2008, ANTIMICROB AGENTS CH, V52, P1351, DOI 10.1128/AAC.01228-07; Markowitz M, 2009, JAIDS-J ACQ IMM DEF, V52, P350, DOI 10.1097/QAI.0b013e3181b064b0; Maroun RG, 2001, BIOCHEMISTRY-US, V40, P13840, DOI 10.1021/bi011328n; Mathias A., 2009, 16 C RETR OPP INF MO, P79; Mckee CJ, 2008, J BIOL CHEM, V283, P31802, DOI 10.1074/jbc.M805843200; Metifiot M, 2010, VIRUSES-BASEL, V2, P1347, DOI 10.3390/v2071347; Min S, 2010, ANTIMICROB AGENTS CH, V54, P254, DOI 10.1128/AAC.00842-09; Molteni V, 2001, ACTA CRYSTALLOGR D, V57, P536, DOI 10.1107/S0907444901001652; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Savarino A, 2006, EXPERT OPIN INV DRUG, V15, P1507, DOI 10.1517/13543784.15.12.1507; Shimura Kazuya, 2009, Antiviral Chemistry & Chemotherapy, V20, P79, DOI 10.3851/IMP1397; Steigbigel R., 2008, 15 C RETR OPP INF BO, P357; Svarovskaia ES, 2004, J VIROL, V78, P3210, DOI 10.1128/JVI.78.7.3210-3222.2004; Tsantrizos Y., 2009, Patent No. [WO2009/062285A1, 2009062285]; Tsantrizos Y. S., 2009, WO Patent, Patent No. [2009062289A1, 2009062289, WO 2,009,062,289 (A1)]; Tsantrizos YS, 2007, International patent, Patent No. [WO 2007/131350 A1, 2007131350, WO2007/131350A1, 2007131350 2007131350]; Tsiang M, 2011, BIOCHEMISTRY-US, V50, P1567, DOI 10.1021/bi101504w; Tsiang M, 2009, J BIOL CHEM, V284, P33580, DOI 10.1074/jbc.M109.040121; Vandekerckhove L, 2006, J VIROL, V80, P1886, DOI 10.1128/JVI.80.4.1886-1896.2006; Wai J., 2007, 14 C RETR OPP INF LO, P96; Wang Y, 2005, J BIOMOL SCREEN, V10, P456, DOI 10.1177/1087057105275212; Williams KL, 2005, J BIOL CHEM, V280, P7949, DOI 10.1074/jbc.M413579200; Wu XY, 1999, J VIROL, V73, P2126, DOI 10.1128/JVI.73.3.2126-2135.1999; Zhao L, 2003, BIOORG MED CHEM LETT, V13, P1175, DOI 10.1016/S0960-894X(03)00040-4; Zheng RL, 1996, P NATL ACAD SCI USA, V93, P13659, DOI 10.1073/pnas.93.24.13659; Zolopa AR, 2010, J INFECT DIS, V201, P814, DOI 10.1086/650698	64	126	133	0	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 15	2012	287	25					21189	21203		10.1074/jbc.M112.347534	http://dx.doi.org/10.1074/jbc.M112.347534			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974FQ	22535962	Green Published, hybrid			2022-12-25	WOS:000306416800039
J	Wu, DT; Seita, Y; Zhang, X; Lu, CW; Roth, MJ				Wu, Dai-tze; Seita, Yasunari; Zhang, Xia; Lu, Chi-Wei; Roth, Monica J.			Antibody-Directed Lentiviral Gene Transduction for Live-Cell Monitoring and Selection of Human iPS and hES Cells	PLOS ONE			English	Article							PLURIPOTENT STEM-CELLS; TARGETED TRANSDUCTION; EXPRESSION; DIFFERENTIATION; GENERATION; EFFICIENT; CULTURE; PROTEIN; TROPHOBLAST; FIBROBLASTS	The identification of stem cells within a mixed population of cells is a major hurdle for stem cell biology-in particular, in the identification of induced pluripotent stem (iPS) cells during the reprogramming process. Based on the selective expression of stem cell surface markers, a method to specifically infect stem cells through antibody-conjugated lentiviral particles has been developed that can deliver both visual markers for live-cell imaging as well as selectable markers to enrich for iPS cells. Antibodies recognizing SSEA4 and CD24 mediated the selective infection of the iPS cells over the parental human fibroblasts, allowing for rapid expansion of these cells by puromycin selection. Adaptation of the vector allows for the selective marking of human embryonic stem (hES) cells for their removal from a population of differentiated cells. This method has the benefit that it not only identifies stem cells, but that specific genes, including positive and negative selection markers, regulatory genes or miRNA can be delivered to the targeted stem cells. The ability to specifically target gene delivery to human pluripotent stem cells has broad applications in tissue engineering and stem cell therapies.	[Wu, Dai-tze] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Pharmacol, Piscataway, NJ 08854 USA; [Zhang, Xia; Roth, Monica J.] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Biochem, Piscataway, NJ 08854 USA; [Seita, Yasunari; Lu, Chi-Wei] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Deptartment Ob Gyn, Piscataway, NJ 08854 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center	Roth, MJ (corresponding author), Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Pharmacol, Piscataway, NJ 08854 USA.	roth@umdnj.edu	Seita, Yasunari/AAF-5173-2020; Roth, Monica/AAN-8742-2020		New Jersey Stem Cell Research Grants [HESC-08-01-00]; National Institutes of Health [RO1CA49932]; Ellison Medical Foundation [AG-NS-0628-09]; Robert Wood Johnson Foundation through Child Health Institute of New Jersey [RY1536]; NATIONAL CANCER INSTITUTE [R01CA049932, P30CA072720] Funding Source: NIH RePORTER	New Jersey Stem Cell Research Grants; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ellison Medical Foundation(Lawrence Ellison Foundation); Robert Wood Johnson Foundation through Child Health Institute of New Jersey; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work is supported by New Jersey Stem Cell Research Grants HESC-08-01-00, and National Institutes of Health RO1CA49932 to MJR. CWL is supported by the Ellison Medical Foundation award AG-NS-0628-09 and by the Robert Wood Johnson Foundation grant RY1536 through the Child Health Institute of New Jersey. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aasen T, 2008, NAT BIOTECHNOL, V26, P1276, DOI 10.1038/nbt.1503; ANDREWS PW, 1984, HYBRIDOMA, V3, P347, DOI 10.1089/hyb.1984.3.347; Apati A, 2008, BBA-BIOMEMBRANES, V1778, P2700, DOI 10.1016/j.bbamem.2008.08.010; Assou S, 2007, STEM CELLS, V25, P961, DOI 10.1634/stemcells.2006-0352; Chan EM, 2009, NAT BIOTECHNOL, V27, P1033, DOI 10.1038/nbt.1580; Chen CC, 2001, BLOOD, V97, P886, DOI 10.1182/blood.V97.4.886; COSSET FL, 1995, J VIROL, V69, P7430, DOI 10.1128/JVI.69.12.7430-7436.1995; Fouchier RAM, 1997, EMBO J, V16, P4531, DOI 10.1093/emboj/16.15.4531; Frank HG, 2001, PLACENTA, V22, pS107, DOI 10.1053/plac.2001.0644; Kamata M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011834; KANNAGI R, 1983, EMBO J, V2, P2355, DOI 10.1002/j.1460-2075.1983.tb01746.x; KAY R, 1991, J IMMUNOL, V147, P1412; Laslett AL, 2003, TRENDS CARDIOVAS MED, V13, P295, DOI 10.1016/S1050-1738(03)00125-7; Lewis JG, 2009, J IMMUNOL METHODS, V346, P71, DOI 10.1016/j.jim.2009.04.011; Liang M, 2009, J GENE MED, V11, P185, DOI 10.1002/jgm.1290; Lowry WE, 2008, P NATL ACAD SCI USA, V105, P2883, DOI 10.1073/pnas.0711983105; Mazari PM, 2009, P NATL ACAD SCI USA, V106, P5848, DOI 10.1073/pnas.0809741106; Morizono K, 2005, NAT MED, V11, P346, DOI 10.1038/nm1192; Nagamatsu T, 2004, PLACENTA, V25, P153, DOI 10.1016/j.placenta.2003.08.015; Niakan KK, 2010, GENE DEV, V24, P312, DOI 10.1101/gad.1833510; Ohno K, 1997, NAT BIOTECHNOL, V15, P763, DOI 10.1038/nbt0897-763; Pariente N, 2008, J GENE MED, V10, P242, DOI 10.1002/jgm.1151; Pariente N, 2007, MOL THER, V15, P1973, DOI 10.1038/sj.mt.6300271; Park IH, 2008, NAT PROTOC, V3, P1180, DOI 10.1038/nprot.2008.92; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; Potgens AJG, 2001, PLACENTA, V22, P251, DOI 10.1053/plac.2000.0597; Sarangi A, 2007, P NATL ACAD SCI USA, V104, P11032, DOI 10.1073/pnas.0704182104; Schuldiner M, 2003, STEM CELLS, V21, P257, DOI 10.1634/stemcells.21-3-257; Seguin CA, 2008, CELL STEM CELL, V3, P182, DOI 10.1016/j.stem.2008.06.018; SHEVINSKY LH, 1982, CELL, V30, P697, DOI 10.1016/0092-8674(82)90274-4; Takahashi K, 2007, NAT PROTOC, V2, P3081, DOI 10.1038/nprot.2007.418; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Watanabe K, 2007, NAT BIOTECHNOL, V25, P681, DOI 10.1038/nbt1310; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; Xu RH, 2002, NAT BIOTECHNOL, V20, P1261, DOI 10.1038/nbt761; Yang L, 2006, P NATL ACAD SCI USA, V103, P11479, DOI 10.1073/pnas.0604993103; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zhang X, 2010, J GENE MED, V12, P945, DOI 10.1002/jgm.1518	38	16	17	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2012	7	4							e34778	10.1371/journal.pone.0034778	http://dx.doi.org/10.1371/journal.pone.0034778			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UD	22536330	Green Published, gold, Green Submitted			2022-12-25	WOS:000305339200019
J	Fang, G; Haznadar, M; Wang, W; Yu, HY; Steinbach, M; Church, TR; Oetting, WS; Van Ness, B; Kumar, V				Fang, Gang; Haznadar, Majda; Wang, Wen; Yu, Haoyu; Steinbach, Michael; Church, Timothy R.; Oetting, William S.; Van Ness, Brian; Kumar, Vipin			High-Order SNP Combinations Associated with Complex Diseases: Efficient Discovery, Statistical Power and Functional Interactions	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; DETECTING GENE-GENE; MULTIFACTOR DIMENSIONALITY REDUCTION; COMBINATORIAL PARTITIONING METHOD; LUNG-CANCER; ENVIRONMENT INTERACTIONS; MISSING HERITABILITY; POPULATION; CARCINOGEN; EXPRESSION	There has been increased interest in discovering combinations of single-nucleotide polymorphisms (SNPs) that are strongly associated with a phenotype even if each SNP has little individual effect. Efficient approaches have been proposed for searching two-locus combinations from genome-wide datasets. However, for high-order combinations, existing methods either adopt a brute-force search which only handles a small number of SNPs (up to few hundreds), or use heuristic search that may miss informative combinations. In addition, existing approaches lack statistical power because of the use of statistics with high degrees-of-freedom and the huge number of hypotheses tested during combinatorial search. Due to these challenges, functional interactions in high-order combinations have not been systematically explored. We leverage discriminative-pattern-mining algorithms from the data-mining community to search for high-order combinations in case-control datasets. The substantially improved efficiency and scalability demonstrated on synthetic and real datasets with several thousands of SNPs allows the study of several important mathematical and statistical properties of SNP combinations with order as high as eleven. We further explore functional interactions in high-order combinations and reveal a general connection between the increase in discriminative power of a combination over its subsets and the functional coherence among the genes comprising the combination, supported by multiple datasets. Finally, we study several significant high-order combinations discovered from a lung-cancer dataset and a kidney-transplant-rejection dataset in detail to provide novel insights on the complex diseases. Interestingly, many of these associations involve combinations of common variations that occur in small fractions of population. Thus, our approach is an alternative methodology for exploring the genetics of rare diseases for which the current focus is on individually rare variations.	[Fang, Gang; Wang, Wen; Steinbach, Michael; Kumar, Vipin] Univ Minnesota, Dept Comp Sci, Minneapolis, MN 55455 USA; [Haznadar, Majda; Van Ness, Brian] Univ Minnesota, Dept Genet Cell Biol & Dev, Minneapolis, MN 55455 USA; [Yu, Haoyu] Univ Minnesota, Minnesota Supercomp Inst, Minneapolis, MN USA; [Church, Timothy R.] Univ Minnesota, Dept Environm Hlth Sci, Minneapolis, MN 55455 USA; [Oetting, William S.] Univ Minnesota, Dept Expt & Clin Pharmacol, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Fang, G (corresponding author), Univ Minnesota, Dept Comp Sci, Minneapolis, MN 55455 USA.	gangfang@cs.umn.edu; kumar@cs.umn.edu	Wang, Wen/E-6320-2012; Church, Timothy/AAH-7017-2020	Wang, Wen/0000-0002-5812-6744; Church, Timothy/0000-0003-3292-5035; Steinbach, Michael/0000-0002-7309-6395	NSF [IIS0916439]; University of Minnesota; University of Minnesota Interdisciplinary Informatics; Direct For Computer & Info Scie & Enginr [0916439] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); University of Minnesota(University of Minnesota System); University of Minnesota Interdisciplinary Informatics; Direct For Computer & Info Scie & Enginr(National Science Foundation (NSF)NSF - Directorate for Computer & Information Science & Engineering (CISE))	This work was supported by NSF grants #IIS0916439, a University of Minnesota Rochester Biomedical Informatics and Computational Biology Program Traineeship Award, and a seed grant from the University of Minnesota Interdisciplinary Informatics. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal R., 1994, P 20 INT C VER LARG, P487; Anastassiou D, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100124; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Baranzini SE, 2009, HUM MOL GENET, V18, P2078, DOI 10.1093/hmg/ddp120; Bay SD, 2001, DATA MIN KNOWL DISC, V5, P213, DOI 10.1023/A:1011429418057; Bayardo RJ, 2000, DATA MIN KNOWL DISC, V4, P217, DOI 10.1023/A:1009895914772; Bey EA, 2007, P NATL ACAD SCI USA, V104, P11832, DOI 10.1073/pnas.0702176104; Brinza D., 2010, BIOINFORMATICS; Cantor RM, 2010, AM J HUM GENET, V86, P6, DOI 10.1016/j.ajhg.2009.11.017; Cardon LR, 2003, LANCET, V361, P598, DOI 10.1016/S0140-6736(03)12520-2; Carrasquillo MM, 2002, NAT GENET, V32, P237, DOI 10.1038/ng998; Christensen K, 2007, NEW ENGL J MED, V356, P1094, DOI 10.1056/NEJMp068126; Church TR, 2010, INT J MOL EPIDEMIOL, V1, P295; Church TR, 2009, CANCER EPIDEM BIOMAR, V18, P260, DOI 10.1158/1055-9965.EPI-08-0718; Cordell HJ, 2009, NAT REV GENET, V10, P392, DOI 10.1038/nrg2579; Costanzo M, 2010, SCIENCE, V327, P425, DOI 10.1126/science.1180823; Dong J.L., 1999, P 5 ACM SIGKDD INT C, P43, DOI [10.1145/312129.312191, DOI 10.1145/312129.312191]; Dowell RD, 2010, SCIENCE, V328, P469, DOI 10.1126/science.1189015; Eichler EE, 2010, NAT REV GENET, V11, P446, DOI 10.1038/nrg2809; Evans DM, 2006, PLOS GENET, V2, P1424, DOI 10.1371/journal.pgen.0020157; Fang G, 2012, IEEE T KNOWL DATA EN, V24, P279, DOI 10.1109/TKDE.2010.241; Fang G, 2010, BIOCOMPUT-PAC SYM, P145; Gao A, 2010, TOXICOL LETT, V193, P236, DOI 10.1016/j.toxlet.2010.01.017; Goldstein DB, 2009, NEW ENGL J MED, V360, P1696, DOI 10.1056/NEJMp0806284; Grahne G, 2003, WORKSH FREQ IT MIN I; Greene CS, 2010, BIOINFORMATICS, V26, P694, DOI 10.1093/bioinformatics/btq009; Greene CS, 2010, BIOCOMPUT-PAC SYM, P327; Gupta R., 2008, P 14 ACM SIGKDD INT; He H, 2009, BMC MED GENET, V10, DOI 10.1186/1471-2350-10-127; Herold C, 2009, BIOINFORMATICS, V25, P3275, DOI 10.1093/bioinformatics/btp596; Hirschhorn JN, 2009, NEW ENGL J MED, V360, P1699, DOI 10.1056/NEJMp0808934; Howard TD, 2002, AM J HUM GENET, V70, P230, DOI 10.1086/338242; Hua X, 2010, BIOINFORMATICS, V26, P1871, DOI 10.1093/bioinformatics/btq290; Huang J, 2004, P NATL ACAD SCI USA, V101, P10529, DOI 10.1073/pnas.0403794101; Huttenhower C, 2009, GENOME RES, V19, P1093, DOI 10.1101/gr.082214.108; Kam-Thong T, 2010, EUROPEAN J IN PRESS; Kraft P, 2009, NEW ENGL J MED, V360, P1701, DOI 10.1056/NEJMp0810107; Lehar J, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.51; Lou XY, 2008, AM J HUM GENET, V83, P457, DOI 10.1016/j.ajhg.2008.09.001; Lou XY, 2007, AM J HUM GENET, V80, P1125, DOI 10.1086/518312; Ma L, 2010, GENET EPIDEMIOL, V34, P434, DOI 10.1002/gepi.20496; Maher B, 2008, NATURE, V456, P18, DOI 10.1038/456018a; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Marchini J, 2005, NAT GENET, V37, P413, DOI 10.1038/ng1537; Moore JH, 2010, BIOINFORMATICS, V26, P445, DOI 10.1093/bioinformatics/btp713; Motsinger-Reif AA, 2008, GENET EPIDEMIOL, V32, P767, DOI 10.1002/gepi.20345; Nelson MR, 2001, GENOME RES, V11, P458, DOI 10.1101/gr.172901; Norris MD, 2005, MOL CANCER THER, V4, P547, DOI 10.1158/1535-7163.MCT-04-0161; Oji Y, 2002, INT J CANCER, V100, P297, DOI 10.1002/ijc.10476; Pattin KA, 2009, EXPERT REV PROTEOMIC, V6, P647, DOI 10.1586/EPR.09.86; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rabinowitz D, 2000, HUM HERED, V50, P211, DOI 10.1159/000022918; RITCHIE M, 2001, AM J HUM GENET, V69, P1245; Schadt EE, 2005, NAT GENET, V37, P710, DOI 10.1038/ng1589; Small KM, 2002, NEW ENGL J MED, V347, P1135, DOI 10.1056/NEJMoa020803; Steinbach M, 2011, LECT NOTES ARTIF INT, V6634, P338, DOI 10.1007/978-3-642-20841-6_28; Storey JD, 2005, PLOS BIOL, V3, P1380, DOI 10.1371/journal.pbio.0030267; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Stram DO, 2004, GENET EPIDEMIOL, V27, P365, DOI 10.1002/gepi.20028; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tentori L, 2005, PHARMACOL RES, V52, P25, DOI 10.1016/j.phrs.2005.02.010; Thorisson GA, 2005, GENOME RES, V15, P1592, DOI 10.1101/gr.4413105; van der Deen M, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-59; Van Ness B, 2008, BMC MED, V6, DOI 10.1186/1741-7015-6-26; Van Steen K, 2011, BRIEFINGS BIOINFORMA; Varadan V, 2006, BIOINFORMATICS, V22, pE497, DOI 10.1093/bioinformatics/btl224; Varadan V, 2006, PLOS COMPUT BIOL, V2, P585, DOI 10.1371/journal.pcbi.0020068; Vicent S, 2010, J CLIN INVEST, V120, P3940, DOI 10.1172/JCI44165; Wan X, 2010, AM J HUMAN GENETICS; Wang HJ, 2009, CANCER-AM CANCER SOC, V115, P595, DOI 10.1002/cncr.24042; Wang K, 2007, AM J HUM GENET, V81, P1278, DOI 10.1086/522374; Wang K, 2010, NAT REV GENET, V11, P843, DOI 10.1038/nrg2884; Wang Z, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011384; Yosef N, 2007, BIOINFORMATICS, V23, pE91, DOI 10.1093/bioinformatics/btl298; Zhang W, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000642; Zhang X, 2010, BIOINFORMATICS, V26, pi217, DOI 10.1093/bioinformatics/btq186; Zhang Y, 2007, NAT GENET, V39, P1167, DOI 10.1038/ng2110	77	41	41	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2012	7	4							e33531	10.1371/journal.pone.0033531	http://dx.doi.org/10.1371/journal.pone.0033531			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TL	22536319	Green Published, Green Submitted, gold			2022-12-25	WOS:000305336200003
J	Kim, ASN; Binns, MA; Alain, C				Kim, Alice S. N.; Binns, Malcolm A.; Alain, Claude			Neuroelectric Evidence for Cognitive Association Formation: An Event-Related Potential Investigation	PLOS ONE			English	Article							RECOGNITION MEMORY; SLOW-WAVE; RECOLLECTION; FAMILIARITY; RETRIEVAL; ORDER; P300; INTERFERENCE; DISSOCIATION; HIPPOCAMPAL	Although many types of learning require associations to be formed, little is known about the brain mechanisms engaged in association formation. In the present study, we measured event-related potentials (ERPs) while participants studied pairs of semantically related words, with each word of a pair presented sequentially. To narrow in on the associative component of the signal, the ERP difference between the first and second words of a pair (Word2-Word1) was derived separately for subsequently recalled and subsequently not-recalled pairs. When the resulting difference waveforms were contrasted, a parietal positivity was observed for subsequently recalled pairs around 460 ms after the word presentation onset, followed by a positive slow wave that lasted until around 845 ms. Together these results suggest that associations formed between semantically related words are correlated with a specific neural signature that is reflected in scalp recordings over the parietal region.	[Kim, Alice S. N.; Binns, Malcolm A.; Alain, Claude] Rotman Res Inst Baycrest, Toronto, ON, Canada; [Kim, Alice S. N.; Alain, Claude] Univ Toronto, Dept Psychol, Toronto, ON M5S 1A1, Canada; [Binns, Malcolm A.] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; Baycrest; University of Toronto; University of Toronto	Kim, ASN (corresponding author), Rotman Res Inst Baycrest, Toronto, ON, Canada.	aa.kim@utoronto.ca	Binns, Malcolm/AAQ-9195-2020	Binns, Malcolm/0000-0001-9998-6612	Canadian Institutes of Health Research [MT 13364, MOP 106619]; Natural Sciences and Engineering Research Council of Canada; Men's Service Group of Baycrest Hospital	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Men's Service Group of Baycrest Hospital	This work was supported by grants from the Canadian Institutes of Health Research to T. W. Picton (grant number MT 13364) and C. Alain (grant number MOP 106619). Additionally, this work was also supported by a Canada Graduate Scholarship from the Natural Sciences and Engineering Research Council of Canada and the Men's Service Group of Baycrest Hospital (A.S.N.K.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achim AM, 2005, J COGNITIVE NEUROSCI, V17, P652, DOI 10.1162/0898929053467578; ALVAREZ P, 1994, P NATL ACAD SCI USA, V91, P7041, DOI 10.1073/pnas.91.15.7041; Caplan JB, 2005, J MATH PSYCHOL, V49, P383, DOI 10.1016/j.jmp.2005.06.004; Caplan JB, 2009, J COGNITIVE NEUROSCI, V21, P1346, DOI 10.1162/jocn.2008.21167; DEESE J, 1957, J EXP PSYCHOL, V54, P180, DOI 10.1037/h0040536; Donaldson DI, 1998, NEUROPSYCHOLOGIA, V36, P377, DOI 10.1016/S0028-3932(97)00143-7; Donchin E., 1991, HDB COGNITIVE PSYCHO, P471; Donchin E, 1978, MULTIDISCIPLINARY PE; Duzel E, 2001, P NATL ACAD SCI USA, V98, P8101, DOI 10.1073/pnas.131205798; FABIANI M, 1990, ELECTROEN CLIN NEURO, V75, P22, DOI 10.1016/0013-4694(90)90149-E; FRIEDMAN D, 1990, BIOL PSYCHOL, V30, P61, DOI 10.1016/0301-0511(90)90091-A; Friedman D, 2000, MICROSC RES TECHNIQ, V51, P6, DOI 10.1002/1097-0029(20001001)51:1<6::AID-JEMT2>3.0.CO;2-R; Garcia-Larrea L, 1998, EVOKED POTENTIAL, V108, P260, DOI 10.1016/S0168-5597(97)00085-3; Johnson Jr R., 1995, HDB NEUROPSYCHOLOGY, V10, P135; KARIS D, 1984, COGNITIVE PSYCHOL, V16, P177, DOI 10.1016/0010-0285(84)90007-0; Kim ASN, 2009, NEUROPSYCHOLOGIA, V47, P3162, DOI 10.1016/j.neuropsychologia.2009.07.015; Kounios J, 2001, NEURON, V29, P297, DOI 10.1016/S0896-6273(01)00199-4; KUTAS M, 1977, SCIENCE, V197, P792, DOI 10.1126/science.887923; LEWANDOWSKY S, 1989, PSYCHOL REV, V96, P25, DOI 10.1037/0033-295X.96.1.25; Madan CR, 2010, J MEM LANG, V63, P46, DOI 10.1016/j.jml.2010.03.001; Mangels JA, 2001, COGNITIVE BRAIN RES, V11, P77, DOI 10.1016/S0926-6410(00)00066-5; Mecklinger A, 2006, CLIN EEG NEUROSCI, V37, P292, DOI 10.1177/155005940603700406; MORRIS CD, 1977, J VERB LEARN VERB BE, V16, P519, DOI 10.1016/S0022-5371(77)80016-9; Murdock B.B., 1974, HUMAN MEMORY THEORY; MURDOCK BB, 1962, J EXP PSYCHOL, V64, P482, DOI 10.1037/h0045106; Murray LJ, 2007, J NEUROSCI, V27, P5515, DOI 10.1523/JNEUROSCI.0406-07.2007; Norman KA, 2003, PSYCHOL REV, V110, P611, DOI 10.1037/0033-295X.110.4.611; PAIVIO A, 1965, J VERB LEARN VERB BE, V4, P32, DOI 10.1016/S0022-5371(65)80064-0; PAIVIO A, 1963, CAN J PSYCHOLOGY, V17, P370, DOI 10.1037/h0083277; PALLER KA, 1987, ELECTROEN CLIN NEURO, V67, P360, DOI 10.1016/0013-4694(87)90124-6; Paller KA, 2002, TRENDS COGN SCI, V6, P93, DOI 10.1016/S1364-6613(00)01845-3; PALLER KA, 1990, J EXP PSYCHOL LEARN, V16, P1021, DOI 10.1037/0278-7393.16.6.1021; Park H, 2008, CEREB CORTEX, V18, P868, DOI 10.1093/cercor/bhm130; Ranganath C, 2004, NEUROPSYCHOLOGIA, V42, P2, DOI 10.1016/j.neuropsychologia.2003.07.006; Rehani M, 2011, Q J EXP PSYCHOL, V64, P1409, DOI 10.1080/17470218.2010.549945; RUCHKIN DS, 1982, PSYCHOPHYSIOLOGY, V19, P629, DOI 10.1111/j.1469-8986.1982.tb02514.x; Rugg M.D., 1995, OX PSYCH S, P133; Rugg MD, 2002, PHILOS T R SOC B, V357, P1097, DOI 10.1098/rstb.2002.1102; Rugg MD, 2000, OXFORD HDB MEMORY, P521; Rugg MD, 2007, TRENDS COGN SCI, V11, P251, DOI 10.1016/j.tics.2007.04.004; Rugg MD, 2008, PROG BRAIN RES, V169, P339, DOI 10.1016/S0079-6123(07)00021-0; SANQUIST TF, 1980, PSYCHOPHYSIOLOGY, V17, P568, DOI 10.1111/j.1469-8986.1980.tb02299.x; Sikstrom S, 2006, COGNITIVE SCI, V30, P243, DOI 10.1207/s15516709cog0000_55; SOMMER W, 1991, ELECTROEN CLIN NEURO, V79, P457, DOI 10.1016/0013-4694(91)90165-Z; STUSS DT, 1978, BEHAV BIOL, V23, P135, DOI 10.1016/S0091-6773(78)91734-0; Tendolkar I, 1997, NEUROREPORT, V8, P501, DOI 10.1097/00001756-199701200-00025; TULVING E, 1973, PSYCHOL REV, V80, P352, DOI 10.1037/h0020071; Tulving E, 2006, DISTINCTIVENESS MEMO, P407, DOI [DOI 10.1093/ACPROF:OSO/9780195169669.003.0018, 10.1093/acprof:oso/9780195169669.003.0018]; Tulving E, 2007, MEMORY MIND FESTSCHR, P31; Tulving E, 2010, MEMORY, AGING AND THE BRAIN: A FESTSCHRIFT IN HONOUR OF LARS-GORAN NILSSON, P92; Wagner AD, 1999, PHILOS T R SOC B, V354, P1307, DOI 10.1098/rstb.1999.0481; Weyerts H, 1997, NEUROREPORT, V8, P1583, DOI 10.1097/00001756-199705060-00007; Woodruff CC, 2006, BRAIN RES, V1100, P125, DOI 10.1016/j.brainres.2006.05.019; Yonelinas AP, 2002, J MEM LANG, V46, P441, DOI 10.1006/jmla.2002.2864; Yu SS, 2010, BRAIN RES, V1320, P74, DOI 10.1016/j.brainres.2009.12.071	55	8	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2012	7	4							e34856	10.1371/journal.pone.0034856	http://dx.doi.org/10.1371/journal.pone.0034856			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TL	22536337	gold, Green Published, Green Submitted			2022-12-25	WOS:000305336200010
J	Simonov, M; Rawlings, RA; Comment, N; Reed, SE; Shi, XY; Nelson, PW				Simonov, Michael; Rawlings, Renata A.; Comment, Nick; Reed, Scott E.; Shi, Xiaoyu; Nelson, Patrick W.			Modeling Adaptive Regulatory T-Cell Dynamics during Early HIV Infection	PLOS ONE			English	Article							RESPONSES	Regulatory T-cells (Tregs) are a subset of CD4(+) T-cells that have been found to suppress the immune response. During HIV viral infection, Treg activity has been observed to have both beneficial and deleterious effects on patient recovery; however, the extent to which this is regulated is poorly understood. We hypothesize that this dichotomy in behavior is attributed to Treg dynamics changing over the course of infection through the proliferation of an 'adaptive' Treg population which targets HIV-specific immune responses. To investigate the role Tregs play in HIV infection, a delay differatial equation model was constructed to examine (1) the possible existence of two distinct Treg populations, normal (nTregs) and adaptive (aTregs), and (2) their respective effects in limiting viral load. Sensitivity analysis was performed to test parameter regimes that show the proportionality of viral load with adaptive regulatory populations and also gave insight into the importance of downregulation of CD4(+) cells by normal Tregs on viral loads. Through the inclusion of Treg populations in the model, a diverse array of viral dynamics was found. Specifically, oscillatory and steady state behaviors were both witnessed and it was seen that the model provided a more accurate depiction of the effector cell population as compared with previous models. Through further studies of adaptive and normal Tregs, improved treatments for HIV can be constructed for patients and the viral mechanisms of infection can be further elucidated.	[Simonov, Michael; Reed, Scott E.] Univ Michigan, Dept Math, Ann Arbor, MI 48109 USA; [Rawlings, Renata A.; Comment, Nick; Nelson, Patrick W.] Univ Michigan, Ctr Computat Med & Bioinformat, Ann Arbor, MI 48109 USA; [Shi, Xiaoyu] Univ Michigan, Dept Biomed Engn, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Simonov, M (corresponding author), Univ Michigan, Dept Math, Ann Arbor, MI 48109 USA.	pwn@umich.edu		Simonov, Michael/0000-0001-8032-1119	National Science Foundation, Division of Mathematical Sciences (NSF-DMS), Alliances for Graduate Education and the Professoriate (NSF-AGEP) [0634590]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K12GM081259] Funding Source: NIH RePORTER	National Science Foundation, Division of Mathematical Sciences (NSF-DMS), Alliances for Graduate Education and the Professoriate (NSF-AGEP); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding was provided by the National Science Foundation, Division of Mathematical Sciences (NSF-DMS) 0634590, Alliances for Graduate Education and the Professoriate (NSF-AGEP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banacloche JG, 2000, J IMMUNOL, V165, P1082; Bassingthwaighte J, 2011, JSIM SIMULATION SYST; Bluestone JA, 2003, NAT REV IMMUNOL, V3, P253, DOI 10.1038/nri1032; Ciupe MS, 2006, MATH BIOSCI, V200, P1, DOI 10.1016/j.mbs.2005.12.006; Eggena MP, 2005, J IMMUNOL, V174, P4407, DOI 10.4049/jimmunol.174.7.4407; Kinter AL, 2004, J EXP MED, V200, P331, DOI 10.1084/jem.20032069; Marino S, 2008, J THEOR BIOL, V254, P178, DOI 10.1016/j.jtbi.2008.04.011; Oswald-Richter K, 2004, PLOS BIOL, V2, P955, DOI 10.1371/journal.pbio.0020198; Perelson AS, 1999, SIAM REV, V41, P3, DOI 10.1137/S0036144598335107; Romagnani S, 2005, MICROBES INFECT, V7, P1015, DOI 10.1016/j.micinf.2005.03.017; Rouse BT, 2006, IMMUNOL REV, V212, P272, DOI 10.1111/j.0105-2896.2006.00412.x; Stafford MA, 2000, J THEOR BIOL, V203, P285, DOI 10.1006/jtbi.2000.1076; Terzieva V, 2008, VIRAL IMMUNOL, V21, P285, DOI 10.1089/vim.2008.0006; Weiss L, 2004, BLOOD, V104, P3249, DOI 10.1182/blood-2004-01-0365	14	5	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2012	7	4							e33924	10.1371/journal.pone.0033924	http://dx.doi.org/10.1371/journal.pone.0033924			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TL	22536321	gold, Green Submitted, Green Published			2022-12-25	WOS:000305336200004
J	Wang, Y; Ma, N; Wang, Y; Chen, GJ				Wang, Yaru; Ma, Na; Wang, Yan; Chen, Guangju			Allosteric Analysis of Glucocorticoid Receptor-DNA Interface Induced by Cyclic Py-Im Polyamide: A Molecular Dynamics Simulation Study	PLOS ONE			English	Article							AMBER FORCE-FIELD; BINDING DOMAIN; MINOR-GROOVE; UNSTRUCTURED REGION; CONTINUUM SOLVENT; STRUCTURAL BASIS; NUCLEIC-ACIDS; RECOGNITION; PROTEIN; INHIBITION	Background: It has been extensively developed in recent years that cell-permeable small molecules, such as polyamide, can be programmed to disrupt transcription factor-DNA interfaces and can silence aberrant gene expression. For example, cyclic pyrrole-imidazole polyamide that competes with glucocorticoid receptor (GR) for binding to glucocorticoid response elements could be expected to affect the DNA dependent binding by interfering with the protein-DNA interface. However, how such small molecules affect the transcription factor-DNA interfaces and gene regulatory pathways through DNA structure distortion is not fully understood so far. Methodology/Principal Findings: In the present work, we have constructed some models, especially the ternary model of polyamides+DNA+GR DNA-binding domain (GRDBD) dimer, and carried out molecular dynamics simulations and free energy calculations for them to address how polyamide molecules disrupt the GRDBD and DNA interface when polyamide and protein bind at the same sites on opposite grooves of DNA. Conclusions/Significance: We found that the cyclic polyamide binding in minor groove of DNA can induce a large structural perturbation of DNA, i.e. a >4 angstrom widening of the DNA minor groove and a compression of the major groove by more than 4 angstrom as compared with the DNA molecule in the GRDBD dimer+DNA complex. Further investigations for the ternary system of polyamides+DNA+GRDBD dimer and the binary system of allosteric DNA+GRDBD dimer revealed that the compression of DNA major groove surface causes GRDBD to move away from the DNA major groove with the initial average distance of similar to 4 angstrom to the final average distance of similar to 10 angstrom during 40 ns simulation course. Therefore, this study straightforward explores how small molecule targeting specific sites in the DNA minor groove disrupts the transcription factor-DNA interface in DNA major groove, and consequently modulates gene expression.	[Wang, Yaru; Ma, Na; Wang, Yan; Chen, Guangju] Beijing Normal Univ, Coll Chem, Beijing 100875, Peoples R China	Beijing Normal University	Wang, Y (corresponding author), Beijing Normal Univ, Coll Chem, Beijing 100875, Peoples R China.	wangy@bnu.edu.cn; wangy@bnu.edu.cn; gjchen@bnu.edu.cn			National Science Foundation of China [21073015, 21131003, 20771017, 20973024]; Major State Basic Research Development Programs [2011CB808500]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Major State Basic Research Development Programs(National Basic Research Program of China)	The authors acknowledge research support from the National Science Foundation of China (No. 21073015, 21131003, 20771017 and 20973024), the Major State Basic Research Development Programs (grant No. 2011CB808500). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez LD, 2008, J MED CHEM, V51, P1352, DOI 10.1021/jm800007w; Alvarez LD, 2008, CHEMMEDCHEM, V3, P1869, DOI 10.1002/cmdc.200800256; Bishop TC, 1996, PROTEINS, V24, P115; Cheatham TE, 1998, J BIOMOL STRUCT DYN, V16, P265, DOI 10.1080/07391102.1998.10508245; Chenoweth DM, 2010, J AM CHEM SOC, V132, P14521, DOI 10.1021/ja105068b; Chenoweth DM, 2009, P NATL ACAD SCI USA, V106, P13175, DOI 10.1073/pnas.0906532106; Dervan PB, 2003, CURR OPIN STRUC BIOL, V13, P284, DOI 10.1016/S0959-440X(03)00081-2; Dervan PB, 2001, BIOORGAN MED CHEM, V9, P2215, DOI 10.1016/S0968-0896(01)00262-0; Diamond MI, 2000, P NATL ACAD SCI USA, V97, P657, DOI 10.1073/pnas.97.2.657; Duan Y, 2003, J COMPUT CHEM, V24, P1999, DOI 10.1002/jcc.10349; Fiamegos YC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018127; Goetz TL, 2000, MOL CELL BIOL, V20, P81, DOI 10.1128/MCB.20.1.81-90.2000; Green SM, 2010, J BIOL CHEM; HARRIS LF, 1993, P NATL ACAD SCI USA, V90, P5534, DOI 10.1073/pnas.90.12.5534; Harris LF, 1995, J BIOMOL STRUCT DYN, V13, P423, DOI 10.1080/07391102.1995.10508852; Hsu CF, 2008, BIOORG MED CHEM LETT, V18, P5851, DOI 10.1016/j.bmcl.2008.05.063; Huey R, 2007, J COMPUT CHEM, V28, P1145, DOI 10.1002/jcc.20634; Jayaram B, 1998, J AM CHEM SOC, V120, P10629, DOI 10.1021/ja981307p; Jensen F, 2017, INTRO COMPUTATIONAL; Kielkopf CL, 1998, SCIENCE, V282, P111, DOI 10.1126/science.282.5386.111; Kollman PA, 2000, ACCOUNTS CHEM RES, V33, P889, DOI 10.1021/ar000033j; Kosikov KM, 2002, J AM CHEM SOC, V124, P4838, DOI 10.1021/ja0125218; KOTTALAM J, 1990, BIOPOLYMERS, V29, P1409, DOI 10.1002/bip.360291008; LAVERY R, 1988, J BIOMOL STRUCT DYN, V6, P63, DOI 10.1080/07391102.1988.10506483; Lee GM, 2008, J MOL BIOL, V382, P1014, DOI 10.1016/j.jmb.2008.07.064; Lee MC, 2004, PROTEINS, V55, P620, DOI 10.1002/prot.10470; Leulliot N, 2001, BIOCHEMISTRY-US, V40, P7947, DOI 10.1021/bi010680y; Lonard DM, 2007, ENDOCR REV, V28, P575, DOI 10.1210/er.2007-0012; LUISI BF, 1991, NATURE, V352, P497, DOI 10.1038/352497a0; McQuarrie D. A, 2000, STAT MECH; Meijsing SH, 2009, SCIENCE, V324, P407, DOI 10.1126/science.1164265; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; Muzikar KA, 2009, P NATL ACAD SCI USA, V106, P16598, DOI 10.1073/pnas.0909192106; Neidle S., 1994, DNA STRUCTURE RECOGN; Nguyen-Hackley DH, 2004, BIOCHEMISTRY-US, V43, P3880, DOI 10.1021/bi030223c; Perez A, 2007, BIOPHYS J, V92, P3817, DOI 10.1529/biophysj.106.097782; Presman DM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013279; Pufall MA, 2005, SCIENCE, V309, P142, DOI 10.1126/science.1111915; Pufall MA, 2002, ANNU REV CELL DEV BI, V18, P421, DOI 10.1146/annurev.cellbio.18.031502.133614; Rocha-Viegas L, 2006, J BIOL CHEM, V281, P33959, DOI 10.1074/jbc.M602408200; Rogatsky I, 2003, P NATL ACAD SCI USA, V100, P13845, DOI 10.1073/pnas.2336092100; Sanner MF, 1999, J MOL GRAPH MODEL, V17, P57; So AYL, 2007, PLOS GENET, V3, P927, DOI 10.1371/journal.pgen.0030094; Srinivasan J, 1998, J AM CHEM SOC, V120, P9401, DOI 10.1021/ja981844+; Stockner T, 2003, J MOL BIOL, V328, P325, DOI 10.1016/S0022-2836(03)00316-4; Strahs D, 2000, J MOL BIOL, V301, P643, DOI 10.1006/jmbi.2000.3863; van Tilborg MAA, 2000, J MOL BIOL, V301, P947, DOI 10.1006/jmbi.2000.4001; van Tilborg PJA, 2000, BIOCHEMISTRY-US, V39, P8747, DOI 10.1021/bi991550g; VANTILBORG MAA, 1995, J MOL BIOL, V247, P689, DOI 10.1016/S0022-2836(05)80148-2; Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035; Yang B, 2011, J COMPUT CHEM, V32, P416, DOI 10.1002/jcc.21630; Zhang Q, 2004, J AM CHEM SOC, V126, P7958, DOI 10.1021/ja0373622	52	11	11	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2012	7	4							e35159	10.1371/journal.pone.0035159	http://dx.doi.org/10.1371/journal.pone.0035159			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TL	22532842	Green Published, gold			2022-12-25	WOS:000305336200025
J	Votion, DM; Gnaiger, E; Lemieux, H; Mouithys-Mickalad, A; Serteyn, D				Votion, Dominique-Marie; Gnaiger, Erich; Lemieux, Helene; Mouithys-Mickalad, Ange; Serteyn, Didier			Physical Fitness and Mitochondrial Respiratory Capacity in Horse Skeletal Muscle	PLOS ONE			English	Article							AEROBIC CAPACITY; GLUTEUS MEDIUS; OXIDATIVE-PHOSPHORYLATION; CELLULAR RESPIRATION; ENDURANCE HORSES; GENE-EXPRESSION; BICEPS FEMORIS; SMALL BIOPSIES; FIBER TYPES; INHIBITION	Background: Within the animal kingdom, horses are among the most powerful aerobic athletic mammals. Determination of muscle respiratory capacity and control improves our knowledge of mitochondrial physiology in horses and high aerobic performance in general. Methodology/Principal Findings: We applied high-resolution respirometry and multiple substrate-uncoupler-inhibitor titration protocols to study mitochondrial physiology in small (1.0-2.5 mg) permeabilized muscle fibres sampled from triceps brachii of healthy horses. Oxidative phosphorylation (OXPHOS) capacity (pmol O-2.s(-2).mg(-1) wet weight) with combined Complex I and II (CI+II) substrate supply (malate+glutamate+succinate) increased from 77 +/- 18 in overweight horses to 103 +/- 18, 122 +/- 15, and 129 +/- 12 in untrained, trained and competitive horses (N = 3, 8, 16, and 5, respectively). Similar to human muscle mitochondria, equine OXPHOS capacity was limited by the phosphorylation system to 0.85 +/- 0.10 (N = 32) of electron transfer capacity, independent of fitness level. In 15 trained horses, OXPHOS capacity increased from 119 +/- 12 to 134 +/- 37 when pyruvate was included in the CI+ II substrate cocktail. Relative to this maximum OXPHOS capacity, Complex I (CI)-linked OXPHOS capacities were only 50% with glutamate+malate, 64% with pyruvate+malate, and 68% with pyruvate+malate+glutamate, and similar to 78% with CII-linked succinate+rotenone. OXPHOS capacity with glutamate+malate increased with fitness relative to CI+ II-supported ETS capacity from a flux control ratio of 0.38 to 0.40, 0.41 and 0.46 in overweight to competitive horses, whereas the CII/CI+II substrate control ratio remained constant at 0.70. Therefore, the apparent deficit of the CI- over CII-linked pathway capacity was reduced with physical fitness. Conclusions/Significance: The scope of mitochondrial density-dependent OXPHOS capacity and the density-independent (qualitative) increase of CI-linked respiratory capacity with increased fitness open up new perspectives of integrative and comparative mitochondrial respiratory physiology.	[Votion, Dominique-Marie] Univ Liege, Equine European Ctr Mont Le Soie, Vielsalm, Belgium; [Votion, Dominique-Marie; Serteyn, Didier] Univ Liege, Fac Vet Med, Equine Clin, Liege, Belgium; [Gnaiger, Erich; Lemieux, Helene] Med Univ Innsbruck, D Swarovski Res Lab, Dept Visceral Transplant & Thorac Surg, Innsbruck, Austria; [Mouithys-Mickalad, Ange; Serteyn, Didier] Univ Liege, Ctr Oxygen Res & Dev, Liege, Belgium	University of Liege; University of Liege; Medical University of Innsbruck; University of Liege	Votion, DM (corresponding author), Univ Liege, Equine European Ctr Mont Le Soie, Vielsalm, Belgium.	dominique.votion@ulg.ac.be		Gnaiger, Erich/0000-0003-3647-5895; Votion, Dominique-Marie/0000-0003-2899-8207; Mouithys Mickalad, Ange/0000-0001-9777-3023; lemieux, Helene/0000-0002-8864-6062	'Ministere de l'Agriculture et de la Ruralite de la Region Wallonne' of Belgium [06/472 10]; National Sciences and Engineering Research Council (Canada); Fonds Quebecois de la Recherche sur la Nature et les Techologies (Quebec, Canada)	'Ministere de l'Agriculture et de la Ruralite de la Region Wallonne' of Belgium; National Sciences and Engineering Research Council (Canada)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Fonds Quebecois de la Recherche sur la Nature et les Techologies (Quebec, Canada)	This study was supported by the 'Ministere de l'Agriculture et de la Ruralite de la Region Wallonne' of Belgium (subvention 06/472 10). H. Lemieux was supported by postdoctoral fellowships from the National Sciences and Engineering Research Council (Canada) and Fonds Quebecois de la Recherche sur la Nature et les Techologies (Quebec, Canada). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aragones J, 2008, NAT GENET, V40, P170, DOI 10.1038/ng.2007.62; Arnaud MG., 1997, NOTATION ETAT CORPOR, V1, P40; Barrey E, 1999, Equine Vet J Suppl, P289; Barrey E, 2009, BMC VET RES, V5, DOI 10.1186/1746-6148-5-29; Benard G, 2008, INT J BIOCHEM CELL B, V40, P1543, DOI 10.1016/j.biocel.2007.11.023; Benard G, 2010, BBA-BIOENERGETICS, V1797, P698, DOI 10.1016/j.bbabio.2010.02.030; Boushel R, 2007, DIABETOLOGIA, V50, P790, DOI 10.1007/s00125-007-0594-3; Boushel R, 2011, MITOCHONDRION, V11, P303, DOI 10.1016/j.mito.2010.12.006; Bouwman FG, 2010, COMP BIOCHEM PHYS D, V5, P55, DOI 10.1016/j.cbd.2009.11.001; Cassart D, 2007, EQUINE VET J, V39, P26, DOI 10.2746/042516407X157765; CHANCE B, 1955, J BIOL CHEM, V217, P429; Chilibeck PD, 1999, EUR J APPL PHYSIOL, V80, P604, DOI 10.1007/s004210050641; CUTMORE CMM, 1985, EQUINE VET J, V17, P354, DOI 10.1111/j.2042-3306.1985.tb02519.x; DELHUMEAU G, 1994, TOXICOL APPL PHARM, V126, P345, DOI 10.1006/taap.1994.1125; DIJESO F, 1988, CR SOC BIOL, V182, P266; Eaton M D, 1999, Equine Vet J Suppl, P521; Eivers SS, 2010, PHYSIOL GENOMICS, V40, P83, DOI 10.1152/physiolgenomics.00041.2009; Gastin PB, 2001, SPORTS MED, V31, P725, DOI 10.2165/00007256-200131100-00003; Gnaiger E, 2000, P NATL ACAD SCI USA, V97, P11080, DOI 10.1073/pnas.97.20.11080; Gnaiger E, 2003, ADV EXP MED BIOL, V543, P39; Gnaiger E, 1995, J BIOENERG BIOMEMBR, V27, P583, DOI 10.1007/BF02111656; Gnaiger E, 2009, INT J BIOCHEM CELL B, V41, P1837, DOI 10.1016/j.biocel.2009.03.013; GOLLNICK PD, 1990, PFLUG ARCH EUR J PHY, V415, P407, DOI 10.1007/BF00373617; GUY PS, 1977, J PHYSIOL-LONDON, V269, P33, DOI 10.1113/jphysiol.1977.sp011891; Hayot M, 2005, EUR RESPIR J, V25, P431, DOI 10.1183/09031936.05.00053404; Hinkle PC, 2005, BBA-BIOENERGETICS, V1706, P1, DOI 10.1016/j.bbabio.2004.09.004; Hoppeler H, 2002, J EXP BIOL, V205, P2143; HOPPELER H, 1985, J EXP BIOL, V115, P355; Hoppeler H, 1999, INT J OBESITY, V23, pS7, DOI 10.1038/sj.ijo.0800878; HOPPELER H, 1987, RESP PHYSIOL, V69, P27, DOI 10.1016/0034-5687(87)90099-5; Jeppesen TD, 2003, ANN NEUROL, V54, P86, DOI 10.1002/ana.10594; Johnson G, 2006, AM J PHYSIOL-ENDOC M, V291, pE460, DOI 10.1152/ajpendo.00258.2005; KAYAR SR, 1989, PFLUG ARCH EUR J PHY, V413, P343, DOI 10.1007/BF00584481; KLINE KH, 1988, COMP BIOCHEM PHYS A, V91, P815, DOI 10.1016/0300-9629(88)90969-3; Kuznetsov AV, 2004, AM J PHYSIOL-HEART C, V286, pH1633, DOI 10.1152/ajpheart.00701.2003; Kuznetsov AV, 2002, ANAL BIOCHEM, V305, P186, DOI 10.1006/abio.2002.5658; Lemieux H, 2011, INT J BIOCHEM CELL B, V43, P1729, DOI 10.1016/j.biocel.2011.08.008; Lenaz G, 2010, ANTIOXID REDOX SIGN, V12, P961, DOI 10.1089/ars.2009.2704; LETELLIER T, 1992, PEDIATR RES, V32, P17, DOI 10.1203/00006450-199207000-00004; LINDHOLM A, 1974, ACTA VET SCAND, V15, P287; LINDSTEDT SL, 1991, NATURE, V353, P748, DOI 10.1038/353748a0; McGivney BA, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-398; Nelson D.L.C., 2005, LEHNINGER PRINCIPLES, V4th ed., P601; Nouette-Gaulain K, 2011, INT J BIOCHEM CELL B, V43, P14, DOI 10.1016/j.biocel.2010.10.005; Pesta D, 2012, METHODS MOL BIOL, V810, P25, DOI 10.1007/978-1-61779-382-0_3; Pesta D, 2011, AM J PHYSIOL-REG I, V301, pR1078, DOI 10.1152/ajpregu.00285.2011; Piercy RJ, 2004, EQUINE SPORTS MED SU, P43; Poole D. C., 2004, Equine and Comparative Exercise Physiology, V1, P5, DOI 10.1079/ECP20036; Quiroz-Rothe E, 2001, HISTOCHEM CELL BIOL, V116, P299, DOI 10.1007/s004180100319; Rasmussen UF, 2000, MOL CELL BIOCHEM, V208, P37, DOI 10.1023/A:1007046028132; Rasmussen UF, 2004, COMP BIOCHEM PHYS A, V137, P435, DOI 10.1016/j.cbpb.2003.11.002; Rasmussen UF, 2001, AM J PHYSIOL-ENDOC M, V280, pE301, DOI 10.1152/ajpendo.2001.280.2.E301; RIVERO JLL, 1995, EQUINE VET J, V27, P51, DOI 10.1111/j.2042-3306.1995.tb03033.x; RIVERO JLL, 1995, VET REC, V137, P187, DOI 10.1136/vr.137.8.187; Rivero JLL, 1996, RES VET SCI, V61, P49, DOI 10.1016/S0034-5288(96)90110-1; Rostovtseva TK, 2008, P NATL ACAD SCI USA, V105, P18746, DOI 10.1073/pnas.0806303105; SALTIN B, 1967, J APPL PHYSIOL, V23, P353, DOI 10.1152/jappl.1967.23.3.353; Scheibye-Knudsen M, 2009, EUR J APPL PHYSIOL, V105, P279, DOI 10.1007/s00421-008-0901-9; Serrano AL, 2001, J ANAT, V199, P329, DOI 10.1046/j.1469-7580.2001.19930329.x; SKLADAL D, 1994, MOD TR BIOTHERMOKIN, V3, P268; SNOW DH, 1976, EQUINE VET J, V8, P150, DOI 10.1111/j.2042-3306.1976.tb03327.x; SNOW DH, 1980, RES VET SCI, V28, P137, DOI 10.1016/S0034-5288(18)32735-8; Straub R., 1983, Equine exercise physiology. Proceedings of the first international conference, P193; TAYLOR CR, 1981, RESP PHYSIOL, V44, P25, DOI 10.1016/0034-5687(81)90075-X; TREMBLAY A, 1994, METABOLISM, V43, P814, DOI 10.1016/0026-0495(94)90259-3; Turner DL, 1997, ACTA PHYSIOL SCAND, V161, P459, DOI 10.1046/j.1365-201X.1997.00246.x; Tyler CM, 1998, PFLUG ARCH EUR J PHY, V436, P391, DOI 10.1007/s004240050648; Van Galen G, 2008, EQUINE VET EDUC, V20, P234, DOI 10.2746/095777308X299103; VANDENHOVEN R, 1985, AM J VET RES, V46, P939; VEKSLER VI, 1987, BIOCHIM BIOPHYS ACTA, V892, P191, DOI 10.1016/0005-2728(87)90174-5; Votion D. M., 2007, Equine and Comparative Exercise Physiology, V4, P105; Votion DM, 2010, EQUINE VET J, V42, P268, DOI 10.1111/j.2042-3306.2010.00271.x; Votion DM, 2009, VET J, V180, P77, DOI 10.1016/j.tvjl.2008.01.016; Weibel ER, 2004, RESP PHYSIOL NEUROBI, V140, P115, DOI 10.1016/j.resp.2004.01.006; WEIBEL ER, 1991, P NATL ACAD SCI USA, V88, P10357, DOI 10.1073/pnas.88.22.10357; Weijs W. A., 2002, European Journal of Morphology, V40, P145, DOI 10.1076/ejom.40.3.145.16687; Westermann CM, 2008, NEUROMUSCULAR DISORD, V18, P355, DOI 10.1016/j.nmd.2008.02.007; Wiswell RA, 2000, MED SCI SPORT EXER, V32, P1165, DOI 10.1097/00005768-200006000-00021; Young BL, 2002, EQUINE VET J, V34, P469, DOI 10.2746/042516402776117755	79	42	43	1	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2012	7	4							e34890	10.1371/journal.pone.0034890	http://dx.doi.org/10.1371/journal.pone.0034890			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959XD	22529950	Green Published, Green Submitted, gold			2022-12-25	WOS:000305350600037
J	Campbell, DD; Parra, MV; Duque, C; Gallego, N; Franco, L; Tandon, A; Hunemeier, T; Bortolini, C; Villegas, A; Bedoya, G; McCarthy, MI; Price, A; Reich, D; Ruiz-Linares, A				Campbell, Desmond D.; Parra, Maria V.; Duque, Constanza; Gallego, Natalia; Franco, Liliana; Tandon, Arti; Huenemeier, Tabita; Bortolini, Catira; Villegas, Alberto; Bedoya, Gabriel; McCarthy, Mark I.; Price, Alkes; Reich, David; Ruiz-Linares, Andres			Amerind Ancestry, Socioeconomic Status and the Genetics of Type 2 Diabetes in a Colombian Population	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; SUSCEPTIBILITY LOCI; MEXICAN-AMERICANS; ADMIXTURE; PREVALENCE; REPLICATION; MELLITUS; KCNQ1	The "thrifty genotype" hypothesis proposes that the high prevalence of type 2 diabetes (T2D) in Native Americans and admixed Latin Americans has a genetic basis and reflects an evolutionary adaptation to a past low calorie/high exercise lifestyle. However, identification of the gene variants underpinning this hypothesis remains elusive. Here we assessed the role of Native American ancestry, socioeconomic status (SES) and 21 candidate gene loci in susceptibility to T2D in a sample of 876 T2D cases and 399 controls from Antioquia (Colombia). Although mean Native American ancestry is significantly higher in T2D cases than in controls (32% v 29%), this difference is confounded by the correlation of ancestry with SES, which is a stronger predictor of disease status. Nominally significant association (P<0.05) was observed for markers in: TCF7L2, RBMS1, CDKAL1, ZNF239, KCNQ1 and TCF1 and a significant bias (P<0.05) towards OR>1 was observed for markers selected from previous T2D genome-wide association studies, consistent with a role for Old World variants in susceptibility to T2D in Latin Americans. No association was found to the only known Native American-specific gene variant previously associated with T2D in a Mexican sample (rs9282541 in ABCA1). An admixture mapping scan with 1,536 ancestry informative markers (AIMs) did not identify genome regions with significant deviation of ancestry in Antioquia. Exclusion analysis indicates that this scan rules out similar to 95% of the genome as harboring loci with ancestry risk ratios >1.22 (at P<0.05).	[Campbell, Desmond D.; Parra, Maria V.; Duque, Constanza; Ruiz-Linares, Andres] UCL, Dept Genet Evolut & Environm, London, England; [Parra, Maria V.; Duque, Constanza; Gallego, Natalia; Franco, Liliana; Villegas, Alberto; Bedoya, Gabriel] Univ Antioquia, Lab Genet Mol, Medellin, Colombia; [Tandon, Arti; Reich, David] Harvard Univ, Sch Med, Dept Genet, Boston, MA USA; [Huenemeier, Tabita; Bortolini, Catira] Univ Fed Rio Grande do Sul, Dept Genet, Porto Alegre, RS, Brazil; [McCarthy, Mark I.] Univ Oxford, Oxford Ctr Diabet Endocrinol & Metab, Churchill Hosp, Oxford, England; [McCarthy, Mark I.] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England; [McCarthy, Mark I.] Churchill Hosp, Oxford NIHR Biomed Res Ctr, Oxford OX3 7LJ, England; [Price, Alkes] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Reich, David] Broad Inst Harvard & MIT, Cambridge, MA USA	University of London; University College London; Universidad de Antioquia; Harvard University; Harvard Medical School; Universidade Federal do Rio Grande do Sul; University of Oxford; University of Oxford; Wellcome Centre for Human Genetics; University of Oxford; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Campbell, DD (corresponding author), UCL, Dept Genet Evolut & Environm, London, England.	a.ruizlin@ucl.ac.uk	Franco, Laercio Joel/H-3814-2013; Hünemeier, Tábita/F-4181-2011; Ruiz-Linares, Andres/AAR-1104-2021; McCarthy, Mark/M-3763-2015	Franco, Laercio Joel/0000-0002-9820-3425; Ruiz-Linares, Andres/0000-0001-8372-1011; Gallego Lopera, Berta Natalia/0000-0001-8109-8473; Franco Hincapie, Liliana/0000-0001-9430-2808; Hunemeier, Tabita/0000-0002-3156-2079; Parra-Marin, Maria Victoria/0000-0002-8475-471X; Campbell, Desmond/0000-0003-1085-714X; McCarthy, Mark/0000-0002-4393-0510	Ruth Kirschstein National Research Service Award from the National Institutes of Health (NIH); Harvard Medical School; NIH grants [NS043538, DK073818]; Colciencias grants [1115-04-16451, 1115-04-012986]; Universidad de Antioquia grant [CODI/sostenibilidad 9889-E01321]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R21DK073818] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS043538] Funding Source: NIH RePORTER	Ruth Kirschstein National Research Service Award from the National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Harvard Medical School; NIH grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Colciencias grants; Universidad de Antioquia grant; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The authors are very grateful to the volunteers that contributed samples for this project. AP was supported by a Ruth Kirschstein National Research Service Award from the National Institutes of Health (NIH). This work was partially funded by discretionary funding from Harvard Medical School (to DR), NIH grants NS043538 (to AR-L) and DK073818 (to DR), Colciencias grants 1115-04-16451 and 1115-04-012986 (to GB and AV), and a Universidad de Antioquia grant [CODI/sostenibilidad 9889-E01321] (to GB and AV). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, R LANG ENV STAT COMP; Aschner P, 2002, DIABETES-METAB RES, V18, pS27, DOI 10.1002/dmrr.280; Bedoya G, 2006, P NATL ACAD SCI USA, V103, P7234, DOI 10.1073/pnas.0508716103; Benyshek DC, 2006, AM J PHYS ANTHROPOL, V131, P120, DOI 10.1002/ajpa.20334; Burrows NR, 2000, DIABETES CARE, V23, P1786, DOI 10.2337/diacare.23.12.1786; Campbell DD, 2007, BEHAV GENET, V37, P408, DOI 10.1007/s10519-006-9123-2; Carvajal-Carmona LG, 2003, HUM GENET, V112, P534, DOI 10.1007/s00439-002-0899-8; Carvajal-Carmona LG, 2000, AM J HUM GENET, V67, P1287, DOI 10.1016/S0002-9297(07)62956-5; CHAKRABORTY R, 1986, GENET EPIDEMIOL, V3, P435, DOI 10.1002/gepi.1370030608; de Ferranti David, 2004, INEQUALITY LATIN AM; Diamond J, 2003, NATURE, V423, P599, DOI 10.1038/423599a; Florez JC, 2009, DIABETOLOGIA, V52, P1528, DOI 10.1007/s00125-009-1412-x; GARDNER LI, 1984, DIABETES, V33, P86, DOI 10.2337/diabetes.33.1.86; King H, 1998, DIABETES CARE, V21, P1414, DOI 10.2337/diacare.21.9.1414; KNOWLER WC, 1978, AM J EPIDEMIOL, V108, P497, DOI 10.1093/oxfordjournals.aje.a112648; Martinez-Marignac VL, 2007, HUM GENET, V120, P807, DOI 10.1007/s00439-006-0273-3; NEEL JV, 1962, AM J HUM GENET, V14, P353; Parra EJ, 2004, J MED GENET, V41, DOI 10.1136/jmg.2004.018887; Patterson N, 2004, AM J HUM GENET, V74, P979, DOI 10.1086/420871; Pollard T.M., 2008, W DIS EVOLUTIONARY P; Price AL, 2007, AM J HUM GENET, V80, P1024, DOI 10.1086/518313; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; Scott LJ, 2007, SCIENCE, V316, P1341, DOI 10.1126/science.1142382; Stumvoll M, 2005, LANCET, V365, P1333, DOI 10.1016/S0140-6736(05)61032-X; Unoki H, 2008, NAT GENET, V40, P1098, DOI 10.1038/ng.208; Villarreal-Molina MT, 2008, DIABETES, V57, P509, DOI 10.2337/db07-0484; Voight BF, 2010, NAT GENET, V42, P579, DOI 10.1038/ng.609; Wang S, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000037; Waters KM, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001078; Williams RC, 2000, AM J HUM GENET, V66, P527, DOI 10.1086/302773; Yasuda K, 2008, NAT GENET, V40, P1092, DOI 10.1038/ng.207; Zeggini E, 2008, NAT GENET, V40, P638, DOI 10.1038/ng.120; Zeggini E, 2007, SCIENCE, V316, P1336, DOI 10.1126/science.1142364	34	41	43	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2012	7	4							e33570	10.1371/journal.pone.0033570	http://dx.doi.org/10.1371/journal.pone.0033570			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WC	22529894	Green Published, Green Submitted, Green Accepted, gold			2022-12-25	WOS:000305347400002
J	Hannula, SE; de Boer, W; van Veen, J				Hannula, Silja Emilia; de Boer, Wietse; van Veen, Johannes			A 3-Year Study Reveals That Plant Growth Stage, Season and Field Site Affect Soil Fungal Communities while Cultivar and GM-Trait Have Minor Effects	PLOS ONE			English	Article							GRADIENT GEL-ELECTROPHORESIS; ACCUMULATING POTATO PLANTS; GENETICALLY-MODIFIED CROPS; 16S RIBOSOMAL-RNA; MICROBIAL COMMUNITIES; BACTERIAL COMMUNITIES; TRANSGENIC POTATOES; RHIZOSPHERE SOIL; DIVERSITY; MICROORGANISMS	In this three year field study the impact of different potato (Solanum tuberosum L.) cultivars including a genetically modified (GM) amylopectin-accumulating potato line on rhizosphere fungal communities are investigated using molecular microbiological methods. The effects of growth stage of a plant, soil type and year on the rhizosphere fungi were included in this study. To compare the effects, one GM cultivar, the parental isoline, and four non-related cultivars were planted in the fields and analysed using T-RFLP on the basis of fungal phylum specific primers combined with multivariate statistical methods. Additionally, fungal biomass and some extracellular fungal enzymes (laccases, Mn-peroxidases and cellulases) were quantified in order to gain insight into the function of the fungal communities. Plant growth stage and year (and agricultural management) had the strongest effect on both diversity and function of the fungal communities while the GM-trait studied was the least explanatory factor. The impact of cultivar and soil type was intermediate. Occasional differences between cultivars, the amylopectin-accumulating potato line, and its parental variety were detected, but these differences were mostly transient in nature and detected either only in one soil, one growth stage or one year.	[Hannula, Silja Emilia; de Boer, Wietse; van Veen, Johannes] Netherlands Inst Ecol NIOO KNAW, Dept Microbial Ecol, Wageningen, Netherlands; [van Veen, Johannes] Leiden Univ, Inst Biol, Leiden, Netherlands	Royal Netherlands Academy of Arts & Sciences; Netherlands Institute of Ecology (NIOO-KNAW); Leiden University; Leiden University - Excl LUMC	Hannula, SE (corresponding author), Netherlands Inst Ecol NIOO KNAW, Dept Microbial Ecol, Wageningen, Netherlands.	e.hannula@nioo.knaw.nl	van Veen, Johannes A/C-3697-2011; de Boer, Wietse/C-2737-2011; Hannula, Silja Emilia/C-7462-2012; KNAW, NIOO-KNAW/A-4320-2012	de Boer, Wietse/0000-0002-5380-2993; Hannula, Silja Emilia/0000-0003-1398-2018; KNAW, NIOO-KNAW/0000-0002-3835-159X	ERGO of the Netherlands Organization for Scientific Research [838.06.052]	ERGO of the Netherlands Organization for Scientific Research	This research was financed by ERGO grant number 838.06.052 of the Netherlands Organization for Scientific Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdo Z, 2006, ENVIRON MICROBIOL, V8, P929, DOI 10.1111/j.1462-2920.2005.00959.x; Acosta-Martinez V, 2008, SOIL BIOL BIOCHEM, V40, P2762, DOI 10.1016/j.soilbio.2008.07.022; Berg G, 2009, FEMS MICROBIOL ECOL, V68, P1, DOI 10.1111/j.1574-6941.2009.00654.x; Birch ANE, 2007, PEDOBIOLOGIA, V51, P251, DOI 10.1016/j.pedobi.2007.04.008; Bodeker ITM, 2009, ISME J, V3, P1387, DOI 10.1038/ismej.2009.77; Broeckling CD, 2008, APPL ENVIRON MICROB, V74, P738, DOI 10.1128/AEM.02188-07; Buee M, 2009, PLANT SOIL, V321, P189, DOI 10.1007/s11104-009-9991-3; Buyer JS, 2002, CAN J MICROBIOL, V48, P955, DOI [10.1139/w02-095, 10.1139/W02-095]; Carlile M, 2001, FUNGI; Culman SW, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-171; de Ridder-Duine AS, 2006, PEDOBIOLOGIA, V50, P293, DOI 10.1016/j.pedobi.2006.03.004; de Vetten N, 2003, NAT BIOTECHNOL, V21, P439, DOI 10.1038/nbt801; DONEGAN KK, 1995, APPL SOIL ECOL, V2, P111, DOI 10.1016/0929-1393(94)00043-7; Donegan KK, 1996, TRANSGENIC RES, V5, P25, DOI 10.1007/BF01979919; Donegan KK, 1999, J APPL ECOL, V36, P920, DOI 10.1046/j.1365-2664.1999.00448.x; Duineveld BM, 2001, APPL ENVIRON MICROB, V67, P172, DOI 10.1128/AEM.67.1.172-178.2001; Dunfield KE, 2003, APPL ENVIRON MICROB, V69, P7310, DOI 10.1128/AEM.69.12.7310-7318.2003; Fitzjohn RG, 2007, MOL ECOL NOTES, V7, P583, DOI 10.1111/j.1471-8286.2007.01744.x; Garbeva P, 2004, ANNU REV PHYTOPATHOL, V42, P243, DOI 10.1146/annurev.phyto.42.012604.135455; Giovannetti M, 2005, RIV BIOL-BIOL FORUM, V98, P393; Gotz M, 2006, FEMS MICROBIOL ECOL, V58, P404, DOI 10.1111/j.1574-6941.2006.00169.x; Gomes NCM, 2003, APPL ENVIRON MICROB, V69, P3758, DOI 10.1128/AEM.69.7.3758-3766.2003; Gomes NCM, 2001, PLANT SOIL, V232, P167, DOI 10.1023/A:1010350406708; Griffiths BS, 2007, PEDOBIOLOGIA, V51, P195, DOI 10.1016/j.pedobi.2007.04.002; Gschwendtner S, 2010, PLANT SOIL, V335, P413, DOI 10.1007/s11104-010-0430-2; Hack H., 2001, BBCH MONOGRAPH; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Hannula SE, 2010, SOIL BIOL BIOCHEM, V42, P2211, DOI 10.1016/j.soilbio.2010.08.020; Hannula SE, 2012, NEW PHYTOLO IN PRESS, pxx; Hart MM, 2009, PEDOBIOLOGIA, V52, P253, DOI 10.1016/j.pedobi.2008.10.005; Helgason T, 1998, NATURE, V394, P431, DOI 10.1038/28764; Inceoglu O, 2010, APPL ENVIRON MICROB, V76, P3675, DOI 10.1128/AEM.00040-10; Jones DL, 2004, NEW PHYTOL, V163, P459, DOI 10.1111/j.1469-8137.2004.01130.x; Kennedy AC, 1999, AGR ECOSYST ENVIRON, V74, P65, DOI 10.1016/S0167-8809(99)00030-4; Lee SH, 2011, MICROB ECOL, V61, P646, DOI 10.1007/s00248-010-9776-5; Lottmann J, 2000, FEMS MICROBIOL ECOL, V33, P41, DOI 10.1111/j.1574-6941.2000.tb00725.x; Lottmann J, 1999, FEMS MICROBIOL ECOL, V29, P365; Lukow T, 2000, FEMS MICROBIOL ECOL, V32, P241, DOI 10.1111/j.1574-6941.2000.tb00717.x; LYNCH JM, 1990, PLANT SOIL, V129, P1, DOI 10.1007/BF00011685; Marschner P, 2003, SOIL BIOL BIOCHEM, V35, P453, DOI 10.1016/S0038-0717(02)00297-3; Marschner P, 2002, PLANT SOIL, V246, P167, DOI 10.1023/A:1020663909890; Milling A, 2004, PLANT SOIL, V266, P23; Raaijmakers JM, 2009, PLANT SOIL, V321, P341, DOI 10.1007/s11104-008-9568-6; Sessitsch A, 2004, PLANT SOIL, V266, P105; Smalla K, 2001, APPL ENVIRON MICROB, V67, P4742, DOI 10.1128/AEM.67.10.4742-4751.2001; Turrini A, 2004, PLANT SOIL, V266, P69; van der Wal A, 2006, SOIL BIOL BIOCHEM, V38, P2890, DOI 10.1016/j.soilbio.2006.04.046; van Overbeek L, 2008, FEMS MICROBIOL ECOL, V64, P283, DOI 10.1111/j.1574-6941.2008.00469.x; Verbruggen E, 2010, NEW PHYTOL, V186, P968, DOI 10.1111/j.1469-8137.2010.03230.x; Wang GH, 2009, PLANT SOIL, V317, P135, DOI 10.1007/s11104-008-9794-y; Wei XD, 2006, PLANT SOIL, V285, P347, DOI 10.1007/s11104-006-9020-8; Weinert N, 2009, APPL ENVIRON MICROB, V75, P3859, DOI 10.1128/AEM.00414-09; Wolfenbarger LL, 2000, SCIENCE, V290, P2088, DOI 10.1126/science.290.5499.2088	53	52	54	2	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2012	7	4							e33819	10.1371/journal.pone.0033819	http://dx.doi.org/10.1371/journal.pone.0033819			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WC	22529898	Green Submitted, Green Published, gold			2022-12-25	WOS:000305347400005
J	Hu, ZL; Fan, Z; Zhao, ZL; Chen, J; Li, JC				Hu, Zhangli; Fan, Zhun; Zhao, Zhonglin; Chen, Jun; Li, Jiancheng			Stable Expression of Antibiotic-Resistant Gene ble from Streptoalloteichus hindustanus in the Mitochondria of Chlamydomonas reinhardtii	PLOS ONE			English	Article							DOMINANT SELECTABLE MARKER; GREEN FLUORESCENT PROTEIN; PHLEOMYCIN-RESISTANCE; TRANSFORMATION; SACCHAROMYCES; CHLOROPLAST; FUSION; EXPORT	The mitochondrial expression of exogenous antibiotic resistance genes has not been demonstrated successfully to date, which has limited the development of antibiotic resistance genes as selectable markers for mitochondrial site-directed transformation in Chlamydomonas reinhardtii. In this work, the plasmid pBSLPNCB was constructed by inserting the gene ble of Streptoalloteichus hindustanus (Sh ble), encoding a small (14-kilodalton) protective protein into the site between TERMINVREP-Left repeats and the cob gene in a fragment of mitochondrial DNA (mtDNA) of C. reinhardtii. The fusion DNA-construct, which contained TERMINVREP-Left, Sh ble, cob, and partial nd4 sequence, were introduced into the mitochondria of the respiratory deficient dum-1 mutant CC-2654 of C. reinhardtii by biolistic particle delivery system. A large number of transformants were obtained after eight weeks in the dark. Subsequent subculture of the transformants on the selection TAP media containing 3 ig/mL Zeomycin for 12 months resulted in genetically modified transgenic algae MT-Bs. Sequencing and Southern analyses on the mitochondrial genome of the different MT-B lines revealed that Sh ble gene had been integrated into the mitochondrial genome of C. reinhardtii. Both Western blot, using the anti-BLE monoclonal antibody, and Zeomycin tolerance analysis confirmed the presence of BLE protein in the transgenic algal cells. It indicates that the Sh ble gene can be stably expressed in the mitochondria of C. reinhardtii.	[Hu, Zhangli; Fan, Zhun; Zhao, Zhonglin; Chen, Jun; Li, Jiancheng] Shenzhen Univ, Coll Life Sci, Shenzhen Key Lab Marine Bioresource & Ecoenvironm, Shenzhen, Peoples R China; [Zhao, Zhonglin] Henan Agr Univ, Coll Sci, Zhengzhou, Peoples R China	Shenzhen University; Henan Agricultural University	Hu, ZL (corresponding author), Shenzhen Univ, Coll Life Sci, Shenzhen Key Lab Marine Bioresource & Ecoenvironm, Shenzhen, Peoples R China.	huzl@szu.edu.cn			National Natural Science Foundation of China [31070323, 41176106, 31000162]; Science and Technology Planning Project of Shenzhen, China	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Planning Project of Shenzhen, China	This work was supported by the National Natural Science Foundation of China (Grant No. 31070323,41176106, 31000162), Science and Technology Planning Project of Shenzhen, China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams KL, 2003, MOL PHYLOGENET EVOL, V29, P380, DOI 10.1016/S1055-7903(03)00194-5; BARON M, 1992, GENE, V114, P239, DOI 10.1016/0378-1119(92)90581-9; Bennett RP, 1998, BIOTECHNIQUES, V24, P478, DOI 10.2144/98243pf01; Cardol P., 2009, CHLAMYDOMONAS SOURCE, P445; Cohen JS, 2001, MITOCHONDRION, V1, P181, DOI 10.1016/S1567-7249(01)00012-5; COLLEAUX L, 1990, MOL GEN GENET, V223, P288, DOI 10.1007/BF00265065; DROCOURT D, 1990, NUCLEIC ACIDS RES, V18, P4009, DOI 10.1093/nar/18.13.4009; Franklin SE, 2004, CURR OPIN PLANT BIOL, V7, P159, DOI 10.1016/j.pbi.2004.01.012; Funes Soledad, 2007, Methods Mol Biol, V372, P137, DOI 10.1007/978-1-59745-365-3_10; GOLDSCHMIDTCLERMONT M, 1991, NUCLEIC ACIDS RES, V19, P4083, DOI 10.1093/nar/19.15.4083; Heitzer M, 2007, ADV EXP MED BIOL, V616, P46; Hu ZL, 2011, MITOCHONDRION, V11, P716, DOI 10.1016/j.mito.2011.05.012; Mireau H, 2003, MOL GENET GENOMICS, V270, P1, DOI 10.1007/s00438-003-0879-2; MULSANT P, 1988, SOMAT CELL MOLEC GEN, V14, P243, DOI 10.1007/BF01534585; NEWMAN SM, 1990, GENETICS, V126, P875; PEREZ P, 1989, PLANT MOL BIOL, V13, P365, DOI 10.1007/BF00015548; POYTON RO, 1996, ADV MOL CEL, V17, P247; RANDOLPHANDERSON BL, 1993, MOL GEN GENET, V236, P235, DOI 10.1007/BF00277118; Remacle C, 2006, P NATL ACAD SCI USA, V103, P4771, DOI 10.1073/pnas.0509501103; Remacle Claire, 1998, Advances in Photosynthesis, V7, P661; Sambrook J, 1989, MOL CLONNING LAB MAN; Soltys BJ, 2000, INT REV CYTOL, V194, P133; Stevens DR, 1996, MOL GEN GENET, V251, P23; Walker TL, 2005, PLANT CELL REP, V24, P629, DOI 10.1007/s00299-005-0004-6; Wang CG, 2004, CHINESE SCI BULL, V49, P1713, DOI 10.1360/04wc0232; Wang CG, 2010, J PHYCOL, V46, P396, DOI 10.1111/j.1529-8817.2009.00789.x; Yamasaki T, 2005, PLANT MOL BIOL, V58, P515, DOI 10.1007/s11103-005-7081-3; Yoon YG, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni140	28	28	30	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2012	7	4							e35542	10.1371/journal.pone.0035542	http://dx.doi.org/10.1371/journal.pone.0035542			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WC	22530046	Green Submitted, Green Published, gold			2022-12-25	WOS:000305347400059
J	Lin, P; Wang, M; Li, Y; Zhang, QL; Yang, F; Zhao, JK				Lin, Peng; Wang, Man; Li, Yan; Zhang, Qiaoli; Yang, Fang; Zhao, Jinkou			Detoxification Center-Based Sampling Missed a Subgroup of Higher Risk Drug Users, a Case from Guangdong, China	PLOS ONE			English	Article							HIV	Background: Injection drug use remains among the most important HIV transmission risk in China. Representativeness of drug users sampled from detoxification centers is questionable. A respondent driven sampling survey was conducted to compare the results with those from the detoxification center in the same city. Methods: In 2008, two independent surveys were conducted in Dongguan, China, one for community-based drug users using respondent driven sampling and the other for drug users in a compulsory detoxification center as routine sentinel surveillance. Demographic and behavioral information were collected using the same structured questionnaire. Intravenous blood samples were collected to measure antibodies to HIV-1, and syphilis. Results: Compared to those 400 drug users recruited from the detoxification center, the 303 community-based drug users had higher HIV prevalence (14.7% versus 4.0%, P = 0.04), lower syphilis prevalence (4.7% versus 10.8%, P = 0.07), higher proportion of injection drug use (83.9% versus 60.2%, P = 0.01) and syringe sharing (47.8% versus 36.3%, P = 0.10), more likely to be separated (12.4% versus 3.8%, P = 0.01) and being migrants from Guangxi province (31.4% versus 18.0%, P = 0.09), more engaging in commercial sex (64.4% versus 52.5%, P = 0.04). HIV prevalence and rate of syringe sharing were consistently higher among drug users from Guangxi. Conclusions: Detoxification center-based sampling missed a subgroup with higher HIV prevalence and higher rate of injection drug use. While detoxification center-based sampled can be used to monitor the trend of HIV prevalence and risk behaviors over time, periodic community-based sampling is still necessary to avoid possible systematic error in detoxification center-based samples.	[Lin, Peng; Li, Yan; Yang, Fang] Ctr Dis Control & Prevent Guangdong Prov, Guangzhou, Guangdong, Peoples R China; [Wang, Man] Zhongshan Municipal Ctr Dis Control & Prevent, Zhongshan, Peoples R China; [Zhang, Qiaoli] Dongguan Municipal Ctr Dis Control & Prevent, Dongguan, Peoples R China; [Zhao, Jinkou] Global Fund Fight AIDS TB & Malaria, Geneva, Switzerland		Lin, P (corresponding author), Ctr Dis Control & Prevent Guangdong Prov, Guangzhou, Guangdong, Peoples R China.	jinkou.zhao@theglobalfund.org		Zhao, Jinkou/0000-0001-9184-3385	China-U.S. Cooperation Program on HIV/AIDS Prevention and Control	China-U.S. Cooperation Program on HIV/AIDS Prevention and Control	The survey was supported by the China-U.S. Cooperation Program on HIV/AIDS Prevention and Control. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chinese Center for Disease Control and Prevention, 2002, GUID PROT HIV AIDS S; Committee of Dongguan Yearbook Compilation, 2006, DONGG YB; Committee of Guangdong Yearbook Compilation, 2006, GUANGD YB; Fu XB, 2008, AIDS BEHAV, V12, pS13, DOI 10.1007/s10461-008-9387-z; Heckathorn DD, 2002, SOC PROBL, V49, P11, DOI 10.1525/sp.2002.49.1.11; Jia YJ, 2008, HARM REDUCT J, V5, DOI 10.1186/1477-7517-5-29; Johnson T, 2005, ANN EPIDEMIOL, V15, P381, DOI 10.1016/j.annepidem.2004.09.004; Kretzschmar M, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-108; Lin P., 2009, Morbidity and Mortality Weekly Report, V58, P396; Lin P, 2003, HUA NAN YU FANG YI X, V29, P12; Liu W, 2006, ADDICTION, V101, P1493, DOI 10.1111/j.1360-0443.2006.01557.x; Lu L, 2008, CELL MOL NEUROBIOL, V28, P479, DOI 10.1007/s10571-007-9225-2; Lu Y, 2007, HARM REDUCT J; Malekinejad M, 2008, AIDS BEHAV, V12, pS105, DOI 10.1007/s10461-008-9421-1; Mathers BM, 2008, LANCET, V372, P1733, DOI 10.1016/S0140-6736(08)61311-2; Ministry of Public Health of China, 2009, EST HIV AIDS EP CHIN; Ruan YH, 2004, SEX TRANSM DIS, V31, P623; Salganik MJ, 2006, J URBAN HEALTH, V83, pI98, DOI 10.1007/s11524-006-9106-x; Salganik MJ, 2004, SOCIOL METHODOL, V34, P193, DOI 10.1111/j.0081-1750.2004.00152.x; Sun XH, 2007, AIDS, V21, pS33, DOI 10.1097/01.aids.0000304694.54884.06; Tang YL, 2006, ADDICTION, V101, P657, DOI 10.1111/j.1360-0443.2006.01367.x; Wu ZY, 2007, LANCET, V369, P679, DOI 10.1016/S0140-6736(07)60315-8; Xiong JG, 2007, YU FANG YI XUE QING, V23, P14; Xu C, 2006, ZHONGGUO AI ZI BING, V12, P409; Zhang QL, 2007, XIAN DAI YU FANG YI, V34, P4537	25	4	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2012	7	4							e35189	10.1371/journal.pone.0035189	http://dx.doi.org/10.1371/journal.pone.0035189			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959WC	22529988	Green Published, Green Submitted, gold			2022-12-25	WOS:000305347400035
J	Ren, F; Chen, XX; Hesketh, J; Gan, F; Huang, KH				Ren, Fei; Chen, Xingxiang; Hesketh, John; Gan, Fang; Huang, Kehe			Selenium Promotes T-Cell Response to TCR-Stimulation and ConA, but Not PHA in Primary Porcine Splenocytes	PLOS ONE			English	Article							MESSENGER-RNA LEVELS; GLUTATHIONE-PEROXIDASE; DIETARY SELENIUM; LYMPHOCYTE ACTIVATION; OXIDATIVE STRESS; VITAMIN-E; SELENOPROTEINS; EXPRESSION; SUPPLEMENTATION; DEFICIENCY	There is controversy in the literature over whether the selenium (Se) influences cellular immune responses, and the mechanisms possibly underlying these effects are unclear. In this study, the effects of Se on T-cell proliferation and IL-2 production were studied in primary porcine splenocytes. Splenocytes were treated with different mitogens in the presence of 0.5-4 mu mol/L sodium selenite. Se significantly promoted T-cell receptor (TCR) or concanavalin A (ConA)-induced T-cell proliferation and IL-2 production but failed to regulate T-cell response to phytohemagglutinin (PHA). In addition, Se significantly increased the levels of cytosolic glutathione peroxidase (GPx1) and thioredoxin reductase 1 (TR1) mRNA, the activity of GPx1 and the concentration of reduced glutathione (GSH) in the unstimulated, or activated splenocytes. These results indicated that Se improved the redox status in all splenocytes, including unstimulated, TCR, ConA and PHA stimulated, but only TCR and ConA-induced T-cell activation was affected by the redox status. N-acetylcysteine (NAC), a pharmacological antioxidant, increased T-cell proliferation and IL-2 production by TCR and ConA stimulated splenocytes but had no effect on the response to PHA in primary porcine splenocytes confirming that PHA-induced T-cell activation is insensitive to the redox status. We conclude that Se promotes GPx1 and TR1 expression and increases antioxidative capacity in porcine splenocytes, which enhances TCR or ConA -induced T-cell activation but not PHA-induced T-cell activation. The different susceptibilities to Se between the TCR, ConA and PHA -induced T-cell activation may help to explain the controversy in the literature over whether or not Se boosts immune responses.	[Ren, Fei; Chen, Xingxiang; Gan, Fang; Huang, Kehe] Nanjing Agr Univ, Inst Nutr & Metab Disorders Domest Anim & Fowls, Nanjing, Jiangsu, Peoples R China; [Hesketh, John] Univ Newcastle, Sch Med, Inst Cell & Mol Biosci, Newcastle Upon Tyne, Tyne & Wear, England	Nanjing Agricultural University; Newcastle University - UK	Ren, F (corresponding author), Nanjing Agr Univ, Inst Nutr & Metab Disorders Domest Anim & Fowls, Nanjing, Jiangsu, Peoples R China.	khhuang@njau.edu.cn			National Natural Science Foundation of China (NSFC) [30871892, 31011130155]; Royal Society; NSFC; Research Fund for the Doctoral Program of Higher Education of China [20110097110014]; Priority Academic Program Development of Jiangsu Higher Education Institutions	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Royal Society(Royal Society of London); NSFC(National Natural Science Foundation of China (NSFC)); Research Fund for the Doctoral Program of Higher Education of China(Research Fund for the Doctoral Program of Higher Education of China (RFDP)Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Priority Academic Program Development of Jiangsu Higher Education Institutions	This work was funded by the National Natural Science Foundation of China (NSFC) (grant numbers 30871892, 31011130155), an international collaboration grant to John Hesketh and Kehe Huang from The Royal Society and NSFC, the Research Fund for the Doctoral Program of Higher Education of China (grant number 20110097110014) and the Priority Academic Program Development of Jiangsu Higher Education Institutions. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnes KM, 2009, J NUTR, V139, P199, DOI 10.3945/jn.108.098624; Baum MK, 1997, J ACQ IMMUN DEF SYND, V15, P370, DOI 10.1097/00042560-199708150-00007; Bellinger FP, 2009, BIOCHEM J, V422, P11, DOI 10.1042/BJ20090219; Brown KM, 2000, CLIN SCI, V98, P593, DOI 10.1042/CS19990276; Butler JE, 2009, VET IMMUNOL IMMUNOP, V128, P147, DOI 10.1016/j.vetimm.2008.10.321; Carter LL, 1998, J IMMUNOTHER, V21, P181, DOI 10.1097/00002371-199805000-00003; COLLINS RJ, 1991, BIOL TRACE ELEM RES, V30, P233, DOI 10.1007/BF02991418; CURELLO S, 1987, CLIN CHEM, V33, P1448; Fairbairn L, 2011, J LEUKOCYTE BIOL, V89, P855, DOI 10.1189/jlb.1110607; Fairweather-Tait SJ, 2011, ANTIOXID REDOX SIGN, V14, P1337, DOI 10.1089/ars.2010.3275; Finch JM, 1996, RES VET SCI, V60, P97, DOI 10.1016/S0034-5288(96)90001-6; Gromer S, 2005, CELL MOL LIFE SCI, V62, P2414, DOI 10.1007/s00018-005-5143-y; Haddad JJ, 2011, CELL IMMUNOL, V270, P53, DOI 10.1016/j.cellimm.2011.04.001; Hoffmann FW, 2010, J NUTR, V140, P1155, DOI 10.3945/jn.109.120725; Hoffmann PR, 2008, ALLERGY, V63, P854, DOI 10.1111/j.1398-9995.2008.01676.x; Jariwalla RJ, 2009, BRIT J NUTR, V101, P182, DOI 10.1017/S0007114508998305; Kesherwani V, 2007, NITRIC OXIDE-BIOL CH, V16, P294, DOI 10.1016/j.niox.2006.11.001; KUCHAN MJ, 1990, J NUTR BIOCHEM, V1, P478, DOI 10.1016/0955-2863(90)90084-X; LEI XG, 1995, J NUTR, V125, P1438; LOPES MF, 1994, INFECT IMMUN, V62, P1484, DOI 10.1128/IAI.62.4.1484-1488.1994; Maquat LE, 2001, BIOFACTORS, V14, P37, DOI 10.1002/biof.5520140106; Methenitou G, 1996, VET HUM TOXICOL, V38, P274; Miao BC, 2005, INT IMMUNOPHARMACOL, V5, P1171, DOI 10.1016/j.intimp.2005.02.011; MUTH OH, 1958, SCIENCE, V128, P1090, DOI 10.1126/science.128.3331.1090; OFLYNN K, 1985, NATURE, V313, P686, DOI 10.1038/313686a0; Patterson JK, 2008, EXP BIOL MED, V233, P651, DOI 10.3181/0709-MR-262; PECANHA LT, 1989, CLIN EXP IMMUNOL, V76, P311; Qin SY, 2009, J TRACE ELEM MED BIO, V23, P29, DOI 10.1016/j.jtemb.2008.11.001; Romanowska M, 2007, LUNG CANCER, V55, P35, DOI 10.1016/j.lungcan.2006.09.007; Safir N, 2003, CLIN CHEM LAB MED, V41, P1005, DOI 10.1515/CCLM.2003.154; Sengupta A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012249; Shen HM, 2000, FREE RADICAL BIO MED, V28, P1115, DOI 10.1016/S0891-5849(00)00206-9; Shrimali RK, 2008, J BIOL CHEM, V283, P20181, DOI 10.1074/jbc.M802559200; Sunde RA, 2009, BIOSCIENCE REP, V29, P329, DOI 10.1042/BSR20080146; Ueno H, 2007, ANTIOXID REDOX SIGN, V9, P115, DOI 10.1089/ars.2007.9.115; Papp LV, 2007, ANTIOXID REDOX SIGN, V9, P775, DOI 10.1089/ars.2007.1528; Williams MS, 1996, J IMMUNOL, V157, P2395; Wu XS, 2010, BRIT J NUTR, V104, P1605, DOI 10.1017/S0007114510002643; Wu XS, 2010, J NUTR BIOCHEM, V21, P153, DOI 10.1016/j.jnutbio.2008.12.006; Zeng HW, 2008, J NUTR BIOCHEM, V19, P1, DOI 10.1016/j.jnutbio.2007.02.005; Zhang HY, 2010, CANCER LETT, V287, P91, DOI 10.1016/j.canlet.2009.06.001; Zhou JC, 2009, J NUTR, V139, P1061, DOI 10.3945/jn.109.104901	42	36	36	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2012	7	4							e35375	10.1371/journal.pone.0035375	http://dx.doi.org/10.1371/journal.pone.0035375			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WC	22530011	Green Submitted, gold, Green Published			2022-12-25	WOS:000305347400044
J	Libraty, DH; Makela, S; Vlk, J; Hurme, M; Vaheri, A; Ennis, FA; Mustonen, J				Libraty, Daniel H.; Makela, Satu; Vlk, Jennifer; Hurme, Mikko; Vaheri, Antti; Ennis, Francis A.; Mustonen, Jukka			The Degree of Leukocytosis and Urine GATA-3 mRNA Levels Are Risk Factors for Severe Acute Kidney Injury in Puumala Virus Nephropathia Epidemica	PLOS ONE			English	Article							HEMORRHAGIC-FEVER; HANTAVIRUS; INTERLEUKIN-6; GENE	Puumala hantavirus (PUUV) infection, also known as nephropathia epidemica, is the most common cause of hemorrhagic fever with renal syndrome (HFRS) in Europe. The pathogenesis of PUUV nephropathia epidemica is complex and multifactorial, and the risk factors for severe acute kidney injury (AKI) during acute PUUV infection are not well defined. We conducted a prospective study of hospitalized patients with PUUV infection in Tampere, Finland to identify acute illness risk factors for HFRS severity. Serial daily blood and urine samples were collected throughout acute illness and at 2 week and 6 month convalescent visits. By univariate analyses, the maximum white blood cell count during acute illness was a risk factor for severe AKI. There were no significant associations between PUUV-induced AKI severity and platelet counts, C-reactive protein, or alanine aminotransferase levels. Maximum plasma interleukin (IL)-6, urine IL-6, and urine IL-8 concentrations were positively associated with PUUV-induced AKI. Finally, the maximum urinary sediment GATA-3 mRNA level was positively correlated with the peak fold-change in serum creatinine, regardless of AKI severity classification. By multivariate analyses, we found that the maximum levels of leukocytes and urinary sediment GATA-3 mRNA during acute illness were independent risk factors for severe PUUV-induced AKI. We have identified novel acute illness risk factors for severe PUUV-induced AKI.	[Libraty, Daniel H.; Vlk, Jennifer] Univ Massachusetts, Sch Med, Dept Med, Worcester, MA 01605 USA; [Makela, Satu; Mustonen, Jukka] Univ Tampere, Sch Med, Dept Med, FIN-33101 Tampere, Finland; [Hurme, Mikko] Univ Tampere, Sch Med, Dept Microbiol, FIN-33101 Tampere, Finland; [Vaheri, Antti] Univ Helsinki, Dept Virol, Haartman Inst, Helsinki, Finland; [Ennis, Francis A.] Univ Massachusetts, Sch Med, Ctr Infect Dis & Vaccine Res, Worcester, MA USA	University of Massachusetts System; University of Massachusetts Worcester; Tampere University; Tampere University; University of Helsinki; University of Massachusetts System; University of Massachusetts Worcester	Libraty, DH (corresponding author), Univ Massachusetts, Sch Med, Dept Med, Worcester, MA 01605 USA.	daniel.libraty@umassmed.edu	Vaheri, Antti/AAV-1523-2020	Hurme, Mikko/0000-0002-8614-1044; Makela, Satu/0000-0001-6967-2401	National Institutes of Health/National Institute of Allergy and Infectious Diseases (NIH/NIAID) [U19 AI57319]; Pirkanmaa Hospital District; European Commission [QLK2 CT 2002-01358]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI057319] Funding Source: NIH RePORTER	National Institutes of Health/National Institute of Allergy and Infectious Diseases (NIH/NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Pirkanmaa Hospital District; European Commission(European CommissionEuropean Commission Joint Research Centre); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by grants from National Institutes of Health/National Institute of Allergy and Infectious Diseases (NIH/NIAID) (U19 AI57319), Competitive Research Funding of the Pirkanmaa Hospital District, and the European Commission (QLK2 CT 2002-01358). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chan RWY, 2007, RHEUMATOLOGY, V46, P44, DOI 10.1093/rheumatology/kel192; Hoffmann SC, 2005, AM J TRANSPLANT, V5, P573, DOI 10.1111/j.1600-6143.2005.00719.x; Hosoya T, 2010, IMMUNOL REV, V238, P110, DOI 10.1111/j.1600-065X.2010.00954.x; Komatsuda A, 2009, CLIN NEPHROL, V71, P608; LABASTIE MC, 1995, KIDNEY INT, V47, P1597, DOI 10.1038/ki.1995.223; Linderholm M, 1996, J INFECT DIS, V173, P38, DOI 10.1093/infdis/173.1.38; Liu ZW, 2008, VIRAL IMMUNOL, V21, P255, DOI 10.1089/vim.2007.0098; Makary P, EPIDEMIOL INFECT, P1; Makela S, 2004, AM J KIDNEY DIS, V43, P809, DOI 10.1053/j.ajkd.2003.12.044; Makela S, 2001, NEPHROL DIAL TRANSPL, V16, P1368, DOI 10.1093/ndt/16.7.1368; Mehta RL, 2007, CRIT CARE, V11, DOI 10.1186/cc5713; Mustonen J, 1996, KIDNEY INT, V49, P217, DOI 10.1038/ki.1996.29; Obara N, 2008, BLOOD, V111, P5223, DOI 10.1182/blood-2007-10-115857; Outinen TK, 2011, J MED VIROL, V83, P731, DOI 10.1002/jmv.22018; Outinen TK, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-132; Sadeghi M, 2011, BMC IMMUNOL, V12, DOI 10.1186/1471-2172-12-65; Temonen M, 1996, CLIN IMMUNOL IMMUNOP, V78, P47, DOI 10.1006/clin.1996.0007; Tipping PG, 2005, CLIN EXP IMMUNOL, V142, P207, DOI 10.1111/j.1365-2249.2005.02842.x; Vapalahti O, 2003, LANCET INFECT DIS, V3, P653, DOI 10.1016/S1473-3099(03)00774-6; Zhu JF, 2006, CELL RES, V16, P3, DOI 10.1038/sj.cr.7310002	20	34	37	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2012	7	4							e35402	10.1371/journal.pone.0035402	http://dx.doi.org/10.1371/journal.pone.0035402			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VO	22523590	Green Published, Green Submitted, gold			2022-12-25	WOS:000305345000063
J	Lubarsky, HV; Gerbersdorf, SU; Hubas, C; Behrens, S; Ricciardi, F; Paterson, DM				Lubarsky, Helen V.; Gerbersdorf, Sabine U.; Hubas, Cedric; Behrens, Sebastian; Ricciardi, Francesco; Paterson, David M.			Impairment of the Bacterial Biofilm Stability by Triclosan	PLOS ONE			English	Article							EXTRACELLULAR POLYMERIC SUBSTANCES; CHROMATOGRAPHY MASS-SPECTROMETRY; GRADIENT GEL-ELECTROPHORESIS; WIDELY USED BIOCIDE; SURFACE WATERS; SEASONAL VARIABILITY; AQUATIC ENVIRONMENT; METHYL-TRICLOSAN; TOXICITY; COMMUNITIES	The accumulation of the widely-used antibacterial and antifungal compound triclosan (TCS) in freshwaters raises concerns about the impact of this harmful chemical on the biofilms that are the dominant life style of microorganisms in aquatic systems. However, investigations to-date rarely go beyond effects at the cellular, physiological or morphological level. The present paper focuses on bacterial biofilms addressing the possible chemical impairment of their functionality, while also examining their substratum stabilization potential as one example of an important ecosystem service. The development of a bacterial assemblage of natural composition - isolated from sediments of the Eden Estuary (Scotland, UK) - on non-cohesive glass beads (<63 mu m) and exposed to a range of triclosan concentrations (control, 2 - 100 mu g L-1) was monitored over time by Magnetic Particle Induction (MagPI). In parallel, bacterial cell numbers, division rate, community composition (DGGE) and EPS (extracellular polymeric substances: carbohydrates and proteins) secretion were determined. While the triclosan exposure did not prevent bacterial settlement, biofilm development was increasingly inhibited by increasing TCS levels. The surface binding capacity (MagPI) of the assemblages was positively correlated to the microbial secreted EPS matrix. The EPS concentrations and composition (quantity and quality) were closely linked to bacterial growth, which was affected by enhanced TCS exposure. Furthermore, TCS induced significant changes in bacterial community composition as well as a significant decrease in bacterial diversity. The impairment of the stabilization potential of bacterial biofilm under even low, environmentally relevant TCS levels is of concern since the resistance of sediments to erosive forces has large implications for the dynamics of sediments and associated pollutant dispersal. In addition, the surface adhesive capacity of the biofilm acts as a sensitive measure of ecosystem effects.	[Lubarsky, Helen V.; Gerbersdorf, Sabine U.] Univ Stuttgart, Inst Hydraul Engn, Stuttgart, Germany; [Lubarsky, Helen V.; Paterson, David M.] Univ St Andrews, Sediment Ecol Res Grp, Scottish Ocean Inst, Sch Biol, St Andrews, Fife, Scotland; [Hubas, Cedric] UPMC, IRD, DMPA, UMR BOREA Biol Organismes & Ecosyst Aquat,MNHN, Paris, France; [Behrens, Sebastian] Univ Tubingen, Geomicrobiol Microbial Ecol Grp, Ctr Appl Geosci ZAG, Tubingen, Germany; [Ricciardi, Francesco] Univ Girona, Inst Aquat Ecol, Girona, Spain	University of Stuttgart; University of St Andrews; UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Museum National d'Histoire Naturelle (MNHN); Eberhard Karls University of Tubingen; Universitat de Girona	Lubarsky, HV (corresponding author), Univ Stuttgart, Inst Hydraul Engn, Stuttgart, Germany.	sabine.gerbersdorf@iws.uni-stuttgart.de	BOREA, UMR BOREA/C-6165-2008; Paterson, David M/D-5202-2013; Gerbersdorf, Sabine U/B-7875-2009; Hubas, Cédric/P-4200-2019; Ricciardi, Francesco/B-3977-2008	BOREA, UMR BOREA/0000-0002-9110-9292; Paterson, David M/0000-0003-1174-6476; Hubas, Cédric/0000-0002-9110-9292; Lubarsky, Helen/0000-0001-8247-3618; Ricciardi, Francesco/0000-0002-0163-8861	Marie Curie Research Training Network [RTN-CT-2006-035695]; Margarete-von-Wrangell Fellowship for postdoctoral lecture qualification; Ministry of Science, Research and the Arts (MSK); European Social Fund (ESF) of Baden-Wurttemberg; MASTS pooling initiative (The Marine Alliance for Science and Technology for Scotland, Scottish Funding Council) [HR09011]	Marie Curie Research Training Network(European Commission); Margarete-von-Wrangell Fellowship for postdoctoral lecture qualification; Ministry of Science, Research and the Arts (MSK); European Social Fund (ESF) of Baden-Wurttemberg(European Social Fund (ESF)); MASTS pooling initiative (The Marine Alliance for Science and Technology for Scotland, Scottish Funding Council)	The authors are grateful for the financial support of this study. Dr. Lubarsky was funded by Marie Curie Research Training Network (RTN-CT-2006-035695, Project KEYBIOEFFECT). Dr. Gerbersdorf currently holds a Margarete-von-Wrangell Fellowship for postdoctoral lecture qualification, financed by the Ministry of Science, Research and the Arts (MSK) and the European Social Fund (ESF) of Baden-Wurttemberg. This work also received funding from the MASTS pooling initiative (The Marine Alliance for Science and Technology for Scotland, Scottish Funding Council, grant reference HR09011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adolfsson-Erici M, 2002, CHEMOSPHERE, V46, P1485, DOI 10.1016/S0045-6535(01)00255-7; Aguera A, 2003, ANAL CHIM ACTA, V480, P193, DOI 10.1016/S0003-2670(03)00040-0; BASSAM BJ, 1991, ANAL BIOCHEM, V196, P80, DOI 10.1016/0003-2697(91)90120-I; Brummer IHM, 2003, APPL ENVIRON MICROB, V69, P4463, DOI 10.1128/AEM.69.8.4463-4473.2003; Brusetti L, 2006, FEMS MICROBIOL ECOL, V56, P154, DOI 10.1111/j.1574-6941.2005.00059.x; Chalew TEA, 2009, J AM WATER RESOUR AS, V45, P4, DOI 10.1111/j.1752-1688.2008.00284.x; CHO BC, 1990, MAR ECOL PROG SER, V63, P253, DOI 10.3354/meps063253; Czaczyk K, 2007, POL J ENVIRON STUD, V16, P799; DECHO AW, 1990, OCEANOGR MAR BIOL, V28, P73; DeLorenzo ME, 2008, ENVIRON TOXICOL, V23, P224, DOI 10.1002/tox.20327; Dobretsov S, 2007, FEMS MICROBIOL ECOL, V60, P177, DOI 10.1111/j.1574-6941.2007.00285.x; Dray S, 2007, J STAT SOFTW, V22, P1, DOI 10.18637/jss.v022.i04; DUBOIS M, 1956, ANAL CHEM, V28, P350, DOI 10.1021/ac60111a017; Escalada MG, 2005, LETT APPL MICROBIOL, V41, P476, DOI 10.1111/j.1472-765X.2005.01790.x; Escalada MG, 2005, J ANTIMICROB CHEMOTH, V55, P879, DOI 10.1093/jac/dki123; Farre M, 2008, ANAL BIOANAL CHEM, V390, P1999, DOI 10.1007/s00216-007-1779-9; Fernandez AS, 2000, APPL ENVIRON MICROB, V66, P4058, DOI 10.1128/AEM.66.9.4058-4067.2000; Flemming HC, 2001, WATER SCI TECHNOL, V43, P1; FUHRMAN JA, 1982, MAR BIOL, V66, P109, DOI 10.1007/BF00397184; Garet MJ, 1996, J MICROBIOL METH, V25, P1, DOI 10.1016/0167-7012(95)00071-2; Gerbersdorf SU, 2008, FEMS MICROBIOL ECOL, V66, P282, DOI 10.1111/j.1574-6941.2008.00586.x; Gerbersdorf SU, 2011, J SOIL SEDIMENT, V11, P1099, DOI 10.1007/s11368-011-0373-0; Gerbersdorf SU, 2009, J SOIL SEDIMENT, V9, P640, DOI 10.1007/s11368-009-0142-5; Halden RU, 2005, ENVIRON SCI TECHNOL, V39, P1420, DOI 10.1021/es049071e; Heath RJ, 1999, J BIOL CHEM, V274, P11110, DOI 10.1074/jbc.274.16.11110; Heidler J, 2007, CHEMOSPHERE, V66, P362, DOI 10.1016/j.chemosphere.2006.04.066; Hubas C, 2007, MAR ECOL PROG SER, V344, P39, DOI 10.3354/meps06947; Hubas C, 2007, MAR BIOL, V151, P41, DOI 10.1007/s00227-006-0446-6; Jain A, 2007, BIOFOULING, V23, P171, DOI 10.1080/08927010701269641; Johnson DR, 2009, ENVIRON MICROBIOL, V11, P1682, DOI 10.1111/j.1462-2920.2009.01893.x; Kolpin DW, 2002, ENVIRON SCI TECHNOL, V36, P1202, DOI 10.1021/es011055j; Larson F, 2009, LIMNOL OCEANOGR-METH, V7, P490, DOI 10.4319/lom.2009.7.490; Lawrence JR, 2009, SCI TOTAL ENVIRON, V407, P3307, DOI 10.1016/j.scitotenv.2009.01.060; Lawrence JR, 2007, ENVIRON TOXICOL CHEM, V26, P573, DOI 10.1897/06-340R.1; LEE S, 1987, APPL ENVIRON MICROB, V53, P1298, DOI 10.1128/AEM.53.6.1298-1303.1987; Levy CW, 1999, NATURE, V398, P383, DOI 10.1038/18803; Lindstrom A, 2002, ENVIRON SCI TECHNOL, V36, P2322, DOI 10.1021/es0114254; Lubarsky HV, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013794; Ludwig W, 2004, NUCLEIC ACIDS RES, V32, P1363, DOI 10.1093/nar/gkh293; Marzorati M, 2008, ENVIRON MICROBIOL, V10, P1571, DOI 10.1111/j.1462-2920.2008.01572.x; McAvoy DC, 2002, ENVIRON TOXICOL CHEM, V21, P1323, DOI 10.1897/1551-5028(2002)021<1323:MOTIWT>2.0.CO;2; McMurry LM, 1998, NATURE, V394, P531, DOI 10.1038/28970; McMurry LM, 1999, ANTIMICROB AGENTS CH, V43, P711, DOI 10.1128/AAC.43.3.711; McMurry LM, 1998, FEMS MICROBIOL LETT, V166, P305, DOI 10.1016/S0378-1097(98)00347-4; Mezcua M, 2004, ANAL CHIM ACTA, V524, P241, DOI 10.1016/j.aca.2004.05.050; Muyzer G, 1995, WATER SCI TECHNOL, V32, P1, DOI 10.1016/0273-1223(96)00001-7; MUYZER G, 1993, APPL ENVIRON MICROB, V59, P695, DOI 10.1128/AEM.59.3.695-700.1993; Oksanen J., 2009, VEGAN COMMUNITY ECOL; Okumura T, 1996, ANAL CHIM ACTA, V325, P175, DOI 10.1016/0003-2670(96)00027-X; Onbasli D, 2009, J HAZARD MATER, V168, P64, DOI 10.1016/j.jhazmat.2009.01.131; Orvos DR, 2002, ENVIRON TOXICOL CHEM, V21, P1338, DOI 10.1897/1551-5028(2002)021<1338:ATOT>2.0.CO;2; Pearson K, 1901, PHILOS MAG, V2, P559, DOI 10.1080/14786440109462720; Pennisi E, 2002, SCIENCE, V296, P250, DOI 10.1126/science.296.5566.250; Peplies J, 2008, SYST APPL MICROBIOL, V31, P251, DOI 10.1016/j.syapm.2008.08.003; Priester JH, 2006, APPL ENVIRON MICROB, V72, P1988, DOI 10.1128/AEM.72.3.1988-1996.2006; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; RAUNKJAER K, 1994, WATER RES, V28, P251, DOI 10.1016/0043-1354(94)90261-5; Ricart M, 2010, J HYDROL, V383, P52, DOI 10.1016/j.jhydrol.2009.08.014; Russell AD, 2004, J ANTIMICROB CHEMOTH, V53, P693, DOI 10.1093/jac/dkh171; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Schreiber F, 2008, AQUAT TOXICOL, V87, P227, DOI 10.1016/j.aquatox.2008.02.002; Schweizer HP, 2001, FEMS MICROBIOL LETT, V202, P1, DOI 10.1111/j.1574-6968.2001.tb10772.x; Shannon CE, 1997, M D COMPUT, V14, P306; SIMPSON EH, 1949, NATURE, V163, P688, DOI 10.1038/163688a0; Singer H, 2002, ENVIRON SCI TECHNOL, V36, P4998, DOI 10.1021/es025750i; Solan M, 2008, AQUAT BIOL, V2, P289, DOI 10.3354/ab00058; Stal LJ, 2003, GEOMICROBIOL J, V20, P463, DOI 10.1080/713851126; Tabak M, 2007, FEMS MICROBIOL LETT, V267, P200, DOI 10.1111/j.1574-6968.2006.00547.x; Underwood GJC, 2003, ADV BOT RES, V40, P183, DOI 10.1016/S0065-2296(05)40005-1; Villalain J, 2001, ARCH BIOCHEM BIOPHYS, V390, P128, DOI 10.1006/abbi.2001.2356; Wilson BA, 2003, ENVIRON SCI TECHNOL, V37, P1713, DOI 10.1021/es0259741; Wittebolle L, 2009, WATER RES, V43, P4149, DOI 10.1016/j.watres.2009.06.034; Yazdankhah SP, 2006, MICROB DRUG RESIST, V12, P83, DOI 10.1089/mdr.2006.12.83	73	35	35	1	72	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2012	7	4							e31183	10.1371/journal.pone.0031183	http://dx.doi.org/10.1371/journal.pone.0031183			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VO	22523534	Green Submitted, Green Published, gold			2022-12-25	WOS:000305345000003
J	Song, HK; Hong, SE; Kim, T; Kim, DH				Song, Hong Ki; Hong, Seong-Eui; Kim, Taeyong; Kim, Do Han			Deep RNA Sequencing Reveals Novel Cardiac Transcriptomic Signatures for Physiological and Pathological Hypertrophy	PLOS ONE			English	Article							MUSCLE LIM PROTEIN-1; GENE-EXPRESSION; MICROARRAY ANALYSIS; SPLICE VARIANTS; MESSENGER-RNA; C-MYC; LOCALIZATION; SKELETAL; ISOFORM; IDENTIFICATION	Although both physiological hypertrophy (PHH) and pathological hypertrophy (PAH) of the heart have similar morphological appearances, only PAH leads to fatal heart failure. In the present study, we used RNA sequencing (RNA-Seq) to determine the transcriptomic signatures for both PHH and PAH. Approximately 13-20 million reads were obtained for both models, among which PAH showed more differentially expressed genes (DEGs) (2,041) than PHH (245). The expression of 417 genes was barely detectable in the normal heart but was suddenly activated in PAH. Among them, Foxm1 and Plk1 are of particular interest, since Ingenuity Pathway Analysis (IPA) using DEGs and upstream motif analysis showed that they are essential hub proteins that regulate the expression of downstream proteins associated with PAH. Meanwhile, 52 genes related to collagen, chemokines, and actin showed opposite expression patterns between PHH and PAH. MAZ-binding motifs were enriched in the upstream region of the participating genes. Alternative splicing (AS) of exon variants was also examined using RNA-Seq data for PAH and PHH. We found 317 and 196 exon inclusions and exon exclusions, respectively, for PAH, and 242 and 172 exon inclusions and exclusions, respectively for PHH. The AS pattern was mostly related to gains or losses of domains, changes in activity, and localization of the encoded proteins. The splicing variants of 8 genes (i.e., Fhl1, Rcan1, Ndrg2, Synpo, Ttll1, Cxxc5, Egfl7, and Tmpo) were experimentally confirmed. Multilateral pathway analysis showed that the patterns of quantitative (DEG) and qualitative (AS) changes differ depending on the type of pathway in PAH and PHH. One of the most significant changes in PHH is the severe downregulation of autoimmune pathways accompanied by significant AS. These findings revealed the unique transcriptomic signatures of PAH and PHH and also provided a more comprehensive understanding at both the quantitative and qualitative levels.	[Song, Hong Ki] Gwangju Inst Sci & Technol, Sch Life Sci, Kwangju, South Korea; Gwangju Inst Sci & Technol, Syst Biol Res Ctr, Kwangju, South Korea	Gwangju Institute of Science & Technology (GIST); Gwangju Institute of Science & Technology (GIST)	Song, HK (corresponding author), Gwangju Inst Sci & Technol, Sch Life Sci, Kwangju, South Korea.	dhkim@gist.ac.kr		Kim, Taeyong/0000-0002-4147-3635	Korea MEST NRF [20110002144]; 2011 GIST Systems Biology Infrastructure Establishment Grant	Korea MEST NRF(National Research Foundation of KoreaMinistry of Education, Science & Technology (MEST), Republic of Korea); 2011 GIST Systems Biology Infrastructure Establishment Grant	This work was supported by the Korea MEST NRF grant (20110002144) and the 2011 GIST Systems Biology Infrastructure Establishment Grant (2011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahuja P, 2007, PHYSIOL REV, V87, P521, DOI 10.1152/physrev.00032.2006; Arndt-Maric R, 2010, CLIN LAB, V56, P519; Asanuma K, 2005, J CLIN INVEST, V115, P1188, DOI 10.1172/JCI200523371; Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Beisvag V, 2009, EUR J CARDIOV PREV R, V16, P690, DOI 10.1097/HJR.0b013e32833158a2; Berger R, 1996, GENOME RES, V6, P361, DOI 10.1101/gr.6.5.361; Bolte C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022217; BOSSONE SA, 1992, P NATL ACAD SCI USA, V89, P7452, DOI 10.1073/pnas.89.16.7452; Boulkroun S, 2002, J BIOL CHEM, V277, P31506, DOI 10.1074/jbc.M200272200; Brown S, 1999, J BIOL CHEM, V274, P27083, DOI 10.1074/jbc.274.38.27083; Brown SE, 2001, MAMM GENOME, V12, P916, DOI 10.1007/s00335-001-3029-3; Casneuf T, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-461; Catalucci D, 2008, FRONT BIOSCI-LANDMRK, V13, P312, DOI 10.2741/2681; Cha H, 2008, J MOL CELL CARDIOL, V45, P796, DOI 10.1016/j.yjmcc.2008.09.124; Chan DW, 2008, J PATHOL, V215, P245, DOI 10.1002/path.2355; CHIEN KR, 1991, FASEB J, V5, P3037, DOI 10.1096/fasebj.5.15.1835945; Damilano F, 2011, CIRCULATION, V123, P391, DOI 10.1161/CIRCULATIONAHA.110.950543; Davies KJA, 2007, FASEB J, V21, P3023, DOI 10.1096/fj.06-7246com; DESJARDINS E, 1993, MOL CELL BIOL, V13, P5710, DOI 10.1128/MCB.13.9.5710; Dreszer TR, 2012, NUCLEIC ACIDS RES, V40, pD918, DOI 10.1093/nar/gkr1055; Eklund AC, 2006, NAT BIOTECHNOL, V24, P1071, DOI 10.1038/nbt0906-1071; Fryknas M, 2006, TUMOR BIOL, V27, P211, DOI 10.1159/000093056; Fu Z, 2008, NAT CELL BIOL, V10, P1076, DOI 10.1038/ncb1767; Galindo Cristi L., 2009, BMC Physiology, V9, P23, DOI 10.1186/1472-6793-9-23; Gupta S, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r24; Han JH, 2011, MOL CELL BIOL, V31, P793, DOI 10.1128/MCB.01117-10; Hayashi Y, 1997, BIOCHEM BIOPH RES CO, V236, P83, DOI 10.1006/bbrc.1997.6911; Henderson DM, 2007, MOL BIOL CELL, V18, P2698, DOI 10.1091/mbc.E06-09-0831; Himeda CL, 2008, MOL CELL BIOL, V28, P6521, DOI 10.1128/MCB.00306-08; Hong CS, 2008, J MOL CELL CARDIOL, V44, P672, DOI 10.1016/j.yjmcc.2008.01.012; Hunter JJ, 1999, NEW ENGL J MED, V341, P1276, DOI 10.1056/NEJM199910213411706; Iemitsu M, 2005, ACTA PHYSIOL SCAND, V185, P259, DOI 10.1111/j.1365-201X.2005.01494.x; Ikebe C, 1998, BIOCHEM BIOPH RES CO, V246, P307, DOI 10.1006/bbrc.1998.8609; Johnson JM, 2003, SCIENCE, V302, P2141, DOI 10.1126/science.1090100; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kogo H, 2004, J BIOL CHEM, V279, P25574, DOI 10.1074/jbc.M310807200; KOMURO I, 1993, ANNU REV PHYSIOL, V55, P55, DOI 10.1146/annurev.ph.55.030193.000415; Ladd AN, 2001, MOL CELL BIOL, V21, P1285, DOI 10.1128/MCB.21.4.1285-1296.2001; Lee JH, 2011, CIRC RES, V109, P1332, DOI 10.1161/CIRCRESAHA.111.249433; Lee S, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkq1015; Marioni JC, 2008, GENOME RES, V18, P1509, DOI 10.1101/gr.079558.108; Matkovich SJ, 2010, CIRC RES, V106, P1459, DOI 10.1161/CIRCRESAHA.110.217513; McGrath MJ, 2003, AM J PHYSIOL-CELL PH, V285, pC1513, DOI 10.1152/ajpcell.00207.2003; McMullen JR, 2003, P NATL ACAD SCI USA, V100, P12355, DOI 10.1073/pnas.1934654100; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Okoniewski MJ, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-276; Pan Q, 2008, NAT GENET, V40, P1413, DOI 10.1038/ng.259; Park JY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022391; Ramakrishna S, 2007, DEV DYNAM, V236, P1000, DOI 10.1002/dvdy.21113; REYES AA, 1991, MOL CELL BIOL, V11, P1654, DOI 10.1128/MCB.11.3.1654; Rezniczek GA, 2003, HUM MOL GENET, V12, P3181, DOI 10.1093/hmg/ddg345; Soncin F, 2003, EMBO J, V22, P5700, DOI 10.1093/emboj/cdg549; Tanaka E, 2011, BIOINFORMATICS, V27, P1603, DOI 10.1093/bioinformatics/btr257; Trichet V, 2000, GENE, V257, P109, DOI 10.1016/S0378-1119(00)00383-8; U M, 2004, LEUKEMIA, V18, P1850, DOI 10.1038/sj.leu.2403516; Ueno S, 2003, BIOCHEM BIOPH RES CO, V307, P771, DOI 10.1016/S0006-291X(03)01252-X; Van den Bosch BJC, 2006, GENOMICS, V88, P480, DOI 10.1016/j.ygeno.2006.04.012; Vencio RZN, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-119; Wontakal SN, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001392; Yamazaki T, 2010, CARDIOVASC RES, V86, P374, DOI 10.1093/cvr/cvq023; Yan C, 1996, J BIOL CHEM, V271, P25699, DOI 10.1074/jbc.271.41.25699; Yang J, 2000, CIRC RES, V87, pE61, DOI 10.1161/01.RES.87.12.e61; Zhang M, 2003, MOL MED, V9, P18, DOI 10.1007/BF03402103; Zhao MM, 2004, PHYSIOL GENOMICS, V19, P93, DOI 10.1152/physiolgenomics.00040.2004	64	85	86	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2012	7	4							e35552	10.1371/journal.pone.0035552	http://dx.doi.org/10.1371/journal.pone.0035552			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VO	22523601	Green Published, gold			2022-12-25	WOS:000305345000075
J	Warrander, LK; Batra, G; Bernatavicius, G; Greenwood, SL; Dutton, P; Jones, RL; Sibley, CP; Heazell, AEP				Warrander, Lynne K.; Batra, Gauri; Bernatavicius, Giovanna; Greenwood, Susan L.; Dutton, Philip; Jones, Rebecca L.; Sibley, Colin P.; Heazell, Alexander E. P.			Maternal Perception of Reduced Fetal Movements Is Associated with Altered Placental Structure and Function	PLOS ONE			English	Article							INTRAUTERINE GROWTH RESTRICTION; APOPTOSIS; PREGNANCIES; MANAGEMENT; WOMEN; PREECLAMPSIA; EXPRESSION; TRANSPORT; FETUSES; SYSTEM	Background: Maternal perception of reduced fetal movement (RFM) is associated with increased risk of stillbirth and fetal growth restriction (FGR). DFM is thought to represent fetal compensation to conserve energy due to insufficient oxygen and nutrient transfer resulting from placental insufficiency. To date there have been no studies of placental structure in cases of DFM. Objective: To determine whether maternal perception of reduced fetal movements (RFM) is associated with abnormalities in placental structure and function. Design: Placentas were collected from women with RFM after 28 weeks gestation if delivery occurred within 1 week. Women with normal movements served as a control group. Placentas were weighed and photographs taken. Microscopic structure was evaluated by immunohistochemical staining and image analysis. System A amino acid transporter activity was measured as a marker of placental function. Placentas from all pregnancies with RFM (irrespective of outcome) had greater area with signs of infarction (3.5% vs. 0.6%; p<0.01), a higher density of syncytial knots (p<0.001) and greater proliferation index (p<0.01). Villous vascularity (p<0.001), trophoblast area (p<0.01) and system A activity (p<0.01) were decreased in placentas from RFM compared to controls irrespective of outcome of pregnancy. Conclusions: This study provides evidence of abnormal placental morphology and function in women with RFM and supports the proposition of a causal association between placental insufficiency and RFM. This suggests that women presenting with RFM require further investigation to identify those with placental insufficiency.	[Warrander, Lynne K.; Greenwood, Susan L.; Dutton, Philip; Jones, Rebecca L.; Sibley, Colin P.; Heazell, Alexander E. P.] Univ Manchester, Manchester Acad Hlth Sci Ctr, Sch Biomed, Maternal & Fetal Hlth Res Ctr, Manchester, Lancs, England; [Batra, Gauri] Royal Manchester Childrens Hosp, Dept Paediat Histopathol, Manchester M27 1HA, Lancs, England; [Bernatavicius, Giovanna] Cent Manchester Univ Hosp NHS Fdn Trust, St Marys Hosp, Manchester, Lancs, England	University of Manchester; Royal Manchester Children's Hospital; University of Manchester	Warrander, LK (corresponding author), Univ Manchester, Manchester Acad Hlth Sci Ctr, Sch Biomed, Maternal & Fetal Hlth Res Ctr, Manchester, Lancs, England.	alexander.heazell@manchester.ac.uk	Jones, Rebecca/E-4481-2011	Jones, Rebecca/0000-0002-8871-0589; Warrander, Lynne/0000-0001-9529-8935; Greenwood, Susan/0000-0003-2867-4368; Heazell, Alexander/0000-0002-4303-7845	Manchester Wellcome Trust Clinical Research Facility; Greater Manchester Clinical Local Research Network; Wolfson Foundation; National Institutes of Health Research; National Institute for Health Research [CL-2009-06-002] Funding Source: researchfish	Manchester Wellcome Trust Clinical Research Facility(Wellcome Trust); Greater Manchester Clinical Local Research Network; Wolfson Foundation; National Institutes of Health Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute for Health Research(National Institute for Health Research (NIHR))	This study was funded by the Manchester Wellcome Trust Clinical Research Facility and the Greater Manchester Clinical Local Research Network. It was underpinned by the National Institutes of Health Research Manchester Biomedical Research Centre and an Action Research Endowment Fund. LW was supported by a studentship from the Wolfson Foundation. AH is funded by a Clinical Lectureship from the National Institutes of Health Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1995, CONF ENQ STILLB DEAT; APELSARID L, 2009, ARCH GYNECOL OBSTET; Biswas S, 2008, EARLY HUM DEV, V84, P357, DOI 10.1016/j.earlhumdev.2007.09.017; CEMACE, 2010, PER MORT 2008; Chen CP, 2002, AM J OBSTET GYNECOL, V187, P764, DOI 10.1067/mob.2002.125243; Crocker IP, 2003, AM J PATHOL, V162, P637, DOI 10.1016/S0002-9440(10)63857-6; Daayana S, 2004, J SOC GYNECOL INVEST, V11, P545, DOI 10.1016/j.jsgi.2004.06.009; DICKE JM, 1988, AM J MED SCI, V295, P223, DOI 10.1097/00000441-198803000-00012; Efkarpidis Savvas, 2004, MedGenMed, V6, P53; Flenady V, 2009, AUST NZ J OBSTET GYN, V49, P358, DOI 10.1111/j.1479-828X.2009.01026.x; Froen JF, 2008, SEMIN PERINATOL, V32, P307, DOI 10.1053/j.semperi.2008.04.015; Froen JF, 2008, SEMIN PERINATOL, V32, P243, DOI 10.1053/j.semperi.2008.04.004; Froen JF, 2001, AM J OBSTET GYNECOL, V184, P694, DOI 10.1067/mob.2001.110697; Glazier JD, 1997, PEDIATR RES, V42, P514, DOI 10.1203/00006450-199710000-00016; Greenwood SL, 2006, METH MOLEC MED, V122, P253; Haws RA, 2009, BMC PREGNANCY CHILDB, V9, DOI 10.1186/1471-2393-9-S1-S5; Heazell AEP, 2008, J OBSTET GYNAECOL, V28, P147, DOI 10.1080/01443610801912618; Heazell AEP, 2008, PLACENTA, V29, P175, DOI 10.1016/j.placenta.2007.11.002; Heazell AEP, 2007, PLACENTA, V28, pS33, DOI 10.1016/j.placenta.2006.10.007; Heazell AEP, 2009, J OBSTET GYNAECOL, V29, P225, DOI 10.1080/01443610802716042; Heazell AEP, 2008, ACTA OBSTET GYN SCAN, V87, P331, DOI 10.1080/00016340801902034; Heazell AEP, 2011, APOPTOSIS, V16, P135, DOI 10.1007/s10495-010-0551-3; Jansson T, 2002, PLACENTA, V23, P392, DOI 10.1053/plac.2002.0826; Levy R, 2002, AM J OBSTET GYNECOL, V186, P1056, DOI 10.1067/mob.2002.122250; Macara L, 1996, PLACENTA, V17, P37, DOI 10.1016/S0143-4004(05)80642-3; O'Sullivan O, 2009, J OBSTET GYNAECOL, V29, P705, DOI 10.3109/01443610903229598; Parast MM, 2008, HUM PATHOL, V39, P948, DOI 10.1016/j.humpath.2007.10.032; PEARSON JF, 1976, BRIT MED J, V1, P1305, DOI 10.1136/bmj.1.6021.1305; RAYBURN WF, 1982, AM J OBSTET GYNECOL, V144, P967, DOI 10.1016/0002-9378(82)90192-2; Salafia CM, 2009, PLACENTA, V30, P468, DOI 10.1016/j.placenta.2008.12.013; Sinha D, 2007, J OBSTET GYNAECOL, V27, P41, DOI 10.1080/01443610601016909; Smith SC, 1997, AM J OBSTET GYNECOL, V177, P1395, DOI 10.1016/S0002-9378(97)70081-4; Unterscheider J, 2009, OBSTET GYNAECOL, V11, P245, DOI 10.1576/toag.11.4.245.27527; VINTZILEOS AM, 1991, AM J OBSTET GYNECOL, V165, P707, DOI 10.1016/0002-9378(91)90314-H; Warrander LK, 2010, MED HYPOTHESES; Yampolsky M, 2009, PLACENTA, V30, P1058, DOI 10.1016/j.placenta.2009.10.001	36	80	82	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2012	7	4							e34851	10.1371/journal.pone.0034851	http://dx.doi.org/10.1371/journal.pone.0034851			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VO	22523561	gold, Green Submitted, Green Published			2022-12-25	WOS:000305345000033
J	Deehan, R; Maerz-Weiss, P; Catlett, NL; Steiner, G; Wong, B; Wright, MB; Blander, G; Elliston, KO; Ladd, W; Bobadilla, M; Mizrahi, J; Haefliger, C; Edgar, A				Deehan, Renee; Maerz-Weiss, Pia; Catlett, Natalie L.; Steiner, Guido; Wong, Ben; Wright, Matthew B.; Blander, Gil; Elliston, Keith O.; Ladd, William; Bobadilla, Maria; Mizrahi, Jacques; Haefliger, Carolina; Edgar, Alan			Comparative Transcriptional Network Modeling of Three PPAR-alpha/gamma Co-Agonists Reveals Distinct Metabolic Gene Signatures in Primary Human Hepatocytes	PLOS ONE			English	Article							PROLIFERATOR-ACTIVATED RECEPTORS; EMERGING ROLE; PROTEIN; INHIBITOR; LIVER; PHOSPHORYLATION; BIOINFORMATICS; PIOGLITAZONE; ALEGLITAZAR; MECHANISMS	Aims: To compare the molecular and biologic signatures of a balanced dual peroxisome proliferator-activated receptor (PPAR)-alpha/gamma agonist, aleglitazar, with tesaglitazar (a dual PPAR-alpha/gamma agonist) or a combination of pioglitazone (Pio; PPAR-gamma agonist) and fenofibrate (Feno; PPAR-alpha agonist) in human hepatocytes. Methods and Results: Gene expression microarray profiles were obtained from primary human hepatocytes treated with EC50-aligned low, medium and high concentrations of the three treatments. A systems biology approach, Causal Network Modeling, was used to model the data to infer upstream molecular mechanisms that may explain the observed changes in gene expression. Aleglitazar, tesaglitazar and Pio/Feno each induced unique transcriptional signatures, despite comparable core PPAR signaling. Although all treatments inferred qualitatively similar PPAR-alpha signaling, aleglitazar was inferred to have greater effects on high- and low-density lipoprotein cholesterol levels than tesaglitazar and Pio/Feno, due to a greater number of gene expression changes in pathways related to high-density and low-density lipoprotein metabolism. Distinct transcriptional and biologic signatures were also inferred for stress responses, which appeared to be less affected by aleglitazar than the comparators. In particular, Pio/Feno was inferred to increase NFE2L2 activity, a key component of the stress response pathway, while aleglitazar had no significant effect. All treatments were inferred to decrease proliferative signaling. Conclusions: Aleglitazar induces transcriptional signatures related to lipid parameters and stress responses that are unique from other dual PPAR-alpha/gamma treatments. This may underlie observed favorable changes in lipid profiles in animal and clinical studies with aleglitazar and suggests a differentiated gene profile compared with other dual PPAR-alpha/gamma agonist treatments.	[Deehan, Renee; Catlett, Natalie L.; Wong, Ben; Blander, Gil; Elliston, Keith O.; Ladd, William] Selventa, Cambridge, MA USA; [Maerz-Weiss, Pia; Steiner, Guido; Wright, Matthew B.; Bobadilla, Maria; Mizrahi, Jacques; Haefliger, Carolina; Edgar, Alan] F Hoffmann La Roche & Cie AG, Basel, Switzerland	Roche Holding	Deehan, R (corresponding author), Selventa, Cambridge, MA USA.	matthew.wright@roche.com		Elliston, Keith/0000-0002-9110-9233; Wright, matthewwright/0000-0002-0532-3381	F. Hoffmann-La Roche AG	F. Hoffmann-La Roche AG(Hoffmann-La Roche)	This work was supported by F. Hoffmann-La Roche AG (www.roche.com). The study design and conduct of the hepatocyte treatments, RNA isolation, microarray hybridizations, and statistical analyses were performed in the laboratories of F. Hoffmann-La Roche, while data analysis was performed at Selventa Laboratories (www.selventa.com). The decision to publish and manuscript preparation was made jointly by scientists and F. Hoffmann-La Roche and Selventa Laboratories. Editorial assistance was funded by F. Hoffmann-La Roche AG.	Abourbih S, 2009, AM J MED, V122, DOI 10.1016/j.amjmed.2009.03.030; Aleksunes LM, 2007, TOXICOL PATHOL, V35, P459, DOI 10.1080/01926230701311344; Barbier O, 2002, ARTERIOSCL THROM VAS, V22, P717, DOI 10.1161/01.ATV.0000015598.86369.04; Bays Harold, 2007, Diab Vasc Dis Res, V4, P181; Bell M, 2008, DIABETES, V57, P2037, DOI 10.2337/db07-1383; Benardeau A, 2009, BIOORG MED CHEM LETT, V19, P2468, DOI 10.1016/j.bmcl.2009.03.036; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Blander G, 2009, J INVEST DERMATOL, V129, P41, DOI 10.1038/jid.2008.179; Brown MS, 1997, CELL, V89, P331, DOI 10.1016/S0092-8674(00)80213-5; Chalhoub N, 2009, ANNU REV PATHOL-MECH, V4, P127, DOI 10.1146/annurev.pathol.4.110807.092311; Chang BHJ, 2007, AM J PHYSIOL-GASTR L, V292, pG1465, DOI 10.1152/ajpgi.00566.2006; Chiquette E, 2004, ARCH INTERN MED, V164, P2097, DOI 10.1001/archinte.164.19.2097; Choi JH, 2010, NATURE, V466, P451, DOI 10.1038/nature09291; Delerive P, 2001, J ENDOCRINOL, V169, P453, DOI 10.1677/joe.0.1690453; Duval C, 2007, BBA-MOL CELL BIOL L, V1771, P961, DOI 10.1016/j.bbalip.2007.05.003; Ericsson H, 2004, DRUG METAB DISPOS, V32, P923; Gartel AL, 2005, CANCER RES, V65, P3980, DOI 10.1158/0008-5472.CAN-04-3995; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Goke Burkhard, 2007, Diab Vasc Dis Res, V4, P204; Gordon S, 2006, ONCOGENE, V25, P1125, DOI 10.1038/sj.onc.1209080; Grosskopf I, 2005, ARTERIOSCL THROM VAS, V25, P2573, DOI 10.1161/01.ATV.0000186189.26141.12; GRUNDY SM, 1987, AM J MED, V83, P9, DOI 10.1016/0002-9343(87)90866-7; Gupta AK, 2007, NEOPLASIA, V9, P271, DOI 10.1593/neo.07124; Hansen BC, 2011, CARDIOVASC DIABETOL, V10, DOI 10.1186/1475-2840-10-7; Henry RR, 2009, LANCET, V374, P126, DOI 10.1016/S0140-6736(09)60870-9; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang XS, 2009, BRIT J PHARMACOL, V158, P706, DOI 10.1111/j.1476-5381.2009.00350.x; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Kast-Woelbern HR, 2004, J BIOL CHEM, V279, P23908, DOI 10.1074/jbc.M403145200; Katso R, 2001, ANNU REV CELL DEV BI, V17, P615, DOI 10.1146/annurev.cellbio.17.1.615; Kersten S, 2000, J BIOL CHEM, V275, P28488, DOI 10.1074/jbc.M004029200; Kumar R, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-419; Laifenfeld D, 2010, TOXICOL SCI, V113, P254, DOI 10.1093/toxsci/kfp213; Lichtenstein L, 2007, ARTERIOSCL THROM VAS, V27, P2420, DOI 10.1161/ATVBAHA.107.151894; Nissen SE, 2005, JAMA-J AM MED ASSOC, V294, P2581, DOI 10.1001/JAMA.294.20.JOC50147; Oyaizu T, 1997, EXP TOXICOL PATHOL, V49, P375, DOI 10.1016/S0940-2993(97)80121-2; Pfutzner A, 2005, J AM COLL CARDIOL, V45, P1925, DOI 10.1016/j.jacc.2005.03.041; Ratner Robert E, 2007, Diab Vasc Dis Res, V4, P214; Rogue A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018816; Romeo S, 2009, J CLIN INVEST, V119, P70, DOI 10.1172/JCI37118; Sahin F, 2010, INT J BIOL SCI, V6, P116; Schlage WK, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-168; Smith JJ, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-31; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Staels B, 2005, DIABETES, V54, P2460, DOI 10.2337/diabetes.54.8.2460; Tall AR, 2008, CELL METAB, V7, P365, DOI 10.1016/j.cmet.2008.03.001; Tenenbaum A, 2005, CARDIOVASC DIABETOL, V4, DOI 10.1186/1475-2840-4-14; Toedter G, 2012, INFLAMM BOWEL DIS; Vu-Dac N, 2003, J BIOL CHEM, V278, P17982, DOI 10.1074/jbc.M212191200; Westra JW, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-105; Wilding John P H, 2007, Diab Vasc Dis Res, V4, P194; Winkler K, 2003, DIABETES CARE, V26, P2588, DOI 10.2337/diacare.26.9.2588; Yoshida K, 2002, J LIPID RES, V43, P1770, DOI 10.1194/jlr.C200010-JLR200	53	16	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2012	7	4							e35012	10.1371/journal.pone.0035012	http://dx.doi.org/10.1371/journal.pone.0035012			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UT	22514701	Green Submitted, gold, Green Published			2022-12-25	WOS:000305341600107
J	Ido, Y; Duranton, A; Lan, F; Cacicedo, JM; Chen, TC; Breton, L; Ruderman, NB				Ido, Yasuo; Duranton, Albert; Lan, Fan; Cacicedo, Jose M.; Chen, Tai C.; Breton, Lionel; Ruderman, Neil B.			Acute Activation of AMP-Activated Protein Kinase Prevents H2O2-Induced Premature Senescence in Primary Human Keratinocytes	PLOS ONE			English	Article							VEIN ENDOTHELIAL-CELLS; CULTURED HUMAN KERATINOCYTES; CELLULAR SENESCENCE; DEPENDENT PATHWAY; OXIDATIVE STRESS; PHOSPHORYLATION; HYPERGLYCEMIA; SIRT1; LKB1; LOCALIZATION	We investigated the effects of AMPK on H2O2-induced premature senescence in primary human keratinocytes. Incubation with 50 mu M H2O2 for 2 h resulted in premature senescence with characteristic increases in senescence-associated beta-galactosidase (SA-gal) staining 3 days later and no changes in AMPK or p38 MAPK activity. The increase in SA-gal staining was preceded by increases in both p53 phosphorylation (S15) (1 h) and transactivation (6 h) and the abundance of the cyclin inhibitor p21(CIP1) (16 h). Incubation with AICAR or resveratrol, both of which activated AMPK, prevented the H2O2-induced increases in both SA-Gal staining and p21 abundance. In addition, AICAR diminished the increase in p53 transactivation. The decreases in SA-Gal expression induced by resveratrol and AICAR were prevented by the pharmacological AMPK inhibitor Compound C, expression of a DN-AMPK or AMPK knock-down with shRNA. Likewise, both knockdown of AMPK and expression of DN-AMPK were sufficient to induce senescence, even in the absence of exogenous H2O2. As reported by others, we found that AMPK activation by itself increased p53 phosphorylation at S15 in embryonic fibroblasts (MEF), whereas under the same conditions it decreased p53 phosphorylation in the keratinocytes, human aortic endothelial cells, and human HT1080 fibrosarcoma cells. In conclusion, the results indicate that H2O2 at low concentrations causes premature senescence in human keratinocytes by activating p53-p21(CIP1) signaling and that these effects can be prevented by acute AMPK activation and enhanced by AMPK downregulation. They also suggest that this action of AMPK may be cell or context-specific.	[Ido, Yasuo; Lan, Fan; Cacicedo, Jose M.; Chen, Tai C.; Ruderman, Neil B.] Boston Univ, Sch Med, Dept Med, Endocrinol Sect, Boston, MA 02118 USA; [Ido, Yasuo; Lan, Fan; Cacicedo, Jose M.; Chen, Tai C.; Ruderman, Neil B.] Boston Univ, Sch Med, Dept Med, Diabet Res Unit, Boston, MA 02118 USA; [Duranton, Albert; Breton, Lionel] LOREAL Rech, Ctr Charles Zviak, Clichy, France	Boston University; Boston University; L'Oreal Group	Ido, Y (corresponding author), Boston Univ, Sch Med, Dept Med, Endocrinol Sect, Boston, MA 02118 USA.	yido@bu.edu; nrude@bu.edu		Chen, Tai/0000-0002-5704-5694; Ido, Yasuo/0000-0002-3036-9971; Ruderman, Neil/0000-0002-6589-6587; /0000-0001-8417-9754; Duranton, Albert/0000-0002-4057-7176	NIH [T32DK07201, R0-1 DK019514 R01 DK067509, P01-067508]; L'Oreal; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK019514, T32DK007201, R01DK067509] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); L'Oreal(L'Oreal Group); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The work was supported by Endocrine training grant T32DK07201 from the NIH (JC), NIH grants R0-1 DK019514 R01 DK067509 and P01-067508 (NR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The L'Oreal Company's role, through the employment of Albert Duranton and Lionel Breton, involved the analysis of the data.; Dr. Duranton and Breton secured support for our research from L'Oreal. They are employees of L'Oreal who helped to fund this study. Dr. Ruderman (NR) is a recipient of a research grant from L'Oreal, however the type of research and its conception and performance were totally the province of the Ruderman-Ido lab. No patentable substances were studied. This does not alter the authors' adherence to all the PLos ONE policies on sharing data and materials.	Acosta JC, 2008, CELL, V133, P1006, DOI 10.1016/j.cell.2008.03.038; Amato S, 2011, SCIENCE, V332, P247, DOI 10.1126/science.1201678; Baker DJ, 2011, NATURE, V479, P232, DOI 10.1038/nature10600; Bernard D, 2004, CANCER RES, V64, P472, DOI 10.1158/0008-5472.CAN-03-0005; Cacicedo JM, 2004, BIOCHEM BIOPH RES CO, V324, P1204, DOI 10.1016/j.bbrc.2004.09.177; Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233; Cao C, 2009, J CELL MOL MED, V13, P3632, DOI 10.1111/j.1582-4934.2008.00453.x; Chen MB, 2011, J CELL PHYSIOL, V226, P1915, DOI 10.1002/jcp.22522; Chen MB, 2011, CELL BIOCHEM BIOPHYS, V60, P311, DOI 10.1007/s12013-011-9153-0; CHEN TC, 1995, J INVEST DERMATOL, V104, P113, DOI 10.1111/1523-1747.ep12613601; Collado M, 2007, CELL, V130, P223, DOI 10.1016/j.cell.2007.07.003; Colombo SL, 2009, BIOCHEM J, V421, P163, DOI 10.1042/BJ20090613; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Egan DF, 2011, SCIENCE, V331, P456, DOI 10.1126/science.1196371; Fu D, 2010, J CELL SCI, V123, P3294, DOI 10.1242/jcs.068098; Gauthier MS, 2011, BIOCHEM BIOPH RES CO, V404, P382, DOI 10.1016/j.bbrc.2010.11.127; Greer EL, 2007, J BIOL CHEM, V282, P30107, DOI 10.1074/jbc.M705325200; Hamid R, 2004, TOXICOL IN VITRO, V18, P703, DOI 10.1016/j.tiv.2004.03.012; Hattori Y, 2006, HYPERTENSION, V47, P1183, DOI 10.1161/01.HYP.0000221429.94591.72; Hayashi T, 2006, P NATL ACAD SCI USA, V103, P17018, DOI 10.1073/pnas.0607873103; HAYFLICK L, 1961, EXP CELL RES, V25, P585, DOI 10.1016/0014-4827(61)90192-6; Hou XY, 2008, J BIOL CHEM, V283, P20015, DOI 10.1074/jbc.M802187200; Huber M, 2000, J INVEST DERMATOL, V114, P661, DOI 10.1046/j.1523-1747.2000.00942.x; Ido Y, 2002, DIABETES, V51, P159, DOI 10.2337/diabetes.51.1.159; Ido Y, 2002, DIABETES, V51, pA396; Imamura K, 2001, BIOCHEM BIOPH RES CO, V287, P562, DOI 10.1006/bbrc.2001.5627; Jager S, 2007, P NATL ACAD SCI USA, V104, P12017, DOI 10.1073/pnas.0705070104; Jones RG, 2005, MOL CELL, V18, P283, DOI 10.1016/j.molcel.2005.03.027; Kuilman T, 2008, CELL, V133, P1019, DOI 10.1016/j.cell.2008.03.039; Kukidome D, 2006, DIABETES, V55, P120, DOI 10.2337/diabetes.55.01.06.db05-0943; Lan F, 2008, J BIOL CHEM, V283, P27628, DOI 10.1074/jbc.M805711200; Maclaine NJ, 2009, AGING-US, V1, P490, DOI 10.18632/aging.100047; Nemoto S, 2004, SCIENCE, V306, P2105, DOI 10.1126/science.1101731; Oakhill JS, 2009, ACTA PHYSIOL, V196, P3, DOI 10.1111/j.1748-1716.2009.01977.x; Pelle E, 2003, J INVEST DERMATOL, V121, P177, DOI 10.1046/j.1523-1747.2003.12330.x; Richter EA, 2009, BIOCHEM J, V418, P261, DOI 10.1042/BJ20082055; Ruderman N, 2004, NAT REV DRUG DISCOV, V3, P340, DOI 10.1038/nrd1344; Saha AK, 2006, BIOCHEM BIOPH RES CO, V349, P519, DOI 10.1016/j.bbrc.2006.08.107; Shelton DN, 1999, CURR BIOL, V9, P939, DOI 10.1016/S0960-9822(99)80420-5; Sinclair DA, 2006, SCI AM, V294, P48, DOI 10.1038/scientificamerican0306-48; Sone H, 2005, DIABETOLOGIA, V48, P58, DOI 10.1007/s00125-004-1605-2; Steinberg GR, 2009, PHYSIOL REV, V89, P1025, DOI 10.1152/physrev.00011.2008; Sung JY, 2011, BIOCHEM BIOPH RES CO, V413, P143, DOI 10.1016/j.bbrc.2011.08.071; Wang WG, 2004, J BIOL CHEM, V279, P48376, DOI 10.1074/jbc.M409014200; Wang WG, 2003, J BIOL CHEM, V278, P27016, DOI 10.1074/jbc.M300318200; Xie ZL, 2008, DIABETES, V57, P3222, DOI 10.2337/db08-0610; Zhao MT, 2011, CELL METAB, V13, P119, DOI 10.1016/j.cmet.2011.01.009; Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI200113505	48	32	33	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2012	7	4							e35092	10.1371/journal.pone.0035092	http://dx.doi.org/10.1371/journal.pone.0035092			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UT	22514710	Green Published, Green Submitted, gold			2022-12-25	WOS:000305341600116
J	Karim, L; Vashishth, D				Karim, Lamya; Vashishth, Deepak			Heterogeneous Glycation of Cancellous Bone and Its Association with Bone Quality and Fragility	PLOS ONE			English	Article							COLLAGEN CROSS-LINKS; NONENZYMATIC GLYCATION; BIOMECHANICAL PROPERTIES; CORTICAL BONE; TRABECULAR MICROARCHITECTURE; MECHANICAL-PROPERTIES; BIOCHEMICAL MARKERS; MINERAL DENSITY; MICRODAMAGE; FRACTURE	Non-enzymatic glycation (NEG) and enzymatic biochemical processes create crosslinks that modify the extracellular matrix (ECM) and affect the turnover of bone tissue. Because NEG affects turnover and turnover at the local level affects microarchitecture and formation and removal of microdamage, we hypothesized that NEG in cancellous bone is heterogeneous and accounts partly for the contribution of microarchitecture and microdamage on bone fragility. Human trabecular bone cores from 23 donors were subjected to compression tests. Mechanically tested cores as well as an additional 19 cores were stained with lead-uranyl acetate and imaged to determine microarchitecture and measure microdamage. Post-yield mechanical properties were measured and damaged trabeculae were extracted from a subset of specimens and characterized for the morphology of induced microdamage. Tested specimens and extracted trabeculae were quantified for enzymatic and non-enzymatic crosslink content using a colorimetric assay and Ultra-high Performance Liquid Chromatography (UPLC). Results show that an increase in enzymatic crosslinks was beneficial for bone where they were associated with increased toughness and decreased microdamage. Conversely, bone with increased NEG required less strain to reach failure and were less tough. NEG heterogeneously modified trabecular microarchitecture where high amounts of NEG crosslinks were found in trabecular rods and with the mechanically deleterious form of microdamage (linear microcracks). The extent of NEG in tibial cancellous bone was the dominant predictor of bone fragility and was associated with changes in microarchitecture and microdamage.	[Karim, Lamya; Vashishth, Deepak] Rensselaer Polytech Inst, Dept Biomed Engn, Ctr Biotechnol & Interdisciplinary Studies, Troy, NY 12180 USA	Rensselaer Polytechnic Institute	Karim, L (corresponding author), Beth Israel Deaconess Med Ctr, Ctr Adv Orthopaed Studies, Boston, MA 02215 USA.	vashid@rpi.edu	Karim, Lamya/V-9875-2019	Karim, Lamya/0000-0002-4558-0884; Vashishth, Deepak/0000-0001-5712-0167	United States National Institutes of Health [AG20618, T32GM067545]; NIH [5 U42 RR006042]; NATIONAL CENTER FOR RESEARCH RESOURCES [U42RR006042] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM067545] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG020618, R56AG020618] Funding Source: NIH RePORTER	United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The study was supported by United States National Institutes of Health grants AG20618 and T32GM067545. We acknowledge National Disease Research Interchange for providing human tissue with support from NIH grant 5 U42 RR006042 (www.nih.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed N, 2002, BIOCHEM J, V364, P1; Allen MJ, 2003, VET CLIN PATH, V32, P101, DOI 10.1111/j.1939-165X.2003.tb00323.x; Bailey AJ, 1998, MECH AGEING DEV, V106, P1, DOI 10.1016/S0047-6374(98)00119-5; Banse X, 2002, BONE, V31, P70, DOI 10.1016/S8756-3282(02)00800-1; Banse X, 2002, J BONE MINER RES, V17, P1621, DOI 10.1359/jbmr.2002.17.9.1621; Burr DB, 1997, J BONE MINER RES, V12, P6, DOI 10.1359/jbmr.1997.12.1.6; Chevalley T, 2011, OSTEOPOROS IN PRESS; Fazzalari NL, 1998, BONE, V22, P381, DOI 10.1016/S8756-3282(97)00298-6; Felsenberg D, 2005, CLIN THER, V27, P1, DOI 10.1016/j.clinthera.2004.12.020; Fyhrie DP, 2000, BONE, V26, P169, DOI 10.1016/S8756-3282(99)00246-X; GROSS J, 1958, J EXP MED, V107, P247, DOI 10.1084/jem.107.2.247; Hernandez CJ, 2005, BONE, V37, P825, DOI 10.1016/j.bone.2005.07.019; HUI SL, 1988, J CLIN INVEST, V81, P1804, DOI 10.1172/JCI113523; Johnell O, 2006, OSTEOPOROSIS INT, V17, P1726, DOI 10.1007/s00198-006-0172-4; Karim L, 2011, J ORTHOP RES, V29, P1739, DOI 10.1002/jor.21448; Keaveny TM, 1997, J ORTHOPAED RES, V15, P101, DOI 10.1002/jor.1100150115; KNOTT L, 1995, BIOCHEM J, V310, P1045, DOI 10.1042/bj3101045; Knott L, 1998, BONE, V22, P181, DOI 10.1016/S8756-3282(97)00279-2; Kuster MS, 1997, J BONE JOINT SURG BR, V79B, P109, DOI 10.1302/0301-620X.79B1.6978; Liu XS, 2008, J BONE MINER RES, V23, P223, DOI 10.1359/JBMR.071009; Nazarian A, 2006, BONE, V39, P1196, DOI 10.1016/j.bone.2006.06.013; Odetti P, 2005, ANN NY ACAD SCI, V1043, P710, DOI 10.1196/annals.1333.082; Parfitt AM, 2002, J BONE MINER RES, V17, P1558, DOI 10.1359/jbmr.2002.17.8.1558; Paschalis EP, 2001, J BONE MINER RES, V16, P1821, DOI 10.1359/jbmr.2001.16.10.1821; Paschalis EP, 2004, J BONE MINER RES, V19, P2000, DOI 10.1359/JBMR.040820; Paul RG, 1996, INT J BIOCHEM CELL B, V28, P1297, DOI 10.1016/S1357-2725(96)00079-9; Rath NC, 1999, POULTRY SCI, V78, P1232, DOI 10.1093/ps/78.8.1232; Robins SP, 1996, CLIN CHEM, V42, P1621; Saito M, 2006, CALCIFIED TISSUE INT, V79, P160, DOI 10.1007/s00223-006-0035-1; Schaffler MB, 1995, BONE, V17, P521, DOI 10.1016/8756-3282(95)00370-3; SCHAFFLER MB, 1994, BONE, V15, P483, DOI 10.1016/8756-3282(94)90271-2; Schuit SCE, 2004, BONE, V34, P195, DOI 10.1016/j.bone.2003.10.001; Schwartz AV, 2009, J CLIN ENDOCR METAB, V94, P2380, DOI 10.1210/jc.2008-2498; Shi XT, 2010, BONE, V46, P1260, DOI 10.1016/j.bone.2010.02.005; Silva MJ, 2009, J BONE MINER RES, V24, P1618, DOI [10.1359/jbmr.090316, 10.1359/JBMR.090316]; Singer BR, 1998, J BONE JOINT SURG BR, V80B, P243, DOI 10.1302/0301-620X.80B2.7762; Sroga GE, 2011, J CHROMAT B IN PRESS; Sroga GE, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.006718; Tang SY, 2007, BONE, V40, P1259, DOI 10.1016/j.bone.2006.10.031; Tang SY, 2007, BONE, V40, P1144, DOI 10.1016/j.bone.2006.12.056; Tang SY, 2010, BONE, V46, P148, DOI 10.1016/j.bone.2009.09.003; Tang SY, 2009, OSTEOPOROSIS INT, V20, P887, DOI 10.1007/s00198-008-0754-4; Valcourt U, 2007, J BIOL CHEM, V282, P5691, DOI 10.1074/jbc.M610536200; Vashishth D, 1997, J BIOMECH, V30, P763, DOI 10.1016/S0021-9290(97)00029-8; Vashishth D, 2001, BONE, V28, P195, DOI 10.1016/S8756-3282(00)00434-8; Vashishth D, 2005, CRIT REV EUKAR GENE, V15, P343, DOI 10.1615/CritRevEukarGeneExpr.v15.i4.40; Vashishth D, 2007, INT J FATIGUE, V29, P1024, DOI 10.1016/j.ijfatigue.2006.09.010; Viguet-Carrin S, 2006, OSTEOPOROSIS INT, V17, P319, DOI 10.1007/s00198-005-2035-9; Viguet-Carrin S, 2006, BONE, V39, P1073, DOI 10.1016/j.bone.2006.05.013; Viguet-Carrin S, 2010, BONE, V46, P342, DOI 10.1016/j.bone.2009.10.001; Wang X, 2002, BONE, V31, P1, DOI 10.1016/S8756-3282(01)00697-4; Wenzel TE, 1996, BONE, V19, P89, DOI 10.1016/8756-3282(96)88871-5	52	65	65	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2012	7	4							e35047	10.1371/journal.pone.0035047	http://dx.doi.org/10.1371/journal.pone.0035047			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UT	22514706	Green Published, Green Submitted, gold			2022-12-25	WOS:000305341600112
J	Krystal, AD; Sutherland, J; Hochman, DW				Krystal, Andrew D.; Sutherland, Janice; Hochman, Daryl W.			Loop Diuretics Have Anxiolytic Effects in Rat Models of Conditioned Anxiety	PLOS ONE			English	Article							POTENTIATED STARTLE RESPONSE; ELEVATED PLUS-MAZE; K-CL COTRANSPORTER; CONTEXTUAL FEAR; FUROSEMIDE; DISORDERS; PREVALENCE; TRANSPORT; BLOCKADE; KINETICS	A number of antiepileptic medications that modulate GABA(A) mediated synaptic transmission are anxiolytic. The loop diuretics furosemide (Lasix) and bumetanide (Bumex) are thought to have antiepileptic properties. These drugs also modulate GABA(A) mediated signalling through their antagonism of cation-chloride cotransporters. Given that loop diuretics may act as antiepileptic drugs that modulate GABAergic signalling, we sought to investigate whether they also mediate anxiolytic effects. Here we report the first investigation of the anxiolytic effects of these drugs in rat models of anxiety. Furosemide and bumetanide were tested in adult rats for their anxiolytic effects using four standard anxiety models: 1) contextual fear conditioning; 2) fear-potentiated startle; 3) elevated plus maze, and 4) open-field test. Furosemide and bumetanide significantly reduced conditioned anxiety in the contextual fear-conditioning and fear-potentiated startle models. At the tested doses, neither compound had significant anxiolytic effects on unconditioned anxiety in the elevated plus maze and open-field test models. These observations suggest that loop diuretics elicit significant anxiolytic effects in rat models of conditioned anxiety. Since loop diuretics are antagonists of the NKCC1 and KCC2 cotransporters, these results implicate the cation-chloride cotransport system as possible molecular mechanism involved in anxiety, and as novel pharmacological target for the development of anxiolytics. In view of these findings, and since furosemide and bumetanide are safe and well tolerated drugs, the clinical potential of loop diuretics for treating some types of anxiety disorders deserves further investigation.	[Krystal, Andrew D.] Duke Univ, Med Ctr, Dept Psychiat & Behav Sci, Durham, NC 27705 USA; [Sutherland, Janice] Univ Lethbridge, Dept Neurosci, Lethbridge, AB T1K 3M4, Canada; [Sutherland, Janice] NeuroInvestigations Inc, Lethbridge, AB, Canada; [Hochman, Daryl W.] Duke Univ, Med Ctr, Dept Surg Surg Sci, Durham, NC USA; [Hochman, Daryl W.] Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC USA	Duke University; University of Lethbridge; Duke University; Duke University	Krystal, AD (corresponding author), Duke Univ, Med Ctr, Dept Psychiat & Behav Sci, Durham, NC 27705 USA.	dhochman@duke.edu	Krystal, Andrew D/J-7109-2013	Krystal, Andrew D/0000-0002-6702-781X	Cytoscan LLC., Seattle, WA, USA	Cytoscan LLC., Seattle, WA, USA	This research was funded by a gift to DWH from Cytoscan LLC., Seattle, WA, USA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHMAD S, 1976, BRIT J CLIN PHARMACO, V3, P621, DOI 10.1111/j.1365-2125.1976.tb04885.x; ANDREASEN F, 1991, COMP BIOCHEM PHYS C, V100, P635, DOI 10.1016/0742-8413(91)90053-V; Association AP DSM-IV APA on, 2000, DIAGN STAT MAN MENT; Blaesse P, 2009, NEURON, V61, P820, DOI 10.1016/j.neuron.2009.03.003; BRATER DC, 1983, CLIN PHARMACOL THER, V34, P207, DOI 10.1038/clpt.1983.154; BRATER DC, 1992, EUR HEART J, V13, P10, DOI 10.1093/eurheartj/13.suppl_G.10; Calabrese EJ, 2008, CRIT REV TOXICOL, V38, P489, DOI 10.1080/10408440802014238; Chen H, 2005, NEUROL RES, V27, P280, DOI 10.1179/016164105X25243; Clark BJ, 2005, BEHAV BRAIN RES, V163, P91, DOI 10.1016/j.bbr.2005.04.007; Davis M, 2001, Curr Protoc Neurosci, VChapter 8, DOI 10.1002/0471142301.ns0811as14; Deisz RA, 2011, J PHYSIOL-LONDON, V589, P1317, DOI 10.1113/jphysiol.2010.201830; Denys Damiaan, 2005, Curr Psychiatry Rep, V7, P252, DOI 10.1007/s11920-005-0078-4; Dzhala VI, 2005, NAT MED, V11, P1205, DOI 10.1038/nm1301; EVANS MG, 1986, PFLUG ARCH EUR J PHY, V406, P65, DOI 10.1007/BF00582955; Farrant M, 2007, PROG BRAIN RES, V160, P59, DOI 10.1016/S0079-6123(06)60005-8; Fendt M, 1999, NEUROSCI BIOBEHAV R, V23, P743, DOI 10.1016/S0149-7634(99)00016-0; Haglund MM, 2005, J NEUROPHYSIOL, V94, P907, DOI 10.1152/jn.00944.2004; Hesdorffer DC, 2001, ANN NEUROL, V50, P458, DOI 10.1002/ana.1136; Hicks D, 2010, MED CLIN N AM, V94, P1127, DOI 10.1016/j.mcna.2010.08.008; HIJZEN TH, 1995, PSYCHOPHARMACOLOGY, V118, P150, DOI 10.1007/BF02245833; Hirschfeld RMA, 2003, J CLIN PSYCHIAT, V64, P20; HOCHMAN DW, 1995, SCIENCE, V270, P99, DOI 10.1126/science.270.5233.99; Hochman DW, 2000, J NEUROPHYSIOL, V83, P406, DOI 10.1152/jn.2000.83.1.406; Hogg S, 1996, PHARMACOL BIOCHEM BE, V54, P21, DOI 10.1016/0091-3057(95)02126-4; Jayakumar AR, 2010, METAB BRAIN DIS, V25, P31, DOI 10.1007/s11011-010-9180-3; JENNINGS ML, 1985, ANNU REV PHYSIOL, V47, P519; Joordens RJE, 1996, PSYCHOPHARMACOLOGY, V126, P104, DOI 10.1007/BF02246344; KESSLER RC, 1994, ARCH GEN PSYCHIAT, V51, P8; Khirug S, 2008, J NEUROSCI, V28, P4635, DOI 10.1523/JNEUROSCI.0908-08.2008; Lehmann H, 2010, NEUROSCIENCE, V167, P974, DOI 10.1016/j.neuroscience.2010.03.005; Lehmann H, 2007, EUR J NEUROSCI, V25, P1278, DOI 10.1111/j.1460-9568.2007.05374.x; Lepine JP, 2002, J CLIN PSYCHIAT, V63, P4; Lydiard RB, 2003, J CLIN PSYCHIAT, V64, P21; MacVicar BA, 2002, GLIA, V37, P114, DOI 10.1002/glia.10023; Montezinho LP, 2010, PSYCHOPHARMACOLOGY, V212, P131, DOI 10.1007/s00213-010-1917-5; Muhammad A, 2011, DEV NEUROSCI-BASEL, V33, P85, DOI 10.1159/000324744; Pain L, 2002, BRIT J ANAESTH, V89, P614, DOI 10.1093/bja/aef228; Pinheiro SH, 2007, AN ACAD BRAS CIENC, V79, P71, DOI 10.1590/S0001-37652007000100010; Prut L, 2003, EUR J PHARMACOL, V463, P3, DOI 10.1016/S0014-2999(03)01272-X; Resstel LBM, 2006, BEHAV BRAIN RES, V172, P294, DOI 10.1016/j.bbr.2006.05.016; Rudolph U, 2011, NAT REV DRUG DISCOV, V10, P685, DOI 10.1038/nrd3502; Russell JM, 2000, PHYSIOL REV, V80, P211, DOI 10.1152/physrev.2000.80.1.211; Santos JM, 2006, EUR J PHARMACOL, V542, P121, DOI 10.1016/j.ejphar.2006.06.019; SCHWARTZ MA, 1981, J CLIN PHARMACOL, V21, P555, DOI 10.1002/j.1552-4604.1981.tb05664.x; Schwartzkroin PA, 1998, EPILEPSY RES, V32, P275, DOI 10.1016/S0920-1211(98)00058-8; Stein DJ, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002795.pub2; Stewart J, 1984, TESTED STUDIES LAB T, P13; Szabadics J, 2006, SCIENCE, V311, P233, DOI 10.1126/science.1121325; THOMPSON SM, 1994, PROG NEUROBIOL, V42, P575, DOI 10.1016/0301-0082(94)90044-2; Walf AA, 2007, NAT PROTOC, V2, P322, DOI 10.1038/nprot.2007.44; Wargo KA, 2009, ANN PHARMACOTHER, V43, P1836, DOI 10.1345/aph.1M177	52	20	21	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2012	7	4							e35417	10.1371/journal.pone.0035417	http://dx.doi.org/10.1371/journal.pone.0035417			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UT	22514741	Green Published, gold, Green Submitted			2022-12-25	WOS:000305341600146
J	Tyan, SW; Hsu, CH; Peng, KL; Chen, CC; Kuo, WH; Lee, EYHP; Shew, JY; Chang, KJ; Juan, LJ; Lee, WH				Tyan, Shiaw-Wei; Hsu, Chih-Hung; Peng, Kai-Lin; Chen, Chun-Chin; Kuo, Wen-Hung; Lee, Eva Y. -H. P.; Shew, Jin-Yuh; Chang, King-Jen; Juan, Li-Jung; Lee, Wen-Hwa			Breast Cancer Cells Induce Stromal Fibroblasts to Secrete ADAMTS1 for Cancer Invasion through an Epigenetic Change	PLOS ONE			English	Article							DNA METHYLATION PATTERNS; H3K27 DEMETHYLASES; TUMOR STROMA; IN-VIVO; CHROMATIN; TUMORIGENESIS; EXPRESSION	Microenvironment plays an important role in cancer development. We have reported that the cancer-associated stromal cells exhibit phenotypic and functional changes compared to stromal cells neighboring to normal tissues. However, the molecular mechanisms as well as the maintenance of these changes remain elusive. Here we showed that through co-culture with breast cancer cells for at least three to four passages, breast normal tissue-associated fibroblasts (NAFs) gained persistent activity for promoting cancer cell invasion, partly via up-regulating ADAM metallopeptidase with thrombospondin type 1 motif, 1 (ADAMTS1). Furthermore, we demonstrated that the DNA methylation pattern in the ADAMTS1 promoter has no alteration. Instead, the loss of EZH2 binding to the ADAMTS1 promoter and the resulting decrease of promoter-associated histone H3K27 methylation may account for the up-regulation of ADAMTS1. Importantly, the lack of EZH2 binding and the H3K27 methylation on the ADAMTS1 promoter were sustained in cancer cell-precocultured NAFs after removal of cancer cells. These results suggest that cancer cells are capable of inducing stromal fibroblasts to secrete ADAMTS1 persistently for their invasion and the effect is epigenetically inheritable.	[Tyan, Shiaw-Wei; Hsu, Chih-Hung; Peng, Kai-Lin; Chen, Chun-Chin; Lee, Eva Y. -H. P.; Shew, Jin-Yuh; Juan, Li-Jung; Lee, Wen-Hwa] Acad Sinica, Genom Res Ctr, Taipei 115, Taiwan; [Peng, Kai-Lin] Natl Yang Ming Univ, Inst Biochem & Mol Biol, Taipei 112, Taiwan; [Kuo, Wen-Hung; Chang, King-Jen] Natl Taiwan Univ Hosp, Dept Surg, Taipei 100, Taiwan; [Chang, King-Jen] Cheng Ching Gen Hosp, Taichung, Taiwan; [Lee, Eva Y. -H. P.] Univ Calif Irvine, Dept Dev & Cell Biol, Irvine, CA 92717 USA; [Lee, Eva Y. -H. P.; Lee, Wen-Hwa] Univ Calif Irvine, Dept Biol Chem, Irvine, CA 92717 USA	Academia Sinica - Taiwan; National Yang Ming Chiao Tung University; National Taiwan University; National Taiwan University Hospital; University of California System; University of California Irvine; University of California System; University of California Irvine	Tyan, SW (corresponding author), Acad Sinica, Genom Res Ctr, Taipei 115, Taiwan.	kingjen@ntu.edu.tw; ljjuan@gate.sinica.edu.tw; whlee@uci.edu	Hsu, Chih-Hung/AEM-8298-2022; Juan, Li-Jung/H-6631-2015; Lee, Wen-Hwa/C-2519-2014	Hsu, Chih-Hung/0000-0001-8071-0122; KUO, WEN-HUNG/0000-0002-9881-4605; Chang, King jen/0000-0001-9811-3422	Academia Sinica	Academia Sinica(Academia Sinica - Taiwan)	This work was supported by grants from Academia Sinica to WHL and LJJ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agger K, 2007, NATURE, V449, P731, DOI 10.1038/nature06145; Allinen M, 2004, CANCER CELL, V6, P17, DOI 10.1016/j.ccr.2004.06.010; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Canals F, 2006, PROTEOMICS, V6, pS28, DOI 10.1002/pmic.200500446; Rodriguez-Manzaneque JC, 2009, INT J BIOCHEM CELL B, V41, P800, DOI 10.1016/j.biocel.2008.08.014; Cha TL, 2005, SCIENCE, V310, P306, DOI 10.1126/science.1118947; Hsu CH, 2004, EMBO J, V23, P2269, DOI 10.1038/sj.emboj.7600239; Hu M, 2008, CURR OPIN GENET DEV, V18, P27, DOI 10.1016/j.gde.2007.12.006; Koken MHM, 1996, DEV BIOL, V173, P119, DOI 10.1006/dbio.1996.0011; Kolset SO, 2008, CELL MOL LIFE SCI, V65, P1073, DOI 10.1007/s00018-007-7455-6; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Kuno K, 2000, FEBS LETT, V478, P241, DOI 10.1016/S0014-5793(00)01854-8; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Lind GE, 2006, CELL ONCOL, V28, P259; Liu YJ, 2006, ONCOGENE, V25, P2452, DOI 10.1038/sj.onc.1209287; Longpre JM, 2004, J BIOL CHEM, V279, P33237, DOI 10.1074/jbc.M313151200; Lu X, 2009, GENE DEV, V23, P1882, DOI 10.1101/gad.1824809; Mueller MM, 2004, NAT REV CANCER, V4, P839, DOI 10.1038/nrc1477; Rocks N, 2008, CANCER RES, V68, P9541, DOI 10.1158/0008-5472.CAN-08-0548; Sandy JD, 2001, J BIOL CHEM, V276, P13372, DOI 10.1074/jbc.M009737200; Sorensen AL, 2010, MOL BIOL CELL, V21, P2066, DOI 10.1091/mbc.E10-01-0018; Swigut T, 2007, CELL, V131, P29, DOI 10.1016/j.cell.2007.09.026; Tlsty TD, 2006, ANNU REV PATHOL-MECH, V1, P119, DOI 10.1146/annurev.pathol.1.110304.100224; Tremblay KD, 1997, MOL CELL BIOL, V17, P4322, DOI 10.1128/MCB.17.8.4322; Tyan SW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015313; Wang GG, 2007, TRENDS MOL MED, V13, P363, DOI 10.1016/j.molmed.2007.07.003; Wu H, 2011, NATURE, V473, P389, DOI 10.1038/nature09934; Xu YF, 2011, MOL CELL, V42, P451, DOI 10.1016/j.molcel.2011.04.005; Yao JY, 2010, J BIOL CHEM, V285, P18828, DOI 10.1074/jbc.M109.077974; Zhu B, 2011, CELL RES, V21, P435, DOI 10.1038/cr.2011.26	30	51	53	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2012	7	4							e35128	10.1371/journal.pone.0035128	http://dx.doi.org/10.1371/journal.pone.0035128			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UT	22514714	Green Published, gold			2022-12-25	WOS:000305341600120
J	Zhao, XS; Malhotra, GK; Band, H; Band, V				Zhao, Xiangshan; Malhotra, Gautam K.; Band, Hamid; Band, Vimla			Derivation of Myoepithelial Progenitor Cells from Bipotent Mammary Stem/Progenitor Cells	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; HUMAN BREAST-TUMORS; STEM-CELLS; CANCER; PROGRESSION; METASTASIS; CARCINOMAS; CULTURES; SUBTYPES; GROWTH	There is increasing evidence that breast and other cancers originate from and are maintained by a small fraction of stem/progenitor cells with self-renewal properties. Recent molecular profiling has identified six major subtypes of breast cancer: basal-like, ErbB2-overexpressing, normal breast epithelial-like, luminal A and B, and claudin-low subtypes. To help understand the relationship among mammary stem/progenitor cells and breast cancer subtypes, we have recently derived distinct hTERT-immortalized human mammary stem/progenitor cell lines: a K5(+)/K19(-) type, and a K5(+)/K19(+) type. Under specific culture conditions, bipotent K5(+)/K19(-) stem/progenitor cells differentiated into stable clonal populations that were K5(-)/K19(-) and exhibit self-renewal and unipotent myoepithelial differentiation potential in contrast to the parental K5(+)/K19(-) cells which are bipotent. These K5(-)/K19(-) cells function as myoepithelial progenitor cells and constitutively express markers of an epithelial to mesenchymal transition (EMT) and show high invasive and migratory abilities. In addition, these cells express a microarray signature of claudin-low breast cancers. The EMT characteristics of an un-transformed unipotent mammary myoepithelial progenitor cells together with claudin-low signature suggests that the claudin-low breast cancer subtype may arise from myoepithelial lineage committed progenitors. Availability of immortal MPCs should allow a more definitive analysis of their potential to give rise to claudin-low breast cancer subtype and facilitate biological and molecular/biochemical studies of this disease.	[Zhao, Xiangshan; Malhotra, Gautam K.; Band, Hamid; Band, Vimla] Univ Nebraska Med Ctr, Dept Genet Cell Biol & Anat, Omaha, NE USA; [Band, Hamid] Univ Nebraska Med Ctr, Dept Pathol & Microbiol, Omaha, NE USA; [Band, Hamid] Univ Nebraska Med Ctr, Dept Biochem & Mol Biol, Omaha, NE USA; [Band, Hamid] Univ Nebraska Med Ctr, Coll Med, Dept Pharmacol & Expt Neurosci, Omaha, NE USA; [Band, Hamid; Band, Vimla] Univ Nebraska Med Ctr, Eppley Inst Res Canc & Allied Dis, Omaha, NE USA	University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center	Zhao, XS (corresponding author), Univ Nebraska Med Ctr, Dept Genet Cell Biol & Anat, Omaha, NE USA.	vband@unmc.edu	Band, Hamid/AAF-4701-2020; Malhotra, Gautam/GYI-8625-2022	Malhotra, Gautam/0000-0003-4563-0172	NIH [CA96844, CA144027, CA87986, CA99163, CA105489, CA116552]; NCI [5U01CA151806-02]; Department of Defense [W81XWH-07-1-0351, W81XWH-11-1-0171]; UNMC graduate student fellowship; NATIONAL CANCER INSTITUTE [R01CA099163, R01CA116552, U01CA151806, R01CA105489, R01CA096844, R01CA144027, R01CA087986] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Department of Defense(United States Department of Defense); UNMC graduate student fellowship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Work in the laboratories was supported by NIH grants CA96844 and CA144027 to VB and CA87986, CA99163, CA105489, CA116552 and NCI 5U01CA151806-02 to HB and Department of Defense grants W81XWH-07-1-0351 and W81XWH-11-1-0171 to VB; and the NCI Core Support Grant to UNMC-Eppley Cancer Center. Gautam Malhotra was supported by a UNMC graduate student fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adriance MC, 2005, BREAST CANCER RES, V7, P190, DOI 10.1186/bcr1286; BAND V, 1990, P NATL ACAD SCI USA, V87, P463, DOI 10.1073/pnas.87.1.463; BAND V, 1989, P NATL ACAD SCI USA, V86, P1249, DOI 10.1073/pnas.86.4.1249; Debnath J, 2003, METHODS, V30, P256, DOI 10.1016/S1046-2023(03)00032-X; DEUGNIER MA, 1995, DEV DYNAM, V204, P107, DOI 10.1002/aja.1002040202; Dick JE, 2003, P NATL ACAD SCI USA, V100, P3547, DOI 10.1073/pnas.0830967100; Dontu G, 2003, GENE DEV, V17, P1253, DOI 10.1101/gad.1061803; Gudjonsson T, 2002, GENE DEV, V16, P693, DOI 10.1101/gad.952602; Herschkowitz JI, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-r76; Herschkowitz JI, 2011, P NATL ACAD SCI US; Hu M, 2008, CANCER CELL, V13, P394, DOI 10.1016/j.ccr.2008.03.007; Hungermann D, 2005, BMC CANCER, V5, DOI 10.1186/1471-2407-5-92; Keller P. J., 2011, P NATL ACAD SCI US; Malhotra GK, 2010, CANCER BIOL THER, V10, P955, DOI 10.4161/cbt.10.10.13879; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Pandey PR, 2010, FRONT BIOSCI-LANDMRK, V15, P226, DOI 10.2741/3617; Pasic L, 2011, GENE DEV, V25, P1641, DOI 10.1101/gad.2025611; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; PETERSEN OW, 1989, IN VITRO CELL DEV B, V25, P259, DOI 10.1007/BF02628464; Polyak K, 2009, BREAST CANCER RES, V11, pS8, DOI 10.1186/bcr2279; Polyak K, 2007, J CLIN INVEST, V117, P3155, DOI 10.1172/JCI33295; Prat A, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2635; Sarrio D, 2012, STEM CELLS, V30, P292, DOI 10.1002/stem.791; Singh A, 2010, ONCOGENE, V29, P4741, DOI 10.1038/onc.2010.215; Sorlie T, 2003, P NATL ACAD SCI USA, V100, P8418, DOI 10.1073/pnas.0932692100; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Spaderna S, 2008, CANCER RES, V68, P537, DOI 10.1158/0008-5472.CAN-07-5682; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Thompson EW, 2005, CANCER RES, V65, P5991, DOI 10.1158/0008-5472.CAN-05-0616; THORNER PS, 1986, CANCER, V57, P745, DOI 10.1002/1097-0142(19860215)57:4<745::AID-CNCR2820570411>3.0.CO;2-8; Van Keymeulen A, 2011, NATURE, V479, P189, DOI 10.1038/nature10573; Zhao X, 2012, J CARCINOGE IN PRESS; Zhao XS, 2010, P NATL ACAD SCI USA, V107, P14146, DOI 10.1073/pnas.1009030107	33	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2012	7	4							e35338	10.1371/journal.pone.0035338	http://dx.doi.org/10.1371/journal.pone.0035338			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UT	22514728	Green Published, gold, Green Submitted			2022-12-25	WOS:000305341600133
J	Lee, PC; Lee, HJ; Kakadiya, R; Sanjiv, K; Su, TL; Lee, TC				Lee, P-C; Lee, H-J; Kakadiya, R.; Sanjiv, K.; Su, T-L; Lee, T-C			Multidrug-resistant cells overexpressing P-glycoprotein are susceptible to DNA crosslinking agents due to attenuated Src/nuclear EGFR cascade-activated DNA repair activity	ONCOGENE			English	Article						DNA crosslinking agents; nnultidrug resistance; Src/nuclear EGFR cascade; DNA repair; DNA-PK nuclear translocation	GROWTH-FACTOR RECEPTOR; DEPENDENT PROTEIN-KINASE; HAMSTER OVARY CELLS; STRAND BREAK REPAIR; IN-VITRO; NUCLEAR TRANSLOCATION; SIGNAL-TRANSDUCTION; HUMAN CANCER; TUMOR-CELLS; SRC	We synthesized several novel bifunctional alkylating derivatives of 3a-aza-cyclopenta[a]indene (BO-1012, BO-1005, BO-1099 and BO-1101) that are potent DNA interstrand crosslinking agents. In in vitro cytotoxicity assay, these compounds were more cytotoxic to multidrug-resistant (MDR) cells, such as KBvin10, KBtax50 and CEM/VBL, than their parental cells. Using a xenograft model, BO-1012, at a dose of 5 mg/kg, partially suppressed the growth of parental KB cells but completely suppressed the growth of KBvin10 cells in nude mice. In exploring the possible mechanism, we found that DNA double-strand break (DSB) repair activity in MDR cells, KBvin10 and CEM/VBL, was significantly reduced compared with their parental cells, KB and CEM. Reduced DSB repair activity in KBvin10 cells was likely due to a defect in nuclear translocation of DNA-dependent protein kinase (DNA-PK), a component of the non-homologous end-joining repair machinery. Furthermore, BO-1012-induced DNA-PK translocation from the cytosol into the nucleus in KB cells is associated with the activation of the Src/nuclear epidermal growth factor receptor (EGFR) cascade, which is defective in MDR cells. As knockdown of P-glycoprotein (P-gp) by siRNA reactivated the Src/nuclear EGFR cascade, DNA-PK translocation and DNA repair activity in MDR cells, overexpression of P-gp attenuates the activity of DNA DSB repair through suppression of Src/nuclear EGFR cascade. Therefore, DNA interstrand crosslinking agents may have potential therapeutic use against P-gp-overexpressing MDR cells. Oncogene (2013) 32, 1144-1154; doi:10.1038/onc.2012.133; published online 23 April 2012	[Lee, P-C; Lee, H-J; Kakadiya, R.; Sanjiv, K.; Su, T-L; Lee, T-C] Acad Sinica, Inst Biomed Sci, Taipei 11529, Taiwan; [Lee, P-C; Lee, T-C] Natl Yang Ming Univ, Inst Pharmacol, Sch Med, Taipei 112, Taiwan	Academia Sinica - Taiwan; National Yang Ming Chiao Tung University	Lee, TC (corresponding author), Acad Sinica, Inst Biomed Sci, Taipei 11529, Taiwan.	tlsu@ibms.sinica.edu.tw; bmtcl@ibms.sinica.edu.tw			Academia Sinica [AS-96-TP-B06, AS-100-TP-B13]; National Science Councils, Taiwan (ROC) [NSC-100-2325-B-001-003]	Academia Sinica(Academia Sinica - Taiwan); National Science Councils, Taiwan (ROC)	We thank Dr Ling-Hui Yih for helpful suggestions and critical comments. This work was supported by grants from the Academia Sinica (AS-96-TP-B06 and AS-100-TP-B13) and the National Science Councils (NSC-100-2325-B-001-003), Taiwan (ROC).	Aleshin A, 2010, NEOPLASIA, V12, P599, DOI 10.1593/neo.10328; Bandyopadhyay D, 1998, J BIOL CHEM, V273, P1568, DOI 10.1074/jbc.273.3.1568; Bell SE, 1998, BRIT J CANCER, V78, P1464, DOI 10.1038/bjc.1998.708; Bergman AM, 2003, BRIT J CANCER, V88, P1963, DOI 10.1038/sj.bjc.6601011; Bjorge JD, 2000, ONCOGENE, V19, P5620, DOI 10.1038/sj.onc.1203923; Bolderson E, 2009, CLIN CANCER RES, V15, P6314, DOI 10.1158/1078-0432.CCR-09-0096; Borowski E, 2005, ACTA BIOCHIM POL, V52, P609; Bradshaw JM, 2010, CELL SIGNAL, V22, P1175, DOI 10.1016/j.cellsig.2010.03.001; CHAN HSL, 1991, NEW ENGL J MED, V325, P1608, DOI 10.1056/NEJM199112053252304; Chaniyara R, 2011, BIOORGAN MED CHEM, V19, P275, DOI 10.1016/j.bmc.2010.11.030; Chou TC, 2006, PHARMACOL REV, V58, P621, DOI 10.1124/pr.58.3.10; Dittmann K, 2005, J BIOL CHEM, V280, P31182, DOI 10.1074/jbc.M506591200; Dittmann K, 2011, RADIOTHER ONCOL, V99, P317, DOI 10.1016/j.radonc.2011.06.001; Dittmann K, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-69; Egloff AM, 2008, SEMIN ONCOL, V35, P286, DOI 10.1053/j.seminoncol.2008.03.008; ERBA E, 1995, INT J CANCER, V62, P170, DOI 10.1002/ijc.2910620211; FORD JM, 1990, PHARMACOL REV, V42, P155; Friedmann BJ, 2006, MOL CANCER THER, V5, P209, DOI 10.1158/1535-7163.MCT-05-0239; Frosina G, 2009, MOL CANCER RES, V7, P989, DOI 10.1158/1541-7786.MCR-09-0030; GOLDSTEIN LJ, 1989, J NATL CANCER I, V81, P116, DOI 10.1093/jnci/81.2.116; Gottesman MM, 2002, NAT REV CANCER, V2, P48, DOI 10.1038/nrc706; Guarino M, 2010, J CELL PHYSIOL, V223, P14, DOI 10.1002/jcp.22011; GUPTA RS, 1985, CANCER TREAT REP, V69, P515; Hall MD, 2011, J MED CHEM, V54, P5878, DOI 10.1021/jm2006047; Hall MD, 2009, TRENDS PHARMACOL SCI, V30, P546, DOI 10.1016/j.tips.2009.07.003; Hatanpaa KJ, 2010, NEOPLASIA, V12, P675, DOI 10.1593/neo.10688; He SN, 2010, INT J MOL SCI, V11, P3039, DOI 10.3390/ijms11093039; Huo LF, 2010, P NATL ACAD SCI USA, V107, P16125, DOI 10.1073/pnas.1000743107; Irby RB, 2000, ONCOGENE, V19, P5636, DOI 10.1038/sj.onc.1203912; Juang SH, 2007, MOL CANCER THER, V6, P193, DOI 10.1158/1535-7163.MCT-06-0482; Kakadiya R, 2009, BIOORGAN MED CHEM, V17, P5614, DOI 10.1016/j.bmc.2009.06.018; Kim LC, 2009, NAT REV CLIN ONCOL, V6, P587, DOI 10.1038/nrclinonc.2009.129; Kimura Y, 2004, MICROBIOL-SGM, V150, P631, DOI 10.1099/mic.0.26786-0; Lage H, 2006, CURR DRUG TARGETS, V7, P813, DOI 10.2174/138945006777709566; Lai KC, 2008, MOL CANCER RES, V6, P1431, DOI 10.1158/1541-7786.MCR-08-0141; Lee CH, 2010, METHODS MOL BIOL, V596, P325, DOI 10.1007/978-1-60761-416-6_14; Lee PC, 2010, NEOPLASIA, V12, P376, DOI 10.1593/neo.10110; LEE TC, 1994, CANCER RES, V54, P1660; LEESMILLER SP, 1995, SCIENCE, V267, P1183, DOI 10.1126/science.7855602; Liccardi G, 2011, CANCER RES, V71, P1103, DOI 10.1158/0008-5472.CAN-10-2384; Lurje G, 2009, ONCOLOGY-BASEL, V77, P400, DOI 10.1159/000279388; Mahaney BL, 2009, BIOCHEM J, V417, P639, DOI 10.1042/BJ20080413; Martin GS, 2001, NAT REV MOL CELL BIO, V2, P467, DOI 10.1038/35073094; Mayer EL, 2010, CLIN CANCER RES, V16, P3526, DOI 10.1158/1078-0432.CCR-09-1834; Medunjanin S, 2010, MOL BIOL CELL, V21, P1620, DOI 10.1091/mbc.E09-08-0724; Meek K, 2004, IMMUNOL REV, V200, P132, DOI 10.1111/j.0105-2896.2004.00162.x; Miyagawa K, 2008, CANCER SCI, V99, P187, DOI 10.1111/j.1349-7006.2007.00644.x; Norgaard JM, 1998, BRIT J HAEMATOL, V100, P534, DOI 10.1046/j.1365-2141.1998.00593.x; O'Connell MJ, 2000, TRENDS CELL BIOL, V10, P296, DOI 10.1016/S0962-8924(00)01773-6; Pan GD, 2009, WORLD J GASTROENTERO, V15, P431, DOI 10.3748/wjg.15.431; Parsons SJ, 2004, ONCOGENE, V23, P7906, DOI 10.1038/sj.onc.1208160; RONINSON IB, 1992, BIOCHEM PHARMACOL, V43, P95, DOI 10.1016/0006-2952(92)90666-7; RONINSON IB, 1986, P NATL ACAD SCI USA, V83, P4538, DOI 10.1073/pnas.83.12.4538; Szakacs G, 2006, NAT REV DRUG DISCOV, V5, P219, DOI 10.1038/nrd1984; Szumiel I, 2006, CELL SIGNAL, V18, P1537, DOI 10.1016/j.cellsig.2006.03.010; Takara K, 2006, CURR PHARM DESIGN, V12, P273, DOI 10.2174/138161206775201965; Turk D, 2009, CANCER RES, V69, P8293, DOI 10.1158/0008-5472.CAN-09-2422; WANG HF, 1993, BIOCHEM BIOPH RES CO, V192, P1093, DOI 10.1006/bbrc.1993.1529; Wang SC, 2009, CLIN CANCER RES, V15, P6484, DOI 10.1158/1078-0432.CCR-08-2813; Wheeler DL, 2009, ONCOLOGIST, V14, P667, DOI 10.1634/theoncologist.2009-0009; Yeatman TJ, 2004, NAT REV CANCER, V4, P470, DOI 10.1038/nrc1366; Yih LH, 2006, CANCER RES, V66, P2098, DOI 10.1158/0008-5472.CAN-05-2308	62	19	19	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	FEB 28	2013	32	9					1144	1154		10.1038/onc.2012.133	http://dx.doi.org/10.1038/onc.2012.133			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	110FU	22525278				2022-12-25	WOS:000316428800008
J	Platt, RJ; Han, TS; Green, BR; Smith, MD; Skalicky, J; Gruszczynski, P; White, HS; Olivera, B; Bulaj, G; Gajewiak, J				Platt, Randall J.; Han, Tiffany S.; Green, Brad R.; Smith, Misty D.; Skalicky, Jack; Gruszczynski, Pawel; White, H. Steve; Olivera, Baldomero; Bulaj, Grzegorz; Gajewiak, Joanna			Stapling Mimics Noncovalent Interactions of gamma-Carboxyglutamates in Conantokins, Peptidic Antagonists of N-Methyl-D-Aspartic Acid Receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HELIX STABILIZATION; BH3 HELIX; IN-VIVO; 6 HZ; NMDA; RESIDUES; EPILEPSY; BINDING; ACTIVATION; METATHESIS	Conantokins are short peptides derived from the venoms of marine cone snails that act as antagonists of the N-methyl-D-aspartate (NMDA) receptor family of excitatory glutamate receptors. These peptides contain gamma-carboxyglutamic acid residues typically spaced at i,i+4 and/or i,i+7 intervals, which by chelating divalent cations induce and stabilize helical conformation of the peptide. Introduction of a dicarba bridge (or a staple) can covalently stabilize peptide helicity and improve its pharmacological properties. To test the hypothesis that stapling can effectively replace gamma-carboxyglutamic acid residues in stabilizing the helical conformation of conantokins, we designed, synthesized, and characterized several stapled analogs of conantokin G (conG), with varying connectivities in terms of staple length and location along the face of the alpha-helix. NMR studies confirmed that the ring-closing metathesis reaction yielded a single product with the Z configuration of the olefinic bond. Based on circular dichroism and molecular modeling, the stapled analogs exhibited significantly enhanced helicity compared with the native peptide in a metal-free environment. Stapling i,i+4 was benign with respect to effects on in vitro and in vivo pharmacological properties. One analog, namely conG[11-15,Si,i+4S(8)], blocked NR2B-containing NMDA receptors with IC50 = 0.7 mu M and provided significant protection in the 6-Hz psychomotor model of pharmacoresistant epilepsy in mice. Remarkably, unlike native conG, conG[11-15,Si,i+4S(8)] produced no behavioral motor toxicity. Our results extend the applications of peptide stapling to helical peptides with extracellular targets and provide a means for engineering conantokins with improved pharmacological properties.	[Platt, Randall J.; Han, Tiffany S.; Green, Brad R.; Olivera, Baldomero; Bulaj, Grzegorz; Gajewiak, Joanna] Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA; [Smith, Misty D.; White, H. Steve] Univ Utah, Dept Pharmacol Toxicol, Salt Lake City, UT 84112 USA; [Skalicky, Jack] Univ Utah, Dept Biochem, Salt Lake City, UT 84112 USA; [Green, Brad R.; Bulaj, Grzegorz] Univ Utah, Dept Med Chem, Salt Lake City, UT 84112 USA; [Gruszczynski, Pawel] Univ Gdansk, Intercoll Fac Biotechnol, PL-80952 Gdansk, Poland; [Gruszczynski, Pawel] Univ Gdansk, Fac Chem, PL-80952 Gdansk, Poland; [Gruszczynski, Pawel] Biolab Innovat Res Technol, PL-80172 Gdansk, Poland; [Gruszczynski, Pawel] Med Univ Gdansk, Gdansk, Poland	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Fahrenheit Universities; University of Gdansk; Fahrenheit Universities; University of Gdansk; Fahrenheit Universities; Medical University Gdansk	Gajewiak, J (corresponding author), Univ Utah, Dept Biol, 257 South,1400 East, Salt Lake City, UT 84112 USA.	jgajewiak@gmail.com		Platt, Randall/0000-0002-2914-7052	National Institute of General Medical Sciences from the National Institute of General Medical Sciences [GM48677]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM048677] Funding Source: NIH RePORTER	National Institute of General Medical Sciences from the National Institute of General Medical Sciences; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM48677 from the National Institute of General Medical Sciences.	Barton ME, 2003, EPILEPSY RES, V56, P17, DOI 10.1016/j.eplepsyres.2003.08.001; Barton ME, 2001, EPILEPSY RES, V47, P217, DOI 10.1016/S0920-1211(01)00302-3; Bhattacharya S, 2008, J BIOL CHEM, V283, P16274, DOI 10.1074/jbc.C800048200; Bird GH, 2010, P NATL ACAD SCI USA, V107, P14093, DOI 10.1073/pnas.1002713107; Blackwell HE, 1998, ANGEW CHEM INT EDIT, V37, P3281, DOI 10.1002/(SICI)1521-3773(19981217)37:23<3281::AID-ANIE3281>3.0.CO;2-V; Blandl T, 1999, J PEPT RES, V53, P453, DOI 10.1034/j.1399-3011.1999.00042.x; Blandl T, 1998, FEBS LETT, V435, P257, DOI 10.1016/S0014-5793(98)01077-1; Cartier GE, 1996, J BIOL CHEM, V271, P7522, DOI 10.1074/jbc.271.13.7522; Case D.A., 2022, AMBER 2020; Cnudde SE, 2007, J AM CHEM SOC, V129, P1586, DOI 10.1021/ja065722q; Cull-Candy S, 2001, CURR OPIN NEUROBIOL, V11, P327, DOI 10.1016/S0959-4388(00)00215-4; Dai QY, 2004, J MOL BIOL, V336, P731, DOI 10.1016/j.jmb.2003.12.027; Danial NN, 2008, NAT MED, V14, P144, DOI 10.1038/nm1717; Gowd KH, 2010, J PEPT SCI, V16, P375, DOI 10.1002/psc.1249; Gowd KH, 2008, TOXICON, V52, P203, DOI 10.1016/j.toxicon.2008.04.178; Guo ZJ, 2010, CHEM BIOL DRUG DES, V75, P348, DOI 10.1111/j.1747-0285.2010.00951.x; HAACK JA, 1990, J BIOL CHEM, V265, P6025; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; Jain A, 2011, BIOMACROMOLECULES, V12, P2729, DOI 10.1021/bm2005017; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kaul R, 1999, BIOORGAN MED CHEM, V7, P105, DOI 10.1016/S0968-0896(98)00221-1; Kim YW, 2010, ORG LETT, V12, P3046, DOI 10.1021/ol1010449; Layer RT, 2004, CURR MED CHEM, V11, P3073, DOI 10.2174/0929867043363901; Ma MT, 2009, J AM CHEM SOC, V131, P4505, DOI 10.1021/ja900047w; MARQUSEE S, 1987, P NATL ACAD SCI USA, V84, P8898, DOI 10.1073/pnas.84.24.8898; MARQUSEE S, 1989, P NATL ACAD SCI USA, V86, P5286, DOI 10.1073/pnas.86.14.5286; Mayne L, 1998, J AM CHEM SOC, V120, P10643, DOI 10.1021/ja981592c; Moellering RE, 2009, NATURE, V462, P182, DOI 10.1038/nature08543; Nateri AS, 2007, EMBO J, V26, P4891, DOI 10.1038/sj.emboj.7601911; Onufriev A, 2004, PROTEINS, V55, P383, DOI 10.1002/prot.20033; Palmer GC, 2001, CURR DRUG TARGETS, V2, P241, DOI 10.2174/1389450013348335; Phillips C, 2011, J AM CHEM SOC, V133, P9696, DOI 10.1021/ja202946k; PRASAD BVV, 1984, CRC CR REV BIOCH MOL, V16, P307; Pretsch E., 2000, TABLES SPECTRAL DATA; Prorok M, 1996, BIOCHEMISTRY-US, V35, P16528, DOI 10.1021/bi9621122; Prorok M, 2001, CURR DRUG TARGETS, V2, P313, DOI 10.2174/1389450013348542; Rigby AC, 1997, BIOCHEMISTRY-US, V36, P15677, DOI 10.1021/bi9718550; Rigby AC, 1997, BIOCHEMISTRY-US, V36, P12394, DOI 10.1021/bi975016p; RUAN FQ, 1990, J AM CHEM SOC, V112, P9403, DOI 10.1021/ja00181a058; Schafmeister CE, 2000, J AM CHEM SOC, V122, P5891, DOI 10.1021/ja000563a; Stewart ML, 2010, NAT CHEM BIOL, V6, P595, DOI [10.1038/NCHEMBIO.391, 10.1038/nchembio.391]; Stohr T, 2007, EPILEPSY RES, V74, P147, DOI 10.1016/j.eplepsyres.2007.03.004; Teichert RW, 2007, J BIOL CHEM, V282, P36905, DOI 10.1074/jbc.M706611200; Verdine GL, 2007, CLIN CANCER RES, V13, P7264, DOI 10.1158/1078-0432.CCR-07-2184; Walensky LD, 2004, SCIENCE, V305, P1466, DOI 10.1126/science.1099191; Warder SE, 1998, J BIOL CHEM, V273, P7512, DOI 10.1074/jbc.273.13.7512; Whelan J, 2004, DRUG DISCOV TODAY, V9, P907, DOI 10.1016/S1359-6446(04)03268-4; White HS, 2000, J PHARMACOL EXP THER, V292, P425; Wu XW, 2003, CHEM PHYS LETT, V381, P512, DOI 10.1016/j.cplett.2003.10.013; Zhou LM, 1996, J NEUROCHEM, V66, P620	50	22	22	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 8	2012	287	24					20727	20736		10.1074/jbc.M112.350462	http://dx.doi.org/10.1074/jbc.M112.350462			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974FB	22518838	hybrid, Green Published			2022-12-25	WOS:000306414500091
J	Sato, M; Hutchinson, DS; Halls, ML; Furness, SGB; Bengtsson, T; Evans, BA; Summers, RJ				Sato, Masaaki; Hutchinson, Dana S.; Halls, Michelle L.; Furness, Sebastian G. B.; Bengtsson, Tore; Evans, Bronwyn A.; Summers, Roger J.			Interaction with Caveolin-1 Modulates G Protein Coupling of Mouse beta(3)-Adrenoceptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INCREASES GLUCOSE-TRANSPORT; BROWN ADIPOSE-TISSUE; PDZ-BINDING MOTIF; ADENYLYL-CYCLASE; NONSHIVERING THERMOGENESIS; NANOSCALE ORGANIZATION; MEMBRANE RAFT; RECEPTOR; LOCALIZATION; ACTIVATION	Caveolins act as scaffold proteins in multiprotein complexes and have been implicated in signaling by G protein-coupled receptors. Studies using knock-out mice suggest that beta(3)-adrenoceptor (beta(3)-AR) signaling is dependent on caveolin-1; however, it is not known whether caveolin-1 is associated with the beta(3)-AR or solely with downstream signaling proteins. We have addressed this question by examining the impact of membrane rafts and caveolin-1 on the differential signaling of mouse beta(3a)- and beta(3b)-AR isoforms that diverge at the distal C terminus. Only the beta(3b)-AR promotes pertussis toxin (PTX)-sensitive cAMP accumulation. When cells expressing the beta(3a)-AR were treated with filipin III to disrupt membrane rafts or transfected with caveolin-1 siRNA, the cyclic AMP response to the beta(3)-AR agonist CL316243 became PTX-sensitive, suggesting G alpha(i/o) coupling. The beta(3a)-AR C terminus, S (P-384) under bar PLNR (P-389) under bar DG (Y-392) under bar EGARP (P-398) under bar PT, resembles a caveolin interaction motif. Mutant beta(3a)-ARs (F389A/Y392A/F398A or P384S/F389A) promoted PTX-sensitive cAMP responses, and in situ proximity assays demonstrated an association between caveolin-1 and the wild type beta(3a)-AR but not the mutant receptors. In membrane preparations, the beta(3b)-AR activated G alpha(o) and mediated PTX-sensitive cAMP responses, whereas the beta(3a)-AR did not activate G alpha(i/o) proteins. The endogenous beta(3a)-AR displayed G alpha(i/o) coupling in brown adipocytes from caveolin-1 knock-out mice or in wild type adipocytes treated with filipin III. Our studies indicate that interaction of the beta(3a)-AR with caveolin inhibits coupling to G alpha(i/o) proteins and suggest that signaling is modulated by a raft-enriched complex containing the beta(3a)-AR, caveolin-1, G alpha(s), and adenylyl cyclase.	[Sato, Masaaki; Hutchinson, Dana S.; Halls, Michelle L.; Furness, Sebastian G. B.; Evans, Bronwyn A.; Summers, Roger J.] Monash Univ, Monash Inst Pharmaceut Sci, Parkville, Vic 3052, Australia; [Sato, Masaaki; Hutchinson, Dana S.; Halls, Michelle L.; Furness, Sebastian G. B.; Evans, Bronwyn A.; Summers, Roger J.] Monash Univ, Dept Pharmacol, Parkville, Vic 3052, Australia; [Sato, Masaaki; Bengtsson, Tore] Stockholm Univ, Dept Physiol, Wenner Gren Inst, Arrhenius Labs F3, SE-10691 Stockholm, Sweden	Monash University; Monash University; Stockholm University	Evans, BA (corresponding author), Monash Univ, Monash Inst Pharmaceut Sci, 399 Royal Parade, Parkville, Vic 3052, Australia.	bronwyn.evans@monash.edu	Hutchinson, Dana/K-3795-2012; Furness, Sebastian/Q-9068-2018; Summers, Roger J/F-6351-2011	Furness, Sebastian/0000-0001-8655-8221; Summers, Roger J/0000-0002-8367-4056; Sato, Masaaki/0000-0003-0564-4318; Hutchinson, Dana/0000-0001-9947-0106; Halls, Michelle/0000-0001-8555-8959	National Health and Medical Research Council of Australia [519461, 545952, 519581]; Australian Research Council [LX0989791]	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council)	This work was supported by National Health and Medical Research Council of Australia Program Grant 519461 (to P. M. Sexton, A. Christopoulos, and R. J.), National Health and Medical Research Council of Australia Career Development Award 545952 (to D. S. H.), National Health and Medical Research Council of Australia C. J. Martin Fellowship 519581 (to M. L. H.), and by Australian Research Council Linkage International Fellowship LX0989791 (to M. S.).	Abrami L, 2001, J BIOL CHEM, V276, P30729, DOI 10.1074/jbc.M102039200; Adli H, 1997, AM J PHYSIOL-ENDOC M, V273, pE247, DOI 10.1152/ajpendo.1997.273.2.E247; Ahmad F, 2009, BIOCHEM J, V424, P399, DOI 10.1042/BJ20090842; Allen JA, 2009, MOL PHARMACOL, V76, P1082, DOI 10.1124/mol.109.060160; Alves ID, 2005, BIOCHEMISTRY-US, V44, P9168, DOI 10.1021/bi050207a; Balijepalli RC, 2006, P NATL ACAD SCI USA, V103, P7500, DOI 10.1073/pnas.0503465103; Bethani I, 2010, EMBO J, V29, P2677, DOI 10.1038/emboj.2010.175; Bhatnagar A, 2004, J BIOL CHEM, V279, P34614, DOI 10.1074/jbc.M404673200; Calaghan S, 2006, CARDIOVASC RES, V69, P816, DOI 10.1016/j.cardiores.2005.10.006; Cheng ZJ, 2010, J BIOL CHEM, V285, P15119, DOI 10.1074/jbc.M109.069427; Chernogubova E, 2005, ENDOCRINOLOGY, V146, P2271, DOI 10.1210/en.2004-1104; Chernogubova E, 2004, ENDOCRINOLOGY, V145, P269, DOI 10.1210/en.2003-0857; Cohen AW, 2005, DIABETES, V54, P679, DOI 10.2337/diabetes.54.3.679; Cohen AW, 2004, DIABETES, V53, P1261, DOI 10.2337/diabetes.53.5.1261; Conklin BR, 1996, MOL PHARMACOL, V50, P885; Couet J, 1997, J BIOL CHEM, V272, P6525, DOI 10.1074/jbc.272.10.6525; Coward P, 1999, ANAL BIOCHEM, V270, P242, DOI 10.1006/abio.1999.4061; Crossthwaite AJ, 2005, J BIOL CHEM, V280, P6380, DOI 10.1074/jbc.M411987200; deWeerd WFC, 1997, J BIOL CHEM, V272, P17858, DOI 10.1074/jbc.272.28.17858; Drab M, 2001, SCIENCE, V293, P2449, DOI 10.1126/science.1062688; Evans BA, 1999, BRIT J PHARMACOL, V127, P1525, DOI 10.1038/sj.bjp.0702688; Halls ML, 2009, MOL PHARMACOL, V75, P415, DOI 10.1124/mol.108.051227; Head BP, 2007, TRENDS CELL BIOL, V17, P51, DOI 10.1016/j.tcb.2006.11.008; Head BP, 2006, J BIOL CHEM, V281, P26391, DOI 10.1074/jbc.M602577200; Hill MM, 2008, CELL, V132, P113, DOI 10.1016/j.cell.2007.11.042; Hutchinson DS, 2005, J PHARMACOL EXP THER, V312, P1064, DOI 10.1124/jpet.104.076901; Hutchinson DS, 2002, BRIT J PHARMACOL, V135, P1903, DOI 10.1038/sj.bjp.0704654; KASLOW HR, 1987, BIOCHEMISTRY-US, V26, P123, DOI 10.1021/bi00375a018; Lajoie P, 2007, J CELL BIOL, V179, P341, DOI 10.1083/jcb.200611106; Lajoie P, 2009, J CELL BIOL, V185, P381, DOI 10.1083/jcb.200811059; Lenard NR, 2006, AM J PHYSIOL-ENDOC M, V291, pE704, DOI 10.1152/ajpendo.00048.2006; Malo A, 2001, EUR J ENDOCRINOL, V145, P87, DOI 10.1530/eje.0.1450087; Mattsson CL, 2010, AM J PHYSIOL-ENDOC M, V299, pE374, DOI 10.1152/ajpendo.00071.2010; Mattsson CL, 2010, BBA-MOL CELL RES, V1803, P983, DOI 10.1016/j.bbamcr.2010.03.015; Mistry R, 2011, METHODS MOL BIOL, V746, P263, DOI 10.1007/978-1-61779-126-0_14; Morris DP, 2008, J BIOL CHEM, V283, P2973, DOI 10.1074/jbc.M705795200; MOSS J, 1983, J BIOL CHEM, V258, P1879; NECHAD M, 1983, EXP CELL RES, V149, P105, DOI 10.1016/0014-4827(83)90384-1; Nevins AK, 2006, J BIOL CHEM, V281, P18961, DOI 10.1074/jbc.M603604200; Nevzorova J, 2002, BRIT J PHARMACOL, V137, P9, DOI 10.1038/sj.bjp.0704845; Ostrom RS, 2000, J PHARMACOL EXP THER, V294, P407; Parton RG, 2006, J CELL SCI, V119, P787, DOI 10.1242/jcs.02853; Parton RG, 2007, NAT REV MOL CELL BIO, V8, P185, DOI 10.1038/nrm2122; Patel H. H., 2008, V186, P167, DOI 10.1007/978-3-540-72843-6_7; Pontier SM, 2008, J BIOL CHEM, V283, P24659, DOI 10.1074/jbc.M800778200; Razani B, 2002, PHARMACOL REV, V54, P431, DOI 10.1124/pr.54.3.431; Sato M, 2005, J PHARMACOL EXP THER, V315, P1354, DOI 10.1124/jpet.105.091736; Sharma P, 2004, CELL, V116, P577, DOI 10.1016/S0092-8674(04)00167-9; SILLENCE MN, 1993, BRIT J PHARMACOL, V109, P1157, DOI 10.1111/j.1476-5381.1993.tb13743.x; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; Soderberg O, 2006, NAT METHODS, V3, P995, DOI 10.1038/nmeth947; Sugawara Y, 2007, CELL SIGNAL, V19, P1301, DOI 10.1016/j.cellsig.2007.01.012; Tanishita T, 1997, J BIOCHEM, V122, P90; Thangavel M, 2009, CELL SIGNAL, V21, P301, DOI 10.1016/j.cellsig.2008.10.017; Varga EV, 1998, EUR J PHARMACOL, V348, pR1, DOI 10.1016/S0014-2999(98)00258-1; Xiang Y, 2003, P NATL ACAD SCI USA, V100, P10776, DOI 10.1073/pnas.1831718100; Xiang Y, 2002, J BIOL CHEM, V277, P33783, DOI 10.1074/jbc.M204136200; Xu W, 2006, J PHARMACOL EXP THER, V317, P1295, DOI 10.1124/jpet.105.099507; Zeng YC, 2003, J BIOL CHEM, V278, P45931, DOI 10.1074/jbc.M307722200	59	21	21	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 8	2012	287	24					20674	20688		10.1074/jbc.M111.280651	http://dx.doi.org/10.1074/jbc.M111.280651			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974FB	22535965	hybrid, Green Published			2022-12-25	WOS:000306414500086
J	Faty, A; Ferre, P; Commans, S				Faty, Aurelie; Ferre, Pascal; Commans, Stephane			The Acute Phase Protein Serum Amyloid A Induces Lipolysis and Inflammation in Human Adipocytes through Distinct Pathways	PLOS ONE			English	Article							LOW-GRADE INFLAMMATION; ADIPOSE-TISSUE; MESSENGER-RNA; CYTOKINE PRODUCTION; INSULIN-RESISTANCE; COUPLED RECEPTOR; LOCAL EXPRESSION; SYNOVIAL TISSUE; BINDING; GENES	Background: The acute phase response (APR) is characterized by alterations in lipid and glucose metabolism leading to an increased delivery of energy substrates. In adipocytes, there is a coordinated decrease in Free Fatty acids (FFAs) and glucose storage, in addition to an increase in FFAs mobilization. Serum Amyloid A (SAA) is an acute phase protein mainly associated with High Density Lipoproteins (HDL). We hypothesized that enrichment of HDL with SAA, during the APR, could be implicated in the metabolic changes occurring in adipocytes. Methodology/Principal Findings: In vitro differentiated human adipocytes (hMADS) were treated with SAA enriched HDL or recombinant SAA and the metabolic phenotype of the cells analyzed. In hMADS, SAA induces an increased lipolysis through an ERK dependent pathway. At the molecular level, SAA represses PPAR gamma 2, C/EBP alpha and SREBP-1c gene expression, three transcription factors involved in adipocyte differentiation or lipid synthesis. In addition, the activation of the NF-kappa B pathway by SAA leads to the induction of pro-inflammatory cytokines and chemokines, as in the case of immune cells. These latter findings were replicated in freshly isolated mature human adipocytes. Conclusions/Significance: Besides its well-characterized role in cholesterol metabolism, SAA has direct metabolic effects on human adipocytes. These metabolic changes could be at least partly responsible for alterations of adipocyte metabolism observed during the APR as well as during pathophysiological conditions such as obesity and conditions leading to insulin resistant states.	[Faty, Aurelie; Commans, Stephane] GlaxoSmithKline, Metab Pathways Ctr Excellence Drug Discovery, Les Ulis, France; [Ferre, Pascal] INSERM, Cordeliers Res Ctr, UMR S Eq 8 872, Paris, France; [Ferre, Pascal] Univ Paris 06, UMR S 872, Cordeliers Res Ctr, Paris, France	GlaxoSmithKline; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite	Faty, A (corresponding author), GlaxoSmithKline, Metab Pathways Ctr Excellence Drug Discovery, Les Ulis, France.	pascal.ferre@crc.jussieu.fr	Ferré, Pascal/K-1250-2013	Ferré, Pascal/0000-0003-0115-7045	GlaxoSmithKline	GlaxoSmithKline(GlaxoSmithKline)	Aurelie Faty and Stephane Commans had their salary paid by GlaxoSmithKline. There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all Plos ONE policies on sharing data and materials.	BADOLATO R, 1995, J IMMUNOL, V155, P4004; BADOLATO R, 1994, J EXP MED, V180, P203, DOI 10.1084/jem.180.1.203; Baranova IN, 2005, J BIOL CHEM, V280, P8031, DOI 10.1074/jbc.M405009200; Cai L, 2005, J BIOL CHEM, V280, P2954, DOI 10.1074/jbc.M411555200; Chait A, 2005, J LIPID RES, V46, P389, DOI 10.1194/jlr.R400017-JLR200; Chambrier C, 2000, CLIN SCI, V99, P312; Chan ED, 1997, P NATL ACAD SCI USA, V94, P13169, DOI 10.1073/pnas.94.24.13169; Chiolero R, 1997, NUTRITION, V13, pS45, DOI 10.1016/S0899-9007(97)00205-0; Cree MG, 2008, AM J PHYSIOL-ENDOC M, V294, pE1, DOI 10.1152/ajpendo.00562.2007; Gabrielsson BG, 2005, OBES RES, V13, P649, DOI 10.1038/oby.2005.72; Gomez-Ambrosi J, 2006, OBES SURG, V16, P262, DOI 10.1381/096089206776116525; Han CY, 2007, DIABETES, V56, P2260, DOI 10.2337/db07-0218; Hatanaka E, 2004, IMMUNOL LETT, V91, P33, DOI 10.1016/j.imlet.2003.09.011; He R, 2003, BLOOD, V101, P1572, DOI 10.1182/blood-2002-05-1431; Ii M, 2006, MOL PHARMACOL, V69, P1288, DOI 10.1124/mol.105.019695; Jernas M, 2006, FASEB J, V20, P1540, DOI 10.1096/fj.05-5678fje; Khovidhunkit W, 2004, J LIPID RES, V45, P1169, DOI 10.1194/jlr.R300019-JLR200; Kumon Y, 1999, J RHEUMATOL, V26, P785; Le YY, 2001, CYTOKINE GROWTH F R, V12, P91, DOI 10.1016/S1359-6101(01)00003-X; Liu LR, 2011, OBESITY, V19, P2301, DOI 10.1038/oby.2011.176; MEEK RL, 1992, P NATL ACAD SCI USA, V89, P7949, DOI 10.1073/pnas.89.17.7949; MEEK RL, 1994, P NATL ACAD SCI USA, V91, P3186, DOI 10.1073/pnas.91.8.3186; Moutsopoulos NM, 2006, ANN NY ACAD SCI, V1088, P251, DOI 10.1196/annals.1366.032; O'Brien Kevin D, 2006, Curr Atheroscler Rep, V8, P62, DOI 10.1007/s11883-006-0066-0; O'Hara R, 2004, ARTHRITIS RHEUM-US, V50, P1788, DOI 10.1002/art.20301; Okamoto H, 2008, J RHEUMATOL, V35, P752; Patel H, 1998, SCAND J IMMUNOL, V48, P410; Poitou C, 2005, DIABETOLOGIA, V48, P519, DOI 10.1007/s00125-004-1654-6; Poitou C, 2006, OBESITY, V14, P309, DOI 10.1038/oby.2006.40; Poitou C, 2009, J CLIN ENDOCR METAB, V94, P1810, DOI 10.1210/jc.2008-2040; Rodriguez AM, 2005, J EXP MED, V201, P1397, DOI 10.1084/jem.20042224; Rodriguez AM, 2004, BIOCHEM BIOPH RES CO, V315, P255, DOI 10.1016/j.bbrc.2004.01.053; Sandri S, 2008, J LEUKOCYTE BIOL, V83, P1174, DOI 10.1189/jlb.0407203; Scheja L, 2008, EXP DIABETES RES, DOI 10.1155/2008/230837; Sjoholm K, 2005, J CLIN ENDOCR METAB, V90, P2233, DOI 10.1210/jc.2004-1830; Skurk T, 2007, J CLIN ENDOCR METAB, V92, P1023, DOI 10.1210/jc.2006-1055; Su SB, 1999, J EXP MED, V189, P395, DOI 10.1084/jem.189.2.395; Subramanian S, 2008, ARTERIOSCL THROM VAS, V28, P685, DOI 10.1161/ATVBAHA.107.157685; Theuma Pierre, 2003, Curr Diab Rep, V3, P248, DOI 10.1007/s11892-003-0072-3; Trager Karl, 2003, Curr Opin Crit Care, V9, P271; Uhlar CM, 1999, EUR J BIOCHEM, V265, P501, DOI 10.1046/j.1432-1327.1999.00657.x; Venteclef N, 2006, MOL CELL BIOL, V26, P6799, DOI 10.1128/MCB.00579-06; Walder K, 2002, DIABETES, V51, P1859, DOI 10.2337/diabetes.51.6.1859; Wang YC, 2010, J NUTR BIOCHEM, V21, P317, DOI 10.1016/j.jnutbio.2009.01.004; Wisse BE, 2004, J AM SOC NEPHROL, V15, P2792, DOI 10.1097/01.ASN.0000141966.69934.21; Wolfe RR, 1997, BAILLIERE CLIN ENDOC, V11, P645, DOI 10.1016/S0950-351X(97)80926-3; Yamada M, 2005, J MED CHEM, V48, P7457, DOI 10.1021/jm050623t; Yang RZ, 2006, PLOS MED, V3, P884, DOI 10.1371/journal.pmed.0030287; Zanetti M, 2008, J RENAL NUTR, V18, P70, DOI 10.1053/j.jrn.2007.10.015	49	25	27	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2012	7	4							e34031	10.1371/journal.pone.0034031	http://dx.doi.org/10.1371/journal.pone.0034031			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TL	22532826	Green Published, Green Submitted, gold			2022-12-25	WOS:000305336200005
J	Mazzaccara, C; Iafusco, D; Liguori, R; Ferrigno, M; Galderisi, A; Vitale, D; Simonelli, F; Landolfo, P; Prisco, F; Masullo, M; Sacchetti, L				Mazzaccara, Cristina; Iafusco, Dario; Liguori, Rosario; Ferrigno, Maddalena; Galderisi, Alfonso; Vitale, Domenico; Simonelli, Francesca; Landolfo, Paolo; Prisco, Francesco; Masullo, Mariorosario; Sacchetti, Lucia			Mitochondrial Diabetes in Children: Seek and You Will Find It	PLOS ONE			English	Article							MACULAR PATTERN DYSTROPHY; COMPLEX-I; CLINICAL CHARACTERISTICS; MOLECULAR-MECHANISMS; CELIAC-DISEASE; MUTATION; DEAFNESS; PREVALENCE; MELAS; HETEROPLASMY	Maternally Inherited Diabetes and Deafness (MIDD) is a rare form of diabetes due to defects in mitochondrial DNA (mtDNA). 3243 A. G is the mutation most frequently associated with this condition, but other mtDNA variants have been linked with a diabetic phenotype suggestive of MIDD. From 1989 to 2009, we clinically diagnosed mitochondrial diabetes in 11 diabetic children. Diagnosis was based on the presence of one or more of the following criteria: 1) maculopathy; 2) hearing impairment; 3) maternal heritability of diabetes/impaired fasting glucose and/or hearing impairment and/or maculopathy in three consecutive generations (or in two generations if 2 or 3 members of a family were affected). We sequenced the mtDNA in the 11 probands, in their mothers and in 80 controls. We identified 33 diabetes-suspected mutations, 1/33 was 3243A>G. Most patients (91%) and their mothers had mutations in complex I and/or IV of the respiratory chain. We measured the activity of these two enzymes and found that they were less active in mutated patients and their mothers than in the healthy control pool. The prevalence of hearing loss (36% vs 75-98%) and macular dystrophy (54% vs 86%) was lower in our mitochondrial diabetic adolescents than reported in adults. Moreover, we found a hitherto unknown association between mitochondrial diabetes and celiac disease. In conclusion, mitochondrial diabetes should be considered a complex syndrome with several phenotypic variants. Moreover, deafness is not an essential component of the disease in children. The whole mtDNA should be screened because the 3243A>G variant is not as frequent in children as in adults. In fact, 91% of our patients were mutated in the complex I and/or IV genes. The enzymatic assay may be a useful tool with which to confirm the pathogenic significance of detected variants.	[Mazzaccara, Cristina; Liguori, Rosario; Vitale, Domenico; Sacchetti, Lucia] CEINGE Adv Biotechnol SC aRL, Naples, Italy; [Mazzaccara, Cristina; Liguori, Rosario; Masullo, Mariorosario; Sacchetti, Lucia] Univ Naples Federico II, Dept Biochem & Med Biotechnol, Naples, Italy; [Iafusco, Dario; Galderisi, Alfonso; Prisco, Francesco] Univ Naples 2, Dept Pediat, Naples, Italy; [Ferrigno, Maddalena] SDN Fdn, Naples, Italy; [Simonelli, Francesca; Landolfo, Paolo] Univ Naples 2, Dept Ophthalmol, Naples, Italy; [Masullo, Mariorosario] Univ Naples Parthenope, Inst & Terr Syst, Dept Study, Naples, Italy	CEINGE Biotecnologie Avanzate; University of Naples Federico II; Universita della Campania Vanvitelli; IRCCS Istituto di Ricerca Diagnostica e Nucleare (SDN); Universita della Campania Vanvitelli; Parthenope University Naples	Mazzaccara, C (corresponding author), CEINGE Adv Biotechnol SC aRL, Naples, Italy.	sacchett@unina.it	Galderisi, Alfonso/G-3259-2018; Mazzaccara, Cristina/AAC-5361-2022; Simonelli, Francesca/AHE-7571-2022; Masullo, Mariorosario/H-4884-2016	Galderisi, Alfonso/0000-0001-8885-3056; Simonelli, Francesca/0000-0001-8520-6769; Ferrigno, Maddalena/0000-0003-4824-5886; Liguori, Rosario/0000-0002-2014-9502; Iafusco, Dario/0000-0002-9398-3856; Masullo, Mariorosario/0000-0003-4485-7383; Mazzaccara, Cristina/0000-0001-7774-2799	CEINGE Regione Campania (DGRC) [1901/2009]	CEINGE Regione Campania (DGRC)	This work was supported by CEINGE Regione Campania (DGRC 1901/2009). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcolado JC, 2002, DIABETIC MED, V19, P89, DOI 10.1046/j.1464-5491.2002.00675.x; Amer Diabet Assoc, 2013, DIABETES CARE, V36, pS67, DOI [10.2337/dc12-s064, 10.2337/dc10-S062, 10.2337/dc13-S067, 10.2337/dc11-S062]; Amer Diabet Assoc, 2010, DIABETES CARE, V33, pS62, DOI 10.2337/dc10-s062; Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779; Balestri P, 2000, J CHILD NEUROL, V15, P755, DOI 10.1177/088307380001501108; Bannwarth S, 2011, DIABETES CARE, V34, P2591, DOI 10.2337/dc11-1012; Boushel R, 2007, DIABETOLOGIA, V50, P790, DOI 10.1007/s00125-007-0594-3; Carelli V, 2003, TRENDS GENET, V19, P257, DOI 10.1016/S0168-9525(03)00072-6; Chen JF, 2007, GENE, V401, P4, DOI 10.1016/j.gene.2007.06.009; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Choo-Kang ATW, 2002, DIABETES, V51, P2317, DOI 10.2337/diabetes.51.7.2317; Crispim D, 2008, ARQ BRAS ENDOCRINOL, V52, P1228, DOI 10.1590/S0004-27302008000800005; de Wit LEA, 2007, J IMMUNOL METHODS, V326, P76, DOI 10.1016/j.jim.2007.07.009; Dube C, 2005, GASTROENTEROLOGY, V128, pS57, DOI 10.1053/j.gastro.2005.02.014; Elstner M, 2008, BIOCHEM BIOPH RES CO, V377, P379, DOI 10.1016/j.bbrc.2008.09.134; Fuss Ivan J, 2009, Curr Protoc Immunol, VChapter 7, DOI 10.1002/0471142735.im0701s85; Guillausseau PJ, 2004, DIABETES METAB, V30, P181, DOI 10.1016/S1262-3636(07)70105-2; Guillausseau PJ, 2001, ANN INTERN MED, V134, P721, DOI 10.7326/0003-4819-134-9_Part_1-200105010-00008; Gutierrez Cortes N, 2012, HUM MUTAT IN PRESS; Hanna MG, 1998, J NEUROL NEUROSUR PS, V65, P512, DOI 10.1136/jnnp.65.4.512; Horvath R, 2008, NEUROMUSCULAR DISORD, V18, P553, DOI 10.1016/j.nmd.2008.05.002; Hosszufalusi N, 2009, DIABETES-METAB RES, V25, P127, DOI 10.1002/dmrr.841; Howes T, 2008, J LARYNGOL OTOL, V122, P1249, DOI 10.1017/S0022215108001503; Kagnoff MF, 2007, J CLIN INVEST, V117, P41, DOI 10.1172/JCI30253; Kirby DM, 2007, METHOD CELL BIOL, V80, P93, DOI 10.1016/S0091-679X(06)80004-X; Laloi-Michelin M, 2009, J CLIN ENDOCR METAB, V94, P3025, DOI 10.1210/jc.2008-2680; Leo-Kottler B, 2002, GRAEF ARCH CLIN EXP, V240, P758, DOI 10.1007/s00417-002-0494-7; Maassen JA, 2006, ENDOCRIN METAB CLIN, V35, P385, DOI 10.1016/j.ecl.2006.02.014; Maassen JA, 2005, ANN MED, V37, P213, DOI 10.1080/07853890510007188; Maassen JA, 2004, DIABETES, V53, pS103, DOI 10.2337/diabetes.53.2007.S103; Maechler P, 2001, NATURE, V414, P807, DOI 10.1038/414807a; Malfatti E, 2007, BRAIN, V130, P1894, DOI 10.1093/brain/awm114; MARIOTTI C, 1994, J CLIN INVEST, V93, P1102, DOI 10.1172/JCI117061; MASSIN P, 1995, AM J OPHTHALMOL, V120, P247, DOI 10.1016/S0002-9394(14)72615-7; Massin P, 1999, OPHTHALMOLOGY, V106, P1821, DOI 10.1016/S0161-6420(99)90356-1; Murphy R, 2008, DIABETIC MED, V25, P383, DOI 10.1111/j.1464-5491.2008.02359.x; Murphy R, 2008, NAT CLIN PRACT ENDOC, V4, P200, DOI 10.1038/ncpendmet0778; Prisco F, 1996, DIABETES CARE, V19, P1454, DOI 10.2337/diacare.19.12.1454; Qian YP, 2005, BIOCHEM BIOPH RES CO, V332, P614, DOI 10.1016/j.bbrc.2005.05.003; Sawada S, 1997, AM J OTOL, V18, P332; Zhang Shi, 2009, Chinese Medical Sciences Journal, V24, P20	41	18	19	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2012	7	4							e34956	10.1371/journal.pone.0034956	http://dx.doi.org/10.1371/journal.pone.0034956			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TL	22536343	Green Published, Green Submitted, gold			2022-12-25	WOS:000305336200017
J	Geng, JN; Chiu, CH; Tang, P; Chen, YP; Shieh, HR; Hu, SN; Chen, YYM				Geng, Jianing; Chiu, Cheng-Hsun; Tang, Petrus; Chen, Yaping; Shieh, Hui-Ru; Hu, Songnian; Chen, Yi-Ywan M.			Complete Genome and Transcriptomes of Streptococcus parasanguinis FW213: Phylogenic Relations and Potential Virulence Mechanisms	PLOS ONE			English	Article							SALIVA-COATED HYDROXYAPATITE; FIMBRIAE-ASSOCIATED ADHESIN; DAMAGED HEART-VALVES; BIOFILM FORMATION; BACTERIAL GENOMES; ESCHERICHIA-COLI; STAPHYLOCOCCUS-AUREUS; LACTOCOCCUS-LACTIS; COMPLETE SEQUENCE; OXIDATIVE STRESS	Streptococcus parasanguinis, a primary colonizer of the tooth surface, is also an opportunistic pathogen for subacute endocarditis. The complete genome of strain FW213 was determined using the traditional shotgun sequencing approach and further refined by the transcriptomes of cells in early exponential and early stationary growth phases in this study. The transcriptomes also discovered 10 transcripts encoding known hypothetical proteins, one pseudogene, five transcripts matched to the Rfam and additional 87 putative small RNAs within the intergenic regions defined by the GLIMMER analysis. The genome contains five acquired genomic islands (GIs) encoding proteins which potentially contribute to the overall pathogenic capacity and fitness of this microbe. The differential expression of the GIs and various open reading frames outside the GIs at the two growth phases suggested that FW213 possess a range of mechanisms to avoid host immune clearance, to colonize host tissues, to survive within oral biofilms and to overcome various environmental insults. Furthermore, the comparative genome analysis of five S. parasanguinis strains indicates that albeit S. parasanguinis strains are highly conserved, variations in the genome content exist. These variations may reflect differences in pathogenic potential between the strains.	[Geng, Jianing; Chen, Yaping; Hu, Songnian] Chinese Acad Sci, Beijing Inst Gen, Key Lab Genome Sci & Informat, Beijing, Peoples R China; [Chiu, Cheng-Hsun] Chang Gung Childrens Hosp, Mol Infect Dis Res Ctr, Div Pediat Infect Dis, Tao Yuan, Taiwan; [Chiu, Cheng-Hsun; Tang, Petrus; Shieh, Hui-Ru; Chen, Yi-Ywan M.] Chang Gung Univ, Grad Inst Basic Med Sci, Tao Yuan, Taiwan; [Tang, Petrus] Chang Gung Univ, Bioinformat Ctr, Tao Yuan, Taiwan; [Chen, Yaping] Chinese Acad Sci, Grad Univ, Beijing, Peoples R China; [Chen, Yi-Ywan M.] Chang Gung Univ, Dept Microbiol & Immunol, Tao Yuan, Taiwan	Chinese Academy of Sciences; Beijing Institute of Genomics, CAS; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung University; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chang Gung University	Geng, JN (corresponding author), Chinese Acad Sci, Beijing Inst Gen, Key Lab Genome Sci & Informat, Beijing, Peoples R China.	mchen@mail.cgu.edu.tw	; Hu, Songnian/C-6509-2013	Tang, Petrus/0000-0002-2779-0116; Hu, Songnian/0000-0003-3966-3111	Chang Gung Memorial Hospital [CMRPG371602, CMPRD1A0451]	Chang Gung Memorial Hospital(Chang Gung Memorial Hospital)	This study was supported by the Chang Gung Memorial Hospital grants CMRPG371602 and CMPRD1A0451. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aanensen DM, 2007, J BACTERIOL, V189, P7856, DOI 10.1128/JB.00837-07; Ahn SJ, 2006, J BACTERIOL, V188, P6877, DOI 10.1128/JB.00536-06; Ajdic D, 2002, P NATL ACAD SCI USA, V99, P14434, DOI 10.1073/pnas.172501299; Ajdic D, 2007, J BACTERIOL, V189, P5049, DOI 10.1128/JB.00338-07; Alexeyenko A, 2006, BIOINFORMATICS, V22, pE9, DOI 10.1093/bioinformatics/btl213; AYOUBI P, 1991, J BACTERIOL, V173, P1617, DOI 10.1128/jb.173.5.1617-1622.1991; Bao QY, 2002, GENOME RES, V12, P689, DOI 10.1101/gr.219302; Bolotin A, 2004, NAT BIOTECHNOL, V22, P1554, DOI 10.1038/nbt1034; Burne RA, 2000, FEMS MICROBIOL LETT, V193, P1; BURNETTECURLEY D, 1995, INFECT IMMUN, V63, P4669, DOI 10.1128/IAI.63.12.4669-4674.1995; Carver TJ, 2005, BIOINFORMATICS, V21, P3422, DOI 10.1093/bioinformatics/bti553; CASIANOCOLON A, 1988, APPL ENVIRON MICROB, V54, P1318; Chen YYM, 2008, APPL ENVIRON MICROB, V74, P1642, DOI 10.1128/AEM.01878-07; Chen YYM, 2011, APPL ENVIRON MICROB, V77, P3967, DOI 10.1128/AEM.02828-10; Chen YYM, 1996, INFECT IMMUN, V64, P585, DOI 10.1128/IAI.64.2.585-592.1996; Chen YYM, 1998, J BACTERIOL, V180, P5769, DOI 10.1128/JB.180.21.5769-5775.1998; COLE RM, 1976, J DENT RES, V55, pA142, DOI 10.1177/002203457605500106011; Delcher AL, 1999, NUCLEIC ACIDS RES, V27, P4636, DOI 10.1093/nar/27.23.4636; Ding F, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-158; FACHONKALWEIT S, 1985, INFECT IMMUN, V48, P617, DOI 10.1128/IAI.48.3.617-624.1985; FENNO JC, 1995, MOL MICROBIOL, V15, P849, DOI 10.1111/j.1365-2958.1995.tb02355.x; FIVESTAYLOR PM, 1985, INFECT IMMUN, V47, P752, DOI 10.1128/IAI.47.3.752-759.1985; Frangeul L, 1999, MICROBIOL-SGM, V145, P2625, DOI 10.1099/00221287-145-10-2625; Froeliger EH, 2001, INFECT IMMUN, V69, P2512, DOI 10.1128/IAI.69.4.2512-2519.2001; Gao F, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-79; Geng JN, 2011, J BACTERIOL, V193, P5596, DOI 10.1128/JB.05670-11; GIAEVER HM, 1988, J BACTERIOL, V170, P2841, DOI 10.1128/jb.170.6.2841-2849.1988; GIBBONS RJ, 1975, ANNU REV MICROBIOL, V29, P19, DOI 10.1146/annurev.mi.29.100175.000315; Giefing-Kroll C, 2011, MICROBIOL-SGM, V157, P1897, DOI 10.1099/mic.0.045211-0; Griffiths-Jones S, 2005, NUCLEIC ACIDS RES, V33, pD121, DOI 10.1093/nar/gki081; Guell M, 2009, SCIENCE, V326, P1268, DOI 10.1126/science.1176951; Heilmann C, 1997, MOL MICROBIOL, V24, P1013, DOI 10.1046/j.1365-2958.1997.4101774.x; Hyink O, 2007, APPL ENVIRON MICROB, V73, P1107, DOI 10.1128/AEM.02265-06; InterPro Database, 2003, NUCL ACIDS RES, V31, P315; Kanehisa M, 2006, NUCLEIC ACIDS RES, V34, pD354, DOI 10.1093/nar/gkj102; KAWAMURA Y, 1995, INT J SYST BACTERIOL, V45, P406, DOI 10.1099/00207713-45-2-406; Koide T, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.42; Kolenbrander PE, 2000, ANNU REV MICROBIOL, V54, P413, DOI 10.1146/annurev.micro.54.1.413; Kreth J, 2008, J BACTERIOL, V190, P4632, DOI 10.1128/JB.00276-08; KUIPERS OP, 1995, J BIOL CHEM, V270, P27299, DOI 10.1074/jbc.270.45.27299; Kurkivuori J, 2007, ORAL ONCOL, V43, P181, DOI 10.1016/j.oraloncology.2006.02.005; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; Lemos JAC, 2005, CURR ISSUES MOL BIOL, V7, P95; Lemos JA, 2008, MICROBIOL-SGM, V154, P3247, DOI 10.1099/mic.0.2008/023770-0; Liang XB, 2011, INFECT IMMUN, V79, P3239, DOI 10.1128/IAI.00029-11; Liu YL, 2008, APPL ENVIRON MICROB, V74, P5023, DOI 10.1128/AEM.00556-08; Livny J, 2005, NUCLEIC ACIDS RES, V33, P4096, DOI 10.1093/nar/gki715; Loo CY, 2003, J BACTERIOL, V185, P2887, DOI 10.1128/JB.185.9.2887-2900.2003; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Luo YF, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-386; Lutwick LI, 1998, CRIT CARE CLIN, V14, P221, DOI 10.1016/S0749-0704(05)70393-6; Martinez B, 1999, MICROBIOL-SGM, V145, P3155, DOI 10.1099/00221287-145-11-3155; Mattos-Graner RO, 2006, J BACTERIOL, V188, P3813, DOI 10.1128/JB.01845-05; Mercier C, 2002, MOL MICROBIOL, V46, P235, DOI 10.1046/j.1365-2958.2002.03160.x; MILLS J, 1984, INFECT IMMUN, V43, P359, DOI 10.1128/IAI.43.1.359-367.1984; Morona JK, 1997, MOL MICROBIOL, V23, P751, DOI 10.1046/j.1365-2958.1997.2551624.x; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Mulder N.J., 2008, CURR PROTOC BIOINFOR, V2, P2, DOI DOI 10.1002/0471250953.BI0207S21; Mulder NJ, 2003, NUCLEIC ACIDS RES, V31, P315, DOI 10.1093/nar/gkg046; Nakagawa I, 2003, GENOME RES, V13, P1042, DOI 10.1101/gr.1096703; Nakano S, 2003, P NATL ACAD SCI USA, V100, P13603, DOI 10.1073/pnas.2235180100; Oetjen J, 2002, INFECT IMMUN, V70, P5706, DOI 10.1128/IAI.70.10.5706-5714.2002; Passalacqua KD, 2009, J BACTERIOL, V191, P3203, DOI 10.1128/JB.00122-09; Perkins TT, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000569; RAMIREZRONDA CH, 1978, J CLIN INVEST, V62, P805, DOI 10.1172/JCI109192; RAMIREZRONDA CH, 1980, INFECT IMMUN, V29, P1; Roberts IS, 1996, ANNU REV MICROBIOL, V50, P285, DOI 10.1146/annurev.micro.50.1.285; Romualdi C, 2003, PHYSIOL GENOMICS, V12, P159, DOI 10.1152/physiolgenomics.00096.2002; Sakata N, 2005, CURR MICROBIOL, V50, P47, DOI 10.1007/s00284-004-4381-9; Selinger DW, 2000, NAT BIOTECHNOL, V18, P1262, DOI 10.1038/82367; Spatafora G, 2002, MICROBIOL-SGM, V148, P755, DOI 10.1099/00221287-148-3-755; Stapleton MR, 2007, J BACTERIOL, V189, P7316, DOI 10.1128/JB.00734-07; Stokes NR, 2003, P NATL ACAD SCI USA, V100, P15959, DOI 10.1073/pnas.2536607100; Suzek BE, 2001, BIOINFORMATICS, V17, P1123, DOI 10.1093/bioinformatics/17.12.1123; Tatusov RL, 2000, NUCLEIC ACIDS RES, V28, P33, DOI 10.1093/nar/28.1.33; Tettelin H, 1999, GENOMICS, V62, P500, DOI 10.1006/geno.1999.6048; Thompson Julie D, 2002, Curr Protoc Bioinformatics, VChapter 2, DOI 10.1002/0471250953.bi0203s00; VANDERMEER JTM, 1991, EUR J CLIN MICROBIOL, V10, P728; Vickerman MM, 2007, J BACTERIOL, V189, P7799, DOI 10.1128/JB.01023-07; Viscount HB, 1997, INFECT IMMUN, V65, P994, DOI 10.1128/IAI.65.3.994-1002.1997; Vriesema AJM, 2000, INFECT IMMUN, V68, P1061, DOI 10.1128/IAI.68.3.1061-1068.2000; Wang BY, 2011, J DENT RES, V90, P501, DOI 10.1177/0022034510388808; Wang FY, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004027; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Wu H, 1999, MOL MICROBIOL, V34, P1070, DOI 10.1046/j.1365-2958.1999.01670.x; Wu H, 1998, MOL MICROBIOL, V28, P487, DOI 10.1046/j.1365-2958.1998.00805.x; Wu H, 2007, INFECT IMMUN, V75, P2181, DOI 10.1128/IAI.01544-06; Wu H, 2007, J BACTERIOL, V189, P1390, DOI 10.1128/JB.00836-06; Wurtzel O, 2010, GENOME RES, V20, P133, DOI 10.1101/gr.100396.109; Xu P, 2007, J BACTERIOL, V189, P3166, DOI 10.1128/JB.01808-06; Yoder-Himes DR, 2009, P NATL ACAD SCI USA, V106, P3976, DOI 10.1073/pnas.0813403106; Yoon SH, 2003, BIOTECHNOL BIOENG, V81, P753, DOI 10.1002/bit.10626	92	14	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2012	7	4							e34769	10.1371/journal.pone.0034769	http://dx.doi.org/10.1371/journal.pone.0034769			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959XD	22529932	gold, Green Published, Green Submitted			2022-12-25	WOS:000305350600025
J	Lyons, SM; Prasad, A				Lyons, Samanthe M.; Prasad, Ashok			Cross-Talk and Information Transfer in Mammalian and Bacterial Signaling	PLOS ONE			English	Article							TRANSDUCTION; EXPRESSION; NETWORKS; LIMITS; GENES	In mammalian and bacterial cells simple phosphorylation circuits play an important role in signaling. Bacteria have hundreds of two-component signaling systems that involve phosphotransfer between a receptor and a response regulator. In mammalian cells a similar pathway is the TGF-beta pathway, where extracellular TGF-beta ligands activate cell surface receptors that phosphorylate Smad proteins, which in turn activate many genes. In TGF-beta signaling the multiplicity of ligands begs the question as to whether cells can distinguish signals coming from different ligands, but transduced through a small set of Smads. Here we use information theory with stochastic simulations of networks to address this question. We find that when signals are transduced through only one Smad, the cell cannot distinguish between different levels of the external ligands. Increasing the number of Smads from one to two significantly improves information transmission as well as the ability to discriminate between ligands. Surprisingly, both total information transmitted and the capacity to discriminate between ligands are quite insensitive to high levels of cross-talk between the two Smads. Robustness against cross-talk requires that the average amplitude of the signals are large. We find that smaller systems, as exemplified by some two-component systems in bacteria, are significantly much less robust against cross-talk. For such system sizes phosphotransfer is also less robust against cross-talk than phosphorylation. This suggests that mammalian signal transduction can tolerate a high amount of cross-talk without degrading information content. This may have played a role in the evolution of new functionalities from small mutations in signaling pathways, allowed for the development of cross-regulation and led to increased overall robustness due to redundancy in signaling pathways. On the other hand the lack of cross-regulation observed in many bacterial two-component systems may partly be due to the loss of information content due to cross-talk.	[Lyons, Samanthe M.; Prasad, Ashok] Colorado State Univ, Sch Biomed Engn, Ft Collins, CO 80523 USA	Colorado State University	Lyons, SM (corresponding author), Colorado State Univ, Sch Biomed Engn, Ft Collins, CO 80523 USA.	ashokp@engr.colostate.edu	Prasad, Ashok/HDN-5956-2022		Colorado State University	Colorado State University	This work was funded by a startup grant from Colorado State University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], SMAD SIGNAL TRANSDUC; Bais M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005393; Batchelor E, 2003, P NATL ACAD SCI USA, V100, P691, DOI 10.1073/pnas.0234782100; Bialek W, 2005, P NATL ACAD SCI USA, V102, P10040, DOI 10.1073/pnas.0504321102; Bomblies K, 2010, CURR BIOL, V20, pR320, DOI 10.1016/j.cub.2010.02.029; Cheong R, 2011, SCIENCE, V334, P354, DOI 10.1126/science.1204553; Cho TJ, 2002, J BONE MINER RES, V17, P513, DOI 10.1359/jbmr.2002.17.3.513; Clarke DC, 2006, IEE P SYST BIOL, V153, P412, DOI 10.1049/ip-syb:20050055; Cover TM, 1991, ELEMENTS INFORM THEO; GILLESPIE DT, 1977, J PHYS CHEM-US, V81, P2340, DOI 10.1021/j100540a008; Henke JM, 2004, J BACTERIOL, V186, P6902, DOI 10.1128/JB.186.20.6902-6914.2004; Hill CS, 2009, CELL RES, V19, P36, DOI 10.1038/cr.2008.325; Igoshin OA, 2008, MOL MICROBIOL, V68, P1196, DOI 10.1111/j.1365-2958.2008.06221.x; Jiang M, 2000, MOL MICROBIOL, V38, P535, DOI 10.1046/j.1365-2958.2000.02148.x; Kisseleva T, 2002, GENE, V285, P1, DOI 10.1016/S0378-1119(02)00398-0; Laub MT, 2007, ANNU REV GENET, V41, P121, DOI 10.1146/annurev.genet.41.042007.170548; Lavery K, 2008, J BIOL CHEM, V283, P20948, DOI 10.1074/jbc.M800850200; Lestas I, 2010, NATURE, V467, P174, DOI 10.1038/nature09333; Ma'ayan A, 2009, J BIOL CHEM, V284, P5451; Marom B, 2011, J BIOL CHEM; Mehta P, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.79; Prince VE, 2002, NAT REV GENET, V3, P827, DOI 10.1038/nrg928; Robinson VL, 2000, NAT STRUCT BIOL, V7, P626, DOI 10.1038/77915; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Stock AM, 2000, ANNU REV BIOCHEM, V69, P183, DOI 10.1146/annurev.biochem.69.1.183; Tkacik G, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.011910; Tkacik G, 2008, P NATL ACAD SCI USA, V105, P12265, DOI 10.1073/pnas.0806077105; Ziv E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001077	28	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2012	7	4							e34488	10.1371/journal.pone.0034488	http://dx.doi.org/10.1371/journal.pone.0034488			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959XD	22529918	Green Submitted, Green Published, gold			2022-12-25	WOS:000305350600017
J	Vanschoenwinkel, B; Pinceel, T; Vanhove, MPM; Denis, C; Jocque, M; Timms, BV; Brendonck, L				Vanschoenwinkel, Bram; Pinceel, Tom; Vanhove, Maarten P. M.; Denis, Carla; Jocque, Merlijn; Timms, Brian V.; Brendonck, Luc			Toward a Global Phylogeny of the "Living Fossil'' Crustacean Order of the Notostraca	PLOS ONE			English	Article							BRANCHIOPODA NOTOSTRACA; TRIOPS BRANCHIOPODA; MOLECULAR TAXONOMY; MITOCHONDRIAL-DNA; GENETIC DIVERSITY; TADPOLE SHRIMP; EVOLUTIONARY; DIVERGENCE; LINEAGES; INVERTEBRATES	Tadpole shrimp (Crustacea, Notostraca) are iconic inhabitants of temporary aquatic habitats worldwide. Often cited as prime examples of evolutionary stasis, surviving representatives closely resemble fossils older than 200 mya, suggestive of an ancient origin. Despite significant interest in the group as 'living fossils' the taxonomy of surviving taxa is still under debate and both the phylogenetic relationships among different lineages and the timing of diversification remain unclear. We constructed a molecular phylogeny of the Notostraca using model based phylogenetic methods. Our analyses supported the monophyly of the two genera Triops and Lepidurus, although for Triops support was weak. Results also revealed high levels of cryptic diversity as well as a peculiar biogeographic link between Australia and North America presumably mediated by historic long distance dispersal. We concluded that, although some present day tadpole shrimp species closely resemble fossil specimens as old as 250 mya, no molecular support was found for an ancient (pre) Mesozoic radiation. Instead, living tadpole shrimp are most likely the result of a relatively recent radiation in the Cenozoic era and close resemblances between recent and fossil taxa are probably the result of the highly conserved general morphology in this group and of homoplasy.	[Vanschoenwinkel, Bram; Pinceel, Tom; Denis, Carla; Brendonck, Luc] Katholieke Univ Leuven, Lab Aquat Ecol & Evolutionary Biol, Louvain, Belgium; [Vanhove, Maarten P. M.] Katholieke Univ Leuven, Lab Anim Diversity & Systemat, Louvain, Belgium; [Jocque, Merlijn] Royal Belgian Inst Nat Sci, Brussels, Belgium; [Timms, Brian V.] Australian Museum, Sydney, NSW 2000, Australia	KU Leuven; KU Leuven; Royal Belgian Institute of Natural Sciences; Australian Museum	Vanschoenwinkel, B (corresponding author), Katholieke Univ Leuven, Lab Aquat Ecol & Evolutionary Biol, Louvain, Belgium.	vanschoenwinkel@bio.kuleuven.be	Vanschoenwinkel, Bram/I-9021-2019; Vanhove, Maarten/AAF-6446-2020	Vanschoenwinkel, Bram/0000-0002-8973-6297; Brendonck, Luc/0000-0001-5383-1420; Vanhove, Maarten/0000-0003-3100-7566	Research Foundation Flanders (FWO-Vlaanderen); fund for scientific research Flanders	Research Foundation Flanders (FWO-Vlaanderen)(FWO); fund for scientific research Flanders(FWO)	BV currently holds a postdoctoral fellowship with the Research Foundation Flanders (FWO-Vlaanderen). This research was funded by the fund for scientific research Flanders. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; Adamowicz SJ, 2009, MOL PHYLOGENET EVOL, V50, P423, DOI 10.1016/j.ympev.2008.11.026; Adamowicz SJ, 2005, GLOBAL ECOL BIOGEOGR, V14, P455, DOI 10.1111/j.1466-822x.2005.00164.x; AVISE JC, 1994, EVOLUTION, V48, P1986, DOI 10.1111/j.1558-5646.1994.tb02228.x; BOILEAU MG, 1992, J EVOLUTION BIOL, V5, P25, DOI 10.1046/j.1420-9101.1992.5010025.x; Brendonck L, 2003, HYDROBIOLOGIA, V491, P65, DOI 10.1023/A:1024454905119; Brendonck L, 1990, J CRUSTACEAN BIOL, V10, P676, DOI 10.2307/1548412; Brendonck L, 2008, HYDROBIOLOGIA, V595, P167, DOI 10.1007/s10750-007-9119-9; Caccone A, 2001, EVOLUTION, V55, P122; Calendini F., 2005, PAUPUP V1 0 3 1 FREE; Cao Y, 1998, J MOL EVOL, V47, P307, DOI 10.1007/PL00006389; Chernyschev BI, 1940, ACAD NAUK UKRIN SSR, V7, P5; Colbourne JK, 1996, PHILOS T ROY SOC B, V351, P349, DOI 10.1098/rstb.1996.0028; Cox AJ, 2001, MOL ECOL, V10, P371, DOI 10.1046/j.1365-294x.2001.01188.x; Darwin C. S., 1859, ORIGIN SPECIES MEANS; Duggen S, 2003, NATURE, V422, P602, DOI 10.1038/nature01553; Dumont H. J., 2002, GUIDES IDENTIFICATIO; Eldredge N, 2005, PALEOBIOLOGY, V31, P133, DOI 10.1666/0094-8373(2005)031[0133:TDOES]2.0.CO;2; FELSENSTEIN J, 1988, ANNU REV GENET, V22, P521, DOI 10.1146/annurev.ge.22.120188.002513; Figuerola J, 2005, AM NAT, V165, P274, DOI 10.1086/427092; Fisher D.C., 1990, P152; FRYER G, 1988, PHILOS T ROY SOC B, V321, P27, DOI 10.1098/rstb.1988.0091; FRYER G, 1995, HYDROBIOLOGIA, V307, P57, DOI 10.1007/BF00031997; Gand G, 1997, GEOBIOS-LYON, V30, P673, DOI 10.1016/S0016-6995(97)80157-X; Gill RE, 2005, CONDOR, V107, P1, DOI 10.1650/7613; Green AJ, 2005, DIVERS DISTRIB, V11, P149, DOI 10.1111/j.1366-9516.2005.00147.x; Guindon S, 2005, NUCLEIC ACIDS RES, V33, pW557, DOI 10.1093/nar/gki352; Guthorl P., 1934, Abhandlungen der Preussischen Geologischen Landesanstalt N F, V164, P1; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [DOI 10.1021/BK-1999-0734.CH008, citeulike-article-id:691774, 10.12691/ajmr-6-4-3]; Hebert PDN, 2005, SYST BIOL, V54, P852, DOI 10.1080/10635150500354886; Hessen DO, 2004, HYDROBIOLOGIA, V519, P73, DOI 10.1023/B:HYDR.0000026486.16615.06; Hewitt G, 2000, NATURE, V405, P907, DOI 10.1038/35016000; Hewitt GM, 1996, BIOL J LINN SOC, V58, P247, DOI 10.1111/j.1095-8312.1996.tb01434.x; Jeppesen E, 2001, HYDROBIOLOGIA, V442, P329, DOI 10.1023/A:1017508211819; Katayama H, 1980, TADPOLE SHRIMPS THEI; KELBER KP, 1998, HALLESCHES JB GEOWIS, V5, P85; Kelber KP, 1999, TRIAS GANZ ANDERE WE, P383; Kerfoot W.C., 1987, P367; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; King JL, 1998, MOL PHYLOGENET EVOL, V10, P23, DOI 10.1006/mpev.1997.0470; KISHINO H, 1989, J MOL EVOL, V29, P170, DOI 10.1007/BF02100115; Knowlton N, 1998, P ROY SOC B-BIOL SCI, V265, P2257, DOI 10.1098/rspb.1998.0568; Korn M, 2006, ZOOTAXA, P57; Korn M, 2006, ZOOL SCR, V35, P301, DOI 10.1111/j.1463-6409.2006.00230.x; Korn M, 2010, ORG DIVERS EVOL, V10, P409, DOI 10.1007/s13127-010-0026-y; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Linder F., 1952, Proceedings of the United States National Museum, V102, P1; LONGHURST ALAN R., 1955, BULL BRIT MUS [NAT HIST] ZOOL, V3, P1; LYNCH M, 1993, GENETICS, V135, P1197; Macdonald KS, 2011, J CRUSTACEAN BIOL, V31, P468, DOI 10.1651/10-3411.1; Mantovani B, 2008, HEREDITY, V100, P496, DOI 10.1038/hdy.2008.3; Mantovani B, 2004, ZOOL SCR, V33, P367, DOI 10.1111/j.0300-3256.2004.00155.x; Mantovani B, 2009, ITAL J ZOOL, V76, P358, DOI 10.1080/11250000802687461; Murugan G, 2002, HYDROBIOLOGIA, V486, P101, DOI 10.1023/A:1021334331277; Murugan G, 2009, AUST J ZOOL, V57, P77, DOI 10.1071/ZO08084; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Rogers DC, 2001, J CRUSTACEAN BIOL, V21, P991, DOI 10.1651/0278-0372(2001)021[0991:ROTNLN]2.0.CO;2; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; RYDER OA, 1986, TRENDS ECOL EVOL, V1, P9, DOI 10.1016/0169-5347(86)90059-5; Sassaman C, 1997, HYDROBIOLOGIA, V359, P125, DOI 10.1023/A:1003168416080; Schmidt HA, 2002, BIOINFORMATICS, V18, P502, DOI 10.1093/bioinformatics/18.3.502; Schubart CD, 1998, NATURE, V393, P363, DOI 10.1038/30724; Shimodaira H, 1999, MOL BIOL EVOL, V16, P1114, DOI 10.1093/oxfordjournals.molbev.a026201; SunoUchi N, 1997, BIOL J LINN SOC, V61, P439, DOI 10.1006/bijl.1997.0138; Swofford DL, 2001, PAUP PHYLOGENETIC AN; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tasch P, 1969, BRANCHIOPODA BOULDER, P129; Troger KA, 1984, ABRISS HIST GEOLOGIE; Vanschoenwinkel B, 2008, FRESHWATER BIOL, V53, P2264, DOI 10.1111/j.1365-2427.2008.02071.x; Vanschoenwinkel B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026730; Vendrasco MJ, 2004, NATURE, V429, P288, DOI 10.1038/nature02548; Voigt Sebastian, 2008, Abhandlungen und Berichte fuer Naturkunde, V31, P7; WALOSSEK D, 1993, LETHAIA, V26, P7, DOI 10.1111/j.1502-3931.1993.tb01504.x; Wares JP, 2001, MOL PHYLOGENET EVOL, V18, P104, DOI 10.1006/mpev.2000.0857; Williams W. D., 1968, Crustaceana, V14, P119, DOI 10.1163/156854068X00476; Xia XH, 2009, PHYLOGENETIC HANDBOOK: A PRACTICAL APPROACH TO PHYLOGENETIC ANALYSIS AND HYPOTHESIS TESTING, 2ND EDITION, P615; Yahya H, 2007, ATLAS CREATION; Zierold T, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-161; Zierold T, 2009, FRESHWATER BIOL, V54, P1392, DOI 10.1111/j.1365-2427.2009.02191.x; Zofkova M, 2009, HYDROBIOLOGIA, V635, P67, DOI 10.1007/s10750-009-9862-1	80	41	46	0	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2012	7	4							e34998	10.1371/journal.pone.0034998	http://dx.doi.org/10.1371/journal.pone.0034998			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959XD	22529967	Green Published, Green Submitted, gold			2022-12-25	WOS:000305350600050
J	Warnefors, M; Eyre-Walker, A				Warnefors, Maria; Eyre-Walker, Adam			A Selection Index for Gene Expression Evolution and Its Application to the Divergence between Humans and Chimpanzees	PLOS ONE			English	Article							PROBE LEVEL DATA; HUMAN GENOME; ADAPTIVE EVOLUTION; NATURAL-SELECTION; MOLECULAR EVOLUTION; NEGATIVE SELECTION; RAPID EVOLUTION; DROSOPHILA; TRANSCRIPTION; POPULATION	The importance of gene regulation in animal evolution is a matter of long-standing interest, but measuring the impact of selection on gene expression has proven a challenge. Here, we propose a selection index of gene expression as a straightforward method for assessing the mode and strength of selection operating on gene expression levels. The index is based on the widely used McDonald-Kreitman test and requires the estimation of four quantities: the within-species and between-species expression variances as well as the sequence heterozygosity and divergence of neutrally evolving sequences. We apply the method to data from human and chimpanzee lymphoblastoid cell lines and show that gene expression is in general under strong stabilizing selection. We also demonstrate how the same framework can be used to estimate the proportion of adaptive gene expression evolution.	[Warnefors, Maria; Eyre-Walker, Adam] Univ Sussex, Sch Life Sci, Brighton, E Sussex, England	University of Sussex	Warnefors, M (corresponding author), Univ Lausanne, Ctr Integrat Genom, Lausanne, Switzerland.	maria.warnefors@gmail.com; a.c.eyre-walker@sussex.ac.uk	Eyre-Walker, Adam/G-6216-2011	Eyre-Walker, Adam/0000-0001-5527-8729	University of Sussex	University of Sussex	This work was funded by the University of Sussex. The funder had no role in study design, data collection, decision to publish, or preparation of the manuscript.	Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Andolfatto P, 2005, NATURE, V437, P1149, DOI 10.1038/nature04107; Babbitt CC, 2010, GENOME BIOL EVOL, V2, P67, DOI 10.1093/gbe/evq002; Becquet C, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030066; Bedford T, 2009, P NATL ACAD SCI USA, V106, P1133, DOI 10.1073/pnas.0812009106; Blekhman R, 2010, GENOME RES, V20, P180, DOI 10.1101/gr.099226.109; Blekhman R, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000271; Boyko AR, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000083; Brawand D, 2011, NATURE, V478, P343, DOI 10.1038/nature10532; BRITTEN RJ, 1969, SCIENCE, V165, P349, DOI 10.1126/science.165.3891.349; Caliskan M, 2011, HUM MOL GENET, V20, P1643, DOI 10.1093/hmg/ddr041; Choy E, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000287; Denver DR, 2005, NAT GENET, V37, P544, DOI 10.1038/ng1554; Eyre-Walker A, 2002, MOL BIOL EVOL, V19, P2142, DOI 10.1093/oxfordjournals.molbev.a004039; Eyre-Walker A, 2006, TRENDS ECOL EVOL, V21, P569, DOI 10.1016/j.tree.2006.06.015; Eyre-Walker A, 2009, MOL BIOL EVOL, V26, P2097, DOI 10.1093/molbev/msp119; Fay JC, 2001, GENETICS, V158, P1227; Fischer A, 2006, CURR BIOL, V16, P1133, DOI 10.1016/j.cub.2006.04.033; Flicek P, 2010, NUCLEIC ACIDS RES, V38, pD557, DOI 10.1093/nar/gkp972; Fraser HB, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002023; Gaffney DJ, 2006, PLOS GENET, V2, P1912, DOI 10.1371/journal.pgen.0020204; Gaffney DJ, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000157; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gilad Y, 2006, NATURE, V440, P242, DOI 10.1038/nature04559; Gojobori J, 2007, P NATL ACAD SCI USA, V104, P3907, DOI 10.1073/pnas.0605565104; Gordon KL, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002432; Haygood R, 2007, NAT GENET, V39, P1140, DOI 10.1038/ng2104; Hey J, 2010, MOL BIOL EVOL, V27, P921, DOI 10.1093/molbev/msp298; Hodgins-Davis A, 2009, TRENDS ECOL EVOL, V24, P649, DOI 10.1016/j.tree.2009.06.011; Holloway AK, 2007, PLOS GENET, V3, P2007, DOI 10.1371/journal.pgen.0030187; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; JENKINS DL, 1995, P ROY SOC B-BIOL SCI, V261, P203, DOI 10.1098/rspb.1995.0137; Khaitovich P, 2005, GENETICS, V170, P929, DOI 10.1534/genetics.104.037135; Khaitovich P, 2004, PLOS BIOL, V2, P682, DOI 10.1371/journal.pbio.0020132; Khaitovich P, 2006, NAT REV GENET, V7, P693, DOI 10.1038/nrg1940; KIMURA M, 1969, GENETICS, V61, P893; KING MC, 1975, SCIENCE, V188, P107, DOI 10.1126/science.1090005; Kohn MH, 2004, MOL BIOL EVOL, V21, P374, DOI 10.1093/molbev/msh026; Kudaravalli S, 2009, MOL BIOL EVOL, V26, P649, DOI 10.1093/molbev/msn289; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lemos B, 2005, MOL BIOL EVOL, V22, P1345, DOI 10.1093/molbev/msi122; Lu J, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-108; MCDONALD JH, 1991, NATURE, V351, P652, DOI 10.1038/351652a0; Mikkelsen TS, 2005, NATURE, V437, P69, DOI 10.1038/nature04072; Nuzhdin SV, 2004, MOL BIOL EVOL, V21, P1308, DOI 10.1093/molbev/msh128; Pereira V, 2009, GENETICS, V183, P1597, DOI 10.1534/genetics.109.110247; Rhead B, 2010, NUCLEIC ACIDS RES, V38, pD613, DOI 10.1093/nar/gkp939; Rifkin SA, 2005, NATURE, V438, P220, DOI 10.1038/nature04114; Rifkin SA, 2003, NAT GENET, V33, P138, DOI 10.1038/ng1086; Rockman MV, 2005, PLOS BIOL, V3, P2208, DOI 10.1371/journal.pbio.0030387; Sahai H, 2003, ANAL VARIANCE RANDOM, VII; Schwartz S, 2003, GENOME RES, V13, P103, DOI 10.1101/gr.809403; Shapiro JA, 2007, P NATL ACAD SCI USA, V104, P2271, DOI 10.1073/pnas.0610385104; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; Sokal R. R., 2012, BIOMETRY; Somel M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001504; Svensson O, 2006, PLOS COMPUT BIOL, V2, P358, DOI 10.1371/journal.pcbi.0020046; Tachida H, 2000, GENE, V261, P3, DOI 10.1016/S0378-1119(00)00475-3; Torgerson DG, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000592; Visel A, 2009, NATURE, V461, P199, DOI 10.1038/nature08451; Whitehead A, 2006, P NATL ACAD SCI USA, V103, P5425, DOI 10.1073/pnas.0507648103; Wilson MD, 2008, SCIENCE, V322, P434, DOI 10.1126/science.1160930; Wray GA, 2007, NAT REV GENET, V8, P206, DOI 10.1038/nrg2063; Yanai I, 2004, OMICS, V8, P15, DOI 10.1089/153623104773547462; Yu N, 2003, GENETICS, V164, P1511	66	14	14	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2012	7	4							e34935	10.1371/journal.pone.0034935	http://dx.doi.org/10.1371/journal.pone.0034935			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959XD	22529958	Green Published, gold, Green Submitted, Green Accepted			2022-12-25	WOS:000305350600043
J	Rutten, N; Gonzales, JL; Elbers, ARW; Velthuis, AGJ				Rutten, Niels; Gonzales, Jose L.; Elbers, Armin R. W.; Velthuis, Annet G. J.			Cost Analysis of Various Low Pathogenic Avian Influenza Surveillance Systems in the Dutch Egg Layer Sector	PLOS ONE			English	Article							RISK; POULTRY; EPIDEMIOLOGY; VALIDATION; CHICKENS; VIRUSES	Background: As low pathogenic avian influenza viruses can mutate into high pathogenic viruses the Dutch poultry sector implemented a surveillance system for low pathogenic avian influenza (LPAI) based on blood samples. It has been suggested that egg yolk samples could be sampled instead of blood samples to survey egg layer farms. To support future decision making about AI surveillance economic criteria are important. Therefore a cost analysis is performed on systems that use either blood or eggs as sampled material. Methodology/Principal Findings: The effectiveness of surveillance using egg or blood samples was evaluated using scenario tree models. Then an economic model was developed that calculates the total costs for eight surveillance systems that have equal effectiveness. The model considers costs for sampling, sample preparation, sample transport, testing, communication of test results and for the confirmation test on false positive results. The surveillance systems varied in sampled material (eggs or blood), sampling location (farm or packing station) and location of sample preparation (laboratory or packing station). It is shown that a hypothetical system in which eggs are sampled at the packing station and samples prepared in a laboratory had the lowest total costs (i.e. (sic) 273,393) a year. Compared to this a hypothetical system in which eggs are sampled at the farm and samples prepared at a laboratory, and the currently implemented system in which blood is sampled at the farm and samples prepared at a laboratory have 6% and 39% higher costs respectively. Conclusions/Significance: This study shows that surveillance for avian influenza on egg yolk samples can be done at lower costs than surveillance based on blood samples. The model can be used in future comparison of surveillance systems for different pathogens and hazards.	[Rutten, Niels; Velthuis, Annet G. J.] Wageningen Univ, Wageningen, Netherlands; [Gonzales, Jose L.; Elbers, Armin R. W.] Cent Vet Inst, Dept Epidemiol Crisis Org & Diagnost, Wageningen, Netherlands; [Gonzales, Jose L.] Univ Utrecht, Fac Vet Med, Dept Farm Anim Hlth, Utrecht, Netherlands	Wageningen University & Research; Wageningen University & Research; Utrecht University	Rutten, N (corresponding author), Wageningen Univ, Wageningen, Netherlands.	Niels.Rutten@wur.nl	Rutten, Cornelis/L-1911-2013	Rutten, Cornelis/0000-0003-2152-1596; Gonzales, Jose L/0000-0002-7889-5380; Velthuis, Annet/0000-0002-5869-8144	Central Veterinary Institute (CVI), part of Wageningen University & Research Centre, The Netherlands (WOT project) [01-001-004]; Foundation for Economic Structure Strengthening (FES) in The Netherlands: FES Program on Avian Influenza	Central Veterinary Institute (CVI), part of Wageningen University & Research Centre, The Netherlands (WOT project)(Netherlands Government); Foundation for Economic Structure Strengthening (FES) in The Netherlands: FES Program on Avian Influenza	Central Veterinary Institute (CVI), part of Wageningen University & Research Centre, The Netherlands (WOT project # 01-001-004: Veterinary Epidemiology and Risk Analysis of Notifiable Contagious Animal Diseases) and partly by the Foundation for Economic Structure Strengthening (FES) in The Netherlands: FES Program on Avian Influenza. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander DJ, 2007, VACCINE, V25, P5637, DOI 10.1016/j.vaccine.2006.10.051; [Anonymous], 2010, PLUIMVEEVLEES EIEREN, p[4, 25]; BEAN WJ, 1985, J VIROL, V54, P151, DOI 10.1128/JVI.54.1.151-160.1985; Beck JR, 2003, AVIAN DIS, V47, P1196, DOI 10.1637/0005-2086-47.s3.1196; Boender GJ, 2007, PLOS COMPUT BIOL, V3, P704, DOI 10.1371/journal.pcbi.0030071; Bowes VA, 2004, AVIAN DIS, V48, P928, DOI 10.1637/7218-060304R; Capua I, 2000, AVIAN PATHOL, V29, P289, DOI 10.1080/03079450050118403; Capua I, 2000, AVIAN PATHOL, V29, P537, DOI 10.1080/03079450020016779; de Wit E, 2008, J CLIN VIROL, V41, P1, DOI 10.1016/j.jcv.2007.10.017; Dekker SEM, 2011, LIVEST SCI, V139, P109, DOI 10.1016/j.livsci.2011.03.011; DeLiberto TJ, 2009, INTEGR ZOOL, V4, P426, DOI 10.1111/j.1749-4877.2009.00180.x; Dijkhuizen A. A., 1997, ANIMAL HLTH EC PRINC; Drummond MF, 2015, METHODS EC EVALUATIO; Elbers ARW, 2004, AVIAN DIS, V48, P691, DOI 10.1637/7149; Elbers ARW, 2007, AVIAN INFLUENZA SURV; European Commission (EC), OFFICIAL J EUROPEAN; Fischer EAJ, 2005, PREV VET MED, V67, P283, DOI 10.1016/j.prevetmed.2004.12.002; Fouchier RAM, 2004, P NATL ACAD SCI USA, V101, P1356, DOI 10.1073/pnas.0308352100; Garcia M, 1996, J GEN VIROL, V77, P1493, DOI 10.1099/0022-1317-77-7-1493; Gonzales JL, 2010, INFLUENZA OTHER RESP, V4, P91, DOI 10.1111/j.1750-2659.2009.00126.x; Gonzales JL, BAYESIAN EVALU UNPUB; Gonzales JL, 2011, VET MICROBIOLOGY; Hasler B, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-225; Harris K., 2010, ANN REPORT SURVEILLA; Henzler DJ, 2003, AVIAN DIS, V47, P1022, DOI 10.1637/0005-2086-47.s3.1022; Jeong OM, 2010, VET MICROBIOL, V144, P287, DOI 10.1016/j.vetmic.2010.01.022; Jonassen CM, 2007, AVIAN DIS, V51, P425, DOI 10.1637/7555-033106R1.1; Koch G, 2006, NJAS-WAGEN J LIFE SC, V54, P179, DOI 10.1016/S1573-5214(06)80021-7; Lewis PD, 2009, BIOL BREEDING POULTR; Martin RAJ, 2007, PREV VET MED, V79, P71, DOI 10.1016/j.prevetmed.2006.09.008; Palisade-Corporation, 2010, RISK; Perdue ML, 2005, AVIAN DIS, V49, P317, DOI 10.1637/7390-060305R.1; Rojas H, 2002, VET REC, V151, P188; Thomas ME, 2010, PREV VET MED, V95, P137, DOI 10.1016/j.prevetmed.2010.02.003; van Asseldonk MAPM, 2005, PREV VET MED, V69, P39, DOI 10.1016/j.prevetmed.2005.01.012; Velthuis AGJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019612; World Health Organization (WHO), 2011, CUM NUMB CONF HUM CA	37	6	6	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2012	7	4							e33930	10.1371/journal.pone.0033930	http://dx.doi.org/10.1371/journal.pone.0033930			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VO	22523543	Green Published, gold			2022-12-25	WOS:000305345000012
J	Hu, P; Carlesso, N; Xu, MJ; Liu, Y; Nebreda, AR; Takemoto, C; Kapur, R				Hu, Ping; Carlesso, Nadia; Xu, Mingjiang; Liu, Yan; Nebreda, Angel R.; Takemoto, Clifford; Kapur, Reuben			Genetic Evidence for Critical Roles of P38 alpha Protein in Regulating Mast Cell Differentiation and Chemotaxis through Distinct Mechanisms	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR; INDUCED APOPTOSIS; TYROSINE KINASE; MAP KINASE; ACTIVATION; PROLIFERATION; MOUSE; MITF; STEM; MELANOCYTE	Mast cells mediate a range of immune responses. However, the mechanisms that contribute to their development remain poorly understood. Here, using a P38 alpha conditional knockout system, we provide evidence to suggest that P38 alpha plays critical roles in regulating mast cell differentiation and migration via distinct mechanisms. Induced deletion of P38 alpha in bone marrow cells retards the maturation of mast cells in part by inhibiting the activation of cAMP response element-binding protein and expression of microphthalmia-associated transcription factor, which encourages the generation of basophils over mast cells. In fully differentiated mast cells, absence of P38 alpha inhibits stem cell factor-induced activation of Akt and ERK, which is associated with reduced chemotaxis. In vivo, conditional deletion of P38 alpha results in reduced numbers of mast cells in certain tissues and a failure to reconstitute these cells in W-sh mice transplanted with P38 alpha(-/-) Lin(-)c-kit(+)Sca-1(+) (LKS+) cells. Our findings suggest that P38 alpha plays a dual role in mast cell development by regulating IL-3-induced differentiation of mast cell progenitor cells as well as by regulating stem cell factor-induced migration of fully differentiated mast cells.	[Hu, Ping; Carlesso, Nadia; Xu, Mingjiang; Liu, Yan; Kapur, Reuben] Indiana Univ Sch Med, Herman B Wells Ctr Pediat Res, Dept Pediat, Indianapolis, IN 46202 USA; [Nebreda, Angel R.] Inst Catalana Recerca & Estudios Avancats, Barcelona 08028, Spain; [Nebreda, Angel R.] Inst Res Biomed IRB Barcelona, Barcelona 08028, Spain; [Takemoto, Clifford] Johns Hopkins Univ, Div Pediat Hematol, Baltimore, MD 21202 USA	Indiana University System; Indiana University Bloomington; ICREA; Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona; Johns Hopkins University	Kapur, R (corresponding author), Indiana Univ Sch Med, Herman B Wells Ctr Pediat Res, Dept Pediat, 1044 W Walnut St,Room W168, Indianapolis, IN 46202 USA.	rkapur@iupui.edu	Takemoto, Clifford M/Y-7558-2018; Nebreda, Angel Rodriguez/R-9594-2019		National Institutes of Health [R01 HL077177, R01 HL08111]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL077177] Funding Source: NIH RePORTER; ICREA Funding Source: Custom	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); ICREA(ICREA)	This work was supported, in whole or in part, by National Institutes of Health Grants R01 HL077177 and R01 HL08111 (to R. K.).	Adams RH, 2000, MOL CELL, V6, P109, DOI 10.1016/S1097-2765(00)00012-5; Arinobu Y, 2005, P NATL ACAD SCI USA, V102, P18105, DOI 10.1073/pnas.0509148102; Bertolotto C, 1998, J CELL BIOL, V142, P827, DOI 10.1083/jcb.142.3.827; Carreira S, 2006, GENE DEV, V20, P3426, DOI 10.1101/gad.406406; Charles N, 2009, IMMUNITY, V30, P533, DOI 10.1016/j.immuni.2009.02.008; Deak M, 1998, EMBO J, V17, P4426, DOI 10.1093/emboj/17.15.4426; Barrantes IDB, 2011, P NATL ACAD SCI USA, V108, P12764, DOI 10.1073/pnas.1015013108; Du JY, 2004, CANCER CELL, V6, P565, DOI 10.1016/j.ccr.2004.10.014; DVORAK AM, 1994, AM J PATHOL, V144, P160; Fukao T, 2002, NAT IMMUNOL, V3, P295, DOI 10.1038/ni768; Galli S J, 1994, Curr Opin Hematol, V1, P33; Gupta M, 2006, J BIOL CHEM, V281, P17552, DOI 10.1074/jbc.M600950200; Haddon DJ, 2009, J IMMUNOL, V183, P228, DOI 10.4049/jimmunol.0900427; Heinrichsdorff J, 2008, EMBO REP, V9, P1048, DOI 10.1038/embor.2008.149; Hui LJ, 2007, NAT GENET, V39, P741, DOI 10.1038/ng2033; Ito A, 1998, BLOOD, V91, P3210, DOI 10.1182/blood.V91.9.3210.3210_3210_3221; Jippo T, 2003, J EXP MED, V197, P1417, DOI 10.1084/jem.20022157; Kalesnikoff J, 2008, NAT IMMUNOL, V9, P1215, DOI 10.1038/ni.f.216; Larribere L, 2005, GENE DEV, V19, P1980, DOI 10.1101/gad.335905; Loercher AE, 2005, J CELL BIOL, V168, P35, DOI 10.1083/jcb.200410115; McGill GG, 2002, CELL, V109, P707, DOI 10.1016/S0092-8674(02)00762-6; McMullen ME, 2005, J BIOL CHEM, V280, P20995, DOI 10.1074/jbc.M407060200; Mekori YA, 2000, IMMUNOL REV, V173, P131, DOI 10.1034/j.1600-065X.2000.917305.x; Metz M, 2006, SCIENCE, V313, P526, DOI 10.1126/science.1128877; Moller C, 2005, BLOOD, V106, P1330, DOI 10.1182/blood-2004-12-4792; Morii E, 2004, J BIOL CHEM, V279, P48923, DOI 10.1074/jbc.M407026200; Noguchi T, 2008, J BIOL CHEM, V283, P7657, DOI 10.1074/jbc.M708402200; Ogihara H, 2001, BLOOD, V97, P645, DOI 10.1182/blood.V97.3.645; Schieven GL, 2009, CURR TOP MED CHEM, V9, P1038, DOI 10.2174/156802609789630974; Soucek L, 2007, NAT MED, V13, P1211, DOI 10.1038/nm1649; Tamura K, 2000, CELL, V102, P221, DOI 10.1016/S0092-8674(00)00027-1; TAN JC, 1990, SCIENCE, V247, P209, DOI 10.1126/science.1688471; Tsujimura T, 1996, BLOOD, V88, P1225, DOI 10.1182/blood.V88.4.1225.bloodjournal8841225; Ventura JJ, 2007, NAT GENET, V39, P750, DOI 10.1038/ng2037; Walsh JC, 2002, IMMUNITY, V17, P665, DOI 10.1016/S1074-7613(02)00452-1; Weller CL, 2005, J EXP MED, V201, P1961, DOI 10.1084/jem.20042407; Zhang D, 2011, J BIOL CHEM, V286, P44913, DOI 10.1074/jbc.M111.310052; ZSEBO KM, 1990, CELL, V63, P213, DOI 10.1016/0092-8674(90)90302-U	38	11	14	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 8	2012	287	24					20258	20269		10.1074/jbc.M112.358119	http://dx.doi.org/10.1074/jbc.M112.358119			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974FB	22518842	hybrid, Green Published			2022-12-25	WOS:000306414500046
J	Kanamarlapudi, V; Thompson, A; Kelly, E; Bernal, AL				Kanamarlapudi, Venkateswarlu; Thompson, Aiysha; Kelly, Eamonn; Bernal, Andres Lopez			ARF6 Activated by the LHCG Receptor through the Cytohesin Family of Guanine Nucleotide Exchange Factors Mediates the Receptor Internalization and Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RIBOSYLATION FACTOR 6; PROTEIN-COUPLED RECEPTORS; BETA-GAMMA-SUBUNITS; PHOSPHATIDYLINOSITOL 3-KINASE; PLASMA-MEMBRANE; BREFELDIN-A; PHOSPHOINOSITIDE 3-KINASE; STIMULATED TRANSLOCATION; ENDOCYTOSIS; CELLS	The luteinizing hormone chorionic gonadotropin receptor (LHCGR) is a G(s)-coupled GPCR that is essential for the maturation and function of the ovary and testis. LHCGR is internalized following its activation, which regulates the biological responsiveness of the receptor. Previous studies indicated that ADP-ribosylation factor (ARF)6 and its GTP-exchange factor (GEF) cytohesin 2 regulate LHCGR internalization in follicular membranes. However, the mechanisms by which ARF6 and cytohesin 2 regulate LHCGR internalization remain incompletely understood. Here we investigated the role of the ARF6 signaling pathway in the internalization of heterologously expressed human LHCGR (HLHCGR) in intact cells using a combination of pharmacological inhibitors, siRNA and the expression of mutant proteins. We found that human CG (HCG)-induced HLHCGR internalization, cAMP accumulation and ARF6 activation were inhibited by Gallein (beta gamma inhibitor), Wortmannin (PI 3-kinase inhibitor), SecinH3 (cytohesin ARF GEF inhibitor), QS11 (an ARF GAP inhibitor), an ARF6 inhibitory peptide and ARF6 siRNA. However, Dynasore (dynamin inhibitor), the dominant negative mutants of NM23-H1 (dynamin activator) and clathrin, and PBP10 (PtdIns 4,5-P2-binding peptide) inhibited agonist- induced HLHCGR and cAMP accumulation but not ARF6 activation. These results indicate that heterotrimeric G-protein, phosphatidylinositol (PI) 3-kinase (PI3K), cytohesin ARF GEF and ARF GAP function upstream of ARF6 whereas dynamin and clathrin act downstream of ARF6 in the regulation of HCG-induced HLHCGR internalization and signaling. In conclusion, we have identified the components and molecular details of the ARF6 signaling pathway required for agonist-induced HLHCGR internalization.	[Kanamarlapudi, Venkateswarlu; Thompson, Aiysha] Swansea Univ, Coll Med, Inst Life Sci, Swansea SA2 8PP, W Glam, Wales; [Kelly, Eamonn] Univ Bristol, Sch Physiol & Pharmacol, Bristol BS8 1TD, Avon, England; [Bernal, Andres Lopez] Univ Bristol, Div Obstet & Gynaecol, Sch Clin Sci, Henry Wellcome Labs Integrat Neurosci & Endocrino, Bristol BS1 3NY, Avon, England	Swansea University; University of Bristol; University of Bristol	Kanamarlapudi, V (corresponding author), Swansea Univ, Coll Med, Inst Life Sci, Singleton Pk, Swansea SA2 8PP, W Glam, Wales.	k.venkateswarlu@swansea.ac.uk	Kanamarlapudi, Venkateswarlu/A-9864-2011	Kanamarlapudi, Venkateswarlu/0000-0002-8739-1483	BBSRC UK; MRC UK; Royal Society UK; Biotechnology and Biological Sciences Research Council [1095087, BB/C515455/2] Funding Source: researchfish; Medical Research Council [G0401232] Funding Source: researchfish; MRC [G0401232] Funding Source: UKRI	BBSRC UK(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Royal Society UK(Royal Society of London); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by BBSRC UK, MRC UK, and the Royal Society UK.	Abel K, 2001, J CELL SCI, V114, P2207; Ascoli M, 2002, ENDOCR REV, V23, P141, DOI 10.1210/er.23.2.141; Benmerah A, 1999, J CELL SCI, V112, P1303; Bhaskaran RS, 2005, J MOL ENDOCRINOL, V34, P447, DOI 10.1677/jme.1.01745; Bonacci TM, 2006, SCIENCE, V312, P443, DOI 10.1126/science.1120378; Chen H, 1999, J BIOL CHEM, V274, P3257, DOI 10.1074/jbc.274.6.3257; Claing A, 2001, J BIOL CHEM, V276, P42509, DOI 10.1074/jbc.M108399200; Claing A, 2004, BIOCHEM CELL BIOL, V82, P610, DOI 10.1139/O04-113; Cullen PJ, 1999, BIOCHEM SOC T, V27, P683, DOI 10.1042/bst0270683; D'Souza-Schorey C, 2006, NAT REV MOL CELL BIO, V7, P347, DOI 10.1038/nrm1910; Derossi D, 1998, TRENDS CELL BIOL, V8, P84, DOI 10.1016/S0962-8924(97)01214-2; Di Fiore PP, 2001, CELL, V106, P1, DOI 10.1016/S0092-8674(01)00428-7; DONALDSON JG, 1992, NATURE, V360, P350, DOI 10.1038/360350a0; FAZIOLI F, 1993, MOL CELL BIOL, V13, P5814, DOI 10.1128/MCB.13.9.5814; Frank S, 1998, J BIOL CHEM, V273, P23, DOI 10.1074/jbc.273.1.23; Fu HM, 2004, BMC CELL BIOL, V5, DOI 10.1186/1471-2121-5-50; Galas MC, 1997, J BIOL CHEM, V272, P2788, DOI 10.1074/jbc.272.5.2788; Gurevich VV, 2006, PHARMACOL THERAPEUT, V110, P465, DOI 10.1016/j.pharmthera.2005.09.008; Hafner M, 2006, NATURE, V444, P941, DOI 10.1038/nature05415; Hanyaloglu AC, 2008, ANNU REV PHARMACOL, V48, P537, DOI 10.1146/annurev.pharmtox.48.113006.094830; Hashimoto S, 2004, P NATL ACAD SCI USA, V101, P6647, DOI 10.1073/pnas.0401753101; Hawkins PT, 2007, SCIENCE, V318, P64, DOI 10.1126/science.1145420; Houndolo T, 2005, J BIOL CHEM, V280, P5598, DOI 10.1074/jbc.M411456200; Hunzicker-Dunn M, 2002, FEBS LETT, V521, P3, DOI 10.1016/S0014-5793(02)02822-3; Kagan JC, 2006, CELL, V125, P943, DOI 10.1016/j.cell.2006.03.047; KLAUSNER RD, 1992, J CELL BIOL, V116, P1071, DOI 10.1083/jcb.116.5.1071; Krauss M, 2003, J CELL BIOL, V162, P113, DOI 10.1083/jcb.200301006; Lawrence J, 2005, MOL PHARMACOL, V67, P1822, DOI 10.1124/mol.105.011338; Lazari RDM, 1998, J BIOL CHEM, V273, P18316, DOI 10.1074/jbc.273.29.18316; Lehmann DM, 2008, MOL PHARMACOL, V73, P410, DOI 10.1124/mol.107.041780; Macia E, 2006, DEV CELL, V10, P839, DOI 10.1016/j.devcel.2006.04.002; Min L, 2000, MOL ENDOCRINOL, V14, P1797, DOI 10.1210/me.14.11.1797; Moss J, 1998, J BIOL CHEM, V273, P21431, DOI 10.1074/jbc.273.34.21431; Mukherjee S, 2000, P NATL ACAD SCI USA, V97, P5901, DOI 10.1073/pnas.100127097; OKADA T, 1994, J BIOL CHEM, V269, P3568; Oldham WM, 2008, NAT REV MOL CELL BIO, V9, P60, DOI 10.1038/nrm2299; Palacios F, 2002, NAT CELL BIOL, V4, P929, DOI 10.1038/ncb881; Paleotti O, 2005, J BIOL CHEM, V280, P21661, DOI 10.1074/jbc.m503099200; Poupart ME, 2007, CELL SIGNAL, V19, P2370, DOI 10.1016/j.cellsig.2007.07.015; Prasad SVN, 2001, J BIOL CHEM, V276, P18953, DOI 10.1074/jbc.M102376200; Rameh LE, 1999, J BIOL CHEM, V274, P8347, DOI 10.1074/jbc.274.13.8347; Smrcka AV, 2008, CELL MOL LIFE SCI, V65, P2191, DOI 10.1007/s00018-008-8006-5; STEPHENS L, 1994, CELL, V77, P83, DOI 10.1016/0092-8674(94)90237-2; Svensson HG, 2008, EUR J IMMUNOL, V38, P818, DOI 10.1002/eji.200737331; Taniguchi CM, 2006, NAT REV MOL CELL BIO, V7, P85, DOI 10.1038/nrm1837; Venkateswarlu K, 2005, METHOD ENZYMOL, V404, P252, DOI 10.1016/S0076-6879(05)04024-3; Venkateswarlu K, 2004, J BIOL CHEM, V279, P6205, DOI 10.1074/jbc.C300482200; Venkateswarlu K, 2003, J BIOL CHEM, V278, P43460, DOI 10.1074/jbc.M304078200; Venkateswarlu K, 2000, BIOCHEM J, V345, P719, DOI 10.1042/0264-6021:3450719; Venkateswarlu K, 1999, J CELL SCI, V112, P1957; Venkateswarlu K, 1998, BIOCHEM J, V335, P139, DOI 10.1042/bj3350139; Venkateswarlu K, 1999, BIOCHEM J, V340, P359, DOI 10.1042/0264-6021:3400359; Venkateswarlu K, 1998, CURR BIOL, V8, P463, DOI 10.1016/S0960-9822(98)70181-2; Volpicelli-Daley LA, 2005, MOL BIOL CELL, V16, P4495, DOI 10.1091/mbc.E04-12-1042; WANG H, 1991, J BIOL CHEM, V266, P780; YANO H, 1993, J BIOL CHEM, V268, P25846; Zeeh JC, 2006, J BIOL CHEM, V281, P11805, DOI 10.1074/jbc.M600149200; Zhang QS, 2007, P NATL ACAD SCI USA, V104, P7444, DOI 10.1073/pnas.0702136104	58	23	23	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 8	2012	287	24					20443	20455		10.1074/jbc.M112.362087	http://dx.doi.org/10.1074/jbc.M112.362087			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974FB	22523074	Green Published, hybrid			2022-12-25	WOS:000306414500062
J	Ming, AYK; Yoo, E; Vorontsov, EN; Altamentova, SM; Kilkenny, DM; Rocheleau, JV				Ming, Aaron Y. K.; Yoo, Eunjong; Vorontsov, Eugene N.; Altamentova, Svetlana M.; Kilkenny, Dawn M.; Rocheleau, Jonathan V.			Dynamics and Distribution of Klotho beta (KLB) and Fibroblast Growth Factor Receptor-1 (FGFR1) in Living Cells Reveal the Fibroblast Growth Factor-21 (FGF21)-induced Receptor Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; METABOLIC-ACTIVITY; STRUCTURAL BASIS; PPAR-ALPHA; NUMBER; BRIGHTNESS; FAMILY; ORGANIZATION; EXPRESSION; ECTODOMAIN	FGF21 stimulates FGFR1c activity in cells that co-express Klotho beta (KLB); however, relatively little is known about the interaction of these receptors at the plasma membrane. We measured the dynamics and distribution of fluorescent protein-tagged KLB and FGFR1c in living cells using fluorescence recovery after photobleaching and number and brightness analysis. We confirmed that fluorescent protein-tagged KLB translocates to the plasma membrane and is active when co-expressed with FGFR1c. FGF21-induced signaling was enhanced in cells treated with lactose, a competitive inhibitor of the galectin lattice, suggesting that lattice-binding modulates KLB and/or FGFR1c activity. Fluorescence recovery after photobleaching analysis consistently revealed that lactose treatment increased KLB mobility at the plasma membrane, but did not affect the mobility of FGFR1c. The association of endogenous KLB with the galectin lattice was also confirmed by co-immunoprecipitation with galectin-3. KLB mobility increased when co-expressed with FGFR1c, suggesting that the two receptors form a heterocomplex independent of the galectin lattice. Number and brightness analysis revealed that KLB and FGFR1c behave as monomers and dimers at the plasma membrane, respectively. Co-expression resulted in monomeric expression of KLB and FGFR1c consistent with formation of a 1:1 heterocomplex. Subsequent addition of FGF21 induced FGFR1 dimerization without changing KLB aggregate size, suggesting formation of a 1:2 KLB-FGFR1c signaling complex. Overall, these data suggest that KLB and FGFR1 form a 1:1 heterocomplex independent of the galectin lattice that transitions to a 1:2 complex upon the addition of FGF21.	[Ming, Aaron Y. K.; Yoo, Eunjong; Vorontsov, Eugene N.; Kilkenny, Dawn M.; Rocheleau, Jonathan V.] Univ Toronto, Inst Biomat & Biomed Engn, Toronto, ON M5S 3G9, Canada; [Rocheleau, Jonathan V.] Univ Toronto, Dept Physiol, Toronto, ON M5S 1A8, Canada; [Rocheleau, Jonathan V.] Univ Toronto, Dept Med, Toronto, ON M5S 1A8, Canada; [Ming, Aaron Y. K.; Vorontsov, Eugene N.; Altamentova, Svetlana M.; Rocheleau, Jonathan V.] Univ Hlth Network, Toronto Gen Res Inst, Toronto, ON M5G 1L7, Canada	University of Toronto; University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital	Rocheleau, JV (corresponding author), Toronto Med Discovery Tower,10th Fl,Rm 10-707,101, Toronto, ON M5G 1L7, Canada.	Jon.Rocheleau@utoronto.ca		Rocheleau, Jonathan/0000-0002-1760-2564	Canadian Foundation for Innovation Leaders Opportunity Fund [18301]; Canadian Institutes for Health Research [NMD106997]; Heart and Stroke Foundation of Ontario [NA6591]; Banting and Best Diabetes Centre, University of Toronto	Canadian Foundation for Innovation Leaders Opportunity Fund(Canada Foundation for Innovation); Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation of Ontario(Heart & Stroke Foundation of Ontario); Banting and Best Diabetes Centre, University of Toronto(University of Toronto)	The microscope used in these studies was purchased through a Canadian Foundation for Innovation Leaders Opportunity Fund (18301) to J. V. Rocheleau.; This work was supported by grants from the Canadian Institutes for Health Research (NMD106997) (to J. V. R. and D. M. K.) and the Heart and Stroke Foundation of Ontario (NA6591) (to J. V. R.).; Supported by the Banting and Best Diabetes Centre, University of Toronto.	Badman MK, 2007, CELL METAB, V5, P426, DOI 10.1016/j.cmet.2007.05.002; Beenken A, 2009, NAT REV DRUG DISCOV, V8, P235, DOI 10.1038/nrd2792; Brewer CF, 2002, CURR OPIN STRUC BIOL, V12, P616, DOI 10.1016/S0959-440X(02)00364-0; Chang Q, 2005, SCIENCE, V310, P490, DOI 10.1126/science.1114245; Dalal RB, 2008, MICROSC RES TECHNIQ, V71, P69, DOI 10.1002/jemt.20526; Digman MA, 2008, BIOPHYS J, V94, P2320, DOI 10.1529/biophysj.107.114645; Garner OB, 2008, BIOCHEM SOC T, V36, P1472, DOI 10.1042/BST0361472; Goetz R, 2007, MOL CELL BIOL, V27, P3417, DOI 10.1128/MCB.02249-06; Goodger SJ, 2008, J BIOL CHEM, V283, P13001, DOI 10.1074/jbc.M704531200; Harmer NJ, 2004, BIOCHEMISTRY-US, V43, P629, DOI 10.1021/bi035320k; Inagaki T, 2007, CELL METAB, V5, P415, DOI 10.1016/j.cmet.2007.05.003; Ito S, 2000, MECH DEVELOP, V98, P115, DOI 10.1016/S0925-4773(00)00439-1; Itoh N, 2004, TRENDS GENET, V20, P563, DOI 10.1016/j.tig.2004.08.007; JOHNSON DE, 1993, ADV CANCER RES, V60, P1; Kharitonenkov A, 2005, J CLIN INVEST, V115, P1627, DOI 10.1172/JCI23606; Kharitonenkov A, 2008, BIODRUGS, V22, P37, DOI 10.2165/00063030-200822010-00004; Kharitonenkov A, 2008, J CELL PHYSIOL, V215, P1, DOI 10.1002/jcp.21357; Kharitonenkov A, 2009, CURR OPIN PHARMACOL, V9, P805, DOI 10.1016/j.coph.2009.07.001; Kharitonenkov A, 2009, CURR OPIN INVEST DR, V10, P359; Kilkenny DM, 2008, MOL ENDOCRINOL, V22, P196, DOI 10.1210/me.2007-0241; Kircheis R, 1997, GENE THER, V4, P409, DOI 10.1038/sj.gt.3300418; Kurosu H, 2006, J BIOL CHEM, V281, P6120, DOI 10.1074/jbc.C500457200; Kurosu H, 2007, J BIOL CHEM, V282, P26687, DOI 10.1074/jbc.M704165200; Lajoie P, 2007, J CELL BIOL, V179, P341, DOI 10.1083/jcb.200611106; Lau KS, 2007, CELL, V129, P123, DOI 10.1016/j.cell.2007.01.049; Lemmon MA, 2010, CELL, V141, P1117, DOI 10.1016/j.cell.2010.06.011; Mohammadi M, 2005, CYTOKINE GROWTH F R, V16, P107, DOI 10.1016/j.cytogfr.2005.01.008; Nagy P, 2010, P NATL ACAD SCI USA, V107, P16524, DOI 10.1073/pnas.1002642107; Nakamura M, 2011, J BIOL CHEM, V286, P26418, DOI 10.1074/jbc.M111.251140; Ogawa Y, 2007, P NATL ACAD SCI USA, V104, P7432, DOI 10.1073/pnas.0701600104; Ornitz DM, 2001, GENOME BIOL, V2; Ossato G, 2010, BIOPHYS J, V98, P3078, DOI 10.1016/j.bpj.2010.02.058; Partridge EA, 2004, SCIENCE, V306, P120, DOI 10.1126/science.1102109; Pellegrini L, 2000, NATURE, V407, P1029, DOI 10.1038/35039551; Reits EAJ, 2001, NAT CELL BIOL, V3, pE145, DOI 10.1038/35078615; Schlessinger J, 2000, MOL CELL, V6, P743, DOI 10.1016/S1097-2765(00)00073-3; Suzuki M, 2008, MOL ENDOCRINOL, V22, P1006, DOI 10.1210/me.2007-0313; Wang F, 1997, J BIOL CHEM, V272, P23887, DOI 10.1074/jbc.272.38.23887; Yie JM, 2009, FEBS LETT, V583, P19, DOI 10.1016/j.febslet.2008.11.023	39	32	33	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 8	2012	287	24					19997	20006		10.1074/jbc.M111.325670	http://dx.doi.org/10.1074/jbc.M111.325670			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974FB	22523080	hybrid, Green Published			2022-12-25	WOS:000306414500021
J	Westesson, O; Lunter, G; Paten, B; Holmes, I				Westesson, Oscar; Lunter, Gerton; Paten, Benedict; Holmes, Ian			Accurate Reconstruction of Insertion-Deletion Histories by Statistical Phylogenetics	PLOS ONE			English	Article							SEQUENCE ALIGNMENT; MAXIMUM-LIKELIHOOD; EVOLUTIONARY TREES; SUBSTITUTION; PREDICTION; PLACEMENT; IMPACT; MODEL; RATES; TIME	The Multiple Sequence Alignment (MSA) is a computational abstraction that represents a partial summary either of indel history, or of structural similarity. Taking the former view (indel history), it is possible to use formal automata theory to generalize the phylogenetic likelihood framework for finite substitution models (Dayhoff's probability matrices and Felsenstein's pruning algorithm) to arbitrary-length sequences. In this paper, we report results of a simulation-based benchmark of several methods for reconstruction of indel history. The methods tested include a relatively new algorithm for statistical marginalization of MSAs that sums over a stochastically-sampled ensemble of the most probable evolutionary histories. For mammalian evolutionary parameters on several different trees, the single most likely history sampled by our algorithm appears less biased than histories reconstructed by other MSA methods. The algorithm can also be used for alignment-free inference, where the MSA is explicitly summed out of the analysis. As an illustration of our method, we discuss reconstruction of the evolutionary histories of human protein-coding genes.	[Westesson, Oscar; Holmes, Ian] Univ Calif Berkeley, Grad Program Bioengn, Univ Calif Berkeley & Univ Calif San Francisco Gr, Berkeley, CA 94720 USA; [Lunter, Gerton] Wellcome Trust Ctr Human Genet, Oxford, England; [Paten, Benedict] Univ Calif Santa Cruz, Baskin Sch Engn, Santa Cruz, CA 95064 USA	University of California System; University of California Berkeley; University of Oxford; Wellcome Centre for Human Genetics; University of California System; University of California Santa Cruz	Holmes, I (corresponding author), Univ Calif Berkeley, Grad Program Bioengn, Univ Calif Berkeley & Univ Calif San Francisco Gr, Berkeley, CA 94720 USA.	protpal@postbox.biowiki.org	Lunter, Gerton/H-4939-2016	Holmes, Ian/0000-0001-7639-5369; Lunter, Gerton/0000-0002-3798-2058	National Institutes of Health/National Human Genome Research Institute [R01-GM076705]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM076705] Funding Source: NIH RePORTER	National Institutes of Health/National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Authors OW and IHH were supported by National Institutes of Health/National Human Genome Research Institute grant R01-GM076705. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2002, NATURE; Beissbarth T, 2004, BIOINFORMATICS, V20, P1464, DOI 10.1093/bioinformatics/bth088; Bradley RK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006478; Bradley RK, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000392; Cartwright RA, 2005, BIOINFORMATICS, V21, P31, DOI 10.1093/bioinformatics/bti1200; Clark AG, 2007, NATURE, V450, P203, DOI 10.1038/nature06341; de la Chaux N, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-191; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; FELSENSTEIN J, 1981, J MOL EVOL, V17, P368, DOI 10.1007/BF01734359; Gomez-Valero L, 2008, MOL ECOL, V17, P4382, DOI 10.1111/j.1365-294X.2008.03912.x; Haussler, 2004, P 8 ANN INT C RES CO, P177, DOI DOI 10.1145/974614.974638; Heger A, 2008, NUCLEIC ACIDS RES, V36, pD267, DOI 10.1093/nar/gkm852; HIGGINS DG, 1992, COMPUT APPL BIOSCI, V8, P189; Holmes I, 2001, BIOINFORMATICS, V17, P803, DOI 10.1093/bioinformatics/17.9.803; Kamneva OK, 2010, GENOME BIOL EVOL, V2, P870, DOI 10.1093/gbe/evq071; Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198; Knudsen B, 1999, BIOINFORMATICS, V15, P446, DOI 10.1093/bioinformatics/15.6.446; Kschischang FR, 2001, IEEE T INFORM THEORY, V47, P498, DOI 10.1109/18.910572; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lee C, 2002, BIOINFORMATICS, V18, P452, DOI 10.1093/bioinformatics/18.3.452; Liu K, 2009, IEEE ACM T COMPUT BI, V6, P7, DOI 10.1109/TCBB.2008.63; Loytynoja A, 2005, P NATL ACAD SCI USA, V102, P10557, DOI 10.1073/pnas.0409137102; Loytynoja A, 2008, SCIENCE, V320, P1632, DOI 10.1126/science.1158395; Lunter G, 2007, BIOINFORMATICS, V23, pI289, DOI 10.1093/bioinformatics/btm185; Margulies EH, 2007, GENOME RES, V17, P760, DOI 10.1101/gr.6034307; Markova-Raina P, 2011, GENOME RES, V21, P863, DOI 10.1101/gr.115949.110; Matsen FA, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-538; Miklos I, 2004, MOL BIOL EVOL, V21, P529, DOI 10.1093/molbev.msh043; Mills R, 2006, GENOME RES, V16; Mohri M, 2002, COMPUT SPEECH LANG, V16, P69, DOI 10.1006/csla.2001.0184; Moore E. F., 1956, AUTOMATA STUDIES, P129; Moses AM, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-12-r98; Nelesen S, 2008, Pac Symp Biocomput, P25; Paten B, 2008, GENOME RES, V18, P1829, DOI 10.1101/gr.076521.108; Pedersen JS, 2006, PLOS COMPUT BIOL, V2, P251, DOI 10.1371/journal.pcbi.0020033; Pollard KS, 2006, NATURE, V443, P167, DOI 10.1038/nature05113; Qu XT, 2009, CURR PROTEIN PEPT SC, V10, P270, DOI 10.2174/138920309788452182; Rannala B, 1996, J MOL EVOL, V43, P304, DOI 10.1007/BF02338839; Saccone S, 2011, NUCL ACIDS RES; Siepel A, 2004, J COMPUT BIOL, V11, P413, DOI 10.1089/1066527041410472; Siepel A, 2004, MOL BIOL EVOL, V21, P468, DOI 10.1093/molbev/msh039; Sinha S, 2005, MBE, V22; Strope CL, 2009, MOL BIOL EVOL, V26, P2581, DOI 10.1093/molbev/msp174; Suchard MA, 2006, BIOINFORMATICS, V22, P2047, DOI 10.1093/bioinformatics/btl175; Thompson JD, 1999, NUCLEIC ACIDS RES, V27, P2682, DOI 10.1093/nar/27.13.2682; THORNE JL, 1991, J MOL EVOL, V33, P114, DOI 10.1007/BF02193625; Thorne JL, 1996, MOL BIOL EVOL, V13, P666, DOI 10.1093/oxfordjournals.molbev.a025627; Wang ZY, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-23; Westesson O, 2011, ALIGNMENT FREE GEN I; Wong KM, 2008, SCIENCE, V319, P473, DOI 10.1126/science.1151532; YANG ZB, 1994, J MOL EVOL, V39, P105; Yang ZH, 2000, GENETICS, V155, P431; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Zhang Z, 2011, MOL BIOL EVOL, V28, P291, DOI 10.1093/molbev/msq196; Zhu LC, 2009, MOL BIOL EVOL, V26, P2353, DOI 10.1093/molbev/msp144	55	20	20	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2012	7	4							e34572	10.1371/journal.pone.0034572	http://dx.doi.org/10.1371/journal.pone.0034572			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UD	22536326	Green Published, Green Submitted, gold			2022-12-25	WOS:000305339200015
J	Matsumura, G; Nitta, N; Matsuda, S; Sakamoto, Y; Isayama, N; Yamazaki, K; Ikada, Y				Matsumura, Goki; Nitta, Naotaka; Matsuda, Shojiro; Sakamoto, Yuki; Isayama, Noriko; Yamazaki, Kenji; Ikada, Yoshito			Long-Term Results of Cell-Free Biodegradable Scaffolds for In Situ Tissue-Engineering Vasculature: In a Canine Inferior Vena Cava Model	PLOS ONE			English	Article							INTRAVASCULAR ULTRASOUND ELASTOGRAPHY; EXTRACARDIAC FONTAN OPERATION; BONE-MARROW; CONDUIT; AUTOGRAFTS; GRAFTS; ARTERIES	We have developed a new biodegradable scaffold that does not require any cell seeding to create an in-situ tissue-engineering vasculature (iTEV). Animal experiments were conducted to test its characteristics and long-term efficacy. An 8-mm tubular biodegradable scaffold, consisting of polyglycolide knitted fibers and an L-lactide and epsilon-caprolactone copolymer sponge with outer glycolide and epsilon-caprolactone copolymer monofilament reinforcement, was implanted into the inferior vena cava (IVC) of 13 canines. All the animals remained alive without any major complications until euthanasia. The utility of the iTEV was evaluated from 1 to 24 months postoperatively. The elastic modulus of the iTEV determined by an intravascular ultrasound imaging system was about 90% of the native IVC after 1 month. Angiography of the iTEV after 2 years showed a well-formed vasculature without marked stenosis or thrombosis with a mean pressure gradient of 0.51 +/- 0.19 mmHg. The length of the iTEV at 2 years had increased by 0.48 +/- 0.15 cm compared with the length of the original scaffold (2-3 cm). Histological examinations revealed a well-formed vessel-like vasculature without calcification. Biochemical analyses showed no significant differences in the hydroxyproline, elastin, and calcium contents compared with the native IVC. We concluded that the findings shown above provide direct evidence that the new scaffold can be useful for cell-free tissue-engineering of vasculature. The long-term results revealed that the iTEV was of good quality and had adapted its shape to the needs of the living body. Therefore, this scaffold would be applicable for pediatric cardiovascular surgery involving biocompatible materials.	[Matsumura, Goki; Isayama, Noriko; Yamazaki, Kenji] Tokyo Womens Med Univ, Heart Inst Japan, Shinjuku Ku, Tokyo, Japan; [Nitta, Naotaka] Natl Inst Adv Ind Sci & Technol, Biomed Sensing & Imaging Grp, Human Technol Res Inst, Tsukuba, Ibaraki, Japan; [Matsuda, Shojiro; Sakamoto, Yuki] Gunze Ltd, Dept Res & Dev, Ayabe, Kyoto, Japan; [Ikada, Yoshito] Nara Med Univ, Dept Indoor Environm Med, Kashihara, Nara 634, Japan	Tokyo Women's Medical University; National Institute of Advanced Industrial Science & Technology (AIST); Nara Medical University	Matsumura, G (corresponding author), Tokyo Womens Med Univ, Heart Inst Japan, Shinjuku Ku, Tokyo, Japan.	smatumur@hij.twmu.ac.jp	MATSUMURA, GOKI/ABB-9716-2020; Nitta, Naotaka/M-4742-2018	MATSUMURA, GOKI/0000-0002-1134-3346; Nitta, Naotaka/0000-0002-6036-4805; Isayama, Noriko/0000-0002-4240-2134	Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan [20390373]	Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a Grant-in Aid for Scientific Research (B: number 20390373) from The Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexi-Meskishvili V, 2000, EUR J CARDIO-THORAC, V18, P690, DOI 10.1016/S1010-7940(00)00593-5; Amodeo A, 1997, J THORAC CARDIOV SUR, V114, P1020, DOI 10.1016/S0022-5223(97)70016-3; Bailey LL, 1997, J THORAC CARDIOV SUR, V114, P1030; de Korte CL, 1998, ULTRASOUND MED BIOL, V24, P401, DOI 10.1016/S0301-5629(97)00280-9; de Korte CL, 2000, CIRCULATION, V102, P617, DOI 10.1161/01.CIR.102.6.617; Hayabuchi Y, 2007, AM HEART J, V153, DOI 10.1016/j.ahj.2007.01.035; Hibino N, 2005, J THORAC CARDIOV SUR, V129, P1064, DOI 10.1016/j.jtcvs.2004.10.030; Hibino N, 2010, J THORAC CARDIOV SUR, V139, P431, DOI 10.1016/j.jtcvs.2009.09.057; Lee C, 2007, EUR J CARDIO-THORAC, V31, P1008, DOI 10.1016/j.ejcts.2007.03.013; Lemler MS, 2006, AM HEART J, V151, P928, DOI 10.1016/j.ahj.2005.06.015; Matsumura G, 2003, CIRCULATION, V108, P1729, DOI 10.1161/01.CIR.0000092165.32213.61; Matsumura G, 2003, BIOMATERIALS, V24, P2303, DOI 10.1016/S0142-9612(03)00043-7; Matsumura G, 2006, TISSUE ENG, V12, P3075, DOI 10.1089/ten.2006.12.3075; Mirensky TL, 2009, J PEDIATR SURG, V44, P1127, DOI 10.1016/j.jpedsurg.2009.02.035; Nitta N, 2008, IEEE ENG MED BIO, P5298, DOI 10.1109/IEMBS.2008.4650410; Ovroutskia S, 2004, EUR J CARDIO-THORAC, V26, P1073, DOI 10.1016/j.ejcts.2004.07.021; Roh JD, 2010, P NATL ACAD SCI USA, V107, P4669, DOI 10.1073/pnas.0911465107; Shin'oka T, 2005, J THORAC CARDIOV SUR, V129, P1330, DOI 10.1016/j.jtcvs.2004.12.047; Watanabe M, 2001, TISSUE ENG, V7, P429, DOI 10.1089/10763270152436481	19	39	40	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2012	7	4							e35760	10.1371/journal.pone.0035760	http://dx.doi.org/10.1371/journal.pone.0035760			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TL	22532873	Green Published, Green Submitted, gold			2022-12-25	WOS:000305336200067
J	de Belchior, ACS; Angeli, JK; Faria, TD; Siman, FDM; Silveira, EA; Meira, EF; da Costa, CP; Vassallo, DV; Padilha, AS				de Belchior, Aucelia C. S.; Angeli, Jhuli K.; Faria, Thais de O.; Siman, Fabiana D. M.; Silveira, Edna A.; Meira, Eduardo F.; da Costa, Carlos P.; Vassallo, Dalton V.; Padilha, Alessandra S.			Post-Weaning Protein Malnutrition Increases Blood Pressure and Induces Endothelial Dysfunctions in Rats	PLOS ONE			English	Article							INTRAUTERINE GROWTH-RETARDATION; NITRIC-OXIDE SYNTHASE; OXIDATIVE STRESS; SUPEROXIDE GENERATION; VASCULAR REACTIVITY; MULTIDEFICIENT DIET; POSTNATAL-GROWTH; HEART-RATE; UNDERNUTRITION; EXPRESSION	Malnutrition during critical periods in early life may increase the subsequent risk of hypertension and metabolic diseases in adulthood, but the underlying mechanisms are still unclear. We aimed to evaluate the effects of post-weaning protein malnutrition on blood pressure and vascular reactivity in aortic rings (conductance artery) and isolated-perfused tail arteries (resistance artery) from control (fed with Labina (R)) and post-weaning protein malnutrition rats (offspring that received a diet with low protein content for three months). Systolic and diastolic blood pressure and heart rate increased in the post-weaning protein malnutrition rats. In the aortic rings, reactivity to phenylephrine (10(-10) -3.10(-4) M) was similar in both groups. Endothelium removal or L-NAME (10(-4) M) incubation increased the response to phenylephrine, but the L-NAME effect was greater in the aortic rings from the post-weaning protein malnutrition rats. The protein expression of the endothelial nitric oxide isoform increased in the aortic rings from the post-weaning protein malnutrition rats. Incubation with apocynin (0.3 mM) reduced the response to phenylephrine in both groups, but this effect was higher in the post-weaning protein malnutrition rats, suggesting an increase of superoxide anion release. In the tail artery of the post-weaning protein malnutrition rats, the vascular reactivity to phenylephrine (0.001-300 mu g) and the relaxation to acetylcholine (10(-10) -10(-3) M) were increased. Post-weaning protein malnutrition increases blood pressure and induces vascular dysfunction. Although the vascular reactivity in the aortic rings did not change, an increase in superoxide anion and nitric oxide was observed in the post-weaning protein malnutrition rats. However, in the resistance arteries, the increased vascular reactivity may be a potential mechanism underlying the increased blood pressure observed in this model.	[de Belchior, Aucelia C. S.; da Costa, Carlos P.] Univ Fed Pernambuco, Dept Fisiol & Farmacol, Recife, PE, Brazil; [de Belchior, Aucelia C. S.; Angeli, Jhuli K.; Faria, Thais de O.; Siman, Fabiana D. M.; Silveira, Edna A.; Meira, Eduardo F.; Vassallo, Dalton V.; Padilha, Alessandra S.] Univ Fed Espirito Santo, Programa Posgrad Ciencias Fisiol, Vitoria, ES, Brazil; [Vassallo, Dalton V.] EMESCAM, Escola Ensino Super Santa Casa Misericordia Vitor, Vitoria, ES, Brazil	Universidade Federal de Pernambuco; Universidade Federal do Espirito Santo; Escola Superior de Ciencias da Santa Casa de Misericordia de Vitoria	de Belchior, ACS (corresponding author), Univ Fed Pernambuco, Dept Fisiol & Farmacol, Recife, PE, Brazil.	ale_padilha@hotmail.com	Vassallo, Dalton/K-8289-2016	Vassallo, Dalton/0000-0002-4463-4174	Fundacao de Amparo a Ciencia e Tecnologia do Estado de Pernambuco (FACEPE); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Fundacao de Amparo a Pesquisa do Espirito Santo/fundacao de apoio a ciencia e tecnologia do espirito santo (FAPES/FUNCITEC); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)	Fundacao de Amparo a Ciencia e Tecnologia do Estado de Pernambuco (FACEPE)(Fundacao de Amparo a Ciencia e Tecnologia do Estado de Pernambuco (FACEPE)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Espirito Santo/fundacao de apoio a ciencia e tecnologia do espirito santo (FAPES/FUNCITEC); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This study was funded by grants from Fundacao de Amparo a Ciencia e Tecnologia do Estado de Pernambuco (FACEPE), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Fundacao de Amparo a Pesquisa do Espirito Santo/fundacao de apoio a ciencia e tecnologia do espirito santo (FAPES/FUNCITEC) and Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Casanello P, 2002, CIRC RES, V91, P127, DOI 10.1161/01.RES.0000027813.55750.E7; Ceravolo GS, 2007, LIFE SCI, V80, P782, DOI 10.1016/j.lfs.2006.11.006; Chang HR, 2002, CLIN EXP PHARMACOL P, V29, P275, DOI 10.1046/j.1440-1681.2002.03643.x; Fazza EL, 1999, EXPER PHYSL, V84, P357; Fiorim J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017117; Franca AS, 1997, BRAZ J MED BIOL RES, V30, P891, DOI 10.1590/S0100-879X1997000700012; Franco MCP, 2007, LIFE SCI, V80, P709, DOI 10.1016/j.lfs.2006.10.028; Franco MD, 2002, J CARDIOVASC PHARM, V40, P501, DOI 10.1097/00005344-200210000-00002; Franco MDP, 2003, CARDIOVASC RES, V59, P767, DOI 10.1016/S0008-6363(03)00461-9; Franco MDP, 2002, CARDIOVASC RES, V56, P145, DOI 10.1016/S0008-6363(02)00508-4; Gardner DS, 1997, HYPERTENSION, V30, P1525, DOI 10.1161/01.HYP.30.6.1525; Goodfellow J, 1998, CARDIOVASC RES, V40, P600, DOI 10.1016/S0008-6363(98)00197-7; GRYGLEWSKI RJ, 1986, NATURE, V320, P454, DOI 10.1038/320454a0; Hernanz R, 2004, AM J PHYSIOL-HEART C, V287, pH225, DOI 10.1152/ajpheart.00548.2003; Hu XW, 2000, CARDIOVASC RES, V48, P233, DOI 10.1016/S0008-6363(00)00167-X; Lamireau D, 2002, STROKE, V33, P2992, DOI 10.1161/01.STR.0000039340.62995.F2; LangleyEvans SC, 1996, CLIN SCI, V91, P607, DOI 10.1042/cs0910607; Li JM, 2004, AM J PHYSIOL-REG I, V287, pR1014, DOI 10.1152/ajpregu.00124.2004; Massin MM, 2001, CARDIOLOGY, V95, P80, DOI 10.1159/000047350; Molendi-Coste O, 2009, NEUROENDOCRINOLOGY, V90, P54, DOI 10.1159/000209222; Monteiro FMF, 2001, BRAZ J MED BIOL RES, V34, P271, DOI 10.1590/S0100-879X2001000200017; NUTTER DO, 1979, CIRC RES, V45, P144, DOI 10.1161/01.RES.45.1.144; Oliveira EL, 2004, NUTR NEUROSCI, V7, P201, DOI 10.1080/10284150412331279827; Padilha AS, 2008, EUR J PHARMACOL, V600, P110, DOI 10.1016/j.ejphar.2008.10.023; Paixao ADO, 2005, NUTR METAB CARDIOVAS, V15, P302, DOI 10.1016/j.numecd.2005.01.005; Paixao ADO, 2003, NUTR RES, V23, P85, DOI 10.1016/S0271-5317(02)00494-3; Petry CJ, 2000, DIABETIC MED, V17, P848, DOI 10.1046/j.1464-5491.2000.00392.x; PISSAIA O, 1980, J NUTR, V110, P2035, DOI 10.1093/jn/110.10.2035; Rossoni LV, 2002, BRIT J PHARMACOL, V135, P771, DOI 10.1038/sj.bjp.0704501; Sawaya AL, 2005, MATERN CHILD NUTR, V1, P155, DOI 10.1111/j.1740-8709.2005.00033.x; Sesso R, 2004, NEPHRON CLIN PRACT, V97, pC61, DOI 10.1159/000078402; Sugizaki M, 2005, J BIOMED SCI, V12, P641, DOI 10.1007/s11373-005-7652-y; TEODOSIO NR, 1990, ARCH LATINOAM NUTR, V40, P533; Tropia FC, 2001, NUTR NEUROSCI, V4, P99, DOI 10.1080/1028415X.2001.11747354; VICTORA CG, 1986, B WORLD HEALTH ORGAN, V64, P299; Vieira LD, 2009, CLIN EXP PHARMACOL P, V36, P1157, DOI 10.1111/j.1440-1681.2009.05212.x; Woodall SM, 1996, PEDIATR RES, V40, P438, DOI 10.1203/00006450-199609000-00012	37	15	15	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2012	7	4							e34876	10.1371/journal.pone.0034876	http://dx.doi.org/10.1371/journal.pone.0034876			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959XD	22529948	gold, Green Published, Green Submitted			2022-12-25	WOS:000305350600035
J	Chotivanich, K; Udomsangpetch, R; Suwanarusk, R; Pukrittayakamee, S; Wilairatana, P; Beeson, JG; Day, NPJ; White, NJ				Chotivanich, Kesinee; Udomsangpetch, Rachanee; Suwanarusk, Rossarin; Pukrittayakamee, Sasithon; Wilairatana, Polrat; Beeson, James G.; Day, Nicholas P. J.; White, Nicholas J.			Plasmodium vivax Adherence to Placental Glycosaminoglycans	PLOS ONE			English	Article							FALCIPARUM-INFECTED ERYTHROCYTES; CHONDROITIN-SULFATE-A; HYALURONIC-ACID; MALARIA; ADHESION; PREGNANCY; RECEPTOR; AREA; CYTOADHERENCE; PATHOGENESIS	Background: Plasmodium vivax infections seldom kill directly but do cause indirect mortality by reducing birth weight and causing abortion. Cytoadherence and sequestration in the microvasculature are central to the pathogenesis of severe Plasmodium falciparum malaria, but the contribution of cytoadherence to pathology in other human malarias is less clear. Methodology: The adherence properties of P. vivax infected red blood cells (PvIRBC) were evaluated under static and flow conditions. Principal Findings: P. vivax isolates from 33 patients were studied. None adhered to immobilized CD36, ICAM-1, or thrombospondin, putative ligands for P. falciparum vascular cytoadherence, or umbilical vein endothelial cells, but all adhered to immobilized chondroitin sulphate A (CSA) and hyaluronic acid (HA), the receptors for adhesion of P. falciparum in the placenta. PvIRBC also adhered to fresh placental cells (N = 5). Pre-incubation with chondroitinase prevented PvIRBC adherence to CSA, and reduced binding to HA, whereas preincubation with hyaluronidase prevented adherence to HA, but did not reduce binding to CSA significantly. Pre-incubation of PvIRBC with soluble CSA and HA reduced binding to the immobilized receptors and prevented placental binding. PvIRBC adhesion was prevented by pre-incubation with trypsin, inhibited by heparin, and reduced by EGTA. Under laminar flow conditions the mean (SD) shear stress reducing maximum attachment by 50% was 0.06 (0.02) Pa but, having adhered, the PvIRBC could then resist detachment by stresses up to 5 Pa. At 37 degrees C adherence began approximately 16 hours after red cell invasion with maximal adherence at 30 hours. At 39 degrees C adherence began earlier and peaked at 24 hours. Significance: Adherence of P. vivax-infected erythrocytes to glycosaminoglycans may contribute to the pathogenesis of vivax malaria and lead to intrauterine growth retardation.	[Chotivanich, Kesinee; Pukrittayakamee, Sasithon; Wilairatana, Polrat; Day, Nicholas P. J.; White, Nicholas J.] Mahidol Univ, Fac Trop Med, Dept Clin Trop Med, Bangkok 10700, Thailand; [Udomsangpetch, Rachanee] Mahidol Univ, Fac Sci, Dept Pathobiol, Bangkok 10700, Thailand; [Suwanarusk, Rossarin] Agcy Sci Technol & Res, Lab Malaria Immunol, Singapore, Singapore; [Beeson, James G.] Royal Melbourne Hosp, Walter & Eliza Hall Inst Med Res, Infect & Immun Div, Parkville, Vic 3050, Australia; [Day, Nicholas P. J.; White, Nicholas J.] Churchill Hosp, Ctr Trop Med, Oxford OX3 7LJ, England	Mahidol University; Mahidol University; Agency for Science Technology & Research (A*STAR); Royal Melbourne Hospital; Walter & Eliza Hall Institute; University of Oxford	Chotivanich, K (corresponding author), Mahidol Univ, Fac Trop Med, Dept Clin Trop Med, Bangkok 10700, Thailand.	nickw@tropmedres.ac	White, Nicholas J/I-4629-2012; White, Nick/AAC-6527-2019; Suwanarusk, Rossarin/E-2115-2013	White, Nick/0000-0002-1897-1978; Suwanarusk, Rossarin/0000-0002-7310-245X	Faculty of Tropical Medicine, Mahidol University; Wellcome Trust	Faculty of Tropical Medicine, Mahidol University; Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by the Faculty of Tropical Medicine, Mahidol University and The Wellcome Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDRYSIAK PM, 1986, AM J TROP MED HYG, V35, P251, DOI 10.4269/ajtmh.1986.35.251; Anstey NM, 2007, J INFECT DIS, V195, P589, DOI 10.1086/510756; Beeson JG, 2005, CURR TOP MICROBIOL, V297, P187; Beeson JG, 2004, J INFECT DIS, V189, P169, DOI 10.1086/380975; Beeson JG, 2002, INT J PARASITOL, V32, P1245, DOI 10.1016/S0020-7519(02)00097-8; Beeson JG, 2000, NAT MED, V6, P86, DOI 10.1038/71582; Buffet PA, 1999, P NATL ACAD SCI USA, V96, P12743, DOI 10.1073/pnas.96.22.12743; Carvalho BO, 2010, J INFECT DIS, V202, P638, DOI 10.1086/654815; Chai WG, 2002, J BIOL CHEM, V277, P22438, DOI 10.1074/jbc.M111401200; Chotivanich K, 2001, T ROY SOC TROP MED H, V95, P677, DOI 10.1016/S0035-9203(01)90113-0; Chotivanich KT, 1998, AM J TROP MED HYG, V59, P73, DOI 10.4269/ajtmh.1998.59.73; Fernando SD, 2003, AM J TROP MED HYG, V69, P582, DOI 10.4269/ajtmh.2003.69.582; Fried M, 1996, SCIENCE, V272, P1502, DOI 10.1126/science.272.5267.1502; Fried M, 1998, NATURE, V395, P851, DOI 10.1038/27570; Fried M, 2006, EXP PARASITOL, V113, P36, DOI 10.1016/j.exppara.2005.12.003; Gardner JP, 1996, P NATL ACAD SCI USA, V93, P3503, DOI 10.1073/pnas.93.8.3503; Luxemburger C, 2001, AM J EPIDEMIOL, V154, P459, DOI 10.1093/aje/154.5.459; McGready R, 2004, AM J TROP MED HYG, V70, P398, DOI 10.4269/ajtmh.2004.70.398; McGready R, 2011, LANCET INFECT D 1212; Mendis K, 2001, AM J TROP MED HYG, V64, P97, DOI 10.4269/ajtmh.2001.64.97; Nosten F, 1999, LANCET, V354, P546, DOI 10.1016/S0140-6736(98)09247-2; Poespoprodjo JR, 2008, CLIN INFECT DIS, V46, P1374, DOI 10.1086/586743; Price RN, 2007, AM J TROP MED HYG, V77, P79, DOI 10.4269/ajtmh.2007.77.79; Ribaut C, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-45; Rogerson SJ, 2007, LANCET INFECT DIS, V7, P105, DOI 10.1016/S1473-3099(07)70022-1; Singh K, 2008, NAT STRUCT MOL BIOL, V15, P932, DOI 10.1038/nsmb.1479; Snounou G, 1996, Methods Mol Biol, V50, P263; STAMPER HB, 1977, J IMMUNOL, V119, P772; Suwanarusk R, 2004, J INFECT DIS, V189, P190, DOI 10.1086/380468; Tjitra E, 2008, PLOS MED, V5, P890, DOI 10.1371/journal.pmed.0050128; UDOMSANGPETCH R, 1992, INFECT IMMUN, V60, P4483, DOI 10.1128/IAI.60.11.4483-4490.1992; Udomsangpetch R, 1995, T ROY SOC TROP MED H, V89, P635, DOI 10.1016/0035-9203(95)90422-0; Udomsangpetch R, 1997, J IMMUNOL, V158, P4358; Udomsangpetch R, 2002, P NATL ACAD SCI USA, V99, P11825, DOI 10.1073/pnas.172398999; Williams TN, 1997, QJM-INT J MED, V90, P751	35	64	64	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2012	7	4							e34509	10.1371/journal.pone.0034509	http://dx.doi.org/10.1371/journal.pone.0034509			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WC	22529919	Green Published, Green Submitted, gold			2022-12-25	WOS:000305347400013
J	Clarke, NE; Fisher, MJ; Porter, KE; Lambert, DW; Turner, AJ				Clarke, Nicola E.; Fisher, Martin J.; Porter, Karen E.; Lambert, Daniel W.; Turner, Anthony J.			Angiotensin Converting Enzyme (ACE) and ACE2 Bind Integrins and ACE2 Regulates Integrin Signalling	PLOS ONE			English	Article							MYOCARDIAL-INFARCTION; CARDIAC FIBROBLASTS; GENE-EXPRESSION; SARS-COV; RECEPTOR; HEART; PROTEIN; DYSFUNCTION; INHIBITOR; THROMBIN	The angiotensin converting enzymes (ACEs) are the key catalytic components of the renin-angiotensin system, mediating precise regulation of blood pressure by counterbalancing the effects of each other. Inhibition of ACE has been shown to improve pathology in cardiovascular disease, whilst ACE2 is cardioprotective in the failing heart. However, the mechanisms by which ACE2 mediates its cardioprotective functions have yet to be fully elucidated. Here we demonstrate that both ACE and ACE2 bind integrin subunits, in an RGD-independent manner, and that they can act as cell adhesion substrates. We show that cellular expression of ACE2 enhanced cell adhesion. Furthermore, we present evidence that soluble ACE2 (sACE2) is capable of suppressing integrin signalling mediated by FAK. In addition, sACE2 increases the expression of Akt, thereby lowering the proportion of the signalling molecule phosphorylated Akt. These results suggest that ACE2 plays a role in cell-cell interactions, possibly acting to fine-tune integrin signalling. Hence the expression and cleavage of ACE2 at the plasma membrane may influence cell-extracellular matrix interactions and the signalling that mediates cell survival and proliferation. As such, ectodomain shedding of ACE2 may play a role in the process of pathological cardiac remodelling.	[Clarke, Nicola E.; Turner, Anthony J.] Univ Leeds, Fac Biol Sci, Inst Mol & Cellular Biol, Leeds, W Yorkshire, England; [Fisher, Martin J.] Univ Leeds, Dept Chem, Leeds LS2 9JT, W Yorkshire, England; [Porter, Karen E.] Univ Leeds, Multidisciplinary Cardiovasc Res Ctr, Leeds, W Yorkshire, England; [Lambert, Daniel W.] Univ Sheffield, Oral Dis Res Grp, Sheffield, S Yorkshire, England	University of Leeds; University of Leeds; University of Leeds; University of Sheffield	Clarke, NE (corresponding author), Univ Leeds, Fac Biol Sci, Inst Mol & Cellular Biol, Leeds, W Yorkshire, England.	a.j.turner@leeds.ac.uk			U.K. Biotechnology and Biological Sciences Research Council (BBSRC)	U.K. Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	NEC was supported by a U.K. Biotechnology and Biological Sciences Research Council (BBSRC; http://www.bbsrc.ac.uk/) Ph.D. research studentship. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balyasnikova IV, 2008, TISSUE ANTIGENS, V72, P354, DOI 10.1111/j.1399-0039.2008.01112.x; Balyasnikova IV, 2003, TISSUE ANTIGENS, V61, P49, DOI 10.1034/j.1399-0039.2003.610104.x; BARSHAVIT R, 1993, J CELL BIOL, V123, P1279, DOI 10.1083/jcb.123.5.1279; BARSHAVIT R, 1991, J CELL BIOL, V112, P335, DOI 10.1083/jcb.112.2.335; BODE W, 1992, PROTEIN SCI, V1, P426; Burrell LM, 2005, EUR HEART J, V26, P369, DOI 10.1093/eurheartj/ehi114; Camargo SMR, 2009, GASTROENTEROLOGY, V136, P872, DOI 10.1053/j.gastro.2008.10.055; Chen H, 1999, CHEM BIOL, V6, P1, DOI 10.1016/S1074-5521(99)80015-5; Clarke NE, 2012, INT J HYPERTENS, V2012, DOI 10.1155/2012/307315; Epelman S, 2009, J CARD FAIL, V15, P565, DOI 10.1016/j.cardfail.2009.01.014; Garrido AM, 2009, MOL CELL ENDOCRINOL, V302, P148, DOI 10.1016/j.mce.2008.11.003; Goulter AB, 2004, BMC MED, V2, DOI 10.1186/1741-7015-2-19; Grobe JL, 2007, CLIN SCI, V113, P357, DOI 10.1042/CS20070160; Grobe JL, 2006, AM J PHYSIOL-HEART C, V290, pH2417, DOI 10.1152/ajpheart.01170.2005; Guy JL, 2008, EXP PHYSIOL, V93, P579, DOI 10.1113/expphysiol.2007.040139; Haga S, 2008, P NATL ACAD SCI USA, V105, P7809, DOI 10.1073/pnas.0711241105; HANKS SK, 1992, P NATL ACAD SCI USA, V89, P8487, DOI 10.1073/pnas.89.18.8487; Iwata M, 2005, AM J PHYSIOL-HEART C, V289, pH2356, DOI 10.1152/ajpheart.00317.2005; Ji YY, 2009, CELL PHYSIOL BIOCHEM, V23, P265, DOI 10.1159/000218173; Jimenez E, 2009, BIOCHEM BIOPH RES CO, V380, P769, DOI 10.1016/j.bbrc.2009.01.142; Jin H, 2001, CIRCULATION, V103, P736; Kassiri Z, 2009, CIRC-HEART FAIL, V2, P446, DOI 10.1161/CIRCHEARTFAILURE.108.840124; KERJASCHKI D, 1989, AM J PATHOL, V134, P481; Krishnamurthy P, 2006, HEART, V92, P1309, DOI 10.1136/hrt.2005.071001; Lambert DW, 2008, FEBS LETT, V582, P385, DOI 10.1016/j.febslet.2007.11.085; Lambert DW, 2005, J BIOL CHEM, V280, P30113, DOI 10.1074/jbc.M505111200; Lambert DW, 2009, CELL MOL LIFE SCI; Lin QS, 2004, BBA-MOL BASIS DIS, V1689, P175, DOI 10.1016/j.bbadis.2004.05.005; Long EO, 2011, J IMMUNOL, V186, P5021, DOI 10.4049/jimmunol.1100646; Mercure C, 2008, CIRC RES, V103, P1319, DOI 10.1161/CIRCRESAHA.108.184911; Mores A, 2008, J MED CHEM, V51, P2216, DOI 10.1021/jm701275z; Nakamura Y, 2003, CARDIOVASC RES, V57, P48, DOI 10.1016/S0008-6363(02)00644-2; Ocaranza MP, 2006, HYPERTENSION, V48, P572, DOI 10.1161/01.HYP.0000237862.94083.45; Passier RCJJ, 1996, AM J PHYSIOL-HEART C, V271, pH1040, DOI 10.1152/ajpheart.1996.271.3.H1040; Pola S, 2003, J BIOL CHEM, V278, P40601, DOI 10.1074/jbc.M306510200; Porter KE, 2009, PHARMACOL THERAPEUT, V123, P255, DOI 10.1016/j.pharmthera.2009.05.002; Porter KE, 2004, CARDIOVASC RES, V61, P745, DOI 10.1016/j.cardiores.2003.11.032; Qi Y, 2011, EXP PHYSL; ROMAN J, 1992, AM J RESP CELL MOL, V6, P472, DOI 10.1165/ajrcmb/6.5.472; Rosenow Felix, 2008, Neoplasia, V10, P168, DOI 10.1593/neo.07898; Rushworth CA, 2008, FEBS J, V275, P6033, DOI 10.1111/j.1742-4658.2008.06733.x; Santos RAS, 2003, P NATL ACAD SCI USA, V100, P8258, DOI 10.1073/pnas.1432869100; Sarkissian SD, 2008, HYPERTENSION, V51, P712, DOI 10.1161/HYPERTENSIONAHA.107.100693; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Soro-Paavonen A, 2012, J HYPERTENS, V30, P375, DOI 10.1097/HJH.0b013e32834f04b6; Sun M, 2003, CIRCULATION, V107, P1046, DOI 10.1161/01.CIR.0000051363.86009.3C; Takagi J, 2007, CURR OPIN CELL BIOL, V19, P557, DOI 10.1016/j.ceb.2007.09.002; Takeda S, 2006, EMBO J, V25, P2388, DOI 10.1038/sj.emboj.7601131; Tallant EA, 2005, AM J PHYSIOL-HEART C, V289, pH1560, DOI 10.1152/ajpheart.00941.2004; Tipnis SR, 2000, J BIOL CHEM, V275, P33238, DOI 10.1074/jbc.M002615200; Towler P, 2004, J BIOL CHEM, V279, P17996, DOI 10.1074/jbc.M311191200; Turner NA, 2003, CARDIOVASC RES, V57, P784, DOI 10.1016/S0008-6363(02)00729-0; van den Borne SWM, 2010, NAT REV CARDIOL, V7, P30, DOI 10.1038/nrcardio.2009.199; Wong DW, 2007, AM J PATHOL, V171, P438, DOI 10.2353/ajpath.2007.060977; Yamamoto K, 2006, HYPERTENSION, V47, P718, DOI 10.1161/01.HYP.0000205833.89478.5b; Yoshiyama M, 2005, HEART, V91, P1080, DOI 10.1136/hrt.2004.035618; Young-Pearse TL, 2008, NEURAL DEV, V3, DOI 10.1186/1749-8104-3-15; Zhang F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012323; Zigrino P, 2011, J BIOL CHEM, V286, P6801, DOI 10.1074/jbc.M110.168617; Zisman LS, 2003, CIRCULATION, V108, P1679, DOI 10.1161/01.CIR.0000094733.61689.D4	60	54	55	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2012	7	4							e34747	10.1371/journal.pone.0034747	http://dx.doi.org/10.1371/journal.pone.0034747			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VO	22523556	gold, Green Published, Green Accepted			2022-12-25	WOS:000305345000027
J	Soo, KY; Atkin, JD; Farg, M; Walker, AK; Horne, MK; Nagley, P				Soo, Kai Y.; Atkin, Julie D.; Farg, Manal; Walker, Adam K.; Horne, Malcolm K.; Nagley, Phillip			Bim Links ER Stress and Apoptosis in Cells Expressing Mutant SOD1 Associated with Amyotrophic Lateral Sclerosis	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; PROTEIN-DISULFIDE-ISOMERASE; MOTOR-NEURON DISEASE; FAMILY-MEMBER BIM; BCL-2 FAMILY; NEURODEGENERATIVE DISEASES; THERAPEUTIC IMPLICATIONS; MOTONEURON LOSS; SPINAL-CORDS; MOUSE MODEL	Endoplasmic reticulum (ER) stress is an important pathway to cell death in amyotrophic lateral sclerosis (ALS). We previously demonstrated that ER stress is linked to neurotoxicity associated with formation of inclusions of mutant Cu, Zn-superoxide dismutase 1 (SOD1). Cells bearing mutant inclusions undergo mitochondrial apoptotic signalling. Here, we demonstrate that the BH3-only protein, Bim, is a direct link between ER stress and mitochondrial apoptosis. In the murine neuroblastoma cell line, Neuro2a, bearing mutant SOD1 inclusions, indicators of both ER stress and apoptosis are expressed. Bim knockdown by siRNA significantly reduced nuclear apoptotic features in these inclusion-bearing cells (but did not affect the proportion of cells overall that bear inclusions). Further, both Bax recruitment to mitochondria and cytochrome c redistribution were also decreased under Bim-depletion conditions. However, upregulation of CHOP, a marker of ER stress, was not reduced by Bim knockdown. Significantly, knockdown of CHOP by siRNA reduced the extent of apoptosis in cells bearing mutant SOD1 inclusions. These sequential links between ER stress, CHOP upregulation, and Bim activation of mitochondrial apoptotic signalling indicate a clear pathway to cell death mediated by mutant SOD1.	[Soo, Kai Y.; Nagley, Phillip] Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic, Australia; [Soo, Kai Y.; Atkin, Julie D.; Farg, Manal; Walker, Adam K.] La Trobe Univ, Dept Biochem, La Trobe Inst Mol Sci, Bundoora, Vic 3083, Australia; [Atkin, Julie D.; Walker, Adam K.; Horne, Malcolm K.] Univ Melbourne, Florey Neurosci Inst, Parkville, Vic 3052, Australia; [Atkin, Julie D.; Walker, Adam K.; Horne, Malcolm K.] Univ Melbourne, Ctr Neurosci, Parkville, Vic 3052, Australia; [Horne, Malcolm K.] St Vincents Hosp, Dept Neurol, Fitzroy, Vic 3065, Australia	Monash University; La Trobe University; Florey Institute of Neuroscience & Mental Health; University of Melbourne; University of Melbourne; St Vincent's Hospital Melbourne	Soo, KY (corresponding author), Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic, Australia.	phillip.nagley@monash.edu	Walker, Adam Keith/B-7418-2009; Horne, Malcolm/AAL-5214-2020	Walker, Adam Keith/0000-0001-7954-5801; Horne, Malcolm/0000-0001-9427-2100; Atkin, Julie/0000-0003-2427-499X	National Health and Medical Research Council of Australia (NHMRC) [236805, 454749]; Motor Neurone Disease Research Institute of Australia; NHMRC [400058]; Australian Postgraduate Award; Australian Rotary Health Research Fund; Bethlehem Griffiths Research Foundation	National Health and Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Motor Neurone Disease Research Institute of Australia; NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Australian Postgraduate Award(Australian Government); Australian Rotary Health Research Fund; Bethlehem Griffiths Research Foundation	Funding was obtained from grants from the National Health and Medical Research Council of Australia (NHMRC), www.nhmrc.gov.au, Program Grant on Brain Injury and Repair (236805) to M. Horne and P. Nagley, and Project Grant (454749) to J. Atkin; Bethlehem Griffiths Research Foundation, www.bethlehemgrf.com.au, to J. Atkin and M. Horne; and Motor Neurone Disease Research Institute of Australia, www.mndaust.asn.au/mndria, to J. Atkin. M. Horne was supported by an NHMRC Practitioner Fellowship (400058). J. Atkin was supported by a Fellowship from the Motor Neurone Disease Research Institute of Australia. A. Walker was supported by an Australian Postgraduate Award administered through the University of Melbourne, http://cms.services.unimelb.edu.au/scholarships/pgrad/local/available/apa, and a scholarship from the Australian Rotary Health Research Fund, www.australianrotaryhealth.org.au. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atkin JD, 2008, NEUROBIOL DIS, V30, P400, DOI 10.1016/j.nbd.2008.02.009; Atkin JD, 2006, J BIOL CHEM, V281, P30152, DOI 10.1074/jbc.M603393200; Boillee S, 2006, NEURON, V52, P39, DOI 10.1016/j.neuron.2006.09.018; Cleveland DW, 2001, NAT REV NEUROSCI, V2, P806, DOI 10.1038/35097565; Heath-Engel HM, 2008, ONCOGENE, V27, P6419, DOI 10.1038/onc.2008.309; Hetz C, 2007, CELL DEATH DIFFER, V14, P1386, DOI 10.1038/sj.cdd.4402166; Hetz CA, 2007, ANTIOXID REDOX SIGN, V9, P2345, DOI 10.1089/ars.2007.1793; Ilieva H, 2009, J CELL BIOL, V187, P761, DOI 10.1083/jcb.200908164; Johnston JA, 2000, P NATL ACAD SCI USA, V97, P12571, DOI 10.1073/pnas.220417997; Karch CM, 2009, P NATL ACAD SCI USA, V106, P7774, DOI 10.1073/pnas.0902505106; Kato S, 2000, ACTA NEUROPATHOL, V100, P490, DOI 10.1007/s004010000226; Kieran D, 2005, J CELL BIOL, V169, P561, DOI 10.1083/jcb.200501085; Kieran D, 2007, P NATL ACAD SCI USA, V104, P20606, DOI 10.1073/pnas.0707906105; Lei K, 2003, P NATL ACAD SCI USA, V100, P2432, DOI 10.1073/pnas.0438011100; Nagley P, 2010, BBA-MOL BASIS DIS, V1802, P167, DOI 10.1016/j.bbadis.2009.09.004; Nickson P, 2007, CARDIOVASC RES, V73, P48, DOI 10.1016/j.cardiores.2006.10.001; Oh YK, 2008, J NEUROCHEM, V104, P993, DOI 10.1111/j.1471-4159.2007.05053.x; Okuno S, 2004, J NEUROSCI, V24, P7879, DOI 10.1523/JNEUROSCI.1745-04.2004; Olzmann JA, 2008, CURR MED CHEM, V15, P47; Puthalakath H, 1999, MOL CELL, V3, P287, DOI 10.1016/S1097-2765(00)80456-6; Puthalakath H, 2007, CELL, V129, P1337, DOI 10.1016/j.cell.2007.04.027; Reimertz C, 2003, J CELL BIOL, V162, P587, DOI 10.1083/jcb.200305149; Saxena S, 2009, NAT NEUROSCI, V12, P627, DOI 10.1038/nn.2297; Shaw BF, 2007, TRENDS BIOCHEM SCI, V32, P78, DOI 10.1016/j.tibs.2006.12.005; Shaw PJ, 2005, J NEUROL NEUROSUR PS, V76, P1046, DOI 10.1136/jnnp.2004.048652; Shi P, 2010, BBA-MOL BASIS DIS, V1802, P707, DOI 10.1016/j.bbadis.2010.05.008; Shibata N, 1996, DEV NEUROSCI-BASEL, V18, P492, DOI 10.1159/000111445; Soo KY, 2009, J NEUROCHEM, V108, P578, DOI 10.1111/j.1471-4159.2008.05799.x; Talbot K, 2002, POSTGRAD MED J, V78, P513, DOI 10.1136/pmj.78.923.513; Teuling E, 2008, HUM MOL GENET, V17, P2849, DOI 10.1093/hmg/ddn182; Turner BJ, 2005, J NEUROSCI, V25, P108, DOI 10.1523/JNEUROSCI.4253-04.2005; Walker AK, 2010, BRAIN, V133, P105, DOI 10.1093/brain/awp267; Wang J, 2002, NEUROBIOL DIS, V10, P128, DOI 10.1006/nbdi.2002.0498; Williams A, 2006, CURR TOP DEV BIOL, V76, P89, DOI 10.1016/S0070-2153(06)76003-3; Winklhofer KF, 2008, EMBO J, V27, P336, DOI 10.1038/sj.emboj.7601930; Woehlbier U, 2011, TRENDS BIOCHEM SCI, V36, P329, DOI 10.1016/j.tibs.2011.03.001; Zetterstrom P, 2007, P NATL ACAD SCI USA, V104, P14157, DOI 10.1073/pnas.0700477104	37	29	31	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2012	7	4							e35413	10.1371/journal.pone.0035413	http://dx.doi.org/10.1371/journal.pone.0035413			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VO	22523592	gold, Green Published			2022-12-25	WOS:000305345000065
J	Sun, HX; Li, MF; Xu, GZ; Chen, H; Jiao, JD; Tian, B; Wang, LY; Hua, YJ				Sun, Hongxing; Li, Mingfeng; Xu, Guangzhi; Chen, Huan; Jiao, Jiandong; Tian, Bing; Wang, Liangyan; Hua, Yuejin			Regulation of MntH by a Dual Mn(II)- and Fe(II)-Dependent Transcriptional Repressor (DR2539) in Deinococcus radiodurans	PLOS ONE			English	Article							EXTREME RADIORESISTANCE; BACILLUS-SUBTILIS; ESCHERICHIA-COLI; RECA PROTEIN; MANGANESE; IDENTIFICATION; EXPRESSION; ACCUMULATION; TYPHIMURIUM; TRANSPORTER	The high intracellular Mn/Fe ratio observed within the bacteria Deinococcus radiodurans may contribute to its remarkable resistance to environmental stresses. We isolated DR2539, a novel regulator of intracellular Mn/Fe homeostasis in D. radiodurans. Electrophoretic gel mobility shift assays (EMSAs) revealed that DR2539 binds specifically to the promoter of the manganese acquisition transporter (MntH) gene, and that DR0865, the only Fur homologue in D. radiodurans, cannot bind to the promoter of mntH, but it can bind to the promoter of another manganese acquisition transporter, MntABC. beta-galactosidase expression analysis indicated that DR2539 acts as a manganese- and iron-dependent transcriptional repressor. Further sequence alignment analysis revealed that DR2539 has evolved some special characteristics. Site-directed mutagenesis suggested that His98 plays an important role in the activities of DR2539, and further protein-DNA binding activity assays showed that the activity of H98Y mutants decreased dramatically relative to wild type DR2539. Our study suggests that D. radiodurans has evolved a very efficient manganese regulation mechanism that involves its high intracellular Mn/Fe ratio and permits resistance to extreme conditions.	[Sun, Hongxing; Li, Mingfeng; Xu, Guangzhi; Jiao, Jiandong; Tian, Bing; Wang, Liangyan; Hua, Yuejin] Zhejiang Univ, Chinese Minist Agr, Key Lab Nucl Agr Sci, Hangzhou 310003, Zhejiang, Peoples R China; [Sun, Hongxing; Li, Mingfeng; Xu, Guangzhi; Jiao, Jiandong; Tian, Bing; Wang, Liangyan; Hua, Yuejin] Zhejiang Univ, Inst Nucl Agr Sci, Hangzhou 310003, Zhejiang, Peoples R China; [Chen, Huan] Wenzhou Med Coll, Sch Lab Med & Life Sci, Zhejiang Prov Key Lab Med Genet, Key Lab Lab Med,Minist Educ, Wenzhou, Zhejiang, Peoples R China; [Chen, Huan] Zhejiang Inst Microbiol, Hangzhou, Zhejiang, Peoples R China	Ministry of Agriculture & Rural Affairs; Zhejiang University; Zhejiang University; Wenzhou Medical University	Sun, HX (corresponding author), Zhejiang Univ, Chinese Minist Agr, Key Lab Nucl Agr Sci, Hangzhou 310003, Zhejiang, Peoples R China.	liangyanwang@zju.edu.cn; yjhua@zju.edu.cn	Sun, Hongxing/AAV-6028-2020; Chen, Huan/CAH-8180-2022		National Natural Science Foundation of China [30830006, 31170079, 31000045, 31100058, 31070080]; Ministry of Health of China [2009ZXJ09001-034]; major project for genetically modified organisms breeding [2009ZX08009-075B]; Ministry of Agriculture of China [201103007]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Health of China; major project for genetically modified organisms breeding; Ministry of Agriculture of China(Ministry of Agriculture & Rural Affairs)	This work was supported by grants from National Natural Science Foundation of China (30830006, 31170079, 31000045, 31100058, 31070080), a major scientific and technological project for significant new drug creation from the Ministry of Health of China (2009ZXJ09001-034), a major project for genetically modified organisms breeding (2009ZX08009-075B) and a grant of Special Fund for Agroscientific Research in the Public Interest from the Ministry of Agriculture of China (201103007). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agranoff D, 1999, J EXP MED, V190, P717, DOI 10.1084/jem.190.5.717; Battista JR, 1999, TRENDS MICROBIOL, V7, P362, DOI 10.1016/S0966-842X(99)01566-8; Blasius M, 2006, MOL MICROBIOL, V60, P165, DOI 10.1111/j.1365-2958.2006.05077.x; Chen H, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001602; Chen HA, 2010, BIOCHEM BIOPH RES CO, V396, P413, DOI 10.1016/j.bbrc.2010.04.106; Chen PR, 2008, CURR OPIN CHEM BIOL, V12, P214, DOI 10.1016/j.cbpa.2007.12.010; Daly MJ, 2007, PLOS BIOL, V5, P769, DOI 10.1371/journal.pbio.0050092; Daly MJ, 2012, DNA REPAIR, V11, P12, DOI 10.1016/j.dnarep.2011.10.024; Daly MJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012570; Daly MJ, 2004, SCIENCE, V306, P1025, DOI 10.1126/science.1103185; de Almeida CB, 2002, MOL GENET GENOMICS, V268, P28, DOI 10.1007/s00438-002-0718-x; FISHER S, 1973, J BACTERIOL, V113, P1373, DOI 10.1128/JB.113.3.1373-1380.1973; Fuangthong M, 2002, P NATL ACAD SCI USA, V99, P6690, DOI 10.1073/pnas.102483199; Gao GJ, 2006, FEMS MICROBIOL LETT, V257, P195, DOI 10.1111/j.1574-6968.2006.00169.x; Guedon E, 2003, MOL MICROBIOL, V48, P495, DOI 10.1046/j.1365-2958.2003.03445.x; Horsburgh MJ, 2002, MOL MICROBIOL, V44, P1269, DOI 10.1046/j.1365-2958.2002.02944.x; Hua YJ, 2003, BIOCHEM BIOPH RES CO, V306, P354, DOI 10.1016/S0006-291X(03)00965-3; Huang LF, 2007, DNA REPAIR, V6, P167, DOI 10.1016/j.dnarep.2006.09.006; Kehres DG, 2000, MOL MICROBIOL, V36, P1085, DOI 10.1046/j.1365-2958.2000.01922.x; Kehres DG, 2002, J BACTERIOL, V184, P3151, DOI 10.1128/JB.184.12.3151-3158.2002; Kim JI, 2002, J BACTERIOL, V184, P1649, DOI 10.1128/JB.184.6.1649-1660.2002; LEIBOWITZ PJ, 1976, PHOTOCHEM PHOTOBIOL, V23, P45; Ma Z, 2009, CHEM REV, V109, P4644, DOI 10.1021/cr900077w; Makarova KS, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000955; Makui H, 2000, MOL MICROBIOL, V35, P1065, DOI 10.1046/j.1365-2958.2000.01774.x; Patzer SI, 2001, J BACTERIOL, V183, P4806, DOI 10.1128/JB.183.16.4806-4813.2001; Qian YL, 2002, J BACTERIOL, V184, P4846, DOI 10.1128/JB.184.17.4846-4856.2002; Que Q, 2000, MOL MICROBIOL, V35, P1454, DOI 10.1046/j.1365-2958.2000.01811.x; Rainey FA, 1997, INT J SYST BACTERIOL, V47, P510, DOI 10.1099/00207713-47-2-510; Shu HY, 2010, AFR J BIOTECHNOL, V9, P2742; Sun HX, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-319; Wang LY, 2008, MOL MICROBIOL, V67, P1211, DOI 10.1111/j.1365-2958.2008.06113.x	32	17	18	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2012	7	4							e35057	10.1371/journal.pone.0035057	http://dx.doi.org/10.1371/journal.pone.0035057			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VO	22523570	Green Published, Green Submitted, gold			2022-12-25	WOS:000305345000042
J	Wang, ZQ; Sturgis, EM; Guo, W; Song, XC; Zhang, FH; Xu, L; Wei, QY; Li, GJ				Wang, Zhongqiu; Sturgis, Erich M.; Guo, Wei; Song, Xicheng; Zhang, Fenghua; Xu, Li; Wei, Qingyi; Li, Guojun			Association of Combined p73 and p53 Genetic Variants with Tumor HPV16-Positive Oropharyngeal Cancer	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; HUMAN-PAPILLOMAVIRUS TYPE-16; NEVER-SMOKERS; NECK CANCERS; G4C14-TO-A4T14 POLYMORPHISM; TONSILLAR CANCER; ORAL-CANCER; E6 PROTEINS; RISK-FACTOR; CODON 72	p53 and p73 interact with human papillomavirus (HPV) E6 and E7 oncoproteins. The interplay between p53 and p73 and HPV16 may lead to deregulation of cell cycle and apoptosis, through which inflammation/immune responses control the HPV clearance and escape of immune surveillance, and subsequently contribute to tumor HPV16 status. In this case-case comparison study, HPV16 status in tumor specimens was analyzed and p53 codon 72 and p73 G4C14-to-A4T14 polymorphisms were genotyped using genomic DNA from blood of 309 oropharyngeal cancer patients. Odds ratios (ORs) and 95% confidence intervals (95% CIs) were calculated in univariate and multivariable logistic regression models to examine the association. The results from this study showed both p53 variant genotypes (Arg/Pro+Pro/Pro) and p73 variant genotypes (GC/AT+AT/AT) were significantly associated with HPV16-positive tumor in oropharyngeal cancer patients (OR, 1.9, 95% CI, 1.1-3.3 and OR, 2.1, 95% CI, 1.2-3.8, respectively), while the combined variant genotypes (p53 Pro carriers and p73 AT carriers) exhibited a significantly greater association with HPV16-positive tumor (OR, 3.2, 95% CI, 1.4-7.4), compared with combined wild-type genotypes (p53 Arg/Arg and p73 GC/GC), and the association was in a statistically significant dose-effect relationship (p = 0.001). Moreover, such association was more pronounced among several subgroups. These findings suggest that variant genotypes of p53 and p73 genes may be individually, or more likely jointly, associated with tumor HPV16-positive oropharyngeal cancer patients, particularly in never smokers. Identification of such susceptible biomarkers would greatly influence on individualized treatment for an improved prognosis.	[Wang, Zhongqiu; Sturgis, Erich M.; Guo, Wei; Song, Xicheng; Zhang, Fenghua; Xu, Li; Li, Guojun] Univ Texas MD Anderson Canc Ctr, Dept Head & Neck Surg, Houston, TX 77030 USA; [Wang, Zhongqiu] Tongji Univ, Sch Med, East Hosp, Dept Radiol, Shanghai 200092, Peoples R China; [Sturgis, Erich M.; Wei, Qingyi; Li, Guojun] Univ Texas MD Anderson Canc Ctr, Dept Epidemiol, Houston, TX 77030 USA; [Guo, Wei] Capital Med Univ, Beijing Tongren Hosp, Dept Otolaryngol Head & Neck Surg, Beijing, Peoples R China; [Song, Xicheng] Qingdao Univ, Yuhuangding Hosp, Dept Otolaryngol Head & Neck Surg, Yantai, Peoples R China; [Zhang, Fenghua] Hebei Gen Hosp, Dept Gen Surg, Shijiazhuang, Peoples R China	University of Texas System; UTMD Anderson Cancer Center; Tongji University; University of Texas System; UTMD Anderson Cancer Center; Capital Medical University; Qingdao University	Wang, ZQ (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Head & Neck Surg, Houston, TX 77030 USA.	gli@mdanderson.org	Xu, Li/B-9535-2012		National Institutes of Health (NIH) [ES011740-01]; NIH [CA135679, CA133099]; NATIONAL CANCER INSTITUTE [R03CA135679, K07CA133099] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES011740] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	Supported by National Institutes of Health (NIH) R01 grant ES011740-01 (Q. W.), NIH R03 grant CA135679 (G. L.), and NIH K07 grant CA133099 (G. L.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baez A, 2004, HEAD NECK-J SCI SPEC, V26, P778, DOI 10.1002/hed.20046; Chen X, 2008, CANCER, V113, P307; Chen XM, 2008, CARCINOGENESIS, V29, P2120, DOI 10.1093/carcin/bgn191; Dahlstrom KR, 2003, CLIN CANCER RES, V9, P2620; Das S, 2006, CANCER BIOL THER, V5, P210, DOI 10.4161/cbt.5.2.2402; Dobrossy L, 2005, CANCER METAST REV, V24, P9, DOI 10.1007/s10555-005-5044-4; Dumont P, 2003, NAT GENET, V33, P357, DOI 10.1038/ng1093; Fakhry C, 2006, J CLIN ONCOL, V24, P2606, DOI 10.1200/JCO.2006.06.1291; FAVRE A, 1986, Z MIKROSK ANAT FORSC, V100, P7; Fouret P, 1997, ARCH OTOLARYNGOL, V123, P513; Gillison ML, 2008, JNCI-J NATL CANCER I, V100, P407, DOI 10.1093/jnci/djn025; Gillison ML, 2000, JNCI-J NATL CANCER I, V92, P709, DOI 10.1093/jnci/92.9.709; Guan XX, 2010, CLIN CANCER RES, V16, P1416, DOI 10.1158/1078-0432.CCR-09-2877; Haber DA, 1998, LANCET, V351, P1; Hammarstedt L, 2006, INT J CANCER, V119, P2620, DOI 10.1002/ijc.22177; Haughey BH, 2011, HEAD NECK-J SCI SPEC, V33, P1683, DOI 10.1002/hed.21669; Helton ES, 2007, J CELL BIOCHEM, V100, P883, DOI 10.1002/jcb.21091; Herrero R, 2003, JNCI-J NATL CANCER I, V95, P1772, DOI [10.1093/jnci/djg/107, 10.1093/jnci/djg107]; Huang CC, 1998, MODERN PATHOL, V11, P971; Ji XM, 2008, CARCINOGENESIS, V29, P875, DOI 10.1093/carcin/bgn039; Ji XM, 2009, CANCER-AM CANCER SOC, V115, P1660, DOI 10.1002/cncr.24184; Jost CA, 1997, NATURE, V389, P191, DOI 10.1038/38298; Kaghad M, 1997, CELL, V90, P809, DOI 10.1016/S0092-8674(00)80540-1; Koch WM, 1999, LARYNGOSCOPE, V109, P1544, DOI 10.1097/00005537-199910000-00002; Koskinen WJ, 2003, INT J CANCER, V107, P401, DOI 10.1002/ijc.11381; Li FL, 2010, CANCER-AM CANCER SOC, V116, P2350, DOI 10.1002/cncr.25072; Li GJ, 2004, CARCINOGENESIS, V25, P1911, DOI 10.1093/carcin/bgh197; Li W, 2003, INT J CANCER, V106, P553, DOI 10.1002/ijc.11261; Lindel K, 2001, CANCER-AM CANCER SOC, V92, P805, DOI 10.1002/1097-0142(20010815)92:4<805::AID-CNCR1386>3.0.CO;2-9; Melino G, 2002, NAT REV CANCER, V2, P605, DOI 10.1038/nrc861; Melino G, 2003, TRENDS BIOCHEM SCI, V28, P663, DOI 10.1016/j.tibs.2003.10.004; Mellin H, 2000, INT J CANCER, V89, P300, DOI 10.1002/1097-0215(20000520)89:3<300::AID-IJC14>3.0.CO;2-G; Munger K, 2002, VIRUS RES, V89, P213, DOI 10.1016/S0168-1702(02)00190-9; Park JS, 2001, INT J CANCER, V91, P822, DOI 10.1002/1097-0215(200002)9999:9999<::AID-IJC1130>3.0.CO;2-0; Perrone F, 2007, CANCER, V109, P2461, DOI 10.1002/cncr.22702; Phillips AC, 2001, APOPTOSIS, V6, P173, DOI 10.1023/A:1011332625740; Pintos J, 1999, CANCER-AM CANCER SOC, V85, P1903, DOI 10.1002/(SICI)1097-0142(19990501)85:9<1903::AID-CNCR4>3.0.CO;2-6; Rich JT, 2011, LARYNGOSCOPE, V121, P2381, DOI 10.1002/lary.21406; Ritchie JM, 2003, INT J CANCER, V104, P336, DOI 10.1002/ijc.10960; SCHEFFNER M, 1990, CELL, V63, P1129, DOI 10.1016/0092-8674(90)90409-8; SCHEFFNER M, 1993, CELL, V75, P495, DOI 10.1016/0092-8674(93)90384-3; Smith EM, 2004, INT J CANCER, V108, P766, DOI 10.1002/ijc.11633; Storey A, 1998, NATURE, V393, P229, DOI 10.1038/30400; Thomas M, 1999, MOL CELL BIOL, V19, P1092; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; VOKES EE, 1993, NEW ENGL J MED, V328, P184, DOI 10.1056/NEJM199301213280306; WERNESS BA, 1990, SCIENCE, V248, P76, DOI 10.1126/science.2157286	47	13	14	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2012	7	4							e35522	10.1371/journal.pone.0035522	http://dx.doi.org/10.1371/journal.pone.0035522			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VO	22523600	Green Published, Green Submitted, gold			2022-12-25	WOS:000305345000074
J	Garmyn, A; Van Rooij, P; Pasmans, F; Hellebuyck, T; Van den Broeck, W; Haesebrouck, F; Martel, A				Garmyn, An; Van Rooij, Pascale; Pasmans, Frank; Hellebuyck, Tom; Van den Broeck, Wim; Haesebrouck, Freddy; Martel, An			Waterfowl: Potential Environmental Reservoirs of the Chytrid Fungus Batrachochytrium dendrobatidis	PLOS ONE			English	Article							AMPHIBIAN DECLINES; CHYTRIDIOMYCOSIS; PATHOGENESIS; DISEASE	Infections with Batrachochytrium dendrobatidis (B. dendrobatidis), the causal agent of chytridiomycosis, have been shown to play an important role in the decline of amphibians worldwide. Spread of the fungus is poorly understood. Bird movement might possibly contribute to the spread of B. dendrobatidis in the environment. Therefore, 397 wild geese in Belgium were screened for presence of B. dendrobatidis on their toes using real-time quantitative PCR (qPCR). In addition, chemotaxis towards, adhesion, survival after desiccation and proliferation of B. dendrobatidis on keratinous toe scales from waterfowl were examined in vitro. qPCR revealed that 76 geese (15%) were positive for B. dendrobatidis. Results of the in vitro tests showed that B. dendrobatidis is attracted to the keratinous toes of aquatic birds on which they can adhere and even proliferate. However, desiccation is poorly tolerated. This suggests waterfowl are potential environmental reservoirs for B. dendrobatidis.	[Garmyn, An; Van Rooij, Pascale; Pasmans, Frank; Hellebuyck, Tom; Haesebrouck, Freddy; Martel, An] Univ Ghent, Fac Vet Med, Dept Pathol Bacteriol & Avian Dis, Merelbeke, Belgium; [Van den Broeck, Wim] Univ Ghent, Fac Vet Med, Dept Morphol, Merelbeke, Belgium	Ghent University; Ghent University	Garmyn, A (corresponding author), Univ Ghent, Fac Vet Med, Dept Pathol Bacteriol & Avian Dis, Merelbeke, Belgium.	an.garmyn@UGent.be	Pasmans, Frank/D-3667-2014; Haesebrouck, Freddy/M-3857-2014; Martel, An/D-3713-2014	Haesebrouck, Freddy/0000-0002-1709-933X; 				Bellrose FC, 1982, WILSON B, V93, P121; Berger L, 2004, AUST VET J, V82, P434, DOI 10.1111/j.1751-0813.2004.tb11137.x; Berger Lee, 2009, Amphibian Biology, V8, P2986; BFIS, 2012, BELGIAN FORUM INVASI; Daszak P, 2004, HERPETOL J, V14, P201; Farrer RA, 2011, P NATL ACAD SCI USA, V108, P18732, DOI 10.1073/pnas.1111915108; Hyla, 2012, AMF REPT NAT; Johnson ML, 2003, EMERG INFECT DIS, V9, P922; Johnson ML, 2005, DIS AQUAT ORGAN, V65, P181, DOI 10.3354/dao065181; Lips KR, 2006, P NATL ACAD SCI USA, V103, P3165, DOI 10.1073/pnas.0506889103; Moss AS, 2008, MYCOLOGIA, V100, P1, DOI 10.3852/mycologia.100.1.1; Pessier AP, 1999, J VET DIAGN INVEST, V11, P194, DOI 10.1177/104063879901100219; Picco AM, 2008, CONSERV BIOL, V22, P1582, DOI 10.1111/j.1523-1739.2008.01025.x; POWELL MJ, 1993, MYCOLOGIA, V85, P1, DOI 10.2307/3760471; Shapard EJ, 2011, MYCOPATHOLOGIA; Stuart SN, 2004, SCIENCE, V306, P1783, DOI 10.1126/science.1103538; Van Rooij P, 2010, ATLA-ALTERN LAB ANIM, V38, P519, DOI 10.1177/026119291003800614; Voyles J, 2011, MICROBES INFECT, V13, P25, DOI 10.1016/j.micinf.2010.09.015; Voyles J, 2009, SCIENCE, V326, P582, DOI 10.1126/science.1176765; Weldon C, 2004, EMERG INFECT DIS, V10, P2100, DOI 10.3201/eid1012.030804	20	81	81	0	76	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2012	7	4							e35038	10.1371/journal.pone.0035038	http://dx.doi.org/10.1371/journal.pone.0035038			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UT	22514705	Green Published, gold, Green Submitted			2022-12-25	WOS:000305341600111
J	Xu, N; Li, Y; Zhao, YT; Guo, L; Fang, YY; Zhao, JH; Wang, XJ; Huang, L; Guo, HS				Xu, Ning; Li, Yan; Zhao, Ying-Tao; Guo, Li; Fang, Yuan-Yuan; Zhao, Jian-Hua; Wang, Xiu-Jie; Huang, Li; Guo, Hui-Shan			Identification and Characterization of Small RNAs in the Hyperthermophilic Archaeon Sulfolobus solfataricus	PLOS ONE			English	Article							NONCODING RNAS; ACQUIRED-RESISTANCE; ANTIVIRAL DEFENSE; REGULATORY ROLES; IMMUNE-SYSTEM; CRISPR RNAS; MICRORNAS; BIOGENESIS; COMPLEX; PROTEIN	The term RNA silencing (RNA interference, RNAi) describes a set of mechanisms that regulate gene expression in eukaryotes. Small interfering RNAs (siRNA) and microRNAs (miRNAs) are two major types of RNAi-associated small RNAs (smRNAs) found in most eukaryotic organisms. Despite the presence of a plethora of non-coding RNAs longer than 50-nucleotide (nt) in length in various species of Archaea, little is known about smRNAs in archaea that resemble the 20-24-nt long smRNAs found in eukaryotes, which have been implicated in the post-transcriptional control of gene expression. Here, we report the finding of a large number of smRNAs approximatelly 20-nt in length, including phased smRNAs and potential miRNAs, from the hyperthermophilic archaeon Sulfolobus solfataricus p2 (Ssp2) based on deep sequencing. The expression of some of the miRNA candidates in Ssp2 was confirmed. Consistent with the Ssp2 hyperthermophilic properties, we found that higher temperatures more efficiently induced the production of the miRNA candidates in an in vitro system using the putative foldback precursor transcripts incubated with Ssp2 extract. Although we initially predicted putative target genes of some miRNA candidates, further analysis mapped the cleavage sites downstream of the miRNA candidate complementary regions, similar to those involved in plant miRNA-mediated TAS transcript cleavage. We also identified smRNAs from clustered, regularly interspaced, short palindromic repeat (CRISPR) loci, which play important roles in prokaryotic microbial defense systems. Archaea represent a unique life form next to Bacteria and Eukarya, and our results may provide a useful resource for further in-depth study on the regulation and evolution of smRNAs in this special organism.	[Xu, Ning; Li, Yan; Zhao, Ying-Tao; Fang, Yuan-Yuan; Zhao, Jian-Hua; Wang, Xiu-Jie; Guo, Hui-Shan] Chinese Acad Sci, Inst Microbiol, State Key Lab Plant Genom, Natl Ctr Plant Gene Res, Beijing, Peoples R China; [Guo, Li; Huang, Li] Chinese Acad Sci, Inst Microbiol, State Key Lab Microbial Resources, Beijing, Peoples R China; [Xu, Ning; Fang, Yuan-Yuan; Zhao, Jian-Hua] Chinese Acad Sci, Grad Univ, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Microbiology, CAS; Chinese Academy of Sciences; Institute of Microbiology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Xu, N (corresponding author), Chinese Acad Sci, Inst Microbiol, State Key Lab Plant Genom, Natl Ctr Plant Gene Res, Beijing, Peoples R China.	guohs@im.ac.cn	Zhao, Ying-Tao/L-2288-2016; Wang, Xiu-Jie/L-1312-2019	Zhao, Yingtao/0000-0003-3748-8428; Zhao, Jian-Hua/0000-0003-2554-1930	National Science Foundation of China [31101423]; Chinese Academy of Sciences (Knowledge Innovation Program) [KSCX2-EW-N-06]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences (Knowledge Innovation Program)(Knowledge Innovation Program of the Chinese Academy of SciencesChinese Academy of Sciences)	This research was supported by grants from the National Science Foundation of China (grant 31101423) and the Chinese Academy of Sciences (Knowledge Innovation Program (KSCX2-EW-N-06)). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen E, 2005, CELL, V121, P207, DOI 10.1016/j.cell.2005.04.004; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Baulcombe D, 2004, NATURE, V431, P356, DOI 10.1038/nature02874; Borsani O, 2005, CELL, V123, P1279, DOI 10.1016/j.cell.2005.11.035; Bourc'his D, 2010, SCIENCE, V330, P617, DOI 10.1126/science.1194776; Brouns SJJ, 2008, SCIENCE, V321, P960, DOI 10.1126/science.1159689; Carte J, 2008, GENE DEV, V22, P3489, DOI 10.1101/gad.1742908; Deltcheva E, 2011, NATURE, V471, P602, DOI 10.1038/nature09886; Dennis PP, 2005, CURR OPIN MICROBIOL, V8, P685, DOI 10.1016/j.mib.2005.10.013; Du TT, 2005, DEVELOPMENT, V132, P4645, DOI 10.1242/dev.02070; Edgell DR, 1997, CELL, V89, P995, DOI 10.1016/S0092-8674(00)80285-8; Felippes FF, 2009, EMBO REP, V10, P264, DOI 10.1038/embor.2008.247; Girard A, 2006, NATURE, V442, P199, DOI 10.1038/nature04917; Godde JS, 2006, J MOL EVOL, V62, P718, DOI 10.1007/s00239-005-0223-z; GOGARTEN JP, 1989, Z NATURFORSCH C, V44, P641; Griffiths-Jones S, 2005, NUCLEIC ACIDS RES, V33, pD121, DOI 10.1093/nar/gki081; Haft DH, 2005, PLOS COMPUT BIOL, V1, P474, DOI 10.1371/journal.pcbi.0010060; Hale C, 2008, RNA, V14, P2572, DOI 10.1261/rna.1246808; Hale CR, 2012, MOL CELL, V45, P292, DOI 10.1016/j.molcel.2011.10.023; Hale CR, 2009, CELL, V139, P945, DOI 10.1016/j.cell.2009.07.040; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; Horvath P, 2008, J BACTERIOL, V190, P1401, DOI 10.1128/JB.01415-07; Horvath P, 2010, SCIENCE, V327, P167, DOI 10.1126/science.1179555; IWABE N, 1989, P NATL ACAD SCI USA, V86, P9355, DOI 10.1073/pnas.86.23.9355; Jones-Rhoades MW, 2006, ANNU REV PLANT BIOL, V57, P19, DOI 10.1146/annurev.arplant.57.032905.105218; Jones-Rhoades MW, 2004, MOL CELL, V14, P787, DOI 10.1016/j.molcel.2004.05.027; Khvorova A, 2003, CELL, V115, P209, DOI 10.1016/S0092-8674(03)00801-8; Lapidot M, 2006, EMBO REP, V7, P1216, DOI 10.1038/sj.embor.7400857; Lau NC, 2001, SCIENCE, V294, P858, DOI 10.1126/science.1065062; Lee RC, 2001, SCIENCE, V294, P862, DOI 10.1126/science.1065329; Li Y, 2010, J GENET GENOMICS, V37, P493, DOI 10.1016/S1673-8527(09)60069-2; Lillestol Reidun K., 2006, Archaea, V2, P59, DOI 10.1155/2006/542818; Lillestol RK, 2009, MOL MICROBIOL, V72, P259, DOI 10.1111/j.1365-2958.2009.06641.x; Lintner NG, 2011, J BIOL CHEM, V286, P21643, DOI 10.1074/jbc.M111.238485; Lintner NG, 2011, J MOL BIOL, V405, P939, DOI 10.1016/j.jmb.2010.11.019; Llave C, 2002, SCIENCE, V297, P2053, DOI 10.1126/science.1076311; Londei P, 2005, FEMS MICROBIOL REV, V29, P185, DOI 10.1016/j.femsre.2004.10.002; Makarova KS, 2006, BIOL DIRECT, V1, DOI 10.1186/1745-6150-1-7; Makarova KS, 2009, BIOL DIRECT, V4, DOI 10.1186/1745-6150-4-29; Mallory AC, 2008, TRENDS PLANT SCI, V13, P359, DOI 10.1016/j.tplants.2008.03.007; Manica A, 2011, MOL MICROBIOL, V80, P481, DOI 10.1111/j.1365-2958.2011.07586.x; Martianov I, 2007, NATURE, V445, P666, DOI 10.1038/nature05519; Mcafee JG, 1995, BIOCHEMISTRY, P34; Meister G, 2004, NATURE, V431, P343, DOI 10.1038/nature02873; Molnar A, 2007, NATURE, V447, P1126, DOI 10.1038/nature05903; Montgomery TA, 2008, CELL, V133, P128, DOI 10.1016/j.cell.2008.02.033; Montgomery TA, 2008, P NATL ACAD SCI USA, V105, P20055, DOI 10.1073/pnas.0810241105; Ohtani N, 2004, NUCLEIC ACIDS RES, V32, P5809, DOI 10.1093/nar/gkh917; Omer AD, 2000, SCIENCE, V288, P517, DOI 10.1126/science.288.5465.517; Park W, 2002, CURR BIOL, V12, P1484, DOI 10.1016/S0960-9822(02)01017-5; Peragine A, 2004, GENE DEV, V18, P2368, DOI 10.1101/gad.1231804; Rajagopalan R, 2006, GENE DEV, V20, P3407, DOI 10.1101/gad.1476406; Reinhart BJ, 2002, GENE DEV, V16, P1616, DOI 10.1101/gad.1004402; Rubio-Somoza I, 2009, CURR OPIN PLANT BIOL, V12, P622, DOI 10.1016/j.pbi.2009.07.003; Schwarz DS, 2003, CELL, V115, P199, DOI 10.1016/S0092-8674(03)00759-1; Song JJ, 2004, SCIENCE, V305, P1434, DOI 10.1126/science.1102514; Sorek R, 2008, NAT REV MICROBIOL, V6, P181, DOI 10.1038/nrmicro1793; Tang TH, 2005, MOL MICROBIOL, V55, P469, DOI 10.1111/j.1365-2958.2004.04428.x; Tang TH, 2002, P NATL ACAD SCI USA, V99, P7536, DOI 10.1073/pnas.112047299; Tyson GW, 2008, ENVIRON MICROBIOL, V10, P200, DOI 10.1111/j.1462-2920.2007.01444.x; van der Oost J, 2009, CELL, V139, P863, DOI 10.1016/j.cell.2009.11.018; Vaucheret H, 2006, GENE DEV, V20, P759, DOI 10.1101/gad.1410506; Vaucheret H, 2004, GENE DEV, V18, P1187, DOI 10.1101/gad.1201404; Voinnet O, 2009, CELL, V136, P669, DOI 10.1016/j.cell.2009.01.046; Wang H, 2011, PLANT J, pno; Wang XJ, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-9-r65; Wang XJ, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-4-r30; WOESE CR, 1990, SYST APPL MICROBIOL, V13, P19, DOI 10.1016/S0723-2020(11)80175-X; Wurtzel O, 2010, GENOME RES, V20, P133, DOI 10.1101/gr.100396.109; Zago MA, 2005, MOL MICROBIOL, V55, P1812, DOI 10.1111/j.1365-2958.2005.04505.x; Zhang HD, 2004, CELL, V118, P57, DOI 10.1016/j.cell.2004.06.017; Zhang J, 2012, MOL CELL, V45, P303, DOI 10.1016/j.molcel.2011.12.013; Zhao T, 2007, GENE DEV, V21, P1190, DOI 10.1101/gad.1543507; ZILLIG W, 1994, SYST APPL MICROBIOL, V16, P609; ZILLIG W, 1989, CAN J MICROBIOL, V35, P73, DOI 10.1139/m89-011; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	78	13	14	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2012	7	4							e35306	10.1371/journal.pone.0035306	http://dx.doi.org/10.1371/journal.pone.0035306			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UT	22514725	Green Published, gold, Green Submitted			2022-12-25	WOS:000305341600130
J	Fieldhouse, RJ; Jorgensen, R; Lugo, MR; Merrill, AR				Fieldhouse, Robert J.; Jorgensen, Rene; Lugo, Miguel R.; Merrill, A. Rod			The 1.8 angstrom Cholix Toxin Crystal Structure in Complex with NAD(+) and Evidence for a New Kinetic Model	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PSEUDOMONAS-AERUGINOSA EXOTOXIN; NICOTINAMIDE ADENINE-DINUCLEOTIDE; ADP-RIBOSYLATING FACTOR; CATALYTIC MECHANISM; VIBRIO-CHOLERAE; ACTIVE-SITE; DOMAIN-III; INHIBITORS; GENERATION; DISCOVERY	Certain Vibrio cholerae strains produce cholix, a potent protein toxin that has diphthamide-specific ADP-ribosyltransferase activity against eukaryotic elongation factor 2. Here we present a 1.8 angstrom crystal structure of cholix in complex with its natural substrate, nicotinamide adenine dinucleotide (NAD(+)). We also substituted hallmark catalytic residues by site-directed mutagenesis and analyzed both NAD(+) binding and ADP-ribosyltransferase activity using a fluorescence-based assay. These data are the basis for a new kinetic model of cholix toxin activity. Further, the new structural data serve as a reference for continuing inhibitor development for this toxin class.	[Fieldhouse, Robert J.; Lugo, Miguel R.; Merrill, A. Rod] Univ Guelph, Dept Mol & Cellular Biol, Guelph, ON N1G 2W1, Canada; [Jorgensen, Rene] Statens Serum Inst, Dept Microbiol Diagnost, DK-2300 Copenhagen S, Denmark	University of Guelph; Statens Serum Institut	Merrill, AR (corresponding author), Univ Guelph, Dept Mol & Cellular Biol, Sci Complex,488 Gordon St, Guelph, ON N1G 2W1, Canada.	rmerrill@uoguelph.ca	Merrill, Rod/M-8313-2014; Jørgensen, René/P-5619-2014	Jørgensen, René/0000-0003-0672-466X	Natural Sciences and Engineering Research Council; Canadian Institutes of Health Research; Cystic Fibrosis Canada; Canadian Institutes of Health Research, Cystic Fibrosis Canada; Human Frontier Science Program; Carlsberg-fondet	Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Cystic Fibrosis Canada; Canadian Institutes of Health Research, Cystic Fibrosis Canada(Canadian Institutes of Health Research (CIHR)); Human Frontier Science Program(Human Frontier Science Program); Carlsberg-fondet(Carlsberg Foundation)	Supported by the Natural Sciences and Engineering Research Council.; Supported by the Canadian Institutes of Health Research and Carlsberg-fondet.; Supported by Cystic Fibrosis Canada.; Supported by the Canadian Institutes of Health Research, Cystic Fibrosis Canada, and the Human Frontier Science Program. To whom correspondence should be addressed: Dept. of Molecular and Cellular Biology, University of Guelph, Science Complex, 488 Gordon St., Guelph, Ontario N1G 2W1, Canada. Tel.: 519-824-4120 (Ext. 53806); Fax: 519-837-1802; E-mail: rmerrill@uoguelph.ca.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Armstrong S, 2004, BIOCHEMISTRY-US, V43, P183, DOI 10.1021/bi034772u; Armstrong S, 2002, J BIOL CHEM, V277, P46669, DOI 10.1074/jbc.M206916200; Armstrong S, 2001, ANAL BIOCHEM, V292, P26, DOI 10.1006/abio.2001.5052; Bag PK, 2008, APPL ENVIRON MICROB, V74, P5635, DOI 10.1128/AEM.00029-08; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Beattie BK, 1999, J BIOL CHEM, V274, P15646, DOI 10.1074/jbc.274.22.15646; Beattie BK, 1996, BIOCHEMISTRY-US, V35, P15134, DOI 10.1021/bi961985t; Bell CE, 1997, ADV EXP MED BIOL, V419, P35; Cegelski L, 2008, NAT REV MICROBIOL, V6, P17, DOI 10.1038/nrmicro1818; Choudhary S, 2011, DRUG DISCOV TODAY, V16, P495, DOI 10.1016/j.drudis.2011.04.003; Costantino G, 2001, J MED CHEM, V44, P3786, DOI 10.1021/jm010116l; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Deng Q, 2008, ANNU REV MICROBIOL, V62, P271, DOI 10.1146/annurev.micro.62.081307.162848; Dunn D, 2007, BIOORG MED CHEM LETT, V17, P542, DOI 10.1016/j.bmcl.2006.10.010; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans Charles, 2010, BMC Chemical Biology, V10, P2, DOI 10.1186/1472-6769-10-2; Evans HR, 2003, J BIOL CHEM, V278, P45924, DOI 10.1074/jbc.M307719200; Fraser CM, 2005, ANNU REV MED, V56, P459, DOI 10.1146/annurev.med.56.062904.144853; Han S, 1999, NAT STRUCT BIOL, V6, P932, DOI 10.1038/13300; Hattori K, 2004, J MED CHEM, V47, P4151, DOI 10.1021/jm0499256; Heifets A, 2010, J MOL GRAPH MODEL, V29, P93, DOI 10.1016/j.jmgm.2010.05.005; Ishida J, 2006, BIOORGAN MED CHEM, V14, P1378, DOI 10.1016/j.bmc.2005.09.061; Jorgensen R, 2005, NATURE, V436, P979, DOI 10.1038/nature03871; Jorgensen R, 2008, EMBO REP, V9, P802, DOI 10.1038/embor.2008.90; Jorgensen R, 2008, J BIOL CHEM, V283, P10671, DOI 10.1074/jbc.M710008200; Kinoshita T, 2004, FEBS LETT, V556, P43, DOI [10.1016/S0014-5793(03)01362-0, 10.5940/jcrsj.46.421]; Kirby CA, 2012, ACTA CRYSTALLOGR F, V68, P115, DOI 10.1107/S1744309111051219; Kuppuraj G, 2011, J PHYS CHEM B, V115, P7932, DOI 10.1021/jp1118663; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LORY S, 1980, INFECT IMMUN, V28, P494; Malabanan MM, 2010, CURR OPIN STRUC BIOL, V20, P702, DOI 10.1016/j.sbi.2010.09.005; Margarit SM, 2006, STRUCTURE, V14, P1219, DOI 10.1016/j.str.2006.05.022; Maurer B, 2011, MOL BIOSYST, V7, P799, DOI 10.1039/c0mb00151a; Mohammadi F, 2001, BIOCHEMISTRY-US, V40, P10273, DOI 10.1021/bi011035u; Morlon-Guyot J, 2009, INFECT IMMUN, V77, P3090, DOI 10.1128/IAI.01390-08; Novikov FN, 2009, J MOL MODEL, V15, P1337, DOI 10.1007/s00894-009-0497-y; O'Neal CJ, 2005, SCIENCE, V309, P1093, DOI 10.1126/science.1113398; OGATA M, 1990, J BIOL CHEM, V265, P20678; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pastan I, 2007, ANNU REV MED, V58, P221, DOI 10.1146/annurev.med.58.070605.115320; Pautsch A, 2005, EMBO J, V24, P3670, DOI 10.1038/sj.emboj.7600813; Purdy A, 2005, J BACTERIOL, V187, P2992, DOI 10.1128/JB.187.9.2992-3001.2005; Purdy AE, 2010, ENV MICROBIOL REP, V2, P198, DOI 10.1111/j.1758-2229.2010.00139.x; Ritter H, 2003, BIOCHEMISTRY-US, V42, P10155, DOI 10.1021/bi034625w; Ruf A, 1998, BIOCHEMISTRY-US, V37, P3893, DOI 10.1021/bi972383s; Sarnovsky R, 2010, CANCER IMMUNOL IMMUN, V59, P737, DOI 10.1007/s00262-009-0794-4; Stierand K, 2006, BIOINFORMATICS, V22, P1710, DOI 10.1093/bioinformatics/btl150; Sundriyal A, 2009, J BIOL CHEM, V284, P28713, DOI 10.1074/jbc.M109.043018; Tsuge H, 2003, J MOL BIOL, V325, P471, DOI 10.1016/S0022-2836(02)01247-0; Turgeon Z, 2011, ANTIMICROB AGENTS CH, V55, P983, DOI 10.1128/AAC.01164-10; Turgeon Z, 2009, FEMS MICROBIOL LETT, V300, P97, DOI 10.1111/j.1574-6968.2009.01777.x; Vagin AA, 2004, ACTA CRYSTALLOGR D, V60, P2184, DOI 10.1107/S0907444904023510; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; Wedekind JE, 2001, J MOL BIOL, V314, P823, DOI 10.1006/jmbi.2001.5195; Yamada K, 2006, ANAL BIOCHEM, V352, P282, DOI 10.1016/j.ab.2006.02.017; Yang HY, 2007, CELL, V130, P1095, DOI 10.1016/j.cell.2007.07.035; Yates SP, 2001, J BIOL CHEM, V276, P35029, DOI 10.1074/jbc.M105002200	58	18	18	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 15	2012	287	25					21176	21188		10.1074/jbc.M111.337311	http://dx.doi.org/10.1074/jbc.M111.337311			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974FQ	22535961	Green Published, hybrid			2022-12-25	WOS:000306416800038
J	Nishimori, H; Ehata, S; Suzuki, HI; Katsuno, Y; Miyazono, K				Nishimori, Hikaru; Ehata, Shogo; Suzuki, Hiroshi I.; Katsuno, Yoko; Miyazono, Kohei			Prostate Cancer Cells and Bone Stromal Cells Mutually Interact with Each Other through Bone Morphogenetic Protein-mediated Signals	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SONIC HEDGEHOG; INDIAN HEDGEHOG; I RECEPTOR; GROWTH; METASTASIS; EXPRESSION; MODEL; DIFFERENTIATION; INHIBITOR; APOPTOSIS	Functional interactions between cancer cells and the bone microenvironment contribute to the development of bone metastasis. Although the bone metastasis of prostate cancer is characterized by increased ossification, the molecular mechanisms involved in this process are not fully understood. Here, the roles of bone morphogenetic proteins (BMPs) in the interactions between prostate cancer cells and bone stromal cells were investigated. In human prostate cancer LNCaP cells, BMP-4 induced the production of Sonic hedgehog (SHH) through a Smad-dependent pathway. In mouse stromal MC3T3-E1 cells, SHH up-regulated the expression of activin receptor IIB (ActR-IIB) and Smad1, which in turn enhanced BMP-responsive reporter activities in these cells. The combined stimulation with BMP-4 and SHH of MC3T3-E1 cells cooperatively induced the expression of osteoblastic markers, including alkaline phosphatase, bone sialoprotein, collagen type II alpha 1, and osteocalcin. When MC3T3-E1 cells and LNCaP cells were co-cultured, the osteoblastic differentiation of MC3T3-E1 cells, which was induced by BMP-4, was accelerated by SHH from LNCaP cells. Furthermore, LNCaP cells and BMP-4 cooperatively induced the production of growth factors, including fibroblast growth factor (FGF)-2 and epidermal growth factor (EGF) in MC3T3-E1 cells, and these may promote the proliferation of LNCaP cells. Taken together, our findings suggest that BMPs provide favorable circumstances for the survival of prostate cancer cells and the differentiation of bone stromal cells in the bone microenvironment, possibly leading to the osteoblastic metastasis of prostate cancer.	[Nishimori, Hikaru; Ehata, Shogo; Suzuki, Hiroshi I.; Katsuno, Yoko; Miyazono, Kohei] Univ Tokyo, Dept Mol Pathol, Grad Sch Med, Bunkyo Ku, Tokyo 1130033, Japan	University of Tokyo	Ehata, S (corresponding author), Univ Tokyo, Dept Mol Pathol, Grad Sch Med, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	ehata-jun@umin.ac.jp; miyazono@m.u-tokyo.ac.jp		Ehata, Shogo/0000-0002-6740-9391; Suzuki, Hiroshi/0000-0003-4682-5086	KAKENHI from Ministry of Education, Culture, Sports, Science, and Technology (MEXT), Japan; KAKENHI from the Japan Society for the Promotion of Science; Grants-in-Aid for Scientific Research [22112002] Funding Source: KAKEN	KAKENHI from Ministry of Education, Culture, Sports, Science, and Technology (MEXT), Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); KAKENHI from the Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a KAKENHI (grant-in-aid for scientific research) on Innovative Areas (Integrative Research on Cancer Microenvironment Network) from the Ministry of Education, Culture, Sports, Science, and Technology (MEXT), Japan (to K. M.). This work was also supported by a KAKENHI (grant-in-aid for Young Scientists) from the Japan Society for the Promotion of Science (to S. E.).	ACHBAROU A, 1994, CANCER RES, V54, P2372; Andresen C., 2003, Journal of Musculoskeletal & Neuronal Interactions, V3, P148; BITGOOD MJ, 1995, DEV BIOL, V172, P126, DOI 10.1006/dbio.1995.0010; Buijs JT, 2007, AM J PATHOL, V171, P1047, DOI 10.2353/ajpath.2007.070168; Cheng L, 1996, J NATL CANCER I, V88, P607, DOI 10.1093/jnci/88.9.607; Culig Z, 1996, PROSTATE, V28, P392, DOI 10.1002/(SICI)1097-0045(199606)28:6<392::AID-PROS9>3.0.CO;2-C; Dai JL, 2005, CANCER RES, V65, P8274, DOI 10.1158/0008-5472.CAN-05-1891; di Magliano MP, 2003, NAT REV CANCER, V3, P903, DOI 10.1038/nrc1229; Ehata S, 2011, ONCOGENE, V30, P1693, DOI 10.1038/onc.2010.546; Ehata S, 2007, CANCER RES, V67, P9694, DOI 10.1158/0008-5472.CAN-07-1522; Ehata S, 2007, CANCER SCI, V98, P127, DOI 10.1111/j.1349-7006.2006.00357.x; Feeley BT, 2006, BONE, V38, P154, DOI 10.1016/j.bone.2005.07.015; Feeley BT, 2005, J BONE MINER RES, V20, P2189, DOI 10.1359/JBMR.050802; Fizazi K, 2003, CLIN CANCER RES, V9, P2587; Grimsrud CD, 2001, J ORTHOPAED RES, V19, P18, DOI 10.1016/S0736-0266(00)00017-6; Hamdy FC, 1997, CANCER RES, V57, P4427; Hatziapostolou M, 2006, J BIOL CHEM, V281, P32217, DOI 10.1074/jbc.M607104200; Hoshino Y, 2011, J BIOCHEM, V149, P55, DOI 10.1093/jb/mvq114; Ibrahim T, 2010, CANCER-AM CANCER SOC, V116, P1406, DOI 10.1002/cncr.24896; Jung K, 2004, INT J CANCER, V111, P783, DOI 10.1002/ijc.20314; Kamiya Y, 2010, J BIOL CHEM, V285, P30804, DOI 10.1074/jbc.M110.166140; Kwon H, 2010, J TISSUE ENG REGEN M, V4, P590, DOI 10.1002/term.268; LANG SH, 1995, PROSTATE, V27, P287, DOI 10.1002/pros.2990270508; LAUFER E, 1994, CELL, V79, P993, DOI 10.1016/0092-8674(94)90030-2; Masuda H, 2003, PROSTATE, V54, P268, DOI 10.1002/pros.10193; Miyazono K, 2004, ONCOGENE, V23, P4232, DOI 10.1038/sj.onc.1207131; Miyazono K, 2010, J BIOCHEM, V147, P35, DOI 10.1093/jb/mvp148; Morikawa M, 2011, NUCLEIC ACIDS RES, V39, P8712, DOI 10.1093/nar/gkr572; Morrissey C, 2010, NEOPLASIA, V12, P192, DOI 10.1593/neo.91836; Mundy GR, 2002, NAT REV CANCER, V2, P584, DOI 10.1038/nrc867; Murtaugh LC, 1999, GENE DEV, V13, P225, DOI 10.1101/gad.13.2.225; Nagano Y, 2010, J BIOCHEM, V147, P545, DOI 10.1093/jb/mvp202; Nemeth JA, 1999, CANCER RES, V59, P1987; Nishimura R, 2012, J BIOCHEM, V151, P247, DOI 10.1093/jb/mvs004; Roodman GD, 2004, NEW ENGL J MED, V350, P1655, DOI 10.1056/NEJMra030831; Sagawa M, 2008, CANCER SCI, V99, P1820, DOI 10.1111/j.1349-7006.2008.00872.x; Seki K, 2004, J BIOL CHEM, V279, P18544, DOI 10.1074/jbc.M311592200; Sherwood ER, 1998, BRIT J CANCER, V77, P855, DOI 10.1038/bjc.1998.142; Spinella-Jaegle S, 2001, J CELL SCI, V114, P2085; Yang SX, 2005, CANCER RES, V65, P5769, DOI 10.1158/0008-5472.CAN-05-0289; Yuasa T, 2002, J CELL PHYSIOL, V193, P225, DOI 10.1002/jcp.10166; Zhang DH, 2003, J BONE MINER RES, V18, P1593, DOI 10.1359/jbmr.2003.18.9.1593; Zunich SM, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-12	43	32	34	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 8	2012	287	24					20037	20046		10.1074/jbc.M112.353094	http://dx.doi.org/10.1074/jbc.M112.353094			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974FB	22532569	Green Published, hybrid			2022-12-25	WOS:000306414500025
J	Karimzadeh, F; Primeau, M; Mountassif, D; Rouiller, I; Lamarche-Vane, N				Karimzadeh, Fereshteh; Primeau, Martin; Mountassif, Driss; Rouiller, Isabelle; Lamarche-Vane, Nathalie			A Stretch of Polybasic Residues Mediates Cdc42 GTPase-activating Protein (CdGAP) Binding to Phosphatidylinositol 3,4,5-Trisphosphate and Regulates Its GAP Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GUANINE-NUCLEOTIDE EXCHANGE; RHO-FAMILY GTPASES; PHOSPHORYLATES CDGAP; CELL MOTILITY; RAC; MEMBRANE; DOMAIN; PHOSPHOLIPIDS; LOCALIZATION; TRANSPORT	The Rho family of small GTPases are membrane-associated molecular switches involved in the control of a wide range of cellular activities, including cell migration, adhesion, and proliferation. Cdc42 GTPase-activating protein (CdGAP) is a phosphoprotein showing GAP activity toward Rac1 and Cdc42. CdGAP activity is regulated in an adhesion-dependent manner and more recently, we have identified CdGAP as a novel molecular target in signaling and an essential component in the synergistic interaction between TGF beta and Neu/ErbB-2 signaling pathways in breast cancer cells. In this study, we identified a small polybasic region (PBR) preceding the RhoGAP domain that mediates specific binding to negatively charged phosphatidylinositol 3,4,5-trisphosphate (PI(3,4,5)P3). In vitro reconstitution of membrane vesicles loaded with prenylated Rac1 demonstrates that the PBR is required for full activation of CdGAP in the presence of PI(3,4,5)P3. In fibroblast cells, the expression of CdGAP protein mutants lacking an intact PBR shows a significant reduced ability of the protein mutants to induce cell rounding or to mediate negative effects on cell spreading. Furthermore, an intact PBR is required for CdGAP to inactivate Rac1 signaling into cells, whereas it is not essential in an in vitro context. Altogether, these studies reveal that specific interaction between negatively charged phospholipid PI(3,4,5)P3 and the stretch of polybasic residues preceding the RhoGAP domain regulates CdGAP activity in vivo and is required for its cellular functions.	[Karimzadeh, Fereshteh; Primeau, Martin; Mountassif, Driss; Rouiller, Isabelle; Lamarche-Vane, Nathalie] McGill Univ, Dept Anat & Cell Biol, Montreal, PQ H3A 2B2, Canada	McGill University	Lamarche-Vane, N (corresponding author), McGill Univ, Dept Anat & Cell Biol, 3640 Univ St,Rm 1-38, Montreal, PQ H3A 2B2, Canada.	nathalie.lamarche@mcgill.ca	Karimzadeh, Fathallah/ABA-6967-2021; Rouiller, Isabelle/AAE-9637-2019; rouiller, isabelle/K-7679-2012	Karimzadeh, Fathallah/0000-0002-7561-5021; rouiller, isabelle/0000-0002-1288-8575	Canadian Institutes for Health Research [MOP-84449]; Canada Foundation for Innovation-Leaders Opportunity Fund	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Canada Foundation for Innovation-Leaders Opportunity Fund	This work was supported by the Canadian Institutes for Health Research Grant MOP-84449 and the Canada Foundation for Innovation-Leaders Opportunity Fund.	Andjelkovic M, 1997, J BIOL CHEM, V272, P31515, DOI 10.1074/jbc.272.50.31515; Bernards A, 2004, TRENDS CELL BIOL, V14, P377, DOI 10.1016/j.tcb.2004.05.003; Bigay J, 2005, EMBO J, V24, P2244, DOI 10.1038/sj.emboj.7600714; Chiang SH, 2003, EMBO J, V22, P2679, DOI 10.1093/emboj/cdg262; Cote JF, 2005, NAT CELL BIOL, V7, P797, DOI 10.1038/ncb1280; Currie RA, 1999, BIOCHEM J, V337, P575, DOI 10.1042/0264-6021:3370575; Danek EI, 2007, J BIOL CHEM, V282, P3624, DOI 10.1074/jbc.M610073200; Erlmann P, 2009, MOL BIOL CELL, V20, P4400, DOI 10.1091/mbc.E09-03-0247; Fivaz M, 2003, NEURON, V40, P319, DOI 10.1016/S0896-6273(03)00634-2; He Y, 2011, ONCOGENE, V30, P1032, DOI 10.1038/onc.2010.477; Heasman SJ, 2008, NAT REV MOL CELL BIO, V9, P690, DOI 10.1038/nrm2476; Heo WD, 2006, SCIENCE, V314, P1458, DOI 10.1126/science.1134389; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; Jenna S, 2002, J BIOL CHEM, V277, P6366, DOI 10.1074/jbc.M105516200; Kliouchnikov L, 2009, MOL BIOL CELL, V20, P859, DOI 10.1091/mbc.E08-10-1010; Knaus UG, 1998, J BIOL CHEM, V273, P21512, DOI 10.1074/jbc.273.34.21512; LaLonde DP, 2006, CURR BIOL, V16, P1375, DOI 10.1016/j.cub.2006.05.057; Lamarche N, 1996, CELL, V87, P519, DOI 10.1016/S0092-8674(00)81371-9; Lamarche-Vane N, 1998, J BIOL CHEM, V273, P29172, DOI 10.1074/jbc.273.44.29172; Levay M, 2009, BIOCHEMISTRY-US, V48, P8615, DOI 10.1021/bi900667y; Li XD, 2002, J BIOL CHEM, V277, P15207, DOI 10.1074/jbc.M109913200; Ligeti E, 2006, METHOD ENZYMOL, V406, P104, DOI 10.1016/S0076-6879(06)06009-5; Ligeti E, 2004, J BIOL CHEM, V279, P5055, DOI 10.1074/jbc.C300547200; Moon SY, 2003, J BIOL CHEM, V278, P4151, DOI 10.1074/jbc.M207789200; Naji L, 2011, BIOCHEM BIOPH RES CO, V409, P96, DOI 10.1016/j.bbrc.2011.04.116; Nakamura T, 2008, GENE DEV, V22, P1244, DOI 10.1101/gad.1632308; Nakazawa T, 2003, MOL BIOL CELL, V14, P2921, DOI 10.1091/mbc.e02-09-0623; Okabe T, 2003, J BIOL CHEM, V278, P9920, DOI 10.1074/jbc.M208872200; Papayannopoulos V, 2005, MOL CELL, V17, P181, DOI 10.1016/j.molcel.2004.11.054; Primeau M, 2011, FEBS LETT, V585, P847, DOI 10.1016/j.febslet.2011.02.022; Rosario M, 2007, J CELL BIOL, V178, P503, DOI 10.1083/jcb.200609146; Rossman KL, 2002, EMBO J, V21, P1315, DOI 10.1093/emboj/21.6.1315; Southgate L, 2011, AM J HUM GENET, V88, P574, DOI 10.1016/j.ajhg.2011.04.013; Tcherkezian J, 2005, MOL CELL BIOL, V25, P6314, DOI 10.1128/MCB.25.15.6314-6329.2005; Tcherkezian J, 2007, BIOL CELL, V99, P67, DOI 10.1042/BC20060086; Tcherkezian J, 2006, BIOL CELL, V98, P445, DOI 10.1042/BC20050101; Varnai P, 1999, J BIOL CHEM, V274, P10983, DOI 10.1074/jbc.274.16.10983; Wennerberg K, 2004, J CELL SCI, V117, P1301, DOI 10.1242/jcs.01118; Wheeler AP, 2004, EXP CELL RES, V301, P43, DOI 10.1016/j.yexcr.2004.08.012; Zhao CM, 2003, J BIOL CHEM, V278, P34641, DOI 10.1074/jbc.M304594200; Zheng Y, 2001, TRENDS BIOCHEM SCI, V26, P724, DOI 10.1016/S0968-0004(01)01973-9	41	11	11	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 1	2012	287	23					19610	19621		10.1074/jbc.M112.344606	http://dx.doi.org/10.1074/jbc.M112.344606			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974EF	22518840	Green Published, hybrid			2022-12-25	WOS:000306411900072
J	Liu, XJ; Liu, D; Qian, DM; Dai, J; An, Y; Jiang, SY; Stanley, B; Yang, JM; Wang, B; Liu, XY; Liu, DX				Liu, Xijun; Liu, Dan; Qian, Dongmeng; Dai, Jenny; An, Yi; Jiang, Shaoyan; Stanley, Bruce; Yang, Jinming; Wang, Bin; Liu, Xinyuan; Liu, David X.			Nucleophosmin (NPM1/B23) Interacts with Activating Transcription Factor 5 (ATF5) Protein and Promotes Proteasome- and Caspase-dependent ATF5 Degradation in Hepatocellular Carcinoma Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEURAL PROGENITOR CELLS; C6 GLIOMA; TARGET; DIFFERENTIATION; PROLIFERATION; INTERFERENCE; INHIBITION; EXPRESSION; APOPTOSIS; FAMILY	Nucleophosmin (NPM1/B23) and the activating transcription factor 5 (ATF5) are both known to subject to cell type-dependent regulation. NPM1 is expressed weakly in hepatocytes and highly expressed in hepatocellular carcinomas (HCC) with a clear correlation between enhanced NPM1 expression and increased tumor grading and poor prognosis, whereas in contrast, ATF5 is expressed abundantly in hepatocytes and down-regulated in HCC. Re-expression of ATF5 in HCC inhibits cell proliferation. We report here that using an unbiased approach, tandem affinity purification (TAP) followed with mass spectrometry (MS), we identified NPM1 as a novel ATF5-interacting protein. Unlike many other NPM1-interacting proteins that interact with the N-terminal oligomerization domain of NPM1, ATF5 binds via its basic leucine zipper to the C-terminal region of NPM1 where its nucleolar localization signal is located. NPM1 association with ATF5, whose staining patterns partially overlap in the nucleoli, promotes ATF5 protein degradation through proteasome-dependent and caspase-dependent pathways. NPM1-c, a mutant NPM1 that is defective in nucleolar localization, failed to stimulate ATF5 polyubiquitination and was unable to down-regulate ATF5. NPM1 interaction with ATF5 displaces HSP70, a known ATF5-interacting protein, from ATF5 protein complexes and antagonizes its role in stabilization of ATF5 protein. NPM1-promoted ATF5 down-regulation diminished ATF5-mediated repression of cAMP-responsive element-dependent gene transcription and abrogates ATF5-induced G(2)/M cell cycle blockade and inhibition of cell proliferation in HCC cells. Our study establishes a mechanistic link between elevated NPM1 expression and depressed ATF5 in HCC and suggests that regulation of ATF5 by NPM1 plays an important role in the proliferation and survival of HCC.	[Liu, Xijun; Liu, Dan; Dai, Jenny; Stanley, Bruce; Yang, Jinming; Liu, David X.] Penn State Coll Med, Hershey, PA 17033 USA; [Qian, Dongmeng; Wang, Bin] Qingdao Univ, Dept Microbiol, Coll Med, Qingdao 266071, Shandong, Peoples R China; [An, Yi] Qingdao Univ, Affiliated Hosp, Coll Med, Qingdao 266071, Shandong, Peoples R China; [Jiang, Shaoyan] Qingdao Univ, Affiliated Cardiovasc Hosp, Coll Med, Qingdao 266071, Shandong, Peoples R China; [Liu, Xinyuan] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, State Key Lab Cell Biol, Shanghai 200031, Peoples R China; [Liu, Xinyuan; Liu, David X.] Zhejiang Sci Tech Univ, Xinyuan Inst Med & Biotechnol, Coll Life Sci, Hangzhou 310018, Zhejiang, Peoples R China	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Qingdao University; Qingdao University; Qingdao University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Zhejiang Sci-Tech University	Liu, DX (corresponding author), Penn State Coll Med, Hershey, PA 17033 USA.	dliu@psu.edu	Stanley, Bruce/R-9856-2019; Liu, Xinyuan/HDM-5505-2022	Stanley, Bruce/0000-0003-1338-2928; Liu, Xijun/0000-0002-5712-9142	American Cancer Society; U.S. Army Medical Research and Material Command; NATIONAL CANCER INSTITUTE [R01CA135038] Funding Source: NIH RePORTER	American Cancer Society(American Cancer Society); U.S. Army Medical Research and Material Command(United States Department of DefenseUnited States ArmyU.S. Army Medical Research & Materiel Command (USAMRMC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grants from the American Cancer Society and the U.S. Army Medical Research and Material Command (to D. X. L.).	Angelastro JM, 2003, J NEUROSCI, V23, P4590; Angelastro JM, 2006, ONCOGENE, V25, P907, DOI 10.1038/sj.onc.1209116; Angelastro JM, 2005, J NEUROSCI, V25, P3889, DOI 10.1523/JNEUROSCI.3447-04.2005; Bertwistle D, 2004, MOL CELL BIOL, V24, P985, DOI 10.1128/MCB.24.3.985-996.2004; Bonetti P, 2008, J CELL BIOL, V182, P19, DOI 10.1083/jcb.200711040; BORER RA, 1989, CELL, V56, P379, DOI 10.1016/0092-8674(89)90241-9; Cazzaniga G, 2005, BLOOD, V106, P1419, DOI 10.1182/blood-2005-03-0899; Chen DL, 2010, NATURE, V464, P624, DOI 10.1038/nature08820; Chen DL, 2005, CELL, V121, P1071, DOI 10.1016/j.cell.2005.03.037; Colombo E, 2011, ONCOGENE, V30, P2595, DOI 10.1038/onc.2010.646; den Besten W, 2005, CELL CYCLE, V4, P1593; Dluzen D, 2011, J BIOL CHEM, V286, P7705, DOI 10.1074/jbc.M110.207639; Gao H, 2005, J BIOL CHEM, V280, P10988, DOI 10.1074/jbc.M412720200; Gho JWM, 2008, CANCER RES, V68, P6743, DOI 10.1158/0008-5472.CAN-07-6469; Greene LA, 2009, J NEUROCHEM, V108, P11, DOI 10.1111/j.1471-4159.2008.05749.x; Grisendi S, 2005, NATURE, V437, P147, DOI 10.1038/nature03915; HAI TW, 1989, GENE DEV, V3, P2083, DOI 10.1101/gad.3.12b.2083; Hansen MB, 2002, GENOMICS, V80, P344, DOI 10.1006/geno.2002.6838; Huang N, 2005, J BIOL CHEM, V280, P5496, DOI 10.1074/jbc.M407856200; Li GF, 2011, J BIOL CHEM, V286, P20251, DOI 10.1074/jbc.M110.211771; Li GF, 2009, MOL CANCER RES, V7, P933, DOI 10.1158/1541-7786.MCR-08-0365; Li J, 2004, J BIOL CHEM, V279, P41275, DOI 10.1074/jbc.C400297200; Lindstrom MS, 2008, J BIOL CHEM, V283, P15568, DOI 10.1074/jbc.M801151200; Liu DX, 2011, MOL CELL BIOL, V31, P3906, DOI 10.1128/MCB.05887-11; Liu X, 2007, P NATL ACAD SCI USA, V104, P9679, DOI 10.1073/pnas.0701806104; Liu XJ, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-684; Maiguel DA, 2004, MOL CELL BIOL, V24, P3703, DOI 10.1128/MCB.24.9.3703-3711.2004; MANIATIS T, 1987, SCIENCE, V236, P1237, DOI 10.1126/science.3296191; Mason JL, 2005, MOL CELL NEUROSCI, V29, P372, DOI 10.1016/j.mcn.2005.03.004; Monaco SE, 2007, INT J CANCER, V120, P1883, DOI 10.1002/ijc.22469; Muratake T, 1996, GENOMICS, V36, P63, DOI 10.1006/geno.1996.0426; Namboodiri VMH, 2004, STRUCTURE, V12, P2149, DOI 10.1016/j.str.2004.09.017; Nishihara H, 2004, J BIOL CHEM, V279, P26176, DOI 10.1074/jbc.M313346200; Okuda M, 2000, CELL, V103, P127, DOI 10.1016/S0092-8674(00)00093-3; Okuda M, 2002, ONCOGENE, V21, P6170, DOI 10.1038/sj.onc.1205708; Okuwaki M, 2001, FEBS LETT, V506, P272, DOI 10.1016/S0014-5793(01)02939-8; Pascual M, 2008, DRUG METAB DISPOS, V36, P1063, DOI 10.1124/dmd.107.019380; Pati D, 1999, MOL CELL BIOL, V19, P5001; Persengiev SP, 2002, GENE DEV, V16, P1806, DOI 10.1101/gad.992202; Peters CS, 2001, J BIOL CHEM, V276, P13718, DOI 10.1074/jbc.M011562200; Prieto C, 2002, BIOCHEMISTRY-US, V41, P7802, DOI 10.1021/bi020120e; Puig O, 2001, METHODS, V24, P218, DOI 10.1006/meth.2001.1183; Ravnskjaer K, 2007, EMBO J, V26, P2880, DOI 10.1038/sj.emboj.7601715; Sheng Z, 2010, NAT MED, V16, P671, DOI 10.1038/nm.2158; Shimizu M, 1998, EXP CELL RES, V239, P93, DOI 10.1006/excr.1997.3884; Takemura M, 1999, J BIOCHEM-TOKYO, V125, P904, DOI 10.1093/oxfordjournals.jbchem.a022367; Uekusa H, 2009, BIOCHEM BIOPH RES CO, V380, P673, DOI 10.1016/j.bbrc.2009.01.158; Verheggen C, 2000, J CELL BIOL, V149, P293, DOI 10.1083/jcb.149.2.293; Watatani Y, 2008, J BIOL CHEM, V283, P2543, DOI 10.1074/jbc.M707781200; Wei YY, 2008, J BIOL CHEM, V283, P18773, DOI 10.1074/jbc.M707879200; Wei YY, 2010, BIOCHEM BIOPH RES CO, V396, P602, DOI 10.1016/j.bbrc.2010.04.110; Wei YY, 2006, BIOCHEM BIOPH RES CO, V339, P591, DOI 10.1016/j.bbrc.2005.11.054; Wu MH, 2002, J BIOL CHEM, V277, P48234, DOI 10.1074/jbc.M206550200; Xu HF, 2008, BREAST CANCER RES TR, V107, P63, DOI 10.1007/s10549-007-9536-5; Xu LS, 2009, J BIOL CHEM, V284, P2706, DOI 10.1074/jbc.M808184200; Yamazaki T, 2010, LIFE SCI, V87, P294, DOI 10.1016/j.lfs.2010.07.006; Zhou DH, 2008, J BIOL CHEM, V283, P7064, DOI 10.1074/jbc.M708530200	57	35	41	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 1	2012	287	23					19599	19609		10.1074/jbc.M112.363622	http://dx.doi.org/10.1074/jbc.M112.363622			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974EF	22528486	Green Published, hybrid			2022-12-25	WOS:000306411900071
J	Garcia, MP; Cavalheiro, JRT; Fernandes, MH				Garcia, Monica Pereira; Tinoco Cavalheiro, Jose Roberto; Fernandes, Maria Helena			Acute and Long-Term Effects of Hyperthermia in B16-F10 Melanoma Cells	PLOS ONE			English	Article							MAGNETITE CATIONIC LIPOSOMES; INTRACELLULAR HYPERTHERMIA; HEAT-TREATMENT; APOPTOSIS; INDUCTION; DIFFERENTIATION; IMMUNOTHERAPY; REGRESSION; RADIATION; PROTEINS	Objective: Hyperthermia uses exogenous heat induction as a cancer therapy. This work addresses the acute and long-term effects of hyperthermia in the highly metastatic melanoma cell line B16-F10. Materials and Methods: Melanoma cells were submitted to one heat treatment, 45 degrees C for 30 min, and thereafter were kept at 37 degrees C for an additional period of 14 days. Cultures maintained at 37 degrees C were used as control. Cultures were assessed for the heat shock reaction. Results: Immediately after the heat shock, cells began a process of fast degradation, and, in the first 24 h, cultures showed decreased viability, alterations in cell morphology and F-actin cytoskeleton organization, significant reduction in the number of adherent cells, most of them in a process of late apoptosis, and an altered gene expression profile. A follow-up of two weeks after heat exposure showed that viability and number of adherent cells remained very low, with a high percentage of early apoptotic cells. Still, heat-treated cultures maintained a low but relatively constant population of cells in S and G(2)/M phases for a long period after heat exposure, evidencing the presence of metabolically active cells. Conclusion: The melanoma cell line B16-F10 is susceptible to one hyperthermia treatment at 45 degrees C, with significant induced acute and long-term effects. However, a low but apparently stable percentage of metabolically active cells survived long after heat exposure.	[Garcia, Monica Pereira; Fernandes, Maria Helena] Univ Porto FMDUP, Lab Farmacol & Biocompatibilidade Celular, Fac Med Dent, Oporto, Portugal; [Tinoco Cavalheiro, Jose Roberto] Univ Porto, Inst Engn Biomed INEB, P-4100 Oporto, Portugal	Universidade do Porto; Universidade do Porto	Fernandes, MH (corresponding author), Univ Porto FMDUP, Lab Farmacol & Biocompatibilidade Celular, Fac Med Dent, Oporto, Portugal.	mhfernandes@fmd.up.pt	Garcia, Mónica Pereira/L-5488-2014; Fernandes, Maria Helena/K-6917-2014	Garcia, Mónica Pereira/0000-0002-8097-3114; Fernandes, Maria Helena/0000-0001-9391-9574	Project FCT [PTDC/SAU-BEB/69497/2006]; Faculty of Dental Medicine, University of Porto, Portugal	Project FCT(Portuguese Foundation for Science and Technology); Faculty of Dental Medicine, University of Porto, Portugal	This work was supported by Project FCT: PTDC/SAU-BEB/69497/2006 ("Hyperthermia treatment of experimental melanoma using a ferromagnetic cement") and Faculty of Dental Medicine, University of Porto, Portugal. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aydin IT, 2012, PIGM CELL MELANOMA R, V25, P37, DOI 10.1111/j.1755-148X.2011.00910.x; Babsky A, 2005, INT J HYPERTHER, V21, P141, DOI 10.1080/02656730400023656; Brehmer M, 2000, BJU INT, V85, P535, DOI 10.1046/j.1464-410x.2000.00473.x; Elmore S, 2007, TOXICOL PATHOL, V35, P495, DOI 10.1080/01926230701320337; Flanagan SW, 1998, FEBS LETT, V431, P285, DOI 10.1016/S0014-5793(98)00779-0; Fukao H, 2000, CLIN CHIM ACTA, V296, P17, DOI 10.1016/S0009-8981(00)00198-4; Goding CR, 2011, ONCOGENE, V30, P2304, DOI 10.1038/onc.2010.641; Grasso S, 2003, EXP BIOL MED, V228, P491, DOI 10.1177/15353702-0322805-12; Halliwell B, 1996, ANNU REV NUTR, V16, P33, DOI 10.1146/annurev.nu.16.070196.000341; Hildebrandt B, 2002, CRIT REV ONCOL HEMAT, V43, P33, DOI 10.1016/S1040-8428(01)00179-2; Ito A, 2003, J BIOSCI BIOENG, V96, P364, DOI 10.1263/jbb.96.364; Ito A, 2003, CANCER SCI, V94, P308, DOI 10.1111/j.1349-7006.2003.tb01438.x; Kanamori M, 2003, CANCER DETECT PREV, V27, P76, DOI 10.1016/S0361-090X(02)00178-2; Kawai N, 2005, PROSTATE, V64, P373, DOI 10.1002/pros.20253; LEGRAND C, 1992, J BIOTECHNOL, V25, P231, DOI 10.1016/0168-1656(92)90158-6; Manjili MH, 2002, INT J HYPERTHER, V18, P506, DOI 10.1080/02656730110116696; Matsuoka Fumiko, 2004, Biomagn Res Technol, V2, P3, DOI 10.1186/1477-044X-2-3; Medic S, 2007, PIGM CELL RES, V20, P80, DOI 10.1111/j.1600-0749.2006.00356.x; Milani V, 2005, INT IMMUNOL, V17, P257, DOI 10.1093/intimm/dxh203; Morgan DM, 1997, METHOD MOL BIOL, P179; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Motoyama Jun, 2008, Biomagn Res Technol, V6, P2, DOI 10.1186/1477-044X-6-2; Nakayama J, 1996, PIGM CELL RES, V9, P154, DOI 10.1111/j.1600-0749.1996.tb00104.x; Nijhuis EHA, 2008, INT J HYPERTHER, V24, P357, DOI 10.1080/02656730801944914; Nijhuis EHA, 2008, INT J RADIAT BIOL, V84, P99, DOI 10.1080/09553000701817084; Nijhuis EHA, 2006, INT J HYPERTHER, V22, P687, DOI 10.1080/02656730601045409; OliveiraFilho RS, 1997, BRAZ J MED BIOL RES, V30, P941, DOI 10.1590/S0100-879X1997000800005; Poon IKH, 2010, CELL DEATH DIFFER, V17, P381, DOI 10.1038/cdd.2009.195; Rong Y, 2000, INT J HYPERTHER, V16, P19, DOI 10.1080/026567300285394; Schmitt E, 2007, J LEUKOCYTE BIOL, V81, P15, DOI 10.1189/jlb.0306167; Sharif-Khatibi L, 2007, INT J HYPERTHER, V23, P645, DOI 10.1080/02656730701769833; Shinkai M, 1999, J MAGN MAGN MATER, V194, P176, DOI 10.1016/S0304-8853(98)00586-1; Slominski A, 2004, PHYSIOL REV, V84, P1155, DOI 10.1152/physrev.00044.2003; Slominski A, 2009, EXP DERMATOL, V18, P760, DOI 10.1111/j.1600-0625.2009.00892.x; Suzuki M, 2003, MELANOMA RES, V13, P129, DOI 10.1097/00008390-200304000-00004; Thannickal VJ, 2000, AM J PHYSIOL-LUNG C, V279, pL1005; van der Zee J, 2002, ANN ONCOL, V13, P1173, DOI 10.1093/annonc/mdf280; Van Dyke T, 2007, NEW ENGL J MED, V356, P79, DOI 10.1056/NEJMcibr066301; Vertrees RA, 2007, CURR CLIN ONCOL, P71, DOI 10.1007/978-1-59745-195-6_6; Vorotnikova E, 2006, INT J RADIAT BIOL, V82, P549, DOI 10.1080/09553000600876678; Yanase M, 1998, JPN J CANCER RES, V89, P463, DOI 10.1111/j.1349-7006.1998.tb00586.x; Yanase M, 1998, JPN J CANCER RES, V89, P775, DOI 10.1111/j.1349-7006.1998.tb03283.x; Yonezawa M, 1996, INT J CANCER, V66, P347; Zhou M, 2007, INT J HYPERTHER, V23, P225, DOI 10.1080/02656730701295441; Zimmermann KC, 2001, J ALLERGY CLIN IMMUN, V108, pS99, DOI 10.1067/mai.2001.117819	45	17	17	3	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2012	7	4							e35489	10.1371/journal.pone.0035489	http://dx.doi.org/10.1371/journal.pone.0035489			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UD	22532856	Green Published, Green Submitted, gold			2022-12-25	WOS:000305339200070
J	Gaj, P; Maryan, N; Hennig, EE; Ledwon, JK; Paziewska, A; Majewska, A; Karczmarski, J; Nesteruk, M; Wolski, J; Antoniewicz, AA; Przytulski, K; Rutkowski, A; Teumer, A; Homuth, G; Starzynska, T; Regula, J; Ostrowski, J				Gaj, Pawel; Maryan, Natalia; Hennig, Ewa E.; Ledwon, Joanna K.; Paziewska, Agnieszka; Majewska, Aneta; Karczmarski, Jakub; Nesteruk, Monika; Wolski, Jan; Antoniewicz, Artur A.; Przytulski, Krzysztof; Rutkowski, Andrzej; Teumer, Alexander; Homuth, Georg; Starzynska, Teresa; Regula, Jaroslaw; Ostrowski, Jerzy			Pooled Sample-Based GWAS: A Cost-Effective Alternative for Identifying Colorectal and Prostate Cancer Risk Variants in the Polish Population	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; COMMON GENETIC-VARIANTS; SUSCEPTIBILITY LOCI; CHROMOSOME 8Q24; MULTIPLE LOCI; HIDDEN HERITABILITY; EARLY-ONSET; IDENTIFICATION; SNPS; MEN	Background: Prostate cancer (PCa) and colorectal cancer (CRC) are the most commonly diagnosed cancers and cancer-related causes of death in Poland. To date, numerous single nucleotide polymorphisms (SNPs) associated with susceptibility to both cancer types have been identified, but their effect on disease risk may differ among populations. Methods: To identify new SNPs associated with PCa and CRC in the Polish population, a genome-wide association study (GWAS) was performed using DNA sample pools on Affymetrix Genome-Wide Human SNP 6.0 arrays. A total of 135 PCa patients and 270 healthy men (PCa sub-study) and 525 patients with adenoma (AD), 630 patients with CRC and 690 controls (AD/CRC sub-study) were included in the analysis. Allele frequency distributions were compared with t-tests and chi(2)-tests. Only those significantly associated SNPs with a proxy SNP (p<0.001; distance of 100 kb; r(2)>0.7) were selected. GWAS marker selection was conducted using PLINK. The study was replicated using extended cohorts of patients and controls. The association with previously reported PCa and CRC susceptibility variants was also examined. Individual patients were genotyped using TaqMan SNP Genotyping Assays. Results: The GWAS selected six and 24 new candidate SNPs associated with PCa and CRC susceptibility, respectively. In the replication study, 17 of these associations were confirmed as significant in additive model of inheritance. Seven of them remained significant after correction for multiple hypothesis testing. Additionally, 17 previously reported risk variants have been identified, five of which remained significant after correction. Conclusion: Pooled-DNA GWAS enabled the identification of new susceptibility loci for CRC in the Polish population. Previously reported CRC and PCa predisposition variants were also identified, validating the global nature of their associations. Further independent replication studies are required to confirm significance of the newly uncovered candidate susceptibility loci.	[Gaj, Pawel; Maryan, Natalia; Hennig, Ewa E.; Ledwon, Joanna K.; Paziewska, Agnieszka; Majewska, Aneta; Nesteruk, Monika; Przytulski, Krzysztof; Regula, Jaroslaw; Ostrowski, Jerzy] Med Ctr Postgrad Educ, Dept Gastroenterol & Hepatol, Warsaw, Poland; [Hennig, Ewa E.; Karczmarski, Jakub; Przytulski, Krzysztof; Regula, Jaroslaw; Ostrowski, Jerzy] Maria Sklodowska Curie Mem Canc Ctr, Dept Oncol Genet, Warsaw, Poland; [Hennig, Ewa E.; Karczmarski, Jakub; Wolski, Jan; Przytulski, Krzysztof; Rutkowski, Andrzej; Regula, Jaroslaw; Ostrowski, Jerzy] Inst Oncol, Warsaw, Poland; [Wolski, Jan] Maria Sklodowska Curie Mem Canc Ctr, Dept Urol, Warsaw, Poland; [Antoniewicz, Artur A.] Med Ctr Postgrad Educ, Dept Urol, Warsaw, Poland; [Rutkowski, Andrzej] Maria Sklodowska Curie Mem Canc Ctr, Dept Colorectal Canc, Warsaw, Poland; [Teumer, Alexander; Homuth, Georg] Ernst Moritz Arndt Univ Greifswald, Interfac Inst Genet & Funct Genom, Greifswald, Germany; [Starzynska, Teresa] Pomeranian Med Univ, Dept Gastroenterol, Szczecin, Poland	Centre of Postgraduate Medical Education - Poland; Maria Sklodowska-Curie National Research Institute of Oncology; Maria Sklodowska-Curie National Research Institute of Oncology; Maria Sklodowska-Curie National Research Institute of Oncology; Centre of Postgraduate Medical Education - Poland; Maria Sklodowska-Curie National Research Institute of Oncology; Ernst Moritz Arndt Universitat Greifswald; Pomeranian Medical University	Gaj, P (corresponding author), Med Ctr Postgrad Educ, Dept Gastroenterol & Hepatol, Warsaw, Poland.	jostrow@warman.com.pl	Teumer, Alexander/S-7438-2019; Ledwon, Joanna/GSD-2218-2022; Starzynska, Teresa/B-1549-2015; Ledwon, Joanna/AAH-9521-2021; Hennig, Ewa E/N-6459-2013	Teumer, Alexander/0000-0002-8309-094X; Starzynska, Teresa/0000-0001-5573-2397; Ledwon, Joanna/0000-0001-8047-4334; Hennig, Ewa E/0000-0002-6388-2237; Regula, Jaroslaw/0000-0001-7071-3151; Ostrowski, Jerzy/0000-0003-1363-3766; , Andrzej/0000-0002-9009-9475; Karczmarski, Jakub/0000-0002-7976-0365; Paziewska, Agnieszka/0000-0002-6644-1509	Polish Ministry of Science and Higher Education [PBZ-MNiSW-05/I/2007/01]	Polish Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland)	This work was supported by a PBZ-MNiSW-05/I/2007/01 grant from the Polish Ministry of Science and Higher Education (http://www.nauka.gov.pl/home/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Affymetrix Inc., 2005, AFF GENECHIP GEN AN; Al Olama AA, 2009, NAT GENET, V41, P1058, DOI 10.1038/ng.452; Barratt BJ, 2002, ANN HUM GENET, V66, P393, DOI [10.1046/j.1469-1809.2002.00125.x, 10.1017/S0003480002001252]; Barrett JC, 2006, NAT GENET, V38, P659, DOI 10.1038/ng1801; Baye TM, 2009, PERS MED, V6, P623, DOI 10.2217/PME.09.54; Beebe-Dimmer JL, 2008, INT J CANCER, V122, P2876, DOI 10.1002/ijc.23471; Broderick P, 2007, NAT GENET, V39, P1315, DOI 10.1038/ng.2007.18; Cal S, 2002, GENE, V283, P49, DOI 10.1016/S0378-1119(01)00861-7; Chang BL, 2011, CANCER EPIDEM BIOMAR, V20, P23, DOI 10.1158/1055-9965.EPI-10-0698; Craig DW, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-138; Curtin K, 2009, CANCER EPIDEM BIOMAR, V18, P616, DOI 10.1158/1055-9965.EPI-08-0690; DUPONT WD, 1990, CONTROL CLIN TRIALS, V11, P116, DOI 10.1016/0197-2456(90)90005-M; Easton DF, 2007, NATURE, V447, P1087, DOI 10.1038/nature05887; Edwards SM, 2003, AM J HUM GENET, V72, P1, DOI 10.1086/345310; Eeles RA, 2008, NAT GENET, V40, P316, DOI 10.1038/ng.90; Eeles RA, 2009, NAT GENET, V41, P1116, DOI 10.1038/ng.450; FitzGerald LM, 2009, CLIN CANCER RES, V15, P3231, DOI 10.1158/1078-0432.CCR-08-2190; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Gao JF, 2007, SCAND J GASTROENTERO, V42, P345, DOI 10.1080/00365520600880856; Ghoussaini M, 2008, JNCI-J NATL CANCER I, V100, P962, DOI 10.1093/jnci/djn190; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Gibson G, 2010, NAT GENET, V42, P558, DOI 10.1038/ng0710-558; Gudmundsson J, 2009, NAT GENET, V41, P1122, DOI 10.1038/ng.448; Guo FJ, 2010, PATHOL ONCOL RES, V16, P319, DOI 10.1007/s12253-009-9226-1; Haerian MS, 2011, J GASTROEN HEPATOL, V26, P1475, DOI 10.1111/j.1440-1746.2011.06831.x; Haiman CA, 2007, NAT GENET, V39, P954, DOI 10.1038/ng2098; Haiman CA, 2007, NAT GENET, V39, P638, DOI 10.1038/ng2015; Hakonarson H, 2011, ANN MED, V43, P451, DOI 10.3109/07853890.2011.573803; He J, 2011, CANCER EPIDEM BIOMAR, V20, P70, DOI 10.1158/1055-9965.EPI-10-0892; Houlston RS, 2010, NAT GENET, V42, P973, DOI 10.1038/ng.670; Houlston RS, 2008, NAT GENET, V40, P1426, DOI 10.1038/ng.262; Huang SP, 2009, CANCER EPIDEM BIOMAR, V18, P3068, DOI 10.1158/1055-9965.EPI-09-0665; Imamura M, 2011, ENDOCR J, V58, P723, DOI 10.1507/endocrj.EJ11-0113; Jaeger E, 2008, NAT GENET, V40, P26, DOI 10.1038/ng.2007.41; John U, 2001, SOZ PRAVENTIV MED, V46, P186, DOI 10.1007/BF01324255; Jostins L, 2011, HUM MOL GENET, V20, pR182, DOI 10.1093/hmg/ddr378; Kaklamani VG, 2008, JAMA-J AM MED ASSOC, V300, P1523, DOI 10.1001/jama.300.13.1523; Kiemeney LA, 2008, NAT GENET, V40, P1307, DOI 10.1038/ng.229; Kim ST, 2010, PROSTATE, V70, P1729, DOI 10.1002/pros.21208; Kraft P, 2009, STAT SCI, V24, P561, DOI 10.1214/09-STS290; Ku CS, 2010, J HUM GENET, V55, P195, DOI 10.1038/jhg.2010.19; Kupfer SS, 2010, GASTROENTEROLOGY, V139, P1677, DOI 10.1053/j.gastro.2010.07.038; Liao LH, 2007, CLIN CHIM ACTA, V380, P191, DOI 10.1016/j.cca.2007.02.033; Liu QR, 2005, P NATL ACAD SCI USA, V102, P11864, DOI 10.1073/pnas.0500329102; Macgregor S, 2007, EUR J HUM GENET, V15, P501, DOI 10.1038/sj.ejhg.5201768; Meaburn E, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gnj027; Montpetit A, 2006, PLOS GENET, V2, P282, DOI 10.1371/journal.pgen.0020027; Ostrowski J, 2009, EXPERT REV MOL DIAGN, V9, P623, DOI 10.1586/ERM.09.41; Osumi D, 2009, CANCER SCI, V100, P888, DOI 10.1111/j.1349-7006.2009.01125.x; Pal P, 2009, PROSTATE, V69, P1548, DOI 10.1002/pros.20999; Park JH, 2010, NAT GENET, V42, P570, DOI 10.1038/ng.610; Perez-Losada J, 2011, INTEGR BIOL-UK, V3, P316, DOI 10.1039/c0ib00094a; Peters U, 2012, HUM GENET, V131, P217, DOI 10.1007/s00439-011-1055-0; Pinho SS, 2011, CELL MOL LIFE SCI, V68, P1011, DOI 10.1007/s00018-010-0595-0; Prokunina-Olsson L, 2010, CANCER EPIDEM BIOMAR, V19, P1349, DOI 10.1158/1055-9965.EPI-09-1181; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Regula J, 2006, NEW ENGL J MED, V355, P1863, DOI 10.1056/NEJMoa054967; Regula J, 2010, BEST PRACT RES CL GA, V24, P407, DOI 10.1016/j.bpg.2010.06.007; Rivas MA, 2011, NAT GENET, V43, P1066, DOI 10.1038/ng.952; Salinas CA, 2009, PROSTATE, V69, P363, DOI 10.1002/pros.20887; Senchenko VN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015612; Slattery ML, 2012, INT J CANCER, V130, P653, DOI 10.1002/ijc.26047; Solovieff N, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-108; Takata R, 2010, NAT GENET, V42, P751, DOI 10.1038/ng.635; Tenesa A, 2008, NAT GENET, V40, P631, DOI 10.1038/ng.133; Thomas G, 2008, NAT GENET, V40, P310, DOI 10.1038/ng.91; Thompson CL, 2009, CARCINOGENESIS, V30, P982, DOI 10.1093/carcin/bgp086; Tomlinson I, 2007, NAT GENET, V39, P984, DOI 10.1038/ng2085; Tomlinson IPM, 2008, NAT GENET, V40, P623, DOI 10.1038/ng.111; Tomlinson IPM, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002105; Tsilidis KK, 2009, CANCER CAUSE CONTROL, V20, P1739, DOI 10.1007/s10552-009-9427-7; Volzke H, 2011, INT J EPIDEMIOL, V40, P294, DOI 10.1093/ije/dyp394; von Holst S, 2010, BRIT J CANCER, V103, P575, DOI 10.1038/sj.bjc.6605774; Wang LL, 2011, GENOMICS, V98, P1, DOI 10.1016/j.ygeno.2011.04.006; Waters KM, 2009, CANCER EPIDEM BIOMAR, V18, P1285, DOI 10.1158/1055-9965.EPI-08-1142; Wiedl T, 2011, J PROTEOMICS, V74, P1884, DOI 10.1016/j.jprot.2011.04.030; Williams SM, 2011, ANN HUM GENET, V75, P348, DOI 10.1111/j.1469-1809.2011.00640.x; Wojciechowska U, 2010, CANC POLAND 2008, P1; Wokolorczyk D, 2009, JNCI-J NATL CANCER I, V101, DOI 10.1093/jnci/djn472; Wokolorczyk D, 2010, EUR J CANCER PREV, V19, P167, DOI 10.1097/CEJ.0b013e32832945c3; Wokolorczyk D, 2008, CANCER RES, V68, P9982, DOI 10.1158/0008-5472.CAN-08-1838; Yamada H, 2009, JNCI-J NATL CANCER I, V101, P1330, DOI 10.1093/jnci/djp287; Yeager M, 2008, HUM GENET, V124, P161, DOI 10.1007/s00439-008-0535-3; Yeager M, 2007, NAT GENET, V39, P645, DOI 10.1038/ng2022; Yeager M, 2009, NAT GENET, V41, P1055, DOI 10.1038/ng.444; YUAN M, 1987, J NATL CANCER I, V78, P479; Zanke BW, 2007, NAT GENET, V39, P989, DOI 10.1038/ng2089; Zheng SL, 2008, NEW ENGL J MED, V358, P910, DOI 10.1056/NEJMoa075819; Zheng SL, 2010, PROSTATE, V70, P425, DOI 10.1002/pros.21076	90	30	31	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2012	7	4							e35307	10.1371/journal.pone.0035307	http://dx.doi.org/10.1371/journal.pone.0035307			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TL	22532847	gold, Green Published, Green Submitted			2022-12-25	WOS:000305336200033
J	Chang, YJ; Huang, YP; Li, ZL; Chen, CH				Chang, Yu-Jia; Huang, Yi-Ping; Li, Zih-Ling; Chen, Ching-Hsein			GRP78 Knockdown Enhances Apoptosis via the Down-Regulation of Oxidative Stress and Akt Pathway after Epirubicin Treatment in Colon Cancer DLD-1 Cells	PLOS ONE			English	Article							PI3K/AKT SIGNALING PATHWAY; UNFOLDED-PROTEIN RESPONSE; MAPK PATHWAY; SURVIVAL; INHIBITION; RESISTANCE; ACTIVATION; INDUCTION; TOXICITY; THERAPY	Introduction: The 78-kDa glucose-regulated protein (GRP78) is induced in the cancer microenvironment and can be considered as a novel predictor of responsiveness to chemotherapy in many cancers. In this study, we found that intracellular reactive oxygen species (ROS) and nuclear factor erythroid 2-related factor 2 (Nrf2) nuclear translocation were higher in GRP78 knockdown DLD-1 colon cancer cells compared with scrambled control cells. Methodology/Principal Findings: Treatment with epirubicin in GRP78 knockdown DLD-1 cells enhanced apoptosis and was associated with decreased production of intracellular ROS. In addition, apoptosis was increased by the antioxidants propyl gallate (PG) and dithiothreitol (DTT) in epirubicin-treated scrambled control cells. Epirubicin-treated GRP78 knockdown cells resulted in more inactivated Akt pathway members, such as phosphorylated Akt and GSK-3 beta, as well as downstream targets of beta-catenin expression. Knockdown of Nrf2 with small interfering RNA (siRNA) increased apoptosis in epirubicin-treated GRP78 knockdown cells, which suggested that Nrf2 may be a primary defense mechanism in GRP78 knockdown cells. We also demonstrated that epirubicin-treated GRP78 knockdown cells could decrease survival pathway signaling through the redox activation of protein phosphatase 2A (PP2A), which is a serine/threonine phosphatase that negatively regulates the Akt pathway. Conclusions: Our results indicate that epirubicin decreased the intracellular ROS in GRP78 knockdown cells, which decreased survival signaling through both the Akt pathway and the activation of PP2A. Together, these mechanisms contributed to the enhanced level of epirubicin-induced apoptosis that was observed in the GRP78 knockdown cells.	[Chang, Yu-Jia] Taipei Med Univ, Coll Med, Grad Inst Clin Med, Taipei, Taiwan; [Chang, Yu-Jia] Taipei Med Univ, Coll Med, Dept Surg, Taipei, Taiwan; [Chang, Yu-Jia] Taipei Med Univ Hosp, Dept Surg, Taipei, Taiwan; [Chang, Yu-Jia] Taipei Med Univ Hosp, Canc Res Ctr, Taipei, Taiwan; [Huang, Yi-Ping; Li, Zih-Ling; Chen, Ching-Hsein] Natl Chiayi Univ, Coll Life Sci, Dept Microbiol Immunol & Biopharmaceut, Chiayi, Taiwan	Taipei Medical University; Taipei Medical University; Taipei Medical University; Taipei Medical University Hospital; Taipei Medical University; Taipei Medical University Hospital; National Chiayi University	Chang, YJ (corresponding author), Taipei Med Univ, Coll Med, Grad Inst Clin Med, Taipei, Taiwan.	chench@mail.ncyu.edu.tw		Chang, Yu-Jia/0000-0003-3978-3244	National Science Council, Taiwan [NSC 99-2320-B-415-002-MY3]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	This study was supported by National Science Council, Taiwan (NSC 99-2320-B-415-002-MY3; National Science Council's Web site: http://web1.nsc.gov.tw/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afanas'ev I, 2011, AGING DIS, V2, P219; Akhdar H, 2009, EUR J CANCER, V45, P2219, DOI 10.1016/j.ejca.2009.05.017; Arafa ESA, 2009, CANCER RES, V69, P8910, DOI 10.1158/0008-5472.CAN-09-1543; Bertolotti A, 2000, NAT CELL BIOL, V2, P326, DOI 10.1038/35014014; Chen L, 2008, FREE RADICAL BIO MED, V45, P1035, DOI 10.1016/j.freeradbiomed.2008.07.011; Chen L, 2009, INT J BIOCHEM CELL B, V41, P1284, DOI 10.1016/j.biocel.2008.10.029; Chiou JF, 2010, ANN SURG ONCOL, V17, P603, DOI 10.1245/s10434-009-0718-8; Clerkin JS, 2008, CANCER LETT, V266, P30, DOI 10.1016/j.canlet.2008.02.029; Conklin KA, 2000, NUTR CANCER, V37, P1, DOI 10.1207/S15327914NC3701_1; Cullinan SB, 2003, MOL CELL BIOL, V23, P7198, DOI 10.1128/MCB.23.20.7198-7209.2003; DeGracia DJ, 2002, J CEREBR BLOOD F MET, V22, P127, DOI 10.1097/00004647-200202000-00001; Ermakova SP, 2006, CANCER RES, V66, P9260, DOI 10.1158/0008-5472.CAN-06-1586; Falasca M, 2010, CURR PHARM DESIGN, V16, P1410, DOI 10.2174/138161210791033950; HOLDENER EE, 1985, INVEST NEW DRUG, V3, P63; HORTOBAGYI GN, 1989, AM J CLIN ONCOL-CANC, V12, P57, DOI 10.1097/00000421-198902000-00014; Kebieche M, 2009, EXP TOXICOL PATHOL, V61, P161, DOI 10.1016/j.etp.2008.06.002; Langer R, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-70; Li JZ, 2006, CURR MOL MED, V6, P45, DOI 10.2174/156652406775574523; Lin YD, 2011, LUNG CANCER, V71, P291, DOI 10.1016/j.lungcan.2010.06.004; Lister A, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-37; Lucke JF, 1996, ANN EMERG MED, V28, P408, DOI 10.1016/S0196-0644(96)70006-9; Mhaidat N., 2011, INT J BIOL BIOMED EN, V5, P41; Misra UK, 2006, J BIOL CHEM, V281, P13694, DOI 10.1074/jbc.M511694200; Naughton R, 2009, LEUKEMIA, V23, P1432, DOI 10.1038/leu.2009.49; Niture SK, 2010, TOXICOL APPL PHARM, V244, P37, DOI 10.1016/j.taap.2009.06.009; Ozkan A, 2004, POL J PHARMACOL, V56, P435; Rushworth Stuart A, 2011, Cancers (Basel), V3, P1605, DOI 10.3390/cancers3021605; Sowinski S, 2008, NAT CELL BIOL, V10, P211, DOI 10.1038/ncb1682; Toker A, 2006, CANCER RES, V66, P3963, DOI 10.1158/0008-5472.CAN-06-0743; Tousoulis Dimitris, 2011, Recent Pat Cardiovasc Drug Discov, V6, P103; Vara JAF, 2004, CANCER TREAT REV, V30, P193, DOI 10.1016/j.ctrv.2003.07.007; Wang SK, 2008, P NATL ACAD SCI USA, V105, P3690, DOI 10.1073/pnas.0712326105; Wendel HG, 2004, NATURE, V428, P332, DOI 10.1038/nature02369; Xing XM, 2011, ACTA HISTOCHEM, V113, P777, DOI 10.1016/j.acthis.2010.11.006; Zhang LH, 2011, BRAIN RES, V1371, P23, DOI 10.1016/j.brainres.2010.11.063	35	12	13	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2012	7	4							e35123	10.1371/journal.pone.0035123	http://dx.doi.org/10.1371/journal.pone.0035123			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959XD	22529978	Green Submitted, gold, Green Published			2022-12-25	WOS:000305350600058
J	He, LJ; Serrano, C; Niphadkar, N; Shobnam, N; Hristova, K				He, Lijuan; Serrano, Christopher; Niphadkar, Nitish; Shobnam, Nadia; Hristova, Kalina			Effect of the G375C and G346E Achondroplasia Mutations on FGFR3 Activation	PLOS ONE			English	Article							RECEPTOR TYROSINE KINASES; GROWTH-FACTOR RECEPTOR-3; TRANSMEMBRANE DOMAIN; THANATOPHORIC DYSPLASIA; SKELETAL DYSPLASIAS; SIGNAL-TRANSDUCTION; MUENKE CRANIOSYNOSTOSIS; ACANTHOSIS NIGRICANS; CROUZON-SYNDROME; DOWN-REGULATION	Two mutations in FGFR3, G380R and G375C are known to cause achondroplasia, the most common form of human dwarfism. The G380R mutation accounts for 98% of the achondroplasia cases, and thus has been studied extensively. Here we study the effect of the G375C mutation on the phosphorylation and the cross-linking propensity of full-length FGFR3 in HEK 293 cells, and we compare the results to previously published results for the G380R mutant. We observe identical behavior of the two achondroplasia mutants in these experiments, a finding which supports a direct link between the severity of dwarfism phenotypes and the level and mechanism of FGFR3 over-activation. The mutations do not increase the cross-linking propensity of FGFR3, contrary to previous expectations that the achondroplasia mutations stabilize the FGFR3 dimers. Instead, the phosphorylation efficiency within un-liganded FGFR3 dimers is increased, and this increase is likely the underlying cause for pathogenesis in achondroplasia. We further investigate the G346E mutation, which has been reported to cause achondroplasia in one case. We find that this mutation does not increase FGFR3 phosphorylation and decreases FGFR3 cross-linking propensity, a finding which raises questions whether this mutation is indeed a genetic cause for human dwarfism.	[He, Lijuan; Serrano, Christopher; Niphadkar, Nitish; Shobnam, Nadia; Hristova, Kalina] Johns Hopkins Univ, Dept Mat Sci & Engn, Baltimore, MD 21218 USA	Johns Hopkins University	He, LJ (corresponding author), Johns Hopkins Univ, Dept Mat Sci & Engn, Baltimore, MD 21218 USA.	kh@jhu.edu	Hristova, Kalina/A-3326-2010		National Institutes of Health [GM68619]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068619] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health GM68619. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adar R, 2002, J BONE MINER RES, V17, P860, DOI 10.1359/jbmr.2002.17.5.860; Bellus GA, 2000, AM J HUM GENET, V67, P1411, DOI 10.1086/316892; Blume-Jensen P, 2001, NATURE, V411, P355, DOI 10.1038/35077225; Bonaventure J, 2007, FEBS J, V274, P3078, DOI 10.1111/j.1742-4658.2007.05835.x; Browne BC, 2009, CURR CANCER DRUG TAR, V9, P419, DOI 10.2174/156800909788166484; Brunelleschi S, 2002, CURR PHARM DESIGN, V8, P1959, DOI 10.2174/1381612023393530; Casteran N, 2003, ONCOGENE, V22, P4710, DOI 10.1038/sj.onc.1206587; Chen FH, 2011, BIOCHEMISTRY-US, V50, P8576, DOI 10.1021/bi200986f; Chen FH, 2011, BBA-BIOMEMBRANES, V1808, P2045, DOI 10.1016/j.bbamem.2011.04.007; Cho JY, 2004, P NATL ACAD SCI USA, V101, P609, DOI 10.1073/pnas.2237184100; Choi SH, 2007, ONCOGENE, V26, P1567, DOI 10.1038/sj.onc.1209957; Cohen MM, 2006, AM J MED GENET A, V140A, P2646, DOI 10.1002/ajmg.a.31368; Cohen MM, 2002, AM J MED GENET, V112, P304, DOI 10.1002/ajmg.10780; Cohen MM, 1998, INT J ORAL MAX SURG, V27, P451, DOI 10.1016/S0901-5027(98)80036-2; Cohen MM, 1997, PEDIATR RADIOL, V27, P442, DOI 10.1007/s002470050165; FANTL WJ, 1993, ANNU REV BIOCHEM, V62, P453, DOI 10.1146/annurev.bi.62.070193.002321; Han X, 2006, BIOPHYS J, V91, P3736, DOI 10.1529/biophysj.106.092247; Harada D, 2009, J BONE MINER METAB, V27, P9, DOI 10.1007/s00774-008-0009-7; He LJ, 2011, J BIOL CHEM, V286, P13272, DOI 10.1074/jbc.M110.205583; He LJ, 2011, BBA-BIOMEMBRANES, V1808, P253, DOI 10.1016/j.bbamem.2010.08.007; He LJ, 2010, J BIOL CHEM, V285, P30103, DOI 10.1074/jbc.M109.094086; He LJ, 2008, J MOL BIOL, V384, P1130, DOI 10.1016/j.jmb.2008.10.036; Horton WA, 2007, LANCET, V370, P162, DOI 10.1016/S0140-6736(07)61090-3; Hubbard SR, 2007, CURR OPIN CELL BIOL, V19, P117, DOI 10.1016/j.ceb.2007.02.010; Ibrahimi OA, 2004, HUM MOL GENET, V13, P69, DOI 10.1093/hmg/ddh011; Li E, 2006, J MOL BIOL, V356, P600, DOI 10.1016/j.jmb.2005.11.077; Li E, 2006, BIOCHEMISTRY-US, V45, P6241, DOI 10.1021/bi060609y; MEYERS GA, 1995, NAT GENET, V11, P462, DOI 10.1038/ng1295-462; Mohammadi M, 1996, MOL CELL BIOL, V16, P977; Monsonego-Ornan E, 2000, MOL CELL BIOL, V20, P516, DOI 10.1128/MCB.20.2.516-522.2000; Monsonego-Ornan E, 2002, FEBS LETT, V528, P83, DOI 10.1016/S0014-5793(02)03255-6; Naski MC, 1996, NAT GENET, V13, P233, DOI 10.1038/ng0696-233; PARK WJ, 1995, AM J HUM GENET, V57, P748; Passos-Bueno MR, 1999, HUM MUTAT, V14, P115; Plotnikov AN, 1999, CELL, V98, P641, DOI 10.1016/S0092-8674(00)80051-3; PONSETI IV, 1970, J BONE JOINT SURG AM, VA 52, P701, DOI 10.2106/00004623-197052040-00004; PRINOS P, 1995, PEDIATR RES, V37, pA151; Robertson SC, 2000, TRENDS GENET, V16, P265, DOI 10.1016/S0168-9525(00)02021-7; Rump P, 2006, AM J MED GENET A, V140A, P284, DOI 10.1002/ajmg.a.31084; Schlessinger J, 2000, CELL, V103, P211, DOI 10.1016/j.cell.2010.06.011; SHIANG R, 1994, CELL, V78, P335, DOI 10.1016/0092-8674(94)90302-6; Vajo Z, 2000, ENDOCR REV, V21, P23, DOI 10.1210/er.21.1.23; VANDERGEER P, 1994, ANNU REV CELL BIOL, V10, P251, DOI 10.1146/annurev.cellbio.10.1.251; Webster MK, 1996, EMBO J, V15, P520, DOI 10.1002/j.1460-2075.1996.tb00384.x; Webster MK, 1997, TRENDS GENET, V13, P178, DOI 10.1016/S0168-9525(97)01131-1; WEINER DB, 1989, NATURE, V339, P230, DOI 10.1038/339230a0; You M, 2007, BIOCHEMISTRY-US, V46, P11039, DOI 10.1021/bi700986n	47	7	7	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2012	7	4							e34808	10.1371/journal.pone.0034808	http://dx.doi.org/10.1371/journal.pone.0034808			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959XD	22529939	Green Published, Green Submitted, gold			2022-12-25	WOS:000305350600030
J	Kim, RS; Avivar-Valderas, A; Estrada, Y; Bragado, P; Sosa, MS; Aguirre-Ghiso, JA; Segall, JE				Kim, Ryung S.; Avivar-Valderas, Alvaro; Estrada, Yeriel; Bragado, Paloma; Sosa, Maria Soledad; Aguirre-Ghiso, Julio A.; Segall, Jeffrey E.			Dormancy Signatures and Metastasis in Estrogen Receptor Positive and Negative Breast Cancer	PLOS ONE			English	Article							CELL-LINES; EXPRESSION; THERAPY	Breast cancers can recur after removal of the primary tumor and treatment to eliminate remaining tumor cells. Recurrence may occur after long periods of time during which there are no clinical symptoms. Tumor cell dormancy may explain these prolonged periods of asymptomatic residual disease and treatment resistance. We generated a dormancy gene signature from published experimental models and applied it to both breast cancer cell line expression data as well as four published clinical studies of primary breast cancers. We found that estrogen receptor (ER) positive breast cell lines and primary tumors have significantly higher dormancy signature scores (P<0.0000001) than ER-cell lines and tumors. In addition, a stratified analysis combining all ER+ tumors in four studies indicated 2.1 times higher hazard of recurrence among patients whose tumors had low dormancy scores (LDS) compared to those whose tumors had high dormancy scores (HDS) (p<0.000005). The trend was shown in all four individual studies. Suppression of two dormancy genes, BHLHE41 and NR2F1, resulted in increased in vivo growth of ER positive MCF7 cells. The patient data analysis suggests that disseminated ER positive tumor cells carrying a dormancy signature are more likely to undergo prolonged dormancy before resuming metastatic growth. Furthermore, genes identified with this approach might provide insight into the mechanisms of dormancy onset and maintenance as well as dormancy models using human breast cancer cell lines.	[Kim, Ryung S.] Albert Einstein Coll Med, Dept Epidemiol & Populat Hlth, Bronx, NY 10467 USA; [Avivar-Valderas, Alvaro; Estrada, Yeriel; Bragado, Paloma; Sosa, Maria Soledad; Aguirre-Ghiso, Julio A.] Mt Sinai Sch Med, Tisch Canc Inst, Dept Med, Div Hematol & Oncol, New York, NY USA; [Avivar-Valderas, Alvaro; Estrada, Yeriel; Bragado, Paloma; Sosa, Maria Soledad; Aguirre-Ghiso, Julio A.] Mt Sinai Sch Med, Tisch Canc Inst, Dept Otolaryngol, New York, NY USA; [Segall, Jeffrey E.] Albert Einstein Coll Med, Dept Anat & Struct Biol, Bronx, NY 10467 USA; [Segall, Jeffrey E.] Albert Einstein Coll Med, Gruss Lipper Biophoton Ctr, Bronx, NY 10467 USA	Yeshiva University; Albert Einstein College of Medicine; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Kim, RS (corresponding author), Albert Einstein Coll Med, Dept Epidemiol & Populat Hlth, Bronx, NY 10467 USA.	julio.aguirre-ghiso@mssm.edu; jeffrey.segall@einstein.yu.edu	Bragado Domingo, Paloma/A-8679-2015	Bragado Domingo, Paloma/0000-0002-7642-1245; Aguirre-Ghiso, Julio/0000-0002-6694-6507	Samuel Waxman Cancer Research Foundation Tumor Dormancy Program; United States National Institutes of Health/National Cancer Institute [CA109182, CA163131, 5P30CA013330-37, 1UL1RR025750-0, CA77522, CA1000324]; NIEHS [ES017146]; NYSTEM; NATIONAL CANCER INSTITUTE [P30CA013330, R01CA077522, R01CA109182, U54CA163131] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025750] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R21ES017146] Funding Source: NIH RePORTER	Samuel Waxman Cancer Research Foundation Tumor Dormancy Program; United States National Institutes of Health/National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NYSTEM; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work is supported by grants from the Samuel Waxman Cancer Research Foundation Tumor Dormancy Program (J.A.A.-G), United States National Institutes of Health/National Cancer Institute (CA109182 and CA163131 to J.A.A.-G, 5P30CA013330-37 to R. K., 1UL1RR025750-0 to R. K., CA77522 and CA1000324 to J.E.S.), NIEHS (ES017146) and NYSTEM to J.A.A.-G. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe O, 2005, LANCET, V365, P1687, DOI 10.1016/s0140-6736(05)66544-0; Adam AP, 2009, CANCER RES, V69, P5664, DOI 10.1158/0008-5472.CAN-08-3820; Adorno M, 2009, CELL, V137, P87, DOI 10.1016/j.cell.2009.01.039; Aguirre-Ghiso JA, 2007, NAT REV CANCER, V7, P834, DOI 10.1038/nrc2256; Almog N, 2009, CANCER RES, V69, P836, DOI 10.1158/0008-5472.CAN-08-2590; ANDERSEN PK, 1982, ANN STAT, V10, P1100, DOI 10.1214/aos/1176345976; Ben T, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2904; Hollander M., 1973, NONPARAMETRIC STAT M; Kenny PA, 2007, MOL ONCOL, V1, P84, DOI 10.1016/j.molonc.2007.02.004; Klopp AH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012180; Li C., 2003, ANAL GENE EXPRESSION, P120; Loi S, 2007, J CLIN ONCOL, V25, P1239, DOI 10.1200/JCO.2006.07.1522; McGillicuddy FC, 2006, VASC PHARMACOL, V44, P469, DOI 10.1016/j.vph.2006.03.002; Muller V, 2005, CLIN CANCER RES, V11, P3678, DOI 10.1158/1078-0432.CCR-04-2469; Naumov GN, 2003, BREAST CANCER RES TR, V82, P199, DOI 10.1023/B:BREA.0000004377.12288.3c; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; Pantel K, 2004, NAT REV CANCER, V4, P448, DOI 10.1038/nrc1370; Pawitan Y, 2005, BREAST CANCER RES, V7, pR953, DOI 10.1186/bcr1325; Takekawa M, 2002, EMBO J, V21, P6473, DOI 10.1093/emboj/cdf643; Team RDC, 2009, R LANG ENV STAT COMP; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; Vessella RL, 2007, CANC BIOL THER, P6; Wang YX, 2005, LANCET, V365, P671, DOI 10.1016/S0140-6736(05)17947-1	23	121	122	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2012	7	4							e35569	10.1371/journal.pone.0035569	http://dx.doi.org/10.1371/journal.pone.0035569			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959XD	22530051	gold, Green Published, Green Submitted			2022-12-25	WOS:000305350600099
J	Menzies, BR; Renfree, MB; Heider, T; Mayer, F; Hildebrandt, TB; Pask, AJ				Menzies, Brandon R.; Renfree, Marilyn B.; Heider, Thomas; Mayer, Frieder; Hildebrandt, Thomas B.; Pask, Andrew J.			Limited Genetic Diversity Preceded Extinction of the Tasmanian Tiger	PLOS ONE			English	Article							POPULATION-STRUCTURE	The Tasmanian tiger or thylacine was the largest carnivorous marsupial when Europeans first reached Australia. Sadly, the last known thylacine died in captivity in 1936. A recent analysis of the genome of the closely related and extant Tasmanian devil demonstrated limited genetic diversity between individuals. While a similar lack of diversity has been reported for the thylacine, this analysis was based on just two individuals. Here we report the sequencing of an additional 12 museum-archived specimens collected between 102 and 159 years ago. We examined a portion of the mitochondrial DNA hypervariable control region and determined that all sequences were on average 99.5% identical at the nucleotide level. As a measure of accuracy we also sequenced mitochondrial DNA from a mother and two offspring. As expected, these samples were found to be 100% identical, validating our methods. We also used 454 sequencing to reconstruct 2.1 kilobases of the mitochondrial genome, which shared 99.91% identity with the two complete thylacine mitochondrial genomes published previously. Our thylacine genomic data also contained three highly divergent putative nuclear mitochondrial sequences, which grouped phylogenetically with the published thylacine mitochondrial homologs but contained 100-fold more polymorphisms than the conserved fragments. Together, our data suggest that the thylacine population in Tasmania had limited genetic diversity prior to its extinction, possibly as a result of their geographic isolation from mainland Australia approximately 10,000 years ago.	[Menzies, Brandon R.; Hildebrandt, Thomas B.] Leibniz Inst Zoo & Wildlife Res, Berlin, Germany; [Menzies, Brandon R.; Renfree, Marilyn B.] Univ Melbourne, Dept Zool, Royal Parade, Vic, Australia; [Heider, Thomas; Pask, Andrew J.] Univ Connecticut, Dept Mol & Cell Biol, Storrs, CT USA; [Mayer, Frieder] Berlin Museum Nat Kunde, Leibniz Inst Evolut & Biodivers Forsch, Berlin, Germany	Leibniz Institut fur Zoo und Wildtierforschung; University of Melbourne; University of Connecticut; Leibniz Institut fur Evolutions und Biodiversitatsforschung	Menzies, BR (corresponding author), Leibniz Inst Zoo & Wildlife Res, Berlin, Germany.	menzies@izw-berlin.de	Menzies, Brandon/K-8538-2012	Renfree, Marilyn/0000-0002-4589-0436; Pask, Andrew/0000-0002-1900-2263; Menzies, Brandon/0000-0002-1897-0115	Humboldt Research fellowship	Humboldt Research fellowship(Alexander von Humboldt Foundation)	This study was funded by a Humboldt Research fellowship awarded to BRM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bensasson D, 2001, TRENDS ECOL EVOL, V16, P314, DOI 10.1016/S0169-5347(01)02151-6; Dixon J.M., 1989, P549; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Guiler K. R., 1961, Australian Journal of Science, V23, P207; Hansen BD, 2009, MOL ECOL, V18, P3346, DOI 10.1111/j.1365-294X.2009.04269.x; Jones ME, 2004, MOL ECOL, V13, P2197, DOI 10.1111/j.1365-294X.2004.02239.x; Kolokotronis SO, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-67; Krajewski C, 1997, P ROY SOC B-BIOL SCI, V264, P911, DOI 10.1098/rspb.1997.0126; Leonard JA, 2005, MOL ECOL, V14, P9, DOI 10.1111/j.1365-294X.2004.02389.x; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Luo ZX, 2011, NATURE, V476, P442, DOI 10.1038/nature10291; Miller W, 2011, P NATL ACAD SCI USA, V108, P12348, DOI 10.1073/pnas.1102838108; Miller W, 2009, GENOME RES, V19, P213, DOI 10.1101/gr.082628.108; PAABO S, 1988, NUCLEIC ACIDS RES, V16, P9775, DOI 10.1093/nar/16.20.9775; Paddle R., 2000, LAST TASMANIAN TIGER; Pask AJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002240; Savolainen P, 2004, P NATL ACAD SCI USA, V101, P12387, DOI 10.1073/pnas.0401814101; Siddle HV, 2007, P NATL ACAD SCI USA, V104, P16221, DOI 10.1073/pnas.0704580104; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Vila C, 1997, SCIENCE, V276, P1687, DOI 10.1126/science.276.5319.1687	21	18	18	1	119	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2012	7	4							e35433	10.1371/journal.pone.0035433	http://dx.doi.org/10.1371/journal.pone.0035433			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959XD	22530022	gold, Green Published			2022-12-25	WOS:000305350600082
J	Patouraux, S; Bonnafous, S; Voican, CS; Anty, R; Saint-Paul, MC; Rosenthal-Allieri, MA; Agostini, H; Njike, M; Barri-Ova, N; Naveau, S; Le Marchand-Brustel, Y; Veillon, P; Cales, P; Perlemuter, G; Tran, A; Gual, P				Patouraux, Stephanie; Bonnafous, Stephanie; Voican, Cosmin S.; Anty, Rodolphe; Saint-Paul, Marie-Christine; Rosenthal-Allieri, Maria-Alessandra; Agostini, Helene; Njike, Micheline; Barri-Ova, Nadege; Naveau, Sylvie; Le Marchand-Brustel, Yannick; Veillon, Pascal; Cales, Paul; Perlemuter, Gabriel; Tran, Albert; Gual, Philippe			The Osteopontin Level in Liver, Adipose Tissue and Serum Is Correlated with Fibrosis in Patients with Alcoholic Liver Disease	PLOS ONE			English	Article							NONALCOHOLIC STEATOHEPATITIS; HEPATOCELLULAR-CARCINOMA; NEUTROPHIL INFILTRATION; INSULIN-RESISTANCE; GENE-EXPRESSION; STELLATE CELLS; RODENT MODEL; MICE; HEPATITIS; OBESITY	Background: Osteopontin (OPN) plays an important role in the progression of chronic liver diseases. We aimed to quantify the liver, adipose tissue and serum levels of OPN in heavy alcohol drinkers and to compare them with the histological severity of hepatic inflammation and fibrosis. Methodology/Principal Findings: OPN was evaluated in the serum of a retrospective and prospective group of 109 and 95 heavy alcohol drinkers, respectively, in the liver of 34 patients from the retrospective group, and in the liver and adipose tissue from an additional group of 38 heavy alcohol drinkers. Serum levels of OPN increased slightly with hepatic inflammation and progressively with the severity of hepatic fibrosis. Hepatic OPN expression correlated with hepatic inflammation, fibrosis, TGF beta expression, neutrophils accumulation and with the serum OPN level. Interestingly, adipose tissue OPN expression also correlated with hepatic fibrosis even after 7 days of alcohol abstinence. The elevated serum OPN level was an independent risk factor in estimating significant (F >= 2) fibrosis in a model combining alkaline phosphatase, albumin, hemoglobin, OPN and FibroMeter (R) levels. OPN had an area under the receiving operator curve that estimated significant fibrosis of 0.89 and 0.88 in the retrospective and prospective groups, respectively. OPN, Hyaluronate (AUROC: 0.88), total Cytokeratin 18 (AUROC: 0.83) and FibroMeter (R) (AUROC: 0.90) estimated significance to the same extent in the retrospective group. Finally, the serum OPN levels also correlated with hepatic fibrosis and estimated significant (F >= 2) fibrosis in 86 patients with chronic hepatitis C, which suggested that its elevated level could be a general response to chronic liver injury. Conclusion/Significance: OPN increased in the liver, adipose tissue and serum with liver fibrosis in alcoholic patients. Further, OPN is a new relevant biomarker for significant liver fibrosis. OPN could thus be an important actor in the pathogenesis of this chronic liver disease.	[Patouraux, Stephanie; Bonnafous, Stephanie; Anty, Rodolphe; Saint-Paul, Marie-Christine; Le Marchand-Brustel, Yannick; Tran, Albert; Gual, Philippe] INSERM, U1065, Equipe Complicat Hepat Obesite 8, Nice, France; [Patouraux, Stephanie; Anty, Rodolphe; Saint-Paul, Marie-Christine; Le Marchand-Brustel, Yannick; Tran, Albert; Gual, Philippe] Univ Nice Sophia Antipolis, Fac Med, Nice, France; [Patouraux, Stephanie; Saint-Paul, Marie-Christine] Ctr Hosp Univ Nice, Hop Archet, Dept Biol, Nice, France; [Bonnafous, Stephanie; Anty, Rodolphe; Le Marchand-Brustel, Yannick; Tran, Albert; Gual, Philippe] Ctr Hosp Univ Nice, Hop Archet, Dept Digest, Nice, France; [Voican, Cosmin S.; Agostini, Helene; Njike, Micheline; Barri-Ova, Nadege; Naveau, Sylvie; Perlemuter, Gabriel] INSERM, U996, IPSIT, Clamart, France; [Voican, Cosmin S.; Agostini, Helene; Njike, Micheline; Barri-Ova, Nadege; Naveau, Sylvie; Perlemuter, Gabriel] Univ Paris Sud, Fac Med Paris Sud, Le Kremlin Bicetre, France; [Agostini, Helene; Njike, Micheline; Barri-Ova, Nadege; Naveau, Sylvie; Perlemuter, Gabriel] AP HP, Hop Antoine Beclere, Serv Hepatogastroenterol, Clamart, France; [Saint-Paul, Marie-Christine] Ctr Hosp Univ Nice, Hop Archet, Dept Immunol, Nice, France; [Veillon, Pascal; Cales, Paul] Ctr Hosp Univ Angers, Serv Hepatol, Angers, France; [Voican, Cosmin S.] Univ Med & Farm Craiova, Craiova, Romania	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur; UDICE-French Research Universities; Universite Cote d'Azur; CHU Nice; CHU Nice; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Antoine-Beclere - APHP; CHU Nice; Universite d'Angers; Centre Hospitalier Universitaire d'Angers; University of Medicine & Pharmacy of Craiova	Patouraux, S (corresponding author), INSERM, U1065, Equipe Complicat Hepat Obesite 8, Nice, France.	gual@unice.fr	Gual, Philippe/M-8787-2017; CALES, Paul/AFN-9693-2022; Gual, Philippe/P-9833-2019	Gual, Philippe/0000-0001-7393-8356; CALES, Paul/0000-0003-4866-5274; Gual, Philippe/0000-0001-7393-8356; Albert, TRAN/0000-0003-0003-5361; Anty, Rodolphe/0000-0001-8194-9805; Anty, Rodolphe/0000-0002-8053-1957; patouraux, stephanie/0000-0001-6004-7685	Institut National de la Sante et de la Recherche Medicale (France); University of Nice; Programme Hospitalier de Recherche Clinique (Centre Hospitalier Universitaire de Nice); AFEF/Schering-Plough; AFEF/ROCHE; Fondation Recherche Medicale; Centre Hospitalier Universitaire de Nice	Institut National de la Sante et de la Recherche Medicale (France)(Institut National de la Sante et de la Recherche Medicale (Inserm)); University of Nice; Programme Hospitalier de Recherche Clinique (Centre Hospitalier Universitaire de Nice); AFEF/Schering-Plough(Merck & CompanySchering Plough Corporation); AFEF/ROCHE(Roche Holding); Fondation Recherche Medicale; Centre Hospitalier Universitaire de Nice	This work was supported by grants from the Institut National de la Sante et de la Recherche Medicale (France), the University of Nice, the Programme Hospitalier de Recherche Clinique (Centre Hospitalier Universitaire de Nice), and charities (AFEF/Schering-Plough and AFEF/ROCHE to PG and AT). SP was supported by the Fondation Recherche Medicale. PG is the recipient of an Interface Grant from Centre Hospitalier Universitaire de Nice. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apte UM, 2005, TOXICOL APPL PHARM, V207, P25, DOI 10.1016/j.taap.2004.12.018; Baneijee A, 2008, TOXICOL APPL PHARM, V233, P238, DOI 10.1016/j.taap.2008.08.008; Banerjee A, 2006, J PATHOL, V208, P473, DOI 10.1002/path.1917; Banerjee A, 2006, TOXICOL PATHOL, V34, P373, DOI 10.1080/01926230600806543; Bataller R, 2011, BEST PRACT RES CL GA, V25, P231, DOI 10.1016/j.bpg.2011.02.010; BEDOSSA P, 1994, HEPATOLOGY, V20, P15; Bertola A, 2009, DIABETES, V58, P125, DOI 10.2337/db08-0400; Bertola A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013577; Cales P, 2005, HEPATOLOGY, V42, P1373, DOI 10.1002/hep.20935; De Minicis S, 2007, GASTROENTEROLOGY, V132, P1937, DOI 10.1053/j.gastro.2007.02.033; Diao HY, 2004, IMMUNITY, V21, P539, DOI 10.1016/j.immuni.2004.08.012; Friedman SL, 2008, GASTROENTEROLOGY, V134, P1655, DOI 10.1053/j.gastro.2008.03.003; Gao B, 2011, GASTROENTEROLOGY, V141, P1572, DOI 10.1053/j.gastro.2011.09.002; Huang WB, 2010, CLIN CHIM ACTA, V411, P675, DOI 10.1016/j.cca.2010.01.029; Kawashima R, 1999, BIOCHEM BIOPH RES CO, V256, P527, DOI 10.1006/bbrc.1999.0372; Kiefer FW, 2011, DIABETOLOGIA, V54, P2132, DOI 10.1007/s00125-011-2170-0; Kiefer FW, 2010, DIABETES, V59, P935, DOI 10.2337/db09-0404; Koh A, 2007, IMMUNOLOGY, V122, P466, DOI 10.1111/j.1365-2567.2007.02682.x; Kon S, 2008, J EXP MED, V205, P25, DOI 10.1084/jem.20071324; Lavallard VJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017599; Lee SH, 2004, BIOCHEM PHARMACOL, V68, P2367, DOI 10.1016/j.bcp.2004.08.022; Lenga Y, 2008, CIRC RES, V102, P319, DOI 10.1161/CIRCRESAHA.107.160408; Lorena D, 2006, J HEPATOL, V44, P383, DOI 10.1016/j.jhep.2005.07.024; Lucey MR, 2009, NEW ENGL J MED, V360, P2758, DOI 10.1056/NEJMra0805786; Manning DS, 2008, GASTROENTEROLOGY, V134, P1670, DOI 10.1053/j.gastro.2008.03.001; Mimura S, 2004, J GASTROENTEROL, V39, P867, DOI 10.1007/s00535-004-1403-0; Naveau S, 1997, HEPATOLOGY, V25, P108, DOI 10.1002/hep.510250120; Naveau S, 2010, J HEPATOL, V52, P895, DOI 10.1016/j.jhep.2010.01.029; Naveau S, 2009, HEPATOLOGY, V49, P97, DOI 10.1002/hep.22576; Naveau S, 2009, ALCOHOL CLIN EXP RES, V33, P1104, DOI 10.1111/j.1530-0277.2009.00932.x; Nguyen-Khac E, 2008, ALIMENT PHARM THER, V28, P1188, DOI 10.1111/j.1365-2036.2008.03831.x; Nomiyama T, 2007, J CLIN INVEST, V117, P2877, DOI 10.1172/JCI31986; Orrego H, 1987, GASTROENTEROLOGY, V92, P208, DOI 10.1016/0016-5085(87)90861-4; Ramaiah SK, 2008, TOXICOL SCI, V103, P4, DOI 10.1093/toxsci/kfm246; Raynard B, 2002, HEPATOLOGY, V35, P635, DOI 10.1053/jhep.2002.31782; Rockey DC, 2009, HEPATOLOGY, V49, P1017, DOI 10.1002/hep.22742; Sahai A, 2004, AM J PHYSIOL-GASTR L, V287, pG264, DOI 10.1152/ajpgi.00002.2004; Sahai A, 2004, AM J PHYSIOL-GASTR L, V287, pG1035, DOI 10.1152/ajpgi.00199.2004; Seth' D, 2006, J HEPATOL, V45, P306, DOI 10.1016/j.jhep.2006.04.013; Sun BS, 2008, HEPATOLOGY, V48, P1834, DOI 10.1002/hep.22531; Syn WK, 2011, HEPATOLOGY, V53, P106, DOI 10.1002/hep.23998; Tran A, 2000, EUR J GASTROEN HEPAT, V12, P989, DOI 10.1097/00042737-200012090-00004; Tran A, 2000, GASTROEN CLIN BIOL, V24, P626; Zhao J, 2008, GASTROENTEROLOGY, V135, P956, DOI 10.1053/j.gastro.2008.05.025; Zhao L, 2008, INT J CLIN PRACT, V62, P1056, DOI 10.1111/j.1742-1241.2007.01368.x	45	62	67	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2012	7	4							e35612	10.1371/journal.pone.0035612	http://dx.doi.org/10.1371/journal.pone.0035612			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959XD	22530059	Green Published, gold			2022-12-25	WOS:000305350600105
J	van der Meij, L; Almela, M; Hidalgo, V; Villada, C; IJzerman, H; van Lange, PAM; Salvador, A				van der Meij, Leander; Almela, Mercedes; Hidalgo, Vanesa; Villada, Carolina; IJzerman, Hans; van Lange, Paul A. M.; Salvador, Alicia			Testosterone and Cortisol Release among Spanish Soccer Fans Watching the 2010 World Cup Final	PLOS ONE			English	Article							CHALLENGE HYPOTHESIS; HORMONAL RESPONSES; STRESS RESPONSES; HUMAN MALES; COMPETITION; STRATEGIES; MEN; GENDER; MOOD; AGE	This field study investigated the release of testosterone and cortisol of a vicarious winning experience in Spanish fans watching the finals between Spain and the Netherlands in the 2010 FIFA World Cup Soccer. Spanish fans (n = 50) watched the match with friends or family in a public place or at home and also participated in a control condition. Consistent with hypotheses, results revealed that testosterone and cortisol levels were higher when watching the match than on a control day. However, neither testosterone nor cortisol levels increased after the victory of the Spanish team. Moreover, the increase in testosterone secretion was not related to participants' sex, age or soccer fandom, but the increase in total cortisol secretion during the match was higher among men than among women and among fans that were younger. Also, increases in cortisol secretion were greater to the degree that people were a stronger fan of soccer. Level of fandom further appeared to account for the sex effect, but not for the age effect. Generally, the testosterone data from this study are in line with the challenge hypothesis, as testosterone levels of watchers increased to prepare their organism to defend or enhance their social status. The cortisol data from this study are in line with social self-preservation theory, as higher cortisol secretion among young and greater soccer fans suggests that especially they perceived that a negative outcome of the match would threaten their own social esteem.	[van der Meij, Leander; Almela, Mercedes; Hidalgo, Vanesa; Villada, Carolina; Salvador, Alicia] Univ Valencia, Lab Social Neurosci, Valencia, Spain; [van der Meij, Leander; IJzerman, Hans; van Lange, Paul A. M.] Vrije Univ Amsterdam, Dept Social & Org Psychol, Amsterdam, Netherlands	University of Valencia; Vrije Universiteit Amsterdam	van der Meij, L (corresponding author), Univ Valencia, Lab Social Neurosci, Valencia, Spain.	L.van.der.Meij@vu.nl	van der Meij, Leander/AAC-8945-2019; Almela, Mercedes/AAE-4481-2021; Salvador, Alicia/B-6045-2011	van der Meij, Leander/0000-0001-6394-3071; VILLADA, CAROLINA/0000-0003-1071-2362; IJzerman, Hans/0000-0002-0990-2276; Hidalgo, Vanesa/0000-0003-3920-1099; Almela, Mercedes/0000-0002-8930-0717; Van Lange, Paul/0000-0001-7774-6984; Salvador, Alicia/0000-0002-8686-8083	Santiago Grisolia; PROMETEO grants of the Generalitat Valenciana [2011-048]; Consolider Eje C Project [SEJ2006-1408];  [ACOMP2011-166]	Santiago Grisolia; PROMETEO grants of the Generalitat Valenciana; Consolider Eje C Project; 	This study was supported by the Santiago Grisolia, the ACOMP2011-166, and the PROMETEO 2011-048 grants of the Generalitat Valenciana, and was developed in the framework of the Consolider Eje C Project SEJ2006-1408. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler NE, 2000, HEALTH PSYCHOL, V19, P586, DOI 10.1037/0278-6133.19.6.586; Almela M, 2011, BIOL PSYCHOL, V87, P421, DOI 10.1016/j.biopsycho.2011.05.008; Archer J, 2006, NEUROSCI BIOBEHAV R, V30, P319, DOI 10.1016/j.neubiorev.2004.12.007; Barlovento comunicacion, 2011, ANAL TELEVISION 2010; Bernhardt PC, 1998, PHYSIOL BEHAV, V65, P59, DOI 10.1016/S0031-9384(98)00147-4; Burnham KP, 2004, SOCIOL METHOD RES, V33, P261, DOI 10.1177/0049124104268644; Chatterton RT, 1997, J CLIN ENDOCR METAB, V82, P2503, DOI 10.1210/jc.82.8.2503; Dickerson SS, 2004, PSYCHOL BULL, V130, P355, DOI 10.1037/0033-2909.130.3.355; Diehl M, 1996, PSYCHOL AGING, V11, P127, DOI 10.1037/0882-7974.11.1.127; DIGGLE PJ, 1988, BIOMETRICS, V44, P959, DOI 10.2307/2531727; Edwards DA, 2006, HORM BEHAV, V50, P681, DOI 10.1016/j.yhbeh.2006.09.005; GLADUE BA, 1989, AGGRESSIVE BEHAV, V15, P409, DOI 10.1002/1098-2337(1989)15:6<409::AID-AB2480150602>3.0.CO;2-P; Gonzalez-Bono E, 1999, HORM BEHAV, V35, P55, DOI 10.1006/hbeh.1998.1496; Granger DA, 2009, PSYCHONEUROENDOCRINO, V34, P1437, DOI 10.1016/j.psyneuen.2009.06.017; Hasegawa M, 2008, BIOMED RES-TOKYO, V29, P43, DOI 10.2220/biomedres.29.43; KIRSCHBAUM C, 1993, NEUROPSYCHOBIOLOGY, V28, P76, DOI 10.1159/000119004; Kivlighan KT, 2005, PSYCHONEUROENDOCRINO, V30, P58, DOI 10.1016/j.psyneuen.2004.05.009; LUGER A, 1987, NEW ENGL J MED, V316, P1309, DOI 10.1056/NEJM198705213162105; MAZUR A, 1980, HORM BEHAV, V14, P236, DOI 10.1016/0018-506X(80)90032-X; Mazur A, 1998, BEHAV BRAIN SCI, V21, P353, DOI 10.1017/S0140525X98001228; Oliveira T, 2009, PSYCHONEUROENDOCRINO, V34, P1056, DOI 10.1016/j.psyneuen.2009.02.006; Otte C, 2005, PSYCHONEUROENDOCRINO, V30, P80, DOI 10.1016/j.psyneuen.2004.06.002; Peters ML, 1998, PSYCHONEUROENDOCRINO, V23, P1, DOI 10.1016/S0306-4530(97)00082-6; Preacher KJ, 2008, BEHAV RES METHODS, V40, P879, DOI 10.3758/BRM.40.3.879; Salvador A, 2005, NEUROSCI BIOBEHAV R, V29, P195, DOI 10.1016/j.neubiorev.2004.07.004; Salvador A, 2003, PSYCHONEUROENDOCRINO, V28, P364, DOI 10.1016/S0306-4530(02)00028-8; Salvador A, 2009, NEUROSCI BIOBEHAV R, V33, P160, DOI 10.1016/j.neubiorev.2008.09.005; Sandin B, 1999, PSICOTHEMA, V11, P37; SAPOLSKY RM, 1986, ENDOCR REV, V7, P284, DOI 10.1210/edrv-7-3-284; Sapolsky RM, 2000, ENDOCR REV, V21, P55, DOI 10.1210/er.21.1.55; SEEMAN TE, 1995, J PSYCHOSOM RES, V39, P69, DOI 10.1016/0022-3999(94)00076-H; Serrano MA, 2000, PSICOTHEMA, V12, P440; Stichting KijkOnderzoek, 2011, SKO JAARV 2010; Suay F, 1999, PSYCHONEUROENDOCRINO, V24, P551, DOI 10.1016/S0306-4530(99)00011-6; Ursin H, 2004, PSYCHONEUROENDOCRINO, V29, P567, DOI 10.1016/S0306-4530(03)00091-X; van der Meij L, 2010, BIOL PSYCHOL, V84, P330, DOI 10.1016/j.biopsycho.2010.03.017; WINGFIELD JC, 1990, AM NAT, V136, P829, DOI 10.1086/285134	37	36	36	2	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2012	7	4							e34814	10.1371/journal.pone.0034814	http://dx.doi.org/10.1371/journal.pone.0034814			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959XD	22529940	gold, Green Published, Green Submitted			2022-12-25	WOS:000305350600031
J	Wong, PCM; Chandrasekaran, B; Zheng, J				Wong, Patrick C. M.; Chandrasekaran, Bharath; Zheng, Jing			The Derived Allele of ASPM Is Associated with Lexical Tone Perception	PLOS ONE			English	Article							ONGOING ADAPTIVE EVOLUTION; GENE-GENE INTERACTION; BRAIN-SIZE GENES; AUDITORY-CORTEX; HESCHLS GYRUS; PITCH; MICROCEPHALIN; LANGUAGE; SPEECH; MCPH1	The ASPM and MCPH1 genes have been implicated in the adaptive evolution of the human brain [Mekel-Bobrov N. et al., 2005. Ongoing adaptive evolution of ASPM, a brain size determinant in homo sapiens. Science 309; Evans P. D. et al., 2005. Microcephalin, a gene regulating brain size, continues to evolve adaptively in humans. Science 309]. Curiously, experimental attempts have failed to connect the implicated SNPs in these genes with higher-level brain functions. These results stand in contrast with a population-level study linking the population frequency of their alleles with the tendency to use lexical tones in a language [Dediu D., Ladd D. R., 2007. Linguistic tone is related to the population frequency of the adaptive haplogroups of two brain size genes, ASPM and microcephalin. Proc. Natl. Acad. Sci. U. S. A. 104]. In the present study, we found a significant correlation between the load of the derived alleles of ASPM and tone perception in a group of European Americans who did not speak a tone language. Moreover, preliminary results showed a significant correlation between ASPM load and hemodynamic responses to lexical tones in the auditory cortex, and such correlation remained after phonemic awareness, auditory working memory, and non-verbal IQ were controlled. As in previous studies, no significant correlation between ASPM and cognitive measures were found. MCPH1 did not correlate with any measures. These results suggest that the association between the recently derived allele of ASPM is likely to be specific and is tied to higher level brain functions in the temporal cortex related to human communication.	[Wong, Patrick C. M.; Chandrasekaran, Bharath] Northwestern Univ, Roxelyn & Richard Pepper Dept Commun Sci & Disord, Evanston, IL 60208 USA; [Wong, Patrick C. M.; Zheng, Jing] Northwestern Univ, Sch Med, Dept Otolaryngol Head & Neck Surg, Chicago, IL 60611 USA; [Wong, Patrick C. M.; Zheng, Jing] Northwestern Univ, Hugh Knowles Ctr Clin & Basic Sci Hearing & Disor, Chicago, IL USA	Northwestern University; Northwestern University; Northwestern University	Wong, PCM (corresponding author), Northwestern Univ, Roxelyn & Richard Pepper Dept Commun Sci & Disord, Evanston, IL 60208 USA.	pwong@northwestern.edu	Wong, Patrick/A-8102-2012; Zheng, Jing/F-5273-2017; Dediu, Dan/E-3279-2012	Zheng, Jing/0000-0003-2790-1143; Dediu, Dan/0000-0002-0704-6365; Chandrasekaran, Bharath/0000-0002-3673-9435; Wong, Patrick/0000-0002-6105-5027	National Science Foundation [BCS-1125144]; National Institutes of Health [R01DC008333, K02AG035382, R21DC009652, ARRA R21DC009652-S1, ARRA RC1DC010633]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025741] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K02AG035382] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R21DC009652, R01DC008333, RC1DC010633, R01DC011813] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work is supported by grants from the National Science Foundation (BCS-1125144) and the National Institutes of Health (R01DC008333, K02AG035382, R21DC009652, & ARRA R21DC009652-S1) awarded to Dr. Wong (PI), and the National Institutes of Health (ARRA RC1DC010633) awarded to Dr. Zheng (PI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1932, STAT METHODS RES WOR; Bates TC, 2008, INTELLIGENCE, V36, P689, DOI 10.1016/j.intell.2008.04.001; Battle NC, 2007, AM J RESP CRIT CARE, V175, P881, DOI 10.1164/rccm.200607-992OC; Bendor D, 2005, NATURE, V436, P1161, DOI 10.1038/nature03867; Bishop DVM, 2001, PHILOS T R SOC B, V356, P369, DOI 10.1098/rstb.2000.0770; Bond J, 2002, NAT GENET, V32, P316, DOI 10.1038/ng995; Brown L., 1997, TEST NONVERBAL INTEL; Castles A, 2004, COGNITION, V91, P77, DOI 10.1016/S0010-0277(03)00164-1; Chandrasekaran B, 2011, J COGNITIVE NEUROSCI; Chandrasekaran B, 2010, J ACOUST SOC AM, V128, P456, DOI 10.1121/1.3445785; Chiao JY, 2010, P ROY SOC B-BIOL SCI, V277, P529, DOI 10.1098/rspb.2009.1650; CHURCH BA, 1994, J EXP PSYCHOL LEARN, V20, P521, DOI 10.1037/0278-7393.20.3.521; Comings DE, 2003, MOL PSYCHIATR, V8, P10, DOI 10.1038/sj.mp.4001095; Cox J, 2006, TRENDS MOL MED, V12, P358, DOI 10.1016/j.molmed.2006.06.006; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; Dediu D, 2007, P NATL ACAD SCI USA, V104, P10944, DOI 10.1073/pnas.0610848104; Dobson-Stone C, 2007, NEUROIMAGE, V37, P394, DOI 10.1016/j.neuroimage.2007.05.011; Donald M, 1991, CHRONOLOGY ANATOMICA; Drayna D, 2001, SCIENCE, V291, P1969, DOI 10.1126/science.291.5510.1969; Dreher JC, 2009, P NATL ACAD SCI USA, V106, P617, DOI 10.1073/pnas.0805517106; Dryer Matthew S., 2013, WORLD ATLAS LANGUAGE; Evans PD, 2005, SCIENCE, V309, P1717, DOI 10.1126/science.1113722; Fish JL, 2006, P NATL ACAD SCI USA, V103, P10438, DOI 10.1073/pnas.0604066103; Gagnepain P, 2008, J NEUROSCI, V28, P5281, DOI 10.1523/JNEUROSCI.0565-08.2008; Grill-Spector K, 2006, TRENDS COGN SCI, V10, P14, DOI 10.1016/j.tics.2005.11.006; Grill-Spector K, 2001, ACTA PSYCHOL, V107, P293, DOI 10.1016/S0001-6918(01)00019-1; Jackson AP, 2002, AM J HUM GENET, V71, P136, DOI 10.1086/341283; Jackson AP, 1998, AM J HUM GENET, V63, P541, DOI 10.1086/301966; Jerison HJ., 1973, EVOLUTION BRAIN INTE; Jocham G, 2009, J NEUROSCI, V29, P3695, DOI 10.1523/JNEUROSCI.5195-08.2009; Kim HS, 2010, P NATL ACAD SCI USA, V107, P15717, DOI 10.1073/pnas.1010830107; Klein TA, 2007, SCIENCE, V318, P1642, DOI 10.1126/science.1145044; Lewin R, 1993, LANGUAGE MODERN HUMA; Liu XZ, 2003, HUM MOL GENET, V12, P1155, DOI 10.1093/hmg/ddg127; Luo H, 2006, P NATL ACAD SCI USA, V103, P19558, DOI 10.1073/pnas.0607065104; Mekel-Bobrov N, 2005, SCIENCE, V309, P1720, DOI 10.1126/science.1116815; Mekel-Bobrov N, 2007, HUM MOL GENET, V16, P600, DOI 10.1093/hmg/ddl487; Morell RJ, 2007, HUM GENET, V122, P103, DOI 10.1007/s00439-007-0384-5; Peretz I, 2007, AM J HUM GENET, V81, P582, DOI 10.1086/521337; Posthuma D, 2006, CURR DIR PSYCHOL SCI, V15, P151, DOI 10.1111/j.1467-8721.2006.00426.x; Rice M.L., 2007, HDB LANGUAGE DEV, P411; Rimol LM, 2009, P NATL ACAD SCI; Tang BL, 2006, BIOCHEM BIOPH RES CO, V345, P911, DOI 10.1016/j.bbrc.2006.05.040; Timpson N, 2007, SCIENCE, V317, DOI 10.1126/science.1141705; VARGHAKHADEM F, 1995, P NATL ACAD SCI USA, V92, P930, DOI 10.1073/pnas.92.3.930; Wang JK, 2008, HUM MOL GENET, V17, P1329, DOI 10.1093/hmg/ddn021; Warrier C, 2009, J NEUROSCI, V29, P61, DOI 10.1523/JNEUROSCI.3489-08.2009; Wiggs CL, 1998, CURR OPIN NEUROBIOL, V8, P227, DOI 10.1016/S0959-4388(98)80144-X; Wong PCM, 2008, CEREB CORTEX, V18, P828, DOI 10.1093/cercor/bhm115; Wong PCM, 2007, APPL PSYCHOLINGUIST, V28, P565, DOI 10.1017/S0142716407070312; Wong PCM, 2007, HUM BRAIN MAPP, V28, P995, DOI 10.1002/hbm.20330; Woodcock R, 2010, WOODCOCK JOHNSON PSY; Yacubian J, 2007, P NATL ACAD SCI USA, V104, P8125, DOI 10.1073/pnas.0702029104; Zatorre RJ, 2008, PHILOS T R SOC B, V363, P1087, DOI 10.1098/rstb.2007.2161; [No title captured]	55	17	17	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2012	7	4							e34243	10.1371/journal.pone.0034243	http://dx.doi.org/10.1371/journal.pone.0034243			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WC	22529908	gold, Green Published, Green Submitted			2022-12-25	WOS:000305347400008
J	Beq, S; Rozlan, S; Pelletier, S; Willems, B; Bruneau, J; Lelievre, JD; Levy, Y; Shoukry, NH; Cheynier, R				Beq, Stephanie; Rozlan, Sandra; Pelletier, Sandy; Willems, Bernard; Bruneau, Julie; Lelievre, Jean-Daniel; Levy, Yves; Shoukry, Naglaa H.; Cheynier, Remi			Altered Thymic Function during Interferon Therapy in HCV-Infected Patients	PLOS ONE			English	Article							CHRONIC HEPATITIS-C; CD8 T-CELLS; IFN-ALPHA; COMBINATION TREATMENT; PEGYLATED INTERFERON; UP-REGULATION; INTERLEUKIN-7; EXPRESSION; RIBAVIRIN; CD4(+)	Interferon alpha (IFN alpha) therapy, despite good efficacy in curing HCV infection, leads to major side effects, in particular inducement of a strong peripheral T-cell lymphocytopenia. We here analyze the early consequences of IFN alpha therapy on both thymic function and peripheral T-cell homeostasis in patients in the acute or chronic phase of HCV-infection as well as in HIV/HCV co-infected patients. The evolution of T-cell subsets and T-cell homeostasis were estimated by flow cytometry while thymic function was measured through quantification of T-cell receptor excision circles (TREC) and estimation of intrathymic precursor T-cell proliferation during the first four months following the initiation of IFN alpha therapy. Beginning with the first month of therapy, a profound lymphocytopenia was observed for all T-cell subsets, including naive T-cells and recent thymic emigrants (RTE), associated with inhibition of intrathymic precursor T-cell proliferation. Interleukin (IL)-7 plasma concentration rapidly dropped while lymphocytopenia progressed. This was neither a consequence of higher consumption of the cytokine nor due to its neutralization by soluble CD127. Decrease in IL-7 plasma concentration under IFNa therapy correlated with the decline in HCV viral load, thymic activity and RTE concentration in blood. These data demonstrate that IFN alpha-based therapy rapidly impacts on thymopoiesis and, consequently, perturbs T-cell homeostasis. Such a side effect might be detrimental for the continuation of IFN alpha therapy and may lead to an increased level of infectious risk, in particular in HIV/HCV co-infected patients. Altogether, this study suggests the therapeutic potential of IL-7 in the maintenance of peripheral T-cell homeostasis in IFN alpha-treated patients.	[Beq, Stephanie; Rozlan, Sandra; Cheynier, Remi] Inst Pasteur, Dept Virol, Paris, France; [Pelletier, Sandy; Willems, Bernard; Bruneau, Julie; Shoukry, Naglaa H.] Hop St Luc, CRCHUM, Montreal, PQ H2X 1P1, Canada; [Pelletier, Sandy] Univ Montreal, Dept Microbiol & Immunol, Montreal, PQ H3C 3J7, Canada; [Willems, Bernard; Shoukry, Naglaa H.] Univ Montreal, Dept Med, Montreal, PQ H3C 3J7, Canada; [Bruneau, Julie] Univ Montreal, Dept Med Familiale, Montreal, PQ, Canada; [Lelievre, Jean-Daniel; Levy, Yves] Univ Paris 12, INSERM, U955, Grp Henri Mondor Albert Chenevier,AP HP,Immunol C, Creteil, France; [Cheynier, Remi] Inst Cochin, INSERM, U1016, Dept Immunol Hematol, Paris, France; [Cheynier, Remi] Univ Paris 05, Fac Med Rene Descartes, UMR S 8104, Paris, France; [Cheynier, Remi] CNRS, UMR 8104, Paris, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Universite de Montreal; Universite de Montreal; Universite de Montreal; Universite de Montreal; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite	Beq, S (corresponding author), Inst Pasteur, Dept Virol, Paris, France.	remi.cheynier@inserm.fr	, Lelievre/AAB-1398-2020; Cheynier, Remi/E-9921-2010	Cheynier, Remi/0000-0003-1146-660X; Lelievre, Jean-Daniel/0000-0002-8182-3628; Pelletier, Sandy/0000-0002-5869-424X	Institut Pasteur; ANRS (Agence Nationale de Recherches sur le SIDA et les hepatitis virales); SIDACTION; Canadian Institutes for Health Research (CIHR) [MOP-74524]; Fonds de la Recherche en Sante du Quebec (FRSQ) [FRSQ-12428]; FRSQ-AIDS and Infectious Disease Network (SIDA-MI)	Institut Pasteur(European Commission); ANRS (Agence Nationale de Recherches sur le SIDA et les hepatitis virales); SIDACTION; Canadian Institutes for Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Fonds de la Recherche en Sante du Quebec (FRSQ)(Fonds de la Recherche en Sante du Quebec); FRSQ-AIDS and Infectious Disease Network (SIDA-MI)(Fonds de la Recherche en Sante du Quebec)	This work was supported by Institut Pasteur, the ANRS (Agence Nationale de Recherches sur le SIDA et les hepatitis virales), SIDACTION, the Canadian Institutes for Health Research (CIHR) (MOP-74524), Fonds de la Recherche en Sante du Quebec (FRSQ) (FRSQ-12428) and the FRSQ-AIDS and Infectious Disease Network (SIDA-MI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida ARM, 2001, J EXP MED, V194, P591, DOI 10.1084/jem.194.5.591; AMAN MJ, 1994, BLOOD, V84, P4142, DOI 10.1182/blood.V84.12.4142.bloodjournal84124142; Antonini MG, 2008, INFECTION, V36, P250, DOI 10.1007/s15010-007-7132-6; Arizcorreta A, 2006, CLIN EXP IMMUNOL, V146, P270, DOI 10.1111/j.1365-2249.2006.03220.x; Arstila TP, 1999, SCIENCE, V286, P958, DOI 10.1126/science.286.5441.958; Badr G, 2008, J VIROL, V82, P10017, DOI 10.1128/JVI.01083-08; Barata JT, 2001, BLOOD, V98, P1524, DOI 10.1182/blood.V98.5.1524; Beq S, 2006, J IMMUNOL, V176, P914, DOI 10.4049/jimmunol.176.2.914; Beq S, 2009, BLOOD; Bonder CS, 2002, CYTOKINE, V17, P187, DOI 10.1006/cyto.2001.0994; CARLOSTELLA C, 1987, BLOOD, V70, P1014; Chevaliez S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008209; Cox AL, 2009, GASTROENTEROLOGY, V136, P26, DOI 10.1053/j.gastro.2008.11.049; Dieterich DT, 2002, J INFECT DIS, V185, pS128, DOI 10.1086/340199; Dion Marie-Lise, 2007, Methods Mol Biol, V380, P197; Dion ML, 2007, BLOOD, V109, P2912, DOI 10.1182/blood-2006-09-047308; Dion ML, 2004, IMMUNITY, V21, P757, DOI 10.1016/j.immuni.2004.10.013; Dondi E, 2004, J IMMUNOL, V173, P3740, DOI 10.4049/jimmunol.173.6.3740; Douek DC, 1998, NATURE, V396, P690, DOI 10.1038/25374; Dulude G, 2008, J IMMUNOL, V181, P7818, DOI 10.4049/jimmunol.181.11.7818; Eguchi H, 2000, CLIN CANCER RES, V6, P2881; Fadilah S. A. W., 1999, Southeast Asian Journal of Tropical Medicine and Public Health, V30, P710; Feld JJ, 2005, NATURE, V436, P967, DOI 10.1038/nature04082; Golden-Mason L, 2006, HEPATOLOGY, V44, P1098, DOI 10.1002/hep.21365; Guimond M, 2009, NAT IMMUNOL, V10, P149, DOI 10.1038/ni.1695; He ZP, 2005, INT J INFECT DIS, V9, P323, DOI 10.1016/j.ijid.2004.07.014; Hofmann WP, 2011, NAT REV GASTRO HEPAT, V8, P257, DOI 10.1038/nrgastro.2011.49; Janot-Sardet C, 2009, J IMMUNOL METHODS; Kamphuis E, 2006, BLOOD, V108, P3253, DOI 10.1182/blood-2006-06-027599; Kaser A, 1999, CYTOKINE, V11, P736, DOI 10.1006/cyto.1998.0484; Kimmig S, 2002, J EXP MED, V195, P789, DOI 10.1084/jem.20011756; Kolumam GA, 2005, J EXP MED, V202, P637, DOI 10.1084/jem.20050821; Landau A, 2000, AIDS, V14, P839, DOI 10.1097/00002030-200005050-00010; Lin Q, 1998, J EXP MED, V187, P79, DOI 10.1084/jem.187.1.79; Manna SK, 2000, J IMMUNOL, V165, P4927, DOI 10.4049/jimmunol.165.9.4927; Mazzucchelli R, 2007, NAT REV IMMUNOL, V7, P144, DOI 10.1038/nri2023; McHutchison JG, 2004, GASTROENTEROL CLIN N, V33, pS51, DOI 10.1016/j.gtc.2003.12.001; Moirand R, 2007, CAN J GASTROENTEROL, V21, P355, DOI 10.1155/2007/576765; Napolitano LA, 2001, NAT MED, V7, P73, DOI 10.1038/83381; Neau D, 2003, HIV Med, V4, P120, DOI 10.1046/j.1468-1293.2003.00140.x; Offner F, 1998, LEUKEMIA LYMPHOMA, V30, P87, DOI 10.3109/10428199809050932; Okada H, 2000, ARCH VIROL, V145, P905, DOI 10.1007/s007050050683; Parker R, 2010, BLOOD, V116, P5589, DOI 10.1182/blood-2010-03-276261; PESCE A, 1993, LANCET, V341, P1597, DOI 10.1016/0140-6736(93)90736-Z; Puoti M, 2004, ANTIVIR THER, V9, P627; Sawa Y, 2009, IMMUNITY, V30, P447, DOI 10.1016/j.immuni.2009.01.007; Schluns KS, 2000, NAT IMMUNOL, V1, P426, DOI 10.1038/80868; Segundo FDS, 2006, J VIROL, V80, P2369, DOI 10.1128/JVI.80.5.2369-2379.2006; Shire NJ, 2007, J VIRAL HEPATITIS, V14, P239, DOI 10.1111/j.1365-2893.2006.00824.x; SORIANO V, 1994, AIDS, V8, P1621, DOI 10.1097/00002030-199411000-00016; SORIANO V, 1995, J INFECTION, V31, P9, DOI 10.1016/S0163-4453(95)91178-2; Stark GR, 1998, ANNU REV BIOCHEM, V67, P227, DOI 10.1146/annurev.biochem.67.1.227; Tsukiyama T, 2001, J IMMUNOL, V166, P304, DOI 10.4049/jimmunol.166.1.304; VENTO S, 1993, LANCET, V341, P958, DOI 10.1016/0140-6736(93)91248-K	54	9	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2012	7	4							e34326	10.1371/journal.pone.0034326	http://dx.doi.org/10.1371/journal.pone.0034326			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VO	22529911	Green Published, Green Submitted, gold			2022-12-25	WOS:000305345000016
J	Garcia-Bocanegra, I; de Val, BP; Arenas-Montes, A; Paniagua, J; Boadella, M; Gortazar, C; Arenas, A				Garcia-Bocanegra, Ignacio; Perez de Val, Bernat; Arenas-Montes, Antonio; Paniagua, Jorge; Boadella, Mariana; Gortazar, Christian; Arenas, Antonio			Seroprevalence and Risk Factors Associated to Mycobacterium bovis in Wild Artiodactyl Species from Southern Spain, 2006-2010	PLOS ONE			English	Article							TUBERCULOSIS-LIKE LESIONS; BOAR SUS-SCROFA; RED DEER; SPOLIGOTYPE DIVERSITY; INFECTION; PREVALENCE; DIAGNOSIS; RESERVOIR; CAPRAE; TESTS	The control of bovine tuberculosis (bTB) is at a critical point in the last stage of eradication in livestock. Wildlife species recently have emerged infected with TB in Europe, particularly ungulates in the Iberian Peninsula. Epidemiological information regarding TB in wild ungulates including affected species, prevalence, associated risk factors and appropriate diagnostic methods need to be obtained in these countries. A cross-sectional study was carried out on wild artiodactyl species, including Eurasian wild boar (Sus scrofa) red deer (Cervus elaphus), roe deer (Capraelus capraelus), fallow deer (Dama dama), Spanish ibex (Capra pyrenaica hispanica) and mouflon (Ovis musimon), in Spain to assess the seroprevalence against Mycobacterium bovis or cross-reacting members of the Mycobcaterium tuberculosis complex (MTBC), and to provide information on associated risk factors. Previously, two in-house indirect enzyme linked immunosorbent assays (bPPD-ELISA and MPB83-ELISA) were developed using known TB status sera. Positive reference sera were selected from infected animals confirmed by culture. The M. bovis isolates belonged to spoligotypes SB0121, SB0120, SB0295, SB0265 and SB0134. Two hundred and two out of 1367 (7.5%; 95% CI: 6.1-8.9) animals presented antibodies against M. bovis by both bPPD-ELISA and MPB83-ELISA. Significantly higher TB seroprevalence was observed in wild boar compared to the other species analyzed. Interestingly, seropositivity against M. bovis was not found in any out of 460 Spanish ibex analyzed. The logistic regression model for wild boar indicated that the seropositivity to M. bovis was associated with age, location and year of sampling, while the only risk factor associated with M. bovis seroprevalence in red deer and fallow deer was the age. The seroprevalence observed indicates a widespread exposure to MTBC in several wild artiodactyl species in southern Spain, which may have important implications not only for conservation but also for animal and public health.	[Garcia-Bocanegra, Ignacio; Arenas-Montes, Antonio; Paniagua, Jorge; Arenas, Antonio] Univ Cordoba Agrifood Excellence Int Campus ceiA3, Fac Vet, Dept Sanidad Anim, Cordoba, Spain; UAB IRTA, Ctr Recerca Sanitat Anim CReSA, Barcelona, Spain; [Boadella, Mariana; Gortazar, Christian] Inst Invest Recursos Cineget IREC CSIC UCLM JCCM, Ciudad Real, Spain	IRTA; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigacion en Recursos Cinegeticos (IREC); Universidad de Castilla-La Mancha	Garcia-Bocanegra, I (corresponding author), Univ Cordoba Agrifood Excellence Int Campus ceiA3, Fac Vet, Dept Sanidad Anim, Cordoba, Spain.	nacho.garcia@uco.es	Gortazar, Christian/E-7918-2012; ARENAS, Antonio J/I-3997-2017; Bocanegra, Ignacio Garcia/G-1443-2016; DE VAL, BERNAT PÉREZ/G-6865-2012; Boadella, Mariana/I-8029-2012	Gortazar, Christian/0000-0003-0012-4006; ARENAS, Antonio J/0000-0001-5334-2440; Bocanegra, Ignacio Garcia/0000-0003-3388-2604; DE VAL, BERNAT PÉREZ/0000-0003-3127-9182; Boadella, Mariana/0000-0001-6402-9927	Ministry of Science and Innovation (MCINN) Plan [AGL 2011-30041]; National Institute for Agriculture and Food Research and Technology (INIA) [FAU2008-00019-C03-01]; EU [TBSTEP 212414]; Ministerio de Medio Ambiente y Medio Rural y Marino (SDGSPP); Grupo Santander - Fundacion Marcelino Botin	Ministry of Science and Innovation (MCINN) Plan; National Institute for Agriculture and Food Research and Technology (INIA)(Instituto de Investigacion Agropecuaria (INIA)); EU(European Commission); Ministerio de Medio Ambiente y Medio Rural y Marino (SDGSPP); Grupo Santander - Fundacion Marcelino Botin	This is a contribution to Ministry of Science and Innovation (MCINN) Plan Nacional research grant AGL 2011-30041, National Institute for Agriculture and Food Research and Technology (INIA) grant FAU2008-00019-C03-01 and European Regional Development Fund (FEDER), and to EU grant TBSTEP 212414. Studies on diseases shared between domestic animals and wildlife are also supported by Ministerio de Medio Ambiente y Medio Rural y Marino (SDGSPP), and Grupo Santander - Fundacion Marcelino Botin. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acevedo P, 2006, ACTA THERIOL, V51, P327, DOI 10.1007/BF03192685; Allepuz A, 2011, PREV VET MED, V100, P44, DOI 10.1016/j.prevetmed.2011.02.012; Aranaz A, 2004, J CLIN MICROBIOL, V42, P2602, DOI 10.1128/JCM.42.6.2602-2608.2004; Aurtenetxe O, 2008, BMC VET RES, V4, DOI 10.1186/1746-6148-4-43; Balseiro A, 2009, VET REC, V164, P468, DOI 10.1136/vr.164.15.468; Boadella M, 2012, PREV VET MED, V104, P160, DOI 10.1016/j.prevetmed.2011.10.005; Boadella M, 2011, ECOHEALTH, V8, P478, DOI 10.1007/s10393-011-0713-y; Boadella M, 2011, EUR J WILDLIFE RES, V57, P697, DOI 10.1007/s10344-011-0550-x; Boadella M, 2011, J VET DIAGN INVEST, V23, P77, DOI 10.1177/104063871102300111; Boniotti MB, 2009, J CLIN MICROBIOL, V47, P636, DOI 10.1128/JCM.01192-08; Carta T, 2012, VET J, V192, P544, DOI 10.1016/j.tvjl.2011.08.010; Castillo L, 2011, PREV VET MED, V98, P58, DOI 10.1016/j.prevetmed.2010.11.008; CORDES DO, 1981, NEW ZEAL VET J, V29, P60, DOI 10.1080/00480169.1981.34798; Cubero MJ, 2002, DISTRIBUCION GENETIC, P199; de Mendoza JH, 2006, PREV VET MED, V74, P239, DOI 10.1016/j.prevetmed.2005.10.005; Duarte EL, 2008, VET MICROBIOL, V130, P415, DOI 10.1016/j.vetmic.2008.02.012; Gortazar C, 2006, EUR J WILDLIFE RES, V52, P81, DOI 10.1007/s10344-005-0022-2; Gortazar C, 2011, VET MICROBIOL, V151, P170, DOI 10.1016/j.vetmic.2011.02.041; Gortazar C, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-27; Gortazar C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002776; Haddad N, 2001, J CLIN MICROBIOL, V39, P3623, DOI 10.1128/JCM.39.10.3623-3632.2001; HOSMER DW, 1989, APPL LOGISTIC REGRES; Jaroso R, 2010, VET MICROBIOL, V146, P285, DOI 10.1016/j.vetmic.2010.05.022; Kamerbeek J, 1997, J CLIN MICROBIOL, V35, P907, DOI 10.1128/JCM.35.4.907-914.1997; KRAEMER HC, 1982, ENCY STAT SCI, P352; Lyashchenko KP, 2008, VET MICROBIOL, V132, P283, DOI 10.1016/j.vetmic.2008.05.029; Mentaberre G, 2010, VET REC, V166, P700, DOI 10.1136/vr.c2552; Mendoza MM, 2012, VET J, V191, P267, DOI 10.1016/j.tvjl.2011.05.006; Naranjo V, 2008, VET MICROBIOL, V127, P1, DOI 10.1016/j.vetmic.2007.10.002; O'Brien DJ, 2006, VET MICROBIOL, V112, P313, DOI 10.1016/j.vetmic.2005.11.014; OREILLY LM, 1995, TUBERCLE LUNG DIS, V76, P1, DOI 10.1016/0962-8479(95)90591-X; Parra A, 2006, RES VET SCI, V80, P140, DOI 10.1016/j.rvsc.2005.05.010; de Val BP, 2011, CLIN VACCINE IMMUNOL, V18, P1872, DOI 10.1128/CVI.05323-11; Quintas H, 2010, VET REC, V166, P437, DOI 10.1136/vr.c1678; RITACCO V, 1990, J VET MED B, V37, P19, DOI 10.1111/j.1439-0450.1990.tb01021.x; Rodriguez E, 2009, INT J TUBERC LUNG D, V13, P1536; Rodriguez S, 2010, VET MICROBIOL, V141, P89, DOI 10.1016/j.vetmic.2009.08.007; Saenz De Buruaga M, 1991, RECONOCIMIENTO SEXO; Santos N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012663; Spanish Ministry of the Environment and Rural and Marine Affairs (MARM), 2011, REP SPAN SAN PROGR; Vicente J, 2006, VET RES, V37, P107, DOI 10.1051/vetres:2005044; Vicente J, 2007, VET RES, V38, P451, DOI 10.1051/vetres:2007002; Waters WR, 2006, CLIN VACCINE IMMUNOL, V13, P648, DOI 10.1128/CVI.00061-06; Wilson G, 2009, SCI REV TUBERC UNPUB; Wilton S, 1992, PCR Methods Appl, V1, P269; Zanella G, 2008, J WILDLIFE DIS, V44, P99, DOI 10.7589/0090-3558-44.1.99	46	32	33	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2012	7	4							e34908	10.1371/journal.pone.0034908	http://dx.doi.org/10.1371/journal.pone.0034908			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VO	22523563	Green Published, gold, Green Submitted			2022-12-25	WOS:000305345000035
J	Uboldi, S; Calura, E; Beltrame, L; Nerini, IF; Marchini, S; Cavalieri, D; Erba, E; Chiorino, G; Ostano, P; D'Angelo, D; D'Incalci, M; Romualdi, C				Uboldi, Sarah; Calura, Enrica; Beltrame, Luca; Nerini, Ilaria Fuso; Marchini, Sergio; Cavalieri, Duccio; Erba, Eugenio; Chiorino, Giovanna; Ostano, Paola; D'Angelo, Daniela; D'Incalci, Maurizio; Romualdi, Chiara			A Systems Biology Approach to Characterize the Regulatory Networks Leading to Trabectedin Resistance in an In Vitro Model of Myxoid Liposarcoma	PLOS ONE			English	Article							PHASE-II; EXPRESSION; PLATINUM; ET-743; GENES; ECTEINASCIDIN-743; IDENTIFICATION; MECHANISM; AGENT; CELLS	Trabectedin, a new antitumor compound originally derived from a marine tunicate, is clinically effective in soft tissue sarcoma. The drug has shown a high selectivity for myxoid liposarcoma, characterized by the translocation t(12; 16)(q13; p11) leading to the expression of FUS-CHOP fusion gene. Trabectedin appears to act interfering with mechanisms of transcription regulation. In particular, the transactivating activity of FUS-CHOP was found to be impaired by trabectedin treatment. Even after prolonged response resistance occurs and thus it is important to elucidate the mechanisms of resistance to trabectedin. To this end we developed and characterized a myxoid liposarcoma cell line resistant to trabectedin (402-91/ET), obtained by exposing the parental 402-91 cell line to stepwise increases in drug concentration. The aim of this study was to compare mRNAs, miRNAs and proteins profiles of 402-91 and 402-91/ET cells through a systems biology approach. We identified 3,083 genes, 47 miRNAs and 336 proteins differentially expressed between 402-91 and 402-91/ET cell lines. Interestingly three miRNAs among those differentially expressed, miR-130a, miR-21 and miR-7, harbored CHOP binding sites in their promoter region. We used computational approaches to integrate the three regulatory layers and to generate a molecular map describing the altered circuits in sensitive and resistant cell lines. By combining transcriptomic and proteomic data, we reconstructed two different networks, i.e. apoptosis and cell cycle regulation, that could play a key role in modulating trabectedin resistance. This approach highlights the central role of genes such as CCDN1, RB1, E2F4, TNF, CDKN1C and ABL1 in both pre- and post-transcriptional regulatory network. The validation of these results in in vivo models might be clinically relevant to stratify myxoid liposarcoma patients with different sensitivity to trabectedin treatment.	[Uboldi, Sarah; Beltrame, Luca; Nerini, Ilaria Fuso; Marchini, Sergio; Erba, Eugenio; D'Incalci, Maurizio] Mario Negri Inst Pharmacol Res, Dept Oncol, Milan, Italy; [Calura, Enrica; Romualdi, Chiara] Univ Padua, Dept Biol, Padua, Italy; [Cavalieri, Duccio] Res & Innovat Ctr, Dept Computat Biol, San Michele All Adige, Trento, Italy; [Chiorino, Giovanna; Ostano, Paola] Fdn Edo & Elvo Tempia Valenta, Canc Genom Lab, Biella, Italy; [D'Angelo, Daniela] CNR, I-80125 Naples, Italy	Istituto di Ricerche Farmacologiche Mario Negri IRCCS; University of Padua; Fondazione Edmund Mach; Consiglio Nazionale delle Ricerche (CNR)	Uboldi, S (corresponding author), Mario Negri Inst Pharmacol Res, Dept Oncol, Via Eritrea 62, Milan, Italy.	maurizio.dincalci@marionegri.it	Beltrame, Luca/AAB-1998-2020; Ostano, Paola/K-1979-2018; D'Incalci, Maurizio/AAA-9021-2020; D'Angelo, Daniela/GVT-9143-2022; Chiorino, Giovanna/K-5037-2016; Fuso Nerini, Ilaria/AAY-1505-2020; CAVALIERI, DUCCIO/T-3097-2017; Romualdi, Chiara/K-1132-2016; Marchini, sergio/J-3968-2018; Calura, Enrica/AAA-1847-2021	Beltrame, Luca/0000-0003-3631-6544; Ostano, Paola/0000-0002-4000-2954; D'Incalci, Maurizio/0000-0001-8784-1360; Chiorino, Giovanna/0000-0002-9502-6400; Fuso Nerini, Ilaria/0000-0002-1715-8299; CAVALIERI, DUCCIO/0000-0001-6426-5719; Romualdi, Chiara/0000-0003-4792-9047; Marchini, sergio/0000-0003-1783-7651; Calura, Enrica/0000-0001-8463-2432; Uboldi, Sarah/0000-0002-6430-0323	University of Padova [CPDR075919]; CINECA [HP10BDJ9X8]; ACTO foundation; Compagnia di San Paolo, Torino, Italy; Associazione Italiana per la Ricerca sul Cancro Funding Source: Custom	University of Padova; CINECA(CINECA, Italy); ACTO foundation; Compagnia di San Paolo, Torino, Italy(Compagnia di San Paolo); Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro)	This work was supported by University of Padova (CPDR075919 to CR). Furthermore, the authors want to acknowledge the CINECA Award N. HP10BDJ9X8, 2010 for the availability of high performance computing resources and support. The authors acknowledge the generous contribution of the Italian Association for Cancer Research (AIRC). IFN is recipient of a fellowship from ACTO foundation. PO and GC are supported by Compagnia di San Paolo, Torino, Italy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alao JP, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-24; Alexiou P, 2010, NUCLEIC ACIDS RES, V38, pD137, DOI 10.1093/nar/gkp888; AMAN P, 1992, GENE CHROMOSOME CANC, V5, P278, DOI 10.1002/gcc.2870050403; Betel D, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r90; Blower PE, 2007, MOL CANCER THER, V6, P1483, DOI 10.1158/1535-7163.MCT-07-0009; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Boni V, 2010, MOL CANCER THER, V9, P2265, DOI 10.1158/1535-7163.MCT-10-0061; Carter NJ, 2010, DRUGS, V70, P355, DOI 10.2165/11202860-000000000-00000; Cline MS, 2007, NAT PROTOC, V2, P2366, DOI 10.1038/nprot.2007.324; Conyers Rachel, 2011, Sarcoma, V2011, P483154, DOI 10.1155/2011/483154; D'Incalci M, 2010, MOL CANCER THER, V9, P2157, DOI 10.1158/1535-7163.MCT-10-0263; Del Campo JM, 2009, ANN ONCOL, V20, P1794, DOI 10.1093/annonc/mdp198; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Duan ZF, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006967; Forni C, 2009, MOL CANCER THER, V8, P449, DOI 10.1158/1535-7163.MCT-08-0848; Friard O, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-435; Giovannetti E, CRITICAL REV ONCOLOG; Grosso F, 2009, ANN ONCOL, V20, P1439, DOI 10.1093/annonc/mdp004; Grosso F, 2007, LANCET ONCOL, V8, P595, DOI 10.1016/S1470-2045(07)70175-4; Gu JY, 2011, MED ONCOL, V28, P211, DOI 10.1007/s12032-009-9413-7; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hebert C, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-5; Huber W., 2003, STAT APPL GENET MOL, V2, pARTICL, DOI [10.2202/1544-6115.1008, DOI 10.2202/1544-6115.1008]; Hurley LH, 2001, ADV EXP MED BIOL, V500, P289; Imoto I, 2001, CANCER RES, V61, P6629; Inui M, 2010, NAT REV MOL CELL BIO, V11, P252, DOI 10.1038/nrm2868; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kastan MB, 2004, NATURE, V432, P316, DOI 10.1038/nature03097; Krasner CN, 2007, BRIT J CANCER, V97, P1618, DOI 10.1038/sj.bjc.6604088; Li YM, 2010, HEMATOLOGY, V15, P215, DOI 10.1179/102453310X12647083620840; Marchini S, 2008, ANN ONCOL, V19, P501, DOI 10.1093/annonc/mdm519; Minuzzo M, 2005, MOL PHARMACOL, V68, P1496, DOI 10.1124/mol.105.013615; Minuzzo M, 2000, P NATL ACAD SCI USA, V97, P6780, DOI 10.1073/pnas.97.12.6780; Monk BJ, 2011, GYNECOL ONCOL, V120, P459, DOI 10.1016/j.ygyno.2010.11.012; Nikolsky Y, 2005, TOXICOL LETT, V158, P20, DOI 10.1016/j.toxlet.2005.02.004; Osella M, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001101; Reiner A, 2003, BIOINFORMATICS, V19, P368, DOI 10.1093/bioinformatics/btf877; Sales G, 2010, NUCLEIC ACIDS RES, V38, pW352, DOI 10.1093/nar/gkq423; Sessa C, 2005, J CLIN ONCOL, V23, P1867, DOI 10.1200/JCO.2005.09.032; Shi L, 2010, BRAIN RES, V1352, P255, DOI 10.1016/j.brainres.2010.07.009; Sill M, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-556; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Smyth GK, 2005, BIOINFORMATICS, V21, P2067, DOI 10.1093/bioinformatics/bti270; Sorrentino A, 2008, GYNECOL ONCOL, V111, P478, DOI 10.1016/j.ygyno.2008.08.017; Sui SJH, 2005, NUCLEIC ACIDS RES, V33, P3154, DOI 10.1093/nar/gki624; Uboldi S, 2011, INT J CANC; Witkiewicz-Kucharczyk A, 2006, TOXICOL LETT, V162, P29, DOI 10.1016/j.toxlet.2005.10.018	47	11	13	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2012	7	4							e35423	10.1371/journal.pone.0035423	http://dx.doi.org/10.1371/journal.pone.0035423			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VO	22523595	Green Published, Green Submitted, gold			2022-12-25	WOS:000305345000068
J	Yuan, JH; Cheng, FY; Zhou, SL				Yuan, Jun-Hui; Cheng, Fang-Yun; Zhou, Shi-Liang			Genetic Structure of the Tree Peony (Paeonia rockii) and the Qinling Mountains as a Geographic Barrier Driving the Fragmentation of a Large Population	PLOS ONE			English	Article							NUCLEAR MICROSATELLITES; HABITAT FRAGMENTATION; F-STATISTICS; PATTERNS; HISTORY; WESTERN; DIFFERENTIATION; PHYLOGEOGRAPHY; CONSERVATION; CONSEQUENCES	Background: Tree peonies are great ornamental plants associated with a rich ethnobotanical history in Chinese culture and have recently been used as an evolutionary model. The Qinling Mountains represent a significant geographic barrier in Asia, dividing mainland China into northern (temperate) and southern (semi-tropical) regions; however, their flora has not been well analyzed. In this study, the genetic differentiation and genetic structure of Paeonia rockii and the role of the Qinling Mountains as a barrier that has driven intraspecific fragmentation were evaluated using 14 microsatellite markers. Methodology/Principal Findings: Twenty wild populations were sampled from the distributional range of P. rockii. Significant population differentiation was suggested (F-ST value of 0.302). Moderate genetic diversity at the population level (H-S of 0.516) and high population diversity at the species level (H-T of 0.749) were detected. Significant excess homozygosity (F-IS of 0.076) and recent population bottlenecks were detected in three populations. Bayesian clusters, population genetic trees and principal coordinate analysis all classified the P. rockii populations into three genetic groups and one admixed Wenxian population. An isolation-by-distance model for P. rockii was suggested by Mantel tests (r = 0.6074, P<0.001) and supported by AMOVA (P<0.001), revealing a significant molecular variance among the groups (11.32%) and their populations (21.22%). These data support the five geographic boundaries surrounding the Qinling Mountains and adjacent areas that were detected with Monmonier's maximum-difference algorithm. Conclusions/Significance: Our data suggest that the current genetic structure of P. rockii has resulted from the fragmentation of a formerly continuously distributed large population following the restriction of gene flow between populations of this species by the Qinling Mountains. This study provides a fundamental genetic profile for the conservation and responsible exploitation of the extant germplasm of this species and for improving the genetic basis for breeding its cultivars.	[Yuan, Jun-Hui; Cheng, Fang-Yun] Beijing Forestry Univ, Landscape Architecture Coll, Beijing, Peoples R China; [Cheng, Fang-Yun] Natl Flower Engn Res Ctr, Key Lab Genet & Breeding Forestry Trees & Ornamen, Beijing, Peoples R China; [Yuan, Jun-Hui] Chinese Acad Sci, Inst Bot, State Key Lab Systemat & Evolutionary Bot, Beijing, Peoples R China; [Yuan, Jun-Hui] Gansu Forestry Technol Coll, Tianshui, Gansu, Peoples R China	Beijing Forestry University; Chinese Academy of Sciences; Institute of Botany, CAS	Yuan, JH (corresponding author), Beijing Forestry Univ, Landscape Architecture Coll, Beijing, Peoples R China.	chengfy8@263.net; slzhou@ibcas.ac.cn		Yuan, Junhui/0000-0003-3312-8599	National Natural Science Foundation of China [31171984, 30930010]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was funded by the National Natural Science Foundation of China (31171984, 30930010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aizawa M, 2008, J BIOGEOGR, V35, P1295, DOI 10.1111/j.1365-2699.2008.01880.x; Angers B, 1998, MOL BIOL EVOL, V15, P143, DOI 10.1093/oxfordjournals.molbev.a025911; Bai WN, 2010, NEW PHYTOL, V188, P892, DOI 10.1111/j.1469-8137.2010.03407.x; Burg TM, 2005, MOL ECOL, V14, P3745, DOI 10.1111/j.1365-294X.2005.02710.x; Chapuis MP, 2007, MOL BIOL EVOL, V24, P621, DOI 10.1093/molbev/msl191; Cheng F. Y., 2007, INT J PLANT BREEDING, V1, P89, DOI [10.3923/ijpbg.2007.89.94, DOI 10.3923/IJPBG.2007.89.94, DOI 10.3923/ijpbg.2007.89.94]; Cheng FangYun, 1997, Acta Horticulturae Sinica, V24, P180; Cheng FY, CHINESE FLARE TREE P; Comes HP, 1998, TRENDS PLANT SCI, V3, P432, DOI 10.1016/S1360-1385(98)01327-2; Cornuet JM, 1996, GENETICS, V144, P2001; Dieringer D, 2003, MOL ECOL NOTES, V3, P167, DOI 10.1046/j.1471-8286.2003.00351.x; Dong YP, 2011, J ASIAN EARTH SCI, V41, P213, DOI 10.1016/j.jseaes.2011.03.002; Doyle J. J., 1987, PHYTOCHEMISTRY B, V19, P11, DOI DOI 10.2307/4119796; ElMousadik A, 1996, THEOR APPL GENET, V92, P832, DOI 10.1007/BF00221895; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Fu LG, 1992, CHINESE RED DATA BOO; Goudet J, 2002, FSTAT PROGRAM ESTIMA, DOI DOI 10.1093/OXFORDJOURNALS.JHERED.A111627; Hartl Daniel L., PRINCIPLES POPULATIO; Heuertz M, 2004, EVOLUTION, V58, P976; Hong D., 2010, PEONIES WORLD TAXONO; Hong DY, 2005, ACTA PHYTOTAXON SIN, V43, P169, DOI 10.1360/aps040065; HONG DY, 1998, ACTA PHYTOTAX SINICA, V36, P538; Honnay O, 2007, CONSERV BIOL, V21, P823, DOI 10.1111/j.1523-1739.2006.00646.x; Jing Xin-Ming, 1999, Acta Phytophysiologica Sinica, V25, P214; Keyghobadi N, 2007, CAN J ZOOL, V85, P1049, DOI 10.1139/Z07-095; Knowles LL, 2002, MOL ECOL, V11, P2623, DOI 10.1046/j.1365-294X.2002.01637.x; Lei FM, 2003, BIODIVERS CONSERV, V12, P239, DOI 10.1023/A:1021928801558; Li J.J., 2005, CHINESE TREE PEONY X; Liu JH, 2010, CHINESE J GEOPHYS-CH, V53, P2405, DOI 10.3969/j.issn.0001-5733.2010.10.014; Liu KJ, 2005, BIOINFORMATICS, V21, P2128, DOI 10.1093/bioinformatics/bti282; Manni F, 2004, HUM BIOL, V76, P173, DOI 10.1353/hub.2004.0034; MANTEL N, 1967, CANCER RES, V27, P209; MARUYAMA T, 1985, GENETICS, V111, P675; Meng Li, 2004, Scientia Silvae Sinicae, V40, P110; MONMONIER MS, 1973, GEOGR ANAL, V5, P245; Moore MJ, 2010, P NATL ACAD SCI USA, V107, P4623, DOI 10.1073/pnas.0907801107; NEI M, 1983, J MOL EVOL, V19, P153, DOI 10.1007/BF02300753; NEI M, 1975, EVOLUTION, V29, P1, DOI 10.2307/2407137; Nordborg M, 2001, HDB STAT GENETICS; Paetkau D, 1997, GENETICS, V147, P1943; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Pei YL, 1995, ACTA PHYTO SIN, V33, P350; Pritchard JK, 2000, GENETICS, V155, P945; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; Richard M, 2001, MOL PHYLOGENET EVOL, V20, P351, DOI 10.1006/mpev.2001.0981; Rousset F, 1997, GENETICS, V145, P1219; Sang T, 1997, AM J BOT, V84, P1120, DOI 10.2307/2446155; Schwarzbach AE, 2002, MOL ECOL, V11, P1703, DOI 10.1046/j.1365-294X.2002.01557.x; Shen L, 2005, HEREDITY, V94, P396, DOI 10.1038/sj.hdy.6800616; SLATKIN M, 1995, GENETICS, V139, P457; Sousa V, 2008, CONSERV GENET, V9, P791, DOI 10.1007/s10592-007-9399-7; Takahashi T, 2005, J PLANT RES, V118, P83, DOI 10.1007/s10265-005-0198-2; Tsuda Y, 2005, MOL ECOL, V14, P3929, DOI 10.1111/j.1365-294X.2005.02715.x; Wang HW, 2006, MOL ECOL, V15, P4109, DOI 10.1111/j.1365-294X.2006.03086.x; Wang JX, 2009, CONSERV GENET, V10, P1029, DOI 10.1007/s10592-008-9680-4; Wang Y, 2011, TRIBOL LETT, V41, P163, DOI 10.1007/s11249-010-9697-y; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI [10.2307/2408641, 10.1111/j.1558-5646.1984.tb05657.x]; Ying JS, 1994, ENDEMIC GENERA SEED; Ying T.-S., 1994, ACTA PHYTOTAXONOMICA, V32, P389; Young A, 1996, TRENDS ECOL EVOL, V11, P413, DOI 10.1016/0169-5347(96)10045-8; Yuan JH, 2011, CONSERV GENET, V12, P1539, DOI 10.1007/s10592-011-0251-8; Yuan JH, 2010, INT J PLANT SCI, V171, P409, DOI 10.1086/651228; Zhang JM, 2009, SCI CHINA SER C, V52, P568, DOI 10.1007/s11427-009-0069-5; Zhang YP, 2002, PURE APPL CHEM, V74, P575, DOI 10.1351/pac200274040575; Zou YuPing, 1999, Acta Phytotaxonomica Sinica, V37, P220	66	60	71	2	83	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2012	7	4							e34955	10.1371/journal.pone.0034955	http://dx.doi.org/10.1371/journal.pone.0034955			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VO	22523566	Green Submitted, gold, Green Published			2022-12-25	WOS:000305345000038
J	O'Shaughnessy, PJ; Monteiro, A; Abel, M				O'Shaughnessy, Peter J.; Monteiro, Ana; Abel, Margaret			Testicular Development in Mice Lacking Receptors for Follicle Stimulating Hormone and Androgen	PLOS ONE			English	Article							LEYDIG-CELL DEVELOPMENT; SERTOLI-CELLS; POSTNATAL-DEVELOPMENT; IN-VIVO; MOUSE; SPERMATOGENESIS; APOPTOSIS; TESTIS; FSH; PROLIFERATION	Post-natal testicular development is dependent on gonadotrophin and androgen stimulation. Follicle stimulating hormone (FSH) acts through receptors (FSHR) on the Sertoli cell to stimulate spermatogenesis while androgens promote testis growth through receptors (AR) on the Sertoli cells, Leydig cells and peritubular myoid cells. In this study we have examined the effects on testis development of ablating FSHRs (FSHRKO mice) and/or ARs ubiquitously (ARKO mice) or specifically on the Sertoli cells (SCARKO mice). Cell numbers were measured using stereological methods. In ARKO mice Sertoli cell numbers were reduced at all ages from birth until adulthood. FSHR ablation also caused small reductions in Sertoli cell numbers up to day 20 with more marked effects seen in the adult. Germ cell numbers were unaffected by FSHR and/or AR ablation at birth. By day 20 ubiquitous AR or FSHR ablation caused a marked reduction in germ cell numbers with a synergistic effect of losing both receptors (germ cell numbers in FSHRKO. ARKO mice were 3% of control). Germ cell numbers in SCARKO mice were less affected. By adulthood, in contrast, clear synergistic control of germ cell numbers had become established between the actions of FSH and androgen through the Sertoli cells. Leydig cell numbers were normal on day 1 and day 5 in all groups. By day 20 and in adult animals total AR or FSHR ablation significantly reduced Leydig cell numbers but Sertoli cell specific AR ablation had no effect. Results show that, prior to puberty, development of most testicular parameters is more dependent on FSH action than androgen action mediated through the Sertoli cells although androgen action through other cells types is crucial. Post-pubertally, germ cell numbers and spermatogenesis are dependent on FSH and androgen action through the Sertoli cells.	[O'Shaughnessy, Peter J.; Monteiro, Ana] Univ Glasgow, Inst Biodivers Anim Hlth & Comparat Med, Coll Med Vet & Life Sci, Glasgow, Lanark, Scotland; [Abel, Margaret] Univ Oxford, Dept Human Anat & Genet, Oxford, England	University of Glasgow; University of Oxford	O'Shaughnessy, PJ (corresponding author), Univ Glasgow, Inst Biodivers Anim Hlth & Comparat Med, Coll Med Vet & Life Sci, Glasgow, Lanark, Scotland.	peter.oshaughnessy@glasgow.ac.uk		Monteiro, Ana/0000-0003-2349-9716	Wellcome Trust	Wellcome Trust(Wellcome TrustEuropean Commission)	This study was supported by funding from the Wellcome Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel MH, 2008, ENDOCRINOLOGY, V149, P3279, DOI 10.1210/en.2008-0086; Abel MH, 2000, ENDOCRINOLOGY, V141, P1795, DOI 10.1210/en.141.5.1795; Baker PJ, 2003, ENDOCRINOLOGY, V144, P138, DOI 10.1210/en.2002-220637; Baker PJ, 1999, EUR J BIOCHEM, V260, P911, DOI 10.1046/j.1432-1327.1999.00245.x; Baker PJ, 2001, REPRODUCTION, V122, P227, DOI 10.1530/rep.0.1220227; BILLIG H, 1995, ENDOCRINOLOGY, V136, P5, DOI 10.1210/en.136.1.5; Chang CS, 2004, P NATL ACAD SCI USA, V101, P6876, DOI 10.1073/pnas.0307306101; Chausiaux OE, 2008, BIOL REPROD, V78, P77, DOI 10.1095/biolreprod.107.060970; De Gendt K, 2004, P NATL ACAD SCI USA, V101, P1327, DOI 10.1073/pnas.0308114100; De Gendt K, 2005, ENDOCRINOLOGY, V146, P4117, DOI 10.1210/en.2005-0300; Dierich A, 1998, P NATL ACAD SCI USA, V95, P13612, DOI 10.1073/pnas.95.23.13612; Greep RO, 1936, ANAT REC, V65, P261, DOI 10.1002/ar.1090650303; HARDY MP, 1989, ENDOCRINOLOGY, V124, P762, DOI 10.1210/endo-124-2-762; Haywood M, 2003, ENDOCRINOLOGY, V144, P509, DOI 10.1210/en.2002-220710; Hirst RC, 2004, REPRODUCTION, V128, P43, DOI 10.1530/rep.1.00176; Johnston H, 2004, ENDOCRINOLOGY, V145, P318, DOI 10.1210/en.2003-1055; Kumar TR, 1997, NAT GENET, V15, P201, DOI 10.1038/ng0297-201; Lim P, 2009, ENDOCRINOLOGY; MAYHEW TM, 1992, J NEUROCYTOL, V21, P313, DOI 10.1007/BF01191700; MCLACHLAN RI, 1995, ENDOCRINOLOGY, V136, P4035, DOI 10.1210/en.136.9.4035; Meachem SJ, 2005, J ENDOCRINOL, V186, P429, DOI 10.1677/joe.1.06121; Nef S, 2000, DEV BIOL, V224, P354, DOI 10.1006/dbio.2000.9785; O'Shaughnessy PJ, 2010, ENDOCRINOLOGY, V151, P2343, DOI 10.1210/en.2009-1333; O'Shaughnessy PJ, 2010, REPRODUCTION, V139, P177, DOI 10.1530/REP-09-0377; O'Shaughnessy PJ, 2002, J CELL SCI, V115, P3491; ORTH JM, 1984, ENDOCRINOLOGY, V115, P1248, DOI 10.1210/endo-115-4-1248; Rodriguez I, 1997, EMBO J, V16, P2262, DOI 10.1093/emboj/16.9.2262; Russell LD, 1990, CLEARWATER, P119; Smith PE, 1927, AM J ANAT, V40, P159, DOI 10.1002/aja.1000400202; VERGOUWEN RPFA, 1991, J REPROD FERTIL, V93, P233, DOI 10.1530/jrf.0.0930233; Walczak-Jedrzejowska R, 2011, INT J ANDROL, V34, pE378, DOI 10.1111/j.1365-2605.2011.01146.x; Welsh M, 2012, INT J ANDROL, V35, P25, DOI 10.1111/j.1365-2605.2011.01150.x; Willems A, 2010, INT J ANDROL, V33, P507, DOI 10.1111/j.1365-2605.2009.00964.x; WREFORD NG, 1995, MICROSC RES TECHNIQ, V32, P423, DOI 10.1002/jemt.1070320505; Yoshida S, 2006, DEVELOPMENT, V133, P1495, DOI 10.1242/dev.02316	35	59	64	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2012	7	4							e35136	10.1371/journal.pone.0035136	http://dx.doi.org/10.1371/journal.pone.0035136			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UT	22514715	Green Published, gold, Green Submitted, Green Accepted			2022-12-25	WOS:000305341600121
J	Hennigan, RF; Moon, CA; Parysek, LM; Monk, KR; Morfini, G; Berth, S; Brady, S; Ratner, N				Hennigan, R. F.; Moon, C. A.; Parysek, L. M.; Monk, K. R.; Morfini, G.; Berth, S.; Brady, S.; Ratner, N.			The NF2 tumor suppressor regulates microtubule-based vesicle trafficking via a novel Rac, MLK and p38(SAPK) pathway	ONCOGENE			English	Article						merlin; NF2; Rac; trafficking; exocytosis	FAST AXONAL-TRANSPORT; MEDIATES CONTACT INHIBITION; HUMAN SCHWANNOMA CELLS; NEUROFIBROMATOSIS TYPE-2; PLASMA-MEMBRANE; P21-ACTIVATED KINASE; SIGNALING PATHWAY; ERM PROTEINS; MERLIN; RECEPTOR	Neurofibromatosis type 2 patients develop schwannomas, meningiomas and ependymomas resulting from mutations in the tumor suppressor gene, NF2, encoding a membrane-cytoskeleton adapter protein called merlin. Merlin regulates contact inhibition of growth and controls the availability of growth factor receptors at the cell surface. We tested if microtubule-based vesicular trafficking might be a mechanism by which merlin acts. We found that schwannoma cells, containing merlin mutations and constitutive activation of the Rho/Rac family of GTPases, had decreased intracellular vesicular trafficking relative to normal human Schwann cells. In Nf2-/- mouse Schwann (SC4) cells, re-expression of merlin as well as inhibition of Rac or its effector kinases, MLK and p38(SAPK), each increased the velocity of Rab6 positive exocytic vesicles. Conversely, an activated Rac mutant decreased Rab6 vesicle velocity. Vesicle motility assays in isolated squid axoplasm further demonstrated that both mutant merlin and active Rac specifically reduce anterograde microtubule-based transport of vesicles dependent upon the activity of p38(SAPK) kinase. Taken together, our data suggest loss of merlin results in the Rac-dependent decrease of anterograde trafficking of exocytic vesicles, representing a possible mechanism controlling the concentration of growth factor receptors at the cell surface. Oncogene (2013) 32, 1135-1143; doi:10.1038/onc.2012.135; published online 23 April 2012	[Hennigan, R. F.; Moon, C. A.; Ratner, N.] Cincinnati Childrens Hosp Med Ctr, Div Expt Hematol & Canc Biol, Cincinnati, OH 45229 USA; [Parysek, L. M.] Univ Cincinnati, Sch Med, Dept Cell & Canc Biol, Cincinnati, OH USA; [Monk, K. R.] Washington Univ, Sch Med, Dept Genet, St Louis, MO 63110 USA; [Morfini, G.; Berth, S.; Brady, S.] Univ Illinois, Dept Anat & Cell Biol, Chicago, IL USA; [Morfini, G.; Berth, S.; Brady, S.; Ratner, N.] Marine Biol Lab, Woods Hole, MA 02543 USA	Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; Washington University (WUSTL); University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Marine Biological Laboratory - Woods Hole	Hennigan, RF (corresponding author), Cincinnati Childrens Hosp Med Ctr, Div Expt Hematol & Canc Biol, 240 Albert Sabin Way, Cincinnati, OH 45229 USA.	Robert.Hennigan@cchmc.org	Morfini, Gerardo/AAP-8070-2021	Morfini, Gerardo/0000-0001-6059-5518; RATNER, NANCY/0000-0001-5030-9354	NIH [R01 CA118032, R01 NS23868]; MBL research fellowships; NATIONAL CANCER INSTITUTE [R01CA118032] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH020016] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS023868] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MBL research fellowships; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by NIH R01 CA118032 (to NR), and MBL research fellowships (to NR and GM), NIH R01 NS23868 (to SIB). We thank Atira Dudley Hardiman for assistance with growth and transfection of human cells, Jamie M Walker for expert technical assistance and Dr Yi Zheng for critical reading of the manuscript.	Alfthan K, 2004, J BIOL CHEM, V279, P18559, DOI 10.1074/jbc.M313916200; Ammoun S, 2011, NAT REV NEUROL, V7, P392, DOI 10.1038/nrneurol.2011.82; Avruch J, 2007, BBA-MOL CELL RES, V1773, P1150, DOI 10.1016/j.bbamcr.2006.11.006; Bensenor LB, 2010, P NATL ACAD SCI USA, V107, P7311, DOI 10.1073/pnas.0907389107; Best A, 1996, J BIOL CHEM, V271, P3756; Bos JL, 2007, CELL, V129, P865, DOI 10.1016/j.cell.2007.05.018; Bosco DA, 2010, NAT NEUROSCI, V13, P1396, DOI 10.1038/nn.2660; Bosco EE, 2010, ONCOGENE, V29, P2540, DOI 10.1038/onc.2010.20; BRADY ST, 1990, P NATL ACAD SCI USA, V87, P1061, DOI 10.1073/pnas.87.3.1061; BRADY ST, 1985, CELL MOTIL CYTOSKEL, V5, P81, DOI 10.1002/cm.970050203; Bretscher A, 2002, NAT REV MOL CELL BIO, V3, P586, DOI 10.1038/nrm882; Chen YA, 2001, NAT REV MOL CELL BIO, V2, P98, DOI 10.1038/35052017; Cole BK, 2008, MOL CELL BIOL, V28, P1274, DOI 10.1128/MCB.01139-07; Curto M, 2007, J CELL BIOL, V177, P893, DOI 10.1083/jcb.200703010; Edelstein A., 2010, COMPUTER CONTROL MIC; Gallo KA, 2002, NAT REV MOL CELL BIO, V3, P663, DOI 10.1038/nrm906; Gao Y, 2004, P NATL ACAD SCI USA, V101, P7618, DOI 10.1073/pnas.0307512101; Gerst JE, 1999, CELL MOL LIFE SCI, V55, P707, DOI 10.1007/s000180050328; Giovannini M, 2000, GENE DEV, V14, P1617; Grigoriev I, 2007, DEV CELL, V13, P305, DOI 10.1016/j.devcel.2007.06.010; Hennigan RF, 2010, MOL CELL BIOL, V30, P54, DOI 10.1128/MCB.00248-09; Jin HC, 2006, NATURE, V442, P576, DOI 10.1038/nature04856; Kaempchen K, 2003, HUM MOL GENET, V12, P1211, DOI 10.1093/hmg/ddg146; Kissil JL, 2002, J BIOL CHEM, V277, P10394, DOI 10.1074/jbc.M200083200; Lallemand D, 2009, ONCOGENE, V28, P854, DOI 10.1038/onc.2008.427; Lerdrup M, 2006, J CELL SCI, V119, P85, DOI 10.1242/jcs.02707; Lerdrup M, 2007, MOL BIOL CELL, V18, P3656, DOI 10.1091/mbc.e07-01-0025; Li W, 2010, CELL, V140, P477, DOI 10.1016/j.cell.2010.01.029; MACCOLLIN M, 1993, JAMA-J AM MED ASSOC, V270, P2316, DOI 10.1001/jama.270.19.2316; Maitra S, 2006, CURR BIOL, V16, P702, DOI 10.1016/j.cub.2006.02.063; McClatchey AI, 2003, NAT REV CANCER, V3, P877, DOI 10.1038/nrc1213; McClatchey AI, 2009, TRENDS CELL BIOL, V19, P198, DOI 10.1016/j.tcb.2009.02.006; Morfini G, 2006, NAT NEUROSCI, V9, P907, DOI 10.1038/nn1717; Morfini GA, 2009, J NEUROSCI, V29, P12776, DOI 10.1523/JNEUROSCI.3463-09.2009; Morfini GA, 2009, NAT NEUROSCI, V12, P864, DOI 10.1038/nn.2346; Morrison H, 2001, GENE DEV, V15, P968, DOI 10.1101/gad.189601; Muranen T, 2007, HUM MOL GENET, V16, P1742, DOI 10.1093/hmg/ddm122; Nagata K, 1998, EMBO J, V17, P149, DOI 10.1093/emboj/17.1.149; Nakai Y, 2006, J NEUROSCI, V26, P3390, DOI 10.1523/JNEUROSCI.4865-05.2006; Okada T, 2005, J CELL BIOL, V171, P361, DOI 10.1083/jcb.200503165; Pelton PD, 1998, ONCOGENE, V17, P2195, DOI 10.1038/sj.onc.1202141; Randhawa VK, 2000, MOL BIOL CELL, V11, P2403, DOI 10.1091/mbc.11.7.2403; Rosenbaum C, 1998, NEUROBIOL DIS, V5, P55, DOI 10.1006/nbdi.1998.0179; ROULEAU GA, 1993, NATURE, V363, P515, DOI 10.1038/363515a0; RUTKOWSKI JL, 1995, NAT MED, V1, P80, DOI 10.1038/nm0195-80; Sampo B, 2003, NEURON, V37, P611, DOI 10.1016/S0896-6273(03)00058-8; Shaw RJ, 1998, J BIOL CHEM, V273, P7757, DOI 10.1074/jbc.273.13.7757; Shaw RJ, 2001, DEV CELL, V1, P63, DOI 10.1016/S1534-5807(01)00009-0; Singh BB, 2004, MOL CELL, V15, P635, DOI 10.1016/j.molcel.2004.07.010; Stenoien DL, 1997, MOL BIOL CELL, V8, P675, DOI 10.1091/mbc.8.4.675; Teramoto H, 1996, J BIOL CHEM, V271, P27225, DOI 10.1074/jbc.271.44.27225; Tibbles LA, 1996, EMBO J, V15, P7026, DOI 10.1002/j.1460-2075.1996.tb01094.x; Woodcock SA, 2010, CURR BIOL, V20, P669, DOI 10.1016/j.cub.2010.02.033; Xiao GH, 2002, J BIOL CHEM, V277, P883, DOI 10.1074/jbc.C100553200	54	13	13	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	FEB 28	2013	32	9					1135	1143		10.1038/onc.2012.135	http://dx.doi.org/10.1038/onc.2012.135			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	110FU	22525268	Green Accepted, hybrid, Green Published			2022-12-25	WOS:000316428800007
J	Lo Re, AE; Fernandez-Barrena, MG; Almada, LL; Mills, LD; Elsawa, SF; Lund, G; Ropolo, A; Molejon, MI; Vaccaro, MI; Fernandez-Zapico, ME				Lo Re, Andrea E.; Fernandez-Barrena, Maite G.; Almada, Luciana L.; Mills, Lisa D.; Elsawa, Sherine F.; Lund, George; Ropolo, Alejandro; Molejon, Maria I.; Vaccaro, Maria I.; Fernandez-Zapico, Martin E.			Novel AKT1-GLI3-VMP1 Pathway Mediates KRAS Oncogene-induced Autophagy in Cancer Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DUCTAL PANCREATIC-CANCER; K-RAS; TRANSFORMATION; HEDGEHOG; DISEASE; INHIBITION; EXPRESSION; SURVIVAL; MOUSE; DEATH	Autophagy is an evolutionarily conserved degradation process of cytoplasmic cellular constituents. It has been suggested that autophagy plays a role in tumor promotion and progression downstream oncogenic pathways; however, the molecular mechanisms underlying this phenomenon have not been elucidated. Here, we provide both in vitro and in vivo evidence of a novel signaling pathway whereby the oncogene KRAS induces the expression of VMP1, a molecule needed for the formation of the authophagosome and capable of inducing autophagy, even under nutrient-replete conditions. RNAi experiments demonstrated that KRAS requires VMP1 to induce autophagy. Analysis of the mechanisms identified GLI3, a transcription factor regulated by the Hedgehog pathway, as an effector of KRAS signaling. GLI3 regulates autophagy as well as the expression and promoter activity of VMP1 in a Hedgehog-independent manner. Chromatin immunoprecipitation assays demonstrated that GLI3 binds to the VMP1 promoter and complexes with the histone acetyltransferase p300 to regulate promoter activity. Knockdown of p300 impaired KRAS- and GLI3-induced activation of this promoter. Finally, we identified the PI3K-AKT1 pathway as the signaling pathway mediating the expression and promoter activity of VMP1 upstream of the GLI3-p300 complex. Together, these data provide evidence of a new regulatory mechanism involved in autophagy that integrates this cellular process into the molecular network of events regulating oncogene-induced autophagy.	[Lo Re, Andrea E.; Fernandez-Barrena, Maite G.; Almada, Luciana L.; Mills, Lisa D.; Elsawa, Sherine F.; Lund, George; Fernandez-Zapico, Martin E.] Mayo Clin, Div Oncol Res, Schulze Ctr Novel Therapeut, Rochester, MN 55905 USA; [Lo Re, Andrea E.; Ropolo, Alejandro; Molejon, Maria I.; Vaccaro, Maria I.] Univ Buenos Aires, Dept Pathophysiol, Sch Pharm & Biochem, Buenos Aires, DF, Argentina	Mayo Clinic; University of Buenos Aires	Vaccaro, MI (corresponding author), Mayo Clin, Div Oncol Res, Schulze Ctr Novel Therapeut, Rochester, MN 55905 USA.	mvaccaro@ffyb.uba.ar; fernandezzapico.martin@mayo.edu	Fernandez-Barrena, Maite G/J-8040-2014; Vaccaro, Maria I./L-8348-2017	Fernandez-Barrena, Maite G/0000-0003-0375-6236; Elsawa, Sherine/0000-0002-3917-3078; Vaccaro, Maria/0000-0002-2456-747X	National Institutes of Health Grant [CA136526]; Mayo Clinic Pancreatic SPORE Grant [P50 CA102701]; Mayo Clinic Center for Cell Signaling in Gastroenterology Grant [P30 DK84567]; Agencia Nacional de Promocion Cientfica y Tecnologica Grants [ANPCyT-PICT01627, ANPCyT-PICT0411]; Consejo Nacional de Investigaciones Cientficas y Tecnicas Grant [CONICET-PIP2527]; University of Buenos Aires Grant [UBA-UBACyTM072]; NATIONAL CANCER INSTITUTE [R01CA136526, P50CA102701] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK084567] Funding Source: NIH RePORTER	National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mayo Clinic Pancreatic SPORE Grant; Mayo Clinic Center for Cell Signaling in Gastroenterology Grant; Agencia Nacional de Promocion Cientfica y Tecnologica Grants; Consejo Nacional de Investigaciones Cientficas y Tecnicas Grant; University of Buenos Aires Grant(University of Buenos Aires); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the National Institutes of Health Grant CA136526, Mayo Clinic Pancreatic SPORE Grant P50 CA102701, and Mayo Clinic Center for Cell Signaling in Gastroenterology Grant P30 DK84567 (to M. E. F.- Z.); Agencia Nacional de Promocion Cientfica y Tecnologica Grants ANPCyT-PICT01627 and ANPCyT-PICT0411 (to A. R.); Consejo Nacional de Investigaciones Cientficas y Tecnicas Grant CONICET-PIP2527; and University of Buenos Aires Grant UBA-UBACyTM072 (to M. I. V.).	Akimaru H, 1997, NATURE, V386, P735, DOI 10.1038/386735a0; Amaravadi RK, 2007, J CLIN INVEST, V117, P326, DOI 10.1172/JCI28833; Chen N, 2010, FEBS LETT, V584, P1427, DOI 10.1016/j.febslet.2009.12.034; Elsawa SF, 2011, J BIOL CHEM, V286, P21524, DOI 10.1074/jbc.M111.234146; Grasso D., 2012, INT J CELL BIOL, V2012; Grasso D, 2011, J BIOL CHEM, V286, P8308, DOI 10.1074/jbc.M110.197301; Grasso D, 2009, PANCREATOLOGY, V9, P81, DOI 10.1159/000178878; Guo JY, 2011, GENE DEV, V25, P460, DOI 10.1101/gad.2016311; Hingorani SR, 2003, CANCER CELL, V4, P437, DOI 10.1016/S1535-6108(03)00309-X; Hui CC, 2011, ANNU REV CELL DEV BI, V27, P513, DOI 10.1146/annurev-cellbio-092910-154048; Kim JH, 2011, AUTOPHAGY, V7, P1187, DOI 10.4161/auto.7.10.16643; Kim MJ, 2011, J BIOL CHEM, V286, P12924, DOI 10.1074/jbc.M110.138958; Kundu M, 2008, ANNU REV PATHOL-MECH, V3, P427, DOI 10.1146/annurev.pathmechdis.2.010506.091842; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Liang XH, 1999, NATURE, V402, P672, DOI 10.1038/45257; Lin WC, 2008, DEV DYNAM, V237, P928, DOI 10.1002/dvdy.21479; Lock R, 2011, CELL CYCLE, V10, P1516, DOI 10.4161/cc.10.10.15434; Lock R, 2011, MOL BIOL CELL, V22, P165, DOI 10.1091/mbc.E10-06-0500; Lum JJ, 2005, NAT REV MOL CELL BIO, V6, P439, DOI 10.1038/nrm1660; Marino G, 2011, MOL CELL, V42, P1, DOI 10.1016/j.molcel.2011.03.003; Nolan-Stevaux O, 2009, GENE DEV, V23, P24, DOI 10.1101/gad.1753809; Notte A, 2011, BIOCHEM PHARMACOL, V82, P427, DOI 10.1016/j.bcp.2011.06.015; Pardo R, 2010, PANCREATOLOGY, V10, P19, DOI 10.1159/000264680; Perez-Mancera PA, 2006, METHOD ENZYMOL, V407, P676, DOI 10.1016/S0076-6879(05)07053-9; Ropolo A, 2007, J BIOL CHEM, V282, P37124, DOI 10.1074/jbc.M706956200; Rosenfeldt MT, 2011, CARCINOGENESIS, V32, P955, DOI 10.1093/carcin/bgr031; Stecca B, 2010, J MOL CELL BIOL, V2, P84, DOI 10.1093/jmcb/mjp052; Tian Y, 2010, CELL, V141, P1042, DOI 10.1016/j.cell.2010.04.034; Tuveson DA, 2005, COLD SH Q B, V70, P65, DOI 10.1101/sqb.2005.70.040; Vaccaro MI, 2008, AUTOPHAGY, V4, P388, DOI 10.4161/auto.5656; White E, 2010, CURR OPIN CELL BIOL, V22, P212, DOI 10.1016/j.ceb.2009.12.008; Yang SH, 2011, GENE DEV, V25, P717, DOI 10.1101/gad.2016111; Yauch RL, 2008, NATURE, V455, P406, DOI 10.1038/nature07275	33	54	54	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 20	2012	287	30					25325	25334		10.1074/jbc.M112.370809	http://dx.doi.org/10.1074/jbc.M112.370809			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	977IW	22535956	Green Published, hybrid			2022-12-25	WOS:000306651700040
J	Callen, L; Moreno, E; Barroso-Chinea, P; Moreno-Delgado, D; Cortes, A; Mallol, J; Casado, V; Lanciego, JL; Franco, R; Lluis, C; Canela, EI; McCormick, PJ				Callen, Lucia; Moreno, Estefania; Barroso-Chinea, Pedro; Moreno-Delgado, David; Cortes, Antoni; Mallol, Josefa; Casado, Vicent; Luis Lanciego, Jose; Franco, Rafael; Lluis, Carmen; Canela, Enric I.; McCormick, Peter J.			Cannabinoid Receptors CB1 and CB2 Form Functional Heteromers in Brain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAT PINEAL-GLAND; ARYLALKYLAMINE N-ACETYLTRANSFERASE; NEURAL PROGENITOR PROLIFERATION; PROXIMITY LIGATION ASSAY; ENDOCANNABINOID SYSTEM; ADENOSINE A(2A); RETINOIC ACID; HUMAN NEUROBLASTOMA; NUCLEUS-ACCUMBENS; MICROGLIAL CELLS	Exploring the role of cannabinoid CB2 receptors in the brain, we present evidence of CB2 receptor molecular and functional interaction with cannabinoid CB1 receptors. Using biophysical and biochemical approaches, we discovered that CB2 receptors can form heteromers with CB1 receptors in transfected neuronal cells and in rat brain pineal gland, nucleus accumbens, and globus pallidus. Within CB1-CB2 receptor heteromers expressed in a neuronal cell model, agonist co-activation of CB1 and CB2 receptors resulted in a negative cross-talk in Akt phosphorylation and neurite outgrowth. Moreover, one specific characteristic of CB1-CB2 receptor heteromers consists of both the ability of CB1 receptor antagonists to block the effect of CB2 receptor agonists and, conversely, the ability of CB2 receptor antagonists to block the effect of CB1 receptor agonists, showing a bidirectional cross-antagonism phenomenon. Taken together, these data illuminate the mechanism by which CB2 receptors can negatively modulate CB1 receptor function.	[Callen, Lucia; Moreno, Estefania; Moreno-Delgado, David; Cortes, Antoni; Mallol, Josefa; Casado, Vicent; Lluis, Carmen; Canela, Enric I.; McCormick, Peter J.] Univ Barcelona, Fac Biol, Dept Biochem & Mol Biol, E-08028 Barcelona, Spain; [Callen, Lucia; Moreno, Estefania; Barroso-Chinea, Pedro; Moreno-Delgado, David; Cortes, Antoni; Mallol, Josefa; Casado, Vicent; Luis Lanciego, Jose; Lluis, Carmen; Canela, Enric I.; McCormick, Peter J.] Univ Navarra, Ctr Invest Biomed Red Enfermedades Neurodegenerat, Pamplona 31008, Spain; [Barroso-Chinea, Pedro; Luis Lanciego, Jose; Franco, Rafael] Univ Navarra, Ctr Invest Med Aplicada, Pamplona 31008, Spain	University of Barcelona; CIBERNED; University of Navarra; University of Navarra	McCormick, PJ (corresponding author), Univ Barcelona, Fac Biol, Dept Biochem & Mol Biol, 643 Ave Diagonal,Planta 2, E-08028 Barcelona, Spain.	pmccormick@ub.edu	Franco, Rafael/C-3694-2015; Canela, Enric I./M-8726-2013; McCormick, Peter/E-7387-2012; Mallol, Josefa/I-4194-2015; Lanciego, Jose L./G-7759-2015; Guillén, Estefanía Moreno/ABE-4371-2020; Casadó, Vicent/K-1660-2014	Franco, Rafael/0000-0003-2549-4919; Canela, Enric I./0000-0003-4992-7440; McCormick, Peter/0000-0002-2225-5181; Mallol, Josefa/0000-0002-2479-4162; Lanciego, Jose L./0000-0003-2301-5419; Casadó, Vicent/0000-0002-1764-3825; Moreno, Estefania/0000-0002-2491-5753	Spanish Ministerio de Economia and Competitividad [SAF2010-18472, SAF2008-03229-E, SAF2008-03118-E]; Centro de Investigacion Biomedica en Red sobre Enfermedades Neurodegenerativas (CIBERNED) [PI2011/02-7]; Formacion de Profesorado Univesitario [AP2007-00808]	Spanish Ministerio de Economia and Competitividad; Centro de Investigacion Biomedica en Red sobre Enfermedades Neurodegenerativas (CIBERNED); Formacion de Profesorado Univesitario	This work was supported by Spanish Ministerio de Economia and Competitividad Grants SAF2010-18472, SAF2008-03229-E, and SAF2008-03118-E within the framework of the Era-NET Neuron program) and a grant for collaborative projects (Grant PI2011/02-7) from the Centro de Investigacion Biomedica en Red sobre Enfermedades Neurodegenerativas (CIBERNED). A Formacion de Profesorado Univesitario Fellow (Grant AP2007-00808).	Aguado T, 2005, FASEB J, V19, P1704, DOI 10.1096/fj.05-3995fje; Akirav I, 2011, FRONT BEHAV NEUROSCI, V5, DOI 10.3389/fnbeh.2011.00067; Ameri A, 1999, PROG NEUROBIOL, V58, P315, DOI 10.1016/S0301-0082(98)00087-2; Ashton JC, 2006, NEUROSCI LETT, V396, P113, DOI 10.1016/j.neulet.2005.11.038; Ashton JC, 2007, CURR OPIN INVEST DR, V8, P373; Balenga NAB, 2011, CELL RES, V21, P1452, DOI 10.1038/cr.2011.60; Bambico FR, 2007, J NEUROSCI, V27, P11700, DOI 10.1523/JNEUROSCI.1636-07.2007; Bellocchio L, 2010, NAT NEUROSCI, V13, P281, DOI 10.1038/nn.2494; Benito C, 2003, J NEUROSCI, V23, P11136; Brusco A, 2008, ANN NY ACAD SCI, V1139, P450, DOI 10.1196/annals.1432.037; Brusco A, 2008, SYNAPSE, V62, P944, DOI 10.1002/syn.20569; Cabral GA, 2008, BRIT J PHARMACOL, V153, P240, DOI 10.1038/sj.bjp.0707584; Carriba P, 2008, NAT METHODS, V5, P727, DOI 10.1038/nmeth.1229; Carriba P, 2007, NEUROPSYCHOPHARMACOL, V32, P2249, DOI 10.1038/sj.npp.1301375; Cruz-Machado SD, 2010, J PINEAL RES, V49, P183, DOI 10.1111/j.1600-079X.2010.00785.x; del Pulgar T, 2000, BIOCHEM J, V347, P369, DOI 10.1042/bj3470369; Di Marzo V, 1998, TRENDS NEUROSCI, V21, P521, DOI 10.1016/S0166-2236(98)01283-1; Di Marzo V, 2011, NAT NEUROSCI, V14, P9, DOI 10.1038/nn.2720; Ehrhart J, 2005, J NEUROINFLAMM, V2, DOI 10.1186/1742-2094-2-29; Encinas M, 2000, J NEUROCHEM, V75, P991, DOI 10.1046/j.1471-4159.2000.0750991.x; Fernandez-Ruiz J, 2004, NEUROTOX RES, V6, P389, DOI 10.1007/BF03033314; Fernandez-Ruiz J, 2007, TRENDS PHARMACOL SCI, V28, P39, DOI 10.1016/j.tips.2006.11.001; Ferre S, 2009, NAT CHEM BIOL, V5, P131, DOI 10.1038/nchembio0309-131; Ferre S, 2009, NEUROPHARMACOLOGY, V56, P226, DOI 10.1016/j.neuropharm.2008.06.076; Fiorentini C, 2010, CURR OPIN PHARMACOL, V10, P87, DOI 10.1016/j.coph.2009.09.008; Freund TF, 2003, PHYSIOL REV, V83, P1017, DOI 10.1152/physrev.00004.2003; Garcia-Gutierrez MS, 2011, J PSYCHOPHARMACOL, V25, P111, DOI 10.1177/0269881110379507; Golech SA, 2004, MOL BRAIN RES, V132, P87, DOI 10.1016/j.molbrainres.2004.08.025; Gong JP, 2006, BRAIN RES, V1071, P10, DOI 10.1016/j.brainres.2005.11.035; Gonzalez S, 2012, MOL PSYCHIATR, V17, P650, DOI 10.1038/mp.2011.93; Harkany T, 2007, TRENDS PHARMACOL SCI, V28, P83, DOI 10.1016/j.tips.2006.12.004; Hojo M, 2008, J PHARMACOL SCI, V108, P308, DOI 10.1254/jphs.08244FP; Hosohata Y, 1997, EUR J PHARMACOL, V321, pR1, DOI 10.1016/S0014-2999(97)00047-2; HOWLETT AC, 1990, TRENDS NEUROSCI, V13, P420, DOI 10.1016/0166-2236(90)90124-S; Howlett AC, 2002, PROSTAG OTH LIPID M, V68-9, P619, DOI 10.1016/S0090-6980(02)00060-6; Huffman JW, 1999, BIOORGAN MED CHEM, V7, P2905, DOI 10.1016/S0968-0896(99)00219-9; Irving A, 2011, CELL RES, V21, P1391, DOI 10.1038/cr.2011.77; Katona I, 2008, NAT MED, V14, P923, DOI 10.1038/nm.f.1869; Katona I, 2006, J NEUROSCI, V26, P5628, DOI 10.1523/JNEUROSCI.0309-06.2006; Klein DC, 2007, J BIOL CHEM, V282, P4233, DOI 10.1074/jbc.R600036200; Klein TW, 2003, J LEUKOCYTE BIOL, V74, P486, DOI 10.1189/jlb.0303101; Kleyer J, 2012, BIOCHEM PHARMACOL, V83, P1393, DOI 10.1016/j.bcp.2012.02.014; Koch M, 2008, J PINEAL RES, V45, P351, DOI 10.1111/j.1600-079X.2008.00597.x; Koch M, 2006, J NEUROCHEM, V98, P267, DOI 10.1111/j.1471-4159.2006.03873.x; Kofalvi A, 2005, J NEUROSCI, V25, P2874, DOI 10.1523/JNEUROSCI.4232-04.2005; Lanciego JL, 2011, J PSYCHOPHARMACOL, V25, P97, DOI 10.1177/0269881110367732; Lopez-Carballo G, 2002, J BIOL CHEM, V277, P25297, DOI 10.1074/jbc.M201869200; Mackie K, 2006, ANNU REV PHARMACOL, V46, P101, DOI 10.1146/annurev.pharmtox.46.120604.141254; Mackie K, 2005, LIFE SCI, V77, P1667, DOI 10.1016/j.lfs.2005.05.011; Mackie K, 2006, AAPS J, V8, pE298, DOI 10.1007/BF02854900; Maldonado R, 2006, TRENDS NEUROSCI, V29, P225, DOI 10.1016/j.tins.2006.01.008; Maresz K, 2005, J NEUROCHEM, V95, P437, DOI 10.1111/j.1471-4159.2005.03380.x; Marsicano G, 2003, SCIENCE, V302, P84, DOI 10.1126/science.1088208; Martin AB, 2008, NEUROPSYCHOPHARMACOL, V33, P1667, DOI 10.1038/sj.npp.1301558; Matyas F, 2006, NEUROSCIENCE, V137, P337, DOI 10.1016/j.neuroscience.2005.09.005; Molina-Holgado E, 2002, J NEUROSCI, V22, P9742, DOI 10.1523/jneurosci.22-22-09742.2002; Moreno E, 2011, J NEUROSCI, V31, P7412, DOI 10.1523/JNEUROSCI.0191-11.2011; Mulder J, 2008, P NATL ACAD SCI USA, V105, P8760, DOI 10.1073/pnas.0803545105; MUNRO S, 1993, NATURE, V365, P61, DOI 10.1038/365061a0; Navarro G, 2008, THESCIENTIFICWORLDJO, V8, P1088, DOI 10.1100/tsw.2008.136; Nunez E, 2004, SYNAPSE, V53, P208, DOI 10.1002/syn.20050; Onaivi ES, 2011, CURR NEUROPHARMACOL, V9, P205, DOI 10.2174/157015911795017416; Onaivi ES, 2006, ANN NY ACAD SCI, V1074, P514, DOI 10.1196/annals.1369.052; Onaivi ES, 2012, J PSYCHOPHARMACOL, V26, P92, DOI 10.1177/0269881111400652; Onaivi ES, 2008, ANN NY ACAD SCI, V1139, P434, DOI 10.1196/annals.1432.036; PAHLMAN S, 1995, EUR J CANCER, V31A, P453, DOI 10.1016/0959-8049(95)00033-F; PAHLMAN S, 1984, CELL DIFFER DEV, V14, P135, DOI 10.1016/0045-6039(84)90038-1; Palazuelos J, 2006, FASEB J, V20, P2405, DOI 10.1096/fj.06-6164fje; Pertwee RG, 2007, BRIT J PHARMACOL, V152, P984, DOI 10.1038/sj.bjp.0707464; Pertwee RG, 1997, PHARMACOL THERAPEUT, V74, P129, DOI 10.1016/S0163-7258(97)82001-3; Pertwee RG, 2005, HANDB EXP PHARMACOL, V168, P1; Pickel VM, 2006, J COMP NEUROL, V495, P299, DOI 10.1002/cne.20881; Pickel VM, 2004, NEUROSCIENCE, V127, P101, DOI 10.1016/j.neuroscience.2004.05.015; Piomelli D, 2003, NAT REV NEUROSCI, V4, P873, DOI 10.1038/nrn1247; Romero J, 2002, PHARMACOL THERAPEUT, V95, P137, DOI 10.1016/S0163-7258(02)00253-X; Rozenfeld R, 2011, EMBO J, V30, P2350, DOI 10.1038/emboj.2011.139; Ryberg E, 2007, BRIT J PHARMACOL, V152, P1092, DOI 10.1038/sj.bjp.0707460; Sagredo O, 2009, GLIA, V57, P1154, DOI 10.1002/glia.20838; Sanchez MG, 2003, CELL SIGNAL, V15, P851, DOI 10.1016/S0898-6568(03)00036-6; Schneider U, 2005, NERVENARZT, V76, P1062, DOI 10.1007/s00115-005-1888-7; Soderberg O, 2008, METHODS, V45, P227, DOI 10.1016/j.ymeth.2008.06.014; Suarez J, 2009, HIPPOCAMPUS, V19, P623, DOI 10.1002/hipo.20537; Svizenska I, 2008, PHARMACOL BIOCHEM BE, V90, P501, DOI 10.1016/j.pbb.2008.05.010; Tebano MT, 2009, J NEUROCHEM, V110, P1921, DOI 10.1111/j.1471-4159.2009.06282.x; Trifilieff P, 2011, BIOTECHNIQUES, V51, P111, DOI 10.2144/000113719; Uchigashima M, 2007, J NEUROSCI, V27, P3663, DOI 10.1523/JNEUROSCI.0448-07.2007; Van Sickle MD, 2005, SCIENCE, V310, P329, DOI 10.1126/science.1115740; Venance L, 2004, M S-MED SCI, V20, P45, DOI 10.1051/medsci/200420145; Ward RJ, 2011, J BIOL CHEM, V286, P37414, DOI 10.1074/jbc.M111.287649; Xi ZX, 2011, NAT NEUROSCI, V14, P1160, DOI 10.1038/nn.2874; Zanettini C, 2011, FRONT BEHAV NEUROSCI, V5, DOI 10.3389/fnbeh.2011.00057	91	152	155	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 15	2012	287	25					20851	20865		10.1074/jbc.M111.335273	http://dx.doi.org/10.1074/jbc.M111.335273			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974FQ	22532560	Green Published, hybrid			2022-12-25	WOS:000306416800007
J	Kim, JK; Kwon, O; Kim, J; Kim, EK; Park, HK; Lee, JE; Kim, KL; Choi, JW; Lim, S; Seok, H; Lee-Kwon, W; Choi, JH; Kang, BH; Kim, S; Ryu, SH; Suh, PG				Kim, Jung Kuk; Kwon, Ohman; Kim, Jinho; Kim, Eung-Kyun; Park, Hye Kyung; Lee, Ji Eun; Kim, Kyung Lock; Choi, Jung Woong; Lim, Seyoung; Seok, Heon; Lee-Kwon, Whaseon; Choi, Jang Hyun; Kang, Byoung Heon; Kim, Sanguk; Ryu, Sung Ho; Suh, Pann-Ghill			PDZ Domain-containing 1 (PDZK1) Protein Regulates Phospholipase C-beta 3 (PLC-beta 3)-specific Activation of Somatostatin by Forming a Ternary Complex with PLC-beta 3 and Somatostatin Receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C-BETA; SIGNAL-TRANSDUCTION; INTRINSIC DISORDER; SCAFFOLD PROTEINS; ACID SEQUENCES; BINDING SITES; SPECIFICITY; ISOZYMES; HORMONE; INAD	Phospholipase C-beta(PLC-beta) is a key molecule in G protein-coupled receptor (GPCR)-mediated signaling. Many studies have shown that the four PLC-beta subtypes have different physiological functions despite their similar structures. Because the PLC-beta subtypes possess different PDZ-binding motifs, they have the potential to interact with different PDZ proteins. In this study, we identified PDZ domain-containing 1 (PDZK1) as a PDZ protein that specifically interacts with PLC-beta 3. To elucidate the functional roles of PDZK1, we next screened for potential interacting proteins of PDZK1 and identified the somatostatin receptors (SSTRs) as another protein that interacts with PDZK1. Through these interactions, PDZK1 assembles as a ternary complex with PLC-beta 3 and SSTRs. Interestingly, the expression of PDZK1 and PLC-beta 3, but not PLC-beta 1, markedly potentiated SST-induced PLC activation. However, disruption of the ternary complex inhibited SST-induced PLC activation, which suggests that PDZK1-mediated complex formation is required for the specific activation of PLC-beta 3 by SST. Consistent with this observation, the knockdown of PDZK1 or PLC-beta 3, but not that of PLC-beta 1, significantly inhibited SST-induced intracellular Ca2+ mobilization, which further attenuated subsequent ERK1/2 phosphorylation. Taken together, our results strongly suggest that the formation of a complex between SSTRs, PDZK1, and PLC-beta 3 is essential for the specific activation of PLC-beta 3 and the subsequent physiologic responses by SST.	[Kim, Jung Kuk; Kim, Eung-Kyun; Park, Hye Kyung; Lee, Ji Eun; Seok, Heon; Lee-Kwon, Whaseon; Choi, Jang Hyun; Kang, Byoung Heon; Suh, Pann-Ghill] Ulsan Natl Inst Sci & Technol, Sch Nanobiotechnol & Chem Engn, Ulsan 689798, South Korea; [Kim, Jung Kuk; Kim, Jinho; Kim, Kyung Lock; Choi, Jung Woong; Lim, Seyoung; Kim, Sanguk; Ryu, Sung Ho; Suh, Pann-Ghill] Pohang Univ Sci & Technol, Div Mol & Life Sci, Pohang 790784, South Korea; [Kwon, Ohman] Pohang Univ Sci & Technol, Sch Interdisciplinary Biosci & Bioengn, Pohang 790784, South Korea	Ulsan National Institute of Science & Technology (UNIST); Pohang University of Science & Technology (POSTECH); Pohang University of Science & Technology (POSTECH)	Suh, PG (corresponding author), Ulsan Natl Inst Sci & Technol, Sch Nanobiotechnol & Chem Engn, Ulsan 689798, South Korea.	pgsuh@unist.ac.kr	Kwon, Ohman/AAQ-6377-2021; Kang, Byoung Heon/E-6165-2010; Choi, Jang Hyun/B-3055-2012; Suh, Pann-Ghill/F-3610-2010	Kang, Byoung Heon/0000-0001-5902-0549; Kim, Kyung Lock/0000-0001-6514-4935; Ryu, Sung Ho/0000-0003-0913-3048; Kim, Sanguk/0000-0002-3449-3814	National Research Foundation of Korea [KRP-2007-341-C00027, 2011-0000878, PGB013]; Korean Government; Korea Health Technology Research and Development Project [A084022]; Ministry of Health and Welfare, Republic of Korea; UNIST (Ulsan National Institute of Science and Technology)	National Research Foundation of Korea(National Research Foundation of Korea); Korean Government(Korean Government); Korea Health Technology Research and Development Project; Ministry of Health and Welfare, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea); UNIST (Ulsan National Institute of Science and Technology)	This work was supported by National Research Foundation of Korea Grants KRP-2007-341-C00027 and 2011-0000878 funded by the Korean Government, Fusion Pioneer Project PGB013 from the National Research Foundation of Korea, and Korea Health Technology Research and Development Project A084022, Ministry of Health and Welfare, Republic of Korea and the year of 2010 Research Fund of the UNIST (Ulsan National Institute of Science and Technology).	AKBAR M, 1994, FEBS LETT, V348, P192, DOI 10.1016/0014-5793(94)00603-2; ARGOS P, 1982, EUR J BIOCHEM, V128, P565; Barbieri F, 2008, ENDOCRINOLOGY, V149, P4736, DOI 10.1210/en.2007-1762; BERG OG, 1987, J MOL BIOL, V193, P723, DOI 10.1016/0022-2836(87)90354-8; BERRIDGE MJ, 1989, NATURE, V341, P197, DOI 10.1038/341197a0; Beuming T, 2005, BIOINFORMATICS, V21, P827, DOI 10.1093/bioinformatics/bti098; BRAZEAU P, 1973, SCIENCE, V179, P77, DOI 10.1126/science.179.4068.77; BRISTOL JA, 1994, TRENDS ENDOCRIN MET, V5, P402, DOI 10.1016/1043-2760(95)92522-K; CHARTON M, 1982, J THEOR BIOL, V99, P629, DOI 10.1016/0022-5193(82)90191-6; Chen JR, 2008, NAT BIOTECHNOL, V26, P1041, DOI 10.1038/nbt.1489; Choi JW, 2010, CELL SIGNAL, V22, P1153, DOI 10.1016/j.cellsig.2010.03.010; COSIC I, 1994, IEEE T BIO-MED ENG, V41, P1101, DOI 10.1109/10.335859; D'haeseleer P, 2006, NAT BIOTECHNOL, V24, P423, DOI 10.1038/nbt0406-423; Day P, 2006, TRENDS PHARMACOL SCI, V27, P509, DOI 10.1016/j.tips.2006.08.003; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; Fanning AS, 1996, CURR BIOL, V6, P1385, DOI 10.1016/S0960-9822(96)00737-3; FAUCHERE JL, 1988, INT J PEPT PROT RES, V32, P269; Fuxreiter M, 2007, BIOINFORMATICS, V23, P950, DOI 10.1093/bioinformatics/btm035; Ghosh MG, 2000, CANCER RES, V60, P6367; GRANTHAM R, 1974, SCIENCE, V185, P862, DOI 10.1126/science.185.4154.862; Han SK, 2006, NEURON, V52, P691, DOI 10.1016/j.neuron.2006.09.036; Hui S, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-507; Hwang JI, 2000, J BIOL CHEM, V275, P16632, DOI 10.1074/jbc.M001410200; Hwang JI, 2005, J BIOL CHEM, V280, P12467, DOI 10.1074/jbc.M410740200; Ikemoto M, 2000, P NATL ACAD SCI USA, V97, P6538, DOI 10.1073/pnas.100114397; JHON DY, 1993, J BIOL CHEM, V268, P6654; Kaushansky A, 2010, NAT PROTOC, V5, P773, DOI 10.1038/nprot.2010.36; Kim D, 1997, NATURE, V389, P290, DOI 10.1038/38508; Kim J, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002510; Kim JK, 2011, CELL SIGNAL, V23, P1022, DOI 10.1016/j.cellsig.2011.01.017; Kim JK, 2011, ADV ENZYME REGUL, V51, P138, DOI 10.1016/j.advenzreg.2010.10.004; Kocher O, 2009, CURR OPIN LIPIDOL, V20, P236, DOI 10.1097/MOL.0b013e32832aee82; KORNAU HC, 1995, SCIENCE, V269, P1737, DOI 10.1126/science.7569905; Kreienkamp HJ, 1997, FEBS LETT, V419, P92, DOI 10.1016/S0014-5793(97)01437-3; Lee HJ, 2010, CELL COMMUN SIGNAL, V8, DOI 10.1186/1478-811X-8-8; Lian LR, 2005, BLOOD, V106, P110, DOI 10.1182/blood-2004-05-2005; Lopez F, 1997, J BIOL CHEM, V272, P24448, DOI 10.1074/jbc.272.39.24448; Magidovich E, 2007, P NATL ACAD SCI USA, V104, P13022, DOI 10.1073/pnas.0704059104; Mahon MJ, 2004, J BIOL CHEM, V279, P23550, DOI 10.1074/jbc.M313229200; Oh YS, 2004, MOL CELL BIOL, V24, P5069, DOI 10.1128/MCB.24.11.5069-5079.2004; PATEL YC, 1994, BIOCHEM BIOPH RES CO, V198, P605, DOI 10.1006/bbrc.1994.1088; Ren S, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-S2-S26; Rhee SG, 2001, ANNU REV BIOCHEM, V70, P281, DOI 10.1146/annurev.biochem.70.1.281; Rosskopf D, 2003, AM J PHYSIOL-CELL PH, V284, pC179, DOI 10.1152/ajpcell.00160.2001; Rubina K, 2005, MOL CELL BIOCHEM, V273, P33, DOI 10.1007/s11010-005-0250-5; Sanchez IE, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000052; Sonnhammer ELL, 1998, NUCLEIC ACIDS RES, V26, P320, DOI 10.1093/nar/26.1.320; STADEN R, 1984, NUCLEIC ACIDS RES, V12, P505, DOI 10.1093/nar/12.1Part2.505; Stiffler MA, 2007, SCIENCE, V317, P364, DOI 10.1126/science.1144592; STORMO GD, 1982, NUCLEIC ACIDS RES, V10, P2997, DOI 10.1093/nar/10.9.2997; STORMO GD, 1989, P NATL ACAD SCI USA, V86, P1183, DOI 10.1073/pnas.86.4.1183; STORMO GD, 1986, NUCLEIC ACIDS RES, V14, P6661, DOI 10.1093/nar/14.16.6661; Strassheim D, 2000, J BIOL CHEM, V275, P39767, DOI 10.1074/jbc.M007775200; Suh PG, 2008, BMB REP, V41, P415, DOI 10.5483/BMBRep.2008.41.6.415; Uversky VN, 2005, J MOL RECOGNIT, V18, P343, DOI 10.1002/jmr.747; Vaccaro P, 2001, J BIOL CHEM, V276, P42122, DOI 10.1074/jbc.M104208200; Valiente M, 2005, J BIOL CHEM, V280, P28936, DOI 10.1074/jbc.M504761200; van Huizen R, 1998, EMBO J, V17, P2285, DOI 10.1093/emboj/17.8.2285; Wang SS, 2000, CELL, V103, P169, DOI 10.1016/S0092-8674(00)00096-9; Weckbecker G, 2003, NAT REV DRUG DISCOV, V2, P999, DOI 10.1038/nrd1255; Wente W, 2005, J BIOL CHEM, V280, P32419, DOI 10.1074/jbc.M507198200; Wes PD, 1999, NAT NEUROSCI, V2, P447, DOI 10.1038/8116; Wiedemann U, 2004, J MOL BIOL, V343, P703, DOI 10.1016/j.jmb.2004.08.064; Xia ZQ, 2003, J BIOL CHEM, V278, P21901, DOI 10.1074/jbc.M301905200; ZIMMERMAN JM, 1968, J THEOR BIOL, V21, P170, DOI 10.1016/0022-5193(68)90069-6	65	20	23	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 15	2012	287	25					21012	21024		10.1074/jbc.M111.337865	http://dx.doi.org/10.1074/jbc.M111.337865			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974FQ	22528496	hybrid, Green Published			2022-12-25	WOS:000306416800023
J	Wang, GH; Dinkins, M; He, Q; Zhu, G; Poirier, C; Campbell, A; Mayer-Proschel, M; Bieberich, E				Wang, Guanghu; Dinkins, Michael; He, Qian; Zhu, Gu; Poirier, Christophe; Campbell, Andrew; Mayer-Proschel, Margot; Bieberich, Erhard			Astrocytes Secrete Exosomes Enriched with Proapoptotic Ceramide and Prostate Apoptosis Response 4 (PAR-4) POTENTIAL MECHANISM OF APOPTOSIS INDUCTION IN ALZHEIMER DISEASE (AD)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KINASE C-ZETA; AMYLOID-BETA; UP-REGULATION; MOUSE-BRAIN; GLIAL-CELLS; STEM-CELLS; ASTROGLIA; NEURONS; PROTEIN; DEGENERATION	Amyloid protein is well known to induce neuronal cell death, whereas only little is known about its effect on astrocytes. We found that amyloid peptides activated caspase 3 and induced apoptosis in primary cultured astrocytes, which was prevented by caspase 3 inhibition. Apoptosis was also prevented by shRNA-mediated down-regulation of PAR-4, a protein sensitizing cells to the sphingolipid ceramide. Consistent with a potentially proapoptotic effect of PAR-4 and ceramide, astrocytes surrounding amyloid plaques in brain sections of the 5xFAD mouse (and Alzheimer disease patient brain) showed caspase 3 activation and were apoptotic when co-expressing PAR-4 and ceramide. Apoptosis was not observed in astrocytes with deficient neutral sphingomyelinase 2 (nSMase2), indicating that ceramide generated by nSMase2 is critical for amyloid-induced apoptosis. Antibodies against PAR-4 and ceramide prevented amyloid-induced apoptosis in vitro and in vivo, suggesting that apoptosis was mediated by exogenous PAR-4 and ceramide, potentially associated with secreted lipid vesicles. This was confirmed by the analysis of lipid vesicles from conditioned medium showing that amyloid peptide induced the secretion of PAR-4 and C18 ceramide-enriched exosomes. Exosomes were not secreted by nSMase2-deficient astrocytes, indicating that ceramide generated by nSMase2 is critical for exosome secretion. Consistent with the ceramide composition in amyloid-induced exosomes, exogenously added C18 ceramide restored PAR-4-containing exosome secretion in nSMase2-deficient astrocytes. Moreover, isolated PAR-4/ceramide-enriched exosomes were taken up by astrocytes and induced apoptosis in the absence of amyloid peptide. Taken together, we report a novel mechanism of apoptosis induction by PAR-4/ceramide-enriched exosomes, which may critically contribute to Alzheimer disease.	[Bieberich, Erhard] Georgia Hlth Sci Univ, Med Coll Georgia, Inst Mol Med & Genet, Program Dev Neurobiol, Augusta, GA 30912 USA; [Poirier, Christophe] Georgia Hlth Sci Univ, Vasc Biol Ctr, Augusta, GA 30912 USA; [Campbell, Andrew; Mayer-Proschel, Margot] Univ Rochester, Med Ctr, Dept Biomed Genet, Rochester, NY 14642 USA	University System of Georgia; Augusta University; University System of Georgia; Augusta University; University of Rochester	Bieberich, E (corresponding author), Georgia Hlth Sci Univ, Med Coll Georgia, Inst Mol Med & Genet, Program Dev Neurobiol, 1120 15th St,Rm CA4012, Augusta, GA 30912 USA.	ebieberich@georgiahealth.edu			National Institutes of Health [1R01AG034389]; Georgia Health Sciences University; American Heart Association; NATIONAL INSTITUTE ON AGING [R01AG034389] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Georgia Health Sciences University; American Heart Association(American Heart Association); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grant 1R01AG034389 (to E. B.). G. W. is supported by awards from Georgia Health Sciences University and American Heart Association.	Agostinho P, 2010, CURR PHARM DESIGN, V16, P2766, DOI 10.2174/138161210793176572; Allaman I, 2011, TRENDS NEUROSCI, V34, P76, DOI 10.1016/j.tins.2010.12.001; Aubin I, 2005, NAT GENET, V37, P803, DOI 10.1038/ng1603; Bieberich E, 2000, J BIOL CHEM, V275, P177, DOI 10.1074/jbc.275.1.177; Bieberich E, 2003, J CELL BIOL, V162, P469, DOI 10.1083/jcb.200212067; Bieberich E, 2004, J CELL BIOL, V167, P723, DOI 10.1083/jcb.200405144; Bieberich E, 2011, JOVE-J VIS EXP, DOI 10.3791/2657; Bieberich E, 2011, NEUROCHEM RES, V36, P1601, DOI 10.1007/s11064-010-0338-5; Burikhanov R, 2009, CELL, V138, P377, DOI 10.1016/j.cell.2009.05.022; Caraci F, 2005, BRAIN RES, V1047, P30, DOI 10.1016/j.brainres.2005.04.004; Cheema SK, 2003, J BIOL CHEM, V278, P19995, DOI 10.1074/jbc.M205865200; Croisier E, 2006, ACTA NEUROPATHOL, V112, P517, DOI 10.1007/s00401-006-0119-z; Czech C, 2000, PROG NEUROBIOL, V60, P363, DOI 10.1016/S0301-0082(99)00033-7; Farfara D, 2008, J CELL MOL MED, V12, P762, DOI 10.1111/j.1582-4934.2008.00314.x; Faure J, 2006, MOL CELL NEUROSCI, V31, P642, DOI 10.1016/j.mcn.2005.12.003; Fukunaga T, 2000, J CELL SCI, V113, P3299; Fuller S, 2010, MUTAT RES-FUND MOL M, V690, P40, DOI 10.1016/j.mrfmmm.2009.08.016; Gamen S, 1998, J IMMUNOL, V161, P1758; Goedert M, 2006, SCIENCE, V314, P777, DOI 10.1126/science.1132814; Guescini M, 2010, J NEURAL TRANSM, V117, P1, DOI 10.1007/s00702-009-0288-8; Herget T, 2000, J BIOL CHEM, V275, P30344, DOI 10.1074/jbc.M000714200; Ittner LM, 2011, NAT REV NEUROSCI, V12, P67, DOI 10.1038/nrn2967; Jana A, 2010, J NEUROSCI, V30, P12676, DOI 10.1523/JNEUROSCI.1243-10.2010; Kobayashi K, 2002, NEUROPATH APPL NEURO, V28, P238, DOI 10.1046/j.1365-2990.2002.00390.x; Lee YJ, 2010, ARCH PHARM RES, V33, P1539, DOI 10.1007/s12272-010-1006-7; Li CY, 2011, CURR ALZHEIMER RES, V8, P67; Lopez-Montero I, 2005, J BIOL CHEM, V280, P25811, DOI 10.1074/jbc.M412052200; Mattson MP, 1999, J MOL NEUROSCI, V13, P17, DOI 10.1385/JMN:13:1-2:17; Mattson MP, 1999, ANN NY ACAD SCI, V893, P154, DOI 10.1111/j.1749-6632.1999.tb07824.x; Meda L, 2001, NEUROBIOL AGING, V22, P885, DOI 10.1016/S0197-4580(01)00307-4; Millucci L, 2010, CURR PROTEIN PEPT SC, V11, P54, DOI 10.2174/138920310790274626; Millucci L, 2009, J BIOSCIENCES, V34, P293, DOI 10.1007/s12038-009-0033-3; Mouser PE, 2006, AM J PATHOL, V168, P936, DOI 10.2353/ajpath.2006.050798; Nagele RG, 2004, NEUROBIOL AGING, V25, P663, DOI 10.1016/j.neurobiolaging.2004.01.007; Paris F, 2001, J BIOL CHEM, V276, P8297, DOI 10.1074/jbc.M008732200; Perez JL, 2010, EXP NEUROL, V223, P410, DOI 10.1016/j.expneurol.2009.10.013; Petrache I, 2005, NAT MED, V11, P491, DOI 10.1038/nm1238; Rodriguez JJ, 2009, CELL DEATH DIFFER, V16, P378, DOI 10.1038/cdd.2008.172; Taylor DD, 2011, METHODS MOL BIOL, V728, P235, DOI 10.1007/978-1-61779-068-3_15; Trajkovic K, 2008, SCIENCE, V319, P1244, DOI 10.1126/science.1153124; Van Eldik LJ, 2007, INT REV NEUROBIOL, V82, P277, DOI 10.1016/S0074-7742(07)82015-0; Verkhratsky A, 2010, NEUROTHERAPEUTICS, V7, P399, DOI 10.1016/j.nurt.2010.05.017; Wang GH, 2005, J BIOL CHEM, V280, P26415, DOI 10.1074/jbc.M501492200; Wang G, 2008, J NEUROCHEM, V106, P718, DOI 10.1111/j.1471-4159.2008.05451.x; Wang G, 2008, GLIA, V56, P449, DOI 10.1002/glia.20626; Wang GH, 2009, J LIPID RES, V50, P2103, DOI 10.1194/jlr.M900097-JLR200; Wang GH, 2009, J BIOL CHEM, V284, P14469, DOI 10.1074/jbc.M808909200; Yuyama K, 2012, J BIOL CHEM, V287, P10977, DOI 10.1074/jbc.M111.324616	48	246	258	1	42	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 15	2012	287	25					21384	21395		10.1074/jbc.M112.340513	http://dx.doi.org/10.1074/jbc.M112.340513			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974FQ	22532571	Green Published, hybrid			2022-12-25	WOS:000306416800056
J	Winkler, E; Kamp, F; Scheuring, J; Ebke, A; Fukumori, A; Steiner, H				Winkler, Edith; Kamp, Frits; Scheuring, Johannes; Ebke, Amelie; Fukumori, Akio; Steiner, Harald			Generation of Alzheimer Disease-associated Amyloid beta(42/43) Peptide by gamma-Secretase Can Be Inhibited Directly by Modulation of Membrane Thickness	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-PROTEIN; BILAYER THICKNESS; PRESENILIN; LIPIDS; CHOLESTEROL; COMPLEX; RECONSTITUTION; TRAFFICKING; MUTATIONS; MECHANISM	Pathogenic generation of amyloid beta-peptide (A beta) by sequential cleavage of beta-amyloid precursor protein (APP) by beta- and gamma-secretases is widely believed to causally underlie Alzheimer disease (AD). beta-Secretase initially cleaves APP thereby generating a membrane-bound APP C-terminal fragment, from which gamma-secretase subsequently liberates 37-43-amino acid long A beta species. Although the latter cleavages are intramembranous and although lipid alterations have been implicated in AD, little is known of how the gamma-secretase-mediated release of the various A beta species, in particular that of the pathogenic longer variants A beta(42) and A beta(43), is affected by the lipid environment. Using a cell-free system, we have directly and systematically investigated the activity of gamma-secretase reconstituted in defined model membranes of different thicknesses. We found that bilayer thickness is a critical parameter affecting both total activity as well as cleavage specificity of gamma-secretase. Whereas the generation of the pathogenic A beta(42/43) species was markedly attenuated in thick membranes, that of the major and rather benign A beta(40) species was enhanced. Moreover, the increased production of A beta(42/43) by familial AD mutants of presenilin 1, the catalytic subunit of gamma-secretase, could be substantially lowered in thick membranes. Our data demonstrate an effective modulation of gamma-secretase activity by membrane thickness, which may provide an approach to lower the generation of the pathogenic A beta(42/43) species.	[Winkler, Edith; Kamp, Frits; Ebke, Amelie; Fukumori, Akio; Steiner, Harald] Univ Munich, Adolf Butenandt Inst, D-80336 Munich, Germany; [Winkler, Edith; Kamp, Frits; Ebke, Amelie; Fukumori, Akio; Steiner, Harald] German Ctr Neurodegenerat Dis DZNE, D-80336 Munich, Germany; [Scheuring, Johannes] Tech Univ Munich, Dept Chem, D-85747 Garching, Germany	University of Munich; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); Technical University of Munich	Steiner, H (corresponding author), Univ Munich, Adolf Butenandt Inst, Schillerstr 44, D-80336 Munich, Germany.	harald.steiner@med.uni-muenchen.de			Deutsche Forschungsgemeinschaft [SFB596]; Bundesministerium fur Bildung und Forschung (Kompetenznetz Degenerative Demenzen); Alzheimer Research Award of the Hans and Ilse Breuer Foundation; Center of Integrated Protein Science Munich; Elitenetzwerk Bayern	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Bundesministerium fur Bildung und Forschung (Kompetenznetz Degenerative Demenzen)(Federal Ministry of Education & Research (BMBF)); Alzheimer Research Award of the Hans and Ilse Breuer Foundation; Center of Integrated Protein Science Munich; Elitenetzwerk Bayern	This work was supported by the Deutsche Forschungsgemeinschaft (SFB596), the Bundesministerium fur Bildung und Forschung (Kompetenznetz Degenerative Demenzen), the Alzheimer Research Award of the Hans and Ilse Breuer Foundation (to H. S.), and the Center of Integrated Protein Science Munich.; Supported by the Elitenetzwerk Bayern.	Andersen OS, 2007, ANNU REV BIOPH BIOM, V36, P107, DOI 10.1146/annurev.biophys.36.040306.132643; Beher D, 2003, BIOCHEMISTRY-US, V42, P8133, DOI 10.1021/bi034045z; BRETSCHER MS, 1993, SCIENCE, V261, P1280, DOI 10.1126/science.8362242; Citron M, 1997, NAT MED, V3, P67, DOI 10.1038/nm0197-67; Di Paolo G, 2011, NAT REV NEUROSCI, V12, P284, DOI 10.1038/nrn3012; Dries DR, 2008, CURR ALZHEIMER RES, V5, P132, DOI 10.2174/156720508783954695; Edbauer D, 2003, NAT CELL BIOL, V5, P486, DOI 10.1038/ncb960; Ehehalt R, 2003, J CELL BIOL, V160, P113, DOI 10.1083/jcb.200207113; Fraering PC, 2004, BIOCHEMISTRY-US, V43, P9774, DOI 10.1021/bi0494976; Grimm MOW, 2008, J BIOL CHEM, V283, P11302, DOI 10.1074/jbc.M801520200; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; Han Xianlin, 2005, Current Alzheimer Research, V2, P65, DOI 10.2174/1567205052772786; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Hartmann T, 1997, NAT MED, V3, P1016, DOI 10.1038/nm0997-1016; Hartmann T, 2007, J NEUROCHEM, V103, P159, DOI 10.1111/j.1471-4159.2007.04715.x; Huber T, 2002, J AM CHEM SOC, V124, P298, DOI 10.1021/ja011383j; Imbimbo BP, 2011, CURR TOP MED CHEM, V11, P1555; Kalvodova L, 2005, J BIOL CHEM, V280, P36815, DOI 10.1074/jbc.M504484200; Kimberly WT, 2003, P NATL ACAD SCI USA, V100, P6382, DOI 10.1073/pnas.1037392100; Lee AG, 2004, BBA-BIOMEMBRANES, V1666, P62, DOI 10.1016/j.bbamem.2004.05.012; Lee SJ, 1998, NAT MED, V4, P730, DOI 10.1038/nm0698-730; Lichtenthaler SF, 2011, J NEUROCHEM, V117, P779, DOI 10.1111/j.1471-4159.2011.07248.x; Mitra K, 2004, P NATL ACAD SCI USA, V101, P4083, DOI 10.1073/pnas.0307332101; Moehlmann T, 2002, P NATL ACAD SCI USA, V99, P8025, DOI 10.1073/pnas.112686799; Osenkowski P, 2008, J BIOL CHEM, V283, P22529, DOI 10.1074/jbc.M801925200; Qi-Takahara Y, 2005, J NEUROSCI, V25, P436, DOI 10.1523/JNEUROSCI.1575-04.2005; Quintero-Monzon O, 2011, BIOCHEMISTRY-US, V50, P9023, DOI 10.1021/bi2007146; RIGAUD JL, 1995, BBA-BIOENERGETICS, V1231, P223, DOI 10.1016/0005-2728(95)00091-V; Saito T, 2011, NAT NEUROSCI, V14, P1023, DOI 10.1038/nn.2858; Scheuner D, 1996, NAT MED, V2, P864, DOI 10.1038/nm0896-864; Seddon AM, 2004, BBA-BIOMEMBRANES, V1666, P105, DOI 10.1016/j.bbamem.2004.04.011; Shirotani K, 2007, NEUROBIOL DIS, V27, P102, DOI 10.1016/j.nbd.2007.04.011; Simons M, 1998, P NATL ACAD SCI USA, V95, P6460, DOI 10.1073/pnas.95.11.6460; Small D. M., 1986, PHYS CHEM LIPIDS ALK; Sobhanifar S, 2010, P NATL ACAD SCI USA, V107, P9644, DOI 10.1073/pnas.1000778107; Steiner H, 2002, J BIOL CHEM, V277, P39062, DOI 10.1074/jbc.C200469200; Steiner H, 2008, CURR ALZHEIMER RES, V5, P147, DOI 10.2174/156720508783954677; Takami M, 2009, J NEUROSCI, V29, P13042, DOI 10.1523/JNEUROSCI.2362-09.2009; Takasugi N, 2003, NATURE, V422, P438, DOI 10.1038/nature01506; van Meer G, 2008, NAT REV MOL CELL BIO, V9, P112, DOI 10.1038/nrm2330; Wahrle S, 2002, NEUROBIOL DIS, V9, P11, DOI 10.1006/nbdi.2001.0470; Wakabayashi T, 2008, PHYSIOLOGY, V23, P194, DOI 10.1152/physiol.00009.2008; WildBode C, 1997, J BIOL CHEM, V272, P16085, DOI 10.1074/jbc.272.26.16085; Wiltfang J, 1997, ELECTROPHORESIS, V18, P527, DOI 10.1002/elps.1150180332; Winkler E, 2009, BIOCHEMISTRY-US, V48, P1183, DOI 10.1021/bi801204g; Wolfe MS, 2009, J BIOL CHEM, V284, P13969, DOI 10.1074/jbc.R800039200; Wrigley JDJ, 2005, J BIOL CHEM, V280, P12523, DOI 10.1074/jbc.M413086200; Zhou H, 2010, BIOCHEM BIOPH RES CO, V402, P291, DOI 10.1016/j.bbrc.2010.10.017; Zinser EG, 2007, BBA-BIOMEMBRANES, V1768, P1991, DOI 10.1016/j.bbamem.2007.02.014	49	76	79	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 15	2012	287	25					21326	21334		10.1074/jbc.M112.356659	http://dx.doi.org/10.1074/jbc.M112.356659			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974FQ	22532566	Green Published, hybrid			2022-12-25	WOS:000306416800051
J	Adijanto, J; Castorino, JJ; Wang, ZX; Maminishkis, A; Grunwald, GB; Philp, NJ				Adijanto, Jeffrey; Castorino, John J.; Wang, Zi-Xuan; Maminishkis, Arvydas; Grunwald, Gerald B.; Philp, Nancy J.			Microphthalmia-associated Transcription Factor (MITF) Promotes Differentiation of Human Retinal Pigment Epithelium (RPE) by Regulating microRNAs-204/211 Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESENCHYMAL TRANSITION; GENE-THERAPY; CONGENITAL AMAUROSIS; MICRORNA EXPRESSION; MIR-200 FAMILY; CELL FATE; LET-7; GROWTH; HMGA2; IDENTIFICATION	The retinal pigment epithelium (RPE) plays a fundamental role in maintaining visual function and dedifferentiation of RPE contributes to the pathophysiology of several ocular diseases. To identify microRNAs (miRNAs) that may be involved in RPE differentiation, we compared the miRNA expression profiles of differentiated primary human fetal RPE (hfRPE) cells to dedifferentiated hfRPE cells. We found that miR-204/211, the two most highly expressed miRNAs in the RPE, were significantly down-regulated in dedifferentiated hfRPE cells. Importantly, transfection of pre-miR-204/211 into hfRPE cells promoted differentiation whereas adding miR-204/211 inhibitors led to their dedifferentiation. Microphthalmia-associated transcription factor (MITF) is a key regulator of RPE differentiation that was also down-regulated in dedifferentiated hfRPE cells. MITF knockdown decreased miR-204/211 expression and caused hfRPE dedifferentiation. Significantly, co-transfection of MITF siRNA with pre-miR-204/211 rescued RPE phenotype. Collectively, our data show that miR-204/211 promote RPE differentiation, suggesting that miR-204/211-based therapeutics may be effective treatments for diseases that involve RPE dedifferentiation such as proliferative vitreoretinopathy.	[Adijanto, Jeffrey; Castorino, John J.; Wang, Zi-Xuan; Grunwald, Gerald B.; Philp, Nancy J.] Thomas Jefferson Univ, Dept Anat Pathol & Cell Biol, Philadelphia, PA 19107 USA; [Maminishkis, Arvydas] NEI, NIH, Bethesda, MD 20892 USA	Jefferson University; National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI)	Philp, NJ (corresponding author), Thomas Jefferson Univ, Dept Anat Pathol & Cell Biol, 1020 Locust St,Rm 534, Philadelphia, PA 19107 USA.	nancy.philp@jefferson.edu		Maminishkis, Arvydas/0000-0003-3345-3375; Philp, Nancy/0000-0001-7028-0448	National Institutes of Health [EY-012042]; NATIONAL EYE INSTITUTE [ZIAEY000419] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported, in whole or in part, by National Institutes of Health Grant EY-012042 (to N. J. P.).	Adijanto J, 2009, J GEN PHYSIOL, V133, P603, DOI 10.1085/jgp.200810169; Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; Bainbridge JWB, 2008, NEW ENGL J MED, V358, P2231, DOI 10.1056/NEJMoa0802268; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bumsted KM, 2000, INVEST OPHTH VIS SCI, V41, P903; Cheli Y, 2010, PIGM CELL MELANOMA R, V23, P27, DOI 10.1111/j.1755-148X.2009.00653.x; Chen CZ, 2004, SCIENCE, V303, P83, DOI 10.1126/science.1091903; Cheng LC, 2009, NAT NEUROSCI, V12, P399, DOI 10.1038/nn.2294; Cheng YH, 2009, CIRC RES, V105, P158, DOI 10.1161/CIRCRESAHA.109.197517; Cideciyan AV, 2009, HUM GENE THER, V20, P999, DOI 10.1089/hum.2009.086; Cordes KR, 2009, NATURE, V460, P705, DOI 10.1038/nature08195; Deo M, 2006, DEV DYNAM, V235, P2538, DOI 10.1002/dvdy.20847; DIEFFENBACH CW, 1993, PCR METH APPL, V3, pS30; Fineberg SK, 2009, NEURON, V64, P303, DOI 10.1016/j.neuron.2009.10.020; Gallagher-Colombo S, 2010, INVEST OPHTH VIS SCI, V51, P5343, DOI 10.1167/iovs.09-5028; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; GRISANTI S, 1995, INVEST OPHTH VIS SCI, V36, P391; Hiscott P, 1999, PROG RETIN EYE RES, V18, P167, DOI 10.1016/S1350-9462(98)00024-X; HODGKINSON CA, 1993, CELL, V74, P395, DOI 10.1016/0092-8674(93)90429-T; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Keene JD, 2006, NAT PROTOC, V1, P302, DOI 10.1038/nprot.2006.47; Kevany BM, 2010, PHYSIOLOGY, V25, P8, DOI 10.1152/physiol.00038.2009; King IN, 2011, DEV CELL, V20, P497, DOI 10.1016/j.devcel.2011.03.010; Korpal M, 2008, J BIOL CHEM, V283, P14910, DOI 10.1074/jbc.C800074200; Kosik KS, 2010, CELL, V143, P21, DOI 10.1016/j.cell.2010.09.008; Lamb TD, 2004, PROG RETIN EYE RES, V23, P307, DOI 10.1016/j.preteyeres.2004.03.001; Lee YS, 2007, GENE DEV, V21, P1025, DOI 10.1101/gad.1540407; Liang Y, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-166; Liu MM, 2011, BRIT J OPHTHALMOL, V95, P604, DOI 10.1136/bjo.2009.174912; Lu JA, 2011, CANCER RES, V71, P225, DOI 10.1158/0008-5472.CAN-10-1850; Lu J, 2008, DEV CELL, V14, P843, DOI 10.1016/j.devcel.2008.03.012; Maguire AM, 2008, NEW ENGL J MED, V358, P2240, DOI 10.1056/NEJMoa0802315; Makeyev EV, 2007, MOL CELL, V27, P435, DOI 10.1016/j.molcel.2007.07.015; Maminishkis A, 2006, INVEST OPHTH VIS SCI, V47, P3612, DOI 10.1167/iovs.05-1622; Mayr C, 2007, SCIENCE, V315, P1576, DOI 10.1126/science.1137999; Mazar J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013779; Park SM, 2007, CELL CYCLE, V6, P2585, DOI 10.4161/cc.6.21.4845; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Shell S, 2007, P NATL ACAD SCI USA, V104, P11400, DOI 10.1073/pnas.0704372104; Simonelli F, 2010, MOL THER, V18, P643, DOI 10.1038/mt.2009.277; Sparrrow JR, 2010, CURR MOL MED, V10, P802; STEELE FR, 1993, P NATL ACAD SCI USA, V90, P1526, DOI 10.1073/pnas.90.4.1526; Steingrimsson E, 2004, ANNU REV GENET, V38, P365, DOI 10.1146/annurev.genet.38.072902.092717; Strauss O, 2005, PHYSIOL REV, V85, P845, DOI 10.1152/physrev.00021.2004; Strunnikova NV, 2010, HUM MOL GENET, V19, P2468, DOI 10.1093/hmg/ddq129; Tamiya S, 2010, INVEST OPHTH VIS SCI, V51, P2755, DOI 10.1167/iovs.09-4725; Tan EJ, 2012, J BIOL CHEM, V287, P7134, DOI 10.1074/jbc.M111.291385; Thomson JM, 2004, NAT METHODS, V1, P47, DOI 10.1038/NMETH704; Thuault S, 2008, J BIOL CHEM, V283, P33437, DOI 10.1074/jbc.M802016200; Tsukiji N, 2009, DEV BIOL, V326, P335, DOI 10.1016/j.ydbio.2008.11.029; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Wang FE, 2010, FASEB J, V24, P1552, DOI 10.1096/fj.08-125856; Witmer AN, 2003, PROG RETIN EYE RES, V22, P1, DOI 10.1016/S1350-9462(02)00043-5; Yasumoto K, 1997, J BIOL CHEM, V272, P503; Yoo AS, 2011, NATURE, V476, P228, DOI 10.1038/nature10323; Zavadil J, 2007, CELLS TISSUES ORGANS, V185, P157, DOI 10.1159/000101316; Zhu Y, 2011, NUCL ACIDS IN PRESS	57	78	85	2	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 8	2012	287	24					20491	20503		10.1074/jbc.M112.354761	http://dx.doi.org/10.1074/jbc.M112.354761			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974FB	22523078	Green Published, hybrid			2022-12-25	WOS:000306414500070
J	Cuperlovic-Culf, M; Ferguson, D; Culf, A; Morin, PJ; Touaibia, M				Cuperlovic-Culf, Miroslava; Ferguson, Dean; Culf, Adrian; Morin, Pier Jr; Touaibia, Mohamed			H-1 NMR Metabolomics Analysis of Glioblastoma Subtypes CORRELATION BETWEEN METABOLOMICS AND GENE EXPRESSION CHARACTERISTICS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR RECEPTOR; SIGNALING PATHWAY; HUMAN BRAIN; CANCER; METABOLITES; NMR; SPECTROSCOPY; SPECTRA; EGFR	Glioblastoma multiforme (GBM) is the most common form of malignant glioma, characterized by unpredictable clinical behaviors that suggest distinct molecular subtypes. With the tumor metabolic phenotype being one of the hallmarks of cancer, we have set upon to investigate whether GBMs show differences in their metabolic profiles. H-1 NMR analysis was performed on metabolite extracts from a selection of nine glioblastoma cell lines. Analysis was performed directly on spectral data and on relative concentrations of metabolites obtained from spectra using a multivariate regression method developed in this work. Both qualitative and quantitative sample clustering have shown that cell lines can be divided into four groups for which the most significantly different metabolites have been determined. Analysis shows that some of the major cancer metabolic markers (such as choline, lactate, and glutamine) have significantly dissimilar concentrations in different GBM groups. The obtained lists of metabolic markers for subgroups were correlated with gene expression data for the same cell lines. Metabolic analysis generally agrees with gene expression measurements, and in several cases, we have shown in detail how the metabolic results can be correlated with the analysis of gene expression. Combined gene expression and metabolomics analysis have shown differential expression of transporters of metabolic markers in these cells as well as some of the major metabolic pathways leading to accumulation of metabolites. Obtained lists of marker metabolites can be leveraged for subtype determination in glioblastomas.	[Cuperlovic-Culf, Miroslava] Natl Res Council Canada, Moncton, NB E1A 7R1, Canada; [Ferguson, Dean; Morin, Pier Jr; Touaibia, Mohamed] Univ Moncton, Dept Chem & Biochem, Moncton, NB E1A 3E9, Canada; [Culf, Adrian] Atlantic Canc Res Inst, Moncton, NB E1C 8X3, Canada	National Research Council Canada; University of Moncton	Cuperlovic-Culf, M (corresponding author), Natl Res Council Canada, 100 Aboiteaux St, Moncton, NB E1A 7R1, Canada.	miroslava.cuperlovic-culf@nrc-cnrc.gc.ca	Cuperlovic-Culf, Miroslava/C-7876-2016	Cuperlovic-Culf, Miroslava/0000-0002-9483-8159	CFI; NRC Cluster Initiative; Atlantic Cancer Research Institute; Beatrice Hunter Cancer Research Institute; Brain Tumor Foundation of Canada	CFI(Canada Foundation for Innovation); NRC Cluster Initiative; Atlantic Cancer Research Institute; Beatrice Hunter Cancer Research Institute; Brain Tumor Foundation of Canada	We thank M. Monette (Bruker Canada) for help in setting up NMR experiments. We acknowledge the contribution of the Canadian Foundation for Innovation (CFI), the New Brunswick Innovation Foundation (NBIF), and Universite de Moncton for the acquisition of the NMR instrument. We also acknowledge the support of the CFI for the funding of a portion of operating costs and maintenance for the NMR instrument through the Infrastructure Operating Fund (IOF).; Supported by the NRC Cluster Initiative. To whom correspondence should be addressed: National Research Council of Canada, 100 des Aboiteaux St., Moncton, New Brunswick E1A 7R1, Canada. Tel.: 506-861-0952; E-mail: miroslava.cuperlovic-culf@nrc-cnrc.gc.ca.; Supported by the Atlantic Cancer Research Institute.; Supported by the Beatrice Hunter Cancer Research Institute and the Brain Tumor Foundation of Canada.	Belacel N, 2004, BIOINFORMATICS, V20, P1690, DOI 10.1093/bioinformatics/bth142; Brahimi-Horn MC, 2007, CURR OPIN CELL BIOL, V19, P223, DOI 10.1016/j.ceb.2007.02.003; Brandes AH, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2729; Brennan C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007752; Cairns RA, 2011, NAT REV CANCER, V11, P85, DOI 10.1038/nrc2981; Chakravarti A, 2004, INT J RADIAT ONCOL, V58, P927, DOI 10.1016/j.ijrobp.2003.09.092; Cuperlovic-Culf M, 2009, MAGN RESON CHEM, V47, pS96, DOI 10.1002/mrc.2502; Dang CV, 2010, CANCER RES, V70, P859, DOI 10.1158/0008-5472.CAN-09-3556; Florian CL, 1995, NMR BIOMED, V8, P253, DOI 10.1002/nbm.1940080605; FLORIAN CL, 1995, CANCER RES, V55, P420; Govindaraju V, 2000, NMR BIOMED, V13, P129, DOI 10.1002/1099-1492(200005)13:3<129::AID-NBM619>3.0.CO;2-V; Griffin JL, 2007, FEBS J, V274, P1132, DOI 10.1111/j.1742-4658.2007.05676.x; Grzmil M, 2011, CANCER RES, V71, P2392, DOI 10.1158/0008-5472.CAN-10-3112; HOWELLS SI, 1992, NMR BIOMED, V5, P59, DOI 10.1002/nbm.1940050203; Kroemer G, 2008, CANCER CELL, V13, P472, DOI 10.1016/j.ccr.2008.05.005; Kuksis A, 2003, INOSITOL PHOSPHOLIPI, P335; Markley JL, 2007, PACIFIC SYMPOSIUM ON BIOCOMPUTING 2007, P157; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Ohgaki H, 2004, CANCER RES, V64, P6892, DOI 10.1158/0008-5472.CAN-04-1337; Peter Y, 2009, MOL CARCINOGEN, V48, P488, DOI 10.1002/mc.20485; Serkova NJ, 2008, PROSTATE, V68, P620, DOI 10.1002/pros.20727; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tulpan D, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-400; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Warburg O, 1924, BIOCHEM Z, V152, P319; Wishart DS, 2009, NUCLEIC ACIDS RES, V37, pD603, DOI 10.1093/nar/gkn810; ZANER KS, 1977, PHYSIOL CHEM PHYS M, V9, P473	28	52	54	2	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 8	2012	287	24					20164	20175		10.1074/jbc.M111.337196	http://dx.doi.org/10.1074/jbc.M111.337196			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974FB	22528487	Green Published, hybrid			2022-12-25	WOS:000306414500037
J	Petit-Paitel, A; Menard, B; Guyon, A; Beringue, V; Nahon, JL; Zsurger, N; Chabry, J				Petit-Paitel, Agnes; Menard, Baptiste; Guyon, Alice; Beringue, Vincent; Nahon, Jean-Louis; Zsuerger, Nicole; Chabry, Joelle			Prion Protein Is a Key Determinant of Alcohol Sensitivity through the Modulation of N-Methyl-D-Aspartate Receptor (NMDAR) Activity	PLOS ONE			English	Article							FYN-KINASE; ETHANOL SENSITIVITY; MICE LACKING; LIPID RAFTS; PRP; LOCALIZATION; MOLECULES; INFECTION; CAVEOLAE; BINDING	The prion protein (PrP) is absolutely required for the development of prion diseases; nevertheless, its physiological functions in the central nervous system remain elusive. Using a combination of behavioral, electrophysiological and biochemical approaches in transgenic mouse models, we provide strong evidence for a crucial role of PrP in alcohol sensitivity. Indeed, PrP knock out (PrP-/-) mice presented a greater sensitivity to the sedative effects of EtOH compared to wild-type (wt) control mice. Conversely, compared to wt mice, those over-expressing mouse, human or hamster PrP genes presented a relative insensitivity to ethanol-induced sedation. An acute tolerance (i.e. reversion) to ethanol inhibition of N-methyl-D-aspartate (NMDA) receptor-mediated excitatory post-synaptic potentials in hippocampal slices developed slower in PrP-/- mice than in wt mice. We show that PrP is required to induce acute tolerance to ethanol by activating a Src-protein tyrosine kinase-dependent intracellular signaling pathway. In an attempt to decipher the molecular mechanisms underlying PrP-dependent ethanol effect, we looked for changes in lipid raft features in hippocampus of ethanol-treated wt mice compared to PrP-/- mice. Ethanol induced rapid and transient changes of buoyancy of lipid raft-associated proteins in hippocampus of wt but not PrP-/- mice suggesting a possible mechanistic link for PrP-dependent signal transduction. Together, our results reveal a hitherto unknown physiological role of PrP on the regulation of NMDAR activity and highlight its crucial role in synaptic functions.	[Petit-Paitel, Agnes; Menard, Baptiste; Guyon, Alice; Nahon, Jean-Louis; Zsuerger, Nicole; Chabry, Joelle] CNRS, Inst Pharmacol Mol & Cellulaire, F-06560 Valbonne, France; [Beringue, Vincent] INRA, UR892, Jouy En Josas, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur; INRAE; UDICE-French Research Universities; Universite Paris Saclay	Chabry, J (corresponding author), CNRS, Inst Pharmacol Mol & Cellulaire, 660 Route Lucioles, F-06560 Valbonne, France.	chabry@ipmc.cnrs.fr	; NAHON, Jean-Louis/O-7977-2016; Guyon, Alice/P-5192-2016	Petit-Paitel, Agnes/0000-0003-1138-9966; NAHON, Jean-Louis/0000-0001-9572-7779; Guyon, Alice/0000-0003-3346-8411	Agence Nationale de Recherche [ANR-06-NEURO-007-01]; IREB (France)	Agence Nationale de Recherche(French National Research Agency (ANR)); IREB (France)	This work was supported by grants from the Agence Nationale de Recherche (ANR-06-NEURO-007-01) and by the IREB (France). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguzzi A, 2008, ANNU REV NEUROSCI, V31, P439, DOI 10.1146/annurev.neuro.31.060407.125620; Arevalo E, 2008, P NATL ACAD SCI USA, V105, P371, DOI 10.1073/pnas.0707815105; Beggs HE, 1997, J BIOL CHEM, V272, P8310, DOI 10.1074/jbc.272.13.8310; Beringue V, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001419; Bjarnadottir M, 2007, J NEUROSCI, V27, P4519, DOI 10.1523/JNEUROSCI.4314-06.2007; Boehm SL, 2004, NEUROSCI LETT, V372, P6, DOI 10.1016/j.neulet.2004.08.028; BUELER H, 1992, NATURE, V356, P577, DOI 10.1038/356577a0; COLLINGE J, 1994, NATURE, V370, P295, DOI 10.1038/370295a0; Criado JR, 2005, NEUROBIOL DIS, V19, P255, DOI 10.1016/j.nbd.2005.01.001; Cronier S, 2007, J VIROL, V81, P13794, DOI 10.1128/JVI.01502-07; Fischer M, 1996, EMBO J, V15, P1255, DOI 10.1002/j.1460-2075.1996.tb00467.x; Gourdain P, 2009, J IMMUNOL, V183, P6619, DOI 10.4049/jimmunol.0804385; GROVER CA, 1994, BRAIN RES, V642, P70, DOI 10.1016/0006-8993(94)90906-7; hare S, 2011, ALCOHOL CLIN EXP RES; HARRIS RA, 1995, P NATL ACAD SCI USA, V92, P3658, DOI 10.1073/pnas.92.9.3658; Herms J, 1999, J NEUROSCI, V19, P8866, DOI 10.1523/JNEUROSCI.19-20-08866.1999; Khosravani H, 2008, J CELL BIOL, V181, P551, DOI 10.1083/jcb.200711002; Lisanti Michael P., 1994, Trends in Cell Biology, V4, P231, DOI 10.1016/0962-8924(94)90114-7; Loeuillet C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013166; Marella M, 2004, J NEUROSCI, V24, P620, DOI 10.1523/JNEUROSCI.4303-03.2004; Miyakawa T, 1997, SCIENCE, V278, P698, DOI 10.1126/science.278.5338.698; Mouillet-Richard S, 2000, SCIENCE, V289, P1925, DOI 10.1126/science.289.5486.1925; Nourissat P, 2008, HEPATOLOGY, V47, P59, DOI 10.1002/hep.21958; Palachick B, 2008, ALCOHOL CLIN EXP RES, V32, P1479, DOI 10.1111/j.1530-0277.2008.00715.x; Peoples RW, 1996, ANNU REV PHARMACOL, V36, P185, DOI 10.1146/annurev.pa.36.040196.001153; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Ron D, 2004, NEUROSCIENTIST, V10, P325, DOI 10.1177/1073858404263516; Sales N, 1998, EUR J NEUROSCI, V10, P2464, DOI 10.1046/j.1460-9568.1998.00258.x; Santuccione A, 2005, J CELL BIOL, V169, P341, DOI 10.1083/jcb.200409127; Schmitt-Ulms G, 2001, J MOL BIOL, V314, P1209, DOI 10.1006/jmbi.2000.5183; Silveri MM, 2002, ALCOHOL CLIN EXP RES, V26, P449, DOI 10.1111/j.1530-0277.2002.tb02560.x; Szabo G, 2007, J IMMUNOL, V178, P1243, DOI 10.4049/jimmunol.178.3.1243; Tansey MG, 2000, NEURON, V25, P611, DOI 10.1016/S0896-6273(00)81064-8; Tobler I, 1996, NATURE, V380, P639, DOI 10.1038/380639a0; Tobler I, 1997, J NEUROSCI, V17, P1869; Vengeliene V, 2008, BRIT J PHARMACOL, V154, P299, DOI 10.1038/bjp.2008.30; Vey M, 1996, P NATL ACAD SCI USA, V93, P14945, DOI 10.1073/pnas.93.25.14945; Walz R, 1999, EPILEPSIA, V40, P1679, DOI 10.1111/j.1528-1157.1999.tb01583.x; WILSON WR, 1990, ALCOHOL, V7, P389, DOI 10.1016/0741-8329(90)90021-4; Yaka R, 2003, ALCOHOL CLIN EXP RES, V27, P1736, DOI 10.1097/01.ALC.0000095924.87729.D8; Yaka R, 2003, J NEUROSCI, V23, P3623	41	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2012	7	4							e34691	10.1371/journal.pone.0034691	http://dx.doi.org/10.1371/journal.pone.0034691			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UD	22536327	Green Published, Green Submitted, gold			2022-12-25	WOS:000305339200016
J	Twin, J; Jensen, JS; Bradshaw, CS; Garland, SM; Fairley, CK; Min, LY; Tabrizi, SN				Twin, Jimmy; Jensen, Jorgen S.; Bradshaw, Catriona S.; Garland, Suzanne M.; Fairley, Christopher K.; Min, Lim Yi; Tabrizi, Sepehr N.			Transmission and Selection of Macrolide Resistant Mycoplasma genitalium Infections Detected by Rapid High Resolution Melt Analysis	PLOS ONE			English	Article							REAL-TIME PCR; 23S RIBOSOMAL-RNA; NONGONOCOCCAL URETHRITIS; AZITHROMYCIN; PNEUMONIAE; MANAGEMENT; MUTATIONS; FAILURE; TRACT	Background: Mycoplasma genitalium (MG) causes urethritis, cervicitis and pelvic inflammatory disease. The MG treatment failure rate using 1 g azithromycin at an Australian Sexual Health clinic in 2007-9 was 31% (95%CI 23-40%). We developed a rapid high resolution melt analysis (HRMA) assay targeting resistance mutations in the MG 23S rRNA gene, and validated it against DNA sequencing by examining pre- and post-treatment archived samples from MG-infected patients. Methodology/Principal Findings: Available MG-positive pre-treatment (n = 82) and post-treatment samples from individuals with clinical treatment failure (n = 20) were screened for 23S rRNA gene mutations. Sixteen (20%) pre-treatment samples possessed resistance mutations (A2058G, A2059G, A2059C), which were significantly more common in patients with symptomatic azithromycin-treatment failure (12/26; 44%) than in those clinically cured (4/56; 7%), p<0.001. All 20 patients experiencing azithromycin-failure had detectable mutations in their post-treatment samples. In 9 of these cases, the same mutational types were present in both pre- and post-treatment samples indicating transmitted resistance, whilst in 11 of these cases (55%), mutations were absent in pre-treatment samples indicating likely selection of resistant isolates have occurred. HRMA was able to detect all mutational changes determined in this study by DNA sequencing. An additional HRMA assay incorporating an unlabelled probe was also developed to detect type 4 single-nucleotide polymorphisms found in other populations, with a slightly lower sensitivity of 90%. Conclusions/Significance: Treatment failure is associated with the detection of macrolide resistance mutations, which appear to be almost equally due to selection of resistant isolates following exposure to 1 g azithromycin and pre- existing transmitted resistance. The application of a rapid molecular assay to detect resistance at the time of initial detection of infection allows clinicians to shorten the time to initiate effective second line treatment. This has the potential to reduce transmission of resistant strains and to avoid sequelae associated with persistent untreated infection.	[Twin, Jimmy; Garland, Suzanne M.; Tabrizi, Sepehr N.] Royal Womens Hosp, Dept Microbiol & Infect Dis, Melbourne, Vic, Australia; [Twin, Jimmy; Garland, Suzanne M.; Tabrizi, Sepehr N.] Murdoch Childrens Res Inst, Melbourne, Vic, Australia; [Jensen, Jorgen S.] Statens Serum Inst, DK-2300 Copenhagen, Denmark; [Bradshaw, Catriona S.; Fairley, Christopher K.; Min, Lim Yi] Alfred Hosp, Melbourne Sexual Hlth Ctr, Melbourne, Vic, Australia; [Bradshaw, Catriona S.] Monash Univ, Dept Epidemiol & Prevent Med, Melbourne, Vic 3004, Australia; [Bradshaw, Catriona S.; Fairley, Christopher K.] Univ Melbourne, Melbourne Sch Populat Hlth, Melbourne, Vic, Australia; [Garland, Suzanne M.; Tabrizi, Sepehr N.] Univ Melbourne, Dept Obstet & Gynecol, Melbourne, Vic, Australia; [Garland, Suzanne M.] Royal Childrens Hosp, Dept Microbiol, Melbourne, Vic, Australia	Murdoch Children's Research Institute; Statens Serum Institut; Florey Institute of Neuroscience & Mental Health; Monash University; University of Melbourne; University of Melbourne; Royal Children's Hospital Melbourne	Twin, J (corresponding author), Royal Womens Hosp, Dept Microbiol & Infect Dis, Melbourne, Vic, Australia.	jimmy.twin@mcri.edu.au	Jensen, Jørgen/I-2917-2012; Jensen, Jørgen Skov/H-5159-2019	Jensen, Jørgen Skov/0000-0002-7464-7435; Christopher, Fairley/0000-0001-9081-1664; bradshaw, catriona/0000-0002-6643-5678				Bjornelius E, 2007, SEX TRANSM INFECT, V84, P72, DOI [10.1136/ti.2007.027375, 10.1136/sti.2007.027375]; Bradshaw CS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003618; Bradshaw CS, 2006, EMERG INFECT DIS, V12, P1149, DOI 10.3201/eid1207.051558; Bradshaw CS, 2010, 2010 AUSTR SEX HLTH; Cao B, 2010, CLIN INFECT DIS, V51, P189, DOI 10.1086/653535; Cohen CR, 2002, LANCET, V359, P765, DOI 10.1016/S0140-6736(02)07848-0; Deguchi T, 2002, J UROLOGY, V167, P1210, DOI 10.1016/S0022-5347(05)65268-8; FitzGerald M, 1996, INT J STD AIDS, V7, P298, DOI 10.1258/0956462961917861; FRASER CM, 1995, SCIENCE, V270, P397, DOI 10.1126/science.270.5235.397; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; Hjorth SV, 2006, J CLIN MICROBIOL, V44, P2078, DOI 10.1128/JCM.00003-06; Horner PJ, 2010, SEX TRANSM INFECT; Ito S, 2011, SEX TRANSM INFECT, V87, P412, DOI 10.1136/sextrans-2011-050035; Jensen JS, 2008, CLIN INFECT DIS, V47, P1546, DOI 10.1086/593188; Jensen JS, 2004, J CLIN MICROBIOL, V42, P683, DOI 10.1128/JCM.42.2.683-692.2004; Jensen JS, 2004, J EUR ACAD DERMATOL, V18, P1, DOI 10.1111/j.1468-3083.2004.00923.x; Jernberg E, 2008, INT J STD AIDS, V19, P676, DOI 10.1258/ijsa.2008.008038; LUCIER TS, 1995, ANTIMICROB AGENTS CH, V39, P2770, DOI 10.1128/AAC.39.12.2770; Ma L, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-130; Mackinnon A, 2000, COMPUT BIOL MED, V30, P127, DOI 10.1016/S0010-4825(00)00006-8; Mena LA, 2009, CLIN INFECT DIS, V48, P1649, DOI 10.1086/599033; Morozumi M, 2010, J INFECT CHEMOTHER, V16, P78, DOI 10.1007/s10156-009-0021-4; Peuchant O, 2009, J ANTIMICROB CHEMOTH, V64, P52, DOI 10.1093/jac/dkp160; Rozen S, 2000, Methods Mol Biol, V132, P365; Sen Yew H, 2011, J CLIN MICROBIOL, V49, P1695, DOI 10.1128/JCM.02475-10; Shahmanesh M, 2009, INT J STD AIDS, V20, P458, DOI 10.1258/ijsa.2009.009143; Shimada Y, 2011, EMERG INFECT DIS, V17, P1148, DOI [10.3201/eid1706.101055, 10.3201/eid/1706.101055]; Svenstrup HF, 2005, J CLIN MICROBIOL, V43, P3121, DOI 10.1128/JCM.43.7.3121-3128.2005; Taylor-Robinson D, 2002, INT J STD AIDS, V13, P145, DOI 10.1258/0956462021924776; TULLY JG, 1981, LANCET, V1, P1288; Twin J, 2011, J CLIN MICROBIOL, V49, P1140, DOI 10.1128/JCM.02328-10; Uuskula A, 2002, INT J STD AIDS, V13, P79, DOI 10.1258/0956462021924695; Wolff BJ, 2008, ANTIMICROB AGENTS CH, V52, P3542, DOI 10.1128/AAC.00582-08	33	80	84	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2012	7	4							e35593	10.1371/journal.pone.0035593	http://dx.doi.org/10.1371/journal.pone.0035593			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UD	22532861	Green Published, Green Submitted, gold			2022-12-25	WOS:000305339200083
J	Vaas, LAI; Sikorski, J; Michael, V; Goker, M; Klenk, HP				Vaas, Lea A. I.; Sikorski, Johannes; Michael, Victoria; Goeker, Markus; Klenk, Hans-Peter			Visualization and Curve-Parameter Estimation Strategies for Efficient Exploration of Phenotype Microarray Kinetics	PLOS ONE			English	Article							METABOLIC RECONSTRUCTION; LONGITUDINAL DATA; SPLINE FUNCTIONS; GROWTH; BIOLOGY; MODELS; EVOLUTION; NETWORKS	Background: The Phenotype MicroArray (OmniLog (R) PM) system is able to simultaneously capture a large number of phenotypes by recording an organism's respiration over time on distinct substrates. This technique targets the object of natural selection itself, the phenotype, whereas previously addressed '-omics' techniques merely study components that finally contribute to it. The recording of respiration over time, however, adds a longitudinal dimension to the data. To optimally exploit this information, it must be extracted from the shapes of the recorded curves and displayed in analogy to conventional growth curves. Methodology: The free software environment R was explored for both visualizing and fitting of PM respiration curves. Approaches using either a model fit (and commonly applied growth models) or a smoothing spline were evaluated. Their reliability in inferring curve parameters and confidence intervals was compared to the native OmniLog (R) PM analysis software. We consider the post-processing of the estimated parameters, the optimal classification of curve shapes and the detection of significant differences between them, as well as practically relevant questions such as detecting the impact of cultivation times and the minimum required number of experimental repeats. Conclusions: We provide a comprehensive framework for data visualization and parameter estimation according to user choices. A flexible graphical representation strategy for displaying the results is proposed, including 95% confidence intervals for the estimated parameters. The spline approach is less prone to irregular curve shapes than fitting any of the considered models or using the native PM software for calculating both point estimates and confidence intervals. These can serve as a starting point for the automated post-processing of PM data, providing much more information than the strict dichotomization into positive and negative reactions. Our results form the basis for a freely available R package for the analysis of PM data.	[Vaas, Lea A. I.; Sikorski, Johannes; Michael, Victoria; Goeker, Markus; Klenk, Hans-Peter] DSMZ German Collect Microorganisms & Cell Culture, Braunschweig, Germany	Leibniz Institut fur Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ)	Goker, M (corresponding author), DSMZ German Collect Microorganisms & Cell Culture, Braunschweig, Germany.	markus.goeker@dsmz.de	Göker, Markus/AAX-6258-2021; Sikorski, Johannes/AAD-9775-2019; Sikorski, Johannes/AAX-1960-2020	Göker, Markus/0000-0002-5144-6200; Sikorski, Johannes/0000-0002-1890-5540	Deutsche Sammlung von Mikroorganismen und Zellkulturen GmbH; European Union [222886 MICROME]; German Research Foundation (DFG) [SFB/TRR 51]; DFG [SI1352/1-2]	Deutsche Sammlung von Mikroorganismen und Zellkulturen GmbH; European Union(European Commission); German Research Foundation (DFG)(German Research Foundation (DFG)); DFG(German Research Foundation (DFG))	Deutsche Sammlung von Mikroorganismen und Zellkulturen GmbH funded this research through the employment of all authors, who contributed to all aspects of the study. This work was supported by the European Union grant 222886 MICROME and the German Research Foundation (DFG) SFB/TRR 51, which is gratefully acknowledged. Also, the DFG grant SI1352/1-2 to JS is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Asab MS, 2011, OMICS, V15, P105, DOI 10.1089/omi.2010.0023; Akaike H, 1983, INT STAT I, V44, P277, DOI DOI 10.1086/PHOS.50.4.187553; Akaike H., 1973, P 2 INT S INF THEOR, VI, P610, DOI DOI 10.1007/978-1-4612-1694-0_15; [Anonymous], [No title captured]; [Anonymous], 2010, R LANG ENV STAT COMP; Baba Tomoya, 2008, V416, P183, DOI 10.1007/978-1-59745-321-9_12; Balding DJ, 2004, APPL LONGITUDINAL AN; Becker R.A., 1996, TOUR TRELLIS GRAPHIC; BiOLOG Inc, 2009, CONV FIL MAN SOFTW P; Birch CPD, 1999, ANN BOT-LONDON, V83, P713, DOI 10.1006/anbo.1999.0877; Bochner BR, 2009, FEMS MICROBIOL REV, V33, P191, DOI 10.1111/j.1574-6976.2008.00149.x; Bochner BR, 2001, GENOME RES, V11, P1246, DOI 10.1101/gr.186501; BOCHNER BR, 1977, APPL ENVIRON MICROB, V33, P434, DOI 10.1128/AEM.33.2.434-444.1977; Bretz F., 2010, MULTIPLE COMP USING; BRISBIN IL, 1987, AUK, V104, P552, DOI 10.2307/4087567; Buchanan AV, 2009, BIOESSAYS, V31, P198, DOI 10.1002/bies.200800133; Bujara M, 2010, CURR OPIN BIOTECH, V21, P586, DOI 10.1016/j.copbio.2010.07.007; Chang WLE, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-109; Chen C., 2008, HDB DATA VISUALIZATI; Christian BW, 2006, INT REV HYDROBIOL, V91, P257, DOI 10.1002/iroh.200510838; CRAVEN P, 1979, NUMER MATH, V31, P377, DOI 10.1007/BF01437407; Cumming G, 2007, J CELL BIOL, V177, P7, DOI 10.1083/jcb.200611141; Di Cagno R, 2010, INT J FOOD MICROBIOL, V143, P246, DOI 10.1016/j.ijfoodmicro.2010.08.018; Dudoit S, 2008, SPRINGER SER STAT, P1; Edwards RL, 2009, MOL MICROBIOL, V71, P1190, DOI [10.1111/j.1365-2958.2009.06593.x, 10.1111/j.1365-2958.2008.06593.x]; EFRON B, 1979, ANN STAT, V7, P1, DOI 10.1214/aos/1176344552; Eilers PHC, 1996, STAT SCI, V11, P89, DOI 10.1214/ss/1038425655; Eugster MJA, 2009, J STAT SOFTW, V30, P1; FELLER W., 1940, ACTA BIOTHEORETICA, V5, P51, DOI 10.1007/BF01602862; Feng XY, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/460717; Fitzmaurice GM, 2008, CIRCULATION, V118, P2005, DOI 10.1161/CIRCULATIONAHA.107.714618; Fodor IK, 2005, JOINT STAT M MINN MN; GARDNER MJ, 1986, BMJ-BRIT MED J, V292, P746, DOI 10.1136/bmj.292.6522.746; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gottschalk PG, 2005, ANAL BIOCHEM, V343, P54, DOI 10.1016/j.ab.2005.04.035; HAACK SK, 1995, APPL ENVIRON MICROB, V61, P1458, DOI 10.1128/AEM.61.4.1458-1468.1995; Hackett CA, 1997, J MICROBIOL METH, V30, P63, DOI 10.1016/S0167-7012(97)00045-6; Hardle W., 1992, APPL NONPARAMETRIC R; Hofner B, 2011, ECOLOGY, V92, P1895, DOI 10.1890/10-2276.1; Homann OR, 2005, PLOS GENET, V1, P715, DOI 10.1371/journal.pgen.0010080; HUTT MT, 2001, DATENANALYSE BIOL; Jacobsen JS, 2007, 11 INT C INF VIS IV0; Johnson RA, 2007, APPL MULTIVARIATE ST; Kahm M, 2010, J STAT SOFTW, V33, P1; Kandpal RP, 2009, BIOTECHNIQUES, V46, P351, DOI 10.2144/000113137; Laird N M, 1992, Stat Methods Med Res, V1, P225, DOI 10.1177/096228029200100302; LAIRD NM, 1982, BIOMETRICS, V38, P963, DOI 10.2307/2529876; Lay JO, 2006, TRAC-TREND ANAL CHEM, V25, P1046, DOI 10.1016/j.trac.2006.10.007; Le Cao KA, 2009, BIOINFORMATICS, V25, P2855, DOI 10.1093/bioinformatics/btp515; Legendre P., 1998, NUMERICAL ECOLOGY, V24; Mayr E, 1997, P NATL ACAD SCI USA, V94, P2091, DOI 10.1073/pnas.94.6.2091; Medina I, 2010, NUCLEIC ACIDS RES, V38, pW210, DOI 10.1093/nar/gkq388; Mitchell DA, 2004, BIOCHEM ENG J, V17, P15, DOI 10.1016/S1369-703X(03)00120-7; Mithani A, 2011, MOL BIOL EVOL, V28, P483, DOI 10.1093/molbev/msq213; Neysens P, 2003, MICROBIOL-SGM, V149, P1073, DOI 10.1099/mic.0.25880-0; Nogales J, 2008, BMC SYST BIOL, V2, DOI 10.1186/1752-0509-2-79; Oh YK, 2007, J BIOL CHEM, V282, P28791, DOI 10.1074/jbc.M703759200; Papin JA, 2004, TRENDS BIOCHEM SCI, V29, P641, DOI 10.1016/j.tibs.2004.10.001; Peugh JL, 2005, EDUC PSYCHOL MEAS, V65, P811, DOI 10.1177/0013164405278558; Puchalka J, 2008, PLOS COMPUT BIOL, V4, P1; Rabe-Hesketh S., 2008, MULTILEVEL LONGITUDI; Reed JL, 2006, P NATL ACAD SCI USA, V103, P17480, DOI 10.1073/pnas.0603364103; RICHARDS FJ, 1959, J EXP BOT, V10, P290, DOI 10.1093/jxb/10.2.290; Ritz C, 2005, J STAT SOFTW, V12, pi05; Ruppin E, 2010, CURR OPIN BIOTECH, V21, P502, DOI 10.1016/j.copbio.2010.07.002; Sabet S, 2009, EXTREMOPHILES, V13, P643, DOI 10.1007/s00792-009-0247-1; Sarkar D, 2008, USE R, P1; Schaarschmidt F, 2009, HORTSCIENCE, V44, P188, DOI 10.21273/HORTSCI.44.1.188; Schenker N, 2001, AM STAT, V55, P182, DOI 10.1198/000313001317097960; Serroyen J, 2009, AM STAT, V63, P378, DOI 10.1198/tast.2009.07256; Shipley B., 2000, CAUSE CORRELATIONS B; Sikorski J, 2007, ENVIRON MICROBIOL, V9, P716, DOI 10.1111/j.1462-2920.2006.01193.x; Singer JD, 1998, J EDUC BEHAV STAT, V23, P323; Spiegelman D, 2005, CAN J MICROBIOL, V51, P355, DOI 10.1139/W05-003; Sturino J, 2010, INT J BIOSTAT, V6, DOI 10.2202/1557-4679.1227; Ventura M, 2009, NAT REV MICROBIOL, V7, P61, DOI 10.1038/nrmicro2047; Verbyla AP, 1999, J ROY STAT SOC C-APP, V48, P269, DOI 10.1111/1467-9876.00154; Vilchez-Vargas R, 2010, ENVIRON MICROBIOL, V12, P3089, DOI 10.1111/j.1462-2920.2010.02340.x; Wang X, 2012, NATURE COMMUNICATION, V1, P147; Warringer J, 2003, YEAST, V20, P53, DOI 10.1002/yea.931; Wenk MR, 2010, CELL, V143, P888, DOI 10.1016/j.cell.2010.11.033; WOLD S, 1974, TECHNOMETRICS, V16, P1, DOI 10.2307/1267485; Xue XL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020075; Zhang WW, 2010, MICROBIOL-SGM, V156, P287, DOI 10.1099/mic.0.034793-0; Zhou L, 2003, J BACTERIOL, V185, P4956, DOI 10.1128/JB.185.16.4956-4972.2003; Zimmerman DL, 2001, TEST-SPAIN, V10, P1, DOI 10.1007/BF02595823; ZWIETERING MH, 1990, APPL ENVIRON MICROB, V56, P1875	87	138	138	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2012	7	4							e34846	10.1371/journal.pone.0034846	http://dx.doi.org/10.1371/journal.pone.0034846			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UD	22536335	Green Published, gold			2022-12-25	WOS:000305339200023
J	Bayer, T; Aranda, M; Sunagawa, S; Yum, LK; DeSalvo, MK; Lindquist, E; Coffroth, MA; Voolstra, CR; Medina, M				Bayer, Till; Aranda, Manuel; Sunagawa, Shinichi; Yum, Lauren K.; DeSalvo, Michael K.; Lindquist, Erika; Coffroth, Mary Alice; Voolstra, Christian R.; Medina, Monica			Symbiodinium Transcriptomes: Genome Insights into the Dinoflagellate Symbionts of Reef-Building Corals	PLOS ONE			English	Article							GENE-EXPRESSION; DNA-CONTENT; STRESS; EVOLUTION; PROTEINS; LINEAGE; SEARCH; MODEL; ZOOXANTHELLAE; THIOREDOXIN	Dinoflagellates are unicellular algae that are ubiquitously abundant in aquatic environments. Species of the genus Symbiodinium form symbiotic relationships with reef-building corals and other marine invertebrates. Despite their ecologic importance, little is known about the genetics of dinoflagellates in general and Symbiodinium in particular. Here, we used 454 sequencing to generate transcriptome data from two Symbiodinium species from different clades (clade A and clade B). With more than 56,000 assembled sequences per species, these data represent the largest transcriptomic resource for dinoflagellates to date. Our results corroborate previous observations that dinoflagellates possess the complete nucleosome machinery. We found a complete set of core histones as well as several H3 variants and H2A.Z in one species. Furthermore, transcriptome analysis points toward a low number of transcription factors in Symbiodinium spp. that also differ in the distribution of DNA-binding domains relative to other eukaryotes. In particular the cold shock domain was predominant among transcription factors. Additionally, we found a high number of antioxidative genes in comparison to non-symbiotic but evolutionary related organisms. These findings might be of relevance in the context of the role that Symbiodinium spp. play as coral symbionts. Our data represent the most comprehensive dinoflagellate EST data set to date. This study provides a comprehensive resource to further analyze the genetic makeup, metabolic capacities, and gene repertoire of Symbiodinium and dinoflagellates. Overall, our findings indicate that Symbiodinium possesses some unique characteristics, in particular the transcriptional regulation in Symbiodinium may differ from the currently known mechanisms of eukaryotic gene regulation.	[Bayer, Till; Aranda, Manuel; Yum, Lauren K.; Voolstra, Christian R.] KAUST, Red Sea Res Ctr, Thuwal, Saudi Arabia; [Sunagawa, Shinichi] European Mol Biol Lab, Heidelberg, Germany; [DeSalvo, Michael K.] Univ Calif San Francisco, UCSF Sch Med, Dept Anesthesia, San Francisco, CA 94143 USA; [Lindquist, Erika] Joint Genome Inst, Dept Energy, Walnut Creek, CA USA; [Coffroth, Mary Alice] SUNY Buffalo, Dept Geol, Grad Program Evolut Ecol & Behav, Buffalo, NY 14260 USA; [Medina, Monica] Univ Calif Merced, Sch Nat Sci, Merced, CA USA	King Abdullah University of Science & Technology; European Molecular Biology Laboratory (EMBL); University of California System; University of California San Francisco; United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; Joint Genome Institute - JGI; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; University of California System; University of California Merced	Bayer, T (corresponding author), KAUST, Red Sea Res Ctr, Thuwal, Saudi Arabia.	christian.voolstra@kaust.edu.sa; mmedina@ucmerced.edu	Aranda Lastra, Manuel/D-9530-2011; Sunagawa, Shinichi/Q-5950-2019; Voolstra, Christian R/H-7158-2014; Bayer, Till/H-6826-2016	Aranda Lastra, Manuel/0000-0001-6673-016X; Sunagawa, Shinichi/0000-0003-3065-0314; Voolstra, Christian R/0000-0003-4555-3795; Bayer, Till/0000-0002-4704-2449	NSF (National Science Foundation) [IOS 0644438, IOS 0926906, OCE 0424994]; KAUST AEA (King Abdullah University of Science and Technology); King Abdullah University of Science and Technology; Office of Science of the U.S. Department of Energy [DE-AC02-05CH11231]; Directorate For Geosciences [0926822] Funding Source: National Science Foundation	NSF (National Science Foundation)(National Science Foundation (NSF)); KAUST AEA (King Abdullah University of Science and Technology); King Abdullah University of Science and Technology(King Abdullah University of Science & Technology); Office of Science of the U.S. Department of Energy(United States Department of Energy (DOE)); Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	This study was supported through NSF (National Science Foundation) awards IOS 0644438 and IOS 0926906 (MM), OCE 0424994 (MAC), a KAUST AEA (King Abdullah University of Science and Technology) 3 Joint Collaborative Research award (CRV), and through a Collaborative Travel Fund to TB made by King Abdullah University of Science and Technology. The work conducted by the U.S. Department of Energy Joint Genome Institute is supported by the Office of Science of the U.S. Department of Energy under Contract No. DE-AC02-05CH11231. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad K, 2002, P NATL ACAD SCI USA, V99, P16477, DOI 10.1073/pnas.172403699; Andersson JO, 2005, CELL MOL LIFE SCI, V62, P1182, DOI 10.1007/s00018-005-4539-z; Aranda M, 2011, MOL ECOL, V20, P2955, DOI 10.1111/j.1365-294X.2011.05153.x; Aravind L, 2003, CELL, V115, P771, DOI 10.1016/S0092-8674(03)01023-7; Aravind L, 2000, P NATL ACAD SCI USA, V97, P11319, DOI 10.1073/pnas.200346997; Arnaiz O, 2007, NUCLEIC ACIDS RES, V35, pD439; Aurrecoechea C, 2009, NUCLEIC ACIDS RES, V37, pD539; Balaji S, 2005, NUCLEIC ACIDS RES, V33, P3994, DOI 10.1093/nar/gki709; BLANK RJ, 1988, ARCH MICROBIOL, V149, P515, DOI 10.1007/BF00446754; Boeckmann B, 2003, NUCLEIC ACIDS RES, V31, P365, DOI 10.1093/nar/gkg095; Bouligand Y, 2001, BIOCHIMIE, V83, P187, DOI 10.1016/S0300-9084(00)01211-6; Chevreux B, 2004, GENOME RES, V14, P1147, DOI 10.1101/gr.1917404; Chibani K, 2009, MOL PLANT, V2, P308, DOI 10.1093/mp/ssn076; Ciccarelli FD, 2006, SCIENCE, V311, P1283, DOI 10.1126/science.1123061; Desalvo MK, 2008, MOL ECOL, V17, P3952, DOI 10.1111/j.1365-294X.2008.03879.x; DeSalvo MK, 2010, MOL ECOL, V19, P1174, DOI 10.1111/j.1365-294X.2010.04534.x; Dietz KJ, 2011, PLANT PHYSIOL, V155, P1477, DOI 10.1104/pp.110.170043; Dodge J, 1966, CHROMOSOMES ALGAE; Dong HJ, 1996, J MOL BIOL, V260, P649, DOI 10.1006/jmbi.1996.0428; Dos Santos CV, 2006, TRENDS PLANT SCI, V11, P329, DOI 10.1016/j.tplants.2006.05.005; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Eckardt NA, 2007, PLANT CELL, V19, P1719, DOI 10.1105/tpc.107.054270; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Edge SE, 2005, MAR POLLUT BULL, V51, P507, DOI 10.1016/j.marpolbul.2005.07.007; Erdner DL, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-88; Eyre-Walker A, 2001, NAT REV GENET, V2, P549, DOI 10.1038/35080577; Finn RD, 2008, NUCLEIC ACIDS RES, V36, pD281, DOI 10.1093/nar/gkm960; Finn RD, 2011, NUCLEIC ACIDS RES, V39, pW29, DOI 10.1093/nar/gkr367; Gill SS, 2010, PLANT PHYSIOL BIOCH, V48, P909, DOI 10.1016/j.plaphy.2010.08.016; GOLDMAN N, 1994, MOL BIOL EVOL, V11, P725; Gonzalez-Romero R, 2008, J MOL EVOL, V66, P505, DOI 10.1007/s00239-008-9109-1; Graham LE, 2000, J PHYCOL, V36, P975; GUILLARD RR, 1962, CAN J MICROBIOL, V8, P229, DOI 10.1139/m62-029; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Hackett JD, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-80; Haider S, 2009, NUCLEIC ACIDS RES, V37, pW23; Hake SB, 2006, P NATL ACAD SCI USA, V103, P6428, DOI 10.1073/pnas.0600803103; Hershberg R, 2008, ANNU REV GENET, V42, P287, DOI 10.1146/annurev.genet.42.110807.091442; Hisabori T, 2007, PHOTOCHEM PHOTOBIOL, V83, P145, DOI 10.1562/2006-02-27-IR-816; Hou YB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006978; Hsiao YY, 2010, COMP FUNCT GENOM, DOI 10.1155/2010/138538; Iguchi A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020140; Iyer LM, 2008, INT J PARASITOL, V38, P1, DOI 10.1016/j.ijpara.2007.07.018; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Keeling PJ, 2008, NAT REV GENET, V9, P605, DOI 10.1038/nrg2386; KELLENBERGER E, 1992, FEMS MICROBIOL LETT, V100, P361, DOI 10.1016/0378-1097(92)90233-E; Kim JM, 1997, SCIENCE, V278, P1954, DOI 10.1126/science.278.5345.1954; Kim S, 2011, MOL BIOL EVOL, V28, P1469, DOI 10.1093/molbev/msq332; Koumandou VL, 2004, TRENDS GENET, V20, P261, DOI 10.1016/j.tig.2004.03.008; Kovalchuk I., 2010, REACTIVE OXYGEN SPEC; LaJeunesse TC, 2005, J PHYCOL, V41, P880, DOI 10.1111/j.0022-3646.2005.04231.x; LaJeunesse TC, 2005, MOL BIOL EVOL, V22, P570, DOI 10.1093/molbev/msi042; LaJeunesse TC, 2001, J PHYCOL, V37, P866, DOI 10.1046/j.1529-8817.2001.01031.x; Leggat W, 2007, J PHYCOL, V43, P1010, DOI 10.1111/j.1529-8817.2007.00387.x; Lespinet O, 2002, GENOME RES, V12, P1048, DOI 10.1101/gr.174302; Lidie KB, 2005, MAR BIOTECHNOL, V7, P481, DOI 10.1007/s10126-004-4110-6; Lin S, 2008, DINOFLAGELLATE METAT, P166; Lin S., 2007, RNA DNA EDITING MOL, P280, DOI [10.1002/9780470262269.ch13, DOI 10.1002/9780470262269.CH13]; Lin SJ, 2011, RES MICROBIOL, V162, P551, DOI 10.1016/j.resmic.2011.04.006; Lin SJ, 2010, P NATL ACAD SCI USA, V107, P20033, DOI 10.1073/pnas.1007246107; Malik HS, 2003, NAT STRUCT BIOL, V10, P882, DOI 10.1038/nsb996; Mavrich TN, 2008, GENOME RES, V18, P1073, DOI 10.1101/gr.078261.108; Mavrich TN, 2008, NATURE, V453, P358, DOI 10.1038/nature06929; Merle PL, 2007, FREE RADICAL BIO MED, V42, P236, DOI 10.1016/j.freeradbiomed.2006.10.038; Mihailovich M, 2010, BIOESSAYS, V32, P109, DOI 10.1002/bies.200900122; Moore RB, 2003, INT J SYST EVOL MICR, V53, P1725, DOI 10.1099/ijs.0.02594-0; Moriya Y, 2007, NUCLEIC ACIDS RES, V35, pW182, DOI 10.1093/nar/gkm321; Moshkin YM, 2009, MOL CELL, V35, P782, DOI 10.1016/j.molcel.2009.07.020; Moustafa A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009688; MUSCATINE L, 1984, PROC R SOC SER B-BIO, V222, P181, DOI 10.1098/rspb.1984.0058; MUSCATINE L, 1981, LIMNOL OCEANOGR, V26, P601, DOI 10.4319/lo.1981.26.4.0601; Nielsen R, 1998, GENETICS, V148, P929; Ning ZM, 2001, GENOME RES, V11, P1725, DOI 10.1101/gr.194201; Nishiyama Y, 2011, PHYSIOL PLANTARUM, V142, P35, DOI 10.1111/j.1399-3054.2011.01457.x; Niwa T, 2007, J CHROMATOGR B, V855, P59, DOI 10.1016/j.jchromb.2006.12.029; Okamoto OK, 2003, J PHYCOL, V39, P519, DOI 10.1046/j.1529-8817.2003.02170.x; Painter HJ, 2011, MOL BIOCHEM PARASIT, V176, P1, DOI 10.1016/j.molbiopara.2010.11.014; Papp E, 2003, BIOFACTORS, V17, P249, DOI 10.1002/biof.5520170124; Peden JF, 1999, ANAL CODON USAGE; Plotkin JB, 2011, NAT REV GENET, V12, P32, DOI 10.1038/nrg2899; Pochon X, 2004, MAR BIOL, V146, P17, DOI 10.1007/s00227-004-1427-2; Pochon X, 2010, MOL PHYLOGENET EVOL, V56, P492, DOI 10.1016/j.ympev.2010.03.040; POLNEFULLER M, 1991, J PHYCOL, V27, P552, DOI 10.1111/j.0022-3646.1991.00552.x; Portune KJ, 2010, MAR GENOM, V3, P51, DOI 10.1016/j.margen.2010.03.002; Pusarla RH, 2005, FEBS J, V272, P5149, DOI 10.1111/j.1742-4658.2005.04930.x; RAE PMM, 1976, SCIENCE, V194, P1062, DOI 10.1126/science.988637; Ramirez-Parra E, 2007, TRENDS PLANT SCI, V12, P570, DOI 10.1016/j.tplants.2007.10.002; Reitzel AM, 2008, BIOL BULL-US, V214, P233, DOI 10.2307/25470666; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Rizzo P, 1987, BIOL DINOFLAGELLATES; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; ROWAN R, 1991, SCIENCE, V251, P1348, DOI 10.1126/science.251.4999.1348; Ryu T, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-58; Sanchez-Puerta MV, 2007, PROTIST, V158, P105, DOI 10.1016/j.protis.2006.09.004; Schmidt A, 2009, J BASIC MICROB, V49, P109, DOI 10.1002/jobm.200800293; Schnitzler CE, 2010, MAR GENOM, V3, P107, DOI 10.1016/j.margen.2010.08.002; Sunagawa S, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-258; Tamura K, 2011, MOL BIOL EVOLUTION; ten Lohuis MR, 1998, J PHYCOL, V34, P152; ten Lohuis MR, 1998, PLANT PHYSIOL, V117, P189, DOI 10.1104/pp.117.1.189; van Nimwegen E, 2003, TRENDS GENET, V19, P479, DOI 10.1016/S0168-9525(03)00203-8; Veldhuis MJW, 1997, J PHYCOL, V33, P527, DOI 10.1111/j.0022-3646.1997.00527.x; Voolstra CR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020392; Voolstra CR, 2009, COMP BIOCHEM PHYS D, V4, P67, DOI 10.1016/j.cbd.2008.11.001; Voolstra CR, 2009, MOL ECOL, V18, P1823, DOI 10.1111/j.1365-294X.2009.04167.x; Wallace, 1990, ECOSYSTEMS WORLD COR; Watanabe T, 2006, J APPL PHYCOL, V18, P219, DOI 10.1007/s10811-006-9106-y; Weis VM, 2008, J EXP BIOL, V211, P3059, DOI 10.1242/jeb.009597; Wilson D, 2007, NUCLEIC ACIDS RES, V36, pD88; WRIGHT F, 1990, GENE, V87, P23, DOI 10.1016/0378-1119(90)90491-9; Yuyama I, 2011, MAR BIOTECHNOL, V13, P32, DOI 10.1007/s10126-010-9265-3; Zdobnov EM, 2001, BIOINFORMATICS, V17, P847, DOI 10.1093/bioinformatics/17.9.847; Zhang H, 2007, P NATL ACAD SCI USA, V104, P4618, DOI 10.1073/pnas.0700258104; Zhang ZD, 1999, NATURE, V400, P155, DOI 10.1038/22099; Zilberman D, 2008, NATURE, V456, P125, DOI 10.1038/nature07324	116	166	167	2	79	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2012	7	4							e35269	10.1371/journal.pone.0035269	http://dx.doi.org/10.1371/journal.pone.0035269			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959XD	22529998	Green Submitted, gold, Green Published			2022-12-25	WOS:000305350600070
J	Goler-Baron, V; Assaraf, YG				Goler-Baron, Vicky; Assaraf, Yehuda G.			Overcoming Multidrug Resistance via Photodestruction of ABCG2-Rich Extracellular Vesicles Sequestering Photosensitive Chemotherapeutics	PLOS ONE			English	Article							BREAST-CANCER CELLS; ANTICANCER; PROTEIN; IMIDAZOACRIDINONES; MITOXANTRONE; INHIBITION; MECHANISMS; EXPRESSION; DRUGS; MCF-7	Multidrug resistance (MDR) remains a dominant impediment to curative cancer chemotherapy. Efflux transporters of the ATP-binding cassette (ABC) superfamily including ABCG2, ABCB1 and ABCC1 mediate MDR to multiple structurally and functionally distinct antitumor agents. Recently we identified a novel mechanism of MDR in which ABCG2-rich extracellular vesicles (EVs) form in between attached neighbor breast cancer cells and highly concentrate various chemotherapeutics in an ABCG2-dependent manner, thereby sequestering them away from their intracellular targets. Hence, development of novel strategies to overcome MDR modalities is a major goal of cancer research. Towards this end, we here developed a novel approach to selectively target and kill MDR cancer cells. We show that illumination of EVs that accumulated photosensitive cytotoxic drugs including imidazoacridinones (IAs) and topotecan resulted in intravesicular formation of reactive oxygen species (ROS) and severe damage to the EVs membrane that is shared by EVs-forming cells, thereby leading to tumor cell lysis and the overcoming of MDR. Furthermore, consistent with the weak base nature of IAs, MDR cells that are devoid of EVs but contained an increased number of lysosomes, highly accumulated IAs in lysosomes and upon photosensitization were efficiently killed via ROS-dependent lysosomal rupture. Combining targeted lysis of IAs-loaded EVs and lysosomes elicited a synergistic cytotoxic effect resulting in MDR reversal. In contrast, topotecan, a bona fide transport substrate of ABCG2, accumulated exclusively in EVs of MDR cells but was neither detected in lysosomes of normal breast epithelial cells nor in non-MDR breast cancer cells. This exclusive accumulation in EVs enhanced the selectivity of the cytotoxic effect exerted by photodynamic therapy to MDR cells without harming normal cells. Moreover, lysosomal alkalinization with bafilomycin A1 abrogated lysosomal accumulation of IAs, consequently preventing lysosomal photodestruction of normal breast epithelial cells. Thus, MDR modalities including ABCG2-dependent drug sequestration within EVs can be rationally converted to a pharmacologically lethal Trojan horse to selectively eradicate MDR cancer cells.	[Goler-Baron, Vicky; Assaraf, Yehuda G.] Technion Israel Inst Technol, Dept Biol, Fred Wyszkowski Canc Res Lab, IL-32000 Haifa, Israel	Technion Israel Institute of Technology	Goler-Baron, V (corresponding author), Technion Israel Inst Technol, Dept Biol, Fred Wyszkowski Canc Res Lab, IL-32000 Haifa, Israel.	assaraf@tx.technion.ac.il			Fred Wyszkowski Cancer Fund	Fred Wyszkowski Cancer Fund	This study was supported by the Fred Wyszkowski Cancer Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adar Y, 2012, CELL DEATH IN PRESS; Allen JD, 1999, CANCER RES, V59, P4237; Altan N, 1998, J EXP MED, V187, P1583, DOI 10.1084/jem.187.10.1583; Assaraf YG, 2007, CANCER METAST REV, V26, P153, DOI 10.1007/s10555-007-9049-z; BEIJNEN JH, 1988, ANAL PROFILES DRUG S, V17, P221; Borst P, 2002, ANNU REV BIOCHEM, V71, P537, DOI 10.1146/annurev.biochem.71.102301.093055; Bram EE, 2009, MOL PHARMACOL, V75, P1149, DOI 10.1124/mol.109.054791; Bugaj AM, 2011, PHOTOCH PHOTOBIO SCI, V10, P1097, DOI 10.1039/c0pp00147c; Burns JH, 1972, ANAL PROFILES DRUG S, V1, P463; Ciftci K, 2003, J PHARM PHARMACOL, V55, P1135, DOI 10.1211/002235703322277177; Diestra JE, 2002, J PATHOL, V198, P213, DOI 10.1002/path.1203; Dolmans DEJGJ, 2003, NAT REV CANCER, V3, P380, DOI 10.1038/nrc1071; Goler-Baron V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016007; Golubovskaya VM, 2008, MOL CARCINOGEN, V47, P222, DOI 10.1002/mc.20380; Gonzalez-Mariscal L, 2008, BBA-BIOMEMBRANES, V1778, P729, DOI 10.1016/j.bbamem.2007.08.018; Gottesman MM, 2002, NAT REV CANCER, V2, P48, DOI 10.1038/nrc706; Haimeur A, 2004, CURR DRUG METAB, V5, P21, DOI 10.2174/1389200043489199; Hartsock A, 2008, BBA-BIOMEMBRANES, V1778, P660, DOI 10.1016/j.bbamem.2007.07.012; Ifergan I, 2005, CANCER RES, V65, P10952, DOI 10.1158/0008-5472.CAN-05-2021; Ifergan I, 2009, BIOCHEM BIOPH RES CO, V380, P5, DOI 10.1016/j.bbrc.2008.12.168; Kawabata S, 2003, CLIN CANCER RES, V9, P3052; Koster DA, 2007, NATURE, V448, P213, DOI 10.1038/nature05938; Larsen AK, 2000, PHARMACOL THERAPEUT, V85, P217, DOI 10.1016/S0163-7258(99)00073-X; Maliepaard M, 2001, CLIN CANCER RES, V7, P935; Niggli V, 2008, INT J BIOCHEM CELL B, V40, P344, DOI 10.1016/j.biocel.2007.02.012; O'Connor AE, 2009, PHOTOCHEM PHOTOBIOL, V85, P1053, DOI 10.1111/j.1751-1097.2009.00585.x; Pommier Y, 2010, CHEM BIOL, V17, P421, DOI 10.1016/j.chembiol.2010.04.012; Radu IA, 2008, ROMANIAN J BIOPHYSIC, V18, P265; Robey RW, 2007, CANCER METAST REV, V26, P39, DOI 10.1007/s10555-007-9042-6; Sarkadi B, 2004, FEBS LETT, V567, P116, DOI 10.1016/j.febslet.2004.03.123; Schindler M, 1996, BIOCHEMISTRY-US, V35, P2811, DOI 10.1021/bi952234e; Skladanowski A, 1996, MOL PHARMACOL, V49, P772; Spink BC, 2006, CELL BIOL INT, V30, P227, DOI 10.1016/j.cellbi.2005.11.006; Szakacs G, 2006, NAT REV DRUG DISCOV, V5, P219, DOI 10.1038/nrd1984; TAYLOR CW, 1991, BRIT J CANCER, V63, P923, DOI 10.1038/bjc.1991.202	35	37	40	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2012	7	4							e35487	10.1371/journal.pone.0035487	http://dx.doi.org/10.1371/journal.pone.0035487			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959XD	22530032	Green Published, Green Submitted, gold			2022-12-25	WOS:000305350600088
J	Luo, ZH; Tang, SH; Li, CW; Fang, HX; Hu, HJ; Yang, J; Ding, JJ; Jiang, ZG				Luo, Zhenhua; Tang, Songhua; Li, Chunwang; Fang, Hongxia; Hu, Huijian; Yang, Ji; Ding, Jingjing; Jiang, Zhigang			Environmental Effects on Vertebrate Species Richness: Testing the Energy, Environmental Stability and Habitat Heterogeneity Hypotheses	PLOS ONE			English	Article							LARGE-SCALE PATTERNS; LATITUDINAL GRADIENTS; BETA DIVERSITY; CLIMATE; RANGE; CHINA; WATER; DETERMINANTS; BIODIVERSITY; BUTTERFLIES	Background: Explaining species richness patterns is a central issue in biogeography and macroecology. Several hypotheses have been proposed to explain the mechanisms driving biodiversity patterns, but the causes of species richness gradients remain unclear. In this study, we aimed to explain the impacts of energy, environmental stability, and habitat heterogeneity factors on variation of vertebrate species richness (VSR), based on the VSR pattern in China, so as to test the energy hypothesis, the environmental stability hypothesis, and the habitat heterogeneity hypothesis. Methodology/Principal Findings: A dataset was compiled containing the distributions of 2,665 vertebrate species and eleven ecogeographic predictive variables in China. We grouped these variables into categories of energy, environmental stability, and habitat heterogeneity and transformed the data into 1006100 km quadrat systems. To test the three hypotheses, AIC-based model selection was carried out between VSR and the variables in each group and correlation analyses were conducted. There was a decreasing VSR gradient from the southeast to the northwest of China. Our results showed that energy explained 67.6% of the VSR variation, with the annual mean temperature as the main factor, which was followed by annual precipitation and NDVI. Environmental stability factors explained 69.1% of the VSR variation and both temperature annual range and precipitation seasonality had important contributions. By contrast, habitat heterogeneity variables explained only 26.3% of the VSR variation. Significantly positive correlations were detected among VSR, annual mean temperature, annual precipitation, and NDVI, whereas the relationship of VSR and temperature annual range was strongly negative. In addition, other variables showed moderate or ambiguous relations to VSR. Conclusions/Significance: The energy hypothesis and the environmental stability hypothesis were supported, whereas little support was found for the habitat heterogeneity hypothesis.	[Luo, Zhenhua; Tang, Songhua; Li, Chunwang; Fang, Hongxia; Yang, Ji; Jiang, Zhigang] Chinese Acad Sci, Inst Zool, Key Lab Anim Ecol & Conservat Biol, Beijing, Peoples R China; [Luo, Zhenhua] Chinese Acad Sci, Grad Sch, Beijing, Peoples R China; [Hu, Huijian] Guangdong Acad Sci, S China Inst Endangered Anim, Guangzhou, Peoples R China; [Ding, Jingjing] Jiangsu Acad Forestry, Nanjing, Peoples R China	Chinese Academy of Sciences; Institute of Zoology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Guangdong Academy of Sciences	Luo, ZH (corresponding author), Chinese Acad Sci, Inst Zool, Key Lab Anim Ecol & Conservat Biol, Beijing, Peoples R China.	jiangzg@ioz.ac.cn	Jiang, Zhigang/E-4598-2014	Jiang, Zhigang/0000-0003-2154-8588	Ministry of Science and Technology of People's Republic of China [2008BAC39B04]; Chinese Academy of Sciences [KSCX2-EW-Z-4]	Ministry of Science and Technology of People's Republic of China(Ministry of Science and Technology, China); Chinese Academy of Sciences(Chinese Academy of Sciences)	This research was funded by the Science and Technology Supporting Project of Ministry of Science and Technology of People's Republic of China (2008BAC39B04) and the Key Program of Knowledge Innovation Program of Chinese Academy of Sciences (KSCX2-EW-Z-4). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS JM, 1989, NATURE, V339, P699, DOI 10.1038/339699a0; Altamirano A, 2010, BIOL CONSERV, V143, P2080, DOI 10.1016/j.biocon.2010.05.016; Baillie J. E. M., 2004, 2004 IUCN RED LIST T; Brown J. H., 1998, BIOGEOGRAPHY; BROWN JH, 1981, AM ZOOL, V21, P877; Burnham K.P., 2002, MODEL SELECTION MULT, V2nd, DOI [DOI 10.1007/B97636, 10.2307/3802723, DOI 10.2307/3802723]; Carrara R, 2010, ECOGRAPHY, V33, P942, DOI 10.1111/j.1600-0587.2009.05756.x; Carroll C, 2010, BIOL CONSERV, V143, P1432, DOI 10.1016/j.biocon.2010.03.018; CGIAR International Research Centers, 1999, CGIAR CONS SPAT INF; Chen C.D, 1998, CHINAS BIODIVERSITY; Clarke A, 2006, P ROY SOC B-BIOL SCI, V273, P2257, DOI 10.1098/rspb.2006.3545; CONNELL JH, 1964, AM NAT, V98, P399, DOI 10.1086/282335; COUSINS SH, 1989, NATURE, V340, P350, DOI 10.1038/340350b0; CURRIE DJ, 1991, AM NAT, V137, P27, DOI 10.1086/285144; Ding TS, 2006, J BIOGEOGR, V33, P683, DOI 10.1111/j.1365-2699.2006.01419.x; Diniz JAF, 2003, GLOBAL ECOL BIOGEOGR, V12, P53, DOI 10.1046/j.1466-822X.2003.00322.x; European Commission Joint Research Centre Institute for Environment and Sustainability, 2003, GLOB LAND COV 2000 D; Fei L, 1999, ATLAS AMPHIBIANS CHI; Francis AP, 2003, AM NAT, V161, P523, DOI 10.1086/368223; Gaston K.J., 2000, PATTERN PROCESS MACR, DOI [10.1002/9780470999592, DOI 10.1002/9780470999592]; Guegan JF, 1998, NATURE, V391, P382, DOI 10.1038/34899; Hawkins BA, 2003, ECOLOGY, V84, P3105, DOI 10.1890/03-8006; Hawkins BA, 2007, ECOLOGY, V88, P255, DOI 10.1890/0012-9658(2007)88[255:GMFPWP]2.0.CO;2; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hillebrand H, 2004, AM NAT, V163, P192, DOI 10.1086/381004; Hortal J, 2008, J BIOGEOGR, V35, P1202, DOI 10.1111/j.1365-2699.2007.01850.x; Hugo S, 2008, GLOBAL ECOL BIOGEOGR, V17, P611, DOI 10.1111/j.1466-8238.2008.00391.x; Huntley B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001439; Hurlbert AH, 2005, ECOL LETT, V8, P319, DOI 10.1111/j.1461-0248.2005.00726.x; Hurlbert AH, 2004, ECOL LETT, V7, P714, DOI 10.1111/j.1461-0248.2004.00630.x; Hurlbert AH, 2007, P NATL ACAD SCI USA, V104, P13384, DOI 10.1073/pnas.0704469104; Institute of Botany Chinese Academy of Sciences., 1996, CHIN VEG DAT; Institute of Geographic Sciences and Natural Resources Research Chinese Academy of Sciences, 2002, THEM DAT HUM EARTH S; JI DM, 2002, ATLAS REPTILES CHINA; Jiang Z, 2012, ASSESSMENT IN PRESS; Jiang Z, 2009, MODERN ECOLOGY FORUM, P75; Jiang Z, 2012, SURVEY REPO IN PRESS; Kerr JT, 1997, NATURE, V385, P252, DOI 10.1038/385252a0; KLOPFER PH, 1960, AM NAT, V94, P293, DOI 10.1086/282130; KLOPFER PH, 1959, AM NAT, V93, P337, DOI 10.1086/282092; Lin Xin, 2009, Shengwu Duoyangxing, V17, P652, DOI 10.3724/SP.J.1003.2009.09065; Luo ZH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027975; MAC ARTHUR ROBERT H., 1967; MACARTHUR R, 1961, ECOLOGY, V42, P594, DOI 10.2307/1932254; MacArthur R. H., 1966, BIOL POPULATIONS; MacKinnon J, 2000, FIELD GUIDE BIRDS CH; Mellin C, 2010, GLOBAL ECOL BIOGEOGR, V19, P212, DOI 10.1111/j.1466-8238.2009.00513.x; Murray K, 2009, ECOLOGY, V90, P348, DOI 10.1890/07-1929.1; OBRIEN EM, 1993, J BIOGEOGR, V20, P181, DOI 10.2307/2845670; Pan QH, 2007, FIELD GUIDE MAMMALS; PIANKA ER, 1966, AM NAT, V100, P33, DOI 10.1086/282398; Qian H, 2007, ECOL LETT, V10, P737, DOI 10.1111/j.1461-0248.2007.01066.x; Qian H, 2009, GLOBAL ECOL BIOGEOGR, V18, P111, DOI 10.1111/j.1466-8238.2008.00415.x; Rahbek C, 2001, P NATL ACAD SCI USA, V98, P4534, DOI 10.1073/pnas.071034898; Rodriguez MA, 2005, ACTA OECOL, V28, P65, DOI 10.1016/j.actao.2005.02.006; ROHDE K, 1992, OIKOS, V65, P514, DOI 10.2307/3545569; Rosa R, 2008, GLOBAL ECOL BIOGEOGR, V17, P600, DOI 10.1111/j.1466-8238.2008.00397.x; Rosenzweig Michael L., 1995, DOI 10.1017/CBO9780511623387.002; Roy K, 1998, P NATL ACAD SCI USA, V95, P3699, DOI 10.1073/pnas.95.7.3699; Sala OE, 2000, SCIENCE, V287, P1770, DOI 10.1126/science.287.5459.1770; Sang A, 2010, BIOL CONSERV, V143, P1405, DOI 10.1016/j.biocon.2010.03.015; SCHALL JJ, 1978, SCIENCE, V201, P679, DOI 10.1126/science.201.4357.679; Sheng H, 2005, ATLAS MAMMALS CHINA; STEVENS GC, 1989, AM NAT, V133, P240, DOI 10.1086/284913; Storch D, 2006, ECOL LETT, V9, P1308, DOI 10.1111/j.1461-0248.2006.00984.x; Tilman D, 2001, SCIENCE, V292, P281, DOI 10.1126/science.1057544; TURNER JRG, 1988, NATURE, V335, P539, DOI 10.1038/335539a0; TURNER JRG, 1987, OIKOS, V48, P195, DOI 10.2307/3565855; Wang Zhiheng, 2009, Shengwu Duoyangxing, V17, P613, DOI 10.3724/SP.J.1003.2009.09161; White P, 2006, ECOGRAPHY, V29, P908, DOI 10.1111/j.2006.0906-7590.04685.x; Whittaker RJ, 2001, J BIOGEOGR, V28, P453, DOI 10.1046/j.1365-2699.2001.00563.x; Whittaker RJ, 2007, GLOBAL ECOL BIOGEOGR, V16, P76, DOI 10.1111/j.1466-8238.2006.00268.x; Willig MR, 2003, ANNU REV ECOL EVOL S, V34, P273, DOI 10.1146/annurev.ecolsys.34.012103.144032; Wright David H., 1993, P66; WRIGHT DH, 1983, OIKOS, V41, P496, DOI 10.2307/3544109; ZHANG RZ, 1985, ACTA ZOOL SINICA, V31, P187; Zhao SQ, 2006, CAN J ZOOL, V84, P1368, DOI 10.1139/Z06-132; Zhao SQ, 2006, GLOBAL ECOL BIOGEOGR, V15, P386, DOI 10.1111/j.1466-822x.2006.00236.x	78	30	35	8	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2012	7	4							e35514	10.1371/journal.pone.0035514	http://dx.doi.org/10.1371/journal.pone.0035514			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959XD	22530038	gold, Green Published, Green Submitted			2022-12-25	WOS:000305350600092
J	Reyal, F; Bollet, MA; Caly, M; Gentien, D; Carpentier, S; Peyro-Saint-Paul, H; Pierga, JY; Cottu, P; Dieras, V; Sigal-Zafrani, B; Vincent-Salomon, A; Sastre-Garau, X				Reyal, Fabien; Bollet, Marc A.; Caly, Martial; Gentien, David; Carpentier, Sabrina; Peyro-Saint-Paul, Helene; Pierga, Jean-Yves; Cottu, Paul; Dieras, Veronique; Sigal-Zafrani, Brigitte; Vincent-Salomon, Anne; Sastre-Garau, Xavier			Respective Prognostic Value of Genomic Grade and Histological Proliferation Markers in Early Stage (pN0) Breast Carcinoma	PLOS ONE			English	Article							INTERNATIONAL EXPERT CONSENSUS; IMMUNOHISTOCHEMICAL EVALUATION; MOLECULAR SUBTYPES; HORMONE-RECEPTORS; PARAFFIN SECTIONS; PRIMARY THERAPY; CANCER; RECOMMENDATIONS; METAANALYSIS; INDEX	Background: Genomic grade (GG) is a 97-gene signature which improves the accuracy and prognostic value of histological grade (HG) in invasive breast carcinoma. Since most of the genes included in the GG are involved in cell proliferation, we performed a retrospective study to compare the prognostic value of GG, Mitotic Index and Ki67 score. Methods: A series of 163 consecutive breast cancers was retained (pT1-2, pN0, pM0, 10-yr follow-up). GG was computed using MapQuant Dx(R). Results: GG was low (GG-1) in 48%, high (GG-3) in 31% and equivocal in 21% of cases. For HG-2 tumors, 50% were classified as GG-1, 18% as GG-3 whereas 31% remained equivocal. In a subgroup of 132 ER+/HER2- tumors GG was the most significant prognostic factor in multivariate Cox regression analysis adjusted for age and tumor size (HR = 5.23, p = 0.02). Conclusions: In a reference comprehensive cancer center setting, compared to histological grade, GG added significant information on cell proliferation in breast cancers. In patients with HG-2 carcinoma, applying the GG to guide the treatment scheme could lead to a reduction in adjuvant therapy prescription. However, based on the results observed and considering (i) the relatively close prognostic values of GG and Ki67, (ii) the reclassification of about 30% of HG-2 tumors as Equivocal GG and (iii) the economical and technical requirements of the MapQuant micro-array GG test, the availability in the near future of a PCR-based Genomic Grade test with improved performances may lead to an introduction in clinical routine of this test for histological grade 2, ER positive, HER2 negative breast carcinoma.	[Reyal, Fabien] Inst Curie, Dept Chirurg, Paris, France; [Bollet, Marc A.] Inst Curie, Dept Radiotherapie, Paris, France; [Caly, Martial; Sigal-Zafrani, Brigitte; Vincent-Salomon, Anne; Sastre-Garau, Xavier] Inst Curie, Dept Biol Tumeurs, Paris, France; [Gentien, David] Inst Curie, Dept Transfert, Paris, France; [Carpentier, Sabrina; Peyro-Saint-Paul, Helene] Ipsogen SA, Marseille, France; [Pierga, Jean-Yves; Cottu, Paul; Dieras, Veronique] Inst Curie, Dept Med Oncol, Paris, France; [Reyal, Fabien] Inst Curie, CNRS, UMR144, Equipe Oncol Mol, Paris, France	UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Sorbonne Universite	Reyal, F (corresponding author), Inst Curie, Dept Chirurg, Paris, France.	Xavier.sastre@curie.net	Cottu, Paul/ABC-8595-2020; Gentien, David/O-9356-2019; Gentien, David/L-7757-2017	Gentien, David/0000-0001-8317-5188; Sastre-Garau, Xavier/0000-0001-5992-2083				[Anonymous], 2007, LANCET ONCOL, V8, P1079, DOI 10.1016/S1470-2045(07)70346-7; Balaton AJ, 1996, ANN PATHOL, V16, P144; Carlson RW, 2011, J NATL COMPR CANC NE, V9, P136, DOI 10.6004/jnccn.2011.0016; Carlson RW, 2009, J NATL COMPR CANC NE, V7, P122, DOI 10.6004/jnccn.2009.0012; Colozza M, 2005, ANN ONCOL, V16, P1723, DOI 10.1093/annonc/mdi352; Colozza M, 2010, LANCET ONCOL, V11, P414, DOI 10.1016/S1470-2045(10)70089-9; de Azambuja E, 2007, BRIT J CANCER, V96, P1504, DOI 10.1038/sj.bjc.6603756; Desmedt C, 2008, CLIN CANCER RES, V14, P5158, DOI 10.1158/1078-0432.CCR-07-4756; Desmedt C, 2006, CELL CYCLE, V5, P2198, DOI 10.4161/cc.5.19.3254; Desmedt C, 2009, BMC MED GENOMICS, V2, DOI 10.1186/1755-8794-2-40; Dowsett M, 2011, JNCI-J NATL CANCER I, V103, P1656, DOI 10.1093/jnci/djr393; ELSTON CW, 1991, HISTOPATHOLOGY, V19, P403, DOI 10.1111/j.1365-2559.1991.tb00229.x; Goldhirsch A, 2007, ANN ONCOL, V18, P1133, DOI 10.1093/annonc/mdm271; Goldhirsch A, 2003, J CLIN ONCOL, V21, P3357, DOI 10.1200/JCO.2003.04.576; Group for Evaluation of Prognostic Factors using Immunohistochemistry in Breast Cancer (GEFPICS-FNCLCC), 1999, ANN PATHOL, V19, P336; Haibe-Kains B, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-394; Hornberger J, 2005, AM J MANAG CARE, V11, P313; Liedtke C, 2009, J CLIN ONCOL, V27, P3185, DOI 10.1200/JCO.2008.18.5934; Loi S, 2007, J CLIN ONCOL, V25, P1239, DOI 10.1200/JCO.2006.07.1522; Oratz R, 2007, J ONCOL PRACT, V3, P182, DOI 10.1200/JOP.0742001; Penault-Llorca F, 2010, ANN PATHOL, V30, P357, DOI 10.1016/j.annpat.2010.07.001; Rakha EA, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2607; Sotiriou C, 2006, JNCI-J NATL CANCER I, V98, P262, DOI 10.1093/jnci/djj052; Stuart-Harris R, 2008, BREAST, V17, P323, DOI 10.1016/j.breast.2008.02.002; VANDIEST PJ, 1992, HUM PATHOL, V23, P603, DOI 10.1016/0046-8177(92)90313-R; VANDIEST PJ, 1992, PATHOL RES PRACT, V188, P405, DOI 10.1016/S0344-0338(11)80027-0; Viale G, 2008, J CLIN ONCOL, V26, P5569, DOI 10.1200/JCO.2008.17.0829; Wirapati P, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2124; Yerushalmi R, 2010, LANCET ONCOL, V11, P174, DOI 10.1016/S1470-2045(09)70262-1	29	15	15	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2012	7	4							e35184	10.1371/journal.pone.0035184	http://dx.doi.org/10.1371/journal.pone.0035184			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959XD	22529987	Green Published, gold, Green Submitted			2022-12-25	WOS:000305350600064
J	Temiz, NA; Donohue, DE; Bacolla, A; Luke, BT; Collins, JR				Temiz, Nuri A.; Donohue, Duncan E.; Bacolla, Albino; Luke, Brian T.; Collins, Jack R.			The Role of Methylation in the Intrinsic Dynamics of B- and Z-DNA	PLOS ONE			English	Article							UNIQUE TETRANUCLEOTIDE SEQUENCES; MOLECULAR-DYNAMICS; NUCLEIC-ACIDS; Z TRANSITION; FORCE-FIELD; TO-Z; CONFORMATIONS; OLIGONUCLEOTIDES; SIMULATIONS; FLEXIBILITY	Methylation of cytosine at the 5-carbon position (5mC) is observed in both prokaryotes and eukaryotes. In humans, DNA methylation at CpG sites plays an important role in gene regulation and has been implicated in development, gene silencing, and cancer. In addition, the CpG dinucleotide is a known hot spot for pathologic mutations genome-wide. CpG tracts may adopt left-handed Z-DNA conformations, which have also been implicated in gene regulation and genomic instability. Methylation facilitates this B-Z transition but the underlying mechanism remains unclear. Herein, four structural models of the dinucleotide d(GC)(5) repeat sequence in B-, methylated B-, Z-, and methylated Z-DNA forms were constructed and an aggregate 100 nanoseconds of molecular dynamics simulations in explicit solvent under physiological conditions was performed for each model. Both unmethylated and methylated B-DNA were found to be more flexible than Z-DNA. However, methylation significantly destabilized the BII, relative to the BI, state through the Gp5mC steps. In addition, methylation decreased the free energy difference between B- and Z-DNA. Comparisons of alpha/gamma backbone torsional angles showed that torsional states changed marginally upon methylation for B-DNA, and Z-DNA. Methylation-induced conformational changes and lower energy differences may contribute to the transition to Z-DNA by methylated, over unmethylated, B-DNA and may be a contributing factor to biological function.	[Temiz, Nuri A.; Donohue, Duncan E.; Bacolla, Albino; Luke, Brian T.; Collins, Jack R.] SAIC Frederick Inc, Frederick Natl Lab Canc Res, Informat Syst Program, Adv Biomed Comp Ctr,Sil Res Ctr Excellence, Frederick, MD USA; [Bacolla, Albino] Univ Texas MD Anderson Canc Ctr, Dept Mol Carcinogenesis, Smithville, TX USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; University of Texas System; UTMD Anderson Cancer Center	Temiz, NA (corresponding author), SAIC Frederick Inc, Frederick Natl Lab Canc Res, Informat Syst Program, Adv Biomed Comp Ctr,Sil Res Ctr Excellence, Frederick, MD USA.	temizna@mail.nih.gov	Bacolla, Albino/N-3877-2013; Bacolla, Albino/AAP-1727-2020	Bacolla, Albino/0000-0003-0206-8423; Bacolla, Albino/0000-0003-0206-8423; Donohue, Duncan/0000-0002-3137-8773	Center for Biomedical Informatics and Information Technology (CBIIT)/Cancer Biomedical Informatics Grid (caBIG) ISRCE yellow task [09-260]; National Cancer Institute/National Institutes of Health [HHSN261200800001E]	Center for Biomedical Informatics and Information Technology (CBIIT)/Cancer Biomedical Informatics Grid (caBIG) ISRCE yellow task; National Cancer Institute/National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the Center for Biomedical Informatics and Information Technology (CBIIT)/Cancer Biomedical Informatics Grid (caBIG) ISRCE yellow task #09-260 to the Frederick National Laboratory for Cancer Research and National Cancer Institute/National Institutes of Health contract HHSN261200800001E (to AB). The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does mention of trade names, commercial products, or organizations imply endorsement by the U. S. Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2008, AMBER 10; Bacolla A, 2009, MOL CARCINOGEN, V48, P273, DOI 10.1002/mc.20507; Bae S, 2011, J AM CHEM SOC, V133, P668, DOI 10.1021/ja107498y; BEHE M, 1981, P NATL ACAD SCI-BIOL, V78, P1619, DOI 10.1073/pnas.78.3.1619; Beveridge DL, 2004, BIOPHYS J, V87, P3799, DOI 10.1529/biophysj.104.045252; Bothe JR, 2011, J AM CHEM SOC, V133, P2016, DOI 10.1021/ja1073068; Brice AR, 2011, J COMPUT CHEM, V32, P1431, DOI 10.1002/jcc.21727; Cheatham TE, 2004, CURR OPIN STRUC BIOL, V14, P360, DOI 10.1016/j.sbi.2004.05.001; Cheatham TE, 1999, J BIOMOL STRUCT DYN, V16, P845, DOI 10.1080/07391102.1999.10508297; Cheatham TE, 2001, BIOPOLYMERS, V56, P232; Cooper David N, 2010, Hum Genomics, V4, P406; CRAWFORD JL, 1980, P NATL ACAD SCI-BIOL, V77, P4016, DOI 10.1073/pnas.77.7.4016; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Dixit SB, 2005, BIOPHYS J, V89, P3721, DOI 10.1529/biophysj.105.067397; Djuranovic D, 2004, BIOPOLYMERS, V73, P356, DOI 10.1002/bip.10528; Djuranovic D, 2003, J BIOMOL STRUCT DYN, V20, P771, DOI 10.1080/07391102.2003.10506894; Feng SH, 2010, SCIENCE, V330, P622, DOI 10.1126/science.1190614; Ha SC, 2005, NATURE, V437, P1183, DOI 10.1038/nature04088; HARTMANN B, 1993, NUCLEIC ACIDS RES, V21, P561, DOI 10.1093/nar/21.3.561; Heddi B, 2006, J AM CHEM SOC, V128, P9170, DOI 10.1021/ja061686j; Heddi B, 2010, NUCLEIC ACIDS RES, V38, P1034, DOI 10.1093/nar/gkp962; Herbert A, 1999, GENETICA, V106, P37, DOI 10.1023/A:1003768526018; Hornik K, R FAQ; Illingworth RS, 2009, FEBS LETT, V583, P1713, DOI 10.1016/j.febslet.2009.04.012; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Killian BJ, 2007, J CHEM PHYS, V127, DOI 10.1063/1.2746329; Kim D, 2009, NUCLEIC ACIDS RES, V37, P4353, DOI 10.1093/nar/gkp364; Kollman PA, 2000, ACCOUNTS CHEM RES, V33, P889, DOI 10.1021/ar000033j; Kulis M, 2010, ADV GENET, V70, P27, DOI [10.1016/S0065-2660(10)70002-X, 10.1016/B978-0-12-380866-0.60002-2]; Lavery R, 2009, NUCLEIC ACIDS RES, V37, P5917, DOI 10.1093/nar/gkp608; Lavery R, 2010, NUCLEIC ACIDS RES, V38, P299, DOI 10.1093/nar/gkp834; Lee J, 2010, J PHYS CHEM B, V114, P9872, DOI 10.1021/jp103419t; Lee M, 2010, P NATL ACAD SCI USA, V107, P4985, DOI 10.1073/pnas.0911528107; Maunakea AK, 2010, CIRC RES, V107, P327, DOI 10.1161/CIRCRESAHA.110.222463; Mirkin SM, 2008, FRONT BIOSCI-LANDMRK, V13, P1064, DOI 10.2741/2744; Orozco M, 2008, CURR OPIN STRUC BIOL, V18, P185, DOI 10.1016/j.sbi.2008.01.005; PECK LJ, 1983, P NATL ACAD SCI-BIOL, V80, P6206, DOI 10.1073/pnas.80.20.6206; Perez A, 2008, NUCLEIC ACIDS RES, V36, P2379, DOI 10.1093/nar/gkn082; Perez A, 2007, J AM CHEM SOC, V129, P14739, DOI 10.1021/ja0753546; Perez A, 2007, BIOPHYS J, V92, P3817, DOI 10.1529/biophysj.106.097782; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Phan AT, 2006, CURR OPIN STRUC BIOL, V16, P288, DOI 10.1016/j.sbi.2006.05.011; Ponomarev SY, 2004, P NATL ACAD SCI USA, V101, P14771, DOI 10.1073/pnas.0406435101; Prabhu NV, 2008, J COMPUT CHEM, V29, P1113, DOI 10.1002/jcc.20874; Rauch C, 2005, J BIOMOL STRUCT DYN, V22, P695, DOI 10.1080/07391102.2005.10507036; Rauch C, 2005, J BIOMOL STRUCT DYN, V22, P595, DOI 10.1080/07391102.2005.10507029; Rauch C, 2003, J AM CHEM SOC, V125, P14990, DOI 10.1021/ja037218g; Rich A, 1996, J BIOL CHEM, V271, P11595, DOI 10.1074/jbc.271.20.11595; Rubin AF, 2009, P NATL ACAD SCI USA, V106, P21766, DOI 10.1073/pnas.0912499106; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Sharma RP, 2010, NEUROPSYCHOPHARMACOL, V35, P2009, DOI 10.1038/npp.2010.85; Srinivasan J, 1998, J AM CHEM SOC, V120, P9401, DOI 10.1021/ja981844+; Srivastava HK, 2011, J CHEM INF MODEL, V51, P558, DOI 10.1021/ci100474n; Varnai P, 2004, NUCLEIC ACIDS RES, V32, P4269, DOI 10.1093/nar/gkh765; Varnai P, 2002, NUCLEIC ACIDS RES, V30, P5398, DOI 10.1093/nar/gkf680; Wells RD, 2007, TRENDS BIOCHEM SCI, V32, P271, DOI 10.1016/j.tibs.2007.04.003; Young MA, 1997, BIOPHYS J, V73, P2313, DOI 10.1016/S0006-3495(97)78263-8; Zheng GH, 2009, NUCLEIC ACIDS RES, V37, pW240, DOI 10.1093/nar/gkp358	58	56	58	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2012	7	4							e35558	10.1371/journal.pone.0035558	http://dx.doi.org/10.1371/journal.pone.0035558			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WC	22530050	Green Published, gold			2022-12-25	WOS:000305347400062
J	Adluri, RS; Thirunavukkarasu, M; Zhan, LJ; Dunna, NR; Akita, Y; Selvaraju, V; Otani, H; Sanchez, JA; Ho, YS; Maulik, N				Adluri, Ram Sudheer; Thirunavukkarasu, Mahesh; Zhan, Lijun; Dunna, Nageswara Rao; Akita, Yuzo; Selvaraju, Vaithinathan; Otani, Hajime; Sanchez, Juan A.; Ho, Ye-Shih; Maulik, Nilanjana			Glutaredoxin-1 Overexpression Enhances Neovascularization and Diminishes Ventricular Remodeling in Chronic Myocardial Infarction	PLOS ONE			English	Article							NF-KAPPA-B; S-GLUTATHIONYLATION; GENE-THERAPY; CARDIOMYOCYTE APOPTOSIS; OXIDATIVE STRESS; EXPRESSION; GROWTH; ANGIOPOIETIN-1; MICE; ANGIOGENESIS	Oxidative stress plays a critical role in the pathophysiology of cardiac failure, including the modulation of neovascularization following myocardial infarction (MI). Redox molecules thioredoxin (Trx) and glutaredoxin (Grx) superfamilies actively maintain intracellular thiol-redox homeostasis by scavenging reactive oxygen species. Among these two superfamilies, the pro-angiogenic function of Trx-1 has been reported in chronic MI model whereas similar role of Grx-1 remains uncertain. The present study attempts to establish the role of Grx-1 in neovascularization and ventricular remodeling following MI. Wild-type (WT) and Grx-1 transgenic (Grx-1(Tg/+)) mice were randomized into wild-type sham (WTS), Grx-1(Tg/+) Sham (Grx-1(Tg/+)S), WTMI,Grx-1(Tg/+)MI. MI was induced by permanent occlusion of the LAD coronary artery. Sham groups underwent identical time-matched surgical procedures without LAD ligation. Significant increase in arteriolar density was observed 7 days (d) after surgical intervention in the Grx-1(Tg/+)MI group as compared to the WTMI animals. Further, improvement in myocardial functional parameters 30 d after MI was observed including decreased LVIDs, LVIDd, increased ejection fraction and, fractional shortening was also observed in the Grx-1(Tg/+)MI group as compared to the WTMI animals. Moreover, attenuation of oxidative stress and apoptotic cardiomyocytes was observed in the Grx-1(Tg/+)MI group as compared to the WTMI animals. Increased expression of p-Akt, VEGF, Ang-1, Bcl-2, survivin and DNA binding activity of NF-kappa B were observed in the Grx-1(Tg/+)MI group when compared to WTMI animals as revealed by Western blot analysis and Gel-shift analysis, respectively. These results are the first to demonstrate that Grx-1 induces angiogenesis and diminishes ventricular remodeling apparently through neovascularization mediated by Akt, VEGF, Ang-1 and NF-kB as well as Bcl-2 and survivin-mediated anti-apoptotic pathway in the infarcted myocardium.	[Adluri, Ram Sudheer; Thirunavukkarasu, Mahesh; Zhan, Lijun; Dunna, Nageswara Rao; Akita, Yuzo; Selvaraju, Vaithinathan; Sanchez, Juan A.; Maulik, Nilanjana] Univ Connecticut, Ctr Hlth, Dept Surg, Mol Cardiol & Angiogenesis Lab, Farmington, CT USA; [Otani, Hajime] Kansai Med Univ, Dept Internal Med 2, Moriguchi, Osaka 570, Japan; [Ho, Ye-Shih] Wayne State Univ, Inst Environm Hlth Sci, Detroit, MI USA	University of Connecticut; Kansai Medical University; Wayne State University	Adluri, RS (corresponding author), Univ Connecticut, Ctr Hlth, Dept Surg, Mol Cardiol & Angiogenesis Lab, Farmington, CT USA.	nmaulik@neuron.uchc.edu	Vaithinathan, Selvaraju/D-4277-2013; sanchez, juan/GSD-8167-2022; Sanchez, Juan A./AAQ-1488-2020	Sanchez, Juan A./0000-0002-6789-3208	National Institutes of Health (NIH) [HL-85804, HL-69910]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL085804, R01HL069910] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the National Institutes of Health (NIH) HL-85804 and HL-69910. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adluri RS, 2011, J MOL CELL CARDIOL, V50, P239, DOI 10.1016/j.yjmcc.2010.11.002; Armulik A, 2005, CIRC RES, V97, P512, DOI 10.1161/01.RES.0000182903.16652.d7; Chen JX, 2008, DIABETES, V57, P3335, DOI 10.2337/db08-0503; Condorelli G, 1999, CIRCULATION, V99, P3071, DOI 10.1161/01.CIR.99.23.3071; Currie MJ, 2001, CLIN CANCER RES, V7, P918; Davis S, 1996, CELL, V87, P1161, DOI 10.1016/S0092-8674(00)81812-7; Dimmeler S, 2000, CIRC RES, V86, P4, DOI 10.1161/01.RES.86.1.4; Gallogly MM, 2009, ANTIOXID REDOX SIGN, V11, P1059, DOI [10.1089/ars.2008.2291, 10.1089/ARS.2008.2291]; Gallogly MM, 2010, ANTIOXID REDOX SIGN, V12, P1339, DOI 10.1089/ars.2009.2791; Green DR, 1998, SCIENCE, V281, P1309, DOI 10.1126/science.281.5381.1309; Grunstein J, 2000, MOL CELL BIOL, V20, P7282, DOI 10.1128/MCB.20.19.7282-7291.2000; Hamada Y, 2007, NEPHROL DIAL TRANSPL, V22, P1547, DOI 10.1093/ndt/gfm099; Hirota K, 2000, BIOCHEM BIOPH RES CO, V274, P177, DOI 10.1006/bbrc.2000.3106; Ho YS, 2007, FREE RADICAL BIO MED, V43, P1299, DOI 10.1016/j.freeradbiomed.2007.07.025; Holash J, 1999, SCIENCE, V284, P1994, DOI 10.1126/science.284.5422.1994; Jones WK, 2005, CARDIOVASC TOXICOL, V5, P183, DOI 10.1385/CT:5:2:183; Katare R, 2010, J MOL CELL CARDIOL; Kupatt C, 2010, J AM COLL CARDIOL, V56, P414, DOI 10.1016/j.jacc.2010.03.050; Lee Y, 2009, APOPTOSIS, V14, P536, DOI 10.1007/s10495-008-0302-x; Leri A, 1998, CIRCULATION, V97, P194, DOI 10.1161/01.CIR.97.2.194; Leri A, 1998, J CLIN INVEST, V101, P1326, DOI 10.1172/JCI316; Lima B, 2009, P NATL ACAD SCI USA, V106, P6297, DOI 10.1073/pnas.0901043106; Mani K, 2008, HEART FAIL REV, V13, P193, DOI 10.1007/s10741-007-9073-7; Maulik N, 2006, ANTIOXID REDOX SIGN, V8, P2161, DOI 10.1089/ars.2006.8.2161; Mieyal JJ, 2008, ANTIOXID REDOX SIGN, V10, P1941, DOI 10.1089/ars.2008.2089; Murata H, 2003, J BIOL CHEM, V278, P50226, DOI 10.1074/jbc.M310171200; Novotny NM, 2009, SHOCK, V31, P335, DOI 10.1097/SHK.0b013e3181862c63; Okuda M, 2001, ARTERIOSCL THROM VAS, V21, P1483, DOI 10.1161/hq0901.095550; Pan S, 2007, CIRC RES, V100, P213, DOI 10.1161/01.RES.0000256089.30318.20; Qanungo S, 2007, J BIOL CHEM, V282, P18427, DOI 10.1074/jbc.M610934200; Reynaert NL, 2006, P NATL ACAD SCI USA, V103, P13086, DOI 10.1073/pnas.0603290103; Samuel SM, 2010, CIRCULATION, V121, P1244, DOI 10.1161/CIRCULATIONAHA.109.872481; Samuel SM, 2010, DIABETES, V59, P51, DOI 10.2337/db09-0336; Shelton MD, 2008, MOL CELLS, V25, P332; Singh VP, 2008, DIABETES, V57, P3297, DOI 10.2337/db08-0805; Song JJ, 2002, J BIOL CHEM, V277, P46566, DOI 10.1074/jbc.M206826200; Sun JH, 2007, CIRC RES, V101, P1155, DOI 10.1161/CIRCRESAHA.107.155879; Suri C, 1998, SCIENCE, V282, P468, DOI 10.1126/science.282.5388.468; Thirunavukkarasu M, 2008, CIRCULATION, V118; Vincent KA, 2002, TRENDS CARDIOVAS MED, V12, P362, DOI 10.1016/S1050-1738(02)00186-X; Yla-Herttuala S, 2009, BIOCHEM SOC T, V37, P1198, DOI 10.1042/BST0371198; Zhao WY, 2009, INT J EXP PATHOL, V90, P621, DOI 10.1111/j.1365-2613.2009.00682.x; Zidar N, 2007, ADV CLIN CHEM, V44, P1, DOI 10.1016/S0065-2423(07)44001-X	43	24	26	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2012	7	4							e34790	10.1371/journal.pone.0034790	http://dx.doi.org/10.1371/journal.pone.0034790			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VO	22523530	Green Published, gold, Green Submitted			2022-12-25	WOS:000305345000029
J	Huang, YY; Haug, MF; Gesemann, M; Neuhauss, SCF				Huang, Ying-Yu; Haug, Marion F.; Gesemann, Matthias; Neuhauss, Stephan C. F.			Novel Expression Patterns of Metabotropic Glutamate Receptor 6 in the Zebrafish Nervous System	PLOS ONE			English	Article							RETINAL BIPOLAR CELLS; PHYLOGENETIC ANALYSIS; 2-AMINO-4-PHOSPHONOBUTYRIC ACID; SYNAPTIC-TRANSMISSION; MAXIMUM-LIKELIHOOD; GENOME DUPLICATION; INPUT MECHANISMS; NIGHT BLINDNESS; LIGHT RESPONSE; GIANT DANIO	The metabotropic glutamate receptor 6 (mGluR6 or GRM6) belongs to the class III of the metabotropic glutamate receptor family. It is the only known mGluR that mediates direct synaptic transmission in the nervous system and is thought to mediate the ON-response in the ON-pathway of the vertebrate retina. Phylogenetic and gene structure analysis indicated that the zebrafish genome harbours two mglur6 paralogs, mglur6a and mglur6b. Besides expression in the inner nuclear layer and distinct regions in the brain, both mglur6 paralogs are expressed in ganglion cells of the retina, an expression pattern which can also be observed in the downstream effector molecules gnaoa and gnaob. This unexpected expression pattern is consistent with immunohistological labeling using a peptide antibody specific for the mGluR6b paralog. These expression patterns contradict the existing view that mGluR6 is solely located on ON-bipolar cells where it functions in signal transmission. Consistent with expression in ON-bipolar cells, we report a decreased b-wave amplitude in the electroretinogram after morpholino-based downregulation of mGluR6b, showing a function in the ON response. Our data suggest more widespread functions of mGluR6 mediated signaling in the central nervous system, possibly including sign reversing synapses in the inner retina.	Neurosci Ctr Zurich, Inst Mol Life Sci, Zurich, Switzerland; Univ Zurich, Ctr Integrat Human Physiol, Zurich, Switzerland	University of Zurich; Zurich Center Integrative Human Physiology (ZIHP)	Huang, YY (corresponding author), Univ Zurich Hosp, Dept Neurol, CH-8091 Zurich, Switzerland.	stephan.neuhauss@imls.uzh.ch	Neuhauss, Stephan/AAX-9915-2020	Neuhauss, Stephan/0000-0002-9615-480X; Huang, Melody Ying-Yu/0000-0003-4368-9648	EU framework7 project RETICIRC; EU framework7 project ZF-HEALTH; Swiss National Science Foundation [31003A_135598/1]	EU framework7 project RETICIRC; EU framework7 project ZF-HEALTH; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This study was partially funded by EU framework7 projects RETICIRC and ZF-HEALTH and the Swiss National Science Foundation (31003A_135598/1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anisimova M, 2006, SYST BIOL, V55, P539, DOI 10.1080/10635150600755453; Bahadori R, 2006, EUR J NEUROSCI, V24, P1664, DOI 10.1111/j.1460-9568.2006.05053.x; Cao Y, 2011, J NEUROSCI, V31, P11521, DOI 10.1523/JNEUROSCI.1682-11.2011; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; DeVries SH, 2000, NEURON, V28, P847, DOI 10.1016/S0896-6273(00)00158-6; Dhingra A, 2000, J NEUROSCI, V20, P9053; Dryja TP, 2005, P NATL ACAD SCI USA, V102, P4884, DOI 10.1073/pnas.0501233102; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Fleisch VC, 2008, J NEUROSCI, V28, P8208, DOI 10.1523/JNEUROSCI.2367-08.2008; Gesemann M, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-117; Ghosh PK, 1997, DEV BRAIN RES, V102, P1, DOI 10.1016/S0165-3806(97)00066-7; GRANT GB, 1995, J NEUROSCI, V15, P3852; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Klooster J, 2011, INVEST OPHTH VIS SCI, V52, P8356, DOI 10.1167/iovs.11-7575; Koike C, 2010, P NATL ACAD SCI USA, V107, P332, DOI 10.1073/pnas.0912730107; Makhankov YV, 2004, J NEUROSCI METH, V135, P205, DOI 10.1016/j.jneumeth.2003.12.015; MASSEY SC, 1983, VISION RES, V23, P1607, DOI 10.1016/0042-6989(83)90174-8; MASU M, 1995, CELL, V80, P757, DOI 10.1016/0092-8674(95)90354-2; Meyer A, 2005, BIOESSAYS, V27, P937, DOI 10.1002/bies.20293; Morgans CW, 2010, BIOESSAYS, V32, P609, DOI 10.1002/bies.200900198; Morgans CW, 2009, P NATL ACAD SCI USA, V106, P19174, DOI 10.1073/pnas.0908711106; MULLINS MC, 1994, CURR BIOL, V4, P189, DOI 10.1016/S0960-9822(00)00048-8; NAKAJIMA Y, 1993, J BIOL CHEM, V268, P11868; Nawy S, 1999, J NEUROSCI, V19, P2938; NAWY S, 1990, NATURE, V346, P269, DOI 10.1038/346269a0; NOMURA A, 1994, CELL, V77, P361, DOI 10.1016/0092-8674(94)90151-1; Saszik S, 2002, VISUAL NEUROSCI, V19, P521, DOI 10.1017/S0952523802194144; Schroeter EH, 2006, VISUAL NEUROSCI, V23, P833, DOI 10.1017/S0952523806230219; Shen Y, 2009, J NEUROSCI, V29, P6088, DOI 10.1523/JNEUROSCI.0132-09.2009; SHIELLS RA, 1981, NATURE, V294, P592, DOI 10.1038/294592a0; SLAUGHTER MM, 1981, SCIENCE, V211, P182, DOI 10.1126/science.6255566; Taylor JS, 2003, GENOME RES, V13, P382, DOI 10.1101/gr.640303; Tehrani A, 2000, INVEST OPHTH VIS SCI, V41, P314; Thisse C, 2008, NAT PROTOC, V3, P59, DOI 10.1038/nprot.2007.514; Vardi T, 2011, J HISTOCHEM CYTOCHEM, V59, P1076, DOI 10.1369/0022155411425386; Whelan S, 2001, MOL BIOL EVOL, V18, P691, DOI 10.1093/oxfordjournals.molbev.a003851; Wong KY, 2004, ZEBRAFISH, V1, P121, DOI 10.1089/zeb.2004.1.121; Wong KY, 2005, J NEUROPHYSIOL, V93, P84, DOI 10.1152/jn.00259.2004; Wong KY, 2005, J NEUROPHYSIOL, V93, P94, DOI 10.1152/jn.00270.2004; Zeitz C, 2005, INVEST OPHTH VIS SCI, V46, P4328, DOI 10.1167/iovs.05-0526	41	22	23	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2012	7	4							e35256	10.1371/journal.pone.0035256	http://dx.doi.org/10.1371/journal.pone.0035256			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VO	22523578	Green Submitted, Green Accepted, Green Published, gold			2022-12-25	WOS:000305345000050
J	Li, B; Zhang, GS; Li, C; He, D; Li, XY; Zhang, CF; Tang, FQ; Deng, XY; Lu, JC; Tang, YH; Li, RJ; Chen, ZC; Duan, CJ				Li, Bin; Zhang, Guangsen; Li, Cui; He, Dan; Li, Xinying; Zhang, Chunfang; Tang, Faqing; Deng, Xiyun; Lu, Jingchen; Tang, Youhong; Li, Ruijuan; Chen, Zhuchu; Duan, Chaojun			Identification of JAK2 as a Mediator of FIP1L1-PDGFRA-Induced Eosinophil Growth and Function in CEL	PLOS ONE			English	Article							HYPEREOSINOPHILIC SYNDROME; FUSION GENE; LEUKEMIA; IMATINIB; APOPTOSIS; KINASE; EOL-1; IL-5; PROLIFERATION; INHIBITION	The Fip1-like1 (FIP1L1)-platelet-derived growth factor receptor alpha fusion gene (F/P) arising in the pluripotent hematopoietic stem cell (HSC), causes 14% to 60% of patients with hypereosinophilia syndrome (HES). These patients, classified as having F/P (+) chronic eosinophilic leukemia (CEL), present with clonal eosinophilia and display a more aggressive disease phenotype than patients with F/P (-) HES patients. The mechanisms underlying predominant eosinophil lineage targeting and the cytotoxicity of eosinophils in this leukemia remain unclear. Given that the Janus tyrosine kinase (JAK)/signal transducers and activators of transcription (Stat) signaling pathway is key to cytokine receptor-mediated eosinophil development and activated Stat3 and Stat5 regulate the expression of genes involved in F/P malignant transformation, we investigated whether and how JAK proteins were involved in the pathogenesis of F/P-induced CEL. F/P activation of JAK2, Stat3 and Stat5, were confirmed in all the 11 F/P (+) CEL patients examined. In vitro inhibition of JAK2 in EOL-1, primary F/P(+) CEL cells (PC) and T674I F/P Imatinib resistant cells(IR) by either JAK2-specific short interfering RNA (siRNA) or the tryphostin derivative AG490(AG490), significantly reduced cellular proliferation and induced cellular apoptosis. The F/P can enhance the IL-5-induced JAK2 activation, and further results indicated that JAK2 inhibition blocked IL-5-induced cellular migration and activation of the EOL-1 and PC cells in vitro. F/P-stimulation of the JAK2 suppressed cells led to a significantly reduction in Stat3 activation, but relatively normal induction of Stat5 activation. Interestingly, JAK2 inhibition also reduced PI3K, Akt and NF-kappa B activity in a dose-dependent manner, and suppressed expression levels of c-Myc and Survivin. These results strongly suggest that JAK2 is activated by F/P and is required for F/P stimulation of cellular proliferation and infiltration, possibly through induction of c-Myc and Survivin expression via activation of multiple signaling pathways, including NF-kappa B, Stat3, and PI3K/Akt.	[Li, Bin; Li, Cui; Li, Xinying; Zhang, Chunfang; Chen, Zhuchu; Duan, Chaojun] Cent S Univ, Xiangya Hosp, Chinese Minist Hlth, Key Lab Canc Prote, Changsha, Hunan, Peoples R China; [Li, Bin; Zhang, Guangsen; Li, Ruijuan] Cent S Univ, Xiang Ya Hosp 2, Inst Mol Hematol, Div Hematol, Changsha, Hunan, Peoples R China; [He, Dan; Duan, Chaojun] Cent S Univ, Xiangya Hosp, Med Res Ctr, Changsha, Hunan, Peoples R China; [Li, Bin; Lu, Jingchen; Tang, Youhong] Cent S Univ, Xiangya Hosp, Div Oncol, Changsha, Hunan, Peoples R China; [Tang, Faqing] Jinan Univ, Zhuhai Hosp, Clin Lab, Zhuhai, Peoples R China; [Deng, Xiyun] Univ Texas Hlth Sci Ctr Houston, Dept Surg, Houston, TX USA	Central South University; Central South University; Central South University; Central South University; Jinan University; University of Texas System; University of Texas Health Science Center Houston	Duan, CJ (corresponding author), Cent S Univ, Xiangya Hosp, Chinese Minist Hlth, Key Lab Canc Prote, Changsha, Hunan, Peoples R China.	duancjxy@126.com			National Natural Scientific Foundation of China [30670990, 30871189, 30973400, 81171841]; Province Natural Scientific Foundation of Hunan [07JJ5063, 2009JT3011]; Province Public Health Bureau [2007065]	National Natural Scientific Foundation of China(National Natural Science Foundation of China (NSFC)); Province Natural Scientific Foundation of Hunan; Province Public Health Bureau	This work was supported by grants from the National Natural Scientific Foundation of China (Nos. 30670990, 30871189, 30973400, and 81171841) and the Province Natural Scientific Foundation of Hunan (No. 07JJ5063, 2009JT3011) and the Province Public Health Bureau (2007065). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bar-Natan M, 2011, LEUKEMIA; Baumgartner C, 2008, EXP HEMATOL, V36, P1244, DOI 10.1016/j.exphem.2008.04.017; BOYUM A, 1968, SCAND J CLIN LAB INV, VS 21, P77; Buitenhuis N, 2007, CANCER RES, V67, P3759, DOI 10.1158/0008-5472.CAN-06-4183; Burbury K, 2011, LEUKEMIA LYMPHOMA, V52, P335, DOI 10.3109/10428194.2010.534210; Burgstaller S, 2007, LEUKEMIA, V21, P2428, DOI 10.1038/sj.leu.2404977; CHUSID MJ, 1975, MEDICINE, V54, P1, DOI 10.1097/00005792-197501000-00001; Cleyrat C, 2010, LEUKEMIA, V24, P1069, DOI 10.1038/leu.2010.23; Cools J, 2004, BLOOD, V103, P2802, DOI 10.1182/blood-2003-07-2479; Cools J, 2003, NEW ENGL J MED, V348, P1201, DOI 10.1056/NEJMoa025217; Fukushima K, 2009, J BIOL CHEM, V284, P7719, DOI 10.1074/jbc.M807489200; Galimberti S, 2007, CLIN EXP RHEUMATOL, V25, P17; Gotlib J, 2008, LEUKEMIA, V22, P1999, DOI 10.1038/leu.2008.287; Grivennikov SI, 2010, CYTOKINE GROWTH F R, V21, P11, DOI 10.1016/j.cytogfr.2009.11.005; Hebenstreit D, 2005, DRUG NEWS PERSPECT, V18, P243, DOI 10.1358/dnp.2005.18.4.908658; Hedvat M, 2009, CANCER CELL, V16, P487, DOI 10.1016/j.ccr.2009.10.015; Ip WK, 2003, CLIN EXP ALLERGY, V33, P241, DOI 10.1046/j.1365-2222.2003.01585.x; Irino T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022148; Ishihara K, 2008, BIOCHEM BIOPH RES CO, V366, P1007, DOI 10.1016/j.bbrc.2007.12.063; Jin YL, 2009, CANCER SCI, V100, P2210, DOI 10.1111/j.1349-7006.2009.01283.x; Kahn JE, 2011, J PROTEOME RES, V10, P1468, DOI 10.1021/pr100836p; Kampe M, 2011, INFLAMMATION; Kanie T, 2004, LEUKEMIA, V18, P548, DOI 10.1038/sj.leu.2403266; Klion AD, 2003, BLOOD, V101, P4660, DOI 10.1182/blood-2003-01-0006; Kudlacz E, 2008, EUR J PHARMACOL, V582, P154, DOI 10.1016/j.ejphar.2007.12.024; Lee JS, 2010, MOL BIOL REP, V37, P2149, DOI 10.1007/s11033-009-9687-z; Lee JS, 2009, CYTOKINE, V48, P186, DOI 10.1016/j.cyto.2009.07.008; Lee WH, 2009, J CELL BIOCHEM, V106, P929, DOI 10.1002/jcb.22069; Ma WL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012165; Monahan J, 1997, J IMMUNOL, V159, P4024; Pan J, 2007, LEUKEMIA, V21, P1395, DOI 10.1038/sj.leu.2404714; Pardanani A, 2006, LEUKEMIA RES, V30, P965, DOI 10.1016/j.leukres.2005.11.011; Pitini V, 2007, LEUKEMIA RES, V31, P725, DOI 10.1016/j.leukres.2006.07.011; Putters J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014676; Samanta AK, 2009, ONCOGENE, V28, P1669, DOI 10.1038/onc.2009.7; Samanta Ajoy K, 2010, Genes Cancer, V1, P346, DOI 10.1177/1947601910372232; Steelman LS, 2008, LEUKEMIA, V22, P686, DOI 10.1038/leu.2008.26; STRATH M, 1985, J IMMUNOL METHODS, V83, P209, DOI 10.1016/0022-1759(85)90242-X; Vardiman JW, 2009, BLOOD, V114, P937, DOI 10.1182/blood-2009-03-209262; Vassina EM, 2006, EUR J IMMUNOL, V36, P1975, DOI 10.1002/eji.200635943; Walz C, 2009, LEUKEMIA, V23, P271, DOI 10.1038/leu.2008.310; Yamada Y, 2006, BLOOD, V107, P4071, DOI 10.1182/blood-2005-08-3153; Yamada Y, 2010, INT ARCH ALLERGY IMM, V152, P101, DOI 10.1159/000312134; Zhu JF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023720; Zhu YM, 2011, J IMMUNOL, V186, P516, DOI 10.4049/jimmunol.1000955	45	17	17	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2012	7	4							e34912	10.1371/journal.pone.0034912	http://dx.doi.org/10.1371/journal.pone.0034912			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VO	22523564	gold, Green Submitted, Green Published			2022-12-25	WOS:000305345000036
J	da Matta, JAM; Aras, R; de Macedo, CRB; da Cruz, CG; Netto, EM				Martins da Matta, Jose Alberto; Aras, Roque, Jr.; Bastos de Macedo, Cristiano Ricardo; da Cruz, Cristiano Goncalves; Netto, Eduardo Martins			Stroke Correlates in Chagasic and Non-Chagasic Cardiomyopathies	PLOS ONE			English	Article							RISK STRATIFICATION; ATRIAL-FIBRILLATION; DISEASE OUTBREAK; TRANSMISSION	Background: Aging and migration have brought changes to the epidemiology and stroke has been shown to be independently associated with Chagas disease. We studied stroke correlates in cardiomyopathy patients with focus on the chagasic etiology. Methodology/Principal Findings: We performed a cross-sectional review of medical records of 790 patients with a cardiomyopathy. Patients with chagasic (329) and non-chagasic (461) cardiomyopathies were compared. There were 108 stroke cases, significantly more frequent in the Chagas group (17.3% versus 11.1%; p<0.01). Chagasic etiology (odds ratio [OR], 1.79), pacemaker (OR, 2.49), atrial fibrillation (OR, 3.03) and coronary artery disease (OR, 1.92) were stroke predictors in a multivariable analysis of the entire cohort. In a second step, the population was split into those with or without a Chagas-related cardiomyopathy. Univariable post-stratification stroke predictors in the Chagas cohort were pacemaker (OR, 2.73), and coronary artery disease (CAD) (OR, 2.58); while atrial fibrillation (OR, 2.98), age over 55 (OR, 2.92), hypertension (OR, 2.62) and coronary artery disease (OR, 1.94) did so in the non-Chagas cohort. Chagasic stroke patients presented a very high frequency of individuals without any vascular risk factors (40.4%; OR, 4.8). In a post-stratification logistic regression model, stroke remained associated with pacemaker (OR, 2.72) and coronary artery disease (OR, 2.60) in 322 chagasic patients, and with age over 55 (OR, 2.38), atrial fibrillation (OR 3.25) and hypertension (OR 2.12; p = 0.052) in 444 non-chagasic patients. Conclusions/Significance: Chagas cardiomyopathy presented both a higher frequency of stroke and an independent association with it. There was a high frequency of strokes without any vascular risk factors in the Chagas as opposed to the non-Chagas cohort. Pacemaker rhythm and CAD were independently associated with stroke in the Chagas group while age over 55 years, hypertension and atrial fibrillation did so in the non-Chagas cardiomyopathies.	[Martins da Matta, Jose Alberto; Aras, Roque, Jr.; Bastos de Macedo, Cristiano Ricardo] Univ Fed Bahia, Hosp Univ Prof Edgard Santos, Salvador, BA, Brazil; [da Cruz, Cristiano Goncalves] Univ Fed Bahia, Hosp Ana Nery, Salvador, BA, Brazil; [Netto, Eduardo Martins] Univ Fed Bahia, Hosp Univ Prof Edgard Santos, Salvador, BA, Brazil	Universidade Federal da Bahia; Universidade Federal da Bahia; Universidade Federal da Bahia	da Matta, JAM (corresponding author), Univ Fed Bahia, Hosp Univ Prof Edgard Santos, Salvador, BA, Brazil.	jalb@ufba.br	Netto, Eduardo/D-1432-2013	Netto, Eduardo/0000-0003-1691-6761				[Anonymous], 2010, 1 WHO; Aras Roque, 2003, Arq. Bras. Cardiol., V81, P414, DOI 10.1590/S0066-782X2003001200008; Armaganijan L, 2010, STROKE, V41, P2453, DOI 10.1161/STROKEAHA.110.594051; Bastos CJC, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000711; Biolo A, 2010, PROG CARDIOVASC DIS, V52, P300, DOI 10.1016/j.pcad.2009.11.008; Carod-Artal FJ, 2005, STROKE, V36, P965, DOI 10.1161/01.STR.0000163104.92943.50; Carod-Artal FJ, 2003, J NEUROL NEUROSUR PS, V74, P516, DOI 10.1136/jnnp.74.4.516; Costa MFFLE, 2001, INT J EPIDEMIOL, V30, P887, DOI 10.1093/ije/30.4.887; Coura JR, 2009, MEM I OSWALDO CRUZ, V104, P31, DOI 10.1590/S0074-02762009000900006; da Saude M., 2005, REV SOC BRAS MED TRO, P1; Valente SADS, 2009, T ROY SOC TROP MED H, V103, P291, DOI 10.1016/j.trstmh.2008.10.047; de Andrade JP, 2011, ARQ BRAS CARDIOL, V96, DOI 10.1590/S0066-782X2011000600002; Delgado S, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000970; Dias JP, 2008, REV SOC BRAS MED TRO, V41, P296, DOI 10.1590/S0037-86822008000300014; Gage BF, 2004, CIRCULATION, V110, P2287, DOI 10.1161/01.CIR.0000145172.55640.93; Goldstein LB, 2011, STROKE, V42, P517, DOI 10.1161/STR.0b013e3181fcb238; Hidron A, 2010, CLIN MICROBIOL REV, V23, P324, DOI 10.1128/CMR.00054-09; Hotez PJ, 2007, NEW ENGL J MED, V357, P1018, DOI 10.1056/NEJMra064142; Leon-Sarmiento FE, 2004, J NEUROL SCI, V217, P61, DOI 10.1016/j.jns.2003.08.015; Lima Costa MF, 2010, STROKE, V41, P2477; Lima-Costa MFF, 2002, INT J EPIDEMIOL, V31, P688, DOI 10.1093/ije/31.3.688; Lip GYH, 2010, CHEST, V137, P263, DOI 10.1378/chest.09-1584; Marin JA, 2007, CIRCULATION, V115, P1109, DOI 10.1161/CIRCULATIONAHA.106.624296; Nunes MCP, 2009, J NEUROL SCI, V278, P96, DOI 10.1016/j.jns.2008.12.015; OLIVEIRA JSM, 1983, AM J CARDIOL, V52, P147, DOI 10.1016/0002-9149(83)90085-1; OLIVEIRA JSM, 1981, BRIT HEART J, V46, P432, DOI 10.1136/hrt.46.4.432; Paixao LC, 2009, STROKE, V40, P3691, DOI 10.1161/STROKEAHA.109.560854; Pinto Dias J C, 1995, Arq Bras Cardiol, V65, P359; Prata A, 2001, Lancet Infect Dis, V1, P92, DOI 10.1016/S1473-3099(01)00065-2; Rassi A, 2000, CLIN CARDIOL, V23, P883, DOI 10.1002/clc.4960231205; Rassi A, 2006, NEW ENGL J MED, V355, P799, DOI 10.1056/NEJMoa053241; Richardson P, 1996, CIRCULATION, V93, P841, DOI 10.1161/01.CIR.93.5.841; de Sousa AS, 2008, ARQ BRAS CARDIOL, V91, P280; World Health Organization, 2005, WHO STEPS STROK MAN; World Health Organization, 2010, CHAG DIS GEN SWITZ F; World Health Organization, 2008, GLOB BURD DIS 2004 U	36	15	16	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2012	7	4							e35116	10.1371/journal.pone.0035116	http://dx.doi.org/10.1371/journal.pone.0035116			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VO	22523572	gold, Green Submitted, Green Published			2022-12-25	WOS:000305345000044
J	Xu, Z; Gao, XX; He, YH; Ju, JY; Zhang, MM; Liu, RH; Wu, YP; Ma, CY; Ma, C; Lin, ZY; Huang, XX; Zhao, Q				Xu, Zhen; Gao, Xinxing; He, Yinghong; Ju, Junyi; Zhang, Miaomiao; Liu, Ronghua; Wu, Yupeng; Ma, Chunyan; Ma, Chi; Lin, Zhaoyu; Huang, Xingxu; Zhao, Quan			Synergistic Effect of SRY and Its Direct Target, WDR5, on Sox9 Expression	PLOS ONE			English	Article							MAMMALIAN SEX DETERMINATION; GLOBIN GENE-EXPRESSION; NF-KAPPA-B; DNA-BINDING; HISTONE H3; LYSINE-4 METHYLATION; DETERMINING REGION; WD-40 PROTEIN; DIFFERENTIATION; ACTIVATION	SRY is a sex-determining gene that encodes a transcription factor, which triggers male development in most mammals. The molecular mechanism of SRY action in testis determination is, however, poorly understood. In this study, we demonstrate that WDR5, which encodes a WD-40 repeat protein, is a direct target of SRY. EMSA experiments and ChIP assays showed that SRY could bind to the WDR5 gene promoter directly. Overexpression of SRY in LNCaP cells significantly increased WDR5 expression concurrent with histone H3K4 methylation on the WDR5 promoter. To specifically address whether SRY contributes to WDR5 regulation, we introduced a 4-hydroxy-tamoxifen-inducible SRY allele into LNCaP cells. Conditional SRY expression triggered enrichment of SRY on the WDR5 promoter resulting in induction of WDR5 transcription. We found that WDR5 was self regulating through a positive feedback loop. WDR5 and SRY interacted and were colocalized in cells. In addition, the interaction of WDR5 with SRY resulted in activation of Sox9 while repressing the expression of beta-catenin. These results suggest that, in conjunction with SRY, WDR5 plays an important role in sex determination.	[Xu, Zhen; He, Yinghong; Ju, Junyi; Zhang, Miaomiao; Liu, Ronghua; Wu, Yupeng; Ma, Chunyan; Ma, Chi; Zhao, Quan] Nanjing Univ, Sch Life Sci, State Key Lab Pharmaceut Biotechnol, Mol Immunol & Canc Res Ctr, Nanjing, Jiangsu, Peoples R China; [Gao, Xinxing; Lin, Zhaoyu; Huang, Xingxu] Nanjing Univ, Model Anim Res Ctr, Nanjing, Jiangsu, Peoples R China; [He, Yinghong] Dali Univ, Sch Basic Med, Yunnan, Peoples R China	Nanjing University; Nanjing University; Dali University	Xu, Z (corresponding author), Nanjing Univ, Sch Life Sci, State Key Lab Pharmaceut Biotechnol, Mol Immunol & Canc Res Ctr, Nanjing, Jiangsu, Peoples R China.	qzhao@nju.edu.cn	Zhao, Quan/E-9147-2011	Zhao, Quan/0000-0002-8533-1938; huang, xingxu/0000-0001-8934-1247; ju, junyi/0000-0002-9141-2363; Lin, Zhaoyu/0000-0003-2095-7814	National Natural Science Foundation of China (NSFC) [31071118, 31170716, 81121062, SBK201140017, 81060248]; Fundamental Research Funds for the Central Universities; Doctoral Program of Higher Education of China RFDP [20090091110033]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Doctoral Program of Higher Education of China RFDP	This work was supported by National Natural Science Foundation of China (NSFC#31071118, NSFC#31170716, NSFC#81121062, SBK201140017(QZ), NSFC#81060248(YH), the Fundamental Research Funds for the Central Universities, and the Doctoral Program of Higher Education of China RFDP#20090091110033. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ang YS, 2011, CELL, V145, P183, DOI 10.1016/j.cell.2011.03.003; BERTA P, 1990, NATURE, V348, P448, DOI 10.1038/348448A0; Bhandari RK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019935; Bowles J, 1999, NAT GENET, V22, P405, DOI 10.1038/11981; Bradford ST, 2009, BIOL REPROD, V80, P1178, DOI 10.1095/biolreprod.108.071480; Carvin CD, 2004, J BIOL CHEM, V279, P33057, DOI 10.1074/jbc.M405033200; Clement TM, 2011, BIOL REPROD; CONNER F, 1994, NUCLEIC ACIDS RES, V22, P3339, DOI 10.1093/nar/22.16.3339; Dou YL, 2005, CELL, V121, P873, DOI 10.1016/j.cell.2005.04.031; DUBIN RA, 1994, MOL ENDOCRINOL, V8, P1182, DOI 10.1210/me.8.9.1182; FERRARI S, 1992, EMBO J, V11, P4497, DOI 10.1002/j.1460-2075.1992.tb05551.x; Gori F, 2001, J BIOL CHEM, V276, P46515, DOI 10.1074/jbc.M105757200; Gori F, 2006, DEV BIOL, V295, P498, DOI 10.1016/j.ydbio.2006.02.031; GUBBAY J, 1990, NATURE, V346, P245, DOI 10.1038/346245a0; Han ZF, 2006, MOL CELL, V22, P137, DOI 10.1016/j.molcel.2006.03.018; HARLEY VR, 1994, NUCLEIC ACIDS RES, V22, P1500, DOI 10.1093/nar/22.8.1500; Kashimada K, 2010, DEVELOPMENT, V137, P3921, DOI 10.1242/dev.048983; Kim Y, 2006, PLOS BIOL, V4, P1000, DOI 10.1371/journal.pbio.0040187; LITTLEWOOD TD, 1995, NUCLEIC ACIDS RES, V23, P1686, DOI 10.1093/nar/23.10.1686; Maatouk DM, 2008, HUM MOL GENET, V17, P2949, DOI 10.1093/hmg/ddn193; Pinskaya M, 2009, EMBO J, V28, P1697, DOI 10.1038/emboj.2009.108; PONTIGGIA A, 1994, EMBO J, V13, P6115, DOI 10.1002/j.1460-2075.1994.tb06958.x; Rank G, 2010, BLOOD, V116, P1585, DOI 10.1182/blood-2009-10-251116; Sekido R, 2009, TRENDS GENET, V25, P19, DOI 10.1016/j.tig.2008.10.008; Sekido R, 2008, NATURE, V453, P930, DOI 10.1038/nature06944; Shi XB, 2006, NATURE, V442, P96, DOI 10.1038/nature04835; SINCLAIR AH, 1990, NATURE, V346, P240, DOI 10.1038/346240a0; Smale S. T., 2010, COLD SPRING HARB PRO, V2010; Taketo T, 2005, DEV DYNAM, V233, P612, DOI 10.1002/dvdy.20352; Trievel RC, 2009, NAT STRUCT MOL BIOL, V16, P678, DOI 10.1038/nsmb0709-678; Wang YY, 2010, P NATL ACAD SCI USA, V107, P815, DOI 10.1073/pnas.0908967107; Wilhelm D, 2005, DEV BIOL, V287, P111, DOI 10.1016/j.ydbio.2005.08.039; Wysocka J, 2005, CELL, V121, P859, DOI 10.1016/j.cell.2005.03.036; Yao YL, 1998, NUCLEIC ACIDS RES, V26, P3776, DOI 10.1093/nar/26.16.3776; Zelivianski S, 2004, NUCLEIC ACIDS RES, V32, P3566, DOI 10.1093/nar/gkh677; Zhao Q, 2006, BLOOD, V107, P2138, DOI 10.1182/blood-2005-06-2497; Zhao Q, 2009, NAT STRUCT MOL BIOL, V16, P304, DOI 10.1038/nsmb.1568	37	22	23	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2012	7	4							e34327	10.1371/journal.pone.0034327	http://dx.doi.org/10.1371/journal.pone.0034327			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VO	22523547	Green Published, gold, Green Submitted			2022-12-25	WOS:000305345000017
J	Vecchi, L; Petris, G; Bestagno, M; Burrone, OR				Vecchi, Lara; Petris, Gianluca; Bestagno, Marco; Burrone, Oscar R.			Selective Targeting of Proteins within Secretory Pathway for Endoplasmic Reticulum-associated Degradation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							QUALITY-CONTROL; ER; SEL1L; TRAFFICKING; DISLOCATION; PROTEASOMES; EXPRESSION; MECHANISM; COMPLEX; STRESS	The endoplasmic reticulum-associated degradation (ERAD) is a cellular quality control mechanism to dispose of misfolded proteins of the secretory pathway via proteasomal degradation. SEL1L is an ER-resident protein that participates in identification of misfolded molecules as ERAD substrates, therefore inducing their ER-to-cytosol retrotranslocation and degradation. We have developed a novel class of fusion proteins, termed degradins, composed of a fragment of SEL1L fused to a target-specific binding moiety located on the luminal side of the ER. The target-binding moiety can be a ligand of the target or derived from specific mAbs. Here, we describe the ability of degradins with two different recognition moieties to promote degradation of a model target. Degradins recognize the target protein within the ER both in secretory and membrane-bound forms, inducing their degradation following retrotranslocation to the cytosol. Thus, degradins represent an effective technique to knock-out proteins within the secretory pathway with high specificity.	[Vecchi, Lara; Petris, Gianluca; Bestagno, Marco; Burrone, Oscar R.] Int Ctr Genet Engn & Biotechnol, Mol Immunol Grp, I-34149 Trieste, Italy	International Center for Genetic Engineering & Biotechnology (ICGEB)	Burrone, OR (corresponding author), Int Ctr Genet Engn & Biotechnol, Mol Immunol Grp, Padriciano 99, I-34149 Trieste, Italy.	burrone@icgeb.org	Petris, Gianluca/N-9754-2018; Vecchi, Lara/AAJ-8208-2021	Petris, Gianluca/0000-0002-2420-6359; 	International Centre for Genetic Engineering and Biotechnology	International Centre for Genetic Engineering and Biotechnology	Supported by an International Centre for Genetic Engineering and Biotechnology predoctoral fellowship for the Corso di Perfezionamento of the Scuola Normale Superiore di Pisa. Present address: Universidade Federal de Uberlandia, Laboratorio de Genetica Molecular, Campus Umuarama, Uberlandia, MG, Brazil.	Baker BM, 2007, J BIOL CHEM, V282, P26845, DOI 10.1074/jbc.M704315200; Beatty WL, 2006, J CELL SCI, V119, P350, DOI 10.1242/jcs.02733; Bernal-Bayard J, 2010, J BIOL CHEM, V285, P16360, DOI 10.1074/jbc.M110.100669; Bernasconi R, 2010, J CELL BIOL, V188, P223, DOI 10.1083/jcb.200910042; Biunno I, 2006, J CELL PHYSIOL, V208, P23, DOI 10.1002/jcp.20574; Brodsky JL, 2009, CURR OPIN CELL BIOL, V21, P516, DOI 10.1016/j.ceb.2009.04.006; Carvalho P, 2006, CELL, V126, P361, DOI 10.1016/j.cell.2006.05.043; Christianson JC, 2008, NAT CELL BIOL, V10, P272, DOI 10.1038/ncb1689; Coffield VM, 2003, NAT BIOTECHNOL, V21, P1321, DOI 10.1038/nbt889; Ellgaard L, 2003, NAT REV MOL CELL BIO, V4, P181, DOI 10.1038/nrm1052; Filesi I, 2007, J NEUROCHEM, V101, P1516, DOI 10.1111/j.1471-4159.2006.04439.x; Gardner RG, 2000, J CELL BIOL, V151, P69, DOI 10.1083/jcb.151.1.69; Giles DK, 2008, MICROBES INFECT, V10, P1494, DOI 10.1016/j.micinf.2008.09.001; Govaerts C, 2004, P NATL ACAD SCI USA, V101, P8342, DOI 10.1073/pnas.0402254101; Iida Y, 2011, J BIOL CHEM, V286, P16929, DOI 10.1074/jbc.M110.215871; Kamauchi S, 2005, FEBS J, V272, P3461, DOI 10.1111/j.1742-4658.2005.04770.x; Kaneko M, 2003, LIFE SCI, V74, P199, DOI 10.1016/j.lfs.2003.09.007; Kikkert M, 2004, J BIOL CHEM, V279, P3525, DOI 10.1074/jbc.M307453200; Kostova Z, 2007, SEMIN CELL DEV BIOL, V18, P770, DOI 10.1016/j.semcdb.2007.09.002; McLear JA, 2008, FASEB J, V22, P2003, DOI 10.1096/fj.07-099689; Mueller B, 2006, J CELL BIOL, V175, P261, DOI 10.1083/jcb.200605196; Paganetti P, 2005, J CELL BIOL, V168, P863, DOI 10.1083/jcb.200410047; PELHAM HRB, 1990, TRENDS BIOCHEM SCI, V15, P483, DOI 10.1016/0968-0004(90)90303-S; Petris G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023712; Pickart CM, 2004, NAT REV MOL CELL BIO, V5, P177, DOI 10.1038/nrm1336; Predonzani A, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-41; Rathman M, 1997, INFECT IMMUN, V65, P1475, DOI 10.1128/IAI.65.4.1475-1485.1997; SAMBROOK J, 1989, MOL CLONING LAB MANA; Schafer A, 2009, EMBO J, V28, P2874, DOI 10.1038/emboj.2009.231; Vangelista L, 1999, J CLIN INVEST, V103, P1571, DOI 10.1172/JCI6551; Vangelista L, 2002, J MOL BIOL, V322, P815, DOI 10.1016/S0022-2836(02)00853-7; Vangelista L, 2002, PROTEIN ENG, V15, P51, DOI 10.1093/protein/15.1.51; Vashist S, 2004, J CELL BIOL, V165, P41, DOI 10.1083/jcb.200309132; Vembar SS, 2008, NAT REV MOL CELL BIO, V9, P944, DOI 10.1038/nrm2546; Wickner W, 2005, SCIENCE, V310, P1452, DOI 10.1126/science.1113752; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0	36	13	14	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 8	2012	287	24					20007	20015		10.1074/jbc.M112.355107	http://dx.doi.org/10.1074/jbc.M112.355107			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974FB	22523070	Green Published, hybrid			2022-12-25	WOS:000306414500022
J	Okabe, Y; Takahashi, T; Mitsumasu, C; Kosai, K; Tanaka, E; Matsuishi, T				Okabe, Yasunori; Takahashi, Tomoyuki; Mitsumasu, Chiaki; Kosai, Ken-ichiro; Tanaka, Eiichiro; Matsuishi, Toyojiro			Alterations of Gene Expression and Glutamate Clearance in Astrocytes Derived from an MeCP2-Null Mouse Model of Rett Syndrome	PLOS ONE			English	Article							CPG-BINDING PROTEIN-2; EMBRYONIC STEM-CELL; DNA METHYLATION; DIFFERENTIATION; DYSFUNCTION; BRAIN; GLIA; TRANSPORTERS; DEFICIENCY; MICROGLIA	Rett syndrome (RTT) is a neurodevelopmetal disorder associated with mutations in the methyl-CpG-binding protein 2 (MeCP2) gene. MeCP2-deficient mice recapitulate the neurological degeneration observed in RTT patients. Recent studies indicated a role of not only neurons but also glial cells in neuronal dysfunction in RTT. We cultured astrocytes from MeCP2-null mouse brain and examined astroglial gene expression, growth rate, cytotoxic effects, and glutamate (Glu) clearance. Semi-quantitative RT-PCR analysis revealed that expression of astroglial marker genes, including GFAP and S100b, was significantly higher in MeCP2-null astrocytes than in control astrocytes. Loss of MeCP2 did not affect astroglial cell morphology, growth, or cytotoxic effects, but did alter Glu clearance in astrocytes. When high extracellular Glu was added to the astrocyte cultures and incubated, a time-dependent decrease of extracellular Glu concentration occurred due to Glu clearance by astrocytes. Although the shapes of the profiles of Glu concentration versus time for each strain of astrocytes were grossly similar, Glu concentration in the medium of MeCP2-null astrocytes were lower than those of control astrocytes at 12 and 18 h. In addition, MeCP2 deficiency impaired downregulation of excitatory amino acid transporter 1 and 2 (EAAT1/2) transcripts, but not induction of glutamine synthetase (GS) transcripts, upon high Glu exposure. In contrast, GS protein was significantly higher in MeCP2-null astrocytes than in control astrocytes. These findings suggest that MeCP2 affects astroglial genes expression in cultured astrocytes, and that abnormal Glu clearance in MeCP2-deficient astrocytes may influence the onset and progression of RTT.	[Okabe, Yasunori; Takahashi, Tomoyuki; Mitsumasu, Chiaki; Kosai, Ken-ichiro; Tanaka, Eiichiro; Matsuishi, Toyojiro] Kurume Univ, Div Gene Therapy & Regenerat Med, Cognit & Mol Res Inst Brain Dis, Kurume, Fukuoka 830, Japan; [Okabe, Yasunori; Tanaka, Eiichiro] Kurume Univ Med, Dept Physiol, Kurume, Fukuoka, Japan; [Takahashi, Tomoyuki; Mitsumasu, Chiaki; Kosai, Ken-ichiro; Matsuishi, Toyojiro] Kurume Univ Med, Dept Pediat, Kurume, Fukuoka, Japan; [Kosai, Ken-ichiro] Kagoshima Univ, Dept Gene Therapy & Regenerat Med, Adv Therapeut Course, Grad Sch Med & Dent Sci, Kagoshima 890, Japan	Kurume University; Kurume University; Kurume University; Kagoshima University	Takahashi, T (corresponding author), Kurume Univ, Div Gene Therapy & Regenerat Med, Cognit & Mol Res Inst Brain Dis, Kurume, Fukuoka 830, Japan.	takahashi_tomoyuki@kurume-u.ac.jp			Japan Society for the Promotion of Science	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported in part by a Grant-in-Aid for Scientific Research (C) and a Grant-in-Aid for Young Scientists (B) from the Japan Society for the Promotion of Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amir RE, 1999, NAT GENET, V23, P185, DOI 10.1038/13810; Ballas N, 2009, NAT NEUROSCI, V12, P311, DOI 10.1038/nn.2275; Bienvenu T, 2006, NAT REV GENET, V7, P415, DOI 10.1038/nrg1878; Calfa G, 2011, EXP BIOL MED, V236, P3, DOI 10.1258/ebm.2010.010261; Chahrour M, 2007, NEURON, V56, P422, DOI 10.1016/j.neuron.2007.10.001; Chen CJ, 2000, J NEUROCHEM, V75, P1557, DOI 10.1046/j.1471-4159.2000.0751557.x; Chen RZ, 2001, NAT GENET, V27, P327, DOI 10.1038/85906; Colantuoni C, 2001, NEUROBIOL DIS, V8, P847, DOI 10.1006/nbdi.2001.0428; Deguchi K, 2000, PEDIATR NEUROL, V22, P259, DOI 10.1016/S0887-8994(00)00120-X; Dunn HG, 2001, CAN J NEUROL SCI, V28, P16; Eid T, 2008, EPILEPSIA, V49, P42, DOI 10.1111/j.1528-1167.2008.01492.x; Erichsen MN, 2010, J MED CHEM, V53, P7180, DOI 10.1021/jm1009154; Eroglu C, 2010, NATURE, V468, P223, DOI 10.1038/nature09612; Guy J, 2001, NAT GENET, V27, P322, DOI 10.1038/85899; HAMBERGER A, 1992, NEUROPEDIATRICS, V23, P212, DOI 10.1055/s-2008-1071344; Horska A, 2009, ANN NEUROL, V65, P90, DOI 10.1002/ana.21562; JELLINGER K, 1988, ACTA NEUROPATHOL, V76, P142, DOI 10.1007/BF00688098; Kawai T, 2004, CIRC J, V68, P691, DOI 10.1253/circj.68.691; Kim SY, 2003, J NEUROCHEM, V87, P1485, DOI 10.1046/j.1471-4159.2003.02128.x; Lappalainen R, 1996, PEDIATR NEUROL, V15, P213, DOI 10.1016/S0887-8994(96)00218-4; Lehmann C, 2009, BRAIN RES, V1297, P1, DOI 10.1016/j.brainres.2009.08.070; Lioy DT, 2011, NATURE, V475, P497, DOI 10.1038/nature10214; Maezawa I, 2010, J NEUROSCI, V30, P5346, DOI 10.1523/JNEUROSCI.5966-09.2010; Maezawa I, 2009, J NEUROSCI, V29, P5051, DOI 10.1523/JNEUROSCI.0324-09.2009; Matsuishi T, 2011, BRAIN DEV-JPN, V33, P627, DOI 10.1016/j.braindev.2010.12.007; Naidu S, 2001, BRAIN DEV-JPN, V23, pS62, DOI 10.1016/S0387-7604(01)00381-3; Namihira M, 2004, FEBS LETT, V572, P184, DOI 10.1016/j.febslet.2004.07.029; Norenberg MD, 2007, METAB BRAIN DIS, V22, P219, DOI 10.1007/s11011-007-9062-5; Okabe Y, 2010, BRAIN RES, V1360, P17, DOI 10.1016/j.brainres.2010.08.090; Pan JW, 1999, J CHILD NEUROL, V14, P524, DOI 10.1177/088307389901400808; Ricciardi S, 2011, HUM MOL GENET, V20, P1182, DOI 10.1093/hmg/ddq563; Saywell W, 2006, BIOCHEM BIOPH RES CO, V340, P776, DOI 10.1016/j.bbrc.2005.12.080; Seifert G, 2006, NAT REV NEUROSCI, V7, P194, DOI 10.1038/nrn1870; Setoguchi H, 2006, J NEUROSCI RES, V84, P969, DOI 10.1002/jnr.21001; Sheldon AL, 2007, NEUROCHEM INT, V51, P333, DOI 10.1016/j.neuint.2007.03.012; Shigeri Y, 2004, BRAIN RES REV, V45, P250, DOI 10.1016/j.brainresrev.2004.04.004; Takahashi T, 2006, MOL THER, V14, P673, DOI 10.1016/j.ymthe.2006.05.010; Takeuchi H, 2005, J BIOL CHEM, V280, P10444, DOI 10.1074/jbc.M413863200; Tsujimura K, 2009, EXP NEUROL, V219, P104, DOI 10.1016/j.expneurol.2009.05.001; Ushikoshi H, 2005, LAB INVEST, V85, P862, DOI 10.1038/labinvest.3700282; Viola A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000157; Ward BC, 2009, J NEUROCHEM, V108, P361, DOI 10.1111/j.1471-4159.2008.05768.x; Yang YJ, 2010, GLIA, V58, P277, DOI 10.1002/glia.20922	43	63	65	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2012	7	4							e35354	10.1371/journal.pone.0035354	http://dx.doi.org/10.1371/journal.pone.0035354			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UD	22532851	Green Published, gold, Green Submitted			2022-12-25	WOS:000305339200059
J	Worni, M; Pietrobon, R; Zammar, GR; Shah, J; Yoo, B; Maldonato, M; Takemoto, S; Vail, TP				Worni, Mathias; Pietrobon, Ricardo; Zammar, Guilherme Roberto; Shah, Jatin; Yoo, Bryan; Maldonato, Mauro; Takemoto, Steven; Vail, Thomas P.			System Dynamics to Model the Unintended Consequences of Denying Payment for Venous Thromboembolism after Total Knee Arthroplasty	PLOS ONE			English	Article							DEEP-VEIN THROMBOSIS; PAY-FOR-PERFORMANCE; QUALITY-OF-LIFE; PULMONARY-EMBOLISM; ETHNIC DISPARITIES; NEVER EVENTS; TOTAL HIP; ORTHOPEDIC-SURGERY; SURGICAL-PATIENTS; SETTING ENDORSE	Background: The Hospital Acquired Condition Strategy (HACS) denies payment for venous thromboembolism (VTE) after total knee arthroplasty (TKA). The intention is to reduce complications and associated costs, while improving the quality of care by mandating VTE prophylaxis. We applied a system dynamics model to estimate the impact of HACS on VTE rates, and potential unintended consequences such as increased rates of bleeding and infection and decreased access for patients who might benefit from TKA. Methods and Findings: The system dynamics model uses a series of patient stocks including the number needing TKA, deemed ineligible, receiving TKA, and harmed due to surgical complication. The flow of patients between stocks is determined by a series of causal elements such as rates of exclusion, surgery and complications. The number of patients harmed due to VTE, bleeding or exclusion were modeled by year by comparing patient stocks that results in scenarios with and without HACS. The percentage of TKA patients experiencing VTE decreased approximately 3-fold with HACS. This decrease in VTE was offset by an increased rate of bleeding and infection. Moreover, results from the model suggest HACS could exclude 1.5% or half a million patients who might benefit from knee replacement through 2020. Conclusion: System dynamics modeling indicates HACS will have the intended consequence of reducing VTE rates. However, an unintended consequence of the policy might be increased potential harm resulting from over administration of prophylaxis, as well as exclusion of a large population of patients who might benefit from TKA.	[Takemoto, Steven; Vail, Thomas P.] Philip R Lee Inst Hlth Policy Studies, San Francisco, CA USA; [Worni, Mathias; Pietrobon, Ricardo] Duke Univ, Med Ctr, Dept Surg, Durham, NC 27710 USA; [Zammar, Guilherme Roberto] Pontificia Univ Catolica Parana, Curitiba, Parana, Brazil; [Takemoto, Steven] Univ Calif San Francisco, Dept Orthopaed Surg, San Francisco, CA USA; [Worni, Mathias; Pietrobon, Ricardo; Zammar, Guilherme Roberto; Shah, Jatin; Maldonato, Mauro] Duke Univ, Dept Surg, Res Res Grp, Durham, NC 27706 USA; [Yoo, Bryan] Stanford Univ, Palo Alto, CA 94304 USA; [Maldonato, Mauro] Univ Basilicata, Dept Stor Linguist & Antropol Sci, I-85100 Potenza, Italy	Duke University; Pontificia Universidade Catolica do Parana; University of California System; University of California San Francisco; Duke University; Stanford University; University of Basilicata	Vail, TP (corresponding author), Philip R Lee Inst Hlth Policy Studies, San Francisco, CA USA.	vailt@orthosurg.ucsf.edu	Shah, Jatin/B-6039-2011; Worni, Mathias/L-1556-2019; MALDONATO, NELSON MAURO/AAG-3791-2021; Vail, Thomas/S-6892-2019	Shah, Jatin/0000-0002-2457-491X; MALDONATO, NELSON MAURO/0000-0002-6401-2305; Pietrobon, Ricardo/0000-0003-2996-2193; Worni, Mathias/0000-0001-9422-431X				Abrams DB, 2010, AM J PREV MED, V38, pS351, DOI 10.1016/j.amepre.2009.12.011; ANDERSON FA, 1991, ARCH INTERN MED, V151, P933, DOI 10.1001/archinte.151.5.933; [Anonymous], 2008, FED REG, V78; [Anonymous], 2008, SURG GEN CALL ACT PR; Ballal RD, 2008, CURR MED RES OPIN, V24, P753, DOI 10.1185/030079908X273048; Bozzette SA, 2003, NEW ENGL J MED, V348, P416, DOI 10.1056/NEJMsa025075; Brown J, 2009, CLIN INFECT DIS, V49, P743, DOI 10.1086/604719; Byrne GJ, 1996, BRIT MED J, V313, P917; Centers for Medicare and Medicaid Services. Washington DUS-DoHHS, 2010, HOSP ACQ COND PRES A; Chien AT, 2007, MED CARE RES REV, V64, p283S, DOI 10.1177/1077558707305426; Cohen AT, 2008, LANCET, V371, P387, DOI 10.1016/S0140-6736(08)60202-0; Cushman M, 2004, AM J MED, V117, P19, DOI 10.1016/j.amjmed.2004.01.018; Durieux P, 2000, JAMA-J AM MED ASSOC, V283, P2816, DOI 10.1001/jama.283.21.2816; Duska LR, 2010, GYNECOL ONCOL, V116, P374, DOI 10.1016/j.ygyno.2009.10.069; Fry DE, 2010, ARCH SURG-CHICAGO, V145, P148, DOI 10.1001/archsurg.2009.277; Galat DD, 2008, J BONE JOINT SURG AM, V90A, P2331, DOI 10.2106/JBJS.G.01370; Geerts WH, 2008, CHEST, V133, p381S, DOI 10.1378/chest.08-0656; Goldhaber SZ, 2004, AM J CARDIOL, V93, P259, DOI 10.1016/j.amjcard.2003.09.057; Hawker GA, 2004, ARTHRIT RHEUM-ARTHR, V51, P635, DOI 10.1002/art.20524; Heit JA, 2006, J THROMB THROMBOLYS, V21, P23, DOI 10.1007/s11239-006-5572-y; Heit JA, 2002, ARCH INTERN MED, V162, P1245, DOI 10.1001/archinte.162.11.1245; Homer JB, 2006, AM J PUBLIC HEALTH, V96, P452, DOI 10.2105/AJPH.2005.062059; Johanson NA, 2009, J AM ACAD ORTHOP SUR, V17, P183, DOI 10.5435/00124635-200903000-00007; Jordan JM, 2007, J RHEUMATOL, V34, P172; Kahn SR, 2007, THROMB RES, V119, P145, DOI 10.1016/j.thromres.2006.01.011; KAHNEMAN D, 1979, ECONOMETRICA, V47, P263, DOI 10.2307/1914185; Kakkar AK, 2010, ANN SURG, V251, P330, DOI 10.1097/SLA.0b013e3181c0e58f; Kirsch M, 2009, AM J GASTROENTEROL, V104, P2671, DOI 10.1038/ajg.2009.196; Kohn LT, 2000, ERR IS HUMAN BUILDIN, Vxxi, P287; Losina E, 2009, ARCH INTERN MED, V169, P1113, DOI 10.1001/archinternmed.2009.136; McDonald R, 2009, J HEALTH POLIT POLIC, V34, P747, DOI 10.1215/03616878-2009-024; Millett C, 2008, ANN FAM MED, V6, P490, DOI 10.1370/afm.907; Millett C, 2007, PLOS MED, V4, P1087, DOI 10.1371/journal.pmed.0040191; Millett C, 2009, DIABETES CARE, V32, P404, DOI 10.2337/dc08-0912; NormanTaylor FH, 1996, J BONE JOINT SURG BR, V78B, P74, DOI 10.1302/0301-620X.78B1.0780074; Nutescu EA, 2008, ANN PHARMACOTHER, V42, P1216, DOI 10.1345/aph.1L135; Patel VP, 2007, J BONE JOINT SURG AM, V89A, P33, DOI 10.2106/JBJS.F.00163; Piazza G, 2009, CIRCULATION, V119, P2196, DOI 10.1161/CIRCULATIONAHA.108.841197; Pietrobon Ricardo, 2004, Health Qual Life Outcomes, V2, P59, DOI 10.1186/1477-7525-2-59; Porter M.E., 2006, REDEFINING HLTH CARE; Prandoni P., 2005, HEMATOLOGY AM SOC HE, P458; Pronovost PJ, 2008, JAMA-J AM MED ASSOC, V299, P2197, DOI 10.1001/jama.299.18.2197; Rasanen P, 2007, ACTA ORTHOP, V78, P108, DOI 10.1080/17453670610013501; Rogers SO, 2007, J AM COLL SURGEONS, V204, P1211, DOI 10.1016/j.jamcollsurg.2007.02.072; Rosenthal MB, 2007, JAMA-J AM MED ASSOC, V297, P740, DOI 10.1001/jama.297.7.740; Saleh K, 2002, J ORTHOP RES, V20, P506, DOI 10.1016/S0736-0266(01)00153-X; Shah J, 2009, ACAD MED, V84, P511, DOI 10.1097/ACM.0b013e31819a8c3c; Sorensen HT, 2007, LANCET, V370, P1773, DOI 10.1016/S0140-6736(07)61745-0; Sterman J., 2000, BUSINESS DYNAMICS, DOI DOI 10.4324/9781351152723-7; Sterman JD, 2006, AM J PUBLIC HEALTH, V96, P505, DOI 10.2105/AJPH.2005.066043; Streiff MB, 2009, JAMA-J AM MED ASSOC, V301, P1063, DOI 10.1001/jama.301.10.1063; Tooher R, 2005, ANN SURG, V241, P397, DOI 10.1097/01.sla.0000154120.96169.99; Turpie AGG, 2009, LANCET, V373, P1673, DOI 10.1016/S0140-6736(09)60734-0; Wachter RM, 2008, JT COMM J QUAL PATIE, V34, P116, DOI 10.1016/S1553-7250(08)34014-8; Werner RM, 2005, CIRCULATION, V111, P1257, DOI 10.1161/01.CIR.0000157729.59754.09; White RH, 2000, NEW ENGL J MED, V343, P1758, DOI 10.1056/NEJM200012143432403; Whitehouse JD, 2002, INFECT CONT HOSP EP, V23, P183, DOI 10.1086/502033	57	5	5	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2012	7	4							e30578	10.1371/journal.pone.0030578	http://dx.doi.org/10.1371/journal.pone.0030578			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959UD	22536313	Green Published, gold, Green Submitted			2022-12-25	WOS:000305339200003
J	Kang, SU; Shin, YS; Hwang, HS; Baek, SJ; Lee, SH; Kim, CH				Kang, Sung Un; Shin, Yoo Seob; Hwang, Hye Sook; Baek, Seung Joon; Lee, Seong-Ho; Kim, Chul-Ho			Tolfenamic Acid Induces Apoptosis and Growth Inhibition in Head and Neck Cancer: Involvement of NAG-1 Expression	PLOS ONE			English	Article							DRUG-ACTIVATED GENE; NONSTEROIDAL ANTIINFLAMMATORY DRUGS; TGF-BETA SUPERFAMILY; COLORECTAL-CANCER; CYCLOOXYGENASE-2 INHIBITORS; COLON-CANCER; CELLS; MEMBER; PROTEIN; RISK	Nonsteroidal anti-inflammatory drug-activated gene-1 (NAG-1) is induced by nonsteroidal anti-inflammatory drugs and possesses proapoptotic and antitumorigenic activities. Although tolfenamic acid (TA) induces apoptosis in head and neck cancer cells, the relationship between NAG-1 and TA has not been determined. This study investigated the induction of apoptosis in head and neck cancer cells treated by TA and the role of NAG-1 expression in this induction. TA reduced head and neck cancer cell viability in a dose-dependent manner and induced apoptosis. The induced apoptosis was coincident with the expression of NAG-1. Overexpression of NAG-1 enhanced the apoptotic effect of TA, whereas suppression of NAG-1 expression by small interfering RNA attenuated TA-induced apoptosis. TA significantly inhibited tumor formation as assessed by xenograft models, and this result accompanied the induction of apoptotic cells and NAG-1 expression in tumor tissue samples. Taken together, these results demonstrate that TA induces apoptosis via NAG-1 expression in head and neck squamous cell carcinoma, providing an additional mechanistic explanation for the apoptotic activity of TA.	[Kang, Sung Un; Shin, Yoo Seob; Hwang, Hye Sook; Kim, Chul-Ho] Ajou Univ, Sch Med, Dept Otolaryngol, Suwon 441749, South Korea; [Kang, Sung Un; Shin, Yoo Seob; Hwang, Hye Sook; Kim, Chul-Ho] Ajou Univ, Sch Med, Ctr Cell Death Regulating Biodrug, Suwon 441749, South Korea; [Baek, Seung Joon] Univ Tennessee, Coll Vet Med, Dept Biomed & Diagnost Sci, Knoxville, TN USA; [Lee, Seong-Ho] Univ Maryland, Dept Nutr & Food Sci, Coll Agr & Nat Resources, College Pk, MD 20742 USA	Ajou University; Ajou University; University of Tennessee System; University of Tennessee Knoxville; UT Institute of Agriculture; University System of Maryland; University of Maryland College Park	Kang, SU (corresponding author), Ajou Univ, Sch Med, Dept Otolaryngol, Suwon 441749, South Korea.	ostium@ajou.ac.kr	kang, sung un/AAK-8050-2021		Korea Research Foundation [KRF-013-2009-1-E00015]; CCRB through Gyeonggi Provincial Government, Korea (GRRC) [Ajou-2011-A03]	Korea Research Foundation(National Research Foundation of Korea); CCRB through Gyeonggi Provincial Government, Korea (GRRC)	This study was supported by the Korea Research Foundation Grant (KRF-013-2009-1-E00015) and CCRB through the "GRRC" Project of Gyeonggi Provincial Government, Korea (GRRC Ajou-2011-A03). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelrahim M, 2007, CANCER RES, V67, P3286, DOI 10.1158/0008-5472.CAN-06-3831; Abdelrahim M, 2006, J NATL CANCER I, V98, P855, DOI 10.1093/jnci/djj232; Baek SJ, 2006, PROG LIPID RES, V45, P1, DOI 10.1016/j.plipres.2005.10.001; Baek SJ, 2005, MOL PHARMACOL, V67, P356, DOI 10.1124/mol.104.005108; Baek SJ, 2004, CARCINOGENESIS, V25, P2425, DOI 10.1093/carcin/bgh255; Baek SJ, 2004, J BIOL CHEM, V279, P6883, DOI 10.1074/jbc.M305295200; Baek SJ, 2002, J PHARMACOL EXP THER, V301, P1126, DOI 10.1124/jpet.301.3.1126; Baek SJ, 2002, CARCINOGENESIS, V23, P425, DOI 10.1093/carcin/23.3.425; Baek SJ, 2001, MOL PHARMACOL, V59, P901, DOI 10.1124/mol.59.4.901; Bootcov MR, 1997, P NATL ACAD SCI USA, V94, P11514, DOI 10.1073/pnas.94.21.11514; Eling TE, 2006, J BIOCHEM MOL BIOL, V39, P649; Fairlie WD, 1999, J LEUKOCYTE BIOL, V65, P2, DOI 10.1002/jlb.65.1.2; Gately S, 2004, SEMIN ONCOL, V31, P2, DOI 10.1053/j.seminoncol.2004.03.040; GIOVANNUCCI E, 1995, NEW ENGL J MED, V333, P609, DOI 10.1056/NEJM199509073331001; Half Elizabeth E, 2006, Future Oncol, V2, P697; HANSEN PE, 1994, PHARMACOL TOXICOL, V75, P81, DOI 10.1111/j.1600-0773.1994.tb02005.x; He TC, 1999, CELL, V99, P335, DOI 10.1016/S0092-8674(00)81664-5; Kim JH, 2008, INT J CANCER, V122, P1765, DOI 10.1002/ijc.23302; Kim JS, 2005, MOL CANCER THER, V4, P487; Kim JH, 2010, J CLIN BIOCHEM NUTR, V47, P74, DOI 10.3164/jcbn.10-02; Kim KS, 2004, BIOCHEM BIOPH RES CO, V325, P1298, DOI 10.1016/j.bbrc.2004.10.176; Kim KS, 2002, GASTROENTEROLOGY, V122, P1388, DOI 10.1053/gast.2002.32972; Lawton LN, 1997, GENE, V203, P17, DOI 10.1016/S0378-1119(97)00485-X; Lee SH, 2008, MOL CANCER THER, V7, P3739, DOI 10.1158/1535-7163.MCT-08-0548; Lee SH, 2005, BIOCHEM BIOPH RES CO, V328, P63, DOI 10.1016/j.bbrc.2004.12.138; MARTINEZ ME, 1995, CANCER EPIDEM BIOMAR, V4, P703; Papineni S, 2009, CARCINOGENESIS, V30, P1193, DOI 10.1093/carcin/bgp092; Paralkar VM, 1998, J BIOL CHEM, V273, P13760, DOI 10.1074/jbc.273.22.13760; Peleg II, 1996, DIGEST DIS SCI, V41, P1319, DOI 10.1007/BF02088554; Reddy BS, 2000, CANCER RES, V60, P293; Shim M, 2005, J BIOL CHEM, V280, P18636, DOI 10.1074/jbc.M414613200; Siegel R, 2011, CA-CANCER J CLIN, V61, P212, DOI 10.3322/caac.20121; SPITZ MR, 1994, SEMIN ONCOL, V21, P281; Taketo MM, 1998, JNCI-J NATL CANCER I, V90, P1609, DOI 10.1093/jnci/90.21.1609; Taketo MM, 1998, J NATL CANCER I, V90, P1529, DOI 10.1093/jnci/90.20.1529; Tarnawski AS, 2003, J MOL MED, V81, P627, DOI 10.1007/s00109-003-0479-y; Williams CS, 1999, ONCOGENE, V18, P7908, DOI 10.1038/sj.onc.1203286; Wilson LC, 2003, INT J CANCER, V105, P747, DOI 10.1002/ijc.11173; Yamaguchi K, 2006, MOL CANCER THER, V5, P1352, DOI 10.1158/1535-7163.MCT-05-0528; Yuan ZP, 2006, CLIN CANCER RES, V12, P3193, DOI 10.1158/1078-0432.CCR-05-2365; Zhang L, 2000, SCIENCE, V290, P989, DOI 10.1126/science.290.5493.989	41	24	25	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2012	7	4							e34988	10.1371/journal.pone.0034988	http://dx.doi.org/10.1371/journal.pone.0034988			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TL	22536345	Green Published, gold			2022-12-25	WOS:000305336200018
J	Pauly, D; Worbs, S; Kirchner, S; Shatohina, O; Dorner, MB; Dorner, BG				Pauly, Diana; Worbs, Sylvia; Kirchner, Sebastian; Shatohina, Olena; Dorner, Martin B.; Dorner, Brigitte G.			Real-Time Cytotoxicity Assay for Rapid and Sensitive Detection of Ricin from Complex Matrices	PLOS ONE			English	Article							RIBOSOME-INACTIVATING PROTEINS; TANDEM MASS-SPECTROMETRY; BIOLOGICAL-ACTIVITY; FOOD MATRICES; LECTINS ABRIN; A-CHAIN; TOXICITY; ANTIBODY; TOXINS; AGGLUTININ	Background: In the context of a potential bioterrorist attack sensitive and fast detection of functionally active toxins such as ricin from complex matrices is necessary to be able to start timely countermeasures. One of the functional detection methods currently available for ricin is the endpoint cytotoxicity assay, which suffers from a number of technical deficits. Methodology/Findings: This work describes a novel online cytotoxicity assay for the detection of active ricin and Ricinus communis agglutinin, that is based on a real-time cell electronic sensing system and impedance measurement. Characteristic growth parameters of Vero cells were monitored online and used as standardized viability control. Upon incubation with toxin the cell status and the cytotoxic effect were visualized using a characteristic cell index-time profile. For ricin, tested in concentrations of 0.06 ng/mL or above, a concentration-dependent decrease of cell index correlating with cytotoxicity was recorded between 3.5 h and 60 h. For ricin, sensitive detection was determined after 24 h, with an IC50 of 0.4 ng/mL (for agglutinin, an IC50 of 30 ng/mL was observed). Using functionally blocking antibodies, the specificity for ricin and agglutinin was shown. For detection from complex matrices, ricin was spiked into several food matrices, and an IC50 ranging from 5.6 to 200 ng/mL was observed. Additionally, the assay proved to be useful in detecting active ricin in environmental sample materials, as shown for organic fertilizer containing R. communis material. Conclusions/Significance: The cell-electrode impedance measurement provides a sensitive online detection method for biologically active cytotoxins such as ricin. As the cell status is monitored online, the assay can be standardized more efficiently than previous approaches based on endpoint measurement. More importantly, the real-time cytotoxicity assay provides a fast and easy tool to detect active ricin in complex sample matrices.	[Pauly, Diana; Worbs, Sylvia; Kirchner, Sebastian; Shatohina, Olena; Dorner, Martin B.; Dorner, Brigitte G.] Robert Koch Inst, Ctr Biol Secur Microbial Toxins, Berlin, Germany	Robert Koch Institute	Pauly, D (corresponding author), Robert Koch Inst, Ctr Biol Secur Microbial Toxins, Berlin, Germany.	DornerB@rki.de	Dorner, Martin B/C-5703-2013; Kirchner, Sebastian/AAF-6646-2019	Dorner, Martin B/0000-0002-8176-797X; Kirchner, Sebastian/0000-0003-0415-5352; Dorner, Brigitte/0000-0002-5100-2546	Federal Ministry of Education and Research [13N9601]	Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF))	This work was supported by grants from the Federal Ministry of Education and Research to BGD (BiGRUDI project, 13N9601; http://www.bmbf.de/en/index.php). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Albretsen JC, 2000, J AM ANIM HOSP ASSOC, V36, P229, DOI 10.5326/15473317-36-3-229; Atienza JM, 2005, J BIOMOL SCREEN, V10, P795, DOI 10.1177/1087057105279635; Audi J, 2005, JAMA-J AM MED ASSOC, V294, P2342, DOI 10.1001/jama.294.18.2342; Bagaria A, 2006, J BIOL CHEM, V281, P34465, DOI 10.1074/jbc.M601777200; BALINT GA, 1974, TOXICOLOGY, V2, P77, DOI 10.1016/0300-483X(74)90044-4; Becher F, 2007, ANAL CHEM, V79, P659, DOI 10.1021/ac061498b; Bevilacqua VLH, 2010, ANAL CHEM, V82, P798, DOI 10.1021/ac9025972; Beyer NH, 2009, CLIN TOXICOL, V47, P219, DOI 10.1080/15563650802716521; Bradberry Sally M., 2003, Toxicological Reviews, V22, P65, DOI 10.2165/00139709-200322010-00007; Brzezinski JL, 2007, J FOOD PROTECT, V70, P2377, DOI 10.4315/0362-028X-70.10.2377; COLOMBATTI M, 1987, J IMMUNOL, V138, P3339; Drociuk Dan, 2009, J S C Med Assoc, V105, P94; Endo Y, 1988, Nucleic Acids Symp Ser, P139; FODSTAD O, 1976, BRIT J CANCER, V34, P418, DOI 10.1038/bjc.1976.187; Garber EAE, 2008, J FOOD PROTECT, V71, P1875, DOI 10.4315/0362-028X-71.9.1875; Griffiths GD, 2007, INHAL TOXICOL, V19, P873, DOI 10.1080/08958370701432124; GRIFFITHS GD, 1994, TOXICOLOGY, V90, P11, DOI 10.1016/0300-483X(94)90201-1; Groseclose S. L., 2000, Morbidity and Mortality Weekly Report, V49, P1; Hale ML, 2001, PHARMACOL TOXICOL, V88, P255, DOI 10.1034/j.1600-0773.2001.d01-113.x; Halter M, 2009, ASSAY DRUG DEV TECHN, V7, DOI 10.1089/adt.2009.192; He XH, 2008, J FOOD PROTECT, V71, P2053, DOI 10.4315/0362-028X-71.10.2053; Hines HB, 2004, ANAL BIOCHEM, V330, P119, DOI 10.1016/j.ab.2004.03.046; Hong IH, 2011, EXP TOXICOL PATHOL, V63, P113, DOI 10.1016/j.etp.2009.10.004; Jang Hae-Young, 1993, Korean Biochemical Journal, V26, P98; Kalb SR, 2009, ANAL CHEM, V81, P2037, DOI 10.1021/ac802769s; Keener WK, 2006, ANAL BIOCHEM, V357, P200, DOI 10.1016/j.ab.2006.07.005; Kull S, 2010, ANAL CHEM, V82, P2916, DOI 10.1021/ac902909r; Langer M, 1996, ANAL BIOCHEM, V243, P150, DOI 10.1006/abio.1996.0493; LIN JY, 1986, TOXICON, V24, P757, DOI 10.1016/0041-0101(86)90100-5; LIN TTS, 1980, EUR J BIOCHEM, V105, P453; LORD JM, 1994, FASEB J, V8, P201, DOI 10.1096/fasebj.8.2.8119491; Lord Michael J., 2003, Toxicological Reviews, V22, P53, DOI 10.2165/00139709-200322010-00006; Lundholt BK, 2003, J BIOMOL SCREEN, V8, P566, DOI 10.1177/1087057103256465; McGrath SC, 2011, ANAL CHEM, V83, P2897, DOI 10.1021/ac102571f; McGuinness CR, 2006, INFECT IMMUN, V74, P3463, DOI 10.1128/IAI.00324-06; Oda T, 1997, BIOSCI BIOTECH BIOCH, V61, P291, DOI 10.1271/bbb.61.291; OLSNES S, 1974, NATURE, V249, P627, DOI 10.1038/249627a0; Pauly D, 2009, POULTRY SCI, V88, P281, DOI 10.3382/ps.2008-00323; Pauly D, 2009, ANALYST, V134, P2028, DOI 10.1039/b911525k; Pelat T, 2009, BMC BIOTECHNOL, V9, DOI 10.1186/1472-6750-9-60; Pfuller U., 1988, LECTINS BIOL BIOCH C, V6, P299; Roday S, 2008, J BIOCHEM BIOPH METH, V70, P945, DOI 10.1016/j.jprot.2007.12.010; Roels S, 2010, J VET DIAGN INVEST, V22, P466, DOI 10.1177/104063871002200325; Schieltz DM, 2011, FORENSIC SCI INT, V209, P70, DOI 10.1016/j.forsciint.2010.12.013; Sweeney EC, 1997, PROTEINS, V28, P586, DOI 10.1002/(SICI)1097-0134(199708)28:4<586::AID-PROT12>3.0.CO;2-C; Thullier P, 2009, CLIN TOXICOL, V47, P643, DOI 10.1080/15563650903140415; Vang O., 1986, LECTINS BIOL BIOCH C, V6, P637; Vervecken W, 2000, INT J BIOCHEM CELL B, V32, P317, DOI 10.1016/S1357-2725(99)00135-1; Wahome PG, 2010, TOXICON, V56, P313, DOI 10.1016/j.toxicon.2010.03.016; Weingart OG, 2010, APPL ENVIRON MICROB, V76, P3293, DOI 10.1128/AEM.02937-09; Worbs S, 2011, TOXINS, V3, P1332, DOI 10.3390/toxins3101332; Zhan JB, 2003, TOXICOLOGY, V186, P119, DOI 10.1016/S0300-483X(02)00726-6	52	24	28	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2012	7	4							e35360	10.1371/journal.pone.0035360	http://dx.doi.org/10.1371/journal.pone.0035360			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TL	22532852	Green Published, gold, Green Submitted, Green Accepted			2022-12-25	WOS:000305336200035
J	Cacquevel, M; Aeschbach, L; Houacine, J; Fraering, PC				Cacquevel, Matthias; Aeschbach, Lorene; Houacine, Jemila; Fraering, Patrick C.			Alzheimer's Disease-Linked Mutations in Presenilin-1 Result in a Drastic Loss of Activity in Purified gamma-Secretase Complexes	PLOS ONE			English	Article							AMYLOID-PRECURSOR-PROTEIN; BETA-PROTEIN; TRANSGENIC MICE; MUTANT PRESENILIN-1; TRANSMEMBRANE ASPARTATES; INTRACELLULAR DOMAINS; MISSENSE MUTATIONS; SENILE PLAQUES; APP MUTATIONS; IN-VIVO	Background: Mutations linked to early onset, familial forms of Alzheimer's disease (FAD) are found most frequently in PSEN1, the gene encoding presenilin-1 (PS1). Together with nicastrin (NCT), anterior pharynx-defective protein 1 (APH1), and presenilin enhancer 2 (PEN2), the catalytic subunit PS1 constitutes the core of the c-secretase complex and contributes to the proteolysis of the amyloid precursor protein (APP) into amyloid-beta (A beta) peptides. Although there is a growing consensus that FAD-linked PS1 mutations affect Ab production by enhancing the A beta 1-42/A beta 1-40 ratio, it remains unclear whether and how they affect the generation of APP intracellular domain (AICD). Moreover, controversy exists as to how PS1 mutations exert their effects in different experimental systems, by either increasing A beta 1-42 production, decreasing A beta 1-40 production, or both. Because it could be explained by the heterogeneity in the composition of gamma-secretase, we purified to homogeneity complexes made of human NCT, APH1aL, PEN2, and the pathogenic PS1 mutants L166P, Delta E9, or P436Q. Methodology/Principal Findings: We took advantage of a mouse embryonic fibroblast cell line lacking PS1 and PS2 to generate different stable cell lines overexpressing human gamma-secretase complexes with different FAD-linked PS1 mutations. A multi-step affinity purification procedure was used to isolate semi-purified or highly purified gamma-secretase complexes. The functional characterization of these complexes revealed that all PS1 FAD-linked mutations caused a loss of gamma-secretase activity phenotype, in terms of A beta 1-40, A beta 1-42 and APP intracellular domain productions in vitro. Conclusion/Significance: Our data support the view that PS1 mutations lead to a strong gamma-secretase loss-of-function phenotype and an increased A beta 1-42/A beta 1-40 ratio, two mechanisms that are potentially involved in the pathogenesis of Alzheimer's disease.	[Cacquevel, Matthias; Aeschbach, Lorene; Houacine, Jemila; Fraering, Patrick C.] Ecole Polytech Fed Lausanne, Brain Mind Inst, Lab Mol & Cellular Biol Alzheimers Dis, Lausanne, Switzerland	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	Cacquevel, M (corresponding author), Ecole Polytech Fed Lausanne, Brain Mind Inst, Lab Mol & Cellular Biol Alzheimers Dis, Lausanne, Switzerland.	patrick.fraering@epfl.ch		Fraering, Patrick/0000-0002-5841-5327	Swiss National Foundation [31003A_134938/1]; National Centre for Competence in Research ("Neuronal Plasticity and Repair"); Strauss foundation	Swiss National Foundation(Swiss National Science Foundation (SNSF)); National Centre for Competence in Research ("Neuronal Plasticity and Repair"); Strauss foundation	This work was supported by the Swiss National Foundation (to and LA and PCF; grant 31003A_134938/1) and the National Centre for Competence in Research ("Neuronal Plasticity and Repair" (to JH and PCF)), and the Strauss foundation (to PCF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beel AJ, 2008, CELL MOL LIFE SCI, V65, P1311, DOI 10.1007/s00018-008-7462-2; Bentahir M, 2006, J NEUROCHEM, V96, P732, DOI 10.1111/j.1471-4159.2005.03578.x; Borchelt DR, 2002, NEUROBIOL AGING, V23, P171, DOI 10.1016/S0197-4580(01)00280-9; Bot N, 2010, J BIOL CHEM; BURDICK D, 1992, J BIOL CHEM, V267, P546; Cacquevel M, 2008, J NEUROCHEM, V104, P210, DOI 10.1111/j.1471-4159.2007.05041.x; Chen FS, 2006, NATURE, V440, P1208, DOI 10.1038/nature04667; Citron M, 1998, NEUROBIOL DIS, V5, P107, DOI 10.1006/nbdi.1998.0183; Citron M, 1997, NAT MED, V3, P67, DOI 10.1038/nm0197-67; CITRON M, 1992, NATURE, V360, P672, DOI 10.1038/360672a0; Delacourte A, 2002, NEUROLOGY, V59, P398, DOI 10.1212/WNL.59.3.398; Dowjat WK, 2004, J ALZHEIMERS DIS, V6, P31; Duff K, 1996, NATURE, V383, P710, DOI 10.1038/383710a0; Dumanchin Cecile, 2006, Hum Mutat, V27, P1063, DOI 10.1002/humu.9458; Esler WP, 2000, NAT CELL BIOL, V2, P428, DOI 10.1038/35017062; Farmery MR, 2003, J BIOL CHEM, V278, P24277, DOI 10.1074/jbc.M211992200; Fraering PC, 2004, BIOCHEMISTRY-US, V43, P9774, DOI 10.1021/bi0494976; Fraering PC, 2004, BIOCHEMISTRY-US, V43, P323, DOI 10.1021/bi035748j; HAASS C, 1995, NAT MED, V1, P1291, DOI 10.1038/nm1295-1291; He G, 2010, NATURE, V467, P95, DOI 10.1038/nature09325; Heilig EA, 2010, J BIOL CHEM; Herreman A, 2003, J CELL SCI, V116, P1127, DOI 10.1242/jcs.00292; Herreman A, 1999, P NATL ACAD SCI USA, V96, P11872, DOI 10.1073/pnas.96.21.11872; Holcomb L, 1998, NAT MED, V4, P97, DOI 10.1038/nm0198-097; Houlden H, 2000, ANN NEUROL, V48, P806, DOI 10.1002/1531-8249(200011)48:5<806::AID-ANA18>3.0.CO;2-F; IWATSUBO T, 1994, NEURON, V13, P45, DOI 10.1016/0896-6273(94)90458-8; Jan A, 2008, J BIOL CHEM, V283, P28176, DOI 10.1074/jbc.M803159200; JARRETT JT, 1993, BIOCHEMISTRY-US, V32, P4693, DOI 10.1021/bi00069a001; Kimberly WT, 2000, J BIOL CHEM, V275, P3173, DOI 10.1074/jbc.275.5.3173; Kumar-Singh S, 2006, HUM MUTAT, V27, P686, DOI 10.1002/humu.20336; Lazarov VK, 2006, P NATL ACAD SCI USA, V103, P6889, DOI 10.1073/pnas.0602321103; Lichtenthaler SF, 1999, FEBS LETT, V453, P288, DOI 10.1016/S0014-5793(99)00730-9; Liu Q, 2007, NEURON, V56, P66, DOI 10.1016/j.neuron.2007.08.008; Mehta ND, 1998, ANN NEUROL, V43, P256, DOI 10.1002/ana.410430217; Moehlmann T, 2002, P NATL ACAD SCI USA, V99, P8025, DOI 10.1073/pnas.112686799; Munter LM, 2010, J BIOL CHEM, V285, P21636, DOI 10.1074/jbc.M109.088005; Murayama O, 1999, NEUROSCI LETT, V265, P61, DOI 10.1016/S0304-3940(99)00187-1; Nelson O, 2007, J CLIN INVEST, V117, P1230, DOI 10.1172/JCI30447; Nyabi O, 2003, J BIOL CHEM, V278, P43430, DOI 10.1074/jbc.M306957200; Osenkowski P, 2009, J MOL BIOL, V385, P642, DOI 10.1016/j.jmb.2008.10.078; Pardossi-Piquard R, 2005, NEURON, V46, P541, DOI 10.1016/j.neuron.2005.04.008; Parks AL, 2007, TRENDS GENET, V23, P140, DOI 10.1016/j.tig.2007.01.008; Qi Y, 2003, BIOCHEMISTRY-US, V42, P1042, DOI 10.1021/bi0267590; Qi-Takahara Y, 2005, J NEUROSCI, V25, P436, DOI 10.1523/JNEUROSCI.1575-04.2005; Radde R, 2006, EMBO REP, V7, P940, DOI 10.1038/sj.embor.7400784; ROGAEV EI, 1995, NATURE, V376, P775, DOI 10.1038/376775a0; SALMON P, 2007, CURR PROTOC HUM GENE, pCH12, DOI DOI 10.1002/0471142905.HG0808S52; Saura CA, 2004, NEURON, V42, P23, DOI 10.1016/S0896-6273(04)00182-5; Scheuner D, 1996, NAT MED, V2, P864, DOI 10.1038/nm0896-864; Schor NF, 2011, ANN NEUROL, V69, P237, DOI 10.1002/ana.22365; Serneels L, 2009, SCIENCE, V324, P639, DOI 10.1126/science.1171176; SHERRINGTON R, 1995, NATURE, V375, P754, DOI 10.1038/375754a0; Siman R, 2000, J NEUROSCI, V20, P8717; Steiner H, 1999, J BIOL CHEM, V274, P7615, DOI 10.1074/jbc.274.12.7615; Thinakaran G, 1996, NEURON, V17, P181, DOI 10.1016/S0896-6273(00)80291-3; Veeraraghavalu K, 2010, J NEUROSCI, V30, P6903, DOI 10.1523/JNEUROSCI.0527-10.2010; Wakabayashi T, 2008, PHYSIOLOGY, V23, P194, DOI 10.1152/physiol.00009.2008; Weihofen A, 2003, TRENDS CELL BIOL, V13, P71, DOI 10.1016/S0962-8924(02)00041-7; Wolfe MS, 2012, J NEUROCHEM, V120, P89, DOI 10.1111/j.1471-4159.2011.07501.x; Wolfe MS, 1999, NATURE, V398, P513, DOI 10.1038/19077; Xu XM, 2009, J ALZHEIMERS DIS, V16, P211, DOI 10.3233/JAD-2009-0957	61	55	56	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2012	7	4							e35133	10.1371/journal.pone.0035133	http://dx.doi.org/10.1371/journal.pone.0035133			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959XD	22529981	Green Published, gold, Green Submitted			2022-12-25	WOS:000305350600060
J	Mani, RJ; Reichard, MV; Morton, RJ; Kocan, KM; Clinkenbeard, KD				Mani, Rinosh J.; Reichard, Mason V.; Morton, Rebecca J.; Kocan, Katherine M.; Clinkenbeard, Kenneth D.			Biology of Francisella tularensis Subspecies holarctica Live Vaccine Strain in the Tick Vector Dermacentor variabilis	PLOS ONE			English	Article							ANAPLASMA-MARGINALE RICKETTSIALES; POLYMERASE-CHAIN-REACTION; ACARI IXODIDAE; UNITED-STATES; TRANSMISSION; ANDERSONI; TULAREMIA; ENDOSYMBIONTS; SALIVA; HOST	Background: The gamma-proteobacterium Francisella tularensis is the etiologic agent of seasonal tick-transmitted tularemia epizootics in rodents and rabbits and of incidental infections in humans. The biology of F. tularensis in its tick vectors has not been fully described, particularly with respect to its quanta and duration of colonization, tissue dissemination, and transovarial transmission. A systematic study of the colonization of Dermacentor variabilis by the F. tularensis subsp. holarctica live vaccine strain (LVS) was undertaken to better understand whether D. variabilis may serve as an inter-epizootic reservoir for F. tularensis. Methodology/Principal Findings: Colony-reared larva, nymph, and adult D. variabilis were artificially fed LVS via glass capillary tubes fitted over the tick mouthparts, and the level of colonization determined by microbial culture. Larvae and nymphs were initially colonized with 8.8 +/- 0.8x10(1) and 1.1 +/- 0.03x10(3) CFU/tick, respectively. Post-molting, a significant increase in colonization of both molted nymphs and adults occurred, and LVS persisted in 42% of molted adult ticks at 126 days post-capillary tube feeding. In adult ticks, LVS initially colonized the gut, disseminated to hemolymph and salivary glands by 21 days, and persisted up to 165 days. LVS was detected in the salivary secretions of adult ticks after four days post intra-hemocoelic inoculation, and LVS recovered from salivary gland was infectious to mice with an infectious dose 50% of 3 CFU. LVS in gravid female ticks colonized via the intra-hemocoelic route disseminated to the ovaries and then to the oocytes, but the pathogen was not recovered from the subsequently-hatched larvae. Conclusions/Significance: This study demonstrates that D. variabilis can be efficiently colonized with F. tularensis using artificial methods. The persistence of F. tularensis in D. variabilis suggests that this tick species may be involved in the maintenance of enzootic foci of tularemia in the central United States.	[Mani, Rinosh J.; Reichard, Mason V.; Morton, Rebecca J.; Kocan, Katherine M.; Clinkenbeard, Kenneth D.] Oklahoma State Univ, Dept Vet Pathobiol, Ctr Vet Hlth Sci, Stillwater, OK 74078 USA	Oklahoma State University System; Oklahoma State University - Stillwater	Mani, RJ (corresponding author), Oklahoma State Univ, Dept Vet Pathobiol, Ctr Vet Hlth Sci, Stillwater, OK 74078 USA.	ken.clinkenbeard@okstate.edu			College of Veterinary Medicine, Oklahoma State University	College of Veterinary Medicine, Oklahoma State University	The study was funded by the College of Veterinary Medicine, Oklahoma State University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Assal N R, 1968, J Okla State Med Assoc, V61, P120; Baldridge GD, 2009, J MED ENTOMOL, V46, P625, DOI 10.1603/033.046.0330; BELL JF, 1945, J INFECT DIS, V76, P83, DOI 10.1093/infdis/76.2.83; Bowman AS, 1997, MED VET ENTOMOL, V11, P277, DOI 10.1111/j.1365-2915.1997.tb00407.x; Broadwater AH, 2002, J MED ENTOMOL, V39, P285, DOI 10.1603/0022-2585-39.2.285; Burg JG, 2001, MED VET ENTOMOL, V15, P413, DOI 10.1046/j.0269-283x.2001.00329.x; BURGDORFER W, 1988, ANN NY ACAD SCI, V539, P172, DOI 10.1111/j.1749-6632.1988.tb31851.x; Eisen L, 2007, J MED ENTOMOL, V44, P389, DOI 10.1603/0022-2585(2007)44[389:ACFRRO]2.0.CO;2; Eisen RJ, 2008, AM J TROP MED HYG, V78, P586, DOI 10.4269/ajtmh.2008.78.586; Eisen RJ, 2009, AM J TROP MED HYG, V80, P259, DOI 10.4269/ajtmh.2009.80.259; FRANCIS E., 1927, Public Health Reports, V42, P2763, DOI 10.2307/4578567; GAGE KL, 1992, MOL CELL PROBE, V6, P333, DOI 10.1016/0890-8508(92)90010-U; Goethert HK, 2010, TICKS TICK-BORNE DIS, V1, P66, DOI 10.1016/j.ttbdis.2010.01.001; Goodman J., 2005, TICK BORNE DIS HUMAN; HOPLA C E, 1960, South Med J, V53, P92, DOI 10.1097/00007611-196001000-00020; HOPLA CE, 1953, AM J HYG, V58, P101, DOI 10.1093/oxfordjournals.aje.a119585; Horka H, 2009, INT J MED MICROBIOL, V299, P373, DOI 10.1016/j.ijmm.2008.10.009; JAWORSKI DC, 1995, J INSECT PHYSIOL, V41, P369, DOI 10.1016/0022-1910(94)00107-R; JELLISON WL, 1950, PUBLIC HEALTH REP, V65, P1321, DOI 10.2307/4587498; JELLISON WL, 1974, TULAREMIA N AM; Kiszewski AE, 2001, ANNU REV ENTOMOL, V46, P167, DOI 10.1146/annurev.ento.46.1.167; Kocan KM, 2005, J MED ENTOMOL, V42, P864, DOI 10.1603/0022-2585(2005)042[0864:CTFSFS]2.0.CO;2; Kollars TM, 2000, EXP APPL ACAROL, V24, P631, DOI 10.1023/A:1026566301325; Kopacek P, 2010, ADV EXP MED BIOL, V708, P137; Krocova Z, 2003, J PARASITOL, V89, P14, DOI 10.1645/0022-3395(2003)089[0014:TSGEAP]2.0.CO;2; Lennette EH, 1964, DIAGNOSTIC PROCEDURE; Madden RD, 2004, EXP APPL ACAROL, V32, P129, DOI 10.1023/B:APPA.0000018316.80224.54; Maier TM, 2004, APPL ENVIRON MICROB, V70, P7511, DOI 10.1128/AEM.70.12.7511-7519.2004; Niebylski ML, 1997, APPL ENVIRON MICROB, V63, P3933, DOI 10.1128/AEM.63.10.3933-3940.1997; PHILIP C. B., 1934, Public Health Reports, V49, P386, DOI 10.2307/4581119; Reese SM, 2011, J MED ENTOMOL, V48, P884, DOI 10.1603/ME11005; Reese SM, 2010, AM J TROP MED HYG, V83, P645, DOI 10.4269/ajtmh.2010.10-0127; Reif KE, 2011, INFECT IMMUN, V79, P4941, DOI 10.1128/IAI.05676-11; Scofield R H, 1992, J Okla State Med Assoc, V85, P165; Scoles GA, 2004, J MED ENTOMOL, V41, P277, DOI 10.1603/0022-2585-41.3.277; Sjostedt A, 2007, ANN NY ACAD SCI, V1105, P1, DOI 10.1196/annals.1409.009; SONENSHINE DE, 1972, ANN ENTOMOL SOC AM, V65, P1164, DOI 10.1093/aesa/65.5.1164; Sonenshine DE., 1991, BIOL TICKS; Staples JE, 2006, EMERG INFECT DIS, V12, P1113; STICH RW, 1993, J MED ENTOMOL, V30, P789, DOI 10.1093/jmedent/30.4.789; Sun LV, 2000, J INVERTEBR PATHOL, V76, P301, DOI 10.1006/jipa.2000.4983; Versage JL, 2003, J CLIN MICROBIOL, V41, P5492, DOI 10.1128/JCM.41.12.5492-5499.2003; Zivkovic Z, 2010, BMC IMMUNOL, V11, DOI 10.1186/1471-2172-11-7	43	12	12	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2012	7	4							e35441	10.1371/journal.pone.0035441	http://dx.doi.org/10.1371/journal.pone.0035441			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959XD	22530023	Green Published, gold, Green Submitted			2022-12-25	WOS:000305350600083
J	Neves, D; Estrozi, LF; Job, V; Gabel, F; Schoehn, G; Dessen, A				Neves, David; Estrozi, Leandro F.; Job, Viviana; Gabel, Frank; Schoehn, Guy; Dessen, Andrea			Conformational States of a Bacterial alpha(2)-Macroglobulin Resemble Those of Human Complement C3	PLOS ONE			English	Article							HUMAN ALPHA-2-MACROGLOBULIN; ALPHA-MACROGLOBULINS; CRYSTAL-STRUCTURE; COMPONENT C3; PROTEIN; SCATTERING; DOMAIN; MACROMOLECULES; ORGANIZATION; ACTIVATION	alpha(2) macroglobulins (alpha Ms-2) are broad-spectrum protease inhibitors that play essential roles in the innate immune system of eukaryotic species. These large, multi-domain proteins are characterized by a broad-spectrum bait region and an internal thioester, which, upon cleavage, becomes covalently associated to the target protease, allowing its entrapment by a large conformational modification. Notably, alpha Ms-2 are part of a larger protein superfamily that includes proteins of the complement system, such as C3, a multi-domain macromolecule which is also characterized by an internal thioester-carrying domain and whose activation represents the pivotal step in the complement cascade. Recently, alpha M-2/C3-like genes were identified in a large number of bacterial genomes, and the Escherichia coli alpha M-2 homolog (ECAM) was shown to be activated by proteases. In this work, we have structurally characterized ECAM by electron microscopy and small angle scattering (SAXS) techniques. ECAM is an elongated, flexible molecule with overall similarities to C3 in its inactive form; activation by methylamine, chymotrypsin, or elastase induces a conformational modification reminiscent of the one undergone by the transformation of C3 into its active form, C3b. In addition, the proposed C-terminus of ECAM displays high flexibility and different conformations, and could be the recognition site for partner macromolecules. This work sheds light on a potential bacterial defense mechanism that mimics structural rearrangements essential for activation of the complement cascade in eukaryotes, and represents a possible novel target for the development of antibacterials.	[Neves, David; Estrozi, Leandro F.; Job, Viviana; Gabel, Frank; Schoehn, Guy; Dessen, Andrea] Univ Grenoble 1, IBS, Grenoble, France; [Neves, David; Estrozi, Leandro F.; Job, Viviana; Gabel, Frank; Schoehn, Guy; Dessen, Andrea] CNRS, Grenoble, France; [Neves, David; Estrozi, Leandro F.; Job, Viviana; Gabel, Frank; Schoehn, Guy; Dessen, Andrea] CEA, Grenoble, France; [Schoehn, Guy] Unit Virus Host Cell Interact UMI 3265 UJF EMBL C, Grenoble, France	UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); CEA; European Molecular Biology Laboratory (EMBL); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA)	Neves, D (corresponding author), Univ Grenoble 1, IBS, Grenoble, France.	andrea.dessen@ibs.fr	Estrozi, Leandro F/A-6578-2013	Estrozi, Leandro F/0000-0003-2548-2547; Gabel, Frank/0000-0003-3446-2601; Dessen, Andrea/0000-0001-6487-4020; Job, Viviana/0000-0001-8421-5292; Schoehn, Guy/0000-0002-1459-3201	Fondation pour la Recherche Medicale (FRM; French Medical Research Foundation) [DEQ20090515390]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq-Brasil); FRM	Fondation pour la Recherche Medicale (FRM; French Medical Research Foundation); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq-Brasil)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FRM(Fondation pour la Recherche Medicale)	This work was funded by grant DEQ20090515390 from the Fondation pour la Recherche Medicale (FRM; French Medical Research Foundation - www.frm.org). DN was supported by a fellowship from the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq-Brasil) and the FRM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcorlo M, 2011, P NATL ACAD SCI USA, V108, P13236, DOI 10.1073/pnas.1106746108; ARAKAWA H, 1989, J BIOL CHEM, V264, P2350; Armstrong PB, 2006, IMMUNOBIOLOGY, V211, P263, DOI 10.1016/j.imbio.2006.01.002; Baxter RHG, 2007, P NATL ACAD SCI USA, V104, P11615, DOI 10.1073/pnas.0704967104; BOISSET N, 1993, J MOL BIOL, V232, P522, DOI 10.1006/jmbi.1993.1408; Boisset N, 1996, J BIOL CHEM, V271, P25762, DOI 10.1074/jbc.271.42.25762; BRANEGARD B, 1982, EUR J BIOCHEM, V122, P663; Budd A, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-6-r38; CARLSSONBOSTEDT L, 1988, J BIOL CHEM, V263, P6738; Chen H, 2010, P NATL ACAD SCI USA, V107, P17621, DOI 10.1073/pnas.1003750107; DELAIN E, 1988, J BIOL CHEM, V263, P2981; DELAIN E, 1992, ELECTRON MICROSC REV, V5, P231, DOI 10.1016/0892-0354(92)90012-F; Doan N, 2008, J BIOL CHEM, V283, P28747, DOI 10.1074/jbc.M803127200; Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030; Fredslund F, 2006, J MOL BIOL, V361, P115, DOI 10.1016/j.jmb.2006.06.009; Gros P, 2008, NAT REV IMMUNOL, V8, P48, DOI 10.1038/nri2231; Guinier A., 1955, SMALL ANGLE SCATTERI; Heymann JB, 2008, J STRUCT BIOL, V161, P232, DOI 10.1016/j.jsb.2007.08.002; Janssen BJC, 2006, NATURE, V444, P213, DOI 10.1038/nature05172; Janssen BJC, 2005, NATURE, V437, P505, DOI 10.1038/nature04005; Jenner L, 1998, STRUCTURE, V6, P595, DOI 10.1016/S0969-2126(98)00061-6; Kantyka T, 2010, BIOCHIMIE, V92, P1644, DOI 10.1016/j.biochi.2010.06.004; Kirkitadze MD, 2001, IMMUNOL REV, V180, P146, DOI 10.1034/j.1600-065X.2001.1800113.x; Kolodziej SJ, 2002, J BIOL CHEM, V277, P28031, DOI 10.1074/jbc.M202714200; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Kotwal GJ, 2000, IMMUNOL TODAY, V21, P242, DOI 10.1016/S0167-5699(00)01606-6; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Marrero A, 2012, ANGEW CHEM INT ED EN; Mattei PJ, 2010, CURR OPIN STRUC BIOL, V20, P749, DOI 10.1016/j.sbi.2010.09.014; Mindell JA, 2003, J STRUCT BIOL, V142, P334, DOI 10.1016/S1047-8477(03)00069-8; Murthy KHM, 2001, CELL, V104, P301, DOI 10.1016/S0092-8674(01)00214-8; Nishida N, 2006, P NATL ACAD SCI USA, V103, P19737, DOI 10.1073/pnas.0609791104; OSTERBERG R, 1984, EUR J BIOCHEM, V143, P541, DOI 10.1111/j.1432-1033.1984.tb08403.x; Qazi U, 2000, J STRUCT BIOL, V131, P19, DOI 10.1006/jsbi.2000.4269; Rooijakkers SHM, 2007, MOL IMMUNOL, V44, P23, DOI 10.1016/j.molimm.2006.06.011; Sahu A, 2001, IMMUNOL REV, V180, P35, DOI 10.1034/j.1600-065X.2001.1800103.x; Schiffer G, 1999, J BIOL CHEM, V274, P32031, DOI 10.1074/jbc.274.45.32031; SOTTRUPJENSEN L, 1989, J BIOL CHEM, V264, P11539; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Svergun DI, 2001, BIOPHYS J, V80, P2946, DOI 10.1016/S0006-3495(01)76260-1; Trapani S, 2006, ACTA CRYSTALLOGR D, V62, P467, DOI 10.1107/S0907444906005361; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Wiesmann C, 2006, NATURE, V444, P217, DOI 10.1038/nature05263	44	24	24	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2012	7	4							e35384	10.1371/journal.pone.0035384	http://dx.doi.org/10.1371/journal.pone.0035384			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WC	22530012	Green Published, gold, Green Submitted			2022-12-25	WOS:000305347400045
J	Pearson, C; Silva, A; Seddon, B				Pearson, Claire; Silva, Ana; Seddon, Benedict			Exogenous Amino Acids Are Essential for Interleukin-7 Induced CD8 T Cell Gowth	PLOS ONE			English	Article							RECEPTOR-DEFICIENT MICE; BCL-2 EXPRESSION; IL-7; DIFFERENTIATION; EXPANSION; CYTOKINE; SURVIVAL; NAIVE; LYMPHOPENIA; HOMEOSTASIS	IL-7 signalling is important in regulating both survival and cellular size (growth) of T cells. While glucose metabolism has previously been implicated in the mechanism of IL-7 induced survival and growth, the role of amino acids has not before been reported. Here, we show IL-7 dependent T cell survival does not require either exogenous glucose or amino acids. In contrast, maintenance of cell size and IL-7 induced growth were specifically dependent on amino acids. Furthermore, cellular amino acid uptake was implicated in the mechanism of IL-7 induced growth. Analysis of IL-7 regulated gene expression revealed that neutral and cationic amino acid transporters were specific transcriptional targets of IL-7 signalling. In contrast, none of the four glucose transporters expressed in T cells were modulated. Taken together, these data reveal for the first time the central importance of amino acid homeostasis for IL-7 regulated T cell growth.	[Pearson, Claire; Silva, Ana; Seddon, Benedict] MRC Natl Inst Med Res, Ridgeway, Div Immune Cell Biol, London, England	MRC National Institute for Medical Research	Pearson, C (corresponding author), Univ Oxford, John Radcliffe Hosp, Translat Gastroenterol Unit, Oxford OX3 9DU, England.	bseddon@nimr.mrc.ac.uk	Sánchez-Margalet, Victor/AAB-9986-2021	Sánchez-Margalet, Victor/0000-0001-8638-8680; Seddon, Benedict/0000-0003-4352-3373	Medical Research Council United Kingdom [U117573801]; Medical Research Council [MC_U117573801] Funding Source: researchfish; MRC [MC_U117573801] Funding Source: UKRI	Medical Research Council United Kingdom(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the Medical Research Council United Kingdom under program code U117573801. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akashi K, 1997, CELL, V89, P1033, DOI 10.1016/S0092-8674(00)80291-3; Araki K, 2009, NATURE, V460, P108, DOI 10.1038/nature08155; ARMANT M, 1995, IMMUNOLOGY, V85, P331; BLOMMAART EFC, 1995, J BIOL CHEM, V270, P2320, DOI 10.1074/jbc.270.5.2320; Graninger WB, 2000, CELL DEATH DIFFER, V7, P966, DOI 10.1038/sj.cdd.4400724; Hara K, 1998, J BIOL CHEM, V273, P14484, DOI 10.1074/jbc.273.23.14484; Jacobs SR, 2010, J IMMUNOL, V184, P3461, DOI 10.4049/jimmunol.0902593; Liu XB, 2010, NAT MED, V16, P191, DOI 10.1038/nm.2077; Maraskovsky E, 1997, CELL, V89, P1011, DOI 10.1016/S0092-8674(00)80289-5; Matsumura I, 1999, EMBO J, V18, P1367, DOI 10.1093/emboj/18.5.1367; Pallard C, 1999, IMMUNITY, V10, P525, DOI 10.1016/S1074-7613(00)80052-7; PESCHON JJ, 1994, J EXP MED, V180, P1955, DOI 10.1084/jem.180.5.1955; Rathmell JC, 2001, J IMMUNOL, V167, P6869, DOI 10.4049/jimmunol.167.12.6869; Saini M, 2009, BLOOD, V113, P5793, DOI 10.1182/blood-2008-12-192252; Schluns KS, 2000, NAT IMMUNOL, V1, P426, DOI 10.1038/80868; Seddon B, 2002, J IMMUNOL, V169, P3752, DOI 10.4049/jimmunol.169.7.3752; Sundrud MS, 2009, SCIENCE, V324, P1334, DOI 10.1126/science.1172638; Veldhoen M, 2009, J EXP MED, V206, P43, DOI 10.1084/jem.20081438; VONFREEDENJEFFRY U, 1995, J EXP MED, V181, P1519, DOI 10.1084/jem.181.4.1519; Wofford JA, 2008, BLOOD, V111, P2101, DOI 10.1182/blood-2007-06-096297	20	14	19	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2012	7	4							e33998	10.1371/journal.pone.0033998	http://dx.doi.org/10.1371/journal.pone.0033998			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WC	22529903	Green Submitted, Green Published, gold			2022-12-25	WOS:000305347400006
J	Rentoft, M; Coates, PJ; Laurell, G; Nylander, K				Rentoft, Matilda; Coates, Philip John; Laurell, Goran; Nylander, Karin			Transcriptional Profiling of Formalin Fixed Paraffin Embedded Tissue: Pitfalls and Recommendations for Identifying Biologically Relevant Changes	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMAS; GENE-EXPRESSION; NECK-CANCER; SAMPLES; RNA; DNA; PERFORMANCE; FAMILY; CHAIN; HEAD	Expression profiling techniques have been used to study the biology of many types of cancer but have been limited to some extent by the requirement for collection of fresh tissue. In contrast, formalin fixed paraffin embedded (FFPE) samples are widely available and represent a vast resource of potential material. The techniques used to handle the degraded and modified RNA from these samples are relatively new and all the pitfalls and limitations of this material for whole genome expression profiling are not yet clarified. Here, we analyzed 70 FFPE tongue carcinoma samples and 17 controls using the whole genome DASL array covering nearly 21000 genes. We identified that sample age is related to quality of extracted RNA and that sample quality influences apparent expression levels in a non-random manner related to gene probe sequence, leading to spurious results. However, by removing sub-standard samples and analysing only those 28 cancers and 15 controls that had similar quality we were able to generate a list of 934 genes significantly altered in tongue cancer compared to control samples of tongue. This list contained previously identified changes and was enriched for genes involved in many cancer-related processes such as tissue remodelling, inflammation, differentiation and apoptosis. Four novel genes of potential importance in tongue cancer development and maintenance, SH3BGL2, SLC2A6, SLC16A3 and CXCL10, were independently confirmed, validating our data. Hence, gene expression profiling can be performed usefully on archival material if appropriate quality assurance steps are taken to ensure sample consistency and we present some recommendations for the use of FFPE material based on our findings.	[Rentoft, Matilda; Nylander, Karin] Umea Univ, Dept Med Biosci Pathol, Umea, Sweden; [Coates, Philip John] Univ Dundee, Ninewells Hosp & Med Sch, Tayside Tissue Bank, Med Res Inst, Dundee DD1 9SY, Scotland; [Laurell, Goran] Norrlands Univ Hosp, Dept Clin Sci Otorhinolaryngol, Umea, Sweden	Umea University; University of Dundee; Umea University	Rentoft, M (corresponding author), Umea Univ, Dept Med Biosci Pathol, Umea, Sweden.	matilda.rentoft@medbio.umu.se	Rentoft, Matilda/AAL-2449-2021; Coates, Philip J/H-6854-2019	Coates, Philip J/0000-0003-1518-6306; Laurell, Goran/0000-0002-7760-246X	Cancer Research Foundation in Northern Sweden; Lion's Cancer Research Foundation; Umea University; Swedish Cancer Society; Vasterbotten County Council	Cancer Research Foundation in Northern Sweden; Lion's Cancer Research Foundation; Umea University; Swedish Cancer Society(Swedish Cancer Society); Vasterbotten County Council	This study was supported by grants from the Cancer Research Foundation in Northern Sweden, Lion's Cancer Research Foundation, Umea University, the Swedish Cancer Society and Vasterbotten County Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	April C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008162; Augustin R, 2010, IUBMB LIFE, V62, P315, DOI 10.1002/iub.315; Berghuis D, 2011, J PATHOL, V223, P347, DOI 10.1002/path.2819; Bibikova M, 2004, AM J PATHOL, V165, P1799, DOI 10.1016/S0002-9440(10)63435-9; Boldrup L, 2011, ORAL ONCOL, V47, P861, DOI 10.1016/j.oraloncology.2011.07.002; Chon HS, 2011, CANCER CONTROL, V18, P8, DOI 10.1177/107327481101800102; Clark-Langone KM, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-279; Cronin M, 2004, AM J PATHOL, V164, P35, DOI 10.1016/S0002-9440(10)63093-3; Ganapathy V, 2009, PHARMACOL THERAPEUT, V121, P29, DOI 10.1016/j.pharmthera.2008.09.005; JOVANOVIC A, 1993, J ORAL PATHOL MED, V22, P459, DOI 10.1111/j.1600-0714.1993.tb00125.x; Kibriya MG, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-622; Kudla G, 2006, PLOS BIOL, V4, P933, DOI 10.1371/journal.pbio.0040180; Le Floch R, 2011, P NATL ACAD SCI USA, V108, P16663, DOI 10.1073/pnas.1106123108; Liu AH, 2009, INT J CLIN EXP PATHO, V2, P519; Loudig O, 2011, HUM PATHOL, V42, P1911, DOI 10.1016/j.humpath.2011.02.011; Majid SM, 2006, ONCOGENE, V25, P756, DOI 10.1038/sj.onc.1209107; Masuda N, 1999, NUCLEIC ACIDS RES, V27, P4436, DOI 10.1093/nar/27.22.4436; Mazzocco M, 2002, GENE, V291, P233, DOI 10.1016/S0378-1119(02)00602-9; Mellin H, 2000, INT J CANCER, V89, P300, DOI 10.1002/1097-0215(20000520)89:3<300::AID-IJC14>3.0.CO;2-G; Mittempergher L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017163; Nannini M, 2009, CANCER TREAT REV, V35, P201, DOI 10.1016/j.ctrv.2008.10.006; Pai SI, 2009, ANNU REV PATHOL-MECH, V4, P49, DOI 10.1146/annurev.pathol.4.110807.092158; Posner MR, 2005, ONCOLOGIST, V10, P11, DOI 10.1634/theoncologist.10-90003-11; Rautava J, 2007, ORAL ONCOL, V43, P911, DOI 10.1016/j.oraloncology.2006.11.012; Rentoft M, 2010, EXP THER MED, V1, P419, DOI 10.3892/etm_00000065; Rentoft M, 2010, ORAL ONCOL, V46, P893, DOI 10.1016/j.oraloncology.2010.05.007; Rentoft M, 2009, INT J ONCOL, V35, P1321, DOI 10.3892/ijo_00000450; Sadi A, 2011, BMC CANCER, V11, DOI [10.1186/1471-2407-11-253, 10.1186/1471-2407-11-25]; Saleh A, 2010, ORAL ONCOL, V46, P379, DOI 10.1016/j.oraloncology.2010.02.022; Sano D, 2007, CANCER METAST REV, V26, P645, DOI 10.1007/s10555-007-9082-y; Silverman S, 2001, J AM DENT ASSOC, V132, p7S, DOI 10.14219/jada.archive.2001.0382; Slodkowska EA, 2009, EXPERT REV MOL DIAGN, V9, P417, DOI 10.1586/ERM.09.32; Srinivasan M, 2002, AM J PATHOL, V161, P1961, DOI 10.1016/S0002-9440(10)64472-0; Vandercappellen J, 2008, CANCER LETT, V267, P226, DOI 10.1016/j.canlet.2008.04.050; Vitucci M, 2011, BRIT J CANCER, V104, P545, DOI 10.1038/sj.bjc.6606031; Ye H, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-69; Ziober AF, 2006, CLIN CANCER RES, V12, P5960, DOI 10.1158/1078-0432.CCR-06-0535	37	14	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2012	7	4							e35276	10.1371/journal.pone.0035276	http://dx.doi.org/10.1371/journal.pone.0035276			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WC	22530001	gold, Green Published, Green Submitted			2022-12-25	WOS:000305347400040
J	Kampichler, C; van Turnhout, CAM; Devictor, V; van der Jeugd, HP				Kampichler, Christian; van Turnhout, Chris A. M.; Devictor, Vincent; van der Jeugd, Henk P.			Large-Scale Changes in Community Composition: Determining Land Use and Climate Change Signals	PLOS ONE			English	Article							AGRI-ENVIRONMENT SCHEMES; BIRD POPULATION; AGRICULTURAL LANDSCAPES; DECIDUOUS FOREST; HABITAT CHANGE; NETHERLANDS; BIODIVERSITY; DYNAMICS; CONSERVATION; RESPONSES	Human land use and climate change are regarded as the main driving forces of present-day and future species extinction. They may potentially lead to a profound reorganisation of the composition and structure of natural communities throughout the world. However, studies that explicitly investigate both forms of impact-land use and climate change-are uncommon. Here, we quantify community change of Dutch breeding bird communities over the past 25 years using time lag analysis. We evaluate the chronological sequence of the community temperature index (CTI) which reflects community response to temperature increase (increasing CTI indicates an increase in relative abundance of more southerly species), and the temporal trend of the community specialisation index (CSI) which reflects community response to land use change (declining CSI indicates an increase of generalist species). We show that the breeding bird fauna underwent distinct directional change accompanied by significant changes both in CTI and CSI which suggests a causal connection between climate and land use change and bird community change. The assemblages of particular breeding habitats neither changed at the same speed and nor were they equally affected by climate versus land use changes. In the rapidly changing farmland community, CTI and CSI both declined slightly. In contrast, CTI increased in the more slowly changing forest and heath communities, while CSI remained stable. Coastal assemblages experienced both an increase in CTI and a decline in CSI. Wetland birds experienced the fastest community change of all breeding habitat assemblages but neither CTI nor CSI showed a significant trend. Overall, our results suggest that the interaction between climate and land use changes differs between habitats, and that comparing trends in CSI and CTI may be useful in tracking the impact of each determinant.	[Kampichler, Christian; van der Jeugd, Henk P.] NIOO KNAW, Vogeltrekstn Dutch Ctr Avian Migrat & Demog, Wageningen, Netherlands; [Kampichler, Christian] Univ Juarez Autonoma Tabasco, Div Ciencias Biol, Villahermosa, Tabasco, Mexico; [van Turnhout, Chris A. M.] SOVON Dutch Ctr Field Ornithol, Nijmegen, Netherlands; [van Turnhout, Chris A. M.] Radboud Univ Nijmegen, Inst Water & Wetland Res, Dept Environm Sci, NL-6525 ED Nijmegen, Netherlands; [van Turnhout, Chris A. M.] Radboud Univ Nijmegen, Inst Water & Wetland Res, Dept Anim Ecol, NL-6525 ED Nijmegen, Netherlands; [Devictor, Vincent] Univ Montpellier 2, Inst Sci Evolut, UMR CNRS UM2 5554, Montpellier, France	Royal Netherlands Academy of Arts & Sciences; Netherlands Institute of Ecology (NIOO-KNAW); Universidad Juarez Autonoma de Tabasco; Radboud University Nijmegen; Radboud University Nijmegen; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Universite de Montpellier	Kampichler, C (corresponding author), NIOO KNAW, Vogeltrekstn Dutch Ctr Avian Migrat & Demog, Wageningen, Netherlands.	christian.kampichler@web.de	Vet, Louise E.M./B-1342-2009; van der Jeugd, Henk/S-3159-2019; van der Jeugd, Henk P/F-4891-2010; KNAW, NIOO-KNAW/A-4320-2012	Vet, Louise E.M./0000-0002-2287-1128; van der Jeugd, Henk/0000-0002-5332-9526; van der Jeugd, Henk P/0000-0002-5332-9526; KNAW, NIOO-KNAW/0000-0002-3835-159X	Fondation pour la Recherche sur la Biodiversite [FABIO 054974, PHYBIO AAP-SCEN-2010-1]	Fondation pour la Recherche sur la Biodiversite	VD received financial support from the Fondation pour la Recherche sur la Biodiversite, http://www.fondationbiodiversite.fr (projects FABIO 054974 and PHYBIO AAP-SCEN-2010-1). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, LAND TUINBOUWCIJFERS; Bennett AF, 2010, CONSERVATION BIOLOGY FOR ALL, P88; Bibby CJ, 2000, BIRD CENSUS TECHNIQU, DOI 10.1016/b978-0-12-095830-6.50007-9; Both C, 2010, P ROYAL SOC B, V1259-1266, P1259; Both C, 2009, J ANIM ECOL, V78, P73, DOI 10.1111/j.1365-2656.2008.01458.x; Brook BW, 2008, TRENDS ECOL EVOL, V23, P453, DOI 10.1016/j.tree.2008.03.011; Clavel J, 2011, FRONT ECOL ENVIRON, V9, P222, DOI 10.1890/080216; Clavero M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018581; Collins SL, 2001, AUK, V118, P583, DOI 10.1642/0004-8038(2001)118[0583:LTRATD]2.0.CO;2; Collins SL, 2000, OIKOS, V91, P285, DOI 10.1034/j.1600-0706.2000.910209.x; Cormont A, 2011, CLIM RES, V49, P59, DOI 10.3354/cr01007; Dawson TP, 2011, SCIENCE, V332, P53, DOI 10.1126/science.1200303; Devictor V, 2008, P ROY SOC B-BIOL SCI, V275, P2743, DOI 10.1098/rspb.2008.0878; Devictor V, 2008, OIKOS, V117, P507, DOI 10.1111/j.2008.0030-1299.16215.x; Devictor V, 2012, NAT CLIM CHANGE, V2, P121, DOI 10.1038/NCLIMATE1347; Devictor V, 2009, DIVERS DISTRIB, V15, P122, DOI 10.1111/j.1472-4642.2008.00510.x; Enemar Anders, 2004, Ornis Svecica, V14, P63; Filippi-Codaccioni O, 2010, BIOL CONSERV, V143, P1493, DOI 10.1016/j.biocon.2010.03.031; Fox AD, 2005, GLOBAL CHANGE BIOL, V11, P881, DOI 10.1111/j.1365-2486.2005.00941.x; Godet L, 2012, BIOL LETT IN PRESS; Gregory RD, 2005, PHILOS T R SOC B, V360, P269, DOI 10.1098/rstb.2004.1602; Hagemeijer W., 1997, EBCC ATLAS EUROPEAN; HALL GA, 1984, WILSON BULL, V96, P228; Holmes RT, 2001, AUK, V118, P589, DOI 10.1642/0004-8038(2001)118[0589:TYBPTI]2.0.CO;2; Hustings F, 2009, WATERVOGELS NEDERLAN; Julliard R, 2006, ECOL LETT, V9, P1237, DOI 10.1111/j.1461-0248.2006.00977.x; Kendeigh S. C., 1982, BIRD POPULATIONS E C; Kleijn D, 2004, CONSERV BIOL, V18, P775, DOI 10.1111/j.1523-1739.2004.00550.x; Kleijn D, 2001, NATURE, V413, P723, DOI 10.1038/35099540; Kleijn D, 2010, IBIS, V152, P475, DOI 10.1111/j.1474-919X.2010.01025.x; Klein Tank AMG, 2009, CLIMATE CHANGE NET S; Kooijman AM, 1998, J ECOL, V86, P511, DOI 10.1046/j.1365-2745.1998.00273.x; Laurance WF, 2010, CONSERVATION BIOLOGY FOR ALL, P73; Legendre P, 2001, OECOLOGIA, V129, P271, DOI 10.1007/s004420100716; Leito A, 2006, ORNIS FENNICA, V83, P124; Lovejoy TE, 2010, CONSERVATION BIOLOGY FOR ALL, P153; Magurran AE, 2010, TRENDS ECOL EVOL, V25, P574, DOI 10.1016/j.tree.2010.06.016; Newton I, 2004, IBIS, V146, P579, DOI 10.1111/j.1474-919X.2004.00375.x; Ng M, 2010, BRIT J MATH STAT PSY, V63, P319, DOI 10.1348/000711009X456845; Nijssen M, 2010, 2011OBN144 MIN EL I; Pereira HM, 2010, SCIENCE, V330, P1496, DOI 10.1126/science.1196624; Perkins AJ, 2011, J APPL ECOL, V48, P514, DOI 10.1111/j.1365-2664.2011.01958.x; Roelofs JGM, 1996, ACTA BOT NEERL, V45, P517; Svensson Soren, 2010, Ornis Svecica, V20, P31; Svensson Soren, 2006, Ornis Svecica, V16, P183; Thibault KM, 2004, ECOLOGY, V85, P2649, DOI 10.1890/04-0321; Travis JMJ, 2003, P ROY SOC B-BIOL SCI, V270, P467, DOI 10.1098/rspb.2002.2246; Van Beusekom R, 2005, RODE LIJST NEDERLAND; Van Der Jeugd HP, 2009, GLOBAL CHANGE BIOL, V15, P1057, DOI 10.1111/j.1365-2486.2008.01804.x; van Eerden M. R., 1996, Gibier Faune Sauvage, V13, P681; van Oldenborgh GJ, 2009, CLIM PAST, V5, P1, DOI 10.5194/cp-5-1-2009; van Turnhout CAM, 2010, ARDEA, V98, P283, DOI 10.5253/078.098.0303; Van Turnhout CAM, 2007, BIOL CONSERV, V134, P505, DOI 10.1016/j.biocon.2006.09.011; Van Turnhout CAM, 2010, BIOL CONSERV, V143, P173, DOI 10.1016/j.biocon.2009.09.023; VANDIJK AJ, 2004, HANDLEIDING BROEDVOG; Warren MS, 2001, NATURE, V414, P65, DOI 10.1038/35102054; Wesolowski T, 2010, ACTA ORNITHOL, V45, P209, DOI 10.3161/000164510X551354	57	66	68	0	97	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2012	7	4							e35272	10.1371/journal.pone.0035272	http://dx.doi.org/10.1371/journal.pone.0035272			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VO	22523579	Green Published, Green Submitted, gold			2022-12-25	WOS:000305345000051
J	Legrand, A; Bui-Quoc, E; Dore-Mazars, K; Lemoine, C; Gerard, CL; Bucci, MP				Legrand, Agathe; Bui-Quoc, Emmanuel; Dore-Mazars, Karine; Lemoine, Christelle; Gerard, Christophe-Loic; Bucci, Maria Pia			Effect of a Dual Task on Postural Control in Dyslexic Children	PLOS ONE			English	Article							SACCADIC EYE-MOVEMENTS; DEVELOPMENTAL DYSLEXIA; LEARNING-DIFFICULTIES; ATTENTIONAL DEMANDS; COGNITIVE LOAD; FOCUS; SWAY; POSTUROGRAPHY; INTERFERENCE; COORDINATION	Several studies have examined postural control in dyslexic children; however, their results were inconclusive. This study investigated the effect of a dual task on postural stability in dyslexic children. Eighteen dyslexic children (mean age 10.3 +/- 1.2 years) were compared with eighteen non-dyslexic children of similar age. Postural stability was recorded with a platform (TechnoConcept (R)) while the child, in separate sessions, made reflex horizontal and vertical saccades of 10 degrees of amplitude, and read a text silently. We measured the surface and the mean speed of the center of pressure (CoP). Reading performance was assessed by counting the number of words read during postural measures. Both groups of children were more stable while performing saccades than while reading a text. Furthermore, dyslexic children were significantly more unstable than non-dyslexic children, especially during the reading task. Finally, the number of words read by dyslexic children was significantly lower than that of non-dyslexic children and, in contrast to the non-dyslexic children. In line with the U-shaped non-linear interaction model, we suggest that the attention consumed by the reading task could be responsible for the loss of postural control in both groups of children. The postural instability observed in dyslexic children supports the hypothesis that such children have a lack of integration of multiple sensorimotor inputs.	[Legrand, Agathe; Dore-Mazars, Karine; Lemoine, Christelle; Bucci, Maria Pia] Univ Paris 05, Inst Psychol, IUPDP, Lab Psychol & Neuropsychol Cognit, Sorbonne Paris Cite, Boulogne Billan, France; [Bui-Quoc, Emmanuel] Hop Robert Debre, Serv Ophtalmol, F-75019 Paris, France; [Dore-Mazars, Karine] Inst Univ France, Paris, France; [Gerard, Christophe-Loic] Hop Robert Debre, Serv Psychopathol Enfant & Adolescent, F-75019 Paris, France	UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut Universitaire de France; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Universite Paris Cite	Legrand, A (corresponding author), Univ Paris 05, Inst Psychol, IUPDP, Lab Psychol & Neuropsychol Cognit, Sorbonne Paris Cite, Boulogne Billan, France.	agathe.legrand@etu.parisdescartes.fr						ABERNETHY B, 1988, J HUM MOVEMENT STUD, V14, P101; *AM PSYCH ASS, 1996, DSM 4 MAN DIAGN STAT; American Psychiatric Association, 1994, DIAGN STAT MAN MENT, V4th ed.; Andersson G, 2003, OTOL NEUROTOL, V24, P289, DOI 10.1097/00129492-200303000-00026; Andersson G, 2002, BRAIN RES BULL, V58, P135, DOI 10.1016/S0361-9230(02)00770-0; Barela JA, 2011, RES DEV DISABIL, V32, P1814, DOI 10.1016/j.ridd.2011.03.011; Biscaldi M, 1998, NEUROPSYCHOLOGIA, V36, P1189, DOI 10.1016/S0028-3932(97)00170-X; Blanchard Yvette, 2005, Pediatr Phys Ther, V17, P189, DOI 10.1097/01.PEP.0000176578.57147.5d; Brandt T., 2003, VERTIGO ITS MULTISEN; Brookes RL, 2010, DYSLEXIA, V16, P358, DOI 10.1002/dys.420; Bruno E, 2009, J VOICE, V23, P71, DOI 10.1016/j.jvoice.2007.06.002; Bucci MP, 2008, GRAEF ARCH CLIN EXP, V246, P417, DOI 10.1007/s00417-007-0723-1; Bucci MP, 2009, J OPHTHALMOL, V2009, DOI 10.1155/2009/325214; Buderath P, 2009, GAIT POSTURE, V29, P249, DOI 10.1016/j.gaitpost.2008.08.016; Chevrie-Muller C, 1997, MEMOIRE ATTENTION L2; Dault MC, 2003, COGNITIVE BRAIN RES, V16, P434, DOI 10.1016/S0926-6410(03)00058-2; ELTERMAN RD, 1980, J LEARN DISABIL, V13, P11, DOI 10.1177/002221948001300104; Fawcett AJ, 1996, ANN DYSLEXIA, V46, P259, DOI 10.1007/BF02648179; FAWCETT AJ, 1995, J MOTOR BEHAV, V27, P235, DOI 10.1080/00222895.1995.9941713; Gagey P. M., 1993, CALCUL SURFACE STATO; GEURTS ACH, 1993, ARCH PHYS MED REHAB, V74, P1144; Glasauer S, 2005, NEUROLOGY, V65, P1291, DOI 10.1212/01.wnl.0000175132.01370.fc; Huang H J, 2001, Pediatr Phys Ther, V13, P133, DOI 10.1097/00001577-200110000-00005; Hutzler F, 2004, BRAIN LANG, V89, P235, DOI 10.1016/S0093-934X(03)00401-2; Huxhold O, 2006, BRAIN RES BULL, V69, P294, DOI 10.1016/j.brainresbull.2006.01.002; Ivanenko YP, 1999, J PHYSIOL-LONDON, V519, P301, DOI 10.1111/j.1469-7793.1999.0301o.x; Kirkby JA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027105; Konczak J, 2005, BRAIN, V128, P1428, DOI 10.1093/brain/awh385; Lacour M, 2008, NEUROPHYSIOL CLIN, V38, P411, DOI 10.1016/j.neucli.2008.09.005; LAJOIE Y, 1993, EXP BRAIN RES, V97, P139; Laufer Y, 2008, GAIT POSTURE, V27, P347, DOI 10.1016/j.gaitpost.2007.04.013; Legrand A, 2011, NEUROSCI LETT, V501, P96, DOI 10.1016/j.neulet.2011.06.056; Leigh R. J., 2006, NEUROLOGY EYE MOVEME; Liberman I.Y., 1973, B ORTON SOC, V23, P65, DOI DOI 10.1007/BF02653842; LOVEGROVE WJ, 1980, SCIENCE, V210, P439, DOI 10.1126/science.7433985; MAKI BE, 1990, J AM GERIATR SOC, V38, P1, DOI 10.1111/j.1532-5415.1990.tb01588.x; McNevin NH, 2002, HUM MOVEMENT SCI, V21, P187, DOI 10.1016/S0167-9457(02)00095-7; Nicolson RI, 1999, LANCET, V353, P1662, DOI 10.1016/S0140-6736(98)09165-X; NICOLSON RI, 1990, COGNITION, V35, P159, DOI 10.1016/0010-0277(90)90013-A; Nicolson RI, 2007, TRENDS NEUROSCI, V30, P135, DOI 10.1016/j.tins.2007.02.003; Oblak B, 1985, EFFECTS VOLUNTARY EY; Olivier I, 2007, NEUROREPORT, V18, P817, DOI 10.1097/WNR.0b013e3280e129e1; Olivier I, 2010, GAIT POSTURE, V32, P494, DOI 10.1016/j.gaitpost.2010.07.008; OLSON RK, 1983, J EXP PSYCHOL HUMAN, V9, P816, DOI 10.1037/0096-1523.9.5.816; Pellecchia GL, 2003, GAIT POSTURE, V18, P29, DOI 10.1016/S0966-6362(02)00138-8; Poblano A, 2002, ARCH MED RES, V33, P485, DOI 10.1016/S0188-4409(02)00397-1; Quercia P, 2011, EXP BRAIN RES, V209, P599, DOI 10.1007/s00221-011-2593-3; Ramus F, 2003, CURR OPIN NEUROBIOL, V13, P212, DOI 10.1016/S0959-4388(03)00035-7; RIDDELL PM, 1990, PERCEPT MOTOR SKILL, V70, P707, DOI 10.2466/PMS.70.3.707-718; Riley MA, 2003, BRAIN RES BULL, V62, P191, DOI 10.1016/j.brainresbull.2003.09.012; RIZZOLATTI G, 1987, NEUROPSYCHOLOGIA, V25, P31, DOI 10.1016/0028-3932(87)90041-8; Rochelle KSH, 2006, J CHILD PSYCHOL PSYC, V47, P1159, DOI 10.1111/j.1469-7610.2006.01641.x; Rougier P, 2006, NEUROPHYSIOL CLIN, V36, P235, DOI 10.1016/j.neucli.2006.09.003; Rougier P, 2007, MOTOR CONTROL, V11, P213, DOI 10.1123/mcj.11.3.213; Schmid M, 2007, EXP BRAIN RES, V179, P375, DOI 10.1007/s00221-006-0795-x; Shumway-Cook A, 2000, J GERONTOL A-BIOL, V55, pM10; ShumwayCook A, 1997, J GERONTOL A-BIOL, V52, pM232, DOI 10.1093/gerona/52A.4.M232; Snowling M., 2000, DYSLEXIA; Stein J, 2001, Dyslexia, V7, P12, DOI 10.1002/dys.186; STEIN JF, 1987, EYE, V1, P433, DOI 10.1038/eye.1987.66; STEIN JF, 1988, BRIT J OPHTHALMOL, V72, P162, DOI 10.1136/bjo.72.3.162; Stoffregen TA, 2007, MOTOR CONTROL, V11, P86; Stoodley CJ, 2005, EXP BRAIN RES, V167, P370, DOI 10.1007/s00221-005-0042-x; STRAUBE A, 1989, CLIN VISION SCI, V4, P107; TALLAL P, 1980, BRAIN LANG, V9, P182, DOI 10.1016/0093-934X(80)90139-X; UCHIDA T, 1979, NEUROSCI LETT, V13, P253, DOI 10.1016/0304-3940(79)91503-9; Vieira S, 2009, NEUROSCI LETT, V462, P125, DOI 10.1016/j.neulet.2009.06.093; Vuillerme N, 2008, NEUROSCIENCE, V155, P291, DOI 10.1016/j.neuroscience.2008.05.018; Vuillerme N, 2000, NEUROSCI LETT, V291, P77, DOI 10.1016/S0304-3940(00)01374-4; WHITE KD, 1980, SCIENCE, V208, P621, DOI 10.1126/science.7367888; Wimmer H, 1999, J LEARN DISABIL, V32, P473, DOI 10.1177/002221949903200513; Wulf G, 2004, J MOTOR BEHAV, V36, P189, DOI 10.3200/JMBR.36.2.189-199	72	31	32	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2012	7	4							e35301	10.1371/journal.pone.0035301	http://dx.doi.org/10.1371/journal.pone.0035301			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959VO	22523583	Green Published, Green Submitted, gold			2022-12-25	WOS:000305345000055
J	Liu, JYW; Kasperaviciute, D; Martinian, L; Thom, M; Sisodiya, SM				Liu, Joan Y. W.; Kasperaviciute, Dalia; Martinian, Lillian; Thom, Maria; Sisodiya, Sanjay M.			Neuropathology of 16p13.11 Deletion in Epilepsy	PLOS ONE			English	Article							TEMPORAL-LOBE EPILEPSY; CEREBRAL CORTICAL SIZE; HIPPOCAMPAL SCLEROSIS; CYTOPLASMIC DYNEIN; PROTEIN; MIGRATION; NDEL1; LIS1; PREDISPOSE; EXPRESSION	16p13.11 genomic copy number variants are implicated in several neuropsychiatric disorders, such as schizophrenia, autism, mental retardation, ADHD and epilepsy. The mechanisms leading to the diverse clinical manifestations of deletions and duplications at this locus are unknown. Most studies favour NDE1 as the leading disease-causing candidate gene at 16p13.11. In epilepsy at least, the deletion does not appear to unmask recessive-acting mutations in NDE1, with haploinsufficiency and genetic modifiers being prime candidate disease mechanisms. NDE1 encodes a protein critical to cell positioning during cortical development. As a first step, it is important to determine whether 16p13.11 copy number change translates to detectable brain structural alteration. We undertook detailed neuropathology on surgically resected brain tissue of two patients with intractable mesial temporal lobe epilepsy (MTLE), who had the same heterozygous NDE1-containing 800 kb 16p13.11 deletion, using routine histological stains and immunohistochemical markers against a range of layer-specific, white matter, neural precursor and migratory cell proteins, and NDE1 itself. Surgical temporal lobectomy samples from a MTLE case known not to have a deletion in NDE1 and three non-epilepsy cases were included as disease controls. We found that apart from a 3 mm hamartia in the temporal cortex of one MTLE case with NDE1 deletion and known hippocampal sclerosis in the other case, cortical lamination and cytoarchitecture were normal, with no differences between cases with deletion and disease controls. How 16p13.11 copy changes lead to a variety of brain diseases remains unclear, but at least in epilepsy, it would not seem to be through structural abnormality or dyslamination as judged by microscopy or immunohistochemistry. The need to integrate additional data with genetic findings to determine their significance will become more pressing as genetic technologies generate increasingly rich datasets. Detailed examination of brain tissue, where available, will be an important part of this process in neurogenetic disease specifically.	[Liu, Joan Y. W.; Kasperaviciute, Dalia; Martinian, Lillian; Sisodiya, Sanjay M.] UCL Inst Neurol, Dept Clin & Expt Epilepsy, London, England; [Thom, Maria] Natl Hosp Neurol & Neurosurg, Div Neuropathol, London WC1N 3BG, England; [Sisodiya, Sanjay M.] Epilepsy Soc, Gerrards Cross, Bucks, England	University of London; University College London; University of London; University College London; UCL Medical School; University College London Hospitals NHS Foundation Trust	Liu, JYW (corresponding author), UCL Inst Neurol, Dept Clin & Expt Epilepsy, London, England.	s.sisodiya@ucl.ac.uk		Liu, Joan/0000-0002-0777-5189	The Wellcome Trust [084730]; The Medical Research Council, UK [GD400126, G79059]; European Commission within the 7th Framework programme, EURIPIDES; Department of Health Biomedical Centre; Medical Research Council [G0400126, G0600934] Funding Source: researchfish; MRC [G0400126, G0600934] Funding Source: UKRI	The Wellcome Trust(Wellcome TrustEuropean Commission); The Medical Research Council, UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Commission within the 7th Framework programme, EURIPIDES; Department of Health Biomedical Centre; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This study was supported by grants from The Wellcome Trust (084730), The Medical Research Council, UK (GD400126 and G79059), and the European Commission within the 7th Framework programme, EURIPIDES. This work was undertaken at University College London and University College London Hospital, who receive part of their funding from the Department of Health Biomedical Centre scheme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alkuraya FS, 2011, AM J HUM GENET, V88, P536, DOI 10.1016/j.ajhg.2011.04.003; Bakircioglu M, 2011, AM J HUM GENET, V88, P523, DOI 10.1016/j.ajhg.2011.03.019; Bandtlow CE, 2004, EUR J NEUROSCI, V20, P195, DOI 10.1111/j.1460-9568.2004.03470.x; Blumcke I, 2001, HIPPOCAMPUS, V11, P311, DOI 10.1002/hipo.1045; Catarino CB, 2011, EPILEPSIA, V52, P1388, DOI 10.1111/j.1528-1167.2011.03087.x; Conrad DF, 2010, NATURE, V464, P704, DOI 10.1038/nature08516; de Kovel CGF, 2010, BRAIN, V133, P23, DOI 10.1093/brain/awp262; Derewenda U, 2007, STRUCTURE, V15, P1467, DOI 10.1016/j.str.2007.09.015; DOBYNS WB, 1992, NEUROLOGY, V42, P1375, DOI 10.1212/WNL.42.7.1375; Feng YY, 2004, NEURON, V44, P279, DOI 10.1016/j.neuron.2004.09.023; Feng YY, 2000, NEURON, V28, P665, DOI 10.1016/S0896-6273(00)00145-8; FERRER I, 1992, BRAIN RES, V572, P33, DOI 10.1016/0006-8993(92)90447-H; Gleeson JG, 1999, NEURON, V23, P257, DOI 10.1016/S0896-6273(00)80778-3; Gong C, 2007, J NEUROSCI, V27, P1803, DOI 10.1523/JNEUROSCI.3111-06.2007; Hadjivassiliou G, 2010, ACTA NEUROPATHOL, V120, P517, DOI 10.1007/s00401-010-0686-x; Hannes FD, 2009, J MED GENET, V46, P223, DOI 10.1136/jmg.2007.055202; Heinzen EL, 2010, AM J HUM GENET, V86, P707, DOI 10.1016/j.ajhg.2010.03.018; Helbig I, 2009, NAT GENET, V41, P160, DOI 10.1038/ng.292; Howell BJ, 2001, J CELL BIOL, V155, P1159, DOI 10.1083/jcb.200105093; Inoue S, 1998, J CELL SCI, V111, P1555; Karki S, 1999, CURR OPIN CELL BIOL, V11, P45, DOI 10.1016/S0955-0674(99)80006-4; Lam C, 2010, J CELL SCI, V123, P202, DOI 10.1242/jcs.059337; LENDAHL U, 1990, CELL, V60, P585, DOI 10.1016/0092-8674(90)90662-X; Liu JYW, 2010, J NEUROSCI METH, V190, P49, DOI 10.1016/j.jneumeth.2010.04.020; LoNigro C, 1997, HUM MOL GENET, V6, P157, DOI 10.1093/hmg/6.2.157; Martinian L, 2009, NEUROPATH APPL NEURO, V35, P394, DOI [10.1111/j.1365-2990.2008.00996.x, 10.1111/j.1365-2990.2009.00996.x]; Mefford HC, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000962; Molnar Z, 2006, NEUROSCI RES, V55, P105, DOI 10.1016/j.neures.2006.02.008; Nagamani SCS, 2011, EUR J HUM GENET, V19, P280, DOI 10.1038/ejhg.2010.184; Need AC, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000373; Ocbina PJ, 2006, MOL CELL NEUROSCI, V33, P126, DOI 10.1016/j.mcn.2006.06.014; Pawlisz AS, 2008, HUM MOL GENET, V17, P2441, DOI 10.1093/hmg/ddn144; Pawlisz AS, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001172; Ramalingam A, 2011, J HUM GENET, V56, P541, DOI 10.1038/jhg.2011.42; Roelofs RF, 2005, GLIA, V52, P289, DOI 10.1002/glia.20243; Sasaki S, 2005, MOL CELL BIOL, V25, P7812, DOI 10.1128/MCB.25.17.7812-7827.2005; Sasaki S, 2000, NEURON, V28, P681, DOI 10.1016/S0896-6273(00)00146-X; Scaravilli F, 1998, NEUROPATHOLOGY EPILE; Shaikh TH, 2009, GENOME RES, V19, P1682, DOI 10.1101/gr.083501.108; Shmueli A, 2010, EMBO J, V29, P107, DOI 10.1038/emboj.2009.325; Siller KH, 2005, MOL BIOL CELL, V16, P5127, DOI 10.1091/mbc.E05-04-0338; Sisodiya SM, 2002, BRAIN, V125, P22, DOI 10.1093/brain/awf002; Thom M, 2004, EPILEPSIA, V45, P916, DOI 10.1111/j.0013-9580.2004.46603.x; Thom M, 2002, J NEUROPATH EXP NEUR, V61, P510, DOI 10.1093/jnen/61.6.510; Thom M, 2009, BRAIN PATHOL, V19, P565, DOI 10.1111/j.1750-3639.2008.00201.x; Ullmann R, 2007, HUM MUTAT, V28, P674, DOI 10.1002/humu.20546; Vergnolle MAS, 2007, CURR BIOL, V17, P1173, DOI 10.1016/j.cub.2007.05.077; Williams NM, 2010, LANCET, V376, P1401, DOI 10.1016/S0140-6736(10)61109-9; WOLF HK, 1995, J NEUROPATH EXP NEUR, V54, P245, DOI 10.1097/00005072-199503000-00011	49	14	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2012	7	4							e34813	10.1371/journal.pone.0034813	http://dx.doi.org/10.1371/journal.pone.0034813			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VO	22523559	Green Published, gold, Green Submitted			2022-12-25	WOS:000305345000031
J	Wan, J; Csaszar, E; Chen, WQ; Li, KZ; Lubec, G				Wan, Jia; Csaszar, Edina; Chen, Wei-Qiang; Li, Kongzhao; Lubec, Gert			Proteins from Avastin (R) (bevacizumab) Show Tyrosine Nitrations for which the Consequences Are Completely Unclear	PLOS ONE			English	Article							MANGANESE SUPEROXIDE-DISMUTASE; CANCER-PATIENTS; CYTOCHROME P4502B1; OVARIAN-CANCER; INCREASED RISK; PEROXYNITRITE; NEURODEGENERATION; INACTIVATION; METAANALYSIS; 3-NITROTYROSINE	Avastin (R) (bevacizumab) is a protein drug widely used for cancer treatment although its further use is questionable due to serious side effects reported. As no systematic proteomic study on posttranslational modifications (PTMs) was reported so far, it was the aim of the current study to use a gel-based proteomics method for determination of Avastin (R)-protein(s). Avastin (R) was run on two-dimensional gel electrophoresis (2-DE), spots were picked, followed by multi-enzyme in-gel digestion. Subsequently, the resulting peptides and posttranslational modifications were identified by mass spectrometry (nano-LC-ESI-MS/MS; HCT and LTQ Orbitrap MS). Heavy and light chains were observed and the 9 spots that were picked from 2DE-gels were identified as bevacizumab with high sequence coverage. MS/MS results showed multiple tyrosine nitrations on the Avastin (R) light and heavy chains that were either represented as nitrotyrosine or as aminotyrosine, which was shown to be generated from nitrotyrosine under reducing conditions. Protein nitration is known to significantly change protein functions and interactions and it may well be that some of the adverse effects of the protein drug Avastin (R) may be due to this PTM, which may have been generated during production-thus, nitration of Avastin (R) is a challenge for the pharmaceutical industry.	[Wan, Jia; Chen, Wei-Qiang; Li, Kongzhao] Med Univ Vienna, Dept Pediat, Vienna, Austria; [Csaszar, Edina] Max F Perutz Labs, Mass Spectrometry Facil, Vienna, Austria	Medical University of Vienna; Medical University of Vienna; University of Vienna; Vienna Biocenter (VBC); Max F. Perutz Laboratories (MFPL)	Wan, J (corresponding author), Med Univ Vienna, Dept Pediat, Vienna, Austria.	gert.lubec@meduniwien.ac.at		Lubec, Gert/0000-0002-6333-9461; CHEN, Weiqiang/0000-0002-7720-4816				Abello N, 2009, J PROTEOME RES, V8, P3222, DOI 10.1021/pr900039c; Balabanli B, 1999, P NATL ACAD SCI USA, V96, P13136, DOI 10.1073/pnas.96.23.13136; Benner EJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001376; Bookman MA, 2010, ANN ONCOL, V21, P211, DOI 10.1093/annonc/mdq368; Chen WQ, 2010, PROTEOMICS, V10, P369, DOI 10.1002/pmic.200900624; Chen YH, 2009, J OCUL PHARMACOL TH, V25, P65, DOI 10.1089/jop.2008.0043; Giasson BI, 2000, SCIENCE, V290, P985, DOI 10.1126/science.290.5493.985; Hapani S, 2010, ONCOLOGY-BASEL, V79, P27, DOI 10.1159/000314980; Heijnen HFG, 2006, FREE RADICAL BIO MED, V40, P1903, DOI 10.1016/j.freeradbiomed.2005.09.006; Ischiropoulos H, 2003, J CLIN INVEST, V111, P163, DOI 10.1172/JCI200317638; Ischiropoulos H, 2009, ARCH BIOCHEM BIOPHYS, V484, P117, DOI 10.1016/j.abb.2008.10.034; Kang SU, 2009, NAT PROTOC, V4, P1093, DOI 10.1038/nprot.2009.92; Lin HL, 2005, CHEM RES TOXICOL, V18, P1203, DOI 10.1021/tx050100o; Lin HL, 2003, CHEM RES TOXICOL, V16, P129, DOI 10.1021/tx020040b; MacMillan-Crow LA, 1999, ARCH BIOCHEM BIOPHYS, V366, P82, DOI 10.1006/abbi.1999.1202; MacMillanCrow LA, 1996, P NATL ACAD SCI USA, V93, P11853, DOI 10.1073/pnas.93.21.11853; Nagpal S, 2011, CHEMOTHER RES PRACT, V602812; Nuijten Mark, 2010, Lung Cancer, V69 Suppl 1, pS4, DOI 10.1016/S0169-5002(10)70132-X; Parastatidis I, 2008, J BIOL CHEM, V283, P33846, DOI 10.1074/jbc.M805522200; Randall LM, 2010, GYNECOL ONCOL, V117, P497, DOI 10.1016/j.ygyno.2010.02.021; Ranpura V, 2011, JAMA-J AM MED ASSOC, V305, P487, DOI 10.1001/jama.2011.51; Ranpura V, 2010, AM J HYPERTENS, V23, P460, DOI 10.1038/ajh.2010.25; Reck M, 2010, ANN ONCOL, V21, P1804, DOI 10.1093/annonc/mdq020; Reynolds MR, 2007, BIOCHEMISTRY-US, V46, P7325, DOI 10.1021/bi700430y; Savvides SN, 2002, J BIOL CHEM, V277, P2779, DOI 10.1074/jbc.M108190200; Smith I, 2011, BREAST CANCER RES TR, V130, P133, DOI 10.1007/s10549-011-1695-8; SOKOLOVSKY M, 1967, BIOCHEM BIOPH RES CO, V27, P20, DOI 10.1016/S0006-291X(67)80033-0; Stevens SM, 2008, MOL CELL PROTEOMICS, V7, P2442, DOI 10.1074/mcp.M800065-MCP200; Stone RL, 2010, LANCET ONCOL, V11, P465, DOI 10.1016/S1470-2045(09)70362-6; Szabo C, 2007, NAT REV DRUG DISCOV, V6, P662, DOI 10.1038/nrd2222; Thomson L, 2007, AM J RESP CELL MOL, V36, P152, DOI 10.1165/rcmb.2006-0288SM; Vadseth C, 2004, J BIOL CHEM, V279, P8820, DOI 10.1074/jbc.M306101200; Vaklavas C, 2010, ONCOLOGIST, V15, P130, DOI 10.1634/theoncologist.2009-0252; Van Meter MEM, 2010, CURR OPIN ONCOL, V22, P586, DOI 10.1097/CCO.0b013e32833edc0c; Willett CG, 2010, ONCOLOGIST, V15, P845, DOI 10.1634/theoncologist.2010-0030; Wozel G, 2010, J DTSCH DERMATOL GES, V8, P243, DOI 10.1111/j.1610-0387.2009.07268.x; Wu SH, 2010, J AM SOC NEPHROL, V21, P1381, DOI 10.1681/ASN.2010020167; Xu SQ, 2006, AM J PHYSIOL-HEART C, V290, pH2220, DOI 10.1152/ajpheart.01293.2005	38	8	8	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2012	7	4							e34511	10.1371/journal.pone.0034511	http://dx.doi.org/10.1371/journal.pone.0034511			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VO	22523550	Green Published, gold, Green Submitted			2022-12-25	WOS:000305345000020
J	Zonari, A; Novikoff, S; Electo, NRP; Breyner, NM; Gomes, DA; Martins, A; Neves, NM; Reis, RL; Goes, AM				Zonari, Alessandra; Novikoff, Silviene; Electo, Naira R. P.; Breyner, Natalia M.; Gomes, Dawidson A.; Martins, Albino; Neves, Nuno M.; Reis, Rui L.; Goes, Alfredo M.			Endothelial Differentiation of Human Stem Cells Seeded onto Electrospun Polyhydroxybutyrate/Polyhydroxybutyrate-Co-Hydroxyvalerate Fiber Mesh	PLOS ONE			English	Article							HUMAN ADIPOSE-TISSUE; IN-VITRO; EXTRACELLULAR-MATRIX; NANOFIBER MESHES; BONE; SCAFFOLDS; VASCULARIZATION; CARTILAGE; BIOCOMPATIBILITY; GROWTH	Tissue engineering is based on the association of cultured cells with structural matrices and the incorporation of signaling molecules for inducing tissue regeneration. Despite its enormous potential, tissue engineering faces a major challenge concerning the maintenance of cell viability after the implantation of the constructs. The lack of a functional vasculature within the implant compromises the delivery of nutrients to and removal of metabolites from the cells, which can lead to implant failure. In this sense, our investigation aims to develop a new strategy for enhancing vascularization in tissue engineering constructs. This study's aim was to establish a culture of human adipose tissue-derived stem cells (hASCs) to evaluate the biocompatibility of electrospun fiber mesh made of polyhydroxybutyrate (PHB) and its copolymer poly-3-hydroxybutyrate-co-3-hydroxyvalerate (PHB-HV) and to promote the differentiation of hASCs into the endothelial lineage. Fiber mesh was produced by blending 30% PHB with 70% PHB-HV and its physical characterization was conducted using scanning electron microscopy analysis (SEM). Using electrospinning, fiber mesh was obtained with diameters ranging 300 nm to 1.3 mu m. To assess the biological performance, hASCs were extracted, cultured, characterized by flow cytometry, expanded and seeded onto electrospun PHB/PHB-HV fiber mesh. Various aspects of the cells were analyzed in vitro using SEM, MTT assay and Calcein-AM staining. The in vitro evaluation demonstrated good adhesion and a normal morphology of the hASCs. After 7, 14 and 21 days of seeding hASCs onto electrospun PHB/PHB-HV fiber mesh, the cells remained viable and proliferative. Moreover, when cultured with endothelial differentiation medium (i.e., medium containing VEGF and bFGF), the hASCs expressed endothelial markers such as VE-Cadherin and the vWF factor. Therefore, the electrospun PHB/PHB-HV fiber mesh appears to be a suitable material that can be used in combination with endothelial-differentiated cells to improve vascularization in engineered bone tissues.	[Zonari, Alessandra; Novikoff, Silviene; Electo, Naira R. P.; Breyner, Natalia M.; Gomes, Dawidson A.; Goes, Alfredo M.] Univ Fed Minas Gerais, Dept Biochem & Immunol, Belo Horizonte, MG, Brazil; [Martins, Albino; Neves, Nuno M.; Reis, Rui L.] Univ Minho, Res Grp Biomat Biodegradables & Biomimet 3Bs, Guimaraes, Portugal; [Martins, Albino; Neves, Nuno M.; Reis, Rui L.] Univ Minho, ICVS PT Govt Associate Lab 3Bs, Braga, Portugal	Universidade Federal de Minas Gerais; Universidade do Minho; Universidade do Minho	Zonari, A (corresponding author), Univ Fed Minas Gerais, Dept Biochem & Immunol, Belo Horizonte, MG, Brazil.	alessandrazonari@gmail.com	Zonari, Alessandra/C-2168-2013; Neves, Nuno M/B-4685-2008; Gomes, Dawidson Assis/O-1372-2013; Martins, Albino/C-8432-2012; Reis, Rui L./A-8938-2008	Zonari, Alessandra/0000-0002-0093-356X; Neves, Nuno M/0000-0003-3041-0687; Gomes, Dawidson Assis/0000-0001-7714-991X; Martins, Albino/0000-0003-3868-0251; Reis, Rui L./0000-0002-4295-6129; UMinho, 3B's Research Group/0000-0002-5195-3456; Breyner, Natalia/0000-0002-2109-9332; Novikoff, Silviene/0000-0002-6541-3477	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq/Brazil); Fundacao de Amparo a Pesquisa de Minas Gerais (FAPEMIG/Brazil); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq/Brazil)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa de Minas Gerais (FAPEMIG/Brazil)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was supported by the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq/Brazil), the Fundacao de Amparo a Pesquisa de Minas Gerais (FAPEMIG/Brazil) and the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirre A, 2010, BIOCHEM BIOPH RES CO, V400, P284, DOI 10.1016/j.bbrc.2010.08.073; da Silva MLA, 2010, BIOMACROMOLECULES, V11, P3228, DOI 10.1021/bm100476r; Araujo JV, 2008, J BIOMAT SCI-POLYM E, V19, P1261, DOI 10.1163/156856208786052335; Arosarena Oneida, 2005, Curr Opin Otolaryngol Head Neck Surg, V13, P233, DOI 10.1097/01.moo.0000170526.51393.c5; Asran AS, 2010, BIOMACROMOLECULES, V11, P3413, DOI 10.1021/bm100912v; Breyner NM, 2010, CELLS TISSUES ORGANS, V191, P119, DOI 10.1159/000231472; Cao Y, 2005, BIOCHEM BIOPH RES CO, V332, P370, DOI 10.1016/j.bbrc.2005.04.135; Carvalho PP, 2011, CELLS TISSUES ORGANS, V194, P494, DOI 10.1159/000324892; Cassell OCS, 2002, BRIT J PLAST SURG, V55, P603, DOI 10.1054/bjps.2002.3950; CHALUPOWICZ DG, 1995, J CELL BIOL, V130, P207, DOI 10.1083/jcb.130.1.207; Chen GQ, 2005, BIOMATERIALS, V26, P6565, DOI 10.1016/j.biomaterials.2005.04.036; Cheng S, 2006, BIOMATERIALS, V27, P3758, DOI 10.1016/j.biomaterials.2006.02.046; Choi GG, 2005, BIOTECHNOL BIOPROC E, V10, P540, DOI 10.1007/BF02932291; Davis GE, 2005, CIRC RES, V97, P1093, DOI 10.1161/01.RES.0000191547.64391.e3; ENGELBERG I, 1991, BIOMATERIALS, V12, P292, DOI 10.1016/0142-9612(91)90037-B; Fischer LJ, 2009, J SURG RES, V152, P157, DOI 10.1016/j.jss.2008.06.029; Frohlich M, 2008, CURR STEM CELL RES T, V3, P254, DOI 10.2174/157488808786733962; Gloria A, 2010, J APPL BIOMATER BIOM, V8, P57; Gogotov IN, 2010, APPL BIOCHEM MICRO+, V46, P607, DOI 10.1134/S0003683810060086; Gory-Faure S, 1999, DEVELOPMENT, V126, P2093; Haimi S, 2009, TISSUE ENG PT A, V15, P1473, DOI 10.1089/ten.tea.2008.0241; Jain RK, 2005, NAT BIOTECHNOL, V23, P821, DOI 10.1038/nbt0705-821; Klenke FM, 2008, J BIOMED MATER RES A, V85A, P777, DOI 10.1002/jbm.a.31559; Kose GT, 2005, BIOMATERIALS, V26, P5187, DOI 10.1016/j.biomaterials.2005.01.037; Ku SH, 2010, BIOMATERIALS, V31, P9431, DOI 10.1016/j.biomaterials.2010.08.071; KUBOTA Y, 1988, J CELL BIOL, V107, P1589, DOI 10.1083/jcb.107.4.1589; LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529; Lee SY, 1996, BIOTECHNOL BIOENG, V49, P1; Lin SD, 2011, TISSUE ENG PT A, V17, P1489, DOI [10.1089/ten.tea.2010.0688, 10.1089/ten.TEA.2010.0688]; Liu HF, 2011, BIOMATERIALS, V32, P3784, DOI 10.1016/j.biomaterials.2011.02.002; Ma GP, 2010, J APPL POLYM SCI, V118, P3619, DOI 10.1002/app.32671; Martins A, 2007, NANOMEDICINE-UK, V2, P929, DOI 10.2217/17435889.2.6.929; Martins A, 2010, BIOMATERIALS, V31, P5875, DOI 10.1016/j.biomaterials.2010.04.010; McCullen SD, 2007, INT J NANOMED, V2, P253; Misra SK, 2006, BIOMACROMOLECULES, V7, P2249, DOI 10.1021/bm060317c; Mo XM, 2004, BIOMATERIALS, V25, P1883, DOI 10.1016/j.biomaterials.2003.08.042; Mountford JC, 2008, TRANSFUSION MED, V18, P1, DOI 10.1111/j.1365-3148.2007.00807.x; Muschler GF, 2003, J BIOMED BIOTECHNOL, P170, DOI 10.1155/s1110724303209165; Narmoneva DA, 2005, BIOMATERIALS, V26, P4837, DOI 10.1016/j.biomaterials.2005.01.005; Nomi M, 2002, MOL ASPECTS MED, V23, P463, DOI 10.1016/S0098-2997(02)00008-0; Oswald J, 2004, STEM CELLS, V22, P377, DOI 10.1634/stemcells.22-3-377; Rada T, 2009, TISSUE ENG PART B-RE, V15, P113, DOI 10.1089/ten.teb.2008.0423; Rathbone S, 2010, J BIOMED MATER RES A, V93A, P1391, DOI 10.1002/jbm.a.32641; Ravindran S, 2010, TISSUE ENG PT A, V16, P327, DOI [10.1089/ten.tea.2009.0110, 10.1089/ten.TEA.2009.0110]; Rouwkema J, 2008, TRENDS BIOTECHNOL, V26, P434, DOI 10.1016/j.tibtech.2008.04.009; Sadler JE, 2009, J THROMB HAEMOST, V7, P24, DOI 10.1111/j.1538-7836.2009.03375.x; Salerno S, 2011, BIOMATERIALS, V32, P8848, DOI 10.1016/j.biomaterials.2011.08.004; Santos MI, 2010, MACROMOL BIOSCI, V10, P12, DOI 10.1002/mabi.200900107; Seal BL, 2001, MAT SCI ENG R, V34, P147, DOI 10.1016/S0927-796X(01)00035-3; Sill TJ, 2008, BIOMATERIALS, V29, P1989, DOI 10.1016/j.biomaterials.2008.01.011; Smith IO, 2009, WIRES NANOMED NANOBI, V1, P226, DOI 10.1002/wnan.26; Sombatmankhong K, 2006, J POLYM SCI POL PHYS, V44, P2923, DOI 10.1002/polb.20915; Suwantong O, 2007, INT J BIOL MACROMOL, V40, P217, DOI 10.1016/j.ijbiomac.2006.07.006; Tokiwa Y, 2004, BIOTECHNOL LETT, V26, P1181, DOI 10.1023/B:BILE.0000036599.15302.e5; Toyokawa N, 2010, ARTHROSCOPY, V26, P375, DOI 10.1016/j.arthro.2009.08.006; Tsigkou O, 2010, P NATL ACAD SCI USA, V107, P3311, DOI 10.1073/pnas.0905445107; Unger RE, 2010, BIOMATERIALS, V31, P6959, DOI 10.1016/j.biomaterials.2010.05.057; Vailhe B, 1997, IN VITRO CELL DEV-AN, V33, P763; Wan C, 2008, P NATL ACAD SCI USA, V105, P686, DOI 10.1073/pnas.0708474105; Wang YY, 2010, BIOMED MATER, V5, DOI 10.1088/1748-6041/5/5/054112; Wernike E, 2010, EUR CELLS MATER, V19, P30; Wu HJ, 2010, J MATER SCI-MATER M, V21, P3207, DOI 10.1007/s10856-010-4164-8; Wu Q, 2009, ARTIF CELL BLOOD SUB, V37, P1, DOI 10.1080/10731190802664429; Xiang P, 2011, INT J BIOL MACROMOL, V49, P281, DOI 10.1016/j.ijbiomac.2011.05.004; Xie JW, 2010, NANOSCALE, V2, P35, DOI 10.1039/b9nr00243j; Ye C, 2009, BIOMATERIALS, V30, P4401, DOI 10.1016/j.biomaterials.2009.05.001; Yu HY, 2009, BIOMATERIALS, V30, P508, DOI 10.1016/j.biomaterials.2008.09.047; Zhang ZY, 2010, BIOMATERIALS, V31, P608, DOI 10.1016/j.biomaterials.2009.09.078; Zhu YX, 2008, CELL BIOCHEM FUNCT, V26, P664, DOI 10.1002/cbf.1488; Zuk PA, 2001, TISSUE ENG, V7, P211, DOI 10.1089/107632701300062859	70	61	62	1	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2012	7	4							e35422	10.1371/journal.pone.0035422	http://dx.doi.org/10.1371/journal.pone.0035422			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VO	22523594	Green Published, gold, Green Submitted			2022-12-25	WOS:000305345000067
J	Doss, CGP; Rajith, B				Doss, C. George Priya; Rajith, B.			Computational Refinement of Functional Single Nucleotide Polymorphisms Associated with ATM Gene	PLOS ONE			English	Article							NON-SYNONYMOUS SNPS; ATAXIA-TELANGIECTASIA; MISSENSE MUTATIONS; POINT MUTATIONS; PREDICTION; IDENTIFICATION; INACTIVATION; ACETYLATION; PHENOTYPES; VARIANTS	Background: Understanding and predicting molecular basis of disease is one of the major challenges in modern biology and medicine. SNPs associated with complex disorders can create, destroy, or modify protein coding sites. Single amino acid substitutions in the ATM gene are the most common forms of genetic variations that account for various forms of cancer. However, the extent to which SNPs interferes with the gene regulation and affects cancer susceptibility remains largely unknown. Principal findings: We analyzed the deleterious nsSNPs associated with ATM gene based on different computational methods. An integrative scoring system and sequence conservation of amino acid residues was adapted for a priori nsSNP analysis of variants associated with cancer. We further extended our approach on SNPs that could potentially influence protein Post Translational Modifications in ATM gene. Significance: In the lack of adequate prior reports on the possible deleterious effects of nsSNPs, we have systematically analyzed and characterized the functional variants in both coding and non coding region that can alter the expression and function of ATM gene. In silico characterization of nsSNPs affecting ATM gene function can aid in better understanding of genetic differences in disease susceptibility.	[Doss, C. George Priya; Rajith, B.] Vellore Inst Technol Univ, Sch Biosci & Technol, Ctr Nanobiotechnol, Med Biotechnol Div, Vellore, Tamil Nadu, India	Vellore Institute of Technology	Doss, CGP (corresponding author), Vellore Inst Technol Univ, Sch Biosci & Technol, Ctr Nanobiotechnol, Med Biotechnol Div, Vellore, Tamil Nadu, India.	georgepriyadoss@vit.ac.in	C, George/ABE-4676-2021; Alizadeh/AAK-1398-2021	C, George Priya Doss/0000-0002-5971-8290				Aly TA, 2006, DIABETES, V55, P1265, DOI 10.2337/db05-1276; [Anonymous], 2011, PLOS ONE, V6; Ansong C, 2011, BMC GENOMICS, V25, P12; Ashkenazy H, 2010, NUCLEIC ACIDS RES, V38, pW529, DOI 10.1093/nar/gkq399; Bandele OJ, 2011, NUCLEIC ACIDS RES, V39, P178, DOI 10.1093/nar/gkq764; Basu A, 2009, P NATL ACAD SCI USA, V106, P13785, DOI 10.1073/pnas.0906801106; Becker-Catania SG, 2000, MOL GENET METAB, V70, P122, DOI 10.1006/mgme.2000.2998; Bedford MT, 2005, MOL CELL, V18, P263, DOI 10.1016/j.molcel.2005.04.003; Botstein D, 2003, NAT GENET, V33, P228, DOI 10.1038/ng1090; Broeks A, 1998, HUM MUTAT, V12, P330, DOI 10.1002/(SICI)1098-1004(1998)12:5<330::AID-HUMU6>3.0.CO;2-H; Bullrich F, 1999, CANCER RES, V59, P24; Capriotti E, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-S2-S6; Cargill M, 1999, NAT GENET, V22, P231, DOI 10.1038/10290; Castellvi-Bel S, 1999, HUM MUTAT, V14, P156, DOI 10.1002/(SICI)1098-1004(1999)14:2<156::AID-HUMU7>3.0.CO;2-E; Chen H, 2006, NUCLEIC ACIDS RES, V34, pW249, DOI 10.1093/nar/gkl233; Conde L, 2006, NUCLEIC ACIDS RES, V34, pW621, DOI 10.1093/nar/gkl071; Doniger SW, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000183; Doss CGP, 2008, FUNCT INTEGR GENOMIC, V8, P309, DOI 10.1007/s10142-008-0086-7; Doss CGP, 2010, INTERDISCIP SCI, V2, P320, DOI 10.1007/s12539-010-0003-3; Doss CGP, 2009, INTERDISCIP SCI, V1, P220, DOI 10.1007/s12539-009-0042-9; Flanagan SE, 2010, GENET TEST MOL BIOMA, V14, P533, DOI 10.1089/gtmb.2010.0036; Fukao T, 1998, HUM MUTAT, V12, P338, DOI 10.1002/(SICI)1098-1004(1998)12:5<338::AID-HUMU7>3.0.CO;2-9; Gilad S, 1996, HUM MOL GENET, V5, P433, DOI 10.1093/hmg/5.4.433; Grasbon-Frodl E, 2004, ACTA NEUROPATHOL, V108, P476, DOI 10.1007/s00401-004-0913-4; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; Grillo G, 2010, NUCLEIC ACIDS RES, V38, pD75, DOI 10.1093/nar/gkp902; Ho AY, 2007, INT J RADIAT ONCOL, V69, P677, DOI 10.1016/j.ijrobp.2007.04.012; Izatt L, 1999, GENE CHROMOSOME CANC, V26, P286, DOI 10.1002/(SICI)1098-2264(199912)26:4<286::AID-GCC2>3.0.CO;2-X; Julenius K, 2005, GLYCOBIOLOGY, V15, P153, DOI 10.1093/glycob/cwh151; Karchin R, 2005, BIOINFORMATICS, V21, P2814, DOI 10.1093/bioinformatics/bti442; Khan S, 2010, HUM MUTAT, V31, P675, DOI 10.1002/humu.21242; Kozlov SV, 2011, J BIOL CHEM, V286, P9107, DOI 10.1074/jbc.M110.204065; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Lee JE, 2005, MUTAT RES-FUND MOL M, V573, P195, DOI 10.1016/j.mrfmmm.2004.08.018; Li A, 2006, BIOCHEM BIOPH RES CO, V350, P818, DOI 10.1016/j.bbrc.2006.08.199; Li AR, 2000, AM J MED GENET, V92, P170, DOI 10.1002/(SICI)1096-8628(20000529)92:3<170::AID-AJMG3>3.0.CO;2-#; Matsuoka S, 2007, SCIENCE, V316, P1160, DOI 10.1126/science.1140321; Mitui M, 2003, HUM MUTAT, V22, P43, DOI 10.1002/humu.10232; Morandell S, 2006, PROTEOMICS, V6, P4047, DOI 10.1002/pmic.200600058; Nadeau JH, 2002, NATURE, V420, P517, DOI 10.1038/420517a; Ng PC, 2006, ANNU REV GENOM HUM G, V7, P61, DOI 10.1146/annurev.genom.7.080505.115630; Palmer JS, 2000, AM J HUM GENET, V66, P176, DOI 10.1086/302711; Ramensky V, 2002, NUCLEIC ACIDS RES, V30, P3894, DOI 10.1093/nar/gkf493; Reinders J, 2007, BIOMOL ENG, V24, P169, DOI 10.1016/j.bioeng.2007.03.002; Ren J, 2009, PROTEOMICS, V9, P3409, DOI 10.1002/pmic.200800646; Sandoval N, 1999, HUM MOL GENET, V8, P69, DOI 10.1093/hmg/8.1.69; Sasaki T, 1998, HUM MUTAT, V12, P186, DOI 10.1002/(SICI)1098-1004(1998)12:3<186::AID-HUMU6>3.0.CO;2-F; Schaffner C, 2000, P NATL ACAD SCI USA, V97, P2773, DOI 10.1073/pnas.050400997; Schaffner C, 1999, BLOOD, V94, P748, DOI 10.1182/blood.V94.2.748.414k02_748_753; SCHNEIDER TD, 1986, J MOL BIOL, V188, P415, DOI 10.1016/0022-2836(86)90165-8; Sethumadhavan R, 2009, J BIOMED SCI, V24, P16; SONENBERG N, 1994, CURR OPIN GENET DEV, V4, P310, DOI 10.1016/S0959-437X(05)80059-0; Stankovic T, 1999, LANCET, V353, P26, DOI 10.1016/S0140-6736(98)10117-4; Stankovic T, 1998, AM J HUM GENET, V62, P334, DOI 10.1086/301706; Stilgenbauer S, 1997, NAT MED, V3, P1155, DOI 10.1038/nm1097-1155; Stoppa-Lyonnet D, 1998, BLOOD, V91, P3920, DOI 10.1182/blood.V91.10.3920.3920_3920_3926; Sun YL, 2007, MOL CELL BIOL, V27, P8502, DOI 10.1128/MCB.01382-07; Taylor KH, 2006, MAMM GENOME, V17, P892, DOI 10.1007/s00335-005-0148-2; Toyoshima M, 1998, AM J MED GENET, V75, P141, DOI 10.1002/(SICI)1096-8628(19980113)75:2<141::AID-AJMG4>3.0.CO;2-W; Vorechovsky I, 1997, NAT GENET, V17, P96, DOI 10.1038/ng0997-96; Vorechovsky I, 1996, CANCER RES, V56, P2726; Walsh C., 2006, POSTTRANSLATIONAL MO; Watters D, 1997, ONCOGENE, V14, P1911, DOI 10.1038/sj.onc.1201037; Wei XU, 2011, [Frontiers in Biology, 生物学前沿], V6, P213; Xue Y, 2011, PROTEIN ENG DES SEL, V24, P255, DOI 10.1093/protein/gzq094; Yuan HY, 2006, NUCLEIC ACIDS RES, V34, pW635, DOI 10.1093/nar/gkl236; Yuille MAR, 1998, ONCOGENE, V16, P789, DOI 10.1038/sj.onc.1201603; Zhou FF, 2006, NAT PROTOC, V1, P1318, DOI 10.1038/nprot.2006.209	69	30	31	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2012	7	4							e34573	10.1371/journal.pone.0034573	http://dx.doi.org/10.1371/journal.pone.0034573			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UT	22529920	Green Published, gold, Green Submitted			2022-12-25	WOS:000305341600044
J	Mass, T; Drake, JL; Haramaty, L; Rosenthal, Y; Schofield, OME; Sherrell, RM; Falkowski, PG				Mass, Tali; Drake, Jeana L.; Haramaty, Liti; Rosenthal, Yair; Schofield, Oscar M. E.; Sherrell, Robert M.; Falkowski, Paul G.			Aragonite Precipitation by "Proto-Polyps" in Coral Cell Cultures	PLOS ONE			English	Article							ORGANIC MATRIX; SCLERACTINIAN CORALS; GALAXEA-FASCICULARIS; REEF; PHOTOSYNTHESIS; CALCIFICATION; BIOMINERALIZATION; RESPONSES	The mechanisms of coral calcification at the molecular, cellular and tissue levels are poorly understood. In this study, we examine calcium carbonate precipitation using novel coral tissue cultures that aggregate to form "proto-polyps". Our goal is to establish an experimental system in which calcification is facilitated at the cellular level, while simultaneously allowing in vitro manipulations of the calcifying fluid. This novel coral culturing technique enables us to study the mechanisms of biomineralization and their implications for geochemical proxies. Viable cell cultures of the hermatypic, zooxanthellate coral, Stylophora pistillata, have been maintained for 6 to 8 weeks. Using an enriched seawater medium with aragonite saturation state similar to open ocean surface waters (Omega(arag) similar to 4), the primary cell cultures assemble into "proto-polyps" which form an extracellular organic matrix (ECM) and precipitate aragonite crystals. These extracellular aragonite crystals, about 10 mm in length, are formed on the external face of the proto-polyps and are identified by their distinctive elongated crystallography and X-ray diffraction pattern. The precipitation of aragonite is independent of photosynthesis by the zooxanthellae, and does not occur in control experiments lacking coral cells or when the coral cells are poisoned with sodium azide. Our results demonstrate that proto-polyps, aggregated from primary coral tissue culture, function (from a biomineralization perspective) similarly to whole corals. This approach provides a novel tool for investigating the biophysical mechanism of calcification in these organisms.	[Mass, Tali; Drake, Jeana L.; Haramaty, Liti; Rosenthal, Yair; Schofield, Oscar M. E.; Sherrell, Robert M.; Falkowski, Paul G.] Rutgers State Univ, Inst Marine & Coastal Sci, New Brunswick, NJ 08903 USA; [Rosenthal, Yair; Sherrell, Robert M.; Falkowski, Paul G.] Rutgers State Univ, Dept Earth & Planetary Sci, Piscataway, NJ USA	Rutgers State University New Brunswick; Rutgers State University New Brunswick	Mass, T (corresponding author), Rutgers State Univ, Inst Marine & Coastal Sci, New Brunswick, NJ 08903 USA.	tmass@marine.rutgers.edu	Mass, Tali/AAA-9046-2020; Schofield, Oscar/H-4169-2018	Schofield, Oscar/0000-0003-2359-4131; Mass, Tali/0000-0002-7298-290X	National Science Foundation [EF1041143]; Emerging Frontiers [1041143] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Emerging Frontiers(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This research was supported by National Science Foundation Grant EF1041143. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Horani FA, 2003, MAR BIOL, V142, P419, DOI 10.1007/s00227-002-0981-8; Allemand D, 1998, J EXP BIOL, V201, P2001; Allemand D, 2004, CR PALEVOL, V3, P453, DOI 10.1016/j.crpv.2004.07.011; Barnes DJ, 1990, ECOSYSTEMS WORLD COR; Clode PL, 2003, BIOL BULL-US, V204, P138, DOI 10.2307/1543549; Clode PL, 2003, PROTOPLASMA, V220, P153, DOI 10.1007/s00709-002-0046-3; Cohen AL, 2003, REV MINERAL GEOCHEM, V54, P151, DOI 10.2113/0540151; Cohen AL, 2009, GEOCHEM GEOPHY GEOSY, V10, DOI 10.1029/2009GC002411; Cuif JP, 2004, GEOCHEM GEOPHY GEOSY, V5, DOI 10.1029/2004GC000783; Cuif JP, 2003, GEOCHIM COSMOCHIM AC, V67, P75, DOI 10.1016/S0016-7037(02)01041-4; Debreuil J, 2011, MAR BIOL, V158, P2765, DOI 10.1007/s00227-011-1775-7; Domart-Coulon IJ, 2001, P NATL ACAD SCI USA, V98, P11885, DOI 10.1073/pnas.211439698; Fietzke J, 2010, J ANAL ATOM SPECTROM, V25, P1953, DOI 10.1039/c0ja00036a; Gattuso JP, 1999, AM ZOOL, V39, P160; Goffredo S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022338; Gorbunov MY, 2000, LIMNOL OCEANOGR, V45, P242, DOI 10.4319/lo.2000.45.1.0242; GRAN G, 1952, ANALYST, V77, P661, DOI 10.1039/an9527700661; Helman Y, 2008, P NATL ACAD SCI USA, V105, P54, DOI 10.1073/pnas.0710604105; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; Johnston I.S., 1980, International Review of Cytology, V67, P171; Kolber ZS, 1998, BBA-BIOENERGETICS, V1367, P88, DOI 10.1016/S0005-2728(98)00135-2; Krief S, 2010, GEOCHIM COSMOCHIM AC, V74, P4988, DOI 10.1016/j.gca.2010.05.023; Langdon C, 2003, GLOBAL BIOGEOCHEM CY, V17, DOI 10.1029/2002GB001941; Lewis E., 1998, PROGRAM DEV CO2 SYST; LEWITUS AJ, 1994, LIMNOL OCEANOGR, V39, P182, DOI 10.4319/lo.1994.39.1.0182; Marshall AT, 1998, CORAL REEFS, V17, P37, DOI 10.1007/s003380050092; Mass T, 2011, LIMNOL OCEANOGR, V56, P2176, DOI 10.4319/lo.2011.56.6.2176; MOPPER K, 1982, LIMNOL OCEANOGR, V27, P336, DOI 10.4319/lo.1982.27.2.0336; Muscatine L, 1997, CORAL REEFS, V16, P205, DOI 10.1007/s003380050075; MUSCATINE L, 1969, BIOL BULL-US, V137, P506, DOI 10.2307/1540172; Pochon X, 2010, J PHYCOL, V46, P53, DOI 10.1111/j.1529-8817.2009.00797.x; Puverel S, 2005, COMP BIOCHEM PHYS B, V141, P480, DOI 10.1016/j.cbpc.2005.05.013; Rahman MA, 2006, CALCIFIED TISSUE INT, V78, P178, DOI 10.1007/s00223-005-0253-y; Sinniger Frederic, 2010, Marine Biodiversity, V40, P57, DOI 10.1007/s12526-009-0034-3; Tchernov D, 2004, P NATL ACAD SCI USA, V101, P13531, DOI 10.1073/pnas.0402907101; Venn A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020013; Watanabe T, 2003, COMP BIOCHEM PHYS B, V136, P767, DOI 10.1016/S1096-4959(03)00177-5; Weiner S, 2003, REV MINERAL GEOCHEM, V54, P1, DOI 10.2113/0540001; YOUNG SD, 1971, COMP BIOCHEM PHYSIOL, V40, P113, DOI 10.1016/0305-0491(71)90067-8	39	41	43	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2012	7	4							e35049	10.1371/journal.pone.0035049	http://dx.doi.org/10.1371/journal.pone.0035049			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UT	22514707	Green Published, gold, Green Submitted			2022-12-25	WOS:000305341600113
J	Bandyopadhyay, GK; Vu, CU; Gentile, S; Lee, H; Biswas, N; Chi, NW; O'Connor, DT; Mahata, SK				Bandyopadhyay, Gautam K.; Vu, Christine U.; Gentile, Stefano; Lee, Howon; Biswas, Nilima; Chi, Nai-Wen; O'Connor, Daniel T.; Mahata, Sushil K.			Catestatin (Chromogranin A(352-372)) and Novel Effects on Mobilization of Fat from Adipose Tissue through Regulation of Adrenergic and Leptin Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RELEASE-INHIBITORY PEPTIDE; DIET-INDUCED OBESITY; A-DERIVED PEPTIDE; CATECHOLAMINE RELEASE; IN-VIVO; OB/OB MICE; ALPHA(2)-ADRENERGIC RECEPTORS; EPINEPHRINE INFUSION; INDUCED LIPOLYSIS; ACID OXIDATION	Chromogranin A knock-out (Chga-KO) mice display increased adiposity despite high levels of circulating catecholamines and leptin. Consistent with diet-induced obese mice, desensitization of leptin receptors caused by hyperleptinemia is believed to contribute to the obese phenotype of these KO mice. In contrast, obesity in ob/ob mice is caused by leptin deficiency. To characterize the metabolic phenotype, Chga-KO mice were treated with the CHGA-derived peptide catestatin (CST) that is deficient in these mice. CST treatment reduced fat depot size and increased lipolysis and fatty acid oxidation. In liver, CST enhanced oxidation of fatty acids as well as their assimilation into lipids, effects that are attributable to the up-regulation of genes promoting fatty acid oxidation (Cpt1 alpha, Ppar alpha, Acox, and Ucp2) and incorporation into lipids (Gpat and CD36). CST did not affect basal or isoproterenol-stimulated cAMP production in adipocytes but inhibited phospholipase C activation by the alpha-adrenergic receptor (AR) agonist phenylephrine, suggesting inhibition of alpha-AR signaling by CST. Indeed, CST mimicked the lipolytic effect of the alpha-AR blocker phentolamine on adipocytes. Moreover, CST reversed the hyperleptinemia of Chga-KO mice and improved leptin signaling as determined by phosphorylation of AMPK and Stat3. CST also improved peripheral leptin sensitivity in diet-induced obese mice. In ob/ob mice, CST enhanced leptin-induced signaling in adipose tissue. In conclusion, our results implicate CST in a novel pathway that promotes lipolysis and fatty acid oxidation by blocking alpha-AR signaling as well as by enhancing leptin receptor signaling.	[Bandyopadhyay, Gautam K.; Vu, Christine U.; Gentile, Stefano; Lee, Howon; Biswas, Nilima; Chi, Nai-Wen; O'Connor, Daniel T.; Mahata, Sushil K.] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Bandyopadhyay, Gautam K.; Chi, Nai-Wen; O'Connor, Daniel T.; Mahata, Sushil K.] Vet Affairs San Diego Healthcare Syst, San Diego, CA 92161 USA	University of California System; University of California San Diego; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA San Diego Healthcare System	Bandyopadhyay, GK (corresponding author), Univ Calif San Diego, Dept Med, 9500 Gilman Dr, La Jolla, CA 92093 USA.	gbandyopadhyay@ucsd.edu; smahata@ucsd.edu	Mahata, Sushil/AAF-8781-2021		National Institutes of Health [R01 DA011311]; Department of Veterans Affairs; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK094894] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA011311] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veterans Affairs(US Department of Veterans Affairs); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health Grant R01 DA011311 (to S. K. M.). This work was also supported by grants from the Department of Veterans Affairs (to S. K. M., D. T. O., and N.-W. C.).	AARDAL S, 1993, J NEUROENDOCRINOL, V5, P405, DOI 10.1111/j.1365-2826.1993.tb00501.x; Angelone T, 2008, ENDOCRINOLOGY, V149, P4780, DOI 10.1210/en.2008-0318; Arner P, 1999, INT J OBESITY, V23, P10, DOI 10.1038/sj.ijo.0800789; Arner P, 2005, BEST PRACT RES CL EN, V19, P471, DOI 10.1016/j.beem.2005.07.004; Aung G, 2011, IMMUNOLOGY, V132, P527, DOI 10.1111/j.1365-2567.2010.03395.x; Bandyopadhyay GK, 2006, DIABETES, V55, P2277, DOI 10.2337/db06-0062; Bandyopadhyay GK, 2005, DIABETES, V54, P2351, DOI 10.2337/diabetes.54.8.2351; Bougneres P, 1997, J CLIN INVEST, V99, P2568, DOI 10.1172/JCI119444; Briolat J, 2005, CELL MOL LIFE SCI, V62, P377, DOI 10.1007/s00018-004-4461-9; Couillard C, 2002, OBES RES, V10, P6, DOI 10.1038/oby.2002.2; Dev NB, 2010, ENDOCRINOLOGY, V151, P2760, DOI 10.1210/en.2009-1110; Egger M, 2008, EUR J PHARMACOL, V598, P104, DOI 10.1016/j.ejphar.2008.09.016; El-Haschimi K, 2000, J CLIN INVEST, V105, P1827, DOI 10.1172/JCI9842; Fritsche A, 1998, EXP CLIN ENDOCR DIAB, V106, P415, DOI 10.1055/s-0029-1212008; Fruhbeck G, 1998, BIOCHEM BIOPH RES CO, V250, P99, DOI 10.1006/bbrc.1998.9277; Fruhbeck G, 1997, BIOCHEM BIOPH RES CO, V240, P590, DOI 10.1006/bbrc.1997.7716; Fung MM, 2010, CLIN EXP HYPERTENS, V32, P278, DOI 10.3109/10641960903265246; Gaede AH, 2012, AM J PHYSIOL-REG I, V302, pR365, DOI 10.1152/ajpregu.00409.2011; Gaede AH, 2010, AM J PHYSIOL-REG I, V299, pR1538, DOI 10.1152/ajpregu.00335.2010; Gayen JR, 2009, ENDOCRINOLOGY, V150, P5027, DOI 10.1210/en.2009-0429; Gayen JR, 2009, J BIOL CHEM, V284, P28498, DOI 10.1074/jbc.M109.020636; Gomez-Ambrosi J, 2001, INT J MOL MED, V8, P103; Guo XX, 2011, BIOCHEM BIOPH RES CO, V407, P807, DOI 10.1016/j.bbrc.2011.03.104; Helle KB, 2010, CARDIOVASC RES, V85, P9, DOI 10.1093/cvr/cvp266; Imbrogno S, 2010, J EXP BIOL, V213, P3636, DOI 10.1242/jeb.045567; Jensen MD, 1997, ANNU REV NUTR, V17, P127, DOI 10.1146/annurev.nutr.17.1.127; KARNIELI E, 1981, J BIOL CHEM, V256, P4772; Kim YB, 2000, ENDOCRINOLOGY, V141, P2328, DOI 10.1210/en.141.7.2328; Knight ZA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011376; Koch C, 2010, J NEUROSCI, V30, P16180, DOI 10.1523/JNEUROSCI.3202-10.2010; LAFONTAN M, 1993, J LIPID RES, V34, P1057; Lafontan M., 1997, Human Reproduction (Oxford), V12, P6; Lafontan M, 2009, PROG LIPID RES, V48, P275, DOI 10.1016/j.plipres.2009.05.001; Lin S, 2000, INT J OBESITY, V24, P639, DOI 10.1038/sj.ijo.0801209; Mahapatra NR, 2005, J CLIN INVEST, V115, P1942, DOI 10.1172/JCI24354; Mahata SK, 2000, MOL ENDOCRINOL, V14, P1525, DOI 10.1210/me.14.10.1525; Mahata SK, 2004, MOL PHARMACOL, V66, P1180, DOI 10.1124/mol.104.002139; Mahata SK, 1997, J CLIN INVEST, V100, P1623, DOI 10.1172/JCI119686; Mahata SK, 2010, REGUL PEPTIDES, V162, P33, DOI 10.1016/j.regpep.2010.01.006; Mao XM, 2006, NAT CELL BIOL, V8, P516, DOI 10.1038/ncb1404; Mazza R, 2008, AM J PHYSIOL-HEART C, V295, pH113, DOI 10.1152/ajpheart.00172.2008; Minokoshi Y, 2002, NATURE, V415, P339, DOI 10.1038/415339a; Montero-Hadjadje M, 2008, ACTA PHYSIOL, V192, P309, DOI 10.1111/j.1748-1716.2007.01806.x; Mori S, 2007, LIPIDS, V42, P307, DOI 10.1007/S11745-007-3034-8; Morris DL, 2009, AM J PHYSIOL-ENDOC M, V297, pE1247, DOI 10.1152/ajpendo.00274.2009; PELLEYMOUNTER MA, 1995, SCIENCE, V269, P540, DOI 10.1126/science.7624776; Polak J, 2007, J LIPID RES, V48, P2236, DOI 10.1194/jlr.M700253-JLR200; Radek KA, 2008, J INVEST DERMATOL, V128, P1525, DOI 10.1038/sj.jid.5701225; Sanchez-Margalet V, 2010, REGUL PEPTIDES, V161, P8, DOI 10.1016/j.regpep.2010.02.005; Scriba D, 2000, EUR J ENDOCRINOL, V143, P439, DOI 10.1530/eje.0.1430439; Seeley RJ, 1996, HORM METAB RES, V28, P664, DOI 10.1055/s-2007-979874; Stallknecht B, 1997, J PHYSIOL-LONDON, V500, P271, DOI 10.1113/jphysiol.1997.sp022017; Stich V, 2003, AM J PHYSIOL-ENDOC M, V285, pE599, DOI 10.1152/ajpendo.00502.2002; Stich V, 1999, AM J PHYSIOL-REG I, V277, pR1076, DOI 10.1152/ajpregu.1999.277.4.R1076; Sugawara M, 2010, FASEB J, V24, P1737, DOI 10.1096/fj.09-142554; TATEMOTO K, 1986, NATURE, V324, P476, DOI 10.1038/324476a0; Taupenot L, 2003, NEW ENGL J MED, V348, P1134, DOI 10.1056/NEJMra021405; Thalmann Sebastien, 2008, V456, P195, DOI 10.1007/978-1-59745-245-8_14; Theurl M, 2010, CIRC RES, V107, P1326, DOI 10.1161/CIRCRESAHA.110.219493; TOWNSEND RR, 1994, AM J PHYSIOL, V266, pE155, DOI 10.1152/ajpendo.1994.266.2.E155; Vaisse C, 1996, NAT GENET, V14, P95, DOI 10.1038/ng0996-95; VanHeek M, 1997, J CLIN INVEST, V99, P385, DOI 10.1172/JCI119171; Wang MY, 2005, P NATL ACAD SCI USA, V102, P18011, DOI 10.1073/pnas.0509001102; WINKLER H, 1992, NEUROSCIENCE, V49, P497, DOI 10.1016/0306-4522(92)90222-N	64	46	49	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 29	2012	287	27					23141	23151		10.1074/jbc.M111.335877	http://dx.doi.org/10.1074/jbc.M111.335877			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	975GB	22535963	hybrid, Green Published			2022-12-25	WOS:000306495000069
J	Lin, HC; Lai, PY; Lin, YP; Huang, JY; Yang, BC				Lin, Huan-Ching; Lai, Po-Yin; Lin, Yu-ping; Huang, Jyun-Yuan; Yang, Bei-Chang			Fas Ligand Enhances Malignant Behavior of Tumor Cells through Interaction with Met, Hepatocyte Growth Factor Receptor, in Lipid Rafts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CD178 CYTOPLASMIC TAIL; T-LYMPHOCYTES; C-MET; DOMAIN; ACTIVATION; DEATH; MICE; INVASIVENESS; INHIBITION; REGULATOR	Many late-stage cancer cells express Fas ligand (FasL) and show high malignancy with metastatic potential. We report here a novel signaling mechanism for FasL that hijacks the Met signal pathway to promote tumor metastasis. FasL-expressing human tumor cells express a significant amount of phosphorylated Met. The down-regulation of FasL in these cells led to decreased Met activity and reduced cell motility. Ectopic expression of human FasL in NIH3T3 cells significantly stimulated their migration and invasion. The inhibition of Met and Stat3 activities reverted the FasL-associated phenotype. Notably, FasL variants activated the Met pathway, even though most of their intracellular domain or Fas binding sites were deleted. FasL interacted with Met through the FasL(105-130) extracellular region in lipid rafts, which consequently led to Met activation. Knocking down Met gene expression by RNAi technology reverted the FasL-associated motility to basal levels. Furthermore, treatment with synthetic peptides corresponding to FasL(117-126) significantly reduced the FasL/Met interaction, Met phosphorylation, and cell motility of FasL(+) transfectants and tumor cells. Finally, the transfectants of truncated FasL showed strong anchorage-independent growth and lung metastasis potential in null mice. Collectively, our results establish the FasL-Met-Stat3 signaling pathway and explains the metastatic phenotype of FasL-expressing tumors.	[Lai, Po-Yin; Yang, Bei-Chang] Natl Cheng Kung Univ, Coll Med, Dept Microbiol & Immunol, Tainan 701, Taiwan; [Yang, Bei-Chang] Natl Cheng Kung Univ, Ctr Infect Dis & Signaling Res, Tainan 701, Taiwan; [Lin, Huan-Ching; Lin, Yu-ping; Huang, Jyun-Yuan; Yang, Bei-Chang] Natl Cheng Kung Univ, Inst Basic Med Sci, Tainan 701, Taiwan	National Cheng Kung University; National Cheng Kung University; National Cheng Kung University	Yang, BC (corresponding author), Natl Cheng Kung Univ, Coll Med, Dept Microbiol & Immunol, Tainan 701, Taiwan.	y1357@mail.ncku.edu.tw			National Science Council of Taiwan [NSC 96-2320-B-006-021-MY3]; Infectious Disease and Signaling Research Center of National Cheng Kung University; Aim for the Top University Project	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan); Infectious Disease and Signaling Research Center of National Cheng Kung University; Aim for the Top University Project	This work was supported in part by grants (to B.C.Y) from the National Science Council of Taiwan (NSC 96-2320-B-006-021-MY3) and the Infectious Disease and Signaling Research Center of National Cheng Kung University and Aim for the Top University Project.	ALDERSON MR, 1995, J EXP MED, V181, P71, DOI 10.1084/jem.181.1.71; Barnhart BC, 2004, EMBO J, V23, P3175, DOI 10.1038/sj.emboj.7600325; Bodmer JL, 2002, TRENDS BIOCHEM SCI, V27, P19, DOI 10.1016/S0968-0004(01)01995-8; BRADLEY MO, 1986, P NATL ACAD SCI USA, V83, P5277, DOI 10.1073/pnas.83.14.5277; Chen YL, 2003, J IMMUNOL, V171, P1183, DOI 10.4049/jimmunol.171.3.1183; Chervonsky AV, 1997, CELL, V89, P17, DOI 10.1016/S0092-8674(00)80178-6; Cramer A, 2005, J CELL BIOCHEM, V95, P805, DOI 10.1002/jcb.20459; Cui HL, 1996, CELL IMMUNOL, V167, P276, DOI 10.1006/cimm.1996.0036; Guo A, 2008, P NATL ACAD SCI USA, V105, P692, DOI 10.1073/pnas.0707270105; HANE M, 1995, FEBS LETT, V373, P265, DOI 10.1016/0014-5793(95)01051-F; Hartel S, 1998, ANAL BIOCHEM, V258, P277, DOI 10.1006/abio.1998.2594; Jodo S, 2005, J IMMUNOL, V174, P4470, DOI 10.4049/jimmunol.174.8.4470; Kirkin V, 2007, CELL DEATH DIFFER, V14, P1678, DOI 10.1038/sj.cdd.4402175; Knox PG, 2003, J IMMUNOL, V170, P677, DOI 10.4049/jimmunol.170.2.677; LYNCH DH, 1994, IMMUNITY, V1, P131, DOI 10.1016/1074-7613(94)90106-6; NAGATA S, 1995, SCIENCE, V267, P1449, DOI 10.1126/science.7533326; Orlinick JR, 1997, J BIOL CHEM, V272, P32221, DOI 10.1074/jbc.272.51.32221; P'Reilly L. A., 2009, NATURE, V461, P659; Popsueva A, 2003, J CELL BIOL, V161, P119, DOI 10.1083/jcb.200212174; Seino K, 1997, TRANSPLANTATION, V64, P1050, DOI 10.1097/00007890-199710150-00018; Sun MY, 2006, J IMMUNOL, V177, P1481, DOI 10.4049/jimmunol.177.3.1481; Suzuki I, 2000, P NATL ACAD SCI USA, V97, P1707, DOI 10.1073/pnas.97.4.1707; Suzuki I, 1998, J EXP MED, V187, P123, DOI 10.1084/jem.187.1.123; TAKAHASHI T, 1994, CELL, V76, P969, DOI 10.1016/0092-8674(94)90375-1; Trusolino L, 2001, CELL, V107, P643, DOI 10.1016/S0092-8674(01)00567-0; Ueoka Y, 2000, BRIT J CANCER, V82, P891, DOI 10.1054/bjoc.1999.1016; Wang R, 1996, P NATL ACAD SCI USA, V93, P8425, DOI 10.1073/pnas.93.16.8425; Wang X, 2002, MOL CELL, V9, P411, DOI 10.1016/S1097-2765(02)00439-2; Watts AD, 1999, EMBO J, V18, P2119, DOI 10.1093/emboj/18.8.2119; Xiao S, 2004, J IMMUNOL, V173, P5095, DOI 10.4049/jimmunol.173.8.5095	30	15	15	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 8	2012	287	24					20664	20673		10.1074/jbc.M111.326058	http://dx.doi.org/10.1074/jbc.M111.326058			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974FB	22535954	Green Published, hybrid			2022-12-25	WOS:000306414500085
J	Biasutti, M; Dufour, N; Ferroud, C; Dab, W; Temime, L				Biasutti, Maria; Dufour, Natacha; Ferroud, Clotilde; Dab, William; Temime, Laura			Cost-Effectiveness of Magnetic Resonance Imaging with a New Contrast Agent for the Early Diagnosis of Alzheimer's Disease	PLOS ONE			English	Article							MILD COGNITIVE IMPAIRMENT; AMYLOID DEPOSITION; DECISION-ANALYSIS; MEMORY LOSS; MODERATE; DONEPEZIL; DEMENTIA; FRANCE; MODEL; APOE	Background: Used as contrast agents for brain magnetic resonance imaging (MRI), markers for beta-amyloid deposits might allow early diagnosis of Alzheimer's disease (AD). We evaluated the cost-effectiveness of such a diagnostic test, MRI+CLP (contrastophore-linker-pharmacophore), should it become clinically available. Methodology/Principal Findings: We compared the cost-effectiveness of MRI+CLP to that of standard diagnosis using currently available cognition tests and of standard MRI, and investigated the impact of a hypothetical treatment efficient in early AD. The primary analysis was based on the current French context for 70-year-old patients with Mild Cognitive Impairment (MCI). In alternative "screen and treat" scenarios, we analyzed the consequences of systematic screenings of over-60 individuals (either population-wide or restricted to the ApoE4 genotype population). We used a Markov model of AD progression; model parameters, as well as incurred costs and quality-of-life weights in France were taken from the literature. We performed univariate and probabilistic multivariate sensitivity analyses. The base-case preferred strategy was the standard MRI diagnosis strategy. In the primary analysis however, MRI+CLP could become the preferred strategy under a wide array of scenarios involving lower cost and/or higher sensitivity or specificity. By contrast, in the "screen and treat" analyses, the probability of MRI+CLP becoming the preferred strategy remained lower than 5%. Conclusions/Significance: It is thought that anti-beta-amyloid compounds might halt the development of dementia in early stage patients. This study suggests that, even should such treatments become available, systematically screening the over-60 population for AD would only become cost-effective with highly specific tests able to diagnose early stages of the disease. However, offering a new diagnostic test based on beta-amyloid markers to elderly patients with MCI might prove cost-effective.	[Biasutti, Maria; Dufour, Natacha; Dab, William; Temime, Laura] Conservatoire Natl Arts & Metiers, Lab Modelisat & Surveillance Risques Sanit, F-75003 Paris, France; [Biasutti, Maria; Dufour, Natacha] Ecole Ponts ParisTech, F-77700 Marne La Vallee, France; [Ferroud, Clotilde] Conservatoire Natl Arts & Metiers, Lab Transformat Chim & Pharmaceut, F-75003 Paris, France	heSam Universite; Conservatoire National Arts & Metiers (CNAM); Ecole des Ponts ParisTech; heSam Universite; Conservatoire National Arts & Metiers (CNAM)	Temime, L (corresponding author), Conservatoire Natl Arts & Metiers, Lab Modelisat & Surveillance Risques Sanit, F-75003 Paris, France.	laura.temime@cnam.fr	Temime, Laura/G-7010-2011	Temime, Laura/0000-0002-8850-5403	Cnam	Cnam	This research was financed by a grant from the Cnam, a public higher education establishment by which all authors were employed at the time. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], DICT VIDAL; Atri A, 2008, ALZ DIS ASSOC DIS, V22, P209, DOI 10.1097/WAD.0b013e31816653bc; Ballard C, 2011, LANCET, V377, P1019, DOI 10.1016/S0140-6736(10)61349-9; Blum-Boisgard C, 2007, MEDICAMENTS SPECIFIQ, P1; Bowen J, 1997, LANCET, V349, P763, DOI 10.1016/S0140-6736(96)08256-6; Caselli RJ, 2010, NEUROSCI LETT, V473, P168, DOI 10.1016/j.neulet.2010.02.016; Cohen JT, 2008, ALZHEIMERS DEMENT, V4, P212, DOI 10.1016/j.jalz.2008.02.003; Commenges D, 2004, STAT MED, V23, P199, DOI 10.1002/sim.1709; Drago V, 2011, J ALZHEIMERS DIS, V26, P159, DOI 10.3233/JAD-2011-0043; Edjerer TT, 2003, WHO GUIDE COST EFFEC; Elliott AF, 2010, J AM GERIATR SOC, V58, P30, DOI 10.1111/j.1532-5415.2009.02631.x; Fagnani F, 2004, DEMENT GERIATR COGN, V17, P5, DOI 10.1159/000074079; Faissol DM, 2009, MATH BIOSCI, V220, P143, DOI 10.1016/j.mbs.2009.05.005; Feldman H, 2004, NEUROLOGY, V63, P644, DOI 10.1212/01.WNL.0000134663.79663.6E; Ferri CP, 2005, LANCET, V366, P2112, DOI 10.1016/S0140-6736(05)67889-0; Forlenza OV, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-89; Forsberg A, 2008, NEUROBIOL AGING, V29, P1456, DOI 10.1016/j.neurobiolaging.2007.03.029; France Benevolat, 2010, SIT BEN FRANC 2010; FRYBACK DG, 1993, MED DECIS MAKING, V13, P89, DOI 10.1177/0272989X9301300202; Furiak NM, 2010, BMC MED INFORM DECIS, V10, DOI 10.1186/1472-6947-10-24; Gagnon M, 2007, CAN J PSYCHIAT, V52, P519, DOI 10.1177/070674370705200810; Genin E, 2011, MOL PSYCHIATR, V16, P903, DOI 10.1038/mp.2011.52; Hampel Harald, 2009, Dialogues Clin Neurosci, V11, P141; Hansson O, 2006, LANCET NEUROL, V5, P228, DOI 10.1016/S1474-4422(06)70355-6; Harris GJ, 1998, AM J NEURORADIOL, V19, P1727; Helmer C, 2006, M S-MED SCI, V22, P288, DOI 10.1051/medsci/2006223288; Himes C L, 2000, J Cross Cult Gerontol, V15, P99, DOI 10.1023/A:1006797731500; INED, 2008, AG SEX SPEC MORT RAT; Katz MJ, 2011, ALZHEIMER DIS ASS DI; Kulasingam SL, 2003, VALUE HEALTH, V6, P542, DOI 10.1046/j.1524-4733.2003.65248.x; Lejeune C, 2005, J NUCL MED, V46, P2020; Marbot C, 2008, TRAVAILLER PARTICULI; Mauskopf J, 2011, AM J ALZHEIMERS DIS, V26, P298, DOI 10.1177/1533317511407481; McKhann GM, 2011, JAMA-J AM MED ASSOC, V305, P2458, DOI 10.1001/jama.2011.810; McMahon PM, 2000, RADIOLOGY, V217, P58, DOI 10.1148/radiology.217.1.r00se1358; McMahon PM, 2003, RADIOLOGY, V228, P515, DOI 10.1148/radiol.2282020915; McShane R, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003154.pub5; Mebane-Sims I, 2009, ALZHEIMERS DEMENT, V5, P234, DOI 10.1016/j.jalz.2009.03.001; Moatti JP, 2003, B CANCER, V90, P1010; Mormino EC, 2009, BRAIN, V132, P1310, DOI 10.1093/brain/awn320; Neumann PJ, 1999, NEUROLOGY, V52, P1138, DOI 10.1212/WNL.52.6.1138; Reese JP, 2011, J ALZHEIMERS DIS; Reimat A, 2002, INNOVATIONS, V15, P73; Reisberg B, 2003, NEW ENGL J MED, V348, P1333, DOI 10.1056/NEJMoa013128; Rigaud AS, 2003, J GERIATR PSYCH NEUR, V16, P140, DOI 10.1177/0891988703252558; Rogers SL, 1998, NEUROLOGY, V50, P136, DOI 10.1212/WNL.50.1.136; Sante Mdl, 2009, TAR CONV CONS MED SP; Sante Mdl, 2009, NOM ACT BIOL MED; Sante Mdl, 2009, CLASS COMM ACT MED; SCHACHTER F, 1994, NAT GENET, V6, P29, DOI 10.1038/ng0194-29; TreeAge Software I, 2009, TREEAGE PROH; Villemagne VL, 2008, NEUROPSYCHOLOGIA, V46, P1688, DOI 10.1016/j.neuropsychologia.2008.02.008; Weiner MW, 2010, ALZHEIMERS DEMENT, V6, P202, DOI 10.1016/j.jalz.2010.03.007; Winblad B, 2001, NEUROLOGY, V57, P489, DOI 10.1212/WNL.57.3.489; Wolk DA, 2009, ANN NEUROL, V65, P557, DOI 10.1002/ana.21598	55	20	21	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2012	7	4							e35559	10.1371/journal.pone.0035559	http://dx.doi.org/10.1371/journal.pone.0035559			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UD	22532859	gold, Green Published, Green Submitted			2022-12-25	WOS:000305339200079
J	Grzywnowicz, M; Zaleska, J; Mertens, D; Tomczak, W; Wlasiuk, P; Kosior, K; Piechnik, A; Bojarska-Junak, A; Dmoszynska, A; Giannopoulos, K				Grzywnowicz, Maciej; Zaleska, Joanna; Mertens, Daniel; Tomczak, Waldemar; Wlasiuk, Paulina; Kosior, Kamila; Piechnik, Agnieszka; Bojarska-Junak, Agnieszka; Dmoszynska, Anna; Giannopoulos, Krzysztof			Programmed Death-1 and Its Ligand Are Novel Immunotolerant Molecules Expressed on Leukemic B Cells in Chronic Lymphocytic Leukemia	PLOS ONE			English	Article							HUMAN PD-1 GENE; CD4(+) T-CELLS; FOLLICULAR LYMPHOMA; HODGKIN-LYMPHOMA; TUMOR-CELLS; ACTIVATION; BLOCKADE; RECEPTOR; B7-H1; IMMUNITY	Programmed death-1 (PD-1) is an immunoreceptor predominantly expressed on exhausted T cells, which through an interaction with its ligand (PD-L1), controls peripheral tolerance by limiting effector functions of T lymphocytes. qRT-PCR for PD-1, PD-L1 and their splicing forms as well as flow cytometric assessment of surface expression was performed in a cohort of 58 chronic lymphocytic leukemia (CLL) patients. In functional studies, we assessed the influence of the proliferative response of leukemic B-cells induced by IL-4 and CD40L on PD-1 transcripts and expression on the protein level. The median level of PD-1, but not PD-L1, transcripts in CLL patients was higher in comparison to healthy volunteers (HVs, n = 43, p = 0.0057). We confirmed the presence of PD-1 and PD-L1 on the CLL cell surface, and found the expression of PD-1, but not PD-L1, to be higher among CLL patients in comparison to HVs (47.2% vs. 14.8%, p<0.0001). The Kaplan-Meier curves for the time to progression and overall survival in groups with high and low surface expression of PD-1 and PD-L1 revealed no prognostic value in CLL patients. After stimulation with IL-4 and CD40L, protein expression of PD-1 was significantly increased in samples that responded and up-regulated CD38. PD-1, which is aberrantly expressed both at mRNA and cell surface levels in CLL cells might represent a novel immunotolerant molecule involved in the pathomechanism of the disease, and could provide a novel target for future therapies.	[Grzywnowicz, Maciej; Zaleska, Joanna; Wlasiuk, Paulina; Piechnik, Agnieszka; Giannopoulos, Krzysztof] Med Univ Lublin, Dept Expt Hematooncol, Lublin, Poland; [Mertens, Daniel; Giannopoulos, Krzysztof] Univ Ulm, Dept Internal Med 3, D-7900 Ulm, Germany; [Mertens, Daniel] German Canc Res Ctr, Cooperat Unit Mech Leukemogenesis, D-6900 Heidelberg, Germany; [Tomczak, Waldemar; Kosior, Kamila; Dmoszynska, Anna; Giannopoulos, Krzysztof] Med Univ Lublin, Dept Hematooncol, Lublin, Poland; [Tomczak, Waldemar; Kosior, Kamila; Giannopoulos, Krzysztof] Med Univ Lublin, Bone Marrow Transplantat Unit, Lublin, Poland; [Bojarska-Junak, Agnieszka] Med Univ Lublin, Dept Clin Immunol, Lublin, Poland	Medical University of Lublin; Ulm University; Helmholtz Association; German Cancer Research Center (DKFZ); Medical University of Lublin; Medical University of Lublin; Medical University of Lublin	Grzywnowicz, M (corresponding author), Med Univ Lublin, Dept Expt Hematooncol, Lublin, Poland.	giannop@tlen.pl	Mertens, Daniel/F-4681-2011; Bojarska-Junak, Agnieszka/AAK-3714-2021	Mertens, Daniel/0000-0003-0227-7188; Bojarska-Junak, Agnieszka/0000-0003-2340-9442; Wlasiuk, Paulina/0000-0001-6738-5513; Karczmarczyk, Agnieszka/0000-0002-0178-4746; Zaleska, Joanna/0000-0002-4417-7831; Tomczak, Waldemar/0000-0002-3205-5781; Giannopoulos, Krzysztof/0000-0003-0135-4030	Polish Foundation for Science (FNP FOCUS) [01/08]	Polish Foundation for Science (FNP FOCUS)	This work was supported by grants from the Polish Foundation for Science (FNP FOCUS 01/08). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agata Y, 1996, INT IMMUNOL, V8, P765, DOI 10.1093/intimm/8.5.765; Barber DL, 2006, NATURE, V439, P682, DOI 10.1038/nature04444; Berger R, 2008, CLIN CANCER RES, V14, P3044, DOI 10.1158/1078-0432.CCR-07-4079; Blank C, 2006, INT J CANCER, V119, P317, DOI 10.1002/ijc.21775; Brown JA, 2003, J IMMUNOL, V170, P1257, DOI 10.4049/jimmunol.170.3.1257; Caligaris-Cappio F, 2008, J CLIN ONCOL, V26, P4497, DOI 10.1200/JCO.2007.15.4393; Carreras J, 2009, J CLIN ONCOL, V27, P1470, DOI 10.1200/JCO.2008.18.0513; Chemnitz JM, 2004, J IMMUNOL, V173, P945, DOI 10.4049/jimmunol.173.2.945; Damle RN, 2007, BLOOD, V110, P3352, DOI 10.1182/blood-2007-04-083832; Damle RN, 2002, BLOOD, V99, P4087, DOI 10.1182/blood.V99.11.4087; Dohner H, 2000, NEW ENGL J MED, V343, P1910, DOI 10.1056/NEJM200012283432602; Dong HD, 2003, J MOL MED, V81, P281, DOI 10.1007/s00109-003-0430-2; Dong HD, 2002, NAT MED, V8, P793, DOI 10.1038/nm730; Dorfman DM, 2006, AM J SURG PATHOL, V30, P802, DOI 10.1097/01.pas.0000209855.28282.ce; Finger LR, 1997, GENE, V197, P177, DOI 10.1016/S0378-1119(97)00260-6; Freeman GJ, 2000, J EXP MED, V192, P1027, DOI 10.1084/jem.192.7.1027; Giannopoulos K, 2008, ONCOL REP, V20, P677, DOI 10.3892/or_00000059; Hamblin TJ, 1999, BLOOD, V94, P1848, DOI 10.1182/blood.V94.6.1848; He XH, 2005, ACTA PHARMACOL SIN, V26, P462, DOI 10.1111/j.1745-7254.2005.00086.x; Hirano F, 2005, CANCER RES, V65, P1089; Iwai Y, 2005, INT IMMUNOL, V17, P133, DOI 10.1093/intimm/dxh194; Iwai Y, 2002, P NATL ACAD SCI USA, V99, P12293, DOI 10.1073/pnas.192461099; Keir ME, 2008, ANNU REV IMMUNOL, V26, P677, DOI 10.1146/annurev.immunol.26.021607.090331; Kuppers R, 2005, NAT REV CANCER, V5, P251, DOI 10.1038/nrc1589; Latchman Y, 2001, NAT IMMUNOL, V2, P261, DOI 10.1038/85330; Murray F, 2008, BLOOD, V111, P1524, DOI 10.1182/blood-2007-07-099564; Nielsen C, 2005, CELL IMMUNOL, V235, P109, DOI 10.1016/j.cellimm.2005.07.007; Okazaki T, 2001, P NATL ACAD SCI USA, V98, P13866, DOI 10.1073/pnas.231486598; Richendollar BG, 2011, HUM PATHOL, V42, P552, DOI 10.1016/j.humpath.2010.08.015; Roncador G, 2007, HAEMATOLOGICA, V92, P1059, DOI 10.3324/haematol.10864; Sharpe AH, 2007, NAT IMMUNOL, V8, P239, DOI 10.1038/ni1443; Sheppard KA, 2004, FEBS LETT, V574, P37, DOI 10.1016/j.febslet.2004.07.083; Shimauchi T, 2007, INT J CANCER, V121, P2585, DOI 10.1002/ijc.23042; Stamatopoulos K, 2007, BLOOD, V109, P259, DOI 10.1182/blood-2006-03-012948; Wan B, 2006, J IMMUNOL, V177, P8844, DOI 10.4049/jimmunol.177.12.8844; Wiestner A, 2003, BLOOD, V101, P4944, DOI 10.1182/blood-2002-10-3306; Xerri L, 2008, HUM PATHOL, V39, P1050, DOI 10.1016/j.humpath.2007.11.012; Yamamoto R, 2008, BLOOD, V111, P3220, DOI 10.1182/blood-2007-05-085159; Yang ZZ, 2006, BLOOD, V107, P3639, DOI 10.1182/blood-2005-08-3376; Zhang L, 2009, BLOOD, V114, P1545, DOI 10.1182/blood-2009-03-206672	40	50	59	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2012	7	4							e35178	10.1371/journal.pone.0035178	http://dx.doi.org/10.1371/journal.pone.0035178			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TL	22532845	Green Published, gold, Green Submitted			2022-12-25	WOS:000305336200027
J	Bello, G; Zanotto, PMD; Iamarino, A; Graf, T; Pinto, AR; Couto-Fernandez, JC; Morgado, MG				Bello, Gonzalo; Zanotto, Paolo M. de A.; Iamarino, Atila; Graef, Tiago; Pinto, Aguinaldo R.; Couto-Fernandez, Jose C.; Morgado, Mariza G.			Phylogeographic Analysis of HIV-1 Subtype C Dissemination in Southern Brazil	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; MOLECULAR EPIDEMIOLOGY; GENETIC DIVERSITY; DRUG-RESISTANCE; CLADE-C; PHYLOGENETICS; INDIVIDUALS; PREVALENCE; MUTATIONS; INFERENCE	The HIV-1 subtype C has spread efficiently in the southern states of Brazil (Rio Grande do Sul, Santa Catarina and Parana). Phylogeographic studies indicate that the subtype C epidemic in southern Brazil was initiated by the introduction of a single founder virus population at some time point between 1960 and 1980, but little is known about the spatial dynamics of viral spread. A total of 135 Brazilian HIV-1 subtype C pol sequences collected from 1992 to 2009 at the three southern state capitals (Porto Alegre, Florianopolis and Curitiba) were analyzed. Maximum-likelihood and Bayesian methods were used to explore the degree of phylogenetic mixing of subtype C sequences from different cities and to reconstruct the geographical pattern of viral spread in this country region. Phylogeographic analyses supported the monophyletic origin of the HIV-1 subtype C clade circulating in southern Brazil and placed the root of that clade in Curitiba (Parana state). This analysis further suggested that Florianopolis (Santa Catarina state) is an important staging post in the subtype C dissemination displaying high viral migration rates from and to the other cities, while viral flux between Curitiba and Porto Alegre (Rio Grande do Sul state) is very low. We found a positive correlation (r(2) = 0.64) between routine travel and viral migration rates among localities. Despite the intense viral movement, phylogenetic intermixing of subtype C sequences from different Brazilian cities is lower than expected by chance. Notably, a high proportion (67%) of subtype C sequences from Porto Alegre branched within a single local monophyletic sub-cluster. These results suggest that the HIV-1 subtype C epidemic in southern Brazil has been shaped by both frequent viral migration among states and in situ dissemination of local clades.	[Bello, Gonzalo; Couto-Fernandez, Jose C.; Morgado, Mariza G.] Fiocruz MS, Inst Oswaldo Cruz, Lab AIDS & Imunol Mol, BR-21045900 Rio De Janeiro, Brazil; [Bello, Gonzalo] Univ Fed Rio de Janeiro, IMPPG, Dept Virol, Rio De Janeiro, Brazil; [Zanotto, Paolo M. de A.; Iamarino, Atila] Univ Sao Paulo, Inst Ciencias Biomed, Dept Microbiol, LEMB, Sao Paulo, Brazil; [Graef, Tiago; Pinto, Aguinaldo R.] Univ Fed Santa Catarina, Dept Microbiol Immunol & Parasitol, Florianopolis, SC, Brazil	Fundacao Oswaldo Cruz; Universidade Federal do Rio de Janeiro; Universidade de Sao Paulo; Universidade Federal de Santa Catarina (UFSC)	Bello, G (corresponding author), Fiocruz MS, Inst Oswaldo Cruz, Lab AIDS & Imunol Mol, BR-21045900 Rio De Janeiro, Brazil.	gbellobr@gmail.com	de A. Zanotto, Paolo M./B-9286-2019; Bello, Gonzalo/E-6842-2013; Bentancor, Gonzalo Jose Bello/N-7377-2019; Pinto, Aguinaldo R/R-6625-2016; Gräf, Tiago/S-8535-2019	de A. Zanotto, Paolo M./0000-0002-8167-0625; Bentancor, Gonzalo Jose Bello/0000-0002-2724-2793; Pinto, Aguinaldo R/0000-0002-0991-8876; Gräf, Tiago/0000-0003-4921-7975; Iamarino, Atila/0000-0003-3904-0248; Couto-Fernandez, Jose Carlos/0000-0001-7091-9774	FAPERJ; CNPq	FAPERJ(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This study was supported by FAPERJ and CNPq grants. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anisimova M, 2006, SYST BIOL, V55, P539, DOI 10.1080/10635150600755453; Bello G, 2008, AIDS, V22, P1993, DOI 10.1097/QAD.0b013e328315e0aa; Bello G, 2009, AIDS RES HUM RETROV, V25, P1065, DOI 10.1089/aid.2009.0106; Brazilian Ministry of Health, 2011, AIDS EP B; Brazilian Ministry of Tourism, 2009, EX REP CHAR SIZ DOM; Brigido LFM, 2007, AIDS RES HUM RETROV, V23, P1579, DOI 10.1089/aid.2007.0102; Brindeiro RM, 2003, AIDS, V17, P1063, DOI 10.1097/00002030-200305020-00016; Veras NMC, 2011, J GEN VIROL, V92, P1698, DOI 10.1099/vir.0.028951-0; Couto-Fernandez JC, 2005, MEM I OSWALDO CRUZ, V100, P73, DOI 10.1590/S0074-02762005000100014; de Oliveira T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009311; Ferreira JLD, 2008, MEM I OSWALDO CRUZ, V103, P800, DOI 10.1590/S0074-02762008000800010; Drummond AJ, 2002, GENETICS, V161, P1307; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Fontella R, 2008, AIDS, V22, P2001, DOI 10.1097/QAD.0b013e3283108f69; da Silva MMG, 2010, BRAZ J INFECT DIS, V14, P495, DOI 10.1590/S1413-86702010000500012; Graf T, 2011, J CLIN VIROL, V51, P186, DOI 10.1016/j.jcv.2011.04.011; Guindon S, 2005, NUCLEIC ACIDS RES, V33, pW557, DOI 10.1093/nar/gki352; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Lemey P, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000520; Locateli D, 2007, J MED VIROL, V79, P1455, DOI 10.1002/jmv.20955; Machado LFA, 2009, AIDS RES HUM RETROV, V25, P961, DOI 10.1089/aid.2009.0027; Toledo PVM, 2010, BRAZ J INFECT DIS, V14, P230, DOI 10.1590/S1413-86702010000300006; Minin VN, 2008, MOL BIOL EVOL, V25, P1459, DOI 10.1093/molbev/msn090; Morgado MG, 1998, MEM I OSWALDO CRUZ, V93, P383, DOI 10.1590/S0074-02761998000300020; Pagel M, 2004, SYST BIOL, V53, P673, DOI 10.1080/10635150490522232; Parker J, 2008, INFECT GENET EVOL, V8, P239, DOI 10.1016/j.meegid.2007.08.001; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Raboni SM, 2010, MEM I OSWALDO CRUZ, V105, P1044, DOI 10.1590/S0074-02762010000800015; Rambaut A, 2014, TRACER V1 6; Rambaut A., 2009, FIGTREE V1 3 1 TREE; Rodrigues R, 2006, VIRUS RES, V116, P201, DOI 10.1016/j.virusres.2005.10.004; Rodrigues R, 2010, AIDS RES HUM RETROV, V26, P351, DOI 10.1089/aid.2009.0214; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Salustiano Cavalcanti AM, 2007, MEM I OSWALDO CRUZ, V102, P785, DOI 10.1590/S0074-02762007005000109; Santos AF, 2007, JAIDS-J ACQ IMM DEF, V45, P328; Simon D, 2010, REV SAUDE PUBLICA; SLATKIN M, 1989, GENETICS, V123, P603; Soares EAJM, 2003, JAIDS-J ACQ IMM DEF, V34, P520, DOI 10.1097/00126334-200312150-00012; Stefani MMA, 2007, J CLIN VIROL, V39, P205, DOI 10.1016/j.jcv.2007.04.012; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Wang TH, 2001, J VIROL, V75, P11686, DOI 10.1128/JVI.75.23.11686-11699.2001	42	20	21	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2012	7	4							e35649	10.1371/journal.pone.0035649	http://dx.doi.org/10.1371/journal.pone.0035649			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959XD	22530062	Green Published, gold, Green Submitted			2022-12-25	WOS:000305350600108
J	Chen, MF; Huang, JJ; Yang, XJ; Liu, BQ; Zhang, WZ; Huang, L; Deng, F; Ma, J; Bai, YJ; Lu, R; Huang, B; Gao, QY; Zhuo, YH; Ge, J				Chen, Mengfei; Huang, Jingjing; Yang, Xuejiao; Liu, Bingqian; Zhang, Weizhong; Huang, Li; Deng, Fei; Ma, Jian; Bai, Yujing; Lu, Rong; Huang, Bing; Gao, Qianying; Zhuo, Yehong; Ge, Jian			Serum Starvation Induced Cell Cycle Synchronization Facilitates Human Somatic Cells Reprogramming	PLOS ONE			English	Article							PLURIPOTENT STEM-CELLS; HUMAN FIBROBLASTS; EXPRESSION; GENERATION; INDUCTION; PROMOTE; DEPENDS; RANGE	Human induced pluripotent stem cells (iPSCs) provide a valuable model for regenerative medicine and human disease research. To date, however, the reprogramming efficiency of human adult cells is still low. Recent studies have revealed that cell cycle is a key parameter driving epigenetic reprogramming to pluripotency. As is well known, retroviruses such as the Moloney murine leukemia virus (MoMLV) require cell division to integrate into the host genome and replicate, whereas the target primary cells for reprogramming are a mixture of several cell types with different cell cycle rhythms. Whether cell cycle synchronization has potential effect on retrovirus induced reprogramming has not been detailed. In this study, utilizing transient serum starvation induced synchronization, we demonstrated that starvation generated a reversible cell cycle arrest and synchronously progressed through G2/M phase after release, substantially improving retroviral infection efficiency. Interestingly, synchronized human dermal fibroblasts (HDF) and adipose stem cells (ASC) exhibited more homogenous epithelial morphology than normal FBS control after infection, and the expression of epithelial markers such as E-cadherin and Epcam were strongly activated. Futhermore, synchronization treatment ultimately improved Nanog positive clones, achieved a 15-20 fold increase. These results suggested that cell cycle synchronization promotes the mesenchymal to epithelial transition (MET) and facilitates retrovirus mediated reprogramming. Our study, utilization of serum starvation rather than additional chemicals, provide a new insight into cell cycle regulation and induced reprogramming of human cells.	[Chen, Mengfei; Huang, Jingjing; Yang, Xuejiao; Liu, Bingqian; Zhang, Weizhong; Huang, Li; Deng, Fei; Ma, Jian; Bai, Yujing; Lu, Rong; Huang, Bing; Gao, Qianying; Zhuo, Yehong; Ge, Jian] Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, State Key Lab Ophthalmol, Guangzhou 510275, Guangdong, Peoples R China; [Chen, Mengfei] Univ Pittsburgh, Sch Med, Dept Microbiol & Mol Genet, Pittsburgh, PA USA	Sun Yat Sen University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Chen, MF (corresponding author), Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, State Key Lab Ophthalmol, Guangzhou 510275, Guangdong, Peoples R China.	zhuoyh@mail.sysu.edu.cn; gejian@mail.sysu.edu.cn	Chen, Mengfei/T-7020-2018; Chen, Mengfei/N-2474-2019; Yang, Xuejiao/GPG-4151-2022	Chen, Mengfei/0000-0001-6922-1221; Yang, Xuejiao/0000-0002-5347-1071	National Basic Research Program of China (973 project) [2007CB512207]; National Natural Science Foundation of China [30973226/H1205, 30872832, 30901634]; China Postdoctoral Science Foundation [20090460814]; High-level Talents Project in Universities and Colleges of Guangdong Province	National Basic Research Program of China (973 project)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); High-level Talents Project in Universities and Colleges of Guangdong Province	Supported by the National Basic Research Program of China (973 project) no. 2007CB512207, National Natural Science Foundation of China nos. 30973226/H1205, 30872832, 30901634, China Postdoctoral Science Foundation funded project 20090460814, and High-level Talents Project in Universities and Colleges of Guangdong Province (2011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aasen T, 2008, NAT BIOTECHNOL, V26, P1276, DOI 10.1038/nbt.1503; Andreadis ST, 1997, J VIROL, V71, P7541, DOI 10.1128/JVI.71.10.7541-7548.1997; Attardi LD, 2004, ONCOGENE, V23, P973, DOI 10.1038/sj.onc.1207026; Brambrink T, 2008, CELL STEM CELL, V2, P151, DOI 10.1016/j.stem.2008.01.004; Cai K, 1998, P NATL ACAD SCI USA, V95, P12254, DOI 10.1073/pnas.95.21.12254; Chen TT, 2010, STEM CELLS, V28, P1315, DOI 10.1002/stem.456; Chuck AS, 1996, HUM GENE THER, V7, P743, DOI 10.1089/hum.1996.7.6-743; Colman A, 2009, CELL STEM CELL, V5, P244, DOI 10.1016/j.stem.2009.08.010; Huangfu DW, 2008, NAT BIOTECHNOL, V26, P1269, DOI 10.1038/nbt.1502; Esteban MA, 2010, CELL STEM CELL, V6, P71, DOI 10.1016/j.stem.2009.12.001; Feng B, 2009, CELL STEM CELL, V4, P301, DOI 10.1016/j.stem.2009.03.005; Gilroy DW, 2001, AM J PHYSIOL-CELL PH, V281, pC188, DOI 10.1152/ajpcell.2001.281.1.C188; Hanna J, 2009, NATURE, V462, P595, DOI 10.1038/nature08592; Hanna JH, 2010, CELL, V143, P508, DOI 10.1016/j.cell.2010.10.008; Hong H, 2009, NATURE, V460, P1132, DOI 10.1038/nature08235; Hu QR, 2010, STEM CELLS, V28, P1981, DOI 10.1002/stem.531; Jaenisch R, 2008, CELL, V132, P567, DOI 10.1016/j.cell.2008.01.015; Kondo T, 2005, P NATL ACAD SCI USA, V102, P4789, DOI 10.1073/pnas.0408239102; KULKARNI GV, 1994, J CELL SCI, V107, P1169; Li RH, 2010, CELL STEM CELL, V7, P51, DOI 10.1016/j.stem.2010.04.014; Lin TX, 2009, NAT METHODS, V6, P805, DOI [10.1038/nmeth.1393, 10.1038/NMETH.1393]; Ling SY, 2011, J BIOL CHEM, V286, P14972, DOI 10.1074/jbc.M110.182527; Lowry WE, 2008, P NATL ACAD SCI USA, V105, P2883, DOI 10.1073/pnas.0711983105; Marchetto MCN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007076; Marson A, 2008, CELL STEM CELL, V3, P132, DOI 10.1016/j.stem.2008.06.019; Meyer JS, 2011, STEM CELLS, V29, P1206, DOI 10.1002/stem.674; Mikkelsen TS, 2008, NATURE, V454, P49, DOI 10.1038/nature07056; Niibe K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017610; Olivera A, 1999, J CELL BIOL, V147, P545, DOI 10.1083/jcb.147.3.545; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; ROE TY, 1993, EMBO J, V12, P2099, DOI 10.1002/j.1460-2075.1993.tb05858.x; Ruiz S, 2011, CURR BIOL, V21, P45, DOI 10.1016/j.cub.2010.11.049; Ruiz S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015526; Samavarchi-Tehrani P, 2010, CELL STEM CELL, V7, P64, DOI 10.1016/j.stem.2010.04.015; Smith KP, 2009, J CELL PHYSIOL, V220, P21, DOI 10.1002/jcp.21681; Sun N, 2009, P NATL ACAD SCI USA, V106, P15720, DOI 10.1073/pnas.0908450106; Suzuki Y, 2007, NAT REV MICROBIOL, V5, P187, DOI 10.1038/nrmicro1579; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Wang Y, 2010, STEM CELL REV REP, V6, P282, DOI 10.1007/s12015-010-9137-2; Wernig M, 2008, NAT BIOTECHNOL, V26, P916, DOI 10.1038/nbt1483; Yang Z, 2008, NAT CELL BIOL, V10, P748, DOI 10.1038/ncb1738; Yoshimura K, 2006, J CELL PHYSIOL, V208, P64, DOI 10.1002/jcp.20636; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zhao W, 2004, CELL RES, V14, P60, DOI 10.1038/sj.cr.7290203	44	62	62	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2012	7	4							e28203	10.1371/journal.pone.0028203	http://dx.doi.org/10.1371/journal.pone.0028203			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959XD	22529890	gold, Green Accepted, Green Published, Green Submitted			2022-12-25	WOS:000305350600001
J	Egea, PF; Muller-Steffner, H; Kuhn, I; Cakir-Kiefer, C; Oppenheimer, NJ; Stroud, RM; Kellenberger, E; Schuber, F				Egea, Pascal F.; Muller-Steffner, Helene; Kuhn, Isabelle; Cakir-Kiefer, Celine; Oppenheimer, Norman J.; Stroud, Robert M.; Kellenberger, Esther; Schuber, Francis			Insights into the Mechanism of Bovine CD38/NAD+Glycohydrolase from the X-Ray Structures of Its Michaelis Complex and Covalently-Trapped Intermediates	PLOS ONE			English	Article							ADP-RIBOSYL CYCLASE; ADENINE DINUCLEOTIDE GLYCOHYDROLASE; CALCIUM-MOBILIZING METABOLITES; HUMAN CD38; NAD+-GLYCOHYDROLASE; ACTIVE-SITE; CRYSTAL-STRUCTURE; TRANSITION-STATE; GLYCOSIDASE MECHANISMS; ENZYMATIC-HYDROLYSIS	Bovine CD38/NAD(+)glycohydrolase (bCD38) catalyses the hydrolysis of NAD(+) into nicotinamide and ADP-ribose and the formation of cyclic ADP-ribose (cADPR). We solved the crystal structures of the mono N-glycosylated forms of the ecto-domain of bCD38 or the catalytic residue mutant Glu218Gln in their apo state or bound to aFNAD or rFNAD, two 2'-fluorinated analogs of NAD(+). Both compounds behave as mechanism-based inhibitors, allowing the trapping of a reaction intermediate covalently linked to Glu218. Compared to the non-covalent (Michaelis) complex, the ligands adopt a more folded conformation in the covalent complexes. Altogether these crystallographic snapshots along the reaction pathway reveal the drastic conformational rearrangements undergone by the ligand during catalysis with the repositioning of its adenine ring from a solvent-exposed position stacked against Trp168 to a more buried position stacked against Trp181. This adenine flipping between conserved tryptophans is a prerequisite for the proper positioning of the N1 of the adenine ring to perform the nucleophilic attack on the C1' of the ribofuranoside ring ultimately yielding cADPR. In all structures, however, the adenine ring adopts the most thermodynamically favorable anti conformation, explaining why cyclization, which requires a syn conformation, remains a rare alternate event in the reactions catalyzed by bCD38 (cADPR represents only 1% of the reaction products). In the Michaelis complex, the substrate is bound in a constrained conformation; the enzyme uses this ground-state destabilization, in addition to a hydrophobic environment and desolvation of the nicotinamide-ribosyl bond, to destabilize the scissile bond leading to the formation of a ribooxocarbenium ion intermediate. The Glu218 side chain stabilizes this reaction intermediate and plays another important role during catalysis by polarizing the 2'-OH of the substrate NAD(+). Based on our structural analysis and data on active site mutants, we propose a detailed analysis of the catalytic mechanism.	[Egea, Pascal F.] Univ Calif Los Angeles, Dept Biol Chem, Los Angeles, CA 90024 USA; [Muller-Steffner, Helene; Kuhn, Isabelle; Cakir-Kiefer, Celine; Schuber, Francis] Univ Strasbourg, CNRS, UMR 7199, Lab Concept & Applicat Mol Bioact,Fac Pharm, Illkirch Graffenstaden, France; [Cakir-Kiefer, Celine] Nancy Univ, UR AFPA, Vandoeuvre Les Nancy, France; [Oppenheimer, Norman J.] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94143 USA; [Stroud, Robert M.] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA; [Kellenberger, Esther] Univ Strasbourg, CNRS, UMR 7200, Lab Innovat Therapeut,Fac Pharm, Illkirch Graffenstaden, France	University of California System; University of California Los Angeles; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Universite de Lorraine; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Egea, PF (corresponding author), Univ Calif Los Angeles, Dept Biol Chem, Los Angeles, CA 90024 USA.	pegea@mednet.ucla.edu; schuber@unistra.fr	Egea, Pascal Francois/AAI-2759-2020; egea, pascal/V-7662-2019	egea, pascal/0000-0003-4432-8625; Kellenberger, Esther/0000-0002-9320-4840	CNRS; French Ministry of Research; Agence Nationale de la Recherche [ANR-05-BLAN-0076]; National Institute of Health [GM60641, GM094625]; UCLA David Geffen School of Medicine; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060641, U54GM094625] Funding Source: NIH RePORTER	CNRS(Centre National de la Recherche Scientifique (CNRS)); French Ministry of Research(Ministry of Research, FranceEuropean Commission); Agence Nationale de la Recherche(French National Research Agency (ANR)); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UCLA David Geffen School of Medicine; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the CNRS, the French Ministry of Research, and the Agence Nationale de la Recherche (Grant ANR-05-BLAN-0076 to FS and EK). PFE was supported by the National Institute of Health grants GM60641 (no longer active) and GM094625 and is currently supported by funds from the UCLA David Geffen School of Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharya P, 2003, J ORG CHEM, V68, P1529, DOI 10.1021/jo026572e; Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Augustin A, 2000, BIOCHEM J, V345, P43, DOI 10.1042/0264-6021:3450043; Bell CE, 1997, PROTEIN SCI, V6, P2084; Berthelier V, 1998, BIOCHEM J, V330, P1383, DOI 10.1042/bj3301383; Bissantz C, 2010, J MED CHEM, V53, P5061, DOI 10.1021/jm100112j; Bruice TC, 2006, CHEM REV, V106, P3119, DOI 10.1021/cr050283j; Buckley N, 1996, J ORG CHEM, V61, P7360, DOI 10.1021/jo960729j; BULL HG, 1978, J BIOL CHEM, V253, P5186; Cakir-Kiefer C, 2000, BIOCHEM J, V349, P203, DOI 10.1042/0264-6021:3490203; Dalvit C, 2011, CHEMMEDCHEM, V6, P104, DOI 10.1002/cmdc.201000412; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; De Flora A, 2004, ANN NY ACAD SCI, V1028, P176, DOI 10.1196/annals.1322.021; Degano M, 1998, BIOCHEMISTRY-US, V37, P6277, DOI 10.1021/bi973012e; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Dudev T, 2010, J AM CHEM SOC, V132, P16533, DOI 10.1021/ja106600k; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fedorov A, 2001, BIOCHEMISTRY-US, V40, P853, DOI 10.1021/bi002499f; Goodrich SP, 2005, BIOCHEMISTRY-US, V44, P11082, DOI 10.1021/bi050704r; Graeff R, 2001, J BIOL CHEM, V276, P12169, DOI 10.1074/jbc.M011299200; Graeff R, 2009, J BIOL CHEM, V284, P27629, DOI 10.1074/jbc.M109.030965; GRAEFF RM, 1994, J BIOL CHEM, V269, P30260; HANDLON AL, 1994, J AM CHEM SOC, V116, P12087, DOI 10.1021/ja00105a073; Hawse WF, 2008, STRUCTURE, V16, P1368, DOI 10.1016/j.str.2008.05.015; Hohenstein EG, 2009, J PHYS CHEM A, V113, P878, DOI 10.1021/jp809062x; Holton J, 2004, P NATL ACAD SCI USA, V101, P1537, DOI 10.1073/pnas.0306241101; HONG L, 1992, J MED CHEM, V35, P3560, DOI 10.1021/jm00097a013; HOWARD M, 1993, SCIENCE, V262, P1056, DOI 10.1126/science.8235624; IUPAC-IUB Joint Commission on Biochemical Nomenclature (JCBN), 1983, EUR J BIOCHEM, V131, P9; JACKSON DG, 1990, J IMMUNOL, V144, P2811; Kahn K, 2001, J AM CHEM SOC, V123, P11960, DOI 10.1021/ja0113807; Kellenberger E, 2011, BIOORG MED CHEM LETT, V21, P3939, DOI 10.1016/j.bmcl.2011.05.022; Khalili-Araghi F, 2009, CURR OPIN STRUC BIOL, V19, P128, DOI 10.1016/j.sbi.2009.02.011; Kuhn I, 2006, BIOCHEMISTRY-US, V45, P11867, DOI 10.1021/bi060930g; Lacapere JJ, 2003, BBA-PROTEINS PROTEOM, V1652, P17, DOI 10.1016/j.bbapap.2003.07.002; LEE HC, 1991, CELL REGUL, V2, P203, DOI 10.1091/mbc.2.3.203; Lee HC, 1997, PHYSIOL REV, V77, P1133, DOI 10.1152/physrev.1997.77.4.1133; LEE HC, 1989, J BIOL CHEM, V264, P1608; Lee HC, 2001, ANNU REV PHARMACOL, V41, P317, DOI 10.1146/annurev.pharmtox.41.1.317; Lee HC, 2006, MOL MED, V12, P317, DOI 10.2119/2006-00086.Lee; Liu Q, 2005, STRUCTURE, V13, P1331, DOI 10.1016/j.str.2005.05.012; Liu Q, 2008, CHEM BIOL, V15, P1068, DOI 10.1016/j.chembiol.2008.08.007; Liu Q, 2007, J BIOL CHEM, V282, P5853, DOI 10.1074/jbc.M609093200; Liu Q, 2006, J BIOL CHEM, V281, P32861, DOI 10.1074/jbc.M606365200; Loverix S, 2005, J BIOL CHEM, V280, P14799, DOI 10.1074/jbc.M413231200; Ma JC, 1997, CHEM REV, V97, P1303, DOI 10.1021/cr9603744; Malavasi F, 2008, PHYSIOL REV, V88, P841, DOI 10.1152/physrev.00035.2007; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Moreno-Garcia ME, 2004, EUR J BIOCHEM, V271, P1025, DOI 10.1111/j.1432-1033.2004.04006.x; Muller K, 2007, SCIENCE, V317, P1881, DOI 10.1126/science.1131943; MULLER CD, 1984, BIOCHEM J, V223, P715, DOI 10.1042/bj2230715; MULLER HM, 1983, BIOCHEM J, V212, P459, DOI 10.1042/bj2120459; Muller-Steffner H, 2010, PROTEIN EXPRES PURIF, V70, P151, DOI 10.1016/j.pep.2009.10.003; MULLERSTEFFNER H, 1994, BIOCHEM BIOPH RES CO, V204, P1279, DOI 10.1006/bbrc.1994.2601; MULLERSTEFFNER H, 1993, ARCH BIOCHEM BIOPHYS, V304, P154, DOI 10.1006/abbi.1993.1333; MullerSteffner HM, 1996, J BIOL CHEM, V271, P23967, DOI 10.1074/jbc.271.39.23967; MULLERSTEFFNER HM, 1992, J BIOL CHEM, V267, P9606; Munshi C, 2000, J BIOL CHEM, V275, P21566, DOI 10.1074/jbc.M909365199; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; O'Hagan D, 2008, CHEM SOC REV, V37, P308, DOI 10.1039/b711844a; OPPENHEIMER NJ, 1994, MOL CELL BIOCHEM, V138, P245, DOI 10.1007/BF00928468; Ortolan E, 2002, CELL BIOCHEM FUNCT, V20, P309, DOI 10.1002/cbf.978; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Perrakis A, 1997, ACTA CRYSTALLOGR D, V53, P448, DOI 10.1107/S0907444997005696; Philip V, 2011, BIOCHEMISTRY-US, V50, P2939, DOI 10.1021/bi200066k; Prasad GS, 1996, NAT STRUCT BIOL, V3, P957, DOI 10.1038/nsb1196-957; Price S.R., 1987, PYRIDINE NUCLEOTIDE, V2B, P513; Rempel BP, 2008, GLYCOBIOLOGY, V18, P570, DOI 10.1093/glycob/cwn041; Rye CS, 2000, CURR OPIN CHEM BIOL, V4, P573, DOI 10.1016/S1367-5931(00)00135-6; Saenger W., 1984, PRINCIPLES NUCL ACID; Sauve AA, 1998, BIOCHEMISTRY-US, V37, P13239, DOI 10.1021/bi981248s; Sauve AA, 2000, J AM CHEM SOC, V122, P7855, DOI 10.1021/ja001139c; SCHUBER F, 1978, EUR J BIOCHEM, V83, P205, DOI 10.1111/j.1432-1033.1978.tb12085.x; SCHUBER F, 1976, EUR J BIOCHEM, V69, P593, DOI 10.1111/j.1432-1033.1976.tb10945.x; Schuber F, 2004, CURR MOL MED, V4, P249, DOI 10.2174/1566524043360708; Singh NJ, 2009, J CHEM THEORY COMPUT, V5, P515, DOI 10.1021/ct800471b; Song EK, 2011, J BIOL CHEM, V286, P44480, DOI 10.1074/jbc.M111.307645; STOLARSKI R, 1980, EUR J BIOCHEM, V108, P111, DOI 10.1111/j.1432-1033.1980.tb04701.x; Sumoza-Toledo A, 2011, J PHYSIOL-LONDON, V589, P1515, DOI 10.1113/jphysiol.2010.201855; TARNUS C, 1987, BIOORG CHEM, V15, P31, DOI 10.1016/0045-2068(87)90004-6; TARNUS C, 1988, BIOORG CHEM, V16, P38, DOI 10.1016/0045-2068(88)90036-3; Tsuzuki S, 2007, J AM CHEM SOC, V129, P8656, DOI 10.1021/ja071372b; Yamamoto-Katayama S, 2002, J MOL BIOL, V316, P711, DOI 10.1006/jmbi.2001.5386; Zechel DL, 2000, ACCOUNTS CHEM RES, V33, P11, DOI 10.1021/ar970172+; Zhang HM, 2011, J MOL BIOL, V405, P1070, DOI 10.1016/j.jmb.2010.11.044; Zhang R, 2008, J ORG CHEM, V73, P3070, DOI 10.1021/jo702565q	86	19	19	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2012	7	4							e34918	10.1371/journal.pone.0034918	http://dx.doi.org/10.1371/journal.pone.0034918			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959XD	22529956	Green Submitted, Green Published, gold			2022-12-25	WOS:000305350600042
J	Gao, P; Song, YX; Wang, ZN; Xu, YY; Tong, LL; Zhu, JL; Tang, QC; Xu, HM				Gao, Peng; Song, Yong-xi; Wang, Zhen-ning; Xu, Ying-ying; Tong, Lin-lin; Zhu, Jin-liang; Tang, Qing-chao; Xu, Hui-mian			Integrated Ratio of Metastatic to Examined Lymph Nodes and Number of Metastatic Lymph Nodes into the AJCC Staging System for Colon Cancer	PLOS ONE			English	Article							III COLORECTAL-CANCER; PROGNOSTIC VALUE; SURVIVAL MODELS	Objective: At present, only the number of metastatic lymph nodes (LNs+) is used for the pN category of AJCC TNM system for colon cancer. Recently, the ratio of metastatic to examined lymph nodes (LNR) has been reported to represent powerful independent predictive capacity in colon cancer. We sought to propose a novel category (nLN) which intergrades LNR and LNs+ into the AJCC staging system for colon cancer. Design: 34476 patients from the National Cancer Institute's Surveillance, Epidemiology, and End Results (SEER) dataset with stage III colon cancer were reviewed. Harrell's C statistic was used to evaluate the predictive capacity. The Cox proportional hazards model was used to construct a novel category. Results: The LNR category had more predictive capacity than the pN category in whole groups of patients (Harrell's C index: 0.6194 vs 0.6113, p = 0.003). Subgroup analysis showed that the LNR category was not better than pN category in predictive capacity if the number of lymph nodes examined was more than 13. We also found that there was significant survival heterogeneity among different pN categories at the same LNR category (P < 0.001). The Harrell's C index for our nLN category which intergrades LNR and LNs+ was 0.6228, which was significant higher than that of the pN category (Harrell's C index: 0.6113, P < 0.001) or LNR category (Harrell's C index: 0.6194, P = 0.005), respectively. Conclusion: To evaluate the prognosis of colon cancer, our nLN category which intergrades LNR with LNs+ is more accurate than the pN category or LNR category, respectively.	[Gao, Peng; Song, Yong-xi; Wang, Zhen-ning; Xu, Ying-ying; Tong, Lin-lin; Zhu, Jin-liang; Tang, Qing-chao; Xu, Hui-mian] China Med Univ, Dept Surg Oncol & Gen Surg, First Hosp, Shenyang, Peoples R China	China Medical University	Wang, ZN (corresponding author), China Med Univ, Dept Surg Oncol & Gen Surg, First Hosp, Shenyang, Peoples R China.	josieon826@yahoo.com.cn	Gao, Peng/B-8031-2013; wang, zhen ning/E-1878-2011; Xu, Yingying/E-3884-2018	wang, zhen ning/0000-0003-0557-3097; Xu, Yingying/0000-0003-4924-9379	National Science Foundation of China [30972879, 81172370]; Specialized Research Fund for the Doctoral Program of Higher Education [200801590006]; Natural Science Foundation of Liaoning Province [20092129]; Program of Scientific and Technological Department of Liaoning Province [2010225032]; Program of Education Department of Liaoning Province [L2011137]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Specialized Research Fund for the Doctoral Program of Higher Education(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Natural Science Foundation of Liaoning Province(Natural Science Foundation of Liaoning Province); Program of Scientific and Technological Department of Liaoning Province; Program of Education Department of Liaoning Province	This work was supported by National Science Foundation of China (no. 30972879 and no. 81172370), Specialized Research Fund for the Doctoral Program of Higher Education (no. 200801590006), Natural Science Foundation of Liaoning Province (no. 20092129), the Program of Scientific and Technological Department of Liaoning Province (no. 2010225032) and the Program of Education Department of Liaoning Province (L2011137). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benson AB, 2012, NCCN CLIN PRACTICE G; Berger AC, 2005, J CLIN ONCOL, V23, P8706, DOI 10.1200/JCO.2005.02.8852; Ceelen W, 2010, ANN SURG ONCOL, V17, P2847, DOI 10.1245/s10434-010-1158-1; Chen SL, 2006, ANN SURG, V244, P602, DOI 10.1097/01.sla.0000237655.11717.50; Chen SL, 2011, ANN SURG, V253, P82, DOI 10.1097/SLA.0b013e3181ffa780; Compton CC, 2000, ARCH PATHOL LAB MED, V124, P979; Derwinger K, 2008, EJSO-EUR J SURG ONC, V34, P771, DOI 10.1016/j.ejso.2007.11.002; Downing SR, 2010, J SURG RES, V163, P264, DOI 10.1016/j.jss.2010.03.017; Edge SB, 2010, AJCC CANC STAGING MA; Greene FL, 2007, LANCET ONCOL, V8, P572, DOI 10.1016/S1470-2045(07)70185-7; Harrell FE, 1996, STAT MED, V15, P361, DOI 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4; Hashiguchi Y, 2010, ANN SURG, V251, P872, DOI 10.1097/SLA.0b013e3181c0e5b1; Hong KD, 2011, J SURG ONCOL, V103, P406, DOI 10.1002/jso.21830; Huh JW, 2010, ANN SURG ONCOL, V17, P2640, DOI 10.1245/s10434-010-1015-2; Le Voyer TE, 2003, J CLIN ONCOL, V21, P2912, DOI 10.1200/JCO.2003.05.062; Moug SJ, 2009, BRIT J CANCER, V100, P1530, DOI 10.1038/sj.bjc.6605049; NAGELKERKE NJD, 1991, BIOMETRIKA, V78, P691, DOI 10.1093/biomet/78.3.691; Newson RB, 2010, STATA J, V10, P339, DOI 10.1177/1536867X1001000303; Noura S, 2010, WORLD J GASTRO SURG, V2, P70, DOI 10.4240/wjgs.v2.i3.70; Priolli DG, 2009, TECH COLOPROCTOL, V13, P113, DOI 10.1007/s10151-009-0467-5; Rosenberg R, 2010, ANN SURG, V251, P1070, DOI 10.1097/SLA.0b013e3181d7789d; Rosenberg R, 2008, ANN SURG, V248, P968, DOI 10.1097/SLA.0b013e318190eddc; Siegel R, 2011, CA-CANCER J CLIN, V61, P212, DOI 10.3322/caac.20121; Song X, 2008, STAT SINICA, V18, P947; Swanson RS, 2003, ANN SURG ONCOL, V10, P65, DOI 10.1245/ASO.2003.03.058; Tong LL, 2011, ANN SURG ONCOL, V18, P2453, DOI 10.1245/s10434-011-1687-2; Vaccaro CA, 2009, DIS COLON RECTUM, V52, P1244, DOI 10.1007/DCR.0b013e3181a65f0b; Volinsky CT, 2000, BIOMETRICS, V56, P256, DOI 10.1111/j.0006-341X.2000.00256.x; Wong KP, 2011, COLORECTAL DIS, V13, P1116, DOI 10.1111/j.1463-1318.2010.02435.x	29	17	17	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2012	7	4							e35021	10.1371/journal.pone.0035021	http://dx.doi.org/10.1371/journal.pone.0035021			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959XD	22529970	Green Published, gold, Green Submitted			2022-12-25	WOS:000305350600052
J	Kasuga, T; Kozanitas, M; Bui, M; Huberli, D; Rizzo, DM; Garbelotto, M				Kasuga, Takao; Kozanitas, Melina; Bui, Mai; Hueberli, Daniel; Rizzo, David M.; Garbelotto, Matteo			Phenotypic Diversification Is Associated with Host-Induced Transposon Derepression in the Sudden Oak Death Pathogen Phytophthora ramorum	PLOS ONE			English	Article							3 CLONAL LINEAGES; GENOME SEQUENCE; CALIFORNIA; EVOLUTION; TRANSMISSION; FOREST; VARIABILITY; POPULATIONS; CINNAMOMI; INFECTION	The oomycete pathogen Phytophthora ramorum is responsible for sudden oak death (SOD) in California coastal forests. P. ramorum is a generalist pathogen with over 100 known host species. Three or four closely related genotypes of P. ramorum (from a single lineage) were originally introduced in California forests and the pathogen reproduces clonally. Because of this the genetic diversity of P. ramorum is extremely low in Californian forests. However, P. ramorum shows diverse phenotypic variation in colony morphology, colony senescence, and virulence. In this study, we show that phenotypic variation among isolates is associated with the host species from which the microbe was originally cultured. Microarray global mRNA profiling detected derepression of transposable elements (TEs) and down-regulation of crinkler effector homologs (CRNs) in the majority of isolates originating from coast live oak (Quercus agrifolia), but this expression pattern was not observed in isolates from California bay laurel (Umbellularia californica). In some instances, oak and bay laurel isolates originating from the same geographic location had identical genotypes based on multilocus simples sequence repeat (SSR) marker analysis but had different phenotypes. Expression levels of the two marker genes analyzed by quantitative reverse transcription PCR were correlated with originating host species, but not with multilocus genotypes. Because oak is a nontransmissive dead-end host for P. ramorum, our observations are congruent with an epi-transposon hypothesis; that is, physiological stress is triggered on P. ramorum while colonizing oak stems and disrupts epigenetic silencing of TEs. This then results in TE reactivation and possibly genome diversification without significant epidemiological consequences. We propose the P. ramorum-oak host system in California forests as an ad hoc model for epi-transposon mediated diversification.	[Kasuga, Takao; Bui, Mai] USDA ARS, Crops Pathol & Genet Res Unit, Davis, CA USA; [Kozanitas, Melina; Hueberli, Daniel; Garbelotto, Matteo] Univ Calif Berkeley, Dept Environm Sci Policy & Management, Berkeley, CA 94720 USA; [Rizzo, David M.] Univ Calif Davis, Dept Plant Pathol, Davis, CA 95616 USA	United States Department of Agriculture (USDA); University of California System; University of California Berkeley; University of California System; University of California Davis	Kasuga, T (corresponding author), USDA ARS, Crops Pathol & Genet Res Unit, Davis, CA USA.	matteog@berkeley.edu	Huberli, Daniel/C-7257-2013		National Science Foundation (NSF); National Institutes of Health (NIH) Ecology of Infectious Diseases [EF-0622770, 1115607]; Gordon and Betty Moore Foundation; Pacific Southwest Research Station, the United States Department of Agriculture (USDA) Forest Service; USDA Agricultural Research Service CRIS Project [5306-22000-014-00D]; Direct For Biological Sciences [1115607] Funding Source: National Science Foundation	National Science Foundation (NSF)(National Science Foundation (NSF)); National Institutes of Health (NIH) Ecology of Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); Pacific Southwest Research Station, the United States Department of Agriculture (USDA) Forest Service; USDA Agricultural Research Service CRIS Project(United States Department of Agriculture (USDA)USDA Agricultural Research Service); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by the National Science Foundation (NSF) and the National Institutes of Health (NIH) Ecology of Infectious Diseases # EF-0622770 (to DMR) and # 1115607 (to MG); The Gordon and Betty Moore Foundation (to DMR and to MG); the Pacific Southwest Research Station, the United States Department of Agriculture (USDA) Forest Service (to MG); and USDA Agricultural Research Service CRIS Project # 5306-22000-014-00D (to TK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-El Samen FM, 2003, PHYTOPATHOLOGY, V93, P293, DOI 10.1094/PHYTO.2003.93.3.293; Akinsanmi OA, 2007, ENVIRON MICROBIOL, V9, P512, DOI 10.1111/j.1462-2920.2006.01168.x; ANAGNOSTAKIS SL, 1987, MYCOLOGIA, V79, P23, DOI 10.2307/3807741; Bourhy H, 2008, J GEN VIROL, V89, P2673, DOI 10.1099/vir.0.2008/003913-0; Brasier C, 2006, PROGR RES PHYTOPHTHO, P166; BRASIER CM, 1995, MYCOL RES, V99, P205, DOI 10.1016/S0953-7562(09)80887-3; Brazma A, 2001, NAT GENET, V29, P365, DOI 10.1038/ng1201-365; Callahan ME, 1999, J VIROL, V73, P9619, DOI 10.1128/JVI.73.11.9619-9624.1999; Davidson JM, 2008, PHYTOPATHOLOGY, V98, P860, DOI 10.1094/PHYTO-98-8-0860; Davidson JM, 2011, PHYTOPATHOLOGY, V101, P492, DOI 10.1094/PHYTO-03-10-0064; Davidson JM, 2005, PHYTOPATHOLOGY, V95, P587, DOI 10.1094/PHYTO-95-0587; Dean RA, 2005, NATURE, V434, P980, DOI 10.1038/nature03449; Della Rocca G, 2011, PHYTOPATHOLOGY, V101, P1408, DOI 10.1094/PHYTO-05-11-0144; Denisov V, 2008, BIORAD B; Dobrowolski MP, 2003, PHYTOPATHOLOGY, V93, P695, DOI 10.1094/PHYTO.2003.93.6.695; Dodd RS, 2005, NEW PHYTOL, V165, P203, DOI 10.1111/j.1469-8137.2004.01200.x; Dudoit S, 2002, STAT SINICA, V12, P111; DUDZINSKI MJ, 1993, AUST J BOT, V41, P721, DOI 10.1071/BT9930721; Eldredge N., 1972, P82; Elliott M, 2011, FOREST PATHOL, V41, P7, DOI 10.1111/j.1439-0329.2009.00627.x; ENGLANDER L, 1980, PHYTOPATHOLOGY, V70, P650, DOI 10.1094/Phyto-70-650; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Gijzen M, 2009, OOMYCETE GENETICS GE; Gomez-Alpizar L, 2007, P NATL ACAD SCI USA, V104, P3306, DOI 10.1073/pnas.0611479104; Grunwald NJ, 2008, PLANT DIS, V92, P314, DOI 10.1094/PDIS-92-2-0314B; Grunwald NJ, 2005, ANNU REV PHYTOPATHOL, V43, P171, DOI 10.1146/annurev.phyto.43.040204.135906; Haas BJ, 2009, NATURE, V461, P393, DOI 10.1038/nature08358; Hayden K, 2006, PHYTOPATHOLOGY, V96, P846, DOI 10.1094/PHYTO-96-0846; Holmes EC, 2006, P NATL ACAD SCI USA, V103, P4803, DOI 10.1073/pnas.0601166103; Huberli D, 2001, MYCOL RES, V105, P1053, DOI 10.1016/S0953-7562(08)61967-X; Huberli D, 2012, FOREST PATHOL, V42, P8, DOI 10.1111/j.1439-0329.2011.00715.x; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Ivors K, 2006, MOL ECOL, V15, P1493, DOI 10.1111/j.1365-294X.2006.02864.x; Ivors KL, 2004, MYCOL RES, V108, P378, DOI 10.1017/S0953756204009827; JONES J P, 1969, Plant Disease Reporter, V53, P907; JONES JP, 1969, PHYTOPATHOLOGY, V59, P504; Kasuga T, 2011, FUNGAL GENETICS REPO, V58, P4; Kerr MK, 2001, GENET RES, V77, P123; KING MC, 1975, SCIENCE, V188, P107, DOI 10.1126/science.1090005; Klosterman SJ, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002137; Kondrashov FA, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-2-research0008; Kozlakidis Z, 2010, VIRUS GENES, V40, P130, DOI 10.1007/s11262-009-0421-7; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ma LJ, 2010, NATURE, V464, P367, DOI 10.1038/nature08850; Madlung A, 2004, ANN BOT-LONDON, V94, P481, DOI 10.1093/aob/mch172; Maloy OC, 1997, ANNU REV PHYTOPATHOL, V35, P87, DOI 10.1146/annurev.phyto.35.1.87; Mascheretti S, 2008, MOL ECOL, V17, P2755, DOI 10.1111/j.1365-294X.2008.03773.x; Mascheretti S, 2009, MOL ECOL, V18, P4577, DOI 10.1111/j.1365-294X.2009.04379.x; Nagle AM, 2011, FOREST PATHOL, V41, P464, DOI 10.1111/j.1439-0329.2010.00703.x; O'Fallon B, 2008, EVOLUTION, V62, P361, DOI 10.1111/j.1558-5646.2007.00289.x; Prospero S, 2007, MOL ECOL, V16, P2958, DOI 10.1111/j.1365-294X.2007.03343.x; Raffaele S, 2010, SCIENCE, V330, P1540, DOI 10.1126/science.1193070; Rebollo R, 2010, GENE, V454, P1, DOI 10.1016/j.gene.2010.01.003; Rizzo DM, 2005, ANNU REV PHYTOPATHOL, V43, P309, DOI 10.1146/annurev.phyto.42.040803.140418; RUTHERFORD FS, 1985, PHYTOPATHOLOGY, V75, P371, DOI 10.1094/Phyto-75-371; Seo J, 2002, COMPUTER, V35, P80; Shan WX, 2004, MOL PLANT MICROBE IN, V17, P394, DOI 10.1094/MPMI.2004.17.4.394; Slotkin RK, 2007, NAT REV GENET, V8, P272, DOI 10.1038/nrg2072; Spanu PD, 2010, SCIENCE, V330, P1543, DOI 10.1126/science.1194573; SWIECKI TJ, 2001, P 5 S OAK WOODL OAKS, P787; Tooley PW, 2009, PHYTOPATHOLOGY, V99, P1045, DOI 10.1094/PHYTO-99-9-1045; Torto TA, 2003, GENOME RES, V13, P1675, DOI 10.1101/gr.910003; TSAO PH, 1969, NATURE, V223, P636, DOI 10.1038/223636a0; Tyler BM, 2006, SCIENCE, V313, P1261, DOI 10.1126/science.1128796; Untergasser A, 2007, NUCLEIC ACIDS RES, V35, pW71, DOI 10.1093/nar/gkm306; Weaver SC, 2004, NAT REV MICROBIOL, V2, P789, DOI 10.1038/nrmicro1006; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI [10.2307/2408641, 10.1111/j.1558-5646.1984.tb05657.x]; Zeh DW, 2009, BIOESSAYS, V31, P715, DOI 10.1002/bies.200900026; Zhang Z, 2010, FUNGAL GENET BIOL, V47, P199, DOI 10.1016/j.fgb.2009.12.001	69	46	47	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2012	7	4							e34728	10.1371/journal.pone.0034728	http://dx.doi.org/10.1371/journal.pone.0034728			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959XD	22529930	Green Submitted, gold, Green Published			2022-12-25	WOS:000305350600023
J	Schecklmann, M; Vielsmeier, V; Steffens, T; Landgrebe, M; Langguth, B; Kleinjung, T				Schecklmann, Martin; Vielsmeier, Veronika; Steffens, Thomas; Landgrebe, Michael; Langguth, Berthold; Kleinjung, Tobias			Relationship between Audiometric Slope and Tinnitus Pitch in Tinnitus Patients: Insights into the Mechanisms of Tinnitus Generation	PLOS ONE			English	Article							HEARING-LOSS; VALIDATION	Background: Different mechanisms have been proposed to be involved in tinnitus generation, among them reduced lateral inhibition and homeostatic plasticity. On a perceptual level these different mechanisms should be reflected by the relationship between the individual audiometric slope and the perceived tinnitus pitch. Whereas some studies found the tinnitus pitch corresponding to the maximum hearing loss, others stressed the relevance of the edge frequency. This study investigates the relationship between tinnitus pitch and audiometric slope in a large sample. Methodology: This retrospective observational study analyzed 286 patients. The matched tinnitus pitch was compared to the frequency of maximum hearing loss and the edge of the audiogram (steepest hearing loss) by t-tests and correlation coefficients. These analyses were performed for the whole group and for sub-groups (uni- vs. bilateral (117 vs. 338 ears), pure-tone vs. narrow-band (340 vs. 115 ears), and low and high audiometric slope (114 vs. 113 ears)). Findings: For the right ear, tinnitus pitch was in the same range and correlated significantly with the frequency of maximum hearing loss, but differed from and did not correlate with the edge frequency. For the left ear, similar results were found but the correlation between tinnitus pitch and maximum hearing loss did not reach significance. Sub-group analyses (bi- and unilateral, tinnitus character, slope steepness) revealed identical results except for the sub-group with high audiometric slope which revealed a higher frequency of maximum hearing loss as compared to the tinnitus pitch. Conclusion: The study-results confirm a relationship between tinnitus pitch and maximum hearing loss but not to the edge frequency, suggesting that tinnitus is rather a fill-in-phenomenon resulting from homeostatic mechanisms, than the result of deficient lateral inhibition. Sub-group analyses suggest that audiometric steepness and the side of affected ear affect this relationship. Future studies should control for these potential confounding factors.	[Schecklmann, Martin; Landgrebe, Michael; Langguth, Berthold] Univ Regensburg, Dept Psychiat & Psychotherapy, Regensburg, Germany; [Schecklmann, Martin; Vielsmeier, Veronika; Landgrebe, Michael; Langguth, Berthold; Kleinjung, Tobias] Univ Regensburg, Interdisciplinary Tinnitus Clin, Regensburg, Germany; [Vielsmeier, Veronika; Steffens, Thomas; Kleinjung, Tobias] Univ Regensburg, Dept Otorhinolaryngol, Regensburg, Germany; [Vielsmeier, Veronika; Steffens, Thomas; Kleinjung, Tobias] Univ Zurich, Dept Otorhinolaryngol, Zurich, Switzerland	University of Regensburg; University of Regensburg; University of Regensburg; University of Zurich	Schecklmann, M (corresponding author), Univ Regensburg, Dept Psychiat & Psychotherapy, Regensburg, Germany.	tobias.kleinjung@usz.ch	Kleinjung, Tobias/AAJ-3141-2020; Langguth, Berthold/AAP-2638-2021	Kleinjung, Tobias/0000-0003-3867-234X; 	Tinnitus Research Initiative (TRI)	Tinnitus Research Initiative (TRI)	The study was funded in part by the Tinnitus Research Initiative (TRI). No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	De Ridder D, 2011, P NATL ACAD SCI USA, V108, P8075, DOI 10.1073/pnas.1018466108; GOEBEL G, 1994, HNO, V42, P166; Henry JA, 2006, ACTA OTO-LARYNGOL, V126, P34, DOI 10.1080/03655230600895291; Henry J A, 1999, J Am Acad Audiol, V10, P261; Hine DW, 2007, PSYCHOL ASSESSMENT, V19, P347, DOI 10.1037/1040-3590.19.3.347; Kaltenbach JA, 2011, HEARING RES, V276, P52, DOI 10.1016/j.heares.2010.12.003; Kleinjung T, 2007, PSYCHIAT PRAX, V34, pS140, DOI 10.1055/s-2006-940218; Konig O, 2006, HEARING RES, V221, P59, DOI 10.1016/j.heares.2006.07.007; Landgrebe M, 2010, BMC MED INFORM DECIS, V10, DOI 10.1186/1472-6947-10-42; Langguth B, 2007, PROG BRAIN RES, V166, P525, DOI 10.1016/S0079-6123(07)66050-6; Llinas RR, 1999, P NATL ACAD SCI USA, V96, P15222, DOI 10.1073/pnas.96.26.15222; Martines F, 2010, AURIS NASUS LARYNX, V37, P685, DOI 10.1016/j.anl.2010.03.008; Moffat G, 2009, HEARING RES, V254, P82, DOI 10.1016/j.heares.2009.04.016; Moller AR, 2003, OTOLARYNG CLIN N AM, V36, P249, DOI 10.1016/S0030-6665(02)00170-6; Moore BCJ, 2010, HEARING RES, V261, P51, DOI 10.1016/j.heares.2010.01.003; Moxon EC, 1970, SENSORINEURAL HEARIN; Norena A, 2002, AUDIOL NEURO-OTOL, V7, P358, DOI 10.1159/000066156; Norena AJ, 2011, NEUROSCI BIOBEHAV R, V35, P1089, DOI 10.1016/j.neubiorev.2010.11.003; Ochi K, 2003, LARYNGOSCOPE, V113, P427, DOI 10.1097/00005537-200303000-00007; Pan T, 2009, INT J AUDIOL, V48, P277, DOI 10.1080/14992020802581974; Roberts LE, 2006, ACTA OTO-LARYNGOL, V126, P27, DOI 10.1080/03655230600895358; Roberts LE, 2010, J NEUROSCI, V30, P14972, DOI 10.1523/JNEUROSCI.4028-10.2010; ROBERTSON D, 1989, J COMP NEUROL, V282, P456, DOI 10.1002/cne.902820311; Schaette R, 2010, HEARING RES, V269, P95, DOI 10.1016/j.heares.2010.06.022; Schaette R, 2009, J NEUROPHYSIOL, V101, P3042, DOI 10.1152/jn.91256.2008; Sereda M, 2011, INT J AUDIOL, V50, P303, DOI 10.3109/14992027.2010.551221; Tyler R S, 1983, Br J Audiol, V17, P101, DOI 10.3109/03005368309078916; Tyler R.S., 2000, TINNITUS HDB, P149	28	85	89	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2012	7	4							e34878	10.1371/journal.pone.0034878	http://dx.doi.org/10.1371/journal.pone.0034878			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959XD	22529949	Green Submitted, gold, Green Accepted, Green Published			2022-12-25	WOS:000305350600036
J	Simon, E; Petke, D; Boger, C; Behrens, HM; Warneke, V; Ebert, M; Rocken, C				Simon, Eva; Petke, Diana; Boeger, Christine; Behrens, Hans-Michael; Warneke, Viktoria; Ebert, Matthias; Roecken, Christoph			The Spatial Distribution of LGR5(+) Cells Correlates With Gastric Cancer Progression	PLOS ONE			English	Article							COUPLED RECEPTOR GPR49; STEM-CELLS; WNT/BETA-CATENIN; SOLID TUMORS; HUMAN COLON; EXPRESSION; MARKER; OVEREXPRESSION; MUSASHI-1; WNT	In this study we tested the prevalence, histoanatomical distribution and tumour biological significance of the Wnt target protein and cancer stem cell marker LGR5 in tumours of the human gastrointestinal tract. Differential expression of LGR5 was studied on transcriptional (real-time polymerase chain reaction) and translational level (immunohistochemistry) in malignant and corresponding non-malignant tissues of 127 patients comprising six different primary tumour sites, i.e. oesophagus, stomach, liver, pancreas, colon and rectum. The clinico-pathological significance of LGR5 expression was studied in 100 patients with gastric carcinoma (GC). Non-neoplastic tissue usually harboured only very few scattered LGR5(+) cells. The corresponding carcinomas of the oesophagus, stomach, liver, pancreas, colon and rectum showed significantly more LGR5(+) cells as well as significantly higher levels of LGR5-mRNA compared with the corresponding non-neoplastic tissue. Double staining experiments revealed a coexpression of LGR5 with the putative stem cell markers CD44, Musashi-1 and ADAM17. Next we tested the hypothesis that the sequential changes of gastric carcinogenesis, i.e. chronic atrophic gastritis, intestinal metaplasia and invasive carcinoma, are associated with a reallocation of the LGR5(+) cells. Interestingly, the spatial distribution of LGR5 changed: in non-neoplastic stomach mucosa, LGR5(+) cells were found predominantly in the mucous neck region; in intestinal metaplasia LGR5(+) cells were localized at the crypt base, and in GC LGR5(+) cells were present at the luminal surface, the tumour centre and the invasion front. The expression of LGR5 in the tumour centre and invasion front of GC correlated significantly with the local tumour growth (T-category) and the nodal spread (N-category). Furthermore, patients with LGR5(+) GCs had a shorter median survival (28.0 +/- 8.6 months) than patients with LGR5(+) GCs (54.5 +/- 6.3 months). Our results show that LGR5 is differentially expressed in gastrointestinal cancers and that the spatial histoanatomical distribution of LGR5(+) cells has to be considered when their tumour biological significance is sought.	[Simon, Eva; Petke, Diana; Boeger, Christine; Behrens, Hans-Michael; Warneke, Viktoria; Roecken, Christoph] Univ Kiel, Inst Pathol, D-2300 Kiel, Germany; [Ebert, Matthias] Heidelberg Univ, Fac Clin Med Mannheim, Dept Med 2, D-6800 Mannheim, Germany	University of Kiel; Ruprecht Karls University Heidelberg	Rocken, C (corresponding author), Univ Kiel, Inst Pathol, D-2300 Kiel, Germany.	christoph.roecken@uksh.de	Halske, Christine/K-1662-2017; Röcken, Christoph/A-9239-2010	Halske, Christine/0000-0001-7986-102X; Röcken, Christoph/0000-0002-6989-8002				Alkatout Ibrahim, 2008, P165, DOI 10.1007/978-1-4020-8274-0_10; Barker N, 2010, GASTROENTEROLOGY, V138, P1681, DOI 10.1053/j.gastro.2010.03.002; Barker N, 2010, CELL STEM CELL, V6, P25, DOI 10.1016/j.stem.2009.11.013; Barker N, 2009, NATURE, V457, P608, DOI 10.1038/nature07602; Bjelakovic G, 2008, ALIMENT PHARM THER, V28, P689, DOI 10.1111/j.1365-2036.2008.03785.x; Boyle P., 2009, WORLD CANC REPORT 20; Carmon KS, 2011, P NATL ACAD SCI USA, V108, P11452, DOI 10.1073/pnas.1106083108; Cho RW, 2008, CURR OPIN GENET DEV, V18, P48, DOI 10.1016/j.gde.2008.01.017; CORREA P, 1992, CANCER RES, V52, P6735; Danciu M, 2005, Rev Med Chir Soc Med Nat Iasi, V109, P854; de Lau W, 2011, NATURE, V476, P293, DOI 10.1038/nature10337; Draheim KM, 2011, METHODS MOL BIOL, V750, P261, DOI 10.1007/978-1-61779-145-1_18; Ebert MPA, 2006, ANN ONCOL, V17, pX253, DOI 10.1093/annonc/mdl269; Fan XS, 2010, INT J COLORECTAL DIS, V25, P583, DOI 10.1007/s00384-010-0903-z; Fanjul M, 2010, J HISTOCHEM CYTOCHEM, V58, P807, DOI 10.1369/jhc.2010.955807; Fenoglio-Preiser C, 2000, WHO CLASSIFICATION T, P39; Ferlay J, 2010, EUR J CANCER, V46, P765, DOI 10.1016/j.ejca.2009.12.014; Frank NY, 2010, J CLIN INVEST, V120, P41, DOI 10.1172/JCI41004; Glinka A, 2011, EMBO REP, V12, P1055, DOI 10.1038/embor.2011.175; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hemmings C, 2010, PATHOLOGY, V42, P105, DOI 10.3109/00313020903488773; Ingold B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010087; Leushacke M, 2012, ONCOGENE, V31, P3009, DOI 10.1038/onc.2011.479; Li F, 2007, CELL RES, V17, P3, DOI 10.1038/sj.cr.7310118; McClanahan T, 2006, CANCER BIOL THER, V5, P419, DOI 10.4161/cbt.5.4.2521; Nishimura S, 2003, DIGEST DIS SCI, V48, P1523, DOI 10.1023/A:1024763723240; Qiao XTT, 2011, J GASTROENTEROL, V46, P855, DOI 10.1007/s00535-011-0413-y; Reya T, 2005, NATURE, V434, P843, DOI 10.1038/nature03319; Rezza A, 2010, J CELL SCI, V123, P3256, DOI 10.1242/jcs.065284; Sato T, 2011, NATURE, V469, P415, DOI 10.1038/nature09637; Schmuck R, 2011, AM J PATHOL, V178, P1792, DOI 10.1016/j.ajpath.2010.12.043; Snippert HJ, 2010, CELL, V143, P134, DOI 10.1016/j.cell.2010.09.016; Sobin L.H., 2009, INT UNION CANC UICC, V7th; Sureban SM, 2008, GASTROENTEROLOGY, V134, P1448, DOI 10.1053/j.gastro.2008.02.057; Takahashi H, 2011, ANN SURG ONCOL, V18, P1166, DOI 10.1245/s10434-010-1373-9; Takaishi S, 2009, STEM CELLS, V27, P1006, DOI 10.1002/stem.30; Takeda K, 2011, ANTICANCER RES, V31, P263; Tanese K, 2008, AM J PATHOL, V173, P835, DOI 10.2353/ajpath.2008.071091; Tian H, 2011, NATURE, V478, P255, DOI 10.1038/nature10408; Todaro M, 2010, GASTROENTEROLOGY, V138, P2151, DOI 10.1053/j.gastro.2009.12.063; Uchida H, 2010, CANCER SCI, V101, P1731, DOI 10.1111/j.1349-7006.2010.01571.x; Visvader JE, 2008, NAT REV CANCER, V8, P755, DOI 10.1038/nrc2499; Walker F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022733; Wang T, 2011, BRIT J CANCER, V105, P658, DOI 10.1038/bjc.2011.287; Welte Y, 2010, CELL COMMUN SIGNAL, V8, DOI 10.1186/1478-811X-8-6; Wenke AK, 2007, CELL ONCOL, V29, P373	46	83	92	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2012	7	4							e35486	10.1371/journal.pone.0035486	http://dx.doi.org/10.1371/journal.pone.0035486			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959XD	22530031	Green Published, gold, Green Submitted			2022-12-25	WOS:000305350600087
J	Alieva, M; Bago, JR; Aguilar, E; Soler-Botija, C; Vila, OF; Molet, J; Gambhir, SS; Rubio, N; Blanco, J				Alieva, Maria; Bago, Juli R.; Aguilar, Elisabet; Soler-Botija, Carolina; Vila, Olaia F.; Molet, Joan; Gambhir, Sanjiv S.; Rubio, Nuria; Blanco, Jeronimo			Glioblastoma Therapy with Cytotoxic Mesenchymal Stromal Cells Optimized by Bioluminescence Imaging of Tumor and Therapeutic Cell Response	PLOS ONE			English	Article							HUMAN ADIPOSE-TISSUE; CANCER GENE-THERAPY; STEM-CELLS; BONE-MARROW; SUICIDE GENE; VEHICLES; GLIOMAS; EXPRESSION; CARCINOMA; VECTORS	Genetically modified adipose tissue derived mesenchymal stromal cells (hAMSCs) with tumor homing capacity have been proposed for localized therapy of chemo- and radiotherapy resistant glioblastomas. We demonstrate an effective procedure to optimize glioblastoma therapy based on the use of genetically modified hAMSCs and in vivo non invasive monitoring of tumor and therapeutic cells. Glioblastoma U87 cells expressing Photinus pyralis luciferase (Pluc) were implanted in combination with hAMSCs expressing a trifunctional Renilla reniformis luciferase-red fluorescent protein-thymidine kinase reporter in the brains of SCID mice that were subsequently treated with ganciclovir (GCV). The resulting optimized therapy was effective and monitoring of tumor cells by bioluminescence imaging (BLI) showed that after 49 days GCV treatment reduced significantly the hAMSC treated tumors; by a factor of 10(4) relative to controls. Using a Pluc reporter regulated by an endothelial specific promoter and in vivo BLI to image hAMSC differentiation we gained insight on the therapeutic mechanism. Implanted hAMSCs homed to tumor vessels, where they differentiated to endothelial cells. We propose that the tumor killing efficiency of genetically modified hAMSCs results from their association with the tumor vascular system and should be useful vehicles to deliver localized therapy to glioblastoma surgical borders following tumor resection.	[Alieva, Maria; Bago, Juli R.; Aguilar, Elisabet; Vila, Olaia F.; Rubio, Nuria; Blanco, Jeronimo] CIBER BBN, Cardiovasc Res Ctr, CSIC ICCC, Barcelona, Spain; [Soler-Botija, Carolina] Hosp Univ Germans & Trias Pujol, Serv Cardiol, Badalona, Spain; [Molet, Joan] Hosp Santa Creu & Sant Pau, Neurosurg Unit, Barcelona, Spain; [Gambhir, Sanjiv S.] Stanford Univ, Dept Radiol, Bio X Program, Stanford, CA 94305 USA	CIBER - Centro de Investigacion Biomedica en Red; CIBERBBN; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Institut Catala de Ciencies Cardiovasculars (ICCC); Hospital Germans Trias i Pujol; Hospital of Santa Creu i Sant Pau; Stanford University	Alieva, M (corresponding author), CIBER BBN, Cardiovasc Res Ctr, CSIC ICCC, Barcelona, Spain.	jblancof@csic-iccc.org	BAGO, JULI R/M-3526-2018; Rubio, Nuria/H-3156-2015; Blanco, Jeronimo/H-2764-2015; Alieva, Maria/ACQ-0401-2022	BAGO, JULI R/0000-0002-2862-4048; Rubio, Nuria/0000-0003-2471-4684; Blanco, Jeronimo/0000-0003-3765-0640; Aguilar Bohorquez, Elisabet/0000-0002-3687-3861; Soler-Botija, Carolina/0000-0002-4584-9134; Vila, Olaia F/0000-0002-1238-2275; Alieva, Maria/0000-0002-1425-9908	EU [214402 Acronym Angioscaff]; Ministerio de Ciencia e Innovacio [SAF2009-07102]; Red Tematica de Investigacion Cooperativa TerCel (Instituto de Salud Carlos III); Ministerio de Ciencia e Innovacion [SAF2009-07315E Accion Explora]	EU(European Commission); Ministerio de Ciencia e Innovacio(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Red Tematica de Investigacion Cooperativa TerCel (Instituto de Salud Carlos III)(Instituto de Salud Carlos III); Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government)	This work was supported by collaborative project no214402 Acronym Angioscaff (EU-FP7), SAF2009-07102 (Ministerio de Ciencia e Innovacio), Red Tematica de Investigacion Cooperativa TerCel (Instituto de Salud Carlos III), SAF2009-07315E Accion Explora (Ministerio de Ciencia e Innovacion). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aboody KS, 2008, GENE THER, V15, P739, DOI 10.1038/gt.2008.41; Altaner C, 2008, CANCER LETT, V270, P191, DOI 10.1016/j.canlet.2008.04.023; Argyriou AA, 2009, MOL MED, V15, P115, DOI 10.2119/molmed.2008.00123; Benedetti S, 2000, NAT MED, V6, P447, DOI 10.1038/74710; Bexell D, 2010, MOL THER, V18, P1067, DOI 10.1038/mt.2010.58; Bexell D, 2009, MOL THER, V17, P183, DOI 10.1038/mt.2008.229; Buckner JC, 2007, MAYO CLIN PROC, V82, P1271, DOI 10.4065/82.10.1271; Carroll NM, 1997, J SURG RES, V69, P413, DOI 10.1006/jsre.1997.5089; CARUSO M, 1993, P NATL ACAD SCI USA, V90, P7024, DOI 10.1073/pnas.90.15.7024; Cihova M, 2011, INT J CANC; Dasari VR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011813; Djouad F, 2003, BLOOD, V102, P3837, DOI 10.1182/blood-2003-04-1193; Ehtesham M, 2002, CANCER RES, V62, P5657; Hall B, 2007, INT J HEMATOL, V86, P8, DOI 10.1532/IJH97.06230; Hamada H, 2005, CANCER SCI, V96, P149, DOI 10.1111/j.1349-7006.2005.00032.x; Huang Q, 2007, J NEURO-ONCOL, V82, P239, DOI 10.1007/s11060-006-9279-x; Kucerova L, 2007, CANCER RES, V67, P6304, DOI 10.1158/0008-5472.CAN-06-4024; Marconi P, 2000, MOL THER, V1, P71, DOI 10.1006/mthe.1999.0008; Menon LG, 2009, STEM CELLS, V27, P2320, DOI 10.1002/stem.136; MOOLTEN FL, 1986, CANCER RES, V46, P5276; Nakamizo A, 2005, CANCER RES, V65, P3307, DOI 10.1158/0008-5472.CAN-04-1874; Nakanishi C, 2011, CIRC J, V75, P2260, DOI 10.1253/circj.CJ-11-0246; Oertel S, 2006, STRAHLENTHER ONKOL, V182, P400, DOI 10.1007/s00066-006-1445-8; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Prockop DJ, 1997, SCIENCE, V276, P71, DOI 10.1126/science.276.5309.71; Ray P, 2004, CANCER RES, V64, P1323, DOI 10.1158/0008-5472.CAN-03-1816; Reiser J, 2005, EXPERT OPIN BIOL TH, V5, P1571, DOI 10.1517/14712598.5.12.1571; Sangro B, 2010, CANCER GENE THER, V17, P837, DOI 10.1038/cgt.2010.40; Sanz L, 2008, MICROVASC RES, V75, P308, DOI 10.1016/j.mvr.2007.11.007; Schneider A, 2010, DTSCH ARZTEBL INT, V107, P776, DOI [10.3238/arztebl.2010.0799, 10.3238/arztebl.2010.0776]; Schneider HJ, 2010, DTSCH ARZTEBL INT, V107, P826, DOI 10.3238/arztebl.2010.0826a; van der Bogt KEA, 2009, TRANSPLANTATION, V87, P642, DOI 10.1097/TP.0b013e31819609d9; Vilalta M, 2009, GENE THER, V16, P547, DOI 10.1038/gt.2008.176; Vilalta M, 2008, STEM CELLS DEV, V17, P993, DOI 10.1089/scd.2007.0201; Zuk PA, 2001, TISSUE ENG, V7, P211, DOI 10.1089/107632701300062859	35	37	37	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2012	7	4							e35148	10.1371/journal.pone.0035148	http://dx.doi.org/10.1371/journal.pone.0035148			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WC	22529983	gold, Green Published, Green Submitted			2022-12-25	WOS:000305347400033
J	Kacsoh, BZ; Schlenke, TA				Kacsoh, Balint Z.; Schlenke, Todd A.			High Hemocyte Load Is Associated with Increased Resistance against Parasitoids in Drosophila suzukii, a Relative of D. melanogaster	PLOS ONE			English	Article							CELLULAR IMMUNE-RESPONSE; SPOTTED WING DROSOPHILA; TABIDA NEES BRACONIDAE; LEPTOPILINA-BOULARDI; EVOLUTIONARY ECOLOGY; HOST DISCRIMINATION; ASOBARA-TABIDA; HYMENOPTERA; LARVAE; ENCAPSULATION	Among the most common parasites of Drosophila in nature are parasitoid wasps, which lay their eggs in fly larvae and pupae. D. melanogaster larvae can mount a cellular immune response against wasp eggs, but female wasps inject venom along with their eggs to block this immune response. Genetic variation in flies for immune resistance against wasps and genetic variation in wasps for virulence against flies largely determines the outcome of any fly-wasp interaction. Interestingly, up to 90% of the variation in fly resistance against wasp parasitism has been linked to a very simple mechanism: flies with increased constitutive blood cell (hemocyte) production are more resistant. However, this relationship has not been tested for Drosophila hosts outside of the melanogaster subgroup, nor has it been tested across a diversity of parasitoid wasp species and strains. We compared hemocyte levels in two fly species from different subgroups, D. melanogaster and D. suzukii, and found that D. suzukii constitutively produces up to five times more hemocytes than D. melanogaster. Using a panel of 24 parasitoid wasp strains representing fifteen species, four families, and multiple virulence strategies, we found that D. suzukii was significantly more resistant to wasp parasitism than D. melanogaster. Thus, our data suggest that the relationship between hemocyte production and wasp resistance is general. However, at least one sympatric wasp species was a highly successful infector of D. suzukii, suggesting specialists can overcome the general resistance afforded to hosts by excessive hemocyte production. Given that D. suzukii is an emerging agricultural pest, identification of the few parasitoid wasps that successfully infect D. suzukii may have value for biocontrol.	[Kacsoh, Balint Z.; Schlenke, Todd A.] Emory Univ, Dept Biol, Atlanta, GA 30322 USA	Emory University	Kacsoh, BZ (corresponding author), Emory Univ, Dept Biol, Atlanta, GA 30322 USA.	tschlen@emory.edu	Kacsoh, Balint/AAF-2165-2019	Kacsoh, Balint/0000-0001-9171-0611; Schlenke, Todd/0000-0003-3091-3057	National Institutes of Health (NIH) [AI081879]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI081879] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by National Institutes of Health (NIH) grant AI081879 to TAS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allemand R, 2002, ANN SOC ENTOMOL FR, V38, P319, DOI 10.1080/00379271.2002.10697346; Askew R.R., 1986, P225; BAKKER K, 1967, ENTOMOL EXP APPL, V10, P295, DOI 10.1007/BF00430053; BAKKER K, 1972, OECOLOGIA, V10, P29, DOI 10.1007/BF00822760; Beers EH, 2011, PEST MANAG SCI, V67, P1386, DOI 10.1002/ps.2279; Bolda MP, 2010, GIANNINI FDN AGR EC, V13, P5; BREHELIN M, 1982, CELL TISSUE RES, V221, P607; Bruck DJ, 2011, PEST MANAG SCI, V67, P1375, DOI 10.1002/ps.2242; Calabria G, 2012, J APPL ENTOMOL, V136, P139, DOI 10.1111/j.1439-0418.2010.01583.x; Carton Y, 2001, IMMUNOGENETICS, V52, P157; CARTON Y, 1981, BIOL J LINN SOC, V16, P227, DOI 10.1111/j.1095-8312.1981.tb01849.x; Carton Y., 1986, P347; Carton Y, 2008, INSECT SCI, V15, P67, DOI 10.1111/j.1744-7917.2008.00188.x; Chiu HL, 2001, ADV EXP MED BIOL, V484, P161; Clausen C.P., 1978, INTRO PARASITES PRED; DeBach P, 1974, BIOL CONTROL NATURAL; Dent D., 1995, INTEGRATED PEST MANA; Dowton M, 2001, BIOL J LINN SOC, V74, P87, DOI 10.1006/bijl.2001.0577; DRIESSEN G, 1990, NETH J ZOOL, V40, P409, DOI 10.1163/156854290X00019; Dubuffet A, 2009, ADV PARASIT, V70, P147, DOI 10.1016/S0065-308X(09)70006-5; Dupas S, 1999, EVOL ECOL, V13, P211, DOI 10.1023/A:1006691431658; Eslin P, 1996, CAN J ZOOL, V74, P2193, DOI 10.1139/z96-248; Eslin P, 1998, J INSECT PHYSIOL, V44, P807, DOI 10.1016/S0022-1910(98)00013-4; Eslin P, 2006, DEV COMP IMMUNOL, V30, P977, DOI 10.1016/j.dci.2006.02.007; Eslin P, 2009, ADV PARASIT, V70, P189, DOI 10.1016/S0065-308X(09)70007-7; Fellowes MDE, 2000, HEREDITY, V84, P1, DOI 10.1046/j.1365-2540.2000.00685.x; Fleury F, 2004, GENETICA, V120, P181, DOI 10.1023/B:GENE.0000017640.78087.9e; Fleury F, 2009, ADV PARASIT, V70, P3, DOI 10.1016/S0065-308X(09)70001-6; Godfray H. C. J., 1994, PARASITOIDS BEHAV EV, DOI 10.1515/9780691207025; Goodhue RE, 2011, PEST MANAG SCI, V67, P1396, DOI 10.1002/ps.2259; Greathead D.J., 1986, P289; Hauser M, 2011, PEST MANAG SCI, V67, P1352, DOI 10.1002/ps.2265; Havard S, 2009, CAN J ZOOL, V87, P635, DOI 10.1139/Z09-046; HERTLEIN MB, 1986, ENVIRON ENTOMOL, V15, P859, DOI 10.1093/ee/15.4.859; Honti V, 2010, MOL IMMUNOL, V47, P1997, DOI 10.1016/j.molimm.2010.04.017; Huffaker C.B, 1971, BIOL CONTROL; Ideo S, 2008, ENTOMOL SCI, V11, P1, DOI 10.1111/j.1479-8298.2007.00244.x; JANSSEN A, 1988, NETH J ZOOL, V38, P61, DOI 10.1163/156854288X00049; Kraaijeveld AR, 2001, P ROY SOC B-BIOL SCI, V268, P259, DOI 10.1098/rspb.2000.1354; Kraaijeveld AR, 2001, EVOLUTION, V55, P1815, DOI 10.1111/j.0014-3820.2001.tb00830.x; La Salle J., 1993, HYMENOPTERA BIODIVER; Labrosse C, 2005, J INSECT PHYSIOL, V51, P161, DOI 10.1016/j.jinsphys.2004.10.004; Lanot R, 2001, DEV BIOL, V230, P243, DOI 10.1006/dbio.2000.0123; Lee JC, 2011, PEST MANAG SCI, V67, P1349, DOI 10.1002/ps.2271; LERNER AB, 1950, PHYSIOL REV, V30, P91, DOI 10.1152/physrev.1950.30.1.91; Markus R, 2005, IMMUNOL LETT, V101, P108, DOI 10.1016/j.imlet.2005.03.021; Mitsui H, 2007, J NAT HIST, V41, P1731, DOI 10.1080/00222930701504797; Moreau SJM, 2005, DEV COMP IMMUNOL, V29, P205, DOI 10.1016/j.dci.2004.07.002; Moreau SJM, 2003, DEV COMP IMMUNOL, V27, P273, DOI 10.1016/S0145-305X(02)00101-5; Poirie M, 2000, P ROY SOC B-BIOL SCI, V267, P1417, DOI 10.1098/rspb.2000.1158; RIZKI MOHAMMED TAHIR MIRZA, 1957, J MORPH, V100, P437, DOI 10.1002/jmor.1051000303; RIZKI MTM, 1959, J BIOPHYS BIOCHEM CY, V5, P235, DOI 10.1083/jcb.5.2.235; RIZKI RM, 1990, P NATL ACAD SCI USA, V87, P8388, DOI 10.1073/pnas.87.21.8388; RIZKI TM, 1992, DEV COMP IMMUNOL, V16, P103, DOI 10.1016/0145-305X(92)90011-Z; ROUAULT J, 1979, CR ACAD SCI D NAT, V289, P643; Russo J, 2001, J INSECT PHYSIOL, V47, P167, DOI 10.1016/S0022-1910(00)00102-5; Schilthuizen M, 1998, SYST ENTOMOL, V23, P253, DOI 10.1046/j.1365-3113.1998.00049.x; Schlenke TA, 2007, PLOS PATHOG, V3, P1486, DOI 10.1371/journal.ppat.0030158; Schmid-Hempel P, 2005, ANNU REV ENTOMOL, V50, P529, DOI 10.1146/annurev.ento.50.071803.130420; Seyahooei MA, 2011, BIOL J LINN SOC, V103, P45, DOI 10.1111/j.1095-8312.2011.01637.x; Sheldon BC, 1996, TRENDS ECOL EVOL, V11, P317, DOI 10.1016/0169-5347(96)10039-2; Siva-Jothy MT, 2005, ADV INSECT PHYSIOL, V32, P1, DOI 10.1016/S0065-2806(05)32001-7; Sorrentino RP, 2004, GENETICS, V166, P1343, DOI 10.1534/genetics.166.3.1343; van Lenteren J.C., 1981, P153; van Lenteren JC, 1976, NETHERLANDS J ZOOLOG, V26, P1; VANALPHEN JJM, 1982, NETH J ZOOL, V32, P232, DOI 10.1163/002829682X00157; VANALPHEN JJM, 1982, NETH J ZOOL, V32, P194, DOI 10.1163/002829682X00139; VET LEM, 1984, ANIM BEHAV, V32, P871, DOI 10.1016/S0003-3472(84)80164-5; WAJNBERG E, 1985, ENTOMOPHAGA, V30, P187, DOI 10.1007/BF02372252; Walsh DB, 2011, J INTEGR PEST MANAG, V2, DOI 10.1603/IPM10010; Williams MJ, 2005, GENES CELLS, V10, P813, DOI 10.1111/j.1365-2443.2005.00883.x	71	148	150	0	97	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2012	7	4							e34721	10.1371/journal.pone.0034721	http://dx.doi.org/10.1371/journal.pone.0034721			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WC	22529929	Green Published, gold, Green Submitted			2022-12-25	WOS:000305347400017
J	Damiano, S; Fusco, R; Morano, A; De Mizio, M; Paterno, R; De Rosa, A; Spinelli, R; Amente, S; Frunzio, R; Mondola, P; Miot, F; Laccetti, P; Santillo, M; Avvedimento, EV				Damiano, Simona; Fusco, Roberta; Morano, Annalisa; De Mizio, Mariarosaria; Paterno, Roberto; De Rosa, Antonella; Spinelli, Rosa; Amente, Stefano; Frunzio, Rodolfo; Mondola, Paolo; Miot, Francoise; Laccetti, Paolo; Santillo, Mariarosaria; Avvedimento, Enrico Vittorio			Reactive Oxygen Species Regulate the Levels of Dual Oxidase (Duox1-2) in Human Neuroblastoma Cells	PLOS ONE			English	Article							GENERATING NADPH OXIDASES; LONG-TERM POTENTIATION; GROWTH-FACTOR; NOX ENZYMES; HYDROGEN-PEROXIDE; ROS; RECEPTOR; ACTIVATION; RAT; INHIBITION	Dual Oxidases (DUOX) 1 and 2 are efficiently expressed in thyroid, gut, lung and immune system. The function and the regulation of these enzymes in mammals are still largely unknown. We report here that DUOX 1 and 2 are expressed in human neuroblastoma SK-N-BE cells as well as in a human oligodendrocyte cell line (MO3-13) and in rat brain and they are induced by platelet derived growth factor (PDGF). The levels of DUOX 1 and 2 proteins and mRNAs are induced by reactive oxygen species (ROS) produced by the membrane NADPH oxidase. As to the mechanism, we find that PDGF stimulates membrane NADPH oxidase to produce ROS, which stabilize DUOX1 and 2 mRNAs and increases the levels of the proteins. Silencing of gp91(phox) (NOX2), or of the other membrane subunit of NADPH oxidase, p22(phox), blocks PDGF induction of DUOX1 and 2. These data unravel a novel mechanism of regulation of DUOX enzymes by ROS and identify a circuitry linking NADPH oxidase activity to DUOX1 and 2 levels in neuroblastoma cells.	[Damiano, Simona; De Mizio, Mariarosaria; Mondola, Paolo; Santillo, Mariarosaria] Univ Naples Federico II, Sez Fisiol, Dipartimento Neurosci, Naples, Italy; [Fusco, Roberta; De Rosa, Antonella; Spinelli, Rosa; Amente, Stefano; Frunzio, Rodolfo; Laccetti, Paolo] Univ Naples Federico II, Dipartimento Biol Strutturale & Funzionale, Naples, Italy; [Morano, Annalisa; Avvedimento, Enrico Vittorio] Univ Naples Federico II, CNR, Ist Endocrinol & Oncol Sperimentale, Dipartimento Biol & Patol Mol & Cellulare, Naples, Italy; [Morano, Annalisa] Ctr Riferimento Oncol Basilicata, IRCCS, Lab Ric Preclin & Traslazionale, Potenza, Italy; [Paterno, Roberto] Univ Naples Federico II, Dipartimento Med Clin & Sperimentale, Naples, Italy; [Miot, Francoise] Univ Libre Bruxelles, Inst Rech Interdisciplinaire Biol Humaine & Mol, Brussels, Belgium	University of Naples Federico II; University of Naples Federico II; Consiglio Nazionale delle Ricerche (CNR); Istituto per Endocrinologia e Oncologia "Gaetano Salvatore" (IEOS-CNR); University of Naples Federico II; IRCCS CROB; University of Naples Federico II; Universite Libre de Bruxelles	Damiano, S (corresponding author), Univ Naples Federico II, Sez Fisiol, Dipartimento Neurosci, Naples, Italy.	paolo.laccetti@unina.it; marsanti@unina.it; avvedim@unina.it	Amente, Stefano/AAU-7605-2020; Morano, Annalisa/K-6955-2012	Amente, Stefano/0000-0003-0612-6096; Morano, Annalisa/0000-0002-5609-4742; Spinelli, Rosa/0000-0001-7308-4119	Academic Spin Off Prius s.r.l. Sistema Integrato Diagnosi Terapia; MIUR (Ministero dell'Universita e della Ricerca); AIRC [IG 11364]; Universita di Napoli Federico II, Naples, Italy	Academic Spin Off Prius s.r.l. Sistema Integrato Diagnosi Terapia; MIUR (Ministero dell'Universita e della Ricerca)(Ministry of Education, Universities and Research (MIUR)); AIRC(Fondazione AIRC per la ricerca sul cancro); Universita di Napoli Federico II, Naples, Italy	This work was partly supported by grants from the Academic Spin Off Prius s.r.l. Sistema Integrato Diagnosi & Terapia (Dr. Avvedimento, Dr. Santillo, Dr. Paterno, Dr. Damiano); MIUR (Ministero dell'Universita e della Ricerca) Dr. Laccetti, Dr. Mondola, Dr. Avvedimento; AIRC (IG 11364), Dr. Laccetti, Dr. Avvedimento. Dr. Fusco is recipient of a fellowship in the PhD program in Molecular Genetics, Universita di Napoli Federico II, Naples, Italy. Funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bae YS, 2000, J BIOL CHEM, V275, P10527, DOI 10.1074/jbc.275.14.10527; Baumer AT, 2008, J BIOL CHEM, V283, P7864, DOI 10.1074/jbc.M704997200; BALLAGI AE, 1994, CELL TRANSPLANT, V3, P453, DOI 10.1177/096368979400300602; Baroni SS, 2006, NEW ENGL J MED, V354, P2667; Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005; Bedard K, 2012, FREE RADICAL BIO MED, V52, P725, DOI 10.1016/j.freeradbiomed.2011.11.023; BJORKMAN U, 1992, ENDOCRINOLOGY, V130, P393, DOI 10.1210/en.130.1.393; Cheng GJ, 2001, GENE, V269, P131, DOI 10.1016/S0378-1119(01)00449-8; CORVILAIN B, 1991, ENDOCRINOLOGY, V128, P779, DOI 10.1210/endo-128-2-779; De Deken X, 2002, EXP CELL RES, V273, P187, DOI 10.1006/excr.2001.5444; Diatchuk V, 1997, J BIOL CHEM, V272, P13292, DOI 10.1074/jbc.272.20.13292; Donko A, 2005, PHILOS T R SOC B, V360, P2301, DOI 10.1098/rstb.2005.1767; Gahtan E, 1998, EUR J NEUROSCI, V10, P538, DOI 10.1046/j.1460-9568.1998.00058.x; Guijarro MV, 2007, CARCINOGENESIS, V28, P2096, DOI 10.1093/carcin/bgm124; Ha EM, 2009, NAT IMMUNOL, V10, P949, DOI 10.1038/ni.1765; Ha EM, 2009, DEV CELL, V16, P386, DOI 10.1016/j.devcel.2008.12.015; Harper RW, 2005, FEBS LETT, V579, P4911, DOI 10.1016/j.febslet.2005.08.002; Hidalgo C, 2007, ANTIOXID REDOX SIGN, V9, P245, DOI 10.1089/ars.2007.9.245; Jaquet V, 2009, ANTIOXID REDOX SIGN, V11, P2535, DOI [10.1089/ars.2009.2585, 10.1089/ARS.2009.2585]; Kishida KT, 2006, MOL CELL BIOL, V26, P5908, DOI 10.1128/MCB.00269-06; Knapp LT, 2002, J NEUROSCI RES, V70, P1, DOI 10.1002/jnr.10371; Lambeth JD, 2007, FREE RADICAL BIO MED, V43, P332, DOI 10.1016/j.freeradbiomed.2007.03.027; Lambeth JD, 2007, FREE RADICAL BIO MED, V43, P319, DOI 10.1016/j.freeradbiomed.2007.03.028; Lambeth JD, 2004, NAT REV IMMUNOL, V4, P181, DOI 10.1038/nri1312; Leulier F, 2009, NAT IMMUNOL, V10, P936, DOI 10.1038/ni0909-936; Meng TC, 2002, MOL CELL, V9, P387, DOI 10.1016/S1097-2765(02)00445-8; Mohapel P, 2005, NEUROSCIENCE, V132, P767, DOI 10.1016/j.neuroscience.2004.11.056; Niethammer P, 2009, NATURE, V459, P996, DOI 10.1038/nature08119; NIKKHAH G, 1993, EXP BRAIN RES, V92, P516; Pachucki J, 2004, MOL CELL ENDOCRINOL, V214, P53, DOI 10.1016/j.mce.2003.11.026; Rigutto S, 2007, EXP CELL RES, V313, P3892, DOI 10.1016/j.yexcr.2007.06.011; Seru R, 2004, J NEUROCHEM, V91, P613, DOI 10.1111/j.1471-4159.2004.02754.x; Singh DK, 2005, CELL, V121, P281, DOI 10.1016/j.cell.2005.02.036; Sorce S, 2009, ANTIOXID REDOX SIGN, V11, P2481, DOI [10.1089/ars.2009.2578, 10.1089/ARS.2009.2578]; STOLK J, 1994, AM J RESP CELL MOL, V11, P95, DOI 10.1165/ajrcmb.11.1.8018341; Svegliati S, 2005, J BIOL CHEM, V280, P36474, DOI 10.1074/jbc.M502851200; Tsatmali M, 2006, MOL CELL NEUROSCI, V33, P345, DOI 10.1016/j.mcn.2006.08.005; Zhao J, 2008, CANCER RES, V68, P4133, DOI 10.1158/0008-5472.CAN-08-0432	38	30	33	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2012	7	4							e34405	10.1371/journal.pone.0034405	http://dx.doi.org/10.1371/journal.pone.0034405			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VO	22523549	Green Published, Green Submitted, gold			2022-12-25	WOS:000305345000019
J	Morin, L; Aveyard, R; Lidbetter, JR; Wilson, PG				Morin, Louise; Aveyard, Ruth; Lidbetter, Jonathan R.; Wilson, Peter G.			Investigating the Host-Range of the Rust Fungus Puccinia psidii sensu lato across Tribes of the Family Myrtaceae Present in Australia	PLOS ONE			English	Article							MELALEUCA-QUINQUENERVIA; EUCALYPTUS RUST; GUAVA RUST; DISEASE; THREAT; AGENT	The exotic rust fungus Puccinia psidii sensu lato was first detected in Australia in April 2010. This study aimed to determine the host-range potential of this accession of the rust by testing its pathogenicity on plants of 122 taxa, representative of the 15 tribes of the subfamily Myrtoideae in the family Myrtaceae. Each taxon was tested in two separate trials (unless indicated otherwise) that comprised up to five replicates per taxon and six replicates of a positive control (Syzygium jambos). No visible symptoms were observed on the following four taxa in either trial: Eucalyptus grandis x camaldulensis, E. moluccana, Lophostemon confertus and Sannantha angusta. Only small chlorotic or necrotic flecks without any uredinia (rust fruiting bodies) were observed on inoculated leaves of seven other taxa (Acca sellowiana, Corymbia calophylla 'Rosea', Lophostemon suaveolens, Psidium cattleyanum, P. guajava 'Hawaiian' and 'Indian', Syzygium unipunctatum). Fully-developed uredinia were observed on all replicates across both trials of 28 taxa from 8 tribes belonging to the following 17 genera: Agonis, Austromyrtus, Beaufortia, Callistemon, Calothamnus, Chamelaucium, Darwinia, Eucalyptus, Gossia, Kunzea, Leptospermum, Melaleuca, Metrosideros, Syzygium, Thryptomene, Tristania, Verticordia. In contrast, the remaining 83 taxa inoculated, including the majority of Corymbia and Eucalyptus species, developed a broad range of symptoms, often across the full spectrum, from fully-developed uredinia to no visible symptoms. These results were encouraging as they indicate that some levels of genetic resistance to the rust possibly exist in these taxa. Overall, our results indicated no apparent association between the presence or absence of disease symptoms and the phylogenetic relatedness of taxa. It is most likely that the majority of the thousands of Myrtaceae species found in Australia have the potential to become infected to some degree by the rust, although this wide host range may not be fully realized in the field.	[Morin, Louise; Aveyard, Ruth] CSIRO, Ecosyst Sci, Canberra, ACT, Australia; [Lidbetter, Jonathan R.] Cent Coast Primary Ind Ctr, New S Wales Dept Primary Ind, Gosford, NSW, Australia; [Wilson, Peter G.] Royal Bot Gardens & Domain Trust, Sydney, NSW, Australia	Commonwealth Scientific & Industrial Research Organisation (CSIRO); NSW Department of Primary Industries	Morin, L (corresponding author), CSIRO, Ecosyst Sci, Canberra, ACT, Australia.	louise.morin@csiro.au	Morin, Louise/B-4822-2009	Morin, Louise/0000-0002-9515-2255	National Management Group on Myrtle Rust (under the auspices of the Australian Government); Commonwealth Scientific and Industrial Research Organisation (CSIRO); New South Wales Department of Primary Industries; Royal Botanic Gardens and Domain Trust	National Management Group on Myrtle Rust (under the auspices of the Australian Government); Commonwealth Scientific and Industrial Research Organisation (CSIRO)(Commonwealth Scientific & Industrial Research Organisation (CSIRO)); New South Wales Department of Primary Industries; Royal Botanic Gardens and Domain Trust	Financial support was provided by the National Management Group on Myrtle Rust (under the auspices of the Australian Government) as part of the nationally-funded interim response plan for myrtle rust, with co-investments from the Commonwealth Scientific and Industrial Research Organisation (CSIRO), New South Wales Department of Primary Industries, and the Royal Botanic Gardens and Domain Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfenas AC, 2005, AUSTRALAS PLANT PATH, V34, P285, DOI 10.1071/AP05023; Alfenas AC, 2003, AUSTRALAS PLANT PATH, V32, P325, DOI 10.1071/AP03021; Anderson R, 2006, WORLDWIDE PUCCINIA P; Aparecido Christiane C., 2003, Summa Phytopathologica, V29, P239; Australian Plant Census, 2011, IBIS DAT; Brown JKM, 2002, SCIENCE, V297, P537, DOI 10.1126/science.1072678; Carnegie AJ, 2010, AUSTRALAS PLANT PATH, V39, P463, DOI 10.1071/AP10102; Carnegie AJ, 2012, AUSTRALAS PLANT PATH, V41, P13, DOI 10.1007/s13313-011-0082-6; Carnegie AJ, 2011, AUSTRALAS PLANT PATH, V40, P346, DOI 10.1007/s13313-011-0066-6; Coelho Lisias, 2001, Summa Phytopathologica, V27, P295; Coutinho TA, 1998, PLANT DIS, V82, P819, DOI 10.1094/PDIS.1998.82.7.819; ESHED N, 1981, PHYTOPATHOLOGY, V71, P156, DOI 10.1094/Phyto-71-156; Evans K. J., 2011, Plant Pathology, V60, P532, DOI 10.1111/j.1365-3059.2010.02396.x; Ferreira F. A., 1983, Revista Arvore, V7, P91; Glen M, 2007, AUSTRALAS PLANT PATH, V36, P1, DOI 10.1071/AP06088; Govaerts R, 2011, WORLD CHECKLIST MYRT; Grgurinovic C. A., 2006, Bulletin OEPP, V36, P486; Junghans DT, 2003, THEOR APPL GENET, V108, P175, DOI 10.1007/s00122-003-1415-9; Kawanishi T, 2009, J GEN PLANT PATHOL, V75, P428, DOI 10.1007/s10327-009-0202-0; Kolmer JA., 2009, ENCY LIFE SCI ELS, P1, DOI [DOI 10.1002/9780470015902.A0021264, 10.1002/9780470015902.a0021264]; Leonard KJ, 2005, MOL PLANT PATHOL, V6, P99, DOI 10.1111/j.1364-3703.2005.00273.x; LOOPE L, 2010, 20101002 US GEOL SUR; MacLachlan JD, 1938, PHYTOPATHOLOGY, V28, P157; MARLATT RB, 1979, PLANT DIS REP, V63, P510; Mellano V, 2006, HLTH GARD HLTH HOME, V1, P3; Morin L, 2011, C20109785 CSIRO EC S; Myerscough Peter J., 1998, Cunninghamia, V5, P787; NSW Department of Primary Industries, 2011, MYRTL RUST HOST LIST; Perez CA, 2011, MYCOL PROG, V10, P273, DOI 10.1007/s11557-010-0698-x; Queensland Department of Primary Industries and Fisheries, 2011, LIST KNOWN PLANTS AF; Rayachhetry MB, 2001, BIOL CONTROL, V22, P38, DOI 10.1006/bcon.2001.0949; Rayachhetry MB, 1997, PLANT DIS, V81, P831, DOI 10.1094/PDIS.1997.81.7.831A; Rayamajhi MB, 2010, BIOL CONTROL, V53, P1, DOI 10.1016/j.biocontrol.2009.07.017; Ribeiro IJA, 2004, ACTA HORTIC, P75, DOI 10.17660/ActaHortic.2004.632.9; RUIZ R A R, 1989, Fitopatologia Brasileira, V14, P70; RYTTER JL, 1984, PLANT DIS, V68, P818, DOI 10.1094/PD-69-818; Simpson JA, 2006, AUSTRALAS PLANT PATH, V35, P549, DOI 10.1071/AP06057; SKINNER DZ, 1995, PLANT DIS, V79, P456, DOI 10.1094/PD-79-0456; Stokstad E, 2007, SCIENCE, V315, P1786, DOI 10.1126/science.315.5820.1786; Tessmann D. J., 2002, Fitopatologia Brasileira, V27, P538, DOI 10.1590/S0100-41582002000500017; Tommerup I. C., 2003, New Zealand Journal of Forestry Science, V33, P420; Uchida J, 2006, PLANT DIS, V90, P524, DOI 10.1094/PD-90-0524C; Uchida JY, 2009, PLANT DIS, V93, P429, DOI 10.1094/PDIS-93-4-0429B; Wilson PG, 2005, PLANT SYST EVOL, V251, P3, DOI 10.1007/s00606-004-0162-y; Zauza EAV, 2010, AUSTRALAS PLANT PATH, V39, P406, DOI 10.1071/AP10077; [Zhuang Jianyun 庄剑云], 2011, [菌物学报, Mygosystema], V30, P853	46	83	87	0	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2012	7	4							e35434	10.1371/journal.pone.0035434	http://dx.doi.org/10.1371/journal.pone.0035434			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VO	22523596	Green Submitted, Green Published, gold			2022-12-25	WOS:000305345000069
J	Sehgal, N; Kumawat, KL; Basu, A; Ravindranath, V				Sehgal, Neha; Kumawat, Kanhaiya Lal; Basu, Anirban; Ravindranath, Vijayalakshmi			Fenofibrate Reduces Mortality and Precludes Neurological Deficits in Survivors in Murine Model of Japanese Encephalitis Viral Infection	PLOS ONE			English	Article							ACTIVATED RECEPTOR-ALPHA; CYTOCHROME P4504F; VIRUS INFECTION; KAPPA-B; BRAIN; INFLAMMATION; PPAR; NEUROPROTECTION; HYPERLIPIDEMIA; REPLICATION	Background: Japanese encephalitis (JE), the most common form of viral encephalitis occurs periodically in endemic areas leading to high mortality and neurological deficits in survivors. It is caused by a flavivirus, Japanese encephalitis virus (JEV), which is transmitted to humans through mosquitoes. No effective cure exists for reducing mortality and morbidity caused by JEV infection, which is primarily due to excessive inflammatory response. Fenofibrate, a peroxisome proliferator-activated receptor-alpha (PPAR alpha) agonist is known to resolve inflammation by repressing nuclear factor-kappa B (NF-kappa B) and enhancing transcription of anti-oxidant and anti-inflammatory genes. In addition, fenofibrate also up-regulates a class of proteins, cytochrome P4504Fs (Cyp4fs), which are involved in detoxification of the potent pro-inflammatory eicosanoid, leukotriene B-4 (LTB4) to 20-hydroxy LTB4. Methodology/Principal Findings: The neuroprotective effect of fenofibrate was examined using in vitro (BV-2 microglial cell line) and in vivo (BALB/cmice) models of JEV infection. Mice were treated with fenofibrate for 2 or 4 days prior to JEV exposure. Pretreatment with fenofibrate for 4 but not 2 days reduced mortality by 80% and brain LTB4 levels decreased concomitantly with the induction of Cyp4f15 and 4f18, which catalyze detoxification of LTB4 through hydroxylation. Expression of cytokines and chemokine decreased significantly as did microglial activation and replication of the JEV virus. Conclusions/Significance: Fenofibrate confers neuroprotection against Japanese encephalitis, in vivo, in mouse model of JEV infection. Thus, fenofibrate, a PPAR alpha agonist that is commonly used as a hypolipidemic drug could potentially be used for prophylaxis during JE epidemics to reduce mortality and morbidity.	[Sehgal, Neha; Kumawat, Kanhaiya Lal; Basu, Anirban; Ravindranath, Vijayalakshmi] Natl Brain Res Ctr, Div Mol & Cellular Neurosci, Manesar, Haryana, India	Department of Biotechnology (DBT) India; National Brain Research Centre (NBRC)	Sehgal, N (corresponding author), Natl Brain Res Ctr, Div Mol & Cellular Neurosci, Manesar, Haryana, India.	viji@cns.iisc.ernet.in		Basu, Anirban/0000-0002-5200-2054	National Institutes of Health [MH 70054]; J.C. Bose National Fellowship; CORE grant from National Brain Research Centre	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); J.C. Bose National Fellowship; CORE grant from National Brain Research Centre	This work was supported by National Institutes of Health grant MH 70054, J.C. Bose National Fellowship and CORE grant from National Brain Research Centre. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Archambeaud-Mouveroux F, 2006, REV MED INTERNE, V27, P573, DOI 10.1016/j.revmed.2006.02.013; Arnaiz SL, 1995, BBA-MOL BASIS DIS, V1272, P175; Azab AN, 2004, PROSTAG LEUKOTR ESS, V70, P67, DOI 10.1016/j.plefa.2003.08.005; Barker BJ, 2003, DIABETES CARE, V26, P2482, DOI 10.2337/diacare.26.8.2482; Berger J, 2002, ANNU REV MED, V53, P409, DOI 10.1146/annurev.med.53.082901.104018; Bharati Kaushik, 2006, Expert Rev Anti Infect Ther, V4, P313, DOI 10.1586/14787210.4.2.313; Block ML, 2007, NAT REV NEUROSCI, V8, P57, DOI 10.1038/nrn2038; Bordet R, 2006, BIOCHEM SOC T, V34, P1341, DOI 10.1042/BST0341341; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chen CJ, 2002, J GEN VIROL, V83, P1897, DOI 10.1099/0022-1317-83-8-1897; Chen XR, 2007, J NEUROTRAUM, V24, P1119, DOI 10.1089/neu.2006.0216; Choi JH, 2006, EUR J PEDIATR, V165, P138, DOI 10.1007/s00431-005-0009-8; CHOMCZYNSKI P, 1993, BIOTECHNIQUES, V15, P532; Corton JC, 2000, ANNU REV PHARMACOL, V40, P491, DOI 10.1146/annurev.pharmtox.40.1.491; Cree MG, 2007, ANN SURG, V245, P214, DOI 10.1097/01.sla.0000250409.51289.ca; Daynes RA, 2002, NAT REV IMMUNOL, V2, P748, DOI 10.1038/nri912; Delerive P, 2000, J BIOL CHEM, V275, P36703, DOI 10.1074/jbc.M004045200; Deplanque D, 2003, J NEUROSCI, V23, P6264; DESAI A, 1995, ACTA NEUROPATHOL, V89, P368, DOI 10.1007/BF00309631; Devchand PR, 1996, NATURE, V384, P39, DOI 10.1038/384039a0; Elsayed EF, 2010, PEDIATR NEPHROL, V25, P7, DOI 10.1007/s00467-009-1223-9; Fruchart JC, 2001, PHARMACOL RES, V44, P345, DOI 10.1006/phrs.2001.0871; Fruchart JC, 2009, ATHEROSCLEROSIS, V205, P1, DOI 10.1016/j.atherosclerosis.2009.03.008; Funk CD, 2001, SCIENCE, V294, P1871, DOI 10.1126/science.294.5548.1871; Ghosh D, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000437; Ghoshal A, 2007, GLIA, V55, P483, DOI 10.1002/glia.20474; Gray E, 2011, EUR J NEUROSCI, V33, P1421, DOI 10.1111/j.1460-9568.2011.07637.x; Halstead Scott B, 2010, Curr Infect Dis Rep, V12, P174, DOI 10.1007/s11908-010-0098-z; Kalsotra A, 2007, ARCH BIOCHEM BIOPHYS, V461, P104, DOI 10.1016/j.abb.2007.02.027; Kalsotra A, 2006, PHARMACOL THERAPEUT, V112, P589, DOI 10.1016/j.pharmthera.2006.03.008; Kaur R, 2003, J NEUROVIROL, V9, P421, DOI 10.1080/13550280390218454; Koh KK, 2008, INT J CARDIOL, V124, P149, DOI 10.1016/j.ijcard.2007.04.080; KUMAR R, 1991, Indian Pediatrics, V28, P1525; KUMAR R, 1993, INDIAN J MED RES-A, V97, P9; MEHL JK, 1980, ANTIMICROB AGENTS CH, V18, P269, DOI 10.1128/AAC.18.2.269; Mishra MK, 2008, J NEUROCHEM, V105, P1582, DOI 10.1111/j.1471-4159.2008.05238.x; Peyrl A, 2011, PEDIAT BLOOD CANC; Ramazan D, 2010, CASE REPORTS MED; Sehgal N, 2011, BIOCHEM PHARMACOL, V82, P53, DOI 10.1016/j.bcp.2011.03.025; Skolnik PR, 2002, JAIDS-J ACQ IMM DEF, V31, P1, DOI 10.1097/00126334-200209010-00001; Soldan SS, 2004, J NEUROIMMUNOL, V146, P209, DOI 10.1016/j.jneuroim.2003.10.033; Stahel PF, 2008, PPAR RES, V2008, DOI 10.1155/2008/538141; Tahmaz M, 2007, RENAL FAILURE, V29, P927, DOI 10.1080/08860220701573640; Thongtan T, 2010, MICROBES INFECT, V12, P37, DOI 10.1016/j.micinf.2009.09.013; Tsimihodimos V, 2009, CURR PHARM DESIGN, V15, P517, DOI 10.2174/138161209787315675; Vanden Berghe W, 2003, ADV EXP MED BIOL, V544, P181; Vrati S, 1999, J GEN VIROL, V80, P1665, DOI 10.1099/0022-1317-80-7-1665; Wang GM, 2010, BRAIN RES, V1359, P247, DOI 10.1016/j.brainres.2010.08.075; Wang Y, 2008, J NEUROTRAUM, V25, P1187, DOI 10.1089/neu.2008.0542; Wei JC, 2010, BIOCHEM BIOPH RES CO, V396, P787, DOI 10.1016/j.bbrc.2010.04.133; Wilder-Smith A, 2010, CURR OPIN INFECT DIS, V23, P426, DOI 10.1097/QCO.0b013e32833c1d01; Wilson Mary E, 2009, Curr Infect Dis Rep, V11, P37; Winter PM, 2004, J INFECT DIS, V190, P1618, DOI 10.1086/423328; Wu JY, 2009, EUR J CLIN PHARMACOL, V65, P1169, DOI 10.1007/s00228-009-0723-7; Youssef J, 2004, J BIOMED BIOTECHNOL, P156, DOI 10.1155/S1110724304308065	55	31	32	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2012	7	4							e35427	10.1371/journal.pone.0035427	http://dx.doi.org/10.1371/journal.pone.0035427			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UT	22514742	Green Published, Green Submitted, gold			2022-12-25	WOS:000305341600147
J	Chakraborty, SK; Basu, NK; Jana, S; Basu, M; Raychoudhuri, A; Owens, IS				Chakraborty, Sunit K.; Basu, Nikhil K.; Jana, Sirsendu; Basu, Mousumi; Raychoudhuri, Amit; Owens, Ida S.			Protein Kinase C alpha and Src Kinase Support Human Prostate-distributed Dihydrotestosterone-metabolizing UDP-glucuronosyltransferase 2B15 Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REGULATED PHOSPHORYLATION; EXPRESSION; CANCER; CELLS; ANDROGEN; EPITHELIUM; ESTROGENS; ENZYMES; DELTA; 5-ALPHA-REDUCTASE	Because human prostate-distributed UDP-glucuronosyl-transferase (UGT) 2B15 metabolizes 5 alpha-dihydrotestosterone (DHT) and 3 alpha-androstane-5 alpha,17 beta-diolmetabolite, we sought to determine whether 2B15 requires regulated phosphorylation similar to UGTs already analyzed. Reversible down-regulation of 2B15-transfected COS-1 cells following curcumin treatment and irreversible inhibition by calphostin C, bisindolylmaleimide, or rottlerin treatment versus activation by phorbol 12-myristate 13-acetate indicated that 2B15 undergoes PKC phosphorylation. Mutation of three predicted PKC and two tyrosine kinase sites in 2B15 caused 70-100 and 80-90% inactivation, respectively. Anti-UGT-1168 antibody trapped 2B15-His-containing co-immunoprecipitates of PKC alpha in 130-140- and >150-kDa complexes by gradient SDS-PAGE analysis. Complexes bound to WT 2B15-His remained intact during electrophoresis, whereas 2B15-His mutants at phosphorylation sites differentially dissociated. PKC alpha siRNA treatment inactivated >50% of COS-1 cell-expressed 2B15. In contrast, treatment of 2B15-transfected COS-1 cells with the Src-specific activator 1,25-dihydroxyvitamin D-3 enhanced activity; treatment with the Src-specific PP2 inhibitor or Src siRNA inhibited >50% of the activity. Solubilized 2B15-His-transfected Src-free fibroblasts subjected to in vitro [gamma-P-33]ATP-dependent phosphorylation by PKC alpha and/or Src, affinity purification, and SDS gel analysis revealed 2-fold more radiolabeling of 55-58-kDa 2B15-His by PKC alpha than by Src; labeling was additive for combined kinases. Collectively, the evidence indicates that 2B15 requires regulated phosphorylation by both PKC alpha and Src, which is consistent with the complexity of synthesis and metabolism of its major substrate, DHT. Whether basal cells import or synthesize testosterone for transport to luminal cells for reduction to DHT by 5 alpha-steroid reductase 2, comparatively low-activity luminal cell 2B15 undergoes a complex pattern of regulated phosphorylation necessary to maintain homeostatic DHT levels to support occupation of the androgen receptor for prostate-specific functions.	[Chakraborty, Sunit K.; Basu, Nikhil K.; Jana, Sirsendu; Basu, Mousumi; Raychoudhuri, Amit; Owens, Ida S.] NICHD, Sect Genet Disorders Drug Metab, Program Dev Endocrinol & Genet, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Basu, NK (corresponding author), NICHD, Sect Genet Disorders Drug Metab, Program Dev Endocrinol & Genet, NIH, Bldg 10,Rm 9D-42, Bethesda, MD 20892 USA.	basun@mail.nih.gov; owensi@mail.nih.gov	RAYCHOUDHURI, AMIT/J-9300-2019		NICHD Intramural Research Program; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD008751] Funding Source: NIH RePORTER	NICHD Intramural Research Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported, in whole or in part, by the NICHD Intramural Research Program.	Andriole GL, 2010, NEW ENGL J MED, V362, P1192, DOI 10.1056/NEJMoa0908127; Arlt W, 2004, BEST PRACT RES CL EN, V18, P363, DOI 10.1016/j.beem.2004.02.006; Barbier O, 2008, BEST PRACT RES CL EN, V22, P259, DOI 10.1016/j.beem.2008.01.001; Basu NK, 2008, J BIOL CHEM, V283, P23048, DOI 10.1074/jbc.M800032200; Basu NK, 2007, BIOCHEM BIOPH RES CO, V360, P7, DOI 10.1016/j.bbrc.2007.05.224; Basu NK, 2005, P NATL ACAD SCI USA, V102, P6285, DOI 10.1073/pnas.0407872102; Basu NK, 2004, J BIOL CHEM, V279, P28320, DOI 10.1074/jbc.M401396200; Basu NK, 2003, BIOCHEM BIOPH RES CO, V303, P98, DOI 10.1016/S0006-291X(03)00241-9; Beaulieu M, 1996, J BIOL CHEM, V271, P22855, DOI 10.1074/jbc.271.37.22855; BELANGER G, 1995, MOL CELL ENDOCRINOL, V113, P165, DOI 10.1016/0303-7207(95)03627-J; Chang KH, 2011, P NATL ACAD SCI USA, V108, P13728, DOI 10.1073/pnas.1107898108; CHEN F, 1993, BIOCHEMISTRY-US, V32, P10648, DOI 10.1021/bi00091a015; Chouinard S, 2004, ENDOCR RES, V30, P717, DOI 10.1081/ERC-200044014; CUNHA GR, 1978, J EXP ZOOL, V205, P181, DOI 10.1002/jez.1402050203; Cunha GR, 2004, J STEROID BIOCHEM, V92, P221, DOI 10.1016/j.jsbmb.2004.10.017; El-Alfy M, 2000, MICROSC RES TECHNIQ, V51, P436, DOI 10.1002/1097-0029(20001201)51:5<436::AID-JEMT6>3.0.CO;2-T; Hornia A, 1999, MOL CELL BIOL, V19, P7672; Labrie F., 2000, DEHYDROEPIANDROSTERO, P299; Leu TH, 2003, BIOCHEM PHARMACOL, V66, P2323, DOI 10.1016/j.bcp.2003.08.017; Levesque E, 1997, PHARMACOGENETICS, V7, P317, DOI 10.1097/00008571-199708000-00007; Luu-The Van, 2011, Horm Mol Biol Clin Investig, V5, P161, DOI 10.1515/HMBCI.2011.007; Mitra PS, 2011, J BIOL CHEM, V286, P1639, DOI 10.1074/jbc.M110.165126; Mitra PS, 2009, BIOCHEM BIOPH RES CO, V382, P651, DOI 10.1016/j.bbrc.2009.03.054; Morley M, 2010, CELL TISSUE RES, V340, P229, DOI 10.1007/s00441-010-0938-z; Mostaghel EA, 2010, CANCER RES, V70, P1286, DOI 10.1158/0008-5472.CAN-09-2509; Nakamura A, 2008, DRUG METAB DISPOS, V36, P1461, DOI 10.1124/dmd.108.021428; Parsons JK, 2010, J UROLOGY, V184, P1040, DOI 10.1016/j.juro.2010.05.033; Pelletier G, 2008, BEST PRACT RES CL EN, V22, P223, DOI 10.1016/j.beem.2008.02.004; Perry C, 2009, AM J PHYSIOL-CELL PH, V297, pC1409, DOI 10.1152/ajpcell.00028.2009; RITTER JK, 1990, J BIOL CHEM, V265, P7900; RUSSELL DW, 1994, ANNU REV BIOCHEM, V63, P25, DOI 10.1146/annurev.bi.63.070194.000325; Sakamaki Y, 2010, J MED CHEM, V53, P5813, DOI 10.1021/jm100649d; Sen A, 2010, J BIOL CHEM, V285, P28787, DOI 10.1074/jbc.M110.134064; Sitrin MD, 1999, STEROIDS, V64, P137, DOI 10.1016/S0039-128X(98)00102-0; Xu SZ, 2007, BASIC CLIN PHARMACOL, V101, P459, DOI 10.1111/j.1742-7843.2007.00143.x	35	8	8	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 13	2012	287	29					24387	24396		10.1074/jbc.M111.335067	http://dx.doi.org/10.1074/jbc.M111.335067			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	977IQ	22532564	hybrid, Green Published			2022-12-25	WOS:000306651100033
J	Kuramoto, K; Okamura, T; Yamaguchi, T; Nakamura, TY; Wakabayashi, S; Morinaga, H; Nomura, M; Yanase, T; Otsu, K; Usuda, N; Matsumura, S; Inoue, K; Fushiki, T; Kojima, Y; Hashimoto, T; Sakai, F; Hirose, F; Osumi, T				Kuramoto, Kenta; Okamura, Tomoo; Yamaguchi, Tomohiro; Nakamura, Tomoe Y.; Wakabayashi, Shigeo; Morinaga, Hidetaka; Nomura, Masatoshi; Yanase, Toshihiko; Otsu, Kinya; Usuda, Nobuteru; Matsumura, Shigenobu; Inoue, Kazuo; Fushiki, Tohru; Kojima, Yumiko; Hashimoto, Takeshi; Sakai, Fumie; Hirose, Fumiko; Osumi, Takashi			Perilipin 5, a Lipid Droplet-binding Protein, Protects Heart from Oxidative Burden by Sequestering Fatty Acid from Excessive Oxidation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIFFERENTIATION-RELATED PROTEIN; ADIPOSE TRIGLYCERIDE LIPASE; PAT-FAMILY; LIPOLYSIS; MICE; METABOLISM; TISSUES; CGI-58; MOUSE; LIVER	Lipid droplets (LDs) are ubiquitous organelles storing neutral lipids, including triacylglycerol (TAG) and cholesterol ester. The properties of LDs vary greatly among tissues, and LD-binding proteins, the perilipin family in particular, play critical roles in determining such diversity. Overaccumulation of TAG in LDs of non-adipose tissues may cause lipotoxicity, leading to diseases such as diabetes and cardiomyopathy. However, the physiological significance of non-adipose LDs in a normal state is poorly understood. To address this issue, we generated and characterized mice deficient in perilipin 5 (Plin5), a member of the perilipin family particularly abundant in the heart. The mutant mice lacked detectable LDs, containing significantly less TAG in the heart. Particulate structures containing another LD-binding protein, Plin2, but negative for lipid staining, remained in mutant mice hearts. LDs were recovered by perfusing the heart with an inhibitor of lipase. Cultured cardiomyocytes from Plin5-null mice more actively oxidized fatty acid than those of wild-type mice. Production of reactive oxygen species was increased in the mutant mice hearts, leading to a greater decline in heart function with age. This was, however, reduced by the administration of N-acetylcysteine, a precursor of an antioxidant, glutathione. Thus, we conclude that Plin5 is essential for maintaining LDs at detectable sizes in the heart, by antagonizing lipase(s). LDs in turn prevent excess reactive oxygen species production by sequestering fatty acid from oxidation and hence suppress oxidative burden to the heart.	[Kuramoto, Kenta; Okamura, Tomoo; Yamaguchi, Tomohiro; Kojima, Yumiko; Hashimoto, Takeshi; Sakai, Fumie; Hirose, Fumiko; Osumi, Takashi] Univ Hyogo, Grad Sch Life Sci, Kamigori, Hyogo 6781297, Japan; [Yamaguchi, Tomohiro] Showa Univ, Sch Pharmaceut Sci, Tokyo 1428555, Japan; [Nakamura, Tomoe Y.; Wakabayashi, Shigeo] Natl Cerebral & Cardiovasc Ctr, Dept Mol Physiol, Res Inst, Suita, Osaka 5658565, Japan; [Morinaga, Hidetaka; Nomura, Masatoshi; Yanase, Toshihiko] Kyushu Univ, Dept Med & Bioregulatory Sci, Fukuoka 8128582, Japan; [Otsu, Kinya] Kings Coll London, Div Cardiovasc, London SE5 9NU, England; [Usuda, Nobuteru] Fujita Hlth Univ, Dept Anat & Cell Biol 2, Sch Med, Toyoake, Aichi 4701192, Japan; [Matsumura, Shigenobu; Inoue, Kazuo; Fushiki, Tohru] Kyoto Univ, Div Food Sci & Biotechnol, Grad Sch Agr, Kyoto 6068502, Japan	University of Hyogo; Showa University; National Cerebral & Cardiovascular Center - Japan; Kyushu University; University of London; King's College London; Fujita Health University; Kyoto University	Osumi, T (corresponding author), Univ Hyogo, Grad Sch Life Sci, Kamigori, Hyogo 6781297, Japan.	osumi@sci.u-hyogo.ac.jp	Matsumura, Shigenobu/Z-2088-2019	Hirose, Fumiko/0000-0003-4586-4892	Japan Society for the Promotion of Science and for Young Scientists; Global Center of Excellence Program (Picobiology, Life Science at the Atomic Level), Ministry of Education, Culture, Sports, Science, and Technology, Japan; Grants-in-Aid for Scientific Research [23390046, 21590248] Funding Source: KAKEN	Japan Society for the Promotion of Science and for Young Scientists(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Global Center of Excellence Program (Picobiology, Life Science at the Atomic Level), Ministry of Education, Culture, Sports, Science, and Technology, Japan; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by grants-in-aid for scientific research from the Japan Society for the Promotion of Science (to T.O.) and for Young Scientists (to T.Y.) and by the Global Center of Excellence Program (Picobiology, Life Science at the Atomic Level), Ministry of Education, Culture, Sports, Science, and Technology, Japan.	Bachmanov AA, 2002, BEHAV GENET, V32, P435, DOI 10.1023/A:1020884312053; Balaban RS, 2005, CELL, V120, P483, DOI 10.1016/j.cell.2005.02.001; Bartholomew SR, 2012, BBA-MOL CELL BIOL L, V1821, P268, DOI 10.1016/j.bbalip.2011.10.017; Bell M, 2008, DIABETES, V57, P2037, DOI 10.2337/db07-1383; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Brasaemle DL, 2007, J LIPID RES, V48, P2547, DOI 10.1194/jlr.R700014-JLR200; Chang BHJ, 2006, MOL CELL BIOL, V26, P1063, DOI 10.1128/MCB.26.3.1063-1076.2006; Dalen KT, 2007, BBA-MOL CELL BIOL L, V1771, P210, DOI 10.1016/j.bbalip.2006.11.011; Friedman EJ, 2011, J BIOL CHEM, V286, P30107, DOI 10.1074/jbc.M111.227256; GOTTO AM, 1986, METHOD ENZYMOL, V128, P3; Granneman JG, 2011, J BIOL CHEM, V286, P5126, DOI 10.1074/jbc.M110.180711; Granneman JG, 2009, J BIOL CHEM, V284, P34538, DOI 10.1074/jbc.M109.068478; Granneman JG, 2009, J BIOL CHEM, V284, P3049, DOI 10.1074/jbc.M808251200; Griesel BA, 2010, DIABETES, V59, P800, DOI 10.2337/db09-1542; Haemmerle G, 2006, SCIENCE, V312, P734, DOI 10.1126/science.1123965; Jenkins CM, 2004, J BIOL CHEM, V279, P48968, DOI 10.1074/jbc.M407841200; Kimmel AR, 2010, J LIPID RES, V51, P468, DOI 10.1194/jlr.R000034; Lass A, 2006, CELL METAB, V3, P309, DOI 10.1016/j.cmet.2006.03.005; Luiken JJFP, 1997, J LIPID RES, V38, P745; Martinez-Botas J, 2000, NAT GENET, V26, P474, DOI 10.1038/82630; Masuda Y, 2006, J LIPID RES, V47, P87, DOI 10.1194/jlr.M500170-JLR200; Matsumura S, 2008, AM J PHYSIOL-REG I, V295, pR82, DOI 10.1152/ajpregu.00060.2008; Miyoshi H, 2007, J BIOL CHEM, V282, P996, DOI 10.1074/jbc.M605770200; NAKAMURA TY, 1993, CIRC RES, V73, P758, DOI 10.1161/01.RES.73.4.758; OHKAWA H, 1979, ANAL BIOCHEM, V95, P351, DOI 10.1016/0003-2697(79)90738-3; Radner FPW, 2010, J BIOL CHEM, V285, P7300, DOI 10.1074/jbc.M109.081877; Schaffer JE, 2003, CURR OPIN LIPIDOL, V14, P281, DOI 10.1097/00041433-200306000-00008; Seddon M, 2007, HEART, V93, P903, DOI 10.1136/hrt.2005.068270; Shen WJ, 2009, J LIPID RES, V50, P2306, DOI 10.1194/jlr.M900176-JLR200; Shinzawa-Itoh K, 2007, EMBO J, V26, P1713, DOI 10.1038/sj.emboj.7601618; STEIN O, 1968, J CELL BIOL, V36, P63, DOI 10.1083/jcb.36.1.63; Suzuki J, 2002, AM J PHYSIOL-ENDOC M, V283, pE94, DOI 10.1152/ajpendo.00017.2002; Sztalryd C, 2003, J CELL BIOL, V161, P1093, DOI 10.1083/jcb.200210169; Sztalryd C, 2006, J BIOL CHEM, V281, P34341, DOI 10.1074/jbc.M602497200; Tansey JT, 2001, P NATL ACAD SCI USA, V98, P6494, DOI 10.1073/pnas.101042998; van der Vusse GJ, 2000, CARDIOVASC RES, V45, P279, DOI 10.1016/S0008-6363(99)00263-1; Wang H, 2011, J LIPID RES, V52, P2159, DOI 10.1194/jlr.M017939; Wang H, 2009, J BIOL CHEM, V284, P32116, DOI 10.1074/jbc.M109.006726; Wang ZM, 2000, AM J PHYSIOL-ENDOC M, V279, pE539, DOI 10.1152/ajpendo.2000.279.3.E539; Wolins NE, 2006, DIABETES, V55, P3418, DOI 10.2337/db06-0399; Xu GH, 2005, J BIOL CHEM, V280, P42841, DOI 10.1074/jbc.M506569200; Xu Q, 2011, BRIT J PHARMACOL, V162, P1012, DOI 10.1111/j.1476-5381.2010.01043.x; Yamaguchi T, 2007, J LIPID RES, V48, P1078, DOI 10.1194/jlr.M600493-JLR200; Yamaguchi T, 2006, J BIOL CHEM, V281, P14232, DOI 10.1074/jbc.M601682200; Zechner R, 2009, J LIPID RES, V50, P3, DOI 10.1194/jlr.R800031-JLR200	45	161	167	1	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 6	2012	287	28					23852	23863		10.1074/jbc.M111.328708	http://dx.doi.org/10.1074/jbc.M111.328708			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	975KX	22532565	Green Published, hybrid			2022-12-25	WOS:000306511300056
J	Hotzy, J; Machtens, JP; Fahlke, C				Hotzy, Jasmin; Machtens, Jan-Philipp; Fahlke, Christoph			Neutralizing Aspartate 83 Modifies Substrate Translocation of Excitatory Amino Acid Transporter 3 (EAAT3) Glutamate Transporters	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANION CHANNELS; CONFORMATIONAL-CHANGES; CHLORIDE CHANNEL; SODIUM; BINDING; EAAC1; GLT-1; MICE; NEURODEGENERATION; DETERMINES	Excitatory amino acid transporters (EAATs) terminate glutamatergic synaptic transmission by removing glutamate from the synaptic cleft into neuronal and glial cells. EAATs are not only secondary active glutamate transporters but also function as anion channels. Gating of EAAT anion channels is tightly coupled to transitions within the glutamate uptake cycle, resulting in Na+- and glutamate-dependent anion currents. A point mutation neutralizing a conserved aspartic acid within the intracellular loop close to the end of transmembrane domain 2 was recently shown to modify the substrate dependence of EAAT anion currents. To distinguish whether this mutation affects transitions within the uptake cycle or directly modifies the opening/closing of the anion channel, we used voltage clamp fluorometry. Using three different sites for fluorophore attachment, V120C, M205C, and A430C, we observed time-, voltage-, and substrate-dependent alterations of EAAT3 fluorescence intensities. The voltage and substrate dependence of fluorescence intensities can be described by a 15-state model of the transport cycle in which several states are connected to branching anion channel states. D83A-mediated changes of fluorescence intensities, anion currents, and secondary active transport can be explained by exclusive modifications of substrate translocation rates. In contrast, sole modification of anion channel opening and closing is insufficient to account for all experimental data. We conclude that D83A has direct effects on the glutamate transport cycle and that these effects result in changed anion channel function.	[Hotzy, Jasmin; Machtens, Jan-Philipp; Fahlke, Christoph] Hannover Med Sch, Inst Neurophysiol, D-30625 Hannover, Germany; [Fahlke, Christoph] Zentrum Syst Neurowissensch Hannover ZSN, D-30559 Hannover, Germany	Hannover Medical School	Fahlke, C (corresponding author), Hannover Med Sch, Inst Neurophysiol, Carl Neuberg Str 1, D-30625 Hannover, Germany.	fahlke.christoph@mh-hannover.de	Fahlke, Christoph/G-3635-2013; Machtens, Jan-Philipp/M-8659-2013	Fahlke, Christoph/0000-0001-8602-9952; Machtens, Jan-Philipp/0000-0003-1673-8571	Deutsche Forschungsgemeinschaft [FA301/9]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft Grant FA301/9 (to Ch. F.).	Aoyama K, 2006, NAT NEUROSCI, V9, P119, DOI 10.1038/nn1609; Bailey CG, 2011, J CLIN INVEST, V121, P446, DOI 10.1172/JCI44474; Bergles DE, 2002, J NEUROSCI, V22, P10153; Boudker O, 2007, NATURE, V445, P387, DOI 10.1038/nature05455; Cha A, 1997, NEURON, V19, P1127, DOI 10.1016/S0896-6273(00)80403-1; Danbolt NC, 2001, PROG NEUROBIOL, V65, P1, DOI 10.1016/S0301-0082(00)00067-8; FAIRMAN WA, 1995, NATURE, V375, P599, DOI 10.1038/375599a0; Fairman WA, 1999, AM J PHYSIOL-RENAL, V277, pF481, DOI 10.1152/ajprenal.1999.277.4.F481; Gandhi Chris S., 2008, V491, P213, DOI 10.1007/978-1-59745-526-8_17; Grewer C, 2000, P NATL ACAD SCI USA, V97, P9706, DOI 10.1073/pnas.160170397; Grewer C, 2008, IUBMB LIFE, V60, P609, DOI 10.1002/iub.98; Huang YHH, 2004, J NEUROSCI, V24, P103, DOI 10.1523/JNEUROSCI.4473-03.2004; Jiang J, 2011, P NATL ACAD SCI USA, V108, P15141, DOI 10.1073/pnas.1112216108; KANNER BI, 1982, BIOCHEMISTRY-US, V21, P6327, DOI 10.1021/bi00267a044; Koch HP, 2007, J BIOL CHEM, V282, P24547, DOI 10.1074/jbc.M704087200; Koch HP, 2005, J NEUROSCI, V25, P1730, DOI 10.1523/JNEUROSCI.4138-04.2005; Kovermann P, 2010, J BIOL CHEM, V285, P23676, DOI 10.1074/jbc.M110.126557; Larsson HP, 2010, P NATL ACAD SCI USA, V107, P13912, DOI 10.1073/pnas.1006289107; Larsson HP, 2004, P NATL ACAD SCI USA, V101, P3951, DOI 10.1073/pnas.0306737101; Leinenweber A, 2011, J BIOL CHEM, V286, P1927, DOI 10.1074/jbc.M110.153486; Levy LM, 1998, J NEUROSCI, V18, P9620, DOI 10.1523/jneurosci.18-23-09620.1998; Lorenz L, 1996, P NATL ACAD SCI USA, V93, P13362, DOI 10.1073/pnas.93.23.13362; Machtens JP, 2011, CHANNELS, V5, P468, DOI 10.4161/chan.5.6.17453; Machtens JP, 2011, J BIOL CHEM, V286, P23780, DOI 10.1074/jbc.M110.207514; Mannuzzu LM, 1996, SCIENCE, V271, P213, DOI 10.1126/science.271.5246.213; Melzer N, 2005, P NATL ACAD SCI USA, V102, P19214, DOI 10.1073/pnas.0508837103; Melzer N, 2003, J BIOL CHEM, V278, P50112, DOI 10.1074/jbc.M307990200; Mim C, 2005, J GEN PHYSIOL, V126, P571, DOI 10.1085/jgp.200509365; Peghini P, 1997, EMBO J, V16, P3822, DOI 10.1093/emboj/16.13.3822; Reyes N, 2009, NATURE, V462, P880, DOI 10.1038/nature08616; Ryan RM, 2004, J BIOL CHEM, V279, P20742, DOI 10.1074/jbc.M304433200; Shimamoto K, 1998, MOL PHARMACOL, V53, P195, DOI 10.1124/mol.53.2.195; Tanaka K, 1997, SCIENCE, V276, P1699, DOI 10.1126/science.276.5319.1699; Torres-Salazar D, 2007, J BIOL CHEM, V282, P34719, DOI 10.1074/jbc.M704118200; Torres-Salazar D, 2006, J NEUROSCI, V26, P7513, DOI 10.1523/JNEUROSCI.4545-05.2006; Trotti D, 1999, NAT NEUROSCI, V2, P427, DOI 10.1038/8091; Vandenberg RJ, 2008, CHANNELS, V2, P51, DOI 10.4161/chan.2.1.6047; Verdon G, 2012, NAT STRUCT MOL BIOL, V19, P355, DOI 10.1038/nsmb.2233; Wadiche JI, 1998, J NEUROSCI, V18, P7650; WADICHE JI, 1995, NEURON, V15, P721, DOI 10.1016/0896-6273(95)90159-0; Watase K, 1998, EUR J NEUROSCI, V10, P976, DOI 10.1046/j.1460-9568.1998.00108.x; Yernool D, 2004, NATURE, V431, P811, DOI 10.1038/nature03018; Zerangue N, 1996, NATURE, V383, P634, DOI 10.1038/383634a0; Zhang Z, 2007, P NATL ACAD SCI USA, V104, P18025, DOI 10.1073/pnas.0704570104	45	10	10	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 8	2012	287	24					20016	20026		10.1074/jbc.M112.344077	http://dx.doi.org/10.1074/jbc.M112.344077			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974FB	22532568	Green Published, hybrid			2022-12-25	WOS:000306414500023
J	Komori, T; Doi, A; Nosaka, T; Furuta, H; Akamizu, T; Kitamura, T; Senba, E; Morikawa, Y				Komori, Tadasuke; Doi, Asako; Nosaka, Tetsuya; Furuta, Hiroto; Akamizu, Takashi; Kitamura, Toshio; Senba, Emiko; Morikawa, Yoshihiro			Regulation of AMP-activated Protein Kinase Signaling by AFF4 Protein, Member of AF4 (ALL1-fused Gene from Chromosome 4) Family of Transcription Factors, in Hypothalamic Neurons	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-HORMONE-SECRETION; FOOD-INTAKE; GHRELIN; EXPRESSION; LEUKEMIA; BRAIN; MOUSE; RATS; PHOSPHORYLATION; PEPTIDE	In the hypothalamus, fasting induces a member of the AF4 family of transcription factors, AFF4, which was originally identified as a fusion partner of the mixed-lineage leukemia gene in infant acute lymphoblastic leukemia. However, the roles of AFF4 in the hypothalamus remain unclear. We show herein that expression of AFF4 increased upon addition of ghrelin and fasting in the growth hormone secretagogue receptor-expressing neurons of the hypothalamus. In the growth hormone secretagogue receptor-expressing hypothalamic neuronal cell line GT1-7, ghrelin markedly induced expression of AFF4 in a time- and dose-dependent manner. Overexpression of AFF4 in GT1-7 cells specifically induced expression of the AMP-activated protein kinase (AMPK) alpha 2 subunit but failed to induce other AMPK subunits and AMPK upstream kinases. The promoter activity of the AMPK alpha 2 gene increased upon addition of AFF4, suggesting that AFF4 regulates transcription of the AMPK alpha 2 gene. Additionally, AFF4 also increased the phosphorylation of acetyl-CoA carboxylase alpha(ACC alpha), a downstream target of AMPK. In GT1-7 cells, ghrelin phosphorylated ACC alpha through AMPK alpha phosphorylation in the early phase (15 min) of the activation. However, ghrelin-induced expression of AMPK alpha 2 and phosphorylation of ACC alpha in the late phase (2 h) of the activation were independent of AMPK alpha phosphorylation. Attenuation of expression of AFF4 by its siRNA in GT1-7 cells decreased ghrelin-induced AMPK alpha 2 expression and ACC alpha phosphorylation in the late phase of the activation. AFF4 may therefore help to maintain activation of AMPK downstream signaling under conditions of prolonged stimulation with ghrelin, such as during fasting.	[Komori, Tadasuke; Senba, Emiko; Morikawa, Yoshihiro] Wakayama Med Univ, Dept Anat & Neurobiol, Wakayama 6418509, Japan; [Doi, Asako; Furuta, Hiroto; Akamizu, Takashi] Wakayama Med Univ, Dept Med 1, Wakayama 6418509, Japan; [Nosaka, Tetsuya] Mie Univ, Grad Sch Med, Dept Microbiol, Tsu, Mie 5148507, Japan; [Kitamura, Toshio] Univ Tokyo, Div Cellular Therapy, Adv Clin Res Ctr, Inst Med Sci, Tokyo 1088639, Japan	Wakayama Medical University; Wakayama Medical University; Mie University; University of Tokyo	Morikawa, Y (corresponding author), Wakayama Med Univ, Dept Anat & Neurobiol, 811-1 Kimiidera, Wakayama 6418509, Japan.	yoshim@wakayama-med.ac.jp	Kitamura, Toshio/AAA-2071-2021	Akamizu, Takashi/0000-0003-4960-8271	Ministry of Education, Culture, Sports, Science, and Technology of Japan [20790742]; Japan Society for the Promotion of Science [23659385]; Chiyoda Mutual Life Foundation; 2007 Wakayama Medical Award for Young Researchers; Wakayama Medical University	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Chiyoda Mutual Life Foundation(Chiyoda Mutual Life Foundation); 2007 Wakayama Medical Award for Young Researchers; Wakayama Medical University	This work was supported by Grant-in-aid for Young Scientists (B) 20790742 from the Ministry of Education, Culture, Sports, Science, and Technology of Japan, Grant-in-aid for Challenging Exploratory Research 23659385 from the Japan Society for the Promotion of Science, grants from the Chiyoda Mutual Life Foundation, the 2007 Wakayama Medical Award for Young Researchers, and a research grant on priority areas from Wakayama Medical University.	Anderson KA, 2008, CELL METAB, V7, P377, DOI 10.1016/j.cmet.2008.02.011; Bagnasco M, 2002, ENDOCRINOLOGY, V143, P726, DOI 10.1210/en.143.2.726; Banks WA, 2002, J PHARMACOL EXP THER, V302, P822, DOI 10.1124/jpet.102.034827; Bennett PA, 1997, ENDOCRINOLOGY, V138, P4552, DOI 10.1210/en.138.11.4552; Bitoun E, 2009, J NEUROSCI, V29, P15366, DOI 10.1523/JNEUROSCI.5188-09.2009; Britanova O, 2002, GENOMICS, V80, P31, DOI 10.1006/geno.2002.6796; Chakrabarti L, 1998, HUM MOL GENET, V7, P441, DOI 10.1093/hmg/7.3.441; Date Y, 2002, GASTROENTEROLOGY, V123, P1120, DOI 10.1053/gast.2002.35954; Doi A, 2006, P NATL ACAD SCI USA, V103, P885, DOI 10.1073/pnas.0502470102; Estable MC, 2002, J BIOMED SCI, V9, P234, DOI 10.1007/BF02256070; Fediuc S, 2006, J LIPID RES, V47, P412, DOI 10.1194/jlr.M500438-JLR200; Gu YH, 2002, J NEUROSCI, V22, P2753, DOI 10.1523/JNEUROSCI.22-07-02753.2002; Guillod-Maximin E, 2009, J ENDOCRINOL, V200, P93, DOI 10.1677/JOE-08-0348; Hirsch A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030956; Horike N, 2008, J BIOL CHEM, V283, P33902, DOI 10.1074/jbc.M802537200; Isaacs AM, 2003, J NEUROSCI, V23, P1631; Kojima M, 1999, NATURE, V402, P656, DOI 10.1038/45230; Komori T, 2008, J COMP NEUROL, V511, P92, DOI 10.1002/cne.21838; Komori T, 2010, J BIOL CHEM, V285, P37884, DOI 10.1074/jbc.M110.148973; Kubota N, 2007, CELL METAB, V6, P55, DOI 10.1016/j.cmet.2007.06.003; Lawrence CB, 2002, ENDOCRINOLOGY, V143, P155, DOI 10.1210/en.143.1.155; Levin BE, 2003, AM J PHYSIOL-ENDOC M, V285, pE949, DOI 10.1152/ajpendo.00186.2003; Li JY, 2002, J BIOL CHEM, V277, P9069, DOI 10.1074/jbc.M110467200; Lopez M, 2008, CELL METAB, V7, P389, DOI 10.1016/j.cmet.2008.03.006; MELLON PL, 1990, NEURON, V5, P1, DOI 10.1016/0896-6273(90)90028-E; Minokoshi Y, 2004, NATURE, V428, P569, DOI 10.1038/nature02440; Minokoshi Y, 2008, NUTRITION, V24, P786, DOI 10.1016/j.nut.2008.06.002; Nakazato M, 2001, NATURE, V409, P194, DOI 10.1038/35051587; Niedzielski MF, 2007, INT J BIOL SCI, V3, P225; Saper CB, 2002, NEURON, V36, P199, DOI 10.1016/S0896-6273(02)00969-8; Skinner J. A., 1998, ANAL TRIPLET REPEAT; Taki T, 1999, P NATL ACAD SCI USA, V96, P14535, DOI 10.1073/pnas.96.25.14535; Tschop M, 2000, NATURE, V407, P908, DOI 10.1038/35038090; Urano A, 2005, MOL CELL BIOL, V25, P6834, DOI 10.1128/MCB.25.15.6834-6845.2005; Wren AM, 2000, ENDOCRINOLOGY, V141, P4325, DOI 10.1210/en.141.11.4325; Zigman JM, 2003, ENDOCRINOLOGY, V144, P3749, DOI 10.1210/en.2003-0241	36	12	12	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 8	2012	287	24					19985	19996		10.1074/jbc.M112.367854	http://dx.doi.org/10.1074/jbc.M112.367854			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974FB	22528490	Green Published, hybrid			2022-12-25	WOS:000306414500020
J	Poras, H; Duquesnoy, S; Dange, E; Pinon, A; Vialette, M; Fournie-Zaluski, MC; Ouimet, T				Poras, Herve; Duquesnoy, Sophie; Dange, Emilie; Pinon, Anthony; Vialette, Michele; Fournie-Zaluski, Marie-Claude; Ouimet, Tanja			Highly Sensitive Quenched Fluorescent Substrate of Legionella Major Secretory Protein (Msp) Based on Its Structural Analysis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PNEUMOPHILA ZINC METALLOPROTEASE; EXTRACELLULAR PROTEASE; PSEUDOMONAS-AERUGINOSA; SEQUENCE; ELASTASE	Legionella pneumophila has been shown to secrete a protease termed major secretory protein (Msp). This protease belongs to the M4 family of metalloproteases and shares 62.9% sequence similarity with pseudolysin (EC 3.4.24.26). With the aim of developing a specific enzymatic assay for the detection and quantification of Msp, the Fluofast substrate library was screened using both enzymes in parallel. Moreover, based on the crystal structure of pseudolysin, a model of the Msp structure was built. Screening of the peptide library identified a lead substrate specifically cleaved by Msp that was subsequently optimized by rational design. The proposed model for Msp is consistent with the enzymatic characteristics of the studied peptide substrates and provides new structural information useful for the characterization of the protease. This study leads to the identification of the first selective and high affinity substrate for Msp that is able to detect picomolar concentrations of the purified enzyme. The identified substrate could be useful for the development of a novel method for the rapid detection of Legionella.	[Poras, Herve; Duquesnoy, Sophie; Dange, Emilie; Fournie-Zaluski, Marie-Claude; Ouimet, Tanja] Pharmaleads, F-75013 Paris, France; [Pinon, Anthony; Vialette, Michele] Inst Pasteur, F-59019 Lille, France	Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille	Poras, H (corresponding author), Pharmaleads, Paris BioPk,11 Rue Watt, F-75013 Paris, France.	herve.poras@pharmaleads.com	PORAS, Hervé/ABE-1773-2020	Pinon, Anthony/0000-0001-7048-3085; PORAS, Herve/0000-0002-3329-7432	Agence Nationale pour la Recherche (Programme de Recherche sur les ECOtechnologies et le Developpement Durable, Ralf project)	Agence Nationale pour la Recherche (Programme de Recherche sur les ECOtechnologies et le Developpement Durable, Ralf project)(French National Research Agency (ANR))	This work was supported by a grant from Agence Nationale pour la Recherche (Programme de Recherche sur les ECOtechnologies et le Developpement Durable, Ralf project).	BAINE WB, 1979, J CLIN MICROBIOL, V9, P453; BERDAL BP, 1982, J CLIN MICROBIOL, V16, P452, DOI 10.1128/JCM.16.3.452-457.1982; BERDAL BP, 1982, ACTA PATH MICRO IM B, V90, P119; BLACK WJ, 1990, J BACTERIOL, V172, P2608, DOI 10.1128/jb.172.5.2608-2613.1990; DOWLING JN, 1992, MICROBIOL REV, V56, P32, DOI 10.1128/MMBR.56.1.32-60.1992; DREYFUS LA, 1986, INFECT IMMUN, V51, P736, DOI 10.1128/IAI.51.3.736-743.1986; GHOSE AK, 2001, COMBINATORIAL LIB DE; Jones G, 1997, J MOL BIOL, V267, P727, DOI 10.1006/jmbi.1996.0897; KEEN MG, 1989, INFECT IMMUN, V57, P732, DOI 10.1128/IAI.57.3.732-738.1989; Lutfullah G, 2008, PROTEIN J, V27, P105, DOI 10.1007/s10930-007-9113-0; MCINTYRE M, 1991, APMIS, V99, P316, DOI 10.1111/j.1699-0463.1991.tb05155.x; MELDAL M, 1994, P NATL ACAD SCI USA, V91, P3314, DOI 10.1073/pnas.91.8.3314; MOFFAT JF, 1994, INFECT IMMUN, V62, P751, DOI 10.1128/IAI.62.2.751-753.1994; MULLER HE, 1980, INFECT IMMUN, V27, P51; Poras H, 2011, ANAL BIOCHEM, V419, P95, DOI 10.1016/j.ab.2011.08.016; QUINN FD, 1989, MOL MICROBIOL, V3, P797, DOI 10.1111/j.1365-2958.1989.tb00228.x; RISTROPH JD, 1980, J CLIN MICROBIOL, V11, P19, DOI 10.1128/JCM.11.1.19-21.1980; Roques B. P., 2007, U. S. Patent, Patent No. [7,169,574, 7169574]; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; SCHECHTER I, 1967, BIOCHEM BIOPH RES CO, V27, P157, DOI 10.1016/S0006-291X(67)80055-X; Soleilhac JM, 1996, ANAL BIOCHEM, V241, P120, DOI 10.1006/abio.1996.0385; THAYER MM, 1991, J BIOL CHEM, V266, P2864; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; THOMPSON MR, 1981, INFECT IMMUN, V34, P299, DOI 10.1128/IAI.34.1.299-302.1981	24	1	1	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 8	2012	287	24					20221	20230		10.1074/jbc.M111.334334	http://dx.doi.org/10.1074/jbc.M111.334334			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974FB	22528499	Green Published, hybrid			2022-12-25	WOS:000306414500042
J	Alonso-Gonzalez, L; Couldrey, C; Meinhardt, MW; Cole, SA; Wells, DN; Laible, G				Alonso-Gonzalez, Lucia; Couldrey, Christine; Meinhardt, Marcus W.; Cole, Sally A.; Wells, David N.; Laible, Goetz			Primary Transgenic Bovine Cells and Their Rejuvenated Cloned Equivalents Show Transgene-Specific Epigenetic Differences	PLOS ONE			English	Article							DNA METHYLATION PATTERNS; NUCLEAR TRANSFER; MASS-SPECTROMETRY; STRESS RESPONSES; PRION PROTEIN; GENE; CATTLE; MICE; EXPRESSION; LIVESTOCK	Cell-mediated transgenesis, based on somatic cell nuclear transfer (SCNT), provides the opportunity to shape the genetic make-up of cattle. Bovine primary fetal fibroblasts, commonly used cells for SCNT, have a limited lifespan, and complex genetic modifications that require sequential transfections can be challenging time and cost-wise. To overcome these limitations, SCNT is frequently used to rejuvenate the cell lines and restore exhausted growth potential. We have designed a construct to be used in a 2-step cassette exchange experiment. Our transgene contains a puromycin resistance marker gene and an enhanced green fluorescence protein (EGFP) expression cassette, both driven by a strong mammalian promoter, and flanked by loxP sites and sequences from the bovine beta-casein locus. Several transgenic cell lines were generated by random insertion into primary bovine cell lines. Two of these original cell lines were rederived by SCNT and new primary cells, with the same genetic makeup as the original donors, were established. While the original cell lines were puromycin-resistant and had a characteristic EGFP expression profile, all rejuvenated cell lines were sensitive to puromycin, and displayed varied EGFP expression, indicative of various degrees of silencing. When the methylation states of individual CpG sites within the transgene were analyzed, a striking increase in transgene-specific methylation was observed in all rederived cell lines. The results indicate that original transgenic donor cells and their rejuvenated derivatives may not be equivalent and differ in the functionality of their transgene sequences.	[Alonso-Gonzalez, Lucia; Couldrey, Christine; Meinhardt, Marcus W.; Cole, Sally A.; Wells, David N.; Laible, Goetz] AgRes Ruakura Res Ctr, Hamilton, New Zealand	AgResearch - New Zealand	Laible, G (corresponding author), Univ Otago, Dept Paediat, Christchurch, New Zealand.	goetz.laible@agresearch.co.nz		Wells, David/0000-0002-8729-4958; Cole, Sally/0000-0002-6997-9056; Laible, Goetz/0000-0003-1048-2819	Ministry of Science and Innovation [C10X0303, C10X0305, C10X0805]	Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	This work was supported by grants from the New Zealand Foundation for Research, Science and Technology (now the Ministry of Science and Innovation) C10X0303, C10X0305 and C10X0805. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brophy B, 2003, NAT BIOTECHNOL, V21, P157, DOI 10.1038/nbt783; Chevalier-Mariette C, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r53; Clark AJ, 2000, TRANSGENIC RES, V9, P263, DOI 10.1023/A:1008974616402; Clark AJ, 1997, NUCLEIC ACIDS RES, V25, P1009, DOI 10.1093/nar/25.5.1009; Clark AJ, 2003, NAT CELL BIOL, V5, P535, DOI 10.1038/ncb992; Coolen MW, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm662; Couldrey C, 2011, CELL REPROGRAM, V13, P171, DOI 10.1089/cell.2010.0065; Couldrey C, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-27; Dean W, 2001, P NATL ACAD SCI USA, V98, P13734, DOI 10.1073/pnas.241522698; Denning C, 2001, Cloning Stem Cells, V3, P221, DOI 10.1089/15362300152725945; Denning C, 2001, NAT BIOTECHNOL, V19, P559, DOI 10.1038/89313; Ehrich M, 2005, P NATL ACAD SCI USA, V102, P15785, DOI 10.1073/pnas.0507816102; Garrick D, 1998, NAT GENET, V18, P56, DOI 10.1038/ng0198-56; Graham Catriona, 2009, Biotechnology Journal, V4, P108, DOI 10.1002/biot.200800200; Humphreys D, 2002, P NATL ACAD SCI USA, V99, P12889, DOI 10.1073/pnas.192433399; Kuroiwa Y, 2004, NAT GENET, V36, P775, DOI 10.1038/ng1373; Laible Goetz, 2009, Biotechnology Journal, V4, P1278, DOI 10.1002/biot.200900006; Li LC, 2002, BIOINFORMATICS, V18, P1427, DOI 10.1093/bioinformatics/18.11.1427; Oback B, 2003, CLONING STEM CELLS, V5, P3, DOI 10.1089/153623003321512111; Oberlander TF, 2008, EPIGENETICS-US, V3, P97, DOI 10.4161/epi.3.2.6034; Rassoulzadegan M, 2002, EMBO J, V21, P440, DOI 10.1093/emboj/21.3.440; Rosser JM, 2010, GENE, V456, P15, DOI 10.1016/j.gene.2010.02.005; Szyf M, 2005, FRONT NEUROENDOCRIN, V26, P139, DOI 10.1016/j.yfrne.2005.10.002; Vassena R, 2007, DEV BIOL, V304, P75, DOI 10.1016/j.ydbio.2006.12.015; Weaver ICG, 2005, J NEUROSCI, V25, P11045, DOI 10.1523/JNEUROSCI.3652-05.2005; Weaver ICG, 2004, NAT NEUROSCI, V7, P847, DOI 10.1038/nn1276	26	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2012	7	4							e35619	10.1371/journal.pone.0035619	http://dx.doi.org/10.1371/journal.pone.0035619			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UD	22532863	Green Published, Green Submitted, gold			2022-12-25	WOS:000305339200086
J	Gong, P; Li, CS; Hua, R; Zhao, H; Tang, ZR; Mei, X; Zhang, MY; Cui, J				Gong, Ping; Li, Chun-Sheng; Hua, Rong; Zhao, Hong; Tang, Zi-Ren; Mei, Xue; Zhang, Ming-Yue; Cui, Juan			Mild Hypothermia Attenuates Mitochondrial Oxidative Stress by Protecting Respiratory Enzymes and Upregulating MnSOD in a Pig Model of Cardiac Arrest	PLOS ONE			English	Article							MULTIPLE ORGAN FAILURE; CARDIOPULMONARY-RESUSCITATION; THERAPEUTIC HYPOTHERMIA; MODERATE HYPOTHERMIA; CEREBRAL-ISCHEMIA; GENE-EXPRESSION; PORCINE MODEL; SEX STEROIDS; BRAIN-INJURY; STROKE	Mild hypothermia is the only effective treatment confirmed clinically to improve neurological outcomes for comatose patients with cardiac arrest. However, the underlying mechanism is not fully elucidated. In this study, our aim was to determine the effect of mild hypothermia on mitochondrial oxidative stress in the cerebral cortex. We intravascularly induced mild hypothermia (33 degrees C), maintained this temperature for 12 h, and actively rewarmed in the inbred Chinese Wuzhishan minipigs successfully resuscitated after 8 min of untreated ventricular fibrillation. Cerebral samples were collected at 24 and 72 h following return of spontaneous circulation (ROSC). We found that mitochondrial malondialdehyde and protein carbonyl levels were significantly increased in the cerebral cortex in normothermic pigs even at 24 h after ROSC, whereas mild hypothermia attenuated this increase. Moreover, mild hypothermia attenuated the decrease in Complex I and Complex III (i.e., major sites of reactive oxygen species production) activities of the mitochondrial respiratory chain and increased antioxidant enzyme manganese superoxide dismutase (MnSOD) activity. This increase in MnSOD activity was consistent with the upregulation of nuclear factor erythroid 2-related factor 2 (Nrf2) mRNA and protein expressions, and with the increase of Nrf2 nuclear translocation in normothermic pigs at 24 and 72 h following ROSC, whereas mild hypothermia enhanced these tendencies. Thus, our findings indicate that mild hypothermia attenuates mitochondrial oxidative stress in the cerebral cortex, which may be associated with reduced impairment of mitochondrial respiratory chain enzymes, and enhancement of MnSOD activity and expression via Nrf2 activation.	[Gong, Ping; Li, Chun-Sheng; Hua, Rong; Zhao, Hong; Tang, Zi-Ren; Mei, Xue; Zhang, Ming-Yue; Cui, Juan] Capital Med Univ, Dept Emergency, Beijing Chaoyang Hosp, Beijing, Peoples R China	Capital Medical University	Li, CS (corresponding author), Capital Med Univ, Dept Emergency, Beijing Chaoyang Hosp, Beijing, Peoples R China.	lcscyyy@163.com	Gong, Ping/AAV-1936-2021	Gong, Ping/0000-0001-9910-7948	National Natural Science Foundation of China [30972863]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National Natural Science Foundation of China (No. 30972863, http://159.226.244.22/portal/proj_search.asp). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALMEIDA A, 1995, J NEUROCHEM, V65, P1698; Arnold S, 2009, J NEUROCHEM, V110, P1, DOI 10.1111/j.1471-4159.2009.06133.x; Bakthavatchalu V, 2012, ONCOGENE, V31, P2129, DOI 10.1038/onc.2011.407; Balaban RS, 2005, CELL, V120, P483, DOI 10.1016/j.cell.2005.02.001; BELZER FO, 1988, TRANSPLANTATION, V45, P673, DOI 10.1097/00007890-198804000-00001; Bernard SA, 2002, NEW ENGL J MED, V346, P557, DOI 10.1056/NEJMoa003289; Busl KM, 2010, NEUROREHABILITATION, V26, P5, DOI 10.3233/NRE-2010-0531; Cadenas E, 2000, FREE RADICAL BIO MED, V29, P222, DOI 10.1016/S0891-5849(00)00317-8; Camara AKS, 2004, AM J PHYSIOL-HEART C, V286, pH1289, DOI 10.1152/ajpheart.00811.2003; Carswell HVO, 2000, AM J PHYSIOL-HEART C, V278, pH290, DOI 10.1152/ajpheart.2000.278.1.H290; Chan PH, 2005, ANN NY ACAD SCI, V1042, P203, DOI 10.1196/annals.1338.022; Cherubini A, 2005, FREE RADICAL BIO MED, V39, P841, DOI 10.1016/j.freeradbiomed.2005.06.025; Enna B, 2000, RESUSCITATION, V47, P41, DOI 10.1016/S0300-9572(00)00200-8; Fredriksson K, 2005, ACTA ANAESTH SCAND, V49, P1101, DOI 10.1111/j.1399-6576.2005.00718.x; Fredriksson K, 2006, AM J PHYSIOL-ENDOC M, V291, pE1044, DOI 10.1152/ajpendo.00218.2006; Fredriksson K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003686; Han Y, 2011, AM J EMERG MED, V29, P731, DOI 10.1016/j.ajem.2010.02.005; HANSFORD RG, 1982, MECH AGEING DEV, V19, P191, DOI 10.1016/0047-6374(82)90010-0; Helfaer MA, 1998, STROKE, V29, P824, DOI 10.1161/01.STR.29.4.824; Herlitz J, 2001, RESUSCITATION, V49, P15, DOI 10.1016/S0300-9572(00)00342-7; Herson PS, 2009, SEMIN REPROD MED, V27, P229, DOI 10.1055/s-0029-1216276; Holzer M, 2002, NEW ENGL J MED, V346, P549; Hoye AT, 2008, ACCOUNTS CHEM RES, V41, P87, DOI 10.1021/ar700135m; Huang Q, 2010, J AGR FOOD CHEM, V58, P5194, DOI 10.1021/jf904536v; Jaiswal AK, 2004, FREE RADICAL BIO MED, V36, P1199, DOI 10.1016/j.freeradbiomed.2004.02.074; Ji XF, 2011, RESUSCITATION   1122; Ji XF, 2011, SHOCK, V35, P530, DOI 10.1097/SHK.0b013e31820e2058; Ji XF, 2010, RESUSCITATION, V81, P1031, DOI 10.1016/j.resuscitation.2010.04.023; Kipp M, 2012, J NEUROENDOCRINOL, V24, P62, DOI 10.1111/j.1365-2826.2011.02163.x; Kudin AP, 2004, J BIOL CHEM, V279, P4127, DOI 10.1074/jbc.M310341200; Lebesgue D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008642; LEI BP, 1994, STROKE, V25, P147, DOI 10.1161/01.STR.25.1.147; MarinGarcia J, 1997, BIOCHEM CELL BIOL, V75, P137, DOI 10.1139/bcb-75-2-137; Marion D, 2009, J NEUROTRAUM, V26, P455, DOI 10.1089/neu.2008.0582; Meybohm P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007588; Neumar RW, 2008, CIRCULATION, V118, P2452, DOI 10.1161/CIRCULATIONAHA.108.190652; Polderman KH, 2008, LANCET, V371, P1955, DOI 10.1016/S0140-6736(08)60837-5; Rea TD, 2003, CIRCULATION, V107, P2780, DOI 10.1161/01.CIR.0000070950.17208.2A; Su ZY, 2011, AM J EMERG MED, V29, P913, DOI 10.1016/j.ajem.2010.04.001; Szabo C, 2003, TOXICOL LETT, V140, P105, DOI 10.1016/S0378-4274(02)00507-6; Wang S, 2010, CRIT CARE MED, V38, P2024, DOI 10.1097/CCM.0b013e3181eed90a; Wu JY, 2009, AM J EMERG MED, V27, P823, DOI 10.1016/j.ajem.2008.07.001; Xu LJ, 2002, J CEREBR BLOOD F MET, V22, P21, DOI 10.1097/00004647-200201000-00003; Zhao H, 2005, J CEREBR BLOOD F MET, V25, P1119, DOI 10.1038/sj.jcbfm.9600111; Zhao H, 2012, RESUSCITATION   0112; Zhao H, 2007, J CEREBR BLOOD F MET, V27, P1879, DOI 10.1038/sj.jcbfm.9600540	46	57	68	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2012	7	4							e35313	10.1371/journal.pone.0035313	http://dx.doi.org/10.1371/journal.pone.0035313			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UD	22532848	gold, Green Published, Green Submitted			2022-12-25	WOS:000305339200054
J	Naidoo, N; Ferber, M; Galante, RJ; McShane, B; Hu, JH; Zimmerman, J; Maislin, G; Cater, J; Wyner, A; Worley, P; Pack, AI				Naidoo, Nirinjini; Ferber, Megan; Galante, Raymond J.; McShane, Blake; Hu, Jia Hua; Zimmerman, John; Maislin, Greg; Cater, Jacqui; Wyner, Abraham; Worley, Paul; Pack, Allan I.			Role of Homer Proteins in the Maintenance of Sleep-Wake States	PLOS ONE			English	Article							GENE-EXPRESSION; DROSOPHILA-MELANOGASTER; MESSENGER-RNA; MICE; WAKEFULNESS; NEURONS; BRAIN; RATS; TIME; HOMEOSTASIS	Sleep is an evolutionarily conserved process that is linked to diurnal cycles and normal daytime wakefulness. Healthy sleep and wakefulness are integral to a healthy lifestyle; this occurs when an organism is able to maintain long bouts of both sleep and wake. Homer proteins, which function as adaptors for group 1 metabotropic glutamate receptors, have been implicated in genetic studies of sleep in both Drosophila and mouse. Drosophila express a single Homer gene product that is upregulated during sleep. By contrast, vertebrates express Homer as both constitutive and immediate early gene (H1a) forms, and H1a is up-regulated during wakefulness. Genetic deletion of Homer in Drosophila results in fragmented sleep and in failure to sustain long bouts of sleep, even under increased sleep drive. However, deletion of Homer1a in mouse results in failure to sustain long bouts of wakefulness. Further evidence for the role of Homer1a in the maintenance of wake comes from the CREB alpha delta mutant mouse, which displays a reduced wake phenotype similar to the Homer1a knockout and fails to up-regulate Homer1a upon sleep loss. Homer1a is a gene whose expression is induced by CREB. Sustained behaviors of the sleep/wake cycle are created by molecular pathways that are distinct from those for arousal or short bouts, and implicate an evolutionarily-conserved role for Homer in sustaining these behaviors.	[Naidoo, Nirinjini; Ferber, Megan; Galante, Raymond J.; Zimmerman, John; Maislin, Greg; Cater, Jacqui; Pack, Allan I.] Univ Penn, Ctr Sleep & Circadian Neurobiol, Philadelphia, PA 19104 USA; [Naidoo, Nirinjini; Maislin, Greg; Pack, Allan I.] Univ Penn, Div Sleep Med, Perelman Sch Med, Philadelphia, PA 19104 USA; [McShane, Blake] Northwestern Univ, Kellogg Sch Management, Chicago, IL 60611 USA; [Hu, Jia Hua; Worley, Paul] Johns Hopkins Univ, Dept Neurosci, Baltimore, MD USA; [Wyner, Abraham] Univ Penn, Wharton Sch, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; Northwestern University; Johns Hopkins University; University of Pennsylvania	Naidoo, N (corresponding author), Univ Penn, Ctr Sleep & Circadian Neurobiol, Philadelphia, PA 19104 USA.	naidoo@mail.med.upenn.edu	Maislin, Greg/S-5322-2019	Pack, Allan/0000-0002-2879-0484	National Institutes of Health [AG17628, AG032500]; NATIONAL INSTITUTE ON AGING [R21AG032500, P01AG017628] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Supported by National Institutes of Health grants AG17628 and AG032500. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Adamantidis AR, 2007, NATURE, V450, P420, DOI 10.1038/nature06310; Anaclet C, 2009, J NEUROSCI, V29, P14423, DOI 10.1523/JNEUROSCI.2604-09.2009; Andretic R, 2005, METHOD ENZYMOL, V393, P759, DOI 10.1016/S0076-6879(05)93040-1; ASTONJONES G, 1981, J NEUROSCI, V1, P876; Behn CGD, 2008, J NEUROPHYSIOL, V99, P3090, DOI 10.1152/jn.01243.2007; Behn CGD, 2007, J NEUROPHYSIOL, V97, P3828, DOI 10.1152/jn.01184.2006; Berke JD, 1998, J NEUROSCI, V18, P5301, DOI 10.1523/JNEUROSCI.18-14-05301.1998; Blanco-Centurion C, 2007, J NEUROSCI, V27, P14041, DOI 10.1523/JNEUROSCI.3217-07.2007; Blumberg MS, 2007, EUR J NEUROSCI, V25, P512, DOI 10.1111/j.1460-9568.2006.05292.x; Blumberg MS, 2005, P NATL ACAD SCI USA, V102, P14860, DOI 10.1073/pnas.0506340102; Bottai D, 2002, J NEUROSCI, V22, P167, DOI 10.1523/JNEUROSCI.22-01-00167.2002; Brakeman PR, 1997, NATURE, V386, P284, DOI 10.1038/386284a0; Cirelli C, 2004, NEURON, V41, P35, DOI 10.1016/S0896-6273(03)00814-6; Diagana TT, 2002, J NEUROSCI, V22, P428, DOI 10.1523/JNEUROSCI.22-02-00428.2002; Franken P, 2001, J NEUROSCI, V21, P2610, DOI 10.1523/JNEUROSCI.21-08-02610.2001; Franken P, 1999, SLEEP, V22, P155; Fuller P, 2011, J COMP NEUROL, V519, P933, DOI 10.1002/cne.22559; Graves LA, 2003, J NEUROPHYSIOL, V90, P1152, DOI 10.1152/jn.00882.2002; Hu JH, 2010, NEURON, V68, P1128, DOI 10.1016/j.neuron.2010.11.008; Huber R, 2004, SLEEP, V27, P628, DOI 10.1093/sleep/27.4.628; Huber R, 2007, SLEEP, V30, P129, DOI 10.1093/sleep/30.2.129; Hunsley MS, 2003, SLEEP, V26, P521; Joho RH, 2006, EUR J NEUROSCI, V23, P1567, DOI 10.1111/j.1460-9568.2006.04672.x; Ko EM, 2003, BRAIN RES, V992, P220, DOI 10.1016/j.brainres.2003.08.044; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lo CC, 2004, P NATL ACAD SCI USA, V101, P17545, DOI 10.1073/pnas.0408242101; Lo CC, 2002, EUROPHYS LETT, V57, P625, DOI 10.1209/epl/i2002-00508-7; Lu J, 2006, J NEUROSCI, V26, P193, DOI 10.1523/JNEUROSCI.2244-05.2006; Mackiewicz M, 2008, PHYSIOL GENOMICS, V33, P91, DOI 10.1152/physiolgenomics.00189.2007; Mackiewicz M., 2007, PHYSL GENOMICS; Maret S, 2007, P NATL ACAD SCI USA, V104, P20090, DOI 10.1073/pnas.0710131104; McShane BB, 2010, J NEUROSCI METH, V193, P321, DOI 10.1016/j.jneumeth.2010.08.024; Naidoo N, 2007, SLEEP, V30, P557, DOI 10.1093/sleep/30.5.557; Nelson SE, 2004, NEUROSCI LETT, V367, P105, DOI 10.1016/j.neulet.2004.05.089; Nielsen HS, 2002, MOL BRAIN RES, V105, P79, DOI 10.1016/S0169-328X(02)00395-9; Nitz DA, 2002, CURR BIOL, V12, P1934, DOI 10.1016/S0960-9822(02)01300-3; Pack AI, 2007, PHYSIOL GENOMICS, V28, P232, DOI 10.1152/physiolgenomics.00139.2006; Parmentier R, 2002, J NEUROSCI, V22, P7695; Peyron C, 1998, J NEUROSCI, V18, P9996; Saper CB, 2010, NEURON, V68, P1023, DOI 10.1016/j.neuron.2010.11.032; Sato M, 2001, J NEUROSCI, V21, P3797, DOI 10.1523/JNEUROSCI.21-11-03797.2001; SCHWARTZ WJ, 1990, J NEUROSCI, V10, P3685; Simasko SM, 2009, BEHAV BRAIN RES, V196, P228, DOI 10.1016/j.bbr.2008.09.003; Stickgold R, 2001, SCIENCE, V294, P1052, DOI 10.1126/science.1063530; Walters CL, 2001, J NEUROSCI, V21, P9438, DOI 10.1523/JNEUROSCI.21-23-09438.2001; Zhang GC, 2007, MOL PHARMACOL, V71, P1148, DOI 10.1124/mol.106.028399; Zimmerman JE, 2008, SLEEP, V31, P1587, DOI 10.1093/sleep/31.11.1587; Zimmerman JE, 2006, PHYSIOL GENOMICS, V27, P337, DOI 10.1152/physiolgenomics.00030.2006	48	44	44	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2012	7	4							e35174	10.1371/journal.pone.0035174	http://dx.doi.org/10.1371/journal.pone.0035174			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UD	22532843	Green Published, Green Submitted, gold			2022-12-25	WOS:000305339200042
J	Sommer, J; Effenberger, T; Volpi, E; Waetzig, GH; Bernhardt, M; Suthaus, J; Garbers, C; Rose-John, S; Floss, DM; Scheller, J				Sommer, Jan; Effenberger, Timo; Volpi, Elena; Waetzig, Georg H.; Bernhardt, Marten; Suthaus, Jan; Garbers, Christoph; Rose-John, Stefan; Floss, Doreen M.; Scheller, Juergen			Constitutively Active Mutant gp130 Receptor Protein from Inflammatory Hepatocellular Adenoma Is Inhibited by an Anti-gp130 Antibody That Specifically Neutralizes Interleukin 11 Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CILIARY NEUROTROPHIC FACTOR; PROXIMAL EXTRACELLULAR DOMAINS; CYTOKINE-INDEPENDENT GROWTH; EMBRYONIC STEM-CELLS; TRANSDUCER GP130; MONOCLONAL-ANTIBODIES; ONCOSTATIN-M; STAT3; ACTIVATION; MEMBRANE	Ligand-independent constitutively active gp130 mutants were described to be responsible for the development of inflammatory hepatocellular adenomas (IHCAs). These variants had gain-of-function somatic mutations within the extracellular domain 2 (D2) of the gp130 receptor chain. Cytokine-dependent Ba/F3 cells were transduced with the constitutively active variant of gp130 featuring a deletion in the domain 2 from Tyr-186 to Tyr-190 (gp130 Delta YY). These cells showed constitutive phosphorylation of signal transducer and activator of transcription-3 (STAT3) and cytokine-independent proliferation. Deletion of the Ig-like domain 1 (D1) of gp130, but not anti-gp130 mAbs directed against D1, abolished constitutive activation of gp130 Delta YY, highlighting that this domain is involved in ligand-independent activation of gp130 Delta YY. Moreover, soluble variants of gp130 were not able to inhibit the constitutive activation of gp130 Delta YY. However, the inhibition of constitutive activation of gp130 Delta YY was achieved by the anti-gp130 mAb B-P4, which specifically inhibits gp130 signaling by IL-11 but not by other IL-6 type cytokines. IL-11 but not IL-6 levels were found previously to be up-regulated in IHCAs, suggesting that mutations in gp130 are leading to IL-11-like signaling. The mAb B-P4 might be a valuable tool to inhibit the constitutive activation of naturally occurring gp130 mutants in IHCAs and rare cases of gp130-associated hepatocellular carcinoma.	[Sommer, Jan; Volpi, Elena; Garbers, Christoph; Floss, Doreen M.; Scheller, Juergen] Univ Dusseldorf, Fac Med, Inst Biochem & Mol Biol 2, D-40225 Dusseldorf, Germany; [Effenberger, Timo; Bernhardt, Marten; Suthaus, Jan; Rose-John, Stefan] Univ Kiel, Inst Biochem, Fac Med, D-2300 Kiel, Germany; [Waetzig, Georg H.] CONARIS Res Inst AG, Kiel, Germany	Heinrich Heine University Dusseldorf; University of Kiel	Scheller, J (corresponding author), Univ Dusseldorf, Fac Med, Inst Biochem & Mol Biol 2, Univ Str 1, D-40225 Dusseldorf, Germany.	jscheller@uni-duesseldorf.de	Garbers, Christoph/D-9932-2015; Scheller, Jürgen/K-5290-2015; Waetzig, Georg/AAV-7486-2021; Rose-John, Stefan/A-7998-2010	Garbers, Christoph/0000-0003-4939-6950; Rose-John, Stefan/0000-0002-7519-3279; Volpi, Elena/0000-0001-8776-0384	Deutsche Forschungsgemeinschaft (DFG, Bonn, Germany) [SCHE 907/2-1, SFB877 A2, SFB841 C1]	Deutsche Forschungsgemeinschaft (DFG, Bonn, Germany)(German Research Foundation (DFG))	This work was funded by Deutsche Forschungsgemeinschaft (DFG, Bonn, Germany) SCHE 907/2-1, SFB877 A2, SFB841 C1.	Boulanger MJ, 2003, SCIENCE, V300, P2101, DOI 10.1126/science.1083901; Bromberg J, 2002, J CLIN INVEST, V109, P1139, DOI 10.1172/JCI200215617; Bromberg JF, 1999, CELL, V98, P295, DOI 10.1016/S0092-8674(00)81959-5; Catlett-Falcone R, 1999, IMMUNITY, V10, P105, DOI 10.1016/S1074-7613(00)80011-4; Ernst M, 2008, J CLIN INVEST, V118, P1727, DOI 10.1172/JCI34944; Fischer M, 1997, NAT BIOTECHNOL, V15, P142, DOI 10.1038/nbt0297-142; GEARING DP, 1994, P NATL ACAD SCI USA, V91, P1119, DOI 10.1073/pnas.91.3.1119; Grivennikov S, 2008, CANCER CELL, V13, P7, DOI 10.1016/j.ccr.2007.12.020; Gu ZJ, 1996, J IMMUNOL METHODS, V190, P21, DOI 10.1016/0022-1759(95)00232-4; Heinrich PC, 2003, BIOCHEM J, V374, P1, DOI 10.1042/BJ20030407; Jenkins BJ, 2005, NAT MED, V11, P845, DOI 10.1038/nm1282; Jostock T, 2001, EUR J BIOCHEM, V268, P160, DOI 10.1046/j.1432-1327.2001.01867.x; Ketteler R, 2002, GENE THER, V9, P477, DOI 10.1038/sj.gt.3301653; Kurth I, 2000, J IMMUNOL, V164, P273, DOI 10.4049/jimmunol.164.1.273; Longerich Thomas, 2009, J Hepatol, V51, P230, DOI 10.1016/j.jhep.2009.03.004; Pflanz S, 2000, J IMMUNOL, V165, P7042, DOI 10.4049/jimmunol.165.12.7042; Pflanz S, 2001, BIOCHEM J, V356, P605, DOI 10.1042/0264-6021:3560605; Pilati C, 2011, J EXP MED, V208, P1359, DOI 10.1084/jem.20110283; Rawat R, 2000, BLOOD, V96, P3514; Rebouissou S, 2009, NATURE, V457, P200, DOI 10.1038/nature07475; Rothbauer U, 2008, MOL CELL PROTEOMICS, V7, P282, DOI 10.1074/mcp.M700342-MCP200; Sambrook J., 2002, MOL CLONING LAB MANU; Scheller J, 2006, SIGNAL TRANSDUCTION, V6, P240, DOI [DOI 10.1002/SITA.200600086, 10.1002/sita.200600086]; Schroers A, 2005, PROTEIN SCI, V14, P783, DOI 10.1110/ps.041117105; Schuster B, 2003, J BIOL CHEM, V278, P9528, DOI 10.1074/jbc.M210044200; Skiniotis G, 2005, NAT STRUCT MOL BIOL, V12, P545, DOI 10.1038/nsmb941; Stuhlmann-Laeisz C, 2006, MOL BIOL CELL, V17, P2986, DOI 10.1091/mbc.E05-12-1129; Suthaus J, 2010, MOL BIOL CELL, V21, P2797, DOI 10.1091/mbc.E10-03-0240; Tenhumberg S, 2006, BIOCHEM BIOPH RES CO, V346, P649, DOI 10.1016/j.bbrc.2006.05.173; Wijdenes J, 1995, EUR J IMMUNOL, V25, P3474, DOI 10.1002/eji.1830251240	30	28	41	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 20	2012	287	17					13743	13751		10.1074/jbc.M111.349167	http://dx.doi.org/10.1074/jbc.M111.349167			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941VZ	22523320	Green Published, Bronze			2022-12-25	WOS:000303996300030
J	Baos, R; Jovani, R; Serrano, D; Tella, JL; Hiraldo, F				Baos, Raquel; Jovani, Roger; Serrano, David; Tella, Jose L.; Hiraldo, Fernando			Developmental Exposure to a Toxic Spill Compromises Long-Term Reproductive Performance in a Wild, Long-Lived Bird: The White Stork (Ciconia ciconia)	PLOS ONE			English	Article							KITES MILVUS-MIGRANS; VALDEZ OIL-SPILL; OXIDATIVE STRESS; HEAVY-METAL; ENVIRONMENTAL-CONDITIONS; ADRENOCORTICAL-RESPONSE; SOUTHWESTERN SPAIN; GENOTOXIC DAMAGE; LIFE; NEUROENDOCRINE	Background/Objective: Exposure to environmental contaminants may result in reduced reproductive success and long-lasting population declines in vertebrates. Emerging data from laboratory studies on model species suggest that certain life-stages, such as development, should be of special concern. However, detailed investigations of long-term consequences of developmental exposure to environmental chemicals on breeding performance are currently lacking in wild populations of long-lived vertebrates. Here, we studied how the developmental exposure to a mine spill (Aznalcollar, SW Spain, April 1998) may affect fitness under natural conditions in a long-lived bird, the White Stork (Ciconia ciconia). Methodology: The reproductive performance of individually-banded storks that were or not developmentally exposed to the spill (i.e. hatched before or after the spill) was compared when these individuals were simultaneously breeding during the seven years after the spill occurred (1999-2005). Principal Findings: Female storks developmentally exposed to the spill experienced a premature breeding senescence compared with their non-developmentally exposed counterparts, doing so after departing from an unusually higher productivity in their early reproductive life (non-developmentally exposed females: 0.5 +/- 0.33SE fledglings/year at 3-yr old vs. 1.38 +/- 0.31SE at 6-7 yr old; developmentally exposed females: 1.5 +/- 0.30SE fledglings/year at 3-yr old vs. 0.86 +/- 0.25SE at 67 yr old). Conclusions/Significance: Following life-history theory, we propose that costly sub-lethal effects reported in stork nestlings after low-level exposure to the spill-derived contaminants might play an important role in shaping this pattern of reproduction, with a clear potential impact on population dynamics. Overall, our study provides evidence that environmental disasters can have long-term, multigenerational consequences on wildlife, particularly when affecting developing individuals, and warns about the risk of widespread low-level contamination in realistic scenarios.	[Baos, Raquel; Serrano, David; Tella, Jose L.; Hiraldo, Fernando] Estac Biol Donana CSIC, Dept Conservat Biol, Seville, Spain; [Jovani, Roger] Estac Biol Donana CSIC, Dept Evolutionary Ecol, Seville, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD)	Baos, R (corresponding author), Estac Biol Donana CSIC, Dept Conservat Biol, Seville, Spain.	raquel@ebd.csic.es	Baos, Raquel/L-9206-2015; Serrano, David/B-5352-2013; Jovani, Roger/C-7080-2013; Tella, José L/I-3707-2015; Hiraldo, Fernando/AAA-8314-2019	Baos, Raquel/0000-0003-1283-6270; Serrano, David/0000-0001-6205-386X; Jovani, Roger/0000-0002-8693-9742; Tella, José L/0000-0002-3038-7424; 	Junta de Andalucia; Ministry of Science and Technology [B0S2002-00857]; EGMASA; CSIC in an i3P grant; Ministry of Education and Culture in an FPU Pre-doctoral Fellowship; Ramon y Cajal from the Ministry of Science and Innovation [RYC-2009-03967]	Junta de Andalucia(Junta de Andalucia); Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); EGMASA; CSIC in an i3P grant; Ministry of Education and Culture in an FPU Pre-doctoral Fellowship; Ramon y Cajal from the Ministry of Science and Innovation	Partial funding for this work was provided by the Junta de Andalucia and the Ministry of Science and Technology (B0S2002-00857). RB was supported by EGMASA and CSIC in an i3P grant, and by the Ministry of Education and Culture in an FPU Pre-doctoral Fellowship. During writing, RJ has been supported by a Ramon y Cajal research contract (RYC-2009-03967) from the Ministry of Science and Innovation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alzaga R, 1999, SCI TOTAL ENVIRON, V242, P167, DOI 10.1016/S0048-9697(99)00382-4; Baos R, 2006, ENVIRON HEALTH PERSP, V114, P1497, DOI 10.1289/ehp.9099; Baos R, 2006, ENVIRON TOXICOL CHEM, V25, P2794, DOI 10.1897/05-570R.1; Baos R, 2006, ENVIRON TOXICOL CHEM, V25, P1153, DOI 10.1897/05-395R.1; Bateson P, 2004, NATURE, V430, P419, DOI 10.1038/nature02725; Bernanke J, 2009, REV ENVIRON CONTAM T, V198, P1, DOI 10.1007/978-0-387-09647-6_1; Bize P, 2008, ECOLOGY, V89, P2584, DOI 10.1890/07-1135.1; Blas J, 2007, P NATL ACAD SCI USA, V104, P8880, DOI 10.1073/pnas.0700232104; Blas J, 2006, GEN COMP ENDOCR, V148, P172, DOI 10.1016/j.ygcen.2006.02.011; Bonilla-Valverde D, 2004, TOXICOLOGY, V197, P123, DOI 10.1016/j.tox.2003.12.010; Chernetsov N, 2006, AUK, V123, P1103, DOI 10.1642/0004-8038(2006)123[1103:SNDOWS]2.0.CO;2; CLUTTONBROCK TH, 1984, AM NAT, V123, P212, DOI 10.1086/284198; Colborn T., 1992, CHEM INDUCED ALTERAT; Consejeria de Medio Ambiente Junta de Andalucia, 2003, CIENC REST RIO GUAD; Damstra T., 2002, GLOBAL ASSESSMENT ST; Di Giulio RT, 1999, REPROD DEV EFFECTS C; Dickerson SM, 2007, REV ENDOCR METAB DIS, V8, P143, DOI 10.1007/s11154-007-9048-y; Eeva T, 2005, OECOLOGIA, V145, P629, DOI 10.1007/s00442-005-0145-x; Ellegren H, 1996, P ROY SOC B-BIOL SCI, V263, P1635, DOI 10.1098/rspb.1996.0239; Elliott John E., 2001, Reviews in Toxicology (Amsterdam), V4, P1; Esler D, 2010, ENVIRON TOXICOL CHEM, V29, P1138, DOI 10.1002/etc.129; FORSLUND P, 1995, TRENDS ECOL EVOL, V10, P374, DOI 10.1016/S0169-5347(00)89141-7; Gil F, 2006, SCI TOTAL ENVIRON, V372, P49, DOI 10.1016/j.scitotenv.2006.08.004; Gore AC, 2008, FRONT NEUROENDOCRIN, V29, P358, DOI 10.1016/j.yfrne.2008.02.002; Grimalt JO, 1999, SCI TOT ENV, V242; Gump BB, 2008, ENVIRON HEALTH PERSP, V116, P249, DOI 10.1289/ehp.10391; Guterman L, 2009, SCIENCE, V323, P1558, DOI 10.1126/science.323.5921.1558; Hanssen SA, 2006, ECOLOGY, V87, P2440, DOI 10.1890/0012-9658(2006)87[2440:COAICA]2.0.CO;2; Harshman LG, 2007, TRENDS ECOL EVOL, V22, P80, DOI 10.1016/j.tree.2006.10.008; Hegyi G, 2011, BEHAV ECOL SOCIOBIOL, V65, P1647, DOI 10.1007/s00265-011-1175-5; Henriksen EO, 2001, J ENVIRON MONITOR, V3, P493, DOI 10.1039/b102683f; Hotchkiss AK, 2008, TOXICOL SCI, V105, P235, DOI 10.1093/toxsci/kfn030; Iwaniuk AN, 2006, BEHAV BRAIN RES, V173, P1, DOI 10.1016/j.bbr.2006.05.026; Jovani R, 2004, ARDEOLA, V51, P357; Jovani R, 2004, ECOGRAPHY, V27, P611, DOI 10.1111/j.0906-7590.2004.03925.x; Jovani R, 2007, P ROY SOC B-BIOL SCI, V274, P2465, DOI 10.1098/rspb.2007.0527; Kim SY, 2010, EVOLUTION, V64, P852, DOI 10.1111/j.1558-5646.2009.00862.x; Lindstrom J, 1999, TRENDS ECOL EVOL, V14, P343, DOI 10.1016/S0169-5347(99)01639-0; Littell R. C., 2006, SAS SYSTEMS MIXED MO, V2nd; Marchamalo J., 1996, Butlleti del Grup Catala d'Anellament, V13, P37; Metcalfe NB, 2001, TRENDS ECOL EVOL, V16, P254, DOI 10.1016/S0169-5347(01)02124-3; Moller AP, 2008, J COMP PHYSIOL B, V178, P735, DOI 10.1007/s00360-008-0262-z; Monaghan P, 2008, FUNCT ECOL, V22, P371, DOI 10.1111/j.1365-2435.2008.01418.x; Monaghan P, 2009, ECOL LETT, V12, P75, DOI 10.1111/j.1461-0248.2008.01258.x; Munoz-Arnanz J, 2008, ORGANOH COMP, V70, P1562; Munoz-Arnanz J, 2011, ENVIRON INT, V37, P1164, DOI 10.1016/j.envint.2011.03.025; Munoz-Arnanz J, 2011, ENVIRON INT, V37, P572, DOI 10.1016/j.envint.2010.11.013; Murtaugh PA, 2009, ECOL LETT, V12, P1061, DOI 10.1111/j.1461-0248.2009.01361.x; Newton I., 1998, POPULATION LIMITATIO; Norris D.O, 2006, ENDOCRINE DISRUPTION; Nowicki S, 1998, AM ZOOL, V38, P179; Nussey DH, 2007, CURR BIOL, V17, pR1000, DOI 10.1016/j.cub.2007.10.005; Ottinger MA, 2008, BRAIN RES REV, V57, P376, DOI 10.1016/j.brainresrev.2007.08.011; Paine RT, 1996, ANNU REV ECOL SYST, V27, P197, DOI 10.1146/annurev.ecolsys.27.1.197; Pastor N, 2004, MUTAGENESIS, V19, P61, DOI 10.1093/mutage/geg035; Pastor N, 2001, MUTAGENESIS, V16, P219, DOI 10.1093/mutage/16.3.219; Peterson CH, 2003, SCIENCE, V302, P2082, DOI 10.1126/science.1084282; PIATT JF, 1990, AUK, V107, P387, DOI 10.2307/4087623; Quinn MJ, 2008, HORM BEHAV, V53, P249, DOI 10.1016/j.yhbeh.2007.10.004; Reed TE, 2008, AM NAT, V171, pE89, DOI 10.1086/524957; Romero-Ruiz A, 2003, ENVIRON TOXICOL CHEM, V22, P92, DOI 10.1002/etc.5620220112; Rowe CL, 2008, BIOSCIENCE, V58, P623, DOI 10.1641/B580709; Sabbioni G, 2002, BIOMARKERS, V7, P347, DOI 10.1080/13547500210147253; Segner H, 2007, NATO SCI PEACE SECUR, P39, DOI 10.1007/978-1-4020-6335-0_4; Sih A, 2004, TRENDS ECOL EVOL, V19, P274, DOI 10.1016/j.tree.2004.02.010; Smits JEG, 2005, TOXICOL PATHOL, V33, P441, DOI 10.1080/01926230590953097; Smits JE, 2007, ENVIRON POLLUT, V145, P538, DOI 10.1016/j.envpol.2006.04.032; Spencer KA, 2010, BEHAV ECOL, V21, P999, DOI 10.1093/beheco/arq090; Stearns S.C., 1992, pi; Symonds MRE, 2011, BEHAV ECOL SOCIOBIOL, V65, P13, DOI 10.1007/s00265-010-1037-6; Tablado Z, 2010, CONSERV BIOL, V24, P1230, DOI 10.1111/j.1523-1739.2010.01483.x; Velando A, 2005, J ORNITHOL, V146, P116, DOI 10.1007/s10336-004-0068-z; Velando A, 2006, P ROY SOC B-BIOL SCI, V273, P1443, DOI 10.1098/rspb.2006.3480; White LD, 2007, TOXICOL APPL PHARM, V225, P1, DOI 10.1016/j.taap.2007.08.001; Wiens JA, 2004, ECOL APPL, V14, P1806, DOI 10.1890/02-5340; WIENS JA, 1995, ECOL APPL, V5, P1069, DOI 10.2307/2269355; Wikelski M, 2002, NATURE, V417, P607, DOI 10.1038/417607a; Wingfield JC, 2009, GEN COMP ENDOCR, V163, P92, DOI 10.1016/j.ygcen.2009.04.030; Zuberogoitia I, 2006, MAR POLLUT BULL, V52, P1176, DOI 10.1016/j.marpolbul.2006.02.016	79	20	20	0	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2012	7	4							e34716	10.1371/journal.pone.0034716	http://dx.doi.org/10.1371/journal.pone.0034716			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959XD	22529928	gold, Green Published, Green Submitted			2022-12-25	WOS:000305350600022
J	Saragosti, J; Silberzan, P; Buguin, A				Saragosti, Jonathan; Silberzan, Pascal; Buguin, Axel			Modeling E. coli Tumbles by Rotational Diffusion. Implications for Chemotaxis	PLOS ONE			English	Article							BACTERIAL MOTILITY; MOVEMENT	The bacterium Escherichia coli in suspension in a liquid medium swims by a succession of runs and tumbles, effectively describing a random walk. The tumbles randomize incompletely, i.e. with a directional persistence, the orientation taken by the bacterium. Here, we model these tumbles by an active rotational diffusion process characterized by a diffusion coefficient and a diffusion time. In homogeneous media, this description accounts well for the experimental reorientations. In shallow gradients of nutrients, tumbles are still described by a unique rotational diffusion coefficient. Together with an increase in the run length, these tumbles significantly contribute to the net chemotactic drift via a modulation of their duration as a function of the direction of the preceding run. Finally, we discuss the limits of this model in propagating concentration waves characterized by steep gradients. In that case, the effective rotational diffusion coefficient itself varies with the direction of the preceding run. We propose that this effect is related to the number of flagella involved in the reorientation process.	[Saragosti, Jonathan; Silberzan, Pascal; Buguin, Axel] UPMC, CNRS, Inst Curie, Ctr Rech,Lab Phys Chim Curie,UMR 168, Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; PSL Research University Paris; Sorbonne Universite; UNICANCER; Institut Curie	Saragosti, J (corresponding author), UPMC, CNRS, Inst Curie, Ctr Rech,Lab Phys Chim Curie,UMR 168, Paris, France.	axel.buguin@curie.fr	Silberzan, Pascal/L-5934-2016	Silberzan, Pascal/0000-0002-8554-882X; Buguin, Axel/0000-0002-1246-4422	C'Nano Ile-de-France; Institut Curie incitative program "nosocomial infections"	C'Nano Ile-de-France(Region Ile-de-France); Institut Curie incitative program "nosocomial infections"	This work was supported by the C'Nano Ile-de-France and the Institut Curie incitative program "nosocomial infections"? The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADLER J, 1966, SCIENCE, V153, P708, DOI 10.1126/science.153.3737.708; Alon U, 1998, EMBO J, V17, P4238, DOI 10.1093/emboj/17.15.4238; Berg, 2018, RANDOM WALKS BIOL; BERG HC, 1972, NATURE, V239, P500, DOI 10.1038/239500a0; Berg HC, E COLI MOTION; BLOCK SM, 1983, J BACTERIOL, V154, P312, DOI 10.1128/JB.154.1.312-323.1983; Brenner MP, 1998, BIOPHYS J, V74, P1677, DOI 10.1016/S0006-3495(98)77880-4; Cluzel P, 2000, SCIENCE, V287, P1652, DOI 10.1126/science.287.5458.1652; Da Re S, 2007, APPL ENVIRON MICROB, V73, P3391, DOI 10.1128/AEM.02625-06; Lambert G, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.168102; LAUFFENBURGER DA, 1991, MICROB ECOL, V22, P175, DOI 10.1007/BF02540222; LOVELY PS, 1975, J THEOR BIOL, V50, P477, DOI 10.1016/0022-5193(75)90094-6; Min TL, 2009, NAT METHODS, V6, P831, DOI [10.1038/NMETH.1380, 10.1038/nmeth.1380]; PARKINSON JS, 1982, J BACTERIOL, V151, P106, DOI 10.1128/JB.151.1.106-113.1982; Perrin F, 1934, J PHYS-PARIS, V5, P497, DOI 10.1051/jphysrad:01934005010049700; Perrin F, 1936, J PHYS-PARIS, V7, P1, DOI 10.1051/jphysrad:01936007010100; Perrin F., 1928, ANN SCI ENS, V45, P1; PURCELL EM, 1977, AM J PHYS, V45, P3, DOI 10.1119/1.10903; Salman H, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.118101; Saragosti J, 2011, P NATL ACAD SCI USA, V108, P16235, DOI 10.1073/pnas.1101996108; Sourjik V, 2002, P NATL ACAD SCI USA, V99, P123, DOI 10.1073/pnas.011589998; Staropoli JF, 2000, BIOPHYS J, V78, P513, DOI 10.1016/S0006-3495(00)76613-6; Vladimirov N, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000717; Webre DJ, 2003, CURR BIOL, V13, pR47, DOI 10.1016/S0960-9822(02)01424-0; Wu XL, 2000, PHYS REV LETT, V84, P3017, DOI 10.1103/PhysRevLett.84.3017	25	68	68	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2012	7	4							e35412	10.1371/journal.pone.0035412	http://dx.doi.org/10.1371/journal.pone.0035412			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959XD	22530021	Green Published, gold, Green Submitted			2022-12-25	WOS:000305350600081
J	Tunstall, NE; Herr, A; de Bruyne, M; Warr, CG				Tunstall, Narelle E.; Herr, Anabel; de Bruyne, Marien; Warr, Coral G.			A Screen for Genes Expressed in the Olfactory Organs of Drosophila melanogaster Identifies Genes Involved in Olfactory Behaviour	PLOS ONE			English	Article							ODORANT RECEPTORS; DISRUPTION PROJECT; DOMAIN PROTEINS	Background: For insects the sense of smell and associated olfactory-driven behaviours are essential for survival. Insects detect odorants with families of olfactory receptor proteins that are very different to those of mammals, and there are likely to be other unique genes and genetic pathways involved in the function and development of the insect olfactory system. Methodology/Principal Findings: We have performed a genetic screen of a set of 505 Drosophila melanogaster gene trap insertion lines to identify novel genes expressed in the adult olfactory organs. We identified 16 lines with expression in the olfactory organs, many of which exhibited expression of the trapped genes in olfactory receptor neurons. Phenotypic analysis showed that six of the lines have decreased olfactory responses in a behavioural assay, and for one of these we showed that precise excision of the P element reverts the phenotype to wild type, confirming a role for the trapped gene in olfaction. To confirm the identity of the genes trapped in the lines we performed molecular analysis of some of the insertion sites. While for many lines the reported insertion sites were correct, we also demonstrated that for a number of lines the reported location of the element was incorrect, and in three lines there were in fact two pGT element insertions. Conclusions/Significance: We identified 16 new genes expressed in the Drosophila olfactory organs, the majority in neurons, and for several of the gene trap lines demonstrated a defect in olfactory-driven behaviour. Further characterisation of these genes and their roles in olfactory system function and development will increase our understanding of how the insect olfactory system has evolved to perform the same essential function to that of mammals, but using very different molecular genetic mechanisms.	[Tunstall, Narelle E.; Herr, Anabel; de Bruyne, Marien; Warr, Coral G.] Monash Univ, Sch Biol Sci, Clayton, Vic, Australia	Monash University	Tunstall, NE (corresponding author), Monash Univ, Sch Biol Sci, Clayton, Vic, Australia.	coral.warr@monash.edu		Warr, Coral/0000-0002-5289-3950	Australian Research Council	Australian Research Council(Australian Research Council)	This study was funded by a Discovery Project grant from the Australian Research Council to CGW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bainton RJ, 2000, CURR BIOL, V10, P187, DOI 10.1016/S0960-9822(00)00336-5; Bellen HJ, 2004, GENETICS, V167, P761, DOI 10.1534/genetics.104.026427; BELLEN HJ, 1992, GENE DEV, V6, P2125, DOI 10.1101/gad.6.11.2125; BELLEN HJ, 1992, GENETICS, V131, P365; Benton R, 2006, PLOS BIOL, V4, P240, DOI 10.1371/journal.pbio.0040020; Benton R, 2009, CELL, V136, P149, DOI 10.1016/j.cell.2008.12.001; Cho KS, 2001, P NATL ACAD SCI USA, V98, P6144, DOI 10.1073/pnas.101596998; Clyne PJ, 1999, NEURON, V22, P327, DOI 10.1016/S0896-6273(00)81093-4; de Bruyne M, 1999, J NEUROSCI, V19, P4520; de Bruyne M, 2001, NEURON, V30, P537, DOI 10.1016/S0896-6273(01)00289-6; Diao FQ, 2009, MOL CELL NEUROSCI, V42, P33, DOI 10.1016/j.mcn.2009.05.003; Edwards Alexis C, 2009, BMC Biol, V7, P29, DOI 10.1186/1741-7007-7-29; Greil F, 2003, GENE DEV, V17, P2825, DOI 10.1101/gad.281503; Harbison ST, 2004, GENETICS, V166, P1807, DOI 10.1534/genetics.166.4.1807; Harbison ST, 2008, GENETICS, V178, P2341, DOI 10.1534/genetics.107.081232; Kitajiri S, 2010, CELL, V141, P786, DOI 10.1016/j.cell.2010.03.049; Leal SM, 2002, J NEUROBIOL, V50, P245, DOI 10.1002/neu.10030; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Li W, 1996, LEARN MEMORY, V2, P320, DOI 10.1101/lm.2.6.320; Lukacsovich T, 2001, GENETICS, V157, P727; Nagel KI, 2011, NAT NEUROSCI, V14, P208, DOI 10.1038/nn.2725; Norga KK, 2003, CURR BIOL, V13, P1388, DOI 10.1016/S0960-9822(03)00546-3; Phillips A M, 1994, Methods Mol Biol, V33, P193; Robertson HM, 2003, P NATL ACAD SCI USA, V100, P14537, DOI 10.1073/pnas.2335847100; SALKOFF L, 1992, TRENDS NEUROSCI, V15, P161, DOI 10.1016/0166-2236(92)90165-5; Sambandan D, 2006, GENETICS, V174, P1349, DOI 10.1534/genetics.106.060574; Sargsyan V, 2011, FRONT CELL NEUROSCI, V5, DOI 10.3389/fncel.2011.00005; Sato K, 2008, NATURE, V452, P1002, DOI 10.1038/nature06850; Shin OH, 2005, J BIOL CHEM, V280, P1641, DOI 10.1074/jbc.M407305200; SKOULAKIS EMC, 1993, NEURON, V11, P197, DOI 10.1016/0896-6273(93)90178-T; Smart R, 2008, INSECT BIOCHEM MOLEC, V38, P770, DOI 10.1016/j.ibmb.2008.05.002; Spradling AC, 1999, GENETICS, V153, P135; Vosshall LB, 1999, CELL, V96, P725, DOI 10.1016/S0092-8674(00)80582-6; Wicher D, 2008, NATURE, V452, P1007, DOI 10.1038/nature06861; WOODARD C, 1989, GENETICS, V123, P315; Yamamoto A, 2008, P NATL ACAD SCI USA, V105, P12393, DOI 10.1073/pnas.0804889105; Yang P, 2000, GENETICS, V155, P1161	37	17	17	3	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2012	7	4							e35641	10.1371/journal.pone.0035641	http://dx.doi.org/10.1371/journal.pone.0035641			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959XD	22530061	gold, Green Published, Green Accepted			2022-12-25	WOS:000305350600107
J	Vaidya, NK; Wang, FB; Zou, XF; Wahl, LM				Vaidya, Naveen K.; Wang, Feng-bin; Zou, Xingfu; Wahl, Lindi M.			Transmission Dynamics of the Recently-Identified BYD Virus Causing Duck Egg-Drop Syndrome	PLOS ONE			English	Article							MATHEMATICAL-MODEL; MALARIA; INFECTION; DISEASE	Baiyangdian (BYD) virus is a recently-identified mosquito-borne flavivirus that causes severe disease in ducks, with extremely rapid transmission, up to 15% mortality within 10 days and 90% reduction in egg production on duck farms within 5 days of infection. Because of the zoonotic nature of flaviviruses, the characterization of BYD virus and its epidemiology are important public health concerns. Here, we develop a mathematical model for the transmission dynamics of this novel virus. We validate the model against BYD outbreak data collected from duck farms in Southeast China, as well as experimental data obtained from an animal facility. Based on our model, the basic reproductive number of BYD virus is high (R-0 = 21) indicating that this virus is highly transmissible, consistent with the dramatic epidemiology observed in BYDV-affected duck farms. Our results indicate that younger ducks are more vulnerable to BYD disease and that ducks infected with BYD virus reduce egg production (to about 33% on average) for about 3 days post-infection; after 3 days infected ducks are no longer able to produce eggs. Using our model, we predict that control measures which reduce contact between mosquitoes and ducks such as mosquito nets are more effective than insecticides.	[Vaidya, Naveen K.; Wang, Feng-bin; Zou, Xingfu; Wahl, Lindi M.] Univ Western Ontario, Dept Appl Math, London, ON N6A 5B9, Canada	Western University (University of Western Ontario)	Vaidya, NK (corresponding author), Univ Western Ontario, Dept Appl Math, London, ON N6A 5B9, Canada.	lwahl@uwo.ca			Natural Sciences and Engineering Research Council (NSERC) of Canada; NSERC Canada Research Chairs Program; NCE-MITACS of Canada	Natural Sciences and Engineering Research Council (NSERC) of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); NSERC Canada Research Chairs Program; NCE-MITACS of Canada	This work was supported by the Natural Sciences and Engineering Research Council (NSERC) of Canada, the NSERC Canada Research Chairs Program, and NCE-MITACS of Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaron JL, 1982, POPULATION DYNAMICS; Abdel-Ghafar AN, 2008, NEW ENGL J MED, V358, P261, DOI 10.1056/NEJMra0707279; ANDERSON R M, 1991; Beigel H, 2005, NEW ENGL J MED, V353, P1374, DOI 10.1056/NEJMra052211; Chitnis N, 2006, SIAM J APPL MATH, V67, P24, DOI 10.1137/050638941; Diekmann O, 2010, J R SOC INTERFACE, V7, P873, DOI 10.1098/rsif.2009.0386; Gould EA, 2008, LANCET, V371, P500, DOI 10.1016/S0140-6736(08)60238-X; Heffernan JM, 2005, J R SOC INTERFACE, V2, P281, DOI 10.1098/rsif.2005.0042; Hvistendahl M, 2011, SCIENCENOW      0329; KOELLA JC, 1991, ACTA TROP, V49, P1, DOI 10.1016/0001-706X(91)90026-G; Lopez O., 2011, GREEN TRENDS INSECT; Macey R, 2001, BERKELEY MADONNA VER; Mackenzie JS, 2004, NAT MED, V10, pS98, DOI 10.1038/nm1144; NEDELMAN J, 1985, MATH BIOSCI, V73, P159, DOI 10.1016/0025-5564(85)90010-0; Ngwa GA, 2000, MATH COMPUT MODEL, V32, P747, DOI 10.1016/S0895-7177(00)00169-2; Rohani P, 2009, P NATL ACAD SCI USA, V106, P10365, DOI 10.1073/pnas.0809026106; Sogoba N, 2007, AM J TROP MED HYG, V77, P82, DOI 10.4269/ajtmh.2007.77.82; Su JL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018106; van den Driessche P, 2002, MATH BIOSCI, V180, P29, DOI 10.1016/S0025-5564(02)00108-6; Weaver SC, 2010, ANTIVIR RES, V85, P328, DOI 10.1016/j.antiviral.2009.10.008; WHO - WORLD HEALTH ORGANIZATION, 2011, MAL; Yan PX, 2011, VIROLOGY, V417, P1, DOI 10.1016/j.virol.2011.06.003	22	8	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2012	7	4							e35161	10.1371/journal.pone.0035161	http://dx.doi.org/10.1371/journal.pone.0035161			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959XD	22529985	Green Published, gold, Green Submitted			2022-12-25	WOS:000305350600063
J	Correia, M; Michel, V; Matos, AA; Carvalho, P; Oliveira, MJ; Ferreira, RM; Dillies, MA; Huerre, M; Seruca, R; Figueiredo, C; Machado, JC; Touati, E				Correia, Marta; Michel, Valerie; Matos, Antonio A.; Carvalho, Patricia; Oliveira, Maria J.; Ferreira, Rui M.; Dillies, Marie-Agnes; Huerre, Michel; Seruca, Raquel; Figueiredo, Ceu; Machado, Jose C.; Touati, Eliette			Docosahexaenoic Acid Inhibits Helicobacter pylori Growth In Vitro and Mice Gastric Mucosa Colonization	PLOS ONE			English	Article							POLYUNSATURATED FATTY-ACIDS; MONOGLYCERIDES; INFECTION	H. pylori drug-resistant strains and non-compliance to therapy are the major causes of H. pylori eradication failure. For some bacterial species it has been demonstrated that fatty acids have a growth inhibitory effect. Our main aim was to assess the ability of docosahexaenoic acid (DHA) to inhibit H. pylori growth both in vitro and in a mouse model. The effectiveness of standard therapy (ST) in combination with DHA on H. pylori eradication and recurrence prevention success was also investigated. The effects of DHA on H. pylori growth were analyzed in an in vitro dose-response study and n in vivo model. We analized the ability of H. pylori to colonize mice gastric mucosa following DHA, ST or a combination of both treatments. Our data demonstrate that DHA decreases H. pylori growth in vitro in a dose-dependent manner. Furthermore, DHA inhibits H. pylori gastric colonization in vivo as well as decreases mouse gastric mucosa inflammation. Addition of DHA to ST was also associated with lower H. pylori infection recurrence in the mouse model. In conclusion, DHA is an inhibitor of H. pylori growth and its ability to colonize mouse stomach. DHA treatment is also associated with a lower recurrence of H. pylori infection in combination with ST. These observations pave the way to consider DHA as an adjunct agent in H. pylori eradication treatment.	[Correia, Marta; Oliveira, Maria J.; Ferreira, Rui M.; Seruca, Raquel; Figueiredo, Ceu; Machado, Jose C.] Univ Porto, Inst Mol Pathol & Immunol, P-4100 Oporto, Portugal; [Correia, Marta; Ferreira, Rui M.; Seruca, Raquel; Figueiredo, Ceu; Machado, Jose C.] Univ Porto, Fac Med, P-4100 Oporto, Portugal; [Correia, Marta; Michel, Valerie; Touati, Eliette] Inst Pasteur, Unite Pathogenese Helicobacter, Paris, France; [Matos, Antonio A.; Carvalho, Patricia] Hosp Curry Cabral, Serv Microscopia Elect, Lisbon, Portugal; [Dillies, Marie-Agnes] Genopole Inst Pasteur, Paris, France; [Huerre, Michel] Inst Pasteur, Unite Rech & Expertise Histotechnol & Pathol, Paris, France; [Matos, Antonio A.; Carvalho, Patricia] Univ Aveiro, Ctr Environm & Marine Studies CESAM, P-3800 Aveiro, Portugal	Universidade do Porto; Universidade do Porto; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Universidade de Aveiro	Correia, M (corresponding author), Univ Porto, Inst Mol Pathol & Immunol, Rua Campo Alegre 823, P-4100 Oporto, Portugal.	josem@ipatimup.pt; etouati@pasteur.fr	seruca, raquel/F-8187-2011; Ferreira, Rui M./J-6915-2013; Figueiredo, Ceu/B-8776-2008; carvalho, patricia A/C-1150-2009; Carvalho, Patricia A/D-8078-2015; Carvalho, Patrícia Sousa Vindeirinho Albuquerque/HCI-2410-2022; Matos, Antonio P. A./A-4539-2013; Machado, Jose Carlos/C-5907-2009; Oliveira, Maria Jose/K-3275-2013	Ferreira, Rui M./0000-0003-0961-2356; Figueiredo, Ceu/0000-0001-5247-840X; carvalho, patricia A/0000-0002-5447-0409; Carvalho, Patricia A/0000-0002-5447-0409; Matos, Antonio P. A./0000-0001-9386-0349; Machado, Jose Carlos/0000-0003-4741-8415; Oliveira, Maria Jose/0000-0002-0724-0272; Seruca, Raquel/0000-0002-8851-4166; Correia, Maria Marta/0000-0001-5040-735X; Touati, Eliette/0000-0002-3450-1773	Fundacao para a Ciencia e a Tecnologia (FCT), Portugal [BD/36689/2007]; Accoes integradas Luso-Francesas (CRUP-PAULIF) Portugal [AF-8/09]; Accoes integradas Luso-Francesas (CRUP-PAULIF) France [AF-8/09]	Fundacao para a Ciencia e a Tecnologia (FCT), Portugal(Portuguese Foundation for Science and Technology); Accoes integradas Luso-Francesas (CRUP-PAULIF) Portugal; Accoes integradas Luso-Francesas (CRUP-PAULIF) France	The Fundacao para a Ciencia e a Tecnologia (FCT), Portugal, provided funds for this study and to Dr. Correia by a PhD fellowship BD/36689/2007. The Accoes integradas Luso-Francesas (CRUP-PAULIF) Portugal and France also provided financial support (AF-8/09). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bergsson G, 2002, INT J ANTIMICROB AG, V20, P258, DOI 10.1016/S0924-8579(02)00205-4; BORGSTROM B, 1957, J CLIN INVEST, V36, P1521, DOI 10.1172/JCI103549; Chaput C, 2006, PLOS PATHOG, V2, P844, DOI 10.1371/journal.ppat.0020097; Dammann HG, 2000, HELICOBACTER, V5, P41, DOI 10.1046/j.1523-5378.2000.00006.x; DAS UN, 1985, CAN MED ASSOC J, V132, P1350; DAS UN, 1989, PROSTAGLANDINS, V38, P689, DOI 10.1016/0090-6980(89)90050-6; Duggan AE, 1997, BRIT J NUTR, V78, P515, DOI 10.1079/BJN19970171; Eaton KA, 2007, COMPARATIVE MED, V57, P57; Ferrero RL, 1998, INFECT IMMUN, V66, P1349, DOI 10.1128/IAI.66.4.1349-1355.1998; Furuyashiki T, 2011, NAT REV ENDOCRINOL, V7, P163, DOI 10.1038/nrendo.2010.194; Gerhard M, 2002, HELICOBACTER, V7, P17, DOI 10.1046/j.1523-5378.7.s1.3.x; Glupczynski F, 2000, EUR J CLIN MICROBIOL, V11, P820; Graham DY, 2002, ARCH INTERN MED, V162, P169, DOI 10.1001/archinte.162.2.169; HOCHBERG Y, 1988, BIOMETRIKA, V75, P800, DOI 10.2307/2336325; Israel DA, 2001, J CLIN INVEST, V107, P611, DOI 10.1172/JCI11450; Kelley DS, 2007, AM J CLIN NUTR, V86, P324, DOI 10.1093/ajcn/86.2.324; KNAPP HR, 1986, J INFECT DIS, V154, P84, DOI 10.1093/infdis/154.1.84; Kuriki K, 2007, CANCER EPIDEM BIOMAR, V16, P2406, DOI 10.1158/1055-9965.EPI-07-0655; Lee A, 1997, GASTROENTEROLOGY, V112, P1386, DOI 10.1016/S0016-5085(97)70155-0; Malfertheiner P, 2007, GUT, V56, P772, DOI 10.1136/gut.2006.101634; Megraud F, 2003, SURVEILLANCE NATL MA, P327; Parsons HK, 2001, ALIMENT PHARM THERAP, V15, P1473, DOI 10.1046/j.1365-2036.2001.01068.x; Peek RM, 2002, NAT REV CANCER, V2, P28, DOI 10.1038/nrc703; Petschow BW, 1996, ANTIMICROB AGENTS CH, V40, P302, DOI 10.1128/AAC.40.2.302; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Roomi M. W., 2010, Experimental Oncology, V32, P84; SANDS JA, 1977, ANTIMICROB AGENTS CH, V12, P523, DOI 10.1128/AAC.12.4.523; Sorberg M, 1996, EUR J CLIN MICROBIOL, V15, P216, DOI 10.1007/BF01591357; Sun CQ, 2003, FEMS IMMUNOL MED MIC, V36, P9, DOI 10.1016/S0928-8244(03)00008-7; TARNAWSKI A, 1987, CLIN INVEST MED, V10, P132; THOMPSON L, 1994, GUT, V35, P1557, DOI 10.1136/gut.35.11.1557; Vakil N, 2006, AM J GASTROENTEROL, V101, P497, DOI 10.1111/j.1572-0241.2006.00454.x; van Zanten SJOV, 2003, ANTIMICROB AGENTS CH, V47, P2249, DOI 10.1128/AAC.47.7.2249-2255.2003	33	62	66	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2012	7	4							e35072	10.1371/journal.pone.0035072	http://dx.doi.org/10.1371/journal.pone.0035072			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WC	22529974	Green Published, gold, Green Submitted			2022-12-25	WOS:000305347400030
J	Hu, ZY; Hua, W; Huang, SM; Yang, HL; Zhan, GM; Wang, XF; Liu, GH; Wang, HZ				Hu, Zhiyong; Hua, Wei; Huang, Shunmou; Yang, Hongli; Zhan, Gaomiao; Wang, Xinfa; Liu, Guihua; Wang, Hanzhong			Discovery of Pod Shatter-Resistant Associated SNPs by Deep Sequencing of a Representative Library Followed by Bulk Segregant Analysis in Rapeseed	PLOS ONE			English	Article							SINGLE-NUCLEOTIDE POLYMORPHISMS; BRASSICA-NAPUS; REDUCED REPRESENTATION; OILSEED RAPE; ORYZA-RUFIPOGON; GENETIC-MARKERS; GENOME; CULTIVARS; REGIONS; SATIVA	Background: Single nucleotide polymorphisms (SNPs) are an important class of genetic marker for target gene mapping. As of yet, there is no rapid and effective method to identify SNPs linked with agronomic traits in rapeseed and other crop species. Methodology/Principal Findings: We demonstrate a novel method for identifying SNP markers in rapeseed by deep sequencing a representative library and performing bulk segregant analysis. With this method, SNPs associated with rapeseed pod shatter-resistance were discovered. Firstly, a reduced representation of the rapeseed genome was used. Genomic fragments ranging from 450-550 bp were prepared from the susceptible bulk (ten F2 plants with the silique shattering resistance index, SSRI <0.10) and the resistance bulk (ten F2 plants with SSRI >0.90), and also Solexa sequencing-produced 90 bp reads. Approximately 50 million of these sequence reads were assembled into contigs to a depth of 20-fold coverage. Secondly, 60,396 'simple SNPs' were identified, and the statistical significance was evaluated using Fisher's exact test. There were 70 associated SNPs whose -log(10)p value over 16 were selected to be further analyzed. The distribution of these SNPs appeared a tight cluster, which consisted of 14 associated SNPs within a 396 kb region on chromosome A09. Our evidence indicates that this region contains a major quantitative trait locus (QTL). Finally, two associated SNPs from this region were mapped on a major QTL region. Conclusions/Significance: 70 associated SNPs were discovered and a major QTL for rapeseed pod shatter-resistance was found on chromosome A09 using our novel method. The associated SNP markers were used for mapping of the QTL, and may be useful for improving pod shatter-resistance in rapeseed through marker-assisted selection and map-based cloning. This approach will accelerate the discovery of major QTLs and the cloning of functional genes for important agronomic traits in rapeseed and other crop species.	[Hu, Zhiyong; Hua, Wei; Huang, Shunmou; Yang, Hongli; Zhan, Gaomiao; Wang, Xinfa; Liu, Guihua; Wang, Hanzhong] Chinese Acad Agr Sci, Oil Crops Res Inst, Minist Agr, Key Lab Biol & Genet Improvement Oil Crops, Wuhan, Hubei, Peoples R China	Chinese Academy of Agricultural Sciences; Oil Crops Research Institute, CAAS; Ministry of Agriculture & Rural Affairs	Hu, ZY (corresponding author), Chinese Acad Agr Sci, Oil Crops Res Inst, Minist Agr, Key Lab Biol & Genet Improvement Oil Crops, Wuhan, Hubei, Peoples R China.	wanghz@oilcrops.cn			National Key Basic Research Program of China [2011CB109300]; Ministry of Agriculture Genetically Modified Organisms Breeding Major Projects of China [2009ZX08009-018B]; Wuhan Chenguang Project [201271031411]	National Key Basic Research Program of China(National Basic Research Program of China); Ministry of Agriculture Genetically Modified Organisms Breeding Major Projects of China; Wuhan Chenguang Project	This work was supported by the National Key Basic Research Program of China (2011CB109300), the Ministry of Agriculture Genetically Modified Organisms Breeding Major Projects of China (2009ZX08009-018B), and Wuhan Chenguang Project (201271031411). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler D, 2000, NATURE, V407, P513, DOI 10.1038/35035083; Amar S, 2008, THEOR APPL GENET, V116, P1051, DOI 10.1007/s00122-008-0734-2; Barbazuk WB, 2007, PLANT J, V51, P910, DOI 10.1111/j.1365-313X.2007.03193.x; Batley J, 2003, PLANT PHYSIOL, V132, P84, DOI 10.1104/pp.102.019422; Bhattramakki D, 2002, PLANT MOL BIOL, V48, P539, DOI 10.1023/A:1014841612043; Bi IV, 2006, CROP SCI, V46, P12, DOI 10.2135/cropsci2004.0706; Feltus FA, 2004, GENOME RES, V14, P1812, DOI 10.1101/gr.2479404; Feng H, 2012, MOL BREEDING, V29, P235, DOI 10.1007/s11032-010-9542-x; Hajduch M, 2006, PLANT PHYSIOL, V141, P32, DOI 10.1104/pp.105.075390; Hasan M, 2008, THEOR APPL GENET, V116, P1035, DOI 10.1007/s00122-008-0733-3; Huang Z, 2012, MOL BREEDING, V29, P181, DOI 10.1007/s11032-010-9536-8; Hyten DL, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-38; KADKOL GP, 1984, EUPHYTICA, V33, P63, DOI 10.1007/BF00022751; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Li WQ, 2010, PLANT CELL REP, V29, P617, DOI 10.1007/s00299-010-0848-2; Liu NJ, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-S1-S26; Martins-Lopes P, 2001, PLANT MOL BIOL REP, V19, P159, DOI 10.1007/BF02772158; MICHELMORE RW, 1991, P NATL ACAD SCI USA, V88, P9828, DOI 10.1073/pnas.88.21.9828; Mittelbach M, 2001, J AM OIL CHEM SOC, V78, P573, DOI 10.1007/s11746-001-0306-z; Monna L, 2006, DNA RES, V13, P43, DOI 10.1093/dnares/dsi030; Morgan CL, 1998, FIELD CROP RES, V58, P153, DOI 10.1016/S0378-4290(98)00099-9; Nasu S, 2002, DNA RES, V9, P163, DOI 10.1093/dnares/9.5.163; Need AC, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000373; Novaes E, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-312; Price JS, 1996, J AGR ENG RES, V65, P183, DOI 10.1006/jaer.1996.0091; Salunkhe AS, 2011, MOL BIOTECHNOL, V49, P90, DOI 10.1007/s12033-011-9382-x; Sanchez CC, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-559; Sun YP, 2010, MOL BREEDING, V26, P493, DOI 10.1007/s11032-010-9390-8; Trick M, 2009, PLANT BIOTECHNOL J, V7, P334, DOI 10.1111/j.1467-7652.2008.00396.x; Van Ooijen JW, 2001, JOINMAP3 0 SOFTWAREF; Van Tassell CP, 2008, NAT METHODS, V5, P247, DOI 10.1038/NMETH.1185; Venuprasad R, 2009, THEOR APPL GENET, V120, P177, DOI 10.1007/s00122-009-1168-1; Wang R, 2007, PLANT BREEDING, V126, P588, DOI 10.1111/j.1439-0523.2007.01382.x; Wang S., 2011, WINDOWS QTL CARTOGRA; Wang XW, 2011, NAT GENET, V43, P1035, DOI 10.1038/ng.919; Wen YanCheng, 2008, Acta Agronomica Sinica, V34, P163, DOI 10.3724/SP.J.1006.2008.00163; Wenger JW, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000942; Westermeier P, 2009, THEOR APPL GENET, V119, P1301, DOI 10.1007/s00122-009-1135-x; Wiedmann RT, 2008, BMC GENET, V9, DOI 10.1186/1471-2156-9-81; Xu AX, 2010, MOL BREEDING, V25, P57, DOI 10.1007/s11032-009-9308-5; ZHANG HB, 1995, PLANT J, V7, P175, DOI 10.1046/j.1365-313X.1995.07010175.x	41	16	20	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2012	7	4							e34253	10.1371/journal.pone.0034253	http://dx.doi.org/10.1371/journal.pone.0034253			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WC	22529909	gold, Green Submitted, Green Published			2022-12-25	WOS:000305347400009
J	Powder, KE; Ku, YC; Brugmann, SA; Veile, RA; Renaud, NA; Helms, JA; Lovett, M				Powder, Kara E.; Ku, Yuan-Chieh; Brugmann, Samantha A.; Veile, Rose A.; Renaud, Nicole A.; Helms, Jill A.; Lovett, Michael			A Cross-Species Analysis of MicroRNAs in the Developing Avian Face	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; NEURAL CREST CELLS; OSTEOBLAST DIFFERENTIATION; DARWINS FINCHES; VERTEBRATE EVOLUTION; EXPRESSION ANALYSIS; METAZOAN MICRORNAS; BEAK MORPHOLOGY; FEEDBACK LOOP; STEM-CELLS	Higher vertebrates use similar genetic tools to derive very different facial features. This diversity is believed to occur through temporal, spatial and species-specific changes in gene expression within cranial neural crest (NC) cells. These contribute to the facial skeleton and contain species-specific information that drives morphological variation. A few signaling molecules and transcription factors are known to play important roles in these processes, but little is known regarding the role of micro-RNAs (miRNAs). We have identified and compared all miRNAs expressed in cranial NC cells from three avian species (chicken, duck, and quail) before and after species-specific facial distinctions occur. We identified 170 differentially expressed miRNAs. These include thirty-five novel chicken orthologs of previously described miRNAs, and six avian-specific miRNAs. Five of these avian-specific miRNAs are conserved over 120 million years of avian evolution, from ratites to galliforms, and their predicted target mRNAs include many components of Wnt signaling. Previous work indicates that mRNA gene expression in NC cells is relatively static during stages when the beak acquires species-specific morphologies. However, miRNA expression is remarkably dynamic within this timeframe, suggesting that the timing of specific developmental transitions is altered in birds with different beak shapes. We evaluated one miRNA: mRNA target pair and found that the cell cycle regulator p27(KIP1) is a likely target of miR-222 in frontonasal NC cells, and that the timing of this interaction correlates with the onset of phenotypic variation. Our comparative genomic approach is the first comprehensive analysis of miRNAs in the developing facial primordial, and in species-specific facial development.	[Powder, Kara E.; Ku, Yuan-Chieh; Veile, Rose A.; Renaud, Nicole A.; Lovett, Michael] Washington Univ, Sch Med, Dept Genet, St Louis, MO 63110 USA; [Brugmann, Samantha A.] Cincinnati Childrens Hosp Med Ctr, Div Dev Biol, Div Plast Surg, Cincinnati, OH USA; [Helms, Jill A.] Stanford Univ, Dept Plast & Reconstruct Surg, Stanford, CA 94305 USA	Washington University (WUSTL); Cincinnati Children's Hospital Medical Center; Stanford University	Powder, KE (corresponding author), Washington Univ, Sch Med, Dept Genet, St Louis, MO 63110 USA.	lovett@genetics.wustl.edu		Lovett, Michael/0000-0002-6510-5829; Helms, Jill/0000-0002-0463-396X; Powder, Kara/0000-0001-7415-4262	National Institutes of Health [NRSA F32DE017499-01, RO1-DE012462-06A1, R01NS039818-09S1]; Louisiana State University Museum of Natural Sciences (LSUMNS); The University of Alaska Museum (UAM); University of Cincinnati; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE012462, F32DE017499] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS039818] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Louisiana State University Museum of Natural Sciences (LSUMNS); The University of Alaska Museum (UAM); University of Cincinnati; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the National Institutes of Health [NRSA F32DE017499-01 to SAB, RO1-DE012462-06A1 JAH, and R01NS039818-09S1 ML]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Tissues and DNAs from various bird species used to assess avian-specific miRNAs were provided by a grant from the Louisiana State University Museum of Natural Sciences (LSUMNS, Dr. R.T Brumfield), The University of Alaska Museum (UAM, Dr. K. Winker) and Dr. K. Petren (University of Cincinnati). We thank the Washington University School of Medicine GTAC for Next-Gen Sequencing services. We are grateful to Drs. Anne Bowcock and Cailin Joyce for critical comments on this manuscript.	Abzhanov A, 2004, SCIENCE, V305, P1462, DOI 10.1126/science.1098095; Abzhanov A, 2006, NATURE, V442, P563, DOI 10.1038/nature04843; Adkins RM, 2001, MOL BIOL EVOL, V18, P777, DOI 10.1093/oxfordjournals.molbev.a003860; Albertson RC, 2005, P NATL ACAD SCI USA, V102, P16287, DOI 10.1073/pnas.0506649102; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Bentwich I, 2005, NAT GENET, V37, P766, DOI 10.1038/ng1590; Berezikov E, 2006, NAT GENET, V38, P1375, DOI 10.1038/ng1914; Brabletz S, 2010, EMBO REP, V11, P670, DOI 10.1038/embor.2010.117; Bracken CP, 2008, CANCER RES, V68, P7846, DOI 10.1158/0008-5472.CAN-08-1942; Brameier Markus, 2010, BMC Res Notes, V3, P64, DOI 10.1186/1756-0500-3-64; Braun J, 2010, ONCOGENE, V29, P4237, DOI 10.1038/onc.2010.169; Brugmann SA, 2006, AM J MED GENET A, V140A, P2521, DOI 10.1002/ajmg.a.31361; Brugmann SA, 2010, HUM MOL GENET, V19, P920, DOI 10.1093/hmg/ddp559; Burnside J, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-185; CARROLL SB, 2005, ENDLESS FORMS MOST B; Chen K, 2006, NAT GENET, V38, P1452, DOI 10.1038/ng1910; Christodoulou F, 2010, NATURE, V463, P1084, DOI 10.1038/nature08744; Cummins JM, 2006, P NATL ACAD SCI USA, V103, P3687, DOI 10.1073/pnas.0511155103; Dobreva G, 2006, CELL, V125, P971, DOI 10.1016/j.cell.2006.05.012; Eames BF, 2004, DEV DYNAM, V231, P4, DOI 10.1002/dvdy.20134; Eberhart JK, 2008, NAT GENET, V40, P290, DOI 10.1038/ng.82; Fehniger TA, 2010, GENOME RES, V20, P1590, DOI 10.1101/gr.107995.110; FitzPatrick DR, 2003, HUM MOL GENET, V12, P2491, DOI 10.1093/hmg/ddg248; Galardi S, 2007, J BIOL CHEM, V282, P23716, DOI 10.1074/jbc.M701805200; Gessert S, 2010, DEV BIOL, V341, P222, DOI 10.1016/j.ydbio.2010.02.031; Giraldez AJ, 2006, SCIENCE, V312, P75, DOI 10.1126/science.1122689; Glazov EA, 2008, GENOME RES, V18, P957, DOI 10.1101/gr.074740.107; Grant P. R., 1986, ECOLOGY EVOLUTION DA; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Grimson A, 2008, NATURE, V455, P1193, DOI 10.1038/nature07415; Hackenberg M, 2009, NUCLEIC ACIDS RES, V37, pW68, DOI 10.1093/nar/gkp347; HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; Hassan MQ, 2010, P NATL ACAD SCI USA, V107, P19879, DOI 10.1073/pnas.1007698107; Hawkins RD, 2006, GENOMICS, V87, P801, DOI 10.1016/j.ygeno.2005.12.014; Heimberg AM, 2008, P NATL ACAD SCI USA, V105, P2946, DOI 10.1073/pnas.0712259105; Hertel J, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-25; Hiard S, 2010, NUCLEIC ACIDS RES, V38, pD640, DOI 10.1093/nar/gkp926; Hillier LW, 2004, NATURE, V432, P695, DOI 10.1038/nature03154; Huang TW, 2010, J MOL CELL BIOL, V2, P152, DOI 10.1093/jmcb/mjq008; Huang YW, 2009, CANCER RES, V69, P9038, DOI 10.1158/0008-5472.CAN-09-1499; JACOB F, 1977, SCIENCE, V196, P1161, DOI 10.1126/science.860134; Joglekar MV, 2009, ISLETS, V1, P137, DOI 10.4161/isl.1.2.9578; Kennell JA, 2008, P NATL ACAD SCI USA, V105, P15417, DOI 10.1073/pnas.0807763105; Kersigo J, 2011, GENESIS, V49, P326, DOI 10.1002/dvg.20714; Kocher TD, 2004, NAT REV GENET, V5, P288, DOI 10.1038/nrg1316; Kontges G, 1996, DEVELOPMENT, V122, P3229; Kumar S, 1998, NATURE, V392, P917, DOI 10.1038/31927; Lambeth LS, 2009, J GEN VIROL, V90, P1164, DOI 10.1099/vir.0.007831-0; Larroux C, 2008, MOL BIOL EVOL, V25, P980, DOI 10.1093/molbev/msn047; Li JJ, 2010, MOL BIOL EVOL, V27, P671, DOI 10.1093/molbev/msp284; Lin SL, 2008, RNA, V14, P2115, DOI 10.1261/rna.1162708; Lin SL, 2011, NUCLEIC ACIDS RES, V39, P1054, DOI 10.1093/nar/gkq850; Lin SL, 2010, NUCL ACIDS RES; Liu B, 2010, SEMIN CELL DEV BIOL, V21, P309, DOI 10.1016/j.semcdb.2009.09.002; Liu W, 2005, DEVELOPMENT, V132, P1453, DOI 10.1242/dev.01676; Loh YHE, 2011, GENOME BIOL EVOL, V3, P55, DOI 10.1093/gbe/evq085; LUMSDEN A, 1991, DEVELOPMENT, V113, P1281; Mallarino R, 2011, P NATL ACAD SCI USA, V108, P4057, DOI 10.1073/pnas.1011480108; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Mukhopadhyay P, 2010, BIRTH DEFECTS RES A, V88, P511, DOI 10.1002/bdra.20684; Nichols SA, 2006, P NATL ACAD SCI USA, V103, P12451, DOI 10.1073/pnas.0604065103; Nie XG, 2011, MECH DEVELOP, V128, P200, DOI 10.1016/j.mod.2010.12.002; NODEN DM, 1978, DEV BIOL, V67, P296, DOI 10.1016/0012-1606(78)90201-4; Noonan JP, 2006, SCIENCE, V314, P1113, DOI 10.1126/science.1131412; Okamura K, 2008, NAT STRUCT MOL BIOL, V15, P354, DOI 10.1038/nsmb.1409; Peterson KJ, 2009, BIOESSAYS, V31, P736, DOI 10.1002/bies.200900033; Prochnik SE, 2007, DEV GENES EVOL, V217, P73, DOI 10.1007/s00427-006-0116-1; Romualdi C, 2001, HUM MOL GENET, V10, P2133, DOI 10.1093/hmg/10.19.2133; Roush S, 2008, TRENDS CELL BIOL, V18, P505, DOI 10.1016/j.tcb.2008.07.007; Santagati F, 2003, NAT REV NEUROSCI, V4, P806, DOI 10.1038/nrn1221; Sauka-Spengler T, 2008, NAT REV MOL CELL BIO, V9, P557, DOI 10.1038/nrm2428; Schneider RA, 2003, SCIENCE, V299, P565, DOI 10.1126/science.1077827; Sempere LF, 2006, J EXP ZOOL PART B, V306B, P575, DOI 10.1002/jez.b.21118; Sheehy NT, 2010, DEVELOPMENT, V137, P4307, DOI 10.1242/dev.052647; Shen RZ, 2010, BIOCHEM BIOPH RES CO, V394, P1047, DOI 10.1016/j.bbrc.2010.03.121; Sibley CG, 1990, PHYLOGENY CLASSIFICA; Silber J, 2008, BMC MED, V6, DOI 10.1186/1741-7015-6-14; Stefani G, 2008, NAT REV MOL CELL BIO, V9, P219, DOI 10.1038/nrm2347; Sun DZ, 2000, DEV BIOL, V228, P337, DOI 10.1006/dbio.2000.9946; Suzuki S, 2009, AM J HUM GENET, V84, P406, DOI 10.1016/j.ajhg.2009.02.002; Tapadia MD, 2005, J ANAT, V207, P461, DOI 10.1111/j.1469-7580.2005.00484.x; Terai Y, 2002, MOL BIOL EVOL, V19, P1628, DOI 10.1093/oxfordjournals.molbev.a004225; Thatcher EJ, 2008, P NATL ACAD SCI USA, V105, P18384, DOI 10.1073/pnas.0803713105; van Tuinen M, 2001, MOL BIOL EVOL, V18, P206, DOI 10.1093/oxfordjournals.molbev.a003794; Wang T, 2010, BIOCHEM BIOPH RES CO, V402, P186, DOI 10.1016/j.bbrc.2010.08.031; Wellner U, 2009, NAT CELL BIOL, V11, P1487, DOI 10.1038/ncb1998; Wheeler BM, 2009, EVOL DEV, V11, P50, DOI 10.1111/j.1525-142X.2008.00302.x; Wu P, 2004, SCIENCE, V305, P1465, DOI 10.1126/science.1098109; Wu P, 2006, DEV DYNAM, V235, P1400, DOI 10.1002/dvdy.20825; Yang JS, 2010, WIDESPREAD REGULATOR; Yuan ZD, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-346; Zehir A, 2010, DEV BIOL, V340, P459, DOI 10.1016/j.ydbio.2010.01.039	93	23	24	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2012	7	4							e35111	10.1371/journal.pone.0035111	http://dx.doi.org/10.1371/journal.pone.0035111			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VO	22523571	Green Published, Green Submitted, gold			2022-12-25	WOS:000305345000043
J	Sigurdsson, G; Fleming, RMT; Heinken, A; Thiele, I				Sigurdsson, Gunnar; Fleming, Ronan M. T.; Heinken, Almut; Thiele, Ines			A Systems Biology Approach to Drug Targets in Pseudomonas aeruginosa Biofilm	PLOS ONE			English	Article							METABOLIC NETWORK ANALYSIS; CONSTRAINT-BASED MODELS; FLUX BALANCE ANALYSIS; QUANTITATIVE PREDICTION; CELLULAR-METABOLISM; MUTANT LIBRARY; RECONSTRUCTION; PAO1; INFECTIONS; GENE	Antibiotic resistance is an increasing problem in the health care system and we are in a constant race with evolving bacteria. Biofilm-associated growth is thought to play a key role in bacterial adaptability and antibiotic resistance. We employed a systems biology approach to identify candidate drug targets for biofilm-associated bacteria by imitating specific microenvironments found in microbial communities associated with biofilm formation. A previously reconstructed metabolic model of Pseudomonas aeruginosa (PA) was used to study the effect of gene deletion on bacterial growth in planktonic and biofilm-like environmental conditions. A set of 26 genes essential in both conditions was identified. Moreover, these genes have no homology with any human gene. While none of these genes were essential in only one of the conditions, we found condition-dependent genes, which could be used to slow growth specifically in biofilm-associated PA. Furthermore, we performed a double gene deletion study and obtained 17 combinations consisting of 21 different genes, which were conditionally essential. While most of the difference in double essential gene sets could be explained by different medium composition found in biofilm-like and planktonic conditions, we observed a clear effect of changes in oxygen availability on the growth performance. Eight gene pairs were found to be synthetic lethal in oxygen-limited conditions. These gene sets may serve as novel metabolic drug targets to combat particularly biofilm-associated PA. Taken together, this study demonstrates that metabolic modeling of human pathogens can be used to identify oxygen-sensitive drug targets and thus, that this systems biology approach represents a powerful tool to identify novel candidate antibiotic targets.	[Sigurdsson, Gunnar; Fleming, Ronan M. T.; Heinken, Almut; Thiele, Ines] Univ Iceland, Ctr Syst Biol, Reykajavik, Iceland; [Thiele, Ines] Univ Iceland, Fac Ind Engn Mech Engn & Comp Sci, Reykajavik, Iceland	University of Iceland; University of Iceland	Sigurdsson, G (corresponding author), Univ Iceland, Ctr Syst Biol, Reykajavik, Iceland.	ines.thiele@gmail.com	Thiele, Ines/A-7629-2014; Fleming, Ronan MT/ABC-4093-2021	Thiele, Ines/0000-0002-8071-7110; Fleming, Ronan MT/0000-0001-5346-9812; Heinken, Almut/0000-0001-6938-8072	Marie Curie International Reintegration Grant within the 7th European Community Framework Program [249261]; student innovation grant by the Icelandic Research Fund (Rannis)	Marie Curie International Reintegration Grant within the 7th European Community Framework Program; student innovation grant by the Icelandic Research Fund (Rannis)	This research was supported by a Marie Curie International Reintegration Grant awarded to IT (No 249261) within the 7th European Community Framework Program. GS was funded, in part, by a student innovation grant by the Icelandic Research Fund (Rannis). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Becker SA, 2007, NAT PROTOC, V2, P727, DOI 10.1038/nprot.2007.99; Bielecki P, 2008, BIOTECHNOL LETT, V30, P777, DOI 10.1007/s10529-007-9620-2; BODEY GP, 1983, REV INFECT DIS, V5, P279; Borriello G, 2004, ANTIMICROB AGENTS CH, V48, P2659, DOI 10.1128/AAC.48.7.2659-2664.2004; Carmeli Y, 1999, ANTIMICROB AGENTS CH, V43, P1379, DOI 10.1128/AAC.43.6.1379; del Pozo JL, 2007, CLIN PHARMACOL THER, V82, P204, DOI 10.1038/sj.clpt.6100247; Driscoll JA, 2007, DRUGS, V67, P351, DOI 10.2165/00003495-200767030-00003; Duarte NC, 2007, P NATL ACAD SCI USA, V104, P1777, DOI 10.1073/pnas.0610772104; Fang KC, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-83; Feist AM, 2008, NAT BIOTECHNOL, V26, P659, DOI 10.1038/nbt1401; Feist AM, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100155; Fleming RMT, 2009, BIOPHYS CHEM, V145, P47, DOI 10.1016/j.bpc.2009.08.007; Fleming RMT, 2011, BIOINFORMATICS, V27, P142, DOI 10.1093/bioinformatics/btq607; Gonzalez O, 2008, MOL BIOSYST, V4, P148, DOI 10.1039/b715203e; Hall-Stoodley L, 2004, NAT REV MICROBIOL, V2, P95, DOI 10.1038/nrmicro821; Jacobs MA, 2003, P NATL ACAD SCI USA, V100, P14339, DOI 10.1073/pnas.2036282100; Jamshidi N, 2007, BMC SYST BIOL, V1, DOI 10.1186/1752-0509-1-26; Kell DB, 2006, DRUG DISCOV TODAY, V11, P1085, DOI 10.1016/j.drudis.2006.10.004; Lee DS, 2009, J BACTERIOL, V191, P4015, DOI 10.1128/JB.01743-08; Lewenza S, 2005, GENOME RES, V15, P583, DOI 10.1101/gr.3513905; Moreau-Marquis S, 2008, PULM PHARMACOL THER, V21, P595, DOI 10.1016/j.pupt.2007.12.001; Musken M, 2010, MICROBIOL-SGM, V156, P431, DOI 10.1099/mic.0.033290-0; Oberhardt MA, 2008, J BACTERIOL, V190, P2790, DOI 10.1128/JB.01583-07; Oberhardt MA, 2010, J BACTERIOL, V192, P5534, DOI 10.1128/JB.00900-10; Oberhardt MA, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.77; Obrzut S, 2010, J CARDIOVASC TRANSL, V3, P643, DOI 10.1007/s12265-010-9223-5; Orth JD, 2010, NAT BIOTECHNOL, V28, P245, DOI 10.1038/nbt.1614; Palsson B, 2009, FEBS LETT, V583, P3900, DOI 10.1016/j.febslet.2009.09.031; Palsson BO., 2006, SYSTEMS BIOL PROPERT; Perumal Deepak, 2007, In Silico Biology, V7, P453; Perumal D, 2011, J DRUG TARGET, V19, P1, DOI 10.3109/10611861003649753; Pommerenke C, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001074; Price ND, 2006, BIOPHYS J, V90, P3919, DOI 10.1529/biophysj.105.072645; Price ND, 2004, NAT REV MICROBIOL, V2, P886, DOI 10.1038/nrmicro1023; Schellenberger J, 2011, NAT PROTOC, V6, P1290, DOI 10.1038/nprot.2011.308; Selvarasu S, 2010, MOL BIOSYST, V6, P152, DOI 10.1039/b912865d; Sigurdsson MI, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-140; Silver LL, 2007, NAT REV DRUG DISCOV, V6, P41, DOI 10.1038/nrd2202; Sriramulu DD, 2005, J MED MICROBIOL, V54, P667, DOI 10.1099/jmm.0.45969-0; Stewart PS, 2001, LANCET, V358, P135, DOI 10.1016/S0140-6736(01)05321-1; Stover CK, 2000, NATURE, V406, P959, DOI 10.1038/35023079; Thiele I, 2005, J BACTERIOL, V187, P5818, DOI 10.1128/JB.187.16.5818-5830.2005; Thiele I, 2010, NAT PROTOC, V5, P93, DOI 10.1038/nprot.2009.203; Wang Y, 2007, SCI CHINA SER C, V50, P385, DOI 10.1007/s11427-007-0044-y; Wishart DS, 2008, NUCLEIC ACIDS RES, V36, pD901, DOI 10.1093/nar/gkm958; Zimmermann GR, 2007, DRUG DISCOV TODAY, V12, P34, DOI 10.1016/j.drudis.2006.11.008	46	30	31	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2012	7	4							e34337	10.1371/journal.pone.0034337	http://dx.doi.org/10.1371/journal.pone.0034337			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VO	22523548	Green Published, Green Submitted, gold			2022-12-25	WOS:000305345000018
J	Kongpetch, S; Kukongviriyapan, V; Prawan, A; Senggunprai, L; Kukongviriyapan, U; Buranrat, B				Kongpetch, Sarinya; Kukongviriyapan, Veerapol; Prawan, Auemduan; Senggunprai, Laddawan; Kukongviriyapan, Upa; Buranrat, Benjaporn			Crucial Role of Heme Oxygenase-1 on the Sensitivity of Cholangiocarcinoma Cells to Chemotherapeutic Agents	PLOS ONE			English	Article							MITOCHONDRIAL PERMEABILITY TRANSITION; PROTOPORPHYRIN-IX; BENZODIAZEPINE-RECEPTOR; ZINC PROTOPORPHYRIN; CARBON-MONOXIDE; TUMOR-GROWTH; IN-VIVO; EXPRESSION; CANCER; INHIBITION	Cancer cells acquire drug resistance via various mechanisms including enhanced cellular cytoprotective and antioxidant activities. Heme oxygenase-1 (HO-1) is a key enzyme exerting potent cytoprotection, cell proliferation and drug resistance. We aimed to investigate roles of HO-1 in human cholangiocarcinoma (CCA) cells for cytoprotection against chemotherapeutic agents. KKU-100 and KKU-M214 CCA cell lines with high and low HO-1 expression levels, respectively, were used to evaluate the sensitivity to chemotherapeutic agents, gemcitabine (Gem) and doxorubicin. Inhibition of HO-1 by zinc protoporphyrin IX (ZnPP) sensitized both cell types to the cytotoxicity of chemotherapeutic agents. HO-1 gene silencing by siRNA validated the cytoprotective effect of HO-1 on CCA cells against Gem. Induction of HO-1 protein expression by stannous chloride enhanced the cytoprotection and suppression of apoptosis caused by anticancer agents. The sensitizing effect of ZnPP was associated with increased ROS formation and loss of mitochondrial transmembrane potential, while Gem alone did not show any effects. A ROS scavenger, Tempol, abolished the sensitizing effect of ZnPP on Gem. Combination of ZnPP and Gem enhanced the release of cytochrome c and increased p21 levels. The results show that HO-1 played a critical role in cytoprotection in CCA cells against chemotherapeutic agents. Targeted inhibition of HO-1 may be a strategy to overcome drug resistance in chemotherapy of bile duct cancer.	[Kongpetch, Sarinya; Kukongviriyapan, Veerapol; Prawan, Auemduan; Senggunprai, Laddawan] Khon Kaen Univ, Fac Med, Dept Pharmacol, Khon Kaen, Thailand; [Kukongviriyapan, Upa] Khon Kaen Univ, Fac Med, Dept Physiol, Khon Kaen, Thailand; [Kukongviriyapan, Veerapol; Prawan, Auemduan; Senggunprai, Laddawan] Khon Kaen Univ, Liver Fluke & Cholangiocarcinoma Res Ctr, Khon Kaen, Thailand; [Buranrat, Benjaporn] Univ Phayao, Fac Pharmaceut Sci, Phayao, Thailand	Khon Kaen University; Khon Kaen University; Khon Kaen University; University of Phayao	Kongpetch, S (corresponding author), Khon Kaen Univ, Fac Med, Dept Pharmacol, Khon Kaen, Thailand.	veerapol@kku.ac.th	PRAWAN, AUEMDUAN/B-1639-2015	prawan, auemduan/0000-0001-6713-567X	Thailand Research Fund, Office of the Higher Education Commission through SHeP-GMS of Khon Kaen University; Faculty of Medicine, Khon Kaen University; Royal Golden Jubilee Ph.D. Programme	Thailand Research Fund, Office of the Higher Education Commission through SHeP-GMS of Khon Kaen University; Faculty of Medicine, Khon Kaen University; Royal Golden Jubilee Ph.D. Programme	This study was supported by Thailand Research Fund, Office of the Higher Education Commission through SHeP-GMS of Khon Kaen University, a grant-in-aid from Faculty of Medicine, Khon Kaen University and a scholarship from the Royal Golden Jubilee Ph.D. Programme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azarashvili T, 2007, CELL CALCIUM, V42, P27, DOI 10.1016/j.ceca.2006.11.004; Berberat PO, 2005, CLIN CANCER RES, V11, P3790, DOI 10.1158/1078-0432.CCR-04-2159; Blechacz B, 2008, HEPATOLOGY, V48, P308, DOI 10.1002/hep.22310; Boutros C, 2007, J SURG RES, V143, P437, DOI 10.1016/j.jss.2007.02.013; Buranrat B, 2007, WORLD J GASTROENTERO, V13, P6219, DOI 10.3748/wjg.13.6219; Buranrat B, 2010, WORLD J GASTROENTERO, V16, P2362, DOI 10.3748/wjg.v16.i19.2362; Correa-Costa M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014298; Doi K, 1999, BRIT J CANCER, V80, P1945, DOI 10.1038/sj.bjc.6690624; Fang J, 2003, CANCER RES, V63, P3567; Giris M, 2010, J SURG RES, V164, P266, DOI 10.1016/j.jss.2009.04.013; Goodman AI, 1997, P SOC EXP BIOL MED, V214, P54; Gozzelino R, 2010, ANNU REV PHARMACOL, V50, P323, DOI 10.1146/annurev.pharmtox.010909.105600; Hezel AF, 2008, ONCOLOGIST, V13, P415, DOI 10.1634/theoncologist.2007-0252; Jinawath N, 2006, HEPATOLOGY, V44, P1025, DOI 10.1002/hep.21330; Jozkowicz A, 2007, ANTIOXID REDOX SIGN, V9, P2099, DOI 10.1089/ars.2007.1659; Kim JS, 2003, BIOCHEM BIOPH RES CO, V304, P463, DOI 10.1016/S0006-291X(03)00618-1; Kuroda H, 2010, LUNG CANCER, V67, P31, DOI 10.1016/j.lungcan.2009.03.015; Li CH, 2005, J BIOL CHEM, V280, P26193, DOI 10.1074/jbc.M501371200; Maines MD, 1996, UROLOGY, V47, P727, DOI 10.1016/S0090-4295(96)00010-6; Malhi H, 2006, J HEPATOL, V45, P856, DOI 10.1016/j.jhep.2006.09.001; Marahatta SB, 2006, CANCER LETT, V236, P276, DOI 10.1016/j.canlet.2005.05.020; Miyake M, 2010, UROL INT, V85, P355, DOI 10.1159/000317785; Miyazaki T, 2010, CANCER SCI, V101, P1409, DOI 10.1111/j.1349-7006.2010.01550.x; Nowis D, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-197; Nuhn P, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-37; Ohgari Y, 2011, J BIOCHEM, V149, P153, DOI 10.1093/jb/mvq126; PASTORINO JG, 1994, J BIOL CHEM, V269, P31041; Patel T, 2011, NAT REV GASTRO HEPAT, V8, P189, DOI 10.1038/nrgastro.2011.20; Prawan A, 2005, EUR J CANCER PREV, V14, P245, DOI 10.1097/00008469-200506000-00008; Ryter SW, 2007, ANTIOXID REDOX SIGN, V9, P2157, DOI 10.1089/ars.2007.1811; Ryter SW, 2006, PHYSIOL REV, V86, P583, DOI 10.1152/physrev.00011.2005; Shin HR, 2010, CANCER SCI, V101, P579, DOI 10.1111/j.1349-7006.2009.01458.x; Sripa B, 2008, CURR OPIN GASTROEN, V24, P349, DOI 10.1097/MOG.0b013e3282fbf9b3; Suphim B, 2010, FOOD CHEM TOXICOL, V48, P2265, DOI 10.1016/j.fct.2010.05.059; Tolis C, 1999, EUR J CANCER, V35, P796, DOI 10.1016/S0959-8049(98)00425-0; Was H, 2006, AM J PATHOL, V169, P2181, DOI 10.2353/ajpath.2006.051365	36	70	72	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2012	7	4							e34994	10.1371/journal.pone.0034994	http://dx.doi.org/10.1371/journal.pone.0034994			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UT	22514698	Green Submitted, Green Published, gold			2022-12-25	WOS:000305341600104
J	Sakakibara, S; Espigol-Frigole, G; Gasperini, P; Uldrick, TS; Yarchoan, R; Tosato, G				Sakakibara, S.; Espigol-Frigole, G.; Gasperini, P.; Uldrick, T. S.; Yarchoan, R.; Tosato, G.			A20/TNFAIP3 inhibits NF-kappa B activation induced by the Kaposi's sarcoma-associated herpesvirus vFLIP oncoprotein	ONCOGENE			English	Article						KSHV; NF-kappa B; vFLIP/K13; endothelial cells; Kaposi's sarcoma; AIDS	ZINC-FINGER PROTEIN; DEPENDENT GENE-EXPRESSION; IKK-GAMMA; ENDOTHELIAL-CELLS; UBIQUITIN CHAINS; KINASE COMPLEX; A20 INTERACTS; KSHV VFLIP; ENZYME A20; RECEPTOR	Kaposi's sarcoma-associated herpesvirus (KSHV) K13/vFLIP (viral Flice-inhibitory protein) induces transcription of numerous genes through NF-kappa B activation, including pro-inflammatory cytokines, which contribute to the pathogenesis of Kaposi's sarcoma (KS). In this study, we report that KSHV vFLIP induces the expression of the NF-kappa B regulatory proteins A20, ABIN-1 and ABIN-3 (A20-binding NF-kappa B inhibitors) in primary human endothelial cells, and that KS spindle cells express A20 in KS tissue. In reporter assays, A20 strongly impaired vFLIP-induced NF-kappa B activation in 293T cells, but ABIN-1 and ABIN-3 did not. Mutational analysis established that the C-terminal domain (residues 427-790) is critical for A20 modulation of NF-kappa B, but the ubiquitin-editing OTU (ovarian tumor) domain is not. In functional assays, A20 inhibited vFLIP-induced expression of the chemokine IP-10, reduced vFLIP-induced cell proliferation and increased IKK1 protein levels. Thus, we demonstrate that A20 negatively regulates NF-kappa B activation directly induced by KSHV vFLIP. By attenuating excessive and prolonged vFLIP-induced NF-kappa B activation that could be harmful to KSHV-infected cells, A20 likely has an important role in the pathogenesis of KSHV-associated diseases, in which vFLIP is expressed. Oncogene (2013) 32, 1223-1232; doi:10.1038/onc.2012.145; published online 23 April 2012	[Sakakibara, S.; Espigol-Frigole, G.; Gasperini, P.; Tosato, G.] NCI, Cellular Oncol Lab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Uldrick, T. S.; Yarchoan, R.] NCI, HIV & AIDS Malignancy Branch, Ctr Canc Res, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Espigol-Frigole, G (corresponding author), NCI, Cellular Oncol Lab, CCR, NIH, Bldg 37,Room 4134, Bethesda, MD 20892 USA.	GESPIGOL@clinic.ub.es		Gasperini, Paola/0000-0002-3016-9742; Tosato, Giovanna/0000-0003-1663-3227; Sakakibara, Shuhei/0000-0003-3157-5870	intramural research program in Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, USA; NATIONAL CANCER INSTITUTE [ZIASC010356, ZIABC010885] Funding Source: NIH RePORTER	intramural research program in Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, USA; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank G Nolan (Stanford University), BK Weaver (Missouri State University), J-M Peloponese Jr, K-T Jeang (NIAID, NIH), DB Conze, JD Ashwell (NCI, NIH), AV Grishin (University of Southern California), A Leonardi (University of Naples, Italy), R Lin (Jewish General Hospital, Canada) for reagents; the patients who volunteered for this study; Dr MN Polizzotto (NCI, NIH), K Aleman and K Wyvill for patient care; the Confocal Microscopy Core Facility (Laboratory of Experimental Carcinogenesis, CCR, NCI) for providing LSM510 and the DNA Minicore Facility (Laboratory of Experimental Carcinogenesis, CCR, NCI) for DNA sequencing, and K Sakakibara (NCI, NIH) for her help in reporter assay. We also thank Drs D Lowy, O Salvucci, H Ohnuki and all members of Laboratory of Cellular Oncology Branch for their advice and help on this work. This study was supported by the intramural research program in Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD20892, USA.	Ambinder RF, 2007, HUMAN HERPESVIRUSES: BIOLOGY, THERAPY, AND IMMUNOPROPHYLAXIS, P885; BAEUERLE PA, 1988, SCIENCE, V242, P540, DOI 10.1126/science.3140380; Bagneris C, 2008, MOL CELL, V30, P620, DOI 10.1016/j.molcel.2008.04.029; Ballon G, 2011, J CLIN INVEST, V121, P1141, DOI 10.1172/JCI44417; Beyaert R, 2000, BIOCHEM PHARMACOL, V60, P1143, DOI 10.1016/S0006-2952(00)00404-4; Boone DL, 2004, NAT IMMUNOL, V5, P1052, DOI 10.1038/ni1110; Chaudhary PM, 1999, ONCOGENE, V18, P5738, DOI 10.1038/sj.onc.1202976; Chugh P, 2005, P NATL ACAD SCI USA, V102, P12885, DOI 10.1073/pnas.0408577102; Compagno M, 2009, NATURE, V459, P717, DOI 10.1038/nature07968; Cooper JT, 1996, J BIOL CHEM, V271, P18068, DOI 10.1074/jbc.271.30.18068; Daniel S, 2004, BLOOD, V104, P2376, DOI 10.1182/blood-2003-02-0635; De Valck D, 1999, ONCOGENE, V18, P4182, DOI 10.1038/sj.onc.1202787; Ea CK, 2006, MOL CELL, V22, P245, DOI 10.1016/j.molcel.2006.03.026; EDGELL CJ, 1983, P NATL ACAD SCI-BIOL, V80, P3734, DOI 10.1073/pnas.80.12.3734; Field N, 2003, J CELL SCI, V116, P3721, DOI 10.1242/jcs.00691; Ganem D, 2006, ANNU REV PATHOL-MECH, V1, P273, DOI 10.1146/annurev.pathol.1.110304.100133; Giulino L, 2011, BLOOD, V117, P4852, DOI 10.1182/blood-2010-10-310995; Grossmann C, 2006, J VIROL, V80, P7179, DOI 10.1128/JVI.01603-05; Grundhoff A, 2001, J VIROL, V75, P1857, DOI 10.1128/JVI.75.4.1857-1863.2001; Guasparri I, 2006, EMBO REP, V7, P114, DOI 10.1038/sj.embor.7400580; Guasparri I, 2004, J EXP MED, V199, P993, DOI 10.1084/jem.20031467; Hacker Hans, 2006, Sci STKE, V2006, pre13, DOI 10.1126/stke.3572006re13; Hadian K, 2011, J BIOL CHEM, V286, P26107, DOI 10.1074/jbc.M111.233163; Harhaj EW, 2011, CELL RES, V21, P22, DOI 10.1038/cr.2010.166; Harhaj EW, 1999, J BIOL CHEM, V274, P22911, DOI 10.1074/jbc.274.33.22911; Heyninck K, 1999, J CELL BIOL, V145, P1471, DOI 10.1083/jcb.145.7.1471; Kato M, 2009, NATURE, V459, P712, DOI 10.1038/nature07969; KRIKOS A, 1992, J BIOL CHEM, V267, P17971; Lee EG, 2000, SCIENCE, V289, P2350, DOI 10.1126/science.289.5488.2350; Li QT, 2005, P NATL ACAD SCI USA, V102, P12425, DOI 10.1073/pnas.0505997102; Li XH, 2001, J BIOL CHEM, V276, P4494, DOI 10.1074/jbc.M008353200; Lin RT, 2006, J BIOL CHEM, V281, P2095, DOI 10.1074/jbc.M510326200; Liu B, 2007, CELL, V129, P903, DOI 10.1016/j.cell.2007.03.056; Liu L, 2002, J BIOL CHEM, V277, P13745, DOI 10.1074/jbc.M110480200; Matta H, 2003, J BIOL CHEM, V278, P52406, DOI 10.1074/jbc.M307308200; Matta H, 2007, J BIOL CHEM, V282, P24858, DOI 10.1074/jbc.M700118200; Matta H, 2011, J BIOL CHEM, V286, P21555, DOI 10.1074/jbc.M111.224048; Mauro C, 2006, J BIOL CHEM, V281, P18482, DOI 10.1074/jbc.M601502200; Narazaki M, 2006, BLOOD, V107, P3892, DOI 10.1182/blood-2005-10-4113; Natoli G, 1998, J BIOL CHEM, V273, P31262, DOI 10.1074/jbc.273.47.31262; O'Reilly SM, 2003, BIOCHEM BIOPH RES CO, V303, P586, DOI 10.1016/S0006-291X(03)00389-9; OHMORI Y, 1993, J BIOL CHEM, V268, P6677; OPIPARI AW, 1990, J BIOL CHEM, V265, P14705; OPIPARI AW, 1992, J BIOL CHEM, V267, P12424; Punj V, 2009, BMC MED GENOMICS, V2, DOI 10.1186/1755-8794-2-50; Rahighi S, 2009, CELL, V136, P1098, DOI 10.1016/j.cell.2009.03.007; Sakakibara S, 2011, J VIROL, V85, P3179, DOI 10.1128/JVI.02333-10; Sakakibara S, 2009, J VIROL, V83, P2140, DOI 10.1128/JVI.01871-08; Salvucci O, 2009, BLOOD, V114, P1707, DOI 10.1182/blood-2008-12-192294; Schulz TF, 2007, HUMAN HERPESVIRUSES: BIOLOGY, THERAPY, AND IMMUNOPROPHYLAXIS, P490; Shembade N, 2011, NAT IMMUNOL, V12, P834, DOI 10.1038/ni.2066; Shembade N, 2010, SCIENCE, V327, P1135, DOI 10.1126/science.1182364; Shembade N, 2009, EMBO J, V28, P513, DOI 10.1038/emboj.2008.285; Song HY, 1996, P NATL ACAD SCI USA, V93, P6721, DOI 10.1073/pnas.93.13.6721; Stilo R, 2008, J CELL SCI, V121, P1165, DOI 10.1242/jcs.021105; Thurau M, 2009, J VIROL, V83, P598, DOI 10.1128/JVI.00629-08; Uldrick TS, 2010, CLIN INFECT DIS, V51, P350, DOI 10.1086/654798; Verstrepen L, 2010, BIOCHEM PHARMACOL, V80, P2009, DOI 10.1016/j.bcp.2010.06.044; Wagner S, 2008, ONCOGENE, V27, P3739, DOI 10.1038/sj.onc.1211042; Weaver BK, 2007, MOL CELL BIOL, V27, P4603, DOI 10.1128/MCB.00223-07; Wertz IE, 2004, NATURE, V430, P694, DOI 10.1038/nature02794; Wullaert A, 2007, J BIOL CHEM, V282, P81, DOI 10.1074/jbc.M607481200; Yamaoka S, 1998, CELL, V93, P1231, DOI 10.1016/S0092-8674(00)81466-X; Yoshikawa A, 2009, FEBS LETT, V583, P3317, DOI 10.1016/j.febslet.2009.09.028; Zhang SQ, 2000, IMMUNITY, V12, P301, DOI 10.1016/S1074-7613(00)80183-1	65	15	22	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR 7	2013	32	10					1223	1232		10.1038/onc.2012.145	http://dx.doi.org/10.1038/onc.2012.145			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	110OP	22525270	Green Accepted			2022-12-25	WOS:000316454500003
J	Bokulich, NA; Bamforth, CW; Mills, DA				Bokulich, Nicholas A.; Bamforth, Charles W.; Mills, David A.			Brewhouse-Resident Microbiota Are Responsible for Multi-Stage Fermentation of American Coolship Ale	PLOS ONE			English	Article							16S RIBOSOMAL-RNA; FRAGMENT-LENGTH-POLYMORPHISMS; WORT ENTEROBACTERIA; LAMBIC FERMENTATION; COMMUNITIES; GUEUZE; GENES; POPULATIONS; DIVERSITY; PRIMERS	American coolship ale (ACA) is a type of spontaneously fermented beer that employs production methods similar to traditional Belgian lambic. In spite of its growing popularity in the American craft-brewing sector, the fermentation microbiology of ACA has not been previously described, and thus the interface between production methodology and microbial community structure is unexplored. Using terminal restriction fragment length polymorphism (TRFLP), barcoded amplicon sequencing (BAS), quantitative PCR (qPCR) and culture-dependent analysis, ACA fermentations were shown to follow a consistent fermentation progression, initially dominated by Enterobacteriaceae and a range of oxidative yeasts in the first month, then ceding to Saccharomyces spp. and Lactobacillales for the following year. After one year of fermentation, Brettanomyces bruxellensis was the dominant yeast population (occasionally accompanied by minor populations of Candida spp., Pichia spp., and other yeasts) and Lactobacillales remained dominant, though various aerobic bacteria became more prevalent. This work demonstrates that ACA exhibits a conserved core microbial succession in absence of inoculation, supporting the role of a resident brewhouse microbiota. These findings establish this core microbial profile of spontaneous beer fermentations as a target for production control points and quality standards for these beers.	[Bokulich, Nicholas A.; Mills, David A.] Univ Calif Davis, Robert Mondavi Inst Wine & Food Sci, Dept Viticulture & Enol, Davis, CA 95616 USA; [Bokulich, Nicholas A.; Bamforth, Charles W.; Mills, David A.] Univ Calif Davis, Robert Mondavi Inst Wine & Food Sci, Dept Food Sci & Technol, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis	Bokulich, NA (corresponding author), Univ Calif Davis, Robert Mondavi Inst Wine & Food Sci, Dept Viticulture & Enol, Davis, CA 95616 USA.	damills@ucdavis.edu	Mills, David Andrew/G-2282-2011; Mills, David/GXF-1821-2022	Mills, David Andrew/0000-0003-1913-9865; Bokulich, Nicholas/0000-0002-1784-8935	Roger C. Briess ASBC scholarship; Cargill Malt ASBC scholarship; Michael J. Lewis endowment; David E. Gallo educational enhancement fund; Adolf L. & Richie C. Heck research fellowship	Roger C. Briess ASBC scholarship; Cargill Malt ASBC scholarship; Michael J. Lewis endowment; David E. Gallo educational enhancement fund; Adolf L. & Richie C. Heck research fellowship	NB was supported in part by the Roger C. Briess ASBC scholarship and Cargill Malt ASBC scholarship, the Michael J. Lewis endowment, David E. Gallo educational enhancement fund, Adolf L. & Richie C. Heck research fellowship, and Wine Spectator scholarship during the completion of this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdo Z, 2006, ENVIRON MICROBIOL, V8, P929, DOI 10.1111/j.1462-2920.2005.00959.x; Blanco P, 2011, J IND MICROBIOL BIOT, V38, P235, DOI 10.1007/s10295-010-0818-2; Bokulich NA, 2012, AM J ENOL VITICULT, V63, P185, DOI 10.5344/ajev.2011.11077; Bokulich NA, 2012, FOOD MICROBIOL, V31, P126, DOI 10.1016/j.fm.2012.02.007; Caporaso JG, 2011, P NATL ACAD SCI USA, V108, P4516, DOI 10.1073/pnas.1000080107; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Ciani M, 2004, ANTON LEEUW INT J G, V85, P159, DOI 10.1023/B:ANTO.0000020284.05802.d7; Cole JR, 2007, NUCLEIC ACIDS RES, V35, pD169, DOI 10.1093/nar/gkl889; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Fleet GH, 2003, INT J FOOD MICROBIOL, V86, P11, DOI 10.1016/S0168-1605(03)00245-9; Hamady M, 2008, NAT METHODS, V5, P235, DOI 10.1038/NMETH.1184; Hamady M, 2009, GENOME RES, V19, P1141, DOI 10.1101/gr.085464.108; Hierro N, 2006, APPL ENVIRON MICROB, V72, P7148, DOI 10.1128/AEM.00388-06; Lafarge V, 2004, APPL ENVIRON MICROB, V70, P5644, DOI 10.1128/AEM.70.9.5644-5650.2004; Lane DS, 1990, NUCL ACID TECHNIQUES, P115, DOI DOI 10.1007/S00227-012-2133-0; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; MARTENS H, 1992, J I BREWING, V98, P421, DOI 10.1002/j.2050-0416.1992.tb01126.x; MARTENS H, 1991, J I BREWING, V97, P435, DOI 10.1002/j.2050-0416.1991.tb01082.x; MUYZER G, 1993, APPL ENVIRON MICROB, V59, P695, DOI 10.1128/AEM.59.3.695-700.1993; Nadkarni MA, 2002, MICROBIOL-SGM, V148, P257, DOI 10.1099/00221287-148-1-257; PRIEST FG, 1974, J I BREWING, V80, P342, DOI 10.1002/j.2050-0416.1974.tb03629.x; Santamaria P, 2008, EUR FOOD RES TECHNOL, V227, P1563, DOI 10.1007/s00217-008-0855-5; Shyu C, 2007, MICROB ECOL, V53, P562, DOI 10.1007/s00248-006-9106-0; SPAEPEN M, 1978, J I BREWING, V84, P278, DOI 10.1002/j.2050-0416.1978.tb03888.x; VANOEVELEN D, 1977, J I BREWING, V83, P356, DOI 10.1002/j.2050-0416.1977.tb03825.x; VANOEVELEN D, 1976, J I BREWING, V82, P322; Verachtert H, 1990, YEAST BIOTECHNOLOGY; Wang Q, 2007, APPL ENV MICROBIOL, V73; White T.J., 1990, PCR PROTOCOLS GUIDE, P315, DOI DOI 10.1016/B978-0-12-372180-8.50042-1	30	120	122	3	121	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2012	7	4							e35507	10.1371/journal.pone.0035507	http://dx.doi.org/10.1371/journal.pone.0035507			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959XD	22530036	Green Published, gold			2022-12-25	WOS:000305350600091
J	Fiore-Donno, AM; Kamono, A; Meyer, M; Schnittler, M; Fukui, M; Cavalier-Smith, T				Fiore-Donno, Anna Maria; Kamono, Akiko; Meyer, Marianne; Schnittler, Martin; Fukui, Manabu; Cavalier-Smith, Thomas			18S rDNA Phylogeny of Lamproderma and Allied Genera (Stemonitales, Myxomycetes, Amoebozoa)	PLOS ONE			English	Article							REPRODUCTIVE-SYSTEMS; RIBOSOMAL-RNA; SLIME-MOLDS; HYPERAMOEBA; INFERENCE; ECOLOGY	The phylogenetic position of the slime-mould genus Lamproderma (Myxomycetes, Amoebozoa) challenges traditional taxonomy: although it displays the typical characters of the order Stemonitales, it appears to be sister to Physarales. This study provides a small subunit (18S or SSU) ribosomal RNA gene-based phylogeny of Lamproderma and its allies, with new sequences from 49 specimens in 12 genera. We found that the order Stemonitales and Lamproderma were both ancestral to Physarales and that Lamproderma constitutes several clades intermingled with species of Diacheopsis, Colloderma and Elaeomyxa. We suggest that these genera may have evolved from Lamproderma by multiple losses of fruiting body stalks and that many taxonomic revisions are needed. We found such high genetic diversity within three Lamproderma species that they probably consist of clusters of sibling species. We discuss the contrasts between genetic and morphological divergence and implications for the morphospecies concept, highlighting the phylogenetically most reliable morphological characters and pointing to others that have been overestimated. In addition, we showed that the first part (similar to 600 bases) of the SSU rDNA gene is a valuable tool for phylogeny in Myxomycetes, since it displayed sufficient variability to distinguish closely related taxa and never failed to cluster together specimens considered of the same species.	[Fiore-Donno, Anna Maria; Schnittler, Martin] Ernst Moritz Arndt Univ Greifswald, Inst Bot & Landscape Ecol, Greifswald, Germany; [Kamono, Akiko; Fukui, Manabu] Hokkaido Univ, Inst Low Temp Sci, Sapporo, Hokkaido 060, Japan; [Meyer, Marianne] Le Bayet, Rognaix, France; [Cavalier-Smith, Thomas] Univ Oxford, Dept Zool, Oxford OX1 3PS, England	Ernst Moritz Arndt Universitat Greifswald; Hokkaido University; University of Oxford	Fiore-Donno, AM (corresponding author), Ernst Moritz Arndt Univ Greifswald, Inst Bot & Landscape Ecol, Greifswald, Germany.	afiore-donno6@infomaniak.ch	Schnittler, Martin/A-8916-2013; Fukui, Manabu/E-1323-2012	Fiore-Donno, Anna Maria/0000-0001-6265-1907	Royal Society	Royal Society(Royal Society of London)	This work was supported by a Royal Society International Joint Project between the Zoology Department of the University of Oxford (UK) and the Institute of Low Temperature Science, Hokkaido University (JP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXOPOULOS CJ, 1971, MYCOLOGIA, V63, P925, DOI 10.2307/3758063; Alexopoulos CJ, 1973, FUNGI ADV TREATISE, P39; Andersen RA, 2000, ILLUSTRATED GUIDE PR; Cavalier-Smith T, 2004, EUR J PROTISTOL, V40, P21, DOI 10.1016/j.ejop.2003.10.001; Clark J, 1997, MYCOLOGIA, V89, P241, DOI 10.2307/3761077; CLARK J, 1990, MYCOLOGIA, V82, P274, DOI 10.2307/3759860; Clark J, 2010, MYCOSPHERE, V1, P337; COLLINS O R, 1981, Journal of the Elisha Mitchell Scientific Society, V97, P101; DENNISON ML, 1945, MYCOLOGIA, V37, P197, DOI 10.2307/3754918; DENNISON ML, 1945, MYCOLOGIA, V37, P80, DOI 10.2307/3754852; Dykova I, 2007, FOLIA PARASIT, V54, P1; ElHage N, 2000, MYCOLOGIA, V92, P54, DOI 10.2307/3761450; Fiore-Donno AM, 2008, MOL PHYLOGENET EVOL, V46, P878, DOI 10.1016/j.ympev.2007.12.011; Fiore-Donno AM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022872; Fiore-Donno AM, 2010, J EUKARYOT MICROBIOL, V57, P189, DOI 10.1111/j.1550-7408.2009.00466.x; Fiore-Donno AM, 2010, PROTIST, V161, P55, DOI 10.1016/j.protis.2009.05.002; Fiore-Donno AM, 2009, MYCOLOGIA, V101, P773, DOI 10.3852/08-075; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hall T, 1999, NUCL ACIDS S SER, V41, P95, DOI DOI 10.1021/BK-1999-0734.CH008; Haskins EF, 1978, PUB WISSENSCH FILM S, V11, P1; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; ING B, 1983, J BIOGEOGR, V10, P299, DOI 10.2307/2844739; Ing B, 1999, MYXOMYCETES BRITAIN; JOHANSEN T, 1988, CURR GENET, V14, P265, DOI 10.1007/BF00376747; KALYANASUNDARAM I, 1989, MYCOL RES, V93, P233, DOI 10.1016/S0953-7562(89)80124-8; Kalyanasundaram I, 1973, TAXONOMY FUNGI, P9; Karpov SA, 1997, EUR J PROTISTOL, V33, P349, DOI 10.1016/S0932-4739(97)80046-6; KOWALSKI DT, 1970, MYCOLOGIA, V62, P621, DOI 10.2307/3757653; Lado C., 2001, CUADERNOS TRABAJO FL, V16, P1; Lado C, 1997, MYXOMYCETES; LANAVE C, 1984, J MOL EVOL, V20, P86, DOI 10.1007/BF02101990; Lundblad EW, 2004, MOL BIOL EVOL, V21, P1283, DOI 10.1093/molbev/msh126; Meylan C, 1931, B SOC VAUD SCI NAT, V57, P359; MEYLAN CH, 1930, BULL SOC VAUDOISE SCI NAT, V57, P147; Moreno G, 2002, FUNGI NON DELINEATI, P1; Neubert H, 2000, MYXOMYCETEN DEUTCHLA; Olive LS, 1975, MYCETOZOANS; Poulain M, 2011, MYXOMYCETES FEDERATI; RODRIGUEZ F, 1990, J THEOR BIOL, V142, P485, DOI 10.1016/S0022-5193(05)80104-3; Ronikier A, 2009, MYCOLOGIA, V101, P1, DOI 10.3852/08-090; Schnittler M., 2000, Stapfia, V73, P55; Schnittler M, 2010, NOVA HEDWIGIA, V90, P277, DOI 10.1127/0029-5035/2010/0090-0277; Shadwick LL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006754; Smirnov AV, 2011, PROTIST, V162, P545, DOI 10.1016/j.protis.2011.04.004; Stamatakis A, 2005, BIOINFORMATICS, V21, P456, DOI 10.1093/bioinformatics/bti191; Stephenson SL, 2000, J BIOGEOGR, V27, P741, DOI 10.1046/j.1365-2699.2000.00442.x; Urich T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002527; Walochnik J, 2004, J EUKARYOT MICROBIOL, V51, P433, DOI 10.1111/j.1550-7408.2004.tb00391.x; Wuyts J, 2000, NUCLEIC ACIDS RES, V28, P4698, DOI 10.1093/nar/28.23.4698; Wuyts J, 2002, NUCLEIC ACIDS RES, V30, P183, DOI 10.1093/nar/30.1.183; Zaman V, 1999, EUR J PROTISTOL, V35, P197, DOI 10.1016/S0932-4739(99)80038-8	51	68	81	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2012	7	4							e35359	10.1371/journal.pone.0035359	http://dx.doi.org/10.1371/journal.pone.0035359			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959XD	22530009	Green Published, Green Submitted, gold			2022-12-25	WOS:000305350600078
J	Lee, LC; Chen, CM; Wang, HC; Hsieh, HH; Chiu, IS; Su, MT; Hsieh-Li, HM; Wu, CH; Lee, GC; Lee-Chen, GJ; Lin, JY				Lee, Li-Ching; Chen, Chiung-Mei; Wang, Hao-Chun; Hsieh, Hsiao-Han; Chiu, I-Sheng; Su, Ming-Tsan; Hsieh-Li, Hsiu-Mei; Wu, Chung-Hsin; Lee, Guan-Chiun; Lee-Chen, Guey-Jen; Lin, Jung-Yaw			Role of the CCAAT-Binding Protein NFY in SCA17 Pathogenesis	PLOS ONE			English	Article							Y TRANSCRIPTION FACTOR; NUCLEAR-FACTOR-Y; ENDOPLASMIC-RETICULUM; EXPANDED POLYGLUTAMINE; CBF/NF-Y; EXPRESSION; GENE; TBP; ASSOCIATION; ACTIVATION	Spinocerebellar ataxia 17 (SCA17) is caused by expansion of the polyglutamine (polyQ) tract in human TATA-box binding protein (TBP) that is ubiquitously expressed in both central nervous system and peripheral tissues. The spectrum of SCA17 clinical presentation is broad. The precise pathogenic mechanism in SCA17 remains unclear. Previously proteomics study using a cellular model of SCA17 has revealed reduced expression of heat shock 70 kDa protein 5 (HSPA5) and heat shock 70 kDa protein 8 (HSPA8), suggesting that impaired protein folding may contribute to the cell dysfunction of SCA17 (Lee et al., 2009). In lymphoblastoid cells, HSPA5 and HSPA8 expression levels in cells with mutant TBP were also significantly lower than that of the control cells (Chen et al., 2010). As nuclear transcription factor Y (NFY) has been reported to regulate HSPA5 transcription, we focused on if NFY activity and HSPA5 expression in SCA17 cells are altered. Here, we show that TBP interacts with NFY subunit A (NFYA) in HEK-293 cells and NFYA incorporated into mutant TBP aggregates. In both HEK-293 and SH-SY5Y cells expressing TBP/Q(61 similar to 79), the level of soluble NFYA was significantly reduced. In vitro binding assay revealed that the interaction between TBP and NFYA is direct. HSPA5 luciferase reporter assay and endogenous HSPA5 expression analysis in NFYA cDNA and siRNA transfection cells further clarified the important role of NFYA in regulating HSPA5 transcription. In SCA17 cells, HSPA5 promoter activity was activated as a compensatory response before aggregate formation. NFYA dysfunction was indicated in SCA17 cells as HSPA5 promoter activity reduced along with TBP aggregate formation. Because essential roles of HSPA5 in protection from neuronal apoptosis have been shown in a mouse model, NFYA could be a target of mutant TBP in SCA17.	[Lee, Li-Ching; Wang, Hao-Chun; Hsieh, Hsiao-Han; Chiu, I-Sheng; Su, Ming-Tsan; Hsieh-Li, Hsiu-Mei; Wu, Chung-Hsin; Lee, Guan-Chiun; Lee-Chen, Guey-Jen; Lin, Jung-Yaw] Natl Taiwan Normal Univ, Dept Life Sci, Taipei, Taiwan; [Chen, Chiung-Mei] Chang Gung Univ, Coll Med, Chang Gung Mem Hosp, Dept Neurol, Taipei, Taiwan; [Lin, Jung-Yaw] Natl Taiwan Univ, Coll Med, Inst Biochem & Mol Biol, Taipei 10764, Taiwan	National Taiwan Normal University; Chang Gung Memorial Hospital; Chang Gung University; National Taiwan University	Lee, LC (corresponding author), Natl Taiwan Normal Univ, Dept Life Sci, Taipei, Taiwan.	t43019@ntnu.edu.tw; jylin@ha.mc.ntu.edu.tw	Chen, Chiung-Mei/AAL-6260-2020; Wu, Chung-Hsin/B-7176-2015; Lin, Jung-Yaw/AGW-9336-2022	Wu, Chung-Hsin/0000-0002-4470-2448; Lin, Jung-Yaw/0000-0002-6341-1160	National Science Council, Executive Yuan [NSC97-2311-B-003-008-MY3, NSC97-2311-B-182A-001-MY3, NSC98-2321-B-003-004, NSC100-2325-B-003-001]; National Taiwan Normal University Taipei [96TOP001, NTNU100-D-02]; Chang Gung Memorial Hospital, Taipei, Taiwan [CMRGP38138]	National Science Council, Executive Yuan(Ministry of Science and Technology, Taiwan); National Taiwan Normal University Taipei; Chang Gung Memorial Hospital, Taipei, Taiwan(Chang Gung Memorial Hospital)	This work was supported by grants NSC97-2311-B-003-008-MY3, NSC97-2311-B-182A-001-MY3, NSC98-2321-B-003-004 and NSC100-2325-B-003-001 from National Science Council, Executive Yuan, 96TOP001 and NTNU100-D-02 from National Taiwan Normal University Taipei, and CMRGP38138 from Chang Gung Memorial Hospital, Taipei, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anttonen AK, 2005, NAT GENET, V37, P1309, DOI 10.1038/ng1677; Chen CM, 2010, CLIN CHIM ACTA, V411, P375, DOI 10.1016/j.cca.2009.12.002; Chen CM, 2009, AM J MED GENET B, V150B, P124, DOI 10.1002/ajmg.b.30785; Chow MKM, 2006, METHOD ENZYMOL, V413, P1, DOI 10.1016/S0076-6879(06)13001-3; Fan WH, 2002, J BIOL CHEM, V277, P8061, DOI 10.1074/jbc.M110225200; Friedman MJ, 2008, J BIOL CHEM, V283, P8283, DOI 10.1074/jbc.M709674200; Friedman MJ, 2007, NAT NEUROSCI, V10, P1519, DOI 10.1038/nn2011; GOSTOUT B, 1993, AM J HUM GENET, V52, P1182; Hayashi K, 2010, J BIOMOL NMR, V48, P147, DOI 10.1007/s10858-010-9445-5; Huang SS, 2011, BRAIN, V134, P1943, DOI 10.1093/brain/awr146; Jacobs SBR, 2003, MOL ENDOCRINOL, V17, P1470, DOI 10.1210/me.2002-0286; Kim S, 2008, PROTEIN EXPRES PURIF, V62, P116, DOI 10.1016/j.pep.2008.06.015; Koide R, 1999, HUM MOL GENET, V8, P2047, DOI 10.1093/hmg/8.11.2047; Lai MT, 2003, CELL SIGNAL, V15, P585, DOI 10.1016/S0898-6568(03)00004-4; Lasek K, 2006, BRAIN, V129, P2341, DOI 10.1093/brain/awl148; Lee LC, 2009, CLIN CHIM ACTA, V400, P56, DOI 10.1016/j.cca.2008.10.013; LI XY, 1992, J BIOL CHEM, V267, P8984; Luo R, 2008, J CELL BIOCHEM, V104, P1708, DOI 10.1002/jcb.21736; Maity SN, 1998, TRENDS BIOCHEM SCI, V23, P174, DOI 10.1016/S0968-0004(98)01201-8; Malhotra JD, 2007, SEMIN CELL DEV BIOL, V18, P716, DOI 10.1016/j.semcdb.2007.09.003; Maltecca F, 2003, NEUROLOGY, V61, P1441, DOI 10.1212/01.WNL.0000094123.09098.A0; Mantovani R, 1999, GENE, V239, P15, DOI 10.1016/S0378-1119(99)00368-6; Marcus N, 1997, DNA CELL BIOL, V16, P1123, DOI 10.1089/dna.1997.16.1123; Nakamura K, 2001, HUM MOL GENET, V10, P1441, DOI 10.1093/hmg/10.14.1441; Onken B, 2006, P NATL ACAD SCI USA, V103, P9045, DOI 10.1073/pnas.0603318103; Reid SJ, 2003, NEUROBIOL DIS, V13, P37, DOI 10.1016/S0969-9961(03)00014-7; Reinert LS, 2006, CANCER RES, V66, P8994, DOI 10.1158/0008-5472.CAN-06-1999; Roder K, 1999, GENE, V234, P61, DOI 10.1016/S0378-1119(99)00180-8; Silveira I, 2002, ARCH NEUROL-CHICAGO, V59, P623, DOI 10.1001/archneur.59.4.623; Wang M, 2010, CELL DEATH DIFFER, V17, P488, DOI 10.1038/cdd.2009.144; Wyttenbach A, 2002, HUM MOL GENET, V11, P1137, DOI 10.1093/hmg/11.9.1137; Yamanaka T, 2008, EMBO J, V27, P827, DOI 10.1038/emboj.2008.23; Yoshida H, 2001, MOL CELL BIOL, V21, P1239, DOI 10.1128/MCB.21.4.1239-1248.2001; Zhu J, 2003, BLOOD, V102, P2420, DOI 10.1182/blood-2003-01-0251; Zhu QS, 2004, J BIOL CHEM, V279, P29902, DOI 10.1074/jbc.M400438200	35	24	25	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2012	7	4							e35302	10.1371/journal.pone.0035302	http://dx.doi.org/10.1371/journal.pone.0035302			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WC	22530004	gold, Green Published, Green Submitted			2022-12-25	WOS:000305347400043
J	Nikovics, K; Dazza, MC; Ekwalanga, M; Mammano, F; Clavel, F; Saragosti, S				Nikovics, Kristina; Dazza, Marie-Christine; Ekwalanga, Michel; Mammano, Fabrizio; Clavel, Francois; Saragosti, Sentob			Counteraction of Tetherin Antiviral Activity by Two Closely Related SIVs Differing by the Presence of a Vpu Gene	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; ANCIENT ADAPTIVE EVOLUTION; PARTICLE RELEASE; TYPE-1 VPU; ENVELOPE GLYCOPROTEIN; HIV-1 RELEASE; CELL-SURFACE; PROTEIN; RESTRICTION; NEF	In different primate lentiviruses, three proteins (Vpu, Env and Nef) have been shown to have anti-tetherin activities. SIVden is a primate lentivirus harbored by a Cercopithecus denti (C. denti) whose genome code for a Vpu gene. We have compared the activity of HIV-1 Vpu and of SIVden Vpu on tetherin proteins from humans, from C. denti and from Cercopithecus neglectus (C. neglectus), a monkey species that is naturally infected by SIVdeb, a virus closely related to SIVden but which does not encode a Vpu protein. Here, we demonstrate that SIVden Vpu, is active against C. denti tetherin, but not against human tetherin. Interestingly, C. neglectus tetherin was more sensitive to SIVden Vpu than to HIV-1 Vpu. We also identify residues in the tetherin transmembrane domains that are responsible for the species-specific Vpu effect. Simultaneous mutation (P40L and T45I) of human tetherin conferred sensitivity to SIVden Vpu, while abolishing its sensitivity to HIV-1 Vpu. We next analyzed the anti-tetherin activity of the Nef proteins from HIV-1, SIVden and SIVdeb. All three Nef proteins were unable to rescue virus release in the presence of human or C. denti tetherin. Conversely, SIVdeb Nef enhanced virus release in the presence of C. neglectus tetherin, suggesting that SIVdeb relies on Nef in its natural host. Finally, while HIV-1 Vpu not only removed human tetherin from the cell surface but also directed it for degradation, SIVden Vpu only induced the redistribution of both C. denti and C. neglectus tetherins, resulting in a predominantly perinuclear localization.	[Nikovics, Kristina; Dazza, Marie-Christine; Mammano, Fabrizio; Clavel, Francois; Saragosti, Sentob] INSERM U941, Paris, France; [Nikovics, Kristina; Dazza, Marie-Christine; Mammano, Fabrizio; Clavel, Francois; Saragosti, Sentob] Univ Paris Diderot, IUH, Paris, France; [Ekwalanga, Michel] Univ Lubumbashi, Lab Clin Univ, Lubumbashi, DEM REP CONGO	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite	Nikovics, K (corresponding author), INSERM U941, Paris, France.	sentob.saragosti@inserm.fr	Mammano, Fabrizio/H-9423-2019	Mammano, Fabrizio/0000-0002-9193-7696	Agence National de Recherche sur le SIDA (ANRS)	Agence National de Recherche sur le SIDA (ANRS)(ANRSFrench National Research Agency (ANR))	This work was supported by Agence National de Recherche sur le SIDA (ANRS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arhel NJ, 2009, CURR TOP MICROBIOL, V339, P147, DOI 10.1007/978-3-642-02175-6_8; Bailes E, 2003, SCIENCE, V300, P1713, DOI 10.1126/science.1080657; Bibollet-Ruche F, 2004, J VIROL, V78, P7748, DOI 10.1128/JVI.78.14.7748-7762.2004; Bour S, 1996, J VIROL, V70, P8285, DOI 10.1128/JVI.70.12.8285-8300.1996; Bour S, 1996, J VIROL, V70, P820, DOI 10.1128/JVI.70.2.820-829.1996; Courgnaud V, 2003, J VIROL, V77, P12523, DOI 10.1128/JVI.77.23.12523-12534.2003; Courgnaud V, 2002, J VIROL, V76, P8298, DOI 10.1128/JVI.76.16.8298-8309.2002; Dazza MC, 2005, J VIROL, V79, P8560, DOI 10.1128/JVI.79.13.8560-8571.2005; Dube M, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000856; Evans DT, 2010, TRENDS MICROBIOL, V18, P388, DOI 10.1016/j.tim.2010.06.010; Fitzpatrick K, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000701; Goffinet C, 2010, J VIROL, V84, P4089, DOI 10.1128/JVI.01549-09; Gupta RK, 2009, P NATL ACAD SCI USA, V106, P20889, DOI 10.1073/pnas.0907075106; Gupta RK, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000443; Hammonds J, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000749; Iwabu Y, 2009, J BIOL CHEM, V284, P35060, DOI 10.1074/jbc.M109.058305; Jia B, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000429; Jouvenet N, 2009, J VIROL, V83, P1837, DOI 10.1128/JVI.02211-08; Kaletsky RL, 2009, P NATL ACAD SCI USA, V106, P2886, DOI 10.1073/pnas.0811014106; KLIMKAIT T, 1990, J VIROL, V64, P621, DOI 10.1128/JVI.64.2.621-629.1990; Kobayashi T, 2011, J VIROL, V85, P932, DOI 10.1128/JVI.01668-10; Lim ES, 2010, J VIROL, V84, P7124, DOI 10.1128/JVI.00468-10; Lim ES, 2009, J VIROL, V83, P11673, DOI 10.1128/JVI.00569-09; Liu J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011904; Matsuoka S, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-21; McNatt MW, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000300; Neil SJD, 2008, NATURE, V451, P425, DOI 10.1038/nature06553; Perez-Caballero D, 2009, CELL, V139, P499, DOI 10.1016/j.cell.2009.08.039; Piguet V, 1999, IMMUNOL REV, V168, P51, DOI 10.1111/j.1600-065X.1999.tb01282.x; Ritter GD, 1996, J VIROL, V70, P2669, DOI 10.1128/JVI.70.4.2669-2673.1996; Ruiz A, 2010, VIROLOGY, V406, P312, DOI 10.1016/j.virol.2010.07.021; Sauter D, 2011, HUM MUTAT; Sauter D, 2010, CELL, V141, P392, DOI 10.1016/j.cell.2010.04.022; Sauter D, 2009, CELL HOST MICROBE, V6, P409, DOI 10.1016/j.chom.2009.10.004; Sawyer SL, 2005, P NATL ACAD SCI USA, V102, P2832, DOI 10.1073/pnas.0409853102; Sawyer SL, 2004, PLOS BIOL, V2, P1278, DOI 10.1371/journal.pbio.0020275; Schmokel J, 2011, J VIROL, V85, P742, DOI 10.1128/JVI.02087-10; Schubert U, 1996, J VIROL, V70, P809, DOI 10.1128/JVI.70.2.809-819.1996; Shingai M, 2011, J VIROL, V85, P9708, DOI 10.1128/JVI.00626-11; Van Damme N, 2008, CELL HOST MICROBE, V3, P245, DOI 10.1016/j.chom.2008.03.001; Yang SJ, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-13; Zhang FW, 2009, CELL HOST MICROBE, V6, P54, DOI 10.1016/j.chom.2009.05.008	42	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2012	7	4							e35411	10.1371/journal.pone.0035411	http://dx.doi.org/10.1371/journal.pone.0035411			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WC	22530020	Green Published, gold, Green Submitted			2022-12-25	WOS:000305347400051
J	Reeves, CV; Wang, X; Charles-Horvath, PC; Vink, JY; Borisenko, VY; Young, JAT; Kitajewski, JK				Reeves, Claire V.; Wang, Xing; Charles-Horvath, Pelisa C.; Vink, Joy Y.; Borisenko, Valeriya Y.; Young, John A. T.; Kitajewski, Jan K.			Anthrax Toxin Receptor 2 Functions in ECM Homeostasis of the Murine Reproductive Tract and Promotes MMP Activity	PLOS ONE			English	Article							CAPILLARY MORPHOGENESIS PROTEIN-2; JUVENILE HYALINE FIBROMATOSIS; METALLOPROTEINASE MT1-MMP; MATRIX; CELLS; EXPRESSION; ACTIVATION; SURFACE; TISSUE; PROGELATINASE	Anthrax Toxin Receptor proteins function as receptors for anthrax toxin, however physiological activity remains unclear. To evaluate the biological role of Antxr2, we generated Antxr2-/- mice. Antxr2-/- mice were viable, however Antxr2 is required for parturition in young females and for preserving fertility in older female mice. Histological analysis of the uterus and cervix revealed aberrant deposition of extracellular matrix proteins such as type I collagen, type VI collagen and fibronectin. A marked disruption of both the circular and longitudinal myometrial cell layers was evident in Antxr2-/- mice. These changes progressed as the mice aged, resulting in a thickened, collagen dense, acellular stroma and the disappearance of normal uterine architecture. To investigate the molecular mechanism underlying the uterine fibrosis we performed immunoblotting for MMP2 using uterine lysates and zymography using conditioned medium from Antxr2-/- mouse embryonic fibroblasts and found reduced levels of activated MMP2 in both. This prompted us to investigate MT1-MMP status, as MMP2 processing is regulated by MT1-MMP. We found MT1-MMP activity, as measured by MMP2 processing and activation, was enhanced by expression of either ANTXR1 or ANTXR2. We identified an ANTXR2/MT1-MMP complex and demonstrated that MT1-MMP activity is dependent on ANTXR2 expression levels in cells. Thus, we have discovered that ANTXR1 and ANTXR2 function as positive regulators of MT1-MMP activity.	[Reeves, Claire V.; Wang, Xing; Vink, Joy Y.; Borisenko, Valeriya Y.; Kitajewski, Jan K.] Columbia Univ, Med Ctr, Dept Obstet & Gynecol, New York, NY 10027 USA; [Charles-Horvath, Pelisa C.] Columbia Univ, Dept Pharmacol, Med Ctr, New York, NY USA; [Young, John A. T.] Salk Inst Biol Studies, Nomis Ctr Immunobiol & Microbial Pathogenesis, La Jolla, CA 92037 USA; [Kitajewski, Jan K.] Columbia Univ, Dept Pathol, Med Ctr, New York, NY USA; [Kitajewski, Jan K.] Columbia Univ, Herbert Irving Comprehens Canc Ctr, Med Ctr, New York, NY USA	Columbia University; Columbia University; Salk Institute; Columbia University; Columbia University	Reeves, CV (corresponding author), Columbia Univ, Med Ctr, Dept Obstet & Gynecol, New York, NY 10027 USA.	jkk9@columbia.edu	Wang, Xing/G-2917-2015	Young, John/0000-0003-1824-2561	NIH [RO1 AI064654]; DOD Breast Cancer Program [X81WH-06-1-0355];  [5T32 CA 009503-24]; NATIONAL CANCER INSTITUTE [T32CA009503] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI064654] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DOD Breast Cancer Program(United States Department of Defense); ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by NIH RO1 AI064654. CR was supported by a fellowship from the DOD Breast Cancer Program X81WH-06-1-0355. PCH was supported by training grant 5T32 CA 009503-24. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atkinson SJ, 1995, J BIOL CHEM, V270, P30479, DOI 10.1074/jbc.270.51.30479; Bell SE, 2001, J CELL SCI, V114, P2755; Burroughs KD, 2000, BIOL REPROD, V63, P1322, DOI 10.1095/biolreprod63.5.1322; Cullen M, 2009, CANCER RES, V69, P6021, DOI 10.1158/0008-5472.CAN-09-1086; Dowling O, 2003, AM J HUM GENET, V73, P957, DOI 10.1086/378781; Fata JE, 2000, CELL MOL LIFE SCI, V57, P77, DOI 10.1007/s000180050500; Hanks S, 2003, AM J HUM GENET, V73, P791, DOI 10.1086/378418; Hernandez-Barrantes S, 2000, J BIOL CHEM, V275, P12080, DOI 10.1074/jbc.275.16.12080; Holmbeck K, 1999, CELL, V99, P81, DOI 10.1016/S0092-8674(00)80064-1; Holmbeck K, 2004, J CELL PHYSIOL, V200, P11, DOI 10.1002/jcp.20065; Hotchkiss KA, 2005, EXP CELL RES, V305, P133, DOI 10.1016/j.yexcr.2004.12.025; HUNT JS, 1985, J LEUKOCYTE BIOL, V38, P255, DOI 10.1002/jlb.38.2.255; Lehti K, 2005, GENE DEV, V19, P979, DOI 10.1101/gad.1294605; LEPPERT PC, 1995, CLIN OBSTET GYNECOL, V38, P267, DOI 10.1097/00003081-199506000-00009; Liu SL, 2009, P NATL ACAD SCI USA, V106, P12424, DOI 10.1073/pnas.0905409106; Morikawa A, 2008, HUM REPROD, V23, P944, DOI 10.1093/humrep/den025; Nanda A, 2004, CANCER RES, V64, P817, DOI 10.1158/0008-5472.CAN-03-2408; NATHANIELSZ PW, 1978, ANNU REV PHYSIOL, V40, P411, DOI 10.1146/annurev.ph.40.030178.002211; OBRIEN WF, 1995, CLIN OBSTET GYNECOL, V38, P221, DOI 10.1097/00003081-199506000-00004; Ohuchi E, 1997, J BIOL CHEM, V272, P2446, DOI 10.1074/jbc.272.4.2446; Overall CM, 2002, BIOL CHEM, V383, P1059, DOI 10.1515/BC.2002.114; Pei DQ, 1996, J BIOL CHEM, V271, P9135, DOI 10.1074/jbc.271.15.9135; Reeves CV, 2010, ONCOGENE, V29, P789, DOI 10.1038/onc.2009.383; Rmali KA, 2005, BIOCHEM BIOPH RES CO, V334, P231, DOI 10.1016/j.bbrc.2005.06.085; ROSSI MJ, 1992, ENDOCRINOLOGY, V130, P1716, DOI 10.1210/en.130.3.1716; Rozanov DV, 2005, INT J BIOCHEM CELL B, V37, P142, DOI 10.1016/j.biocel.2004.06.005; RudolphOwen LA, 1997, ENDOCRINOLOGY, V138, P4902, DOI 10.1210/en.138.11.4902; SATO H, 1994, NATURE, V370, P61, DOI 10.1038/370061a0; Scobie HM, 2006, PLOS PATHOG, V2, P949, DOI 10.1371/journal.ppat.0020111; Scobie HM, 2005, J INFECT DIS, V192, P1047, DOI 10.1086/432731; Scobie HM, 2003, P NATL ACAD SCI USA, V100, P5170, DOI 10.1073/pnas.0431098100; Shynlova O, 2006, BIOL REPROD, V74, P839, DOI 10.1095/biolreprod.105.048124; STRONGIN AY, 1995, J BIOL CHEM, V270, P5331, DOI 10.1074/jbc.270.10.5331; Stucki U, 2001, AM J MED GENET, V100, P122, DOI 10.1002/1096-8628(20010422)100:2<122::AID-AJMG1236>3.0.CO;2-0; Tanaka K, 2009, J DERMATOL SCI, V55, P197, DOI 10.1016/j.jdermsci.2009.06.005; Wang X, 1999, FEBS LETT, V462, P261, DOI 10.1016/S0014-5793(99)01534-3; Wang X, 2009, J ANDROL, V30, P259, DOI 10.2164/jandrol.108.006494; Whittaker CA, 2002, MOL BIOL CELL, V13, P3369, DOI 10.1091/mbc.E02-05-0259; Wood GA, 2007, REPRODUCTION, V133, P1035, DOI 10.1530/REP-06-0302; Young JAT, 2007, ANNU REV BIOCHEM, V76, P243, DOI 10.1146/annurev.biochem.75.103004.142728; Zhou ZJ, 2000, P NATL ACAD SCI USA, V97, P4052, DOI 10.1073/pnas.060037197	41	34	34	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2012	7	4							e34862	10.1371/journal.pone.0034862	http://dx.doi.org/10.1371/journal.pone.0034862			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WC	22529944	Green Submitted, Green Published, gold			2022-12-25	WOS:000305347400022
J	Rodriguez, D; Gonzalez-Aseguinolaza, G; Rodriguez, JR; Vijayan, A; Gherardi, M; Rueda, P; Casal, JI; Esteban, M				Rodriguez, Dolores; Gonzalez-Aseguinolaza, Gloria; Rodriguez, Juan R.; Vijayan, Aneesh; Gherardi, Magdalena; Rueda, Paloma; Casal, J. Ignacio; Esteban, Mariano			Vaccine Efficacy against Malaria by the Combination of Porcine Parvovirus-Like Particles and Vaccinia Virus Vectors Expressing CS of Plasmodium	PLOS ONE			English	Article							CD8(+) T-CELLS; PROTECTIVE IMMUNITY; IMMUNIZATION SCHEDULES; AFRICAN CHILDREN; ANTIGEN CARRIER; DENDRITIC CELLS; INFLUENZA-VIRUS; TRIAL; MVA; INDUCTION	With the aim to develop an efficient and cost-effective approach to control malaria, we have generated porcine parvovirus-like particles (PPV-VLPs) carrying the CD8(+) T cell epitope (SYVPSAEQI) of the circumsporozoite (CS) protein from Plasmodium yoelii fused to the PPV VP2 capsid protein (PPV-PYCS), and tested in prime/boost protocols with poxvirus vectors for efficacy in a rodent malaria model. As a proof-of concept, we have characterized the anti-CS CD8(+) T cell response elicited by these hybrid PPV-VLPs in BALB/c mice after immunizations with the protein PPV-PYCS administered alone or in combination with recombinant vaccinia virus (VACV) vectors from the Western Reserve (WR) and modified virus Ankara (MVA) strains expressing the entire P. yoelii CS protein. The results of different immunization protocols showed that the combination of PPV-PYCS prime/poxvirus boost was highly immunogenic, inducing specific CD8+ T cell responses to CS resulting in 95% reduction in liver stage parasites two days following sporozoite challenge. In contrast, neither the administration of PPV-PYCS alone nor the immunization with the vectors given in the order poxvirus/VLPs was as effective. The immune profile induced by VLPs/MVA boost was associated with polyfunctional and effector memory CD8+ T cell responses. These findings highlight the use of recombinant parvovirus PPV-PYCS particles as priming agents and poxvirus vectors, like MVA, as booster to enhance specific CD8+ T cell responses to Plasmodium antigens and to control infection. These observations are relevant in the design of T cell-inducing vaccines against malaria.	[Rodriguez, Dolores; Rodriguez, Juan R.; Vijayan, Aneesh; Esteban, Mariano] CSIC, CNB, Dept Mol & Cellular Biol, Madrid, Spain; [Gonzalez-Aseguinolaza, Gloria] CIMA, Pamplona, Spain; [Rueda, Paloma; Casal, J. Ignacio] INGENASA, Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB)	Rodriguez, D (corresponding author), CSIC, CNB, Dept Mol & Cellular Biol, Madrid, Spain.	mesteban@cnb.csic.es	Casal, Ignacio/M-2312-2014; Esteban, Mariano/ABG-5375-2020; Gonzalez-Aseguinolaza, Gloria/H-9928-2015; Vijayan, Aneesh/AAH-5640-2019; VIJAYAN, ANEESH/K-1961-2014; Rodriguez, Dolores/ABF-9855-2020	Casal, Ignacio/0000-0003-1085-2840; Esteban, Mariano/0000-0003-0846-2827; Gonzalez-Aseguinolaza, Gloria/0000-0002-1600-4562; Vijayan, Aneesh/0000-0002-2828-5285; VIJAYAN, ANEESH/0000-0002-2828-5285; Rodriguez Fernandez-Alba, Juan Ramon/0000-0002-0819-8280; Rodriguez, Dolores/0000-0001-6365-4501	Marcelino Botin Foundation; La Caixa Foundation;  [SAF-2008-02036]	Marcelino Botin Foundation; La Caixa Foundation(La Caixa Foundation); 	This work was supported by SAF-2008-02036 and the Marcelino Botin Foundation (to Dr. Esteban) La Caixa Foundation International PhD Program Fellowship (to Dr. Vijayan). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnandji ST, 2011, NEW ENGL J MED, V365, P1863, DOI 10.1056/NEJMoa1102287; Alonso PL, 2004, LANCET, V364, P1411, DOI 10.1016/S0140-6736(04)17223-1; Antonis AFG, 2006, VACCINE, V24, P5481, DOI 10.1016/j.vaccine.2006.03.089; Aponte JJ, 2007, LANCET, V370, P1543, DOI 10.1016/S0140-6736(07)61542-6; Barbosa A, 2009, INFECT IMMUN, V77, P4502, DOI 10.1128/IAI.00442-09; Delaloye J, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000480; Gomez CE, 2011, J VIROL, V85, P11468, DOI 10.1128/JVI.05165-11; ESTEBAN M, 1984, VIROLOGY, V133, P220, DOI 10.1016/0042-6822(84)90443-4; Garcia-Arriaza J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012395; Gherardi MM, 2003, J VIROL, V77, P7048, DOI 10.1128/JVI.77.12.7048-7057.2003; Gomez CE, 2008, CURR GENE THER, V8, P97, DOI 10.2174/156652308784049363; Gonzalez-Aseguinolaza G, 2003, J VIROL, V77, P11859, DOI 10.1128/JVI.77.21.11859-11866.2003; Good MF, 2010, IMMUNITY, V33, P555, DOI 10.1016/j.immuni.2010.10.005; Guerra S, 2007, J VIROL, V81, P8707, DOI 10.1128/JVI.00444-07; Hill AVS, 2010, HUM VACCINES, V6, P78, DOI 10.4161/hv.6.1.10116; Hurtado A, 1996, J VIROL, V70, P5422, DOI 10.1128/JVI.70.8.5422-5429.1996; Kester KE, 2008, VACCINE, V26, P2191, DOI 10.1016/j.vaccine.2008.02.048; LI SQ, 1993, P NATL ACAD SCI USA, V90, P5214, DOI 10.1073/pnas.90.11.5214; Lo-Man R, 1998, EUR J IMMUNOL, V28, P1401, DOI 10.1002/(SICI)1521-4141(199804)28:04<1401::AID-IMMU1401>3.0.CO;2-M; MARTINEZ C, 1992, VACCINE, V10, P684, DOI 10.1016/0264-410X(92)90090-7; MIYAHIRA Y, 1995, J IMMUNOL METHODS, V181, P45, DOI 10.1016/0022-1759(94)00327-S; Moron G, 2002, J EXP MED, V195, P1233, DOI 10.1084/jem.20011930; Olotu A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025786; Olotu A, 2011, LANCET INFECT DIS, V11, P102, DOI 10.1016/S1473-3099(10)70262-0; Overstreet MG, 2008, IMMUNOL REV, V225, P272, DOI 10.1111/j.1600-065X.2008.00671.x; Porter DW, 2011, VACCINE; Reyes-Sandoval A, 2011, J IMMUNOL, V187, P1347, DOI 10.4049/jimmunol.1100302; Reyes-Sandoval A, 2010, INFECT IMMUN, V78, P145, DOI 10.1128/IAI.00740-09; RODRIGUES M, 1994, J IMMUNOL, V153, P4636; Rueda P, 2004, J GEN VIROL, V85, P563, DOI 10.1099/vir.0.19525-0; Sedlik C, 1997, P NATL ACAD SCI USA, V94, P7503, DOI 10.1073/pnas.94.14.7503; Sedlik C, 2000, J VIROL, V74, P5769, DOI 10.1128/JVI.74.13.5769-5775.2000; WHO, 2010, WORLD MALARIA REPORT 2010, P1	33	12	18	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2012	7	4							e34445	10.1371/journal.pone.0034445	http://dx.doi.org/10.1371/journal.pone.0034445			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WC	22529915	gold, Green Published			2022-12-25	WOS:000305347400012
J	Takala, H; Ylanne, J				Takala, Heikki; Ylanne, Jari			Binding Properties and Stability of the Ras-Association Domain of Rap1-GTP Interacting Adapter Molecule (RIAM)	PLOS ONE			English	Article							ACTIVATION; INTEGRINS; ENANASP; GTPASE; LIGAND; SIGNAL; SWITCH	The Rap1-GTP interacting adapter protein (RIAM) is an important protein in Rap1-mediated integrin activation. By binding to both Rap1 GTPase and talin, RIAM recruits talin to the cell membrane, thus facilitating talin-dependent integrin activation. In this article, we studied the role of the RIAM Ras-association (RA) and pleckstrin-homology (PH) domains in the interaction with Rap1. We found that the RA domain was sufficient for GTP-dependent interaction with Rap1B, and the addition of the PH domain did not change the binding affinity. We also detected GTP-independent interaction of Rap1B with the N-terminus of RIAM. In addition, we found that the PH domain stabilized the RA domain both in vitro and in cells.	[Takala, Heikki] Univ Jyvaskyla, Dept Biol & Environm Sci, Jyvaskyla, Finland; Univ Jyvaskyla, Nanosci Ctr, Jyvaskyla, Finland	University of Jyvaskyla; University of Jyvaskyla	Takala, H (corresponding author), Univ Jyvaskyla, Dept Biol & Environm Sci, Jyvaskyla, Finland.	jylanne@jyu.fi	Takala, Heikki/GVT-1834-2022; Takala, Heikki/ABC-9139-2020	Takala, Heikki/0000-0003-2518-8583; Takala, Heikki/0000-0003-2518-8583; Ylanne, Jari/0000-0003-4627-021X	Academy of Finland [1147613, 138327]; Ellen and Artturi Nyyssonen Foundation	Academy of Finland(Academy of Finland); Ellen and Artturi Nyyssonen Foundation	This work was supported by Academy of Finland grant 1147613, 138327 to JY and by a fellowship from the Ellen and Artturi Nyyssonen Foundation to HT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boettner B, 2009, CURR OPIN CELL BIOL, V21, P684, DOI 10.1016/j.ceb.2009.06.004; Bos JL, 2001, NAT REV MOL CELL BIO, V2, P369, DOI 10.1038/35073073; Bos JL, 2005, CURR OPIN CELL BIOL, V17, P123, DOI 10.1016/j.ceb.2005.02.009; Brinkmann T, 2002, J BIOL CHEM, V277, P12525, DOI 10.1074/jbc.M109176200; Calderwood DA, 2004, J CELL SCI, V117, P657, DOI 10.1242/jcs.01014; Chrzanowska-Wodnicka M, 2005, J CLIN INVEST, V115, P680, DOI 10.1172/JCI200522973; Depetris RS, 2009, NAT STRUCT MOL BIOL, V16, P833, DOI 10.1038/nsmb.1642; Filchtinski D, 2010, J MOL BIOL, V399, P422, DOI 10.1016/j.jmb.2010.03.046; Fontana A, 2004, ACTA BIOCHIM POL, V51, P299; Han JW, 2006, CURR BIOL, V16, P1796, DOI 10.1016/j.cub.2006.08.035; HERRMANN C, 1995, J BIOL CHEM, V270, P2901, DOI 10.1074/jbc.270.7.2901; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Jenzora A, 2005, FEBS LETT, V579, P455, DOI 10.1016/j.febslet.2004.10.110; Katagiri K, 2000, MOL CELL BIOL, V20, P1956, DOI 10.1128/MCB.20.6.1956-1969.2000; Kinbara K, 2003, NAT REV MOL CELL BIO, V4, P767, DOI 10.1038/nrm1229; Krause M, 2004, DEV CELL, V7, P571, DOI 10.1016/j.devcel.2004.07.024; Lad Y, 2008, J BIOL CHEM, V283, P35154, DOI 10.1074/jbc.M802592200; Lafuente EM, 2004, DEV CELL, V7, P585, DOI 10.1016/j.devcel.2004.07.021; Lee HS, 2009, J BIOL CHEM, V284, P5119, DOI 10.1074/jbc.M807117200; Menasche G, 2007, MOL CELL BIOL, V27, P4070, DOI 10.1128/MCB.02011-06; Miinalainen IJ, 2003, J BIOL CHEM, V278, P20154, DOI 10.1074/jbc.M302851200; NASSAR M, 1995, NATURE, V375, P554, DOI 10.1038/375554a0; Pantoliano MW, 2001, J BIOMOL SCREEN, V6, P429, DOI 10.1089/108705701753364922; Pentikainen U, 2011, J BIOL CHEM, V286, P26921, DOI 10.1074/jbc.M110.195958; Reedquist KA, 2000, J CELL BIOL, V148, P1151, DOI 10.1083/jcb.148.6.1151; Sebzda E, 2002, NAT IMMUNOL, V3, P251, DOI 10.1038/ni765; Tadokoro S, 2003, SCIENCE, V302, P103, DOI 10.1126/science.1086652; Vetter IR, 2001, SCIENCE, V294, P1299, DOI 10.1126/science.1062023; Watanabe N, 2008, J CELL BIOL, V181, P1211, DOI 10.1083/jcb.200803094; Wohlgemuth S, 2005, J MOL BIOL, V348, P741, DOI 10.1016/j.jmb.2005.02.048	30	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2012	7	4							e31955	10.1371/journal.pone.0031955	http://dx.doi.org/10.1371/journal.pone.0031955			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VO	22523535	Green Published, Green Submitted, gold			2022-12-25	WOS:000305345000004
J	Wang, HJ; Tan, G; Dong, L; Cheng, L; Li, KJ; Wang, ZY; Luo, HF				Wang, Hongjiang; Tan, Guang; Dong, Lei; Cheng, Lei; Li, Kejun; Wang, Zhongyu; Luo, Haifeng			Circulating MiR-125b as a Marker Predicting Chemoresistance in Breast Cancer	PLOS ONE			English	Article							CHEMOTHERAPY RESPONSE; BAK1 EXPRESSION; TUMOR-CELLS; MICRORNA; RESISTANCE; BIOMARKERS; METASTASIS; GROWTH; RNA; SUPPRESSION	Background: Chemotherapy is an important component in the treatment paradigm for breast cancers. However, the resistance of cancer cells to chemotherapeutic agents frequently results in the subsequent recurrence and metastasis. Identification of molecular markers to predict treatment outcome is therefore warranted. The aim of the present study was to evaluate whether expression of circulating microRNAs (miRNAs) can predict clinical outcome in breast cancer patients treated with adjuvant chemotherapy. Methodology/Principal Findings: Circulating miRNAs in blood serum prior to treatment were determined by quantitative Real-Time PCR in 56 breast cancer patients with invasive ductal carcinoma and pre-operative neoadjuvant chemotherapy. Proliferating cell nuclear antigen (PCNA) immunostaining and TUNEL were performed in surgical samples to determine the effects of chemotherapy on cancer cell proliferation and apoptosis, respectively. Among the miRNAs tested, only miR-125b was significantly associated with therapeutic response, exhibiting higher expression level in non-responsive patients (n = 26, 46%; p = 0.008). In addition, breast cancers with high miR-125b expression had higher percentage of proliferating cells and lower percentage of apoptotic cells in the corresponding surgical specimens obtained after neoadjuvant chemotherapy. Increased resistance to anticancer drug was observed in vitro in breast cancer cells with ectopic miR-125b expression; conversely, reducing miR-125b level sensitized breast cancer cells to chemotherapy. Moreover, we demonstrated that the E2F3 was a direct target of miR-125b in breast cancer cells. Conclusions/Significance: These data suggest that circulating miR-125b expression is associated with chemotherapeutic resistance of breast cancer. This finding has important implications in the development of targeted therapeutics for overcoming chemotherapeutic resistance in novel anti-cancer strategies.	[Wang, Hongjiang; Tan, Guang; Dong, Lei; Cheng, Lei; Li, Kejun; Wang, Zhongyu; Luo, Haifeng] Dalian Med Univ, Affiliated Hosp 1, Dept Gen Surg, Dalian, Peoples R China	Dalian Medical University	Wang, HJ (corresponding author), Dalian Med Univ, Affiliated Hosp 1, Dept Gen Surg, Dalian, Peoples R China.	hjwang@dlmedu.edu.cn			National Natural Science Foundation of China [81141098]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	These studies were supported, in part, by grants from the National Natural Science Foundation of China (No.81141098). No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbato C, 2009, J BIOMED BIOTECHNOL, DOI 10.1155/2009/803069; Bloomston M, 2007, JAMA-J AM MED ASSOC, V297, P1901, DOI 10.1001/jama.297.17.1901; Bockmeyer CL, 2011, BREAST CANC RES TREA; Burger H, 2003, CLIN CANCER RES, V9, P827; CHEN LP, 1995, GYNECOL ONCOL, V56, P231; Cho WCS, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-60; Cho William C. S., 2011, Frontiers in Genetics, V2, P7, DOI 10.3389/fgene.2011.00007; Corcoran C, 2011, CLIN CHEM, V57, P18, DOI 10.1373/clinchem.2010.150730; Doench JG, 2004, GENE DEV, V18, P504, DOI 10.1101/gad.1184404; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Faneyte IF, 2003, BRIT J CANCER, V88, P406, DOI 10.1038/sj.bjc.6600749; Feng N, 2011, MOL BIOL REP; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Fujita Y, 2008, BIOCHEM BIOPH RES CO, V377, P114, DOI 10.1016/j.bbrc.2008.09.086; Gebeshuber CA, 2009, EMBO REP, V10, P400, DOI 10.1038/embor.2009.9; Geisler S, 2003, CLIN CANCER RES, V9, P5582; Hannafon BN, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2839; Hartkopf AD, 2011, ANTICANCER RES, V31, P979; He M, 2011, BREAST CANCER RES TR, V126, P231, DOI 10.1007/s10549-010-1276-2; Heneghan HM, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2798; Iaquinta PJ, 2007, CURR OPIN CELL BIOL, V19, P649, DOI 10.1016/j.ceb.2007.10.006; Iorio MV, 2007, CANCER RES, V67, P8699, DOI 10.1158/0008-5472.CAN-07-1936; Iorio MV, 2005, CANCER RES, V65, P7065, DOI 10.1158/0008-5472.CAN-05-1783; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Kong W, 2010, J BIOL CHEM, V285, P17869, DOI 10.1074/jbc.M110.101055; Kovalchuk O, 2008, MOL CANCER THER, V7, P2152, DOI 10.1158/1535-7163.MCT-08-0021; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Lange CA, 2011, ENDOCR-RELAT CANCER, V18, pC19, DOI 10.1530/ERC-11-0112; Le MTN, 2009, GENE DEV, V23, P862, DOI 10.1101/gad.1767609; Ma L, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2720; Maragkakis M, 2009, NUCLEIC ACIDS RES, V37, pW273, DOI 10.1093/nar/gkp292; Martinez LA, 2010, MOL CELL BIOL, V30, P524, DOI 10.1128/MCB.00938-09; Mudduluru G, 2011, ONCOGENE, V30, P2888, DOI 10.1038/onc.2011.13; Noonan EJ, 2011, MICRORNAS IN CANCER TRANSLATIONAL RESEARCH, P415, DOI 10.1007/978-94-007-0298-1_18; Ozek NS, 2010, ANALYST, V135, P3094, DOI 10.1039/c0an00543f; Pattingre S, 2005, CELL, V122, P927, DOI 10.1016/j.cell.2005.07.002; Polager S, 2008, TRENDS CELL BIOL, V18, P528, DOI 10.1016/j.tcb.2008.08.003; Rajabi Hasan, 2010, Genes Cancer, V1, P62; Schwarzenbach H, 2011, NAT REV CANCER, V11, P426, DOI 10.1038/nrc3066; Scott GK, 2007, J BIOL CHEM, V282, P1479, DOI 10.1074/jbc.M609383200; Senderowicz AM, 2003, CANCER CHEMOTH PHARM, V52, pS61, DOI 10.1007/s00280-003-0624-x; Shi XB, 2007, P NATL ACAD SCI USA, V104, P19983, DOI 10.1073/pnas.0706641104; Shimono Y, 2009, CELL, V138, P592, DOI 10.1016/j.cell.2009.07.011; Sieuwerts AM, 2011, CLIN CANCER RES, V17, P3600, DOI 10.1158/1078-0432.CCR-11-0255; Tan M, 2002, MOL CELL, V9, P993, DOI 10.1016/S1097-2765(02)00510-5; Therasse P, 2000, J NATL CANCER I, V92, P205, DOI 10.1093/jnci/92.3.205; Tian S, 2010, BIOCHEM BIOPH RES CO, V396, P435, DOI 10.1016/j.bbrc.2010.04.112; Tordai A, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2088; Veerla S, 2009, INT J CANCER, V124, P2236, DOI 10.1002/ijc.24183; Visone R, 2007, ONCOGENE, V26, P7590, DOI 10.1038/sj.onc.1210564; Weigel MT, 2010, ENDOCR-RELAT CANCER, V17, pR245, DOI 10.1677/ERC-10-0136; Xia HF, 2009, CELL PHYSIOL BIOCHEM, V23, P347, DOI 10.1159/000218181; Yu DC, 2011, INT J MOL SCI, V12, P2055, DOI 10.3390/ijms12032055; Zhang Y, 2011, CANCER RES, V71, P3552, DOI 10.1158/0008-5472.CAN-10-2435; Zhao H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013735; Zhao JJ, 2008, J BIOL CHEM, V283, P31079, DOI 10.1074/jbc.M806041200; Zhou M, 2010, J BIOL CHEM, V285, P21496, DOI 10.1074/jbc.M109.083337	57	49	62	4	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2012	7	4							e34210	10.1371/journal.pone.0034210	http://dx.doi.org/10.1371/journal.pone.0034210			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VO	22523546	Green Submitted, gold, Green Published			2022-12-25	WOS:000305345000015
J	Byers, SL; Wiles, MV; Dunn, SL; Taft, RA				Byers, Shannon L.; Wiles, Michael V.; Dunn, Sadie L.; Taft, Robert A.			Mouse Estrous Cycle Identification Tool and Images	PLOS ONE			English	Article							MICE; CYCLICITY; VAGINA	The efficiency of producing timed pregnant or pseudopregnant mice can be increased by identifying those in proestrus or estrus. Visual observation of the vagina is the quickest method, requires no special equipment, and is best used when only proestrus or estrus stages need to be identified. Strain to strain differences, especially in coat color can make it difficult to determine the stage of the estrous cycle accurately by visual observation. Presented here are a series of images of the vaginal opening at each stage of the estrous cycle for 3 mouse strains of different coat colors: black (C57BL/6J), agouti (CByB6F1/J) and albino (BALB/cByJ). When all 4 stages (proestrus, estrus, metestrus, and diestrus) need to be identified, vaginal cytology is regarded as the most accurate method. An identification tool is presented to aid the user in determining the stage of estrous when using vaginal cytology. These images and descriptions are an excellent resource for learning how to determine the stage of the estrous cycle by visual observation or vaginal cytology.	[Byers, Shannon L.; Dunn, Sadie L.; Taft, Robert A.] Jackson Lab, Reprod Sci R&D, Bar Harbor, ME 04609 USA	Jackson Laboratory	Byers, SL (corresponding author), Jackson Lab, Reprod Sci R&D, 600 Main St, Bar Harbor, ME 04609 USA.	rob.taft@jax.org		Taft, Robert/0000-0002-3634-3342; wiles, michael/0000-0002-3620-8386				Achiraman S, 2011, ZOOL SCI, V28, P600, DOI 10.2108/zsj.28.600; Allen E, 1922, AM J ANAT, V30, P297, DOI 10.1002/aja.1000300303; BRONSON FH, 1966, BIOL LABORATORY MOUS, P187; Caligioni CS., 2009, ASSESSING REPROD STA; CHAMPLIN AK, 1973, BIOL REPROD, V8, P491, DOI 10.1093/biolreprod/8.4.491; FELICIO LS, 1984, BIOL REPROD, V31, P446, DOI 10.1095/biolreprod31.3.446; Green E. L., 1968, BIOL LAB MOUSE; NELSON JF, 1982, BIOL REPROD, V27, P327, DOI 10.1095/biolreprod27.2.327; Ramos SD, 2001, J APPL PHYSIOL, V91, P667, DOI 10.1152/jappl.2001.91.2.667; SNELL GD, 1966, BIOL LAB MOUSE	10	574	590	7	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2012	7	4							e35538	10.1371/journal.pone.0035538	http://dx.doi.org/10.1371/journal.pone.0035538			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UT	22514749	Green Published, Green Submitted, gold			2022-12-25	WOS:000305341600154
J	Ji, PF; Liu, GM; Xu, J; Wang, XM; Li, JT; Zhao, ZX; Zhang, XF; Zhang, Y; Xu, P; Sun, XW				Ji, Peifeng; Liu, Guiming; Xu, Jian; Wang, Xumin; Li, Jiongtang; Zhao, Zixia; Zhang, Xiaofeng; Zhang, Yan; Xu, Peng; Sun, Xiaowen			Characterization of Common Carp Transcriptome: Sequencing, De Novo Assembly, Annotation and Comparative Genomics	PLOS ONE			English	Article							CYPRINUS-CARPIO; EXPRESSION ANALYSIS; CHANNEL CATFISH; GENE-EXPRESSION; EST SEQUENCES; GENERATION; MARKERS; FAMILY; LOCI; TAGS	Background: Common carp (Cyprinus carpio) is one of the most important aquaculture species of Cyprinidae with an annual global production of 3.4 million tons, accounting for nearly 14% of the freshwater aquaculture production in the world. Due to the economical and ecological importance of common carp, genomic data are eagerly needed for genetic improvement purpose. However, there is still no sufficient transcriptome data available. The objective of the project is to sequence transcriptome deeply and provide well-assembled transcriptome sequences to common carp research community. Result: Transcriptome sequencing of common carp was performed using Roche 454 platform. A total of 1,418,591 clean ESTs were collected and assembled into 36,811 cDNA contigs, with average length of 888 bp and N50 length of 1,002 bp. Annotation was performed and a total of 19,165 unique proteins were identified from assembled contigs. Gene ontology and KEGG analysis were performed and classified all contigs into functional categories for understanding gene functions and regulation pathways. Open Reading Frames (ORFs) were detected from 29,869 (81.1%) contigs with an average ORF length of 763 bp. From these contigs, 9,625 full-length cDNAs were identified with sequence length from 201 bp to 9,956 bp. Comparative analysis revealed that 27,693(75.2%) contigs have significant similarity to zebrafish Refseq proteins, and 24,371(66.2%), 24,501(66.5%) and 25,025(70.0%) to teraodon, medaka and three-spined stickleback refseq proteins. A total of 2,064 microsatellites were initially identified from 1,730 contigs, and 1,639 unique sequences had sufficient flanking sequences on both sides for primer design. Conclusion: The transcriptome of common carp had been deep sequenced, de novo assembled and characterized, providing the valuable resource for better understanding of common carp genome. The transcriptome data will facilitate future functional studies on common carp genome, and gradually apply in breeding programs of common carp, as well as closely related other Cyprinids.	[Ji, Peifeng; Xu, Jian; Li, Jiongtang; Zhao, Zixia; Zhang, Yan; Xu, Peng; Sun, Xiaowen] Chinese Acad Fishery Sci, Ctr Appl Aquat Genom, Beijing, Peoples R China; [Liu, Guiming; Wang, Xumin] Chinese Acad Sci, Beijing Inst Genom, CAS Key Lab Genome Sci & Informat, Beijing, Peoples R China; [Zhang, Xiaofeng; Sun, Xiaowen] Chinese Acad Fishery Sci, Heilongjiang Fisheries Res Inst, Harbin, Peoples R China	Chinese Academy of Fishery Sciences; Chinese Academy of Sciences; Beijing Institute of Genomics, CAS; Chinese Academy of Fishery Sciences; Heilongjiang River Fisheries Research Institute, CAFS	Ji, PF (corresponding author), Chinese Acad Fishery Sci, Ctr Appl Aquat Genom, Beijing, Peoples R China.	xupeng@cafs.ac.cn; sunxw2002@163.com	Zhao, Zi-Xia/AAM-8065-2021; wang, xumin/HII-8627-2022; Sun, Xiaowen/F-1516-2014; Xu, Jian/H-5349-2019; Xu, Peng/J-4018-2012	Zhao, Zi-Xia/0000-0003-1099-3387; Xu, Jian/0000-0003-0274-4268; Xu, Peng/0000-0002-1531-5078	National Department Public Benefit Research Foundation [200903045]; National High-tech R&D Program of China [2011AA100401]; National Natural Science Foundation of China [31101893]	National Department Public Benefit Research Foundation; National High-tech R&D Program of China(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the grants from National Department Public Benefit Research Foundation (No. 200903045), National High-tech R&D Program of China (2011AA100401), and National Natural Science Foundation of China (No. 31101893). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abernathy JW, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-176; Cheng L, 2010, ANIM GENET, V41, P191, DOI 10.1111/j.1365-2052.2009.01985.x; Chevreux B, 2004, GENOME RES, V14, P1147, DOI 10.1101/gr.1917404; Christoffels A, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-S5-S2; FAO, 2007, STAT WORLD FISH AQ 2; Hale MC, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-404; Hampton M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027021; He SP, 2008, MOL PHYLOGENET EVOL, V46, P818, DOI 10.1016/j.ympev.2007.06.001; Hou R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021560; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; Jung H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027938; Kongchum P, 2010, FISH SHELLFISH IMMUN, V29, P356, DOI 10.1016/j.fsi.2010.04.013; Kroupova H, 2010, ENVIRON TOXICOL CHEM, V29, P535, DOI 10.1002/etc.84; Kulhanek SA, 2011, ECOL APPL, V21, P203, DOI 10.1890/09-1639.1; Kumar S, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-571; Li Y, 2011, MAR BIOTECHNOL, V13, P706, DOI 10.1007/s10126-010-9332-9; Liu D, 2010, MAR BIOTECHNOL, V12, P186, DOI 10.1007/s10126-009-9212-3; Mao Rui-Xin, 2009, Yichuan, V31, P407, DOI 10.3724/SP.J.1005.2009.00407; Min XJ, 2005, NUCLEIC ACIDS RES, V33, pW669, DOI 10.1093/nar/gki436; Moens LN, 2007, J BIOCHEM MOL TOXIC, V21, P299, DOI 10.1002/jbt.20190; Moriya Y, 2007, NUCLEIC ACIDS RES, V35, pW182, DOI 10.1093/nar/gkm321; Nandi S, 2007, GENETICA, V131, P81, DOI 10.1007/s10709-006-9115-4; Sha Z, 2008, MOL IMMUNOLOGY; Sun X, 2004, AQUACULTURE, V238, P8; THURSTON MI, 2005, MSATFINDER DETECTION; Van Campenhout K, 2009, ENVIRON TOXICOL CHEM, V28, P209, DOI 10.1897/08-136.1; Wan Y, 2011, MOL BIOL REP, P1; Wang CH, 2004, AQUACULTURE, V231, P83, DOI 10.1016/j.aquaculture.2003.10.040; Wang D, 2007, AQUACULTURE, V271, P558, DOI 10.1016/j.aquaculture.2007.06.001; Wang Q, 2006, MOL IMMUNOL, V43, P1676, DOI 10.1016/j.molimm.2005.09.023; Wang SL, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-1-r8; Williams DR, 2008, J FISH BIOL, V72, P2095, DOI 10.1111/j.1095-8649.2008.01875.x; Xu J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021057; Xu P, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-537; Xu P, 2011, MAR BIOTECHNOL, V13, P215, DOI 10.1007/s10126-010-9283-1; Xu P, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-188; Yan XC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030925; Zhang Ya-Qin, 2011, Medical Mycology, V49, P435, DOI 10.3109/13693786.2010.540723; Zhang Y, 2008, J GENET GENOMICS, V35, P97, DOI 10.1016/S1673-8527(08)60015-6; Zhou Jianfeng, 2004, Genetika, V40, P1389	40	109	119	2	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2012	7	4							e35152	10.1371/journal.pone.0035152	http://dx.doi.org/10.1371/journal.pone.0035152			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UT	22514716	Green Published, gold, Green Submitted			2022-12-25	WOS:000305341600122
J	Payne, NL; Sun, GZ; Herszfeld, D; Tat-Goh, PA; Verma, PJ; Parkington, HC; Coleman, HA; Tonta, MA; Siatskas, C; Bernard, CCA				Payne, Natalie L.; Sun, Guizhi; Herszfeld, Daniella; Tat-Goh, Pollyanna A.; Verma, Paul J.; Parkington, Helena C.; Coleman, Harold A.; Tonta, Mary A.; Siatskas, Christopher; Bernard, Claude C. A.			Comparative Study on the Therapeutic Potential of Neurally Differentiated Stem Cells in a Mouse Model of Multiple Sclerosis	PLOS ONE			English	Article							IN-VITRO DIFFERENTIATION; AUTOIMMUNE ENCEPHALOMYELITIS; STEM/PRECURSOR CELLS; PRECURSOR CELLS; BONE-MARROW; BRAIN; EXPRESSION; RECOVERY; NEURONS; NEUROPROTECTION	Background: Transplantation of neural stem cells (NSCs) is a promising novel approach to the treatment of neuroinflammatory diseases such as multiple sclerosis (MS). NSCs can be derived from primary central nervous system (CNS) tissue or obtained by neural differentiation of embryonic stem (ES) cells, the latter having the advantage of readily providing an unlimited number of cells for therapeutic purposes. Using a mouse model of MS, we evaluated the therapeutic potential of NSCs derived from ES cells by two different neural differentiation protocols that utilized adherent culture conditions and compared their effect to primary NSCs derived from the subventricular zone (SVZ). Methodology/Principal Findings: The proliferation and secretion of pro-inflammatory cytokines by antigen-stimulated splenocytes was reduced in the presence of SVZ-NSCs, while ES cell-derived NSCs exerted differential immunosuppressive effects. Surprisingly, intravenously injected NSCs displayed no significant therapeutic impact on clinical and pathological disease outcomes in mice with experimental autoimmune encephalomyelitis (EAE) induced by recombinant myelin oligodendrocyte glycoprotein, independent of the cell source. Studies tracking the biodistribution of transplanted ES cell-derived NSCs revealed that these cells were unable to traffic to the CNS or peripheral lymphoid tissues, consistent with the lack of cell surface homing molecules. Attenuation of peripheral immune responses could only be achieved through multiple high doses of NSCs administered intraperitoneally, which led to some neuroprotective effects within the CNS. Conclusion/Significance: Systemic transplantation of these NSCs does not have a major influence on the clinical course of rMOG-induced EAE. Improving the efficiency at which NSCs home to inflammatory sites may enhance their therapeutic potential in this model of CNS autoimmunity.	[Payne, Natalie L.; Sun, Guizhi; Herszfeld, Daniella; Siatskas, Christopher; Bernard, Claude C. A.] Monash Univ, Monash Immunol & Stem Cell Labs, Clayton, Vic, Australia; [Tat-Goh, Pollyanna A.; Verma, Paul J.] Monash Univ, Monash Inst Med Res, Ctr Reprod & Dev, Clayton, Vic, Australia; [Parkington, Helena C.; Coleman, Harold A.; Tonta, Mary A.] Monash Univ, Dept Physiol, Clayton, Vic 3168, Australia	Monash University; Monash University; Monash University	Payne, NL (corresponding author), Monash Univ, Monash Immunol & Stem Cell Labs, Clayton, Vic, Australia.	Claude.Bernard@monash.edu.au	Verma, Paul/AAQ-4657-2021	Bernard, Claude Charles Andre/0000-0003-2816-5328	Baker Foundation; National Health and Medical Research Council of Australia; Diana Asmar Fund; Eva and Les Erdi AUSiMED Fellowship in Neurological Diseases; Cure Multiple Sclerosis Fellowship-Neurological Diseases; Trish MS Research Foundation; Monash University	Baker Foundation; National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Diana Asmar Fund; Eva and Les Erdi AUSiMED Fellowship in Neurological Diseases; Cure Multiple Sclerosis Fellowship-Neurological Diseases; Trish MS Research Foundation; Monash University(Monash University)	This work was supported by grants from the Baker Foundation, the National Health and Medical Research Council of Australia, the Diana Asmar Fund, The Eva and Les Erdi AUSiMED Fellowship in Neurological Diseases and Cure Multiple Sclerosis Fellowship-Neurological Diseases. N.P. was supported by a Trish MS Research Foundation Postgraduate Research Scholarship and a Monash University Postgraduate Publication Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aharonowiz M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003145; Akesson E, 2009, STEM CELL RES, V2, P56, DOI 10.1016/j.scr.2008.06.002; Bacigaluppi M, 2009, BRAIN, V132, P2239, DOI 10.1093/brain/awp174; Bakshi A, 2005, BRAIN RES, V1065, P8, DOI 10.1016/j.brainres.2005.09.059; Bettadapura J, 1998, J NEUROCHEM, V70, P1593, DOI 10.1046/j.1471-4159.1998.70041593.x; Bettelli E, 2003, J EXP MED, V197, P1073, DOI 10.1084/jem.20021603; Brocke S, 1999, P NATL ACAD SCI USA, V96, P6896, DOI 10.1073/pnas.96.12.6896; Brustle O, 1997, P NATL ACAD SCI USA, V94, P14809, DOI 10.1073/pnas.94.26.14809; Campos LS, 2004, J NEUROSCI RES, V78, P761, DOI 10.1002/jnr.20333; Codarri L, 2010, CURR OPIN NEUROL, V23, P205, DOI 10.1097/WCO.0b013e3283391feb; Conti L, 2005, PLOS BIOL, V3, P1594, DOI 10.1371/journal.pbio.0030283; Conti L, 2010, NAT REV NEUROSCI, V11, P176, DOI 10.1038/nrn2761; Crocker SJ, 2011, NEUROPATH APPL NEURO, V37, P643, DOI 10.1111/j.1365-2990.2011.01165.x; Einstein O, 2003, MOL CELL NEUROSCI, V24, P1074, DOI 10.1016/j.mcn.2003.08.009; Einstein O, 2006, EXP NEUROL, V198, P275, DOI 10.1016/j.expneurol.2005.11.007; Einstein O, 2007, ANN NEUROL, V61, P209, DOI 10.1002/ana.21033; Fields RD, 2002, SCIENCE, V298, P556, DOI 10.1126/science.298.5593.556; Glaser T, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000298; Gordon D, 2008, NEUROSCI LETT, V448, P71, DOI 10.1016/j.neulet.2008.10.040; Gu XQ, 2004, AM J PHYSIOL-CELL PH, V287, pC691, DOI 10.1152/ajpcell.00066.2004; Honczarenko M, 2006, STEM CELLS, V24, P1030, DOI 10.1634/stemcells.2005-0319; Imitola J, 2005, PHARMACOL THERAPEUT, V106, P163, DOI 10.1016/j.pharmthera.2004.11.007; Imitola J, 2004, P NATL ACAD SCI USA, V101, P18117, DOI 10.1073/pnas.0408258102; Johnson MA, 2007, J NEUROSCI, V27, P3069, DOI 10.1523/JNEUROSCI.4562-06.2007; Kim SY, 2009, J NEUROSCI RES, V87, P2264, DOI 10.1002/jnr.22050; Krumbholz M, 2006, BRAIN, V129, P200, DOI 10.1093/brain/awh680; Lee ST, 2005, NEUROSCI RES, V52, P243, DOI 10.1016/j.neures.2005.03.016; LINNINGTON C, 1984, J NEUROIMMUNOL, V6, P387, DOI 10.1016/0165-5728(84)90064-X; Liu KKY, 2009, J NEUROIMMUNOL, V215, P49, DOI 10.1016/j.jneuroim.2009.08.003; Liu S, 2000, P NATL ACAD SCI USA, V97, P6126, DOI 10.1073/pnas.97.11.6126; Martino G, 2006, NAT REV NEUROSCI, V7, P395, DOI 10.1038/nrn1908; McDonald JW, 1999, NAT MED, V5, P1410, DOI 10.1038/70986; McQualter JL, 2001, J EXP MED, V194, P873, DOI 10.1084/jem.194.7.873; Ng ES, 2005, BLOOD, V106, P1601, DOI 10.1182/blood-2005-03-0987; Parsons XH, 2009, CYTOTHERAPY, V11, P815, DOI 10.3109/14653240903180092; Payne Natalie, 2011, Curr Stem Cell Res Ther, V6, P50, DOI 10.2174/157488811794480735; Payne N, 2008, J AUTOIMMUN, V31, P288, DOI 10.1016/j.jaut.2008.04.002; Pendharkar AV, 2010, STROKE, V41, P2064, DOI 10.1161/STROKEAHA.109.575993; Pera MF, 2010, NATURE, V465, P713, DOI 10.1038/nature09228; Perez-Alvarez MJ, 2008, J NEUROSCI RES, V86, P1871, DOI 10.1002/jnr.21623; Pluchino S, 2005, NATURE, V436, P266, DOI 10.1038/nature03889; Pluchino S, 2003, NATURE, V422, P688, DOI 10.1038/nature01552; Pluchino S, 2008, J NEUROL SCI, V265, P105, DOI 10.1016/j.jns.2007.07.020; Pluchino S, 2009, ANN NEUROL, V66, P343, DOI 10.1002/ana.21745; Pluchino S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005959; Politi LS, 2007, STEM CELLS, V25, P2583, DOI 10.1634/stemcells.2007-0037; Prowse ABJ, 2011, STEM CELL RES, V6, P1, DOI 10.1016/j.scr.2010.09.005; Rafei M, 2009, MOL THER, V17, P1799, DOI 10.1038/mt.2009.157; Rafei M, 2008, BLOOD, V112, P4991, DOI 10.1182/blood-2008-07-166892; Rampon C, 2008, STEM CELLS, V26, P1673, DOI 10.1634/stemcells.2008-0122; Reekmans KP, 2011, CELL TRANSPLANT, V20, P851, DOI 10.3727/096368910X543411; Reid CA, 2006, NEUROPHARMACOLOGY, V51, P587, DOI 10.1016/j.neuropharm.2006.05.001; Reubinoff BE, 2001, NAT BIOTECHNOL, V19, P1134, DOI 10.1038/nbt1201-1134; REYNOLDS BA, 1992, J NEUROSCI, V12, P4565, DOI 10.1523/jneurosci.12-11-04565.1992; Robey TE, 2008, J MOL CELL CARDIOL, V45, P567, DOI 10.1016/j.yjmcc.2008.03.009; Rossi B, 2011, J LEUKOCYTE BIOL, V89, P539, DOI 10.1189/jlb.0710432; Sackstein R, 2008, NAT MED, V14, P181, DOI 10.1038/nm1703; Schwarz SC, 2010, TRANSL RES, V156, P155, DOI 10.1016/j.trsl.2010.07.002; Shin S, 2007, STEM CELLS, V25, P1298, DOI 10.1634/stemcells.2006-0660; SPRINKLE TJ, 1989, CRIT REV NEUROBIOL, V4, P235; SZABO P, 1994, DEVELOPMENT, V120, P1651; Tat PA, 2010, CELL TRANSPLANT, V19, P525, DOI 10.3727/096368910X491374; Tran PB, 2003, NAT REV NEUROSCI, V4, P444, DOI 10.1038/nrn1116; Tsuji O, 2010, P NATL ACAD SCI USA, V107, P12704, DOI 10.1073/pnas.0910106107; Vierbuchen T, 2010, NATURE, V463, P1035, DOI 10.1038/nature08797; Weber MS, 2010, ANN NEUROL, V68, P369, DOI 10.1002/ana.22081; Yang JX, 2010, AM J PATHOL, V177, P1989, DOI 10.2353/ajpath.2010.091203; Ying QL, 2003, NAT BIOTECHNOL, V21, P183, DOI 10.1038/nbt780; Zhang SC, 2001, NAT BIOTECHNOL, V19, P1129, DOI 10.1038/nbt1201-1129	69	15	15	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2012	7	4							e35093	10.1371/journal.pone.0035093	http://dx.doi.org/10.1371/journal.pone.0035093			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UT	22514711	gold, Green Published, Green Submitted			2022-12-25	WOS:000305341600117
J	Porcheron, G; Chanteloup, NK; Trotereau, A; Bree, A; Schouler, C				Porcheron, Gaelle; Chanteloup, Nathalie Katy; Trotereau, Angelina; Bree, Annie; Schouler, Catherine			Effect of Fructooligosaccharide Metabolism on Chicken Colonization by an Extra-Intestinal Pathogenic Escherichia coli Strain	PLOS ONE			English	Article							CARBON CATABOLITE REPRESSION; INTESTINAL COLONIZATION; COLONIC MICROBIOTA; INDUCER EXCLUSION; BROILER-CHICKENS; GENOMIC ISLAND; VIRULENCE; BACTERIA; CECUM; ENTEROBACTERIACEAE	Extra-intestinal pathogenic Escherichia coli (ExPEC) strains cause many diseases in humans and animals. While remaining asymptomatic, they can colonize the intestine for subsequent extra-intestinal infection and dissemination in the environment. We have previously identified the fos locus, a gene cluster within a pathogenicity island of the avian ExPEC strain BEN2908, involved in the metabolism of short-chain fructooligosaccharides (scFOS). It is assumed that these sugars are metabolized by the probiotic bacteria of the microbiota present in the intestine, leading to a decrease in the pathogenic bacterial population. However, we have previously shown that scFOS metabolism helps BEN2908 to colonize the intestine, its reservoir. As the fos locus is located on a pathogenicity island, one aim of this study was to investigate a possible role of this locus in the virulence of the strain for chicken. We thus analysed fos gene expression in extracts of target organs of avian colibacillosis and performed a virulence assay in chickens. Moreover, in order to understand the involvement of the fos locus in intestinal colonization, we monitored the expression of fos genes and their implication in the growth ability of the strain in intestinal extracts of chicken. We also performed intestinal colonization assays in axenic and Specific Pathogen-Free (SPF) chickens. We demonstrated that the fos locus is not involved in the virulence of BEN2908 for chickens and is strongly involved in axenic chicken cecal colonization both in vitro and in vivo. However, even if the presence of a microbiota does not inhibit the growth advantage of BEN2908 in ceca in vitro, overall, growth of the strain is not favoured in the ceca of SPF chickens. These findings indicate that scFOS metabolism by an ExPEC strain can contribute to its fitness in ceca but this benefit is fully dependent on the bacteria present in the microbiota.	[Porcheron, Gaelle; Chanteloup, Nathalie Katy; Trotereau, Angelina; Bree, Annie; Schouler, Catherine] INRA, Infectiol & Sante Publ UMR1282, F-37380 Nouzilly, France; [Porcheron, Gaelle; Chanteloup, Nathalie Katy; Trotereau, Angelina; Bree, Annie; Schouler, Catherine] Univ Tours, Infectiol & Sante Publ UMR1282, Tours, France	INRAE; Universite de Tours	Porcheron, G (corresponding author), INRA, Infectiol & Sante Publ UMR1282, F-37380 Nouzilly, France.	Catherine.Schouler@tours.inra.fr	Schouler, Catherine/AAE-2207-2022	Schouler, Catherine/0000-0002-3480-6278; Porcheron, Gaelle/0000-0002-0406-7662	Era-NET PathoGenoMics European [ANR-06-PATHO-002-01]; Institut National de la Recherche Agronomique; Institut Federatif de Recherche [136]	Era-NET PathoGenoMics European; Institut National de la Recherche Agronomique; Institut Federatif de Recherche	This work was funded by the Era-NET PathoGenoMics European program (grant ANR-06-PATHO-002-01), the Institut National de la Recherche Agronomique and the Institut Federatif de Recherche 136 (Agents Transmissibles et Infectiologie). GP is a pre-doctoral fellow of INRA (MICA)/Region Centre (France). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARNES EM, 1972, AM J CLIN NUTR, V25, P1475; Barnes HJ, 2003, DIS POULTRY, V11th, P56; Barrangou R, 2003, P NATL ACAD SCI USA, V100, P8957, DOI 10.1073/pnas.1332765100; Belanger L, 2011, FEMS IMMUNOL MED MIC, V62, P1, DOI 10.1111/j.1574-695X.2011.00797.x; Bjerrum L, 2006, POULTRY SCI, V85, P1151, DOI 10.1093/ps/85.7.1151; Bruckner R, 2002, FEMS MICROBIOL LETT, V209, P141; CAIN JR, 1976, AM J CLIN NUTR, V29, P1397, DOI 10.1093/ajcn/29.12.1397; Chanteloup NK, 2011, VET MICROBIOL, V147, P435, DOI 10.1016/j.vetmic.2010.07.013; Chouikha I, 2006, J BACTERIOL, V188, P977, DOI 10.1128/JB.188.3.977-987.2006; CLENCH MH, 1995, WILSON BULL, V107, P93; Deutscher J, 2008, CURR OPIN MICROBIOL, V11, P87, DOI 10.1016/j.mib.2008.02.007; DHO M, 1982, AVIAN DIS, V26, P787, DOI 10.2307/1589865; Dho-Moulin M, 1999, VET RES, V30, P299; Diard M, 2010, J BACTERIOL, V192, P4885, DOI 10.1128/JB.00804-10; Duncan SH, 2002, INT J SYST EVOL MICR, V52, P2141, DOI [10.1099/ijs.0.02241-0, 10.1099/00207713-52-6-2141]; Edelman S, 2003, VET MICROBIOL, V91, P41, DOI 10.1016/S0378-1135(02)00153-0; Ewers C, 2009, APPL ENVIRON MICROB, V75, P184, DOI 10.1128/AEM.01324-08; Falony G, 2009, APPL ENVIRON MICROB, V75, P454, DOI 10.1128/AEM.01488-08; FRETER R, 1983, INFECT IMMUN, V39, P686, DOI 10.1128/IAI.39.2.686-703.1983; FRETER R, 1981, INFECT IMMUN, V34, P241, DOI 10.1128/IAI.34.1.241-249.1981; GIBSON GR, 1995, J NUTR, V125, P1401, DOI 10.1093/jn/125.6.1401; Gorke B, 2008, NAT REV MICROBIOL, V6, P613, DOI 10.1038/nrmicro1932; Gong JH, 2002, FEMS MICROBIOL LETT, V208, P1, DOI 10.1111/j.1574-6968.2002.tb11051.x; Gusils C, 2003, CAN J MICROBIOL, V49, P472, DOI [10.1139/w03-055, 10.1139/W03-055]; HARRY EG, 1965, VET REC, V77, P35; Hennequin C, 2009, INFECT IMMUN, V77, P5449, DOI 10.1128/IAI.00837-09; Herias MV, 1997, INFECT IMMUN, V65, P531; HERIAS MV, 1995, INFECT IMMUN, V63, P4781; Hermans D, 2010, POULTRY SCI, V89, P1144, DOI 10.3382/ps.2010-00717; Hogema BM, 1998, MOL MICROBIOL, V30, P487, DOI 10.1046/j.1365-2958.1998.01053.x; Jantunen ME, 2001, J MED MICROBIOL, V50, P650, DOI 10.1099/0022-1317-50-7-650; Johnson JR, 2002, J LAB CLIN MED, V139, P155, DOI 10.1067/mlc.2002.121550; Johnson JR, 2001, INFECT IMMUN, V69, P1306, DOI 10.1128/IAI.69.3.1306-1314.2001; Kaplan H, 2003, APPL ENVIRON MICROB, V69, P2217, DOI 10.1128/AEM.69.4.2217-2222.2003; Le Bars J, 1976, Ann Rech Vet, V7, P383; Leatham-Jensen MP, 2012, INFECT IMMUN; Miller JH, 1972, EXPT MOL GENETICS, Vxvi, P466; Moreno E, 2009, MICROBES INFECT, V11, P274, DOI 10.1016/j.micinf.2008.12.002; Nowrouzian FL, 2005, J INFECT DIS, V191, P1078, DOI 10.1086/427996; Nowrouzian FL, 2006, MICROBES INFECT, V8, P834, DOI 10.1016/j.micinf.2005.10.011; Olsen KN, 2008, ANTON LEEUW INT J G, V94, P423, DOI 10.1007/s10482-008-9260-0; Picard B, 1999, INFECT IMMUN, V67, P546, DOI 10.1128/IAI.67.2.546-553.1999; PLUSCHKE G, 1983, INFECT IMMUN, V39, P599, DOI 10.1128/IAI.39.2.599-608.1983; Porcheron G, 2011, MOL MICROBIOL, V81, P717, DOI 10.1111/j.1365-2958.2011.07725.x; Ritsema T, 2003, CURR OPIN PLANT BIOL, V6, P223, DOI 10.1016/S1369-5266(03)00034-7; Roberfroid M, 2010, BRIT J NUTR, V104, pS1, DOI 10.1017/S0007114510003363; Roberfroid MB, 2001, AM J CLIN NUTR, V73, p406S, DOI 10.1093/ajcn/73.2.406s; Ron EZ, 2006, CURR OPIN MICROBIOL, V9, P28, DOI 10.1016/j.mib.2005.12.001; Rouquet G, 2009, J BACTERIOL, V191, P4427, DOI 10.1128/JB.00103-09; Russo TA, 2000, J INFECT DIS, V181, P1753, DOI 10.1086/315418; Russo TA, 2003, MICROBES INFECT, V5, P449, DOI 10.1016/S1286-4579(03)00049-2; Ryan SM, 2005, APPL ENVIRON MICROB, V71, P3475, DOI 10.1128/AEM.71.7.3475-3482.2005; SAIER MH, 1989, MICROBIOL REV, V53, P109, DOI 10.1128/MMBR.53.1.109-120.1989; Schierack P, 2008, ENVIRON MICROBIOL, V10, P1742, DOI 10.1111/j.1462-2920.2008.01595.x; Schierack P, 2007, MICROBIOL-SGM, V153, P3830, DOI 10.1099/mic.0.2007/010173-0; Schouler C, 2009, J BACTERIOL, V191, P388, DOI 10.1128/JB.01052-08; SELDEN R, 1971, ANN INTERN MED, V74, P657, DOI 10.7326/0003-4819-74-5-657; Shpigel NY, 2008, CURR OPIN MICROBIOL, V11, P60, DOI 10.1016/j.mib.2008.01.004; Smith JL, 2007, FOODBORNE PATHOG DIS, V4, P134, DOI 10.1089/fpd.2007.0087; Sonnenburg ED, 2010, CELL, V141, P1241, DOI 10.1016/j.cell.2010.05.005; TURK DE, 1982, POULTRY SCI, V61, P1225, DOI 10.3382/ps.0611225; Whittow G.C., 1986, P221; Wiles TJ, 2008, EXP MOL PATHOL, V85, P11, DOI 10.1016/j.yexmp.2008.03.007; Yamamoto Shingo, 2007, Journal of Infection and Chemotherapy, V13, P68, DOI 10.1007/s10156-007-0506-y; Zhang LX, 2002, J CLIN MICROBIOL, V40, P3951, DOI 10.1128/JCM.40.11.3951-3955.2002; Zhu XY, 2002, APPL ENVIRON MICROB, V68, P124, DOI 10.1128/AEM.68.1.124-137.2002	66	10	11	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2012	7	4							e35475	10.1371/journal.pone.0035475	http://dx.doi.org/10.1371/journal.pone.0035475			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UT	22514747	Green Published, gold, Green Submitted			2022-12-25	WOS:000305341600152
J	Zhu, CS; Xiong, ZJ; Chen, XH; Peng, FH; Hu, XQ; Chen, YM; Wang, Q				Zhu, Cansheng; Xiong, Zhaojun; Chen, Xiaohong; Peng, Fuhua; Hu, Xueqiang; Chen, Yanming; Wang, Qing			Artemisinin Attenuates Lipopolysaccharide-Stimulated Proinflammatory Responses by Inhibiting NF-kappa B Pathway in Microglia Cells	PLOS ONE			English	Article							PARKINSONS-DISEASE; NITRIC-OXIDE; ALZHEIMERS-DISEASE; ACTIVATION; MECHANISMS; INFLAMMATION; DERIVATIVES; INDUCTION; CYTOKINES; PROTEINS	Microglial activation plays an important role in neuroinflammation, which contributes to neuronal damage, and inhibition of microglial activation may have therapeutic benefits that could alleviate the progression of neurodegeneration. Recent studies have indicated that the antimalarial agent artemisinin has the ability to inhibit NF-kappa B activation. In this study, the inhibitory effects of artemisinin on the production of proinflammatory mediators were investigated in lipopolysaccharide (LPS)-stimulated primary microglia. Our results show that artemisinin significantly inhibited LPS-induced production of tumor necrosis factor-alpha (TNF-alpha), interleukin-6 (IL-6), monocyte chemotactic protein-1 (MCP-1) and nitric oxide (NO). Artemisinin significantly decreased both the mRNA and the protein levels of these pro-inflammatory cytokines and inducible nitric oxide synthase (iNOS) and increased the protein levels of I kappa B-alpha, which forms a cytoplasmic inactive complex with the p65-p50 heterodimeric complex. Artemisinin treatment significantly inhibited basal and LPS-induced migration of BV-2 microglia. Electrophoretic mobility shift assays revealed increased NF-kappa B binding activity in LPS-stimulated primary microglia, and this increase could be prevented by artemisinin. The inhibitory effects of artemisinin on LPS-stimulated microglia were blocked after I kappa B-alpha was silenced with I kappa B-alpha siRNA. Our results suggest that artemisinin is able to inhibit neuroinflammation by interfering with NF-kappa B signaling. The data provide direct evidence of the potential application of artemisinin for the treatment of neuroinflammatory diseases.	[Zhu, Cansheng; Chen, Xiaohong; Peng, Fuhua; Hu, Xueqiang; Wang, Qing] Sun Yat Sen Univ, Affiliated Hosp 3, Dept Neurol, Guangzhou 510275, Guangdong, Peoples R China; [Xiong, Zhaojun] Sun Yat Sen Univ, Affiliated Hosp 3, Dept Cardiovasc Dis, Guangzhou 510275, Guangdong, Peoples R China; [Chen, Yanming] Sun Yat Sen Univ, Affiliated Hosp 3, Dept Endocrinol & Metab, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University	Zhu, CS (corresponding author), Sun Yat Sen Univ, Affiliated Hosp 3, Dept Neurol, Guangzhou 510275, Guangdong, Peoples R China.	yanmingch@qq.com; qingwangzssy@yahoo.com.cn		Wang, Qing/0000-0002-3882-6540				Akundi RS, 2005, GLIA, V51, P199, DOI 10.1002/glia.20198; Aldieri E, 2003, FEBS LETT, V552, P141, DOI 10.1016/S0014-5793(03)00905-0; Baldwin AS, 1996, ANNU REV IMMUNOL, V14, P649, DOI 10.1146/annurev.immunol.14.1.649; Barron KD, 1995, J NEUROL SCI, V134, P57, DOI 10.1016/0022-510X(95)00209-K; Carmody RJ, 2007, CELL MOL IMMUNOL, V4, P31; Choi DK, 2005, J NEUROSCI, V25, P6594, DOI 10.1523/JNEUROSCI.0970-05.2005; Dignam DJ, 1983, NUCLEIC ACIDS RES, V11, P1475; Dirscherl K, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-3; Efferth T, 2006, CURR DRUG TARGETS, V7, P407, DOI 10.2174/138945006776359412; Eikelenboom P, 2004, J NEURAL TRANSM, V111, P281, DOI 10.1007/s00702-003-0055-1; Fiebich BL, 2002, J NEUROIMMUNOL, V132, P18, DOI 10.1016/S0165-5728(02)00279-5; Graeber MB, 2010, ACTA NEUROPATHOL, V119, P89, DOI 10.1007/s00401-009-0622-0; Hashioka S, 2007, EXP NEUROL, V206, P33, DOI 10.1016/j.expneurol.2007.03.022; Haynes RK, 2001, CURR OPIN INFECT DIS, V14, P719, DOI 10.1097/00001432-200112000-00010; Karin M, 2000, ANNU REV IMMUNOL, V18, P621, DOI 10.1146/annurev.immunol.18.1.621; Kaur G, 2010, NEUROSURG CLIN N AM, V21, P43, DOI 10.1016/j.nec.2009.08.009; Koning N, 2007, ANN NEUROL, V62, P504, DOI 10.1002/ana.21220; Krause DL, 2010, INT J ALZHEIMERS DIS, V14; Le WD, 2001, J NEUROSCI, V21, P8447, DOI 10.1523/JNEUROSCI.21-21-08447.2001; Lee SM, 2004, J NEUROCHEM, V91, P568, DOI 10.1111/j.1471-4159.2004.02780.x; Liu B, 2003, J PHARMACOL EXP THER, V304, P1, DOI 10.1124/jpet.102.035048; MCGEER PL, 1993, GLIA, V7, P84, DOI 10.1002/glia.440070114; MCGEER PL, 1988, NEUROLOGY, V38, P1285, DOI 10.1212/WNL.38.8.1285; Minghetti L, 1998, PROG NEUROBIOL, V54, P99, DOI 10.1016/S0301-0082(97)00052-X; Nomura Y, 2001, LIFE SCI, V68, P1695, DOI 10.1016/S0024-3205(01)00967-5; Park JS, 2007, J PHARMACOL EXP THER, V320, P1237, DOI 10.1124/jpet.106.114322; Qian L, 2010, J NEURAL TRANSM, V117, P971, DOI 10.1007/s00702-010-0428-1; Schieven GL, 2005, CURR TOP MED CHEM, V5, P921, DOI 10.2174/1568026054985902; Ullrich O, 2001, FASEB J, V15, P1460, DOI 10.1096/fj.00-0540fje; Wang JX, 2009, ACTA PHARMACOL SIN, V30, P1428, DOI 10.1038/aps.2009.138; Wang MJ, 2002, EUR J NEUROSCI, V16, P2103, DOI 10.1046/j.1460-9568.2002.02290.x; Wang Y, 2011, INT J MOL MED, V27, P233, DOI 10.3892/ijmm.2010.580; Wang ZJ, 2007, J IMMUNOL, V179, P5958, DOI 10.4049/jimmunol.179.9.5958; Wartenberg M, 2003, LAB INVEST, V83, P1647, DOI 10.1097/01.LAB.0000098424.38003.FF; White NJ, 2004, J CLIN INVEST, V113, P1084, DOI [10.1172/JCI21682, 10.1172/JCI200421682]; Xu H, 2007, RHEUMATOLOGY, V46, P920, DOI 10.1093/rheumatology/kem014; Zielasek J, 1996, ADV NEUROIMMUNOL, V6, P191, DOI 10.1016/0960-5428(96)00017-4	37	50	51	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2012	7	4							e35125	10.1371/journal.pone.0035125	http://dx.doi.org/10.1371/journal.pone.0035125			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UT	22514713	Green Published, gold, Green Submitted			2022-12-25	WOS:000305341600119
J	Hollern, DP; Yuwanita, I; Andrechek, ER				Hollern, D. P.; Yuwanita, I.; Andrechek, E. R.			A mouse model with T58A mutations in Myc reduces the dependence on KRas mutations and has similarities to claudin- low human breast cancer	ONCOGENE			English	Article						Myc; Ras; breast cancer; mammary gland; mutation	TRANSGENIC MICE; GENE; RAS; AMPLIFICATION; PROTEIN; OVEREXPRESSION; CLASSIFICATION; TUMORIGENESIS; HETEROGENEITY; ACTIVATION	Expression of c-Myc is highly prevalent in human breast cancer and stability of the oncoprotein is regulated through Ras-regulated phosphorylation at serine 62 and threonine 58. Previous studies have illustrated the importance of accumulation of KRas mutations in Myc-mediated tumor formation. To examine Myc dependence upon Ras mutations we have generated MMTV regulated Myc and Myc T58A transgenic mice. Expression of the more stable T58A Myc allele resulted in a reduction in KRas-activating mutations. However, in a low-level expression T58A Myc transgenic, the majority of the tumors were squamous or epithelial-to-mesenchymal in nature and accumulated KRas mutations at a higher frequency. Interestingly, we show that these mice develop similar gene expression patterns and signaling pathway utilization as a subtype of human claudin-low breast cancer. Indeed, our results demonstrate a clear division in human claudin-low tumors based on Myc pathway activation and target genes. Together, our results demonstrate that Myc expression and stability has critical effects on molecular heterogeneity in mouse mammary tumors that parallel subtypes of human breast cancer. Oncogene (2013) 32, 1296-1304; doi:10.1038/onc.2012.142; published online 23 April 2012	[Hollern, D. P.; Yuwanita, I.; Andrechek, E. R.] Michigan State Univ, Dept Physiol, E Lansing, MI 48824 USA	Michigan State University	Andrechek, ER (corresponding author), Michigan State Univ, Dept Physiol, 2194 BPS Bldg, E Lansing, MI 48824 USA.	andrech1@msu.edu		Andrechek, Eran/0000-0002-8680-3423	Elsa U Pardee foundation	Elsa U Pardee foundation	A portion of this project was funded by a grant from the Elsa U Pardee foundation to ERA.	AMATI B, 1992, NATURE, V359, P423, DOI 10.1038/359423a0; Andrechek ER, 2008, DEVELOPMENT, V135, P2403, DOI 10.1242/dev.019018; Andrechek ER, 2010, J MOL MED, V88, P1095, DOI 10.1007/s00109-010-0644-z; Andrechek ER, 2009, P NATL ACAD SCI USA, V106, P16387, DOI 10.1073/pnas.0901250106; Bild AH, 2006, NATURE, V439, P353, DOI 10.1038/nature04296; Blancato J, 2004, BRIT J CANCER, V90, P1612, DOI 10.1038/sj.bjc.6601703; Carvalho CM, 2008, J AM STAT ASSOC, V103, P1438, DOI 10.1198/016214508000000869; Chrzan P, 2001, CLIN BIOCHEM, V34, P557, DOI 10.1016/S0009-9120(01)00260-0; D'Cruz CM, 2001, NAT MED, V7, P235, DOI 10.1038/84691; Deming SL, 2000, BRIT J CANCER, V83, P1688, DOI 10.1054/bjoc.2000.1522; Gatza ML, 2010, P NATL ACAD SCI USA, V107, P6994, DOI 10.1073/pnas.0912708107; Herschkowitz JI, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-r76; Herschkowitz JI, 2012, P NATL ACAD SCI USA, V109, P2778, DOI 10.1073/pnas.1018862108; Kim J, 2010, CELL, V143, P313, DOI 10.1016/j.cell.2010.09.010; Lim E, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2560; McCormack SJ, 1998, ONCOGENE, V16, P2755, DOI 10.1038/sj.onc.1201804; Nesbit CE, 1999, ONCOGENE, V18, P3004, DOI 10.1038/sj.onc.1202746; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Podsypanina K, 2008, P NATL ACAD SCI USA, V105, P5242, DOI 10.1073/pnas.0801197105; Prat A, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2635; Sears R, 2000, GENE DEV, V14, P2501, DOI 10.1101/gad.836800; Sears R, 1999, MOL CELL, V3, P169, DOI 10.1016/S1097-2765(00)80308-1; Singh A, 2009, CANCER CELL, V15, P489, DOI 10.1016/j.ccr.2009.03.022; SINN E, 1987, CELL, V49, P465, DOI 10.1016/0092-8674(87)90449-1; Sorlie T, 2003, P NATL ACAD SCI USA, V100, P8418, DOI 10.1073/pnas.0932692100; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Sotiriou C, 2003, P NATL ACAD SCI USA, V100, P10393, DOI 10.1073/pnas.1732912100; STEWART TA, 1984, CELL, V38, P627, DOI 10.1016/0092-8674(84)90257-5; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Wang XY, 2011, CANCER RES, V71, P925, DOI 10.1158/0008-5472.CAN-10-1032	30	17	19	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR 7	2013	32	10					1296	1304		10.1038/onc.2012.142	http://dx.doi.org/10.1038/onc.2012.142			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	110OP	22525269				2022-12-25	WOS:000316454500010
J	Visser, WF; Verhoeven-Duif, NM; de Koning, TJ				Visser, Wouter F.; Verhoeven-Duif, Nanda M.; de Koning, Tom J.			Identification of a Human trans-3-Hydroxy-L-proline Dehydratase, the First Characterized Member of a Novel Family of Proline Racemase-like Enzymes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							D-AMINO ACIDS; BASEMENT-MEMBRANE COLLAGEN; TRYPANOSOMA-CRUZI; D-SERINE; QUANTIFICATION; SUSCEPTIBILITY; MECHANISM	A family of eukaryotic proline racemase-like genes has recently been identified. Several members of this family have been well characterized and are known to catalyze the racemization of free proline or trans-4-hydroxyproline. However, the majority of eukaryotic proline racemase-like proteins, including a human protein called C14orf149, lack a specific cysteine residue that is known to be critical for racemase activity. Instead, these proteins invariably contain a threonine residue at this position. The function of these enzymes has remained unresolved until now. In this study, we demonstrate that three enzymes of this type, including human C14orf149, catalyze the dehydration of trans-3-hydroxy-L-proline to Delta(1)-pyrroline-2-carboxylate (Pyr2C). These are the first enzymes of this subclass of proline racemase-like genes for which the enzymatic activity has been resolved. C14orf149 is also the first human enzyme that acts on trans-3-hydroxy-L-proline. Interestingly, a mutant enzyme in which the threonine in the active site is mutated back into cysteine regained 3-hydroxyproline epimerase activity. This result suggests that the enzymatic activity of these enzymes is dictated by a single residue. Presumably, human C14orf149 serves to degrade trans-3-hydroxy-L-proline from the diet and originating from the degradation of proteins that contain this amino acid, such as collagen IV, which is an important structural component of basement membrane.	[Visser, Wouter F.; Verhoeven-Duif, Nanda M.; de Koning, Tom J.] UMC Utrecht, Dept Metab Dis, Wilhelmina Childrens Hosp Utrecht, NL-3508 AB Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center	Visser, WF (corresponding author), UMC Utrecht, Dept Metab Dis, Wilhelmina Childrens Hosp Utrecht, Huispost KC 02-069-1,Postbus 85090, NL-3508 AB Utrecht, Netherlands.	w.visser-2@umcutrecht.nl	Pinheiro, Maísa/E-7424-2012; De Koning, Tom J/AAE-1323-2020	De Koning, Tom J/0000-0001-5609-1309				ADAMS E, 1980, ANNU REV BIOCHEM, V49, P1005, DOI 10.1146/annurev.bi.49.070180.005041; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Buschiazzo A, 2006, P NATL ACAD SCI USA, V103, P1705, DOI 10.1073/pnas.0509010103; Chamond N, 2003, J BIOL CHEM, V278, P15484, DOI 10.1074/jbc.M210830200; Chamond N, 2009, MOL BIOCHEM PARASIT, V165, P170, DOI 10.1016/j.molbiopara.2009.02.002; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Fuchs SA, 2005, MOL GENET METAB, V85, P168, DOI 10.1016/j.ymgme.2005.03.003; GARWEG G, 1980, J NEUROCHEM, V35, P616, DOI 10.1111/j.1471-4159.1980.tb03700.x; Goytia M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000885; GRYDER RM, 1975, J BIOL CHEM, V250, P2470; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Kim PM, 2010, P NATL ACAD SCI USA, V107, P3175, DOI 10.1073/pnas.0914706107; Krane SM, 2008, AMINO ACIDS, V35, P703, DOI 10.1007/s00726-008-0073-2; Letunic I, 2011, NUCLEIC ACIDS RES, V39, pW475, DOI [10.1093/nar/gkr201, 10.1093/nar/gkr931]; MEISTER A, 1957, J BIOL CHEM, V229, P789; MEISTER A, 1954, J BIOL CHEM, V206, P577; MESTICHELLI LJJ, 1979, J BIOL CHEM, V254, P640; Mineharu Y, 2008, J HUM GENET, V53, P325, DOI 10.1007/s10038-008-0255-5; NAGATA Y, 1992, EXPERIENTIA, V48, P986, DOI 10.1007/BF01919147; Ozturk AK, 2006, STROKE, V37, P1021, DOI 10.1161/01.STR.0000206153.92675.b9; Patzold R, 2005, BIOMED CHROMATOGR, V19, P466, DOI 10.1002/bmc.515; RADHAKRISHNAN AN, 1957, J BIOL CHEM, V226, P559; Reina-San-Martin B, 2000, NAT MED, V6, P890, DOI 10.1038/78651; RUDNICK G, 1975, BIOCHEMISTRY-US, V14, P4515, DOI 10.1021/bi00691a028; Tiainen P, 2008, J BIOL CHEM, V283, P19432, DOI 10.1074/jbc.M802973200; Visser WF, 2011, J CHROMATOGR A, V1218, P7130, DOI 10.1016/j.chroma.2011.07.087; Vranka JA, 2004, J BIOL CHEM, V279, P23615, DOI 10.1074/jbc.M312807200; WELLNER D, 1964, BIOCHEMISTRY-US, V3, P1746, DOI 10.1021/bi00899a028; Wolosker H, 1999, P NATL ACAD SCI USA, V96, P721, DOI 10.1073/pnas.96.2.721	29	28	31	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 22	2012	287	26					21654	21662		10.1074/jbc.M112.363218	http://dx.doi.org/10.1074/jbc.M112.363218			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974GH	22528483	Green Published, hybrid			2022-12-25	WOS:000306418600008
J	Good, DW; George, T; Watts, BA				Good, David W.; George, Thampi; Watts, Bruns A., III			Toll-like Receptor 2 Is Required for LPS-induced Toll-like Receptor 4 Signaling and Inhibition of Ion Transport in Renal Thick Ascending Limb	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSEPITHELIAL HCO3-ABSORPTION; PATTERN-RECOGNITION RECEPTORS; INNATE IMMUNE-SYSTEM; NERVE GROWTH-FACTOR; CUTTING EDGE; LIPOTEICHOIC ACID; NA+/H+-EXCHANGE; LIPOPOLYSACCHARIDE-BINDING; MEDIATES INHIBITION; SEPTIC SHOCK	Previously we demonstrated that basolateral LPS inhibits HCO3- absorption in the renal medullary thick ascending limb (MTAL) through TLR4-dependent ERK activation. Here we report that the response of the MTAL to basolateral LPS requires TLR2 in addition to TLR4. The basolateral addition of LPS (ultrapure Escherichia coli K12) decreased HCO3- absorption in isolated, perfused MTALs from wild-type mice but had no effect in MTALs from TLR2(-/-) mice. In contrast, inhibition of HCO3- absorption by lumen LPS was preserved in TLR2(-/-) MTALs, indicating that TLR2 is involved specifically in mediating the basolateral LPS response. LPS also did not increase ERK phosphorylation in MTALs from TLR2(-/-) mice. TLR2 deficiency had no effect on expression of TLR4, MD-2, or MyD88. However, LPS-induced recruitment of MyD88 to the basolateral membrane was impaired in TLR2(-/-) MTALs. Inhibition of HCO3- absorption by LPS did not require CD14. Co-immuno-precipitation studies demonstrated an association between TLR4 and TLR2. Inhibition of HCO3- absorption by TLR2-specific ligands was preserved in MTALs from TLR4(-/-) mice. These results indicate that the effect of basolateral LPS to inhibit HCO3- absorption in the MTAL through MyD88-dependent ERK activation depends on a novel interaction between TLR4 and TLR2. TLR2 plays a dual role in the induction of intracellular signals that impair MTAL function, both through cooperation with TLR4 to mediate ERK signaling by LPS and through a TLR4-independent signaling pathway activated by Gram-positive bacterial ligands. Regulation of TLR2 expression and its interaction with TLR4 may provide new mechanisms for controlling and therapeutic targeting of TLR4-mediated LPS responses.	[Good, David W.] Univ Texas Med Branch, Div Nephrol, Dept Internal Med, Galveston, TX 77555 USA; [Good, David W.] Univ Texas Med Branch, Dept Neurosci & Cell Biol, Galveston, TX 77555 USA	University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston	Good, DW (corresponding author), Univ Texas Med Branch, Div Nephrol, Dept Internal Med, 4-200 John Sealy Annex,301 Univ Blvd, Galveston, TX 77555 USA.	dgood@utmb.edu			National Institutes of Health, NIDDK [DK-038217]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK038217] Funding Source: NIH RePORTER	National Institutes of Health, NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health, NIDDK, Grant DK-038217.	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Alexopoulou L, 2002, NAT MED, V8, P878, DOI 10.1038/nm732; AUSTGEN TR, 1991, ARCH SURG-CHICAGO, V126, P23; Baumgart K, 2008, CRIT CARE MED, V36, P640, DOI 10.1097/CCM.0B013E318162ED7B; Beutler B, 2005, IMMUNOGENETICS, V57, P385, DOI 10.1007/s00251-005-0011-3; Beutler B, 2000, CURR OPIN IMMUNOL, V12, P20, DOI 10.1016/S0952-7915(99)00046-1; Brightbill HD, 1999, SCIENCE, V285, P732, DOI 10.1126/science.285.5428.732; Brown HJ, 2006, J IMMUNOL, V177, P1925, DOI 10.4049/jimmunol.177.3.1925; Chowdhury P, 2006, CLIN EXP IMMUNOL, V145, P346, DOI 10.1111/j.1365-2249.2006.03116.x; Cohen J, 2002, NATURE, V420, P885, DOI 10.1038/nature01326; Dixon DR, 2005, J DENT RES, V84, P584, DOI 10.1177/154405910508400702; Doi K, 2009, J CLIN INVEST, V119, P2868, DOI 10.1172/JCI39421; Ecelbarger CA, 1996, AM J PHYSIOL-RENAL, V271, pF619, DOI 10.1152/ajprenal.1996.271.3.F619; El-Achkar TM, 2008, EUR J CLIN INVEST, V38, P39, DOI 10.1111/j.1365-2362.2008.02007.x; Gomez J, 2007, EUR J CLIN MICROBIOL, V26, P239, DOI 10.1007/s10096-007-0272-x; Good DW, 2008, J BIOL CHEM, V283, P26602, DOI 10.1074/jbc.M803019200; Good DW, 2011, AM J PHYSIOL-RENAL, V301, pF334, DOI 10.1152/ajprenal.00106.2011; Good DW, 2010, AM J PHYSIOL-RENAL, V299, pF536, DOI 10.1152/ajprenal.00108.2010; Good DW, 2009, AM J PHYSIOL-RENAL, V297, pF866, DOI 10.1152/ajprenal.00335.2009; Good DW, 2004, AM J PHYSIOL-RENAL, V287, pF1244, DOI 10.1152/ajprenal.00176.2004; GOOD DW, 1990, J CLIN INVEST, V85, P1006, DOI 10.1172/JCI114530; Good DW, 2000, AM J PHYSIOL-CELL PH, V279, pC1443, DOI 10.1152/ajpcell.2000.279.5.C1443; Grinevich V, 2004, KIDNEY INT, V65, P54, DOI 10.1111/j.1523-1755.2004.00378.x; Hajjar AM, 2001, J IMMUNOL, V166, P15, DOI 10.4049/jimmunol.166.1.15; HAZIOT A, 1988, J IMMUNOL, V141, P547; Heine H, 1999, J IMMUNOL, V162, P6971; Hirschfeld M, 2001, INFECT IMMUN, V69, P1477, DOI 10.1128/IAI.69.3.1477-1482.2001; Hirschfeld M, 2000, J IMMUNOL, V165, P618, DOI 10.4049/jimmunol.165.2.618; Hoshino K, 1999, J IMMUNOL, V162, P3749; Kawai T, 2006, CELL DEATH DIFFER, V13, P816, DOI 10.1038/sj.cdd.4401850; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Kellum JA, 2004, CHEST, V125, P243, DOI 10.1378/chest.125.1.243; Kim GH, 1999, J AM SOC NEPHROL, V10, P935; Klenzak J, 2005, CRIT CARE CLIN, V21, P211, DOI 10.1016/j.ccc.2005.01.002; Kraut JA, 2001, AM J KIDNEY DIS, V38, P703, DOI 10.1053/ajkd.2001.27688; Laghmani K, 1997, J CLIN INVEST, V99, P24, DOI 10.1172/JCI119128; Lee HK, 2004, J BIOL CHEM, V279, P10564, DOI 10.1074/jbc.M311564200; LEE JD, 1992, J EXP MED, V175, P1697, DOI 10.1084/jem.175.6.1697; Lee MS, 2007, ANNU REV BIOCHEM, V76, P447, DOI 10.1146/annurev.biochem.76.060605.122847; Lee SW, 2008, EMERG MED J, V25, P659, DOI 10.1136/emj.2007.055558; Leemans JC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005704; Levy EM, 1996, JAMA-J AM MED ASSOC, V275, P1489, DOI 10.1001/jama.275.19.1489; Lien E, 2002, CRIT CARE MED, V30, pS1, DOI 10.1097/00003246-200201001-00001; Lim SW, 2005, TRANSPLANTATION, V80, P691, DOI 10.1097/01.tp.0000173594.69089.a0; Lotze MT, 2005, NAT REV IMMUNOL, V5, P331, DOI 10.1038/nri1594; Manukyan M, 2005, EUR J IMMUNOL, V35, P911, DOI 10.1002/eji.200425336; Morr M, 2002, EUR J IMMUNOL, V32, P3337, DOI 10.1002/1521-4141(2002012)32:12<3337::AID-IMMU3337>3.0.CO;2-I; Nagai Y, 2002, NAT IMMUNOL, V3, P667, DOI 10.1038/ni809; Olesen ETB, 2009, NEPHROL DIAL TRANSPL, V24, P2338, DOI 10.1093/ndt/gfp011; Oppert M, 2008, NEPHROL DIAL TRANSPL, V23, P904, DOI 10.1093/ndt/gfm610; Ozinsky A, 2000, P NATL ACAD SCI USA, V97, P13766, DOI 10.1073/pnas.250476497; Pfeiffer A, 2001, EUR J IMMUNOL, V31, P3153, DOI 10.1002/1521-4141(200111)31:11<3153::AID-IMMU3153>3.0.CO;2-0; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Prohinar P, 2007, J BIOL CHEM, V282, P1010, DOI 10.1074/jbc.M609400200; Qureshi ST, 1999, J EXP MED, V189, P615, DOI 10.1084/jem.189.4.615; Russell JA, 2000, CRIT CARE MED, V28, P3405, DOI 10.1097/00003246-200010000-00005; Sandor F, 2003, J CELL BIOL, V162, P1099, DOI 10.1083/jcb.200304093; Schmidt C, 2007, AM J PHYSIOL-RENAL, V292, pF804, DOI 10.1152/ajprenal.00258.2006; Schrier RW, 2004, NEW ENGL J MED, V351, P159, DOI 10.1056/NEJMra032401; Schroder NWJ, 2003, J BIOL CHEM, V278, P15587, DOI 10.1074/jbc.M212829200; Schromm AB, 2001, J EXP MED, V194, P79, DOI 10.1084/jem.194.1.79; Schwandner R, 1999, J BIOL CHEM, V274, P17406, DOI 10.1074/jbc.274.25.17406; Shigeoka AA, 2007, J IMMUNOL, V178, P6252, DOI 10.4049/jimmunol.178.10.6252; Shimazu R, 1999, J EXP MED, V189, P1777, DOI 10.1084/jem.189.11.1777; Takeuchi O, 2000, J IMMUNOL, V165, P5392, DOI 10.4049/jimmunol.165.10.5392; Takeuchi O, 2002, J IMMUNOL, V169, P10, DOI 10.4049/jimmunol.169.1.10; Takeuchi O, 2001, INT IMMUNOL, V13, P933, DOI 10.1093/intimm/13.7.933; Takeuchi O, 1999, IMMUNITY, V11, P443, DOI 10.1016/S1074-7613(00)80119-3; Tapping RI, 2003, J ENDOTOXIN RES, V9, P264, DOI 10.1179/096805103225001477; Triantafilou K, 2001, NAT IMMUNOL, V2, P338, DOI 10.1038/86342; Triantafilou M, 2004, J BIOL CHEM, V279, P40882, DOI 10.1074/jbc.M400466200; Triantafilou M, 2004, BIOCHEM J, V381, P527, DOI 10.1042/BJ20040172; Triantafilou M, 2002, J CELL SCI, V115, P2603; Vabulas RM, 2001, J BIOL CHEM, V276, P31332, DOI 10.1074/jbc.M103217200; Visintin A, 2003, J BIOL CHEM, V278, P48313, DOI 10.1074/jbc.M306802200; Wang WD, 2008, AM J PHYSIOL-RENAL, V294, pF1473, DOI 10.1152/ajprenal.00036.2008; Watts B. A., 2011, J AM SOC NEPHROL, V22, p80A; Watts BA, 2005, J BIOL CHEM, V280, P11439, DOI 10.1074/jbc.M410719200; Watts BA, 2002, AM J PHYSIOL-RENAL, V282, pF1056, DOI 10.1152/ajprenal.00133.2001; Watts BA, 2006, AM J PHYSIOL-RENAL, V291, pF1005, DOI 10.1152/ajprenal.00507.2005; Watts BA, 2011, AM J PHYSIOL-CELL PH, V301, pC1296, DOI 10.1152/ajpcell.00237.2011; Werts C, 2001, NAT IMMUNOL, V2, P346, DOI 10.1038/86354; WRIGHT SD, 1995, J IMMUNOL, V155, P6; Wu HL, 2007, J CLIN INVEST, V117, P2847, DOI 10.1172/JCI31008; Yang LE, 2008, AM J PHYSIOL-RENAL, V295, pF1003, DOI 10.1152/ajprenal.90235.2008; Yoshimura A, 1999, J IMMUNOL, V163, P1; Zhang BZ, 2008, J AM SOC NEPHROL, V19, P923, DOI 10.1681/ASN.2007090982	87	52	57	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 8	2012	287	24					20208	20220		10.1074/jbc.M111.336255	http://dx.doi.org/10.1074/jbc.M111.336255			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974FB	22523073	Green Published, hybrid			2022-12-25	WOS:000306414500041
J	Liu, XD; Ko, S; Xu, Y; Fattah, EA; Xiang, Q; Jagannath, C; Ishii, T; Komatsu, M; Eissa, NT				Liu, Xian-De; Ko, Soyoung; Xu, Yi; Fattah, Elmoataz Abdel; Xiang, Qian; Jagannath, Chinnaswamy; Ishii, Tetsuro; Komatsu, Masaaki; Eissa, N. Tony			Transient Aggregation of Ubiquitinated Proteins Is a Cytosolic Unfolded Protein Response to Inflammation and Endoplasmic Reticulum Stress	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR NRF2; AUTOPHAGY-DEFICIENT MICE; QUALITY-CONTROL; P62; DEGRADATION; MACROPHAGES; P62/SQSTM1; ACTIVATION; CELLS; COMPARTMENTS	Failure to maintain protein homeostasis (proteostasis) leads to accumulation of unfolded proteins and contributes to the pathogenesis of many human diseases. Accumulation of unfolded proteins in the endoplasmic reticulum (ER) elicits unfolded protein response (UPR) that serves to attenuate protein translation, and increase protein refolding or degradation. In contrast to UPR in the ER, the regulatory molecules operative in cytosolic responses and their potential relation to ER stress are not well elucidated. Aggresome-like induced structures (ALIS) have been described as transient aggregation of ubiquitinated proteins in the cytosol. In this study, we show that cells respond to inflammation, infection or ER stress by cytosolic formation of ALIS, indicating that ALIS formation represents an early event in cellular adjustment to altered proteostasis that occurs under these conditions. This response was aided by rapid transcriptional up-regulation of polyubiqutin-binding protein p62. NF-kappa B and mTOR activation were also required for ALIS formation. Importantly, we show a cross talk between UPR in the ER and cytosolic ALIS. Down-regulation of ER UPR in XBP1 deficient cells increases cyotosolic ALIS formation. Furthermore, lysosomal activity but not macroautophagy is responsible for ALIS clearance. This study reveals the underlying regulatory mechanisms of ALIS formation and clearance, and provides a previously unrecognized common adaptive mechanism for cellular responses against inflammation and ER stress.	[Liu, Xian-De; Ko, Soyoung; Xu, Yi; Fattah, Elmoataz Abdel; Xiang, Qian; Eissa, N. Tony] Baylor Coll Med, Dept Med, Houston, TX 77030 USA; [Jagannath, Chinnaswamy] Univ Texas Hlth Sci Ctr, Dept Pathol & Lab Med, Houston, TX 77030 USA; [Ishii, Tetsuro] Univ Tsukuba, Tsukuba, Ibaraki 3058575, Japan; [Komatsu, Masaaki] Tokyo Metropolitan Inst Med Sci, Tokyo 156850, Japan	Baylor College of Medicine; University of Texas System; University of Texas Health Science Center Houston; University of Tsukuba; Tokyo Metropolitan Institute of Medical Science	Eissa, NT (corresponding author), Baylor Coll Med, Dept Med, 1 Baylor Plaza,BCM 285 Suite 535E, Houston, TX 77030 USA.	teissa@bcm.edu	Komatsu, Masaaki/B-8321-2011	Komatsu, Masaaki/0000-0001-7672-7722; Liu, xiande/0000-0002-9639-0458	NHLBI; NIAID; National Institutes of Health; American Heart Association	NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association)	This work was supported, in whole or in part, by NHLBI and NIAID, National Institutes of Health and the American Heart Association.	Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Aoki H, 2008, AUTOPHAGY, V4, P467, DOI 10.4161/auto.5668; Bjorkoy G, 2005, J CELL BIOL, V171, P603, DOI 10.1083/jcb.200507002; Buchberger A, 2010, MOL CELL, V40, P238, DOI 10.1016/j.molcel.2010.10.001; Canadien V, 2005, J IMMUNOL, V174, P2471, DOI 10.4049/jimmunol.174.5.2471; Collins CA, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000430; Conn CS, 2011, CELL CYCLE, V10, P1940, DOI 10.4161/cc.10.12.15858; Feldman ME, 2009, PLOS BIOL, V7, P371, DOI 10.1371/journal.pbio.1000038; Fujita KI, 2011, P NATL ACAD SCI USA, V108, P1427, DOI 10.1073/pnas.1014156108; Ganley IG, 2011, MOL CELL, V42, P731, DOI 10.1016/j.molcel.2011.04.024; Hara T, 2006, NATURE, V441, P885, DOI 10.1038/nature04724; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Hotamisligil GS, 2010, CELL, V140, P900, DOI 10.1016/j.cell.2010.02.034; Ishii T, 2000, J BIOL CHEM, V275, P16023, DOI 10.1074/jbc.275.21.16023; Jagannath C, 2009, NAT MED, V15, P267, DOI 10.1038/nm.1928; Jain A, 2010, J BIOL CHEM, V285, P22576, DOI 10.1074/jbc.M110.118976; Jarosch E, 2002, TRAFFIC, V3, P530, DOI 10.1034/j.1600-0854.2002.30803.x; Kaganovich D, 2008, NATURE, V454, P1088, DOI 10.1038/nature07195; Klionsky DJ, 2008, AUTOPHAGY, V4, P849, DOI 10.4161/auto.6845; Komatsu M, 2007, CELL, V131, P1149, DOI 10.1016/j.cell.2007.10.035; Komatsu M, 2006, NATURE, V441, P880, DOI 10.1038/nature04723; Lelouard H, 2004, J CELL BIOL, V164, P667, DOI 10.1083/jcb.200312073; Lelouard H, 2002, NATURE, V417, P177, DOI 10.1038/417177a; Ling JH, 2012, CANCER CELL, V21, P105, DOI 10.1016/j.ccr.2011.12.006; Martinon F, 2010, NAT IMMUNOL, V11, P411, DOI 10.1038/ni.1857; Moscat J, 2009, CELL, V137, P1001, DOI 10.1016/j.cell.2009.05.023; Mu TW, 2008, CELL, V134, P769, DOI 10.1016/j.cell.2008.06.037; Nagaoka U, 2004, J NEUROCHEM, V91, P57, DOI 10.1111/j.1471-4159.2004.02692.x; Nishida Y, 2009, NATURE, V461, P654, DOI 10.1038/nature08455; O'Neill LAJ, 2007, NAT REV IMMUNOL, V7, P353, DOI 10.1038/nri2079; Okazaki M, 1999, GENOMICS, V60, P87, DOI 10.1006/geno.1999.5902; Okiyoneda T, 2010, SCIENCE, V329, P805, DOI 10.1126/science.1191542; Pandit L, 2009, P NATL ACAD SCI USA, V106, P1211, DOI 10.1073/pnas.0810968106; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Ponpuak M, 2010, IMMUNITY, V32, P329, DOI 10.1016/j.immuni.2010.02.009; Raasi S, 2005, NAT STRUCT MOL BIOL, V12, P708, DOI 10.1038/nsmb962; Ribes S, 2010, INFECT IMMUN, V78, P865, DOI 10.1128/IAI.01110-09; Riley BE, 2010, J CELL BIOL, V191, P537, DOI 10.1083/jcb.201005012; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Seibenhener ML, 2004, MOL CELL BIOL, V24, P8055, DOI 10.1128/MCB.24.18.8055-8068.2004; Szeto J, 2006, AUTOPHAGY, V2, P189, DOI 10.4161/auto.2731; Takeda K, 2004, SEMIN IMMUNOL, V16, P3, DOI 10.1016/j.smim.2003.10.003; TRAENCKNER EBM, 1995, EMBO J, V14, P2876, DOI 10.1002/j.1460-2075.1995.tb07287.x; Waza M, 2005, NAT MED, V11, P1088, DOI 10.1038/nm1298; Woo CW, 2009, NAT CELL BIOL, V11, P1473, DOI 10.1038/ncb1996; Xu Y, 2007, IMMUNITY, V27, P135, DOI 10.1016/j.immuni.2007.05.022; Yu K, 2009, CANCER RES, V69, P6232, DOI 10.1158/0008-5472.CAN-09-0299; Zhang J, 2009, BLOOD, V114, P157, DOI 10.1182/blood-2008-04-151639	48	70	72	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 1	2012	287	23					19687	19698		10.1074/jbc.M112.350934	http://dx.doi.org/10.1074/jbc.M112.350934			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974EF	22518844	Green Published, hybrid			2022-12-25	WOS:000306411900079
J	Qu, XP; Zhuang, GL; Yu, LL; Meng, G; Ferrara, N				Qu, Xueping; Zhuang, Guanglei; Yu, Lanlan; Meng, Gloria; Ferrara, Napoleone			Induction of Bv8 Expression by Granulocyte Colony-stimulating Factor in CD11b(+)Gr1(+) Cells KEY ROLE OF Stat3 SIGNALING	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOTHELIAL GROWTH-FACTOR; DEPENDENT TUMOR ANGIOGENESIS; PROTEIN-COUPLED RECEPTORS; PROGENITOR CELLS; MYELOID CELLS; CANCER; IDENTIFICATION; INFLAMMATION; MOBILIZATION; ACTIVATION	Bv8, also known as prokineticin 2, has been characterized as an important mediator of myeloid cell mobilization and myeloid cell-dependent tumor angiogenesis. Bv8 expression is dramatically enhanced by G-CSF, both in vitro and in vivo. The mechanisms involved in such up-regulation remain unknown. Using pharmacological inhibitors that interfere with multiple signaling pathways known to be activated by G-CSF, we show that signal transducer and activator of transcription 3 (Stat3) activation is required for Bv8 up-regulation in mouse bone marrow cells, whereas other Stat family members and extracellular signal-regulated kinase (ERK) activation are not involved. We further identified CD11b(+) Gr1(+) myeloid cells as the primary cell population in which Stat3 signaling is activated by G-CSF. Bv8 expression induced by G-CSF was also significantly reduced by siRNA-mediated Stat3 knockdown. Moreover, chromatin immunoprecipitation studies indicate that G-CSF significantly induces binding of phospho-Stat3 to the Bv8 promoter, which was abolished by pretreatment with the Stat3 inhibitor WP1066. Luciferase assay confirmed that the phospho-Stat3 binding site is a functional enhancer of the Bv8 promoter. The key role of Stat3 signaling in regulating G-CSF-induced Bv8 expression was further confirmed by in vivo studies. We show that the regulation of Bv8 expression in human bone marrow cells is also Stat3 signaling-dependent. Stat3 is recognized as a key regulator of inflammation-dependent tumorigenesis. We propose that such a role of Stat3 reflects at least in part its ability to regulate Bv8 expression.	[Qu, Xueping; Zhuang, Guanglei; Yu, Lanlan; Meng, Gloria; Ferrara, Napoleone] Genentech Inc, San Francisco, CA 94080 USA	Roche Holding; Genentech	Ferrara, N (corresponding author), Genentech Inc, 1 DNA Way, San Francisco, CA 94080 USA.	nf@gene.com	Zhuang, Guanglei/K-6097-2013	Zhuang, Guanglei/0000-0001-8141-5096				Avalos BR, 1996, BLOOD, V88, P761, DOI 10.1182/blood.V88.3.761.bloodjournal883761; Belvin M., 2011, U. S. Patent, Patent No. [20,110,086,837, 20110086837]; Bollrath J, 2009, CANCER CELL, V15, P91, DOI 10.1016/j.ccr.2009.01.002; Carmeliet P, 2003, NAT MED, V9, P653, DOI 10.1038/nm0603-653; Cheng MY, 2002, NATURE, V417, P405, DOI 10.1038/417405a; Christopher MJ, 2007, CURR OPIN HEMATOL, V14, P3, DOI 10.1097/00062752-200701000-00003; Chung AS, 2010, NAT REV CANCER, V10, P505, DOI 10.1038/nrc2868; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Ferrara N, 2004, ENDOCR REV, V25, P581, DOI 10.1210/er.2003-0027; Ferrara N, 2007, ANNU REV MED, V58, P491, DOI 10.1146/annurev.med.58.061705.145635; Fremin C, 2010, J HEMATOL ONCOL, V3, DOI 10.1186/1756-8722-3-8; Gabrilovich DI, 2009, NAT REV IMMUNOL, V9, P162, DOI 10.1038/nri2506; Giannini E, 2009, P NATL ACAD SCI USA, V106, P14646, DOI 10.1073/pnas.0903720106; Iwamaru A, 2007, ONCOGENE, V26, P2435, DOI 10.1038/sj.onc.1210031; Johnston S., 2007, AACR NCI EORTC S MOL; Kamezaki K, 2005, STEM CELLS, V23, P252, DOI 10.1634/stemcells.2004-0173a; Karnoub AE, 2007, NATURE, V449, P557, DOI 10.1038/nature06188; Kerbel RS, 2008, NEW ENGL J MED, V358, P2039, DOI 10.1056/NEJMra0706596; Kortylewski M, 2009, CANCER CELL, V15, P114, DOI 10.1016/j.ccr.2008.12.018; Kowanetz M, 2010, P NATL ACAD SCI USA, V107, P21248, DOI 10.1073/pnas.1015855107; Kujawski M, 2008, J CLIN INVEST, V118, P3367, DOI 10.1172/JCI35213; LeCouter J, 2004, P NATL ACAD SCI USA, V101, P16813, DOI 10.1073/pnas.0407697101; LeCouter J, 2003, P NATL ACAD SCI USA, V100, P2685, DOI 10.1073/pnas.0337667100; LeCouter J, 2001, NATURE, V412, P877, DOI 10.1038/35091000; Li M, 2001, MOL PHARMACOL, V59, P692, DOI 10.1124/mol.59.4.692; Lin DCH, 2002, J BIOL CHEM, V277, P19276, DOI 10.1074/jbc.M202139200; Lin WW, 2007, J CLIN INVEST, V117, P1175, DOI 10.1172/JCI31537; Masuda Y, 2002, BIOCHEM BIOPH RES CO, V293, P396, DOI 10.1016/S0006-291X(02)00239-5; McLemore ML, 2001, IMMUNITY, V14, P193, DOI 10.1016/S1074-7613(01)00101-7; Melchiorri D, 2001, EUR J NEUROSCI, V13, P1694, DOI 10.1046/j.1460-9568.2001.01549.x; Meraz MA, 1996, CELL, V84, P431, DOI 10.1016/S0092-8674(00)81288-X; Mollay C, 1999, EUR J PHARMACOL, V374, P189, DOI 10.1016/S0014-2999(99)00229-0; Natori T, 2002, BIOCHEM BIOPH RES CO, V297, P1058, DOI 10.1016/S0006-291X(02)02335-5; NICHOLSON SE, 1995, BLOOD, V86, P3698, DOI 10.1182/blood.V86.10.3698.bloodjournal86103698; Okazaki T, 2006, INT IMMUNOL, V18, P1, DOI 10.1093/intimm/dxh334; Orimo A, 2006, CELL CYCLE, V5, P1597, DOI 10.4161/cc.5.15.3112; Shaked Y, 2009, BBA-REV CANCER, V1796, P1, DOI 10.1016/j.bbcan.2009.07.002; Shojaei F, 2008, TRENDS CELL BIOL, V18, P372, DOI 10.1016/j.tcb.2008.06.003; Shojaei F, 2008, P NATL ACAD SCI USA, V105, P2640, DOI 10.1073/pnas.0712185105; Shojaei F, 2007, NATURE, V450, P825, DOI 10.1038/nature06348; Shojaei F, 2007, NAT BIOTECHNOL, V25, P911, DOI 10.1038/nbt1323; Shojaei F, 2009, P NATL ACAD SCI USA, V106, P6742, DOI 10.1073/pnas.0902280106; Smith TJ, 2006, J CLIN ONCOL, V24, P3187, DOI 10.1200/JCO.2006.06.4451; Takeda K, 1996, NATURE, V380, P627, DOI 10.1038/380627a0; Teglund S, 1998, CELL, V93, P841, DOI 10.1016/S0092-8674(00)81444-0; Thierfelder WE, 1996, NATURE, V382, P171, DOI 10.1038/382171a0; TIAN SS, 1994, BLOOD, V84, P1760; Voloshin T, 2011, BLOOD, V118, P3426, DOI 10.1182/blood-2010-11-320812; Yu H, 2009, NAT REV CANCER, V9, P798, DOI 10.1038/nrc2734; Zhong CL, 2009, CLIN CANCER RES, V15, P2675, DOI 10.1158/1078-0432.CCR-08-1954	50	58	61	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 1	2012	287	23					19574	19584		10.1074/jbc.M111.326801	http://dx.doi.org/10.1074/jbc.M111.326801			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974EF	22528488	hybrid, Green Published			2022-12-25	WOS:000306411900069
J	Lech, GP; Reigh, RC				Lech, Gregory P.; Reigh, Robert C.			Plant Products Affect Growth and Digestive Efficiency of Cultured Florida Pompano (Trachinotus carolinus) Fed Compounded Diets	PLOS ONE			English	Article							APPARENT DIGESTIBILITY COEFFICIENTS; JUVENILE JAPANESE FLOUNDER; AMINO-ACID AVAILABILITY; SOY PROTEIN-CONCENTRATE; RED-SEA BREAM; FEED INGREDIENTS; FISH-MEAL; SOYBEAN-MEAL; CANOLA-MEAL; PARTIAL REPLACEMENT	Costs of compounded diets containing fish meal as a primary protein source can be expected to rise as fish meal prices increase in response to static supply and growing demand. Alternatives to fish meal are needed to reduce production costs in many aquaculture enterprises. Some plant proteins are potential replacements for fish meal because of their amino acid composition, lower cost and wide availability. In this study, we measured utilization of soybean meal (SBM) and soy protein concentrate (SPC) by Florida pompano fed compounded diets, to determine the efficacy of these products as fish meal replacements. We also calculated apparent digestibility coefficients (ADCs) for canola meal (CM), corn gluten meal (CGM), and distillers dried grains with solubles (DDGS), following typical methods for digestibility trials. Juvenile Florida pompano were fed fish-meal-free diets containing graded levels of SBM and SPC, and weight gain was compared to a control diet that contained SBM, SPC, and fish meal. Fish fed diets that contained 25-30 percent SBM in combination with 43-39 percent SPC had weight gain equivalent to fish fed the control diet with fish meal, while weight gain of fish fed other soy combinations was significantly less than that of the control group. Apparent crude protein digestibility of CGM was significantly higher than that of DDGS but not significantly different from CM. Apparent energy digestibility of DDGS was significantly lower than CGM but significantly higher than CM. Findings suggested that composition of the reference diet used in a digestibility trial affects the values of calculated ADCs, in addition to the chemical and physical attributes of the test ingredient.	[Lech, Gregory P.; Reigh, Robert C.] Louisiana State Univ, Ctr Agr, Aquaculture Res Stn, Baton Rouge, LA 70803 USA	Louisiana State University System; Louisiana State University	Reigh, RC (corresponding author), Louisiana State Univ, Ctr Agr, Aquaculture Res Stn, Baton Rouge, LA 70803 USA.	rreigh@agcenter.lsu.edu			National Oceanic and Atmospheric Administration [NA08OAR4170840]; Louisiana Agricultural Experiment Station [LAB94014]	National Oceanic and Atmospheric Administration(National Oceanic Atmospheric Admin (NOAA) - USA); Louisiana Agricultural Experiment Station	This research was funded in part by Grant Number NA08OAR4170840 from the National Oceanic and Atmospheric Administration (www.noaa.gov) Marine Aquaculture Research program to RCR, with additional support from the Louisiana Agricultural Experiment Station under Project LAB94014. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allan GL, 2000, AQUACULTURE, V186, P293, DOI 10.1016/S0044-8486(99)00380-4; ANDERSON JS, 1992, AQUACULTURE, V108, P111, DOI 10.1016/0044-8486(92)90322-C; AUSTRENG E, 1978, AQUACULTURE, V13, P265, DOI 10.1016/0044-8486(78)90008-X; Biswas AK, 2007, AQUACULTURE, V267, P284, DOI 10.1016/j.aquaculture.2007.01.014; Bonaldo A, 2006, AQUACULTURE, V261, P580, DOI 10.1016/j.aquaculture.2006.08.013; Burel C, 2000, AQUACULTURE, V188, P285, DOI 10.1016/S0044-8486(00)00337-9; Burel C., 2008, ALTERNATIVE PROTEIN, P343; Burr GS, 2012, AQUACULTURE, V334, P110, DOI 10.1016/j.aquaculture.2011.12.044; Chatzifotis S, 2008, AQUACULTURE, V275, P201, DOI 10.1016/j.aquaculture.2007.12.013; Cheng Z. J., 2004, Journal of Applied Aquaculture, V15, P101, DOI 10.1300/J028v15n03_08; Cheng ZJJ, 2003, AQUACULT NUTR, V9, P77, DOI 10.1046/j.1365-2095.2003.00226.x; Cho C Y, 1990, World Rev Nutr Diet, V61, P132; CHO CY, 1982, COMP BIOCHEM PHYS B, V73, P25, DOI 10.1016/0305-0491(82)90198-5; Deng JM, 2006, AQUACULTURE, V258, P503, DOI 10.1016/j.aquaculture.2006.04.004; Denstadli V, 2006, AQUACULTURE, V256, P365, DOI 10.1016/j.aquaculture.2006.02.021; Erdogan F, 2010, J ANIM VET ADV, V9, P831, DOI 10.3923/javaa.2010.831.836; FAO, 2011, 5001 FAO UN; Forster I, 1999, AQUACULT NUTR, V5, P143, DOI 10.1046/j.1365-2095.1999.00082.x; Francis G, 2001, AQUACULTURE, V199, P197, DOI 10.1016/S0044-8486(01)00526-9; Gatlin DM, 2007, AQUAC RES, V38, P551, DOI 10.1111/j.1365-2109.2007.01704.x; Glencross B, 2004, AQUAC RES, V35, P15, DOI 10.1111/j.1365-2109.2004.00974.x; Glencross BD, 2007, AQUACULT NUTR, V13, P17, DOI 10.1111/j.1365-2095.2007.00450.x; Gonzalez-Felix ML, 2010, AQUACULTURE, V310, P240, DOI 10.1016/j.aquaculture.2010.10.016; Gothreaux C.T., 2008, THESIS LOUISIANA STA; Gothreaux CT, 2010, N AM J AQUACULT, V72, P309, DOI 10.1577/A09-079.1; HAJEN WE, 1993, AQUACULTURE, V112, P333, DOI 10.1016/0044-8486(93)90394-E; Halver JE, 2002, FISH NUTR, P780; Hansen AC, 2007, AQUACULTURE, V272, P599, DOI 10.1016/j.aquaculture.2007.08.034; Horwitz W., 2002, GAITHERSBERGOFFICIAL; Kader MA, 2010, AQUACULTURE, V308, P136, DOI 10.1016/j.aquaculture.2010.07.037; Khan MA, 2003, AQUACULT NUTR, V9, P391, DOI 10.1046/j.1365-2095.2003.00268.x; Kissil GW, 2000, AQUAC RES, V31, P595, DOI 10.1046/j.1365-2109.2000.00477.x; Krogdahl A, 2010, AQUAC RES, V41, P333, DOI 10.1111/j.1365-2109.2009.02426.x; Landero JL, 2011, ANIM FEED SCI TECH, V170, P136, DOI 10.1016/j.anifeedsci.2011.08.003; Lazo JP, 1998, AQUACULTURE, V169, P225, DOI 10.1016/S0044-8486(98)00384-6; Lee SM, 2002, AQUACULTURE, V207, P79, DOI 10.1016/S0044-8486(01)00751-7; Matsunari H, 2008, AQUACULTURE, V274, P142, DOI 10.1016/j.aquaculture.2007.11.002; McGoogan BB, 1996, AQUACULTURE, V141, P233, DOI 10.1016/0044-8486(95)01217-6; Muirhead S, 2011, FEEDSTUFFS WEEK 1212; National Research Council, 2011, NUTR REQ FISH SHRIMP; National Research Council, 1993, NUTR REQ FISH; Park GS, 2002, FISHERIES SCI, V68, P824, DOI 10.1046/j.1444-2906.2002.00498.x; Pereira TG, 2003, AQUAC RES, V34, P1111, DOI 10.1046/j.1365-2109.2003.00909.x; Peres H, 2008, ALTERNATIVE PROTEIN, P281; Riche M, 2010, AQUACULT NUTR, V16, P223, DOI 10.1111/j.1365-2095.2009.00654.x; Riche M, 2009, J WORLD AQUACULT SOC, V40, P45, DOI 10.1111/j.1749-7345.2008.00234.x; Sajjadi M, 2004, AQUACULTURE, V240, P417, DOI 10.1016/j.aquaculture.2004.07.003; Salze G, 2010, AQUACULTURE, V298, P294, DOI 10.1016/j.aquaculture.2009.11.003; SMITH RR, 1980, PROG FISH CULT, V42, P195, DOI 10.1577/1548-8659(1980)42[195:EOLOAD]2.0.CO;2; Sugiura SH, 1998, AQUACULTURE, V159, P177, DOI 10.1016/S0044-8486(97)00177-4; Sullivan JA, 1995, AQUACULTURE, V138, P313, DOI 10.1016/0044-8486(95)01071-8; Takagi S, 2008, AQUACULTURE, V280, P198, DOI 10.1016/j.aquaculture.2008.05.012; Takagi S, 2010, FISHERIES SCI, V76, P119, DOI 10.1007/s12562-009-0185-y; Tibbetts SM, 2006, AQUACULTURE, V261, P1314, DOI 10.1016/j.aquaculture.2006.08.052; Tibbetts SM, 2004, AQUAC RES, V35, P643, DOI 10.1111/j.1365-2109.2004.01060.x; Walker AB, 2010, N AM J AQUACULT, V72, P343, DOI 10.1577/A09-085.1; Webster C.D., 2008, ALTERNATIVE PROTEIN, P475; Weirich CR, 2006, N AM J AQUACULT, V68, P330, DOI 10.1577/A05-082.1; Williams T.N., 2008, THESIS U MAINE ORONO; Zhao H, 2010, AQUACULT NUTR, V16, P648, DOI 10.1111/j.1365-2095.2009.00708.x; Zhou P, 2010, N AM J AQUACULT, V72, P298, DOI 10.1577/A10-002.1; Zhou QC, 2004, AQUACULTURE, V241, P441, DOI 10.1016/j.aquaculture.2004.08.044	62	45	50	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2012	7	4							e34981	10.1371/journal.pone.0034981	http://dx.doi.org/10.1371/journal.pone.0034981			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UD	22536344	Green Submitted, Green Published, gold			2022-12-25	WOS:000305339200030
J	Chen, YQ; Cao, LY; Zhong, MH; Zhang, Y; Han, C; Li, QL; Yang, JY; Zhou, DH; Shi, W; He, BX; Liu, F; Yu, J; Sun, Y; Cao, Y; Li, YM; Li, WX; Guo, DY; Cao, ZJ; Yan, HM				Chen, Yaoqing; Cao, Luyang; Zhong, Maohua; Zhang, Yan; Han, Chen; Li, Qiaoli; Yang, Jingyi; Zhou, Dihan; Shi, Wei; He, Benxia; Liu, Fang; Yu, Jie; Sun, Ying; Cao, Yuan; Li, Yaoming; Li, Wenxin; Guo, Deying; Cao, Zhijian; Yan, Huimin			Anti-HIV-1 Activity of a New Scorpion Venom Peptide Derivative Kn2-7	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; ANTIMICROBIAL PEPTIDES; HIV-1 INFECTION; ANTIVIRAL ACTIVITY; CATIONIC PEPTIDES; NEUTRALIZING ANTIBODIES; VIRUCIDAL ACTIVITY; DOUBLE-BLIND; MICROBICIDES; VACCINE	For over 30 years, HIV/AIDS has wreaked havoc in the world. In the absence of an effective vaccine for HIV, development of new anti-HIV agents is urgently needed. We previously identified the antiviral activities of the scorpion-venom-peptide-derived mucroporin-M1 for three RNA viruses (measles viruses, SARS-CoV, and H5N1). In this investigation, a panel of scorpion venom peptides and their derivatives were designed and chosen for assessment of their anti-HIV activities. A new scorpion venom peptide derivative Kn2-7 was identified as the most potent anti-HIV-1 peptide by screening assays with an EC50 value of 2.76 mu g/ml (1.65 mu M) and showed low cytotoxicity to host cells with a selective index (SI) of 13.93. Kn2-7 could inhibit all members of a standard reference panel of HIV-1 subtype B pseudotyped virus (PV) with CCR5-tropic and CXCR4-tropic NL4-3 PV strain. Furthermore, it also inhibited a CXCR4-tropic replication-competent strain of HIV-1 subtype B virus. Binding assay of Kn2-7 to HIV-1 PV by Octet Red system suggested the anti-HIV-1 activity was correlated with a direct interaction between Kn2-7 and HIV-1 envelope. These results demonstrated that peptide Kn2-7 could inhibit HIV-1 by direct interaction with viral particle and may become a promising candidate compound for further development of microbicide against HIV-1.	[Chen, Yaoqing; Cao, Luyang; Li, Wenxin; Guo, Deying; Cao, Zhijian; Yan, Huimin] Wuhan Univ, Coll Life Sci, State Key Lab Virol, Wuhan 430072, Peoples R China; [Zhong, Maohua; Zhang, Yan; Han, Chen; Li, Qiaoli; Yang, Jingyi; Zhou, Dihan; Shi, Wei; He, Benxia; Liu, Fang; Yu, Jie; Sun, Ying; Cao, Yuan; Li, Yaoming; Yan, Huimin] Chinese Acad Sci, Wuhan Inst Virol, State Key Lab Virol, Wuhan, Peoples R China	Wuhan University; Chinese Academy of Sciences; Wuhan Institute of Virology, CAS	Chen, YQ (corresponding author), Wuhan Univ, Coll Life Sci, State Key Lab Virol, Wuhan 430072, Peoples R China.	zjcao@whu.edu.cn; hmyan@wh.iov.cn	chen, yaoqing/S-2623-2016	chen, yaoqing/0000-0002-1278-3327; Yan, Huimin/0000-0002-7243-8429	National Natural Science Foundation of China (NSFC) [30670097]; National Basic Research Program of China (973 Program) [2005CB522903, 2010CB530100, 2012CB518904]; Ministry of Science and Technology of the People's Republic of China [2008ZX10001-010, 2012ZX10001-008]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China (973 Program)(National Basic Research Program of China); Ministry of Science and Technology of the People's Republic of China(Ministry of Science and Technology, China)	This work was financially supported by the National Natural Science Foundation of China (NSFC) (No. 30670097 to HY), the National Basic Research Program of China (973 Program) (Nos. 2005CB522903, 2010CB530100, and 2012CB518904), and the National S&T Major Project on Major Infectious Diseases (Nos. 2008ZX10001-010, 2012ZX10001-008) from the Ministry of Science and Technology of the People's Republic of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdiche Y, 2008, ANAL BIOCHEM, V377, P209, DOI 10.1016/j.ab.2008.03.035; ADACHI A, 1986, J VIROL, V59, P284, DOI 10.1128/JVI.59.2.284-291.1986; Arien KK, 2011, REV MED VIROL, V21, P110, DOI 10.1002/rmv.684; Boman HG, 2000, IMMUNOL REV, V173, P5, DOI 10.1034/j.1600-065X.2000.917301.x; Brogden KA, 2005, NAT REV MICROBIOL, V3, P238, DOI 10.1038/nrmicro1098; Buchbinder SP, 2008, LANCET, V372, P1881, DOI 10.1016/S0140-6736(08)61591-3; Cao ZJ, 2006, TOXICON, V47, P348, DOI 10.1016/j.toxicon.2005.11.013; Carriel-Gomes MC, 2007, MEM I OSWALDO CRUZ, V102, P469, DOI 10.1590/S0074-02762007005000028; Choudhry V, 2007, VIROLOGY, V363, P79, DOI 10.1016/j.virol.2007.01.015; Cole AL, 2006, J IMMUNOL, V176, P6900, DOI 10.4049/jimmunol.176.11.6900; Conde R, 2000, FEBS LETT, V471, P165, DOI 10.1016/S0014-5793(00)01384-3; CORY AH, 1991, CANCER COMMUN, V3, P207, DOI 10.3727/095535491820873191; Dai C, 2008, ANTIMICROB AGENTS CH, V52, P3967, DOI 10.1128/AAC.00542-08; Dai L, 2001, BIOCHEM BIOPH RES CO, V286, P820, DOI 10.1006/bbrc.2001.5472; DALGLEISH AG, 1984, NATURE, V312, P763, DOI 10.1038/312763a0; Deng HK, 1996, NATURE, V381, P661, DOI 10.1038/381661a0; Do T, 2008, PROTEIN EXPRES PURIF, V60, P147, DOI 10.1016/j.pep.2008.04.009; Doranz BJ, 1996, CELL, V85, P1149, DOI 10.1016/S0092-8674(00)81314-8; EHRENSTEIN G, 1977, Q REV BIOPHYS, V10, P1, DOI 10.1017/S0033583500000123; Feng Y, 1996, SCIENCE, V272, P872, DOI 10.1126/science.272.5263.872; Fjell CD, 2007, BIOINFORMATICS, V23, P1148, DOI 10.1093/bioinformatics/btm068; HAMILTON MA, 1977, NEW ZEAL MED J, V86, P327; Hancock REW, 1998, TRENDS BIOTECHNOL, V16, P82, DOI 10.1016/S0167-7799(97)01156-6; Jenssen H, 2006, CLIN MICROBIOL REV, V19, P491, DOI 10.1128/CMR.00056-05; Li M, 2005, J VIROL, V79, P10108, DOI 10.1128/JVI.79.16.10108-10125.2005; Li QL, 2011, PEPTIDES, V32, P1518, DOI 10.1016/j.peptides.2011.05.015; Liu R, 1996, CELL, V86, P367, DOI 10.1016/S0092-8674(00)80110-5; Ma YB, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-290; MARTIN E, 1995, J LEUKOCYTE BIOL, V58, P128, DOI 10.1002/jlb.58.2.128; Matanic VCA, 2004, INT J ANTIMICROB AG, V23, P382, DOI 10.1016/j.ijantimicag.2003.07.022; McCormack S, 2010, LANCET, V376, P1329, DOI 10.1016/S0140-6736(10)61086-0; Moerman L, 2002, EUR J BIOCHEM, V269, P4799, DOI 10.1046/j.1432-1033.2002.03177.x; Mohan KVK, 2010, ANTIVIR RES, V86, P306, DOI 10.1016/j.antiviral.2010.03.012; Montefiori DC., 2005, CURR PROTOC IMMUNOL, VChapter 12:12.11.11-12.11.15, DOI [10.1002/0471142735.im1211s64, DOI 10.1002/0471142735.IM1211S64]; Neurath AR, 2002, BMC INFECT DIS, V2, DOI 10.1186/1471-2334-2-27; Oren Z, 1998, BIOPOLYMERS, V47, P451; PearcePratt R, 1996, BIOL REPROD, V54, P173, DOI 10.1095/biolreprod54.1.173; Platt EJ, 1998, J VIROL, V72, P2855, DOI 10.1128/JVI.72.4.2855-2864.1998; Possani LD, 2000, BIOCHIMIE, V82, P861, DOI 10.1016/S0300-9084(00)01167-6; REED L. J., 1938, AMER JOUR HYG, V27, P493; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; ROST B, 1993, J MOL BIOL, V232, P584, DOI 10.1006/jmbi.1993.1413; SAKAI K, 1991, J VIROL, V65, P5765, DOI 10.1128/JVI.65.11.5765-5773.1991; Sun LL, 2005, J VIROL, V79, P14318, DOI 10.1128/JVI.79.22.14318-14329.2005; Tao J, 2007, ANTIVIR RES, V75, P227, DOI 10.1016/j.antiviral.2007.03.008; Tao W, 2008, AIDS RES HUM RETROV, V24, P925, DOI 10.1089/aid.2008.0043; Telwatte S, 2011, ANTIVIR RES, V90, P195, DOI 10.1016/j.antiviral.2011.03.186; Titti F, 2007, EXPERT OPIN EMERG DR, V12, P23, DOI 10.1517/14728214.12.1.23; Torre VS, 2000, J VIROL, V74, P4868, DOI 10.1128/JVI.74.10.4868-4876.2000; Torres-Larios A, 2000, EUR J BIOCHEM, V267, P5023, DOI 10.1046/j.1432-1327.2000.01556.x; UNAIDS, 2010, UNAIDS REP GLOB AIDS; Vzorov AN, 2007, ANTIVIR RES, V73, P60, DOI 10.1016/j.antiviral.2006.07.008; Wang Z, 2004, NUCLEIC ACIDS RES, V32, pD590, DOI 10.1093/nar/gkh025; Wei XP, 2003, NATURE, V422, P307, DOI 10.1038/nature01470; Wei XP, 2002, ANTIMICROB AGENTS CH, V46, P1896, DOI 10.1128/AAC.46.6.1896-1905.2002; Yan R, 2011, PEPTIDES, V32, P11, DOI 10.1016/j.peptides.2010.10.008; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a; Zeng XC, 2004, PEPTIDES, V25, P143, DOI 10.1016/j.peptides.2003.12.003; Zhang Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024296; Zhao ZH, 2009, ANTIMICROB AGENTS CH, V53, P3472, DOI 10.1128/AAC.01436-08	60	49	53	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2012	7	4							e34947	10.1371/journal.pone.0034947	http://dx.doi.org/10.1371/journal.pone.0034947			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TL	22536342	Green Published, Green Submitted, gold			2022-12-25	WOS:000305336200015
J	Talan, MI; Ahmet, I; Lakatta, EG				Talan, Mark I.; Ahmet, Ismayil; Lakatta, Edward G.			Did Clinical Trials in Which Erythropoietin Failed to Reduce Acute Myocardial Infarct Size Miss a Narrow Therapeutic Window?	PLOS ONE			English	Article							RECOMBINANT-HUMAN-ERYTHROPOIETIN; CONTROLLED PILOT TRIAL; CARDIOPROTECTION; REPERFUSION; RATIONALE; REVEAL; DESIGN	Background: To test a hypothesis that in negative clinical trials of erythropoietin in patients with acute myocardial infarction (MI) the erythropoietin (rhEPO) could be administered outside narrow therapeutic window. Despite overwhelming evidence of cardioprotective properties of rhEPO in animal studies, the outcomes of recently concluded phase II clinical trials have failed to demonstrate the efficacy of rhEPO in patients with acute MI. However, the time between symptoms onset and rhEPO administration in negative clinical trials was much longer that in successful animal experiments. Methodology/Principal Findings: MI was induced in rats either by a permanent ligation of a descending coronary artery or by a 2-hr occlusion followed by a reperfusion. rhEPO, 3000 IU/kg, was administered intraperitoneally at the time of reperfusion, 4 hrs after beginning of reperfusion, or 6 hrs after permanent occlusion. MI size was measured histologically 24 hrs after coronary occlusion. The area of myocardium at risk was similar among groups. The MI size in untreated rats averaged similar to 42% of area at risk, or similar to 24% of left ventricle, and was reduced by more than 50% (p<0.001) in rats treated with rhEPO at the time of reperfusion. The MI size was not affected by treatment administered 4 hrs after reperfusion or 6 hrs after permanent coronary occlusion. Therefore, our study in a rat experimental model of MI demonstrates that rhEPO administered within 2 hrs of a coronary occlusion effectively reduces MI size, but when rhEPO was administered following a delay similar to that encountered in clinical trials, it had no effect on MI size. Conclusions/Significance: The clinical trials that failed to demonstrate rhEPO efficacy in patients with MI may have missed a narrow therapeutic window defined in animal experiments.	[Talan, Mark I.; Ahmet, Ismayil; Lakatta, Edward G.] NIA, Cardiovasc Sci Lab, Intramural Res Program, Natl Inst Hlth, Baltimore, MD 21224 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	Talan, MI (corresponding author), NIA, Cardiovasc Sci Lab, Intramural Res Program, Natl Inst Hlth, Baltimore, MD 21224 USA.	talanm@grc.nia.nih.gov	Lakatta, Edward G/AAL-1447-2020; Stefanadis, Christodoulos/ABH-2232-2020	Lakatta, Edward/0000-0002-4772-0035; Stefanadis, Christodoulos/0000-0001-5974-6454	NATIONAL INSTITUTE ON AGING [ZIAAG000866] Funding Source: NIH RePORTER	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Ahmet I, 2005, CIRCULATION, V112, P3115, DOI 10.1161/CIRCULATIONAHA.105.563817; Ahmet I, 2011, J MOL CELL CARDIOL, V51, P263, DOI 10.1016/j.yjmcc.2011.04.015; Belonje AM, 2008, AM HEART J, V155, P817, DOI 10.1016/j.ahj.2007.12.036; Bhatt DL, 2011, JAMA-J AM MED ASSOC, V305, P1908, DOI 10.1001/jama.2011.600; Binbrek AS, 2007, CORONARY ARTERY DIS, V18, P583, DOI 10.1097/MCA.0b013e3282ef4ed6; Binbrek AS, 2009, AM J CARDIOL, V104, P1035, DOI 10.1016/j.amjcard.2009.05.050; Bogoyevitch MA, 2004, CARDIOVASC RES, V63, P208, DOI 10.1016/j.cardiores.2004.03.017; Ferrario M, 2011, INT J CARDIOL, V147, P124, DOI 10.1016/j.ijcard.2009.10.028; Gibson CM, 2008, AM HEART J, V156, P1035, DOI 10.1016/j.ahj.2008.07.029; Hirata A, 2006, J AM COLL CARDIOL, V48, P176, DOI 10.1016/j.jacc.2006.04.008; Koul Deepak, 2007, Recent Pat Cardiovasc Drug Discov, V2, P5, DOI 10.2174/157489007779606112; Latini R, 2008, HEART FAIL REV, V13, P415, DOI 10.1007/s10741-008-9084-z; Liem A, 2009, INT J CARDIOL, V131, P285, DOI 10.1016/j.ijcard.2007.07.076; Lipsic E, 2006, J AM COLL CARDIOL, V48, P2161, DOI 10.1016/j.jacc.2006.08.031; Lipsic E, 2006, CARDIOVASC DRUG THER, V20, P135, DOI 10.1007/s10557-006-7680-5; Melloni C, 2010, AM HEART J, V160, P795, DOI 10.1016/j.ahj.2010.09.007; Moon C, 2005, CARDIOVASC DRUG THER, V19, P243, DOI 10.1007/s10557-005-3189-6; Najjar SS, 2011, JAMA-J AM MED ASSOC, V305, P1863, DOI 10.1001/jama.2011.592; Ott I, 2010, CIRC-CARDIOVASC INTE, V3, P408, DOI 10.1161/CIRCINTERVENTIONS.109.904425; Ozawa T, 2010, CIRC J, V74, P1415, DOI 10.1253/circj.CJ-10-0109; Riksen NP, 2008, TRENDS PHARMACOL SCI, V29, P258, DOI 10.1016/j.tips.2008.02.002; Taniguchi N, 2010, CIRC J, V74, P2365, DOI 10.1253/circj.CJ-10-0267; Vogiatzi G, 2010, EXPERT OPIN BIOL TH, V10, P251, DOI 10.1517/14712590903547819; Voors AA, 2010, EUR HEART J, V31, P2593, DOI 10.1093/eurheartj/ehq304; Yoshimura N, 2010, CIRC J, V74, P2741, DOI 10.1253/circj.CJ-10-0912	25	13	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2012	7	4							e34819	10.1371/journal.pone.0034819	http://dx.doi.org/10.1371/journal.pone.0034819			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959XD	22529941	Green Published, Green Submitted, gold			2022-12-25	WOS:000305350600032
J	Willis, PM; Rosenthal, GG; Ryan, MJ				Willis, Pamela M.; Rosenthal, Gil G.; Ryan, Michael J.			An Indirect Cue of Predation Risk Counteracts Female Preference for Conspecifics in a Naturally Hybridizing Fish Xiphophorus birchmanni	PLOS ONE			English	Article							MATE CHOICE; SEXUAL SELECTION; BODY-SIZE; GREEN SWORDTAIL; SPECIATION; NIGRENSIS; COMMUNICATION; CRICKETS; BEHAVIOR; ZONES	Mate choice is context dependent, but the importance of current context to interspecific mating and hybridization is largely unexplored. An important influence on mate choice is predation risk. We investigated how variation in an indirect cue of predation risk, distance to shelter, influences mate choice in the swordtail Xiphophorus birchmanni, a species which sometimes hybridizes with X. malinche in the wild. We conducted mate choice experiments to determine whether females attend to the distance to shelter and whether this cue of predation risk can counteract female preference for conspecifics. Females were sensitive to shelter distance independent of male presence. When conspecific and heterospecific X. malinche males were in equally risky habitats (i.e., equally distant from shelter), females associated primarily with conspecifics, suggesting an innate preference for conspecifics. However, when heterospecific males were in less risky habitat (i.e., closer to shelter) than conspecific males, females no longer exhibited a preference, suggesting that females calibrate their mate choices in response to predation risk. Our findings illustrate the potential for hybridization to arise, not necessarily through reproductive "mistakes'', but as one of many potential outcomes of a context dependent mate choice strategy.	[Willis, Pamela M.; Ryan, Michael J.] Univ Texas Austin, Sect Integrat Biol, Austin, TX 78712 USA; [Rosenthal, Gil G.] Texas A&M Univ, Dept Biol, College Stn, TX 77843 USA; [Rosenthal, Gil G.] Ctr Invest Cient Huastecas Aguazarca, Calnali, Hidalgo, Mexico	University of Texas System; University of Texas Austin; Texas A&M University System; Texas A&M University College Station	Willis, PM (corresponding author), Univ Texas Austin, Sect Integrat Biol, Austin, TX 78712 USA.	pamwillis@utexas.edu	Rosenthal, Gil/E-6924-2015	Rosenthal, Gil/0000-0003-0342-9024	Society for Integrative and Comparative Biology; Southwestern Association of Naturalists; American Livebearer Association; PADI Foundation grants; Zoology Scholarship Endowment for Excellence Fellowship from the University of Texas	Society for Integrative and Comparative Biology; Southwestern Association of Naturalists; American Livebearer Association; PADI Foundation grants; Zoology Scholarship Endowment for Excellence Fellowship from the University of Texas	This work was funded by grants to PMW from the Society for Integrative and Comparative Biology, the Southwestern Association of Naturalists, the American Livebearer Association, and the PADI Foundation grants. PMW was supported by a Zoology Scholarship Endowment for Excellence Fellowship from the University of Texas. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baayen RH, 2008, J MEM LANG, V59, P390, DOI 10.1016/j.jml.2007.12.005; Basolo AL, 2004, BIOL J LINN SOC, V83, P87, DOI 10.1111/j.1095-8312.2004.00369.x; Basolo AL, 1995, P R SOC B, V259, P2223; BERGLUND A, 1995, BEHAVIOUR, V132, P213, DOI 10.1163/156853995X00702; BREDEN F, 1987, NATURE, V329, P831, DOI 10.1038/329831a0; Brooksmythe I, 2008, ANIM BEHAV, V76, P1775; Burke JM, 2001, ANNU REV GENET, V35, P31, DOI 10.1146/annurev.genet.35.102401.085719; Burnham K.P., 2002, MODEL SELECTION MULT, DOI 10.1007/b97636; Coleman SW, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000118; Cotton S, 2006, CURR BIOL, V16, pR755, DOI 10.1016/j.cub.2006.08.022; Culumber ZW, 2011, MOL ECOL, V20, P342, DOI 10.1111/j.1365-294X.2010.04949.x; Cummings ME, 2003, P ROY SOC B-BIOL SCI, V270, P897, DOI 10.1098/rspb.2003.2334; Cummings M, 2006, ANIM BEHAV, V72, P217, DOI 10.1016/j.anbehav.2006.01.009; DILL LM, 1984, BEHAV ECOL SOCIOBIOL, V16, P65, DOI 10.1007/BF00293105; Fisher HS, 2007, BIOL LETTERS, V3, P5, DOI 10.1098/rsbl.2006.0556; Fisher HS, 2006, P ROY SOC B-BIOL SCI, V273, P1187, DOI 10.1098/rspb.2005.3406; Fisher HS, 2010, ETHOLOGY, V116, P32, DOI 10.1111/j.1439-0310.2009.01710.x; FORSGREN E, 1992, AM NAT, V140, P1041, DOI 10.1086/285455; Gerlai R, 2007, ETHOLOGY, V113, P673, DOI 10.1111/j.1439-0310.2007.01372.x; GOMULKIEWICZ R, 1991, AM NAT, V138, P1396, DOI 10.1086/285293; GORDON M, 1953, COPEIA, P148; Gow JL, 2006, MOL ECOL, V15, P739, DOI 10.1111/j.1365-294X.2006.02825.x; Gray DA, 1999, J INSECT BEHAV, V12, P691, DOI 10.1023/A:1020983821436; Hebets EA, 2008, ANIM BEHAV, V76, P355, DOI 10.1016/j.anbehav.2007.12.021; HEDRICK AV, 1993, ANIM BEHAV, V46, P193, DOI 10.1006/anbe.1993.1176; HEWITT GM, 1988, TRENDS ECOL EVOL, V3, P158, DOI 10.1016/0169-5347(88)90033-X; HUGHES JJ, 1993, ANIM BEHAV, V46, P1243, DOI 10.1006/anbe.1993.1320; Jennions MD, 1997, BIOL REV, V72, P283, DOI 10.1017/S0006323196005014; Johnson JB, 2003, BEHAV ECOL, V14, P619, DOI 10.1093/beheco/arg046; Kallman KD, 2006, ZEBRAFISH, V3, P271, DOI 10.1089/zeb.2006.3.271; Kodric-Brown A, 2001, AM NAT, V157, P316, DOI 10.1086/319191; LIMA SL, 1990, CAN J ZOOL, V68, P619, DOI 10.1139/z90-092; Lynch KS, 2005, ANIM BEHAV, V69, P689, DOI 10.1016/j.anbehav.2004.05.016; Mallet J, 2007, NATURE, V446, P279, DOI 10.1038/nature05706; Mayr E., 1963, ANIMAL SPECIES EVOLU, P797; MORRIS MR, 1995, BEHAV ECOL SOCIOBIOL, V37, P303, DOI 10.1007/BF00174134; Naisbit RE, 2001, P ROY SOC B-BIOL SCI, V268, P1849, DOI 10.1098/rspb.2001.1753; Nuechterlein GL, 1998, BEHAV ECOL, V9, P313, DOI 10.1093/beheco/9.3.313; Orrock JL, 2004, BEHAV ECOL, V15, P433, DOI 10.1093/beheco/arh031; Pfennig KS, 2007, SCIENCE, V318, P965, DOI 10.1126/science.1146035; POCKLINGTON R, 1995, ANIM BEHAV, V49, P1122, DOI 10.1006/anbe.1995.0141; RAUCHENBERGER M, 1990, AM MUS NOVIT, P1; Rosenthal GG, 2001, AM NAT, V158, P146, DOI 10.1086/321309; Rosenthal GG, 2003, COPEIA, P299, DOI 10.1643/0045-8511(2003)003[0299:DOSSCI]2.0.CO;2; RYAN MJ, 1990, BEHAV ECOL SOCIOBIOL, V26, P231; Seehausen O, 1997, SCIENCE, V277, P1808, DOI 10.1126/science.277.5333.1808; Seehausen O, 2004, TRENDS ECOL EVOL, V19, P198, DOI 10.1016/j.tree.2004.01.003; Seehausen O, 2008, MOL ECOL, V17, P30, DOI 10.1111/j.1365-294X.2007.03529.x; SHELLY TE, 1992, BEHAV ECOL SOCIOBIOL, V30, P277, DOI 10.1007/BF00166713; Tatarenkov A, 2010, MOL ECOL, V19, P257, DOI 10.1111/j.1365-294X.2009.04464.x; Taylor EB, 2006, MOL ECOL, V15, P343, DOI 10.1111/j.1365-294X.2005.02794.x; Thibert-Plante X, 2011, J EVOLUTION BIOL, V24, P2186, DOI 10.1111/j.1420-9101.2011.02348.x; Velema G., 2010, THESIS U BRIT COLUMB; Walling CA, 2010, BEHAV ECOL SOCIOBIOL, V64, P541, DOI 10.1007/s00265-009-0869-4; Wiley C, 2007, J EVOLUTION BIOL, V20, P854, DOI 10.1111/j.1420-9101.2007.01316.x; Willis PM, 2011, BEHAV ECOL; WILSON D S, 1982, Evolutionary Theory, V6, P15; Wirtz P, 1999, ANIM BEHAV, V58, P1, DOI 10.1006/anbe.1999.1144; Wong BBM, 2006, AM NAT, V167, P136, DOI 10.1086/498278	59	25	25	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2012	7	4							e34802	10.1371/journal.pone.0034802	http://dx.doi.org/10.1371/journal.pone.0034802			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959XD	22529936	Green Published, gold			2022-12-25	WOS:000305350600028
J	Albrecht, E; Komolka, K; Kuzinski, J; Maak, S				Albrecht, Elke; Komolka, Katrin; Kuzinski, Judith; Maak, Steffen			Agouti Revisited: Transcript Quantification of the ASIP Gene in Bovine Tissues Related to Protein Expression and Localization	PLOS ONE			English	Article							BLACK-AND-TAN; COPY NUMBER VARIATION; SIGNALING PROTEIN; COAT COLOR; MOLECULAR CHARACTERIZATION; ECTOPIC EXPRESSION; ADIPOSE-TISSUES; HUMAN HOMOLOG; MUTATIONS; RECEPTOR	Beside its role in melanogenesis, the agouti signaling protein (ASIP) has been related to obesity. The potentially crucial role in adipocyte development makes it a tempting candidate for economic relevant, fat related traits in farm animals. The objective of our study was to characterize the mRNA expression of different ASIP transcripts and of putative targets in different bovine tissues, as well as to study consequences on protein abundance and localization. ASIP mRNA abundance was determined by RT-qPCR in adipose and further tissues of cattle representing different breeds and crosses. ASIP mRNA was up-regulated more than 9-fold in intramuscular fat of Japanese Black cattle compared to Holstein (p < 0.001). Further analyses revealed that a transposon-derived transcript was solely responsible for the increased ASIP mRNA abundance. This transcript was observed in single individuals of different breeds indicating a wide spread occurrence of this insertion at the ASIP locus in cattle. The protein was detected in different adipose tissues, skin, lung and liver, but not in skeletal muscle by Western blot with a bovine-specific ASIP antibody. However, the protein abundance was not related to the observed ASIP mRNA over-expression. Immuno-histochemical analyses revealed a putative nuclear localization of ASIP additionally to the expected cytosolic signal in different cell types. The expression of melanocortin receptors (MCR) 1 to 5 as potential targets for ASIP was analyzed by RT-PCR in subcutaneous fat. Only MC1R and MC4R were detected indicating a similar receptor expression like in human adipose tissue. Our results provide evidence for a widespread expression of ASIP in bovine tissues at mRNA and, for the first time, at protein level. ASIP protein is detectable in adipocytes as well as in further cells of adipose tissue. We generated a basis for a more detailed investigation of ASIP function in peripheral tissues of various mammalian species.	[Albrecht, Elke; Komolka, Katrin; Kuzinski, Judith; Maak, Steffen] Leibniz Inst Farm Anim Biol FBN, Res Unit Muscle Biol & Growth, Dummerstorf, Germany	Forschungsinstitut fur Nutztierbiologie (FBN)	Albrecht, E (corresponding author), Leibniz Inst Farm Anim Biol FBN, Res Unit Muscle Biol & Growth, Dummerstorf, Germany.	maak@fbn-dummerstorf.de	Albrecht, Elke/ABB-6155-2021	Albrecht, Elke/0000-0001-5974-1514				Adelson DL, 2009, P NATL ACAD SCI USA, V106, P12855, DOI 10.1073/pnas.0901282106; Albrecht E, 2011, MEAT SCI, V89, P13, DOI 10.1016/j.meatsci.2011.03.012; Amweg AN, 2011, THERIOGENOLOGY, V75, P628, DOI 10.1016/j.theriogenology.2010.10.003; Anno S, 2008, INT J BIOL SCI, V4, P81; Badaoui B, 2011, BIOCHEM GENET, V49, P523, DOI 10.1007/s10528-011-9427-7; Bae JS, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-232; BULTMAN SJ, 1991, P NATL ACAD SCI USA, V88, P8062, DOI 10.1073/pnas.88.18.8062; BULTMAN SJ, 1994, GENE DEV, V8, P481, DOI 10.1101/gad.8.4.481; BULTMAN SJ, 1992, CELL, V71, P1195, DOI 10.1016/S0092-8674(05)80067-4; Chagnon YC, 1997, MOL MED, V3, P663, DOI 10.1007/BF03401705; Claycombe KJ, 2000, PHYSIOL GENOMICS, V2, P101, DOI 10.1152/physiolgenomics.2000.2.3.101; Cone RD, 1996, RECENT PROG HORM RES, V51, P287; Doghman M, 2004, ENDOCRINOLOGY, V145, P541, DOI 10.1210/en.2003-0605; Dreger DL, 2011, J HERED, V102, pS11, DOI 10.1093/jhered/esr042; Drogemuller C, 2006, MAMM GENOME, V17, P58, DOI 10.1007/s00335-005-0104-1; DUHL DMJ, 1994, NAT GENET, V8, P59, DOI 10.1038/ng0994-59; Fadista J, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-284; Fontanesi L, 2009, CYTOGENET GENOME RES, V126, P333, DOI 10.1159/000268089; Fontanesi L, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-59; Fontanesi L, 2010, GENOMICS, V95, P166, DOI 10.1016/j.ygeno.2009.11.003; Girardot M, 2005, PIGM CELL RES, V18, P34, DOI 10.1111/j.1600-0749.2004.00195.x; Girardot M, 2006, PIGM CELL RES, V19, P346, DOI 10.1111/j.1600-0749.2006.00312.x; Gotoh T, 2009, MEAT SCI; Graphodatskaya D, 2006, ANIM SCI J, V77, P33, DOI 10.1111/j.1740-0929.2006.00317.x; Gratten J, 2010, HEREDITY, V104, P206, DOI 10.1038/hdy.2009.105; Hiller B, 2011, LIPIDS, V46, P557, DOI 10.1007/s11745-011-3571-z; Hiragaki T, 2008, GENETICS, V178, P771, DOI 10.1534/genetics.107.077040; Hoch M, 2007, OBESITY, V15, P40, DOI 10.1038/oby.2007.525; Jackson PJ, 2006, CHEM BIOL, V13, P1297, DOI 10.1016/j.chembiol.2006.10.006; Kanetsky PA, 2002, AM J HUM GENET, V70, P770, DOI 10.1086/339076; Kijas JW, 2011, GENE, V482, P73, DOI 10.1016/j.gene.2011.04.011; KLEBIG ML, 1995, P NATL ACAD SCI USA, V92, P4728, DOI 10.1073/pnas.92.11.4728; KLUNGLAND H, 1995, MAMM GENOME, V6, P636, DOI 10.1007/BF00352371; KWON HY, 1994, P NATL ACAD SCI USA, V91, P9760, DOI 10.1073/pnas.91.21.9760; Leeb T, 2000, ANIM GENET, V31, P335, DOI 10.1046/j.1365-2052.2000.00656.x; Liakos P, 1998, ENDOCR RES, V24, P427, DOI 10.3109/07435809809032628; Liakos P, 2000, MOL CELL ENDOCRINOL, V159, P99, DOI 10.1016/S0303-7207(99)00196-3; Liu GE, 2010, GENOME RES, V20, P693, DOI 10.1101/gr.105403.110; LU DS, 1994, NATURE, V371, P799, DOI 10.1038/371799a0; Matsunaga N, 2000, BIOCHEM BIOPH RES CO, V270, P176, DOI 10.1006/bbrc.2000.2409; Michaud EJ, 1997, J ENDOCRINOL, V155, P207, DOI 10.1677/joe.0.1550207; MICHAUD EJ, 1993, GENE DEV, V7, P1203, DOI 10.1101/gad.7.7a.1203; Miltenberger RJ, 2002, GENETICS, V160, P659; Mynatt RL, 2001, AM J PHYSIOL-CELL PH, V280, pC954, DOI 10.1152/ajpcell.2001.280.4.C954; Norris BJ, 2008, GENOME RES, V18, P1282, DOI 10.1101/gr.072090.107; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Rieder S, 2001, MAMM GENOME, V12, P450, DOI 10.1007/s003350020017; Royo LJ, 2005, J ANIM BREED GENET, V122, P357, DOI 10.1111/j.1439-0388.2005.00541.x; Shi KR, 2006, ANIM GENET, V37, P300, DOI 10.1111/j.1365-2052.2006.01446.x; SIRACUSA LD, 1994, TRENDS GENET, V10, P423, DOI 10.1016/0168-9525(94)90112-0; Smith SR, 2003, DIABETES, V52, P2914, DOI 10.2337/diabetes.52.12.2914; Sumida Takeshi, 2004, Animal Science Journal, V75, P49, DOI 10.1111/j.1740-0929.2004.00154.x; VRIELING H, 1994, P NATL ACAD SCI USA, V91, P5667, DOI 10.1073/pnas.91.12.5667; WILSON BD, 1995, HUM MOL GENET, V4, P223, DOI 10.1093/hmg/4.2.223; Xue BZ, 1998, FASEB J, V12, P1391, DOI 10.1096/fasebj.12.13.1391; Yabuuchi M, 2010, J POULT SCI, V47, P176, DOI 10.2141/jpsa.009110; Yang YK, 1997, MOL ENDOCRINOL, V11, P274, DOI 10.1210/me.11.3.274; YEN TT, 1994, FASEB J, V8, P479, DOI 10.1096/fasebj.8.8.8181666; Zhang CL, 2011, RES VET SCI, V90, P241, DOI 10.1016/j.rvsc.2010.06.007; Zimin AV, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-4-r42	60	28	29	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2012	7	4							e35282	10.1371/journal.pone.0035282	http://dx.doi.org/10.1371/journal.pone.0035282			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WC	22530003	Green Submitted, Green Published, gold			2022-12-25	WOS:000305347400042
J	Kloog, I; Coull, BA; Zanobetti, A; Koutrakis, P; Schwartz, JD				Kloog, Itai; Coull, Brent A.; Zanobetti, Antonella; Koutrakis, Petros; Schwartz, Joel D.			Acute and Chronic Effects of Particles on Hospital Admissions in New-England	PLOS ONE			English	Article							PARTICULATE AIR-POLLUTION; CONGESTIVE-HEART-FAILURE; LONG-TERM EXPOSURE; CASE-CROSSOVER ANALYSIS; FINE PARTICULATE; CARDIOVASCULAR-DISEASE; MEDICARE BENEFICIARIES; MYOCARDIAL-INFARCTION; RESPIRATORY-DISEASES; EMERGENCY ADMISSIONS	Background: Many studies have reported significant associations between exposure to PM2.5 and hospital admissions, but all have focused on the effects of short-term exposure. In addition all these studies have relied on a limited number of PM2.5 monitors in their study regions, which introduces exposure error, and excludes rural and suburban populations from locations in which monitors are not available, reducing generalizability and potentially creating selection bias. Methods: Using our novel prediction models for exposure combining land use regression with physical measurements (satellite aerosol optical depth) we investigated both the long and short term effects of PM2.5 exposures on hospital admissions across New-England for all residents aged 65 and older. We performed separate Poisson regression analysis for each admission type: all respiratory, cardiovascular disease (CVD), stroke and diabetes. Daily admission counts in each zip code were regressed against long and short-term PM2.5 exposure, temperature, socio-economic data and a spline of time to control for seasonal trends in baseline risk. Results: We observed associations between both short-term and long-term exposure to PM2.5 and hospitalization for all of the outcomes examined. In example, for respiratory diseases, for every 10-mu g/m(3) increase in short-term PM2.5 exposure there is a 0.70 percent increase in admissions (CI = 0.35 to 0.52) while concurrently for every 10-mu g/m(3) increase in long-term PM2.5 exposure there is a 4.22 percent increase in admissions (CI = 1.06 to 4.75). Conclusions: As with mortality studies, chronic exposure to particles is associated with substantially larger increases in hospital admissions than acute exposure and both can be detected simultaneously using our exposure models.	[Kloog, Itai; Zanobetti, Antonella; Koutrakis, Petros; Schwartz, Joel D.] Harvard Univ, Sch Publ Hlth, Dept Environm Hlth, Exposure Epidemiol & Risk Program, Boston, MA 02115 USA; [Coull, Brent A.] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health	Kloog, I (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Environm Hlth, Exposure Epidemiol & Risk Program, 665 Huntington Ave, Boston, MA 02115 USA.	ekloog@hsph.harvard.edu			Harvard Environmental Protection Agency (EPA) Center [R-832416, RD 83479801]; NIH [ES00002, ES012044]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES012044, P30ES000002] Funding Source: NIH RePORTER	Harvard Environmental Protection Agency (EPA) Center(United States Environmental Protection Agency); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	The research was supported by the Harvard Environmental Protection Agency (EPA) Center, Grants R-832416 and RD 83479801, NIH grants ES00002 and ES012044. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adar SD, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000372; Andersen ZJ, 2011, THORAX; Andersen ZJ, 2012, DIABETES CARE, V35, P92, DOI 10.2337/dc11-1155; [Anonymous], 2000, US CENS POP HOUS; Baja ES, 2010, ENVIRON HEALTH PERSP, V118, P840, DOI 10.1289/ehp.0901396; Bartoli CR, 2009, ENVIRON HEALTH PERSP, V117, P333, DOI 10.1289/ehp.11380; Bauer M, 2010, J AM COLL CARDIOL, V56, P1803, DOI 10.1016/j.jacc.2010.04.065; Brauner EV, 2008, AM J RESP CRIT CARE, V177, P419, DOI 10.1164/rccm.200704-632OC; Brook RD, 2004, CIRCULATION, V109, P2655, DOI 10.1161/01.CIR.0000128587.30041.C8; Brunekreef B, 2002, LANCET, V360, P1233, DOI 10.1016/S0140-6736(02)11274-8; Soares SRC, 2009, ATHEROSCLEROSIS, V207, P368, DOI 10.1016/j.atherosclerosis.2009.04.041; D'Ippoliti D, 2003, EPIDEMIOLOGY, V14, P528, DOI 10.1097/01.ede.0000082046.22919.72; Dominici F, 2006, JAMA-J AM MED ASSOC, V295, P1127, DOI 10.1001/jama.295.10.1127; Engel-Cox JA, 2004, ATMOS ENVIRON, V38, P2495, DOI 10.1016/j.atmosenv.2004.01.039; Fusco D, 2001, EUR RESPIR J, V17, P1143, DOI 10.1183/09031936.01.00005501; Gryparis A, 2009, BIOSTATISTICS, V10, P258, DOI 10.1093/biostatistics/kxn033; Gupta P, 2006, ATMOS ENVIRON, V40, P5880, DOI 10.1016/j.atmosenv.2006.03.016; Halonen JI, 2010, ENVIRON HEALTH-GLOB, V9, DOI 10.1186/1476-069X-9-42; Hansen CS, 2007, TOXICOL APPL PHARM, V219, P24, DOI 10.1016/j.taap.2006.10.032; Hruba F, 2001, J EXPO ANAL ENV EPID, V11, P33, DOI 10.1038/sj.jea.7500141; Ilabaca M, 1999, J AIR WASTE MANAGE, V49, P154, DOI 10.1080/10473289.1999.10463879; Kloog I, 2011, ATMOSPHERIC ENV; Koelemeijer RBA, 2006, ATMOS ENVIRON, V40, P5304, DOI 10.1016/j.atmosenv.2006.04.044; Kramer U, 2010, ENVIRON HEALTH PERSP, V118, P1273, DOI 10.1289/ehp.0901689; Krewski D, 2009, RES REP HLTH EFF I, V2009, P115; Krewski Daniel, 2009, Res Rep Health Eff Inst, P5; Kunzli N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009096; Laden F, 2000, ENVIRON HEALTH PERSP, V108, P941, DOI 10.2307/3435052; LAIRD N, 1981, J AM STAT ASSOC, V76, P231, DOI 10.2307/2287816; Liu Y., 2004, J GEOPHYS RES D, V109, P3269; Madrigano J, 2010, OCCUP ENVIRON MED, V67, P312, DOI 10.1136/oem.2009.046193; Mann JK, 2002, ENVIRON HEALTH PERSP, V110, P1247, DOI 10.1289/ehp.021101247; Medina-Ramon M, 2006, AM J EPIDEMIOL, V163, P579, DOI 10.1093/aje/kwj078; Miller KA, 2007, NEW ENGL J MED, V356, P447, DOI 10.1056/NEJMoa054409; NCDC, 2010, NAT CLIM DAT CTR DAT; O'Neill MS, 2005, CIRCULATION, V111, P2913, DOI 10.1161/CIRCULATIONAHA.104.517110; Ostro B, 2010, ENVIRON HEALTH PERSP, V118, P363, DOI 10.1289/ehp.0901181; Oudin A, 2011, CEREBROVASC DIS, V31, P284, DOI 10.1159/000322600; Paciorek CJ, 2009, ANN APPL STAT, V3, P370, DOI 10.1214/08-AOAS204; Pope CA, 2006, J AIR WASTE MANAGE, V56, P709, DOI 10.1080/10473289.2006.10464485; POPE CA, 1995, INHAL TOXICOL, V7, P1, DOI 10.3109/08958379509014267; Puett RC, 2009, ENVIRON HEALTH PERSP, V117, P1697, DOI 10.1289/ehp.0900572; Schwartz J, 1996, J AIR WASTE MANAGE, V46, P927, DOI 10.1080/10473289.1996.10467528; Schwartz J, 1996, EPIDEMIOLOGY, V7, P20, DOI 10.1097/00001648-199601000-00005; SCHWARTZ J, 1995, AM J EPIDEMIOL, V142, P23, DOI 10.1093/oxfordjournals.aje.a117541; SCHWARTZ J, 1994, AM J EPIDEMIOL, V139, P589, DOI 10.1093/oxfordjournals.aje.a117048; Schwartz J, 1997, EPIDEMIOLOGY, V8, P371, DOI 10.1097/00001648-199707000-00004; Spix C, 1998, ARCH ENVIRON HEALTH, V53, P54, DOI 10.1080/00039899809605689; Sun QH, 2005, JAMA-J AM MED ASSOC, V294, P3003, DOI 10.1001/jama.294.23.3003; Sun QH, 2008, INHAL TOXICOL, V20, P127, DOI [10.1080/08958370701821482, 10.1080/08958370701821482 ]; Symons JM, 2006, AM J EPIDEMIOL, V164, P421, DOI 10.1093/aje/kwj206; USCB, 2000, US CENS BUR 2000; Wellenius GA, 2005, STROKE, V36, P2549, DOI 10.1161/01.STR.0000189687.78760.47; Wellenius GA, 2005, AM J EPIDEMIOL, V161, P1030, DOI 10.1093/aje/kwi135; Wellenius GA, 2003, ENVIRON HEALTH PERSP, V111, P402, DOI 10.1289/ehp.5775; Zanobetti A, 2001, AM J RESP CRIT CARE, V164, P831, DOI 10.1164/ajrccm.164.5.2012039; Zanobetti A, 2005, ENVIRON HEALTH PERSP, V113, P978, DOI 10.1289/ehp.7550; Zanobetti A, 2000, ENVIRON HEALTH PERSP, V108, P1071, DOI 10.2307/3434961; Zanobetti A, 2009, ENVIRON HEALTH-GLOB, V8, DOI 10.1186/1476-069X-8-58; Zeger SL, 2000, ENVIRON HEALTH PERSP, V108, P419, DOI 10.2307/3454382	60	118	120	4	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2012	7	4							e34664	10.1371/journal.pone.0034664	http://dx.doi.org/10.1371/journal.pone.0034664			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WC	22529923	Green Published, gold, Green Submitted			2022-12-25	WOS:000305347400015
J	Nguyen, MTA; Chen, A; Lu, WJ; Fan, WQ; Li, PP; Oh, DY; Patsouris, D				Nguyen, M. T. Audrey; Chen, Ai; Lu, Wendell J.; Fan, WuQiang; Li, Ping-Ping; Oh, Da Young; Patsouris, David			Regulation of Chemokine and Chemokine Receptor Expression by PPAR gamma in Adipocytes and Macrophages	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; ENDOPLASMIC-RETICULUM STRESS; INDUCED INSULIN-RESISTANCE; TOLL-LIKE RECEPTORS; FREE FATTY-ACIDS; FACTOR-KAPPA-B; ADIPOSE-TISSUE; INDUCED INFLAMMATION; METABOLIC DISEASE; 3T3-L1 ADIPOCYTES	Background: PPAR gamma plays a key role in adipocyte biology, and Rosiglitazone (Rosi), a thiazolidinedione (TZD)/PPAR gamma agonist, is a potent insulin-sensitizing agent. Recent evidences demonstrate that adipose tissue inflammation links obesity with insulin resistance and that the insulin-sensitizing effects of TZDs result, in part, from their anti-inflammatory properties. However the underlying mechanisms are unclear. Methodology and Principal Findings: In this study, we establish a link between free fatty acids (FFAs) and PPAR gamma in the context of obesity-associated inflammation. We show that treatment of adipocytes with FFAs, in particular Arachidonic Acid (ARA), downregulates PPAR gamma protein and mRNA levels. Furthermore, we demonstrate that the downregulation of PPAR gamma by ARA requires the activation the of Endoplamsic Reticulum (ER) stress by the TLR4 pathway. Knockdown of adipocyte PPAR gamma resulted in upregulation of MCP1 gene expression and secretion, leading to enhanced macrophage chemotaxis. Rosi inhibited these effects. In a high fat feeding mouse model, we show that Rosi treatment decreases recruitment of proinflammatory macrophages to epididymal fat. This correlates with decreased chemokine and decreased chemokine receptor expression in adipocytes and macrophages, respectively. Conclusions and Significance: In summary, we describe a novel link between FAs, the TLR4/ER stress pathway and PPAR gamma, and adipocyte-driven recruitment of macrophages. We thus both describe an additional potential mechanism for the anti-inflammatory and insulin-sensitizing actions of TZDs and an additional detrimental property associated with the activation of the TLR4 pathway by FA.	[Nguyen, M. T. Audrey; Chen, Ai; Lu, Wendell J.; Fan, WuQiang; Li, Ping-Ping; Oh, Da Young; Patsouris, David] Univ Calif San Diego, Dept Med 0673, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Nguyen, MTA (corresponding author), Genentech Inc, San Francisco, CA 94080 USA.	david.patsouris@inserm.fr	Li, Pingping/F-1109-2019	Li, Pingping/0000-0003-0679-270X	National Institution of Health [DK033651, DK074868, T32 DK 007494, DK063491]; Eunice Kennedy Shriver National Institute of Child Health and Human Development/National Institutes of Health (NICHD/NIH) [U54 HD 012303-25]; l'agence nationale pour la recherche (ANR) [ANR-09-RPDOC-018-01]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD012303] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK074868, R01DK033651, P30DK063491, R37DK033651, T32DK007494] Funding Source: NIH RePORTER	National Institution of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Eunice Kennedy Shriver National Institute of Child Health and Human Development/National Institutes of Health (NICHD/NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); l'agence nationale pour la recherche (ANR)(French National Research Agency (ANR)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grants from the National Institution of Health: DK033651, DK074868, T32 DK 007494, and DK063491. This work was also supported by the Eunice Kennedy Shriver National Institute of Child Health and Human Development/National Institutes of Health (NICHD/NIH) through cooperative agreement of U54 HD 012303-25 as part of the specialized Cooperative Centers Program in Reproduction and Infertility Research. DP is supported by l'agence nationale pour la recherche (ANR; ANR-09-RPDOC-018-01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barak Y, 1999, MOL CELL, V4, P585, DOI 10.1016/S1097-2765(00)80209-9; Camp HS, 1999, FEBS LETT, V447, P186, DOI 10.1016/S0014-5793(99)00268-9; Choi JH, 2010, NATURE, V466, P451, DOI 10.1038/nature09291; Chung S, 2006, ENDOCRINOLOGY, V147, P5340, DOI 10.1210/en.2006-0536; Desvergne B, 1999, ENDOCR REV, V20, P649, DOI 10.1210/er.20.5.649; Fan WQ, 2009, J BIOL CHEM, V284, P12188, DOI 10.1074/jbc.M808915200; Gregoire FM, 2009, MOL ENDOCRINOL, V23, P975, DOI 10.1210/me.2008-0473; Han CY, 2010, DIABETES, V59, P386, DOI 10.2337/db09-0925; He WM, 2003, P NATL ACAD SCI USA, V100, P15712, DOI 10.1073/pnas.2536828100; Hevener AL, 2000, DIABETES, V49, P2154, DOI 10.2337/diabetes.49.12.2154; Hevener AL, 2003, NAT MED, V9, P1491, DOI 10.1038/nm956; Hevener AL, 2007, J CLIN INVEST, V117, P1658, DOI 10.1172/JCI31561; Hirabara SM, 2007, J CELL PHYSIOL, V210, P7, DOI 10.1002/jcp.20811; Hotamisligil GS, 2010, CELL, V140, P900, DOI 10.1016/j.cell.2010.02.034; Imai T, 2004, P NATL ACAD SCI USA, V101, P4543, DOI 10.1073/pnas.0400356101; Inouye KE, 2007, DIABETES, V56, P2242, DOI 10.2337/db07-0425; Jiao P, 2009, DIABETES, V58, P104, DOI 10.2337/db07-1344; Jiao P, 2011, OBESITY, V19, P483, DOI 10.1038/oby.2010.200; Kersten S, 2000, NATURE, V405, P421, DOI 10.1038/35013000; KLIEWER SA, 1995, CELL, V83, P813, DOI 10.1016/0092-8674(95)90194-9; Lee JY, 2003, J LIPID RES, V44, P479, DOI 10.1194/jlr.M200361-JLR200; Liao W, 2007, AM J PHYSIOL-ENDOC M, V293, pE219, DOI 10.1152/ajpendo.00695.2006; Liu N, 2010, LIFE SCI, V87, P367, DOI 10.1016/j.lfs.2010.07.012; Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881; Lumeng CN, 2008, DIABETES, V57, P3239, DOI 10.2337/db08-0872; Mantovani A, 2004, TRENDS IMMUNOL, V25, P677, DOI 10.1016/j.it.2004.09.015; Martinon F, 2010, NAT IMMUNOL, V11, P411, DOI 10.1038/ni.1857; McClelland S, 2010, ATHEROSCLEROSIS, V211, P96, DOI 10.1016/j.atherosclerosis.2010.02.003; Nguyen MTA, 2007, J BIOL CHEM, V282, P35279, DOI 10.1074/jbc.M706762200; Nguyen MTA, 2005, J BIOL CHEM, V280, P35361, DOI 10.1074/jbc.M504611200; Odegaard JI, 2011, ANNU REV PATHOL-MECH, V6, P275, DOI 10.1146/annurev-pathol-011110-130138; Ogawa S, 2005, CELL, V122, P707, DOI 10.1016/j.cell.2005.06.029; Oh DY, 2010, CELL, V142, P687, DOI 10.1016/j.cell.2010.07.041; Park SH, 2010, J BIOL CHEM, V285, P35330, DOI 10.1074/jbc.M110.136259; Pascual Gabriel, 2007, Novartis Found Symp, V286, P183; Patsouris D, 2008, CELL METAB, V8, P301, DOI 10.1016/j.cmet.2008.08.015; Patsouris David, 2004, Curr Opin Investig Drugs, V5, P1045; Patsouris D, 2009, J BIOL CHEM, V284, P31223, DOI 10.1074/jbc.M109.041665; RON D, 1992, GENE DEV, V6, P439, DOI 10.1101/gad.6.3.439; Ruan H, 2003, J BIOL CHEM, V278, P28181, DOI 10.1074/jbc.M303141200; Schenk S, 2008, J CLIN INVEST, V118, P2992, DOI 10.1172/JCI34260; Sears DD, 2007, BIOCHEM BIOPH RES CO, V364, P515, DOI 10.1016/j.bbrc.2007.10.057; Sears DD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007250; Semple RK, 2006, J CLIN INVEST, V116, P581, DOI 10.1172/JCI28003; Shi H, 2006, J CLIN INVEST, V116, P3015, DOI 10.1172/JCI28898; Solinas G, 2007, CELL METAB, V6, P386, DOI 10.1016/j.cmet.2007.09.011; Straus DS, 2000, P NATL ACAD SCI USA, V97, P4844, DOI 10.1073/pnas.97.9.4844; Suganami T, 2005, ARTERIOSCL THROM VAS, V25, P2062, DOI 10.1161/01.ATV.0000183883.72263.13; Suganami T, 2007, ARTERIOSCL THROM VAS, V27, P84, DOI 10.1161/01.ATV.0000251608.09329.9a; Sun K, 2011, J CLIN INVEST, V121, P2094, DOI 10.1172/JCI45887; TONTONOZ P, 1995, MOL CELL BIOL, V15, P351, DOI 10.1128/MCB.15.1.351; WU ZD, 1995, GENE DEV, V9, P2350, DOI 10.1101/gad.9.19.2350; ZHU YJ, 1995, P NATL ACAD SCI USA, V92, P7921, DOI 10.1073/pnas.92.17.7921	53	37	39	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2012	7	4							e34976	10.1371/journal.pone.0034976	http://dx.doi.org/10.1371/journal.pone.0034976			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WC	22529965	gold, Green Published			2022-12-25	WOS:000305347400027
J	Zhao, YX; Guo, SC; Sun, JF; Huang, ZH; Zhu, TY; Zhang, HY; Gu, J; He, YH; Wang, W; Ma, KL; Wang, JN; Yu, J				Zhao, Yangxing; Guo, Shicheng; Sun, Jinfeng; Huang, Zhaohui; Zhu, Tongyu; Zhang, Hongyu; Gu, Jun; He, Yinghua; Wang, Wei; Ma, Kelong; Wang, Jina; Yu, Jian			Methylcap-Seq Reveals Novel DNA Methylation Markers for the Diagnosis and Recurrence Prediction of Bladder Cancer in a Chinese Population	PLOS ONE			English	Article							URINE SEDIMENTS; GENES; HYPERMETHYLATION; EPIGENETICS; BIOMARKERS; PATTERNS	Purpose: There is a need to supplement or supplant the conventional diagnostic tools, namely, cystoscopy and B-type ultrasound, for bladder cancer (BC). We aimed to identify novel DNA methylation markers for BC through genome-wide profiling of BC cell lines and subsequent methylation-specific PCR (MSP) screening of clinical urine samples. Experimental Design: The methyl-DNA binding domain (MBD) capture technique, methylCap/seq, was performed to screen for specific hypermethylated CpG islands in two BC cell lines (5637 and T24). The top one hundred hypermethylated targets were sequentially screened by MSP in urine samples to gradually narrow the target number and optimize the composition of the diagnostic panel. The diagnostic performance of the obtained panel was evaluated in different clinical scenarios. Results: A total of 1,627 hypermethylated promoter targets in the BC cell lines was identified by Illumina sequencing. The top 104 hypermethylated targets were reduced to eight genes (VAX1, KCNV1, ECEL1, TMEM26, TAL1, PROX1, SLC6A20, and LMX1A) after the urine DNA screening in a small sample size of 8 normal control and 18 BC subjects. Validation in an independent sample of 212 BC patients enabled the optimization of five methylation targets, including VAX1, KCNV1, TAL1, PPOX1, and CFTR, which was obtained in our previous study, for BC diagnosis with a sensitivity and specificity of 88.68% and 87.25%, respectively. In addition, the methylation of VAX1 and LMX1A was found to be associated with BC recurrence. Conclusions: We identified a promising diagnostic marker panel for early non-invasive detection and subsequent BC surveillance.	[Zhao, Yangxing; Sun, Jinfeng; Zhang, Hongyu; Gu, Jun; He, Yinghua; Wang, Wei; Ma, Kelong; Yu, Jian] Shanghai Jiao Tong Univ, State Key Lab Oncogenes & Related Genes, Shanghai Canc Inst, Renji Hosp,Sch Med, Shanghai 200030, Peoples R China; [Guo, Shicheng] Fudan Univ, Minist Educ, Key Lab Contemporary Anthropol, Shanghai 200433, Peoples R China; [Guo, Shicheng] Fudan Univ, State Key Lab Genet Engn, Sch Life Sci, Shanghai 200433, Peoples R China; [Guo, Shicheng] Fudan Univ, Inst Biomed Sci, Shanghai 200433, Peoples R China; [Huang, Zhaohui] Suzhou Univ, Oncol Inst Wuxi, Affiliated Hosp 4, Wuxi, Peoples R China; [Zhu, Tongyu; Wang, Jina] Fudan Univ, Dept Urol, Shanghai Key Lab Organ Transplantat, Zhongshan Hosp, Shanghai 200433, Peoples R China	Shanghai Jiao Tong University; Fudan University; Fudan University; Fudan University; Fudan University	Zhao, YX (corresponding author), Shanghai Jiao Tong Univ, State Key Lab Oncogenes & Related Genes, Shanghai Canc Inst, Renji Hosp,Sch Med, Shanghai 200030, Peoples R China.	gyujian@163.com	SUN, JIN/GPX-9641-2022; Guo, Shicheng/A-1204-2016; Huang, Zhaohui/S-9410-2019	Guo, Shicheng/0000-0002-7047-9972; Huang, Zhaohui/0000-0002-0117-9976	National Science foundation [30872963]; State Key Laboratory of Oncogenes and Related Genes foundation [91-11-01]; Science and Technology Commission of Shanghai [114119a4100]; Shanghai Science foundation [09ZR1429900]; Shanghai Cancer institute, master & doctoral foundation [SB09-07]	National Science foundation(National Science Foundation (NSF)); State Key Laboratory of Oncogenes and Related Genes foundation; Science and Technology Commission of Shanghai(Science & Technology Commission of Shanghai Municipality (STCSM)); Shanghai Science foundation; Shanghai Cancer institute, master & doctoral foundation	This work was supported by the National Science foundation grants (30872963); the State Key Laboratory of Oncogenes and Related Genes foundation (91-11-01); Medical guide project from Science and Technology Commission of Shanghai (114119a4100); Shanghai Science foundation grants (09ZR1429900); and Shanghai Cancer institute, master & doctoral foundation (SB09-07). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aleman A, 2008, BRIT J CANCER, V98, P466, DOI 10.1038/sj.bjc.6604143; Battagli C, 2003, CANCER RES, V63, P8695; Baylin SB, 2006, NAT REV CANCER, V6, P107, DOI 10.1038/nrc1799; Baylin Stephen B, 2005, Nat Clin Pract Oncol, V2 Suppl 1, pS4, DOI 10.1038/ncponc0354; Benoit A, 2004, BIOCHEM J, V380, P881, DOI 10.1042/BJ20040215; Berger SL, 2007, NATURE, V447, P407, DOI 10.1038/nature05915; Bharti K, 2011, DEVELOPMENT, V138, P873, DOI 10.1242/dev.056465; BIRD AP, 1986, NATURE, V321, P209, DOI 10.1038/321209a0; Botteman MF, 2003, PHARMACOECONOMICS, V21, P1315, DOI 10.1007/BF03262330; Brinkman AB, 2010, METHODS, V52, P232, DOI 10.1016/j.ymeth.2010.06.012; Cardoso BA, 2011, LEUKEMIA, V25, P1578, DOI 10.1038/leu.2011.140; Chan MWY, 2002, CLIN CANCER RES, V8, P464; Chen RZ, 1998, NATURE, V395, P89, DOI 10.1038/25779; Chung W, 2011, CANCER EPIDEM BIOMAR, V20, P1483, DOI 10.1158/1055-9965.EPI-11-0067; Costa VL, 2010, CLIN CANCER RES, V16, P5842, DOI 10.1158/1078-0432.CCR-10-1312; Dong WJ, 2011, CANCER SCI, V102, P361, DOI 10.1111/j.1349-7006.2010.01804.x; Dumache R, 2011, MED-SURG J, V115, P163; Ebihara M, 2004, GENE, V325, P89, DOI 10.1016/j.gene.2003.09.044; Eden A, 2003, SCIENCE, V300, P455, DOI 10.1126/science.1083557; Enokida H, 2008, INT J CLIN ONCOL, V13, P298, DOI 10.1007/s10147-008-0811-1; Feinberg AP, 2007, NATURE, V447, P433, DOI 10.1038/nature05919; Friedrich MG, 2004, CLIN CANCER RES, V10, P7457, DOI 10.1158/1078-0432.CCR-04-0930; Herr Harry W., 1997, P273; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Kaufman DS, 2009, LANCET, V374, P239, DOI 10.1016/S0140-6736(09)60491-8; Kitamura Hiroshi, 2006, Int J Clin Oncol, V11, P28, DOI 10.1007/s10147-006-0552-y; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Li N, 2010, METHODS, V52, P203, DOI 10.1016/j.ymeth.2010.04.009; [刘恩莉 Liu Enchi], 2004, [肿瘤, Tumor], V24, P11; Ma YH, 2005, J CELL SCI, V118, P1607, DOI 10.1242/jcs.02291; Mitra AP, 2009, ANNU REV PATHOL-MECH, V4, P251, DOI 10.1146/annurev.pathol.4.110807.092230; Negraes PD, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-238; Reik W, 2007, NATURE, V447, P425, DOI 10.1038/nature05918; Reinert T, 2011, CLIN CANC RES; Rodriguez-Paredes M, 2011, NAT MED, V17, P330, DOI 10.1038/nm.2305; Tada Y, 2000, CLIN CANCER RES, V6, P4618; Town L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025228; Tsou JA, 2007, LUNG CANCER, V58, P220, DOI 10.1016/j.lungcan.2007.06.015; Urakami S, 2006, CLIN CANCER RES, V12, P2109, DOI 10.1158/1078-0432.CCR-05-2468; Versmold B, 2007, INT J CANCER, V121, P547, DOI 10.1002/ijc.22705; Wilhelm-Benartzi CS, 2010, CARCINOGENESIS, V31, P1972, DOI 10.1093/carcin/bgq178; Wolff EM, 2010, CANCER RES, V70, P8169, DOI 10.1158/0008-5472.CAN-10-1335; Yagi K, 2010, CLIN CANCER RES, V16, P21, DOI 10.1158/1078-0432.CCR-09-2006; Yu J, 2003, CELL RES, V13, P319, DOI 10.1038/sj.cr.7290177; Yu J, 2007, CLIN CANCER RES, V13, P7296, DOI 10.1158/1078-0432.CCR-07-0861; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	46	47	47	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2012	7	4							e35175	10.1371/journal.pone.0035175	http://dx.doi.org/10.1371/journal.pone.0035175			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WC	22529986	gold, Green Published, Green Submitted			2022-12-25	WOS:000305347400034
J	Han, MA; Choi, KS; Lee, HY; Jun, JK; Jung, KW; Kang, S; Park, EC				Han, Mi Ah; Choi, Kui Son; Lee, Hoo-Yeon; Jun, Jae Kwan; Jung, Kyu Won; Kang, Sokbom; Park, Eun-Cheol			Performance of Papanicolaou Testing and Detection of Cervical Carcinoma In Situ in Participants of Organized Cervical Cancer Screening in South Korea	PLOS ONE			English	Article							SOCIOECONOMIC-STATUS; UNITED-STATES; MORTALITY; TRENDS; SURVIVAL; WOMEN; RISK; DISPARITIES; BREAST; EFFICIENCY	Background: The present study measured the performance of the Papanicolaou (Pap) test and detection of cervical carcinoma in situ (CIS) and cancer in participants of organized cervical cancer screening in South Korea, and examined differences in the proportion of CIS according to socio-demographic factors. Methods: Data were obtained from the National Cancer Screening Program and National Health Insurance Cancer Screening Program databases. We analyzed data from 4,072,997 screenings of women aged 30 years or older who underwent cervical cancer screening by Pap test between January 1, 2005 and December 31, 2006. We calculated the performances of the Pap test and compared that according to socio-demographic factors. Results: The positivity rate for all screenings was 6.6%. The cancer detection rate (CDR) and interval cancer rate (ICR) were 0.32 per 1,000 screenings, and 0.13 per 1,000 negative screenings, respectively. About 63.4% of screen-detected CIS+ cases (CIS or invasive cervical cancer) were CIS. The CDR and ICR, and percentage of CIS among all CIS+ were significantly different by age group and health insurance status. The odds ratios of CDR and ICR were higher for Medical Aid Program (MAP) recipients compared with National Health Insurance (NHI) beneficiaries. The likelihood of a detected CIS+ case to be CIS was significantly lower among MAP recipients than among NHI beneficiaries. Conclusions: The difference in performance of cervical cancer screening among different socio-demographic groups may indicate an important influence of socio-demographic factors on preventive behavior. The findings of the study support the critical need for increasing efforts to raise awareness and provide more screening in at-risk populations, specifically low-income groups.	[Han, Mi Ah] Chosun Univ, Dept Prevent Med, Coll Med, Kwangju, South Korea; [Choi, Kui Son; Jun, Jae Kwan; Jung, Kyu Won] Natl Canc Ctr, Natl Canc Control Res Inst, Goyang, South Korea; [Lee, Hoo-Yeon] Dankook Univ, Dept Social Med, Coll Med, Cheonan, South Korea; [Kang, Sokbom] Natl Canc Ctr, Res Inst & Hosp, Branch Uterine Canc, Goyang, South Korea; [Park, Eun-Cheol] Yonsei Univ, Coll Med, Dept Prevent Med, Seoul, South Korea; [Park, Eun-Cheol] Yonsei Univ, Coll Med, Inst Hlth Serv Res, Seoul, South Korea	Chosun University; National Cancer Center - Korea (NCC); Dankook University; National Cancer Center - Korea (NCC); Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System	Han, MA (corresponding author), Chosun Univ, Dept Prevent Med, Coll Med, Kwangju, South Korea.	kschoi@ncc.re.kr	Park, Eun-Cheol/O-5644-2019	Park, Eun-Cheol/0000-0002-2306-5398; Kang, Sokbom/0000-0002-8428-9555	National Cancer Center of Korea [1010200]; National R&D Program for Cancer Control, Ministry of Health and Welfare, Republic of Korea [0820420]	National Cancer Center of Korea; National R&D Program for Cancer Control, Ministry of Health and Welfare, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea)	This work was supported by a Grant-in-Aid for Cancer Research and Control from the National Cancer Center of Korea (grant number: 1010200) and a grant from the National R&D Program for Cancer Control, Ministry of Health and Welfare, Republic of Korea (0820420). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aklimunnessa K, 2006, JPN J CLIN ONCOL, V36, P511, DOI 10.1093/jjco/hyl060; [Anonymous], MAN INT STAT CLASS D; Bergstrom R, 1999, BRIT J CANCER, V81, P159, DOI 10.1038/sj.bjc.6690666; Day N, 1995, J Med Screen, V2, P180; DAY NE, 1989, BRIT J CANCER, V59, P954, DOI 10.1038/bjc.1989.203; DEVESA SS, 1987, J NATL CANCER I, V79, P701; Ferlay J, 2010, IARC CANCERBASE, V10; Fritz A, 2000, INT CLASSIFICATION D; Goldie SJ, 2005, NEW ENGL J MED, V353, P2158, DOI 10.1056/NEJMsa044278; GUSTAFSSON L, 1995, BRIT J CANCER, V72, P498, DOI 10.1038/bjc.1995.362; Gustafsson L, 1995, INT J CANCER, V63, P804, DOI 10.1002/ijc.2910630610; Halapy E, 2005, BREAST CANCER RES TR, V90, P299, DOI 10.1007/s10549-004-5168-1; HENSCHKE UK, 1973, CANCER-AM CANCER SOC, V31, P763, DOI 10.1002/1097-0142(197304)31:4<763::AID-CNCR2820310401>3.0.CO;2-S; Hiatt RA, 2001, PREV MED, V33, P190, DOI 10.1006/pmed.2001.0871; IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, 2004, IARC WORK GROUP EV C; Insinga RP, 2004, AM J OBSTET GYNECOL, V191, P105, DOI 10.1016/j.ajog.2004.01.043; JANERICH DT, 1995, AM J PUBLIC HEALTH, V85, P791, DOI 10.2105/AJPH.85.6.791; Jun JK, 2009, INT J CANCER, V124, P188, DOI 10.1002/ijc.23841; Jung KW, 2010, J KOREAN MED SCI, V25, P1113, DOI 10.3346/jkms.2010.25.8.1113; KERNER JF, 1993, ANNU REV PUBL HEALTH, V14, P355; Khan MJ, 2005, CANCER-AM CANCER SOC, V104, P61, DOI 10.1002/cncr.21129; Kim CW, 2008, PUBLIC HEALTH, V122, P229, DOI 10.1016/j.puhe.2007.07.003; Kim Y, 2011, ASIAN PAC J CANCER P, V12, P725; KOSARY CL, 1994, SEMIN SURG ONCOL, V10, P31, DOI 10.1002/ssu.2980100107; Kwak MS, 2009, PREV MED, V49, P48, DOI 10.1016/j.ypmed.2009.05.007; Laaksonen M, 2005, EUR J PUBLIC HEALTH, V15, P262, DOI 10.1093/eurpub/cki115; Lee HY, 2010, CANCER EPIDEM BIOMAR, V19, P1919, DOI 10.1158/1055-9965.EPI-09-1308; Levi F, 1996, BRIT J CANCER, V74, P1321, DOI 10.1038/bjc.1996.538; Mackillop WJ, 1997, J CLIN ONCOL, V15, P1680, DOI 10.1200/JCO.1997.15.4.1680; Marcus AC, 1998, PREV MED, V27, P13, DOI 10.1006/pmed.1997.0251; Miller MG, 2003, OBSTET GYNECOL, V101, P29, DOI 10.1016/S0029-7844(02)02454-7; Ministry of Health & Welfare = National Cancer Center, 2008, QUAL GUID CERV CANC; MITCHELL H, 1990, BRIT MED J, V300, P1622, DOI 10.1136/bmj.300.6740.1622; National Cancer Center, 2010, ANN REP NAT CANC SCR; Parikh S, 2003, INT J CANCER, V105, P687, DOI 10.1002/ijc.11141; Park Mi Jin, 2010, J Prev Med Public Health, V43, P330, DOI 10.3961/jpmph.2010.43.4.330; POLETTO L, 1990, CANCER LETT, V49, P201, DOI 10.1016/0304-3835(90)90159-U; Sambamoorthi U, 2003, PREV MED, V37, P475, DOI 10.1016/S0091-7435(03)00172-5; Sasieni P, 2009, BRIT MED J, V339, pb2968, DOI DOI 10.1136/BMJ.B2968; Schindeler S, 2008, J MED SCREEN, V15, P36, DOI 10.1258/jms.2008.007036; Segnan N, 1997, SOCIOECONOMIC STATUS; Shanta V, 2000, J Indian Med Assoc, V98, P49; SHELTON D, 1992, Ethnicity and Disease, V2, P47; Shin HR, 2008, INT J CANCER, V122, P393, DOI 10.1002/ijc.23015; SOBUE T, 1988, JPN J CANCER RES, V79, P1269, DOI 10.1111/j.1349-7006.1988.tb01555.x; Sung HY, 2000, CANCER, V88, P2283, DOI 10.1002/(SICI)1097-0142(20000515)88:10<2283::AID-CNCR12>3.3.CO;2-4; Tabora N, 2009, CANCER CAUSE CONTROL, V20, P1663, DOI 10.1007/s10552-009-9414-z; THOMS WW, 1995, CANCER, V76, P2518, DOI 10.1002/1097-0142(19951215)76:12<2518::AID-CNCR2820761217>3.0.CO;2-#; Vinh-Hung V, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-164; Ward E, 2004, CA-CANCER J CLIN, V54, P78, DOI 10.3322/canjclin.54.2.78; Won YJ, 2009, CANCER RES TREAT, V41, P122, DOI 10.4143/crt.2009.41.3.122; Yoo KY, 2008, JPN J CLIN ONCOL, V38, P327, DOI 10.1093/jjco/hyn026	52	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2012	7	4							e35469	10.1371/journal.pone.0035469	http://dx.doi.org/10.1371/journal.pone.0035469			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959VO	22530028	Green Published, gold, Green Submitted			2022-12-25	WOS:000305345000072
J	Herrera-Valdez, MA				Herrera-Valdez, Marco Arieli			Membranes with the Same Ion Channel Populations but Different Excitabilities	PLOS ONE			English	Article							EXCITATORY SYNAPTIC-TRANSMISSION; MATHEMATICAL-MODEL; NICOTINIC ACETYLCHOLINE; DELAYED-RECTIFIER; SODIUM-CHANNELS; VOLTAGE-CLAMP; ELECTRICAL-ACTIVITY; DROSOPHILA NEURONS; BIOPHYSICAL MODEL; HUXLEY EQUATIONS	Electrical signaling allows communication within and between different tissues and is necessary for the survival of multicellular organisms. The ionic transport that underlies transmembrane currents in cells is mediated by transporters and channels. Fast ionic transport through channels is typically modeled with a conductance-based formulation that describes current in terms of electrical drift without diffusion. In contrast, currents written in terms of drift and diffusion are not as widely used in the literature in spite of being more realistic and capable of displaying experimentally observable phenomena that conductance-based models cannot reproduce (e. g. rectification). The two formulations are mathematically related: conductance-based currents are linear approximations of drift-diffusion currents. However, conductance-based models of membrane potential are not first-order approximations of drift-diffusion models. Bifurcation analysis and numerical simulations show that the two approaches predict qualitatively and quantitatively different behaviors in the dynamics of membrane potential. For instance, two neuronal membrane models with identical populations of ion channels, one written with conductance-based currents, the other with drift-diffusion currents, undergo transitions into and out of repetitive oscillations through different mechanisms and for different levels of stimulation. These differences in excitability are observed in response to excitatory synaptic input, and across different levels of ion channel expression. In general, the electrophysiological profiles of membranes modeled with drift-diffusion and conductance-based models having identical ion channel populations are different, potentially causing the input-output and computational properties of networks constructed with these models to be different as well. The drift-diffusion formulation is thus proposed as a theoretical improvement over conductance-based models that may lead to more accurate predictions and interpretations of experimental data at the single cell and network levels.	[Herrera-Valdez, Marco Arieli] Univ Arizona, Dept Math, Tucson, AZ 85721 USA; [Herrera-Valdez, Marco Arieli] Univ Arizona, Evelyn F McKnight Brain Inst, Tucson, AZ USA; [Herrera-Valdez, Marco Arieli] Univ Puerto Rico Cayey, Dept Math & Phys, Cayey, PR USA; [Herrera-Valdez, Marco Arieli] Univ Puerto Rico Cayey, Inst Interdisciplinary Res, Cayey, PR USA	University of Arizona; University of Arizona; University of Puerto Rico; University of Puerto Rico at Cayey; University of Puerto Rico; University of Puerto Rico at Cayey	Herrera-Valdez, MA (corresponding author), Univ Arizona, Dept Math, Tucson, AZ 85721 USA.	marco.herrera@upr.edu	Herrera-Valdez, Marco Arieli/J-5782-2019	Herrera-Valdez, Marco Arieli/0000-0001-8224-9077	University of Puerto Rico through its BRIC program from the National; Center for Minority Health and Health Disparities (NCMHD) [1P20MD006144-01]; BRIC team from the Institute of Interdisciplinary Research at the University of Puerto Rico in Cayey; National Institute on Minority Health and Health Disparities [P20MD006144] Funding Source: NIH RePORTER	University of Puerto Rico through its BRIC program from the National; Center for Minority Health and Health Disparities (NCMHD); BRIC team from the Institute of Interdisciplinary Research at the University of Puerto Rico in Cayey; National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	Partial funding for this publication was provided by the University of Puerto Rico through its BRIC program from the National. No additional external funding was received for this study Center for Minority Health and Health Disparities (NCMHD), grant #1P20MD006144-01. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The author thanks Joceline Lega for her guidance, criticism, and encouragement. Thanks also to Sandra Berger, Greg Buzzard, and Errol Montes-Pizarro for their comments and all the discussions we had related to this manuscript. Special thanks to Erin McKiernan and the two unknown reviewers for their encouragement and suggestions which helped to improve this manuscript. The author extends special thanks to Isar Godreau and other members of the BRIC team from the Institute of Interdisciplinary Research at the University of Puerto Rico in Cayey for their financial and logistic support, which made this publication possible.	ADRAIN RH, 1970, J PHYSIOL-LONDON, V208, P607; ALDRICH RW, 1983, NATURE, V306, P436, DOI 10.1038/306436a0; AVRON E, 1991, BIOL CYBERN, V65, P487, DOI 10.1007/BF00204662; BAER SM, 1989, SIAM J APPL MATH, V49, P55, DOI 10.1137/0149003; Baranauskas G, 2006, J NEUROSCI, V26, P671, DOI 10.1523/JNEUROSCI.2283-05.2006; BUCHHOLTZ F, 1992, J NEUROPHYSIOL, V67, P332, DOI 10.1152/jn.1992.67.2.332; Caldwell JH, 2000, P NATL ACAD SCI USA, V97, P5616, DOI 10.1073/pnas.090034797; Chu ZG, 2000, BRAIN RES, V887, P399, DOI 10.1016/S0006-8993(00)03076-6; Clay JR, 2009, FRONT CELL NEUROSCI, V3, DOI 10.3389/neuro.03.020.2009; Clay JR, 2008, J R SOC INTERFACE, V5, P1421, DOI 10.1098/rsif.2008.0166; CLAY JR, 1984, BIOPHYS J, V45, P481, DOI 10.1016/S0006-3495(84)84172-7; CLAY JR, 1991, J PHYSIOL-LONDON, V444, P499, DOI 10.1113/jphysiol.1991.sp018890; DEMIR SS, 1994, AM J PHYSIOL, V266, pC832, DOI 10.1152/ajpcell.1994.266.3.C832; Destexhe A, 1994, J Comput Neurosci, V1, P195, DOI 10.1007/BF00961734; DESTEXHE A, 1994, NEURAL COMPUT, V6, P14, DOI 10.1162/neco.1994.6.1.14; DIFRANCESCO D, 1985, PHILOS T ROY SOC B, V307, P353, DOI 10.1098/rstb.1985.0001; Duch C, 2008, J NEUROPHYSIOL, V100, P2525, DOI 10.1152/jn.90758.2008; Eisenberg B, 1998, ACCOUNTS CHEM RES, V31, P117, DOI 10.1021/ar950051e; Endresen LP, 2000, EUR BIOPHYS J BIOPHY, V29, P90, DOI 10.1007/s002490050254; Ermentrout G. B., 2010, INTERDISCIPLINARY AP, V35; FOHLMEISTER JF, 1990, BRAIN RES, V510, P343, DOI 10.1016/0006-8993(90)91388-W; Fohlmeister JF, 1997, J NEUROPHYSIOL, V78, P1935, DOI 10.1152/jn.1997.78.4.1935; Galligan JJ, 2000, J AUTONOM NERV SYST, V81, P97, DOI 10.1016/S0165-1838(00)00130-2; Gerstner W., 2002, SPIKING NEURON MODEL; Goldman DE, 1943, J GEN PHYSIOL, V27, P37, DOI 10.1085/jgp.27.1.37; HARDIE RC, 1994, J GEN PHYSIOL, V103, P389, DOI 10.1085/jgp.103.3.389; Herrera-Valdez MA, 2009, THESIS U ARIZONA; Herrera-Valdez MA, 2011, THESIS MATH U ARIZON; Herrera-Valdez MA, 2011, J THEOR BIOL, V270, P164, DOI 10.1016/j.jtbi.2010.09.042; Hille B., 1992, IONIC CHANNELS EXCIT; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; HOUNSGAARD J, 1984, EXP BRAIN RES, V55, P391; Ikeno H, 1999, NEUROCOMPUTING, V26-7, P177, DOI 10.1016/S0925-2312(99)00079-X; Islas LD, 1999, J GEN PHYSIOL, V114, P723, DOI 10.1085/jgp.114.5.723; Izhikevich E., 2007, DYNAMICAL SYSTEMS NE; JACK JJB, 1981, J PHYSIOL-LONDON, V321, P65, DOI 10.1113/jphysiol.1981.sp013972; Johnston D., 1995, FDN CELLULAR NEUROPH; KATZ B, 1973, J PHYSIOL-LONDON, V231, P549, DOI 10.1113/jphysiol.1973.sp010248; KEPLER TB, 1992, BIOL CYBERN, V66, P381, DOI 10.1007/BF00197717; King GF, 2008, CHANNELS, V2, P100, DOI 10.4161/chan.2.2.6022; Koch C., 1998, METHODS NEURONAL MOD, DOI 10.1016/s0898-1221(98)91179-8; KRINSKII VI, 1973, BIOFIZIKA+, V18, P506; Kuhn A, 2004, J NEUROSCI, V24, P2345, DOI 10.1523/JNEUROSCI.3349-03.2004; Lee D, 1999, J NEUROSCI, V19, P5311; Lee RH, 1998, J NEUROPHYSIOL, V80, P583, DOI 10.1152/jn.1998.80.2.583; Lin WH, 2009, J NEUROPHYSIOL, V102, P1994, DOI 10.1152/jn.00613.2009; Mitchell CC, 2003, B MATH BIOL, V65, P767, DOI 10.1016/S0092-8240(03)00041-7; MORRIS C, 1981, BIOPHYS J, V35, P193, DOI 10.1016/S0006-3495(81)84782-0; NEHER E, 1971, J GEN PHYSIOL, V58, P36, DOI 10.1085/jgp.58.1.36; Nonner W, 1998, BIOPHYS J, V75, P1287, DOI 10.1016/S0006-3495(98)74048-2; Nowotny T, 2007, NEURAL COMPUT, V19, P1985, DOI 10.1162/neco.2007.19.8.1985; ODOWD DK, 1988, J NEUROSCI, V8, P3633; PAK MD, 1991, J NEUROSCI, V11, P869; Pedersen MG, 2010, BIOPHYS J, V99, P3200, DOI 10.1016/j.bpj.2010.09.004; Peng IF, 2007, J NEUROPHYSIOL, V97, P780, DOI 10.1152/jn.01012.2006; Prinz AA, 2003, J NEUROPHYSIOL, V90, P3998, DOI 10.1152/jn.00641.2003; RALL W, 1962, ANN NY ACAD SCI, V96, P1071, DOI 10.1111/j.1749-6632.1962.tb54120.x; RALL W, 1973, BIOPHYS J, V13, P648, DOI 10.1016/S0006-3495(73)86014-X; RALL W, 1959, EXP NEUROL, V1, P491, DOI 10.1016/0014-4886(59)90046-9; RASMUSSON RL, 1990, AM J PHYSIOL, V259, pH352, DOI 10.1152/ajpheart.1990.259.2.H352; RASMUSSON RL, 1990, AM J PHYSIOL, V259, pH370, DOI 10.1152/ajpheart.1990.259.2.H370; RIBALET B, 1982, AM J PHYSIOL, V242, pC296, DOI 10.1152/ajpcell.1982.242.5.C296; RINZEL J, 1985, FED PROC, V44, P2944; RINZEL J, 1988, BIOPHYS J, V54, P551, DOI 10.1016/S0006-3495(88)82988-6; Rinzel J., 1989, ANAL NEURAL EXCITABI; Roerig B, 1997, J NEUROSCI, V17, P8353; SALKOFF L, 1992, TRENDS NEUROSCI, V15, P161, DOI 10.1016/0166-2236(92)90165-5; Schulz DJ, 2007, P NATL ACAD SCI USA, V104, P13187, DOI 10.1073/pnas.0705827104; Smith LA, 1996, J NEUROSCI, V16, P7868; Stevens CF, 1979, ION PERMEATION MEMBR, V3; Strogatz S.H., 1994, NONLINEAR DYNAMICS C; Tang X, 2010, NEUROSCIENCE, V166, P397, DOI 10.1016/j.neuroscience.2010.01.005; TRAUB RD, 1991, J NEUROPHYSIOL, V66, P635, DOI 10.1152/jn.1991.66.2.635; TSUNODA S, 1995, J NEUROSCI, V15, P1741, DOI 10.1523/JNEUROSCI.15-03-01741.1995; TSUNODA S, 1995, J NEUROSCI, V15, P5209; VANDENBERG CA, 1991, BIOPHYS J, V60, P1499, DOI 10.1016/S0006-3495(91)82185-3; WALMSLEY B, 1987, J NEUROSCI, V7, P1037; Warmke JW, 1997, J GEN PHYSIOL, V110, P119, DOI 10.1085/jgp.110.2.119; WEI A, 1990, SCIENCE, V248, P599, DOI 10.1126/science.2333511; WEISS T, 1996, CELLULAR BIOPHYSICS, V1; Weiss T., 1996, CELLULAR BIOPHYSICS, VII; Wilders R, 2007, MED BIOL ENG COMPUT, V45, P189, DOI 10.1007/s11517-006-0127-0; Willms AR, 1999, J COMPUT NEUROSCI, V6, P145, DOI 10.1023/A:1008880518515; Yang J, 2009, NEUROSCIENCE, V163, P799, DOI 10.1016/j.neuroscience.2009.07.007	84	2	3	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2012	7	4							e34636	10.1371/journal.pone.0034636	http://dx.doi.org/10.1371/journal.pone.0034636			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VO	22523552	gold, Green Submitted, Green Published			2022-12-25	WOS:000305345000022
J	Malchiodi-Albedi, F; Paradisi, S; Di Nottia, M; Simone, D; Travaglione, S; Falzano, L; Guidotti, M; Frank, C; Cutarelli, A; Fabbri, A; Fiorentini, C				Malchiodi-Albedi, Fiorella; Paradisi, Silvia; Di Nottia, Michela; Simone, Daiana; Travaglione, Sara; Falzano, Loredana; Guidotti, Marco; Frank, Claudio; Cutarelli, Alessandro; Fabbri, Alessia; Fiorentini, Carla			CNF1 Improves Astrocytic Ability to Support Neuronal Growth and Differentiation In vitro	PLOS ONE			English	Article							LONG-TERM POTENTIATION; RHO-GTPASES; ACTIVATION; PLASTICITY; ROLES; MORPHOGENESIS; NEUROGENESIS; INFLAMMATION; INDUCTION; SURVIVAL	Modulation of cerebral Rho GTPases activity in mice brain by intracerebral administration of Cytotoxic Necrotizing Factor 1 (CNF1) leads to enhanced neurotransmission and synaptic plasticity and improves learning and memory. To gain more insight into the interactions between CNF1 and neuronal cells, we used primary neuronal and astrocytic cultures from rat embryonic brain to study CNF1 effects on neuronal differentiation, focusing on dendritic tree growth and synapse formation, which are strictly modulated by Rho GTPases. CNF1 profoundly remodeled the cytoskeleton of hippocampal and cortical neurons, which showed philopodia-like, actin-positive projections, thickened and poorly branched dendrites, and a decrease in synapse number. CNF1 removal, however, restored dendritic tree development and synapse formation, suggesting that the toxin can reversibly block neuronal differentiation. On differentiated neurons, CNF1 had a similar effacing effect on synapses. Therefore, a direct interaction with CNF1 is apparently deleterious for neurons. Since astrocytes play a pivotal role in neuronal differentiation and synaptic regulation, we wondered if the beneficial in vivo effect could be mediated by astrocytes. Primary astrocytes from embryonic cortex were treated with CNF1 for 48 hours and used as a substrate for growing hippocampal neurons. Such neurons showed an increased development of neurites, in respect to age-matched controls, with a wider dendritic tree and a richer content in synapses. In CNF1-exposed astrocytes, the production of interleukin 1 beta, known to reduce dendrite development and complexity in neuronal cultures, was decreased. These results demonstrate that astrocytes, under the influence of CNF1, increase their supporting activity on neuronal growth and differentiation, possibly related to the diminished levels of interleukin 1 beta. These observations suggest that the enhanced synaptic plasticity and improved learning and memory described in CNF1-injected mice are probably mediated by astrocytes.	[Malchiodi-Albedi, Fiorella; Paradisi, Silvia; Simone, Daiana] Ist Super Sanita, Dept Cell Biol & Neurosci, I-00161 Rome, Italy; [Di Nottia, Michela; Travaglione, Sara; Falzano, Loredana; Fabbri, Alessia; Fiorentini, Carla] Ist Super Sanita, Dept Therapeut Res & Med Evaluat, I-00161 Rome, Italy; [Guidotti, Marco] Ist Super Sanita, Dept Vet Publ Hlth & Food Safety, I-00161 Rome, Italy; [Frank, Claudio; Cutarelli, Alessandro] Ist Super Sanita, Natl Ctr Rare Dis, I-00161 Rome, Italy	Istituto Superiore di Sanita (ISS); Istituto Superiore di Sanita (ISS); Istituto Superiore di Sanita (ISS); Istituto Superiore di Sanita (ISS)	Malchiodi-Albedi, F (corresponding author), Ist Super Sanita, Dept Cell Biol & Neurosci, Viale Regina Elena 299, I-00161 Rome, Italy.	fiorella.malchiodi@iss.it; carla.fiorentini@iss.it	Travaglione, Sara/AAJ-2516-2021; Di Nottia, Michela/J-5207-2018; FIORENTINI, CARLA/AAG-8005-2019; Fabbri, Alessia/AAA-4594-2019; Guidotti, Marco/D-2069-2015; Fiorentini, Carla/Q-2088-2015; Malchiodi-Albedi, Fiorella/A-5944-2015; FRANK, CLAUDIO/A-6642-2015	Di Nottia, Michela/0000-0001-8970-0617; FIORENTINI, CARLA/0000-0003-1707-6282; Fabbri, Alessia/0000-0002-3075-3367; Fiorentini, Carla/0000-0003-1707-6282; Malchiodi-Albedi, Fiorella/0000-0001-7202-0391; FRANK, CLAUDIO/0000-0002-6016-5750; Travaglione, Sara/0000-0002-2816-0490; falzano, loredana/0000-0003-4074-180X	Italia-USA Collaboration Program [Fascicolo 11US/1]; Cure_FXS project under the E-Rare program	Italia-USA Collaboration Program; Cure_FXS project under the E-Rare program	This work was partially supported by "Italia-USA Collaboration Program", Fascicolo 11US/1 (to Dr. Fiorentini) and by the Cure_FXS project (www.cure-fxs.eu) under the E-Rare program (to Dr. Fiorentini and Dr. Malchiodi-Albedi). No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asrar S, 2009, NEUROPHARMACOLOGY, V56, P73, DOI 10.1016/j.neuropharm.2008.06.055; Barres BA, 2008, NEURON, V60, P430, DOI 10.1016/j.neuron.2008.10.013; Cerri C, 2011, J NEUROSCI, V31, P15163, DOI 10.1523/JNEUROSCI.2617-11.2011; Chen CJ, 2000, J NEUROCHEM, V75, P1557, DOI 10.1046/j.1471-4159.2000.0751557.x; Cordero-Llana O, 2011, CELL DEATH DIFFER, V18, P907, DOI 10.1038/cdd.2010.169; De Filippis B, 2012, NEUROPSYCHOPHARMACOL, V37, P1152, DOI 10.1038/npp.2011.301; De Viti S, 2010, BEHAV BRAIN RES, V212, P78, DOI 10.1016/j.bbr.2010.03.049; Diana G, 2007, P NATL ACAD SCI USA, V104, P636, DOI 10.1073/pnas.0610059104; Emirandetti A, 2006, BRAIN RES, V1095, P35, DOI 10.1016/j.brainres.2006.04.021; FALZANO L, 1993, MOL MICROBIOL, V9, P1247, DOI 10.1111/j.1365-2958.1993.tb01254.x; Flatau G, 1997, NATURE, V387, P729, DOI 10.1038/42743; Fortin DA, 2010, J NEUROSCI, V30, P11565, DOI 10.1523/JNEUROSCI.1746-10.2010; Fu WY, 2007, NAT NEUROSCI, V10, P67, DOI 10.1038/nn1811; Garay Paula A, 2010, Front Synaptic Neurosci, V2, P136, DOI 10.3389/fnsyn.2010.00136; Gilmore JH, 2004, NEUROPSYCHOPHARMACOL, V29, P1221, DOI 10.1038/sj.npp.1300446; Glass CK, 2010, CELL, V140, P918, DOI 10.1016/j.cell.2010.02.016; Hotulainen P, 2010, J CELL BIOL, V189, P619, DOI 10.1083/jcb.201003008; KANAI Y, 1993, TRENDS NEUROSCI, V16, P365, DOI 10.1016/0166-2236(93)90094-3; Kasri NN, 2008, PFLUG ARCH EUR J PHY, V455, P787, DOI 10.1007/s00424-007-0385-1; Kuzumaki N, 2010, SYNAPSE, V64, P721, DOI 10.1002/syn.20800; Linseman DA, 2008, FRONT BIOSCI-LANDMRK, V13, P657, DOI 10.2741/2710; Luo LQ, 2000, NAT REV NEUROSCI, V1, P173, DOI 10.1038/35044547; Malchiodi-Albedi F, 2001, GLIA, V34, P68, DOI 10.1002/glia.1041; Menet V, 2001, J NEUROSCI, V21, P6147; Middeldorp J, 2011, PROG NEUROBIOL, V93, P421, DOI 10.1016/j.pneurobio.2011.01.005; Murakoshi H, 2011, NATURE, V472, P100, DOI 10.1038/nature09823; O'Kane EM, 2003, J NEUROCHEM, V87, P1309, DOI 10.1046/j.1471-4159.2003.02102.x; Pavone F, 2009, PAIN, V145, P219, DOI 10.1016/j.pain.2009.06.026; Penzes P, 2003, NEURON, V37, P263, DOI 10.1016/S0896-6273(02)01168-6; Rex CS, 2009, J CELL BIOL, V186, P85, DOI 10.1083/jcb.200901084; Rossi D, 2009, BRAIN RES BULL, V80, P224, DOI 10.1016/j.brainresbull.2009.07.012; Rozovsky I, 2005, NEUROBIOL AGING, V26, P705, DOI 10.1016/j.neurobiolaging.2004.06.009; Saneyoshi T, 2010, CURR OPIN NEUROBIOL, V20, P108, DOI 10.1016/j.conb.2009.09.013; Schmidt G, 1997, NATURE, V387, P725, DOI 10.1038/42735; Stipursky J, 2011, LIFE SCI, V89, P524, DOI 10.1016/j.lfs.2011.04.005; Tashiro A, 2008, METHOD ENZYMOL, V439, P285, DOI 10.1016/S0076-6879(07)00421-1; Tolias KF, 2005, NEURON, V45, P525, DOI 10.1016/j.neuron.2005.01.024; Tolias KF, 2011, PROG NEUROBIOL, V94, P133, DOI 10.1016/j.pneurobio.2011.04.011; Tong LQ, 2008, NEUROBIOL AGING, V29, P1380, DOI 10.1016/j.neurobiolaging.2007.02.027; VERNADAKIS A, 1988, INT REV NEUROBIOL, V30, P149; Wang HG, 2005, NEURON, V45, P389, DOI 10.1016/j.neuron.2005.01.011; Whitney NP, 2009, J NEUROCHEM, V108, P1343, DOI 10.1111/j.1471-4159.2009.05886.x	42	27	28	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2012	7	4							e34115	10.1371/journal.pone.0034115	http://dx.doi.org/10.1371/journal.pone.0034115			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VO	22523545	Green Submitted, Green Published, gold			2022-12-25	WOS:000305345000014
J	Chen, QQ; Wang, H; Hetmanski, JB; Zhang, TX; Ruczinski, I; Schwender, H; Liang, KY; Fallin, MD; Redett, RJ; Raymond, GV; Chou, YHW; Chen, PKT; Yeow, V; Chong, SS; Cheah, FSH; Jabs, EW; Scott, AF; Beaty, TH				Chen, Qianqian; Wang, Hong; Hetmanski, Jacqueline B.; Zhang, Tianxiao; Ruczinski, Ingo; Schwender, Holger; Liang, Kung Yee; Fallin, M. Daniele; Redett, Richard J.; Raymond, Gerald V.; Chou, Yah-Huei Wu; Chen, Philip Kuo-Ting; Yeow, Vincent; Chong, Samuel S.; Cheah, Felicia S. H.; Jabs, Ethylin Wang; Scott, Alan F.; Beaty, Terri H.			BMP4 Was Associated with NSCL/P in an Asian Population	PLOS ONE			English	Article							NONSYNDROMIC CLEFT-LIP; 4 GENE POLYMORPHISMS; PALATE; LINKAGE; SUSCEPTIBILITY; LIP/PALATE; VARIANTS; FUSION	Background: The Bone Morphogenetic Protein 4 gene (BMP4) is located in chromosome 14q22-q23 which has shown evidence of linkage for isolated nonsyndromic cleft lip with or without cleft palate (NSCL/P) in a genome wide linkage analysis of human multiplex families. BMP4 has been shown to play crucial roles in lip and palatal development in animal models. Several candidate gene association analyses also supported its potential risk for NSCL/P, however, results across these association studies have been inconsistent. The aim of the current study was to test for possible association between markers in and around the BMP4 gene and NSCL/P in Asian and Maryland trios. Methodology/Principal Findings: Family Based Association Test was used to test for deviation from Mendelian assortment for 12 SNPs in and around BMP4. Nominal significant evidence of linkage and association was seen for three SNPs (rs10130587, rs2738265 and rs2761887) in 221 Asian trios and for one SNP (rs762642) in 76 Maryland trios. Statistical significance still held for rs10130587 after Bonferroni correction (corrected p = 0.019) among the Asian group. Estimated odds ratio for carrying the apparent high risk allele at this SNP was 1.61 (95% CI = 1.20, 2.18). Conclusions: Our results provided further evidence of association between BMP4 and NSCL/P.	[Chen, Qianqian; Wang, Hong] Peking Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Beijing 100871, Peoples R China; [Hetmanski, Jacqueline B.; Ruczinski, Ingo; Fallin, M. Daniele; Beaty, Terri H.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA; [Zhang, Tianxiao] Washington Univ, Div Biol & Biomed Sci, St Louis, MO USA; [Schwender, Holger] TU Dortmund Univ, Dept Fac Stat, Dortmund, Germany; [Liang, Kung Yee] Natl Yang Ming Univ, Dept Life Sci, Taipei 112, Taiwan; [Liang, Kung Yee] Natl Yang Ming Univ, Inst Genome Sci, Taipei 112, Taiwan; [Redett, Richard J.] Johns Hopkins Univ, Sch Med, Dept Surg, Baltimore, MD 21205 USA; [Raymond, Gerald V.] Johns Hopkins Univ, Sch Med, Kennedy Krieger Inst, Baltimore, MD USA; [Chou, Yah-Huei Wu] Chang Gung Mem Hosp, Dept Med Res, Taipei 10591, Taiwan; [Chen, Philip Kuo-Ting] Chang Gung Mem Hosp, Craniofacial Ctr, Taipei 10591, Taiwan; [Yeow, Vincent] KK Womens & Childrens Hosp, Dept Plast Surg, Singapore, Singapore; [Chong, Samuel S.; Cheah, Felicia S. H.] Natl Univ Singapore, Dept Pediat, Singapore 117548, Singapore; [Jabs, Ethylin Wang] Johns Hopkins Univ, Sch Med, Dept Pediat, Baltimore, MD 21205 USA; [Jabs, Ethylin Wang] Mt Sinai Sch Med, Dept Genet & Genom Sci, New York, NY USA; [Scott, Alan F.] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA	Peking University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Washington University (WUSTL); Dortmund University of Technology; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Johns Hopkins University; Johns Hopkins University; Kennedy Krieger Institute; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; KK Women's & Children's Hospital; National University of Singapore; Johns Hopkins University; Icahn School of Medicine at Mount Sinai; Johns Hopkins University	Wang, H (corresponding author), Peking Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Beijing 100871, Peoples R China.	hwang2010@yahoo.cn	Chong, Samuel S./D-8098-2015	Chong, Samuel S./0000-0002-1872-5937; Jabs, Ethylin/0000-0001-8983-5466	National Institute of Dental & Craniofacial Research [R21-DE-013707, R01-DE-014581]; Fogarty Institution [D43-TW006176]; FOGARTY INTERNATIONAL CENTER [D43TW006176] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE014581] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R21DE013707] Funding Source: NIH RePORTER	National Institute of Dental & Craniofacial Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); Fogarty Institution; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This research was supported by grants from the National Institute of Dental & Craniofacial Research (No. R21-DE-013707 and R01-DE-014581) and Fogarty Institution (No. D43-TW006176). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Ashique AM, 2002, DEVELOPMENT, V129, P4647; Barlow AJ, 1997, DEVELOPMENT, V124, P391; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Beaty TH, 2010, NAT GENET, V42, P525, DOI 10.1038/ng.580; Birnbaum S, 2009, NAT GENET, V41, P473, DOI 10.1038/ng.333; Dixon MJ, 2011, NAT REV GENET, V12, P167, DOI 10.1038/nrg2933; Grant SFA, 2009, J PEDIATR-US, V155, P909, DOI 10.1016/j.jpeds.2009.06.020; Hashmi SS, 2005, AM J MED GENET A, V134A, P368, DOI 10.1002/ajmg.a.30618; Jianyan L, 2010, INT J ORAL MAX SURG, V39, P50, DOI 10.1016/j.ijom.2009.10.010; Jugessur A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005385; Laird NM, 2006, NAT REV GENET, V7, P385, DOI 10.1038/nrg1839; Lidral AC, 2004, BIRTH DEFECTS RES A, V70, P893, DOI 10.1002/bdra.20096; Lin JY, 2008, DNA CELL BIOL, V27, P601, DOI 10.1089/dna.2008.0777; Liu W, 2005, DEVELOPMENT, V132, P1453, DOI 10.1242/dev.01676; Mangold E, 2010, NAT GENET, V42, P24, DOI 10.1038/ng.506; Marazita ML, 2009, HUM HERED, V68, P151, DOI 10.1159/000224636; Marazita ML, 2004, AM J HUM GENET, V75, P161, DOI 10.1086/422475; MITCHELL LE, 2002, CLEFT LIP PALATE, P214; Mossey P., 2002, CLEFT LIP PALATE, P127; Mossey PA, 2009, LANCET, V374, P1773, DOI 10.1016/S0140-6736(09)60695-4; Murray JC, 2002, CLIN GENET, V61, P248, DOI 10.1034/j.1399-0004.2002.610402.x; Oliphant A., 2002, BIOTECHNIQUES, V32, pS56, DOI DOI 10.2144/JUN0207; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Paiva KBS, 2010, ACTA HISTOCHEM, V112, P508, DOI 10.1016/j.acthis.2009.05.007; SPIELMAN RS, 1993, AM J HUM GENET, V52, P506; Suazo J, 2010, DNA CELL BIOL, V29, P59, DOI 10.1089/dna.2009.0944; Suzuki S, 2009, AM J HUM GENET, V84, P406, DOI 10.1016/j.ajhg.2009.02.002; Trainor PA, 2005, SEMIN CELL DEV BIOL, V16, P683, DOI 10.1016/j.semcdb.2005.06.007; Wang H, 2011, CLEFT PALAT IN PRESS; WOZNEY JM, 1988, SCIENCE, V242, P1528, DOI 10.1126/science.3201241	31	20	27	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2012	7	4							e35347	10.1371/journal.pone.0035347	http://dx.doi.org/10.1371/journal.pone.0035347			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UT	22514733	Green Published, gold, Green Submitted			2022-12-25	WOS:000305341600138
J	Zerlanko, BJ; Bartholin, L; Melhuish, TA; Wotton, D				Zerlanko, Brad J.; Bartholin, Laurent; Melhuish, Tiffany A.; Wotton, David			Premature Senescence and Increased TGF beta Signaling in the Absence of Tgif1	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; SMAD TRANSCRIPTIONAL COREPRESSOR; LARGE GENE LISTS; TETRAPLOIDY CHECKPOINT; TARGETED DISRUPTION; FUNCTIONAL-ANALYSIS; CELLS; PROTEIN; SPECIFICITY; PROGRESSION	Transforming growth factor beta (TGF beta) signaling regulates cell cycle progression in several cell types, primarily by inducing a G1 cell cycle arrest. Tgif1 is a transcriptional corepressor that limits TGFb responsive gene expression. Here we demonstrate that primary mouse embryo fibroblasts (MEFs) lacking Tgif1 proliferate slowly, accumulate increased levels of DNA damage, and senesce prematurely. We also provide evidence that the effects of loss of Tgif1 on proliferation and senescence are not limited to primary cells. The increased DNA damage in Tgif1 null MEFs can be partially reversed by culturing cells at physiological oxygen levels, and growth in normoxic conditions also partially rescues the proliferation defect, suggesting that in the absence of Tgif1 primary MEFs are less able to cope with elevated levels of oxidative stress. Additionally, we show that Tgif1 null MEFs are more sensitive to TGF beta-mediated growth inhibition, and that treatment with a TGFb receptor kinase inhibitor increases proliferation of Tgif1 null MEFs. Conversely, persistent treatment of wild type cells with low levels of TGFb slows proliferation and induces senescence, suggesting that TGF beta signaling also contributes to cellular senescence. We suggest that in the absence of Tgif1, a persistent increase in TGFb responsive transcription and a reduced ability to deal with hyperoxic stress result in premature senescence in primary MEFs.	[Zerlanko, Brad J.] Univ Virginia, Dept Biochem & Mol Genet, Charlottesville, VA 22903 USA; Univ Virginia, Ctr Cell Signaling, Charlottesville, VA USA	University of Virginia; University of Virginia	Zerlanko, BJ (corresponding author), Univ Virginia, Dept Biochem & Mol Genet, Charlottesville, VA 22903 USA.	dw2p@virginia.edu	Bartholin, Laurent/Q-6655-2017	Bartholin, Laurent/0000-0002-5637-3223; Wotton, David/0000-0002-4652-5350	National Institutes of Health [HD39926, HD52707]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD039926, R01HD052707] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008136] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health grants, HD39926 and HD52707, to DW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHMED SA, 1994, J IMMUNOL METHODS, V170, P211, DOI 10.1016/0022-1759(94)90396-4; ALEXANDROW MG, 1995, CANCER RES, V55, P1452; Bartholin L, 2002, ONCOGENE, V21, P2227, DOI 10.1038/sj.onc.1205294; Bartholin L, 2006, MOL CELL BIOL, V26, P990, DOI 10.1128/MCB.26.3.990-1001.2006; Bartholin L, 2008, DEV BIOL, V319, P285, DOI 10.1016/j.ydbio.2008.04.027; Bertolino E, 1995, J BIOL CHEM, V270, P31178, DOI 10.1074/jbc.270.52.31178; Borel F, 2002, P NATL ACAD SCI USA, V99, P9819, DOI 10.1073/pnas.152205299; Burglin TR, 1997, NUCLEIC ACIDS RES, V25, P4173, DOI 10.1093/nar/25.21.4173; DATTO MB, 1995, P NATL ACAD SCI USA, V92, P5545, DOI 10.1073/pnas.92.12.5545; Feng XH, 2005, ANNU REV CELL DEV BI, V21, P659, DOI 10.1146/annurev.cellbio.21.022404.142018; Gripp KW, 2000, NAT GENET, V25, P205, DOI 10.1038/76074; Hamid R, 2009, MOL ONCOL, V3, P451, DOI 10.1016/j.molonc.2009.07.004; HANNON GJ, 1994, NATURE, V371, P257, DOI 10.1038/371257a0; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Huang HM, 2008, CANCER RES, V68, P3724, DOI 10.1158/0008-5472.CAN-08-0479; Hyman CA, 2003, MOL CELL BIOL, V23, P9262, DOI 10.1128/MCB.23.24.9262-9274.2003; Ikushima H, 2010, NAT REV CANCER, V10, P415, DOI 10.1038/nrc2853; Inman GJ, 2002, MOL PHARMACOL, V62, P65, DOI 10.1124/mol.62.1.65; Jin JZ, 2006, DEV DYNAM, V235, P547, DOI 10.1002/dvdy.20642; Lanni JS, 1997, P NATL ACAD SCI USA, V94, P9679, DOI 10.1073/pnas.94.18.9679; Lo RS, 2001, EMBO J, V20, P128, DOI 10.1093/emboj/20.1.128; Lombard DB, 2005, CELL, V120, P497, DOI 10.1016/j.cell.2005.01.028; MacLaren A, 2004, MOL CELL BIOL, V24, P9006, DOI 10.1128/MCB.24.20.9006-9018.2004; Mar L, 2006, MOL CELL BIOL, V26, P4302, DOI 10.1128/MCB.02156-05; Massague J, 2005, GENE DEV, V19, P2783, DOI 10.1101/gad.1350705; Massague J, 2000, CELL, V103, P295, DOI 10.1016/S0092-8674(00)00121-5; Melhuish TA, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-2; Melhuish TA, 2001, J BIOL CHEM, V276, P32109, DOI 10.1074/jbc.M103377200; Melhuish TA, 2000, J BIOL CHEM, V275, P39762, DOI 10.1074/jbc.C000416200; Melhuish TA, 2010, J CELL BIOCHEM, V111, P380, DOI 10.1002/jcb.22713; Merrill JC, 2010, J MOL BIOL, V398, P657, DOI 10.1016/j.jmb.2010.03.048; Mostoslavsky R, 2006, CELL, V124, P315, DOI 10.1016/J.CEL.2005.11.044; Muenke M, 2000, CURR OPIN GENET DEV, V10, P262, DOI 10.1016/S0959-437X(00)00084-8; Powers SE, 2010, DEVELOPMENT, V137, P249, DOI 10.1242/dev.040782; Rodier F, 2011, J CELL BIOL, V192, P547, DOI 10.1083/jcb.201009094; Sage J, 2000, GENE DEV, V14, P3037, DOI 10.1101/gad.843200; Schmierer B, 2007, NAT REV MOL CELL BIO, V8, P970, DOI 10.1038/nrm2297; Seo SR, 2004, EMBO J, V23, P3780, DOI 10.1038/sj.emboj.7600398; Seo SR, 2006, MOL CELL, V23, P547, DOI 10.1016/j.molcel.2006.06.018; Shen J, 2005, MOL CELL BIOL, V25, P3639, DOI 10.1128/MCB.25.9.3639-3647.2005; Sherr CJ, 2000, CELL, V102, P407, DOI 10.1016/S0092-8674(00)00046-5; Suzuki M, 2006, RADIAT RES, V165, P269, DOI 10.1667/RR3508.1; Taniguchi K, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002524; Uetake Y, 2004, J CELL BIOL, V165, P609, DOI 10.1083/jcb.200403014; Warner BJ, 1999, MOL CELL BIOL, V19, P5913; Wotton D, 1999, CELL, V97, P29, DOI 10.1016/S0092-8674(00)80712-6; Wotton D, 2001, CELL GROWTH DIFFER, V12, P457; Wotton D, 2001, CURR TOP MICROBIOL, V254, P145	49	21	21	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2012	7	4							e35460	10.1371/journal.pone.0035460	http://dx.doi.org/10.1371/journal.pone.0035460			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UT	22514746	Green Published, Green Submitted, gold			2022-12-25	WOS:000305341600151
J	Emery, AC; Eiden, LE				Emery, Andrew C.; Eiden, Lee E.			Signaling through the neuropeptide GPCR PAC(1) induces neuritogenesis via a single linear cAMP- and ERK-dependent pathway using a novel cAMP sensor	FASEB JOURNAL			English	Article						adenylate cyclase; neurite; Neuroscreen-1; PC12; signal transduction	CYCLASE-ACTIVATING POLYPEPTIDE; PROTEIN-KINASE-A; NERVE GROWTH-FACTOR; VASOACTIVE-INTESTINAL-PEPTIDE; PC12 CELLS; NEURITE OUTGROWTH; NEURONAL DIFFERENTIATION; RAP1 ACTIVATION; GENE-EXPRESSION; CYCLIC-AMP	Both cAMP and ERK are necessary for neuroendocrine cell neuritogenesis, and pituitary adenylate cyclase-activating polypeptide (PACAP) activates each. It is important to know whether cAMP and ERK are arranged in a novel, linear pathway or in two parallel pathways using known signaling mechanisms. Native cellular responses [cAMP elevation, ERK phosphorylation, cAMP responsive element binding (CREB) phosphorylation, and neuritogenesis] and promoter-reporter gene activation after treatment with forskolin, cAMP analogs, and PACAP were measured in Neuroscreen-1 (NS-1) cells, a PC12 variant enabling simultaneous morphological, molecular biological, and biochemical analysis. Forskolin (25 mu M) and cAMP analogs (8-bromo-cAMP, dibutyryl-cAMP, and 8-chlorophenylthio-cAMP) stimulated ERK phosphorylation and neuritogenesis in NS-1 cells. Both ERK phosphorylation and neuritogenesis were MEK dependent (blocked by 10 mu M U0126) and PKA independent (insensitive to 30 mu M H-89 or 100 nM myristoylated protein kinase A inhibitor). CREB phosphorylation induced by PACAP was blocked by H-89. The exchange protein activated by cAMP (Epac)-selective 8-(4-chlorophenylthio)-2'-O-Me-cAMP (100-500 mu M) activated Rap1 without affecting the other cAMP-dependent processes. Thus, PACAP-38 potently stimulated two distinct and independent cAMP pathways leading to CREB or ERK activation in NS-1 cells. Drug concentrations for appropriate effect were derived from control data for all compounds. In summary, a novel PKA- and Epac-independent signaling pathway: PACAP -> adenylate cyclase -> cAMP -> ERK -> neuritogenesis has been identified.-Emery, A. C., Eiden, L. E. Signaling through the neuropeptide GPCR PAC(1) induces neuritogenesis via a single linear cAMP- and ERK-dependent pathway using a novel cAMP sensor. FASEB J. 26, 3199-3211 (2012). www.fasebj.org	[Emery, Andrew C.; Eiden, Lee E.] NIMH, Mol Neurosci Sect, Lab Cellular & Mol Regulat, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH)	Eiden, LE (corresponding author), NIMH, Mol Neurosci Sect, Lab Cellular & Mol Regulat, 49 Convent Dr,Bldg 49,Rm 5A-38, Bethesda, MD 20892 USA.	eidenl@mail.nih.gov		Eiden, Lee/0000-0001-7524-944X; Emery, Andrew/0000-0002-6760-2570	NIMH Intramural Research Project [1-Z01-MH002386]; NATIONAL INSTITUTE OF MENTAL HEALTH [ZIAMH002386, Z01MH002386] Funding Source: NIH RePORTER	NIMH Intramural Research Project; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	The authors thank Dr. Tomris Mustafa [U.S. National Institute of Mental Health (NIMH)] and Dr. Tamas Balla (Eunice Kennedy Shriver National Institute of Child Health and Human Development) for their helpful suggestions and feedback about this manuscript. All work performed was supported by NIMH Intramural Research Project 1-Z01-MH002386. The authors declare no conflicts of interest.	Abad C, 2001, J IMMUNOL, V167, P3182, DOI 10.4049/jimmunol.167.6.3182; Armstrong BD, 2008, NEUROSCIENCE, V151, P63, DOI 10.1016/j.neuroscience.2007.09.084; Bers DM, 2007, J PHYSIOL-LONDON, V583, P415, DOI 10.1113/jphysiol.2007.140764; Burgun C, 2000, FEBS LETT, V484, P189, DOI 10.1016/S0014-5793(00)02153-0; Cheadle C, 2008, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-43; Chen D, 1999, P NATL ACAD SCI USA, V96, P13468, DOI 10.1073/pnas.96.23.13468; Chen Y, 2006, REGUL PEPTIDES, V137, P4, DOI 10.1016/j.regpep.2006.06.016; Cibelli G, 2001, EUR J NEUROSCI, V13, P1339, DOI 10.1046/j.0953-816x.2001.01510.x; DEUTSCH PJ, 1992, J BIOL CHEM, V267, P5108; DiCicco-Bloom E, 2000, DEV BIOL, V219, P197, DOI 10.1006/dbio.2000.9604; Dumaz N, 2005, FEBS J, V272, P3491, DOI 10.1111/j.1742-4658.2005.04763.x; Engh RA, 1996, J BIOL CHEM, V271, P26157, DOI 10.1074/jbc.271.42.26157; Enserink JM, 2002, NAT CELL BIOL, V4, P901, DOI 10.1038/ncb874; Gerdin Matthew J, 2007, Sci STKE, V2007, ppe15; GINTY DD, 1991, J BIOL CHEM, V266, P15325; Greengard P, 2001, SCIENCE, V294, P1024, DOI 10.1126/science.294.5544.1024; GRESSENS P, 1993, NATURE, V362, P155, DOI 10.1038/362155a0; Grumolato L, 2003, ENDOCRINOLOGY, V144, P2368, DOI 10.1210/en.2002-0106; Grumolato L, 2003, EUR J NEUROSCI, V17, P71, DOI 10.1046/j.1460-9568.2003.02426.x; Guirland C, 2003, J NEUROSCI, V23, P2274; Gutkind J S, 2000, Sci STKE, V2000, pre1, DOI 10.1126/stke.2000.40.re1; Hamelink C, 2002, J NEUROSCI, V22, P5310; Hammack SE, 2009, PSYCHONEUROENDOCRINO, V34, P833, DOI 10.1016/j.psyneuen.2008.12.013; Hashimoto H, 2001, P NATL ACAD SCI USA, V98, P13355, DOI 10.1073/pnas.231094498; Holighaus Y, 2012, J MOL NEUROSCI, V46, P75, DOI 10.1007/s12031-011-9653-9; Kandel ER, 2001, SCIENCE, V294, P1030, DOI 10.1126/science.1067020; Kim HS, 2006, EXP MOL MED, V38, P85, DOI 10.1038/emm.2006.10; Lazarovici P, 1998, MOL PHARMACOL, V54, P547, DOI 10.1124/mol.54.3.547; Lelievre V, 2008, DEV BIOL, V313, P359, DOI 10.1016/j.ydbio.2007.10.031; Lioudyno M, 1998, J NEUROSCI RES, V51, P243, DOI 10.1002/(SICI)1097-4547(19980115)51:2<243::AID-JNR13>3.0.CO;2-9; Macdonald DS, 2005, J NEUROSCI, V25, P11374, DOI 10.1523/JNEUROSCI.3871-05.2005; Monaghan TK, 2008, J NEUROCHEM, V104, P74, DOI 10.1111/j.1471-4159.2007.05018.x; Nijholt IM, 2008, CELL SIGNAL, V20, P1715, DOI 10.1016/j.cellsig.2008.05.001; Obara Y, 2004, J CELL SCI, V117, P6085, DOI 10.1242/jcs.01527; Ohtaki H, 2006, P NATL ACAD SCI USA, V103, P7488, DOI 10.1073/pnas.0600375103; Ohtaki H, 2008, J MOL NEUROSCI, V36, P16, DOI 10.1007/s12031-008-9077-3; Otto C, 2001, J NEUROSCI, V21, P5520, DOI 10.1523/JNEUROSCI.21-15-05520.2001; Pham N, 2000, CURR BIOL, V10, P555, DOI 10.1016/S0960-9822(00)00473-5; Radio NM, 2008, TOXICOL SCI, V105, P106, DOI 10.1093/toxsci/kfn114; Ravni A, 2008, MOL PHARMACOL, V73, P1688, DOI 10.1124/mol.107.044792; Roscioni SS, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-88; Samal BB, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.131pt4; Ster J, 2007, P NATL ACAD SCI USA, V104, P2519, DOI 10.1073/pnas.0611031104; Stork PJS, 2002, TRENDS CELL BIOL, V12, P258, DOI 10.1016/S0962-8924(02)02294-8; Stroth N, 2011, J NEUROENDOCRINOL, V23, P944, DOI 10.1111/j.1365-2826.2011.02202.x; SUN H, 1993, CELL, V75, P487, DOI 10.1016/0092-8674(93)90383-2; Tan YV, 2009, P NATL ACAD SCI USA, V106, P2012, DOI 10.1073/pnas.0812257106; Ueda Y, 1996, J BIOL CHEM, V271, P23512, DOI 10.1074/jbc.271.38.23512; Vaudry D, 2002, J NEUROCHEM, V83, P1272, DOI 10.1046/j.1471-4159.2002.01242.x; Vaudry D, 1998, NEUROSCIENCE, V84, P801, DOI 10.1016/S0306-4522(97)00545-9; Vaudry D, 1999, P NATL ACAD SCI USA, V96, P9415, DOI 10.1073/pnas.96.16.9415; Vaudry D, 2003, J NEUROSCI RES, V72, P303, DOI 10.1002/jnr.10530; Voice JK, 2003, J IMMUNOL, V170, P308, DOI 10.4049/jimmunol.170.1.308; Wang ZP, 2006, MOL CELL BIOL, V26, P2130, DOI 10.1128/MCB.26.6.2130-2145.2006; Waschek JA, 2006, ANN NY ACAD SCI, V1070, P120, DOI 10.1196/annals.1317.089; York RD, 1998, NATURE, V392, P622, DOI 10.1038/33451	56	51	52	1	10	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2012	26	8					3199	3211		10.1096/fj.11-203042	http://dx.doi.org/10.1096/fj.11-203042			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	984BI	22532442	Green Published			2022-12-25	WOS:000307162800011
J	Christian, WV; Li, N; Hinkle, PM; Ballatori, N				Christian, Whitney V.; Li, Na; Hinkle, Patricia M.; Ballatori, Nazzareno			beta-Subunit of the Ost alpha-Ost beta Organic Solute Transporter Is Required Not Only for Heterodimerization and Trafficking but Also for Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GREEN-FLUORESCENT PROTEIN; BASOLATERAL BILE-ACID; MEMBRANE-PROTEINS; LIVING CELLS; TRANSMEMBRANE HELICES; ENDOPLASMIC-RETICULUM; STEROID TRANSPORTER; MAMMALIAN-CELLS; POLAR RESIDUES; CHO-CELLS	The organic solute transporter, Ost/Slc51, is composed of two distinct proteins that must heterodimerize to generate transport activity, but the role of the individual subunits in mediating transport activity is unknown. The present study identified regions in Ost beta required for heterodimerization with Ost alpha, trafficking of the Ost alpha-Ost beta complex to the plasma membrane, and bile acid transport activity in HEK293 cells. Bimolecular fluorescence complementation analysis revealed that a 25-amino acid peptide containing the Ost beta transmembrane (TM) domain heterodimerized with Ost alpha, although the resulting complex failed to reach the plasma membrane and generate cellular [H-3]taurocholate transport activity. Deletion of the single TM domain of Ost beta abolished interaction with Ost alpha, demonstrating that the TM segment is necessary and sufficient for formation of a heteromeric complex with Ost alpha. Mutation of the highly conserved tryptophan-asparagine sequence within the TM domain of Ost beta to alanines did not prevent cell surface trafficking, but abolished transport activity. Removal of the N-terminal 27 amino acids of Ost beta resulted in a transporter complex that reached the plasma membrane and exhibited transport activity at 30 degrees C. Complete deletion of the C terminus of Ost beta abolished [H-3]taurocholate transport activity, but reinsertion of two native arginines immediately C-terminal to the TM domain rescued this defect. These positively charged residues establish the correct N-exo/C-cyt topology of the peptide, in accordance with the positive inside rule. Together, the results demonstrate that Ost beta is required for both proper trafficking of Ost alpha and formation of the functional transport unit, and identify specific residues of Ost beta critical for these processes.	[Hinkle, Patricia M.] Univ Rochester, Sch Med, Dept Physiol & Pharmacol, Rochester, NY 14642 USA; [Christian, Whitney V.; Li, Na; Ballatori, Nazzareno] Univ Rochester, Sch Med, Dept Environm Med, Rochester, NY 14642 USA	University of Rochester; University of Rochester	Hinkle, PM (corresponding author), Univ Rochester, Sch Med, Dept Physiol & Pharmacol, Box 711, Rochester, NY 14642 USA.	patricia_hinkle@urmc.rochester.edu			National Institute of Health [DK067214, DK48823, DK19974]; NIEHS/National Institutes of Health [ES07026, ES03828, ES01247]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK048823, R01DK067214, R01DK019974] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES003828, P50ES003828, R01ES007026, T32ES007026, P30ES001247] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIEHS/National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institute of Health Grants DK067214, DK48823, and DK19974 and NIEHS/National Institutes of Health Training Grant ES07026 and Center Grants ES03828 and ES01247. This work has been partially published in abstract form (Christian, W. V., Li, N., and Ballatori, N. (2011) FASEB J. 25, 554.1).	Ballatori N, 2005, HEPATOLOGY, V42, P1270, DOI 10.1002/hep.20961; Ballatori N, 2008, AM J PHYSIOL-GASTR L, V295, pG179, DOI 10.1152/ajpgi.90319.2008; Ballatori N, 2011, DIGEST DIS, V29, P13, DOI 10.1159/000324123; Ballatori N, 2009, FRONT BIOSCI-LANDMRK, V14, P2829, DOI 10.2741/3416; BOKMAN SH, 1981, BIOCHEM BIOPH RES CO, V101, P1372, DOI 10.1016/0006-291X(81)91599-0; CASTELLINO RC, 1995, AM J PHYSIOL-HEART C, V269, pH385, DOI 10.1152/ajpheart.1995.269.1.H385; Chiang CF, 2001, ARCH BIOCHEM BIOPHYS, V394, P229, DOI 10.1006/abbi.2001.2537; Choma C, 2000, NAT STRUCT BIOL, V7, P161; Cooray SN, 2009, MOL CELL ENDOCRINOL, V300, P17, DOI 10.1016/j.mce.2008.10.004; Corish P, 1999, PROTEIN ENG, V12, P1035, DOI 10.1093/protein/12.12.1035; Dawson JP, 2003, J MOL BIOL, V331, P255, DOI 10.1016/S0022-2836(03)00714-9; Dawson PA, 2005, J BIOL CHEM, V280, P6960, DOI 10.1074/jbc.M412752200; DENNING GM, 1992, NATURE, V358, P761, DOI 10.1038/358761a0; Dolly JO, 1996, J BIOENERG BIOMEMBR, V28, P231, DOI 10.1007/BF02110698; Fox SR, 2005, BIOTECHNOL APPL BIOC, V41, P255, DOI 10.1042/BA20040066; Galbraith DJ, 2006, BIOTECHNOL PROGR, V22, P753, DOI 10.1021/bp050339v; Gehret AU, 2010, MOL PHARMACOL, V77, P288, DOI 10.1124/mol.109.059733; Geisse S, 2009, METHOD ENZYMOL, V463, P223, DOI 10.1016/S0076-6879(09)63015-9; Goder V, 2001, FEBS LETT, V504, P87, DOI 10.1016/S0014-5793(01)02712-0; Gorokhova S, 2007, HUM MOL GENET, V16, P2394, DOI 10.1093/hmg/ddm167; Gratkowski H, 2001, P NATL ACAD SCI USA, V98, P880, DOI 10.1073/pnas.98.3.880; Harley CA, 1998, J BIOL CHEM, V273, P24963, DOI 10.1074/jbc.273.38.24963; He X, 2004, DEVELOPMENT, V131, P1663, DOI 10.1242/dev.01117; Higy M, 2004, BIOCHEMISTRY-US, V43, P12716, DOI 10.1021/bi048368m; Hu CD, 2002, MOL CELL, V9, P789, DOI 10.1016/S1097-2765(02)00496-3; Kaufmann H, 1999, BIOTECHNOL BIOENG, V63, P573, DOI 10.1002/(SICI)1097-0290(19990605)63:5<573::AID-BIT7>3.0.CO;2-Y; Kerppola TK, 2006, NAT PROTOC, V1, P1278, DOI 10.1038/nprot.2006.201; Kerppola TK, 2006, NAT METHODS, V3, P969, DOI 10.1038/nmeth1206-969; Li N, 2007, BIOCHEM J, V407, P363, DOI 10.1042/BJ20070716; LJUNGGREN HG, 1990, NATURE, V346, P476, DOI 10.1038/346476a0; MacKinnon R, 2005, SCIENCE, V307, P1425, DOI 10.1126/science.1110525; March JC, 2003, APPL MICROBIOL BIOT, V62, P303, DOI 10.1007/s00253-003-1339-y; Meier C, 2002, EMBO J, V21, P580, DOI 10.1093/emboj/21.4.580; Morth JP, 2011, NAT REV MOL CELL BIO, V12, P60, DOI 10.1038/nrm3031; Powell K, 2002, ADV DRUG DELIVER REV, V54, P1395, DOI 10.1016/S0169-409X(02)00148-5; Rao A, 2008, P NATL ACAD SCI USA, V105, P3891, DOI 10.1073/pnas.0712328105; RICHARDSON JS, 1988, SCIENCE, V240, P1648, DOI 10.1126/science.3381086; Seward DJ, 2003, J BIOL CHEM, V278, P27473, DOI 10.1074/jbc.M301106200; SIPOS L, 1993, EUR J BIOCHEM, V213, P1333, DOI 10.1111/j.1432-1033.1993.tb17885.x; Soroka CJ, 2010, SEMIN LIVER DIS, V30, P178, DOI 10.1055/s-0030-1253226; Sun AQ, 2007, AM J PHYSIOL-GASTR L, V292, pG1586, DOI 10.1152/ajpgi.00457.2006; Trauner M, 2003, PHYSIOL REV, V83, P633, DOI 10.1152/physrev.00027.2002; Tsien RY, 1998, ANNU REV BIOCHEM, V67, P509, DOI 10.1146/annurev.biochem.67.1.509; Ulmschneider MB, 2001, BBA-BIOMEMBRANES, V1512, P1, DOI 10.1016/S0005-2736(01)00299-1; Verrey F, 2000, PFLUG ARCH EUR J PHY, V440, P503, DOI 10.1007/s004240050001; VONHEIJNE G, 1988, EUR J BIOCHEM, V174, P671; VONHEIJNE G, 1986, EMBO J, V5, P3021, DOI 10.1002/j.1460-2075.1986.tb04601.x; Wang W, 2001, P NATL ACAD SCI USA, V98, P9431, DOI 10.1073/pnas.161099898; Wang Y, 2009, J NEUROSCI, V29, P12625, DOI 10.1523/JNEUROSCI.1776-09.2009; Yang KC, 2009, ACTA PHARMACOL SIN, V30, P740, DOI 10.1038/aps.2009.63; Zhou FX, 2001, P NATL ACAD SCI USA, V98, P2250, DOI 10.1073/pnas.041593698; Zhou FX, 2000, NAT STRUCT BIOL, V7, P154	52	21	26	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 15	2012	287	25					21233	21243		10.1074/jbc.M112.352245	http://dx.doi.org/10.1074/jbc.M112.352245			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974FQ	22535958	Green Published, hybrid			2022-12-25	WOS:000306416800043
J	Shan, Q; Han, L; Lynch, JW				Shan, Qiang; Han, Lu; Lynch, Joseph W.			Distinct Properties of Glycine Receptor beta+/alpha- Interface UNAMBIGUOUSLY CHARACTERIZING HETEROMERIC INTERFACE RECONSTITUTED IN HOMOMERIC PROTEIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GATED ION-CHANNEL; NICOTINIC ACETYLCHOLINE-RECEPTOR; AMINOBUTYRIC ACID(A) RECEPTOR; BENZODIAZEPINE BINDING-SITE; X-RAY-STRUCTURE; LIGAND-BINDING; CHLORIDE CHANNEL; OPEN STATE; M2 DOMAIN; SUBUNIT	The glycine receptor (GlyR) exists either in homomeric alpha or heteromeric alpha beta forms. Its agonists bind at extracellular subunit interfaces. Unlike subunit interfaces from the homomeric alpha GlyR, subunit interfaces from the heteromeric alpha beta GlyR have not been characterized unambiguously because of the existence of multiple types of interface within single receptors. Here, we report that, by reconstituting beta+/alpha- interfaces in a homomeric GlyR (alpha Chb+a- GlyR), we were able to functionally characterize the alpha beta GlyR beta+/alpha- interfaces. We found that the beta+/alpha- interface had a higher agonist sensitivity than that of the beta+/alpha- interface. This high sensitivity was contributed primarily by loop A. We also found that the beta+/alpha- interface differentially modulates the agonist properties of glycine and taurine. Using voltage clamp fluorometry, we found that the conformational changes induced by glycine binding to the beta+/alpha- interface were different from those induced by glycine binding to the beta+/alpha- interface in the alpha GlyR. Moreover, the distinct conformational changes found at the beta+/alpha- interface in the alpha Chb+a- GlyR were also found in the heteromeric alpha beta GlyR, which suggests that the alpha Chb+a- GlyR reconstitutes structural components and recapitulates functional properties, of the beta+/alpha- interface in the heteromeric alpha beta GlyR. Our investigation not only provides structural and functional information about the GlyR beta+/alpha- interface, which could direct GlyR beta+/alpha- interface-specific drug design, but also provides a general methodology for unambiguously characterizing properties of specific protein interfaces from heteromeric proteins.	[Shan, Qiang] Univ Sydney, Brain & Mind Res Inst, Sydney, NSW 2050, Australia; [Shan, Qiang; Han, Lu; Lynch, Joseph W.] Univ Queensland, Queensland Brain Inst, Brisbane, Qld, Australia; [Lynch, Joseph W.] Univ Queensland, Sch Biomed Sci, Brisbane, Qld, Australia	University of Sydney; University of Queensland; University of Queensland	Shan, Q (corresponding author), Univ Sydney, Brain & Mind Res Inst, Sydney, NSW 2050, Australia.	qshan@yahoo.com			Australian Research Council; National Health and Medical Research Council of Australia	Australian Research Council(Australian Research Council); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by the Australian Research Council and the National Health and Medical Research Council of Australia.	Barnes NM, 2009, NEUROPHARMACOLOGY, V56, P273, DOI 10.1016/j.neuropharm.2008.08.003; BLOUNT P, 1989, NEURON, V3, P349, DOI 10.1016/0896-6273(89)90259-6; Bocquet N, 2009, NATURE, V457, P111, DOI 10.1038/nature07462; Bouzat C, 2004, NATURE, V430, P896, DOI 10.1038/nature02753; Brejc K, 2001, NATURE, V411, P269, DOI 10.1038/35077011; Buhr A, 1996, MOL PHARMACOL, V49, P1080; Colquhoun D, 1998, BRIT J PHARMACOL, V125, P924; Duncalfe LL, 1996, J BIOL CHEM, V271, P9209, DOI 10.1074/jbc.271.16.9209; Gandhi CS, 2005, TRENDS NEUROSCI, V28, P472, DOI 10.1016/j.tins.2005.07.005; Grudzinska J, 2005, NEURON, V45, P727, DOI 10.1016/j.neuron.2005.01.028; Hibbs RE, 2011, NATURE, V474, P54, DOI 10.1038/nature10139; Hilf RJC, 2008, NATURE, V452, P375, DOI 10.1038/nature06717; Hilf RJC, 2009, NATURE, V457, P115, DOI 10.1038/nature07461; Karlin A, 1995, NEURON, V15, P1231, DOI 10.1016/0896-6273(95)90004-7; Kucken AM, 2000, MOL PHARMACOL, V57, P932; Lee WY, 2009, J NEUROSCI, V29, P3189, DOI 10.1523/JNEUROSCI.6185-08.2009; Lewis TM, 2003, J PHYSIOL-LONDON, V549, P361, DOI 10.1113/jphysiol.2002.037796; LIMAN ER, 1992, NEURON, V9, P861, DOI 10.1016/0896-6273(92)90239-A; Lummis SCR, 2005, NATURE, V438, P248, DOI 10.1038/nature04130; Lynagh T, 2011, J BIOL CHEM, V286, P43913, DOI 10.1074/jbc.M111.262634; Lynch JW, 2009, NEUROPHARMACOLOGY, V56, P303, DOI 10.1016/j.neuropharm.2008.07.034; Lynch JW, 2001, J NEUROSCI, V21, P2589, DOI 10.1523/JNEUROSCI.21-08-02589.2001; Lynch JW, 2004, PHYSIOL REV, V84, P1051, DOI 10.1152/physrev.00042.2003; Miller PS, 2010, TRENDS PHARMACOL SCI, V31, P161, DOI 10.1016/j.tips.2009.12.005; Olsen RW, 2008, PHARMACOL REV, V60, P243, DOI 10.1124/pr.108.00505; Olsen RW, 2009, NEUROPHARMACOLOGY, V56, P141, DOI 10.1016/j.neuropharm.2008.07.045; Pless SA, 2008, CLIN EXP PHARMACOL P, V35, P1137, DOI 10.1111/j.1440-1681.2008.04954.x; Pless SA, 2007, J BIOL CHEM, V282, P36057, DOI 10.1074/jbc.M706468200; Pless SA, 2009, J BIOL CHEM, V284, P27370, DOI 10.1074/jbc.M109.048405; Pless SA, 2009, J BIOL CHEM, V284, P15847, DOI 10.1074/jbc.M809343200; Ramerstorfer J, 2011, J NEUROSCI, V31, P870, DOI 10.1523/JNEUROSCI.5012-10.2011; Shan Q, 2001, J NEUROCHEM, V76, P1109, DOI 10.1046/j.1471-4159.2001.00124.x; Shan Q, 2012, BRIT J PHARMACOL, V165, P2113, DOI 10.1111/j.1476-5381.2011.01701.x; Shan Q, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028105; Shan QA, 2010, J NEUROSCI METH, V193, P86, DOI 10.1016/j.jneumeth.2010.08.033; Sieghart W, 2012, BRIT J PHARMACOL, V166, P476, DOI 10.1111/j.1476-5381.2011.01779.x; SINE SM, 1991, J BIOL CHEM, V266, P19369; Taly A, 2009, NAT REV DRUG DISCOV, V8, P733, DOI 10.1038/nrd2927; Thompson AJ, 2010, Q REV BIOPHYS, V43, P449, DOI 10.1017/S0033583510000168; Unwin N, 2005, J MOL BIOL, V346, P967, DOI 10.1016/j.jmb.2004.12.031; Vogel N, 2009, J BIOL CHEM, V284, P36128, DOI 10.1074/jbc.M109.043448	41	6	6	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 15	2012	287	25					21244	21252		10.1074/jbc.M111.337741	http://dx.doi.org/10.1074/jbc.M111.337741			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974FQ	22535951	Green Published, hybrid			2022-12-25	WOS:000306416800044
J	Sheng, JZ; Xu, YM; Dulaney, SB; Huang, XF; Liu, J				Sheng, Juzheng; Xu, Yongmei; Dulaney, Steven B.; Huang, Xuefei; Liu, Jian			Uncovering Biphasic Catalytic Mode of C-5-epimerase in Heparan Sulfate Biosynthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEPARIN/HEPARAN SULFATE; GLUCURONYL C5-EPIMERASE; SPECIFICITY; 2-O-SULFOTRANSFERASE; SULFOTRANSFERASES; OLIGOSACCHARIDES; ANTITHROMBIN; DERIVATIVES; EXPRESSION; CLONING	Heparan sulfate (HS), a highly sulfated polysaccharide, is biosynthesized through a pathway involving several enzymes. C-5-epimerase (C-5-epi) is a key enzyme in this pathway. C-5-epi is known for being a two-way catalytic enzyme, displaying a "reversible" catalytic mode by converting a glucuronic acid to an iduronic acid residue, and vice versa. Here, we discovered that C-5-epi can also serve as a one-way catalyst to convert a glucuronic acid to an iduronic acid residue, displaying an "irreversible" catalytic mode. Our data indicated that the reversible or irreversible catalytic mode strictly depends on the saccharide substrate structures. The biphasic mode of C-5-epi offers a novel mechanism to regulate the biosynthesis of HS with the desired biological functions.	[Dulaney, Steven B.; Huang, Xuefei] Michigan State Univ, Dept Chem, E Lansing, MI 48824 USA; [Sheng, Juzheng; Xu, Yongmei; Liu, Jian] Univ N Carolina, Eshelman Sch Pharm, Div Chem Biol & Med Chem, Chapel Hill, NC 27599 USA	Michigan State University; University of North Carolina; University of North Carolina Chapel Hill	Huang, XF (corresponding author), Michigan State Univ, Dept Chem, E Lansing, MI 48824 USA.	xuefei@chemistry.msu.edu; jian_liu@unc.edu	Huang, Xuefei/G-3371-2014; Sheng, Juzheng/G-2693-2013	Huang, Xuefei/0000-0002-6468-5526; Sheng, Juzheng/0000-0003-2856-9162	National Institutes of Health [AI50050, HL094463, GM072667]; National Science Foundation [CHE-1111550]; Direct For Mathematical & Physical Scien [1111550] Funding Source: National Science Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL094463] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI050050] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM072667] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by National Institutes of Health Grants AI50050, HL094463, and GM072667 and National Science Foundation Grant CHE-1111550.	Babu P, 2011, ANAL BIOANAL CHEM, V401, P237, DOI 10.1007/s00216-011-5087-z; Bethea HN, 2008, P NATL ACAD SCI USA, V105, P18724, DOI 10.1073/pnas.0806975105; Bishop JR, 2007, NATURE, V446, P1030, DOI 10.1038/nature05817; CAMPBELL P, 1994, J BIOL CHEM, V269, P26953; Chen J, 2007, CHEM BIOL, V14, P986, DOI 10.1016/j.chembiol.2007.07.015; Das SK, 2001, CHEM-EUR J, V7, P4821; DOMON B, 1988, GLYCOCONJUGATE J, V5, P397, DOI 10.1007/BF01049915; Esko JD, 2002, ANNU REV BIOCHEM, V71, P435, DOI 10.1146/annurev.biochem.71.110601.135458; Feyerabend TB, 2006, NAT CHEM BIOL, V2, P195, DOI 10.1038/nchembio777; Gama CI, 2006, NAT CHEM BIOL, V2, P467, DOI 10.1038/nchembio810; Guerrini M, 2008, J BIOL CHEM, V283, P26662, DOI 10.1074/jbc.M801102200; Hagner-McWhirter A, 2000, GLYCOBIOLOGY, V10, P159, DOI 10.1093/glycob/10.2.159; Kobayashi M, 1999, J BIOL CHEM, V274, P10474, DOI 10.1074/jbc.274.15.10474; Kreuger J, 2006, J CELL BIOL, V174, P323, DOI 10.1083/jcb.200604035; Li JP, 1997, J BIOL CHEM, V272, P28158, DOI 10.1074/jbc.272.44.28158; Li K, 2010, J BIOL CHEM, V285, P11106, DOI 10.1074/jbc.M109.081059; Liu HY, 2009, NAT PROD REP, V26, P313, DOI 10.1039/b819896a; Liu RP, 2010, J BIOL CHEM, V285, P34240, DOI 10.1074/jbc.M110.159152; Sheng JZ, 2011, J BIOL CHEM, V286, P19768, DOI 10.1074/jbc.M111.224311; Wang Z, 2010, CHEM-EUR J, V16, P8365, DOI 10.1002/chem.201000987; Xu D, 2008, NAT CHEM BIOL, V4, P200, DOI 10.1038/nchembio.66; Xu YM, 2012, GLYCOBIOLOGY, V22, P96, DOI 10.1093/glycob/cwr109; Xu YM, 2011, SCIENCE, V334, P498, DOI 10.1126/science.1207478; Zhao GH, 2010, NAT PROTOC, V5, P636, DOI 10.1038/nprot.2010.3; Zhou XX, 2011, GLYCOBIOLOGY, V21, P771, DOI 10.1093/glycob/cwr001	25	48	52	1	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 15	2012	287	25					20996	21002		10.1074/jbc.M112.359885	http://dx.doi.org/10.1074/jbc.M112.359885			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974FQ	22528493	hybrid, Green Published			2022-12-25	WOS:000306416800021
J	Ramos, C; Chardonnet, S; Marchand, CH; Decottignies, P; Ango, F; Daniel, H; Le Marechal, P				Ramos, Cathy; Chardonnet, Solenne; Marchand, Christophe H.; Decottignies, Paulette; Ango, Fabrice; Daniel, Herve; Le Marechal, Pierre			Native Presynaptic Metabotropic Glutamate Receptor 4 (mGluR4) Interacts with Exocytosis Proteins in Rat Cerebellum	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SYNAPTIC TRANSMISSION; PROTEOMIC ANALYSIS; BINDING; PHOSPHORYLATION; SYNAPTOTAGMIN; LOCALIZATION; EXPRESSION; COMPLEXES; MEMBRANE; MUNC18-1	The eight pre- or/and post-synaptic metabotropic glutamatergic receptors (mGluRs) modulate rapid excitatory transmission sustained by ionotropic receptors. They are classified in three families according to their percentage of sequence identity and their pharmacological properties. mGluR4 belongs to group III and is mainly localized presynaptically. Activation of group III mGluRs leads to depression of excitatory transmission, a process that is exclusively provided by mGluR4 at parallel fiber-Purkinje cell synapse in rodent cerebellum. This function relies at least partly on an inhibition of presynaptic calcium influx, which controls glutamate release. To improve the understanding of molecular mechanisms of the mGluR4 depressant effect, we decided to identify the proteins interacting with this receptor. Immunoprecipitations using anti-mGluR4 antibodies were performed with cerebellar extracts. 183 putative partners that co-immunoprecipitated with anti-mGluR4 antibodies were identified and classified according to their cellular functions. It appears that native mGluR4 interacts with several exocytosis proteins such as Munc18-1, synapsins, and syntaxin. In addition, native mGluR4 was retained on a Sepharose column covalently grafted with recombinant Munc18-1, and immunohistochemistry experiments showed that Munc18-1 and mGluR4 colocalized at plasma membrane in HEK293 cells, observations in favor of an interaction between the two proteins. Finally, affinity chromatography experiments using peptides corresponding to the cytoplasmic domains of mGluR4 confirmed the interaction observed between mGluR4 and a selection of exocytosis proteins, including Munc18-1. These results could give indications to explain how mGluR4 can modulate glutamate release at parallel fiber-Purkinje cell synapses in the cerebellum in addition to the inhibition of presynaptic calcium influx.	[Ramos, Cathy; Chardonnet, Solenne; Marchand, Christophe H.; Decottignies, Paulette; Daniel, Herve; Le Marechal, Pierre] Univ Paris Sud, CNRS, Inst Biochim & Biophys Mol & Cellulaire, UMR 8619, F-91405 Orsay, France; [Ango, Fabrice] CNRS, Inst Genom Fonct, Mise Pl Circuits GABAerg, UMR5203, F-34094 Montpellier 5, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS)	Le Marechal, P (corresponding author), Univ Paris Sud, CNRS, Inst Biochim & Biophys Mol & Cellulaire, UMR 8619, F-91405 Orsay, France.	pierre.le-marechal@u-psud.fr	MARCHAND, Christophe H/B-5854-2008	MARCHAND, Christophe H/0000-0002-0729-3841; Ango, Fabrice/0000-0002-5548-209X	Agence Nationale pour la Recherche [ANR-07-NEURO-047-01]	Agence Nationale pour la Recherche(French National Research Agency (ANR))	This work was supported in part by Agence Nationale pour la Recherche Grant ANR-07-NEURO-047-01).	Abitbol K, 2008, J NEUROCHEM, V105, P2069, DOI 10.1111/j.1471-4159.2008.05290.x; Ango F, 2002, MOL CELL NEUROSCI, V20, P323, DOI 10.1006/mcne.2002.1100; Anwyl R, 1999, BRAIN RES REV, V29, P83, DOI 10.1016/S0165-0173(98)00050-2; Becamel C, 2004, J BIOL CHEM, V279, P20257, DOI 10.1074/jbc.M312106200; BROSE N, 1992, SCIENCE, V256, P1021, DOI 10.1126/science.1589771; Burkhardt P, 2008, EMBO J, V27, P923, DOI 10.1038/emboj.2008.37; Burre J, 2010, SCIENCE, V329, P1663, DOI 10.1126/science.1195227; Cesca F, 2010, PROG NEUROBIOL, V91, P313, DOI 10.1016/j.pneurobio.2010.04.006; Condliffe SB, 2010, J BIOL CHEM, V285, P24968, DOI 10.1074/jbc.M110.145813; Conn PJ, 1997, ANNU REV PHARMACOL, V37, P205, DOI 10.1146/annurev.pharmtox.37.1.205; Corti C, 2002, NEUROSCIENCE, V110, P403, DOI 10.1016/S0306-4522(01)00591-7; Costes SV, 2004, BIOPHYS J, V86, P3993, DOI [10.1529/biophysj.103.038422, 10.1529/biophysi.103.038422]; Daniel H, 2001, J PHYSIOL-LONDON, V537, P793; Darios F, 2010, EMBO REP, V11, P528, DOI 10.1038/embor.2010.66; Dulubova I, 2003, P NATL ACAD SCI USA, V100, P32, DOI 10.1073/pnas.232701299; Dulubova I, 2007, P NATL ACAD SCI USA, V104, P2697, DOI 10.1073/pnas.0611318104; El Far O, 2001, J BIOL CHEM, V276, P30662, DOI 10.1074/jbc.M102573200; El Far O, 2000, EUR J NEUROSCI, V12, P4215, DOI 10.1046/j.1460-9568.2000.01309.x; Farr CD, 2004, J NEUROCHEM, V91, P438, DOI 10.1111/j.1471-4159.2004.02735.x; Goyer A, 2002, EUR J BIOCHEM, V269, P272, DOI 10.1046/j.0014-2956.2001.02648.x; Hirbec H, 2002, J BIOL CHEM, V277, P15221, DOI 10.1074/jbc.C200112200; Khanna R, 2007, J BIOCHEM MOL BIOL, V40, P302; LARSONPRIOR LJ, 1990, J NEUROPHYSIOL, V63, P637, DOI 10.1152/jn.1990.63.3.637; Li Q, 2004, J NEUROSCI, V24, P4070, DOI 10.1523/JNEUROSCI.0346-04.2004; Lorez M, 2003, BRIT J PHARMACOL, V138, P614, DOI 10.1038/sj.bjp.0705099; Marchand CH, 2012, J BACTERIOL, V194, P587, DOI 10.1128/JB.06138-11; Mateos JM, 1998, HISTOCHEM CELL BIOL, V109, P135, DOI 10.1007/s004180050211; Moritz A, 2009, BIOCHEM BIOPH RES CO, V390, P82, DOI 10.1016/j.bbrc.2009.09.070; Nakajima Y, 2011, BIOCHEM BIOPH RES CO, V412, P602, DOI 10.1016/j.bbrc.2011.08.006; Nakajima Y, 2009, P NATL ACAD SCI USA, V106, P18385, DOI 10.1073/pnas.0910088106; Pekhletski R, 1996, J NEUROSCI, V16, P6364; Perroy J, 2002, EMBO J, V21, P2990, DOI 10.1093/emboj/cdf313; Pozzi D, 2008, P NATL ACAD SCI USA, V105, P323, DOI 10.1073/pnas.0706211105; Rathore SS, 2010, P NATL ACAD SCI USA, V107, P22399, DOI 10.1073/pnas.1012997108; Rizo J, 2008, NAT STRUCT MOL BIOL, V15, P665, DOI 10.1038/nsmb.1450; Sala C, 2005, J NEUROSCI, V25, P4587, DOI 10.1523/JNEUROSCI.4822-04.2005; Santos SD, 2010, J PROTEOME RES, V9, P1670, DOI 10.1021/pr900766r; Shen JS, 2007, CELL, V128, P183, DOI 10.1016/j.cell.2006.12.016; Takai Y, 2001, PHYSIOL REV, V81, P153, DOI 10.1152/physrev.2001.81.1.153; TANABE Y, 1993, J NEUROSCI, V13, P1372; Yao J, 2010, J NEUROSCI, V30, P5569, DOI 10.1523/JNEUROSCI.4781-09.2010; Zilly FE, 2006, PLOS BIOL, V4, P1789, DOI 10.1371/journal.pbio.0040330	42	10	11	0	10	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 8	2012	287	24					20176	20186		10.1074/jbc.M112.347468	http://dx.doi.org/10.1074/jbc.M112.347468			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974FB	22528491	Green Published, hybrid			2022-12-25	WOS:000306414500038
J	Moreira, R; Balseiro, P; Planas, JV; Fuste, B; Beltran, S; Novoa, B; Figueras, A				Moreira, Rebeca; Balseiro, Pablo; Planas, Josep V.; Fuste, Berta; Beltran, Sergi; Novoa, Beatriz; Figueras, Antonio			Transcriptomics of In Vitro Immune-Stimulated Hemocytes from the Manila Clam Ruditapes philippinarum Using High-Throughput Sequencing	PLOS ONE			English	Article							PROTEINASE-INHIBITOR GENE; MESSENGER-RNA EXPRESSION; OYSTER CRASSOSTREA-GIGAS; DUPLEX-SPECIFIC NUCLEASE; SCALLOP CHLAMYS-FARRERI; HEAT-SHOCK PROTEINS; TNF-ALPHA FACTOR; MOLECULAR-CLONING; ZHIKONG SCALLOP; PACIFIC OYSTER	Background: The Manila clam (Ruditapes philippinarum) is a worldwide cultured bivalve species with important commercial value. Diseases affecting this species can result in large economic losses. Because knowledge of the molecular mechanisms of the immune response in bivalves, especially clams, is scarce and fragmentary, we sequenced RNA from immune-stimulated R. philippinarum hemocytes by 454- pyrosequencing to identify genes involved in their immune defense against infectious diseases. Methodology and Principal Findings: High-throughput deep sequencing of R. philippinarum using 454 pyrosequencing technology yielded 974,976 high-quality reads with an average read length of 250 bp. The reads were assembled into 51,265 contigs and the 44.7% of the translated nucleotide sequences into protein were annotated successfully. The 35 most frequently found contigs included a large number of immune-related genes, and a more detailed analysis showed the presence of putative members of several immune pathways and processes like the apoptosis, the toll like signaling pathway and the complement cascade. We have found sequences from molecules never described in bivalves before, especially in the complement pathway where almost all the components are present. Conclusions: This study represents the first transcriptome analysis using 454- pyrosequencing conducted on R. philippinarum focused on its immune system. Our results will provide a rich source of data to discover and identify new genes, which will serve as a basis for microarray construction and the study of gene expression as well as for the identification of genetic markers. The discovery of new immune sequences was very productive and resulted in a large variety of contigs that may play a role in the defense mechanisms of Ruditapes philippinarum.	[Moreira, Rebeca; Balseiro, Pablo; Novoa, Beatriz; Figueras, Antonio] CSIC, Inst Invest Marinas, Vigo, Spain; [Planas, Josep V.] Univ Barcelona, Fac Biol, Dept Fisiol & Immunol, Barcelona, Spain; [Planas, Josep V.] Univ Barcelona, Inst Biomed, Barcelona, Spain; [Fuste, Berta; Beltran, Sergi] Univ Barcelona, Ctr Cient & Tecnol, Barcelona, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Marinas (IIM); University of Barcelona; University of Barcelona; University of Barcelona	Moreira, R (corresponding author), CSIC, Inst Invest Marinas, Vigo, Spain.	antoniofigueras@iim.csic.es	Novoa, Beatriz/K-3785-2014; Figueras, Antonio/AAB-8921-2019; Figueras, Antonio/B-5133-2015; Balseiro, Pablo/I-7406-2013; Beltran, Sergi/I-3408-2015	Figueras, Antonio/0000-0002-0617-0030; Figueras, Antonio/0000-0002-0617-0030; Beltran, Sergi/0000-0002-2810-3445; Planas, Josep/0000-0002-6525-9617; Balseiro, Pablo/0000-0002-9365-6775; Novoa, Beatriz/0000-0003-4888-8419; Moreira, Rebeca/0000-0001-7797-7221	Spanish Ministerio de Ciencia e Innovacion (MICINN) [AGL2008-05111]; EU [245119]; Spanish MICINN through a Formacion de Personal Investigador [BES-2009029765]	Spanish Ministerio de Ciencia e Innovacion (MICINN)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); EU(European Commission); Spanish MICINN through a Formacion de Personal Investigador	This work has been funded by the Spanish Ministerio de Ciencia e Innovacion (MICINN) (AGL2008-05111) and by the EU Project REPROSEED (245119). R. M. wishes to acknowledge additional funding from the Spanish MICINN through a Formacion de Personal Investigador Spanish research grant (BES-2009029765). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adl SM, 2005, J EUKARYOT MICROBIOL, V52, P399, DOI 10.1111/j.1550-7408.2005.00053.x; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bai XD, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0016336, 10.1371/journal.pone.0016368]; Balseiro P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023140; Batista FM, 2007, J VIROL METHODS, V139, P1, DOI 10.1016/j.jviromet.2006.09.005; Beaz-Hidalgo R, 2010, ENV MICROBIOL REP, V2, P34, DOI 10.1111/j.1758-2229.2010.00135.x; Bettencourt R, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-559; Bower SM, 2003, SYNOPSIS INFECT DIS; Brogden KA, 2005, NAT REV MICROBIOL, V3, P238, DOI 10.1038/nrmicro1098; Bulgakov AA, 2004, FISH SHELLFISH IMMUN, V16, P487, DOI 10.1016/j.fsi.2003.08.006; Canesi L, 2002, MICROSC RES TECHNIQ, V57, P469, DOI 10.1002/jemt.10100; Charlet M, 1996, J BIOL CHEM, V271, P21808, DOI 10.1074/jbc.271.36.21808; Chevreux B, 2004, GENOME RES, V14, P1147, DOI 10.1101/gr.1917404; Clark MS, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-362; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Costa MM, 2009, DEV COMP IMMUNOL, V33, P162, DOI 10.1016/j.dci.2008.08.005; Craft JA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008875; CROOK NE, 1993, J VIROL, V67, P2168, DOI 10.1128/JVI.67.4.2168-2174.1993; DAVIS HC, 1954, SCIENCE, V120, P36, DOI 10.1126/science.120.3105.36; De Maio A, 1999, SHOCK, V11, P1, DOI 10.1097/00024382-199901000-00001; Do Carmo S, 2008, J NEUROSCI, V28, P10330, DOI 10.1523/JNEUROSCI.2644-08.2008; Do Carmo S, 2007, BBA-MOL CELL RES, V1773, P954, DOI 10.1016/j.bbamcr.2007.03.007; Dunkelberger JR, 2010, CELL RES, V20, P34, DOI 10.1038/cr.2009.139; Fleischer A, 2002, EUR J IMMUNOL, V32, P3498, DOI 10.1002/1521-4141(200212)32:12<3498::AID-IMMU3498>3.0.CO;2-C; Fleury E, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-341; FUJII N, 1992, J BIOL CHEM, V267, P22452; Gerdol M, 2011, DEV COMP IMMUNOL, V35, P635, DOI 10.1016/j.dci.2011.01.018; Gestal C, 2007, GENE, V406, P134, DOI 10.1016/j.gene.2007.07.030; Gestal C, 2010, DEV COMP IMMUNOL, V34, P926, DOI 10.1016/j.dci.2010.02.012; Gestal C, 2008, REV FISH SCI, V16, P133, DOI 10.1080/10641260802325518; Ghiselli F, 2011, MOL BIOL EV IN PRESS; Gourdine JP, 2007, FISH SHELLFISH IMMUN, V22, P498, DOI 10.1016/j.fsi.2006.06.013; Gueguen Y, 2003, GENE, V303, P139, DOI 10.1016/S0378-1119(02)01149-6; Henderson NC, 2009, IMMUNOL REV, V230, P160, DOI 10.1111/j.1600-065X.2009.00794.x; Huan P, 2011, MAR BIOTECH IN PRESS; Hubert F, 1996, EUR J BIOCHEM, V240, P302, DOI 10.1111/j.1432-1033.1996.0302h.x; Itoh N, 2008, COMP BIOCHEM PHYS B, V150, P409, DOI 10.1016/j.cbpb.2008.04.011; Jenny MJ, 2002, MAR BIOTECHNOL, V4, P81, DOI 10.1007/s10126-001-0072-8; Kadomatsu T, 2011, FEBS J, V278, P559, DOI 10.1111/j.1742-4658.2010.07979.x; Kang YS, 2006, DEV COMP IMMUNOL, V30, P1119, DOI 10.1016/j.dci.2006.03.005; Kim JY, 2008, DEV COMP IMMUNOL, V32, P1131, DOI 10.1016/j.dci.2008.03.002; Kim JY, 2008, FISH SHELLFISH IMMUN, V25, P598, DOI 10.1016/j.fsi.2008.07.015; Kim YM, 2008, NATURE, V452, P234, DOI 10.1038/nature06726; Kim YM, 2006, J BIOL CHEM, V281, P26854, DOI 10.1074/jbc.M601251200; Kishore U, 2004, TRENDS IMMUNOL, V25, P551, DOI 10.1016/j.it.2004.08.006; La Peyre JF, 2010, DEV COMP IMMUNOL, V34, P84, DOI 10.1016/j.dci.2009.08.007; Lakhal F, 2008, APPL ENVIRON MICROB, V74, P5750, DOI 10.1128/AEM.01043-08; Li CH, 2011, FISH SHELLFISH IMMUN, V30, P447, DOI 10.1016/j.fsi.2010.10.023; Li CH, 2010, CELL STRESS CHAPERON, V15, P897, DOI 10.1007/s12192-010-0198-6; Li L, 2009, FISH SHELLFISH IMMUN, V27, P625, DOI 10.1016/j.fsi.2009.07.009; Metzker ML, 2010, NAT REV GENET, V11, P31, DOI 10.1038/nrg2626; Milan M, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-234; Montagnani C, 2001, FEBS LETT, V500, P64, DOI 10.1016/S0014-5793(01)02559-5; Moreira R, 2012, DEV COMP IMMUNOL, V36, P140, DOI 10.1016/j.dci.2011.06.012; Ni DJ, 2007, DEV COMP IMMUNOL, V31, P548, DOI 10.1016/j.dci.2006.09.001; OLAFSEN JA, 1995, ADV EXP MED BIOL, V371, P343; Ordas MC, 2000, FISH SHELLFISH IMMUN, V10, P611, DOI 10.1006/fsim.2000.0276; Ordas MC, 2000, FISH SHELLFISH IMMUN, V10, P597, DOI 10.1006/fsim.2000.0274; Paillard C, 2004, AQUAT LIVING RESOUR, V17, P477, DOI 10.1051/alr:2004054; Pallavicini A, 2008, DEV COMP IMMUNOL, V32, P213, DOI 10.1016/j.dci.2007.05.008; Parcellier A, 2003, BIOCHEM BIOPH RES CO, V304, P505, DOI 10.1016/S0006-291X(03)00623-5; Park EM, 2008, FISH SHELLFISH IMMUN, V24, P11, DOI 10.1016/j.fsi.2007.07.003; Phan IQH, 2003, NUCLEIC ACIDS RES, V31, P3822, DOI 10.1093/nar/gkg516; Prado-Alvarez M, 2009, FISH SHELLFISH IMMUN, V26, P305, DOI 10.1016/j.fsi.2008.11.015; Prado-Alvarez M, 2009, FISH SHELLFISH IMMUN, V26, P72, DOI 10.1016/j.fsi.2008.03.002; Qiu LM, 2007, FISH SHELLFISH IMMUN, V22, P451, DOI 10.1016/j.fsi.2006.05.003; Qiu LM, 2009, FISH SHELLFISH IMMUN, V26, P359, DOI 10.1016/j.fsi.2008.10.010; Rassart E, 2000, BBA-PROTEIN STRUCT M, V1482, P185, DOI 10.1016/S0167-4838(00)00162-X; Roach JC, 2005, P NATL ACAD SCI USA, V102, P9577, DOI 10.1073/pnas.0502272102; Ruddell RG, 2009, HEPATOLOGY, V49, P887, DOI 10.1002/hep.22716; Shagin DA, 2002, GENOME RES, V12, P1935, DOI 10.1101/gr.547002; Su JG, 2004, AQUACULTURE, V239, P69, DOI 10.1016/j.aquaculture.2004.03.012; Su JG, 2007, FISH SHELLFISH IMMUN, V23, P646, DOI 10.1016/j.fsi.2007.01.023; Tafalla C, 2003, DEV COMP IMMUNOL, V27, P197, DOI 10.1016/S0145-305X(02)00098-8; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Tanguy A, 2008, GENE, V408, P27, DOI 10.1016/j.gene.2007.10.021; Vasta GR, 2004, CURR OPIN STRUC BIOL, V14, P617, DOI 10.1016/j.sbi.2004.09.008; Venier P, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-69; Venier P, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-72; Vera JC, 2008, MOL ECOL, V17, P1636, DOI 10.1111/j.1365-294X.2008.03666.x; Villalba A, 2004, AQUAT LIVING RESOUR, V17, P411, DOI 10.1051/alr:2004050; Wang AM, 2011, MAR BIOTECHNOL, V13, P275, DOI 10.1007/s10126-010-9296-9; Wang B, 2008, FISH SHELLFISH IMMUN, V24, P629, DOI 10.1016/j.fsi.2008.01.017; Xue QG, 2006, COMP BIOCHEM PHYS B, V145, P16, DOI 10.1016/j.cbpb.2006.05.010; Xue QG, 2009, FISH SHELLFISH IMMUN, V27, P250, DOI 10.1016/j.fsi.2009.05.006; Yu YD, 2007, FISH SHELLFISH IMMUN, V23, P419, DOI 10.1016/j.fsi.2006.12.004; Zhang DC, 2009, FISH SHELLFISH IMMUN, V27, P391, DOI 10.1016/j.fsi.2009.04.006; Zhang DK, 2004, SCIENCE, V303, P1522, DOI 10.1126/science.1094351; Zhang H, 2008, FISH SHELLFISH IMMUN, V25, P281, DOI 10.1016/j.fsi.2008.06.003; Zhao JM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013480; Zhao JM, 2010, COMP BIOCHEM PHYS B, V156, P56, DOI 10.1016/j.cbpb.2010.02.001; Zhu L, 2006, FISH SHELLFISH IMMUN, V20, P320, DOI 10.1016/j.fsi.2005.05.009; Zhulidov PA, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh031	94	98	102	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2012	7	4							e35009	10.1371/journal.pone.0035009	http://dx.doi.org/10.1371/journal.pone.0035009			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TL	22536348	Green Published, Green Submitted, gold			2022-12-25	WOS:000305336200021
J	Finer, M; Jenkins, CN				Finer, Matt; Jenkins, Clinton N.			Proliferation of Hydroelectric Dams in the Andean Amazon and Implications for Andes-Amazon Connectivity	PLOS ONE			English	Article							GREENHOUSE-GAS EMISSIONS; HYDROLOGIC CONNECTIVITY; FLOW REGULATION; RIVER; FRAGMENTATION; CONSERVATION; PERSPECTIVE; SEDIMENT; THREATS; WORLDS	Due to rising energy demands and abundant untapped potential, hydropower projects are rapidly increasing in the Neotropics. This is especially true in the wet and rugged Andean Amazon, where regional governments are prioritizing new hydroelectric dams as the centerpiece of long-term energy plans. However, the current planning for hydropower lacks adequate regional and basin-scale assessment of potential ecological impacts. This lack of strategic planning is particularly problematic given the intimate link between the Andes and Amazonian flood plain, together one of the most species rich zones on Earth. We examined the potential ecological impacts, in terms of river connectivity and forest loss, of the planned proliferation of hydroelectric dams across all Andean tributaries of the Amazon River. Considering data on the full portfolios of existing and planned dams, along with data on roads and transmission line systems, we developed a new conceptual framework to estimate the relative impacts of all planned dams. There are plans for 151 new dams greater than 2 MW over the next 20 years, more than a 300% increase. These dams would include five of the six major Andean tributaries of the Amazon. Our ecological impact analysis classified 47% of the potential new dams as high impact and just 19% as low impact. Sixty percent of the dams would cause the first major break in connectivity between protected Andean headwaters and the lowland Amazon. More than 80% would drive deforestation due to new roads, transmission lines, or inundation. We conclude with a discussion of three major policy implications of these findings. 1) There is a critical need for further strategic regional and basin scale evaluation of dams. 2) There is an urgent need for a strategic plan to maintain Andes-Amazon connectivity. 3) Reconsideration of hydropower as a low-impact energy source in the Neotropics.	[Finer, Matt] Save Amer Forests, Washington, DC USA; [Finer, Matt] Ctr Int Environm Law, Washington, DC USA; [Jenkins, Clinton N.] N Carolina State Univ, Dept Biol, Raleigh, NC 27695 USA	University of North Carolina; North Carolina State University	Finer, M (corresponding author), Save Amer Forests, Washington, DC USA.	matt.finer@gmail.com	Jenkins, Clinton/D-6134-2011	Jenkins, Clinton/0000-0003-2198-0637	National Geographic Society Committee for Research and Exploration; Blue Moon Fund; Gordon and Betty Moore Foundation; Threshold Foundation; Conservation, Food and Health Foundation; NASA [ROSES-NNX09AK22G]	National Geographic Society Committee for Research and Exploration(National Geographic Society); Blue Moon Fund; Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); Threshold Foundation; Conservation, Food and Health Foundation; NASA(National Aeronautics & Space Administration (NASA))	This research was supported by the National Geographic Society Committee for Research and Exploration, Blue Moon Fund, Gordon and Betty Moore Foundation, Threshold Foundation, and Conservation, Food and Health Foundation. Jenkins was supported by a NASA Biodiversity Grant (ROSES-NNX09AK22G). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aalto R, 2002, IAHS-AISH P, P339; Anderson EP, 2008, AQUAT CONSERV, V18, P408, DOI 10.1002/aqc.882; Anderson EP, 2006, AQUAT CONSERV, V16, P679, DOI 10.1002/aqc.806; Anderson EP, 2011, CONSERV BIOL, V25, P30, DOI 10.1111/j.1523-1739.2010.01568.x; Anderson EP, 2010, ENV FLOWS CONCEPT AD; [Anonymous], 2011, HYDR SUST ASS PROT; [Anonymous], 2011, NATURE, V474, P420; Asamblea Nacional, 2008, CONST REPBL EC; BARROW C, 1988, J BIOGEOGR, V15, P67, DOI 10.2307/2845047; Barthem R., 1997, CATFISH CONNECTION E; Bass MS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008767; Consejo Nacional de Electricidad, 2009, INV REC EN EC CON FI; Consejo Nacional de Electricidad, 2009, PLAN MAESTR EL 2009; Dunne T, 1998, GEOL SOC AM BULL, V110, P450, DOI 10.1130/0016-7606(1998)110<0450:EOSBTF>2.3.CO;2; DYNESIUS M, 1994, SCIENCE, V266, P753, DOI 10.1126/science.266.5186.753; Electro Oriente, 2011, POT HIDR REG LOR; Empresa Nacional de Electricidad, 2009, MEM AN 2008; Empresa Nacional de Electricidad, 2010, PLAN ESTR 2007 2014; Esselman PC, 2010, ECOL SOC, V15; Fearnside PM, 2004, CLIMATIC CHANGE, V66, P1, DOI 10.1023/B:CLIM.0000043174.02841.23; Fearnside PM, 2002, WATER AIR SOIL POLL, V133, P69, DOI 10.1023/A:1012971715668; Finer M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002932; Freeman MC, 2007, J AM WATER RESOUR AS, V43, P5, DOI 10.1111/j.1752-1688.2007.00002.x; Fundacion Alisos, 2011, RET DES SOST TRANSF; Goulding M, 2010, CUENCA RIO INAMBARI; Graf WL, 1999, WATER RESOUR RES, V35, P1305, DOI 10.1029/1999WR900016; Greathouse EA, 2006, ECOL APPL, V16, P339, DOI 10.1890/05-0243; Hoorn C, 2010, SCIENCE, V330, P927, DOI 10.1126/science.1194585; International Labour Organisation, 1989, CONV NO 169 IND TRIB; International Rivers, 2010, DAMS AM; International Rivers, 2008, RIP OFFS FAIL KYOT P; Jansson R, 2000, ECOLOGY, V81, P899, DOI 10.1890/0012-9658(2000)081[0899:FORFIR]2.0.CO;2; Jarvis A., 2008, EOS T AGU, V89, P93, DOI [DOI 10.1029/2008EO100001, 10.1029/2008EO100001]; Josse C, 2007, DIGITAL ECOLOGICAL S; Laraque A, 2009, HYDROL PROCESS, V23, P3509, DOI 10.1002/hyp.7463; Laurance WF, 2009, TRENDS ECOL EVOL, V24, P659, DOI 10.1016/j.tree.2009.06.009; Mcclain ME, 2008, BIOSCIENCE, V58, P325, DOI 10.1641/B580408; McLarney MO, THREAT BIODIVERSITY; MEADE RH, 1985, SCIENCE, V228, P488, DOI 10.1126/science.228.4698.488; Ministerio de Energia y Minas, 2009, PER SECT EL 2009 DOC; Ministerio de Energia y Minas, 2007, EL RES EJ FICH EST C; Ministerio de Energia y Minas, 1976, EV POT HIDR NAC 1973; Ministerio de Energia y Minas, 2008, PORT PROYECT GEN TRA; Ministerio de Energia y Minas, 2009, AN EST EL 2008; Ministerio de Energia y Minas, 2009, PLAN REF EL 2008 201; Ministerio de Hidrocarburos y Energia, 2010, PLAN ESTR I 2010 201; Ministerio de Hidrocarburos y Energia, 2009, PLAN DES EN AN ESX 2; Ministerio de Hidrocarburos y Energia, 2010, PROYECC SECT 2010 20; Ministerio de Hidrocarburos y Energia, 2009, BAL EN NAC 2000 2007; Ministerio de Minas y Energia, 2007, PORT PROYECT GEN EN; Ministerio de Minas y Energia, 2009, B EST MIN EN 2003 20; Ministerio de Minas y Energia, 2009, PLAN EXP REF GEN TRA; NatureServe, 2009, SIST EC AND NORT CTR; Nilsson C, 2005, SCIENCE, V308, P405, DOI 10.1126/science.1107887; Nogueira C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011390; Olson DM, 2001, BIOSCIENCE, V51, P933, DOI 10.1641/0006-3568(2001)051[0933:TEOTWA]2.0.CO;2; Orme CDL, 2005, NATURE, V436, P1016, DOI 10.1038/nature03850; Pringle C, 2003, HYDROL PROCESS, V17, P2685, DOI 10.1002/hyp.5145; Pringle CM, 2000, BIOSCIENCE, V50, P807, DOI 10.1641/0006-3568(2000)050[0807:REOHAO]2.0.CO;2; Red Amazonica de Informacion Socioambiental Georreferenciada, 2009, MAP AM 2009 AR PROT; Republica del Peru, 2011, LEY DER CONS PREV PU; Revenga C, 2005, PHILOS T ROY SOC B, V360, P397, DOI 10.1098/rstb.2004.1595; Revenga C., 2000, PILOT ANAL GLOBAL EC; St Louis VL, 2000, BIOSCIENCE, V50, P766, DOI 10.1641/0006-3568(2000)050[0766:RSASOG]2.0.CO;2; Stanford JA, 2001, REGUL RIVER, V17, P303, DOI 10.1002/rrr.659; Tollefson J, 2011, NATURE, V474, P430, DOI 10.1038/474430a; United Nations, 2011, UN DECL RIGHTS IND P; Vorosmarty CJ, 2010, NATURE, V467, P555, DOI 10.1038/nature09440; WCD (World Commission on Dams), 2000, DAMS DEV NEW FRAMEWO; Wipfli MS, 2007, J AM WATER RESOUR AS, V43, P72, DOI 10.1111/j.1752-1688.2007.00007.x	70	287	296	5	137	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2012	7	4							e35126	10.1371/journal.pone.0035126	http://dx.doi.org/10.1371/journal.pone.0035126			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959XD	22529979	Green Published, gold, Green Submitted			2022-12-25	WOS:000305350600059
J	Lichter, S; Rafferty, B; Flohr, Z; Martini, A				Lichter, Seth; Rafferty, Benjamin; Flohr, Zachary; Martini, Ashlie			Protein High-Force Pulling Simulations Yield Low-Force Results	PLOS ONE			English	Article							STEERED MOLECULAR-DYNAMICS; FRACTURE-MECHANICS; ESCHERICHIA-COLI; SINGLE PROTEIN; RNASE-H; UBIQUITIN; TITIN; DOMAINS; INTERMEDIATE; BARNASE	All-atom explicit-solvent molecular dynamics simulations are used to pull with extremely large constant force (750-3000 pN) on three small proteins. The introduction of a nondimensional timescale permits direct comparison of unfolding across all forces. A crossover force of approximately 1100 pN divides unfolding dynamics into two regimes. At higher forces, residues sequentially unfold from the pulling end while maintaining the remainder of the protein force-free. Measurements of hydrodynamic viscous stresses are made easy by the high speeds of unfolding. Using an exact low-Reynolds-number scaling, these measurements can be extrapolated to provide, for the first time, an estimate of the hydrodynamic force on low-force unfolding. Below 1100 pN, but surprisingly still at extremely large applied force, intermediate states and cooperative unfoldings as seen at much lower forces are observed. The force-insensitive persistence of these structures indicates that decomposition into unfolded fragments requires a large fluctuation. This finding suggests how proteins are constructed to resist transient high force. The progression of alpha helix and beta sheet unfolding is also found to be insensitive to force. The force-insensitivity of key aspects of unfolding opens the possibility that numerical simulations can be accelerated by high applied force while still maintaining critical features of unfolding.	[Lichter, Seth] Northwestern Univ, Dept Mech Engn, Evanston, IL 60208 USA; [Rafferty, Benjamin; Flohr, Zachary] Purdue Univ, Coll Engn, W Lafayette, IN 47907 USA; [Martini, Ashlie] Univ Calif Merced, Sch Engn, Merced, CA USA	Northwestern University; Purdue University System; Purdue University; Purdue University West Lafayette Campus; University of California System; University of California Merced	Lichter, S (corresponding author), Northwestern Univ, Dept Mech Engn, Evanston, IL 60208 USA.	s-lichter@northwestern.edu	Martini, Ashlie/F-9320-2012; Lichter, Seth H/B-7598-2009	Martini, Ashlie/0000-0003-2017-6081; 	Network for Computational Nanotechnology under National Science Foundation Cooperative Agreement [EEC-0634750]	Network for Computational Nanotechnology under National Science Foundation Cooperative Agreement	AM, BR and ZF were supported by the Network for Computational Nanotechnology under National Science Foundation Cooperative Agreement EEC-0634750. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackbarow T, 2007, P NATL ACAD SCI USA, V104, P16410, DOI 10.1073/pnas.0705759104; Baker D, 2000, NATURE, V405, P39, DOI 10.1038/35011000; Balsera M, 1997, BIOPHYS J, V73, P1281, DOI 10.1016/S0006-3495(97)78161-X; Batchelor G., 1967, INTRO FLUID DYNAMICS; Berman HM, 2002, ACTA CRYSTALLOGR D, V58, P899, DOI 10.1107/S0907444902003451; Best RB, 2008, J PHYS CHEM B, V112, P5968, DOI 10.1021/jp075955j; Best RB, 2008, J AM CHEM SOC, V130, P3706, DOI 10.1021/ja0762691; Branden C., 1998, INTRO PROTEIN STRUCT, V2nd; Buehler MJ, 2007, MATER TODAY, V10, P46, DOI 10.1016/S1369-7021(07)70208-0; BYCROFT M, 1991, BIOCHEMISTRY-US, V30, P8697, DOI 10.1021/bi00099a030; Cecconi C, 2005, SCIENCE, V309, P2057, DOI 10.1126/science.1116702; Chamberlain AK, 1996, NAT STRUCT BIOL, V3, P782, DOI 10.1038/nsb0996-782; Cieplak M, 2002, PROTEINS, V49, P104, DOI 10.1002/prot.10188; Cieplak M, 2006, J CHEM PHYS, V124, DOI 10.1063/1.2192768; Connell KB, 2009, J MOL BIOL, V391, P450, DOI 10.1016/j.jmb.2009.05.085; Creighton T. E., 1993, PROTEINS STRUCTURES; Das A, 2009, PROTEINS, V75, P1024, DOI 10.1002/prot.22314; Djikaev YS, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.011909; Elston T, 1998, NATURE, V391, P510, DOI 10.1038/35185; Evans E, 1997, BIOPHYS J, V72, P1541, DOI 10.1016/S0006-3495(97)78802-7; Evans E., 2002, PHYS BIOMOLECULES CE, P145, DOI DOI 10.1007/3-540-45701-1_4; Fernandez JM, 2004, SCIENCE, V303, P1674, DOI 10.1126/science.1092497; Forman JR, 2007, CURR OPIN STRUC BIOL, V17, P58, DOI 10.1016/j.sbi.2007.01.006; Fujiwara M, 2000, BIOL PHARM BULL, V23, P1147; Gao M, 2002, J MUSCLE RES CELL M, V23, P513, DOI 10.1023/A:1023466608163; Gao M, 2002, BIOPHYS J, V83, P3435, DOI 10.1016/S0006-3495(02)75343-5; Gao M, 2002, J MOL BIOL, V323, P939, DOI 10.1016/S0022-2836(02)01001-X; Imparato A, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.158104; Irback A, 2005, P NATL ACAD SCI USA, V102, P13427, DOI 10.1073/pnas.0501581102; Izrailev S, 1997, BIOPHYS J, V72, P1568, DOI 10.1016/S0006-3495(97)78804-0; Jorgensen WL, 1996, J AM CHEM SOC, V118, P11225, DOI 10.1021/ja9621760; Jorgensen WL, 1983, J CHEM PHYS, V79; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kaminski GA, 2001, J PHYS CHEM B, V105, P6474, DOI 10.1021/jp003919d; Kirmizialtin S, 2006, PHYS STATUS SOLIDI B, V243, P2038, DOI 10.1002/pssb.200666812; Kleiner A, 2007, BIOPHYS J, V92, P2054, DOI 10.1529/biophysj.106.081257; Lee EH, 2009, STRUCTURE, V17, P1295, DOI 10.1016/j.str.2009.09.001; Li AJ, 1998, J MOL BIOL, V275, P677, DOI 10.1006/jmbi.1997.1484; Li MS, 2007, BIOPHYS J, V92, P547, DOI 10.1529/biophysj.106.087684; Li PC, 2004, J PHYS CHEM B, V108, P745, DOI 10.1021/jp0363895; Li PC, 2003, J CHEM PHYS, V119, P9260, DOI 10.1063/1.1615233; Lu H, 1998, BIOPHYS J, V75, P662, DOI 10.1016/S0006-3495(98)77556-3; Luccioli S, 2010, PHYS REV E, V81; Matouschek A, 2003, CURR OPIN STRUC BIOL, V13, P98, DOI 10.1016/S0959-440X(03)00010-1; MATOUSCHEK A, 1989, NATURE, V340, P122, DOI 10.1038/340122a0; Matysiak S, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.118103; Mitsui K, 2000, BIOCHEM BIOPH RES CO, V272, P55, DOI 10.1006/bbrc.2000.2742; Nova A, 2010, NANO LETT, V10, P2626, DOI 10.1021/nl101341w; Oberhauser AF, 1998, NATURE, V393, P181, DOI 10.1038/30270; Paramore S, 2006, BIOPHYS J, V90, P92, DOI 10.1529/biophysj.105.066969; Pedersen JA, 2010, J BIOMECH, V43, P900, DOI 10.1016/j.jbiomech.2009.11.007; Raschke TM, 1999, NAT STRUCT BIOL, V6, P825; Raschke TM, 1997, NAT STRUCT BIOL, V4, P298, DOI 10.1038/nsb0497-298; Rohs R, 1999, BIOPHYS J, V76, P2760, DOI 10.1016/S0006-3495(99)77429-1; Schlierf M, 2004, P NATL ACAD SCI USA, V101, P7299, DOI 10.1073/pnas.0400033101; Schmitt TJ, 2009, J CHEM PHYS, V131, DOI 10.1063/1.3270167; Shank EA, 2010, NATURE, V465, P637, DOI 10.1038/nature09021; Shaqfeh ESG, 2005, J NON-NEWTON FLUID, V130, P1, DOI 10.1016/j.jnnfm.2005.05.011; Shieh AC, 2011, PHYS BIOL, V8, DOI 10.1088/1478-3975/8/1/015012; SIMON SM, 1992, P NATL ACAD SCI USA, V89, P3770, DOI 10.1073/pnas.89.9.3770; Spudich GM, 2004, J MOL BIOL, V335, P609, DOI 10.1016/j.jmb.2003.10.052; Szymczak P, 2006, J PHYS-CONDENS MAT, V18, pL21, DOI 10.1088/0953-8984/18/1/L04; TIRADO MM, 1980, J CHEM PHYS, V73, P1986, DOI 10.1063/1.440288; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; VIJAYKUMAR S, 1987, J MOL BIOL, V194, P531, DOI 10.1016/0022-2836(87)90679-6; Wilcox AJ, 2005, P NATL ACAD SCI USA, V102, P15435, DOI 10.1073/pnas.0507324102; Wong KB, 2000, J MOL BIOL, V296, P1257, DOI 10.1006/jmbi.2000.3523	67	2	2	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2012	7	4							e34781	10.1371/journal.pone.0034781	http://dx.doi.org/10.1371/journal.pone.0034781			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959XD	22529933	gold, Green Published, Green Submitted			2022-12-25	WOS:000305350600026
J	Miehe, S; Crause, P; Schmidt, T; Lohn, M; Kleemann, HW; Licher, T; Dittrich, W; Rutten, H; Strubing, C				Miehe, Susanne; Crause, Peter; Schmidt, Thorsten; Loehn, Matthias; Kleemann, Heinz-Werner; Licher, Thomas; Dittrich, Werner; Ruetten, Hartmut; Struebing, Carsten			Inhibition of Diacylglycerol-Sensitive TRPC Channels by Synthetic and Natural Steroids	PLOS ONE			English	Article							VASCULAR SMOOTH-MUSCLE; CALCIUM-ENTRY; RAT AORTA; PROGESTERONE; MICE; CELLS; PREGNANCY; ACTIVATION; EXPRESSION; MECHANISMS	TRPC channels are a family of nonselective cation channels that regulate ion homeostasis and intracellular Ca2+ signaling in numerous cell types. Important physiological functions such as vasoregulation, neuronal growth, and pheromone recognition have been assigned to this class of ion channels. Despite their physiological relevance, few selective pharmacological tools are available to study TRPC channel function. We, therefore, screened a selection of pharmacologically active compounds for TRPC modulating activity. We found that the synthetic gestagen norgestimate inhibited diacylglycerol-sensitive TRPC3 and TRPC6 with IC(50)s of 3-5 mu M, while half-maximal inhibition of TRPC5 required significantly higher compound concentrations (>10 mu M). Norgestimate blocked TRPC-mediated vasopressin-induced cation currents in A7r5 smooth muscle cells and caused vasorelaxation of isolated rat aorta, indicating that norgestimate could be an interesting tool for the investigation of TRP channel function in native cells and tissues. The steroid hormone progesterone, which is structurally related to norgestimate, also inhibited TRPC channel activity with IC(50)s ranging from 6 to 18 mu M but showed little subtype selectivity. Thus, TRPC channel inhibition by high gestational levels of progesterone may contribute to the physiological decrease of uterine contractility and immunosuppression during pregnancy.	[Miehe, Susanne; Crause, Peter; Schmidt, Thorsten; Loehn, Matthias; Kleemann, Heinz-Werner; Licher, Thomas; Dittrich, Werner; Ruetten, Hartmut; Struebing, Carsten] Sanofi Aventis Deutschland GmbH, Res & Dev, Frankfurt, Germany	Sanofi-Aventis	Miehe, S (corresponding author), Sanofi Aventis Deutschland GmbH, Res & Dev, Frankfurt, Germany.	carsten.struebing@sanofi.com			Sanofi-Aventis	Sanofi-Aventis(Sanofi-Aventis)	This work was funded by Sanofi-Aventis. The funder employed the authors, who designed the study, collected the data, analyzed the data, and prepared the manuscript. Sanofi-Aventis approved the decision to publish the manuscript.	Barbagallo M, 2001, HYPERTENSION, V37, P142, DOI 10.1161/01.HYP.37.1.142; Becker EBE, 2009, P NATL ACAD SCI USA, V106, P6706, DOI 10.1073/pnas.0810599106; Beech DJ, 2005, CLIN EXP PHARMACOL P, V32, P597, DOI 10.1111/j.1440-1681.2005.04251.x; Boulay G, 1997, J BIOL CHEM, V272, P29672, DOI 10.1074/jbc.272.47.29672; Chang K, 2008, REPROD SCI, V15, P336, DOI 10.1177/1933719108317975; Crews JK, 1999, ARTERIOSCL THROM VAS, V19, P1034, DOI 10.1161/01.ATV.19.4.1034; Dalrymple A, 2002, MOL HUM REPROD, V8, P946, DOI 10.1093/molehr/8.10.946; Dietrich A, 2005, MOL CELL BIOL, V25, P6980, DOI 10.1128/MCB.25.16.6980-6989.2005; Dietrich A, 2010, THROMB HAEMOSTASIS, V103, P262, DOI 10.1160/TH09-08-0517; Drab M, 2001, SCIENCE, V293, P2449, DOI 10.1126/science.1062688; Facemire CS, 2004, AM J PHYSIOL-RENAL, V286, pF546, DOI 10.1152/ajprenal.00338.2003; Freichel M, 2001, NAT CELL BIOL, V3, P121, DOI 10.1038/35055019; GANGRADE NK, 1992, BIOPHARM DRUG DISPOS, V13, P703, DOI 10.1002/bdd.2510130908; Glusa E, 1997, MATURITAS, V28, P181, DOI 10.1016/S0378-5122(97)00057-1; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; Hartmann J, 2008, NEURON, V59, P392, DOI 10.1016/j.neuron.2008.06.009; He LP, 2005, J BIOL CHEM, V280, P10997, DOI 10.1074/jbc.M411797200; JOHANSSON ED, 1969, ACTA ENDOCRINOL-COP, V61, P607, DOI 10.1530/acta.0.0610607; Jung S, 2002, AM J PHYSIOL-CELL PH, V282, pC347, DOI 10.1152/ajpcell.00283.2001; Kawabata A, 1999, J PHARMACOL EXP THER, V288, P358; Kiyonaka S, 2009, P NATL ACAD SCI USA, V106, P5400, DOI 10.1073/pnas.0808793106; Kraft R, 2007, BIOCHEM BIOPH RES CO, V361, P230, DOI 10.1016/j.bbrc.2007.07.019; Ku CY, 2006, J SOC GYNECOL INVEST, V13, P217, DOI 10.1016/j.jsgi.2005.12.007; Leypold BG, 2002, P NATL ACAD SCI USA, V99, P6376, DOI 10.1073/pnas.082127599; Majeed Y, 2011, BRIT J PHARMACOL, V162, P1509, DOI 10.1111/j.1476-5381.2010.01136.x; Maruyama Y, 2006, CIRC RES, V98, P1520, DOI 10.1161/01.RES.0000226495.34949.28; Mukerji MS, 2000, J PHARM PHARMACOL, V52, P843, DOI 10.1211/0022357001774525; Pena F, 2008, MINI-REV MED CHEM, V8, P812, DOI 10.2174/138955708784912166; Ramsey IS, 2006, ANNU REV PHYSIOL, V68, P619, DOI 10.1146/annurev.physiol.68.040204.100431; Riccio A, 2009, CELL, V137, P761, DOI 10.1016/j.cell.2009.03.039; RUNNEBAUM B, 1975, ACTA ENDOCRINOL-COP, V80, P569, DOI 10.1530/acta.0.0800569; Schwarz E. C., 2007, V179, P445; Seth M, 2009, CIRC RES, V105, P1023, DOI 10.1161/CIRCRESAHA.109.206581; Soboloff J, 2005, J BIOL CHEM, V280, P39786, DOI 10.1074/jbc.M506064200; STITES DP, 1983, IMMUNOL REV, V75, P117, DOI 10.1111/j.1600-065X.1983.tb01093.x; Stowers L, 2002, SCIENCE, V295, P1493, DOI 10.1126/science.1069259; Trebak M., 2007, V179, P593; Venkatachalam K, 2007, ANNU REV BIOCHEM, V76, P387, DOI 10.1146/annurev.biochem.75.103004.142819; Yang M, 2002, BIOL REPROD, V67, P988, DOI 10.1095/biolreprod.102.004119; Zanou N, 2010, AM J PHYSIOL-CELL PH, V298, pC149, DOI 10.1152/ajpcell.00241.2009; Zhang ML, 2002, J PHARM PHARMACOL, V54, P1667, DOI 10.1211/002235702405; Zitt C, 2004, J BIOL CHEM, V279, P12427, DOI 10.1074/jbc.M309297200	42	35	36	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2012	7	4							e35393	10.1371/journal.pone.0035393	http://dx.doi.org/10.1371/journal.pone.0035393			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WC	22530015	Green Published, gold, Green Submitted			2022-12-25	WOS:000305347400047
J	Brasen, JC; Jacobsen, JCB; Holstein-Rathlou, NH				Brasen, Jens Christian; Jacobsen, Jens Christian Brings; Holstein-Rathlou, Niels-Henrik			The Nanostructure of Myoendothelial Junctions Contributes to Signal Rectification between Endothelial and Vascular Smooth Muscle Cells	PLOS ONE			English	Article							MATHEMATICAL-MODEL; GAP-JUNCTIONS; CALCIUM DYNAMICS; CA2+; RAT; POTASSIUM; CHANNELS; MICRODOMAINS; ARTERIOLES; DIFFUSION	Micro-anatomical structures in tissues have potential physiological effects. In arteries and arterioles smooth muscle cells and endothelial cells are separated by the internal elastic lamina, but the two cell layers often make contact through micro protrusions called myoendothelial junctions. Cross talk between the two cell layers is important in regulating blood pressure and flow. We have used a spatiotemporal mathematical model to investigate how the myoendothelial junctions affect the information flow between the two cell layers. The geometry of the model mimics the structure of the two cell types and the myoendothelial junction. The model is implemented as a 2D axi-symmetrical model and solved using the finite element method. We have simulated diffusion of Ca2+ and IP3 between the two cell types and we show that the micro-anatomical structure of the myoendothelial junction in itself may rectify a signal between the two cell layers. The rectification is caused by the asymmetrical structure of the myoendothelial junction. Because the head of the myoendothelial junction is separated from the cell it is attached to by a narrow neck region, a signal generated in the neighboring cell can easily drive a concentration change in the head of the myoendothelial protrusion. Subsequently the signal can be amplified in the head, and activate the entire cell. In contrast, a signal in the cell from which the myoendothelial junction originates will be attenuated and delayed in the neck region as it travels into the head of the myoendothelial junction and the neighboring cell.	[Brasen, Jens Christian; Jacobsen, Jens Christian Brings; Holstein-Rathlou, Niels-Henrik] Univ Copenhagen, Dept Biomed Sci, Copenhagen, Denmark	University of Copenhagen	Brasen, JC (corresponding author), Univ Copenhagen, Dept Biomed Sci, Copenhagen, Denmark.	jcbrasen@sund.ku.dk	Jacobsen, Jens Christian/B-7304-2008; Holstein-Rathlou, Niels-Henrik/B-2781-2008; Brasen, Jens Christian/C-4301-2015	Brasen, Jens Christian/0000-0003-4446-6331; Holstein-Rathlou, Niels-Henrik/0000-0003-1683-3464	Danish Council for Independent Research - Medical Sciences [10-082148]	Danish Council for Independent Research - Medical Sciences(Det Frie Forskningsrad (DFF))	The study was supported by The Danish Council for Independent Research - Medical Sciences (grant no. 10-082148). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLBRITTON NL, 1992, SCIENCE, V258, P1812, DOI 10.1126/science.1465619; Beny JL, 1999, NEWS PHYSIOL SCI, V14, P68; Berridge MJ, 2006, CELL CALCIUM, V40, P405, DOI 10.1016/j.ceca.2006.09.002; BERRIDGE MJ, 1993, NATURE, V361, P315, DOI 10.1038/361315a0; Brasen JC, 2010, CELL CALCIUM, V47, P339, DOI 10.1016/j.ceca.2010.01.005; Brenner R, 2000, NATURE, V407, P870, DOI 10.1038/35038011; Burns WR, 2004, MICROCIRCULATION, V11, P279, DOI 10.1080/10739680490425985; CHAD JE, 1984, BIOPHYS J, V45, P993, DOI 10.1016/S0006-3495(84)84244-7; Chadha PS, 2011, J PHARMACOL EXP THER, V336, P701, DOI 10.1124/jpet.110.165795; Chilton L, 2011, CARDIOVASC RES, V92, P169, DOI 10.1093/cvr/cvr179; Davies EV, 1996, BIOCHEM SOC T, V24, pS92, DOI 10.1042/bst024092s; de Wit C, 2006, BIOL CHEM, V387, P3, DOI 10.1515/BC.2006.002; DEYOUNG GW, 1992, P NATL ACAD SCI USA, V89, P9895, DOI 10.1073/pnas.89.20.9895; Dora KA, 2003, J VASC RES, V40, P480, DOI 10.1159/000074549; Dora KA, 1997, P NATL ACAD SCI USA, V94, P6529, DOI 10.1073/pnas.94.12.6529; Dora KA, 2008, CIRC RES, V102, P1247, DOI 10.1161/CIRCRESAHA.108.172379; Evans WH, 2002, MOL MEMBR BIOL, V19, P121, DOI 10.1080/09687680210139839; Haddy FJ, 2006, AM J PHYSIOL-REG I, V290, pR546, DOI 10.1152/ajpregu.00491.2005; Hille B., 2001, ION CHANNELS EXCITAB, V3rd Edn; Isakson BE, 2008, J CELL SCI, V121, P3664, DOI 10.1242/jcs.037481; Isakson BE, 2007, CIRC RES, V100, P246, DOI 10.1161/01.RES.0000257744.23795.93; Jaggar JH, 2000, AM J PHYSIOL-CELL PH, V278, pC235, DOI 10.1152/ajpcell.2000.278.2.C235; Kapela A, 2008, J THEOR BIOL, V253, P238, DOI 10.1016/j.jtbi.2008.03.004; Kapela A, 2009, MICROCIRCULATION, V16, P694, DOI 10.3109/10739680903177539; Kotaleski JH, 2010, NAT REV NEUROSCI, V11, P239, DOI 10.1038/nrn2807; LEDERER WJ, 1990, SCIENCE, V248, P283, DOI 10.1126/science.2326638; Ledoux J, 2008, P NATL ACAD SCI USA, V105, P9627, DOI 10.1073/pnas.0801963105; Mather S, 2005, CIRC RES, V97, P399, DOI 10.1161/01.RES.0000178008.46759.d0; MCCARRON JG, 1990, AM J PHYSIOL, V259, pH902, DOI 10.1152/ajpheart.1990.259.3.H902; Means S, 2006, BIOPHYS J, V91, P537, DOI 10.1529/biophysj.105.075036; Naraghi M, 1997, J NEUROSCI, V17, P6961; Nausch LWM, 2012, AM J PHYSIOL-HEART C, V302, pH594, DOI 10.1152/ajpheart.00773.2011; Sandow SL, 2006, J ANAT, V209, P689, DOI 10.1111/j.1469-7580.2006.00647.x; Sandow SL, 2009, CLIN EXP PHARMACOL P, V36, P67, DOI 10.1111/j.1440-1681.2008.05076.x; Sandow SL, 2000, CIRC RES, V86, P341, DOI 10.1161/01.RES.86.3.341; Sandow SL, 2011, MICROCIRCUL IN PRESS; Silva HS, 2007, AM J PHYSIOL-CELL PH, V293, pC277, DOI 10.1152/ajpcell.00542.2006; Smith PD, 2008, J PHYSIOL-LONDON, V586, P1147, DOI 10.1113/jphysiol.2007.145474; Tran CH, 2012, AM J PHYSL IN PRESS; Unger VM, 1999, SCIENCE, V283, P1176, DOI 10.1126/science.283.5405.1176	40	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2012	7	4							e33632	10.1371/journal.pone.0033632	http://dx.doi.org/10.1371/journal.pone.0033632			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VO	22523541	Green Published, Green Submitted, gold			2022-12-25	WOS:000305345000010
J	Hellier, JL; Arevalo, NL; Smith, L; Xiong, KN; Restrepo, D				Hellier, Jennifer L.; Arevalo, Nicole L.; Smith, Lynelle; Xiong, Ka-Na; Restrepo, Diego			alpha 7-Nicotinic Acetylcholine Receptor: Role in Early Odor Learning Preference in Mice	PLOS ONE			English	Article							DEFICIENT SENSORY INHIBITION; MAIN OLFACTORY-BULB; NICOTINIC RECEPTORS; NEWBORN MICE; DBA/2 MICE; HIPPOCAMPAL INTERNEURONS; LAMINAR DISTRIBUTION; CHOLINERGIC MARKERS; INDUCED PLASTICITY; KNOCKOUT MICE	Recently, we have shown that mice with decreased expression of alpha 7-nicotinic acetylcholine receptors (alpha 7) in the olfactory bulb were associated with a deficit in odor discrimination compared to wild-type mice. However, it is unknown if mice with decreased alpha 7-receptor expression also show a deficit in early odor learning preference (ELP), an enhanced behavioral response to odors with attractive value observed in rats. In this study, we modified ELP methods performed in rats and implemented similar conditions in mice. From post-natal days 5-18, wild-type mice were stroked simultaneously with an odor presentation (conditioned odor) for 90 s daily. Control mice were only stroked, exposed to odor, or neither. On the day of testing (P21), mice that were stroked in concert with a conditioned odor significantly investigated the conditioned odor compared to a novel odor, as observed similarly in rats. However, mice with a decrease in alpha 7-receptor expression that were stroked during a conditioned odor did not show a behavioral response to that odorant. These results suggest that decreased alpha 7-receptor expression has a role in associative learning, olfactory preference, and/or sensory processing deficits.	[Hellier, Jennifer L.; Arevalo, Nicole L.; Smith, Lynelle; Xiong, Ka-Na; Restrepo, Diego] Univ Colorado Anschutz Med Campus, Dept Cell & Dev Biol, Aurora, CO USA; [Restrepo, Diego] Univ Colorado Anschutz Med Campus, Program Neurosci, Aurora, CO USA; [Hellier, Jennifer L.; Arevalo, Nicole L.; Smith, Lynelle; Xiong, Ka-Na; Restrepo, Diego] Univ Colorado Anschutz Med Campus, Rocky Mt Taste & Smell Ctr, Aurora, CO USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus	Hellier, JL (corresponding author), Univ Colorado Anschutz Med Campus, Dept Cell & Dev Biol, Aurora, CO USA.	Jennifer.Hellier@ucdenver.edu			NIH [MH06858, DC 04657, DC00566, DC008855]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [P30DC004657, R01DC000566, R01DC008855] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by NIH grants MH06858, DC 04657, DC00566, and DC008855 (DR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams CE, 2008, BRAIN RES, V1194, P138, DOI 10.1016/j.brainres.2007.12.007; Akil H, 2010, SCIENCE, V327, P1580, DOI 10.1126/science.1188654; Alkondon M, 1997, J PHARMACOL EXP THER, V283, P1396; Arnaiz-Cot JJ, 2008, EUR J NEUROSCI, V27, P1097, DOI 10.1111/j.1460-9568.2008.06077.x; Bouslama M, 2007, NEUROSCIENCE, V150, P712, DOI 10.1016/j.neuroscience.2007.09.030; Bouslama M, 2006, NEUROSCIENCE, V141, P795, DOI 10.1016/j.neuroscience.2006.04.002; Bouslama M, 2005, BEHAV BRAIN RES, V161, P102, DOI 10.1016/j.bbr.2005.01.010; Doucette W, 2007, LEARN MEMORY, V14, P539, DOI 10.1101/lm.606407; Doucette W, 2011, NEURON, V69, P1176, DOI 10.1016/j.neuron.2011.02.024; Durand E, 2003, J APPL PHYSIOL, V94, P812, DOI 10.1152/japplphysiol.00488.2002; El-Etri MM, 1999, NEUROSCIENCE, V93, P611, DOI 10.1016/S0306-4522(99)00169-4; Fletcher ML, 2002, J NEUROSCI, V22, DOI 10.1523/JNEUROSCI.22-02-j0005.2002; Frazier CJ, 2003, J NEUROPHYSIOL, V89, P3018, DOI 10.1152/jn.01036.2002; FREEDMAN R, 1995, BIOL PSYCHIAT, V38, P22, DOI 10.1016/0006-3223(94)00252-X; Freedman R, 2000, J CHEM NEUROANAT, V20, P299, DOI 10.1016/S0891-0618(00)00109-5; Guan ZZ, 1999, NEUROREPORT, V10, P1779, DOI 10.1097/00001756-199906030-00028; Hashimoto K, 2005, PSYCHOPHARMACOLOGY, V183, P13, DOI 10.1007/s00213-005-0142-0; Hellier JL, 2010, BRAIN RES, V1358, P140, DOI 10.1016/j.brainres.2010.08.027; Hogg RC, 2007, BIOCHEM PHARMACOL, V73, P459, DOI 10.1016/j.bcp.2006.08.010; Jiang MR, 1996, J NEUROSCI, V16, P6319; JOHANSON IB, 1980, BEHAV NEURAL BIOL, V29, P132, DOI 10.1016/S0163-1047(80)92596-0; Kelso ML, 2006, BRAIN RES, V1083, P204, DOI 10.1016/j.brainres.2006.01.127; Kulak JM, 1997, J NEUROSCI, V17, P5263; LARGE TH, 1986, J NEUROCHEM, V46, P671, DOI 10.1111/j.1471-4159.1986.tb13024.x; LEJEUNE H, 1995, J CHEM NEUROANAT, V9, P99, DOI 10.1016/0891-0618(95)00070-N; LeJeune H, 1996, J COMP NEUROL, V373, P433, DOI 10.1002/(SICI)1096-9861(19960923)373:3<433::AID-CNE8>3.0.CO;2-3; LEJEUNE H, 1993, J COMP NEUROL, V336, P279; Leonard S, 2000, EUR J PHARMACOL, V393, P237, DOI 10.1016/S0014-2999(00)00035-2; Marutle A, 2001, J CHEM NEUROANAT, V22, P115, DOI 10.1016/S0891-0618(01)00117-X; MCLEAN JH, 1993, BEHAV NEURAL BIOL, V60, P152, DOI 10.1016/0163-1047(93)90257-I; Metherate R, 2004, LEARN MEMORY, V11, P50, DOI 10.1101/lm.69904; Moberg PJ, 2006, J CLIN EXP NEUROPSYC, V28, P1444, DOI 10.1080/13803390500434409; O'Leary KT, 2003, J NEUROCHEM, V84, P952, DOI 10.1046/j.1471-4159.2003.01575.x; Oliva AM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011359; Paylor R, 1998, LEARN MEMORY, V5, P302; Roalf DR, 2006, J NEUROPSYCH CLIN N, V18, P389, DOI 10.1176/appi.neuropsych.18.3.389; Ross RG, 2010, J CHILD PSYCHOL PSYC, V51, P535, DOI 10.1111/j.1469-7610.2009.02187.x; Rupp CI, 2005, SCHIZOPHRENIA BULL, V31, P155, DOI 10.1093/schbul/sbi018; Rupp CI, 2005, SCHIZOPHR RES, V74, P149, DOI 10.1016/j.schres.2004.07.010; Salcedo E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025441; Samama B, 1999, NEUROBIOL LEARN MEM, V71, P219, DOI 10.1006/nlme.1998.3869; SAYKIN AJ, 1991, ARCH GEN PSYCHIAT, V48, P618; Simosky JK, 2003, PSYCHOPHARMACOLOGY, V165, P386, DOI 10.1007/s00213-002-1285-x; Simosky JK, 2001, BIOL PSYCHIAT, V50, P493, DOI 10.1016/S0006-3223(01)01093-9; Simosky JK, 2008, BRAIN RES, V1233, P129, DOI 10.1016/j.brainres.2008.07.057; Slotnick B, 2005, CURR PROTOC NEUROSCI; Stevens KE, 1998, PSYCHOPHARMACOLOGY, V136, P320, DOI 10.1007/s002130050573; Stevens KE, 1996, NEUROPSYCHOPHARMACOL, V15, P152, DOI 10.1016/0893-133X(95)00178-G; Stoker AK, 2011, STUDIES KNOCKOUT MIC; Stopfer M, 1997, NATURE, V390, P70, DOI 10.1038/36335; Sullivan RM, 2000, BEHAV NEUROSCI, V114, P957, DOI 10.1037/0735-7044.114.5.957; SULLIVAN RM, 1986, DEV BRAIN RES, V27, P278, DOI 10.1016/0165-3806(86)90256-7; SULLIVAN RM, 1995, DEV PSYCHOBIOL, V28, P213, DOI 10.1002/dev.420280403; SULLIVAN RM, 1994, BRAIN RES, V643, P306, DOI 10.1016/0006-8993(94)90038-8; SULLIVAN RM, 1992, DEV BRAIN RES, V70, P279, DOI 10.1016/0165-3806(92)90207-D; Sullivan RM, 2003, LEARN MEMORY, V10, P1, DOI 10.1101/lm.58203; SULLIVAN RM, 1993, BEHAV NEUROSCI, V107, P254, DOI 10.1037/0735-7044.107.2.254; SULLIVAN RM, 1991, DEV BRAIN RES, V60, P219, DOI 10.1016/0165-3806(91)90050-S; SULLIVAN RM, 1989, PSYCHOBIOLOGY, V17, P29; SULLIVAN RM, 1988, DEV PSYCHOBIOL, V21, P215, DOI 10.1002/dev.420210303; SULLIVAN RM, 1989, J NEUROSCI, V9, P3998; SULLIVAN RM, 1988, PHYSIOL BEHAV, V44, P85, DOI 10.1016/0031-9384(88)90349-6; Turetsky BI, 2009, SCHIZOPHRENIA BULL, V35, P1117, DOI 10.1093/schbul/sbp111; Turetsky BI, 2009, NEUROPSYCHOPHARMACOL, V34, P767, DOI 10.1038/npp.2008.139; WILSON DA, 1994, BEHAV NEURAL BIOL, V61, P1, DOI 10.1016/S0163-1047(05)80039-1; WILSON DA, 1987, J NEUROSCI, V7, P3154; Wilson DA, 2004, LEARN MEMORY, V11, P28, DOI 10.1101/lm.66404; WILSON DA, 1991, BEHAV NEUROSCI, V105, P843, DOI 10.1037/0735-7044.105.6.843; Woodruff-Pak Diana S, 2002, Behav Cogn Neurosci Rev, V1, P5, DOI 10.1177/1534582302001001002; Young JW, 2011, GENES BRAIN BEHAV, V10, P720, DOI 10.1111/j.1601-183X.2011.00711.x; Yu WF, 2007, NEUROSCIENCE, V146, P1618, DOI 10.1016/j.neuroscience.2007.03.002; Yuan Q, 2003, J NEUROSCI, V23, P4760	72	11	11	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2012	7	4							e35251	10.1371/journal.pone.0035251	http://dx.doi.org/10.1371/journal.pone.0035251			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UT	22514723	Green Submitted, gold, Green Published			2022-12-25	WOS:000305341600128
J	Pullamsetti, SS; Banat, GA; Schmall, A; Szibor, M; Pomagruk, D; Hanze, J; Kolosionek, E; Wilhelm, J; Braun, T; Grimminger, F; Seeger, W; Schermuly, RT; Savai, R				Pullamsetti, S. S.; Banat, G. A.; Schmall, A.; Szibor, M.; Pomagruk, D.; Haenze, J.; Kolosionek, E.; Wilhelm, J.; Braun, T.; Grimminger, F.; Seeger, W.; Schermuly, R. T.; Savai, R.			Phosphodiesterase-4 promotes proliferation and angiogenesis of lung cancer by crosstalk with HIF	ONCOGENE			English	Article						lung cancer; hypoxia; phosphodiesterases; proliferation; angiogenesis	TUMOR-GROWTH; CELLS; HYPOXIA; INHIBITION; EXPRESSION; APOPTOSIS; COMPONENTS; MIGRATION; LEUKEMIA; TARGETS	Lung cancer is the leading cause of cancer death worldwide. Recent data suggest that cyclic nucleotide phosphodiesterases (PDEs) are relevant in various cancer pathologies. Pathophysiological role of phosphodiesterase 4 (PDE4) with possible therapeutic prospects in lung cancer was investigated. We exposed 10 different lung cancer cell lines (adenocarcinoma, squamous and large cell carcinoma) to hypoxia and assessed expression and activity of PDE4 by real-time PCR, immunocytochemistry, western blotting and PDE activity assays. Expression and activity of distinct PDE4 isoforms (PDE4A and PDE4D) increased in response to hypoxia in eight of the studied cell lines. Furthermore, we analyzed various in silico predicted hypoxia-responsive elements (p-HREs) found in PDE4A and PDE4D genes. Performing mutation analysis of the p-HRE in luciferase reporter constructs, we identified four functional HRE sites in the PDE4A gene and two functional HRE sites in the PDE4D gene that mediated hypoxic induction of the reporter. Silencing of hypoxia-inducible factor subunits (HIF1 alpha and HIF2 alpha by small interfering RNA reduced hypoxic induction of PDE4A and PDE4D. Vice versa, using a PDE4 inhibitor (PDE4i) as a cyclic adenosine monophosphate (cAMP) -elevating agent, cAMP analogs or protein kinase A (PKA)-modulating drugs and an exchange protein directly activated by cAMP (EPAC) activator, we demonstrated that PDE4-cAMP-PKA/EPAC axis enhanced HIF signaling as measured by HRE reporter gene assay, HIF and HIF target genes expression ((lactate dehydrogenase A), LDHA, (pyruvate dehydrogenase kinase 1) PDK1 and (vascular endothelial growth factor A) VEGFA). Notably, inhibition of PDE4 by PDE4i or silencing of PDE4A and PDE4D reduced human lung tumor cell proliferation and colony formation. On the other hand, overexpression of PDE4A or PDE4D increased human lung cancer proliferation. Moreover, PDE4i treatment reduced hypoxia-induced VEGF secretion in human cells. In vivo, PDE4i inhibited tumor xenograft growth in nude mice by attenuating proliferation and angiogenesis. Our findings suggest that PDE4 is expressed in lung cancer, crosstalks with HIF signaling and promotes lung cancer progression. Thus, PDE4 may represent a therapeutic target for lung cancer therapy. Oncogene (2013) 32, 1121-1134; doi:10.1038/onc.2012.136; published online 23 April 2012	[Pullamsetti, S. S.; Schmall, A.; Seeger, W.; Schermuly, R. T.; Savai, R.] Max Planck Inst Heart & Lung Res, Dept Lung Dev & Remodelling, D-61231 Bad Nauheim, Germany; [Pullamsetti, S. S.; Banat, G. A.; Pomagruk, D.; Kolosionek, E.; Wilhelm, J.; Grimminger, F.; Seeger, W.; Schermuly, R. T.] Univ Giessen, Univ Giessen Lung Ctr, D-35390 Giessen, Germany; [Szibor, M.; Braun, T.] Max Planck Inst Heart & Lung Res, Dept Cardiac Dev & Remodelling, D-61231 Bad Nauheim, Germany; [Haenze, J.] Philipps Univ, Dept Urol & Pediat Urol, Marburg, Germany	Max Planck Society; Justus Liebig University Giessen; Max Planck Society; Philipps University Marburg	Savai, R (corresponding author), Max Planck Inst Heart & Lung Res, Pk Str 1, D-61231 Bad Nauheim, Germany.	rajkumar.savai@mpi-bn.mpg.de	Braun, Thomas/B-2310-2008; Wilhelm, Jochen/AAX-4302-2021	Wilhelm, Jochen/0000-0001-5544-9647; Pullamsetti, Soni Savai/0000-0003-0440-8831; Grimminger, Friedrich/0000-0001-8725-6276; Seeger, Werner/0000-0003-1946-0894; Hanze, Jorg/0000-0001-5424-7808; Braun, Thomas/0000-0002-6165-4804; Savai, Rajkumar/0000-0003-1538-2091; Schermuly, Ralph/0000-0002-5167-6970	STARTUP AWARD from Justus-Liebig University Giessen, Germany; LOEWE-Center UGMLC (University of Giessen); LOEWE-Center UGMLC (University of Marburg Lung Center)	STARTUP AWARD from Justus-Liebig University Giessen, Germany; LOEWE-Center UGMLC (University of Giessen); LOEWE-Center UGMLC (University of Marburg Lung Center)	The authors thank Marianne Hoeck and Katharina Weidl for her excellent technical assistance. Dr Rajkumar Saves research was supported by the STARTUP AWARD from Justus-Liebig University Giessen, Germany and LOEWE-Center UGMLC (Universities of Giessen and Marburg Lung Center).	Chen TC, 2002, CANCER BIOL THER, V1, P268, DOI 10.4161/cbt.80; Conti M, 2003, J BIOL CHEM, V278, P5493, DOI 10.1074/jbc.R200029200; Conti M, 2007, ANNU REV BIOCHEM, V76, P481, DOI 10.1146/annurev.biochem.76.060305.150444; Cox G, 2000, LUNG CANCER, V29, P169, DOI 10.1016/S0169-5002(00)00124-0; Dastidar SG, 2007, CURR OPIN INVEST DR, V8, P364; Deguchi A, 2004, CANCER RES, V64, P3966, DOI 10.1158/0008-5472.CAN-03-3740; Goldhoff P, 2008, CLIN CANCER RES, V14, P7717, DOI 10.1158/1078-0432.CCR-08-0827; Harris AL, 2002, NAT REV CANCER, V2, P38, DOI 10.1038/nrc704; Hung JJ, 2009, THORAX, V64, P1082, DOI 10.1136/thx.2009.115691; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Kolosionek E, 2009, MOL BIOL CELL, V20, P4751, DOI 10.1091/mbc.E09-01-0019; Lerner A, 2006, BIOCHEM J, V393, P21, DOI 10.1042/BJ20051368; Lipworth BJ, 2005, LANCET, V365, P167, DOI 10.1016/S0140-6736(05)17708-3; Malec V, 2010, FREE RADICAL BIO MED, V48, P1626, DOI 10.1016/j.freeradbiomed.2010.03.008; Marko D, 2000, CHEM RES TOXICOL, V13, P944, DOI 10.1021/tx000090l; Marko Doris, 1998, Cell Biochemistry and Biophysics, V28, P75, DOI 10.1007/BF02737806; McEwan DG, 2007, CANCER RES, V67, P5248, DOI 10.1158/0008-5472.CAN-07-0097; Millen J, 2006, EUR J CELL BIOL, V85, P679, DOI 10.1016/j.ejcb.2006.01.006; Mouratidis PXE, 2009, PANCREAS, V38, P78, DOI 10.1097/MPA.0b013e318183d72f; Murata K, 2001, CLIN EXP METASTAS, V18, P599, DOI 10.1023/A:1011926116777; Narita M, 2007, ONCOL REP, V17, P1133; Nunes AR, 2009, ADV EXP MED BIOL, V648, P113, DOI 10.1007/978-90-481-2259-2_13; Ogawa R, 2002, BLOOD, V99, P3390, DOI 10.1182/blood.V99.9.3390; Omori K, 2007, CIRC RES, V100, P309, DOI 10.1161/01.RES.0000256354.95791.f1; Pallis AG, 2009, EUR J CANCER, V45, P2473, DOI 10.1016/j.ejca.2009.06.005; Rossi Antonio, 2009, Curr Drug Discov Technol, V6, P91; Savai R, 2005, INT J ONCOL, V27, P393; Semenza GL, 2006, EXP PHYSIOL, V91, P803, DOI 10.1113/expphysiol.2006.033498; Sowter HM, 2003, CANCER RES, V63, P6130; Swinson DEB, 2006, CLIN LUNG CANCER, V7, P250, DOI 10.3816/CLC.2006.n.002; Timoshenko AV, 2003, EXP CELL RES, V289, P265, DOI 10.1016/S0014-4827(03)00269-6; Wenger Roland H, 2005, Sci STKE, V2005, pre12, DOI 10.1126/stke.3062005re12; Yamanaka Y, 2002, CANCER LETT, V176, P143, DOI 10.1016/S0304-3835(01)00764-9; Zhang LZ, 2008, P NATL ACAD SCI USA, V105, P19532, DOI 10.1073/pnas.0806152105	34	98	102	0	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 28	2013	32	9					1121	1134		10.1038/onc.2012.136	http://dx.doi.org/10.1038/onc.2012.136			14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	110FU	22525277				2022-12-25	WOS:000316428800006
J	Galavotti, S; Bartesaghi, S; Faccenda, D; Shaked-Rabi, M; Sanzone, S; McEvoy, A; Dinsdale, D; Condorelli, F; Brandner, S; Campanella, M; Grose, R; Jones, C; Salomoni, P				Galavotti, S.; Bartesaghi, S.; Faccenda, D.; Shaked-Rabi, M.; Sanzone, S.; McEvoy, A.; Dinsdale, D.; Condorelli, F.; Brandner, S.; Campanella, M.; Grose, R.; Jones, C.; Salomoni, P.			The autophagy-associated factors DRAM1 and p62 regulate cell migration and invasion in glioblastoma stem cells	ONCOGENE			English	Article						autophagy; cancer stem cell; invasion	MALIGNANT GLIOMA-CELLS; HUMAN BRAIN-TUMORS; INDUCED CYTOTOXICITY; GENE-EXPRESSION; GLUCOSE TRANSPORTERS; IONIZING-RADIATION; MYELOID-LEUKEMIA; CANCER; DEATH; CHLOROQUINE	The aggressiveness of glioblastoma multiforme (GBM) is defined by local invasion and resistance to therapy. Within established GBM, a subpopulation of tumor-initiating cells with stem-like properties (GBM stem cells, GSCs) is believed to underlie resistance to therapy. The metabolic pathway autophagy has been implicated in the regulation of survival in GBM. However, the status of autophagy in GBM and its role in the cancer stem cell fraction is currently unclear. We found that a number of autophagy regulators are highly expressed in GBM tumors carrying a mesenchymal signature, which defines aggressiveness and invasion, and are associated with components of the MAPK pathway. This autophagy signature included the autophagy-associated genes DRAM1 and SQSTM1, which encode a key regulator of selective autophagy, p62. High levels of DRAM1 were associated with shorter overall survival in GBM patients. In GSCs, DRAM? and SQSTM1 expression correlated with activation of MAPK and expression of the mesenchymal marker c-MET. DRAM1 knockdown decreased p62 localization to autophagosomes and its autophagy-mediated degradation, thus suggesting a role for DRAM1 in p62-mediated autophagy. In contrast, autophagy induced by starvation or inhibition of mTOR/PI-3K was not affected by either DRAM1 or p62 downregulation. Functionally, DRAM1 and p62 regulate cell motility and invasion in GSCs. This was associated with alterations of energy metabolism, in particular reduced ATP and lactate levels. Taken together, these findings shed new light on the role of autophagy in GBM and reveal a novel function of the autophagy regulators DRAM1 and p62 in control of migration/invasion in cancer stem cells. Oncogene (2013) 32, 699-712; doi:10.1038/onc.2012.111; published online 23 April 2012	[Galavotti, S.; Bartesaghi, S.; Salomoni, P.] UCL Canc Inst, Samantha Dickson Brain Canc Unit, London WC1E 6BT, England; [Faccenda, D.; Campanella, M.] Univ London Royal Vet Coll, London, England; [Shaked-Rabi, M.; Brandner, S.] UCL, Neurol Inst, London, England; [Sanzone, S.; Condorelli, F.] Univ Piemonte Orientale, Novara, Italy; [McEvoy, A.] Natl Hosp Neurol & Neurosurg, London WC1N 3BG, England; [Dinsdale, D.] MRC Toxicol Unit, Leicester, Leics, England; [Campanella, M.] UCL Consortium Mitochondrial Res, London, England; [Grose, R.] Barts Canc Inst, London, England; [Jones, C.] Inst Canc Res, London SW3 6JB, England	University of London; University College London; University of London; University of London Royal Veterinary College; University of London; University College London; University of Eastern Piedmont Amedeo Avogadro; University of London; University College London; UCL Medical School; University College London Hospitals NHS Foundation Trust; University of London; University College London; University of London; Queen Mary University London; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK	Salomoni, P (corresponding author), UCL Canc Inst, Samantha Dickson Brain Canc Unit, London WC1E 6BT, England.	p.salomoni@ucl.ac.uk	Brandner, Sebastian/J-4562-2014; Condorelli, Fabrizio/AAT-1953-2020; Jones, Chris/ABE-6059-2021; Bartesaghi, Stefano/G-1916-2015	Brandner, Sebastian/0000-0002-9821-0342; Condorelli, Fabrizio/0000-0002-9943-0857; Jones, Chris/0000-0001-8118-2296; Bartesaghi, Stefano/0000-0002-2083-7807; Grose, Richard/0000-0002-4738-0173	Samantha Dickson Brain Tumour Trust [SDK-I-0805]; University of Modena and Reggio Emilia, Modena, Italy; NHS; Cancer Research UK [C8851/A10844]; National Hospital Development foundation; UCLH CBRC [31]; BBSRC [BB/I013695/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/I013695/1] Funding Source: researchfish; The Brain Tumour Charity [8/47] Funding Source: researchfish	Samantha Dickson Brain Tumour Trust; University of Modena and Reggio Emilia, Modena, Italy; NHS; Cancer Research UK(Cancer Research UK); National Hospital Development foundation; UCLH CBRC; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); The Brain Tumour Charity	We thank Susan Short, Sergio Quezada, Steven Pollard and Daniel Hochhauser (UCL Cancer Institute, London, UK), Sharon Tooze (CRUK London Research Institute, London, UK), Bruno Calabretta (Kimmel Cancer Center, Philadelphia, USA), Andrea Cossarizza and Paola Loria (University of Modena and Reggio Emilia, Italy) for reagents and critical discussion. We also thank other members of PS lab (UCL Cancer Institute) and Melania Capasso (Bans and the London, UK). We thank Carol Mercer and Pat Dennis (University of Cincinnati, USA) for the BHMT plasmid, and Scott Lowe (CSHL, USA) for the hRAS-V12 IRES GFP plasmid (Addgene). Finally, we thank the UCL Scientific Services and in particular Tomas Adejumo for support with flow cytometry. PS is supported by the Samantha Dickson Brain Tumour Trust and a generous donation by David Hunter and Wendy Tansey in memory of Peter Clark. SG is recipient of a PhD studentship from the University of Modena and Reggio Emilia, Modena, Italy. CJ acknowledges NHS funding to the NIHR Biomedical Research Centre. ET acknowledges Cancer Research UK funding to his laboratory (C8851/A10844). MSR is funded by the National Hospital Development foundation and SB (Institute of Neurology, loN) received support from UCLH CBRC (Ref 31) and the Samantha Dickson Brain tumor trust (Ref SDK-I-0805). SB (IoN) acknowledges the Neurosurgical team at the National Hospital for their continued support of the brain tumor bank.	Beckner ME, 2010, INT J CANCER, V126, P2282, DOI 10.1002/ijc.24918; Beckner ME, 2005, LAB INVEST, V85, P316, DOI 10.1038/labinvest.3700239; Behrends C, 2010, NATURE, V466, P68, DOI 10.1038/nature09204; Bellodi C, 2009, J CLIN INVEST, V119, P1109, DOI 10.1172/JCI35660; Bilir A, 2008, INT J ONCOL, V32, P829; BOADO RJ, 1994, MOL BRAIN RES, V27, P51, DOI 10.1016/0169-328X(94)90183-X; Briceno Eduardo, 2003, Neurosurg Focus, V14, pe3; BROOKS DJ, 1986, J CEREBR BLOOD F MET, V6, P230, DOI 10.1038/jcbfm.1986.36; Campanella M, 2008, CELL METAB, V8, P13, DOI 10.1016/j.cmet.2008.06.001; Campello S, 2006, J EXP MED, V203, P2879, DOI 10.1084/jem.20061877; Carro MS, 2010, NATURE, V463, P318, DOI 10.1038/nature08712; Chen HC, 2007, CELL, V130, P548, DOI 10.1016/j.cell.2007.06.026; Cheng Y, 2011, CANCER RES, V71, P2654, DOI 10.1158/0008-5472.CAN-10-2889; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Comoglio PM, 2008, NAT REV DRUG DISCOV, V7, P504, DOI 10.1038/nrd2530; Crighton D, 2007, AUTOPHAGY, V3, P72, DOI 10.4161/auto.3438; Crighton D, 2006, CELL, V126, P121, DOI 10.1016/j.cell.2006.05.034; Dang LN, 2010, TRENDS MOL MED, V16, P387, DOI 10.1016/j.molmed.2010.07.002; Day SE, 2011, MAGN RESON MED, V65, P557, DOI 10.1002/mrm.22698; De Bacco F, 2011, J NATL CANCER I, V103, P645, DOI 10.1093/jnci/djr093; Dikic I, 2010, CANCER RES, V70, P3431, DOI 10.1158/0008-5472.CAN-09-4027; Fan QW, 2011, AUTOPHAGY, V7, P536, DOI 10.4161/auto.7.5.14779; Fung C, 2008, MOL BIOL CELL, V19, P797, DOI 10.1091/mbc.E07-10-1092; Gatenby RA, 2004, NAT REV CANCER, V4, P891, DOI 10.1038/nrc1478; Geng Y, 2010, NEURO-ONCOLOGY, V12, P473, DOI 10.1093/neuonc/nop048; Guo JY, 2011, GENE DEV, V25, P460, DOI 10.1101/gad.2016311; Hoyer-Hansen M, 2008, AUTOPHAGY, V4, P574, DOI 10.4161/auto.5921; Huse JT, 2010, NAT REV CANCER, V10, P319, DOI 10.1038/nrc2818; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Kanzawa T, 2003, CANCER RES, V63, P2103; Kanzawa T, 2004, CELL DEATH DIFFER, V11, P448, DOI 10.1038/sj.cdd.4401359; Katayama M, 2007, CELL DEATH DIFFER, V14, P548, DOI 10.1038/sj.cdd.4402030; Kim MJ, 2011, J BIOL CHEM, V286, P12924, DOI 10.1074/jbc.M110.138958; KIRSCH WM, 1967, J NEUROSURG, V27, P45, DOI 10.3171/jns.1967.27.1.0045; Komatsu M, 2007, CELL, V131, P1149, DOI 10.1016/j.cell.2007.10.035; Kroemer G, 2008, CANCER CELL, V13, P472, DOI 10.1016/j.ccr.2008.05.005; Kroemer G, 2010, CURR OPIN CELL BIOL, V22, P121, DOI 10.1016/j.ceb.2010.02.003; Lee Y, 2008, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-52; Livesey KM, 2009, CURR OPIN INVEST DR, V10, P1269; Llaguno SA, 2009, CANCER CELL, V15, P45, DOI 10.1016/j.ccr.2008.12.006; Lock R, 2011, CELL CYCLE, V10, P1516, DOI 10.4161/cc.10.10.15434; Lock R, 2011, MOL BIOL CELL, V22, P165, DOI 10.1091/mbc.E10-06-0500; Lu Z, 2008, J CLIN INVEST, V118, P3917, DOI 10.1172/JCI35512; Lusa L, 2007, JNCI-J NATL CANCER I, V99, P1715, DOI 10.1093/jnci/djm216; Martinou M, 2011, CANCER GENOM PROTEOM, V8, P33; Mathew R, 2011, CURR OPIN GENET DEV, V21, P113, DOI 10.1016/j.gde.2010.12.008; Moscat J, 2009, CELL, V137, P1001, DOI 10.1016/j.cell.2009.05.023; Munshi A, 2009, CANCER, V115, P2380, DOI 10.1002/cncr.24288; NAGAMATSU S, 1993, J NEUROCHEM, V61, P2048, DOI 10.1111/j.1471-4159.1993.tb07441.x; Natsumeda M, 2011, NEUROPATHOLOGY, V31, P486, DOI 10.1111/j.1440-1789.2010.01197.x; NISHIOKA T, 1992, CANCER RES, V52, P3972; Paugh BS, 2010, J CLIN ONCOL, V28, P3061, DOI 10.1200/JCO.2009.26.7252; Perou CM, 2010, LANCET ONCOL, V11, P718, DOI 10.1016/S1470-2045(10)70176-5; Phillips HS, 2006, CANCER CELL, V9, P157, DOI 10.1016/j.ccr.2006.02.019; Pollard SM, 2009, CELL STEM CELL, V4, P568, DOI 10.1016/j.stem.2009.03.014; Ravikumar B, 2010, PHYSIOL REV, V90, P1383, DOI 10.1152/physrev.00030.2009; Reitman ZJ, 2010, JNCI-J NATL CANCER I, V102, P932, DOI 10.1093/jnci/djq187; Ricci-Vitiani L, 2010, NATURE, V468, P824, DOI 10.1038/nature09557; Salomoni P, 2009, AUTOPHAGY, V5, P1050, DOI 10.4161/auto.5.7.9509; Schafer ZT, 2009, NATURE, V461, P109, DOI 10.1038/nature08268; Shima Y, 2007, BIOCHEM BIOPH RES CO, V353, P60, DOI 10.1016/j.bbrc.2006.11.137; Shingu T, 2009, AUTOPHAGY, V5, P537, DOI 10.4161/auto.5.4.8164; Shingu T, 2009, INT J CANCER, V124, P1060, DOI 10.1002/ijc.24030; Siegelin MD, 2011, J CLIN INVEST, V121, P1349, DOI 10.1172/JCI44855; Singh R, 2011, CELL METAB, V13, P495, DOI 10.1016/j.cmet.2011.04.004; Sotelo J, 2006, ANN INTERN MED, V144, P337, DOI 10.7326/0003-4819-144-5-200603070-00008; Tatsuta T, 2008, EMBO J, V27, P306, DOI 10.1038/sj.emboj.7601972; Terpstra M, 1998, CANCER RES, V58, P5083; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Wang R, 2010, NATURE, V468, P829, DOI 10.1038/nature09624; Wei HJ, 2011, GENE DEV, V25, P1510, DOI 10.1101/gad.2051011; White E, 2009, CLIN CANCER RES, V15, P5308, DOI 10.1158/1078-0432.CCR-07-5023; Wild-Bode C, 2001, CANCER RES, V61, P2744; Wolf A, 2011, NEUROBIOL DIS, V44, P84, DOI 10.1016/j.nbd.2011.06.007; Wolf A, 2011, J EXP MED, V208, P313, DOI 10.1084/jem.20101470; Yang SH, 2011, GENE DEV, V25, P717, DOI 10.1101/gad.2016111; Zhou BBS, 2009, NAT REV DRUG DISCOV, V8, P806, DOI 10.1038/nrd2137	77	178	190	4	74	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	FEB 7	2013	32	6					699	712		10.1038/onc.2012.111	http://dx.doi.org/10.1038/onc.2012.111			14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	101AF	22525272	Green Published			2022-12-25	WOS:000315746700004
J	Gilbert, NC; Rui, Z; Neau, DB; Waight, MT; Bartlett, SG; Boeglin, WE; Brash, AR; Newcomer, ME				Gilbert, Nathaniel C.; Rui, Zhe; Neau, David B.; Waight, Maria T.; Bartlett, Sue G.; Boeglin, William E.; Brash, Alan R.; Newcomer, Marcia E.			Conversion of human 5-lipoxygenase to a 15-lipoxygenase by a point mutation to mimic phosphorylation at Serine-663	FASEB JOURNAL			English	Article						leukotrienes; crystal structure; crystallography; eicosanoids	ARACHIDONIC-ACID; LEUKOTRIENE BIOSYNTHESIS; CRYSTAL-STRUCTURE; HUMAN PLATELETS; PROTEIN; ACTIVATION; MODEL; 8R-LIPOXYGENASE; LIPOXYGENASES; INFLAMMATION	The enzyme 5-lipoxygenase (5-LOX) initiates biosynthesis of the proinflammatory leukotriene lipid mediators and, together with 15-LOX, is also required for synthesis of the anti-inflammatory lipoxins. The catalytic activity of 5-LOX is regulated through multiple mechanisms, including Ca2+-targeted membrane binding and phosphorylation at specific serine residues. To investigate the consequences of phosphorylation at S663, we mutated the residue to the phosphorylation mimic Asp, providing a homogenous preparation suitable for catalytic and structural studies. The S663D enzyme exhibits robust 15-LOX activity, as determined by spectrophotometric and HPLC analyses, with only traces of 5-LOX activity remaining; synthesis of the anti-inflammatory lipoxin A(4) from arachidonic acid is also detected. The crystal structure of the S663D mutant in the absence and presence of arachidonic acid (in the context of the previously reported Stable-5-LOX) reveals substantial remodeling of helices that define the active site so that the once fully encapsulated catalytic machinery is solvent accessible. Our results suggest that phosphorylation of 5-LOX at S663 could not only down-regulate leukotriene synthesis but also stimulate lipoxin production in inflammatory cells that do not express 15-LOX, thus redirecting lipid mediator biosynthesis to the production of proresolving mediators of inflammation.-Gilbert, N. C., Rui, Z., Neau, D. B., Waight, M. T., Bartlett, S. G., Boeglin, W. E., Brash, A. R., Newcomer, M. E. Conversion of human 5-lipoxygenase to a 15-lipoxygenase by a point mutation to mimic phosphorylation at Serine-663. FASEB J. 26, 3222-3229 (2012). www.fasebj.org	[Gilbert, Nathaniel C.; Rui, Zhe; Waight, Maria T.; Bartlett, Sue G.; Newcomer, Marcia E.] Louisiana State Univ, Dept Biol Sci, Baton Rouge, LA 70803 USA; [Neau, David B.] Argonne Natl Lab, NE Collaborat Access Team, Argonne, IL 60439 USA; [Boeglin, William E.; Brash, Alan R.] Vanderbilt Univ, Dept Pharmacol, Nashville, TN USA; [Boeglin, William E.; Brash, Alan R.] Vanderbilt Univ, Vanderbilt Inst Chem Biol, Nashville, TN USA	Louisiana State University System; Louisiana State University; United States Department of Energy (DOE); Argonne National Laboratory; Vanderbilt University; Vanderbilt University	Newcomer, ME (corresponding author), Louisiana State Univ, Dept Biol Sci, Baton Rouge, LA 70803 USA.	newcomer@lsu.edu	Gilbert, Nathaniel/I-8223-2018; Rui, Zhe/D-9541-2013	Rui, Zhe/0000-0001-8113-2694; Gilbert, Nathaniel/0000-0002-6706-811X	American Heart Association [08553920E]; National Science Foundation [MCB 0818387]; U.S. National Institutes of Health (NIH) [HL 107887]; NIH [GM-15431]; Louisiana Governors' Biotechnology Initiative; National Center for Research Resources [5P41RR015301-10]; National Institute of General Medical Sciences from the NIH [8 P41 GM103403-10]; U.S. DOE [DE-AC02-06CH11357]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR015301] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL107887] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM015431, P01GM015431, P41GM103403] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); National Science Foundation(National Science Foundation (NSF)); U.S. National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Louisiana Governors' Biotechnology Initiative; National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institute of General Medical Sciences from the NIH; U.S. DOE(United States Department of Energy (DOE)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded in part by grants from the American Heart Association (08553920E), the National Science Foundation (MCB 0818387), and the U.S. National Institutes of Health (NIH; HL 107887) to M.E.N. and from the NIH (GM-15431) to A.R.B. Preliminary work was performed at the Center for Advanced Microstructures and Devices (Baton Rouge), funded in part by the Louisiana Governors' Biotechnology Initiative. The work includes research conducted at the Advanced Photon Source on the Northeastern Collaborative Access Team beamlines, which are supported by grants from the National Center for Research Resources (5P41RR015301-10) and the National Institute of General Medical Sciences (8 P41 GM103403-10) from the NIH. Use of the Advanced Photon Source, an Office of Science User Facility operated for the U.S. Department of Energy (DOE) Office of Science by Argonne National Laboratory, was supported by the U.S. DOE under contract DE-AC02-06CH11357. Coordinates and structure factors have been deposited in the Protein Data Bank (3V92, S663A-Stable-5-LOX; 3V98, S663D-Stable-5-LOX; 3V99, S663D-Stable-5-LOX with AA).	AHARONY D, 1986, J BIOL CHEM, V261, P1512; Ariel A, 2003, J IMMUNOL, V170, P6266, DOI 10.4049/jimmunol.170.12.6266; Borngraber S, 1998, PROTEIN EXPRES PURIF, V14, P237, DOI 10.1006/prep.1998.0963; Boutaud O, 1999, J BIOL CHEM, V274, P33764, DOI 10.1074/jbc.274.47.33764; BOYINGTON JC, 1993, SCIENCE, V260, P1482, DOI 10.1126/science.8502991; Choi J, 2008, PROTEINS, V70, P1023, DOI 10.1002/prot.21590; Coffa G, 2005, BIOCHEM BIOPH RES CO, V338, P87, DOI 10.1016/j.bbrc.2005.07.185; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; DIXON RAF, 1990, NATURE, V343, P282, DOI 10.1038/343282a0; EDENIUS C, 1991, ADV PROSTAG THROMB L, V21, P97; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans JF, 2008, TRENDS PHARMACOL SCI, V29, P72, DOI 10.1016/j.tips.2007.11.006; FIORE S, 1990, J EXP MED, V172, P1451, DOI 10.1084/jem.172.5.1451; Flamand N, 2006, J BIOL CHEM, V281, P129, DOI 10.1074/jbc.M506513200; Flamand N, 2009, J BIOL CHEM, V284, P306, DOI 10.1074/jbc.M805593200; Folco G, 2006, PHARMACOL REV, V58, P375, DOI 10.1124/pr.58.3.8; Gilbert NC, 2011, SCIENCE, V331, P217, DOI 10.1126/science.1197203; Gillmor SA, 1997, NAT STRUCT BIOL, V4, P1003, DOI 10.1038/nsb1297-1003; HUANG WD, 1994, P NATL ACAD SCI USA, V91, P8960, DOI 10.1073/pnas.91.19.8960; Lee YH, 1997, NAT STRUCT BIOL, V4, P615, DOI 10.1038/nsb0897-615; Leger J, 1997, J BIOL CHEM, V272, P8441, DOI 10.1074/jbc.272.13.8441; Luo M, 2005, J BIOL CHEM, V280, P40609, DOI 10.1074/jbc.M507045200; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Neau DB, 2009, BIOCHEMISTRY-US, V48, P7906, DOI 10.1021/bi900084m; Oldham ML, 2005, J BIOL CHEM, V280, P39545, DOI 10.1074/jbc.M506675200; Pergola C, 2008, P NATL ACAD SCI USA, V105, P19881, DOI 10.1073/pnas.0809120105; Radmark O, 2010, BIOCHEM BIOPH RES CO, V396, P105, DOI 10.1016/j.bbrc.2010.02.173; Radmark O, 2009, J LIPID RES, V50, pS40, DOI 10.1194/jlr.R800062-JLR200; Serhan CN, 2008, NAT REV IMMUNOL, V8, P349, DOI 10.1038/nri2294; SERHAN CN, 1984, P NATL ACAD SCI-BIOL, V81, P5335, DOI 10.1073/pnas.81.17.5335; SHIMIZU T, 1984, P NATL ACAD SCI-BIOL, V81, P689, DOI 10.1073/pnas.81.3.689; SkrzypczakJankun E, 1997, PROTEINS, V29, P15, DOI [10.1002/(SICI)1097-0134(199709)29:1&lt;15::AID-PROT2&gt;3.0.CO;2-E, 10.1002/(SICI)1097-0134(199709)29:1<15::AID-PROT2>3.3.CO;2-F]; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Vliegenthart J. F. G., 1982, FREE RADICAL BIO MED, P29; Werz O, 2000, P NATL ACAD SCI USA, V97, P5261, DOI 10.1073/pnas.050588997; Werz O, 2003, ADV EXP MED BIOL, V525, P129; Werz O, 2002, FASEB J, V16, P1441, DOI 10.1096/fj.01-0909fje; Werz O, 2002, J BIOL CHEM, V277, P14793, DOI 10.1074/jbc.M111945200; Winter G, 2010, J APPL CRYSTALLOGR, V43, P186, DOI 10.1107/S0021889809045701; Yamada T, 2011, FASEB J, V25, P561, DOI 10.1096/fj.10-170027; YAMAMOTO S, 1992, BIOCHIM BIOPHYS ACTA, V1128, P117, DOI 10.1016/0005-2760(92)90297-9; Youn B, 2006, PROTEINS, V65, P1008, DOI 10.1002/prot.21182; Zwart Peter H., 2008, V426, P419, DOI 10.1007/978-1-60327-058-8_28	43	96	99	0	13	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	AUG	2012	26	8					3222	3229		10.1096/fj.12-205286	http://dx.doi.org/10.1096/fj.12-205286			8	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	984BI	22516296	Green Published, Green Submitted			2022-12-25	WOS:000307162800013
J	Kikutani, S; Tanaka, R; Yamazaki, Y; Hara, S; Hisabori, T; Kroth, PG; Matsuda, Y				Kikutani, Sae; Tanaka, Rie; Yamazaki, Yukiko; Hara, Satoshi; Hisabori, Toru; Kroth, Peter G.; Matsuda, Yusuke			Redox Regulation of Carbonic Anhydrases via Thioredoxin in Chloroplast of the Marine Diatom Phaeodactylum tricornutum	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CO2; PROTEINS; ACCUMULATION; ARABIDOPSIS; GENOME; IDENTIFICATION; LOCALIZATION; EXPRESSION; PROTEOMICS; EVOLUTION	Thioredoxins (Trxs) are important regulators of photosynthetic fixation of CO2 and nitrogen in plant chloroplasts. To date, they have been considered to play a minor role in controlling the Calvin cycle in marine diatoms, aquatic primary producers, although diatoms possess a set of plastidic Trxs. In this study we examined the influences of the redox state and the involvement of Trxs in the enzymatic activities of pyrenoidal carbonic anhydrases, PtCA1 and PtCA2, in the marine diatom Phaeodactylum tricornutum. The recombinant mature PtCA1 and -2 (mPtCA1 and -2) were completely inactivated following oxidation by 50 mu M CuCl2, whereas DTT activated CAs in a concentration-dependent manner. The maximum activity of mPtCAs in the presence of 6 mM reduced DTT increased significantly by addition of 10 mu M Trxs from Arabidopsis thaliana (AtTrx-f2 and -m2) and 5 mu M Trxs from P. tricornutum (PtTrxF and -M). Analyses of mPtCA activation by Trxs in the presence of DTT revealed that the maximum mPtCA1 activity was enhanced similar to 3-fold in the presence of Trx, whereas mPtCA2 was only weakly activated by Trxs, and that PtTrxs activate PtCAs more efficiently compared with AtTrxs. Site-directed mutagenesis of potential disulfide-forming cysteines in mPtCA1 and mPtCA2 resulted in a lack of oxidative inactivation of both mPtCAs. These results reveal the first direct evidence of a target of plastidic Trxs in diatoms, indicating that Trxs may participate in the redox control of inorganic carbon flow in the pyrenoid, a focal point of the CO2-concentrating mechanism.	[Kikutani, Sae; Tanaka, Rie; Yamazaki, Yukiko; Matsuda, Yusuke] Kwansei Gakuin Univ, Res Ctr Environm Biosci, Dept Biosci, Sanda, Hyogo 6691337, Japan; [Hara, Satoshi; Hisabori, Toru] Tokyo Inst Technol, Chem Resources Lab, Tokyo, Kanagawa 2268503, Japan; [Kroth, Peter G.] Univ Konstanz, Fachbereich Biol, D-78457 Constance, Germany	Kwansei Gakuin University; Tokyo Institute of Technology; University of Konstanz	Matsuda, Y (corresponding author), Kwansei Gakuin Univ, Res Ctr Environm Biosci, Dept Biosci, 2-1 Gakuen, Sanda, Hyogo 6691337, Japan.	yusuke@kwansei.ac.jp	Kroth, Peter G/A-9728-2008; Hara, Satoshi/C-1341-2015; Hisabori, Toru/E-5205-2014	Kroth, Peter G/0000-0003-4734-8955; Hara, Satoshi/0000-0001-6275-6469; Hisabori, Toru/0000-0003-2046-0277	Ministry of Education, Culture, Sports, Science, and Technology of Japan; Steel Industry Foundation for the Advancement of Environmental Protection Technology	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Steel Industry Foundation for the Advancement of Environmental Protection Technology(Steel Industry Foundation for the Advancement of Environmental Protection Technology)	This work was supported by grants from the Ministry of Education, Culture, Sports, Science, and Technology of Japan to Kwansei Gakuin University, Research Center for Environmental Bioscience, and by the Steel Industry Foundation for the Advancement of Environmental Protection Technology (to Y. M.).	Armbrust EV, 2004, SCIENCE, V306, P79, DOI 10.1126/science.1101156; Arsova B, 2010, PLANT CELL, V22, P1498, DOI 10.1105/tpc.109.071001; Balmer Y, 2004, PHOTOSYNTH RES, V79, P275, DOI 10.1023/B:PRES.0000017207.88257.d4; Balmer Y, 2003, P NATL ACAD SCI USA, V100, P370, DOI 10.1073/pnas.232703799; Bosco MB, 2012, PROTIST, V163, P188, DOI 10.1016/j.protis.2011.07.001; Bjorkbacka H, 1997, BIOCHEMISTRY-US, V36, P4287, DOI 10.1021/bi962825k; Bowler C, 2008, NATURE, V456, P239, DOI 10.1038/nature07410; Buchanan BB, 2005, ANNU REV PLANT BIOL, V56, P187, DOI 10.1146/annurev.arplant.56.032604.144246; Collin V, 2004, PLANT PHYSIOL, V136, P4088, DOI 10.1104/pp.104.052233; COLMAN B, 1995, PLANT CELL ENVIRON, V18, P919, DOI 10.1111/j.1365-3040.1995.tb00601.x; Cox EH, 2000, BIOCHEMISTRY-US, V39, P12128, DOI 10.1021/bi001416s; Falkowski PG, 1997, NATURE, V387, P272, DOI 10.1038/387272a0; Field CB, 1998, SCIENCE, V281, P237, DOI 10.1126/science.281.5374.237; FUKUZAWA H, 1992, P NATL ACAD SCI USA, V89, P4437, DOI 10.1073/pnas.89.10.4437; Funke RP, 1997, PLANT PHYSIOL, V114, P237, DOI 10.1104/pp.114.1.237; Gelhaye E, 2005, CELL MOL LIFE SCI, V62, P24, DOI 10.1007/s00018-004-4296-4; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Harada H, 2005, CAN J BOT, V83, P909, DOI 10.1139/B05-078; Harada H, 2005, PLANT PHYSIOL, V139, P1041, DOI 10.1104/pp.105.065185; Harada H, 2006, PLANT PHYSIOL, V142, P1318, DOI 10.1104/pp.106.086561; Hiltonen T, 1998, PLANT PHYSIOL, V117, P1341, DOI 10.1104/pp.117.4.1341; JOHANSSON IM, 1993, EUR J BIOCHEM, V218, P439, DOI 10.1111/j.1432-1033.1993.tb18394.x; Johnston AM, 1996, EUR J PHYCOL, V31, P285, DOI 10.1080/09670269600651491; Kroth PG, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001426; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lemaire SD, 2004, PHOTOSYNTH RES, V82, P203, DOI 10.1007/s11120-004-1091-x; Lemaire SD, 2004, P NATL ACAD SCI USA, V101, P7475, DOI 10.1073/pnas.0402221101; Liaud MF, 2000, MOL BIOL EVOL, V17, P213, DOI 10.1093/oxfordjournals.molbev.a026301; Marchand C, 2004, PROTEOMICS, V4, P2696, DOI 10.1002/pmic.200400805; Matsuda Y, 2001, PLANT CELL ENVIRON, V24, P611, DOI 10.1046/j.1365-3040.2001.00702.x; Meyer Y, 2002, METHOD ENZYMOL, V347, P394; Meyer Y, 2009, ANNU REV GENET, V43, P335, DOI 10.1146/annurev-genet-102108-134201; Michels AK, 2005, PLANT PHYSIOL, V137, P911, DOI 10.1104/pp.104.055285; Motohashi K, 2001, P NATL ACAD SCI USA, V98, P11224, DOI 10.1073/pnas.191282098; PRICE GD, 1989, PLANT PHYSIOL, V91, P505, DOI 10.1104/pp.91.2.505; Raven JA, 1997, PLANT CELL ENVIRON, V20, P147, DOI 10.1046/j.1365-3040.1997.d01-67.x; Reinfelder JR, 2004, PLANT PHYSIOL, V135, P2106, DOI 10.1104/pp.104.041319; Rouhier N, 2005, ANTIOXID REDOX SIGN, V7, P919, DOI 10.1089/ars.2005.7.919; Satoh D, 2001, PLANT PHYSIOL, V126, P1459, DOI 10.1104/pp.126.4.1459; Schurmann P, 2008, ANTIOXID REDOX SIGN, V10, P1235, DOI 10.1089/ars.2007.1931; Stumpp MT, 1999, BIOCHEM J, V341, P157, DOI 10.1042/0264-6021:3410157; Tachibana M, 2011, PHOTOSYNTH RES, V109, P205, DOI 10.1007/s11120-011-9634-4; Tanaka Y, 2005, PLANT PHYSIOL, V138, P207, DOI 10.1104/pp.104.058982; Trimborn S, 2009, J EXP MAR BIOL ECOL, V376, P26, DOI 10.1016/j.jembe.2009.05.017; Vallat BK, 2008, PROTEINS, V72, P910, DOI 10.1002/prot.21976; Van K, 1999, PLANT PHYSIOL, V120, P757, DOI 10.1104/pp.120.3.757; Weber T, 2009, MOL PLANT, V2, P468, DOI 10.1093/mp/ssp010; WILBUR KM, 1948, J BIOL CHEM, V176, P147; Xu Y, 2008, NATURE, V452, P56, DOI 10.1038/nature06636	50	33	34	0	35	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 8	2012	287	24					20689	20700		10.1074/jbc.M111.322743	http://dx.doi.org/10.1074/jbc.M111.322743			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974FB	22535967	Green Published, hybrid			2022-12-25	WOS:000306414500087
J	Mittal, A; Bohm, S; Grutter, MG; Bordignon, E; Seeger, MA				Mittal, Anshumali; Boehm, Simon; Gruetter, Markus G.; Bordignon, Enrica; Seeger, Markus A.			Asymmetry in the Homodimeric ABC Transporter MsbA Recognized by a DARPin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI MSBA; P-GLYCOPROTEIN; CONFORMATIONAL CYCLE; ALTERNATING ACCESS; ATP HYDROLYSIS; IN-VITRO; BINDING; MEMBRANE; PROTEINS; DEPENDENCE	ABC transporters harness the energy from ATP binding and hydrolysis to translocate substrates across the membrane. Binding of two ATP molecules at the nucleotide binding domains (NBDs) leads to the formation of an outward-facing state. The conformational changes required to reset the transporter to the inward-facing state are initiated by sequential hydrolysis of the bound nucleotides. In a homodimeric ABC exporter such as MsbA responsible for lipid A transport in Escherichia coli, sequential ATP hydrolysis implies the existence of an asymmetric conformation. Here we report the in vitro selection of a designed ankyrin repeat protein (DARPin) specifically binding to detergent-solubilized MsbA. Only one DARPin binds to the homodimeric transporter in the absence as well as in the presence of nucleotides, suggesting that it recognizes asymmetries in MsbA. DARPin binding increases the rate of ATP hydrolysis by a factor of two independent of the substrate-induced ATPase stimulation. Electron paramagnetic resonance (EPR) measurements are found to be in good agreement with the available crystal structures and reveal that DARPin binding does not affect the large nucleotide-driven conformational changes of MsbA. The binding epitope was mapped by cross-linking and EPR to the membrane-spanning part of the transmembrane domain (TMD). Using cross-linked DARPin-MsbA complexes, 8-azido-ATP was found to preferentially photolabel one chain of the homodimer, suggesting that the asymmetries captured by DARPin binding at the TMDs are propagated to the NBDs. This work demonstrates that in vitro selected binders are useful tools to study the mechanism of membrane proteins.	[Boehm, Simon; Bordignon, Enrica] Swiss Fed Inst Technol, Phys Chem Lab, CH-8093 Zurich, Switzerland; [Mittal, Anshumali; Gruetter, Markus G.; Seeger, Markus A.] Univ Zurich, Dept Biochem, CH-8057 Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Zurich	Bordignon, E (corresponding author), Swiss Fed Inst Technol, Phys Chem Lab, CH-8093 Zurich, Switzerland.	enrica.bordignon@phys.chem.ethz.ch; m.seeger@bioc.uzh.ch	Mittal, Anshumali/G-9685-2012	Mittal, Anshumali/0000-0002-0478-2682; Seeger, Markus/0000-0003-1761-8571; Bordignon, Enrica/0000-0003-2450-5161	Swiss National Science Foundation; Forschungskredit of the University of Zurich	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Forschungskredit of the University of Zurich	This work was funded by the Swiss NCCR Structural Biology program, an Ambizione Grant from the Swiss National Science Foundation (to M. A. S.) and a Forschungskredit of the University of Zurich (to M. A. S.).	Aittoniemi J, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000762; Aller SG, 2009, SCIENCE, V323, P1718, DOI 10.1126/science.1168750; Alvarado D, 2010, CELL, V142, P568, DOI 10.1016/j.cell.2010.07.015; Binz HK, 2004, NAT BIOTECHNOL, V22, P575, DOI 10.1038/nbt962; Binz HK, 2003, J MOL BIOL, V332, P489, DOI 10.1016/S0022-2836(03)00896-9; Booth PJ, 2005, CURR OPIN STRUC BIOL, V15, P435, DOI 10.1016/j.sbi.2005.06.002; Borbat PP, 2007, PLOS BIOL, V5, P2211, DOI 10.1371/journal.pbio.0050271; Dawson RJP, 2007, FEBS LETT, V581, P935, DOI 10.1016/j.febslet.2007.01.073; Dawson RJP, 2006, NATURE, V443, P180, DOI 10.1038/nature05155; Doshi R, 2010, PROTEINS, V78, P2867, DOI 10.1002/prot.22813; Eckford PDW, 2008, J BIOL CHEM, V283, P12840, DOI 10.1074/jbc.M708274200; Forrer J, 2008, J MAGN RESON, V190, P280, DOI 10.1016/j.jmr.2007.11.009; Geertsma ER, 2008, NAT PROTOC, V3, P256, DOI 10.1038/nprot.2007.519; Gyimesi G, 2011, BBA-BIOMEMBRANES, V1808, P2954, DOI 10.1016/j.bbamem.2011.07.038; Holland IB, 2011, ESSAYS BIOCHEM, V50, P1, DOI [10.1042/BSE0500001, 10.1042/bse0500001]; Huber T, 2007, J STRUCT BIOL, V159, P206, DOI 10.1016/j.jsb.2007.01.013; Jeschke G, 2006, APPL MAGN RESON, V30, P473, DOI 10.1007/BF03166213; Jeschke G, 2009, PHYS CHEM CHEM PHYS, V11, P6580, DOI 10.1039/b905724b; Kohl A, 2003, P NATL ACAD SCI USA, V100, P1700, DOI 10.1073/pnas.0337680100; Koide S, 2009, CURR OPIN STRUC BIOL, V19, P449, DOI 10.1016/j.sbi.2009.04.008; Lee SY, 2005, P NATL ACAD SCI USA, V102, P15441, DOI 10.1073/pnas.0507651102; Loo TW, 2001, J BIOL CHEM, V276, P36877, DOI 10.1074/jbc.C100467200; Monroe N, 2011, J STRUCT BIOL, V174, P269, DOI 10.1016/j.jsb.2011.01.014; Murakami S, 2006, NATURE, V443, P173, DOI 10.1038/nature05076; Orelle C, 2003, J BIOL CHEM, V278, P47002, DOI 10.1074/jbc.M308268200; Pannier M, 2000, J MAGN RESON, V142, P331, DOI 10.1006/jmre.1999.1944; Polissi A, 1996, MOL MICROBIOL, V20, P1221, DOI 10.1111/j.1365-2958.1996.tb02642.x; Polyhach Y, 2011, PHYS CHEM CHEM PHYS, V13, P2356, DOI 10.1039/c0cp01865a; Procko E, 2009, FASEB J, V23, P1287, DOI 10.1096/fj.08-121855; Renatus M, 2001, P NATL ACAD SCI USA, V98, P14250, DOI 10.1073/pnas.231465798; Reuter G, 2003, J BIOL CHEM, V278, P35193, DOI 10.1074/jbc.M306226200; Ritchie TK, 2011, J BIOL CHEM, V286, P39489, DOI 10.1074/jbc.M111.284554; Schultz KM, 2011, BIOCHEMISTRY-US, V50, P3599, DOI 10.1021/bi101666p; Seeger MA, 2006, SCIENCE, V313, P1295, DOI 10.1126/science.1131542; Senior AE, 1995, FEBS LETT, V377, P285, DOI 10.1016/0014-5793(95)01345-8; Sennhauser G, 2008, STRUCTURE, V16, P1443, DOI 10.1016/j.str.2008.08.010; Sennhauser G, 2007, PLOS BIOL, V5, P106, DOI 10.1371/journal.pbio.0050007; Smriti, 2009, J BIOL CHEM, V284, P13904, DOI 10.1074/jbc.M900837200; URBATSCH IL, 1995, J BIOL CHEM, V270, P19383, DOI 10.1074/jbc.270.33.19383; VanVeen HW, 1996, P NATL ACAD SCI USA, V93, P10668, DOI 10.1073/pnas.93.20.10668; Venter H, 2008, BIOCHEM PHARMACOL, V75, P866, DOI 10.1016/j.bcp.2007.10.022; Ward A, 2007, P NATL ACAD SCI USA, V104, P19005, DOI 10.1073/pnas.0709388104; Wiener MC, 2004, METHODS, V34, P364, DOI 10.1016/j.ymeth.2004.03.025; Woebking B, 2005, J BACTERIOL, V187, P6363, DOI 10.1128/JB.187.18.6363-6369.2005; Zahnd C, 2007, NAT METHODS, V4, P269, DOI 10.1038/NMETH1003; Zaitseva J, 2006, EMBO J, V25, P3432, DOI 10.1038/sj.emboj.7601208; Zhou ZM, 1998, J BIOL CHEM, V273, P12466, DOI 10.1074/jbc.273.20.12466; Zou P, 2009, J MOL BIOL, V393, P574, DOI 10.1016/j.jmb.2009.08.051; Zou P, 2009, J MOL BIOL, V393, P586, DOI 10.1016/j.jmb.2009.08.050	49	40	40	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 8	2012	287	24					20395	20406		10.1074/jbc.M112.359794	http://dx.doi.org/10.1074/jbc.M112.359794			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974FB	22523072	Green Accepted, Green Published, hybrid			2022-12-25	WOS:000306414500058
J	Wang, XH; Pineau, C; Gu, S; Guschinskaya, N; Pickersgill, RW; Shevchik, VE				Wang, Xiaohui; Pineau, Camille; Gu, Shuang; Guschinskaya, Natalia; Pickersgill, Richard W.; Shevchik, Vladimir E.			Cysteine Scanning Mutagenesis and Disulfide Mapping Analysis of Arrangement of GspC and GspD Protomers within the Type 2 Secretion System	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OUTER-MEMBRANE PROTEIN; II SECRETION; ERWINIA-CHRYSANTHEMI; MULTIPLE INTERACTIONS; CRYSTAL-STRUCTURE; CHOLERA-TOXIN; DOMAIN; MACHINERY; PATHWAY; SPECIFICITY	The type II secretion system (T2SS) secretes enzymes and toxins across the outer membrane of Gram-negative bacteria. The precise assembly of T2SS, which consists of at least 12 core-components called Gsp, remains unclear. The outer membrane secretin, GspD, forms the channels, through which folded proteins are secreted, and interacts with the inner membrane component, GspC. The periplasmic regions of GspC and GspD consist of several structural domains, HRGspC and PDZ(GspC), and N0(GspD) to N3(GspD), respectively, and recent structural and functional studies have proposed several interaction sites between these domains. We used cysteine mutagenesis and disulfide bonding analysis to investigate the organization of GspC and GspD protomers and to map their interaction sites within the secretion machinery of the plant pathogen Dickeya dadantii. At least three distinct GspC-GspD interactions were detected, and they involve two sites in HRGspC, two in N0(GspD), and one in N2(GspD). None of these interactions occurs through static interfaces because the same sites are also involved in self-interactions with equivalent neighboring domains. Disulfide self-bonding of critical interaction sites halts secretion, indicating the transient nature of these interactions. The secretion substrate diminishes certain interactions and provokes an important rearrangement of the HRGspC structure. The T2SS components OutE/L/M affect various interaction sites differently, reinforcing some but diminishing the others, suggesting a possible switching mechanism of these interactions during secretion. Disulfide mapping shows that the organization of GspD and GspC subunits within the T2SS could be compatible with a hexamer of dimers arrangement rather than an organization with 12-fold rotational symmetry.	[Gu, Shuang; Pickersgill, Richard W.] Queen Mary Univ London, Sch Biol & Chem Sci, London E1 4NS, England; [Wang, Xiaohui; Pineau, Camille; Guschinskaya, Natalia; Shevchik, Vladimir E.] Univ Lyon, F-69003 Lyon, France; [Wang, Xiaohui; Pineau, Camille; Guschinskaya, Natalia; Shevchik, Vladimir E.] Univ Lyon 1, INSA Lyon, F-69621 Villeurbanne, France; [Wang, Xiaohui; Pineau, Camille; Guschinskaya, Natalia; Shevchik, Vladimir E.] CNRS, UMR5240, F-69622 Lyon, France	University of London; Queen Mary University London; Institut National des Sciences Appliquees de Lyon - INSA Lyon; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National des Sciences Appliquees de Lyon - INSA Lyon	Pickersgill, RW (corresponding author), Queen Mary Univ London, Sch Biol & Chem Sci, London E1 4NS, England.	r.w.pickersgill@qmul.ac.uk; vladimir.shevchik@insa-lyon.fr		Shevchik, Vladimir/0000-0002-8031-8638	French ANR-2010-BLANC-1531 SecPath program [ANR-2010-BLANC-1531]; LyonBioPole; Biotechnology and Biological Sciences Research Council; Higher Education Funding Council for England; Queen Mary University of London; CNRS; MRC [MC_U117533887] Funding Source: UKRI; Medical Research Council [MC_U117533887] Funding Source: researchfish	French ANR-2010-BLANC-1531 SecPath program(French National Research Agency (ANR)); LyonBioPole; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Higher Education Funding Council for England(UK Research & Innovation (UKRI)Higher Education Funding Council for England (HEFCE)); Queen Mary University of London; CNRS(Centre National de la Recherche Scientifique (CNRS)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the CNRS, a grant from French ANR-2010-BLANC-1531 SecPath program and LyonBioPole, the Biotechnology and Biological Sciences Research Council, Higher Education Funding Council for England, and Queen Mary University of London.	Bouley J, 2001, J MOL BIOL, V308, P205, DOI 10.1006/jmbi.2001.4594; Burkhardt J, 2011, J BIOL CHEM, V286, P9977, DOI 10.1074/jbc.M110.212688; Chami M, 2005, J BIOL CHEM, V280, P37732, DOI 10.1074/jbc.M504463200; CHANG ACY, 1978, J BACTERIOL, V134, P1141, DOI 10.1128/JB.134.3.1141-1156.1978; Cianciotto NP, 2005, TRENDS MICROBIOL, V13, P581, DOI 10.1016/j.tim.2005.09.005; Collins RF, 2004, J BIOL CHEM, V279, P39750, DOI 10.1074/jbc.M405971200; Douzi B, 2011, J BIOL CHEM, V286, P40792, DOI 10.1074/jbc.M111.294843; Dykxhoorn DM, 1996, GENE, V177, P133, DOI 10.1016/0378-1119(96)00289-2; Webb Benjamin, 2016, Curr Protoc Bioinformatics, V54, DOI [10.1002/0471140864.ps0209s50, 10.1002/cpps.20, 10.1002/0471250953.bi0506s15, 10.1002/cpbi.3]; Filloux A, 2004, BBA-MOL CELL RES, V1694, P163, DOI 10.1016/j.bbamcr.2004.05.003; Gerard-Vincent M, 2002, MOL MICROBIOL, V44, P1651, DOI 10.1046/j.1365-2958.2002.02991.x; Gu S, 2012, J BIOL CHEM, V287, P9072, DOI 10.1074/jbc.M111.300624; Gu S, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002531; Hardie KR, 1996, EMBO J, V15, P978, DOI 10.1002/j.1460-2075.1996.tb00434.x; Hodgkinson JL, 2009, NAT STRUCT MOL BIOL, V16, P477, DOI 10.1038/nsmb.1599; Hugouvieux-Cotte-Pattat N, 2009, J BACTERIOL, V191, P6960, DOI 10.1128/JB.00594-09; Jain S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016624; Johnson TL, 2006, FEMS MICROBIOL LETT, V255, P175, DOI 10.1111/j.1574-6968.2006.00102.x; Kanamaru S, 2002, NATURE, V415, P553, DOI 10.1038/415553a; Korotkov KV, 2006, J MOL BIOL, V363, P311, DOI 10.1016/j.jmb.2006.08.037; Korotkov KV, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002228; Korotkov KV, 2011, TRENDS BIOCHEM SCI, V36, P433, DOI 10.1016/j.tibs.2011.04.002; Korotkov KV, 2009, STRUCTURE, V17, P255, DOI 10.1016/j.str.2008.11.011; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lee HM, 2004, J BACTERIOL, V186, P2946, DOI 10.1128/JB.186.10.2946-2955.2004; Login FH, 2006, J BIOL CHEM, V281, P33152, DOI 10.1074/jbc.M606245200; Login FH, 2010, MOL MICROBIOL, V76, P944, DOI 10.1111/j.1365-2958.2010.07149.x; Misic AM, 2010, J MOL BIOL, V400, P1011, DOI 10.1016/j.jmb.2010.05.066; Nouwen N, 2000, EMBO J, V19, P2229, DOI 10.1093/emboj/19.10.2229; Opalka N, 2003, J MOL BIOL, V325, P461, DOI 10.1016/S0022-2836(02)01246-9; Patrick M, 2011, J BIOL CHEM, V286, P10378, DOI 10.1074/jbc.M110.167031; Peabody CR, 2003, MICROBIOL-SGM, V149, P3051, DOI 10.1099/mic.0.26364-0; Possot OM, 2000, J BACTERIOL, V182, P2142, DOI 10.1128/JB.182.8.2142-2152.2000; Py B, 1999, J MOL BIOL, V289, P659, DOI 10.1006/jmbi.1999.2803; Py B, 2001, EMBO REP, V2, P244, DOI 10.1093/embo-reports/kve042; Reichow SL, 2011, CHANNELS, V5, P215, DOI 10.4161/chan.5.3.15268; Reichow SL, 2010, NAT STRUCT MOL BIOL, V17, P1226, DOI 10.1038/nsmb.1910; Remaut H, 2006, TRENDS BIOCHEM SCI, V31, P436, DOI 10.1016/j.tibs.2006.06.007; Robert V, 2005, FEMS MICROBIOL LETT, V252, P43, DOI 10.1016/j.femsle.2005.08.029; Robien MA, 2003, J MOL BIOL, V333, P657, DOI 10.1016/j.jmb.2003.07.015; Shevchik VE, 1998, MICROBIOL-UK, V144, P3219, DOI 10.1099/00221287-144-11-3219; Shevchik VE, 1997, EMBO J, V16, P3007, DOI 10.1093/emboj/16.11.3007; Thomas JD, 1997, MICROBIOL-UK, V143, P713, DOI 10.1099/00221287-143-3-713; Tsai RT, 2002, BIOCHEM J, V367, P865, DOI 10.1042/BJ20020909; Yip CK, 2005, NATURE, V435, P702, DOI 10.1038/nature03554	45	32	32	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 1	2012	287	23					19082	19093		10.1074/jbc.M112.346338	http://dx.doi.org/10.1074/jbc.M112.346338			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974EF	22523076	Green Published, hybrid			2022-12-25	WOS:000306411900019
J	Chen, B; Zhong, L; Roush, SF; Pentassuglia, L; Peng, XY; Samaras, S; Davidson, JM; Sawyer, DB; Lim, CC				Chen, Billy; Zhong, Lin; Roush, Sarah F.; Pentassuglia, Laura; Peng, Xuyang; Samaras, Susan; Davidson, Jeffrey M.; Sawyer, Douglas B.; Lim, Chee Chew			Disruption of a GATA4/Ankrd1 Signaling Axis in Cardiomyocytes Leads to Sarcomere Disarray: Implications for Anthracycline Cardiomyopathy	PLOS ONE			English	Article							ANKYRIN-REPEAT PROTEIN; HUMAN DILATED CARDIOMYOPATHY; INDUCED CARDIOTOXICITY; CARDIAC MYOCYTES; SKELETAL-MUSCLE; NUCLEAR-PROTEIN; GENE-EXPRESSION; Z-DISC; CARP; TITIN	Doxorubicin (Adriamycin) is an effective anti-cancer drug, but its clinical usage is limited by a dose-dependent cardiotoxicity characterized by widespread sarcomere disarray and loss of myofilaments. Cardiac ankyrin repeat protein (CARP, ANKRD1) is a transcriptional regulatory protein that is extremely susceptible to doxorubicin; however, the mechanism(s) of doxorubicin-induced CARP depletion and its specific role in cardiomyocytes have not been completely defined. We report that doxorubicin treatment in cardiomyocytes resulted in inhibition of CARP transcription, depletion of CARP protein levels, inhibition of myofilament gene transcription, and marked sarcomere disarray. Knockdown of CARP with small interfering RNA (siRNA) similarly inhibited myofilament gene transcription and disrupted cardiomyocyte sarcomere structure. Adenoviral overexpression of CARP, however, was unable to rescue the doxorubicin-induced sarcomere disarray phenotype. Doxorubicin also induced depletion of the cardiac transcription factor GATA4 in cardiomyocytes. CARP expression is regulated in part by GATA4, prompting us to examine the relationship between GATA4 and CARP in cardiomyocytes. We show in co-transfection experiments that GATA4 operates upstream of CARP by activating the proximal CARP promoter. GATA4-siRNA knockdown in cardiomyocytes inhibited CARP expression and myofilament gene transcription, and induced extensive sarcomere disarray. Adenoviral overexpression of GATA4 (AdV-GATA4) in cardiomyocytes prior to doxorubicin exposure maintained GATA4 levels, modestly restored CARP levels, and attenuated sarcomere disarray. Interestingly, siRNA-mediated depletion of CARP completely abolished the Adv-GATA4 rescue of the doxorubicin-induced sarcomere phenotype. These data demonstrate co-dependent roles for GATA4 and CARP in regulating sarcomere gene expression and maintaining sarcomeric organization in cardiomyocytes in culture. The data further suggests that concurrent depletion of GATA4 and CARP in cardiomyocytes by doxorubicin contributes in large part to myofibrillar disarray and the overall pathophysiology of anthracycline cardiomyopathy.	[Zhong, Lin; Roush, Sarah F.; Pentassuglia, Laura; Peng, Xuyang; Sawyer, Douglas B.; Lim, Chee Chew] Vanderbilt Univ, Sch Med, Div Cardiovasc Med, Nashville, TN 37212 USA; [Chen, Billy] Boston Univ, Sch Med, Dept Med, Program Mol Med, Boston, MA 02118 USA; [Samaras, Susan; Davidson, Jeffrey M.] Vanderbilt Univ, Sch Med, Dept Pathol Microbiol & Immunol, Nashville, TN 37212 USA; [Davidson, Jeffrey M.] Vet Affairs Tennessee Valley Healthcare Syst, Res Serv, Nashville, TN USA	Vanderbilt University; Boston University; Vanderbilt University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Tennessee Valley Healthcare System	Lim, CC (corresponding author), Vanderbilt Univ, Sch Med, Div Cardiovasc Med, Nashville, TN 37212 USA.	chee.lim@vanderbilt.edu	Davidson, Jeff/AAI-7288-2021		American Heart Association Established Investigator Award; NIH [RO1HL068144, RO1DK065656, K01AG024056, RO1HL095813]; VA; Genentech, Inc.; Roche, Inc.; Acorda Therapeutics, Inc.; Roch, Inc.; Acorda Therapuetics, Inc.; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL095813, R01HL068144] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK065656] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K01AG024056] Funding Source: NIH RePORTER	American Heart Association Established Investigator Award(American Heart Association); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); VA(US Department of Veterans Affairs); Genentech, Inc.(Roche HoldingGenentech); Roche, Inc.(Roche Holding); Acorda Therapeutics, Inc.; Roch, Inc.; Acorda Therapuetics, Inc.; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was supported by the American Heart Association Established Investigator Award and NIH grant RO1HL068144 to DBS, NIH grant RO1DK065656 and VA support to JMD, and NIH grants K01AG024056 and RO1HL095813 to CCL. DBS has received grant support from Genentech, Inc., Roche, Inc., and Acorda Therapeutics, Inc. DBS has been a consultant for Oncothyreon, Millennium Pharmaceuticals, and Regeneron. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors have read the journal's policy and have the following conflicts: DBS has received grant support from Genentech, Inc., Roch, Inc., and Acorda Therapuetics, Inc. DBS has been a consultant for Oncothyreon, Millenium Pharmaceuticals, and Regeneron. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Aihara Y, 2000, J MOL CELL CARDIOL, V32, P1401, DOI 10.1006/jmcc.2000.1173; Aihara Y, 2000, HYPERTENSION, V36, P48, DOI 10.1161/01.HYP.36.1.48; Aries A, 2004, P NATL ACAD SCI USA, V101, P6975, DOI 10.1073/pnas.0401833101; Arimura T, 2009, J AM COLL CARDIOL, V54, P334, DOI 10.1016/j.jacc.2008.12.082; Bang ML, 2001, J CELL BIOL, V153, P413, DOI 10.1083/jcb.153.2.413; Barash IA, 2007, AM J PHYSIOL-CELL PH, V293, pC218, DOI 10.1152/ajpcell.00055.2007; Belgrano A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025519; Charron F, 2001, GENE DEV, V15, P2702, DOI 10.1101/gad.915701; Chen B, 2007, CARDIOVASC TOXICOL, V7, P114, DOI 10.1007/s12012-007-0005-5; CHU W, 1995, J BIOL CHEM, V270, P10236, DOI 10.1074/jbc.270.17.10236; Coumans JVF, 1997, J MOL CELL CARDIOL, V29, P895, DOI 10.1006/jmcc.1996.0317; Duboscq-Bidot L, 2009, EUR HEART J, V30, P2128, DOI 10.1093/eurheartj/ehp225; Durocher D, 1997, EMBO J, V16, P5687, DOI 10.1093/emboj/16.18.5687; Granzier HL, 2004, CIRC RES, V94, P284, DOI 10.1161/01.RES.0000117769.88862.F8; Ikeda K, 2003, J BIOL CHEM, V278, P3514, DOI 10.1074/jbc.M204563200; Jeyaseelan R, 1997, J BIOL CHEM, V272, P22800, DOI 10.1074/jbc.272.36.22800; Kemp TJ, 2000, GENOMICS, V66, P229, DOI 10.1006/geno.2000.6213; Kim Y, 2003, MOL PHARMACOL, V63, P368, DOI 10.1124/mol.63.2.368; Knoll R, 2002, CELL, V111, P943, DOI 10.1016/s0092-8674(02)01226-6; Kobayashi S, 2010, J BIOL CHEM, V285, P793, DOI 10.1074/jbc.M109.070037; Kojic S, 2010, ARCH BIOCHEM BIOPHYS, V502, P60, DOI 10.1016/j.abb.2010.06.029; Kuo HC, 1999, DEVELOPMENT, V126, P4223; Lange S, 2005, SCIENCE, V308, P1599, DOI 10.1126/science.1110463; Lim CC, 2004, J BIOL CHEM, V279, P8290, DOI 10.1074/jbc.M308033200; Linke WA, 2008, CARDIOVASC RES, V77, P637, DOI 10.1016/j.cardiores.2007.03.029; Maeda T, 2002, GENE, V297, P1, DOI 10.1016/S0378-1119(02)00924-1; Mikhailov AT, 2008, INT J DEV BIOL, V52, P811, DOI 10.1387/ijdb.082655am; Miller MK, 2003, J MOL BIOL, V333, P951, DOI 10.1016/j.jmb.2003.09.012; Oka T, 2006, CIRC RES, V98, P837, DOI 10.1161/01.RES.0000215985.18538.c4; Pikkarainen S, 2003, J BIOL CHEM, V278, P23807, DOI 10.1074/jbc.M302719200; Sawyer DB, 2002, CIRCULATION, V105, P1551, DOI 10.1161/01.CIR.0000013839.41224.1C; Sawyer DB, 2010, PROG CARDIOVASC DIS, V53, P105, DOI 10.1016/j.pcad.2010.06.007; Sheikh F, 2008, J CLIN INVEST, V118, P3870, DOI 10.1172/JCI34472; Shi Y, 2005, AM J PATHOL, V166, P303, DOI 10.1016/S0002-9440(10)62254-7; Singal P, 2000, MOL CELL BIOCHEM, V207, P77, DOI 10.1023/A:1007094214460; SINGAL PK, 1987, J MOL CELL CARDIOL, V19, P817, DOI 10.1016/S0022-2828(87)80392-9; Torrado Mario, 2005, J Mol Cell Cardiol, V38, P353, DOI 10.1016/j.yjmcc.2004.11.034; Warren CM, 2003, ELECTROPHORESIS, V24, P1695, DOI 10.1002/elps.200305392; Witt CC, 2008, EMBO J, V27, P350, DOI 10.1038/sj.emboj.7601952; Witt SH, 2005, J MUSCLE RES CELL M, V26, P401, DOI 10.1007/s10974-005-9022-9; Zou YM, 1997, DEVELOPMENT, V124, P793	41	29	30	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2012	7	4							e35743	10.1371/journal.pone.0035743	http://dx.doi.org/10.1371/journal.pone.0035743			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UD	22532871	Green Published, Green Submitted, gold			2022-12-25	WOS:000305339200106
J	Moore, JM; Rabaia, NA; Smith, LE; Fagerlie, S; Gurley, K; Loukinov, D; Disteche, CM; Collins, SJ; Kemp, CJ; Lobanenkov, VV; Filippova, GN				Moore, James M.; Rabaia, Natalia A.; Smith, Leslie E.; Fagerlie, Sara; Gurley, Kay; Loukinov, Dmitry; Disteche, Christine M.; Collins, Steven J.; Kemp, Christopher J.; Lobanenkov, Victor V.; Filippova, Galina N.			Loss of Maternal CTCF Is Associated with Peri-Implantation Lethality of Ctcf Null Embryos	PLOS ONE			English	Article							ENHANCER-BLOCKING ACTIVITY; PROTEIN CTCF; ZYGOTIC TRANSITION; GENE-EXPRESSION; X-INACTIVATION; BINDING-SITES; METHYLATION; OOCYTE; TRANSCRIPTION; PROMOTER	CTCF is a highly conserved, multifunctional zinc finger protein involved in critical aspects of gene regulation including transcription regulation, chromatin insulation, genomic imprinting, X-chromosome inactivation, and higher order chromatin organization. Such multifunctional properties of CTCF suggest an essential role in development. Indeed, a previous report on maternal depletion of CTCF suggested that CTCF is essential for pre-implantation development. To distinguish between the effects of maternal and zygotic expression of CTCF, we studied pre-implantation development in mice harboring a complete loss of function Ctcf knockout allele. Although we demonstrated that homozygous deletion of Ctcf is early embryonically lethal, in contrast to previous observations, we showed that the Ctcf nullizygous embryos developed up to the blastocyst stage (E3.5) followed by peri-implantation lethality (E4.5-E5.5). Moreover, one-cell stage Ctcf nullizygous embryos cultured ex vivo developed to the 16-32 cell stage with no obvious abnormalities. Using a single embryo assay that allowed both genotype and mRNA expression analyses of the same embryo, we demonstrated that pre-implantation development of the Ctcf nullizygous embryos was associated with the retention of the maternal wild type Ctcf mRNA. Loss of this stable maternal transcript was temporally associated with loss of CTCF protein expression, apoptosis of the developing embryo, and failure to further develop an inner cell mass and trophoectoderm ex vivo. This indicates that CTCF expression is critical to early embryogenesis and loss of its expression rapidly leads to apoptosis at a very early developmental stage. This is the first study documenting the presence of the stable maternal Ctcf transcript in the blastocyst stage embryos. Furthermore, in the presence of maternal CTCF, zygotic CTCF expression does not seem to be required for pre-implantation development.	[Moore, James M.; Rabaia, Natalia A.; Smith, Leslie E.; Fagerlie, Sara; Gurley, Kay; Collins, Steven J.; Kemp, Christopher J.; Filippova, Galina N.] Fred Hutchinson Canc Res Ctr, Human Biol Div, Seattle, WA 98104 USA; [Loukinov, Dmitry; Lobanenkov, Victor V.] NIAID, Mol Pathol Sect, Immunopathol Lab, NIH, Rockville, MD USA; [Disteche, Christine M.] Univ Washington, Dept Pathol, Seattle, WA 98195 USA	Fred Hutchinson Cancer Center; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of Washington; University of Washington Seattle	Filippova, GN (corresponding author), Fred Hutchinson Canc Res Ctr, Human Biol Div, 1124 Columbia St, Seattle, WA 98104 USA.	gfilippo@fhcrc.org	Lobanenkov, Victor/ABD-5710-2021; Lobanenkov, Victor V./AGQ-8903-2022	Lobanenkov, Victor/0000-0001-6665-3635	National Institutes of Health [CA68360];  [GM 46883]; NATIONAL CANCER INSTITUTE [P30CA015704, R01CA068360] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001021, ZIAAI000860] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM046883] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health grant CA68360 (G.N.F. and V. V. L.) and in part by grant GM 46883 (C. M. D.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreu-Vieyra CV, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000453; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Bell AC, 1999, CELL, V98, P387, DOI 10.1016/S0092-8674(00)81967-4; Bell AC, 2000, NATURE, V405, P482, DOI 10.1038/35013100; Bultman SJ, 2006, GENE DEV, V20, P1744, DOI 10.1101/gad.1435106; Burcin M, 1997, MOL CELL BIOL, V17, P1281, DOI 10.1128/MCB.17.3.1281; Cai CL, 2010, MOL BIOL CELL, V21, P3137, DOI 10.1091/mbc.E10-03-0255; Chao W, 2002, SCIENCE, V295, P345, DOI 10.1126/science.1065982; Colegrove-Otero LJ, 2005, CRIT REV BIOCHEM MOL, V40, P21, DOI 10.1080/10409230590918612; Cuddapah S, 2009, GENOME RES, V19, P24, DOI 10.1101/gr.082800.108; Docquier F, 2005, CANCER RES, V65, P5112, DOI 10.1158/0008-5472.CAN-03-3498; Dodge JE, 2004, MOL CELL BIOL, V24, P2478, DOI 10.1128/MCB.24.6.2478-2486.2004; EDELHOFF S, 1994, ONCOGENE, V9, P665; Fedoriw AM, 2004, SCIENCE, V303, P238, DOI 10.1126/science.1090934; Filippova GN, 2008, CURR TOP DEV BIOL, V80, P337, DOI 10.1016/S0070-2153(07)80009-3; Filippova GN, 2005, DEV CELL, V8, P31, DOI 10.1016/j.devcel.2004.10.018; Filippova GN, 1996, MOL CELL BIOL, V16, P2802; Filippova GN, 1998, GENE CHROMOSOME CANC, V22, P26, DOI 10.1002/(SICI)1098-2264(199805)22:1<26::AID-GCC4>3.0.CO;2-9; GEBAUER F, 1994, EMBO J, V13, P5712, DOI 10.1002/j.1460-2075.1994.tb06909.x; Ghirlando R., 2012, BIOCH BIOPHYS ACTA; Hamatani T, 2004, DEV CELL, V6, P117, DOI 10.1016/S1534-5807(03)00373-3; Hark AT, 2000, NATURE, V405, P486, DOI 10.1038/35013106; Heath H, 2008, EMBO J, V27, P2839, DOI 10.1038/emboj.2008.214; Kim TH, 2007, CELL, V128, P1231, DOI 10.1016/j.cell.2006.12.048; KLENOVA EM, 1993, MOL CELL BIOL, V13, P7612, DOI 10.1128/MCB.13.12.7612; Ling JQ, 2006, SCIENCE, V312, P269, DOI 10.1126/science.1123191; LOBANENKOV VV, 1990, ONCOGENE, V5, P1743; Lykke-Andersen K, 2008, MOL BIOL CELL, V19, P4383, DOI 10.1091/mbc.E08-02-0219; Ma J, 2006, DEVELOPMENT, V133, P2053, DOI 10.1242/dev.02371; Ma PP, 2008, DEV BIOL, V319, P110, DOI 10.1016/j.ydbio.2008.04.011; Mager J, 2006, MAMM GENOME, V17, P941, DOI 10.1007/s00335-006-0034-6; Mukhopadhyay R, 2004, GENOME RES, V14, P1594, DOI 10.1101/gr.2408304; Nagy A., 2003, MANIPULATING MOUSE E; Oh B, 2000, DEVELOPMENT, V127, P3795; Ohlsson R, 2001, TRENDS GENET, V17, P520, DOI 10.1016/S0168-9525(01)02366-6; Payer B, 2003, CURR BIOL, V13, P2110, DOI 10.1016/j.cub.2003.11.026; Phillips JE, 2009, CELL, V137, P1194, DOI 10.1016/j.cell.2009.06.001; Rasko JEJ, 2001, CANCER RES, V61, P6002; Renaud S, 2005, NUCLEIC ACIDS RES, V33, P6850, DOI 10.1093/nar/gki989; Rhee HS, 2011, CELL, V147, P1408, DOI 10.1016/j.cell.2011.11.013; ROWE LB, 1994, MAMM GENOME, V5, P253, DOI 10.1007/BF00389540; Schier AF, 2007, SCIENCE, V316, P406, DOI 10.1126/science.1140693; Schoenherr CJ, 2003, NAT GENET, V33, P66, DOI 10.1038/ng1057; Schultz RM, 2002, HUM REPROD UPDATE, V8, P323, DOI 10.1093/humupd/8.4.323; Stitzel ML, 2007, SCIENCE, V316, P407, DOI 10.1126/science.1138236; Tadros W, 2009, DEVELOPMENT, V136, P3033, DOI 10.1242/dev.033183; Tallquist MD, 2000, GENESIS, V26, P113, DOI 10.1002/(SICI)1526-968X(200002)26:2<113::AID-GENE3>3.0.CO;2-2; Vastenhouw NL, 2010, NATURE, V464, P922, DOI 10.1038/nature08866; Vostrov AA, 1997, J BIOL CHEM, V272, P33353, DOI 10.1074/jbc.272.52.33353; Wallace JA, 2007, CURR OPIN GENET DEV, V17, P400, DOI 10.1016/j.gde.2007.08.005; Wan LB, 2008, DEVELOPMENT, V135, P2729, DOI 10.1242/dev.024539; Wu XM, 2003, BIOL REPROD, V69, P861, DOI 10.1095/biolreprod.103.016022; Xu N, 2007, NAT GENET, V39, P1390, DOI 10.1038/ng.2007.5; Yang YX, 1999, J NEUROCHEM, V73, P2286, DOI 10.1046/j.1471-4159.1999.0732286.x; Zeng FY, 2005, DEV BIOL, V283, P40, DOI 10.1016/j.ydbio.2005.03.038; Zhang H, 2011, J CELL BIOL, V193, P475, DOI 10.1083/jcb.201101021	56	107	110	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2012	7	4							e34915	10.1371/journal.pone.0034915	http://dx.doi.org/10.1371/journal.pone.0034915			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UD	22532833	Green Published, Green Submitted, gold			2022-12-25	WOS:000305339200027
J	Prado, P; Tomas, F; Pinna, S; Farina, S; Roca, G; Ceccherelli, G; Romero, J; Alcoverro, T				Prado, Patricia; Tomas, Fiona; Pinna, Stefania; Farina, Simone; Roca, Guillem; Ceccherelli, Giulia; Romero, Javier; Alcoverro, Teresa			Habitat and Scale Shape the Demographic Fate of the Keystone Sea Urchin Paracentrotus lividus in Mediterranean Macrophyte Communities	PLOS ONE			English	Article							SUPPLY-SIDE ECOLOGY; LONG-DISTANCE DISPERSAL; STRONGYLOCENTROTUS-DROEBACHIENSIS; BENTHIC INVERTEBRATES; SEDIMENT RETENTION; LARVAL DISPERSAL; TROPHIC LINKAGES; SEAGRASS MEADOW; ABUNDANCE; RECRUITMENT	Demographic processes exert different degrees of control as individuals grow, and in species that span several habitats and spatial scales, this can influence our ability to predict their population at a particular life-history stage given the previous life stage. In particular, when keystone species are involved, this relative coupling between demographic stages can have significant implications for the functioning of ecosystems. We examined benthic and pelagic abundances of the sea urchin Paracentrotus lividus in order to: 1) understand the main life-history bottlenecks by observing the degree of coupling between demographic stages; and 2) explore the processes driving these linkages. P. lividus is the dominant invertebrate herbivore in the Mediterranean Sea, and has been repeatedly observed to overgraze shallow beds of the seagrass Posidonia oceanica and rocky macroalgal communities. We used a hierarchical sampling design at different spatial scales (100 s, 10 s and <1 km) and habitats (seagrass and rocky macroalgae) to describe the spatial patterns in the abundance of different demographic stages (larvae, settlers, recruits and adults). Our results indicate that large-scale factors (potentially currents, nutrients, temperature, etc.) determine larval availability and settlement in the pelagic stages of urchin life history. In rocky macroalgal habitats, benthic processes (like predation) acting at large or medium scales drive adult abundances. In contrast, adult numbers in seagrass meadows are most likely influenced by factors like local migration (from adjoining rocky habitats) functioning at much smaller scales. The complexity of spatial and habitat-dependent processes shaping urchin populations demands a multiplicity of approaches when addressing habitat conservation actions, yet such actions are currently mostly aimed at managing predation processes and fish numbers. We argue that a more holistic ecosystem management also needs to incorporate the landscape and habitat-quality level processes (eutrophication, fragmentation, etc.) that together regulate the populations of this keystone herbivore.	[Prado, Patricia] IRTA, Tarragona, Spain; [Prado, Patricia] E Carolina Univ, Dept Biol, Greenville, NC USA; [Tomas, Fiona] Inst Mediterraneo Estudios Avanzados IMEDEA, Islas Baleares, Spain; [Pinna, Stefania; Ceccherelli, Giulia] Univ Sassari, Dept Sci Nat & Environm Resources, I-07100 Sassari, Italy; [Farina, Simone; Roca, Guillem; Alcoverro, Teresa] CSIC, CEAB, Girona, Spain; [Romero, Javier] Univ Barcelona, Dept Ecol, Fac Biol, E-08028 Barcelona, Spain	IRTA; University of North Carolina; East Carolina University; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto Mediterraneo de Estudios Avanzados (IMEDEA); University of Sassari; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centre d'Estudis Avancats de Blanes (CEAB); University of Barcelona	Prado, P (corresponding author), IRTA, Tarragona, Spain.	patricia.prado@irta.cat	Alcoverro, Teresa/J-9258-2012; Farina, Simone/ABF-4876-2021; Villegas, Patricia Prado/J-7483-2012; Prado, Patricia/N-9903-2019; Farina, Simone/AAB-9308-2021; Romero, Javier/A-8905-2013; Tomas, Fiona/G-3713-2010	Alcoverro, Teresa/0000-0002-3910-9594; Villegas, Patricia Prado/0000-0002-4986-2010; Prado, Patricia/0000-0002-4986-2010; Farina, Simone/0000-0003-0169-8044; Romero, Javier/0000-0002-2772-8486; Ceccherelli, Giulia/0000-0002-9832-9677; Roca, Guillem/0000-0002-8225-6047; Tomas, Fiona/0000-0001-8682-2504	Plan Nacional de I+D+i - Ministerio de Ciencia e Innovacion (Spain) [CTM2010-22273-C02]; Juan de la Cierva program	Plan Nacional de I+D+i - Ministerio de Ciencia e Innovacion (Spain)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Juan de la Cierva program	This work was supported by the project CTM2010-22273-C02 awarded by the Plan Nacional de I+D+i - Ministerio de Ciencia e Innovacion (Spain) and F.T. was funded by the Juan de la Cierva program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAILEY KM, 1989, ADV MAR BIOL, V25, P1; BALLESTEROS E, 1993, MONOGRAFIES SOC HIST, V2, P663; Ballesteros E, 1992, ARXIU SECCIO CIENCIE, V101, P616; Barnes DKA, 2001, J MAR BIOL ASSOC UK, V81, P359, DOI 10.1017/S0025315401003927; Baums IB, 2006, LIMNOL OCEANOGR, V51, P1969, DOI 10.4319/lo.2006.51.5.1969; Bittner M, SEA SURFACE TEMPERAT; Boudouresque C.F., 1987, C INT PAR LIV OURS C, P159; BOUDOURESQUE CF, 2001, EDIBLE SEA URCHINS B, V32, P177; Calderon I, 2009, MOL ECOL, V18, P962; Hernandez JC, 2010, MAR ECOL PROG SER, V413, P69, DOI 10.3354/meps08684; Ceccherelli G, 2009, J SHELLFISH RES, V28, P397, DOI 10.2983/035.028.0224; Cowen Robert K., 2003, Gulf and Caribbean Research, V14, P129; Cowen RK, 2009, ANNU REV MAR SCI, V1, P443, DOI 10.1146/annurev.marine.010908.163757; DANCE C, 1987, MAR ECOL-P S Z N I, V8, P131, DOI 10.1111/j.1439-0485.1987.tb00179.x; DENNY M, 1992, BIOL BULL, V183, P220, DOI 10.2307/1542209; EMLET RB, 1983, BIOL BULL, V164, P433, DOI 10.2307/1541253; Estrada M, 1996, SCI MAR, V60, P55; Fagan WE, 1999, AM NAT, V153, P165, DOI 10.1086/303162; Farina S, 2009, MAR ECOL PROG SER, V377, P131, DOI 10.3354/meps07692; FENAUX L, 1994, LIMNOL OCEANOGR, V39, P84, DOI 10.4319/lo.1994.39.1.0084; Fernandez C, 2001, J MAR BIOL ASSOC UK, V81, P361, DOI 10.1017/S0025315401003939; FORMAN RTT, 1981, BIOSCIENCE, V31, P733, DOI 10.2307/1308780; Francour P, 1997, MAR ECOL-P S Z N I, V18, P157, DOI 10.1111/j.1439-0485.1997.tb00434.x; Friedlander AM, 1991, J EXPT MARINE BIOL E, V224, P1; Gacia E, 2001, ESTUAR COAST SHELF S, V52, P505, DOI 10.1006/ecss.2000.0753; Gacia E, 1999, AQUAT BOT, V65, P255, DOI 10.1016/S0304-3770(99)00044-3; GAINES S, 1985, P NATL ACAD SCI USA, V82, P3707, DOI 10.1073/pnas.82.11.3707; Garcia-Charton JA, 2001, MAR BIOL, V138, P917, DOI 10.1007/s002270000524; GROSBERG RK, 1992, TRENDS ECOL EVOL, V7, P130, DOI 10.1016/0169-5347(92)90148-5; Guidetti P, 2004, HELGOLAND MAR RES, V58, P110, DOI 10.1007/s10152-004-0176-4; Harrold C., 1987, Echinoderm Studies, V2, P137; Hereu B, 2005, MAR BIOL, V146, P293, DOI 10.1007/s00227-004-1439-y; Hereu B, 2004, MAR BIOL, V144, P1011, DOI 10.1007/s00227-003-1266-6; Hereu B, 2008, ECOLOGY, V89, P3423, DOI 10.1890/07-0613.1; Hughes TP, 2000, ECOLOGY, V81, P2241, DOI 10.1890/0012-9658(2000)081[2241:SSEWBW]2.0.CO;2; Hughes TP, 1999, NATURE, V397, P59, DOI 10.1038/16237; Iuri V, 2007, HYDROBIOLOGIA, V580, P77, DOI 10.1007/s10750-006-0464-x; KEOUGH MJ, 1984, ECOLOGY, V65, P423, DOI 10.2307/1941405; Kramer DL, 1999, ENVIRON BIOL FISH, V55, P65, DOI 10.1023/A:1007481206399; LEWIN R, 1986, SCIENCE, V234, P25, DOI 10.1126/science.234.4772.25; LODGE DM, 1987, CAN J FISH AQUAT SCI, V44, P591, DOI 10.1139/f87-072; Lopez S, 1998, MAR ECOL PROG SER, V172, P239, DOI 10.3354/meps172239; Marcus NH, 1998, LIMNOL OCEANOGR, V43, P763, DOI 10.4319/lo.1998.43.5.0763; Mariani S, 2000, MAR BIOL, V137, P783, DOI 10.1007/s002270000400; Maron JL, 2001, OECOLOGIA, V126, P595, DOI 10.1007/s004420000558; MCCLANAHAN TR, 1990, OECOLOGIA, V83, P362, DOI 10.1007/BF00317561; Micheli F, 1999, CONSERV BIOL, V13, P869, DOI 10.1046/j.1523-1739.1999.98233.x; Pace ML, 1999, TRENDS ECOL EVOL, V14, P483, DOI 10.1016/S0169-5347(99)01723-1; PEARCE CM, 1990, BIOL BULL-US, V179, P304, DOI 10.2307/1542322; PEARCE CM, 1991, J EXP MAR BIOL ECOL, V147, P147, DOI 10.1016/0022-0981(91)90179-Z; Peterson BJ, 2002, OIKOS, V97, P361, DOI 10.1034/j.1600-0706.2002.970306.x; Pinna S, 2012, MAR ECOL PROG SER, V445, P173, DOI 10.3354/meps09457; Planes S, 2011, MAR ECOL PROG SER, V431, P205, DOI 10.3354/meps09089; Prado P, 2008, MAR ECOL PROG SER, V371, P11, DOI 10.3354/meps07662; Prado P, 2007, MAR ECOL PROG SER, V340, P63, DOI 10.3354/meps340063; Prado P, 2009, ESTUAR COAST SHELF S, V85, P472, DOI 10.1016/j.ecss.2009.09.012; RAIMONDI PT, 1990, ECOL MONOGR, V60, P283, DOI 10.2307/1943059; RICHMOND RH, 1987, MAR BIOL, V93, P527, DOI 10.1007/BF00392790; Ries L, 2004, ECOLOGY, V85, P2917, DOI 10.1890/03-8021; Rilov G, 2006, ECOLOGY, V87, P731, DOI 10.1890/04-1853; Rilov G, 2006, MAR ECOL PROG SER, V327, P83, DOI 10.3354/meps327083; Rilov G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023958; Robinson A.R., 2001, OCEAN CURRENTS MEDIT, DOI [10.1006/rwos.2001.0376, DOI 10.1006/RWOS.2001.0376]; Ruiz JM, 2009, BOT MAR, V52, P449, DOI 10.1515/BOT.2009.053; Sala E, 1998, OIKOS, V82, P425, DOI 10.2307/3546364; Sala E, 1996, MAR ECOL PROG SER, V140, P71, DOI 10.3354/meps140071; SCHELTEMA RS, 1988, BIOL BULL, V174, P145, DOI 10.2307/1541781; SCHELTEMA RS, 1986, B MAR SCI, V39, P241; Shanks AL, 2003, ECOL APPL, V13, pS159; Tomas F, 2006, MAR ECOL PROG SER, V306, P125, DOI 10.3354/meps306125; Tomas F, 2005, MAR ECOL PROG SER, V287, P115, DOI 10.3354/meps287115; Tomas F, 2004, MAR ECOL PROG SER, V282, P173, DOI 10.3354/meps282173; Underwood T., 1997, EXPT ECOLOGY THEIR L; Zacherl D, 2003, J BIOGEOGR, V30, P913, DOI 10.1046/j.1365-2699.2003.00899.x	74	32	32	3	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2012	7	4							e35170	10.1371/journal.pone.0035170	http://dx.doi.org/10.1371/journal.pone.0035170			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UD	22536355	Green Published, gold			2022-12-25	WOS:000305339200040
J	Qiao, H; May, JM				Qiao, Huan; May, James M.			Interaction of the Transcription Start Site Core Region and Transcription Factor YY1 Determine Ascorbate Transporter SVCT2 Exon 1a Promoter Activity	PLOS ONE			English	Article							VITAMIN-C TRANSPORTER; RNA-POLYMERASE-II; BINDING-PROTEIN; DNA-BINDING; ACTIVATES TRANSCRIPTION; INITIATOR; GENE; EXPRESSION; P300; ACETYLATION	Transcription of the ascorbate transporter, SVCT2, is driven by two distinct promoters in exon 1 of the transporter sequence. The exon 1a promoter lacks a classical transcription start site and little is known about regulation of promoter activity in the transcription start site core (TSSC) region. Here we present evidence that the TSSC binds the multifunctional initiator-binding protein YY1. Electrophoresis shift assays using YY1 antibody showed that YY1 is present as one of two major complexes that specifically bind to the TSSC. The other complex contains the transcription factor NF-Y. Mutations in the TSSC that decreased YY1 binding also impaired the exon 1a promoter activity despite the presence of an upstream activating NF-Y/USF complex, suggesting that YY1 is involved in the regulation of the exon 1a transcription. Furthermore, YY1 interaction with NF-Y and/or USF synergistically enhanced the exon 1a promoter activity in transient transfections and co-activator p300 enhanced their synergistic activation. We propose that the TSSC plays a vital role in the exon 1a transcription and that this function is partially carried out by the transcription factor YY1. Moreover, co-activator p300 might be able to synergistically enhance the TSSC function via a "bridge" mechanism with upstream sequences.	[Qiao, Huan; May, James M.] Vanderbilt Univ, Sch Med, Dept Med, Nashville, TN 37212 USA	Vanderbilt University	Qiao, H (corresponding author), Vanderbilt Univ, Sch Med, Dept Med, Nashville, TN 37212 USA.	huan.qiao@vanderbilt.edu			National Institutes of Health [NS 057674]; core facilities of the Vanderbilt Diabetes Research and Training Center [DK 020593]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK020593, P60DK020593] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS057674] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); core facilities of the Vanderbilt Diabetes Research and Training Center; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by a grant from the National Institutes of Health (NS 057674) and by the core facilities of the Vanderbilt Diabetes Research and Training Center (DK 020593). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Austen M, 1998, ONCOGENE, V17, P511, DOI 10.1038/sj.onc.1201968; Barlev NA, 2001, MOL CELL, V8, P1243, DOI 10.1016/S1097-2765(01)00414-2; BASU A, 1993, J BIOL CHEM, V268, P4188; Biondi C, 2007, MOL HUM REPROD, V13, P77, DOI 10.1093/molehr/gal092; De Smet C, 2004, MOL CELL BIOL, V24, P4781, DOI 10.1128/MCB.24.11.4781-4790.2004; De Smet C, 1999, MOL CELL BIOL, V19, P7327; DESMET C, 1995, IMMUNOGENETICS, V42, P282, DOI 10.1007/BF00176446; Erkeland SJ, 2003, BLOOD, V101, P1111, DOI 10.1182/blood-2002-04-1207; Frontini M, 2002, J BIOL CHEM, V277, P5841, DOI 10.1074/jbc.M103651200; Fujita I, 2001, BRIT J NUTR, V86, P145, DOI 10.1079/BJN2001406; Gess B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017139; Gilthorpe J, 2002, DEVELOPMENT, V129, P3887; Goueli BS, 2003, ONCOGENE, V22, P8042, DOI 10.1038/sj.onc.1206847; GUTMAN A, 1994, MOL CELL BIOL, V14, P8143, DOI 10.1128/MCB.14.12.8143; HARIHARAN N, 1991, P NATL ACAD SCI USA, V88, P9799, DOI 10.1073/pnas.88.21.9799; Harrison FE, 2010, FREE RADICAL BIO MED, V49, P821, DOI 10.1016/j.freeradbiomed.2010.06.008; HYDEDERUYSCHER RP, 1995, NUCLEIC ACIDS RES, V23, P4457, DOI 10.1093/nar/23.21.4457; Iacobazzi V, 2009, BIOCHEM BIOPH RES CO, V385, P220, DOI 10.1016/j.bbrc.2009.05.030; JAVAHERY R, 1994, MOL CELL BIOL, V14, P116, DOI 10.1128/MCB.14.1.116; Kim J, 2003, HUM MOL GENET, V12, P233, DOI 10.1093/hmg/ddg028; Kraus RJ, 1996, NUCLEIC ACIDS RES, V24, P1531, DOI 10.1093/nar/24.8.1531; Li Q, 1998, EMBO J, V17, P6300, DOI 10.1093/emboj/17.21.6300; Lin IG, 2000, MOL CELL BIOL, V20, P2343, DOI 10.1128/MCB.20.7.2343-2349.2000; Mantovani R, 1999, GENE, V239, P15, DOI 10.1016/S0378-1119(99)00368-6; MANTOVANI R, 1994, J BIOL CHEM, V269, P20340; Matsumura N, 2009, MOL CANCER RES, V7, P210, DOI 10.1158/1541-7786.MCR-08-0255; Munshi N, 2001, SCIENCE, V293, P1133, DOI 10.1126/science.293.5532.1133; Mutskov VJ, 2002, GENE DEV, V16, P1540, DOI 10.1101/gad.988502; Okada Y, 2004, BLOOD, V104, P2027, DOI 10.1182/blood-2003-09-3107; Puri PL, 1997, EMBO J, V16, P369, DOI 10.1093/emboj/16.2.369; Qiao H, 2008, BRAIN RES, V1208, P79, DOI 10.1016/j.brainres.2008.02.102; Qiao H, 2011, BIOCHEM J, V440, P73, DOI 10.1042/BJ20110392; Qiao H, 2011, FREE RADICAL BIO MED, V50, P1196, DOI 10.1016/j.freeradbiomed.2011.02.006; Qiao H, 2009, FREE RADICAL BIO MED, V46, P1221, DOI 10.1016/j.freeradbiomed.2009.02.004; Reynolds A, 2004, NAT BIOTECHNOL, V22, P326, DOI 10.1038/nbt936; RONCHI A, 1995, NUCLEIC ACIDS RES, V23, P4565, DOI 10.1093/nar/23.22.4565; ROY AL, 1991, NATURE, V354, P245, DOI 10.1038/354245a0; Rubin SA, 2005, BBA-GENE STRUCT EXPR, V1732, P76, DOI 10.1016/j.bbaexp.2005.11.002; Salsi V, 2003, J BIOL CHEM, V278, P6642, DOI 10.1074/jbc.M210065200; Sankar N, 2008, ONCOGENE, V27, P5717, DOI 10.1038/onc.2008.181; Savini I, 2007, BIOCHEM BIOPH RES CO, V361, P385, DOI 10.1016/j.bbrc.2007.07.007; SETO E, 1991, NATURE, V354, P241, DOI 10.1038/354241a0; Sotiriou S, 2002, NAT MED, V8, P514, DOI 10.1038/nm0502-514; Tamaru H, 2001, NATURE, V414, P277, DOI 10.1038/35104508; Tiscornia G, 2006, NAT PROTOC, V1, P241, DOI 10.1038/nprot.2006.37; Tsukaguchi H, 1999, NATURE, V399, P70, DOI 10.1038/19986; USHEVA A, 1994, CELL, V76, P1115, DOI 10.1016/0092-8674(94)90387-5; Weis L, 1997, MOL CELL BIOL, V17, P2973, DOI 10.1128/MCB.17.6.2973; Wu XM, 2003, ARCH BIOCHEM BIOPHYS, V420, P114, DOI 10.1016/j.abb.2003.09.013; Wu XM, 2003, BBA-MOL CELL RES, V1641, P65, DOI 10.1016/S0167-4889(03)00065-X; YANT SR, 1995, NUCLEIC ACIDS RES, V23, P4353, DOI 10.1093/nar/23.21.4353	51	8	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2012	7	4							e35746	10.1371/journal.pone.0035746	http://dx.doi.org/10.1371/journal.pone.0035746			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UD	22532872	Green Published, gold, Green Submitted			2022-12-25	WOS:000305339200107
J	Orton, RJ; Bessell, PR; Birch, CPD; O'Hare, A; Kao, RR				Orton, Richard J.; Bessell, Paul R.; Birch, Colin P. D.; O'Hare, Anthony; Kao, Rowland R.			Risk of Foot-and-Mouth Disease Spread Due to Sole Occupancy Authorities and Linked Cattle Holdings	PLOS ONE			English	Article							GREAT-BRITAIN; UK FOOT; EPIDEMIC; TRANSMISSION; MOVEMENTS; DYNAMICS; NETWORK; IMPACT	Livestock movements in Great Britain are well recorded, have been extensively analysed with respect to their role in disease spread, and have been used in real time to advise governments on the control of infectious diseases. Typically, livestock holdings are treated as distinct entities that must observe movement standstills upon receipt of livestock, and must report livestock movements. However, there are currently two dispensations that can exempt holdings from either observing standstills or reporting movements, namely the Sole Occupancy Authority (SOA) and Cattle Tracing System (CTS) Links, respectively. In this report we have used a combination of data analyses and computational modelling to investigate the usage and potential impact of such linked holdings on the size of a Foot-and-Mouth Disease (FMD) epidemic. Our analyses show that although SOAs are abundant, their dynamics appear relatively stagnant. The number of CTS Links is also abundant, and increasing rapidly. Although most linked holdings are only involved in a single CTS Link, some holdings are involved in numerous links that can be amalgamated to form "CTS Chains" which can be both large and geographically dispersed. Our model predicts that under a worst case scenario of "one infected - all infected", SOAs do pose a risk of increasing the size (in terms of number of infected holdings) of a FMD epidemic, but this increase is mainly due to intra-SOA infection spread events. Furthermore, although SOAs do increase the geographic spread of an epidemic, this increase is predominantly local. Whereas, CTS Chains pose a risk of increasing both the size and the geographical spread of the disease substantially, under a worse case scenario. Our results highlight the need for further investigations into whether CTS Chains are transmission chains, and also investigations into intra-SOA movements and livestock distributions due to the lack of current data.	[Orton, Richard J.; Bessell, Paul R.; O'Hare, Anthony; Kao, Rowland R.] Univ Glasgow, Boyd Orr Ctr Populat & Ecosyst Hlth, Inst Biodivers Anim Hlth & Comparat Med, Coll Med Vet & Life Sci, Glasgow, Lanark, Scotland; [Birch, Colin P. D.] Vet Labs Agcy, Addlestone, Surrey, England	University of Glasgow; Veterinary Laboratories Agency	Orton, RJ (corresponding author), Univ Glasgow, Boyd Orr Ctr Populat & Ecosyst Hlth, Inst Biodivers Anim Hlth & Comparat Med, Coll Med Vet & Life Sci, Glasgow, Lanark, Scotland.	Richard.Orton@glasgow.ac.uk	O'Hare, Anthony/K-8241-2013; Birch, Colin P. D./C-7572-2011	O'Hare, Anthony/0000-0003-2561-9582; Birch, Colin P. D./0000-0002-4608-9093; Kao, Rowland/0000-0003-0919-6401	Department for Environment Food and Rural Affairs (DEFRA); Wellcome Trust	Department for Environment Food and Rural Affairs (DEFRA)(Department for Environment, Food & Rural Affairs (DEFRA)); Wellcome Trust(Wellcome TrustEuropean Commission)	This work was funded by Department for Environment Food and Rural Affairs (DEFRA; http://www.defra.gov.uk). RRK and AO are funded under a Wellcome Trust Senior Research Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexandersen S, 2003, J COMP PATHOL, V129, P268, DOI 10.1016/S0021-9975(03)00045-8; Anderson I., 2002, FOOT MOUTH DIS 2001; Anon, 2003, IDENTIFYING TRACKING; Anon, 2009, GUIDANCE KEEPERS ENG; Davies G, 2002, COMP IMMUNOL MICROB, V25, P331, DOI 10.1016/S0147-9571(02)00030-9; DEFRA, 2006, REV LIV MOV CONTR; Ferguson NM, 2001, SCIENCE, V292, P1155, DOI 10.1126/science.1061020; Gibbens JC, 2001, VET REC, V149, P729, DOI 10.1136/vr.149.24.729; Green DM, 2006, P ROY SOC B-BIOL SCI, V273, P2729, DOI 10.1098/rspb.2006.3648; Green DM, 2008, P R SOC B, V275, P1001, DOI 10.1098/rspb.2007.1601; Haydon DT, 2004, NAT REV MICROBIOL, V2, P675, DOI 10.1038/nrmicro960; Kao RR, 2007, J R SOC INTERFACE, V4, P907, DOI 10.1098/rsif.2007.1129; Kao RR, 2003, P ROY SOC B-BIOL SCI, V270, P2557, DOI 10.1098/rspb.2003.2546; Keeling MJ, 2001, SCIENCE, V294, P813, DOI 10.1126/science.1065973; Kiss IZ, 2006, J R SOC INTERFACE, V3, P669, DOI 10.1098/rsif.2006.0129	15	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2012	7	4							e35089	10.1371/journal.pone.0035089	http://dx.doi.org/10.1371/journal.pone.0035089			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TL	22532841	Green Submitted, Green Published, Green Accepted, gold			2022-12-25	WOS:000305336200023
J	Chen, CL; Wang, P; Su, Q; Wang, SL; Wang, FJ				Chen, Chuanli; Wang, Pei; Su, Qin; Wang, Shiliang; Wang, Fengjun			Myosin Light Chain Kinase Mediates Intestinal Barrier Disruption following Burn Injury	PLOS ONE			English	Article							EPITHELIAL BARRIER; TNF-ALPHA; BACTERIAL TRANSLOCATION; INTERFERON-GAMMA; GUT; TIGHT; APOPTOSIS; PERMEABILITY; EXPRESSION; DYSFUNCTION	Background: Severe burn injury results in the loss of intestinal barrier function, however, the underlying mechanism remains unclear. Myosin light chain (MLC) phosphorylation mediated by MLC kinase (MLCK) is critical to the pathophysiological regulation of intestinal barrier function. We hypothesized that the MLCK-dependent MLC phosphorylation mediates the regulation of intestinal barrier function following burn injury, and that MLCK inhibition attenuates the burn-induced intestinal barrier disfunction. Methodology/Principal Findings: Male balb/c mice were assigned randomly to either sham burn (control) or 30% total body surface area (TBSA) full thickness burn without or with intraperitoneal injection of ML-9 (2 mg/kg), an MLCK inhibitor. In vivo intestinal permeability to fluorescein isothiocyanate (FITC)-dextran was measured. Intestinal mucosa injury was assessed histologically. Tight junction proteins ZO-1, occludin and claudin-1 was analyzed by immunofluorescent assay. Expression of MLCK and phosphorylated MLC in ileal mucosa was assessed by Western blot. Intestinal permeability was increased significantly after burn injury, which was accompanied by mucosa injury, tight junction protein alterations, and increase of both MLCK and MLC phosphorylation. Treatment with ML-9 attenuated the burn-caused increase of intestinal permeability, mucosa injury, tight junction protein alterations, and decreased MLC phosphorylation, but not MLCK expression. Conclusions/Significance: The MLCK-dependent MLC phosphorylation mediates intestinal epithelial barrier dysfunction after severe burn injury. It is suggested that MLCK-dependent MLC phosphorylation may be a critical target for the therapeutic treatment of intestinal epithelial barrier disruption after severe burn injury.	[Chen, Chuanli; Wang, Pei; Su, Qin; Wang, Shiliang; Wang, Fengjun] Third Mil Med Univ, Southwest Hosp, Inst Burn Res, State Key Lab Trauma Burns & Combined Injury, Chongqing, Peoples R China; [Su, Qin] Third Mil Med Univ, Sch Nursing, Dept Mil Nursing, Chongqing, Peoples R China	Army Medical University; Army Medical University	Chen, CL (corresponding author), Third Mil Med Univ, Southwest Hosp, Inst Burn Res, State Key Lab Trauma Burns & Combined Injury, Chongqing, Peoples R China.	wangfj@tmmu.edu.cn	Wang, Fengjun/A-4114-2009		National Natural Science Foundation of China [30571923]; Chongqing Natural Science Foundation [CSTC-2005BB5045]; Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry [2006-331]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chongqing Natural Science Foundation(Natural Science Foundation of Chongqing); Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry(Scientific Research Foundation for the Returned Overseas Chinese Scholars)	This work was supported by the National Natural Science Foundation of China (30571923), the Chongqing Natural Science Foundation (CSTC-2005BB5045), and the Project Sponsored by the Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry (2006-331). The relevant grant number is 3. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Sadi R, 2008, J IMMUNOL, V180, P5653, DOI 10.4049/jimmunol.180.8.5653; Beaurepaire C, 2009, J INTERF CYTOK RES, V29, P133, DOI 10.1089/jir.2008.0057; Blikslager AT, 2007, PHYSIOL REV, V87, P545, DOI 10.1152/physrev.00012.2006; Bojarski C, 2000, ANN NY ACAD SCI, V915, P270; Bruewer M, 2003, J IMMUNOL, V171, P6164, DOI 10.4049/jimmunol.171.11.6164; Chin AC, 2003, P NATL ACAD SCI USA, V100, P11104, DOI 10.1073/pnas.1831452100; Clayburgh DR, 2004, LAB INVEST, V84, P282, DOI 10.1038/labinvest.3700050; Costantini TW, 2010, MOL IMAGING, V9, P30, DOI 10.2310/7290.2010.00001; Costantini TW, 2009, J SURG RES, V156, P64, DOI 10.1016/j.jss.2009.03.066; Costantini TW, 2009, SHOCK, V31, P416, DOI 10.1097/SHK.0b013e3181863080; Costantini TW, 2009, J TRAUMA, V66, P17, DOI 10.1097/TA.0b013e318191bb1f; Deitch EA, 2002, SURGERY, V131, P241, DOI 10.1067/msy.2002.116408; Feighery LM, 2008, PHARM RES-DORDR, V25, P1377, DOI 10.1007/s11095-007-9527-6; Finnerty CC, 2007, SHOCK, V27, P4, DOI 10.1097/01.shk.0000235138.20775.36; Finnerty CC, 2009, CYTOKINE, V45, P20, DOI 10.1016/j.cyto.2008.10.005; Fujiyoshi N, 2006, SURGERY, V140, P810, DOI 10.1016/j.surg.2006.03.003; Gitter AH, 2000, FASEB J, V14, P1749, DOI 10.1096/fj.99-0898com; Iiboshi Y, 1996, JPEN-PARENTER ENTER, V20, P406, DOI 10.1177/0148607196020006406; Jones BA, 1997, AM J PHYSIOL-GASTR L, V273, pG1174, DOI 10.1152/ajpgi.1997.273.6.G1174; Kannan KB, 2011, AM J PHYSIOL-GASTR L, V300, pG853, DOI 10.1152/ajpgi.00459.2010; Leaphart CL, 2007, SURGERY, V141, P563, DOI 10.1016/j.surg.2007.01.021; Liu HM, 2011, CYTOKINE, V56, P56, DOI 10.1016/j.cyto.2011.07.355; [刘依凌 LIU Yiling], 2008, [第三军医大学学报, Acta Academiae Medicinae Militaris Tertiae], V30, P817; Ma TY, 2005, AM J PHYSIOL-GASTR L, V288, pG422, DOI 10.1152/ajpgi.00412.2004; Magnotti LJ, 2005, J BURN CARE REHABIL, V26, P383, DOI 10.1097/01.bcr.0000176878.79267.e8; Orman MA, 2011, CYTOKINE, V55, P362, DOI 10.1016/j.cyto.2011.05.010; OTAMIRI T, 1987, ACTA CHIR SCAND, V153, P51; Peterson CY, 2010, SURG INFECT, V11, P137, DOI 10.1089/sur.2009.053; Prasad S, 2005, LAB INVEST, V85, P1139, DOI 10.1038/labinvest.3700316; Qi HB, 2011, CELL PHYSIOL BIOCHEM, V27, P251, DOI 10.1159/000327951; Ramzy PI, 2000, J AM COLL SURGEONS, V190, P281, DOI 10.1016/S1072-7515(99)00269-0; Rosenberger P, 2007, FASEB J, V21, P2613, DOI 10.1096/fj.06-8004com; Schulzke JD, 2006, ANN NY ACAD SCI, V1072, P288, DOI 10.1196/annals.1326.027; Schwarz BT, 2007, GASTROENTEROLOGY, V132, P2383, DOI 10.1053/j.gastro.2007.02.052; Shao LJ, 2005, BURNS, V31, P838, DOI 10.1016/j.burns.2005.05.005; Shen L, 2006, J CELL SCI, V119, P2095, DOI 10.1242/jcs.02915; Shen L, 2011, ANNU REV PHYSIOL, V73, P283, DOI 10.1146/annurev-physiol-012110-142150; Spies M, 2002, AM J PHYSIOL-GASTR L, V283, pG703, DOI 10.1152/ajpgi.00149.2001; Suzuki T, 2011, J BIOL CHEM, V286, P31263, DOI 10.1074/jbc.M111.238147; Turner JR, 2006, AM J PATHOL, V169, P1901, DOI 10.2353/ajpath.2006.060681; Turner JR, 2009, NAT REV IMMUNOL, V9, P799, DOI 10.1038/nri2653; Wang FJ, 2006, GASTROENTEROLOGY, V131, P1153, DOI 10.1053/j.gastro.2006.08.022; Wang FJ, 2005, AM J PATHOL, V166, P409, DOI 10.1016/S0002-9440(10)62264-X; Wang Pei, 2009, Zhonghua Shao Shang Za Zhi, V25, P57; Weber CR, 2010, J BIOL CHEM, V285, P12037, DOI 10.1074/jbc.M109.064808; WILMORE DW, 1988, SURGERY, V104, P917; Wolf SE, 1999, J AM COLL SURGEONS, V188, P10, DOI 10.1016/S1072-7515(98)00260-9; Yeh WL, 2007, MOL PHARMACOL, V72, P440, DOI 10.1124/mol.107.036418; Yuan ZQ, 2008, BURNS, V34, P247, DOI 10.1016/j.burns.2007.03.016; Zhao Yun, 2004, Zhonghua Shao Shang Za Zhi, V20, P214; [赵云 Zhao Yun], 2004, [第三军医大学学报, Acta Academiae Medicinae Militaris Tertiae], V26, P1631	51	62	72	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2012	7	4							e34946	10.1371/journal.pone.0034946	http://dx.doi.org/10.1371/journal.pone.0034946			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959XD	22529961	Green Published, Green Submitted, gold			2022-12-25	WOS:000305350600046
J	Ma, XL; Chang, WJ; Zhang, CP; Zhou, X; Yu, FY				Ma, Xiaoling; Chang, Wenjiao; Zhang, Cuiping; Zhou, Xin; Yu, Fangyou			Staphylococcal Panton-Valentine Leukocidin Induces Pro-Inflammatory Cytokine Production and Nuclear Factor-Kappa B Activation in Neutrophils	PLOS ONE			English	Article							VIRULENCE DETERMINANTS; MEDICAL PROGRESS; AUREUS; LUNG; ASSOCIATION; APOPTOSIS; GENE	Panton-Valentine leukocidin (PVL) is a cytotoxin secreted by Staphylococcus aureus and associated with severe necrotizing infections. PVL targets polymorphonuclear leukocytes, especially neutrophils, which are the first line of defense against infections. Although PVL can induce neutrophil death by necrosis or apoptosis, the specific inflammatory responses of neutrophils to this toxin are unclear. In this study, both in vivo and in vitro studies demonstrated that recombinant PVL has an important cytotoxic role in human neutrophils, leading to apoptosis at low concentrations and necrosis at high concentrations. Recombinant PVL also increased the levels of pro-inflammatory cytokine secretion from neutrophils. The up-regulation of pro-inflammatory cytokines was due to nuclear factor-kappa B (NF-kappa B) activation induced by PVL. Moreover, blocking NF-kB inhibited the production of inflammatory cytokines. To test the role of neutrophil immune responses during the pathogenesis of PVL-induced acute lung injury, we used immunocompetent or neutropenic rabbits to develop a model of necrotizing pneumonia. Immunocompetent rabbits challenged with PVL demonstrated increased inflammation containing neutrophilic infiltrates. In addition, there were elevated levels of inflammatory cytokines (IL-6, IL-8, TNF-alpha and IL-10) and NF-kappa B in the lung homogenate. In contrast, the lung tissues from neutropenic rabbits contained mild or moderate inflammation, and the levels of inflammatory cytokines and NF-kappa B increased only slightly. Data from the current study support growing evidence that neutrophils play an important role in the pathogenesis of PVL-induced tissue injury and inflammation. PVL can stimulate neutrophils to release pro-inflammatory mediators, thereby causing an acute inflammatory response. The ability of PVL to induce inflammatory cytokine release may be associated with the activation of NF-kappa B or its pore-forming properties.	[Ma, Xiaoling; Chang, Wenjiao; Zhang, Cuiping; Zhou, Xin] Anhui Med Univ, Anhui Prov Hosp, Dept Lab Med, Hefei, Peoples R China; [Yu, Fangyou] First Affiliated Hosp, Wenzhou Med Coll, Dept Lab Med, Wenzhou, Peoples R China	Anhui Medical University; Wenzhou Medical University	Ma, XL (corresponding author), Anhui Med Univ, Anhui Prov Hosp, Dept Lab Med, Hefei, Peoples R China.	xiaolingma@126.com	MA, XIAO/HHN-5611-2022		Anhui Provincial Natural Science Foundation [11040606M205]	Anhui Provincial Natural Science Foundation(Natural Science Foundation of Anhui Province)	This work ws supported by the Anhui Provincial Natural Science Foundation-11040606M205(http://220.178.98.52/zrkxjj/2011jjxmb.xls). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barr Beth, 2006, Tex Med, V102, P56; Boehning D, 2003, NAT CELL BIOL, V5, P1051, DOI 10.1038/ncb1063; Boehning D, 2005, P NATL ACAD SCI USA, V102, P1466, DOI 10.1073/pnas.0409650102; Boyle-Vavra S, 2007, LAB INVEST, V87, P3, DOI 10.1038/labinvest.3700501; Brown EL, 2008, CLIN VACCINE IMMUNOL; Diep BA, 2008, TRENDS MICROBIOL, V16, P361, DOI 10.1016/j.tim.2008.05.002; Diep BA, 2010, P NATL ACAD SCI USA, V107, P5587, DOI 10.1073/pnas.0912403107; Dubrous P, 2007, ANN BIOL CLIN-PARIS, V65, P277, DOI 10.1684/abc.2007.0049; Fridkin SK, 2005, NEW ENGL J MED, P352; Genestier AL, 2005, J CLIN INVEST, V115, P3117, DOI 10.1172/JCI22684; Gilbert M, 2006, CAN MED ASSOC J, V175, P149, DOI 10.1503/cmaj.051565; Gillet Y, 2002, LANCET, V359, P753, DOI 10.1016/S0140-6736(02)07877-7; Goodman RB, 2003, CYTOKINE GROWTH F R, V14, P523, DOI 10.1016/S1359-6101(03)00059-5; Jayasinghe L, 2005, PROTEIN SCI, V14, P2550, DOI 10.1110/ps.051648505; Kazakova SV, 2005, NEW ENGL J MED, P352; KONIG B, 1995, J INFECT DIS, V171, P607, DOI 10.1093/infdis/171.3.607; Labandeira-Rey M, 2007, SCIENCE, V315, P1130, DOI 10.1126/science.1137165; Liu C, 2008, CLIN INFECT DIS, V46, P1637, DOI 10.1086/587893; Loffler B, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000715; Lopez-Aguilar C, 2007, J CLIN MICROBIOL, V45, P274, DOI 10.1128/JCM.02032-06; Lowy FD, 1998, NEW ENGL J MED, V339, P520, DOI 10.1056/NEJM199808203390806; Miles G, 2002, PROTEIN SCI, V11, P894, DOI 10.1110/ps.4360102; Montgomery CP, 2009, INFECT IMMUN, V77, P2159, DOI 10.1128/IAI.00021-09; Otto M, 2010, ANNU REV MICROBIOL, P64; Purcell K, 2005, ARCH PEDIAT ADOL MED, V159, P980, DOI 10.1001/archpedi.159.10.980; Tseng CW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006387; Wang R, 2007, NAT MED, V13, P1510, DOI 10.1038/nm1656; Ware LB, 2000, NEW ENGL J MED, V342, P1334, DOI 10.1056/NEJM200005043421806; Wu BQ, 2010, CAN J MICROBIOL, V56, P229, DOI [10.1139/W10-002, 10.1139/w10-002]; Zivkovic A, 2011, J IMMUNOL, V186, P1608, DOI 10.4049/jimmunol.1001665	30	41	45	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2012	7	4							e34970	10.1371/journal.pone.0034970	http://dx.doi.org/10.1371/journal.pone.0034970			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959XD	22529963	gold, Green Published, Green Submitted			2022-12-25	WOS:000305350600048
J	Zhang, JW; Zhou, F; Niu, F; Lu, M; Wu, XL; Sun, JG; Wang, GJ				Zhang, Jingwei; Zhou, Fang; Niu, Fang; Lu, Meng; Wu, Xiaolan; Sun, Jianguo; Wang, Guangji			Stereoselective Regulations of P-Glycoprotein by Ginsenoside Rh2 Epimers and the Potential Mechanisms From the View of Pharmacokinetics	PLOS ONE			English	Article							INTESTINAL BACTERIA; CACO-2 CELLS; IN-VITRO; 20(S)-GINSENOSIDE; ENANTIOMERS; STEREOSPECIFICITY; TRANSPORTERS; METABOLISM; VERAPAMIL; RECEPTOR	Chirality is an interesting topic and it is meaningful to explore the interactions between chiral small molecules and stereoselective biomacromolecules, with pre-clinical and clinical significances. We have previously demonstrated that 20(S)- ginsenoside Rh2 is an effective P-glycoprotein (P-gp) inhibitor in vitro and in vivo. Considering the stereochemistry of ginsenoside Rh2, in our present study, the regulatory effects of 20(R)-Rh2 on P-gp were assayed in vivo, and the differential regulations of P-gp by ginsenoside Rh2 epimers in vivo were compared and studied. Results showed that 20(S)-Rh2 enhanced the oral absorption of digoxin in rats in a dose-dependent manner; 20(R)-Rh2 at low dosage increased the oral absorption of digoxin, but this effect diminished with elevated dosage of 20(R)-Rh2. Further studies indicated stereoselective pharmacokinetic profiles and intestinal biotransformations of Rh2 epimers. In vitro studies showed that Rh2 epimers and their corresponding deglycosylation metabolites protopanaxadiol (Ppd) epimers all exhibited stereoselective regulations of P-gp. In conclusion, in view of the in vitro and in vivo dispositions of Rh2 and the regulations of P-gp by Rh2 and Ppd, it is suggested that the P-gp regulatory effect of Rh2 in vivo actually is a double actions of both Rh2 and Ppd, and the net effect is determined by the relative balance between Rh2 and Ppd with the same configuration. Our study provides new evidence of the chiral characteristics of P-gp, and is helpful to elucidate the stereoselective P-gp regulation mechanisms of ginsenoside Rh2 epimers in vivo from a pharmacokinetic view.	[Zhang, Jingwei; Zhou, Fang; Niu, Fang; Lu, Meng; Wu, Xiaolan; Sun, Jianguo; Wang, Guangji] China Pharmaceut Univ, Key Lab Drug Metab & Pharmacokinet, Nanjing 210009, Jiangsu, Peoples R China	China Pharmaceutical University	Zhang, JW (corresponding author), China Pharmaceut Univ, Key Lab Drug Metab & Pharmacokinet, Nanjing 210009, Jiangsu, Peoples R China.	zhoufangcpu@hotmail.com; guangjiwang@hotmail.com	niu, fang/A-8912-2019	niu, fang/0000-0002-5035-7409	China National Nature Science Foundation [30973583, 30801411]; China 'Creation of New Drugs' Key Technology Projects [2009ZX09304-001, 2009ZX09502-004]; Jiangsu Province Nature Science Foundation [BE2010723, BK2010437]	China National Nature Science Foundation(National Natural Science Foundation of China (NSFC)); China 'Creation of New Drugs' Key Technology Projects; Jiangsu Province Nature Science Foundation	This work was supported by China National Nature Science Foundation No. 30973583 (GW) and No. 30801411 (FZ); China 'Creation of New Drugs' Key Technology Projects No. 2009ZX09304-001 (HH) and 2009ZX09502-004 (GW); Jiangsu Province Nature Science Foundation No. BE2010723 (GW) and No. BK2010437 (FZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aller SG, 2009, SCIENCE, V323, P1718, DOI 10.1126/science.1168750; Bae EA, 2002, BIOL PHARM BULL, V25, P58, DOI 10.1248/bpb.25.58; Berginc K, 2011, J MED FOOD, V14, P135, DOI 10.1089/jmf.2010.0041; Berginc K, 2010, DRUG METAB PHARMACOK, V25, P307, DOI 10.2133/dmpk.25.307; Bhatia P, 2008, XENOBIOTICA, V38, P656, DOI [10.1080/00498250802109207, 10.1080/00498250802109207 ]; Bhatti MM, 1997, BIOPHARM DRUG DISPOS, V18, P387, DOI 10.1002/(SICI)1099-081X(199707)18:5<387::AID-BDD26>3.0.CO;2-X; BLASCHKE G, 1979, ARZNEIMITTEL-FORSCH, V29-2, P1640; Dey S, 1999, BIOCHEMISTRY-US, V38, P6630, DOI 10.1021/bi983038l; Gu Y, 2010, XENOBIOTICA, V40, P602, DOI 10.3109/00498254.2010.500744; Gu Y, 2009, FOOD CHEM TOXICOL, V47, P2257, DOI 10.1016/j.fct.2009.06.013; Hasegawa H, 2004, J PHARMACOL SCI, V95, P153, DOI 10.1254/jphs.FMJ04001X4; Jeong SM, 2004, MOL CELLS, V18, P383; Kang DI, 2005, BIOCHEM BIOPH RES CO, V333, P1194, DOI 10.1016/j.bbrc.2005.06.026; Liu J, 2010, FITOTERAPIA, V81, P902, DOI 10.1016/j.fitote.2010.05.020; Liu J, 2009, BIOORG MED CHEM LETT, V19, P3320, DOI 10.1016/j.bmcl.2009.04.054; Lv H, 2008, INT J PHARM, V351, P31, DOI 10.1016/j.ijpharm.2007.09.026; Nunez MC, 2009, CURR MED CHEM, V16, P2064, DOI 10.2174/092986709788682173; Oswald S, 2011, HANDB EXP PHARMACOL, V201, P403, DOI 10.1007/978-3-642-14541-4_11; Qi LW, 2011, PHYTOCHEMISTRY, V72, P689, DOI 10.1016/j.phytochem.2011.02.012; Qi LW, 2010, BIOCHEM PHARMACOL, V80, P947, DOI 10.1016/j.bcp.2010.06.023; Qian Tianxiu, 2010, Chin Med, V5, P19, DOI 10.1186/1749-8546-5-19; Robinson MA, 1996, BIOPHARM DRUG DISPOS, V17, P577, DOI 10.1002/(SICI)1099-081X(199610)17:7<577::AID-BDD984>3.3.CO;2-G; Rulcova A, 2010, J THROMB HAEMOST, V8, P2708, DOI 10.1111/j.1538-7836.2010.04036.x; Smith SW, 2009, TOXICOL SCI, V110, P4, DOI 10.1093/toxsci/kfp097; Sun H, 2008, EXPERT OPIN DRUG MET, V4, P395, DOI [10.1517/17425255.4.4.395, 10.1517/17425255.4.4.395 ]; Tawab MA, 2003, DRUG METAB DISPOS, V31, P1065, DOI 10.1124/dmd.31.8.1065; WAINER IW, 1992, AM J HOSP PHARM, V49, pS4, DOI 10.1093/ajhp/49.9_Suppl_1.S4; Weiss M, 2012, J CLIN PHARMACOL, V52, P381, DOI 10.1177/0091270010396711; Xie HT, 2005, BIOL PHARM BULL, V28, P383, DOI 10.1248/bpb.28.383; Zhang JW, 2010, DRUG METAB DISPOS, V38, P2179, DOI 10.1124/dmd.110.034793	30	24	29	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2012	7	4							e35768	10.1371/journal.pone.0035768	http://dx.doi.org/10.1371/journal.pone.0035768			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959XD	22530069	Green Submitted, Green Published, gold			2022-12-25	WOS:000305350600114
J	Audet, JN; Gowing, G; Paradis, R; Soucy, G; Julien, JP				Audet, Jean-Nicolas; Gowing, Genevieve; Paradis, Renee; Soucy, Genevieve; Julien, Jean-Pierre			Ablation of Proliferating Cells in the CNS Exacerbates Motor Neuron Disease Caused by Mutant Superoxide Dismutase	PLOS ONE			English	Article							GROWTH-FACTOR-I; MOUSE MODEL; EXTEND SURVIVAL; ANIMAL-MODEL; SPINAL-CORD; MICROGLIA; IGF-1; PROGRESSION; ASTROCYTES; SOD1	Proliferation of glia and immune cells is a common pathological feature of many neurodegenerative diseases including amyotrophic lateral sclerosis (ALS). Here, to investigate the role of proliferating cells in motor neuron disease, SOD1(G93A) transgenic mice were treated intracerebroventicularly (ICV) with the anti-mitotic drug cytosine arabinoside (Ara-C). ICV delivery of Ara-C accelerated disease progression in SOD1(G93A) mouse model of ALS. Ara-C treatment caused substantial decreases in the number of microglia, NG2+ progenitors, Olig2+ cells and CD3+ T cells in the lumbar spinal cord of symptomatic SOD1(G93A) transgenic mice. Exacerbation of disease was also associated with significant alterations in the expression inflammatory molecules IL-1 beta, IL-6, TGF-beta and the growth factor IGF-1.	[Audet, Jean-Nicolas; Gowing, Genevieve; Paradis, Renee; Soucy, Genevieve; Julien, Jean-Pierre] Univ Laval, CHUQ, Res Ctr, Dept Psychiat & Neurosci, Quebec City, PQ, Canada	Laval University	Audet, JN (corresponding author), Univ Laval, CHUQ, Res Ctr, Dept Psychiat & Neurosci, Quebec City, PQ, Canada.	jean-pierre.julien@crchul.ulaval.ca	Audet, Jean-Nicolas/P-2535-2014	Audet, Jean-Nicolas/0000-0002-0511-183X	Canadian Institutes in Health Research (CIHR)	Canadian Institutes in Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	This work was supported by the Canadian Institutes in Health Research (CIHR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banerjee R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002740; Beers DR, 2008, P NATL ACAD SCI USA, V105, P15558, DOI 10.1073/pnas.0807419105; Beers DR, 2006, P NATL ACAD SCI USA, V103, P16021, DOI 10.1073/pnas.0607423103; Boillee S, 2006, SCIENCE, V312, P1389, DOI 10.1126/science.1123511; Chiu IM, 2008, P NATL ACAD SCI USA, V105, P17913, DOI 10.1073/pnas.0804610105; Clement AM, 2003, SCIENCE, V302, P113, DOI 10.1126/science.1086071; Day WA, 2005, NEUROBIOL DIS, V19, P323, DOI 10.1016/j.nbd.2005.01.010; Di Giorgio FP, 2007, NAT NEUROSCI, V10, P608, DOI 10.1038/nn1885; Dobrowolny G, 2005, J CELL BIOL, V168, P193, DOI 10.1083/jcb.200407021; Dodge JC, 2010, MOL THER, V18, P2075, DOI 10.1038/mt.2010.206; Franz CK, 2009, NEUROBIOL DIS, V33, P473, DOI 10.1016/j.nbd.2008.12.003; Gowing G, 2008, J NEUROSCI, V28, P10234, DOI 10.1523/JNEUROSCI.3494-08.2008; Gowing G, 2009, EXP NEUROL, V220, P267, DOI 10.1016/j.expneurol.2009.08.021; Henkel JS, 2009, J NEUROIMMUNE PHARM, V4, P389, DOI 10.1007/s11481-009-9171-5; Ilieva H, 2009, J CELL BIOL, V187, P761, DOI 10.1083/jcb.200908164; Kaspar BK, 2003, SCIENCE, V301, P839, DOI 10.1126/science.1086137; Katsuno M, 2011, Curr Mol Med, V11, P48, DOI 10.2174/156652411794474356; Lasiene J, 2011, NEUROL RES INT, V2011, DOI 10.1155/2011/718987; Lepore AC, 2008, NAT NEUROSCI, V11, P1294, DOI 10.1038/nn.2210; Lepore AC, 2007, BRAIN RES, V1185, P256, DOI 10.1016/j.brainres.2007.09.034; Liu Y, 2009, J BIOL CHEM, V284, P3691, DOI 10.1074/jbc.M804446200; Marchetto MCN, 2008, CELL STEM CELL, V3, P649, DOI 10.1016/j.stem.2008.10.001; Masahira N, 2006, DEV BIOL, V293, P358, DOI 10.1016/j.ydbio.2006.02.029; Nagai M, 2007, NAT NEUROSCI, V10, P615, DOI 10.1038/nn1876; Nagano I, 2005, J NEUROL SCI, V235, P61, DOI 10.1016/j.jns.2005.04.011; Narai H, 2005, J NEUROSCI RES, V82, P452, DOI 10.1002/jnr.20668; Nguyen MD, 2004, J NEUROSCI, V24, P1340, DOI 10.1523/JNEUROSCI.4786-03.2004; Nishiyama A, 2009, NAT REV NEUROSCI, V10, P9, DOI 10.1038/nrn2495; Ono K, 2009, MOL CELLS, V27, P397, DOI 10.1007/s10059-009-0067-2; Riddoch-Contreras J, 2009, EXP NEUROL, V215, P281, DOI 10.1016/j.expneurol.2008.10.014; Rothstein JD, 2009, ANN NEUROL, V65, pS3, DOI 10.1002/ana.21543; Tada S, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-19; Turner BJ, 2008, PROG NEUROBIOL, V85, P94, DOI 10.1016/j.pneurobio.2008.01.001; Weydt P, 2004, GLIA, V48, P179, DOI 10.1002/glia.20062; Xiao Q, 2007, J NEUROCHEM, V102, P2008, DOI 10.1111/j.1471-4159.2007.04677.x; Yamanaka K, 2008, P NATL ACAD SCI USA, V105, P7594, DOI 10.1073/pnas.0802556105; Yamanaka K, 2008, NAT NEUROSCI, V11, P251, DOI 10.1038/nn2047; Zhao WH, 2010, GLIA, V58, P231, DOI 10.1002/glia.20919	38	17	17	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2012	7	4							e34932	10.1371/journal.pone.0034932	http://dx.doi.org/10.1371/journal.pone.0034932			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VO	22523565	Green Published, gold, Green Submitted			2022-12-25	WOS:000305345000037
J	Nishijima, N; Marusawa, H; Ueda, Y; Takahashi, K; Nasu, A; Osaki, Y; Kou, T; Yazumi, S; Fujiwara, T; Tsuchiya, S; Shimizu, K; Uemoto, S; Chiba, T				Nishijima, Norihiro; Marusawa, Hiroyuki; Ueda, Yoshihide; Takahashi, Ken; Nasu, Akihiro; Osaki, Yukio; Kou, Tadayuki; Yazumi, Shujiro; Fujiwara, Takeshi; Tsuchiya, Soken; Shimizu, Kazuharu; Uemoto, Shinji; Chiba, Tsutomu			Dynamics of Hepatitis B Virus Quasispecies in Association with Nucleos(t)ide Analogue Treatment Determined by Ultra-Deep Sequencing	PLOS ONE			English	Article							PRECORE REGION; E-ANTIGEN; FULMINANT; VARIANTS; ANTIBODY; THERAPY; DNA; NUCLEOSIDE; INFECTION; MUTATION	Background and Aims: Although the advent of ultra-deep sequencing technology allows for the analysis of heretofore-undetectable minor viral mutants, a limited amount of information is currently available regarding the clinical implications of hepatitis B virus (HBV) genomic heterogeneity. Methods: To characterize the HBV genetic heterogeneity in association with anti-viral therapy, we performed ultra-deep sequencing of full-genome HBV in the liver and serum of 19 patients with chronic viral infection, including 14 therapy-naive and 5 nucleos(t)ide analogue(NA)-treated cases. Results: Most genomic changes observed in viral variants were single base substitutions and were widely distributed throughout the HBV genome. Four of eight (50%) chronic therapy-naive HBeAg-negative patients showed a relatively low prevalence of the G1896A pre-core (pre-C) mutant in the liver tissues, suggesting that other mutations were involved in their HBeAg seroconversion. Interestingly, liver tissues in 4 of 5 (80%) of the chronic NA-treated anti-HBe-positive cases had extremely low levels of the G1896A pre-C mutant (0.0%, 0.0%, 0.1%, and 1.1%), suggesting the high sensitivity of the G1896A pre-C mutant to NA. Moreover, various abundances of clones resistant to NA were common in both the liver and serum of treatment-naive patients, and the proportion of M204VI mutants resistant to lamivudine and entecavir expanded in response to entecavir treatment in the serum of 35.7% (5/14) of patients, suggesting the putative risk of developing drug resistance to NA. Conclusion: Our findings illustrate the strong advantage of deep sequencing on viral genome as a tool for dissecting the pathophysiology of HBV infection.	[Nishijima, Norihiro; Marusawa, Hiroyuki; Ueda, Yoshihide; Takahashi, Ken; Nasu, Akihiro; Chiba, Tsutomu] Kyoto Univ, Grad Sch Med, Dept Gastroenterol & Hepatol, Kyoto, Japan; [Osaki, Yukio] Osaka Red Cross Hosp, Dept Gastroenterol & Hepatol, Osaka, Japan; [Kou, Tadayuki; Yazumi, Shujiro] Kitano Hosp, Tazuke Kofukai Med Res Inst, Dept Gastroenterol & Hepatol, Osaka, Japan; [Fujiwara, Takeshi; Tsuchiya, Soken; Shimizu, Kazuharu] Kyoto Univ, Grad Sch Pharmaceut Sci, Dept Nanobio Drug Discovery, Kyoto, Japan; [Uemoto, Shinji] Kyoto Univ, Grad Sch Med, Dept Surg, Kyoto, Japan	Kyoto University; Osaka Red Cross Hospital; Kitano Hospital; Kyoto University; Kyoto University	Nishijima, N (corresponding author), Kyoto Univ, Grad Sch Med, Dept Gastroenterol & Hepatol, Kyoto, Japan.	maru@kuhp.kyoto-u.ac.jp	Ueda, Yoshihide/S-7620-2016; Nishijima, Norihiro/GMX-2899-2022	Ueda, Yoshihide/0000-0003-3196-3494; Marusawa, Hiroyuki/0000-0002-4286-2712	JSPS [21229009, 23390196]; Health and Labor Science Research [H22-08]; Research on Hepatitis from the Ministry of Health, Labor and Welfare, Japan	JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Health and Labor Science Research; Research on Hepatitis from the Ministry of Health, Labor and Welfare, Japan	This work was supported by JSPS Grant-in-aid for Scientific Research 21229009, 23390196, and Health and Labor Science Research Grants (H22-08) and Research on Hepatitis from the Ministry of Health, Labor and Welfare, Japan. (http://mhlw-grants.niph.go.jp/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAHANE Y, 1990, GASTROENTEROLOGY, V99, P1113, DOI 10.1016/0016-5085(90)90632-B; CARMAN WF, 1991, HEPATOLOGY, V14, P219, DOI 10.1002/hep.1840140203; Chang KM, 2010, CLIN LIVER DIS, V14, P409, DOI 10.1016/j.cld.2010.05.012; Chowdhury A, 2005, J GASTROEN HEPATOL, V20, P1712, DOI 10.1111/j.1440-1746.2005.04070.x; Dienstag JL, 2008, NEW ENGL J MED, V359, P1486, DOI 10.1056/NEJMra0801644; Dienstag JL, 2009, HEPATOLOGY, V49, pS112, DOI 10.1002/hep.22920; Domingo E, 2007, VIRUS RES, V127, P131, DOI 10.1016/j.virusres.2007.02.001; Fishman SL, 2009, INFECT GENET EVOL, V9, P1158, DOI 10.1016/j.meegid.2009.07.011; Ghany MG, 2009, HEPATOLOGY, V49, pS174, DOI 10.1002/hep.22900; Han Y, 2009, J GASTROEN HEPATOL, V24, P1417, DOI 10.1111/j.1440-1746.2009.05864.x; Hedskog C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011345; Hollinger FB, 2007, J VIRAL HEPATITIS, V14, P11, DOI 10.1111/j.1365-2893.2007.00910.x; Ikeda K, 2007, ANN INTERN MED, V146, P649, DOI 10.7326/0003-4819-146-9-200705010-00008; Kramvis A, 1999, J VIRAL HEPATITIS, V6, P415, DOI 10.1046/j.1365-2893.1999.00189.x; Kwon H, 2011, NAT REV GASTROENTERO; Lataillade M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010952; Lisotti Andrea, 2008, Int J Med Sci, V5, P309; Lok AS, 2007, HEPATOLOGY, V46, P254, DOI 10.1002/hep.21698; Lok ASF, 2007, HEPATOLOGY, V45, P507, DOI 10.1002/hep.21513; Louvel S, 2008, HIV MED, V9, P133, DOI 10.1111/j.1468-1293.2007.00529.x; Margeridon-Thermet S, 2009, J INFECT DIS, V199, P1275, DOI 10.1086/597808; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Marusawa H, 2003, EMBO J, V22, P2729, DOI 10.1093/emboj/cdg263; Matsumoto Y, 2007, NAT MED, V13, P470, DOI 10.1038/nm1566; Murray JM, 2006, HEPATOLOGY, V44, P1117, DOI 10.1002/hep.21364; Nasu A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024907; Ngui SL, 1997, J VIRAL HEPATITIS, V4, P309, DOI 10.1046/j.1365-2893.1997.00066.x; Ntziora F, 2009, J CLIN MICROBIOL, V47, P2544, DOI 10.1128/JCM.00045-09; OKAMOTO H, 1990, J VIROL, V64, P1298, DOI 10.1128/JVI.64.3.1298-1303.1990; OMATA M, 1991, NEW ENGL J MED, V324, P1699, DOI 10.1056/NEJM199106133242404; Orito E, 2001, HEPATOLOGY, V33, P218, DOI 10.1053/jhep.2001.20532; Rozera G, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-15; Ruike Y, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-137; Simen BB, 2009, J INFECT DIS, V199, P693, DOI 10.1086/596736; Solmone M, 2009, J VIROL, V83, P1718, DOI 10.1128/JVI.02011-08; Yu JW, 2011, LIVER INT, V31, P499, DOI 10.1111/j.1478-3231.2011.02450.x; Zoulim F, 2009, GASTROENTEROLOGY, V137, P1593, DOI 10.1053/j.gastro.2009.08.063	37	68	70	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2012	7	4							e35052	10.1371/journal.pone.0035052	http://dx.doi.org/10.1371/journal.pone.0035052			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VO	22523569	Green Submitted, gold, Green Published			2022-12-25	WOS:000305345000041
J	Raghavendran, HRB; Sathyanath, R; Shin, J; Kim, HK; Han, JM; Cho, J; Son, CG				Raghavendran, Hanumantha Rao Balaji; Sathyanath, Rekha; Shin, JangWoo; Kim, Hyeong Keug; Han, Jong Min; Cho, JungHyo; Son, Chang Gue			Panax ginseng Modulates Cytokines in Bone Marrow Toxicity and Myelopoiesis: Ginsenoside Rg1 Partially Supports Myelopoiesis	PLOS ONE			English	Article							COLONY-STIMULATING FACTOR; TUMOR-NECROSIS-FACTOR; ENDOTHELIAL-CELLS SUPPORT; FACTOR-ALPHA; PROLIFERATION; INTERLEUKIN-3; DIFFERENTIATION; 5-FLUOROURACIL; ENHANCEMENT; LIGAND	In this study, we have demonstrated that Korean Panax ginseng (KG) significantly enhances myelopoiesis in vitro and reconstitutes bone marrow after 5-flurouracil-induced (5FU) myelosuppression in mice. KG promoted total white blood cell, lymphocyte, neutrophil and platelet counts and improved body weight, spleen weight, and thymus weight. The number of CFU-GM in bone marrow cells of mice and serum levels of IL-3 and GM-CSF were significantly improved after KG treatment. KG induced significant c-Kit, SCF and IL-1 mRNA expression in spleen. Moreover, treatment with KG led to marked improvements in 5FU-induced histopathological changes in bone marrow and spleen, and partial suppression of thymus damage. The levels of IL-3 and GM-CSF in cultured bone marrow cells after 24 h stimulation with KG were considerably increased. The mechanism underlying promotion of myelopoiesis by KG was assessed by monitoring gene expression at two time-points of 4 and 8 h. Treatment with Rg1 (0.5, 1 and 1.5 mu mol) specifically enhanced c-Kit, IL-6 and TNF-alpha mRNA expression in cultured bone marrow cells. Our results collectively suggest that the anti-myelotoxicity activity and promotion of myelopoiesis by KG are mediated through cytokines. Moreover, the ginsenoside, Rg1, supports the role of KG in myelopoiesis to some extent.	[Raghavendran, Hanumantha Rao Balaji; Sathyanath, Rekha; Shin, JangWoo; Kim, Hyeong Keug; Han, Jong Min; Cho, JungHyo; Son, Chang Gue] Univ Daejeon, Daejeon Oriental Hosp Daejeon, Liver & Immunol Res Ctr, Taejon, South Korea		Raghavendran, HRB (corresponding author), Univ Daejeon, Daejeon Oriental Hosp Daejeon, Liver & Immunol Res Ctr, Taejon, South Korea.	hbr_bala@yahoo.com; ckson@dju.ac.kr	raghavendran, hanumantha rao balaji/B-8507-2012; son, chang gue/ABC-2215-2021		National Research Foundation from the Republic of Korea's Ministry of Education, Science and Technology [R01-2007-000-11248-0, 20110003150]	National Research Foundation from the Republic of Korea's Ministry of Education, Science and Technology	This study was supported by a grant from the National Research Foundation (R01-2007-000-11248-0 and 20110003150) from the Republic of Korea's Ministry of Education, Science and Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alenzi Faris Q., 2005, Yale Journal of Biology and Medicine, V78, P25; AlmeidaPorada G, 1996, J LAB CLIN MED, V128, P399, DOI 10.1016/S0022-2143(96)80012-6; Artym Jolanta, 2007, Postepy Hig Med Dosw (Online), V61, P129; Attele AS, 1999, BIOCHEM PHARMACOL, V58, P1685, DOI 10.1016/S0006-2952(99)00212-9; BARTOLD PM, 1991, J PERIODONTAL RES, V26, P339, DOI 10.1111/j.1600-0765.1991.tb02072.x; Batard P, 2000, J CELL SCI, V113, P383; Cashman JD, 1998, BLOOD, V92, P2338, DOI 10.1182/blood.V92.7.2338.2338_2338_2344; Chang Yuan S, 2003, Integr Cancer Ther, V2, P13, DOI 10.1177/1534735403251167; Chen Di, 2003, Zhongguo Zhong Xi Yi Jie He Za Zhi, V23, P845; Chen M.-W., 2005, MIL MED J S CHINA, V19, P4; Chen Xiao-Hong, 2006, Zhongguo Shi Yan Xue Ye Xue Za Zhi, V14, P343; Dalmau SR, 1997, LEUKEMIA RES, V21, P93, DOI 10.1016/S0145-2126(96)00052-5; DAVIS TA, 1995, BLOOD, V85, P1751, DOI 10.1182/blood.V85.7.1751.bloodjournal8571751; De Maria R, 1999, NATURE, V401, P489, DOI 10.1038/46809; deHaan G, 1996, BLOOD, V87, P4581, DOI 10.1182/blood.V87.11.4581.bloodjournal87114581; Deonarain R, 2003, P NATL ACAD SCI USA, V100, P13453, DOI 10.1073/pnas.2230460100; DINARELLO CA, 1989, ADV IMMUNOL, V44, P153, DOI 10.1016/S0065-2776(08)60642-2; FACKLER MJ, 1995, BLOOD, V85, P3040, DOI 10.1182/blood.V85.11.3040.bloodjournal85113040; Gao RL, 2007, ACTA PHARMACOL SIN, V28, P703, DOI 10.1111/j.1745-7254.2007.00551.x; GILMORE GL, 1995, EXP HEMATOL, V23, P1319; Grem JL, 2000, INVEST NEW DRUG, V18, P299, DOI 10.1023/A:1006416410198; IKEBUCHI K, 1987, P NATL ACAD SCI USA, V84, P9035, DOI 10.1073/pnas.84.24.9035; Jodrell DI, 2001, BRIT J CANCER, V84, P600, DOI 10.1054/bjoc.2000.1664; JONES AT, 1993, BLOOD, V82, P1133; Joo SS, 2004, FITOTERAPIA, V75, P337, DOI 10.1016/j.fitote.2004.02.008; Kang Xin-Mei, 2005, Zhongguo Zhong Xi Yi Jie He Za Zhi, V25, P730; Kim HJ, 2007, J VET SCI, V8, P39, DOI 10.4142/jvs.2007.8.1.39; KOIKE K, 1987, J CELL PHYSIOL, V131, P458, DOI 10.1002/jcp.1041310319; LEARY AG, 1987, BLOOD, V70, P1343; Lee DCW, 2011, MOLECULES, V16, P2802, DOI 10.3390/molecules16042802; Lee YJ, 1997, MOL CELL ENDOCRINOL, V133, P135, DOI 10.1016/S0303-7207(97)00160-3; LEONARD JP, 1994, BLOOD, V83, P1499; Leung KW, 2006, J BIOL CHEM, V281, P36280, DOI 10.1074/jbc.M606698200; Li HB, 2006, J PRACT ONCOL, V20, P18; Li WM, 2000, CYTOKINE, V12, P1017, DOI 10.1006/cyto.1999.0678; Lu XZ, 2008, ACTA PHARMACOL SIN, V29, P1209, DOI 10.1111/j.1745-7254.2008.00874.x; Lund JE., 2000, SCHALMS VET HEMATOLO, V5th ed, P44; METCALF D, 1989, NATURE, V339, P27, DOI 10.1038/339027a0; NAND S, 1994, BLOOD, V83, P357; PAQUETTE RL, 1988, BLOOD, V71, P1596; RAFII S, 1995, BLOOD, V86, P3353, DOI 10.1182/blood.V86.9.3353.bloodjournal8693353; Reya T, 1998, BLOOD, V91, P2935, DOI 10.1182/blood.V91.8.2935.2935_2935_2947; ROODMAN GD, 1987, EXP HEMATOL, V15, P928; Ryan D. H., 2001, WILLIAMS HEMATOLOGY, V6, P9; Saif M Wasif, 2005, Clin Colorectal Cancer, V5, P89, DOI 10.3816/CCC.2005.n.020; Shi AW, 2009, ACTA PHARMACOL SIN, V30, P299, DOI 10.1038/aps.2009.6; SMITH JW, 1992, J CLIN ONCOL, V10, P1141, DOI 10.1200/JCO.1992.10.7.1141; SMITH KA, 1988, SCIENCE, V240, P1169, DOI 10.1126/science.3131876; Tomiak A, 2000, AM J CLIN ONCOL-CANC, V23, P94, DOI 10.1097/00000421-200002000-00025; Vento S, 2008, LANCET ONCOL, V9, P982, DOI 10.1016/S1470-2045(08)70255-9; Voog E, 2000, J CLIN ONCOL, V18, P325, DOI 10.1200/JCO.2000.18.2.325; WINTON EF, 1994, BLOOD, V84, P65; Yance DR, 2006, INTEGR CANCER THER, V5, P9, DOI 10.1177/1534735405285562; Yun TK, 2003, MUTAT RES-FUND MOL M, V523, P63, DOI 10.1016/S0027-5107(02)00322-6; Zeuner A, 2007, CANCER RES, V67, P2007; Zhang QH, 2008, FOOD CHEM TOXICOL, V46, P293, DOI 10.1016/j.fct.2007.08.025	56	27	27	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2012	7	4							e33733	10.1371/journal.pone.0033733	http://dx.doi.org/10.1371/journal.pone.0033733			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VO	22523542	Green Published, gold, Green Submitted			2022-12-25	WOS:000305345000011
J	Hwang, YY; Barakat, AI				Hwang, Yongyun; Barakat, Abdul I.			Dynamics of Mechanical Signal Transmission through Prestressed Stress Fibers	PLOS ONE			English	Article							VASCULAR ENDOTHELIAL-CELLS; SHEAR-STRESS; LIVING CELLS; EXTRACELLULAR-MATRIX; ACTIN-FILAMENTS; ION CHANNELS; MECHANOTRANSDUCTION; INTEGRINS; MICROTUBULES; PROPAGATION	Transmission of mechanical stimuli through the actin cytoskeleton has been proposed as a mechanism for rapid long-distance mechanotransduction in cells; however, a quantitative understanding of the dynamics of this transmission and the physical factors governing it remains lacking. Two key features of the actin cytoskeleton are its viscoelastic nature and the presence of prestress due to actomyosin motor activity. We develop a model of mechanical signal transmission through prestressed viscoelastic actin stress fibers that directly connect the cell surface to the nucleus. The analysis considers both temporally stationary and oscillatory mechanical signals and accounts for cytosolic drag on the stress fibers. To elucidate the physical parameters that govern mechanical signal transmission, we initially focus on the highly simplified case of a single stress fiber. The results demonstrate that the dynamics of mechanical signal transmission depend on whether the applied force leads to transverse or axial motion of the stress fiber. For transverse motion, mechanical signal transmission is dominated by prestress while fiber elasticity has a negligible effect. Conversely, signal transmission for axial motion is mediated uniquely by elasticity due to the absence of a prestress restoring force. Mechanical signal transmission is significantly delayed by stress fiber material viscosity, while cytosolic damping becomes important only for longer stress fibers. Only transverse motion yields the rapid and long-distance mechanical signal transmission dynamics observed experimentally. For simple networks of stress fibers, mechanical signals are transmitted rapidly to the nucleus when the fibers are oriented largely orthogonal to the applied force, whereas the presence of fibers parallel to the applied force slows down mechanical signal transmission significantly. The present results suggest that cytoskeletal prestress mediates rapid mechanical signal transmission and allows temporally oscillatory signals in the physiological frequency range to travel a long distance without significant decay due to material viscosity and/or cytosolic drag.	[Hwang, Yongyun; Barakat, Abdul I.] Ecole Polytech, CNRS, Hydrodynam Lab LadHyX, Dept Mech,UMR7646, F-91128 Palaiseau, France; [Barakat, Abdul I.] Univ Calif Davis, Davis, CA 95616 USA	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); Institut Polytechnique de Paris; University of California System; University of California Davis	Hwang, YY (corresponding author), Ecole Polytech, CNRS, Hydrodynam Lab LadHyX, Dept Mech,UMR7646, F-91128 Palaiseau, France.	barakat@ladhyx.polytechnique.fr	Barakat, Abdul I/AAI-3117-2020	Barakat, Abdul I/0000-0002-7551-3631	Ecole Polytechnique through a Gaspard Monge International Scholarship; AXA Research Fund	Ecole Polytechnique through a Gaspard Monge International Scholarship; AXA Research Fund(AXA Research Fund)	YH is supported by Ecole Polytechnique through a Gaspard Monge International Scholarship. This work was funded in part by an endowment in Cardiovascular Cellular Engineering from the AXA Research Fund (http://www.axa-research.org/en/). No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barakat AI, 1999, CIRC RES, V85, P820, DOI 10.1161/01.RES.85.9.820; Barakat AI, 2006, BIOMATERIALS, V27, P671, DOI 10.1016/j.biomaterials.2005.07.036; Bewley TR, 2008, NUMERICAL RENAISSANC; Boal D. H., 2002, MECH CELL; Brangwynne CP, 2006, J CELL BIOL, V173, P733, DOI 10.1083/jcb.200601060; Chappell DC, 1998, CIRC RES, V82, P532, DOI 10.1161/01.RES.82.5.532; Chien S, 2007, AM J PHYSIOL-HEART C, V292, pH1209, DOI 10.1152/ajpheart.01047.2006; Deguchi S, 2006, J BIOMECH, V39, P2603, DOI 10.1016/j.jbiomech.2005.08.026; Fudge DS, 2003, BIOPHYS J, V85, P2015, DOI 10.1016/S0006-3495(03)74629-3; Gautam M, 2006, J BIOL CHEM, V281, P36492, DOI 10.1074/jbc.M605866200; Giannone G, 2006, TRENDS CELL BIOL, V16, P213, DOI 10.1016/j.tcb.2006.02.005; GITTES F, 1993, J CELL BIOL, V120, P923, DOI 10.1083/jcb.120.4.923; Hahn C, 2009, NAT REV MOL CELL BIO, V10, P53, DOI 10.1038/nrm2596; Helmke BP, 2002, ANN BIOMED ENG, V30, P284, DOI 10.1114/1.1467926; Howard J., 2001, MECH MOTOR PROTEINS; Howard J, 2009, ANNU REV BIOPHYS, V38, P217, DOI 10.1146/annurcv.biophys.050708.133732; Hu SH, 2005, BIOCHEM BIOPH RES CO, V329, P423, DOI 10.1016/j.bbrc.2005.02.026; Hu SH, 2004, AM J PHYSIOL-CELL PH, V287, pC1184, DOI 10.1152/ajpcell.00224.2004; Hu SH, 2003, AM J PHYSIOL-CELL PH, V285, pC1082, DOI 10.1152/ajpcell.00159.2003; Hu Shaohua, 2006, Molecular & Cellular Biomechanics, V3, P49; Inman DJ, 2001, ENG VIBRATION; Itano N, 2003, P NATL ACAD SCI USA, V100, P5181, DOI 10.1073/pnas.0531397100; Jaalouk DE, 2009, NAT REV MOL CELL BIO, V10, P63, DOI 10.1038/nrm2597; Katoh K, 1998, MOL BIOL CELL, V9, P1919, DOI 10.1091/mbc.9.7.1919; Kumar S, 2006, BIOPHYS J, V90, P3762, DOI 10.1529/biophysj.105.071506; Lieu DK, 2004, AM J PHYSIOL-CELL PH, V286, pC1367, DOI 10.1152/ajpcell.00243.2003; Lu L, 2008, BIOPHYS J, V95, P6060, DOI 10.1529/biophysj.108.133462; Ma L, 1997, NAT CELL BIOL, V3, P503; Maniotis AJ, 1997, P NATL ACAD SCI USA, V94, P849, DOI 10.1073/pnas.94.3.849; Matthews BD, 2006, J CELL SCI, V119, P508, DOI 10.1242/jcs.02760; Meyer CJ, 2000, NAT CELL BIOL, V2, P666, DOI 10.1038/35023621; Na S, 2008, P NATL ACAD SCI USA, V105, P6626, DOI 10.1073/pnas.0711704105; Prat AG, 1996, AM J PHYSIOL-CELL PH, V270, pC1532, DOI 10.1152/ajpcell.1996.270.5.C1532; Shyy JY, 2002, CIRC RES, V91, P769, DOI 10.1161/01.RES.0000038487.19924.18; Stamenovic D, 2002, AM J PHYSIOL-CELL PH, V282, pC617, DOI 10.1152/ajpcell.00271.2001; Tedgui A, 2001, CIRC RES, V88, P877, DOI 10.1161/hh0901.090440; Tzima E, 2005, NATURE, V437, P426, DOI 10.1038/nature03952; Wang N, 2005, BIOCHEM BIOPH RES CO, V328, P1133, DOI 10.1016/j.bbrc.2005.01.070; Wang N, 2001, P NATL ACAD SCI USA, V98, P7765, DOI 10.1073/pnas.141199598; Wang N, 2009, NAT REV MOL CELL BIO, V10, P75, DOI 10.1038/nrm2594; Wang YX, 2005, NATURE, V434, P1040, DOI 10.1038/nature03469; Weinbaum S, 2007, ANNU REV BIOMED ENG, V9, P121, DOI 10.1146/annurev.bioeng.9.060906.151959; WONG AJ, 1983, SCIENCE, V219, P867, DOI 10.1126/science.6681677	43	11	11	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2012	7	4							e35343	10.1371/journal.pone.0035343	http://dx.doi.org/10.1371/journal.pone.0035343			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UT	22514731	gold, Green Published			2022-12-25	WOS:000305341600136
J	Madsen, R; Banday, VS; Moritz, T; Trygg, J; Lejon, K				Madsen, Rasmus; Banday, Viqar Showkat; Moritz, Thomas; Trygg, Johan; Lejon, Kristina			Altered Metabolic Signature in Pre-Diabetic NOD Mice	PLOS ONE			English	Article							NONOBESE DIABETIC MICE; ISLET AUTOIMMUNITY; GENE-EXPRESSION; AMINO-ACID; TYPE-1; POLYMORPHISMS; CHILDREN; REGION; MOUSE; CELLS	Altered metabolism proceeding seroconversion in children progressing to Type 1 diabetes has previously been demonstrated. We tested the hypothesis that non-obese diabetic (NOD) mice show a similarly altered metabolic profile compared to C57BL/6 mice. Blood samples from NOD and C57BL/6 female mice was collected at 0, 1, 2, 3, 4, 5, 6, 7, 9, 11, 13 and 15 weeks and the metabolite content was analyzed using GC-MS. Based on the data of 89 identified metabolites OPLS-DA analysis was employed to determine the most discriminative metabolites. In silico analysis of potential involved metabolic enzymes was performed using the dbSNP data base. Already at 0 weeks NOD mice displayed a unique metabolic signature compared to C57BL/6. A shift in the metabolism was observed for both strains the first weeks of life, a pattern that stabilized after 5 weeks of age. Multivariate analysis revealed the most discriminative metabolites, which included inosine and glutamic acid. In silico analysis of the genes in the involved metabolic pathways revealed several SNPs in either regulatory or coding regions, some in previously defined insulin dependent diabetes (Idd) regions. Our result shows that NOD mice display an altered metabolic profile that is partly resembling the previously observation made in children progressing to Type 1 diabetes. The level of glutamic acid was one of the most discriminative metabolites in addition to several metabolites in the TCA cycle and nucleic acid components. The in silico analysis indicated that the genes responsible for this reside within previously defined Idd regions.	[Madsen, Rasmus; Trygg, Johan] Umea Univ, Dept Chem, Computat Life Sci Cluster CLiC, Umea, Sweden; [Banday, Viqar Showkat; Lejon, Kristina] Umea Univ, Div Immunol, Dept Clin Microbiol, Umea, Sweden; [Moritz, Thomas] Swedish Univ Agr Sci, Dept Forest Genet & Plant Physiol, Umea Plant Sci Ctr, S-90183 Umea, Sweden	Umea University; Umea University; Swedish University of Agricultural Sciences; Umea University	Madsen, R (corresponding author), Umea Univ, Dept Chem, Computat Life Sci Cluster CLiC, Umea, Sweden.	kristina.lejon@climi.umu.se		Madsen, Rasmus Bodker/0000-0001-8538-7491; Moritz, Thomas/0000-0002-4258-3190; Banday, Viqar/0000-0002-5081-2272	Kempe Foundation; Medical Faculty at Umea University; Insamlingsstiftelsen at Umea University; Magnus Bergvalls stiftelse; JDRF [1-2008-1011]; Children Diabetes Foundation in Sweden	Kempe Foundation; Medical Faculty at Umea University; Insamlingsstiftelsen at Umea University; Magnus Bergvalls stiftelse; JDRF(Juvenile Diabetes Research Foundation); Children Diabetes Foundation in Sweden	This work was supported by the Kempe Foundation, the Medical Faculty at Umea University, Insamlingsstiftelsen at Umea University, Magnus Bergvalls stiftelse, JDRF (1-2008-1011), and the Children Diabetes Foundation in Sweden. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akesson L, 2011, METABOLOMICS, P1; Andersen CM, 2010, J CHEMOMETR, V24, P728, DOI 10.1002/cem.1360; Bylesjo M, 2006, J CHEMOMETR, V20, P341, DOI 10.1002/cem.1006; Chen YG, 2011, J IMMUNOL, V186, P4278, DOI 10.4049/jimmunol.1003733; Driver JP, 2011, SEMIN IMMUNOPATHOL, V33, P67, DOI 10.1007/s00281-010-0204-1; Duan J, 2003, MOL PSYCHIATR, V8, P901, DOI 10.1038/sj.mp.4001403; Field LL, 2005, DIABETES, V54, P1588, DOI 10.2337/diabetes.54.5.1588; FLOYD JC, 1963, J CLIN INVEST, V42, P1714, DOI 10.1172/JCI104857; Fonseca SG, 2010, ISLETS, V2, P1, DOI 10.4161/isl.2.1.10456; FORSGREN S, 1991, SCAND J IMMUNOL, V34, P445, DOI 10.1111/j.1365-3083.1991.tb01567.x; Guyton AC, 2011, MEDICAL PHYSL; Jollife I. T., 2002, PRINCIPAL COMPONENT; Jonsson P, 2005, ANAL CHEM, V77, P5635, DOI 10.1021/ac050601e; Makino S, 1980, Jikken Dobutsu, V29, P1; Miller GM, 2002, MOL PSYCHIATR, V7, P44, DOI 10.1038/sj/mp/4000921; Newsholme P, 2001, J NUTR, V131, p2515S, DOI 10.1093/jn/131.9.2515S; Oresic M, 2008, J EXP MED, V205, P2975, DOI 10.1084/jem.20081800; Oskouie FG, 2011, J IMMUNOL, V186, P6798, DOI 10.4049/jimmunol.1004222; Pflueger M, 2011, DIABETES, V60, P2740, DOI 10.2337/db10-1652; Redestig H, 2009, ANAL CHEM, V81, P7974, DOI 10.1021/ac901143w; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Shoda LKM, 2005, IMMUNITY, V23, P115, DOI 10.1016/j.immuni.2005.08.002; Sysi-Aho M, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002257; TISCH R, 1993, NATURE, V366, P72, DOI 10.1038/366072a0; Todd JA, 2010, IMMUNITY, V32, P457, DOI 10.1016/j.immuni.2010.04.001; Trygg J, 2002, J CHEMOMETR, V16, P119, DOI 10.1002/cem.695; Trygg J., 2005, ANAL CHEM, V77, P8086; Trygg J, 2007, J PROTEOME RES, V6, P469, DOI 10.1021/pr060594q; Vehik K, 2011, DIABETES-METAB RES, V27, P3, DOI 10.1002/dmrr.1141; WOLD S, 1978, TECHNOMETRICS, V20, P397, DOI 10.2307/1267639	30	12	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2012	7	4							e35445	10.1371/journal.pone.0035445	http://dx.doi.org/10.1371/journal.pone.0035445			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UT	22514744	Green Submitted, Green Published, gold			2022-12-25	WOS:000305341600149
J	Seber, LE; Barnett, BW; McConnell, EJ; Hume, SD; Cai, J; Boles, K; Davis, KR				Seber, Lauren E.; Barnett, Brian W.; McConnell, Elizabeth J.; Hume, Steven D.; Cai, Jian; Boles, Kati; Davis, Keith R.			Scalable Purification and Characterization of the Anticancer Lunasin Peptide from Soybean	PLOS ONE			English	Article							CORE HISTONE ACETYLATION; AMINO-ACID-SEQUENCE; SEED PEPTIDE; GLYCINE-MAX; CANCER; CELLS; PROTEIN; EXPRESSION; ACTIVATION; INHIBITOR	Lunasin is a peptide derived from the soybean 2S albumin seed protein that has both anticancer and anti-inflammatory activities. Large-scale animal studies and human clinical trials to determine the efficacy of lunasin in vivo have been hampered by the cost of synthetic lunasin and the lack of a method for obtaining gram quantities of highly purified lunasin from plant sources. The goal of this study was to develop a large-scale method to generate highly purified lunasin from defatted soy flour. A scalable method was developed that utilizes the sequential application of anion-exchange chromatography, ultrafiltration, and reversed-phase chromatography. This method generates lunasin preparations of >99% purity with a yield of 442 mg/kg defatted soy flour. Mass spectrometry of the purified lunasin revealed that the peptide is 44 amino acids in length and represents the original published sequence of lunasin with an additional C-terminal asparagine residue. Histone-binding assays demonstrated that the biological activity of the purified lunasin was similar to that of synthetic lunasin. This study provides a robust method for purifying commercial-scale quantities of biologically-active lunasin and clearly identifies the predominant form of lunasin in soy flour. This method will greatly facilitate the development of lunasin as a potential nutraceutical or therapeutic anticancer agent.	[Seber, Lauren E.; Davis, Keith R.] Univ Louisville, James Graham Brown Canc Ctr, Louisville, KY 40292 USA; [Seber, Lauren E.; Barnett, Brian W.; McConnell, Elizabeth J.; Boles, Kati; Davis, Keith R.] Owensboro Canc Res Program, Owensboro, KY USA; [Hume, Steven D.] Kentucky BioProc LLC, Owensboro, KY USA; [Cai, Jian; Davis, Keith R.] Univ Louisville, Dept Pharmacol & Toxicol, Louisville, KY 40292 USA	University of Louisville; University of Louisville	Seber, LE (corresponding author), Univ Louisville, James Graham Brown Canc Ctr, Louisville, KY 40292 USA.	keith.davis@louisville.edu	Davis, Keith R/C-5623-2009; Davis, Keith/H-3242-2019	Davis, Keith R/0000-0002-7432-8610; Davis, Keith/0000-0002-7432-8610	Kentucky Soybean Promotion Board; Owensboro Grain Company, LLC; United States Army Medical Research & Materiel Command; Telemedicine & Advanced Technology Research Center [W81XWH-09-2-0022]	Kentucky Soybean Promotion Board; Owensboro Grain Company, LLC; United States Army Medical Research & Materiel Command; Telemedicine & Advanced Technology Research Center	This research and development project was made possible by funds provided by the Kentucky Soybean Promotion Board (www.kysoy.org), Owensboro Grain Company, LLC (www.owensborograin.com), and a contract that was awarded and administered by the United States Army Medical Research & Materiel Command and the Telemedicine & Advanced Technology Research Center (www.tatrc.org/), under Contract Number: W81XWH-09-2-0022. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The views, opinions and/or findings contained in this research are those of the authors and do not necessarily reflect the views of the Department of Defense and should not be construed as an official Department of Defense/Army position, policy or decision unless so designated by other documentation. No official endorsement should be made.	AMPE C, 1986, EUR J BIOCHEM, V159, P597, DOI 10.1111/j.1432-1033.1986.tb09926.x; de Lumen BO, 2005, NUTR REV, V63, P16, DOI [10.1301/nr.2004.janr.16-21, 10.1111/j.1753-4887.2005.tb00106.x]; De Mejia EG, 2004, J AGR FOOD CHEM, V52, P5882, DOI 10.1021/jf0496752; de Mejia EG, 2009, PEPTIDES, V30, P2388, DOI 10.1016/j.peptides.2009.08.005; de Mejia EG, 2010, MOL NUTR FOOD RES, V54, P406, DOI 10.1002/mnfr.200900073; DEMEJIA E, 2006, SEXUALITY REPROD MEN, V4, P91; Dia VP, 2009, FOOD CHEM, V114, P108, DOI 10.1016/j.foodchem.2008.09.023; Dia VP, 2011, CANCER LETT, V313, P167, DOI 10.1016/j.canlet.2011.09.002; Dia VP, 2011, PEPTIDES, V32, P1979, DOI 10.1016/j.peptides.2011.09.009; Dia VP, 2011, MOL NUTR FOOD RES, V55, P623, DOI 10.1002/mnfr.201000419; Dia VP, 2010, CANCER LETT, V295, P44, DOI 10.1016/j.canlet.2010.02.010; Dia VP, 2008, J AGR FOOD CHEM, V56, P11707, DOI 10.1021/jf802475z; ERICSON ML, 1986, J BIOL CHEM, V261, P4576; Galvez AF, 2001, CANCER RES, V61, P7473; Galvez AF, 1999, NAT BIOTECHNOL, V17, P495, DOI 10.1038/8676; Galvez AF, 2011, NUTR CANCER, V63, P623, DOI 10.1080/01635581.2011.539312; Hernandez-Ledesma B, 2011, MOL NUTR FOOD RES, V55, P989, DOI 10.1002/mnfr.201000632; Hernandez-Ledesma B, 2009, BIOCHEM BIOPH RES CO, V390, P803, DOI 10.1016/j.bbrc.2009.10.053; Hernandez-Ledesma B, 2009, PEPTIDES, V30, P426, DOI 10.1016/j.peptides.2008.11.002; Hsieh CC, 2010, CHEM-BIOL INTERACT, V186, P127, DOI 10.1016/j.cbi.2010.04.027; Hsieh CC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008890; Jeong HJ, 2003, J AGR FOOD CHEM, V51, P7901, DOI 10.1021/jf034460y; Jeong HJ, 2002, J AGR FOOD CHEM, V50, P5903, DOI 10.1021/jf0256945; Jeong HJ, 2007, CANCER LETT, V255, P42, DOI 10.1016/j.canlet.2007.03.022; Jeong HJ, 2007, J AGR FOOD CHEM, V55, P632, DOI 10.1021/jf062405u; Jeong JB, 2007, J AGR FOOD CHEM, V55, P10707, DOI 10.1021/jf072363p; Jeong JB, 2010, CANCER LETT, V293, P58, DOI 10.1016/j.canlet.2009.12.019; KREBBERS E, 1988, PLANT PHYSIOL, V87, P859, DOI 10.1104/pp.87.4.859; Lam Y, 2003, NUTR CANCER, V47, P88, DOI 10.1207/s15327914nc4701_11; Lin J, 2004, BBA-PROTEINS PROTEOM, V1698, P203, DOI 10.1016/j.bbapap.2003.12.001; Maldonado-Cervantes E, 2010, PEPTIDES, V31, P1635, DOI 10.1016/j.peptides.2010.06.014; ODANI S, 1987, J BIOL CHEM, V262, P10502; Omoni AO, 2005, NUTR REV, V63, P272, DOI 10.1111/j.1753-4887.2005.tb00141.x; Silva-Sanchez C, 2008, J AGR FOOD CHEM, V56, P1233, DOI 10.1021/jf072911z; Wang WY, 2008, J AOAC INT, V91, P936	35	40	43	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2012	7	4							e35409	10.1371/journal.pone.0035409	http://dx.doi.org/10.1371/journal.pone.0035409			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UT	22514740	gold, Green Published, Green Submitted			2022-12-25	WOS:000305341600145
J	Galeano, F; Rossetti, C; Tomaselli, S; Cifaldi, L; Lezzerini, M; Pezzullo, M; Boldrini, R; Massimi, L; Di Rocco, CM; Locatelli, F; Gallo, A				Galeano, F.; Rossetti, C.; Tomaselli, S.; Cifaldi, L.; Lezzerini, M.; Pezzullo, M.; Boldrini, R.; Massimi, L.; Di Rocco, C. M.; Locatelli, F.; Gallo, A.			ADAR2-editing activity inhibits glioblastoma growth through the modulation of the CDC14B/Skp2/p21/p27 axis	ONCOGENE			English	Article						RNA editing; ADAR2; GBM; cell cycle; CDC14B	TO-INOSINE RNA; MESSENGER-RNA; DOWN-REGULATION; EDITING SITES; CELL-CYCLE; SKP2; ENZYME; P21; IDENTIFICATION; HYBRIDIZATION	Grade IV astrocytoma or glioblastoma multiforme (GBM) is one of the most aggressive and lethal tumors affecting humans. ADAR2-mediated A-to-I RNA editing, an essential post-transcriptional modification event in brain, is impaired in GBMs and astrocytoma cell lines. However, the role of ADAR2 editing in astrocytomas remains to be defined. Here, we show that ADAR2 editing rescue in astrocytomas prevents tumor growth in vivo and modulates an important cell cycle pathway involving the Skp2/p21/p27 proteins, often altered in glioblastoma. We demonstrate that ADAR2 deaminase activity is essential to inhibit tumor growth. Indeed, we identify the phosphatase CDC14B, which acts upstream of the Skp2/p21/p27 pathway, as a novel and critical ADAR2 target gene involved in glioblastonna growth. Specifically, ADAR2-mediated editing on CDC14B pre-mRNA increases its expression with a consequent reduction of the Skp2 target protein, as shown both in vitro and in vivo. We found that, compared to normal brain, both CDC14B editing and expression are progressively impaired in astrocytomas from grade I to IV, being very low in GBMs. These findings (1) demonstrate that post-transcriptional A-to-I RNA editing might be crucial for glioblastoma pathogenesis, (2) identify ADAR2-editing enzyme as a novel candidate tumor suppressor gene and (3) provide proof of principle that ADAR2 or its substrates may represent a suitable target(s) for possible novel, more effective and less toxic approaches to the treatment of GBMs. Oncogene (2013) 32, 998-1009; doi:10.1038/onc.2012.125; published online 23 April 2012	[Galeano, F.; Rossetti, C.; Tomaselli, S.; Cifaldi, L.; Lezzerini, M.; Pezzullo, M.; Boldrini, R.; Locatelli, F.; Gallo, A.] IRCCS, Osped Pediat Bambino Gesu, Oncohaematol Dept, Lab RNA Editing, I-00165 Rome, Italy; [Massimi, L.; Di Rocco, C. M.] Policlin Gemelli, Pediat Neurosurg Dept, Rome, Italy; [Locatelli, F.] Univ Pavia, Oncohaematol Dept, I-27100 Pavia, Italy	IRCCS Bambino Gesu; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; University of Pavia	Gallo, A (corresponding author), IRCCS, Osped Pediat Bambino Gesu, Oncohaematol Dept, Lab RNA Editing, Piazza S Onofrio 4, I-00165 Rome, Italy.	angela.gallo@opbg.net	Gallo, Angela/E-7837-2011; Gallo, Angela/AAA-5003-2020; Pezzullo, Marco/AAI-2404-2019; Cifaldi, Loredana/AAI-1972-2019	Gallo, Angela/0000-0003-0297-1807; Gallo, Angela/0000-0003-0297-1807; Cifaldi, Loredana/0000-0001-5014-430X	Associazione Italiana per la Ricerca sul Cancro (AIRC, Milan, Italy); AIRC	Associazione Italiana per la Ricerca sul Cancro (AIRC, Milan, Italy)(Fondazione AIRC per la ricerca sul cancro); AIRC(Fondazione AIRC per la ricerca sul cancro)	This study was supported by the Associazione Italiana per la Ricerca sul Cancro (AIRC, Milan, Italy) grant to A Gallo and a special project 5 x 1000 AIRC grant to F Locatelli. The authors are grateful to Genevieve Rodier for the CDC14B clones, to Alekos Athanasiadis and to Ernesto Picardi for bioinformatics support and to Mattia Locatelli for statistical analysis.	Abukhdeir Abde M., 2008, Expert Reviews in Molecular Medicine, V10, P1, DOI 10.1017/S1462399408000744; Athanasiadis A, 2004, PLOS BIOL, V2, P2144, DOI 10.1371/journal.pbio.0020391; BASILIO C, 1962, P NATL ACAD SCI USA, V48, P613, DOI 10.1073/pnas.48.4.613; Bass BL, 2002, ANNU REV BIOCHEM, V71, P817, DOI 10.1146/annurev.biochem.71.110601.135501; Bassermann F, 2008, CELL, V134, P256, DOI 10.1016/j.cell.2008.05.043; Cenci C, 2008, J BIOL CHEM, V283, P7251, DOI 10.1074/jbc.M708316200; Chen LL, 2008, CELL CYCLE, V7, P3294, DOI 10.4161/cc.7.21.6927; Chiarle R, 2002, AM J PATHOL, V160, P1457, DOI 10.1016/S0002-9440(10)62571-0; Chiesa M, 2011, CELL CYCLE, V10, P1607, DOI 10.4161/cc.10.10.15566; Colman H, 2010, NEURO-ONCOLOGY, V12, P49, DOI 10.1093/neuonc/nop007; Coqueret O, 2003, TRENDS CELL BIOL, V13, P65, DOI 10.1016/S0962-8924(02)00043-0; DENG CX, 1995, CELL, V82, P675, DOI 10.1016/0092-8674(95)90039-X; Dominissini D, 2011, CARCINOGENESIS, V32, P1569, DOI 10.1093/carcin/bgr124; Farajollahi S, 2010, TRENDS GENET, V26, P221, DOI 10.1016/j.tig.2010.02.001; Galeano F, 2010, INT J CANCER, V127, P127, DOI 10.1002/ijc.25022; Gallo A, 2003, EMBO J, V22, P3421, DOI 10.1093/emboj/cdg327; Gallo A, 2011, BIOL REV CAMB PHILOS, V87, P95, DOI DOI 10.1111/J.1469-185X.2011.00186.X; Greenberger S, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-608; Greger IH, 2002, NEURON, V34, P759, DOI 10.1016/S0896-6273(02)00693-1; Halfter H, 2006, CANCER RES, V66, P6530, DOI 10.1158/0008-5472.CAN-04-3734; Heale BSE, 2009, EMBO J, V28, P3145, DOI 10.1038/emboj.2009.244; Hershko DD, 2008, CANCER-AM CANCER SOC, V112, P1415, DOI 10.1002/cncr.23317; Higuchi M, 2000, NATURE, V406, P78, DOI 10.1038/35017558; Ishiuchi S, 2002, NAT MED, V8, P971, DOI 10.1038/nm746; Jackson RJ, 2003, CANCER RES, V63, P3021; Keegan LP, 2001, NAT REV GENET, V2, P869, DOI 10.1038/35098584; Kiran A, 2010, BIOINFORMATICS, V26, P1772, DOI 10.1093/bioinformatics/btq285; Kitagawa K, 2009, CANCER SCI, V100, P1374, DOI 10.1111/j.1349-7006.2009.01196.x; KLEIHUES P, 1993, BRAIN PATHOL, V3, P255, DOI 10.1111/j.1750-3639.1993.tb00752.x; Kwon CH, 2008, CANCER RES, V68, P3286, DOI 10.1158/0008-5472.CAN-07-6867; LAI F, 1995, J BIOL CHEM, V270, P17098, DOI 10.1074/jbc.270.29.17098; Lee SH, 2005, J MOL MED, V83, P296, DOI 10.1007/s00109-004-0611-7; Levanon EY, 2004, NAT BIOTECHNOL, V22, P1001, DOI 10.1038/nbt996; Li JB, 2009, SCIENCE, V324, P1210, DOI 10.1126/science.1170995; Maas S, 2001, P NATL ACAD SCI USA, V98, P14687, DOI 10.1073/pnas.251531398; Macbeth MR, 2005, SCIENCE, V309, P1534, DOI 10.1126/science.1113150; Maher EA, 2001, GENE DEV, V15, P1311, DOI 10.1101/gad.891601; Martin-Caballero J, 2004, ONCOGENE, V23, P8231, DOI 10.1038/sj.onc.1207863; Nakayama KI, 2005, SEMIN CELL DEV BIOL, V16, P323, DOI 10.1016/j.semcdb.2005.02.010; Nishikura K, 2004, NAT BIOTECHNOL, V22, P962, DOI 10.1038/nbt0804-962; Nishikura K, 2006, NAT REV MOL CELL BIO, V7, P919, DOI 10.1038/nrm2061; Nishikura K, 2010, ANNU REV BIOCHEM, V79, P321, DOI 10.1146/annurev-biochem-060208-105251; Ohlson J, 2007, RNA, V13, P698, DOI 10.1261/rna.349107; Paul MS, 1998, EMBO J, V17, P1120, DOI 10.1093/emboj/17.4.1120; Paz N, 2007, GENOME RES, V17, P1586, DOI 10.1101/gr.6493107; Picardi E, 2011, BIOINFORMATICS, V27, P1311, DOI 10.1093/bioinformatics/btr117; Rodier G, 2008, EMBO J, V27, P679, DOI 10.1038/emboj.2008.6; Rueter SM, 1999, NATURE, V399, P75, DOI 10.1038/19992; Saigusa K, 2005, CANCER SCI, V96, P676, DOI 10.1111/j.1349-7006.2005.00099.x; Schiffer D, 2002, NEUROSCI LETT, V328, P125, DOI 10.1016/S0304-3940(02)00483-4; Seeburg PH, 1998, BRAIN RES REV, V26, P217, DOI 10.1016/S0165-0173(97)00062-3; Seeburg PH, 2002, NEURON, V35, P17, DOI 10.1016/S0896-6273(02)00760-2; Stupp Roger, 2005, Curr Neurol Neurosci Rep, V5, P198, DOI 10.1007/s11910-005-0047-7; Tumurbaatar I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014711; Wahlstedt H, 2009, GENOME RES, V19, P978, DOI 10.1101/gr.089409.108; Yang L, 2010, FASEB J, V24, P3720, DOI 10.1096/fj.09-152363; Zhu Y, 2005, CANCER CELL, V8, P119, DOI 10.1016/j.ccr.2005.07.004; Zhu YA, 2002, NAT REV CANCER, V2, P616, DOI 10.1038/nrc866; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	59	95	100	1	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 21	2013	32	8					998	1009		10.1038/onc.2012.125	http://dx.doi.org/10.1038/onc.2012.125			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	111LQ	22525274	Green Published, hybrid			2022-12-25	WOS:000316523200007
J	Wu, S; Dole, K; Hong, F; Noman, AM; Issacs, J; Liu, B; Li, ZH				Wu, Shuang; Dole, Krystal; Hong, Feng; Noman, Abu Shadat M.; Issacs, Jennifer; Liu, Bei; Li, Zihai			Chaperone gp96-independent Inhibition of Endotoxin Response by Chaperone-based Peptide Inhibitors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TOLL-LIKE RECEPTORS; SHOCK-PROTEIN GP96; CELL-SURFACE; BACTERIAL LIPOPOLYSACCHARIDE; CRYSTAL-STRUCTURE; HSP90; CANCER; IMMUNITY; COMPLEX; TOLL-LIKE-RECEPTOR-4	HSP90 chaperones a large number of proteins, and it plays essential roles in multiple signaling pathways to maintain protein homeostasis in the cytosol. In addition, HSP90 has been implicated in mediating recognition of lipopolysaccharide (LPS). However, no pharmacologic agents have been developed to interrogate this pathway. Herein we demonstrate that a peptide-based inhibitor that was previously reported to inhibit the master Toll-like receptor-chaperone gp96, an endoplasmic reticulum paralog of HSP90, in fact blocks HSP90-LPS interaction. It inhibited the binding of LPS to the cell surface of both wild type and gp96-null cells and thereby abrogated the cellular response to LPS but not to other Toll-like receptor ligands. We also generated a series of peptide derivatives (named peptide inhibitors of endotoxin responsiveness (PIERs)) from the N-terminal helix structure of HSP90 and demonstrated their effectiveness in blocking LPS activity. PIER inhibition of LPS signaling was partially reversed by CD14 expression. Moreover, we found that a cell-permeable PIER abrogated HSP90 function and caused degradation of multiple known HSP90 client proteins in cancer cells. Thus, targeting HSP90 is a promising modality for treatment of both LPS-mediated pathology and cancer.	[Li, Zihai] Med Univ S Carolina, Hollings Canc Ctr, Dept Microbiol & Immunol, Charleston, SC 29425 USA; [Dole, Krystal; Issacs, Jennifer] Med Univ S Carolina, Dept Cell & Mol Pharmacol & Expt Therapeut, Charleston, SC 29425 USA	Medical University of South Carolina; Medical University of South Carolina	Li, ZH (corresponding author), Med Univ S Carolina, Hollings Canc Ctr, Dept Microbiol & Immunol, Charleston, SC 29425 USA.	zihai@musc.edu			National Institutes of Health [AI070603, AI077283]; Hollings Cancer Center at the Medical University of South Carolina [P30 CA138313]; NATIONAL CANCER INSTITUTE [P30CA138313] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI070603, R01AI077283] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Hollings Cancer Center at the Medical University of South Carolina; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants AI070603 and AI077283 (to Z. L.) and P30 CA138313 (a pilot research grant from the Hollings Cancer Center at the Medical University of South Carolina).	Ali MMU, 2006, NATURE, V440, P1013, DOI 10.1038/nature04716; Beutler B, 2003, NAT REV IMMUNOL, V3, P169, DOI 10.1038/nri1004; Byrd CA, 1999, P NATL ACAD SCI USA, V96, P5645, DOI 10.1073/pnas.96.10.5645; Dollins DE, 2007, MOL CELL, V28, P41, DOI 10.1016/j.molcel.2007.08.024; ERKELLERYUKSEL FM, 1992, J AUTOIMMUN, V5, P803, DOI 10.1016/0896-8411(92)90194-U; Eustace BK, 2004, NAT CELL BIOL, V6, P507, DOI 10.1038/ncb1131; Gopal U, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017649; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; Gupta D, 1996, J BIOL CHEM, V271, P23310, DOI 10.1074/jbc.271.38.23310; Horng T, 2002, NATURE, V420, P329, DOI 10.1038/nature01180; Kagan JC, 2008, NAT IMMUNOL, V9, P361, DOI 10.1038/ni1569; Kagan JC, 2006, CELL, V125, P943, DOI 10.1016/j.cell.2006.03.047; Kamal A, 2003, NATURE, V425, P407, DOI 10.1038/nature01913; Kampinga HH, 2009, CELL STRESS CHAPERON, V14, P105, DOI 10.1007/s12192-008-0068-7; Kawai T, 2011, IMMUNITY, V34, P637, DOI 10.1016/j.immuni.2011.05.006; Kim HM, 2007, CELL, V130, P906, DOI 10.1016/j.cell.2007.08.002; Kliger Y, 2009, P NATL ACAD SCI USA, V106, P13797, DOI 10.1073/pnas.0906514106; Liu B, 2003, P NATL ACAD SCI USA, V100, P15824, DOI 10.1073/pnas.2635458100; Liu B, 2008, BLOOD, V112, P1223, DOI 10.1182/blood-2008-03-143107; Liu B, 2006, J IMMUNOL, V177, P6880, DOI 10.4049/jimmunol.177.10.6880; Liu B, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1070; Montanari P, 2012, CELL MICROBIOL, V14, P368, DOI 10.1111/j.1462-5822.2011.01722.x; Morales C, 2009, J IMMUNOL, V183, P5121, DOI 10.4049/jimmunol.0900811; Pearl LH, 2006, ANNU REV BIOCHEM, V75, P271, DOI 10.1146/annurev.biochem.75.103004.142738; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Poulaki V, 2007, FASEB J, V21, P2113, DOI 10.1096/fj.06-7637com; Randow F, 2001, NAT CELL BIOL, V3, P891, DOI 10.1038/ncb1001-891; Rice JW, 2008, ARTHRITIS RHEUM-US, V58, P3765, DOI 10.1002/art.24047; Shin BK, 2003, J BIOL CHEM, V278, P7607, DOI 10.1074/jbc.M210455200; Sidera K, 2008, CELL CYCLE, V7, P1564, DOI 10.4161/cc.7.11.6054; TOBIAS PS, 1988, J BIOL CHEM, V263, P13479; Trepel J, 2010, NAT REV CANCER, V10, P537, DOI 10.1038/nrc2887; Triantafilou K, 2001, J CELL SCI, V114, P2535; Triantafilou K, 2001, HUM IMMUNOL, V62, P50, DOI 10.1016/S0198-8859(00)00222-6; Triantafilou K, 2001, NAT IMMUNOL, V2, P338, DOI 10.1038/86342; Triantafilou M, 2004, BIOCHEM SOC T, V32, P636, DOI 10.1042/BST0320636; Triantafilou M, 2008, NOVART FDN SYMP, V291, P79; Triantafilou M, 2008, NOVART FDN SYMP, V291, P137; Triantafilou Martha, 2008, Novartis Found Symp, V291, P74; Tsutsumi S, 2008, ONCOGENE, V27, P2478, DOI 10.1038/sj.onc.1210897; Usmani SZ, 2009, CURR MOL MED, V9, P654, DOI 10.2174/156652409788488757; Whitesell L, 2005, NAT REV CANCER, V5, P761, DOI 10.1038/nrc1716; Yang Y, 2007, IMMUNITY, V26, P215, DOI 10.1016/j.immuni.2006.12.005; Yun TJ, 2011, J IMMUNOL, V186, P563, DOI 10.4049/jimmunol.1000222; Zhao RM, 2005, CELL, V120, P715, DOI 10.1016/j.cell.2004.12.024	45	9	9	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 8	2012	287	24					19896	19903		10.1074/jbc.M112.343848	http://dx.doi.org/10.1074/jbc.M112.343848			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974FB	22532561	hybrid, Green Published			2022-12-25	WOS:000306414500012
J	Xue, J; Lv, DD; Jiao, S; Zhao, WT; Li, XB; Sun, H; Yan, B; Fan, L; Hu, RG; Fang, J				Xue, Jing; Lv, Dan-dan; Jiao, Shi; Zhao, Wenting; Li, Xuebing; Sun, Heng; Yan, Bing; Fan, Li; Hu, Rong-gui; Fang, Jing			pVHL Mediates K63-Linked Ubiquitination of nCLU	PLOS ONE			English	Article							LINDAU TUMOR-SUPPRESSOR; PROLINE HYDROXYLATION; PROTEIN-KINASE; HIF-ALPHA; CLUSTERIN; UBIQUITYLATION; COMPONENT; COMPLEX; FATE	pVHL, product of von Hippel-Lindau (VHL) tumor suppressor gene, functions as the substrate recognition component of an E3-ubiquitin ligase that targets proteins for ubiquitination and proteasomal degradation. Hypoxia-inducible factor alpha (HIF alpha) is the well-known substrate of pVHL. Besides HIF alpha, pVHL also binds to many other proteins and has multiple functions. In this manuscript, we report that the nuclear clusterin (nCLU) is a target of pVHL. We found that pVHL had a direct interaction with nCLU. nCLU bound to pVHL at pVHL's beta domain, the site for recognition of substrate, indicating that nCLU might be a substrate of pVHL. Interestingly, pVHL bound to nCLU but did not lead to nCLU destruction. Further studies indicated that pVHL mediated K63-linked ubiquitination of nCLU and promoted nCLU nuclear translocation. In summary, our results disclose a novel function of pVHL that mediates K63-linked ubiquitination and identify nCLU as a new target of pVHL.	[Xue, Jing; Lv, Dan-dan; Jiao, Shi; Zhao, Wenting; Li, Xuebing; Sun, Heng; Yan, Bing; Fan, Li; Fang, Jing] Chinese Acad Sci, SIBS, Inst Nutr Sci, Key Lab Nutr & Metab, Shanghai, Peoples R China; [Hu, Rong-gui] Chinese Acad Sci, SIBS, Inst Biochem & Cell Biol, Shanghai, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Fang, J (corresponding author), Chinese Acad Sci, SIBS, Inst Nutr Sci, Key Lab Nutr & Metab, Shanghai, Peoples R China.	jfang@sibs.ac.cn	Yan, Binghua/ACD-0393-2022	Yan, Binghua/0000-0003-3255-6559	National Natural Science Foundation of China [30970586]; Chinese Academy of Sciences [KSCX2-EW-R-08]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences(Chinese Academy of Sciences)	The work was supported by National Natural Science Foundation of China (30970586)(http://www.nsfc.gov.cn); Chinese Academy of Sciences (KSCX2-EW-R-08). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bettuzzi S, 2009, ADV CANCER RES, V104, P59, DOI 10.1016/S0065-230X(09)04005-6; Bhoj VG, 2009, NATURE, V458, P430, DOI 10.1038/nature07959; Chitalia VC, 2008, NAT CELL BIOL, V10, P1208, DOI 10.1038/ncb1781; Czyzyk-Krzeska MF, 2004, TRENDS MOL MED, V10, P146, DOI 10.1016/j.molmed.2004.02.004; DESILVA HV, 1990, BIOCHEMISTRY-US, V29, P5380, DOI 10.1021/bi00474a025; Frew IJ, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.124pe30; Geetha T, 2005, EMBO J, V24, P3859, DOI 10.1038/sj.emboj.7600845; Grosfeld A, 2007, J BIOL CHEM, V282, P13264, DOI 10.1074/jbc.M611648200; Ivan M, 2001, SCIENCE, V292, P464, DOI 10.1126/science.1059817; Iwai K, 1999, P NATL ACAD SCI USA, V96, P12436, DOI 10.1073/pnas.96.22.12436; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Kaelin WG, 2008, NAT REV CANCER, V8, P865, DOI 10.1038/nrc2502; Kaelin WG, 2007, ANNU REV PATHOL-MECH, V2, P145, DOI 10.1146/annurev.pathol.2.010506.092049; Kamura T, 1999, SCIENCE, V284, P657, DOI 10.1126/science.284.5414.657; Kim WY, 2004, J CLIN ONCOL, V22, P4991, DOI 10.1200/JCO.2004.05.061; Klock G, 2009, ADV CANCER RES, V104, P115, DOI 10.1016/S0065-230X(09)04007-X; Kuznetsova AV, 2003, P NATL ACAD SCI USA, V100, P2706, DOI 10.1073/pnas.0436037100; Leskov KS, 2003, J BIOL CHEM, V278, P11590, DOI 10.1074/jbc.M209233200; Lisztwan J, 1999, GENE DEV, V13, P1822, DOI 10.1101/gad.13.14.1822; Nakamura E, 2006, AM J PATHOL, V168, P574, DOI 10.2353/ajpath.2006.050867; Nath D, 2009, NATURE, V458, P421, DOI 10.1038/458421a; Ohh M, 1998, MOL CELL, V1, P959, DOI 10.1016/S1097-2765(00)80096-9; Okuda H, 2001, J BIOL CHEM, V276, P43611, DOI 10.1074/jbc.M107880200; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Pucci S, 2004, ONCOGENE, V23, P2298, DOI 10.1038/sj.onc.1207404; Rizzi F, 2009, J CELL PHYSIOL, V219, P314, DOI 10.1002/jcp.21671; Schofield CJ, 2004, NAT REV MOL CELL BIO, V5, P343, DOI 10.1038/nrm1366; Shannan B, 2006, CELL DEATH DIFFER, V13, P12, DOI 10.1038/sj.cdd.4401779; van Wijk SJL, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.55; Wu CJ, 2006, NAT CELL BIOL, V8, P398, DOI 10.1038/ncb1384; Xue J, 2010, GASTROENTEROLOGY, V138, P606, DOI 10.1053/j.gastro.2009.09.049; Yang H, 2007, MOL CELL, V28, P15, DOI 10.1016/j.molcel.2007.09.010; Yang WL, 2010, ONCOGENE, V29, P4493, DOI 10.1038/onc.2010.190	33	15	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2012	7	4							e35848	10.1371/journal.pone.0035848	http://dx.doi.org/10.1371/journal.pone.0035848			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UD	22532874	Green Published, gold, Green Submitted			2022-12-25	WOS:000305339200118
J	Yang, HC; Chang, LC; Liang, YJ; Lin, CH; Wang, PL				Yang, Hsin-Chou; Chang, Lun-Ching; Liang, Yu-Jen; Lin, Chien-Hsing; Wang, Pei-Li			A Genome-Wide Homozygosity Association Study Identifies Runs of Homozygosity Associated with Rheumatoid Arthritis in the Human Major Histocompatibility Complex	PLOS ONE			English	Article							SINGLE-NUCLEOTIDE POLYMORPHISMS; RECENT POSITIVE SELECTION; EXTENDED TRACTS; RISK LOCUS; SUSCEPTIBILITY; GENE; HETEROZYGOSITY; DISEASE; PTPN22; COMMON	Rheumatoid arthritis (RA) is a chronic inflammatory disorder with a polygenic mode of inheritance. This study examined the hypothesis that runs of homozygosity (ROHs) play a recessive-acting role in the underlying RA genetic mechanism and identified RA-associated ROHs. Ours is the first genome-wide homozygosity association study for RA and characterized the ROH patterns associated with RA in the genomes of 2,000 RA patients and 3,000 normal controls of the Wellcome Trust Case Control Consortium. Genome scans consistently pinpointed two regions within the human major histocompatibility complex region containing RA-associated ROHs. The first region is from 32,451,664 bp to 32,846,093 bp (-log10(p)>22.6591). RA-susceptibility genes, such as HLA-DRB1, are contained in this region. The second region ranges from 32,933,485 bp to 33,585,118 bp (-log10(p)>8.3644) and contains other HLA-DPA1 and HLA-DPB1 genes. These two regions are physically close but are located in different blocks of linkage disequilibrium, and similar to 40% of the RA patients' genomes carry these ROHs in the two regions. By analyzing homozygote intensities, an ROH that is anchored by the single nucleotide polymorphism rs2027852 and flanked by HLA-DRB6 and HLA-DRB1 was found associated with increased risk for RA. The presence of this risky ROH provides a 62% accuracy to predict RA disease status. An independent genomic dataset from 868 RA patients and 1,194 control subjects of the North American Rheumatoid Arthritis Consortium successfully validated the results obtained using the Wellcome Trust Case Control Consortium data. In conclusion, this genome-wide homozygosity association study provides an alternative to allelic association mapping for the identification of recessive variants responsible for RA. The identified RA-associated ROHs uncover recessive components and missing heritability associated with RA and other autoimmune diseases.	[Yang, Hsin-Chou; Chang, Lun-Ching; Liang, Yu-Jen; Wang, Pei-Li] Acad Sinica, Inst Stat Sci, Taipei 11529, Taiwan; [Liang, Yu-Jen] Natl Taiwan Univ, Grad Inst Biomed Elect & Bioinformat, Taipei 10764, Taiwan; [Lin, Chien-Hsing] Natl Hlth Res Inst, Div Mol & Genom Med, Miaoli Cty, Taiwan	Academia Sinica - Taiwan; National Taiwan University; National Health Research Institutes - Taiwan	Yang, HC (corresponding author), Acad Sinica, Inst Stat Sci, Taipei 11529, Taiwan.	hsinchou@stat.sinica.edu.tw	Yang, Hsin-Chou/AAP-2547-2021	Yang, Hsin-Chou/0000-0001-6853-7881	National Science Council of Taiwan [NSC 97-2314-B-001-006-MY3, NSC 100-2314B-001-005-MY3]; National Research Program for Genomic Medicine [NSC 97-3112-B-001-027, NSC 98-3112-B-001-013, NSC 99-3112-B-001-009, NSC 99-3112-B-001029]; Academia Sinica [AS-100-CDA-M03]; Wellcome Trust [079113]; National Institutes of Health [N01-AR-2-2263, R01-AR-44422]; National Arthritis Foundation; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR044422, N01AR022263] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM031575] Funding Source: NIH RePORTER	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan); National Research Program for Genomic Medicine(Ministry of Science and Technology, Taiwan); Academia Sinica(Academia Sinica - Taiwan); Wellcome Trust(Wellcome Trust); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Arthritis Foundation; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The work was supported by a National Science Council of Taiwan grant (NSC 97-2314-B-001-006-MY3, NSC 100-2314B-001-005-MY3), by grants from the National Research Program for Genomic Medicine (NSC 97-3112-B-001-027, NSC 98-3112-B-001-013, NSC 99-3112-B-001-009, and NSC 99-3112-B-001029), and the Career Development Award of Academia Sinica (AS-100-CDA-M03). This study made use of data generated by the Wellcome Trust Case Control Consortium. A full list of the investigators who contributed to the generation of the data is available at www.wtccc.org.uk. The Wellcome Trust (Award 079113) provided funding for that project. This study also made use of data provided by Genetic Analysis Workshop 16 (R01 GM031575) and gathered with the support of grants from the National Institutes of Health (N01-AR-2-2263 and R01-AR-44422) and the National Arthritis Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alamanos Y, 2005, AUTOIMMUN REV, V4, P130, DOI 10.1016/j.autrev.2004.09.002; ALBANI S, 1995, NAT MED, V1, P448, DOI 10.1038/nm0595-448; Barton A, 2008, NAT GENET, V40, P1156, DOI 10.1038/ng.218; Baschal EE, 2009, CLIN IMMUNOL, V132, P203, DOI 10.1016/j.clim.2009.03.530; BEGOVICH AB, 1989, P NATL ACAD SCI USA, V86, P9489, DOI 10.1073/pnas.86.23.9489; Begovich AB, 2004, AM J HUM GENET, V75, P330, DOI 10.1086/422827; Bersaglieri T, 2004, AM J HUM GENET, V74, P1111, DOI 10.1086/421051; Broman KW, 1999, AM J HUM GENET, V65, P1493, DOI 10.1086/302661; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Campbell H, 2007, HUM MOL GENET, V16, P233, DOI 10.1093/hmg/ddl473; Campbell H, 2009, GENOME MED, V1, DOI 10.1186/gm91; Carlton VEH, 2005, AM J HUM GENET, V77, P567, DOI 10.1086/468189; CARTHY D, 1995, REV RHUM, V62, P163; CAVENEE WK, 1983, NATURE, V305, P779, DOI 10.1038/305779a0; Christodoulou K, 1997, HUM MOL GENET, V6, P635, DOI 10.1093/hmg/6.4.635; Constantin A, 2002, J RHEUMATOL, V29, P15; Curtis D, 2008, ANN HUM GENET, V72, P261, DOI 10.1111/j.1469-1809.2007.00411.x; Datta SK, 2000, NAT MED, V6, P259, DOI 10.1038/73101; Fernando MMA, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000024; Firestein GS, 2003, NATURE, V423, P356, DOI 10.1038/nature01661; Gibson J, 2006, HUM MOL GENET, V15, P789, DOI 10.1093/hmg/ddi493; Goldberg EK, 2000, AM J HUM GENET, V67, P417, DOI 10.1086/302999; Gregersen PK, 2010, BULL HOSP JT DIS, V68, P179; Gregersen PK, 2009, NAT GENET, V41, P820, DOI 10.1038/ng.395; GREGERSEN PK, 1987, ARTHRITIS RHEUM, V30, P1205, DOI 10.1002/art.1780301102; Gunduz E, 2009, CANCER INVEST, V27, P661, DOI 10.1080/07357900802563010; HASTIE T, 1994, J AM STAT ASSOC, V89, P1255, DOI 10.2307/2290989; Hirschhorn JN, 2005, NAT REV GENET, V6, P95, DOI 10.1038/nrg1521; Huggins R, 2008, J HUM GENET, V53, P983, DOI 10.1007/s10038-008-0340-9; Huie ML, 2002, AM J HUM GENET, V70, P1054, DOI 10.1086/339691; Jawaheer D, 2002, AM J HUM GENET, V71, P585, DOI 10.1086/342407; Jawaheer D, 2001, AM J HUM GENET, V68, P927, DOI 10.1086/319518; John S, 2004, AM J HUM GENET, V75, P54, DOI 10.1086/422195; Klareskog L, 2006, ARTHRITIS RHEUM-US, V54, P38, DOI 10.1002/art.21575; KOUFOS A, 1985, NATURE, V316, P330, DOI 10.1038/316330a0; Kretz-Rommel A, 2000, NAT MED, V6, P298; Ku CS, 2011, HUM GENET, V129, P1, DOI 10.1007/s00439-010-0920-6; KULLBACK S, 1951, ANN MATH STAT, V22, P79, DOI 10.1214/aoms/1177729694; Kurreeman FAS, 2007, PLOS MED, V4, P1515, DOI 10.1371/journal.pmed.0040278; LANDER ES, 1987, SCIENCE, V236, P1567, DOI 10.1126/science.2884728; Lencz T, 2007, P NATL ACAD SCI USA, V104, P19942, DOI 10.1073/pnas.0710021104; Li LH, 2006, HUM MUTAT, V27, P1115, DOI 10.1002/humu.20399; Limaye N, 2008, GENES IMMUN, V9, P61, DOI 10.1038/sj.gene.6364446; Loader C., 1999, LOCAL REGRESSION LIK; LYNN AH, 1995, AM J HUM GENET, V57, P150; Mahdi H, 2009, NAT GENET, V41, P1319, DOI 10.1038/ng.480; Marigorta UM, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-55; McQuillan R, 2008, AM J HUM GENET, V83, P359, DOI 10.1016/j.ajhg.2008.08.007; Nalls MA, 2009, NEUROGENETICS, V10, P183, DOI 10.1007/s10048-009-0182-4; Nalls MA, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000415; Newton JL, 2004, GENES IMMUN, V5, P151, DOI 10.1038/sj.gene.6364045; Nothnagel M, 2010, HUM MOL GENET, V19, P2927, DOI 10.1093/hmg/ddq198; OLLIER W, 1992, RHEUM DIS CLIN N AM, V18, P741; Parvari R, 1998, AM J HUM GENET, V63, P163, DOI 10.1086/301915; Peiffer DA, 2006, GENOME RES, V16, P1136, DOI 10.1101/gr.5402306; Pfeifer D, 2007, BLOOD, V109, P1202, DOI 10.1182/blood-2006-07-034256; Plenge RM, 2005, AM J HUM GENET, V77, P1044, DOI 10.1086/498651; Plenge RM, 2007, NEW ENGL J MED, V357, P1199, DOI 10.1056/NEJMoa073491; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Raychaudhuri S, 2008, NAT GENET, V40, P1216, DOI 10.1038/ng.233; Remmers EF, 2007, NEW ENGL J MED, V357, P977, DOI 10.1056/NEJMoa073003; Ridgway WM, 1999, SCIENCE, V284, P749, DOI 10.1126/science.284.5415.749; Sabeti PC, 2007, NATURE, V449, P913, DOI 10.1038/nature06250; Sabeti PC, 2002, NATURE, V419, P832, DOI 10.1038/nature01140; Seldin MF, 1999, ARTHRITIS RHEUM, V42, P1071, DOI 10.1002/1529-0131(199906)42:6<1071::AID-ANR1>3.0.CO;2-8; SHEFFIELD VC, 1994, HUM MOL GENET, V3, P1331, DOI 10.1093/hmg/3.8.1331; Sokka T, 2008, CLIN EXP RHEUMATOL, V26, pS35, DOI 10.1161/CIRCULATIONAHA.109.192644; Stahl EA, 2010, NAT GENET, V42, P508, DOI 10.1038/ng.582; Thomson W, 2007, NAT GENET, V39, P1431, DOI 10.1038/ng.2007.32; Wang K, 2007, GENOME RES, V17, P1665, DOI 10.1101/gr.6861907; Wang S, 2009, GENET EPIDEMIOL, V33, P172, DOI 10.1002/gepi.20344; WEYAND CM, 1992, ANN INTERN MED, V117, P801, DOI 10.7326/0003-4819-117-10-801; Weyand CM, 2000, ARTHRITIS RES, V2, P212, DOI 10.1186/ar90; WILCOXON F, 1946, J ECON ENTOMOL, V39, P269, DOI 10.1093/jee/39.2.269; Winick JD, 1999, AM J HUM GENET, V64, P1679, DOI 10.1086/302423; WORDSWORTH BP, 1989, P NATL ACAD SCI USA, V86, P10049, DOI 10.1073/pnas.86.24.10049; WORDSWORTH P, 1991, ANN RHEUM DIS, V50, P343, DOI 10.1136/ard.50.6.343; Wu CC, 2009, HUM GENET, V126, P303, DOI 10.1007/s00439-009-0672-3; Yamamoto G, 2007, AM J HUM GENET, V81, P114, DOI 10.1086/518809; Yang HC, 2011, GENET EPIDEMIOL, V35, P247, DOI 10.1002/gepi.20573; Yang HC, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-415; Yang HC, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-196; Yang TL, 2010, J CLIN ENDOCR METAB, V95, P3777, DOI 10.1210/jc.2009-1715; YEN JH, 1995, J RHEUMATOL, V22, P2034; YOKOTA J, 1987, P NATL ACAD SCI USA, V84, P9252, DOI 10.1073/pnas.84.24.9252; Zhang L, 2011, HUM MUTAT, V32, P345, DOI 10.1002/humu.21432	87	24	25	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2012	7	4							e34840	10.1371/journal.pone.0034840	http://dx.doi.org/10.1371/journal.pone.0034840			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UD	22536334	Green Published, gold, Green Submitted			2022-12-25	WOS:000305339200022
J	Bloemberg, D; Quadrilatero, J				Bloemberg, Darin; Quadrilatero, Joe			Rapid Determination of Myosin Heavy Chain Expression in Rat, Mouse, and Human Skeletal Muscle Using Multicolor Immunofluorescence Analysis	PLOS ONE			English	Article							FIBER-TYPE COMPOSITION; RESISTANCE EXERCISE; ACTOMYOSIN ATPASE; MITOCHONDRIAL BIOGENESIS; ADENOSINE TRIPHOSPHATASE; CONTRACTILE PROPERTIES; DEHYDROGENASE ACTIVITY; MONOCLONAL-ANTIBODIES; METABOLIC PROPERTIES; DIAPHRAGM MUSCLE	Skeletal muscle is a heterogeneous tissue comprised of fibers with different morphological, functional, and metabolic properties. Different muscles contain varying proportions of fiber types; therefore, accurate identification is important. A number of histochemical methods are used to determine muscle fiber type; however, these techniques have several disadvantages. Immunofluorescence analysis is a sensitive method that allows for simultaneous evaluation of multiple MHC isoforms on a large number of fibers on a single cross-section, and offers a more precise means of identifying fiber types. In this investigation we characterized pure and hybrid fiber type distribution in 10 rat and 10 mouse skeletal muscles, as well as human vastus lateralis (VL) using multicolor immunofluorescence analysis. In addition, we determined fiber type-specific cross-sectional area (CSA), succinate dehydrogenase (SDH) activity, and a-glycerophosphate dehydrogenase (GPD) activity. Using this procedure we were able to easily identify pure and hybrid fiber populations in rat, mouse, and human muscle. Hybrid fibers were identified in all species and made up a significant portion of the total population in some rat and mouse muscles. For example, rat mixed gastrocnemius (MG) contained 12.2% hybrid fibers whereas mouse white tibialis anterior (WTA) contained 12.1% hybrid fibers. Collectively, we outline a simple and time-efficient method for determining MHC expression in skeletal muscle of multiple species. In addition, we provide a useful resource of the pure and hybrid fiber type distribution, fiber CSA, and relative fiber type-specific SDH and GPD activity in a number of rat and mouse muscles.	[Bloemberg, Darin; Quadrilatero, Joe] Univ Waterloo, Dept Kinesiol, Waterloo, ON N2L 3G1, Canada	University of Waterloo	Bloemberg, D (corresponding author), Univ Waterloo, Dept Kinesiol, Waterloo, ON N2L 3G1, Canada.	jquadril@uwaterloo.ca			Natural Sciences and Engineering Research Council of Canada (NSERC)	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	This research was supported by the Natural Sciences and Engineering Research Council of Canada (NSERC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akimoto T, 2004, AM J PHYSIOL-CELL PH, V287, pC1311, DOI 10.1152/ajpcell.00248.2004; Allen DL, 2001, AM J PHYSIOL-CELL PH, V280, pC637, DOI 10.1152/ajpcell.2001.280.3.C637; Andersen JL, 1999, J APPL PHYSIOL, V86, P455, DOI 10.1152/jappl.1999.86.2.455; Arany Z, 2007, CELL METAB, V5, P35, DOI 10.1016/j.cmet.2006.12.003; ARMSTRONG RB, 1984, AM J ANAT, V171, P259, DOI 10.1002/aja.1001710303; Bamman MM, 1998, J APPL PHYSIOL, V84, P157, DOI 10.1152/jappl.1998.84.1.157; BARNARD RJ, 1971, AM J PHYSIOL, V220, P410, DOI 10.1152/ajplegacy.1971.220.2.410; BLANCO CE, 1988, HISTOCHEM J, V20, P230, DOI 10.1007/BF01747468; BROOKE MH, 1970, J HISTOCHEM CYTOCHEM, V18, P670, DOI 10.1177/18.9.670; Delp MD, 1996, J APPL PHYSIOL, V80, P261, DOI 10.1152/jappl.1996.80.1.261; Dunn SE, 1997, AM J PHYSIOL-CELL PH, V273, pC371, DOI 10.1152/ajpcell.1997.273.2.C371; Dunn SE, 1999, PFLUG ARCH EUR J PHY, V437, P432, DOI 10.1007/s004240050798; FUCHTBAUER EM, 1991, J HISTOCHEM CYTOCHEM, V39, P355, DOI 10.1177/39.3.1825216; Garcia-Roves PM, 2008, J BIOL CHEM, V283, P35724, DOI 10.1074/jbc.M805078200; Geng TY, 2010, AM J PHYSIOL-CELL PH, V298, pC572, DOI 10.1152/ajpcell.00481.2009; GOLLNICK PD, 1984, HISTOCHEMISTRY, V81, P379, DOI 10.1007/BF00514333; GORZA L, 1990, J HISTOCHEM CYTOCHEM, V38, P257, DOI 10.1177/38.2.2137154; Graziotti GH, 2001, J HISTOCHEM CYTOCHEM, V49, P1033, DOI 10.1177/002215540104900811; Green H, 1999, AM J PHYSIOL-REG I, V276, pR591, DOI 10.1152/ajpregu.1999.276.2.R591; GREEN HJ, 1991, J APPL PHYSIOL, V70, P2032, DOI 10.1152/jappl.1991.70.5.2032; Gregory CM, 2003, CAN J APPL PHYSIOL, V28, P491, DOI 10.1139/h03-036; Gregory CM, 2001, MUSCLE NERVE, V24, P387, DOI 10.1002/1097-4598(200103)24:3<387::AID-MUS1010>3.0.CO;2-M; GUTH L, 1970, EXP NEUROL, V28, P365, DOI 10.1016/0014-4886(70)90244-X; HALKJAERKRISTENSEN J, 1979, HISTOCHEM J, V11, P127, DOI 10.1007/BF01002990; Hallauer PL, 2002, AM J PHYSIOL-CELL PH, V282, pC113, DOI 10.1152/ajpcell.00294.2001; Harridge SDR, 1996, PFLUG ARCH EUR J PHY, V432, P913, DOI 10.1007/s004240050215; Harrison BC, 2003, J APPL PHYSIOL, V95, P2462, DOI 10.1152/japplphysiol.00603.2003; Landisch RM, 2008, MUSCLE NERVE, V38, P1290, DOI 10.1002/mus.21141; Louhglin M, 1993, MUSCLE BIOPSY LAB IN; Lucas CA, 2000, BIOCHEM BIOPH RES CO, V272, P303, DOI 10.1006/bbrc.2000.2768; McClung JM, 2007, J PHYSIOL-LONDON, V585, P203, DOI 10.1113/jphysiol.2007.141119; Miller TA, 2001, AM J PHYSIOL-REG I, V281, pR1710, DOI 10.1152/ajpregu.2001.281.5.R1710; Norenberg KM, 2004, J APPL PHYSIOL, V97, P2322, DOI 10.1152/japplphysiol.00955.2003; PADYKULA HA, 1955, J HISTOCHEM CYTOCHEM, V3, P170, DOI 10.1177/3.3.170; PETER JB, 1972, BIOCHEMISTRY-US, V11, P2627, DOI 10.1021/bi00764a013; Pette D, 1990, Rev Physiol Biochem Pharmacol, V116, P1; Quadrilatero J, 2010, AM J PHYSIOL-ENDOC M, V298, pE534, DOI 10.1152/ajpendo.00678.2009; Rivero JLL, 1998, J MUSCLE RES CELL M, V19, P733, DOI 10.1023/A:1005482816442; Rivero JLL, 1999, HISTOCHEM CELL BIOL, V111, P277, DOI 10.1007/s004180050358; Ryall JG, 2004, J PHYSIOL-LONDON, V555, P175, DOI 10.1113/jphysiol.2003.056770; SCHIAFFINO S, 1989, J MUSCLE RES CELL M, V10, P197, DOI 10.1007/BF01739810; Schiaffino S, 2010, ACTA PHYSIOL, V199, P451, DOI 10.1111/j.1748-1716.2010.02130.x; SCHIAFFINO S, 1994, J APPL PHYSIOL, V77, P493, DOI 10.1152/jappl.1994.77.2.493; Schuenke MD, 2008, GROWTH HORM IGF RES, V18, P479, DOI 10.1016/j.ghir.2008.04.003; Seth A, 2007, CELL METAB, V6, P236, DOI 10.1016/j.cmet.2007.08.004; Shortreed KE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007293; SIECK GC, 1995, J APPL PHYSIOL, V79, P1629, DOI 10.1152/jappl.1995.79.5.1629; Smerdu V, 2008, EUR J HISTOCHEM, V52, P179; SMERDU V, 1994, AM J PHYSIOL-CELL PH, V267, pC1723, DOI 10.1152/ajpcell.1994.267.6.C1723; Spangenburg EE, 2003, ACTA PHYSIOL SCAND, V178, P413, DOI 10.1046/j.1365-201X.2003.01158.x; STARON RS, 1993, HISTOCHEMISTRY, V100, P149, DOI 10.1007/BF00572901; Staron RS, 1999, HISTOCHEM CELL BIOL, V111, P117, DOI 10.1007/s004180050341; Totsuka Y, 2003, J APPL PHYSIOL, V95, P720, DOI 10.1152/japplphysiol.00946.2002; Trollet C, 2010, HUM MOL GENET, V19, P2191, DOI 10.1093/hmg/ddq098; Zierath JR, 2004, PLOS BIOL, V2, P1523, DOI 10.1371/journal.pbio.0020348	55	368	374	6	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2012	7	4							e35273	10.1371/journal.pone.0035273	http://dx.doi.org/10.1371/journal.pone.0035273			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959XD	22530000	Green Published, Green Submitted, gold			2022-12-25	WOS:000305350600072
J	Wu, CK; Huang, YT; Lee, JK; Chiang, LT; Chiang, FT; Huang, SW; Lin, JL; Tseng, CD; Chen, YH; Tsai, CT				Wu, Cho-Kai; Huang, Yin-Tsen; Lee, Jen-Kuang; Chiang, Liang-Ting; Chiang, Fu-Tien; Huang, Shu-Wei; Lin, Jiunn-Lee; Tseng, Chuen-Den; Chen, Yau-Hung; Tsai, Chia-Ti			Cardiac Myosin Binding Protein C and MAP-Kinase Activating Death Domain-Containing Gene Polymorphisms and Diastolic Heart Failure	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; HYPERTROPHIC CARDIOMYOPATHY; PHOSPHORYLATION; MYOCARDIUM; MUTATIONS; MYOCYTES; VARIANT	Objective: Myosin binding protein C (MYBPC3) plays a role in ventricular relaxation. The aim of the study was to investigate the association between cardiac myosin binding protein C (MYBPC3) gene polymorphisms and diastolic heart failure (DHF) in a human case-control study. Methods: A total of 352 participants of 1752 consecutive patients from the National Taiwan University Hospital and its affiliated hospital were enrolled. 176 patients diagnosed with DHF confirmed by echocardiography were recruited. Controls were matched 1-to-1 by age, sex, hypertension, diabetes, renal function and medication use. We genotyped 12 single nucleotide polymorphisms (SNPs) according to HapMap Han Chinese Beijing databank across a 40 kb genetic region containing the MYBPC3 gene and the neighboring DNA sequences to capture 100% of haplotype variance in all SNPs with minor allele frequencies >= 5%. We also analyzed associations of these tagging SNPs and haplotypes with DHF and linkage disequilibrium (LD) structure of the MYBPC3 gene. Results: In a single locus analysis, SNP rs2290149 was associated with DHF (allele-specific p = 0.004; permuted p = 0.031). The SNP with a minor allele frequency of 9.4%, had an odds ratio 2.14 (95% CI 1.25-3.66; p = 0.004) for the additive model and 2.06 for the autosomal dominant model (GG+GA : AA, 95% CI 1.17-3.63; p = 0.013), corresponding to a population attributable risk fraction of 12.02%. The haplotypes in a LD block of rs2290149 (C-C-G-C) was also significantly associated with DHF (odds ratio 2.10 (1.53-2.89); permuted p = 0.029). Conclusions: We identified a SNP (rs2290149) among the tagging SNP set that was significantly associated with early DHF in a Chinese population.	[Wu, Cho-Kai; Chiang, Liang-Ting; Lin, Jiunn-Lee; Tseng, Chuen-Den; Tsai, Chia-Ti] Natl Taiwan Univ, Div Cardiol, Dept Internal Med, Coll Med & Hosp, Taipei 10764, Taiwan; [Wu, Cho-Kai; Chiang, Fu-Tien] Natl Taiwan Univ, Coll Med, Grad Inst Clin Med, Taipei 10764, Taiwan; [Huang, Yin-Tsen; Chiang, Fu-Tien] Far Eastern Mem Hosp, Dept Family Med, New Taipei City, Taiwan; [Huang, Yin-Tsen; Chiang, Fu-Tien] Far Eastern Mem Hosp, Hlth Management Ctr, New Taipei City, Taiwan; [Lee, Jen-Kuang] Natl Taiwan Univ Hosp, Dept Lab Med, Taipei, Taiwan; [Lee, Jen-Kuang] Far Eastern Mem Hosp, Dept Clin Pathol, New Taipei City, Taiwan; [Lee, Jen-Kuang] Natl Taiwan Univ, Grad Inst Biomed Elect & Bioinformat, Taipei 10764, Taiwan; [Huang, Shu-Wei] Natl Yang Ming Univ, Coll Med, Grad Inst Biomed Engn, Taipei 112, Taiwan; [Chen, Yau-Hung] Tamkang Univ, Dept Chem, Tamsui 25137, Taiwan	National Taiwan University; National Taiwan University; Far Eastern Memorial Hospital; Far Eastern Memorial Hospital; National Taiwan University; National Taiwan University Hospital; Far Eastern Memorial Hospital; National Taiwan University; National Yang Ming Chiao Tung University; Tamkang University	Wu, CK (corresponding author), Natl Taiwan Univ, Div Cardiol, Dept Internal Med, Coll Med & Hosp, Taipei 10764, Taiwan.	yauhung@mail.tku.edu.tw; fang31@ms39.hinet.net		WU, CHO-KAI/0000-0002-3867-150X; CHIANG, FU-TIEN/0000-0003-4936-8968; TSAI, CHIA-TI/0000-0002-4853-8665	Institute of Biomedical Medical Sciences CRC Research Program of Institute of Biomedical Science, Academia Sinica [IBMS-CRC99-P02]; National Science Council of Tiawan R.O.C. [NSC 99-2314-B-002-131-MY3]	Institute of Biomedical Medical Sciences CRC Research Program of Institute of Biomedical Science, Academia Sinica; National Science Council of Tiawan R.O.C.	This work was supported in part by the Institute of Biomedical Medical Sciences CRC Research Program of Institute of Biomedical Science, Academia Sinica (IBMS-CRC99-P02) and by a grant (NSC 99-2314-B-002-131-MY3) from the National Science Council of Tiawan R.O.C. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angeja BG, 2003, CIRCULATION, V107, P659, DOI 10.1161/01.CIR.0000053948.10914.49; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Borbely A, 2009, CIRC RES, V104, P780, DOI 10.1161/CIRCRESAHA.108.193326; Chatterjee K, 2007, J CARD FAIL, V13, P569, DOI 10.1016/j.cardfail.2007.04.006; Cowie MR, 1997, EUR HEART J, V18, P208; Defer N, 2007, J BIOL CHEM, V282, P35564, DOI 10.1074/jbc.M704003200; Dhandapany PS, 2009, NAT GENET, V41, P187, DOI 10.1038/ng.309; El-Armouche A, 2007, J MOL CELL CARDIOL, V43, P223, DOI 10.1016/j.yjmcc.2007.05.003; Flashman E, 2004, CIRC RES, V94, P1279, DOI 10.1161/01.RES.0000127175.21818.C2; Girolami F, 2010, J AM COLL CARDIOL, V55, P1444, DOI 10.1016/j.jacc.2009.11.062; GULICK T, 1989, P NATL ACAD SCI USA, V86, P6753, DOI 10.1073/pnas.86.17.6753; Harris SP, 2002, CIRC RES, V90, P594, DOI 10.1161/01.RES.0000012222.70819.64; Jurinke Christian, 2002, Adv Biochem Eng Biotechnol, V77, P57; Katz AM, 2006, CIRCULATION, V113, P1922, DOI 10.1161/CIRCULATIONAHA.106.620765; Kubo T, 2005, J AM COLL CARDIOL, V46, P1737, DOI 10.1016/j.jacc.2005.05.087; Kurada BRVVSN, 2009, J BIOL CHEM, V284, P13533, DOI 10.1074/jbc.M808554200; Leszek P, 2008, J CARD FAIL, V14, P873, DOI 10.1016/j.cardfail.2008.07.232; McClellan G, 2001, BIOPHYS J, V81, P1083, DOI 10.1016/S0006-3495(01)75765-7; Niimura H, 1998, NEW ENGL J MED, V338, P1248, DOI 10.1056/NEJM199804303381802; Pohlmann L, 2007, CIRC RES, V101, P928, DOI 10.1161/CIRCRESAHA.107.158774; Purcell S, 2003, BIOINFORMATICS, V19, P149, DOI 10.1093/bioinformatics/19.1.149; Sadayappan S, 2006, P NATL ACAD SCI USA, V103, P16918, DOI 10.1073/pnas.0607069103; Spinale FG, 2000, CIRCULATION, V102, P1944, DOI 10.1161/01.CIR.102.16.1944; Stelzer JE, 2006, BIOPHYS J, V90, P4119, DOI 10.1529/biophysj.105.078147; Wu CK, 2010, PHARMACOGENOMICS J, V10, P46, DOI 10.1038/tpj.2009.39; Wu CK, 2009, ATHEROSCLEROSIS, V205, P497, DOI 10.1016/j.atherosclerosis.2008.12.033; Wu CK, 2009, J HYPERTENS, V27, P502, DOI 10.1097/HJH.0b013e32831fda3a; Yip GWK, 2008, HEART, V94, P573, DOI 10.1136/hrt.2007.117978; YOKOYAMA T, 1993, J CLIN INVEST, V92, P2303, DOI 10.1172/JCI116834	29	12	12	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2012	7	4							e35242	10.1371/journal.pone.0035242	http://dx.doi.org/10.1371/journal.pone.0035242			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WC	22529996	Green Submitted, Green Published, gold			2022-12-25	WOS:000305347400038
J	He, HL; Guo, J; Chen, XL; Xie, BB; Zhang, XY; Yu, Y; Chen, B; Zhou, BC; Zhang, YZ				He, Hai-Lun; Guo, Jun; Chen, Xiu-Lan; Xie, Bin-Bin; Zhang, Xi-Ying; Yu, Yong; Chen, Bo; Zhou, Bai-Cheng; Zhang, Yu-Zhong			Structural and Functional Characterization of Mature Forms of Metalloprotease E495 from Arctic Sea-Ice Bacterium Pseudoalteromonas sp SM495	PLOS ONE			English	Article							KIDNEY-DISEASE DOMAIN; MARINE BACTERIUM; BINDING DOMAIN; SP SM9913; DEEP-SEA; PROTEASE; PURIFICATION; SEQUENCE; CLONING; GENE	E495 is the most abundant protease secreted by the Arctic sea-ice bacterium Pseudoalteromonas sp. SM495. As a thermolysin family metalloprotease, E495 was found to have multiple active forms in the culture of strain SM495. E495-M (containing only the catalytic domain) and E495-M-C1 (containing the catalytic domain and one PPC domain) were two stable mature forms, and E495-M-C1-C2 (containing the catalytic domain and two PPC domains) might be an intermediate. Compared to E495-M, E495-M-C1 had similar affinity and catalytic efficiency to oligopeptides, but higher affinity and catalytic efficiency to proteins. The PPC domains from E495 were expressed as GST-fused proteins. Both of the recombinant PPC domains were shown to have binding ability to proteins C-phycocyanin and casein, and domain PPC1 had higher affinity to C-phycocyanin than domain PPC2. These results indicated that the domain PPC1 in E495-M-C1 could be helpful in binding protein substrate, and therefore, improving the catalytic efficiency. Site-directed mutagenesis on the PPC domains showed that the conserved polar and aromatic residues, D26, D28, Y30, Y/W65, in the PPC domains played key roles in protein binding. Our study may shed light on the mechanism of organic nitrogen degradation in the Arctic sea ice.	[He, Hai-Lun; Guo, Jun; Chen, Xiu-Lan; Xie, Bin-Bin; Zhang, Xi-Ying; Zhou, Bai-Cheng; Zhang, Yu-Zhong] Shandong Univ, Marine Biotechnol Res Ctr, State Key Lab Microbial Technol, Jinan 250100, Peoples R China; [Yu, Yong; Chen, Bo] Polar Res Inst China, SOA Key Lab Polar Sci, Shanghai, Peoples R China	Shandong University; Polar Research Institute of China	He, HL (corresponding author), Shandong Univ, Marine Biotechnol Res Ctr, State Key Lab Microbial Technol, Jinan 250100, Peoples R China.	zhangyz@sdu.edu.cn			National Natural Science Foundation of China [31025001, 31070061, 40876072, 31000034]; Hi-Tech Research and Development program of China [2006AA09Z414]; Natural Science Foundation of Shandong Province, P. R. China [JQ200910, ZR2009DZ002]; Foundation for Young Scientists in Shandong Province [2007BS07007]; Independent Innovation Foundation of Shandong University [2009TS079]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Hi-Tech Research and Development program of China(National High Technology Research and Development Program of China); Natural Science Foundation of Shandong Province, P. R. China(Natural Science Foundation of Shandong Province); Foundation for Young Scientists in Shandong Province; Independent Innovation Foundation of Shandong University	The work was supported by National Natural Science Foundation of China (31025001, 31070061, 40876072, 31000034), Hi-Tech Research and Development program of China (2006AA09Z414), Natural Science Foundation of Shandong Province, P. R. China (JQ200910, ZR2009DZ002), Foundation for Young Scientists in Shandong Province (2007BS07007), Independent Innovation Foundation of Shandong University (2009TS079). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Becquevort S, 2009, POLAR BIOL, V32, P879, DOI 10.1007/s00300-009-0589-2; Bowman JP, 1997, APPL ENVIRON MICROB, V63, P3068, DOI 10.1128/AEM.63.8.3068-3078.1997; Chakrabarti SK, 2000, CURR MICROBIOL, V40, P239, DOI 10.1007/s002849910048; Chang AK, 2007, J BACTERIOL, V189, P6832, DOI 10.1128/JB.00396-07; Chen XL, 2007, MICROBIOL-SGM, V153, P2116, DOI 10.1099/mic.0.2007/006056-0; Cushing PR, 2008, BIOCHEMISTRY-US, V47, P10084, DOI 10.1021/bi8003928; FEDER J, 1970, BIOCHEMISTRY-US, V9, P2784, DOI 10.1021/bi00816a005; Ferrandon S, 2003, BBA-GEN SUBJECTS, V1621, P31, DOI 10.1016/S0304-4165(03)00029-1; Gary R, 1997, J BIOL CHEM, V272, P24522, DOI 10.1074/jbc.272.39.24522; He HL, 2004, FOOD CHEM, V84, P307, DOI 10.1016/S0308-8146(03)00242-5; Hu ZJ, 2000, PROTEINS, V39, P331, DOI 10.1002/(SICI)1097-0134(20000601)39:4<331::AID-PROT60>3.0.CO;2-A; Inouye K, 2007, BIOTECHNOL ANN REV, V13, P43, DOI 10.1016/S1387-2656(07)13003-9; Jin F, 1996, INFECT IMMUN, V64, P230, DOI 10.1128/IAI.64.1.230-237.1996; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lee SO, 2002, BIOSCI BIOTECH BIOCH, V66, P1366, DOI 10.1271/bbb.66.1366; Liu LN, 2005, J BIOTECHNOL, V116, P91, DOI 10.1016/j.jbiotec.2004.09.017; Marchler-Bauer A, 2005, NUCLEIC ACIDS RES, V33, pD192, DOI 10.1093/nar/gki069; MATSUDAIRA P, 1987, J BIOL CHEM, V262, P10035; Miyoshi S, 1997, J BACTERIOL, V179, P7606, DOI 10.1128/jb.179.23.7606-7609.1997; NARUKAWA H, 1993, FEMS MICROBIOL LETT, V108, P43; NIES M, 1980, PLANTA, V150, P330, DOI 10.1007/BF00384663; Nirasawa S, 2004, HDB PROTEOLYTIC ENZY, P374; Orikoshi H, 2005, J APPL MICROBIOL, V99, P551, DOI 10.1111/j.1365-2672.2005.02630.x; Pace CN, 2009, NAT STRUCT MOL BIOL, V16, P681, DOI 10.1038/nsmb0709-681; PHILLIPS PK, 1984, J CLIN PATHOL, V37, P329, DOI 10.1136/jcp.37.3.329; Rao MB, 1998, MICROBIOL MOL BIOL R, V62, P597, DOI 10.1128/MMBR.62.3.597-635.1998; Rawlings ND, 2002, NUCLEIC ACIDS RES, V30, P343, DOI 10.1093/nar/30.1.343; Rawlings ND, 2008, NUCLEIC ACIDS RES, V36, pD320, DOI 10.1093/nar/gkm954; Su HN, 2010, J APPL PHYCOL, V22, P65, DOI 10.1007/s10811-009-9427-8; Takahashi T, 2005, J BIOCHEM, V138, P701, DOI 10.1093/jb/mvi173; Takashima S, 2007, FEBS LETT, V581, P5891, DOI 10.1016/j.febslet.2007.11.068; THOMAS DN, 2003, SEA ICE AN INTRO ITS; Tsujibo H, 1996, BIOSCI BIOTECH BIOCH, V60, P1284, DOI 10.1271/bbb.60.1284; Verkhivker GM, 2002, PROTEINS, V48, P539, DOI 10.1002/prot.10164; Weigt M, 2009, P NATL ACAD SCI USA, V106, P67, DOI 10.1073/pnas.0805923106; Worthington Biochemical Corporation, 1972, WORTH ENZ MAN; Wu JW, 2011, APPL MICROBIOL BIOT, V92, P253, DOI 10.1007/s00253-011-3532-8; Xie BB, 2009, J BIOL CHEM, V284, P9257, DOI 10.1074/jbc.M808421200; Yan BQ, 2009, EXTREMOPHILES, V13, P725, DOI 10.1007/s00792-009-0263-1; Yeats C, 2003, BMC MICROBIOL, V3, DOI 10.1186/1471-2180-3-3; Zhao GY, 2008, J BIOL CHEM, V283, P36100, DOI 10.1074/jbc.M804438200	41	15	16	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2012	7	4							e35442	10.1371/journal.pone.0035442	http://dx.doi.org/10.1371/journal.pone.0035442			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VO	22523598	Green Submitted, gold, Green Published			2022-12-25	WOS:000305345000071
J	Benton, M; Macartney-Coxson, D; Eccles, D; Griffiths, L; Chambers, G; Lea, R				Benton, Miles; Macartney-Coxson, Donia; Eccles, David; Griffiths, Lyn; Chambers, Geoff; Lea, Rod			Complete Mitochondrial Genome Sequencing Reveals Novel Haplotypes in a Polynesian Population	PLOS ONE			English	Article							DNA VARIANT; HUMAN MTDNA; EVOLUTIONARY HISTORY; DIABETES-MELLITUS; POLYMORPHISMS; SELECTION; SUSCEPTIBILITY; MICRONESIANS; ASSOCIATION; PREVALENCE	The high risk of metabolic disease traits in Polynesians may be partly explained by elevated prevalence of genetic variants involved in energy metabolism. The genetics of Polynesian populations has been shaped by island hoping migration events which have possibly favoured thrifty genes. The aim of this study was to sequence the mitochondrial genome in a group of Maoris in an effort to characterise genome variation in this Polynesian population for use in future disease association studies. We sequenced the complete mitochondrial genomes of 20 non-admixed Maori subjects using Affymetrix technology. DNA diversity analyses showed the Maori group exhibited reduced mitochondrial genome diversity compared to other worldwide populations, which is consistent with historical bottleneck and founder effects. Global phylogenetic analysis positioned these Maori subjects specifically within mitochondrial haplogroup - B4a1a1. Interestingly, we identified several novel variants that collectively form new and unique Maori motifs - B4a1a1c, B4a1a1a3 and B4a1a1a5. Compared to ancestral populations we observed an increased frequency of non-synonymous coding variants of several mitochondrial genes in the Maori group, which may be a result of positive selection and/or genetic drift effects. In conclusion, this study reports the first complete mitochondrial genome sequence data for a Maori population. Overall, these new data reveal novel mitochondrial genome signatures in this Polynesian population and enhance the phylogenetic picture of maternal ancestry in Oceania. The increased frequency of several mitochondrial coding variants makes them good candidates for future studies aimed at assessment of metabolic disease risk in Polynesian populations.	[Benton, Miles; Eccles, David; Chambers, Geoff] Victoria Univ Wellington, Sch Biol Sci, Wellington, New Zealand; [Macartney-Coxson, Donia; Eccles, David; Lea, Rod] Kenepuru Sci Ctr, Inst Environm Sci & Res, Sandringham, New Zealand; [Benton, Miles; Griffiths, Lyn; Lea, Rod] Griffith Univ, Griffith Hlth Inst, Genom Res Ctr, Nathan, Qld 4111, Australia	Victoria University Wellington; Griffith University; Menzies Health Institute Queensland	Benton, M (corresponding author), Victoria Univ Wellington, Sch Biol Sci, Wellington, New Zealand.	r.lea@griffith.edu.au		Chambers, Geoffrey/0000-0003-1019-6855; Benton, Miles/0000-0003-3442-965X; Lea, Rodney/0000-0002-1148-5862; Griffiths, Lyn/0000-0002-6774-5475; Macartney-Coxson, Donia/0000-0002-1051-537X	Wellington Health Research Council [1387]	Wellington Health Research Council	This research was funded by the Wellington Health Research Council Grant #1387. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achilli A, 2004, AM J HUM GENET, V75, P910, DOI 10.1086/425590; Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779; Bellwood P, 2011, INVESTIGATING ARCHAEOLOGICAL CULTURES: MATERIAL CULTURE, VARIABILITY, AND TRANSMISSION, P321, DOI 10.1007/978-1-4419-6970-5_16; Bhat A, 2007, HUM GENET, V120, P821, DOI 10.1007/s00439-006-0272-4; Chinnery PF, 2007, J MED GENET, V44, DOI 10.1136/jmg.2007.048876; DOWSE GK, 1991, AM J EPIDEMIOL, V133, P1093, DOI 10.1093/oxfordjournals.aje.a115822; Eltsov N, 2009, MTPHYL SOFTWARE TOOL; Guo LJ, 2005, MITOCHONDRION, V5, P15, DOI 10.1016/j.mito.2004.09.001; HAGELBERG E, 1993, P ROY SOC B-BIOL SCI, V252, P163, DOI 10.1098/rspb.1993.0061; HERTZBERG M, 1989, AM J HUM GENET, V44, P504; Ingman M, 2001, J HERED, V92, P454, DOI 10.1093/jhered/92.6.454; Ingman M, 2003, GENOME RES, V13, P1600, DOI 10.1101/gr.686603; Ingman M, 2000, NATURE, V408, P708, DOI 10.1038/35047064; Ingman M, 2006, NUCLEIC ACIDS RES, V34, pD749, DOI 10.1093/nar/gkj010; Kim JH, 2002, DIABETIC MED, V19, P681, DOI 10.1046/j.1464-5491.2002.00747.x; Kivisild T, 2006, GENETICS, V172, P373, DOI 10.1534/genetics.105.043901; Kong QP, 2003, AM J HUM GENET, V73, P671, DOI 10.1086/377718; Kumar S, 2008, BRIEF BIOINFORM, V9, P299, DOI 10.1093/bib/bbn017; Lea RA, 2007, PHARMACOGENETICS ADM; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Liou CW, 2007, J CLIN ENDOCR METAB, V92, P235, DOI 10.1210/jc.2006-0653; Lum JK, 2000, AM J PHYS ANTHROPOL, V113, P151; Lum JK, 1998, AM J PHYS ANTHROPOL, V105, P109, DOI 10.1002/(SICI)1096-8644(199802)105:2<109::AID-AJPA1>3.0.CO;2-Q; LUM JK, 1994, HUM BIOL, V66, P567; Macaulay V, 2005, SCIENCE, V308, P1034, DOI 10.1126/science.1109792; Maechler P, 2006, BIOCHEM SOC T, V34, P824, DOI 10.1042/BST0340824; Maitra A, 2004, GENOME RES, V14, P812, DOI 10.1101/gr.2228504; MELTON T, 1995, AM J HUM GENET, V57, P403; Merriwether DA, 2005, P NATL ACAD SCI USA, V102, P13034, DOI 10.1073/pnas.0506195102; Ministry of Health, 2008, PORTR HLTH KEY RES 2; Mishmar D, 2003, P NATL ACAD SCI USA, V100, P171, DOI 10.1073/pnas.0136972100; Mohlke KL, 2005, HUM GENET, V118, P245, DOI 10.1007/s00439-005-0046-4; Moilanen JS, 2003, MOL BIOL EVOL, V20, P2132, DOI 10.1093/molbev/msg230; Murray-McIntosh RP, 1998, P NATL ACAD SCI USA, V95, P9047, DOI 10.1073/pnas.95.15.9047; NEEL JV, 1962, AM J HUM GENET, V14, P353; O'Rahilly S, 2009, NATURE, V462, P307, DOI 10.1038/nature08532; Pierson MJ, 2006, DECIPHERING HUMAN PO; Poulton J, 1998, DIABETOLOGIA, V41, P54, DOI 10.1007/s001250050866; Poulton J, 2002, DIABETIC MED, V19, P969, DOI 10.1046/j.0742-3071.2002.00836.x; REDD AJ, 1995, MOL BIOL EVOL, V12, P604; Ruiz-Pesini E, 2007, NUCLEIC ACIDS RES, V35, pD823, DOI 10.1093/nar/gkl927; Saxena R, 2006, AM J HUM GENET, V79, P54, DOI 10.1086/504926; Soares Pedro, 2011, Am J Hum Genet, V88, P239, DOI 10.1016/j.ajhg.2011.01.009; SYKES B, 1995, AM J HUM GENET, V57, P1463; Tabbada KA, 2010, MOL BIOL EVOL, V27, P21, DOI 10.1093/molbev/msp215; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Trejaut JA, 2005, PLOS BIOL, V3, P1; van Oven M, 2009, HUM MUTAT, V30, pE386, DOI 10.1002/humu.20921; Whyte ALH, 2005, HUM BIOL, V77, P157, DOI 10.1353/hub.2005.0045; Yang TL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021595; ZIMMET P, 1990, DIABETES METAB REV, V6, P91, DOI 10.1002/dmr.5610060203; ZIMMET P, 1977, DIABETOLOGIA, V13, P111, DOI 10.1007/BF00745137	52	24	24	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2012	7	4							e35026	10.1371/journal.pone.0035026	http://dx.doi.org/10.1371/journal.pone.0035026			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UT	22514703	Green Published, gold			2022-12-25	WOS:000305341600109
J	Xiang, S; Dong, HH; Liang, HF; He, SQ; Zhang, W; Li, CH; Zhang, BX; Zhang, BH; Jing, K; Tomlinson, S; van Rooijen, N; Jiang, L; Cianflone, K; Chen, XP				Xiang, Shuai; Dong, Han-Hua; Liang, Hui-Fang; He, Song-Qing; Zhang, Wei; Li, Chang-Hai; Zhang, Bi-Xiang; Zhang, Bin-Hao; Jing, Kai; Tomlinson, Stephen; van Rooijen, Nico; Jiang, Li; Cianflone, Katherine; Chen, Xiao-Ping			Oval Cell Response Is Attenuated by Depletion of Liver Resident Macrophages in the 2-AAF/Partial Hepatectomy Rat	PLOS ONE			English	Article							HEPATIC PROGENITOR CELLS; PRECURSOR-PRODUCT RELATIONSHIP; KUPFFER CELLS; GADOLINIUM CHLORIDE; HEPATOCELLULAR-CARCINOMA; STEM-CELLS; IN-VIVO; REGENERATION; HEPATOCYTES; EXPRESSION	Background/Aims: Macrophages are known to play an important role in hepatocyte mediated liver regeneration by secreting inflammatory mediators. However, there is little information available on the role of resident macrophages in oval cell mediated liver regeneration. In the present study we aimed to investigate the role of macrophages in oval cell expansion induced by 2-acetylaminofluorene/partial hepatectomy (2-AAF/PH) in rats. Methodology/Principal Findings: We depleted macrophages in the liver of 2-AAF/PH treated rats by injecting liposome encapsulated clodronate 48 hours before PH. Regeneration of remnant liver mass, as well as proliferation and differentiation of oval cells were measured. We found that macrophage-depleted rats suffered higher mortality and liver transaminase levels. We also showed that depletion of macrophages yielded a significant decrease of EPCAM and PCK positive oval cells in immunohistochemical stained liver sections 9 days after PH. Meanwhile, oval cell differentiation was also attenuated as a result of macrophage depletion, as large foci of small basophilic hepatocytes were observed by day 9 following hepatectomy in control rats whereas they were almost absent in macrophage depleted rats. Accordingly, real-time polymerase chain reaction analysis showed lower expression of albumin mRNA in macrophage depleted livers. Then we assessed whether macrophage depletion may affect hepatic production of stimulating cytokines for liver regeneration. We showed that macrophage-depletion significantly inhibited hepatic expression of tumor necrosis factor-a and interleukin-6, along with a lack of signal transducer and activator of transcription 3 phosphorylation during the early period following hepatectomy. Conclusions: These data indicate that macrophages play an important role in oval cell mediated liver regeneration in the 2-AAF/PH model.	[Xiang, Shuai; Dong, Han-Hua; Liang, Hui-Fang; Li, Chang-Hai; Jiang, Li; Chen, Xiao-Ping] Huazhong Univ Sci & Technol, Tongji Hosp, Hepat Surg Ctr, Wuhan 430074, Peoples R China; [He, Song-Qing; Zhang, Wei; Zhang, Bi-Xiang; Zhang, Bin-Hao; Jing, Kai] Guilin Med Univ, Affiliated Hosp, Dept Hepatobiliary Surg, Guilin, Peoples R China; [Tomlinson, Stephen] Med Univ S Carolina, Dept Microbiol & Immunol, Darby Childrens Res Inst, Charleston, SC 29425 USA; [van Rooijen, Nico] Vrije Univ Amsterdam, Med Ctr, Dept Mol Cell Biol, Amsterdam, Netherlands; [Cianflone, Katherine] Univ Laval, Ctr Rech, Inst Univ Cardiol & Pneumol Quebec, Quebec City, PQ, Canada	Huazhong University of Science & Technology; Guilin Medical University; Medical University of South Carolina; Vrije Universiteit Amsterdam; Laval University	Xiang, S (corresponding author), Huazhong Univ Sci & Technol, Tongji Hosp, Hepat Surg Ctr, Wuhan 430074, Peoples R China.	chenxp@medmail.com.cn	Van Rooijen, Nico/Z-1578-2019		National Natural Science Foundation of China [30872499, 30972797, 30973498]; Natural Science Foundation of Hubei Province of China [2008CDB146]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Hubei Province of China(Natural Science Foundation of Hubei Province)	This work was supported by the grants from The National Natural Science Foundation of China (Grant No. 30872499, 30972797 and 30973498) (website:http://www.nsfc.gov.cn/Portal0/default152.htm) and The Natural Science Foundation of Hubei Province of China (Grant No. 2008CDB146)(http://www.hbstd.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abshagen K, 2007, AM J PHYSIOL-GASTR L, V292, pG1570, DOI 10.1152/ajpgi.00399.2006; Bilzer M, 2006, LIVER INT, V26, P1175, DOI 10.1111/j.1478-3231.2006.01342.x; Boulton RA, 1998, J HEPATOL, V29, P271, DOI 10.1016/S0168-8278(98)80013-5; BRAUN L, 1989, CANCER RES, V49, P1554; DECKER K, 1990, EUR J BIOCHEM, V192, P245, DOI 10.1111/j.1432-1033.1990.tb19222.x; Devey L, 2009, MOL THER, V17, P65, DOI 10.1038/mt.2008.237; Dong XS, 2010, J HUAZHONG U SCI-MED, V30, P55, DOI 10.1007/s11596-010-0110-8; Dong ZJ, 2007, CELL MOL IMMUNOL, V4, P241; Evarts RP, 1996, CARCINOGENESIS, V17, P2143, DOI 10.1093/carcin/17.10.2143; EVARTS RP, 1989, CANCER RES, V49, P1541; EVARTS RP, 1987, CARCINOGENESIS, V8, P1737, DOI 10.1093/carcin/8.11.1737; Faa G, 1998, J HEPATOL, V29, P628, DOI 10.1016/S0168-8278(98)80158-X; Fausto N, 2006, HEPATOLOGY, V43, pS45, DOI 10.1002/hep.20969; Fausto N, 2003, MECH DEVELOP, V120, P117, DOI 10.1016/S0925-4773(02)00338-6; Gao B, 2005, CELL MOL IMMUNOL, V2, P92; Gregory SH, 1998, J IMMUNOL, V160, P6056; HARDONK MJ, 1992, J LEUKOCYTE BIOL, V52, P296, DOI 10.1002/jlb.52.3.296; Jensen CH, 2004, AM J PATHOL, V164, P1347, DOI 10.1016/S0002-9440(10)63221-X; Jin CX, 2011, BIOCHEM BIOPH RES CO, V409, P803, DOI 10.1016/j.bbrc.2011.05.094; Ju C, 2002, CHEM RES TOXICOL, V15, P1504, DOI 10.1021/tx0255976; Kinoshita M, 2010, J HEPATOL, V53, P903, DOI 10.1016/j.jhep.2010.04.037; Knight B, 2000, J EXP MED, V192, P1809, DOI 10.1084/jem.192.12.1809; Knight B, 2007, J HEPATOL, V46, P134, DOI 10.1016/j.jhep.2006.08.015; Kuhlmann WD, 2006, INT J EXP PATHOL, V87, P343, DOI 10.1111/j.1365-2613.2006.00485.x; Laszlo V, 2008, HISTOCHEM CELL BIOL, V130, P1005, DOI 10.1007/s00418-008-0482-z; Lee CM, 2004, INT J BIOCHEM CELL B, V36, P481, DOI 10.1016/j.biocel.2003.08.004; Lee JS, 2006, NAT MED, V12, P410, DOI 10.1038/nm1377; Libbrecht L, 2002, SEMIN CELL DEV BIOL, V13, P389, DOI 10.1016/S1084952102001258; Libbrecht L, 2000, J HEPATOL, V33, P76, DOI 10.1016/S0168-8278(00)80162-2; Lowes KN, 1999, AM J PATHOL, V154, P537, DOI 10.1016/S0002-9440(10)65299-6; Lowes KN, 2003, J GASTROEN HEPATOL, V18, P4, DOI 10.1046/j.1440-1746.2003.02906.x; Meijer C, 2000, LIVER, V20, P66, DOI 10.1034/j.1600-0676.2000.020001066.x; Nagy P, 1998, HEPATOLOGY, V28, P423, DOI 10.1002/hep.510280220; NAGY P, 1994, J CELL BIOL, V126, P223, DOI 10.1083/jcb.126.1.223; Olynyk JK, 1998, AM J PATHOL, V152, P347; Paku S, 2001, AM J PATHOL, V158, P1313, DOI 10.1016/S0002-9440(10)64082-5; Rai RM, 1996, AM J PHYSIOL-GASTR L, V270, pG909, DOI 10.1152/ajpgi.1996.270.6.G909; Roskams TA, 2003, SEMIN LIVER DIS, V23, P385; Santoni-Rugiu E, 2005, APMIS, V113, P876, DOI 10.1111/j.1600-0463.2005.apm_386.x; Shupe T, 2005, STEM CELL REV, V1, P261, DOI 10.1385/SCR:1:3:261; Strick-Marchand H, 2008, J IMMUNOL, V181, P2764, DOI 10.4049/jimmunol.181.4.2764; Theise ND, 2006, AM J PHYSIOL-GASTR L, V290, pG189, DOI 10.1152/ajpgi.00041.2005; VANROOIJEN N, 1990, CELL TISSUE RES, V260, P215, DOI 10.1007/BF00318625; VANROOIJEN N, 1994, J IMMUNOL METHODS, V174, P83; VanRooijen N, 1996, HEPATOLOGY, V23, P1239; Viebahn CS, 2010, J HEPATOL, V53, P500, DOI 10.1016/j.jhep.2010.04.010; Yin L, 2002, HISTOL HISTOPATHOL, V17, P65, DOI 10.14670/HH-17.65; Zhang W, 2009, WORLD J GASTROENTERO, V15, P552, DOI 10.3748/wjg.15.552	48	28	29	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2012	7	4							e35180	10.1371/journal.pone.0035180	http://dx.doi.org/10.1371/journal.pone.0035180			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UT	22514719	Green Published, gold, Green Submitted			2022-12-25	WOS:000305341600125
J	Saqui-Salces, M; Dowdle, WE; Reiter, JF; Merchant, JL				Saqui-Salces, Milena; Dowdle, William E.; Reiter, Jeremy F.; Merchant, Juanita L.			A high-fat diet regulates gastrin and acid secretion through primary cilia	FASEB JOURNAL			English	Article						gastric hyperplasia; endocrine cell; chemosensing; somatostatin; ghrelin	POLYCYSTIC KIDNEY-DISEASE; SONIC HEDGEHOG; FOOD-INTAKE; SOMATOSTATIN RECEPTOR-3; SYNERGISTIC INTERACTION; ATROPHIC GASTRITIS; GHRELIN SECRETION; GENE-EXPRESSION; MOUSE STOMACH; LEAN MICE	The role of primary cilia in the gastrointestinal tract has not been examined. Here we report the presence of primary cilia on gastric endocrine cells producing gastrin, ghrelin, and somatostatin (Sst), hormones regulated by food intake. During eating, cilia in the gastric antrum decreased, whereas gastric acid and circulating gastrin increased. Mice fed high-fat chow showed a delayed decrease in antral cilia, increased plasma gastrin, and gastric acidity. Mice fed high-fat chow for 3 wk showed lower cilia numbers and acid but higher gastrin levels than mice fed a standard diet, suggesting that fat affects gastric physiology. Ex vivo experiments showed that cilia in the corpus responded to acid and distension, whereas cilia in the antrum responded to food. To analyze the role of gastric cilia, we conditionally deleted the intraflagellar transport protein Ift88 (Ift88(-/fl)). In fed Ift88(-/fl) mice, gastrin levels were higher, and gastric acidity was lower. Moreover, gastrin and Sst gene expression did not change in response to food as in controls. At 8 mo, Ift88(-/fl) mice developed foveolar hyperplasia, hypergastrinemia, and hypochlorhydria associated with endocrine dysfunction. Our results show that components of food (fat) are sensed by antral cilia on endocrine cells, which modulates gastrin secretion and gastric acidity.-Saqui-Salces, M., Dowdle, W. E., Reiter, J. F., Merchant, J. L. A high-fat diet regulates gastrin and acid secretion through primary cilia. FASEB J. 26, 3127-3139 (2012). www.fasebj.org	[Saqui-Salces, Milena; Merchant, Juanita L.] Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA; [Merchant, Juanita L.] Univ Michigan, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA; [Dowdle, William E.; Reiter, Jeremy F.] Univ Calif San Francisco, Dept Biochem & Biophys, Cardiovasc Res Inst, San Francisco, CA 94143 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of California System; University of California San Francisco	Merchant, JL (corresponding author), Univ Michigan, Dept Internal Med & Mol & Integrat Physiol, 109 Zina Pitcher Pl,BSRB,Rm 2051, Ann Arbor, MI 48109 USA.	merchanj@umich.edu	Merchant, Juanita/AAF-8277-2019; Dowdle, William/F-3424-2011	Merchant, Juanita/0000-0002-6559-8184; Saqui-Salces, Milena/0000-0001-5848-0092	U.S. National Institutes of Health [P01-DK62041, R01-AR054396, R01-GM095941]; California Institute for Regenerative Medicine [TG2-01153]; Burroughs Wellcome Fund; Packard Foundation; Sandler Family Supporting Foundation; Helmsley Charitable Trust; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR054396] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK062041, P30DK074038, R37DK045729] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM095941] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); California Institute for Regenerative Medicine(California Institute for Regenerative Medicine); Burroughs Wellcome Fund(Burroughs Wellcome Fund); Packard Foundation(The David & Lucile Packard Foundation); Sandler Family Supporting Foundation; Helmsley Charitable Trust; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank Linda C. Samuelson for her critical comments on the preparation of this manuscript. The research was made possible by grants from the U.S. National Institutes of Health (P01-DK62041 to J.L.M.; R01-AR054396, and R01-GM095941 to J.F.R.) and from the California Institute for Regenerative Medicine (TG2-01153), the Burroughs Wellcome Fund, the Packard Foundation, the Sandler Family Supporting Foundation, and the Helmsley Charitable Trust (to J.F.R.).	Al Massadi O, 2010, J ENDOCRINOL INVEST, V33, P599, DOI 10.1007/BF03346655; BACHWICH D, 1992, MOL ENDOCRINOL, V6, P1175, DOI 10.1210/me.6.8.1175; Baly C, 2007, BRAIN RES, V1129, P130, DOI 10.1016/j.brainres.2006.10.030; Barrachina MD, 1997, AM J PHYSIOL-REG I, V272, pR1007, DOI 10.1152/ajpregu.1997.272.3.R1007; Barrachina MD, 1997, P NATL ACAD SCI USA, V94, P10455, DOI 10.1073/pnas.94.19.10455; Bewick GA, 2009, DIABETES, V58, P840, DOI 10.2337/db08-1428; Boushey RP, 2003, GASTROENTEROLOGY, V125, P1164, DOI 10.1016/S0016-5085(03)01195-8; BRUNO JF, 1993, ENDOCRINOLOGY, V133, P2561, DOI 10.1210/en.133.6.2561; Caspary T, 2007, DEV CELL, V12, P767, DOI 10.1016/j.devcel.2007.03.004; Dezaki K, 2011, DIABETES, V60, P2315, DOI 10.2337/db11-0368; Dixit D, 2006, AM J PHYSIOL-GASTR L, V291, pG1129, DOI 10.1152/ajpgi.00518.2005; DOXSEY SJ, 1994, CELL, V76, P639, DOI 10.1016/0092-8674(94)90504-5; Girard D, 2011, NAT REV ENDOCRINOL, V7, P77, DOI 10.1038/nrendo.2010.210; Gomez G, 1996, REGUL PEPTIDES, V67, P55, DOI 10.1016/S0167-0115(96)00107-3; Grossini E, 2011, J APPL PHYSIOL, V110, P95, DOI 10.1152/japplphysiol.00625.2010; Guo DF, 2011, TRENDS ENDOCRIN MET, V22, P286, DOI 10.1016/j.tem.2011.02.009; Haid D, 2011, J MOL HISTOL, V42, P355, DOI 10.1007/s10735-011-9339-1; Handel M, 1999, NEUROSCIENCE, V89, P909, DOI 10.1016/S0306-4522(98)00354-6; Harfe BD, 2004, CELL, V118, P517, DOI 10.1016/j.cell.2004.07.024; Hashimoto K, 1999, ARCH HISTOL CYTOL, V62, P181, DOI 10.1679/aohc.62.181; Hass N, 2010, CELL TISSUE RES, V339, P493, DOI 10.1007/s00441-009-0907-6; Haycraft CJ, 2007, DEVELOPMENT, V134, P307, DOI 10.1242/dev.02732; Hildebrand P, 2001, GUT, V49, P23, DOI 10.1136/gut.49.1.23; Howard TA, 1996, J ANAT, V189, P303; Iwakura H, 2010, ENDOCRINOLOGY, V151, P2940, DOI 10.1210/en.2010-0090; Iwanaga T, 2011, BIOMED RES-TOKYO, V32, P73, DOI 10.2220/biomedres.32.73; Jackson K, 2011, DIGEST DIS SCI, V56, P125, DOI 10.1007/s10620-010-1422-z; Judd LM, 2005, J GASTROEN HEPATOL, V20, P1266, DOI 10.1111/j.1440-1746.2005.03867.x; KARAM SM, 1993, ANAT REC, V236, P333, DOI 10.1002/ar.1092360206; Kentish S, 2012, J PHYSIOL-LONDON, V590, P209, DOI 10.1113/jphysiol.2011.222158; Kidd M, 2009, GASTROENTEROLOGY, V137, P231, DOI 10.1053/j.gastro.2009.01.005; KORMAN MG, 1971, GUT, V12, P619, DOI 10.1136/gut.12.8.619; LeSauter J, 2009, P NATL ACAD SCI USA, V106, P13582, DOI 10.1073/pnas.0906426106; Lin FM, 2003, P NATL ACAD SCI USA, V100, P5286, DOI 10.1073/pnas.0836980100; MANELA FD, 1992, LIFE SCI, V51, P1363, DOI 10.1016/0024-3205(92)90636-4; MCINTOSH C, 1978, GUT, V19, P655, DOI 10.1136/gut.19.7.655; Mensah-Osman E, 2008, AM J PHYSIOL-GASTR L, V295, pG843, DOI 10.1152/ajpgi.00607.2007; Mensah-Osman E, 2008, REGUL PEPTIDES, V151, P115, DOI 10.1016/j.regpep.2008.03.009; Pashankar DS, 2001, J PEDIATR GASTR NUTR, V33, P537, DOI 10.1097/00005176-200111000-00005; Perez-Tilve D, 2011, FASEB J, V25, P2814, DOI 10.1096/fj.11-183632; Rau T, 2005, J PATHOL, V206, P383, DOI 10.1002/path.1795; SAKAI N, 1989, Auris Nasus Larynx, V16, P177; SANDVIK AK, 1995, AM J PHYSIOL-GASTR L, V269, pG542, DOI 10.1152/ajpgi.1995.269.4.G542; Saqui-Salces M, 2011, HISTOCHEM CELL BIOL, V136, P191, DOI 10.1007/s00418-011-0831-1; Satir P, 2010, J CELL SCI, V123, P499, DOI 10.1242/jcs.050377; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Seoane LM, 2007, J ENDOCRINOL INVEST, V30, pRC22, DOI 10.1007/BF03350806; Shinozaki K, 2010, NUTR CANCER, V62, P1067, DOI 10.1080/01635581.2010.492086; Silva AP, 2005, EUR J ENDOCRINOL, V152, P887, DOI 10.1530/eje.1.01914; Singh P, 2000, CURR OPIN GASTROEN, V16, P68, DOI 10.1097/00001574-200001000-00013; Singla V, 2006, SCIENCE, V313, P629, DOI 10.1126/science.1124534; Steiger A, 2011, MOL CELL ENDOCRINOL, V340, P88, DOI 10.1016/j.mce.2011.02.013; Takaishi S, 2011, AM J PHYSIOL-GASTR L, V300, pG334, DOI 10.1152/ajpgi.00134.2010; TAUPIN DR, 1995, PEPTIDES, V16, P1001, DOI 10.1016/0196-9781(95)00070-Z; Tellez N, 2011, ENDOCRINOLOGY, V152, P2580, DOI 10.1210/en.2011-0066; Tennant SM, 2008, INFECT IMMUN, V76, P639, DOI 10.1128/IAI.01138-07; Ueno H, 2005, REGUL PEPTIDES, V126, P11, DOI 10.1016/j.regpep.2004.08.007; UVNASMOBERG K, 1984, SCAND J GASTROENTERO, V19, P131; UVNASWALLENSTEN K, 1980, ACTA PHYSIOL SCAND, V110, P391, DOI 10.1111/j.1748-1716.1980.tb06686.x; VALENZUELA JE, 1976, GASTROENTEROLOGY, V71, P409; Vesper BJ, 2009, CURR DRUG METAB, V10, P84, DOI 10.2174/138920009787048392; Waghray M, 2010, GASTROENTEROLOGY, V138, P562, DOI 10.1053/j.gastro.2009.10.043; WALSH JH, 1975, NEW ENGL J MED, V292, P1324, DOI 10.1056/NEJM197506192922505; Wang TC, 2000, GASTROENTEROLOGY, V118, P36, DOI 10.1016/S0016-5085(00)70412-4; Waters AM, 2011, PEDIATR NEPHROL, V26, P1039, DOI 10.1007/s00467-010-1731-7; WU V, 1991, GASTROENTEROLOGY, V101, P1552, DOI 10.1016/0016-5085(91)90391-W; Xia Q, 2004, REGUL PEPTIDES, V122, P173, DOI 10.1016/j.regpep.2004.06.016; Xiao C, 2010, GASTROENTEROLOGY, V138, P550, DOI 10.1053/j.gastro.2009.11.002; Yoder BK, 2002, J AM SOC NEPHROL, V13, P2508, DOI 10.1097/01.ASN.0000029587.47950.25; Zavros Y, 1998, AM J PHYSIOL-GASTR L, V274, pG742, DOI 10.1152/ajpgi.1998.274.4.G742; Zavros Y, 2003, P NATL ACAD SCI USA, V100, P12944, DOI 10.1073/pnas.2135193100; Zavros Y, 2005, ONCOGENE, V24, P2354, DOI 10.1038/sj.onc.1208407; Zavros Y, 1997, J PHYSIOL-LONDON, V505, P811, DOI 10.1111/j.1469-7793.1997.811ba.x	73	38	38	0	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2012	26	8					3127	3139		10.1096/fj.11-197426	http://dx.doi.org/10.1096/fj.11-197426			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	984BI	22516298	Green Published, Green Submitted			2022-12-25	WOS:000307162800005
J	Vila-Bedmar, R; Garcia-Guerra, L; Nieto-Vazquez, I; Mayor, F; Lorenzo, M; Murga, C; Fernandez-Veledo, S				Vila-Bedmar, Rocio; Garcia-Guerra, Lucia; Nieto-Vazquez, Iria; Mayor, Federico, Jr.; Lorenzo, Margarita; Murga, Cristina; Fernandez-Veledo, Sonia			GRK2 contribution to the regulation of energy expenditure and brown fat function	FASEB JOURNAL			English	Article						brown adipose tissue; thermogenesis; cold exposure; obesity	ACTIVATED PROTEIN-KINASE; MITOCHONDRIAL UNCOUPLING PROTEIN; DIET-INDUCED OBESITY; ADIPOSE-TISSUE; ADAPTIVE THERMOGENESIS; INSULIN-RESISTANCE; ACID-METABOLISM; ADULT HUMANS; 2 PLAYS; RECEPTOR	Obesity is a major health problem and an important risk factor for the development of multiple disorders. Previous studies in our laboratory have revealed that down-regulation of GRK2 decreases age-related adiposity, but the physiological and molecular mechanisms underlying this outcome remain unclear. We evaluate whether the lean phenotype results from a direct effect of GRK2 on energy homeostasis. The study of white adipose tissue (WAT) in wild-type (WT) and GRK2(+/-) littermates showed a reduced expression of lipogenic enzymes and enhanced lipolytic rate in adult GRK2(+/-) mice. Moreover, hemizygous mice display higher energy expenditure and lower respiratory exchange ratio. Analysis of brown adipose tissue (BAT) from adult GRK2(+/-) mice showed a less deteriorated morphology associated with age compared to WT, which is correlated with a higher basal core temperature. BAT from young GRK2(+/-) mice showed an increase in gene expression of thermogenesis-related genes. Accordingly, hemizygous mice displayed better thermogenic capacity and exhibited a more oxidative phenotype in both BAT and WAT than WT littermates. Overexpression of GRK2 in brown adipocytes corroborated the negative effect of this kinase in BAT function and differentiation. Collectively, our data point to GRK2 inhibition as a potential tool for the enhancement of brown fat activity, which may have important therapeutic implications for the treatment of obesity and associated metabolic disorders.-Vila-Bedmar, R., Garcia-Guerra, L., Nieto-Vazquez, I., Mayor, F., Jr., Lorenzo, M., Murga, C., Fernandez-Veledo, S. GRK2 contribution to the regulation of energy expenditure and brown fat function. FASEB J. 26, 3503-3514 (2012). www.fasebj.org	[Fernandez-Veledo, Sonia] Univ Rovira & Virgili, Hosp Univ Tarragona Joan XXIII, Res Unit, IISPV,CIBERDEM, Tarragona 43007, Spain; [Garcia-Guerra, Lucia] UAM, CSIC, Inst Invest Biomed Alberto Sols, CIBER Enfermedades Neurodegenerat CIBERNED, Madrid, Spain; [Vila-Bedmar, Rocio; Mayor, Federico, Jr.; Murga, Cristina] Inst Invest Sanitaria IIS La Princesa, Madrid, Spain; [Vila-Bedmar, Rocio; Mayor, Federico, Jr.; Murga, Cristina] UAM, CSIC, Ctr Biol Mol Severo Ochoa, Madrid, Spain; [Vila-Bedmar, Rocio; Mayor, Federico, Jr.; Murga, Cristina] UAM, CSIC, Dept Biol Mol, Madrid, Spain; [Vila-Bedmar, Rocio; Garcia-Guerra, Lucia; Nieto-Vazquez, Iria; Lorenzo, Margarita; Fernandez-Veledo, Sonia] Univ Complutense, Dept Biochem & Mol Biol 2, Sch Pharm, Ctr Invest Biomed Red CIBER Diabet & Enfermedades, E-28040 Madrid, Spain	CIBER - Centro de Investigacion Biomedica en Red; CIBERDEM; Universitat Rovira i Virgili; Hospital Universitari De Tarragona Joan XXIII; Institut d'Investigacio Sanitaria Pere Virgili (IISPV); Autonomous University of Madrid; CIBERNED; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas Alberto Sols (IIBM); Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM); Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; Complutense University of Madrid	Fernandez-Veledo, S (corresponding author), Univ Rovira & Virgili, Hosp Univ Tarragona Joan XXIII, Res Unit, IISPV,CIBERDEM, C-O Dr Mallafre Guasch 4, Tarragona 43007, Spain.	sonia.fernandezveledo@gmail.com	Mayor, Federico/N-7644-2016; Bedmar, Rocio Vila/R-9140-2018; Fernández-Veledo, Sonia/V-4625-2018; Murga, Cristina/E-1965-2014	Bedmar, Rocio Vila/0000-0002-0973-5156; Fernández-Veledo, Sonia/0000-0003-2906-3788; Murga, Cristina/0000-0002-8964-4077; Garcia, Lucia/0000-0002-8321-3137; Mayor Menendez, Federico/0000-0003-1434-8449	Ministerio de Educacion y Ciencia [SAF2008-00552, BFU2008-04043]; Fundacion Ramon Areces, Comunidad de Madrid [S-SAL-0159-2006]; Ministerio Sanidad y Consumo-Instituto Carlos III via The Cardiovascular Network (RECAVA) [RD06-0014/0037, PS09/0128]; Fondo de Investigacion Sanitaria (FIS) Miguel Servet [CP10/00438]; European Regional Development Fund (ERDF)	Ministerio de Educacion y Ciencia(Spanish Government); Fundacion Ramon Areces, Comunidad de Madrid(Comunidad de Madrid); Ministerio Sanidad y Consumo-Instituto Carlos III via The Cardiovascular Network (RECAVA); Fondo de Investigacion Sanitaria (FIS) Miguel Servet; European Regional Development Fund (ERDF)(European Commission)	This work was funded by grants from Ministerio de Educacion y Ciencia (SAF2008-00552 to F. M. and BFU2008-04043 to S. F. V.), Fundacion Ramon Areces, Comunidad de Madrid (S-SAL-0159-2006), and Ministerio Sanidad y Consumo-Instituto Carlos III via The Cardiovascular Network (RECAVA, RD06-0014/0037 to F. M. and PS09/0128 to C. M.). S. F. V. is supported by a fellowship from the Fondo de Investigacion Sanitaria (FIS) Miguel Servet CP10/00438, cofinanced by the European Regional Development Fund (ERDF). R. B. V. designed and conducted experiments, interpreted data, prepared figures, and drafted and revised the manuscript; L. G. G. conducted experiments and prepared figures; I.N.V. designed experiments and analyzed results; F. M. conceived and designed experiments, analyzed results, performed critical revision, and approved the final manuscript; M. L. conceived and designed experiments and interpreted and revised results; C. M. analyzed and interpreted data and prepared, revised, and approved the final manuscript; S. F. V. conceived and designed experiments, analyzed and interpreted results, and drafted, revised, and approved the final manuscript. The authors declare no conflicts of interest.	Anis Y, 2004, DIABETOLOGIA, V47, P1232, DOI 10.1007/s00125-004-1444-1; Atgie C, 1997, AM J PHYSIOL-CELL PH, V273, pC1136, DOI 10.1152/ajpcell.1997.273.4.C1136; Barroso E, 2011, ENDOCRINOLOGY, V152, P1848, DOI 10.1210/en.2010-1468; BIANCO AC, 1987, AM J PHYSIOL, V253, pE255, DOI 10.1152/ajpendo.1987.253.3.E255; Bianco AC, 2002, ENDOCR REV, V23, P38, DOI 10.1210/er.23.1.38; Brinks H, 2011, FUTUR CARDIOL, V7, P547, DOI [10.2217/FCA.11.36, 10.2217/fca.11.36]; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; Cannon B, 2010, INT J OBESITY, V34, pS7, DOI 10.1038/ijo.2010.177; Cao WH, 2004, MOL CELL BIOL, V24, P3057, DOI 10.1128/MCB.24.7.3057-3067.2004; Carpentier AC, 2008, DIABETES METAB, V34, P97, DOI 10.1016/j.diabet.2007.10.009; CARVALHO SD, 1991, ENDOCRINOLOGY, V128, P2149, DOI 10.1210/endo-128-4-2149; Christoffolete MA, 2004, DIABETES, V53, P577, DOI 10.2337/diabetes.53.3.577; Cipolletta E, 2009, CARDIOVASC RES, V84, P407, DOI 10.1093/cvr/cvp252; Collins S, 2004, MOL ENDOCRINOL, V18, P2123, DOI 10.1210/me.2004-0193; Collins S, 2010, INT J OBESITY, V34, pS28, DOI 10.1038/ijo.2010.180; Cypess AM, 2009, NEW ENGL J MED, V360, P1509, DOI 10.1056/NEJMoa0810780; de Jesus LA, 2001, J CLIN INVEST, V108, P1379, DOI 10.1172/JCI200113803; Enerback S, 1997, NATURE, V387, P90, DOI 10.1038/387090a0; Florez-Duquet M, 1998, PHYSIOL REV, V78, P339, DOI 10.1152/physrev.1998.78.2.339; Garcia-Guerra L, 2010, DIABETES, V59, P2407, DOI 10.2337/db10-0771; Golozoubova V, 2001, FASEB J, V15, P2048, DOI 10.1096/fj.00-0536fje; Gray SL, 2006, ENDOCRINOLOGY, V147, P5708, DOI 10.1210/en.2006-0684; Haemmerle G, 2006, SCIENCE, V312, P734, DOI 10.1126/science.1123965; Hall JA, 2010, ENDOCRINOLOGY, V151, P4573, DOI 10.1210/en.2010-0511; Harvey A. N., 2011, CURR MOL PHARM; Hernandez A, 1996, MOL CELL ENDOCRINOL, V121, P37, DOI 10.1016/0303-7207(96)03849-X; Hutchinson DS, 2005, DIABETOLOGIA, V48, P2386, DOI 10.1007/s00125-005-1936-7; Jimenez-Sainz MC, 2006, MOL BIOL CELL, V17, P25, DOI 10.1091/mbc.e05-05-0399; Kolditz CI, 2010, CURR OPIN CLIN NUTR, V13, P377, DOI 10.1097/MCO.0b013e32833bed6a; Kopecky J, 1995, J CLIN INVEST, V96, P2914, DOI 10.1172/JCI118363; LIGGETT SB, 1993, P NATL ACAD SCI USA, V90, P3665, DOI 10.1073/pnas.90.8.3665; Lopez M, 2010, NAT MED, V16, P1001, DOI 10.1038/nm.2207; Lowell BB, 2000, NATURE, V404, P652, DOI 10.1038/35007527; Mayor Federico Jr., 2011, Archives of Physiology and Biochemistry, V117, P125, DOI 10.3109/13813455.2011.584693; McDonald RB, 1999, J BIOENERG BIOMEMBR, V31, P507, DOI 10.1023/A:1005404708710; Mulligan JD, 2007, J PHYSIOL-LONDON, V580, P677, DOI 10.1113/jphysiol.2007.128652; Nedergaard J, 2007, AM J PHYSIOL-ENDOC M, V293, pE444, DOI 10.1152/ajpendo.00691.2006; Nedergaard J, 2010, CELL METAB, V11, P268, DOI 10.1016/j.cmet.2010.03.007; Peregrin S, 2006, CURR BIOL, V16, P2042, DOI 10.1016/j.cub.2006.08.083; Perwitz N, 2010, DIABETES OBES METAB, V12, P158, DOI 10.1111/j.1463-1326.2009.01133.x; Petrovic N, 2008, AM J PHYSIOL-ENDOC M, V295, pE287, DOI 10.1152/ajpendo.00035.2008; Puigserver P, 2001, MOL CELL, V8, P971, DOI 10.1016/S1097-2765(01)00390-2; Qi JZ, 2008, EMBO J, V27, P1537, DOI 10.1038/emboj.2008.92; Ribas C, 2007, BBA-BIOMEMBRANES, V1768, P913, DOI 10.1016/j.bbamem.2006.09.019; Ricquier D, 2005, P NUTR SOC, V64, P47, DOI 10.1079/PNS2004408; Robidoux J, 2005, MOL CELL BIOL, V25, P5466, DOI 10.1128/MCB.25.13.5466-5479.2005; Sabio G, 2010, GENE DEV, V24, P256, DOI 10.1101/gad.1878510; Sell H, 2004, INT J BIOCHEM CELL B, V36, P2098, DOI 10.1016/j.biocel.2004.04.003; Shahid G, 2007, J BIOL CHEM, V282, P20612, DOI 10.1074/jbc.M700744200; Silva JE, 2008, THYROID, V18, P157, DOI 10.1089/thy.2007.0252; St-Onge MP, 2005, CURR OPIN CLIN NUTR, V8, P523; Tabbi-Anneni I, 2010, AM J PHYSIOL-ENDOC M, V298, pE961, DOI 10.1152/ajpendo.00655.2009; Tansey JT, 2001, P NATL ACAD SCI USA, V98, P6494, DOI 10.1073/pnas.101042998; Usui I, 2004, EMBO J, V23, P2821, DOI 10.1038/sj.emboj.7600297; Valle A, 2008, REJUV RES, V11, P597, DOI 10.1089/rej.2007.0626; Vila-Bedmar Rocio, 2011, Archives of Physiology and Biochemistry, V117, P195, DOI 10.3109/13813455.2011.560951; Vila-Bedmar R, 2010, ENDOCRINOLOGY, V151, P980, DOI 10.1210/en.2009-0810; Villena JA, 2007, P NATL ACAD SCI USA, V104, P1418, DOI 10.1073/pnas.0607696104; Virtanen KA, 2009, NEW ENGL J MED, V360, P1518, DOI 10.1056/NEJMoa0808949; Weiser M, 1997, J CLIN PHARMACOL, V37, P453, DOI 10.1002/j.1552-4604.1997.tb04323.x; Zingaretti MC, 2009, FASEB J, V23, P3113, DOI 10.1096/fj.09-133546	61	24	24	0	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	AUG	2012	26	8					3503	3514		10.1096/fj.11-202267	http://dx.doi.org/10.1096/fj.11-202267			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	984BI	22516294				2022-12-25	WOS:000307162800037
J	Pandey, V; Kumar, V				Pandey, Vijaya; Kumar, Vijay			HBx Protein of Hepatitis B Virus Promotes Reinitiation of DNA Replication by Regulating Expression and Intracellular Stability of Replication Licensing Factor CDC6	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-CYCLE; X-PROTEIN; MAMMALIAN CDC6; CHROMOSOMAL INSTABILITY; HEPATOCELLULAR-CARCINOMA; RETINOBLASTOMA PROTEIN; TUMOR-GROWTH; GENE; E2F; PHOSPHORYLATION	Prevention of re-replication via negative regulation of replication initiator proteins, such as CDC6, is key to maintenance of genomic integrity, whereas their up-regulation is generally associated with perturbation in cell cycle, genomic instability, and potentially, tumorigenesis. The HBx oncoprotein of hepatitis B virus is well known to deregulate cell cycle and has been intricately linked to development of hepatocellular carcinoma. Despite a clear understanding of the proliferative effects of HBx on cell cycle, a mechanistic link between HBx-mediated hepato-carcinogenesis and host cell DNA replication remains poorly perused. Here we show that HBx overexpression in both the cellular as well as the transgenic environment resulted in the accumulation of CDC6 through transcriptional and post-translational up-regulation. The HBx-mediated increase in CDK2 activity altered the E2F1-Rb (retinoblastoma) balance, which favored CDC6 gene expression by E2F1. Besides, HBx impaired the APC(Cdh1)-dependent protein degradation pathway and conferred intracellular stability to CDC6 protein. Increase in CDC6 levels correlated with increase in CDC6 occupancy on the beta-globin origin of replication, suggesting increment in origin licensing and re-replication. In conclusion, our findings strongly suggest a novel role for CDC6 in abetting the oncogenic sabotage carried out by HBx and support the paradigm that pre-replicative complex proteins have a role in oncogenic transformation.	[Pandey, Vijaya; Kumar, Vijay] Int Ctr Genet Engn & Biotechnol, Virol Grp, New Delhi 110067, India	Department of Biotechnology (DBT) India; International Center for Genetic Engineering & Biotechnology (ICGEB); International Center for Genetic Engineering & Biotechnology (ICGEB), New Delhi	Kumar, V (corresponding author), Int Ctr Genet Engn & Biotechnol, Virol Grp, Aruna Asaf Ali Marg, New Delhi 110067, India.	vijay@icgeb.res.in		Pandey, Vijaya/0000-0002-5675-5504	Department of Biotechnology, Ministry of Science and Technology, Government of India, New Delhi [BT/PR13228/Med/29/157/2009]	Department of Biotechnology, Ministry of Science and Technology, Government of India, New Delhi(Department of Biotechnology (DBT) IndiaMinistry of Science and Technology, Government of India)	This work was supported by Grant BT/PR13228/Med/29/157/2009 of the Department of Biotechnology, Ministry of Science and Technology, Government of India, New Delhi.	Arentson E, 2002, ONCOGENE, V21, P1150, DOI 10.1038/sj.onc.1205175; Asano M, 1999, EMBO J, V18, P2435, DOI 10.1093/emboj/18.9.2435; Bassermann F, 2008, CELL, V134, P256, DOI 10.1016/j.cell.2008.05.043; Bell SP, 2002, ANNU REV BIOCHEM, V71, P333, DOI 10.1146/annurev.biochem.71.110601.135425; Benhenda S, 2009, ADV CANCER RES, V103, P75, DOI 10.1016/S0065-230X(09)03004-8; Borlado LR, 2008, CARCINOGENESIS, V29, P237, DOI 10.1093/carcin/bgm268; Bouchard MJ, 2004, J VIROL, V78, P12725, DOI 10.1128/JVI.78.23.12725-12734.2004; Carter SL, 2006, NAT GENET, V38, P1043, DOI 10.1038/ng1861; Christensen J, 2005, NUCLEIC ACIDS RES, V33, P5458, DOI 10.1093/nar/gki855; Cook JG, 2002, P NATL ACAD SCI USA, V99, P1347, DOI 10.1073/pnas.032677499; Di Paola D, 2010, NUCLEIC ACIDS RES, V38, P2314, DOI 10.1093/nar/gkp1192; Drury LS, 1997, EMBO J, V16, P5966, DOI 10.1093/emboj/16.19.5966; Duursma A, 2005, MOL CELL BIOL, V25, P6937, DOI 10.1128/MCB.25.16.6937-6947.2005; Enjuanes A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019736; Francis D, 2007, NEW PHYTOL, V174, P261, DOI 10.1111/j.1469-8137.2007.02038.x; Gearhart TL, 2011, VIRUS RES, V155, P363, DOI 10.1016/j.virusres.2010.09.023; Gonzalez S, 2006, NATURE, V440, P702, DOI 10.1038/nature04585; Hateboer G, 1998, MOL CELL BIOL, V18, P6679, DOI 10.1128/MCB.18.11.6679; Herbig U, 2000, MOL BIOL CELL, V11, P4117, DOI 10.1091/mbc.11.12.4117; Herwig S, 1997, EUR J BIOCHEM, V246, P581, DOI 10.1111/j.1432-1033.1997.t01-2-00581.x; Hsieh JK, 1997, GENE DEV, V11, P1840, DOI 10.1101/gad.11.14.1840; Janbandhu VC, 2010, J BIOL CHEM, V285, P17453, DOI 10.1074/jbc.M109.058974; Jiang W, 1999, P NATL ACAD SCI USA, V96, P6193, DOI 10.1073/pnas.96.11.6193; Johnson David G., 1998, Frontiers in Bioscience, V3, pD447; Jung JK, 2007, CANCER RES, V67, P5771, DOI 10.1158/0008-5472.CAN-07-0529; Karakaidos P, 2004, AM J PATHOL, V165, P1351, DOI 10.1016/S0002-9440(10)63393-7; Kew MC, 2011, J GASTROEN HEPATOL, V26, P144, DOI 10.1111/j.1440-1746.2010.06546.x; Kumar V, 1996, P NATL ACAD SCI USA, V93, P5647, DOI 10.1073/pnas.93.11.5647; Kumar V, 1998, HYBRIDOMA, V17, P157, DOI 10.1089/hyb.1998.17.157; Lakhtakia R, 2003, J GASTROEN HEPATOL, V18, P80, DOI 10.1046/j.1440-1746.2003.02902.x; Lau E, 2006, CELL CYCLE, V5, P1602, DOI 10.4161/cc.5.15.3124; Mailand N, 2005, CELL, V122, P915, DOI 10.1016/j.cell.2005.08.013; Masai H, 2010, ANNU REV BIOCHEM, V79, P89, DOI 10.1146/annurev.biochem.052308.103205; Mukherji A., 2008, PLEIOTROPIC FUNCTION, P165; Mukherji A, 2007, BIOCHEM J, V401, P247, DOI 10.1042/BJ20061091; Ohta S, 2001, ONCOL REP, V8, P1063; Ohtani K, 1998, ONCOGENE, V17, P1777, DOI 10.1038/sj.onc.1202105; Petersen BO, 2000, GENE DEV, V14, P2330, DOI 10.1101/gad.832500; Petersen BO, 1999, EMBO J, V18, P396, DOI 10.1093/emboj/18.2.396; Rakotomalala L, 2008, J BIOL CHEM, V283, P28729, DOI 10.1074/jbc.M802751200; SELLS MA, 1987, P NATL ACAD SCI USA, V84, P1005, DOI 10.1073/pnas.84.4.1005; Tatsumi Y, 2006, J CELL SCI, V119, P3128, DOI 10.1242/jcs.03031; Vaziri C, 2003, MOL CELL, V11, P997, DOI 10.1016/S1097-2765(03)00099-6; VOUSDEN KH, 1995, SEMIN CANCER BIOL, V6, P109, DOI 10.1006/scbi.1995.0014; Wang CX, 2000, BLOOD, V96, P259, DOI 10.1182/blood.V96.1.259.013k36_259_263; Williams RS, 1997, P NATL ACAD SCI USA, V94, P142, DOI 10.1073/pnas.94.1.142; Yan Z, 1998, P NATL ACAD SCI USA, V95, P3603, DOI 10.1073/pnas.95.7.3603	47	17	18	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 8	2012	287	24					20545	20554		10.1074/jbc.M112.359760	http://dx.doi.org/10.1074/jbc.M112.359760			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974FB	22523071	Green Published, hybrid			2022-12-25	WOS:000306414500075
J	Hebecker, M; Jozsi, M				Hebecker, Mario; Jozsi, Mihaly			Factor H-related Protein 4 Activates Complement by Serving as a Platform for the Assembly of Alternative Pathway C3 Convertase via Its Interaction with C3b Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEMOLYTIC-UREMIC SYNDROME; REACTIVE-PROTEIN; MOLECULAR-BASIS; NECROTIC CELLS; BINDING; FHR-4; POLYANIONS; PROPERDIN; DISEASE; HEPARIN	Human complement factor H-related protein (CFHR) 4 belongs to the factor H family of plasma glycoproteins that are composed of short consensus repeat (SCR) domains. Although factor H is a well known inhibitor of the alternative complement pathway, the functions of the CFHR proteins are poorly understood. CFHR4 lacks SCRs homologous to the complement inhibitory domains of factor H and, accordingly, has no significant complement regulatory activities. We have previously shown that CFHR4 binds C-reactive protein via its most N-terminal SCR, which leads to classical complement pathway activation. CFHR4 binds C3b via its C terminus, but the significance of this interaction is unclear. Therefore, we set out to clarify the functional relevance of C3b binding by CFHR4. Here, we report a novel role for CFHR4 in the complement system. CFHR4 serves as a platform for the assembly of an alternative pathway C3 convertase by binding C3b. This is based on the sustained ability of CFHR4-bound C3b to bind factor B and properdin, leading to an active convertase that generates C3a and C3b from C3. The CFHR4-C3bBb convertase is less sensitive to the factor H-mediated decay compared with the C3bBb convertase. CFHR4 mutants containing exchanges of conserved residues within the C-terminal C3b-binding site showed significantly reduced C3b binding and alternative pathway complement activation. In conclusion, our results suggest that, in contrast to the complement inhibitor factor H, CFHR4 acts as an enhancer of opsonization by promoting complement activation.	[Hebecker, Mario; Jozsi, Mihaly] Hans Knoell Inst, Leibniz Inst Nat Prod Res & Infect Biol, Jr Res Grp Cellular Immunobiol, D-07745 Jena, Germany	Hans Knoll Institute (HKI)	Jozsi, M (corresponding author), Hans Knoell Inst, Leibniz Inst Nat Prod Res & Infect Biol, Jr Res Grp Cellular Immunobiol, Beutenbergstr 11A, D-07745 Jena, Germany.	mihaly.jozsi@gmx.net	Jozsi, Mihaly/I-7872-2018	Jozsi, Mihaly/0000-0002-5520-5535				de Cordoba SR, 2004, MOL IMMUNOL, V41, P355, DOI 10.1016/j.molimm.2004.02.005; Ferreira VP, 2009, J IMMUNOL, V182, P7009, DOI 10.4049/jimmunol.0804031; Friberg N, 2008, J IMMUNOL, V181, P8624, DOI 10.4049/jimmunol.181.12.8624; Fritsche LG, 2010, HUM MOL GENET, V19, P4694, DOI 10.1093/hmg/ddq399; Harboe M, 2008, J CELL MOL MED, V12, P1074, DOI 10.1111/j.1582-4934.2008.00350.x; Hebecker M, 2010, MOL IMMUNOL, V47, P1347, DOI 10.1016/j.molimm.2009.12.005; Heinen S, 2009, BLOOD, V114, P2439, DOI 10.1182/blood-2009-02-205641; Hellwage J, 1999, FEBS LETT, V462, P345, DOI 10.1016/S0014-5793(99)01554-9; Hellwage J, 1997, IMMUNOPHARMACOLOGY, V38, P149, DOI 10.1016/S0162-3109(97)00075-1; Hellwage J, 2002, J IMMUNOL, V169, P6935, DOI 10.4049/jimmunol.169.12.6935; Jokiranta TS, 2006, EMBO J, V25, P1784, DOI 10.1038/sj.emboj.7601052; Jozsi M, 2005, EUR J HUM GENET, V13, P321, DOI 10.1038/sj.ejhg.5201324; Jozsi M, 2008, TRENDS IMMUNOL, V29, P380, DOI 10.1016/j.it.2008.04.008; Kajander T, 2011, P NATL ACAD SCI USA, V108, P2897, DOI 10.1073/pnas.1017087108; Kopp A, 2012, BIOMOLECULES, V2, P46, DOI 10.3390/biom2010046; KUHN S, 1995, GENE, V162, P225, DOI 10.1016/0378-1119(95)00360-I; Losse J, 2010, J IMMUNOL, V184, P912, DOI 10.4049/jimmunol.0901702; McRae JL, 2005, J IMMUNOL, V174, P6250, DOI 10.4049/jimmunol.174.10.6250; McRae JL, 2001, J BIOL CHEM, V276, P6747, DOI 10.1074/jbc.M007495200; Mihlan M, 2009, MOL IMMUNOL, V46, P335, DOI 10.1016/j.molimm.2008.10.029; Morgan HP, 2011, NAT STRUCT MOL BIOL, V18, P463, DOI 10.1038/nsmb.2018; NEWMAN SL, 1985, J EXP MED, V161, P1414, DOI 10.1084/jem.161.6.1414; Ricklin D, 2010, NAT IMMUNOL, V11, P785, DOI 10.1038/ni.1923; Sahu A, 2001, IMMUNOL REV, V180, P35, DOI 10.1034/j.1600-065X.2001.1800103.x; Skerka C, 1997, J BIOL CHEM, V272, P5627, DOI 10.1074/jbc.272.9.5627; Spitzer D, 2007, J IMMUNOL, V179, P2600, DOI 10.4049/jimmunol.179.4.2600; Thurman JM, 2006, J IMMUNOL, V176, P1305, DOI 10.4049/jimmunol.176.3.1305; Trouw LA, 2007, J BIOL CHEM, V282, P28540, DOI 10.1074/jbc.M704354200; Xu W, 2008, J IMMUNOL, V180, P7613, DOI 10.4049/jimmunol.180.11.7613; Zipfel PF, 2009, NAT REV IMMUNOL, V9, P729, DOI 10.1038/nri2620	30	60	62	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 1	2012	287	23					19528	19536		10.1074/jbc.M112.364471	http://dx.doi.org/10.1074/jbc.M112.364471			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974EF	22518841	hybrid, Green Published			2022-12-25	WOS:000306411900065
J	Ying, TL; Chen, WZ; Gong, R; Feng, Y; Dimitrov, DS				Ying, Tianlei; Chen, Weizao; Gong, Rui; Feng, Yang; Dimitrov, Dimiter S.			Soluble Monomeric IgG1 Fc	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; DOMAIN ANTIBODIES; THERAPEUTIC ANTIBODIES; PROTEIN THERAPEUTICS; CRYSTAL-STRUCTURE; CONSTANT DOMAINS; FUSION PROTEIN; RECEPTOR; COMPLEX; STOICHIOMETRY	Antibody fragments are emerging as promising biopharma-ceuticals because of their relatively small size and other unique properties. However, compared with full-size antibodies, these antibody fragments lack the ability to bind the neonatal Fc receptor (FcRn) and have reduced half-lives. Fc engineered to bind antigens but preserve interactions with FcRn and Fc fused with monomeric proteins currently are being developed as candidate therapeutics with prolonged half-lives; in these and other cases, Fc is a dimer of two CH2-CH3 chains. To further reduce the size of Fc but preserve FcRn binding, we generated three human soluble monomeric IgG1 Fcs (mFcs) by using a combination of structure-based rational protein design combined with multiple screening strategies. These mFcs were highly soluble and retained binding to human FcRn comparable with that of Fc. These results provide direct experimental evidence that efficient binding to human FcRn does not require human Fc dimerization. The newly identified mFcs are promising for the development of mFc fusion proteins and for novel types of mFc-based therapeutic antibodies of small size and long half-lives.	[Ying, Tianlei; Chen, Weizao; Gong, Rui; Feng, Yang; Dimitrov, Dimiter S.] NIH, Prot Interact Grp, Ctr Canc Res, Nanobiol Program,Frederick Natl Lab Canc Res, Frederick, MD 21702 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Ying, TL (corresponding author), NIH, Prot Interact Grp, Ctr Canc Res, Nanobiol Program,Frederick Natl Lab Canc Res, Bldg 469,Rm 140, Frederick, MD 21702 USA.	yingt@mail.nih.gov	应, 天雷/P-5396-2019	应, 天雷/0000-0002-9597-2843	National Institutes of Health, National Cancer Institute, Center for Cancer Research, Frederick National Laboratory for Cancer Research [N01-CO-12400]; NATIONAL CANCER INSTITUTE [ZIABC010701, ZIABC011155] Funding Source: NIH RePORTER	National Institutes of Health, National Cancer Institute, Center for Cancer Research, Frederick National Laboratory for Cancer Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the Intramural Research Program of the National Institutes of Health, National Cancer Institute, Center for Cancer Research, Frederick National Laboratory for Cancer Research, under Contract No. N01-CO-12400.	Beck A, 2011, MABS-AUSTIN, V3, P415, DOI 10.4161/mabs.3.5.17334; Bitonti AJ, 2004, P NATL ACAD SCI USA, V101, P9763, DOI 10.1073/pnas.0403235101; Brown JH, 2006, PROTEIN SCI, V15, P1, DOI 10.1110/ps.051658406; BURMEISTER WP, 1994, NATURE, V372, P336, DOI 10.1038/372336a0; Carter PJ, 2006, NAT REV IMMUNOL, V6, P343, DOI 10.1038/nri1837; Casadevall A, 2004, NAT REV MICROBIOL, V2, P695, DOI 10.1038/nrmicro974; Chen WZ, 2008, P NATL ACAD SCI USA, V105, P17121, DOI 10.1073/pnas.0805297105; Dall'Acqua W, 1998, BIOCHEMISTRY-US, V37, P9266, DOI 10.1021/bi980270i; DEISENHOFER J, 1981, BIOCHEMISTRY-US, V20, P2361, DOI 10.1021/bi00512a001; Dimitrov DS, 2010, MABS-AUSTIN, V2, P347, DOI 10.4161/mabs.2.3.11779; Dimitrov Dimiter S., 2009, V525, P1, DOI 10.1007/978-1-59745-554-1_1; Dimitrov DS, 2009, MABS, V1, P26, DOI 10.4161/mabs.1.1.7480; Dumont JA, 2006, BIODRUGS, V20, P151, DOI 10.2165/00063030-200620030-00002; Feng Y, 2011, PROTEIN EXPRES PURIF, V79, P66, DOI 10.1016/j.pep.2011.03.012; Flanagan Meg L, 2007, Methods Mol Biol, V378, P33, DOI 10.1007/978-1-59745-323-3_3; Fouts TR, 2000, J VIROL, V74, P11427, DOI 10.1128/JVI.74.24.11427-11436.2000; Gong R, 2009, J BIOL CHEM, V284, P14203, DOI 10.1074/jbc.M900769200; Goodsell DS, 2000, ANNU REV BIOPH BIOM, V29, P105, DOI 10.1146/annurev.biophys.29.1.105; Holt LJ, 2003, TRENDS BIOTECHNOL, V21, P484, DOI 10.1016/j.tibtech.2003.08.007; HUBER AH, 1993, J MOL BIOL, V230, P1077, DOI 10.1006/jmbi.1993.1220; JAIN RK, 1990, CANCER RES, V50, pS814; Jazayeri JA, 2008, BIODRUGS, V22, P11, DOI 10.2165/00063030-200822010-00002; Labrijn AF, 2003, J VIROL, V77, P10557, DOI 10.1128/JVI.77.19.10557-10565.2003; Leader B, 2008, NAT REV DRUG DISCOV, V7, P21, DOI 10.1038/nrd2399; Martin WL, 1999, BIOCHEMISTRY-US, V38, P12639, DOI 10.1021/bi9913505; Martin WL, 2001, MOL CELL, V7, P867, DOI 10.1016/S1097-2765(01)00230-1; MILLER S, 1990, J MOL BIOL, V216, P965, DOI 10.1016/S0022-2836(99)80014-X; Nelson AL, 2009, NAT BIOTECHNOL, V27, P331, DOI 10.1038/nbt0409-331; Peters RT, 2010, BLOOD, V115, P2057, DOI 10.1182/blood-2009-08-239665; Popov S, 1996, MOL IMMUNOL, V33, P521, DOI 10.1016/0161-5890(96)00004-1; Reichert JM, 2011, MABS-AUSTIN, V3, P76, DOI 10.4161/mabs.3.1.13895; Reichert JM, 2010, MABS-AUSTIN, V2, P695, DOI 10.4161/mabs.2.6.13603; Roopenian DC, 2007, NAT REV IMMUNOL, V7, P715, DOI 10.1038/nri2155; Saerens D, 2008, CURR OPIN PHARMACOL, V8, P600, DOI 10.1016/j.coph.2008.07.006; Sanchez LM, 1999, BIOCHEMISTRY-US, V38, P9471, DOI 10.1021/bi9907330; Schrama D, 2006, NAT REV DRUG DISCOV, V5, P147, DOI 10.1038/nrd1957; SIMISTER NE, 1989, NATURE, V337, P184, DOI 10.1038/337184a0; Waldmann TA, 2003, NAT MED, V9, P269, DOI 10.1038/nm0303-269	38	51	72	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 1	2012	287	23					19399	19408		10.1074/jbc.M112.368647	http://dx.doi.org/10.1074/jbc.M112.368647			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974EF	22518843	Green Published, hybrid			2022-12-25	WOS:000306411900054
J	Caceres, ID; Valmas, N; Hilliard, MA; Lu, H				Caceres, Ivan de Carlos; Valmas, Nicholas; Hilliard, Massimo A.; Lu, Hang			Laterally Orienting C. elegans Using Geometry at Microscale for High-Throughput Visual Screens in Neurodegeneration and Neuronal Development Studies	PLOS ONE			English	Article							GENETIC SCREENS; SIGNALS	C. elegans is an excellent model system for studying neuroscience using genetics because of its relatively simple nervous system, sequenced genome, and the availability of a large number of transgenic and mutant strains. Recently, microfluidic devices have been used for high-throughput genetic screens, replacing traditional methods of manually handling C. elegans. However, the orientation of nematodes within microfluidic devices is random and often not conducive to inspection, hindering visual analysis and overall throughput. In addition, while previous studies have utilized methods to bias head and tail orientation, none of the existing techniques allow for orientation along the dorso-ventral body axis. Here, we present the design of a simple and robust method for passively orienting worms into lateral body positions in microfluidic devices to facilitate inspection of morphological features with specific dorso-ventral alignments. Using this technique, we can position animals into lateral orientations with up to 84% efficiency, compared to 21% using existing methods. We isolated six mutants with neuronal development or neurodegenerative defects, showing that our technology can be used for on-chip analysis and high-throughput visual screens.	[Caceres, Ivan de Carlos; Lu, Hang] Georgia Inst Technol, Interdisciplinary Bioengn Grad Program, Atlanta, GA 30332 USA; [Valmas, Nicholas; Hilliard, Massimo A.] Univ Queensland, Queensland Brain Inst, Brisbane, Qld, Australia; [Lu, Hang] Georgia Inst Technol, Sch Chem & Biomol Engn, Atlanta, GA 30332 USA	University System of Georgia; Georgia Institute of Technology; University of Queensland; University System of Georgia; Georgia Institute of Technology	Lu, H (corresponding author), Georgia Inst Technol, Interdisciplinary Bioengn Grad Program, Atlanta, GA 30332 USA.	hang.lu@gatech.edu		Hilliard, Massimo A/0000-0001-7458-5812; Valmas, Nicholas/0000-0002-6925-9673	Goizueta Foundation; U.S. National Science Foundation [IGERT DGE-0333411, CAREER CBET 0954578]; U.S. National Institutes of Health [F31GM093351, R21EB012803, R01GM088333, R01AG035317, R01NS060129]; National Health and Medical Research Council of Australia [569500, 631605, 631634]; Directorate For Engineering [0954578] Funding Source: National Science Foundation; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R21EB012803] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM088333, F31GM093351] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS060129] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG035317] Funding Source: NIH RePORTER	Goizueta Foundation; U.S. National Science Foundation(National Science Foundation (NSF)); U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Directorate For Engineering(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work is supported by the Goizueta Foundation (fellowship to IC), the U.S. National Science Foundation (IGERT DGE-0333411 for IC, CAREER CBET 0954578 to HL), U.S. National Institutes of Health (F31GM093351 to IC; R21EB012803, R01GM088333, and R01AG035317 to HL; R01NS060129 to MAH), and the National Health and Medical Research Council of Australia (Project Grants # 569500, 631605, 631634 to MAH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler CE, 2006, NAT NEUROSCI, V9, P511, DOI 10.1038/nn1666; Altun Z.F., 2008, WORMATLAS; Antebi Adam, 1997, Cold Spring Harbor Monograph Series, V33, P583; Arimura N, 2007, NAT REV NEUROSCI, V8, P194, DOI 10.1038/nrn2056; Ben-Yakar A, 2009, CURR OPIN NEUROBIOL, V19, P561, DOI 10.1016/j.conb.2009.10.010; BRENNER S, 1974, GENETICS, V77, P71; Chokshi TV, 2010, LAB CHIP, V10, P2758, DOI 10.1039/c004658b; Chung KH, 2008, NAT METHODS, V5, P637, DOI 10.1038/nmeth.1227; Crane MM, 2010, LAB CHIP, V10, P1509, DOI 10.1039/b927258e; Crane MM, 2009, LAB CHIP, V9, P38, DOI 10.1039/b813730g; Hao JC, 2001, NEURON, V32, P25, DOI 10.1016/S0896-6273(01)00448-2; Hilliard MA, 2006, DEV CELL, V10, P379, DOI 10.1016/j.devcel.2006.01.013; Hobert O, 2005, SPECIFICATION NERVOU; Huang X, 2002, NEURON, V34, P563, DOI 10.1016/S0896-6273(02)00672-4; Jorgensen EM, 2002, NAT REV GENET, V3, P356, DOI 10.1038/nrg794; Kaletta T, 2006, NAT REV DRUG DISCOV, V5, P387, DOI 10.1038/nrd2031; Krajniak J, 2010, LAB CHIP, V10, P1862, DOI 10.1039/c001986k; Samara C, 2010, P NATL ACAD SCI USA, V107, P18342, DOI 10.1073/pnas.1005372107; Shaham S, 2006, S METHODS CELL BIOL; Shaham S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001117; Stirman JN, 2010, J NEUROSCI METH, V191, P90, DOI 10.1016/j.jneumeth.2010.05.019; Unger MA, 2000, SCIENCE, V288, P113, DOI 10.1126/science.288.5463.113; Zeng F, 2008, LAB CHIP, V8, P653, DOI 10.1039/b804808h	23	41	41	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2012	7	4							e35037	10.1371/journal.pone.0035037	http://dx.doi.org/10.1371/journal.pone.0035037			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UD	22536350	Green Submitted, Green Published, gold			2022-12-25	WOS:000305339200033
J	Drummond, SPA; Anderson, DE; Straus, LD; Vogel, EK; Perez, VB				Drummond, Sean P. A.; Anderson, Dane E.; Straus, Laura D.; Vogel, Edward K.; Perez, Veronica B.			The Effects of Two Types of Sleep Deprivation on Visual Working Memory Capacity and Filtering Efficiency	PLOS ONE			English	Article							SHORT-TERM-MEMORY; INDIVIDUAL-DIFFERENCES; PREFRONTAL CORTEX; NEURAL BASIS; PERFORMANCE; TASK; ATTENTION; COST; DISTRACTION; VARIABILITY	Sleep deprivation has adverse consequences for a variety of cognitive functions. The exact effects of sleep deprivation, though, are dependent upon the cognitive process examined. Within working memory, for example, some component processes are more vulnerable to sleep deprivation than others. Additionally, the differential impacts on cognition of different types of sleep deprivation have not been well studied. The aim of this study was to examine the effects of one night of total sleep deprivation and 4 nights of partial sleep deprivation (4 hours in bed/night) on two components of visual working memory: capacity and filtering efficiency. Forty-four healthy young adults were randomly assigned to one of the two sleep deprivation conditions. All participants were studied: 1) in a well-rested condition (following 6 nights of 9 hours in bed/night); and 2) following sleep deprivation, in a counter-balanced order. Visual working memory testing consisted of two related tasks. The first measured visual working memory capacity and the second measured the ability to ignore distractor stimuli in a visual scene (filtering efficiency). Results showed neither type of sleep deprivation reduced visual working memory capacity. Partial sleep deprivation also generally did not change filtering efficiency. Total sleep deprivation, on the other hand, did impair performance in the filtering task. These results suggest components of visual working memory are differentially vulnerable to the effects of sleep deprivation, and different types of sleep deprivation impact visual working memory to different degrees. Such findings have implications for operational settings where individuals may need to perform with inadequate sleep and whose jobs involve receiving an array of visual information and discriminating the relevant from the irrelevant prior to making decisions or taking actions (e. g., baggage screeners, air traffic controllers, military personnel, health care providers).	[Drummond, Sean P. A.] VA San Diego Healthcare Syst, Psychol Serv, San Diego, CA USA; [Drummond, Sean P. A.; Anderson, Dane E.; Straus, Laura D.] VA San Diego Healthcare Syst, Res Serv, San Diego, CA USA; [Drummond, Sean P. A.] Univ Calif San Diego, Dept Psychiat, San Diego, CA 92103 USA; [Drummond, Sean P. A.; Straus, Laura D.] SDSU UCSD, Joint Doctoral Program Clin Psychol, San Diego, CA USA; [Vogel, Edward K.] Univ Oregon, Dept Psychol, Eugene, OR 97403 USA; [Perez, Veronica B.] Univ Calif San Francisco, Dept Psychiat, San Francisco, CA 94143 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA San Diego Healthcare System; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA San Diego Healthcare System; University of California System; University of California San Diego; University of Oregon; University of California System; University of California San Francisco	Drummond, SPA (corresponding author), VA San Diego Healthcare Syst, Psychol Serv, San Diego, CA USA.	drummond@ucsd.edu	Vogel, Edward K/AAW-9466-2021	Drummond, Sean/0000-0002-9815-626X	National Science Foundation [0729021]; VA San Diego Healthcare System Center for Excellence in Stress and Mental Health; Direct For Social, Behav & Economic Scie [0729021] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); VA San Diego Healthcare System Center for Excellence in Stress and Mental Health(US Department of Veterans Affairs); Direct For Social, Behav & Economic Scie(National Science Foundation (NSF)NSF - Directorate for Social, Behavioral & Economic Sciences (SBE))	This work was supported by a grant from the National Science Foundation (www.nsf.gov; award #0729021 to SPAD). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Lesley Wetherell for support with IT issues related to collection and processing of data, and Ryan Wong for assistance coordinating the project. We would also like to thank the VA San Diego Healthcare System Center for Excellence in Stress and Mental Health for support.	Anderson BA, 2011, P NATL ACAD SCI USA, V108, P10367, DOI 10.1073/pnas.1104047108; Anticevic A, 2011, BIOL PSYCHIAT; Awh E, 2007, PSYCHOL SCI, V18, P622, DOI 10.1111/j.1467-9280.2007.01949.x; Broadway JM, 2010, BEHAV RES METHODS, V42, P563, DOI 10.3758/BRM.42.2.563; Burgess GC, 2011, J EXPT PSYCHOL GEN; Chee MWL, 2007, P NATL ACAD SCI USA, V104, P9487, DOI 10.1073/pnas.0610712104; Chee MWL, 2004, J NEUROSCI, V24, P4560, DOI 10.1523/JNEUROSCI.0007-04.2004; Chen Z, 2000, PERCEPT PSYCHOPHYS, V62, P482, DOI 10.3758/BF03212100; Chuah YML, 2006, J NEUROSCI, V26, P7156, DOI 10.1523/JNEUROSCI.0906-06.2006; Clapp WC, 2010, CEREB CORTEX, V20, P859, DOI 10.1093/cercor/bhp150; Cohen J., 1988, STAT POWER ANAL BEHA, V2nd ed., DOI DOI 10.4324/9780203771587; Conway ARA, 2003, TRENDS COGN SCI, V7, P547, DOI 10.1016/j.tics.2003.10.005; Cowan N, 2005, COGNITIVE PSYCHOL, V51, P42, DOI 10.1016/j.cogpsych.2004.12.001; Cowan N, 2001, BEHAV BRAIN SCI, V24, P87, DOI 10.1017/S0140525X01003922; Dinges DF, 1997, SLEEP, V20, P267; DINGES DF, 1985, BEHAV RES METH INSTR, V17, P652, DOI 10.3758/BF03200977; Dolcos F, 2007, BRAIN RES, V1152, P171, DOI 10.1016/j.brainres.2007.03.059; Doran SM, 2001, ARCH ITAL BIOL, V139, P253; Drummond SPA, 2004, SLEEP, V27, P445; Drummond SPA, 1999, NEUROREPORT, V10, P3745, DOI 10.1097/00001756-199912160-00004; Drummond SPA, 2001, NEUROPSYCHOPHARMACOL, V25, pS68, DOI 10.1016/S0893-133X(01)00325-6; Drummond SPA, 2001, J SLEEP RES, V10, P85, DOI 10.1046/j.1365-2869.2001.00245.x; Drummond SPA, 2005, SLEEP, V28, P1059; Frey DJ, 2004, J SLEEP RES, V13, P305, DOI 10.1111/j.1365-2869.2004.00429.x; Fukuda K, 2011, PSYCHOL SCI, V22, P361, DOI 10.1177/0956797611398493; Fukuda K, 2010, PSYCHON B REV, V17, P673, DOI 10.3758/17.5.673; Fukuda K, 2009, J NEUROSCI, V29, P8726, DOI 10.1523/JNEUROSCI.2145-09.2009; KAHNEMAN D, 1983, J EXP PSYCHOL HUMAN, V9, P510, DOI 10.1037/0096-1523.9.4.510; Kurtz Matthew M, 2006, Expert Rev Neurother, V6, P47, DOI 10.1586/14737175.6.1.47; Mcnab F, 2008, NAT NEUROSCI, V11, P103, DOI 10.1038/nn2024; PASHLER H, 1988, PERCEPT PSYCHOPHYS, V44, P369, DOI 10.3758/BF03210419; Raidy DJ, 2005, PERCEPT MOTOR SKILL, V101, P451, DOI 10.2466/pms.101.2.451-467; Smith K, 2002, MANAGE SCI, V48, P711, DOI 10.1287/mnsc.48.6.711.194; Todd JJ, 2004, NATURE, V428, P751, DOI 10.1038/nature02466; Toepper M, 2010, NEUROSCIENCE, V165, P1244, DOI 10.1016/j.neuroscience.2009.11.019; Turner TH, 2007, NEUROPSYCHOLOGY, V21, P787, DOI 10.1037/0894-4105.21.6.787; Van Dongen HPA, 2003, SLEEP, V26, P117, DOI 10.1093/sleep/26.2.117; Vandewalle G, 2009, J NEUROSCI, V29, P7948, DOI 10.1523/JNEUROSCI.0229-09.2009; Vogel EK, 2005, NATURE, V438, P500, DOI 10.1038/nature04171; Vogel EK, 2004, NATURE, V428, P748, DOI 10.1038/nature02447; Vogel EK, 2001, J EXP PSYCHOL HUMAN, V27, P92, DOI 10.1037/0096-1523.27.1.92; Yoon JH, 2006, NEUROIMAGE, V29, P1117, DOI 10.1016/j.neuroimage.2005.08.024	42	62	63	1	74	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2012	7	4							e35653	10.1371/journal.pone.0035653	http://dx.doi.org/10.1371/journal.pone.0035653			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959XD	22530064	Green Published, gold			2022-12-25	WOS:000305350600110
J	Novakova, L; Bojanowski, V; Havlicek, J; Croy, I				Novakova, Lenka; Bojanowski, Viola; Havlicek, Jan; Croy, Ilona			Differential Patterns of Food Appreciation during Consumption of a Simple Food in Congenitally Anosmic Individuals: An Explorative Study	PLOS ONE			English	Article							SENSORY-SPECIFIC SATIETY; OLFACTORY DYSFUNCTION; HUMAN BRAIN; SATIATION; IMPACT; TASTE; PLEASANTNESS; DISORDERS; QUALITY; HUMANS	Food is evaluated for various attributes. One of the key food evaluation domains is hedonicity. As food is consumed, its hedonic valence decreases (due to prolonged sensory stimulation) and hedonic habituation results. The aim of the present study was to investigate changes in food pleasantness ratings during consumption of a simple food by individuals without olfactory experience with food as compared to normosmics. 15 congenital anosmics and 15 normosmic controls were each presented with ten 10 g banana slices. Each was visually inspected, then smelled and chewed for ten seconds and subsequently rated for hedonicity on a 21-point scale. There was a significant difference in pleasantness ratings between congenital anosmics and controls (F(1, 26) = 6.71, p =.02) with the anosmics exhibiting higher ratings than the controls, a significant main repeated-measures effect on the ratings (F(1.85, 48) = 12.15, p<.001), which showed a decreasing trend over the course of consumption, as well as a significant portion* group interaction (F(1.85, 48) = 3.54, p = .04), with the anosmic participants experiencing a less pronounced decline. The results of the present explorative study suggest that over the course of consumption of a simple food, congenitally anosmic individuals experience differential patterns of appreciation of food as compared to normosmics. In this particular case, the decrease of hedonic valence was less pronounced in congenital anosmics.	[Novakova, Lenka; Havlicek, Jan] Charles Univ Prague, Fac Humanities, Dept Anthropol, Prague, Czech Republic; [Bojanowski, Viola; Croy, Ilona] Univ Dresden, Sch Med, Dept Otorhinolaryngol, Interdisciplinary Ctr Smell & Taste Res, Dresden, Germany	Charles University Prague; Technische Universitat Dresden	Novakova, L (corresponding author), Charles Univ Prague, Fac Humanities, Dept Anthropol, Prague, Czech Republic.	lenka.novakova@fhs.cuni.cz	Havlíček, Jan/F-8985-2011; Martinec Nováková, Lenka/F-6474-2015	Havlíček, Jan/0000-0003-2374-7337; Martinec Nováková, Lenka/0000-0002-5695-2903; Croy, Ilona/0000-0002-0361-5559	Grant Agency of the Charles University [GAUK 6010]; Czech Science Foundation [GACR P407/10/1303]; Czech Ministry of Education [MSM 0021620843]	Grant Agency of the Charles University; Czech Science Foundation(Grant Agency of the Czech Republic); Czech Ministry of Education(Ministry of Education, Youth & Sports - Czech Republic)	The study was supported by the Grant Agency of the Charles University (GAUK 6010), Czech Science Foundation (GACR P407/10/1303) and the Czech Ministry of Education (MSM 0021620843). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aschenbrenner K, 2008, J PSYCHIATR RES, V43, P129, DOI 10.1016/j.jpsychires.2008.03.003; Blundell J, 2010, OBES REV, V11, P251, DOI 10.1111/j.1467-789X.2010.00714.x; DAVIDSON TM, 1987, WESTERN J MED, V146, P434; de Araujo IET, 2003, EUR J NEUROSCI, V18, P2059, DOI 10.1046/j.1460-9568.2003.02915.x; FERRIS AM, 1989, ANN NY ACAD SCI, V561, P113, DOI 10.1111/j.1749-6632.1989.tb20975.x; Gottfried JA, 2003, NEURON, V39, P375, DOI 10.1016/S0896-6273(03)00392-1; Graaf C. de, 2005, Food, diet and obesity, P137, DOI 10.1533/9781845690840.1.137; Havermans RC, 2010, CHEM SENSES, V35, P735, DOI 10.1093/chemse/bjq074; HENION KE, 1971, J EXP PSYCHOL, V90, P275, DOI 10.1037/h0031549; HETHERINGTON M, 1989, APPETITE, V12, P57, DOI 10.1016/0195-6663(89)90068-8; Kringelbach ML, 2004, NEUROSCIENCE, V126, P807, DOI 10.1016/j.neuroscience.2004.04.035; Lawless H. T., 1998, SENSORY EVALUATION F; MATTES RD, 1990, AM J CLIN NUTR, V51, P233, DOI 10.1093/ajcn/51.2.233; Mela DJ, 2006, APPETITE, V47, P10, DOI 10.1016/j.appet.2006.02.006; Miwa T, 2001, ARCH OTOLARYNGOL, V127, P497, DOI 10.1001/archotol.127.5.497; Morrot G, 2001, BRAIN LANG, V79, P309, DOI 10.1006/brln.2001.2493; Nordin S, 2000, INT J PSYCHOL, V35, P108; ROLLS BJ, 1981, PHYSIOL BEHAV, V27, P137, DOI 10.1016/0031-9384(81)90310-3; Rolls ET, 1997, PHYSIOL BEHAV, V61, P461, DOI 10.1016/S0031-9384(96)00464-7; Ruijschop RMAJ, 2010, CHEM SENSES, V35, P91, DOI 10.1093/chemse/bjp086; Steiner JE, 2001, NEUROSCI BIOBEHAV R, V25, P53, DOI 10.1016/S0149-7634(00)00051-8; Stevenson RJ, 2010, CHEM SENSES, V35, P3, DOI 10.1093/chemse/bjp083; Temmel AFP, 2002, ARCH OTOLARYNGOL, V128, P635, DOI 10.1001/archotol.128.6.635; Van Toller S, 1999, CHEM SENSES, V24, P705, DOI 10.1093/chemse/24.6.705; Vickers Z, 2001, FOOD QUAL PREFER, V12, P521, DOI 10.1016/S0950-3293(01)00047-7; Weijzen PLG, 2009, BRIT J NUTR, V102, P1091, DOI 10.1017/S000711450932574X; Yeomans MR, 2010, CHEMOSENS PERCEPT, V3, P34, DOI 10.1007/s12078-009-9052-6; Yeomans MR, 1996, APPETITE, V27, P119, DOI 10.1006/appe.1996.0040; Zandstra EH, 1999, FOOD QUAL PREFER, V10, P411, DOI 10.1016/S0950-3293(98)00050-0; Zijlstra N, 2009, AM J CLIN NUTR, V90, P269, DOI 10.3945/ajcn.2009.27694	30	8	8	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2012	7	4							e33921	10.1371/journal.pone.0033921	http://dx.doi.org/10.1371/journal.pone.0033921			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959XD	22529901	gold, Green Submitted, Green Published			2022-12-25	WOS:000305350600008
J	Rigo, A; Gottardi, M; Damiani, E; Bonifacio, M; Ferrarini, I; Mauri, P; Vinante, F				Rigo, Antonella; Gottardi, Michele; Damiani, Ernesto; Bonifacio, Massimiliano; Ferrarini, Isacco; Mauri, Pierluigi; Vinante, Fabrizio			CXCL12 and [N33A]CXCL12 in 5637 and HeLa Cells: Regulating HER1 Phosphorylation via Calmodulin/Calcineurin	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; 7-TRANSMEMBRANE RECEPTORS; DIPHTHERIA-TOXIN; CANCER GROWTH; CXCR4; ACTIVATION; EXPRESSION; EGF; DIFFERENTIATION; DOWNSTREAM	In the human neoplastic cell lines 5637 and HeLa, recombinant CXCL12 elicited, as expected, downstream signals via both G-protein-dependent and beta-arrestin-dependent pathways responsible for inducing a rapid and a late wave, respectively, of ERK1/2 phosphorylation. In contrast, the structural variant [N33A]CXCL12 triggered no beta-arrestin-dependent phosphorylation of ERK1/2, and signaled via G protein-dependent pathways alone. Both CXCL12 and [N33A]CXCL12, however, generated signals that transinhibited HER1 phosphorylation via intracellular pathways. 1) Prestimulation of CXCR4/HER1-positive 5637 or HeLa cells with CXCL12 modified the HB-EGF-dependent activation of HER1 by delaying the peak phosphorylation of tyrosine 1068 or 1173. 2) Prestimulation with the synthetic variant [N33A]CXCL12, while preserving CXCR4-related chemotaxis and CXCR4 internalization, abolished HER1 phosphorylation. 3) In cells knockdown of beta-arrestin 2, CXCL12 induced a full inhibition of HER1 like [N33A]CXCL12 in non-silenced cells. 4) HER1 phosphorylation was restored as usual by inhibiting PCK, calmodulin or calcineurin, whereas the inhibition of CaMKII had no discernable effect. We conclude that both recombinant CXCL12 and its structural variant [N33A]CXCL12 may transinhibit HER1 via G-proteins/calmodulin/calcineurin, but [N33A]CXCL12 does not activate beta-arrestin-dependent ERK1/2 phosphorylation and retains a stronger inhibitory effect. Therefore, we demonstrated that CXCL12 may influence the magnitude and the persistence of signaling downstream of HER1 in turn involved in the proliferative potential of numerous epithelial cancer. In addition, we recognized that [N33A]CXCL12 activates preferentially G-protein-dependent pathways and is an inhibitor of HER1.	[Rigo, Antonella; Gottardi, Michele; Bonifacio, Massimiliano; Ferrarini, Isacco; Vinante, Fabrizio] Univ Verona, Sect Hematol, Dept Med, I-37100 Verona, Italy; [Damiani, Ernesto] Univ Padua, Dept Expt Biomed Sci, Padua, Italy; [Mauri, Pierluigi] CNR, Inst Biomed Technol, Prote & Metabol Unit, I-20133 Milan, Italy	University of Verona; University of Padua; Consiglio Nazionale delle Ricerche (CNR); Istituto di Tecnologie Biomediche (ITB-CNR)	Rigo, A (corresponding author), Univ Verona, Sect Hematol, Dept Med, I-37100 Verona, Italy.	fabrizio.vinante@univr.it	Mauri, Pietro Luigi/AAC-3095-2019; damiani, ernesto/J-6060-2012; damiani, ernesto/AAI-5709-2020; Bonifacio, Massimiliano/AAL-4520-2020	Mauri, Pietro Luigi/0000-0003-4364-0393; damiani, ernesto/0000-0002-9557-6496; damiani, ernesto/0000-0002-9557-6496; Bonifacio, Massimiliano/0000-0003-0716-1686; Gottardi, Michele/0000-0003-0704-6979; Vinante, Fabrizio/0000-0002-3855-6747	Italian Association for Cancer Research (AIRC, Milan, Italy)/Cariverona Foundation (Verona, Italy); Venetian Institute of Oncology (IOV, Padua, Italy)	Italian Association for Cancer Research (AIRC, Milan, Italy)/Cariverona Foundation (Verona, Italy)(Fondazione AIRC per la ricerca sul cancro); Venetian Institute of Oncology (IOV, Padua, Italy)	This work was supported by grants from the Italian Association for Cancer Research (AIRC, Milan, Italy)/Cariverona Foundation (Verona, Italy) and from the Venetian Institute of Oncology (IOV, Padua, Italy). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreev J, 2001, J BIOL CHEM, V276, P20130, DOI 10.1074/jbc.M102307200; Baribaud F, 2001, J VIROL, V75, P8957, DOI 10.1128/JVI.75.19.8957-8967.2001; Cabioglu N, 2005, CANCER RES, V65, P6493, DOI 10.1158/0008-5472.CAN-04-1303; D'Ambrosio D, 2002, J IMMUNOL, V169, P2303, DOI 10.4049/jimmunol.169.5.2303; Daub H, 1996, NATURE, V379, P557, DOI 10.1038/379557a0; Dealwis C, 1998, P NATL ACAD SCI USA, V95, P6941, DOI 10.1073/pnas.95.12.6941; Duda DG, 2011, CLIN CANCER RES, V17, P2074, DOI 10.1158/1078-0432.CCR-10-2636; Guo L, 2003, J AM SOC MASS SPECTR, V14, P1022, DOI 10.1016/S1044-0305(03)00206-X; HIGASHIYAMA S, 1991, SCIENCE, V251, P936, DOI 10.1126/science.1840698; Kim S, 2009, NATURE, V457, P36; Koizumi K, 2007, CANCER SCI, V98, P1652, DOI 10.1111/j.1349-7006.2007.00606.x; Krampera M, 2005, BLOOD, V106, P59, DOI 10.1182/blood-2004-09-3645; Kryczek I, 2007, AM J PHYSIOL-CELL PH, V292, pC987, DOI 10.1152/ajpcell.00406.2006; Lefkowitz RJ, 2007, ACTA PHYSIOL, V190, P9, DOI 10.1111/j.1365-201X.2007.01693.x; Leftowitz RJ, 2005, SCIENCE, V308, P512, DOI 10.1126/science.1109237; Li HB, 2004, BIOCHEM J, V381, P257, DOI 10.1042/BJ20040515; Li YM, 2004, CANCER CELL, V6, P459, DOI 10.1016/j.ccr.2004.09.027; Mahtouk K, 2005, ONCOGENE, V24, P3512, DOI 10.1038/sj.onc.1208536; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Mantovani A, 2010, CANCER CELL, V17, P111, DOI 10.1016/j.ccr.2010.01.019; Mauri P, 2003, BIOL CHEM, V384, P575, DOI 10.1515/BC.2003.065; McCormick PJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008102; Moll NM, 2010, EXPERT REV HEMATOL, V3, P315, DOI 10.1586/EHM.10.16; Montresor A, 2009, CANCER RES, V69, P9281, DOI 10.1158/0008-5472.CAN-09-2009; Rajagopal S, 2010, NAT REV DRUG DISCOV, V9, P373, DOI 10.1038/nrd3024; Reiter E, 2012, ANNU REV PHARMACOL, V52, P179, DOI 10.1146/annurev.pharmtox.010909.105800; Rigo A, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-273; Saito T, 2004, ENDOCRINOLOGY, V145, P4232, DOI 10.1210/en.2004-0401; Sanchez-Martin L, 2011, BLOOD, V117, P88, DOI 10.1182/blood-2009-12-258186; Sengupta P, 2007, J BIOL CHEM, V282, P8474, DOI 10.1074/jbc.M607211200; Shenoy SK, 2011, TRENDS PHARMACOL SCI, V32, P521, DOI 10.1016/j.tips.2011.05.002; Shepard HM, 2008, J CLIN INVEST, V118, P3574, DOI 10.1172/JCI36049; Shukla AK, 2008, P NATL ACAD SCI USA, V105, P9988, DOI 10.1073/pnas.0804246105; Shukla AK, 2011, TRENDS BIOCHEM SCI, V36, P457, DOI 10.1016/j.tibs.2011.06.003; Singh RK, 2011, CANCER RES, V71, P3268, DOI 10.1158/0008-5472.CAN-10-2769; Solinas G, 2009, J LEUKOCYTE BIOL, V86, P1065, DOI 10.1189/jlb.0609385; Sun Y, 2002, J BIOL CHEM, V277, P49212, DOI 10.1074/jbc.M207294200; Tan Y, 2006, EXP HEMATOL, V34, P1553, DOI 10.1016/j.exphem.2006.07.001; Thalappilly S, 2010, ONCOGENE, V29, P2528, DOI 10.1038/onc.2010.1; Thelen M, 2008, J NEUROIMMUNOL, V198, P9, DOI 10.1016/j.jneuroim.2008.04.020; Tilley DG, 2009, J BIOL CHEM, V284, P20375, DOI 10.1074/jbc.M109.005793; Ueda H, 1997, J BIOL CHEM, V272, P24966, DOI 10.1074/jbc.272.40.24966; Vinante F, 1999, BLOOD, V93, P1715, DOI 10.1182/blood.V93.5.1715.405k26_1715_1723; Vinante F, 2002, BLOOD, V99, P52, DOI 10.1182/blood.V99.1.52; Vinante F, 1999, BLOOD, V94, P3169, DOI 10.1182/blood.V94.9.3169.421k30_3169_3177; Whalen EJ, 2011, TRENDS MOL MED, V17, P126, DOI 10.1016/j.molmed.2010.11.004; Xiao KH, 2010, P NATL ACAD SCI USA, V107, P15299, DOI 10.1073/pnas.1008461107; Zandstra PW, 2000, BLOOD, V96, P1215, DOI 10.1182/blood.V96.4.1215.h8001215_1215_1222	48	8	8	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2012	7	4							e34432	10.1371/journal.pone.0034432	http://dx.doi.org/10.1371/journal.pone.0034432			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959XD	22529914	gold, Green Published, Green Submitted			2022-12-25	WOS:000305350600014
J	Waite, DW; Deines, P; Taylor, MW				Waite, David W.; Deines, Peter; Taylor, Michael W.			Gut Microbiome of the Critically Endangered New Zealand Parrot, the Kakapo (Strigops habroptilus)	PLOS ONE			English	Article							16S RIBOSOMAL-RNA; GRADIENT GEL-ELECTROPHORESIS; PHYLOGENETIC ANALYSIS; GASTROINTESTINAL-TRACT; BACTERIAL COMMUNITIES; INTESTINAL-TRACT; SEQUENCE DATA; METHANOGENS; DIVERSITY; ARCHAEA	The kakapo, a parrot endemic to New Zealand, is currently the focus of intense research and conservation efforts with the aim of boosting its population above the current 'critically endangered' status. While virtually nothing is known about the microbiology of the kakapo, given the acknowledged importance of gut-associated microbes in vertebrate nutrition and pathogen defense, it should be of great conservation value to analyze the microbes associated with kakapo. Here we describe the first study of the bacterial communities that reside within the gastrointestinal tract (GIT) of both juvenile and adult kakapo. Samples from along the GIT, taken from the choana (approximate to throat), crop and faeces, were subjected to 16 S rRNA gene library analysis. Phylogenetic analysis of >1000 16 S rRNA gene clones, derived from six birds, revealed low phylum-level diversity, consisting almost exclusively of Firmicutes (including lactic acid bacteria) and Gammaproteobacteria. The relative proportions of Firmicutes and Gammaproteobacteria were highly consistent among individual juveniles, irrespective of sampling location, but differed markedly among adult birds. Diversity at a finer phylogenetic resolution (i.e. operational taxonomic units (OTUs) of 99% sequence identity) was also low in all samples, with only one or two OTUs dominating each sample. These data represent the first analysis of the bacterial communities associated with the kakapo GIT, providing a baseline for further microbiological study, and facilitating conservation efforts for this unique bird.	[Waite, David W.; Deines, Peter; Taylor, Michael W.] Univ Auckland, Sch Biol Sci, Ctr Microbial Innovat, Auckland 1, New Zealand; [Deines, Peter] Massey Univ, Inst Nat Sci, Auckland, New Zealand	University of Auckland; Massey University	Waite, DW (corresponding author), Univ Auckland, Sch Biol Sci, Ctr Microbial Innovat, Auckland 1, New Zealand.	mw.taylor@auckland.ac.nz	Deines, Peter/B-7022-2012	Deines, Peter/0000-0003-0926-489X; Waite, David/0000-0002-0184-2942; Taylor, Michael/0000-0002-0463-7813	Department of Conservation; University of Auckland [9841 3626187]; Alexander von Humboldt Foundation	Department of Conservation; University of Auckland; Alexander von Humboldt Foundation(Alexander von Humboldt Foundation)	This work was supported by funding from the Department of Conservation as well as a University of Auckland Faculty Research Development Fund (grant 9841 3626187) to MWT, Feodor Lynen Research Fellowship from the Alexander von Humboldt Foundation to PD, and a University of Auckland Doctoral Scholarship to DW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashelford KE, 2006, APPL ENVIRON MICROB, V72, P5734, DOI 10.1128/AEM.00556-06; Backhed F, 2004, P NATL ACAD SCI USA, V101, P15718, DOI 10.1073/pnas.0407076101; Bjorkholm B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006958; Blanco G, 2006, J APPL ECOL, V43, P990, DOI 10.1111/j.1365-2664.2006.01200.x; Bolam DN, 2011, GUT MICROBES, V2, P86, DOI 10.4161/gmic.2.2.15232; BOOM R, 1990, J CLIN MICROBIOL, V28, P495, DOI 10.1128/JCM.28.3.495-503.1990; Brangenberg N, 2003, J AVIAN MED SURG, V17, P203, DOI 10.1647/2003-023; Brisbin Jennifer T., 2008, Animal Health Research Reviews, V9, P101, DOI 10.1017/S146625230800145X; Burtt EH, 2011, BIOL LETTERS, V7, P214, DOI 10.1098/rsbl.2010.0716; Chassard C, 2007, FEMS MICROBIOL ECOL, V61, P121, DOI 10.1111/j.1574-6941.2007.00314.x; Christensen H, 2003, J APPL MICROBIOL, V95, P354, DOI 10.1046/j.1365-2672.2003.01986.x; CLENCH MH, 1995, WILSON BULL, V107, P93; Costa R, 2004, BRAZ J MICROBIOL, V35, P230, DOI 10.1590/S1517-83822004000200011; DELONG EF, 1992, P NATL ACAD SCI USA, V89, P5685, DOI 10.1073/pnas.89.12.5685; Dethlefsen L, 2008, PLOS BIOL, V6, P2383, DOI 10.1371/journal.pbio.0060280; Dongowski G, 2000, APPL ENVIRON MICROB, V66, P1321, DOI 10.1128/AEM.66.4.1321-1327.2000; Drummond A, 2010, GENEIOUS 5 5; DUBOS R, 1964, AM J MED SCI, V248, P267, DOI 10.1097/00000441-196409000-00003; Eason Daryl K., 2006, Notornis, V53, P116; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; Elliott GP, 2001, BIOL CONSERV, V99, P121, DOI 10.1016/S0006-3207(00)00191-9; Eribe ERK, 2008, ANAEROBE, V14, P131, DOI 10.1016/j.anaerobe.2008.04.004; FINEGOLD SM, 1974, AM J CLIN NUTR, V27, P1456, DOI 10.1093/ajcn/27.12.1456; Gartrell BD, 2005, AVIAN PATHOL, V34, P383, DOI 10.1080/03079450500268583; Gill SR, 2006, SCIENCE, V312, P1355, DOI 10.1126/science.1124234; Godoy-Vitorino F, 2008, APPL ENVIRON MICROB, V74, P5905, DOI 10.1128/AEM.00574-08; Godoy-Vitorino F, 2012, ISME J, V6, P531, DOI 10.1038/ismej.2011.131; Godoy-Vitorino F, 2010, ISME J, V4, P611, DOI 10.1038/ismej.2009.147; GRAJAL A, 1989, SCIENCE, V245, P1236, DOI 10.1126/science.245.4923.1236; Gregersen RH, 2010, J APPL MICROBIOL, V108, P1235, DOI 10.1111/j.1365-2672.2009.04518.x; Hehemann JH, 2010, NATURE, V464, P908, DOI 10.1038/nature08937; Hiura T, 2010, ANIM FEED SCI TECH, V155, P1, DOI 10.1016/j.anifeedsci.2009.09.015; HOOIJKAAS H, 1984, EUR J IMMUNOL, V14, P1127, DOI 10.1002/eji.1830141212; Hopkins MJ, 2001, GUT, V48, P198, DOI 10.1136/gut.48.2.198; Horrocks M, 2008, REV PALAEOBOT PALYNO, V149, P229, DOI 10.1016/j.revpalbo.2007.12.009; Houston D, 2007, BIOL CONSERV, V138, P248, DOI 10.1016/j.biocon.2007.04.023; HUDSON JA, 1964, P SOC EXP BIOL MED, V116, P628; Ichinohe T, 2011, P NATL ACAD SCI USA, V108, P5354, DOI 10.1073/pnas.1019378108; Irbis C, 2004, J GEN APPL MICROBIOL, V50, P203, DOI 10.2323/jgam.50.203; Ishii K, 2001, APPL ENVIRON MICROB, V67, P3753, DOI 10.1128/AEM.67.8.3753-3755.2001; Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033; Janiga M, 2007, J ORNITHOL, V148, P135, DOI 10.1007/s10336-006-0104-2; Khachatryan ZA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003064; Kim YS, 2007, J NUTR, V137, p2576S, DOI 10.1093/jn/137.11.2576S; Klomp JE, 2008, J AVIAN BIOL, V39, P530, DOI 10.1111/j.0908-8857.2008.04333.x; Laure R, 2005, ENVIRON MICROBIOL, V7, P530; Ley RE, 2008, NAT REV MICROBIOL, V6, P776, DOI 10.1038/nrmicro1978; Ley RE, 2008, SCIENCE, V320, P1647, DOI 10.1126/science.1155725; LLOYD BD, 1994, BIOL CONSERV, V69, P75, DOI 10.1016/0006-3207(94)90330-1; Lu JR, 2008, J MICROBIOL, V46, P469, DOI 10.1007/s12275-008-0117-z; Ludwig W, 2004, NUCLEIC ACIDS RES, V32, P1363, DOI 10.1093/nar/gkh293; Martens EC, 2009, J BIOL CHEM, V284, P24673, DOI 10.1074/jbc.R109.022848; Martinez I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015046; Matsui H, 2010, ANAEROBE, V16, P83, DOI 10.1016/j.anaerobe.2009.07.005; Meinl W, 2009, DRUG METAB DISPOS, V37, P1179, DOI 10.1124/dmd.108.025916; MERTON DV, 1984, IBIS, V126, P277, DOI 10.1111/j.1474-919X.1984.tb00250.x; Moreno J, 2003, AUK, V120, P784, DOI 10.1642/0004-8038(2003)120[0784:BEOCBO]2.0.CO;2; Morton E.S., 1978, P123; MUYZER G, 1993, APPL ENVIRON MICROB, V59, P695, DOI 10.1128/AEM.59.3.695-700.1993; O'Hara AM, 2006, EMBO REP, V7, P688, DOI 10.1038/sj.embor.7400731; Ohkuma M, 2008, TRENDS MICROBIOL, V16, P345, DOI 10.1016/j.tim.2008.04.004; OLIVER WRB, 1955, NZ BIRDS; Pacheco MA, 2004, CONDOR, V106, P139, DOI 10.1650/7406; Petersen A, 2010, LETT APPL MICROBIOL, V51, P61, DOI 10.1111/j.1472-765X.2010.02861.x; Polz MF, 1998, APPL ENVIRON MICROB, V64, P3724; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Rajilic-Stojanovic M, 2009, ENVIRON MICROBIOL, V11, P1736, DOI 10.1111/j.1462-2920.2009.01900.x; Russell JB, 2001, SCIENCE, V292, P1119, DOI 10.1126/science.1058830; Sabathe F, 2002, FEMS MICROBIOL LETT, V217, P15, DOI 10.1016/S0378-1097(02)00991-6; Sadeghi H., 2008, J BIOL SCI, V8, P826, DOI DOI 10.3923/JBS.2008.826.830; SAVAGE DC, 1977, ANNU REV MICROBIOL, V31, P107, DOI 10.1146/annurev.mi.31.100177.000543; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Shanks OC, 2011, APPL ENVIRON MICROB, V77, P2992, DOI 10.1128/AEM.02988-10; Shawkey MD, 2007, AM NAT, V169, pS112, DOI 10.1086/510100; Shin EC, 2004, ANAEROBE, V10, P313, DOI 10.1016/j.anaerobe.2004.08.002; Shoham Y, 1999, TRENDS MICROBIOL, V7, P275, DOI 10.1016/S0966-842X(99)01533-4; Spring S, 1998, ARCH MICROBIOL, V169, P136, DOI 10.1007/s002030050553; Stappenbeck TS, 2002, P NATL ACAD SCI USA, V99, P15451, DOI 10.1073/pnas.202604299; Tajima K, 2001, FEMS MICROBIOL LETT, V200, P67, DOI 10.1111/j.1574-6968.2001.tb10694.x; Thomas F, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00093; Tokura M, 1999, CURR MICROBIOL, V39, P123, DOI 10.1007/s002849900432; Torok VA, 2008, APPL ENVIRON MICROB, V74, P783, DOI 10.1128/AEM.01384-07; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Vaahtovuo J, 2001, ANTON LEEUW INT J G, V80, P35, DOI 10.1023/A:1012058107731; Vaishnava S, 2011, SCIENCE, V334, P255, DOI 10.1126/science.1209791; van der Wielen PWJJ, 2002, MICROBIAL ECOL, V44, P286, DOI 10.1007/s00248-002-2015-y; VAREL VH, 1992, APPL ENVIRON MICROB, V58, P1645, DOI 10.1128/AEM.58.5.1645-1649.1992; von Wintzingerode F, 1997, FEMS MICROBIOL REV, V21, P213; Warnick TA, 2002, INT J SYST EVOL MICR, V52, P1155, DOI [10.1099/ijs.0.02125-0, 10.1099/00207713-52-4-1155]; Webster NS, 2004, ENVIRON MICROBIOL, V6, P288, DOI 10.1111/j.1462-2920.2004.00570.x; Xenoulis PG, 2010, VET MICROBIOL, V146, P320, DOI 10.1016/j.vetmic.2010.05.024; Yegani M, 2008, POULTRY SCI, V87, P2052, DOI 10.3382/ps.2008-00091; Yi P, 2011, VET MICROBI IN PRESS; Yu ZT, 2008, APPL ENVIRON MICROB, V74, P889, DOI 10.1128/AEM.00684-07; Zoetendal EG, 2008, GUT, V57, P1605, DOI 10.1136/gut.2007.133603	95	57	59	4	93	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2012	7	4							e35803	10.1371/journal.pone.0035803	http://dx.doi.org/10.1371/journal.pone.0035803			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959XD	22530070	gold, Green Submitted, Green Published			2022-12-25	WOS:000305350600115
J	Birznieks, I; Boonstra, TW; Macefield, VG				Birznieks, Ingvars; Boonstra, Tjeerd W.; Macefield, Vaughan G.			Modulation of Human Muscle Spindle Discharge by Arterial Pulsations - Functional Effects and Consequences	PLOS ONE			English	Article							SYMPATHETIC-NERVE; LEG MUSCLES; CAT; AFFERENTS; RESPONSES; STRETCH; NOISE; PAIN; LOCALIZATION; STIMULATION	Arterial pulsations are known to modulate muscle spindle firing; however, the physiological significance of such synchronised modulation has not been investigated. Unitary recordings were made from 75 human muscle spindle afferents innervating the pretibial muscles. The modulation of muscle spindle discharge by arterial pulsations was evaluated by R-wave triggered averaging and power spectral analysis. We describe various effects arterial pulsations may have on muscle spindle afferent discharge. Afferents could be "driven" by arterial pulsations, e. g., showing no other spontaneous activity than spikes generated with cardiac rhythmicity. Among afferents showing ongoing discharge that was not primarily related to cardiac rhythmicity we illustrate several mechanisms by which individual spikes may become phase-locked. However, in the majority of afferents the discharge rate was modulated by the pulse wave without spikes being phase locked. Then we assessed whether these influences changed in two physiological conditions in which a sustained increase in muscle sympathetic nerve activity was observed without activation of fusimotor neurones: a maximal inspiratory breath-hold, which causes a fall in systolic pressure, and acute muscle pain, which causes an increase in systolic pressure. The majority of primary muscle spindle afferents displayed pulse-wave modulation, but neither apnoea nor pain had any significant effect on the strength of this modulation, suggesting that the physiological noise injected by the arterial pulsations is robust and relatively insensitive to fluctuations in blood pressure. Within the afferent population there was a similar number of muscle spindles that were inhibited and that were excited by the arterial pulse wave, indicating that after signal integration at the population level, arterial pulsations of opposite polarity would cancel each other out. We speculate that with close-to-threshold stimuli the arterial pulsations may serve as an endogenous noise source that may synchronise the sporadic discharge within the afferent population and thus facilitate the detection of weak stimuli.	[Birznieks, Ingvars] Univ Western Sydney, Sch Sci & Hlth, Sydney, NSW, Australia; [Birznieks, Ingvars; Macefield, Vaughan G.] Neurosci Res Australia, Sydney, NSW, Australia; [Boonstra, Tjeerd W.] Black Dog Inst, Sydney, NSW, Australia; [Macefield, Vaughan G.] Univ Western Sydney, Sch Med, Sydney, NSW, Australia; [Birznieks, Ingvars] Univ New S Wales, Sch Med Sci, Sydney, NSW, Australia; [Boonstra, Tjeerd W.] Univ New S Wales, Sch Psychiat, Sydney, NSW, Australia	Western Sydney University; Neuroscience Research Australia; Black Dog Institute; Western Sydney University; University of New South Wales Sydney; University of New South Wales Sydney	Birznieks, I (corresponding author), Univ Western Sydney, Sch Sci & Hlth, Sydney, NSW, Australia.	i.birznieks@uws.edu.au	Boonstra, Tjeerd/C-5433-2011; B, Ingvars/Q-8634-2019; Birznieks, Ingvars/D-4181-2012	Boonstra, Tjeerd/0000-0002-6969-7243; B, Ingvars/0000-0003-4916-1254; Birznieks, Ingvars/0000-0003-4916-1254; Macefield, Vaughan/0000-0003-3325-6566	Australian Research Council (ARC); National Health and Medical Research Council (NHMRC) of Australia [TS0669860]; NHMRC [APP1029782]	Australian Research Council (ARC)(Australian Research Council); National Health and Medical Research Council (NHMRC) of Australia(National Health and Medical Research Council (NHMRC) of Australia); NHMRC(National Health and Medical Research Council (NHMRC) of Australia)	This research was supported by a grant from the Australian Research Council (ARC; http://www.arc.gov.au/) and National Health and Medical Research Council (NHMRC; http://www.nhmrc.gov.au) of Australia TS0669860 and NHMRC Project Grant APP1029782. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstrong B, 2008, SPORTS MED, V38, P101, DOI 10.2165/00007256-200838020-00002; BARKER D, 1981, PROC R SOC SER B-BIO, V212, P317, DOI 10.1098/rspb.1981.0042; Birznieks I, 2008, J PHYSIOL-LONDON, V586, P2713, DOI 10.1113/jphysiol.2008.151746; Bombardi C, 2006, TISSUE CELL, V38, P121, DOI 10.1016/j.tice.2005.12.003; Boonstra TW, 2007, NEUROIMAGE, V36, P370, DOI 10.1016/j.neuroimage.2007.03.012; Boonstra TW, 2009, EUR J NEUROSCI, V29, P613, DOI 10.1111/j.1460-9568.2008.06584.x; Breakspear M, 2003, PHYSICA D, V182, P1, DOI 10.1016/S0167-2789(03)00136-2; BROWN AG, 1967, J PHYSIOL-LONDON, V193, P707, DOI 10.1113/jphysiol.1967.sp008390; BURKE D, 1979, J PHYSIOL-LONDON, V291, P277, DOI 10.1113/jphysiol.1979.sp012812; BURKE D, 1987, J NEUROPHYSIOL, V58, P417, DOI 10.1152/jn.1987.58.2.417; Castellan NJ, 1988, NONPARAMETRIC STAT B; Cordo P, 1996, NATURE, V383, P769, DOI 10.1038/383769a0; EDIN BB, 1990, J NEUROPHYSIOL, V63, P1307, DOI 10.1152/jn.1990.63.6.1307; EDIN BB, 1990, J NEUROPHYSIOL, V63, P1314, DOI 10.1152/jn.1990.63.6.1314; Efron B., 1986, STAT SCI, V1, P54, DOI DOI 10.1214/SS/1177013815; ELLAWAY PH, 1977, J PHYSIOL-LONDON, V273, pP92; EMONETDENAND F, 1985, J PHYSIOL-LONDON, V360, P201, DOI 10.1113/jphysiol.1985.sp015612; EMONETDENAND F, 1985, J PHYSIOL-LONDON, V360, P187, DOI 10.1113/jphysiol.1985.sp015611; HAMM TM, 1985, J PHYSIOL-LONDON, V365, P77, DOI 10.1113/jphysiol.1985.sp015760; Hellstrom F, 2005, EXP BRAIN RES, V165, P328, DOI 10.1007/s00221-005-2309-7; HUNT CC, 1982, ARCH ITAL BIOL, V120, P371; JACKSON DA, 1993, ECOLOGY, V74, P2204, DOI 10.2307/1939574; Jarvis MR, 2001, NEURAL COMPUT, V13, P717, DOI 10.1162/089976601300014312; JOHANSSON H, 1991, MED HYPOTHESES, V35, P196, DOI 10.1016/0306-9877(91)90233-O; KIRKWOOD PA, 1982, J PHYSIOL-LONDON, V322, P287, DOI 10.1113/jphysiol.1982.sp014038; MACEFIELD G, 1990, J PHYSIOL-LONDON, V429, P113, DOI 10.1113/jphysiol.1990.sp018247; Macefield VG, 2003, EXP PHYSIOL, V88, P617, DOI 10.1113/eph8802548; Macefield VG, 2003, J PHYSIOL-LONDON, V551, P1005, DOI 10.1113/jphysiol.2003.040196; MACEFIELD VG, 1995, J AUTONOM NERV SYST, V53, P137, DOI 10.1016/0165-1838(94)00173-H; Matre D, 2002, EUR J PAIN, V6, P245, DOI 10.1053/eujp.2002.0332; Matre D, 2003, ACTA PHYSIOL SCAND, V178, P261, DOI 10.1046/j.1365-201X.2003.01122.x; MATTHEWS PB, 1969, J PHYSIOL-LONDON, V202, P59, DOI 10.1113/jphysiol.1969.sp008795; MATTHEWS PBC, 1981, J PHYSIOL-LONDON, V320, P1; McDonnell MD, 2011, NAT REV NEUROSCI, V12, P415, DOI 10.1038/nrn3061; McIntosh AR, 2004, NEUROIMAGE, V23, P764, DOI 10.1016/j.neuroimage.2004.05.018; MCKEON B, 1981, J NEUROPHYSIOL, V46, P788, DOI 10.1152/jn.1981.46.4.788; Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058; NORDH E, 1983, BRAIN RES, V271, P89, DOI 10.1016/0006-8993(83)91367-7; Noteboom JT, 2001, J APPL PHYSIOL, V91, P2093, DOI 10.1152/jappl.2001.91.5.2093; Powers RK, 2000, J NEUROPHYSIOL, V83, P483, DOI 10.1152/jn.2000.83.1.483; PROSKE U, 1985, EXP BRAIN RES, V59, P166; Rivlin-Etzion M, 2006, J NEUROPHYSIOL, V95, P3245, DOI 10.1152/jn.00055.2005; Taylor A, 1976, Prog Brain Res, V44, P171; Thunberg J, 2002, EXP BRAIN RES, V142, P319, DOI 10.1007/s00221-001-0941-4; WELCH PD, 1967, IEEE T ACOUST SPEECH, VAU15, P70, DOI 10.1109/TAU.1967.1161901	47	14	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2012	7	4							e35091	10.1371/journal.pone.0035091	http://dx.doi.org/10.1371/journal.pone.0035091			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WC	22529975	gold, Green Published, Green Submitted			2022-12-25	WOS:000305347400031
J	Du, GW; Lewis, MM; Shaffer, ML; Chen, HL; Yang, QX; Mailman, RB; Huang, XM				Du, Guangwei; Lewis, Mechelle M.; Shaffer, Michele L.; Chen, Honglei; Yang, Qing X.; Mailman, Richard B.; Huang, Xuemei			Serum Cholesterol and Nigrostriatal R2*Values in Parkinson's Disease	PLOS ONE			English	Article							SUBSTANTIA-NIGRA; BRAIN IRON; ALZHEIMERS-DISEASE; ALPHA-SYNUCLEIN; BASAL GANGLIA; RISK-FACTORS; IN-VITRO; NEURODEGENERATION; TRANSFERRIN; FERRITIN	Background: The occurrence of Parkinson's disease (PD) is known to be associated both with increased nigrostriatal iron content and with low serum cholesterol and PD, but there has been no study to determine a potential relationship between these two factors. Methods: High-resolution MRI (T1-, T2, and multiple echo T2*-weighted imaging) and fasting lipid levels were obtained from 40 patients with PD and 29 healthy controls. Iron content was estimated from mean R2* values (R2* = 1/T2*) calculated for each nigrostriatal structure including substantia nigra, caudate, putamen, and globus pallidus. This was correlated with serum cholesterol levels after controlling for age, gender, and statin use. Results: In patients with PD, higher serum cholesterol levels were associated with lower iron content in the substantia nigra (R = -0.43, p = 0.011 for total-cholesterol, R = -0.31, p = 0.080 for low-density lipoprotein) and globus pallidus (R = -0.38, p = 0.028 for total-cholesterol, R = -0.27, p = 0.127 for low-density lipoprotein), but only a trend toward significant association of higher total-cholesterol with lower iron content in the striatum (R = -0.34, p = 0.052 for caudate; R = -0.32, p = 0.061 for putamen). After adjusting for clinical measures, the cholesterol-iron relationships held or became even stronger in the substantia nigra and globus pallidus, but weaker in the caudate and putamen. There was no significant association between serum cholesterol levels and nigrostriatal iron content for controls. Conclusions: The data show that higher serum total-cholesterol concentration is associated with lower iron content in substantia nigra and globus pallidus in Parkinson's disease patients. Further studies should investigate whether this is mechanistic or epiphenomenological relationship.	[Du, Guangwei; Lewis, Mechelle M.; Mailman, Richard B.; Huang, Xuemei] Penn State Univ, Milton S Hershey Med Ctr, Dept Neurol, Hershey, PA 17033 USA; [Lewis, Mechelle M.; Mailman, Richard B.; Huang, Xuemei] Penn State Univ, Milton S Hershey Med Ctr, Dept Pharmacol, Hershey, PA 17033 USA; [Yang, Qing X.; Huang, Xuemei] Penn State Univ, Milton S Hershey Med Ctr, Dept Radiol, Hershey, PA 17033 USA; [Yang, Qing X.; Huang, Xuemei] Penn State Univ, Milton S Hershey Med Ctr, Dept Neurosurg, Hershey, PA 17033 USA; [Huang, Xuemei] Penn State Univ, Milton S Hershey Med Ctr, Dept Kinesiol, Hershey, PA 17033 USA; [Shaffer, Michele L.] Penn State Univ, Milton S Hershey Med Ctr, Dept Publ Hlth Sci, Hershey, PA 17033 USA; [Chen, Honglei] NIEHS, Epidemiol Branch, Res Triangle Pk, NC 27709 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Du, GW (corresponding author), Penn State Univ, Milton S Hershey Med Ctr, Dept Neurol, Hershey, PA 17033 USA.	Xuemei@psu.edu	Yang, Heroine/GRY-2630-2022	Chen, Honglei/0000-0003-3446-7779; Mailman, Richard/0000-0003-1353-2738	National Institute of Neurological Disorders and Stroke [NS060722]; General Clinical Research Center from National Institutes of Health (NIH) [M01RR10732]; GCRC [C06RR016499]; Pennsylvania Department of Health Tobacco CURE Funds; National Institute of Health; National Institute of Environmental Health Sciences; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [TL1TR000125, UL1TR000127] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR016499, M01RR010732] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES101986] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS060722] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); General Clinical Research Center from National Institutes of Health (NIH); GCRC(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Pennsylvania Department of Health Tobacco CURE Funds; National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institute of Neurological Disorders and Stroke (NS060722 to XH), General Clinical Research Center grant from National Institutes of Health (NIH) (M01RR10732) and GCRC Construction Grant (C06RR016499) awarded to the Pennsylvania State University College of Medicine, the Pennsylvania Department of Health Tobacco CURE Funds, and the intramural research program of the National Institute of Health and the National Institute of Environmental Health Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altamura S, 2009, J ALZHEIMERS DIS, V16, P879, DOI 10.3233/JAD-2009-1010; Bar-On P, 2008, J NEUROCHEM, V105, P1656, DOI 10.1111/j.1471-4159.2008.05254.x; BAUDREXEL S, 2010, NEUROIMAGE; Beard J, 2003, J NUTR, V133, p1468S, DOI 10.1093/jn/133.5.1468S; BEARD JL, 1993, NUTR REV, V51, P157, DOI 10.1111/j.1753-4887.1993.tb03096.x; Benarroch EE, 2009, NEUROLOGY, V72, P1436, DOI 10.1212/WNL.0b013e3181a26b30; CALNE DB, 1992, ANN NEUROL, V32, pS125, DOI 10.1002/ana.410320721; Curtis ARJ, 2001, NAT GENET, V28, P350, DOI 10.1038/ng571; Damier P, 1999, BRAIN, V122, P1421, DOI 10.1093/brain/122.8.1421; Damier P, 1999, BRAIN, V122, P1437, DOI 10.1093/brain/122.8.1437; de Lau LML, 2006, AM J EPIDEMIOL, V164, P998, DOI 10.1093/aje/kwj283; Denk C, 2010, J MAGN RESON IMAGING, V31, P185, DOI 10.1002/jmri.21995; DEXTER DT, 1989, J NEUROCHEM, V52, P1830, DOI 10.1111/j.1471-4159.1989.tb07264.x; DEXTER DT, 1991, BRAIN, V114, P1953, DOI 10.1093/brain/114.4.1953; Dorman DC, 2006, TOXICOL SCI, V92, P219, DOI 10.1093/toxsci/kfj209; FEARNLEY JM, 1991, BRAIN, V114, P2283, DOI 10.1093/brain/114.5.2283; Gitlin JD, 1998, PEDIATR RES, V44, P271, DOI 10.1203/00006450-199809000-00001; GORELL JM, 1995, NEUROLOGY, V45, P1138, DOI 10.1212/WNL.45.6.1138; Gouttard S., 2007, MED IM COMP COMP ASS, P37; Graham JM, 2000, BRAIN, V123, P2423, DOI 10.1093/brain/123.12.2423; Gregory A, 2005, FOLIA NEUROPATHOL, V43, P286, DOI 10.1016/B978-0-444-63233-3.00019-1; Griffiths PD, 1999, BRAIN, V122, P667, DOI 10.1093/brain/122.4.667; Griffiths PD, 1996, NEUROSCI LETT, V211, P53, DOI 10.1016/0304-3940(96)12719-1; Haacke EM, 2005, MAGN RESON IMAGING, V23, P1, DOI 10.1016/j.mri.2004.10.001; HALLGREN B, 1958, J NEUROCHEM, V3, P41, DOI 10.1111/j.1471-4159.1958.tb12607.x; Herzog J, 2003, MOVEMENT DISORD, V18, P1332, DOI 10.1002/mds.10518; Hu G, 2008, NEUROLOGY, V70, P1972, DOI 10.1212/01.wnl.0000312511.62699.a8; Huang X, 2011, PLOS ONE IN PRESS; Huang XM, 2008, MOVEMENT DISORD, V23, P1013, DOI 10.1002/mds.22013; Huang XM, 2007, MOVEMENT DISORD, V22, P377, DOI 10.1002/mds.21290; Ikeda K, 2011, NEURODEGENER DIS; Jenner P, 2003, ANN NEUROL, V53, pS26, DOI 10.1002/ana.10483; Joshi S, 2004, NEUROIMAGE, V23, pS151, DOI 10.1016/j.neuroimage.2004.07.068; Klos KJ, 2006, EUR J NEUROL, V13, P1139, DOI 10.1111/j.1468-1331.2006.01407.x; Kwon DH, 2012, ANN NEUROL, V71, P267, DOI 10.1002/ana.22592; Langkammer C, 2010, RADIOLOGY, V257, P455, DOI 10.1148/radiol.10100495; LaVaute T, 2001, NAT GENET, V27, P209, DOI 10.1038/84859; Lewis MM, 2011, MOV DISORD; LOEFFLER DA, 1995, J NEUROCHEM, V65, P710; Lotfipour AK, 2012, J MAGN RESON IMAGING, V35, P48, DOI 10.1002/jmri.22752; Manova ES, 2009, AM J NEURORADIOL, V30, P569, DOI 10.3174/ajnr.A1401; Martin WRW, 2008, NEUROLOGY, V70, P1411, DOI 10.1212/01.wnl.0000286384.31050.b5; Massey LA, 2010, NEUROIMAG CLIN N AM, V20, P7, DOI 10.1016/j.nic.2009.10.001; Miyake Y, 2010, J NEUROL SCI, V293, P82, DOI 10.1016/j.jns.2010.03.002; Oikawa H, 2002, AM J NEURORADIOL, V23, P1747; Peran P, 2010, BRAIN; Powers KM, 2009, PARKINSONISM RELAT D, V15, P47, DOI 10.1016/j.parkreldis.2008.03.002; Scigliano G, 2006, STROKE, V37, P1184, DOI 10.1161/01.STR.0000217384.03237.9c; Simon KC, 2007, NEUROLOGY, V69, P1688, DOI 10.1212/01.wnl.0000271883.45010.8a; SOFIC E, 1988, J NEURAL TRANSM, V74, P199, DOI 10.1007/BF01244786; Stepien K, 2005, PHARMACOL REP, V57, P561; Tofaris GK, 2007, ARCH NEUROL-CHICAGO, V64, P280, DOI 10.1001/archneur.64.2.280; VAILLANCOURT DE, 2010, NEUROBIOL AGING; Yushkevich PA, 2006, NEUROIMAGE, V31, P1116, DOI 10.1016/j.neuroimage.2006.01.015; Zecca L, 2004, NAT REV NEUROSCI, V5, P863, DOI 10.1038/nrn1537; Zecca L, 2008, J NEUROCHEM, V106, P1866, DOI 10.1111/j.1471-4159.2008.05541.x; Zhou B, 2001, NAT GENET, V28, P345, DOI 10.1038/ng572	57	16	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2012	7	4							e35397	10.1371/journal.pone.0035397	http://dx.doi.org/10.1371/journal.pone.0035397			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WC	22530017	Green Published, Green Submitted, gold			2022-12-25	WOS:000305347400049
J	Leray, M; Beraud, M; Anker, A; Chancerelle, Y; Mills, SC				Leray, Matthieu; Beraud, Maxime; Anker, Arthur; Chancerelle, Yannick; Mills, Suzanne C.			Acanthaster planci Outbreak: Decline in Coral Health, Coral Size Structure Modification and Consequences for Obligate Decapod Assemblages	PLOS ONE			English	Article							SPATIAL-DISTRIBUTION; COMMUNITY STRUCTURE; TERRESTRIAL RUNOFF; SPECIES RICHNESS; CLIMATE-CHANGE; REEF FISHES; RECRUITMENT; TRAPEZIA; DIVERSITY; CRUSTACEA	Although benthic motile invertebrate communities encompass the vast majority of coral reef diversity, their response to habitat modification has been poorly studied. A variety of benthic species, particularly decapods, provide benefits to their coral host enabling them to cope with environmental stressors, and as a result benefit the overall diversity of coral-associated species. However, little is known about how invertebrate assemblages associated with corals will be affected by global perturbations, (either directly or indirectly via their coral host) or their consequences for ecosystem resilience. Analysis of a ten year dataset reveals that the greatest perturbation at Moorea over this time was an outbreak of the corallivorous sea star Acanthaster planci from 2006 to 2009 impacting habitat health, availability and size structure of Pocillopora spp. populations and highlights a positive relationship between coral head size and survival. We then present the results of a mensurative study in 2009 conducted at the end of the perturbation (A. planci outbreak) describing how coral-decapod communities change with percent coral mortality for a selected coral species, Pocillopora eydouxi. The loss of coral tissue as a consequence of A. planci consumption led to an increase in rarefied total species diversity, but caused drastic modifications in community composition driven by a shift from coral obligate to non-obligate decapod species. Our study highlights that larger corals left with live tissue in 2009, formed a restricted habitat where coral obligate decapods, including mutualists, could subsist. We conclude that the size structure of Pocillopora populations at the time of an A. planci outbreak may greatly condition the magnitude of coral mortality as well as the persistence of local populations of obligate decapods.	[Leray, Matthieu; Beraud, Maxime; Mills, Suzanne C.] Univ Perpignan, CBETM, USR CRIOBE CNRS EPHE 3278, Lab Excellence CORAIL, F-66025 Perpignan, France; [Anker, Arthur] Univ Fed Ceara, Lab Ciencias Mar Labomar, Fortaleza, Ceara, Brazil; [Chancerelle, Yannick] CRIOBE, USR CRIOBE CNRS EPHE 3278, Lab Excellence CORAIL, Moorea, France	Universite Perpignan Via Domitia; Universidade Federal do Ceara	Leray, M (corresponding author), Univ Perpignan, CBETM, USR CRIOBE CNRS EPHE 3278, Lab Excellence CORAIL, F-66025 Perpignan, France.	leray.upmc@gmail.com	Anker, Arthur/AAL-5555-2021; Mills, Suzanne/K-5538-2012	Mills, Suzanne/0000-0001-8948-3384	Partner University Fund of the French American Cultural Exchange; ANR [ANR-12-JCJC-Live]; Polynesia Mana; CRISP (Coral Reef InitiativeS for the Pacific); Total Foundation; Gordon and Betty Moore Foundation	Partner University Fund of the French American Cultural Exchange; ANR(French National Research Agency (ANR)); Polynesia Mana; CRISP (Coral Reef InitiativeS for the Pacific); Total Foundation(Total SA); Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation)	This research was supported by grants from the Partner University Fund of the French American Cultural Exchange, ANR (ANR-12-JCJC-Live and Let Die), Polynesia Mana, CRISP (Coral Reef InitiativeS for the Pacific) and Total Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.r We thank volunteers from CRIOBE station in Moorea and Planete Urgence for field assistance, C. W. Osenberg, A. C. Stier, S. Lemer, M. Gil, S. C. McKeon, R. Galzin and two anonymous reviewers for helpful comments, G. Paulay and J. Poupin for assistance with identification of some decapod specimens, and the Moorea BIOCODE project (funded through Gordon and Betty Moore Foundation) for logistical support. This study was part of M. Leray PhD research program at Universite Pierre et Marie Curie (Paris VI) and Ecole Pratique des Hautes Etudes (EPHE) under the supervision of S.C. Mills.	ABELE LG, 1976, AM ZOOL, V16, P194; Adjeroud M, 2009, CORAL REEFS, V28, P775, DOI 10.1007/s00338-009-0515-7; Almany GR, 2007, SCIENCE, V316, P742, DOI 10.1126/science.1140597; Anderson MJ, 2006, ECOL LETT, V9, P683, DOI 10.1111/j.1461-0248.2006.00926.x; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Bak RPM, 1999, AM ZOOL, V39, P56; Balmford A, 2002, SCIENCE, V297, P950, DOI 10.1126/science.1073947; Beldade R, 2012, P ROYAL S B IN PRESS; BIRKELAND C, 1982, MAR BIOL, V69, P175, DOI 10.1007/BF00396897; Bouchet P, 2002, BIOL J LINN SOC, V75, P421, DOI 10.1046/j.1095-8312.2002.00052.x; BRANHAM JM, 1971, SCIENCE, V172, P1155, DOI 10.1126/science.172.3988.1155; BRODIE JE, 1992, AUST J MAR FRESH RES, V43, P539; Bruno JF, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000711; Caley MJ, 2001, ECOLOGY, V82, P3435, DOI 10.2307/2680163; Caley MJ, 1996, ANNU REV ECOL SYST, V27, P477, DOI 10.1146/annurev.ecolsys.27.1.477; CASTRO P, 1976, Micronesica, V12, P99; CASTRO P, 1978, MAR BIOL, V46, P237, DOI 10.1007/BF00390685; CHACE FA, 1993, SMITHSONIAN CONTRIBU, V543; CHESHER RH, 1969, SCIENCE, V165, P280, DOI 10.1126/science.165.3890.280; COLES SL, 1980, MAR ECOL PROG SER, V2, P281, DOI 10.3354/meps002281; COLWELL R. K, 2009, ESTIMATES STAT ESTIM; Colwell RK, 2004, ECOLOGY, V85, P2717, DOI 10.1890/03-0557; Enquist BJ, 2011, GLOBAL CHANGE BIOL, V17, P1408, DOI 10.1111/j.1365-2486.2010.02326.x; Fabricius KE, 2010, CORAL REEFS, V29, P593, DOI 10.1007/s00338-010-0628-z; Feary DA, 2007, OECOLOGIA, V153, P727, DOI 10.1007/s00442-007-0773-4; GLYNN P W, 1974, Environmental Conservation, V1, P295; GLYNN PW, 1980, OECOLOGIA, V47, P287, DOI 10.1007/BF00398518; GLYNN PW, 1985, BIOL BULL, V168, P276, DOI 10.2307/1541240; GLYNN PW, 1987, SYMBIOSIS, V4, P301; GLYNN PW, 1976, ECOL MONOGR, V46, P431, DOI 10.2307/1942565; GOTELLI NJ, 1985, MAR ECOL PROG SER, V21, P89, DOI 10.3354/meps021089; GOTELLI NJ, 1983, MAR ECOL PROG SER, V13, P131, DOI 10.3354/meps013131; HECK KL, 1975, ECOLOGY, V56, P1459, DOI 10.2307/1934716; Hedley J., 2003, VIDANA 1 0 VIDEO ANA; Henle K, 2004, BIODIVERS CONSERV, V13, P207, DOI 10.1023/B:BIOC.0000004319.91643.9e; Holbrook SJ, 2008, MAR ECOL PROG SER, V371, P263, DOI 10.3354/meps07690; Hooper DU, 2005, ECOL MONOGR, V75, P3, DOI 10.1890/04-0922; Hughes TP, 2003, SCIENCE, V301, P929, DOI 10.1126/science.1085046; Jones GP, 2004, P NATL ACAD SCI USA, V101, P8251, DOI 10.1073/pnas.0401277101; Kaandorp JA, 1999, MAR BIOL, V134, P295, DOI 10.1007/s002270050547; Kane C, 2009, ENVIRON BIOL FISH, V84, P1, DOI 10.1007/s10641-008-9377-z; Kayal M, 2011, CORAL REEFS, V30, P827, DOI 10.1007/s00338-011-0763-1; KNUDSEN JW, 1967, PAC SCI, V21, P51; LASSIG BR, 1977, MAR BIOL, V42, P85, DOI 10.1007/BF00392016; LUCAS J S, 1973, Micronesica, V9, P197; McKeon CS, 2010, THESIS U FLORIDA GAI; McManus JW, 2004, PROG OCEANOGR, V60, P263, DOI 10.1016/j.pocean.2004.02.014; Mills SC, 2004, ANIM CONSERV, V7, P257, DOI 10.1017/S1367943004001416; Mills SC, 2012, CORAL REEFS IN PRESS; MORAN PJ, 1986, OCEANOGR MAR BIOL, V24, P379; Odinetz MO, 1983, THESIS U PIERRE MARI; Oksanen J., 2009, VEGAN COMMUNITY ECOL; Pearson R. G., 1969, Fish Notes Qd, V3, P27; PEARSON RG, 1981, MAR ECOL PROG SER, V4, P105, DOI 10.3354/meps004105; Penin L, 2007, B MAR SCI, V80, P379; Pratchett M, 2000, CORAL REEFS, V19, P36, DOI 10.1007/s003380050223; Pratchett MS, 2009, MAR ENVIRON RES, V67, P230, DOI 10.1016/j.marenvres.2009.03.001; Pratchett MS, 2001, MAR ECOL PROG SER, V214, P111, DOI 10.3354/meps214111; PRESTON NP, 1994, MAR ECOL PROG SER, V104, P27, DOI 10.3354/meps104027; Przeslawski R, 2008, GLOBAL CHANGE BIOL, V14, P2773, DOI 10.1111/j.1365-2486.2008.01693.x; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Riegl Bernhard, 2007, V192, P315, DOI 10.1007/978-0-387-33537-7_10; Sheppard CRC, 2003, NATURE, V425, P294, DOI 10.1038/nature01987; Shima JS, 2008, ECOLOGY, V89, P86, DOI 10.1890/07-0021.1; Stella JS, 2011, CORAL REEFS, V30, P719, DOI 10.1007/s00338-011-0748-0; Stella JS, 2011, OCEANOGR MAR BIOL, V49, P43; Stewart HL, 2006, CORAL REEFS, V25, P609, DOI 10.1007/s00338-006-0132-7; Stier AC, 2010, CORAL REEFS, V29, P1019, DOI 10.1007/s00338-010-0663-9; Stier AC, 2012, PLOS ONE IN PRESS; Swihart RK, 2003, DIVERS DISTRIB, V9, P1, DOI 10.1046/j.1472-4642.2003.00158.x; Syms C, 2000, ECOLOGY, V81, P2714, DOI 10.1890/0012-9658(2000)081[2714:DHSATD]2.0.CO;2; Tsuchiya M, 1999, GALAXEA, V1, P65; Uthicke S, 2009, ECOL MONOGR, V79, P3, DOI 10.1890/07-2136.1; Wilkinson C., 2004, STATUS CORAL REEFS W, V1; Wilson SK, 2006, GLOBAL CHANGE BIOL, V12, P2220, DOI 10.1111/j.1365-2486.2006.01252.x; YAMAGUCHI M, 1986, CORAL REEFS, V5, P23, DOI 10.1007/BF00302168	77	35	36	0	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2012	7	4							e35456	10.1371/journal.pone.0035456	http://dx.doi.org/10.1371/journal.pone.0035456			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WC	22530026	gold, Green Published			2022-12-25	WOS:000305347400053
J	Lu, Z; Lu, YH				Lu, Zhe; Lu, Yahai			Methanocella conradii sp nov., a Thermophilic, Obligate Hydrogenotrophic Methanogen, Isolated from Chinese Rice Field Soil	PLOS ONE			English	Article							CLUSTER-I METHANOGENS; ARCHAEAL COMMUNITY; GENOME; TAXONOMY; PROPOSAL; SUBUNIT; ACETATE; ROOTS	Background: Methanocellales contributes significantly to anthropogenic methane emissions that cause global warming, but few pure cultures for Methanocellales are available to permit subsequent laboratory studies (physiology, biochemistry, etc.). Methodology/Principal Findings: By combining anaerobic culture and molecular techniques, a novel thermophilic methanogen, strain HZ254(T) was isolated from a Chinese rice field soil located in Hangzhou, China. The phylogenetic analyses of both the 16S rRNA gene and mcrA gene (encoding the alpha subunit of methyl-coenzyme M reductase) confirmed its affiliation with Methanocellales, and Methanocella paludicola SANAE(T) was the most closely related species. Cells were non-motile rods, albeit with a flagellum, 1.4-2.8 mu m long and by 0.2-0.3 mu m in width. They grew at 37-60 degrees C (optimally at 55 degrees C) and salinity of 0-5 g NaCl l(-1) (optimally at 0-1 g NaCl l(-1)). The pH range for growth was 6.4-7.2 (optimum 6.8). Under the optimum growth condition, the doubling time was 6.5-7.8 h, which is the shortest ever observed in Methanocellales. Strain HZ254(T) utilized H-2/CO2 but not formate for growth and methane production. The DNA G+C content of this organism was 52.7 mol%. The sequence identities of 16S rRNA gene and mcrA gene between strain HZ254(T) and SANAE(T) were 95.0 and 87.5% respectively, and the genome based Average Nucleotide Identity value between them was 74.8%. These two strains differed in phenotypic features with regard to substrate utilization, possession of a flagellum, doubling time (under optimal conditions), NaCl and temperature ranges. Taking account of the phenotypic and phylogenetic characteristics, we propose strain HZ254(T) as a representative of a novel species, Methanocella conradii sp. nov. The type strain is HZ254(T) (= CGMCC 1.5162(T) = JCM 17849(T) = DSM 24694(T)). Conclusions/Significance: Strain HZ254(T) could potentially serve as an excellent laboratory model for studying Methanocellales due to its fast growth and consistent cultivability.	[Lu, Zhe; Lu, Yahai] China Agr Univ, Coll Resources & Environm Sci, Beijing 100094, Peoples R China	China Agricultural University	Lu, Z (corresponding author), China Agr Univ, Coll Resources & Environm Sci, Beijing 100094, Peoples R China.	yhlu@cau.edu.cn	Lu, Yahai/A-5030-2013; Lyu, Zhe/H-8273-2019	Lu, Yahai/0000-0002-1702-9868; Lyu, Zhe/0000-0003-0184-6609	Natural Science Foundation of China [40625003, 40830534]; Chinese Ministry of Education	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Ministry of Education(Ministry of Education, China)	The study was supported by the Natural Science Foundation of China (grant no: 40625003; 40830534; www.nsfc.gov.cn) and the Chang Jiang Scholars Program of Chinese Ministry of Education (www.cksp.edu.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angel R, 2012, ISME J, V6, P847, DOI 10.1038/ismej.2011.141; Angel R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020453; BOONE DR, 1988, INT J SYST BACTERIOL, V38, P212, DOI 10.1099/00207713-38-2-212; Cole C, 2008, NUCLEIC ACIDS RES, V36, pW197, DOI 10.1093/nar/gkn238; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; Conrad R, 2006, CURR OPIN BIOTECH, V17, P262, DOI 10.1016/j.copbio.2006.04.002; DELONG EF, 1992, P NATL ACAD SCI USA, V89, P5685, DOI 10.1073/pnas.89.12.5685; Erkel C, 2005, FEMS MICROBIOL ECOL, V53, P187, DOI 10.1016/j.femsec.2004.12.004; Erkel C, 2006, SCIENCE, V313, P370, DOI 10.1126/science.1127062; Fey A, 2001, ENVIRON MICROBIOL, V3, P295, DOI 10.1046/j.1462-2920.2001.00195.x; Fukada H, 1998, PROTEINS, V33, P159, DOI 10.1002/(SICI)1097-0134(19981101)33:2<159::AID-PROT2>3.3.CO;2-F; Garrity GM, 2001, BERGEYS MANUAL SYSTE, V1, P211; Goris J, 2007, INT J SYST EVOL MICR, V57, P81, DOI 10.1099/ijs.0.64483-0; Grosskopf R, 1998, APPL ENVIRON MICROB, V64, P4983; Hungate RE., 1969, METHODS MICROBIOLO B, Vvol 3, P117, DOI 10.1016/S0580-9517(08)70503-8; KOGA Y, 1993, MICROBIOL REV, V57, P164, DOI 10.1128/MMBR.57.1.164-182.1993; Konstantinidis KT, 2007, CURR OPIN MICROBIOL, V10, P504, DOI 10.1016/j.mib.2007.08.006; Konstantinidis KT, 2005, J BACTERIOL, V187, P6258, DOI 10.1128/JB.187.18.6258-6264.2005; Liu FH, 2010, ENVIRON MICROBIOL, V12, P2341, DOI 10.1111/j.1462-2920.2010.02289.x; Lu YH, 2005, SCIENCE, V309, P1088, DOI 10.1126/science.1113435; Lu YH, 2005, ENVIRON MICROBIOL, V7, P326, DOI 10.1111/j.1462-2920.2005.00697.x; Lu Z, 2012, J BACTERIOL, V194, P2398, DOI 10.1128/JB.00207-12; Lueders T, 2001, ENVIRON MICROBIOL, V3, P194, DOI 10.1046/j.1462-2920.2001.00179.x; Peng JJ, 2008, APPL ENVIRON MICROB, V74, P2894, DOI 10.1128/AEM.00070-08; Richter M, 2009, P NATL ACAD SCI USA, V106, P19126, DOI 10.1073/pnas.0906412106; Rui JP, 2011, FEMS MICROBIOL ECOL, V77, P264, DOI 10.1111/j.1574-6941.2011.01104.x; Sakai S, 2008, INT J SYST EVOL MICR, V58, P929, DOI 10.1099/ijs.0.65571-0; Sakai S, 2007, APPL ENVIRON MICROB, V73, P4326, DOI 10.1128/AEM.03008-06; Sakai S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022898; Sakai S, 2010, INT J SYST EVOL MICR, V60, P2918, DOI 10.1099/ijs.0.020883-0; Sizova MV, 2003, FEMS MICROBIOL ECOL, V45, P301, DOI 10.1016/S0168-6496(03)00165-X; SPRINGER E, 1995, INT J SYST BACTERIOL, V45, P554, DOI 10.1099/00207713-45-3-554; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Widdel F., 1992, PROKARYOTES, DOI 10.1007/978-1-4757-2191-1_2; Wu LQ, 2009, MICROB ECOL, V58, P819, DOI 10.1007/s00248-009-9554-4; Yuan QA, 2009, ENV MICROBIOL REP, V1, P362, DOI 10.1111/j.1758-2229.2009.00065.x; Yuan YL, 2009, ENV MICROBIOL REP, V1, P347, DOI 10.1111/j.1758-2229.2009.00036.x; ZWIETERING MH, 1990, APPL ENVIRON MICROB, V56, P1875	38	39	49	0	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2012	7	4							e35279	10.1371/journal.pone.0035279	http://dx.doi.org/10.1371/journal.pone.0035279			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WC	22530002	Green Published, gold, Green Submitted			2022-12-25	WOS:000305347400041
J	Wood, DO; Hines, A; Tucker, AM; Woodard, A; Driskell, LO; Burkhardt, NY; Kurtti, TJ; Baldridge, GD; Munderloh, UG				Wood, David O.; Hines, Andria; Tucker, Aimee M.; Woodard, Andrew; Driskell, Lonnie O.; Burkhardt, Nicole Y.; Kurtti, Timothy J.; Baldridge, Gerald D.; Munderloh, Ulrike G.			Establishment of a Replicating Plasmid in Rickettsia prowazekii	PLOS ONE			English	Article							HOST CELL-INTERACTIONS; ESCHERICHIA-COLI; TRANSPOSON MUTAGENESIS; VERO CELLS; GENE; TRANSFORMATION; MONACENSIS; RESISTANCE; PROTEINS; VIRULENT	Rickettsia prowazekii, the causative agent of epidemic typhus, grows only within the cytosol of eukaryotic host cells. This obligate intracellular lifestyle has restricted the genetic analysis of this pathogen and critical tools, such as replicating plasmid vectors, have not been developed for this species. Although replicating plasmids have not been reported in R. prowazekii, the existence of well-characterized plasmids in several less pathogenic rickettsial species provides an opportunity to expand the genetic systems available for the study of this human pathogen. Competent R. prowazekii were transformed with pRAM18dRGA, a 10.3 kb vector derived from pRAM18 of R. amblyommii. A plasmid-containing population of R. prowazekii was obtained following growth under antibiotic selection, and the rickettsial plasmid was maintained extrachromosomally throughout multiple passages. The transformant population exhibited a generation time comparable to that of the wild type strain with a copy number of approximately 1 plasmid per rickettsia. These results demonstrate for the first time that a plasmid can be maintained in R. prowazekii, providing an important genetic tool for the study of this obligate intracellular pathogen.	[Wood, David O.; Hines, Andria; Tucker, Aimee M.; Woodard, Andrew; Driskell, Lonnie O.] Univ S Alabama, Coll Med, Dept Microbiol & Immunol, Mol Biol Lab, Mobile, AL 36688 USA; [Burkhardt, Nicole Y.; Kurtti, Timothy J.; Baldridge, Gerald D.; Munderloh, Ulrike G.] Univ Minnesota, Dept Entomol, St Paul, MN USA	University of South Alabama; University of Minnesota System; University of Minnesota Twin Cities	Wood, DO (corresponding author), Univ S Alabama, Coll Med, Dept Microbiol & Immunol, Mol Biol Lab, Mobile, AL 36688 USA.	dowood@jaguar1.usouthal.edu			Public Health Service [AI020384, AI049424]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI049424, R56AI020384, R01AI020384, R37AI020384, R01AI049424, R01AI081690] Funding Source: NIH RePORTER	Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by Public Health Service grants AI020384 to DOW and AI049424 to UGM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baldridge GD, 2005, APPL ENVIRON MICROB, V71, P2095, DOI 10.1128/AEM.71.4.2095-2105.2005; Baldridge GD, 2008, APPL ENVIRON MICROB, V74, P645, DOI 10.1128/AEM.02262-07; Baldridge GD, 2007, APPL ENVIRON MICROB, V73, P4984, DOI 10.1128/AEM.00988-07; Baldridge GD, 2010, APPL ENVIRON MICROB, V76, P1718, DOI 10.1128/AEM.02988-09; Bechah Y, 2010, GENOME RES, V20, P655, DOI 10.1101/gr.103564.109; Burkhardt NY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029511; Clark TR, 2011, INFECT IMMUN, V79, P1631, DOI 10.1128/IAI.00048-11; Driskell LO, 2009, INFECT IMMUN, V77, P3244, DOI 10.1128/IAI.00395-09; Felsheim RF, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008361; GIMENEZ DF, 1964, STAIN TECHNOL, V39, P135, DOI 10.3109/10520296409061219; Heinzen RA, 1999, INFECT IMMUN, V67, P4201, DOI 10.1128/IAI.67.8.4201-4207.1999; HEINZEN RA, 1993, INFECT IMMUN, V61, P1926, DOI 10.1128/IAI.61.5.1926-1935.1993; Liu ZM, 2007, APPL ENVIRON MICROB, V73, P6644, DOI 10.1128/AEM.01727-07; Ogata H, 2005, PLOS BIOL, V3, P1391, DOI 10.1371/journal.pbio.0030248; Qin AP, 2004, APPL ENVIRON MICROB, V70, P2816, DOI 10.1128/AEM.70.5.2816-2822.2004; Rachek LI, 1998, J BACTERIOL, V180, P2118, DOI 10.1128/JB.180.8.2118-2124.1998; Rachek LI, 2000, J BACTERIOL, V182, P3289, DOI 10.1128/JB.182.11.3289-3291.2000; Seitz H, 2000, MOL MICROBIOL, V37, P1270, DOI 10.1046/j.1365-2958.2000.02096.x; SILVERMAN DJ, 1980, INFECT IMMUN, V29, P778; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; Sutton MD, 1998, J BIOL CHEM, V273, P34255, DOI 10.1074/jbc.273.51.34255; Van Kirk LS, 2000, INFECT IMMUN, V68, P4706, DOI 10.1128/IAI.68.8.4706-4713.2000; WEISS E, 1982, ANNU REV MICROBIOL, V36, P345, DOI 10.1146/annurev.mi.36.100182.002021; WEISS E, 1973, BACTERIOL REV, V37, P259, DOI 10.1128/MMBR.37.3.259-283.1973; WINKLER HH, 1976, J BIOL CHEM, V251, P389; WISSEMAN CL, 1975, INFECT IMMUN, V11, P1391, DOI 10.1128/IAI.11.6.1391-1401.1975; WOOD HE, 1990, GENE, V96, P83, DOI 10.1016/0378-1119(90)90344-Q	27	17	17	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2012	7	4							e34715	10.1371/journal.pone.0034715	http://dx.doi.org/10.1371/journal.pone.0034715			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WC	22529927	Green Submitted, Green Published, gold			2022-12-25	WOS:000305347400016
J	Hofmann, AD; Beyer, M; Krause-Buchholz, U; Wobus, M; Bornhauser, M; Rodel, G				Hofmann, Andreas D.; Beyer, Mandy; Krause-Buchholz, Udo; Wobus, Manja; Bornhaeuser, Martin; Roedel, Gerhard			OXPHOS Supercomplexes as a Hallmark of the Mitochondrial Phenotype of Adipogenic Differentiated Human MSCs	PLOS ONE			English	Article							HEMATOPOIETIC STEM-CELLS; OXIDATIVE-PHOSPHORYLATION; ANTIOXIDANT ENZYMES; BIOGENESIS; ORGANIZATION; OXIDASE; COMPLEX; NICHE; YEAST	Mitochondria are essential organelles with multiple functions, especially in energy metabolism. Recently, an increasing number of data has highlighted the role of mitochondria for cellular differentiation processes. Metabolic differences between stem cells and mature derivatives require an adaptation of mitochondrial function during differentiation. In this study we investigated alterations of the mitochondrial phenotype of human mesenchymal stem cells undergoing adipogenic differentiation. Maturation of adipocytes is accompanied by mitochondrial biogenesis and an increase of oxidative metabolism. Adaptation of the mt phenotype during differentiation is reflected by changes in the distribution of the mitochondrial network as well as marked alterations of gene expression and organization of the oxidative phosphorylation system (OXPHOS). Distinct differences in the supramolecular organization forms of cytochrome c oxidase (COX) were detected using 2D blue native (BN)-PAGE analysis. Most remarkably we observed a significant increase in the abundance of OXPHOS supercomplexes in mitochondria, emphasizing the change of the mitochondrial phenotype during adipogenic differentiation.	[Hofmann, Andreas D.; Beyer, Mandy; Krause-Buchholz, Udo; Roedel, Gerhard] Tech Univ Dresden, Inst Genet, D-01062 Dresden, Germany; [Wobus, Manja; Bornhaeuser, Martin] Tech Univ Dresden, Univ Hosp Carl Gustav Carus, Med Clin & Polyclin 1, D-01062 Dresden, Germany	Technische Universitat Dresden; Technische Universitat Dresden; Carl Gustav Carus University Hospital	Hofmann, AD (corresponding author), Tech Univ Dresden, Inst Genet, D-01062 Dresden, Germany.	andreas.hofmann@mailbox.tu-dresden.de	Roedel, Gerhard/AAH-3762-2022; Roedel, Gerhard/AFQ-8997-2022; Krause, Udo/N-8167-2014	Krause, Udo/0000-0001-9493-4522	Dresden International Graduate School for Biomedicine and Bioengineering (DIGS-BB); Center for Regenerative Therapies Dresden (CRTD)	Dresden International Graduate School for Biomedicine and Bioengineering (DIGS-BB); Center for Regenerative Therapies Dresden (CRTD)	The work was supported by the Dresden International Graduate School for Biomedicine and Bioengineering (DIGS-BB) and by a seed grant of the Center for Regenerative Therapies Dresden (CRTD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acin-Perez R, 2008, MOL CELL, V32, P529, DOI 10.1016/j.molcel.2008.10.021; Chen CT, 2008, STEM CELLS, V26, P960, DOI 10.1634/stemcells.2007-0509; Cho YM, 2006, BIOCHEM BIOPH RES CO, V348, P1472, DOI 10.1016/j.bbrc.2006.08.020; Chung Susan, 2007, Nat Clin Pract Cardiovasc Med, V4 Suppl 1, pS60, DOI 10.1038/ncpcardio0766; Cross M, 2008, CELLS TISSUES ORGANS, V188, P150, DOI 10.1159/000114206; Detmer SA, 2007, NAT REV MOL CELL BIO, V8, P870, DOI 10.1038/nrm2275; Finck BN, 2006, J CLIN INVEST, V116, P615, DOI 10.1172/JCI27794; Gey U, 2008, J BIOL CHEM, V283, P9759, DOI 10.1074/jbc.M708779200; Godecke A, J TISSUE ENG REGEN M, V5, P648; Inoue SI, 2010, FEBS LETT, V584, P3402, DOI 10.1016/j.febslet.2010.06.036; Ivanovic Z, 2009, J CELL PHYSIOL, V219, P271, DOI 10.1002/jcp.21690; Johnson DT, 2007, AM J PHYSIOL-CELL PH, V292, pC698, DOI 10.1152/ajpcell.00109.2006; Krings A, 2012, BONE, V50, P546, DOI 10.1016/j.bone.2011.06.016; Lonergan T, 2007, MITOCHONDRION, V7, P289, DOI 10.1016/j.mito.2007.05.002; Lonergan T, 2006, J CELL PHYSIOL, V208, P149, DOI 10.1002/jcp.20641; Moyes CD, 1997, AM J PHYSIOL-CELL PH, V272, pC1345, DOI 10.1152/ajpcell.1997.272.4.C1345; Nesti C, 2007, BIOSCIENCE REP, V27, P165, DOI 10.1007/s10540-007-9044-1; Nogueira V, 2001, J BIOL CHEM, V276, P46104, DOI 10.1074/jbc.M107425200; Oswald C, 2009, J MOL BIOL, V389, P470, DOI 10.1016/j.jmb.2009.04.034; Piccoli C, 2005, J BIOL CHEM, V280, P26467, DOI 10.1074/jbc.M500047200; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Rehman J, 2010, J MOL MED, V88, P981, DOI 10.1007/s00109-010-0678-2; Rosca MG, 2008, CARDIOVASC RES, V80, P30, DOI 10.1093/cvr/cvn184; Schagger H, 2000, EMBO J, V19, P1777, DOI 10.1093/emboj/19.8.1777; Schagger H, 2001, J BIOL CHEM, V276, P37861; St John JC, 2005, CLONING STEM CELLS, V7, P141, DOI 10.1089/clo.2005.7.141; Suda T, 2005, TRENDS IMMUNOL, V26, P426, DOI 10.1016/j.it.2005.06.006; Van Raam BJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002013; Wilson-Fritch L, 2003, MOL CELL BIOL, V23, P1085, DOI 10.1128/MCB.23.3.1085-1094.2003	29	60	61	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2012	7	4							e35160	10.1371/journal.pone.0035160	http://dx.doi.org/10.1371/journal.pone.0035160			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VO	22523573	gold, Green Submitted, Green Published			2022-12-25	WOS:000305345000045
J	Bankapur, A; Krishnamurthy, RS; Zachariah, E; Santhosh, C; Chougule, B; Praveen, B; Valiathan, M; Mathur, D				Bankapur, Aseefhali; Krishnamurthy, R. Sagar; Zachariah, Elsa; Santhosh, Chidangil; Chougule, Basavaraj; Praveen, Bhavishna; Valiathan, Manna; Mathur, Deepak			Micro-Raman Spectroscopy of Silver Nanoparticle Induced Stress on Optically-Trapped Stem Cells	PLOS ONE			English	Article							RED-BLOOD-CELLS; UV RESONANCE RAMAN; OXIDATIVE STRESS; IRON-OXIDE; CARBON NANOTUBES; LIVING CELLS; DNA-DAMAGE; TOXICITY; CYTOTOXICITY; TWEEZERS	We report here results of a single-cell Raman spectroscopy study of stress effects induced by silver nanoparticles in human mesenchymal stem cells (hMSCs). A high-sensitivity, high-resolution Raman Tweezers set-up has been used to monitor nanoparticle-induced biochemical changes in optically-trapped single cells. Our micro-Raman spectroscopic study reveals that hMSCs treated with silver nanoparticles undergo oxidative stress at doping levels in excess of 2 mu g/ml, with results of a statistical analysis of Raman spectra suggesting that the induced stress becomes more dominant at nanoparticle concentration levels above 3 mu g/ml.	[Bankapur, Aseefhali; Zachariah, Elsa; Santhosh, Chidangil; Praveen, Bhavishna; Mathur, Deepak] Manipal Univ, Ctr Atom & Mol Phys, Manipal, Karnataka, India; [Krishnamurthy, R. Sagar; Chougule, Basavaraj] Stempeut Res Pvt Ltd, Manipal, Karnataka, India; [Valiathan, Manna] Kasturba Med Coll & Hosp, Dept Pathol, Manipal, Karnataka, India; [Mathur, Deepak] Tata Inst Fundamental Res, Mumbai 400005, Maharashtra, India	Manipal Academy of Higher Education (MAHE); Manipal Academy of Higher Education (MAHE); Kasturba Medical College, Manipal; Tata Institute of Fundamental Research (TIFR)	Bankapur, A (corresponding author), Manipal Univ, Ctr Atom & Mol Phys, Manipal, Karnataka, India.	atmol1@tifr.res.in	Bankapur, Aseefhali/G-8637-2015; Bankapur, Aseefhali/AAN-1484-2020; Mathur, Deepak/K-5000-2019	Bankapur, Aseefhali/0000-0001-9237-8980; Bankapur, Aseefhali/0000-0001-9237-8980; Mathur, Deepak/0000-0002-2322-6331; CHIDANGIL, SANTHOSH/0000-0002-2973-6834	Manipal University; Tata Institute of Fundamental Research	Manipal University; Tata Institute of Fundamental Research(Tata Institute of Fundamental Research (TIFR))	The work is funded by research grants given by Manipal University and Tata Institute of Fundamental Research. No funding has been obtained from Stempeutics Research Private Limited. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. RSK and BC are employees of Stempeutics Research Pvt. Ltd. These authors contributed to all aspects of the study reported in this submission.	ABELLO L, 1989, SURF SCI, V215, P158, DOI 10.1016/0039-6028(89)90707-3; Ahamed M, 2008, TOXICOL APPL PHARM, V233, P404, DOI 10.1016/j.taap.2008.09.015; Ami D, 2008, BBA-MOL CELL RES, V1783, P98, DOI 10.1016/j.bbamcr.2007.08.003; AshaRani PV, 2009, ACS NANO, V3, P279, DOI 10.1021/nn800596w; ASHKIN A, 1987, NATURE, V330, P769, DOI 10.1038/330769a0; ASHKIN A, 1970, PHYS REV LETT, V24, P156, DOI 10.1103/PhysRevLett.24.156; Bankapur A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010427; Braydich-Stolle L, 2005, TOXICOL SCI, V88, P412, DOI 10.1093/toxsci/kfi256; Carlson C, 2008, J PHYS CHEM B, V112, P13608, DOI 10.1021/jp712087m; Chan JW, 2006, BIOPHYS J, V90, P648, DOI 10.1529/biophysj.105.066761; Chang WT, 2009, J RAMAN SPECTROSC, V40, P1194, DOI 10.1002/jrs.2261; Chen K, 2006, OPT LETT, V31, P2015, DOI 10.1364/OL.31.002015; Creely CM, 2005, OPT EXPRESS, V13, P6105, DOI 10.1364/OPEX.13.006105; Creely CM, 2005, OPT COMMUN, V245, P465, DOI 10.1016/j.optcom.2004.10.011; De Luca AC, 2008, OPT EXPRESS, V16, P7943, DOI 10.1364/OE.16.007943; Delcroix GJR, 2009, BRAIN RES, V1255, P18, DOI 10.1016/j.brainres.2008.12.013; Deng JL, 2005, J RAMAN SPECTROSC, V36, P257, DOI 10.1002/jrs.1301; Donaldson Ken, 2003, Ann Ist Super Sanita, V39, P405; Duran N, 2010, J BRAZIL CHEM SOC, V21, P949, DOI 10.1590/S0103-50532010000600002; Erdmann K, 2005, AAPS J, V7, pE195, DOI 10.1208/aapsj070118; Foldbjerg R, 2011, ARCH TOXICOL, V85, P743, DOI 10.1007/s00204-010-0545-5; Gessner R, 2004, CHEMPHYSCHEM, V5, P1159, DOI 10.1002/cphc.200400026; Grabinski C, 2007, CARBON, V45, P2828, DOI 10.1016/j.carbon.2007.08.039; Greulich C, 2009, LANGENBECK ARCH SURG, V394, P495, DOI 10.1007/s00423-009-0472-1; Harvey TJ, 2008, J BIOMED OPT, V13, DOI 10.1117/1.2999609; Hawi SR, 1996, CANCER LETT, V110, P35, DOI 10.1016/S0304-3835(96)04455-2; Heymer A, 2008, BIOMATERIALS, V29, P1473, DOI 10.1016/j.biomaterials.2007.12.003; Hsin YH, 2008, TOXICOL LETT, V179, P130, DOI 10.1016/j.toxlet.2008.04.015; Huang DM, 2005, FASEB J, V19, P2014, DOI 10.1096/fj.05-4288fje; Huang DM, 2008, TOXICOL APPL PHARM, V231, P208, DOI 10.1016/j.taap.2008.04.009; Huang DM, 2009, BIOMATERIALS, V30, P3645, DOI 10.1016/j.biomaterials.2009.03.032; Jess PRT, 2007, J RAMAN SPECTROSC, V38, P1082, DOI 10.1002/jrs.1712; Kawata K, 2009, ENVIRON SCI TECHNOL, V43, P6046, DOI 10.1021/es900754q; Kim JS, 2007, NANOMED-NANOTECHNOL, V3, P95, DOI 10.1016/j.nano.2006.12.001; Knief P, 2009, ANALYST, V134, P1182, DOI 10.1039/b821393c; Lara Humberto H., 2010, Journal of Nanobiotechnology, V8, P1, DOI [10.1186/1477-3155-8-1, 10.1186/1477-3155-8-15]; Li N, 2008, FREE RADICAL BIO MED, V44, P1689, DOI 10.1016/j.freeradbiomed.2008.01.028; Li P, 2005, OPT LETT, V30, P156, DOI 10.1364/OL.30.000156; Lin Weisheng, 2008, Toxicological and Environmental Chemistry, V90, P983, DOI 10.1080/02772240701802559; Liu HL, 2010, INT J NANOMED, V5, P1017, DOI 10.2147/IJN.S14572; Liu W, 2010, NANOTOXICOLOGY, V4, P319, DOI 10.3109/17435390.2010.483745; MANOHARAN R, 1990, J MICROBIOL METH, V11, P1, DOI 10.1016/0167-7012(90)90042-5; Moritz TJ, 2010, J RAMAN SPECTROSC, V41, P33, DOI 10.1002/jrs.2436; Musarrat Javed, 2009, International Journal of Nanoparticles, V2, P402, DOI 10.1504/IJNP.2009.028775; Nallathamby PD, 2010, NANOSCALE, V2, P942, DOI 10.1039/c0nr00080a; Nel A, 2006, SCIENCE, V311, P622, DOI 10.1126/science.1114397; NELSON WH, 1992, APPL SPECTROSC REV, V27, P67, DOI 10.1080/05704929208018270; Neuman KC, 1999, BIOPHYS J, V77, P2856, DOI 10.1016/S0006-3495(99)77117-1; Oberdorster E, 2004, ENVIRON HEALTH PERSP, V112, P1058, DOI 10.1289/ehp.7021; Ojeda JF, 2006, OPT EXPRESS, V14, P5385, DOI 10.1364/OE.14.005385; Panacek A, 2006, J PHYS CHEM B, V110, P16248, DOI 10.1021/jp063826h; Park EJ, 2008, TOXICOLOGY, V245, P90, DOI 10.1016/j.tox.2007.12.022; Park TH, 2007, J BIOTECHNOL, V131, pS65, DOI 10.1016/j.jbiotec.2007.07.112; Parker F, APPL INFRARED RAMAN; Perna G, 2007, J MOL STRUCT, V834, P182, DOI 10.1016/j.molstruc.2006.12.014; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Podstawka E, 2004, APPL SPECTROSC, V58, P581, DOI 10.1366/000370204774103417; Poland CA, 2008, NAT NANOTECHNOL, V3, P423, DOI 10.1038/nnano.2008.111; Prucek R, 2011, BIOMATERIALS, V32, P4704, DOI 10.1016/j.biomaterials.2011.03.039; PUPPELS GJ, 1991, BIOPHYS J, V60, P1046, DOI 10.1016/S0006-3495(91)82142-7; PUPPELS GJ, 1990, NATURE, V347, P301, DOI 10.1038/347301a0; Rai M, 2009, BIOTECHNOL ADV, V27, P76, DOI 10.1016/j.biotechadv.2008.09.002; Raja SN, 2008, J BIOMED OPT, V13; Ramser K, 2004, J BIOMED OPT, V9, P593, DOI 10.1117/1.1689336; Rao S, 2009, BIOPHYS J, V96, P209, DOI 10.1529/biophysj.108.139097; Reeves JF, 2008, MUTAT RES-FUND MOL M, V640, P113, DOI 10.1016/j.mrfmmm.2007.12.010; Samberg ME, 2010, ENVIRON HEALTH PERSP, V118, P407, DOI 10.1289/ehp.0901398; Sayes CM, 2005, BIOMATERIALS, V26, P7587, DOI 10.1016/j.biomaterials.2005.05.027; Schrand AM, 2007, J PHYS CHEM B, V111, P2, DOI 10.1021/jp066387v; Singh GP, 2005, ANAL CHEM, V77, P2564, DOI 10.1021/ac048359j; Snook RD, 2009, INTEGR BIOL-UK, V1, P43, DOI 10.1039/b815253e; Sriram MI, 2010, INT J NANOMED, V5, P753, DOI 10.2147/IJN.S11727; Stewart S, 1999, SPECTROCHIM ACTA A, V55, P1615, DOI 10.1016/S1386-1425(98)00293-5; SVOBODA K, 1994, ANNU REV BIOPH BIOM, V23, P247, DOI 10.1146/annurev.bb.23.060194.001335; Sze K, 1970, INORG CHEM, V14, P1975; Tang H, 2007, OPT EXPRESS, V15, P12708, DOI 10.1364/OE.15.012708; TU AT, 1976, INT J PEPT PROT RES, V8, P337; Warheit DB, 2004, TOXICOL SCI, V77, P117, DOI 10.1093/toxsci/kfg228; Wise JP, 2010, AQUAT TOXICOL, V97, P34, DOI 10.1016/j.aquatox.2009.11.016; WOLD S, 1987, CHEMOMETR INTELL LAB, V2, P37, DOI 10.1016/0169-7439(87)80084-9; Xia T, 2006, NANO LETT, V6, P1794, DOI 10.1021/nl061025k; Xie CG, 2004, OPT EXPRESS, V12, P6208, DOI 10.1364/OPEX.12.006208; Xie CG, 2002, OPT LETT, V27, P249, DOI 10.1364/OL.27.000249; Yen HJ, 2009, SMALL, V5, P1553, DOI 10.1002/smll.200900126; Zachariah E, 2010, J PHOTOCH PHOTOBIO B, V100, P113, DOI 10.1016/j.jphotobiol.2010.05.009	85	26	26	1	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2012	7	4							e35075	10.1371/journal.pone.0035075	http://dx.doi.org/10.1371/journal.pone.0035075			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UT	22514708	Green Submitted, gold, Green Published			2022-12-25	WOS:000305341600114
J	Cafueri, G; Parodi, F; Pistorio, A; Bertolotto, M; Ventura, F; Gambini, C; Bianco, P; Dallegri, F; Pistoia, V; Pezzolo, A; Palombo, D				Cafueri, Giuseppe; Parodi, Federica; Pistorio, Angela; Bertolotto, Maria; Ventura, Francesco; Gambini, Claudio; Bianco, Paolo; Dallegri, Franco; Pistoia, Vito; Pezzolo, Annalisa; Palombo, Domenico			Endothelial and Smooth Muscle Cells from Abdominal Aortic Aneurysm Have Increased Oxidative Stress and Telomere Attrition	PLOS ONE			English	Article							SEQUENCE VARIANT; HUMAN-DISEASE; T-CELLS; LENGTH; DNA; PATHOGENESIS; INFLAMMATION; MUTATIONS; MEDIATORS; LINKAGE	Background: Abdominal aortic aneurysm (AAA) is a complex multi-factorial disease with life-threatening complications. AAA is typically asymptomatic and its rupture is associated with high mortality rate. Both environmental and genetic risk factors are involved in AAA pathogenesis. Aim of this study was to investigate telomere length (TL) and oxidative DNA damage in paired blood lymphocytes, aortic endothelial cells (EC), vascular smooth muscle cells (VSMC), and epidermal cells from patients with AAA in comparison with matched controls. Methods: TL was assessed using a modification of quantitative (Q)-FISH in combination with immunofluorescence for CD31 or alpha-smooth muscle actin to detect EC and VSMC, respectively. Oxidative DNA damage was investigated by immunofluorescence staining for 7, 8-dihydro-8-oxo-2'-deoxyguanosine (8-oxo-dG). Results and Conclusions: Telomeres were found to be significantly shortened in EC, VSMC, keratinocytes and blood lymphocytes from AAA patients compared to matched controls. 8-oxo-dG immunoreactivity, indicative of oxidative DNA damage, was detected at higher levels in all of the above cell types from AAA patients compared to matched controls. Increased DNA double strand breaks were detected in AAA patients vs controls by nuclear staining for gamma-H2AX histone. There was statistically significant inverse correlation between TL and accumulation of oxidative DNA damage in blood lymphocytes from AAA patients. This study shows for the first time that EC and VSMC from AAA have shortened telomeres and oxidative DNA damage. Similar findings were obtained with circulating lymphocytes and keratinocytes, indicating the systemic nature of the disease. Potential translational implications of these findings are discussed.	[Cafueri, Giuseppe; Palombo, Domenico] Univ Genoa, Dept Surg Sci & Integrated Diagnost, Genoa, Italy; [Parodi, Federica; Pistoia, Vito; Pezzolo, Annalisa] IRCCS Gaslini Hosp, Lab Oncol, Genoa, Italy; [Pistorio, Angela] IRCCS Gaslini Hosp, Epidemiol & Biostat Unit, Genoa, Italy; [Bertolotto, Maria; Dallegri, Franco] Univ Genoa, Dept Internal Med, I-16126 Genoa, Italy; [Ventura, Francesco] Univ Genoa, Dept Legal Med, Genoa, Italy; [Gambini, Claudio] IRCCS Gaslini Hosp, Pathol Lab, Genoa, Italy; [Bianco, Paolo] Univ Roma La Sapienza, Dept Mol Med, Rome, Italy	University of Genoa; University of Genoa; IRCCS Istituto Giannina Gaslini; University of Genoa; IRCCS Istituto Giannina Gaslini; University of Genoa; University of Genoa; University of Genoa; IRCCS Istituto Giannina Gaslini; Sapienza University Rome	Cafueri, G (corresponding author), Univ Genoa, Dept Surg Sci & Integrated Diagnost, Genoa, Italy.	annalisapezzolo@ospedale-gaslini.ge.it	Pezzolo, Annalisa/AAA-7424-2020; Pistorio, Angela/D-1375-2009; Ventura, Francesco/GPX-6074-2022	Pistorio, Angela/0000-0002-6895-8720; Bertolotto, Maria Bianca/0000-0002-4889-8046; DALLEGRI, FRANCO/0000-0001-9537-4547	Progetti di Ricerca Corrente Ministero della Salute, Italy	Progetti di Ricerca Corrente Ministero della Salute, Italy	This study was supported by Progetti di Ricerca Corrente Ministero della Salute, Italy to G. Gaslini Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aida J, 2008, EXP GERONTOL, V43, P833, DOI 10.1016/j.exger.2008.06.001; ALLSOPP RC, 1992, P NATL ACAD SCI USA, V89, P10114, DOI 10.1073/pnas.89.21.10114; [Anonymous], 1997, SWINSCOW TVD STAT SQ; Atturu G, 2010, EUR J VASC ENDOVASC, V39, P559, DOI 10.1016/j.ejvs.2010.01.013; Blackburn EH, 2000, NATURE, V408, P53, DOI 10.1038/35040500; Blasco MA, 2005, NAT REV GENET, V6, P611, DOI 10.1038/nrg1656; Blasco MA, 1997, CELL, V91, P25, DOI 10.1016/S0092-8674(01)80006-4; Bonner WM, 2008, NAT REV CANCER, V8, P957, DOI 10.1038/nrc2523; Calado RT, 2009, NEW ENGL J MED, V361, P2353, DOI 10.1056/NEJMra0903373; Canela A, 2007, P NATL ACAD SCI USA, V104, P5300, DOI 10.1073/pnas.0609367104; Chan SWL, 2002, ONCOGENE, V21, P553, DOI 10.1038/sj.onc.1205082; Demissie S, 2006, AGING CELL, V5, P325, DOI 10.1111/j.1474-9726.2006.00224.x; Ejiri J, 2003, CARDIOVASC RES, V59, P988, DOI 10.1016/S0008-6363(03)00523-6; Flores I, 2006, CURR OPIN CELL BIOL, V18, P254, DOI 10.1016/j.ceb.2006.03.003; Forester ND, 2005, IMMUNOLOGY, V115, P262, DOI 10.1111/j.1365-2567.2005.02157.x; Gretarsdottir S, 2010, NAT GENET, V42, P692, DOI 10.1038/ng.622; Guo DC, 2007, NAT GENET, V39, P1488, DOI 10.1038/ng.2007.6; HARLEY CB, 1990, NATURE, V345, P458, DOI 10.1038/345458a0; Hashimoto T, 2001, NEUROSURGERY, V49, P124, DOI 10.1097/00006123-200107000-00019; Helgadottir A, 2008, NAT GENET, V40, P217, DOI 10.1038/ng.72; Henderson EL, 1999, CIRCULATION, V99, P96, DOI 10.1161/01.CIR.99.1.96; Houard X, 2009, CARDIOVASC RES, V82, P532, DOI 10.1093/cvr/cvp048; Ishibashi M, 2004, ARTERIOSCL THROM VAS, V24, pE174, DOI 10.1161/01.ATV.0000143384.69170.2d; Kawanishi S, 2004, ANN NY ACAD SCI, V1019, P278, DOI 10.1196/annals.1297.047; Kuivaniemi H, 2008, CIRCULATION, V117, P242, DOI 10.1161/CIRCULATIONAHA.107.690982; Lindholt JS, 2006, EUR J VASC ENDOVASC, V31, P453, DOI 10.1016/j.ejvs.2005.10.030; Martens UM, 1998, NAT GENET, V18, P76, DOI 10.1038/ng0198-018; Martinez-Pinna R, 2010, ATHEROSCLEROSIS, V212, P333, DOI 10.1016/j.atherosclerosis.2010.05.031; Mason PJ, 2005, CURR MOL MED, V5, P159, DOI 10.2174/1566524053586581; Matthews C, 2006, CIRC RES, V99, P156, DOI 10.1161/01.RES.0000233315.38086.bc; McCormick ML, 2007, ARTERIOSCL THROM VAS, V27, P461, DOI 10.1161/01.ATV.0000257552.94483.14; Miller FJ, 2002, ARTERIOSCL THROM VAS, V22, P560, DOI 10.1161/01.ATV.0000013778.72404.30; Mitchell JR, 1999, NATURE, V402, P551, DOI 10.1038/990141; Nahrendorf M, 2011, ARTERIOSCL THROM VAS, V31, P750, DOI 10.1161/ATVBAHA.110.221499; Narath R, 2005, CYTOM PART A, V68A, P113, DOI 10.1002/cyto.a.20190; Norman PE, 2004, BRIT MED J, V329, P1259, DOI 10.1136/bmj.38272.478438.55; Okuda K, 2000, ATHEROSCLEROSIS, V152, P391, DOI 10.1016/S0021-9150(99)00482-7; Passos JF, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.5; Pellier I, 2011, PEDIATRICS, V127, pE498, DOI 10.1542/peds.2009-2987; Pezzolo A, 2007, J CLIN ONCOL, V25, P376, DOI 10.1200/JCO.2006.09.0696; Ramos-Mozo P, 2011, ARTERIOSCL THROM VAS, V31, P3011, DOI 10.1161/ATVBAHA.111.237537; Rhee DB, 2011, DNA REPAIR, V10, P34, DOI 10.1016/j.dnarep.2010.09.008; Rogakou EP, 1999, J CELL BIOL, V146, P905, DOI 10.1083/jcb.146.5.905; Sahin E, 2011, NATURE, V470, P359, DOI 10.1038/nature09787; Satoh K, 2010, ANTIOXID REDOX SIGN, V12, P675, DOI 10.1089/ars.2009.2875; Satoh K, 2009, NAT MED, V15, P649, DOI 10.1038/nm.1958; Scholzen T, 2000, J CELL PHYSIOL, V182, P311, DOI 10.1002/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9; Shibamura H, 2004, CIRCULATION, V109, P2103, DOI 10.1161/01.CIR.0000127857.77161.A1; Shimizu K, 2006, ARTERIOSCL THROM VAS, V26, P987, DOI 10.1161/01.ATV.0000214999.12921.4f; Sova H, 2010, BRIT J CANCER, V102, P1018, DOI 10.1038/sj.bjc.6605565; Thompson RW, 2002, CARDIOVASC SURG, V10, P389, DOI 10.1016/S0967-2109(02)00042-X; Tieu BC, 2009, J CLIN INVEST, V119, P3637, DOI 10.1172/JCI38308; Touat Z, 2006, AM J PATHOL, V168, P1022, DOI 10.2353/ajpath.2006.050868; Trouba KJ, 2002, ANTIOXID REDOX SIGN, V4, P665, DOI 10.1089/15230860260220175; VAZIRI H, 1993, AM J HUM GENET, V52, P661; Wang ZL, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000951; Westin ER, 2011, ANTIOXID REDOX SIGN, V14, P985, DOI 10.1089/ars.2010.3444; Wilson WRW, 2008, EUR HEART J, V29, P2689, DOI 10.1093/eurheartj/ehn386; Wu K, 2000, J IMMUNOL, V165, P4742, DOI 10.4049/jimmunol.165.8.4742; Zhu LM, 2006, NAT GENET, V38, P343, DOI 10.1038/ng1721	60	69	70	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2012	7	4							e35312	10.1371/journal.pone.0035312	http://dx.doi.org/10.1371/journal.pone.0035312			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UT	22514726	Green Published, gold, Green Submitted			2022-12-25	WOS:000305341600131
J	Mueller, AC; Sun, D; Dutta, A				Mueller, A. C.; Sun, D.; Dutta, A.			The miR-99 family regulates the DNA damage response through its target SNF2H	ONCOGENE			English	Article						microRNA; DNA repair; cancer; SNF2H; miR-99	STRAND BREAK REPAIR; GENE-EXPRESSION; DOWN-REGULATION; MICRORNA; IDENTIFICATION; INO80; PHOSPHORYLATION; GAMMA-H2AX; COMPLEX; GLIOMA	Chromatin remodeling factors are becoming known as crucial facilitators of recruitment of repair proteins to sites of DNA damage. Multiple chromatin remodeling protein complexes are now known to be required for efficient double strand break repair. In a screen for microRNAs (miRNAs) that modulate the DNA damage response, we discovered that expression of the miR-99 family of miRNAs correlates with radiation sensitivity. These miRNAs were also transiently induced following radiation. The nniRNAs target the SWI/SNF chromatin remodeling factor SNF2H/SMARCA5, a component of the ACF1 complex. We found that by reducing levels of SNF2H, miR-99a and miR-100 reduced BRCA1 localization to sites of DNA damage. Introduction of the miR-99 family of miRNAs into cells reduced the rate and overall efficiency of repair by both homologous recombination and non-homologous end joining. Finally, induction of the miR-99 family following radiation prevents an increase in SNF2H expression and reduces the recruitment of BRCA1 to the sites of DNA damage following a second dose of radiation, reducing the efficiency of repair after multiple rounds of radiation, as used in fractionated radiotherapy. Oncogene (2013) 32, 1164-1172; doi:10.1038/onc.2012.131; published online 23 April 2012	[Mueller, A. C.; Sun, D.; Dutta, A.] Univ Virginia, Sch Med, Dept Biochem & Mol Genet, Charlottesville, VA 22908 USA	University of Virginia	Dutta, A (corresponding author), Univ Virginia, Sch Med, Dept Biochem & Mol Genet, Charlottesville, VA 22908 USA.	ad8q@virginia.edu	Dutta, Anindya/P-3203-2016	Mueller, Adam/0000-0003-2678-0159; Dutta, Anindya/0000-0002-4319-0073	DOD BCRP predoctoral traineeship [BC073568]; DOD PCRP predoctoral traineeship [PC094499];  [P01CA104106]; NATIONAL CANCER INSTITUTE [R01CA134697, P01CA104106] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007267] Funding Source: NIH RePORTER	DOD BCRP predoctoral traineeship; DOD PCRP predoctoral traineeship; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	AM was supported by DOD BCRP predoctoral traineeship BC073568. DS was supported by DOD PCRP predoctoral traineeship PC094499. This work was supported by P01CA104106 to AD. We thank members of the Dutta Laboratory for their help and discussion.	Bruno IG, 2011, MOL CELL, V42, P500, DOI 10.1016/j.molcel.2011.04.018; Celeste A, 2002, SCIENCE, V296, P922, DOI 10.1126/science.1069398; Chan JA, 2005, CANCER RES, V65, P6029, DOI 10.1158/0008-5472.CAN-05-0137; Chang TC, 2007, MOL CELL, V26, P745, DOI 10.1016/j.molcel.2007.05.010; Chen CZ, 2004, SCIENCE, V303, P83, DOI 10.1126/science.1091903; Dey BK, 2011, MOL CELL BIOL, V31, P203, DOI 10.1128/MCB.01009-10; Doghman M, 2010, CANCER RES, V70, P4666, DOI 10.1158/0008-5472.CAN-09-3970; Doil C, 2009, CELL, V136, P435, DOI 10.1016/j.cell.2008.12.041; Gagan J, 2011, J BIOL CHEM, V286, P19431, DOI 10.1074/jbc.M111.219006; Golding SE, 2009, MOL CANCER THER, V8, P2894, DOI 10.1158/1535-7163.MCT-09-0519; Golding SE, 2009, CANCER BIOL THER, V8, P730, DOI 10.4161/cbt.8.8.7927; He L, 2005, NATURE, V435, P828, DOI 10.1038/nature03552; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; He L, 2007, NATURE, V447, P1130, DOI 10.1038/nature05939; Houbaviy HB, 2003, DEV CELL, V5, P351, DOI 10.1016/S1534-5807(03)00227-2; Hu HL, 2011, J MOL CELL BIOL, V3, P151, DOI 10.1093/jmcb/mjq042; Huen MSY, 2007, CELL, V131, P901, DOI 10.1016/j.cell.2007.09.041; Huse JT, 2009, GENE DEV, V23, P1327, DOI 10.1101/gad.1777409; Jha S, 2008, MOL CELL BIOL, V28, P2690, DOI 10.1128/MCB.01983-07; Kolas NK, 2007, SCIENCE, V318, P1637, DOI 10.1126/science.1150034; Lal A, 2009, NAT STRUCT MOL BIOL, V16, P492, DOI 10.1038/nsmb.1589; Lan L, 2010, MOL CELL, V40, P976, DOI 10.1016/j.molcel.2010.12.003; Larsen DH, 2010, J CELL BIOL, V190, P731, DOI 10.1083/jcb.200912135; Lee HS, 2010, EMBO J, V29, P1434, DOI 10.1038/emboj.2010.27; Lee YS, 2007, GENE DEV, V21, P1025, DOI 10.1101/gad.1540407; Lee YS, 2009, ANNU REV PATHOL-MECH, V4, P199, DOI 10.1146/annurev.pathol.4.110807.092222; Mailand N, 2007, CELL, V131, P887, DOI 10.1016/j.cell.2007.09.040; Marcu LG, 2010, CANCER TREAT REV, V36, P606, DOI 10.1016/j.ctrv.2010.04.004; Meng FY, 2007, GASTROENTEROLOGY, V133, P647, DOI 10.1053/j.gastro.2007.05.022; Mladenov E, 2011, MUTAT RES-FUND MOL M, V711, P61, DOI 10.1016/j.mrfmmm.2011.02.005; Morrison AJ, 2004, CELL, V119, P767, DOI 10.1016/j.cell.2004.11.037; Moskwa P, 2011, MOL CELL, V41, P210, DOI 10.1016/j.molcel.2010.12.005; Nakamura K, 2011, MOL CELL, V41, P515, DOI 10.1016/j.molcel.2011.02.002; Pierce AJ, 1999, GENE DEV, V13, P2633, DOI 10.1101/gad.13.20.2633; Ransburgh DJR, 2010, CANCER RES, V70, P988, DOI 10.1158/0008-5472.CAN-09-2850; Roberts SA, 2007, J BIOL CHEM, V282, P10605, DOI 10.1074/jbc.M611125200; Sirotkin AV, 2010, J CELL PHYSIOL, V223, P49, DOI 10.1002/jcp.21999; Skvortsova I, 2008, PROTEOMICS, V8, P4521, DOI 10.1002/pmic.200800113; Stewart GS, 2003, NATURE, V421, P961, DOI 10.1038/nature01446; Sun DD, 2011, CANCER RES, V71, P1313, DOI 10.1158/0008-5472.CAN-10-1031; Suzuki HI, 2009, NATURE, V460, P529, DOI 10.1038/nature08199; Tsukuda T, 2005, NATURE, V438, P379, DOI 10.1038/nature04148; van Attikum H, 2004, CELL, V119, P777, DOI 10.1016/j.cell.2004.11.033; van Attikum H, 2005, NAT REV MOL CELL BIO, V6, P757, DOI 10.1038/nrm1737; van Attikum H, 2007, EMBO J, V26, P4113, DOI 10.1038/sj.emboj.7601835; van Attikum H, 2009, TRENDS CELL BIOL, V19, P207, DOI 10.1016/j.tcb.2009.03.001; Wang P, 2009, CANCER RES, V69, P8157, DOI 10.1158/0008-5472.CAN-09-1996	47	100	107	1	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 28	2013	32	9					1164	1172		10.1038/onc.2012.131	http://dx.doi.org/10.1038/onc.2012.131			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	110FU	22525276	Green Accepted			2022-12-25	WOS:000316428800010
J	Wei, S; Chen, X; McGraw, K; Zhang, L; Komrokji, R; Clark, J; Caceres, G; Billingsley, D; Sokol, L; Lancet, J; Fortenbery, N; Zhou, J; Eksioglu, EA; Sallman, D; Wang, H; Epling-Burnettel, PK; Djeu, J; Sekeres, M; Maciejewski, JP; List, A				Wei, S.; Chen, X.; McGraw, K.; Zhang, L.; Komrokji, R.; Clark, J.; Caceres, G.; Billingsley, D.; Sokol, L.; Lancet, J.; Fortenbery, N.; Zhou, J.; Eksioglu, E. A.; Sallman, D.; Wang, H.; Epling-Burnettel, P. K.; Djeu, J.; Sekeres, M.; Maciejewski, J. P.; List, A.			Lenalidomide promotes p53 degradation by inhibiting MDM2 auto-ubiquitination in myelodysplastic syndrome with chromosome 5q deletion	ONCOGENE			English	Article						myelodysplastic syndrome; drug resistance; MDM2	RIBOSOMAL-PROTEIN L11; CANCER; PP2A; PHOSPHORYLATION; UBIQUITINATION; IDENTIFICATION; 5Q-SYNDROME; MUTATIONS; MECHANISM; PATHWAY	Allelic deletion of the RPS14 gene is a key effector of the hypoplastic anemia in patients with myelodysplastic syndrome (MDS) and chromosome 5q deletion (del(5q)). Disruption of ribosome integrity liberates free ribosomal proteins to bind to and trigger degradation of mouse double minute 2 protein (MDM2), with consequent p53 transactivation. Herein we show that p53 is overexpressed in erythroid precursors of primary bone marrow del(5q) MDS specimens accompanied by reduced cellular MDM2. More importantly, we show that lenalidonnide (Len) acts to stabilize MDM2, thereby accelerating p53 degradation. Biochemical and molecular analyses showed that Len inhibits the haplodeficient protein phosphatase 2A catalytic domain alpha (PP2Ac alpha) phosphatase resulting in hyperphosphorylation of inhibitory serine-166 and serine-186 residues on MDM2, and displaces binding of RPS14 to suppress MDM2 autoubiquitination whereas PP2Ac alpha overexpression promotes drug resistance. Bone marrow specimens from del(5q) MDS patients resistant to Len overexpressed PP2Ac alpha accompanied by restored accumulation of p53 in erythroid precursors. Our findings indicate that Len restores MDM2 functionality in the 5q-syndrome to overcome p53 activation in response to nucleolar stress, and therefore may warrant investigation in other disorders of ribosomal biogenesis. Oncogene (2013) 32, 1110-1120; doi:10.1038/onc.2012.139; published online 23 April 2012	[Wei, S.; Chen, X.; McGraw, K.; Zhang, L.; Komrokji, R.; Clark, J.; Caceres, G.; Billingsley, D.; Sokol, L.; Lancet, J.; Fortenbery, N.; Zhou, J.; Eksioglu, E. A.; Sallman, D.; Wang, H.; Epling-Burnettel, P. K.; Djeu, J.; List, A.] H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL 33647 USA; [Sekeres, M.; Maciejewski, J. P.] Cleveland Clin, Taussig Canc Inst, Cleveland, OH 44106 USA	H Lee Moffitt Cancer Center & Research Institute; Cleveland Clinic Foundation	Wei, S (corresponding author), H Lee Moffitt Canc Ctr & Res Inst, MRC 4072,12902 Magnolia Dr, Tampa, FL 33647 USA.	sheng.wei@moffitt.org	Eksioglu, Erika/E-6315-2015	Eksioglu, Erika/0000-0003-4458-7192; LIST, ALAN/0000-0002-1647-2972; Sekeres, Mikkael/0000-0003-2009-6524	NIH [1R01CA131076, AI056213]; NATIONAL CANCER INSTITUTE [R01CA131076, P30CA076292] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI056213] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by NIH Grants 1R01CA131076 and AI056213.	Barlow JL, 2010, NAT MED, V16, P59, DOI 10.1038/nm.2063; Dai MS, 2006, J BIOL CHEM, V281, P24304, DOI 10.1074/jbc.M602596200; Danilova N, 2008, BLOOD, V112, P5228, DOI 10.1182/blood-2008-01-132290; Dutt S, 2011, BLOOD, V117, P2567, DOI 10.1182/blood-2010-07-295238; Ebert BL, 2009, LEUKEMIA, V23, P1252, DOI 10.1038/leu.2009.53; Ebert BL, 2008, NATURE, V451, P335, DOI 10.1038/nature06494; Ebert BL, 2011, SEMIN ONCOL, V38, P621, DOI 10.1053/j.seminoncol.2011.04.010; Fang SY, 2000, J BIOL CHEM, V275, P8945, DOI 10.1074/jbc.275.12.8945; Fumagalli S, 2009, NAT CELL BIOL, V11, P501, DOI 10.1038/ncb1858; Gandhi AK, 2006, LEUKEMIA RES, V30, P849, DOI 10.1016/j.leukres.2006.01.010; Ginzinger DG, 2000, CANCER RES, V60, P5405; Harris SL, 2005, ONCOGENE, V24, P2899, DOI 10.1038/sj.onc.1208615; Honda R, 2000, ONCOGENE, V19, P1473, DOI 10.1038/sj.onc.1203464; Ito T, 2010, SCIENCE, V327, P1345, DOI 10.1126/science.1177319; Jadersten M, 2011, J CLIN ONCOL, V29, P1971, DOI 10.1200/JCO.2010.31.8576; Jones NC, 2008, NAT MED, V14, P125, DOI 10.1038/nm1725; Joslin JM, 2007, BLOOD, V110, P719, DOI 10.1182/blood-2007-01-068809; Kruse JP, 2009, CELL, V137, P609, DOI 10.1016/j.cell.2009.04.050; Lehmann S, 2007, LEUKEMIA, V21, P1931, DOI 10.1038/sj.leu.2404852; Li HH, 2004, MOL CELL, V13, P867, DOI 10.1016/S1097-2765(04)00123-6; Li LK, 2003, MOL CELL BIOL, V23, P9389, DOI 10.1128/MCB.23.24.9389-9404.2003; List A, 2005, NEW ENGL J MED, V352, P549, DOI 10.1056/NEJMoa041668; List A, 2006, NEW ENGL J MED, V355, P1456, DOI 10.1056/NEJMoa061292; List A, 2009, CLIN LYMPHOMA MYELOM, V9, pS302, DOI 10.3816/CLM.2009.s.028; Liu G, 2007, J PATHOL, V213, P360, DOI 10.1002/path.2238; Lohrum MAE, 2003, CANCER CELL, V3, P577, DOI 10.1016/S1535-6108(03)00134-X; Look A Thomas, 2005, Hematology Am Soc Hematol Educ Program, P156; McGowan KA, 2008, NAT GENET, V40, P963, DOI 10.1038/ng.188; Meek DW, 2010, SEMIN CANCER BIOL, V20, P19, DOI 10.1016/j.semcancer.2009.10.005; Meek DW, 2003, MOL CANCER RES, V1, P1017; Mi J, 2009, MOL CANCER THER, V8, P135, DOI 10.1158/1535-7163.MCT-08-0457; Nimer SD, 2008, BLOOD, V111, P4841, DOI 10.1182/blood-2007-08-078139; OCONNOR PM, 1993, CANCER RES, V53, P4776; Oda K, 2000, CELL, V102, P849, DOI 10.1016/S0092-8674(00)00073-8; Ogawara Y, 2002, J BIOL CHEM, V277, P21843, DOI 10.1074/jbc.M109745200; Okamoto K, 2002, MOL CELL, V9, P761, DOI 10.1016/S1097-2765(02)00504-X; Quarello P, 2010, HAEMATOL-HEMATOL J, V95, P206, DOI 10.3324/haematol.2009.011783; Starczynowski DT, 2010, NAT MED, V16, P49, DOI 10.1038/nm.2054; Vara JAF, 2004, CANCER TREAT REV, V30, P193, DOI 10.1016/j.ctrv.2003.07.007; Volonte D, 2009, AGING-US, V1, P831, DOI 10.18632/aging.100079; Wade M, 2010, TRENDS CELL BIOL, V20, P299, DOI 10.1016/j.tcb.2010.01.009; Wei S, 2009, P NATL ACAD SCI USA, V106, P12974, DOI 10.1073/pnas.0811267106; Westermarck J, 2008, TRENDS MOL MED, V14, P152, DOI 10.1016/j.molmed.2008.02.001; Whelan JA, 2003, J IMMUNOL METHODS, V278, P261, DOI 10.1016/S0022-1759(03)00223-0; Yokobori T, 2009, CANCER RES, V69, P3788, DOI 10.1158/0008-5472.CAN-08-2846; Zhang YP, 2009, CANCER CELL, V16, P369, DOI 10.1016/j.ccr.2009.09.024; Zhou BBS, 2000, NATURE, V408, P433, DOI 10.1038/35044005; Zhou BHP, 2001, NAT CELL BIOL, V3, P973, DOI 10.1038/ncb1101-973	48	65	71	0	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 28	2013	32	9					1110	1120		10.1038/onc.2012.139	http://dx.doi.org/10.1038/onc.2012.139			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	110FU	22525275	Green Accepted			2022-12-25	WOS:000316428800005
J	Tsai, YCC; Mueller-Cajar, O; Saschenbrecker, S; Hartl, FU; Hayer-Hartl, M				Tsai, Yi-Chin C.; Mueller-Cajar, Oliver; Saschenbrecker, Sandra; Hartl, F. Ulrich; Hayer-Hartl, Manajit			Chaperonin Cofactors, Cpn10 and Cpn20, of Green Algae and Plants Function as Hetero-oligomeric Ring Complexes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MASS-SPECTROMETRY; CO-CHAPERONIN; ARABIDOPSIS-THALIANA; MOLECULAR CHAPERONES; PROTEIN COMPLEXES; CRYSTAL-STRUCTURE; CHLOROPLAST CHAPERONINS; ESCHERICHIA-COLI; CENTRAL CAVITY; MOBILE LOOP	The chloroplast chaperonin system of plants and green algae is a curiosity as both the chaperonin cage and its lid are encoded by multiple genes, in contrast to the single genes encoding the two components of the bacterial and mitochondrial systems. In the green alga Chlamydomonas reinhardtii (Cr), three genes encode chaperonin cofactors, with cpn10 encoding a single similar to 10-kDa domain and cpn20 and cpn23 encoding tandem cpn10 domains. Here, we characterized the functional interaction of these proteins with the Escherichia coli chaperonin, GroEL, which normally cooperates with GroES, a heptamer of similar to 10-kDa subunits. The C. reinhardtii cofactor proteins alone were all unable to assist GroEL-mediated refolding of bacterial ribulosebisphosphate carboxylase/oxygenase but gained this ability when CrCpn20 and/or CrCpn23 was combined with CrCpn10. Native mass spectrometry indicated the formation of hetero-oligomeric species, consisting of seven similar to 10-kDa domains. The cofactor "heptamers" interacted with GroEL and encapsulated substrate protein in a nucleotide-dependent manner. Different hetero-oligomer arrangements, generated by constructing cofactor concatamers, indicated a preferential heptamer configuration for the functional CrCpn10-CrCpn23 complex. Formation of heptamer Cpn10/Cpn20 hetero-oligomers was also observed with the Arabidopsis thaliana (At) cofactors, which functioned with the chloroplast chaperonin, AtCpn60 alpha(7)beta(7). It appears that hetero-oligomer formation occurs more generally for chloroplast chaperonin cofactors, perhaps adapting the chaperonin system for the folding of specific client proteins.	[Tsai, Yi-Chin C.; Mueller-Cajar, Oliver; Saschenbrecker, Sandra; Hartl, F. Ulrich; Hayer-Hartl, Manajit] Max Planck Inst Biochem, Dept Cellular Biochem, D-82152 Martinsried, Germany; [Saschenbrecker, Sandra] EUROIMMUN AG, D-23560 Lubeck, Germany	Max Planck Society; EUROIMMUN	Hayer-Hartl, M (corresponding author), Klopferspitz 18, D-82152 Martinsried, Germany.	mhartl@biochem.mpg.de	Hartl, F. Ulrich/Y-8206-2019; Mueller-Cajar, Oliver/A-7237-2018; Hayer-Hartl, Manajit/V-8078-2017	Mueller-Cajar, Oliver/0000-0003-2866-5963; Hayer-Hartl, Manajit/0000-0001-8213-6742; Saschenbrecker, Sandra/0000-0002-4769-915X	Deutsche Forschungsgemeinschaft [SFB 594]; Munich Center for Integrated Protein Science	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Munich Center for Integrated Protein Science	This work was supported by Deutsche Forschungsgemeinschaft Grant SFB 594 and Munich Center for Integrated Protein Science.	Asamizu E, 1999, DNA Res, V6, P369, DOI 10.1093/dnares/6.6.369; Baker RT, 2005, METHOD ENZYMOL, V398, P540, DOI 10.1016/S0076-6879(05)98044-0; Baldwin AJ, 2011, J MOL BIOL, V413, P297, DOI 10.1016/j.jmb.2011.07.016; BANEYX F, 1995, J BIOL CHEM, V270, P10695, DOI 10.1074/jbc.270.18.10695; Benesch JLP, 2007, CHEM REV, V107, P3544, DOI 10.1021/cr068289b; Benesch JLP, 2009, J AM SOC MASS SPECTR, V20, P341, DOI 10.1016/j.jasms.2008.11.014; BERTSCH U, 1992, P NATL ACAD SCI USA, V89, P8696, DOI 10.1073/pnas.89.18.8696; Bonshtien AL, 2009, CELL STRESS CHAPERON, V14, P509, DOI 10.1007/s12192-009-0104-2; Boston RS, 1996, PLANT MOL BIOL, V32, P191, DOI 10.1007/BF00039383; Brinker A, 2001, CELL, V107, P223, DOI 10.1016/S0092-8674(01)00517-7; Catanzariti AM, 2004, PROTEIN SCI, V13, P1331, DOI 10.1110/ps.04618904; Chakraborty K, 2010, CELL, V142, P112, DOI 10.1016/j.cell.2010.05.027; Clare DK, 2006, J MOL BIOL, V358, P905, DOI 10.1016/j.jmb.2006.02.033; Dickson R, 2000, J BIOL CHEM, V275, P11829, DOI 10.1074/jbc.275.16.11829; Frydman J, 2001, ANNU REV BIOCHEM, V70, P603, DOI 10.1146/annurev.biochem.70.1.603; Geels RBJ, 2008, RAPID COMMUN MASS SP, V22, P3633, DOI 10.1002/rcm.3782; GOLOUBINOFF P, 1989, NATURE, V342, P884, DOI 10.1038/342884a0; Hartl FU, 2011, NATURE, V475, P324, DOI 10.1038/nature10317; Hartl FU, 2009, NAT STRUCT MOL BIOL, V16, P574, DOI 10.1038/nsmb.1591; HayerHartl MK, 1996, EMBO J, V15, P6111, DOI 10.1002/j.1460-2075.1996.tb00999.x; Hill JE, 2001, CELL STRESS CHAPERON, V6, P190, DOI 10.1379/1466-1268(2001)006<0190:ATTIAI>2.0.CO;2; Hunt JF, 1997, CELL, V90, P361, DOI 10.1016/S0092-8674(00)80343-8; Hunt JF, 1996, NATURE, V379, P37, DOI 10.1038/379037a0; Koumoto Y, 2001, J BIOL CHEM, V276, P29688, DOI 10.1074/jbc.M102330200; Koumoto Y, 1999, PLANT J, V17, P467, DOI 10.1046/j.1365-313X.1999.00388.x; Krutchinsky AN, 2000, METH MOL B, V146, P239, DOI 10.1385/1-59259-045-4:239; Landry SJ, 1996, P NATL ACAD SCI USA, V93, P11622, DOI 10.1073/pnas.93.21.11622; LANGER T, 1992, EMBO J, V11, P4757, DOI 10.1002/j.1460-2075.1992.tb05581.x; Liu CM, 2010, NATURE, V463, P197, DOI 10.1038/nature08651; Loo JA, 1997, MASS SPECTROM REV, V16, P1; Mande SC, 1996, SCIENCE, V271, P203, DOI 10.1126/science.271.5246.203; MARTIN J, 1991, NATURE, V352, P36, DOI 10.1038/352036a0; Mayhew M, 1996, NATURE, V379, P420, DOI 10.1038/379420a0; Munoz IG, 2011, NAT STRUCT MOL BIOL, V18, P14, DOI 10.1038/nsmb.1971; Nishio K, 1999, BIOCHEM BIOPH RES CO, V266, P584, DOI 10.1006/bbrc.1999.1868; Peng LW, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001040; Richardson A, 1999, J BIOL CHEM, V274, P52, DOI 10.1074/jbc.274.1.52; Richardson A, 2001, J BIOL CHEM, V276, P4981, DOI 10.1074/jbc.M008628200; Rostom Adam A., 1999, Current Opinion in Structural Biology, V9, P135, DOI 10.1016/S0959-440X(99)80018-9; Sakane I, 2007, J MOL BIOL, V367, P1171, DOI 10.1016/j.jmb.2007.01.037; Sameshima T, 2010, BIOCHEM J, V427, P247, DOI 10.1042/BJ20091845; Schroda M, 2004, PHOTOSYNTH RES, V82, P221, DOI 10.1007/s11120-004-2216-y; Sharkia R, 2003, BBA-PROTEINS PROTEOM, V1651, P76, DOI 10.1016/S1570-9639(03)00237-1; Sharon M, 2007, ANNU REV BIOCHEM, V76, P167, DOI 10.1146/annurev.biochem.76.061005.090816; Shewmaker F, 2004, PROTEIN SCI, V13, P2139, DOI 10.1110/ps.04773204; Sobott F, 2002, ANAL CHEM, V74, P1402, DOI 10.1021/ac0110552; Tahallah N, 2001, RAPID COMMUN MASS SP, V15, P596, DOI 10.1002/rcm.275; TODD MJ, 1993, BIOCHEMISTRY-US, V32, P8560, DOI 10.1021/bi00084a024; Uetrecht C, 2011, ANGEW CHEM INT EDIT, V50, P8248, DOI 10.1002/anie.201008120; van den Heuvel RH, 2004, CURR OPIN CHEM BIOL, V8, P519, DOI 10.1016/j.cbpa.2004.08.006; van Duijn E, 2005, NAT METHODS, V2, P371, DOI 10.1038/nmeth753; VIITANEN PV, 1995, J BIOL CHEM, V270, P18158, DOI 10.1074/jbc.270.30.18158; Vitlin A, 2011, PLANT MOL BIOL, V77, P105, DOI 10.1007/s11103-011-9797-6; Weiss C, 2009, PLANT MOL BIOL, V69, P227, DOI 10.1007/s11103-008-9432-3; Weissman JS, 1996, CELL, V84, P481, DOI 10.1016/S0092-8674(00)81293-3; WEISSMAN JS, 1995, CELL, V83, P577, DOI 10.1016/0092-8674(95)90098-5; Wysocki VH, 2008, J AM SOC MASS SPECTR, V19, P903, DOI 10.1016/j.jasms.2008.04.026; Xu ZH, 1997, NATURE, V388, P741, DOI 10.1038/41944	58	39	39	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 8	2012	287	24					20471	20481		10.1074/jbc.M112.365411	http://dx.doi.org/10.1074/jbc.M112.365411			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974FB	22518837	Green Published, hybrid			2022-12-25	WOS:000306414500068
J	Zhang, Y; Gladysheva, IP; Houng, AK; Reed, GL				Zhang, Yi; Gladysheva, Inna P.; Houng, Aiilyan K.; Reed, Guy L.			Streptococcus uberis Plasminogen Activator (SUPA) Activates Human Plasminogen through Novel Species-specific and Fibrin-targeted Mechanisms	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CATALYTIC DOMAIN; STREPTOKINASE; BINDING; COMPLEX; SITE; STAPHYLOKINASE; ANTIPLASMIN; INHIBITORS; INFECTION; TITRATION	Bacterial plasminogen (Pg) activators generate plasmin to degrade fibrin blood clots and other proteins that modulate the pathogenesis of infection, yet despite strong homology between mammalian Pgs, the activity of bacterial Pg activators is thought to be restricted to the Pg of their host mammalian species. Thus, we found that Streptococcus uberis Pg activator (SUPA), isolated from a Streptococcus species that infects cows but not humans, robustly activated bovine but not human Pg in purified systems and in plasma. Consistent with this, SUPA formed a higher avidity complex (118-fold) with bovine Pg than with human Pg and non-proteolytically activated bovine but not human Pg. Surprisingly, however, the presence of human fibrin overrides the species-restricted action of SUPA. First, human fibrin enhanced the binding avidity of SUPA for human Pg by 4-8-fold in the presence and absence of chloride ion (a negative regulator). Second, although SUPA did not protect plasmin from inactivation by alpha(2)-antiplasmin, fibrin did protect human plasmin, which formed a 31-fold higher avidity complex with SUPA than Pg. Third, fibrin significantly enhanced Pg activation by reducing the K-m (4-fold) and improving the catalytic efficiency of the SUPA complex (6-fold). Taken together, these data suggest that indirect molecular interactions may override the species-restricted activity of bacterial Pg activators; this may affect the pathogenesis of infections or may be exploited to facilitate the design of new blood clot-dissolving drugs.	[Zhang, Yi; Gladysheva, Inna P.; Houng, Aiilyan K.; Reed, Guy L.] Univ Tennessee, Hlth Sci Ctr, Dept Med, Memphis, TN 38163 USA	University of Tennessee System; University of Tennessee Health Science Center	Reed, GL (corresponding author), Univ Tennessee, Hlth Sci Ctr, Dept Med, Suite D334,956 Court Ave, Memphis, TN 38163 USA.	glreed@uthsc.edu	Gladysheva, Inna/AAU-9465-2020	Gladysheva, Inna/0000-0002-2501-9029	National Institutes of Health [HL58496, HL78562]; American Heart Association [SDG 0835376N]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL058496, R01HL078562] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The work was supported, in whole or in part, by National Institutes of Health Grants HL58496 and HL78562 (to G. L. R.). This work was also supported by American Heart Association Grant SDG 0835376N (to I. P. G.).	BLASI F, 1987, J CELL BIOL, V104, P801, DOI 10.1083/jcb.104.4.801; Bode W, 1997, CURR OPIN STRUC BIOL, V7, P865, DOI 10.1016/S0959-440X(97)80159-5; BOK RA, 1985, BIOCHEMISTRY-US, V24, P3279, DOI 10.1021/bi00334a031; Boxrud PD, 2000, BIOCHEMISTRY-US, V39, P13974, DOI 10.1021/bi000594i; Boyle MDP, 1997, THROMB HAEMOSTASIS, V77, P1; Castellino FJ, 2005, THROMB HAEMOSTASIS, V93, P647, DOI 10.1160/TH04-12-0842; CHASE T, 1969, BIOCHEMISTRY-US, V8, P2212, DOI 10.1021/bi00833a063; CHIBBER BAK, 1986, J BIOL CHEM, V261, P5289; CHRISTENSEN U, 1992, BIOCHEM J, V285, P419, DOI 10.1042/bj2850419; CLIFFTON EE, 1953, BLOOD, V8, P554, DOI 10.1182/blood.V8.6.554.554; Collen D, 2004, J THROMB HAEMOST, V2, P541, DOI 10.1111/j.1538-7933.2004.00645.x; FRIBERGER P, 1978, HAEMOSTASIS, V7, P138; Gladysheva IP, 2003, P NATL ACAD SCI USA, V100, P9168, DOI 10.1073/pnas.1631716100; Gladysheva IP, 2002, J BIOL CHEM, V277, P26846, DOI 10.1074/jbc.M202999200; JAMESON GW, 1973, BIOCHEM J, V131, P107, DOI 10.1042/bj1310107; Johnsen LB, 2000, BIOCHEMISTRY-US, V39, P6440, DOI 10.1021/bi9922502; KOLEV K, 1994, J BIOL CHEM, V269, P17030; Lahteenmaki K, 2005, TRENDS MICROBIOL, V13, P79, DOI 10.1016/j.tim.2004.12.003; Lahteenmaki K, 2001, FEMS MICROBIOL REV, V25, P531, DOI 10.1111/j.1574-6976.2001.tb00590.x; LEE PP, 1988, BIOCHEMISTRY-US, V27, P7506, DOI 10.1021/bi00419a049; Leigh JA, 1999, VACCINE, V17, P851, DOI 10.1016/S0264-410X(98)00270-9; LEIGH JA, 1994, FEMS MICROBIOL LETT, V118, P153, DOI 10.1016/0378-1097(94)90611-4; LIJNEN HR, 1986, J BIOL CHEM, V261, P1253; RAMPLING MW, 1976, CLIN CHIM ACTA, V67, P43, DOI 10.1016/0009-8981(76)90215-1; REED GL, 1995, BIOCHEMISTRY-US, V34, P10266, DOI 10.1021/bi00032a021; REED GL, 1990, P NATL ACAD SCI USA, V87, P1114, DOI 10.1073/pnas.87.3.1114; Sazonova IY, 2004, J BIOL CHEM, V279, P24994, DOI 10.1074/jbc.M400253200; Sazonova IY, 2001, J BIOL CHEM, V276, P12609, DOI 10.1074/jbc.M009265200; Schneider M, 2004, J BIOL CHEM, V279, P13333, DOI 10.1074/jbc.M313164200; Sifringer M, 2007, NEUROBIOL DIS, V25, P526, DOI 10.1016/j.nbd.2006.10.019; Sun HM, 2004, SCIENCE, V305, P1283, DOI 10.1126/science.1101245; Wang SG, 1999, BIOCHEMISTRY-US, V38, P5232, DOI 10.1021/bi981915h; Wang SG, 2000, EUR J BIOCHEM, V267, P3994, DOI 10.1046/j.1432-1327.2000.01434.x; Wang XQ, 1998, SCIENCE, V281, P1662, DOI 10.1126/science.281.5383.1662; Ward PN, 2004, J MOL BIOL, V342, P1101, DOI 10.1016/j.jmb.2004.07.079; Wiles KG, 2010, J BIOL CHEM, V285, P21153, DOI 10.1074/jbc.M110.107730; WOHL RC, 1980, J BIOL CHEM, V255, P2005	37	7	7	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 1	2012	287	23					19171	19176		10.1074/jbc.M112.359315	http://dx.doi.org/10.1074/jbc.M112.359315			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974EF	22518846	Green Published, hybrid			2022-12-25	WOS:000306411900027
J	Agnvall, B; Jongren, M; Strandberg, E; Jensen, P				Agnvall, Beatrix; Jongren, Markus; Strandberg, Erling; Jensen, Per			Heritability and Genetic Correlations of Fear-Related Behaviour in Red Junglefowl-Possible Implications for Early Domestication	PLOS ONE			English	Article							WHITE LEGHORN LAYERS; GALLUS-GALLUS; RESOURCE-ALLOCATION; SELECTION; DEPRIVATION; FEARFULNESS; EXPRESSION; EVOLUTION; RESPONSES; CHICKENS	Domesticated species differ from their wild ancestors in a number of traits, generally referred to as the domesticated phenotype. Reduced fear of humans is assumed to have been an early prerequisite for the successful domestication of virtually all species. We hypothesized that fear of humans is linked to other domestication related traits. For three generations, we selected Red Junglefowl (ancestors of domestic chickens) solely on the reaction in a standardized Fear of Human-test. In this, the birds were exposed for a gradually approaching human, and their behaviour was continuously scored. This generated three groups of animals, high (H), low (L) and intermediate (I) fearful birds. The birds in each generation were additionally tested in a battery of behaviour tests, measuring aspects of fearfulness, exploration, and sociality. The results demonstrate that the variation in fear response of Red Junglefowl towards humans has a significant genetic component and is genetically correlated to behavioural responses in other contexts, of which some are associated with fearfulness and others with exploration. Hence, selection of Red Junglefowl on low fear for humans can be expected to lead to a correlated change of other behavioural traits over generations. It is therefore likely that domestication may have caused an initial suite of behavioural modifications, even without selection on anything besides tameness.	[Agnvall, Beatrix; Jongren, Markus; Jensen, Per] Linkoping Univ, IFM Biol, Div Zool, Avian Behav Genom & Physiol Grp, Linkoping, Sweden; [Strandberg, Erling] Swedish Univ Agr Sci, Dept Anim Breeding & Genet, S-75007 Uppsala, Sweden	Linkoping University; Swedish University of Agricultural Sciences	Agnvall, B (corresponding author), Linkoping Univ, IFM Biol, Div Zool, Avian Behav Genom & Physiol Grp, Linkoping, Sweden.	perje@ifm.liu.se	Strandberg, Erling/G-9579-2011	Strandberg, Erling/0000-0001-5154-8146	Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning (Formas); Swedish Research Council (VR)	Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning (Formas)(Swedish Research Council Formas); Swedish Research Council (VR)(Swedish Research Council)	This study was financed by the Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning (Formas), and by the Swedish Research Council (VR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Nasser A, 2007, WORLD POULTRY SCI J, V63, P285, DOI 10.1017/S004393390700147X; Albert FW, 2008, HORM BEHAV, V53, P413, DOI 10.1016/j.yhbeh.2007.11.010; Appelby MC, 2004, POULTRY BEHAV WELFAR; BELYAEV DK, 1985, APPL ANIM BEHAV SCI, V13, P359, DOI 10.1016/0168-1591(85)90015-2; BELYAEV DK, 1979, J HERED, V70, P301, DOI 10.1093/oxfordjournals.jhered.a109263; Bracha HS, 2004, CNS SPECTRUMS, V9, P679, DOI 10.1017/S1092852900001954; Campler M, 2009, BEHAV PROCESS, V81, P39, DOI 10.1016/j.beproc.2008.12.018; CASTLE WE, 1947, P NATL ACAD SCI USA, V33, P109, DOI 10.1073/pnas.33.5.109; Clutton-Brock J, 1999, NATURAL HIST DOMESTI; Collias NE, 1996, ANIM BEHAV, V51, P1337, DOI 10.1006/anbe.1996.0137; COLLIAS NE, 1967, CONDOR, V69, P360, DOI 10.2307/1366199; Devlin RH, 2001, NATURE, V409, P781, DOI 10.1038/35057314; Edelaar P, 2012, BEHAV ECOLOGY; Eklund B, 2011, BEHAV PROCESS, V86, P250, DOI 10.1016/j.beproc.2010.12.010; Erhard HW, 1999, APPL ANIM BEHAV SCI, V64, P31, DOI 10.1016/S0168-1591(99)00028-3; Eriksson J, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000010; Forkman B, 2007, PHYSIOL BEHAV, V92, P340, DOI 10.1016/j.physbeh.2007.03.016; Hakansson J, 2008, APPL ANIM BEHAV SCI, V114, P409, DOI 10.1016/j.applanim.2008.04.003; HAMMER RP, 1992, PHARMACOL BIOCHEM BE, V42, P25, DOI 10.1016/0091-3057(92)90440-Q; Jackson S, 1996, EVOLUTION, V50, P1638, DOI [10.2307/2410900, 10.1111/j.1558-5646.1996.tb03936.x]; Jones RB, 2002, APPL ANIM BEHAV SCI, V75, P337, DOI 10.1016/S0168-1591(01)00198-8; Jongren M, 2010, GENES BRAIN BEHAV, V9, P751, DOI 10.1111/j.1601-183X.2010.00612.x; Keeling LJ, SOCIAL BEHAV FARM AN; Kunzl C, 1999, HORM BEHAV, V35, P28, DOI 10.1006/hbeh.1998.1493; Lindqvist CES, 2002, BEHAVIOUR, V139, P1195, DOI 10.1163/15685390260437335; Liu YP, 2006, MOL PHYLOGENET EVOL, V38, P12, DOI 10.1016/j.ympev.2005.09.014; Malmkvist J, 2002, ANIM BEHAV, V64, P487, DOI 10.1006/anbe.2002.3058; Mormede P, 2002, PSYCHONEUROENDOCRINO, V27, P563, DOI 10.1016/S0306-4530(01)00093-2; Park CC, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-43; Ponder CA, 2008, BEHAV GENET, V38, P277, DOI 10.1007/s10519-008-9203-6; PRICE EO, 1984, Q REV BIOL, V59, P1, DOI 10.1086/413673; Price EO, 1999, APPL ANIM BEHAV SCI, V65, P245, DOI 10.1016/S0168-1591(99)00087-8; Savolainen P, 2002, SCIENCE, V298, P1610, DOI 10.1126/science.1073906; Schutz K, 2002, BEHAV GENET, V32, P423, DOI 10.1023/A:1020880211144; Schutz KE, 2001, APPL ANIM BEHAV SCI, V74, P1, DOI 10.1016/S0168-1591(01)00156-3; Schutz KE, 2001, ETHOLOGY, V107, P753, DOI 10.1046/j.1439-0310.2001.00703.x; Serpell J, 1985, DOMESTIC DOG ITS EVO; Talbot CJ, 2003, MAMM GENOME, V14, P223, DOI 10.1007/s00335-002-3059-5; Tartar JL, 2009, BEHAV BRAIN RES, V197, P450, DOI 10.1016/j.bbr.2008.08.035; Trut LN, 2004, RUSS J GENET+, V40, P644, DOI 10.1023/B:RUGE.0000033312.92773.c1; Vaisanen J, 2005, BRIT POULTRY SCI, V46, P156, DOI 10.1080/00071660500062638; WEST B, 1988, J ARCHAEOL SCI, V15, P515, DOI 10.1016/0305-4403(88)90080-5; Wright D, 2010, MOL ECOL, V19, P5140, DOI 10.1111/j.1365-294X.2010.04882.x	43	57	59	1	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2012	7	4							e35162	10.1371/journal.pone.0035162	http://dx.doi.org/10.1371/journal.pone.0035162			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TL	22536354	Green Published, gold, Green Accepted			2022-12-25	WOS:000305336200026
J	Byrne, R; Rath, E; Hladik, A; Niederreiter, B; Bonelli, M; Frantal, S; Smolen, JS; Scheinecker, C				Byrne, Ruth; Rath, Eva; Hladik, Anastasiya; Niederreiter, Birgit; Bonelli, Michael; Frantal, Sophie; Smolen, Josef S.; Scheinecker, Clemens			A Dynamic Real Time In Vivo and Static Ex Vivo Analysis of Granulomonocytic Cell Migration in the Collagen-Induced Arthritis Model	PLOS ONE			English	Article							RHEUMATOID-ARTHRITIS; INFLAMMATORY ARTHRITIS; IMAGING REVEALS; IMMUNE-SYSTEM; MURINE MODEL; LYMPH-NODES; BONE-MARROW; NEUTROPHILS; MICE; GLUCOCORTICOIDS	Neutrophilic granulocytes and monocytes (granulomonocytic cells; GMC) drive the inflammatory process at the earliest stages of rheumatoid arthritis (RA). The migratory behavior and functional properties of GMC within the synovial tissue are, however, only incompletely characterized. Here we have analyzed GMC in the murine collagen-induced arthritis (CIA) model of RA using multi-photon real time in vivo microscopy together with ex vivo analysis of GMC in tissue sections. GMC were abundant as soon as clinical arthritis was apparent. GMC were motile and migrated randomly through the synovial tissue. In addition, we observed the frequent formation of cell clusters consisting of both neutrophilic granulocytes and monocytes that actively contributed to the inflammatory process of arthritis. Treatment of animals with a single dose of prednisolone reduced the mean velocity of cell migration and diminished the overall immigration of GMC. In summary, our study shows that the combined application of real time in vivo microscopy together with elaborate static post-mortem analysis of GMC enables the description of dynamic migratory characteristics of GMC together with their precise location in a complex anatomical environment. Moreover, this approach is sensitive enough to detect subtle therapeutic effects within a very short period of time.	[Byrne, Ruth; Rath, Eva; Hladik, Anastasiya; Niederreiter, Birgit; Bonelli, Michael; Smolen, Josef S.; Scheinecker, Clemens] Med Univ Vienna, Div Rheumatol, Vienna, Austria; [Frantal, Sophie] Med Univ Vienna, Ctr Med Stat Informat & Intelligent Syst, Vienna, Austria	Medical University of Vienna; Medical University of Vienna	Byrne, R (corresponding author), Med Univ Vienna, Div Rheumatol, Vienna, Austria.	clemens.scheinecker@meduniwien.ac.at		Bonelli, Michael/0000-0002-6122-7482	European Community [HEALTH-F2-2008-223404]	European Community(European Commission)	The research leading to these results has received funding from the European Community's Seventh Framework Programme FP7 under grant agreement no. HEALTH-F2-2008-223404 (Masterswitch). This study is a publication of the Joint and Bone Center - Center for musculoskeletal research of the Medical University of Vienna. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bajenoff M, 2007, EUR J IMMUNOL, V37, pS18, DOI 10.1002/eji.200737663; BAXTER JD, 1972, AM J MED, V53, P573, DOI 10.1016/0002-9343(72)90154-4; Brand DD, 2003, SPRINGER SEMIN IMMUN, V25, P3, DOI 10.1007/s00281-003-0127-1; Campbell IK, 2000, EUR J IMMUNOL, V30, P1568, DOI 10.1002/1521-4141(200006)30:6<1568::AID-IMMU1568>3.0.CO;2-R; Chtanova T, 2008, IMMUNITY, V29, P487, DOI 10.1016/j.immuni.2008.07.012; Cox G, 1997, J LEUKOCYTE BIOL, V61, P224, DOI 10.1002/jlb.61.2.224; Cox Guy, 2006, V319, P15; Eyles JL, 2008, BLOOD, V112, P5193, DOI 10.1182/blood-2008-02-139535; Faust N, 2000, BLOOD, V96, P719; Feldmann M, 1996, CELL, V85, P307, DOI 10.1016/S0092-8674(00)81109-5; Germain RN, 2006, NAT REV IMMUNOL, V6, P497, DOI 10.1038/nri1884; Goldring SR, 2000, CURR OPIN RHEUMATOL, V12, P195, DOI 10.1097/00002281-200005000-00006; Gompels LL, 2010, RHEUMATOLOGY, V49, P1436, DOI 10.1093/rheumatology/keq012; Graham DB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004652; HADLER NM, 1979, J IMMUNOL, V123, P572; Hayer S, 2007, ARTHRITIS RHEUM-US, V56, P79, DOI 10.1002/art.22313; Khapli SM, 2003, J IMMUNOL, V171, P142, DOI 10.4049/jimmunol.171.1.142; Kreisel D, 2010, P NATL ACAD SCI USA, V107, P18073, DOI 10.1073/pnas.1008737107; Lean JM, 2000, BONE, V27, P29, DOI 10.1016/S8756-3282(00)00306-9; LEE JC, 1994, NATURE, V372, P739, DOI 10.1038/372739a0; Liu L, 2005, INFLAMM RES, V54, P37, DOI 10.1007/s00011-004-1320-y; MODDERMAN WE, 1991, BONE, V12, P81, DOI 10.1016/8756-3282(91)90004-3; MOHR W, 1981, ANN RHEUM DIS, V40, P171, DOI 10.1136/ard.40.2.171; Pesu M, 2008, IMMUNOL REV, V223, P132, DOI 10.1111/j.1600-065X.2008.00644.x; Peters NC, 2008, SCIENCE, V321, P970, DOI 10.1126/science.1159194; Pettit AR, 2001, AM J PATHOL, V159, P1689, DOI 10.1016/S0002-9440(10)63016-7; Redlich K, 2002, J CLIN INVEST, V110, P1419, DOI 10.1172/JCI200215582; Scheinecker C, 2005, ARTHRITIS RES THER, V7, P246, DOI 10.1186/ar1843; SCHLEIMER RP, 1993, EUR J CLIN PHARMACOL, V45, pS43, DOI 10.1007/BF01844203; SCHLEIMER RP, 1993, EUR J CLIN PHARMACOL, V45, pS3, DOI 10.1007/BF01844196; Schramm R, 2004, INFLAMM RES, V53, P644, DOI 10.1007/s00011-004-1307-8; Stoll S, 2002, SCIENCE, V296, P1873, DOI 10.1126/science.1071065; Sumen C, 2004, IMMUNITY, V21, P315, DOI 10.1016/S1074-7613(04)00237-7; Suzuki M, 1997, EXP ANIM TOKYO, V46, P259, DOI 10.1538/expanim.46.259; VANDEWIJNGAERT FP, 1987, BONE MINER, V3, P111; WILLIAMS RO, 1992, P NATL ACAD SCI USA, V89, P9784, DOI 10.1073/pnas.89.20.9784; Wipke BT, 2001, J IMMUNOL, V167, P1601, DOI 10.4049/jimmunol.167.3.1601; Wright HL, 2010, RHEUMATOLOGY, V49, P1618, DOI 10.1093/rheumatology/keq045; Zinselmeyer BH, 2008, INFLAMM RES, V57, P93, DOI 10.1007/s00011-007-7195-y; Zwerina J, 2007, P NATL ACAD SCI USA, V104, P11742, DOI 10.1073/pnas.0610812104	40	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2012	7	4							e35194	10.1371/journal.pone.0035194	http://dx.doi.org/10.1371/journal.pone.0035194			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959XD	22529989	gold, Green Published, Green Submitted			2022-12-25	WOS:000305350600065
J	Horio, M; Kohno, M; Fujita, Y; Ishima, T; Inoue, R; Mori, H; Hashimoto, K				Horio, Mao; Kohno, Mami; Fujita, Yuko; Ishima, Tamaki; Inoue, Ran; Mori, Hisashi; Hashimoto, Kenji			Role of Serine Racemase in Behavioral Sensitization in Mice after Repeated Administration of Methamphetamine	PLOS ONE			English	Article							SIGNAL-REGULATED KINASE; CONDITIONED PLACE PREFERENCE; KNOCK-OUT MICE; AMPHETAMINE TREATMENT; MOUSE-BRAIN; DOPAMINE; GLUTAMATE; NMDA; NEUROTOXICITY; MK-801	Background: The N-methyl-D-aspartate (NMDA) receptors play a role in behavioral abnormalities observed after administration of the psychostimulant, methamphetamine (METH). Serine racemase (SRR) is an enzyme which synthesizes D-serine, an endogenous co-agonist of NMDA receptors. Using Srr knock-out (KO) mice, we investigated the role of SRR on METH-induced behavioral abnormalities in mice. Methodology/Principal Findings: Evaluations of behavior in acute hyperlocomotion, behavioral sensitization, and conditioned place preference (CPP) were performed. The role of SRR on the release of dopamine (DA) in the nucleus accumbens after administration of METH was examined using in vivo microdialysis technique. Additionally, phosphorylation levels of ERK1/2 proteins in the striatum, frontal cortex and hippocampus were examined using Western blot analysis. Acute hyperlocomotion after a single administration of METH (3 mg/kg) was comparable between wild-type (WT) and Srr-KO mice. However, repeated administration of METH (3 mg/kg/day, once daily for 5 days) resulted in behavioral sensitization in WT, but not Srr-KO mice. Pretreatment with D-serine (900 mg/kg, 30 min prior to each METH treatment) did not affect the development of behavioral sensitization after repeated METH administration. In the CPP paradigm, METH-induced rewarding effects were demonstrable in both WT and Srr-KO mice. In vivo microdialysis study showed that METH (1 mg/kg)induced DA release in the nucleus accumbens of Srr-KO mice previously treated with METH was significantly lower than that of the WT mice previously treated with METH. Interestingly, a single administration of METH (3 mg/kg) significantly increased the phosphorylation status of ERK1/2 in the striatum of WT, but not Srr-KO mice. Conclusions/Significance: These findings suggest first, that SRR plays a role in the development of behavioral sensitization in mice after repeated administration of METH, and second that phosphorylation of ERK1/2 by METH may contribute to the development of this sensitization as seen in WT but not Srr-KO mice.	[Horio, Mao; Kohno, Mami; Fujita, Yuko; Ishima, Tamaki; Hashimoto, Kenji] Chiba Univ, Ctr Forens Mental Hlth, Div Clin Neurosci, Chiba, Japan; [Inoue, Ran; Mori, Hisashi] Toyama Univ, Grad Sch Med, Dept Mol Neurosci, Toyama 930, Japan	Chiba University; University of Toyama	Horio, M (corresponding author), Chiba Univ, Ctr Forens Mental Hlth, Div Clin Neurosci, Chiba, Japan.	hashimoto@faculty.chiba-u.jp	Hashimoto, Kenji/I-5800-2015	Hashimoto, Kenji/0000-0002-8892-0439	Japan Society for the Promotion of Science, Japan; Intramural Research Grant for Neurological and Psychiatric Disorders of National Center of Neurology and Psychiatry (NCNP), Japan; Ishidsu Shun Memorial Scholarship, Japan	Japan Society for the Promotion of Science, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Intramural Research Grant for Neurological and Psychiatric Disorders of National Center of Neurology and Psychiatry (NCNP), Japan; Ishidsu Shun Memorial Scholarship, Japan	This study was supported by grants from Grants-in-Aid for Scientific Research of Japan Society for the Promotion of Science, Japan (to K. H.) and Intramural Research Grant for Neurological and Psychiatric Disorders of National Center of Neurology and Psychiatry (NCNP), Japan (to K. H.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Mao Horio was supported by Ishidsu Shun Memorial Scholarship, Japan. We would like to thank Professor Masaomi Iyo (Department of Psychiatry, Chiba University Graduate School of Medicine) for his support.	Basu AC, 2009, MOL PSYCHIATR, V14, P719, DOI 10.1038/mp.2008.130; Berke JD, 2000, NEURON, V25, P515, DOI 10.1016/S0896-6273(00)81056-9; Bertran-Gonzalez J, 2008, J NEUROSCI, V28, P5671, DOI 10.1523/JNEUROSCI.1039-08.2008; Cadet JL, 2003, FASEB J, V17, P1775, DOI 10.1096/fj.03-0073rev; Chao J, 2004, ANNU REV MED, V55, P113, DOI 10.1146/annurev.med.55.091902.103730; Chen H, 2012, PSYCHOPHARM IN PRESS; Chen Hongxian, 2010, Curr Drug Abuse Rev, V3, P222; Chen JC, 2001, LIFE SCI, V68, P973, DOI 10.1016/S0024-3205(00)00995-4; EARLE ML, 1991, J NEURAL TRANSM-GEN, V86, P217, DOI 10.1007/BF01250707; Featherstone RE, 2007, PROG NEURO-PSYCHOPH, V31, P1556, DOI 10.1016/j.pnpbp.2007.08.025; Franklin KBJ, 2008, MOUSE BRAIN STEREOTA, V3rd; Fujita Y, 2012, PHARMACOL BIOCHEM BE, V101, P303, DOI 10.1016/j.pbb.2012.01.005; Gerfen CR, 2008, J NEUROSCI, V28, P7113, DOI 10.1523/JNEUROSCI.3952-07.2008; Girault JA, 2007, CURR OPIN PHARMACOL, V7, P77, DOI 10.1016/j.coph.2006.08.012; Gonzales R, 2010, ANNU REV PUBL HEALTH, V31, P385, DOI 10.1146/annurev.publhealth.012809.103600; Hagiwara H, 2009, BRAIN RES, V1301, P189, DOI 10.1016/j.brainres.2009.09.010; Hashimoto K, 2007, NEW RES METHAMPHETAM, P1; HOFFMAN DC, 1994, PHARMACOL BIOCHEM BE, V47, P907, DOI 10.1016/0091-3057(94)90295-X; Horio M, 2011, NEUROCHEM INT, V59, P853, DOI 10.1016/j.neuint.2011.08.017; Inoue R, 2008, J NEUROSCI, V28, P14486, DOI 10.1523/JNEUROSCI.5034-08.2008; Karila L, 2010, BRIT J CLIN PHARMACO, V69, P578, DOI 10.1111/j.1365-2125.2010.03639.x; KARLER R, 1991, BRAIN RES, V552, P295, DOI 10.1016/0006-8993(91)90095-D; Kim HS, 1997, BRAIN RES BULL, V44, P221, DOI 10.1016/S0361-9230(97)00093-2; KURIBARA H, 1992, PSYCHOPHARMACOLOGY, V108, P271, DOI 10.1007/BF02245111; Martineau M, 2006, TRENDS NEUROSCI, V29, P481, DOI 10.1016/j.tins.2006.06.008; Miya K, 2008, J COMP NEUROL, V510, P641, DOI 10.1002/cne.21822; Miyamoto Y, 2004, EUR J NEUROSCI, V19, P151, DOI 10.1111/j.1460-9568.2004.03086.x; Mizoguchi H, 2004, MOL PHARMACOL, V65, P1293, DOI 10.1124/mol.65.5.1293; ODELL SJ, 1991, BRAIN RES, V564, P256, DOI 10.1016/0006-8993(91)91461-9; OHMORI T, 1994, PHARMACOL BIOCHEM BE, V48, P587, DOI 10.1016/0091-3057(94)90318-2; Pierce RC, 1997, BRAIN RES REV, V25, P192, DOI 10.1016/S0165-0173(97)00021-0; Rajadhyaksha A, 2004, J NEUROSCI, V24, P7464, DOI 10.1523/JNEUROSCI.0612-04.2004; Robinson TE, 1986, BRAIN RES REV, V396, P157; SATO M, 1983, BIOL PSYCHIAT, V18, P429; Schell MJ, 2004, PHILOS T R SOC B, V359, P943, DOI 10.1098/rstb.2003.1399; Segal DS, 1997, J PHARMACOL EXP THER, V282, P561; Shi XD, 2007, J NEUROCHEM, V103, P706, DOI 10.1111/j.1471-4159.2007.04760.x; Tata DA, 2007, ADDICTION, V102, P49, DOI 10.1111/j.1360-0443.2007.01770.x; Tzschentke TM, 1998, PROG NEUROBIOL, V56, P613, DOI 10.1016/S0301-0082(98)00060-4; Ujike H, 2004, ANN NY ACAD SCI, V1025, P279, DOI 10.1196/annals.1316.035; Valjent E, 2005, P NATL ACAD SCI USA, V102, P491, DOI 10.1073/pnas.0408305102; Valjent E, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-20; Vanderschuren LJMJ, 2000, PSYCHOPHARMACOLOGY, V151, P99, DOI 10.1007/s002130000493; WOLF ME, 1991, BRAIN RES, V562, P164, DOI 10.1016/0006-8993(91)91202-C; Wolosker H, 1999, P NATL ACAD SCI USA, V96, P13409, DOI 10.1073/pnas.96.23.13409; Wolosker H, 1999, P NATL ACAD SCI USA, V96, P721, DOI 10.1073/pnas.96.2.721; Wolosker H, 2007, MOL NEUROBIOL, V36, P152, DOI 10.1007/s12035-007-0038-6; Zhai HF, 2008, CELL MOL NEUROBIOL, V28, P157, DOI 10.1007/s10571-007-9240-3; Zhang L, 2006, PROG NEURO-PSYCHOPH, V30, P1381, DOI 10.1016/j.pnpbp.2006.05.015	49	18	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2012	7	4							e35494	10.1371/journal.pone.0035494	http://dx.doi.org/10.1371/journal.pone.0035494			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959XD	22530033	Green Submitted, Green Published, gold			2022-12-25	WOS:000305350600089
J	Mallmann, AB; Fuchs, SC; Gus, M; Fuchs, FD; Moreira, LB				Mallmann, Adroaldo Baseggio; Fuchs, Sandra Costa; Gus, Miguel; Fuchs, Flavio Danni; Moreira, Leila Beltrami			Population-Attributable Risks for Ischemic Stroke in a Community in South Brazil: A Case-Control Study	PLOS ONE			English	Article							CAROTID BRUITS; MORTALITY; ASSOCIATION; CARDIOLOGY; LIFE; CHOLESTEROL; PREVENTION; ADULTS	Background: Risk factors for ischemic stroke are mostly known, but it is still unclear in most countries, what are their combined population-attributable risk percent (PAR%). In a case-control study the individual odds ratios (ORs) and the individual and combined PAR%, including risk factors not addressed in previous studies were estimated. Methods: Cases and controls were selected from patients attending to an emergency department. Cases were patients aged with 45 years or more with the first episode of ischemic stroke, characterized by a focal neurological deficit or change in the mental status occurring during the previous 24 hours. Controls, matched to cases by age and gender, were selected from patients without neurological complaints. Results: 133 cases and 272 controls were studied. Odds ratios for ischemic stroke were: atrial fibrillation (27.3; CI 95% 7.5-99.9), left ventricular hypertrophy (20.3; CI 95% 8.8-46.4), history of hypertension (11.2; CI 95% 5.4-23.3), physical inactivity (6.6; CI 95% 3.3-13.1), low levels of HDL-cholesterol (5.0; CI 95% 2.8-8.9), heavy smoking (2.8; CI 95% 1.5-5.0), carotid bruit (2.5; CI 95% 1.3-4.6), diabetes (2.4; CI 95% 1.4-4.0) and alcohol abuse (2.1; CI 95% 1.1-4.0), The combination of these risk factors accounted for 98.9% (95% CI; 96.4%-99.7%) of the PAR% for all stroke. Conclusions: Nine risk factors, easily identified, explain almost 100% of the population attributable risk for ischemic stroke.	[Mallmann, Adroaldo Baseggio] Univ Passo Fundo, Sch Med, Passo Fundo, Brazil; [Fuchs, Sandra Costa; Moreira, Leila Beltrami] Univ Fed Rio Grande do Sul, Postgrad Program Cardiol, Porto Alegre, RS, Brazil; [Gus, Miguel; Fuchs, Flavio Danni] Univ Fed Rio Grande do Sul, Hosp Clin Porto Alegre, Div Cardiol, Porto Alegre, RS, Brazil	Universidade de Passo Fundo; Universidade Federal do Rio Grande do Sul; Universidade Federal do Rio Grande do Sul	Mallmann, AB (corresponding author), Univ Passo Fundo, Sch Med, Passo Fundo, Brazil.	mgus@terra.com.br	MOREIRA, LEILA LEILA B/AAC-2240-2019; Moreira, Leila/G-1251-2013; Fuchs, Sandra C/T-2670-2019; Fuchs, Flávio D/L-5078-2016; Iats, Inct/K-2300-2013	MOREIRA, LEILA LEILA B/0000-0002-4730-7988; Moreira, Leila/0000-0002-4730-7988; fuchs, flavio/0000-0002-1191-0523				Amer Diabet Assoc, 2012, DIABETES CARE, V35, pS64, DOI [10.2337/dc12-S064, 10.2337/dc09-S062, 10.2337/dc11-S011]; BONITA R, 1988, STROKE, V19, P1497, DOI 10.1161/01.STR.19.12.1497; Chiuve SE, 2008, CIRCULATION, V118, P947, DOI 10.1161/CIRCULATIONAHA.108.781062; Curioni C, 2009, REV PANAM SALUD PUBL, V25, P9, DOI 10.1590/S1020-49892009000100002; de Oliveira GMM, 2006, REV PANAM SALUD PUBL, V19, P85, DOI 10.1590/S1020-49892006000200003; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Goldstein LB, 2011, STROKE, V42, P517, DOI 10.1161/STR.0b013e3181fcb238; Greenland P, 2010, CIRCULATION, V122, pE584, DOI 10.1161/CIR.0b013e3182051b4c; Gus M, 2004, AM J HYPERTENS, V17, P50, DOI 10.1016/j.amjhyper.2003.08.010; Hancock EW, 2009, J AM COLL CARDIOL, V53, P992, DOI 10.1016/j.jacc.2008.12.015; Johansson EP, 2008, BMC NEUROL, V8, DOI 10.1186/1471-2377-8-23; Lewington S, 2007, LANCET, V370, P1829, DOI 10.1016/S0140-6736(07)61778-4; Lotufo Paulo Andrade, 2005, Sao Paulo Med. J., V123, P3; Martins T, 2006, REV NEUROLOGIA, V42, P655, DOI 10.33588/rn.4211.2005301; O'Donnell MJ, 2010, LANCET, V376, P112, DOI 10.1016/S0140-6736(10)60834-3; Pickett CA, 2010, STROKE, V41, P2295, DOI 10.1161/STROKEAHA.110.585554; Rothwell PM, 2004, LANCET, V363, P1925, DOI 10.1016/S0140-6736(04)16405-2; Sacco RL, 1998, STROKE, V29, P380, DOI 10.1161/01.STR.29.2.380; Song JW, 2010, PLAST RECONSTR SURG, V126, P2234, DOI 10.1097/PRS.0b013e3181f44abc; Souza Maria de Fátima Marinho de, 2006, Arq. Bras. Cardiol., V87, P735, DOI 10.1590/S0066-782X2006001900009; Sposito AC, 2007, ARQ BRAS CARDIOL, V88, P2, DOI 10.1590/S0066-782X2007000700002; Steffens AA, 2006, J HYPERTENS, V24, P1489, DOI 10.1097/01.hjh.0000239282.27938.0f; Strong K, 2007, LANCET NEUROL, V6, P182, DOI 10.1016/S1474-4422(07)70031-5; Thrift AG, 2010, LANCET, V376, P1538, DOI 10.1016/S0140-6736(10)62025-9; Whitlock G, 2009, LANCET, V373, P1083, DOI 10.1016/S0140-6736(09)60318-4; Zhang YR, 2011, ARCH INTERN MED, V171, P1811, DOI 10.1001/archinternmed.2011.443	26	16	18	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2012	7	4							e35680	10.1371/journal.pone.0035680	http://dx.doi.org/10.1371/journal.pone.0035680			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959XD	22530066	Green Published, gold, Green Submitted			2022-12-25	WOS:000305350600112
J	Porter, KM; Epstein, DL; Liton, PB				Porter, Kristine M.; Epstein, David L.; Liton, Paloma B.			Up-Regulated Expression of Extracellular Matrix Remodeling Genes in Phagocytically Challenged Trabecular Meshwork Cells	PLOS ONE			English	Article							OPEN-ANGLE GLAUCOMA; DISTINCT SIGNALING PATHWAYS; OXIDATIVE STRESS; ELECTRON-MICROSCOPY; OUTFLOW PATHWAY; MEDFLY HEMOCYTES; ANTERIOR CHAMBER; AQUEOUS OUTFLOW; ORGAN-CULTURE; PHAGOCYTOSIS	Background: Cells in the trabecular meshwork (TM), the tissue responsible for draining aqueous humor out of the eye, are known to be highly phagocytic. Phagocytic function in TM cells is thought to play an important role in the normal functioning of the outflow pathway. Dysfunction of phagocytosis could lead to abnormalities of outflow resistance and increased intraocular pressure (IOP). However, the molecular mechanisms triggered by phagocytosis in TM cells are completely unknown. Methodology/Principal Findings: Gene expression profile analysis of human TM cells phagocytically challenged to E. coli or pigment under physiological and oxidative stress environment were performed using Affymetrix U133 plus 2.0 array and analyzed with Genespring GX. Despite the differential biological response elicited by E. coli and pigment particles, a number of genes, including MMP1, MMP3, TNFSF11, DIO2, KYNU, and KCCN2 showed differential expression with both phagocytic ligands in all conditions. Data was confirmed by qPCR in both human and porcine TM cells. Metacore pathway analysis and the usage of recombinant adenovirus encoding the dominant negative mutant of IkB identified NF-kappa B as a transcription factor mediating the up-regulation of at least MMP1 and MMP3 in TM cells with phagocytosis. In-gel zymography demonstrated increased collagenolytic and caseinolytic activities in the culture media of TM cells challenge to E. coli. In addition, collagenolytic I activity was further confirmed using the self-quenched fluorescent substrate DQ-Collagen I. Conclusions/Significance: Here we report for the first time the differential gene expression profile of TM cells phagocytically challenged with either E. coli or pigment. Our data indicate a potential role of phagocytosis in outflow pathway tissue homeostasis through the up-regulation and/or proteolytic activation of extracellular matrix remodeling genes.	[Porter, Kristine M.; Epstein, David L.; Liton, Paloma B.] Duke Univ, Dept Ophthalmol, Durham, NC 27706 USA	Duke University	Porter, KM (corresponding author), Duke Univ, Dept Ophthalmol, Durham, NC 27706 USA.	paloma.liton@duke.edu	Liton, Paloma/K-4229-2019	Liton, Paloma/0000-0002-1440-3762	National Institutes of Health [R21EY019137, ARRA R21EY019137-S, R01EY020491, P30EY005722]; Research to Prevent Blindness; NATIONAL EYE INSTITUTE [P30EY005722, R21EY019137, R01EY020491] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research to Prevent Blindness(Research to Prevent Blindness (RPB)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	National Institutes of Health Grants R21EY019137, ARRA R21EY019137-S, R01EY020491, P30EY005722, Research to Prevent Blindness. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALVARADO J, 1984, OPHTHALMOLOGY, V91, P564; Baud'huin M, 2007, CELL MOL LIFE SCI, V64, P2334, DOI 10.1007/s00018-007-7104-0; BILL A, 1975, INVEST OPHTH VISUAL, V14, P1; Bradley JMB, 1998, INVEST OPHTH VIS SCI, V39, P2649; BULLER C, 1990, INVEST OPHTH VIS SCI, V31, P2156; Dismuke WM, 2009, J OCUL PHARMACOL TH, V25, P309, DOI 10.1089/jop.2008.0133; EPSTEIN DL, 1986, INVEST OPHTH VIS SCI, V27, P387; Gogly B, 1998, ANAL BIOCHEM, V255, P211, DOI 10.1006/abio.1997.2318; GRANT GA, 1987, J BIOL CHEM, V262, P5886; GRIERSON I, 1973, BRIT J OPHTHALMOL, V57, P400, DOI 10.1136/bjo.57.6.400; GRIERSON I, 1978, BRIT J OPHTHALMOL, V62, P694, DOI 10.1136/bjo.62.10.694; Hoffmann E, 2010, EUR J CELL BIOL, V89, P693, DOI 10.1016/j.ejcb.2010.04.006; IWAMOTO T, 1971, AM J OPHTHALMOL, V72, P420, DOI 10.1016/0002-9394(71)91315-8; JOHNSON DH, 1989, CURR EYE RES, V8, P1121, DOI 10.3109/02713688909000037; Keller KE, 2009, EXP EYE RES, V88, P676, DOI 10.1016/j.exer.2008.11.023; Kumar DM, 2007, J GLAUCOMA, V16, P334; Lamirand A, 2011, J ENDOCRINOL, V208, P183, DOI 10.1677/JOE-10-0218; Lamprou I, 2005, BBA-MOL CELL RES, V1744, P1, DOI 10.1016/j.bbamcr.2004.09.031; Lamprou I, 2007, IMMUNOLOGY, V121, P314, DOI 10.1111/j.1365-2567.2007.02576.x; Leske MC, 2008, OPHTHALMOLOGY, V115, P85, DOI 10.1016/j.ophtha.2007.03.017; Liton PB, 2008, INVEST OPHTH VIS SCI, V49, P3961, DOI 10.1167/iovs.08-1915; Liton P, 2006, MOL VIS, V12, P774; Liton PB, 2009, AUTOPHAGY, V5, P122, DOI 10.4161/auto.5.1.7304; Liton PB, 2005, EXP GERONTOL, V40, P745, DOI 10.1016/j.exger.2005.06.005; Lutjen-Drecoll E, 1999, PROG RETIN EYE RES, V18, P91, DOI 10.1016/S1350-9462(98)00011-1; Popov Y, 2010, AM J PHYSIOL-GASTR L, V298, pG323, DOI 10.1152/ajpgi.00394.2009; Quigley HA, 2011, LANCET, V377, P1367, DOI 10.1016/S0140-6736(10)61423-7; Rohen J W, 1968, Albrecht Von Graefes Arch Klin Exp Ophthalmol, V175, P143, DOI 10.1007/BF02385060; Ronkko S, 2007, GRAEF ARCH CLIN EXP, V245, P697, DOI 10.1007/s00417-006-0440-1; Sacca SC, 2007, EXP EYE RES, V84, P389, DOI 10.1016/j.exer.2006.10.008; SAMUELSON DA, 1984, AM J VET RES, V45, P2359; SHABO AL, 1972, AM J OPHTHALMOL, V73, P25, DOI 10.1016/0002-9394(72)90300-5; SHIRATO S, 1989, INVEST OPHTH VIS SCI, V30, P2499; Snoek-van Beurden PAM, 2005, BIOTECHNIQUES, V38, P73, DOI 10.2144/05381RV01; Spiga MG, 2010, INVEST OPHTH VIS SCI, V51, P3029, DOI 10.1167/iovs.09-4918; Tamm ER, 2009, EXP EYE RES, V88, P648, DOI 10.1016/j.exer.2009.02.007; TRIPATHI RC, 1982, EXP EYE RES, V35, P611, DOI 10.1016/S0014-4835(82)80074-2; VANBUSKIRK EM, 1978, AM J OPHTHALMOL, V85, P160; Visse R, 2003, CIRC RES, V92, P827, DOI 10.1161/01.RES.0000070112.80711.3D; Vu TH, 2000, GENE DEV, V14, P2123, DOI 10.1101/gad.815400; Walker DG, 2006, J LEUKOCYTE BIOL, V79, P596, DOI 10.1189/jlb.0705377; Wang N, 2001, NAT MED, V7, P304, DOI 10.1038/85446; WILHELM SM, 1984, COLLAGEN REL RES, V4, P129; YAMASHITA T, 1965, AM J OPHTHALMOL, V60, P427, DOI 10.1016/0002-9394(65)90706-3; Yang P, 2004, INVEST OPHTH VIS SCI, V45, P2438, DOI 10.1167/iovs.03-0805; Zanon-Moreno V, 2008, J GLAUCOMA, V17, P263, DOI 10.1097/IJG.0b013e31815c3a7f; Zeold A, 2006, ENDOCRINOLOGY, V147, P4419, DOI 10.1210/en.2005-1608; ZHOU LL, 1995, INVEST OPHTH VIS SCI, V36, P787	48	26	30	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2012	7	4							e34792	10.1371/journal.pone.0034792	http://dx.doi.org/10.1371/journal.pone.0034792			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959XD	22529935	Green Published, gold, Green Submitted			2022-12-25	WOS:000305350600027
J	Li, F; Zhou, ML				Li, Feng; Zhou, Mingliang			Local Microenvironment Provides Important Cues for Cell Differentiation in Lingual Epithelia	PLOS ONE			English	Article							EPIDERMAL STEM-CELLS; TGF-BETA; STRATIFIED EPITHELIA; TRANSGENIC MICE; MOUSE TONGUE; CYCLE ARREST; HOMEOSTASIS; CANCER; SKIN; PROLIFERATION	Transgenic Keratin14-rtTA-PTR mice specifically express Keratin14 (K14) in the tongue epithelia, as well as co-express EGFP and the dominant negative Delta Tgfbr2 genes upon treatment with Doxycycline (Dox). As TGF-beta signaling negatively regulates the stem cell cycle and proliferation, its disruption by Dox induction in these transgenic mice shortens the cell cycle and allows observation of the final fate of those mutated cell lineages within a short period of time. Here, we used inducible transgenic mice to track the K14+ cells through the cell migration stream by immunohistochemical an immunofluorescent imaging. We showed that these cells have different development patterns from the tip to posterior of the tongue, achieved presumably by integrating positional information from the microenvironment. The expression of the K14 gene was variable, depending on the location of the tongue and papillae. Disruption of TGF-beta signaling in K14+ progenitor cells resulted in proliferation of stem cell pools.	[Li, Feng] Shanghai Jiao Tong Univ, Sch Med, Xinhua Hosp, Dev Biol Lab, Shanghai 200030, Peoples R China; [Zhou, Mingliang] Monell Chem Senses Ctr, Philadelphia, PA 19104 USA; [Li, Feng] Shanghai Jiao Tong Univ, Sch Med, Dept Lab Anim Sci, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Monell Chemical Senses Center; Shanghai Jiao Tong University	Li, F (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Xinhua Hosp, Dev Biol Lab, Shanghai 200030, Peoples R China.	lifengwest@gmail.com		Li, Feng/0000-0003-1291-5315	National Institutes of Health [R01 DC007487]; National Science Foundation [DBJ-0216310]; Shanghai Municipal Education Commission [08YZ42]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Shanghai Municipal Education Commission(Shanghai Municipal Education Commission (SHMEC))	This work was supported by National Institutes of Health (R01 DC007487) and National Science Foundation (DBJ-0216310) and Shanghai Municipal Education Commission (Technological innovation projects 08YZ42). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bierie B, 2006, CYTOKINE GROWTH F R, V17, P29, DOI 10.1016/j.cytogfr.2005.09.006; Bierie B, 2006, NAT REV CANCER, V6, P506, DOI 10.1038/nrc1926; Blanpain C, 2007, CELL, V128, P445, DOI 10.1016/j.cell.2007.01.014; Blanpain C, 2009, NAT REV MOL CELL BIO, V10, P207, DOI 10.1038/nrm2636; Bonfanti P, 2010, NATURE, V466, P978, DOI 10.1038/nature09269; Buck A, 2006, SIGNAL TRANSDUCTION, V6, P345; CAMERON IL, 1966, J EXP ZOOL, V163, P271, DOI 10.1002/jez.1401630306; Falk S, 2008, CELL STEM CELL, V2, P472, DOI 10.1016/j.stem.2008.03.006; Foster KW, 2005, ONCOGENE, V24, P1491, DOI 10.1038/sj.onc.1208307; Frugier T, 2005, GENESIS, V42, P1, DOI 10.1002/gene.20115; Frye M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000763; GIEHL K, 2006, SIGNAL TRANSDUCTION, V6, P355; Gu BN, 2010, J CELL BIOCHEM, V110, P1279, DOI 10.1002/jcb.22650; Guasch G, 2007, CANCER CELL, V12, P313, DOI 10.1016/j.ccr.2007.08.020; Iavarone A, 1997, NATURE, V387, P417; Ito M, 2005, NAT MED, V11, P1351, DOI 10.1038/nm1328; Jones PH, 2007, CELL STEM CELL, V1, P371, DOI 10.1016/j.stem.2007.09.014; Leung CT, 2007, NAT NEUROSCI, V10, P720, DOI 10.1038/nn1882; Massague J, 2006, FEBS LETT, V580, P2811, DOI 10.1016/j.febslet.2006.04.033; Merkle FT, 2007, SCIENCE, V317, P381, DOI 10.1126/science.1144914; Moses H, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a003277; Niemann C, 2002, DEVELOPMENT, V129, P95; Okubo T, 2006, GENE DEV, V20, P2654, DOI 10.1101/gad.1457106; Okubo T, 2009, STEM CELLS, V27, P442, DOI 10.1634/stemcells.2008-0611; Owens DM, 2003, NAT REV CANCER, V3, P444, DOI 10.1038/nrc1096; Raff M, 2003, ANNU REV CELL DEV BI, V19, P1, DOI 10.1146/annurev.cellbio.19.111301.143037; Rawlins EL, 2006, DEVELOPMENT, V133, P2455, DOI 10.1242/dev.02407; REYNISDOTTIR I, 1995, GENE DEV, V9, P1831, DOI 10.1101/gad.9.15.1831; Ross M. H., 1989, HISTOLOGY TEXT ATLAS; Siegel PM, 2003, NAT REV CANCER, V3, P807, DOI 10.1038/nrc1208; Simons BD, 2011, CELL, V145, P851, DOI 10.1016/j.cell.2011.05.033; Sjolund J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023057; Slack JMW, 2000, SCIENCE, V287, P1431, DOI 10.1126/science.287.5457.1431; Stover DG, 2007, J CELL BIOCHEM, V101, P851, DOI 10.1002/jcb.21149; Taylor G, 2000, CELL, V102, P451, DOI 10.1016/S0092-8674(00)00050-7; Tu WH, 2003, NEOPLASIA, V5, P267, DOI 10.1016/S1476-5586(03)80058-1; Tumbar T, 2004, SCIENCE, V303, P359, DOI 10.1126/science.1092436; Watt FM, 2006, CURR OPIN GENET DEV, V16, P518, DOI 10.1016/j.gde.2006.08.006; Watt FM, 2009, EMBO MOL MED, V1, P260, DOI 10.1002/emmm.200900033; Watt FM, 2000, SCIENCE, V287, P1427, DOI 10.1126/science.287.5457.1427; Xie W, 1999, ONCOGENE, V18, P3593, DOI 10.1038/sj.onc.1202673; Xu J, 2009, CELL RES, V19, P156, DOI 10.1038/cr.2009.5	42	4	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2012	7	4							e35362	10.1371/journal.pone.0035362	http://dx.doi.org/10.1371/journal.pone.0035362			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UT	22514735	gold, Green Published, Green Submitted			2022-12-25	WOS:000305341600140
J	Moes, M; Le Bechec, A; Crespo, I; Laurini, C; Halavatyi, A; Vetter, G; del Sol, A; Friederich, E				Moes, Michele; Le Bechec, Antony; Crespo, Isaac; Laurini, Christina; Halavatyi, Aliaksandr; Vetter, Guillaume; del Sol, Antonio; Friederich, Evelyne			A Novel Network Integrating a miRNA-203/SNAI1 Feedback Loop which Regulates Epithelial to Mesenchymal Transition	PLOS ONE			English	Article							MICRORNA EXPRESSION PROFILES; GENE-EXPRESSION; ZEB1; CELLS; SNAIL; REPRESSION; INDUCTION; TARGETS; EMT	Background: The majority of human cancer deaths are caused by metastasis. The metastatic dissemination is initiated by the breakdown of epithelial cell homeostasis. During this phenomenon, referred to as epithelial to mesenchymal transition (EMT), cells change their genetic and trancriptomic program leading to phenotypic and functional alterations. The challenge of understanding this dynamic process resides in unraveling regulatory networks involving master transcription factors (e. g. SNAI1/2, ZEB1/2 and TWIST1) and microRNAs. Here we investigated microRNAs regulated by SNAI1 and their potential role in the regulatory networks underlying epithelial plasticity. Results: By a large-scale analysis on epithelial plasticity, we highlighted miR-203 and its molecular link with SNAI1 and the miR-200 family, key regulators of epithelial homeostasis. During SNAI1-induced EMT in MCF7 breast cancer cells, miR-203 and miR-200 family members were repressed in a timely correlated manner. Importantly, miR-203 repressed endogenous SNAI1, forming a double negative miR203/SNAI1 feedback loop. We integrated this novel miR203/SNAI1 with the known miR200/ZEB feedback loops to construct an a priori EMT core network. Dynamic simulations revealed stable epithelial and mesenchymal states, and underscored the crucial role of the miR203/SNAI1 feedback loop in state transitions underlying epithelial plasticity. Conclusion: By combining computational biology and experimental approaches, we propose a novel EMT core network integrating two fundamental negative feedback loops, miR203/SNAI1 and miR200/ZEB. Altogether our analysis implies that this novel EMT core network could function as a switch controlling epithelial cell plasticity during differentiation and cancer progression.	[Moes, Michele; Le Bechec, Antony; Laurini, Christina; Halavatyi, Aliaksandr; Vetter, Guillaume; Friederich, Evelyne] Univ Luxembourg, Cytoskeleton & Cell Plast Lab, Life Sci Res Unit FSCT, Luxembourg, Luxembourg; [Crespo, Isaac; del Sol, Antonio] Univ Luxembourg, Luxembourg Ctr Syst Biomed, Esch Sur Alzette, Luxembourg	University of Luxembourg; University of Luxembourg	Moes, M (corresponding author), Univ Luxembourg, Cytoskeleton & Cell Plast Lab, Life Sci Res Unit FSCT, Luxembourg, Luxembourg.	moesmichele@gmail.com; evelyne.friederich@uni.lu	del Sol, Antonio/M-7431-2017	del Sol, Antonio/0000-0002-9926-617X; Le Bechec, Antony/0000-0002-9629-0916; Crespo, Isaac/0000-0003-1603-9535; Crespo, Isaac/0000-0003-3151-3901	National Research Fund, Luxembourg [FNR/BIOSAN/07/12, TR-PDR BFR08-084, TR-PHD BFR08-112]; Fondation Cancer; University of Luxembourg	National Research Fund, Luxembourg(Luxembourg National Research Fund); Fondation Cancer; University of Luxembourg	This work has been supported by the National Research Fund, Luxembourg (FNR/BIOSAN/07/12, ALB: AFR fellowship TR-PDR BFR08-084; AH: AFR PhD Fellowship TR-PHD BFR08-112), the "Fondation Cancer'' and the University of Luxembourg. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Castilla MA, 2011, J PATHOL, V223, P72, DOI 10.1002/path.2802; Baffa R, 2009, J PATHOL, V219, P214, DOI 10.1002/path.2586; Batlle E, 2000, NAT CELL BIOL, V2, P84, DOI 10.1038/35000034; Beltran M, 2008, GENE DEV, V22, P756, DOI 10.1101/gad.455708; Betel D, 2008, NUCLEIC ACIDS RES, V36, pD149, DOI 10.1093/nar/gkm995; Blower PE, 2007, MOL CANCER THER, V6, P1483, DOI 10.1158/1535-7163.MCT-07-0009; Brabletz S, 2010, EMBO REP, V11, P670, DOI 10.1038/embor.2010.117; Bracken CP, 2009, CELL MOL LIFE SCI, V66, P1682, DOI 10.1007/s00018-009-8750-1; Bracken CP, 2008, CANCER RES, V68, P7846, DOI 10.1158/0008-5472.CAN-08-1942; Burk U, 2008, EMBO REP, V9, P582, DOI 10.1038/embor.2008.74; Chaffer CL, 2011, SCIENCE, V331, P1559, DOI 10.1126/science.1203543; Dave N, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.168625; Gill JG, 2011, STEM CELLS, V29, P764, DOI 10.1002/stem.628; Gordon AJE, 2009, PLOS BIOL, V7, P364, DOI 10.1371/journal.pbio.1000044; Gregory PA, 2008, CELL CYCLE, V7, P3112, DOI 10.4161/cc.7.20.6851; Guaita S, 2002, J BIOL CHEM, V277, P39209, DOI 10.1074/jbc.M206400200; Huang S, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.128701; Le B'echec Antony, 2008, In Silico Biology, V8, P63; Le Bechec A, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-67; Liu HF, 2010, MOL CANCER THER, V9, P1080, DOI 10.1158/1535-7163.MCT-09-0965; Nicoloso MS, 2009, NAT REV CANCER, V9, P293, DOI 10.1038/nrc2619; Nissan X, 2011, DEV BIOL, V356, P506, DOI 10.1016/j.ydbio.2011.06.004; Park SM, 2008, GENE DEV, V22, P894, DOI 10.1101/gad.1640608; Peinado H, 2007, NAT REV CANCER, V7, P415, DOI 10.1038/nrc2131; Saini S, 2011, CLIN CANCER RES, V17, P5287, DOI 10.1158/1078-0432.CCR-10-2619; Saumet A, 2009, BLOOD, V113, P412, DOI 10.1182/blood-2008-05-158139; Shiraishi T, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000851; Sokilde R, 2011, MOL CANCER THER, V10, P375, DOI 10.1158/1535-7163.MCT-10-0605; Tasseff R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008864; Taube JH, 2010, P NATL ACAD SCI USA, V107, P15449, DOI 10.1073/pnas.1004900107; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Thuault S, 2008, J BIOL CHEM, V283, P33437, DOI 10.1074/jbc.M802016200; Tran DD, 2011, MOL CANCER RES, V9, P1644, DOI 10.1158/1541-7786.MCR-11-0371; Vetter G, 2009, BIOCHEM BIOPH RES CO, V385, P485, DOI 10.1016/j.bbrc.2009.05.025; Viticchie G, 2011, CELL CYCLE, V10, P1121, DOI 10.4161/cc.10.7.15180; Wellner U, 2009, NAT CELL BIOL, V11, P1487, DOI 10.1038/ncb1998; Yatskou Mikalai, 2008, BMC Res Notes, V1, P80, DOI 10.1186/1756-0500-1-80; Zhong Q, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.80	38	135	139	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2012	7	4							e35440	10.1371/journal.pone.0035440	http://dx.doi.org/10.1371/journal.pone.0035440			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UT	22514743	gold, Green Published, Green Submitted			2022-12-25	WOS:000305341600148
J	Gu, SJ; Boyer, TG; Naski, MC				Gu, Shoujun; Boyer, Thomas G.; Naski, Michael C.			Basic Helix-Loop-Helix Transcription Factor Twist1 Inhibits Transactivator Function of Master Chondrogenic Regulator Sox9	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SAETHRE-CHOTZEN-SYNDROME; II COLLAGEN GENE; CHONDROCYTE DIFFERENTIATION; DORSOVENTRAL PATTERN; DROSOPHILA EMBRYOS; AGGRECAN GENE; ZYGOTIC GENE; BETA-CATENIN; EXPRESSION; CARTILAGE	Canonical Wnt signaling strongly inhibits chondrogenesis. Previously, we identified Twist1 as a critical downstream mediator of Wnt in repression of chondrocyte differentiation. However, the mechanistic basis for the antichondrogenic activity of Twist1 has not heretofore been established. Here, we show that Twist1 suppresses cartilage development by directly inhibiting the transcriptional activity of Sox9, the master regulator of chondrogenesis. Twist1, through its carboxyl-terminal Twist-box, binds to the Sox9 high mobility group DNA-binding domain, inhibiting Sox9 transactivation potential. In chondrocyte precursor cells, Twist1, in a Twist-box-dependent manner, inhibits Sox9-dependent activation of chondrocyte marker gene expression by blocking Sox9-enhancer DNA association. These findings identify Twist1 as an inhibitor of Sox9 and further suggest that the balance between Twist1 and Sox9 may determine the earliest steps of chondrogenesis.	[Gu, Shoujun; Naski, Michael C.] Univ Texas Hlth Sci Ctr San Antonio, Dept Biochem, San Antonio, TX 78245 USA; [Boyer, Thomas G.] Univ Texas Hlth Sci Ctr San Antonio, Inst Biotechnol, Dept Mol Med, San Antonio, TX 78245 USA	University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio	Boyer, TG (corresponding author), 19715 Lambda Dr, San Antonio, TX 78245 USA.	boyer@uthscsa.edu; mikenaski@yahoo.com			NIAMS, National Institutes of Health [AR053100]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR053100] Funding Source: NIH RePORTER	NIAMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by NIAMS, National Institutes of Health Public Health Grant AR053100.	Akiyama H, 2002, GENE DEV, V16, P2813, DOI 10.1101/gad.1017802; Akiyama H, 2005, P NATL ACAD SCI USA, V102, P14665, DOI 10.1073/pnas.0504750102; Akiyama H, 2004, GENE DEV, V18, P1072, DOI 10.1101/gad.1171104; Bell DM, 1997, NAT GENET, V16, P174, DOI 10.1038/ng0697-174; Bi WM, 2001, P NATL ACAD SCI USA, V98, P6698, DOI 10.1073/pnas.111092198; Bi WM, 1999, NAT GENET, V22, P85, DOI 10.1038/8792; Bialek P, 2004, DEV CELL, V6, P423, DOI 10.1016/S1534-5807(04)00058-9; Capdevila J, 2001, ANNU REV CELL DEV BI, V17, P87, DOI 10.1146/annurev.cellbio.17.1.87; Cheng GZ, 2008, CANCER RES, V68, P957, DOI 10.1158/0008-5472.CAN-07-5067; Connerney J, 2008, DEV BIOL, V318, P323, DOI 10.1016/j.ydbio.2008.03.037; Connerney J, 2006, DEV DYNAM, V235, P1345, DOI 10.1002/dvdy.20717; Day TF, 2005, DEV CELL, V8, P739, DOI 10.1016/j.devcel.2005.03.016; Ding N, 2008, MOL CELL, V31, P347, DOI 10.1016/j.molcel.2008.05.023; Dong YF, 2007, MOL ENDOCRINOL, V21, P2805, DOI 10.1210/me.2007-0199; ElGhouzzi V, 1997, NAT GENET, V15, P42; Firulli BA, 2005, NAT GENET, V37, P373, DOI 10.1038/ng1525; Genzer MA, 2007, NUCLEIC ACIDS RES, V35, P1178, DOI 10.1093/nar/gkm014; Gitelman I, 1997, DEV BIOL, V189, P205, DOI 10.1006/dbio.1997.8614; Hamamori Y, 1997, MOL CELL BIOL, V17, P6563, DOI 10.1128/MCB.17.11.6563; Han Y, 2008, MOL CELL BIOL, V28, P4999, DOI 10.1128/MCB.00695-08; Hiyama A, 2010, ARTHRITIS RHEUM-US, V62, P3036, DOI 10.1002/art.27599; Jenkins E, 2005, MATRIX BIOL, V24, P177, DOI 10.1016/j.matbio.2005.02.004; Lefebvre V, 1996, MOL CELL BIOL, V16, P4512; Lefebvre V, 1998, EMBO J, V17, P5718, DOI 10.1093/emboj/17.19.5718; Lefebvre V, 1997, MOL CELL BIOL, V17, P2336, DOI 10.1128/MCB.17.4.2336; Li QQ, 2009, CLIN CANCER RES, V15, P2657, DOI 10.1158/1078-0432.CCR-08-2372; Olsen BR, 2000, ANNU REV CELL DEV BI, V16, P191, DOI 10.1146/annurev.cellbio.16.1.191; Puisieux A, 2006, BRIT J CANCER, V94, P13, DOI 10.1038/sj.bjc.6602876; Qin Q, 2012, CELL RES, V22, P90, DOI 10.1038/cr.2011.144; REARDON W, 1994, J MED GENET, V31, P393, DOI 10.1136/jmg.31.5.393; Reinhold MI, 2006, J BIOL CHEM, V281, P1381, DOI 10.1074/jbc.M504875200; Rice DPC, 2000, DEVELOPMENT, V127, P1845; Ryu JH, 2002, DEVELOPMENT, V129, P5541, DOI 10.1242/dev.00110; Sekiya I, 2000, J BIOL CHEM, V275, P10738, DOI 10.1074/jbc.275.15.10738; Shimizu H, 2007, DEV GROWTH DIFFER, V49, P449, DOI 10.1111/j.1440-169x.2007.00945.x; SIMPSON P, 1983, GENETICS, V105, P615; THISSE B, 1987, NUCLEIC ACIDS RES, V15, P3439, DOI 10.1093/nar/15.8.3439; THISSE B, 1988, EMBO J, V7, P2175, DOI 10.1002/j.1460-2075.1988.tb03056.x; Tickle C, 2003, DEV CELL, V4, P449, DOI 10.1016/S1534-5807(03)00095-9; Watanabe H, 1998, J BIOCHEM, V124, P687, DOI 10.1093/oxfordjournals.jbchem.a022166; Yang J, 2004, CELL, V117, P927, DOI 10.1016/j.cell.2004.06.006; Zhao Q, 1997, DEV DYNAM, V209, P377, DOI 10.1002/(SICI)1097-0177(199708)209:4<377::AID-AJA5>3.0.CO;2-F	42	29	31	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 15	2012	287	25					21082	21092		10.1074/jbc.M111.328567	http://dx.doi.org/10.1074/jbc.M111.328567			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974FQ	22532563	hybrid, Green Published			2022-12-25	WOS:000306416800029
J	Lusher, SJ; Raaijmakers, HCA; Vu-Pham, D; Kazemier, B; Bosch, R; McGuire, R; Azevedo, R; Hamersma, H; Dechering, K; Oubrie, A; van Duin, M; de Vlieg, J				Lusher, Scott J.; Raaijmakers, Hans C. A.; Vu-Pham, Diep; Kazemier, Bert; Bosch, Rolien; McGuire, Ross; Azevedo, Rita; Hamersma, Hans; Dechering, Koen; Oubrie, Arthur; van Duin, Marcel; de Vlieg, Jacob			X-ray Structures of Progesterone Receptor Ligand Binding Domain in Its Agonist State Reveal Differing Mechanisms for Mixed Profiles of 11 beta-Substituted Steroids	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN ANDROGEN RECEPTOR; UTERINE LEIOMYOMA CELLS; ESTROGEN-RECEPTOR; MODULATOR ASOPRISNIL; MINERALOCORTICOID RECEPTOR; CRYSTAL-STRUCTURES; AMINO-ACID; ANTAGONISM; CONFORMATION; ACTIVATION	We present here the x-ray structures of the progesterone receptor (PR) in complex with two mixed profile PR modulators whose functional activity results from two differing molecular mechanisms. The structure of Asoprisnil bound to the agonist state of PR demonstrates the contribution of the ligand to increasing stability of the agonist conformation of helix-12 via a specific hydrogen-bond network including Glu(723). This interaction is absent when the full antagonist, RU486, binds to PR. Combined with a previously reported structure of Asoprisnil bound to the antagonist state of the receptor, this structure extends our understanding of the complex molecular interactions underlying the mixed agonist/antagonist profile of the compound. In addition, we present the structure of PR in its agonist conformation bound to the mixed profile compound Org3H whose reduced antagonistic activity and increased agonistic activity compared with reference antagonists is due to an induced fit around Trp(755), resulting in a decreased steric clash with Met(909) but inducing a new internal clash with Val(912) in helix-12. This structure also explains the previously published observation that 16 alpha attachments to RU486 analogs induce mixed profiles by altering the binding of 11 beta substituents. Together these structures further our understanding of the steric and electrostatic factors that contribute to the function of steroid receptor modulators, providing valuable insight for future compound design.	[Lusher, Scott J.; Raaijmakers, Hans C. A.; Bosch, Rolien; McGuire, Ross; Azevedo, Rita; Hamersma, Hans; Oubrie, Arthur; de Vlieg, Jacob] MSD, Dept Mol Design & Informat, NL-5340 BH Oss, Netherlands; [Vu-Pham, Diep; Kazemier, Bert; Dechering, Koen] MSD, Dept Mol Pharmacol & DMPK, NL-5340 BH Oss, Netherlands; [van Duin, Marcel] MSD, Dept Womens Hlth, NL-5340 BH Oss, Netherlands; [de Vlieg, Jacob] Radboud Univ Nijmegen, Computat Drug Discovery Grp, NL-6526 HP Nijmegen, Netherlands	Merck & Company; Merck & Company; Merck & Company; Radboud University Nijmegen	Lusher, SJ (corresponding author), MSD, Dept Mol Design & Informat, POB 20, NL-5340 BH Oss, Netherlands.	s.lusher@esciencecenter.nl	McGuire, Ross/P-8855-2015	McGuire, Ross/0000-0003-3404-6456; Azevedo, Rita/0000-0002-0180-3636; raaijmakers, hans/0000-0002-2567-7363; Oubrie, Arthur/0000-0001-6765-9246				Afhuppe W, 2009, J STEROID BIOCHEM, V113, P105, DOI 10.1016/j.jsbmb.2008.11.015; BAGCHI MK, 1990, NATURE, V345, P547, DOI 10.1038/345547a0; Benagiano G, 2008, EXPERT OPIN PHARMACO, V9, P2473, DOI [10.1517/14656566.9.14.2473, 10.1517/14656566.9.14.2473 ]; Benagiano G, 2008, EXPERT OPIN PHARMACO, V9, P2459, DOI [10.1517/14656566.9.14.2459, 10.1517/14656566.9.14.2459 ]; Benagiano G, 2008, EXPERT OPIN PHARMACO, V9, P2487, DOI [10.1517/14656566.9.14.2487, 10.1517/14656566.9.14.2487 ]; Bledsoe RK, 2005, J BIOL CHEM, V280, P31283, DOI 10.1074/jbc.M504098200; Bohl CE, 2008, BIOORG MED CHEM LETT, V18, P5567, DOI 10.1016/j.bmcl.2008.09.002; Bohl CE, 2007, J BIOL CHEM, V282, P13648, DOI 10.1074/jbc.M611711200; Bohl CE, 2005, P NATL ACAD SCI USA, V102, P6201, DOI 10.1073/pnas.0500381102; Bohl CE, 2005, J BIOL CHEM, V280, P37747, DOI 10.1074/jbc.M507464200; Brown AR, 2011, BIOORG MED CHEM LETT, V21, P137, DOI 10.1016/j.bmcl.2010.11.054; Brzozowski AM, 1997, NATURE, V389, P753, DOI 10.1038/39645; Cantin L, 2007, J BIOL CHEM, V282, P30910, DOI 10.1074/jbc.M705524200; Chen W, 2006, J CLIN ENDOCR METAB, V91, P1296, DOI 10.1210/jc.2005-2379; Chwalisz K, 2005, ENDOCR REV, V26, P423, DOI 10.1210/er.2005-0001; Chwalisz K, 2007, FERTIL STERIL, V87, P1399, DOI 10.1016/j.fertnstert.2006.11.094; Dayan G, 2006, MOL PHARMACOL, V70, P579, DOI 10.1124/mol.105.021931; De Jesus-Tran KP, 2006, PROTEIN SCI, V15, P987, DOI 10.1110/ps.051905906; DeManno D, 2003, STEROIDS, V68, P1019, DOI 10.1016/j.steroids.2003.09.008; Duke CB, 2011, J MED CHEM, V54, P3973, DOI 10.1021/jm2000097; Fagart J, 2005, NAT STRUCT MOL BIOL, V12, P554, DOI 10.1038/nsmb939; Hubbard RE, 2000, EUR J CANCER, V36, pS17; Jackson TA, 1997, MOL ENDOCRINOL, V11, P693, DOI 10.1210/me.11.6.693; Kallander LS, 2010, BIOORG MED CHEM LETT, V20, P371, DOI 10.1016/j.bmcl.2009.10.092; Kauppi B, 2003, J BIOL CHEM, V278, P22748, DOI 10.1074/jbc.M212711200; Kong EH, 2003, BIOCHEM SOC T, V31, P56, DOI 10.1042/BST0310056; Krieger E, 2004, PROTEINS, V57, P678, DOI 10.1002/prot.20251; Levenson AS, 1998, CANCER RES, V58, P1872; Levenson AS, 2001, J STEROID BIOCHEM, V76, P61, DOI 10.1016/S0960-0760(00)00143-6; Lusher SJ, 2011, J BIOL CHEM, V286, P35079, DOI 10.1074/jbc.M111.273029; Madauss KP, 2007, MOL ENDOCRINOL, V21, P1066, DOI 10.1210/me.2006-0524; Madauss KP, 2007, MED RES REV, V27, P374, DOI 10.1002/med.20083; Madauss KP, 2004, J MED CHEM, V47, P3381, DOI 10.1021/jm030640n; Manas ES, 2004, STRUCTURE, V12, P2197, DOI 10.1016/j.str.2004.09.015; Matias PM, 2000, J BIOL CHEM, V275, P26164, DOI 10.1074/jbc.M004571200; Nettles KW, 2008, NAT CHEM BIOL, V4, P241, DOI 10.1038/nchembio.76; Ohara Noriyuki, 2007, Reprod Sci, V14, P20, DOI 10.1177/1933719107311464; Petit-Topin I, 2009, MOL PHARMACOL, V75, P1317, DOI 10.1124/mol.108.054312; Pflugrath JW, 1999, ACTA CRYSTALLOGR D, V55, P1718, DOI 10.1107/S090744499900935X; Pike ACW, 2000, BIOCHEM SOC T, V28, P396, DOI 10.1042/0300-5127:0280396; Pike ACW, 1999, EMBO J, V18, P4608, DOI 10.1093/emboj/18.17.4608; Pike ACW, 2000, J STEROID BIOCHEM, V74, P261, DOI 10.1016/S0960-0760(00)00102-3; Potterton E, 2003, ACTA CRYSTALLOGR D, V59, P1131, DOI 10.1107/S0907444903008126; Raaijmakers HCA, 2009, J BIOL CHEM, V284, P19572, DOI 10.1074/jbc.M109.007872; Schoch GA, 2010, J MOL BIOL, V395, P568, DOI 10.1016/j.jmb.2009.11.011; Shiau AK, 2002, NAT STRUCT BIOL, V9, P359, DOI 10.1038/nsb787; Smith CL, 2004, ENDOCR REV, V25, P45, DOI 10.1210/er.2003-0023; Spitz IM, 2003, STEROIDS, V68, P981, DOI 10.1016/j.steroids.2003.08.007; Spitz IM, 2000, STEROIDS, V65, P807, DOI 10.1016/S0039-128X(00)00194-X; Tanenbaum DM, 1998, P NATL ACAD SCI USA, V95, P5998, DOI 10.1073/pnas.95.11.5998; Thompson SK, 2009, BIOORG MED CHEM LETT, V19, P4777, DOI 10.1016/j.bmcl.2009.06.055; VEGETO E, 1992, CELL, V69, P703, DOI 10.1016/0092-8674(92)90234-4; VEGETO E, 1993, MOL ENDOCRINOL, V7, P1244, DOI 10.1210/me.7.10.1244; Wagner BL, 1996, P NATL ACAD SCI USA, V93, P8739, DOI 10.1073/pnas.93.16.8739; Wang JY, 2006, HUM REPROD, V21, P1869, DOI 10.1093/humrep/del035; Williams ARW, 2007, HUM REPROD, V22, P1696, DOI 10.1093/humrep/dem026; Williams SP, 1998, NATURE, V393, P392, DOI 10.1038/30775; Winneker RC, 2008, STEROIDS, V73, P689, DOI 10.1016/j.steroids.2008.03.005; Wu YL, 2005, MOL CELL, V18, P413, DOI 10.1016/j.molcel.2005.04.014; Zhang ZM, 2005, J BIOL CHEM, V280, P28468, DOI 10.1074/jbc.M504144200	60	24	26	2	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 8	2012	287	24					20333	20343		10.1074/jbc.M111.308403	http://dx.doi.org/10.1074/jbc.M111.308403			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974FB	22535964	hybrid, Green Published			2022-12-25	WOS:000306414500053
J	Gulledge, AT; Carnevale, NT; Stuart, GJ				Gulledge, Allan T.; Carnevale, Nicholas T.; Stuart, Greg J.			Electrical Advantages of Dendritic Spines	PLOS ONE			English	Article							LONG-TERM POTENTIATION; CA1 PYRAMIDAL NEURONS; AMPA RECEPTOR EXPRESSION; SYNAPTIC INTEGRATION; CALCIUM-CHANNELS; STRUCTURAL PLASTICITY; BASAL DENDRITES; SODIUM-CHANNELS; RAT HIPPOCAMPUS; NERVOUS-SYSTEM	Many neurons receive excitatory glutamatergic input almost exclusively onto dendritic spines. In the absence of spines, the amplitudes and kinetics of excitatory postsynaptic potentials (EPSPs) at the site of synaptic input are highly variable and depend on dendritic location. We hypothesized that dendritic spines standardize the local geometry at the site of synaptic input, thereby reducing location-dependent variability of local EPSP properties. We tested this hypothesis using computational models of simplified and morphologically realistic spiny neurons that allow direct comparison of EPSPs generated on spine heads with EPSPs generated on dendritic shafts at the same dendritic locations. In all morphologies tested, spines greatly reduced location-dependent variability of local EPSP amplitude and kinetics, while having minimal impact on EPSPs measured at the soma. Spine-dependent standardization of local EPSP properties persisted across a range of physiologically relevant spine neck resistances, and in models with variable neck resistances. By reducing the variability of local EPSPs, spines standardized synaptic activation of NMDA receptors and voltage-gated calcium channels. Furthermore, spines enhanced activation of NMDA receptors and facilitated the generation of NMDA spikes and axonal action potentials in response to synaptic input. Finally, we show that dynamic regulation of spine neck geometry can preserve local EPSP properties following plasticity-driven changes in synaptic strength, but is inefficient in modifying the amplitude of EPSPs in other cellular compartments. These observations suggest that one function of dendritic spines is to standardize local EPSP properties throughout the dendritic tree, thereby allowing neurons to use similar voltage-sensitive postsynaptic mechanisms at all dendritic locations.	[Gulledge, Allan T.] Geisel Sch Med Dartmouth, Dept Physiol & Neurobiol, Hanover, NH USA; [Carnevale, Nicholas T.] Yale Univ, Sch Med, Dept Neurobiol, New Haven, CT USA; [Stuart, Greg J.] Australian Natl Univ, John Curtin Sch Med Res, Eccles Inst Neurosci, Canberra, ACT 2601, Australia	Dartmouth College; Yale University; Australian National University; John Curtin School of Medical Research	Gulledge, AT (corresponding author), Geisel Sch Med Dartmouth, Dept Physiol & Neurobiol, Hanover, NH USA.	allan.gulledge@dartmouth.edu	Gulledge, Allan T/C-2733-2008	Gulledge, Allan T/0000-0002-5721-374X; stuart, greg/0000-0001-9395-2219	National Institutes of Health [R01 MH83806]; National Health and Medical Research Council of Australia; NIH [NS11613, DC00086]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH083806] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS011613] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC009977] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by National Institutes of Health grant R01 MH83806 (ATG), the National Health and Medical Research Council of Australia (GJS), and NIH grants NS11613 and DC00086 (NTC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araya R, 2007, P NATL ACAD SCI USA, V104, P12347, DOI 10.1073/pnas.0705282104; Araya R, 2006, P NATL ACAD SCI USA, V103, P17961, DOI 10.1073/pnas.0608755103; Arellano JI, 2007, FRONT NEUROSCI-SWITZ, V1, P131, DOI 10.3389/neuro.01.1.1.010.2007; Bekkers JM, 2000, J PHYSIOL-LONDON, V525, P611, DOI 10.1111/j.1469-7793.2000.t01-2-00611.x; Berger T, 2001, J NEUROPHYSIOL, V85, P855, DOI 10.1152/jn.2001.85.2.855; Bloodgood BL, 2005, SCIENCE, V310, P866, DOI 10.1126/science.1114816; Bloodgood BL, 2007, NEURON, V53, P249, DOI 10.1016/j.neuron.2006.12.017; Bloodgood BL, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000190; Branco T, 2011, NEURON, V69, P885, DOI 10.1016/j.neuron.2011.02.006; Cajal S, 1899, REGIAS CONSEJOS INVE; Carnevale NT, 2006, NEURON BOOK; CHANG HT, 1952, COLD SPRING HARB SYM, V17, P189, DOI 10.1101/SQB.1952.017.01.019; Chklovskii DB, 2004, NEURON, V43, P609, DOI 10.1016/j.neuron.2004.08.012; Diamond J, 1970, EXCITATORY SYNAPTIC, P213; Dunaevsky A, 1999, P NATL ACAD SCI USA, V96, P13438, DOI 10.1073/pnas.96.23.13438; Faber ESL, 2005, NAT NEUROSCI, V8, P635, DOI 10.1038/nn1450; FIFKOVA E, 1981, EXP NEUROL, V74, P621, DOI 10.1016/0014-4886(81)90197-7; Fischer M, 1998, NEURON, V20, P847, DOI 10.1016/S0896-6273(00)80467-5; Grunditz A, 2008, J NEUROSCI, V28, P13457, DOI 10.1523/JNEUROSCI.2702-08.2008; Gulledge AT, 2005, J NEUROBIOL, V64, P75, DOI 10.1002/neu.20144; HARRIS KM, 1989, J NEUROSCI, V9, P2982; HARRIS KM, 1992, J NEUROSCI, V12, P2685; Hines ML, 2001, NEUROSCIENTIST, V7, P123, DOI 10.1177/107385840100700207; Holbro N, 2010, P NATL ACAD SCI USA, V107, P15975, DOI 10.1073/pnas.1004562107; Isope P, 2005, J PHYSIOL-LONDON, V562, P257, DOI 10.1113/jphysiol.2004.074211; Jaffe DB, 1999, J NEUROPHYSIOL, V82, P3268, DOI 10.1152/jn.1999.82.6.3268; JASLOVE SW, 1992, NEUROSCIENCE, V47, P495, DOI 10.1016/0306-4522(92)90161-T; Kasai H, 2003, TRENDS NEUROSCI, V26, P360, DOI 10.1016/S0166-2236(03)00162-0; Katz Y, 2009, NEURON, V63, P171, DOI 10.1016/j.neuron.2009.06.023; KAWATO M, 1984, BIOPHYS J, V46, P155, DOI 10.1016/S0006-3495(84)84008-4; KAWATO M, 1983, J THEOR BIOL, V103, P507, DOI 10.1016/0022-5193(83)90280-1; KOCH C, 1993, J NEUROSCI, V13, P413; Kole MHP, 2008, NAT NEUROSCI, V11, P178, DOI 10.1038/nn2040; Kole MHP, 2006, J NEUROSCI, V26, P1677, DOI 10.1523/JNEUROSCI.3664-05.2006; Kopec CD, 2006, J NEUROSCI, V26, P2000, DOI 10.1523/JNEUROSCI.3918-05.2006; Korkotian E, 2007, CELL CALCIUM, V42, P41, DOI 10.1016/j.ceca.2006.11.006; Korkotian E, 2006, CELL CALCIUM, V40, P441, DOI 10.1016/j.ceca.2006.08.008; Korngreen A, 2000, J PHYSIOL-LONDON, V525, P621, DOI 10.1111/j.1469-7793.2000.00621.x; Lamprecht R, 2004, NAT REV NEUROSCI, V5, P45, DOI 10.1038/nrn1301; Lang C, 2004, P NATL ACAD SCI USA, V101, P16665, DOI 10.1073/pnas.0407581101; Larkum ME, 2009, SCIENCE, V325, P756, DOI 10.1126/science.1171958; Lee SJR, 2009, NATURE, V458, P299, DOI 10.1038/nature07842; Leitch B, 2009, NEUROSCIENCE, V164, P641, DOI 10.1016/j.neuroscience.2009.08.006; LESTER RAJ, 1990, NATURE, V346, P565, DOI 10.1038/346565a0; Lorincz A, 2010, SCIENCE, V328, P906, DOI 10.1126/science.1187958; Magee JC, 1998, J NEUROSCI, V18, P7613; Mainen ZF, 1996, NATURE, V382, P363, DOI 10.1038/382363a0; Martone ME, 2002, J STRUCT BIOL, V138, P145, DOI 10.1016/S1047-8477(02)00006-0; Matsuzaki M, 2001, NAT NEUROSCI, V4, P1086, DOI 10.1038/nn736; Matsuzaki M, 2004, NATURE, V429, P761, DOI 10.1038/nature02617; MULLER W, 1991, NATURE, V354, P73, DOI 10.1038/354073a0; Nevian T, 2007, NAT NEUROSCI, V10, P206, DOI 10.1038/nn1826; Ngo-Anh TJ, 2005, NAT NEUROSCI, V8, P642, DOI 10.1038/nn1449; Nicholson DA, 2006, NEURON, V50, P431, DOI 10.1016/j.neuron.2006.03.022; Oertner TG, 2009, FRONT COMPUT NEUROSC, V3, DOI 10.3389/neuro.10.007.2009; Okamoto KI, 2004, NAT NEUROSCI, V7, P1104, DOI 10.1038/nn1311; Otmakhov N, 2004, J NEUROSCI, V24, P9324, DOI 10.1523/JNEUROSCI.2350-04.2004; Palmer LM, 2009, J NEUROSCI, V29, P6897, DOI 10.1523/JNEUROSCI.5847-08.2009; Peterka DS, 2011, NEURON, V69, P9, DOI 10.1016/j.neuron.2010.12.010; PETERS A, 1970, AM J ANAT, V127, P321, DOI 10.1002/aja.1001270402; Rall W., 1974, CELLULAR MECH SUBSER, P13; RINZEL J, 1974, BIOPHYS J, V14, P759, DOI 10.1016/S0006-3495(74)85948-5; Roth A, 2001, J PHYSIOL-LONDON, V535, P445, DOI 10.1111/j.1469-7793.2001.00445.x; Sabatini BL, 2000, NATURE, V408, P589, DOI 10.1038/35046076; Sabatini BL, 2002, NEURON, V33, P439, DOI 10.1016/S0896-6273(02)00573-1; Schiller J, 2000, NATURE, V404, P285, DOI 10.1038/35005094; Schmidt-Hieber C, 2007, J NEUROSCI, V27, P8430, DOI 10.1523/JNEUROSCI.1787-07.2007; Segev I, 2000, SCIENCE, V290, P744, DOI 10.1126/science.290.5492.744; SEGEV I, 1995, J COMPUT NEUROSCI, V2, P117, DOI 10.1007/BF00961883; Spruston N, 2008, NAT REV NEUROSCI, V9, P206, DOI 10.1038/nrn2286; Stuart G, 1998, J NEUROSCI, V18, P3501; STUART GJ, 1994, NATURE, V367, P69, DOI 10.1038/367069a0; Svoboda K, 1996, SCIENCE, V272, P716, DOI 10.1126/science.272.5262.716; Tanaka JI, 2008, SCIENCE, V319, P1683, DOI 10.1126/science.1152864; Turrigiano GG, 2004, NAT REV NEUROSCI, V5, P97, DOI 10.1038/nrn1327; WILSON CJ, 1984, J NEUROSCI, V4, P281; YUSTE R, 1995, NATURE, V375, P682, DOI 10.1038/375682a0	77	54	54	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2012	7	4							e36007	10.1371/journal.pone.0036007	http://dx.doi.org/10.1371/journal.pone.0036007			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UD	22532875	Green Submitted, Green Published, gold			2022-12-25	WOS:000305339200125
J	Wu, ST; Li, RW; Li, WZ; Beshah, E; Dawson, HD; Urban, JF				Wu, Sitao; Li, Robert W.; Li, Weizhong; Beshah, Ethiopia; Dawson, Harry D.; Urban, Joseph F., Jr.			Worm Burden-Dependent Disruption of the Porcine Colon Microbiota by Trichuris suis Infection	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; ALTERNATIVELY ACTIVATED MACROPHAGES; CAMPYLOBACTER-JEJUNI; SWINE; EXPRESSION; INDUCTION; ULTRAFAST; SEQUENCES; NEMATODES; ALIGNMENT	Helminth infection in pigs serves as an excellent model for the study of the interaction between human malnutrition and parasitic infection and could have important implications in human health. We had observed that pigs infected with Trichuris suis for 21 days showed significant changes in the proximal colon microbiota. In this study, interactions between worm burden and severity of disruptions to the microbial composition and metabolic potentials in the porcine proximal colon microbiota were investigated using metagenomic tools. Pigs were infected by a single dose of T. suis eggs for 53 days. Among infected pigs, two cohorts were differentiated that either had adult worms or were worm-free. Infection resulted in a significant change in the abundance of approximately 13% of genera detected in the proximal colon microbiota regardless of worm status, suggesting a relatively persistent change over time in the microbiota due to the initial infection. A significant reduction in the abundance of Fibrobacter and Ruminococcus indicated a change in the fibrolytic capacity of the colon microbiota in T. suis infected pigs. In addition, similar to 10% of identified KEGG pathways were affected by infection, including ABC transporters, peptidoglycan biosynthesis, and lipopolysaccharide biosynthesis as well as alpha-linolenic acid metabolism. Trichuris suis infection modulated host immunity to Campylobacter because there was a 3-fold increase in the relative abundance in the colon microbiota of infected pigs with worms compared to naive controls, but a 3-fold reduction in worm-free infected pigs compared to controls. The level of pathology observed in infected pigs with worms compared to worm-free infected pigs may relate to the local host response because expression of several Th2-related genes were enhanced in infected pigs with worms versus those worm-free. Our findings provided insight into the dynamics of the proximal colon microbiota in pigs in response to T. suis infection.	[Li, Robert W.] ARS, USDA, Bovine Funct Genom Lab, Beltsville, MD USA; [Wu, Sitao; Li, Weizhong] Univ Calif San Diego, Ctr Res Biol Syst, San Diego, CA 92103 USA; [Beshah, Ethiopia; Dawson, Harry D.; Urban, Joseph F., Jr.] ARS, USDA, Diet Genom & Immunol Lab, Beltsville, MD USA	United States Department of Agriculture (USDA); University of California System; University of California San Diego; United States Department of Agriculture (USDA)	Li, RW (corresponding author), ARS, USDA, Bovine Funct Genom Lab, Beltsville, MD USA.	robert.li@ars.usda.gov	Dawson, Harry/H-8242-2013; Dawson, Harry/ABG-2734-2021; Li, Weizhong/A-9735-2008	Dawson, Harry/0000-0002-7648-9952; Li, Weizhong/0000-0003-1804-9403; Urban, Joseph/0000-0002-1590-8869	National Human Genome Research Institute (NHGRI) [R01HG005978]; National Center for Research Resources (NCRR) [R01RR025030]; CAMERA project; Gordon and Betty Moore Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES [R01RR025030] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG005978] Funding Source: NIH RePORTER	National Human Genome Research Institute (NHGRI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Center for Research Resources (NCRR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); CAMERA project; Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	SW and WL were supported by Award R01HG005978 from the National Human Genome Research Institute (NHGRI), Award R01RR025030 from National Center for Research Resources (NCRR) and CAMERA project funded by Gordon and Betty Moore Foundation. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NHGRI, NCRR or the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anthony RM, 2006, NAT MED, V12, P955, DOI 10.1038/nm1451; Artis D, 2004, P NATL ACAD SCI USA, V101, P13596, DOI 10.1073/pnas.0404034101; Bager P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022346; Boes J, 2000, PARASITOLOGY, V121, pS97, DOI 10.1017/S003118200000648X; Cliffe LJ, 2005, SCIENCE, V308, P1463, DOI 10.1126/science.1108661; Cox MP, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-485; Dawson HD, 2012, MINIPIG IN BIOMEDICAL RESEARCH, P323; Dawson HD, 2005, INFECT IMMUN, V73, P1116, DOI 10.1128/IAI.73.2.1116-1128.2005; Famularo G, 2003, CURR PHARM DESIGN, V9, P1973, DOI 10.2174/1381612033454207; Festi D, 2011, DIGEST DIS, V29, P518, DOI 10.1159/000332975; Glass EM, 2010, COLD SPRING HARB PRO; Hasnain SZ, 2011, J EXP MED, V208, P893, DOI 10.1084/jem.20102057; HIGUCHI R, 1993, BIO-TECHNOL, V11, P1026, DOI 10.1038/nbt0993-1026; Khodoun M, 2009, J ALLERGY CLIN IMMUN, V123, P342, DOI 10.1016/j.jaci.2008.11.004; Kringel H, 2006, INT J PARASITOL, V36, P915, DOI 10.1016/j.ijpara.2006.04.008; Kringel H, 2006, VET PARASITOL, V139, P132, DOI 10.1016/j.vetpar.2006.03.002; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li RW, 2012, ENVIRON MICROBIOL, V14, P129, DOI 10.1111/j.1462-2920.2011.02543.x; Li RW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024417; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Li RW, 2012, INFECT IMMUNITY; Liu B, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-S2-S4; Mansfield LS, 2004, COMPARATIVE MED, V54, P514; Mansfield LS, 2003, AM J TROP MED HYG, V68, P70; Mansfield LS, 1996, VET IMMUNOL IMMUNOP, V50, P1, DOI 10.1016/0165-2427(95)05482-0; Meyer F, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-386; Morimoto M, 2006, J IMMUNOL, V176, P491, DOI 10.4049/jimmunol.176.1.491; Nair MG, 2008, J IMMUNOL, V181, P4709, DOI 10.4049/jimmunol.181.7.4709; Neeb ZP, 2010, COMPARATIVE MED, V60, P300; Parthasarathy G, 2009, MICROB PATHOGENESIS, V47, P38, DOI 10.1016/j.micpath.2009.04.011; Rho MN, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq747; Roepstorff A, 2011, VET PARASITOL, V180, P72, DOI 10.1016/j.vetpar.2011.05.029; Seksik P, 2003, GUT, V52, P237, DOI 10.1136/gut.52.2.237; Shanahan F, 2001, GASTROENTEROLOGY, V120, P622, DOI 10.1053/gast.2001.22122; Shin JL, 2004, CAN J GASTROENTEROL, V18, P175, DOI 10.1155/2004/298064; Stephenson LS, 2000, PARASITOLOGY, V121, pS73, DOI 10.1017/S0031182000006867; Suen G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018814; Summers RW, 2005, GASTROENTEROLOGY, V128, P825, DOI 10.1053/j.gastro.2005.01.005; Summers RW, 2003, AM J GASTROENTEROL, V98, P2034, DOI [10.1016/S0002-9270(03)00623-3, 10.1111/j.1572-0241.2003.07660.x]; Van Kruiningen HJ, 2005, INFLAMM BOWEL DIS, V11, P515, DOI 10.1097/01.MIB.0000160369.47671.a2; White JR, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000352; Wilson MS, 2011, GASTROENTEROLOGY, V140, P254, DOI 10.1053/j.gastro.2010.09.047; Xu J, 2007, PLOS BIOL, V5, P1574, DOI 10.1371/journal.pbio.0050156; Young VB, 2011, CURRENT OPINION GAST; Zaiss DM, 2006, SCIENCE, V314, P1746, DOI 10.1126/science.1133715; Zhao AP, 2008, GASTROENTEROLOGY, V135, P217, DOI 10.1053/j.gastro.2008.03.077; Zheng J, 2008, INFECT IMMUN, V76, P4498, DOI 10.1128/IAI.01317-07	47	86	88	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2012	7	4							e35470	10.1371/journal.pone.0035470	http://dx.doi.org/10.1371/journal.pone.0035470			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UD	22532855	Green Published, gold, Green Submitted			2022-12-25	WOS:000305339200068
J	Mizutani, R; Wakamatsu, A; Tanaka, N; Yoshida, H; Tochigi, N; Suzuki, Y; Oonishi, T; Tani, H; Tano, K; Ijiri, K; Isogai, T; Akimitsu, N				Mizutani, Rena; Wakamatsu, Ai; Tanaka, Noriyuki; Yoshida, Hiroshi; Tochigi, Naobumi; Suzuki, Yoshio; Oonishi, Tadahiro; Tani, Hidenori; Tano, Keiko; Ijiri, Kenichi; Isogai, Takao; Akimitsu, Nobuyoshi			Identification and Characterization of Novel Genotoxic Stress-Inducible Nuclear Long Noncoding RNAs in Mammalian Cells	PLOS ONE			English	Article							DOSAGE COMPENSATION; MESSENGER-RNAS; HUMAN GENOME; GENE; TRANSCRIPTION; EXPRESSION; CHROMATIN; PATHWAYS; DECAY	Whole transcriptome analyses have revealed a large number of novel transcripts including long and short noncoding RNAs (ncRNAs). Currently, there is great interest in characterizing the functions of the different classes of ncRNAs and their relevance to cellular processes. In particular, nuclear long ncRNAs may be involved in controlling various aspects of biological regulation, such as stress responses. By a combination of bioinformatic and experimental approaches, we identified 25 novel nuclear long ncRNAs from 6,088,565 full-length human cDNA sequences. Some nuclear long ncRNAs were conserved among vertebrates, whereas others were found only among primates. Expression profiling of the nuclear long ncRNAs in human tissues revealed that most were expressed ubiquitously. A subset of the identified nuclear long ncRNAs was induced by the genotoxic agents mitomycin C or doxorubicin, in HeLa Tet-off cells. There were no commonly altered nuclear long ncRNAs between mitomycin C- and doxorubicin-treated cells. These results suggest that distinct sets of nuclear long ncRNAs play roles in cellular defense mechanisms against specific genotoxic agents, and that particular long ncRNAs have the potential to be surrogate indicators of a specific cell stress.	[Mizutani, Rena; Tani, Hidenori; Tano, Keiko; Ijiri, Kenichi; Akimitsu, Nobuyoshi] Univ Tokyo, Radioisotope Ctr, Tokyo, Japan; [Wakamatsu, Ai; Isogai, Takao] Univ Tokyo, Grad Sch Pharmaceut Sci, Tokyo, Japan; [Tanaka, Noriyuki; Yoshida, Hiroshi; Tochigi, Naobumi; Suzuki, Yoshio] Asahi Gen Hosp, Chiba, Japan; [Oonishi, Tadahiro] Med Consultat Off Inc, Yokohama, Kanagawa, Japan	University of Tokyo; University of Tokyo	Mizutani, R (corresponding author), Univ Tokyo, Radioisotope Ctr, Tokyo, Japan.	akimitsu@ric.u-tokyo.ac.jp	Tani, Hidenori/F-2042-2010; Tani, Hidenori/A-7175-2017	Tani, Hidenori/0000-0001-6390-4136; Tani, Hidenori/0000-0001-6390-4136	Takeda Science Foundation; Naito Foundation; Japan Society for the Promotion of Science	Takeda Science Foundation(Takeda Science Foundation (TSF)); Naito Foundation(Naito Memorial Foundation); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was financially supported by the Takeda Science Foundation, the Naito Foundation, and Grants-in-Aid for Scientific Research and a Research Fellowship from the Japan Society for the Promotion of Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker KE, 2004, CURR OPIN CELL BIOL, V16, P293, DOI 10.1016/j.ceb.2004.03.003; BALABAN N, 1995, FEMS MICROBIOL LETT, V133, P155, DOI 10.1016/0378-1097(95)00356-A; Bernard D, 2010, EMBO J, V29, P3082, DOI 10.1038/emboj.2010.199; Bertone P, 2004, SCIENCE, V306, P2242, DOI 10.1126/science.1103388; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Brosnan CA, 2009, CURR OPIN CELL BIOL, V21, P416, DOI 10.1016/j.ceb.2009.04.001; Cabili MN, 2011, GENE DEV, V25, P1915, DOI 10.1101/gad.17446611; Chen LL, 2009, MOL CELL, V35, P467, DOI 10.1016/j.molcel.2009.06.027; Cheng J, 2005, SCIENCE, V308, P1149, DOI 10.1126/science.1108625; Clemson CM, 2009, MOL CELL, V33, P717, DOI 10.1016/j.molcel.2009.01.026; Ebisuya M, 2008, NAT CELL BIOL, V10, P1106, DOI 10.1038/ncb1771; Emberley E, 2003, BIOCHEM BIOPH RES CO, V301, P509, DOI 10.1016/S0006-291X(02)03070-X; Erwin JA, 2008, CURR OPIN CELL BIOL, V20, P349, DOI 10.1016/j.ceb.2008.04.007; Faghihi MA, 2008, NAT MED, V14, P723, DOI 10.1038/nm1784; Fejes-Toth K, 2009, NATURE, V457, P1028, DOI 10.1038/nature07759; Frith MC, 2006, PLOS GENET, V2, P515, DOI 10.1371/journal.pgen.0020052; Guttman M, 2011, NATURE, V477, P295, DOI 10.1038/nature10398; Hanyu-Nakamura K, 2008, NATURE, V451, P730, DOI 10.1038/nature06498; He F, 2003, MOL CELL, V12, P1439, DOI 10.1016/S1097-2765(03)00446-5; Heard E, 2006, GENE DEV, V20, P1848, DOI 10.1101/gad.1422906; Huarte M, 2010, CELL, V142, P409, DOI 10.1016/j.cell.2010.06.040; Jolly C, 2004, J CELL BIOL, V164, P25, DOI 10.1083/jcb.200306104; Jolly C, 2006, NUCLEIC ACIDS RES, V34, P5508, DOI 10.1093/nar/gkl711; Kikuchi K, 2009, NUCLEIC ACIDS RES, V37, P4987, DOI 10.1093/nar/gkp426; Kondo T, 2007, NAT CELL BIOL, V9, P660, DOI 10.1038/ncb1595; Kotake Y, 2011, ONCOGENE, V30, P1956, DOI 10.1038/onc.2010.568; Kultz D, 2005, ANNU REV PHYSIOL, V67, P225, DOI 10.1146/annurev.physiol.67.040403.103635; Leung AKL, 2010, MOL CELL, V40, P205, DOI 10.1016/j.molcel.2010.09.027; Lindblad-Toh K, 2011, NATURE, V478, P476, DOI 10.1038/nature10530; Mattick JS, 2011, SCIENCE, V331, P874, DOI 10.1126/science.1203703; Mattick JS, 2004, NAT REV GENET, V5, P316, DOI 10.1038/nrg1321; Nagalakshmi U, 2008, SCIENCE, V320, P1344, DOI 10.1126/science.1158441; Pandey RR, 2008, MOL CELL, V32, P232, DOI 10.1016/j.molcel.2008.08.022; Payer B, 2008, ANNU REV GENET, V42, P733, DOI 10.1146/annurev.genet.42.110807.091711; Preker P, 2008, SCIENCE, V322, P1851, DOI 10.1126/science.1164096; Quiles JL, 2002, TOXICOLOGY, V180, P79, DOI 10.1016/S0300-483X(02)00383-9; Quinones A, 2001, MUTAT RES-GEN TOX EN, V494, P73, DOI 10.1016/S1383-5718(01)00179-6; Rajski SR, 1998, CHEM REV, V98, P2723, DOI 10.1021/cr9800199; Rinn JL, 2007, CELL, V129, P1311, DOI 10.1016/j.cell.2007.05.022; Rizzi N, 2004, MOL BIOL CELL, V15, P543, DOI 10.1091/mbc.E03-07-0487; Sasaki YTF, 2007, BIOCHEM BIOPH RES CO, V357, P991, DOI 10.1016/j.bbrc.2007.04.034; Sasaki YTF, 2009, P NATL ACAD SCI USA, V106, P2525, DOI 10.1073/pnas.0807899106; Seila AC, 2008, SCIENCE, V322, P1849, DOI 10.1126/science.1162253; Sonkoly E, 2005, J BIOL CHEM, V280, P24159, DOI 10.1074/jbc.M501704200; Sunwoo H, 2009, GENOME RES, V19, P347, DOI 10.1101/gr.087775.108; Tano K, 2010, FEBS LETT, V584, P4575, DOI 10.1016/j.febslet.2010.10.008; Tsai MC, 2010, SCIENCE, V329, P689, DOI 10.1126/science.1192002; vandeSande K, 1996, SCIENCE, V273, P370, DOI 10.1126/science.273.5273.370; Wadler CS, 2007, P NATL ACAD SCI USA, V104, P20454, DOI 10.1073/pnas.0708102104; Wakamatsu A, 2009, DNA RES, V16, P371, DOI 10.1093/dnares/dsp022; Wilhelm BT, 2008, NATURE, V453, P1239, DOI 10.1038/nature07002; Wyers F, 2005, CELL, V121, P725, DOI 10.1016/j.cell.2005.04.030; Yap KL, 2010, MOL CELL, V38, P662, DOI 10.1016/j.molcel.2010.03.021; Yu WQ, 2008, NATURE, V451, P202, DOI 10.1038/nature06468	54	44	45	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2012	7	4							e34949	10.1371/journal.pone.0034949	http://dx.doi.org/10.1371/journal.pone.0034949			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TL	22532836	Green Submitted, Green Published, gold			2022-12-25	WOS:000305336200016
J	Wu, Y; Zhang, C; Dong, YZ; Wang, SX; Song, P; Viollet, B; Zou, MH				Wu, Yong; Zhang, Cheng; Dong, Yunzhou; Wang, Shuangxi; Song, Ping; Viollet, Benoit; Zou, Ming-Hui			Activation of the AMP-Activated Protein Kinase by Eicosapentaenoic Acid (EPA, 20:5 n-3) Improves Endothelial Function In Vivo	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; UNCOUPLING PROTEIN-2; FATTY-ACIDS; MALONYL-COA; FISH-OIL; INSULIN-RESISTANCE; ENERGY-CHARGE; CELLS; EXPRESSION; METFORMIN	The aim of the present study was to test the hypothesis that the cardiovascular-protective effects of eicosapentaenoic acid (EPA) may be due, in part, to its ability to stimulate the AMP-activated protein kinase (AMPK)-induced endothelial nitric oxide synthase (eNOS) activation. The role of AMPK in EPA-induced eNOS phosphorylation was investigated in bovine aortic endothelial cells (BAEC), in mice deficient of either AMPK alpha 1 or AMPK alpha 2, in eNOS knockout (KO) mice, or in Apo-E/AMPK alpha 1 dual KO mice. EPA-treatment of BAEC increased both AMPK-Thr172 phosphorylation and AMPK activity, which was accompanied by increased eNOS phosphorylation, NO release, and upregulation of mitochondrial uncoupling protein-2 (UCP-2). Pharmacologic or genetic inhibition of AMPK abolished EPA-enhanced NO release and eNOS phosphorylation in HUVEC. This effect of EPA was absent in the aortas isolated from either eNOS KO mice or AMPK alpha 1 KO mice fed a high-fat, high-cholesterol (HFHC) diet. EPA via upregulation of UCP-2 activates AMPK alpha 1 resulting in increased eNOS phosphorylation and consequent improvement of endothelial function in vivo.	[Wu, Yong; Zhang, Cheng; Dong, Yunzhou; Wang, Shuangxi; Song, Ping; Zou, Ming-Hui] Univ Oklahoma, Hlth Sci Ctr, Dept Med, Div Endocrinol & Diabet, Oklahoma City, OK 73190 USA; [Viollet, Benoit] Univ Paris 05, CNRS, INSERM, Dept Genet Dev & Pathol Mol,Inst Cochil,U567, F-75270 Paris, France	University of Oklahoma System; University of Oklahoma Health Sciences Center; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Wu, Y (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Dept Med, Div Endocrinol & Diabet, Oklahoma City, OK 73190 USA.	ming-hui-zou@ouhsc.edu	Viollet, Benoit/N-2397-2019; Viollet, Benoit/O-6927-2017; Song, Ping/N-8456-2018	Viollet, Benoit/0000-0002-0121-0224; Viollet, Benoit/0000-0002-0121-0224; Song, Ping/0000-0002-6143-4270	National Institutes of Health [HL079584, HL080499, HL07439, HL089920, HL096032, HL105157, HL110448]; National Established Investigator of the American Heart Association; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL079584, R01HL096032, R01HL089920, R01HL105157, R43HL110448, R01HL080499, R01HL110488, T32HL007439] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Established Investigator of the American Heart Association; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health Grants (HL079584, HL080499, HL07439, HL089920, HL096032, HL105157, and HL110448). MZ is a recipient of the National Established Investigator of the American Heart Association. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander JW, 1998, NUTRITION, V14, P627, DOI 10.1016/S0899-9007(98)00004-5; Armstrong MB, 2001, AM J PHYSIOL-ENDOC M, V281, pE1197, DOI 10.1152/ajpendo.2001.281.6.E1197; Aubert J, 1997, BIOCHEM BIOPH RES CO, V238, P606, DOI 10.1006/bbrc.1997.7348; Camirand A, 1998, ENDOCRINOLOGY, V139, P428, DOI 10.1210/en.139.1.428; Chen H, 2003, J BIOL CHEM, V278, P45021, DOI 10.1074/jbc.M307878200; Chen LY, 2000, J CARDIOVASC PHARM, V35, P502, DOI 10.1097/00005344-200003000-00022; Choi HC, 2008, J BIOL CHEM, V283, P20186, DOI 10.1074/jbc.M803020200; Connor SL, 1997, AM J CLIN NUTR, V66, P1020; Davignon J, 2004, CIRCULATION, V109, P27, DOI 10.1161/01.CIR.0000131515.03336.f8; Davis BJ, 2006, DIABETES, V55, P496, DOI 10.2337/diabetes.55.02.06.db05-1064; Dimmeler S, 1999, NATURE, V399, P601, DOI 10.1038/21224; Dulloo AG, 2001, BRIT J NUTR, V86, P123, DOI 10.1079/BJN2001412; Hardie DG, 2001, BIOESSAYS, V23, P1112, DOI 10.1002/bies.10009; Hardie DG, 1999, BIOCHEM J, V338, P717, DOI 10.1042/0264-6021:3380717; HARRIS WS, 1989, J LIPID RES, V30, P785; Hawley SA, 1996, J BIOL CHEM, V271, P27879, DOI 10.1074/jbc.271.44.27879; Hawley Simon A, 2003, J Biol, V2, P28, DOI 10.1186/1475-4924-2-28; Hennig B, 1996, J AM COLL NUTR, V15, P345; Hu HB, 2004, AM J PHYSIOL-LUNG C, V286, pL1066, DOI 10.1152/ajplung.00378.2003; Hurley RL, 2005, J BIOL CHEM, V280, P29060, DOI 10.1074/jbc.M503824200; Johansen O, 1999, ARTERIOSCL THROM VAS, V19, P1681, DOI 10.1161/01.ATV.19.7.1681; Kemp BE, 2003, BIOCHEM SOC T, V31, P162; Krauss RM, 2000, CIRCULATION, V102, P2284; Kris-Etherton PM, 2002, CIRCULATION, V106, P2747, DOI 10.1161/01.CIR.0000038493.65177.94; Lizcano JM, 2004, EMBO J, V23, P833, DOI 10.1038/sj.emboj.7600110; Marfella R, 1996, DIABETES CARE, V19, P934, DOI 10.2337/diacare.19.9.934; Marx N, 1999, ARTERIOSCL THROM VAS, V19, P546, DOI 10.1161/01.ATV.19.3.546; Mattiasson G, 2006, ANTIOXID REDOX SIGN, V8, P1, DOI 10.1089/ars.2006.8.1; McBride A, 2009, CELL METAB, V9, P23, DOI 10.1016/j.cmet.2008.11.008; MCVEIGH GE, 1994, ARTERIOSCLER THROMB, V14, P1425, DOI 10.1161/01.ATV.14.9.1425; Medvedev AV, 2001, J BIOL CHEM, V276, P10817, DOI 10.1074/jbc.M010587200; Nishimura M, 2000, CLIN EXP PHARMACOL P, V27, P618, DOI 10.1046/j.1440-1681.2000.03311.x; Ogita H, 2003, J CARDIOVASC PHARM, V41, P964, DOI 10.1097/00005344-200306000-00020; Ouchi N, 2004, J BIOL CHEM, V279, P1304, DOI 10.1074/jbc.M310389200; Park H, 2002, J BIOL CHEM, V277, P32571, DOI 10.1074/jbc.M201692200; Patane G, 2002, DIABETES, V51, P2749, DOI 10.2337/diabetes.51.9.2749; Reilly JM, 2000, BIOCHEM BIOPH RES CO, V277, P541, DOI 10.1006/bbrc.2000.3705; Rotstein NP, 1996, J NEUROCHEM, V66, P1851; Ruderman NB, 1999, AM J PHYSIOL-ENDOC M, V276, pE1, DOI 10.1152/ajpendo.1999.276.1.E1; Ruderman NB, 2003, BIOCHEM SOC T, V31, P202, DOI 10.1042/bst0310202; Saraswathi V, 2004, J LIPID RES, V45, P794, DOI 10.1194/jlr.M300497-JLR200; Schulz E, 2005, CIRCULATION, V111, P3473, DOI 10.1161/CIRCULATIONAHA.105.546812; Stahmann N, 2006, MOL CELL BIOL, V26, P5933, DOI 10.1128/MCB.00383-06; TURNER RC, 1995, DIABETES RES CLIN PR, V28, pS151, DOI 10.1016/0168-8227(95)01105-M; Turner RC, 1998, LANCET, V352, P854, DOI 10.1016/s0140-6736(98)07037-8; Wu GY, 2002, ANNU REV NUTR, V22, P61, DOI 10.1146/annurev.nutr.22.110901.145329; Zhang YJ, 2006, ARTERIOSCL THROM VAS, V26, P1281, DOI 10.1161/01.ATV.0000221230.08596.98; Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI200113505; Zou MH, 2004, J BIOL CHEM, V279, P43940, DOI 10.1074/jbc.M404421200; Zou MH, 2003, J BIOL CHEM, V278, P34003, DOI 10.1074/jbc.M300215200; Zou MH, 2002, J BIOL CHEM, V277, P32552, DOI 10.1074/jbc.M204512200	51	42	45	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2012	7	4							e35508	10.1371/journal.pone.0035508	http://dx.doi.org/10.1371/journal.pone.0035508			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TL	22532857	Green Published, gold, Green Submitted			2022-12-25	WOS:000305336200049
J	Ackers, ML; Greenberg, AE; Lin, CY; Bartholow, BN; Goodman, AH; Longhi, M; Gurwith, M				Ackers, Marta-Louise; Greenberg, Alan E.; Lin, Carol Y.; Bartholow, Bradford N.; Goodman, Adrian Hirsch; Longhi, Michael; Gurwith, Marc			High and Persistent HIV Seroincidence in Men Who Have Sex with Men across 47 US Cities	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS VACCINE; SEXUALLY-TRANSMITTED-DISEASES; RISK BEHAVIOR; YOUNG MEN; SUBSTANCE USE; DRUG-USE; HOMOSEXUAL-MEN; SAN-FRANCISCO; UNITED-STATES; ANAL SEX	Objective: To provide HIV seroincidence data among men who have sex with men (MSM) in the United States and to identify predictive factors for seroconversion. Methods: From 1998-2002, 4684 high-risk MSM, age 18-60 years, participated in a randomized, placebo-controlled HIV vaccine efficacy trial at 56 U. S. clinical trial sites. Demographics, behavioral data, and HIV status were assessed at baseline and 6 month intervals. Since no overall vaccine efficacy was detected, data were combined from both trial arms to calculate HIV incidence based on person-years (py) of follow-up. Predictors of seroconversion, adjusted hazards ratio (aHR), were evaluated using a Cox proportional hazard model with time-varying covariates. Results: Overall, HIV incidence was 2.7/100 py and was relatively uniform across study sites and study years. HIV incidence was highest among young men and men reporting unprotected sex, recreational drug use, and a history of a sexually transmitted infection. Independent predictors of HIV seroconversion included: age 18-30 years (aHR = 2.4; 95% CI 1.4,4.0), having >10 partners (aHR = 2.4; 95% CI 1.7,3.3), having a known HIV-positive male sex partner (aHR = 1.6; 95% CI 1.2, 2.0), unprotected anal intercourse with HIV positive/unknown male partners (aHR = 1.7; 95% CI 1.3, 2.3), and amphetamine (aHR = 1.6; 95% CI 1.1, 2.1) and popper (aHR = 1.7; 95% CI 1.3, 2.2) use. Conclusions: HIV seroincidence was high among MSM despite repeated HIV counseling and reported declines in sexual risk behaviors. Continuing development of new HIV prevention strategies and intensification of existing efforts will be necessary to reduce the rate of new HIV infections, especially among young men.	[Ackers, Marta-Louise; Greenberg, Alan E.; Lin, Carol Y.; Bartholow, Bradford N.] Ctr Dis Control & Prevent, Natl Ctr HIV STD & TB Prevent, Div HIV AIDS Prevent, Epidemiol Branch, Atlanta, GA USA; [Lin, Carol Y.] Ctr Dis Control & Prevent, Natl Ctr HIV STD & TB Prevent, Div HIV AIDS Prevent, Quantitat Sci & Data Management Branch, Atlanta, GA USA; [Goodman, Adrian Hirsch; Longhi, Michael; Gurwith, Marc] VaxGen Inc, Brisbane, CA USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA	Ackers, ML (corresponding author), Ctr Dis Control & Prevent, Div Global HIV AIDS, Atlanta, GA 30333 USA.	mda6@cdc.gov			VaxGen, Inc.; US Centers for Disease Control and Prevention	VaxGen, Inc.; US Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	This work was supported by VaxGen, Inc., and US Centers for Disease Control and Prevention. No funding bodies had any role in the study design, data collection, analysis, decision to publish or preparation of the manuscript.	Sifakis F., 2005, Morbidity and Mortality Weekly Report, V54, P597; Centers of Disease Control and Prevention, 2001, MMWR Recomm Rep, V50, P1, DOI 10.1103/PhysRevE.106.055304; Bartholow BN, 2005, JAIDS-J ACQ IMM DEF, V39, P90, DOI 10.1097/01.qai.0000143600.41363.78; Benotsch EG, 2002, ARCH SEX BEHAV, V31, P177, DOI 10.1023/A:1014739203657; Buchacz K, 2008, JAIDS-J ACQ IMM DEF, V47, P234, DOI 10.1097/QAI.0b013e31815e4011; Buchbinder SP, 1996, J INFECT DIS, V174, P954, DOI 10.1093/infdis/174.5.954; BURCHAM JL, 1989, MED J AUSTRALIA, V150, P634, DOI 10.5694/j.1326-5377.1989.tb136727.x; Catania JA, 2001, AM J PUBLIC HEALTH, V91, P907, DOI 10.2105/AJPH.91.6.907; CDC, 2001, HIV SURV REP, V21; Centers for Disease Control and Prevention (CDC), 2002, MMWR Morb Mortal Wkly Rep, V51, P853; Centers for Disease Control and Prevention (CDC), 2003, MMWR Morb Mortal Wkly Rep, V52, P1117; Centers for Disease Control and Prevention (CDC), 2001, MMWR Morb Mortal Wkly Rep, V50, P117; Centers for Disease Control and Prevention (CDC), 2001, MMWR Morb Mortal Wkly Rep, V50, P440; Chen SY, 2002, AM J PUBLIC HEALTH, V92, P1387, DOI 10.2105/AJPH.92.9.1387-a; Clatts MC, 2005, J URBAN HEALTH, V82, pI9, DOI 10.1093/jurban/jti019; Cohen J, 2003, SCIENCE, V300, P28; Cohen MS, 2011, NEW ENGL J MED, V365, P493, DOI [10.1056/NEJMoa1105243, 10.1056/NEJMoa1600693]; Colfax G, 2005, J URBAN HEALTH, V82, pI62, DOI 10.1093/jurban/jti025; Colfax GN, 2001, J ACQ IMMUN DEF SYND, V28, P373, DOI 10.1097/00126334-200112010-00011; Crepaz N, 2000, AIDS EDUC PREV, V12, P405; Ekstrand ML, 1999, AIDS, V13, P1525, DOI 10.1097/00002030-199908200-00013; Fernandez MI, 2005, J URBAN HEALTH, V82, pI79, DOI 10.1093/jurban/jti027; Fernyak SE, 2002, JAIDS-J ACQ IMM DEF, V31, P63, DOI 10.1097/00126334-200209010-00009; Flores SA, 2009, AIDS EDUC PREV, V21, P91, DOI 10.1521/aeap.2009.21.2.91; Flynn MN, 2005, J INFECT DIS, V191, P654, DOI 10.1086/428404; Garofalo R, 2007, AM J PUBLIC HEALTH, V97, P1113, DOI 10.2105/AJPH.2005.075630; Golden MR, 2004, JAIDS-J ACQ IMM DEF, V36, P734, DOI 10.1097/00126334-200406010-00011; Grant RM, 2010, NEW ENGL J MED, V363, P2587, DOI 10.1056/NEJMoa1011205; Hall HI, 2008, JAMA-J AM MED ASSOC, V300, P520, DOI 10.1001/jama.300.5.520; Harro CD, 2004, JAIDS-J ACQ IMM DEF, V37, P1385, DOI 10.1097/01.qai.0000122983.87519.b5; Hirshfield S, 2004, AIDS CARE, V16, P1036, DOI 10.1080/09540120412331292525; Holmberg SD, 1996, AM J PUBLIC HEALTH, V86, P642, DOI 10.2105/AJPH.86.5.642; Kim AA, 2001, J ACQ IMMUN DEF SYND, V28, P89; Koblin B, 2004, LANCET, V364, P41, DOI 10.1016/S0140-6736(04)16588-4; Koblin BA, 2000, AIDS, V14, P1793, DOI 10.1097/00002030-200008180-00015; Koblin BA, 2006, AIDS, V20, P731, DOI 10.1097/01.aids.0000216374.61442.55; Mansergh G, 2006, SEX TRANSM INFECT, V82, P131, DOI 10.1136/sti.2005.017129; Mansergh G, 1998, AIDS, V12, P1119, DOI 10.1097/00002030-199810000-00003; McFarlane M, 2000, JAMA-J AM MED ASSOC, V284, P443, DOI 10.1001/jama.284.4.443; McNall M, 1999, ARCH PEDIAT ADOL MED, V153, P1130, DOI 10.1001/archpedi.153.11.1130; Metsch LR, 2008, CLIN INFECT DIS, V47, P577, DOI 10.1086/590153; MORRIS M, 1995, AIDS EDUC PREV, V7, P24; Oster Alexandra M., 2011, Morbidity and Mortality Weekly Report, V60, P694; PageShafer K, 1997, AM J EPIDEMIOL, V146, P531, DOI 10.1093/oxfordjournals.aje.a009311; Prejean J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017502; Rietmeijer CA, 2003, SEX TRANSM DIS, V30, P15, DOI 10.1097/00007435-200301000-00004; Rusch M, 2004, SEX TRANSM DIS, V31, P492, DOI 10.1097/01.olq.0000135991.21755.18; Seage GR, 2001, AM J EPIDEMIOL, V153, P619, DOI 10.1093/aje/153.7.619; Smith A., 2010, Morbidity and Mortality Weekly Report, V59, P1201; Stone E, 1999, J ACQ IMMUN DEF SYND, V20, P495, DOI 10.1097/00042560-199904150-00013; Sullivan PS, 2009, ANN EPIDEMIOL, V19, P423, DOI 10.1016/j.annepidem.2009.03.004; Valleroy LA, 2000, JAMA-J AM MED ASSOC, V284, P198, DOI 10.1001/jama.284.2.198; Weber AE, 2003, AIDS, V17, P774, DOI 10.1097/00002030-200303280-00024; Weinstock H, 1998, J ACQ IMMUN DEF SYND, V19, P506, DOI 10.1097/00042560-199812150-00010; Woody GE, 1999, DRUG ALCOHOL DEPEN, V53, P197, DOI 10.1016/S0376-8716(98)00134-3; Workowski Kimberly A, 2010, MMWR Recomm Rep, V59, P1	56	43	48	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2012	7	4							e34972	10.1371/journal.pone.0034972	http://dx.doi.org/10.1371/journal.pone.0034972			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959XD	22529964	Green Published, gold			2022-12-25	WOS:000305350600049
J	Bribian, A; Fontana, X; Llorens, F; Gavin, R; Reina, M; Garcia-Verdugo, JM; Torres, JM; de Castro, F; del Rio, JA				Bribian, Ana; Fontana, Xavier; Llorens, Franc; Gavin, Rosalina; Reina, Manuel; Manuel Garcia-Verdugo, Jose; Maria Torres, Juan; de Castro, Fernando; Antonio del Rio, Jose			Role of the Cellular Prion Protein in Oligodendrocyte Precursor Cell Proliferation and Differentiation in the Developing and Adult Mouse CNS	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; PROGENITOR CELLS; GLIA GENERATE; PSA-NCAM; EXPRESSION; MIGRATION; MICE; PRPC; LINEAGE; PROTEOGLYCAN	There are numerous studies describing the signaling mechanisms that mediate oligodendrocyte precursor cell (OPC) proliferation and differentiation, although the contribution of the cellular prion protein (PrPc) to this process remains unclear. PrPc is a glycosyl-phosphatidylinositol (GPI)-anchored glycoprotein involved in diverse cellular processes during the development and maturation of the mammalian central nervous system (CNS). Here we describe how PrPc influences oligodendrocyte proliferation in the developing and adult CNS. OPCs that lack PrPc proliferate more vigorously at the expense of a delay in differentiation, which correlates with changes in the expression of oligodendrocyte lineage markers. In addition, numerous NG2-positive cells were observed in cortical regions of adult PrPc knockout mice, although no significant changes in myelination can be seen, probably due to the death of surplus cells.	[Bribian, Ana; Llorens, Franc; Antonio del Rio, Jose] Catalonian Inst Bioengn IBEC, Barcelona, Spain; [Bribian, Ana; Fontana, Xavier; Llorens, Franc; Gavin, Rosalina; Reina, Manuel; Antonio del Rio, Jose] Univ Barcelona, Dept Cell Biol, Barcelona, Spain; [Bribian, Ana; Llorens, Franc; Gavin, Rosalina; Antonio del Rio, Jose] Ctr Invest Biomed Red Sobre Enfermedades Neurodeg, Barcelona, Spain; [Manuel Garcia-Verdugo, Jose] Univ Valencia, Inst Cabanillas Biodiversidad & Biol Evolutiva, Lab Neurobiol Comparada, Valencia, Spain; [Maria Torres, Juan] Ctr Invest Sanidad Anim CISA INIA, Madrid, Spain; [de Castro, Fernando] Hosp Nacl Paraplejicos, Unidad Neurol Expt, GNDe Grp Neurobiol Desarrollo, Toledo, Spain; [de Castro, Fernando] Inst Cajal CSIC, Madrid, Spain	Barcelona Institute of Science & Technology; Institut de Bioenginyeria de Catalunya; University of Barcelona; CIBERNED; University of Valencia; Hospital Nacional de Paraplejicos; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto Cajal (IC)	Bribian, A (corresponding author), Catalonian Inst Bioengn IBEC, Parc Cientific Barcelona, Barcelona, Spain.	jadelrio@ibec.pcb.ub.es	del rio, jose antonio/L-9232-2014; Bribian, Ana/M-2978-2014; García-Verdugo, José Manuel/L-8421-2017; Torres, Juan Maria/L-8768-2013; Gavín, Rosalina/D-4341-2014; Del Rio Fernandez, Jose A/AAD-1121-2020; de Castro, Fernando/Q-8624-2018; Reina, Manuel/D-4655-2014	del rio, jose antonio/0000-0002-5214-4909; García-Verdugo, José Manuel/0000-0001-9872-6499; Torres, Juan Maria/0000-0003-0443-9232; Gavín, Rosalina/0000-0003-1982-2162; de Castro, Fernando/0000-0002-7018-8032; Reina, Manuel/0000-0002-0701-200X; , Franc/0000-0002-9756-7497	Instituto de Salud Carlos III, MICINN [BFU2009-10848, SAF2009-07845]; FP7-PRIORITY; Generalitat of Catalunya [SGR2009-366]; FISCAM [PAI08-0242-3822]	Instituto de Salud Carlos III, MICINN(Instituto de Salud Carlos IIIMinistry of Science and Innovation, Spain (MICINN)Spanish Government); FP7-PRIORITY; Generalitat of Catalunya(Generalitat de Catalunya); FISCAM	This work was supported by grants from the Instituto de Salud Carlos III, MICINN (BFU2009-10848 to JADR and SAF2009-07845 to FdC), FP7-PRIORITY, Generalitat of Catalunya (SGR2009-366) to JAD and FISCAM (PAI08-0242-3822) to FDC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirre A, 2007, NEURON GLIA BIOL, V3, P209, DOI 10.1017/S1740925X08000082; Bailly Y, 2004, J COMP NEUROL, V473, P244, DOI 10.1002/cne.20117; Bainbridge J, 2005, IMMUNOL LETT, V96, P147, DOI 10.1016/j.imlet.2004.08.006; Barmada S, 2004, NEUROBIOL DIS, V16, P527, DOI 10.1016/j.nbd.2004.05.005; BARRES BA, 1993, CURR BIOL, V3, P489, DOI 10.1016/0960-9822(93)90039-Q; Belachew S, 2002, J NEUROSCI, V22, P8553; Bonfanti L, 2006, PROG NEUROBIOL, V80, P129, DOI 10.1016/j.pneurobio.2006.08.003; Bremer J, 2010, NAT NEUROSCI, V13, P310, DOI 10.1038/nn.2483; Bribian A, 2006, MOL CELL NEUROSCI, V33, P2, DOI 10.1016/j.mcn.2006.05.009; Brown DR, 1998, NEUROREPORT, V9, P1425, DOI 10.1097/00001756-199805110-00032; Brown DR, 2002, J NEUROSCI RES, V67, P211, DOI 10.1002/jnr.10118; BUELER H, 1992, NATURE, V356, P577, DOI 10.1038/356577a0; Calver AR, 1998, NEURON, V20, P869, DOI 10.1016/S0896-6273(00)80469-9; Chong SYC, 2010, J CELL BIOL, V188, P305, DOI 10.1083/jcb.200905111; de Castro F, 2005, BRAIN RES REV, V49, P227, DOI 10.1016/j.brainresrev.2004.12.034; DELRIO JA, 1989, DEV BRAIN RES, V49, P311, DOI 10.1016/0165-3806(89)90033-3; Diers-Fenger M, 2001, GLIA, V34, P213, DOI 10.1002/glia.1055; Dimou L, 2008, J NEUROSCI, V28, P10434, DOI 10.1523/JNEUROSCI.2831-08.2008; Etxeberria A, 2010, NAT NEUROSCI, V13, P287, DOI 10.1038/nn.2500; Fontana X, 2006, CEREB CORTEX, V16, P301, DOI 10.1093/cercor/bhi120; Ford MJ, 2002, NEUROSCIENCE, V113, P177, DOI 10.1016/S0306-4522(02)00155-0; Ford MJ, 2002, NEUROSCIENCE, V111, P533, DOI 10.1016/S0306-4522(01)00603-0; FOURNIER JG, 1995, CR ACAD SCI III-VIE, V318, P339; Fujisawa M, 2004, J REPROD DEVELOP, V50, P565, DOI 10.1262/jrd.50.565; GALLO V, 1995, J NEUROSCI, V15, P394; Hermann A, 2010, CELL TISSUE RES, V340, P45, DOI 10.1007/s00441-010-0940-5; Hu W, 2010, BRAIN, V133, P375, DOI 10.1093/brain/awp298; Kang SH, 2010, NEURON, V68, P668, DOI 10.1016/j.neuron.2010.09.009; Karapetyan YE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005730; Karram K, 2005, J ANAT, V207, P735, DOI 10.1111/j.1469-7580.2005.00461.x; Kim BH, 2005, NEUROREPORT, V16, P425, DOI 10.1097/00001756-200504040-00002; Lee YJ, 2010, J NEUROCHEM, V114, P362, DOI 10.1111/j.1471-4159.2010.06601.x; Levine JM, 1996, PERSPECT DEV NEUROBI, V3, P245; Levine JM, 2001, TRENDS NEUROSCI, V24, P39, DOI 10.1016/S0166-2236(00)01691-X; Li RL, 2001, CELL IMMUNOL, V207, P49, DOI 10.1006/cimm.2000.1751; Liang J, 2007, FASEB J, V21, P2247, DOI 10.1096/fj.06-7799com; Liebmann C, 2011, MOL CELL ENDOCRINOL, V331, P222, DOI 10.1016/j.mce.2010.04.008; Ligon KL, 2006, P NATL ACAD SCI USA, V103, P7853, DOI 10.1073/pnas.0511001103; Lin G, 2009, GLIA, V57, P592, DOI 10.1002/glia.20788; Liu T, 2001, BRAIN RES, V896, P118, DOI 10.1016/S0006-8993(01)02050-9; Loubet D, 2011, FASEB J IN PRESS; Lytle JM, 2009, GLIA, V57, P270, DOI 10.1002/glia.20755; MCCARTHY KD, 1980, J CELL BIOL, V85, P890, DOI 10.1083/jcb.85.3.890; Merchan P, 2007, MOL CELL NEUROSCI, V36, P355, DOI 10.1016/j.mcn.2007.07.012; Mingorance A, 2005, MOL CELL NEUROSCI, V29, P471, DOI 10.1016/j.mcn.2005.03.016; Molina-Holgado E, 2002, J NEUROSCI, V22, P9742, DOI 10.1523/jneurosci.22-22-09742.2002; Monnet C, 2004, FEBS LETT, V576, P114, DOI 10.1016/j.febslet.2004.08.076; Morel E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003000; MOSER M, 1995, NEURON, V14, P509, DOI 10.1016/0896-6273(95)90307-0; Nguyen L, 2003, CURR MED CHEM, V10, P2185, DOI 10.2174/0929867033456774; Nishiyama A, 1999, J NEUROPATH EXP NEUR, V58, P1113, DOI 10.1097/00005072-199911000-00001; Nishiyama A, 2009, NAT REV NEUROSCI, V10, P9, DOI 10.1038/nrn2495; Parchi P, 2000, MICROSC RES TECHNIQ, V50, P16, DOI 10.1002/1097-0029(20000701)50:1<16::AID-JEMT4>3.0.CO;2-Y; Pasquini LA, 2003, J NEUROSCI, V23, P4635; Prestori F, 2008, J NEUROSCI, V28, P7091, DOI 10.1523/JNEUROSCI.0409-08.2008; Radovanovic I, 2005, J NEUROSCI, V25, P4879, DOI 10.1523/JNEUROSCI.0328-05.2005; Raff M, 2006, BIOCHEM SOC T, V34, P663, DOI 10.1042/BST0340663; Raff M, 2007, COLD SPRING HARB SYM, V72, P431, DOI 10.1101/sqb.2007.72.007; Raff M, 2001, NOVART FDN SYMP, V237, P100, DOI 10.1002/0470846666.ch9; Raff M., 2001, NOVART FDN SYMP, V237, P158; Rivers LE, 2008, NAT NEUROSCI, V11, P1392, DOI 10.1038/nn.2220; Santos TG, 2011, STEM CELLS, V29, P1126, DOI 10.1002/stem.664; Seki Tatsunori, 2003, Anatomical Science International, V78, P69, DOI 10.1046/j.0022-7722.2003.00043.x; Simons M, 2006, J CELL SCI, V119, P4381, DOI 10.1242/jcs.03242; Sohn J, 2006, J NEUROSCI, V26, P9722, DOI 10.1523/JNEUROSCI.1716-06.2006; SORIANO E, 1991, J HISTOCHEM CYTOCHEM, V39, P255, DOI 10.1177/39.3.1671576; Spassky N, 2002, J NEUROSCI, V22, P5992; Steele AD, 2006, P NATL ACAD SCI USA, V103, P3416, DOI 10.1073/pnas.0511290103; Tichopad A, 2003, MOL CELL PROBE, V17, P5, DOI 10.1016/S0890-8508(02)00114-7; Tripathi RB, 2010, J NEUROSCI, V30, P16383, DOI 10.1523/JNEUROSCI.3411-10.2010; Trotter J, 2010, BRAIN RES REV, V63, P72, DOI 10.1016/j.brainresrev.2009.12.006; Tsutsui S, 2008, AM J PATHOL, V173, P1029, DOI 10.2353/ajpath.2008.071062; von Bohlen und Halbach O, 2011, CELL TISSUE RES, V345, P1, DOI 10.1007/s00441-011-1196-4; WESTAWAY D, 1994, CELL, V76, P117, DOI 10.1016/0092-8674(94)90177-5; Wong BS, 2001, J NEUROCHEM, V76, P565, DOI 10.1046/j.1471-4159.2001.00028.x; Zhang CC, 2006, P NATL ACAD SCI USA, V103, P2184, DOI 10.1073/pnas.0510577103; Zhu XQ, 2008, DEVELOPMENT, V135, P145, DOI 10.1242/dev.004895	77	40	40	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2012	7	4							e33872	10.1371/journal.pone.0033872	http://dx.doi.org/10.1371/journal.pone.0033872			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959XD	22529900	Green Published, Green Submitted, gold			2022-12-25	WOS:000305350600007
J	Chen, JQ; Korostyshevsky, D; Lee, S; Perlstein, EO				Chen, Jingqiu; Korostyshevsky, Daniel; Lee, Sean; Perlstein, Ethan O.			Accumulation of an Antidepressant in Vesiculogenic Membranes of Yeast Cells Triggers Autophagy	PLOS ONE			English	Article							CHLORPROMAZINE; DRUGS; DESIPRAMINE; ANESTHETICS; EXPRESSION; SERTRALINE; TRANSPORT; PATHWAYS; GENES; STATE	Many antidepressants are cationic amphipaths, which spontaneously accumulate in natural or reconstituted membranes in the absence of their specific protein targets. However, the clinical relevance of cellular membrane accumulation by antidepressants in the human brain is unknown and hotly debated. Here we take a novel, evolutionarily informed approach to studying the effects of the selective-serotonin reuptake inhibitor sertraline/Zoloft (R) on cell physiology in the model eukaryote Saccharomyces cerevisiae (budding yeast), which lacks a serotonin transporter entirely. We biochemically and pharmacologically characterized cellular uptake and subcellular distribution of radiolabeled sertraline, and in parallel performed a quantitative ultrastructural analysis of organellar membrane homeostasis in untreated vs. sertraline-treated cells. These experiments have revealed that sertraline enters yeast cells and then reshapes vesiculogenic membranes by a complex process. Internalization of the neutral species proceeds by simple diffusion, is accelerated by proton motive forces generated by the vacuolar H+-ATPase, but is counteracted by energy-dependent xenobiotic efflux pumps. At equilibrium, a small fraction (10-15%) of reprotonated sertraline is soluble while the bulk (90-85%) partitions into organellar membranes by adsorption to interfacial anionic sites or by intercalation into the hydrophobic phase of the bilayer. Asymmetric accumulation of sertraline in vesiculogenic membranes leads to local membrane curvature stresses that trigger an adaptive autophagic response. In mutants with altered clathrin function, this adaptive response is associated with increased lipid droplet formation. Our data not only support the notion of a serotonin transporter-independent component of antidepressant function, but also enable a conceptual framework for characterizing the physiological states associated with chronic but not acute antidepressant administration in a model eukaryote.	[Chen, Jingqiu; Korostyshevsky, Daniel; Lee, Sean; Perlstein, Ethan O.] Princeton Univ, Lewis Sigler Inst Integrat Gen, Princeton, NJ 08544 USA	Princeton University	Chen, JQ (corresponding author), Princeton Univ, Lewis Sigler Inst Integrat Gen, Princeton, NJ 08544 USA.	eperlste@princeton.edu		Perlstein, Ethan/0000-0002-4734-4391	Lewis-Sigler Institute	Lewis-Sigler Institute	The Lewis-Sigler Institute provided all financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BANTA LM, 1988, J CELL BIOL, V107, P1369, DOI 10.1083/jcb.107.4.1369; BOIRON P, 1987, ANTIMICROB AGENTS CH, V31, P244, DOI 10.1128/AAC.31.2.244; BOULANGER Y, 1980, CAN J BIOCHEM CELL B, V58, P986, DOI 10.1139/o80-134; Brett CL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017619; Calabrese F, 2010, MOL PHARMACOL, V77, P846, DOI 10.1124/mol.109.063081; Chen CY, 1998, GENETICS, V150, P577; Chen JY, 1997, BBA-BIOMEMBRANES, V1323, P299, DOI 10.1016/S0005-2736(96)00197-6; Daniel WA, 2003, PROG NEURO-PSYCHOPH, V27, P65, DOI 10.1016/S0278-5846(02)00317-2; de Duve C, 1978, Ann N Y Acad Sci, V308, P226; De Filippi L, 2007, CURR GENET, V52, P171, DOI 10.1007/s00294-007-0151-0; Duman RS, 1997, ARCH GEN PSYCHIAT, V54, P597; Fornai F, 2002, ANN NY ACAD SCI, V965, P381; Gaspar ML, 2008, J BIOL CHEM, V283, P25735, DOI 10.1074/jbc.M802685200; GOLDSTEIN DB, 1984, ANNU REV PHARMACOL, V24, P43, DOI 10.1146/annurev.pa.24.040184.000355; Graham TR, 2011, TRENDS CELL BIOL, V21, P113, DOI 10.1016/j.tcb.2010.10.002; HONEGGER UE, 1983, J PHARMACOL EXP THER, V225, P436; Jerabek H, 2010, J AM CHEM SOC, V132, P7990, DOI 10.1021/ja910843d; KAISER CA, 1990, CELL, V61, P723, DOI 10.1016/0092-8674(90)90483-U; Kane PA, 2006, MICROBIOL MOL BIOL R, V70, P177, DOI 10.1128/MMBR.70.1.177-191.2006; KEAN LS, 1993, J CELL BIOL, V123, P1403, DOI 10.1083/jcb.123.6.1403; KOE BK, 1983, J PHARMACOL EXP THER, V226, P686; Li NX, 2010, SCIENCE, V329, P959, DOI 10.1126/science.1190287; LIEBER MR, 1984, J BIOL CHEM, V259, P9225; NOVICK P, 1979, P NATL ACAD SCI USA, V76, P1858, DOI 10.1073/pnas.76.4.1858; Peropadre A, 2011, CHEM RES TOXICOL, V24, P185, DOI 10.1021/tx100262c; Pickholz M, 2007, BIOPHYS CHEM, V125, P425, DOI 10.1016/j.bpc.2006.10.010; Rainey MM, 2010, GENETICS, V185, P1221, DOI 10.1534/genetics.110.117846; Santos JS, 2004, MAGN RESON CHEM, V42, P105, DOI 10.1002/mrc.1327; SEEMAN P, 1972, PHARMACOL REV, V24, P583; SHEETZ MP, 1974, P NATL ACAD SCI USA, V71, P4457, DOI 10.1073/pnas.71.11.4457; SHIH CK, 1988, MOL CELL BIOL, V8, P3094, DOI 10.1128/MCB.8.8.3094; STOFFEL P, 1987, BIOCHEM PHARMACOL, V36, P655, DOI 10.1016/0006-2952(87)90716-7; STURTON RG, 1977, BIOCHEM J, V162, P25, DOI 10.1042/bj1620025; Thompson BJ, 2011, P NATL ACAD SCI USA, V108, P3785, DOI 10.1073/pnas.1011920108; Vaden DL, 2001, J BIOL CHEM, V276, P15466, DOI 10.1074/jbc.M004179200; WANG LH, 1993, J CELL BIOL, V123, P1107, DOI 10.1083/jcb.123.5.1107; Young TJ, 2003, J ANTIMICROB CHEMOTH, V51, P1045, DOI 10.1093/jac/dkg184; Zhang JZ, 2007, BIOPHYS J, V92, P3988, DOI 10.1529/biophysj.106.102434; Zhang LQ, 2010, J PHARMACOL EXP THER, V332, P977, DOI 10.1124/jpet.109.162644; Zschocke J, 2011, NEUROPSYCHOPHARMACOL, V36, P1754, DOI 10.1038/npp.2011.57	40	15	15	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2012	7	4							e34024	10.1371/journal.pone.0034024	http://dx.doi.org/10.1371/journal.pone.0034024			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959XD	22529904	Green Submitted, Green Published, gold			2022-12-25	WOS:000305350600010
J	Thompson, CK; Meitzen, J; Replogle, K; Drnevich, J; Lent, KL; Wissman, AM; Farin, FM; Bammler, TK; Beyer, RP; Clayton, DF; Perkel, DJ; Brenowitz, EA				Thompson, Christopher K.; Meitzen, John; Replogle, Kirstin; Drnevich, Jenny; Lent, Karin L.; Wissman, Anne Marie; Farin, Federico M.; Bammler, Theo K.; Beyer, Richard P.; Clayton, David F.; Perkel, David J.; Brenowitz, Eliot A.			Seasonal Changes in Patterns of Gene Expression in Avian Song Control Brain Regions	PLOS ONE			English	Article							MYOCYTE ENHANCER FACTOR-2; FEMALE CANARY BRAIN; ZEBRA FINCH BRAIN; GROWTH-FACTOR-I; FACTOR 2D MEF2D; CONTROL-SYSTEM; NEURONAL APOPTOSIS; BREEDING CONDITIONS; CELL-PROLIFERATION; PROJECTION NEURONS	Photoperiod and hormonal cues drive dramatic seasonal changes in structure and function of the avian song control system. Little is known, however, about the patterns of gene expression associated with seasonal changes. Here we address this issue by altering the hormonal and photoperiodic conditions in seasonally-breeding Gambel's white-crowned sparrows and extracting RNA from the telencephalic song control nuclei HVC and RA across multiple time points that capture different stages of growth and regression. We chose HVC and RA because while both nuclei change in volume across seasons, the cellular mechanisms underlying these changes differ. We thus hypothesized that different genes would be expressed between HVC and RA. We tested this by using the extracted RNA to perform a cDNA microarray hybridization developed by the SoNG initiative. We then validated these results using qRT-PCR. We found that 363 genes varied by more than 1.5 fold (> log(2) 0.585) in expression in HVC and/or RA. Supporting our hypothesis, only 59 of these 363 genes were found to vary in both nuclei, while 132 gene expression changes were HVC specific and 172 were RA specific. We then assigned many of these genes to functional categories relevant to the different mechanisms underlying seasonal change in HVC and RA, including neurogenesis, apoptosis, cell growth, dendrite arborization and axonal growth, angiogenesis, endocrinology, growth factors, and electrophysiology. This revealed categorical differences in the kinds of genes regulated in HVC and RA. These results show that different molecular programs underlie seasonal changes in HVC and RA, and that gene expression is time specific across different reproductive conditions. Our results provide insights into the complex molecular pathways that underlie adult neural plasticity.	[Thompson, Christopher K.] Freie Univ, Inst Biol, Berlin, Germany; [Meitzen, John] Univ Minnesota, Dept Neurosci, Minneapolis, MN USA; [Replogle, Kirstin; Clayton, David F.] Univ Illinois, Dept Cell & Dev Biol, Champaign, IL USA; [Drnevich, Jenny] Univ Illinois, Roy J Carver Biotechnol Ctr, Urbana, IL USA; [Lent, Karin L.; Brenowitz, Eliot A.] Univ Washington, Dept Psychol, Seattle, WA 98195 USA; [Wissman, Anne Marie] Northwestern Univ, Dept Neurobiol & Physiol, Evanston, IL 60208 USA; [Farin, Federico M.; Bammler, Theo K.; Beyer, Richard P.] Univ Washington, Dept Environm & Occupat Hlth Sci, Seattle, WA 98195 USA; [Perkel, David J.] Univ Washington, Dept Otolaryngol, Seattle, WA 98195 USA; [Perkel, David J.; Brenowitz, Eliot A.] Univ Washington, Dept Biol, Seattle, WA 98195 USA	Free University of Berlin; University of Minnesota System; University of Minnesota Twin Cities; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Washington; University of Washington Seattle; Northwestern University; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Thompson, CK (corresponding author), Freie Univ, Inst Biol, Berlin, Germany.	ckt@zedat.fu-berlin.de	Clayton, David/B-2190-2008	Clayton, David/0000-0002-6395-3488	United States National Institutes of Health [MH53032, MH066128, NS045264, P30ES07033, P30HD02274, T32 DA07234]; Alexander von Humboldt Foundation; BBSRC [BBS/E/D/20310000] Funding Source: UKRI; MRC [MR/K001744/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/D/20310000] Funding Source: researchfish; Medical Research Council [MR/K001744/1] Funding Source: researchfish; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD002274] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES007033] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R56MH066128, R01MH053032, R01MH066128] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS045264, R01NS075331] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [T32DA007234] Funding Source: NIH RePORTER	United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This study was supported by United States National Institutes of Health grants MH53032 to EAB, MH066128 to DJP, NS045264 to DFC, P30ES07033 and P30HD02274 to FMF, T32 DA07234 to JM, and a fellowship from the Alexander von Humboldt Foundation to CKT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALVAREZBUYLLA A, 1988, P NATL ACAD SCI USA, V85, P8722, DOI 10.1073/pnas.85.22.8722; ANSCOMBE FJ, 1973, AM STAT, V27, P17, DOI 10.2307/2682899; Bottjer SW, 1997, BRAIN BEHAV EVOLUT, V50, P284, DOI 10.1159/000113342; Brenowitz EA, 2008, NEUROSCIENCE BIRDSON; Butts BD, 2005, MOL CELL NEUROSCI, V30, P279, DOI 10.1016/j.mcn.2005.07.011; Butts BD, 2003, HORM METAB RES, V35, P763; Camby I, 2006, GLYCOBIOLOGY, V16, p137R, DOI 10.1093/glycob/cwl025; CANADY RA, 1988, J NEUROSCI, V8, P3770; Catchpole C. K., 1995; Chen XQ, 2005, P NATL ACAD SCI USA, V102, P7730, DOI 10.1073/pnas.0408350102; Dittrich F, 1999, P NATL ACAD SCI USA, V96, P8241, DOI 10.1073/pnas.96.14.8241; GOLDMAN SA, 1983, P NATL ACAD SCI-BIOL, V80, P2390, DOI 10.1073/pnas.80.8.2390; Harris JA, 2008, J NEUROSCI, V28, P10990, DOI 10.1523/JNEUROSCI.2697-08.2008; Hartog TE, 2009, J NEUROSCI, V29, P15511, DOI 10.1523/JNEUROSCI.2564-09.2009; HIDALGO A, 1995, J NEUROBIOL, V27, P470, DOI 10.1002/neu.480270404; HILL KM, 1991, BEHAV NEURAL BIOL, V56, P240, DOI 10.1016/0163-1047(91)90379-5; Hille B., 2001, ION CHANNELS EXCITAB, V3rd Edn; Huesmann GR, 2006, NEURON, V52, P1061, DOI 10.1016/j.neuron.2006.10.033; Jarvis ED, 1997, P NATL ACAD SCI USA, V94, P4097, DOI 10.1073/pnas.94.8.4097; Jiang JW, 1998, J NEUROBIOL, V36, P1, DOI 10.1002/(SICI)1097-4695(199807)36:1<1::AID-NEU1>3.0.CO;2-6; Jiang L, 2008, INT J CANCER, V123, P1779, DOI 10.1002/ijc.23734; Katz A, 2008, EUR J NEUROSCI, V28, P99, DOI 10.1111/j.1460-9568.2008.06303.x; Key MD, 2006, METHOD ENZYMOL, V407, P513, DOI 10.1016/S0076-6879(05)07041-2; Kim DH, 2008, J NEUROSCI, V28, P208, DOI 10.1523/JNEUROSCI.3674-07.2008; Kimpo RR, 1997, NEURON, V18, P315, DOI 10.1016/S0896-6273(00)80271-8; KIRN J, 1994, P NATL ACAD SCI USA, V91, P7844, DOI 10.1073/pnas.91.17.7844; Li J, 2006, BEHAV BRAIN RES, V172, P202, DOI 10.1016/j.bbr.2006.04.022; Li MT, 2001, J NEUROSCI, V21, P6544, DOI 10.1523/JNEUROSCI.21-17-06544.2001; Li XC, 2000, P NATL ACAD SCI USA, V97, P8584, DOI 10.1073/pnas.140222497; Linseman DA, 2003, J BIOL CHEM, V278, P41472, DOI 10.1074/jbc.M307245200; Linseman DA, 2003, J NEUROCHEM, V85, P1488, DOI 10.1046/j.1471-4159.2003.09799.x; Lombardino AJ, 2006, J NEUROSCI METH, V157, P195, DOI 10.1016/j.jneumeth.2006.04.026; Louissaint A, 2002, NEURON, V34, P945, DOI 10.1016/S0896-6273(02)00722-5; Lovell PV, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003440; Meitzen J, 2008, HORM BEHAV; Meitzen J, 2008, GEN COMP ENDOCRINOL; Meitzen J, 2007, J NEUROSCI, V27, P12045, DOI 10.1523/JNEUROSCI.3289-07.2007; Meitzen J, 2007, J COMP PHYSIOL A, V193, P677, DOI 10.1007/s00359-007-0222-1; Meitzen J, 2009, J NEUROSCI, V29, P6558, DOI 10.1523/JNEUROSCI.5571-08.2009; Meitzen J, 2009, HORM BEHAV, V55, P217, DOI 10.1016/j.yhbeh.2008.10.006; Mello CV, 2002, J COMP PHYSIOL A, V188, P943, DOI 10.1007/s00359-002-0347-1; Mukai M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008182; Newman AEM, 2010, J COMP NEUROL, V518, P3662, DOI 10.1002/cne.22395; NOTTEBOHM F, 1981, SCIENCE, V214, P1368, DOI 10.1126/science.7313697; Nottebohm F, 1987, HDB PHYSL 1, V5, P85; Okamoto S, 2002, P NATL ACAD SCI USA, V99, P3974, DOI 10.1073/pnas.022036399; Park KHJ, 2005, J NEUROBIOL, V64, P181, DOI 10.1002/neu.20145; Park SW, 2007, J NEUROSURG, V107, P593, DOI 10.3171/JNS-07/09/0593; Pearen MA, 2010, MOL ENDOCRINOL, V24, P1891, DOI 10.1210/me.2010-0015; Rasika S, 1999, NEURON, V22, P53, DOI 10.1016/S0896-6273(00)80678-9; Reiner A, 2004, J COMP NEUROL, V473, P377, DOI 10.1002/cne.20118; Replogle K, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-131; Rothermundt M, 2003, MICROSC RES TECHNIQ, V60, P614, DOI 10.1002/jemt.10303; Schlinger BA, 2006, J EXP ZOOL PART A, V305A, P743, DOI 10.1002/jez.a.303; Scotto-Lomassese S, 2007, EUR J NEUROSCI, V25, P1663, DOI 10.1111/j.1460-9568.2007.05418.x; Seasholtz AF, 2002, J ENDOCRINOL, V175, P89, DOI 10.1677/joe.0.1750089; Singh TD, 2003, J NEUROBIOL, V54, P593, DOI 10.1002/neu.10178; SMITH GT, 1995, J NEUROBIOL, V28, P114; Smith PD, 2006, J NEUROSCI, V26, P440, DOI 10.1523/JNEUROSCI.2875-05.2006; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Song B, 2003, NEUROSCI LETT, V349, P183, DOI 10.1016/S0304-3940(03)00830-9; Sperry TS, 2005, BEHAV BRAIN RES, V157, P119, DOI 10.1016/j.bbr.2004.06.015; Sperry TS, 2003, J NEUROENDOCRINOL, V15, P150, DOI 10.1046/j.1365-2826.2003.00968.x; Spinazzi R, 2006, INT J MOL MED, V18, P1107; Storey John D, 2003, Methods Mol Biol, V224, P149; Tang XL, 2005, J NEUROSCI, V25, P4823, DOI 10.1523/JNEUROSCI.1331-05.2005; Thompson CK, 2008, J NEUROSCI, V28, P7130, DOI 10.1523/JNEUROSCI.0663-08.2008; Thompson CK, 2007, P NATL ACAD SCI USA, V104, P15520, DOI 10.1073/pnas.0707239104; Thompson CK, 2009, J NEUROSCI, V29, P4586, DOI 10.1523/JNEUROSCI.5423-08.2009; Tramontin AD, 1999, J NEUROBIOL, V40, P316, DOI 10.1002/(SICI)1097-4695(19990905)40:3<316::AID-NEU4>3.0.CO;2-S; Tramontin AD, 2000, J NEUROSCI, V20, P854, DOI 10.1523/JNEUROSCI.20-02-00854.2000; Tramontin AD, 2003, J NEUROBIOL, V57, P130, DOI 10.1002/neu.10263; Tramontin AD, 1998, J COMP NEUROL, V396, P186, DOI 10.1002/(SICI)1096-9861(19980629)396:2<186::AID-CNE4>3.0.CO;2-X; Velho TAF, 2005, EUR J NEUROSCI, V22, P1667, DOI 10.1111/j.1460-9568.2005.04369.x; Vinci MC, 2007, AM J PHYSIOL-HEART C, V293, pH2140, DOI 10.1152/ajpheart.00390.2007; Wade J, 2004, ANN NY ACAD SCI, V1016, P540, DOI 10.1196/annals.1298.015; Wang XM, 2009, J BIOL CHEM, V284, P32619, DOI 10.1074/jbc.M109.067785; Warren WC, 2010, NATURE, V464, P757, DOI 10.1038/nature08819; WINGFIELD JC, 1978, BIOL REPROD, V19, P1046, DOI 10.1095/biolreprod19.5.1046; Wissman AM, 2009, J NEUROSCI, V29, P6461, DOI 10.1523/JNEUROSCI.0638-09.2009; Wood WE, 2011, J NEUROSCI, V31, P13808, DOI 10.1523/JNEUROSCI.2281-11.2011; Wu X, 2009, BIOINFORMATICS, V25, P832, DOI 10.1093/bioinformatics/btp059; Xie F, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-28; Zeigler HP, 2008, NEUROSCIENCE BIRDSON	84	30	31	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2012	7	4							e35119	10.1371/journal.pone.0035119	http://dx.doi.org/10.1371/journal.pone.0035119			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959XD	22529977	Green Published, Green Submitted, gold			2022-12-25	WOS:000305350600057
J	Peng, H; Hamanaka, RB; Katsnelson, J; Hao, LL; Yang, WD; Chandel, NS; Lavker, RM				Peng, Han; Hamanaka, Robert B.; Katsnelson, Julia; Hao, Liang-Liang; Yang, Wending; Chandel, Navdeep S.; Lavker, Robert M.			MicroRNA-31 targets FIH-1 to positively regulate corneal epithelial glycogen metabolism	FASEB JOURNAL			English	Article						Akt signaling; energy metabolism; keratinocytes	HYPOXIA-INDUCIBLE FACTOR; OXYGEN-SENSING PATHWAY; ANKYRIN REPEAT DOMAIN; PROLYL HYDROXYLATION; ASPARAGINYL HYDROXYLATION; TRANSCRIPTIONAL ACTIVITY; HIF; EXPRESSION; PROTEIN; CELLS	Corneal epithelium relies on abundant glycogen stores as its primary energy source. MicroRNA-31 (miR-31), a corneal epithelial-preferred miRNA, negatively regulates factor inhibiting hypoxia-inducible factor-1 (FIH-1). Since HIF-1 alpha is involved in anaerobic energy production, we investigated the role that miR-31 and FIH-1 play in regulating corneal epithelial glycogen. We used antagomirs (antago) to reduce the level of miR-31 in primary human corneal epithelial keratinocytes (HCEKs), and a miR-31-resistant FIH-1 to increase FIH-1 levels. Antago-31 raised FIH-1 levels and significantly reduced glycogen stores in HCEKs compared to irrelevant-antago treatment. Similarly, HCEKs retrovirally transduced with a miR-31-resistant FIH-1 had markedly reduced glycogen levels compared with empty vector controls. In addition, we observed no change in a HIF-1 alpha reporter or known genes downstream of HIF-1 alpha indicating that the action of FIH-1 and miR-31 on glycogen is HIF-1 alpha-independent. An enzyme-dead FIH-1 mutation failed to restore glycogen stores, indicating that FIH-1 negatively regulates glycogen in a hydroxylase-independent manner. FIH-1 overexpression in HCEKs decreased AKT signaling, activated GSK-3 beta, and inactivated glycogen synthase. Treatment of FIH-1-transduced HCEKs with either a myristolated Akt or a GSK-3 beta inhibitor restored glycogen stores, confirming the direct involvement of Akt/GSK-3 beta signaling. Silencing FIH-1 in HCEKs reversed the observed changes in Akt-signaling. Glycogen regulation in a HIF-1 alpha-independent manner is a novel function for FIH-1 and provides new insight into how the corneal epithelium regulates its energy requirements.-Peng, H., Hamanaka, R. B., Katsnelson, J., Hao, L., Yang, W., Chandel, N. S., Lavker, R. M. MicroRNA-31 targets FIH-1 to positively regulate corneal epithelial glycogen metabolism. FASEB J. 26, 3140-3147 (2012). www.fasebj.org	[Peng, Han; Hao, Liang-Liang; Yang, Wending; Lavker, Robert M.] Northwestern Univ, Feinberg Sch Med, Dept Dermatol, Chicago, IL 60611 USA; [Hamanaka, Robert B.; Chandel, Navdeep S.] Northwestern Univ, Feinberg Sch Med, Dept Med, Chicago, IL 60611 USA; [Katsnelson, Julia] Rush Univ, Sch Med, Chicago, IL 60612 USA	Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Rush University	Lavker, RM (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Dermatol, 303 E Chicago Ave,Ward 9-124, Chicago, IL 60611 USA.	r-lavker@northwestern.edu	Peng, Han/I-1922-2012	Hao, Liang/0000-0003-2071-7044; Peng, Han/0000-0002-1105-8254	National Institute of Arthritis and Musculoskeletal and Skin Diseases [AR057216]; U.S. National Institutes of Health grants [EY06769, EY017536, EY019463, 1F32HL099007, 5P30AR057216]; NATIONAL EYE INSTITUTE [R01EY019463, R21EY017536, R01EY006769, F32EY006769] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [F32HL099007] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR057216] Funding Source: NIH RePORTER	National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); U.S. National Institutes of Health grants; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	The authors thank Nihal Kaplan for critical reading of the manuscript and helpful discussions. The Northwestern University Skin Disease Research Center Pathology Core assisted in morphological analyses, and the DNA/RNA Delivery Core assisted with retroviral and lentiviral constructs with support from the National Institute of Arthritis and Musculoskeletal and Skin Diseases, grant AR057216. This research is supported by U.S. National Institutes of Health grants EY06769, EY017536, and EY019463 (R.M.L.), 1F32HL099007 (R.B.H.), and 5P30AR057216 (N.S.C.).	Barad O, 2004, GENOME RES, V14, P2486, DOI 10.1101/gr.2845604; Bartrons R, 2007, J BIOENERG BIOMEMBR, V39, P223, DOI 10.1007/S10863-007-9080-3; Bruick RK, 2001, SCIENCE, V294, P1337, DOI 10.1126/science.1066373; Buchanan J, 2005, ENDOCRINOLOGY, V146, P5341, DOI 10.1210/en.2005-0938; Cockman ME, 2009, ANN NY ACAD SCI, V1177, P9, DOI 10.1111/j.1749-6632.2009.05042.x; Coleman ML, 2007, J BIOL CHEM, V282, P24027, DOI 10.1074/jbc.M704102200; Cursiefen C, 2006, P NATL ACAD SCI USA, V103, P11405, DOI 10.1073/pnas.0506112103; Epstein ACR, 2001, CELL, V107, P43, DOI 10.1016/S0092-8674(01)00507-4; Getsios S, 2009, J CELL BIOL, V185, P1243, DOI 10.1083/jcb.200809044; Gunton JE, 2005, CELL, V122, P337, DOI 10.1016/j.cell.2005.05.027; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Kaji Y, 2005, BRIT J OPHTHALMOL, V89, P254, DOI 10.1136/bjo.2004.055541; Kimura K, 2010, EXP EYE RES, V90, P337, DOI 10.1016/j.exer.2009.11.012; KINOSHITA S, 1982, INVEST OPHTH VIS SCI, V23, P73; Koivunen P, 2004, J BIOL CHEM, V279, P9899, DOI 10.1074/jbc.M312254200; Lando D, 2002, GENE DEV, V16, P1466, DOI 10.1101/gad.991402; Liu CJ, 2010, CANCER RES, V70, P1635, DOI 10.1158/0008-5472.CAN-09-2291; Lu L, 2001, EXP BIOL MED, V226, P653, DOI 10.1177/153537020222600711; Mahon PC, 2001, GENE DEV, V15, P2675, DOI 10.1101/gad.924501; Masson N, 2001, EMBO J, V20, P5197, DOI 10.1093/emboj/20.18.5197; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; Ohh M, 2000, NAT CELL BIOL, V2, P423, DOI 10.1038/35017054; Piatigorsky J, 2008, SEMIN CELL DEV BIOL, V19, P69, DOI 10.1016/j.semcdb.2007.10.010; Rayasam GV, 2009, BRIT J PHARMACOL, V156, P885, DOI 10.1111/j.1476-5381.2008.00085.x; REBUFFESCRIVE M, 1993, METABOLISM, V42, P1405, DOI 10.1016/0026-0495(93)90190-Y; Ryan D, 2006, MOL VIS, V12, P1175; Semenza GL, 2001, CELL, V107, P1, DOI 10.1016/S0092-8674(01)00518-9; Sridharan V, 2007, AM J PHYSIOL-CELL PH, V292, pC719, DOI 10.1152/ajpcell.00100.2006; Stolze IP, 2004, J BIOL CHEM, V279, P42719, DOI 10.1074/jbc.M406713200; Sun LJ, 1999, J BIOL CHEM, V274, P17334, DOI 10.1074/jbc.274.24.17334; SURWIT RS, 1988, DIABETES, V37, P1163, DOI 10.2337/diabetes.37.9.1163; THOFT RA, 1977, INVEST OPHTH VIS SCI, V16, P14; THOFT RA, 1975, AM J OPHTHALMOL, V80, P139, DOI 10.1016/0002-9394(75)90884-3; Wei ZG, 1996, INVEST OPHTH VIS SCI, V37, P523; Weidemann A, 2008, CELL DEATH DIFFER, V15, P621, DOI 10.1038/cdd.2008.12; Weinberg F, 2010, P NATL ACAD SCI USA, V107, P8788, DOI 10.1073/pnas.1003428107; Xu KP, 2009, DIABETES, V58, P1077, DOI 10.2337/db08-0997; Xu KP, 2011, INVEST OPHTH VIS SCI, V52, P3301, DOI 10.1167/iovs.10-5670; Yamamoto Nobutaka, 2006, Eye Contact Lens, V32, P114, DOI 10.1097/01.icl.0000177384.27778.4c; Yu J, 2010, FASEB J, V24, P3950, DOI 10.1096/fj.10-157404; Yu J, 2008, P NATL ACAD SCI USA, V105, P19300, DOI 10.1073/pnas.0803992105; Zhang N, 2010, CELL METAB, V11, P364, DOI 10.1016/j.cmet.2010.03.001; Zhou MY, 2006, J BIOL CHEM, V281, P19600, DOI 10.1074/jbc.M600777200	43	44	47	0	12	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	AUG	2012	26	8					3140	3147		10.1096/fj.11-198515	http://dx.doi.org/10.1096/fj.11-198515			8	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	984BI	22532441	Green Published			2022-12-25	WOS:000307162800006
J	Boncompagni, S; Moussa, CEH; Levy, E; Pezone, MJ; Lopez, JR; Protasi, F; Shtifman, A				Boncompagni, Simona; Moussa, Charbel E. -H.; Levy, Ezra; Pezone, Matthew J.; Lopez, Jose R.; Protasi, Feliciano; Shtifman, Alexander			Mitochondrial Dysfunction in Skeletal Muscle of Amyloid Precursor Protein-overexpressing Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INCLUSION-BODY MYOSITIS; ENDOPLASMIC-RETICULUM STRESS; BETA-PEPTIDE; CA2+; ABNORMALITIES; APP; ACCUMULATION; BIOPSIES; INCREASE; CALCIUM	Inclusion body myositis, the most common muscle disorder in the elderly, is partly characterized by abnormal expression of amyloid precursor protein (APP) and intracellular accumulation of its proteolytic fragments collectively known as beta-amyloid. The present study examined the effects of beta-amyloid accumulation on mitochondrial structure and function of skeletal muscle from transgenic mice (MCK-beta APP) engineered to accumulate intramyofiber beta-amyloid. Electron microscopic analysis revealed that a large fraction of myofibers from 2-3-month-old MCK-beta APP mice contained numerous, heterogeneous alterations in mitochondria, and other cellular organelles. [H-1-decoupled] C-13 NMR spectroscopy showed a substantial reduction in TCA cycle activity and indicated a switch from aerobic to anaerobic glucose metabolism in the MCK-beta APP muscle. Isolated muscle fibers from the MCK-beta APP mice also exhibited a reduction in cytoplasmic pH, an increased rate of ROS production, and a partially depolarized plasmalemma. Treatment of MCK-beta APP muscle cells with Ru360, a mitochondrial Ca2+ uniporter antagonist, reversed alterations in the plasmalemmal membrane potential (V-m) and pH. Consistent with altered redox state of the cells, treatment of MCK-beta APP muscle cells with glutathione reversed the effects of beta-amyloid accumulation on Ca2+ transient amplitudes. We conclude that structural and functional alterations in mitochondria precede the reported appearance of histopathological and clinical features in the MCK-beta APP mice and may represent key early events in the pathogenesis of inclusion body myositis.	[Levy, Ezra; Pezone, Matthew J.; Shtifman, Alexander] Tufts Univ, Dept Neurol, Steward St Elizabeths Med Ctr, Sch Med, Boston, MA 02135 USA; [Boncompagni, Simona; Protasi, Feliciano] Univ Gabriele dAnnunzio, CeSI Ctr Sci Invecchiamento, I-66100 Chieti, Italy; [Boncompagni, Simona; Protasi, Feliciano] Univ Gabriele dAnnunzio, DNI Dept Neurosci & Imaging, I-66100 Chieti, Italy; [Moussa, Charbel E. -H.] Georgetown Univ, Sch Med, Dept Neurosci, Dept Biochem & Mol & Cell Biol, Washington, DC 20057 USA; [Lopez, Jose R.] Brigham & Womens Hosp, Dept Anesthesia, Boston, MA 02115 USA	St. Elizabeth's Medical Center; Tufts University; G d'Annunzio University of Chieti-Pescara; G d'Annunzio University of Chieti-Pescara; Georgetown University; Harvard University; Brigham & Women's Hospital	Shtifman, A (corresponding author), Tufts Univ, Dept Neurol, Steward St Elizabeths Med Ctr, Sch Med, 736 Cambridge St,CBR-406, Boston, MA 02135 USA.	alex.shtifman@steward.org			National Institutes of Health [K01-AR053114, R03-AR054519, AG30378]; Italian Telethon ONLUS Foundation [GGP08153]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R03AR054519, K01AR053114] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K01AG030378] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Italian Telethon ONLUS Foundation(Fondazione Telethon); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants K01-AR053114 and R03-AR054519 (to A. S.) and AG30378 (to C. M.). This work was also supported by Research Grant GGP08153 from the Italian Telethon ONLUS Foundation (to F. P.).	Aleardi AM, 2005, J BIOENERG BIOMEMBR, V37, P207, DOI 10.1007/s10863-005-6631-3; ALLEN DG, 1995, EXP PHYSIOL, V80, P497, DOI 10.1113/expphysiol.1995.sp003864; ASKANAS V, 1991, NEUROSCI LETT, V130, P73, DOI 10.1016/0304-3940(91)90230-Q; ASKANAS V, 1992, AM J PATHOL, V141, P31; Askanas V, 1996, P NATL ACAD SCI USA, V93, P1314, DOI 10.1073/pnas.93.3.1314; ASKANAS V, 1993, ANN NEUROL, V34, P551, DOI 10.1002/ana.410340408; Askanas V, 1997, NEUROREPORT, V8, P2155, DOI 10.1097/00001756-199707070-00012; ASKANAS V, 1994, AM J PATHOL, V144, P177; Askanas V., 1998, INCLUSION BODY MYOSI; Askanas V, 2009, BRAIN PATHOL, V19, P493, DOI 10.1111/j.1750-3639.2009.00290.x; Boncompagni S, 2009, P NATL ACAD SCI USA, V106, P21996, DOI 10.1073/pnas.0911496106; Boncompagni S, 2009, MOL BIOL CELL, V20, P1058, DOI 10.1091/mbc.E08-07-0783; Brookes PS, 2004, AM J PHYSIOL-CELL PH, V287, pC817, DOI 10.1152/ajpcell.00139.2004; Casley CS, 2002, NEUROBIOL DIS, V10, P258, DOI 10.1006/nbdi.2002.0516; Casley CS, 2002, J NEUROCHEM, V80, P91, DOI 10.1046/j.0022-3042.2001.00681.x; Chen Q, 2003, CELL DEATH DIFFER, V10, P323, DOI 10.1038/sj.cdd.4401148; Chung MJ, 2002, ULTRASTRUCT PATHOL, V26, P3, DOI 10.1080/01913120252934260; DENTON RM, 1986, CELL CALCIUM, V7, P377, DOI 10.1016/0143-4160(86)90040-0; DENTON RM, 1985, NATURE, V315, P635, DOI 10.1038/315635a0; Dobrowolny G, 2008, CELL METAB, V8, P425, DOI 10.1016/j.cmet.2008.09.002; Eckert A, 2008, NEURODEGENER DIS, V5, P157, DOI 10.1159/000113689; Fidzianska A, 2006, ACTA NEUROPATHOL, V112, P185, DOI 10.1007/s00401-006-0079-3; Grant SM, 1999, NEUROREPORT, V10, P41, DOI 10.1097/00001756-199901180-00008; Hong WK, 2007, NEUROCHEM RES, V32, P1483, DOI 10.1007/s11064-007-9336-7; Horvath R, 1998, J NEUROPATH EXP NEUR, V57, P396, DOI 10.1097/00005072-199805000-00003; Keil U, 2004, J BIOL CHEM, V279, P50310, DOI 10.1074/jbc.M405600200; Khalifat N, 2012, J ALZHEIMERS DIS, V28, P33, DOI 10.3233/JAD-2011-110389; Kim S, 2011, MOL CELLS, V32, P289, DOI 10.1007/s10059-011-0075-x; Lopez JR, 2008, J NEUROCHEM, V105, P262, DOI 10.1111/j.1471-4159.2007.05135.x; Lopez JR, 2010, MUSCLE NERVE, V42, P731, DOI 10.1002/mus.21745; Matlib MA, 1998, J BIOL CHEM, V273, P10223, DOI 10.1074/jbc.273.17.10223; Moussa CEH, 2006, FASEB J, V20, P2165, DOI 10.1096/fj.06-5763fje; Nogalska A, 2010, ACTA NEUROPATHOL, V120, P661, DOI 10.1007/s00401-010-0737-3; Nogalska A, 2010, AM J PATHOL, V177, P1377, DOI 10.2353/ajpath.2010.100050; Oldfors A, 2006, NEUROLOGY, V66, pS49, DOI 10.1212/01.wnl.0000192127.63013.8d; Pereira C, 1998, NEUROREPORT, V9, P1749, DOI 10.1097/00001756-199806010-00015; Schmidt J, 2008, BRAIN, V131, P1228, DOI 10.1093/brain/awn053; Scragg JL, 2004, FASEB J, V18, P150, DOI 10.1096/fj.04-2659fje; Shtifman A, 2010, NEUROBIOL AGING, V31, P2080, DOI 10.1016/j.neurobiolaging.2008.11.003; Sugarman MC, 2006, NEUROBIOL AGING, V27, P423, DOI 10.1016/j.neurobiolaging.2005.02.011; Sugarman MC, 2002, P NATL ACAD SCI USA, V99, P6334, DOI 10.1073/pnas.082545599; Vattemi G, 2009, ACTA NEUROPATHOL, V117, P569, DOI 10.1007/s00401-009-0511-6; Wang W, 2008, CELL, V134, P279, DOI 10.1016/j.cell.2008.06.017; Webster NJ, 2006, NEUROBIOL AGING, V27, P439, DOI 10.1016/j.neurobiolaging.2005.02.002; Wolosker H, 1997, BIOCHEM J, V321, P545, DOI 10.1042/bj3210545; YUNIS EJ, 1971, LAB INVEST, V25, P240; Zissimopoulos S, 2006, BIOCHEM SOC T, V34, P919, DOI 10.1042/BST0340919; Zissimopoulos S, 2007, J BIOL CHEM, V282, P6976, DOI 10.1074/jbc.M607590200	48	22	22	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 8	2012	287	24					20534	20544		10.1074/jbc.M112.359588	http://dx.doi.org/10.1074/jbc.M112.359588			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974FB	22518836	Green Published, hybrid			2022-12-25	WOS:000306414500074
J	Garcia-Manyes, S; Badilla, CL; Alegre-Cebollada, J; Javadi, Y; Fernandez, JM				Garcia-Manyes, Sergi; Badilla, Carmen L.; Alegre-Cebollada, Jorge; Javadi, Yalda; Fernandez, Julio M.			Spontaneous Dimerization of Titin Protein Z1Z2 Domains Induces Strong Nanomechanical Anchoring	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CLASSICAL CADHERINS; ADHESIVE BINDING; SINGLE-PROTEIN; CELL-ADHESION; Z-DISK; MUSCLE; ELASTICITY; SARCOMERE; COMPLEX; TELETHONIN	Muscle elasticity strongly relies on the mechanical anchoring of the giant protein titin to both the sarcomere M-band and the Z-disk. Such strong attachment ensures the reversible dynamics of the stretching-relaxing cycles determining the muscle passive elasticity. Similarly, the design of biomaterials with enhanced elastic function requires experimental strategies able to secure the constituent molecules to avoid mechanical failure. Here we show that an engineered titin-mimicking protein is able to spontaneously dimerize in solution. Our observations reveal that the titin Z1Z2 domains are key to induce dimerization over a long-range distance in proteins that would otherwise remain in their monomeric form. Using single molecule force spectroscopy, we measure the threshold force that triggers the noncovalent transition from protein dimer to monomer, occurring at similar to 700 piconewtons. Such extremely high mechanical stability is likely to be a natural protective mechanism that guarantees muscle integrity. We propose a simple molecular model to understand the force-induced dimer-to-monomer transition based on the geometric distribution of forces occurring within a dimeric protein under mechanical tension.	[Garcia-Manyes, Sergi] Kings Coll London, Dept Phys, London WC2R 2LS, England; [Garcia-Manyes, Sergi] Kings Coll London, Randall Div Cell & Mol Biophys, London WC2R 2LS, England; [Garcia-Manyes, Sergi; Badilla, Carmen L.; Alegre-Cebollada, Jorge; Javadi, Yalda; Fernandez, Julio M.] Columbia Univ, Dept Biol Sci, New York, NY 10027 USA	University of London; King's College London; University of London; King's College London; Columbia University	Garcia-Manyes, S (corresponding author), Kings Coll London, Dept Phys, London WC2R 2LS, England.	sergi.garcia-manyes@kcl.ac.uk; jfernandez@columbia.edu	Alegre-Cebollada, Jorge/I-4301-2014	Alegre-Cebollada, Jorge/0000-0003-0542-0170; Garcia-Manyes, Sergi/0000-0001-5140-2606	Fundacion IberCaja; Fundacion Mart Martin Escudero; National Institute of Health [HL66030, HL61228]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL066030, R01HL061228] Funding Source: NIH RePORTER	Fundacion IberCaja; Fundacion Mart Martin Escudero; National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the Fundacion IberCaja (to S. G. M. and J. A. C.), by the Fundacion Mart Martin Escudero (J. A. C.), and by National Institute of Health Grants HL66030 and HL61228 (to J. M. F.).	Bertz M, 2009, P NATL ACAD SCI USA, V106, P13307, DOI 10.1073/pnas.0902312106; BUSTAMANTE C, 1994, SCIENCE, V265, P1599, DOI 10.1126/science.8079175; Cao Y, 2008, NAT NANOTECHNOL, V3, P512, DOI 10.1038/nnano.2008.168; Carrion-Vazquez M, 2003, NAT STRUCT BIOL, V10, P738, DOI 10.1038/nsb965; Carrion-Vazquez M, 1999, P NATL ACAD SCI USA, V96, P3694, DOI 10.1073/pnas.96.7.3694; Ciatto C, 2010, NAT STRUCT MOL BIOL, V17, P339, DOI 10.1038/nsmb.1781; del Rio A, 2009, SCIENCE, V323, P638, DOI 10.1126/science.1162912; Garcia-Manyes S, 2007, BIOPHYS J, V93, P2436, DOI 10.1529/biophysj.107.104422; Gautel M, 2011, CURR OPIN CELL BIOL, V23, P39, DOI 10.1016/j.ceb.2010.12.001; GRANZIER HL, 1995, BIOPHYS J, V68, P1027, DOI 10.1016/S0006-3495(95)80278-X; Hagel L., 2001, CURR PROTOC PROTEIN; HARBURY PB, 1993, SCIENCE, V262, P1401, DOI 10.1126/science.8248779; Harrison OJ, 2005, J CELL SCI, V118, P711, DOI 10.1242/jcs.01665; Harrison OJ, 2010, NAT STRUCT MOL BIOL, V17, P348, DOI 10.1038/nsmb.1784; Kellermayer MSZ, 1997, SCIENCE, V276, P1112, DOI 10.1126/science.276.5315.1112; Kellermayer MSZ, 2003, BBA-BIOENERGETICS, V1604, P105, DOI 10.1016/S0005-2728(03)00029-X; Kruger M, 2011, J BIOL CHEM, V286, P9905, DOI 10.1074/jbc.R110.173260; LABEIT S, 1995, SCIENCE, V270, P293, DOI 10.1126/science.270.5234.293; Lange S, 2006, TRENDS CELL BIOL, V16, P11, DOI 10.1016/j.tcb.2005.11.007; Langer R, 2004, NATURE, V428, P487, DOI 10.1038/nature02388; Lee EH, 2006, STRUCTURE, V14, P497, DOI 10.1016/j.str.2005.12.005; Li HB, 2002, NATURE, V418, P998, DOI 10.1038/nature00938; Li HB, 2001, P NATL ACAD SCI USA, V98, P10682, DOI 10.1073/pnas.191189098; Liversage AD, 2001, J MOL BIOL, V305, P401, DOI 10.1006/jmbi.2000.4279; Lv S, 2010, NATURE, V465, P69, DOI 10.1038/nature09024; Marino M, 2006, STRUCTURE, V14, P1437, DOI 10.1016/j.str.2006.07.009; Markert CD, 2010, HUM MOL GENET, V19, P2268, DOI 10.1093/hmg/ddq105; Oberhauser AF, 2002, J MOL BIOL, V319, P433, DOI 10.1016/S0022-2836(02)00306-6; Oberhauser AF, 1998, NATURE, V393, P181, DOI 10.1038/30270; Patel SD, 2006, CELL, V124, P1255, DOI 10.1016/j.cell.2005.12.046; Posy S, 2008, J MOL BIOL, V378, P954, DOI 10.1016/j.jmb.2008.02.063; Rief M, 1997, SCIENCE, V276, P1109, DOI 10.1126/science.276.5315.1109; Sarkar A, 2007, BIOPHYS J, V92, pL36, DOI 10.1529/biophysj.106.097741; SHAPIRO L, 1995, NATURE, V374, P327, DOI 10.1038/374327a0; Tskhovrebova L, 2003, NAT REV MOL CELL BIO, V4, P679, DOI 10.1038/nrm1198; Tskhovrebova L, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/612482; Valbuena A, 2009, P NATL ACAD SCI USA, V106, P13791, DOI 10.1073/pnas.0813093106; Vendome J, 2011, NAT STRUCT MOL BIOL, V18, P693, DOI 10.1038/nsmb.2051; Voelkel T, 2011, PFLUG ARCH EUR J PHY, V462, P143, DOI 10.1007/s00424-011-0938-1; Zhang RL, 2009, HUM MOL GENET, V18, P4130, DOI 10.1093/hmg/ddp362; Zou PJ, 2006, NATURE, V439, P229, DOI 10.1038/nature04343; Zou PJ, 2003, J BIOL CHEM, V278, P2636, DOI 10.1074/jbc.M210217200	42	10	10	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 8	2012	287	24					20240	20247		10.1074/jbc.M112.355883	http://dx.doi.org/10.1074/jbc.M112.355883			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974FB	22523089	hybrid, Green Published			2022-12-25	WOS:000306414500044
J	Schmid, M; Lehmann, MJ; Lucius, R; Gupta, N				Schmid, Manuela; Lehmann, Maik J.; Lucius, Richard; Gupta, Nishith			Apicomplexan Parasite, Eimeria falciformis, Co-opts Host Tryptophan Catabolism for Life Cycle Progression in Mouse	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							T-CELL PROLIFERATION; NITRIC-OXIDE SYNTHASE; INDOLEAMINE 2,3-DIOXYGENASE; DENDRITIC CELLS; INTERFERON-GAMMA; IFN-GAMMA; KYNURENINE PATHWAY; TOXOPLASMA-GONDII; INTRACELLULAR CHLAMYDIA; EPITHELIAL-CELLS	The obligate intracellular apicomplexan parasites, e.g. Toxoplasma gondii and Plasmodium species, induce an IFN gamma-driven induction of host indoleamine 2,3-dioxygenase (IDO), the first and rate-limiting enzyme of tryptophan catabolism in the kynurenine pathway. Induction of IDO1 supposedly depletes cellular levels of tryptophan in host cells, which is proposed to inhibit the in vitro growth of auxotrophic pathogens. In vivo function of IDO during infections, however, is not clear, let alone controversial. We show that Eimeria falciformis, an apicomplexan parasite infecting the mouse caecum, induces IDO1 in the epithelial cells of the organ, and the enzyme expression coincides with the parasite development. The absence or inhibition of IDO1/2 and of two downstream enzymes in infected animals is detrimental to the Eimeria growth. The reduced parasite yield is not due to a lack of an immunosuppressive effect of IDO1 in the parasitized IDO1(-/-) or inhibitor-treated mice because they did not show an accentuated Th1 and IFN gamma response. Noticeably, the parasite development is entirely rescued by xanthurenic acid, a by-product of tryptophan catabolism inducing exflagellation in male gametes of Plasmodium in the mosquito mid-gut. Our data demonstrate a conceptual subversion of the host defense (IFN gamma, IDO) by an intracellular pathogen for progression of its natural life cycle. Besides, we show utility of E. falciformis, a monoxenous parasite of a well appreciated host, i.e. mouse, to identify in vivo factors underlying the parasite-host interactions.	[Schmid, Manuela; Lehmann, Maik J.; Lucius, Richard; Gupta, Nishith] Humboldt Univ, Dept Mol Parasitol, D-10115 Berlin, Germany	Humboldt University of Berlin	Gupta, N (corresponding author), Humboldt Univ, Dept Mol Parasitol, Philippstr 13, D-10115 Berlin, Germany.	Gupta.Nishith@staff.hu-berlin.de		Gupta, Nishith/0000-0003-1452-5126	Helmholtz Foundation; German Research Foundation	Helmholtz Foundation(Helmholtz Association); German Research Foundation(German Research Foundation (DFG))	This work was supported by fellowship and research grants from the Helmholtz Foundation to MS and from German Research Foundation (to N. G. and R. L.).	Adams O, 2004, J VIROL, V78, P2632, DOI 10.1128/JVI.78.5.2632-2636.2004; Adams O, 2004, MICROBES INFECT, V6, P806, DOI 10.1016/j.micinf.2004.04.007; Arai M, 2001, MOL BIOCHEM PARASIT, V116, P17, DOI 10.1016/S0166-6851(01)00299-7; Ball HJ, 2007, GENE, V396, P203, DOI 10.1016/j.gene.2007.04.010; Bell LV, 2011, PARASITE IMMUNOL, V33, P244, DOI 10.1111/j.1365-3024.2010.01272.x; Belli SI, 2009, INT J PARASITOL, V39, P1063, DOI 10.1016/j.ijpara.2009.05.004; Billker O, 1998, NATURE, V392, P289, DOI 10.1038/32667; Bodaghi B, 1999, J IMMUNOL, V162, P957; Bozza S, 2005, J IMMUNOL, V174, P2910, DOI 10.4049/jimmunol.174.5.2910; BYRNE GI, 1986, INFECT IMMUN, V53, P347, DOI 10.1128/IAI.53.2.347-351.1986; CARLIN JM, 1989, EXPERIENTIA, V45, P535, DOI 10.1007/BF01990503; Divanovic S, 2012, J INFECT DIS, V205, P152, DOI 10.1093/infdis/jir621; Fallarino F, 2002, INT IMMUNOL, V14, P65, DOI 10.1093/intimm/14.1.65; Fallarino I, 2002, CELL DEATH DIFFER, V9, P1069, DOI 10.1038/sj.cdd.4401073; Frumento G, 2002, J EXP MED, V196, P459, DOI 10.1084/jem.20020121; Fujigaki S, 2002, INFECT IMMUN, V70, P779, DOI 10.1128/IAI.70.2.779-786.2002; Grohmann U, 2000, J IMMUNOL, V165, P1357, DOI 10.4049/jimmunol.165.3.1357; Harrington L, 2008, INFECT IMMUN, V76, P3045, DOI 10.1128/IAI.00193-08; Hoshi M, 2010, J IMMUNOL, V185, P3305, DOI 10.4049/jimmunol.0901150; Hwu P, 2000, J IMMUNOL, V164, P3596, DOI 10.4049/jimmunol.164.7.3596; MacKenzie CR, 1999, J MED MICROBIOL, V48, P935, DOI 10.1099/00222615-48-10-935; Mellor AL, 2004, INT IMMUNOL, V16, P1391, DOI 10.1093/intimm/dxh140; Mellor AL, 2004, NAT REV IMMUNOL, V4, P762, DOI 10.1038/nri1457; Mellor AL, 2002, J IMMUNOL, V168, P3771, DOI 10.4049/jimmunol.168.8.3771; Miu J, 2009, INT J PARASITOL, V39, P363, DOI 10.1016/j.ijpara.2008.10.005; Munn DH, 1998, SCIENCE, V281, P1191, DOI 10.1126/science.281.5380.1191; Munn DH, 1999, J EXP MED, V189, P1363, DOI 10.1084/jem.189.9.1363; Okuda S, 1996, P NATL ACAD SCI USA, V93, P12553, DOI 10.1073/pnas.93.22.12553; Knubel CP, 2010, FASEB J, V24, P2689, DOI 10.1096/fj.09-150920; Pellicciari R, 2006, CHEMMEDCHEM, V1, P528, DOI 10.1002/cmdc.200500095; PFEFFERKORN ER, 1984, P NATL ACAD SCI-BIOL, V81, P908, DOI 10.1073/pnas.81.3.908; ROSE ME, 1992, PARASITOLOGY, V105, P349, DOI 10.1017/S0031182000074515; ROSE ME, 1991, PARASITE IMMUNOL, V13, P63, DOI 10.1111/j.1365-3024.1991.tb00263.x; Rottenberg ME, 2000, J IMMUNOL, V164, P4812, DOI 10.4049/jimmunol.164.9.4812; Rover S, 1997, J MED CHEM, V40, P4378, DOI 10.1021/jm970467t; SALTER M, 1985, BIOCHEM J, V229, P499, DOI 10.1042/bj2290499; SCHMATZ DM, 1984, J PROTOZOOL, V31, P181, DOI 10.1111/j.1550-7408.1984.tb04314.x; SHI YF, 1989, INFECT IMMUN, V57, P146, DOI 10.1128/IAI.57.1.146-151.1989; SHIMIZU T, 1978, J BIOL CHEM, V253, P4700; Silva NM, 2002, INFECT IMMUN, V70, P859, DOI 10.1128/IAI.70.2.859-868.2002; Stange J, 2012, J IMMUNOL, V188, P2410, DOI 10.4049/jimmunol.1102062; STOCKDALE PGH, 1985, INT J PARASITOL, V15, P447, DOI 10.1016/0020-7519(85)90032-3; Stone TW, 2002, NAT REV DRUG DISCOV, V1, P609, DOI 10.1038/nrd870; TAKIKAWA O, 1986, J BIOL CHEM, V261, P3648; TAYLOR MW, 1991, FASEB J, V5, P2516, DOI 10.1096/fasebj.5.11.1907934; Terness P, 2002, J EXP MED, V196, P447, DOI 10.1084/jem.20020052; THOMAS SM, 1993, J IMMUNOL, V150, P5529; Wei HF, 2000, J NEUROCHEM, V75, P81, DOI 10.1046/j.1471-4159.2000.0750081.x; YOSHIDA R, 1980, ARCH BIOCHEM BIOPHYS, V203, P343, DOI 10.1016/0003-9861(80)90185-X; Zmarowski A, 2009, EUR J NEUROSCI, V29, P529, DOI 10.1111/j.1460-9568.2008.06594.x	50	16	16	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 8	2012	287	24					20197	20207		10.1074/jbc.M112.351999	http://dx.doi.org/10.1074/jbc.M112.351999			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974FB	22535959	hybrid, Green Published			2022-12-25	WOS:000306414500040
J	Corbo, RM; Gambina, G; Scacchi, R				Corbo, Rosa Maria; Gambina, Giuseppe; Scacchi, Renato			How Contemporary Human Reproductive Behaviors Influence the Role of Fertility-Related Genes: The Example of the P53 Gene	PLOS ONE			English	Article							ACE I/D POLYMORPHISM; OVARIAN STIMULATION; ASSOCIATION; DISORDERS; MUTATIONS; SELECTION; GENOTYPE; PATHWAY; BIOLOGY	Studies on human fertility genes have identified numerous risk/protective alleles involved in the occurrence of reproductive system diseases causing infertility or subfertility. Investigations we carried out in populations at natural fertility seem to suggest that the clinical relevance that some fertility genes are now acquiring depends on their interaction with contemporary reproductive behaviors (birth control, delayed childbearing, and spacing birth order, among others). In recent years, a new physiological role in human fertility regulation has emerged for the tumor-suppressor p53 gene (P53), and the P53 Arg72Pro polymorphism has been associated with recurrent implantation failure in humans. To lend support to our previous observations, we examined the impact of Arg72Pro polymorphism on fertility in two samples of Italian women not selected for impaired fertility but collected from populations with different (premodern and modern) reproductive behaviors. Among the women at near-natural fertility (n = 98), the P53 genotypes were not associated with different reproductive efficiency, whereas among those with modern reproductive behaviors (n = 68), the P53 genotypes were associated with different mean numbers of children [Pro/Pro = 0.75, Pro/Arg = 1.7<Arg/Arg = 2, (p = 0.056)] and a significant negative relationship between the number of children and P53 Pro allele frequencies (p = 0.028) was observed. These results are consistent with those of clinical studies reporting an association between the P53 Pro allele and recurrent implantation failure. By combining these findings with previous ones, we suggest here that some common variants of fertility genes may have become "detrimental" following exposure to modern reproductive patterns and might therefore be associated with reduced reproductive success. Set within an evolutionary framework, this change could lead to the selection of a set of gene variants fitter to current reproductive behaviors as the shift to later child-bearing age in developed countries.	[Corbo, Rosa Maria] Univ Roma La Sapienza, Dept Biol & Biotechnol Charles Darwin, Rome, Italy; [Gambina, Giuseppe] Hosp Verona, Alzheimers Dis & Other Dementias Ctr, Div Neurol, Verona, Italy; [Corbo, Rosa Maria; Scacchi, Renato] CNR Inst Mol Biol & Pathol, Rome, Italy	Sapienza University Rome; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biologia e Patologia Molecolari (IBPM-CNR)	Corbo, RM (corresponding author), Univ Roma La Sapienza, Dept Biol & Biotechnol Charles Darwin, Rome, Italy.	rosamaria.corbo@uniroma1.it			La Sapienza University, Progetti AST	La Sapienza University, Progetti AST	This work was supported by La Sapienza University, Progetti AST 2009 (to RMC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altmae S, 2011, HUM REPROD UPDATE, V17, P813, DOI 10.1093/humupd/dmr034; Altmae S, 2007, MOL HUM REPROD, V13, P521, DOI 10.1093/molehr/gam035; Armitage P., 2001, STAT METHODS MED RES; Buchholz T, 2003, HUM REPROD, V18, P2473, DOI 10.1093/humrep/deg474; Cohen J., 1988, STAT POWER ANAL BEHA, V2nd ed., DOI DOI 10.4324/9780203771587; Corbo RM, 2007, MOL HUM REPROD, V13, P537, DOI 10.1093/molehr/gam041; Corbo RM, 2011, ANN HUM BIOL, V38, P102, DOI 10.3109/03014460.2010.481265; Corbo RM, 2011, J GERONTOL A-BIOL, V66, P51, DOI 10.1093/gerona/glq160; Di Rienzo A, 2005, TRENDS GENET, V21, P596, DOI 10.1016/j.tig.2005.08.007; Dossenbach-Glaninger A, 2008, BRIT J HAEMATOL, V141, P269, DOI 10.1111/j.1365-2141.2008.07058.x; Fatini C, 2000, BLOOD COAGUL FIBRIN, V11, P657, DOI 10.1097/00001721-200010000-00010; Fisher RA, 1958, GENETICAL THEORY NAT; Frejka T, 2006, DEMOGR RES, V15, P147, DOI 10.4054/DemRes.2006.15.6; Giannoudis A, 1999, INT J CANCER, V83, P66, DOI 10.1002/(SICI)1097-0215(19990924)83:1<66::AID-IJC13>3.0.CO;2-K; Hu WW, 2008, CELL CYCLE, V7, P848, DOI 10.4161/cc.7.7.5658; Hu WW, 2007, NATURE, V450, P721, DOI 10.1038/nature05993; Hu WW, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a001073; Istituto Centrale di Statistica, 1974, NOTE RELAZIONI, V50, P96; Istituto Nazionale di Statistica, 1997, ANALISI COORTI INFOR, V35, P59; Jeong BS, 2010, FASEB J, V24, P1347, DOI 10.1096/fj.09-146001; Kang HJ, 2009, P NATL ACAD SCI USA, V106, P9761, DOI 10.1073/pnas.0904280106; Kay C, 2006, REPROD BIOMED ONLINE, V13, P492, DOI 10.1016/S1472-6483(10)60635-9; Kohler HP, 2006, INT J ANDROL, V29, P46, DOI 10.1111/j.1365-2605.2005.00606.x; Kosova G, 2010, P NATL ACAD SCI USA, V107, P1772, DOI 10.1073/pnas.0906196106; Layman LC, 2002, J MED GENET, V39, P153, DOI 10.1136/jmg.39.3.153; Levine AJ, 2006, CELL DEATH DIFFER, V13, P1027, DOI 10.1038/sj.cdd.4401910; Levine AJ, 2011, NAT REV MOL CELL BIO, V12, P259, DOI 10.1038/nrm3086; Lussiana C, 2008, OBSTET GYNECOL SURV, V63, P785, DOI 10.1097/OGX.0b013e31818957eb; Matzuk MM, 2008, NAT MED, V14, P1197, DOI 10.1038/nm.f.1895; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Neel JV, 1999, NUTR REV, V57, pS2, DOI 10.1111/j.1753-4887.1999.tb01782.x; NEEL JV, 1962, AM J HUM GENET, V14, P353; O'Brien KLO, 2010, FERTIL STERIL, V93, P1, DOI 10.1016/j.fertnstert.2009.10.045; Rodgers JL, 2001, CURR DIR PSYCHOL SCI, V10, P184, DOI 10.1111/1467-8721.00145; Simoni M, 2008, HUM REPROD UPDATE, V14, P459, DOI 10.1093/humupd/dmn024; Sucheston L, 2011, HUM MOL GENET, V20, P1502, DOI 10.1093/hmg/ddr028; Sundarrajan C, 1999, MOL HUM REPROD, V5, P797, DOI 10.1093/molehr/5.9.797; Tempfer CB, 2009, HUM REPROD UPDATE, V15, P97, DOI 10.1093/humupd/dmn040; Tenti P, 2000, CANCER EPIDEM BIOMAR, V9, P435; ULIZZI L, 1979, ANN HUM GENET, V43, P137, DOI 10.1111/j.1469-1809.1979.tb02006.x; Velde ERT, 2002, HUM REPROD UPDATE, V8, P141, DOI 10.1093/humupd/8.2.141; Yoon SH, 2010, HUM REPROD, V25, P283, DOI 10.1093/humrep/dep375	42	14	14	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2012	7	4							e35431	10.1371/journal.pone.0035431	http://dx.doi.org/10.1371/journal.pone.0035431			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UD	22532853	Green Published, gold, Green Submitted			2022-12-25	WOS:000305339200064
J	Kalpakidou, AK; Allin, MP; Walshe, M; Giampietro, V; Nam, KW; McGuire, P; Rifkin, L; Murray, RM; Nosarti, C				Kalpakidou, Anastasia K.; Allin, Matthew P.; Walshe, Muriel; Giampietro, Vincent; Nam, Kie-woo; McGuire, Philip; Rifkin, Larry; Murray, Robin M.; Nosarti, Chiara			Neonatal Brain Injury and Neuroanatomy of Memory Processing following Very Preterm Birth in Adulthood: An fMRI Study	PLOS ONE			English	Article							DEFICIT HYPERACTIVITY DISORDER; SCHOOL-AGED CHILDREN; INTRAVENTRICULAR HEMORRHAGE; PREFRONTAL CORTEX; EPISODIC MEMORY; WORKING-MEMORY; ULTRASOUND APPEARANCE; NEURODEVELOPMENTAL IMPAIRMENT; FUNCTIONAL NEUROANATOMY; RESPONSE-INHIBITION	Altered functional neuroanatomy of high-order cognitive processing has been described in very preterm individuals (born before 33 weeks of gestation; VPT) compared to controls in childhood and adolescence. However, VPT birth may be accompanied by different types of adverse neonatal events and associated brain injury, the severity of which may have differential effects on brain development and subsequent neurodevelopmental outcome. We conducted a functional magnetic resonance imaging (fMRI) study to investigate how differing degrees of neonatal brain injury, detected by neonatal ultrasounds, affect the functional neuroanatomy of memory processing in VPT young adults. We used a verbal paired associates learning task, consisting of four encoding, four cued-recall and four baseline condition blocks. To further investigate whether differences in neural activation between the groups were modulated by structural brain changes, structural MRI data were also collected. We studied 12 VPT young adults with a history of periventricular haemorrhage with associated ventricular dilatation, 17 VPT individuals with a history of uncomplicated periventricular haemorrhage, 12 individuals with normal ultrasonographic findings, and 17 controls. Results of a linear trend analysis demonstrated that during completion of the paired associates learning task right frontal and right parietal brain activation decreased as the severity of neonatal brain injury increased. There were no statistically significant between-group differences in on-line task performance and participants' intelligence quotient (IQ) at assessment. This pattern of differential activation across the groups was observed particularly in the right middle frontal gyrus during encoding and in the right posterior cingulate gyrus during recall. Structural MRI data analysis revealed that grey matter volume in the right superior temporal gyrus, right cerebellum, left middle temporal gyrus, right globus pallidus and right medial frontal gyrus decreased with increasing severity of neonatal brain injury. However, the significant between-group functional neuroanatomical differences were not directly attributable to the detected structural regional differences.	[Kalpakidou, Anastasia K.; Allin, Matthew P.; Walshe, Muriel; Nam, Kie-woo; McGuire, Philip; Rifkin, Larry; Murray, Robin M.; Nosarti, Chiara] Kings Coll London, Inst Psychiat, Dept Psychosis Studies, Kings Hlth Partners, London WC2R 2LS, England; [Giampietro, Vincent] Kings Coll London, Inst Psychiat, Dept Neuroimaging, Kings Hlth Partners, London WC2R 2LS, England	University of London; King's College London; University of London; King's College London	Nosarti, C (corresponding author), Kings Coll London, Inst Psychiat, Dept Psychosis Studies, Kings Hlth Partners, London WC2R 2LS, England.	chiara.nosarti@kcl.ac.uk	Nosarti, Chiara/G-5638-2010; Murray, Robin M/F-8658-2012; Walshe, Muriel/E-5214-2010; Giampietro, Vincent P/D-1279-2011; Walshe, Margaret/M-9102-2016	Nosarti, Chiara/0000-0001-6305-9710; Murray, Robin M/0000-0003-0829-0519; Walshe, Muriel/0000-0001-6829-1105; Giampietro, Vincent P/0000-0002-9381-8201; Walshe, Margaret/0000-0003-3924-8073; McGuire, Philip/0000-0003-4381-0532; Rifkin, Larry/0000-0003-2590-9010	Cerebra Foundation for The Brain Injured Infant	Cerebra Foundation for The Brain Injured Infant	The study was funded by the Cerebra Foundation for The Brain Injured Infant (CN and RMM). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allin M, 2008, J NEUROL NEUROSUR PS, V79, P381, DOI 10.1136/jnnp.2006.110858; Allin M, 2004, DEV MED CHILD NEUROL, V46, P46, DOI 10.1017/S0012162204000088; Anderson PJ, 2004, PEDIATRICS, V114, P50, DOI 10.1542/peds.114.1.50; [Anonymous], 1983, CANADIAN PSYCHOL; Ashburner J, 2007, NEUROIMAGE, V38, P95, DOI 10.1016/j.neuroimage.2007.07.007; Bhattacharyya S, 2009, ARCH GEN PSYCHIAT, V66, P442, DOI 10.1001/archgenpsychiatry.2009.17; Blumenfeld RS, 2007, NEUROSCIENTIST, V13, P280, DOI 10.1177/1073858407299290; Blumenfeld RS, 2006, J NEUROSCI, V26, P916, DOI 10.1523/JNEUROSCI.2353-05.2006; BOWER GH, 1970, J VERB LEARN VERB BE, V9, P529, DOI 10.1016/S0022-5371(70)80096-2; Brammer MJ, 1997, MAGN RESON IMAGING, V15, P763, DOI 10.1016/S0730-725X(97)00135-5; Buckner RL, 1998, P NATL ACAD SCI USA, V95, P891, DOI 10.1073/pnas.95.3.891; Bullmore ET, 1999, IEEE T MED IMAGING, V18, P32, DOI 10.1109/42.750253; Bullmore ET, 2001, HUM BRAIN MAPP, V12, P61, DOI 10.1002/1097-0193(200102)12:2<61::AID-HBM1004>3.0.CO;2-W; Cabeza R, 2000, J COGNITIVE NEUROSCI, V12, P1, DOI 10.1162/08989290051137585; Cansino S, 2002, CEREB CORTEX, V12, P1048, DOI 10.1093/cercor/12.10.1048; Castellanos FX, 2002, JAMA-J AM MED ASSOC, V288, P1740, DOI 10.1001/jama.288.14.1740; Castellanos FX, 1996, ARCH GEN PSYCHIAT, V53, P607; COSTELLO AMD, 1988, DEV MED CHILD NEUROL, V30, P711; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; Curtis WJ, 2006, DEV NEUROPSYCHOL, V29, P341, DOI 10.1207/s15326942dn2902_4; Dickstein SG, 2006, J CHILD PSYCHOL PSYC, V47, P1051, DOI 10.1111/j.1469-7610.2006.01671.x; Downie ALS, 2005, CHILD NEUROPSYCHOL, V11, P479, DOI 10.1080/09297040591001085; Elvevag B, 2000, NEUROPSYCHOLOGIA, V38, P1565, DOI 10.1016/S0028-3932(00)00074-9; Fletcher JM, 1997, DEV MED CHILD NEUROL, V39, P596; Fletcher PC, 1998, BRAIN, V121, P1239, DOI 10.1093/brain/121.7.1239; Fletcher PC, 1998, BRAIN, V121, P1249, DOI 10.1093/brain/121.7.1249; FLETCHER PC, 1995, BRAIN, V118, P401, DOI 10.1093/brain/118.2.401; FRISK V, 1994, DEV NEUROPSYCHOL, V10, P313, DOI 10.1080/87565649409540586; Friston KJ, 1999, NEUROIMAGE, V10, P1, DOI 10.1006/nimg.1999.0439; Gimenez M, 2005, NEUROIMAGE, V25, P561, DOI 10.1016/j.neuroimage.2004.10.046; Gimenez M, 2004, NEUROIMAGE, V23, P869, DOI 10.1016/j.neuroimage.2004.07.029; GRESSENS P, 1992, BIOL NEONATE, V61, P4; HMSO (1991) Her Majesty's Stationary Office (HMSO), 1991, STANDARD OCCUPATIONA; Inder TE, 2006, J PEDIATR-US, V149, P152, DOI 10.1016/j.jpeds.2006.05.046; Isaacs EB, 2000, PEDIATR RES, V47, P713, DOI 10.1203/00006450-200006000-00006; Isaacs EB, 2003, P NATL ACAD SCI USA, V100, P13060, DOI 10.1073/pnas.1233825100; Kesler SR, 2004, PEDIATR NEUROL, V31, P318, DOI 10.1016/j.pediatrneurol.2004.06.008; Kuban K, 1999, J PEDIATR-US, V134, P539, DOI 10.1016/S0022-3476(99)70237-4; Kucera H, 1967, COMPUTATIONAL ANALUS; Lacadie CM, 2008, NEUROIMAGE, V42, P717, DOI 10.1016/j.neuroimage.2008.04.240; Langenecker SA, 2007, BRAIN RES, V1135, P58, DOI 10.1016/j.brainres.2006.11.068; Lawrence EJ, 2010, J PEDIAT; Lawrence EJ, 2009, HUM BRAIN MAPP, V30, P1038, DOI 10.1002/hbm.20564; Levitan IB, 1997, NEURON, P23; Lubsen J, 2011, SEMIN PERINATOL, V35, P34, DOI 10.1053/j.semperi.2010.10.006; Luciana M, 1999, DEV MED CHILD NEUROL, V41, P521, DOI 10.1017/S0012162299001140; Luu TM, 2009, PEDIATRICS, V123, P1037, DOI 10.1542/peds.2008-1162; Maddock RF, 2001, NEUROSCIENCE, V104, P667, DOI 10.1016/S0306-4522(01)00108-7; Meltzer JA, 2005, NEUROIMAGE, V24, P384, DOI 10.1016/j.neuroimage.2004.09.001; Morris R, 1999, EUR J NEUROSCI, V11, P2506, DOI 10.1046/j.1460-9568.1999.00672.x; Narberhaus A, 2009, NEUROIMAGE; Nosarti C, 2006, DEV MED CHILD NEUROL, V48, P265, DOI 10.1017/S0012162206000582; Nosarti C, 2011, DEV NEUROPSYCHOL, V36, P118, DOI 10.1080/87565641.2011.540546; Nosarti C, 2002, BRAIN, V125, P1616, DOI 10.1093/brain/awf157; Nosarti C, 2009, NEUROIMAGE; Nosarti C, 2008, BRAIN; PANETH N, 1994, BRAIN DAMAGE PRETERM; PETRIDES M, 1995, P NATL ACAD SCI USA, V92, P5803, DOI 10.1073/pnas.92.13.5803; Rose SA, 1996, CHILD DEV, V67, P2005, DOI 10.1111/j.1467-8624.1996.tb01840.x; ROSS G, 1992, DEV PSYCHOL, V28, P1067, DOI 10.1037/0012-1649.28.6.1067; ROTH SC, 1993, DEV MED CHILD NEUROL, V35, P755; Rushe TM, 1999, SCHIZOPHR RES, V35, P85, DOI 10.1016/S0920-9964(98)00117-0; Simmons A, 1999, MAGNET RESON MED, V41, P1274, DOI 10.1002/(SICI)1522-2594(199906)41:6<1274::AID-MRM27>3.0.CO;2-1; STEWART AL, 1989, DEV MED CHILD NEUROL, V31, P756; Stewart AL, 1999, LANCET, V353, P1653, DOI 10.1016/S0140-6736(98)07130-X; STEWART AL, 1983, ARCH DIS CHILD, V58, P598, DOI 10.1136/adc.58.8.598; Summerfield C, 2006, PLOS BIOL, V4, P855, DOI 10.1371/journal.pbio.0040128; SUZUKI WA, 1994, J COMP NEUROL, V350, P497, DOI 10.1002/cne.903500402; Talairach I., 1988, COPLANAR STEREOTACTI; VALENSTEIN E, 1987, BRAIN, V110, P1631, DOI 10.1093/brain/110.6.1631; Valera EM, 2010, AM J PSYCHIAT, V167, P86, DOI 10.1176/appi.ajp.2009.09020249; Vasileiadis GT, 2004, PEDIATRICS, V114, pE367, DOI 10.1542/peds.2004-0500; Vollmer B, 2006, DEV MED CHILD NEUROL, V48, P348, DOI 10.1017/S0012162206000764; Wechsler D, 1987, WMS R WECHSLER MEMOR; Wechsler D., 1999, WECHSLER ABBREVIATED; WILSON M, 1988, BEHAV RES METH INSTR, V20, P6, DOI 10.3758/BF03202594; Woodward LJ, 2005, BRAIN, V128, P2578, DOI 10.1093/brain/awh618	77	24	25	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2012	7	4							e34858	10.1371/journal.pone.0034858	http://dx.doi.org/10.1371/journal.pone.0034858			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UD	22532832	Green Published, Green Submitted, gold			2022-12-25	WOS:000305339200025
J	Patron, JP; Fendler, A; Bild, M; Jung, U; Muller, H; Arntzen, MO; Piso, C; Stephan, C; Thiede, B; Mollenkopf, HJ; Jung, K; Kaufmann, SHE; Schreiber, J				Patron, Juan P.; Fendler, Annika; Bild, Matthias; Jung, Ulrike; Mueller, Henrik; Arntzen, Magnus O.; Piso, Chloe; Stephan, Carsten; Thiede, Bernd; Mollenkopf, Hans-Joachim; Jung, Klaus; Kaufmann, Stefan H. E.; Schreiber, Joerg			MiR-133b Targets Antiapoptotic Genes and Enhances Death Receptor-Induced Apoptosis	PLOS ONE			English	Article							GLUTATHIONE-S-TRANSFERASE; NF-KAPPA-B; TUMOR-SUPPRESSIVE MICRORNAS; SQUAMOUS-CELL CARCINOMA; INHIBITORY MOLECULE; COLORECTAL-CANCER; PROTEIN-SYNTHESIS; EXPRESSION; IDENTIFICATION; FAS	Despite the importance of microRNAs (miRs) for regulation of the delicate balance between cell proliferation and death, evidence for their specific involvement during death receptor (DR)-mediated apoptosis is scarce. Transfection with miR-133b rendered resistant HeLa cells sensitive to tumor necrosis factor-alpha (TNF alpha)-induced cell death. Similarly, miR-133b caused exacerbated proapoptotic responses to TNF-related apoptosis-inducing ligand (TRAIL) or an activating antibody to Fas/CD95. Comprehensive analysis, encompassing global RNA or protein expression profiling performed by microarray experiments and pulsed stable isotope labeling with amino acids in cell culture (pSILAC), led to the discovery of the antiapoptotic protein Fas apoptosis inhibitory molecule (FAIM) as immediate miR-133b target. Moreover, miR-133b impaired the expression of the detoxifying protein glutathione-S-transferase pi (GSTP1). Expression of miR-133b in tumor specimens of prostate cancer patients was significantly downregulated in 75% of the cases, when compared with matched healthy tissue. Furthermore, introduction of synthetic miR-133b into an ex-vivo model of prostate cancer resulted in impaired proliferation and cellular metabolic activity. PC3 cells were also sensitized to apoptotic stimuli after transfection with miR-133b similar to HeLa cells. These data reveal the ability of a single miR to influence major apoptosis pathways, suggesting an essential role for this molecule during cellular transformation, tumorigenesis and tissue homeostasis.	[Patron, Juan P.; Bild, Matthias; Jung, Ulrike; Mueller, Henrik; Piso, Chloe; Kaufmann, Stefan H. E.; Schreiber, Joerg] Max Planck Inst Infect Biol, Dept Immunol, Berlin, Germany; [Fendler, Annika; Stephan, Carsten] Charite, Dept Urol, D-13353 Berlin, Germany; [Fendler, Annika; Jung, Klaus] Berlin Inst Urol Res, Berlin, Germany; [Fendler, Annika] Free Univ Berlin, Dept Biol Chem & Pharm, Berlin, Germany; [Arntzen, Magnus O.; Thiede, Bernd] Univ Oslo, Biotechnol Ctr Oslo, Oslo, Norway; [Arntzen, Magnus O.] Univ Oslo, Rikshosp, Prote Core Facil, N-0027 Oslo, Norway; [Arntzen, Magnus O.] Norwegian Univ Life Sci, Prote Core Facil, As, Norway; [Mollenkopf, Hans-Joachim] Max Planck Inst Infect Biol, Core Facil Microarray, Berlin, Germany	Max Planck Society; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; University of Oslo; University of Oslo; National Hospital Norway; Norwegian University of Life Sciences; Max Planck Society	Kaufmann, SHE (corresponding author), Max Planck Inst Infect Biol, Dept Immunol, Berlin, Germany.	kaufmann@mpiib-berlin.mpg.de	Jung, Klaus/Z-2122-2018; Arntzen, Magnus Ø/N-6983-2016; Mollenkopf, Hans-Joachim/AAH-2500-2019; Kaufmann, Stefan HE/I-5454-2014	Jung, Klaus/0000-0001-9797-5362; Arntzen, Magnus Ø/0000-0002-1803-727X; Mollenkopf, Hans-Joachim/0000-0003-1167-4783; Kaufmann, Stefan HE/0000-0001-9866-8268; Stephan, Carsten/0000-0002-3270-258X; Fendler, Annika/0000-0002-7267-0981				Aggarwal BB, 2003, NAT REV IMMUNOL, V3, P745, DOI 10.1038/nri1184; Bandres E, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-29; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Beg AA, 1996, SCIENCE, V274, P782, DOI 10.1126/science.274.5288.782; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Crawford M, 2009, BIOCHEM BIOPH RES CO, V388, P483, DOI 10.1016/j.bbrc.2009.07.143; Dutta J, 2006, ONCOGENE, V25, P6800, DOI 10.1038/sj.onc.1209938; Fischer U, 2003, CELL DEATH DIFFER, V10, P76, DOI 10.1038/sj.cdd.4401160; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Garofalo M, 2010, CELL DEATH DIFFER, V17, P200, DOI 10.1038/cdd.2009.105; Garzon R, 2009, ANNU REV MED, V60, P167, DOI 10.1146/annurev.med.59.053006.104707; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Haas JD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020171; Hansen T, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000873; Hu G, 2010, CANCER BIOL THER, V10, P190, DOI 10.4161/cbt.10.2.12186; Hudson RS, 2011, NUCL ACIDS RES; Huo J, 2009, CELL DEATH DIFFER, V16, P1062, DOI 10.1038/cdd.2009.26; Hutvagner G, 2004, PLOS BIOL, V2, P465, DOI 10.1371/journal.pbio.0020098; Ichimi T, 2009, INT J CANCER, V125, P345, DOI 10.1002/ijc.24390; Kano M, 2010, INT J CANCER, V127, P2804, DOI 10.1002/ijc.25284; KAUFMANN SH, 1993, CANCER RES, V53, P3976; KERR JFR, 1972, BRIT J CANCER, V26, P239, DOI 10.1038/bjc.1972.33; Kim J, 2007, SCIENCE, V317, P1220, DOI 10.1126/science.1140481; Kojima S, 2012, BRIT J CANCER, V106, P405, DOI 10.1038/bjc.2011.462; Kozaki KI, 2008, CANCER RES, V68, P2094, DOI 10.1158/0008-5472.CAN-07-5194; Kroemer G, 2009, CELL DEATH DIFFER, V16, P3, DOI 10.1038/cdd.2008.150; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; McCarthy JJ, 2008, BBA-GENE REGUL MECH, V1779, P682, DOI 10.1016/j.bbagrm.2008.03.001; Meister G, 2004, RNA, V10, P544, DOI 10.1261/rna.5235104; Mendell JT, 2008, CELL, V133, P217, DOI 10.1016/j.cell.2008.04.001; Mutallip M, 2011, INT J MOL MED, V27, P345, DOI 10.3892/ijmm.2010.589; Navon R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008003; Nohata N, 2012, ONCOTARGET, V3, P9; Patel VA, 2006, J BIOL CHEM, V281, P4663, DOI 10.1074/jbc.M508342200; Pillai RS, 2007, TRENDS CELL BIOL, V17, P118, DOI 10.1016/j.tcb.2006.12.007; Qin W, 2011, ONCOGENE; Rodriguez-Berriguete G, 2012, PROSTATE, V72, P40, DOI 10.1002/pros.21404; Schaefer A, 2010, INT J CANCER, V126, P1166, DOI 10.1002/ijc.24827; Schneider TJ, 1999, J EXP MED, V189, P949, DOI 10.1084/jem.189.6.949; Segura MF, 2007, J NEUROSCI, V27, P11228, DOI 10.1523/JNEUROSCI.3462-07.2007; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; Sole C, 2004, J CELL BIOL, V167, P479, DOI 10.1083/jcb.200403093; Song GS, 2009, J BIOL CHEM, V284, P31921, DOI 10.1074/jbc.M109.046862; Townsend DM, 2003, ONCOGENE, V22, P7369, DOI 10.1038/sj.onc.1206940; Tran N, 2007, BIOCHEM BIOPH RES CO, V358, P12, DOI 10.1016/j.bbrc.2007.03.201; Ungefroren H, 1998, CANCER RES, V58, P1741; Walden TB, 2009, J CELL PHYSIOL, V218, P444, DOI 10.1002/jcp.21621; Wang XH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002557; Witten D, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-58; Wong TS, 2008, CLIN CANCER RES, V14, P2588, DOI 10.1158/1078-0432.CCR-07-0666; Wu Y, 2006, ONCOGENE, V25, P5787, DOI 10.1038/sj.onc.1209576; Xiao FF, 2009, NUCLEIC ACIDS RES, V37, pD105, DOI 10.1093/nar/gkn851; Yoshino H, 2011, BRIT J CANCER, V104, P808, DOI 10.1038/bjc.2011.23	54	76	84	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2012	7	4							e35345	10.1371/journal.pone.0035345	http://dx.doi.org/10.1371/journal.pone.0035345			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UD	22532850	Green Submitted, Green Published, gold			2022-12-25	WOS:000305339200058
J	Vilotti, S; Codrich, M; Dal Ferro, M; Pinto, M; Ferrer, I; Collavin, L; Gustincich, S; Zucchelli, S				Vilotti, Sandra; Codrich, Marta; Dal Ferro, Marco; Pinto, Milena; Ferrer, Isidro; Collavin, Licio; Gustincich, Stefano; Zucchelli, Silvia			Parkinson's Disease DJ-1 L166P Alters rRNA Biogenesis by Exclusion of TTRAP from the Nucleolus and Sequestration into Cytoplasmic Aggregates via TRAF6	PLOS ONE			English	Article							MITOCHONDRIAL-FUNCTION; DOPAMINERGIC-NEURONS; OXIDATIVE DAMAGE; ALPHA-SYNUCLEIN; LEWY BODIES; DYSFUNCTION; PROTEASOME; UBIQUITIN; PROTEIN; STRESS	Mutations in PARK7/DJ-1 gene are associated to autosomal recessive early onset forms of Parkinson's disease (PD). Although large gene deletions have been linked to a loss-of-function phenotype, the pathogenic mechanism of missense mutations is less clear. The L166P mutation causes misfolding of DJ-1 protein and its degradation. L166P protein may also accumulate into insoluble cytoplasmic aggregates with a mechanism facilitated by the E3 ligase TNF receptor associated factor 6 (TRAF6). Upon proteasome impairment L166P activates the JNK/p38 MAPK apoptotic pathway by its interaction with TRAF and TNF Receptor Associated Protein (TTRAP). When proteasome activity is blocked in the presence of wild-type DJ-1, TTRAP forms aggregates that are localized to the cytoplasm or associated to nucleolar cavities, where it is required for a correct rRNA biogenesis. In this study we show that in post-mortem brains of sporadic PD patients TTRAP is associated to the nucleolus and to Lewy Bodies, cytoplasmic aggregates considered the hallmark of the disease. In SH-SY5Y neuroblastoma cells, misfolded mutant DJ-1 L166P alters rRNA biogenesis inhibiting TTRAP localization to the nucleolus and enhancing its recruitment into cytoplasmic aggregates with a mechanism that depends in part on TRAF6 activity. This work suggests that TTRAP plays a role in the molecular mechanisms of both sporadic and familial PD. Furthermore, it unveils the existence of an interplay between cytoplasmic and nucleolar aggregates that impacts rRNA biogenesis and involves TRAF6.	[Vilotti, Sandra; Codrich, Marta; Pinto, Milena; Gustincich, Stefano; Zucchelli, Silvia] SISSA, Neurobiol Sect, I-34014 Trieste, Italy; [Dal Ferro, Marco; Collavin, Licio] Lab Nazl Consorzio Interuniv Biotecnol, Trieste, Italy; [Dal Ferro, Marco; Collavin, Licio] Univ Trieste, Dept Life Sci DSV, Trieste, Italy; [Ferrer, Isidro; Gustincich, Stefano; Zucchelli, Silvia] Univ Barcellona, Univ Hosp Bellvitge, Inst Neuropathol, Inst Invest Biomed Bellvitge, Llbregat, Spain; [Ferrer, Isidro; Gustincich, Stefano; Zucchelli, Silvia] Italian Inst Technol, SISSA Unit, Trieste, Italy	International School for Advanced Studies (SISSA); University of Trieste; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Bellvitge University Hospital; University of Barcelona; International School for Advanced Studies (SISSA); Istituto Italiano di Tecnologia - IIT	Gustincich, S (corresponding author), SISSA, Neurobiol Sect, I-34014 Trieste, Italy.	gustinci@sissa.it; silvia.zucchelli@sissa.it	Pinto, Milena/K-6095-2017; Collavin, Licio/A-5312-2010; Codrich, Marta/AAC-7724-2022	Pinto, Milena/0000-0001-9202-1527; Collavin, Licio/0000-0001-6815-5381; Zucchelli, Silvia/0000-0003-4556-2990; Gustincich, Stefano/0000-0002-2749-2514	Telethon [GGP06268]; Giovanni Armenise-Harvard Foundation; Italian Institute of Technology	Telethon(Fondazione Telethon); Giovanni Armenise-Harvard Foundation; Italian Institute of Technology(Istituto Italiano di Tecnologia - IIT)	The following fundings have supported this work: Telethon Grant GGP06268; The Giovanni Armenise-Harvard Foundation; and the Italian Institute of Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andres-Mateos E, 2007, P NATL ACAD SCI USA, V104, P14807, DOI 10.1073/pnas.0703219104; Betarbet R, 2005, EXP NEUROL, V191, pS17, DOI 10.1016/j.expneurol.2004.08.021; Blaise R, 2001, LEUKEMIA LYMPHOMA, V42, P1173, DOI 10.3109/10428190109097742; Bonifati V, 2003, SCIENCE, V299, P256, DOI 10.1126/science.1077209; Carnemolla A, 2009, J BIOL CHEM, V284, P18167, DOI 10.1074/jbc.M109.018325; Cattaneo E, 2001, TRENDS NEUROSCI, V24, P182, DOI 10.1016/S0166-2236(00)01721-5; Caudle WM, 2009, NEUROSCI LETT, V459, P11, DOI 10.1016/j.neulet.2009.04.060; Dez C, 2006, EMBO J, V25, P1534, DOI 10.1038/sj.emboj.7601035; DiFiglia M, 1997, SCIENCE, V277, P1990, DOI 10.1126/science.277.5334.1990; Ding QX, 2005, J NEUROSCI, V25, P9171, DOI 10.1523/JNEUROSCI.3040-05.2005; Foti R, 2010, J BIOL CHEM, V285, P18565, DOI 10.1074/jbc.M109.088294; Hao LY, 2010, P NATL ACAD SCI USA, V107, P9747, DOI 10.1073/pnas.0911175107; Henras AK, 2008, CELL MOL LIFE SCI, V65, P2334, DOI 10.1007/s00018-008-8027-0; Herrera FE, 2007, J BIOL CHEM, V282, P24905, DOI 10.1074/jbc.M701013200; Kim RH, 2005, P NATL ACAD SCI USA, V102, P5215, DOI 10.1073/pnas.0501282102; Kruger T, 2010, J CELL SCI, V123, P1203, DOI 10.1242/jcs.062398; LaRiviere FJ, 2006, MOL CELL, V24, P619, DOI 10.1016/j.molcel.2006.10.008; Latonen L, 2011, ONCOGENE; Ledesma FC, 2009, NATURE, V461, P674, DOI 10.1038/nature08444; Lesage S, 2009, HUM MOL GENET, V18, pR48, DOI 10.1093/hmg/ddp012; Macedo MG, 2003, HUM MOL GENET, V12, P2807, DOI 10.1093/hmg/ddg304; McNaught KS, 2003, EXP NEUROL, V179, P38, DOI 10.1006/exnr.2002.8050; Murayama A, 2008, CELL, V133, P627, DOI 10.1016/j.cell.2008.03.030; Narla A, 2010, BLOOD, V115, P3196, DOI 10.1182/blood-2009-10-178129; Navarro A, 2009, FREE RADICAL BIO MED, V46, P1574, DOI 10.1016/j.freeradbiomed.2009.03.007; Olzmann JA, 2007, J CELL BIOL, V178, P1025, DOI 10.1083/jcb.200611128; Parlato R, 2008, J NEUROSCI, V28, P12759, DOI 10.1523/JNEUROSCI.2439-08.2008; Pei HP, 2003, ONCOGENE, V22, P2699, DOI 10.1038/sj.onc.1206374; Petrucelli L, 2002, NEURON, V36, P1007, DOI 10.1016/S0896-6273(02)01125-X; Pype S, 2000, J BIOL CHEM, V275, P18586, DOI 10.1074/jbc.M000531200; Rideout HJ, 2005, J NEUROCHEM, V93, P1304, DOI 10.1111/j.1471-4159.2005.03124.x; Rieker C, 2011, J NEUROSCI, V31, P453, DOI 10.1523/JNEUROSCI.0590-10.2011; Sau D, 2007, HUM MOL GENET, V16, P1604, DOI 10.1093/hmg/ddm110; Schmid M, 2008, TRENDS BIOCHEM SCI, V33, P501, DOI 10.1016/j.tibs.2008.07.003; Schmitz KM, 2010, GENE DEV, V24, P2264, DOI 10.1101/gad.590910; Schultheiss U, 2001, EMBO J, V20, P5678, DOI 10.1093/emboj/20.20.5678; Stavreva DA, 2006, MOL CELL BIOL, V26, P5131, DOI 10.1128/MCB.02227-05; Thomas KJ, 2011, HUM MOL GENET, V20, P40, DOI 10.1093/hmg/ddq430; Vasseur S, 2009, P NATL ACAD SCI USA, V106, P1111, DOI 10.1073/pnas.0812745106; Vilotti S, 2011, CELL DEATH DIFFER; Wang C, 2005, HUM MOL GENET, V14, P3885, DOI 10.1093/hmg/ddi413; Zucchelli S, 2009, CELL DEATH DIFFER, V16, P428, DOI 10.1038/cdd.2008.169; Zucchelli S, 2011, J BIOL CHEM; Zucchelli S, 2010, HUM MOL GENET, V19, P3759, DOI 10.1093/hmg/ddq290	44	42	45	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2012	7	4							e35051	10.1371/journal.pone.0035051	http://dx.doi.org/10.1371/journal.pone.0035051			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UD	22532838	Green Published, gold, Green Submitted			2022-12-25	WOS:000305339200034
J	Chen, J; Lippincott-Schwartz, J; Liu, J				Chen, Jing; Lippincott-Schwartz, Jennifer; Liu, Jian			Intracellular Spatial Localization Regulated by the Microtubule Network	PLOS ONE			English	Article							DROSOPHILA NEUROBLASTS; CELL-DIVISION; CYTOPLASMIC DYNEIN; CORTICAL POLARITY; SPINDLE POLES; MESSENGER-RNA; LIVING CELLS; PROTEIN; DORSAL; EMBRYOS	The commonly recognized mechanisms for spatial regulation inside the cell are membrane-bounded compartmentalization and biochemical association with subcellular organelles. We use computational modeling to investigate another spatial regulation mechanism mediated by the microtubule network in the cell. Our results demonstrate that the mitotic spindle can impose strong sequestration and concentration effects on molecules with binding affinity for microtubules, especially dynein-directed cargoes. The model can recapitulate the essence of three experimental observations on distinct microtubule network morphologies: the sequestration of germ plasm components by the mitotic spindles in the Drosophila syncytial embryo, the asymmetric cell division initiated by the time delay in centrosome maturation in the Drosophila neuroblast, and the diffusional block between neighboring energids in the Drosophila syncytial embryo. Our model thus suggests that the cell cycle-dependent changes in the microtubule network are critical for achieving different spatial regulation effects. The microtubule network provides a spatially extensive docking platform for molecules and gives rise to a "structured cytoplasm", in contrast to a free and fluid environment.	[Chen, Jing; Liu, Jian] NHLBI, NIH, Bethesda, MD 20892 USA; [Lippincott-Schwartz, Jennifer] NICHHD, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Chen, J (corresponding author), NHLBI, NIH, Bldg 10, Bethesda, MD 20892 USA.	Jian.Liu@nih.gov	Chen, Jing/D-4845-2016	Chen, Jing/0000-0001-6321-0505; Liu, Jian/0000-0003-2935-0349	National Heart, Lung and Blood Institute at National Institutes of Health (NIH); National Institute of Child Health and Human Development at NIH; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD001609] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL006086] Funding Source: NIH RePORTER	National Heart, Lung and Blood Institute at National Institutes of Health (NIH); National Institute of Child Health and Human Development at NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Dr. Chen and Dr. Liu were supported by the Intramural Research Program of National Heart, Lung and Blood Institute at National Institutes of Health (NIH); Dr. Lippincott-Schwartz was supported by the Intramural Research Program of National Institute of Child Health and Human Development at NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberts B, 2008, MOL BIOL CELL; Becalska AN, 2009, DEVELOPMENT, V136, P2493, DOI 10.1242/dev.032391; Boucrot E, 2007, P NATL ACAD SCI USA, V104, P7939, DOI 10.1073/pnas.0702511104; DeLotto R, 2007, DEVELOPMENT, V134, P4233, DOI 10.1242/dev.010934; Dunster K, 2002, EUR J CELL BIOL, V81, P117, DOI 10.1078/0171-9335-00232; FERRANDON D, 1994, CELL, V79, P1221, DOI 10.1016/0092-8674(94)90013-2; FOE VE, 1983, J CELL SCI, V61, P31; Frescas D, 2006, J CELL BIOL, V173, P219, DOI 10.1083/jcb.200601156; GILLESPIE SKH, 1994, MOL CELL BIOL, V14, P3559, DOI 10.1128/MCB.14.6.3559; Howell BJ, 2000, J CELL BIOL, V150, P1233, DOI 10.1083/jcb.150.6.1233; Howell BJ, 2001, J CELL BIOL, V155, P1159, DOI 10.1083/jcb.200105093; Januschke J, 2010, J CELL BIOL, V188, P693, DOI 10.1083/jcb.200905024; KARR TL, 1986, J CELL BIOL, V102, P1494, DOI 10.1083/jcb.102.4.1494; King SJ, 2000, NAT CELL BIOL, V2, P20, DOI 10.1038/71338; Knoblich JA, 2008, CELL, V132, P583, DOI 10.1016/j.cell.2008.02.007; Kozlowski C, 2007, CELL, V129, P499, DOI 10.1016/j.cell.2007.03.027; Lerit DA, 2011, CURR BIOL, V21, P439, DOI 10.1016/j.cub.2011.01.073; Lippincott-Schwartz J, 2001, NAT REV MOL CELL BIO, V2, P444, DOI 10.1038/35073068; Mavrakis M, 2009, DEV CELL, V16, P93, DOI 10.1016/j.devcel.2008.11.003; Miller JR, 1999, J CELL BIOL, V146, P427, DOI 10.1083/jcb.146.2.427; Montagnac G, 2008, CURR OPIN CELL BIOL, V20, P454, DOI 10.1016/j.ceb.2008.03.011; Nipper RW, 2007, P NATL ACAD SCI USA, V104, P14306, DOI 10.1073/pnas.0701812104; Odell GM, 2008, J CELL BIOL, V183, P471, DOI 10.1083/jcb.200807129; PRENDERGAST FG, 1978, BIOCHEMISTRY-US, V17, P3448, DOI 10.1021/bi00610a004; Ross JL, 2006, NAT CELL BIOL, V8, P562, DOI 10.1038/ncb1421; Rowning BA, 1997, P NATL ACAD SCI USA, V94, P1224, DOI 10.1073/pnas.94.4.1224; Rusan NM, 2007, J CELL BIOL, V177, P13, DOI 10.1083/jcb.200612140; Siegrist SE, 2005, CELL, V123, P1323, DOI 10.1016/j.cell.2005.09.043; St Johnston D, 2005, NAT REV MOL CELL BIO, V6, P363, DOI 10.1038/nrm1643; Wang ZH, 1999, CELL STRUCT FUNCT, V24, P373, DOI 10.1247/csf.24.373; Yang G, 2008, J CELL BIOL, V182, P631, DOI 10.1083/jcb.200801105; Zheng YX, 2010, NAT REV MOL CELL BIO, V11, P529, DOI 10.1038/nrm2919	32	10	10	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2012	7	4							e34919	10.1371/journal.pone.0034919	http://dx.doi.org/10.1371/journal.pone.0034919			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TL	22532834	Green Submitted, gold, Green Published			2022-12-25	WOS:000305336200013
J	Dusingize, JC; Hoover, DR; Shi, QH; Mutimura, E; Kiefer, E; Cohen, M; Anastos, K				Dusingize, Jean-Claude; Hoover, Donald R.; Shi, Qiuhu; Mutimura, Eugene; Kiefer, Elizabeth; Cohen, Mardge; Anastos, Kathryn			Association of Serum Albumin with Markers of Nutritional Status among HIV-Infected and Uninfected Rwandan Women	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS-INFECTION; BIOELECTRICAL-IMPEDANCE ANALYSIS; PROTEIN-ENERGY MALNUTRITION; BODY CELL MASS; FAT-FREE MASS; PULMONARY TUBERCULOSIS; DISEASE PROGRESSION; OLDER PERSONS; MORTALITY; SEVERITY	Introduction: The objectives of this study are to address if and how albumin can be used as an indication of malnutrition in HIV infected and uninfected Africans. Methods: In 2005, 710 HIV-infected and 226 HIV-uninfected women enrolled in a cohort study. Clinical/demographic parameters, CD4 count, albumin, liver transaminases; anthropometric measurements and Bioelectrical Impedance Analysis (BIA) were performed. Malnutrition outcomes were defined as body mass index (BMI), Fat-free mass index (FFMI) and Fat mass index (FMI). Separate linear predictive models including albumin were fit to these outcomes in HIV negative and HIV positive women by CD4 strata (CD4>350,200-350 and,200 cells/mu l). Results: In unadjusted models for each outcome in HIV-negative and HIV positive women with CD4>350 cells/mu l, serum albumin was not significantly associated with BMI, FFMI or FMI. Albumin was significantly associated with all three outcomes (p<0.05) in HIV+ women with CD4 200-350 cells/mu l, and highly significant in HIV+ women with CD4<200 cells/mu l (P<0.001). In multivariable linear regression, albumin remained associated with FFMI in women with CD4 count<200 cells/mu l (p<0.01) but not in HIV+ women with CD4>200. Discussion: While serum albumin is widely used to indicate nutritional status it did not consistently predict malnutrition outcomes in HIV- women or HIV+ women with higher CD4. This result suggests that albumin may measure end stage disease as well as malnutrition and should not be used as a proxy for nutritional status without further study of its association with validated measures.	[Dusingize, Jean-Claude; Kiefer, Elizabeth; Anastos, Kathryn] Albert Einstein Coll Med, Bronx, NY 10467 USA; [Hoover, Donald R.] Rutgers State Univ, Dept Stat & Biostat, Piscataway, NJ USA; [Hoover, Donald R.] Rutgers State Univ, Inst Hlth Hlth Care Policy & Aging Res, Piscataway, NJ USA; [Shi, Qiuhu] New York Med Coll, Valhalla, NY 10595 USA; [Mutimura, Eugene] Womens Equity Access Care & Treatment WE ACTx, Kigali, Rwanda; [Mutimura, Eugene] Kigali Hlth Inst, Kigali, Rwanda; [Cohen, Mardge] Rush Univ, Chicago, IL 60612 USA; [Cohen, Mardge] Stroger Cook Cty Hosp, Chicago, IL USA	Yeshiva University; Albert Einstein College of Medicine; Rutgers State University New Brunswick; Rutgers State University New Brunswick; New York Medical College; Rush University; John H Stroger Junior Hospital Cook County	Dusingize, JC (corresponding author), Albert Einstein Coll Med, Bronx, NY 10467 USA.	dusingize@gmail.com		Dusingize, Jean Claude/0000-0001-5721-100X	National Institute of Allergy and Infectious Diseases [UO1-AI-35004]; Fogarty International Center, United States National Institutes of Health [D43-TW001403]; Center for AIDS Research of the Albert Einstein College of Medicine; Montefiore Medical Center; National Institutes of Health (NIH) [AI-51519]; National Institute of Diabetes and Digestive and Kidney Disease [DK54615]; Chicago WIHS [U01-AI-34993]; CTSA Grant [UL1 RR025750]; FOGARTY INTERNATIONAL CENTER [D43TW001403] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [D43CA153793] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025750] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI035004, P30AI051519, U01AI034993, U01AI096299] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK054615] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Fogarty International Center, United States National Institutes of Health; Center for AIDS Research of the Albert Einstein College of Medicine; Montefiore Medical Center; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Diabetes and Digestive and Kidney Disease(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Chicago WIHS; CTSA Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported by supplements from the National Institute of Allergy and Infectious Diseases to the Bronx/Manhattan Women's Interagency HIV Study (WIHS), which is funded by the National Institute of Allergy and Infectious Diseases (UO1-AI-35004). This work was also supported by the AIDS International Training and Research Program (Fogarty International Center, United States National Institutes of Health D43-TW001403) and the Center for AIDS Research of the Albert Einstein College of Medicine and Montefiore Medical Center funded by the National Institutes of Health (NIH AI-51519) and by the National Institute of Diabetes and Digestive and Kidney Disease (DK54615), and the Chicago WIHS (U01-AI-34993). This study was also supported in part by the CTSA Grant UL1 RR025750, a component of the National Institutes of Health (NIH), and NIH roadmap for Medical Research. Its contents are solely the responsibility of the authors and do not necessarily represent the official view of the NCRR or NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2008, Stud Fam Plann, V39, P147; Beck FK, 2002, AM FAM PHYSICIAN, V65, P1575; Brown Todd T, 2009, AIDS Res Ther, V6, P8, DOI 10.1186/1742-6405-6-8; Bukusuba J, 2007, BRIT J NUTR, V98, P211, DOI 10.1017/S0007114507691806; CEDERHOLM T, 1995, AM J MED, V98, P67, DOI 10.1016/S0002-9343(99)80082-5; Covinsky KE, 2002, J AM GERIATR SOC, V50, P631, DOI 10.1046/j.1532-5415.2002.50156.x; DOWEIKO JP, 1991, JPEN-PARENTER ENTER, V15, P476, DOI 10.1177/0148607191015004476; Eveleth PB, 1996, AM J HUM BIOL, V8, P786, DOI 10.1002/(SICI)1520-6300(1996)8:6<786::AID-AJHB11>3.0.CO;2-I; Feldman JG, 2000, AIDS, V14, P863, DOI 10.1097/00002030-200005050-00013; Goldwasser P, 1997, J CLIN EPIDEMIOL, V50, P693, DOI 10.1016/S0895-4356(97)00015-2; Graham SM, 2007, AIDS RES HUM RETROV, V23, P1197, DOI 10.1089/aid.2007.0065; Hattori K, 1997, AM J HUM BIOL, V9, P573, DOI 10.1002/(SICI)1520-6300(1997)9:5<573::AID-AJHB5>3.0.CO;2-V; Kotler D, 2004, JAIDS-J ACQ IMM DEF, V37, pS280, DOI 10.1097/01.qai.0000144383.55091.c1; Kotler Donald P., 1996, American Journal of Clinical Nutrition, V64, p489S, DOI 10.1093/ajcn/64.3.489S; Kresge KJ, 2006, IAVI REP, V10, P16; Kyle UG, 2004, CLIN NUTR, V23, P1430, DOI 10.1016/j.clnu.2004.09.012; Kyle UG, 2003, CURR OPIN CLIN NUTR, V6, P387, DOI 10.1097/01.mco.0000078988.18774.3d; Kyle UG, 2002, CURR OPIN CLIN NUTR, V5, P427, DOI 10.1097/00075197-200207000-00012; Larmarange J, 2009, MED SCI PARIS, P87; MACALLAN DC, 1995, NEW ENGL J MED, V333, P83, DOI 10.1056/NEJM199507133330202; Mupere E, 2010, ANN EPIDEMIOL, V20, P210, DOI 10.1016/j.annepidem.2009.11.001; Omran ML, 2000, NUTRITION, V16, P50, DOI 10.1016/S0899-9007(99)00224-5; Papathakis PC, 2006, JAIDS-J ACQ IMM DEF, V43, P467, DOI 10.1097/01.qai.0000243094.42276.92; PHILLIPS A, 1989, LANCET, V2, P1434; Powanda MC, 2003, J NUTR, V133, p322S, DOI 10.1093/jn/133.1.322S; REUBEN DB, 1995, J AM GERIATR SOC, V43, P415, DOI 10.1111/j.1532-5415.1995.tb05818.x; Roubenoff Ronenn, 1996, American Journal of Clinical Nutrition, V64, p459S, DOI 10.1093/ajcn/64.3.459S; Sabin CA, 2002, LANCET, V360, P1546, DOI 10.1016/S0140-6736(02)11519-4; Semba RD, 1999, BRIT J NUTR, V81, P181, DOI 10.1017/S0007114599000379; Shah S, 2001, J NUTR, V131, P2843, DOI 10.1093/jn/131.11.2843; Tang AM, 2002, JAIDS-J ACQ IMM DEF, V31, P230, DOI 10.1097/00126334-200210010-00014; Van Lettow M, 2004, INT J TUBERC LUNG D, V8, P211; VANITALLIE TB, 1990, AM J CLIN NUTR, V52, P953, DOI 10.1093/ajcn/52.6.953	33	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2012	7	4							e35079	10.1371/journal.pone.0035079	http://dx.doi.org/10.1371/journal.pone.0035079			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TL	22532840	gold, Green Published, Green Submitted			2022-12-25	WOS:000305336200022
J	Pitchers, KK; Schmid, S; Di Sebastiano, AR; Wang, X; Laviolette, SR; Lehman, MN; Coolen, LM				Pitchers, Kyle K.; Schmid, Susanne; Di Sebastiano, Andrea R.; Wang, Xu; Laviolette, Steven R.; Lehman, Michael N.; Coolen, Lique M.			Natural Reward Experience Alters AMPA and NMDA Receptor Distribution and Function in the Nucleus Accumbens	PLOS ONE			English	Article							MEDIAL PREFRONTAL CORTEX; RATS RATTUS-NORVEGICUS; BEHAVIORAL SENSITIZATION; SEXUAL-BEHAVIOR; DELTA-FOSB; SURFACE EXPRESSION; SILENT SYNAPSES; PREOPTIC AREA; INSTRUMENTAL BEHAVIOR; STRUCTURAL PLASTICITY	Natural reward and drugs of abuse converge upon the mesolimbic system which mediates motivation and reward behaviors. Drugs induce neural adaptations in this system, including transcriptional, morphological, and synaptic changes, which contribute to the development and expression of drug-related memories and addiction. Previously, it has been reported that sexual experience in male rats, a natural reward behavior, induces similar neuroplasticity in the mesolimbic system and affects natural reward and drug-related behavior. The current study determined whether sexual experience causes long-lasting changes in mating, or ionotropic glutamate receptor trafficking or function in the nucleus accumbens (NAc), following 3 different reward abstinence periods: 1 day, 1 week, or 1 month after final mating session. Male Sprague Dawley rats mated during 5 consecutive days (sexual experience) or remained sexually naive to serve as controls. Sexually experienced males displayed facilitation of initiation and performance of mating at each time point. Next, intracellular and membrane surface expression of N-methyl-D-aspartate (NMDA: NR1 subunit) and alpha-amino-3-hydroxy-5-methylisoxazole-4-propionate (AMPA: GluA1, GluA2 subunits) receptors in the NAc was determined using a bis(sulfosuccinimidyl) suberate (BS3) protein cross-linking assay followed by Western Blot analysis. NR1 expression was increased at 1 day abstinence both at surface and intracellular, but decreased at surface at 1 week of abstinence. GluA2 was increased intracellularly at 1 week and increased at the surface after 1 month of abstinence. Finally, whole-cell patch clamp electrophysiological recordings determined reduced AMPA/NMDA ratio of synaptic currents in NAc shell neurons following stimulation of cortical afferents in sexually experienced males after all reward abstinence periods. Together, these data show that sexual experience causes long-term alterations in glutamate receptor expression and function in the NAc. Although not identical, this sex experience-induced neuroplasticity has similarities to that caused by psychostimulants, suggesting common mechanisms for reinforcement of natural and drug reward.	[Pitchers, Kyle K.; Schmid, Susanne; Di Sebastiano, Andrea R.; Wang, Xu; Laviolette, Steven R.; Lehman, Michael N.; Coolen, Lique M.] Univ Western Ontario, Schulich Sch Med & Dent, Dept Anat, London, ON, Canada; [Pitchers, Kyle K.; Schmid, Susanne; Di Sebastiano, Andrea R.; Wang, Xu; Laviolette, Steven R.; Lehman, Michael N.; Coolen, Lique M.] Univ Western Ontario, Schulich Sch Med & Dent, Dept Cell Biol, London, ON, Canada; [Pitchers, Kyle K.; Di Sebastiano, Andrea R.; Lehman, Michael N.; Coolen, Lique M.] Univ Michigan, Dept Mol, Ann Arbor, MI 48109 USA; [Pitchers, Kyle K.; Di Sebastiano, Andrea R.; Lehman, Michael N.; Coolen, Lique M.] Univ Michigan, Dept Integrat Physiol, Ann Arbor, MI 48109 USA; [Coolen, Lique M.] Univ Michigan, Dept Psychol, Ann Arbor, MI 48109 USA	Western University (University of Western Ontario); Western University (University of Western Ontario); University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Pitchers, KK (corresponding author), Univ Western Ontario, Schulich Sch Med & Dent, Dept Anat, London, ON, Canada.	coolenlm@umich.edu	Lehman, Michael/ABC-9076-2020; Schmid, Susanne/J-3201-2012	Schmid, Susanne/0000-0001-5366-8061; Coolen, Lique/0000-0003-2920-1116; Lehman, Michael/0000-0002-9076-5108	Canadian Institutes of Health Research; Natural Sciences and Engineering Research Council	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC))	Canadian Institutes of Health Research to LMC and ARD, and Natural Sciences and Engineering Research Council to LMC and KKP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGMO A, 1993, BEHAV NEUROSCI, V107, P812, DOI 10.1037/0735-7044.107.5.812; AGMO A, 1990, BEHAV NEUROSCI, V104, P177, DOI 10.1037/0735-7044.104.1.177; Agmo A, 1997, BRAIN RES PROTOC, V1, P203, DOI 10.1016/S1385-299X(96)00036-0; Avena NM, 2008, PHYSIOL BEHAV, V94, P309, DOI 10.1016/j.physbeh.2008.01.008; Avena Nicole M, 2009, Eat Disord, V17, P89, DOI 10.1080/10640260802371604; Avena NM, 2009, J NUTR, V139, P623, DOI 10.3945/jn.108.097584; Bachtell RK, 2008, J NEUROSCI, V28, P12808, DOI 10.1523/JNEUROSCI.2060-08.2008; Balfour ME, 2004, NEUROPSYCHOPHARMACOL, V29, P718, DOI 10.1038/sj.npp.1300350; Belujon P, 2011, ANN NY ACAD SCI, V1216, P114, DOI 10.1111/j.1749-6632.2010.05896.x; Bisaga A, 2007, HUM PSYCHOPHARM CLIN, V22, P41, DOI 10.1002/hup.816; Boudreau AC, 2005, J NEUROSCI, V25, P9144, DOI 10.1523/JNEUROSCI.2252-05.2005; Boudreau AC, 2007, J NEUROSCI, V27, P10621, DOI 10.1523/JNEUROSCI.2163-07.2007; Boudreau AC, 2009, J NEUROCHEM, V110, P363, DOI 10.1111/j.1471-4159.2009.06140.x; Bradley KC, 2005, GENES BRAIN BEHAV, V4, P31, DOI 10.1111/j.1601-183X.2004.00093.x; Bradley KC, 2001, J NEUROSCI, V21, P2123, DOI 10.1523/JNEUROSCI.21-06-02123.2001; Brown TE, 2011, J NEUROSCI, V31, P8163, DOI 10.1523/JNEUROSCI.0016-11.2011; Chen BT, 2008, NEURON, V59, P288, DOI 10.1016/j.neuron.2008.05.024; Conrad KL, 2008, NATURE, V454, P118, DOI 10.1038/nature06995; Cornish JL, 2000, J NEUROSCI, V20, part. no., DOI 10.1523/JNEUROSCI.20-15-j0006.2000; Davis JF, 2010, BIOL PSYCHIAT, V67, P1199, DOI 10.1016/j.biopsych.2009.12.029; Dietz DM, 2009, PHARMACOPSYCHIATRY, V42, pS69, DOI 10.1055/s-0029-1202847; Dominguez JM, 2007, BEHAV NEUROSCI, V121, P1023, DOI 10.1037/0735-7044.121.5.1023; EVERITT BJ, 1987, J COMP PSYCHOL, V101, P407, DOI 10.1037/0735-7036.101.4.407; EVERITT BJ, 1989, NEUROSCIENCE, V30, P63, DOI 10.1016/0306-4522(89)90353-9; EVERITT BJ, 1987, J COMP PSYCHOL, V101, P395, DOI 10.1037/0735-7036.101.4.395; Famous KR, 2008, J NEUROSCI, V28, P11061, DOI 10.1523/JNEUROSCI.1221-08.2008; Feil J, 2010, NEUROSCI BIOBEHAV R, V35, P248, DOI 10.1016/j.neubiorev.2010.03.001; Ferrario CR, 2010, NEUROPSYCHOPHARMACOL, V35, P818, DOI 10.1038/npp.2009.190; FLEMING AS, 1991, BEHAV NEURAL BIOL, V56, P319, DOI 10.1016/0163-1047(91)90499-G; Frohmader KS, 2011, J NEUROSCI, V31, P16473, DOI 10.1523/JNEUROSCI.4013-11.2011; Frohmader KS, 2010, HORM BEHAV, V58, P149, DOI 10.1016/j.yhbeh.2009.11.009; Gao C, 2008, J NEUROCHEM, V106, P2489, DOI 10.1111/j.1471-4159.2008.05597.x; Ghasemzadeh MB, 2009, NEUROSCIENCE, V159, P414, DOI 10.1016/j.neuroscience.2008.10.027; Goldstein RZ, 2011, NAT REV NEUROSCI, V12, P652, DOI 10.1038/nrn3119; Grimm JW, 2001, NATURE, V412, P141, DOI 10.1038/35084134; Groc L, 2006, TRENDS NEUROSCI, V29, P132, DOI 10.1016/j.tins.2006.01.005; Hu XT, 2005, NEUROPSYCHOPHARMACOL, V30, P916, DOI 10.1038/sj.npp.1300654; Hu XT, 2004, J NEUROPHYSIOL, V92, P1597, DOI 10.1152/jn.00217.2004; Huang YHH, 2009, NEURON, V63, P40, DOI 10.1016/j.neuron.2009.06.007; Ishikawa A, 2008, NEUROSCIENCE, V155, P573, DOI 10.1016/j.neuroscience.2008.06.037; Ishikawa M, 2009, J NEUROSCI, V29, P5820, DOI 10.1523/JNEUROSCI.5703-08.2009; KAGAN J, 1955, J COMP PHYSIOL PSYCH, V48, P59, DOI 10.1037/h0043461; Kalivas PW, 2009, NAT REV NEUROSCI, V10, P561, DOI 10.1038/nrn2515; KARLER R, 1989, LIFE SCI, V45, P599, DOI 10.1016/0024-3205(89)90045-3; Kourrich S, 2007, J NEUROSCI, V27, P7921, DOI 10.1523/JNEUROSCI.1859-07.2007; Kourrich S, 2009, J NEUROSCI, V29, P12275, DOI 10.1523/JNEUROSCI.3028-09.2009; Li YH, 2006, J PSYCHOPHARMACOL, V20, P40, DOI [10.1177/02698881105057250, 10.1177/0269881105057250]; Liao DH, 1999, NAT NEUROSCI, V2, P37, DOI 10.1038/4540; Lopez HH, 2002, PHARMACOL BIOCHEM BE, V72, P65, DOI 10.1016/S0091-3057(01)00732-8; Mameli M, 2009, NAT NEUROSCI, V12, P1036, DOI 10.1038/nn.2367; Marie H, 2005, NEURON, V45, P741, DOI 10.1016/j.neuron.2005.01.039; McClung CA, 2003, NAT NEUROSCI, V6, P1208, DOI 10.1038/nn1143; McCutcheon JE, 2011, J NEUROSCI, V31, P5737, DOI 10.1523/JNEUROSCI.0350-11.2011; MCGEORGE AJ, 1989, NEUROSCIENCE, V29, P503, DOI 10.1016/0306-4522(89)90128-0; Morgane PJ, 2005, PROG NEUROBIOL, V75, P143, DOI 10.1016/j.pneurobio.2005.01.001; Moussawi K, 2009, NAT NEUROSCI, V12, P182, DOI 10.1038/nn.2250; Mu P, 2010, J NEUROSCI, V30, P3689, DOI 10.1523/JNEUROSCI.4063-09.2010; Nelson CL, 2009, J NEUROCHEM, V109, P35, DOI 10.1111/j.1471-4159.2009.05911.x; Numan M, 2007, DEV PSYCHOBIOL, V49, P12, DOI 10.1002/dev.20198; Pickard L, 2000, J NEUROSCI, V20, P7922; Pierce RC, 1996, J NEUROSCI, V16, P1550; Pitchers KK, 2010, GENES BRAIN BEHAV, V9, P831, DOI 10.1111/j.1601-183X.2010.00621.x; Pitchers KK, 2010, BIOL PSYCHIAT, V67, P872, DOI 10.1016/j.biopsych.2009.09.036; Powell WS, 2003, BEHAV NEUROSCI, V117, P69, DOI 10.1037/0735-7044.117.1.69; Robinson TE, 2004, NEUROPHARMACOLOGY, V47, P33, DOI 10.1016/j.neuropharm.2004.06.025; Schumann J, 2009, J NEUROSCI, V29, P6955, DOI 10.1523/JNEUROSCI.1329-09.2009; SHEFFIELD FD, 1951, J COMP PHYSIOL PSYCH, V44, P3, DOI 10.1037/h0060074; Stuber GD, 2011, NATURE, V475, P377, DOI 10.1038/nature10194; Suto N, 2004, NEUROPSYCHOPHARMACOL, V29, P2149, DOI 10.1038/sj.npp.1300533; Tenk CM, 2009, HORM BEHAV, V55, P93, DOI 10.1016/j.yhbeh.2008.08.012; Thomas MJ, 2008, BRIT J PHARMACOL, V154, P327, DOI 10.1038/bjp.2008.77; Thomas MJ, 2001, NAT NEUROSCI, V4, P1217, DOI 10.1038/nn757; Vanderschuren LJMJ, 2000, PSYCHOPHARMACOLOGY, V151, P99, DOI 10.1007/s002130000493; vanFurth WR, 1995, BRAIN RES REV, V21, P162, DOI 10.1016/0165-0173(96)82985-7; Vialou V, 2010, NAT NEUROSCI, V13, P745, DOI 10.1038/nn.2551; Vucetic Z, 2010, WIRES SYST BIOL MED, V2, P577, DOI 10.1002/wsbm.77; Wallace DL, 2008, J NEUROSCI, V28, P10272, DOI 10.1523/JNEUROSCI.1531-08.2008; Wolf ME, 2010, NEUROSCI BIOBEHAV R, V35, P185, DOI 10.1016/j.neubiorev.2010.01.013; Wolf ME, 2010, TRENDS NEUROSCI, V33, P391, DOI 10.1016/j.tins.2010.06.003; Wolf ME, 1998, PROG NEUROBIOL, V54, P679, DOI 10.1016/S0301-0082(97)00090-7; YOSHIDA M, 1992, NEUROSCI LETT, V139, P73, DOI 10.1016/0304-3940(92)90861-Z; Young LJ, 2004, NAT NEUROSCI, V7, P1048, DOI 10.1038/nn1327; Young LJ, 2001, HORM BEHAV, V40, P133, DOI 10.1006/hbeh.2001.1691; Zhang XF, 2002, J PHARMACOL EXP THER, V301, P1119, DOI 10.1124/jpet.301.3.1119; Zhang XF, 1998, J NEUROSCI, V18, P488	85	39	39	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2012	7	4							e34700	10.1371/journal.pone.0034700	http://dx.doi.org/10.1371/journal.pone.0034700			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959XD	22529926	gold, Green Published, Green Submitted			2022-12-25	WOS:000305350600021
J	Zhang, XM; Azhar, G; Wei, JY				Zhang, Xiaomin; Azhar, Gohar; Wei, Jeanne Y.			The Expression of microRNA and microRNA Clusters in the Aging Heart	PLOS ONE			English	Article							SERUM RESPONSE FACTOR; CARDIAC-HYPERTROPHY; ARGONAUTE PROTEINS; GENE-EXPRESSION; BIOGENESIS PATHWAYS; CELL-PROLIFERATION; MESSENGER-RNAS; CANCER-CELLS; RAT-HEART; SENESCENCE	Background: The microRNAs have been implicated in the process of cardiac development, cardiac hypertrophy, and heart failure. However, the impact of adult aging on cardiac expression of miRNA clusters, as well as both miRNA guide (miR) and passenger (miR*) strands has not been well established. Methods/Results: We explored the expression profile of both miR and miR* in the hearts of young adult versus old mice. We found that 65 miRNAs were differentially expressed in the old versus young adult hearts; approximately half of them were clustered miRNAs that were distributed in 11 miRNA clusters. Each miRNA cluster contained from 2 to as many as 71 miRNA genes. The majority of the clusters displayed similar expression, with most cluster members within a cluster being either increased or decreased together, suggesting that most clusters are likely to be regulated by a common signaling mechanism and that the combined expression of multiple miRNA genes in a cluster could pose an impact on a broad range of targets during aging. We also found age-related changes in the expression of miR*s. The expression of both miR and miR* correlated with that of pri-miRNA transcript over the time course from development and maturation through adult aging. Age-related changes in the expression of Ago1 and Ago2 proteins in the heart were also observed. Transfection assay revealed that both Ago1 and Ago2 synergistically induced miR-21 and miR-21* when the mir-21 plasmid was co-transfected with either. Conclusion: The data revealed age-related changes in the expression of pri-miRNA transcript, Argonaut proteins and both miR and miR* strands. The major changes occurred later in life, from middle to old age. It is likely that the expression of miR and miR* is regulated by both pri-miRNA transcription as well as Ago1 and Ago2 proteins during adult aging.	[Zhang, Xiaomin; Azhar, Gohar; Wei, Jeanne Y.] Univ Arkansas Med Sci & Geriatr Res, Cent Arkansas Vet Healthcare Syst, Educ & Clin Ctr, Donald W Reynolds Dept Geriatr, Little Rock, AR USA	Geriatric Research Education & Clinical Center; University of Arkansas System; University of Arkansas Medical Sciences; US Department of Veterans Affairs; Veterans Health Administration (VHA); Central Arkansas Veterans Healthcare System	Zhang, XM (corresponding author), Univ Arkansas Med Sci & Geriatr Res, Cent Arkansas Vet Healthcare Syst, Educ & Clin Ctr, Donald W Reynolds Dept Geriatr, Little Rock, AR USA.	weijeanne@uams.edu	Zhang, Xiaomin/GVT-8927-2022		National Institutes of Health from the Department of Health and Human Services [AG-018388, AG-026091, AG-028718]; Geriatric Research, Education, and Clinical Center (GRECC); Central Arkansas Veterans Healthcare System; NATIONAL INSTITUTE ON AGING [R01AG018388, P30AG028718, R01AG026091] Funding Source: NIH RePORTER	National Institutes of Health from the Department of Health and Human Services; Geriatric Research, Education, and Clinical Center (GRECC); Central Arkansas Veterans Healthcare System(US Department of Veterans Affairs); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was supported in part by National Institutes of Health grants AG-018388, AG-026091, and AG-028718 from the Department of Health and Human Services, The Geriatric Research, Education, and Clinical Center (GRECC), and the Central Arkansas Veterans Healthcare System. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arroyo JD, 2011, P NATL ACAD SCI USA, V108, P5003, DOI 10.1073/pnas.1019055108; Arvey A, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.24; BALL KL, 1994, J MOL CELL CARDIOL, V26, P519, DOI 10.1006/jmcc.1994.1062; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bennett LB, 2009, GENE CHROMOSOME CANC, V48, P828, DOI 10.1002/gcc.20687; BESSE S, 1993, AM J PHYSIOL, V265, pH183, DOI 10.1152/ajpheart.1993.265.1.H183; Brett JO, 2011, AGING-US, V3, P108, DOI 10.18632/aging.100285; Busk PK, 2010, BIOCHEM BIOPH RES CO, V396, P989, DOI 10.1016/j.bbrc.2010.05.039; CARRIER L, 1992, CIRC RES, V70, P999, DOI 10.1161/01.RES.70.5.999; Cenik ES, 2011, CURR BIOL, V21, pR446, DOI 10.1016/j.cub.2011.05.020; Chatterjee S, 2011, DEV CELL, V20, P388, DOI 10.1016/j.devcel.2011.02.008; Cheloufi S, 2010, NATURE, V465, P584, DOI 10.1038/nature09092; Chen LH, 2010, AGEING RES REV, V9, pS59, DOI 10.1016/j.arr.2010.08.002; CHEVALIER B, 1992, BASIC RES CARDIOL, V87, P187; Chinchilla A, 2011, CARDIOVASC RES, V89, P98, DOI 10.1093/cvr/cvq264; Corcoran DL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005279; Cullen BR, 2004, MOL CELL, V16, P861, DOI 10.1016/j.molcel.2004.12.002; Czech B, 2011, NAT REV GENET, V12, P19, DOI 10.1038/nrg2916; Czech B, 2009, MOL CELL, V36, P445, DOI 10.1016/j.molcel.2009.09.028; Drummond MJ, 2011, PHYSIOL GENOMICS, V43, P595, DOI 10.1152/physiolgenomics.00148.2010; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Ghildiyal M, 2010, RNA, V16, P43, DOI 10.1261/rna.1972910; Grillari J, 2010, BIOGERONTOLOGY, V11, P501, DOI 10.1007/s10522-010-9272-9; Grillari J, 2010, EXP GERONTOL, V45, P302, DOI 10.1016/j.exger.2010.01.007; Hackl M, 2010, AGING CELL, V9, P291, DOI 10.1111/j.1474-9726.2010.00549.x; Han M, 2011, CURR OPIN CARDIOL, V26, P181, DOI 10.1097/HCO.0b013e328345983d; Havens MA, 2012, NUCLEIC ACIDS RES, V40, P4626, DOI 10.1093/nar/gks026; Hertel J, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-25; Khan AA, 2009, NAT BIOTECHNOL, V27, P549, DOI 10.1038/nbt.1543; KIMBALL KA, 1991, EUR J PHARM-MOLEC PH, V208, P231, DOI 10.1016/0922-4106(91)90100-V; Kuzmin A, 2008, GENE EXPR PATTERNS, V8, P107, DOI 10.1016/j.modgep.2007.09.005; Lanceta J, 2010, EXP GERONTOL, V45, P269, DOI 10.1016/j.exger.2009.12.009; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li GR, 2009, MECH AGEING DEV, V130, P731, DOI 10.1016/j.mad.2009.09.002; Lin ZQ, 2009, P NATL ACAD SCI USA, V106, P12103, DOI 10.1073/pnas.0811371106; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Martineza I, 2011, P NATL ACAD SCI USA, V108, P522, DOI 10.1073/pnas.1017346108; Mayr C, 2009, CELL, V138, P673, DOI 10.1016/j.cell.2009.06.016; Morrisey EE, 2010, J CLIN INVEST, V120, P3817, DOI 10.1172/JCI44596; Nishi H, 2011, MOL CELL BIOL, V31, P744, DOI 10.1128/MCB.00581-10; Ohdaira H, 2012, CELL PROLIFERAT, V45, P32, DOI 10.1111/j.1365-2184.2011.00798.x; Okamura K, 2008, NAT STRUCT MOL BIOL, V15, P354, DOI 10.1038/nsmb.1409; Okamura K, 2009, MOL CELL, V36, P431, DOI 10.1016/j.molcel.2009.09.027; Pugh KG, 2001, DRUG AGING, V18, P263, DOI 10.2165/00002512-200118040-00004; Saini HK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-564; Saito Takaya, 2012, Silence, V3, P3, DOI 10.1186/1758-907X-3-3; Sandberg R, 2008, SCIENCE, V320, P1643, DOI 10.1126/science.1155390; Sayed D, 2007, CIRC RES, V100, P416, DOI 10.1161/01.RES.0000257913.42552.23; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Seitz H, 2008, CURR BIOL, V18, P147, DOI 10.1016/j.cub.2007.12.049; Shomron N, 2009, J BIOMED BIOTECHNOL, DOI 10.1155/2009/594678; Siomi H, 2010, MOL CELL, V38, P323, DOI 10.1016/j.molcel.2010.03.013; Thum T, 2007, CIRCULATION, V116, P258, DOI 10.1161/CIRCULATIONAHA.107.687947; Turchinovich A, 2011, NUCLEIC ACIDS RES, V39, P7223, DOI 10.1093/nar/gkr254; van Almen GC, 2011, AGING CELL, V10, P769, DOI 10.1111/j.1474-9726.2011.00714.x; Vasa-Nicotera M, 2011, ATHEROSCLEROSIS, V217, P326, DOI 10.1016/j.atherosclerosis.2011.03.034; VIJG J, 1995, J AM GERIATR SOC, V43, P426, DOI 10.1111/j.1532-5415.1995.tb05819.x; Wang BB, 2009, NAT STRUCT MOL BIOL, V16, P1259, DOI 10.1038/nsmb.1712; Wei JY, 2000, AGING WELL COMPLETE; Winter J, 2011, RNA BIOL, V8, P1149, DOI 10.4161/rna.8.6.17665; Winter J, 2009, NAT CELL BIOL, V11, P228, DOI 10.1038/ncb0309-228; Woods K, 2007, J BIOL CHEM, V282, P2130, DOI 10.1074/jbc.C600252200; Yang JS, 2011, MOL CELL, V43, P892, DOI 10.1016/j.molcel.2011.07.024; YOUNES A, 1995, AM J PHYSIOL-HEART C, V269, pH1003, DOI 10.1152/ajpheart.1995.269.3.H1003; Zamore PD, 2005, SCIENCE, V309, P1519, DOI 10.1126/science.1111444; Zhang XM, 2011, J BIOMED SCI, V18, DOI 10.1186/1423-0127-18-15; Zhang XM, 2004, J BIOL CHEM, V279, P55626, DOI 10.1074/jbc.M405945200; Zhang XM, 2003, AM J PHYSIOL-REG I, V285, pR552, DOI 10.1152/ajpregu.00631.2002	68	62	68	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2012	7	4							e34688	10.1371/journal.pone.0034688	http://dx.doi.org/10.1371/journal.pone.0034688			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959XD	22529925	gold, Green Published, Green Submitted			2022-12-25	WOS:000305350600020
J	Ayele, K; Tesfa, B; Abebe, L; Tilahun, T; Girma, E				Ayele, Ketema; Tesfa, Bisrat; Abebe, Lakew; Tilahun, Tizta; Girma, Eshetu			Self Care Behavior among Patients with Diabetes in Harari, Eastern Ethiopia: The Health Belief Model Perspective	PLOS ONE			English	Article								Background: Diabetes mellitus is a chronic disease that requires lifelong medical treatments and a life style adjustment. To prevent serious morbidity and mortality, it requires dedication to demanding self-care behaviors in multiple domains. The objective of this study was to identify predictors of self care behaviors among patients with diabetes. Methods: From a total of 425 follow up diabetic patients, a quantitative cross sectional study was conducted among 222 of them from three different hospitals in Harar town, from March to April, 2011. The sample was taken using simple random sampling method. Data was collected using pretested questionnaire. Descriptive statistics multiple logistic regression analysis were also used to assess the predicators of self care behaviors among patients with diabetes. Result: Majority of the study respondents 134 (60.4%) were female and the mean age was 49.7 (SD +/- 14.7) years. More than half 147(66.2%) of them were medically diagnosed with type-2 diabetes. 208(93.7%) had general knowledge about diabetes and specific knowledge about diabetes self care 207(93.2%). Large proportion of them had moderate perceived susceptibility 174(78.4%) and severity 112(50.5%). More than half of the respondents 149(67.1%) had less perceived barrier while only 30 (13.5%) of them had high self efficacy to self care practices related to diabetes mellitus. Only 87(39.2%) followed the recommended self care practices on diabetes. Conclusions: Patients with less frequent information were less likely to take diabetes self care. Patients who were more educated, middle income, had high perceived severity of diabetes and less perceived barrier to self care were more likely to take diabetes self care. To increase the self care behavior, diabetes messages should focus on severity of diabetes and how to overcome barriers for self care by segmenting the audiences based on income and educational status with increasing the frequency and reach of message on diabetes.	[Ayele, Ketema] Harar Hlth Sci Coll, Harai, Ethiopia; [Tesfa, Bisrat; Abebe, Lakew; Girma, Eshetu] Jimma Univ, Dept Hlth Educ & Behav Sci, Jimma, Ethiopia; [Tilahun, Tizta] Jimma Univ, Dept Populat & Family Hlth, Jimma, Ethiopia	Jimma University; Jimma University	Ayele, K (corresponding author), Harar Hlth Sci Coll, Harai, Ethiopia.	grm_sht@yahoo.com	Tilahun, Tizta/K-7468-2017	Tilahun, Tizta/0000-0002-3842-9844	Jimma University	Jimma University	This study was funded by Jimma University. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abduelkarem A, CHANGES SOME HLTH IN; Aburuz SM, 2002, INT J PHARM PRACTICE, V10S, P96; Adibe O, 2009, INT J DRUG DEV RES, V1, P85; Bahru Y, 2009, ASSESSMENT DIABETES; Ben Abdelaziz Ahmed, 2006, Tunis Med, V84, P415; Brooke L, 2008, ENV FACTORS DIABETES; Deshmukh S, 2000, INT J DIAB DEV COUNT, V20; Diabetes Monitor, 2005, DIAB MON INF ED SUPP; Elizabeth R, DIABETES SELF CARE A; Julia L, 2010, AUST PRESCR, V33, P138; Katie W, 2005, DIABETES CARE, V28, P1346; Khattab M, 2010, J DIABETES COMPLICAT, V24, P84, DOI 10.1016/j.jdiacomp.2008.12.008; King H, 1998, DIABETES CARE, V21, P1414, DOI 10.2337/diacare.21.9.1414; Lefebvre C., 1998, HLTH ED Q, V15, P299; LESTER FT, 1991, DIABETIC MED, V8, P272, DOI 10.1111/j.1464-5491.1991.tb01585.x; Levetan C, 2003, DIABETES CARE, V26, P1, DOI 10.2337/diacare.26.1.1; Morowati A, 2009, DANESHVAR MED, V16, P81; Okolie VU, 2009, INT J MED MED SCI, V1, P353; Peyrot M, 2005, DIABETIC MED, V22, P1379, DOI 10.1111/j.1464-5491.2005.01644.x; Rachel G, 2006, BRIT J HEALTH PSYCH, V11, P155; Rosenstock M, 1988, HLTH ED Q, V15, P175; Sigurthardottir AK, 2005, J CLIN NURS, V14, P301, DOI 10.1111/j.1365-2702.2004.01043.x; Tan M, 2009, SELF CARE PRACTICES; Venkat N, 2003, DIABETES PANDEMIC PO; *WHO, 2003, DIAB EST PROJ; World Health Organization, 2005, RES HLTH ACT CRIS DI; Yeweyenhareg Feleke, 2005, Ethiopian Journal of Health Development, V19, P203	27	99	103	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2012	7	4							e35515	10.1371/journal.pone.0035515	http://dx.doi.org/10.1371/journal.pone.0035515			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WC	22530039	Green Published, gold, Green Submitted			2022-12-25	WOS:000305347400057
J	Lau, BWM; Lee, JCD; Li, Y; Fung, SMY; Sang, YH; Shen, JG; Chang, RCC; So, KF				Lau, Benson Wui-Man; Lee, Jada Chia-Di; Li, Yue; Fung, Sophia Man-Yuk; Sang, Yan-Hua; Shen, Jiangang; Chang, Raymond Chuen-Chung; So, Kwok-Fai			Polysaccharides from Wolfberry Prevents Corticosterone-Induced Inhibition of Sexual Behavior and Increases Neurogenesis	PLOS ONE			English	Article							LYCIUM-BARBARUM POLYSACCHARIDES; RETINAL GANGLION-CELLS; POSTNATAL NEUROGENESIS; INDUCED DAMAGE; EXPOSURE; PROLIFERATION; MEDICINE; BRAIN	Lycium barbarum, commonly known as wolfberry, has been used as a traditional Chinese medicine for the treatment of infertility and sexual dysfunction. However, there is still a scarcity of experimental evidence to support the pro-sexual effect of wolfberry. The aim of this study is to determine the effect of Lycium barbarum polysaccharides (LBP) on male sexual behavior of rats. Here we report that oral feeding of LBP for 21 days significantly improved the male copulatory performance including increase of copulatory efficiency, increase of ejaculation frequency and shortening of ejaculation latency. Furthermore, sexual inhibition caused by chronic corticosterone was prevented by LBP. Simultaneously, corticosterone suppressed neurogenesis in subventricular zone and hippocampus in adult rats, which could be reversed by LBP. The neurogenic effect of LBP was also shown in vitro. Significant correlation was found between neurogenesis and sexual performance, suggesting that the newborn neurons are associated with reproductive successfulness. Blocking neurogenesis in male rats abolished the pro-sexual effect of LBP. Taken together, these results demonstrate the pro-sexual effect of LBP on normal and sexually-inhibited rats, and LBP may modulate sexual behavior by regulating neurogenesis.	[Lau, Benson Wui-Man; Lee, Jada Chia-Di; Fung, Sophia Man-Yuk; Sang, Yan-Hua; Chang, Raymond Chuen-Chung; So, Kwok-Fai] Univ Hong Kong, Li Ka Shing Fac Med, Dept Anat, Pokfulam, Hong Kong, Peoples R China; [Lau, Benson Wui-Man; Lee, Jada Chia-Di; Chang, Raymond Chuen-Chung; So, Kwok-Fai] Univ Hong Kong, State Key Lab Brain & Cognit Sci, Pokfulam, Hong Kong, Peoples R China; [Lau, Benson Wui-Man; Lee, Jada Chia-Di; Li, Yue; Shen, Jiangang; Chang, Raymond Chuen-Chung; So, Kwok-Fai] Univ Hong Kong, Fac Med, Res Ctr Heart Brain Hormone & Hth Aging, Pokfulam, Hong Kong, Peoples R China; [Li, Yue; Shen, Jiangang] Univ Hong Kong, Sch Chinese Med, Hong Kong, Hong Kong, Peoples R China; [Chang, Raymond Chuen-Chung] Univ Hong Kong, LKS Fac Med, Dept Anat, Lab Neurodegenerat Dis, Pokfulam, Hong Kong, Peoples R China; [So, Kwok-Fai] Univ Hong Kong, Guangzhou, Guangdong, Peoples R China; [So, Kwok-Fai] Jinan Univ, Joint Lab Brain Funct & Hlth BFAH, Guangzhou, Guangdong, Peoples R China	University of Hong Kong; University of Hong Kong; University of Hong Kong; University of Hong Kong; University of Hong Kong; University of Hong Kong; Jinan University	Lau, BWM (corresponding author), Univ Hong Kong, Li Ka Shing Fac Med, Dept Anat, Pokfulam, Hong Kong, Peoples R China.	hrmaskf@hkucc.hku.hk	Li, Kevin/AAX-1664-2020; Chang, Raymond Chuen-Chung/C-1107-2009	Li, Kevin/0000-0001-8198-9911; Chang, Raymond Chuen-Chung/0000-0001-8538-7993; LAU, Wui Man/0000-0002-4552-2780; So, Kwok-Fai/0000-0003-4039-4246	Azalea Endowment Fund; University of Hong Kong Alzheimer's Disease Research Network under Strategic Research Theme on Healthy Aging; Fundamental Research Funds for the Central Universities [09ykpy25, 09ykpy31]	Azalea Endowment Fund; University of Hong Kong Alzheimer's Disease Research Network under Strategic Research Theme on Healthy Aging; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This study was supported by the Azalea (1972) Endowment Fund, the University of Hong Kong Alzheimer's Disease Research Network under Strategic Research Theme on Healthy Aging and the Fundamental Research Funds for the Central Universities, no. 09ykpy25, 09ykpy31. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Buylla A, 2002, J NEUROSCI, V22, P629, DOI 10.1523/JNEUROSCI.22-03-00629.2002; Amagase H, 2009, NUTR RES, V29, P19, DOI 10.1016/j.nutres.2008.11.005; Amstislavskaya TG, 2010, PHARMACOL BIOCHEM BE, V96, P211, DOI 10.1016/j.pbb.2010.05.007; Chan HC, 2007, EXP NEUROL, V203, P269, DOI 10.1016/j.expneurol.2006.05.031; Chang RCC, 2008, CELL MOL NEUROBIOL, V28, P643, DOI 10.1007/s10571-007-9181-x; Chen LP, 2011, NEURAL REGEN RES, V6, P1618, DOI 10.3969/j.issn.1673-5374.2011.21.003; Chen X, 2010, NEUROSCIENCE, V165, P705, DOI 10.1016/j.neuroscience.2009.11.007; Chiu K, 2010, J CELL BIOCHEM, V110, P311, DOI 10.1002/jcb.22539; DAS GD, 1971, BRAIN RES, V30, P323, DOI 10.1016/0006-8993(71)90082-5; DAS GD, 1970, BRAIN RES, V21, P122, DOI 10.1016/0006-8993(70)90026-0; Deng HB, 2003, BIOMED ENVIRON SCI, V16, P267; EVERITT BJ, 1990, NEUROSCI BIOBEHAV R, V14, P217, DOI 10.1016/S0149-7634(05)80222-2; Gan L, 2003, EUR J PHARMACOL, V471, P217, DOI 10.1016/S0014-2999(03)01827-2; Gheusi G, 2009, BEHAV BRAIN RES, V200, P315, DOI 10.1016/j.bbr.2009.02.006; Hawken PAR, 2009, BIOL REPROD, V80, P1146, DOI 10.1095/biolreprod.108.075341; Ho YS, 2007, BRAIN RES, V1158, P123, DOI 10.1016/j.brainres.2007.04.075; Ho YS, 2010, AGEING RES REV, V9, P354, DOI 10.1016/j.arr.2009.10.001; Ho YS, 2009, CELL MOL NEUROBIOL, V29, P1233, DOI 10.1007/s10571-009-9419-x; Huang LY, 2002, HORM BEHAV, V41, P343, DOI 10.1006/hbeh.2002.1767; Lau BWM, 2009, NEUROREPORT, V20, P371, DOI 10.1097/WNR.0b013e328324edcd; Lau BWM, 2011, J SEX MED, V8, P1390, DOI 10.1111/j.1743-6109.2010.02081.x; Lau BWM, 2011, CELL TRANSPLANT, V20, P21, DOI 10.3727/096368910X532765; Lau BW, 2010, CELL TRANSPLANT; Lee SH, 2011, NEURAL REGEN RES, V6, P2085, DOI 10.3969/j.issn.1673-5374.2011.27.001; Leuner B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011597; Li M, 2011, CHEMBIOCHEM, V12, P449, DOI 10.1002/cbic.201000570; Li SY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016380; Luo Q, 2006, LIFE SCI, V79, P613, DOI 10.1016/j.lfs.2006.02.012; Luo Q, 2011, PHYTOTHER RES, V25, P694, DOI 10.1002/ptr.3314; Mak GK, 2007, NAT NEUROSCI, V10, P1003, DOI 10.1038/nn1928; Niu AJ, 2008, INT J BIOL MACROMOL, V42, P447, DOI 10.1016/j.ijbiomac.2008.02.003; Slotnick B, 2001, TRENDS COGN SCI, V5, P216, DOI 10.1016/S1364-6613(00)01625-9; Smith MT, 2001, HORM BEHAV, V39, P11, DOI 10.1006/hbeh.2000.1630; SNYDER EY, 1992, CELL, V68, P33, DOI 10.1016/0092-8674(92)90204-P; Wang YR, 2002, J ETHNOPHARMACOL, V82, P169, DOI 10.1016/S0378-8741(02)00169-1; Wen Jing, 2010, Zhongguo Zhong Xi Yi Jie He Za Zhi, V30, P295; Yau SY, 2011, NEURAL REGEN RES, V6, P2645, DOI 10.3969/j.issn.1673-5374.2011.34.001; Yu MS, 2005, EXP GERONTOL, V40, P716, DOI 10.1016/j.exger.2005.06.010	38	44	45	0	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2012	7	4							e33374	10.1371/journal.pone.0033374	http://dx.doi.org/10.1371/journal.pone.0033374			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VO	22523540	Green Published, gold			2022-12-25	WOS:000305345000009
J	He, HJ; Su, JB; Shu, SY; Zhang, Y; Ao, Y; Liu, B; Feng, DR; Wang, JF; Wang, HB				He, Hanjie; Su, Jianbin; Shu, Shengying; Zhang, Yang; Ao, Ying; Liu, Bing; Feng, Dongru; Wang, Jinfa; Wang, Hongbin			Two Homologous Putative Protein Tyrosine Phosphatases, OsPFA-DSP2 and AtPFA-DSP4, Negatively Regulate the Pathogen Response in Transgenic Plants	PLOS ONE			English	Article							ARABIDOPSIS INNATE IMMUNITY; OXYGEN SPECIES NETWORK; TRANSCRIPTION FACTOR; FUNCTIONAL GENOMICS; DISEASE RESISTANCE; HYDROGEN-PEROXIDE; GENE-EXPRESSION; RICE; PHOSPHORYLATION; TISSUE	Protein phosphatases, together with protein kinases, regulate protein phosphorylation and dephosphorylation, and play critical roles in plant growth and biotic stress responses. However, little is known about the biological functions of plant protein tyrosine dual-specificity phosphatase (PFA-DSP) in biotic stresses. Here, we found that OsPFA-DSP2 was mainly expressed in calli, seedlings, roots, and young panicles, and localized in cytoplasm and nucleus. Ectopic overexpression of OsPFA-DSP2 in rice increased sensitivity to Magnaporthe grisea (M. grisea Z1 strain), inhibited the accumulation of hydrogen peroxide (H2O2) and suppressed the expression of pathogenesis-related (PR) genes after fungal infection. Interestingly, transgenic Arabidopsis plants overexpressing AtPFA-DSP4, which is homologous to OsPFA-DSP2, also exhibited sensitivity to Pseudomonas syringae pv. tomato DC3000 (Pst DC3000), reduced accumulation of H2O2 and decreased photosynthesic capacity after infection compared with Col-0. These results indicate that OsPFA-DSP2 and AtPFA-DSP4 act as negative regulators of the pathogen response in transgenic plants.	[He, Hanjie; Su, Jianbin; Shu, Shengying; Zhang, Yang; Ao, Ying; Liu, Bing; Feng, Dongru; Wang, Jinfa; Wang, Hongbin] Sun Yat Sen Univ, Key Lab Gene Engn, Minist Educ,Sch Life Sci, State Key Lab Biocontrol & Guangdong,Key Lab Plan, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University	He, HJ (corresponding author), Sun Yat Sen Univ, Key Lab Gene Engn, Minist Educ,Sch Life Sci, State Key Lab Biocontrol & Guangdong,Key Lab Plan, Guangzhou 510275, Guangdong, Peoples R China.	wanghb@mail.sysu.edu.cn	Su, Jianbin/L-6647-2019	Wang, Hong-Bin/0000-0003-4957-0509	National Natural Science Foundation of China [30800600, 30970237]; Natural Science Foundation of Guangdong Province, People's Republic of China [8151027501000016]; Fundamental Research Funds for the Central Universities [10lgpy34]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Guangdong Province, People's Republic of China(National Natural Science Foundation of Guangdong Province); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This research was supported by grants from the National Natural Science Foundation of China (no. 30800600 and no. 30970237), the Natural Science Foundation of Guangdong Province, People's Republic of China (no. 8151027501000016) and the Fundamental Research Funds for the Central Universities (10lgpy34). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aceti DJ, 2008, PROTEINS, V73, P241, DOI 10.1002/prot.22041; Alonso A, 2004, CELL, V117, P699, DOI 10.1016/j.cell.2004.05.018; Anderson JC, 2011, PLANT J, V67, P258, DOI 10.1111/j.1365-313X.2011.04588.x; Torres MA, 2010, PHYSIOL PLANTARUM, V138, P414, DOI 10.1111/j.1399-3054.2009.01326.x; Asai T, 2002, NATURE, V415, P977, DOI 10.1038/415977a; Bartels S, 2010, TRENDS PLANT SCI, V15, P322, DOI 10.1016/j.tplants.2010.04.003; Bartels S, 2009, PLANT CELL, V21, P2884, DOI 10.1105/tpc.109.067678; Brock AK, 2010, PLANT PHYSIOL, V153, P1098, DOI 10.1104/pp.110.156109; Chen SB, 2009, PLANT PHYSIOL, V150, P1111, DOI 10.1104/pp.109.137125; Earley KW, 2006, PLANT J, V45, P616, DOI 10.1111/j.1365-313X.2005.02617.x; Fukuoka S, 2009, SCIENCE, V325, P998, DOI 10.1126/science.1175550; Glazebrook J, 2005, ANNU REV PHYTOPATHOL, V43, P205, DOI 10.1146/annurev.phyto.43.040204.135923; Gupta R, 2002, PLANT CELL, V14, P2495, DOI 10.1105/tpc.005702; He P, 2006, CELL, V125, P563, DOI 10.1016/j.cell.2006.02.047; Hirochika H, 1996, P NATL ACAD SCI USA, V93, P7783, DOI 10.1073/pnas.93.15.7783; Hruz Tomas, 2008, Advances in Bioinformatics, V2008, P420747, DOI 10.1155/2008/420747; HUNTER T, 1995, CELL, V80, P225, DOI 10.1016/0092-8674(95)90405-0; Ishihama N, 2011, PLANT CELL, V23, P1153, DOI 10.1105/tpc.110.081794; JEFFERSON RA, 1987, EMBO J, V6, P3901; Kato T, 2009, PLANT MOL BIOL, V70, P617, DOI 10.1007/s11103-009-9495-9; Kotchoni SO, 2006, J BIOSCIENCES, V31, P389, DOI 10.1007/BF02704112; Kovtun Y, 2000, P NATL ACAD SCI USA, V97, P2940, DOI 10.1073/pnas.97.6.2940; Lee JS, 2009, PLANT J, V57, P975, DOI 10.1111/j.1365-313X.2008.03741.x; Li YG, 2012, PLANT SCI, V188, P10, DOI 10.1016/j.plantsci.2012.02.005; Liu B, 2012, PLANT CELL REP, DOI [10.1007/s00299-012-1231-2, DOI 10.1007/S00299-012-1231-2]; Luan S, 2003, ANNU REV PLANT BIOL, V54, P63, DOI 10.1146/annurev.arplant.54.031902.134743; Lumbreras V, 2010, PLANT J, V63, P1017, DOI 10.1111/j.1365-313X.2010.04297.x; Mao GH, 2011, PLANT CELL, V23, P1639, DOI 10.1105/tpc.111.084996; Mellersh DG, 2002, PLANT J, V29, P257, DOI 10.1046/j.0960-7412.2001.01215.x; Mittler R, 2004, TRENDS PLANT SCI, V9, P490, DOI 10.1016/j.tplants.2004.08.009; Monroe-Augustus M, 2003, PLANT CELL, V15, P2979, DOI 10.1105/tpc.017046; Mullineaux P, 2002, CURR OPIN PLANT BIOL, V5, P43, DOI 10.1016/S1369-5266(01)00226-6; Nanda AK, 2010, J INTEGR PLANT BIOL, V52, P195, DOI 10.1111/j.1744-7909.2010.00933.x; Neill S, 2002, CURR OPIN PLANT BIOL, V5, P388, DOI 10.1016/S1369-5266(02)00282-0; Overmyer K, 2003, TRENDS PLANT SCI, V8, P335, DOI 10.1016/S1360-1385(03)00135-3; Park CJ, 2008, PLOS BIOL, V6, P1910, DOI 10.1371/journal.pbio.0060231; Pitzschke A, 2009, CURR OPIN PLANT BIOL, V12, P421, DOI 10.1016/j.pbi.2009.06.008; Qin GZ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021945; Quan LJ, 2008, J INTEGR PLANT BIOL, V50, P2, DOI 10.1111/j.1744-7909.2007.00599.x; Ribot C, 2008, J PLANT PHYSIOL, V165, P114, DOI 10.1016/j.jplph.2007.06.013; Roma-Mateo C, 2007, J MOL BIOL, V374, P899, DOI 10.1016/j.jmb.2007.10.008; Singh A, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-435; Swanson S, 2010, PHYSIOL PLANTARUM, V138, P384, DOI 10.1111/j.1399-3054.2009.01313.x; Toki S, 2006, PLANT J, V47, P969, DOI 10.1111/j.1365-313X.2006.02836.x; Torii KU, 1998, EMBO J, V17, P5577, DOI 10.1093/emboj/17.19.5577; Vilela B, 2010, PLANT SIGNAL BEHAV, V5, P1497, DOI 10.4161/psb.5.11.13645; Zhang Y, 2011, PLANT METHODS, V7, DOI 10.1186/1746-4811-7-30	47	11	16	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2012	7	4							e34995	10.1371/journal.pone.0034995	http://dx.doi.org/10.1371/journal.pone.0034995			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UT	22514699	Green Published, gold, Green Submitted			2022-12-25	WOS:000305341600105
J	Johnson, CJ; Aiken, JM; McKenzie, D; Samuel, MD; Pedersen, JA				Johnson, Chad J.; Aiken, Judd M.; McKenzie, Debbie; Samuel, Michael D.; Pedersen, Joel A.			Highly Efficient Amplification of Chronic Wasting Disease Agent by Protein Misfolding Cyclic Amplification with Beads (PMCAb)	PLOS ONE			English	Article							IN-VITRO AMPLIFICATION; WHITE-TAILED DEER; PRION PROTEIN; PRESYMPTOMATIC DETECTION; INFLUENCE SUSCEPTIBILITY; INFECTIOUS PRIONS; CWD PRIONS; POLYMORPHISMS; SCRAPIE; ELK	Protein misfolding cyclic amplification (PMCA) has emerged as an important technique for detecting low levels of pathogenic prion protein in biological samples. The method exploits the ability of the pathogenic prion protein to convert the normal prion protein to a proteinase K-resistant conformation. Inclusion of Teflon (R) beads in the PMCA reaction (PMCAb) has been previously shown to increase the sensitivity and robustness of detection for the 263 K and SSLOW strains of hamster-adapted prions. Here, we demonstrate that PMCAb with saponin dramatically increases the sensitivity of detection for chronic wasting disease (CWD) agent without compromising the specificity of the assay (i.e., no false positive results). Addition of Teflon (R) beads increased the robustness of the PMCA reaction, resulting in a decrease in the variability of PMCA results. Three rounds of serial PMCAb allowed detection of CWD agent from a 6.7 x 10(-13) dilution of 10% brain homogenate (1.3 fg of source brain). Titration of the same brain homogenate in transgenic mice expressing cervid prion protein (Tg(CerPrP)1536(+/-) mice) allowed detection of CWD agent from the 10(-6) dilution of 10% brain homogenate. PMCAb is, thus, more sensitive than bioassay in transgenic mice by a factor exceeding 10(5). Additionally, we are able to amplify CWD agent from brain tissue and lymph nodes of CWD-positive white-tailed deer having Prnp alleles associated with reduced disease susceptibility.	[Johnson, Chad J.; Pedersen, Joel A.] Univ Wisconsin, Environm Chem & Technol Program, Madison, WI 53706 USA; [Johnson, Chad J.; Pedersen, Joel A.] Univ Wisconsin, Dept Soil Sci, Madison, WI 53706 USA; [Aiken, Judd M.; McKenzie, Debbie] Univ Alberta, Ctr Prions & Prot Misfolding Dis, Edmonton, AB, Canada; [Samuel, Michael D.] Univ Wisconsin, US Geol Survey, Wisconsin Cooperat Wildlife Res Unit, Madison, WI USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Alberta; United States Department of the Interior; United States Geological Survey; University of Wisconsin System; University of Wisconsin Madison	Johnson, CJ (corresponding author), Univ Wisconsin, Environm Chem & Technol Program, Madison, WI 53706 USA.	joelpedersen@wisc.edu	Pedersen, Joel A./L-4007-2019; McKenzie, Debbie/G-4459-2015	Pedersen, Joel A./0000-0002-3918-1860; McKenzie, Debbie/0000-0002-9291-6977; Aiken, Judd/0000-0001-6119-4521	NSF [DEB-0914484, CBET-0547484]; NIH [R01 NS060034]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS060034] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by NSF grants DEB-0914484 (MDS) and CBET-0547484 (JAP), NIH grant R01 NS060034 (JMA/JAP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguzzi A, 2009, PHYSIOL REV, V89, P1105, DOI 10.1152/physrev.00006.2009; Angers RC, 2009, EMERG INFECT DIS, V15, P696, DOI 10.3201/eid1505.081458; Bian JF, 2010, J VIROL, V84, P8322, DOI 10.1128/JVI.00633-10; Browning SR, 2004, J VIROL, V78, P13345, DOI 10.1128/JVI.78.23.13345-13350.2004; Castilla J, 2005, CELL, V121, P195, DOI 10.1016/j.cell.2005.02.011; Castilla J, 2008, EMBO J, V27, P2557, DOI 10.1038/emboj.2008.181; Caughey B, 2009, ANNU REV BIOCHEM, V78, P177, DOI 10.1146/annurev.biochem.78.082907.145410; Deleault NR, 2007, P NATL ACAD SCI USA, V104, P9741, DOI 10.1073/pnas.0702662104; Gonzalez-Montalban N, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001277; Gonzalez-Romero D, 2008, FEBS LETT, V582, P3161, DOI 10.1016/j.febslet.2008.08.003; Haley NJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004848; Johnson C, 2006, J GEN VIROL, V87, P2109, DOI 10.1099/vir.0.81615-0; Johnson CJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017450; Kelly AC, 2008, PRION, V2, P28, DOI 10.4161/pri.2.1.6321; Kurt TD, 2007, J VIROL, V81, P9605, DOI 10.1128/JVI.00635-07; Meyerett C, 2008, VIROLOGY, V382, P267, DOI 10.1016/j.virol.2008.09.023; Murayama Y, 2007, NEUROSCI LETT, V413, P270, DOI 10.1016/j.neulet.2006.11.056; Naslavsky N, 1997, J BIOL CHEM, V272, P6324, DOI 10.1074/jbc.272.10.6324; O'Rourke KI, 1999, J GEN VIROL, V80, P2765, DOI 10.1099/0022-1317-80-10-2765; O'Rourke KI, 2004, J GEN VIROL, V85, P1339, DOI 10.1099/vir.0.79785-0; Pritzkow S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020384; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Robinson SJ, 2012, ECOL APPIN PRESS; Saa P, 2006, J BIOL CHEM, V281, P35245, DOI 10.1074/jbc.M603964200; Saa P, 2006, SCIENCE, V313, P92, DOI 10.1126/science.1129051; Saborio GP, 2001, NATURE, V411, P810, DOI 10.1038/35081095; Soto C, 2005, FEBS LETT, V579, P638, DOI 10.1016/j.febslet.2004.12.035; Soto C, 2011, TRENDS BIOCHEM SCI, V36, P151, DOI 10.1016/j.tibs.2010.11.001; Tamguney G, 2009, NATURE, V461, P529, DOI 10.1038/nature08289; Thorne L, 2008, J GEN VIROL, V89, P3177, DOI 10.1099/vir.0.2008/004226-0; Wilson GA, 2009, J TOXICOL ENV HEAL A, V72, P1025, DOI 10.1080/15287390903084264	31	27	29	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2012	7	4							e35383	10.1371/journal.pone.0035383	http://dx.doi.org/10.1371/journal.pone.0035383			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UT	22514738	Green Published, Green Submitted, gold			2022-12-25	WOS:000305341600143
J	Eneling, K; Brion, L; Pinto, V; Pinho, MJ; Sznajder, JI; Mochizuki, N; Emoto, K; Soares-da-Silva, P; Bertorello, AM				Eneling, Kristina; Brion, Laura; Pinto, Vanda; Pinho, Maria J.; Sznajder, Jacob I.; Mochizuki, Naoki; Emoto, Kazuo; Soares-da-Silva, Patricio; Bertorello, Alejandro M.			Salt-inducible kinase 1 regulates E-cadherin expression and intercellular junction stability	FASEB JOURNAL			English	Article						epithelial polarity; sodium transport; vectorial transport; transepithelial resistance; metastatic transformation; liver kinase B1	EPITHELIAL-CELL PHENOTYPE; SODIUM-TRANSPORT; PROTEIN-KINASES; P120 CATENIN; TUMOR-CELLS; LKB1; MOUSE; CANCER; FAMILY; SNAIL	The protein kinase liver kinase B1 (LKB1) regulates cell polarity and intercellular junction stability. Also, LKB1 controls the activity of salt-inducible kinase 1 (SIK1). The role and relevance of SIK1 and its downstream effectors in linking the LKB1 signals within these processes are partially understood. We hypothesize that SIK1 may link LKB1 signals to the maintenance of epithelial junction stability by regulating E-cadherin expression. Results from our studies using a mouse lung alveolar epithelial (MLE-12) cell line or human renal proximal tubule (HK2) cell line transiently or stably lacking the expression of SIK1 (using SIK1 siRNAs or shRNAs), or with its expression abrogated (sik1(+/+) vs. sik1(-/-) mice), indicate that suppression of SIK1 (similar to 40%) increases the expression of the transcriptional re-pressors Snail2 (similar to 12-fold), Zeb1 (similar to 100%), Zeb2 (similar to 50%), and TWIST (similar to 20-fold) by activating cAMP-response element binding protein. The lack of SIK1 and activation of transcriptional repressors decreases the availability of E-cadherin (mRNA and protein expression by similar to 100 and 80%, respectively) and the stability of intercellular junctions in epithelia (decreases in transepithelial resistance). Furthermore, LKB1-mediated increases in E-cadherin expression are impaired in cells where SIK1 has been disabled. We conclude that SIK1 is a key regulator of E-cadherin expression, and thereby contributes to the stability of intercellular junctions.-Eneling, K., Brion, L., Pinto, V., Pinho, M. J., Sznajder, J. I., Mochizuki, N., Emoto, K., Soares-da-Silva, P., Bertorello, A. M. Salt-inducible kinase 1 regulates E-cadherin expression and intercellular junction stability. FASEB J. 26, 3230-3239 (2012). www.fasebj.org	[Eneling, Kristina; Brion, Laura; Bertorello, Alejandro M.] Karolinska Inst, Karolinska Univ Hosp Solna, Atherosclerosis Res Unit, Membrane Signaling Networks,Dept Med,Ctr Mol Med, S-17176 Stockholm, Sweden; [Pinto, Vanda; Pinho, Maria J.; Soares-da-Silva, Patricio] Fac Med, Dept Pharmacol & Therapeut, Oporto, Portugal; [Sznajder, Jacob I.] Northwestern Univ, Dept Med, Chicago, IL 60611 USA; [Mochizuki, Naoki] Natl Cerebral & Cardiovasc Ctr, Dept Cell Biol, Osaka, Japan; [Emoto, Kazuo] Osaka Biosci Inst, Osaka, Japan	Karolinska Institutet; Karolinska University Hospital; Universidade do Porto; Northwestern University; National Cerebral & Cardiovascular Center - Japan	Bertorello, AM (corresponding author), Karolinska Inst, Karolinska Univ Hosp Solna, Atherosclerosis Res Unit, Membrane Signaling Networks,Dept Med,Ctr Mol Med, CMM L5 01, S-17176 Stockholm, Sweden.	alejandro.bertorello@ki.se	Soares-da-Silva, Patricio/A-6704-2015; Pinto, Vanda/H-9446-2013; EMOTO, KAZUO/G-4992-2014	Soares-da-Silva, Patricio/0000-0002-2446-5078; Pinho, Maria Joao/0000-0001-8173-0379; Pinto, Vanda/0000-0001-9979-1663	Swedish Research Council [10860]; Swedish Heart and Lung Foundation; AFA Insurance Sweden; U.S. National Heart, Lung, and Blood Institute grant [HL-48129]; Fundacao para a Ciencia e a Tecnologia grant [PIC/IC/83204/2007]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL048129, R37HL048129] Funding Source: NIH RePORTER	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Heart and Lung Foundation(Swedish Heart-Lung Foundation); AFA Insurance Sweden; U.S. National Heart, Lung, and Blood Institute grant; Fundacao para a Ciencia e a Tecnologia grant; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The authors thank Hiroshi Takemori (National Institute of Biomedical Innovation, Osaka, Japan), Giuseppe Bianchi (San Raffaele Hospital, Milan, Italy), and Amparo Cano (Universidad Autonoma de Madrid, Madrid, Spain) for providing reagents. The study was supported by grants from the Swedish Research Council (10860), the Swedish Heart and Lung Foundation, AFA Insurance Sweden, U.S. National Heart, Lung, and Blood Institute grant HL-48129, and Fundacao para a Ciencia e a Tecnologia grant PIC/IC/83204/2007.	Amin N, 2009, P NATL ACAD SCI USA, V106, P8941, DOI 10.1073/pnas.0812469106; Anastasiadis PZ, 2000, J CELL SCI, V113, P1319; Nieto MA, 2011, ANNU REV CELL DEV BI, V27, P347, DOI 10.1146/annurev-cellbio-092910-154036; Baas AF, 2004, CELL, V116, P457, DOI 10.1016/S0092-8674(04)00114-X; Batlle E, 2000, NAT CELL BIOL, V2, P84, DOI 10.1038/35000034; Bolos V, 2003, J CELL SCI, V116, P499, DOI 10.1242/jcs.00224; Cheng HL, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000369; Dave N, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.168625; Davis MA, 2003, J CELL BIOL, V163, P525, DOI 10.1083/jcb.200307111; Drewes G, 1997, CELL, V89, P297, DOI 10.1016/S0092-8674(00)80208-1; Ferrandi M, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001815; FISH EM, 1994, NEW ENGL J MED, V330, P1580; Gomes P, 2006, AM J PHYSIOL-REG I, V290, pR1142, DOI 10.1152/ajpregu.00102.2005; Gu Y, 2012, ONCOGENE, V31, P469, DOI 10.1038/onc.2011.247; Hajra KM, 1999, ONCOGENE, V18, P7274, DOI 10.1038/sj.onc.1203336; Ireton RC, 2002, J CELL BIOL, V159, P465, DOI 10.1083/jcb.200205115; Jaleel M, 2005, FEBS LETT, V579, P1417, DOI 10.1016/j.febslet.2005.01.042; Katoh Y, 2006, FEBS J, V273, P2730, DOI 10.1111/j.1742-4658.2006.05291.x; Koo SH, 2005, NATURE, V437, P1109, DOI 10.1038/nature03967; Larre I, 2010, P NATL ACAD SCI USA, V107, P11387, DOI 10.1073/pnas.1000500107; Lin XZ, 2001, MOL ENDOCRINOL, V15, P1264, DOI 10.1210/me.15.8.1264; Lizcano JM, 2004, EMBO J, V23, P833, DOI 10.1038/sj.emboj.7600110; MARRS JA, 1995, J CELL BIOL, V129, P507, DOI 10.1083/jcb.129.2.507; Pearson HB, 2008, CANCER RES, V68, P2223, DOI 10.1158/0008-5472.CAN-07-5169; Pedrosa R, 2008, HYPERTENSION, V51, P1332, DOI 10.1161/HYPERTENSIONAHA.107.102434; Peinado H, 2007, NAT REV CANCER, V7, P415, DOI 10.1038/nrc2131; Pinto V, 2008, MOL CELL BIOCHEM, V310, P191, DOI 10.1007/s11010-007-9680-6; QUIGLEY JP, 1969, BIOCHIM BIOPHYS ACTA, V173, P456, DOI 10.1016/0005-2736(69)90010-8; Rajasekaran SA, 2001, MOL BIOL CELL, V12, P279, DOI 10.1091/mbc.12.2.279; RODRIGUEZBOULAN E, 1989, SCIENCE, V245, P718, DOI 10.1126/science.2672330; Romito A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009029; Roy BC, 2010, LUNG CANCER, V70, P136, DOI 10.1016/j.lungcan.2010.02.004; RUIZ JC, 1994, MECH DEVELOP, V48, P153, DOI 10.1016/0925-4773(94)90056-6; Sjostrom M, 2007, P NATL ACAD SCI USA, V104, P16922, DOI 10.1073/pnas.0706838104; Stenstrom K, 2009, J HYPERTENS, V27, P2452, DOI 10.1097/HJH.0b013e328330cf15; Takemori H, 2007, FEBS J, V274, P3202, DOI 10.1111/j.1742-4658.2007.05889.x; Tripodi G, 1996, J CLIN INVEST, V97, P2815, DOI 10.1172/JCI118737; Wang ZN, 1999, FEBS LETT, V453, P135, DOI 10.1016/S0014-5793(99)00708-5; Zhang L, 2011, J BIOL CHEM, V286, P16879, DOI 10.1074/jbc.M110.186932	39	22	24	1	15	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	AUG	2012	26	8					3230	3239		10.1096/fj.12-205609	http://dx.doi.org/10.1096/fj.12-205609			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	984BI	22522110	Green Published			2022-12-25	WOS:000307162800014
J	Leong, DW; Komen, JC; Hewitt, CA; Arnaud, E; McKenzie, M; Phipson, B; Bahlo, M; Laskowski, A; Kinkel, SA; Davey, GM; Heath, WR; Voss, AK; Zahedi, RP; Pitt, JJ; Chrast, R; Sickmann, A; Ryan, MT; Smyth, GK; Thorburn, DR; Scott, HS				Leong, Dillon W.; Komen, Jasper C.; Hewitt, Chelsee A.; Arnaud, Estelle; McKenzie, Matthew; Phipson, Belinda; Bahlo, Melanie; Laskowski, Adrienne; Kinkel, Sarah A.; Davey, Gayle M.; Heath, William R.; Voss, Anne K.; Zahedi, Rene P.; Pitt, James J.; Chrast, Roman; Sickmann, Albert; Ryan, Michael T.; Smyth, Gordon K.; Thorburn, David R.; Scott, Hamish S.			Proteomic and Metabolomic Analyses of Mitochondrial Complex I-deficient Mouse Model Generated by Spontaneous B2 Short Interspersed Nuclear Element (SINE) Insertion into NADH Dehydrogenase (Ubiquinone) Fe-S Protein 4 (Ndufs4) Gene	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OXIDATIVE-PHOSPHORYLATION; AQDQ SUBUNIT; MUTATIONS; DISORDERS; APOPTOSIS; RETROTRANSPOSITION; HETEROGENEITY; INVOLVEMENT; INTEGRATION; EXPRESSION	Eukaryotic cells generate energy in the form of ATP, through a network of mitochondrial complexes and electron carriers known as the oxidative phosphorylation system. In mammals, mitochondrial complex I (CI) is the largest component of this system, comprising 45 different subunits encoded by mitochondrial and nuclear DNA. Humans diagnosed with mutations in the gene NDUFS4, encoding a nuclear DNA-encoded subunit of CI (NADH dehydrogenase ubiquinone Fe-S protein 4), typically suffer from Leigh syndrome, a neurodegenerative disease with onset in infancy or early childhood. Mitochondria from NDUFS4 patients usually lack detectable NDUFS4 protein and show a CI stability/assembly defect. Here, we describe a recessive mouse phenotype caused by the insertion of a transposable element into Ndufs4, identified by a novel combined linkage and expression analysis. Designated Ndufs4(fky), the mutation leads to aberrant transcript splicing and absence of NDUFS4 protein in all tissues tested of homozygous mice. Physical and behavioral symptoms displayed by Ndufs4(fky/fky) mice include temporary fur loss, growth retardation, unsteady gait, and abnormal body posture when suspended by the tail. Analysis of CI in Ndufs4(fky/fky) mice using blue native PAGE revealed the presence of a faster migrating crippled complex. This crippled CI was shown to lack subunits of the "Nassembly module", which contains the NADH binding site, but contained two assembly factors not present in intact CI. Metabolomic analysis of the blood by tandem mass spectrometry showed increased hydroxyacylcarnitine species, implying that the CI defect leads to an imbalanced NADH/NAD(+) ratio that inhibits mitochondrial fatty acid beta-oxidation.	[Leong, Dillon W.; Hewitt, Chelsee A.; Kinkel, Sarah A.; Voss, Anne K.; Scott, Hamish S.] Walter & Eliza Hall Inst Med Res, Div Mol Med, Parkville, Vic 3052, Australia; [Kinkel, Sarah A.; Davey, Gayle M.; Heath, William R.] Walter & Eliza Hall Inst Med Res, Div Immunol, Parkville, Vic 3052, Australia; [Phipson, Belinda; Bahlo, Melanie; Smyth, Gordon K.] Walter & Eliza Hall Inst Med Res, Bioinformat Div, Parkville, Vic 3052, Australia; [Komen, Jasper C.; Laskowski, Adrienne; Thorburn, David R.] Univ Melbourne, Royal Childrens Hosp, Murdoch Childrens Res Inst, Parkville, Vic 3052, Australia; [Komen, Jasper C.; Laskowski, Adrienne; Thorburn, David R.] Univ Melbourne, Dept Paediat, Parkville, Vic 3052, Australia; [Arnaud, Estelle; Chrast, Roman] Univ Lausanne, Dept Med Genet, CH-1005 Lausanne, Switzerland; [McKenzie, Matthew] Monash Inst Med Res, Ctr Reprod & Dev, Clayton, Vic 3168, Australia; [Kinkel, Sarah A.; Voss, Anne K.; Smyth, Gordon K.; Scott, Hamish S.] Univ Melbourne, Dept Med Biol, Parkville, Vic 3052, Australia; [Bahlo, Melanie; Smyth, Gordon K.] Univ Melbourne, Dept Math & Stat, Parkville, Vic 3052, Australia; [Zahedi, Rene P.] Leibniz Inst Analyt Wissensch eV, D-44227 Dortmund, Germany; [Pitt, James J.; Sickmann, Albert] Royal Childrens Hosp, Murdoch Childrens Res Inst, VCGS Pathol, Parkville, Vic 3052, Australia; [Sickmann, Albert] Ruhr Univ Bochum, Med Proteom Ctr, D-44780 Bochum, Germany; [Ryan, Michael T.] La Trobe Univ, Dept Biochem, Bundoora, Vic 3086, Australia; [Scott, Hamish S.] SA Pathol, Ctr Canc Biol, Dept Mol Pathol, Adelaide, SA 5000, Australia; [Scott, Hamish S.] Univ Adelaide, Sch Med, Adelaide, SA 5005, Australia; [Scott, Hamish S.] Univ Adelaide, Sch Mol & Biomed Sci, Adelaide, SA 5005, Australia	Walter & Eliza Hall Institute; Walter & Eliza Hall Institute; Walter & Eliza Hall Institute; Murdoch Children's Research Institute; Royal Children's Hospital Melbourne; University of Melbourne; University of Melbourne; University of Lausanne; Monash University; University of Melbourne; University of Melbourne; Dortmund University of Technology; Leibniz Institut fur Analytische Wissenschaften (ISAS); Murdoch Children's Research Institute; Royal Children's Hospital Melbourne; Ruhr University Bochum; La Trobe University; Centre for Cancer Biology; SA Pathology; University of Adelaide; University of Adelaide	Thorburn, DR (corresponding author), Univ Melbourne, Royal Childrens Hosp, Murdoch Childrens Res Inst, Flemington Rd, Parkville, Vic 3052, Australia.	david.thorburn@mcri.edu.au; hamish.scott@health.sa.gov.au	Thorburn, David R/G-6266-2013; McKenzie, Matthew/H-4926-2019; Phipson, Belinda/AAP-2213-2020; Ryan, Michael T/C-6673-2011; Ryan, Michael/X-2152-2019; Sickmann, Albert/A-1010-2011; Smyth, Gordon/B-5276-2008; Zahedi, Rene/HGU-5710-2022; Zahedi, René/A-9148-2012; Scott, Hamish/B-2122-2009; Voss, Anne K/F-5110-2013	McKenzie, Matthew/0000-0001-7508-1800; Phipson, Belinda/0000-0002-1711-7454; Ryan, Michael T/0000-0003-2586-8829; Ryan, Michael/0000-0003-2586-8829; Sickmann, Albert/0000-0002-2388-5265; Smyth, Gordon/0000-0001-9221-2892; Zahedi, René/0000-0002-4960-5460; Scott, Hamish/0000-0002-5813-631X; Voss, Anne K/0000-0002-3853-9381; Hewitt, Chelsee/0000-0001-7472-6128; thorburn, david/0000-0002-7725-9470; Bahlo, Melanie/0000-0001-5132-0774; Davey, Gayle/0000-0002-9514-6023; Chrast, Roman/0000-0003-4189-3514; Heath, William/0000-0001-9670-259X	Australian Postgraduate Award; National Health and Medical Research Council(NHMRC) [257501, 607403, 602530]; Australian Research Council; Victorian Government; Walter and Eliza Hall Institute of Medical Research; Commonwealth	Australian Postgraduate Award(Australian Government); National Health and Medical Research Council(NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council); Victorian Government; Walter and Eliza Hall Institute of Medical Research; Commonwealth	This work was supported by an Australian Postgraduate Award (to S.A.K.), National Health and Medical Research Council(NHMRC) fellowships (to H.H.S, D.R.T., G.K.S., and A.K.V.), NHMRC career development awards (to M.M. and M.B.), NHMRC Program Grant 257501, and NHMRC Project Grants 607403 and 602530, the Australian Research Council (to M.T.R.), the Victorian Government's Operational Infrastructure Support Program, and the Nossal Leadership Award from the Walter and Eliza Hall Institute of Medical Research (to H.S.S.).; Efficient animal management and data collection were facilitated by the Walter and Eliza Hall Institute of Medical Research (WEHI) and Murdoch Childrens Research Institute animal technicians. Processing of histological samples was aided by WEHI Histology and the Integrative Neuroscience Facility. Affymetrix exon arrays and linkage genotyping were performed by the Australian Genome Research Facility, which was established through the Commonwealth-funded Major National Research Facilities Program.	Belanger M, 2011, CELL METAB, V14, P724, DOI 10.1016/j.cmet.2011.08.016; Berge KE, 2000, SCIENCE, V290, P1771, DOI 10.1126/science.290.5497.1771; Bodemer C, 1999, PEDIATRICS, V103, P428, DOI 10.1542/peds.103.2.428; Budde SMS, 2000, BIOCHEM BIOPH RES CO, V275, P63, DOI 10.1006/bbrc.2000.3257; Budde SMS, 2003, J INHERIT METAB DIS, V26, P813, DOI 10.1023/B:BOLI.0000010003.14113.af; Calvaruso MA, 2012, HUM MOL GENET, V21, P115, DOI 10.1093/hmg/ddr446; Chang YF, 2007, ANNU REV BIOCHEM, V76, P51, DOI 10.1146/annurev.biochem.76.050106.093909; Chinnery P, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004426.pub2; Cost GJ, 1998, BIOCHEMISTRY-US, V37, P18081, DOI 10.1021/bi981858s; Dai MH, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni179; Davey GP, 1998, J BIOL CHEM, V273, P12753, DOI 10.1074/jbc.273.21.12753; Dewannieux M, 2005, J MOL BIOL, V349, P241, DOI 10.1016/j.jmb.2005.03.068; Dewannieux M, 2003, NAT GENET, V35, P41, DOI 10.1038/ng1223; DiMauro S, 2008, ANNU REV NEUROSCI, V31, P91, DOI 10.1146/annurev.neuro.30.051606.094302; Druker R, 2004, J INHERIT METAB DIS, V27, P319, DOI 10.1023/B:BOLI.0000031096.81518.66; Dubinsky JM, 2009, EXP NEUROL, V218, P293, DOI 10.1016/j.expneurol.2009.05.020; Dunning CJR, 2007, EMBO J, V26, P3227, DOI 10.1038/sj.emboj.7601748; Ghezzi D, 2010, AM J HUM GENET, V86, P639, DOI 10.1016/j.ajhg.2010.03.002; Gilbert N, 2004, HUM MUTAT, V24, P9, DOI 10.1002/humu.20060; Gu YH, 2007, BRAIN DEV-JPN, V29, P105, DOI 10.1016/j.braindev.2006.05.012; Houten SM, 2010, J INHERIT METAB DIS, V33, P469, DOI 10.1007/s10545-010-9061-2; Ingraham CA, 2009, MITOCHONDRION, V9, P204, DOI 10.1016/j.mito.2009.02.001; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Iuso A, 2006, J BIOL CHEM, V281, P10374, DOI 10.1074/jbc.M513387200; Johnston AJ, 2002, J BIOL CHEM, V277, P42197, DOI 10.1074/jbc.M205613200; Joza N, 2005, MOL CELL BIOL, V25, P10261, DOI 10.1128/MCB.25.23.10261-10272.2005; Jurka J, 1997, P NATL ACAD SCI USA, V94, P1872, DOI 10.1073/pnas.94.5.1872; Kirby DM, 1999, NEUROLOGY, V52, P1255, DOI 10.1212/WNL.52.6.1255; Klein JA, 2002, NATURE, V419, P367, DOI 10.1038/nature01034; Kruse SE, 2008, CELL METAB, V7, P312, DOI 10.1016/j.cmet.2008.02.004; Kubota Y, 1999, J AM ACAD DERMATOL, V41, P469, DOI 10.1016/S0190-9622(99)70123-4; Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125; Kurts C, 1996, J EXP MED, V184, P923, DOI 10.1084/jem.184.3.923; Lawn RM, 1999, J CLIN INVEST, V104, pR25, DOI 10.1172/JCI8119; Lazarou M, 2007, MOL CELL BIOL, V27, P4228, DOI 10.1128/MCB.00074-07; McKenzie M, 2007, ANAL BIOCHEM, V364, P128, DOI 10.1016/j.ab.2007.02.022; McKenzie M, 2006, J MOL BIOL, V361, P462, DOI 10.1016/j.jmb.2006.06.057; Mckenzie M, 2010, IUBMB LIFE, V62, P497, DOI 10.1002/iub.335; Morava E, 2006, BIOL NEONATE, V90, P207, DOI 10.1159/000093590; Naini A, 2005, J NEUROL SCI, V229, P187, DOI 10.1016/j.jns.2004.11.026; Ogilvie I, 2005, J CLIN INVEST, V115, P2784, DOI 10.1172/JCI26020; Ostergaard E, 2005, AM J MED GENET A, V138A, P384, DOI 10.1002/ajmg.a.30972; Pallotti F, 2001, METHOD CELL BIOL, V65, P1, DOI 10.1016/S0091-679X(01)65002-7; Parfait B, 1999, EUR J PEDIATR, V158, P55, DOI 10.1007/s004310051009; Petruzzella V, 2001, HUM MOL GENET, V10, P529, DOI 10.1093/hmg/10.5.529; Phipson B, 2010, STAT APPL GENET MOL, V9, DOI 10.2202/1544-6115.1585; Pospisilik JA, 2007, CELL, V131, P476, DOI 10.1016/j.cell.2007.08.047; Quintana A, 2010, P NATL ACAD SCI USA, V107, P10996, DOI 10.1073/pnas.1006214107; Rahman S, 1996, ANN NEUROL, V39, P343, DOI 10.1002/ana.410390311; Rashed MS, 1997, CLIN CHEM, V43, P1129; Rubio-Gozalbo ME, 2000, NEUROPEDIATRICS, V31, P114, DOI 10.1055/s-2000-7491; Scacco S, 2003, J BIOL CHEM, V278, P44161, DOI 10.1074/jbc.M307615200; Silengo M, 2003, EUR J PEDIATR, V162, P459, DOI 10.1007/s00431-003-1228-5; Sims NR, 2008, NAT PROTOC, V3, P1228, DOI 10.1038/nprot.2008.105; Skladal D, 2003, BRAIN, V126, P1905, DOI 10.1093/brain/awg170; Smeitink JA, 2006, CELL METAB, V3, P9, DOI 10.1016/j.cmet.2005.12.001; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Su AI, 2002, P NATL ACAD SCI USA, V99, P4465, DOI 10.1073/pnas.012025199; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517; Tucker EJ, 2011, IUBMB LIFE, V63, P669, DOI 10.1002/iub.495; van den Heuvel L, 1998, AM J HUM GENET, V62, P262, DOI 10.1086/301716; Van Vlies N, 2005, BIOCHEM J, V387, P185, DOI 10.1042/BJ20041489; Vogel RO, 2007, MOL GENET METAB, V91, P176, DOI 10.1016/j.ymgme.2007.02.007; WANDERS RJA, 1993, BIOCHIM BIOPHYS ACTA, V1181, P219, DOI 10.1016/0925-4439(93)90024-U; Webster KE, 2005, P NATL ACAD SCI USA, V102, P4068, DOI 10.1073/pnas.0500702102; Winkler C, 2007, ELECTROPHORESIS, V28, P2095, DOI 10.1002/elps.200600670; Wu D, 2010, BIOINFORMATICS, V26, P2176, DOI 10.1093/bioinformatics/btq401	68	42	43	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 8	2012	287	24					20652	20663		10.1074/jbc.M111.327601	http://dx.doi.org/10.1074/jbc.M111.327601			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974FB	22535952	Green Accepted, Green Published, hybrid			2022-12-25	WOS:000306414500084
J	Haupt, K; Jahreis, G; Linnert, M; Maestre-Martinez, M; Malesevic, M; Pechstein, A; Edlich, F; Lucke, C				Haupt, Katja; Jahreis, Guenther; Linnert, Miriam; Maestre-Martinez, Mitcheell; Malesevic, Miroslav; Pechstein, Arndt; Edlich, Frank; Luecke, Christian			The FKBP38 Catalytic Domain Binds to Bcl-2 via a Charge-sensitive Loop	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANTIAPOPTOTIC PROTEIN BCL-2; REGULATOR FKBP38; CELL-DEATH; REPLICATION; INHIBITOR; APOPTOSIS; DEPENDS; FAMILY; SITE; RHEB	FKBP38 is a regulator of the prosurvival protein Bcl-2, but in the absence of detailed structural insights, the molecular mechanism of the underlying interaction has remained unknown. Here, we report the contact regions between Bcl-2 and the catalytic domain of FKBP38 derived by heteronuclear NMR spectroscopy. The data reveal that a previously identified charge-sensitive loop near the putative active site of FKBP38 is mainly responsible for Bcl-2 binding. The corresponding binding epitope of Bcl-2 could be identified via a peptide library-based membrane assay. Site-directed mutagenesis of the key residues verified the contact sites of this electrostatic protein/protein interaction. The derived structure model of the complex between Bcl-2 and the FKBP38 catalytic domain features both electrostatic and hydrophobic intermolecular contacts and provides a rationale for the regulation of the FKBP38/Bcl-2 interaction by Ca2+.	[Edlich, Frank] Univ Freiburg, ZBMZ, Inst Biochem & Mol Biol, Ctr Biol Signaling Studies BIOSS, D-79104 Freiburg, Germany; [Edlich, Frank] Univ Freiburg, Ctr Biochem & Mol Cell Res ZBMZ, Inst Biochem & Mol Biol, D-79104 Freiburg, Germany; [Haupt, Katja; Jahreis, Guenther; Linnert, Miriam; Maestre-Martinez, Mitcheell; Malesevic, Miroslav; Pechstein, Arndt; Edlich, Frank; Luecke, Christian] Max Planck Res Unit Enzymol Prot Folding, D-06120 Halle, Saale, Germany	University of Freiburg; University of Freiburg; Max Planck Society	Edlich, F (corresponding author), Univ Freiburg, ZBMZ, Inst Biochem & Mol Biol, Ctr Biol Signaling Studies BIOSS, Stefan Meier Str 17, D-79104 Freiburg, Germany.	frank.edlich@biochemie.uni-freiburg.de; luecke@enzyme-halle.mpg.de	Malesevic, Miroslav/D-8128-2012	Malesevic, Miroslav/0000-0002-1484-3709				Adams JM, 1998, SCIENCE, V281, P1322, DOI 10.1126/science.281.5381.1322; Bai XC, 2007, SCIENCE, V318, P977, DOI 10.1126/science.1147379; Barth S, 2007, MOL CELL BIOL, V27, P3758, DOI 10.1128/MCB.01324-06; Barth S, 2009, J BIOL CHEM, V284, P23046, DOI 10.1074/jbc.M109.032631; Bulgakov OV, 2004, DEVELOPMENT, V131, P2149, DOI 10.1242/dev.01122; Chao DT, 1998, ANNU REV IMMUNOL, V16, P395, DOI 10.1146/annurev.immunol.16.1.395; Cho A, 2008, DEV BIOL, V321, P27, DOI 10.1016/j.ydbio.2008.05.558; Choi BH, 2010, J BIOL CHEM, V285, P9770, DOI 10.1074/jbc.M109.032466; Dominguez C, 2003, J AM CHEM SOC, V125, P1731, DOI 10.1021/ja026939x; Edlich F, 2005, EMBO J, V24, P2688, DOI 10.1038/sj.emboj.7600739; Edlich F, 2007, J BIOL CHEM, V282, P36496, DOI 10.1074/jbc.M705061200; Edlich F, 2011, CURR OPIN PHARMACOL, V11, P348, DOI 10.1016/j.coph.2011.03.011; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Hubbard SJ, 1993, NACCESS COMPUTER PRO; Jones S, 1996, P NATL ACAD SCI USA, V93, P13, DOI 10.1073/pnas.93.1.13; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kang CB, 2005, FEBS LETT, V579, P1469, DOI 10.1016/j.febslet.2005.01.053; KUBONIWA H, 1995, NAT STRUCT BIOL, V2, P768, DOI 10.1038/nsb0995-768; LAM E, 1995, GENE, V160, P297, DOI 10.1016/0378-1119(95)00216-S; Ma DZ, 2008, J BIOL CHEM, V283, P25963, DOI 10.1074/jbc.M802356200; Maestre-Martinez M, 2006, J BIOMOL NMR, V34, P197, DOI 10.1007/s10858-006-0018-6; Maestre-Martinez M, 2010, BIOL CHEM, V391, P1157, DOI 10.1515/BC.2010.122; Maestre-Martinez M, 2011, J MOL RECOGNIT, V24, P23, DOI 10.1002/jmr.1020; Malesevic M, 2010, BIOCHEMISTRY-US, V49, P8626, DOI 10.1021/bi101015p; Mulder FAA, 1999, J MOL BIOL, V292, P111, DOI 10.1006/jmbi.1999.3034; Okamoto T, 2006, EMBO J, V25, P5015, DOI 10.1038/sj.emboj.7601367; Petros AM, 2001, P NATL ACAD SCI USA, V98, P3012, DOI 10.1073/pnas.041619798; Rosner M, 2003, ONCOGENE, V22, P4786, DOI 10.1038/sj.onc.1206776; Schendel SL, 1997, P NATL ACAD SCI USA, V94, P5113, DOI 10.1073/pnas.94.10.5113; Shirane M, 2003, NAT CELL BIOL, V5, P28, DOI 10.1038/ncb894; THOMPSON CB, 1995, SCIENCE, V267, P1456, DOI 10.1126/science.7878464; Wang RB, 2006, BLOOD, V107, P1636, DOI 10.1182/blood-2005-06-2559; WISHART DS, 1995, J BIOMOL NMR, V6, P135, DOI 10.1007/BF00211777; WISHART DS, 1994, J BIOMOL NMR, V4, P171	34	14	14	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 1	2012	287	23					19665	19673		10.1074/jbc.M111.317214	http://dx.doi.org/10.1074/jbc.M111.317214			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974EF	22523079	hybrid, Green Published			2022-12-25	WOS:000306411900077
J	Greibe, E; Fedosov, S; Nexo, E				Greibe, Eva; Fedosov, Sergey; Nexo, Ebba			The Cobalamin-Binding Protein in Zebrafish Is an Intermediate between the Three Cobalamin-Binding Proteins in Human	PLOS ONE			English	Article							HUMAN TRANSCOBALAMIN-II; HUMAN INTRINSIC-FACTOR; GENOMIC STRUCTURE; HAPTOCORRIN; PURIFICATION; RABBIT; SERUM; CDNA	In humans, three soluble extracellular cobalamin-binding proteins; transcobalamin (TC), intrinsic factor (IF), and haptocorrin (HC), are involved in the uptake and transport of cobalamin. In this study, we investigate a cobalamin-binding protein from zebrafish (Danio rerio) and summarize current knowledge concerning the phylogenetic evolution of kindred proteins. We identified a cobalamin binding capacity in zebrafish protein extracts (8.2 pmol/fish) and ambient water (13.5 pmol/fish) associated with a single protein. The protein showed resistance toward degradation by trypsin and chymotrypsin (like human IF, but unlike human HC and TC). The cobalamin analogue, cobinamide, bound weaker to the zebrafish cobalamin binder than to human HC, but stronger than to human TC and IF. Affinity for another analogue, adenosyl-pseudo-cobalamin was low compared with human HC and TC, but high compared with human IF. The absorbance spectrum of the purified protein in complex with hydroxo-cobalamin resembled those of human HC and IF, but not TC. We searched available databases to further explore the phylogenies of the three cobalamin-binding proteins in higher vertebrates. Apparently, TC-like proteins are the oldest evolutionary derivatives followed by IF and HC (the latter being present only in reptiles and most but not all mammals). Our findings suggest that the only cobalamin-binding protein in zebrafish is an intermediate between the three human cobalamin binders. These findings support the hypothesis about a common ancestral gene for all cobalamin-binding proteins in higher vertebrates.	[Greibe, Eva; Nexo, Ebba] Aarhus Univ Hosp, Dept Clin Biochem, DK-8000 Aarhus, Denmark; [Fedosov, Sergey] Aarhus Univ, Dept Mol Biol, Dept Mol Biol & Genet, DK-8000 Aarhus, Denmark	Aarhus University; Aarhus University	Greibe, E (corresponding author), Aarhus Univ Hosp, Dept Clin Biochem, DK-8000 Aarhus, Denmark.	evagreibe@gmail.com	Greibe, Eva/E-3375-2018; Fedosov, Sergey N./J-2340-2019	Greibe, Eva/0000-0002-0417-1195; Fedosov, Sergey N./0000-0002-7016-2959; Nexo, Ebba/0000-0001-9406-9081	Danish Medical Research Council; Lundbeck Foundation	Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Lundbeck Foundation(Lundbeckfonden)	The study was funded by the Danish Medical Research Council and the Lundbeck Foundation. Funding was given to cover lab expensis in general (not just this project) and no grant number is relevant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Fedosov SN, 2007, BIOCHEMISTRY-US, V46, P6446, DOI 10.1021/bi062063l; Fedosov SN, 2002, J BIOL CHEM, V277, P9989, DOI 10.1074/jbc.M111399200; Fieber W, 2002, HELV CHIM ACTA, V85, P927, DOI 10.1002/1522-2675(200203)85:3<927::AID-HLCA927>3.0.CO;2-A; GOTTLIEB C, 1965, BLOOD-J HEMATOL, V25, P875, DOI 10.1182/blood.V25.6.875.875; HANSEN M, 1992, SCAND J CLIN LAB INV, V52, P647, DOI 10.3109/00365519209115508; HEWITT JE, 1990, EUR J BIOCHEM, V189, P125, DOI 10.1111/j.1432-1033.1990.tb15468.x; HEWITT JE, 1991, GENOMICS, V10, P432, DOI 10.1016/0888-7543(91)90329-D; Hygum K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020638; JOHNSTON J, 1992, GENOMICS, V12, P459, DOI 10.1016/0888-7543(92)90435-U; Kalra S, 2004, ARCH BIOCHEM BIOPHYS, V431, P189, DOI 10.1016/j.abb.2004.08.011; Kim S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008403; LI N, 1993, BIOCHIM BIOPHYS ACTA, V1172, P21, DOI 10.1016/0167-4781(93)90264-E; LI N, 1995, BIOCHEM BIOPH RES CO, V208, P756, DOI 10.1006/bbrc.1995.1402; Morkbak AL, 2007, CLIN CHEM LAB MED, V45, P1751, DOI 10.1515/CCLM.2007.343; NEXO BA, 1982, BIOCHIM BIOPHYS ACTA, V708, P178, DOI 10.1016/0167-4838(82)90218-7; NEXO E, 1988, SCAND J CLIN LAB INV, V48, P269, DOI 10.3109/00365518809167494; NEXO E, 1975, BIOCHIM BIOPHYS ACTA, V379, P189, DOI 10.1016/0005-2795(75)90021-5; NEXO E, 1981, BIOCHIM BIOPHYS ACTA, V667, P370, DOI 10.1016/0005-2795(81)90204-X; POLAK DM, 1979, J DAIRY SCI, V62, P697, DOI 10.3168/jds.S0022-0302(79)83312-3; Quardros EV, 2010, BRIT J HAEMATOL, V148, P195; Spence R, 2008, BIOL REV, V83, P13, DOI 10.1111/j.1469-185X.2007.00030.x; STUPPERICH E, 1991, EUR J BIOCHEM, V199, P299, DOI 10.1111/j.1432-1033.1991.tb16124.x; UCSC website, HUM GEN BROWS GAT; Wuerges J, 2007, BIOCHEM J, V403, P431, DOI 10.1042/BJ20061394	24	21	21	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2012	7	4							e35660	10.1371/journal.pone.0035660	http://dx.doi.org/10.1371/journal.pone.0035660			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UD	22532867	Green Published, Green Submitted, gold			2022-12-25	WOS:000305339200091
J	Pacheco, MA; Reid, MJC; Schillaci, MA; Lowenberger, CA; Galdikas, BMF; Jones-Engel, L; Escalante, AA				Pacheco, M. Andreina; Reid, Michael J. C.; Schillaci, Michael A.; Lowenberger, Carl A.; Galdikas, Birute M. F.; Jones-Engel, Lisa; Escalante, Ananias A.			The Origin of Malarial Parasites in Orangutans	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM; RIBOSOMAL-RNA; CYTOCHROME-B; GENE; EVOLUTION; VIVAX; MADAGASCAR; PHYLOGENY; MIOCENE; ANTIGEN	Background: Recent findings of Plasmodium in African apes have changed our perspectives on the evolution of malarial parasites in hominids. However, phylogenetic analyses of primate malarias are still missing information from Southeast Asian apes. In this study, we report molecular data for a malaria parasite lineage found in orangutans. Methodology/Principal Findings: We screened twenty-four blood samples from Pongo pygmaeus (Kalimantan, Indonesia) for Plasmodium parasites by PCR. For all the malaria positive orangutan samples, parasite mitochondrial genomes (mtDNA) and two antigens: merozoite surface protein 1 42 kDa (MSP-1(42)) and circumsporozoite protein gene (CSP) were amplified, cloned, and sequenced. Fifteen orangutans tested positive and yielded 5 distinct mitochondrial haplotypes not previously found. The haplotypes detected exhibited low genetic divergence among them, indicating that they belong to one species. We report phylogenetic analyses using mitochondrial genomes, MSP-1(42) and CSP. We found that the orangutan malaria parasite lineage was part of a monophyletic group that includes all the known non-human primate malaria parasites found in Southeast Asia; specifically, it shares a recent common ancestor with P. inui (a macaque parasite) and P. hylobati (a gibbon parasite) suggesting that this lineage originated as a result of a host switch. The genetic diversity of MSP-1(42) in orangutans seems to be under negative selection. This result is similar to previous findings in non-human primate malarias closely related to P. vivax. As has been previously observed in the other Plasmodium species found in non-human primates, the CSP shows high polymorphism in the number of repeats. However, it has clearly distinctive motifs from those previously found in other malarial parasites. Conclusion: The evidence available from Asian apes indicates that these parasites originated independently from those found in Africa, likely as the result of host switches from other non-human primates.	[Pacheco, M. Andreina; Escalante, Ananias A.] Arizona State Univ, Ctr Evolutionary Med & Informat, Biodesign Inst, Tempe, AZ 85287 USA; [Reid, Michael J. C.] Univ Toronto, Dept Anthropol, Toronto, ON M5S 1A1, Canada; [Schillaci, Michael A.] Univ Toronto Scarborough, Dept Social Sci, Toronto, ON, Canada; [Lowenberger, Carl A.] Simon Fraser Univ, Dept Biol Sci, Burnaby, BC V5A 1S6, Canada; [Galdikas, Birute M. F.] Simon Fraser Univ, Dept Archaeol, Burnaby, BC V5A 1S6, Canada; [Jones-Engel, Lisa] Univ Washington, Natl Primate Res Ctr, Seattle, WA 98195 USA; [Escalante, Ananias A.] Arizona State Univ, Sch Life Sci, Tempe, AZ USA	Arizona State University; Arizona State University-Tempe; University of Toronto; University of Toronto; University Toronto Scarborough; Simon Fraser University; Simon Fraser University; University of Washington; University of Washington Seattle; Arizona State University; Arizona State University-Tempe	Escalante, AA (corresponding author), Arizona State Univ, Ctr Evolutionary Med & Informat, Biodesign Inst, Tempe, AZ 85287 USA.	Ananias.Escalante@asu.edu	Reid, Michael/AAM-1640-2020	Jones-Engel, Lisa/0000-0001-6912-494X; Pacheco, Maria Andreina/0000-0002-5682-7299; Escalante, Ananias/0000-0002-1532-3430	U.S. National Institutes of Health [GM084320]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084320, R01GM080586] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by a grant from the U.S. National Institutes of Health, GM084320 to AAE. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Ali JR, 2010, NATURE, V463, P653, DOI 10.1038/nature08706; Arora N, 2010, P NATL ACAD SCI USA, V107, P21376, DOI 10.1073/pnas.1010169107; Begun DR, 2010, ANNU REV ANTHROPOL, V39, P67, DOI 10.1146/annurev.anthro.012809.105047; Benton MJ, 2007, MOL BIOL EVOL, V24, P26, DOI 10.1093/molbev/msl150; Bird MI, 2005, QUATERNARY SCI REV, V24, P2228, DOI 10.1016/j.quascirev.2005.04.004; Chaimanee Y, 2004, NATURE, V427, P439, DOI 10.1038/nature02245; Coatney R.G., 1971, PRIMATE MALARIA; COLLINS WE, 1970, EXP PARASITOL, V27, P507, DOI 10.1016/0014-4894(70)90054-8; Cornejo OE, 2006, TRENDS PARASITOL, V22, P558, DOI 10.1016/j.pt.2006.09.007; CORREDOR V, 1993, MOL BIOL EVOL, V10, P924; Delson E., 1980, P10; Dhorda M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019801; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; ESCALANTE AA, 1995, MOL BIOL EVOL, V12, P616; Escalante AA, 1998, P NATL ACAD SCI USA, V95, P8124, DOI 10.1073/pnas.95.14.8124; Escalante AA, 2005, P NATL ACAD SCI USA, V102, P1980, DOI 10.1073/pnas.0409652102; ESCALANTE AA, 1994, P NATL ACAD SCI USA, V91, P11373, DOI 10.1073/pnas.91.24.11373; GALINSKI MR, 1987, CELL, V48, P311, DOI 10.1016/0092-8674(87)90434-X; Garnham PCC, 1966, MALARIA PARASITES OT; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hayakawa T, 2008, MOL BIOL EVOL, V25, P2233, DOI 10.1093/molbev/msn171; HOLDER AA, 1982, J EXP MED, V156, P1528, DOI 10.1084/jem.156.5.1528; Huang CC, 2010, J PARASITOL, V96, P8, DOI 10.1645/GE-2165.1; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Imwong M, 2009, J CLIN MICROBIOL, V47, P4173, DOI 10.1128/JCM.00811-09; Krief S, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000765; Lee KS, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002015; Liu WM, 2010, NATURE, V467, P420, DOI 10.1038/nature09442; Locke DP, 2011, NATURE, V469, P529, DOI 10.1038/nature09687; Lohman DJ, 2011, ANNU REV ECOL EVOL S, V42, P205, DOI 10.1146/annurev-ecolsys-102710-145001; Mailund T, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001319; MCDONALD JH, 1991, NATURE, V351, P652, DOI 10.1038/351652a0; Mendes C, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001192; Mu JB, 2005, MOL BIOL EVOL, V22, P1686, DOI 10.1093/molbev/msi160; Ollomo B, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000446; Pacheco MA, 2007, INFECT GENET EVOL, V7, P180, DOI 10.1016/j.meegid.2006.08.002; Pacheco MA, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-299; Perkins SL, 2002, J PARASITOL, V88, P972, DOI 10.1645/0022-3395(2002)088[0972:AMPOMP]2.0.CO;2; PETERS W, 1976, PHILOS T R SOC B, V275, P439, DOI 10.1098/rstb.1976.0089; Poux C, 2005, SYST BIOL, V54, P719, DOI 10.1080/10635150500234534; Prugnolle F, 2010, P NATL ACAD SCI USA, V107, P1458, DOI 10.1073/pnas.0914440107; Reid MJC, 2006, EMERG INFECT DIS, V12, P1902; Rich SM, 2009, P NATL ACAD SCI USA, V106, P14902, DOI 10.1073/pnas.0907740106; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Singh B, 2004, LANCET, V363, P1017, DOI 10.1016/S0140-6736(04)15836-4; Singh B, 2009, EMERG INFECT DIS, V15, P1657, DOI 10.3201/eid1510.090364; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Thinh VN, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-74	48	36	36	2	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2012	7	4							e34990	10.1371/journal.pone.0034990	http://dx.doi.org/10.1371/journal.pone.0034990			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UD	22536346	gold, Green Published, Green Submitted			2022-12-25	WOS:000305339200031
J	Liang, SN; Lan, BL				Liang, Shiuan-Ni; Lan, Boon Leong			Comparison of Newtonian and Special-Relativistic Trajectories with the General-Relativistic Trajectory for a Low-Speed Weak-Gravity System	PLOS ONE			English	Article								We show, contrary to expectation, that the trajectory predicted by general-relativistic mechanics for a low-speed weak-gravity system is not always well-approximated by the trajectories predicted by special-relativistic and Newtonian mechanics for the same parameters and initial conditions. If the system is dissipative, the breakdown of agreement occurs for chaotic trajectories only. If the system is non-dissipative, the breakdown of agreement occurs for chaotic trajectories and non-chaotic trajectories. The agreement breaks down slowly for non-chaotic trajectories but rapidly for chaotic trajectories. When the predictions are different, general-relativistic mechanics must therefore be used, instead of special-relativistic mechanics (Newtonian mechanics), to correctly study the dynamics of a weak-gravity system (a low-speed weak-gravity system).	[Liang, Shiuan-Ni; Lan, Boon Leong] Monash Univ, Sch Sci, Bandar Sunway, Selangor, Malaysia	Monash University; Monash University Sunway	Liang, SN (corresponding author), Monash Univ, Sch Sci, Bandar Sunway, Selangor, Malaysia.	lan.boon.leong@monash.edu		Liang, Shiuan-Ni/0000-0001-9953-339X	Fundamental Research Grant Scheme [FRGS/2/2010/ST/MUSM/02/1]	Fundamental Research Grant Scheme	This work was funded by a Fundamental Research Grant Scheme FRGS/2/2010/ST/MUSM/02/1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Choquet-Bruhat Y., 2009, GEN RELATIVITY EINST; Davies P., 1992, NEW PHYS, P1; de Pater I, 2010, PLANETARY SCI, P302; Einstein A., 1961, RELATIVITY SPECIAL G, P115; French A. P., 1968, SPECIAL RELATIVITY; Hartle J.B., 2003, GRAVITY INTRO EINSTE; Lan BL, 2009, TOPICS ON CHAOTIC SYSTEMS, P199, DOI 10.1142/9789814271349_0023; Lan BL, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.036201; Lan BL, 2010, COMMUN NONLINEAR SCI, V15, P2497, DOI 10.1016/j.cnsns.2009.10.008; Lan BL, 2009, CHAOS SOLITON FRACT, V42, P534, DOI 10.1016/j.chaos.2009.01.021; Lan BL, 2006, CHAOS, V16, DOI 10.1063/1.2218379; LAPIDUS IR, 1972, AM J PHYS, V40, P1509, DOI 10.1119/1.1986879; Liang SN, 2011, RESULTS PHYS, V1, P36, DOI 10.1016/j.rinp.2011.10.001; LICHTENBERG AJ, 1983, REGULAR STOCHASTIC M; Lissauer JJ, 1999, REV MOD PHYS, V71, P835, DOI 10.1103/RevModPhys.71.835; Sprott JC, 2003, CHAOS TIME SERIES AN; TUFILLARO NB, 1986, J PHYS-PARIS, V47, P1477, DOI 10.1051/jphys:019860047090147700; TUFILLARO NB, 1992, EXPT APPROACH NONLIN; Wald R., 1984, GEN RELATIVITY	19	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2012	7	4							e34720	10.1371/journal.pone.0034720	http://dx.doi.org/10.1371/journal.pone.0034720			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TL	22536328	Green Published, gold, Green Submitted			2022-12-25	WOS:000305336200008
J	Fabrick, JA; Tabashnik, BE				Fabrick, Jeffrey A.; Tabashnik, Bruce E.			Similar Genetic Basis of Resistance to Bt Toxin Cry1Ac in Boll-Selected and Diet-Selected Strains of Pink Bollworm	PLOS ONE			English	Article							BACILLUS-THURINGIENSIS TOXINS; PECTINOPHORA-GOSSYPIELLA; INSECT RESISTANCE; TRANSGENIC COTTON; FITNESS COSTS; HELICOVERPA-ARMIGERA; HELIOTHIS-VIRESCENS; CROSS-RESISTANCE; DIAMONDBACK MOTH; CROPS	Genetically engineered cotton and corn plants producing insecticidal Bacillus thuringiensis (Bt) toxins kill some key insect pests. Yet, evolution of resistance by pests threatens long-term insect control by these transgenic Bt crops. We compared the genetic basis of resistance to Bt toxin Cry1Ac in two independently derived, laboratory-selected strains of a major cotton pest, the pink bollworm (Pectinophora gossypiella [Saunders]). The Arizona pooled resistant strain (AZP-R) was started with pink bollworm from 10 field populations and selected with Cry1Ac in diet. The Bt4R resistant strain was started with a long-term susceptible laboratory strain and selected first with Bt cotton bolls and later with Cry1Ac in diet. Previous work showed that AZP-R had three recessive mutations (r1, r2, and r3) in the pink bollworm cadherin gene (PgCad1) linked with resistance to Cry1Ac and Bt cotton producing Cry1Ac. Here we report that inheritance of resistance to a diagnostic concentration of Cry1Ac was recessive in Bt4R. In interstrain complementation tests for allelism, F-1 progeny from crosses between AZP-R and Bt4R were resistant to Cry1Ac, indicating a shared resistance locus in the two strains. Molecular analysis of the Bt4R cadherin gene identified a novel 15-bp deletion (r4) predicted to cause the loss of five amino acids upstream of the Cry1Ac-binding region of the cadherin protein. Four recessive mutations in PgCad1 are now implicated in resistance in five different strains, showing that mutations in cadherin are the primary mechanism of resistance to Cry1Ac in laboratory-selected strains of pink bollworm from Arizona.	[Fabrick, Jeffrey A.] USDA ARS, US Arid Land Agr Res Ctr, Maricopa, AZ USA; [Tabashnik, Bruce E.] Univ Arizona, Dept Entomol, Tucson, AZ 85721 USA	United States Department of Agriculture (USDA); University of Arizona	Fabrick, JA (corresponding author), USDA ARS, US Arid Land Agr Res Ctr, Maricopa, AZ USA.	jeff.fabrick@ars.usda.gov		Fabrick, Jeffrey/0000-0002-3893-9545	USDA-Agriculture and Food Research Initiative [2008-35302-0390]	USDA-Agriculture and Food Research Initiative(United States Department of Agriculture (USDA))	This work was supported by USDA-Agriculture and Food Research Initiative Grant 2008-35302-0390. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bagla P, 2010, SCIENCE, V327, P1439, DOI 10.1126/science.327.5972.1439; Bartlett A. C., 1995, 1995 Proceedings Beltwide Cotton Conferences, San Antonio, TX, USA, January 4-7, 1995: Volume 2., P766; Bartlett A. C., 1985, HDB INSECT REARING, V2, P415; Baxter SW, 2011, GENETICS, V189, P675, DOI 10.1534/genetics.111.130971; Bravo A, 2011, INSECT BIOCHEM MOLEC, V41, P423, DOI 10.1016/j.ibmb.2011.02.006; Carriere Y, 2005, J ECON ENTOMOL, V98, P947, DOI 10.1603/0022-0493-98.3.947; Carriere Y, 2003, P NATL ACAD SCI USA, V100, P1519, DOI 10.1073/pnas.0436708100; Carriere Y, 2001, J ECON ENTOMOL, V94, P1571, DOI 10.1603/0022-0493-94.6.1571; Carriere Y, 2006, J ECON ENTOMOL, V99, P1925, DOI 10.1603/0022-0493-99.6.1925; Dhurua S, 2011, PEST MANAG SCI, V67, P898, DOI 10.1002/ps.2127; Fabrick JA, 2007, INSECT BIOCHEM MOLEC, V37, P97, DOI 10.1016/j.ibmb.2006.10.010; Fabrick JA, 2011, INSECT MOL BIOL, V20, P651, DOI 10.1111/j.1365-2583.2011.01095.x; Fabrick JA, 2009, J INSECT SCI, V9, DOI 10.1673/031.009.2401; Ferre J, 2002, ANNU REV ENTOMOL, V47, P501, DOI 10.1146/annurev.ento.47.091201.145234; Gahan LJ, 2001, SCIENCE, V293, P857, DOI 10.1126/science.1060949; Gassmann AJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022629; Gonzalez-Cabrera J, 2003, INSECT BIOCHEM MOLEC, V33, P929, DOI 10.1016/S0965-1748(03)00099-7; Henneberry TJ, 2006, SOUTHWEST ENTOMOL, V31, P169; Henneberry T. J., 1998, Integrated Pest Management Reviews, V3, P31, DOI 10.1023/A:1009673622862; Herrero S, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-96; Hutchison WD, 2010, SCIENCE, V330, P222, DOI 10.1126/science.1190242; Jurat-Fuentes JL, 2004, BIOCHEMISTRY-US, V43, P14299, DOI 10.1021/bi048500i; Kruger M, 2009, CROP PROT, V28, P684, DOI 10.1016/j.cropro.2009.04.001; Liu YB, 2001, J ECON ENTOMOL, V94, P1237, DOI 10.1603/0022-0493-94.5.1237; Liu YB, 1999, NATURE, V400, P519, DOI 10.1038/22919; Liu YB, 2001, J ECON ENTOMOL, V94, P248, DOI 10.1603/0022-0493-94.1.248; Liu YB, 1997, APPL ENVIRON MICROB, V63, P2218, DOI 10.1128/AEM.63.6.2218-2223.1997; Mendelsohn M, 2003, NAT BIOTECHNOL, V21, P1003, DOI 10.1038/nbt0903-1003; Morin S, 2004, INSECT BIOCHEM MOLEC, V34, P1225, DOI 10.1016/j.ibmb.2004.08.003; Morin S, 2003, P NATL ACAD SCI USA, V100, P5004, DOI 10.1073/pnas.0831036100; National Research Council, 2010, IMP GEN ENG CROPS FA; Sanahuja G, 2011, PLANT BIOTECHNOL J, V9, P283, DOI 10.1111/j.1467-7652.2011.00595.x; Storer NP, 2010, J ECON ENTOMOL, V103, P1031, DOI 10.1603/EC10040; Tabashnik BE, 2000, P NATL ACAD SCI USA, V97, P12980, DOI 10.1073/pnas.97.24.12980; Tabashnik BE, 2003, J ECON ENTOMOL, V96, P1031, DOI 10.1603/0022-0493-96.4.1031; Tabashnik BE, 2000, APPL ENVIRON MICROB, V66, P4582, DOI 10.1128/AEM.66.10.4582-4584.2000; TABASHNIK BE, 1994, ANNU REV ENTOMOL, V39, P47, DOI 10.1146/annurev.en.39.010194.000403; Tabashnik BE, 2005, J ECON ENTOMOL, V98, P635, DOI 10.1603/0022-0493-98.3.635; Tabashnik BE, 2004, J ECON ENTOMOL, V97, P721, DOI 10.1603/0022-0493(2004)097[0721:SGBORT]2.0.CO;2; Tabashnik BE, 1997, P NATL ACAD SCI USA, V94, P12780, DOI 10.1073/pnas.94.24.12780; Tabashnik BE, 2002, APPL ENVIRON MICROB, V68, P3790, DOI 10.1128/AEM.68.8.3790-3794.2002; Tabashnik BE, 2002, J ECON ENTOMOL, V95, P1018, DOI 10.1603/0022-0493-95.5.1018; Tabashnik BE, 2005, P NATL ACAD SCI USA, V102, P15389, DOI 10.1073/pnas.0507857102; Tabashnik BE, 2008, NAT BIOTECHNOL, V26, P199, DOI 10.1038/nbt1382; Tabashnik BE, 2006, J ECON ENTOMOL, V99, P1525, DOI 10.1603/0022-0493-99.5.1525; Tabashnik BE, 2010, NAT BIOTECHNOL, V28, P1304, DOI 10.1038/nbt.1704; Tabashnik BE, 2009, J ECON ENTOMOL, V102, P2011, DOI 10.1603/029.102.0601; Tabashnik BE, 2009, P NATL ACAD SCI USA, V106, P11889, DOI 10.1073/pnas.0901351106; Wan P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029975; Williams JL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021863; Wu KM, 2008, SCIENCE, V321, P1676, DOI 10.1126/science.1160550; Xu XJ, 2005, APPL ENVIRON MICROB, V71, P948, DOI 10.1128/AEM.71.2.948-954.2005; Zhang XB, 2006, P NATL ACAD SCI USA, V103, P9897, DOI 10.1073/pnas.0604017103; Zhao J, 2010, INSECT BIOCHEM MOLEC, V40, P113, DOI 10.1016/j.ibmb.2010.01.001	54	43	45	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2012	7	4							e35658	10.1371/journal.pone.0035658	http://dx.doi.org/10.1371/journal.pone.0035658			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959XD	22530065	Green Submitted, gold, Green Published			2022-12-25	WOS:000305350600111
J	Lee, NS; Rohan, JG; Zitting, M; Kamath, S; Weitz, A; Sipos, A; Salvaterra, PM; Hasegawa, K; Pera, M; Chow, RH				Lee, Nan Sook; Rohan, Joyce G.; Zitting, Madison; Kamath, Sonia; Weitz, Andrew; Sipos, Arnold; Salvaterra, Paul M.; Hasegawa, Kouichi; Pera, Martin; Chow, Robert H.			A Novel Dual-Color Reporter for Identifying Insulin-Producing Beta- Cells and Classifying Heterogeneity of Insulinoma Cell Lines	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; GENE-EXPRESSION; TRANSGENIC MICE; ENDOCRINE PANCREAS; ADULT HUMAN; IN-VIVO; MOUSE; SECRETION; PROMOTER; GLUCOSE	Many research studies use immortalized cell lines as surrogates for primary beta-cells. We describe the production and use of a novel "indirect" dual-fluorescent reporter system that leads to mutually exclusive expression of EGFP in insulin-producing (INS+) beta-cells or mCherry in non-beta-cells. Our system uses the human insulin promoter to initiate a Cre-mediated shift in reporter color within a single transgene construct and is useful for FACS selection of cells from single cultures for further analysis. Application of our reporter to presumably clonal HIT-T15 insulinoma cells, as well as other presumably clonal lines, indicates that these cultures are in fact heterogeneous with respect to INS+ phenotype. Our strategy could be easily applied to other cell-or tissue-specific promoters. We anticipate its utility for FACS purification of INS+ and glucose-responsive beta-like-cells from primary human islet cell isolates or in vitro differentiated pluripotent stem cells.	[Lee, Nan Sook; Rohan, Joyce G.; Kamath, Sonia; Chow, Robert H.] Univ So Calif, Dept Physiol & Biophys, Los Angeles, CA 90089 USA; [Lee, Nan Sook; Rohan, Joyce G.; Kamath, Sonia; Chow, Robert H.] Univ So Calif, Zilkha Neurogenet Inst, Los Angeles, CA USA; [Zitting, Madison; Weitz, Andrew] Univ So Calif, Dept Biomed Engn, Los Angeles, CA 90089 USA; [Sipos, Arnold] Univ So Calif, Sch Med, Los Angeles, CA USA; [Salvaterra, Paul M.] Beckman Res Inst City Hope, Div Neurosci, Duarte, CA USA; [Hasegawa, Kouichi; Pera, Martin] Univ So Calif, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, Los Angeles, CA USA	University of Southern California; University of Southern California; University of Southern California; University of Southern California; City of Hope; Beckman Research Institute of City of Hope; University of Southern California	Lee, NS (corresponding author), Univ So Calif, Dept Physiol & Biophys, Los Angeles, CA 90089 USA.	nanlee@usc.edu	Chow, Robert/B-8155-2013; PERA, MARTIN/A-9812-2012; Hasegawa, Kouichi/Y-9349-2019	PERA, MARTIN/0000-0001-6239-0428; Hasegawa, Kouichi/0000-0001-5947-5471; Rohan, Joyce/0000-0001-5102-6639	Wright Foundation (USC)	Wright Foundation (USC)	This work was supported by the Wright Foundation (USC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akerman I, 2011, DEV CELL, V20, P411, DOI 10.1016/j.devcel.2011.04.002; Alexopoulou AN, 2008, BMC CELL BIOL, V9, DOI 10.1186/1471-2121-9-2; ALWINE JC, 1985, MOL CELL BIOL, V5, P1034, DOI 10.1128/MCB.5.5.1034; Bonini P, 2001, JOP, V2, P105; Chung SM, 2002, STEM CELLS, V20, P139, DOI 10.1634/stemcells.20-2-139; Collombat P, 2005, DEVELOPMENT, V132, P2969, DOI 10.1242/dev.01870; Collombat P, 2003, GENE DEV, V17, P2591, DOI 10.1101/gad.269003; D'Amour KA, 2006, NAT BIOTECHNOL, V24, P1392, DOI 10.1038/nbt1259; deVargas LM, 1997, J BIOL CHEM, V272, P26573, DOI 10.1074/jbc.272.42.26573; Dhawan S, 2011, DEV CELL, V20, P419, DOI 10.1016/j.devcel.2011.03.012; EFRAT S, 1988, P NATL ACAD SCI USA, V85, P9037, DOI 10.1073/pnas.85.23.9037; Emerich DF, 2002, EXPERT OPIN BIOL TH, V2, P793, DOI 10.1517/14712598.2.8.793; FROMONTRACINE M, 1990, MOL ENDOCRINOL, V4, P669, DOI 10.1210/mend-4-5-669; GILLIGAN A, 1989, DIABETES, V38, P1056, DOI 10.2337/diabetes.38.8.1056; Gopel S, 2004, J PHYSIOL-LONDON, V556, P711, DOI 10.1113/jphysiol.2003.059675; GROMADA J, 1995, DIABETES, V44, P767, DOI 10.2337/diabetes.44.7.767; Han GC, 2007, J AGR FOOD CHEM, V55, P10641, DOI 10.1021/jf0722598; Hasegawa K, 2002, FEBS LETT, V520, P47, DOI 10.1016/S0014-5793(02)02761-8; Hay CW, 2006, DIABETES, V55, P3201, DOI 10.2337/db06-0788; Heikal AA, 2010, BIOMARK MED, V4, P241, DOI 10.2217/BMM.10.1; Hill JA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012958; Hohmeier HE, 2000, DIABETES, V49, P424, DOI 10.2337/diabetes.49.3.424; Irminger JC, 1996, BIOCHEM J, V320, P11, DOI 10.1042/bj3200011; Itier JM, 1996, DIFFERENTIATION, V60, P309, DOI 10.1046/j.1432-0436.1996.6050309.x; Kawamura Y, 2006, MOL ENDOCRINOL, V20, P844, DOI 10.1210/me.2005-0138; Kiselyuk A, 2010, J BIOMOL SCREEN, V15, P663, DOI 10.1177/1087057110372257; Kroon E, 2008, NAT BIOTECHNOL, V26, P443, DOI 10.1038/nbt1393; LAIMINS L, 1986, P NATL ACAD SCI USA, V83, P3151, DOI 10.1073/pnas.83.10.3151; Le Lay J, 2004, J BIOL CHEM, V279, P22228, DOI 10.1074/jbc.M312673200; Lee NS, 2008, BIOCHEM BIOPH RES CO, V377, P434, DOI 10.1016/j.bbrc.2008.09.159; Lester Linda B, 2004, Reprod Biol Endocrinol, V2, P42, DOI 10.1186/1477-7827-2-42; Lorenz P, 2004, BIOTECHNOL LETT, V26, P1589, DOI 10.1023/B:BILE.0000045658.33723.d6; Meyer K, 1998, DIABETES, V47, P1974, DOI 10.2337/diabetes.47.12.1974; Mezzanotte L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019277; Moede T, 2001, DIABETES, V50, pS15, DOI 10.2337/diabetes.50.2007.S15; RADVANYI F, 1993, MOL CELL BIOL, V13, P4223, DOI 10.1128/MCB.13.7.4223; Rorsman P, 2011, PROG BIOPHYS MOL BIO; Rovira M, 2007, CLONING STEM CELLS, V9, P327, DOI 10.1089/clo.2006.0064; Russ HA, 2008, DIABETES, V57, P1575, DOI 10.2337/db07-1283; SANTERRE RF, 1981, P NATL ACAD SCI-BIOL, V78, P4339, DOI 10.1073/pnas.78.7.4339; SJOHOLM A, 1993, J CLIN INVEST, V92, P1910, DOI 10.1172/JCI116784; Skelin M, 2010, ALTEX-ALTERN ANIM EX, V27, P105; Smith-Arica JR, 2003, CLONING STEM CELLS, V5, P51, DOI 10.1089/153623003321512166; SWOPE SL, 1984, P NATL ACAD SCI-BIOL, V81, P1822, DOI 10.1073/pnas.81.6.1822; Szabat M, 2010, DIABETOLOGIA, V53, P1680, DOI 10.1007/s00125-010-1758-0; Szabat M, 2011, ISLETS, V3, P175, DOI 10.4161/isl.3.4.15881; Szabat M, 2009, ENDOCRINOLOGY, V150, P1627, DOI 10.1210/en.2008-1224; Ulrich AB, 2002, PANCREAS, V24, P111, DOI 10.1097/00006676-200203000-00001; Wang SZ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004200; Ward CM, 2002, STEM CELLS, V20, P472, DOI 10.1634/stemcells.20-5-472; Zhou Q, 2008, NATURE, V455, P627, DOI 10.1038/nature07314	51	3	3	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2012	7	4							e35521	10.1371/journal.pone.0035521	http://dx.doi.org/10.1371/journal.pone.0035521			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959XD	22530041	Green Published, gold			2022-12-25	WOS:000305350600094
J	Marum, L; Miguel, A; Ricardo, CP; Miguel, C				Marum, Liliana; Miguel, Andreia; Ricardo, Candido P.; Miguel, Celia			Reference Gene Selection for Quantitative Real-time PCR Normalization in Quercus suber	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; SUPERIOR REFERENCE GENES; TISSUE-SPECIFIC GENES; RT-PCR; HOUSEKEEPING GENES; TRANSCRIPT NORMALIZATION; RELATIVE QUANTIFICATION; EXPRESSION; IDENTIFICATION; VALIDATION	The use of reverse transcription quantitative PCR technology to assess gene expression levels requires an accurate normalization of data in order to avoid misinterpretation of experimental results and erroneous analyses. Despite being the focus of several transcriptomics projects, oaks, and particularly cork oak (Quercus suber), have not been investigated regarding the identification of reference genes suitable for the normalization of real-time quantitative PCR data. In this study, ten candidate reference genes (Act, CACs, EF-1 alpha, GAPDH, His3, PsaH, Sand, PP2A, ss-Tub and Ubq) were evaluated to determine the most stable internal reference for quantitative PCR normalization in cork oak. The transcript abundance of these genes was analysed in several tissues of cork oak, including leaves, reproduction cork, and periderm from branches at different developmental stages (1-, 2-, and 3-year old) or collected in different dates (active growth period versus dormancy). The three statistical methods (geNorm, NormFinder, and CV method) used in the evaluation of the most suitable combination of reference genes identified Act and CACs as the most stable candidates when all the samples were analysed together, while ss-Tub and PsaH showed the lowest expression stability. However, when different tissues, developmental stages, and collection dates were analysed separately, the reference genes exhibited some variation in their expression levels. In this study, and for the first time, we have identified and validated reference genes in cork oak that can be used for quantification of target gene expression in different tissues and experimental conditions and will be useful as a starting point for gene expression studies in other oaks.	[Marum, Liliana; Miguel, Andreia; Ricardo, Candido P.; Miguel, Celia] ITQB UNL, IBET, Oeiras, Portugal		Marum, L (corresponding author), ITQB UNL, IBET, Oeiras, Portugal.	marum@itqb.unl.pt; cmiguel@itqb.unl.pt	Miguel, Celia/D-2153-2012; Ricardo, Candido/B-7891-2008	Miguel, Celia/0000-0002-1427-952X; Ricardo, Candido/0000-0003-4905-1274; Marum, Liliana/0000-0002-6938-479X	Fundacao Ciencia e Tecnologia (FCT) [PEst-OE/EQB/LA0004/2011, PTDC/AGR-GPL/098369/2008, BPD/SFRH/47679/2008, BD/SFRH/44474/2008]	Fundacao Ciencia e Tecnologia (FCT)(Portuguese Foundation for Science and Technology)	This research was supported by Fundacao Ciencia e Tecnologia (FCT;http://www.fct.pt), through projects PEst-OE/EQB/LA0004/2011 and PTDC/AGR-GPL/098369/2008, and grants BPD/SFRH/47679/2008 (to LM) and BD/SFRH/44474/2008 (to AM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Artico S, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-49; Beisson F, 2007, PLANT CELL, V19, P351, DOI 10.1105/tpc.106.048033; Brunner Amy M., 2004, BMC Plant Biology, V4, P14, DOI 10.1186/1471-2229-4-14; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Czechowski T, 2005, PLANT PHYSIOL, V139, P5, DOI 10.1104/pp.105.063743; Demidenko NV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019434; Die JV, 2010, PLANTA, V232, P145, DOI 10.1007/s00425-010-1158-1; Exposito-Rodriguez M, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-131; Farre D, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r140; Gutierrez L, 2008, PLANT BIOTECHNOL J, V6, P609, DOI 10.1111/j.1467-7652.2008.00346.x; Hellemans J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r19; Hong SM, 2010, PLANT CELL PHYSIOL, V51, P1694, DOI 10.1093/pcp/pcq128; Huis R, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-71; Jarosova J, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-146; Kakar K, 2008, PLANT METHODS, V4, DOI 10.1186/1746-4811-4-18; Kamphuis W, 2001, INVEST OPHTH VIS SCI, V42, P3209; Kouadjo KE, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-127; Kuijk EW, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-58; Lawson MJ, 2008, GENE, V407, P54, DOI 10.1016/j.gene.2007.09.017; Li QF, 2010, PLANT MOL BIOL REP, V28, P49, DOI 10.1007/s11105-009-0124-1; Lin YL, 2010, PLANT SCI, V178, P359, DOI 10.1016/j.plantsci.2010.02.005; Maroufi A, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-15; Marum L, 2011, BMC P; Migocka M, 2011, MOL BREEDING, DOI [10.1007/s11032-11010-19487-11030, DOI 10.1007/S11032-11010-19487-11030]; Miguel A, 2011, BMC P; Nolan T, 2006, NAT PROTOC, V1, P1559, DOI 10.1038/nprot.2006.236; Paiva JA, 2011, BMC P; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Phillips MA, 2009, PLANT MOL BIOL REP, V27, P407, DOI 10.1007/s11105-008-0072-1; Ramakers C, 2003, NEUROSCI LETT, V339, P62, DOI 10.1016/S0304-3940(02)01423-4; Ramos M, 2011, BMC P; Reid KE, 2006, BMC PLANT BIOL, V6, DOI 10.1186/1471-2229-6-27; Remans T, 2008, PLANTA, V227, P1343, DOI 10.1007/s00425-008-0706-4; Rozen S, PRIMER3 WWW GEN USER, P365; Schmidt GW, 2010, MOL GENET GENOMICS, V283, P233, DOI 10.1007/s00438-010-0511-1; Silva SP, 2005, INT MATER REV, V50, P345, DOI 10.1179/174328005X41168; Silveira ED, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-84; Soler M, 2008, TREE PHYSIOL, V28, P743, DOI 10.1093/treephys/28.5.743; Soler M, 2007, PLANT PHYSIOL, V144, P419, DOI 10.1104/pp.106.094227; Stothard P, 2000, BIOTECHNIQUES, V28, P1102, DOI 10.2144/00286ir01; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vashisth T, 2011, PLANT CELL REP, DOI [10.1007/s00299-00011-01121-z, DOI 10.1007/S00299-00011-01121-Z]; Warrington JA, 2000, PHYSIOL GENOMICS, V2, P143, DOI 10.1152/physiolgenomics.2000.2.3.143; Xu M, 2011, ANAL BIOCHEM, V408, P337, DOI 10.1016/j.ab.2010.08.044; Yang YF, 2010, MOL BIOL REP, V37, P507, DOI 10.1007/s11033-009-9703-3; Zhang LQ, 2004, MOL BIOL EVOL, V21, P236, DOI 10.1093/molbev/msh010; Zhao S, 2005, J COMPUT BIOL, V12, P1047, DOI 10.1089/cmb.2005.12.1047	49	84	86	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2012	7	4							e35113	10.1371/journal.pone.0035113	http://dx.doi.org/10.1371/journal.pone.0035113			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959XD	22529976	gold, Green Submitted, Green Published			2022-12-25	WOS:000305350600056
J	Vabret, N; Bailly-Bechet, M; Najburg, V; Muller-Trutwin, M; Verrier, B; Tangy, F				Vabret, Nicolas; Bailly-Bechet, Marc; Najburg, Valerie; Mueller-Trutwin, Michaela; Verrier, Bernard; Tangy, Frederic			The Biased Nucleotide Composition of HIV-1 Triggers Type I Interferon Response and Correlates with Subtype D Increased Pathogenicity	PLOS ONE			English	Article							PLASMACYTOID DENDRITIC CELLS; DISEASE PROGRESSION; IMMUNE ACTIVATION; INNATE IMMUNITY; POOL IMBALANCE; SIV INFECTION; VIRAL SUBTYPE; VIRUS; RECOGNITION; GENOME	The genome of human immunodeficiency virus (HIV) has an average nucleotide composition strongly biased as compared to the human genome. The consequence of such nucleotide composition on HIV pathogenicity has not been investigated yet. To address this question, we analyzed the role of nucleotide bias of HIV-derived nucleic acids in stimulating type-I interferon response in vitro. We found that the biased nucleotide composition of HIV is detected in human cells as compared to humanized sequences, and triggers a strong innate immune response, suggesting the existence of cellular immune mechanisms able to discriminate RNA sequences according to their nucleotide composition or to detect specific secondary structures or linear motifs within biased RNA sequences. We then extended our analysis to the entire genome scale by testing more than 1300 HIV-1 complete genomes to look for an association between nucleotide composition of HIV-1 group M subtypes and their pathogenicity. We found that subtype D, which has an increased pathogenicity compared to the other subtypes, has the most divergent nucleotide composition relative to the human genome. These data support the hypothesis that the biased nucleotide composition of HIV-1 may be related to its pathogenicity.	[Vabret, Nicolas; Najburg, Valerie; Tangy, Frederic] Inst Pasteur, CNRS, URA 3015, Unite Genom Virale & Vaccinat, Paris, France; [Bailly-Bechet, Marc] Univ Lyon 1, CNRS, UMR 5558, Lab Biometrie & Biol Evolut, F-69622 Villeurbanne, France; [Mueller-Trutwin, Michaela] Inst Pasteur, Unite Regulat Infect Retrovirales, Paris, France; [Verrier, Bernard] Univ Lyon 1, CNRS, FRE 3310, Inst Biol & Chim Prot, F-69365 Lyon, France	Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; VetAgro Sup; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Claude Bernard Lyon 1	Vabret, N (corresponding author), Inst Pasteur, CNRS, URA 3015, Unite Genom Virale & Vaccinat, Paris, France.	ftangy@pasteur.fr	Bailly-Bechet, Marc/B-6292-2012; verrier, bernard/J-4094-2017	Muller-Trutwin, Michaela/0000-0002-3854-2396; verrier, bernard/0000-0002-8478-7095	Centre National de la Recherche Scientifique [PEPS-60593a]; Agence Nationale de la Recherche contre le SIDA [ANRS-2010-311]; European Commission (Europrise) [LSHP CT-2006-037611]	Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Agence Nationale de la Recherche contre le SIDA(French National Research Agency (ANR)); European Commission (Europrise)(European CommissionEuropean Commission Joint Research Centre)	This work was supported by the Centre National de la Recherche Scientifique (PEPS-60593a), the Agence Nationale de la Recherche contre le SIDA (ANRS-2010-311), and the European Commission (Europrise, LSHP CT-2006-037611). Dr. Vabret is a fellow from Ecole Normale Superieure (ENS), Lyon. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bauer S, 2009, ADV EXP MED BIOL, V653, P15; Beignon AS, 2005, J CLIN INVEST, V115, P3265, DOI 10.1172/JCI26032; BERKHOUT B, 1994, NUCLEIC ACIDS RES, V22, P1705, DOI 10.1093/nar/22.9.1705; Berkhout B, 2002, AIDS RES HUM RETROV, V18, P133, DOI 10.1089/08892220252779674; Bishop KN, 2004, SCIENCE, V305, P645, DOI 10.1126/science.1100658; Bousheri S, 2009, JAIDS-J ACQ IMM DEF, V52, P548, DOI 10.1097/QAI.0b013e3181c1d456; Brenchley JM, 2010, IMMUNITY, V32, P737, DOI 10.1016/j.immuni.2010.06.004; Chiu YH, 2009, CELL, V138, P576, DOI 10.1016/j.cell.2009.06.015; Deforche K, 2007, J COMPUT BIOL, V14, P1105, DOI 10.1089/cmb.2007.0073; Diebold S, 2010, IMMUNOL LETT, V128, P17, DOI 10.1016/j.imlet.2009.09.010; Doitsh G, 2010, CELL, V143, P789, DOI 10.1016/j.cell.2010.11.001; Easterbrook PJ, 2010, J INT AIDS SOC, V13, DOI 10.1186/1758-2652-13-4; Grossman Z, 2002, NAT MED, V8, P319, DOI 10.1038/nm0402-319; Harris LD, 2010, J VIROL, V84, P7886, DOI 10.1128/JVI.02612-09; Jacquelin B, 2009, J CLIN INVEST, V119, P3544, DOI 10.1172/JCI40093; Kaleebu P, 2002, J INFECT DIS, V185, P1244, DOI 10.1086/340130; Kiwanuka N, 2010, JAIDS-J ACQ IMM DEF, V54, P180, DOI 10.1097/QAI.0b013e3181c98fc0; Lepelley A, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001284; Malathi K, 2007, NATURE, V448, P816, DOI 10.1038/nature06042; Mandl JN, 2008, NAT MED, V14, P1077, DOI 10.1038/nm.1871; Manel N, 2010, NATURE, V467, P214, DOI 10.1038/nature09337; Meier A, 2007, J VIROL, V81, P8180, DOI 10.1128/JVI.00421-07; Mulder LCF, 2008, P NATL ACAD SCI USA, V105, P5501, DOI 10.1073/pnas.0710190105; Nascimbeni M, 2009, BLOOD, V113, P6112, DOI 10.1182/blood-2008-07-170803; Pandrea I, 2008, TRENDS IMMUNOL, V29, P419, DOI 10.1016/j.it.2008.05.004; Rehwinkel J, 2010, J CLIN IMMUNOL, V30, P491, DOI 10.1007/s10875-010-9384-7; Saito T, 2008, NATURE, V454, P523, DOI 10.1038/nature07106; Sauter D, 2009, CELL HOST MICROBE, V6, P409, DOI 10.1016/j.chom.2009.10.004; Silvestri G, 2005, J VIROL, V79, P4043, DOI 10.1128/JVI.79.7.4043-4054.2005; Smith HC, 2011, TRENDS BIOCH SCI; Sodora DL, 2008, AIDS, V22, P439, DOI 10.1097/QAD.0b013e3282f2dbe7; Sodora DL, 2009, NAT MED, V15, P861, DOI 10.1038/nm.2013; Solis M, 2010, J VIROL; VANHEMERT FJ, 1995, J MOL EVOL, V41, P132, DOI 10.1007/BF00170664; VARTANIAN JP, 1994, P NATL ACAD SCI USA, V91, P3092, DOI 10.1073/pnas.91.8.3092; Wood N, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000414; Yoneyama M, 2010, REV MED VIROL, V20, P4, DOI 10.1002/rmv.633	37	28	31	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2012	7	4							e33502	10.1371/journal.pone.0033502	http://dx.doi.org/10.1371/journal.pone.0033502			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959XD	22529893	Green Published, gold, Green Submitted			2022-12-25	WOS:000305350600004
J	Zhang, JB; Shan, LY; Koussih, L; Redhu, NS; Halayko, AJ; Chakir, J; Gounni, AS				Zhang, Jingbo; Shan, Lianyu; Koussih, Latifa; Redhu, Naresh Singh; Halayko, Andrew J.; Chakir, Jamila; Gounni, Abdelilah S.			Pentraxin 3 (PTX3) Expression in Allergic Asthmatic Airways: Role in Airway Smooth Muscle Migration and Chemokine Production	PLOS ONE			English	Article							RECOGNITION RECEPTOR PTX3; FC-EPSILON-RI; BRONCHOALVEOLAR LAVAGE FLUID; ACUTE MYOCARDIAL-INFARCTION; GAMMA-INDUCIBLE PROTEIN-10; FIBROBLAST-GROWTH-FACTOR; C-REACTIVE PROTEIN; ENDOTHELIAL-CELLS; INNATE IMMUNITY; TNF-ALPHA	Background: Pentraxin 3 (PTX3) is a soluble pattern recognition receptor with non-redundant functions in inflammation and innate immunity. PTX3 is produced by immune and structural cells. However, very little is known about the expression of PTX3 and its role in allergic asthma. Objectives and Methods: We sought to determine the PTX3 expression in asthmatic airways and its function in human airway smooth muscle cells (HASMC). In vivo PTX3 expression in bronchial biopsies of mild, moderate and severe asthmatics was analyzed by immunohistochemistry. PTX3 mRNA and protein were measured by real-time RT-PCR and ELISA, respectively. Proliferation and migration were examined using H-3-thymidine incorporation, cell count and Boyden chamber assays. Results: PTX3 immunoreactivity was increased in bronchial tissues of allergic asthmatics compared to healthy controls, and mainly localized in the smooth muscle bundle. PTX3 protein was expressed constitutively by HASMC and was significantly up-regulated by TNF, and IL-1 beta but not by Th2 (IL-4, IL-9, IL-13), Th1 (IFN-gamma), or Th-17 (IL-17) cytokines. In vitro, HASMC released significantly higher levels of PTX3 at the baseline and upon TNF stimulation compared to airway epithelial cells (EC). Moreover, PTX3 induced CCL11/eotaxin-1 release whilst inhibited the fibroblast growth factor-2 (FGF-2)-driven HASMC chemotactic activity. Conclusions: Our data provide the first evidence that PTX3 expression is increased in asthmatic airways. HASMC can both produce and respond to PTX3. PTX3 is a potent inhibitor of HASMC migration induced by FGF-2 and can upregulate CCL11/eotaxin-1 release. These results raise the possibility that PTX3 may play a dual role in allergic asthma.	[Zhang, Jingbo; Shan, Lianyu; Koussih, Latifa; Redhu, Naresh Singh; Halayko, Andrew J.; Gounni, Abdelilah S.] Univ Manitoba, Fac Med, Dept Immunol, Winnipeg, MB R3E 0W3, Canada; [Halayko, Andrew J.] Univ Manitoba, Fac Med, Dept Physiol, Winnipeg, MB, Canada; [Chakir, Jamila] Univ Laval, Inst Univ Cardiol & Pneumol Quebec, Ste Foy, PQ G1K 7P4, Canada; [Zhang, Jingbo] Third Mil Med Univ, Xinqiao Hosp, Chongqing, Peoples R China	University of Manitoba; University of Manitoba; Laval University; Army Medical University	Zhang, JB (corresponding author), Univ Manitoba, Fac Med, Dept Immunol, Winnipeg, MB R3E 0W3, Canada.	gounni@cc.umanitoba.ca	Gounni, Abdelilah Soussi/AAH-3456-2020	Soussi Gounni, Abdelilah/0000-0002-7282-0388; Gounni, Abdelilah/0000-0003-1265-6560; Halayko, Andrew/0000-0002-7865-4552	Canadian Institutes of Health Research (CIHR) grant; Manitoba Research Chair; Manitoba Health Research Council-Manitoba Institute of Child Health (MHRC-MICH); Canadian Thoracic Society-Canada Lung Association (CTS-CLA) graduate studentship	Canadian Institutes of Health Research (CIHR) grant(Canadian Institutes of Health Research (CIHR)); Manitoba Research Chair; Manitoba Health Research Council-Manitoba Institute of Child Health (MHRC-MICH); Canadian Thoracic Society-Canada Lung Association (CTS-CLA) graduate studentship	This work was supported by the Canadian Institutes of Health Research (CIHR) grant and Manitoba Research Chair to ASG. JZ is supported by a postdoctoral fellowship from the Manitoba Health Research Council-Manitoba Institute of Child Health (MHRC-MICH). NSR is supported by the Canadian Thoracic Society-Canada Lung Association (CTS-CLA) graduate studentship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amrani Y, 2007, AM J RESP CELL MOL, V36, P387, DOI 10.1165/ajrcmb.36.3.387; [Anonymous], 1987, AM REV RESPIR DIS, V136, P225; Azzurri A, 2005, MICROBES INFECT, V7, P1, DOI 10.1016/j.micinf.2004.09.004; Berry MA, 2006, NEW ENGL J MED, V354, P697, DOI 10.1056/NEJMoa050580; Bosse Y, 2008, TRENDS MOL MED, V14, P3, DOI 10.1016/j.molmed.2007.11.003; Bozza S, 2006, BLOOD, V108, P3387, DOI 10.1182/blood-2006-03-009266; BREVIARIO F, 1992, J BIOL CHEM, V267, P22190; Camozzi M, 2005, ARTERIOSCL THROM VAS, V25, P1837, DOI 10.1161/01.ATV.0000177807.54959.7d; Camozzi M, 2006, J BIOL CHEM, V281, P22605, DOI 10.1074/jbc.M601023200; Chakir J, 2001, J ALLERGY CLIN IMMUN, V107, P36, DOI 10.1067/mai.2001.111929; Chambers LS, 2003, AM J PHYSIOL-LUNG C, V285, pL619, DOI 10.1152/ajplung.00416.2002; Chambers LS, 2001, AM J PHYSIOL-LUNG C, V281, pL1369, DOI 10.1152/ajplung.2001.281.6.L1369; Cheng SS, 2002, EXP MOL PATHOL, V73, P1, DOI 10.1006/exmp.2002.2439; Cheng SS, 2002, J IMMUNOL, V168, P2887, DOI 10.4049/jimmunol.168.6.2887; Deban L, 2010, NAT IMMUNOL, V11, P328, DOI 10.1038/ni.1854; Dekkers Bart G J, 2009, Proc Am Thorac Soc, V6, P683, DOI 10.1513/pats.200907-056DP; Dias AAM, 2001, J LEUKOCYTE BIOL, V69, P928; Doni A, 2003, EUR J IMMUNOL, V33, P2886, DOI 10.1002/eji.200324390; Doni A, 2008, J BIOL CHEM, V283, P29983, DOI 10.1074/jbc.M805631200; Fazzini F, 2001, ARTHRITIS RHEUM, V44, P2841, DOI 10.1002/1529-0131(200112)44:12<2841::AID-ART472>3.0.CO;2-6; Fregonese L, 2005, J ALLERGY CLIN IMMUN, V115, P1148, DOI 10.1016/j.jaci.2005.01.068; Fukakusa M, 2005, J ALLERGY CLIN IMMUN, V115, P280, DOI 10.1016/j.jaci.2004.10.036; Fulkerson PC, 2006, AM J PATHOL, V169, P2117, DOI 10.2353/ajpath.2006.060617; Garlanda C, 2002, NATURE, V420, P182, DOI 10.1038/nature01195; Gaziano R, 2004, ANTIMICROB AGENTS CH, V48, P4414, DOI 10.1128/AAC.48.11.4414-4421.2004; Goncharova EA, 2006, NAT PROTOC, V1, P2933, DOI 10.1038/nprot.2006.434; Goncharova EA, 2006, NAT PROTOC, V1, P2905, DOI 10.1038/nprot.2006.433; Gounni AS, 2006, AM J PHYSIOL-LUNG C, V291, pL312, DOI 10.1152/ajplung.00005.2006; Gounni AS, 2005, J IMMUNOL, V175, P2613, DOI 10.4049/jimmunol.175.4.2613; Hakonarson H, 1998, P NATL ACAD SCI USA, V95, P5257, DOI 10.1073/pnas.95.9.5257; Halayko AJ, 2003, RESP PHYSIOL NEUROBI, V137, P209, DOI 10.1016/S1569-9048(03)00148-4; Han B, 2005, J IMMUNOL, V175, P8303, DOI 10.4049/jimmunol.175.12.8303; Humbles AA, 1997, J EXP MED, V186, P601, DOI 10.1084/jem.186.4.601; Jaillon S, 2007, J EXP MED, V204, P793, DOI 10.1084/jem.20061301; Klouche M, 2004, ATHEROSCLEROSIS, V175, P221, DOI 10.1016/j.atherosclerosis.2004.03.020; Koppelman GH, 2002, J ALLERGY CLIN IMMUN, V109, P498, DOI 10.1067/mai.2002.122235; Latini R, 2004, CIRCULATION, V110, P2349, DOI 10.1161/01.CIR.0000145167.30987.2E; Luchetti MM, 2000, CLIN EXP IMMUNOL, V119, P196, DOI 10.1046/j.1365-2249.2000.01110.x; Maina V, 2009, J LEUKOCYTE BIOL, V86, P123, DOI 10.1189/jlb.0608345; Manfredi AA, 2008, CURR OPIN IMMUNOL, V20, P538, DOI 10.1016/j.coi.2008.05.004; Mantovani A, 2008, J CLIN IMMUNOL, V28, P1, DOI 10.1007/s10875-007-9126-7; Mauri T, INTENSIVE CARE MED, V36, P621; Mauri T, 2008, CRIT CARE MED, V36, P2302, DOI 10.1097/CCM.0b013e3181809aaf; Naureckas ET, 1999, AM J RESP CRIT CARE, V160, P2062, DOI 10.1164/ajrccm.160.6.9903131; Norata GD, 2008, ARTERIOSCL THROM VAS, V28, P925, DOI 10.1161/ATVBAHA.107.160606; Ortega-Hernandez OD, 2008, LONG PENTRAXIN 3 ITS; Panettieri RA, 2003, RESP PHYSIOL NEUROBI, V137, P277, DOI 10.1016/S1569-9048(03)00153-8; Pauwels NS, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-134; Pizzichini M. M., 2009, AM J RESP CRIT  0401, V179, pA2532; Redhu NS, 2011, AM J PHYSIOL-LUNG C, V300, pL479, DOI 10.1152/ajplung.00301.2009; Redhu NS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006153; Redington AE, 2001, J ALLERGY CLIN IMMUN, V107, P384, DOI 10.1067/mai.2001.112268; Renauld JC, 2001, J CLIN PATHOL, V54, P577, DOI 10.1136/jcp.54.8.577; Roth M, 2010, SWISS MED WKLY; Roth M, 2010, ANN ALLERG ASTHMA IM, V104, P152, DOI 10.1016/j.anai.2009.11.022; Salio M, 2008, CIRCULATION, V117, P1055, DOI 10.1161/CIRCULATIONAHA.107.749234; Salustri A, 2004, DEVELOPMENT, V131, P1577, DOI 10.1242/dev.01056; Scarchilli L, 2007, J BIOL CHEM, V282, P30161, DOI 10.1074/jbc.M703738200; Semiali A, 2008, AM J RESP CELL MOL, V38, P202, DOI 10.1165/rcmb.2007-0031OC; Shan LY, 2010, J IMMUNOL, V184, P7134, DOI 10.4049/jimmunol.0902515; Shelton RC, 2004, NEUROPSYCHOPHARMACOL, V29, P126, DOI 10.1038/sj.npp.1300307; Tliba O, 2009, ANNU REV PHYSIOL, V71, P509, DOI 10.1146/annurev.physiol.010908.163227; Tong M, 2007, CLIN J AM SOC NEPHRO, V2, P889, DOI 10.2215/CJN.00870207; Van Pottelberge GR, 2011, EUR RESP J; Varani S, 2002, MOL ENDOCRINOL, V16, P1154, DOI 10.1210/me.16.6.1154	65	24	24	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2012	7	4							e34965	10.1371/journal.pone.0034965	http://dx.doi.org/10.1371/journal.pone.0034965			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959XD	22529962	Green Published, Green Submitted, gold			2022-12-25	WOS:000305350600047
J	Kim, SJ; Oh, HJ; Yoo, DE; Shin, DH; Lee, MJ; Kim, HR; Park, JT; Han, SH; Yoo, TH; Choi, KH; Kang, SW				Kim, Seung Jun; Oh, Hyung Jung; Yoo, Dong Eun; Shin, Dong Ho; Lee, Mi Jung; Kim, Hyoung Rae; Park, Jung Tak; Han, Seung Hyeok; Yoo, Tae-Hyun; Choi, Kyu Hun; Kang, Shin-Wook			Electrocardiographic Left Ventricular Hypertrophy and Outcome in Hemodialysis Patients	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; HYPERTENSIVE PATIENTS; MORTALITY RISK; RENAL-DISEASE; MASS INDEX; FOLLOW-UP; DIALYSIS; HEART; ASSOCIATION; REGRESSION	Background and Aims: Electrocardiography (ECG) is the most widely used initial screening test for the assessment of left ventricular hypertrophy (LVH), an independent predictor of cardiovascular mortality in patients with end-stage renal disease (ESRD). However, traditional ECG criteria based only on voltage to detect LVH have limited clinical utility for the detection of LVH because of their poor sensitivity. Methods: This prospective observational study was undertaken to compare the prognostic significance of commonly used ECG criteria for LVH, namely Sokolow-Lyon voltage (SV) or voltage-duration product (SP) and Cornell voltage (CV) or voltage-duration product (CP) criteria, and to investigate the association between echocardiographic LV mass index (LVMI) and ECG-LVH criteria in ESRD patients, who consecutively started maintenance hemodialysis (HD) between January 2006 and December 2008. Results: A total of 317 patients, who underwent both ECG and echocardiography, were included. Compared to SV and CV criteria, SP and CP criteria, respectively, correlated more closely with LVMI. In addition, CP criteria provided the highest positive predictive value for echocardiographic LVH. The 5-year cardiovascular survival rates were significantly lower in patients with ECG-LVH by each criterion. In multivariate analyses, echocardiographic LVH [adjusted hazard ratio (HR): 11.71; 95% confidence interval (CI): 1.57-87.18; P = 0.016] and ECG-LVH by SP (HR: 3.43; 95% CI: 1.32-8.92; P = 0.011) and CP (HR: 3.07; 95% CI: 1.16-8.11; P = 0.024) criteria, but not SV and CV criteria, were significantly associated with cardiovascular mortality. Conclusions: The product of QRS voltage and duration is helpful in identifying the presence of LVH and predicting cardiovascular mortality in incident HD patients.	[Kim, Seung Jun; Oh, Hyung Jung; Yoo, Dong Eun; Shin, Dong Ho; Lee, Mi Jung; Kim, Hyoung Rae; Park, Jung Tak; Han, Seung Hyeok; Yoo, Tae-Hyun; Choi, Kyu Hun; Kang, Shin-Wook] Yonsei Univ, Coll Med, Dept Internal Med, Seoul, South Korea; [Kang, Shin-Wook] Yonsei Univ, Severance Biomed Sci Inst, Seoul 120749, South Korea	Yonsei University; Yonsei University Health System; Yonsei University	Kim, SJ (corresponding author), Yonsei Univ, Coll Med, Dept Internal Med, Seoul, South Korea.	kswkidney@yuhs.ac	Kim, Seung Jun/N-5248-2019; Han, Seung Hyeok/W-8825-2019; Han, Seung Hyeok/K-4559-2018	Kim, Seung Jun/0000-0002-6913-6358; Han, Seung Hyeok/0000-0001-7923-5635; Han, Seung Hyeok/0000-0001-7923-5635; Kang, Shin-Wook/0000-0002-5677-4756; Park, Jung Tak/0000-0002-2325-8982; Yoo, Tae-Hyun/0000-0002-9183-4507; Choi, Kyu Hun/0000-0003-0095-9011; Lee, Mi Jung/0000-0001-8888-029X	Yonsei University; National Research Foundation of Korea (NRF); Korea government (MEST) [2011-0030711]; Ministry of Health and Welfare, Republic of Korea [A102065]	Yonsei University; National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Korea government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government); Ministry of Health and Welfare, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea)	This work was supported by the Brain Korea 21 Project for Medical Science, Yonsei University, by the National Research Foundation of Korea (NRF) grant funded by the Korea government (MEST) (No. 2011-0030711), and by a grant of the Korea Healthcare Technology R&D Project, Ministry of Health and Welfare, Republic of Korea (A102065). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal R, 2011, CLIN J AM SOC NEPHRO, V6, P528, DOI 10.2215/CJN.07770910; Barrios V, 2006, J RENIN-ANGIO-ALDO S, V7, P236, DOI 10.3317/jraas.2006.044; Bolton K, 2005, AM J KIDNEY DIS, V45, pS7, DOI 10.1053/j.ajkd.2005.01.016; Calderon A, 2010, CLIN EXP HYPERTENS, V32, P145, DOI 10.3109/10641960903254455; CASALE PN, 1985, J AM COLL CARDIOL, V6, P572, DOI 10.1016/S0735-1097(85)80115-7; Cheung AK, 2004, KIDNEY INT, V65, P2380, DOI 10.1111/j.1523-1755.2004.00657.x; DEVEREUX RB, 1986, AM J CARDIOL, V57, P450, DOI 10.1016/0002-9149(86)90771-X; Foley RN, 1998, AM J KIDNEY DIS, V32, pS112, DOI 10.1053/ajkd.1998.v32.pm9820470; FOLEY RN, 1995, KIDNEY INT, V47, P186, DOI 10.1038/ki.1995.22; Fujii H, 2007, INTERNAL MED, V46, P1507, DOI 10.2169/internalmedicine.46.0269; Glassock RJ, 2009, CLIN J AM SOC NEPHRO, V4, pS79, DOI 10.2215/CJN.04860709; Goodkin DA, 2003, J AM SOC NEPHROL, V14, P3270, DOI 10.1097/01.ASN.0000100127.54107.57; GOTCH FA, 1985, KIDNEY INT, V28, P526, DOI 10.1038/ki.1985.160; Gross ML, 2008, SEMIN DIALYSIS, V21, P308, DOI 10.1111/j.1525-139X.2008.00454.x; HARNETT JD, 1993, NEPHRON, V65, P212, DOI 10.1159/000187476; Krane V, 2009, CLIN J AM SOC NEPHRO, V4, P394, DOI 10.2215/CJN.02020408; Levin A, 2005, AM J KIDNEY DIS, V46, P799, DOI 10.1053/j.ajkd.2005.08.007; Levin A, 1999, AM J KIDNEY DIS, V34, P125, DOI 10.1016/S0272-6386(99)70118-6; LEVY D, 1990, NEW ENGL J MED, V322, P1561, DOI 10.1056/NEJM199005313222203; LEVY D, 1990, CIRCULATION, V81, P815, DOI 10.1161/01.CIR.81.3.815; Liao YL, 1997, J AM COLL CARDIOL, V29, P641, DOI 10.1016/S0735-1097(96)00552-9; London GM, 2001, J AM SOC NEPHROL, V12, P2759, DOI 10.1681/ASN.V12122759; MacRae JM, 2006, SEMIN DIALYSIS, V19, P349, DOI 10.1111/j.1525-139X.2006.00185.x; Martin LC, 2004, AM J HYPERTENS, V17, P1163, DOI 10.1016/j.amjhyper.2004.07.017; Mathew J, 2001, CIRCULATION, V104, P1615, DOI 10.1161/hc3901.096700; Middleton RJ, 2001, J AM SOC NEPHROL, V12, P1079, DOI 10.1681/ASN.V1251079; MOLLOY TJ, 1992, J AM COLL CARDIOL, V20, P1180, DOI 10.1016/0735-1097(92)90376-X; Naito Y, 2009, AM J PHYSIOL-HEART C, V296, pH585, DOI 10.1152/ajpheart.00463.2008; Okin PM, 2004, JAMA-J AM MED ASSOC, V292, P2343, DOI 10.1001/jama.292.19.2343; OKIN PM, 1995, J AM COLL CARDIOL, V25, P417, DOI 10.1016/0735-1097(94)00371-V; Okin PM, 2001, AM J HYPERTENS, V14, P775, DOI 10.1016/S0895-7061(01)01291-2; Okin PM, 2000, HYPERTENSION, V35, P13, DOI 10.1161/01.HYP.35.1.13; Rautaharju PM, 2009, J AM COLL CARDIOL, V53, P982, DOI 10.1016/j.jacc.2008.12.014; Shlipak MG, 2005, JAMA-J AM MED ASSOC, V293, P1737, DOI 10.1001/jama.293.14.1737; SILBERBERG JS, 1989, KIDNEY INT, V36, P286, DOI 10.1038/ki.1989.192; Stewart GA, 1999, KIDNEY INT, V56, P2248, DOI 10.1046/j.1523-1755.1999.00786.x; Truong QA, 2010, J HYPERTENS, V28, P1959, DOI 10.1097/HJH.0b013e32833b49cb; WILLEMS JL, 1972, CIRCULATION, V45, P1057, DOI 10.1161/01.CIR.45.5.1057; Zoccali C, 2004, KIDNEY INT, V65, P1492, DOI 10.1111/j.1523-1755.2004.00530.x	39	22	26	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2012	7	4							e35534	10.1371/journal.pone.0035534	http://dx.doi.org/10.1371/journal.pone.0035534			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WC	22530043	Green Published, Green Submitted, gold			2022-12-25	WOS:000305347400058
J	Vanheel, A; Daniels, R; Plaisance, S; Baeten, K; Hendriks, JJA; Leprince, P; Dumont, D; Robben, J; Brone, B; Stinissen, P; Noben, JP; Hellings, N				Vanheel, Annelies; Daniels, Ruth; Plaisance, Stephane; Baeten, Kurt; Hendriks, Jerome J. A.; Leprince, Pierre; Dumont, Debora; Robben, Johan; Brone, Bert; Stinissen, Piet; Noben, Jean-Paul; Hellings, Niels			Identification of Protein Networks Involved in the Disease Course of Experimental Autoimmune Encephalomyelitis, an Animal Model of Multiple Sclerosis	PLOS ONE			English	Article							CEREBROSPINAL-FLUID PROTEOME; DIFFERENCE GEL-ELECTROPHORESIS; BRAIN-DAMAGE; SJL MICE; MOUSE; EXPRESSION; PATHOLOGY; INFLAMMATION; CHANNELS; MARKERS	A more detailed insight into disease mechanisms of multiple sclerosis (MS) is crucial for the development of new and more effective therapies. MS is a chronic inflammatory autoimmune disease of the central nervous system. The aim of this study is to identify novel disease associated proteins involved in the development of inflammatory brain lesions, to help unravel underlying disease processes. Brainstem proteins were obtained from rats with MBP induced acute experimental autoimmune encephalomyelitis (EAE), a well characterized disease model of MS. Samples were collected at different time points: just before onset of symptoms, at the top of the disease and following recovery. To analyze changes in the brainstem proteome during the disease course, a quantitative proteomics study was performed using two-dimensional difference in-gel electrophoresis (2D-DIGE) followed by mass spectrometry. We identified 75 unique proteins in 92 spots with a significant abundance difference between the experimental groups. To find disease-related networks, these regulated proteins were mapped to existing biological networks by Ingenuity Pathway Analysis (IPA). The analysis revealed that 70% of these proteins have been described to take part in neurological disease. Furthermore, some focus networks were created by IPA. These networks suggest an integrated regulation of the identified proteins with the addition of some putative regulators. Post-synaptic density protein 95 (DLG4), a key player in neuronal signalling and calcium-activated potassium channel alpha 1 (KCNMA1), involved in neurotransmitter release, are 2 putative regulators connecting 64% of the identified proteins. Functional blocking of the KCNMA1 in macrophages was able to alter myelin phagocytosis, a disease mechanism highly involved in EAE and MS pathology. Quantitative analysis of differentially expressed brainstem proteins in an animal model of MS is a first step to identify disease-associated proteins and networks that warrant further research to study their actual contribution to disease pathology.	[Vanheel, Annelies; Daniels, Ruth; Baeten, Kurt; Hendriks, Jerome J. A.; Dumont, Debora; Brone, Bert; Stinissen, Piet; Noben, Jean-Paul; Hellings, Niels] Hasselt Univ, Biomed Res Inst, Hasselt, Belgium; [Vanheel, Annelies; Daniels, Ruth; Baeten, Kurt; Hendriks, Jerome J. A.; Dumont, Debora; Brone, Bert; Stinissen, Piet; Noben, Jean-Paul; Hellings, Niels] Transnat Univ Limburg, Sch Life Sci, Hasselt, Belgium; [Leprince, Pierre] Univ Liege, GIGA Neurosci, Liege, Belgium; [Plaisance, Stephane] VIB, Bioinformat Training & Serv Facil BITS, Ghent, Belgium; [Robben, Johan] Katholieke Univ Leuven, B-3001 Heverlee, Belgium	Hasselt University; Hasselt University; University of Liege; Flanders Institute for Biotechnology (VIB); KU Leuven	Vanheel, A (corresponding author), Hasselt Univ, Biomed Res Inst, Hasselt, Belgium.	Niels.hellings@uhasselt.be	Noben, Jean-Paul/E-8066-2011; Plaisance, Stephane/ABI-6307-2020; Hendriks, Jerome J/C-7698-2013; HELLINGS, Niels/AAS-5033-2020; Plaisance, Stephane/B-3488-2009	Noben, Jean-Paul/0000-0003-3368-5686; Plaisance, Stephane/0000-0002-1651-241X; Hendriks, Jerome J/0000-0002-7717-8582; Plaisance, Stephane/0000-0002-1651-241X; Hellings, Niels/0000-0003-2308-406X; Stinissen, Piet/0000-0002-4830-4084; Leprince, pierre/0000-0002-7233-6553; Brone, Bert/0000-0002-4851-9480	Alma-In-Silico [EMR INT4.-1.3.-2008-03/003]; LSM tUL impuls phase II; Hasselt University; Research Foundation - Flanders (FWO)	Alma-In-Silico; LSM tUL impuls phase II; Hasselt University; Research Foundation - Flanders (FWO)(FWO)	This work was supported by Alma-In-Silico NR. EMR INT4.-1.3.-2008-03/003, LSM tUL impuls phase II and Hasselt University. JJAH was supported by The Research Foundation - Flanders (FWO). PL is a FRS-FNRS Research Associate. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alt C, 2005, BRAIN PATHOL, V15, P1; Baeten K, 2008, J NEUROIMMUNOL, V195, P1, DOI 10.1016/j.jneuroim.2007.11.008; BANATI RB, 1995, GLIA, V14, P209, DOI 10.1002/glia.440140306; Barnett MH, 2004, ANN NEUROL, V55, P458, DOI 10.1002/ana.20016; Bhat R, 2010, P NATL ACAD SCI USA, V107, P2580, DOI 10.1073/pnas.0915139107; Bhat R, 2009, NEURON, V64, P123, DOI 10.1016/j.neuron.2009.09.015; Bogie JFJ, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-85; Cross AH, 2001, J NEUROIMMUNOL, V112, P1, DOI 10.1016/S0165-5728(00)00409-4; Dasgupta B, 2005, CANCER RES, V65, P9843, DOI 10.1158/0008-5472.CAN-05-1842; Dumont D, 2004, PROTEOMICS, V4, P2117, DOI 10.1002/pmic.200300715; Duzhak T, 2003, CELL MOL BIOL, V49, P723; Ebers GC, 2008, LANCET NEUROL, V7, P268, DOI 10.1016/S1474-4422(08)70042-5; Fountoulakis M, 2005, J CHROMATOGR B, V819, P115, DOI 10.1016/j.jchromb.2005.01.037; Han MH, 2008, NATURE, V451, P1076, DOI 10.1038/nature06559; Imlach WL, 2008, J PHARMACOL EXP THER, V327, P657, DOI 10.1124/jpet.108.143933; Lafon-Cazal M, 2003, J BIOL CHEM, V278, P24438, DOI 10.1074/jbc.M211980200; Lassmann H, 2007, BRAIN PATHOL, V17, P210, DOI 10.1111/j.1750-3639.2007.00064.x; Lau A, 2010, PFLUG ARCH EUR J PHY, V460, P525, DOI 10.1007/s00424-010-0809-1; Lehmensiek V, 2007, MULT SCLER, V13, P840, DOI 10.1177/1352458507076406; Linker RA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007624; Liu SL, 2009, J CELL MOL MED, V13, P1586, DOI 10.1111/j.1582-4934.2009.00850.x; Liu T, 2007, J PROTEOME RES, V6, P2565, DOI 10.1021/pr070012k; Luhder F, 2009, J NEUROIMMUNOL, V217, P1, DOI 10.1016/j.jneuroim.2009.08.008; Marouga R, 2005, ANAL BIOANAL CHEM, V382, P669, DOI 10.1007/s00216-005-3126-3; Mikkat S, 2010, PROTEOMICS, V10, P1050, DOI 10.1002/pmic.200800932; Pitt D, 2000, NAT MED, V6, P67, DOI 10.1038/71555; Qin ZY, 2009, CELL MOL NEUROBIOL, V29, P203, DOI 10.1007/s10571-008-9312-z; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Siman R, 2004, NEUROBIOL DIS, V16, P311, DOI 10.1016/j.nbd.2004.03.016; Sironi L, 2004, J NEUROSCI RES, V78, P115, DOI 10.1002/jnr.20219; Sizova D, 2007, NEUROBIOL AGING, V28, P357, DOI 10.1016/j.neurobiolaging.2006.01.011; STORNETTA RL, 1988, SCIENCE, V242, P1444, DOI 10.1126/science.3201232; Svejgaard A, 2008, IMMUNOGENETICS, V60, P275, DOI 10.1007/s00251-008-0295-1; Szewczyk A, 2009, IUBMB LIFE, V61, P134, DOI 10.1002/iub.155; Trapp BD, 1998, NEW ENGL J MED, V338, P278, DOI 10.1056/NEJM199801293380502; Tuller T, 2011, HUM MOL GENET; Tumani H, 2009, NEUROSCI LETT, V452, P214, DOI 10.1016/j.neulet.2009.01.057; Tumani H, 2010, EXPERT REV PROTEOMIC, V7, P29, DOI 10.1586/EPR.09.99; van Horssen J, 2010, FREE RADICAL BIO MED, V49, P1283, DOI 10.1016/j.freeradbiomed.2010.07.013; Viswanathan S, 2006, NAT PROTOC, V1, P1351, DOI 10.1038/nprot.2006.234; Zellner M, 2008, ELECTROPHORESIS, V29, P3621, DOI 10.1002/elps.200700935; Zhu B, 2003, AM J PATHOL, V162, P1639, DOI 10.1016/S0002-9440(10)64298-8; Zipp F, 2009, J NEUROL SCI, V287, pS24, DOI 10.1016/S0022-510X(09)71297-3	43	29	31	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2012	7	4							e35544	10.1371/journal.pone.0035544	http://dx.doi.org/10.1371/journal.pone.0035544			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WC	22530047	Green Published, gold			2022-12-25	WOS:000305347400060
J	Boratko, A; Gergely, P; Csortos, C				Boratko, Anita; Gergely, Pal; Csortos, Csilla			Cell Cycle Dependent Association of EBP50 with Protein Phosphatase 2A in Endothelial Cells	PLOS ONE			English	Article							EXCHANGER REGULATORY FACTOR; MITOTIC EXIT; EZRIN; BINDING; PHOSPHORYLATION; RECEPTOR; RADIXIN; PHOSPHOPROTEIN; MIGRATION; OLIGOMERIZATION	Ezrin-radixin-moesin (ERM)-binding phosphoprotein 50 (EBP50) is a phosphorylatable PDZ domain-containing adaptor protein that is abundantly expressed in epithelium but was not yet studied in the endothelium. We report unusual nuclear localization of EBP50 in bovine pulmonary artery endothelial cells (BPAEC). Immunofluorescent staining and cellular fractionation demonstrated that EBP50 is present in the nuclear and perinuclear region in interphase cells. In the prophase of mitosis EBP50 redistributes to the cytoplasmic region in a phosphorylation dependent manner and during mitosis EBP50 co-localizes with protein phosphatase 2A (PP2A). Furthermore, in vitro wound healing of BPAEC expressing phospho-mimic mutant of EBP50 was accelerated indicating that EBP50 is involved in the regulation of the cell division. Cell cycle dependent specific interactions were detected between EBP50 and the subunits of PP2A (A, C, and B alpha) with immunoprecipitation and pull-down experiments. The interaction of EBP50 with the Ba containing form of PP2A suggests that this holoenzyme of PP2A can be responsible for the dephosphorylation of EBP50 in cytokinesis. Moreover, the results underline the significance of EBP50 in cell division via reversible phosphorylation of the protein with cyclin dependent kinase and PP2A in normal cells.	[Boratko, Anita; Gergely, Pal; Csortos, Csilla] Univ Debrecen, Dept Med Chem, H-4012 Debrecen, Hungary; [Boratko, Anita; Gergely, Pal; Csortos, Csilla] Hlth Sci Ctr, Debrecen, Hungary; [Gergely, Pal] Univ Debrecen, Hungarian Acad Sci, Cell Biol & Signaling Res Grp, H-4012 Debrecen, Hungary	University of Debrecen; Hungarian Academy of Sciences; University of Debrecen	Boratko, A (corresponding author), Univ Debrecen, Dept Med Chem, H-4012 Debrecen, Hungary.	csortos@med.unideb.hu	Gergely, Pál/A-5547-2008		Hungarian Science Research Fund [CNK80709]; New Hungary Development Plan [TAMOP 4.2.1./B-09/1/KONV-2010-0007]; European Social Fund	Hungarian Science Research Fund(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); New Hungary Development Plan; European Social Fund(European Social Fund (ESF))	This work was supported by CNK80709 (GP) from the Hungarian Science Research Fund (www.otka.hu) and the TAMOP 4.2.1./B-09/1/KONV-2010-0007 project implemented through the New Hungary Development Plan, co-financed by the European Social Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baeyens N, 2011, J CELL BIOCHEM, V112, P2574, DOI 10.1002/jcb.23183; Baeyens N, 2010, AM J PHYSIOL-CELL PH, V299, pC1530, DOI 10.1152/ajpcell.00175.2010; Batchelor CL, 2004, EXP CELL RES, V296, P208, DOI 10.1016/j.yexcr.2004.02.010; Bhattacharya S, 2010, J BIOL CHEM, V285, P9981, DOI 10.1074/jbc.M109.074005; Csortos C, 2007, AM J PHYSIOL-LUNG C, V293, pL843, DOI 10.1152/ajplung.00120.2007; Dai JL, 2004, ONCOGENE, V23, P8681, DOI 10.1038/sj.onc.1207962; Donowitz M, 2005, J PHYSIOL-LONDON, V567, P3, DOI 10.1113/jphysiol.2005.090399; Fievet B, 2007, BBA-MOL CELL RES, V1773, P653, DOI 10.1016/j.bbamcr.2006.06.013; Fouassier L, 2000, J BIOL CHEM, V275, P25039, DOI 10.1074/jbc.C000092200; Fouassier L, 2005, EXP CELL RES, V306, P264, DOI 10.1016/j.yexcr.2005.02.011; Fouassier L, 2009, AM J PATHOL, V174, P869, DOI 10.2353/ajpath.2009.080079; Garbett D, 2010, J CELL BIOL, V191, P397, DOI 10.1083/jcb.201004115; Hall RA, 1999, J BIOL CHEM, V274, P24328, DOI 10.1074/jbc.274.34.24328; Hall RA, 1998, P NATL ACAD SCI USA, V95, P8496, DOI 10.1073/pnas.95.15.8496; He JQ, 2001, J BIOL CHEM, V276, P41559, DOI 10.1074/jbc.M106859200; Hsu CC, 2010, AM J PHYSIOL-CELL PH, V299, pC528, DOI 10.1152/ajpcell.00504.2009; Ingraffea J, 2002, EUR J CELL BIOL, V81, P61, DOI 10.1078/0171-9335-00218; Keese CR, 2004, P NATL ACAD SCI USA, V101, P1554, DOI 10.1073/pnas.0307588100; Kutay U, 2008, CURR OPIN CELL BIOL, V20, P669, DOI 10.1016/j.ceb.2008.09.010; LaLonde DP, 2010, MOL BIOL CELL, V21, P1519, DOI 10.1091/mbc.E10-01-0008; Lau AG, 2001, BIOCHEMISTRY-US, V40, P8572, DOI 10.1021/bi0103516; Mochida S, 2009, EMBO J, V28, P2777, DOI 10.1038/emboj.2009.238; Muranen T, 2005, ONCOGENE, V24, P1150, DOI 10.1038/sj.onc.1208283; Nigg EA, 1997, NATURE, V386, P779, DOI 10.1038/386779a0; Pan Y, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1616; Raghuram V, 2003, P NATL ACAD SCI USA, V100, P9620, DOI 10.1073/pnas.1633250100; Reczek D, 1997, J CELL BIOL, V139, P169, DOI 10.1083/jcb.139.1.169; Schmieder S, 2004, J AM SOC NEPHROL, V15, P2289, DOI 10.1097/01.ASN.0000135968.49899.E8; Schmitz MHA, 2010, NAT CELL BIOL, V12, P886, DOI 10.1038/ncb2092; Sharma GD, 2003, J BIOL CHEM, V278, P21989, DOI 10.1074/jbc.M302650200; Shibata T, 2003, HEPATOLOGY, V38, P178, DOI 10.1053/jhep.2003.50270; Vereb G, 2000, P NATL ACAD SCI USA, V97, P6013, DOI 10.1073/pnas.97.11.6013; Voltz JW, 2007, J BIOL CHEM, V282, P33879, DOI 10.1074/jbc.M703481200; Wade JB, 2001, AM J PHYSIOL-CELL PH, V280, pC192, DOI 10.1152/ajpcell.2001.280.1.C192; Wang SS, 1998, FEBS LETT, V427, P103, DOI 10.1016/S0014-5793(98)00402-5; Weinman EJ, 2006, ANNU REV PHYSIOL, V68, P491, DOI 10.1146/annurev.physiol.68.040104.131050; WEINMAN EJ, 1995, J CLIN INVEST, V95, P2143, DOI 10.1172/JCI117903; Weinman EJ, 1998, J CLIN INVEST, V101, P2199, DOI 10.1172/JCI204; Wu JQ, 2009, NAT CELL BIOL, V11, P644, DOI 10.1038/ncb1871	39	12	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2012	7	4							e35595	10.1371/journal.pone.0035595	http://dx.doi.org/10.1371/journal.pone.0035595			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VO	22523604	Green Published, gold			2022-12-25	WOS:000305345000078
J	Johnen, G; Gawrych, K; Bontrup, H; Pesch, B; Taeger, D; Banek, S; Kluckert, M; Wellhausser, H; Eberle, F; Nasterlack, M; Leng, G; Stenzl, A; Bruning, T				Johnen, Georg; Gawrych, Katarzyna; Bontrup, Heike; Pesch, Beate; Taeger, Dirk; Banek, Severine; Kluckert, Matthias; Wellhaeusser, Harald; Eberle, Friedhelm; Nasterlack, Michael; Leng, Gabriele; Stenzl, Arnulf; Bruening, Thomas		UroScreen Study Grp	Performance of Survivin mRNA as a Biomarker for Bladder Cancer in the Prospective Study UroScreen	PLOS ONE			English	Article							INTERNATIONAL CONSENSUS PANEL; TUMOR-MARKERS; PROGNOSTIC-SIGNIFICANCE; URINE DETECTION; AURORA B; EXPRESSION; CARCINOMA; DIAGNOSIS; REVEALS; RECURRENCE	Background: Urinary biomarkers have the potential to improve the early detection of bladder cancer. Most of the various known markers, however, have only been evaluated in studies with cross-sectional design. For proper validation a longitudinal design would be preferable. We used the prospective study UroScreen to evaluate survivin, a potential biomarker that has multiple functions in carcinogenesis. Methods/Results: Survivin was analyzed in 5,716 urine samples from 1,540 chemical workers previously exposed to aromatic amines. The workers participated in a surveillance program with yearly examinations between 2003 and 2010. RNA was extracted from urinary cells and survivin was determined by Real-Time PCR. During the study, 19 bladder tumors were detected. Multivariate generalized estimation equation (GEE) models showed that beta-actin, representing RNA yield and quality, had the strongest influence on survivin positivity. Inflammation, hematuria and smoking did not confound the results. Survivin had a sensitivity of 21.1% for all and 36.4% for high-grade tumors. Specificity was 97.5%, the positive predictive value (PPV) 9.5%, and the negative predictive value (NPV) 99.0%. Conclusions: In this prospective and so far largest study on survivin, the marker showed a good NPV and specificity but a low PPV and sensitivity. This was partly due to the low number of cases, which limits the validity of the results. Compliance, urine quality, problems with the assay, and mRNA stability influenced the performance of survivin. However, most issues could be addressed with a more reliable assay in the future. One important finding is that survivin was not influenced by confounders like inflammation and exhibited a relatively low number of false-positives. Therefore, despite the low sensitivity, survivin may still be considered as a component of a multimarker panel.	[Johnen, Georg; Gawrych, Katarzyna; Bontrup, Heike; Pesch, Beate; Taeger, Dirk; Kluckert, Matthias; Bruening, Thomas] Inst Ruhr Univ Bochum IPA, Inst Prevent & Occupat Med German Social Accid In, Bochum, Germany; [Banek, Severine; Stenzl, Arnulf] Univ Tubingen, Inst Urol, Tubingen, Germany; [Kluckert, Matthias; Wellhaeusser, Harald] German Social Accid Insurances Inst Raw Mat & Che, Heidelberg, Germany; [Eberle, Friedhelm; Nasterlack, Michael] BASF SE, Ludwigshafen, Germany; [Leng, Gabriele] Currenta GmbH & Co OHG, Safety Hlth Protect, Leverkusen, Germany	Ruhr University Bochum; Eberhard Karls University of Tubingen; BASF; Lanxess	Johnen, G (corresponding author), Inst Ruhr Univ Bochum IPA, Inst Prevent & Occupat Med German Social Accid In, Bochum, Germany.	johnen@ipa-dguv.de	Brüning, Thomas/G-8120-2015; Johnen, Georg/AFG-8027-2022	Brüning, Thomas/0000-0001-9560-5464; Johnen, Georg/0000-0002-3773-5946; Burek, Katarzyna/0000-0003-4251-4942; Taeger, Dirk/0000-0002-5340-5584	German Social Accident Insurance (DGUV; Sankt Augustin, Germany) [FB093]; Matritech/Alere	German Social Accident Insurance (DGUV; Sankt Augustin, Germany); Matritech/Alere	Fujirebio Diagnostics, Inc. (FDI; Malvern, PA; http://www.fdi.com) has provided survivin reagents at no costs. Part of the study was supported by a grant (FB093 to AS) of the German Social Accident Insurance (DGUV; Sankt Augustin, Germany; http://www.dguv.de), by Abbott Laboratories (Abbott Park, IL; http://www.abbottmolecular.com) who supplied UroVysion kits, and Matritech/Alere GmbH (Koln, Germany; http://www.alere.com) who supplied NMP22 ELISA kits. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors have read the journal's policy and have the following conflicts: The author GL is an employee of Currenta GmbH & Co. OHG. FE and MN are employees of BASF SE. AS received free assay kits from Abbott Laboratories and Matritech/Alere GmbH. AS also received travel grants from Matritech/Alere. GJ received free assay reagents from Fujirebio Diagnostics, Inc. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials. The authors declare no other competing interests.	Adida C, 2000, BLOOD, V96, P1921; Altieri DC, 2008, NAT REV CANCER, V8, P61, DOI 10.1038/nrc2293; Altieri DC, 2001, TRENDS MOL MED, V7, P542, DOI 10.1016/S1471-4914(01)02243-2; Ambrosini G, 1997, NAT MED, V3, P917, DOI 10.1038/nm0897-917; Caldas H, 2007, BLOOD, V109, P1479, DOI 10.1182/blood-2006-02-003749; Chantalat L, 2000, MOL CELL, V6, P183, DOI 10.1016/S1097-2765(00)00019-8; Freedman ND, 2011, JAMA-J AM MED ASSOC, V306, P737, DOI 10.1001/jama.2011.1142; Habuchi T, 2005, UROLOGY, V66, P64, DOI 10.1016/j.urology.2005.08.065; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Horstmann M, 2010, WORLD J UROL, V28, P399, DOI 10.1007/s00345-010-0538-2; Huber S, 2012, BJU INT IN PRESS; Jeyaprakash AA, 2007, CELL, V131, P271, DOI 10.1016/j.cell.2007.07.045; Kelly AE, 2010, SCIENCE, V330, P235, DOI 10.1126/science.1189505; Kenney DM, 2007, TUMOR BIOL, V28, P57, DOI 10.1159/000099033; Kren L, 2004, APPL IMMUNOHISTO M M, V12, P44; Lokeshwar VB, 2005, UROLOGY, V66, P35, DOI 10.1016/j.urology.2005.08.064; Lotan Y, 2006, CANCER-AM CANCER SOC, V107, P982, DOI 10.1002/cncr.22084; Lotan Y, 2010, UROL ONCOL-SEMIN ORI, V28, P441, DOI 10.1016/j.urolonc.2009.11.004; Lotan Y, 2009, CANCER-AM CANCER SOC, V115, P4096, DOI 10.1002/cncr.24463; Mehrotra S, 2010, CANCER CELL, V17, P53, DOI 10.1016/j.ccr.2009.11.021; Moussa O, 2006, J UROLOGY, V175, P2312, DOI 10.1016/S0022-5347(06)00254-0; Nasterlack M, 2011, AKTUEL UROL, V42, P128, DOI 10.1055/s-0031-1271424; Nasterlack M, 2001, S MED, V12, P17; Pesch B, 2011, BJU INT, V108, P546, DOI 10.1111/j.1464-410X.2010.09971.x; Ransohoff DF, 2010, J CLIN ONCOL, V28, P698, DOI 10.1200/JCO.2009.25.6065; Rathert P, 1991, URINZYTOLOGIE PRAXIS; Robert-Koch-Institut und die Gesellschaft der epidemiologischen Krebsregister in Deutschland e. V, 2010, KREBS DEUTSCHL 2005, V7; Sanchez-Carbayo M, 2001, CANCER-AM CANCER SOC, V92, P2820, DOI 10.1002/1097-0142(20011201)92:11<2820::AID-CNCR10092>3.0.CO;2-I; Sarela AI, 2000, GUT, V46, P645, DOI 10.1136/gut.46.5.645; Schmitz-Drager BJ, 2012, ICUD BLADDER TUMORS, V21, P1; Shariat SF, 2004, J UROLOGY, V171, P626, DOI 10.1097/01.ju.0000107826.78479.90; Shariat SF, 2009, CLIN CANCER RES, V15, P7012, DOI 10.1158/1078-0432.CCR-08-2554; Smith SD, 2001, JAMA-J AM MED ASSOC, V285, P324, DOI 10.1001/jama.285.3.324; Sun CH, 2005, BIOCHEMISTRY-US, V44, P11, DOI 10.1021/bi0485171; Swana HS, 1999, NEW ENGL J MED, V341, P452, DOI 10.1056/NEJM199908053410614; Takai N, 2002, CANCER LETT, V184, P105, DOI 10.1016/S0304-3835(02)00190-8; Tran J, 2002, P NATL ACAD SCI USA, V99, P4349, DOI 10.1073/pnas.072586399; Verdecia MA, 2000, NAT STRUCT BIOL, V7, P602; Wang FW, 2010, SCIENCE, V330, P231, DOI 10.1126/science.1189435; Wang HD, 2004, J CANCER RES CLIN, V130, P487, DOI 10.1007/s00432-004-0561-z; Weber DG, 2010, BIOMARK INSIGHTS, V5, P95; Weikert S, 2005, INT J CANCER, V116, P100, DOI 10.1002/ijc.21000; Yamagishi Y, 2010, SCIENCE, V330, P239, DOI 10.1126/science.1194498	43	21	22	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2012	7	4							e35363	10.1371/journal.pone.0035363	http://dx.doi.org/10.1371/journal.pone.0035363			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VO	22530010	Green Published, gold, Green Submitted			2022-12-25	WOS:000305345000059
J	Liu, JB; Chen, DW; Yao, Y; Yu, B; Mao, XB; He, J; Huang, ZQ; Zheng, P				Liu, Jingbo; Chen, Daiwen; Yao, Ying; Yu, Bing; Mao, Xiangbing; He, Jun; Huang, Zhiqing; Zheng, Ping			Intrauterine Growth Retardation Increases the Susceptibility of Pigs to High-Fat Diet-Induced Mitochondrial Dysfunction in Skeletal Muscle	PLOS ONE			English	Article							IMPAIRED OXIDATIVE-PHOSPHORYLATION; MTDNA COPY NUMBER; GENE-EXPRESSION; BIRTH-WEIGHT; INSULIN-RESISTANCE; RAT-LIVER; IN-UTERO; FETAL; RESTRICTION; ENZYMES	It has been recognized that there is a relationship between prenatal growth restriction and the development of metabolic-related diseases in later life, a process involved in mitochondrial dysfunction. In addition, intrauterine growth retardation (IUGR) increases the susceptibility of offspring to high-fat (HF) diet-induced metabolic syndrome. Recent findings suggested that HF feeding decreased mitochondrial oxidative capacity and impaired mitochondrial function in skeletal muscle. Therefore, we hypothesized that the long-term consequences of IUGR on mitochondrial biogenesis and function make the offspring more susceptible to HF diet-induced mitochondrial dysfunction. Normal birth weight (NBW), and IUGR pigs were allotted to control or HF diet in a completely randomized design, individually. After 4 weeks of feeding, growth performance and molecular pathways related to mitochondrial function were determined. The results showed that IUGR decreased growth performance and plasma insulin concentrations. In offspring fed a HF diet, IUGR was associated with enhanced plasma leptin levels, increased concentrations of triglyceride and malondialdehyde (MDA), and reduced glycogen and ATP contents in skeletal muscle. High fat diet-fed IUGR offspring exhibited decreased activities of lactate dehydrogenase (LDH) and glucose-6-phosphate dehydrogenase (G6PD). These alterations in metabolic traits of IUGR pigs were accompanied by impaired mitochondrial respiration function, reduced mitochondrial DNA (mtDNA) contents, and down-regulated mRNA expression levels of genes responsible for mitochondrial biogenesis and function. In conclusion, our results suggest that IUGR make the offspring more susceptible to HF diet-induced mitochondrial dysfunction.	[Liu, Jingbo; Chen, Daiwen; Yao, Ying; Yu, Bing; Mao, Xiangbing; He, Jun; Huang, Zhiqing; Zheng, Ping] Sichuan Agr Univ, Inst Anim Nutr, Yaan, Sichuan, Peoples R China; [Liu, Jingbo; Chen, Daiwen; Yao, Ying; Yu, Bing; Mao, Xiangbing; He, Jun; Huang, Zhiqing; Zheng, Ping] Minist Educ, Key Lab Anim Dis Resistance Nutr, Beijing, Peoples R China	Sichuan Agricultural University	Liu, JB (corresponding author), Sichuan Agr Univ, Inst Anim Nutr, Yaan, Sichuan, Peoples R China.	dwchen@sicau.edu.cn			Program for Changjiang Scholars and Innovative Research Team in University, Ministry of Education of China [IRT0555-5]; earmarked fund for China Agriculture Research System [CARS-36]	Program for Changjiang Scholars and Innovative Research Team in University, Ministry of Education of China(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)Ministry of Education, China); earmarked fund for China Agriculture Research System	This work was supported by Program for Changjiang Scholars and Innovative Research Team in University, Ministry of Education of China (IRT0555-5), and the earmarked fund for China Agriculture Research System (CARS-36). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barker DJP, 2000, THERIOGENOLOGY, V53, P555, DOI 10.1016/S0093-691X(99)00258-7; Barrientos A, 2002, METHODS, V26, P307, DOI 10.1016/S1046-2023(02)00036-1; Boden G, 1997, DIABETES, V46, P3, DOI 10.2337/diabetes.46.1.3; Coupe B, 2009, AM J PHYSIOL-REG I, V297, pR813, DOI 10.1152/ajpregu.00201.2009; Crescenzo R, 2008, OBESITY, V16, P958, DOI 10.1038/oby.2008.10; Desai M, 2007, AM J OBSTET GYNECOL, V196; Ekstrand MI, 2004, HUM MOL GENET, V13, P935, DOI 10.1093/hmg/ddh109; Gardner PR, 2002, METHOD ENZYMOL, V349, P9, DOI 10.1016/S0076-6879(02)49317-2; Gluckman PD, 2008, NEW ENGL J MED, V359, P61, DOI 10.1056/NEJMra0708473; Gluckman PD, 2007, AM J HUM BIOL, V19, P1, DOI 10.1002/ajhb.20590; Godfrey K, 2006, CURR OPIN OBSTET GYN, V16, P267, DOI DOI 10.1016/j.curobgyn.2006.07.004; Godfrey KM, 2007, PEDIATR RES, V61, p5R, DOI 10.1203/pdr.0b013e318045bedb; Godfrey KM, 2000, AM J CLIN NUTR, V71, p1344S, DOI 10.1093/ajcn/71.5.1344s; Gondret F, 2005, LIVEST PROD SCI, V93, P137, DOI 10.1016/j.livprodsci.2004.09.009; HALES CN, 1992, DIABETOLOGIA, V35, P595, DOI 10.1007/BF00400248; He J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015110; Hock MB, 2009, ANNU REV PHYSIOL, V71, P177, DOI 10.1146/annurev.physiol.010908.163119; Hoeks J, 2008, FEBS LETT, V582, P510, DOI 10.1016/j.febslet.2008.01.013; IDE T, 1987, LIPIDS, V22, P6, DOI 10.1007/BF02534867; Iossa S, 2003, BRIT J NUTR, V90, P953, DOI 10.1079/BJN2003000968; Jacob S, 1999, DIABETES, V48, P1113, DOI 10.2337/diabetes.48.5.1113; Jorgensen W, 2009, AM J PHYSIOL-ENDOC M, V297, pE1349, DOI 10.1152/ajpendo.00505.2009; Kouba M, 1999, MEAT SCI, V52, P39, DOI 10.1016/S0309-1740(98)00146-6; Lane RH, 2001, PEDIATR RES, V50, P83, DOI 10.1203/00006450-200107000-00016; Lane RH, 1996, PEDIATR RES, V39, P390, DOI 10.1203/00006450-199603000-00003; Lee HK, 1998, DIABETES RES CLIN PR, V42, P161, DOI 10.1016/S0168-8227(98)00110-7; Lee YY, 2011, BRIT J NUTR, V106, P1198, DOI 10.1017/S0007114511001632; Lee YY, 2005, J NUTR BIOCHEM, V16, P195, DOI 10.1016/j.jnutbio.2004.11.002; Li ZY, 2011, BIOCHEM BIOPH RES CO, V414, P5, DOI 10.1016/j.bbrc.2011.09.046; Liu JB, 2011, ARCH ANIM NUTR, V65, P376, DOI 10.1080/1745039X.2011.594352; Maniura-Weber K, 2004, NUCLEIC ACIDS RES, V32, P6015, DOI 10.1093/nar/gkh921; Merrifield CA, 2011, MOL BIOSYST, V7, P2577, DOI 10.1039/c1mb05023k; Morise A, 2011, BRIT J NUTR, V105, P1471, DOI 10.1017/S0007114510005386; Morris TJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007271; Mortensen OH, 2010, J BIOMED SCI, V17, DOI 10.1186/1423-0127-17-S1-S38; Mortensen OH, 2010, PEDIATR RES, V67, P47, DOI 10.1203/PDR.0b013e3181c4735c; *NAT RES COUNC, 1996, GUID CAR US LAB AN; National Research Council, 1998, NUTR REQ SWIN, Vtenth; OGATA ES, 1990, PEDIATR RES, V27, P56, DOI 10.1203/00006450-199001000-00017; Park KS, 2003, J NUTR, V133, P3085, DOI 10.1093/jn/133.10.3085; Petersen KF, 2003, SCIENCE, V300, P1140, DOI 10.1126/science.1082889; Peterside IE, 2003, AM J PHYSIOL-ENDOC M, V285, pE1258, DOI 10.1152/ajpendo.00437.2002; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Poore KR, 2004, J PHYSIOL-LONDON, V558, P295, DOI 10.1113/jphysiol.2004.061390; POWELL SE, 1980, J ANIM SCI, V50, P860, DOI 10.2527/jas1980.505860x; Puigserver P, 2003, ENDOCR REV, V24, P78, DOI 10.1210/er.2002-0012; Rueda-Clausen CF, 2011, DIABETES, V60, P507, DOI 10.2337/db10-1239; Scarpulla RC, 2006, J CELL BIOCHEM, V97, P673, DOI 10.1002/jcb.20743; Scifres CM, 2009, J PHYSIOL-LONDON, V587, P3453, DOI 10.1113/jphysiol.2009.173252; Selak MA, 2003, AM J PHYSIOL-ENDOC M, V285, pE130, DOI 10.1152/ajpendo.00322.2002; Serviddio G, 2007, REDOX REP, V12, P91, DOI 10.1179/135100007X162112; Serviddio G, 2010, J PHARMACOL EXP THER, V332, P922, DOI 10.1124/jpet.109.161612; Simmons Rebecca A, 2007, Curr Opin Endocrinol Diabetes Obes, V14, P13, DOI 10.1097/MED.0b013e328013da5b; Sreekumar R, 2007, INDIAN J MED RES, V125, P399; Taylor PD, 2007, EXP PHYSIOL, V92, P287, DOI 10.1113/expphysiol.2005.032854; Vickers MH, 2000, AM J PHYSIOL-ENDOC M, V279, pE83; Wu G, 2006, J ANIM SCI, V84, P2316, DOI 10.2527/jas.2006-156	57	41	45	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2012	7	4							e34835	10.1371/journal.pone.0034835	http://dx.doi.org/10.1371/journal.pone.0034835			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VO	22523560	Green Submitted, Green Published, gold			2022-12-25	WOS:000305345000032
J	Wang, W; Lundin, VF; Millan, I; Zeng, AN; Chen, XY; Yang, J; Allen, E; Chen, NN; Bach, G; Hsu, A; Maloney, MT; Kapur, M; Yang, Y				Wang, Wei; Lundin, Victor F.; Millan, Ivan; Zeng, Anne; Chen, Xinyu; Yang, Jie; Allen, Elizabeth; Chen, Ningna; Bach, Gillian; Hsu, Andrew; Maloney, Michael T.; Kapur, Mridu; Yang, Yanmin			Nemitin, a Novel Map8/Map1s Interacting Protein with Wd40 Repeats	PLOS ONE			English	Article							MICROTUBULE-ASSOCIATED PROTEIN-8; LIS1; DEGRADATION; DOMAIN; DYNEIN; TAU; 1S; 1B	In neurons, a highly regulated microtubule cytoskeleton is essential for many cellular functions. These include axonal transport, regional specialization and synaptic function. Given the critical roles of microtubule-associated proteins (MAPs) in maintaining and regulating microtubule stability and dynamics, we sought to understand how this regulation is achieved. Here, we identify a novel LisH/WD40 repeat protein, tentatively named nemitin (neuronal enriched MAP interacting protein), as a potential regulator of MAP8-associated microtubule function. Based on expression at both the mRNA and protein levels, nemitin is enriched in the nervous system. Its protein expression is detected as early as embryonic day 11 and continues through adulthood. Interestingly, when expressed in non-neuronal cells, nemitin displays a diffuse pattern with puncta, although at the ultrastructural level it localizes along the microtubule network in vivo in sciatic nerves. These results suggest that the association of nemitin to microtubules may require an intermediary protein. Indeed, co-expression of nemitin with microtubule-associated protein 8 (MAP8) results in nemitin losing its diffuse pattern, instead decorating microtubules uniformly along with MAP8. Together, these results imply that nemitin may play an important role in regulating the neuronal cytoskeleton through an interaction with MAP8.	[Wang, Wei; Lundin, Victor F.; Millan, Ivan; Zeng, Anne; Allen, Elizabeth; Chen, Ningna; Bach, Gillian; Hsu, Andrew; Maloney, Michael T.; Kapur, Mridu; Yang, Yanmin] Stanford Univ, Dept Neurol, Sch Med, Stanford, CA 94305 USA; [Chen, Xinyu; Yang, Jie] Shanghai Jiao Tong Univ, Sch Med, Dept Biochem & Cell Biol, Shanghai 200030, Peoples R China	Stanford University; Shanghai Jiao Tong University	Wang, W (corresponding author), Stanford Univ, Dept Neurol, Sch Med, Stanford, CA 94305 USA.	yanmin.yang@stanford.edu	Kapur, Mridu/M-2669-2019	Kapur, Mridu/0000-0002-3313-5038; Zeng, Anne/0000-0002-1452-2462	National Institutes of Health/National Institute of Neurological Disorders and Stroke [R01NS060897]; Human Frontier Science Program Postdoctoral Fellowship; Regina Casper Stanford Graduate Fellowship; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS060897] Funding Source: NIH RePORTER	National Institutes of Health/National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Human Frontier Science Program Postdoctoral Fellowship(Human Frontier Science Program); Regina Casper Stanford Graduate Fellowship; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health/National Institute of Neurological Disorders and Stroke R01NS060897, a Human Frontier Science Program Postdoctoral Fellowship, and a Regina Casper Stanford Graduate Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen E, 2005, NATURE, V438, P224, DOI 10.1038/nature04256; Ballatore C, 2007, NAT REV NEUROSCI, V8, P663, DOI 10.1038/nrn2194; Dehmelt L, 2005, GENOME BIOL, V6; Ding JQ, 2006, HUM MOL GENET, V15, P1451, DOI 10.1093/hmg/ddl069; Ding JQ, 2006, BIOCHEM BIOPH RES CO, V339, P172, DOI 10.1016/j.bbrc.2005.10.199; Ding JQ, 2002, J CELL BIOL, V158, P427, DOI 10.1083/jcb.200202055; Dixit R, 2008, SCIENCE, V319, P1086, DOI 10.1126/science.1152993; DOBYNS WB, 1993, JAMA-J AM MED ASSOC, V270, P2838, DOI 10.1001/jama.270.23.2838; Eriksson M, 2007, BIOCHEM BIOPH RES CO, V361, P127, DOI 10.1016/j.bbrc.2007.06.179; Halpain S, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-6-224; Hirokawa N, 1996, J CELL BIOL, V132, P667, DOI 10.1083/jcb.132.4.667; Iqbal K, 2009, ACTA NEUROPATHOL, V118, P53, DOI 10.1007/s00401-009-0486-3; Jorgensen ND, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008463; Kett LR, 2012, HUM MOL GENET, V21, P890, DOI 10.1093/hmg/ddr526; Lu R, 2004, P NATL ACAD SCI USA, V101, P15201, DOI 10.1073/pnas.0404995101; Mateja A, 2006, J MOL BIOL, V357, P621, DOI 10.1016/j.jmb.2006.01.002; McKenney RJ, 2010, CELL, V141, P304, DOI 10.1016/j.cell.2010.02.035; Orban-Nemeth Z, 2005, J BIOL CHEM, V280, P2257, DOI 10.1074/jbc.M408984200; Stirnimann CU, 2010, TRENDS BIOCHEM SCI, V35, P565, DOI 10.1016/j.tibs.2010.04.003; Su QN, 2004, NAT CELL BIOL, V6, P941, DOI 10.1038/ncb1169; Wang W, 2005, CURR BIOL, V15, P2050, DOI 10.1016/j.cub.2005.10.052; Xie R, 2011, J BIOL CHEM, V286, P10367, DOI 10.1074/jbc.M110.206532; Xu C, 2011, PROTEIN CELL, V2, P202, DOI 10.1007/s13238-011-1018-1; Yang YM, 1999, CELL, V98, P229, DOI 10.1016/S0092-8674(00)81017-X	24	6	9	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2012	7	4							e33094	10.1371/journal.pone.0033094	http://dx.doi.org/10.1371/journal.pone.0033094			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VO	22523538	gold, Green Published, Green Submitted			2022-12-25	WOS:000305345000007
J	Zhao, KQ; Cowan, AT; Lee, RJ; Goldstein, N; Droguett, K; Chen, B; Zheng, CQ; Villalon, M; Palmer, JN; Kreindler, JL; Cohen, NA				Zhao, Ke-Qing; Cowan, Andrew T.; Lee, Robert J.; Goldstein, Natalia; Droguett, Karla; Chen, Bei; Zheng, Chunquan; Villalon, Manuel; Palmer, James N.; Kreindler, James L.; Cohen, Noam A.			Molecular modulation of airway epithelial ciliary response to sneezing	FASEB JOURNAL			English	Article						chronic rhinosinusitis; mucociliary clearance; ATP; calcium	BEAT FREQUENCY; EXTRACELLULAR ATP; INTRACELLULAR CALCIUM; PROTEIN-KINASE; CA2+ RELEASE; STIMULATION; TRANSPORT; CELLS; MECHANOSENSITIVITY; PHOSPHORYLATION	Our purpose was to evaluate the effect of the mechanical force of a sneeze on sinonasal cilia function and determine the molecular mechanism responsible for eliciting the ciliary response to a sneeze. A novel model was developed to deliver a stimulation simulating a sneeze (55 mmHg for 50 ms) at 26 degrees C to the apical surface of mouse and human nasal epithelial cells. Ciliary beating was visualized, and changes in ciliary beat frequency (CBF) were determined. To interrogate the molecular cascades driving sneeze-induced changes of CBF, pharmacologic manipulation of intra- and extracellular calcium, purinergic, PKA, and nitric oxide (NO) signaling were performed. CBF rapidly increases by >= 150% in response to a sneeze, which is dependent on the release of adenosine triphosphate (ATP), calcium influx, and PKA activation. Furthermore, apical release of ATP is independent of calcium influx, but calcium influx and subsequent increase in CBF are dependent on the ATP release. Lastly, we observed a blunted ciliary response in surgical specimens derived from patients with chronic rhinosinusitis compared to control patients. Apical ATP release with subsequent calcium mobilization and PKA activation are involved in sinonasal ciliary response to sneezing, which is blunted in patients with upper-airway disease.-Zhao, K.-Q., Cowan, A. T., Lee, R. J., Goldstein, N., Droguett, K., Chen, B., Zheng, C., Villalon, M., Palmer, J. N., Kreindler, J. L., Cohen, N. A. Molecular modulation of airway epithelial ciliary response to sneezing. FASEB J. 26, 3178-3187 (2012). www.fasebj.org	[Zhao, Ke-Qing; Lee, Robert J.; Goldstein, Natalia; Chen, Bei; Palmer, James N.; Cohen, Noam A.] Univ Penn, Dept Otorhinolaryngol Head & Neck Surg, Philadelphia, PA 19104 USA; [Zhao, Ke-Qing; Zheng, Chunquan] Fudan Univ, Dept Otorhinolaryngol Head & Neck Surg, Sch Shanghai Med, Eye & Ear Nose & Throat Hosp, Shanghai 200433, Peoples R China; [Cowan, Andrew T.] Temple Univ, Dept Otolaryngol Head & Neck Surg, Philadelphia, PA 19122 USA; [Droguett, Karla; Villalon, Manuel] Pontificia Univ Catolica Chile, Dept Physiol, Santiago, Chile; [Goldstein, Natalia] Pontificia Univ Catolica Chile, Dept Med Sci, Santiago, Chile; [Kreindler, James L.] Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA; [Kreindler, James L.] Univ Penn, Dept Pediat, Sch Med, Philadelphia, PA 19104 USA; [Cohen, Noam A.] Philadelphia Vet Affairs Med Ctr, Surg Serv, Philadelphia, PA USA	University of Pennsylvania; Fudan University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pontificia Universidad Catolica de Chile; Pontificia Universidad Catolica de Chile; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; US Department of Veterans Affairs; Veterans Health Administration (VHA); Philadelphia Veterans Affairs Medical Center	Cohen, NA (corresponding author), Univ Penn, Dept Otorhinolaryngol Head & Neck Surg, Ravdin Bldg,5th Floor,3400 Spruce St, Philadelphia, PA 19104 USA.	cohenn@uphs.upenn.edu	Lee, Robert J./L-4397-2017	Lee, Robert J./0000-0001-5826-6686; Cohen, Noam/0000-0002-9462-3932	Flight Attendant Medical Research Institute (FAMRI) Clinical Innovator Award (CIA) grant [082478]; Fondo Nacional de Desarrollo Cientifico y Tecnologico (FONDECYT) grant [1080679]; Proyecto Anillo ACT-79; Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT) grant [24090041]	Flight Attendant Medical Research Institute (FAMRI) Clinical Innovator Award (CIA) grant; Fondo Nacional de Desarrollo Cientifico y Tecnologico (FONDECYT) grant(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Proyecto Anillo ACT-79(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT PIA/ANILLOS); Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT) grant(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT))	Financial support for these experiments was provided by Flight Attendant Medical Research Institute (FAMRI) Clinical Innovator Award (CIA) grant 082478 to N.A.C., Fondo Nacional de Desarrollo Cientifico y Tecnologico (FONDECYT) grant 1080679 to M.V., Proyecto Anillo ACT-79 to K.D., and Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT) grant 24090041 to M.V.	Antunes MB, 2007, BIOTECHNIQUES, V43, P195, DOI 10.2144/000112531; Bonfils P, 2005, ANN OTO RHINOL LARYN, V114, P74, DOI 10.1177/000348940511400114; Boucher RC, 2004, EUR RESPIR J, V23, P146, DOI 10.1183/09031936.03.00057003; Braiman A, 1998, AM J PHYSIOL-CELL PH, V275, pC790, DOI 10.1152/ajpcell.1998.275.3.C790; Braverman I, 1998, J OTOLARYNGOL, V27, P145; Button B, 2007, J PHYSIOL-LONDON, V580, P577, DOI 10.1113/jphysiol.2006.126086; Chen B, 2007, AM J RHINOL, V21, P346, DOI 10.2500/ajr.2007.21.3029; Chen B, 2006, AM J RHINOL, V20, P325, DOI 10.2500/ajr.2006.20.2870; Cherry Donald K, 2002, Adv Data, P1; Cohen NA, 2006, ANN OTO RHINOL LARYN, V115, P20; Communi D, 1999, BRIT J PHARMACOL, V127, P562, DOI 10.1038/sj.bjp.0702560; Cressman VL, 1999, J BIOL CHEM, V274, P26461, DOI 10.1074/jbc.274.37.26461; Gwaltney JM, 2000, CLIN INFECT DIS, V30, P387, DOI 10.1086/313661; HAMASAKI T, 1991, P NATL ACAD SCI USA, V88, P7918, DOI 10.1073/pnas.88.18.7918; Hochstrasser M, 1996, J EUKARYOT MICROBIOL, V43, P356, DOI 10.1111/j.1550-7408.1996.tb04000.x; JAIN B, 1993, BIOCHEM BIOPH RES CO, V191, P83, DOI 10.1006/bbrc.1993.1187; Korngreen A, 1996, J PHYSIOL-LONDON, V497, P53, DOI 10.1113/jphysiol.1996.sp021749; Korngreen A, 1998, J PHYSIOL-LONDON, V508, P703, DOI 10.1111/j.1469-7793.1998.703bp.x; Kultgen PL, 2002, MOL BIOL CELL, V13, P4156, DOI 10.1091/mbc.E02-07-0391; Lansley AB, 1999, BIOPHYS J, V77, P629, DOI 10.1016/S0006-3495(99)76919-5; Lazarowski ER, 2000, J BIOL CHEM, V275, P31061, DOI 10.1074/jbc.M003255200; Leipziger J, 2003, AM J PHYSIOL-RENAL, V284, pF419, DOI 10.1152/ajprenal.00075.2002; Lin L, 2010, HISTOCHEM CELL BIOL, V134, P93, DOI 10.1007/s00418-010-0717-7; Ly Nghi, 2002, Adv Data, P1; Ma WY, 1999, NATURE, V400, P894, DOI 10.1038/23743; Ma WY, 2002, J GEN PHYSIOL, V120, P875, DOI 10.1085/jgp.20028695; MASON SJ, 1991, BRIT J PHARMACOL, V103, P1649, DOI 10.1111/j.1476-5381.1991.tb09842.x; Meltzer Eli O, 2004, J Allergy Clin Immunol, V114, P155, DOI 10.1016/j.jaci.2004.09.029; Morse DM, 2001, AM J PHYSIOL-CELL PH, V280, pC1485, DOI 10.1152/ajpcell.2001.280.6.C1485; Mwimbi XKMS, 2003, CELL SIGNAL, V15, P395, DOI 10.1016/S0898-6568(02)00143-2; PARADISO AM, 1995, NATURE, V377, P643, DOI 10.1038/377643a0; Ramsingh R, 2011, AM J PHYSIOL-LUNG C, V300, pL587, DOI 10.1152/ajplung.00345.2010; SADE J, 1970, AM REV RESPIR DIS, V102, P48; SALATHE M, 1993, J CELL SCI, V106, P1211; Salathe M, 1999, J PHYSIOL-LONDON, V520, P851, DOI 10.1111/j.1469-7793.1999.00851.x; SANDERSON MJ, 1990, CELL REGUL, V1, P585, DOI 10.1091/mbc.1.8.585; SANDERSON MJ, 1986, P NATL ACAD SCI USA, V83, P7302, DOI 10.1073/pnas.83.19.7302; Schwiebert EM, 2003, BBA-BIOMEMBRANES, V1615, P7, DOI 10.1016/S0005-2736(03)00210-4; Shaari J, 2006, AM J RHINOL, V20, P150, DOI 10.1177/194589240602000205; Sisson JH, 2003, J MICROSC-OXFORD, V211, P103, DOI 10.1046/j.1365-2818.2003.01209.x; SLEIGH MA, 1988, AM REV RESPIR DIS, V137, P726, DOI 10.1164/ajrccm/137.3.726; Speert D. P., 2006, NOVART FDN SYMP, V279, P51; Speert D. P., 2006, NOVART FDN SYMP, V279, P216; Speert David P, 2006, Novartis Found Symp, V279, P42; Tarran R, 2006, ANNU REV PHYSIOL, V68, P543, DOI 10.1146/annurev.physiol.68.072304.112754; Uzlaner N, 1999, J PHYSIOL-LONDON, V516, P179, DOI 10.1111/j.1469-7793.1999.179aa.x; VILLALON M, 1989, BIOPHYS J, V56, P1255, DOI 10.1016/S0006-3495(89)82772-9; Wallace DV, 2008, J ALLERGY CLIN IMMUN, V122, pS1, DOI 10.1016/j.jaci.2008.06.003; WEISS T, 1992, J MEMBRANE BIOL, V127, P185; Winters SL, 2007, AM J PHYSIOL-LUNG C, V292, pL614, DOI 10.1152/ajplung.00288.2005; WONG LB, 1992, AM J RESP CELL MOL, V7, P447, DOI 10.1165/ajrcmb/7.4.447; Wyatt TA, 2001, AM J PHYSIOL-LUNG C, V281, pL575, DOI 10.1152/ajplung.2001.281.3.L575; Yang B, 1997, ANN OTO RHINOL LARYN, V106, P230, DOI 10.1177/000348949710600309; Zhang L, 2003, J PHYSIOL-LONDON, V551, P765, DOI 10.1113/jphysiol.2003.041707; Zhang L, 2003, J PHYSIOL-LONDON, V546, P733, DOI 10.1113/jphysiol.2002.028704; Zhang L, 2008, ORL-J OTO-RHIN-LARYN, V70, P91, DOI 10.1159/000114531; Zhou HB, 2009, INHAL TOXICOL, V21, P875, DOI 10.1080/08958370802555898; Zsembery A, 2003, J BIOL CHEM, V278, P13398, DOI 10.1074/jbc.M212277200	58	33	33	0	11	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2012	26	8					3178	3187		10.1096/fj.11-202184	http://dx.doi.org/10.1096/fj.11-202184			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	984BI	22516297				2022-12-25	WOS:000307162800009
J	Lundin, D; Poole, AM; Sjoberg, BM; Hogbom, M				Lundin, Daniel; Poole, Anthony M.; Sjoberg, Britt-Marie; Hogbom, Martin			Use of Structural Phylogenetic Networks for Classification of the Ferritin-like Superfamily	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HYDROGEN-PEROXIDE DETOXIFICATION; IB RIBONUCLEOTIDE REDUCTASE; IRON-CARBOXYLATE PROTEINS; DPS-LIKE PROTEIN; ESCHERICHIA-COLI; DNA-BINDING; LISTERIA-INNOCUA; EVOLUTION; DATABASE; BACTERIOFERRITIN	In the postgenomic era, bioinformatic analysis of sequence similarity is an immensely powerful tool to gain insight into evolution and protein function. Over long evolutionary distances, however, sequence-based methods fail as the similarities become too low for phylogenetic analysis. Macromolecular structure generally appears better conserved than sequence, but clear models for how structure evolves over time are lacking. The exponential growth of three-dimensional structural information may allow novel structure-based methods to drastically extend the evolutionary time scales amenable to phylogenetics and functional classification of proteins. To this end, we analyzed 80 structures from the functionally diverse ferritin-like superfamily. Using evolutionary networks, we demonstrate that structural comparisons can delineate and discover groups of proteins beyond the "twilight zone" where sequence similarity does not allow evolutionary analysis, suggesting that considerable and useful evolutionary signal is preserved in three-dimensional structures.	[Lundin, Daniel; Sjoberg, Britt-Marie; Hogbom, Martin] Stockholm Univ, Dept Biochem & Biophys, S-10691 Stockholm, Sweden; [Lundin, Daniel] Royal Inst Technol, Sci Life Lab, S-17121 Solna, Sweden; [Poole, Anthony M.] Univ Canterbury, Sch Biol Sci, Christchurch 8140, New Zealand; [Poole, Anthony M.] Univ Canterbury, Biomol Interact Ctr, Christchurch 8140, New Zealand	Stockholm University; Royal Institute of Technology; University of Canterbury; University of Canterbury	Lundin, D (corresponding author), Stockholm Univ, Dept Biochem & Biophys, S-10691 Stockholm, Sweden.	daniel.lundin@scilifelab.se		Sjoberg, Britt-Marie/0000-0001-5953-3360; Hogbom, Martin/0000-0001-5574-9383; Lundin, Daniel/0000-0002-8779-6464; Poole, Anthony/0000-0001-9940-2824	Swedish Research Council; Swedish Foundation for Strategic Research; Royal Swedish Academy of Sciences Research Fellowship; Knut and Alice Wallenberg Foundation; Royal Society of New Zealand	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Royal Swedish Academy of Sciences Research Fellowship; Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Royal Society of New Zealand(Royal Society of New Zealand)	This work was supported by grants from the Swedish Research Council (to A.M.P. and B.M.S.), and grants from the Swedish Research Council and the Swedish Foundation for Strategic Research (to M.H.).; Recipient of a Royal Swedish Academy of Sciences Research Fellowship supported by a grant from the Knut and Alice Wallenberg Foundation. Also supported by a Rutherford Discovery Fellowship from the Royal Society of New Zealand.	Andersson CS, 2009, P NATL ACAD SCI USA, V106, P5633, DOI 10.1073/pnas.0812971106; Andrews SC, 1998, ADV MICROB PHYSIOL, V40, P281, DOI 10.1016/S0065-2911(08)60134-4; Andrews SC, 2010, BBA-GEN SUBJECTS, V1800, P691, DOI 10.1016/j.bbagen.2010.05.010; Bergsten J, 2005, CLADISTICS, V21, P163, DOI 10.1111/j.1096-0031.2005.00059.x; Boal AK, 2010, SCIENCE, V329, P1526, DOI 10.1126/science.1190187; Bozzi M, 1997, J BIOL CHEM, V272, P3259, DOI 10.1074/jbc.272.6.3259; Breitling R, 2001, MOL BIOL EVOL, V18, P2154, DOI 10.1093/oxfordjournals.molbev.a003761; Bryant D, 2004, MOL BIOL EVOL, V21, P255, DOI 10.1093/molbev/msh018; Bujnicki JM, 2000, J MOL EVOL, V50, P39, DOI 10.1007/s002399910005; Chiancone E, 2010, BBA-GEN SUBJECTS, V1800, P798, DOI 10.1016/j.bbagen.2010.01.013; Cotruvo JA, 2010, BIOCHEMISTRY-US, V49, P1297, DOI 10.1021/bi902106n; Dyer DH, 2005, PROTEIN SCI, V14, P1508, DOI 10.1110/ps.041288005; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Finn RD, 2010, NUCLEIC ACIDS RES, V38, pD211, DOI 10.1093/nar/gkp985; FROLOW F, 1993, ACTA CRYSTALLOGR D, V49, P597, DOI 10.1107/S0907444993007073; Furnham N, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002403; Garau G, 2005, ANTIMICROB AGENTS CH, V49, P2778, DOI 10.1128/AAC.49.7.2778-2784.2005; Gascuel O, 1997, MOL BIOL EVOL, V14, P685, DOI 10.1093/oxfordjournals.molbev.a025808; Gauss GH, 2006, BIOCHEMISTRY-US, V45, P10815, DOI 10.1021/bi060782u; Gauss GH, 2012, J BACTERIOL, V194, P15, DOI 10.1128/JB.05260-11; Greene LH, 2007, NUCLEIC ACIDS RES, V35, pD291, DOI 10.1093/nar/gkl959; Hillis DM, 2007, MOL PHYLOGENET EVOL, V42, P331, DOI 10.1016/j.ympev.2006.08.001; Hogbom M, 2011, METALLOMICS, V3, P110, DOI 10.1039/c0mt00095g; Hogbom M, 2010, J BIOL INORG CHEM, V15, P339, DOI 10.1007/s00775-009-0606-5; Huson DH, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-460; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Ilari A, 2005, BIOCHEMISTRY-US, V44, P5579, DOI 10.1021/bi050005e; Illergard K, 2009, PROTEINS, V77, P499, DOI 10.1002/prot.22458; Jaroszewski L, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000205; Krebs C, 2011, CURR OPIN CHEM BIOL, V15, P291, DOI 10.1016/j.cbpa.2011.02.019; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Leahy JG, 2003, FEMS MICROBIOL REV, V27, P449, DOI 10.1016/S0168-6445(03)00023-8; Lundin D, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-383; Lundin D, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-589; Merkx M, 2001, ANGEW CHEM INT EDIT, V40, P2782, DOI 10.1002/1521-3773(20010803)40:15<2782::AID-ANIE2782>3.0.CO;2-P; MURZIN AG, 1995, J MOL BIOL, V247, P536, DOI 10.1006/jmbi.1995.0159; Nordlund P, 1995, CURR OPIN STRUC BIOL, V5, P758, DOI 10.1016/0959-440X(95)80008-5; Nordlund N, 2006, ANNU REV BIOCHEM, V75, P681, DOI 10.1146/annurev.biochem.75.103004.142443; Penny D, 2001, J MOL EVOL, V53, P711, DOI 10.1007/s002390010258; RIDLEY M, 1986, EVOLUTION CLASSIFICA; Rost B, 1999, PROTEIN ENG, V12, P85, DOI 10.1093/protein/12.2.85; Rusch DB, 2007, PLOS BIOL, V5, P398, DOI 10.1371/journal.pbio.0050077; Schirmer A, 2010, SCIENCE, V329, P559, DOI 10.1126/science.1187936; Shanklin J, 2009, J BIOL CHEM, V284, P18559, DOI 10.1074/jbc.R900009200; Sjoberg BM, 2010, SCIENCE, V329, P1475, DOI 10.1126/science.1196347; Terwilliger TC, 2009, ANNU REV BIOPHYS, V38, P371, DOI 10.1146/annurev.biophys.050708.133740; Warui DM, 2011, J AM CHEM SOC, V133, P3316, DOI 10.1021/ja111607x; Weeratunga SK, 2009, BIOCHEMISTRY-US, V48, P7420, DOI 10.1021/bi900561a; Wilkinson M, 2007, TRENDS ECOL EVOL, V22, P114, DOI 10.1016/j.tree.2007.01.002; Zhao GH, 2002, J BIOL CHEM, V277, P27689, DOI 10.1074/jbc.M202094200	50	50	51	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 8	2012	287	24					20565	20575		10.1074/jbc.M112.367458	http://dx.doi.org/10.1074/jbc.M112.367458			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974FB	22535960	Green Published, hybrid			2022-12-25	WOS:000306414500077
J	Suckow, AT; Zhang, C; Egodage, S; Comoletti, D; Taylor, P; Miller, MT; Sweet, IR; Chessler, SD				Suckow, Arthur T.; Zhang, Charles; Egodage, Sonya; Comoletti, Davide; Taylor, Palmer; Miller, Meghan T.; Sweet, Ian R.; Chessler, Steven D.			Transcellular Neuroligin-2 Interactions Enhance Insulin Secretion and Are Integral to Pancreatic beta Cell Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SYNAPTIC ADHESION; CA2+ CHANNELS; ISLET CELLS; NEUREXIN; EXOCYTOSIS; PROTEIN; REVEALS; GRANULES; DOCKING; COMPLEX	Normal glucose-stimulated insulin secretion is dependent on interactions between neighboring beta cells. Elucidation of the reasons why this cell-to-cell contact is essential will probably yield critical insights into beta cell maturation and function. In the central nervous system, transcellular protein interactions (i.e. interactions between proteins on the surfaces of different cells) involving neuroligins are key mediators of synaptic functional development. We previously demonstrated that beta cells express neuroligin-2 and that insulin secretion is affected by changes in neuroligin-2 expression. Here we show that the effect of neuroligin-2 on insulin secretion is mediated by transcellular interactions. Neuroligin-2 binds with nanomolar affinity to a partner on the beta cell surface and contributes to the increased insulin secretion brought about by beta cell-to-beta cell contact. It does so in a manner seemingly independent of interactions with neurexin, a known binding partner. As in the synapse, transcellular neuroligin-2 interactions enhance the functioning of the submembrane exocytic machinery. Also, as in the synapse, neuroligin-2 clustering is important. Neuroligin-2 in soluble form, rather than presented on a cell surface, decreases insulin secretion by rat islets and MIN-6 cells, most likely by interfering with endogenous neuroligin interactions. Prolonged contact with neuroligin-2-expressing cells increases INS-1 beta cell proliferation and insulin content. These results extend the known parallels between the synaptic and beta cell secretory machineries to extracellular interactions. Neuroligin-2 interactions are one of the few transcellular protein interactions thus far identified that directly enhance insulin secretion. Together, these results indicate a significant role for transcellular neuroligin-2 interactions in the establishment of beta cell function.	[Suckow, Arthur T.; Zhang, Charles; Egodage, Sonya; Chessler, Steven D.] Univ Calif San Diego, Dept Med, UCSD Sch Med, La Jolla, CA 92093 USA; [Suckow, Arthur T.; Zhang, Charles; Egodage, Sonya; Chessler, Steven D.] Univ Calif San Diego, Pediat Diabet Res Ctr, UCSD Sch Med, La Jolla, CA 92093 USA; [Suckow, Arthur T.] Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, Biomed Sci Grad Program, La Jolla, CA 92093 USA; [Comoletti, Davide; Taylor, Palmer; Miller, Meghan T.] Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, Dept Pharmacol, La Jolla, CA 92093 USA; [Sweet, Ian R.] Univ Washington, Dept Med, Seattle, WA 98195 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of Washington; University of Washington Seattle	Chessler, SD (corresponding author), Univ Calif San Diego, Dept Med, UCSD Sch Med, 9500 Gilman Dr,MC 0983, La Jolla, CA 92093 USA.	schessler@ucsd.edu			National Institutes of Health [R01DK080971, DK17047]; Juvenile Diabetes Research Foundation [37-2009-44]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK017047, R01DK080971] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007752] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01DK080971 and Grant DK17047 (for the University of Washington Diabetes Endocrine Research Center Islet Core). This work was also supported by Juvenile Diabetes Research Foundation Grant 37-2009-44.	Aoyagi K, 2011, FRONT BIOSCI-LANDMRK, V16, P1197, DOI 10.2741/3784; ASFARI M, 1992, ENDOCRINOLOGY, V130, P167, DOI 10.1210/en.130.1.167; Barg S, 2002, DIABETES, V51, pS74, DOI 10.2337/diabetes.51.2007.S74; Barg S, 2001, BIOPHYS J, V81, P3308, DOI 10.1016/S0006-3495(01)75964-4; Bosco D, 2011, PHYSIOL REV, V91, P1393, DOI 10.1152/physrev.00027.2010; Bottos A, 2009, P NATL ACAD SCI USA, V106, P20782, DOI 10.1073/pnas.0809510106; Chen W, 2009, ENDOCRINOLOGY, V150, P570, DOI 10.1210/en.2008-1009; Chen X, 2008, NAT STRUCT MOL BIOL, V15, P50, DOI 10.1038/nsmb1350; Chessler SD, 2002, DIABETES, V51, P1763, DOI 10.2337/diabetes.51.6.1763; Comoletti D, 2006, BIOCHEMISTRY-US, V45, P12816, DOI 10.1021/bi0614131; Craig AM, 2007, CURR OPIN NEUROBIOL, V17, P43, DOI 10.1016/j.conb.2007.01.011; Dalby B, 2004, METHODS, V33, P95, DOI 10.1016/j.ymeth.2003.11.023; De Jaco A, 2006, J BIOL CHEM, V281, P9667, DOI 10.1074/jbc.M510262200; Dean C, 2003, NAT NEUROSCI, V6, P708, DOI 10.1038/nn1074; Deeney JT, 2000, J BIOL CHEM, V275, P9363, DOI 10.1074/jbc.275.13.9363; Deeney JT, 2007, FEBS LETT, V581, P4080, DOI 10.1016/j.febslet.2007.07.052; Easom RA, 2000, SEMIN CELL DEV BIOL, V11, P253, DOI 10.1006/scdb.2000.0174; Esni F, 1999, J CELL BIOL, V144, P325, DOI 10.1083/jcb.144.2.325; Fabrichny IP, 2007, NEURON, V56, P979, DOI 10.1016/j.neuron.2007.11.013; GERDES J, 1984, J IMMUNOL, V133, P1710; Graf ER, 2004, CELL, V119, P1013, DOI 10.1016/j.cell.2004.11.035; Hauge-Evans AC, 1999, DIABETES, V48, P1402, DOI 10.2337/diabetes.48.7.1402; Ichtchenko K, 1996, J BIOL CHEM, V271, P2676, DOI 10.1074/jbc.271.5.2676; Ivarsson R, 2005, TRAFFIC, V6, P1027, DOI 10.1111/j.1600-0854.2005.00342.x; Jain R, 2009, DIABETES OBES METAB, V11, P159, DOI 10.1111/j.1463-1326.2009.01102.x; Jaques F, 2008, ENDOCRINOLOGY, V149, P2494, DOI 10.1210/en.2007-0974; JUNGERS J, 1981, J LAB CLIN MED, V98, P30; Kelly C, 2011, ISLETS, V3, P41, DOI 10.4161/isl.3.2.14805; Kenakin T. P., 2006, PHARM PRIMER THEORY, P59; Ko J, 2009, EMBO J, V28, P3244, DOI 10.1038/emboj.2009.249; Koehnke J, 2008, STRUCTURE, V16, P410, DOI 10.1016/j.str.2007.12.024; Konstantinova I, 2007, CELL, V129, P359, DOI 10.1016/j.cell.2007.02.044; Lang T, 2001, EMBO J, V20, P2202, DOI 10.1093/emboj/20.9.2202; Leone P, 2010, EMBO J, V29, P2461, DOI 10.1038/emboj.2010.123; Leung YM, 2007, ENDOCR REV, V28, P653, DOI 10.1210/er.2007-0010; Levinson JN, 2005, J BIOL CHEM, V280, P17312, DOI 10.1074/jbc.M413812200; Li JS, 2004, AM J PHYSIOL-ENDOC M, V286, pE818, DOI 10.1152/ajpendo.00307.2003; Maffei A, 2004, ENDOCRINOLOGY, V145, P4513, DOI 10.1210/en.2004-0691; Marshall C, 2005, MOL ENDOCRINOL, V19, P213, DOI 10.1210/me.2004-0064; Miller MT, 2011, STRUCTURE, V19, P767, DOI 10.1016/j.str.2011.03.011; Mosedale M, 2012, J BIOL CHEM, V287, P6350, DOI 10.1074/jbc.M111.299081; Ohara-Imaizumi M, 2004, J BIOL CHEM, V279, P8403, DOI 10.1074/jbc.M308954200; Ohara-Imaizumi M, 2007, J CELL BIOL, V177, P695, DOI 10.1083/jcb.200608132; PAPADIMITRIOU JM, 1970, J CELL BIOL, V47, P71, DOI 10.1083/jcb.47.1.71; Ravier MA, 2005, DIABETES, V54, P1798, DOI 10.2337/diabetes.54.6.1798; Reissner C, 2008, P NATL ACAD SCI USA, V105, P15124, DOI 10.1073/pnas.0801639105; Rutter GA, 2006, CELL CALCIUM, V40, P539, DOI 10.1016/j.ceca.2006.08.015; Scheiffele P, 2000, CELL, V101, P657, DOI 10.1016/S0092-8674(00)80877-6; Shi P, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1518; SPIESS Y, 1982, DIABETES, V31, P189, DOI 10.2337/diabetes.31.3.189; Straub SG, 2002, DIABETES-METAB RES, V18, P451, DOI 10.1002/dmrr.329; Suckow AT, 2010, AM J PHYSIOL-ENDOC M, V299, pE23, DOI 10.1152/ajpendo.00664.2009; Suckow AT, 2008, ENDOCRINOLOGY, V149, P6006, DOI 10.1210/en.2008-0274; Sweet IR, 2004, BIOCHEM BIOPH RES CO, V314, P976, DOI 10.1016/j.bbrc.2003.12.182; Thurmond DC, 2003, MOL ENDOCRINOL, V17, P732, DOI 10.1210/me.2002-0333; Varoqueaux F, 2006, NEURON, V51, P741, DOI 10.1016/j.neuron.2006.09.003; Wiser O, 1999, P NATL ACAD SCI USA, V96, P248, DOI 10.1073/pnas.96.1.248; Wooding S, 1998, MOL BIOL CELL, V9, P2667, DOI 10.1091/mbc.9.9.2667; ZUCKER RM, 1988, CYTOMETRY, V9, P226, DOI 10.1002/cyto.990090307	59	22	23	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 8	2012	287	24					19816	19826		10.1074/jbc.M111.280537	http://dx.doi.org/10.1074/jbc.M111.280537			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974FB	22528485	hybrid, Green Published			2022-12-25	WOS:000306414500005
J	Galati, A; Magdinier, F; Colasanti, V; Bauwens, S; Pinte, S; Ricordy, R; Giraud-Panis, MJ; Pusch, MC; Savino, M; Cacchione, S; Gilson, E				Galati, Alessandra; Magdinier, Frederique; Colasanti, Valentina; Bauwens, Serge; Pinte, Sebastien; Ricordy, Ruggero; Giraud-Panis, Marie-Josephe; Pusch, Miriam Caroline; Savino, Maria; Cacchione, Stefano; Gilson, Eric			TRF2 Controls Telomeric Nucleosome Organization in a Cell Cycle Phase-Dependent Manner	PLOS ONE			English	Article							CHROMATIN-STRUCTURE; CHROMOSOME ENDS; BINDING-SITES; DNA-DAMAGE; SEQUENCES; COMPLEX; INTEGRITY; INTERACTS; PROTEINS; H3.3	Mammalian telomeres stabilize chromosome ends as a result of their assembly into a peculiar form of chromatin comprising a complex of non-histone proteins named shelterin. TRF2, one of the shelterin components, binds to the duplex part of telomeric DNA and is essential to fold the telomeric chromatin into a protective cap. Although most of the human telomeric DNA is organized into tightly spaced nucleosomes, their role in telomere protection and how they interplay with telomere-specific factors in telomere organization is still unclear. In this study we investigated whether TRF2 can regulate nucleosome assembly at telomeres. By means of chromatin immunoprecipitation (ChIP) and Micrococcal Nuclease (MNase) mapping assay, we found that the density of telomeric nucleosomes in human cells was inversely proportional to the dosage of TRF2 at telomeres. This effect was not observed in the G1 phase of the cell cycle but appeared coincident of late or post-replicative events. Moreover, we showed that TRF2 overexpression altered nucleosome spacing at telomeres increasing internucleosomal distance. By means of an in vitro nucleosome assembly system containing purified histones and remodeling factors, we reproduced the short nucleosome spacing found in telomeric chromatin. Importantly, when in vitro assembly was performed in the presence of purified TRF2, nucleosome spacing on a telomeric DNA template increased, in agreement with in vivo MNase mapping. Our results demonstrate that TRF2 negatively regulates the number of nucleosomes at human telomeres by a cell cycle-dependent mechanism that alters internucleosomal distance. These findings raise the intriguing possibility that telomere protection is mediated, at least in part, by the TRF2-dependent regulation of nucleosome organization.	[Galati, Alessandra; Colasanti, Valentina; Savino, Maria; Cacchione, Stefano] Univ Roma La Sapienza, Dipartimento Biol & Biotecnol, Rome, Italy; [Galati, Alessandra; Magdinier, Frederique; Bauwens, Serge; Pinte, Sebastien; Giraud-Panis, Marie-Josephe; Gilson, Eric] Univ Lyon, CNRS, Ecole Normale Super Lyon, Lab Biol Mol Cellule,UMR5239, Lyon, France; [Ricordy, Ruggero; Savino, Maria] CNR, Ist Biol & Patol Mol, Rome, Italy; [Giraud-Panis, Marie-Josephe; Gilson, Eric] Univ Nice, CNRS, INSERM, U1081,IRCAN,UMR 7284,Fac Med 28, F-06034 Nice, France; [Pusch, Miriam Caroline] Univ Munich, Adolf Butenandt Inst, Munich, Germany; [Gilson, Eric] CHU Nice, Archet Hosp 2, Dept Med Genet, Nice, France; [Savino, Maria; Cacchione, Stefano] Ist Pasteur Fdn Cenci Bolognetti, Rome, Italy	Sapienza University Rome; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; Ecole Normale Superieure de Lyon (ENS de LYON); Universite Jean Monnet; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biologia e Patologia Molecolari (IBPM-CNR); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); CHU Nice; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur; University of Munich; CHU Nice; Fondazione Cenci Bolognetti	Cacchione, S (corresponding author), Univ Roma La Sapienza, Dipartimento Biol & Biotecnol, Rome, Italy.	stefano.cacchione@uniroma1.it; Eric.Gilson@unice.fr	Magdinier, Frederique/I-4735-2016	Magdinier, Frederique/0000-0002-0159-9559; Cacchione, Stefano/0000-0002-7278-3695; Giraud-Panis, Marie-Josephe/0000-0001-7941-2873	Ligue Nationale contre le Cancer ("equipe labellisee"); Institut National du Cancer (INCa); ANR; European Community [RISC-RAD FI6R-CT-2003- 508842, TELOMARKER Health-F2-2007-200950]; Istituto Pasteur-Fondazione Cenci Bolognetti; Ministero dell'Istruzione dell'Universita e della Ricerca; Agenzia Spaziale Italiana (ASI) [CUP F11J11000010001]; EMBO	Ligue Nationale contre le Cancer ("equipe labellisee")(Ligue nationale contre le cancer); Institut National du Cancer (INCa)(Institut National du Cancer (INCA) France); ANR(French National Research Agency (ANR)); European Community(European Commission); Istituto Pasteur-Fondazione Cenci Bolognetti(Istituto Pasteur Italia Fondazione Cenci Bolognetti); Ministero dell'Istruzione dell'Universita e della Ricerca(Ministry of Education, Universities and Research (MIUR)); Agenzia Spaziale Italiana (ASI)(Agenzia Spaziale Italiana (ASI)); EMBO(European Molecular Biology Organization (EMBO))	The work in EG's lab is supported by grants from the Ligue Nationale contre le Cancer ("equipe labellisee"), the Institut National du Cancer (INCa, program TELOFUN), the ANR program TELOREP and the European Community (RISC-RAD FI6R-CT-2003- 508842, TELOMARKER Health-F2-2007-200950). The work in SC's lab was supported by grants from Istituto Pasteur-Fondazione Cenci Bolognetti (http://www.istitutopasteur.it/), by Ministero dell'Istruzione dell'Universita e della Ricerca (PRIN 2009), and by Agenzia Spaziale Italiana (ASI, CUP F11J11000010001). AG has been supported by a short-term EMBO fellowship and by a post-doctoral fellowship from Istituto Pasteur-Fondazione Cenci Bolognetti. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amiard S, 2007, NAT STRUCT MOL BIOL, V14, P147, DOI 10.1038/nsmb1192; Azzalin CM, 2007, SCIENCE, V318, P798, DOI 10.1126/science.1147182; Baker AM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019124; Baker AM, 2009, NUCLEIC ACIDS RES, V37, P5019, DOI 10.1093/nar/gkp515; Baur JA, 2001, SCIENCE, V292, P2075, DOI 10.1126/science.1062329; Benetti R, 2008, CELL CYCLE, V7, P3461, DOI 10.4161/cc.7.21.7013; Blank TA, 1997, METHODS, V12, P28, DOI 10.1006/meth.1997.0444; Blasco MA, 2007, NAT REV GENET, V8, P299, DOI 10.1038/nrg2047; Brunori M, 2006, ONCOGENE, V25, P990, DOI 10.1038/sj.onc.1209135; Cacchione S, 1997, FEBS LETT, V400, P37, DOI 10.1016/S0014-5793(96)01318-X; CONRAD MN, 1990, CELL, V63, P739, DOI 10.1016/0092-8674(90)90140-A; de Lange T, 2005, GENE DEV, V19, P2100, DOI 10.1101/gad.1346005; FAJKUS J, 1995, MOL GEN GENET, V247, P633, DOI 10.1007/BF00290355; Galati A, 2006, J MOL BIOL, V360, P377, DOI 10.1016/j.jmb.2006.04.071; Gilson E, 2007, NAT REV MOL CELL BIO, V8, P825, DOI 10.1038/nrm2259; Goldberg AD, 2010, CELL, V140, P678, DOI 10.1016/j.cell.2010.01.003; Groth A, 2007, CELL, V128, P721, DOI 10.1016/j.cell.2007.01.030; Karlseder J, 1999, SCIENCE, V283, P1321, DOI 10.1126/science.283.5406.1321; Koerber RT, 2009, MOL CELL, V35, P889, DOI 10.1016/j.molcel.2009.09.011; Koering CE, 2002, EMBO REP, V3, P1055, DOI 10.1093/embo-reports/kvf215; LEJNINE S, 1995, P NATL ACAD SCI USA, V92, P2393, DOI 10.1073/pnas.92.6.2393; Liu D, 2004, J BIOL CHEM, V279, P51338, DOI 10.1074/jbc.M409293200; Lowary PT, 1998, J MOL BIOL, V276, P19, DOI 10.1006/jmbi.1997.1494; MAKAROV VL, 1993, CELL, V73, P775, DOI 10.1016/0092-8674(93)90256-P; Mattern KA, 2004, MOL CELL BIOL, V24, P5587, DOI 10.1128/MCB.24.12.5587-5594.2004; McEachern MJ, 2000, ANNU REV GENET, V34, P331, DOI 10.1146/annurev.genet.34.1.331; Mechelli R, 2004, FEBS LETT, V566, P131, DOI 10.1016/j.febslet.2004.04.032; Munoz P, 2005, NAT GENET, V37, P1063, DOI 10.1038/ng1633; Nikitina T, 2004, J CELL BIOL, V166, P161, DOI 10.1083/jcb.200403118; O'Sullivan RJ, 2010, NAT STRUCT MOL BIOL, V17, P1218, DOI 10.1038/nsmb.1897; Ottaviani A, 2008, BIOCHIMIE, V90, P93, DOI 10.1016/j.biochi.2007.07.022; Pisano S, 2008, CELL MOL LIFE SCI, V65, P3553, DOI 10.1007/s00018-008-8307-8; Pisano S, 2007, J MOL BIOL, V369, P1153, DOI 10.1016/j.jmb.2007.04.027; Pisano S, 2006, BIOPHYS CHEM, V124, P81, DOI 10.1016/j.bpc.2006.05.012; Pisano S, 2010, NUCLEIC ACIDS RES, V38, P2247, DOI 10.1093/nar/gkp1228; Poulet A, 2011, NUCL ACIDS IN PRESS; Rossetti L, 1998, BIOCHEMISTRY-US, V37, P6727, DOI 10.1021/bi9726180; Rossetti L, 2001, J MOL BIOL, V306, P903, DOI 10.1006/jmbi.2001.4458; Simonet T, 2011, CELL RES, V21, P1028, DOI 10.1038/cr.2011.40; Takai H, 2003, CURR BIOL, V13, P1549, DOI 10.1016/S0960-9822(03)00542-6; Tiscornia G, 2006, NAT PROTOC, V1, P241, DOI 10.1038/nprot.2006.37; TOMMERUP H, 1994, MOL CELL BIOL, V14, P5777, DOI 10.1128/MCB.14.9.5777; van Steensel B, 1998, CELL, V92, P401, DOI 10.1016/S0092-8674(00)80932-0; Wong LH, 2010, GENOME RES, V20, P351, DOI 10.1101/gr.101477.109; WRIGHT JH, 1992, GENE DEV, V6, P197, DOI 10.1101/gad.6.2.197; Wu P, 2008, MOL CELL BIOL, V28, P5724, DOI 10.1128/MCB.01764-07; Xin HW, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-232; Yang D, 2011, CELL RES, V21, P1013, DOI 10.1038/cr.2011.39; Ye J, 2010, CELL, V142, P230, DOI 10.1016/j.cell.2010.05.032; Yu LN, 1999, MOL CELL BIOL, V19, P5279	50	32	34	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2012	7	4							e34386	10.1371/journal.pone.0034386	http://dx.doi.org/10.1371/journal.pone.0034386			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UD	22536324	Green Published, gold, Green Submitted			2022-12-25	WOS:000305339200012
J	Chatterjee, S; Seifried, L; Feigin, ME; Gibbons, DL; Scuoppo, C; Lin, W; Rizvi, ZH; Lind, E; Dissanayake, D; Kurie, J; Ohashi, P; Muthuswamy, SK				Chatterjee, Samit; Seifried, Laurie; Feigin, Michael E.; Gibbons, Don L.; Scuoppo, Claudio; Lin, Wei; Rizvi, Zain H.; Lind, Evan; Dissanayake, Dilan; Kurie, Jonathan; Ohashi, Pam; Muthuswamy, Senthil K.			Dysregulation of Cell Polarity Proteins Synergize with Oncogenes or the Microenvironment to Induce Invasive Behavior in Epithelial Cells	PLOS ONE			English	Article							BREAST-CANCER; MESENCHYMAL TRANSITION; MOUSE MODEL; EXPRESSION; METASTASIS; RECEPTORS; ERBB2; PROLIFERATION; TUMORIGENESIS; INFLAMMATION	Changes in expression and localization of proteins that regulate cell and tissue polarity are frequently observed in carcinoma. However, the mechanisms by which changes in cell polarity proteins regulate carcinoma progression are not well understood. Here, we report that loss of polarity protein expression in epithelial cells primes them for cooperation with oncogenes or changes in tissue microenvironment to promote invasive behavior. Activation of ErbB2 in cells lacking the polarity regulators Scribble, Dlg1 or AF-6, induced invasive properties. This cooperation required the ability of ErbB2 to regulate the Par6/aPKC polarity complex. Inhibition of the ErbB2-Par6 pathway was sufficient to block ErbB2-induced invasion suggesting that two polarity hits may be needed for ErbB2 to promote invasion. Interestingly, in the absence of ErbB2 activation, either a combined loss of two polarity proteins, or exposure of cells lacking one polarity protein to cytokines IL-6 or TNFa induced invasive behavior in epithelial cells. We observed the invasive behavior only when cells were plated on a stiff matrix (Matrigel/Collagen-1) and not when plated on a soft matrix (Matrigel alone). Cells lacking two polarity proteins upregulated expression of EGFR and activated Akt. Inhibition of Akt activity blocked the invasive behavior identifying a mechanism by which loss of polarity promotes invasion of epithelial cells. Thus, we demonstrate that loss of polarity proteins confers phenotypic plasticity to epithelial cells such that they display normal behavior under normal culture conditions but display aggressive behavior in response to activation of oncogenes or exposure to cytokines.	[Chatterjee, Samit; Seifried, Laurie; Lind, Evan; Dissanayake, Dilan; Ohashi, Pam; Muthuswamy, Senthil K.] Univ Toronto, Campbell Family Inst Breast Canc Res, Ontario Canc Inst, Toronto, ON, Canada; [Chatterjee, Samit; Feigin, Michael E.; Scuoppo, Claudio; Muthuswamy, Senthil K.] Watson Sch Biol Sci, Cold Spring Harbor Lab, Cold Spring Harbor, NY USA; [Gibbons, Don L.; Lin, Wei; Rizvi, Zain H.; Kurie, Jonathan] Univ Texas MD Anderson Canc Ctr, Dept Thoracic Head & Neck Med Oncol, Houston, TX 77030 USA	University of Toronto; University Toronto Affiliates; University Health Network Toronto; Cold Spring Harbor Laboratory; University of Texas System; UTMD Anderson Cancer Center	Chatterjee, S (corresponding author), Univ Toronto, Campbell Family Inst Breast Canc Res, Ontario Canc Inst, Toronto, ON, Canada.	s.muthuswamy@utoronto.ca	Muthuswamy, Senthil K/AGY-2834-2022	Muthuswamy, Senthil K/0000-0001-6564-9634; Feigin, Michael/0000-0002-8189-5568; Dissanayake, Dilan/0000-0003-4270-7015; Lind, Evan/0000-0001-7026-2012; Ohashi, Pamela S./0000-0003-2915-9317	Terri Brodeur Breast Cancer Foundation; Era of Hope Scholar award from DOD Breast Cancer Research Program [CA098830, BC075024]; Rita Allen Foundation, Lee K Margaret Lau Chair for breast cancer research; Campbell Family Institute For Breast cancer research [NCI K08CA151651]; Howard Hughes Medical Institute Research Training Fellowship Award; Ontario Ministry of Health and Long Term Care; NATIONAL CANCER INSTITUTE [R01CA098830, K08CA151651, R56CA098830] Funding Source: NIH RePORTER	Terri Brodeur Breast Cancer Foundation; Era of Hope Scholar award from DOD Breast Cancer Research Program; Rita Allen Foundation, Lee K Margaret Lau Chair for breast cancer research; Campbell Family Institute For Breast cancer research; Howard Hughes Medical Institute Research Training Fellowship Award; Ontario Ministry of Health and Long Term Care(Ministry of Health and Long-Term Care, Ontario); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by Terri Brodeur Breast Cancer Foundation fellowship to SC and by CA098830, BC075024, Era of Hope Scholar award from DOD Breast Cancer Research Program; Rita Allen Foundation, Lee K Margaret Lau Chair for breast cancer research; Campbell Family Institute For Breast cancer research to SKM; NCI K08CA151651 to DLG and Howard Hughes Medical Institute Research Training Fellowship Award to ZHR. This was also funded in part by the Ontario Ministry of Health and Long Term Care. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrechek ER, 2000, P NATL ACAD SCI USA, V97, P3444, DOI 10.1073/pnas.050408497; Aranda V, 2006, NAT CELL BIOL, V8, P1235, DOI 10.1038/ncb1485; Benoy Ina, 2002, Clin Breast Cancer, V2, P311, DOI 10.3816/CBC.2002.n.008; Damonte P, 2007, LAB INVEST, V87, P1218, DOI 10.1038/labinvest.3700683; Debnath J, 2003, METHODS, V30, P256, DOI 10.1016/S1046-2023(03)00032-X; Dow LE, 2008, ONCOGENE, V27, P5988, DOI 10.1038/onc.2008.219; Ebnet K, 2000, J BIOL CHEM, V275, P27979; Etienne-Manneville S, 2008, ONCOGENE, V27, P6970, DOI 10.1038/onc.2008.347; Gibbons DL, 2009, GENE DEV, V23, P2140, DOI 10.1101/gad.1820209; Gibbons DL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005401; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; Hennessy BT, 2007, CLIN CANCER RES, V13, P7421, DOI 10.1158/1078-0432.CCR-07-0760; Hennessy BT, 2009, CANCER RES, V69, P4116, DOI 10.1158/0008-5472.CAN-08-3441; Huang L, 2010, CURR OPIN GENET DEV, V20, P41, DOI 10.1016/j.gde.2009.12.001; Humbert PO, 2006, TRENDS CELL BIOL, V16, P622, DOI 10.1016/j.tcb.2006.10.005; Joshi A, 2010, FRONT BIOSCI-LANDMRK, V15, P180, DOI 10.2741/3614; Joyce JA, 2009, NAT REV CANCER, V9, P239, DOI 10.1038/nrc2618; Karreth FA, 2009, CURR OPIN GENET DEV, V19, P4, DOI 10.1016/j.gde.2008.12.006; Kondapaka SB, 2003, MOL CANCER THER, V2, P1093; Krieg AM, 2002, ANNU REV IMMUNOL, V20, P709, DOI 10.1146/annurev.immunol.20.100301.064842; Lee MH, 2008, J CELL SCI, V121, P1141, DOI 10.1242/jcs.016634; Leek RD, 1998, BRIT J CANCER, V77, P2246, DOI 10.1038/bjc.1998.373; Lu J, 2009, CANCER CELL, V16, P195, DOI 10.1016/j.ccr.2009.08.010; Lutz MB, 1999, J IMMUNOL METHODS, V223, P77, DOI 10.1016/S0022-1759(98)00204-X; Macara IG, 2008, CELL, V135, P801, DOI 10.1016/j.cell.2008.11.006; Mandai K, 1997, J CELL BIOL, V139, P517, DOI 10.1083/jcb.139.2.517; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; MILES DW, 1994, INT J CANCER, V56, P777, DOI 10.1002/ijc.2910560603; Miyata M, 2009, J CELL SCI, V122, P4319, DOI 10.1242/jcs.048439; Muthuswamy SK, 2001, NAT CELL BIOL, V3, P785, DOI 10.1038/ncb0901-785; Nelson WJ, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a000513; Nofech-Mozes S, 2005, ADV ANAT PATHOL, V12, P256, DOI 10.1097/01.pap.0000184177.65919.5e; Ozdamar B, 2005, SCIENCE, V307, P1603, DOI 10.1126/science.1105718; Pagliarini RA, 2003, SCIENCE, V302, P1227, DOI 10.1126/science.1088474; Paszek MJ, 2005, CANCER CELL, V8, P241, DOI 10.1016/j.ccr.2005.08.010; Pollard JW, 2008, J LEUKOCYTE BIOL, V84, P623, DOI 10.1189/jlb.1107762; Reischauer S, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000720; Salgado R, 2003, INT J CANCER, V103, P642, DOI 10.1002/ijc.10833; Sarrio D, 2008, CANCER RES, V68, P989, DOI 10.1158/0008-5472.CAN-07-2017; SCHOENENBERGER CA, 1991, J CELL BIOL, V112, P873, DOI 10.1083/jcb.112.5.873; Spaderna S, 2008, CANCER RES, V68, P537, DOI 10.1158/0008-5472.CAN-07-5682; Suzuki A, 2006, J CELL SCI, V119, P979, DOI 10.1242/jcs.02898; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Wang SC, 2001, SEMIN ONCOL, V28, P115, DOI 10.1016/S0093-7754(01)90289-1; Xiang B, 2006, METHOD ENZYMOL, V406, P692, DOI 10.1016/S0076-6879(06)06054-X	45	27	29	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2012	7	4							e34343	10.1371/journal.pone.0034343	http://dx.doi.org/10.1371/journal.pone.0034343			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959XD	22529912	Green Accepted, gold, Green Published, Green Submitted			2022-12-25	WOS:000305350600013
J	Fiaz, AW; Leon-Kloosterziel, KM; Gort, G; Schulte-Merker, S; van Leeuwen, JL; Kranenbarg, S				Fiaz, Ansa W.; Leon-Kloosterziel, Karen M.; Gort, Gerrit; Schulte-Merker, Stefan; van Leeuwen, Johan L.; Kranenbarg, Sander			Swim-Training Changes the Spatio-Temporal Dynamics of Skeletogenesis in Zebrafish Larvae (Danio rerio)	PLOS ONE			English	Article							DEVELOPMENTAL CONSTRAINTS; SKELETAL-MUSCLE; AXIAL SKELETON; TELEOST FISH; GROWTH-PLATE; OSTARIOPHYSI; PERFORMANCE; MORPHOLOGY; EVOLUTION; CARTILAGE	Fish larvae experience many environmental challenges during development such as variation in water velocity, food availability and predation. The rapid development of structures involved in feeding, respiration and swimming increases the chance of survival. It has been hypothesized that mechanical loading induced by muscle forces plays a role in prioritizing the development of these structures. Mechanical loading by muscle forces has been shown to affect larval and embryonic bone development in vertebrates, but these investigations were limited to the appendicular skeleton. To explore the role of mechanical load during chondrogenesis and osteogenesis of the cranial, axial and appendicular skeleton, we subjected zebrafish larvae to swim-training, which increases physical exercise levels and presumably also mechanical loads, from 5 until 14 days post fertilization. Here we show that an increased swimming activity accelerated growth, chondrogenesis and osteogenesis during larval development in zebrafish. Interestingly, swim-training accelerated both perichondral and intramembranous ossification. Furthermore, swim-training prioritized the formation of cartilage and bone structures in the head and tail region as well as the formation of elements in the anal and dorsal fins. This suggests that an increased swimming activity prioritized the development of structures which play an important role in swimming and thereby increasing the chance of survival in an environment where water velocity increases. Our study is the first to show that already during early zebrafish larval development, skeletal tissue in the cranial, axial and appendicular skeleton is competent to respond to swim-training due to increased water velocities. It demonstrates that changes in water flow conditions can result into significant spatio-temporal changes in skeletogenesis.	[Fiaz, Ansa W.; Leon-Kloosterziel, Karen M.; Gort, Gerrit; Schulte-Merker, Stefan; van Leeuwen, Johan L.; Kranenbarg, Sander] Univ Wageningen & Res Ctr, Dept Anim Sci, Expt Zool Grp, Wageningen, Netherlands; [Schulte-Merker, Stefan] KNAW & UMC Utrecht, Hubrecht Inst, Utrecht, Netherlands	Wageningen University & Research; Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW)	Fiaz, AW (corresponding author), Univ Wageningen & Res Ctr, Dept Anim Sci, Expt Zool Grp, Wageningen, Netherlands.	ansa.fiaz@wur.nl	van Leeuwen, Johan/N-3437-2019; van Leeuwen, Johan L/B-7897-2011	van Leeuwen, Johan/0000-0002-4433-880X; 	Netherlands Organization for Scientific Research	Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO))	This work was supported by the Netherlands Organization for Scientific Research (www.nwo.nl,017.005.014). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bagatto B, 2001, J EXP BIOL, V204, P4335; BALLINTIJN CM, 1969, J EXP BIOL, V50, P569; Bensimon-Brito A, 2010, J APPL ICHTHYOL, V26, P235, DOI 10.1111/j.1439-0426.2010.01412.x; Bird NC, 2003, DEV DYNAM, V228, P337, DOI 10.1002/dvdy.10387; BRETT JR, 1964, J FISH RES BOARD CAN, V21, P1183, DOI 10.1139/f64-103; Cahu C, 2003, AQUACULTURE, V227, P245, DOI 10.1016/S0044-8486(03)00507-6; Carter DR, 2003, PHILOS T ROY SOC B, V358, P1461, DOI 10.1098/rstb.2003.1346; Cloutier R, 2010, INT J ZOOL, V2010, P1; Cubbage CC, 1996, J MORPHOL, V229, P121, DOI 10.1002/(SICI)1097-4687(199608)229:2<121::AID-JMOR1>3.0.CO;2-4; Danos N, 2010, J APPL ICHTHYOL, V26, P156, DOI 10.1111/j.1439-0426.2010.01396.x; DAVISON W, 1989, COMP BIOCHEM PHYS A, V94, P1, DOI 10.1016/0300-9629(89)90775-5; FUIMAN LA, 1983, J FISH BIOL, V23, P117, DOI 10.1111/j.1095-8649.1983.tb02886.x; Germiller JA, 1997, J ORTHOP RES, V15, P362, DOI 10.1002/jor.1100150308; Gibb AC, 2006, PHYSIOL BIOCHEM ZOOL, V79, P7, DOI 10.1086/498192; Glucksman A, 1941, J ANAT, V76, P231; Gomez C, 2007, J ANAT, V210, P259, DOI 10.1111/j.1469-7580.2007.00698.x; Grande T, 2004, ZOOL J LINN SOC-LOND, V140, P241, DOI 10.1111/j.1096-3642.2003.00097.x; Hammond CL, 2007, J EXP BIOL, V210, P2667, DOI 10.1242/jeb.005751; Hernandez LP, 2002, INTEGR COMP BIOL, V42, P222, DOI 10.1093/icb/42.2.222; Heywood JL, 2005, J MUSCLE RES CELL M, V26, P49, DOI 10.1007/s10974-005-9007-8; Kardong KV, 2002, VERTEBRATES COMP ANA; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; KLEINNULEND J, 1986, ARTHRITIS RHEUM-US, V29, P1002, DOI 10.1002/art.1780290809; Lamb KJ, 2003, INT J EXP PATHOL, V84, P191, DOI 10.1046/j.1365-2613.2003.00353.x; Mikic B, 2004, ANN BIOMED ENG, V32, P18, DOI 10.1023/B:ABME.0000007787.39262.a7; Muller UK, 2004, J EXP BIOL, V207, P853, DOI 10.1242/jeb.00821; Nowlan NC, 2007, ANN NY ACAD SCI, V1101, P389, DOI 10.1196/annals.1389.003; Nusslein-Volhard C., 2002, ZEBRAFISH PRACTICAL; Osse J. W. M., 1999, Journal of Fish Biology, V55, P156, DOI 10.1006/jfbi.1999.1071; Palstra AP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014483; Parichy DM, 2009, DEV DYNAM, V238, P2975, DOI 10.1002/dvdy.22113; Plaut I, 2001, COMP BIOCHEM PHYS A, V131, P41, DOI 10.1016/S1095-6433(01)00462-7; Richardson MK, 2003, J EXP ZOOL PART B, V296B, P8, DOI 10.1002/jez.b.00013; RODRIGUEZ JI, 1988, J BONE JOINT SURG AM, V70A, P1052, DOI 10.2106/00004623-198870070-00014; Rombough P, 2002, J EXP BIOL, V205, P1787; Saint-Amant L, 1998, J NEUROBIOL, V37, P622, DOI 10.1002/(SICI)1097-4695(199812)37:4<622::AID-NEU10>3.0.CO;2-S; Sfakianakis DG, 2011, ENVIRON BIOL FISH, V92, P197, DOI 10.1007/s10641-011-9833-z; SMITH JM, 1985, Q REV BIOL, V60, P265, DOI 10.1086/414425; Spoorendonk KM, 2008, DEVELOPMENT, V135, P3765, DOI 10.1242/dev.024034; van der Meulen T, 2005, THESIS WAGENINGEN U; Videler JJ, 1993, FISH SWIMMING, P1, DOI [10.1007/978-94-011-1580-3, DOI 10.1007/978-94-011-1580-3]; vonHerbing IH, 1996, J MORPHOL, V227, P15; WEBB PW, 1977, J EXP BIOL, V68, P123; WEISEL GF, 1967, J MORPHOL, V121, P1, DOI 10.1002/jmor.1051210102; Witten PE, 2009, BIOL REV, V84, P315, DOI 10.1111/j.1469-185X.2009.00077.x	45	44	45	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2012	7	4							e34072	10.1371/journal.pone.0034072	http://dx.doi.org/10.1371/journal.pone.0034072			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959XD	22529905	Green Published, Green Submitted, gold			2022-12-25	WOS:000305350600011
J	Klose, C; Surma, MA; Gerl, MJ; Meyenhofer, F; Shevchenko, A; Simons, K				Klose, Christian; Surma, Michal A.; Gerl, Mathias J.; Meyenhofer, Felix; Shevchenko, Andrej; Simons, Kai			Flexibility of a Eukaryotic Lipidome - Insights from Yeast Lipidomics	PLOS ONE			English	Article							TANDEM MASS-SPECTROMETRY; PLASMA-MEMBRANE ATPASE; SACCHAROMYCES-CEREVISIAE; SUBCELLULAR MEMBRANES; MOLECULAR-BIOLOGY; CELL-SURFACE; CHAIN-LENGTH; FATTY-ACIDS; SPHINGOLIPIDS; GENE	Mass spectrometry-based shotgun lipidomics has enabled the quantitative and comprehensive assessment of cellular lipid compositions. The yeast Saccharomyces cerevisiae has proven to be a particularly valuable experimental system for studying lipid-related cellular processes. Here, by applying our shotgun lipidomics platform, we investigated the influence of a variety of commonly used growth conditions on the yeast lipidome, including glycerophospholipids, triglycerides, ergosterol as well as complex sphingolipids. This extensive dataset allowed for a quantitative description of the intrinsic flexibility of a eukaryotic lipidome, thereby providing new insights into the adjustments of lipid biosynthetic pathways. In addition, we established a baseline for future lipidomic experiments in yeast. Finally, flexibility of lipidomic features is proposed as a new parameter for the description of the physiological state of an organism.	[Klose, Christian; Surma, Michal A.; Gerl, Mathias J.; Meyenhofer, Felix; Shevchenko, Andrej; Simons, Kai] Max Planck Inst Mol Cell Biol & Genet, Dresden, Germany	Max Planck Society	Klose, C (corresponding author), Max Planck Inst Mol Cell Biol & Genet, Dresden, Germany.	simons@mpi-cbg.de	Surma, Michal/B-1955-2016	Surma, Michal/0000-0001-7833-2214; Klose, Christian/0000-0003-2853-4533; Simons, Kai/0000-0002-9231-9996; Meyenhofer, Felix/0000-0001-8870-8369; Gerl, Mathias/0000-0002-8074-7221	DFG [SI459/2-1, TRR83 TP02]; ESF "LIPIDPROD" [SI459/3-1]; BMBF "ForMaT" [03FO1212]; Klaus Tschira Foundation	DFG(German Research Foundation (DFG)); ESF "LIPIDPROD"; BMBF "ForMaT"(Federal Ministry of Education & Research (BMBF)); Klaus Tschira Foundation	This work was supported by DFG "Schwerpunktprogramm1175" grant no: SI459/2-1, DFG "Transregio 83" grant no: TRR83 TP02, ESF "LIPIDPROD" grant no: SI459/3-1, BMBF "ForMaT" grant no: 03FO1212 and the Klaus Tschira Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson MS, 1996, J BIOL CHEM, V271, P26596, DOI 10.1074/jbc.271.43.26596; Barz WP, 1999, MOL BIOL CELL, V10, P1043, DOI 10.1091/mbc.10.4.1043; Beattie ME, 2005, BIOPHYS J, V89, P1760, DOI 10.1529/biophysj.104.049635; Berthold MR, 2008, STUD CLASS DATA ANAL, P319, DOI 10.1145/1656274.1656280; BOGGS JM, 1987, BIOCHIM BIOPHYS ACTA, V906, P353, DOI 10.1016/0304-4157(87)90017-7; Boumann HA, 2005, BIOCHEM SOC T, V33, P1146, DOI 10.1042/BST0331146; Boumann HA, 2004, FEBS LETT, V569, P173, DOI 10.1016/j.febslet.2004.05.043; Boumann HA, 2003, BIOCHEMISTRY-US, V42, P3054, DOI 10.1021/bi026801r; Breslow DK, 2010, NATURE, V463, P1048, DOI 10.1038/nature08787; Carman GM, 2007, J BIOL CHEM, V282, P37293, DOI 10.1074/jbc.R700038200; Carman GM, 2011, ANNU REV BIOCHEM, V80, P859, DOI 10.1146/annurev-biochem-060409-092229; Carvalho M, 2010, DEVELOPMENT, V137, P3675, DOI 10.1242/dev.044560; CEVC G, 1991, BIOCHEMISTRY-US, V30, P7186, DOI 10.1021/bi00243a021; CRONAN JE, 1978, ANNU REV BIOCHEM, V47, P163, DOI 10.1146/annurev.bi.47.070178.001115; Daum G, 1998, YEAST, V14, P1471, DOI 10.1002/(SICI)1097-0061(199812)14:16<1471::AID-YEA353>3.0.CO;2-Y; Dennis EA, 2010, J BIOL CHEM, V285, P39976, DOI 10.1074/jbc.M110.182915; Ejsing CS, 2009, P NATL ACAD SCI USA, V106, P2136, DOI 10.1073/pnas.0811700106; Funk M, 2002, METHOD ENZYMOL, V350, P248, DOI 10.1016/S0076-6879(02)50967-8; Gaigg B, 2005, J BIOL CHEM, V280, P22515, DOI 10.1074/jbc.M413472200; Gaigg B, 2006, J BIOL CHEM, V281, P34135, DOI 10.1074/jbc.M603791200; Gallet PF, 1997, BIOCHEM J, V324, P627, DOI 10.1042/bj3240627; Gaspar ML, 2006, J BIOL CHEM, V281, P22773, DOI 10.1074/jbc.M603548200; Gerl MJ, 2012, J CELL BIOL, V196, P213, DOI 10.1083/jcb.201108175; Goffrini P, 2002, J BACTERIOL, V184, P427, DOI 10.1128/JB.184.2.427-432.2002; Graessler J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006261; Guan XL, 2009, MOL BIOL CELL, V20, P2083, DOI 10.1091/mbc.E08-11-1126; Herzog R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029851; Herzog R, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-1-r8; HUNTER K, 1972, BIOCHIM BIOPHYS ACTA, V260, P639, DOI 10.1016/0005-2760(72)90013-6; Janssen MJFW, 2000, YEAST, V16, P641, DOI 10.1002/(SICI)1097-0061(200005)16:7<641::AID-YEA578>3.0.CO;2-U; Jiang JC, 1998, GENOME RES, V8, P1259, DOI 10.1101/gr.8.12.1259; JOLLOW D, 1968, J CELL BIOL, V37, P221, DOI 10.1083/jcb.37.2.221; Kaiser HJ, 2009, P NATL ACAD SCI USA, V106, P16645, DOI 10.1073/pnas.0908987106; Klose C, 2010, J BIOL CHEM, V285, P30224, DOI 10.1074/jbc.M110.123554; Kohlwein SD, 2010, J BIOL CHEM, V285, P15663, DOI 10.1074/jbc.R110.118356; KOVAC L, 1967, BIOCHIM BIOPHYS ACTA, V144, P94, DOI 10.1016/0005-2760(67)90080-X; Kurat CF, 2006, J BIOL CHEM, V281, P491, DOI 10.1074/jbc.M508414200; Kurat CF, 2009, MOL CELL, V33, P53, DOI 10.1016/j.molcel.2008.12.019; Lee AG, 2004, BBA-BIOMEMBRANES, V1666, P62, DOI 10.1016/j.bbamem.2004.05.012; LESTER RL, 1993, J BIOL CHEM, V268, P845; Martin CE, 2007, BBA-MOL CELL BIOL L, V1771, P271, DOI 10.1016/j.bbalip.2006.06.010; Mouritsen OG, 2005, FRONT COLLECT, P1, DOI 10.1007/b138577; Nagiec MM, 1997, J BIOL CHEM, V272, P9809, DOI 10.1074/jbc.272.15.9809; NAGIEC MM, 1993, J BIOL CHEM, V268, P22156; Oh CS, 1997, J BIOL CHEM, V272, P17376, DOI 10.1074/jbc.272.28.17376; OKUYAMA H, 1979, J BIOL CHEM, V254, P2281; Proszynski TJ, 2004, MOL BIOL CELL, V15, P1533, DOI 10.1091/mbc.E03-07-0511; PROUDLOC.JW, 1969, BIOCHEM BIOPH RES CO, V37, P847, DOI 10.1016/0006-291X(69)90969-3; Qian OY, 1999, GENETICS, V152, P89; RATTRAY JBM, 1975, BACTERIOL REV, V39, P197, DOI 10.1128/MMBR.39.3.197-231.1975; Sampaio JL, 2011, P NATL ACAD SCI USA, V108, P1903, DOI 10.1073/pnas.1019267108; Sandhoff R, 1999, J LIPID RES, V40, P126; Santangelo GM, 2006, MICROBIOL MOL BIOL R, V70, P253, DOI 10.1128/MMBR.70.1.253-282.2006; Schneiter R, 1999, J CELL BIOL, V146, P741, DOI 10.1083/jcb.146.4.741; Sherman F, 2002, METHOD ENZYMOL, V350, P3, DOI 10.1016/S0076-6879(02)50954-X; Stottrup BL, 2006, BIOPHYS J, V90, P3176, DOI 10.1529/biophysj.105.072959; Surma MA, 2011, TRAFFIC, V12, P1139, DOI 10.1111/j.1600-0854.2011.01221.x; Tuller G, 1999, YEAST, V15, P1555, DOI 10.1002/(SICI)1097-0061(199910)15:14<1555::AID-YEA479>3.0.CO;2-Z; Wenk MR, 2010, CELL, V143, P888, DOI 10.1016/j.cell.2010.11.033	59	175	180	1	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2012	7	4							e35063	10.1371/journal.pone.0035063	http://dx.doi.org/10.1371/journal.pone.0035063			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959XD	22529973	Green Published, Green Submitted, gold			2022-12-25	WOS:000305350600055
J	Wefers, B; Hitz, C; Holter, SM; Trumbach, D; Hansen, J; Weber, P; Putz, B; Deussing, JM; de Angelis, MH; Roenneberg, T; Zheng, F; Alzheimer, C; Silva, A; Wurst, W; Kuhn, R				Wefers, Benedikt; Hitz, Christiane; Hoelter, Sabine M.; Truembach, Dietrich; Hansen, Jens; Weber, Peter; Puetz, Benno; Deussing, Jan M.; de Angelis, Martin Hrabe; Roenneberg, Till; Zheng, Fang; Alzheimer, Christian; Silva, Alcino; Wurst, Wolfgang; Kuehn, Ralf			MAPK Signaling Determines Anxiety in the Juvenile Mouse Brain but Depression-Like Behavior in Adults	PLOS ONE			English	Article							HIPPOCAMPAL CA1 AREA; B-RAF; SYNAPTIC PLASTICITY; POSTNATAL ONTOGENY; PATHWAY; GENE; SYSTEM; STRESS; EXPRESSION; NEURONS	MAP kinase signaling has been implicated in brain development, long-term memory, and the response to antidepressants. Inducible Braf knockout mice, which exhibit protein depletion in principle forebrain neurons, enabled us to unravel a new role of neuronal MAPK signaling for emotional behavior. Braf mice that were induced during adulthood showed normal anxiety but increased depression-like behavior, in accordance with pharmacological findings. In contrast, the inducible or constitutive inactivation of Braf in the juvenile brain leads to normal depression-like behavior but decreased anxiety in adults. In juvenile, constitutive mutants we found no alteration of GABAergic neurotransmission but reduced neuronal arborization in the dentate gyrus. Analysis of gene expression in the hippocampus revealed nine downregulated MAPK target genes that represent candidates to cause the mutant phenotype. Our results reveal the differential function of MAPK signaling in juvenile and adult life phases and emphasize the early postnatal period as critical for the determination of anxiety in adults. Moreover, these results validate inducible gene inactivation as a new valuable approach, allowing it to discriminate between gene function in the adult and the developing postnatal brain.	[Wefers, Benedikt; Hitz, Christiane; Hoelter, Sabine M.; Truembach, Dietrich; Hansen, Jens; Wurst, Wolfgang; Kuehn, Ralf] Helmholtz Zentrum Munchen, Inst Dev Genet, German Res Ctr Environm Hlth, Neuherberg, Germany; [de Angelis, Martin Hrabe] Helmholtz Zentrum Munchen GmbH, Inst Expt Genet, German Res Ctr Environm Hlth, Neuherberg, Germany; [Roenneberg, Till] Univ Munich, Inst Med Psychol, D-80804 Munich, Germany; [Zheng, Fang; Alzheimer, Christian] Univ Erlangen Nurnberg, Inst Physiol & Pathophysiol, D-91054 Erlangen, Germany; [Silva, Alcino] Univ Calif Los Angeles, Dept Neurobiol, Los Angeles, CA USA; [Wurst, Wolfgang; Kuehn, Ralf] Tech Univ Munchen Weihenstephan, Lehrstuhl Entwicklungsgenet, Neuherberg, Germany; [Wurst, Wolfgang] Deutsch Zentrum Neurodegenerat Erkrankungen eV DZ, Munich, Germany; [Weber, Peter; Puetz, Benno; Deussing, Jan M.; Wurst, Wolfgang] Max Planck Inst Psychiat, D-80804 Munich, Germany	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Munich; University of Erlangen Nuremberg; University of California System; University of California Los Angeles; Technical University of Munich; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); Max Planck Society	Wefers, B (corresponding author), Helmholtz Zentrum Munchen, Inst Dev Genet, German Res Ctr Environm Hlth, Neuherberg, Germany.	ralf.kuehn@helmholtz-muenchen.de	Hölter, Sabine M./N-5868-2014; Hansen, Jens/E-8791-2015; Pütz, Benno/P-2630-2016; Hansen, Jens/ABF-4463-2020; Deussing, Jan M/ABB-5993-2021; Silva, Alcino/ABD-7684-2021; de Angelis, Martin Hrabe/F-5531-2012; Kühn, Ralf/U-1278-2017	Hölter, Sabine M./0000-0003-4878-5241; Hansen, Jens/0000-0001-7520-1577; Pütz, Benno/0000-0002-2208-209X; Hansen, Jens/0000-0001-7520-1577; Silva, Alcino/0000-0002-1587-4558; de Angelis, Martin Hrabe/0000-0002-7898-2353; Kühn, Ralf/0000-0003-1694-9803; Deussing, Jan/0000-0002-9329-5252; Wurst, Wolfgang/0000-0003-4422-7410; Roenneberg, Till/0000-0003-2939-0332	Klinische Kooperationsgruppe (KKG) of the Max-Planck-Institute of Psychiatry; Federal Ministry of Education and Research (BMBF) in the framework of the National Genome Research Network (NGFN) [01GS08151]; BMBF [01GS0858]; Deutsche Forschungsgemeinschaft (DFG) [AL 294/9-1]; Helmholtz Alliance "Mental Health in an Ageing Society" [HA215]; Helmholtz Zentrum Munchen; EUMODIC [LSHG-2006-037188]	Klinische Kooperationsgruppe (KKG) of the Max-Planck-Institute of Psychiatry; Federal Ministry of Education and Research (BMBF) in the framework of the National Genome Research Network (NGFN)(Federal Ministry of Education & Research (BMBF)); BMBF(Federal Ministry of Education & Research (BMBF)); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Helmholtz Alliance "Mental Health in an Ageing Society"; Helmholtz Zentrum Munchen(Helmholtz Association); EUMODIC	This work was possible with support of the Klinische Kooperationsgruppe (KKG) of the Max-Planck-Institute of Psychiatry and the Helmholtz Zentrum Munchen, and by the Federal Ministry of Education and Research (BMBF) in the framework of the National Genome Research Network (NGFN, http://www.ngfn.de/) #01GS08151, EUMODIC grant (http://www.eumodic.org/) #LSHG-2006-037188, and the DIGTOP grant by BMBF #01GS0858 (Disease Genes to Protein Pathways, http://www.digtop.de/), the Deutsche Forschungsgemeinschaft (Dr. Alzheimer) DFG AL 294/9-1 as well as the Helmholtz Alliance "Mental Health in an Ageing Society" (http://www.neuro-ageing.de/) HA215. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoki Y, 2008, HUM MUTAT, V29, P992, DOI 10.1002/humu.20748; Arur S, 2009, P NATL ACAD SCI USA, V106, P4776, DOI 10.1073/pnas.0812285106; Barkus C, 2010, EUR J PHARMACOL, V626, P49, DOI 10.1016/j.ejphar.2009.10.014; Bell-Horner CL, 2006, J NEUROBIOL, V66, P1467, DOI 10.1002/neu.20327; Bentires-Alj M, 2006, NAT MED, V12, P283, DOI 10.1038/nm0306-283; Bergami M, 2008, P NATL ACAD SCI USA, V105, P15570, DOI 10.1073/pnas.0803702105; Bergami Matteo, 2009, Commun Integr Biol, V2, P14; Chen AP, 2006, J NEUROSCI RES, V83, P28, DOI 10.1002/jnr.20703; Chen ZY, 2006, SCIENCE, V314, P140, DOI 10.1126/science.1129663; Cohen CD, 2006, P NATL ACAD SCI USA, V103, P5682, DOI 10.1073/pnas.0511257103; Coogan AN, 2004, J NEUROCHEM, V90, P769, DOI 10.1111/j.1471-4159.2004.02554.x; Cook EH, 2008, NATURE, V455, P919, DOI 10.1038/nature07458; Corson LB, 2003, DEVELOPMENT, V130, P4527, DOI 10.1242/dev.00669; Coyle JT, 2003, NEURON, V38, P157, DOI 10.1016/S0896-6273(03)00195-8; Crusio WE, 2009, GENES BRAIN BEHAV, V8, P1, DOI 10.1111/j.1601-183X.2008.00438.x; Duman CH, 2007, BIOL PSYCHIAT, V61, P661, DOI 10.1016/j.biopsych.2006.05.047; Duric V, 2010, NAT MED; Ebner K, 2002, EUR J NEUROSCI, V15, P384, DOI 10.1046/j.0953-816x.2001.01869.x; Einat H, 2003, J NEUROSCI, V23, P7311; Erdmann G, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-63; Fanselow MS, 2010, NEURON, V65, P7, DOI 10.1016/j.neuron.2009.11.031; Gailus-Durner V, 2005, NAT METHODS, V2, P403, DOI 10.1038/nmeth0605-403; Galabova-Kovacs G, 2008, J CELL BIOL, V180, P947, DOI 10.1083/jcb.200709069; Gerlai R, 1996, TRENDS NEUROSCI, V19, P177, DOI 10.1016/S0166-2236(96)20020-7; Gross C, 2004, NAT REV NEUROSCI, V5, P545, DOI 10.1038/nrn1429; Gross C, 2002, NATURE, V416, P396, DOI 10.1038/416396a; Hao YL, 2004, J NEUROSCI, V24, P6590, DOI 10.1523/JNEUROSCI.5747-03.2004; Holmes A, 2001, NEUROSCI BIOBEHAV R, V25, P261, DOI 10.1016/S0149-7634(01)00012-4; Ko Shanelle W., 2005, Shengli Xuebao, V57, P421; Kopnisky KL, 2003, NEUROSCIENCE, V116, P425, DOI 10.1016/S0306-4522(02)00573-0; Ma XM, 2008, J NEUROSCI, V28, P711, DOI 10.1523/JNEUROSCI.5283-07.2008; Minichiello L, 1999, NEURON, V24, P401, DOI 10.1016/S0896-6273(00)80853-3; Mozhui K, 2010, J NEUROSCI, V30, P5357, DOI 10.1523/JNEUROSCI.5017-09.2010; Muller MB, 2003, NAT NEUROSCI, V6, P1100, DOI 10.1038/nn1123; Nakatani N, 2006, HUM MOL GENET, V15, P1949, DOI 10.1093/hmg/ddl118; Obrietan K, 1998, NAT NEUROSCI, V1, P693, DOI 10.1038/3695; Oler JA, 2010, NATURE, V466, P864, DOI 10.1038/nature09282; Owens DM, 2007, ONCOGENE, V26, P3203, DOI 10.1038/sj.onc.1210412; Pinheiro J., 2011, NLME LINEAR NONLINEA; POKORNY J, 1981, BRAIN RES BULL, V7, P113, DOI 10.1016/0361-9230(81)90075-7; POKORNY J, 1981, BRAIN RES BULL, V7, P121, DOI 10.1016/0361-9230(81)90076-9; Porsolt R D, 2001, Curr Protoc Neurosci, VChapter 8, DOI 10.1002/0471142301.ns0810as14; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Refojo D, 2005, P NATL ACAD SCI USA, V102, P6183, DOI 10.1073/pnas.0502070102; Revest JM, 2005, NAT NEUROSCI, V8, P664, DOI 10.1038/nn1441; Roenneberg T, 2000, METHOD ENZYMOL, V305, P104; Scobie KN, 2009, J NEUROSCI, V29, P9875, DOI 10.1523/JNEUROSCI.2260-09.2009; STORM SM, 1990, ONCOGENE, V5, P345; Sweatt JD, 2001, J NEUROCHEM, V76, P1, DOI 10.1046/j.1471-4159.2001.00054.x; Thomas GM, 2004, NAT REV NEUROSCI, V5, P173, DOI 10.1038/nrn1346; Tronche F, 1999, NAT GENET, V23, P99, DOI 10.1038/12703; Vaillant AR, 2002, NEURON, V34, P985, DOI 10.1016/S0896-6273(02)00717-1; Wan PTC, 2004, CELL, V116, P855, DOI 10.1016/S0092-8674(04)00215-6; Wojnowski L, 1997, NAT GENET, V16, P293, DOI 10.1038/ng0797-293; Wolfer DP, 2002, TRENDS NEUROSCI, V25, P336, DOI 10.1016/S0166-2236(02)02192-6; Wulff K, 2010, NAT REV NEUROSCI, V11, P589, DOI 10.1038/nrn2868; Yacubova E, 2002, NATURE, V415, P77, DOI 10.1038/415077a; Yasuda S, 2009, MOL PSYCHIATR, V14, P51, DOI 10.1038/sj.mp.4002099; Zambrowicz BP, 2003, NAT REV DRUG DISCOV, V2, P38, DOI 10.1038/nrd987; Zhong J, 2007, NAT NEUROSCI, V10, P598, DOI 10.1038/nn1898; Zou H, 2011, GENES BRAIN BEHAV, V10, P615, DOI 10.1111/j.1601-183X.2011.00702.x	61	31	31	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2012	7	4							e35035	10.1371/journal.pone.0035035	http://dx.doi.org/10.1371/journal.pone.0035035			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959XD	22529971	Green Submitted, Green Accepted, Green Published, gold			2022-12-25	WOS:000305350600053
J	Chan, RCK; Wang, Y; Yan, C; Zhao, Q; McGrath, J; Hsi, XL; Stone, WS				Chan, Raymond C. K.; Wang, Yi; Yan, Chao; Zhao, Qing; McGrath, John; Hsi, Xiaolu; Stone, William S.			A Study of Trait Anhedonia in Non-Clinical Chinese Samples: Evidence from the Chapman Scales for Physical and Social Anhedonia	PLOS ONE			English	Article							SCHIZOTYPAL PERSONALITY FEATURES; INDIVIDUAL-DIFFERENCES; SCHIZOPHRENIA; PLEASURE; REWARD; SCHIZOTAXIA; DISORDERS; BEHAVIOR	Background: Recent studies suggest that anhedonia, an inability to experience pleasure, can be measured as an enduring trait in non-clinical samples. In order to examine trait anhedonia in a non-clinical sample, we examined the properties of a range of widely used questionnaires capturing anhedonia. Methods: 887 young adults were recruited from colleges. All of them were administered a set of checklists, including Chapman Scale for Social Anhedonia (CRSAS) and the Chapman Scale for Physical Anhedonia Scale (CPAS), The Temporal Experience of Pleasure Scale(TEPS), and The Schizotypal Personality Questionnaire (SPQ). Results: Males showed significantly higher level of physical (F = 5.09, p<0.001) and social (F = 4.38, p<0.005) anhedonia than females. As expected, individuals with schizotypal personality features also demonstrated significantly higher scores of physical (t = 3.81, p<0.001) and social (t = 7.33, p<0.001) trait anhedonia than individuals without SPD features, but no difference on self-report anticipatory and consummatory pleasure experience. Conclusions: Concerning the comparison on each item of physical and social anhedonia, the results indicated that individuals with SPD feature exhibited higher than individuals without SPD features on more items of social anhedonia than physical anhedonia scale. These preliminary findings suggested that trait anhedonia can be identified a non-clinical sample. Exploring the demographic and clinical correlates of trait anhedonia in the general population may provide clues to the pathogenesis of psychotic disorder.	[Chan, Raymond C. K.; Wang, Yi; Yan, Chao; Zhao, Qing] Chinese Acad Sci, Inst Psychol, Key Lab Mental Hlth, Neuropsychol & Appl Cognit Neurosci Lab, Beijing 100101, Peoples R China; [Wang, Yi; Yan, Chao; Zhao, Qing] Chinese Acad Sci, Grad Sch, Beijing, Peoples R China; [McGrath, John] Pk Ctr Mental Hlth, Queensland Ctr Mental Hlth Res, Wacol, Australia; [McGrath, John] Univ Queensland, Queensland Brain Inst, St Lucia, Qld, Australia; [McGrath, John] Univ Queensland, Dept Psychiat, St Lucia, Qld, Australia; [Hsi, Xiaolu] MIT, MIT Med, Cambridge, MA USA; [Hsi, Xiaolu; Stone, William S.] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Dept Psychiat, Boston, MA 02215 USA	Chinese Academy of Sciences; Institute of Psychology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Queensland Centre for Mental Health Research; University of Queensland; University of Queensland; Massachusetts Institute of Technology (MIT); Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Chan, RCK (corresponding author), Chinese Acad Sci, Inst Psychol, Key Lab Mental Hlth, Neuropsychol & Appl Cognit Neurosci Lab, Beijing 100101, Peoples R China.	rckchan@psych.ac.cn	Chan, Raymond CK/B-6717-2009; Zhao, Qing/E-3000-2010; wang, yi/AAI-8689-2020; McGrath, John Joseph/G-5493-2010	Chan, Raymond CK/0000-0002-3414-450X; wang, yi/0000-0001-6880-5831; McGrath, John Joseph/0000-0002-4792-6068	National Key Technologies RD Program [2012BAI36B01]; National Science Fund China Grant [81088001, 91132701]; Knowledge Innovation Project of the Chinese Academy of Sciences [KSCX2-EW-J-8]; Key Laboratory of Mental Health, Institute of Psychology	National Key Technologies RD Program(National Key Technology R&D Program); National Science Fund China Grant; Knowledge Innovation Project of the Chinese Academy of Sciences(Knowledge Innovation Program of the Chinese Academy of Sciences); Key Laboratory of Mental Health, Institute of Psychology	This study was supported partially by a grant from the National Key Technologies R&D Program (2012BAI36B01), the National Science Fund China Grant (81088001, 91132701), the Knowledge Innovation Project of the Chinese Academy of Sciences (KSCX2-EW-J-8), and the Key Laboratory of Mental Health, Institute of Psychology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auriacombe M, 1997, PSYCHOPHARMACOLOGY, V134, P337, DOI 10.1007/s002130050459; Berenbaum H, 2006, J ABNORM PSYCHOL, V115, P359, DOI 10.1037/0021-843X.115.2.359; Berridge KC, 1998, BRAIN RES REV, V28, P309, DOI 10.1016/S0165-0173(98)00019-8; Berridge KC, 2003, TRENDS NEUROSCI, V26, P507, DOI 10.1016/S0166-2236(03)00233-9; Berridge KC, 2008, PSYCHOPHARMACOLOGY, V199, P457, DOI 10.1007/s00213-008-1099-6; Blanchard JJ, 2011, SCHIZOPHRENIA BULL, V37, P291, DOI 10.1093/schbul/sbq104; Blanchard JJ, 2000, J ABNORM PSYCHOL, V109, P87, DOI 10.1037/0021-843X.109.1.87; Camisa KM, 2005, PSYCHIAT RES, V133, P23, DOI 10.1016/j.psychres.2004.09.002; Chan RCK, 2011, PSYCHIAT RES, V185, P340, DOI 10.1016/j.psychres.2010.06.009; Chan RCK, 2011, PSYCHIAT RES, V185, P254, DOI 10.1016/j.psychres.2009.10.008; Chan RCK, 2010, AUST NZ J PSYCHIAT, V44, P800, DOI 10.3109/00048674.2010.482920; Chan RCK, 2010, PSYCHIAT RES, V178, P208, DOI 10.1016/j.psychres.2010.03.017; Chan RCK, 2010, PSYCHIAT RES, V175, P181, DOI 10.1016/j.psychres.2009.01.020; CHAN RCK, 3 FACTOR STRUC UNPUB; Chapman L. J., 1978, REVISED PHYS A UNPUB; Eckblad M.L., 1982, REVISED SOCIAL UNPUB; Faraone SV, 2001, SCHIZOPHRENIA BULL, V27, P1; FENTON WS, 1991, ARCH GEN PSYCHIAT, V48, P978; Gard DE, 2006, J RES PERS, V40, P1086, DOI 10.1016/j.jrp.2005.11.001; Gard DE, 2007, SCHIZOPHR RES, V93, P253, DOI 10.1016/j.schres.2007.03.008; HAFNER H, 1992, EUR ARCH PSY CLIN N, V242, P109, DOI 10.1007/BF02191557; Harvey PO, 2007, MOL PSYCHIATR, V12, P767, DOI 10.1038/sj.mp.4002021; Harvey PO, 2010, J PSYCHIATR RES, V44, P707, DOI 10.1016/j.jpsychires.2009.12.008; HOLLENBECK JR, 1987, J APPL PSYCHOL, V72, P212, DOI 10.1037/0021-9010.72.2.212; Horan WP, 2007, PSYCHIAT RES, V149, P147, DOI 10.1016/j.psychres.2006.06.002; HORAN WP, 2008, SCHIZOPHR B; Kerns JG, 2006, J ABNORM PSYCHOL, V115, P418, DOI 10.1037/0021-843X.115.3.418; Kirkpatrick B, 2011, SCHIZOPHRENIA BULL, V37, P300, DOI 10.1093/schbul/sbq059; Kwapil T. R., 1998, NORMS WISCONSIN PSYC; Kwapil TR, 1998, J ABNORM PSYCHOL, V107, P558, DOI 10.1037/0021-843X.107.4.558; Marder SR, 2011, SCHIZOPHRENIA BULL, V37, P250, DOI 10.1093/schbul/sbq161; Martin EA, 2011, PSYCHIAT RES, V187, P94, DOI 10.1016/j.psychres.2010.12.028; Meehl PE, 1973, READINGS ABNORMAL PS, V17, P83; Meehl PE., 1990, J PERS DISORD, V4, P1, DOI [10.1521/pedi.1990.4.1.1, DOI 10.1521/PEDI.1990.4.1.1]; RAINE A, 1991, SCHIZOPHRENIA BULL, V17, P555, DOI 10.1093/schbul/17.4.555; Tsuang MT, 2002, SCHIZOPHR RES, V54, P169, DOI 10.1016/S0920-9964(01)00364-4; van Os J, 2009, PSYCHOL MED, V39, P179, DOI 10.1017/S0033291708003814; Xiao ZW, 2011, AIDS CARE, V23, P105, DOI 10.1080/09540121.2010.532537; Yan Chao, 2011, East Asian Arch Psychiatry, V21, P115; Zhang K, 1999, AIDS CARE, V11, P581, DOI 10.1080/09540129947730; Zong JG, 2010, SCHIZOPHR RES, V122, P185, DOI 10.1016/j.schres.2010.04.013	41	80	86	4	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2012	7	4							e34275	10.1371/journal.pone.0034275	http://dx.doi.org/10.1371/journal.pone.0034275			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959WC	22529910	Green Published, gold, Green Submitted			2022-12-25	WOS:000305347400010
J	Lepelletier, D; Ravaud, P; Baron, G; Lucet, JC				Lepelletier, Didier; Ravaud, Philippe; Baron, Gabriel; Lucet, Jean-Christophe			Agreement among Health Care Professionals in Diagnosing Case Vignette-Based Surgical Site Infections	PLOS ONE			English	Article							QUALITY-OF-CARE; SURVEILLANCE METHODS; RATES; PERFORMANCE; INPATIENTS; PNEUMONIA; HELICS	Objective: To assess agreement in diagnosing surgical site infection (SSI) among healthcare professionals involved in SSI surveillance. Methods: Case-vignette study done in 2009 in 140 healthcare professionals from seven specialties (20 in each specialty, Anesthesiologists, Surgeons, Public health specialists, Infection control physicians, Infection control nurses, Infectious diseases specialists, Microbiologists) in 29 University and 36 non-University hospitals in France. We developed 40 case-vignettes based on cardiac and gastrointestinal surgery patients with suspected SSI. Each participant scored six randomly assigned case-vignettes before and after reading the SSI definition on an online secure relational database. The intraclass correlation coefficient (ICC) was used to assess agreement regarding SSI diagnosis on a seven-point Likert scale and the kappa coefficient to assess agreement for superficial or deep SSI on a three-point scale. Results: Based on a consensus, SSI was present in 21 of 40 vignettes (52.5%). Intraspecialty agreement for SSI diagnosis ranged across specialties from 0.15 (95% confidence interval, 0.00-0.59) (anesthesiologists and infection control nurses) to 0.73 (0.32-0.90) (infectious diseases specialists). Reading the SSI definition improved agreement in the specialties with poor initial agreement. Intraspecialty agreement for superficial or deep SSI ranged from 0.10 (-0.19-0.38) to 0.54 (0.25-0.83) (surgeons) and increased after reading the SSI definition only among the infection control nurses from 0.10 (-0.19-0.38) to 0.41 (-0.09-0.72). Interspecialty agreement for SSI diagnosis was 0.36 (0.22-0.54) and increased to 0.47 (0.31-0.64) after reading the SSI definition. Conclusion: Among healthcare professionals evaluating case-vignettes for possible surgical site infection, there was large disagreement in diagnosis that varied both between and within specialties.	[Lepelletier, Didier; Lucet, Jean-Christophe] Hop Bichat Claude Bernard, Assistance Publ Hop Paris, Infect Control Unit, F-75877 Paris 18, France; [Lepelletier, Didier; Ravaud, Philippe; Baron, Gabriel; Lucet, Jean-Christophe] Univ Paris Diderot, Paris, France; [Ravaud, Philippe; Baron, Gabriel] Hop Hotel Dieu, Assistance Publ Hop Paris, Ctr Epidemiol Clin, Paris, France; [Ravaud, Philippe; Baron, Gabriel] INSERM, U738, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Hotel-Dieu - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm)	Lepelletier, D (corresponding author), Hop Bichat Claude Bernard, Assistance Publ Hop Paris, Infect Control Unit, F-75877 Paris 18, France.	jean-christophe.lucet@bch.aphp.fr	ravaud, philippe/C-1694-2009	Ravaud, Philippe/0000-0001-8264-9206	French Ministry of Health [PREQHOS 0901]	French Ministry of Health	This study was supported by the French Ministry of Health (national grant PREQHOS 0901). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Astagneau P, 2010, CURR OPIN INFECT DIS, V23, P306, DOI 10.1097/QCO.0b013e32833ae7e3; Beaujean D, 2002, EUR J CLIN MICROBIOL, V21, P444, DOI 10.1007/s10096-002-0745-x; Bonett DG, 2002, STAT MED, V21, P1331, DOI 10.1002/sim.1108; Chalfine A, 2006, INFECT CONT HOSP EP, V27, P794, DOI 10.1086/506393; Culver DH, 1991, AM J MED S3B, V91, P152, DOI DOI 10.1016/0002-9343(91)90361-Z; Edmond MB, 2007, J HOSP INFECT, V65, P182, DOI 10.1016/S0195-6701(07)60040-1; Edwards JR, 2009, AM J INFECT CONTROL, V37, P783, DOI 10.1016/j.ajic.2009.10.001; Fleiss JL, 2013, STAT METHODS RATES P; Fung CH, 2008, ANN INTERN MED, V148, P111, DOI 10.7326/0003-4819-148-2-200801150-00006; GLENISTER HM, 1993, J HOSP INFECT, V23, P229, DOI 10.1016/0195-6701(93)90028-X; Haustein T, 2011, LANCET INFECT DIS, V11, P471, DOI 10.1016/S1473-3099(10)70315-7; Hejblum G, 2008, CHEST, V133, P1107, DOI 10.1378/chest.06-3014; HORAN TC, 1992, INFECT CONT HOSP EP, V13, P606; Hospital in Europe Link for Infection Control through Surveillance, 2004, SURV SURG SIT INF; Klompas M, 2008, CLIN INFECT DIS, V46, P1443, DOI 10.1086/587103; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Lin MY, 2010, JAMA-J AM MED ASSOC, V304, P2035, DOI 10.1001/jama.2010.1637; Mangram AJ, 1999, INFECT CONT HOSP EP, V20, P250, DOI 10.1086/501620; McKibben L, 2005, INFECT CONT HOSP EP, V26, P580, DOI 10.1086/502585; Niedner MF, 2010, AM J INFECT CONTROL, V38, P585, DOI 10.1016/j.ajic.2010.04.211; Nunnaly JC, PSYCHOMETRIC THEORY; Perla RJ, 2009, AM J INFECT CONTROL, V37, P615, DOI 10.1016/j.ajic.2009.03.003; Pittet D, 2004, ANN INTERN MED, V141, P1, DOI 10.7326/0003-4819-141-1-200407060-00008; Rosenthal R, 2010, J HOSP INFECT, V75, P178, DOI 10.1016/j.jhin.2009.10.028; Seror R, 2010, ANN RHEUM DIS, V69, P1103, DOI 10.1136/ard.2009.110619; Suetens C, 2007, J HOSP INFECT, V65, P171, DOI 10.1016/S0195-6701(07)60038-3; TAYLOR G, 1990, AM J INFECT CONTROL, V18, P295, DOI 10.1016/0196-6553(90)90228-K; Wachter RM, 2008, ANN INTERN MED, V149, P29, DOI 10.7326/0003-4819-149-1-200807010-00007; Wilson AP, 2004, BRIT MED J, V14, P14; Wilson J, 2007, J HOSP INFECT, V65, P165, DOI 10.1016/S0195-6701(07)60037-1; Wong ES., 2004, HOSP EPIDEMIOLOGY IN, P287; Yokoe DS, 2004, EMERG INFECT DIS, V10, P1924, DOI 10.3201/eid1011.040572	32	13	13	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2012	7	4							e35131	10.1371/journal.pone.0035131	http://dx.doi.org/10.1371/journal.pone.0035131			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WC	22529980	Green Published, gold, Green Submitted			2022-12-25	WOS:000305347400032
J	Nadal, P; Pinto, A; Svobodova, M; Canela, N; O'Sullivan, CK				Nadal, Pedro; Pinto, Alessandro; Svobodova, Marketa; Canela, Nuria; O'Sullivan, Ciara K.			DNA Aptamers against the Lup an 1 Food Allergen	PLOS ONE			English	Article							IN-VITRO SELECTION; SINGLE-STRANDED-DNA; RNA APTAMER; HIGH ENANTIOSELECTIVITY; L-ARGININE; BIND; RECOGNITION; BIOSENSOR; PROTEINS; MOLECULES	Using in vitro selection, high affinity DNA aptamers to the food allergen Lup an 1, beta-conglutin, were selected from a pool of DNA, 93 bases in length, containing a randomised sequence of 49 bases. beta-conglutin was purified from lupin flour and chemically crosslinked to carboxylated magnetic beads. Peptide mass fingerprinting was used to confirm the presence of the beta-conglutin. Single stranded DNA was generated from the randomised pool using T7 Gene 6 Exonuclease and was subsequently incubated with the magnetic beads and the captured DNA was released and amplified prior to a further round of Systematic Evolution of Ligands by Exponential Enrichment (SELEX). Evolution was monitored using enzyme linked oligonucleotide assay and surface plasmon resonance. Once a plateau in evolution was reached, the isolated DNA sequences were cloned and sequenced. The consensus motif was identified via alignment of the sequences and the affinities of these sequences for immobilised beta-conglutin were determined using surface plasmon resonance. The selected aptamer was demonstrated to be highly specific, showing no cross-reactivity with other flour ingredients or with other conglutin fractions of lupin. The secondary structures of the selected aptamers were predicted using m-fold. Finally, the functionality of the selected aptamers was demonstrated using a competitive assay for the quantitative detection of beta-conglutin. Future work will focus on structure elucidation and truncation of the selected sequences to generate a smaller aptamer for application to the analysis of the Lup an 1 allergen in foodstuffs.	[Nadal, Pedro; Pinto, Alessandro; Svobodova, Marketa; O'Sullivan, Ciara K.] Univ Rovira & Virgili, Dept Engn Quim, Tarragona, Spain; [Canela, Nuria] Univ Rovira & Virgili, Serv Recursos Cient & Tecn, Tarragona, Spain; [O'Sullivan, Ciara K.] Inst Catalana Recerca & Estudis Avancats, Barcelona, Spain	Universitat Rovira i Virgili; Universitat Rovira i Virgili; ICREA	Nadal, P (corresponding author), Univ Rovira & Virgili, Dept Engn Quim, Tarragona, Spain.	ciara.osullivan@urv.cat	O'Sullivan, Ciara K/G-2428-2019; Sullivan, Ciara O'/U-9481-2019; pinto, alessandro/A-2762-2011; Svobodova, Marketa/L-6258-2014; Sullivan, Ciara K O'/J-8655-2014; Canela, Núria/I-5401-2015	O'Sullivan, Ciara K/0000-0003-2603-2230; pinto, alessandro/0000-0003-3369-4910; Svobodova, Marketa/0000-0001-7612-6724; Sullivan, Ciara K O'/0000-0002-0965-4655; Canela, Núria/0000-0003-0261-2396; Nadal Polo, Pedro/0000-0002-9460-0386	ICREA Funding Source: Custom	ICREA(ICREA)		[Anonymous], 2006, OFFICIAL J EUROPEA L, P110; Berens C, 2001, BIOORGAN MED CHEM, V9, P2549, DOI 10.1016/S0968-0896(01)00063-3; BOCK LC, 1992, NATURE, V355, P564, DOI 10.1038/355564a0; Cao XX, 2009, NUCLEIC ACIDS RES, V37, P4621, DOI 10.1093/nar/gkp489; Chen JH, 2012, FOOD CONTROL, V25, P555, DOI 10.1016/j.foodcont.2011.11.039; Conrad RC, 1996, METHOD ENZYMOL, V267, P336; Cowan JA, 2000, NUCLEIC ACIDS RES, V28, P2935, DOI 10.1093/nar/28.15.2935; Cox JC, 2001, BIOORGAN MED CHEM, V9, P2525, DOI 10.1016/S0968-0896(01)00028-1; Darwin Charles, 1958, ORIGIN SPECIES MEANS; Dooper MMBW, 2007, INT ARCH ALLERGY IMM, V143, P49, DOI 10.1159/000098224; Duranti M, 2008, TRENDS FOOD SCI TECH, V19, P624, DOI 10.1016/j.tifs.2008.07.002; Ecker C, 2012, FOOD CHEM, V130, P759, DOI 10.1016/j.foodchem.2011.07.100; ELLINGTON AD, 1990, NATURE, V346, P818, DOI 10.1038/346818a0; FAMULOK M, 1994, J AM CHEM SOC, V116, P1698, DOI 10.1021/ja00084a010; Geiger A, 1996, NUCLEIC ACIDS RES, V24, P1029, DOI 10.1093/nar/24.6.1029; Goggin DE, 2008, J AGR FOOD CHEM, V56, P6370, DOI 10.1021/jf800840u; Grate D, 1999, P NATL ACAD SCI USA, V96, P6131, DOI 10.1073/pnas.96.11.6131; HARUNA I, 1965, P NATL ACAD SCI USA, V54, P1189, DOI 10.1073/pnas.54.4.1189; HARUNA I, 1965, SCIENCE, V150, P884, DOI 10.1126/science.150.3698.884; HARUNA I, 1965, P NATL ACAD SCI USA, V54, P579, DOI 10.1073/pnas.54.2.579; Holden L, 2007, J AGR FOOD CHEM, V55, P2536, DOI 10.1021/jf063320w; Huang HP, 2009, ELECTROCHEM COMMUN, V11, P816, DOI 10.1016/j.elecom.2009.01.009; HUIZENGA DE, 1995, BIOCHEMISTRY-US, V34, P656, DOI 10.1021/bi00002a033; Jappe U, 2010, MOL NUTR FOOD RES, V54, P113, DOI 10.1002/mnfr.200900365; Keefe AD, 2010, NAT REV DRUG DISCOV, V9, P537, DOI 10.1038/nrd3141; Kikin O, 2006, NUCLEIC ACIDS RES, V34, pW676, DOI 10.1093/nar/gkl253; Kwon M, 2001, MOL CELLS, V11, P303; Lee YJ, 2012, BIOCHEM BIOPH RES CO, V417, P414, DOI 10.1016/j.bbrc.2011.11.130; McKeague M, 2010, INT J MOL SCI, V11, P4864, DOI 10.3390/ijms11124864; Mehta J, 2011, J BIOTECHNOL, V155, P361, DOI 10.1016/j.jbiotec.2011.06.043; MILLS DR, 1967, P NATL ACAD SCI USA, V58, P217, DOI 10.1073/pnas.58.1.217; Nadal P, 2011, J AGR FOOD CHEM, V59, P2752, DOI 10.1021/jf104062d; NIKIFOROV TT, 1994, NUCLEIC ACIDS RES, V22, P4167, DOI 10.1093/nar/22.20.4167; Ohk SH, 2010, J APPL MICROBIOL, V109, P808, DOI 10.1111/j.1365-2672.2010.04709.x; Potty ASR, 2011, INT J BIOL MACROMOL, V48, P392, DOI 10.1016/j.ijbiomac.2010.12.007; ROBERTSON DL, 1990, NATURE, V344, P467, DOI 10.1038/344467a0; SASSANFAR M, 1993, NATURE, V364, P550, DOI 10.1038/364550a0; SCHNEIDER DJ, 1995, BIOCHEMISTRY-US, V34, P9599, DOI 10.1021/bi00029a037; Shoji A, 2007, J AM CHEM SOC, V129, P1456, DOI 10.1021/ja067098n; Singh G, 2012, ECOTOXICOLO IN PRESS; Song KM, 2011, ANAL BIOCHEM, V415, P175, DOI 10.1016/j.ab.2011.04.007; Su W, 2012, BIOSENS BIOELECTRON, V32, P32, DOI 10.1016/j.bios.2011.11.009; TUERK C, 1990, SCIENCE, V249, P505, DOI 10.1126/science.2200121; Zhou J, 2010, ANAL BIOANAL CHEM, V398, P2471, DOI 10.1007/s00216-010-3987-y; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	45	108	113	1	85	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2012	7	4							e35253	10.1371/journal.pone.0035253	http://dx.doi.org/10.1371/journal.pone.0035253			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WC	22529997	gold, Green Submitted, Green Published			2022-12-25	WOS:000305347400039
J	Verma, D; Sarndahl, E; Andersson, H; Eriksson, P; Fredrikson, M; Jonsson, JI; Lerm, M; Soderkvist, P				Verma, Deepti; Sarndahl, Eva; Andersson, Henrik; Eriksson, Per; Fredrikson, Mats; Jonsson, Jan-Ingvar; Lerm, Maria; Soderkvist, Peter			The Q705K Polymorphism in NLRP3 Is a Gain-of-Function Alteration Leading to Excessive Interleukin-1 beta and IL-18 Production	PLOS ONE			English	Article							NF-KAPPA-B; FAMILIAL MEDITERRANEAN FEVER; CIAS1 MUTATIONS; CUTTING EDGE; RHEUMATOID-ARTHRITIS; PERIODIC SYNDROME; INFLAMMASOME ACTIVATION; PROCESSING INFLAMMASOME; IL-1-BETA SECRETION; NALP3 INFLAMMASOME	Background: The Q705K polymorphism in NLRP3 has been implicated in several chronic inflammatory diseases. In this study we determine the functional role of this commonly occurring polymorphism using an in-vitro system. Principal Findings: NLRP3-WT and NLRP3-Q705K were retrovirally transduced into the human monocytic cell line THP-1, followed by the assessment of IL-1 beta and IL-18 levels in the cell culture supernatant. THP-1 cells expressing the above NLRP3 variants were sorted based upon Green Fluorescent Protein (GFP) expression. Cytokine response to alum (one of the most widely used adjuvants in vaccines) in the cells stably expressing NLRP3-WT and NLRP3-Q705K were determined. IL-1 beta and IL-18 levels were found to be elevated in THP-1 cells transduced with NLRP3-Q705K compared to the NLRP3-WT. Upon exposure to alum, THP-1 cells stably expressing NLRP3-Q705K displayed an increased release of IL-1 beta, IL-18 and TNF-alpha, in a caspase-1 and IL-1 receptor-dependent manner. Conclusions: Collectively, these findings show that the Q705K polymorphism in NLRP3 is a gain-of-function alteration leading to an overactive NLRP3 inflammasome. The option of IL-1 beta blockade may be considered in patients with chronic inflammatory disorders that are unresponsive to conventional treatments.	[Verma, Deepti; Soderkvist, Peter] Linkoping Univ, Fac Hlth Sci, Dept Clin & Expt Med, Div Cell Biol, Linkoping, Sweden; [Sarndahl, Eva] Univ Orebro, Dept Clin Med, Sch Hlth & Med Sci, Orebro, Sweden; [Andersson, Henrik; Jonsson, Jan-Ingvar; Lerm, Maria] Linkoping Univ, Fac Hlth Sci, Div Microbiol & Mol Med, Dept Clin & Expt Med, Linkoping, Sweden; [Eriksson, Per] Linkoping Univ, Fac Hlth Sci, Div Rheumatol, Dept Clin & Expt Med, Linkoping, Sweden; [Fredrikson, Mats] Linkoping Univ, Fac Hlth Sci, Div Occupat & Environm Med, Dept Clin & Expt Med, Linkoping, Sweden	Linkoping University; Orebro University; Linkoping University; Linkoping University; Linkoping University	Verma, D (corresponding author), Linkoping Univ, Fac Hlth Sci, Dept Clin & Expt Med, Div Cell Biol, Linkoping, Sweden.	deepti.verma@liu.se	Lerm, Maria/AAA-1780-2020; Verma, Deepti/AAI-9039-2020; Lerm, Maria/AAM-8705-2020	Lerm, Maria/0000-0002-5092-9892; Andersson, Henrik/0000-0002-6020-5177	Medical Research Council of Southeast Sweden [FORSS-8984]; County Council of Ostergotland; King Gustaf V Memorial Foundation; Swedish Research Council [529-2003-5994, 2005-7046, 2007-2673, 2009-3821, K2010-64X-21463-01-3, K2010-57X-21435-01-3, K2010-55X-20451-04-03]	Medical Research Council of Southeast Sweden(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); County Council of Ostergotland; King Gustaf V Memorial Foundation; Swedish Research Council(Swedish Research CouncilEuropean Commission)	Funding for this study was provided by grants from the Medical Research Council of Southeast Sweden (FORSS-8984), the County Council of Ostergotland, King Gustaf V Memorial Foundation and the Swedish Research Council (ML, #529-2003-5994, #2005-7046, #2007-2673, #2009-3821, JIJ K2010-64X-21463-01-3, ES K2010-57X-21435-01-3, PS, K2010-55X-20451-04-03). The founders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agostini L, 2004, IMMUNITY, V20, P319, DOI 10.1016/S1074-7613(04)00046-9; Aksentijevich I, 2002, ARTHRITIS RHEUM-US, V46, P3340, DOI 10.1002/art.10688; Aksentijevich I, 2007, ARTHRITIS RHEUM-US, V56, P1273, DOI 10.1002/art.22491; Allen IC, 2009, IMMUNITY, V30, P556, DOI 10.1016/j.immuni.2009.02.005; ALTOMONTE L, 1992, CLIN RHEUMATOL, V11, P202, DOI 10.1007/BF02207957; Barker BR, 2011, CURR OPIN IMMUNOL, V23, P591, DOI 10.1016/j.coi.2011.07.005; Bauernfeind FG, 2009, J IMMUNOL, V183, P787, DOI 10.4049/jimmunol.0901363; Blomgran JR BP, 2012, PLOS ONE IN PRESS; Bodar EJ, 2009, BRIT J HAEMATOL, V144, P279, DOI 10.1111/j.1365-2141.2008.07036.x; Born TL, 1998, J BIOL CHEM, V273, P29445, DOI 10.1074/jbc.273.45.29445; Burns K, 2003, J EXP MED, V197, P263, DOI 10.1084/jem.20021790; Dinarello CA, 2000, NEW ENGL J MED, V343, P732, DOI 10.1056/NEJM200009073431011; Dinarello CA, 1996, BLOOD, V87, P2095, DOI 10.1182/blood.V87.6.2095.bloodjournal8762095; DINARELLO CA, 1987, J IMMUNOL, V139, P1902; Dowds TA, 2004, J BIOL CHEM, V279, P21924, DOI 10.1074/jbc.M401178200; Duncan JA, 2007, P NATL ACAD SCI USA, V104, P8041, DOI 10.1073/pnas.0611496104; Eisenbarth SC, 2008, NATURE, V453, P1122, DOI 10.1038/nature06939; Eliasson P, 2010, EXP HEMATOL, V38, P301, DOI 10.1016/j.exphem.2010.01.005; Fontalba A, 2007, J IMMUNOL, V179, P4867, DOI 10.4049/jimmunol.179.7.4867; Franchi L, 2008, EUR J IMMUNOL, V38, P2085, DOI 10.1002/eji.200838549; Franchi L, 2009, J IMMUNOL, V183, P792, DOI 10.4049/jimmunol.0900173; Gattorno M, 2007, ARTHRITIS RHEUM, V56, P3138, DOI 10.1002/art.22842; Gershoni-Baruch R, 2002, EUR J HUM GENET, V10, P145, DOI 10.1038/sj.ejhg.5200776; Greten FR, 2007, CELL, V130, P918, DOI 10.1016/j.cell.2007.07.009; Hasegawa M, 2005, J BIOL CHEM, V280, P15122, DOI 10.1074/jbc.M412284200; ISSAID, 2003, INF; Kastbom A, 2008, RHEUMATOLOGY, V47, P415, DOI 10.1093/rheumatology/kem372; Kastner Daniel L, 2005, Hematology Am Soc Hematol Educ Program, P74; Li HF, 2008, J IMMUNOL, V181, P17, DOI 10.4049/jimmunol.181.1.17; Li HF, 2007, J IMMUNOL, V178, P5271, DOI 10.4049/jimmunol.178.8.5271; Li XX, 2005, J MOL MED, V83, P258, DOI 10.1007/s00109-004-0622-4; Lindblad EB, 2004, IMMUNOL CELL BIOL, V82, P497, DOI 10.1111/j.0818-9641.2004.01286.x; Martinon F, 2004, CURR BIOL, V14, P1929, DOI 10.1016/j.cub.2004.10.027; Masumoto J, 2003, BIOCHEM BIOPH RES CO, V303, P69, DOI 10.1016/S0006-291X(03)00309-7; Ozen S, 2009, ANN RHEUM DIS, V68, P246, DOI 10.1136/ard.2008.092031; Pontillo A, 2010, AUTOIMMUNITY, V43, P583, DOI 10.3109/08916930903540432; Pontillo A, 2011, AM J GASTROENTEROL, V106, P539, DOI 10.1038/ajg.2010.474; Roberts RL, 2010, GENES IMMUN, V11, P351, DOI 10.1038/gene.2010.11; Rosengren S, 2007, J ALLERGY CLIN IMMUN, V119, P991, DOI 10.1016/j.jaci.2006.12.649; Schoultz I, 2009, AM J GASTROENTEROL, V104, P1180, DOI 10.1038/ajg.2009.29; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; Singh-Grewal D, 2007, ANN RHEUM DIS, V66, P1541, DOI 10.1136/ard.2007.075655; Stojanov Silvia, 2005, Expert Reviews in Molecular Medicine, V7, P1, DOI 10.1017/S1462399405009749; Taxman DJ, 2006, J IMMUNOL, V177, P4252, DOI 10.4049/jimmunol.177.7.4252; Ting TV, 2007, PEDIATR NEUROL, V36, P338, DOI 10.1016/j.pediatrneurol.2006.12.008; Touitou I, 2006, ANN RHEUM DIS, V65, P1530, DOI 10.1136/ard.2006.054312; Touitou I, 2007, ARTHRITIS RHEUM, V56, P1706, DOI 10.1002/art.22507; van den Berg WB, 2000, ANN RHEUM DIS, V59, P81, DOI 10.1136/ard.59.suppl_1.i81; Verma D, 2008, ARTHRITIS RHEUM, V58, P888, DOI 10.1002/art.23286; Verma D, 2010, ARTHRITIS RHEUM-US, V62, P2138, DOI 10.1002/art.27489; Willingham SB, 2007, CELL HOST MICROBE, V2, P147, DOI 10.1016/j.chom.2007.07.009	51	104	105	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2012	7	4							e34977	10.1371/journal.pone.0034977	http://dx.doi.org/10.1371/journal.pone.0034977			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WC	22529966	Green Published, gold, Green Submitted			2022-12-25	WOS:000305347400028
J	Driscoll, I; Martin, B; An, Y; Maudsley, S; Ferrucci, L; Mattson, MP; Resnick, SM				Driscoll, Ira; Martin, Bronwen; An, Yang; Maudsley, Stuart; Ferrucci, Luigi; Mattson, Mark P.; Resnick, Susan M.			Plasma BDNF Is Associated with Age-Related White Matter Atrophy but Not with Cognitive Function in Older, Non-Demented Adults	PLOS ONE			English	Article							FACTOR VAL66MET POLYMORPHISM; NEUROTROPHIC FACTOR; ENERGY RESTRICTION; HIPPOCAMPAL; VOLUME; HEALTHY; WEIGHT; IMPACT; IMPAIRMENT; DEPRESSION	Brain derived neurotrophic factor (BDNF) seems to be involved in regulation of synaptic plasticity and neurogenesis. BDNF plasma and serum levels have been associated with depression, Alzheimer's disease, and other psychiatric and neurodegenerative disorders. In a community sample, drawn from the Baltimore Longitudinal Study of Aging (BLSA), we examined whether BDNF plasma concentration was associated with rates of age-related change in cognitive performance (n = 429) and regional brain volume (n = 59). Plasma BDNF levels, which were significantly higher in females (p<0.05), were not associated with either concurrent cognitive performance or rates of age-related change in performance across cognitive domains (p's>0.05). Sex differences in the relationship between BDNF and the trajectories of regional brain volume changes were observed for the whole brain and frontal white matter volumes (p<0.05), whereby lower plasma BDNF was associated with steeper volume decline in females but not males. Together, our findings contribute to furthering the understanding of the relationships between plasma BDNF, structural brain integrity and cognition. Potential mechanisms mediating these relationships merit further investigation.	[Driscoll, Ira; An, Yang; Resnick, Susan M.] NIA, Lab Behav Neurosci, Baltimore, MD 21224 USA; [Driscoll, Ira] Univ Wisconsin Milwaukee, Dept Psychol, Milwaukee, WI USA; [Martin, Bronwen] NIA, Clin Invest Lab, Baltimore, MD 21224 USA; [Maudsley, Stuart; Mattson, Mark P.] NIA, Neurosci Lab, Baltimore, MD 21224 USA; [Ferrucci, Luigi] NIA, Clin Res Branch, Baltimore, MD 21224 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); University of Wisconsin System; University of Wisconsin Milwaukee; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	Driscoll, I (corresponding author), NIA, Lab Behav Neurosci, Baltimore, MD 21224 USA.	driscoli@uwm.edu	Maudsley, Stuart/AAV-9929-2021; Maudsley, Stuart/Q-4782-2019	Maudsley, Stuart/0000-0002-1868-184X; Martin, Bronwen/0000-0002-9185-6925	Intramural Research Program of the National Institute on Aging; NATIONAL INSTITUTE ON AGING [ZIAAG000916, ZIAAG000015, ZIAAG000319, ZIAAG000318, ZIAAG000915, ZIAAG000191, ZIAAG000331, ZIAAG000917, ZIAAG000312, ZIAAG000325] Funding Source: NIH RePORTER	Intramural Research Program of the National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This research was supported by the Intramural Research Program of the National Institute on Aging. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BENTON AL, 1968, NEUROPSYCHOLOGIA, V6, P53, DOI 10.1016/0028-3932(68)90038-9; Brunoni AR, 2008, INT J NEUROPSYCHOPH, V11, P1169, DOI 10.1017/S1461145708009309; Bueller JA, 2006, BIOL PSYCHIAT, V59, P812, DOI 10.1016/j.biopsych.2005.09.022; Carlson O, 2007, METABOLISM, V56, P1729, DOI 10.1016/j.metabol.2007.07.018; Cirulli F, 2011, PSYCHONEUROENDOCRINO, V36, P372, DOI 10.1016/j.psyneuen.2010.10.019; Davatzikos C, 2001, NEUROIMAGE, V14, P1361, DOI 10.1006/nimg.2001.0937; DEFRIES JC, 1974, SCIENCE, V183, P338, DOI 10.1126/science.183.4122.338; Delis DC., 2000, CALIFORNIA VERBAL LE; Driscoll I, 2006, ANN NEUROL, V60, P688, DOI 10.1002/ana.21031; Erickson KI, 2010, J NEUROSCI, V30, P5368, DOI 10.1523/JNEUROSCI.6251-09.2010; Golden E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010099; Goldszal AF, 1998, J COMPUT ASSIST TOMO, V22, P827, DOI 10.1097/00004728-199809000-00030; GROBER E, 1987, DEV NEUROPSYCHOL, V3, P13, DOI 10.1080/87565648709540361; Grundman M, 2002, J MOL NEUROSCI, V19, P23, DOI 10.1007/s12031-002-0006-6; Gunstad J, 2008, J GERIATR PSYCH NEUR, V21, P166, DOI 10.1177/0891988708316860; Harrell FE, 2001, REGRESSION MODELING; HARTLEY HO, 1967, BIOMETRIKA, V54, P93, DOI 10.1093/biomet/54.1-2.93; Harvie MN, 2011, INT J OBESITY, V35, P714, DOI 10.1038/ijo.2010.171; Husson I, 2005, CEREB CORTEX, V15, P250, DOI 10.1093/cercor/bhh127; Johnson JB, 2007, FREE RADICAL BIO MED, V42, P665, DOI 10.1016/j.freeradbiomed.2006.12.005; Kapczinski F, 2011, J PSYCHIATR RES, V45, P156, DOI 10.1016/j.jpsychires.2010.05.015; Komulainen P, 2008, NEUROBIOL LEARN MEM, V90, P596, DOI 10.1016/j.nlm.2008.07.014; LAIRD NM, 1982, BIOMETRICS, V38, P963, DOI 10.2307/2529876; Lee HY, 2008, NEUROPSYCHOBIOLOGY, V57, P194, DOI 10.1159/000149817; Li G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005424; Lommatzsch M, 2005, NEUROBIOL AGING, V26, P115, DOI 10.1016/j.neurobiolaging.2004.03.002; Martin B, 2007, ENDOCRINOLOGY, V148, P4318, DOI 10.1210/en.2007-0161; Mattson MP, 2004, TRENDS NEUROSCI, V27, P589, DOI 10.1016/j.tins.2004.08.001; Mattson MP, 2004, AGEING RES REV, V3, P445, DOI 10.1016/j.arr.2004.08.001; Meltser I, 2008, J CLIN INVEST, V118, P1563, DOI 10.1172/JCI32796; Mercader JM, 2007, GENES BRAIN BEHAV, V6, P706, DOI 10.1111/j.1601-183X.2007.00301.x; Newcombe F., 1969, MISSILE WOUNDS BRAIN; Petersen RC, 2004, J INTERN MED, V256, P183, DOI 10.1111/j.1365-2796.2004.01388.x; Pezawas L, 2004, J NEUROSCI, V24, P10099, DOI 10.1523/JNEUROSCI.2680-04.2004; Piccinni A, 2008, CHRONOBIOL INT, V25, P819, DOI 10.1080/07420520802387773; Reitan RM, 1992, TRAIL MAKING TEST MA; Resnick SM, 2000, CEREB CORTEX, V10, P464, DOI 10.1093/cercor/10.5.464; Rybakowski JK, 2006, MOL PSYCHIATR, V11, P122, DOI 10.1038/sj.mp.4001765; Sasahara K, 2007, J NEUROSCI, V27, P7408, DOI 10.1523/JNEUROSCI.0710-07.2007; Savitz J, 2006, GENES BRAIN BEHAV, V5, P311, DOI 10.1111/j.1601-183X.2005.00163.x; Savitz JB, 2009, NEUROSCIENCE, V164, P300, DOI 10.1016/j.neuroscience.2009.03.082; Shen DG, 2002, IEEE T MED IMAGING, V21, P1421, DOI 10.1109/TMI.2002.803111; SHOCK NW, 1984, 842450 NIH; Szeszko PR, 2005, MOL PSYCHIATR, V10, P631, DOI 10.1038/sj.mp.4001656; Terracciano A, 2010, GENES BRAIN BEHAV, V9, P512, DOI 10.1111/j.1601-183X.2010.00579.x; Trajkovska V, 2007, BRAIN RES BULL, V73, P143, DOI 10.1016/j.brainresbull.2007.03.009; van Haren NE, 2008, CURR OPIN PSYCHIATR, V21, P161, DOI 10.1097/YCO.0b013e3282f4f25b; Wechsler D., 1997, WAIS 3 WECHSLER ADUL, V3rd, DOI 10.1111/j.1749-6632.1989.tb21005.x; Weinstock-Guttman B, 2007, J NEUROIMMUNOL, V188, P167, DOI 10.1016/j.jneuroim.2007.06.003; Wilson JR, 1978, SEXUAL BEHAV, P317; Young E A, 1998, J Gend Specif Med, V1, P21; ZONDERMAN AB, 1995, ARCH CLIN NEUROPSYCH, V10, P111, DOI 10.1016/0887-6177(94)00040-9	52	77	77	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2012	7	4							e35217	10.1371/journal.pone.0035217	http://dx.doi.org/10.1371/journal.pone.0035217			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VO	22523577	gold, Green Submitted, Green Published			2022-12-25	WOS:000305345000049
J	Raz, S; Graham, JH; Cohen, A; de Bivort, BL; Grishkan, I; Nevo, E				Raz, Shmuel; Graham, John H.; Cohen, Ayelet; de Bivort, Benjamin L.; Grishkan, Isabella; Nevo, Eviatar			Growth and Asymmetry of Soil Microfungal Colonies from "Evolution Canyon," Lower Nahal Oren, Mount Carmel, Israel	PLOS ONE			English	Article							FLUCTUATING ASYMMETRY; DEVELOPMENTAL STABILITY; DROSOPHILA-MELANOGASTER; INTERSLOPE DIVERGENCE; VASCULAR PLANTS; BIODIVERSITY; PATTERNS; STRESS; SIZE; INSTABILITY	Background: Fluctuating asymmetry is a contentious indicator of stress in populations of animals and plants. Nevertheless, it is a measure of developmental noise, typically obtained by measuring asymmetry across an individual organism's left-right axis of symmetry. These individual, signed asymmetries are symmetrically distributed around a mean of zero. Fluctuating asymmetry, however, has rarely been studied in microorganisms, and never in fungi. Objective and Methods: We examined colony growth and random phenotypic variation of five soil microfungal species isolated from the opposing slopes of "Evolution Canyon," Mount Carmel, Israel. This canyon provides an opportunity to study diverse taxa inhabiting a single microsite, under different kinds and intensities of abiotic and biotic stress. The south-facing "African" slope of "Evolution Canyon" is xeric, warm, and tropical. It is only 200 m, on average, from the north-facing "European" slope, which is mesic, cool, and temperate. Five fungal species inhabiting both the south-facing "African" slope, and the north-facing "European" slope of the canyon were grown under controlled laboratory conditions, where we measured the fluctuating radial asymmetry and sizes of their colonies. Results: Different species displayed different amounts of radial asymmetry (and colony size). Moreover, there were highly significant slope by species interactions for size, and marginally significant ones for fluctuating asymmetry. There were no universal differences (i.e., across all species) in radial asymmetry and colony size between strains from "African" and "European" slopes, but colonies of Clonostachys rosea from the "African" slope were more asymmetric than those from the "European" slope. Conclusions and Significance: Our study suggests that fluctuating radial asymmetry has potential as an indicator of random phenotypic variation and stress in soil microfungi. Interaction of slope and species for both growth rate and asymmetry of microfungi in a common environment is evidence of genetic differences between the "African" and "European" slopes of "Evolution Canyon."	[Raz, Shmuel; Cohen, Ayelet; Grishkan, Isabella; Nevo, Eviatar] Univ Haifa, Inst Evolut, Dept Evolutionary & Environm Biol, IL-31999 Haifa, Israel; [Graham, John H.] Berry Coll, Dept Biol, Mt Berry, GA USA; [Raz, Shmuel; de Bivort, Benjamin L.] Harvard Univ, Rowland Inst Harvard, Cambridge, MA 02138 USA	University of Haifa; Harvard University	Raz, S (corresponding author), Univ Haifa, Inst Evolut, Dept Evolutionary & Environm Biol, IL-31999 Haifa, Israel.	razshmu@gmail.com	רז, שמואל/ABD-3478-2021	Graham, John/0000-0003-1974-132X				Ashford AE, 2002, PLANT SOIL, V244, P177, DOI 10.1023/A:1020271121683; BOX GEP, 1964, J ROY STAT SOC B, V26, P211, DOI 10.1111/j.2517-6161.1964.tb00553.x; Carlile MJ, 1994, GROWING FUNGUS, P3; Clausen J., 1940, CARNEGIE I WASH PUBL, V1, P452; Cowart NM, 1999, INT J PLANT SCI, V160, P116, DOI 10.1086/314104; Davet P, 2000, DETECTION ISOLATION; Debat V, 2006, EVOLUTION, V60, P2529, DOI 10.1554/06-045.1; Derzhavets Elena, 1997, Drosophila Information Service, V80, P73; Domsch KH, 2007, COMPENDIUM SOIL FUNG; Ellanskaya IA, 1997, MICROBIOS, V92, P19; Freeman D. Carl, 2003, P367; Garcia D, 2010, FOOD MICROBIOL, V27, P909, DOI 10.1016/j.fm.2010.05.015; Graham JH, 2003, BIOL J LINN SOC, V80, P57, DOI 10.1046/j.1095-8312.2003.00220.x; GRAHAM JH, 1993, AM SOC TEST MATER, V1179, P136, DOI 10.1520/STP19239S; GRAHAM JH, 1985, EVOLUTION, V39, P104, DOI 10.1111/j.1558-5646.1985.tb04083.x; Graham JH, 2010, SYMMETRY-BASEL, V2, P466, DOI 10.3390/sym2020466; Grishkan I, 2000, ISRAEL J PLANT SCI, V48, P297, DOI 10.1560/LAJV-KKNY-F0HD-59KG; JONES JS, 1987, NATURE, V325, P298, DOI 10.1038/325298a0; Kennington WJ, 2003, EVOLUTION, V57, P932, DOI 10.1111/j.0014-3820.2003.tb00304.x; Lamb BC, 1998, GENETICS, V149, P87; Lavie B., 1993, Barley Genetics Newsletter, V23, P12; Leamy LJ, 2005, ANNU REV ECOL EVOL S, V36, P1, DOI 10.1146/annurev.ecolsys.36.102003.152640; Leamy LJ, 2002, EVOLUTION, V56, P642, DOI 10.1111/j.0014-3820.2002.tb01373.x; MATHER K, 1953, HEREDITY, V7, P297, DOI 10.1038/hdy.1953.41; Midgley GF, 1998, PLANT CELL ENVIRON, V21, P437, DOI 10.1046/j.1365-3040.1998.00274.x; MOLLER AP, 1994, J EVOLUTION BIOL, V7, P97, DOI 10.1046/j.1420-9101.1994.7010097.x; Nevo E, 1999, ISR J PLANT SCI, V47, P49, DOI 10.1080/07929978.1999.10676751; NEVO E, 1995, P ROY SOC B-BIOL SCI, V262, P149, DOI 10.1098/rspb.1995.0189; Nevo E, 1997, THEOR POPUL BIOL, V52, P231, DOI 10.1006/tpbi.1997.1330; Nevo E, 1996, ISR J ZOOL, V42, P395; Nevo E, 2001, P NATL ACAD SCI USA, V98, P6233, DOI 10.1073/pnas.101109298; Nevo E., 2009, TRENDS EVOL BIOL, V1, P3; Nevo E, 2006, ISR J ECOL EVOL, V52, P485; Palmer A. Richard, 2003, P279; PALMER AR, 1986, ANNU REV ECOL SYST, V17, P391, DOI 10.1146/annurev.es.17.110186.002135; PARSONS PA, 1992, HEREDITY, V68, P361, DOI 10.1038/hdy.1992.51; Pavlicek Tomas, 2003, Israel Journal of Earth Sciences, V52, P1, DOI 10.1560/QD0A-9T22-4FGL-FGH6; Pelabon C, 2004, EVOLUTION, V58, P504, DOI 10.1111/j.0014-3820.2004.tb01674.x; Polak M., 2003, CAUSES CONSEQUENCES; Rayner ADM, 1994, GROWING FUNGUS, P21; Raz S, 2011, BIOL J LINN SOC, V102, P786, DOI 10.1111/j.1095-8312.2011.01615.x; Raz S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005214; Ritchie F, 2006, MYCOL RES, V110, P725, DOI 10.1016/j.mycres.2006.04.008; Ritz K., 2004, Mycologist, V18, P52, DOI 10.1017/S0269915X04002010; Sangster TA, 2008, P NATL ACAD SCI USA, V105, P2963, DOI 10.1073/pnas.0712200105; Santos M, 2002, J EVOLUTION BIOL, V15, P720, DOI 10.1046/j.1420-9101.2002.00450.x; Singaravelan N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002993; VANVALEN L, 1962, EVOLUTION, V16, P125; Waddington C., 1957, STRATEGY GENES; Zakharov V.M., 1989, Soviet Scientific Reviews Section F Physiology and General Biology Reviews, V4, P1	50	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2012	7	4							e34689	10.1371/journal.pone.0034689	http://dx.doi.org/10.1371/journal.pone.0034689			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VO	22523554	Green Published, gold, Green Submitted			2022-12-25	WOS:000305345000025
J	Yadavalli, V; Jolley, CC; Malleda, C; Thangaraj, B; Fromme, P; Subramanyam, R				Yadavalli, Venkateswarlu; Jolley, Craig C.; Malleda, Chandramouli; Thangaraj, Balakumar; Fromme, Petra; Subramanyam, Rajagopal			Alteration of Proteins and Pigments Influence the Function of Photosystem I under Iron Deficiency from Chlamydomonas reinhardtii	PLOS ONE			English	Article							LIGHT-HARVESTING COMPLEX; MANGANESE SUPEROXIDE-DISMUTASE; PSI-LHCI; EXCITATION DYNAMICS; THYLAKOID MEMBRANES; SYNECHOCOCCUS-SP; SUPERCOMPLEX; CORE; ORGANIZATION; BINDING	Background: Iron is an essential micronutrient for all organisms because it is a component of enzyme cofactors that catalyze redox reactions in fundamental metabolic processes. Even though iron is abundant on earth, it is often present in the insoluble ferric [Fe (III)] state, leaving many surface environments Fe-limited. The haploid green alga Chlamydomonas reinhardtii is used as a model organism for studying eukaryotic photosynthesis. This study explores structural and functional changes in PSI-LHCI supercomplexes under Fe deficiency as the eukaryotic photosynthetic apparatus adapts to Fe deficiency. Results: 77K emission spectra and sucrose density gradient data show that PSI and LHCI subunits are affected under iron deficiency conditions. The visible circular dichroism (CD) spectra associated with strongly-coupled chlorophyll dimers increases in intensity. The change in CD signals of pigments originates from the modification of interactions between pigment molecules. Evidence from sucrose gradients and non-denaturing (green) gels indicates that PSI-LHCI levels were reduced after cells were grown for 72 h in Fe-deficient medium. Ultrafast fluorescence spectroscopy suggests that red-shifted pigments in the PSI-LHCI antenna were lost during Fe stress. Further, denaturing gel electrophoresis and immunoblot analysis reveals that levels of the PSI subunits PsaC and PsaD decreased, while PsaE was completely absent after Fe stress. The light harvesting complexes were also susceptible to iron deficiency, with Lhca1 and Lhca9 showing the most dramatic decreases. These changes in the number and composition of PSI-LHCI supercomplexes may be caused by reactive oxygen species, which increase under Fe deficiency conditions. Conclusions: Fe deficiency induces rapid reduction of the levels of photosynthetic pigments due to a decrease in chlorophyll synthesis. Chlorophyll is important not only as a light-harvesting pigment, but also has a structural role, particularly in the pigment-rich LHCI subunits. The reduced level of chlorophyll molecules inhibits the formation of large PSI-LHCI supercomplexes, further decreasing the photosynthetic efficiency.	[Yadavalli, Venkateswarlu; Malleda, Chandramouli] Univ Hyderabad, Sch Life Sci, Dept Biochem, Hyderabad 500134, Andhra Pradesh, India; [Jolley, Craig C.; Thangaraj, Balakumar; Fromme, Petra] Arizona State Univ, Ctr Bioenergy & Photosynth, Dept Chem & Biochem, Tempe, AZ USA; [Subramanyam, Rajagopal] Univ Hyderabad, Sch Life Sci, Dept Plant Sci, Hyderabad 500134, Andhra Pradesh, India	University of Hyderabad; Arizona State University; Arizona State University-Tempe; University of Hyderabad	Yadavalli, V (corresponding author), Univ Hyderabad, Sch Life Sci, Dept Biochem, Hyderabad 500134, Andhra Pradesh, India.	psrajagopal@yahoo.com	thangaraj, balakumar/M-7831-2015	Fromme, Petra/0000-0003-0953-4909	Council of Scientific and Industrial Research [38(1279)/11/EMR-II]; Department of Biotechnology [BT/PR11277/GBD/27/152/2008]; Department of Science and Technology [SR/SO/BB-34/2006, SR/FT/L-89/2006]; University of Hyderabad-Centre for Education and Research in Biology and Biotechnology; University Grand Commission, India; National Science Foundation [MCB-0417142]	Council of Scientific and Industrial Research(Council of Scientific & Industrial Research (CSIR) - India); Department of Biotechnology; Department of Science and Technology(Department of Science & Technology (India)); University of Hyderabad-Centre for Education and Research in Biology and Biotechnology; University Grand Commission, India; National Science Foundation(National Science Foundation (NSF))	This work was supported by Council of Scientific and Industrial Research (No. 38(1279)/11/EMR-II), and Department of Biotechnology (BT/PR11277/GBD/27/152/2008), Department of Science and Technology (SR/SO/BB-34/2006 and SR/FT/L-89/2006, FIST), University of Hyderabad-Centre for Education and Research in Biology and Biotechnology, University Grand Commission-special assistant programme, India to RS and the National Science Foundation under Grant No. MCB-0417142 to PF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amunts A, 2007, NATURE, V447, P58, DOI 10.1038/nature05687; Andaluz S, 2006, PHOTOSYNTH RES, V89, P141, DOI 10.1007/s11120-006-9092-6; Banowetz GM, 2004, ANAL BIOCHEM, V332, P314, DOI 10.1016/j.ab.2004.06.015; BASSI R, 1987, EUR J BIOCHEM, V163, P221, DOI 10.1111/j.1432-1033.1987.tb10791.x; Batsmanova L M, 2008, Ukr Biokhim Zh (1999), V80, P101; BAUM JA, 1979, DIFFERENTIATION, V13, P133, DOI 10.1111/j.1432-0436.1979.tb01576.x; Beauchamp Charles, ANAL BIOCHEM, V44, P276, DOI [10.1016/0003-2697(71)90370-8, DOI 10.1016/0003-2697(71)90370-8]; Briat JF, 2007, CURR OPIN PLANT BIOL, V10, P276, DOI 10.1016/j.pbi.2007.04.003; Chang-Quan W, 2008, ACTA PHYSIOL PLANT, V30, P841, DOI 10.1007/s11738-008-0189-8; Chauhan D, 2011, BIOCHEMISTRY-US, V50, P686, DOI 10.1021/bi1009425; Chen CN, 1996, BOT BULL ACAD SINICA, V37, P107; CHITNIS PR, 1995, PHOTOSYNTH RES, V44, P23, DOI 10.1007/BF00018294; CHO HM, 1984, BIOPHYS J, V45, P455, DOI 10.1016/S0006-3495(84)84168-5; Coale KH, 1996, NATURE, V379, P621, DOI 10.1038/379621a0; Drazkiewicz M, 2007, CHEMOSPHERE, V67, P188, DOI 10.1016/j.chemosphere.2006.08.032; Fischer N, 1997, BIOCHEMISTRY-US, V36, P93, DOI 10.1021/bi962244v; Germano M, 2002, FEBS LETT, V525, P121, DOI 10.1016/S0014-5793(02)03100-9; Gibasiewicz K, 2005, J PHYS CHEM B, V109, P21180, DOI 10.1021/jp0530909; Gibasiewicz K, 2002, J PHYS CHEM B, V106, P6322, DOI [10.1021/jp014608l, 10.1021/jp0146081]; Gibasiewicz K, 2001, J PHYS CHEM B, V105, P11498, DOI 10.1021/jp012089g; Gobets B, 2001, BBA-BIOENERGETICS, V1507, P80, DOI 10.1016/S0005-2728(01)00203-1; GUIKEMA JA, 1984, PLANT PHYSIOL, V74, P90, DOI 10.1104/pp.74.1.90; HWANGSCHWEITZER RH, 1992, J LUMIN, V51, P99, DOI 10.1016/0022-2313(92)90022-2; Ihalainen JA, 2005, FEBS LETT, V579, P4787, DOI 10.1016/j.febslet.2005.06.091; Jeanjean R, 2008, BBA-BIOENERGETICS, V1777, P308, DOI 10.1016/j.bbabio.2007.11.009; Jordan P, 2001, NATURE, V411, P909, DOI 10.1038/35082000; Kargul J, 2003, J BIOL CHEM, V278, P16135, DOI 10.1074/jbc.M300262200; Kitayama K, 1999, J PHYCOL, V35, P136, DOI 10.1046/j.1529-8817.1999.3510136.x; LI N, 1991, BIOCHEMISTRY-US, V30, P7863, DOI 10.1021/bi00245a028; Li W, 2009, J INTEGR PLANT BIOL, V51, P279, DOI 10.1111/j.1744-7909.2008.00790.x; LUNEBERG J, 1994, FEBS LETT, V338, P197, DOI 10.1016/0014-5793(94)80364-1; Lynnes JA, 1998, PLANTA, V204, P360, DOI 10.1007/s004250050267; MARTIN JH, 1994, NATURE, V371, P123, DOI 10.1038/371123a0; Merchant SS, 2006, BBA-MOL CELL RES, V1763, P578, DOI 10.1016/j.bbamcr.2006.04.007; Moseley JL, 2002, EMBO J, V21, P6709, DOI 10.1093/emboj/cdf666; Msilini N, 2011, PHOTOSYNTH RES, V107, P247, DOI 10.1007/s11120-011-9628-2; Murakami A, 1997, PHOTOSYNTH RES, V53, P141, DOI 10.1023/A:1005818317797; Naumann B, 2005, J BIOL CHEM, V280, P20431, DOI 10.1074/jbc.M414486200; Naumann B, 2007, PROTEOMICS, V7, P3964, DOI 10.1002/pmic.200700407; OHOKA H, 1988, J BIOCHEM-TOKYO, V103, P962, DOI 10.1093/oxfordjournals.jbchem.a122394; PUSHNIK JC, 1982, J PLANT NUTR, V5, P311, DOI 10.1080/01904168209362960; Saenger W, 2002, CURR OPIN STRUC BIOL, V12, P244, DOI 10.1016/S0959-440X(02)00317-2; SARVARI E, 1994, ELECTROPHORESIS, V15, P1068, DOI 10.1002/elps.11501501159; Setif P, 2002, BBA-BIOENERGETICS, V1555, P204, DOI 10.1016/S0005-2728(02)00279-7; Singh AK, 2003, PLANT PHYSIOL, V132, P1825, DOI 10.1104/pp.103.024018; Sonoike K, 2011, PHYSIOL PLANTARUM, V142, P56, DOI 10.1111/j.1399-3054.2010.01437.x; Straus N.A., 1994, MOL BIOL CYANOBACTER, P731, DOI DOI 10.1007/978-94-011-0227-8_25; Strzepek RF, 2004, NATURE, V431, P689, DOI 10.1038/nature02954; Subramanyam R, 2006, FEBS LETT, V580, P233, DOI 10.1016/j.febslet.2005.12.003; Subramanyam R, 2010, PROTOCOLS ALGAL RES, P138; Subramanyam R, 2010, PLANTA, V231, P913, DOI 10.1007/s00425-009-1097-x; Thangaraj B, 2011, BIOPHYS J, V100, P135, DOI 10.1016/j.bpj.2010.09.069; Timperio AM, 2007, J EXP BOT, V58, P3695, DOI 10.1093/jxb/erm219; Touraine B, 2004, PLANT J, V40, P101, DOI 10.1111/j.1365-313X.2004.02189.x; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Varsano T, 2006, J BIOL CHEM, V281, P10305, DOI 10.1074/jbc.M511057200; Wollman FA, 1999, BBA-BIOENERGETICS, V1411, P21, DOI 10.1016/S0005-2728(99)00043-2; Yadavalli V, 2011, MOL BIOSYST, V7, P3143, DOI 10.1039/c1mb05218g; YU JP, 1995, PLANT MOL BIOL, V29, P331, DOI 10.1007/BF00043656	59	28	28	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2012	7	4							e35084	10.1371/journal.pone.0035084	http://dx.doi.org/10.1371/journal.pone.0035084			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UT	22514709	Green Submitted, Green Published, gold			2022-12-25	WOS:000305341600115
J	Cauvi, DM; Song, DH; Vazquez, DE; Hawisher, D; Bermudez, JA; Williams, MR; Bickler, S; Coimbra, R; De Maio, A				Cauvi, David M.; Song, Donghuan; Vazquez, Daniel E.; Hawisher, Dennis; Bermudez, Jose A.; Williams, Michael R.; Bickler, Stephen; Coimbra, Raul; De Maio, Antonio			Period of Irreversible Therapeutic Intervention during Sepsis Correlates with Phase of Innate Immune Dysfunction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-NECROSIS-FACTOR; INFLAMMATORY RESPONSE; HYPERTONIC SALINE; NEUTROPHIL ACTIVATION; HEMORRHAGIC-SHOCK; ABDOMINAL SEPSIS; UNITED-STATES; SEPTIC SHOCK; GOLDEN HOUR; INJURY	Sepsis is a major health problem in the United States with high incidence and elevated patient care cost. Using an animal model of sepsis, cecum ligation, and puncture, we observed that mice became rapidly hypothermic reaching a threshold temperature of 28 degrees C within 5-10 h after initiation of the insult, resulting in a reliable predictor of mortality, which occurred within 30-72 h of the initial procedure. We also observed that the inflammatory gene expression in lung and liver developed early within 1-2 h of the insult, reaching maximum levels at 6 h, followed by a decline, approaching basal conditions within 20 h. This decrease in inflammatory gene expression at 20 h after cecal ligation and puncture was not due to resolution of the insult but rather was an immune dysfunction stage that was demonstrated by the inability of the animal to respond to a secondary external inflammatory stimulus. Removal of the injury source, ligated cecum, within 6 h of the initial insult resulted in increased survival, but not after 20 h of cecal ligation and puncture. We concluded that the therapeutic window for resolving sepsis is early after the initial insult and coincides with a stage of hyperinflammation that is followed by a condition of innate immune dysfunction in which reversion of the outcome is no longer possible.	[De Maio, Antonio] Univ Calif San Diego, Dept Surg, Sch Med, La Jolla, CA 92093 USA; [Bermudez, Jose A.; Williams, Michael R.] Univ Calif San Diego, Initiat Maximizing Student Dev Program, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego	De Maio, A (corresponding author), Univ Calif San Diego, Dept Surg, Sch Med, 9500 Gilman Dr,0739, La Jolla, CA 92093 USA.	ademaio@ucsd.edu	Coimbra, Raul/AAP-3019-2020	Coimbra, Raul/0000-0002-3759-6851	National Institutes of Health [GM073825]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM073825, R25GM083275] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM073825.	Abraham E, 2000, J IMMUNOL, V165, P2950, DOI 10.4049/jimmunol.165.6.2950; Angle N, 1998, SHOCK, V9, P164, DOI 10.1097/00024382-199803000-00002; Angus D C, 2001, Crit Care Med, V29, P1303, DOI 10.1097/00003246-200107000-00002; BAKER CC, 1983, SURGERY, V94, P331; BAUSS F, 1987, INFECT IMMUN, V55, P1622, DOI 10.1128/IAI.55.7.1622-1625.1987; Biswas SK, 2009, TRENDS IMMUNOL, V30, P475, DOI 10.1016/j.it.2009.07.009; Bone RC, 1996, CLIN CHEST MED, V17, P175, DOI 10.1016/S0272-5231(05)70307-5; Buhr ED, 2010, SCIENCE, V330, P379, DOI 10.1126/science.1195262; Bulger EM, 2007, ANN SURG, V245, P635, DOI 10.1097/01.sla.0000251367.44890.ae; CHAUDRY IH, 1980, J TRAUMA, V20, P649, DOI 10.1097/00005373-198008000-00003; Costantini TW, 2009, J TRAUMA, V67, P1162, DOI 10.1097/TA.0b013e3181ba3577; De Maio A, 1998, SHOCK, V10, P319; De Maio A, 2005, SHOCK, V23, P11, DOI 10.1097/01.shk.0000144134.03598.c5; Deitch EA, 2003, SHOCK, V19, P328, DOI 10.1097/00024382-200304000-00006; Dellinger RP, 2008, CRIT CARE MED, V36, P296, DOI 10.1097/01.CCM.0000298158.12101.41; Deree J, 2007, J TRAUMA, V62, P104, DOI 10.1097/TA.0b013e31802d96cb; DERIJK RH, 1994, AM J PHYSIOL, V266, pR1, DOI 10.1152/ajpregu.1994.266.1.R1; Docke WD, 1997, NAT MED, V3, P678, DOI 10.1038/nm0697-678; ERTEL W, 1995, BLOOD, V85, P1341, DOI 10.1182/blood.V85.5.1341.bloodjournal8551341; Esmann L, 2010, J IMMUNOL, V184, P391, DOI 10.4049/jimmunol.0900564; Flierl MA, 2008, FASEB J, V22, P2198, DOI 10.1096/fj.07-105221; Fox S, 2010, J INNATE IMMUN, V2, P216, DOI 10.1159/000284367; Fulton WB, 2006, J IMMUNOL, V176, P3767, DOI 10.4049/jimmunol.176.6.3767; GERARD C, 1993, J EXP MED, V177, P547, DOI 10.1084/jem.177.2.547; Gogos CA, 2000, J INFECT DIS, V181, P176, DOI 10.1086/315214; Heckbert SR, 1998, J TRAUMA, V45, P545, DOI 10.1097/00005373-199809000-00022; Heidecke CD, 1999, AM J SURG, V178, P288, DOI 10.1016/S0002-9610(99)00183-X; Hildebrand Frank, 2005, Surg Technol Int, V14, P41; Hotchkiss RS, 2006, NAT REV IMMUNOL, V6, P813, DOI 10.1038/nri1943; Hotchkiss RS, 2009, NAT MED, V15, P496, DOI 10.1038/nm0509-496; Hotchkiss RS, 2001, J IMMUNOL, V166, P6952, DOI 10.4049/jimmunol.166.11.6952; Hotchkiss RS, 2003, NEW ENGL J MED, V348, P138, DOI 10.1056/NEJMra021333; Huang X, 2009, P NATL ACAD SCI USA, V106, P6303, DOI 10.1073/pnas.0809422106; Koedel U, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000461; Latifi SQ, 2002, INFECT IMMUN, V70, P4441, DOI 10.1128/IAI.70.8.4441-4446.2002; Lederer JA, 1999, SHOCK, V11, P153, DOI 10.1097/00024382-199903000-00001; Lerner EB, 2003, ACAD EMERG MED, V10, P949, DOI 10.1197/S1069-6563(03)00313-0; Lerner EB, 2001, ACAD EMERG MED, V8, P758, DOI 10.1111/j.1553-2712.2001.tb00201.x; Livingston DH, 2003, ANN SURG, V238, P748, DOI 10.1097/01.sla.0000094441.38807.09; Martin GS, 2003, NEW ENGL J MED, V348, P1546, DOI 10.1056/NEJMoa022139; Merlino James I, 2004, Surg Infect (Larchmt), V5, P21, DOI 10.1089/sur.2004.5.21; Moore KW, 2001, ANNU REV IMMUNOL, V19, P683, DOI 10.1146/annurev.immunol.19.1.683; Muenzer JT, 2010, INFECT IMMUN, V78, P1582, DOI 10.1128/IAI.01213-09; MUNOZ C, 1991, J CLIN INVEST, V88, P1747, DOI 10.1172/JCI115493; Murphey ED, 2006, SHOCK, V26, P417, DOI 10.1097/01.shk.0000226343.70904.4f; Murphy TJ, 2004, J LEUKOCYTE BIOL, V75, P400, DOI 10.1189/jlb.0503233; MUSTARD RA, 1991, ARCH SURG-CHICAGO, V126, P170; Muthu K, 2008, J BURN CARE RES, V29, P12, DOI 10.1097/BCR.0b013e31815fa499; Nemzek JA, 2004, SHOCK, V21, P17, DOI 10.1097/01.shk.0000101667.49265.fd; Newgard CD, 2010, ANN EMERG MED, V55, P235, DOI 10.1016/j.annemergmed.2009.07.024; Ostuni R, 2010, CELL MOL LIFE SCI, V67, P4109, DOI 10.1007/s00018-010-0464-x; Pellegrini JD, 2000, J SURG RES, V88, P200, DOI 10.1006/jsre.1999.5797; Reddy RC, 2001, INFECT IMMUN, V69, P1394, DOI 10.1128/IAI.69.3.1394-1401.2001; Remick DG, 2007, AM J PATHOL, V170, P1435, DOI 10.2353/ajpath.2007.060872; Remick DG, 2006, FRONT BIOSCI-LANDMRK, V11, P1006, DOI 10.2741/1858; Remick DG, 2002, SHOCK, V17, P463, DOI 10.1097/00024382-200206000-00004; RICHARDSON JD, 1982, ANN SURG, V195, P732, DOI 10.1097/00000658-198206000-00009; Rivers E, 2001, NEW ENGL J MED, V345, P1368, DOI 10.1056/NEJMoa010307; Sewnath ME, 2001, J IMMUNOL, V166, P6323, DOI 10.4049/jimmunol.166.10.6323; Steinhauser ME, 1999, J IMMUNOL, V162, P392; Stewart D, 2002, SHOCK, V18, P342, DOI 10.1097/00024382-200210000-00009; Stiell IG, 2008, CAN MED ASSOC J, V178, P1141, DOI 10.1503/cmaj.071154; Stiles BG, 1999, INFECT IMMUN, V67, P1521, DOI 10.1128/IAI.67.3.1521-1525.1999; Torres D, 2005, AM J PATHOL, V167, P1677, DOI 10.1016/S0002-9440(10)61250-3; Torres MB, 2005, J SURG RES, V125, P88, DOI 10.1016/j.jss.2004.11.025; Varma TK, 2005, INFECT IMMUN, V73, P7340, DOI 10.1128/IAI.73.11.7340-7347.2005; Walley ER, 1996, INFECT IMMUN, V64, P4733, DOI 10.1128/IAI.64.11.4733-4738.1996; Wang HC, 1999, SCIENCE, V285, P248, DOI 10.1126/science.285.5425.248; Ward PA, 2008, BIOCHEM PHARMACOL, V76, P1383, DOI 10.1016/j.bcp.2008.09.017; Williams MA, 1998, J INFECT DIS, V178, P1421, DOI 10.1086/314447; Xiao HY, 2006, INFECT IMMUN, V74, P5227, DOI 10.1128/IAI.01220-05	71	21	22	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 8	2012	287	24					19804	19815		10.1074/jbc.M112.359562	http://dx.doi.org/10.1074/jbc.M112.359562			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974FB	22518839	Green Published, hybrid			2022-12-25	WOS:000306414500004
J	Chiodelli, P; Urbinati, C; Mitola, S; Tanghetti, E; Rusnati, M				Chiodelli, Paola; Urbinati, Chiara; Mitola, Stefania; Tanghetti, Elena; Rusnati, Marco			Sialic Acid Associated with alpha(v)beta(3) Integrin Mediates HIV-1 Tat Protein Interaction and Endothelial Cell Proangiogenic Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IN-VITRO; ALPHA-V-BETA-3 INTEGRIN; ANIONIC SITES; CANCER CELLS; GROWTH; ADHESION; ANGIOGENESIS; GLYCOSYLATION; GANGLIOSIDE; BINDING	Sialic acid (NeuAc) is a major anion on endothelial cells (ECs) that regulates different biological processes including angiogenesis. NeuAc is present in the oligosaccharidic portion of integrins, receptors that interact with extracellular matrix components and growth factors regulating cell adhesion, migration, and proliferation. Tat is a cationic polypeptide that, once released by HIV-1(+) cells, accumulates in the extracellular matrix, promoting EC adhesion and proangiogenic activation by engaging alpha(v)beta(3). By using two complementary approaches (NeuAc removal by neuraminidase or its masking by NeuAc-binding lectin from Maackia amurensis, MAA), we investigated the presence of NeuAc on endothelial alpha(v)beta(3) and its role in Tat interaction, EC adhesion, and proangiogenic activation. alpha(v)beta(3) immunoprecipitation with biotinylated MAA or Western blot analysis of neuraminidase-treated ECs demonstrated that NeuAc is associated with both the alpha(v) and the beta(3) subunits. Surface plasmon resonance analysis demonstrated that the masking of alpha(v)beta(3)-associated NeuAc by MAA prevents Tat/alpha(v)beta(3) interaction. MAA and neuraminidase prevent alpha(v)beta(3)-dependent EC adhesion to Tat, the consequent FAK and ERK1/2 phosphorylation, and EC proliferation, migration, and regeneration in a wound-healing assay. Finally, MAA inhibits Tat-induced neo-vascularization in the ex vivo human artery ring sprouting assay. The inhibitions are specific because the NeuAc-unrelated lectin from Ulex europaeus is ineffective on Tat. Also, MAA and neuraminidase affect only weakly integrin-dependent EC adhesion and proangiogenic activation by fibronectin. In conclusion, NeuAc is associated with endothelial alpha(v)beta(3) and mediates Tat-dependent EC adhesion and proangiogenic activation. These data point to the possibility to target integrin glycosylation for the treatment of angiogenesis/AIDS-associated pathologies.	[Chiodelli, Paola; Urbinati, Chiara; Mitola, Stefania; Rusnati, Marco] Univ Brescia, Unit Gen Pathol & Immunol, Dept Biomed Sci & Biotechnol, Sch Med, I-25123 Brescia, Italy; [Tanghetti, Elena] Univ Brescia, Unit Histol, Dept Biomed Sci & Biotechnol, Sch Med, I-25123 Brescia, Italy	University of Brescia; University of Brescia	Rusnati, M (corresponding author), Univ Brescia, Unit Gen Pathol & Immunol, Dept Biomed Sci & Biotechnol, Sch Med, Viale Europa 11, I-25123 Brescia, Italy.	rusnati@med.unibs.it	Rusnati, Marco/F-1168-2010; Chiodelli, Paola/K-1418-2016	Rusnati, Marco/0000-0001-9968-5908; Urbinati, Chiara Eva/0000-0002-0138-7871; MITOLA, Stefania/0000-0002-5557-738X; Chiodelli, Paola/0000-0002-8702-0623	Ministero dell'Istruzione, dell'Universita e della Ricerca; Istituto Superiore di Sanita (AIDS Project); Cassa di Risparmio delle Provincie Lombarde	Ministero dell'Istruzione, dell'Universita e della Ricerca(Ministry of Education, Universities and Research (MIUR)); Istituto Superiore di Sanita (AIDS Project); Cassa di Risparmio delle Provincie Lombarde(Fondazione Cariplo)	This work was supported by grants from Ministero dell'Istruzione, dell'Universita e della Ricerca, Istituto Superiore di Sanita (AIDS Project), and Cassa di Risparmio delle Provincie Lombarde (to M. R.).	Albini A, 1996, NAT MED, V2, P1371, DOI 10.1038/nm1296-1371; Angelucci A, 2007, CURR PHARM DESIGN, V13, P2129; Auzzas L, 2010, CURR MED CHEM, V17, P1255, DOI 10.2174/092986710790936301; Banks WA, 2004, NEUROSCIENCE, V128, P143, DOI 10.1016/j.neuroscience.2004.06.021; Banks WA, 1998, J NEUROSCI RES, V54, P522, DOI 10.1002/(SICI)1097-4547(19981115)54:4<522::AID-JNR9>3.0.CO;2-O; Barillari G, 1999, BLOOD, V94, P663; BOUWSTRA JB, 1987, BIOL CHEM H-S, V368, P269, DOI 10.1515/bchm3.1987.368.1.269; Brockhausen I, 2002, GLYCOBIOLOGY, V12, P33, DOI 10.1093/glycob/12.1.33; Caswell PT, 2009, NAT REV MOL CELL BIO, V10, P843, DOI 10.1038/nrm2799; Chiang CH, 2010, J CELL PHYSIOL, V223, P492, DOI 10.1002/jcp.22068; Christie DR, 2008, J OVARIAN RES, V1, DOI 10.1186/1757-2215-1-3; Chung TW, 2009, GLYCOBIOLOGY, V19, P229, DOI 10.1093/glycob/cwn114; CORFIELD AP, 1983, BIOCHIM BIOPHYS ACTA, V744, P121, DOI 10.1016/0167-4838(83)90080-8; Doiron AL, 2004, TECH PAPERS ISA, V449, P331; DOSSANTOS WLC, 1995, ACTA NEUROPATHOL, V90, P305; Duchesne L, 2006, J BIOL CHEM, V281, P27178, DOI 10.1074/jbc.M601248200; Eliceiri BP, 1998, MOL MED, V4, P741, DOI 10.1007/BF03401768; FOLKMAN J, 1987, SCIENCE, V235, P442, DOI 10.1126/science.2432664; Graham KL, 2003, J VIROL, V77, P9969, DOI 10.1128/JVI.77.18.9969-9978.2003; GRINSPAN JB, 1983, J CELL PHYSIOL, V114, P328, DOI 10.1002/jcp.1041140312; Harduin-Lepers A, 2005, GLYCOBIOLOGY, V15, P805, DOI 10.1093/glycob/cwi063; Henry CBS, 1996, TISSUE CELL, V28, P449, DOI 10.1016/S0040-8166(96)80030-9; KAJIJI S, 1989, EMBO J, V8, P673, DOI 10.1002/j.1460-2075.1989.tb03425.x; KARLSSON KA, 1991, TRENDS PHARMACOL SCI, V12, P265, DOI 10.1016/0165-6147(91)90568-D; Kopitz J, 2010, IUBMB LIFE, V62, P624, DOI 10.1002/iub.358; Kremser ME, 2008, BBA-GEN SUBJECTS, V1780, P1421, DOI 10.1016/j.bbagen.2008.07.011; Lang ZH, 2001, BIOCHEM BIOPH RES CO, V282, P1031, DOI 10.1006/bbrc.2001.4630; Lauder H, 1998, Angiogenesis, V2, P67, DOI 10.1023/A:1009006527462; Mitola S, 2008, BLOOD, V112, P1154, DOI 10.1182/blood-2007-09-111450; Monti E, 2010, ADV CARBOHYD CHEM BI, V64, P403, DOI 10.1016/S0065-2318(10)64007-3; Morova J, 2008, P NATL ACAD SCI USA, V105, P5355, DOI 10.1073/pnas.0711400105; Mousa SA, 2008, MOL BIOTECHNOL, V38, P33, DOI 10.1007/s12033-007-0072-7; MURESAN V, 1987, HISTOCHEM J, V19, P170, DOI 10.1007/BF01695141; Nacev BA, 2011, J BIOL CHEM, V286, P44045, DOI 10.1074/jbc.M111.278754; Noonan D, 2000, Adv Pharmacol, V48, P229; Renkonen R, 1997, GLYCOCONJUGATE J, V14, P593, DOI 10.1023/A:1018536509950; RIDLEY AJ, 1992, CELL, V70, P401, DOI 10.1016/0092-8674(92)90164-8; Roberts M, 2001, CURR BIOL, V11, P1392, DOI 10.1016/S0960-9822(01)00442-0; Rusnati M, 1998, J BIOL CHEM, V273, P16027, DOI 10.1074/jbc.273.26.16027; Rusnati M, 1999, MOL BIOL CELL, V10, P313, DOI 10.1091/mbc.10.2.313; Rusnati M, 2002, P NATL ACAD SCI USA, V99, P4367, DOI 10.1073/pnas.072651899; Rusnati M, 1997, MOL BIOL CELL, V8, P2449, DOI 10.1091/mbc.8.12.2449; Rusnati M, 2001, ENDOTHELIUM-J ENDOTH, V8, P65, DOI 10.3109/10623320109063158; Rusnati M, 2006, ENDOTHELIUM-J ENDOTH, V13, P93, DOI 10.1080/10623320600698011; Sakarya S, 2004, GLYCOBIOLOGY, V14, P481, DOI 10.1093/glycob/cwh065; Scatena M, 1998, J CELL BIOL, V141, P1083, DOI 10.1083/jcb.141.4.1083; Schauer R, 2009, CURR OPIN STRUC BIOL, V19, P507, DOI 10.1016/j.sbi.2009.06.003; Semel AC, 2002, J BIOL CHEM, V277, P32830, DOI 10.1074/jbc.M202493200; Stewart PL, 2007, TRENDS MICROBIOL, V15, P500, DOI 10.1016/j.tim.2007.10.001; Terada M, 2005, BIOMED PHARMACOTHER, V59, P423, DOI 10.1016/j.biopha.2005.07.005; Traving C, 1998, CELL MOL LIFE SCI, V54, P1330, DOI 10.1007/s000180050258; Urbinati C, 2005, ARTERIOSCL THROM VAS, V25, P2315, DOI 10.1161/01.ATV.0000186182.14908.7b; Urbinati C, 2005, J CELL SCI, V118, P3949, DOI 10.1242/jcs.02518; Urbinati C, 2004, FEBS LETT, V568, P171, DOI 10.1016/j.febslet.2004.05.033; Urbinati C, 2012, ARTERIOSCL THROM VAS, V32, pE25, DOI 10.1161/ATVBAHA.111.242396; Urbinati C, 2008, MOLECULES, V13, P2758, DOI 10.3390/molecules13112758; VORBRODT AW, 1989, J NEUROCYTOL, V18, P359, DOI 10.1007/BF01190839; WELIM HB, 1989, CELL TISSUE RES, V255, P627; Woodard-Grice AV, 2008, J BIOL CHEM, V283, P26364, DOI 10.1074/jbc.M800836200	59	23	24	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 8	2012	287	24					20456	20466		10.1074/jbc.M111.337139	http://dx.doi.org/10.1074/jbc.M111.337139			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974FB	22528484	hybrid, Green Published			2022-12-25	WOS:000306414500063
J	Solomonov, I; Korkotian, E; Born, B; Feldman, Y; Bitler, A; Rahimi, F; Li, HY; Bitan, G; Sagi, I				Solomonov, Inna; Korkotian, Eduard; Born, Benjamin; Feldman, Yishay; Bitler, Arkady; Rahimi, Farid; Li, Huiyuan; Bitan, Gal; Sagi, Irit			Zn2+-A beta 40 Complexes Form Metastable Quasi-spherical Oligomers That Are Cytotoxic to Cultured Hippocampal Neurons	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYLOID-BETA-PROTEIN; ALZHEIMERS-DISEASE; A-BETA; TRANSGENIC MICE; SYNAPTIC ZINC; AGGREGATION; FIBRILS; NEUROTOXICITY; ACCUMULATION; HYPOTHESIS	The roles of metal ions in promoting amyloid beta-protein (A beta) oligomerization associated with Alzheimer disease are increasingly recognized. However, the detailed structures dictating toxicity remain elusive for A beta oligomers stabilized by metal ions. Here, we show that small Zn2+-bound A beta 1-40 (Zn2+-A beta 40) oligomers formed in cell culture medium exhibit quasispherical structures similar to native amylospheroids isolated recently from Alzheimer disease patients. These quasi-spherical Zn2+-A beta 40 oligomers irreversibly inhibit spontaneous neuronal activity and cause massive cell death in primary hippocampal neurons. Spectroscopic and x-ray diffraction structural analyses indicate that despite their non-fibrillar morphology, the metastable Zn2+-A beta 40 oligomers are rich in beta-sheet and cross-beta structures. Thus, Zn2+ promotes A beta 40 neurotoxicity by structural organization mechanisms mediated by coordination chemistry.	[Solomonov, Inna; Born, Benjamin; Sagi, Irit] Weizmann Inst Sci, Dept Biol Struct, IL-76100 Rehovot, Israel; [Solomonov, Inna; Born, Benjamin; Sagi, Irit] Weizmann Inst Sci, Dept Regulat Biol, IL-76100 Rehovot, Israel; [Korkotian, Eduard] Weizmann Inst Sci, Dept Neurobiol, IL-76100 Rehovot, Israel; [Feldman, Yishay; Bitler, Arkady] Weizmann Inst Sci, Dept Chem Res Support, IL-76100 Rehovot, Israel; [Rahimi, Farid; Li, Huiyuan; Bitan, Gal] Univ Calif Los Angeles, Dept Neurol, David Geffen Sch Med, Los Angeles, CA 90095 USA; [Bitan, Gal] Univ Calif Los Angeles, Brain Res Inst, Los Angeles, CA 90095 USA; [Bitan, Gal] Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90095 USA	Weizmann Institute of Science; Weizmann Institute of Science; Weizmann Institute of Science; Weizmann Institute of Science; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Sagi, I (corresponding author), Weizmann Inst Sci, Dept Biol Struct, IL-76100 Rehovot, Israel.	irit.sagi@weizmann.ac.il	Bitan, Gal/U-2204-2019; Rahimi, Farid/E-6522-2018; Korkotian, Eduard/P-4559-2019; Korkotian, Eduard/K-1744-2012	Bitan, Gal/0000-0001-7046-3754; Rahimi, Farid/0000-0002-0920-8188; Korkotian, Eduard/0000-0001-5515-3387	National Institutes of Health [AG027818, CA098799]; United States-Israel Binational Science Foundation [2007187]; Weizmann Institute; Israel Science Foundation; Kimmelman Center at the Weizmann Institute; Ambach family fund; Human Frontier Science Program cross-disciplinary fellowship; NATIONAL CANCER INSTITUTE [R01CA098799] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG027818] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States-Israel Binational Science Foundation(US-Israel Binational Science Foundation); Weizmann Institute; Israel Science Foundation(Israel Science Foundation); Kimmelman Center at the Weizmann Institute; Ambach family fund; Human Frontier Science Program cross-disciplinary fellowship(Human Frontier Science Program); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported in part by National Institutes of Health Grants AG027818 (to G.B.) and CA098799 (to I. Sagi). This work was also supported by United States-Israel Binational Science Foundation Grant 2007187 (to G.B. and I. Sagi), by a Human Frontier Science Program cross-disciplinary fellowship and a Dean of Faculty fellowship of the Weizmann Institute (to B.B.), and by the Israel Science Foundation, the Kimmelman Center at the Weizmann Institute, and the Ambach family fund (to I. Sagi).	Adlard PA, 2008, NEURON, V59, P43, DOI 10.1016/j.neuron.2008.06.018; Bernstein SL, 2009, NAT CHEM, V1, P326, DOI [10.1038/NCHEM.247, 10.1038/nchem.247]; Bitan G, 2003, J BIOL CHEM, V278, P34882, DOI 10.1074/jbc.M300825200; BUSH AI, 1994, SCIENCE, V265, P1464, DOI 10.1126/science.8073293; Chen WT, 2011, J BIOL CHEM, V286, P9646, DOI 10.1074/jbc.M110.177246; Cherny RA, 1999, J BIOL CHEM, V274, P23223, DOI 10.1074/jbc.274.33.23223; Chimon S, 2007, NAT STRUCT MOL BIOL, V14, P1157, DOI 10.1038/nsmb1345; Cuajungco MP, 2000, J BIOL CHEM, V275, P19439, DOI 10.1074/jbc.C000165200; Dahlgren KN, 2002, J BIOL CHEM, V277, P32046, DOI 10.1074/jbc.M201750200; Deshpande A, 2009, J NEUROSCI, V29, P4004, DOI 10.1523/JNEUROSCI.5980-08.2009; Dong J, 2003, BIOCHEMISTRY-US, V42, P2768, DOI 10.1021/bi0272151; Eilers Jens, 1995, P213; Faux NG, 2010, J ALZHEIMERS DIS, V20, P509, DOI 10.3233/JAD-2010-1390; Frederickson CJ, 2005, NAT REV NEUROSCI, V6, P449, DOI 10.1038/nrn1671; Garai K, 2006, BIOCHEM BIOPH RES CO, V345, P210, DOI 10.1016/j.bbrc.2006.04.056; GLENNER GG, 1974, J HISTOCHEM CYTOCHEM, V22, P1141, DOI 10.1177/22.12.1141; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Heininger K, 2000, REV NEUROSCIENCE, V11, P213; Hoshi M, 2003, P NATL ACAD SCI USA, V100, P6370, DOI 10.1073/pnas.1237107100; Huang XD, 1997, J BIOL CHEM, V272, P26464, DOI 10.1074/jbc.272.42.26464; Isaacs AM, 2006, J BIOL CHEM, V281, P27916, DOI 10.1074/jbc.M602061200; Itkin A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018250; Jahn TR, 2010, J MOL BIOL, V395, P717, DOI 10.1016/j.jmb.2009.09.039; Khazipov R, 2001, J NEUROSCI, V21, P9770, DOI 10.1523/JNEUROSCI.21-24-09770.2001; KIRSCHNER DA, 1987, P NATL ACAD SCI USA, V84, P6953, DOI 10.1073/pnas.84.19.6953; Klein WL, 2004, NEUROBIOL AGING, V25, P569, DOI 10.1016/j.neurobiolaging.2004.02.010; Klein WL, 2001, TRENDS NEUROSCI, V24, P219, DOI 10.1016/S0166-2236(00)01749-5; Kodali R, 2010, J MOL BIOL, V401, P503, DOI 10.1016/j.jmb.2010.06.023; LaFerla FM, 2002, NAT REV NEUROSCI, V3, P862, DOI 10.1038/nrn960; Lee JY, 2002, P NATL ACAD SCI USA, V99, P7705, DOI 10.1073/pnas.092034699; LEVINE H, 1993, PROTEIN SCI, V2, P404, DOI 10.1002/pro.5560020312; Lovell MA, 1998, J NEUROL SCI, V158, P47, DOI 10.1016/S0022-510X(98)00092-6; Malinchik SB, 1998, BIOPHYS J, V74, P537, DOI 10.1016/S0006-3495(98)77812-9; Miller LM, 2006, J STRUCT BIOL, V155, P30, DOI 10.1016/j.jsb.2005.09.004; Miller Y, 2010, P NATL ACAD SCI USA, V107, P9490, DOI 10.1073/pnas.0913114107; Neher E, 2011, IMAGING LAB MANUAL, P417; Nichols MR, 2002, BIOCHEMISTRY-US, V41, P6115, DOI 10.1021/bi015985r; Noy D, 2008, J AM CHEM SOC, V130, P1376, DOI 10.1021/ja076282l; Ono K, 2009, P NATL ACAD SCI USA, V106, P14745, DOI 10.1073/pnas.0905127106; Palop JJ, 2006, NATURE, V443, P768, DOI 10.1038/nature05289; PAPA M, 1995, J NEUROSCI, V15, P1; Petkova AT, 2002, P NATL ACAD SCI USA, V99, P16742, DOI 10.1073/pnas.262663499; Rahimi F, 2008, CURR ALZHEIMER RES, V5, P319, DOI 10.2174/156720508784533358; Rezaei-Ghaleh N, 2011, BIOPHYS J, V101, P1202, DOI 10.1016/j.bpj.2011.06.062; Sachse C, 2008, P NATL ACAD SCI USA, V105, P7462, DOI 10.1073/pnas.0712290105; Selkoe DJ, 2008, BEHAV BRAIN RES, V192, P106, DOI 10.1016/j.bbr.2008.02.016; Serpell LC, 2000, BBA-MOL BASIS DIS, V1502, P16, DOI 10.1016/S0925-4439(00)00029-6; Stine WB, 2003, J BIOL CHEM, V278, P11612, DOI 10.1074/jbc.M210207200; Stoltenberg M, 2007, NEUROSCIENCE, V150, P357, DOI 10.1016/j.neuroscience.2007.09.025; Tycko R, 2011, ANNU REV PHYS CHEM, V62, P279, DOI 10.1146/annurev-physchem-032210-103539; Uhhaas PJ, 2006, NEURON, V52, P155, DOI 10.1016/j.neuron.2006.09.020; Wolfe MS, 2003, CURR TOP DEV BIOL, V54, P233, DOI 10.1016/S0070-2153(03)54011-X	52	35	36	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 8	2012	287	24					20555	20564		10.1074/jbc.M112.344036	http://dx.doi.org/10.1074/jbc.M112.344036			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974FB	22528492	Green Published, hybrid			2022-12-25	WOS:000306414500076
J	Testerink, N; Ajat, M; Houweling, M; Brouwers, JF; Pully, VV; van Manen, HJ; Otto, C; Helms, JB; Vaandrager, AB				Testerink, Nicole; Ajat, Mokrish; Houweling, Martin; Brouwers, Jos F.; Pully, Vishnu V.; van Manen, Henk-Jan; Otto, Cees; Helms, J. Bernd; Vaandrager, Arie B.			Replacement of Retinyl Esters by Polyunsaturated Triacylglycerol Species in Lipid Droplets of Hepatic Stellate Cells during Activation	PLOS ONE			English	Article							RAT-LIVER; RAMAN-SPECTROSCOPY; KUPFFER CELLS; BIOLOGY; PROLIFERATION; DEGRADATION; EXPRESSION; EXPANSION; PROTEIN; FAT	Activation of hepatic stellate cells has been recognized as one of the first steps in liver injury and repair. During activation, hepatic stellate cells transform into myofibroblasts with concomitant loss of their lipid droplets (LDs) and production of excessive extracellular matrix. Here we aimed to obtain more insight in the dynamics and mechanism of LD loss. We have investigated the LD degradation processes in rat hepatic stellate cells in vitro with a combined approach of confocal Raman microspectroscopy and mass spectrometric analysis of lipids (lipidomics). Upon activation of the hepatic stellate cells, LDs reduce in size, but increase in number during the first 7 days, but the total volume of neutral lipids did not decrease. The LDs also migrate to cellular extensions in the first 7 days, before they disappear. In individual hepatic stellate cells. all LDs have a similar Raman spectrum, suggesting a similar lipid profile. However, Raman studies also showed that the retinyl esters are degraded more rapidly than the triacylglycerols upon activation. Lipidomic analyses confirmed that after 7 days in culture hepatic stellate cells have lost most of their retinyl esters, but not their triacylglycerols and cholesterol esters. Furthermore, we specifically observed a large increase in triacylglycerol-species containing polyunsaturated fatty acids, partly caused by an enhanced incorporation of exogenous arachidonic acid. These results reveal that lipid droplet degradation in activated hepatic stellate cells is a highly dynamic and regulated process. The rapid replacement of retinyl esters by polyunsaturated fatty acids in LDs suggests a role for both lipids or their derivatives like eicosanoids during hepatic stellate cell activation.	[Testerink, Nicole; Ajat, Mokrish; Houweling, Martin; Brouwers, Jos F.; Helms, J. Bernd; Vaandrager, Arie B.] Univ Utrecht, Dept Biochem & Cell Biol, Fac Vet Sci, Utrecht, Netherlands; [Pully, Vishnu V.; van Manen, Henk-Jan; Otto, Cees] Univ Twente, MIRA Inst Biomed Technol & Tech Med, Dept Sci & Technol, NL-7500 AE Enschede, Netherlands	Utrecht University; University of Twente	Vaandrager, AB (corresponding author), Univ Utrecht, Dept Biochem & Cell Biol, Fac Vet Sci, Utrecht, Netherlands.	A.B.Vaandrager@uu.nl	Otto, Cees/H-8421-2019; Ajat, Mokrish/AAD-4086-2021; Brouwers, Jos F/AAH-1444-2019	Brouwers, Jos F/0000-0003-2924-3279; Ajat, Mokrish/0000-0002-2905-4630; Vaandrager, Arie/0000-0001-9394-9239	European Union [202272]	European Union(European Commission)	This work was supported by the seventh framework program of the European Union-funded "LipidomicNet" project (proposal number 202272). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blaner WS, 2009, BBA-MOL CELL BIOL L, V1791, P467, DOI 10.1016/j.bbalip.2008.11.001; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Bozza PT, 2009, BBA-MOL CELL BIOL L, V1791, P540, DOI 10.1016/j.bbalip.2009.01.005; Cao Y, 1998, GENOMICS, V49, P327, DOI 10.1006/geno.1998.5268; CLEMENT B, 1984, CELL MOL BIOL, V30, P489; Cubero FJ, 2008, HEPATOLOGY, V48, P2027, DOI 10.1002/hep.22592; Darios F, 2006, NATURE, V440, P813, DOI 10.1038/nature04598; Dudas J, 2003, CELL TISSUE RES, V313, P301, DOI 10.1007/s00441-003-0768-3; Failloux N, 2003, APPL SPECTROSC, V57, P1117, DOI 10.1366/00037020360695973; Friedman SL, 2008, PHYSIOL REV, V88, P125, DOI 10.1152/physrev.00013.2007; FRIEDMAN SL, 1993, AM J PHYSIOL, V264, pG947, DOI 10.1152/ajpgi.1993.264.5.G947; Gressner AM, 1998, CELL TISSUE RES, V292, P447, DOI 10.1007/s004410051073; Hanlon EB, 2000, PHYS MED BIOL, V45, pR1, DOI 10.1088/0031-9155/45/2/201; Harizi H, 2008, TRENDS MOL MED, V14, P461, DOI 10.1016/j.molmed.2008.08.005; HENDRIKS HFJ, 1988, EUR J BIOCHEM, V171, P237, DOI 10.1111/j.1432-1033.1988.tb13782.x; HENDRIKS HFJ, 1985, EXP CELL RES, V160, P138, DOI 10.1016/0014-4827(85)90243-5; Hernandez-Gea V, 2012, GASTROENTEROLOGY; Kluwe J, 2011, GUT, V60, P1260, DOI 10.1136/gut.2010.209551; Krahmer N, 2011, CELL METAB, V14, P504, DOI 10.1016/j.cmet.2011.07.013; Long AP, 2012, TRAFFIC; Martin S, 2006, NAT REV MOL CELL BIO, V7, P373, DOI 10.1038/nrm1912; Mathew J, 1996, HEPATO-GASTROENTEROL, V43, P72; Mello T, 2008, BIOCHEM BIOPH RES CO, V374, P460, DOI 10.1016/j.bbrc.2008.07.024; MORIWAKI H, 1988, J LIPID RES, V29, P1523; PUPPELS GJ, 1990, NATURE, V347, P301, DOI 10.1038/347301a0; Rapoport SI, 2001, J MOL NEUROSCI, V16, P243, DOI 10.1385/JMN:16:2-3:243; Retra K, 2008, RAPID COMMUN MASS SP, V22, P1853, DOI 10.1002/rcm.3562; Riccalton-Banks L, 2003, MOL CELL BIOCHEM, V248, P97, DOI 10.1023/A:1024184826728; Safadi Rifaat, 2002, MedGenMed, V4, P27; Schreiber R, 2009, J LIPID RES, V50, P2514, DOI 10.1194/jlr.M000950; SMEDSROD B, 1994, GUT, V35, P1509, DOI 10.1136/gut.35.11.1509; Smirnova E, 2006, EMBO REP, V7, P106, DOI 10.1038/sj.embor.7400559; Uzunbajakava N, 2003, BIOPHYS J, V84, P3968, DOI 10.1016/S0006-3495(03)75124-8; van Manen HJ, 2005, P NATL ACAD SCI USA, V102, P10159, DOI 10.1073/pnas.0502746102; Vinas O, 2003, HEPATOLOGY, V38, P919, DOI 10.1053/jhep.2003.50392; Welte MA, 2009, BIOCHEM SOC T, V37, P991, DOI 10.1042/BST0370991; Xia YH, 2010, J CANCER RES CLIN, V136, P309, DOI 10.1007/s00432-009-0666-5; YAMADA M, 1987, HEPATOLOGY, V7, P1224, DOI 10.1002/hep.1840070609; Yamaguchi K, 2008, HEPATOLOGY, V47, P625, DOI 10.1002/hep.21988; YOST RW, 1988, J BIOL CHEM, V263, P18693	40	62	64	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2012	7	4							e34945	10.1371/journal.pone.0034945	http://dx.doi.org/10.1371/journal.pone.0034945			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UD	22536341	Green Published, Green Submitted, gold			2022-12-25	WOS:000305339200028
J	Wouters, E; Booysen, FL; Ponnet, K; Van Loon, FB				Wouters, Edwin; Booysen, Frederik le Roux; Ponnet, Koen; Van Loon, Francis Baron			Wording Effects and the Factor Structure of the Hospital Anxiety & Depression Scale in HIV/AIDS Patients on Antiretroviral Treatment in South Africa	PLOS ONE			English	Article							ROSENBERG SELF-ESTEEM; HIV-INFECTED INDIVIDUALS; QUALITY-OF-LIFE; MODEL; DISORDERS; HEALTH; OUTPATIENT; PREVALENCE; VALIDATION; PREDICTORS	Background: Given the immense burden of HIV/AIDS on health systems in sub-Saharan Africa and the intricate link between HIV/AIDS and mental health problems, health care providers need a valid and reliable instrument to assess mental health rapidly. The Hospital Anxiety and Depression Scale (HADS) may constitute such an instrument. The aims of this study were to: (1) examine the factor structure of the HADS in a population of South African HIV/AIDS patients on antiretroviral treatment (ART); and (2) identify and control the disturbing influence of systematic wording effects in vulnerable respondent groups. Methodology/Principal Findings: The translated scale was administered to 716 HIV/AIDS patients enrolled in the public sector ART program in South Africa. A combined confirmatory factor analysis and correlated-traits-correlated-methods framework was used to determine the preferred factor structure of the HADS, while controlling for the disturbing influence of systematic wording effects. When assessing the structure without a negative wording factor, all three factor structures displayed an acceptable fit to the data. The three-factor solution best fitted the data. Addition of a method factor significantly improved the fit of all three factor solutions. Using x 2 difference testing, Razavi's one-factor solution displayed a superior fit compared to the other two factor solutions. Conclusions: The study outcomes support the use of the HADS as a valid and reliable means to screen for mental health problems in HIV/AIDS patients enrolled in a public-sector ART program in a resource-limited context. The results demonstrate the importance of evaluating and correcting for wording effects when examining the factor structure of the screening instrument in vulnerable patient groups. In light of the inter-relationships between HIV/AIDS and mental health problems and the scarcity of adequate screening tools, additional studies on this topic are required.	[Wouters, Edwin; Ponnet, Koen; Van Loon, Francis Baron] Univ Antwerp, Dept Sociol, B-2020 Antwerp, Belgium; [Wouters, Edwin; Ponnet, Koen; Van Loon, Francis Baron] Univ Antwerp, Res Ctr Longitudinal & Life Course Studies, B-2020 Antwerp, Belgium; [Wouters, Edwin; Booysen, Frederik le Roux] Univ Orange Free State, Ctr Hlth Syst Res & Dev, Bloemfontein, South Africa; [Booysen, Frederik le Roux] Univ Orange Free State, Dept Econ, Bloemfontein, South Africa; [Ponnet, Koen] Univ Antwerp, MIOS, B-2020 Antwerp, Belgium	University of Antwerp; University of Antwerp; University of the Free State; University of the Free State; University of Antwerp	Wouters, E (corresponding author), Univ Antwerp, Dept Sociol, B-2020 Antwerp, Belgium.	edwin.wouters@ua.ac.be	le R Booysen, Frederik/K-9152-2015; Wouters, Edwin/AAE-1649-2021; Ponnet, Koen/K-9389-2017; Booysen, Frederik/ABB-2868-2021	le R Booysen, Frederik/0000-0001-7449-3221; Wouters, Edwin/0000-0003-2268-3829; Ponnet, Koen/0000-0002-6911-7632; 	Research Committee of the World Bank; Bank Netherlands Program Partnership; WB-DfiD 'Evaluation of the Community Response to HIV and AIDS'; Health Economics and Aids Research Division (HEARD) at the University of Kwazulu-Natal; University of the Free State (UFS); National Research Foundation (NRF) of South Africa	Research Committee of the World Bank; Bank Netherlands Program Partnership; WB-DfiD 'Evaluation of the Community Response to HIV and AIDS'; Health Economics and Aids Research Division (HEARD) at the University of Kwazulu-Natal; University of the Free State (UFS); National Research Foundation (NRF) of South Africa(National Research Foundation - South Africa)	The study was funded by the Research Committee of the World Bank, The Bank Netherlands Program Partnership, the WB-DfiD 'Evaluation of the Community Response to HIV and AIDS,' the Health Economics and Aids Research Division (HEARD) at the University of Kwazulu-Natal, the University of the Free State (UFS), and the National Research Foundation (NRF) of South Africa. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The findings, interpretations, and conclusions in the article are those of the authors and do not reflect the views of funding agencies.	Alessandri G, 2010, STRUCT EQU MODELING, V17, P642, DOI 10.1080/10705511.2010.510064; [Anonymous], GLOB BURD DIS 2004 U; Au A, 2004, AIDS BEHAV, V8, P119, DOI 10.1023/B:AIBE.0000030243.50415.c0; Barnette JJ, 2000, EDUC PSYCHOL MEAS, V60, P361, DOI 10.1177/00131640021970592; Barth Jurgen, 2005, Health Qual Life Outcomes, V3, P15, DOI 10.1186/1477-7525-3-15; Berard RMF, 1998, PSYCHO-ONCOL, V7, P112, DOI 10.1002/(SICI)1099-1611(199803/04)7:2<112::AID-PON300>3.0.CO;2-W; Billiet JB, 2000, STRUCT EQU MODELING, V7, P608, DOI 10.1207/S15328007SEM0704_5; Bjelland I, 2002, J PSYCHOSOM RES, V52, P69, DOI 10.1016/S0022-3999(01)00296-3; Boarts JM, 2009, J EVID-INFORM SOC WO, V6, P4, DOI 10.1080/15433710802633247; Brown T. A., 2015, CONFIRMATORY FACTOR, VSecond; Caci H, 2003, PSYCHIAT RES, V118, P89, DOI 10.1016/S0165-1781(03)00044-1; Campos LN, 2010, AIDS BEHAV, V14, P289, DOI 10.1007/s10461-008-9435-8; Chandra PS, 2003, J PSYCHOSOM RES, V54, P199, DOI 10.1016/S0022-3999(02)00567-6; Chen Y.-H., 2010, INT J ED PSYCHOL ASS, V6, P21; CLARK LA, 1991, J ABNORM PSYCHOL, V100, P316, DOI 10.1037/0021-843X.100.3.316; Corwyn RF, 2000, J RES PERS, V34, P357, DOI 10.1006/jrpe.2000.2291; Desmond DM, 2005, INT J GERIATR PSYCH, V20, P344, DOI 10.1002/gps.1289; DiStefano C, 2006, STRUCT EQU MODELING, V13, P440, DOI 10.1207/s15328007sem1303_6; DiStefano C, 2009, STRUCT EQU MODELING, V16, P134, DOI 10.1080/10705510802565403; DiStefano C, 2009, PERS INDIV DIFFER, V46, P309, DOI 10.1016/j.paid.2008.10.020; Dunbar M, 2000, BRIT J CLIN PSYCHOL, V39, P79, DOI 10.1348/014466500163121; Eid M, 2000, PSYCHOMETRIKA, V65, P241, DOI 10.1007/BF02294377; Eidecker J, 2010, J ANXIETY DISORD, V24, P596, DOI 10.1016/j.janxdis.2010.03.020; Farinpour R, 2003, J CLIN EXP NEUROPSYC, V25, P654, DOI 10.1076/jcen.25.5.654.14577; Floyd FJ, 1995, PSYCHOL ASSESSMENT, V7, P286, DOI 10.1037/1040-3590.7.3.286; Greenberger E, 2003, PERS INDIV DIFFER, V35, P1241, DOI 10.1016/S0191-8869(02)00331-8; Gupta R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014252; Hand GA, 2006, AIDS CARE, V18, P1011, DOI 10.1080/09540120600568376; Holzemer WL, 1999, AIDS PATIENT CARE ST, V13, P185, DOI 10.1089/apc.1999.13.185; Horan PM, 2003, STRUCT EQU MODELING, V10, P435, DOI 10.1207/S15328007SEM1003_6; Hunt-Shanks T, 2010, BRIT J HEALTH PSYCH, V15, P97, DOI 10.1348/135910709X432745; Ickovics JR, 2001, JAMA-J AM MED ASSOC, V285, P1466, DOI 10.1001/jama.285.11.1466; Johnston M, 2000, J PSYCHOSOM RES, V48, P579, DOI 10.1016/S0022-3999(00)00102-1; Lambert S, 2005, SEX TRANSM INFECT, V81, P333, DOI 10.1136/sti.2004.013516; Lisspers J, 1997, ACTA PSYCHIAT SCAND, V96, P281, DOI 10.1111/j.1600-0447.1997.tb10164.x; Marsh H.W., 1995, STRUCTURAL EQUATION, P177; Marsh HW, 1996, J PERS SOC PSYCHOL, V70, P810, DOI 10.1037/0022-3514.70.4.810; Martin CR, 2008, J EVAL CLIN PRACT, V14, P281, DOI 10.1111/j.1365-2753.2007.00850.x; Martin CR, 2005, CURR PSYCHIATRY REV, V1, P69, DOI 10.2174/1573400052953510; Martin CR, 2004, BRIT J CLIN PSYCHOL, V43, P51, DOI 10.1348/014466504772812968; Matsudaira T, 2009, HEALTH QUAL LIFE OUT, V7, DOI 10.1186/1477-7525-7-42; Meade CS, 2005, CLIN PSYCHOL REV, V25, P433, DOI 10.1016/j.cpr.2005.02.001; Montazeri Ali, 2003, Health Qual Life Outcomes, V1, P14, DOI 10.1186/1477-7525-1-14; MUTHEN B, 1984, PSYCHOMETRIKA, V49, P115, DOI 10.1007/BF02294210; Muthen L.K., 1998, MPLUS USERS GUIDE, V8th; Myer L, 2008, AIDS PATIENT CARE ST, V22, P147, DOI 10.1089/apc.2007.0102; Quilty LC, 2006, STRUCT EQU MODELING, V13, P99, DOI 10.1207/s15328007sem1301_5; Rauch WA, 2007, PERS INDIV DIFFER, V42, P1597, DOI 10.1016/j.paid.2006.10.035; Raykov T, 2009, MEAS EVAL COUNS DEV, V42, P223, DOI 10.1177/0748175609344096; RAZAVI D, 1990, BRIT J PSYCHIAT, V156, P79, DOI 10.1192/bjp.156.1.79; Reda AA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016049; Schmitt DP, 2005, J PERS SOC PSYCHOL, V89, P623, DOI 10.1037/0022-3514.89.4.623; Schonberger M, 2010, PSYCHIAT RES, V179, P342, DOI 10.1016/j.psychres.2009.07.003; Smit J, 2006, PUBLIC HEALTH, V120, P534, DOI 10.1016/j.puhe.2006.01.009; SNAITH RP, 1986, BRIT MED J, V292, P344, DOI 10.1136/bmj.292.6516.344; Tomas JM, 1999, STRUCT EQU MODELING, V6, P84, DOI 10.1080/10705519909540120; UNAIDS, 2010, GLOB REP UNAIDS REP; Van der Bijl H, S AFRICAN J PSYCHIAT, V13, P46; Weems G. H., 2003, ASSESS EVAL HIGH EDU, V28, P587, DOI DOI 10.1080/0260293032000130234; Ye SQ, 2009, PERS INDIV DIFFER, V46, P197, DOI 10.1016/j.paid.2008.09.027; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	61	29	30	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2012	7	4							e34881	10.1371/journal.pone.0034881	http://dx.doi.org/10.1371/journal.pone.0034881			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959UD	22536338	Green Published, Green Submitted, gold			2022-12-25	WOS:000305339200026
J	Zhang, Y; Xu, ST; Wang, HL; Zhu, Z; Ji, YX; Liu, CY; Zhang, XJ; Sun, LW; Zhou, JH; Lu, PS; Hu, Y; Feng, DX; Zhang, ZY; Wang, CY; Fang, XQ; Zheng, HY; Liu, L; Sun, XD; Tang, W; Wang, Y; Liu, Y; Gao, H; Tian, H; Ma, JT; Gu, SY; Wang, S; Feng, Y; Bo, F; Liu, JF; Si, Y; Zhou, SJ; Ma, YY; Wu, SW; Zhou, SD; Li, FC; Ding, ZR; Yang, ZH; Rota, PA; Featherstone, D; Jee, Y; Bellini, WJ; Xu, WB				Zhang, Yan; Xu, Songtao; Wang, Huiling; Zhu, Zhen; Ji, Yixin; Liu, Chunyu; Zhang, Xiaojie; Sun, Liwei; Zhou, Jianhui; Lu, Peishan; Hu, Ying; Feng, Daxing; Zhang, Zhenying; Wang, Changyin; Fang, Xueqiang; Zheng, Huanying; Liu, Leng; Sun, Xiaodong; Tang, Wei; Wang, Yan; Liu, Yan; Gao, Hui; Tian, Hong; Ma, Jiangtao; Gu, Suyi; Wang, Shuang; Feng, Yan; Bo, Fang; Liu, Jianfeng; Si, Yuan; Zhou, Shujie; Ma, Yuyan; Wu, Shengwei; Zhou, Shunde; Li, Fangcai; Ding, Zhengrong; Yang, Zhaohui; Rota, Paul A.; Featherstone, David; Jee, Youngmee; Bellini, William J.; Xu, Wenbo			Single Endemic Genotype of Measles Virus Continuously Circulating in China for at Least 16 Years	PLOS ONE			English	Article							REPUBLIC-OF-CHINA; GENETIC-CHARACTERIZATION; MOLECULAR EPIDEMIOLOGY; UNITED-STATES; ELIMINATION	The incidence of measles in China from 1991 to 2008 was reviewed, and the nucleotide sequences from 1507 measles viruses (MeV) isolated during 1993 to 2008 were phylogenetically analyzed. The results showed that measles epidemics peaked approximately every 3 to 5 years with the range of measles cases detected between 56,850 and 140,048 per year. The Chinese MeV strains represented three genotypes; 1501 H1, 1 H2 and 5 A. Genotype H1 was the predominant genotype throughout China continuously circulating for at least 16 years. Genotype H1 sequences could be divided into two distinct clusters, H1a and H1b. A 4.2% average nucleotide divergence was found between the H1a and H1b clusters, and the nucleotide sequence and predicted amino acid homologies of H1a viruses were 92.3%-100% and 84.7%-100%, H1b were 97.1%-100% and 95.3%-100%, respectively. Viruses from both clusters were distributed throughout China with no apparent geographic restriction and multiple co-circulating lineages were present in many provinces. Cluster H1a and H1b viruses were co-circulating during 1993 to 2005, while no H1b viruses were detected after 2005 and the transmission of that cluster has presumably been interrupted. Analysis of the nucleotide and predicted amino acid changes in the N proteins of H1a and H1b viruses showed no evidence of selective pressure. This study investigated the genotype and cluster distribution of MeV in China over a 16-year period to establish a genetic baseline before MeV elimination in Western Pacific Region (WPR). Continuous and extensive MeV surveillance and the ability to quickly identify imported cases of measles will become more critical as measles elimination goals are achieved in China in the near future. This is the first report that a single endemic genotype of measles virus has been found to be continuously circulating in one country for at least 16 years.	[Zhang, Yan; Xu, Songtao; Wang, Huiling; Zhu, Zhen; Ji, Yixin; Xu, Wenbo] China Ctr Dis Control & Prevent, Natl Inst Viral Dis Control & Prevent, WHO WPRO Reg Reference Measles Lab, Beijing, Peoples R China; [Liu, Chunyu] Chinese Acad Med Sci, Inst Pathogen Biol, Beijing 100730, Peoples R China; [Liu, Chunyu] Peking Union Med Coll, Beijing 100021, Peoples R China; [Zhang, Xiaojie; Sun, Liwei] Changchun Childrens Hosp, Changchun, Jilin, Peoples R China; [Zhou, Jianhui; Wang, Shuang] Jilin Prov Ctr Dis Control & Prevent, Changchun, Jilin, Peoples R China; [Lu, Peishan; Hu, Ying] Jiangsu Prov Ctr Dis Control & Prevent, Nanjing, Jiangsu, Peoples R China; [Feng, Daxing; Zhang, Zhenying] Henan Prov Ctr Dis Control & Prevent, Zhengzhou, Henan, Peoples R China; [Wang, Changyin; Fang, Xueqiang] Shandong Prov Ctr Dis Control & Prevent, Jinan, Shandong, Peoples R China; [Zheng, Huanying; Liu, Leng] Guangdong Prov Ctr Dis Control & Prevent, Guangzhou, Guangdong, Peoples R China; [Sun, Xiaodong; Tang, Wei] Shanghai Prov Ctr Dis Control & Prevent, Shanghai, Peoples R China; [Wang, Yan] Liaoning Prov Ctr Dis Control & Prevent, Shenyang, Liaoning, Peoples R China; [Liu, Yan] Hebei Prov Ctr Dis Control & Prevent, Baoding, Hebei, Peoples R China; [Gao, Hui] Shanxi Prov Ctr Dis Control & Prevent, Taiyuan, Shanxi, Peoples R China; [Tian, Hong] Tianjin Prov Ctr Dis Control & Prevent, Tianjin, Peoples R China; [Ma, Jiangtao] Ningxia Prov Ctr Dis Control & Prevent, Ningxia, Peoples R China; [Gu, Suyi] Innermongolia Prov Ctr Dis Control & Prevent, Hohhot, Innermongolia, Peoples R China; [Feng, Yan] Zhejiang Prov Ctr Dis Control & Prevent, Hangzhou, Zhejiang, Peoples R China; [Bo, Fang] Heilongjiang Prov Ctr Dis Control & Prevent, Haerbin, Heilongjiang, Peoples R China; [Liu, Jianfeng] Gansu Prov Ctr Dis Control & Prevent, Lanzhou, Gansu, Peoples R China; [Si, Yuan] Shannxi Prov Ctr Dis Control & Prevent, Xian, Shannxi, Peoples R China; [Zhou, Shujie] Anhui Prov Ctr Dis Control & Prevent, Hefei, Anhui, Peoples R China; [Ma, Yuyan] Guangxi Prov Ctr Dis Control & Prevent, Nanning, Guangxi, Peoples R China; [Wu, Shengwei] Guizhou Prov Ctr Dis Control & Prevent, Guiyang, Guizhou, Peoples R China; [Zhou, Shunde] Jiangxi Prov Ctr Dis Control & Prevent, Nanchang, Jiangxi, Peoples R China; [Li, Fangcai] Hunan Prov Ctr Dis Control & Prevent, Changsha, Hunan, Peoples R China; [Ding, Zhengrong] Yunnan Prov Ctr Dis Control & Prevent, Kunming, Yunnan, Peoples R China; [Yang, Zhaohui] Hubei Prov Ctr Dis Control & Prevent, Wuhan, Hubei, Peoples R China; [Rota, Paul A.; Bellini, William J.] Ctr Dis Control & Prevent, Div Viral Dis, Atlanta, GA USA; [Featherstone, David] WHO, CH-1211 Geneva, Switzerland; [Jee, Youngmee] WHO, Western Pacific Reg Off, Expanded Programme Immunizat, Manila, Philippines	Chinese Center for Disease Control & Prevention; National Institute for Viral Disease Control & Prevention, Chinese Center for Disease Control & Prevention; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Pathogen Biology - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Jiangsu Provincial Center for Disease Control & Prevention; Chinese Center for Disease Control & Prevention; Guangdong Provincial Center for Disease Control & Prevention; Shanghai Center for Disease Control & Prevention; Tianjin Center for Disease Control & Prevention; Zhejiang Provincial Center for Disease Control & Prevention; Centers for Disease Control & Prevention - USA; World Health Organization; WHO Western Pacific Regional Office; World Health Organization	Xu, WB (corresponding author), China Ctr Dis Control & Prevent, Natl Inst Viral Dis Control & Prevent, WHO WPRO Reg Reference Measles Lab, Beijing, Peoples R China.	wenbo_xu1@yahoo.com.cn	Jee, Youngmee/AGW-0164-2022	Jee, Youngmee/0000-0001-5369-6628	WHO; WHO headquarters, WPRO, US CDC	WHO(World Health Organization); WHO headquarters, WPRO, US CDC	This study was supported by the grants of WHO fund for WPRO Measles Regional Reference Laboratory. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank all the provincial and prefecture measles laboratory staffs and epidemiologists in mainland China for providing clinical specimens, isolates and epidemiologic data; We thank WHO headquarters, WPRO, US CDC for the technical and financial support. We also acknowledge anonymous reviewers for comments that improved the manuscript.	[Anonymous], 2009, Wkly Epidemiol Rec, V84, P509; [Anonymous], WKLY EPIDEMIOL REC; Bellini WJ, 1998, EMERG INFECT DIS, V4, P29, DOI 10.3201/eid0401.980105; Cui AL, 2009, INFECT GENET EVOL, V9, P71, DOI 10.1016/j.meegid.2008.10.004; Ji YX, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-105; Ji Yixin, 2009, Virol J, V6, P135, DOI 10.1186/1743-422X-6-135; KOBUNE F, 1990, J VIROL, V64, P700, DOI 10.1128/JVI.64.2.700-705.1990; Liffick SL, 2001, VIRUS RES, V77, P81, DOI 10.1016/S0168-1702(01)00268-4; Ma C, 2011, J INFECT DIS, V204, pS447, DOI 10.1093/infdis/jir103; Ono N, 2001, J VIROL, V75, P4399, DOI 10.1128/JVI.75.9.4399-4401.2001; Rota JS, 1998, J INFECT DIS, V177, P204, DOI 10.1086/513825; Rota PA, 2003, J INFECT DIS, V187, pS270, DOI 10.1086/368042; Rota PA, 2002, EMERG INFECT DIS, V8, P902, DOI 10.3201/eid0809.020206; Wang Hui-ling, 2010, Chinese Journal of Virology, V26, P103; WHO, 2005, Wkly Epidemiol Rec, V80, P347; WHO, 2005, 56 SESS WHO REG COMM; WHO, 2003, WKLY EPIDEMIOL REC, V78, P229; *WHO, 2001, WKLY EPIDEMIOL REC, V76, P241; World Health Organization, 2005, Wkly Epidemiol Rec, V80, P384; World Health Organization, 2001, WKLY EPIDEMIOL REC, V76, P249; Xu WB, 1998, VIRUS RES, V54, P147, DOI 10.1016/S0168-1702(98)00020-3; Yang ZH, 2000, TRENDS ECOL EVOL, V15, P496, DOI 10.1016/S0169-5347(00)01994-7; Zhang Y, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-14; Zhang Y, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-120; Zhang Yan, 2009, Zhongguo Yi Miao He Mian Yi, V15, P304; Zhang Y, 2010, EMERG INFECT DIS, V16, P943, DOI 10.3201/eid1606.100089; Zhang Y, 2010, J CLIN MICROBIOL, V48, P619, DOI 10.1128/JCM.02338-09; Zhang Y, 2009, J CLIN VIROL, V44, P262, DOI 10.1016/j.jcv.2009.02.002; Zhu Z, 2010, J CLIN MICROBIOL, V48, P1775, DOI 10.1128/JCM.02055-09	29	20	31	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2012	7	4							e34401	10.1371/journal.pone.0034401	http://dx.doi.org/10.1371/journal.pone.0034401			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UD	22532829	Green Published, gold, Green Submitted			2022-12-25	WOS:000305339200013
J	Taniuchi, K; Yokotani, K; Saibara, T				Taniuchi, Keisuke; Yokotani, Kunihiko; Saibara, Toshiji			BART Inhibits Pancreatic Cancer Cell Invasion by PKC alpha Inactivation through Binding to ANX7	PLOS ONE			English	Article							PROTEIN-KINASE-C; TUMOR-SUPPRESSOR GENE; POSTTRANSCRIPTIONAL REGULATION; MIGRATION; PROLIFERATION; ACTIVATION; CLONING; MOUSE; G3BP	A novel function for the binder of Arl two (BART) molecule in pancreatic cancer cells is reported. BART inhibits invasiveness of pancreatic cancer cells through binding to a Ca2+-dependent, phosphorylated, guanosine triphosphatase (GTPase) membrane fusion protein, annexin7 (ANX7). A tumor suppressor function for ANX7 was previously reported based on its prognostic role in human cancers and the cancer-prone mouse phenotype ANX7(+/-). Further investigation demonstrated that the BART-ANX7 complex is transported toward cell protrusions in migrating cells when BART supports the binding of ANX7 to the protein kinase C (PKC) isoform PKC alpha. Recent evidence has suggested that phosphorylation of ANX7 by PKC significantly potentiates ANX7-induced fusion of phospholipid vesicles; however, the current data suggest that the BART-ANX7 complex reduces PKC alpha activity. Knocking down endogenous BART and ANX7 increases activity of PKC alpha, and specific inhibitors of PKC alpha significantly abrogate invasiveness induced by BART and ANX7 knockdown. These results imply that BART contributes to regulating PKC alpha activity through binding to ANX7, thereby affecting the invasiveness of pancreatic cancer cells. Thus, it is possible that BART and ANX7 can distinctly regulate the downstream signaling of PKC alpha that is potentially relevant to cell invasion by acting as anti-invasive molecules.	[Taniuchi, Keisuke; Yokotani, Kunihiko] Kochi Univ, Sch Med, Dept Pharmacol, Nanko Ku, Kochi 780, Japan; [Saibara, Toshiji] Kochi Univ, Dept Gastroenterol & Hepatol, Sch Med, Nanko Ku, Kochi 780, Japan	Kochi University; Kochi University	Taniuchi, K (corresponding author), Kochi Univ, Sch Med, Dept Pharmacol, Nanko Ku, Kochi 780, Japan.	ktaniuchi@kochi-u.ac.jp			Ministry of Health, Labour, and Welfare of Japan	Ministry of Health, Labour, and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan)	This work was supported by a Grant-in-Aid from the Ministry of Health, Labour, and Welfare of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahrendt SA, 2002, ONCOLOGY-NY, V16, P725; Baumgart M, 2005, CELL ONCOL, V27, P3; CLARK J, 1993, P NATL ACAD SCI USA, V90, P8952, DOI 10.1073/pnas.90.19.8952; Edwards AS, 1997, J BIOL CHEM, V272, P18382, DOI 10.1074/jbc.272.29.18382; Haughian JM, 2009, J CELL PHYSIOL, V220, P112, DOI 10.1002/jcp.21741; Huang C, 2004, J CELL SCI, V117, P4619, DOI 10.1242/jcs.01481; Hung CH, 2001, J BIOL CHEM, V276, P12813, DOI 10.1074/jbc.M008482200; Huttenlocher A, 1998, J CELL BIOL, V141, P515, DOI 10.1083/jcb.141.2.515; IWAMURA T, 1987, JPN J CANCER RES, V78, P54; Jiang XH, 2004, CANCER RES, V64, P5787, DOI 10.1158/0008-5472.CAN-03-1172; Mauro LV, 2010, PANCREAS, V39, pE31, DOI 10.1097/MPA.0b013e3181bce796; Mellor H, 1998, BIOCHEM J, V332, P281, DOI 10.1042/bj3320281; Musashi M, 2000, INT J HEMATOL, V72, P12; NISHIZUKA Y, 1995, FASEB J, V9, P484, DOI 10.1096/fasebj.9.7.7737456; NISHIZUKA Y, 1988, NATURE, V334, P661, DOI 10.1038/334661a0; Nomura N, 2007, MOL VIS, V13, P2320; Park MJ, 2000, NEUROSCI LETT, V290, P201, DOI 10.1016/S0304-3940(00)01358-6; Ron D, 1999, FASEB J, V13, P1658, DOI 10.1096/fasebj.13.13.1658; Schonwasser DC, 1998, MOL CELL BIOL, V18, P790, DOI 10.1128/MCB.18.2.790; Sharer JD, 1999, J BIOL CHEM, V274, P27553, DOI 10.1074/jbc.274.39.27553; Srivastava M, 2003, P NATL ACAD SCI USA, V100, P14287, DOI 10.1073/pnas.2235927100; Srivastava M, 2001, P NATL ACAD SCI USA, V98, P4575, DOI 10.1073/pnas.071055798; Srivastava M, 1999, P NATL ACAD SCI USA, V96, P13783, DOI 10.1073/pnas.96.24.13783; Taniuchi K, 2011, INT J ONCOL, V39, P1243, DOI 10.3892/ijo.2011.1156; Taniuchi K, 2011, MOL CANCER RES, V9, P856, DOI 10.1158/1541-7786.MCR-10-0574; Taniuchi K, 2011, CANCER RES, V71, P895, DOI 10.1158/0008-5472.CAN-10-2743; Waterman-Storer CM, 2000, MOL BIOL CELL, V11, P2471, DOI 10.1091/mbc.11.7.2471; Wu TT, 2008, J CELL BIOCHEM, V103, P9, DOI 10.1002/jcb.21378; Zhou CJ, 2006, MOL BIOL CELL, V17, P2476, DOI 10.1091/mbc.E05-10-0929	29	14	17	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2012	7	4							e35674	10.1371/journal.pone.0035674	http://dx.doi.org/10.1371/journal.pone.0035674			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TL	22532868	gold, Green Published, Green Submitted			2022-12-25	WOS:000305336200064
J	Eisen, RJ; Borchert, JN; Mpanga, JT; Atiku, LA; MacMillan, K; Boegler, KA; Montenieri, JA; Monaghan, A; Gage, KL				Eisen, Rebecca J.; Borchert, Jeff N.; Mpanga, Joseph T.; Atiku, Linda A.; MacMillan, Katherine; Boegler, Karen A.; Montenieri, John A.; Monaghan, Andrew; Gage, Kenneth L.			Flea Diversity as an Element for Persistence of Plague Bacteria in an East African Plague Focus	PLOS ONE			English	Article							WESTERN USAMBARA MOUNTAINS; EARLY-PHASE TRANSMISSION; SOUTHWESTERN UNITED-STATES; YERSINIA-PESTIS; ENDEMIC REGION; NILE REGION; NEW-MEXICO; CLIMATE; RISK; RODENTS	Plague is a flea-borne rodent-associated zoonotic disease that is caused by Yersinia pestis and characterized by long quiescent periods punctuated by rapidly spreading epidemics and epizootics. How plague bacteria persist during inter-epizootic periods is poorly understood, yet is important for predicting when and where epizootics are likely to occur and for designing interventions aimed at local elimination of the pathogen. Existing hypotheses of how Y. pestis is maintained within plague foci typically center on host abundance or diversity, but little attention has been paid to the importance of flea diversity in enzootic maintenance. Our study compares host and flea abundance and diversity along an elevation gradient that spans from low elevation sites outside of a plague focus in the West Nile region of Uganda (similar to 725-1160 m) to higher elevation sites within the focus (similar to 1380-1630 m). Based on a year of sampling, we showed that host abundance and diversity, as well as total flea abundance on hosts was similar between sites inside compared with outside the plague focus. By contrast, flea diversity was significantly higher inside the focus than outside. Our study highlights the importance of considering flea diversity in models of Y. pestis persistence.	[Eisen, Rebecca J.; Borchert, Jeff N.; MacMillan, Katherine; Boegler, Karen A.; Montenieri, John A.; Gage, Kenneth L.] Ctr Dis Control & Prevent, Div Vector Borne Dis, Ft Collins, CO USA; [Mpanga, Joseph T.; Atiku, Linda A.] Uganda Virus Res Inst, Entebbe, Uganda; [Monaghan, Andrew] Natl Ctr Atmospher Res, Boulder, CO 80307 USA	Centers for Disease Control & Prevention - USA; Uganda Virus Research Institute; National Center Atmospheric Research (NCAR) - USA	Eisen, RJ (corresponding author), Ctr Dis Control & Prevent, Div Vector Borne Dis, Ft Collins, CO USA.	dyn2@cdc.gov	Borchert, Jeff/GSD-7753-2022	Monaghan, Andrew/0000-0002-8170-2359	Centers for Disease Control and Prevention's Climate and Health Program; US Agency for International Development Emerging Pandemic Threats Program	Centers for Disease Control and Prevention's Climate and Health Program; US Agency for International Development Emerging Pandemic Threats Program(United States Agency for International Development (USAID))	This study was funded by the Centers for Disease Control and Prevention's Climate and Health Program and the US Agency for International Development Emerging Pandemic Threats Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amatre G, 2009, AM J TROP MED HYG, V81, P718, DOI 10.4269/ajtmh.2009.09-0104; Anisimov AP, 2004, CLIN MICROBIOL REV, V17, P434, DOI 10.1128/CMR.17.2.434-464.2004; Bacot A W, 1914, J Hyg (Lond), V13, P423; Brown HE, 2010, AM J TROP MED HYG, V82, P95, DOI 10.4269/ajtmh.2010.09-0247; BURROUGHS AL, 1953, PARASITOLOGY, V43, P35, DOI 10.1017/S0031182000018321; CAMPBELL GL, 1995, ANN INTERN MED, V122, P151, DOI 10.7326/0003-4819-122-2-199501150-00014; DAVIS DHS, 1968, T ROY SOC TROP MED H, V62, P838, DOI 10.1016/0035-9203(68)90013-8; Davis S, 2004, SCIENCE, V304, P736, DOI 10.1126/science.1095854; Eisen RJ, 2008, AM J TROP MED HYG, V78, P949, DOI 10.4269/ajtmh.2008.78.949; Eisen RJ, 2007, J MED ENTOMOL, V44, P678, DOI 10.1603/0022-2585(2007)44[678:ETOYPB]2.0.CO;2; Eisen RJ, 2007, AM J TROP MED HYG, V77, P121, DOI 10.4269/ajtmh.2007.77.121; Eisen RJ, 2007, J MED ENTOMOL, V44, P530, DOI 10.1603/0022-2585(2007)44[530:HPITSU]2.0.CO;2; Eisen RJ, 2010, AM J TROP MED HYG, V82, P904, DOI 10.4269/ajtmh.2010.09-0737; Eisen RJ, 2009, VET RES, V40, DOI 10.1051/vetres:2008039; Enscore RE, 2002, AM J TROP MED HYG, V66, P186, DOI 10.4269/ajtmh.2002.66.186; Gage KL, 2008, AM J PREV MED, V35, P436, DOI 10.1016/j.amepre.2008.08.030; Gage KL, 2005, ANNU REV ENTOMOL, V50, P505, DOI 10.1146/annurev.ento.50.071803.130337; Gratz N., 1999, PLAGUE MANUAL EPIDEM, V6, P63; Haselbarth E, 1966, ARTHROPOD PARASITES, P117; Hopkins G. H. E., 1947, Uganda Journal, V11, P133; Hopkins G. H. E., 1966, ILLUSTRATED CATALOGU; Hopkins G.H.E., 1949, REPORT RATS FLEAS PL; ISAACSON M, 1981, J INFECT DIS, V144, P80, DOI 10.1093/infdis/144.1.80; Kausrud KL, 2007, P ROY SOC B-BIOL SCI, V274, P1963, DOI 10.1098/rspb.2007.0568; Kilonzo B.S., 1976, East Afr J med Res, V3, P117; KILONZO BS, 1992, ACTA TROP, V50, P323, DOI 10.1016/0001-706X(92)90067-8; Kilonzo BS, 1977, SIMPLE LIGHT TRAP FI; Krasnov B.R., 2008, FUNCTIONAL EVOLUTION; Krasnov BR, 2001, J MED ENTOMOL, V38, P629, DOI 10.1603/0022-2585-38.5.629; Laudisoit Anne, 2009, Current Zoology, V55, P200; Link VB, 1955, HIST PLAGUE US; Liu Y., 2000, ATLAS PLAGUE ITS ENV; MacMillan K, 2012, AM J TROP MED HYG, V86, P514, DOI 10.4269/ajtmh.2012.11-0569; Monaghan AJ, 2012, J APPL METE IN PRESS; Msangi A.S., 1975, University Sci J Dar-es-Salaam, V1, P8; Nakazawa Y, 2007, VECTOR-BORNE ZOONOT, V7, P529, DOI 10.1089/vbz.2007.0125; Neerinckx S, 2010, AM J TROP MED HYG, V82, P492, DOI 10.4269/ajtmh.2010.09-0426; Neerinckx S, 2010, VECTOR-BORNE ZOONOT, V10, P101; Neerinckx SB, 2008, INT J HEALTH GEOGR, V7, DOI 10.1186/1476-072X-7-54; NJUNWA KJ, 1989, MED VET ENTOMOL, V3, P17, DOI 10.1111/j.1365-2915.1989.tb00469.x; Perry RD, 1997, CLIN MICROBIOL REV, V10, P35, DOI 10.1128/CMR.10.1.35; POLLITZER B., 1954, Plague; SIMPSON EH, 1949, NATURE, V163, P688, DOI 10.1038/163688a0; Skamarock WC, 2008, J COMPUT PHYS, V227, P3465, DOI 10.1016/j.jcp.2007.01.037; Smit F.G.A.M., 1973, P325; Stenseth NC, 2006, P NATL ACAD SCI USA, V103, P13110, DOI 10.1073/pnas.0602447103; Tikhomirov E., 1999, PLAGUE MANUAL EPIDEM, P11; TURNER R. W., 1974, Bull. Hlth. Stud. Indonesia, V2, P15; VELIMIROVIC B, 1969, Z TROPENMED PARASIT, V20, P373; Vetter SM, 2010, MICROBIOL-SGM, V156, P2216, DOI 10.1099/mic.0.037952-0; Winters AM, 2009, AM J TROP MED HYG, V80, P1014, DOI 10.4269/ajtmh.2009.80.1014	51	31	35	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2012	7	4							e35598	10.1371/journal.pone.0035598	http://dx.doi.org/10.1371/journal.pone.0035598			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959XD	22530057	Green Submitted, Green Published, gold			2022-12-25	WOS:000305350600103
J	Li, QR; Wang, CY; Tang, C; Li, N; Li, JS				Li, Qiurong; Wang, Chenyang; Tang, Chun; Li, Ning; Li, Jieshou			Molecular-Phylogenetic Characterization of the Microbiota in Ulcerated and Non-Ulcerated Regions in the Patients with Crohn's Disease	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; INVASIVE ESCHERICHIA-COLI; FECAL MICROBIOTA; ILEAL MUCOSA; MICROFLORA; FLORA; SUSCEPTIBILITY; PREVALENCE; BACTERIA; EPIDEMIOLOGY	Background: The dysbiosis of intestinal microbiota has been established in Crohn's disease (CD), but the molecular characterization of this dysbiosis in Chinese subjects with CD remains unclear. This study aims to investigate the predominant bacterial composition of the faecal and mucosal-associated microbiota in Chinese CD patients using culture-independent techniques. Methods/Principal Findings: Eighteen patients with CD and 9 healthy controls were included in this study. The faeces and the intestinal mucosal tissues from the ulcerated and nonulcerated sites were subjected to bacterial community fingerprinting using denaturing gradient gel electrophoresis (DGGE). The predominant bacterial composition in the faeces and mucosa was determined with DNA sequencing and BLAST. We showed that the bacterial diversity in the faeces of CD patients was reduced compared with that in healthy controls (p<0.01). The faecal bacterial dysbiosis of the patients was characterized by an elevated abundance of gamma-Proteobacteria (especially Escherichia coli and Shigella flexneri) and a reduced proportion of Bacteroidetes and Firmicutes. Five bacterial species defined the microbiota imbalance of the ulcerated mucosa in CD, including an increase in Escherichia coli, a decrease in Faecalibacterium prausnitzii, Lactobacillus coleohominis, Bacteroides sp and Streptococcus gallolyticus in the bacterial community as compared with the nonulcerated (p<0.01). Conclusions/Significance: This is the first description of intestinal microbiota dysbiosis in Chinese CD patients. These results allow a better understanding of the faecal and mucosal microbiota in CD, showing a predominance of some opportunistic pathogenic bacteria and a decrease in beneficial bacterial species. The findings may provide novel insights into the pathogenesis of CD in Chinese population.	[Li, Qiurong; Wang, Chenyang; Tang, Chun; Li, Ning; Li, Jieshou] Jinling Hosp, Res Inst Gen Surg, Nanjing, Jiangsu, Peoples R China; [Li, Qiurong; Wang, Chenyang; Li, Ning; Li, Jieshou] Nanjing Univ, Sch Med, Dept Surg, Nanjing, Jiangsu, Peoples R China	Nanjing University	Li, QR (corresponding author), Jinling Hosp, Res Inst Gen Surg, Nanjing, Jiangsu, Peoples R China.	liqiurong@yahoo.com	Li, jie/GXG-4583-2022		National Natural Science Foundation in China [81070375]; Key Project of National Natural Science Foundation in China [30830098]; National High-tech R&D Program (863 Program) of China [2012AA021007]; National Basic Research Program (973 Program) in China [2009CB522405]; Scientific Research Fund in Jiangsu Province [BK2009317]; Deutscher Akademischer Austauschdienst Researcher Fellowship (Bioscience Special Program, Germany)	National Natural Science Foundation in China(National Natural Science Foundation of China (NSFC)); Key Project of National Natural Science Foundation in China(National Natural Science Foundation of China (NSFC)); National High-tech R&D Program (863 Program) of China(National High Technology Research and Development Program of China); National Basic Research Program (973 Program) in China(National Basic Research Program of China); Scientific Research Fund in Jiangsu Province; Deutscher Akademischer Austauschdienst Researcher Fellowship (Bioscience Special Program, Germany)(Deutscher Akademischer Austausch Dienst (DAAD))	This work was supported by the National Natural Science Foundation in China (81070375), Key Project of National Natural Science Foundation in China (30830098), National High-tech R&D Program (863 Program) of China (2012AA021007), National Basic Research Program (973 Program) in China (No. 2009CB522405) and Scientific Research Fund in Jiangsu Province (BK2009317). The funders of the study had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the Deutscher Akademischer Austauschdienst Researcher Fellowship (Bioscience Special Program, Germany) for Dr. Qiurong Li.	Andoh A, 2009, ALIMENT PHARM THER, V29, P75, DOI 10.1111/j.1365-2036.2008.03860.x; BENNO Y, 1989, APPL ENVIRON MICROB, V55, P1100, DOI 10.1128/AEM.55.5.1100-1105.1989; Bercik P, 2011, GASTROENTEROLOGY, V141, P599, DOI 10.1053/j.gastro.2011.04.052; BEST WR, 1976, GASTROENTEROLOGY, V70, P439; Bibiloni R, 2006, J MED MICROBIOL, V55, P1141, DOI 10.1099/jmm.0.46498-0; Cho JH, 1998, P NATL ACAD SCI USA, V95, P7502, DOI 10.1073/pnas.95.13.7502; D'Haens GR, 1998, GASTROENTEROLOGY, V114, P262, DOI 10.1016/S0016-5085(98)70476-7; Darfeuille-Michaud A, 1998, GASTROENTEROLOGY, V115, P1405, DOI 10.1016/S0016-5085(98)70019-8; Darfeuille-Michaud A, 2004, GASTROENTEROLOGY, V127, P412, DOI 10.1053/j.gastro.2004.04.061; Darfeuille-Michaud A, 2002, INT J MED MICROBIOL, V292, P185, DOI 10.1078/1438-4221-00201; Dicksved J, 2007, APPL ENVIRON MICROB, V73, P2284, DOI 10.1128/AEM.02223-06; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; El-Tawil AM, 2004, INT J COLORECTAL DIS, V19, P498, DOI 10.1007/s00384-004-0605-5; Elson CO, 2002, NEW ENGL J MED, V346, P614, DOI 10.1056/NEJM200202213460812; Frank DN, 2007, P NATL ACAD SCI USA, V104, P13780, DOI 10.1073/pnas.0706625104; GIAFFER MH, 1991, J MED MICROBIOL, V35, P238, DOI 10.1099/00222615-35-4-238; Guarner F, 2003, LANCET, V361, P512, DOI 10.1016/S0140-6736(03)12489-0; Hooper LV, 2001, SCIENCE, V292, P1115, DOI 10.1126/science.1058709; Hooper LV, 2001, SCIENCE, V291, P881, DOI 10.1126/science.291.5505.881; Hugot JP, 2003, LANCET, V362, P2012, DOI 10.1016/S0140-6736(03)15024-6; Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107; Kleessen B, 2002, SCAND J GASTROENTERO, V37, P1034, DOI 10.1080/003655202320378220; Lay C, 2005, APPL ENVIRON MICROB, V71, P4153, DOI 10.1128/AEM.71.7.4153-4155.2005; LENNARDJONES JE, 1989, SCAND J GASTROENTERO, V24, P2, DOI 10.3109/00365528909091339; Leong RWL, 2004, INFLAMM BOWEL DIS, V10, P646, DOI 10.1097/00054725-200409000-00022; Li QR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020460; Loftus EV, 2004, GASTROENTEROLOGY, V126, P1504, DOI 10.1053/j.gastro.2004.01.063; Mai V, 2004, J NUTR, V134, P473, DOI 10.1093/jn/134.2.473; Mai V, 2009, NUTR J, V8, DOI 10.1186/1475-2891-8-49; Manichanh C, 2006, GUT, V55, P205, DOI 10.1136/gut.2005.073817; Marteau P, 2004, ALIMENT PHARM THER, V20, P18, DOI 10.1111/j.1365-2036.2004.02062.x; Martin HM, 2004, GASTROENTEROLOGY, V127, P80, DOI 10.1053/j.gastro.2004.03.054; Martinez-Medina M, 2006, INFLAMM BOWEL DIS, V12, P1136, DOI 10.1097/01.mib.0000235828.09305.0c; Ng SC, 2012, INFLAMM BOWEL DIS, V18, P1164, DOI 10.1002/ibd.21845; Ogura Y, 2001, NATURE, V411, P603, DOI 10.1038/35079114; Ott SJ, 2004, GUT, V53, P685, DOI 10.1136/gut.2003.025403; RUSELERVANEMBDEN JGH, 1983, A VAN LEEUW J MICROB, V49, P125, DOI 10.1007/BF00393670; RUTGEERTS P, 1991, LANCET, V338, P771, DOI 10.1016/0140-6736(91)90663-A; Sartor RB, 2008, GASTROENTEROLOGY, V134, P577, DOI 10.1053/j.gastro.2007.11.059; Sartor RB, 1997, INFLAMM BOWEL DIS, V3, P230, DOI 10.1002/ibd.3780030309; Sasaki M, 2007, LAB INVEST, V87, P1042, DOI 10.1038/labinvest.3700661; Seksik P, 2006, ALIMENT PHARM THER, V24, P11, DOI 10.1111/j.1365-2036.2006.03053.x; Seksik P, 2003, GUT, V52, P237, DOI 10.1136/gut.52.2.237; Shanon CE, 1963, MATH THEORY COMMUNIC; Sokol H, 2006, INFLAMM BOWEL DIS, V12, P106, DOI 10.1097/01.MIB.0000200323.38139.c6; Sokol H, 2008, P NATL ACAD SCI USA, V105, P16731, DOI 10.1073/pnas.0804812105; Swidsinski A, 2002, GASTROENTEROLOGY, V122, P44, DOI 10.1053/gast.2002.30294; Vanhoutte T, 2006, APPL ENVIRON MICROB, V72, P5990, DOI 10.1128/AEM.00233-06; Zheng JJ, 2010, J DIGEST DIS, V11, P161, DOI 10.1111/j.1751-2980.2010.00431.x; Zoetendal EG, 2002, APPL ENVIRON MICROB, V68, P3401, DOI 10.1128/AEM.68.7.3401-3407.2002	50	40	44	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2012	7	4							e34939	10.1371/journal.pone.0034939	http://dx.doi.org/10.1371/journal.pone.0034939			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959XD	22529960	Green Published, Green Submitted, gold			2022-12-25	WOS:000305350600045
J	Bao, H; Duong, F				Bao, Huan; Duong, Franck			Discovery of an Auto-Regulation Mechanism for the Maltose ABC Transporter MalFGK(2)	PLOS ONE			English	Article							BINDING CASSETTE TRANSPORTER; ESCHERICHIA-COLI; LIGAND-BINDING; MATHEMATICAL TREATMENT; CYTOPLASMIC MEMBRANE; CRYSTAL-STRUCTURE; ACTIVE-TRANSPORT; TRANSITION-STATE; ATP HYDROLYSIS; DOMINANT ROLE	The maltose transporter MalFGK(2), together with the substrate-binding protein MalE, is one of the best-characterized ABC transporters. In the conventional model, MalE captures maltose in the periplasm and delivers the sugar to the transporter. Here, using nanodiscs and proteoliposomes, we instead find that MalE is bound with high-affinity to MalFGK2 to facilitate the acquisition of the sugar. When the maltose concentration exceeds the transport capacity, MalE captures maltose and dissociates from the transporter. This mechanism explains why the transport rate is high when MalE has low affinity for maltose, and low when MalE has high affinity for maltose. Transporter-bound MalE facilitates the acquisition of the sugar at low concentrations, but also captures and dissociates from the transporter past a threshold maltose concentration. In vivo, this maltose-forced dissociation limits the rate of transport. Given the conservation of the substrate-binding proteins, this mode of allosteric regulation may be universal to ABC importers.	[Bao, Huan; Duong, Franck] Univ British Columbia, Fac Med, Dept Biochem & Mol Biol, Fac Med,Life Sci Inst, Vancouver, BC, Canada	University of British Columbia	Bao, H (corresponding author), Univ British Columbia, Fac Med, Dept Biochem & Mol Biol, Fac Med,Life Sci Inst, Vancouver, BC, Canada.	FDuong@mail.ubc.ca	Bao, Huan/K-8531-2012	Bao, Huan/0000-0002-8135-6492; Bao, Huan/0000-0002-4301-4627; Duong Van Hoa, Franck/0000-0001-7328-6124	Natural Sciences and Engineering Research Council of Canada (NSERC) [312067-10]	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by grant 312067-10 from the Natural Sciences and Engineering Research Council of Canada to FD (NSERC, www.nserc.ca). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ames GFL, 1996, J BIOL CHEM, V271, P14264, DOI 10.1074/jbc.271.24.14264; Austermuhle MI, 2004, J BIOL CHEM, V279, P28243, DOI 10.1074/jbc.M403508200; Bayburt TH, 2010, FEBS LETT, V584, P1721, DOI 10.1016/j.febslet.2009.10.024; BOHL E, 1995, J THEOR BIOL, V172, P83, DOI 10.1006/jtbi.1995.0006; Bordignon E, 2010, MOL MICROBIOL, V77, P1354, DOI 10.1111/j.1365-2958.2010.07319.x; BRASS JM, 1986, J BACTERIOL, V165, P787, DOI 10.1128/jb.165.3.787-795.1986; Chen J, 2001, P NATL ACAD SCI USA, V98, P1525, DOI 10.1073/pnas.041542498; Dalal K, 2010, METHODS MOL BIOL, V619, P145, DOI 10.1007/978-1-60327-412-8_9; Dalal K, 2009, J BIOL CHEM, V284, P7897, DOI 10.1074/jbc.M808305200; Daus ML, 2009, J BACTERIOL, V191, P754, DOI 10.1128/JB.01439-08; Davdison AL, 1990, J BIOL CHEM, V265, P4254; Davidson AL, 2008, MICROBIOL MOL BIOL R, V72, P317, DOI 10.1128/MMBR.00031-07; Davidson AL, 2007, TRENDS MICROBIOL, V15, P448, DOI 10.1016/j.tim.2007.09.005; DEAN DA, 1989, P NATL ACAD SCI USA, V86, P9134, DOI 10.1073/pnas.86.23.9134; Denisov IG, 2004, J AM CHEM SOC, V126, P3477, DOI 10.1021/ja0393574; DIETZEL I, 1978, ARCH MICROBIOL, V118, P207, DOI 10.1007/BF00415731; DOUVILLE K, 1995, J BIOL CHEM, V270, P20106, DOI 10.1074/jbc.270.34.20106; Duan XQ, 2002, BIOCHEMISTRY-US, V41, P706, DOI 10.1021/bi015784n; Frank GA, 2008, BIOCONJUGATE CHEM, V19, P1339, DOI 10.1021/bc800118j; George AM, 2011, STRUCTURE, V19, P1540, DOI 10.1016/j.str.2011.10.007; Gould AD, 2009, BIOCHEMISTRY-US, V48, P8051, DOI 10.1021/bi9007066; Grote M, 2009, J BIOL CHEM, V284, P17521, DOI 10.1074/jbc.M109.006270; Hall JA, 1997, J BIOL CHEM, V272, P17605, DOI 10.1074/jbc.272.28.17605; Holland IB, 2011, ESSAYS BIOCHEM, V50, P1, DOI [10.1042/BSE0500001, 10.1042/bse0500001]; Hollenstein K, 2007, CURR OPIN STRUC BIOL, V17, P412, DOI 10.1016/j.sbi.2007.07.003; Khare D, 2009, MOL CELL, V33, P528, DOI 10.1016/j.molcel.2009.01.035; Landmesser H, 2002, BBA-BIOMEMBRANES, V1565, P64, DOI 10.1016/S0005-2736(02)00506-0; LANZETTA PA, 1979, ANAL BIOCHEM, V100, P95, DOI 10.1016/0003-2697(79)90115-5; Ledvina PS, 1998, PROTEIN SCI, V7, P2550, DOI 10.1002/pro.5560071208; Lewinson O, 2010, NAT STRUCT MOL BIOL, V17, P332, DOI 10.1038/nsmb.1770; MANSON MD, 1985, J BIOL CHEM, V260, P9727; Marme N, 2003, BIOCONJUGATE CHEM, V14, P1133, DOI 10.1021/bc0341324; Marvin JS, 2001, NAT STRUCT BIOL, V8, P795, DOI 10.1038/nsb0901-795; MERINO G, 1995, J THEOR BIOL, V177, P171, DOI 10.1006/jtbi.1995.0236; Merino G, 1997, J BACTERIOL, V179, P7687, DOI 10.1128/jb.179.24.7687-7694.1997; MILLER DM, 1983, J BIOL CHEM, V258, P3665; Millet O, 2003, P NATL ACAD SCI USA, V100, P12700, DOI 10.1073/pnas.2134311100; Oldham ML, 2007, NATURE, V450, P515, DOI 10.1038/nature06264; Oldham ML, 2011, SCIENCE, V332, P1202, DOI 10.1126/science.1200767; Oldham ML, 2008, CURR OPIN STRUC BIOL, V18, P726, DOI 10.1016/j.sbi.2008.09.007; Oliveira ASF, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002128; Orelle C, 2008, P NATL ACAD SCI USA, V105, P12837, DOI 10.1073/pnas.0803799105; Reich-Slotky R, 2000, J BACTERIOL, V182, P993, DOI 10.1128/JB.182.4.993-1000.2000; Rizk SS, 2011, NAT STRUCT MOL BIOL, V18, P437, DOI 10.1038/nsmb.2002; Seeger MA, 2009, BBA-PROTEINS PROTEOM, V1794, P725, DOI 10.1016/j.bbapap.2008.12.004; SHARFF AJ, 1992, BIOCHEMISTRY-US, V31, P10657, DOI 10.1021/bi00159a003; SHUMAN HA, 1982, J BIOL CHEM, V257, P5455; SILHAVY TJ, 1975, P NATL ACAD SCI USA, V72, P2120, DOI 10.1073/pnas.72.6.2120; Telmer PG, 2003, J BIOL CHEM, V278, P34555, DOI 10.1074/jbc.M301004200; Tirado-Lee L, 2011, STRUCTURE, V19, P1701, DOI 10.1016/j.str.2011.10.004; TREPTOW NA, 1985, J BACTERIOL, V163, P654, DOI 10.1128/JB.163.2.654-660.1985; WANDERSMAN C, 1979, J BACTERIOL, V140, P1	52	33	33	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2012	7	4							e34836	10.1371/journal.pone.0034836	http://dx.doi.org/10.1371/journal.pone.0034836			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WC	22529943	Green Submitted, gold, Green Published			2022-12-25	WOS:000305347400021
J	Hamfjord, J; Stangeland, AM; Hughes, T; Skrede, ML; Tveit, KM; Ikdahl, T; Kure, EH				Hamfjord, Julian; Stangeland, Astrid M.; Hughes, Timothy; Skrede, Martina L.; Tveit, Kjell M.; Ikdahl, Tone; Kure, Elin H.			Differential Expression of miRNAs in Colorectal Cancer: Comparison of Paired Tumor Tissue and Adjacent Normal Mucosa Using High-Throughput Sequencing	PLOS ONE			English	Article							DIGITAL GENE-EXPRESSION; CLINICOPATHOLOGICAL FEATURES; TARGETING TAGLN2; MICRORNAS; PROFILES; GROWTH; MICROARRAYS; THERAPY; PATHWAY; AND-145	We present the results of a global study of dysregulated miRNAs in paired samples of normal mucosa and tumor from eight patients with colorectal cancer. Although there is existing data of miRNA contribution to colorectal tumorigenesis, these studies are typically small to medium scale studies of cell lines or non-paired tumor samples. The present study is to our knowledge unique in two respects. Firstly, the normal and adjacent tumor tissue samples are paired, thus taking into account the baseline differences between individuals when testing for differential expression. Secondly, we use high-throughput sequencing, thus enabling a comprehensive survey of all miRNAs expressed in the tissues. We use Illumina sequencing technology to perform sequencing and two different tools to statistically test for differences in read counts per gene between samples: edgeR when using the pair information and DESeq when ignoring this information, i.e., treating tumor and normal samples as independent groups. We identify 37 miRNAs that are significantly dysregulated in both statistical approaches, 19 down-regulated and 18 up-regulated. Some of these miRNAs are previously published as potential regulators in colorectal adenocarcinomas such as miR-1, miR-96 and miR-145. Our comprehensive survey of differentially expressed miRNAs thus confirms some existing findings. We have also discovered 16 dysregulated miRNAs, which to our knowledge have not previously been associated with colorectal carcinogenesis: the following significantly down-regulated miR-490-3p, -628-3p/-5p, -1297, -3151, -3163, -3622a-5p, 3656 and the up-regulated miR-105, -549, -1269, -1827, -3144-3p, -3177, -3180-3p, -4326. Although the study is preliminary with only eight patients included, we believe the results add to the present knowledge on miRNA dysregulation in colorectal carcinogenesis. As such the results would serve as a robust training set for validation of potential biomarkers in a larger cohort study. Finally, we also present data supporting the hypothesis that there are differences in miRNA expression between adenocarcinomas and neuroendocrine tumors of the colon.	[Hamfjord, Julian; Stangeland, Astrid M.; Skrede, Martina L.; Kure, Elin H.] Oslo Univ Hosp, Inst Canc Res, Dept Genet, Oslo, Norway; [Hughes, Timothy] Oslo Univ Hosp, Dept Med Genet, Oslo, Norway; [Hamfjord, Julian; Skrede, Martina L.; Tveit, Kjell M.; Ikdahl, Tone; Kure, Elin H.] Oslo Univ Hosp, Dept Oncol, Oslo, Norway; [Stangeland, Astrid M.; Kure, Elin H.] Oslo Univ Hosp, Dept Pathol, Oslo, Norway; [Hamfjord, Julian; Tveit, Kjell M.] Univ Oslo, Fac Med, Oslo, Norway; [Kure, Elin H.] Telemark Univ Coll, Fac Arts & Sci, Dept Environm & Hlth Studies, Bo, Norway	University of Oslo; University of Oslo; University of Oslo; University of Oslo; University of Oslo; University College of Southeast Norway	Hamfjord, J (corresponding author), Oslo Univ Hosp, Inst Canc Res, Dept Genet, Oslo, Norway.	elin.kure@rr-research.no		Hughes, Thomas/0000-0001-5880-9951	"Ivar, Ragna og Morten Holes legat til fremme av kreftforskningen i Norge" (Ivar, Ragna and Morten Holes' Foundation to serve cancer research in Norway); Research Council of Norway; Southeastern Regional Health Authorities	"Ivar, Ragna og Morten Holes legat til fremme av kreftforskningen i Norge" (Ivar, Ragna and Morten Holes' Foundation to serve cancer research in Norway); Research Council of Norway(Research Council of Norway); Southeastern Regional Health Authorities	External funding received from "Ivar, Ragna og Morten Holes legat til fremme av kreftforskningen i Norge" (Ivar, Ragna and Morten Holes' Foundation to serve cancer research in Norway). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The sequencing service was provided by the Norwegian High-Throughput Sequencing Centre, a national technology platform supported by the "Functional Genomics" and "Infrastructure" programs of the Research Council of Norway and the Southeastern Regional Health Authorities.	Akao Y, 2010, CANCER GENE THER, V17, P398, DOI 10.1038/cgt.2009.88; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Asghar U, 2010, CLIN COLORECTAL CANC, V9, P274, DOI 10.3816/CCC.2010.n.040; Bandres E, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-29; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Boyerinas B, 2010, ENDOCR-RELAT CANCER, V17, pF19, DOI 10.1677/ERC-09-0184; Caldarella A, 2011, PATHOL ONCOL RES; Cho WCS, 2010, INT J BIOCHEM CELL B, V42, P1273, DOI 10.1016/j.biocel.2009.12.014; Cho WCS, 2010, BBA-REV CANCER, V1805, P209, DOI 10.1016/j.bbcan.2009.11.003; Chou YT, 2010, CANCER RES, V70, P8822, DOI 10.1158/0008-5472.CAN-10-0638; Cummins JM, 2006, P NATL ACAD SCI USA, V103, P3687, DOI 10.1073/pnas.0511155103; Di Pietro M, 2005, GASTROENTEROLOGY, V129, P1047, DOI 10.1053/j.gastro.2005.06.028; Farazi TA, 2011, J PATHOL, V223, P102, DOI 10.1002/path.2806; Feng M, 2011, ONCOGENE, V30, P2242, DOI 10.1038/onc.2010.602; Ferlay J, 2008, IARC CANCERBASE; Galamb O, 2010, BRIT J CANCER, V102, P765, DOI 10.1038/sj.bjc.6605515; Gaur A, 2007, CANCER RES, V67, P2456, DOI 10.1158/0008-5472.CAN-06-2698; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Guo JM, 2009, J GASTROEN HEPATOL, V24, P652, DOI 10.1111/j.1440-1746.2008.05666.x; Hackenberg M, 2009, NUCLEIC ACIDS RES, V37, pW68, DOI 10.1093/nar/gkp347; Hao J, 2011, FEBS LETT, V585, P207, DOI 10.1016/j.febslet.2010.11.039; Hiroki E, 2010, CANCER SCI, V101, P241, DOI 10.1111/j.1349-7006.2009.01385.x; Hua Z, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000116; John B, 2004, PLOS BIOL, V2, P1862, DOI 10.1371/journal.pbio.0020363; Kumar MS, 2007, NAT GENET, V39, P673, DOI 10.1038/ng2003; La Rocca G, 2009, J CELL PHYSIOL, V220, P485, DOI 10.1002/jcp.21796; Lee DY, 2007, P NATL ACAD SCI USA, V104, P20350, DOI 10.1073/pnas.0706901104; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Linsen SEV, 2009, NAT METHODS, V6, P474, DOI 10.1038/nmeth0709-474; Liu L, 2010, BIOCHEM BIOPH RES CO, V400, P236, DOI 10.1016/j.bbrc.2010.08.046; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Luo HC, 2009, J EXP CLIN CANC RES, V28, DOI 10.1186/1756-9966-28-82; Malone JH, 2011, BMC BIOL, V9, DOI 10.1186/1741-7007-9-34; Matsuzaki S, 2009, ANN SURG ONCOL, V16, P2042, DOI 10.1245/s10434-009-0469-6; MELO SA, 2010, FEBS LETT; Michael MZ, 2003, MOL CANCER RES, V1, P882; Motoyama K, 2009, INT J ONCOL, V34, P1069, DOI 10.3892/ijo_00000233; Nagel R, 2008, CANCER RES, V68, P5795, DOI 10.1158/0008-5472.CAN-08-0951; Navon R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008003; Nguyen HTT, 2010, J BIOL CHEM, V285, P1479, DOI 10.1074/jbc.M109.057141; Nohata N, 2011, ONCOTARGET, V2, P29; Pradervand S, 2010, BIOTECHNIQUES, V48, P219, DOI 10.2144/000113367; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Roukos DH, 2010, EXPERT REV MOL DIAGN, V10, P33, DOI 10.1586/ERM.09.69; Sabates-Beliver J, 2007, MOL CANCER RES, V5, P1263, DOI 10.1158/1541-7786.MCR-07-0267; Sarver AL, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-401; Saydam O, 2011, CANCER RES, V71, P852, DOI 10.1158/0008-5472.CAN-10-1219; Schetter AJ, 2008, JAMA-J AM MED ASSOC, V299, P425, DOI 10.1001/jama.299.4.425; Shi B, 2007, J BIOL CHEM, V282, P32582, DOI 10.1074/jbc.M702806200; Slaby O, 2007, ONCOLOGY-BASEL, V72, P397, DOI 10.1159/000113489; Slaby O, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-102; Stark MS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009685; Tazawa H, 2011, EXPERT OPIN BIOL TH, V11, P145, DOI 10.1517/14712598.2011.542749; Veronese A, 2010, CANCER RES, V70, P3140, DOI 10.1158/0008-5472.CAN-09-4456; VOGELSTEIN B, 1988, NEW ENGL J MED, V319, P525, DOI 10.1056/NEJM198809013190901; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Wang CJ, 2009, DIS MARKERS, V26, P27, DOI [10.3233/DMA-2009-0601, 10.1155/2009/921907]; Wang X., 2011, MED ONCOL; Wang YX, 2010, J DIGEST DIS, V11, P50, DOI 10.1111/j.1751-2980.2009.00413.x; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Yan HL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020628; Yoon A, 2011, NUCLEIC ACIDS RES, V39, P8078, DOI 10.1093/nar/gkr492; Yoshino H, 2011, BRIT J CANCER, V104, P808, DOI 10.1038/bjc.2011.23	63	126	129	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2012	7	4							e34150	10.1371/journal.pone.0034150	http://dx.doi.org/10.1371/journal.pone.0034150			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WC	22529906	gold, Green Published, Green Submitted			2022-12-25	WOS:000305347400007
J	Krishnamurthy, P; Silberberg, G; Lansner, A				Krishnamurthy, Pradeep; Silberberg, Gilad; Lansner, Anders			A Cortical Attractor Network with Martinotti Cells Driven by Facilitating Synapses	PLOS ONE			English	Article							GABAERGIC INTERNEURONS; DISYNAPTIC INHIBITION; SYNAPTIC MECHANISMS; NEURAL-NETWORKS; DYNAMICS; NEURONS; OSCILLATIONS; RAT; EXCITATION; MODEL	The population of pyramidal cells significantly outnumbers the inhibitory interneurons in the neocortex, while at the same time the diversity of interneuron types is much more pronounced. One acknowledged key role of inhibition is to control the rate and patterning of pyramidal cell firing via negative feedback, but most likely the diversity of inhibitory pathways is matched by a corresponding diversity of functional roles. An important distinguishing feature of cortical interneurons is the variability of the short-term plasticity properties of synapses received from pyramidal cells. The Martinotti cell type has recently come under scrutiny due to the distinctly facilitating nature of the synapses they receive from pyramidal cells. This distinguishes these neurons from basket cells and other inhibitory interneurons typically targeted by depressing synapses. A key aspect of the work reported here has been to pinpoint the role of this variability. We first set out to reproduce quantitatively based on in vitro data the di-synaptic inhibitory microcircuit connecting two pyramidal cells via one or a few Martinotti cells. In a second step, we embedded this microcircuit in a previously developed attractor memory network model of neocortical layers 2/3. This model network demonstrated that basket cells with their characteristic depressing synapses are the first to discharge when the network enters an attractor state and that Martinotti cells respond with a delay, thereby shifting the excitation-inhibition balance and acting to terminate the attractor state. A parameter sensitivity analysis suggested that Martinotti cells might, in fact, play a dominant role in setting the attractor dwell time and thus cortical speed of processing, with cellular adaptation and synaptic depression having a less prominent role than previously thought.	[Krishnamurthy, Pradeep; Lansner, Anders] Stockholm Univ, Dept Numer Anal & Comp Sci, S-10691 Stockholm, Sweden; [Silberberg, Gilad] Karolinska Inst, Nobel Inst Neurophysiol, Dept Neurosci, S-10401 Stockholm, Sweden; [Krishnamurthy, Pradeep; Lansner, Anders] Royal Inst Technol KTH, Dept Computat Biol, Sch Comp Sci & Commun, Stockholm, Sweden	Stockholm University; Karolinska Institutet; Royal Institute of Technology	Krishnamurthy, P (corresponding author), Stockholm Univ, Dept Numer Anal & Comp Sci, S-10691 Stockholm, Sweden.	ala@csc.kth.se	Silberberg, Gilad/A-1048-2012; Lansner, Anders/E-4824-2016	Silberberg, Gilad/0000-0001-9964-505X; Lansner, Anders/0000-0002-2358-7815	Swedish Science Council [VR-621-2004-3807]; VINNOVA (Swedish Government Agency for Innovation Systems); Swedish Foundation for Strategic Research (through the Stockholm Brain Institute); European Union (FACETS project) [FP6-2004-IST-FETPI-015879]	Swedish Science Council; VINNOVA (Swedish Government Agency for Innovation Systems)(Vinnova); Swedish Foundation for Strategic Research (through the Stockholm Brain Institute)(Swedish Foundation for Strategic Research); European Union (FACETS project)	This work was partly supported by grants from the Swedish Science Council (VR-621-2004-3807), VINNOVA (Swedish Government Agency for Innovation Systems), the Swedish Foundation for Strategic Research (through the Stockholm Brain Institute), and from the European Union (FACETS project, FP6-2004-IST-FETPI-015879). No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott LF, 1997, SCIENCE, V275, P220, DOI 10.1126/science.275.5297.221; Amit DJ, 1997, CEREB CORTEX, V7, P237, DOI 10.1093/cercor/7.3.237; Arieli A, 1996, SCIENCE, V273, P1868, DOI 10.1126/science.273.5283.1868; Ascoli GA, 2008, NAT REV NEUROSCI, V9, P557, DOI 10.1038/nrn2402; Bartos M, 2007, NAT REV NEUROSCI, V8, P45, DOI 10.1038/nrn2044; Berger TK, 2009, J PHYSIOL-LONDON, V587, P5411, DOI 10.1113/jphysiol.2009.176552; Brunel N, 2003, J NEUROPHYSIOL, V90, P415, DOI 10.1152/jn.01095.2002; Buxhoeveden DP, 2002, BRAIN BEHAV EVOLUT, V60, P125, DOI 10.1159/000065935; Cardin JA, 2009, NATURE, V459, P663, DOI 10.1038/nature08002; Compte A, 2000, CEREB CORTEX, V10, P910, DOI 10.1093/cercor/10.9.910; Compte A, 2003, J NEUROPHYSIOL, V89, P2707, DOI 10.1152/jn.00845.2002; Connors BW, 2007, NAT NEUROSCI, V10, P808, DOI 10.1038/nn0707-808; Cossart R, 2003, NATURE, V423, P283, DOI 10.1038/nature01614; Deans MR, 2001, NEURON, V31, P477, DOI 10.1016/S0896-6273(01)00373-7; Destexhe A, 2001, NEUROSCIENCE, V107, P13, DOI 10.1016/S0306-4522(01)00344-X; Destexhe A, 1994, J Comput Neurosci, V1, P195, DOI 10.1007/BF00961734; Djurfeldt M, 2008, IBM J RES DEV, V52, P31, DOI 10.1147/rd.521.0031; Douglas RJ, 2004, ANNU REV NEUROSCI, V27, P419, DOI 10.1146/annurev.neuro.27.070203.144152; Fanselow EE, 2010, J NEUROPHYSIOL, V104, P596, DOI 10.1152/jn.00206.2010; Fransen E, 1998, NETWORK-COMP NEURAL, V9, P235, DOI 10.1088/0954-898X/9/2/006; Fuhrmann G, 2002, J NEUROPHYSIOL, V87, P140, DOI 10.1152/jn.00258.2001; Galarreta M, 2002, P NATL ACAD SCI USA, V99, P12438, DOI 10.1073/pnas.192159599; Gupta A, 2000, SCIENCE, V287, P273, DOI 10.1126/science.287.5451.273; Haider B, 2006, J NEUROSCI, V26, P4535, DOI 10.1523/JNEUROSCI.5297-05.2006; Hellwig B, 2000, BIOL CYBERN, V82, P111, DOI 10.1007/PL00007964; Hines ML, 1997, NEURAL COMPUT, V9, P1179, DOI 10.1162/neco.1997.9.6.1179; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; Holcman D, 2006, PLOS COMPUT BIOL, V2, P174, DOI 10.1371/journal.pcbi.0020023; Holmgren C, 2003, J PHYSIOL-LONDON, V551, P139, DOI 10.1113/jphysiol.2003.044784; Horn D, 1991, NEURAL COMPUT, V3, P510, DOI 10.1162/neco.1991.3.4.510; Johansson C, 2007, NEURAL COMPUT, V19, P1871, DOI 10.1162/neco.2007.19.7.1871; Kalisman N, 2003, BIOL CYBERN, V88, P210, DOI 10.1007/s00422-002-0377-3; Kapfer C, 2007, NAT NEUROSCI, V10, P743, DOI 10.1038/nn1909; Kenet T, 2003, NATURE, V425, P954, DOI 10.1038/nature02078; Knoblauch A, 2002, BIOL CYBERN, V87, P168, DOI 10.1007/s00422-002-0332-3; Liu BH, 2009, J NEUROSCI, V29, P10520, DOI 10.1523/JNEUROSCI.1915-09.2009; Lundqvist M, 2006, NETWORK-COMP NEURAL, V17, P253, DOI 10.1080/09548980600774619; Lundqvist M, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000803; Ma WP, 2010, J NEUROSCI, V30, P14371, DOI 10.1523/JNEUROSCI.3248-10.2010; Mainen T.J., 1998, METHODS NEURONAL MOD, V2, P1; Markram H, 1998, P NATL ACAD SCI USA, V95, P5323, DOI 10.1073/pnas.95.9.5323; Markram H, 2004, NAT REV NEUROSCI, V5, P793, DOI 10.1038/nrn1519; Melamed O, 2008, J COMPUT NEUROSCI, V25, P308, DOI 10.1007/s10827-008-0080-z; Miesenbock G, 2009, SCIENCE, V326, P395, DOI 10.1126/science.1174520; Mountcastle VB, 1997, BRAIN, V120, P701, DOI 10.1093/brain/120.4.701; Pastrana E, 2011, NAT METHODS, V8, P24, DOI 10.1038/NMETH.F.323; Pospischil M, 2008, BIOL CYBERN, V99, P427, DOI 10.1007/s00422-008-0263-8; Reig R, 2006, CEREB CORTEX, V16, P688, DOI 10.1093/cercor/bhj014; Reig R, 2007, PLOS COMPUT BIOL, V2, P1; Sanchez-Vives MV, 2000, J NEUROSCI, V20, P4286; Silberberg G, 2004, J PHYSIOL-LONDON, V556, P19, DOI 10.1113/jphysiol.2004.060962; Silberberg G, 2008, CURRENT OPINION NEUR, V18, P1; Silberberg G, 2007, NEURON, V53, P735, DOI 10.1016/j.neuron.2007.02.012; Tabak J, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001124; Thomson AM, 2002, CEREB CORTEX, V12, P936, DOI 10.1093/cercor/12.9.936; Timofeev I, 2000, CEREB CORTEX, V10, P1185, DOI 10.1093/cercor/10.12.1185; Tsodyks M, 1999, SCIENCE, V286, P1943, DOI 10.1126/science.286.5446.1943; Tsodyks M, 1998, NEURAL COMPUT, V10, P821, DOI 10.1162/089976698300017502; Wang XJ, 2004, P NATL ACAD SCI USA, V101, P1368, DOI 10.1073/pnas.0305337101; Wang XJ, 1999, J NEUROSCI, V19, P9587; Wang XJ, 1996, J NEUROSCI, V16, P6402; Yamada WM, 1989, METHODS NEURONAL MOD, P97	62	14	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2012	7	4							e30752	10.1371/journal.pone.0030752	http://dx.doi.org/10.1371/journal.pone.0030752			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VO	22523533	Green Submitted, Green Published, gold			2022-12-25	WOS:000305345000002
J	Karaayvaz, M; Zhang, C; Liang, SR; Shroyer, KR; Ju, JF				Karaayvaz, Mihriban; Zhang, Cecilia; Liang, Sharon; Shroyer, Kenneth R.; Ju, Jingfang			Prognostic Significance of miR-205 in Endometrial Cancer	PLOS ONE			English	Article							MICRORNA EXPRESSION PROFILES; CELL-PROLIFERATION; DOWN-REGULATION; SMALL RNAS; CARCINOMA; PTEN; MUTATIONS; FEATURES; GROWTH; TUMORS	Purpose: microRNAs have emerged as key regulators of gene expression, and their altered expression has been associated with tumorigenesis and tumor progression. Thus, microRNAs have potential as both cancer biomarkers and/or potential novel therapeutic targets. Although accumulating evidence suggests the role of aberrant microRNA expression in endometrial carcinogenesis, there are still limited data available about the prognostic significance of microRNAs in endometrial cancer. The goal of this study is to investigate the prognostic value of selected key microRNAs in endometrial cancer by the analysis of archival formalin-fixed paraffin-embedded tissues. Experimental Design: Total RNAs were extracted from 48 paired normal and endometrial tumor specimens using Trizol based approach. The expression of miR-26a, let-7g, miR-21, miR-181b, miR-200c, miR-192, miR-215, miR-200c, and miR-205 were quantified by real time qRT-PCR expression analysis. Targets of the differentially expressed miRNAs were quantified using immunohistochemistry. Statistical analysis was performed by GraphPad Prism 5.0. Results: The expression levels of miR-200c (P<0.0001) and miR-205 (P<0.0001) were significantly increased in endometrial tumors compared to normal tissues. Kaplan-Meier survival analysis revealed that high levels of miR-205 expression were associated with poor patient overall survival (hazard ratio, 0.377; Logrank test, P = 0.028). Furthermore, decreased expression of a miR-205 target PTEN was detected in endometrial cancer tissues compared to normal tissues. Conclusion: miR-205 holds a unique potential as a prognostic biomarker in endometrial cancer.	[Karaayvaz, Mihriban; Shroyer, Kenneth R.; Ju, Jingfang] SUNY Stony Brook, Dept Pathol, Stony Brook, NY 11794 USA; [Zhang, Cecilia] Suny Downstate Med Ctr, Dept Physiol & Pharmacol, Brooklyn, NY 11203 USA; [Liang, Sharon] Hofstra Univ, Hofstra N Shore LIJ Sch Med, Dept Obstet Gynecol, Hempstead, NY 11550 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; Hofstra University; Northwell Health	Karaayvaz, M (corresponding author), SUNY Stony Brook, Dept Pathol, Stony Brook, NY 11794 USA.	jingfang.ju@stonybrookmedicine.edu		Ju, Jingfang/0000-0002-4821-7458; Karaayvaz, Mihriban/0000-0002-6264-2477	Stony Brook University Translational Research Laboratory [R01CA155019, R33CA147966]; NATIONAL CANCER INSTITUTE [R33CA147966, R01CA155019] Funding Source: NIH RePORTER	Stony Brook University Translational Research Laboratory; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by Stony Brook University Translational Research Laboratory Start-up fund (Dr. Ju), R01CA155019 (Dr. Ju) and R33CA147966 (Dr. Ju). No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baffa R, 2009, J PATHOL, V219, P214, DOI 10.1002/path.2586; Bansal N, 2009, CANCER CONTROL, V16, P8, DOI 10.1177/107327480901600102; BOKHMAN JV, 1983, GYNECOL ONCOL, V15, P10, DOI 10.1016/0090-8258(83)90111-7; Boren T, 2008, GYNECOL ONCOL, V110, P206, DOI 10.1016/j.ygyno.2008.03.023; Braun CJ, 2008, CANCER RES, V68, P10094, DOI 10.1158/0008-5472.CAN-08-1569; Brennecke J, 2003, CELL, V113, P25, DOI 10.1016/S0092-8674(03)00231-9; Chan JA, 2005, CANCER RES, V65, P6029, DOI 10.1158/0008-5472.CAN-05-0137; Chung TKH, 2012, INT J CANCER, V130, P1036, DOI 10.1002/ijc.26060; Chung TKH, 2009, INT J CANCER, V124, P1358, DOI 10.1002/ijc.24071; Cohn DE, 2010, AM J OBSTET GYNECOL, V202, DOI 10.1016/j.ajog.2010.02.051; Djordjevic B, 2012, MOD PATHOL; Feber A, 2008, J THORAC CARDIOV SUR, V135, P255, DOI 10.1016/j.jtcvs.2007.08.055; Gandellini P, 2009, CANCER RES, V69, P2287, DOI 10.1158/0008-5472.CAN-08-2894; Garg K, 2012, INT J GYNECOL PATHOL, V31, P48, DOI 10.1097/PGP.0b013e3182230d00; Ghodgaonkar MM, 2009, CELL DEATH DIFFER, V16, P858, DOI 10.1038/cdd.2009.15; Gottardo F, 2007, UROL ONCOL-SEMIN ORI, V25, P387, DOI 10.1016/j.urolonc.2007.01.019; Greene SB, 2010, J CELL SCI, V123, P606, DOI 10.1242/jcs.056812; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; He L, 2005, NATURE, V435, P828, DOI 10.1038/nature03552; Hiroki E, 2010, CANCER SCI, V101, P241, DOI 10.1111/j.1349-7006.2009.01385.x; Huse JT, 2009, GENE DEV, V23, P1327, DOI 10.1101/gad.1777409; Hwang HW, 2006, BRIT J CANCER, V94, P776, DOI 10.1038/sj.bjc.6603023; Iorio MV, 2007, CANCER RES, V67, P8699, DOI 10.1158/0008-5472.CAN-07-1936; Iorio MV, 2005, CANCER RES, V65, P7065, DOI 10.1158/0008-5472.CAN-05-1783; Johnson CD, 2007, CANCER RES, V67, P7713, DOI 10.1158/0008-5472.CAN-07-1083; Kanamori Y, 2001, CLIN CANCER RES, V7, P892; Kong DH, 1997, NAT GENET, V17, P143, DOI 10.1038/ng1097-143; Kumar MS, 2008, P NATL ACAD SCI USA, V105, P3903, DOI 10.1073/pnas.0712321105; Ladeiro Y, 2008, HEPATOLOGY, V47, P1955, DOI 10.1002/hep.22256; Lou YH, 2010, INT J MOL MED, V26, P819, DOI 10.3892/ijmm_00000530; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Lu JA, 2011, CANCER RES, V71, P225, DOI 10.1158/0008-5472.CAN-10-1850; Macwhinnie N, 2004, INT J GYNECOL CANCER, V14, P938, DOI 10.1111/j.1048-891X.2004.14533.x; Meng FY, 2006, GASTROENTEROLOGY, V130, P2113, DOI 10.1053/j.gastro.2006.02.057; Mhawech-Fauceglia P, 2010, AM J CLIN PATHOL, V133, P899, DOI 10.1309/AJCPQDQXJ4FNRFQB; Nakada C, 2008, J PATHOL, V216, P418, DOI 10.1002/path.2437; Nam EJ, 2008, CLIN CANCER RES, V14, P2690, DOI 10.1158/1078-0432.CCR-07-1731; Navarro F, 2010, J IMMUNOL, V184, P5939, DOI 10.4049/jimmunol.0902567; Oberli A, 2008, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-9; Pallares J, 2005, MODERN PATHOL, V18, P719, DOI 10.1038/modpathol.3800347; Qu C, 2012, CELL CYCLE, V11; Ratner ES, 2010, GYNECOL ONCOL, V118, P251, DOI 10.1016/j.ygyno.2010.05.010; Risinger JI, 1997, CANCER RES, V57, P4736; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Snowdon J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022828; Tang FC, 2010, DIFFERENTIATION, V79, P141, DOI 10.1016/j.diff.2009.11.002; Tashiro H, 1997, CANCER RES, V57, P3935; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; WIGHTMAN B, 1993, CELL, V75, P855, DOI 10.1016/0092-8674(93)90530-4; Wu WG, 2009, EUR J CANCER PREV, V18, P50, DOI 10.1097/CEJ.0b013e328305a07a; Zhang BH, 2007, J CELL PHYSIOL, V210, P279, DOI 10.1002/jcp.20869; Zhang SY, 2010, CLIN CANCER RES, V16, P4325, DOI 10.1158/1078-0432.CCR-09-2990	52	85	91	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2012	7	4							e35158	10.1371/journal.pone.0035158	http://dx.doi.org/10.1371/journal.pone.0035158			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UT	22514717	Green Published, Green Accepted, gold			2022-12-25	WOS:000305341600123
J	Pilizota, T; Shaevitz, JW				Pilizota, Teuta; Shaevitz, Joshua W.			Fast, Multiphase Volume Adaptation to Hyperosmotic Shock by Escherichia coli	PLOS ONE			English	Article							MEDIATED WATER PERMEABILITY; PROTEIN-DNA INTERACTIONS; BETAINE CARRIER BETP; CORYNEBACTERIUM-GLUTAMICUM; ELECTRON-MICROSCOPY; OSMOTIC-STRESS; TURGOR; CELL; OSMOSENSOR; TRANSPORT	All living cells employ an array of different mechanisms to help them survive changes in extra cellular osmotic pressure. The difference in the concentration of chemicals in a bacterium's cytoplasm and the external environment generates an osmotic pressure that inflates the cell. It is thought that the bacterium Escherichia coli use a number of interconnected systems to adapt to changes in external pressure, allowing them to maintain turgor and live in surroundings that range more than two-hundred-fold in external osmolality. Here, we use fluorescence imaging to make the first measurements of cell volume changes over time during hyperosmotic shock and subsequent adaptation on a single cell level in vivo with a time resolution on the order of seconds. We directly observe two previously unseen phases of the cytoplasmic water efflux upon hyperosmotic shock. Furthermore, we monitor cell volume changes during the post-shock recovery and observe a two-phase response that depends on the shock magnitude. The initial phase of recovery is fast, on the order of 15-20 min and shows little cell-to-cell variation. For large sucrose shocks, a secondary phase that lasts several hours adds to the recovery. We find that cells are able to recover fully from shocks as high as 1 Osmol/kg using existing systems, but that for larger shocks, protein synthesis is required for full recovery.	[Pilizota, Teuta; Shaevitz, Joshua W.] Princeton Univ, Lewis Sigler Inst Integrat Genom, Princeton, NJ 08544 USA; [Shaevitz, Joshua W.] Princeton Univ, Dept Phys, Princeton, NJ 08544 USA	Princeton University; Princeton University	Pilizota, T (corresponding author), Princeton Univ, Lewis Sigler Inst Integrat Genom, Princeton, NJ 08544 USA.	shaevitz@princeton.edu		Pilizota, Teuta/0000-0002-2156-0221	Alfred P. Sloan Foundation; Pew Charitable Trusts; National Science Foundation [PHY-0844466]	Alfred P. Sloan Foundation(Alfred P. Sloan Foundation); Pew Charitable Trusts; National Science Foundation(National Science Foundation (NSF))	This work was supported by awards from the Alfred P. Sloan Foundation, Pew Charitable Trusts and National Science Foundation Award PHY-0844466 to JWS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allersma MW, 1998, BIOPHYS J, V74, P1074, DOI 10.1016/S0006-3495(98)74031-7; ASHA H, 1993, J BACTERIOL, V175, P4528, DOI 10.1128/JB.175.14.4528-4537.1993; BALDWIN WW, 1995, J BACTERIOL, V177, P235, DOI 10.1128/jb.177.1.235-237.1995; BAYER ME, 1967, J BACTERIOL, V93, P1104, DOI 10.1128/JB.93.3.1104-1112.1967; Berg HC, 2003, ANNU REV BIOCHEM, V72, P19, DOI 10.1146/annurev.biochem.72.121801.161737; Calamita G, 1998, P NATL ACAD SCI USA, V95, P3627, DOI 10.1073/pnas.95.7.3627; Cayley DS, 2000, BIOPHYS J, V78, P1748, DOI 10.1016/S0006-3495(00)76726-9; Cayley S, 2004, J MOL RECOGNIT, V17, P488, DOI 10.1002/jmr.695; CAYLEY S, 1991, J MOL BIOL, V222, P281, DOI 10.1016/0022-2836(91)90212-O; Cayley S, 2003, BIOCHEMISTRY-US, V42, P12596, DOI 10.1021/bi0347297; CAYLEY S, 1992, J BACTERIOL, V174, P1586, DOI 10.1128/jb.174.5.1586-1595.1992; Corry B, 2008, BBA-BIOMEMBRANES, V1778, P1859, DOI 10.1016/j.bbamem.2007.06.022; COTAROBLES EH, 1963, J BACTERIOL, V85, P499, DOI 10.1128/JB.85.3.499-503.1963; COWIE DB, 1949, J CELL COMPAR PHYSL, V34, P243, DOI 10.1002/jcp.1030340205; Culham DE, 2003, BIOCHEMISTRY-US, V42, P410, DOI 10.1021/bi0264364; DECAD GM, 1976, J BACTERIOL, V128, P325, DOI 10.1128/JB.128.1.325-336.1976; Delamarche C, 1999, J BACTERIOL, V181, P4193, DOI 10.1128/JB.181.14.4193-4197.1999; Deng Y, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.158101; DINNIBIER U, 1988, ARCH MICROBIOL, V150, P348, DOI 10.1007/BF00408306; DUBOCHET J, 1983, J BACTERIOL, V155, P381, DOI 10.1128/JB.155.1.381-390.1983; HAHN F. E., 1955, J BACT, V69, P215; Hamann K, 2008, J BACTERIOL, V190, P2360, DOI 10.1128/JB.01635-07; KOCH AL, 1985, CAN J MICROBIOL, V31, P1071, DOI 10.1139/m85-204; Kolbe M, 2000, SCIENCE, V288, P1390, DOI 10.1126/science.288.5470.1390; Konopka MC, 2006, J BACTERIOL, V188, P6115, DOI 10.1128/JB.01982-05; Konopka MC, 2009, J BACTERIOL, V191, P231, DOI 10.1128/JB.00536-08; Korber DR, 1996, APPL ENVIRON MICROB, V62, P3939, DOI 10.1128/AEM.62.11.3939-3947.1996; Kralj JM, 2011, SCIENCE, V333, P345, DOI 10.1126/science.1204763; Kubori T, 1998, SCIENCE, V280, P602, DOI 10.1126/science.280.5363.602; Lo CJ, 2007, BIOPHYS J, V93, P294, DOI 10.1529/biophysj.106.095265; Mallo RC, 2006, J BACTERIOL, V188, P820, DOI 10.1128/JB.188.2.820-822.2006; MEURY J, 1985, EUR J BIOCHEM, V151, P613, DOI 10.1111/j.1432-1033.1985.tb09148.x; Mika JT, 2010, MOL MICROBIOL, V77, P200, DOI 10.1111/j.1365-2958.2010.07201.x; MILNER JL, 1988, J BIOL CHEM, V263, P14900; Morbach S, 2002, CHEMBIOCHEM, V3, P385, DOI 10.1002/1439-7633(20020503)3:5<384::AID-CBIC384>3.0.CO;2-H; Neuman KC, 2004, REV SCI INSTRUM, V75, P2787, DOI 10.1063/1.1785844; OHYAMA T, 1992, J BACTERIOL, V174, P2922, DOI 10.1128/JB.174.9.2922-2928.1992; Pilizota T, 2007, BIOPHYS J, V93, P264, DOI 10.1529/biophysj.106.091074; Racher KI, 1999, BIOCHEMISTRY-US, V38, P1676, DOI 10.1021/bi981279n; Record MT, 1998, TRENDS BIOCHEM SCI, V23, P143, DOI 10.1016/S0968-0004(98)01196-7; Rubenhagen R, 2000, J BIOL CHEM, V275, P735, DOI 10.1074/jbc.275.2.735; Rubenhagen R, 2001, EMBO J, V20, P5412, DOI 10.1093/emboj/20.19.5412; SCHULTZ SG, 1961, J GEN PHYSIOL, V45, P355, DOI 10.1085/jgp.45.2.355; Soupene E, 2002, J BACTERIOL, V184, P4304, DOI 10.1128/JB.184.15.4304-4307.2002; Su J, 2009, INFECT IMMUN, V77, P667, DOI 10.1128/IAI.01027-08; SUTHERLAND L, 1986, J BACTERIOL, V168, P805, DOI 10.1128/jb.168.2.805-814.1986; van der Heide T, 2000, P NATL ACAD SCI USA, V97, P7102, DOI 10.1073/pnas.97.13.7102; Walter JM, 2007, P NATL ACAD SCI USA, V104, P2408, DOI 10.1073/pnas.0611035104; Wang SY, 2010, P NATL ACAD SCI USA, V107, P9182, DOI 10.1073/pnas.0911517107; Wood JM, 2007, METHOD ENZYMOL, V428, P77, DOI 10.1016/S0076-6879(07)28005-X; Wood Janet M, 2006, Sci STKE, V2006, ppe43; Yasuda R, 2001, NATURE, V410, P898, DOI 10.1038/35073513	52	48	52	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2012	7	4							e35205	10.1371/journal.pone.0035205	http://dx.doi.org/10.1371/journal.pone.0035205			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UT	22514721	Green Published, gold, Green Submitted			2022-12-25	WOS:000305341600127
J	Van, DN; Roberts, CF; Marion, JD; Lepine, S; Harikumar, KB; Schreiter, J; Dumur, CI; Fang, XJ; Spiegel, S; Bell, JK				Van, Danielle N.; Roberts, Charlotte F.; Marion, James D.; Lepine, Sandrine; Harikumar, Kuzhuvelil B.; Schreiter, Jessica; Dumur, Catherine I.; Fang, Xianjun; Spiegel, Sarah; Bell, Jessica K.			Innate immune agonist, dsRNA, induces apoptosis in ovarian cancer cells and enhances the potency of cytotoxic chemotherapeutics	FASEB JOURNAL			English	Article						pattern recognition receptors; targeted therapy; biomarker; type I interferon; caspase	DOUBLE-STRANDED-RNA; TOLL-LIKE RECEPTOR-3; NF-KAPPA-B; RIG-I; TARGETED ACTIVATION; EXPRESSION; GENE; HELICASE; INDUCTION; CARCINOMA	Ovarian cancer is the most lethal gynecological cancer. Here we show that innate immune agonist, dsRNA, directly induces ovarian cancer cell death and identify biomarkers associated with responsiveness to this targeted treatment. Nuclear staining and MTT assays following dsRNA stimulation revealed two subpopulations, sensitive (OVCAR-3, CAOV-3; patient samples malignant 1 and 2) and resistant (DOV-13, SKOV-3). Microarray analysis identified 75 genes with differential expression that further delineated these two subpopulations. qPCR and immunoblot analyses showed increased dsRNA receptor expression after stimulation as compared to resistant and immortalized ovarian surface epithelial cells (e.g., 70-fold with malignant 2, 43-fold with OVCAR-3). Using agonists, antagonists, and shRNA-mediated knockdown of dsRNA receptors, we show that TLR3, RIG-I, and mda5 coordinated a caspase 8/9- and interferon-dependent cell death. In resistant cells, dsRNA receptor overexpression restored dsRNA sensitivity. When dsRNA was combined with carboplatin or paclitaxel, cell viability significantly decreased over individual treatments (1.5- to 7.5-fold). Isobologram analyses showed synergism in dsRNA combinations (CI=0.4-0.82) vs. an additive effect in carboplatin/paclitaxel treatment (CI=1.5-2). Our data identify a predictive marker, dsRNA receptor expression, to target dsRNA responsive populations and show that, in dsRNA-sensitive cells, dsRNA induces apoptosis and enhances the potency of cytotoxic chemotherapeutics.-Van, D. N., Roberts, C. F., Marion, J. D., Lepine, S., Harikumar, K. B., Schreiter, J., Dumur, C. I., Fang, X., Spiegel, S., Bell, J. K. Innate immune agonist, dsRNA, induces apoptosis in ovarian cancer cells and enhances the potency of cytotoxic chemotherapeutics. FASEB J. 26, 3188-3198 (2012). www.fasebj.org	[Van, Danielle N.; Roberts, Charlotte F.; Marion, James D.; Lepine, Sandrine; Harikumar, Kuzhuvelil B.; Fang, Xianjun; Spiegel, Sarah; Bell, Jessica K.] Virginia Commonwealth Univ, Dept Biochem & Mol Biol, Richmond, VA USA; [Dumur, Catherine I.] Virginia Commonwealth Univ, Dept Pathol, Richmond, VA USA; [Schreiter, Jessica] Centocor Res & Dev Inc, Discovery Res, Radnor, PA USA	Virginia Commonwealth University; Virginia Commonwealth University; Johnson & Johnson; Johnson & Johnson USA	Bell, JK (corresponding author), Sanger 2-040D,1101 E Marshall St, Richmond, VA 23298 USA.	jbell6@vcu.edu	Dumur, Catherine/AAH-9489-2020; Harikumar, Kuzhuvelil/AAC-2407-2020; Bell, Jessica/I-3893-2013	Harikumar, Kuzhuvelil/0000-0002-1763-4179; Bell, Jessica/0000-0003-1455-3274	U.S. National Institutes of Health (NIH) grants [CA144083, CA102196, CA61774, GM043880, CA12282801]; V Scholar award (Jimmy V Foundation); NIH-National Institute of Neuological Disease and Stroke Center core grant [5P30NS047463-02]; NIH-National Cancer Institute Cancer Center [P30 CA016059]; NATIONAL CANCER INSTITUTE [F31CA144083, R01CA102196, P30CA016059, R01CA061774] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM043880, R01GM043880] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS047463] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); V Scholar award (Jimmy V Foundation); NIH-National Institute of Neuological Disease and Stroke Center core grant; NIH-National Cancer Institute Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The authors thank Drs. Charles Chalfant, Paul Fisher, Andrew Larner [Virginia Commonwealth University (VCU), Richmond, VA, USA] and the Canadian Ovarian Cancer Research Culture Bank for generously sharing reagents. The authors also thank Drs. Paul Dent and Tomasz Kordula for helpful discussions during the development of these experiments. This work was funded by U.S. National Institutes of Health (NIH) grants CA144083 (D.N.V.), CA102196 (X.F.), CA61774 (S.S.), GM043880 (S.S.), and CA12282801 (J.K.B) and by a V Scholar award (Jimmy V Foundation; J.K.B). Microscopy was performed at the VCU Department of Anatomy and Neurobiology Microscopy Facility with funding from NIH-National Institute of Neuological Disease and Stroke Center core grant 5P30NS047463-02. VCU Massey Cancer Center Tissue and Data Acquisition and Analysis Core services were supported with funding from NIH-National Cancer Institute Cancer Center support grant P30 CA016059.	Ahmed AA, 2010, J PATHOL, V221, P49, DOI 10.1002/path.2696; Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; Bertrand MJM, 2008, MOL CELL, V30, P689, DOI 10.1016/j.molcel.2008.05.014; Besch R, 2009, J CLIN INVEST, V119, P2399, DOI 10.1172/JCI37155; BOUSSIF O, 1995, P NATL ACAD SCI USA, V92, P7297, DOI 10.1073/pnas.92.16.7297; Cancer Genome Atlas Research Network, 2011, Nature, V474, P609, DOI 10.1038/nature10166; Chou TC, 2006, PHARMACOL REV, V58, P621, DOI 10.1124/pr.58.3.10; Dumur CI, 2008, DIAGN MOL PATHOL, V17, P200, DOI 10.1097/PDM.0b013e318169bfaf; Dumur CI, 2004, CLIN CHEM, V50, P1994, DOI 10.1373/clinchem.2004.033225; Friboulet L, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-327; Hitomi J, 2004, J CELL BIOL, V165, P347, DOI 10.1083/jcb.200310015; Howlader N, 2011, SEER CANC STAT REV 1; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Jeung HC, 2008, ANN ONCOL, V19, P520, DOI 10.1093/annonc/mdm536; Kang DC, 2002, P NATL ACAD SCI USA, V99, P637, DOI 10.1073/pnas.022637199; Kubler K, 2011, EUR J IMMUNOL, V41, P3028, DOI 10.1002/eji.201141555; Kubler K, 2010, CANCER RES, V70, P5293, DOI 10.1158/0008-5472.CAN-10-0825; LACOUR J, 1980, LANCET, V2, P161; LEVIN D, 1978, P NATL ACAD SCI USA, V75, P1121, DOI 10.1073/pnas.75.3.1121; Li L, 2004, SCIENCE, V305, P1471, DOI 10.1126/science.1098231; Nomi N, 2010, ONCOL REP, V24, P225, DOI 10.3892/or_00000850; Paone A, 2008, CARCINOGENESIS, V29, P1334, DOI 10.1093/carcin/bgn149; Peng S, 2009, CANCER SCI, V100, P529, DOI 10.1111/j.1349-7006.2008.01062.x; Perrot I, 2010, J IMMUNOL, V185, P2080, DOI 10.4049/jimmunol.1000532; Pignata S, 2011, CANCER LETT, V303, P73, DOI 10.1016/j.canlet.2011.01.026; Salaun B, 2006, J IMMUNOL, V176, P4894, DOI 10.4049/jimmunol.176.8.4894; Salaun B, 2011, CANCER RES, V71, P1607, DOI 10.1158/0008-5472.CAN-10-3490; Shepherd TG, 2006, NAT PROTOC, V1, P2643, DOI 10.1038/nprot.2006.328; Storey JD, 2002, J ROY STAT SOC B, V64, P479, DOI 10.1111/1467-9868.00346; Teoh D, 2011, GYNECOL ONCOL, V121, P187, DOI 10.1016/j.ygyno.2010.11.017; Tormo D, 2009, CANCER CELL, V16, P103, DOI 10.1016/j.ccr.2009.07.004; Varfolomeev E, 2007, CELL, V131, P669, DOI 10.1016/j.cell.2007.10.030; YAGINUMA Y, 1992, CANCER RES, V52, P4196; Yang F, 2003, J IMMUNOL, V170, P5630, DOI 10.4049/jimmunol.170.11.5630; Yap TA, 2009, NAT REV CANCER, V9, P167, DOI 10.1038/nrc2583; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087; Yu M, 2011, CYTOKINE GROWTH F R, V22, P63, DOI 10.1016/j.cytogfr.2011.02.001; Zhang L, 2002, J MOL BIOL, V317, P225, DOI 10.1006/jmbi.2001.5350	39	26	27	0	13	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2012	26	8					3188	3198		10.1096/fj.11-202333	http://dx.doi.org/10.1096/fj.11-202333			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	984BI	22532440	Green Published			2022-12-25	WOS:000307162800010
J	Pelletier, L; Kato, A; Chiaradia, A; Ropert-Coudert, Y				Pelletier, Laure; Kato, Akiko; Chiaradia, Andre; Ropert-Coudert, Yan			Can Thermoclines Be a Cue to Prey Distribution for Marine Top Predators? A Case Study with Little Penguins	PLOS ONE			English	Article							THICK-BILLED MURRES; EUDYPTULA-MINOR; CLIMATE; TEMPERATURE; ECOSYSTEMS; BEHAVIOR; ISLAND; CYCLE	The use of top predators as bio-platforms is a modern approach to understanding how physical changes in the environment may influence their foraging success. This study examined if the presence of thermoclines could be a reliable signal of resource availability for a marine top predator, the little penguin (Eudyptula minor). We studied weekly foraging activity of 43 breeding individual penguins equipped with accelerometers. These loggers also recorded water temperature, which we used to detect changes in thermal characteristics of their foraging zone over 5 weeks during the penguin's guard phase. Data showed the thermocline was detected in the first 3 weeks of the study, which coincided with higher foraging efficiency. When a thermocline was not detected in the last two weeks, foraging efficiency decreased as well. We suggest that thermoclines can represent temporary markers of enhanced food availability for this top-predator to which they must optimally adjust their breeding cycle.	[Pelletier, Laure; Kato, Akiko; Ropert-Coudert, Yan] Univ Strasbourg, IPHC, Strasbourg, France; [Pelletier, Laure; Kato, Akiko; Ropert-Coudert, Yan] CNRS, UMR7178, Strasbourg, France; [Chiaradia, Andre] Phillip Isl Nat Pk, Cowes, Vic, Australia	UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute of Nuclear and Particle Physics (IN2P3); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Pelletier, L (corresponding author), Univ Strasbourg, IPHC, Strasbourg, France.	laure.pelletier@iphc.cnrs.fr	Kato, Akiko/W-2447-2019; Chiaradia, Andre/AFK-6634-2022; Chiaradia, Andre/AAG-4928-2022	Chiaradia, Andre/0000-0002-6178-4211; Chiaradia, Andre/0000-0002-6178-4211; Kato, Akiko/0000-0002-8947-3634	Japan Society for Promotion of Science; Region Alsace; Centre National de la Recherche Scientifique (CNRS); BHP-Billiton	Japan Society for Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Region Alsace(Region Grand-Est); Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); BHP-Billiton	This study was funded by grants from the Japan Society for Promotion of Science, the Region Alsace, the Centre National de la Recherche Scientifique (CNRS) and the BHP-Billiton. Note that Phillip Island Nature Park is a not-for profit organization dedicated to the protection and conservation of little penguins. The Park is controlled by a Board of Management appointed by the Minister for Environment of Victoria, Australia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainley DG, 2004, ECOL MONOGR, V74, P159, DOI 10.1890/02-4073; Ashmole N.P., 1971, AVIAN BIOL, P224; Bates D, IME4 LINEAR MIXED EF; Bost CA, 2009, J MARINE SYST, V78, P363, DOI 10.1016/j.jmarsys.2008.11.022; Chiaradia A, 2007, MAR BIOL, V151, P1535, DOI 10.1007/s00227-006-0593-9; Chiaradia A, 2006, ARDEA, V94, P257; Chiaradia A, 2012, AUSTRAL ECOL, V37, P610, DOI 10.1111/j.1442-9993.2011.02323.x; Collins M, 1999, WILDLIFE RES, V26, P705, DOI 10.1071/WR98003; Cullen JM, 2009, MAR ECOL PROG SER, V378, P269, DOI 10.3354/meps07881; Daunt F, 2003, MAR ECOL PROG SER, V255, P283, DOI 10.3354/meps255283; Durant JM, 2007, CLIM RES, V33, P271, DOI 10.3354/cr033271; Elliott KH, 2009, AUK, V126, P613, DOI 10.1525/auk.2009.08245; Francis RC, 1998, FISH OCEANOGR, V7, P1, DOI 10.1046/j.1365-2419.1998.00052.x; FRANKS PJS, 1992, MAR ECOL PROG SER, V82, P1, DOI 10.3354/meps082001; GALES R, 1990, ECOLOGY, V71, P2297, DOI 10.2307/1938641; GASPAR P, 1988, J PHYS OCEANOGR, V18, P161, DOI 10.1175/1520-0485(1988)018<0161:MTSCOT>2.0.CO;2; Gaston Anthony J., 2007, Marine Ornithology, V35, P119; Georges JY, 2003, CR GEOSCI, V335, P551, DOI 10.1016/S1631-0713(03)00101-9; Hansen JE, 2001, FISH OCEANOGR, V10, P193, DOI 10.1046/j.1365-2419.2001.00166.x; Kato A, 2006, MAR ECOL PROG SER, V308, P293, DOI 10.3354/meps308293; Kitagawa T, 2000, MAR ECOL PROG SER, V206, P251, DOI 10.3354/meps206251; Kitagawa T, 2001, MAR ECOL PROG SER, V220, P253, DOI 10.3354/meps220253; Kokubun N, 2010, AQUAT BIOL, V8, P289, DOI 10.3354/ab00243; Lin E., 2007, PHYS SCI BASIS WORKI, V3, P6; Matsumoto Kei, 2008, Ornithological Science, V7, P37, DOI 10.2326/1347-0558(2008)7[37:EFAORA]2.0.CO;2; Minster JF, 1997, MACHINE OCEAN, P87; Nisbet ICT, 2009, J AVIAN BIOL, V40, P296, DOI 10.1111/j.1600-048X.2008.04563.x; R Development Core Team, 2009, R FDN STAT COMP; Ropert-Coudert Y, 2006, MAR BIOL, V149, P139, DOI 10.1007/s00227-005-0188-x; Ropert-Coudert Y, 2007, DEEP-SEA RES PT II, V54, P415, DOI 10.1016/j.dsr2.2006.11.018; Ropert-Coudert Y, 2009, P ROY SOC B-BIOL SCI, V276, P4105, DOI 10.1098/rspb.2009.1399; Ropert-Coudert Yan, 2006, Marine Ornithology, V34, P71; Russell RW, 1999, MAR ECOL PROG SER, V182, P77, DOI 10.3354/meps182077; Saether BE, 2000, SCIENCE, V288, P1975; SCHREIBER E.A., 2001, BIOL MARINE BIRDS, V1st; Shultz MT, 2009, MAR ECOL PROG SER, V393, P247, DOI 10.3354/meps08136; Takahashi A, 2008, DEEP-SEA RES PT II, V55, P1837, DOI 10.1016/j.dsr2.2008.04.005; Thomas DW, 2001, SCIENCE, V291, P2598, DOI 10.1126/science.1057487; Visser ME, 2005, P ROY SOC B-BIOL SCI, V272, P2561, DOI 10.1098/rspb.2005.3356; Wilson RP, 1997, WILDLIFE SOC B, V25, P101; Zimmer I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016098	41	36	36	2	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2012	7	4							e31768	10.1371/journal.pone.0031768	http://dx.doi.org/10.1371/journal.pone.0031768			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UD	22536314	Green Published, gold, Green Submitted			2022-12-25	WOS:000305339200004
J	Ross, F; Hernandez, P; Porcal, W; Lopez, GV; Cerecetto, H; Gonzalez, M; Basika, T; Carmona, C; Flo, M; Maggioli, G; Bonilla, M; Gladyshev, VN; Boiani, M; Salinas, G				Ross, Fabiana; Hernandez, Paola; Porcal, Williams; Lopez, Gloria V.; Cerecetto, Hugo; Gonzalez, Mercedes; Basika, Tatiana; Carmona, Carlos; Flo, Martin; Maggioli, Gabriela; Bonilla, Mariana; Gladyshev, Vadim N.; Boiani, Mariana; Salinas, Gustavo			Identification of Thioredoxin Glutathione Reductase Inhibitors That Kill Cestode and Trematode Parasites	PLOS ONE			English	Article							CRASSICEPS METACESTODE CYSTICERCI; ESCHERICHIA-COLI; SCHISTOSOMA-MANSONI; ECHINOCOCCOSIS; PLATYHELMINTHS; SELENOCYSTEINE; DISEASES; SELENIUM; SYSTEMS; ASSAY	Parasitic flatworms are responsible for serious infectious diseases that affect humans as well as livestock animals in vast regions of the world. Yet, the drug armamentarium available for treatment of these infections is limited: praziquantel is the single drug currently available for 200 million people infected with Schistosoma spp. and there is justified concern about emergence of drug resistance. Thioredoxin glutathione reductase (TGR) is an essential core enzyme for redox homeostasis in flatworm parasites. In this work, we searched for flatworm TGR inhibitors testing compounds belonging to various families known to inhibit thioredoxin reductase or TGR and also additional electrophilic compounds. Several furoxans and one thiadiazole potently inhibited TGRs from both classes of parasitic flatworms: cestoda (tapeworms) and trematoda (flukes), while several benzofuroxans and a quinoxaline moderately inhibited TGRs. Remarkably, five active compounds from diverse families possessed a phenylsulfonyl group, strongly suggesting that this moiety is a new pharmacophore. The most active inhibitors were further characterized and displayed slow and nearly irreversible binding to TGR. These compounds efficiently killed Echinococcus granulosus larval worms and Fasciola hepatica newly excysted juveniles in vitro at a 20 mu M concentration. Our results support the concept that the redox metabolism of flatworm parasites is precarious and particularly susceptible to destabilization, show that furoxans can be used to target both flukes and tapeworms, and identified phenylsulfonyl as a new drug-hit moiety for both classes of flatworm parasites.	[Ross, Fabiana; Flo, Martin; Bonilla, Mariana; Salinas, Gustavo] Univ Republica, Catedra Inmunol, Fac Quim, Montevideo, Uruguay; [Basika, Tatiana; Carmona, Carlos; Maggioli, Gabriela] Univ Republica, Fac Ciencias, Unidad Biol Parasitaria, Montevideo, Uruguay; [Hernandez, Paola; Porcal, Williams; Lopez, Gloria V.; Cerecetto, Hugo; Gonzalez, Mercedes; Boiani, Mariana] Univ Republica, Grp Quim Med, Lab Quim Organ, Fac Quim, Montevideo, Uruguay; [Gladyshev, Vadim N.] Brigham & Womens Hosp, Dept Med, Div Genet, Boston, MA 02115 USA; [Gladyshev, Vadim N.] Harvard Univ, Sch Med, Boston, MA USA	Universidad de la Republica, Uruguay; Universidad de la Republica, Uruguay; Universidad de la Republica, Uruguay; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Salinas, G (corresponding author), Univ Republica, Catedra Inmunol, Fac Quim, Montevideo, Uruguay.	gsalin@fq.edu.uy	Gladyshev, Vadim N/A-9894-2013; Lopez, Gloria Virginia/ABA-3286-2021; Gladyshev, Vadim N/J-6187-2013	Lopez, Gloria Virginia/0000-0001-7515-3915; Bonilla, Mariana/0000-0002-9206-345X; Hernandez, Paola/0000-0002-3515-1082; Gonzalez, Mercedes/0000-0002-0808-0610; Gladyshev, Vadim/0000-0002-0372-7016; Salinas, Gustavo/0000-0003-3350-3002	Fogarty International Research Collaboration Award/National Institutes of Health - FIRCA/NIH [RO3TW008588]; Universidad de la Republica [CSIC 625]; NIH [GM065204]; FOGARTY INTERNATIONAL CENTER [R03TW008588] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM065204, R01GM065204] Funding Source: NIH RePORTER	Fogarty International Research Collaboration Award/National Institutes of Health - FIRCA/NIH; Universidad de la Republica; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants RO3TW008588 (Fogarty International Research Collaboration Award/National Institutes of Health - FIRCA/NIH) and CSIC 625 (Universidad de la Republica) to GS, and grant GM065204 (NIH) to VNG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alger HM, 2002, MOL BIOCHEM PARASIT, V121, P129, DOI 10.1016/S0166-6851(02)00031-2; Andricopulo AD, 2006, BIOORG MED CHEM LETT, V16, P2283, DOI 10.1016/j.bmcl.2006.01.027; Arner ESJ, 1999, J MOL BIOL, V292, P1003, DOI 10.1006/jmbi.1999.3085; Arner ESJ, 1999, METHOD ENZYMOL, V300, P226; Bar-Noy S, 2001, FREE RADICAL BIO MED, V30, P51, DOI 10.1016/S0891-5849(00)00448-2; BAZ A, 1995, IMMUNOLOGY, V84, P350; Bonilla M, 2008, J BIOL CHEM, V283, P17898, DOI 10.1074/jbc.M710609200; Brennan GP, 2007, EXP MOL PATHOL, V82, P104, DOI 10.1016/j.yexmp.2007.01.009; CARLBERG I, 1985, METHOD ENZYMOL, V113, P484; CARMONA C, 1993, MOL BIOCHEM PARASIT, V62, P9, DOI 10.1016/0166-6851(93)90172-T; Cioli D, 2008, TRENDS PARASITOL, V24, P379, DOI 10.1016/j.pt.2008.05.006; GHOSE AK, 1987, J CHEM INF COMP SCI, V27, P21, DOI 10.1021/ci00053a005; Guevara-Flores A, 2011, PARASITOL INT, V60, P156, DOI 10.1016/j.parint.2011.01.005; Hotez PJ, 2008, J CLIN INVEST, V118, P1311, DOI 10.1172/JCI34261; Huang HH, 2011, BIOCHEMISTRY; Jolliffe, 2002, PRINCIPAL COMPONENT; Keiser J, 2005, EMERG INFECT DIS, V11, P1507, DOI 10.3201/eid1110.050614; Kern P, 2010, CURR OPIN INFECT DIS, V23, P505, DOI 10.1097/QCO.0b013e32833d7516; Maggioli G, 2011, EXP PARASITOL, V129, P323, DOI 10.1016/j.exppara.2011.09.013; Mansour TE., 2002, CHEMOTHERAPEUTIC TAR, DOI 10.1017/CBO9780511546440; Martinez-Gonzalez JJ, 2010, PARASITOL RES, V107, P227, DOI 10.1007/s00436-010-1867-1; Muller S, 1997, ARCH MICROBIOL, V168, P421, DOI 10.1007/s002030050517; Nwaka S, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000440; Otero L, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-237; Rai G, 2009, TETRAHEDRON LETT, V50, P1710, DOI 10.1016/j.tetlet.2009.01.120; Rai G, 2009, J MED CHEM, V52, P6474, DOI 10.1021/jm901021k; Rendon JL, 2004, MOL BIOCHEM PARASIT, V133, P61, DOI 10.1016/j.molbiopara.2003.09.003; Rengby O, 2004, APPL ENVIRON MICROB, V70, P5159, DOI 10.1128/AEM.70.9.5159-5167.2004; Salinas G, 2004, TRENDS PARASITOL, V20, P340, DOI 10.1016/j.pt.2004.05.002; Sayed AA, 2008, NAT MED, V14, P407, DOI 10.1038/nm1737; Simeonov A, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000127; Storer JW, 1994, STRUCTURE REACTIVITY; TADA H, 1986, J IMMUNOL METHODS, V93, P157, DOI 10.1016/0022-1759(86)90183-3; Torgerson PR, 2003, RES VET SCI, V74, P191, DOI 10.1016/S0034-5288(03)00006-7	34	31	32	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2012	7	4							e35033	10.1371/journal.pone.0035033	http://dx.doi.org/10.1371/journal.pone.0035033			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UD	22536349	Green Published, gold, Green Submitted			2022-12-25	WOS:000305339200032
J	Sun, MX; Liang, AP; Watson, GS; Watson, JA; Zheng, YM; Ju, J; Jiang, L				Sun, Mingxia; Liang, Aiping; Watson, Gregory S.; Watson, Jolanta A.; Zheng, Yongmei; Ju, Jie; Jiang, Lei			Influence of Cuticle Nanostructuring on the Wetting Behaviour/States on Cicada Wings	PLOS ONE			English	Article							HIGH ADHESIVE FORCE; WATER; SURFACES; LOTUS; LEGS; FABRICATION; DESIGN; FILMS	The nanoscale protrusions of different morphologies on wing surfaces of four cicada species were examined under an environmental scanning electron microscope (ESEM). The water contact angles (CAs) of the wing surfaces were measured along with droplet adhesion values using a high-sensitivity microelectromechanical balance system. The water CA and adhesive force measurements obtained were found to relate to the nanostructuring differences of the four species. The adhesive forces in combination with the Cassie-Baxter and Wenzel approximations were used to predict wetting states of the insect wing cuticles. The more disordered and inhomogeneous surface of the species Leptopsalta bifuscata demonstrated a Wenzel type wetting state or an intermediate state of spreading and imbibition with a CA of 81.3 degrees and high adhesive force of 149.5 mu N. Three other species (Cryptotympana atrata, Meimuna opalifer and Aola bindusara) exhibited nanostructuring of the form of conically shaped protrusions, which were spherically capped. These surfaces presented a range of high adhesional values; however, the CAs were highly hydrophobic (C. atrata and A. bindusara) and in some cases close to superhydrophobic (M. opalifer). The wetting states of A. bindusara, C. atrata and M. opalifer (based on adhesion and CAs) are most likely represented by the transitional region between the Cassie-Baxter and Wenzel approximations to varying degrees.	[Sun, Mingxia; Liang, Aiping] Chinese Acad Sci, Inst Zool, Key Lab Zool Systemat & Evolut, Beijing, Peoples R China; [Watson, Gregory S.; Watson, Jolanta A.] James Cook Univ, Sch Pharm & Mol Sci, Townsville, Qld 4811, Australia; [Zheng, Yongmei] Beihang Univ, Minist Educ, Sch Chem & Environm, Key Lab Bioinspired Smart Interfacial Sci & Techn, Beijing, Peoples R China; [Ju, Jie; Jiang, Lei] Chinese Acad Sci, Inst Chem, Ctr Mol Sci, Beijing 100080, Peoples R China	Chinese Academy of Sciences; Institute of Zoology, CAS; James Cook University; Beihang University; Chinese Academy of Sciences; Institute of Chemistry, CAS	Liang, AP (corresponding author), Chinese Acad Sci, Inst Zool, Key Lab Zool Systemat & Evolut, Beijing, Peoples R China.	liangap@ioz.ac.cn; zhengym@buaa.edu.cn	Watson, Gregory S/D-2195-2009; , 许永傲/AAC-2581-2019; Ju, Jie/M-6709-2017; Sun (孙), Mingxia (明霞)/ABA-7705-2021; Jiang, Lei/B-1066-2011; Watson, Jolanta A/A-9332-2008	Ju, Jie/0000-0001-8931-3270; Watson, Jolanta A/0000-0002-5027-9025; Sun, Mingxia/0000-0002-1184-516X; Watson, Gregory/0000-0001-9843-9211	Chinese Academy of Sciences [KSCX2-EW-G-4]; National Basic Research Program of China (973 Program) [2011CB302102]; National Natural Science Foundation of China [30970400, 31172128]; Key Laboratory of the Zoological Systematics and Evolution of the Chinese Academy of Sciences [O529YX5105]	Chinese Academy of Sciences(Chinese Academy of Sciences); National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Laboratory of the Zoological Systematics and Evolution of the Chinese Academy of Sciences	This work was supported by the following sources: Main Direction Program of Knowledge Innovation of Chinese Academy of Sciences (grant no KSCX2-EW-G-4), the National Basic Research Program of China (973 Program) (grant no 2011CB302102), the National Natural Science Foundation of China (grant nos 30970400, 31172128), and the Key Laboratory of the Zoological Systematics and Evolution of the Chinese Academy of Sciences (grant no O529YX5105). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barthlott W, 1997, PLANTA, V202, P1, DOI 10.1007/s004250050096; Bhushan B., 2002, INTRO TRIBOLOGY, P169; Bhushan B, 2010, LANGMUIR, V26, P8207, DOI 10.1021/la904585j; Bico J, 2002, COLLOID SURFACE A, V206, P41, DOI 10.1016/S0927-7757(02)00061-4; Cassie ABD, 1944, T FARADAY SOC, V40, P0546, DOI 10.1039/tf9444000546; Chang FM, 2009, APPL PHYS LETT, V95, DOI 10.1063/1.3204006; Cheng ZJ, 2010, LANGMUIR, V26, P8233, DOI 10.1021/la904510n; Cho WK, 2008, ADV FUNCT MATER, V18, P1089, DOI 10.1002/adfm.200701454; Cong Q, 2004, J BIONIC ENG, V1, P249; Feng L, 2008, LANGMUIR, V24, P4114, DOI 10.1021/la703821h; Feng XQ, 2007, LANGMUIR, V23, P4892, DOI 10.1021/la063039b; Gao XF, 2004, NATURE, V432, P36, DOI 10.1038/432036a; Gorb SN, 2000, ARTHROPOD STRUCT DEV, V29, P129, DOI 10.1016/S1467-8039(00)00020-7; Green DW, 2012, ADV HEALTHC MATER, V1, P140, DOI 10.1002/adhm.201100039; HOLDGATE MW, 1955, J EXP BIOL, V32, P591; Hong SH, 2009, NANOTECHNOLOGY, V20, DOI 10.1088/0957-4484/20/38/385303; Hu HM, 2011, BIOFOULING, V27, P1125, DOI 10.1080/08927014.2011.637187; Hu HMS, 2011, J EXP BIOL, V214, P915, DOI 10.1242/jeb.051128; Jin MH, 2005, ADV MATER, V17, P1977, DOI 10.1002/adma.200401726; JOANNY JF, 1984, J CHEM PHYS, V81, P552, DOI 10.1063/1.447337; Koch K, 2009, SOFT MATTER, V5, P1386, DOI 10.1039/b818940d; Kostovski G, 2009, BIOSENS BIOELECTRON, V24, P1531, DOI 10.1016/j.bios.2008.10.016; Kostovski G, 2011, ADV MATER, V23, P531, DOI 10.1002/adma.201002796; Neithhuis C, 1997, ANN BOT, V79, P667; Parker AR, 2001, NATURE, V414, P33, DOI 10.1038/35102108; Quere D, 2008, PHILOS T R SOC A, V366, P1539, DOI 10.1098/rsta.2007.2171; Song F, 2004, J EXP BIOL, V207, P3035, DOI 10.1242/jeb.01122; Stoddart PR, 2006, NANOTECHNOLOGY, V17, P680, DOI 10.1088/0957-4484/17/3/011; Sun MX, 2011, BIOINSPIR BIOMIM, V6, DOI 10.1088/1748-3182/6/2/026003; Sun MX, 2009, J EXP BIOL, V212, P3148, DOI 10.1242/jeb.033373; Vincent JFV, 2004, ARTHROPOD STRUCT DEV, V33, P187, DOI 10.1016/j.asd.2004.05.006; Wagner P., 1996, ACTA ZOOLOGICA, V77, P213, DOI DOI 10.1111/J.1463-6395.1996.TB01265.X; Wang S, 2007, ADV MATER, V19, P3423, DOI 10.1002/adma.200700934; Watson GS, 2008, BIOPHYS J, V94, P3352, DOI 10.1529/biophysj.107.109348; Watson GS, 2010, ACS NANO, V4, P129, DOI 10.1021/nn900869b; Watson GS, 2010, J STRUCT BIOL, V171, P44, DOI 10.1016/j.jsb.2010.03.008; Watson J. A., 2006, P SOC PHOTO-OPT INS, V6037, P375; Watson JA, 2011, BIOPHYS J, V100, P1149, DOI 10.1016/j.bpj.2010.12.3736; Wenzel RN, 1936, IND ENG CHEM, V28, P988, DOI 10.1021/ie50320a024; Xie GY, 2008, NANOTECHNOLOGY, V19, DOI 10.1088/0957-4484/19/9/095605; Zhang GM, 2006, SMALL, V2, P1440, DOI 10.1002/smll.200600255; Zhang JH, 2008, SOFT MATTER, V4, P2232, DOI 10.1039/b807857b; Zhao WJ, 2010, J PHYS CHEM C, V114, P11509, DOI 10.1021/jp102052e; Zheng YM, 2007, SOFT MATTER, V3, P178, DOI 10.1039/b612667g	44	51	51	1	80	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2012	7	4							e35056	10.1371/journal.pone.0035056	http://dx.doi.org/10.1371/journal.pone.0035056			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UD	22536351	Green Submitted, gold, Green Published, Green Accepted			2022-12-25	WOS:000305339200036
J	Tang, JW; Nicolle, A; Pantelic, J; Koh, GC; De Wang, L; Amin, M; Klettner, CA; Cheong, DKW; Sekhar, C; Tham, KW				Tang, Julian W.; Nicolle, Andre; Pantelic, Jovan; Koh, Gerald C.; De Wang, Liang; Amin, Muhammad; Klettner, Christian A.; Cheong, David K. W.; Sekhar, Chandra; Tham, Kwok Wai			Airflow Dynamics of Coughing in Healthy Human Volunteers by Shadowgraph Imaging: An Aid to Aerosol Infection Control	PLOS ONE			English	Article							INFLUENZA-VIRUS	Cough airflow dynamics have been previously studied using a variety of experimental methods. In this study, real-time, non-invasive shadowgraph imaging was applied to obtain additional analyses of cough airflows produced by healthy volunteers. Twenty healthy volunteers (10 women, mean age 32.2 +/- 12.9 years; 10 men, mean age 25.3 +/- 2.5 years) were asked to cough freely, then into their sleeves (as per current US CDC recommendations) in this study to analyze cough airflow dynamics. For the 10 females (cases 1-10), their maximum detectable cough propagation distances ranged from 0.16-0.55 m, with maximum derived velocities of 2.2-5.0 m/s, and their maximum detectable 2-D projected areas ranged from 0.010-0.11 m(2), with maximum derived expansion rates of 0.15-0.55 m(2)/s. For the 10 males (cases 11-20), their maximum detectable cough propagation distances ranged from 0.31-0.64 m, with maximum derived velocities of 3.2-14 m/s, and their maximum detectable 2-D projected areas ranged from 0.04-0.14 m(2), with maximum derived expansion rates of 0.25-1.4 m(2)/s. These peak velocities were measured when the visibility of the exhaled airflows was optimal and compare favorably with those reported previously using other methods, and may be seen as a validation of these previous approaches in a more natural setting. However, the propagation distances can only represent a lower limit due to the inability of the shadowgraph method to visualize these cough airflows once their temperature cools to that of the ambient air, which is an important limitation of this methodology. The qualitative high-speed video footage of these volunteers coughing into their sleeves demonstrates that although this method rarely completely blocks the cough airflow, it decelerates, splits and redirects the airflow, eventually reducing its propagation. The effectiveness of this intervention depends on optimum positioning of the arm over the nose and mouth during coughing, though unsightly stains on sleeves may make it unacceptable to some.	[Tang, Julian W.; Nicolle, Andre; De Wang, Liang; Amin, Muhammad; Klettner, Christian A.] Natl Univ Hosp, Dept Lab Med, Queenstown, Singapore; [Pantelic, Jovan; Cheong, David K. W.; Sekhar, Chandra; Tham, Kwok Wai] Natl Univ Singapore, Sch Design & Environm, Dept Bldg, Queenstown, Singapore; [Koh, Gerald C.] Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Queenstown, Singapore	National University of Singapore; National University of Singapore	Tang, JW (corresponding author), Natl Univ Hosp, Dept Lab Med, Queenstown, Singapore.	jwtang49@hotmail.com	THAM, Kwok Wai/B-6541-2009; Sekhar, Chandra/F-3253-2017	THAM, Kwok Wai/0000-0002-2957-1152; Pantelic, Jovan/0000-0001-7541-8274; Cheong, David/0000-0001-7680-4281; Tang, Julian/0000-0002-4963-1028; Koh, Choon Huat Gerald/0000-0002-6453-6897; Sekhar, Chandra/0000-0002-0814-8662	National Medical Research Council (NMRC) of Singapore [NMRC/1208/2009]	National Medical Research Council (NMRC) of Singapore(National Medical Research Council, Singapore)	Funding for this study (including the support to Dr. Nicolle) is provided by the National Medical Research Council (NMRC) of Singapore, Grant No. NMRC/1208/2009 to Dr. Tang. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blachere FM, 2009, CLIN INFECT DIS, V48, P438, DOI 10.1086/596478; Chao CYH, 2009, J AEROSOL SCI, V40, P122, DOI 10.1016/j.jaerosci.2008.10.003; Clark RP, 2009, J R SOC INTERFACE, V6, pS767, DOI 10.1098/rsif.2009.0236.focus; Eames I, 2009, J R SOC INTERFACE, V6, pS697, DOI 10.1098/rsif.2009.0407.focus; Fabian P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002691; Gupta JK, 2009, INDOOR AIR, V19, P517, DOI 10.1111/j.1600-0668.2009.00619.x; Lindsley WG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015100; Lindsley WG, 2010, CLIN INFECT DIS, V50, P693, DOI 10.1086/650457; McCool FD, 2006, CHEST, V129, p48S, DOI 10.1378/chest.129.1_suppl.48S; Stelzer-Braid S, 2009, J MED VIROL, V81, P1674, DOI 10.1002/jmv.21556; Tang JW, 2008, NEW ENGL J MED, V359, pE19, DOI 10.1056/NEJMicm072576; Tang JW, 2006, J HOSP INFECT, V64, P100, DOI 10.1016/j.jhin.2006.05.022; Tang JW, 2011, J HOSP INFECT, V77, P213, DOI 10.1016/j.jhin.2010.09.037; Tang JLW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021392; Tang JW, 2009, J R SOC INTERFACE, V6, pS727, DOI 10.1098/rsif.2009.0295.focus; Tang JWT, 2009, NEW ENGL J MED, V361, pE62, DOI 10.1056/NEJMicm0904279; VanSciver M, 2011, AEROSOL SCI TECH, V45, P415, DOI 10.1080/02786826.2010.542785; Xie XJ, 2009, J R SOC INTERFACE, V6, pS703, DOI 10.1098/rsif.2009.0388.focus; Yang W, 2011, J R SOC INTERFACE, V8, P1176, DOI 10.1098/rsif.2010.0686; Zhu SW, 2006, BUILD ENVIRON, V41, P1691, DOI 10.1016/j.buildenv.2005.06.024	20	46	47	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2012	7	4							e34818	10.1371/journal.pone.0034818	http://dx.doi.org/10.1371/journal.pone.0034818			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UD	22536332	Green Published, Green Submitted, gold			2022-12-25	WOS:000305339200021
J	Cordero, MD; Cano-Garcia, FJ; Alcocer-Gomez, E; De Miguel, M; Sanchez-Alcazar, JA				Cordero, Mario D.; Javier Cano-Garcia, Francisco; Alcocer-Gomez, Elisabet; De Miguel, Manuel; Antonio Sanchez-Alcazar, Jose			Oxidative Stress Correlates with Headache Symptoms in Fibromyalgia: Coenzyme Q(10) Effect on Clinical Improvement	PLOS ONE			English	Article							TRIGGERS MITOCHONDRIA DEGRADATION; LIPID-PEROXIDATION; CHRONIC-FATIGUE; RISK-FACTOR; DEFICIENCY; MIGRAINE; SUPPLEMENTATION; INFLAMMATION; DYSFUNCTION; BRAIN	Background: Fibromyalgia (FM) is a chronic pain syndrome with unknown etiology and a wide spectrum of symptoms such as allodynia, debilitating fatigue, joint stiffness and migraine. Recent studies have shown some evidences demonstrating that oxidative stress is associated to clinical symptoms in FM of fibromyalgia. We examined oxidative stress and bioenergetic status in blood mononuclear cells (BMCs) and its association to headache symptoms in FM patients. The effects of oral coenzyme Q(10) (CoQ(10)) supplementation on biochemical markers and clinical improvement were also evaluated. Methods: We studied 20 FM patients and 15 healthy controls. Clinical parameters were evaluated using the Fibromyalgia Impact Questionnaire (FIQ), visual analogues scales (VAS), and the Headache Impact Test (HIT-6). Oxidative stress was determined by measuring CoQ(10), catalase and lipid peroxidation (LPO) levels in BMCs. Bioenergetic status was assessed by measuring ATP levels in BMCs. Results: We found decreased CoQ(10), catalase and ATP levels in BMCs from FM patients as compared to normal control (P<0.05 and P<0.001, respectively) We also found increased level of LPO in BMCs from FM patients as compared to normal control (P<0.001). Significant negative correlations between CoQ(10) or catalase levels in BMCs and headache parameters were observed (r = -0.59, P<0.05; r = -0.68, P<0.05, respectively). Furthermore, LPO levels showed a significant positive correlation with HIT-6 (r = 0.33, P<0.05). Oral CoQ(10) supplementation restored biochemical parameters and induced a significant improvement in clinical and headache symptoms (P<0.001). Discussion: The results of this study suggest a role for mitochondrial dysfunction and oxidative stress in the headache symptoms associated with FM. CoQ10 supplementation should be examined in a larger placebo controlled trial as a possible treatment in FM.	[Cordero, Mario D.; Antonio Sanchez-Alcazar, Jose] Univ Pablo de Olavide CSIC Junta de Andalucia, Ctr Andaluz Biol Desarrollo CABD, Seville, Spain; [Cordero, Mario D.; Antonio Sanchez-Alcazar, Jose] ISCIII, Ctr Invest Biomed Red Enfermedades Raras CIBERER, Seville, Spain; [Cordero, Mario D.; De Miguel, Manuel] Univ Seville, Fac Med, Dept Citol & Histol Normal & Patol, Seville, Spain; [Javier Cano-Garcia, Francisco; Alcocer-Gomez, Elisabet] Univ Seville, Fac Psicol, Dept Personalidad Evaluac & Tratamiento Psicol, Seville, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); Universidad Pablo de Olavide; CSIC - Andalusian Center for Developmental Biology (CABD); CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Instituto de Salud Carlos III; University of Sevilla; University of Sevilla	Cordero, MD (corresponding author), Univ Pablo de Olavide CSIC Junta de Andalucia, Ctr Andaluz Biol Desarrollo CABD, Seville, Spain.	mdcormor@upo.es	Sanchéz-Alcázar, José A. A/L-4925-2014; Magaña, Felipe/B-6966-2013; Cordero, Mario D./L-8006-2014; Cano-García, Francisco Javier/A-5005-2008; De-Miguel, Manuel/B-3713-2017	Sanchéz-Alcázar, José A. A/0000-0001-9705-1469; Cordero, Mario D./0000-0003-0151-3644; Cano-García, Francisco Javier/0000-0002-7581-2455; De-Miguel, Manuel/0000-0002-6751-1695; Alcocer-Gomez, Elisabet/0000-0001-9799-431X	IV Plan Propio de Investigacion (University of Seville) [2010/00000453, FIS PI10/00543, FIS EC08/00076]; Ministerio de Sanidad, Spain and Fondo Europeo de Desarrollo Regional (FEDER-Union Europea) [SAS 111242]; Servicio Andaluz de Salud-Junta de Andalucia [CTS-5725]; Federacion Andaluza de Fibromialgia y Fatiga Cronica (ALBA Andalucia)	IV Plan Propio de Investigacion (University of Seville); Ministerio de Sanidad, Spain and Fondo Europeo de Desarrollo Regional (FEDER-Union Europea); Servicio Andaluz de Salud-Junta de Andalucia; Federacion Andaluza de Fibromialgia y Fatiga Cronica (ALBA Andalucia)	This work has been supported by IV Plan Propio de Investigacion (University of Seville, ref. 2010/00000453), FIS PI10/00543 grant, FIS EC08/00076 grant, Ministerio de Sanidad, Spain and Fondo Europeo de Desarrollo Regional (FEDER-Union Europea), SAS 111242 grant, Servicio Andaluz de Salud-Junta de Andalucia, Proyecto de Investigacion de Excelencia de la Junta de Andalucia CTS-5725 and Federacion Andaluza de Fibromialgia y Fatiga Cronica (ALBA Andalucia). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen JK, 2004, NAT MED, V10, pS18, DOI 10.1038/nrn1434; BATTINO M, 1990, INT J TISSUE REACT, V12, P137; BEERS RF, 1952, J BIOL CHEM, V195, P133; Belaunzaran OM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018268; Bisaglia M, 2002, NEUROCHEM INT, V41, P43, DOI 10.1016/S0197-0186(01)00136-X; Centonze V, 2004, NEUROL SCI, V25, pS291, DOI 10.1007/s10072-004-0314-4; Ciancarelli I, 2003, CEPHALALGIA, V23, P39, DOI 10.1046/j.1468-2982.2003.00447.x; Cordero MD, 2009, CLIN BIOCHEM, V42, P732, DOI 10.1016/j.clinbiochem.2008.12.010; Cotan D, 2011, FASEB J, V25, P2669, DOI 10.1096/fj.10-165340; Dupic L, 2011, CRIT CARE, V15, DOI 10.1186/cc10429; Gupta R, 2009, ANN INDIAN ACAD NEUR, V12, P167, DOI 10.4103/0972-2327.56316; Gur A, 2008, CURR PAIN HEADACHE R, V12, P175, DOI 10.1007/s11916-008-0031-4; Hershey AD, 2007, HEADACHE, V47, P73, DOI 10.1111/j.1526-4610.2007.00652.x; Keller JN, 1998, REV NEUROSCIENCE, V9, P105; Kunitomo M, 2008, J PHARMACOL SCI, V107, P128, DOI 10.1254/jphs.FP0072365; Lawrence RC, 2008, ARTHRITIS RHEUM, V58, P26, DOI 10.1002/art.23176; LENAZ G, 1990, FREE RADICAL RES COM, V8, P317, DOI 10.3109/10715769009053365; Littarru GP, 2010, NUTRITION, V26, P250, DOI 10.1016/j.nut.2009.08.008; Lodi R, 1997, J NEUROL NEUROSUR PS, V62, P574, DOI 10.1136/jnnp.62.6.574; Lucas HJ, 2006, INT J IMMUNOPATH PH, V19, P5; Maes M, 2009, NEUROENDOCRINOL LETT, V30, P462; Maes M, 2009, NEUROENDOCRINOL LETT, V30, P470; Maharaj H, 2006, METAB BRAIN DIS, V21, P189, DOI 10.1007/s11011-006-9012-7; Marcus DA, 2005, CLIN RHEUMATOL, V24, P595, DOI 10.1007/s10067-005-1121-x; MOSKOWITZ MA, 1993, NEUROLOGY, V43, P16; Peres MFP, 2001, NEUROLOGY, V57, P1326, DOI 10.1212/WNL.57.7.1326; RAUCHOVA H, 1992, J BIOENERG BIOMEMBR, V24, P235, DOI 10.1007/BF00762682; Rodriguez-Hernandez A, 2009, AUTOPHAGY, V5, P19, DOI 10.4161/auto.5.1.7174; Salemi S, 2003, J RHEUMATOL, V30, P146; SAMORI B, 1992, J MEMBRANE BIOL, V128, P193; Sarzi-Puttini P, 2008, SEMIN ARTHRITIS RHEU, V37, P353, DOI 10.1016/j.semarthrit.2007.08.008; Sarzi-Puttini P, 2011, BEST PRACT RES CL RH, V25, P311, DOI 10.1016/j.berh.2011.03.001; Sparaco M, 2006, CEPHALALGIA, V26, P361, DOI 10.1111/j.1468-2982.2005.01059.x; Staud Roland, 2002, Curr Rheumatol Rep, V4, P299, DOI 10.1007/s11926-002-0038-5; Tomasetti M, 2001, FASEB J, V15, P1425, DOI 10.1096/fj.00-0694fje; Tuncel D, 2008, BIOL TRACE ELEM RES, V126, P92, DOI 10.1007/s12011-008-8193-9; Turunen M, 2004, BBA-BIOMEMBRANES, V1660, P171, DOI 10.1016/j.bbamem.2003.11.012; Uzar E, 2011, EUR REV MED PHARMACO, V15, P1111; Vanmolkot FH, 2007, CEPHALALGIA, V27, P843, DOI 10.1111/j.1468-2982.2007.01324.x; Wang ZQ, 2004, J PHARMACOL EXP THER, V309, P869, DOI 10.1124/jpet.103.064154; WOLFE F, 1990, ARTHRITIS RHEUM-US, V33, P160, DOI 10.1002/art.1780330203; Wolfe F, 1997, ARTHRITIS RHEUM, V40, P1571, DOI 10.1002/art.1780400905	42	65	65	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2012	7	4							e35677	10.1371/journal.pone.0035677	http://dx.doi.org/10.1371/journal.pone.0035677			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TL	22532869	Green Published, gold, Green Submitted			2022-12-25	WOS:000305336200065
J	Ma, TF; Zhao, XL; Cai, L; Zhang, N; Ren, SQ; Ji, F; Tian, T; Lu, W				Ma, Teng-Fei; Zhao, Xiao-Lei; Cai, Lei; Zhang, Nan; Ren, Si-Qiang; Ji, Fang; Tian, Tian; Lu, Wei			Regulation of Spike Timing-Dependent Plasticity of Olfactory Inputs in Mitral Cells in the Rat Olfactory Bulb	PLOS ONE			English	Article							NEOCORTICAL PYRAMIDAL NEURONS; ACTION-POTENTIAL PROPAGATION; GRANULE CELLS; LATERAL INHIBITION; SYNAPTIC PLASTICITY; ODOR DISCRIMINATION; TERM PLASTICITY; NMDA RECEPTORS; CALCIUM INFLUX; IN-VIVO	The recent history of activity input onto granule cells (GCs) in the main olfactory bulb can affect the strength of lateral inhibition, which functions to generate contrast enhancement. However, at the plasticity level, it is unknown whether and how the prior modification of lateral inhibition modulates the subsequent induction of long-lasting changes of the excitatory olfactory nerve (ON) inputs to mitral cells (MCs). Here we found that the repetitive stimulation of two distinct excitatory inputs to the GCs induced a persistent modification of lateral inhibition in MCs in opposing directions. This bidirectional modification of inhibitory inputs differentially regulated the subsequent synaptic plasticity of the excitatory ON inputs to the MCs, which was induced by the repetitive pairing of excitatory postsynaptic potentials (EPSPs) with postsynaptic bursts. The regulation of spike timing-dependent plasticity (STDP) was achieved by the regulation of the interspike-interval (ISI) of the postsynaptic bursts. This novel form of inhibition-dependent regulation of plasticity may contribute to the encoding or processing of olfactory information in the olfactory bulb.	[Ma, Teng-Fei; Zhao, Xiao-Lei; Cai, Lei; Zhang, Nan; Ren, Si-Qiang; Ji, Fang; Tian, Tian; Lu, Wei] Nanjing Med Univ, Dept Neurobiol, Nanjing, Jiangsu, Peoples R China; [Ma, Teng-Fei; Zhao, Xiao-Lei; Cai, Lei; Zhang, Nan; Ren, Si-Qiang; Ji, Fang; Tian, Tian; Lu, Wei] Nanjing Med Univ, Key Lab Neurodegenerat Dis Jiangsu Prov, Nanjing, Jiangsu, Peoples R China; [Lu, Wei] Nanjing Med Univ, Lab Reprod Med, Nanjing, Jiangsu, Peoples R China; [Lu, Wei] Nanjing Med Univ, Key Lab Human Funct Genom Jiangsu Prov, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University; Nanjing Medical University; Nanjing Medical University; Nanjing Medical University	Lu, W (corresponding author), Nanjing Med Univ, Dept Neurobiol, Nanjing, Jiangsu, Peoples R China.	lu@njmu.edu.cn	Ma, Tengfei/B-6383-2017	Ma, Tengfei/0000-0002-8916-7370	National Natural Science Foundation of China (NSFC) [31025011, 30770704]; Major State Basic Research Program of China [2010CB912002]; State Key Laboratory of Bioelectronics, Southeast University; National Natural Science Foundation of China (NSFC) [31025011, 30770704]; Major State Basic Research Program of China [2010CB912002]; State Key Laboratory of Bioelectronics, Southeast University	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Major State Basic Research Program of China(National Basic Research Program of China); State Key Laboratory of Bioelectronics, Southeast University; National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Major State Basic Research Program of China(National Basic Research Program of China); State Key Laboratory of Bioelectronics, Southeast University	This work was supported by grants to W.L. from the National Natural Science Foundation of China (NSFC. no. 31025011 and no. 30770704), the Major State Basic Research Program of China (2010CB912002) and the Open Research fund of State Key Laboratory of Bioelectronics, Southeast University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham NM, 2010, NEURON, V65, P399, DOI 10.1016/j.neuron.2010.01.009; Arevian AC, 2008, NAT NEUROSCI, V11, P80, DOI 10.1038/nn2030; Balu R, 2007, J NEUROSCI, V27, P5621, DOI 10.1523/JNEUROSCI.4630-06.2007; Birtoli B, 2004, J NEUROSCI, V24, P4935, DOI 10.1523/JNEUROSCI.0795-04.2004; Brennan PA, 1997, PROG NEUROBIOL, V51, P457, DOI 10.1016/S0301-0082(96)00069-X; Cang JH, 2003, J NEUROSCI, V23, P4108; Carlson GC, 2000, J NEUROSCI, V20, P2011; Cassenaer S, 2007, NATURE, V448, P709, DOI 10.1038/nature05973; Chen WR, 1997, BRAIN RES, V745, P189, DOI 10.1016/S0006-8993(96)01150-X; Chen WR, 2000, NEURON, V25, P625, DOI 10.1016/S0896-6273(00)81065-X; Debarbieux F, 2003, J NEUROSCI, V23, P5553; Dietz SB, 2005, J PHYSIOL-LONDON, V569, P475, DOI 10.1113/jphysiol.2005.095844; Egger V, 2003, J NEUROSCI, V23, P7551; Egger V, 2006, SEMIN CELL DEV BIOL, V17, P424, DOI 10.1016/j.semcdb.2006.04.006; Ennis M, 1998, ANN NY ACAD SCI, V855, P457, DOI 10.1111/j.1749-6632.1998.tb10606.x; Friedrich RW, 2004, J NEUROPHYSIOL, V91, P2658, DOI 10.1152/jn.01143.2003; Gao Y, 2009, NAT NEUROSCI, V12, P731, DOI 10.1038/nn.2319; Gire DH, 2008, J NEUROPHYSIOL, V99, P2021, DOI 10.1152/jn.01324.2007; Hayar A, 2007, J NEUROPHYSIOL, V98, P1052, DOI 10.1152/jn.01214.2006; Kapoor V, 2006, J NEUROSCI, V26, P11709, DOI 10.1523/JNEUROSCI.3371-06.2006; Kononenko NI, 2004, J NEUROPHYSIOL, V91, P267, DOI 10.1152/jn.00314.2003; Krahe R, 2004, NAT REV NEUROSCI, V5, P13, DOI 10.1038/nrn1296; Lagier S, 2004, J NEUROSCI, V24, P4382, DOI 10.1523/JNEUROSCI.5570-03.2004; Li CY, 2007, J PHYSIOL-LONDON, V581, P221, DOI 10.1113/jphysiol.2006.123810; Lledo PM, 2005, PHYSIOL REV, V85, P281, DOI 10.1152/physrev.00008.2004; Lobb CJ, 2010, J NEUROPHYSIOL, V104, P403, DOI 10.1152/jn.00204.2010; Malenka RC, 2004, NEURON, V44, P5, DOI 10.1016/j.neuron.2004.09.012; Malenka RC, 1999, SCIENCE, V285, P1870, DOI 10.1126/science.285.5435.1870; Margrie TW, 2001, P NATL ACAD SCI USA, V98, P319, DOI 10.1073/pnas.011523098; Mutoh H, 2005, J NEUROSCI, V25, P4252, DOI 10.1523/JNEUROSCI.4721-04.2005; Najac M, 2011, J NEUROSCI, V31, P8722, DOI 10.1523/JNEUROSCI.0527-11.2011; Nevian T, 2006, J NEUROSCI, V26, P11001, DOI 10.1523/JNEUROSCI.1749-06.2006; Pressler RT, 2006, NEURON, V49, P889, DOI 10.1016/j.neuron.2006.02.019; Schaefer AT, 2006, PLOS BIOL, V4, P1010, DOI 10.1371/journal.pbio.0040163; Schoppa NE, 2006, NEURON, V49, P271, DOI 10.1016/j.neuron.2005.11.038; Schoppa NE, 2003, TRENDS NEUROSCI, V26, P501, DOI 10.1016/S0166-2236(03)00228-5; Schoppa NE, 2001, NEURON, V31, P639, DOI 10.1016/S0896-6273(01)00389-0; Schoppa NE, 1998, J NEUROSCI, V18, P6790; Schoppa NE, 1999, NAT NEUROSCI, V2, P1106, DOI 10.1038/16033; Shao Z, 2009, J NEUROPHYSIOL, V101, P1988, DOI 10.1152/jn.91116.2008; Shepherd GM, 2004, OLFACTORY BULB SYNAP; SOFTKY WR, 1993, J NEUROSCI, V13, P334; SPRUSTON N, 1995, SCIENCE, V268, P297, DOI 10.1126/science.7716524; Stopfer M, 1997, NATURE, V390, P70, DOI 10.1038/36335; Strowbridge BW, 2010, NEURON, V65, P295, DOI 10.1016/j.neuron.2010.01.029; Urban NN, 2002, PHYSIOL BEHAV, V77, P607, DOI 10.1016/S0031-9384(02)00895-8; Wachowiak M, 2006, SEMIN CELL DEV BIOL, V17, P411, DOI 10.1016/j.semcdb.2006.04.007; Williams SR, 2000, J NEUROSCI, V20, P8238, DOI 10.1523/JNEUROSCI.20-22-08238.2000; Xiong WH, 2002, NEURON, V34, P115, DOI 10.1016/S0896-6273(02)00628-1; YOKOI M, 1995, P NATL ACAD SCI USA, V92, P3371, DOI 10.1073/pnas.92.8.3371; Yuan Q, 2009, LEARN MEMORY, V16, P676, DOI 10.1101/lm.1569309	51	11	11	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2012	7	4							e35001	10.1371/journal.pone.0035001	http://dx.doi.org/10.1371/journal.pone.0035001			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TL	22536347	Green Published, gold, Green Submitted			2022-12-25	WOS:000305336200019
J	Balbach, ST; Esteves, TC; Houghton, FD; Siatkowski, M; Pfeiffer, MJ; Tsurumi, C; Kanzler, B; Fuellen, G; Boiani, M				Balbach, Sebastian Thomas; Esteves, Telma Cristina; Houghton, Franchesca Dawn; Siatkowski, Marcin; Pfeiffer, Martin Johannes; Tsurumi, Chizuko; Kanzler, Benoit; Fuellen, Georg; Boiani, Michele			Nuclear Reprogramming: Kinetics of Cell Cycle and Metabolic Progression as Determinants of Success	PLOS ONE			English	Article							CLONED MOUSE EMBRYOS; ZYGOTIC GENOME ACTIVATION; NITRIC-OXIDE; STEM-CELLS; PREIMPLANTATION EMBRYO; FERTILIZED BLASTOCYSTS; IN-VIVO; EXPRESSION; CULTURE; PROLIFERATION	Establishment of totipotency after somatic cell nuclear transfer (NT) requires not only reprogramming of gene expression, but also conversion of the cell cycle from quiescence to the precisely timed sequence of embryonic cleavage. Inadequate adaptation of the somatic nucleus to the embryonic cell cycle regime may lay the foundation for NT embryo failure and their reported lower cell counts. We combined bright field and fluorescence imaging of histone H-2b-GFP expressing mouse embryos, to record cell divisions up to the blastocyst stage. This allowed us to quantitatively analyze cleavage kinetics of cloned embryos and revealed an extended and inconstant duration of the second and third cell cycles compared to fertilized controls generated by intracytoplasmic sperm injection (ICSI). Compared to fertilized embryos, slow and fast cleaving NT embryos presented similar rates of errors in M phase, but were considerably less tolerant to mitotic errors and underwent cleavage arrest. Although NT embryos vary substantially in their speed of cell cycle progression, transcriptome analysis did not detect systematic differences between fast and slow NT embryos. Profiling of amino acid turnover during pre-implantation development revealed that NT embryos consume lower amounts of amino acids, in particular arginine, than fertilized embryos until morula stage. An increased arginine supplementation enhanced development to blastocyst and increased embryo cell numbers. We conclude that a cell cycle delay, which is independent of pluripotency marker reactivation, and metabolic restraints reduce cell counts of NT embryos and impede their development.	[Balbach, Sebastian Thomas; Esteves, Telma Cristina; Pfeiffer, Martin Johannes; Boiani, Michele] Max Planck Inst Mol Biomed, Munster, Germany; [Houghton, Franchesca Dawn] Univ Southampton, Southampton Gen Hosp, Fac Med, Southampton, Hants, England; [Siatkowski, Marcin] DZNE, German Ctr Neurodegenerat Disorders, Rostock, Germany; [Siatkowski, Marcin; Fuellen, Georg] Univ Rostock, Inst Biostat & Informat Med & Ageing Res, Rostock, Germany; [Tsurumi, Chizuko] Univ Hosp Freiburg, Dept Radiat Oncol, Freiburg, Germany; [Kanzler, Benoit] Max Planck Inst Immunobiol & Epigenet, Freiburg, Germany	Max Planck Society; University of Southampton; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); University of Rostock; University of Freiburg; Max Planck Society	Balbach, ST (corresponding author), Max Planck Inst Mol Biomed, Munster, Germany.	mboiani@mpi-muenster.mpg.de	Balbach, Sebastian Thomas/A-1107-2009; Boiani, Michele/M-3519-2015; Pfeiffer, Martin Johannes/A-9332-2011	Balbach, Sebastian Thomas/0000-0003-0212-5758; Boiani, Michele/0000-0003-2765-2781; Pfeiffer, Martin Johannes/0000-0001-9264-9218; Houghton, Franchesca/0000-0002-5167-1694; Esteves, Telma Cristina/0000-0002-8642-4722	Deutsche Forschungsgemeinschaft (DFG) [SPP 1356]; UK Medical Research Council [G0701153]; MRC [G0701153] Funding Source: UKRI; Medical Research Council [G0701153] Funding Source: researchfish	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This project was supported in part by the Deutsche Forschungsgemeinschaft (DFG, www.dfg.de), SPP 1356. Dr. Houghton acknowledges support from the UK Medical Research Council (G0701153; www.mrc.ac.uk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balbach ST, 2010, DEV BIOL, V343, P71, DOI 10.1016/j.ydbio.2010.04.012; Balbach ST, 2007, DEV BIOL, V308, P309, DOI 10.1016/j.ydbio.2007.05.034; Becker KA, 2006, J CELL PHYSIOL, V209, P883, DOI 10.1002/jcp.20776; Blake JA, 2011, NUCLEIC ACIDS RES, V39, pD842, DOI 10.1093/nar/gkq1008; Boiani M, 2005, STEM CELLS, V23, P1089, DOI 10.1634/stemcells.2004-0352; Boiani M, 2004, CYTOGENET GENOME RES, V105, P270, DOI 10.1159/000078198; Boiani M, 2003, EMBO J, V22, P5304, DOI 10.1093/emboj/cdg507; Boiani M, 2002, GENE DEV, V16, P1209, DOI 10.1101/gad.966002; Booth PJ, 2005, REPRODUCTION, V130, P655, DOI 10.1530/rep.1.00727; BOWMAN P, 1970, J EMBRYOL EXP MORPH, V24, P203; Brambrink T, 2006, P NATL ACAD SCI USA, V103, P933, DOI 10.1073/pnas.0510485103; Brison DR, 2004, HUM REPROD, V19, P2319, DOI 10.1093/humrep/deh409; Bultman SJ, 2006, GENE DEV, V20, P1744, DOI 10.1101/gad.1435106; Castedo M, 2004, ONCOGENE, V23, P2825, DOI 10.1038/sj.onc.1207528; Cavaleri FM, 2008, MECH DEVELOP, V125, P153, DOI 10.1016/j.mod.2007.09.007; Chirino-Galindo G, 2009, BIRTH DEFECTS RES B, V86, P58, DOI 10.1002/bdrb.20182; Chu L, 2008, EUR J PHARMACOL, V591, P59, DOI 10.1016/j.ejphar.2008.06.066; Colussi C, 2009, FASEB J, V23, P2131, DOI 10.1096/fj.08-115618; Day ML, 2001, REPROD FERT DEVELOP, V13, P69, DOI 10.1071/RD00048; Ding JJ, 2009, PROTEOMICS, V9, P2711, DOI 10.1002/pmic.200800824; Du P, 2007, BIOL DIRECT, V2, DOI 10.1186/1745-6150-2-16; Du P, 2008, BIOINFORMATICS, V24, P1547, DOI 10.1093/bioinformatics/btn224; Esteves TC, 2011, AGING CELL, V10, P80, DOI 10.1111/j.1474-9726.2010.00644.x; Falco G, 2007, DEV BIOL, V307, P539, DOI 10.1016/j.ydbio.2007.05.003; Foster David A, 2010, Genes Cancer, V1, P1124, DOI 10.1177/1947601910392989; Gao SR, 2003, BIOL REPROD, V69, P48, DOI 10.1095/biolreprod.102.014522; Gates AH, 2008, CIBA FDN S PREIMPL S, P270; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Goval JJ, 2000, EUR J MORPHOL, V38, P88, DOI 10.1076/0924-3860(200004)38:2;1-F;FT088; Hamatani T, 2004, DEV CELL, V6, P117, DOI 10.1016/S1534-5807(03)00373-3; Hanna J, 2009, NATURE, V462, P595, DOI 10.1038/nature08592; HARLOW GM, 1982, AUST J BIOL SCI, V35, P187, DOI 10.1071/BI9820187; Houghton FD, 2006, DIFFERENTIATION, V74, P11, DOI 10.1111/j.1432-0436.2006.00052.x; Houghton FD, 2002, HUM REPROD, V17, P999, DOI 10.1093/humrep/17.4.999; Huber Wolfgang, 2002, Bioinformatics, V18 Suppl 1, pS96; KALOUSEK DK, 1983, SCIENCE, V221, P665, DOI 10.1126/science.6867735; Kawasumi M, 2007, J REPROD DEVELOP, V53, P615, DOI 10.1262/jrd.19007; Kim JY, 2011, BIOL REPROD, V84, P70, DOI 10.1095/biolreprod.110.085753; Kubiak JZ, 2001, NOVART FDN SYMP, V237, P79, DOI 10.1002/0470846666.ch7; Lane M, 1998, HUM REPROD, V13, P991, DOI 10.1093/humrep/13.4.991; LEMAIRE P, 1995, CELL, V81, P85, DOI 10.1016/0092-8674(95)90373-9; Li CB, 2011, ZYGOTE, V19, P271, DOI 10.1017/S0967199410000377; Lightfoot DA, 2006, DEV BIOL, V289, P384, DOI 10.1016/j.ydbio.2005.11.001; Loi P, 2008, BIOESSAYS, V30, P66, DOI 10.1002/bies.20684; LUK GD, 1980, SCIENCE, V210, P195, DOI 10.1126/science.6774420; Maccarrone M, 2001, FEBS LETT, V507, P30, DOI 10.1016/S0014-5793(01)02949-0; Manser RC, 2004, BIOL REPROD, V71, P528, DOI 10.1095/biolreprod.103.025742; Marzluff WF, 2002, GENOMICS, V80, P487, DOI 10.1006/geno.2002.6850; Munne S, 2005, FERTIL STERIL, V84, P1328, DOI 10.1016/j.fertnstert.2005.06.025; Pfeiffer MJ, 2011, J PROTEOME RES, V10, P2140, DOI 10.1021/pr100706k; Pfeiffer MJ, 2010, INT J DEV BIOL, V54, P1649, DOI 10.1387/ijdb.103197mp; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; ROWLEY R, 1992, NATURE, V356, P353, DOI 10.1038/356353a0; Schultz RM, 2002, HUM REPROD UPDATE, V8, P323, DOI 10.1093/humupd/8.4.323; Sean D, 2007, BIOINFORMATICS, V23, P1846, DOI 10.1093/bioinformatics/btm254; Singhal N, 2010, CELL, V141, P943, DOI 10.1016/j.cell.2010.04.037; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Stokes PJ, 2007, HUM REPROD, V22, P829, DOI 10.1093/humrep/del447; STREFFER C, 1980, CELL TISSUE KINET, V13, P135, DOI 10.1111/j.1365-2184.1980.tb00456.x; Sturmey RG, 2008, REPROD BIOMED ONLINE, V17, P486, DOI 10.1016/S1472-6483(10)60234-9; Szabo PE, 2002, MECH DEVELOP, V115, P157, DOI 10.1016/S0925-4773(02)00087-4; Tay JI, 1997, HUM REPROD, V12, P2451, DOI 10.1093/humrep/12.11.2451; Varshavsky A., 2011, PROTEIN SCI; Vassena R, 2007, MOL REPROD DEV, V74, P1548, DOI 10.1002/mrd.20723; Wakayama S, 2006, STEM CELLS, V24, P2023, DOI 10.1634/stemcells.2005-0537; WANG JP, 1992, J REPROD FERTIL, V94, P431, DOI 10.1530/jrf.0.0940431; Wang JL, 2011, CHEM BIOL, V18, P121, DOI 10.1016/j.chembiol.2010.10.016; Wang QT, 2004, DEV CELL, V6, P133, DOI 10.1016/S1534-5807(03)00404-0; Wang QX, 1997, MOL REPROD DEV, V47, P265, DOI 10.1002/(SICI)1098-2795(199707)47:3&lt;265::AID-MRD5&gt;3.0.CO;2-J; Wong CC, 2010, NAT BIOTECHNOL, V28, P1115, DOI 10.1038/nbt.1686; Wossidlo M, 2010, EMBO J, V29, P1877, DOI 10.1038/emboj.2010.80; Yamagata K, 2009, J REPROD DEVELOP, V55, P343, DOI 10.1262/jrd.20166; Yu Y, 2007, REPRODUCTION, V133, P947, DOI 10.1530/REP-06-0358; Zeng FY, 2004, DEV BIOL, V272, P483, DOI 10.1016/j.ydbio.2004.05.018; Zuccotti M, 2002, MOL REPROD DEV, V61, P14, DOI 10.1002/mrd.1126	76	17	17	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2012	7	4							e35322	10.1371/journal.pone.0035322	http://dx.doi.org/10.1371/journal.pone.0035322			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959XD	22530006	Green Accepted, gold, Green Published, Green Submitted			2022-12-25	WOS:000305350600075
J	Fei, JW; de Villiers, EM				Fei, Jian-Wei; de Villiers, Ethel-Michele			Differential Regulation of Cutaneous Oncoprotein HPVE6 by wtp53, Mutant p53R248W and Delta Np63 alpha is HPV Type Dependent	PLOS ONE			English	Article							SQUAMOUS-CELL-CARCINOMA; HUMAN-PAPILLOMAVIRUS; INDUCED APOPTOSIS; E6 PROTEINS; E7 ONCOPROTEIN; SKIN-CANCER; CYCLIN D1; B PATHWAY; WILD-TYPE; P53	UV exposure and p53 mutations are major factors in non-melanoma skin cancer, whereas a role for HPV infections has not been defined. Previous data demonstrated the wtp53-mediated degradation of cutaneous HPV20E6 by caspase-3. Delta Np63 alpha and hot-spot mutant p53R248W conveyed a protective effect on HPV20E6 under these conditions. We demonstrate a differential regulation by wtp53 of the E6 genes of cutaneous types HPV4, HPV5, HPV7, HPV27, HPV38, HPV48, HPV60 and HPV77. Caspase- or proteasome-mediated down-regulation was HPV type dependent. Mutant p53R248W up-regulated expression of all these E6 proteins as did Delta Np63 alpha except for HPV38E6 which was down-regulated by the latter. None of these cellular proteins affected HPV41E6 expression. Ectopic expression of both mutp53R248W and Delta Np63 alpha in the normal NIKS keratinocyte cell line harbouring endogenous p53 and p63however led to a down-regulation of HPV20E6. We demonstrate that HPV20E6 expression in these cells is modulated by additional, yet unidentified, cellular protein(s), which are not necessarily involved in apoptosis or autophagy. We further demonstrate proliferation of HPV20E6-expressing keratinocytes. Levels of proteins involved in cell cycle control, cyclin-D1, cdk6 and p16(INK4a), phosphorylated pRB, as well as c-Jun and p-c-Jun, were all increased in these cells. HPV20E6 did not compete for the interaction between p16(INK4a) with cyclin-D1 or cdk6. Phosphorylation of pRB in the HPV20E6 expressing cells seems to be sufficient to override the cytokenetic block induced by the p16(INK4a)/pRB pathway. The present study demonstrates the diverse influence of p53 family members on individual cutaneous HPVE6 proteins. HPV20E6 expression also resulted in varying protein levels of factors involved in proliferation and differentiation.	[Fei, Jian-Wei; de Villiers, Ethel-Michele] Deutsch Krebsforschungszentrum, Div Characterizat Tumorviruses, D-6900 Heidelberg, Germany	Helmholtz Association; German Cancer Research Center (DKFZ)	Fei, JW (corresponding author), Deutsch Krebsforschungszentrum, Div Characterizat Tumorviruses, D-6900 Heidelberg, Germany.	e.devilliers@dkfz.de						Alam S, 2010, J VIROL, V84, P4630, DOI 10.1128/JVI.02431-09; Antonsson A, 2000, J VIROL, V74, P11636, DOI 10.1128/JVI.74.24.11636-11641.2000; Arron ST, 2011, J INVEST DERMATOL, V131, P1745, DOI 10.1038/jid.2011.91; Asgari MM, 2008, J INVEST DERMATOL, V128, P1409, DOI 10.1038/sj.jid.5701227; Astori G, 1998, J INVEST DERMATOL, V110, P752, DOI 10.1046/j.1523-1747.1998.00191.x; Aylon Y, 2011, CURR OPIN GENET DEV, V21, P86, DOI 10.1016/j.gde.2010.10.002; Bedard KM, 2008, J VIROL, V82, P3894, DOI 10.1128/JVI.01818-07; Bernard HU, 2010, VIROLOGY, V401, P70, DOI 10.1016/j.virol.2010.02.002; BRASH DE, 1991, P NATL ACAD SCI USA, V88, P10124, DOI 10.1073/pnas.88.22.10124; Cain K, 2003, DRUG METAB REV, V35, P337, DOI 10.1081/DMR-120026497; Chen ACH, 2008, J GEN VIROL, V89, P2891, DOI 10.1099/vir.0.2008/003665-0; de Koning MNC, 2009, J GEN VIROL, V90, P1611, DOI 10.1099/vir.0.010017-0; de Villiers EM, 2004, VIROLOGY, V324, P17, DOI 10.1016/j.virol.2004.03.033; de Villiers EM, 1999, SEMIN CANCER BIOL, V9, P413, DOI 10.1006/scbi.1999.0145; Dell'Orso S, 2011, OMICS, V15, P305, DOI 10.1089/omi.2010.0084; Eisenberg-Lerner A, 2009, CELL DEATH DIFFER, V16, P966, DOI 10.1038/cdd.2009.33; Ekstrom J, 2011, INT J CANCER, V129, P2643, DOI 10.1002/ijc.26204; Fei JW, 2006, ONCOGENE, V25, P3914, DOI 10.1038/sj.onc.1209420; Fei JW, 2008, INT J CANCER, V123, P108, DOI 10.1002/ijc.23506; Fei JW, 2005, CELL CYCLE, V4, P689, DOI 10.4161/cc.4.5.1653; Flores ER, 2007, CELL CYCLE, V6, P300, DOI 10.4161/cc.6.3.3793; Forslund O, 2007, J INFECT DIS, V196, P876, DOI 10.1086/521031; Gabet AS, 2008, FASEB J, V22, P622, DOI 10.1096/fj.07-8389com; Galluzzi L, 2012, CELL DEATH DIFFER, V19, P107, DOI 10.1038/cdd.2011.96; Ghittoni R, 2010, VIRUS GENES, V40, P1, DOI 10.1007/s11262-009-0412-8; Goldstein I, 2011, CANCER GENE THER, V18, P2, DOI 10.1038/cgt.2010.63; Graziano V, 2011, BBA-REV CANCER, V1816, P57, DOI 10.1016/j.bbcan.2011.04.002; Hibi K, 2000, P NATL ACAD SCI USA, V97, P5462, DOI 10.1073/pnas.97.10.5462; Howie HL, 2009, VIROLOGY, V384, P324, DOI 10.1016/j.virol.2008.11.017; Inoue S, 2009, CELL DEATH DIFFER, V16, P1053, DOI 10.1038/cdd.2009.29; Jackson S, 2000, GENE DEV, V14, P3065, DOI 10.1101/gad.182100; Kawamura K, 2006, CANCER SCI, V97, P252, DOI 10.1111/j.1349-7006.2006.00168.x; King KE, 2008, CANCER RES, V68, P5122, DOI 10.1158/0008-5472.CAN-07-6123; KIYONO T, 1992, VIROLOGY, V186, P628, DOI 10.1016/0042-6822(92)90029-O; Lambert PF, 2005, METH MOLEC MED, V119, P141; Larsson LG, 2011, SEMIN CANCER BIOL, V21, P367, DOI 10.1016/j.semcancer.2011.10.005; Leverrier S, 2007, APOPTOSIS, V12, P549, DOI 10.1007/s10495-006-0004-1; Mantovani F, 2001, ONCOGENE, V20, P7874, DOI 10.1038/sj.onc.1204869; Massimi P, 2008, VIROLOGY, V371, P374, DOI 10.1016/j.virol.2007.10.015; Melino G, 2011, CELL DEATH DIFFER, V18, P1487, DOI 10.1038/cdd.2011.81; Michel A, 2006, J VIROL, V80, P11153, DOI 10.1128/JVI.00954-06; Nobre RJ, 2009, J VIROL, V83, P2907, DOI 10.1128/JVI.02490-08; Olivier M, 2002, HUM MUTAT, V19, P607, DOI 10.1002/humu.10081; Ortega S, 2002, BBA-REV CANCER, V1602, P73, DOI 10.1016/S0304-419X(02)00037-9; Petitjean A, 2008, CARCINOGENESIS, V29, P273, DOI 10.1093/carcin/bgm258; Pim D, 2005, ONCOGENE, V24, P7830, DOI 10.1038/sj.onc.1208935; Pim D, 2002, ONCOGENE, V21, P8140, DOI 10.1038/sj.onc.1206026; Plasmeijer EI, 2010, INT J CANCER, V126, P2614, DOI 10.1002/ijc.24991; Sablina AA, 2008, CANCER METAST REV, V27, P137, DOI 10.1007/s10555-008-9116-0; Struijk L, 2008, J GEN VIROL, V89, P2303, DOI 10.1099/vir.0.83317-0; Su XH, 2009, EMBO J, V28, P1904, DOI 10.1038/emboj.2009.151; Sun Y, 2004, CLIN CANCER RES, V10, P5087, DOI 10.1158/1078-0432.CCR-03-0622; Takahashi A, 2007, CELL DIV, V2, DOI 10.1186/1747-1028-2-10; Tashiro E, 2007, CANCER SCI, V98, P629, DOI 10.1111/j.1349-7006.2007.00449.x; Underbrink MP, 2008, J VIROL, V82, P10408, DOI 10.1128/JVI.00902-08; Van Dross R, 2005, JNCI-J NATL CANCER I, V97, P656, DOI 10.1093/jnci/dji113; Vasiljevic N, 2008, VIRUS RES, V137, P213, DOI 10.1016/j.virusres.2008.07.013; Wang X, 2011, AM J PATHOL, V178, P345, DOI 10.1016/j.ajpath.2010.11.032; Westermarck J, 2008, TRENDS MOL MED, V14, P152, DOI 10.1016/j.molmed.2008.02.001; Woods M, 2010, INT J ONCOL, V37, P1471, DOI 10.3892/ijo_00000799; Xu J, 2011, NAT CHEM BIOL, V7, P285, DOI 10.1038/nchembio.546; Yan JL, 2007, P NATL ACAD SCI USA, V104, P1841, DOI 10.1073/pnas.0605562104; ZIEGLER A, 1993, P NATL ACAD SCI USA, V90, P4216, DOI 10.1073/pnas.90.9.4216; zur Hausen H, 2002, NAT REV CANCER, V2, P342, DOI 10.1038/nrc798	64	4	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2012	7	4							e35540	10.1371/journal.pone.0035540	http://dx.doi.org/10.1371/journal.pone.0035540			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959XD	22530045	gold, Green Submitted, Green Published			2022-12-25	WOS:000305350600097
J	Harbison, NW; Bhattacharya, S; Eliezer, D				Harbison, Nicholas W.; Bhattacharya, Shibani; Eliezer, David			Assigning Backbone NMR Resonances for Full Length Tau Isoforms: Efficient Compromise between Manual Assignments and Reduced Dimensionality	PLOS ONE			English	Article							MICROTUBULE-ASSOCIATED PROTEIN; PAIRED HELICAL FILAMENT; SPECTRAL INFORMATION; ALZHEIMERS-DISEASE; NERVOUS-SYSTEM; REPEAT DOMAIN; GFT-NMR; BINDING; PHOSPHORYLATION; SPECTROSCOPY	Tau protein is the longest disordered protein for which nearly complete backbone NMR resonance assignments have been reported. Full-length tau protein was initially assigned using a laborious combination of bootstrapping assignments from shorter tau fragments and conventional triple resonance NMR experiments. Subsequently it was reported that assignments of comparable quality could be obtained in a fully automated fashion from data obtained using reduced dimensionality NMR (RDNMR) experiments employing a large number of indirect dimensions. Although the latter strategy offers many advantages, it presents some difficulties if manual intervention, confirmation, or correction of the assignments is desirable, as may often be the case for long disordered and degenerate polypeptide sequences. Here we demonstrate that nearly complete backbone resonance assignments for full-length tau isoforms can be obtained without resorting either to bootstrapping from smaller fragments or to very high dimensionality experiments and automation. Instead, a set of RDNMR triple resonance experiments of modest dimensionality lend themselves readily to efficient and unambiguous manual assignments. An analysis of the backbone chemical shifts obtained in this fashion indicates several regions in full length tau with a notable propensity for helical or strand-like structure that are in good agreement with previous observations.	[Harbison, Nicholas W.; Eliezer, David] Weill Cornell Med Coll, Dept Biochem, Tri Inst Program Chem Biol, New York, NY USA; [Bhattacharya, Shibani] New York Struct Biol Ctr, New York, NY USA	Cornell University	Harbison, NW (corresponding author), Weill Cornell Med Coll, Dept Biochem, Tri Inst Program Chem Biol, New York, NY USA.	dae2005@med.cornell.edu			NIH/NIA [AG025440, AG019391]; NSF (National Science Foundation) [DMR-0454672]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM066354] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG025440, R01AG019391, R37AG019391] Funding Source: NIH RePORTER	NIH/NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NSF (National Science Foundation)(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by NIH/NIA grants AG025440 and AG019391 (Dr. Eliezer) and GM066354 (NYSBC - New York Structural Biology Center,) (www.nih.gov) and NSF (National Science Foundation) agreement DMR-0454672 (NYSBC) (www.nsf.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atreya HS, 2005, J AM CHEM SOC, V127, P4554, DOI 10.1021/ja042562e; Atreya HS, 2004, P NATL ACAD SCI USA, V101, P9642, DOI 10.1073/pnas.0403529101; Barre P, 2006, J MOL BIOL, V362, P312, DOI 10.1016/j.jmb.2006.07.018; Bibow S, 2011, ANGEW CHEM INT EDIT, V50, P11520, DOI 10.1002/anie.201105493; Bibow S, 2011, J AM CHEM SOC, V133, P15842, DOI 10.1021/ja205836j; BINDER LI, 1985, J CELL BIOL, V101, P1371, DOI 10.1083/jcb.101.4.1371; BRANDT R, 1995, J CELL BIOL, V131, P1327, DOI 10.1083/jcb.131.5.1327; Cavanagh J, 2007, PROTEIN NMR SPECTROSCOPY: PRINCIPLES AND PRACTICE, 2ND EDITION, P1; CLEVELAND DW, 1977, J MOL BIOL, V116, P207, DOI 10.1016/0022-2836(77)90213-3; CLEVELAND DW, 1977, J MOL BIOL, V116, P227, DOI 10.1016/0022-2836(77)90214-5; COUCHIE D, 1992, P NATL ACAD SCI USA, V89, P4378, DOI 10.1073/pnas.89.10.4378; Drewes G, 1997, CELL, V89, P297, DOI 10.1016/S0092-8674(00)80208-1; Dyson HJ, 1998, NAT STRUCT BIOL, V5, P499, DOI 10.1038/739; Eliezer D, 2005, BIOCHEMISTRY-US, V44, P1026, DOI 10.1021/bi048953n; Eliezer D, 2009, CURR OPIN STRUC BIOL, V19, P23, DOI 10.1016/j.sbi.2008.12.004; Fauquant C, 2011, J BIOL CHEM, V286, P33358, DOI 10.1074/jbc.M111.223545; Freuh D, 2006, PHI7AJ AM CHEM SOC, V128, P5757; Garcia ML, 2001, CURR OPIN CELL BIOL, V13, P41, DOI 10.1016/S0955-0674(00)00172-1; Goedert M, 2000, ANN NY ACAD SCI, V920, P74; GOEDERT M, 1989, NEURON, V3, P519, DOI 10.1016/0896-6273(89)90210-9; GUSTKE N, 1994, BIOCHEMISTRY-US, V33, P9511, DOI 10.1021/bi00198a017; Ingram EM, 2002, TRENDS MOL MED, V8, P555, DOI 10.1016/S1471-4914(02)02440-1; Jeganathan S, 2006, BIOCHEMISTRY-US, V45, P2283, DOI 10.1021/bi0521543; Jenkins SM, 1998, NEUROREPORT, V9, P67, DOI 10.1097/00001756-199801050-00014; Kim S, 2003, J AM CHEM SOC, V125, P1385, DOI 10.1021/ja028197d; KSIEZAKREDING H, 1991, NEURON, V6, P717, DOI 10.1016/0896-6273(91)90169-Z; Landrieu I, 2006, J AM CHEM SOC, V128, P3575, DOI 10.1021/ja054656+; Landrieu I, 2010, BIOCHEM SOC T, V38, P1006, DOI 10.1042/BST0381006; Leroy A, 2010, J BIOL CHEM, V285, P33435, DOI 10.1074/jbc.M110.149419; Lippens G, 2006, PROTEIN PEPTIDE LETT, V13, P235, DOI 10.2174/092986606775338461; LOPRESTI P, 1995, P NATL ACAD SCI USA, V92, P10369, DOI 10.1073/pnas.92.22.10369; Mukrasch MD, 2007, J BIOL CHEM, V282, P12230, DOI 10.1074/jbc.M607159200; Mukrasch MD, 2009, PLOS BIOL, V7, P399, DOI 10.1371/journal.pbio.1000034; Narayanan RL, 2010, J AM CHEM SOC, V132, P11906, DOI 10.1021/ja105657f; Peterson DW, 2008, BIOCHEMISTRY-US, V47, P7393, DOI 10.1021/bi702466a; Sibille N, 2012, PROTEINS, V80, P454, DOI 10.1002/prot.23210; Sillen A, 2007, BIOCHEMISTRY-US, V46, P3055, DOI 10.1021/bi061920i; Smet C, 2004, CHEMBIOCHEM, V5, P1639, DOI 10.1002/cbic.200400145; Szyperski T, 2006, MAGN RESON CHEM, V44, pS51, DOI 10.1002/mrc.1817; von Bergen M, 2000, P NATL ACAD SCI USA, V97, P5129, DOI 10.1073/pnas.97.10.5129; Wagner U, 1996, J CELL SCI, V109, P1537; Wei ML, 1998, J NEUROCHEM, V70, P1346; WEISEMANN R, 1993, J BIOMOL NMR, V3, P113; WISCHIK CM, 1988, P NATL ACAD SCI USA, V85, P4884, DOI 10.1073/pnas.85.13.4884; Wishart DS, 2001, METHOD ENZYMOL, V338, P3; WUTHRICK K, 1986, NMR PROTEINS NUCL AC; Xia YL, 2004, J BIOMOL NMR, V29, P467, DOI 10.1023/B:JNMR.0000034352.75619.3f	47	30	30	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2012	7	4							e34679	10.1371/journal.pone.0034679	http://dx.doi.org/10.1371/journal.pone.0034679			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959XD	22529924	Green Published, Green Submitted, gold			2022-12-25	WOS:000305350600019
J	Martinez-Vaquero, LA; Cuesta, JA; Sanchez, A				Martinez-Vaquero, Luis A.; Cuesta, Jose A.; Sanchez, Angel			Generosity Pays in the Presence of Direct Reciprocity: A Comprehensive Study of 2x2 Repeated Games	PLOS ONE			English	Article							TIT-FOR-TAT; WIN-STAY; EVOLUTION; COOPERATION; AUTOMATA; RULES	By applying a technique previously developed to study ecosystem assembly [Capitan et al., Phys. Rev. Lett. 103, 168101 (2009)] we study the evolutionary stable strategies of iterated 2x2 games. We focus on memory-one strategies, whose probability to play a given action depends on the actions of both players in the previous time step. We find the asymptotically stable populations resulting from all possible invasions of any known stable population. The results of this invasion process are interpreted as transitions between different populations that occur with a certain probability. Thus the whole process can be described as a Markov chain whose states are the different stable populations. With this approach we are able to study the whole space of symmetric 2x2 games, characterizing the most probable results of evolution for the different classes of games. Our analysis includes quasi-stationary mixed equilibria that are relevant as very long-lived metastable states and is compared to the predictions of a fixation probability analysis. We confirm earlier results on the success of the Pavlov strategy in a wide range of parameters for the iterated Prisoner's Dilemma, but find that as the temptation to defect grows there are many other possible successful strategies. Other regions of the diagram reflect the equilibria structure of the underlying one-shot game, albeit often some non-expected strategies arise as well. We thus provide a thorough analysis of iterated 2x2 games from which we are able to extract some general conclusions. Our most relevant finding is that a great deal of the payoff parameter range can still be understood by focusing on win-stay, lose-shift strategies, and that very ambitious ones, aspiring to obtaining always a high payoff, are never evolutionary stable.	[Martinez-Vaquero, Luis A.; Cuesta, Jose A.; Sanchez, Angel] Univ Carlos III Madrid, Dept Matemat, GISC, Madrid, Spain; [Cuesta, Jose A.; Sanchez, Angel] Univ Zaragoza, Inst Biocomput & Fis Sistemas Complejos BIFI, Zaragoza, Spain	Universidad Carlos III de Madrid; University of Zaragoza	Martinez-Vaquero, LA (corresponding author), Univ Carlos III Madrid, Dept Matemat, GISC, Madrid, Spain.	cuesta@math.uc3m.es	Cuesta, Jose A/Z-4696-2019; Martinez-Vaquero, Luis A./AAD-3883-2021; Sánchez, Angel/A-9229-2008; Cuesta, Jose A/A-7157-2008	Martinez-Vaquero, Luis A./0000-0001-8194-8757; Sánchez, Angel/0000-0003-1874-2881; Cuesta, Jose A/0000-0001-9890-9367	Ministerio de Ciencia e Innovacion, Spain; European Research Area Complexity-Net; Comunidad de Madrid, Spain; Alianza 4 Universidades	Ministerio de Ciencia e Innovacion, Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); European Research Area Complexity-Net; Comunidad de Madrid, Spain(Comunidad de Madrid); Alianza 4 Universidades	This work was supported in part by Ministerio de Ciencia e Innovacion, Spain (http://www.micinn.es) through grants MOSAICO and PRODIEVO, by European Research Area Complexity-Net (http://www.complexitynet.eu) though grant RESINEE, and by Comunidad de Madrid, Spain (http://www.madrid.org) through grant MODELICO. Luis A. Martinez-Vaquero was supported by a postdoctoral fellowship from Alianza 4 Universidades (http://www.alliance4universities.eu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AXELROD R, 1981, SCIENCE, V211, P1390, DOI 10.1126/science.7466396; Axelrod R., 1984, EVOLUTION COOPERATIO, DOI DOI 10.2307/3323905; BINMORE KG, 1992, J ECON THEORY, V57, P278, DOI 10.1016/0022-0531(92)90037-I; Capitan JA, 2011, J THEOR BIOL, V269, P330, DOI 10.1016/j.jtbi.2010.09.032; Capitan JA, 2011, J THEOR BIOL, V269, P344, DOI 10.1016/j.jtbi.2010.10.031; Capitan JA, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.168101; Darwin G., 1871, P423; Dugatkin L.A., 1997, COOPERATION ANIMALS; FUDENBERG D, 1990, AM ECON REV, V80, P274; Fudenberg D, 2012, AM EC REV IN PRESS; Fudenberg D, 2006, J ECON THEORY, V131, P251, DOI 10.1016/j.jet.2005.04.006; Gracia A, 2009, P NATL ACAD SCI USA, V106, P6573, DOI 10.1073/pnas.0900965106; HAMILTON WD, 1964, J THEOR BIOL, V7, P1, DOI 10.1016/0022-5193(64)90039-6; Hammerstein P, 2003, DAHL WS ENV, P83; Hammerstein P, GENETIC CULTURAL EVO; Hofbauer J., 1998, EVOLUTIONARY GAMES P; Hublin JJ, 2009, P NATL ACAD SCI USA, V106, P6429, DOI 10.1073/pnas.0902614106; Imhof LA, 2005, P NATL ACAD SCI USA, V102, P10797, DOI 10.1073/pnas.0502589102; Imhof LA, 2007, J THEOR BIOL, V247, P574, DOI 10.1016/j.jtbi.2007.03.027; Kappeler PM, COOPERATION PRIMATES; Karlin S., 1975, 1 COURSE STOCHASTIC, V2; Kollock P, 1998, ANNU REV SOCIOL, V24, P183, DOI 10.1146/annurev.soc.24.1.183; KRAINES D, 1989, THEOR DECIS, V26, P47, DOI 10.1007/BF00134056; Lordkipanidze D, 2005, NATURE, V434, P717, DOI 10.1038/434717b; NOWAK M, 1993, NATURE, V364, P56, DOI 10.1038/364056a0; NOWAK M, 1989, J THEOR BIOL, V137, P21, DOI 10.1016/S0022-5193(89)80146-8; NOWAK M, 1993, P NATL ACAD SCI USA, V90, P5091, DOI 10.1073/pnas.90.11.5091; NOWAK MA, 1992, NATURE, V355, P250, DOI 10.1038/355250a0; NOWAK MA, 1992, NATURE, V359, P826, DOI 10.1038/359826a0; NOWAK MA, 1995, J MATH BIOL, V33, P703; Nowak MA, 2006, SCIENCE, V314, P1560, DOI 10.1126/science.1133755; Posch M, 1999, P ROY SOC B-BIOL SCI, V266, P1427, DOI 10.1098/rspb.1999.0797; Rand DG, 2009, J THEOR BIOL, V256, P45, DOI 10.1016/j.jtbi.2008.09.015; Rapoport Anatol, 1966, GEN SYST, P203, DOI DOI 10.1007/BF00132457; Roca CP, 2009, PHYS LIFE REV, V6, P208, DOI 10.1016/j.plrev.2009.08.001; RUBINSTEIN A, 1986, J ECON THEORY, V39, P83, DOI 10.1016/0022-0531(86)90021-9; SELTEN R, 1984, BEHAV BRAIN SCI, V7, P115, DOI 10.1017/S0140525X00026479; Seneta E, 2006, SPRINGER SER STAT, P1, DOI 10.1007/0-387-32792-4; Sigmund K, 2010, PRINC SER THEOR COMP, P1; Sugden R, 1986, EC RIGHTS COOPERATIO; Szathmary E, 1995, MAJOR TRANSITIONS EV; TRIVERS RL, 1971, Q REV BIOL, V46, P35, DOI 10.1086/406755	42	17	17	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2012	7	4							e35135	10.1371/journal.pone.0035135	http://dx.doi.org/10.1371/journal.pone.0035135			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959XD	22529982	Green Published, gold, Green Submitted			2022-12-25	WOS:000305350600061
J	Ramirez, AG; Weiss, NS; Holden, AEC; Suarez, L; Cooper, SP; Munoz, E; Naylor, SL				Ramirez, Amelie G.; Weiss, Nancy S.; Holden, Alan E. C.; Suarez, Lucina; Cooper, Sharon P.; Munoz, Edgar; Naylor, Susan L.			Incidence and Risk Factors for Hepatocellular Carcinoma in Texas Latinos: Implications for Prevention Research	PLOS ONE			English	Article							PRIMARY LIVER-CANCER; C VIRUS-INFECTION; UNITED-STATES; PREVALENCE; INCREASES; OBESITY; NATION; IMPACT	Background: Hepatocellular carcinoma (HCC) is increasing in the U. S. despite a decline in cancer overall. Latinos have higher rates of HCC than the general population according to the Surveillance, Epidemiology, and End Results (SEER) Program. Not included in SEER, Texas Latinos make up one-fifth of the U. S. Latino population. To determine whether HCC incidence differs among U. S. and Texas Latinos, this descriptive study compares HCC incidence from 1995 through 2006 among three Latino populations: U. S. SEER, Texas overall and a South Texas subset. To identify lines of prevention research, we compare prevalence of known HCC risk factors among these Latino groups. Methods: Data were collected from the U. S. SEER Program, Texas Cancer Registry and Texas Department of State Health Services (TDSHS). Annual age-specific and age-adjusted HCC incidence rates, annual percent changes (APCs) and 95% confidence intervals were calculated as well as prevalence of obesity, diabetes, heavy alcohol use and cigarette smoking. Results: Of the three Latino groups compared, South Texas Latinos had the highest age-adjusted HCC incidence rates and SEER Latinos had the lowest (10.6/100,000 (10.1-11.1) and 7.5/100,000 (7.2-7.7), respectively). HCC incidence significantly increased over time (APCs>0) among Latinos in all three geographic groups. Between 1995 and 2006, there was an increase in obesity among all three populations, and obesity was highest among South Texas Latinos. Diabetes increased among U. S. Latinos, and Latino women in South Texas had significantly higher diabetes prevalence than U. S. Latino women. Cigarette smoking and heavy alcohol use were similar among groups. Conclusions: The incidence of HCC among Latinos in South Texas is higher than elsewhere in the United States. Higher rates of HCC among Texas and South Texas Latinos may be associated with greater prevalence of obesity and diabetes, risk factors for HCC that are amenable to intervention.	[Ramirez, Amelie G.; Weiss, Nancy S.; Holden, Alan E. C.; Munoz, Edgar] Univ Texas Hlth Sci Ctr San Antonio, Inst Hlth Promot Res, San Antonio, TX 78229 USA; [Ramirez, Amelie G.; Holden, Alan E. C.] Univ Texas Hlth Sci Ctr San Antonio, Canc Therapy & Res Ctr, San Antonio, TX 78229 USA; [Naylor, Susan L.] Univ Texas Hlth Sci Ctr San Antonio, Dept Cellular & Struct Biol, San Antonio, TX 78229 USA; [Suarez, Lucina] Texas Dept State Hlth Serv, Environm Epidemiol & Dis Registries, Austin, TX USA; [Cooper, Sharon P.] Univ Texas Hlth Sci Ctr Houston, Sch Publ Health, San Antonio, TX USA	University of Texas System; University of Texas Health San Antonio; Cancer Therapy & Research Center; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; Texas Department of State Health Services; University of Texas System; University of Texas Health Science Center Houston	Ramirez, AG (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Inst Hlth Promot Res, San Antonio, TX 78229 USA.	ramirezag@uthscsa.edu	Munoz, Edgar/L-1857-2019	Munoz, Edgar/0000-0002-1555-8408	Cancer Center Support Group of the Cancer Therapy and Research Center at the University of Texas Health Science at Center San Antonio, an NCI-designated Cancer Center [P30CA054174]; Redes En Accion: The National Latino Cancer Research Network [U01 CA114657-05]; NATIONAL CANCER INSTITUTE [P30CA054174, U01CA114657] Funding Source: NIH RePORTER	Cancer Center Support Group of the Cancer Therapy and Research Center at the University of Texas Health Science at Center San Antonio, an NCI-designated Cancer Center; Redes En Accion: The National Latino Cancer Research Network; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The authors gratefully acknowledge the Cancer Center Support Group of the Cancer Therapy and Research Center at the University of Texas Health Science at Center San Antonio, an NCI-designated Cancer Center (grant # P30CA054174) and Redes En Accion: The National Latino Cancer Research Network (U01 CA114657-05) for support of this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alter MJ, 1999, NEW ENGL J MED, V341, P556, DOI 10.1056/NEJM199908193410802; [Anonymous], 2010, GLOBOCAN 2008 CANC I; Barazani Y, 2007, WORLD J SURG, V31, P1243, DOI 10.1007/s00268-007-9041-3; Barnard ND, 2009, NUTRITION, V25, P58, DOI 10.1016/j.nut.2008.07.012; Bennett P H, 1976, Recent Prog Horm Res, V32, P333; Bouvier L, SHAPING TEXAS EFFECT; Caldwell SH, 2004, GASTROENTEROLOGY, V127, pS97, DOI 10.1053/j.gastro.2004.09.021; Davila JA, 2005, GUT, V54, P533, DOI 10.1136/gut.2004.052167; Edwards BK, 2010, CANCER-AM CANCER SOC, V116, P544, DOI 10.1002/cncr.24760; El-Serag H, 2010, J FAM PRACTICE, V59, pS37; GOTTLIEB K, 1979, AM J PHYS ANTHROPOL, V50, P444; Gwynn ER, 2005, HDB HISPANIC CULTURE, P339; Hassan MM, 2002, J CLIN GASTROENTEROL, V35, P266, DOI 10.1097/00004836-200209000-00013; Howe HL, 2006, CANCER-AM CANCER SOC, V107, P1711, DOI 10.1002/cncr.22193; Institute for Health Promotion Research UTHSCSA, 2007, S TEX HLTH STAT REV; McGlynn KA, 2011, CLIN LIVER DIS, V15, P223, DOI 10.1016/j.cld.2011.03.006; Modiano M, 1995, J NATL CANC I MONOGR; Morgan TR, 2004, GASTROENTEROLOGY, V127, pS87, DOI 10.1053/j.gastro.2004.09.020; NAACCR: North American Association of Central Cancer Registries, 2008, GUID ENH LAT LAT ID; Ogden CL, 2010, CHANGES TERMINOLOGY; Polesel J, 2009, ANN ONCOL, V20, P353, DOI 10.1093/annonc/mdn565; Ramirez AG, 2004, PREV MED, V39, P263, DOI 10.1016/j.ypmed.2004.03.034; REED TE, 1974, SCIENCE, V185, P283, DOI 10.1126/science.185.4147.283; *SEER, 2008, SURV EP END RES SEER; SEER: SEER: Surveillance Epidemiology and End Results (SEER) Program SEER* Stat Database: Incidence-SEER 13 Regs Limited-Use Nov 2008 Sub, 1992, SEER SURV EP END RES; SUAREZ L, 1987, AM J PUBLIC HEALTH, V77, P631, DOI 10.2105/AJPH.77.5.631; Sun G, 2007, FOOD ADDIT CONTAM A, V24, P181, DOI 10.1080/02652030601013471; TDSHS: Texas Department of State Health Services IDCU, 2009, TEX CANC REG PUBL US; U.S. Census Bureau, 2010, AM FACTFINDER; *USDA, 2006, MEAS RUR RUR URB CON; Welzel TM, 2011, HEPATOLOGY, V54, P463, DOI 10.1002/hep.24397; Yalamanchili Kanthi, 2005, Proc (Bayl Univ Med Cent), V18, P3	32	26	26	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2012	7	4							e35573	10.1371/journal.pone.0035573	http://dx.doi.org/10.1371/journal.pone.0035573			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959XD	22530052	gold, Green Submitted, Green Published			2022-12-25	WOS:000305350600100
J	Wegner, W; Burckhardt, BC; Burckhardt, G; Henjakovic, M				Wegner, Waja; Burckhardt, Birgitta Christina; Burckhardt, Gerhard; Henjakovic, Maja			Male-Dominant Activation of Rat Renal Organic Anion Transporter 1 (Oat1) and 3 (Oat3) Expression by Transcription Factor BCL6	PLOS ONE			English	Article							ADVERSE DRUG-REACTIONS; RNA-POLYMERASE-III; GENE-EXPRESSION; GENDER-DIFFERENCES; ANDROGEN RECEPTOR; SEX-DIFFERENCES; CATION TRANSPORTERS; AMINOHIPPURIC ACID; MOLECULAR-CLONING; KIDNEY	Background: Organic anion transporters 1 (Oat1) and 3 (Oat3) mediate the transport of organic anions, including frequently prescribed drugs, across cell membranes in kidney proximal tubule cells. In rats, these transporters are known to be male-dominant and testosterone-dependently expressed. The molecular mechanisms that are involved in the sex-dependent expression are unknown. Our aim was to identify genes that show a sex-dependent expression and could be involved in male-dominant regulation of Oat1 and Oat3. Methodology/Principal Findings: Promoter activities of Oat1 and Oat3 were analyzed using luciferase assays. Expression profiling was done using a SurePrint G3 rat GE 8x60K microarray. RNA was isolated from renal cortical slices of four adult rats per sex. To filter the achieved microarray data for genes expressed in proximal tubule cells, transcription database alignment was carried out. We demonstrate that predicted androgen response elements in the promoters of Oat1 and Oat3 are not functional when the promoters were expressed in OK cells. Using microarray analyses we analyzed 17,406 different genes. Out of these genes, 56 exhibit a sex-dependent expression in rat proximal tubule cells. As genes potentially involved in the regulation of Oat1 and Oat3 expression, we identified, amongst others, the male-dominant hydroxysteroid (17-beta) dehydrogenase 1 (Hsd17b1), B-cell CLL/lymphoma 6 (BCL6), and polymerase (RNA) III (DNA directed) polypeptide G (Polr3g). Moreover, our results revealed that the transcription factor BCL6 activates promoter constructs of Oat1 and Oat3. Conclusion: The results indicate that the male-dominant expression of both transporters, Oat1 and Oat3, is possibly not directly regulated by the classical androgen receptor mediated transcriptional pathway but appears to be regulated by the transcription factor BCL6.	[Wegner, Waja; Burckhardt, Birgitta Christina; Burckhardt, Gerhard; Henjakovic, Maja] Univ Med Ctr Gottingen, Dept Syst Physiol & Pathophysiol, Gottingen, Germany	University of Gottingen	Wegner, W (corresponding author), Univ Med Ctr Gottingen, Dept Syst Physiol & Pathophysiol, Gottingen, Germany.	maja.henjakovic@med.uni-goettingen.de			Deutsche Forschungsgemeinschaft (DFG; German Research Foundation)	Deutsche Forschungsgemeinschaft (DFG; German Research Foundation)(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft (DFG; German Research Foundation). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albagli O, 1999, ONCOGENE, V18, P5063, DOI 10.1038/sj.onc.1202892; Anderson GD, 2005, J WOMENS HEALTH, V14, P19, DOI 10.1089/jwh.2005.14.19; Asaka J, 2006, PHARM RES-DORDR, V23, P697, DOI 10.1007/s11095-006-9665-2; Burckhardt G, 2011, HANDB EXP PHARMACOL, V201, P29, DOI 10.1007/978-3-642-14541-4_2; Cerrutti JA, 2002, MOL CELL BIOCHEM, V233, P175, DOI 10.1023/A:1015563021602; Cha SH, 2001, MOL PHARMACOL, V59, P1277, DOI 10.1124/mol.59.5.1277; Cleutjens KBJM, 1996, J BIOL CHEM, V271, P6379, DOI 10.1074/jbc.271.11.6379; Dent AL, 2002, CRIT REV ONCOL HEMAT, V41, P1, DOI 10.1016/S1040-8428(01)00164-0; Franconi F, 2007, PHARMACOL RES, V55, P81, DOI 10.1016/j.phrs.2006.11.001; Gabr MM, 2011, J PHYSL PATHOPHYSIOL, V2, P6; Gandhi M, 2004, ANNU REV PHARMACOL, V44, P499, DOI [10.1146/annurev.pharmtox.44.101802.121453, 10.2165/00003088-200948030-00001]; Garcia JF, 2006, J HISTOCHEM CYTOCHEM, V54, P31, DOI 10.1369/jhc.5A6646.2005; Giacomini KM, 2010, NAT REV DRUG DISCOV, V9, P215, DOI 10.1038/nrd3028; Hasegawa M, 2002, J PHARMACOL EXP THER, V300, P746, DOI 10.1124/jpet.300.3.746; Hosoyamada M, 1999, AM J PHYSIOL-RENAL, V276, pF122, DOI 10.1152/ajprenal.1999.276.1.F122; HUANG KC, 1955, AM J PHYSIOL, V183, P387, DOI 10.1152/ajplegacy.1955.183.3.387; Kaulfuss S, 2008, MOL ENDOCRINOL, V22, P1606, DOI 10.1210/me.2006-0546; Kenneth NS, 2008, NUCLEIC ACIDS RES, V36, P3757, DOI 10.1093/nar/gkn272; Keppler D, 2011, HANDB EXP PHARMACOL, V201, P299, DOI 10.1007/978-3-642-14541-4_8; Khamdang S, 2002, J PHARMACOL EXP THER, V303, P534, DOI 10.1124/jpet.102.037580; Kikuchi R, 2006, MOL PHARMACOL, V70, P887, DOI 10.1124/mol.106.025494; KLEINMAN LI, 1966, ENDOCRINOLOGY, V78, P403, DOI 10.1210/endo-78-2-403; Koepsell H, 2007, PHARM RES-DORDR, V24, P1227, DOI 10.1007/s11095-007-9254-z; Kojima R, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V134848; Kusuhara H, 1999, J BIOL CHEM, V274, P13675, DOI 10.1074/jbc.274.19.13675; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ljubojevic M, 2004, AM J PHYSIOL-RENAL, V287, pF124, DOI 10.1152/ajprenal.00029.2004; Luu-The V, 2001, J STEROID BIOCHEM, V76, P143, DOI 10.1016/S0960-0760(00)00155-2; Marchais-Oberwinkler S, 2011, J STEROID BIOCHEM, V125, P66, DOI 10.1016/j.jsbmb.2010.12.013; MARTEL C, 1992, J STEROID BIOCHEM, V41, P597, DOI 10.1016/0960-0760(92)90390-5; Martin RM, 1998, BRIT J CLIN PHARMACO, V46, P505, DOI 10.1046/j.1365-2125.1998.00817.x; Meyer RD, 2009, MOL ENDOCRINOL, V23, P1914, DOI 10.1210/me.2009-0242; Morey JS, 2006, BIOL PROCED ONLINE, V8, P175, DOI 10.1251/bpo126; Morris ME, 2003, PHARMACOL REV, V55, P229, DOI 10.1124/pr.55.2.1; Ogasawara K, 2007, AM J PHYSIOL-RENAL, V292, pF1819, DOI 10.1152/ajprenal.00017.2007; Opitz L, 2010, BMC MED GENOMICS, V3, DOI 10.1186/1755-8794-3-36; PALVIMO JJ, 1993, MOL ENDOCRINOL, V7, P1399, DOI 10.1210/me.7.11.1399; Perez-Rosado A, 2008, J PATHOL, V214, P498, DOI 10.1002/path.2279; Puranen T, 1997, ENDOCRINOLOGY, V138, P3532, DOI 10.1210/en.138.8.3532; RENNIE PS, 1993, MOL ENDOCRINOL, V7, P23, DOI 10.1210/me.7.1.23; Reyes JL, 1998, ENDOCRINOLOGY, V139, P1581, DOI 10.1210/en.139.4.1581; Saji T, 2008, J PHARMACOL EXP THER, V324, P784, DOI 10.1124/jpet.107.128249; Schneider R, 2007, AM J PHYSIOL-RENAL, V292, pF1599, DOI 10.1152/ajprenal.00473.2006; Sekine T, 1997, J BIOL CHEM, V272, P18526, DOI 10.1074/jbc.272.30.18526; Sugiyama D, 2001, J PHARMACOL EXP THER, V298, P316; Sweet DH, 1997, J BIOL CHEM, V272, P30088, DOI 10.1074/jbc.272.48.30088; Tojo A, 1999, J AM SOC NEPHROL, V10, P464; VanWert AL, 2008, PHARM RES-DORDR, V25, P453, DOI 10.1007/s11095-007-9407-0; VanWert AL, 2008, MOL PHARMACOL, V74, P122, DOI 10.1124/mol.107.042853; VanWert AL, 2010, BIOPHARM DRUG DISPOS, V31, P1, DOI 10.1002/bdd.693; Wagner SD, 2011, BRIT J HAEMATOL, V152, P3, DOI 10.1111/j.1365-2141.2010.08420.x; White RJ, 2011, NAT REV GENET, V12, P459, DOI 10.1038/nrg3001; Zopf Y, 2009, PHARMACOLOGY, V84, P333, DOI 10.1159/000248311	53	16	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2012	7	4							e35556	10.1371/journal.pone.0035556	http://dx.doi.org/10.1371/journal.pone.0035556			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959XD	22530049	Green Submitted, Green Published, gold			2022-12-25	WOS:000305350600098
J	Vazquez, SG; Martinez, AA; Flores-Alonso, JC				Garcia Vazquez, Susana; Aragon Martinez, Andres; Carlos Flores-Alonso, Juan			Confocal Microscopy and Image Analysis Indicates a Region-Specific Relation between Active Caspases and Cytoplasm in Ejaculated and Epididymal Sperm	PLOS ONE			English	Article							SWIM-UP PROCEDURE; HUMAN SPERMATOZOA; APOPTOSIS; ACTIVATION; MARKERS; CELLS; PARAMETERS; INHIBITOR; VIABILITY; MEMBRANE	Previously, it was suggested a relation between the presence of apoptosis markers with cytoplasm in mammalian sperm. In this work, flow cytometry, confocal microscopy and image analysis were used to analyze the relationship between active caspase-3 and -7 and intracellular esterases expression in ejaculated or epididymal ram sperm. Sperm obtained from ejaculates from the caput, corpus, or cauda of the epididymis were treated with an inhibitor of active caspase-3 and -7 and a marker of cytoplasmic esterases. Additionally, ejaculated sperm were incubated for one, two, or three hours before evaluation for active caspases. Sperm subpopulations positive for active caspases and/or intracellular esterases were detected by flow cytometry and confocal microscopy; however, image analysis of confocal images showed that the correlation between active caspases and cytoplasmic esterases in sperm is region-specific. Lower values of Spearman correlation coefficients were found when whole sperm or head sperm was analyzed; however, a high correlation was observed for midpiece sperm. Incubation of sperm for two or three hours promoted the autoactivation of caspases. It has been suggested that the presence of apoptotic markers in sperm are related with a process of abortive apoptosis and with errors during spermiogenesis. Our results permit us suggest that the origin of the relationship between active caspases and cytoplasmic esterases is due to differentiation errors occurring during spermiogenesis because the percentages of sperm with active caspases are not different in the caput, corpus, or cauda of the epididymis. In this study we demonstrate that existing sperm subpopulations can express active caspases and intracellular esterases and that the correlation between these molecules is high in midpiece sperm.	[Garcia Vazquez, Susana; Aragon Martinez, Andres] Univ Autonoma Estado Mexico, Fac Med Vet & Zootecnia, Reprod Biol Lab, El Cerrillo, Toluca, Mexico; [Aragon Martinez, Andres] Univ Autonoma Metropolitana Iztapalapa, Dept Reprod Biol, Mexico City 09340, DF, Mexico; [Carlos Flores-Alonso, Juan] Hosp Gen Zona 5, Inst Mexicano Seguro Social, Ctr Invest Biomed Oriente, Reprod Biol Lab, Puebla, Mexico	Universidad Autonoma Metropolitana - Mexico; Instituto Mexicano del Seguro Social	Vazquez, SG (corresponding author), Univ Autonoma Estado Mexico, Fac Med Vet & Zootecnia, Reprod Biol Lab, El Cerrillo, Toluca, Mexico.	armandres@gmail.com	Martínez, Andrés Aragón/AAH-6750-2020; Flores-Alonso, Juan/ABB-9987-2020	Martínez, Andrés Aragón/0000-0003-2352-2197; Flores Alonso, Juan Carlos/0000-0002-0366-1256	Programa Integral de Fortalecimiento Institucional [FE009/2009]; Universida Autonoma del Estado de Mexico [2887/2010]	Programa Integral de Fortalecimiento Institucional; Universida Autonoma del Estado de Mexico	This work was supported by Programa Integral de Fortalecimiento Institucional managed by Secretaria de Educacion Publica (grant number FE009/2009) and Universida Autonoma del Estado de Mexico (grant number 2887/2010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham MC, 2004, TRENDS CELL BIOL, V14, P184, DOI 10.1016/j.tcb.2004.03.002; Bauer G, 2007, INT J RADIAT BIOL, V83, P873, DOI 10.1080/09553000701727523; Blanco-Rodriguez J, 1999, BIOL REPROD, V61, P1541, DOI 10.1095/biolreprod61.6.1541; Boatright KM, 2003, CURR OPIN CELL BIOL, V15, P725, DOI 10.1016/j.ceb.2003.10.009; Cisternas P, 2006, MOL REPROD DEV, V73, P1318, DOI 10.1002/mrd.20561; Cooper TG, 2011, ASIAN J ANDROL, V13, P130, DOI 10.1038/aja.2010.97; French AP, 2008, NAT PROTOC, V3, P619, DOI 10.1038/nprot.2008.31; Grunewald S, 2005, FERTIL STERIL, V83, P1106, DOI 10.1016/j.fertnstert.2004.12.011; Hendricks KEM, 2009, THERIOGENOLOGY, V71, P1138, DOI 10.1016/j.theriogenology.2008.12.006; Hikim APS, 2003, J STEROID BIOCHEM, V85, P175, DOI 10.1016/S0960-0760(03)00193-6; Kerr JB, 2006, KNOBIL AND NEILL'S PHYSIOLOGY OF REPRODUCTION, VOLS 1 AND 2, 3RD EDITON, P827; Kotwicka M, 2008, REPROD BIOMED ONLINE, V16, P657, DOI 10.1016/S1472-6483(10)60479-8; Kuzelova K, 2007, CYTOM PART A, V71A, P605, DOI 10.1002/cyto.a.20415; Marchetti C, 2004, HUM REPROD, V19, P1127, DOI 10.1093/humrep/deh222; Marti E, 2008, ANIM REPROD SCI, V106, P113, DOI 10.1016/j.anireprosci.2007.04.009; Mattioli M, 2009, REPRODUCTION, V138, P679, DOI 10.1530/REP-08-0316; Morales ECL, 2012, J ANIM VET ADV, V11, P431; Moran JM, 2008, THERIOGENOLOGY, V70, P91, DOI 10.1016/j.theriogenology.2008.02.010; Paasch U, 2003, J ANDROL, V24, P246; Pichardo AI, 2010, J ANDROL, V31, P169, DOI 10.2164/jandrol.108.007021; Pozarowski P, 2003, CYTOM PART A, V55A, P50, DOI 10.1002/cyto.a.10074; Rasband W.S., 2005, IMAGEJ COMPUTER PROG; Ricci G, 2009, FERTIL STERIL, V91, P632, DOI 10.1016/j.fertnstert.2007.11.068; Sakkas D, 1999, EXP CELL RES, V251, P350, DOI 10.1006/excr.1999.4586; Sakkas D, 2002, BIOL REPROD, V66, P1061, DOI 10.1095/biolreprod66.4.1061; Team RDC, 2009, R LANG ENV STAT COMP; Tripathi R, 2009, J REPROD IMMUNOL, V83, P31, DOI 10.1016/j.jri.2009.05.009; Uggeri J, 2004, HISTOCHEM CELL BIOL, V122, P499, DOI 10.1007/s00418-004-0712-y; Well M, 1998, J CELL SCI, V111, P2707; Weng SL, 2002, MOL HUM REPROD, V8, P984, DOI 10.1093/molehr/8.11.984	30	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2012	7	4							e35477	10.1371/journal.pone.0035477	http://dx.doi.org/10.1371/journal.pone.0035477			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WC	22530029	gold, Green Published, Green Submitted			2022-12-25	WOS:000305347400054
J	Pomponi, D; Bernardi, ML; Liso, M; Palazzo, P; Tuppo, L; Rafaiani, C; Santoro, M; Labrada, A; Ciardiello, MA; Mari, A; Scala, E				Pomponi, Debora; Bernardi, Maria Livia; Liso, Marina; Palazzo, Paola; Tuppo, Lisa; Rafaiani, Chiara; Santoro, Mario; Labrada, Alexis; Ciardiello, Maria Antonietta; Mari, Adriano; Scala, Enrico			Allergen Micro-Bead Array for IgE Detection: A Feasibility Study Using Allergenic Molecules Tested on a Flexible Multiplex Flow Cytometric Immunoassay	PLOS ONE			English	Article							MICROARRAYED RECOMBINANT ALLERGENS; IMMUNOGLOBULIN-E REACTIVITY; PURIFIED ALLERGENS; DETECTION SYSTEM; ANTIBODIES; PROTEIN; DIAGNOSIS; KIWELLIN	Background: Allergies represent the most prevalent non infective diseases worldwide. Approaching IgE-mediated sensitizations improved much by adopting allergenic molecules instead of extracts, and by using the micro-technology for multiplex testing. Objective and Methods: To provide a proof-of-concept that a flow cytometric bead array is a feasible mean for the detection of specific IgE reactivity to allergenic molecules in a multiplex-like way. A flow cytometry Allergenic Molecule-based micro-bead Array system (ABA) was set by coupling allergenic molecules with commercially available micro-beads. Allergen specific polyclonal and monoclonal antibodies, as well as samples from 167 allergic patients, characterized by means of the ISAC microarray system, were used as means to show the feasibility of the ABA. Three hundred and thirty-six sera were tested for 1 or more of the 16 selected allergens, for a total number of 1,519 tests on each of the two systems. Results: Successful coupling was initially verified by detecting the binding of rabbit polyclonal IgG, mouse monoclonal, and pooled human IgE toward three allergens, namely nDer s 1, nPen m 1, and nPru p 3. The ABA assay showed to detect IgE to nAct d 1, nAct d 11, rAln g 1, nAmb a 1, nArt v 3, rBet v 1, rCor a 1, nCup a 1, nDer p 1, nDer s 1, rHev b 5, nOle e 1, rPar j 2, nPen m 1, rPhl p 1, and nPru p 3. Results obtained by ABA IgE testing were highly correlated to ISAC testing (r = 0.87, p<0.0001). No unspecific binding was recorded because of high total IgE values. Conclusion: The ABA assay represents a useful and flexible method for multiplex IgE detection using allergenic molecules. As also shown by our initial experiments with monoclonals and polyclonals, ABA is suitable for detecting other human and non-human immunoglobulins.	[Pomponi, Debora; Bernardi, Maria Livia; Liso, Marina; Palazzo, Paola; Tuppo, Lisa; Rafaiani, Chiara; Santoro, Mario; Mari, Adriano; Scala, Enrico] IDI IRCCS, Ctr Mol Allergol, Rome, Italy; [Tuppo, Lisa; Ciardiello, Maria Antonietta] CNR, Inst Prot Biochem, I-80125 Naples, Italy; [Labrada, Alexis] Ctr Nacl Biopreparados, Allergens Dept, Havana, Cuba	IRCCS Istituto Dermopatico dell'Immacolata (IDI); Consiglio Nazionale delle Ricerche (CNR); Istituto di Biochimica delle Proteine (IBP-CNR)	Pomponi, D (corresponding author), IDI IRCCS, Ctr Mol Allergol, Rome, Italy.	adriano.mari@idi.it	Santoro, Mario/GVU-5164-2022; Liso, Marina/AAB-3723-2019; Scala, Enrico/H-6997-2012; Labrada, Alexis/AAD-9750-2019	Santoro, Mario/0000-0001-6626-9430; Scala, Enrico/0000-0002-9391-9168; Labrada, Alexis/0000-0003-0956-7946; LISO, MARINA/0000-0002-8766-1869; CIARDIELLO, MARIA ANTONIETTA/0000-0002-7203-0554	Italian Ministry of Health, Programma Ricerca Corrente	Italian Ministry of Health, Programma Ricerca Corrente	This study has been funded by the Italian Ministry of Health, Programma Ricerca Corrente 2008-2010. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bernardi ML, 2010, CLIN EXP ALLERGY, V40, P1819, DOI 10.1111/j.1365-2222.2010.03603.x; Bomert M, 2011, CLIN CHEM LAB MED, V49, P1691, DOI 10.1515/CCLM.2011.631; Ciardiello MA, 2010, ALLERGY, V65, P597, DOI 10.1111/j.1398-9995.2009.02277.x; Cox L, 2008, ANN ALLERG ASTHMA IM, V101, P580, DOI 10.2500/aap.2008.29.3162; D'Avino R, 2011, ALLERGY, V66, P870, DOI 10.1111/j.1398-9995.2011.02555.x; Duffort OA, 2002, J AGR FOOD CHEM, V50, P7738, DOI 10.1021/jf0258398; Egger M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019062; Erwin EA, 2005, J ALLERGY CLIN IMMUN, V115, P1029, DOI 10.1016/j.jaci.2004.12.1131; Ferbas J, 2007, CLIN VACCINE IMMUNOL, V14, P1165, DOI 10.1128/CVI.00157-07; Fulton RJ, 1997, CLIN CHEM, V43, P1749; Harwanegg C, 2003, CLIN EXP ALLERGY, V33, P7, DOI 10.1046/j.1365-2222.2003.01550.x; Herbert OC, 2009, WORLD ALLERGY ORGAN, V2, P130, DOI 10.1097/WOX.0b013e3181accf27; Hiller R, 2002, FASEB J, V16, P414, DOI 10.1096/fj.01-0711fje; Kettman JR, 1998, CYTOMETRY, V33, P234, DOI 10.1002/(SICI)1097-0320(19981001)33:2<234::AID-CYTO19>3.3.CO;2-5; King EM, 2007, J ALLERGY CLIN IMMUN, V120, P1126, DOI 10.1016/j.jaci.2007.06.043; KING TP, 1964, BIOCHEMISTRY-US, V3, P458, DOI 10.1021/bi00891a026; Mari A, 2010, CURR ALLERGY ASTHM R, V10, P357, DOI 10.1007/s11882-010-0132-0; Mari A, 2009, CURR ALLERGY ASTHM R, V9, P376, DOI 10.1007/s11882-009-0055-9; Matsson PNJ, 2009, ILA20A229 CLSI, V29, P1; Morgan E, 2004, CLIN IMMUNOL, V110, P252, DOI 10.1016/j.clim.2003.11.017; Portnoy JA, 2006, CURR ALLERGY ASTHM R, V6, P455, DOI 10.1007/s11882-006-0021-8; Radauer C, 2011, MOL IMMUNOL, V48, P600, DOI 10.1016/j.molimm.2010.10.019; Ring J, 1999, INT ARCH ALLERGY IMM, V118, P403, DOI 10.1159/000024148; Scala E, 2010, CLIN EXP ALLERGY, V40, P911, DOI 10.1111/j.1365-2222.2010.03470.x; Scala E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024912; Sewer M, 2000, INT ARCH ALLERGY IMM, V123, P242, DOI 10.1159/000024450; Shreffler WG, 2011, J ALLERGY CLIN IMMUN, V127, P843, DOI 10.1016/j.jaci.2011.02.011; Tuppo L, 2008, J AGR FOOD CHEM, V56, P3812, DOI 10.1021/jf703620m; Varro Rudolf, 2007, Methods Mol Biol, V378, P125, DOI 10.1007/978-1-59745-323-3_9	29	36	38	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2012	7	4							e35697	10.1371/journal.pone.0035697	http://dx.doi.org/10.1371/journal.pone.0035697			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WC	22530068	Green Submitted, Green Published, gold			2022-12-25	WOS:000305347400065
J	Arama, J; Boulay, AC; Bosc, C; Delphin, C; Loew, D; Rostaing, P; Amigou, E; Ezan, P; Wingertsmann, L; Guillaud, L; Andrieux, A; Giaume, C; Cohen-Salmon, M				Arama, Jessica; Boulay, Anne-Cecile; Bosc, Christophe; Delphin, Christian; Loew, Damarys; Rostaing, Philippe; Amigou, Edwige; Ezan, Pascal; Wingertsmann, Laure; Guillaud, Laurent; Andrieux, Annie; Giaume, Christian; Cohen-Salmon, Martine			Bmcc1s, a Novel Brain-Isoform of Bmcc1, Affects Cell Morphology by Regulating MAP6/STOP Functions	PLOS ONE			English	Article							STOP PROTEINS; CDC42GAP HOMOLOGY/SEC14P-LIKE; INTERMEDIATE-FILAMENTS; BCH DOMAIN; BNIP-2; MICROTUBULES; EXPRESSION; PHOSPHORYLATION; LOCALIZATION; PURIFICATION	The BCH (BNIP2 and Cdc42GAP Homology) domain-containing protein Bmcc1/Prune2 is highly enriched in the brain and is involved in the regulation of cytoskeleton dynamics and cell survival. However, the molecular mechanisms accounting for these functions are poorly defined. Here, we have identified Bmcc1s, a novel isoform of Bmcc1 predominantly expressed in the mouse brain. In primary cultures of astrocytes and neurons, Bmcc1s localized on intermediate filaments and microtubules and interacted directly with MAP6/STOP, a microtubule-binding protein responsible for microtubule cold stability. Bmcc1s overexpression inhibited MAP6-induced microtubule cold stability by displacing MAP6 away from microtubules. It also resulted in the formation of membrane protrusions for which MAP6 was a necessary cofactor of Bmcc1s. This study identifies Bmcc1s as a new MAP6 interacting protein able to modulate MAP6-induced microtubule cold stability. Moreover, it illustrates a novel mechanism by which Bmcc1 regulates cell morphology.	[Arama, Jessica; Boulay, Anne-Cecile; Amigou, Edwige; Ezan, Pascal; Giaume, Christian; Cohen-Salmon, Martine] Coll France, INSERM, U1050, CIRB,CNRS,Unite Mixte Rech 7241, F-75231 Paris, France; [Arama, Jessica; Boulay, Anne-Cecile; Amigou, Edwige; Ezan, Pascal; Giaume, Christian; Cohen-Salmon, Martine] Univ Paris 06, Paris, France; [Arama, Jessica; Boulay, Anne-Cecile; Amigou, Edwige; Ezan, Pascal; Giaume, Christian; Cohen-Salmon, Martine] MEMOLIFE Lab Excellence, Paris, France; [Arama, Jessica; Boulay, Anne-Cecile; Amigou, Edwige; Ezan, Pascal; Giaume, Christian; Cohen-Salmon, Martine] Paris Sci Lettre Res Univ, Paris, France; [Bosc, Christophe; Delphin, Christian; Andrieux, Annie] Univ Grenoble 1, Fac Med, INSERM, U836,Inst Neurosci,Equipe Physiopathol Cytosquele, La Tronche, France; [Loew, Damarys] Inst Curie, Lab Prote Mass Spectrometry, Paris, France; [Rostaing, Philippe; Wingertsmann, Laure] Ecole Normale Super, Inst Biol, INSERM, U1024, F-75231 Paris, France; [Guillaud, Laurent] Okinawa Inst Sci & Technol, Cell & Mol Synapt Funct Unit, Okinawa, Japan	UDICE-French Research Universities; PSL Research University Paris; College de France; Ecole Normale Superieure (ENS); Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Okinawa Institute of Science & Technology Graduate University	Arama, J (corresponding author), Univ London, Sch Pharm, Dept Pharmacol, London WC1N 1AX, England.	martine.cohen-salmon@college-de-france.fr	Guillaud, Laurent/Q-4214-2016; Bosc, Christophe/Q-8877-2019; Bosc, Christophe/P-3401-2017; ANDRIEUX, ANNIE/B-2134-2017; Boulay, Anne-Cecile/I-1257-2017; Christian, Delphin/P-9284-2017	Guillaud, Laurent/0000-0002-9688-0991; Bosc, Christophe/0000-0002-3195-6692; Bosc, Christophe/0000-0002-3195-6692; ANDRIEUX, ANNIE/0000-0002-4022-6405; Boulay, Anne-Cecile/0000-0001-5620-6209; Damarys, Loew/0000-0002-9111-8842; Christian, Delphin/0000-0003-3240-8695; Cohen-Salmon, Martine/0000-0002-5312-8476	Agence Nationale pour la Recherche ANR-programme blanc Neurosciences; Canceropole Ile-de-France; "'l'Institut National du Cancer"	Agence Nationale pour la Recherche ANR-programme blanc Neurosciences(French National Research Agency (ANR)); Canceropole Ile-de-France(Region Ile-de-France); "'l'Institut National du Cancer"(Institut National du Cancer (INCA) France)	This work was supported by Agence Nationale pour la Recherche ANR-programme blanc Neurosciences. The Laboratory of Proteomic Mass Spectrometry is supported by "Canceropole Ile-de-France" and "'l'Institut National du Cancer". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrieux A, 2002, GENE DEV, V16, P2350, DOI 10.1101/gad.223302; Aoyama T, 2009, J CELL SCI, V122, P4177, DOI 10.1242/jcs.048579; Baratier J, 2006, J BIOL CHEM, V281, P19561, DOI 10.1074/jbc.M509602200; Bosc C, 2003, BIOCHEMISTRY-US, V42, P12125, DOI 10.1021/bi0352163; Bosc C, 1996, P NATL ACAD SCI USA, V93, P2125, DOI 10.1073/pnas.93.5.2125; Buschdorf JP, 2006, J CELL SCI, V119, P3337, DOI 10.1242/jcs.03061; Buschdorf JP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002686; Clarke RA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004995; del Castillo FJ, 2010, HUM MOL GENET, V19, P262, DOI 10.1093/hmg/ddp490; Fevrier B, 2004, P NATL ACAD SCI USA, V101, P9683, DOI 10.1073/pnas.0308413101; Froger N, 2009, J NEUROCHEM, V111, P1383, DOI 10.1111/j.1471-4159.2009.06407.x; Galiano MR, 2004, J NEUROSCI RES, V78, P329, DOI 10.1002/jnr.20260; Gory-Faure S, 2006, J BIOL CHEM, V281, P28387, DOI 10.1074/jbc.M603380200; Guillaud L, 1998, J CELL BIOL, V142, P167, DOI 10.1083/jcb.142.1.167; GURLAND G, 1995, J CELL BIOL, V131, P1275, DOI 10.1083/jcb.131.5.1275; Hornung JP, 1999, J COMP NEUROL, V414, P348; Iwama E, 2011, J MOL NEUROSCI; Kang JS, 2008, J CELL BIOL, V182, P497, DOI 10.1083/jcb.200801119; Kreitzer G, 1999, MOL BIOL CELL, V10, P1105, DOI 10.1091/mbc.10.4.1105; Letournel F, 2003, J NEUROPATH EXP NEUR, V62, P1211, DOI 10.1093/jnen/62.12.1211; Li SM, 2011, NEUROSCI LETT, V503, P208, DOI 10.1016/j.neulet.2011.08.037; Low BC, 1999, J BIOL CHEM, V274, P33123, DOI 10.1074/jbc.274.46.33123; Low BC, 2000, J BIOL CHEM, V275, P14415, DOI 10.1074/jbc.275.19.14415; Lua BL, 2005, J CELL SCI, V118, P2707, DOI 10.1242/jcs.02383; Machida T, 2006, ONCOGENE, V25, P1931, DOI 10.1038/sj.onc.1209225; MARGOLIS RL, 1986, P NATL ACAD SCI USA, V83, P639, DOI 10.1073/pnas.83.3.639; MASSON D, 1993, J CELL BIOL, V123, P357, DOI 10.1083/jcb.123.2.357; Nectoux J, 2010, J CELL MOL MED, V14, P1962, DOI 10.1111/j.1582-4934.2010.01107.x; PIROLLET F, 1989, BIOCHEMISTRY-US, V28, P835, DOI 10.1021/bi00428a064; Poullet P, 2007, PROTEOMICS, V7, P2553, DOI 10.1002/pmic.200600784; Rouach N, 2003, J PHYSIOL-LONDON, V553, P729, DOI 10.1113/jphysiol.2003.053439; Shang X, 2003, J BIOL CHEM, V278, P45903, DOI 10.1074/jbc.M304514200; Soh UJK, 2008, J CELL SCI, V121, P1739, DOI 10.1242/jcs.021774; Zhou Yi Ting, 2005, Experimental Cell Research, V303, P263, DOI 10.1016/j.yexcr.2004.08.044; Zhou YT, 2002, J BIOL CHEM, V277, P7483, DOI 10.1074/jbc.M109459200; Zhou YT, 2010, MOL BIOL CELL	36	16	16	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2012	7	4							e35488	10.1371/journal.pone.0035488	http://dx.doi.org/10.1371/journal.pone.0035488			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VO	22523599	Green Submitted, Green Published, gold			2022-12-25	WOS:000305345000073
J	Kamal, MZ; Mohammad, TAS; Krishnamoorthy, G; Rao, NM				Kamal, Md Zahid; Mohammad, Tabrez Anwar Shamim; Krishnamoorthy, G.; Rao, Nalam Madhusudhana			Role of Active Site Rigidity in Activity: MD Simulation and Fluorescence Study on a Lipase Mutant	PLOS ONE			English	Article							BACILLUS-SUBTILIS LIPASE; DIRECTED EVOLUTION; ENZYME CATALYSIS; CONFORMATIONAL DYNAMICS; DIHYDROFOLATE-REDUCTASE; AMYLOID PROTOFIBRILS; CRYSTAL-STRUCTURES; CHEMICAL STEP; PROTEIN; STABILITY	Relationship between stability and activity of enzymes is maintained by underlying conformational flexibility. In thermophilic enzymes, a decrease in flexibility causes low enzyme activity while in less stable proteins such as mesophiles and psychrophiles, an increase in flexibility is associated with enhanced enzyme activity. Recently, we identified a mutant of a lipase whose stability and activity were enhanced simultaneously. In this work, we probed the conformational dynamics of the mutant and the wild type lipase, particularly flexibility of their active site using molecular dynamic simulations and time-resolved fluorescence techniques. In contrast to the earlier observations, our data show that active site of the mutant is more rigid than wild type enzyme. Further investigation suggests that this lipase needs minimal reorganization/flexibility of active site residues during its catalytic cycle. Molecular dynamic simulations suggest that catalytically competent active site geometry of the mutant is relatively more preserved than wild type lipase, which might have led to its higher enzyme activity. Our study implies that widely accepted positive correlation between conformation flexibility and enzyme activity need not be stringent and draws attention to the possibility that high enzyme activity can still be accomplished in a rigid active site and stable protein structures. This finding has a significant implication towards better understanding of involvement of dynamic motions in enzyme catalysis and enzyme engineering through mutations in active site.	[Kamal, Md Zahid; Rao, Nalam Madhusudhana] CSIR, Ctr Cellular & Mol Biol, Hyderabad, Andhra Pradesh, India; [Mohammad, Tabrez Anwar Shamim] Ctr DNA Fingerprinting & Diagnost, Hyderabad, Andhra Pradesh, India; [Krishnamoorthy, G.] Tata Inst Fundamental Res, Dept Chem Sci, Mumbai 400005, Maharashtra, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Centre for Cellular & Molecular Biology (CCMB); Department of Biotechnology (DBT) India; Centre for DNA Fingerprinting & Diagnostics (CDFD); Tata Institute of Fundamental Research (TIFR)	Kamal, MZ (corresponding author), CSIR, Ctr Cellular & Mol Biol, Hyderabad, Andhra Pradesh, India.	madhu@ccmb.res.in	MOHAMMAD, TABREZ/AAN-7495-2020	MOHAMMAD, TABREZ/0000-0002-9553-7841	Council of Scientific and Industrial Research [NWP0044, CMM0021]	Council of Scientific and Industrial Research(Council of Scientific & Industrial Research (CSIR) - India)	The work reported here was supported by the grants from the Council of Scientific and Industrial Research (NWP0044 and CMM0021). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharya P, 2004, J MOL BIOL, V341, P1271, DOI 10.1016/j.jmb.2004.06.059; Adamczyk AJ, 2011, P NATL ACAD SCI USA, V108, P14115, DOI 10.1073/pnas.1111252108; Ahmad S, 2008, J MOL BIOL, V381, P324, DOI 10.1016/j.jmb.2008.05.063; Ahmad S, 2009, PROTEIN SCI, V18, P1183, DOI 10.1002/pro.126; Akanuma S, 1998, PROTEIN SCI, V7, P698, DOI 10.1002/pro.5560070319; Benkovic SJ, 2008, BIOCHEMISTRY-US, V47, P3317, DOI 10.1021/bi800049z; Bhabha G, 2011, SCIENCE, V332, P234, DOI 10.1126/science.1198542; D'Amico S, 2003, J BIOL CHEM, V278, P7891, DOI 10.1074/jbc.M212508200; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Droge MJ, 2006, CHEMBIOCHEM, V7, P149, DOI 10.1002/cbic.200500308; Eisenmesser EZ, 2005, NATURE, V438, P117, DOI 10.1038/nature04105; Fraser JS, 2009, NATURE, V462, P669, DOI 10.1038/nature08615; Giver L, 1998, P NATL ACAD SCI USA, V95, P12809, DOI 10.1073/pnas.95.22.12809; Goel T, 2010, J PHYS CHEM B, V114, P8986, DOI 10.1021/jp912029m; Gribenko AV, 2009, P NATL ACAD SCI USA, V106, P2601, DOI 10.1073/pnas.0808220106; Gunasekaran K, 2007, J MOL BIOL, V365, P257, DOI 10.1016/j.jmb.2006.09.062; Gutteridge A, 2005, J MOL BIOL, V346, P21, DOI 10.1016/j.jmb.2004.11.013; Hammes-Schiffer S, 2006, ANNU REV BIOCHEM, V75, P519, DOI 10.1146/annurev.biochem.75.103004.142800; Hecky J, 2005, BIOCHEMISTRY-US, V44, P12640, DOI 10.1021/bi0501885; Henzler-Wildman KA, 2007, NATURE, V450, P838, DOI 10.1038/nature06410; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Hibbs RE, 2006, J BIOL CHEM, V281, P39708, DOI 10.1074/jbc.M604752200; Hollien J, 1999, P NATL ACAD SCI USA, V96, P13674, DOI 10.1073/pnas.96.24.13674; Jha A, 2009, J MOL BIOL, V393, P735, DOI 10.1016/j.jmb.2009.08.053; Kamal MZ, 2011, J MOL BIOL, V413, P726, DOI 10.1016/j.jmb.2011.09.002; Kamerlin SCL, 2010, PROTEINS, V78, P1339, DOI 10.1002/prot.22654; Korkegian A, 2005, SCIENCE, V308, P857, DOI 10.1126/science.1107387; Labeikovsky W, 2007, J MOL BIOL, V367, P1370, DOI 10.1016/j.jmb.2007.01.049; Lakshmikanth GS, 1999, BIOPHYS J, V77, P1100, DOI 10.1016/S0006-3495(99)76960-2; Lazaridis T, 1997, PROTEIN SCI, V6, P2589; Lehmann M, 2000, BBA-PROTEIN STRUCT M, V1543, P408, DOI 10.1016/S0167-4838(00)00238-7; Markwell M A, 1981, Methods Enzymol, V72, P296; McElheny D, 2005, P NATL ACAD SCI USA, V102, P5032, DOI 10.1073/pnas.0500699102; Miyazaki K, 2000, J MOL BIOL, V297, P1015, DOI 10.1006/jmbi.2000.3612; Mukhopadhyay S, 2006, J MOL BIOL, V358, P935, DOI 10.1016/j.jmb.2006.02.006; Papaleo E, 2008, FEBS LETT, V582, P1008, DOI 10.1016/j.febslet.2008.02.048; Pisliakov AV, 2009, P NATL ACAD SCI USA, V106, P17359, DOI 10.1073/pnas.0909150106; Richard P.Haugland, 2002, HDB FLUORESCENCENT P, P79; Smith AJT, 2008, J AM CHEM SOC, V130, P15361, DOI 10.1021/ja803213p; Tousignant A, 2004, CHEM BIOL, V11, P1037, DOI 10.1016/j.chembiol.2004.06.007; Van den Burg B, 1998, P NATL ACAD SCI USA, V95, P2056, DOI 10.1073/pnas.95.5.2056; VAN PG, 2001, J MOL BIOL, V309, P215; VARLEY PG, 1991, J MOL BIOL, V220, P531, DOI 10.1016/0022-2836(91)90028-5; Wolf-Watz M, 2004, NAT STRUCT MOL BIOL, V11, P945, DOI 10.1038/nsmb821; Yang H, 2003, SCIENCE, V302, P262, DOI 10.1126/science.1086911; Zavodszky P, 1998, P NATL ACAD SCI USA, V95, P7406, DOI 10.1073/pnas.95.13.7406; Zhao HM, 1999, PROTEIN ENG, V12, P47, DOI 10.1093/protein/12.1.47	48	59	63	2	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2012	7	4							e35188	10.1371/journal.pone.0035188	http://dx.doi.org/10.1371/journal.pone.0035188			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UT	22514720	Green Submitted, Green Published, gold			2022-12-25	WOS:000305341600126
J	Seong, HA; Ha, H				Seong, Hyun-A; Ha, Hyunjung			Murine Protein Serine-threonine Kinase 38 Activates p53 Function through Ser(15) Phosphorylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article								Murine protein serine-threonine kinase 38 (MPK38) is a member of the AMP-activated protein kinase-related serine/threonine kinase family. In this study, we show that MPK38 physically associates with p53 via the carboxyl-terminal domain of MPK38 and the central DNA-binding domain of p53. This interaction is increased by 5-fluorouracil or doxorubicin treatment and is responsible for Ser(15) phosphorylation of p53. Ectopic expression of wild-type Mpk38, but not kinase-dead Mpk38, stimulates p53-mediated transcription in a dose-dependent manner and up-regulates p53 targets, including p53, p21, MDM2, and BAX. Consistently, knockdown of MPK38 shows an opposite trend, inhibiting p53-mediated transcription. MPK38 functionally enhances p53-mediated apoptosis and cell cycle arrest in a kinase-dependent manner by stimulating p53 nuclear translocation. We also demonstrate that MPK38-mediated p53 activation is induced by removing MDM2, a negative regulator of p53, from the p53-MDM2 complex as well as by stabilization of interaction between p53 and its positive regulators, including NM23-H1, serine/threonine kinase receptor-associated protein, and 14-3-3. This leads to the enhancement of p53 stability. Together, these results suggest that MPK38 may act as a novel regulator for promoting p53 activity through direct phosphorylation of p53 at Ser(15).	[Seong, Hyun-A; Ha, Hyunjung] Chungbuk Natl Univ, Sch Life Sci, Dept Biochem, Cheongju 361763, South Korea	Chungbuk National University	Ha, H (corresponding author), Chungbuk Natl Univ, Sch Life Sci, Dept Biochem, Cheongju 361763, South Korea.	hyunha@chungbuk.ac.kr			National Research Foundation of Korea [R0A-2007-000-20006-0]	National Research Foundation of Korea(National Research Foundation of Korea)	This work was supported by National Research Foundation of Korea Grant R0A-2007-000-20006-0.	Appella E, 2001, EUR J BIOCHEM, V268, P2764, DOI 10.1046/j.1432-1327.2001.02225.x; Badouel C, 2006, CELL CYCLE, V5, P883, DOI 10.4161/cc.5.8.2683; Banin S, 1998, SCIENCE, V281, P1674, DOI 10.1126/science.281.5383.1674; Beullens M, 2005, J BIOL CHEM, V280, P40003, DOI 10.1074/jbc.M507274200; Blot J, 2002, DEV BIOL, V241, P327, DOI 10.1006/dbio.2001.0525; Bode AM, 2004, NAT REV CANCER, V4, P793, DOI 10.1038/nrc1455; Canman CE, 1998, SCIENCE, V281, P1677, DOI 10.1126/science.281.5383.1677; Chartrain I, 2006, BIOL CELL, V98, P253, DOI 10.1042/BC20050041; Chehab NH, 2000, GENE DEV, V14, P278; Davezac N, 2002, ONCOGENE, V21, P7630, DOI 10.1038/sj.onc.1205870; Dumaz N, 1999, EMBO J, V18, P7002, DOI 10.1093/emboj/18.24.7002; Giaccia AJ, 1998, GENE DEV, V12, P2973, DOI 10.1101/gad.12.19.2973; Gil M, 1997, GENE, V195, P295, DOI 10.1016/S0378-1119(97)00181-9; Gray D, 2005, CANCER RES, V65, P9751, DOI 10.1158/0008-5472.CAN-04-4531; Heyer BS, 1997, MOL REPROD DEV, V47, P148, DOI 10.1002/(SICI)1098-2795(199706)47:2&lt;148::AID-MRD4&gt;3.0.CO;2-M; Hirao A, 2000, SCIENCE, V287, P1824, DOI 10.1126/science.287.5459.1824; Jakobsen SN, 2001, J BIOL CHEM, V276, P46912, DOI 10.1074/jbc.C100483200; Jones RG, 2005, MOL CELL, V18, P283, DOI 10.1016/j.molcel.2005.03.027; Jung HY, 2008, J BIOL CHEM, V283, P20383, DOI 10.1074/jbc.M800050200; Jung HY, 2007, J BIOL CHEM, V282, P35293, DOI 10.1074/jbc.M705181200; Jung H, 2008, J BIOL CHEM, V283, P34541, DOI 10.1074/jbc.M807219200; Kato K, 2002, ONCOGENE, V21, P6082, DOI 10.1038/sj.onc.1205737; Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1; Meek DW, 1999, ONCOGENE, V18, P7666, DOI 10.1038/sj.onc.1202951; Meek DW, 2004, DNA REPAIR, V3, P1049, DOI 10.1016/j.dnarep.2004.03.027; MOMAND J, 1992, CELL, V69, P1237, DOI 10.1016/0092-8674(92)90644-R; Okoshi R, 2008, J BIOL CHEM, V283, P3979, DOI 10.1074/jbc.M705232200; Prives C, 1999, J PATHOL, V187, P112; Rhodes DR, 2004, P NATL ACAD SCI USA, V101, P9309, DOI 10.1073/pnas.0401994101; Seong HA, 2005, J BIOL CHEM, V280, P42897, DOI 10.1074/jbc.M507539200; Seong HA, 2002, BIOCHEM J, V361, P597, DOI 10.1042/0264-6021:3610597; Seong HA, 2007, J BIOL CHEM, V282, P12075, DOI 10.1074/jbc.M609832200; Seong HA, 2010, J BIOL CHEM, V285, P30959, DOI 10.1074/jbc.M110.138370; Shieh SY, 1997, CELL, V91, P325, DOI 10.1016/S0092-8674(00)80416-X; Shieh SY, 2000, GENE DEV, V14, P289; Stavridi ES, 2001, CANCER RES, V61, P7030; Suzuki A, 2003, ONCOGENE, V22, P6177, DOI 10.1038/sj.onc.1206899; Suzuki A, 2003, J BIOL CHEM, V278, P48, DOI 10.1074/jbc.M206025200; Tibbetts RS, 1999, GENE DEV, V13, P152, DOI 10.1101/gad.13.2.152; Toledo F, 2006, NAT REV CANCER, V6, P909, DOI 10.1038/nrc2012; Vousden KH, 2002, NAT REV CANCER, V2, P594, DOI 10.1038/nrc864; Vulsteke V, 2004, J BIOL CHEM, V279, P8642, DOI 10.1074/jbc.M311466200	42	35	39	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 15	2012	287	25					20797	20810		10.1074/jbc.M112.347757	http://dx.doi.org/10.1074/jbc.M112.347757			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	V32MR	22532570	hybrid, Green Published			2022-12-25	WOS:000208955800002
J	Lim, M; Choi, SK; Cho, YE; Yeon, SI; Kim, EC; Ahn, DS; Lee, YH				Lim, Mihwa; Choi, Soo-Kyoung; Cho, Young-Eun; Yeon, Soo-In; Kim, Eok-Cheon; Ahn, Duck-Sun; Lee, Young-Ho			The Role of Sphingosine Kinase 1/Sphingosine-1-Phosphate Pathway in the Myogenic Tone of Posterior Cerebral Arteries	PLOS ONE			English	Article							BASILAR ARTERIES; IN-VIVO; SPHINGOSINE-1-PHOSPHATE; VASOSPASM; PRESSURE; MEDIATOR; PLASMA; DEPOLARIZATION; 1-PHOSPHATE; ACTIVATION	Aims: The goal of the current study was to determine whether the sphingosine kinase 1 (SK1)/sphingosine-1-phosphate (S1P) pathway is involved in myogenic vasoconstriction under normal physiological conditions. In the present study, we assessed whether endogenous S1P generated by pressure participates in myogenic vasoconstriction and which signaling pathways are involved in SK1/S1P-induced myogenic response under normal physiological conditions. Methods and Results: We measured pressure-induced myogenic response, Ca2+ concentration, and 20 kDa myosin light chain phosphorylation (MLC20) in rabbit posterior cerebral arteries (PCAs). SK1 was expressed and activated by elevated transmural pressure in rabbit PCAs. Translocation of SK1 by pressure elevation was blocked in the absence of external Ca2+ and in the presence of mechanosensitive ion channel and voltage-sensitive Ca2+ channel blockers. Pressure-induced myogenic tone was inhibited in rabbit PCAs treated with sphingosine kinase inhibitor (SKI), but was augmented by treatment with NaF, which is an inhibitor of sphingosine-1-phosphate phosphohydrolase. Exogenous S1P further augmented pressure-induced myogenic responses. Pressure induced an increase in Ca2+ concentration leading to the development of myogenic tone, which was inhibited by SKI. Exogenous S1P further increased the pressure-induced increased Ca2+ concentration and myogenic tone, but SKI had no effect. Pressure- and exogenous S1P-induced myogenic tone was inhibited by pre-treatment with the Rho kinase inhibitor and NADPH oxidase inhibitors. Pressure- and exogenous S1P-induced myogenic tone were inhibited by pre-treatment with S1P receptor blockers, W146 (S1P1), JTE013 (S1P2), and CAY10444 (S1P3). MLC20 phosphorylation was increased when the transmural pressure was raised from 40 to 80 mmHg and exogenous S1P further increased MLC20 phosphorylation. The pressure-induced increase of MLC20 phosphorylation was inhibited by pre-treatment of arteries with SKI. Conclusions: Our results suggest that the SK1/S1P pathway may play an important role in pressure-induced myogenic responses in rabbit PCAs under normal physiological conditions.	[Lim, Mihwa; Choi, Soo-Kyoung; Cho, Young-Eun; Yeon, Soo-In; Kim, Eok-Cheon; Ahn, Duck-Sun; Lee, Young-Ho] Yonsei Univ, Coll Med, Dept Physiol, BK Project Med Sci 21, Seoul, South Korea	Yonsei University; Yonsei University Health System	Lee, YH (corresponding author), Yonsei Univ, Coll Med, Dept Physiol, BK Project Med Sci 21, Seoul, South Korea.	yhlee@yuhs.ac		Ahn, Duck Sun/0000-0001-9351-6951; Lee, Young-Ho/0000-0002-5749-1045; Choi, Soo-Kyoung/0000-0002-7115-6358	Yonsei University College of Medicine [6-2010-0056]	Yonsei University College of Medicine(General Electric)	This study was supported by a faculty research grant from Yonsei University College of Medicine in 2010 (No. 6-2010-0056). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alemany R, 2001, FEBS LETT, V509, P239, DOI 10.1016/S0014-5793(01)03168-4; Alewijnse AE, 2004, BRIT J PHARMACOL, V143, P666, DOI 10.1038/sj.bjp.0705934; Bayliss WM, 1902, J PHYSIOL-LONDON, V28, P220; Bolz SS, 2003, CIRCULATION, V108, P342, DOI 10.1161/01.CIR.0000080324.12530.0D; Cho YE, 2011, CARDIOVASC RES, V91, P162, DOI 10.1093/cvr/cvr043; Choi SK, 2009, CARDIOVASC RES, V82, P324, DOI 10.1093/cvr/cvp054; COOK DA, 1984, PHARMACOLOGY, V29, P1, DOI 10.1159/000137986; DAVIS MJ, 1992, AM J PHYSIOL, V262, pC1083, DOI 10.1152/ajpcell.1992.262.4.C1083; Dietrich HH, 2000, NEUROSURGERY, V46, P517, DOI 10.1097/00006123-200003000-00001; Dora KA, 2005, AM J PHYSIOL-HEART C, V289, pH1323, DOI 10.1152/ajpheart.00513.2005; Drummond HA, 2004, HYPERTENSION, V44, P643, DOI 10.1161/01.HYP.0000144465.56360.ad; Duong CQ, 2004, BBA-MOL CELL BIOL L, V1682, P112; FOLKOW B, 1962, ARCH INT PHARMACOD T, V139, P455; Grand T, 2008, BRIT J PHARMACOL, V153, P1697, DOI 10.1038/bjp.2008.38; HARDER DR, 1984, CIRC RES, V55, P197, DOI 10.1161/01.RES.55.2.197; Hill MA, 2006, CLIN HEMORHEOL MICRO, V34, P67; Hla T, 1999, BIOCHEM PHARMACOL, V58, P201; Keller M, 2006, FASEB J, V20, P702, DOI 10.1096/fj.05-4075fje; Liliom K, 2001, BIOCHEM J, V355, P189, DOI 10.1042/0264-6021:3550189; MEININGER GA, 1990, AM J PHYSIOL, V258, pH1032, DOI 10.1152/ajpheart.1990.258.4.H1032; MERRITT JE, 1990, BIOCHEM J, V271, P515, DOI 10.1042/bj2710515; Michel MC, 2007, ACTA PAEDIATR, V96, P44, DOI 10.1111/j.1651-2227.2007.00207.x; Mulders ACM, 2006, ARTERIOSCL THROM VAS, V26, P2043, DOI 10.1161/01.ATV.0000237569.95046.b9; Nowicki PT, 2001, CIRC RES, V89, P114, DOI 10.1161/hh1401.094367; Okajima F, 2002, BBA-MOL CELL BIOL L, V1582, P132, DOI 10.1016/S1388-1981(02)00147-6; Peter BF, 2008, CIRC RES, V103, P315, DOI 10.1161/CIRCRESAHA.108.173575; Peters SLM, 2007, CURR OPIN PHARMACOL, V7, P186, DOI 10.1016/j.coph.2006.09.008; Pitson SM, 2005, J EXP MED, V201, P49, DOI 10.1084/jem.20040559; Salomone S, 2010, PHARMACOL RES, V62, P465, DOI 10.1016/j.phrs.2010.09.002; Scherer EQ, 2006, CARDIOVASC RES, V70, P79, DOI 10.1016/j.cardiores.2006.01.011; Tosaka M, 2001, STROKE, V32, P2913, DOI 10.1161/hs1201.099525; WEIR B, 1995, BRIT J NEUROSURG, V9, P375, DOI 10.1080/02688699550041386; Yeon DS, 2002, CARDIOVASC RES, V53, P431, DOI 10.1016/S0008-6363(01)00496-5	33	15	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2012	7	4							e35177	10.1371/journal.pone.0035177	http://dx.doi.org/10.1371/journal.pone.0035177			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UD	22532844	Green Published, Green Submitted, gold			2022-12-25	WOS:000305339200043
J	Kobie, JJ; Alcena, DC; Zheng, B; Bryk, P; Mattiacio, JL; Brewer, M; LaBranche, C; Young, FM; Dewhurst, S; Montefiori, DC; Rosenberg, AF; Feng, CY; Jin, X; Keefer, MC; Sanz, I				Kobie, James J.; Alcena, Danielle C.; Zheng, Bo; Bryk, Peter; Mattiacio, Jonelle L.; Brewer, Matthew; LaBranche, Celia; Young, Faith M.; Dewhurst, Stephen; Montefiori, David C.; Rosenberg, Alexander F.; Feng, Changyong; Jin, Xia; Keefer, Michael C.; Sanz, Ignacio			9G4 Autoreactivity Is Increased in HIV-Infected Patients and Correlates with HIV Broadly Neutralizing Serum Activity	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; SYSTEMIC-LUPUS-ERYTHEMATOSUS; CONNECTIVE-TISSUE DISEASE; V(H)4-21 GENE SEGMENT; RED-BLOOD-CELLS; MEMORY B-CELLS; PERIPHERAL-BLOOD; ANTIPHOSPHOLIPID ANTIBODIES; ANTICARDIOLIPIN ANTIBODIES; I-ANTIGEN	The induction of a broadly neutralizing antibody (BNAb) response against HIV-1 would be a desirable feature of a protective vaccine. Vaccine strategies thus far have failed to elicit broadly neutralizing antibody responses; however a minority of HIV-infected patients do develop circulating BNAbs, from which several potent broadly neutralizing monoclonal antibodies (mAbs) have been isolated. The findings that several BNmAbs exhibit autoreactivity and that autoreactive serum antibodies are observed in some HIV patients have advanced the possibility that enforcement of self-tolerance may contribute to the rarity of BNAbs. To examine the possible breakdown of tolerance in HIV patients, we utilized the 9G4 anti-idiotype antibody system, enabling resolution of both autoreactive VH4-34 gene-expressing B cells and serum antibodies. Compared with healthy controls, HIV patients had significantly elevated 9G4+ serum IgG antibody concentrations and frequencies of 9G4+ B cells, a finding characteristic of systemic lupus erythematosus (SLE) patients, both of which positively correlated with HIV viral load. Compared to the global 9G4-IgD- memory B cell population, the 9G4+IgD- memory fraction in HIV patients was dominated by isotype switched IgG+ B cells, but had a more prominent bias toward "IgM only" memory. HIV envelope reactivity was observed both in the 9G4+ serum antibody and 9G4+ B cell population. 9G4+ IgG serum antibody levels positively correlated (r = 0.403, p = 0.0019) with the serum HIV BNAbs. Interestingly, other serum autoantibodies commonly found in SLE (anti-dsDNA, ANA, anti-CL) did not correlate with serum HIV BNAbs. 9G4-associated autoreactivity is preferentially expanded in chronic HIV infection as compared to other SLE autoreactivities. Therefore, the 9G4 system provides an effective tool to examine autoreactivity in HIV patients. Our results suggest that the development of HIV BNAbs is not merely a consequence of a general breakdown in tolerance, but rather a more intricate expansion of selective autoreactive B cells and antibodies.	[Kobie, James J.; Zheng, Bo; Bryk, Peter; Rosenberg, Alexander F.; Sanz, Ignacio] Univ Rochester, Med Ctr, Div Allergy Immunol & Rheumatol, Rochester, NY 14642 USA; [Alcena, Danielle C.; Mattiacio, Jonelle L.; Brewer, Matthew; Dewhurst, Stephen] Univ Rochester, Med Ctr, Dept Microbiol & Immunol, Rochester, NY 14642 USA; [LaBranche, Celia; Montefiori, David C.] Duke Univ, Med Ctr, Dept Surg, Lab AIDS Vaccine Res & Dev, Durham, NC 27710 USA; [Young, Faith M.] Univ Rochester, Med Ctr, JP Wilmot Canc Ctr, Rochester, NY 14642 USA; [Feng, Changyong] Univ Rochester, Med Ctr, Dept Biostat & Computat Biol, Rochester, NY 14642 USA; [Jin, Xia; Keefer, Michael C.] Univ Rochester, Med Ctr, Div Infect Dis, Rochester, NY 14642 USA	University of Rochester; University of Rochester; Duke University; University of Rochester; University of Rochester; University of Rochester	Kobie, JJ (corresponding author), Univ Rochester, Med Ctr, Div Allergy Immunol & Rheumatol, Rochester, NY 14642 USA.	james_kobie@urmc.rochester.edu	Alcéna-Stiner, Danielle C./ABG-9478-2020; Alcena-Stiner, Danielle/GVS-5132-2022	Dewhurst, Stephen/0000-0001-7729-7920; Alcena-Stiner, Danielle C./0000-0002-7466-9423	National Institutes of Health (NIH) [R01AI084808, R21AI078459, R37AI049660]; University of Rochester Developmental Center for AIDS Research [P30 AI078498]; University of Washington Center for AIDS Research [5P30AI027757]; Bill and Melinda Gates Foundation [38619]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI078459, P30AI027757, R01AI084808, R37AI049660, UM1AI068614, P30AI078498, T32AI049815] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Rochester Developmental Center for AIDS Research; University of Washington Center for AIDS Research; Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work supported by National Institutes of Health (NIH) grants R01AI084808, R21AI078459, and R37AI049660 to IS, the University of Rochester Developmental Center for AIDS Research grant P30 AI078498 (NIH/NIAID), the University of Washington Center for AIDS Research grant 5P30AI027757 (NIH/NIAID), and the Collaboration for AIDS Vaccine Discovery grant 38619 from the Bill and Melinda Gates Foundation to DM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhat Neelima M, 2004, Hum Antibodies, V13, P63; BHAT NM, 1993, J IMMUNOL, V151, P5011; Bhat NM, 2002, J RHEUMATOL, V29, P2114; BORRETZEN M, 1995, SCAND J IMMUNOL, V42, P90, DOI 10.1111/j.1365-3083.1995.tb03630.x; Cappione A, 2005, J CLIN INVEST, V115, P3205, DOI 10.1172/JCI24179; Cappione AJ, 2004, J IMMUNOL, V172, P4298, DOI 10.4049/jimmunol.172.7.4298; Catera R, 2008, MOL MED, V14, P665, DOI 10.2119/2008-00102.Catera; Dennison SM, 2011, J VIROL, V85, P1340, DOI 10.1128/JVI.01680-10; Doria-Rose NA, 2010, J VIROL, V84, P1631, DOI 10.1128/JVI.01482-09; Doria-Rose NA, 2009, J VIROL, V83, P188, DOI 10.1128/JVI.01583-08; Douvas A, 1996, AIDS RES HUM RETROV, V12, P1509, DOI 10.1089/aid.1996.12.1509; Forster J, 1996, INFECTION, V24, P407, DOI 10.1007/BF01713039; Gray ES, 2009, J VIROL, V83, P8925, DOI 10.1128/JVI.00758-09; Haas A, 2011, J VIROL; Haynes BF, 2005, SCIENCE, V308, P1906, DOI 10.1126/science.1111781; Jenks SA, 2010, ARTHRITIS RHEUM S10, V62, P486; KLEIN U, 1993, EUR J IMMUNOL, V23, P3272, DOI 10.1002/eji.1830231232; KLEIN U, 1994, J EXP MED, V180, P1383, DOI 10.1084/jem.180.4.1383; Martinez V, 2009, CLIN INFECT DIS, V48, P123, DOI 10.1086/595013; Mascola JR, 2005, J VIROL, V79, P10103, DOI 10.1128/JVI.79.16.10103-10107.2005; Mattiacio J, 2011, VACCINE, V29, P2637, DOI 10.1016/j.vaccine.2011.01.038; Mikell I, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001251; Milner ECB, 2005, SPRINGER SEMIN IMMUN, V26, P433, DOI 10.1007/s00281-004-0188-9; Mockridge CI, 2004, AUTOIMMUNITY, V37, P9, DOI 10.1080/08916930310001624656; Moir S, 2008, J EXP MED, V205, P1797, DOI 10.1084/jem.20072683; Moir S, 2009, NAT REV IMMUNOL, V9, P235, DOI 10.1038/nri2524; Morrow M, 2008, AIDS RES HUM RETROV, V24, P621, DOI 10.1089/aid.2007.0186; PASCUAL V, 1991, J IMMUNOL, V146, P4385; Petrovas C, 1999, J AUTOIMMUN, V13, P347, DOI 10.1006/jaut.1999.0324; Piantadosi A, 2009, J VIROL, V83, P10269, DOI 10.1128/JVI.01149-09; POTTER KN, 1993, J EXP MED, V178, P1419, DOI 10.1084/jem.178.4.1419; Potter KN, 2002, J IMMUNOL, V169, P3777, DOI 10.4049/jimmunol.169.7.3777; Pugh-Bernard AE, 2001, J CLIN INVEST, V108, P1061, DOI 10.1172/JCI12462; SANZ I, 1989, EMBO J, V8, P3741, DOI 10.1002/j.1460-2075.1989.tb08550.x; Sather DN, 2009, J VIROL, V83, P757, DOI 10.1128/JVI.02036-08; Scheid JF, 2011, SCIENCE; Scherer EM, 2007, AIDS, V21, P2131, DOI 10.1097/QAD.0b013e3282a4a632; Scherl M, 2006, LUPUS, V15, P865, DOI 10.1177/0961203306071405; Simek MD, 2009, J VIROL, V83, P7337, DOI 10.1128/JVI.00110-09; Singh H, 2011, AIDS, V25, P1247, DOI 10.1097/QAD.0b013e32834785cf; STEVENSON FK, 1988, NOUV REV FR HEMATOL, V30, P299; STEVENSON FK, 1993, J AUTOIMMUN, V6, P809, DOI 10.1006/jaut.1993.1066; Tomaras GD, 2009, CURR OPIN HIV AIDS, V4, P373, DOI 10.1097/COH.0b013e32832f00c0; Uthman IW, 2002, SEMIN ARTHRITIS RHEU, V31, P256, DOI 10.1053/sarh.2002.28303; van Gils MJ, 2009, AIDS, V23, P2405, DOI 10.1097/QAD.0b013e32833243e7; VANES JH, 1991, J EXP MED, V173, P461, DOI 10.1084/jem.173.2.461; Verkoczy L, 2011, CURR OPIN IMMUNOL, V23, P383, DOI 10.1016/j.coi.2011.04.003; Weller S, 2004, BLOOD, V104, P3647, DOI 10.1182/blood-2004-01-0346; Zachou K, 2006, CLIN IMMUNOL, V119, P203, DOI 10.1016/j.clim.2006.01.002; Zheng NY, 2004, J CLIN INVEST, V113, P1188, DOI 10.1172/JCI200420255; Zhou TQ, 2010, SCIENCE, V329, P811, DOI 10.1126/science.1192819	51	34	35	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2012	7	4							e35356	10.1371/journal.pone.0035356	http://dx.doi.org/10.1371/journal.pone.0035356			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959XD	22530008	Green Published, Green Submitted, gold			2022-12-25	WOS:000305350600077
J	AuCoin, DP; Reed, DE; Marlenee, NL; Bowen, RA; Thorkildson, P; Judy, BM; Torres, AG; Kozel, TR				AuCoin, David P.; Reed, Dana E.; Marlenee, Nicole L.; Bowen, Richard A.; Thorkildson, Peter; Judy, Barbara M.; Torres, Alfredo G.; Kozel, Thomas R.			Polysaccharide Specific Monoclonal Antibodies Provide Passive Protection against Intranasal Challenge with Burkholderia pseudomallei	PLOS ONE			English	Article							COLONY-STIMULATING FACTOR; CAPSULAR POLYSACCHARIDE; PSEUDOMONAS-PSEUDOMALLEI; CRYPTOCOCCUS-NEOFORMANS; IN-VITRO; LIPOPOLYSACCHARIDE; MELIOIDOSIS; SUSCEPTIBILITY; IMMUNOTHERAPY; RESISTANCE	Burkholderia pseudomallei is a Gram-negative bacillus that is the causative agent of melioidosis. The bacterium is inherently resistant to many antibiotics and mortality rates remain high in endemic areas. The lipopolysaccharide (LPS) and capsular polysaccharide (CPS) are two surface-associated antigens that contribute to pathogenesis. We previously developed two monoclonal antibodies (mAbs) specific to the CPS and LPS; the CPS mAb was shown to identify antigen in serum and urine from melioidosis patients. The goal of this study was to determine if passive immunization with CPS and LPS mAbs alone and in combination would protect mice from a lethal challenge with B. pseudomallei. Intranasal (i.n.) challenge experiments were performed with B. pseudomallei strains 1026b and K96423. Both mAbs provided significant protection when administered alone. A combination of mAbs was protective when low doses were administered. In addition, combination therapy provided a significant reduction in spleen colony forming units (cfu) compared to results when either the CPS or LPS mAbs were administered alone.	[AuCoin, David P.; Reed, Dana E.; Thorkildson, Peter; Kozel, Thomas R.] Univ Nevada, Sch Med, Dept Microbiol & Immunol, Reno, NV 89557 USA; [Marlenee, Nicole L.; Bowen, Richard A.] Colorado State Univ, Dept Biomed Sci, Ft Collins, CO 80523 USA; [Torres, Alfredo G.] Univ Texas Med Branch, Dept Pathol, Galveston, TX USA; [Judy, Barbara M.; Torres, Alfredo G.] Univ Texas Med Branch, Dept Microbiol & Immunol, Galveston, TX USA	Nevada System of Higher Education (NSHE); University of Nevada Reno; Colorado State University; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston	AuCoin, DP (corresponding author), Univ Nevada, Sch Med, Dept Microbiol & Immunol, Reno, NV 89557 USA.	daucoin@medicine.nevada.edu	Pacific-Southwest, RCE/B-6155-2009	Torres, Alfredo/0000-0001-6450-0643	National Institute of Allergy and Infectious Diseases [U54AI065359];  [NO1-AI-30065]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI059348, U54AI065359] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); ; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This project was supported by award number U54AI065359 from the National Institute of Allergy and Infectious Diseases to D.P.A., and by NO1-AI-30065 to A.G.T. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anuntagool N, 1998, CLIN DIAGN LAB IMMUN, V5, P225, DOI 10.1128/CDLI.5.2.225-229.1998; Anuntagool N, 2002, MICROBIOL IMMUNOL, V46, P143, DOI 10.1111/j.1348-0421.2002.tb02679.x; Anuntagool N, 2000, Southeast Asian J Trop Med Public Health, V31 Suppl 1, P146; Arjcharoen S, 2007, INFECT IMMUN, V75, P4298, DOI 10.1128/IAI.00285-07; Bottex C, 2005, IMMUNOPHARM IMMUNOT, V27, P565, DOI 10.1080/08923970500493995; Brett PJ, 1996, INFECT IMMUN, V64, P2824, DOI 10.1128/IAI.64.7.2824-2828.1996; Bryan LE, 1995, CAN J INFECT DIS, V5, P170; CHAOWAGUL W, 1993, J INFECT DIS, V168, P1181, DOI 10.1093/infdis/168.5.1181; Charuchaimontri C, 1999, CLIN INFECT DIS, V29, P813, DOI 10.1086/520441; Cheng AC, 2004, EUR J CLIN MICROBIOL, V23, P205, DOI 10.1007/s10096-003-1088-y; Cheng AC, 2004, CLIN INFECT DIS, V38, P32, DOI 10.1086/380456; Cheng Allen C, 2003, Commun Dis Intell Q Rep, V27, P272; CHOU TC, 1994, JNCI-J NATL CANCER I, V86, P1517, DOI 10.1093/jnci/86.20.1517; CHOU TC, 1983, TRENDS PHARMACOL SCI, V4, P450, DOI 10.1016/0165-6147(83)90490-X; Currie BJ, 2000, T ROY SOC TROP MED H, V94, P301, DOI 10.1016/S0035-9203(00)90333-X; DANCE DAB, 1989, J ANTIMICROB CHEMOTH, V24, P295, DOI 10.1093/jac/24.3.295; DeShazer D, 1998, MOL MICROBIOL, V30, P1081, DOI 10.1046/j.1365-2958.1998.01139.x; Estes DM, 2010, EXPERT REV ANTI-INFE, V8, P325, DOI [10.1586/eri.10.4, 10.1586/ERI.10.4]; Ho M, 1997, INFECT IMMUN, V65, P3648, DOI 10.1128/IAI.65.9.3648-3653.1997; Jenney AWJ, 2001, INT J ANTIMICROB AG, V17, P109, DOI 10.1016/S0924-8579(00)00334-4; Jones SM, 2002, J MED MICROBIOL, V51, P1055, DOI 10.1099/0022-1317-51-12-1055; KNIREL YA, 1992, CARBOHYD RES, V233, P185, DOI 10.1016/S0008-6215(00)90930-3; Kozel TR, 2007, INFECT IMMUN, V75, P152, DOI 10.1128/IAI.01133-06; Kozel TR, 2004, P NATL ACAD SCI USA, V101, P5042, DOI 10.1073/pnas.0401351101; Limmathurotsakul D, 2010, AM J TROP MED HYG, V82, P1113, DOI 10.4269/ajtmh.2010.10-0038; Nelson M, 2004, J MED MICROBIOL, V53, P1177, DOI 10.1099/jmm.0.45766-0; Nuti DE, 2011, MBIO, V2, DOI 10.1128/mBio.00136-11; Panomket P, 2009, ANN TROP MED PARASIT, V103, P635, DOI 10.1179/000349809X12502035776117; PERRY MB, 1995, INFECT IMMUN, V63, P3348, DOI 10.1128/IAI.63.9.3348-3352.1995; Powell K, 2003, FEMS MICROBIOL LETT, V224, P315, DOI 10.1016/S0378-1097(03)00473-7; Propst KL, 2010, ANTIMICROB AGENTS CH, V54, P1785, DOI 10.1128/AAC.01513-09; Reckseidler SL, 2001, INFECT IMMUN, V69, P34, DOI 10.1128/IAI.69.1.34-44.2001; Reckseidler-Zenteno SL, 2009, MINI-REV MED CHEM, V9, P265, DOI 10.2174/138955709787316047; Reckseidler-Zenteno SL, 2005, INFECT IMMUN, V73, P1106, DOI 10.1128/IAI.73.2.1106-1115.2005; Sarkar-Tyson M, 2010, CLIN THER, V32, P1437, DOI 10.1016/j.clinthera.2010.07.020; Taborda CP, 2003, J IMMUNOL, V170, P3621, DOI 10.4049/jimmunol.170.7.3621; Taborda CP, 2001, J IMMUNOL, V166, P2100, DOI 10.4049/jimmunol.166.3.2100; White NJ, 2003, LANCET, V361, P1715, DOI 10.1016/S0140-6736(03)13374-0; Whitlock GC, 2009, J MED MICROBIOL, V58, P554, DOI 10.1099/jmm.0.007724-0; Woods DE, 1999, MICROBES INFECT, V1, P157, DOI 10.1016/S1286-4579(99)80007-0; Zaragoza O, 2007, INFECT IMMUN, V75, P2729, DOI 10.1128/IAI.00094-07; Zhang SM, 2011, CLIN VACCINE IMMUNOL, V18, P825, DOI 10.1128/CVI.00533-10; Zou NX, 2008, HYBRIDOMA, V27, P231, DOI 10.1089/hyb.2008.0012	43	33	33	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2012	7	4							e35386	10.1371/journal.pone.0035386	http://dx.doi.org/10.1371/journal.pone.0035386			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WC	22530013	gold, Green Published, Green Submitted			2022-12-25	WOS:000305347400046
J	Chou, AH; Liu, CC; Chang, CP; Guo, MS; Hsieh, SY; Yang, WH; Chao, HJ; Wu, CL; Huang, JL; Lee, MS; Hu, AYC; Lin, SC; Huang, YY; Hu, MH; Chow, YH; Chiang, JR; Chang, JY; Chong, PL				Chou, Ai-Hsiang; Liu, Chia-Chyi; Chang, Cheng-Peng; Guo, Meng-Shin; Hsieh, Shih-Yang; Yang, Wen-Hsueh; Chao, Hsin-Ju; Wu, Chien-Long; Huang, Ju-Lan; Lee, Min-Shi; Hu, Alan Yung-Chi; Lin, Sue-Chen; Huang, Yu-Yun; Hu, Mei-Hua; Chow, Yen-Hung; Chiang, Jen-Ron; Chang, Jui-Yuan; Chong, Pele			Pilot Scale Production of Highly Efficacious and Stable Enterovirus 71 Vaccine Candidates	PLOS ONE			English	Article							INACTIVATED VACCINE; CELL-CULTURE; INFECTION; MICE; IDENTIFICATION; IMMUNIZATION; EVOLUTION; RECEPTOR; TAIWAN; LETHAL	Background: Enterovirus 71 (EV71) has caused several epidemics of hand, foot and mouth diseases (HFMD) in Asia and now is being recognized as an important neurotropic virus. Effective medications and prophylactic vaccine against EV71 infection are urgently needed. Based on the success of inactivated poliovirus vaccine, a prototype chemically inactivated EV71 vaccine candidate has been developed and currently in human phase 1 clinical trial. Principal Finding: In this report, we present the development of a serum-free cell-based EV71 vaccine. The optimization at each step of the manufacturing process was investigated, characterized and quantified. In the up-stream process development, different commercially available cell culture media either containing serum or serum-free was screened for cell growth and virus yield using the roller-bottle technology. VP-SFM serum-free medium was selected based on the Vero cell growth profile and EV71 virus production. After the up-stream processes (virus harvest, diafiltration and concentration), a combination of gel-filtration liquid chromatography and/or sucrose-gradient ultracentrifugation down-stream purification processes were investigated at a pilot scale of 40 liters each. Although the combination of chromatography and sucrose-gradient ultracentrifugation produced extremely pure EV71 infectious virus particles, the overall yield of vaccine was 7-10% as determined by a VP2-based quantitative ELISA. Using chromatography as the downstream purification, the virus yield was 30-43%. To retain the integrity of virus neutralization epitopes and the stability of the vaccine product, the best virus inactivation was found to be 0.025% formalin-treatment at 37 degrees C for 3 to 6 days. Furthermore, the formalin-inactivated virion vaccine candidate was found to be stable for >18 months at 4 degrees C and a microgram of viral proteins formulated with alum adjuvant could induce strong virus-neutralizing antibody responses in mice, rats, rabbits, and non-human primates. Conclusion: These results provide valuable information supporting the current cell-based serum-free EV71 vaccine candidate going into human Phase I clinical trials.	[Chou, Ai-Hsiang; Liu, Chia-Chyi; Chang, Cheng-Peng; Guo, Meng-Shin; Hsieh, Shih-Yang; Yang, Wen-Hsueh; Chao, Hsin-Ju; Wu, Chien-Long; Huang, Ju-Lan; Lee, Min-Shi; Hu, Alan Yung-Chi; Lin, Sue-Chen; Huang, Yu-Yun; Hu, Mei-Hua; Chow, Yen-Hung; Chang, Jui-Yuan; Chong, Pele] Natl Hlth Res Inst, Natl Inst Infect Dis & Vaccinol, Vaccine R&D Ctr, Zhunan, Taiwan; [Chiang, Jen-Ron] Taiwan Ctr Dis Control, Vaccine Ctr, Taipei, Taiwan; [Chong, Pele] China Med Univ, Grad Inst Immunol, Taichung, Taiwan	National Health Research Institutes - Taiwan; China Medical University Taiwan	Chou, AH (corresponding author), Natl Hlth Res Inst, Natl Inst Infect Dis & Vaccinol, Vaccine R&D Ctr, Zhunan, Taiwan.	pelechong@nhri.org.tw	Hu, Alan Yung-Chih/G-3708-2011; Liu, Chia-Chyi/A-8215-2012; Chong, Pele/E-3855-2010; Lee, Min-Shi/E-3992-2010; Chow, Yen-Hung/E-3863-2010	Liu, Chia-Chyi/0000-0002-6257-0389; 	National Science Council(NSC) of Taiwan [98A1-VCSP01-014]	National Science Council(NSC) of Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by a grant (No. 98A1-VCSP01-014) from the National Science Council(NSC) of Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bek EJ, 2011, VACCINE, V29, P4829, DOI 10.1016/j.vaccine.2011.04.070; Bible JM, 2008, J CLIN MICROBIOL, V46, P3192, DOI 10.1128/JCM.00628-08; Brown BA, 1995, VIRUS RES, V39, P195, DOI 10.1016/0168-1702(95)00087-9; Chan YF, 2010, INFECT GENET EVOL, V10, P404, DOI 10.1016/j.meegid.2009.05.010; Chang HW, 2011, J VIROL METHODS, V173, P189, DOI 10.1016/j.jviromet.2011.02.003; Chang JY, 2012, VACCINE, V30, P703, DOI 10.1016/j.vaccine.2011.11.087; Chung YC, 2008, VACCINE, V26, P1855, DOI 10.1016/j.vaccine.2008.01.058; Dong CH, 2011, VACCINE, V29, P6269, DOI 10.1016/j.vaccine.2011.06.044; Ho MT, 1999, NEW ENGL J MED, V341, P929, DOI 10.1056/NEJM199909233411301; Huang ML, 2011, J FORMOS MED ASSOC, V110, P425, DOI 10.1016/S0929-6646(11)60063-6; Huang SW, 2009, J CLIN MICROBIOL, V47, P3653, DOI 10.1128/JCM.00630-09; Lee MS, 2010, EXPERT REV VACCINES, V9, P149, DOI [10.1586/erv.09.152, 10.1586/ERV.09.152]; Liu CC, 2007, VACCINE, V25, P19, DOI 10.1016/j.vaccine.2006.06.083; Liu CC, 2011, J VIROL METHODS, V176, P60, DOI 10.1016/j.jviromet.2011.06.001; Liu CC, 2011, VACCINE, V29, P4362, DOI 10.1016/j.vaccine.2011.04.010; Liu CC, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0020005, 10.1371/journal.pone.0021464]; McMinn PC, 2002, FEMS MICROBIOL REV, V26, P91, DOI 10.1111/j.1574-6976.2002.tb00601.x; Nishimura Y, 2009, NAT MED, V15, P794, DOI 10.1038/nm.1961; PANEZUTTI H, 1993, INFECT IMMUN, V61, P1867, DOI 10.1128/IAI.61.5.1867-1872.1993; REED L. J., 1938, AMER JOUR HYG, V27, P493; SCHMIDT NJ, 1974, J INFECT DIS, V129, P304, DOI 10.1093/infdis/129.3.304; Solomon T, 2010, LANCET INFECT DIS, V10, P778, DOI 10.1016/S1473-3099(10)70194-8; Tung Wong Siew, 2007, Genet Vaccines Ther, V5, P6, DOI 10.1186/1479-0556-5-6; Wu CN, 2001, VACCINE, V20, P895, DOI 10.1016/S0264-410X(01)00385-1; Wu SC, 2004, VACCINE, V22, P3858, DOI 10.1016/j.vaccine.2004.05.037; Xu J, 2010, VACCINE, V28, P3516, DOI 10.1016/j.vaccine.2010.03.003; Yamayoshi S, 2009, NAT MED, V15, P798, DOI 10.1038/nm.1992	27	47	55	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2012	7	4							e34834	10.1371/journal.pone.0034834	http://dx.doi.org/10.1371/journal.pone.0034834			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WC	22529942	Green Submitted, Green Published, gold			2022-12-25	WOS:000305347400020
J	Goyret, J; Kelber, A				Goyret, Joaquin; Kelber, Almut			Chromatic Signals Control Proboscis Movements during Hovering Flight in the Hummingbird Hawkmoth Macroglossum stellatarum	PLOS ONE			English	Article							ANIMAL COLOR-VISION; INNATE PREFERENCES; BOMBUS-TERRESTRIS; SENSORY CONTROL; MANDUCA-SEXTA; MOTH; DISCRIMINATION; PERCEPTION; HONEYBEES; PATTERNS	Most visual systems are more sensitive to luminance than to colour signals. Animals resolve finer spatial detail and temporal changes through achromatic signals than through chromatic ones. Probably, this explains that detection of small, distant, or moving objects is typically mediated through achromatic signals. Macroglossum stellatarum are fast flying nectarivorous hawkmoths that inspect flowers with their long proboscis while hovering. They can visually control this behaviour using floral markings known as nectar guides. Here, we investigate whether this is mediated by chromatic or achromatic cues. We evaluated proboscis placement, foraging efficiency, and inspection learning of naive moths foraging on flower models with coloured markings that offered either chromatic, achromatic or both contrasts. Hummingbird hawkmoths could use either achromatic or chromatic signals to inspect models while hovering. We identified three, apparently independent, components controlling proboscis placement: After initial contact, 1) moths directed their probing towards the yellow colour irrespectively of luminance signals, suggesting a dominant role of chromatic signals; and 2) moths tended to probe mainly on the brighter areas of models that offered only achromatic signals. 3) During the establishment of the first contact, naive moths showed a tendency to direct their proboscis towards the small floral marks independent of their colour or luminance. Moths learned to find nectar faster, but their foraging efficiency depended on the flower model they foraged on. Our results imply that M. stellatarum can perceive small patterns through colour vision. We discuss how the different informational contents of chromatic and luminance signals can be significant for the control of flower inspection, and visually guided behaviours in general.	[Goyret, Joaquin; Kelber, Almut] Lund Univ, Dept Biol, Lund Vis Grp, Lund, Skane, Sweden	Lund University	Goyret, J (corresponding author), Cornell Univ, Dept Neurobiol & Behav, Ithaca, NY 14853 USA.	jg549@cornell.edu	; Kelber, Almut/H-6216-2014	Goyret, Joaquin/0000-0002-6509-4824; Kelber, Almut/0000-0003-3937-2808	Swedish Research Council; Wenner Foundation; Gren Foundation; Royal Physiographic Society in Lund	Swedish Research Council(Swedish Research CouncilEuropean Commission); Wenner Foundation; Gren Foundation; Royal Physiographic Society in Lund	The work was supported by the following funding agencies: Swedish Research Council, The Wenner-Gren Foundations, and Royal Physiographic Society in Lund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blackiston D, 2011, J EXP BIOL, V214, P509, DOI 10.1242/jeb.048728; Briscoe AD, 2001, ANNU REV ENTOMOL, V46, P471, DOI 10.1146/annurev.ento.46.1.471; Endler JA, 1996, AM NAT, V148, P421, DOI 10.1086/285934; FARINA WM, 1994, J COMP PHYSIOL A, V174, P239; FARINA WM, 1995, J COMP PHYSIOL A, V176, P551, DOI 10.1007/BF00196420; Frisch K. von, 1914, Zool Jahrb Allg Jena, V35; Giger AD, 1996, J COMP PHYSIOL A, V178, P763; GOULSON D, 1993, ECOL ENTOMOL, V18, P315, DOI 10.1111/j.1365-2311.1993.tb01107.x; Goyret J, 2006, J EXP BIOL, V209, P1585, DOI 10.1242/jeb.02169; Goyret J, 2011, BEHAV ECOL, V22, P976, DOI 10.1093/beheco/arr078; Goyret J, 2010, J EXP BIOL, V213, P3676, DOI 10.1242/jeb.045831; HELVERSEN OV, 1972, J COMP PHYSIOL, V80, P439, DOI 10.1007/BF00696438; Hori S, 2006, J COMP PHYSIOL A, V192, P691, DOI 10.1007/s00359-005-0091-4; Johnsen S, 2006, J EXP BIOL, V209, P789, DOI 10.1242/jeb.02053; Kaiser W., 1975, P359; Kelber A, 1999, J COMP PHYSIOL A, V184, P535, DOI 10.1007/s003590050353; Kelber A, 2003, BIOL REV, V78, P81, DOI 10.1017/S1464793102005985; Kelber A, 2005, P ROY SOC B-BIOL SCI, V272, P2143, DOI 10.1098/rspb.2005.3207; Kelber A, 2003, INTEGR COMP BIOL, V43, P571, DOI 10.1093/icb/43.4.571; Kelber A, 2002, P ROY SOC B-BIOL SCI, V269, P2573, DOI 10.1098/rspb.2002.2201; Kelber A, 1996, J EXP BIOL, V199, P1127; Kelber A, 1997, J EXP BIOL, V200, P827; Kelber A, 1999, J EXP BIOL, V202, P2619; Kelber A, 2010, P ROY SOC B-BIOL SCI, V277, P1617, DOI 10.1098/rspb.2009.2118; Kern R, 1998, J COMP PHYSIOL A, V182, P225, DOI 10.1007/s003590050173; Koshitaka H, 2011, J COMP PHYSIOL A, V197, P1105, DOI 10.1007/s00359-011-0671-4; LEHRER M, 1995, NATURWISSENSCHAFTEN, V82, P145, DOI 10.1007/BF01177278; LEHRER M, 1990, PROC R SOC SER B-BIO, V238, P321, DOI 10.1098/rspb.1990.0002; LEHRER M, 1985, J COMP PHYSIOL A, V157, P405, DOI 10.1007/BF00615140; Lehrer M, 1993, SENSORY SYSTEMS ARTH, P966; Lind O, 2011, J VISION, V11, DOI 10.1167/11.7.2; Lindstedt C, 2011, BEHAV ECOL, V22, P580, DOI 10.1093/beheco/arr017; LIVINGSTONE MS, 1987, J NEUROSCI, V7, P3416; Lorenz Konrad, 1981, FDN ETHOLOGY; Lunau K, 2006, NATURWISSENSCHAFTEN, V93, P325, DOI 10.1007/s00114-006-0105-2; LUNAU K, 1995, J COMP PHYSIOL A, V177, P1; LUNAU K, 1994, J COMP PHYSIOL A, V174, P575, DOI 10.1007/BF00217378; Lunau K, 2009, J COMP PHYSIOL A, V195, P1121, DOI 10.1007/s00359-009-0484-x; MAZOKHIN-PORSHNIAKOV G A, 1962, Biofizika, V7, P211; Osorio D, 2005, P ROY SOC B-BIOL SCI, V272, P1745, DOI 10.1098/rspb.2005.3156; Osorio D, 1999, EVOL ECOL, V13, P673, DOI 10.1023/A:1011059715610; Pelkwijk J. J.ter, 1937, Zeitschrift fuer Tierpsychologie Berlin, V1, P193; Pfaff M, 1991, ZOOL JB PHYSL, P315; Reisenman CE, 2006, J COMP PHYSIOL A, V192, P39, DOI 10.1007/s00359-005-0045-x; Schaerer S, 1996, VISION RES, V36, P4025, DOI 10.1016/S0042-6989(96)00149-6; Schwemer J, 1973, J COMP PHYSIOL A, V86, P99; Skorupski P, 2010, J NEUROSCI, V30, P3896, DOI 10.1523/JNEUROSCI.5700-09.2010; Sprayberry JDH, 2007, J EXP BIOL, V210, P37, DOI 10.1242/jeb.02616; Weiss MR, 2003, ANIM BEHAV, V65, P425, DOI 10.1006/anbe.2003.2084	49	17	17	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2012	7	4							e34629	10.1371/journal.pone.0034629	http://dx.doi.org/10.1371/journal.pone.0034629			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WC	22529922	Green Published, gold, Green Submitted			2022-12-25	WOS:000305347400014
J	Lelievre, J; Almela, MJ; Lozano, S; Miguel, C; Franco, V; Leroy, D; Herreros, E				Lelievre, Joel; Jesus Almela, Maria; Lozano, Sonia; Miguel, Celia; Franco, Virginia; Leroy, Didier; Herreros, Esperanza			Activity of Clinically Relevant Antimalarial Drugs on Plasmodium falciparum Mature Gametocytes in an ATP Bioluminescence "Transmission Blocking" Assay	PLOS ONE			English	Article							IN-VITRO ACTIVITY; METHYLENE-BLUE; QUANTITATIVE ASSESSMENT; HEMOGLOBIN DEGRADATION; MALARIA PARASITES; INVITRO ACTIVITY; PRIMAQUINE; ARTESUNATE; CULTURE; STAGE	Background: Current anti-malarial drugs have been selected on the basis of their activity against the symptom-causing asexual blood stage of the parasite. Which of these drugs also target gametocytes, in the sexual stage responsible for disease transmission, remains unknown. Blocking transmission is one of the main strategies in the eradication agenda and requires the identification of new molecules that are active against gametocytes. However, to date, the main limitation for measuring the effect of molecules against mature gametocytes on a large scale is the lack of a standardized and reliable method. Here we provide an efficient method to produce and purify mature gametocytes in vitro. Based on this new procedure, we developed a robust, affordable, and sensitive ATP bioluminescence-based assay. We then assessed the activity of 17 gold-standard anti-malarial drugs on Plasmodium late stage gametocytes. Methods and Findings: Difficulties in producing large amounts of gametocytes have limited progress in the development of malaria transmission blocking assays. We improved the method established by Ifediba and Vanderberg to obtain viable, mature gametocytes en masse, whatever the strain used. We designed an assay to determine the activity of antimalarial drugs based on the intracellular ATP content of purified stage IV-V gametocytes after 48 h of drug exposure in 96/384-well microplates. Measurements of drug activity on asexual stages and cytotoxicity on HepG2 cells were also obtained to estimate the specificity of the active drugs. Conclusions: The work described here represents another significant step towards determination of the activity of new molecules on mature gametocytes of any strain with an automated assay suitable for medium/high-throughput screening. Considering that the biology of the forms involved in the sexual and asexual stages is very different, a screen of our 2 million-compound library may allow us to discover novel anti-malarial drugs to target gametocyte-specific metabolic pathways.	[Lelievre, Joel; Jesus Almela, Maria; Lozano, Sonia; Miguel, Celia; Franco, Virginia; Herreros, Esperanza] GlaxoSmithKline R&D, Malaria Discovery Performance Unit, Madrid, Spain; [Leroy, Didier] Med Malaria Venture, Geneva, Switzerland	GlaxoSmithKline	Lelievre, J (corresponding author), GlaxoSmithKline R&D, Malaria Discovery Performance Unit, Tres Cantos Med Dev Campus, Madrid, Spain.	Joel.l.lelievre@gsk.com; esperanza.a.herreros@gsk.com	Herreros, Esperanza/GQH-7182-2022		GSK	GSK(GlaxoSmithKline)	The authors have read the journal's policy and have the following conflicts: JL SL MJA EH CM are employees of GlaxoSmithKline (GSK) and work was funded by GSK under a general research program. DL is employee of Medicines for Malaria Venture (MMV). This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials. Neither GSK nor MMV have influenced or biased the content of this work.	Adjalley SH, 2011, P NATL ACAD SCI USA, V108, pE1214, DOI 10.1073/pnas.1112037108; Adjuik M, 2004, LANCET, V363, P9, DOI 10.1016/S0140-6736(03)15162-8; Akoachere M, 2005, ANTIMICROB AGENTS CH, V49, P4592, DOI 10.1128/AAC.49.11.4592-4597.2005; BASCO LK, 1992, AM J TROP MED HYG, V47, P521, DOI 10.4269/ajtmh.1992.47.521; BASCO LK, 1992, BRIT J CLIN PHARMACO, V33, P517, DOI 10.1111/j.1365-2125.1992.tb04081.x; Benoit-Vical F, 2007, ANTIMICROB AGENTS CH, V51, P1463, DOI 10.1128/AAC.00967-06; Biswas S, 2001, J Postgrad Med, V47, P240; Bregani ER, 2000, PANMINERVA MED, V42, P197; Buchholz K, 2011, J INFECT DIS, V203, P1445, DOI 10.1093/infdis/jir037; Butcher GA, 1997, INT J PARASITOL, V27, P975, DOI 10.1016/S0020-7519(97)00079-9; Butcher GA, 2003, AM J TROP MED HYG, V68, P111, DOI 10.4269/ajtmh.2003.68.111; Chavalitshewinkoon-Petmitr Porntip, 2000, Parasitology International, V48, P275, DOI 10.1016/S1383-5769(99)00028-8; Chevalley S, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-49; Chotivanich K, 2006, ANTIMICROB AGENTS CH, V50, P1927, DOI 10.1128/AAC.01472-05; Coulibaly B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005318; CROUCH SPM, 1993, J IMMUNOL METHODS, V160, P81, DOI 10.1016/0022-1759(93)90011-U; Czesny B, 2009, ANTIMICROB AGENTS CH, V53, P4080, DOI 10.1128/AAC.00088-09; Delves M, 2012, PLOS MED IN PRESS; DESJARDINS RE, 1979, ANTIMICROB AGENTS CH, V16, P710, DOI 10.1128/AAC.16.6.710; EKONG RM, 1990, BIOCHEM PHARMACOL, V40, P297, DOI 10.1016/0006-2952(90)90691-D; Fivelman QL, 2007, MOL BIOCHEM PARASIT, V154, P119, DOI 10.1016/j.molbiopara.2007.04.008; GUPTA SK, 1985, J PROTOZOOL, V32, P91, DOI 10.1111/j.1550-7408.1985.tb03020.x; Hawley SR, 1998, ANTIMICROB AGENTS CH, V42, P682, DOI 10.1128/AAC.42.3.682; Hoppe HC, 2004, ANTIMICROB AGENTS CH, V48, P2370, DOI 10.1128/AAC.48.7.2370-2378.2004; Ifediba T, 1981, NATURE, V294, P364, DOI 10.1038/294364a0; Kurth F, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-79; LANNERS HN, 1991, PARASITOL RES, V77, P478, DOI 10.1007/BF00928413; Mann VH, 1996, INT J PARASITOL, V26, P117, DOI 10.1016/0020-7519(95)00073-9; Moore LR, 2006, FASEB J, V20, P747, DOI 10.1096/fj.05-5122fje; Mungthin M, 1998, ANTIMICROB AGENTS CH, V42, P2973, DOI 10.1128/AAC.42.11.2973; O'Neill PM, 2003, J MED CHEM, V46, P4933, DOI 10.1021/jm030796n; Peatey CL, 2009, J INFECT DIS, V200, P1518, DOI 10.1086/644645; Peatey CL, 2011, MOL BIOCH PARASITOL; Price RN, 1996, LANCET, V347, P1654, DOI 10.1016/S0140-6736(96)91488-9; Pukrittayakamee S, 2004, ANTIMICROB AGENTS CH, V48, P1329, DOI 10.1128/AAC.48.4.1329-1334.2004; RIECKMANN KH, 1968, B WORLD HEALTH ORGAN, V38, P625; Ringwald P, 1996, AM J TROP MED HYG, V55, P254, DOI 10.4269/ajtmh.1996.55.254; Shimizu S, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-73; Silvestrini F, 2005, MOL BIOCHEM PARASIT, V143, P100, DOI 10.1016/j.molbiopara.2005.04.015; SINDEN RE, 1979, PARASITOLOGY, V79, P277, DOI 10.1017/S003118200005335X; SMALLEY ME, 1977, PARASITOLOGY, V74, P1, DOI 10.1017/S0031182000047478; Souri E, 2002, IRAN J PHARM THERAPE, P17; SQUATRITO RC, 1995, GYNECOL ONCOL, V58, P101, DOI 10.1006/gyno.1995.1190; Talman AM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009156; Tanaka TQ, 2011, MOL BIOCHEM PARASIT, V177, P160, DOI 10.1016/j.molbiopara.2011.02.005; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; VANDERBERG JP, 1977, B WORLD HEALTH ORGAN, V55, P377; VANHUYSSEN W, 1993, TROP MED PARASITOL, V44, P329; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206	49	111	111	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2012	7	4							e35019	10.1371/journal.pone.0035019	http://dx.doi.org/10.1371/journal.pone.0035019			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UT	22514702	gold, Green Published			2022-12-25	WOS:000305341600108
J	Ma, WT; Hu, JM				Ma, Wentao; Hu, Jiming			Computer Simulation on the Cooperation of Functional Molecules during the Early Stages of Evolution	PLOS ONE			English	Article							PREBIOTIC EVOLUTION; DARWINIAN SELECTION; EUTECTIC PHASE; RNA WORLD; WATER-ICE; ORIGIN; REPLICATORS; MODELS; COEXISTENCE; RIBOZYMES	It is very likely that life began with some RNA (or RNA-like) molecules, self-replicating by base-pairing and exhibiting enzyme-like functions that favored the self-replication. Different functional molecules may have emerged by favoring their own self-replication at different aspects. Then, a direct route towards complexity/efficiency may have been through the coexistence/cooperation of these molecules. However, the likelihood of this route remains quite unclear, especially because the molecules would be competing for limited common resources. By computer simulation using a Monte-Carlo model (with "micro-resolution'' at the level of nucleotides and membrane components), we show that the coexistence/cooperation of these molecules can occur naturally, both in a naked form and in a protocell form. The results of the computer simulation also lead to quite a few deductions concerning the environment and history in the scenario. First, a naked stage (with functional molecules catalyzing template-replication and metabolism) may have occurred early in evolution but required high concentration and limited dispersal of the system (e. g., on some mineral surface); the emergence of protocells enabled a "habitat-shift'' into bulk water. Second, the protocell stage started with a substage of "pseudo-protocells'', with functional molecules catalyzing template-replication and metabolism, but still missing the function involved in the synthesis of membrane components, the emergence of which would lead to a subsequent "true-protocell'' substage. Third, the initial unstable membrane, composed of prebiotically available fatty acids, should have been superseded quite early by a more stable membrane (e. g., composed of phospholipids, like modern cells). Additionally, the membrane-takeover probably occurred at the transition of the two substages of the protocells. The scenario described in the present study should correspond to an episode in early evolution, after the emergence of single "genes'', but before the appearance of a "chromosome'' with linked genes.	[Ma, Wentao] Wuhan Univ, Coll Life Sci, Wuhan 430072, Hubei, Peoples R China; [Hu, Jiming] Wuhan Univ, Coll Chem & Mol Sci, Wuhan 430072, Hubei, Peoples R China	Wuhan University; Wuhan University	Ma, WT (corresponding author), Wuhan Univ, Coll Life Sci, Wuhan 430072, Hubei, Peoples R China.	mwt@whu.edu.cn			National Natural Science Foundation of China [31170958, 30870660, 20927003, 90913013]; National 973 Basic Research Program of China [2010CB530500, 2010CB530503]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National 973 Basic Research Program of China(National Basic Research Program of China)	The study was supported by the National Natural Science Foundation of China (No. 31170958, 30870660, 20927003, 90913013) and the National 973 Basic Research Program of China (No. 2010CB530500, 2010CB530503). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACEVEDO OL, 1986, NATURE, V321, P790, DOI 10.1038/321790a0; Bada JL, 2002, SCIENCE, V296, P1982, DOI 10.1126/science.1069487; Bartel DP, 1999, TRENDS CELL BIOL, V9, pM9, DOI 10.1016/S0962-8924(99)01669-4; Biondi E, 2007, GENE, V389, P10, DOI 10.1016/j.gene.2006.09.002; Branciamore S, 2009, J MOL EVOL, V69, P458, DOI 10.1007/s00239-009-9278-6; Budin I, 2011, P NATL ACAD SCI USA, V108, P5249, DOI 10.1073/pnas.1100498108; Chen IA, 2004, SCIENCE, V305, P1474, DOI 10.1126/science.1100757; Chen IA, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a002170; Chen X, 2007, CHEM BIODIVERS, V4, P633, DOI 10.1002/cbdv.200790055; Czaran T., 2000, GEOMETRY ECOLOGICAL, P116, DOI [10.1017/cbo9780511525537.009, DOI 10.1017/CBO9780511525537.009]; Dawkins R, 1976, SELFISH GENE; De Lucrezia D, 2007, ORIGINS LIFE EVOL B, V37, P379, DOI 10.1007/s11084-007-9098-x; EIGEN M, 1971, NATURWISSENSCHAFTEN, V58, P465, DOI 10.1007/BF00623322; Ertem G, 2004, ORIGINS LIFE EVOL B, V34, P549, DOI 10.1023/B:ORIG.0000043130.49790.a7; Ferris JP, 2002, ORIGINS LIFE EVOL B, V32, P311, DOI 10.1023/A:1020543312109; Ferris JP, 1996, NATURE, V381, P59, DOI 10.1038/381059a0; Fontanari JF, 2006, J THEOR BIOL, V239, P247, DOI 10.1016/j.jtbi.2005.08.039; Franchi M, 2005, GENE, V346, P205, DOI 10.1016/j.gene.2004.11.002; Franchi M, 2004, ORIGINS LIFE EVOL B, V34, P133, DOI 10.1023/B:ORIG.0000009834.81642.cb; GANTI T, 1975, BIOSYSTEMS, V7, P15, DOI 10.1016/0303-2647(75)90038-6; Ganti T., 1974, Biologia, Hungary, V22, P17; GILBERT W, 1986, NATURE, V319, P618, DOI 10.1038/319618a0; GUERRIERTAKADA C, 1983, CELL, V35, P849, DOI 10.1016/0092-8674(83)90117-4; Hanczyc MM, 2003, SCIENCE, V302, P618, DOI 10.1126/science.1089904; Hogeweg P, 2003, ORIGINS LIFE EVOL B, V33, P375, DOI 10.1023/A:1025754907141; Janas T, 2006, COLD SPRING HARB MON, V43, P207; Joyce GF, 2002, NATURE, V418, P214, DOI 10.1038/418214a; Kazakov SA, 2006, RNA, V12, P446, DOI 10.1261/rna.2123506; Konnyu B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020931; Konnyu B, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-267; KRUGER K, 1982, CELL, V31, P147, DOI 10.1016/0092-8674(82)90414-7; Lifson S, 2001, J THEOR BIOL, V212, P107, DOI 10.1006/jtbi.2001.2361; Ma W, 2007, RNA, V13, P2012, DOI 10.1261/rna.658507; Ma WT, 2010, ASTROBIOLOGY, V10, P437, DOI 10.1089/ast.2009.0385; Ma WT, 2010, BIOSYSTEMS, V99, P201, DOI 10.1016/j.biosystems.2009.11.003; Mansy SS, 2008, NATURE, V454, P122, DOI 10.1038/nature07018; Mansy SS, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a002188; Monnard PA, 2001, ORIGINS LIFE EVOL B, V31, P147, DOI 10.1023/A:1006769503968; Monnard PA, 2008, CHEM BIODIVERS, V5, P1521, DOI 10.1002/cbdv.200890141; Monnard PA, 2008, J INORG BIOCHEM, V102, P1104, DOI 10.1016/j.jinorgbio.2008.01.026; Munteanu A, 2007, PHILOS T R SOC B, V362, P1847, DOI 10.1098/rstb.2007.2077; Powner MW, 2009, NATURE, V459, P239, DOI 10.1038/nature08013; Rasmussen S, 2004, SCIENCE, V303, P963, DOI 10.1126/science.1093669; Ricardo A, 2004, SCIENCE, V303, P196, DOI 10.1126/science.1092464; Robertson MP, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a003608; Sacerdote MG, 2005, P NATL ACAD SCI USA, V102, P6004, DOI 10.1073/pnas.0408440102; Scheuring I, 2003, ORIGINS LIFE EVOL B, V33, P319, DOI 10.1023/A:1025742505324; Scheuring I, 2001, J THEOR BIOL, V212, P99, DOI 10.1006/jtbi.2001.2360; Schrum JP, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a002212; Silvestre DGM, 2005, EUR PHYS J B, V47, P423, DOI 10.1140/epjb/e2005-00346-5; SMITH JM, 1993, J THEOR BIOL, V164, P437, DOI 10.1006/jtbi.1993.1165; Szabo P, 2002, NATURE, V420, P340, DOI 10.1038/nature01187; Szathmary E, 2005, TOP CURR CHEM, V259, P167, DOI 10.1007/tcc001; Szathmary E, 2005, NATURE, V433, P469, DOI 10.1038/433469a; SZATHMARY E, 1987, J THEOR BIOL, V128, P463, DOI 10.1016/S0022-5193(87)80191-1; Szathmary E, 2006, PHILOS T R SOC B, V361, P1761, DOI 10.1098/rstb.2006.1912; Szostak JW, 2001, NATURE, V409, P387, DOI 10.1038/35053176; Takeuchi N, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000542; Takeuchi N, 2008, BIOL DIRECT, V3, DOI 10.1186/1745-6150-3-33; Trinks H, 2005, ORIGINS LIFE EVOL B, V35, P429, DOI 10.1007/s11084-005-5009-1; Vlassov AV, 2005, J MOL EVOL, V61, P264, DOI 10.1007/s00239-004-0362-7; Vlassov AV, 2004, NUCLEIC ACIDS RES, V32, P2966, DOI 10.1093/nar/gkh601; WALDE P, 1994, J AM CHEM SOC, V116, P7541, DOI 10.1021/ja00096a010; Yarus M, 1999, CURR OPIN CHEM BIOL, V3, P260, DOI 10.1016/S1367-5931(99)80041-6; Zintzaras E, 2002, J THEOR BIOL, V217, P167, DOI 10.1006/jtbi.2002.3026; Zintzaras E, 2010, J THEOR BIOL, V267, P605, DOI 10.1016/j.jtbi.2010.09.011	66	20	21	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2012	7	4							e35454	10.1371/journal.pone.0035454	http://dx.doi.org/10.1371/journal.pone.0035454			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UT	22514745	Green Published, Green Submitted, gold			2022-12-25	WOS:000305341600150
J	Cho, KW; Park, JH; Park, CW; Lee, D; Lee, E; Kim, DJ; Kim, KJ; Yoon, SH; Park, Y; Kim, E; Cho, S; Jang, S; Park, BC; Chi, SW; Yoo, SH; Jang, MH; Kim, HN; Kim, E; Jo, K; Park, YW				Cho, K-W; Park, J. H.; Park, C-W; Lee, D.; Lee, E.; Kim, D. J.; Kim, K. J.; Yoon, S. H.; Park, Y.; Kim, E.; Cho, S.; Jang, S.; Park, B-C; Chi, S-W; Yoo, S. H.; Jang, M. H.; Kim, H. N.; Kim, E.; Jo, K.; Park, Y. W.			Identification of a pivotal endocytosis motif in c-Met and selective modulation of HGF-dependent aggressiveness of cancer using the 16-mer endocytic peptide	ONCOGENE			English	Article						c-Met; endocytosis; dileucine motif; peptide delivery; cancer	GLUCOSE-TRANSPORTER GLUT4; DILEUCINE MOTIF; RECEPTOR; CLATHRIN; PHOSPHORYLATION; TRAFFICKING; PENETRATIN; BINDING; DOMAIN; INTERNALIZATION	Since c-Met has an important role in the development of cancer, it is considered as an attractive target for cancer therapy. Although molecular mechanisms for oncogenic property of c-Met have been actively investigated, regulatory elements for c-Met endocytosis and its effect on c-Met signaling remain unclear. In this study, we identified a pivotal endocytic motif in c-Met and tested it for selective modulation of HGF-induced c-Met response. Using various chimeric constructs with the cytoplasmic tail of c-Met, we were able to demonstrate that a dileucine motif located in the C-terminus of c-Met acts to regulate its endocytosis. Synthetic peptide Ant-3S, consisting of antennapedia-derived protein transduction domain (designated as Ant) and c-Met-derived 16 amino-acids (designated as 3S, spanning amino-acids 1378 to 1393), rapidly moved into cancer cells and disrupted c-Met trafficking. Importantly, an extension of c-Met retention time on the membrane by Ant-3S peptide significantly decreased phosphorylation-dependent c-Met signal transduction. Additionally, the peptide effectively inhibited HGF-induced cell growth, scattering and migration. The underlying molecular mechanism for these observations has been investigated and revealed that the dileucine motif interacts with endocytic machinery, including adaptin beta and caveolin-1, for sustained and enhanced signal transduction. Finally, Ant-3S peptide specifically blocked internalization of interleukin-2 receptor alpha-subunit/3S chimeric protein, but not the other receptors, including Glut4, Glut8 and transferrin receptor. Such results indicate the presence of a selective endocytic assembly for c-Met. It also suggests a potential for c-Met-specific anti-cancer therapy using the identified endocytic motif in this study. Oncogene (2013) 32, 1018-1029; doi:10.1038/onc.2012.122; published online 23 April 2012	[Cho, K-W; Park, J. H.; Park, C-W; Lee, D.; Lee, E.; Kim, D. J.; Kim, K. J.; Yoon, S. H.; Park, Y.; Kim, E.; Cho, S.; Jang, S.; Park, B-C; Park, Y. W.] Korea Res Inst Biosci & Biotechnol, Aging Res Ctr, Taejon, South Korea; [Park, J. H.; Kim, E.] Chungnam Natl Univ, Coll Biol Sci & Biotechnol, Taejon, South Korea; [Chi, S-W] Korea Res Inst Biosci & Biotechnol, Med Prote Res Ctr, Taejon, South Korea; [Yoo, S. H.; Jang, M. H.; Kim, H. N.] A&R Therapeut, Taejon, South Korea; [Jo, K.] Natl Canc Ctr, Natl OncoVenture, Goyang 410769, Gyeonggi Do, South Korea	Korea Research Institute of Bioscience & Biotechnology (KRIBB); Chungnam National University; Korea Research Institute of Bioscience & Biotechnology (KRIBB); National Cancer Center - Korea (NCC)	Jo, K (corresponding author), Natl Canc Ctr, Natl OncoVenture, 323 Ilsan Ro, Goyang 410769, Gyeonggi Do, South Korea.	kiwonjo@ncc.re.kr; ywpark@kribb.re.kr		Kim, Eunhee/0000-0002-7738-1222	Ministry of Knowledge Economy (Regional R&D Cluster Project) of Korea [B0009735]	Ministry of Knowledge Economy (Regional R&D Cluster Project) of Korea(Ministry of Trade, Industry & Energy (MOTIE), Republic of Korea)	We thank the members of the Kiwon and Young Woo laboratory for their inputs and discussions. We thank Julie Kim and Oh Gordon Chong for editing. This work was supported by the Ministry of Knowledge Economy (Regional R&D Cluster Project B0009735) of Korea.	Abella JV, 2005, MOL CELL BIOL, V25, P9632, DOI 10.1128/MCB.25.21.9632-9645.2005; Al-Hasani H, 1999, FEBS LETT, V460, P338, DOI 10.1016/S0014-5793(99)01369-1; Ball LJ, 2000, EMBO J, V19, P4903, DOI 10.1093/emboj/19.18.4903; Branco MC, 2011, CURR OPIN CHEM BIOL, V15, P427, DOI 10.1016/j.cbpa.2011.03.021; Byland R, 2007, MOL BIOL CELL, V18, P414, DOI 10.1091/mbc.E06-06-0535; Cantiani L, 2007, CANCER RES, V67, P7675, DOI 10.1158/0008-5472.CAN-06-4697; Clark SG, 1997, P NATL ACAD SCI USA, V94, P10438, DOI 10.1073/pnas.94.19.10438; Craig HM, 2000, VIROLOGY, V271, P9, DOI 10.1006/viro.2000.0277; Craven SE, 2000, J BIOL CHEM, V275, P20045, DOI 10.1074/jbc.M910153199; Czajlik A, 2002, J PEPT SCI, V8, P151, DOI 10.1002/psc.380; DEROSSI D, 1994, J BIOL CHEM, V269, P10444; Derossi D, 1996, J BIOL CHEM, V271, P18188, DOI 10.1074/jbc.271.30.18188; Diviani D, 2003, J BIOL CHEM, V278, P19331, DOI 10.1074/jbc.M302110200; Doray B, 2007, MOL BIOL CELL, V18, P1887, DOI 10.1091/mbc.E07-01-0012; FERRACINI R, 1991, J BIOL CHEM, V266, P19558; Flessner LB, 2009, TRAFFIC, V10, P324, DOI 10.1111/j.1600-0854.2008.00866.x; Garippa RJ, 1996, J BIOL CHEM, V271, P20660, DOI 10.1074/jbc.271.34.20660; Garnier J, 1996, METHOD ENZYMOL, V266, P540; Gomes DA, 2008, J BIOL CHEM, V283, P4344, DOI 10.1074/jbc.M706550200; GREEN M, 1988, CELL, V55, P1179, DOI 10.1016/0092-8674(88)90262-0; Grepin R, 2010, J ONCOL, V2010, DOI 10.1155/2010/835680; Joffre C, 2011, NAT CELL BIOL, V13, P827, DOI 10.1038/ncb2257; JOLIOT A, 1991, P NATL ACAD SCI USA, V88, P1864, DOI 10.1073/pnas.88.5.1864; Kamei T, 1999, ONCOGENE, V18, P6776, DOI 10.1038/sj.onc.1203114; Kelly BT, 2008, NATURE, V456, P976, DOI 10.1038/nature07422; Kermorgant S, 2004, EMBO J, V23, P3721, DOI 10.1038/sj.emboj.7600396; Kermorgant S, 2003, J BIOL CHEM, V278, P28921, DOI 10.1074/jbc.M302116200; Kermorgant S, 2008, J CELL BIOL, V182, P855, DOI 10.1083/jcb.200806076; Kirisits A, 2007, INT J BIOCHEM CELL B, V39, P2173, DOI 10.1016/j.biocel.2007.07.012; Le Roy C, 2005, NAT REV MOL CELL BIO, V6, P112, DOI 10.1038/nrm1571; Li N, 2007, J BIOL CHEM, V282, P16764, DOI 10.1074/jbc.M610835200; Lindberg M, 2003, EUR J BIOCHEM, V270, P3055, DOI 10.1046/j.1432-1033.2003.03685.x; Lindgren M, 2000, BIOCONJUGATE CHEM, V11, P619, DOI 10.1021/bc990156s; Lindsay MA, 2002, CURR OPIN PHARMACOL, V2, P587, DOI 10.1016/S1471-4892(02)00199-6; Lisinski I, 2001, BIOCHEM J, V358, P517, DOI 10.1042/0264-6021:3580517; Liu GS, 1999, J MOL CELL CARDIOL, V31, P1937, DOI 10.1006/jmcc.1999.1026; Liu ZX, 2002, J BIOL CHEM, V277, P10452, DOI 10.1074/jbc.M107551200; Mettlen M, 2009, MOL BIOL CELL, V20, P3251, DOI 10.1091/mbc.E09-03-0256; Peschard P, 2001, MOL CELL, V8, P995, DOI 10.1016/S1097-2765(01)00378-1; Petrelli A, 2002, NATURE, V416, P187, DOI 10.1038/416187a; Polo S, 2006, CELL, V124, P897, DOI 10.1016/j.cell.2006.02.025; Rosca EV, 2011, CURR PHARM BIOTECHNO, V12, P1101; ROTHENBERGER S, 1987, CELL, V49, P423, DOI 10.1016/0092-8674(87)90295-9; Schmidt U, 2006, J CELL SCI, V119, P2321, DOI 10.1242/jcs.02943; Schroeder B, 2010, EMBO J, V29, P3039, DOI 10.1038/emboj.2010.190; Shewan AM, 2000, BIOCHEM J, V350, P99, DOI 10.1042/0264-6021:3500099; Shojaei F, 2010, CANCER RES, V70, P10090, DOI 10.1158/0008-5472.CAN-10-0489; Singleton PA, 2007, J BIOL CHEM, V282, P30643, DOI 10.1074/jbc.M702573200; Sorkin A, 2009, NAT REV MOL CELL BIO, V10, P609, DOI 10.1038/nrm2748; Stein A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002524; Tong JF, 2009, MOL CELL PROTEOMICS, V8, P2131, DOI 10.1074/mcp.M900148-MCP200; Wang W, 2003, J BIOL CHEM, V278, P36848, DOI 10.1074/jbc.M301540200	52	10	10	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 21	2013	32	8					1018	1029		10.1038/onc.2012.122	http://dx.doi.org/10.1038/onc.2012.122			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	111LQ	22525273				2022-12-25	WOS:000316523200009
J	Lu, DM; Sun, HQ; Wang, HZ; Barylko, B; Fukata, Y; Fukata, M; Albanesi, JP; Yin, HL				Lu, Dongmei; Sun, Hui-qiao; Wang, Hanzhi; Barylko, Barbara; Fukata, Yuko; Fukata, Masaki; Albanesi, Joseph P.; Yin, Helen L.			Phosphatidylinositol 4-Kinase II alpha Is Palmitoylated by Golgi-localized Palmitoyltransferases in Cholesterol-dependent Manner	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN PALMITOYLATION; FAMILY; MEMBRANE; TRANSFERASES; ENZYMES; PSD-95; CELLS; YEAST; IDENTIFICATION; COMPARTMENTS	Phosphatidylinositol 4-kinase II alpha (PI4KII alpha) is predominantly Golgi-localized, and it generates >50% of the phosphatidylinositol 4-phosphate in the Golgi. The lipid kinase activity, Golgi localization, and "integral" membrane binding of PI4KII alpha and its association with low buoyant density "raft" domains are critically dependent on palmitoylation of its cysteine-rich (CCPCC177)-C-173 motif and are also highly cholesterol-dependent. Here, we identified the palmitoyl acyltransferases (Asp-His-His-Cys (DHHC) PATs) that palmitoylate PI4KII alpha and show for the first time that palmitoylation is cholesterol-dependent. DHHC3 and DHHC7 PATs, which robustly palmitoylated PI4KII alpha and were colocalized with PI4KII alpha in the trans-Golgi network (TGN), were characterized in detail. Overexpression of DHHC3 or DHHC7 increased PI4KII alpha palmitoylation by >3-fold, whereas overexpression of the dominant-negative PATs or PAT silencing by RNA interference decreased PI4KII alpha palmitoylation, "integral" membrane association, and Golgi localization. Wild-type and dominant-negative DHHC3 and DHHC7 co-immunoprecipitated with PI4KII alpha, whereas non-candidate DHHC18 and DHHC23 did not. The PI4KII alpha (CCPCC177)-C-173 palmitoylation motif is required for interaction because the palmitoylation-defective SSPSS mutant did not co-immunoprecipitate with DHHC3. Cholesterol depletion and repletion with methyl-beta-cyclodextrin reversibly altered PI4KII alpha association with these DHHCs as well as PI4KII alpha localization at the TGN and "integral" membrane association. Significantly, the Golgi phosphatidylinositol 4-phosphate level was altered in parallel with changes in PI4KII alpha behavior. Our study uncovered a novel mechanism for the preferential recruitment and activation of PI4KII alpha to the TGN by interaction with Golgi- and raft-localized DHHCs in a cholesterol-dependent manner.	[Lu, Dongmei; Sun, Hui-qiao; Wang, Hanzhi; Yin, Helen L.] Univ Texas SW Med Ctr Dallas, Dept Physiol, Dallas, TX 75390 USA; [Barylko, Barbara; Albanesi, Joseph P.] Univ Texas SW Med Ctr Dallas, Dept Pharmacol, Dallas, TX 75390 USA; [Fukata, Yuko; Fukata, Masaki] Natl Inst Physiol Sci, Dept Cell Physiol, Div Membrane Physiol, Okazaki, Aichi 4448787, Japan	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS)	Yin, HL (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Physiol, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	helen.yin@utsouthwestern.edu	Fukata, Masaki/AAZ-2476-2021	Fukata, Masaki/0000-0001-5200-9806; Fukata, Yuko/0000-0001-7724-8643	National Institutes of Health [R01 GM66110, P50 GM21681, GM75401]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM066110, R01GM075401, P50GM021681] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 GM66110 and P50 GM21681 (to H. L. Y.) and GM75401 (to J. P. A.).	Balla A, 2002, J BIOL CHEM, V277, P20041, DOI 10.1074/jbc.M111807200; Balla A, 2006, TRENDS CELL BIOL, V16, P351, DOI 10.1016/j.tcb.2006.05.003; Balla A, 2008, MOL BIOL CELL, V19, P711, DOI 10.1091/mbc.E07-07-0713; Barylko B, 2001, J BIOL CHEM, V276, P7705, DOI 10.1074/jbc.C000861200; Barylko B, 2009, J BIOL CHEM, V284, P9994, DOI 10.1074/jbc.M900724200; Claas C, 2001, J BIOL CHEM, V276, P7974, DOI 10.1074/jbc.M008650200; El-Husseini AE, 2002, CELL, V108, P849, DOI 10.1016/S0092-8674(02)00683-9; Fernandez-Hernando C, 2006, J CELL BIOL, V174, P369, DOI 10.1083/jcb.200601051; Fukata M, 2004, NEURON, V44, P987, DOI 10.1016/j.neuron.2004.12.005; Fukata Y, 2006, METHODS, V40, P177, DOI 10.1016/j.ymeth.2006.05.015; Fukata Y, 2010, NAT REV NEUROSCI, V11, P161, DOI 10.1038/nrn2788; Graham TR, 2011, TRENDS CELL BIOL, V21, P113, DOI 10.1016/j.tcb.2010.10.002; Greaves J, 2008, J BIOL CHEM, V283, P25014, DOI 10.1074/jbc.M802140200; Greaves J, 2007, J CELL BIOL, V176, P249, DOI 10.1083/jcb.200610151; Greaves J, 2011, MOL BIOL CELL, V22, P1887, DOI 10.1091/mbc.E10-11-0924; Greaves J, 2011, J CELL SCI, V124, P1351, DOI 10.1242/jcs.079095; Greaves J, 2011, TRENDS BIOCHEM SCI, V36, P245, DOI 10.1016/j.tibs.2011.01.003; Greaves J, 2010, J BIOL CHEM, V285, P24629, DOI 10.1074/jbc.M110.119289; Hammond GRV, 2009, BIOCHEM J, V422, P23, DOI 10.1042/BJ20090428; Huang K, 2009, FASEB J, V23, P2605, DOI 10.1096/fj.08-127399; Jia LX, 2011, J BIOL CHEM, V286, P13695, DOI 10.1074/jbc.M110.193763; Levy AD, 2011, MOL BIOL CELL, V22, P1930, DOI 10.1091/mbc.E10-10-0824; Linder ME, 2007, NAT REV MOL CELL BIO, V8, P74, DOI 10.1038/nrm2084; Martin BR, 2012, NAT METHODS, V9, P84, DOI [10.1038/NMETH.1769, 10.1038/nmeth.1769]; Minogue S, 2006, J CELL SCI, V119, P571, DOI 10.1242/jcs.02752; Minogue S, 2010, J LIPID RES, V51, P2314, DOI 10.1194/jlr.M005751; Mitchell DA, 2006, J LIPID RES, V47, P1118, DOI 10.1194/jlr.R600007-JLR200; Nadolski MJ, 2007, FEBS J, V274, P5202, DOI 10.1111/j.1742-4658.2007.06056.x; Noritake J, 2009, J CELL BIOL, V186, P147, DOI 10.1083/jcb.200903101; Ohno Y, 2006, BBA-MOL CELL BIOL L, V1761, P474, DOI 10.1016/j.bbalip.2006.03.010; Parat MO, 2001, J BIOL CHEM, V276, P15776, DOI 10.1074/jbc.M006722200; Pizarro-Cerda J, 2007, CELL MICROBIOL, V9, P2381, DOI 10.1111/j.1462-5822.2007.00967.x; Salazar G, 2005, MOL BIOL CELL, V16, P3692, DOI 10.1091/mbc.E05-01-0020; Santiago-Tirado FH, 2011, DEV CELL, V20, P47, DOI 10.1016/j.devcel.2010.11.006; Tsutsumi R, 2009, MOL CELL BIOL, V29, P435, DOI 10.1128/MCB.01144-08; Wang J, 2007, MOL BIOL CELL, V18, P2646, DOI 10.1091/mbc.E06-10-0897; Wang YJ, 2003, CELL, V114, P299, DOI 10.1016/S0092-8674(03)00603-2; Waugh MG, 2011, J LIPID RES, V52, P582, DOI 10.1194/jlr.D012807; Waugh MG, 2006, J BIOL CHEM, V281, P3757, DOI 10.1074/jbc.M506527200; Wei YJ, 2002, J BIOL CHEM, V277, P46586, DOI 10.1074/jbc.M206860200; Weixel KM, 2005, J BIOL CHEM, V280, P10501, DOI 10.1074/jbc.M414304200; Yanai A, 2006, NAT NEUROSCI, V9, P824, DOI 10.1038/nn1702	42	60	63	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 22	2012	287	26					21856	21865		10.1074/jbc.M112.348094	http://dx.doi.org/10.1074/jbc.M112.348094			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974GH	22535966	Green Published, hybrid			2022-12-25	WOS:000306418600027
J	Gorski, PA; Trieber, CA; Lariviere, E; Schuermans, M; Wuytack, F; Young, HS; Vangheluwe, P				Gorski, Przemek A.; Trieber, Catharine A.; Lariviere, Els; Schuermans, Marleen; Wuytack, Frank; Young, Howard S.; Vangheluwe, Peter			Transmembrane Helix 11 Is a Genuine Regulator of the Endoplasmic Reticulum Ca2+ Pump and Acts as a Functional Parallel of beta-Subunit on alpha-Na+, K+-ATPase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STRUCTURAL BASIS; CRYSTAL-STRUCTURE; PHOSPHOLAMBAN; ISOFORMS; SERCA2A	The housekeeping sarco(endo) plasmic reticulum Ca2+ ATPase SERCA2b transports Ca2+ across the endoplasmic reticulum membrane maintaining a vital Ca2+ gradient. Compared with the muscle-specific isoforms SERCA2a and SERCA1a, SERCA2b houses an 11th transmembrane segment (TM11) and a short luminal extension (LE) at its C terminus (2b-tail). The 2b-tail imposes a 2-fold higher apparent Ca2+ affinity and lower V-max. Previously, we assumed that LE is the sole functional region of the 2b-tail and that TM11 is a passive element providing an additional membrane passage. However, here we show that peptides corresponding to the TM11 region specifically modulate the activity of the homologous SERCA1a in co-reconstituted proteoliposomes and mimic the 2b-tail effect (i.e. lower V-max and higher Ca2+ affinity). Using truncated 2b-tail variants we document that TM11 regulates SERCA1a independently from LE, confirming that TM11 is a second, previously unrecognized functional region of the 2b-tail. A phylogenetic analysis further indicates that TM11 is the oldest and most conserved feature of the 2b-tail, found in the SERCA pump of all Bilateria, whereas LE is only present in Nematoda and vertebrates. Considering remarkable similarities with the Na+, K+-ATPase alpha-beta interaction, we now propose a model for interaction of TM11 with TM7 and TM10 in the anchoring sub-domain of the Ca2+ pump. This model involves a TM11-induced helix bending of TM7. In conclusion, more than just a passive structural feature, TM11 acts as a genuine regulator of Ca2+ transport through interaction with the pump.	[Gorski, Przemek A.; Trieber, Catharine A.; Young, Howard S.] Univ Alberta, Dept Biochem, Edmonton, AB T6G 2H7, Canada; [Trieber, Catharine A.; Young, Howard S.] Univ Alberta, Natl Inst Nanotechnol, Edmonton, AB T6G 2H7, Canada; [Lariviere, Els; Schuermans, Marleen; Wuytack, Frank; Vangheluwe, Peter] Katholieke Univ KU Leuven, Dept Mol Cell Biol, B-3000 Louvain, Belgium	University of Alberta; National Research Council Canada; University of Alberta; KU Leuven	Young, HS (corresponding author), Univ Alberta, Dept Biochem, Med Sci Bldg,Rm 327, Edmonton, AB T6G 2H7, Canada.	hyoung@ualberta.ca; peter.vangheluwe@med.kuleuven.be	Vangheluwe, Peter/P-5476-2017	Vangheluwe, Peter/0000-0002-7822-2944; Young, Howard/0000-0002-5990-8422; Trieber, Catharine/0000-0002-1336-1126	Flanders Research Foundation (FWO-Vlaanderen) [G.0646.08]; Interuniversity Attraction Poles Program P6/28 of the Belgian State; Federal Office for Scientific Technical and Cultural Affairs; Canadian Institutes of Health Research [MOP53306]; Alberta Innovates-Technology Futures	Flanders Research Foundation (FWO-Vlaanderen)(FWO); Interuniversity Attraction Poles Program P6/28 of the Belgian State; Federal Office for Scientific Technical and Cultural Affairs; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Alberta Innovates-Technology Futures	This work was supported by the Research Program of the Flanders Research Foundation (FWO-Vlaanderen) G.0646.08 and by the Interuniversity Attraction Poles Program P6/28 of the Belgian State, Federal Office for Scientific Technical and Cultural Affairs. This work was also supported by Grant MOP53306 from the Canadian Institutes of Health Research (to H. S. Y.).; Recipient of a Canada graduate scholarship doctoral award from the Canadian Institutes of Health Research and the Alberta Innovates-Technology Futures.	Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Dally S, 2010, J MOL CELL CARDIOL, V48, P633, DOI 10.1016/j.yjmcc.2009.11.012; Dode L, 2003, J BIOL CHEM, V278, P47877, DOI 10.1074/jbc.M306784200; ESCALANTE R, 1993, J BIOL CHEM, V268, P14090; Hasler U, 2001, J BIOL CHEM, V276, P16356, DOI 10.1074/jbc.M008778200; LYTTON J, 1992, J BIOL CHEM, V267, P14483; MacLennan DH, 2003, NAT REV MOL CELL BIO, V4, P566, DOI 10.1038/nrm1151; Menguy T, 1998, J BIOL CHEM, V273, P20134, DOI 10.1074/jbc.273.32.20134; Moncoq K, 2007, J BIOL CHEM, V282, P9748, DOI 10.1074/jbc.M611653200; Morth JP, 2007, NATURE, V450, P1043, DOI 10.1038/nature06419; Olesen C, 2007, NATURE, V450, P1036, DOI 10.1038/nature06418; Poulsen H, 2010, NATURE, V467, P99, DOI 10.1038/nature09309; Schagger H, 2006, NAT PROTOC, V1, P16, DOI 10.1038/nprot.2006.4; Shinoda T, 2009, NATURE, V459, P446, DOI 10.1038/nature07939; Toyoshima C, 2004, ANNU REV BIOCHEM, V73, P269, DOI 10.1146/annurev.biochem.73.011303.073700; Toyoshima C, 2003, P NATL ACAD SCI USA, V100, P467, DOI 10.1073/pnas.0237326100; Toyoshima C, 2009, BBA-MOL CELL RES, V1793, P941, DOI 10.1016/j.bbamcr.2008.10.008; Trieber CA, 2005, BIOCHEMISTRY-US, V44, P3289, DOI 10.1021/bi047878d; Trieber CA, 2009, BIOCHEMISTRY-US, V48, P9287, DOI 10.1021/bi900852m; Vandecaetsbeek I, 2011, BBA-MOL CELL RES, V1813, P1118, DOI 10.1016/j.bbamcr.2010.12.020; Vandecaetsbeek I, 2009, BIOFACTORS, V35, P484, DOI 10.1002/biof.63; Vandecaetsbeek I, 2009, P NATL ACAD SCI USA, V106, P18533, DOI 10.1073/pnas.0906797106; Vangheluwe P, 2009, CHEM REV, V109, P4733, DOI 10.1021/cr900013m; VERBOOMEN H, 1992, BIOCHEM J, V286, P591, DOI 10.1042/bj2860591; VERBOOMEN H, 1994, BIOCHEM J, V303, P979, DOI 10.1042/bj3030979; Zhang ZS, 2001, J BIOL CHEM, V276, P15232, DOI 10.1074/jbc.M010813200; Zwaal RR, 2001, J BIOL CHEM, V276, P43557, DOI 10.1074/jbc.M104693200	27	13	13	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 8	2012	287	24					19876	19885		10.1074/jbc.M111.335620	http://dx.doi.org/10.1074/jbc.M111.335620			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974FB	22528494	Green Published, hybrid			2022-12-25	WOS:000306414500010
J	Truschel, ST; Zhang, M; Bachert, C; Macbeth, MR; Linstedt, AD				Truschel, Steven T.; Zhang, Ming; Bachert, Collin; Macbeth, Mark R.; Linstedt, Adam D.			Allosteric Regulation of GRASP Protein-dependent Golgi Membrane Tethering by Mitotic Phosphorylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOMAIN; BINDING; COMPLEX	Mitotic phosphorylation of the conserved GRASP domain of GRASP65 disrupts its self-association, leading to a loss of Golgi membrane tethering, cisternal unlinking, and Golgi breakdown. Recently, the structural basis of the GRASP self-interaction was determined, yet the mechanism by which phosphorylation disrupts this activity is unknown. Here, we present the crystal structure of a GRASP phosphomimic containing an aspartic acid substitution for a serine residue (Ser-189) that in GRASP65 is phosphorylated by PLK1, causing a block in membrane tethering and Golgi ribbon formation. The structure revealed a conformational change in the GRASP internal ligand that prevented its insertion into the PDZ binding pocket, and gel filtration assays showed that this phosphomimic mutant exhibited a significant reduction in dimer formation. Interestingly, the structure also revealed an apparent propagation of conformational change from the site of phosphorylation to the shifted ligand, and alanine substitution of two residues (Glu-145 and Ser-146) at penultimate positions in this chain rescued dimer formation by the phosphomimic. These data reveal the structural basis of the phosphoinhibition of GRASP-mediated membrane tethering and provide a mechanism for its allosteric regulation.	[Truschel, Steven T.; Zhang, Ming; Bachert, Collin; Macbeth, Mark R.; Linstedt, Adam D.] Carnegie Mellon Univ, Dept Biol Sci, Pittsburgh, PA 15213 USA	Carnegie Mellon University	Linstedt, AD (corresponding author), Carnegie Mellon Univ, Dept Biol Sci, 4400 5th Ave, Pittsburgh, PA 15213 USA.	linstedt@andrew.cmu.edu		Truschel, Steven/0000-0003-3394-6006	National Institutes of Health [GM095549]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM095549] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The work was supported, in whole or in part, by National Institutes of Health Grant GM095549 (to A. D. L. and M. R. M.).	Adey NB, 2000, CANCER RES, V60, P35; Bachert C, 2010, J BIOL CHEM, V285, P16294, DOI 10.1074/jbc.M110.116129; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Chung HJ, 2004, J NEUROSCI, V24, P10248, DOI 10.1523/JNEUROSCI.0546-04.2004; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Feinstein TN, 2008, MOL BIOL CELL, V19, P2696, DOI 10.1091/mbc.E07-11-1200; Feinstein TN, 2007, MOL BIOL CELL, V18, P594, DOI 10.1091/mbc.E06-06-0530; Hung AY, 2002, J BIOL CHEM, V277, P5699, DOI 10.1074/jbc.R100065200; Jesch SA, 2001, MOL BIOL CELL, V12, P1811, DOI 10.1091/mbc.12.6.1811; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Preisinger C, 2005, EMBO J, V24, P753, DOI 10.1038/sj.emboj.7600569; Puthenveedu MA, 2006, NAT CELL BIOL, V8, P238, DOI 10.1038/ncb1366; Sengupta D, 2010, J BIOL CHEM, V285, P39994, DOI 10.1074/jbc.M110.189449; Sengupta D, 2009, J CELL BIOL, V186, P41, DOI 10.1083/jcb.200902110; Truschel ST, 2011, J BIOL CHEM, V286, P20125, DOI 10.1074/jbc.C111.245324; Voltz JW, 2007, J BIOL CHEM, V282, P33879, DOI 10.1074/jbc.M703481200; Wang YZ, 2005, J BIOL CHEM, V280, P4921, DOI 10.1074/jbc.M412407200; Wang YZ, 2003, EMBO J, V22, P3279, DOI 10.1093/emboj/cdg317	20	29	30	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 8	2012	287	24					19870	19875		10.1074/jbc.M111.326256	http://dx.doi.org/10.1074/jbc.M111.326256			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974FB	22523075	hybrid, Green Published			2022-12-25	WOS:000306414500009
J	Dawes, FE; Bulach, DM; Kuzevski, A; Bettelheim, KA; Venturini, C; Djordjevic, SP; Walker, MJ				Dawes, Fay E.; Bulach, Dieter M.; Kuzevski, Alexander; Bettelheim, Karl A.; Venturini, Carola; Djordjevic, Steven P.; Walker, Mark J.			Molecular Characterization of a 21.4 Kilobase Antibiotic Resistance Plasmid from an alpha-Hemolytic Escherichia coli O108:H- Human Clinical Isolate	PLOS ONE			English	Article							NUCLEOTIDE-SEQUENCE; GENES; INSERTION; BACTERIA; DNA; IDENTIFICATION; SALMONELLA; INTEGRONS; INCX1; PCR	This study characterizes the 21.4 kilobase plasmid pECTm80 isolated from Escherichia coli strain 80, an alpha hemolytic human clinical diarrhoeal isolate (serotype O108:H-). DNA sequence analysis of pECTm80 revealed it belonged to incompatibility group X1, and contained plasmid partition and toxin-antitoxin systems, an R6K-like triple origin (ori) replication system, genes required for replication regulation, insertion sequences IS1R, ISEc37 and a truncated transposase gene (Tn3-like Delta tnpA) of the Tn3 family, and carried a class 2 integron. The class 2 integron of pECTm80 contains an intact cassette array dfrA1-sat2, encoding resistance to trimethoprim and streptothricin, and an aadA1 gene cassette truncated by the insertion of IS1R. The complex plasmid replication system includes alpha, beta and gamma origins of replication. Pairwise BLASTn comparison of pECTm80 with plasmid pE001 reveals a conserved plasmid backbone suggestive of a common ancestral lineage. Plasmid pECTm80 is of potential clinical importance, as it carries multiple genes to ensure its stable maintenance through successive bacterial cell divisions and multiple antibiotic resistance genes.	[Dawes, Fay E.; Walker, Mark J.] Univ Wollongong, Sch Biol Sci, Wollongong, NSW 2522, Australia; [Bulach, Dieter M.] Monash Univ, Dept Microbiol, Clayton, Vic 3168, Australia; [Bulach, Dieter M.] Monash Univ, Victorian Bioinformat Consortium, Clayton, Vic, Australia; [Kuzevski, Alexander; Bettelheim, Karl A.] Univ Melbourne, Dept Microbiol & Immunol, Microbiol Diagnost Unit, Parkville, Vic 3052, Australia; [Venturini, Carola; Walker, Mark J.] Univ Queensland, Sch Chem & Mol Biosci, Brisbane, Qld, Australia; [Venturini, Carola; Walker, Mark J.] Univ Queensland, Australian Infect Dis Res Ctr, Brisbane, Qld, Australia; [Djordjevic, Steven P.] Elizabeth Macarthur Agr Inst, Microbiol & Immunol Sect, Menangle, NSW, Australia; [Djordjevic, Steven P.] Univ Technol Sydney, Ithree Inst, Sydney, NSW 2007, Australia	University of Wollongong; Monash University; Monash University; University of Melbourne; University of Queensland; University of Queensland; University of Technology Sydney	Walker, MJ (corresponding author), Univ Wollongong, Sch Biol Sci, Wollongong, NSW 2522, Australia.	mark.walker@uq.edu.au	Djordjevic, Steven/A-2024-2013; Venturini, Carola/G-6642-2018; djordjevic, steven/GNP-4000-2022; Bulach, Dieter M/D-5793-2011; Walker, Mark J./F-6940-2011	Djordjevic, Steven/0000-0001-9301-5372; Venturini, Carola/0000-0003-2370-8661; djordjevic, steven/0000-0001-9301-5372; Bulach, Dieter M/0000-0001-9823-6078; Walker, Mark/0000-0001-7423-2769	University of Wollongong, Industry and Investment New South Wales; Australian Research Council [LP0348851]; Australian Postgraduate Award	University of Wollongong, Industry and Investment New South Wales; Australian Research Council(Australian Research Council); Australian Postgraduate Award(Australian Government)	This research was supported by grants from the University of Wollongong, Industry and Investment New South Wales and the Australian Research Council (grant no. LP0348851). FED was supported by an Australian Postgraduate Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABELES AL, 1985, J MOL BIOL, V185, P261, DOI 10.1016/0022-2836(85)90402-4; ACHESON DWK, 1990, J INFECT DIS, V161, P134, DOI 10.1093/infdis/161.1.134; Besemer J, 2001, NUCLEIC ACIDS RES, V29, P2607, DOI 10.1093/nar/29.12.2607; Bettelheim KA, 2003, J MED MICROBIOL, V52, P155, DOI 10.1099/jmm.0.04903-0; BETTELHEIM KA, 1995, J APPL BACTERIOL, V79, P178, DOI 10.1111/j.1365-2672.1995.tb00932.x; Bielak E, 2011, J ANTIMICROB CHEMOTH, V66, P2465, DOI 10.1093/jac/dkr331; Chen J, 1998, LETT APPL MICROBIOL, V27, P369, DOI 10.1046/j.1472-765X.1998.00445.x; Chu CS, 2006, MICROBES INFECT, V8, P1931, DOI 10.1016/j.micinf.2005.12.026; Dawes FE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012754; Dillon B, 2005, J MICROBIOL METH, V62, P221, DOI 10.1016/j.mimet.2005.02.007; FINAN TM, 1986, J BACTERIOL, V167, P66, DOI 10.1128/jb.167.1.66-72.1986; Flashner Y, 1996, MOL MICROBIOL, V19, P985, DOI 10.1046/j.1365-2958.1996.428960.x; Hansson K, 2002, J BACTERIOL, V184, P1712, DOI 10.1128/JB.184.6.1712-1721.2002; Hayes F, 1998, J BACTERIOL, V180, P6415; Holcik M, 1997, MICROBIOL-SGM, V143, P3403, DOI 10.1099/00221287-143-11-3403; JENSEN RB, 1995, MOL MICROBIOL, V17, P205, DOI 10.1111/j.1365-2958.1995.mmi_17020205.x; JONES CS, 1993, J GEN MICROBIOL, V139, P735, DOI 10.1099/00221287-139-4-735; KONOWALCHUK J, 1977, INFECT IMMUN, V18, P775, DOI 10.1128/IAI.18.3.775-779.1977; Literak I, 2010, APPL ENVIRON MICROB, V76, P8126, DOI 10.1128/AEM.01446-10; Mahillon J, 1998, MICROBIOL MOL BIOL R, V62, P725, DOI 10.1128/MMBR.62.3.725-774.1998; Mazel D, 2000, ANTIMICROB AGENTS CH, V44, P1568, DOI 10.1128/AAC.44.6.1568-1574.2000; Norman A, 2008, PLASMID, V60, P59, DOI 10.1016/j.plasmid.2008.03.003; Normark BH, 2002, J INTERN MED, V252, P91, DOI 10.1046/j.1365-2796.2002.01026.x; Nunez B, 1997, MOL MICROBIOL, V24, P1157, DOI 10.1046/j.1365-2958.1997.4111778.x; OHTSUBO H, 1978, P NATL ACAD SCI USA, V75, P615, DOI 10.1073/pnas.75.2.615; ORSKOV F, 1978, J INFECT DIS, V137, P630, DOI 10.1093/infdis/137.5.630; Ratnakar PVAL, 1996, P NATL ACAD SCI USA, V93, P5522, DOI 10.1073/pnas.93.11.5522; Rozen S, 2000, Methods Mol Biol, V132, P365; Rutherford K, 2000, BIOINFORMATICS, V16, P944, DOI 10.1093/bioinformatics/16.10.944; Salyers AA, 1997, ANTIMICROB AGENTS CH, V41, P2321, DOI 10.1128/AAC.41.11.2321; Sambrook J, 2001, MOL CLONING LAB MANU; Sullivan MJ, 2011, BIOINFORMATICS, V27, P1009, DOI 10.1093/bioinformatics/btr039; SUNDSTROM L, 1991, J BACTERIOL, V173, P3025; TALMADGE K, 1980, GENE, V12, P235, DOI 10.1016/0378-1119(80)90105-5; THRELFALL EJ, 1986, J ANTIMICROB CHEMOTH, V18, P175, DOI 10.1093/jac/18.Supplement_C.175; Toukdarian A, 2004, PLASMID BIOL; Toussaint A, 2002, PLASMID, V47, P26, DOI 10.1006/plas.2001.1552; Venturini C, 2010, FASEB J, V24, P1160, DOI 10.1096/fj.09-144972; Wild J, 2004, ANN MICROBIOL, V54, P471; YOUNG HK, 1994, J ANTIMICROB CHEMOTH, V34, P715, DOI 10.1093/jac/34.5.715	40	0	0	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2012	7	4							e34718	10.1371/journal.pone.0034718	http://dx.doi.org/10.1371/journal.pone.0034718			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UD	22532831	Green Published, gold			2022-12-25	WOS:000305339200017
J	Li, LPH; Shiao, AS; Chen, KC; Lee, PL; Niddam, DM; Chang, SY; Hsieh, JC				Li, Lieber Po-Hung; Shiao, An-Suey; Chen, Kuang-Chao; Lee, Po-Lei; Niddam, David M.; Chang, Shyue-Yih; Hsieh, Jen-Chuen			Neuromagnetic Index of Hemispheric Asymmetry Prognosticating the Outcome of Sudden Hearing Loss	PLOS ONE			English	Article							AUDITORY CORTICAL RESPONSES; HEALTHY-SIDE DOMINANCE; UNILATERAL DEAFNESS; BRAIN-STEM; PLASTICITY; SYSTEM; CORTEX; INHIBITION; EXPERIENCE; RECOVERY	The longitudinal relationship between central plastic changes and clinical presentations of peripheral hearing impairment remains unknown. Previously, we reported a unique plastic pattern of "healthy-side dominance" in acute unilateral idiopathic sudden sensorineural hearing loss (ISSNHL). This study aimed to explore whether such hemispheric asymmetry bears any prognostic relevance to ISSNHL along the disease course. Using magnetoencephalography (MEG), interhemispheric differences in peak dipole amplitude and latency of N100m to monaural tones were evaluated in 21 controls and 21 ISSNHL patients at two stages: initial and fixed stage (1 month later). Dynamics/Prognostication of hemispheric asymmetry were assessed by the interplay between hearing level/hearing gain and ipsilateral/contralateral ratio (I/C) of N100m latency and amplitude. Healthy-side dominance of N100m amplitude was observed in ISSNHL initially. The pattern changed with disease process. There is a strong correlation between the hearing level at the fixed stage and initial I/C-amplitude on affected-ear stimulation in ISSNHL. The optimal cut-off value with the best prognostication effect for the hearing improvement at the fixed stage was an initial I/C-latency on affected-ear stimulation of 1.34 (between subgroups of complete and partial recovery) and an initial I/C-latency on healthy-ear stimulation of 0.76 (between subgroups of partial and no recovery), respectively. This study suggested that a dynamic process of central auditory plasticity can be induced by peripheral lesions. The hemispheric asymmetry at the initial stage bears an excellent prognostic potential for the treatment outcomes and hearing level at the fixed stage in ISSNHL. Our study demonstrated that such brain signature of central auditory plasticity in terms of both N100m latency and amplitude at defined time can serve as a prognostication predictor for ISSNHL. Further studies are needed to explore the long-term temporal scenario of auditory hemispheric asymmetry and to get better psychoacoustic correlates of pathological hemispheric asymmetry in ISSNHL.	[Li, Lieber Po-Hung; Niddam, David M.; Hsieh, Jen-Chuen] Taipei Vet Gen Hosp, Dept Med Res & Educ, Integrated Brain Res Lab, Taipei, Taiwan; [Li, Lieber Po-Hung; Chen, Kuang-Chao; Chang, Shyue-Yih] Cheng Hsin Gen Hosp, Dept Otolaryngol, Taipei, Taiwan; [Shiao, An-Suey] Taipei Vet Gen Hosp, Dept Otolaryngol, Taipei, Taiwan; [Li, Lieber Po-Hung; Shiao, An-Suey; Chen, Kuang-Chao; Chang, Shyue-Yih] Natl Yang Ming Univ, Fac Med, Taipei 112, Taiwan; [Niddam, David M.; Hsieh, Jen-Chuen] Natl Yang Ming Univ, Brain Res Ctr, Taipei 112, Taiwan; [Hsieh, Jen-Chuen] Natl Yang Ming Univ, Inst Brain Sci, Taipei 112, Taiwan; [Lee, Po-Lei] Natl Cent Univ, Dept Elect Engn, Tao Yuan, Taiwan	Taipei Veterans General Hospital; Cheng Hsin General Hospital; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Central University	Hsieh, JC (corresponding author), Taipei Vet Gen Hosp, Dept Med Res & Educ, Integrated Brain Res Lab, Taipei, Taiwan.	jcbrain.hsieh@gmail.com	Niddam, David/AAB-1910-2022; Li, Lieber/AAG-7397-2022; Li, Lieber/AFL-7454-2022	Niddam, David/0000-0002-4488-9310; 	National Health Research Institute [NHRI-EX95-9332SI]; National Science Council (NSC) [97-2314-B-075-025]; National Yang-Ming University [100F117CY14]; Taipei Veterans General Hospital [V98C1-150, V99C1-184, V100C-189]; Cheng Hsin General Hospital of Taiwan [9943]	National Health Research Institute(National Health Research Institutes - Taiwan); National Science Council (NSC)(Ministry of Science and Technology, Taiwan); National Yang-Ming University; Taipei Veterans General Hospital(Taipei Veterans General Hospital); Cheng Hsin General Hospital of Taiwan	This work was supported by the National Health Research Institute (NHRI-EX95-9332SI), National Science Council (NSC 97-2314-B-075-025), National Yang-Ming University (100F117CY14), Taipei Veterans General Hospital (V98C1-150, V99C1-184, V100C-189), and Cheng Hsin General Hospital (9943) of Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BYL FM, 1984, LARYNGOSCOPE, V94, P647; Dijkhuizen RM, 2003, J NEUROSCI, V23, P510, DOI 10.1523/JNEUROSCI.23-02-00510.2003; Durham D, 2000, HEARING RES, V147, P145, DOI 10.1016/S0378-5955(00)00128-3; Fetterman BL, 1996, AM J OTOL, V17, P529; Fujiki N, 1998, NEUROREPORT, V9, P3129, DOI 10.1097/00001756-199810050-00002; GSTOETTNER W, 1992, EUR ARCH OTO-RHINO-L, V249, P253, DOI 10.1007/BF00714487; Harada T, 1996, BRIT J AUDIOL, V30, P363, DOI 10.3109/03005369609078423; HARI R, 1988, EXP BRAIN RES, V71, P87; Hirano Koji, 1999, Auris Nasus Larynx, V26, P111, DOI 10.1016/S0385-8146(98)00072-8; Hoth S, 2005, EUR ARCH OTO-RHINO-L, V262, P217, DOI 10.1007/s00405-004-0797-x; Hsieh JC, 2002, ANN NEUROL, V51, P381, DOI 10.1002/ana.10149; Illing RB, 2006, HEARING RES, V216, P189, DOI 10.1016/j.heares.2005.12.014; JACOBSON GP, 1994, J CLIN NEUROPHYSIOL, V11, P343, DOI 10.1097/00004691-199405000-00005; Kanno A, 2000, NEUROSCI LETT, V293, P187, DOI 10.1016/S0304-3940(00)01525-1; Li LPH, 2006, EUR J NEUROSCI, V24, P937, DOI 10.1111/j.1460-9568.2006.04961.x; Li LPH, 2003, ANN NEUROL, V53, P810, DOI 10.1002/ana.10599; Mamak Aydin, 2005, Ear Nose Throat J, V84, P641; Morita T, 2007, NEUROSCI RES, V58, P6, DOI 10.1016/j.neures.2007.01.010; Mossop JE, 2000, HEARING RES, V147, P183, DOI 10.1016/S0378-5955(00)00054-X; MURAI K, 1994, ACTA OTO-LARYNGOL, P17; Narozny W, 2006, ANN OTO RHINOL LARYN, V115, P553, DOI 10.1177/000348940611500710; Ochi K, 2003, LARYNGOSCOPE, V113, P427, DOI 10.1097/00005537-200303000-00007; PEKKONEN E, 1995, NEUROREPORT, V6, P1803, DOI 10.1097/00001756-199509000-00023; Ponton CW, 2001, HEARING RES, V154, P32, DOI 10.1016/S0378-5955(01)00214-3; Sato K, 2000, HEARING RES, V147, P137, DOI 10.1016/S0378-5955(00)00127-1; Scheffler K, 1998, CEREB CORTEX, V8, P156, DOI 10.1093/cercor/8.2.156; Suzuki M, 2002, NEUROREPORT, V13, P1829, DOI 10.1097/00001756-200210070-00029; VASAMA JP, 1994, HEARING RES, V78, P91, DOI 10.1016/0378-5955(94)90047-7; WILSON WR, 1980, ARCH OTOLARYNGOL, V106, P772; Woldorff MG, 1999, HUM BRAIN MAPP, V7, P49, DOI 10.1002/(SICI)1097-0193(1999)7:1<49::AID-HBM5>3.3.CO;2-A	30	15	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2012	7	4							e35055	10.1371/journal.pone.0035055	http://dx.doi.org/10.1371/journal.pone.0035055			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UD	22532839	Green Published, gold			2022-12-25	WOS:000305339200035
J	Martin, LJ; Gupta, J; Jyothula, SSSK; Kovacic, MB; Myers, JMB; Patterson, TL; Ericksen, MB; He, H; Gibson, AM; Baye, TM; Amirisetty, S; Tsoras, AM; Sha, YB; Eissa, NT; Hershey, GKK				Martin, Lisa J.; Gupta, Jayanta; Jyothula, Soma S. S. K.; Kovacic, Melinda Butsch; Myers, Jocelyn M. Biagini; Patterson, Tia L.; Ericksen, Mark B.; He, Hua; Gibson, Aaron M.; Baye, Tesfaye M.; Amirisetty, Sushil; Tsoras, Anna M.; Sha, Youbao; Eissa, N. Tony; Hershey, Gurjit K. Khurana			Functional Variant in the Autophagy-Related 5 Gene Promotor is Associated with Childhood Asthma	PLOS ONE			English	Article							ALLERGIC DISEASES; NASAL; RISK; IMMUNOLOGY; EXPRESSION; LOCI; SNP	Rationale and Objective: Autophagy is a cellular process directed at eliminating or recycling cellular proteins. Recently, the autophagy pathway has been implicated in immune dysfunction, the pathogenesis of inflammatory disorders, and response to viral infection. Associations between two genes in the autophagy pathway, ATG5 and ATG7, with childhood asthma were investigated. Methods: Using genetic and experimental approaches, we examined the association of 13 HapMap-derived tagging SNPs in ATG5 and ATG7 with childhood asthma in 312 asthmatic and 246 non-allergic control children. We confirmed our findings by using independent cohorts and imputation analysis. Finally, we evaluated the functional relevance of a disease associated SNP. Measurements and Main Results: We demonstrated that ATG5 single nucleotide polymorphisms rs12201458 and rs510432 were associated with asthma (p = 0.00085 and 0.0025, respectively). In three independent cohorts, additional variants in ATG5 in the same LD block were associated with asthma (p<0.05). We found that rs510432 was functionally relevant and conferred significantly increased promotor activity. Furthermore, Atg5 expression was increased in nasal epithelium of acute asthmatics compared to stable asthmatics and non-asthmatic controls. Conclusion: Genetic variants in ATG5, including a functional promotor variant, are associated with childhood asthma. These results provide novel evidence for a role for ATG5 in childhood asthma.	[Martin, Lisa J.; Gupta, Jayanta; Kovacic, Melinda Butsch; Myers, Jocelyn M. Biagini; Patterson, Tia L.; Ericksen, Mark B.; He, Hua; Gibson, Aaron M.; Baye, Tesfaye M.; Amirisetty, Sushil; Tsoras, Anna M.; Hershey, Gurjit K. Khurana] Univ Cincinnati, Dept Pediat, Cincinnati Childrens Hosp Med Ctr, Cincinnati, OH 45221 USA; [Jyothula, Soma S. S. K.; Sha, Youbao; Eissa, N. Tony] Baylor Coll Med, Dept Med, Houston, TX 77030 USA	Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; Baylor College of Medicine	Hershey, GKK (corresponding author), Univ Cincinnati, Dept Pediat, Cincinnati Childrens Hosp Med Ctr, Cincinnati, OH 45221 USA.	Gurjit.Khurana.Hershey@cchmc.org	Martin, Lisa/E-2425-2016; Jyothula, Soma S.S.K/AAJ-2911-2020	Martin, Lisa/0000-0001-8702-9946; Jyothula, Soma S.S.K/0000-0002-8837-7878; Biagini, Jocelyn/0000-0002-4378-6133	National Institutes of Health [U19 AI070235, U19 AI07041209]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI070235] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was funded by National Institutes of Health grants U19 AI070235 (GKKH and LJM) and U19 AI07041209 (NTE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1987, AM REV RESPIR DIS, V136, P225; Baye TM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016522; Binia A, 2011, J HUM GENET, V56, P97, DOI 10.1038/jhg.2010.134; Bloom B, 2010, HYATTSVILLE VITAL HL, P1; Braunstahl GJ, 2001, J ALLERGY CLIN IMMUN, V107, P469, DOI 10.1067/mai.2001.113046; Braunstahl GJ, 2001, AM J RESP CRIT CARE, V164, P858, DOI 10.1164/ajrccm.164.5.2006082; Butsch Kovacic M, 2011, PLOS ONE IN PRESS; Chen ZH, 2010, P NATL ACAD SCI US; Chen ZH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003316; de Bakker PIW, 2005, NAT GENET, V37, P1217, DOI 10.1038/ng1669; Eder W, 2006, NEW ENGL J MED, V355, P2226, DOI 10.1056/NEJMra054308; Gaga M, 2000, CLIN EXP ALLERGY, V30, P663; Guajardo JR, 2005, J ALLERGY CLIN IMMUN, V115, P243, DOI 10.1016/j.jaci.2004.10.032; Guevin C, 2010, VIROLOGY, V405, P1, DOI 10.1016/j.virol.2010.05.032; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Hussey S, 2009, SEMIN IMMUNOL, V21, P233, DOI 10.1016/j.smim.2009.05.004; Inoue D, 2011, BIOCHEM BIOPH RES CO, V405, P13, DOI 10.1016/j.bbrc.2010.12.092; Jounai N, 2007, P NATL ACAD SCI USA, V104, P14050, DOI 10.1073/pnas.0704014104; Kay AB, 2001, NEW ENGL J MED, V344, P30, DOI 10.1056/NEJM200101043440106; Kay AB, 2001, NEW ENGL J MED, V344, P109, DOI 10.1056/NEJM200101113440206; Lee HK, 2010, IMMUNITY, V32, P227, DOI 10.1016/j.immuni.2009.12.006; Lee N, 2009, J INFECT DIS, V200, P492, DOI 10.1086/600383; Litonjua AA, 1998, AM J RESP CRIT CARE, V158, P176, DOI 10.1164/ajrccm.158.1.9710014; Miller BC, 2008, AUTOPHAGY, V4, P309, DOI 10.4161/auto.5474; Naclerio RM, 1998, J ALLERGY CLIN IMMUN, V101, pS345, DOI 10.1016/S0091-6749(98)70217-9; Nothnagel M, 2009, HUM GENET, V125, P163, DOI 10.1007/s00439-008-0606-5; Orvedahl A, 2010, CELL HOST MICROBE, V7, P115, DOI 10.1016/j.chom.2010.01.007; Poon A, 2011, CURR OPIN ALLERGY CL, V11, P407, DOI 10.1097/ACI.0b013e32834a9540; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Ryter SW, 2011, AUTOPHAGY, V7, P436, DOI 10.4161/auto.7.4.14501; TOGIAS A, 1988, J ALLERGY CLIN IMMUN, V81, P782, DOI 10.1016/0091-6749(88)90932-3; Willer CJ, 2008, NAT GENET, V40, P161, DOI 10.1038/ng.76; Willer CJ, 2010, BIOINFORMATICS, V26, P2190, DOI 10.1093/bioinformatics/btq340; Willis-Owen SAG, 2009, J ALLERGY CLIN IMMUN, V123, P14, DOI 10.1016/j.jaci.2008.09.016; Woo D, 2002, STROKE, V33, P1190, DOI 10.1161/01.STR.0000014774.88027.22; Yousefi S, 2006, NAT CELL BIOL, V8, P1124, DOI 10.1038/ncb1482; Yuan HY, 2006, NUCLEIC ACIDS RES, V34, pW635, DOI 10.1093/nar/gkl236; Zhang J, 2008, RESP RES, V9, DOI 10.1186/1465-9921-9-4	38	125	130	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2012	7	4							e33454	10.1371/journal.pone.0033454	http://dx.doi.org/10.1371/journal.pone.0033454			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UD	22536318	gold, Green Published, Green Submitted			2022-12-25	WOS:000305339200006
J	Merrins, MJ; Bertram, R; Sherman, A; Satin, LS				Merrins, Matthew J.; Bertram, Richard; Sherman, Arthur; Satin, Leslie S.			Phosphofructo-2-kinase/Fructose-2,6-bisphosphatase Modulates Oscillations of Pancreatic Islet Metabolism	PLOS ONE			English	Article							LIVER 6-PHOSPHOFRUCTO-2-KINASE FRUCTOSE-2,6-BISPHOSPHATASE; SITE-DIRECTED MUTAGENESIS; PULSATILE INSULIN-SECRETION; FRUCTOSE 2,6-BISPHOSPHATE; GLUCOSE-METABOLISM; CRYSTAL-STRUCTURE; GLYCOLYTIC OSCILLATIONS; BETA-CELLS; MUSCLE PHOSPHOFRUCTOKINASE; LIVING CELLS	Pulses of insulin from pancreatic beta-cells help maintain blood glucose in a narrow range, although the source of these pulses is unclear. It has been proposed that a positive feedback circuit exists within the glycolytic pathway, the autocatalytic activation of phosphofructokinase-1 (PFK1), which endows pancreatic beta-cells with the ability to generate oscillations in metabolism. Flux through PFK1 is controlled by the bifunctional enzyme PFK2/FBPase2 (6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase) in two ways: via (1) production/degradation of fructose-2,6-bisphosphate (Fru2,6-BP), a potent allosteric activator of PFK1, as well as (2) direct activation of glucokinase due to a protein-protein interaction. In this study, we used a combination of live-cell imaging and mathematical modeling to examine the effects of inducibly-expressed PFK2/FBPase2 mutants on glucose-induced Ca2+ pulsatility in mouse islets. Irrespective of the ability to bind glucokinase, mutants of PFK2/FBPase2 that increased the kinase: phosphatase ratio reduced the period and amplitude of Ca2+ oscillations. Mutants which reduced the kinase: phosphatase ratio had the opposite effect. These results indicate that the main effect of the bifunctional enzyme on islet pulsatility is due to Fru2,6-BP alteration of the threshold for autocatalytic activation of PFK1 by Fru1,6-BP. Using computational models based on PFK1-generated islet oscillations, we then illustrated how moderate elevation of Fru-2,6-BP can increase the frequency of glycolytic oscillations while reducing their amplitude, with sufficiently high activation resulting in termination of slow oscillations. The concordance we observed between PFK2/FBPase2-induced modulation of islet oscillations and the models of PFK1-driven oscillations furthermore suggests that metabolic oscillations, like those found in yeast and skeletal muscle, are shaped early in glycolysis.	[Merrins, Matthew J.; Satin, Leslie S.] Univ Michigan, Dept Pharmacol, Ann Arbor, MI 48109 USA; [Merrins, Matthew J.; Satin, Leslie S.] Univ Michigan, Brehm Diabet Ctr, Ann Arbor, MI 48109 USA; [Bertram, Richard] Florida State Univ, Dept Math, Tallahassee, FL 32306 USA; [Bertram, Richard] Florida State Univ, Program Neurosci, Tallahassee, FL 32306 USA; [Bertram, Richard] Florida State Univ, Program Mol Biophys, Tallahassee, FL 32306 USA; [Sherman, Arthur] NIDDKD, Lab Biol Modeling, NIH, Bethesda, MD 20892 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; State University System of Florida; Florida State University; State University System of Florida; Florida State University; State University System of Florida; Florida State University; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Merrins, MJ (corresponding author), Univ Michigan, Dept Pharmacol, Ann Arbor, MI 48109 USA.	mmerrins@umich.edu	Bertram, Richard/ABI-5859-2020	Sherman, Arthur/0000-0002-8372-5941; Merrins, Matthew J./0000-0003-1599-9227	National Institutes of Health [F32DK085960, R01DK46409]; National Science Foundation [NSF-DMS0917664]; NIH/NIDDK; Michigan Diabetes Research and Training Center (MDRTC) Morphology and Image Analysis Core [DK20572]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK020572, ZIADK013027, R01DK046409, P60DK020572, F32DK085960] Funding Source: NIH RePORTER; Division Of Mathematical Sciences [0917664] Funding Source: National Science Foundation	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NIH/NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Michigan Diabetes Research and Training Center (MDRTC) Morphology and Image Analysis Core; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Division Of Mathematical Sciences(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	This work was supported by the National Institutes of Health (F32DK085960 to MJM, R01DK46409 to LS), the National Science Foundation (NSF-DMS0917664 to RB), and the NIH/NIDDK Intramural Research Program (AS). Additional support was provided by the Michigan Diabetes Research and Training Center (MDRTC) Morphology and Image Analysis Core (DK20572). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arden C, 2008, BIOCHEM J, V411, P41, DOI 10.1042/BJ20070962; Baltrusch S, 2001, J BIOL CHEM, V276, P43915, DOI 10.1074/jbc.M105470200; Baltrusch S, 2006, ENDOCRINOLOGY, V147, P5768, DOI 10.1210/en.2006-0694; Banaszynski LA, 2006, CELL, V126, P995, DOI 10.1016/j.cell.2006.07.025; Beemiller P, 2006, PLOS BIOL, V4, P987, DOI 10.1371/journal.pbio.0040162; Bertram R, 2004, BIOPHYS J, V87, P3074, DOI 10.1529/biophysj.104.049262; Bertram R, 2007, AM J PHYSIOL-ENDOC M, V293, pE890, DOI 10.1152/ajpendo.00359.2007; Bertram R, 2007, BIOPHYS J, V92, P1544, DOI 10.1529/biophysj.106.097154; Boada J, 2000, FEBS LETT, V480, P261, DOI 10.1016/S0014-5793(00)01950-5; BRATUSCHMARRAIN PR, 1986, DIABETES, V35, P922, DOI 10.2337/diabetes.35.8.922; BURCH PT, 1985, DIABETES, V34, P1014, DOI 10.2337/diabetes.34.10.1014; ELMAGHRABI MR, 1987, J BIOL CHEM, V262, P11714; FOE LG, 1983, BIOCHEMISTRY-US, V22, P4601, DOI 10.1021/bi00288a039; Garcia-Herrero CM, 2007, DIABETOLOGIA, V50, P325, DOI 10.1007/s00125-006-0542-7; GILON P, 1993, J BIOL CHEM, V268, P22265; Gopel S, 1999, J PHYSIOL-LONDON, V521, P717, DOI 10.1111/j.1469-7793.1999.00717.x; Hasemann CA, 1996, STRUCTURE, V4, P1017, DOI 10.1016/S0969-2126(96)00109-8; Hoppe A, 2002, BIOPHYS J, V83, P3652, DOI 10.1016/S0006-3495(02)75365-4; HUE L, 1987, BIOCHEM J, V245, P313, DOI 10.1042/bj2450313; Jung SK, 2000, J BIOL CHEM, V275, P6642, DOI 10.1074/jbc.275.9.6642; KEIZER J, 1989, BIOPHYS J, V56, P229, DOI 10.1016/S0006-3495(89)82669-4; KURLAND IJ, 1992, J BIOL CHEM, V267, P4416; LANG DA, 1979, NEW ENGL J MED, V301, P1023, DOI 10.1056/NEJM197911083011903; Langer S, 2010, MOL ENDOCRINOL, V24, P1988, DOI 10.1210/me.2010-0115; Lee YH, 1997, NAT STRUCT BIOL, V4, P615, DOI 10.1038/nsb0897-615; Lee YH, 1996, BIOCHEMISTRY-US, V35, P6010, DOI 10.1021/bi9600613; Luciani DS, 2006, J PHYSIOL-LONDON, V572, P379, DOI 10.1113/jphysiol.2005.101766; MacDonald MJ, 2003, J BIOL CHEM, V278, P51894, DOI 10.1074/jbc.M309038200; MALAISSE WJ, 1982, DIABETES, V31, P90, DOI 10.2337/diabetes.31.1.90; Massa L, 2004, DIABETES, V53, P1020, DOI 10.2337/diabetes.53.4.1020; Matschinsky FM, 1996, DIABETES, V45, P223, DOI 10.2337/diabetes.45.2.223; Meier JJ, 2005, DIABETES, V54, P1649, DOI 10.2337/diabetes.54.6.1649; Menge BA, 2011, DIABETES, V60, P2160, DOI 10.2337/db11-0251; Merrins MJ, 2010, BIOPHYS J, V99, P76, DOI 10.1016/j.bpj.2010.04.012; Nilsson T, 1996, BIOCHEM J, V314, P91, DOI 10.1042/bj3140091; Nunemaker CS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008428; Nunemaker CS, 2005, DIABETES, V54, P3517, DOI 10.2337/diabetes.54.12.3517; ORAHILLY S, 1988, NEW ENGL J MED, V318, P1225, DOI 10.1056/NEJM198805123181902; Perez JX, 2000, AM J PHYSIOL-CELL PH, V279, pC1359, DOI 10.1152/ajpcell.2000.279.5.C1359; Richard P, 2003, FEMS MICROBIOL REV, V27, P547, DOI 10.1016/S0168-6445(03)00065-2; Sakurai T, 1996, BIOCHEM BIOPH RES CO, V218, P159, DOI 10.1006/bbrc.1996.0028; SENER A, 1984, BIOCHEM J, V221, P759, DOI 10.1042/bj2210759; Smith WE, 2007, MOL ENDOCRINOL, V21, P1478, DOI 10.1210/me.2006-0356; SMOLEN P, 1995, J THEOR BIOL, V174, P137, DOI 10.1006/jtbi.1995.0087; TAULER A, 1988, P NATL ACAD SCI USA, V85, P6642, DOI 10.1073/pnas.85.18.6642; TAULER A, 1990, J BIOL CHEM, V265, P15617; TORNHEIM K, 1979, J THEOR BIOL, V79, P491, DOI 10.1016/0022-5193(79)90240-6; TORNHEIM K, 1988, J BIOL CHEM, V263, P2619; Tornheim K, 1997, DIABETES, V46, P1375, DOI 10.2337/diabetes.46.9.1375; Vertommen D, 1996, J BIOL CHEM, V271, P17875, DOI 10.1074/jbc.271.30.17875; Westermark PO, 2003, BIOPHYS J, V85, P126, DOI 10.1016/S0006-3495(03)74460-9; Wu CD, 2002, AM J PHYSIOL-ENDOC M, V282, pE38, DOI 10.1152/ajpendo.2002.282.1.E38; Wu CD, 2006, AM J PHYSIOL-ENDOC M, V291, pE536, DOI 10.1152/ajpendo.00126.2006; YANEY GC, 1995, DIABETES, V44, P1285, DOI 10.2337/diabetes.44.11.1285; Yuen MH, 1999, J BIOL CHEM, V274, P2176, DOI 10.1074/jbc.274.4.2176	55	20	21	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2012	7	4							e34036	10.1371/journal.pone.0034036	http://dx.doi.org/10.1371/journal.pone.0034036			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UD	22532827	gold, Green Published, Green Submitted			2022-12-25	WOS:000305339200009
J	Benavides, VC; Mallela, MK; Booth, CJ; Wendler, CC; Rivkees, SA				Benavides, Valeria C.; Mallela, Murali K.; Booth, Carmen J.; Wendler, Christopher C.; Rivkees, Scott A.			Propylthiouracil Is Teratogenic in Murine Embryos	PLOS ONE			English	Article							PRENATAL METHIMAZOLE EXPOSURE; ANTITHYROID DRUGS; GRAVES-DISEASE; MATERNAL HYPERTHYROIDISM; PREGNANCY; MANAGEMENT; HYPOTHYROIDISM; CARBIMAZOLE; DEFECTS; THERAPY	Background: Hyperthyroidism during pregnancy is treated with the antithyroid drugs (ATD) propylthiouracil (PTU) and methimazole (MMI). PTU currently is recommended as the drug of choice during early pregnancy. Yet, despite widespread ATD use in pregnancy, formal studies of ATD teratogenic effects have not been performed. Methods: We examined the teratogenic effects of PTU and MMI during embryogenesis in mice. To span different periods of embryogenesis, dams were treated with compounds or vehicle daily from embryonic day (E) 7.5 to 9.5 or from E3.5 to E7.5. Embryos were examined for gross malformations at E10.5 or E18.5 followed by histological and micro-CT analysis. Influences of PTU on gene expression levels were examined by RNA microarray analysis. Results: When dams were treated from E7.5 to E9.5 with PTU, neural tube and cardiac abnormalities were observed at E10.5. Cranial neural tube defects were significantly more common among the PTU-exposed embryos than those exposed to MMI or vehicle. Blood in the pericardial sac, which is a feature indicative of abnormal cardiac function and/or abnormal vasculature, was observed more frequently in PTU-treated than MMI-treated or vehicle-treated embryos. Following PTU treatment, a total of 134 differentially expressed genes were identified. Disrupted genetic pathways were those associated with cytoskeleton remodeling and keratin filaments. At E 18.5, no gross malformations were evident in either ATD group, but the number of viable PTU embryos per dam at E18.5 was significantly lower from those at E10.5, indicating loss of malformed embryos. These data show that PTU exposure during embryogenesis is associated with delayed neural tube closure and cardiac abnormalities. In contrast, we did not observe structural or cardiac defects associated with MMI exposure except at the higher dose. We find that PTU exposure during embryogenesis is associated with fetal loss. These observations suggest that PTU has teratogenic potential.	[Benavides, Valeria C.; Mallela, Murali K.; Wendler, Christopher C.; Rivkees, Scott A.] Yale Univ, Sch Med, Yale Pediat Thyroid Ctr, Sect Dev Endocrinol & Biol,Dept Pediat, New Haven, CT 06520 USA; [Booth, Carmen J.] Yale Univ, Sch Med, Comparat Med Sect, New Haven, CT 06510 USA; [Mallela, Murali K.; Wendler, Christopher C.; Rivkees, Scott A.] Univ Florida, Dept Pediat, Gainesville, FL USA	Yale University; Yale University; State University System of Florida; University of Florida	Benavides, VC (corresponding author), Yale Univ, Sch Med, Yale Pediat Thyroid Ctr, Sect Dev Endocrinol & Biol,Dept Pediat, New Haven, CT 06520 USA.	srivkees@ufl.edu			National Institutes of Health [RO1HD065200]; Endocrine Fellows Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD065200] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000064] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Endocrine Fellows Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This work was supported by National Institutes of Health grant RO1HD065200 to SAR and an award from the Endocrine Fellows Foundation to VB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abalovich M, 2007, J CLIN ENDOCR METAB, V92, pS1, DOI 10.1210/jc.2007-0141; [Anonymous], 2000, GUID DEV TOX STUD; [Anonymous], NATL VITAL STAT REPO; Aramaki M, 2005, AM J MED GENET A, V139A, P156, DOI 10.1002/ajmg.a.30917; Bahn Rebecca S, 2009, Thyroid, V19, P673, DOI 10.1089/thy.2009.0169; Barbero P, 2004, AM J MED GENET A, V129A, P83, DOI 10.1002/ajmg.a.20668; Barbero P, 2008, AM J MED GENET A, V146A, P2390, DOI 10.1002/ajmg.a.32497; Blidda S, 2011, THYROID, V21, P75, DOI 10.1089/thy.2010.0286; Bliddal S, 2011, NAT REV ENDOCRINOL, V7, P396, DOI 10.1038/nrendo.2011.34; Briggs GG, 2005, PROPYLTHIOURACIL DRU, P1365; Calikoglu AS, 1996, NEUROSCI LETT, V213, P132; Chan GW, 2007, NAT CLIN PRACT ENDOC, V3, P470, DOI 10.1038/ncpendmet0508; Chattaway JM, 2007, ANN PHARMACOTHER, V41, P1018, DOI 10.1345/aph.1H535; Clark SM, 2006, THER DRUG MONIT, V28, P477, DOI 10.1097/00007691-200608000-00001; Clementi M, 2010, J CLIN ENDOCR METAB, V95, pE337, DOI 10.1210/jc.2010-0652; Cooper DS, 2005, NEW ENGL J MED, V352, P905, DOI 10.1056/NEJMra042972; Cooper DS, 2003, LANCET, V362, P459, DOI 10.1016/S0140-6736(03)14073-1; Cunningham AR, 2009, INT J PEDIATR ENDOCR, DOI 10.1155/2009/936154; De Felice Mario, 2007, V10, P1, DOI 10.1159/000106814; Di Gianantonio E, 2001, TERATOLOGY, V64, P262, DOI 10.1002/tera.1072; Diav-Citrin O, 2002, TERATOLOGY, V65, P38, DOI 10.1002/tera.1095.abs; Feldt-Rasmussen U, 2011, J THROID RES, V2011, DOI 10.4061/2011/598712; Gittenberger-De Groot AC, 2005, PEDIATR RES, V57, P169, DOI 10.1203/01.PDR.0000148710.69159.61; GOLDEY ES, 1995, TOXICOL APPL PHARM, V135, P67, DOI 10.1006/taap.1995.1209; GREENMAN GW, 1962, NEW ENGL J MED, V267, P426, DOI 10.1056/NEJM196208302670902; Griffin CT, 2001, SCIENCE, V293, P1666, DOI 10.1126/science.1061259; HERBST AL, 1965, NEW ENGL J MED, V273, P627, DOI 10.1056/NEJM196509162731203; Kaufman M.H., 1992, ATLAS MOUSE DEV; Koren G, 2006, THER DRUG MONIT, V28, P12, DOI 10.1097/01.ftd.0000192135.54477.d9; KREMENTZ ET, 1957, SURGERY, V41, P619; Laurberg P, 2009, EUR J ENDOCRINOL, V160, P1, DOI 10.1530/EJE-08-0663; Luna LG, 1968, MANUAL HISTOLOGIC ST, V3; Luton D, 2005, J CLIN ENDOCR METAB, V90, P6093, DOI 10.1210/jc.2004-2555; MANDEL SJ, 1994, THYROID, V4, P129, DOI 10.1089/thy.1994.4.129; Mandel SR, 2001, J CLIN ENDOCR METAB, V86, P2354, DOI 10.1210/jc.86.6.2354; MOMOTANI N, 1984, CLIN ENDOCRINOL, V20, P695, DOI 10.1111/j.1365-2265.1984.tb00119.x; de Escobar GM, 2008, SEMIN PERINATOL, V32, P380, DOI 10.1053/j.semperi.2008.09.002; Mortimer RH, 1997, J CLIN ENDOCR METAB, V82, P3099, DOI 10.1210/jc.82.9.3099; MUJTABA Q, 1975, OBSTET GYNECOL, V46, P282; Nucera C, 2010, J CELL MOL MED, V14, P2417, DOI 10.1111/j.1582-4934.2009.00947.x; Ohta K, 2007, CLIN NEPHROL, V68, P315; Olson EN, 2004, NAT MED, V10, P467, DOI 10.1038/nm0504-467; Patil-Sisodia K, 2010, ENDOCR PRACT, V16, P118, DOI 10.4158/EP09233.RA; Pearce SHS, 2004, CLIN ENDOCRINOL, V61, P589, DOI 10.1111/j.1365-2265.2004.02135.x; Rivkees SA, 2010, HORM RES PAEDIAT, V74, P305, DOI 10.1159/000320028; Rivkees SA, 2009, INT J PEDIATR ENDOCR, DOI 10.1155/2009/132041; SCHARDEIN JL, 1985, ENVIRON HEALTH PERSP, V61, P55, DOI 10.2307/3430062; STANISSTREET M, 1990, TERATOLOGY, V41, P721, DOI 10.1002/tera.1420410609; VANDIJKE CP, 1987, ANN INTERN MED, V106, P60, DOI 10.7326/0003-4819-106-1-60; Weetman AP, 2003, HORM RES, V59, P114, DOI 10.1159/000067837; WING DA, 1994, AM J OBSTET GYNECOL, V170, P90; ZOLCINSKI A, 1964, Ginekol Pol, V35, P593	52	17	18	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2012	7	4							e35213	10.1371/journal.pone.0035213	http://dx.doi.org/10.1371/journal.pone.0035213			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959XD	22529993	gold, Green Published, Green Submitted			2022-12-25	WOS:000305350600068
J	Li, HY; Zheng, XM; Che, MX; Hu, HY				Li, Hai-Yin; Zheng, Xue-Ming; Che, Mei-Xia; Hu, Hong-Yu			A Redox-Sensitive Luciferase Assay for Determining the Localization and Topology of Endoplasmic Reticulum Proteins	PLOS ONE			English	Article							GREEN FLUORESCENT PROTEIN; GAUSSIA LUCIFERASE; SECRETORY PATHWAY; QUALITY-CONTROL; DEGRADATION; STRESS; DOMAIN	Correct localization and transmembrane topology are crucial for the proteins residing and functioning in the endoplasmic reticulum (ER). We have developed a rapid and convenient assay, based on the redox-sensitive luciferase from Gaussia princeps (Gluc) and green fluorescence protein (GFP), to determine the localization or topology of ER proteins. Using the tandem Gluc-GFP reporter fused to different positions of a target protein, we successfully characterized the topologies of two ER transmembrane proteins Herp and HRD1 that are involved in the ER quality control system. This assay method may also be applicable to the proteins in secretory pathway, plasma membrane, and other compartments of cells.	[Li, Hai-Yin; Zheng, Xue-Ming; Che, Mei-Xia; Hu, Hong-Yu] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, State Key Lab Mol Biol, Shanghai, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Li, HY (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, State Key Lab Mol Biol, Shanghai, Peoples R China.	hyhu@sibs.ac.cn	Che, Meixia/Q-2119-2019	Che, Meixia/0000-0002-4515-1414	National Basic Research Program of China [2012CB911003]; National Natural Science Foundation of China [30870485]; Sino-Swiss Joint Research Projects [GJHZ0909]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Sino-Swiss Joint Research Projects	This work was supported by grants from the National Basic Research Program of China (2012CB911003), the National Natural Science Foundation of China (30870485), and the Sino-Swiss Joint Research Projects (GJHZ0909). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badr CE, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000571; Becker T, 2009, SCIENCE, V326, P1369, DOI 10.1126/science.1178535; Bernasconi R, 2010, J CELL BIOL, V188, P223, DOI 10.1083/jcb.200910042; Brach T, 2009, PLANT J, V57, P534, DOI 10.1111/j.1365-313X.2008.03704.x; Buchberger A, 2010, MOL CELL, V40, P238, DOI 10.1016/j.molcel.2010.10.001; Dayel MJ, 1999, BIOPHYS J, V76, P2843, DOI 10.1016/S0006-3495(99)77438-2; Deak PM, 2001, J BIOL CHEM, V276, P10663, DOI 10.1074/jbc.M008608200; Ellgaard L, 2003, NAT REV MOL CELL BIO, V4, P181, DOI 10.1038/nrm1052; Inouye S, 2008, BIOCHEM BIOPH RES CO, V365, P96, DOI 10.1016/j.bbrc.2007.10.152; Kokame K, 2000, J BIOL CHEM, V275, P32846, DOI 10.1074/jbc.M002063200; Laudon H, 2005, J BIOL CHEM, V280, P35352, DOI 10.1074/jbc.M507217200; Lohman JR, 2008, BIOCHEMISTRY-US, V47, P8678, DOI 10.1021/bi800498g; Lorenz H, 2006, NAT METHODS, V3, P205, DOI 10.1038/nmeth857; OU WJ, 1995, J BIOL CHEM, V270, P18051, DOI 10.1074/jbc.270.30.18051; Pan CJ, 1998, J BIOL CHEM, V273, P6144, DOI 10.1074/jbc.273.11.6144; Rathnayaka T, 2010, BBA-PROTEINS PROTEOM, V1804, P1902, DOI 10.1016/j.bbapap.2010.04.014; Remy I, 2006, NAT METHODS, V3, P977, DOI 10.1038/nmeth979; Snapp EL, 2009, TRENDS CELL BIOL, V19, P649, DOI 10.1016/j.tcb.2009.08.002; Tannous BA, 2005, MOL THER, V11, P435, DOI 10.1016/j.ymthe.2004.10.016; van Lith M, 2011, J CELL SCI, V124, P2349, DOI 10.1242/jcs.085530; Vembar SS, 2008, NAT REV MOL CELL BIO, V9, P944, DOI 10.1038/nrm2546; Wright LP, 2009, MOL CELL BIOL, V29, P1826, DOI 10.1128/MCB.01719-08	22	9	9	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2012	7	4							e35628	10.1371/journal.pone.0035628	http://dx.doi.org/10.1371/journal.pone.0035628			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959XD	22530060	Green Published, gold, Green Submitted			2022-12-25	WOS:000305350600106
J	Li, J; Gong, CY; Feng, XD; Zhou, XK; Xu, XP; Xie, L; Wang, RN; Zhang, DF; Wang, H; Deng, P; Zhou, M; Ji, N; Zhou, Y; Wang, Y; Wang, ZY; Liao, G; Geng, N; Chu, LY; Qian, ZY; Wang, Z; Chen, QM				Li, Jing; Gong, Changyang; Feng, Xiaodong; Zhou, Xikun; Xu, Xiaoping; Xie, Liang; Wang, Ruinan; Zhang, Dunfang; Wang, Hui; Deng, Peng; Zhou, Min; Ji, Ning; Zhou, Yu; Wang, Yun; Wang, Zhiyong; Liao, Ga; Geng, Ning; Chu, Liangyin; Qian, Zhiyong; Wang, Zhi; Chen, Qianming			Biodegradable Thermosensitive Hydrogel for SAHA and DDP Delivery: Therapeutic Effects on Oral Squamous Cell Carcinoma Xenografts	PLOS ONE			English	Article							SUBEROYLANILIDE HYDROXAMIC ACID; HISTONE DEACETYLASE INHIBITOR; PCL-PEG HYDROGEL; PHASE-II TRIAL; IN-VITRO; CISPLATIN; SYSTEM; ANGIOGENESIS; MECHANISMS; EXPRESSION	Background: OSCC is one of the most common malignancies and numerous clinical agents currently applied in combinative chemotherapy. Here we reported a novel therapeutic strategy, SAHA and DDP-loaded PECE (SAHA-DDP/PECE), can improve the therapeutic effects of intratumorally chemotherapy on OSCC cell xenografts. Objective/Purpose: The objective of this study was to evaluate the therapeutic efficacy of the SAHA-DDP/PECE in situ controlled drug delivery system on OSCC cell xenografts. Methods: A biodegradable and thermosensitive hydrogel was successfully developed to load SAHA and DDP. Tumor-beared mice were intratumorally administered with SAHA-DDP/PECE at 50 mg/kg (SAHA) +2 mg/kg (DDP) in 100 ul PECE hydrogel every two weeks, SAHA-DDP at 50 mg/kg(SAHA) +2 mg/kg(DDP) in NS, 2 mg/kg DDP solution, 50 mg/kg SAHA solution, equal volume of PECE hydrogel, or equal volume of NS on the same schedule, respectively. The antineoplastic actions of SAHA and DDP alone and in combination were evaluated using the determination of tumor volume, immunohistochemistry, western blot, and TUNEL analysis. Results: The hydrogel system was a free-flowing sol at 10 degrees C, become gel at body temperature, and could sustain more than 14 days in situ. SAHA-DDP/PECE was subsequently injected into tumor OSCC tumor-beared mice. The results demonstrated that such a strategy as this allows the carrier system to show a sustained release of SAHA and DDP in vivo, and could improved therapeutic effects compared with a simple additive therapeutic effect of SAHA and DDP on mouse model. Conclusions: Our research indicated that the novel SAHA-DDP/PECE system based on biodegradable PECE copolymer enhanced the therapeutic effects and could diminished the side effects of SAHA/DDP. The present work might be of great importance to the further exploration of the potential application of SAHA/DDP-hydrogel controlled drug release system in the treatment of OSCC.	[Li, Jing; Feng, Xiaodong; Xu, Xiaoping; Xie, Liang; Wang, Ruinan; Zhang, Dunfang; Wang, Hui; Deng, Peng; Zhou, Min; Ji, Ning; Zhou, Yu; Wang, Yun; Wang, Zhiyong; Liao, Ga; Geng, Ning; Chu, Liangyin; Wang, Zhi; Chen, Qianming] Sichuan Univ, W China Coll Stomatol, State Key Lab Oral Dis, Chengdu 610064, Peoples R China; [Gong, Changyang; Zhou, Xikun; Qian, Zhiyong] Sichuan Univ, W China Med Sch, W China Hosp, State Key Lab Biotherapy, Chengdu 610064, Peoples R China; [Gong, Changyang; Zhou, Xikun; Qian, Zhiyong] Sichuan Univ, W China Med Sch, W China Hosp, Ctr Canc, Chengdu 610064, Peoples R China	Sichuan University; Sichuan University; Sichuan University	Li, J (corresponding author), Sichuan Univ, W China Coll Stomatol, State Key Lab Oral Dis, Chengdu 610064, Peoples R China.	anderson-qian@163.com; wangzhi0506@vip.163.com; qmchen@scu.edu.cn	Zhou, Xikun/T-8272-2019	Zhang, Dunfang/0000-0001-7545-9930	National Science Foundation for Distinguished Young Scholars of China [30725041]; State Key Program of National Natural Science of China [30930100]; National Natural Science Foundation of China [30901676, 81072218, 30801294]; Science Funds for Talented Professionals of Sichuan Province in China [09ZQ026-037]; Fok Ying-Tong Education Foundation, China [122030]	National Science Foundation for Distinguished Young Scholars of China(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); State Key Program of National Natural Science of China(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science Funds for Talented Professionals of Sichuan Province in China; Fok Ying-Tong Education Foundation, China(Fok Ying Tung Education Foundation)	This work was supported by grants from the National Science Foundation for Distinguished Young Scholars of China (No. 30725041), State Key Program of National Natural Science of China (No. 30930100), the National Natural Science Foundation of China (No. 30901676, 81072218, 30801294), the Science Funds for Talented Professionals of Sichuan Province in China (No. 09ZQ026-037), the Fok Ying-Tong Education Foundation, China (No. 122030). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bagan J, 2010, ORAL ONCOL, V46, P414, DOI 10.1016/j.oraloncology.2010.03.009; Blumenschein GR, 2008, INVEST NEW DRUG, V26, P81, DOI 10.1007/s10637-007-9075-2; Brandwein-Gensler A, 2005, AM J SURG PATHOL, V29, P167; Crump M, 2007, EJC SUPPL, V5, P346, DOI 10.1016/S1359-6349(07)71294-6; De Ruijter AJM, 2003, BIOCHEM J, V370, P737, DOI 10.1042/BJ20021321; Debaere D, 2011, B-ENT, V7, P1; Dong GE, 2010, AM J PHYSIOL-RENAL, V298, pF293, DOI 10.1152/ajprenal.00410.2009; El-Awady EE, 2011, EUR J PHARMACOL, V650, P335, DOI 10.1016/j.ejphar.2010.09.085; Fang F, 2009, ACS NANO, V3, P4080, DOI 10.1021/nn900785b; Gong CY, 2009, J PHARM SCI-US, V98, P3707, DOI 10.1002/jps.21694; Gong CY, 2009, J BIOMED MATER RES B, V91B, P26, DOI 10.1002/jbm.b.31370; Gong CY, 2009, BMC BIOTECHNOL, V9, DOI 10.1186/1472-6750-9-8; Gong CY, 2009, GROWTH FACTORS, V27, P377, DOI 10.3109/08977190903159938; Gong CY, 2007, SMART MATER STRUCT, V16, P927, DOI 10.1088/0964-1726/16/3/043; Gong CY, 2011, J NANOPART RES, V13, P721, DOI 10.1007/s11051-010-0071-7; Gong CY, 2010, NANOTECHNOLOGY, V21, DOI 10.1088/0957-4484/21/21/215103; Gong CY, 2009, J PHYS CHEM B, V113, P10183, DOI 10.1021/jp902697d; Gong CY, 2009, INT J PHARMACEUT, V365, P89, DOI 10.1016/j.ijpharm.2008.08.027; Gou ML, 2010, J BIOMED MATER RES A, V93A, P219, DOI 10.1002/jbm.a.32546; Gregorc V, 2011, CLIN CANCER RES, V17, P1964, DOI 10.1158/1078-0432.CCR-10-1376; Iamaroon A, 2003, J ORAL PATHOL MED, V32, P195, DOI 10.1034/j.1600-0714.2003.00128.x; Jin KL, 2010, J GYNECOL ONCOL, V21, P262, DOI 10.3802/jgo.2010.21.4.262; Kelly WK, 2005, J CLIN ONCOL, V23, P3923, DOI 10.1200/JCO.2005.14.167; Kelly WK, 2003, CLIN CANCER RES, V9, P3578; Koberle B, 2010, BBA-REV CANCER, V1806, P172, DOI 10.1016/j.bbcan.2010.07.004; Maisch B, 2010, EUR HEART J, V31, P337; Marks PA, 2007, ONCOGENE, V26, P1351, DOI 10.1038/sj.onc.1210204; McCaul JA, 2008, ORAL ONCOL, V44, P261, DOI 10.1016/j.oraloncology.2007.02.010; Plummer R, 2011, BRIT J CANCER, V104, P593, DOI 10.1038/bjc.2011.6; Prestwich RJ, 2011, CLIN ONCOL-UK, V23, pS23, DOI 10.1016/j.clon.2011.01.376; Richon VM, 2000, P NATL ACAD SCI USA, V97, P10014, DOI 10.1073/pnas.180316197; Rikiishi H, 2007, INT J ONCOL, V30, P1181; Sato T, 2006, INT J ONCOL, V28, P1233; Shen J, 2007, BIOCHEM PHARMACOL, V73, P1901, DOI 10.1016/j.bcp.2007.03.009; Shieh YS, 2004, J ORAL PATHOL MED, V33, P601, DOI 10.1111/j.1600-0714.2004.00252.x; Shivamallappa SM, 2011, INT J ORAL SCI, V3, P216, DOI 10.4248/IJOS11077; Suzuki M, 2009, CANCER CHEMOTH PHARM, V64, P1115, DOI 10.1007/s00280-009-0969-x; Wang YS, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-402; Xu LP, 2011, MOL CANCER THER, V10, P550, DOI 10.1158/1535-7163.MCT-10-0571; Yin D, 2007, CLIN CANCER RES, V13, P1045, DOI 10.1158/1078-0432.CCR-06-1261	40	63	65	4	75	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2012	7	4							e33860	10.1371/journal.pone.0033860	http://dx.doi.org/10.1371/journal.pone.0033860			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959XD	22529899	Green Published, gold, Green Submitted			2022-12-25	WOS:000305350600006
J	Zou, Q; Hu, YX; Xue, J; Fan, XX; Jin, Y; Shi, XH; Meng, D; Wang, XZ; Feng, CC; Xie, XP; Zhang, YZ; Kang, YM; Liang, XX; Wu, B; Wang, M; Wang, B				Zou, Qiang; Hu, Yanxin; Xue, Jia; Fan, Xiaoxu; Jin, Yi; Shi, Xianghua; Meng, Di; Wang, Xianzheng; Feng, Congcong; Xie, Xiaoping; Zhang, Yizhi; Kang, Youmin; Liang, Xiaoxuan; Wu, Bing; Wang, Ming; Wang, Bin			Use of Praziquantel as an Adjuvant Enhances Protection and Tc-17 Responses to Killed H5N1 Virus Vaccine in Mice	PLOS ONE			English	Article							CYTOTOXIC T-LYMPHOCYTE; INFLUENZA-A VIRUSES; IMMUNE-RESPONSES; HUMAN CD8(+); TC17 CELLS; INFECTION; INDUCTION; CHALLENGE; COMBINATION; RECOGNITION	Background: H5N1 is a highly pathogenic influenza A virus, which can cause severe illness or even death in humans. Although the widely used killed vaccines are able to provide some protection against infection via neutralizing antibodies, cytotoxic T-lymphocyte responses that are thought to eradicate viral infections are lacking. Methodology/Principal Findings: Aiming to promote cytotoxic responses against H5N1 infection, we extended our previous finding that praziquantel (PZQ) can act as an adjuvant to induce IL-17-producing CD8(+) T cells (Tc17). We found that a single immunization of 57BL/6 mice with killed viral vaccine plus PZQ induced antigen-specific Tc17 cells, some of which also secreted IFN-gamma. The induced Tc17 had cytolytic activities. Induction of these cells was impaired in CD8 knockout (KO) or IFN-gamma KO mice, and was even lower in IL-17 KO mice. Importantly, the inoculation of killed vaccine with PZQ significantly reduced virus loads in the lung tissues and prolonged survival. Protection against H5N1 virus infection was obtained by adoptively transferring PZQ-primed wild type CD8(+) T cells and this was more effective than transfer of activated IFN-gamma KO or IL-17 KO CD8(+) T cells. Conclusions/Significance: Our results demonstrated that adding PZQ to killed H5N1 vaccine could promote broad Tc17-mediated cytotoxic T lymphocyte activity, resulting in improved control of highly pathogenic avian influenza virus infection.	[Zou, Qiang; Wang, Xianzheng; Wang, Bin] Fudan Univ, Shanghai Med Coll, Key Lab Med Mol Virol MOH & MOE, Shanghai 200433, Peoples R China; [Zou, Qiang; Shi, Xianghua; Feng, Congcong; Xie, Xiaoping; Zhang, Yizhi; Kang, Youmin; Liang, Xiaoxuan; Wu, Bing; Wang, Bin] China Agr Univ, Coll Biol Sci, State Key Lab Agrobiotechnol, Beijing 100094, Peoples R China; [Hu, Yanxin; Xue, Jia; Fan, Xiaoxu; Jin, Yi; Meng, Di; Wang, Ming] China Agr Univ, Coll Vet Med, Beijing 100094, Peoples R China	Fudan University; China Agricultural University; China Agricultural University	Zou, Q (corresponding author), Fudan Univ, Shanghai Med Coll, Key Lab Med Mol Virol MOH & MOE, Shanghai 200433, Peoples R China.	bwang3@fudan.edu.cn; bwang3@fudan.edu.cn	Xie, Xiaoping/K-5710-2018	Xie, Xiaoping/0000-0001-6616-1059; Kang, Youmin/0000-0003-2597-6117; Xue, Jia/0000-0001-8683-621X	National High-Tech 863 Project of China; Scientific Technology Development Foundation of Shanghai [09DZ1908602]	National High-Tech 863 Project of China; Scientific Technology Development Foundation of Shanghai	This work was partly supported by the National High-Tech 863 Project of China (Development of Novel Adjuvants for Influenza Vaccines) and Scientific Technology Development Foundation of Shanghai (09DZ1908602). No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BENDER BS, 1992, J EXP MED, V175, P1143, DOI 10.1084/jem.175.4.1143; Boon ACM, 2002, J VIROL, V76, P582, DOI 10.1128/JVI.76.2.582-590.2002; Cho Y, 2003, J VIROL, V77, P4679, DOI 10.1128/JVI.77.8.4679-4684.2003; Cioli D, 2003, PARASITOL RES, V90, pS3, DOI 10.1007/s00436-002-0751-z; Ciric B, 2009, J IMMUNOL, V182, P5296, DOI 10.4049/jimmunol.0900036; CROFT M, 1994, J EXP MED, V180, P1715, DOI 10.1084/jem.180.5.1715; Curtis MM, 2009, J IMMUNOL, V183, P381, DOI 10.4049/jimmunol.0900939; Doherty PC, 2006, NAT IMMUNOL, V7, P449, DOI 10.1038/ni1343; EICHELBERGER M, 1991, J EXP MED, V174, P875, DOI 10.1084/jem.174.4.875; El Sahly H, 2010, EXPERT REV VACCINES, V9, P1135, DOI [10.1586/ERV.10.111, 10.1586/erv.10.111]; Epstein SL, 2006, J INFECT DIS, V193, P49, DOI 10.1086/498980; ERARD F, 1993, SCIENCE, V260, P1802, DOI 10.1126/science.8511588; Exley C, 2004, LANCET INFECT DIS, V4, P324, DOI 10.1016/S1473-3099(04)01039-4; Hamada H, 2009, J IMMUNOL, V182, P3469, DOI 10.4049/jimmunol.0801814; Hien TT, 2004, NEW ENGL J MED, V350, P1179, DOI 10.1056/NEJMoa040419; Hinrichs CS, 2009, BLOOD, V114, P596, DOI 10.1182/blood-2009-02-203935; Huang MH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012279; Huber M, 2009, EUR J IMMUNOL, V39, P1716, DOI 10.1002/eji.200939412; Intlekofer AM, 2008, SCIENCE, V321, P408, DOI 10.1126/science.1159806; Jameson J, 1999, J IMMUNOL, V162, P7578; Jameson J, 1998, J VIROL, V72, P8682, DOI 10.1128/JVI.72.11.8682-8689.1998; Jin Y, 2011, J GENE MED, V13, P243, DOI 10.1002/jgm.1558; Kienzle N, 2002, J IMMUNOL, V168, P1672, DOI 10.4049/jimmunol.168.4.1672; Kistner O, 2007, VACCINE, V25, P6028, DOI 10.1016/j.vaccine.2007.05.013; Kondo T, 2009, J IMMUNOL, V182, P1794, DOI 10.4049/jimmunol.0801347; Kreijtz JHCM, 2008, J VIROL, V82, P5161, DOI 10.1128/JVI.02694-07; Kreijtz JHCM, 2007, VACCINE, V25, P612, DOI 10.1016/j.vaccine.2006.08.036; Lau YF, 2010, J VIROL, V84, P8639, DOI 10.1128/JVI.00596-10; Lee HK, 2007, SCIENCE, V315, P1398, DOI 10.1126/science.1136880; Lee LYH, 2008, J CLIN INVEST, V118, P3478, DOI 10.1172/JCI32460; Liu SJ, 2007, J LEUKOCYTE BIOL, V82, P354, DOI 10.1189/jlb.0207111; MCMICHAEL AJ, 1983, NEW ENGL J MED, V309, P13, DOI 10.1056/NEJM198307073090103; Nicholson KG, 2001, LANCET, V357, P1937, DOI 10.1016/S0140-6736(00)05066-2; Ninomiya A, 2007, VACCINE, V25, P3554, DOI 10.1016/j.vaccine.2007.01.083; Ortega C, 2009, J LEUKOCYTE BIOL, V86, P435, DOI [10.1189/jlb.0109046, 10.1189/JLB.0109046]; Palese P, 2002, J CLIN INVEST, V110, P9, DOI 10.1172/JCI200215999; Park KD, 2006, BLOOD, V108, P1770, DOI 10.1182/blood-2005-10-006536; REISS CS, 1980, J IMMUNOL, V125, P2182; Russell CJ, 2005, CELL, V123, P368, DOI 10.1016/j.cell.2005.10.019; Sawai T, 2008, IMMUNOLOGY, V124, P155, DOI 10.1111/j.1365-2567.2007.02745.x; Schmitz JE, 2003, J VIROL, V77, P2165, DOI 10.1128/JVI.77.3.2165-2173.2003; Schubert C, 2009, NAT MED, V15, P984, DOI [10.1038/nm0909-986, 10.1038/nm0909-985, 10.1038/nm0909-984]; Sha Z, 2000, J VIROL, V74, P4999, DOI 10.1128/JVI.74.11.4999-5005.2000; Uiprasertkul M, 2005, EMERG INFECT DIS, V11, P1036, DOI 10.3201/eid1107.041313; Wack A, 2008, VACCINE, V26, P552, DOI 10.1016/j.vaccine.2007.11.054; Wrammert J, 2011, J EXP MED, V208, P181, DOI 10.1084/jem.20101352; Yamada S, 2006, NATURE, V444, P378, DOI 10.1038/nature05264; Yeh N, 2010, J IMMUNOL, V185, P2089, DOI 10.4049/jimmunol.1000818; Zou Q, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025525; Zou Q, 2010, VACCINE, V28, P2032, DOI 10.1016/j.vaccine.2009.10.101	50	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2012	7	4							e34865	10.1371/journal.pone.0034865	http://dx.doi.org/10.1371/journal.pone.0034865			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959XD	22529945	Green Published, Green Submitted, gold			2022-12-25	WOS:000305350600033
J	Donovan, J; Copeland, PR				Donovan, Jesse; Copeland, Paul R.			Selenocysteine Insertion Sequence Binding Protein 2L Is Implicated as a Novel Post-Transcriptional Regulator of Selenoprotein Expression	PLOS ONE			English	Article							EUKARYOTIC SECIS ELEMENTS; RNA-BINDING; MAMMALIAN SELENOPROTEIN; INCORPORATION MACHINERY; BINDING-PROTEIN-2; DOMAIN; SBP2; IDENTIFICATION; TRANSLATION; EFFICIENCY	The amino acid selenocysteine (Sec) is encoded by UGA codons. Recoding of UGA from stop to Sec requires a Sec insertion sequence (SECIS) element in the 3' UTR of selenoprotein mRNAs. SECIS binding protein 2 (SBP2) binds the SECIS element and is essential for Sec incorporation into the nascent peptide. SBP2-like (SBP2L) is a paralogue of SBP2 in vertebrates and is the only SECIS binding protein in some invertebrates where it likely directs Sec incorporation. However, vertebrate SBP2L does not promote Sec incorporation in in vitro assays. Here we present a comparative analysis of SBP2 and SBP2L SECIS binding properties and demonstrate that its inability to promote Sec incorporation is not due to lower SECIS affinity but likely due to lack of a SECIS dependent domain association that is found in SBP2. Interestingly, however, we find that an invertebrate version of SBP2L is fully competent for Sec incorporation in vitro. Additionally, we present the first evidence that SBP2L interacts with selenoprotein mRNAs in mammalian cells, thereby implying a role in selenoprotein expression.	[Donovan, Jesse; Copeland, Paul R.] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Microbiol Mol Genet & Immunol, Piscataway, NJ 08854 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center	Donovan, J (corresponding author), Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA.	paul.copeland@umdnj.edu		Copeland, Paul/0000-0003-3343-0587	National Institutes of Health [GM077073]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077073] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by National Institutes of Health grant GM077073. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allmang C, 2002, RNA, V8, P1308, DOI 10.1017/S1355838202020034; Allmang C., 2006, SELENIUM ITS MOL BIO, V5, P51; BERRY MJ, 1993, EMBO J, V12, P3315, DOI 10.1002/j.1460-2075.1993.tb06001.x; Bubenik JL, 2007, J BIOL CHEM, V282, P34653, DOI 10.1074/jbc.M707059200; Budiman ME, 2009, MOL CELL, V35, P479, DOI 10.1016/j.molcel.2009.06.026; Caban K, 2006, CELL MOL LIFE SCI, V63, P73, DOI 10.1007/s00018-005-5402-y; Chapple CE, 2009, BIOINFORMATICS, V25, P674, DOI 10.1093/bioinformatics/btp020; Clery A, 2007, NUCLEIC ACIDS RES, V35, P1868, DOI 10.1093/nar/gkm066; Copeland PR, 2000, EMBO J, V19, P306, DOI 10.1093/emboj/19.2.306; Copeland PR, 1999, J BIOL CHEM, V274, P25447, DOI 10.1074/jbc.274.36.25447; Copeland PR, 2001, MOL CELL BIOL, V21, P1491, DOI 10.1128/MCB.21.5.1491-1498.2001; Donovan J, 2010, J MOL BIOL, V400, P659, DOI 10.1016/j.jmb.2010.05.026; Donovan J, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-229; Donovan J, 2008, J BIOL CHEM, V283, P35129, DOI 10.1074/jbc.M806008200; Fagegaltier D, 2000, NUCLEIC ACIDS RES, V28, P2679, DOI 10.1093/nar/28.14.2679; Fletcher JE, 2001, RNA, V7, P1442; Gagnon KT, 2010, RNA, V16, P79, DOI 10.1261/rna.1692310; Hornbeck PV, 2004, PROTEOMICS, V4, P1551, DOI 10.1002/pmic.200300772; Jiang L, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-289; Kinzy SA, 2005, NUCLEIC ACIDS RES, V33, P5172, DOI 10.1093/nar/gki826; Korotkov KV, 2002, MOL CELL BIOL, V22, P1402, DOI 10.1128/MCB.22.5.1402-1411.2002; Latreche L, 2009, NUCLEIC ACIDS RES, V37, P5868, DOI 10.1093/nar/gkp635; Lescure A, 2002, GENE, V291, P279, DOI 10.1016/S0378-1119(02)00629-7; Lobanov AV, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-3-r62; Mehta A, 2004, J BIOL CHEM, V279, P37852, DOI 10.1074/jbc.M404639200; Shepherdley CA, 2004, ENDOCRINOLOGY, V145, P1255, DOI 10.1210/en.2003-1248; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Takeuchi A, 2009, NUCLEIC ACIDS RES, V37, P2126, DOI 10.1093/nar/gkp078; Wu C, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r130	29	20	21	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2012	7	4							e35581	10.1371/journal.pone.0035581	http://dx.doi.org/10.1371/journal.pone.0035581			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WC	22530054	Green Submitted, gold, Green Published			2022-12-25	WOS:000305347400064
J	Klitgaard, K; Friis, C; Jensen, TK; Angen, O; Boye, M				Klitgaard, Kirstine; Friis, Carsten; Jensen, Tim K.; Angen, Oystein; Boye, Mette			Transcriptional Portrait of Actinobacillus pleuropneumoniae during Acute Disease - Potential Strategies for Survival and Persistence in the Host	PLOS ONE			English	Article							ARGININE TRANSLOCATION PATHWAY; SIALIC-ACID METABOLISM; IN-VITRO GROWTH; ESCHERICHIA-COLI; HAEMOPHILUS-INFLUENZAE; PSEUDOMONAS-AERUGINOSA; VIRULENCE FACTORS; IRON HOMEOSTASIS; UREASE ACTIVITY; TRANSCRIBED SEQUENCES	Background: Gene expression profiles of bacteria in their natural hosts can provide novel insight into the host-pathogen interactions and molecular determinants of bacterial infections. In the present study, the transcriptional profile of the porcine lung pathogen Actinobacillus pleuropneumoniae was monitored during the acute phase of infection in its natural host. Methodology/Principal Findings: Bacterial expression profiles of A. pleuropneumoniae isolated from lung lesions of 25 infected pigs were compared in samples taken 6, 12, 24 and 48 hours post experimental challenge. Within 6 hours, focal, fibrino hemorrhagic lesions could be observed in the pig lungs, indicating that A. pleuropneumoniae had managed to establish itself successfully in the host. We identified 237 differentially regulated genes likely to encode functions required by the bacteria for colonization and survival in the host. This group was dominated by genes involved in various aspects of energy metabolism, especially anaerobic respiration and carbohydrate metabolism. Remodeling of the bacterial envelope and modifications of posttranslational processing of proteins also appeared to be of importance during early infection. The results suggested that A. pleuropneumoniae is using various strategies to increase its fitness, such as applying Na+ pumps as an alternative way of gaining energy. Furthermore, the transcriptional data provided potential clues as to how A. pleuropneumoniae is able to circumvent host immune factors and survive within the hostile environment of host macrophages. This persistence within macrophages may be related to urease activity, mobilization of various stress responses and active evasion of the host defenses by cell surface sialylation. Conclusions/Significance: The data presented here highlight the importance of metabolic adjustments to host conditions as virulence factors of infecting microorganisms and help to provide insight into the mechanisms behind the efficient colonization and persistence of A. pleuropneumoniae during acute disease.	[Klitgaard, Kirstine; Jensen, Tim K.; Angen, Oystein; Boye, Mette] Tech Univ Denmark, Natl Vet Inst, Frederiksberg C, Denmark; [Friis, Carsten] Tech Univ Denmark, Natl Food Inst, DK-2800 Lyngby, Denmark	Technical University of Denmark; Technical University of Denmark	Klitgaard, K (corresponding author), Tech Univ Denmark, Natl Vet Inst, Frederiksberg C, Denmark.	kksc@vet.dtu.dk		Klitgaard, Kirstine/0000-0002-8379-9430; Jensen, Tim Kare/0000-0002-8048-4695	Danish Research Council for Technology and Production Sciences [274-07-0127]	Danish Research Council for Technology and Production Sciences	This work was supported by the Danish Research Council for Technology and Production Sciences (274-07-0127), http://www.fi.dk/. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews SC, 2003, FEMS MICROBIOL REV, V27, P215, DOI 10.1016/S0168-6445(03)00055-X; Auger E, 2009, INFECT IMMUN, V77, P1426, DOI 10.1128/IAI.00297-08; Baker J, 2010, APPL ENVIRON MICROB, V76, P150, DOI 10.1128/AEM.02268-09; Baltes N, 2005, INFECT IMMUN, V73, P4614, DOI 10.1128/IAI.73.8.4614-4619.2005; Baltes N, 2004, INFECT IMMUN, V72, P6711, DOI 10.1128/IAI.72.11.6711-6716.2004; Baltes N, 2003, INFECT IMMUN, V71, P6784, DOI 10.1128/IAI.71.12.6784-6792.2003; Baltes N, 2001, INFECT IMMUN, V69, P472, DOI 10.1128/IAI.69.1.472-478.2001; Baltes N, 2007, VET MICROBIOL, V123, P110, DOI 10.1016/j.vetmic.2007.03.026; Beenken KE, 2012, INFECT IMMU IN PRESS; Bizzini A, 2010, J BACTERIOL, V192, P779, DOI 10.1128/JB.00959-09; Boekema BKHL, 2004, INFECT IMMUN, V72, P691, DOI 10.1128/IAI.72.2.691-700.2004; Bogdan CT, 2000, IMMUNOL REV, V173, P17, DOI 10.1034/j.1600-065X.2000.917307.x; Booth IR, 2003, BIOCHEM SOC T, V31, P1406; Bosse JT, 2002, MICROBES INFECT, V4, P225, DOI 10.1016/S1286-4579(01)01534-9; Bosse JT, 2001, J BACTERIOL, V183, P1242, DOI 10.1128/JB.183.4.1242-1247.2001; Bosse JT, 2000, CAN J VET RES, V64, P145; Bouchet V, 2003, P NATL ACAD SCI USA, V100, P8898, DOI 10.1073/pnas.1432026100; Boyce JD, 2004, EMERG INFECT DIS, V10, P1357, DOI 10.3201/eid1008.031036; Boysen A, 2010, J BIOL CHEM, V285, P10690, DOI 10.1074/jbc.M109.089755; Buettner FFR, 2009, PROTEOMICS, V9, P2383, DOI 10.1002/pmic.200800439; Camejo A, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000449; Carter MQ, 2011, APPL ENVIRON MICROB, V77, P3685, DOI 10.1128/AEM.02315-10; Challacombe Jean F., 2008, P53; Chiers K, 2010, VET RES, V41, DOI 10.1051/vetres/2010037; Chin N, 1996, FEMS MICROBIOL LETT, V143, P1, DOI 10.1111/j.1574-6968.1996.tb08452.x; Cross BCS, 2009, NAT REV MOL CELL BIO, V10, P255, DOI 10.1038/nrm2657; CRUIJSEN TLM, 1992, INFECT IMMUN, V60, P4867, DOI 10.1128/IAI.60.11.4867-4871.1992; De Buck E, 2008, TRENDS MICROBIOL, V16, P442, DOI 10.1016/j.tim.2008.06.004; Deslandes V, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-98; Dreyfus A, 2004, VET MICROBIOL, V99, P227, DOI 10.1016/j.vetmic.2004.01.004; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Ferguson GP, 1998, ARCH MICROBIOL, V170, P209, DOI 10.1007/s002030050635; FREY J, 1995, TRENDS MICROBIOL, V3, P257, DOI 10.1016/S0966-842X(00)88939-8; Fuller TE, 1999, MICROB PATHOGENESIS, V27, P311, DOI 10.1006/mpat.1999.0309; Fuller TE, 2000, MICROB PATHOGENESIS, V29, P39, DOI 10.1006/mpat.2000.0364; Gawronski JD, 2009, P NATL ACAD SCI USA, V106, P16422, DOI 10.1073/pnas.0906627106; Genevaux P, 2007, MOL MICROBIOL, V66, P840, DOI 10.1111/j.1365-2958.2007.05961.x; Graham MR, 2005, AM J PATHOL, V166, P455, DOI 10.1016/S0002-9440(10)62268-7; Hartlova A, 2011, PROTEOMICS, V11, P3212, DOI 10.1002/pmic.201000767; Hase CC, 2001, MICROBIOL MOL BIOL R, V65, P353, DOI 10.1128/MMBR.65.3.353-370.2001; Heyes DJ, 2009, J BIOL CHEM, V284, P35514, DOI 10.1074/jbc.M109.056630; HOLTJE JV, 1991, J GEN MICROBIOL, V137, P441, DOI 10.1099/00221287-137-3-441; Hong M, 2011, VET MICROBIOL, V148, P89, DOI 10.1016/j.vetmic.2010.07.023; Hood DW, 1999, MOL MICROBIOL, V33, P679, DOI 10.1046/j.1365-2958.1999.01509.x; Horst SA, 2010, J BACTERIOL, V192, P2929, DOI 10.1128/JB.01652-09; Huang KX, 1999, APPL ENVIRON MICROB, V65, P3244; Hung MN, 2006, J BACTERIOL, V188, P5606, DOI 10.1128/JB.00306-06; Inzana Thomas J., 2008, P177; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jack RL, 2001, J BACTERIOL, V183, P1801, DOI 10.1128/JB.183.5.1801-1804.2001; Jacobsen I, 2005, INFECT IMMUN, V73, P3740, DOI 10.1128/IAI.73.6.3740-3744.2005; Jacobsen I, 2005, INFECT IMMUN, V73, P226, DOI 10.1128/IAI.73.1.226-234.2005; Kachlany Scott C., 2008, P113; Kadioglu A, 2008, NAT REV MICROBIOL, V6, P288, DOI 10.1038/nrmicro1871; Kemmer G, 2001, J BACTERIOL, V183, P3974, DOI 10.1128/JB.183.13.3974-3981.2001; Klitgaard K, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-698; Labrie J, 2010, VET RES, V41, DOI 10.1051/vetres/2009051; LaRocque RC, 2005, INFECT IMMUN, V73, P4488, DOI 10.1128/IAI.73.8.4488-4493.2005; Lee VT, 2001, GENE DEV, V15, P1725, DOI 10.1101/gad.896801; Li YJ, 2009, CHEM REV, V109, P4617, DOI 10.1021/cr900010n; Lone AG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006139; Masse E, 2005, TRENDS BIOCHEM SCI, V30, P462, DOI 10.1016/j.tibs.2005.06.005; Masse E, 2002, P NATL ACAD SCI USA, V99, P4620, DOI 10.1073/pnas.032066599; Maughan Heather, 2008, P79; McHugh JP, 2003, J BIOL CHEM, V278, P29478, DOI 10.1074/jbc.M303381200; Mikael LG, 2003, INFECT IMMUN, V71, P2911, DOI 10.1128/IAI.71.5.2911-2915.2003; Mills DC, 2012, INFECT IMMU IN PRESS; Morton DJ, 2007, MICROBES INFECT, V9, P932, DOI 10.1016/j.micinf.2007.03.013; Mullen LM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003991; Nielsen KK, 2005, APPL ENVIRON MICROB, V71, P2949, DOI 10.1128/AEM.71.6.2949-2954.2005; NIVEN DF, 1990, INT J SYST BACTERIOL, V40, P1, DOI 10.1099/00207713-40-1-1; Novotny LA, 2011, MUCOSAL IMMUNOL, V4, P456, DOI 10.1038/mi.2011.6; Ochsner UA, 2002, P NATL ACAD SCI USA, V99, P8312, DOI 10.1073/pnas.082238299; Ogunnariwo JA, 2001, J BACTERIOL, V183, P890, DOI 10.1128/JB.183.3.890-896.2001; Palchevskiy V, 2006, J BACTERIOL, V188, P3902, DOI 10.1128/JB.01974-05; Palmer T, 2005, TRENDS MICROBIOL, V13, P175, DOI 10.1016/j.tim.2005.02.002; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; POHL S, 1983, INT J SYST BACTERIOL, V33, P510, DOI 10.1099/00207713-33-3-510; Price CE, 2010, BBA-MOL CELL RES, V1803, P748, DOI 10.1016/j.bbamcr.2010.01.019; Reidl J, 1996, J EXP MED, V183, P621, DOI 10.1084/jem.183.2.621; Renesto P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003681; Rioux S, 2000, MICROB PATHOGENESIS, V28, P279, DOI 10.1006/mpat.1999.0347; Rose RW, 2002, MOL MICROBIOL, V45, P943, DOI 10.1046/j.1365-2958.2002.03090.x; Rozen S, 2000, Methods Mol Biol, V132, P365; Schaller A, 1999, MICROBIOL-SGM, V145, P2105, DOI 10.1099/13500872-145-8-2105; Severi E, 2007, MICROBIOL-SGM, V153, P2817, DOI 10.1099/mic.0.2007/009480-0; Sheehan BJ, 2003, INFECT IMMUN, V71, P3960, DOI 10.1128/IAI.71.7.3960-3970.2003; Sheikh A, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001419; Son MS, 2007, INFECT IMMUN, V75, P5313, DOI 10.1128/IAI.01807-06; Srikumar R, 2004, MICROBIOL-SGM, V150, P1723, DOI 10.1099/mic.0.27046-0; Steenbergen SM, 2005, INFECT IMMUN, V73, P1284, DOI 10.1128/IAI.73.3.1284-1294.2005; STOJILJKOVIC I, 1994, MOL MICROBIOL, V13, P719, DOI 10.1111/j.1365-2958.1994.tb00465.x; Tatusov RL, 1997, SCIENCE, V278, P631, DOI 10.1126/science.278.5338.631; Turner S, 2003, BIOCHEM J, V373, P865, DOI 10.1042/BJ20030088; Vasil ML, 2007, BIOMETALS, V20, P587, DOI 10.1007/s10534-006-9067-2; Vasil ML, 1999, MOL MICROBIOL, V34, P399, DOI 10.1046/j.1365-2958.1999.01586.x; Vimr ER, 2004, MICROBIOL MOL BIOL R, V68, P132, DOI 10.1128/MMBR.68.1.132-153.2004; WEISER JN, 1994, INFECT IMMUN, V62, P2582, DOI 10.1128/IAI.62.6.2582-2589.1994; Yin X, 2012, MICROBIOLOG IN PRESS; Zakharian E, 2007, BIOPHYS J, V92, P588, DOI 10.1529/biophysj.106.095273; Zhang W, 2011, PROTEOME SCI, V9, DOI 10.1186/1477-5956-9-32	102	27	27	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2012	7	4							e35549	10.1371/journal.pone.0035549	http://dx.doi.org/10.1371/journal.pone.0035549			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WC	22530048	Green Published, Green Submitted, gold			2022-12-25	WOS:000305347400061
J	Nouri, MN; Ahmed, A; Bril, V; Orszag, A; Ng, E; Nwe, P; Perkins, BA				Nouri, Maryam Nabavi; Ahmed, Ausma; Bril, Vera; Orszag, Andrej; Ng, Eduardo; Nwe, Patti; Perkins, Bruce A.			Diabetic Neuropathy and Axon Reflex-Mediated Neurogenic Vasodilatation in Type 1 Diabetes	PLOS ONE			English	Article							DISTAL SYMMETRIC POLYNEUROPATHY; C-FIBER FUNCTION; PERIPHERAL NEUROPATHY; PITTSBURGH EPIDEMIOLOGY; ELECTRODIAGNOSTIC-MEDICINE; AMERICAN-ASSOCIATION; PHYSICAL-MEDICINE; SCREENING-TESTS; COMPLICATIONS; PREVALENCE	Objective: Axon reflex-mediated neurogenic vasodilatation in response to cutaneous heating may reflect early, pre-clinical small fibre dysfunction. We aimed to evaluate the distribution of the vascular flare area measured by laser doppler imaging ("LDIFLARE area") in type 1 diabetes and in healthy volunteers. Research and Methods: Concurrent with clinical and electrophysiological examination to classify diabetic sensorimotor polyneuropathy (DSP), LDIFLARE area (cm(2)) was determined in 89 type 1 diabetes subjects matched to 64 healthy volunteers. We examined the association and diagnostic performance of LDI with clinical and subclinical measures of DSP and its severity. Results: Compared to the 64 healthy volunteers, the 56 diabetes controls without DSP had significantly lower LDIFLARE area (p = 0.006). The 33 diabetes cases with DSP had substantially lower LDIFLARE area as compared to controls without DSP (p = 0.002). There was considerable overlap in LDIFLARE area between all groups such that the ROC curve had an AUC of 0.72 and optimal sensitivity of 70% for the detection of clinical DSP. Use of a subclinical definition for DSP, according to subclinical sural nerve impairment, was associated with improved AUC of 0.75 and sensitivity of 79%. In multivariate analysis higher HbA1c and body mass index had independent associations with smaller LDIFLARE area. Conclusions: Axon reflex-mediated neurogenic vasodilatation in response to cutaneous heating is a biomarker of early nerve dysfunction in DSP. Its independent association with glycemic exposure in diabetes subjects and both glycemic exposure and BMI in healthy volunteers highlights the existence of small-fibre dysfunction in the natural history of DSP.	[Nouri, Maryam Nabavi; Bril, Vera; Ng, Eduardo; Nwe, Patti] Univ Toronto, Dept Med, Div Neurol, Toronto, ON, Canada; [Ahmed, Ausma; Orszag, Andrej; Perkins, Bruce A.] Univ Toronto, Dept Med, Div Endocrinol & Metab, Toronto, ON, Canada	University of Toronto; University of Toronto	Nouri, MN (corresponding author), Univ Toronto, Dept Med, Div Neurol, Toronto, ON, Canada.	bruce.perkins@uhn.on.ca	BRIL, vera/ABA-6509-2020; Perkins, Bruce A/L-3726-2017	Orszag, Andrej/0000-0002-0027-1607; Nabavi Nouri, Maryam/0000-0001-6317-4890	Juvenile Diabetes Research Foundation [17-2008-715]; Banting and Best Diabetes Centre	Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); Banting and Best Diabetes Centre	Funded by the Juvenile Diabetes Research Foundation (operating grant No.17-2008-715). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; BAP was a Canadian Diabetes Association Scholar. AA was supported by a Charles Hollenberg Studentship from the Banting and Best Diabetes Centre.	Baba M, 2002, INTERNAL MED, V41, P1079, DOI 10.2169/internalmedicine.41.1079; Bornmyr S, 1999, DIABETES CARE, V22, P593, DOI 10.2337/diacare.22.4.593; Boulton AJM, 2005, DIABETES CARE, V28, P956, DOI 10.2337/diacare.28.4.956; Bril V, 2002, DIABETES CARE, V25, P2048, DOI 10.2337/diacare.25.11.2048; Caselli A, 2006, J NEUROL NEUROSUR PS, V77, P927, DOI 10.1136/jnnp.2005.069609; Dworkin RH, 2010, J PAIN, V11, P360, DOI 10.1016/j.jpain.2009.08.005; England JD, 2009, NEUROLOGY, V72, P177, DOI 10.1212/01.wnl.0000336345.70511.0f; England JD, 2005, NEUROLOGY, V64, P199, DOI 10.1212/01.WNL.0000149522.32823.EA; Green AQ, 2010, DIABETES CARE, V33, P174, DOI 10.2337/dc09-0101; Green AQ, 2009, MUSCLE NERVE, V40, P985, DOI 10.1002/mus.21333; Hossain P, 2005, LANCET, V366, P1340, DOI 10.1016/S0140-6736(05)67546-0; KAHN R, 1992, DIABETES CARE, V15, P1092; Krishnan STM, 2007, DIABETES CARE, V30, P3058, DOI 10.2337/dc07-1421; Krishnan STM, 2009, DIABETES CARE, V32, P451, DOI 10.2337/dc08-1453; Krishnan STM, 2004, DIABETES CARE, V27, P2930, DOI 10.2337/diacare.27.12.2930; Lin Q, 1999, J NEUROPHYSIOL, V82, P2602, DOI 10.1152/jn.1999.82.5.2602; MASER RE, 1989, DIABETES, V38, P1456, DOI 10.2337/diabetes.38.11.1456; Nathan DM, 2009, DIABETES CARE, V32, P1327, DOI 10.2337/dc09-9033; Oh SJ, 2002, CLIN ELECTROMYOGRAPH, P86; Olaleye D, 2001, DIABETES RES CLIN PR, V54, P115, DOI 10.1016/S0168-8227(01)00278-9; ORCHARD TJ, 1990, DIABETES, V39, P1116, DOI 10.2337/diabetes.39.9.1116; Pambianco G, 2011, DIABETES RES CLIN PR, V92, P280, DOI 10.1016/j.diabres.2011.02.005; Perkins BA, 2003, CLIN NEUROPHYSIOL, V114, P1167, DOI 10.1016/S1388-2457(03)00025-7; Perkins BA, 2001, DIABETES CARE, V24, P250, DOI 10.2337/diacare.24.2.250; Perkins BA, 2010, DIABETES CARE, V33, P1549, DOI 10.2337/dc09-1835; Quadrado MJ, 2006, CORNEA, V25, P761, DOI 10.1097/01.ico.0000224635.49439.d1; Quattrini C, 2007, DIABETES, V56, P2148, DOI 10.2337/db07-0285; Schmelz M, 2000, NEUROREPORT, V11, P645, DOI 10.1097/00001756-200002280-00041; Smith AG, 2008, NEUROLOGIST, V14, P23, DOI 10.1097/NRL.0b013e31815a3956; Sumner CJ, 2003, NEUROLOGY, V60, P108, DOI 10.1212/WNL.60.1.108; Tavakoli M, 2011, JOVE-J VIS EXP, DOI 10.3791/2194; Tesfaye S, 1996, DIABETOLOGIA, V39, P1377, DOI 10.1007/s001250050586; Vinik AI, 2005, MUSCLE NERVE, V32, P619, DOI 10.1002/mus.20423; Yarnitsky D, 1997, MUSCLE NERVE, V20, P198; Zinman LH, 2004, DIABETES CARE, V27, P1674, DOI 10.2337/diacare.27.7.1674	35	19	19	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2012	7	4							e34807	10.1371/journal.pone.0034807	http://dx.doi.org/10.1371/journal.pone.0034807			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WC	22529938	Green Published, Green Submitted, gold			2022-12-25	WOS:000305347400019
J	Ivanek, R; Osterberg, J; Gautam, R; Lewerin, SS				Ivanek, Renata; Osterberg, Julia; Gautam, Raju; Lewerin, Susanna Sternberg			Salmonella Fecal Shedding and Immune Responses are Dose- and Serotype- Dependent in Pigs	PLOS ONE			English	Article							ANTIBODY-RESPONSES; MULTISTATE MODELS; RISK-FACTORS; TIME-COURSE; TYPHIMURIUM; TRANSMISSION; ENTERICA; FEED; HERD; EXCRETION	Despite the public health importance of Salmonella infection in pigs, little is known about the associated dynamics of fecal shedding and immunity. In this study, we investigated the transitions of pigs through the states of Salmonella fecal shedding and immune response post-Salmonella inoculation as affected by the challenge dose and serotype. Continuous-time multistate Markov models were developed using published experimental data. The model for shedding had four transient states, of which two were shedding (continuous and intermittent shedding) and two non-shedding (latency and intermittent non-shedding), and one absorbing state representing permanent cessation of shedding. The immune response model had two transient states representing responses below and above the seroconversion level. The effects of two doses [low (0.65 x 10(6) CFU/pig) and high (0.65 x 10(9) CFU/pig)] and four serotypes (Salmonella Yoruba, Salmonella Cubana, Salmonella Typhimurium, and Salmonella Derby) on the models' transition intensities were evaluated using a proportional intensities model. Results indicated statistically significant effects of the challenge dose and serotype on the dynamics of shedding and immune response. The time spent in the specific states was also estimated. Continuous shedding was on average 10-26 days longer, while intermittent non-shedding was 2-4 days shorter, in pigs challenged with the high compared to low dose. Interestingly, among pigs challenged with the high dose, the continuous and intermittent shedding states were on average up to 10-17 and 3-4 days longer, respectively, in pigs infected with S. Cubana compared to the other three serotypes. Pigs challenged with the high dose of S. Typhimurium or S. Derby seroconverted on average up to 8-11 days faster compared to the low dose. These findings highlight that Salmonella fecal shedding and immune response following Salmonella challenge are dose-and serotype-dependent and that the detection of specific Salmonella strains and immune responses in pigs are time-sensitive.	[Ivanek, Renata; Gautam, Raju] Texas A&M Univ, Coll Vet Med & Biomed Sci, Dept Vet Integrat Biosci, College Stn, TX 77843 USA; [Osterberg, Julia] Swedish Natl Vet Inst, Dept Anim Hlth & Antimicrobial Strategies, Uppsala, Sweden; [Lewerin, Susanna Sternberg] Swedish Univ Agr Sci, Dept Biomed Sci & Vet Publ Hlth, Uppsala, Sweden	Texas A&M University System; Texas A&M University College Station; National Veterinary Institute SVA; Swedish University of Agricultural Sciences	Ivanek, R (corresponding author), Texas A&M Univ, Coll Vet Med & Biomed Sci, Dept Vet Integrat Biosci, College Stn, TX 77843 USA.	rivanek@cvm.tamu.edu	Lewerin, Susanna Sternberg/C-1621-2015; Ivanek, Renata/B-9005-2009	Lewerin, Susanna Sternberg/0000-0001-7907-8377; Ivanek, Renata/0000-0001-6348-4709	National Science Foundation [NSF-EF-0913367]; Direct For Biological Sciences [0913042, 0913367] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by the National Science Foundation grant NSF-EF-0913367 to RI funded under the American Recovery and Reinvestment Act of 2009. Any opinions, findings, and conclusions or recommendations expressed in this material are those of the authors and do not necessarily reflect the views of the National Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bahnson PB, 2006, PREV VET MED, V76, P249, DOI 10.1016/j.prevetmed.2006.05.009; Boqvist S, 2003, ACTA VET SCAND, V44, P181, DOI 10.1186/1751-0147-44-181; Callaway T. R., 2006, Current Issues in Intestinal Microbiology, V7, P65; Centers for Disease Control and Prevention (CDC), 2006, REP FOODB DIS OUTBR; Charles SD, 2000, SWINE HEALTH PROD, V8, P107; Doyle ME, 2009, WHITE PAPER HUMAN IL; Doyle P.M., 1997, FOOD MICROBIOLOGY FU, P171; Eriksson Erik, 2007, BMC Vet Res, V3, P21, DOI 10.1186/1746-6148-3-21; FEDORKACRAY PJ, 1994, VET MICROBIOL, V41, P333, DOI 10.1016/0378-1135(94)90029-9; Garcia-Feliz C, 2009, PREV VET MED, V91, P130, DOI 10.1016/j.prevetmed.2009.05.011; GENTLEMAN RC, 1994, STAT MED, V13, P805, DOI 10.1002/sim.4780130803; Gill J, 2004, SOCIOL METHOD RES, V33, P54, DOI 10.1177/0049124103262681; Gray JT, 1996, AM J VET RES, V57, P313; Hendriksen SWM, 2004, EMERG INFECT DIS, V10, P2225, DOI 10.3201/eid1012.040286; Hougaard P, 1999, LIFETIME DATA ANAL, V5, P239, DOI 10.1023/A:1009672031531; Huston CL, 2002, J AM VET MED ASSOC, V220, P650, DOI 10.2460/javma.2002.220.650; Ivanek R, 2004, J FOOD PROTECT, V67, P2403, DOI 10.4315/0362-028X-67.11.2403; Ivaneka R, 2007, J THEOR BIOL, V245, P44, DOI 10.1016/j.jtbi.2006.09.031; Jackson C, 2010, MULTISTATE MARKOV HI; Jackson Christopher, 2007, MULTISTATE MODELLING; Jensen AN, 2006, APPL ENVIRON MICROB, V72, P1833, DOI 10.1128/AEM.72.3.1833-1842.2006; KALBFLEISCH JD, 1985, J AM STAT ASSOC, V80, P863, DOI 10.2307/2288545; KAY R, 1986, BIOMETRICS, V42, P855, DOI 10.2307/2530699; Korsak N, 2006, INT J FOOD MICROBIOL, V108, P246, DOI 10.1016/j.ijfoodmicro.2005.09.013; Machado LM, 2007, COMPUT METH PROG BIO, V86, P131, DOI 10.1016/j.cmpb.2007.01.010; MALMQVIST M, 1995, ACTA VET SCAND, V36, P21; MARSHALL G, 1995, STAT MED, V14, P1975, DOI 10.1002/sim.4780141804; Molla B, 2010, APPL ENVIRON MICROB, V76, P7188, DOI 10.1128/AEM.01169-10; Nielsen B, 1995, VET MICROBIOL, V47, P205, DOI 10.1016/0378-1135(95)00113-1; Osterberg J, 2008, VET REC, V162, P580, DOI 10.1136/vr.162.18.580; Osterberg J, 2006, ACTA VET SCAND, V47, P13, DOI 10.1186/1751-0147-47-13; Osterberg J, 2009, VET REC, V165, P404, DOI 10.1136/vr.165.14.404; Osterberg J, 2001, BERL MUNCH TIERARZTL, V114, P331; Osterberg J, 2010, ACTA VET SCAND, V52, DOI 10.1186/1751-0147-52-30; *R DEV COR TEAM, 2004, R LANG ENV STAT COMP; Radke BR, 2003, PREV VET MED, V59, P241, DOI 10.1016/S0167-5877(03)00103-X; Rccourt J, 1997, FOOD MICROBIOLOGY FU, P337; Sanchez J, 2007, PREV VET MED, V81, P148, DOI 10.1016/j.prevetmed.2007.04.005; Scherer K, 2008, J FOOD PROTECT, V71, P699, DOI 10.4315/0362-028X-71.4.699; Taormina PJ, 1999, EMERG INFECT DIS, V5, P626, DOI 10.3201/eid0505.990503; van Winsen RL, 2001, VET MICROBIOL, V80, P267, DOI 10.1016/S0378-1135(01)00313-3; WHO (World Health Organization), 2005, DRUG RES SALM	42	15	16	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2012	7	4							e34660	10.1371/journal.pone.0034660	http://dx.doi.org/10.1371/journal.pone.0034660			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VO	22523553	Green Published, gold, Green Submitted			2022-12-25	WOS:000305345000023
J	Kapoor, P; Singh, H; Gautam, A; Chaudhary, K; Kumar, R; Raghava, GPS				Kapoor, Pallavi; Singh, Harinder; Gautam, Ankur; Chaudhary, Kumardeep; Kumar, Rahul; Raghava, Gajendra P. S.			TumorHoPe: A Database of Tumor Homing Peptides	PLOS ONE			English	Article							DELIVERY; NANOPARTICLES; PREDICTION; THERAPY	Background: Cancer is responsible for millions of immature deaths every year and is an economical burden on developing countries. One of the major challenges in the present era is to design drugs that can specifically target tumor cells not normal cells. In this context, tumor homing peptides have drawn much attention. These peptides are playing a vital role in delivering drugs in tumor tissues with high specificity. In order to provide service to scientific community, we have developed a database of tumor homing peptides called TumorHoPe. Description: TumorHoPe is a manually curated database of experimentally validated tumor homing peptides that specifically recognize tumor cells and tumor associated microenvironment, i.e., angiogenesis. These peptides were collected and compiled from published papers, patents and databases. Current release of TumorHoPe contains 744 peptides. Each entry provides comprehensive information of a peptide that includes its sequence, target tumor, target cell, techniques of identification, peptide receptor, etc. In addition, we have derived various types of information from these peptide sequences that include secondary/tertiary structure, amino acid composition, and physicochemical properties of peptides. Peptides in this database have been found to target different types of tumors that include breast, lung, prostate, melanoma, colon, etc. These peptides have some common motifs including RGD (Arg-Gly-Asp) and NGR (Asn-Gly-Arg) motifs, which specifically recognize tumor angiogenic markers. TumorHoPe has been integrated with many web-based tools like simple/complex search, database browsing and peptide mapping. These tools allow a user to search tumor homing peptides based on their amino acid composition, charge, polarity, hydrophobicity, etc. Conclusion: TumorHoPe is a unique database of its kind, which provides comprehensive information about experimentally validated tumor homing peptides and their target cells. This database will be very useful in designing peptide-based drugs and drug-delivery system. It is freely available at http://crdd.osdd.net/raghava/tumorhope/.	[Kapoor, Pallavi; Singh, Harinder; Gautam, Ankur; Chaudhary, Kumardeep; Kumar, Rahul; Raghava, Gajendra P. S.] Inst Microbial Technol, CSIR, Bioinformat Ctr, Sect 39A, Chandigarh, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Microbial Technology (IMTECH)	Kapoor, P (corresponding author), Inst Microbial Technol, CSIR, Bioinformat Ctr, Sect 39A, Chandigarh, India.	raghava@imtech.res.in	Chaudhary, Kumardeep/Q-9740-2018; Kumar, Rahul/ABB-3530-2020; Raghava, Gajendra P.S./AAA-2413-2022; Singh, Harinder/V-7699-2019; Raghava, Gajendra/B-1717-2009; kumar, rahul/GZG-2171-2022	Chaudhary, Kumardeep/0000-0002-4117-6403; Raghava, Gajendra P.S./0000-0002-8902-2876; Singh, Harinder/0000-0003-4897-9759; Kumar, Rahul/0000-0002-6927-5390	Council of Scientific and Industrial Research (CSIR); Open Source Drug Discovery (OSDD); Department of Biotechnology, Government of India	Council of Scientific and Industrial Research (CSIR)(Council of Scientific & Industrial Research (CSIR) - India); Open Source Drug Discovery (OSDD); Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India)	The authors are thankful to Council of Scientific and Industrial Research (CSIR), Open Source Drug Discovery (OSDD) and Department of Biotechnology, Government of India for providing research fellowships. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Blanco E, 2011, CANCER SCI, V102, P1247, DOI 10.1111/j.1349-7006.2011.01941.x; Brahmachary M, 2004, NUCLEIC ACIDS RES, V32, pD586, DOI 10.1093/nar/gkh032; Corti A, 2011, MED RES REV; Corti A, 2008, BLOOD, V112, P2628, DOI 10.1182/blood-2008-04-150862; EISENBERG D, 1984, ANNU REV BIOCHEM, V53, P595, DOI 10.1146/annurev.bi.53.070184.003115; Ellerby HM, 1999, NAT MED, V5, P1032, DOI 10.1038/12469; Engel JB, 2007, MOL PHARM, V4, P652, DOI 10.1021/mp0700514; HOPP TP, 1981, P NATL ACAD SCI-BIOL, V78, P3824, DOI 10.1073/pnas.78.6.3824; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Jiang YQ, 2006, MOL MED, V12, P81, DOI 10.2119/2006-00011.Jiang; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Karmali PP, 2009, NANOMED-NANOTECHNOL, V5, P73, DOI 10.1016/j.nano.2008.07.007; Kaur H, 2007, PROTEIN PEPTIDE LETT, V14, P626; Khandare JJ, 2006, CRIT REV THER DRUG, V23, P401; Laakkonen P, 2010, INTEGR BIOL-UK, V2, P326, DOI 10.1039/c0ib00013b; Lata Sneh, 2009, BMC Res Notes, V2, P61, DOI 10.1186/1756-0500-2-61; Pearson W R, 2000, Methods Mol Biol, V132, P185; Rashid M, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-307; Reubi JC, 2003, ENDOCR REV, V24, P389, DOI 10.1210/er.2002-0007; Rosca EV, 2011, CURR PHARM BIOTECHNO, V12, P1101; Ru BB, 2010, MOLECULES, V15, P8279, DOI 10.3390/molecules15118279; Ruoslahti E, 2010, J CELL BIOL, V188, P759, DOI 10.1083/jcb.200910104; Ruoslahti ESR, 1997, US005622699A, Patent No. US005622699A; Saha S, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-79; Tang Y, 2010, PHARM RES-DORDR, V27, P2242, DOI 10.1007/s11095-010-0231-6; Temming K, 2006, BIOCONJUGATE CHEM, V17, P1385, DOI 10.1021/bc060087z; Thomas S, 2010, NUCLEIC ACIDS RES, V38, pD774, DOI 10.1093/nar/gkp1021	28	86	89	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2012	7	4							e35187	10.1371/journal.pone.0035187	http://dx.doi.org/10.1371/journal.pone.0035187			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VO	22523575	Green Published, gold, Green Submitted			2022-12-25	WOS:000305345000047
J	Stier, AC; Gil, MA; McKeon, CS; Lemer, S; Leray, M; Mills, SC; Osenberg, CW				Stier, Adrian C.; Gil, Michael A.; McKeon, C. Seabird; Lemer, Sarah; Leray, Matthieu; Mills, Suzanne C.; Osenberg, Craig W.			Housekeeping Mutualisms: Do More Symbionts Facilitate Host Performance?	PLOS ONE			English	Article							ANTAGONISTIC INTERACTIONS; COMMUNITY STRUCTURE; SEDIMENT-REJECTION; CORALS; GROWTH; COMPETITION; MECHANISMS; CRUSTACEA; BRACHYURA; BEHAVIOR	Mutualisms often involve one host supporting multiple symbionts, whose identity, density and intraguild interactions can influence the nature of the mutualism and performance of the host. However, the implications of multiple co-occurring symbionts on services to a host have rarely been quantified. In this study, we quantified effects of decapod symbionts on removal of sediment from their coral host. Our field survey showed that all common symbionts typically occur as pairs and never at greater abundances. Two species, the crab Trapezia serenei and the shrimp Alpheus lottini, were most common and co-occurred more often than expected by chance. We conducted a mesocosm experiment to test for effects of decapod identity and density on sediment removal. Alone, corals removed 10% of sediment, but removal increased to 30% and 48% with the presence of two and four symbionts, respectively. Per-capita effects of symbionts were independent of density and identity. Our results suggest that symbiont density is restricted by intraspecific competition. Thus, increased sediment removal from a coral host can only be achieved by increasing the number of species of symbionts on that coral, even though these species are functionally equivalent. Symbiont diversity plays a key role, not through added functionality but by overcoming density limitation likely imposed by intraspecific mating systems.	[Stier, Adrian C.; Gil, Michael A.; McKeon, C. Seabird; Osenberg, Craig W.] Univ Florida, Dept Biol, Gainesville, FL 32610 USA; [Lemer, Sarah; Leray, Matthieu; Mills, Suzanne C.] Univ Perpignan, Lab Excellence CORAIL, USR 3278, CNRS,EPHE,CBETM, F-66025 Perpignan, France; [McKeon, C. Seabird] Smithsonian Marine Stn, Smithsonian Inst Marine Sci Network, Ft Pierce, FL USA	State University System of Florida; University of Florida; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); Universite Perpignan Via Domitia; Smithsonian Institution; Smithsonian National Museum of Natural History	Stier, AC (corresponding author), Univ Florida, Dept Biol, Gainesville, FL 32610 USA.	adrian.stier@gmail.com	Mills, Suzanne/K-5538-2012; Osenberg, Craig/M-9904-2013	Mills, Suzanne/0000-0001-8948-3384; McKeon, Seabird/0000-0001-7261-8094; Leray, Matthieu/0000-0002-7327-1878; Stier, Adrian/0000-0002-4704-4145; Osenberg, Craig/0000-0003-1918-7904; Lemer, Sarah/0000-0003-0048-7296	Partnership University Fund of the French American Cultural Exchange (Ocean Bridges Program); National Science Foundation [OCE-1130359, DGE-0802270]; Division Of Ocean Sciences [1130359] Funding Source: National Science Foundation	Partnership University Fund of the French American Cultural Exchange (Ocean Bridges Program); National Science Foundation(National Science Foundation (NSF)); Division Of Ocean Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	Financial support was provided by the Partnership University Fund of the French American Cultural Exchange (Ocean Bridges Program, http://facecouncil.org/puf/) and the National Science Foundation (Grant No. OCE-1130359; and a Graduate Research Fellowship awarded to Dr. Gil, Grant No. DGE-0802270) for financial support. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abele L.G., 1976, Journal Biogeogr, V3, P35; Altshuler DL, 1999, OECOLOGIA, V119, P600, DOI 10.1007/s004420050825; BILLICK I, 1994, ECOLOGY, V75, P1529, DOI 10.2307/1939614; BOUCHER DH, 1982, ANNU REV ECOL SYST, V13, P315, DOI 10.1146/annurev.es.13.110182.001531; Bracken MES, 2007, ECOLOGY, V88, P2211, DOI 10.1890/06-0881.1; Bruno JF, 2003, TRENDS ECOL EVOL, V18, P119, DOI 10.1016/S0169-5347(02)00045-9; Caley MJ, 2001, ECOLOGY, V82, P2001; CASTRO P, 1978, MAR BIOL, V46, P237, DOI 10.1007/BF00390685; Crowley PH, 2011, TRENDS ECOL IN PRESS, DOI [10.1016/j.tree.2011.1007.1011, DOI 10.1016/J.TREE.2011.1007.1011]; DODGE RE, 1974, NATURE, V247, P574, DOI 10.1038/247574a0; Domenech J, 2004, FOREST ECOL MANAG, V194, P293, DOI 10.1016/j.foreco.2004.02.026; Fabricius KE, 2005, MAR POLLUT BULL, V50, P125, DOI 10.1016/j.marpolbul.2004.11.028; GLYNN PW, 1983, MAR BIOL LETT, V4, P105; Goheen JR, 2010, CURR BIOL, V20, P1768, DOI 10.1016/j.cub.2010.08.015; Gomulkiewicz R, 2003, AM NAT, V162, pS80, DOI 10.1086/378705; Griffen BD, 2006, OECOLOGIA, V148, P702, DOI 10.1007/s00442-006-0414-3; Hay ME, 2004, ANNU REV ECOL EVOL S, V35, P175, DOI 10.1146/annurev.ecolsys.34.011802.132357; HUBBARD DK, 1985, B MAR SCI, V36, P325; Hubbard J.A.E.B., 1972, Geologische Rundschau, V62, P598; HUBER ME, 1986, MAR ECOL PROG SER, V30, P21, DOI 10.3354/meps030021; HUBER ME, 1987, J CRUSTACEAN BIOL, V7, P238, DOI 10.2307/1548604; Jonsson LM, 2001, OIKOS, V93, P353, DOI 10.1034/j.1600-0706.2001.930301.x; LASKER HR, 1980, J EXP MAR BIOL ECOL, V47, P77, DOI 10.1016/0022-0981(80)90139-2; Loreau M, 2004, OIKOS, V104, P606, DOI 10.1111/j.0030-1299.2004.12685.x; McKeon CS, 2011, OECOLOGIA IN PRESS; McKeon CS, 2010, DIVERSITY TROPICAL M; Morris WF, 2007, ECOLOGY, V88, P1021, DOI 10.1890/06-0442; Oliveira RS, 2005, CHEMOSPHERE, V60, P1462, DOI 10.1016/j.chemosphere.2005.01.038; Palmer TM, 2003, AM NAT, V162, pS63, DOI 10.1086/378682; Palmer TM, 2008, SCIENCE, V319, P192, DOI 10.1126/science.1151579; Patton W.K., 1974, SYMBIOSIS SEA, P210; Pratchett MS, 2001, MAR ECOL PROG SER, V214, P111, DOI 10.3354/meps214111; Raine NE, 2004, ECOL ENTOMOL, V29, P345, DOI 10.1111/j.0307-6946.2004.00608.x; Rypien KL, 2010, ENVIRON MICROBIOL, V12, P28, DOI 10.1111/j.1462-2920.2009.02027.x; Sih A, 1998, TRENDS ECOL EVOL, V13, P350, DOI 10.1016/S0169-5347(98)01437-2; Stachowicz JJ, 2005, ECOLOGY, V86, P2418, DOI 10.1890/04-0819; STAFFORDSMITH MG, 1992, AUST J MAR FRESH RES, V43, P683, DOI 10.1071/MF9920683; Stanton ML, 2003, AM NAT, V162, pS10, DOI 10.1086/378646; Stewart HL, 2006, CORAL REEFS, V25, P609, DOI 10.1007/s00338-006-0132-7; Stier AC, 2010, CORAL REEFS, V29, P1019, DOI 10.1007/s00338-010-0663-9; Vance-Chalcraft HD, 2007, ECOLOGY, V88, P2689, DOI 10.1890/06-1869.1; Yachi S, 1999, P NATL ACAD SCI USA, V96, P1463, DOI 10.1073/pnas.96.4.1463	42	27	28	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2012	7	4							e32079	10.1371/journal.pone.0032079	http://dx.doi.org/10.1371/journal.pone.0032079			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VO	22523536	Green Submitted, Green Published, gold			2022-12-25	WOS:000305345000005
J	Wither, RG; Colic, S; Wu, CP; Bardakjian, BL; Zhang, L; Eubanks, JH				Wither, Robert G.; Colic, Sinisa; Wu, Chiping; Bardakjian, Berj L.; Zhang, Liang; Eubanks, James H.			Daily Rhythmic Behaviors and Thermoregulatory Patterns Are Disrupted in Adult Female MeCP2-Deficient Mice	PLOS ONE			English	Article							CPG-BINDING PROTEIN-2; RETT-SYNDROME; MOUSE MODEL; CIRCADIAN-CLOCK; HEART-RATE; MECP2; SLEEP; ABNORMALITIES; DEFICIENCY; MUTATIONS	Mutations in the X-linked gene encoding Methyl-CpG-binding protein 2 (MECP2) have been associated with neurodevelopmental and neuropsychiatric disorders including Rett Syndrome, X-linked mental retardation syndrome, severe neonatal encephalopathy, and Angelman syndrome. Although alterations in the performance of MeCP2-deficient mice in specific behavioral tasks have been documented, it remains unclear whether or not MeCP2 dysfunction affects patterns of periodic behavioral and electroencephalographic (EEG) activity. The aim of the current study was therefore to determine whether a deficiency in MeCP2 is sufficient to alter the normal daily rhythmic patterns of core body temperature, gross motor activity and cortical delta power. To address this, we monitored individual wild-type and MeCP2-deficient mice in their home cage environment via telemetric recording over 24 hour cycles. Our results show that the normal daily rhythmic behavioral patterning of cortical delta wave activity, core body temperature and mobility are disrupted in one-year old female MeCP2-deficient mice. Moreover, female MeCP2-deficient mice display diminished overall motor activity, lower average core body temperature, and significantly greater body temperature fluctuation than wild-type mice in their home-cage environment. Finally, we show that the epileptiform discharge activity in female MeCP2-deficient mice is more predominant during times of behavioral activity compared to inactivity. Collectively, these results indicate that MeCP2 deficiency is sufficient to disrupt the normal patterning of daily biological rhythmic activities.	[Wither, Robert G.; Eubanks, James H.] Univ Hlth Network, Toronto Western Res Inst, Div Genet & Dev, Toronto, ON, Canada; [Wu, Chiping; Zhang, Liang] Univ Hlth Network, Toronto Western Res Inst, Div Fundamental Neurobiol, Toronto, ON, Canada; [Wu, Chiping; Bardakjian, Berj L.; Zhang, Liang; Eubanks, James H.] Univ Toronto, Epilepsy Res Program, Toronto, ON, Canada; [Wither, Robert G.; Eubanks, James H.] Univ Toronto, Dept Physiol, Toronto, ON, Canada; [Zhang, Liang] Univ Toronto, Dept Med Neurol, Toronto, ON, Canada; [Eubanks, James H.] Univ Toronto, Dept Surg Neurosurg, Toronto, ON, Canada; [Colic, Sinisa; Bardakjian, Berj L.] Univ Toronto, Dept Elect & Comp Engn, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University of Toronto; University of Toronto; University of Toronto; University of Toronto	Wither, RG (corresponding author), Univ Hlth Network, Toronto Western Res Inst, Div Genet & Dev, Toronto, ON, Canada.	jeubanks@uhnres.utoronto.ca		Eubanks, James/0000-0001-8595-2024	Canadian Institutes of Health Research [MOP-106481, MOP-20158]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	Funding provided by an operating grant awarded by the Canadian Institutes of Health Research to JHE (MOP-106481), and by a Canadian Institutes of Health Research to BLJ (MOP-20158). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adegbola AA, 2009, HUM GENET, V124, P615, DOI 10.1007/s00439-008-0585-6; Alvarez-Saavedra M, 2011, HUM MOL GENET, V20, P731, DOI 10.1093/hmg/ddq519; Amir RE, 1999, NAT GENET, V23, P185, DOI 10.1038/13810; Boggio Elena M, 2010, Front Synaptic Neurosci, V2, P28, DOI 10.3389/fnsyn.2010.00028; Buzsaki G., 2006, RHYTHMS BRAIN; Calfa G, 2011, J NEUROPHYSIOL, V105, P1768, DOI 10.1152/jn.00800.2010; Chahrour M, 2007, NEURON, V56, P422, DOI 10.1016/j.neuron.2007.10.001; Chen RZ, 2001, NAT GENET, V27, P327, DOI 10.1038/85906; Cheng HYM, 2007, NEURON, V54, P813, DOI 10.1016/j.neuron.2007.05.017; Chiu AWL, 2006, J NEURAL ENG, V3, P9, DOI 10.1088/1741-2560/3/1/002; D'Cruz JA, 2010, NEUROBIOL DIS, V38, P8, DOI 10.1016/j.nbd.2009.12.018; De Filippis B, 2010, GENES BRAIN BEHAV, V9, P213, DOI 10.1111/j.1601-183X.2009.00551.x; El-Hayek YH, 2011, CEREB CORTEX, V21, P2863, DOI 10.1093/cercor/bhr080; Ellaway C, 2001, BRAIN DEV-JPN, V23, pS101, DOI 10.1016/S0387-7604(01)00356-4; Franken P, 2009, EUR J NEUROSCI, V29, P1820, DOI 10.1111/j.1460-9568.2009.06723.x; Franken P, 2001, J NEUROSCI, V21, P2610, DOI 10.1523/JNEUROSCI.21-08-02610.2001; Franken P, 1998, AM J PHYSIOL-REG I, V275, pR1127, DOI 10.1152/ajpregu.1998.275.4.R1127; Gonzales ML, 2010, CURR PSYCHIAT REP, V12, P127, DOI 10.1007/s11920-010-0097-7; GROSSMANN A, 1984, SIAM J MATH ANAL, V15, P723, DOI 10.1137/0515056; Guy J, 2001, NAT GENET, V27, P322, DOI 10.1038/85899; Guy J, 2007, SCIENCE, V315, P1143, DOI 10.1126/science.1138389; Hammer S, 2002, MENT RETARD DEV D R, V8, P94, DOI 10.1002/mrdd.10023; Jentarra GM, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-19; Jugloff DGM, 2008, HUM MOL GENET, V17, P1386, DOI 10.1093/hmg/ddn026; Lusardi TA, 2010, J CEREBR BLOOD F MET, V30, P744, DOI 10.1038/jcbfm.2009.253; Moretti P, 2005, HUM MOL GENET, V14, P205, DOI 10.1093/hmg/ddi016; Nagarajan RP, 2008, AUTISM RES, V1, P169, DOI 10.1002/aur.24; Nomura Y, 2005, BRAIN DEV-JPN, V27, pS35, DOI 10.1016/j.braindev.2005.03.017; Pelka GJ, 2006, BRAIN, V129, P887, DOI 10.1093/brain/awl022; PIAZZA CC, 1990, BRAIN DEV-JPN, V12, P488, DOI 10.1016/S0387-7604(12)80213-0; Rothman SM, 2005, EPILEPSY BEHAV, V7, P214, DOI 10.1016/j.yebeh.2005.05.021; Shahbazian MD, 2002, NEURON, V35, P243, DOI 10.1016/S0896-6273(02)00768-7; Sheward WJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009783; Suffczynski P, 2006, IEEE T BIO-MED ENG, V53, P524, DOI 10.1109/TBME.2005.869800; Ward CS, 2011, J NEUROSCI, V31, P10359, DOI 10.1523/JNEUROSCI.0057-11.2011; Yang JN, 2009, AM J PHYSIOL-HEART C, V296, pH1141, DOI 10.1152/ajpheart.00754.2008	36	36	36	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2012	7	4							e35396	10.1371/journal.pone.0035396	http://dx.doi.org/10.1371/journal.pone.0035396			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VO	22523589	Green Published, gold, Green Submitted			2022-12-25	WOS:000305345000062
J	Heymann, EW; Luttmann, K; Michalczyk, IM; Saboya, PPP; Ziegenhagen, B; Bialozyt, R				Heymann, Eckhard W.; Luettmann, Kathrin; Michalczyk, Inga M.; Pinedo Saboya, Pedro Pablo; Ziegenhagen, Birgit; Bialozyt, Ronald			DNA Fingerprinting Validates Seed Dispersal Curves from Observational Studies in the Neotropical Legume Parkia	PLOS ONE			English	Article							SAGUINUS-FUSCICOLLIS; SPATIAL-PATTERNS; MONKEYS; TAMARINS; ECOLOGY; IDENTIFICATION; LEGUMINOSAE; FRUGIVORES; PRIMATES; DISTANCE	Background: Determining the distances over which seeds are dispersed is a crucial component for examining spatial patterns of seed dispersal and their consequences for plant reproductive success and population structure. However, following the fate of individual seeds after removal from the source tree till deposition at a distant place is generally extremely difficult. Here we provide a comparison of observationally and genetically determined seed dispersal distances and dispersal curves in a Neotropical animal-plant system. Methodology/Principal Findings: In a field study on the dispersal of seeds of three Parkia (Fabaceae) species by two Neotropical primate species, Saguinus fuscicollis and Saguinus mystax, in Peruvian Amazonia, we observationally determined dispersal distances. These dispersal distances were then validated through DNA fingerprinting, by matching DNA from the maternally derived seed coat to DNA from potential source trees. We found that dispersal distances are strongly rights-kewed, and that distributions obtained through observational and genetic methods and fitted distributions do not differ significantly from each other. Conclusions/Significance: Our study showed that seed dispersal distances can be reliably estimated through observational methods when a strict criterion for inclusion of seeds is observed. Furthermore, dispersal distances produced by the two primate species indicated that these primates fulfil one of the criteria for efficient seed dispersers. Finally, our study demonstrated that DNA extraction methods so far employed for temperate plant species can be successfully used for hard-seeded tropical plants.	[Heymann, Eckhard W.; Luettmann, Kathrin] Deutsch Primatenzentrum GmbH, Abt Verhaltensokol & Soziobiol, Gottingen, Germany; [Michalczyk, Inga M.; Ziegenhagen, Birgit; Bialozyt, Ronald] Univ Marburg, AG Nat Schutzbiol, Marburg, Germany; [Michalczyk, Inga M.] Mobile DNAnal, Ebsdorfergrund, Germany; [Pinedo Saboya, Pedro Pablo] Univ Nacl Amazonia Peruana, Fac Ciencias Forestales, Iquitos, Peru	Deutsches Primatenzentrum (DPZ); Philipps University Marburg; Universidad Nacional de la Amazonia Peruana	Heymann, EW (corresponding author), Deutsch Primatenzentrum GmbH, Abt Verhaltensokol & Soziobiol, Gottingen, Germany.	eheyman@gwdg.de	Heymann, Eckhard W./I-2422-2014; Bialozyt, Ronald B/I-2021-2014	Heymann, Eckhard W./0000-0002-4259-8018; Bialozyt, Ronald B/0000-0003-0101-9443	Deutsche Forschungsgemeinschaft [HE 1870/15-1, HE 1870/15-2]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	Funding provided by the Deutsche Forschungsgemeinschaft, grant no. HE 1870/15-1 and HE 1870/15-2. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bowler M, 2011, INT J PRIMATOL, V32, P1109, DOI 10.1007/s10764-011-9527-6; Chapman Colin A., 1995, Evolutionary Anthropology, V4, P74, DOI 10.1002/evan.1360040303; Culot L, 2009, THESIS U LIEGE LIEGE; Culot L, 2010, INT J PRIMATOL, V31, P553, DOI 10.1007/s10764-010-9413-7; Dew JL, 2008, CAM S BIO EVOL ANTHR, V55, P155; Dumolin S, 1995, THEOR APPL GENET, V91, P1253, DOI 10.1007/BF00220937; ENCARNACION F, 1985, Candollea, V40, P237; Feldmann Marianne, 2000, Ecotropica (Bonn), V6, P207; Godoy JA, 2001, MOL ECOL, V10, P2275, DOI 10.1046/j.0962-1083.2001.01342.x; HEYMANN EW, 1995, J ZOOL, V237, P211, DOI 10.1111/j.1469-7998.1995.tb02759.x; Heymann EW, 2000, BIOL REV, V75, P169, DOI 10.1017/S0006323199005460; Holbrook K. M., 2007, Seed dispersal: theory and its application in a changing world, P300, DOI 10.1079/9781845931650.0300; Holbrook KM, 2000, OECOLOGIA, V125, P249, DOI 10.1007/s004420000445; HOPKINS HC, 1984, J ECOL, V72, P1, DOI 10.2307/2260003; HOPKINS HC, 1983, TROPICAL RAIN FOREST, P197; Hopkins HCF., 1986, FLORA NEOTROP, V43, P1; Jordano P, 2007, P NATL ACAD SCI USA, V104, P3278, DOI 10.1073/pnas.0606793104; Jordano P., 2007, Seed dispersal: theory and its application in a changing world, P229, DOI 10.1079/9781845931650.0229; KINZEY WG, 1993, INT J PRIMATOL, V14, P207, DOI 10.1007/BF02192632; Knogge C, 2003, FOLIA PRIMATOL, V74, P33, DOI 10.1159/000068392; Komsta L, 2011, MOMENTS MOMENTS CUMU; Leins P., 2008, BLUTE FRUCHT MORPHOL, V2; LUCKOW M, 1995, AM J BOT, V82, P1300, DOI 10.2307/2446253; Luettmann K, 2010, AM J BOT, V97, pE34, DOI 10.3732/ajb.1000096; Nathan R, 2000, TRENDS ECOL EVOL, V15, P278, DOI 10.1016/S0169-5347(00)01874-7; Neill DA, 2009, NOVON, V19, P204, DOI 10.3417/2007152; Oliveira ACM, 2000, J TROP ECOL, V16, P709, DOI 10.1017/S0266467400001668; Peakall R., 2006, GENALEX 6 GENETIC AN; Peres CA, 2000, J TROP ECOL, V16, P287, DOI 10.1017/S0266467400001413; Pritchard JK, 2000, GENETICS, V155, P945; Reinehr A, 2010, SAMENAUSBREITUNG LEO; SCHUPP EW, 1993, VEGETATIO, V108, P15; Sezen UU, 2009, P ROY SOC B-BIOL SCI, V276, P2037, DOI 10.1098/rspb.2008.1793; Soulsbury CD, 2007, CONSERV GENET, V8, P733, DOI 10.1007/s10592-006-9194-x; Stevenson PR, 2000, AM J PRIMATOL, V50, P275, DOI 10.1002/(SICI)1098-2345(200004)50:4&lt;275::AID-AJP4&gt;3.0.CO;2-K; Sun C, 1997, OECOLOGIA, V112, P94, DOI 10.1007/s004420050288; Taberlet P, 1999, BIOL J LINN SOC, V68, P41, DOI 10.1111/j.1095-8312.1999.tb01157.x; Taberlet P, 1996, NUCLEIC ACIDS RES, V24, P3189, DOI 10.1093/nar/24.16.3189; Tsuji Y, 2010, J TROP ECOL, V26, P115, DOI 10.1017/S0266467409990290; Valenta K, 2010, BIOTROPICA, V42, P223, DOI 10.1111/j.1744-7429.2009.00551.x; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Vasquez Martinez R, 1997, FLORULA RESERVAS BIO; Venables W., 2003, MODERN APPL STAT S; Wang BC, 2002, TRENDS ECOL EVOL, V17, P379, DOI 10.1016/S0169-5347(02)02541-7; Wehncke EV, 2007, J TROP ECOL, V23, P519, DOI 10.1017/S0266467407004257; Wehncke EV, 2003, J ECOL, V91, P677, DOI 10.1046/j.1365-2745.2003.00798.x; Wenny DG, 2000, ECOL MONOGR, V70, P331, DOI 10.1890/0012-9615(2000)070[0331:SDSPAS]2.0.CO;2; Zhang BC, 2016, J BASIC MICROB, V56, P670, DOI 10.1002/jobm.201500751; Ziegenhagen B., 1993, Plant Molecular Biology Reporter, V11, P117, DOI 10.1007/BF02670469; Ziegenhagen B, 2003, TREES-STRUCT FUNCT, V17, P345, DOI 10.1007/s00468-002-0244-9	50	16	16	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2012	7	4							e35480	10.1371/journal.pone.0035480	http://dx.doi.org/10.1371/journal.pone.0035480			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UT	22514748	gold, Green Published, Green Submitted			2022-12-25	WOS:000305341600153
J	Suzuki, T; Shioya, T; Murayama, T; Sugihara, M; Odagiri, F; Nakazato, Y; Nishizawa, H; Chugun, A; Sakurai, T; Daida, H; Morimoto, S; Kurebayashi, N				Suzuki, Takeshi; Shioya, Takao; Murayama, Takashi; Sugihara, Masami; Odagiri, Fuminori; Nakazato, Yuji; Nishizawa, Hiroto; Chugun, Akihito; Sakurai, Takashi; Daida, Hiroyuki; Morimoto, Sachio; Kurebayashi, Nagomi			Multistep Ion Channel Remodeling and Lethal Arrhythmia Precede Heart Failure in a Mouse Model of Inherited Dilated Cardiomyopathy	PLOS ONE			English	Article							GENE-EXPRESSION; VENTRICULAR REPOLARIZATION; K+ CURRENTS; MUTATIONS; ARRHYTHMOGENESIS; REFRACTORINESS; HYPERTROPHY; TRANSIENTS; DELETION; DEFECTS	Background: Patients with inherited dilated cardiomyopathy (DCM) frequently die with severe heart failure (HF) or die suddenly with arrhythmias, although these symptoms are not always observed at birth. It remains unclear how and when HF and arrhythmogenic changes develop in these DCM mutation carriers. In order to address this issue, properties of the myocardium and underlying gene expressions were studied using a knock-in mouse model of human inherited DCM caused by a deletion mutation Delta K210 in cardiac troponinT. Methodology/Principal Findings: By 1 month, DCM mice had already enlarged hearts, but showed no symptoms of HF and a much lower mortality than at 2 months or later. At around 2 months, some would die suddenly with no clear symptoms of HF, whereas at 3 months, many of the survivors showed evident symptoms of HF. In isolated left ventricular myocardium (LV) from 2 month-mice, spontaneous activity frequently occurred and action potential duration (APD) was prolonged. Transient outward (I-to) and ultrarapid delayed rectifier K+ (I-Kur) currents were significantly reduced in DCM myocytes. Correspondingly, down-regulation of Kv4.2, Kv1.5 and KChIP2 was evident in mRNA and protein levels. In LVs at 3-months, more frequent spontaneous activity, greater prolongation of APD and further down-regulation in above K+ channels were observed. At 1 month, in contrast, infrequent spontaneous activity and down-regulation of Kv4.2, but not Kv1.5 or KChIP2, were observed. Conclusions/Significance: Our results suggest that at least three steps of electrical remodeling occur in the hearts of DCM model mice, and that the combined down-regulation of Kv4.2, Kv1.5 and KChIP2 prior to the onset of HF may play an important role in the premature sudden death in this DCM model. DCM mice at 1 month or before, on the contrary, are associated with low risk of death in spite of inborn disorder and enlarged heart.	[Suzuki, Takeshi; Murayama, Takashi; Sugihara, Masami; Odagiri, Fuminori; Nishizawa, Hiroto; Chugun, Akihito; Sakurai, Takashi; Kurebayashi, Nagomi] Juntendo Univ, Grad Sch Med, Dept Cellular & Mol Pharmacol, Bunkyo Ku, Tokyo, Japan; [Suzuki, Takeshi; Sugihara, Masami; Odagiri, Fuminori; Nakazato, Yuji; Nishizawa, Hiroto; Daida, Hiroyuki] Juntendo Univ, Grad Sch Med, Dept Cardiovasc Med, Bunkyo Ku, Tokyo, Japan; [Shioya, Takao] Saga Univ, Dept Physiol, Fac Med, Saga 840, Japan; [Morimoto, Sachio] Kyushu Univ, Dept Clin Pharmacol, Fac Med Sci, Fukuoka 812, Japan	Juntendo University; Juntendo University; Saga University; Kyushu University	Suzuki, T (corresponding author), Juntendo Univ, Grad Sch Med, Dept Cellular & Mol Pharmacol, Bunkyo Ku, Tokyo, Japan.	nagomik@juntendo.ac.jp		Morimoto, Sachio/0000-0001-9171-3636	"High Technology Research Center'' Project for Private Universities: matching fund Ministry of Education, Culture, Sports, Science and Technology of Japan; Uehara Memorial Foundation; Vehicle Racing Commemorative Foundation; Institute of Seizon and Life Sciences;  [8590241];  [23136514]	"High Technology Research Center'' Project for Private Universities: matching fund Ministry of Education, Culture, Sports, Science and Technology of Japan; Uehara Memorial Foundation(Uehara Memorial Foundation); Vehicle Racing Commemorative Foundation; Institute of Seizon and Life Sciences; ; 	This work was supported by a Grant-in Aid (#18590241 and #23136514) and a "High Technology Research Center'' Project for Private Universities: matching fund subsidy from the Ministry of Education, Culture, Sports, Science and Technology of Japan (to NK). The authors also thank the Uehara Memorial Foundation, the Vehicle Racing Commemorative Foundation (to NK) and the Institute of Seizon and Life Sciences for financial support (to SM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baartscheer A, 2003, CARDIOVASC RES, V58, P99, DOI 10.1016/S0008-6363(02)00854-4; Baker LC, 2000, CIRC RES, V86, P396, DOI 10.1161/01.RES.86.4.396; Borlak J, 2003, FASEB J, V17, P1592, DOI 10.1096/fj.02-0889com; Brouillette J, 2004, J PHYSIOL-LONDON, V559, P777, DOI 10.1113/jphysiol.2004.063446; Brunet S, 2004, J PHYSIOL-LONDON, V559, P103, DOI 10.1113/jphysiol.2004.063347; Chang AN, 2005, HEART FAIL REV, V10, P225, DOI 10.1007/s10741-005-5252-6; Costantini DL, 2005, CELL, V123, P347, DOI 10.1016/j.cell.2005.08.004; Coughlin SS, 1997, J NATL MED ASSOC, V89, P277; DEC GW, 1994, NEW ENGL J MED, V331, P1564, DOI 10.1056/NEJM199412083312307; Du CK, 2007, CIRC RES, V101, P185, DOI 10.1161/CIRCRESAHA.106.146670; FUSTER V, 1981, AM J CARDIOL, V47, P525, DOI 10.1016/0002-9149(81)90534-8; Gramlich M, 2009, J MOL CELL CARDIOL, V47, P352, DOI 10.1016/j.yjmcc.2009.04.014; Grandy SA, 2007, AM J PHYSIOL-HEART C, V293, pH2168, DOI 10.1152/ajpheart.00521.2007; Guo WN, 2005, CIRC RES, V97, P1342, DOI 10.1161/01.RES.0000196559.63223.aa; Guo WN, 1999, J PHYSIOL-LONDON, V521, P587, DOI 10.1111/j.1469-7793.1999.00587.x; Haghighi K, 2006, P NATL ACAD SCI USA, V103, P1388, DOI 10.1073/pnas.0510519103; Harrell MD, 2007, PHYSIOL GENOMICS, V28, P273, DOI 10.1152/physiolgenomics.00163.2006; Janse MJ, 2004, CARDIOVASC RES, V61, P208, DOI 10.1016/j.cardiores.2003.11.018; Janse MJ, 2003, PROG BIOPHYS MOL BIO, V82, P187, DOI 10.1016/S0079-6107(03)00015-4; Kamisago M, 2000, NEW ENGL J MED, V343, P1688, DOI 10.1056/NEJM200012073432304; Kaprielian R, 1999, J PHYSIOL-LONDON, V517, P229, DOI 10.1111/j.1469-7793.1999.0229z.x; Knollmann BC, 2000, J PHYSIOL-LONDON, V525, P483, DOI 10.1111/j.1469-7793.2000.t01-1-00483.x; Kurebayashi N, 2004, AM J PHYSIOL-CELL PH, V287, pC1646, DOI 10.1152/ajpcell.00200.2004; Kurebayashi N, 2008, AM J PHYSIOL-CELL PH, V294, pC1419, DOI 10.1152/ajpcell.00413.2007; Kuwahara K, 2003, EMBO J, V22, P6310, DOI 10.1093/emboj/cdg601; London B, 2001, CIRC RES, V88, P940, DOI 10.1161/hh0901.090929; Marionneau C, 2005, J PHYSIOL-LONDON, V562, P223, DOI 10.1113/jphysiol.2004.074047; McCauley MD, 2009, DIS MODEL MECH, V2, P563, DOI 10.1242/dmm.002840; Morimoto S, 2002, P NATL ACAD SCI USA, V99, P913, DOI 10.1073/pnas.022628899; Morimoto S, 2008, CARDIOVASC RES, V77, P659, DOI 10.1093/cvr/cvm084; Mounkes LC, 2005, HUM MOL GENET, V14, P2167, DOI 10.1093/hmg/ddi221; Nattel S, 2007, PHYSIOL REV, V87, P425, DOI 10.1152/physrev.00014.2006; Nikolova V, 2004, J CLIN INVEST, V113, P357, DOI 10.1172/JCI200419448; Nishizawa H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007069; Otten E, 2010, NETH HEART J, V18, P478, DOI 10.1007/BF03091819; Pogwizd SM, 2004, TRENDS CARDIOVAS MED, V14, P61, DOI 10.1016/j.tcm.2003.12.002; Pogwizd SM, 2001, CIRC RES, V88, P1159, DOI 10.1161/hh1101.091193; Rivard K, 2009, AM J PHYSIOL-HEART C, V296, pH704, DOI 10.1152/ajpheart.00337.2008; Roden DM, 2006, J INTERN MED, V259, P59, DOI 10.1111/j.1365-2796.2005.01589.x; Sabir IN, 2007, PFLUG ARCH EUR J PHY, V454, P209, DOI 10.1007/s00424-007-0217-3; Seidman JG, 2001, CELL, V104, P557, DOI 10.1016/S0092-8674(01)00242-2; Shioya T, 2007, J PHYSIOL SCI, V57, P327, DOI 10.2170/physiolsci.RP010107; Sugihara M, 2011, J PHARM SCI; Suzuki M, 2001, CIRC RES, V88, P570, DOI 10.1161/01.RES.88.6.570; Tomaselli GF, 1999, CARDIOVASC RES, V42, P270, DOI 10.1016/S0008-6363(99)00017-6; Waldeyer C, 2009, BASIC RES CARDIOL, V104, P523, DOI 10.1007/s00395-009-0019-1; Wang YY, 2010, CARDIOVASC RES, V87, P636, DOI 10.1093/cvr/cvq133; Wu TJ, 1998, J AM COLL CARDIOL, V32, P187, DOI 10.1016/S0735-1097(98)00184-3; Xu Q, 2010, J MOL CELL CARDIOL, V48, P899, DOI 10.1016/j.yjmcc.2010.03.005; Zhan DY, 2009, CARDIOVASC RES, V84, P64, DOI 10.1093/cvr/cvp168	50	17	18	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2012	7	4							e35353	10.1371/journal.pone.0035353	http://dx.doi.org/10.1371/journal.pone.0035353			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UT	22514734	gold, Green Published, Green Submitted			2022-12-25	WOS:000305341600139
J	Smollett, KL; Smith, KM; Kahramanoglou, C; Arnvig, KB; Buxton, RS; Davis, EO				Smollett, Katherine L.; Smith, Kimberley M.; Kahramanoglou, Christina; Arnvig, Kristine B.; Buxton, Roger S.; Davis, Elaine O.			Global Analysis of the Regulon of the Transcriptional Repressor LexA, a Key Component of SOS Response in Mycobacterium tuberculosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DAMAGE-INDUCIBLE GENES; CHIP-SEQ DATA; DNA-DAMAGE; ESCHERICHIA-COLI; CELL-DIVISION; GENOME SEQUENCE; PROMOTER MOTIF; BETA-PROPELLER; RECA; IDENTIFICATION	The DNA damage response is crucial for bacterial survival. The transcriptional repressor LexA is a key component of the SOS response, the main mechanism for the regulation of DNA repair genes in many bacteria. In contrast, in mycobacteria gene induction by DNA damage is carried out by two mechanisms; a relatively small number of genes are thought to be regulated by LexA, and a larger number by an alternate, independent mechanism. In this study we have used ChIP-seq analysis to identify 25 in vivo LexA-binding sites, including nine regulating genes not previously known to be part of this regulon. Some of these binding sites were found to be internal to the predicted open reading frame of the gene they are thought to regulate; experimental analysis has confirmed that these LexA-binding sites regulate the expression of the expected genes, and transcriptional start site analysis has found that their apparent relative location is due to misannotation of these genes. We have also identified novel binding sites for LexA in the promoters of genes that show no apparent DNA damage induction, show positive regulation by LexA, and those encoding small RNAs.	[Smollett, Katherine L.; Smith, Kimberley M.; Kahramanoglou, Christina; Arnvig, Kristine B.; Buxton, Roger S.; Davis, Elaine O.] Natl Inst Med Res, MRC, Div Mycobacterial Res, London NW7 1AA, England	MRC National Institute for Medical Research	Smollett, KL (corresponding author), UCL, RNAP Lab, Darwin Bldg,Gower St, London WC1E 6BT, England.	k.smollett@ucl.ac.uk	Smollett, Katherine/AAC-2362-2020; Smollett, Katherine L/E-3650-2012	Smollett, Katherine/0000-0001-7961-7377; Smollett, Katherine L/0000-0001-7961-7377; Arnvig, Kristine/0000-0002-6850-2547	United Kingdom Medical Research Council Program [U1175 32056]; European Union FP7 Program SysteMtb [HEALTH-241587]; United Kingdom Medical Research Council Programs [U117585867, U117581288]; MRC [MC_U117585867] Funding Source: UKRI; Medical Research Council [MC_U117585867] Funding Source: researchfish	United Kingdom Medical Research Council Program(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Union FP7 Program SysteMtb; United Kingdom Medical Research Council Programs(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by United Kingdom Medical Research Council Program U1175 32056 and in part by European Union FP7 Program SysteMtb HEALTH-241587 and United Kingdom Medical Research Council Programs U117585867 and U117581288.	[Anonymous], 2011, GLOB TUB CONTR; Arnvig KB, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002342; Arnvig KB, 2009, MOL MICROBIOL, V73, P397, DOI 10.1111/j.1365-2958.2009.06777.x; Bailey T L, 1994, Proc Int Conf Intell Syst Mol Biol, V2, P28; Boshoff HIM, 2003, CELL, V113, P183, DOI 10.1016/S0092-8674(03)00270-8; Boysen A, 2010, J BIOL CHEM, V285, P10690, DOI 10.1074/jbc.M109.089755; Brooks PC, 2006, J BACTERIOL, V188, P6034, DOI 10.1128/JB.00340-06; Brooks PC, 2001, J BACTERIOL, V183, P4459, DOI 10.1128/JB.183.15.4459-4467.2001; Burney S, 1999, MUTAT RES-FUND MOL M, V424, P37, DOI 10.1016/S0027-5107(99)00006-8; Cairns J, 2011, BIOINFORMATICS, V27, P713, DOI 10.1093/bioinformatics/btq685; Camus JC, 2002, MICROBIOL-SGM, V148, P2967, DOI 10.1099/00221287-148-10-2967; Chauhan A, 2006, MOL MICROBIOL, V62, P132, DOI 10.1111/j.1365-2958.2006.05333.x; Cho BK, 2011, NUCLEIC ACIDS RES, V39, P6456, DOI 10.1093/nar/gkr307; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Davis Elaine O., 2009, P79; Davis EO, 2002, MOL MICROBIOL, V46, P791, DOI 10.1046/j.1365-2958.2002.03199.x; Davis EO, 2002, J BACTERIOL, V184, P3287, DOI 10.1128/JB.184.12.3287-3295.2002; Dawson LF, 2010, J BACTERIOL, V192, P599, DOI 10.1128/JB.01066-09; Dos Vultos T, 2009, FEMS MICROBIOL REV, V33, P471, DOI 10.1111/j.1574-6976.2009.00170.x; Dullaghan EM, 2002, MICROBIOL-SGM, V148, P3609, DOI 10.1099/00221287-148-11-3609; Erill I, 2006, NUCLEIC ACIDS RES, V34, P66, DOI 10.1093/nar/gkj412; Erill I, 2007, FEMS MICROBIOL REV, V31, P637, DOI 10.1111/j.1574-6976.2007.00082.x; Fleischmann RD, 2002, J BACTERIOL, V184, P5479, DOI 10.1128/JB.184.19.5479-5490.2002; Gamulin V, 2004, FEMS MICROBIOL LETT, V238, P57, DOI 10.1016/j.femsle.2004.07.017; Gomez JE, 2000, P NATL ACAD SCI USA, V97, P8554, DOI 10.1073/pnas.140225297; Gordon SV, 1999, MICROBIOL-SGM, V145, P881, DOI 10.1099/13500872-145-4-881; Grainger DC, 2007, NUCLEIC ACIDS RES, V35, P269, DOI 10.1093/nar/gkl1023; Grant CE, 2011, BIOINFORMATICS, V27, P1017, DOI 10.1093/bioinformatics/btr064; Gutekunst K, 2005, MOL MICROBIOL, V58, P810, DOI 10.1111/j.1365-2958.2005.04867.x; Hartkoorn RC, 2012, J BACTERIOL, V194, P2001, DOI 10.1128/JB.06692-11; Haydel SE, 2006, J BACTERIOL, V188, P150, DOI 10.1128/JB.188.1.150-159.2006; HUISMAN O, 1984, P NATL ACAD SCI-BIOL, V81, P4490, DOI 10.1073/pnas.81.14.4490; Jochmann N, 2009, MICROBIOL-SGM, V155, P1459, DOI 10.1099/mic.0.025841-0; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Miller JH., 1972, EXPT MOL GENETICS; Movahedzadeh F, 1997, MICROBIOL-UK, V143, P929, DOI 10.1099/00221287-143-3-929; Nathan C, 2000, P NATL ACAD SCI USA, V97, P8841, DOI 10.1073/pnas.97.16.8841; Oatway WH, 1936, J INFECT DIS, V59, P306, DOI 10.1093/infdis/59.3.306; Pang XH, 2011, TUBERCULOSIS, V91, pS142, DOI 10.1016/j.tube.2011.10.024; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Rand L, 2003, MOL MICROBIOL, V50, P1031, DOI 10.1046/j.1365-2958.2003.03765.x; Rutherford K, 2000, BIOINFORMATICS, V16, P944, DOI 10.1093/bioinformatics/16.10.944; Sala C, 2009, MOL MICROBIOL, V71, P1102, DOI 10.1111/j.1365-2958.2008.06583.x; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Shimada T, 2008, NUCLEIC ACIDS RES, V36, P3950, DOI 10.1093/nar/gkn339; Smollett KL, 2009, MICROBIOL-SGM, V155, P186, DOI 10.1099/mic.0.022889-0; Spyrou C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-299; Tapias A, 2002, NUCLEIC ACIDS RES, V30, P1539, DOI 10.1093/nar/30.7.1539; Wade JT, 2005, GENE DEV, V19, P2619, DOI 10.1101/gad.1355605; Waldor MK, 2005, CURR OPIN MICROBIOL, V8, P459, DOI 10.1016/j.mib.2005.06.001; Wang Y, 2011, J BIOL CHEM, V286, P31159, DOI 10.1074/jbc.M111.241802; Warner DF, 2010, P NATL ACAD SCI USA, V107, P13093, DOI 10.1073/pnas.1002614107	53	56	58	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 22	2012	287	26					22004	22014		10.1074/jbc.M112.357715	http://dx.doi.org/10.1074/jbc.M112.357715			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974GH	22528497	Green Published, hybrid			2022-12-25	WOS:000306418600039
J	Tennstaedt, A; Popsel, S; Truebestein, L; Hauske, P; Brockmann, A; Schmidt, N; Irle, I; Sacca, B; Niemeyer, CM; Brandt, R; Ksiezak-Reding, H; Tirniceriu, AL; Egensperger, R; Baldi, A; Dehmelt, L; Kaiser, M; Huber, R; Clausen, T; Ehrmann, M				Tennstaedt, Annette; Poepsel, Simon; Truebestein, Linda; Hauske, Patrick; Brockmann, Anke; Schmidt, Nina; Irle, Inga; Sacca, Barbara; Niemeyer, Christof M.; Brandt, Roland; Ksiezak-Reding, Hanna; Tirniceriu, Anca Laura; Egensperger, Rupert; Baldi, Alfonso; Dehmelt, Leif; Kaiser, Markus; Huber, Robert; Clausen, Tim; Ehrmann, Michael			Human High Temperature Requirement Serine Protease A1 (HTRA1) Degrades Tau Protein Aggregates	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PAIRED HELICAL FILAMENTS; ALZHEIMER-DISEASE; QUALITY CONTROL; IN-VITRO; INDUCED CYTOTOXICITY; BETA-STRUCTURE; PROTEOLYSIS; DEGP; DOMAIN; GENE	Protective proteases are key elements of protein quality control pathways that are up-regulated, for example, under various protein folding stresses. These proteases are employed to prevent the accumulation and aggregation of misfolded proteins that can impose severe damage to cells. The high temperature requirement A (HtrA) family of serine proteases has evolved to perform important aspects of ATP-independent protein quality control. So far, however, no HtrA protease is known that degrades protein aggregates. We show here that human HTRA1 degrades aggregated and fibrillar tau, a protein that is critically involved in various neurological disorders. Neuronal cells and patient brains accumulate less tau, neurofibrillary tangles, and neuritic plaques, respectively, when HTRA1 is expressed at elevated levels. Furthermore, HTRA1 mRNA and HTRA1 activity are up-regulated in response to elevated tau concentrations. These data suggest that HTRA1 is performing regulated proteolysis during protein quality control, the implications of which are discussed.	[Tennstaedt, Annette; Poepsel, Simon; Truebestein, Linda; Hauske, Patrick; Brockmann, Anke; Schmidt, Nina; Irle, Inga; Kaiser, Markus; Huber, Robert; Ehrmann, Michael] Univ Duisburg Essen, Fac Biol, Ctr Med Biotechnol, D-45141 Essen, Germany; [Sacca, Barbara; Niemeyer, Christof M.] Tech Univ Dortmund, Fak Chem, D-44227 Dortmund, Germany; [Brandt, Roland] Univ Osnabruck, Fachbereich Biol Chem, D-49076 Osnabruck, Germany; [Ksiezak-Reding, Hanna] Mt Sinai Sch Med, Dept Neurol, New York, NY 10029 USA; [Tirniceriu, Anca Laura; Egensperger, Rupert] Univ Munich, Ctr Neuropathol & Prion Res, D-81377 Munich, Germany; [Baldi, Alfonso] Univ Naples 2, Sect Pathol, Dept Biochem & Biophys, I-80100 Naples, Italy; [Dehmelt, Leif] Max Planck Inst Mol Physiol, D-44227 Dortmund, Germany; [Huber, Robert] Tech Univ Dortmund Univ, Dept Chem Biol, D-44227 Dortmund, Germany; [Huber, Robert] Max Planck Inst Biochem, D-82152 Martinsried, Germany; [Huber, Robert; Ehrmann, Michael] Cardiff Univ, Sch Biosci, Cardiff CF10 3US, S Glam, Wales; [Clausen, Tim] Res Inst Mol Pathol, A-1030 Vienna, Austria	University of Duisburg Essen; Dortmund University of Technology; University Osnabruck; Icahn School of Medicine at Mount Sinai; University of Munich; Universita della Campania Vanvitelli; Max Planck Society; Dortmund University of Technology; Max Planck Society; Cardiff University; Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP)	Ehrmann, M (corresponding author), Univ Duisburg Essen, Fac Biol, Ctr Med Biotechnol, Univ Str, D-45141 Essen, Germany.	michael.ehrmann@uni-due.de	Baldi, Alfonso/ABG-2397-2021; Sacca, Barbara/B-9554-2015; Poepsel, Simon/AAG-2009-2019; Ehrmann, Michael/A-7307-2012; Dehmelt, Leif/AAF-9616-2020; Niemeyer, Christof M/L-3568-2013	Sacca, Barbara/0000-0003-2708-2272; Ehrmann, Michael/0000-0002-1927-260X; Dehmelt, Leif/0000-0002-6559-6496; Niemeyer, Christof M/0000-0002-8837-081X; Poepsel, Simon/0000-0002-8304-4062; Brandt, Roland/0000-0003-0101-1257; Baldi, Alfonso/0000-0002-8693-3842; Clausen, Tim/0000-0003-1582-6924	Federal Ministry of Education and Research; Second University of Naples; Futura-onlus; Deutsche Forschungsgemeinschaft; Alzheimer's Research Trust; Fonds der Chemischen Industrie; Innovation, Science, Research, and Technology Ministry of Nordrhein-West-falen, Germany; Alzheimers Research UK [ART-PPG2005A-4] Funding Source: researchfish	Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); Second University of Naples; Futura-onlus; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Alzheimer's Research Trust; Fonds der Chemischen Industrie(Fonds der Chemischen IndustrieEuropean Commission); Innovation, Science, Research, and Technology Ministry of Nordrhein-West-falen, Germany; Alzheimers Research UK(Alzheimer&apos;s Research UK (ARUK))	Brain tissue was obtained from the German Brain Bank "Brain-Net," which is supported by the Federal Ministry of Education and Research.; Supported by grants from Second University of Naples and Futura-onlus.; Supported by Deutsche Forschungsgemeinschaft, Alzheimer's Research Trust, the Fonds der Chemischen Industrie, and a grant from the Innovation, Science, Research, and Technology Ministry of Nordrhein-West-falen, Germany.	Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Barghorn S, 2004, BIOCHEMISTRY-US, V43, P1694, DOI 10.1021/bi0357006; Beleford D, 2010, J BIOL CHEM, V285, P12011, DOI 10.1074/jbc.M109.097790; Berriman J, 2003, P NATL ACAD SCI USA, V100, P9034, DOI 10.1073/pnas.1530287100; Braak H, 2006, ACTA NEUROPATHOL, V112, P389, DOI 10.1007/s00401-006-0127-z; Brandt R, 2005, BBA-MOL BASIS DIS, V1739, P331, DOI 10.1016/j.bbadis.2004.06.018; Campioni M, 2010, MOL CANCER RES, V8, P1248, DOI 10.1158/1541-7786.MCR-09-0473; Chamberland A, 2009, J BIOL CHEM, V284, P27352, DOI 10.1074/jbc.M109.037051; Chien J, 2009, MOL CELL BIOL, V29, P4177, DOI 10.1128/MCB.00035-09; Chien J, 2009, CURR CANCER DRUG TAR, V9, P451, DOI 10.2174/156800909788486704; Chien J, 2009, J CELL BIOCHEM, V107, P253, DOI 10.1002/jcb.22121; Chien J, 2006, J CLIN INVEST, V116, P1994, DOI 10.1172/JCI27698; Clausen T, 2002, MOL CELL, V10, P443, DOI 10.1016/S1097-2765(02)00658-5; Clausen T, 2011, NAT REV MOL CELL BIO, V12, P152, DOI 10.1038/nrm3065; Clawson GA, 2008, J CELL BIOCHEM, V105, P81, DOI 10.1002/jcb.21804; CROWTHER RA, 1991, P NATL ACAD SCI USA, V88, P2288, DOI 10.1073/pnas.88.6.2288; Dentillo DB, 2010, REPROD SCI, V17, P1016, DOI 10.1177/1933719110377662; Egensperger R, 1998, BRAIN PATHOL, V8, P439; Ehrmann M, 2004, ANNU REV GENET, V38, P709, DOI 10.1146/annurev.genet.38.072902.093416; Eidenmuller J, 2000, BIOCHEMISTRY-US, V39, P13166, DOI 10.1021/bi001290z; Fath T, 2002, J NEUROSCI, V22, P9733; Friedhoff P, 1998, BIOCHEMISTRY-US, V37, P10223, DOI 10.1021/bi980537d; Grau S, 2005, P NATL ACAD SCI USA, V102, P6021, DOI 10.1073/pnas.0501823102; Grau S, 2006, J BIOL CHEM, V281, P6124, DOI 10.1074/jbc.M500361200; Hadfield KD, 2008, J BIOL CHEM, V283, P5928, DOI 10.1074/jbc.M709299200; Hara K, 2009, NEW ENGL J MED, V360, P1729, DOI 10.1056/NEJMoa0801560; Hasenbein S, 2010, J MOL BIOL, V397, P957, DOI 10.1016/j.jmb.2010.02.027; Hauske P, 2009, BIOORGAN MED CHEM, V17, P2920, DOI 10.1016/j.bmc.2009.01.073; Isaac DD, 2005, P NATL ACAD SCI USA, V102, P17775, DOI 10.1073/pnas.0508936102; Jones A, 2011, P NATL ACAD SCI USA, V108, P14578, DOI 10.1073/pnas.1102853108; Karring H, 2012, EXP EYE RES, V96, P163, DOI 10.1016/j.exer.2011.11.014; Kley J, 2011, NAT STRUCT MOL BIOL, V18, P728, DOI 10.1038/nsmb.2055; Krojer T, 2008, P NATL ACAD SCI USA, V105, P7702, DOI 10.1073/pnas.0803392105; Krojer T, 2008, NATURE, V453, P885, DOI 10.1038/nature07004; Krojer T, 2010, NAT STRUCT MOL BIOL, V17, P844, DOI 10.1038/nsmb.1840; Launay S, 2008, CELL DEATH DIFFER, V15, P1408, DOI 10.1038/cdd.2008.82; Li WK, 2006, BIOCHEMISTRY-US, V45, P15692, DOI 10.1021/bi061422+; Meltzer M, 2008, ANGEW CHEM INT EDIT, V47, P1332, DOI 10.1002/anie.200703273; MERCKEN M, 1995, FEBS LETT, V368, P10, DOI 10.1016/0014-5793(95)00590-6; Merdanovic M, 2011, ANNU REV MICROBIOL, V65, P149, DOI 10.1146/annurev-micro-090110-102925; Merdanovic M, 2010, NAT STRUCT MOL BIOL, V17, P837, DOI 10.1038/nsmb.1839; Milner JM, 2008, ARTHRITIS RHEUM-US, V58, P3644, DOI 10.1002/art.24046; MIRRA SS, 1991, NEUROLOGY, V41, P479, DOI 10.1212/WNL.41.4.479; MORGENSTERN JP, 1990, NUCLEIC ACIDS RES, V18, P3587, DOI 10.1093/nar/18.12.3587; Morris M, 2011, NEURON, V70, P410, DOI 10.1016/j.neuron.2011.04.009; Polur I, 2010, HISTOL HISTOPATHOL, V25, P599, DOI 10.14670/HH-25.599; Rissman RA, 2004, J CLIN INVEST, V114, P121, DOI 10.1172/JCI200420640; Roger B, 2004, CURR BIOL, V14, P363, DOI 10.1016/j.cub.2004.01.058; Sawa J, 2011, J BIOL CHEM, V286, P30680, DOI 10.1074/jbc.M111.243832; Severino A, 2007, J AM COLL CARDIOL, V50, P1029, DOI 10.1016/j.jacc.2007.06.006; Spiess C, 1999, CELL, V97, P339, DOI 10.1016/S0092-8674(00)80743-6; Spugnini EP, 2006, CLIN CANCER RES, V12, P6133, DOI 10.1158/1078-0432.CCR-06-1056; Suzuki Y, 2001, MOL CELL, V8, P613, DOI 10.1016/S1097-2765(01)00341-0; Talanian RV, 1997, J BIOL CHEM, V272, P9677; Truebestein L, 2011, NAT STRUCT MOL BIOL, V18, P386, DOI 10.1038/nsmb.2013; Tsuchiya A, 2005, BONE, V37, P323, DOI 10.1016/j.bone.2005.03.015; Vierkotten S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022959; Wilken C, 2004, CELL, V117, P483, DOI 10.1016/S0092-8674(04)00454-4; Xia SJ, 2007, LAB INVEST, V87, P318, DOI 10.1038/labinvest.3700521; Yang LS, 1997, J NEUROCHEM, V69, P1548; Yang ZL, 2006, SCIENCE, V314, P992, DOI 10.1126/science.1133811; Yang ZL, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000836	62	57	58	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 15	2012	287	25					20931	20941		10.1074/jbc.M111.316232	http://dx.doi.org/10.1074/jbc.M111.316232			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974FQ	22535953	hybrid, Green Published			2022-12-25	WOS:000306416800015
J	Guan, HB; Singh, NP; Singh, UP; Nagarkatti, PS; Nagarkatti, M				Guan, Hongbing; Singh, Narendra P.; Singh, Udai P.; Nagarkatti, Prakash S.; Nagarkatti, Mitzi			Resveratrol Prevents Endothelial Cells Injury in High-Dose Interleukin-2 Therapy against Melanoma	PLOS ONE			English	Article							VASCULAR LEAK SYNDROME; IMMATURE MYELOID CELLS; SUPPRESSOR-CELLS; T-CELLS; RECOMBINANT INTERLEUKIN-2; CYTOSOLIC FOXO1; NK CELLS; IMMUNOTHERAPY; INDUCTION; CARCINOMA	Immunotherapy with high-dose interleukin-2 (HDIL-2) is an effective treatment for patients with metastatic melanoma and renal cell carcinoma. However, it is accompanied by severe toxicity involving endothelial cell injury and induction of vascular leak syndrome (VLS). In this study, we found that resveratrol, a plant polyphenol with anti-inflammatory and anti-cancer properties, was able to prevent the endothelial cell injury and inhibit the development of VLS while improving the efficacy of HDIL-2 therapy in the killing of metastasized melanoma. Specifically, C57BL/6 mice were injected with B16F10 cells followed by resveratrol by gavage the next day and continued treatment with resveratrol once a day. On day 9, mice received HDIL-2. On day 12, mice were evaluated for VLS and tumor metastasis. We found that resveratrol significantly inhibited the development of VLS in lung and liver by protecting endothelial cell integrity and preventing endothelial cells from undergoing apoptosis. The metastasis and growth of the tumor in lung were significantly inhibited by HDIL-2 and HDIL-2 + resveratrol treatment. Notably, HDIL-2 + resveratrol co-treatment was more effective in inhibiting tumor metastasis and growth than HDIL-2 treatment alone. We also analyzed the immune status of Gr-1(+)CD11b(+) myeloid-derived suppressor cells (MDSC) and FoxP3(+)CD4(+) regulatory T cells (Treg). We found that resveratrol induced expansion and suppressive function of MDSC which inhibited the development of VLS after adoptive transfer. However, resveratrol suppressed the HDIL-2-induced expansion of Treg cells. We also found that resveratrol enhanced the susceptibility of melanoma to the cytotoxicity of IL-2-activated killer cells, and induced the expression of the tumor suppressor gene FoxO1. Our results suggested the potential use of resveratrol in HDIL-2 treatment against melanoma. We also demonstrated, for the first time, that MDSC is the dominant suppressor cell than regulatory T cell in the development of VLS.	[Guan, Hongbing; Singh, Narendra P.; Singh, Udai P.; Nagarkatti, Prakash S.; Nagarkatti, Mitzi] Univ S Carolina, Sch Med, Dept Pathol Microbiol & Immunol, Columbia, SC 29208 USA	University of South Carolina; University of South Carolina System; University of South Carolina Columbia	Nagarkatti, M (corresponding author), Univ S Carolina, Sch Med, Dept Pathol Microbiol & Immunol, Columbia, SC 29208 USA.	Mitzi.Nagarkatti@uscmed.sc.edu		Nagarkatti, Prakash/0000-0003-2663-0759; Singh, Udai/0000-0002-7048-4325	National Institute of Health [R01 AI053703, R01 AI058300, R01 HL058641, P01 AT003961]; National Center for Complementary & Integrative Health [P01AT003961] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL058641] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI058300, R01AI053703] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES019313] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Complementary & Integrative Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported in part by National Institute of Health Grants R01 AI053703, R01 AI058300, R01 HL058641, and P01 AT003961. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Assier E, 2004, J IMMUNOL, V172, P7661, DOI 10.4049/jimmunol.172.12.7661; Baluna R, 1997, IMMUNOPHARMACOLOGY, V37, P117, DOI 10.1016/S0162-3109(97)00041-6; Baluna R, 1999, P NATL ACAD SCI USA, V96, P3957, DOI 10.1073/pnas.96.7.3957; COTRAN RS, 1988, J IMMUNOL, V140, P1883; DAMLE NK, 1989, J IMMUNOL, V142, P2660; Donskov F, 2004, CANCER IMMUNOL IMMUN, V53, P729, DOI 10.1007/s00262-004-0525-9; Dutcher J, 2002, ONCOLOGY-NY, V16, P4; Elies J, 2011, MOL NUTR FOOD RES, V55, P1237, DOI 10.1002/mnfr.201100240; Gabrilovich DI, 2009, NAT REV IMMUNOL, V9, P162, DOI 10.1038/nri2506; Gatouillat G, 2010, J CELL BIOCHEM, V110, P893, DOI 10.1002/jcb.22601; Greten TF, 2011, INT IMMUNOPHARMACOL, V11, P802, DOI 10.1016/j.intimp.2011.01.003; Guan H, 2007, J IMMUNOL, V179, P3715, DOI 10.4049/jimmunol.179.6.3715; Gupta SC, 2011, ANN NY ACAD SCI, V1215, P150, DOI 10.1111/j.1749-6632.2010.05852.x; Hoechst B, 2009, HEPATOLOGY, V50, P799, DOI 10.1002/hep.23054; Kusmartsev S, 2005, J IMMUNOL, V174, P4880, DOI 10.4049/jimmunol.174.8.4880; Kusmartsev S, 2004, J IMMUNOL, V172, P989, DOI 10.4049/jimmunol.172.2.989; Lentsch AB, 1999, CANCER IMMUNOL IMMUN, V47, P243, DOI 10.1007/s002620050527; Li HQ, 2009, J IMMUNOL, V182, P240, DOI 10.4049/jimmunol.182.1.240; McDermott DF, 2009, CANCER-AM CANCER SOC, V115, P2298, DOI 10.1002/cncr.24236; McKallip RJ, 2003, J BIOL CHEM, V278, P43818, DOI 10.1074/jbc.M304467200; Medema RH, 2010, NAT CELL BIOL, V12, P642, DOI 10.1038/ncb0710-642; Melencio L, 2006, INT IMMUNOL, V18, P1461, DOI 10.1093/intimm/dxl079; Movahedi K, 2008, BLOOD, V111, P4233, DOI 10.1182/blood-2007-07-099226; Mustafa A, 2002, J IMMUNOTHER, V25, P476, DOI 10.1097/00002371-200211000-00004; Nagaraj S, 2007, NAT MED, V13, P828, DOI 10.1038/nm1609; Namasivayam N, 2011, ANN NY ACAD SCI, V1215, P60, DOI 10.1111/j.1749-6632.2010.05873.x; Narita Y, 2009, BIOMED RES-TOKYO, V30, P7, DOI 10.2220/biomedres.30.7; Osmond GW, 2012, J SURG RES, V172, P109, DOI 10.1016/j.jss.2010.07.033; Rafi AQ, 1998, J IMMUNOL, V161, P3077; Rodriguez PC, 2009, CANCER RES, V69, P1553, DOI 10.1158/0008-5472.CAN-08-1921; ROSENBERG SA, 1985, J EXP MED, V161, P1169, DOI 10.1084/jem.161.5.1169; ROSENSTEIN M, 1986, J IMMUNOL, V137, P1735; Schwartz RN, 2002, ONCOLOGY-NY, V16, P11; Singh NP, 2007, MOL PHARMACOL, V72, P1508, DOI 10.1124/mol.107.038984; Singh NP, 2011, MOL NUTR FOOD RES, V55, P1207, DOI 10.1002/mnfr.201000576; Singh UP, 2012, BRAIN BEHAV IMMUN, V26, P72, DOI 10.1016/j.bbi.2011.07.236; Wang H, 2011, HEART FAIL REV; Watanabe S, 2008, J IMMUNOL, V181, P3291, DOI 10.4049/jimmunol.181.5.3291; Yang Y, 2008, INT IMMUNOPHARMACOL, V8, P542, DOI 10.1016/j.intimp.2007.12.006; Zhao Y, 2010, NAT CELL BIOL, V12, P665, DOI 10.1038/ncb2069	40	39	41	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2012	7	4							e35650	10.1371/journal.pone.0035650	http://dx.doi.org/10.1371/journal.pone.0035650			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UD	22532866	Green Published, Green Submitted, gold			2022-12-25	WOS:000305339200090
J	Mutanga, JN; Raymond, J; Towle, MS; Mutembo, S; Fubisha, RC; Lule, F; Muhe, L				Mutanga, Jane N.; Raymond, Juliette; Towle, Megan S.; Mutembo, Simon; Fubisha, Robert Captain; Lule, Frank; Muhe, Lulu			Institutionalizing Provider-Initiated HIV Testing and Counselling for Children: An Observational Case Study from Zambia	PLOS ONE			English	Article							CARE; CHALLENGES; SETTINGS; AFRICA	Background: Provider-initiated testing and counselling (PITC) is a priority strategy for increasing access for HIV-exposed children to prevention measures, and infected children to treatment and care interventions. This article examines efforts to scale-up paediatric PITC at a second-level hospital located in Zambia's Southern Province, and serving a catchment area of 1.2 million people. Methods and Principal Findings: Our retrospective case study examined best practices and enabling factors for rapid institutionalization of PITC in Livingstone General Hospital. Methods included clinical observations, key informant interviews with programme management, and a desk review of hospital management information systems (HMIS) uptake data following the introduction of PITC. After PITC roll-out, the hospital experienced considerably higher testing uptake. In a 36-month period following PITC institutionalization, of total inpatient children eligible for PITC (n = 5074), 98.5% of children were counselled, and 98.2% were tested. Of children tested (n = 4983), 15.5% were determined HIV-infected; 77.6% of these results were determined by DNA polymerase chain reaction (PCR) testing in children under the age of 18 months. Of children identified as HIV-infected in the hospital's inpatient and outpatient departments (n = 1342), 99.3% were enrolled in HIV care, including initiation on co-trimoxazole prophylaxis. A number of good operational practices and enabling factors in the Livingstone General Hospital experience can inform rapid PITC institutionalization for inpatient and outpatient children. These include the placement of full-time nurse counsellors at key areas of paediatric intake, who interface with patients immediately and conduct testing and counselling. They are reinforced through task-shifting to peer counsellors in the wards. Nurse counsellor capacity to draw specimen for DNA PCR for children under 18 months has significantly enhanced early infant diagnosis. The hospital's bolstered antiretroviral supply chain, package of on-site HIV services, and follow-up care for children and families improved the continuum of service uptake. Conclusions and Significance: The clinical impact and operational experience emphasizes that institutional PITC is a feasible strategy for increasing access to paediatric HIV care, particularly in generalized epidemic settings.	[Mutanga, Jane N.] Livingstone Gen Hosp, Livingstone, Zambia; [Mutembo, Simon] So Prov Med Off, Livingstone, Zambia; [Fubisha, Robert Captain] Livingstone Paediat Ctr Excellence, Dept Paediat & Child Hlth, Livingstone, Zambia; [Lule, Frank] WHO, Reg Off Afr, Brazzaville, Rep Congo; [Muhe, Lulu] World Hlth Org Headquarters, Geneva, Switzerland	World Health Organization; World Health Organization	Muhe, L (corresponding author), Livingstone Gen Hosp, Livingstone, Zambia.	muhel@who.int	Mutanga, Jane N./AAO-1771-2020	Mutanga, Jane Namangolwa/0000-0002-1951-3565; mutembo, simon/0000-0002-5389-5966; Muhe, Lulu M/0000-0002-2776-9923	World Health Organization (WHO) Headquarters, Maternal, Child and Adolescent Health Department	World Health Organization (WHO) Headquarters, Maternal, Child and Adolescent Health Department	World Health Organization (WHO) Headquarters, Maternal, Child and Adolescent Health Department, provided financial support for the documentation of best practices at Livingstone General Hospital by an external consultant. LM is a staff member at the WHO Headquarters Maternal, Child and Adolescent Health Department. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2008, EP FACT SHEET HIV AI; Bolu OO, 2007, AM J OBSTET GYNECOL, V197, pS83, DOI 10.1016/j.ajog.2007.03.006; Eley B, 2007, ANN TROP PAEDIATR, V27, P1, DOI 10.1179/146532807X170448; Jones SA, 2005, B WORLD HEALTH ORGAN, V83, P559; Kankasa C, 2009, JAIDS-J ACQ IMM DEF, V51, P202, DOI 10.1097/QAI.0b013e31819c173f; Livingstone General Hospital, HLTH INF MAN SYST; McCollum ED, 2011, PEDIATR INFECT DIS J, V30, pE75, DOI 10.1097/INF.0b013e3182103f8a; McCollum ED, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009626; Meyers T, 2007, J INFECT DIS, V196, pS474, DOI 10.1086/521116; Ministry of Health Republic of Zambia, 2007, ZAMB DEM HLTH SURV; Ministry of Health Republic of Zambia, 2006, ZAMB NAT GUID HIV CO; Ministry of Health Republic of Zambia, 2007, PS MEM PROV IN TEST; Mwale JC, 2008, USING QUALITY IMPROV; Newell ML, 2004, LANCET, V364, P1236, DOI 10.1016/S0140-6736(04)17140-7; Orne-Gliemann J, 2008, AIDS, V22, P797, DOI 10.1097/QAD.0b013e3282f4f45a; Republic of Zambia Ministry of Health, 2008, ASS IMPL STAT PROV I; Sabin M, 2010, JAMA-J AM MED ASSOC, V304, P342, DOI 10.1001/jama.2010.995; Sherman GG, 2004, SAMJ S AFR MED J, V94, P289; Tene G, 2006, OPTIMIZING ENTRY CAR; Topp SM, 2011, B WORLD HEALTH ORGAN, V89, P328, DOI 10.2471/BLT.10.084442; UNAIDS, 2009, ZAMB COUNTR PROF; UNICEF, 2008, CHILDR AIDS 3 STOCKT; van Dijk JH, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-169; Wanyenze RK, 2010, TROP MED INT HEALTH, V15, P113, DOI 10.1111/j.1365-3156.2009.02417.x; Weigel R, 2009, BMC PEDIAT, V9, P80; WHO, 2010, UNAIDS REP GLOB AIDS; WHO UNICEF, 2008, SCAL HIV REL PREV DI; World Health Organization, 2007, GUID PROV IN HIV TES; World Health Organization, 2010, UN ACC SCAL PRIOR HI	29	39	39	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2012	7	4							e29656	10.1371/journal.pone.0029656	http://dx.doi.org/10.1371/journal.pone.0029656			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UD	22536311	gold, Green Published			2022-12-25	WOS:000305339200001
J	Alguacil, MD; Torrecillas, E; Hernandez, G; Roldan, A				del Mar Alguacil, Maria; Torrecillas, Emma; Hernandez, Guillermina; Roldan, Antonio			Changes in the Diversity of Soil Arbuscular Mycorrhizal Fungi after Cultivation for Biofuel Production in a Guantanamo (Cuba) Tropical System	PLOS ONE			English	Article							MOLECULAR DIVERSITY; PLANT; COMMUNITIES; GRASSLAND; CARBON; ROOTS; BIODIVERSITY; INOCULATION; RHIZOSPHERE; ECOSYSTEM	The arbuscular mycorrhizal fungi (AMF) are a key, integral component of the stability, sustainability and functioning of ecosystems. In this study, we characterised the AMF biodiversity in a native vegetation soil and in a soil cultivated with Jatropha curcas or Ricinus communis, in a tropical system in Guantanamo (Cuba), in order to verify if a change of land use to biofuel plant production had any effect on the AMF communities. We also asses whether some soil properties related with the soil fertility (total N, Organic C, microbial biomass C, aggregate stability percentage, pH and electrical conductivity) were changed with the cultivation of both crop species. The AM fungal small sub-unit (SSU) rRNA genes were subjected to PCR, cloning, sequencing and phylogenetic analyses. Twenty AM fungal sequence types were identified: 19 belong to the Glomeraceae and one to the Paraglomeraceae. Two AMF sequence types related to cultured AMF species (Glo G3 for Glomus sinuosum and Glo G6 for Glomus intraradices-G. fasciculatum-G. irregulare) did not occur in the soil cultivated with J. curcas and R. communis. The soil properties (total N, Organic C and microbial biomass C) were higher in the soil cultivated with the two plant species. The diversity of the AMF community decreased in the soil of both crops, with respect to the native vegetation soil, and varied significantly depending on the crop species planted. Thus, R. communis soil showed higher AMF diversity than J. curcas soil. In conclusion, R. communis could be more suitable for the long-term conservation and sustainable management of these tropical ecosytems.	[del Mar Alguacil, Maria; Torrecillas, Emma; Roldan, Antonio] CSIC Ctr Edafol & Biol Aplicada Segura, Dept Soil & Water Conservat, Murcia, Spain; [Hernandez, Guillermina] Inst Ecol & Sistemat CITMA, Grp Ecol Suelo, Havana, Cuba	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Edafologia y Biologia Aplicada del Segura (CEBAS)	Alguacil, MD (corresponding author), CSIC Ctr Edafol & Biol Aplicada Segura, Dept Soil & Water Conservat, Campus Espinardo, Murcia, Spain.	mmalguacil@cebas.csic.es	del Mar Alguacil, Maria/M-3859-2014; Roldan, Antonio/F-6241-2013	del Mar Alguacil, Maria/0000-0001-8495-8707; Roldan, Antonio/0000-0002-2610-7784	Ministerio de Educacion y Ciencia, Spain	Ministerio de Educacion y Ciencia, Spain(Spanish Government)	MM Alguacil was supported by the Ramon and Cajal programme (Ministerio de Educacion y Ciencia, Spain). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; MM Alguacil was supported by the Ramon and Cajal programme (Ministerio de Educacion y Ciencia, Spain).	Alguacil MM, 2011, SOIL BIOL BIOCHEM, V43, P167, DOI 10.1016/j.soilbio.2010.09.029; Alguacil MM, 2009, ENVIRON MICROBIOL, V11, P2649, DOI 10.1111/j.1462-2920.2009.01990.x; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Auge RM, 2001, PLANT SOIL, V230, P87, DOI 10.1023/A:1004891210871; Blaszkowski J, 2010, BOTANY, V88, P132, DOI 10.1139/B09-104; Cano Asseleih L. M., 1989, Journal of Food Biochemistry, V13, P1, DOI 10.1111/j.1745-4514.1989.tb00381.x; Caravaca F, 2002, APPL SOIL ECOL, V20, P107, DOI 10.1016/S0929-1393(02)00015-X; Cesaro P, 2008, APPL ENVIRON MICROB, V74, P5776, DOI 10.1128/AEM.00719-08; Charoenpakdee S, 2010, MYCOSPHERE, V1, P167; Colwell RK., 2013, STAT ESTIMATION SPEC; DELUCA TH, 1993, SOIL SCI SOC AM J, V57, P1296, DOI 10.2136/sssaj1993.03615995005700050022x; FAO, 1998, WORLD REF BAS SOIL R; Florez JP, 2004, THESIS U F DEPAULA S; Garcia C, 1997, COMMUN SOIL SCI PLAN, V28, P123, DOI 10.1080/00103629709369777; GIOVANNETTI M, 1980, NEW PHYTOL, V84, P489, DOI 10.1111/j.1469-8137.1980.tb04556.x; Gonzalez JM, 2005, BIOINFORMATICS, V21, P333, DOI 10.1093/bioinformatics/bti008; Hempel S, 2007, ENVIRON MICROBIOL, V9, P1930, DOI 10.1111/j.1462-2920.2007.01309.x; Hijri I, 2006, MOL ECOL, V15, P2277, DOI 10.1111/j.1365-294X.2006.02921.x; Husband R, 2002, MOL ECOL, V11, P2669, DOI 10.1046/j.1365-294X.2002.01647.x; Jumpponen A, 2005, BIOL FERT SOILS, V41, P217, DOI 10.1007/s00374-005-0845-8; Kovacs GM, 2002, PHYTON-ANN REI BOT A, V42, P211; Kumar A, 2010, J PLANT GROWTH REGUL, V29, P297, DOI 10.1007/s00344-009-9136-1; Lapola DM, 2009, BIOMASS BIOENERG, V33, P1087, DOI 10.1016/j.biombioe.2009.04.005; LAX A, 1994, ARID SOIL RES REHAB, V8, P9; Lee J, 2008, FEMS MICROBIOL ECOL, V65, P339, DOI 10.1111/j.1574-6941.2008.00531.x; Lekberg Y, 2007, J ECOL, V95, P95, DOI 10.1111/j.1365-2745.2006.01193.x; Li LF, 2010, FEMS MICROBIOL ECOL, V71, P418, DOI 10.1111/j.1574-6941.2009.00815.x; Nicholas KB., 1997, GENEDOC TOOL EDITING; Opik M, 2003, NEW PHYTOL, V160, P581, DOI 10.1046/j.1469-8137.2003.00917.x; Opik M, 2008, NEW PHYTOL, V179, P867, DOI 10.1111/j.1469-8137.2008.02515.x; Opik M, 2006, J ECOL, V94, P778, DOI 10.1111/j.1365-2745.2006.01136.x; PHILLIPS JM, 1970, T BRIT MYCOL SOC, V55, P158, DOI 10.1016/S0007-1536(70)80110-3; Picone C, 2003, ADV AGROECOL, P95; Pozo MJ, 2007, CURR OPIN PLANT BIOL, V10, P393, DOI 10.1016/j.pbi.2007.05.004; Prueksakorn K, 2 JOINT INT C SUST E; Recalde ER, 2009, CULTIVOS ENERGETICOS; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Schreiner RP, 2009, MYCOLOGIA, V101, P599, DOI 10.3852/08-169; Sikes BA, 2009, J ECOL, V97, P1274, DOI 10.1111/j.1365-2745.2009.01557.x; Singh AK, 2011, NATL ACAD SCI LETT, V34, P27; Smith S.E., 2008, MYCORRHIZAL SYMBIOSI, V3rd ed; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; SWOFFORD DL, 2002, PAUP PHYLOGENETIC AN; Sykorova Z, 2007, APPL ENVIRON MICROB, V73, P5426, DOI 10.1128/AEM.00987-07; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; ter Braak C.F.J., 2004, CANOCO REFERENCE MAN; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; van der Heijden MGA, 1998, NATURE, V396, P69, DOI 10.1038/23932; VANCE ED, 1987, SOIL BIOL BIOCHEM, V19, P703, DOI 10.1016/0038-0717(87)90052-6; Vandenkoornhuyse P, 2002, MOL ECOL, V11, P1555, DOI 10.1046/j.1365-294X.2002.01538.x; Vandenkoornhuyse P, 2003, MOL ECOL, V12, P3085, DOI 10.1046/j.1365-294X.2003.01967.x; Wardle DA, 1999, SOIL BIOL BIOCHEM, V31, P1707, DOI 10.1016/S0038-0717(99)00090-5; White T., 1990, PCR PROTOCOLS GUIDE, P315; Wilson GWT, 2009, ECOL LETT, V12, P452, DOI 10.1111/j.1461-0248.2009.01303.x; Wirsel SGR, 2004, FEMS MICROBIOL ECOL, V48, P129, DOI 10.1016/j.femsec.2004.01.006; YEOMANS JC, 1988, COMMUN SOIL SCI PLAN, V19, P1467, DOI 10.1080/00103628809368027	56	29	33	1	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2012	7	4							e34887	10.1371/journal.pone.0034887	http://dx.doi.org/10.1371/journal.pone.0034887			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TL	22536339	Green Submitted, Green Published, gold			2022-12-25	WOS:000305336200011
J	Hamshou, M; Van Damme, EJM; Vandenborre, G; Ghesquiere, B; Trooskens, G; Gevaert, K; Smagghe, G				Hamshou, Mohamad; Van Damme, Els J. M.; Vandenborre, Gianni; Ghesquiere, Bart; Trooskens, Geert; Gevaert, Kris; Smagghe, Guy			GalNAc/Gal-Binding Rhizoctonia solani Agglutinin Has Antiproliferative Activity in Drosophila melanogaster S2 Cells via MAPK and JAK/STAT Signaling	PLOS ONE			English	Article							TRANSDUCTION PATHWAY; TYROSINE KINASE; FUNGAL LECTIN; PROTEIN; LINES; ACTIVATION	Rhizoctonia solani agglutinin, further referred to as RSA, is a lectin isolated from the plant pathogenic fungus Rhizoctonia solani. Previously, we reported a high entomotoxic activity of RSA towards the cotton leafworm Spodoptera littoralis. To better understand the mechanism of action of RSA, Drosophila melanogaster Schneider S2 cells were treated with different concentrations of the lectin and FITC-labeled RSA binding was examined using confocal fluorescence microscopy. RSA has antiproliferative activity with a median effect concentration (EC50) of 0.35 mu M. In addition, the lectin was typically bound to the cell surface but not internalized. In contrast, the N-acetylglucosamine-binding lectin WGA and the galactose-binding lectin PNA, which were both also inhibitory for S2 cell proliferation, were internalized whereas the mannose-binding lectin GNA did not show any activity on these cells, although it was internalized. Extracted DNA and nuclei from S2 cells treated with RSA were not different from untreated cells, confirming inhibition of proliferation without apoptosis. Pre-incubation of RSA with N-acetylgalactosamine clearly inhibited the antiproliferative activity by RSA in S2 cells, demonstrating the importance of carbohydrate binding. Similarly, the use of MEK and JAK inhibitors reduced the activity of RSA. Finally, RSA affinity chromatography of membrane proteins from S2 cells allowed the identification of several cell surface receptors involved in both signaling transduction pathways.	[Hamshou, Mohamad; Vandenborre, Gianni; Smagghe, Guy] Univ Ghent, Fac Biosci Engn, Dept Crop Protect, Lab Agrozool, B-9000 Ghent, Belgium; [Hamshou, Mohamad; Van Damme, Els J. M.; Vandenborre, Gianni] Univ Ghent, Fac Biosci Engn, Dept Mol Biotechnol, Lab Biochem & Glycobiol, B-9000 Ghent, Belgium; [Ghesquiere, Bart; Gevaert, Kris] VIB, Dept Med Prot Res, Ghent, Belgium; [Ghesquiere, Bart; Gevaert, Kris] Univ Ghent, Dept Biochem, B-9000 Ghent, Belgium; [Trooskens, Geert] Univ Ghent, Fac Biosci Engn, Dept Math Modelling Stat & Bioinformat, B-9000 Ghent, Belgium	Ghent University; Ghent University; Flanders Institute for Biotechnology (VIB); Ghent University; Ghent University	Hamshou, M (corresponding author), Univ Ghent, Fac Biosci Engn, Dept Crop Protect, Lab Agrozool, B-9000 Ghent, Belgium.	guy.smagghe@ugent.be	Gevaert, Kris/D-6489-2017; Ghesquiere, Bart/HGU-8736-2022; Gevaert, Kris/H-3637-2013; Gevaert, Kris/AAE-4212-2019; Van Damme, Els/U-3904-2019; Smagghe, Guy/AAE-8914-2019; Van Damme, Els J/B-4410-2015	Gevaert, Kris/0000-0002-4237-0283; Ghesquiere, Bart/0000-0003-1547-1705; Gevaert, Kris/0000-0002-4237-0283; Gevaert, Kris/0000-0002-4237-0283; Van Damme, Els/0000-0001-9848-766X; Smagghe, Guy/0000-0001-8334-3313; 	Research Council of Ghent University (BOF-UGent) [BOF10/GOA/003]; Hercules Foundation; Fund for Scientific Research-Flanders (FWO-Vlaanderen) [3G016306]; FWO-Vlaanderen [3G016306, G.0156.05, G.0077.06, G.0042.07]; Concerted Research Actions [BOF07/GOA/012, BOF343 UGent]; Interuniversity Attraction Poles [IUAP06]	Research Council of Ghent University (BOF-UGent)(Ghent University); Hercules Foundation; Fund for Scientific Research-Flanders (FWO-Vlaanderen)(FWO); FWO-Vlaanderen(FWO); Concerted Research Actions; Interuniversity Attraction Poles(Belgian Federal Science Policy Office)	This research was supported by the Research Council of Ghent University (BOF-UGent; project BOF10/GOA/003), the Hercules Foundation, and the Fund for Scientific Research-Flanders (FWO-Vlaanderen; 3G016306) to GS and EVD. The UGent/VIB lab acknowledges support by research grants from the FWO-Vlaanderen (3G016306, G.0156.05, G.0077.06, G.0042.07), the Concerted Research Actions (BOF07/GOA/012) from BOF343 UGent, and the Interuniversity Attraction Poles (IUAP06). BG is a postdoctoral research fellow of the FWO-Vlaanderen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; Arbouzova NI, 2006, DEVELOPMENT, V133, P2605, DOI 10.1242/dev.02411; BIGGS WH, 1994, EMBO J, V13, P1628, DOI 10.1002/j.1460-2075.1994.tb06426.x; BRUNNER D, 1994, CELL, V76, P875, DOI 10.1016/0092-8674(94)90362-X; Candy L, 2001, BIOCHEM BIOPH RES CO, V282, P655, DOI 10.1006/bbrc.2001.4626; DAVIS RJ, 1993, J BIOL CHEM, V268, P14553; Francis F, 2003, EUR J CELL BIOL, V82, P515, DOI 10.1078/0171-9335-00338; Goldsmith ZG, 2007, ONCOGENE, V26, P3122, DOI 10.1038/sj.onc.1210407; Guillot J, 1997, BIOCHEM SYST ECOL, V25, P203, DOI 10.1016/S0305-1978(96)00110-X; Hamshou M, 2010, FUNGAL BIOL-UK, V114, P34, DOI 10.1016/j.mycres.2009.10.002; Hamshou M, 2007, Commun Agric Appl Biol Sci, V72, P639; Hamshou M, 2010, INSECT BIOCHEM MOLEC, V40, P883, DOI 10.1016/j.ibmb.2010.08.008; Howard MC, 1993, FUNDAMENTAL IMMUNOLO, V3, P763; IHLE JN, 1995, NATURE, V377, P591, DOI 10.1038/377591a0; KELLENS JTC, 1990, J GEN MICROBIOL, V136, P2489, DOI 10.1099/00221287-136-12-2489; Konska Grazyna, 2006, International Journal of Medicinal Mushrooms, V8, P19, DOI 10.1615/IntJMedMushr.v8.i1.20; Kuramoto T, 2005, J BIOCHEM, V137, P41, DOI 10.1093/jb/mvi005; Leonard WJ, 2000, J ALLERGY CLIN IMMUN, V105, P877, DOI 10.1067/mai.2000.106899; McKay MM, 2007, ONCOGENE, V26, P3113, DOI 10.1038/sj.onc.1210394; Ojaniemi M, 1997, J BIOL CHEM, V272, P25993, DOI 10.1074/jbc.272.41.25993; Patterson M, 2002, NAT REV GENET, V3, P162, DOI 10.1038/nrg763; Pujari R, 2010, BBA-GEN SUBJECTS, V1800, P1268, DOI 10.1016/j.bbagen.2010.09.003; Ragab A, 2011, EMBO J, V30, P1123, DOI 10.1038/emboj.2011.4; Rawal S, 2005, MOL CELL BIOCHEM, V268, P93, DOI 10.1007/s11010-005-3698-4; Rawlings JS, 2004, J CELL SCI, V117, P1281, DOI 10.1242/jcs.00963; SCHNEIDER I, 1972, J EMBRYOL EXP MORPH, V27, P353; Shahidi-Noghabi S, 2011, ARCH INSECT BIOCHEM, V76, P211, DOI 10.1002/arch.20405; Shahidi-Noghabi S, 2010, J INSECT PHYSIOL, V56, P1101, DOI 10.1016/j.jinsphys.2010.03.012; SIMON MA, 1991, CELL, V67, P701, DOI 10.1016/0092-8674(91)90065-7; Soin T, 2008, J INSECT PHYSIOL, V54, P429, DOI 10.1016/j.jinsphys.2007.11.001; Trigueros V, 2003, BBA-GEN SUBJECTS, V1621, P292, DOI 10.1016/S0304-4165(03)00098-9; TSUDA L, 1993, CELL, V72, P407, DOI 10.1016/0092-8674(93)90117-9; Van Damme EJM, 1998, HDB PLANT LECTINS PR; Vandenborre G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016682; Vandenborre G, 2010, J PROTEOME RES, V9, P3235, DOI 10.1021/pr1001753; VRANKEN AM, 1987, FEBS LETT, V216, P67, DOI 10.1016/0014-5793(87)80758-5; Wang M, 2002, J ECON ENTOMOL, V95, P603, DOI 10.1603/0022-0493-95.3.603; WASSARMAN DA, 1997, ADV DEV BIO, V5, P1; Xu SC, 1997, MOL ENDOCRINOL, V11, P1618, DOI 10.1210/me.11.11.1618	39	16	17	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2012	7	4							e33680	10.1371/journal.pone.0033680	http://dx.doi.org/10.1371/journal.pone.0033680			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959XD	22529896	Green Published, gold, Green Submitted			2022-12-25	WOS:000305350600005
J	Ohi, K; Hashimoto, R; Nakazawa, T; Okada, T; Yasuda, Y; Yamamori, H; Fukumoto, M; Umeda-Yano, S; Iwase, M; Kazui, H; Yamamoto, T; Kano, M; Takeda, M				Ohi, Kazutaka; Hashimoto, Ryota; Nakazawa, Takanobu; Okada, Takeya; Yasuda, Yuka; Yamamori, Hidenaga; Fukumoto, Motoyuki; Umeda-Yano, Satomi; Iwase, Masao; Kazui, Hiroaki; Yamamoto, Tadashi; Kano, Masanobu; Takeda, Masatoshi			The p250GAP Gene Is Associated with Risk for Schizophrenia and Schizotypal Personality Traits	PLOS ONE			English	Article							GTPASE-ACTIVATING-PROTEIN; IONOTROPIC GLUTAMATE RECEPTORS; HIGH-ACTIVITY ALLELE; COGNITIVE ENDOPHENOTYPES; POPULATION-LEVEL; RHO-FAMILY; EXPRESSION; DISORDERS; SUBUNIT; COMT	Background: Hypofunction of the glutamate N-Methyl-d-aspartate (NMDA) receptor has been implicated in the pathophysiology of schizophrenia. p250GAP is a brain-enriched NMDA receptor-interacting RhoGAP. p250GAP is involved in spine morphology, and spine morphology has been shown to be altered in the post-mortem brains of patients with schizophrenia. Schizotypal personality disorder has a strong familial relationship with schizophrenia. Several susceptibility genes for schizophrenia have been related to schizotypal traits. Methods: We first investigated the association of eight linkage disequilibrium-tagging single-nucleotide polymorphisms (SNPs) that cover the p250GAP gene with schizophrenia in a Japanese sample of 431 schizophrenia patients and 572 controls. We then investigated the impact of the risk genetic variant in the p250GAP gene on schizotypal personality traits in 180 healthy subjects using the Schizotypal Personality Questionnaire. Results: We found a significant difference in genotype frequency between the patients and the controls in rs2298599 (chi(2) = 17.6, p = 0.00015). The minor A/A genotype frequency of rs2298599 was higher in the patients (18%) than in the controls (9%) (chi(2) = 15.5, p = 0.000083). Moreover, we found that subjects with the rs2298599 risk A/A genotype, compared with G allele carriers, had higher scores of schizotypal traits (F-1,F-178 = 4.08, p = 0.045), particularly the interpersonal factor (F1,178 = 5.85, p = 0.017). Discussion: These results suggest that a genetic variation in the p250GAP gene might increase susceptibility not only for schizophrenia but also for schizotypal personality traits. We concluded that the p250GAP gene might be a new candidate gene for susceptibility to schizophrenia.	[Ohi, Kazutaka; Hashimoto, Ryota; Okada, Takeya; Yasuda, Yuka; Yamamori, Hidenaga; Fukumoto, Motoyuki; Iwase, Masao; Kazui, Hiroaki; Takeda, Masatoshi] Osaka Univ, Grad Sch Med, Dept Psychiat, Osaka, Japan; [Ohi, Kazutaka; Hashimoto, Ryota; Okada, Takeya; Yasuda, Yuka; Yamamori, Hidenaga; Fukumoto, Motoyuki] Japan Sci & Technol Agcy JST, CREST, Saitama, Japan; [Ohi, Kazutaka] Natl Hosp Org, Yamato Mental Med Ctr, Nara, Japan; [Hashimoto, Ryota; Takeda, Masatoshi] Kanazawa Univ, Osaka Univ, United Grad Sch Child Dev, Mol Res Ctr Childrens Mental Dev, Osaka, Japan; [Hashimoto, Ryota; Takeda, Masatoshi] Hamamatsu Univ Sch Med, Osaka, Japan; [Nakazawa, Takanobu; Yamamoto, Tadashi] Univ Tokyo, Inst Med Sci, Div Oncol, Tokyo, Japan; [Nakazawa, Takanobu; Kano, Masanobu] Univ Tokyo, Grad Sch Med, Dept Neurophysiol, Tokyo, Japan; [Yamamori, Hidenaga; Umeda-Yano, Satomi] Osaka Univ, Grad Sch Med, Dept Mol Neuropsychiat, Osaka, Japan	Osaka University; Japan Science & Technology Agency (JST); Kanazawa University; Osaka University; Hamamatsu University School of Medicine; University of Tokyo; University of Tokyo; Osaka University	Ohi, K (corresponding author), Osaka Univ, Grad Sch Med, Dept Psychiat, Osaka, Japan.	hashimor@psy.med.osaka-u.ac.jp	Hashimoto, Ryota/AAE-3200-2019; Hashimoto, Ryota/P-8572-2014; Nakazawa, Takanobu/E-1012-2014; Ohi, Kazutaka/J-7851-2019	Hashimoto, Ryota/0000-0002-5941-4238; Hashimoto, Ryota/0000-0002-5941-4238; Nakazawa, Takanobu/0000-0002-5049-9140; Ohi, Kazutaka/0000-0001-9577-9640; NAKAZAWA, Takanobu/0000-0003-4863-1277; Kano, Masanobu/0000-0002-0725-3292	Japanese Ministry of Health, Labor and Welfare [H22-seishin-ippan-001]; Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT) KAKENHI [22390225, 23659565, 221S0003]; CREST of JST; Japan Foundation for Neuroscience and Mental Health; Ministry of Education, Culture, Sports, Science, and Technology, Japan; Grants-in-Aid for Scientific Research [23791331, 22390225] Funding Source: KAKEN	Japanese Ministry of Health, Labor and Welfare(Ministry of Health, Labour and Welfare, Japan); Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT) KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); CREST of JST(Core Research for Evolutional Science and Technology (CREST)); Japan Foundation for Neuroscience and Mental Health(Japan Foundation for Neuroscience and Mental Health); Ministry of Education, Culture, Sports, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by research grants from the Japanese Ministry of Health, Labor and Welfare (H22-seishin-ippan-001); the Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT) KAKENHI [22390225-Grant-in-Aid for Scientific Research (B), 23659565-Grant-in-Aid for Challenging Exploratory Research and 221S0003-Grant-in-Aid for Scientific Research on Innovative Areas (Comprehensive Brain Science Network)]; the CREST of JST; and the Japan Foundation for Neuroscience and Mental Health. Additionally, this work was supported by the Strategic Research Program for Brain Sciences (Development of Biomarker Candidates for Social Behavior) of the Ministry of Education, Culture, Sports, Science, and Technology, Japan. No additional external funding was received for this study. The funders had no role in the study design, data collection and analyses, decision to publish, or preparation of the manuscript.	Arnsten AFT, 2011, INT J DEV NEUROSCI, V29, P215, DOI 10.1016/j.ijdevneu.2011.02.006; Avramopoulos D, 2002, MOL PSYCHIATR, V7, P706, DOI 10.1038/sj.mp.4001070; Beneyto M, 2008, NEUROPSYCHOPHARMACOL, V33, P2175, DOI 10.1038/sj.npp.1301604; Bennett MR, 2011, PROG NEUROBIOL, V95, P275, DOI 10.1016/j.pneurobio.2011.08.003; Cardno AG, 2000, AM J MED GENET, V97, P12, DOI 10.1002/(SICI)1096-8628(200021)97:1<12::AID-AJMG3>3.3.CO;2-L; Cichon S, 2009, AM J PSYCHIAT, V166, P540, DOI 10.1176/appi.ajp.2008.08091354; du Bois TM, 2007, BRAIN RES REV, V53, P260, DOI 10.1016/j.brainresrev.2006.09.001; Ericson M, 2011, BEHAV GENET, V41, P499, DOI 10.1007/s10519-010-9401-x; Gao XM, 2000, AM J PSYCHIAT, V157, P1141, DOI 10.1176/appi.ajp.157.7.1141; Harrison PJ, 2005, MOL PSYCHIATR, V10, P40, DOI 10.1038/sj.mp.4001558; Hashimoto R, 2007, MOL PSYCHIATR, V12, P1026, DOI 10.1038/sj.mp.4001982; Hashimoto R, 2006, HUM MOL GENET, V15, P3024, DOI 10.1093/hmg/ddl244; Heimer L, 2000, BRAIN RES REV, V31, P205, DOI 10.1016/S0165-0173(99)00039-9; Herin GA, 2004, EUR J PHARMACOL, V500, P101, DOI 10.1016/j.ejphar.2004.07.015; Iijima Y, 2010, KOUDOURYOUHOUKENKYU, V36, P29, DOI DOI 10.24468/jjbt.36.1_29; Kendler KS, 2007, PSYCHOL MED, V37, P655, DOI 10.1017/S0033291706009755; KENDLER KS, 1993, ARCH GEN PSYCHIAT, V50, P781; Kircher T, 2009, PSYCHOL MED, V39, P1657, DOI 10.1017/S0033291709005388; KORNHUBER J, 1989, J NEURAL TRANSM, V77, P231, DOI 10.1007/BF01248936; Kristiansen LV, 2010, SYNAPSE, V64, P495, DOI 10.1002/syn.20754; Lin CCH, 2007, BEHAV GENET, V37, P334, DOI 10.1007/s10519-006-9104-5; Lin HF, 2005, PSYCHOL MED, V35, P1589, DOI 10.1017/S0033291705005957; Ma XH, 2007, PSYCHIAT RES, V153, P7, DOI 10.1016/j.psychres.2007.02.003; Moon SY, 2003, J BIOL CHEM, V278, P4151, DOI 10.1074/jbc.M207789200; Mueller HT, 2004, MOL BRAIN RES, V121, P60, DOI 10.1016/j.molbrainres.2003.11.004; Nakamura T, 2002, MOL CELL BIOL, V22, P8721, DOI 10.1128/MCB.22.24.8721-8734.2002; Nakazawa T, 2003, MOL BIOL CELL, V14, P2921, DOI 10.1091/mbc.e02-09-0623; Nakazawa T, 2008, J NEUROCHEM, V105, P1384, DOI 10.1111/j.1471-4159.2008.05335.x; Ohi K, 2010, SCHIZOPHR RES, V116, P126, DOI 10.1016/j.schres.2009.12.002; Ohi K, 2009, SCHIZOPHR RES, V109, P80, DOI 10.1016/j.schres.2009.01.019; Okabe T, 2003, J BIOL CHEM, V278, P9920, DOI 10.1074/jbc.M208872200; Olney JW, 1999, J PSYCHIAT RES, V33, P523, DOI 10.1016/S0022-3956(99)00029-1; PorteraCailliau C, 1996, J NEUROCHEM, V66, P692, DOI 10.1046/j.1471-4159.1996.66020692.x; Pulay Attila J, 2009, Prim Care Companion J Clin Psychiatry, V11, P53; RAINE A, 1994, SCHIZOPHRENIA BULL, V20, P191, DOI 10.1093/schbul/20.1.191; RAINE A, 1991, SCHIZOPHRENIA BULL, V17, P555, DOI 10.1093/schbul/17.4.555; Schurhoff F, 2007, AM J MED GENET B, V144B, P64, DOI 10.1002/ajmg.b.30395; Sheldrick AJ, 2008, EUR PSYCHIAT, V23, P385, DOI 10.1016/j.eurpsy.2008.05.002; Skol AD, 2006, NAT GENET, V38, P209, DOI 10.1038/ng1706; Solano JJR, 2000, SCHIZOPHR RES, V44, P137, DOI 10.1016/S0920-9964(99)00203-0; Someya T, 1994, P 32 SCI M U HLTH CA, P286; Stefanis NC, 2007, BIOL PSYCHIAT, V62, P784, DOI 10.1016/j.biopsych.2006.11.015; Stefanis NC, 2008, BEHAV BRAIN FUNCT, V4, DOI 10.1186/1744-9081-4-46; Tada T, 2006, CURR OPIN NEUROBIOL, V16, P95, DOI 10.1016/j.conb.2005.12.001; Torgersen S, 2000, COMPR PSYCHIAT, V41, P416, DOI 10.1053/comp.2000.16560; Tsuang M, 2000, BIOL PSYCHIAT, V47, P210, DOI 10.1016/S0006-3223(99)00289-9; Vo N, 2005, P NATL ACAD SCI USA, V102, P16426, DOI 10.1073/pnas.0508448102; WATANABE M, 1992, NEUROREPORT, V3, P1138, DOI 10.1097/00001756-199212000-00027; Wenzel A, 1997, J NEUROCHEM, V68, P469; Yasuda Y, 2011, NEUROSCI LETT, V495, P216, DOI 10.1016/j.neulet.2011.03.069; Yoshihara Y, 2009, CURR OPIN NEUROBIOL, V19, P146, DOI 10.1016/j.conb.2009.05.013; Zavitsanou K, 2002, NEUROPSYCHOPHARMACOL, V27, P826, DOI 10.1016/S0893-133X(02)00347-0	52	14	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2012	7	4							e35696	10.1371/journal.pone.0035696	http://dx.doi.org/10.1371/journal.pone.0035696			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959XD	22530067	Green Published, Green Submitted, gold			2022-12-25	WOS:000305350600113
J	Pabst, S; Hammerstingl, C; Hundt, F; Gerhardt, T; Grohe, C; Nickenig, G; Woitas, R; Skowasch, D				Pabst, Stefan; Hammerstingl, Christoph; Hundt, Felix; Gerhardt, Thomas; Grohe, Christian; Nickenig, Georg; Woitas, Rainer; Skowasch, Dirk			Pulmonary Hypertension in Patients with Chronic Kidney Disease on Dialysis and without Dialysis: Results of the PEPPER-Study	PLOS ONE			English	Article							HEMODIALYSIS-PATIENTS; NITRIC-OXIDE; ENDOTHELIN-1; PREVALENCE	Pulmonary hypertension (PH) is common in patients with dialysis-dependent chronic kidney disease and is an independent predictor of mortality. However, specific hemodynamics of the pulmonary circulation, changes induced by hemodialysis and characterization into pre- or postcapillary PH have not been evaluated in patients with chronic kidney disease. We assessed consecutive patients with end-stage chronic kidney disease in WHO FC >= II with dyspnea unexplained by other causes on hemodialysis (group 1, n = 31) or without dialysis (group 2, n = 31) using right heart catheterization (RHC). In group 1, RHC was performed before and after dialysis. In end-stage chronic kidney disease, prevalence of precapillary PH was 13% (4/31), and postcapillary PH was discovered in 65% (20/31). All four cases of precapillary PH were unmasked after dialysis. In group 2, two cases of precapillary PH were detected (6%), and postcapillary PH was diagnosed in 22 cases (71%). This is the first study examining a large cohort of patients with chronic kidney disease invasively by RHC for the prevalence of PH. The prevalence of precapillary PH was 13% in patients with end-stage kidney disease. That suggests careful screening for precapillary PH in this selected patient population. RHC should be performed after hemodialysis.	[Pabst, Stefan; Hammerstingl, Christoph; Nickenig, Georg; Skowasch, Dirk] Univ Bonn, Dept Internal Med Cardiol Pneumol 2, Bonn, Germany; [Hundt, Felix; Woitas, Rainer] Univ Bonn, Dept Internal Med Nephrol 1, Bonn, Germany; [Gerhardt, Thomas] Praxis Nieren & Hochdruckkrankheiten Bonn, Bonn, Germany; [Grohe, Christian] Lungenklin Berlin Buch, Berlin, Germany	University of Bonn; University of Bonn	Pabst, S (corresponding author), Univ Bonn, Dept Internal Med Cardiol Pneumol 2, Bonn, Germany.	Dirk.Skowasch@ukb.uni-bonn.de	Hammerstingl, Christoph/GQQ-3316-2022		Actelion Pharmaceuticals; GlaxoSmithKline	Actelion Pharmaceuticals; GlaxoSmithKline(GlaxoSmithKline)	The study was sponsored by Actelion Pharmaceuticals. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors have read the journal's policy and have the following conflicts: SP, CH, and DS received remuneration for lecturing and grants for travel expenses from Actelion Pharmaceuticals and GlaxoSmithKline. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Abdelwhab S, 2008, AM J NEPHROL, V28, P990, DOI 10.1159/000146076; ARESE M, 1995, NEPHROL DIAL TRANSPL, V10, P1386; AznarSalatti J, 1995, NEPHROL DIAL TRANSPL, V10, P2199, DOI 10.1093/ndt/10.12.2199; Bozbas SS, 2009, TRANSPL P, V41, P2753, DOI 10.1016/j.transproceed.2009.07.049; Coresh J, 2007, JAMA-J AM MED ASSOC, V298, P2038, DOI 10.1001/jama.298.17.2038; Eknoyan G, 2002, AM J KIDNEY DIS, V39, pS14, DOI 10.1053/ajkd.2002.30939; El-Shafey EM, 2008, CLIN EXP NEPHROL, V12, P370, DOI 10.1007/s10157-008-0065-2; Galie N, 2009, EUR RESPIR J, V34, P1219, DOI 10.1183/09031936.00139009; Havlucu Y, 2007, RESPIRATION, V74, P503, DOI 10.1159/000102953; Humbert M, 2006, AM J RESP CRIT CARE, V173, P1023, DOI 10.1164/rccm.200510-1668OC; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Liefeldt L, 2004, AM J KIDNEY DIS, V43, P923, DOI 10.1053/j.ajkd.2003.12.054; Nakhoul F, 2005, NEPHROL DIAL TRANSPL, V20, P1686, DOI 10.1093/ndt/gfh840; Odetti P, 2006, HORM METAB RES, V38, P817, DOI 10.1055/s-2006-956501; Ramasubbu K, 2010, INT J GEN MED, V3, P279, DOI 10.2147/IJGM.S12946; Simonneau G, 2009, J AM COLL CARDIOL, V54, pS43, DOI [10.1016/j.jacc.2013.10.029, 10.1016/j.jacc.2009.04.012]; Stefanidis I, 2004, J CARDIOVASC PHARM, V44, pS43, DOI 10.1097/01.fjc.0000166215.50415.36; Thambyrajah J, 2000, HEART, V83, P205, DOI 10.1136/heart.83.2.205; Tomic M, 2008, RENAL FAILURE, V30, P836, DOI 10.1080/08860220802356218; Unal A, 2010, HEMODIAL INT, V14, P398, DOI 10.1111/j.1542-4758.2010.00478.x; Yigla M, 2003, CHEST, V123, P1577, DOI 10.1378/chest.123.5.1577; Yigla M, 2009, KIDNEY INT, V75, P969, DOI 10.1038/ki.2009.10	22	96	107	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2012	7	4							e35310	10.1371/journal.pone.0035310	http://dx.doi.org/10.1371/journal.pone.0035310			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959XD	22530005	gold, Green Published, Green Submitted			2022-12-25	WOS:000305350600074
J	Szczesniak, R				Szczesniak, Radoslaw			Pairing Mechanism for the High-T-C Superconductivity: Symmetries and Thermodynamic Properties	PLOS ONE			English	Article							ELECTRON-PHONON INTERACTION; VAN-HOVE SINGULARITY; 2-DIMENSIONAL HUBBARD-MODEL; TRANSITION-TEMPERATURE; ENERGY-GAP; TUNNELING SPECTROSCOPY; SPECTRAL-FUNCTION; VORTEX CORES; PSEUDOGAP; ISOTOPE	The pairing mechanism for the high-T-C superconductors based on the electron-phonon (EPH) and electron-electron-phonon (EEPH) interactions has been presented. On the fold mean-field level, it has been proven, that the obtained s-wave model supplements the predictions based on the BCS van Hove scenario. In particular: (i) For strong EEPH coupling and T<TC the energy gap (Delta(tot)) is very weak temperature dependent; up to the critical temperature Delta(tot) extends into the anomalous normal state to the Nernst temperature. (ii) The model explains well the experimental dependence of the ratio R-1 equivalent to 2 Delta((0))(tot)/k(B)T(C) on doping for the reported superconductors in the terms of the few fundamental parameters. In the presented paper, the properties of the d-wave superconducting state in the two-dimensional system have been also studied. The obtained results, like for s-wave, have shown the energy gap amplitude crossover from the BCS to non-BCS behavior, as the value of the EEPH potential increases. However, for T>T-C the energy gap amplitude extends into the anomalous normal state to the pseudogap temperature. Finally, it has been presented that the anisotropic model explains the dependence of the ratio R-1 on doping for the considered superconductors.	Czestochowa Tech Univ, Inst Phys, Czestochowa, Poland	Technical University Czestochowa	Szczesniak, R (corresponding author), Czestochowa Tech Univ, Inst Phys, Czestochowa, Poland.	szczesni@wip.pcz.pl		Szczesniak, Radoslaw/0000-0002-2996-7077	Czestochowa University of Technology [BS/PB-203-301/2011]	Czestochowa University of Technology	This work is supported by Czestochowa University of Technology, BS/PB-203-301/2011. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen PB, 1982, SOLID STATE PHYS ADV; Almasan C., 1991, CHEM HIGH TEMPERATUR; Andersen OK, 1995, J PHYS CHEM SOLIDS, V56, P1573, DOI 10.1016/0022-3697(95)00269-3; ANDERSON PW, 1987, SCIENCE, V235, P1196, DOI 10.1126/science.235.4793.1196; Balci H, 2002, PHYS REV B, V66, DOI 10.1103/PhysRevB.66.174510; BARDEEN J, 1957, PHYS REV, V108, P1175, DOI 10.1103/PhysRev.108.1175; BARDEEN J, 1957, PHYS REV, V106, P162, DOI 10.1103/PhysRev.106.162; BEDNORZ JG, 1988, REV MOD PHYS, V60, P585, DOI 10.1103/RevModPhys.60.585; BEDNORZ JG, 1986, Z PHYS B CON MAT, V64, P189, DOI 10.1007/BF01303701; Bennemann K.H., 2003, PHYS SUPERCONDUCTORS; Biswas A, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.207004; Bohnen KP, 2003, EUROPHYS LETT, V64, P104, DOI 10.1209/epl/i2003-00143-x; Born V, 2002, PHYSICA C, V382, P224, DOI 10.1016/S0921-4534(02)01140-1; Campuzano JC, 1999, PHYS REV LETT, V83, P3709, DOI 10.1103/PhysRevLett.83.3709; CARBOTTE JP, 1990, REV MOD PHYS, V62, P1027, DOI 10.1103/RevModPhys.62.1027; CHAO KA, 1977, J PHYS C SOLID STATE, V10, pL271, DOI 10.1088/0022-3719/10/10/002; Cuk T, 2005, PHYS STATUS SOLIDI B, V242, P11, DOI 10.1002/pssb.200404959; Czerwonko J, 1998, ACTA PHYS POL B, V29, P3885; Czerwonko J, 2000, J PHYS ELEMENT PART, V31, P145; Dagan Y, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.147004; DAGOTTO E, 1994, REV MOD PHYS, V66, P763, DOI 10.1103/RevModPhys.66.763; Damascelli A, 2003, REV MOD PHYS, V75, P473, DOI 10.1103/RevModPhys.75.473; EDWARDS HL, 1995, PHYS REV LETT, V75, P1387, DOI 10.1103/PhysRevLett.75.1387; EDWARDS HL, 1992, PHYS REV LETT, V69, P2967, DOI 10.1103/PhysRevLett.69.2967; ELIASHBERG GM, 1960, SOV PHYS JETP-USSR, V11, P696; EMERY VJ, 1987, PHYS REV LETT, V58, P2794, DOI 10.1103/PhysRevLett.58.2794; Fong HF, 1997, PHYS REV LETT, V78, P713, DOI 10.1103/PhysRevLett.78.713; Fournier P, 2003, PHYS REV B, V68, DOI 10.1103/PhysRevB.68.094507; Franck J. P., 1994, PHYS PROPERTIES HIGH; FROHLICH H, 1950, PHYS REV, V79, P845, DOI 10.1103/PhysRev.79.845; FROHLICH H, 1954, PROC R SOC LON SER-A, V223, P296, DOI 10.1098/rspa.1954.0116; Gasser W., 1999, GREENSCHE FUNKTIONEN; GOICOCHEA AG, 1994, PHYS REV B, V49, P6864, DOI 10.1103/PhysRevB.49.6864; Gonnelli RS, 1997, PHYSICA C, V275, P162, DOI 10.1016/S0921-4534(96)00700-9; Gupta AK, 1998, PHYS REV B, V58, pR8901, DOI 10.1103/PhysRevB.58.R8901; Gweon GH, 2004, NATURE, V430, P187, DOI 10.1038/nature02731; Hackl A, 2009, PHYS REV B, V79, DOI 10.1103/PhysRevB.79.235124; Hague JP, 2006, AIP CONF PROC, V846, P255; Heid R, 2009, PHYS REV B, V80, DOI 10.1103/PhysRevB.80.024507; Hewitt KC, 2002, PHYS REV B, V66, DOI 10.1103/PhysRevB.66.054516; HIRSCH JE, 1994, PHYSICA B, V199, P366, DOI 10.1016/0921-4526(94)91840-6; Hirsch JE, 2002, PHYS REV B, V66, DOI 10.1103/PhysRevB.66.064507; Hirsch JE, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.206402; Hofer J, 2000, PHYS REV LETT, V84, P4192, DOI 10.1103/PhysRevLett.84.4192; Hoffman JE, 2002, SCIENCE, V295, P466, DOI 10.1126/science.1066974; HOFFMANN A, 1995, J LOW TEMP PHYS, V99, P201, DOI 10.1007/BF00752288; Homes CC, 2006, PHYS REV B, V74, DOI 10.1103/PhysRevB.74.214515; Howald C, 2001, PHYS REV B, V64, DOI 10.1103/PhysRevB.64.100504; HUBBARD J, 1963, PROC R SOC LON SER-A, V276, P238, DOI 10.1098/rspa.1963.0204; HYBERTSEN MS, 1990, PHYS REV B, V41, P11068, DOI 10.1103/PhysRevB.41.11068; IMADA M, 1991, J PHYS SOC JPN, V60, P2740, DOI 10.1143/JPSJ.60.2740; IMADA M, 1989, J PHYS SOC JPN, V58, P3752, DOI 10.1143/JPSJ.58.3752; Johannsen N, 2007, PHYS REV B, V76, DOI 10.1103/PhysRevB.76.020512; Kaminski A, 2004, PHYS REV B, V69, DOI 10.1103/PhysRevB.69.212509; Kanigel A, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.157001; Kato T, 2003, PHYSICA C, V392, P221, DOI 10.1016/S0921-4534(03)01076-1; Khlopkin MN, 1999, PHYS SOLID STATE+, V41, P1050, DOI 10.1134/1.1130935; Kim C, 1998, PHYS REV LETT, V80, P4245, DOI 10.1103/PhysRevLett.80.4245; KIM JH, 1993, PHYS REV LETT, V71, P4218, DOI 10.1103/PhysRevLett.71.4218; Krasnov VM, 2000, PHYS REV LETT, V84, P5860, DOI 10.1103/PhysRevLett.84.5860; Kulic ML, 2006, J SUPERCOND NOV MAGN, V19, P213, DOI 10.1007/s10948-006-0159-6; Kulic ML, 2007, PHYS REV B, V76, DOI 10.1103/PhysRevB.76.132511; Kulic ML, 2004, AIP CONF PROC, V715, P75, DOI 10.1063/1.1800734; Kulic ML, 2000, PHYS REP, V338, P1, DOI 10.1016/S0370-1573(00)00008-9; LANG IG, 1963, SOV PHYS JETP-USSR, V16, P1301; Lee PA, 2006, REV MOD PHYS, V78, P17, DOI 10.1103/RevModPhys.78.17; Li PC, 2007, PHYS REV B, V75, DOI 10.1103/PhysRevB.75.184509; Li PC, 2007, PHYS REV B, V76, DOI 10.1103/PhysRevB.76.174512; Liang RX, 2006, PHYS REV B, V73, DOI 10.1103/PhysRevB.73.180505; Lin J, 2005, PHYS REV B, V72, DOI 10.1103/PhysRevB.72.214506; LITTLEWOOD PB, 1989, PHYS REV LETT, V63, P2602, DOI 10.1103/PhysRevLett.63.2602; Mamedov TA, 1999, PHYS LETT A, V257, P201, DOI 10.1016/S0375-9601(99)00318-7; Markiewicz RS, 1997, J PHYS CHEM SOLIDS, V58, P1179, DOI 10.1016/S0022-3697(97)00025-5; Marsiglio F, 2003, PHYS REV B, V68, DOI 10.1103/PhysRevB.68.224507; Matsuda A, 2003, PHYSICA C, V388, P207, DOI 10.1016/S0921-4534(02)02378-X; Matsuda A, 1999, PHYS REV B, V60, P1377, DOI 10.1103/PhysRevB.60.1377; McElroy K, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.197005; MILLIS AJ, 1990, PHYS REV B, V42, P167, DOI 10.1103/PhysRevB.42.167; MONTHOUX P, 1992, PHYS REV LETT, V69, P961, DOI 10.1103/PhysRevLett.69.961; Morr DK, 1998, PHYS REV LETT, V81, P1086, DOI 10.1103/PhysRevLett.81.1086; Murakami H, 2001, APPL SURF SCI, V175, P306, DOI 10.1016/S0169-4332(01)00047-2; MURAKAMI H, 1995, J PHYS SOC JPN, V64, P1287, DOI 10.1143/JPSJ.64.1287; Nakano T, 1998, J PHYS SOC JPN, V67, P2622, DOI 10.1143/JPSJ.67.2622; Nakayama K, 2009, PHYS REV B, V79, DOI 10.1103/PhysRevB.79.140503; NEWNS DM, 1995, PHYS REV B, V52, P13611, DOI 10.1103/PhysRevB.52.13611; Nunner TS, 1999, PHYS REV B, V59, P8859, DOI 10.1103/PhysRevB.59.8859; Oda M, 1997, PHYSICA C, V281, P135, DOI 10.1016/S0921-4534(97)00505-4; Oda M, 2000, PHYSICA C, V341, P847, DOI 10.1016/S0921-4534(00)00710-3; Oki T, 2001, PHYSICA C, V353, P213, DOI 10.1016/S0921-4534(00)01751-2; Ong NP, 2004, ANN PHYS-BERLIN, V13, P9, DOI 10.1002/andp.200310034; Plate M, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.077001; Ponomarev YG, 2000, C SERIES I PHYS, V2, P167; PRESLAND MR, 1991, PHYSICA C, V176, P95, DOI 10.1016/0921-4534(91)90700-9; Pryadko LP, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.067002; RADTKE RJ, 1993, PHYS REV B, V48, P15957, DOI 10.1103/PhysRevB.48.15957; Renner C, 1998, PHYS REV LETT, V80, P149, DOI 10.1103/PhysRevLett.80.149; Renner C, 1998, PHYS REV LETT, V80, P3606, DOI 10.1103/PhysRevLett.80.3606; Rullier-Albenque F, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.067002; Sarkar S, 1996, PHYS REV B, V54, P14974, DOI 10.1103/PhysRevB.54.14974; SARKAR S, 1995, PHYS REV B, V52, P12545, DOI 10.1103/PhysRevB.52.12545; SARKAR S, 1995, PHYS REV B, V51, P12854, DOI 10.1103/PhysRevB.51.12854; SCALAPINO DJ, 1992, PHYS REV LETT, V68, P2830, DOI 10.1103/PhysRevLett.68.2830; Schneider T, 2005, PHYS STATUS SOLIDI B, V242, P58, DOI 10.1002/pssb.200404955; Sutherland M, 2003, PHYS REV B, V67, DOI 10.1103/PhysRevB.67.174520; Szczesniak R, 2008, SOLID STATE COMMUN, V145, P137, DOI 10.1016/j.ssc.2007.10.010; Szczesniak R, 2007, PHYS STATUS SOLIDI B, V244, P2538, DOI 10.1002/pssb.200674629; Szczesniak R, 2006, SOLID STATE COMMUN, V138, P347, DOI 10.1016/j.ssc.2006.03.012; Szczesniak R, 2006, ACTA PHYS POL A, V109, P179, DOI 10.12693/APhysPolA.109.179; Szczesniak R, 2003, ACTA PHYS SLOVACA, V53, P477; Szczesniak R, 2012, J SUPERCOND NOV MAGN, V25, P399, DOI 10.1007/s10948-011-1326-y; Szczesniak R, 2012, PHYSICA C, V472, P15, DOI 10.1016/j.physc.2011.09.017; Szczesniak R, 2011, PHYSICA B, V406, P3493, DOI 10.1016/j.physb.2011.06.033; Szczesniak R, 2011, PHYSICA B, V406, P2235, DOI 10.1016/j.physb.2011.03.038; Szczesniak R, 2010, PHYSICA B, V405, P4897, DOI 10.1016/j.physb.2010.09.036; Szczesniak R, 2002, ACTA PHYS POL A, V102, P401, DOI 10.12693/APhysPolA.102.401; Szczesniak R, 2009, SOLID STATE COMMUN, V149, P2053, DOI 10.1016/j.ssc.2009.08.019; Szczesniak R, 2009, PHYS LETT A, V373, P473, DOI 10.1016/j.physleta.2008.11.040; Szczesniak R, 2001, SOLID STATE COMMUN, V117, P369, DOI 10.1016/S0038-1098(00)00477-4; Tanaka K, 2006, SCIENCE, V314, P1910, DOI 10.1126/science.1133411; Tohayama T., 2003, PHYS REV B, V67; Tohyama T, 2000, SUPERCOND SCI TECH, V13, pR17, DOI 10.1088/0953-2048/13/4/201; Tsuei CC, 1997, NATURE, V387, P481, DOI 10.1038/387481a0; Tsuei CC, 1996, SCIENCE, V271, P329, DOI 10.1126/science.271.5247.329; VANHOVE L, 1953, PHYS REV, V89, P1189, DOI 10.1103/PhysRev.89.1189; VEDENEEV SI, 1995, PHYS REV B, V51, P16380, DOI 10.1103/PhysRevB.51.16380; Wang Y, 2007, PHYS REV B, V76, DOI 10.1103/PhysRevB.76.064512; Wang YY, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.247002; Wen HH, 2005, PHYS REV B, V72, DOI 10.1103/PhysRevB.72.134507; WON H, 1994, PHYS REV B, V49, P1397, DOI 10.1103/PhysRevB.49.1397; XU JH, 1987, PHYS LETT A, V120, P489, DOI 10.1016/0375-9601(87)90118-6; Xu ZA, 2005, PHYS REV B, V72, DOI 10.1103/PhysRevB.72.144527; Yeh NC, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.087003; Yoshida T, 2007, J PHYS-CONDENS MAT, V19, DOI 10.1088/0953-8984/19/12/125209; Zimmers A, 2004, PHYS REV B, V70, DOI 10.1103/PhysRevB.70.132502; Zimmers A, 2007, PHYS REV B, V76, DOI 10.1103/PhysRevB.76.064515	137	44	44	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2012	7	4							e31873	10.1371/journal.pone.0031873	http://dx.doi.org/10.1371/journal.pone.0031873			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959XD	22529891	gold, Green Published, Green Submitted			2022-12-25	WOS:000305350600002
J	Barrett, MA; Zheng, SB; Roshankar, G; Alsop, RJ; Belanger, RKR; Huynh, C; Kucerka, N; Rheinstadter, MC				Barrett, Matthew A.; Zheng, Songbo; Roshankar, Golnaz; Alsop, Richard J.; Belanger, Randy K. R.; Huynh, Chris; Kucerka, Norbert; Rheinstaedter, Maikel C.			Interaction of Aspirin (Acetylsalicylic Acid) with Lipid Membranes	PLOS ONE			English	Article							SUBGEL PHASE; DMPC; BILAYERS; CHOLESTEROL; HYDRATION; DPPC	We studied the interaction of Aspirin (acetylsalicylic acid) with lipid membranes using x-ray diffraction for bilayers containing up to 50 mol% of aspirin. From 2D x-ray intensity maps that cover large areas of reciprocal space we determined the position of the ASA molecules in the phospholipid bilayers and the molecular arrangement of the molecules in the plane of the membranes. We present direct experimental evidence that ASA molecules participate in saturated lipid bilayers of DMPC (1,2-dimyristoyl-sn-glycero-3-phosphocholine) and preferably reside in the head group region of the membrane. Up to 50 mol% ASA molecules can be dissolved in this type of bilayer before the lateral membrane organization is disturbed and the membranes are found to form an ordered, 2D crystal-like structure. Furthermore, ASA and cholesterol were found to co-exist in saturated lipid bilayers, with the ASA molecules residing in the head group region and the cholesterol molecules participating in the hydrophobic membrane core.	[Barrett, Matthew A.; Zheng, Songbo; Roshankar, Golnaz; Alsop, Richard J.; Belanger, Randy K. R.; Huynh, Chris; Rheinstaedter, Maikel C.] McMaster Univ, Dept Phys & Astron, Hamilton, ON L8S 4M1, Canada; [Kucerka, Norbert; Rheinstaedter, Maikel C.] Natl Res Council Canada, Canadian Neutron Beam Ctr, Chalk River, ON, Canada	McMaster University; Atomic Energy of Canada Limited; National Research Council Canada	Barrett, MA (corresponding author), McMaster Univ, Dept Phys & Astron, Hamilton, ON L8S 4M1, Canada.	rheinstadter@mcmaster.ca	Rheinstadter, Maikel C/D-5322-2009; Kucerka, Norbert/Q-7476-2016	Rheinstadter, Maikel C/0000-0002-0558-7475; Kucerka, Norbert/0000-0002-1075-6640	Natural Sciences and Engineering Research Council of Canada (NSERC); National Research Council Canada (NRC); Canada Foundation for Innovation (CFI); Ontario Ministry of Economic Development and Innovation	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); National Research Council Canada (NRC); Canada Foundation for Innovation (CFI)(Canada Foundation for Innovation); Ontario Ministry of Economic Development and Innovation	This research was funded by the Natural Sciences and Engineering Research Council of Canada (NSERC), the National Research Council Canada (NRC), the Canada Foundation for Innovation (CFI), and the Ontario Ministry of Economic Development and Innovation. Silicon substrates were partially provided by ComDev. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi T, 2000, CHEM PHYS LIPIDS, V107, P93, DOI 10.1016/S0009-3084(00)00154-7; CASAL HL, 1987, CHEM PHYS LIPIDS, V43, P47, DOI 10.1016/0009-3084(87)90016-8; de Meyer FJM, 2010, J PHYS CHEM B, V114, P10451, DOI 10.1021/jp103903s; Fragneto G, 2007, CR PHYS, V8, P865, DOI 10.1016/j.crhy.2007.09.003; KATSARAS J, 1995, BIOCHEMISTRY-US, V34, P4684, DOI 10.1021/bi00014a023; KING GI, 1971, PHYS LETT A, VA 35, P259, DOI 10.1016/0375-9601(71)90371-9; Kucerka N, 2010, BIOCHEMISTRY-US, V49, P7485, DOI 10.1021/bi100891z; Kucerka N, 2009, J AM CHEM SOC, V131, P16358, DOI 10.1021/ja907659u; Meyer HW, 2000, CHEM PHYS LIPIDS, V105, P149, DOI 10.1016/S0009-3084(00)00124-9; NAGLE JF, 1989, BIOPHYS J, V55, P309, DOI 10.1016/S0006-3495(89)82806-1; Nagle JF, 1996, BIOPHYS J, V70, P1419, DOI 10.1016/S0006-3495(96)79701-1; Nomura K, 2011, J PHYS CHEM B, V115, P14991, DOI 10.1021/jp208958a; Pabst G, 2010, CHEM PHYS LIPIDS, V163, P460, DOI 10.1016/j.chemphyslip.2010.03.010; RAGHUNATHAN VA, 1995, PHYS REV LETT, V74, P4456, DOI 10.1103/PhysRevLett.74.4456; Seddon AM, 2009, CHEM SOC REV, V38, P2509, DOI 10.1039/b813853m; Tristram-Nagle S, 2002, BIOPHYS J, V83, P3324, DOI 10.1016/S0006-3495(02)75333-2; VANDENBERG ET, 1991, J COLLOID INTERF SCI, V147, P103, DOI 10.1016/0021-9797(91)90139-Y	17	57	57	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2012	7	4							e34357	10.1371/journal.pone.0034357	http://dx.doi.org/10.1371/journal.pone.0034357			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WC	22529913	Green Published, Green Submitted, gold			2022-12-25	WOS:000305347400011
J	Ceci, M; Welshhans, K; Ciotti, MT; Brandi, R; Parisi, C; Paoletti, F; Pistillo, L; Bassell, GJ; Cattaneo, A				Ceci, Marcello; Welshhans, Kristy; Ciotti, Maria Teresa; Brandi, Rossella; Parisi, Chiara; Paoletti, Francesca; Pistillo, Luana; Bassell, Gary J.; Cattaneo, Antonino			RACK1 Is a Ribosome Scaffold Protein for beta-actin mRNA/ZBP1 Complex	PLOS ONE			English	Article							ACTIVATED C-KINASE; MESSENGER-RNA; STRESS GRANULES; SRC; LOCALIZATION; TRANSLATION; RECEPTOR; SUBUNIT; GROWTH; PHOSPHORYLATION	In neurons, specific mRNAs are transported in a translationally repressed manner along dendrites or axons by transport ribonucleic-protein complexes called RNA granules. ZBP1 is one RNA binding protein present in transport RNPs, where it transports and represses the translation of cotransported mRNAs, including beta-actin mRNA. The release of beta-actin mRNA from ZBP1 and its subsequent translation depends on the phosphorylation of ZBP1 by Src kinase, but little is known about how this process is regulated. Here we demonstrate that the ribosomal-associated protein RACK1, another substrate of Src, binds the beta-actin mRNA/ZBP1 complex on ribosomes and contributes to the release of beta-actin mRNA from ZBP1 and to its translation. We identify the Src binding and phosphorylation site Y246 on RACK1 as the critical site for the binding to the beta-actin mRNA/ZBP1 complex. Based on these results we propose RACK1 as a ribosomal scaffold protein for specific mRNA-RBP complexes to tightly regulate the translation of specific mRNAs.	[Ceci, Marcello; Brandi, Rossella; Parisi, Chiara; Paoletti, Francesca; Pistillo, Luana; Cattaneo, Antonino] EBRI, Rome, Italy; [Welshhans, Kristy] Kent State Univ, Dept Biol Sci, Kent, OH 44242 USA; [Ciotti, Maria Teresa] CNR, Inst Neurobiol & Mol Med, Rome, Italy; [Bassell, Gary J.] Emory Univ, Sch Med, Dept Cell Biol, Atlanta, GA USA; [Cattaneo, Antonino] Scuola Normale Super Pisa, Pisa, Italy	University System of Ohio; Kent State University; Kent State University Kent; Kent State University Salem; Consiglio Nazionale delle Ricerche (CNR); Emory University; Scuola Normale Superiore di Pisa	Ceci, M (corresponding author), EBRI, Rome, Italy.	a.cattaneo@ebri.it	parisi, Chiara/K-6330-2016; Cattaneo, Antonino/AAA-7252-2019; Welshhans, Kristy/ABD-9300-2020; Cattaneo, Antonino/K-4471-2016	parisi, Chiara/0000-0003-1350-3929; Cattaneo, Antonino/0000-0002-6975-8923; Welshhans, Kristy/0000-0001-6624-4719; Ceci, Marcello/0000-0002-5066-1590	IIT, Technology Italian Institute; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F32NS064727] Funding Source: NIH RePORTER	IIT, Technology Italian Institute; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work is supported by grant from IIT, Technology Italian Institute (WWW.iit.itproject to A. Cattaneo) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson P, 2006, J CELL BIOL, V172, P803, DOI 10.1083/jcb.200512082; Angenstein F, 2002, J NEUROSCI, V22, P8827; Arimoto K, 2008, NAT CELL BIOL, V10, P1324, DOI 10.1038/ncb1791; Ashique AM, 2006, BRAIN RES, V1069, P31, DOI 10.1016/j.brainres.2005.11.018; Atlas R, 2007, J NEUROSCI RES, V85, P173, DOI 10.1002/jnr.21099; Bramham CR, 2007, NAT REV NEUROSCI, V8, P776, DOI 10.1038/nrn2150; Buchan JR, 2009, MOL CELL, V36, P932, DOI 10.1016/j.molcel.2009.11.020; Capsoni S, 2002, P NATL ACAD SCI USA, V99, P12432, DOI 10.1073/pnas.192442999; Ceci M, 2003, NATURE, V426, P579, DOI 10.1038/nature02160; Chang BY, 1998, MOL CELL BIOL, V18, P3245, DOI 10.1128/MCB.18.6.3245; Coyle SM, 2009, MOL CELL BIOL, V29, P1626, DOI 10.1128/MCB.01718-08; Daftuar L, 2010, CELL CYCLE, V9, P4259, DOI 10.4161/cc.9.21.13527; Doan AT, 2007, EXP CELL RES, V313, P2667, DOI 10.1016/j.yexcr.2007.05.013; Eom T, 2003, J NEUROSCI, V23, P10433; Farina KL, 2003, J CELL BIOL, V160, P77, DOI 10.1083/jcb.200206003; FREDERICKSON RM, 1991, MOL CELL BIOL, V11, P2896, DOI 10.1128/MCB.11.5.2896; Huang YZ, 2010, J BIOL CHEM, V285, P8207, DOI 10.1074/jbc.M109.091041; Huttelmaier S, 2005, NATURE, V438, P512, DOI 10.1038/nature04115; Jannot G, 2011, EMBO REP, V12, P581, DOI 10.1038/embor.2011.66; Kaech S, 2006, NAT PROTOC, V1, P2406, DOI 10.1038/nprot.2006.356; Karni R, 2005, MOL CELL BIOL, V25, P5031, DOI 10.1128/MCB.25.12.5031-5039.2005; Kedersha N, 2002, MOL BIOL CELL, V13, P195, DOI 10.1091/mbc.01-05-0221; Krichevsky AM, 2001, NEURON, V32, P683, DOI 10.1016/S0896-6273(01)00508-6; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lopez-Bergami P, 2007, CANCER CELL, V11, P447, DOI 10.1016/j.ccr.2007.03.009; Luo M, 2002, BIOCHEM J, V365, P817, DOI 10.1042/BJ20020263; Mamidipudi V, 2004, MOL CELL BIOL, V24, P6788, DOI 10.1128/MCB.24.15.6788-6798.2004; Nho RS, 2011, J BIOL CHEM; Otsuka M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024359; Perycz M, 2011, J NEUROSCI, V31, P5271, DOI 10.1523/JNEUROSCI.2387-10.2011; Rabl J, 2011, SCIENCE, V331, P730, DOI 10.1126/science.1198308; RON D, 1994, P NATL ACAD SCI USA, V91, P839, DOI 10.1073/pnas.91.3.839; Sasaki Y, 2010, J NEUROSCI, V30, P9349, DOI 10.1523/JNEUROSCI.0499-10.2010; Sengupta J, 2004, NAT STRUCT MOL BIOL, V11, P957, DOI 10.1038/nsmb822; Shi GX, 2008, MOL CELL BIOL, V28, P4940, DOI 10.1128/MCB.02193-07; Sutton MA, 2006, CELL, V127, P49, DOI 10.1016/j.cell.2006.09.014; Tongiorgi E, 1997, J NEUROSCI, V17, P9492; Vojtechova M, 2008, NEOPLASIA, V10, P99, DOI 10.1593/neo.07905; Zeitelhofer M, 2008, J NEUROSCI, V28, P7555, DOI 10.1523/JNEUROSCI.0104-08.2008; Zhang HL, 2001, NEURON, V31, P261, DOI 10.1016/S0896-6273(01)00357-9	40	39	39	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2012	7	4							e35034	10.1371/journal.pone.0035034	http://dx.doi.org/10.1371/journal.pone.0035034			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VO	22523568	gold, Green Submitted, Green Published			2022-12-25	WOS:000305345000040
J	Reber, A; Chapuisat, M				Reber, Anabelle; Chapuisat, Michel			No Evidence for Immune Priming in Ants Exposed to a Fungal Pathogen	PLOS ONE			English	Article							RED FLOUR BEETLE; DISEASE RESISTANCE; GROUP FACILITATION; MEALWORM BEETLE; SOCIAL IMMUNITY; INSECT; PROPHYLAXIS; DEFENSE; RESIN; INFECTION	There is accumulating evidence that invertebrates can acquire long-term protection against pathogens through immune priming. However, the range of pathogens eliciting immune priming and the specificity of the response remain unclear. Here, we tested if the exposure to a natural fungal pathogen elicited immune priming in ants. We found no evidence for immune priming in Formica selysi workers exposed to Beauveria bassiana. The initial exposure of ants to the fungus did not alter their resistance in a subsequent challenge with the same fungus. There was no sign of priming when using homologous and heterologous combinations of fungal strains for exposure and subsequent challenges at two time intervals. Hence, within the range of conditions tested, the immune response of this social insect to the fungal pathogen appears to lack memory and strain-specificity. These results show that immune priming is not ubiquitous across pathogens, hosts and conditions, possibly because of immune evasion by the pathogen or efficient social defences by the host.	[Reber, Anabelle; Chapuisat, Michel] Univ Lausanne, Dept Ecol & Evolut, Lausanne, Switzerland	University of Lausanne	Reber, A (corresponding author), Univ Lausanne, Dept Ecol & Evolut, Lausanne, Switzerland.	Michel.Chapuisat@unil.ch	Chapuisat, Michel/T-8686-2017	Chapuisat, Michel/0000-0001-7207-199X	Swiss National Science Foundation [31003A_125306]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This study was supported by grant 31003A_125306 from the Swiss National Science Foundation to MC (http://www.snf.ch). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ben-Ami F, 2010, AM NAT, V175, P106, DOI 10.1086/648672; Boughton RK, 2011, FUNCT ECOL, V25, P81, DOI 10.1111/j.1365-2435.2010.01817.x; Castella G, 2008, ECOL ENTOMOL, V33, P408, DOI 10.1111/j.1365-2311.2007.00983.x; Chai LYA, 2009, MED MYCOL, V47, P227, DOI 10.1080/13693780802209082; Chapuisat M, 2004, EVOLUTION, V58, P1064, DOI 10.1111/j.0014-3820.2004.tb00440.x; Chapuisat M, 2007, P ROY SOC B-BIOL SCI, V274, P2013, DOI 10.1098/rspb.2007.0531; Cotter SC, 2010, BEHAV ECOL, V21, P663, DOI 10.1093/beheco/arq070; Cremer S, 2007, CURR BIOL, V17, pR693, DOI 10.1016/j.cub.2007.06.008; Gonzalez-Tokman DM, 2010, PHYSIOL ENTOMOL, V35, P364, DOI 10.1111/j.1365-3032.2010.00752.x; HAJEK AE, 1994, ANNU REV ENTOMOL, V39, P293, DOI 10.1146/annurev.en.39.010194.001453; Hamilton C, 2011, BIOL LETTERS, V7, P89, DOI 10.1098/rsbl.2010.0466; Hamilton W.D., 1987, P81; Hauton C, 2007, BIOESSAYS, V29, P1138, DOI 10.1002/bies.20650; Heinze J, 2010, CURR BIOL, V20, P249, DOI 10.1016/j.cub.2009.12.031; Korner P, 2004, J INVERTEBR PATHOL, V87, P59, DOI 10.1016/j.jip.2004.07.004; Kurtti TJ, 2008, MICROBIOL-SGM, V154, P1700, DOI 10.1099/mic.0.2008/016667-0; Kurtz J, 2005, TRENDS IMMUNOL, V26, P186, DOI 10.1016/j.it.2005.02.001; Kurtz J, 2003, NATURE, V425, P37, DOI 10.1038/425037a; Lacey L.A, 1997, MANUAL TECHNIQUES IN; Little TJ, 2005, NAT IMMUNOL, V6, P651, DOI 10.1038/ni1219; Little TJ, 2003, CURR BIOL, V13, P489, DOI 10.1016/S0960-9822(03)00163-5; Meunier J, 2009, J EVOLUTION BIOL, V22, P1906, DOI 10.1111/j.1420-9101.2009.01805.x; Moino Jr. Alcides, 2002, Sci. agric. (Piracicaba, Braz.), V59, P267, DOI 10.1590/S0103-90162002000200010; Moret Y, 2001, NATURE, V414, P506, DOI 10.1038/35107138; Moret Y, 2006, P R SOC B, V273, P1399, DOI 10.1098/rspb.2006.3465; Moret Y, 2003, P ROY SOC B-BIOL SCI, V270, P2475, DOI 10.1098/rspb.2003.2511; Mowlds P, 2008, MICROBES INFECT, V10, P628, DOI 10.1016/j.micinf.2008.02.011; Pham LN, 2007, PLOS PATHOG, V3, DOI 10.1371/journal.ppat.0030026; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Reber A, 2012, INSECT SOC, V59, P231, DOI 10.1007/s00040-011-0209-3; Reber A, 2011, J EVOLUTION BIOL, V24, P954, DOI 10.1111/j.1420-9101.2011.02230.x; Reber A, 2008, ECOL LETT, V11, P682, DOI 10.1111/j.1461-0248.2008.01177.x; Rodrigues J, 2010, SCIENCE, V330, P448; Rosengaus RB, 1999, NATURWISSENSCHAFTEN, V86, P588, DOI 10.1007/s001140050679; Rosset H, 2007, EVOL ECOL, V21, P577, DOI 10.1007/s10682-006-9139-3; Roth O, 2009, P ROY SOC B-BIOL SCI, V276, P145, DOI 10.1098/rspb.2008.1157; Roth O, 2010, J ANIM ECOL, V79, P403, DOI 10.1111/j.1365-2656.2009.01617.x; Rowley AF, 2007, J IMMUNOL, V179, P7209, DOI 10.4049/jimmunol.179.11.7209; Sadd BM, 2007, CURR BIOL, V17, pR1046, DOI 10.1016/j.cub.2007.11.007; Sadd BM, 2006, CURR BIOL, V16, P1206, DOI 10.1016/j.cub.2006.04.047; Sadd BM, 2009, EVOL APPL, V2, P113, DOI 10.1111/j.1752-4571.2008.00057.x; Sadd BM, 2005, BIOL LETTERS, V1, P386, DOI 10.1098/rsbl.2005.0369; Schmid-Hempel P, 2003, P ROY SOC B-BIOL SCI, V270, P357, DOI 10.1098/rspb.2002.2265; Schmid-Hempel P, 2005, ANNU REV ENTOMOL, V50, P529, DOI 10.1146/annurev.ento.50.071803.130420; Schmid-Hempel P., 1998, Parasites in social insects.; Schmid-Hempel P, 2009, PHILOS T R SOC B, V364, P85, DOI 10.1098/rstb.2008.0157; Schmid-Hempel P, 2008, TRENDS ECOL EVOL, V23, P318, DOI 10.1016/j.tree.2008.02.011; Simone M, 2009, EVOLUTION, V63, P3016, DOI 10.1111/j.1558-5646.2009.00772.x; Thomas AM, 2010, ECOL ENTOMOL, V35, P200, DOI 10.1111/j.1365-2311.2009.01169.x; Tidbury HJ, 2011, P ROY SOC B-BIOL SCI, V278, P871, DOI 10.1098/rspb.2010.1517; Traniello JFA, 2002, P NATL ACAD SCI USA, V99, P6838, DOI 10.1073/pnas.102176599; Ugelvig LV, 2007, CURR BIOL, V17, P1967, DOI 10.1016/j.cub.2007.10.029; Wilson-Rich N, 2009, ANNU REV ENTOMOL, V54, P405, DOI 10.1146/annurev.ento.53.103106.093301	53	63	64	1	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2012	7	4							e35372	10.1371/journal.pone.0035372	http://dx.doi.org/10.1371/journal.pone.0035372			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VO	22523588	Green Submitted, Green Published, gold			2022-12-25	WOS:000305345000061
J	Sun, J; Zhou, M; Mao, ZT; Li, CX				Sun, Jie; Zhou, Meng; Mao, Zhitao; Li, Chuanxing			Characterization and Evolution of microRNA Genes Derived from Repetitive Elements and Duplication Events in Plants	PLOS ONE			English	Article							ARABIDOPSIS; GENOME; IDENTIFICATION; FAMILIES; RESOURCE; CONSERVATION; PRECURSORS; SEQUENCES; ORIGIN; MIRNAS	MicroRNAs (miRNAs) are a major class of small non-coding RNAs that act as negative regulators at the post-transcriptional level in animals and plants. In this study, all known miRNAs in four plant species (Arabidopsis thaliana, Populus trichocarpa, Oryza sativa and Sorghum bicolor) have been analyzed, using a combination of computational and comparative genomic approaches, to systematically identify and characterize the miRNAs that were derived from repetitive elements and duplication events. The study provides a complete mapping, at the genome scale, of all the miRNAs found on repetitive elements in the four test plant species. Significant differences between repetitive element-related miRNAs and non-repeat-derived miRNAs were observed for many characteristics, including their location in protein-coding and intergenic regions in genomes, their conservation in plant species, sequence length of their hairpin precursors, base composition of their hairpin precursors and the minimum free energy of their hairpin structures. Further analysis showed that a considerable number of miRNA families in the four test plant species arose from either tandem duplication events, segmental duplication events or a combination of the two. However, comparative analysis suggested that the contribution made by these two duplication events differed greatly between the perennial tree species tested and the other three annual species. The expansion of miRNA families in A. thaliana, O. sativa and S. bicolor are more likely to occur as a result of tandem duplication events than from segmental duplications. In contrast, genomic segmental duplications contributed significantly more to the expansion of miRNA families in P. trichocarpa than did tandem duplication events. Taken together, this study has successfully characterized miRNAs derived from repetitive elements and duplication events at the genome scale and provides comprehensive knowledge and deeper insight into the origins and evolution of miRNAs in plants.	[Sun, Jie; Zhou, Meng; Mao, Zhitao; Li, Chuanxing] Harbin Med Univ, Coll Bioinformat Sci & Technol, Harbin, Peoples R China	Harbin Medical University	Sun, J (corresponding author), Harbin Med Univ, Coll Bioinformat Sci & Technol, Harbin, Peoples R China.	biofomeng@hotmail.com	Zhou, Meng/G-7674-2011	Zhou, Meng/0000-0001-9987-9024; Li, Chuan-Xing/0000-0003-2189-5010; Sun, Jie/0000-0002-0932-7195	Foundation of Harbin Medical University [WLD-QN1107]	Foundation of Harbin Medical University	This work was partially supported by the Foundation of Harbin Medical University(WLD-QN1107). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen E, 2004, NAT GENET, V36, P1282, DOI 10.1038/ng1478; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Arabidopsis Genome Initiative, 2000, Nature (London), V408, P796, DOI 10.1038/35048692; Barakat Abdelali, 2007, BMC Genomics, V8, P481, DOI 10.1186/1471-2164-8-481; Bentwich I, 2005, NAT GENET, V37, P766, DOI 10.1038/ng1590; Cannon Steven B., 2004, BMC Plant Biology, V4, P10, DOI 10.1186/1471-2229-4-10; De Felippes FF, 2008, RNA, V14, P2455, DOI 10.1261/rna.1149408; Fahlgren N, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000219; Friedman R, 2001, GENOME RES, V11, P373, DOI 10.1101/gr.155801; Gazzani S, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-62; Guddeti S, 2005, CELL RES, V15, P631, DOI 10.1038/sj.cr.7290333; Hertel J, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-25; HOFACKER IL, 1994, MONATSH CHEM, V125, P167, DOI 10.1007/BF00818163; Jiang DH, 2006, CELL RES, V16, P507, DOI 10.1038/sj.cr.7310062; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; Li AL, 2007, CELL RES, V17, P212, DOI 10.1038/sj.cr.7310113; Li Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019212; Lu J, 2008, NAT GENET, V40, P351, DOI 10.1038/ng.73; Maher C, 2006, GENOME RES, V16, P510, DOI 10.1101/gr.4680506; Matsumoto T, 2005, NATURE, V436, P793, DOI 10.1038/nature03895; Mendes ND, 2009, NUCLEIC ACIDS RES, V37, P2419, DOI 10.1093/nar/gkp145; Merchan F, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-12-r136; Mica E, 2006, J EXP BOT, V57, P2601, DOI 10.1093/jxb/erl013; Ni M, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-329; Nozawa M, 2010, GENOME BIOL EVOL, V2, P180, DOI 10.1093/gbe/evq009; Ouyang S, 2004, NUCLEIC ACIDS RES, V32, pD360, DOI 10.1093/nar/gkh099; Ouyang S, 2007, NUCLEIC ACIDS RES, V35, pD883, DOI 10.1093/nar/gkl976; Paterson AH, 2009, NATURE, V457, P551, DOI 10.1038/nature07723; Piriyapongsa J, 2008, RNA, V14, P814, DOI 10.1261/rna.916708; Piriyapongsa J, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000203; Prince VE, 2002, NAT REV GENET, V3, P827, DOI 10.1038/nrg928; Smalheiser NR, 2005, TRENDS GENET, V21, P322, DOI 10.1016/j.tig.2005.04.008; Swarbreck D, 2008, NUCLEIC ACIDS RES, V36, pD1009, DOI 10.1093/nar/gkm965; Tuskan GA, 2006, SCIENCE, V313, P1596, DOI 10.1126/science.1128691; Voinnet O, 2009, CELL, V136, P669, DOI 10.1016/j.cell.2009.01.046; Xue LJ, 2009, NUCLEIC ACIDS RES, V37, P916, DOI 10.1093/nar/gkn998; Yuan ZD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017666; Yuan ZD, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-346; Zhang BH, 2006, PLANT J, V46, P243, DOI 10.1111/j.1365-313X.2006.02697.X; Zhang LF, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000716; Zhang R, 2007, GENOME RES, V17, P612, DOI 10.1101/gr.6146507; Zhou FF, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-14; Zhou M, 2011, FEBS J, V278, P929, DOI 10.1111/j.1742-4658.2011.08008.x	43	34	37	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2012	7	4							e34092	10.1371/journal.pone.0034092	http://dx.doi.org/10.1371/journal.pone.0034092			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VO	22523544	Green Submitted, gold, Green Published			2022-12-25	WOS:000305345000013
J	Sundram, V; Chauhan, SC; Ebeling, M; Jaggi, M				Sundram, Vasudha; Chauhan, Subhash C.; Ebeling, Mara; Jaggi, Meena			Curcumin Attenuates beta-catenin Signaling in Prostate Cancer Cells through Activation of Protein Kinase D1	PLOS ONE			English	Article							E-CADHERIN; ANDROGEN RECEPTOR; SUBCELLULAR-LOCALIZATION; C-MU; PHOSPHORYLATION; EXPRESSION; MOTILITY; PROLIFERATION; APOPTOSIS; GROWTH	Prostate cancer is the most commonly diagnosed cancer affecting 1 in 6 males in the US. Understanding the molecular basis of prostate cancer progression can serve as a tool for early diagnosis and development of novel treatment strategies for this disease. Protein Kinase D1 (PKD1) is a multifunctional kinase that is highly expressed in normal prostate. The decreased expression of PKD1 has been associated with the progression of prostate cancer. Therefore, synthetic or natural products that regulate this signaling pathway can serve as novel therapeutic modalities for prostate cancer prevention and treatment. Curcumin, the active ingredient of turmeric, has shown anti-cancer properties via modulation of a number of different molecular pathways. Herein, we have demonstrated that curcumin activates PKD1, resulting in changes in beta-catenin signaling by inhibiting nuclear beta-catenin transcription activity and enhancing the levels of membrane beta-catenin in prostate cancer cells. Modulation of these cellular events by curcumin correlated with decreased cell proliferation, colony formation and cell motility and enhanced cell-cell aggregation in prostate cancer cells. In addition, we have also revealed that inhibition of cell motility by curcumin is mediated by decreasing the levels of active cofilin, a downstream target of PKD1. The potent anti-cancer effects of curcumin in vitro were also reflected in a prostate cancer xenograft mouse model. The in vivo inhibition of tumor growth also correlated with enhanced membrane localization of beta-catenin. Overall, our findings herein have revealed a novel molecular mechanism of curcumin action via the activation of PKD1 in prostate cancer cells.	[Sundram, Vasudha; Chauhan, Subhash C.; Ebeling, Mara; Jaggi, Meena] Sanford Res USD, Canc Biol Res Ctr, Sioux Falls, SD USA; [Chauhan, Subhash C.; Jaggi, Meena] Univ S Dakota, Sanford Sch Med, Dept OB GYN, Sioux Falls, SD USA; [Chauhan, Subhash C.; Jaggi, Meena] Univ S Dakota, Sanford Sch Med, Basic Biomed Sci Div, Sioux Falls, SD USA	Sanford Health; University of South Dakota; University of South Dakota	Sundram, V (corresponding author), Sanford Res USD, Canc Biol Res Ctr, Sioux Falls, SD USA.	meena.jaggi@sanfordhealth.org			NIH [P20 RR024219]; department of defense (DOD) [DOD PC073643, DOD PC073887]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); department of defense (DOD)(United States Department of Defense)	This project was supported by COBRE Grant (P20 RR024219) from NIH (http://www.ncrr.nih.gov/) and by grants from the department of defense (DOD) (http://cdmrp.army.mil/) to MJ (DOD PC073643) and to SCC (DOD PC073887). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal BB, 2003, ANTICANCER RES, V23, P363; Anand P, 2008, BIOCHEM PHARMACOL, V76, P1590, DOI 10.1016/j.bcp.2008.08.008; Biswas MHU, 2010, CANCER RES, V70, P2095, DOI 10.1158/0008-5472.CAN-09-4155; Chauhan SC, 2009, CANCER RES, V69, P765, DOI 10.1158/0008-5472.CAN-08-0587; Chesire DR, 2002, ONCOGENE, V21, P2679, DOI 10.1038/sj.onc.1205352; Choi HY, 2010, PROSTATE CANCER P D, V13, P343, DOI 10.1038/pcan.2010.26; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Dorai T, 2001, PROSTATE, V47, P293, DOI 10.1002/pros.1074; Dorai T, 2000, MOL UROL, V4, P1; Dorai T, 2000, PROSTATE CANCER P D, V3, P84, DOI 10.1038/sj.pcan.4500399; Du C, 2010, CANCER RES, V70, P7810, DOI 10.1158/0008-5472.CAN-09-4481; Du C, 2009, CANCER RES, V69, P1117, DOI 10.1158/0008-5472.CAN-07-6270; Eiseler T, 2010, J BIOL CHEM, V285, P18672, DOI 10.1074/jbc.M109.093880; Eiseler T, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2232; Eiseler T, 2009, NAT CELL BIOL, V11, P545, DOI 10.1038/ncb1861; Goel A, 2008, MOL NUTR FOOD RES, V52, P1010, DOI 10.1002/mnfr.200700354; Guha S, 2010, BIOCHEM PHARMACOL, V80, P1946, DOI 10.1016/j.bcp.2010.07.002; Hassan S, 2009, ONCOGENE, V28, P4386, DOI 10.1038/onc.2009.291; Jaggi M, 2005, UROL ONCOL-SEMIN ORI, V23, P402, DOI 10.1016/j.urolonc.2005.03.024; Jaggi M, 2005, CANCER RES, V65, P483; Jaggi M, 2003, BIOCHEM BIOPH RES CO, V307, P254, DOI 10.1016/S0006-291X(03)01161-6; Jaggi M, 2008, MOL CANCER THER, V7, P2703, DOI 10.1158/1535-7163.MCT-08-0119; Jaggi M, 2007, FRONT BIOSCI-LANDMRK, V12, P3757, DOI 10.2741/2349; Jaiswal AS, 2002, ONCOGENE, V21, P8414, DOI 10.1038/sj.onc.1205947; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; JOHNSON KR, 1993, EXP CELL RES, V207, P252, DOI 10.1006/excr.1993.1191; Kisfalvi K, 2010, J CELL PHYSIOL, V223, P309, DOI 10.1002/jcp.22036; LaValle CR, 2010, BBA-REV CANCER, V1806, P183, DOI 10.1016/j.bbcan.2010.05.003; Lin YC, 2011, J BIOL CHEM, V286, P27039, DOI 10.1074/jbc.M111.244418; Lopez-Lazaro M, 2008, MOL NUTR FOOD RES, V52, pS103, DOI 10.1002/mnfr.200700238; Maher DM, 2011, MOL CARCINOGEN, V50, P47, DOI 10.1002/mc.20695; Mak P, 2008, BIOCHEM BIOPH RES CO, V373, P618, DOI 10.1016/j.bbrc.2008.06.097; Mukhopadhyay A, 2001, ONCOGENE, V20, P7597, DOI 10.1038/sj.onc.1204997; Nakamura K, 2002, INT J ONCOL, V21, P825; Nelson WJ, 2004, SCIENCE, V303, P1483, DOI 10.1126/science.1094291; Park CH, 2005, FEBS LETT, V579, P2965, DOI 10.1016/j.febslet.2005.04.013; Peterburs P, 2009, CANCER RES, V69, P5634, DOI 10.1158/0008-5472.CAN-09-0718; Rozengurt E, 2005, J BIOL CHEM, V280, P13205, DOI 10.1074/jbc.R500002200; Rykx A, 2003, FEBS LETT, V546, P81, DOI 10.1016/S0014-5793(03)00487-3; Sharma RA, 2004, CLIN CANCER RES, V10, P6847, DOI 10.1158/1078-0432.CCR-04-0744; Spratley SJ, 2011, J BIOL CHEM; Storz P, 2009, CELL CYCLE, V8, P1975; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Sundram V, 2011, MOL CANCER RES, V9, P985, DOI 10.1158/1541-7786.MCR-10-0365; Syed V, 2008, J CELL BIOCHEM, V104, P82, DOI 10.1002/jcb.21603; Teiten MH, 2011, INT J ONCOL, V38, P603, DOI 10.3892/ijo.2011.905; VALVERDE AM, 1994, P NATL ACAD SCI USA, V91, P8572, DOI 10.1073/pnas.91.18.8572; Van Lint J, 2002, TRENDS CELL BIOL, V12, P193, DOI 10.1016/S0962-8924(02)02262-6; Wheelock MJ, 2003, ANNU REV CELL DEV BI, V19, P207, DOI 10.1146/annurev.cellbio.19.011102.111135; Yallapu MM, 2010, J OVARIAN RES, V3, DOI 10.1186/1757-2215-3-11	50	70	74	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2012	7	4							e35368	10.1371/journal.pone.0035368	http://dx.doi.org/10.1371/journal.pone.0035368			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VO	22523587	Green Submitted, Green Published, gold			2022-12-25	WOS:000305345000060
J	El-Mashtoly, SF; Kubo, M; Gu, YZ; Sawai, H; Nakashima, S; Ogura, T; Aono, S; Kitagawa, T				El-Mashtoly, Samir F.; Kubo, Minoru; Gu, Yuzong; Sawai, Hitomi; Nakashima, Satoru; Ogura, Takashi; Aono, Shigetoshi; Kitagawa, Teizo			Site-specific Protein Dynamics in Communication Pathway from Sensor to Signaling Domain of Oxygen Sensor Protein, HemAT-Bs TIME-RESOLVED ULTRAVIOLET RESONANCE RAMAN STUDY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BACILLUS-SUBTILIS; LIGAND-BINDING; STRUCTURAL DYNAMICS; SENSING MECHANISM; HYDROGEN-BOND; CHEMOTAXIS; TYROSINE; TRANSMISSION; TRANSDUCTION; INTENSITIES	HemAT-Bs is a heme-based signal transducer protein responsible for aerotaxis. Time-resolved ultraviolet resonance Raman (UVRR) studies of wild-type and Y70F mutant of the full-length HemAT-Bs and the truncated sensor domain were performed to determine the site-specific protein dynamics following carbon monoxide (CO) photodissociation. The UVRR spectra indicated two phases of intensity changes for Trp, Tyr, and Phe bands of both full-length and sensor domain proteins. The W16 and W3 Raman bands of Trp, the F8a band of Phe, and the Y8a band of Tyr increased in intensity at hundreds of nanoseconds after CO photodissociation, and this was followed by recovery in similar to 50 mu s. These changes were assigned to Trp-132 (G-helix), Tyr-70 (B-helix), and Phe-69 (B-helix) and/or Phe-137 (G-helix), suggesting that the change in the heme structure drives the displacement of B- and G-helices. The UVRR difference spectra of the sensor domain displayed a positive peak for amide I in hundreds of nanoseconds after photolysis, which was followed by recovery in similar to 50 mu s. This difference band was absent in the spectra of the full-length protein, suggesting that the isolated sensor domain undergoes conformational changes of the protein backbone upon CO photolysis and that the changes are restrained by the signaling domain. The time-resolved difference spectrum at 200 mu s exhibited a pattern similar to that of the static (reduced - CO) difference spectrum, although the peak intensities were much weaker. Thus, the rearrangements of the protein moiety toward the equilibrium ligand-free structure occur in a time range of hundreds of microseconds.	[El-Mashtoly, Samir F.] Ruhr Univ Bochum, Lehrstuhl Biophys, D-44780 Bochum, Germany; [Kubo, Minoru; Nakashima, Satoru; Ogura, Takashi; Kitagawa, Teizo] Univ Hyogo, Grad Sch Life Sci, Picobiol Inst, Kobe, Hyogo 6781297, Japan; [Gu, Yuzong; Sawai, Hitomi; Aono, Shigetoshi] Natl Inst Nat Sci, Okazaki Inst Integrat Biosci, Okazaki, Aichi 4448787, Japan	Ruhr University Bochum; University of Hyogo; National Institutes of Natural Sciences (NINS) - Japan; Okazaki Institute for Integrative Bioscience (OIIB)	El-Mashtoly, SF (corresponding author), Ruhr Univ Bochum, Lehrstuhl Biophys, D-44780 Bochum, Germany.	samir@bph.rub.de; teizo@sci.u-hyogo.ac.jp	Asano, Yasuhisa/K-5898-2016; Sawai, Hitomi/AAW-5541-2021; Sawai, Hitomi/AAU-2584-2020; El-Mashtoly, Samir/C-8761-2014; Gu, Yuzong/ABC-5639-2021; Aono, Shigetoshi/ABD-7618-2020	Asano, Yasuhisa/0000-0003-3645-3952; El-Mashtoly, Samir/0000-0001-6087-8817; Gu, Yuzong/0000-0002-7107-5187; Aono, Shigetoshi/0000-0002-2870-3694; Nakashima, Satoru/0000-0001-8378-1153; Sawai, Hitomi/0000-0002-0714-8337	Japan Society for the Promotion of Science [243600086, 21026033, 22018026, 23685040]; Grants-in-Aid for Scientific Research [23350084, 23685040] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants-in-aid for Scientific Research (B) from the Japan Society for the Promotion of Science 243600086 (to T. K.) and 21026033 (to S. A.), Grant-in-aid 22018026 for Priority Area 477 (to T. O.), and 23685040 for Young Scientists (A) (to M. K.).	Aono S, 2002, J BIOL CHEM, V277, P13528, DOI 10.1074/jbc.M112256200; Aono S, 2008, DALTON T, P3137, DOI 10.1039/b802070c; AUSTIN JC, 1993, ADV SPECTROSC, V20, P55; Balakrishnan G, 2008, CURR OPIN STRUC BIOL, V18, P623, DOI 10.1016/j.sbi.2008.06.001; BISCHOFF DS, 1992, MOL MICROBIOL, V6, P23, DOI 10.1111/j.1365-2958.1992.tb00833.x; Chi ZH, 1998, J PHYS CHEM B, V102, P9595, DOI 10.1021/jp9828336; El-Mashtoly SF, 2008, J BIOL CHEM, V283, P6942, DOI 10.1074/jbc.M709209200; El-Mashtoly SF, 2007, J AM CHEM SOC, V129, P3556, DOI 10.1021/ja0669777; El-Mashtoly SF, 2011, J PHYS CHEM LETT, V2, P2212, DOI 10.1021/jz201017y; El-Mashtoly SF, 2005, J PHYS CHEM B, V109, P23666, DOI 10.1021/jp054772z; Gao Y, 2006, J BIOL CHEM, V281, P24637, DOI 10.1074/jbc.M603198200; GARRITY LF, 1995, PHARMACOL THERAPEUT, V68, P87, DOI 10.1016/0163-7258(95)00027-5; Gilles-Gonzalez MA, 2005, J INORG BIOCHEM, V99, P1, DOI 10.1016/j.jinorgbio.2004.11.006; HESSLING B, 1993, BIOPHYS J, V65, P1929, DOI 10.1016/S0006-3495(93)81264-5; Hou SB, 2001, P NATL ACAD SCI USA, V98, P9353, DOI 10.1073/pnas.161185598; Hou SB, 2000, NATURE, V403, P540, DOI 10.1038/35000570; Kneipp J, 2004, J PHYS CHEM B, V108, P15919, DOI 10.1021/jp047848k; Kubo M, 2006, J BIOL CHEM, V281, P11271, DOI 10.1074/jbc.M513261200; Kubo M, 2008, APPL SPECTROSC, V62, P30, DOI 10.1366/000370208783412573; Matsuno M, 1998, B CHEM SOC JPN, V71, P851, DOI 10.1246/bcsj.71.851; Mokdad A, 2007, FEBS LETT, V581, P4512, DOI 10.1016/j.febslet.2007.08.031; Ohta T, 2005, INORG CHEM, V44, P758, DOI 10.1021/ic0486318; Ohta T, 2004, J AM CHEM SOC, V126, P15000, DOI 10.1021/ja046896f; Ottemann KM, 1999, SCIENCE, V285, P1751, DOI 10.1126/science.285.5434.1751; Pinakoulaki E, 2006, P NATL ACAD SCI USA, V103, P14796, DOI 10.1073/pnas.0604248103; Pinakoulaki E, 2006, BIOCHEMISTRY-US, V45, P7763, DOI 10.1021/bi0604072; RODGERS KR, 1992, J AM CHEM SOC, V114, P3697, DOI 10.1021/ja00036a019; RODGERS KR, 1994, SCIENCE, V265, P1697, DOI 10.1126/science.8085153; Sato A, 2007, P NATL ACAD SCI USA, V104, P9627, DOI 10.1073/pnas.0611560104; SU C, 1990, J RAMAN SPECTROSC, V21, P435, DOI 10.1002/jrs.1250210709; SWEENEY JA, 1990, J PHYS CHEM-US, V94, P4784, DOI 10.1021/j100375a009; Szurmant H, 2004, J MOL BIOL, V344, P919, DOI 10.1016/j.jmb.2004.09.093; Szurmant L, 2004, MICROBIOL MOL BIOL R, V68, P301, DOI 10.1128/MMBR.68.2.301-319.2004; TAKEUCHI H, 1989, J RAMAN SPECTROSC, V20, P233, DOI 10.1002/jrs.1250200407; Takeuchi H., 1986, ADV SPECTROSCOPY SPE, V13, P113; Uchida T, 2005, ACCOUNTS CHEM RES, V38, P662, DOI 10.1021/ar030267d; Unno M, 2010, BIOPHYS J, V98, P1949, DOI 10.1016/j.bpj.2010.01.007; Yoshimura H, 2007, BIOCHEM BIOPH RES CO, V357, P1053, DOI 10.1016/j.bbrc.2007.04.041; Yoshimura H, 2006, BIOCHEMISTRY-US, V45, P8301, DOI 10.1021/bi060315c; Zhang W, 2005, BIOPHYS J, V88, P2801, DOI 10.1529/biophysj.104.047936; Zhang W, 2003, STRUCTURE, V11, P1097, DOI 10.1016/S0969-2126(03)00169-2	41	11	11	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 8	2012	287	24					19973	19984		10.1074/jbc.M112.357855	http://dx.doi.org/10.1074/jbc.M112.357855			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974FB	22528495	Green Published, hybrid			2022-12-25	WOS:000306414500019
J	Callan, DE; Gamez, M; Cassel, DB; Terzibas, C; Callan, A; Kawato, M; Sato, M				Callan, Daniel E.; Gamez, Mario; Cassel, Daniel B.; Terzibas, Cengiz; Callan, Akiko; Kawato, Mitsuo; Sato, Masa-aki			Dynamic Visuomotor Transformation Involved with Remote Flying of a Plane Utilizes the 'Mirror Neuron' System	PLOS ONE			English	Article							CORTICAL ACTIVITY; INTERNAL-MODELS; MENTAL ROTATION; VIRTUAL-REALITY; BRAIN ACTIVITY; VISUAL-CORTEX; IMITATION; MOTION; MECHANISMS; FMRI	Brain regions involved with processing dynamic visuomotor representational transformation are investigated using fMRI. The perceptual-motor task involved flying (or observing) a plane through a simulated Red Bull Air Race course in first person and third person chase perspective. The third person perspective is akin to remote operation of a vehicle. The ability for humans to remotely operate vehicles likely has its roots in neural processes related to imitation in which visuomotor transformation is necessary to interpret the action goals in an egocentric manner suitable for execution. In this experiment for 3rd person perspective the visuomotor transformation is dynamically changing in accordance to the orientation of the plane. It was predicted that 3rd person remote flying, over 1st, would utilize brain regions composing the 'Mirror Neuron' system that is thought to be intimately involved with imitation for both execution and observation tasks. Consistent with this prediction differential brain activity was present for 3rd person over 1st person perspectives for both execution and observation tasks in left ventral premotor cortex, right dorsal premotor cortex, and inferior parietal lobule bilaterally (Mirror Neuron System) (Behaviorally: 1st>3rd). These regions additionally showed greater activity for flying (execution) over watching (observation) conditions. Even though visual and motor aspects of the tasks were controlled for, differential activity was also found in brain regions involved with tool use, motion perception, and body perspective including left cerebellum, temporo-occipital regions, lateral occipital cortex, medial temporal region, and extrastriate body area. This experiment successfully demonstrates that a complex perceptual motor real-world task can be utilized to investigate visuomotor processing. This approach (Aviation Cerebral Experimental Sciences ACES) focusing on direct application to lab and field is in contrast to standard methodology in which tasks and conditions are reduced to their simplest forms that are remote from daily life experience.	[Callan, Daniel E.; Gamez, Mario; Cassel, Daniel B.; Terzibas, Cengiz; Sato, Masa-aki] ATR Neural Informat Anal Labs, Kyoto, Japan; [Callan, Akiko] NICT Multimodal Commun Grp, Kyoto, Japan; [Kawato, Mitsuo] ATR Computat Neurosci Labs, Kyoto, Japan	National Institute of Information & Communications Technology (NICT) - Japan	Callan, DE (corresponding author), ATR Neural Informat Anal Labs, Kyoto, Japan.	dcallan@atr.jp		Callan, Daniel/0000-0002-8851-6065	National Institute of Information and Communications Technology; KAKENHI [21500321]; Ministry of Internal Affairs and Communications	National Institute of Information and Communications Technology; KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Ministry of Internal Affairs and Communications	This research was supported in part by the National Institute of Information and Communications Technology, by KAKENHI Grant-in-Aid for Scientific Research(C) (21500321), and by a contract with the Ministry of Internal Affairs and Communications entitled, 'Novel and innovative R&D making use of brain structures.' The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartels A, 2008, CEREB CORTEX, V18, P705, DOI 10.1093/cercor/bhm107; Busan P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004621; Caplovitz GP, 2010, NEUROPSYCHOLOGIA, V48, P2699, DOI 10.1016/j.neuropsychologia.2010.05.017; Caspers S, 2010, NEUROIMAGE, V50, P1148, DOI 10.1016/j.neuroimage.2009.12.112; Cate AD, 2011, BRAIN RES, V1388, P109, DOI 10.1016/j.brainres.2011.02.022; Chaminade T, 2005, NEUROPSYCHOLOGIA, V43, P115, DOI 10.1016/j.neuropsychologia.2004.04.026; Chaminade T, 2002, NEUROREPORT, V13, P1975, DOI 10.1097/00001756-200210280-00029; Chan AWY, 2004, NEUROREPORT, V15, P2407, DOI 10.1097/00001756-200410250-00021; Chen AH, 2011, J NEUROSCI, V31, P11617, DOI 10.1523/JNEUROSCI.1266-11.2011; Creem-Regehr SH, 2007, NEUROIMAGE, V35, P916, DOI 10.1016/j.neuroimage.2006.11.057; Decety J, 2003, NEUROPSYCHOLOGIA, V41, P127, DOI 10.1016/S0028-3932(02)00143-4; Decety J, 2002, NEUROIMAGE, V15, P265, DOI 10.1006/nimg.2001.0938; Doeller CF, 2010, NATURE, V463, P657, DOI 10.1038/nature08704; Ekstrom AD, 2003, NATURE, V425, P184, DOI 10.1038/nature01964; Ellis S. R., 2002, Proceedings of the Human Factors and Ergonomics Society 46th Annual Meeting, P1551; Franklin DW, 2011, NEURON, V72, P425, DOI 10.1016/j.neuron.2011.10.006; GIBSON J J, 1955, Am J Psychol, V68, P372, DOI 10.2307/1418521; Grafton ST, 2001, J COGNITIVE NEUROSCI, V13, P217, DOI 10.1162/089892901564270; Graydon FX, 2005, COGNITIVE BRAIN RES, V22, P373, DOI 10.1016/j.cogbrainres.2004.09.007; Grefkes C, 2004, NEUROIMAGE, V23, P1494, DOI 10.1016/j.neuroimage.2004.08.031; Howe PD, 2009, J VISION, V9, DOI 10.1167/9.4.10; Huddleston WE, 2008, CEREB CORTEX, V18, P1272, DOI 10.1093/cercor/bhm158; Iacoboni M, 1999, SCIENCE, V286, P2526, DOI 10.1126/science.286.5449.2526; Imamizu H, 2000, NATURE, V403, P192, DOI 10.1038/35003194; Imamizu H, 2003, P NATL ACAD SCI USA, V100, P5461, DOI 10.1073/pnas.0835746100; Imamizu H, 2012, CEREBELLUM IN PRESS; Imamizu H, 2007, CORTEX, V43, P338, DOI 10.1016/S0010-9452(08)70459-3; Jackson PL, 2006, NEUROIMAGE, V31, P429, DOI 10.1016/j.neuroimage.2005.11.026; Kovacs G, 2008, CEREB CORTEX, V18, P1779, DOI 10.1093/cercor/bhm203; Lamm C, 2007, NEUROIMAGE, V36, P1374, DOI 10.1016/j.neuroimage.2007.04.012; Langner R, 2011, CEREB CORTEX, V21, P2850, DOI 10.1093/cercor/bhr083; Larsson J, 2006, J NEUROSCI, V26, P13128, DOI 10.1523/JNEUROSCI.1657-06.2006; Lissek S, 2007, NEUROIMAGE, V37, P912, DOI 10.1016/j.neuroimage.2007.05.037; Liu S, 2009, J NEUROSCI, V29, P8936, DOI 10.1523/JNEUROSCI.1607-09.2009; Loose R, 1999, CLIN NEUROPHYSIOL, V110, P192, DOI 10.1016/S0168-5597(98)00058-6; Mellet E, 2010, HUM BRAIN MAPP, V31, P1065, DOI 10.1002/hbm.20917; Meltzoff AN, 2003, PHILOS T R SOC B, V358, P491, DOI 10.1098/rstb.2002.1261; Mikhelashvili-Browner N, 2003, AM J NEURORADIOL, V24, P488; Molenberghs P, 2009, NEUROSCI BIOBEHAV R, V33, P975, DOI 10.1016/j.neubiorev.2009.03.010; Pine DS, 2002, NEUROIMAGE, V15, P396, DOI 10.1006/nimg.2001.0988; Rizzolatti G, 2001, NAT REV NEUROSCI, V2, P661, DOI 10.1038/35090060; Saxe R, 2006, CEREB CORTEX, V16, P178, DOI 10.1093/cercor/bhi095; Stark A, 2008, CEREB CORTEX, V18, P2358, DOI 10.1093/cercor/bhm260; Stein BE., 1993, MERGING SENSES; Stiers P, 2006, NEUROIMAGE, V29, P74, DOI 10.1016/j.neuroimage.2005.07.033; Stoodley C, NEUROIMAGE IN PRESS; Takahashi K, 2007, J NEUROSCI, V27, P9742, DOI 10.1523/JNEUROSCI.0817-07.2007; Tanaka S, 2002, NEUROREPORT, V13, P1599, DOI 10.1097/00001756-200209160-00005; Van Overwalle F, 2009, NEUROIMAGE, V48, P564, DOI 10.1016/j.neuroimage.2009.06.009; Vogeley K, 2004, J COGNITIVE NEUROSCI, V16, P817, DOI 10.1162/089892904970799; Wise SP, 1998, EXP BRAIN RES, V121, P285, DOI 10.1007/s002210050462; Wolbers T, 2008, NAT NEUROSCI, V11, P1223, DOI 10.1038/nn.2189; Yamagishi N, 2008, BRAIN RES, V1197, P115, DOI 10.1016/j.brainres.2007.12.063; Zacks J, 1999, NEUROPSYCHOLOGIA, V37, P1029, DOI 10.1016/S0028-3932(99)00012-3; Zacks JM, 2008, J COGNITIVE NEUROSCI, V20, P1, DOI 10.1162/jocn.2008.20013; Zacks JM, 2002, NEUROIMAGE, V16, P857, DOI 10.1006/nimg.2002.1129	56	14	14	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2012	7	4							e33873	10.1371/journal.pone.0033873	http://dx.doi.org/10.1371/journal.pone.0033873			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UD	22536320	Green Submitted, Green Published, gold			2022-12-25	WOS:000305339200007
J	Gittenberger, E; Hamann, TD; Asami, T				Gittenberger, Edmund; Hamann, Thomas D.; Asami, Takahiro			Chiral Speciation in Terrestrial Pulmonate Snails	PLOS ONE			English	Article							WHOLE-BODY ENANTIOMORPHY; SINGLE-GENE SPECIATION; MATERNAL INHERITANCE; EVOLUTION; COILING; ASYMMETRY; GASTROPOD; DIRECTIONS; DIMORPHISM; HANDEDNESS	On the basis of data in the literature, the percentages of dextral versus sinistral species of snails have been calculated for western Europe, Turkey, North America (north of Mexico), and Japan. When the family of Clausiliidae is represented, about a quarter of all snail species may be sinistral, whereas less than one per cent of the species may be sinistral where that family does not occur. The number of single-gene speciation events on the basis of chirality, resulting in the origin of mirror image species, is not closely linked to the percentage of sinistral versus dextral species in a particular region. Turkey is nevertheless exceptional by both a high percentage of sinistral species and a high number of speciation events resulting in mirror image species. Shell morphology and genetic background may influence the ease of chirality-linked speciation, whereas sinistrality may additionally be selected against by internal selection. For the Clausiliidae, the fossil record and the recent fauna suggest that successful reversals in coiling direction occurred with a frequency of once every three to four million years.	[Gittenberger, Edmund; Hamann, Thomas D.] Netherlands Ctr Biodivers, Leiden, Netherlands; [Asami, Takahiro] Shinshu Univ, Dept Biol, Matsumoto, Nagano 390, Japan	Naturalis Biodiversity Center; Shinshu University	Gittenberger, E (corresponding author), Netherlands Ctr Biodivers, Leiden, Netherlands.	Edi.Gittenberger@ncbnaturalis.nnm.nl			Grants-in-Aid for Scientific Research [20405007] Funding Source: KAKEN	Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))		Asami T, 1998, AM NAT, V152, P225, DOI 10.1086/286163; Asami T., 1993, FORMA, V8, P263; Asami T, 2008, J HERED, V99, P552, DOI 10.1093/jhered/esn032; Bromham L, 2001, TRENDS ECOL EVOL, V16, P125, DOI 10.1016/S0169-5347(00)02076-0; CAIN AJ, 1977, PHILOS T ROY SOC B, V277, P377, DOI 10.1098/rstb.1977.0026; Davison A, 2009, HEREDITY, V103, P268, DOI 10.1038/hdy.2009.49; De Weerd DRU, 2006, BIOL J LINN SOC, V88, P155; Deniu C, 2004, INVERTEBRATA, V37; Dietl GP, 2006, BIOL LETTERS, V2, P439, DOI 10.1098/rsbl.2006.0465; FREEMAN G, 1982, ROUX ARCH DEV BIOL, V191, P69, DOI 10.1007/BF00848443; GITTENBERGER E, 1995, NATURE, V373, P19, DOI 10.1038/373019b0; GITTENBERGER E, 1988, EVOLUTION, V42, P826, DOI 10.1111/j.1558-5646.1988.tb02502.x; GOULD SJ, 1985, EVOLUTION, V39, P1364, DOI 10.1111/j.1558-5646.1985.tb05701.x; Harada Y, 2004, DEV GENES EVOL, V214, P159, DOI 10.1007/s00427-004-0392-6; Hierck BP, 2005, J MOLLUS STUD, V71, P192, DOI 10.1093/mollus/eyi023; Hoso M, 2007, BIOL LETTERS, V3, P169, DOI 10.1098/rsbl.2006.0600; Hoso M, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1133; Inoda T, 2003, AM NAT, V162, P811, DOI 10.1086/378903; Johnson Michael S., 1993, Oxford Surveys in Evolutionary Biology, V9, P167; KERNEY MP, 1983, LANDSCHNECKEN NORD U; Meisenheimer J., 1912, LEIPZIG, V4, P1, DOI [10.1017/CBO9781107415324.004., DOI 10.1017/CBO9781107415324.004]; Minato H., 1988, SYSTEMATIC BIBLIOGRA; Minato H, 1994, VENUS S, P21; Nakadera Y, 2010, J EVOLUTION BIOL, V23, P2377, DOI 10.1111/j.1420-9101.2010.02099.x; Nordsieck H., 2007, WORLDWIDE DOOR SNAIL; Nunes GKM, 2007, REV BRAS ZOOL, V24, P258, DOI 10.1590/S0101-81752007000100036; Okumura T, 2008, DEV DYNAM, V237, P3497, DOI 10.1002/dvdy.21788; Oliverio M, 2010, AM J MED GENET A, V152A, P2419, DOI 10.1002/ajmg.a.33655; ORR HA, 1991, EVOLUTION, V45, P764, DOI 10.1111/j.1558-5646.1991.tb04345.x; Pilsbry, 1939, ACADEMY NATURAL SCI, V3, P267; Pilsbry H. A, 1940, ACAD NATURAL SCI MON ACAD NATURAL SCI MON, V1, P575; Pilsbry H.A., 1948, ACAD NATURAL SCI PHI, V3, P521; Pilsbry HA, 1946, ACAD NATURAL SCI PHI, V3, P1; Preece R. C., 2008, Basteria, V72, P267; ROBERTSON R, 1993, RES EXPLOR, V9, P104; Schilthuizen M, 2007, J EVOLUTION BIOL, V20, P1941, DOI 10.1111/j.1420-9101.2007.01370.x; Schilthuizen M, 2005, NATURWISSENSCHAFTEN, V92, P504, DOI 10.1007/s00114-05-0045-2; Schilthuizen M, 2005, HEREDITY, V95, P216, DOI 10.1038/sj.hdy.6800715; Schuatt H., 2005, TURKISH LAND SNAILS; Stone J, 2002, P ROY SOC B-BIOL SCI, V269, P861, DOI 10.1098/rspb.2001.1934; Sutcharit C, 2007, J EVOLUTION BIOL, V20, P661, DOI 10.1111/j.1420-9101.2006.01246.x; Sutcharit C, 2006, J MOLLUS STUD, V72, P1, DOI 10.1093/mollus/eyi044; Ueshima R, 2003, NATURE, V425, P679, DOI 10.1038/425679a; Utsuno H, 2011, EVOLUTION, V65, P2399, DOI 10.1111/j.1558-5646.2011.01293.x; Utsuno H, 2010, MOLLUSCAN RES, V30, P37; Utsuno H, 2010, J HERED, V101, P11, DOI 10.1093/jhered/esp058; VanBatenburg FHD, 1996, HEREDITY, V76, P278, DOI 10.1038/hdy.1996.41; Vermeij Geerat J., 1993, pi; VERMEIJ GJ, 1975, NATURE, V254, P419, DOI 10.1038/254419a0; Wade CM, 2007, J MOLLUS STUD, V73, P411, DOI 10.1093/mollus/eym030; Wandelt J, 2004, CURR BIOL, V14, pR654, DOI 10.1016/j.cub.2004.08.010; Wood WB, 1998, SEMIN CELL DEV BIOL, V9, P53, DOI 10.1006/scdb.1997.0189; Wood WB, 2005, PLOS BIOL, V3, P1348, DOI 10.1371/journal.pbio.0030292; Zilch A., 1960, HDB PALAOZOOLOGIE, P401	54	31	34	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2012	7	4							e34005	10.1371/journal.pone.0034005	http://dx.doi.org/10.1371/journal.pone.0034005			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UD	22532825	gold, Green Submitted, Green Published			2022-12-25	WOS:000305339200008
J	Kohler, J; Erlenkamp, G; Eberlin, A; Rumpf, T; Slynko, I; Metzger, E; Schule, R; Sippl, W; Jung, M				Koehler, Jens; Erlenkamp, German; Eberlin, Adrien; Rumpf, Tobias; Slynko, Inna; Metzger, Eric; Schuele, Roland; Sippl, Wolfgang; Jung, Manfred			Lestaurtinib Inhibits Histone Phosphorylation and Androgen-Dependent Gene Expression in Prostate Cancer Cells	PLOS ONE			English	Article							MOLECULAR-DYNAMICS; KINASE INHIBITOR; DOCKING; CHROMATIN; RECEPTOR; EPIGENETICS; ALIGNMENT; ACCURACY; PROTEINS; CEP701	Background: Epigenetics is defined as heritable changes in gene expression that are not based on changes in the DNA sequence. Posttranslational modification of histone proteins is a major mechanism of epigenetic regulation. The kinase PRK1 (protein kinase C related kinase 1, also known as PKN1) phosphorylates histone H3 at threonine 11 and is involved in the regulation of androgen receptor signalling. Thus, it has been identified as a novel drug target but little is known about PRK1 inhibitors and consequences of its inhibition. Methodology/Principal Finding: Using a focused library screening approach, we identified the clinical candidate lestaurtinib (also known as CEP-701) as a new inhibitor of PRK1. Based on a generated 3D model of the PRK1 kinase using the homolog PKC-theta (protein kinase c theta) protein as a template, the key interaction of lestaurtinib with PRK1 was analyzed by means of molecular docking studies. Furthermore, the effects on histone H3 threonine phosphorylation and androgen-dependent gene expression was evaluated in prostate cancer cells. Conclusions/Significance: Lestaurtinib inhibits PRK1 very potently in vitro and in vivo. Applied to cell culture it inhibits histone H3 threonine phosphorylation and androgen-dependent gene expression, a feature that has not been known yet. Thus our findings have implication both for understanding of the clinical activity of lestaurtinib as well as for future PRK1 inhibitors.	[Koehler, Jens; Rumpf, Tobias; Jung, Manfred] Univ Freiburg, Inst Pharmaceut Sci, D-79106 Freiburg, Germany; [Erlenkamp, German; Slynko, Inna; Sippl, Wolfgang] Univ Halle Wittenberg, Dept Pharmaceut Chem, Halle, Germany; [Eberlin, Adrien; Metzger, Eric; Schuele, Roland] Univ Freiburg, Med Ctr, Womens Hosp, Dept Urol, Freiburg, Germany; [Eberlin, Adrien; Metzger, Eric; Schuele, Roland] Univ Freiburg, Med Ctr, Clin Res Ctr, Freiburg, Germany	University of Freiburg; Martin Luther University Halle Wittenberg; University of Freiburg; University of Freiburg	Jung, M (corresponding author), Univ Munster, Inst Pharmaceut & Med Chem, Munster, Germany.	manfred.jung@pharmazie.uni-freiburg.de	Sippl, Wolfgang/P-5944-2014; Jung, Manfred/Q-8029-2016	Sippl, Wolfgang/0000-0002-5985-9261; Jung, Manfred/0000-0002-6361-7716				Allis CD, 2007, CELL, V131, P633, DOI 10.1016/j.cell.2007.10.039; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; [Anonymous], 2008, AMBER 10; Berger SL, 2009, GENE DEV, V23, P781, DOI 10.1101/gad.1787609; Case D, 2006, AMBER 9; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Charifson PS, 1999, J MED CHEM, V42, P5100, DOI 10.1021/jm990352k; DARDEN TA, 1993, J CHEM PHYS, V103, P8577; Englebienne P, 2009, J CHEM INF MODEL, V49, P1568, DOI 10.1021/ci8004308; Friesner RA, 2004, J MED CHEM, V47, P1739, DOI 10.1021/jm0306430; Frigo DE, 2009, MOL ENDOCRINOL, V23, P1385, DOI 10.1210/me.2009-0010; Gingrich DE, 2002, BIOORG MED CHEM LETT, V12, P2829, DOI 10.1016/S0960-894X(02)00638-8; Handel AE, 2009, TRENDS MOL MED; Hexner EO, 2008, BLOOD, V111, P5663, DOI 10.1182/blood-2007-04-083402; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; Hurd PJ, 2009, J BIOL CHEM, V284, P16575, DOI 10.1074/jbc.M109.005421; Jones G, 1997, J MOL BIOL, V267, P727, DOI 10.1006/jmbi.1996.0897; Knapper S, 2006, BLOOD, V108, P3262, DOI 10.1182/blood-2006-04-015560; Kufareva I, 2008, J MED CHEM, V51, P7921, DOI 10.1021/jm8010299; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Ma AH, 2006, CANCER RES, V66, P8439, DOI 10.1158/0008-5472.CAN-06-1636; Markaki Y, 2009, J CELL SCI, V122, P2809, DOI 10.1242/jcs.043810; Meier R, 2010, J CHEM INF MODEL, V50, P879, DOI 10.1021/ci900467x; Metzger E, 2005, NATURE, V437, P436, DOI 10.1038/nature04020; Metzger E, 2008, NAT CELL BIOL, V10, P53, DOI 10.1038/ncb1668; Metzger E, 2010, NATURE, V464, P792, DOI 10.1038/nature08839; Ngan S, 2009, ONCOGENE, V28, P2051, DOI 10.1038/onc.2009.68; Pandini G, 2005, CANCER RES, V65, P1849, DOI 10.1158/0008-5472.CAN-04-1837; Papait R, 2009, IDRUGS, V12, P264; PASTOR RW, 1988, MOL PHYS, V65, P1409, DOI 10.1080/00268978800101881; Patnaik D, 2008, J BIOMOL SCREEN, V13, P1025, DOI 10.1177/1087057108326081; Fidalgo JAP, 2009, CLIN TRANSL ONCOL, V11, P787, DOI 10.1007/s12094-009-0447-2; Prescott JL, 1998, PROSTATE, V35, P71, DOI 10.1002/(SICI)1097-0045(19980401)35:1<71::AID-PROS10>3.0.CO;2-H; Rae JM, 2006, PROSTATE, V66, P886, DOI 10.1002/pros.20403; Revill P, 2007, DRUG FUTURE, V32, P215, DOI 10.1358/dof.2007.032.03.1084137; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Shabbir M, 2010, EXPERT OPIN INV DRUG, V19, P427, DOI 10.1517/13543781003598862; Shen YQ, 2001, ACTA CRYSTALLOGR D, V57, P1196, DOI 10.1107/S0907444901007703; Sobel RE, 2005, J UROLOGY, V173, P342, DOI 10.1097/01.ju.0000141580.30910.57; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035; Xu ZB, 2004, J BIOL CHEM, V279, P50401, DOI 10.1074/jbc.M409216200	42	29	31	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2012	7	4							e34973	10.1371/journal.pone.0034973	http://dx.doi.org/10.1371/journal.pone.0034973			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UD	22532837	Green Submitted, Green Published, gold			2022-12-25	WOS:000305339200029
J	Larson, B; Schnippel, K; Ndibongo, B; Long, L; Fox, MP; Rosen, S				Larson, Bruce; Schnippel, Kathryn; Ndibongo, Buyiswa; Long, Lawrence; Fox, Matthew P.; Rosen, Sydney			How to Estimate the Cost of Point-of-Care CD4 Testing in Program Settings: An Example Using the Alere Pima (TM) Analyzer in South Africa	PLOS ONE			English	Article							T-CELL ENUMERATION; HIV; PERFORMANCE; LINKAGE; BLOOD	Integrating POC CD4 testing technologies into HIV counseling and testing (HCT) programs may improve post-HIV testing linkage to care and treatment. As evaluations of these technologies in program settings continue, estimates of the costs of POC CD4 tests to the service provider will be needed and estimates have begun to be reported. Without a consistent and transparent methodology, estimates of the cost per CD4 test using POC technologies are likely to be difficult to compare and may lead to erroneous conclusions about costs and cost-effectiveness. This paper provides a step-by-step approach for estimating the cost per CD4 test from a provider's perspective. As an example, the approach is applied to one specific POC technology, the Pima (TM) Analyzer. The costing approach is illustrated with data from a mobile HCT program in Gauteng Province of South Africa. For this program, the cost per test in 2010 was estimated at $23.76 (material costs = $8.70; labor cost per test = $7.33; and equipment, insurance, and daily quality control = $7.72). Labor and equipment costs can vary widely depending on how the program operates and the number of CD4 tests completed over time. Additional costs not included in the above analysis, for on-going training, supervision, and quality control, are likely to increase further the cost per test. The main contribution of this paper is to outline a methodology for estimating the costs of incorporating POC CD4 testing technologies into an HCT program. The details of the program setting matter significantly for the cost estimate, so that such details should be clearly documented to improve the consistency, transparency, and comparability of cost estimates.	[Larson, Bruce; Fox, Matthew P.; Rosen, Sydney] Boston Univ, Ctr Global Hlth & Dev, Boston, MA 02215 USA; [Schnippel, Kathryn; Ndibongo, Buyiswa; Long, Lawrence; Fox, Matthew P.; Rosen, Sydney] Univ Witwatersrand, Dept Med, Hlth Econ & Epidemiol Res Off, Fac Hlth Sci, ZA-2001 Johannesburg, South Africa; [Fox, Matthew P.] Boston Univ, Dept Epidemiol, Sch Publ Hlth, Boston, MA USA; [Larson, Bruce] Boston Univ, Dept Int Hlth, Sch Publ Hlth, Boston, MA USA	Boston University; University of Witwatersrand; Boston University; Boston University	Larson, B (corresponding author), Boston Univ, Ctr Global Hlth & Dev, Boston, MA 02215 USA.	blarson@bu.edu	Fox, Matthew/K-2004-2019	Fox, Matthew/0000-0001-9887-0634; Rosen, Sydney/0000-0002-6560-2964; Schnippel, Kathryn/0000-0003-0757-4325; Long, Lawrence/0000-0003-4986-4988; Larson, Bruce/0000-0002-9322-2387	South Africa Mission of the United States Agency for International Development [GHSA-00-00020-00]; National Institute of Allergy and Infectious Diseases [K01AI083097]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K01AI083097] Funding Source: NIH RePORTER	South Africa Mission of the United States Agency for International Development; National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funding for this study was provided by the South Africa Mission of the United States Agency for International Development under the terms of Cooperative Agreement GHSA-00-00020-00, Country Research Activity (G/PHN/HN/CS). MF was supported by Award Number K01AI083097 from the National Institute of Allergy and Infectious Diseases. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boardman A, 2006, COST BENEFIT ANAL CO; Diaw PA, 2011, 6 IAS C HIV PATH TRE; Diaw PA, 2011, JAIDS-J ACQ IMM DEF, V58, pE103, DOI 10.1097/QAI.0b013e318235b378; Drummond MF., 2005, METHODS EC EVALUATIO, P55; Faal M, 2011, JAIDS-J ACQ IMM DEF, V58, pE54, DOI 10.1097/QAI.0b013e3182303921; Glencross D, 2011, 6 IAS C HIV PATH TRE; Glencross DK, 2008, CYTOM PART B-CLIN CY, V74B, pS69, DOI 10.1002/cyto.b.20397; Glencross DK, 2012, J INT AIDS SOC, V15, DOI 10.1186/1758-2652-15-3; Govindasamy D, 2011, JAIDS-J ACQ IMM DEF, V58, P344, DOI 10.1097/QAI.0b013e31822e0c4c; Jani IV, 2010, CLIN INFECT DIS, V51, P609, DOI 10.1086/655763; Jani IV, 2011, LANCET; Larson BA, 2011, RAPID POINT OF CARE; Larson BA, 2010, B WORLD HEALTH ORGAN, V88, P675, DOI 10.2471/BLT.09.068981; Losina E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009538; McCoy SI, 2009, AIDS CARE, V21, P1313, DOI 10.1080/09540120902803174; Mtapuri-Zinyowera S, 2010, JAIDS-J ACQ IMM DEF, V55, P1, DOI 10.1097/QAI.0b013e3181e93071; Nsigaye R, 2009, J INT AIDS SOC, V12, DOI 10.1186/1758-2652-12-31; Pai NP, 2012, DISCOV MED, V13, P35; Rosen S, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001056; Sitoe N, COST COMPARISON POIN; Sukapirom K, 2011, JAIDS J ACQ IN PRESS	21	45	45	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2012	7	4							e35444	10.1371/journal.pone.0035444	http://dx.doi.org/10.1371/journal.pone.0035444			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UD	22532854	Green Published, gold, Green Submitted			2022-12-25	WOS:000305339200065
J	Zhu, YL; Jiang, QL; Lou, XJ; Ji, XW; Wen, ZZ; Wu, J; Tao, HY; Jiang, TT; He, W; Wang, CH; Du, Q; Zheng, S; Mao, JS; Huang, J				Zhu, Yongliang; Jiang, Qiaoli; Lou, Xiaojun; Ji, Xiaowei; Wen, Zhenzhen; Wu, Jia; Tao, Haiying; Jiang, Tingting; He, Wei; Wang, Caihua; Du, Qin; Zheng, Shu; Mao, Jianshan; Huang, Jian			MicroRNAs Up-Regulated by CagA of Helicobacter pylori Induce Intestinal Metaplasia of Gastric Epithelial Cells	PLOS ONE			English	Article							VIRULENCE FACTOR CAGA; MESENCHYMAL TRANSDIFFERENTIATION; CARCINOMA-CELLS; CANCER; PROTEIN; FOXA1; TRANSCRIPTION; PHOSPHORYLATION; DIFFERENTIATION; CARCINOGENESIS	CagA of Helicobacter pylori is a bacterium-derived oncogenic protein closely associated with the development of gastric cancers. MicroRNAs (miRNAs) are a class of widespread non-coding RNAs, many of which are involved in cell growth, cell differentiation and tumorigenesis. The relationship between CagA protein and miRNAs is unclear. Using mammalian miRNA profile microarrays, we found that miRNA-584 and miRNA-1290 expression was up-regulated in CagA-transformed cells, miRNA-1290 was up-regulated in an Erk1/2-dependent manner, and miRNA-584 was activated by NF-kappa B. miRNA-584 sustained Erk1/2 activities through inhibition of PPP2a activities, and miRNA-1290 activated NF-kappa B by knockdown of NKRF. Foxa1 was revealed to be an important target of miRNA-584 and miRNA-1290. Knockdown of Foxa1 promoted the epithelial-mesenchymal transition significantly. Overexpression of miRNA-584 and miRNA-1290 induced intestinal metaplasia of gastric epithelial cells in knock-in mice. These results indicate that miRNA-584 and miRNA-1290 interfere with cell differentiation and remodel the tissues. Thus, the miRNA pathway is a new pathogenic mechanism of CagA.	[Zhu, Yongliang; Jiang, Qiaoli; Lou, Xiaojun; Ji, Xiaowei; Wen, Zhenzhen; Wu, Jia; Tao, Haiying; Jiang, Tingting; He, Wei; Wang, Caihua; Du, Qin; Mao, Jianshan] Zhejiang Univ, Sch Med, Affiliated Hosp 2, Dept Gastroenterol, Hangzhou 310003, Zhejiang, Peoples R China; [Zheng, Shu; Huang, Jian] Zhejiang Univ, Sch Med, Inst Canc, Hangzhou 310003, Zhejiang, Peoples R China; [Zheng, Shu; Huang, Jian] Zhejiang Univ, Sch Med, Educ Minist, Key Lab Canc Prevent & Intervent, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University; Zhejiang University	Zhu, YL (corresponding author), Zhejiang Univ, Sch Med, Affiliated Hosp 2, Dept Gastroenterol, Hangzhou 310003, Zhejiang, Peoples R China.	zhuyongliangch@yahoo.com.cn			National Science Foundation Committee of China [30670113, 81071768, 31090361]; Natural Science Foundation of Zhejiang province [R2090074, Y2090322]; Foundation of Scientific technology bureau of Zhejiang province [2009C33081, 2011C23091]	National Science Foundation Committee of China; Natural Science Foundation of Zhejiang province(Natural Science Foundation of Zhejiang Province); Foundation of Scientific technology bureau of Zhejiang province	This work was supported by grants from National Science Foundation Committee of China (30670113, 81071768, 31090361) (http://isisn.nsfc.gov.cn/egrantweb/), Natural Science Foundation of Zhejiang province (R2090074, Y2090322) (http://www.zjnsf.gov.cn/), and Foundation of Scientific technology bureau of Zhejiang province (2009C33081, 2011C23091) (http://www.zjkjt.gov.cn/html/node02/zxsb.jsp). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida R, 2005, J PATHOL, V207, P396, DOI 10.1002/path.1861; Amieva MR, 2003, SCIENCE, V300, P1430, DOI 10.1126/science.1081919; Belian E, 2010, ANTICANCER RES, V30, P629; Bhowmick NA, 2001, MOL BIOL CELL, V12, P27, DOI 10.1091/mbc.12.1.27; Calin GA, 2008, P NATL ACAD SCI USA, V105, P5166, DOI 10.1073/pnas.0800121105; Chen CZ, 2004, SCIENCE, V303, P83, DOI 10.1126/science.1091903; Ellenrieder V, 2001, CANCER RES, V61, P4222; Gao N, 2005, DEVELOPMENT, V132, P3431, DOI 10.1242/dev.01917; Hatakeyama M, 2005, CANCER SCI, V96, P835, DOI 10.1111/j.1349-7006.2005.00130.x; Hatakeyama M, 2004, NAT REV CANCER, V4, P688, DOI 10.1038/nrc1433; Hatakeyama M, 2008, ONCOGENE, V27, P7047, DOI 10.1038/onc.2008.353; Higashi H, 2002, SCIENCE, V295, P683, DOI 10.1126/science.1067147; Hirata Y, 2002, GASTROENTEROLOGY, V123, P1962, DOI 10.1053/gast.2002.37044; Hornstein E, 2005, NATURE, V438, P671, DOI 10.1038/nature04138; Iliopoulos D, 2010, MOL CELL, V39, P493, DOI 10.1016/j.molcel.2010.07.023; Inui M, 2010, NAT REV MOL CELL BIO, V11, P252, DOI 10.1038/nrm2868; Lee IO, 2010, J BIOL CHEM, V285, P16042, DOI 10.1074/jbc.M110.111054; Li ZY, 2009, J CLIN INVEST, V119, P1537, DOI 10.1172/JCI38201; Liu Z, 2010, MICROBES INFECT, V12, P854, DOI 10.1016/j.micinf.2010.06.002; Lupien M, 2008, CELL, V132, P958, DOI 10.1016/j.cell.2008.01.018; Matsushima K, 2011, INT J CANCER, V128, P361, DOI 10.1002/ijc.25348; Murata-Kamiya N, 2010, CELL HOST MICROBE, V7, P399, DOI 10.1016/j.chom.2010.04.005; Ohnishi N, 2008, P NATL ACAD SCI USA, V105, P1003, DOI 10.1073/pnas.0711183105; Poy MN, 2009, P NATL ACAD SCI USA, V106, P5813, DOI 10.1073/pnas.0810550106; Saadat I, 2007, NATURE, V447, P330, DOI 10.1038/nature05765; Shimono Y, 2009, CELL, V138, P592, DOI 10.1016/j.cell.2009.07.011; Shmuely H, 2001, AM J GASTROENTEROL, V96, P3406; Tan YJ, 2010, STEM CELLS DEV, V19, P1365, DOI 10.1089/scd.2009.0386; Taube JH, 2010, J BIOL CHEM, V285, P16135, DOI 10.1074/jbc.M109.088096; Tsang YH, 2010, ONCOGENE, V29, P5643, DOI 10.1038/onc.2010.304; Ueno K, 2011, BRIT J CANCER, V104, P308, DOI 10.1038/sj.bjc.6606028; Vatamaniuk MZ, 2006, DIABETES, V55, P2730, DOI 10.2337/db05-0470; Wan HJ, 2005, J BIOL CHEM, V280, P13809, DOI 10.1074/jbc.M414122200; Wong BCY, 2004, JAMA-J AM MED ASSOC, V291, P187, DOI 10.1001/jama.291.2.187; Xu J, 2009, CELL RES, V19, P156, DOI 10.1038/cr.2009.5; Yang HB, 2009, AM J GASTROENTEROL, V104, P1642, DOI 10.1038/ajg.2009.172; Ye DZ, 2009, GASTROENTEROLOGY, V137, P2052, DOI 10.1053/j.gastro.2009.08.059; Yeh JM, 2009, INT J CANCER, V124, P157, DOI 10.1002/ijc.23864; Zhu YL, 2005, ONCOGENE, V24, P3886, DOI 10.1038/sj.onc.1208551; Zhu YL, 2005, WORLD J GASTROENTERO, V11, P880, DOI 10.3748/wjg.v11.i6.880	40	49	57	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2012	7	4							e35147	10.1371/journal.pone.0035147	http://dx.doi.org/10.1371/journal.pone.0035147			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UD	22536353	Green Published, Green Submitted, gold			2022-12-25	WOS:000305339200039
J	Fenning, S; Woolcock, R; Haga, K; Iqbal, J; Fox, KA; Murray, SA; Denvir, MA				Fenning, Stephen; Woolcock, Rebecca; Haga, Kristin; Iqbal, Javaid; Fox, Keith A.; Murray, Scott A.; Denvir, Martin A.			Identifying Acute Coronary Syndrome Patients Approaching End-of-Life	PLOS ONE			English	Article							ADVANCED HEART-FAILURE; CARDIAC TROPONIN-T; GRACE RISK SCORE; PALLIATIVE CARE; GLOBAL REGISTRY; HOSPITAL MORTALITY; COMMUNITY; EVENTS; VALIDATION; STATEMENT	Background: Acute coronary syndrome (ACS) is common in patients approaching the end-of-life (EoL), but these patients rarely receive palliative care. We compared the utility of a palliative care prognostic tool (Gold Standards Framework (GSF)) and the Global Registry of Acute Coronary Events (GRACE) score, to help identify patients approaching EoL. Methods and Findings: 172 unselected consecutive patients with confirmed ACS admitted over an eight-week period were assessed using prognostic tools and followed up for 12 months. GSF criteria identified 40 (23%) patients suitable for EoL care while GRACE identified 32 (19%) patients with >= 10% risk of death within 6 months. Patients meeting GSF criteria were older (p = 0.006), had more comorbidities (1.6 +/- 0.7 vs. 1.2 +/- 0.9, p = 0.007), more frequent hospitalisations before (p = 0.001) and after (0.0001) their index admission, and were more likely to die during follow-up (GSF+ 20% vs GSF-7%, p = 0.03). GRACE score was predictive of 12-month mortality (C-statistic 0.75) and this was improved by the addition of previous hospital admissions and previous history of stroke (C-statistic 0.88). Conclusions: This study has highlighted a potentially large number of ACS patients eligible for EoL care. GSF or GRACE could be used in the hospital setting to help identify these patients. GSF identifies ACS patients with more comorbidity and at increased risk of hospital readmission.	[Fenning, Stephen; Woolcock, Rebecca; Haga, Kristin; Fox, Keith A.; Denvir, Martin A.] Royal Infirm Edinburgh NHS Trust, Edinburgh Heart Ctr, Edinburgh, Midlothian, Scotland; [Iqbal, Javaid] Univ Sheffield, Dept Cardiovasc Sci, Sheffield, S Yorkshire, England; [Murray, Scott A.] Univ Edinburgh, Primary Palliat Care Res Grp, Ctr Populat Hlth Sci, Edinburgh, Midlothian, Scotland	Royal Infirmary of Edinburgh; University of Edinburgh; University of Sheffield; University of Edinburgh	Fenning, S (corresponding author), Royal Infirm Edinburgh NHS Trust, Edinburgh Heart Ctr, Edinburgh, Midlothian, Scotland.	mdenvir@staffmail.ed.ac.uk	Denvir, Martin A/ABA-3141-2021; Fox, keith A A/I-3742-2013	Fox, Keith/0000-0002-0140-2752; Iqbal, Javaid/0000-0002-9729-7503; Fenning, Stephen/0000-0001-9297-7393	National Institute for Health Research [CL-2009-04-001] Funding Source: researchfish	National Institute for Health Research(National Institute for Health Research (NIHR))		Abu-Assi E, 2010, AM HEART J, V160, P826, DOI 10.1016/j.ahj.2010.06.053; Al-Hweish A, 2010, HEMODIAL INT, V14, P308, DOI 10.1111/j.1542-4758.2010.00455.x; Barnett M, 2006, Nurs Stand, V21, P41; Boyd K, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c4863; Boyd KJ, 2004, EUR J HEART FAIL, V6, P585, DOI 10.1016/j.ejheart.2003.11.018; Chang VT, 1998, CANCER, V83, P173, DOI 10.1002/(SICI)1097-0142(19980701)83:1<173::AID-CNCR23>3.0.CO;2-T; Ekerstad N, 2011, CIRCULATION, V124, P2397, DOI 10.1161/CIRCULATIONAHA.111.025452; Elbarouni B, 2009, AM HEART J, V158, P392, DOI 10.1016/j.ahj.2009.06.010; England & Wales Department of Health, 2008, END LIF CAR STRAT PR; Goodlin SJ, 2004, J CARD FAIL, V10, P200, DOI 10.1016/j.cardfail.2003.09.006; Gurm HS, 2012, AM J CARDIOL, V109, P19, DOI 10.1016/j.amjcard.2011.07.062; Hanratty B, 2002, BRIT MED J, V325, P581, DOI 10.1136/bmj.325.7364.581; Hauptman PJ, 2005, ARCH INTERN MED, V165, P374, DOI 10.1001/archinte.165.4.374; HEDLEY R, 1986, J FAM PRACTICE, V22, P141; Hogg W, 2009, CAN FAM PHYSICIAN, V55, pE76; Hoiseth AD, 2011, THORAX, V66, P775, DOI 10.1136/thx.2010.153122; Hsieh BPC, 2009, AM HEART J, V158, P673, DOI 10.1016/j.ahj.2009.07.021; Jaarsma T, 2009, EUR J HEART FAIL, V11, P433, DOI 10.1093/eurjhf/hfp041; Moores L, 2010, J THROMB HAEMOST, V8, P517, DOI 10.1111/j.1538-7836.2009.03725.x; Murray SA, 2005, BRIT MED J, V330, P611, DOI 10.1136/bmj.330.7492.611; Murray SA, 2002, BRIT MED J, V325, P929, DOI 10.1136/bmj.325.7370.929; Murray SA, 2005, BMJ-BRIT MED J, V330, P1007, DOI 10.1136/bmj.330.7498.1007; National End of Life Care Programme, 2006, GOLD STAND FRAM PROG; NHS Quality Improvement Scotland, 2010, 18 NHS QUAL IMPR SCO, P31; Pieper KS, 2009, AM HEART J, V157, P1097, DOI 10.1016/j.ahj.2009.04.004; Scottish Intercollegiate Guidelines Network, 2007, AC COR SYNDR NAT CLI; Yusufali A, 2011, ANGIOLOGY, V62, P390, DOI 10.1177/0003319710387921	27	19	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2012	7	4							e35536	10.1371/journal.pone.0035536	http://dx.doi.org/10.1371/journal.pone.0035536			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959XD	22530044	Green Published, Green Accepted, gold			2022-12-25	WOS:000305350600096
J	Hanelt, B; Bolek, MG; Schmidt-Rhaesa, A				Hanelt, Ben; Bolek, Matthew G.; Schmidt-Rhaesa, Andreas			Going Solo: Discovery of the First Parthenogenetic Gordiid (Nematomorpha: Gordiida)	PLOS ONE			English	Article							HAIRWORMS NEMATOMORPHA; EVOLUTION; REDESCRIPTION; BIOLOGY; WORM	Despite the severe fitness costs associated with sexual reproduction, its persistence and pervasiveness among multicellular organisms testifies to its intrinsic, short-term advantages. However, the reproductive assurance hypothesis predicts selection favoring asexual reproduction in sparse populations and when mate finding is difficult. Difficulties in finding mates is especially common in parasites, whose life cycles involve multiple hosts, or being released from the host into the external environment where the parasite can find itself trapped without a sexual partner. To solve this problem and guarantee reproduction, parasites in numerous phyla have evolved reproductive strategies, as predicted by the reproductive assurance hypothesis, such as hermaphroditism or parthenogenesis. However, this type of strategy has not been reported from species in the phylum Nematomorpha, whose populations have often been described as sparse. A new Nematomorpha species, Paragordius obamai n.sp., was discovered from Kenya, Africa, and appears to have solved the problem of being trapped without a mate by eliminating the need for males. Paragordius obamai n.sp. represents the first and only known species within this phylum to reproduce asexually. To determine the mechanism of this mating strategy, we ruled out the involvement of reproduction manipulating endosymbionts by use of next generation sequencing data, thus suggesting that parthenogenesis is determined genetically and may have evolved as a means to assure reproduction. Since this new parthenogenetic species and a closely related gonochoristic North American congener, P. varius, are easy to propagate in the laboratory, these gordiids can be used as model systems to test hypotheses on the genetic advantages and disadvantages of asexual reproduction and the genetic determinants of reproductive strategies in parasites.	[Hanelt, Ben] Univ New Mexico, Dept Biol, Ctr Evolutionary & Theoret Immunol, Albuquerque, NM 87131 USA; [Bolek, Matthew G.] Oklahoma State Univ, Dept Zool, Stillwater, OK 74078 USA; [Schmidt-Rhaesa, Andreas] Univ Hamburg, Bioctr Grindel, Zool Museum & Inst, Hamburg, Germany	University of New Mexico; Oklahoma State University System; Oklahoma State University - Stillwater; University of Hamburg	Hanelt, B (corresponding author), Univ New Mexico, Dept Biol, Ctr Evolutionary & Theoret Immunol, Albuquerque, NM 87131 USA.	bhanelt@unm.edu		Hanelt, Ben/0000-0001-9298-7356	National Science Foundation [DEB-0949951, DEB-0950066]; National Institute of Health [AI044913]; National Institutes of Health from the Institute Development Award Program of the National Center for Research Resources [1P20RR18754]; Direct For Biological Sciences [0949951] Funding Source: National Science Foundation; Division Of Environmental Biology [0950066] Funding Source: National Science Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR018754] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI044913] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health from the Institute Development Award Program of the National Center for Research Resources; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Science Foundation, DEB-0949951 to MG Bolek and DEB-0950066 to B Hanelt and A Schmidt-Rhaesa, and travel was supported by National Institute of Health grant AI044913 to ES Loker. Support was also provided by the UNM Center for Evolutionary and Theoretical Immunology (CETI) and the University of New Mexico Molecular Biology Facility, supported by National Institutes of Health grant 1P20RR18754 from the Institute Development Award Program of the National Center for Research Resources. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bell G., 1982, MASTERPIECE NATURE E; Biron DG, 2006, INSECT MOL BIOL, V15, P731, DOI 10.1111/j.1365-2583.2006.00671.x; Bolek Matthew G., 2010, Zootaxa, V2631, P36; Cordaux R, 2011, TRENDS GENET, V27, P332, DOI 10.1016/j.tig.2011.05.002; de Villalobos C, 2000, P ACAD NAT SCI PHILA, V150, P135; de Villalobos LC, 2001, CONTRIB ZOOL, V70, P73, DOI 10.1163/18759866-07002002; Dowd SE, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-93; Dunn CW, 2008, NATURE, V452, P745, DOI 10.1038/nature06614; Duron O, 2007, CURR MICROBIOL, V55, P193, DOI 10.1007/s00284-006-0578-4; FELSENSTEIN J, 1974, GENETICS, V78, P737; Ghosh A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022451; Gontcharova Viktoria, 2010, Open Microbiol J, V4, P47, DOI 10.2174/1874285801004010047; Hanelt B, 2009, PARASITOLOGY, V136, P211, DOI 10.1017/S0031182008005337; Hanelt B, 2005, ADV PARASIT, V59, P243, DOI 10.1016/S0065-308X(05)59004-3; Hanelt B, 2003, INVERTEBR BIOL, V122, P12, DOI 10.1111/j.1744-7410.2003.tb00068.x; Hanelt B, 2004, J NAT HIST, V38, P939, DOI 10.1080/0022293021000058718; Hanelt B, 2002, J PARASITOL, V88, P557, DOI 10.1645/0022-3395(2002)088[0557:MAONCO]2.0.CO;2; Hanelt B, 2001, J PARASITOL, V87, P1049, DOI 10.1645/0022-3395(2001)087[1049:PSASOF]2.0.CO;2; Hudson AJ, 2009, J PARASITOL, V95, P1545, DOI 10.1645/GE-2145.1; Inoue I., 1959, Annotationes Zoologicae Japonenses, V32, P209; JAIN SK, 1976, ANNU REV ECOL SYST, V7, P469, DOI 10.1146/annurev.es.07.110176.002345; Kirjanova E. S., 1959, Zoologicheskii Zhurnal, V38, P509; Koivisto RKK, 2003, BIOL J LINN SOC, V79, P43, DOI 10.1046/j.1095-8312.2003.00185.x; KONDRASHOV AS, 1988, NATURE, V336, P435, DOI 10.1038/336435a0; Lane DS, 1990, NUCL ACID TECHNIQUES, P115, DOI DOI 10.1007/S00227-012-2133-0; Lloyd DG, 1980, DEMOGRAPHY EVOLUTION; Looney C, 2012, J PARASITOL IN PRESS; Maynard Smith J., 1971, GROUP SELECTION, P163; Middelbos IS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009768; Montgomery Jr TH, 1903, ZOOL JB ANAT ONTOG, V18, P387; POULIN R, 1995, J PARASITOL, V81, P121, DOI 10.2307/3284023; PRICE PW, 1977, EVOLUTION, V31, P405, DOI [10.2307/2407761, 10.1111/j.1558-5646.1977.tb01021.x]; Pritchard MH, 1982, COLLECTION PRESERVAT; RAJARAM B, 1975, ACTA HISTOCHEM, V54, P257; Schmidt-Rhaesa A, 2005, ZOOMORPHOLOGY, V124, P33, DOI 10.1007/s00435-005-0109-z; Schmidt-Rhaesa A, 2003, P ACAD NAT SCI PHILA, V153, P77, DOI 10.1635/0097-3157(2003)153[0077:RACONF]2.0.CO;2; Schmidt-Rhaesa A., 1997, SUSSWASSERFAUNA MITT, P1; Schmidt-Rhaesa Andreas, 2008, Verhandlungen des Naturwissenschaftlichen Vereins in Hamburg, P37; Schmidt-Thaesa Andreas, 2010, Zootaxa, V2533, P1; Sciacchitano I., 1964, Annali Mus Stor nat Giacomo Doria, V73, P272; SMITH JM, 1978, EVOLUTION SEX; Suomalainen E, 1987, CYTOLOGY EVOLUTION P; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Thomas F, 2002, J EVOLUTION BIOL, V15, P356, DOI 10.1046/j.1420-9101.2002.00410.x; THORNE GERALD, 1940, JOUR WASHINGTON ACAD SCI, V30, P219; von Linstow O, 1906, MITT ZOOL MUS BERLIN, V3, P241	47	22	22	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2012	7	4							e34472	10.1371/journal.pone.0034472	http://dx.doi.org/10.1371/journal.pone.0034472			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959XD	22529916	Green Published, gold			2022-12-25	WOS:000305350600015
J	Haroon, F; Handel, U; Angenstein, F; Goldschmidt, J; Kreutzmann, P; Lison, H; Fischer, KD; Scheich, H; Wetzel, W; Schluter, D; Budinger, E				Haroon, Fahad; Haendel, Ulrike; Angenstein, Frank; Goldschmidt, Juergen; Kreutzmann, Peter; Lison, Holger; Fischer, Klaus-Dieter; Scheich, Henning; Wetzel, Wolfram; Schlueter, Dirk; Budinger, Eike			Toxoplasma gondii Actively Inhibits Neuronal Function in Chronically Infected Mice	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM; CRYPTOGENIC EPILEPSY; HOST-CELLS; BEHAVIOR; SEROPOSITIVITY; MODULATION; PERSISTENT; PROTEIN; GRA3	Upon infection with the obligate intracellular parasite Toxoplasma gondii, fast replicating tachyzoites infect a broad spectrum of host cells including neurons. Under the pressure of the immune response, tachyzoites convert into slow-replicating bradyzoites, which persist as cysts in neurons. Currently, it is unclear whether T. gondii alters the functional activity of neurons, which may contribute to altered behaviour of T. gondii-infected mice and men. In the present study we demonstrate that upon oral infection with T. gondii cysts, chronically infected BALB/c mice lost over time their natural fear against cat urine which was paralleled by the persistence of the parasite in brain regions affecting behaviour and odor perception. Detailed immunohistochemistry showed that in infected neurons not only parasitic cysts but also the host cell cytoplasm and some axons stained positive for Toxoplasma antigen suggesting that parasitic proteins might directly interfere with neuronal function. In fact, in vitro live cell calcium (Ca2+) imaging studies revealed that tachyzoites actively manipulated Ca2+ signalling upon glutamate stimulation leading either to hyper- or hypo-responsive neurons. Experiments with the endoplasmatic reticulum Ca2+ uptake inhibitor thapsigargin indicate that tachyzoites deplete Ca2+ stores in the endoplasmatic reticulum. Furthermore in vivo studies revealed that the activity-dependent uptake of the potassium analogue thallium was reduced in cyst harbouring neurons indicating their functional impairment. The percentage of nonfunctional neurons increased over time In conclusion, both bradyzoites and tachyzoites functionally silence infected neurons, which may significantly contribute to the altered behaviour of the host.	[Haroon, Fahad; Haendel, Ulrike; Schlueter, Dirk] Otto Von Guericke Univ, Inst Med Mikrobiol, Magdeburg, Germany; [Angenstein, Frank] Leibniz Inst Neurobiol, Speziallab Nichtinvas Bildgebung, Magdeburg, Germany; [Goldschmidt, Juergen; Lison, Holger; Scheich, Henning; Budinger, Eike] Leibniz Inst Neurobiol, Abt Akust Lernen & Sprache, Magdeburg, Germany; [Kreutzmann, Peter; Fischer, Klaus-Dieter] Otto Von Guericke Univ, Inst Biochem & Zellbiol, Magdeburg, Germany; [Wetzel, Wolfram] Leibniz Inst Neurobiol, Speziallab Verhaltenspharmakol, Magdeburg, Germany	Otto von Guericke University; University of Hamburg; University Medical Center Hamburg-Eppendorf; Leibniz Institut fur Neurobiologie (LIN); Leibniz Institut fur Neurobiologie (LIN); Otto von Guericke University; Leibniz Institut fur Neurobiologie (LIN)	Haroon, F (corresponding author), Otto Von Guericke Univ, Inst Med Mikrobiol, Magdeburg, Germany.	dirk.schlueter@med.ovgu.de		Budinger, Eike/0000-0003-2420-8159	Deutsche Forschungsgemeinschaft [SCHL 392/7-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft (grant SCHL 392/7-1, http://www.dfg.de/index.jsp). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akyol A, 2007, SEIZURE-EUR J EPILEP, V16, P233, DOI 10.1016/j.seizure.2006.12.008; Badea A, 2007, NEUROIMAGE, V37, P683, DOI 10.1016/j.neuroimage.2007.05.046; Fendt M, 2006, J CHEM ECOL, V32, P2617, DOI 10.1007/s10886-006-9186-9; FERGUSON DJP, 1987, PARASITOL RES, V73, P483, DOI 10.1007/BF00535321; FERGUSON DJP, 1989, PARASITOL RES, V75, P599, DOI 10.1007/BF00930955; Gail M, 2001, MOL GENET GENOMICS, V265, P905, DOI 10.1007/s004380100487; Gieseler A, 2009, BIOCHEM PHARMACOL, V77, P888, DOI 10.1016/j.bcp.2008.11.003; Gilbert LA, 2007, EUKARYOT CELL, V6, P73, DOI 10.1128/EC.00309-06; Goldschmidt J, 2004, NEUROIMAGE, V23, P638, DOI 10.1016/j.neuroimage.2004.05.023; Goldschmidt J, 2010, NEUROIMAGE, V49, P303, DOI 10.1016/j.neuroimage.2009.08.012; Henriquez FL, 2005, PARASITOLOGY, V131, P169, DOI 10.1017/S0031182005007559; Henriquez SA, 2009, NEUROIMMUNOMODULAT, V16, P122, DOI 10.1159/000180267; Hermes G, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-48; Hinze-Selch D, 2010, FOLIA PARASIT, V57, P129, DOI 10.14411/fp.2010.016; Kijlstra A, 2008, INT J PARASITOL, V38, P1359, DOI 10.1016/j.ijpara.2008.06.002; Kim JY, 2008, KOREAN J PARASITOL, V46, P209, DOI 10.3347/kjp.2008.46.4.209; Luder CGK, 2005, CURR TOP MICROBIOL, V289, P219; Palmer BS, 2007, SEIZURE-EUR J EPILEP, V16, P657, DOI 10.1016/j.seizure.2007.05.010; Paxinos G., 2001, MOUSE BRAIN STEREOTA; Prandota J, 2009, INT J NEUROSCI, V119, P2144, DOI 10.3109/00207450903149217; Ravindran S, 2008, TRAFFIC, V9, P647, DOI 10.1111/j.1600-0854.2008.00723.x; Schluter D, 2002, J IMMUNOL, V169, P315, DOI 10.4049/jimmunol.169.1.315; Schwarcz R, 2007, SCHIZOPHRENIA BULL, V33, P652, DOI 10.1093/schbul/sbm030; Stommel EW, 2001, EPILEPSIA, V42, P436, DOI 10.1046/j.1528-1157.2001.25500.x; Vyas A, 2007, NEUROSCIENCE, V148, P342, DOI 10.1016/j.neuroscience.2007.06.021; Vyas A, 2007, P NATL ACAD SCI USA, V104, P6442, DOI 10.1073/pnas.0608310104; Webster JP, 2010, FOLIA PARASIT, V57, P95, DOI 10.14411/fp.2010.012; Xie CS, 2000, FREE RADICAL BIO MED, V28, P665, DOI 10.1016/S0891-5849(99)00268-3; Yolken RH, 2008, MOL PSYCHIATR, V13, P470, DOI 10.1038/mp.2008.5; Zhang YW, 2001, INFECT IMMUN, V69, P501, DOI 10.1128/IAI.69.1.501-507.2001	30	62	69	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2012	7	4							e35516	10.1371/journal.pone.0035516	http://dx.doi.org/10.1371/journal.pone.0035516			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959XD	22530040	gold, Green Published, Green Submitted			2022-12-25	WOS:000305350600093
J	Hospodsky, D; Qian, J; Nazaroff, WW; Yamamoto, N; Bibby, K; Rismani-Yazdi, H; Peccia, J				Hospodsky, Denina; Qian, Jing; Nazaroff, William W.; Yamamoto, Naomichi; Bibby, Kyle; Rismani-Yazdi, Hamid; Peccia, Jordan			Human Occupancy as a Source of Indoor Airborne Bacteria	PLOS ONE			English	Article							RIBOSOMAL-RNA GENE; RESIDENTIAL INDOOR; PARTICULATE MATTER; DIVERSITY; COMMUNITY; EXPOSURE; PARTICLES; TIME; RESUSPENSION; FRAGMENTS	Exposure to specific airborne bacteria indoors is linked to infectious and noninfectious adverse health outcomes. However, the sources and origins of bacteria suspended in indoor air are not well understood. This study presents evidence for elevated concentrations of indoor airborne bacteria due to human occupancy, and investigates the sources of these bacteria. Samples were collected in a university classroom while occupied and when vacant. The total particle mass concentration, bacterial genome concentration, and bacterial phylogenetic populations were characterized in indoor, outdoor, and ventilation duct supply air, as well as in the dust of ventilation system filters and in floor dust. Occupancy increased the total aerosol mass and bacterial genome concentration in indoor air PM10 and PM2.5 size fractions, with an increase of nearly two orders of magnitude in airborne bacterial genome concentration in PM10. On a per mass basis, floor dust was enriched in bacterial genomes compared to airborne particles. Quantitative comparisons between bacterial populations in indoor air and potential sources suggest that resuspended floor dust is an important contributor to bacterial aerosol populations during occupancy. Experiments that controlled for resuspension from the floor implies that direct human shedding may also significantly impact the concentration of indoor airborne particles. The high content of bacteria specific to the skin, nostrils, and hair of humans found in indoor air and in floor dust indicates that floors are an important reservoir of human-associated bacteria, and that the direct particle shedding of desquamated skin cells and their subsequent resuspension strongly influenced the airborne bacteria population structure in this human-occupied environment. Inhalation exposure to microbes shed by other current or previous human occupants may occur in communal indoor environments.	[Hospodsky, Denina; Qian, Jing; Yamamoto, Naomichi; Bibby, Kyle; Rismani-Yazdi, Hamid; Peccia, Jordan] Yale Univ, Dept Chem & Environm Engn, New Haven, CT 06520 USA; [Nazaroff, William W.] Univ Calif Berkeley, Dept Civil & Environm Engn, Berkeley, CA 94720 USA; [Yamamoto, Naomichi] Japan Soc Promot Sci, Chiyoda Ku, Tokyo, Japan	Yale University; University of California System; University of California Berkeley; Japan Society for the Promotion of Science	Hospodsky, D (corresponding author), Yale Univ, Dept Chem & Environm Engn, New Haven, CT 06520 USA.	Jordan.peccia@yale.edu	Nazaroff, William W/C-4106-2008; Yamamoto, Naomichi/D-4099-2014; Nazaroff, William/AAJ-7352-2021; Bibby, Kyle J/C-6189-2018	Nazaroff, William W/0000-0001-5645-3357; Yamamoto, Naomichi/0000-0002-5969-5500; Nazaroff, William/0000-0001-5645-3357; Bibby, Kyle J/0000-0003-3142-6090; Qian, Jing/0000-0002-9666-210X	Alfred P. Sloan Foundation "Microbiology for the Built Environment Program''	Alfred P. Sloan Foundation "Microbiology for the Built Environment Program''	The research was funded by the Alfred P. Sloan Foundation "Microbiology for the Built Environment Program''. The funders had no role in study design, data collection, and analysis, decision to publish, or preparation of the manuscript.	Bibby K, 2010, WATER RES, V44, P4252, DOI 10.1016/j.watres.2010.05.039; Boreson J, 2004, ATMOSPHERIC ENV; Bowers RM, 2011, ISME J, V5, P601, DOI 10.1038/ismej.2010.167; Bowers RM, 2009, APPL ENVIRON MICROB, V75, P5121, DOI 10.1128/AEM.00447-09; Brasche S, 2005, INT J HYG ENVIR HEAL, V208, P247, DOI 10.1016/j.ijheh.2005.03.003; Brodie EL, 2007, P NATL ACAD SCI USA, V104, P299, DOI 10.1073/pnas.0608255104; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Cephas KD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023503; Chen Q, 2009, ENVIRON SCI TECHNOL, V43, P4641, DOI 10.1021/es802296j; Costello EK, 2009, SCIENCE, V326, P1694, DOI 10.1126/science.1177486; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Douwes J, 2003, ANN OCCUP HYG, V47, P187, DOI 10.1093/annhyg/meg032; Falkinham JO, 2009, J APPL MICROBIOL, V107, P356, DOI 10.1111/j.1365-2672.2009.04161.x; Ferro AR, 2004, ENVIRON SCI TECHNOL, V38, P1759, DOI 10.1021/es0263893; Fields BS, 2002, CLIN MICROBIOL REV, V15, P506, DOI 10.1128/CMR.15.3.506-526.2002; Fierer N, 2008, P NATL ACAD SCI USA, V105, P17994, DOI 10.1073/pnas.0807920105; Fox A, 2005, J ENVIRON MONITOR, V7, P450, DOI 10.1039/b418038k; Fox K, 2010, J ENVIRON MONITOR, V12, P917, DOI 10.1039/b925250a; Frank DN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010598; Grice EA, 2009, SCIENCE, V324, P1190, DOI 10.1126/science.1171700; Hamady M, 2010, ISME J, V4, P17, DOI 10.1038/ismej.2009.97; Ilic B, 2001, J VAC SCI TECHNOL B, V19, P2825, DOI 10.1116/1.1421572; Johnson GR, 2009, J AEROSOL MED PULM D, V22, P229, DOI 10.1089/jamp.2008.0720; Klepeis NE, 2001, J EXPO ANAL ENV EPID, V11, P231, DOI 10.1038/sj.jea.7500165; Koistinen KJ, 2004, SCAND J WORK ENV HEA, V30, P36; Kopperud RJ, 2004, J AIR WASTE MANAGE, V54, P1188, DOI 10.1080/10473289.2004.10470983; Lamoth F, 2010, FEMS MICROBIOL REV, V34, P260, DOI 10.1111/j.1574-6976.2009.00207.x; Lazarev V. N., 2010, Biotekhnologiya, P11; Leaderer BP, 2002, ENVIRON HEALTH PERSP, V110, P419, DOI 10.1289/ehp.02110419; Lee ZMP, 2009, NUCLEIC ACIDS RES, V37, pD489, DOI 10.1093/nar/gkn689; LEYDEN JJ, 1987, J INVEST DERMATOL, V88, pS65, DOI 10.1111/1523-1747.ep12468965; Li Y, 2007, INDOOR AIR, V17, P2, DOI 10.1111/j.1600-0668.2006.00445.x; Lighthart B, 1997, FEMS MICROBIOL ECOL, V23, P263, DOI 10.1016/S0168-6496(97)00036-6; Liu ZZ, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm541; MACKINTOSH CA, 1978, J HYG-CAMBRIDGE, V81, P471, DOI 10.1017/S0022172400025341; Milstone LM, 2004, J DERMATOL SCI, V36, P131, DOI 10.1016/j.jdermsci.2004.05.004; Nadkarni MA, 2002, MICROBIOL-SGM, V148, P257, DOI 10.1099/00221287-148-1-257; Nasidze I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023352; Nasidze I, 2009, GENOME RES, V19, P636, DOI 10.1101/gr.084616.108; National Research Council, 1998, COMM RES PRIOR AIRB; Nicas M, 2005, J OCCUP ENVIRON HYG, V2, P143, DOI 10.1080/15459620590918466; NOBLE WC, 1976, J MED MICROBIOL, V9, P53, DOI 10.1099/00222615-9-1-53; Ozkaynak H, 1996, J EXPO ANAL ENV EPID, V6, P57; Peccia J, 2008, ENVIRON SCI TECHNOL, V42, P4631; Qian J, 2012, INDOOR AIR, V22, P339, DOI 10.1111/j.1600-0668.2012.00769.x; Qian J, 2008, J AIR WASTE MANAGE, V58, P502, DOI 10.3155/1047-3289.58.4.502; Quince C, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-38; Quince C, 2009, NAT METHODS, V6, P639, DOI [10.1038/NMETH.1361, 10.1038/nmeth.1361]; Rintala H, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-56; ROTH RR, 1988, ANNU REV MICROBIOL, V42, P441, DOI 10.1146/annurev.mi.42.100188.002301; Scheff P A, 2000, Appl Occup Environ Hyg, V15, P835; Taubel M, 2009, J ALLERGY CLIN IMMUN, V124, P834, DOI 10.1016/j.jaci.2009.07.045; THATCHER TL, 1995, ATMOS ENVIRON, V29, P1487, DOI 10.1016/1352-2310(95)00016-R; Viau E, 2010, ENVIRON SCI TECHNOL, V44, P3142, DOI 10.1021/es902943w; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Xie XJ, 2009, J R SOC INTERFACE, V6, pS703, DOI 10.1098/rsif.2009.0388.focus; Yang W, 2011, J EXPO SCI ENV EPID, V21, P310, DOI 10.1038/jes.2010.23; Zaura E, 2009, BMC MICROBIOL, V9; Zhang HJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006108	59	314	322	10	187	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2012	7	4							e34867	10.1371/journal.pone.0034867	http://dx.doi.org/10.1371/journal.pone.0034867			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959XD	22529946	Green Published, gold			2022-12-25	WOS:000305350600034
J	Middelberg, RPS; Heath, AC; Madden, PAF; Montgomery, GW; Martin, NG; Whitfield, JB				Middelberg, Rita P. S.; Heath, Andrew C.; Madden, Pamela A. F.; Montgomery, Grant W.; Martin, Nicholas G.; Whitfield, John B.			Evidence of Differential Allelic Effects between Adolescents and Adults for Plasma High-Density Lipoprotein	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; LIPID-LEVELS; POPULATION; LOCI; CHILDREN; TWINS; RISK	A recent meta-analysis of genome-wide association (GWA) studies identified 95 loci that influence lipid traits in the adult population and found that collectively these explained about 25-30% of heritability for each trait. Little is known about how these loci affect lipid levels in early life, but there is evidence that genetic effects on HDL- and LDL-cholesterol (HDL-C, LDLC) and triglycerides vary with age. We studied Australian adults (N = 10,151) and adolescents (N = 2,363) who participated in twin and family studies and for whom we have lipid phenotypes and genotype information for 91 of the 95 genetic variants. Heterogeneity tests between effect sizes in adult and adolescent cohorts showed an excess of heterogeneity for HDL-C (p(Het)<0.05 at 5 out of 37 loci), but no more than expected by chance for LDL-C (1 out of 14 loci), or trigycerides (0 out 24). There were 2 (out of 5) with opposite direction of effect in adolescents compared to adults for HDL-C, but none for LDL-C. The biggest difference in effect size was for LDL-C at rs6511720 near LDLR, adolescents (0.021 +/- 0.033 mmol/L) and adults (0.157 +/- 0.023 mmol/L), p(Het) = 0.013; followed by ZNF664 (p(Het) = 0.018) and PABPC4 (p(Het) = 0.034) for HDL-C. Our findings suggest that some of the previously identified variants associate differently with lipid traits in adolescents compared to adults, either because of developmental changes or because of greater interactions with environmental differences in adults.	[Middelberg, Rita P. S.; Montgomery, Grant W.; Martin, Nicholas G.; Whitfield, John B.] Queensland Inst Med Res, Brisbane, Qld 4006, Australia; [Middelberg, Rita P. S.] Prince Charles Hosp, Dept Med, Brisbane, Qld, Australia; [Heath, Andrew C.; Madden, Pamela A. F.] Washington Univ, Sch Med, Dept Psychiat, St Louis, MO 63110 USA; [Heath, Andrew C.; Madden, Pamela A. F.] Midwest Alcoholism Res Ctr, St Louis, MO USA	QIMR Berghofer Medical Research Institute; Prince Charles Hospital; Washington University (WUSTL)	Middelberg, RPS (corresponding author), Queensland Inst Med Res, Brisbane, Qld 4006, Australia.	ritaM@qimr.edu.au	Montgomery, Grant W/B-7148-2008; Martin, Nicholas/R-9235-2019	Montgomery, Grant W/0000-0002-4140-8139; Martin, Nicholas/0000-0003-4069-8020; Whitfield, John/0000-0002-1103-0876	National Health and Medical Research Council [241944, 389875]; NIH [AA07535, AA13320, AA13321, AA14041, AA11998, AA17688, DA012854, DA019951]; Wellcome Trust [WT084766/Z/08/Z]; NHMRC [619667, 611512]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [P50AA011998, R01AA014041, R01AA007535, P60AA011998, R01AA013321, R01AA013320, K05AA017688] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R56DA012854, R01DA012854, K08DA019951] Funding Source: NIH RePORTER	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wellcome Trust(Wellcome TrustEuropean Commission); NHMRC(National Health and Medical Research Council (NHMRC) of Australia); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	Financial support was provided by the National Health and Medical Research Council (http://www.nhmrc.gov.au)(241944, 389875), NIH (http://www.nih.gov/)(AA07535, AA13320, AA13321, AA14041, AA11998, AA17688, DA012854, DA019951), and Wellcome Trust for funding (WT084766/Z/08/Z). GWM was supported by a NHMRC Fellowship (619667), and RPSM was supported by a NHMRC Training Fellowship (611512). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; Aulchenko YS, 2009, NAT GENET, V41, P47, DOI 10.1038/ng.269; Azizi F, 2001, EUR J EPIDEMIOL, V17, P281, DOI 10.1023/A:1017932212350; BERENSON GS, 1981, AM J EPIDEMIOL, V113, P157, DOI 10.1093/oxfordjournals.aje.a113080; CARR AB, 1981, CLIN CHEM, V27, P1469; Heath AC, 2011, BIOL PSYCHIAT, V70, P513, DOI 10.1016/j.biopsych.2011.02.028; Kathiresan S, 2009, NAT GENET, V41, P56, DOI 10.1038/ng.291; LEMAY A, 1991, CLIN ENDOCRINOL, V35, P305, DOI 10.1111/j.1365-2265.1991.tb03541.x; Li Y, 2010, GENET EPIDEMIOL, V34, P816, DOI 10.1002/gepi.20533; Li Y, 2009, ANNU REV GENOM HUM G, V10, P387, DOI 10.1146/annurev.genom.9.081307.164242; MARTIN NG, 1985, BEHAV GENET, V15, P93, DOI 10.1007/BF01065891; McGregor B, 1999, GENET EPIDEMIOL, V16, P40, DOI 10.1002/(SICI)1098-2272(1999)16:1<40::AID-GEPI4>3.3.CO;2-T; Medland SE, 2009, AM J HUM GENET, V85, P750, DOI 10.1016/j.ajhg.2009.10.009; Middelberg RP, 2006, TWIN RES HUM GENET, V9, P550, DOI 10.1375/twin.9.4.550; Middelberg RPS, 2007, TWIN RES HUM GENET, V10, P127, DOI 10.1375/twin.10.1.127; Nance W E, 1998, Twin Res, V1, P3, DOI 10.1375/twin.1.1.3; Painter JN, 2011, NAT GENET, V43, P51, DOI 10.1038/ng.731; Smith EN, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001094; Snieder H, 1997, AM J HUM GENET, V60, P638; *STATACORP, 1997, STAT STAT SOFTW REL; Sullivan PF, 2009, MOL PSYCHIATR, V14, P359, DOI 10.1038/mp.2008.125; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; Whitfield JB, 1998, ALCOHOL CLIN EXP RES, V22, P1463; WHITFIELD JB, 1983, ATHEROSCLEROSIS, V48, P265, DOI 10.1016/0021-9150(83)90044-8; Willer CJ, 2010, BIOINFORMATICS, V26, P2190, DOI 10.1093/bioinformatics/btq340; Wright M, 2001, Twin Res, V4, P48, DOI 10.1375/1369052012146; Wright MJ, 2004, AUST J PSYCHOL, V56, P65, DOI 10.1080/00049530410001734865; Zhu G, 1999, AM J HUM GENET, V65, P483, DOI 10.1086/302494	28	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2012	7	4							e35605	10.1371/journal.pone.0035605	http://dx.doi.org/10.1371/journal.pone.0035605			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959XD	22530058	Green Published, Green Submitted, gold			2022-12-25	WOS:000305350600104
J	Mima, Y; Fukumoto, S; Koyama, H; Okada, M; Tanaka, S; Shoji, T; Emoto, M; Furuzono, T; Nishizawa, Y; Inaba, M				Mima, Yohei; Fukumoto, Shinya; Koyama, Hidenori; Okada, Masahiro; Tanaka, Shinji; Shoji, Tetsuo; Emoto, Masanori; Furuzono, Tsutomu; Nishizawa, Yoshiki; Inaba, Masaaki			Enhancement of Cell-Based Therapeutic Angiogenesis Using a Novel Type of Injectable Scaffolds of Hydroxyapatite-Polymer Nanocomposite Microspheres	PLOS ONE			English	Article							ASSEMBLING PEPTIDE NANOFIBERS; MARROW MONONUCLEAR-CELLS; MYOCARDIAL-INFARCTION; INTERNAL-FIXATION; PROGENITOR CELLS; TRANSPLANTATION; TISSUE; IMPLANTATION; GROWTH; BIOCOMPATIBILITY	Background: Clinical trials demonstrate the effectiveness of cell-based therapeutic angiogenesis in patients with severe ischemic diseases; however, their success remains limited. Maintaining transplanted cells in place are expected to augment the cell-based therapeutic angiogenesis. We have reported that nano-hydroxyapatite (HAp) coating on medical devices shows marked cell adhesiveness. Using this nanotechnology, HAp-coated poly(L-lactic acid) (PLLA) microspheres, named nano-scaffold (NS), were generated as a non-biological, biodegradable and injectable cell scaffold. We investigate the effectiveness of NS on cell-based therapeutic angiogenesis. Methods and Results: Bone marrow mononuclear cells (BMNC) and NS or control PLLA microspheres (LA) were intramuscularly co-implanted into mice ischemic hindlimbs. When BMNC derived from enhanced green fluorescent protein (EGFP)-transgenic mice were injected into ischemic muscle, the muscle GFP level in NS+BMNC group was approximate fivefold higher than that in BMNC or LA+BMNC groups seven days after operation. Kaplan-Meier analysis demonstrated that NS+BMNC markedly prevented hindlimb necrosis (P < 0.05 vs. BMNC or LA+BMNC). NS+BMNC revealed much higher induction of angiogenesis in ischemic tissues and collateral blood flow confirmed by three-dimensional computed tomography angiography than those of BMNC or LA+BMNC groups. NS-enhanced therapeutic angiogenesis and arteriogenesis showed good correlations with increased intramuscular levels of vascular endothelial growth factor and fibroblast growth factor-2. NS co-implantation also prevented apoptotic cell death of transplanted cells, resulting in prolonged cell retention. Conclusion: A novel and feasible injectable cell scaffold potentiates cell-based therapeutic angiogenesis, which could be extremely useful for the treatment of severe ischemic disorders.	[Mima, Yohei; Fukumoto, Shinya; Koyama, Hidenori; Tanaka, Shinji; Shoji, Tetsuo; Emoto, Masanori; Furuzono, Tsutomu; Nishizawa, Yoshiki; Inaba, Masaaki] Osaka City Univ, Grad Sch Med, Dept Metab Endocrinol & Mol Med, Osaka 558, Japan; [Furuzono, Tsutomu] Kinki Univ, Sch Biol Oriented Sci & Technol, Dept Biomed Engn, Wakayama, Japan	Osaka Metropolitan University; Kindai University (Kinki University)	Mima, Y (corresponding author), Osaka City Univ, Grad Sch Med, Dept Metab Endocrinol & Mol Med, Osaka 558, Japan.	sfukumoto@med.osaka-cu.ac.jp	Koyama, Hidenori/AAU-2346-2020	Koyama, Hidenori/0000-0001-7930-2228; Okada, Masahiro/0000-0001-9441-3284	Ministry of Education, Culture, Sports, Science and Technology, Japan [20592102]; R&D of Nano-devices for Practical Utilization of Nanotechnology of the New Energy and Industrial Technology Development Organization (NEDO), Japan [08007436-0, 10000354-0]; Japan Science and Technology Agency (JST) [AS2314097F]; Grants-in-Aid for Scientific Research [23591329] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); R&D of Nano-devices for Practical Utilization of Nanotechnology of the New Energy and Industrial Technology Development Organization (NEDO), Japan(New Energy and Industrial Technology Development Organization (NEDO)); Japan Science and Technology Agency (JST)(Japan Science & Technology Agency (JST)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported in part by a Grant-in-Aid for Scientific Research (20592102 to S. F.) from the Ministry of Education, Culture, Sports, Science and Technology, Japan. This study was also supported in part by the R&D of Nano-devices for Practical Utilization of Nanotechnology of the New Energy and Industrial Technology Development Organization (NEDO), Japan (08007436-0 to S. F. and 10000354-0 to T. F.), and Adaptable and Seamless Technology transfer Program through target-driven R&D (A-STEP) by Japan Science and Technology Agency (JST) (AS2314097F to S. F.). No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott JD, 2004, CIRCULATION, V110, P3300, DOI 10.1161/01.CIR.0000147780.30124.CF; Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004; Aoki, 1994, MED APPL HYDROXYAPAT; Aranguren XL, 2009, J MOL MED, V87, P3, DOI 10.1007/s00109-008-0394-3; Athanasiou KA, 1996, BIOMATERIALS, V17, P93, DOI 10.1016/0142-9612(96)85754-1; Awad O, 2006, ARTERIOSCL THROM VAS, V26, P758, DOI 10.1161/01.ATV.0000203513.29227.6f; Bostman O, 2000, BIOMATERIALS, V21, P2615, DOI 10.1016/S0142-9612(00)00129-0; Brenner W, 2004, J NUCL MED, V45, P512; Ceradini DJ, 2004, NAT MED, V10, P858, DOI 10.1038/nm1075; Cheng AS, 2008, SEMIN THORAC CARDIOV, V20, P94, DOI 10.1053/j.semtcvs.2008.04.003; Cho HJ, 2007, J EXP MED, V204, P3257, DOI 10.1084/jem.20070166; Clausen BH, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-46; Couffinhal T, 1998, AM J PATHOL, V152, P1667; Davis ME, 2005, CIRCULATION, V111, P442, DOI 10.1161/01.CIR.0000153847.47301.80; Dubois G, 2008, J BIOMED MATER RES B, V87B, P222, DOI 10.1002/jbm.b.31099; Fujii S, 2009, LANGMUIR, V25, P9759, DOI 10.1021/la901100z; Furuzono T, 2006, ASAIO J, V52, P315, DOI 10.1097/01.mat.0000214860.08820.f9; Furuzono T, 2004, J MATER SCI-MATER M, V15, P19, DOI 10.1023/B:JMSM.0000010093.39298.5a; Furuzono T, 2009, J BIOMED MATER RES B, V89B, P77, DOI 10.1002/jbm.b.31189; Hiasa K, 2004, CIRCULATION, V109, P2454, DOI 10.1161/01.CIR.0000128213.96779.61; Hile DD, 2004, J BIOMED MATER RES B, V71B, P201, DOI 10.1002/jbm.b.30091; Iba O, 2002, CIRCULATION, V106, P2019, DOI 10.1161/01.CIR.0000031332.45480.79; Ignatius AA, 1996, BIOMATERIALS, V17, P831, DOI 10.1016/0142-9612(96)81421-9; Kadono H, 2010, ASAIO J, V56, P61, DOI 10.1097/MAT.0b013e3181c945ae; Kajiguchi M, 2007, CIRC J, V71, P196, DOI 10.1253/circj.71.196; Kamihata H, 2001, CIRCULATION, V104, P1046, DOI 10.1161/hc3501.093817; Kondo K, 2009, ARTERIOSCL THROM VAS, V29, P61, DOI 10.1161/ATVBAHA.108.166496; Korf-Klingebiel M, 2008, EUR HEART J, V29, P2851, DOI 10.1093/eurheartj/ehn456; LEHTO M, 1985, J BONE JOINT SURG BR, V67, P820, DOI 10.1302/0301-620X.67B5.3902851; Malafaya PB, 2007, ADV DRUG DELIVER REV, V59, P207, DOI 10.1016/j.addr.2007.03.012; Matoba S, 2008, AM HEART J, V156, P1010, DOI 10.1016/j.ahj.2008.06.025; Nakagawa M, 2006, J BIOMED MATER RES A, V77A, P112, DOI 10.1002/jbm.a.30521; Narmoneva DA, 2005, BIOMATERIALS, V26, P4837, DOI 10.1016/j.biomaterials.2005.01.005; Okada M, 2007, J NANOPART RES, V9, P807, DOI 10.1007/s11051-006-9126-1; Okada M, 2010, MATER SCI ENG B-ADV, V173, P199, DOI 10.1016/j.mseb.2009.12.009; Phelps EA, 2009, REGEN MED, V4, P65, DOI 10.2217/17460751.4.1.65; Qin S, 2008, CIRC J, V72, P2075, DOI 10.1253/circj.CJ-08-0392; Rezwan K, 2006, BIOMATERIALS, V27, P3413, DOI 10.1016/j.biomaterials.2006.01.039; SCHAKENRAAD JM, 1990, J BIOMED MATER RES, V24, P529, DOI 10.1002/jbm.820240502; Schioppa T, 2003, J EXP MED, V198, P1391, DOI 10.1084/jem.20030267; Shoji T, 2006, DIABETES, V55, P2245, DOI 10.2337/db05-1375; Sieveking DP, 2009, VASC MED, V14, P153, DOI 10.1177/1358863X08098698; Sung HJ, 2004, BIOMATERIALS, V25, P5735, DOI 10.1016/j.biomaterials.2004.01.066; Suuronen EJ, 2006, CIRCULATION, V114, pI138, DOI 10.1161/CIRCULATIONAHA.105.001081; Takahashi M, 2010, CIRC J, V74, P418, DOI 10.1253/circj.CJ-09-1021; Takahashi M, 2006, AM J PHYSIOL-HEART C, V291, pH886, DOI 10.1152/ajpheart.00142.2006; Tang YL, 2009, CIRC RES, V104, P1209, DOI 10.1161/CIRCRESAHA.109.197723; Tateno K, 2006, CIRC RES, V98, P1194, DOI 10.1161/01.RES.0000219901.13974.15; Toma C, 2002, CIRCULATION, V105, P93, DOI 10.1161/hc0102.101442; van Weel V, 2008, ANN VASC SURG, V22, P582, DOI 10.1016/j.avsg.2008.02.017; WILLIAMS DF, 1977, J BIOENG, V1, P231; Wragg A, 2008, J MOL MED, V86, P1221, DOI 10.1007/s00109-008-0390-7; Yanagida H, 2009, J BIOSCI BIOENG, V108, P235, DOI 10.1016/j.jbiosc.2009.04.003; Yau TM, 2005, CIRCULATION, V112, pI123, DOI 10.1161/CIRCULATIONAHA.104.525147; Zhang G, 2008, TISSUE ENG PT A, V14, P1025, DOI 10.1089/ten.tea.2007.0289; Zhuang ZW, 2006, RADIOLOGY, V240, P698, DOI 10.1148/radiol.2403050976	56	52	52	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2012	7	4							e35199	10.1371/journal.pone.0035199	http://dx.doi.org/10.1371/journal.pone.0035199			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959XD	22529991	gold, Green Published, Green Submitted			2022-12-25	WOS:000305350600067
J	Bid, HK; Oswald, D; Li, CL; London, CA; Lin, JY; Houghton, PJ				Bid, Hemant K.; Oswald, Duane; Li, Chenglong; London, Cheryl A.; Lin, Jiayuh; Houghton, Peter J.			Anti-Angiogenic Activity of a Small Molecule STAT3 Inhibitor LLL12	PLOS ONE			English	Article							PRECLINICAL TESTING PROGRAM; GROWTH-SUPPRESSIVE ACTIVITY; BREAST-CANCER CELLS; SIGNAL TRANSDUCER; ENDOTHELIAL-CELLS; ACTIVATOR; TRANSCRIPTION-3; OSTEOSARCOMA; EXPRESSION; TUMORS	Background: Recent data indicate the Signal Transducer and Activator of Transcription 3 (STAT3) pathway is required for VEGF production and angiogenesis in various types of cancers. STAT3 inhibitors have been shown to reduce tumor microvessel density in tumors but a direct anti-angiogenic activity has not been described. Methodology/Principal Findings: We investigated the direct action of a small molecule inhibitor of STAT3 (LLL12) in human umbilical cord vascular endothelial cells (HUVECs) in vitro, in a Matrigel model for angiogenesis in vivo, and its antitumor activity in a xenograft model of osteosarcoma. LLL12 (100 nM) significantly inhibited VEGF-stimulated STAT3 phosphorylation in HUVECs, reduced their proliferation/migration and inhibited VEGF-induced tube formation. Morphologic analysis of LLL12 treated HUVECs demonstrated marked changes in actin/tubulin distribution and bundling. In scid mice, LLL12 reduced microvessel invasion into VEGF-infused Matrigel plugs by similar to 90% at a dose of 5 mg/kg daily. Following a period of tumor progression (2 weeks), LLL12 completely suppressed further growth of established OS-1 osteosarcoma xenografts. Pharmacodynamic studies showed robust phosphorylated STAT3 in control tumors, whereas phospho-STAT3 was not detected in LLL12-treated OS-1 tumors. Treated tumors demonstrated decreased proliferation (Ki67 staining), and decreased microvessel density (CD34 staining), but no significant increase in apoptosis (TUNEL staining), relative to controls. Assay of angiogenic factors, using an antibody array, showed VEGF, MMP-9, Angiopoietin1/2, Tissue Factor and FGF-1 expression were dramatically reduced in LLL12-treated tumors compared to control tumors. Conclusions: These findings provide the first evidence that LLL12 effectively inhibits tumor angiogenesis both in vitro and in vivo.	[Bid, Hemant K.; Oswald, Duane; Lin, Jiayuh; Houghton, Peter J.] Nationwide Childrens Hosp, Ctr Childhood Canc, Columbus, OH USA; [Li, Chenglong] Ohio State Univ, Coll Pharm, Columbus, OH 43210 USA; [London, Cheryl A.] Ohio State Univ, Coll Vet Med, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Bid, HK (corresponding author), Nationwide Childrens Hosp, Ctr Childhood Canc, Columbus, OH USA.	Peter.Houghton@nationwidechildrens.org	London, Cheryl/E-6561-2012; Lin, Jiayuh/E-3515-2011; Li, Chenglong/E-7182-2010; Houghton, Peter/E-3265-2011	Li, Chenglong/0000-0003-3174-8719; 	Research Institute at Nationwide Children's Hospital; Ohio State University	Research Institute at Nationwide Children's Hospital(Ohio State University); Ohio State University(Ohio State University)	This work was supported by internal funds (start-up) from The Research Institute at Nationwide Children's Hospital, and a seed grant from Ohio State University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ball S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018820; Bartoli M, 2003, FASEB J, V17, P1562, DOI 10.1096/fj.02-1084fje; Buettner R, 2002, CLIN CANCER RES, V8, P945; Chen CL, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-111; Chen Z, 2008, MED RES REV, V28, P185, DOI 10.1002/med.20101; Dechow TN, 2004, P NATL ACAD SCI USA, V101, P10602, DOI 10.1073/pnas.0404100101; Fossey SL, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-81; Hedvat M, 2009, CANCER CELL, V16, P487, DOI 10.1016/j.ccr.2009.10.015; Houghton PJ, 2007, PEDIATR BLOOD CANCER, V49, P928, DOI 10.1002/pbc.21078; Lai R, 2006, J PATHOL, V208, P624, DOI 10.1002/path.1941; Li WC, 2006, CLIN CANCER RES, V12, P7140, DOI 10.1158/1078-0432.CCR-06-0484; Lin L, 2010, CANCER RES, V70, P2445, DOI 10.1158/0008-5472.CAN-09-2468; Lin L, 2010, NEOPLASIA, V12, P39, DOI 10.1593/neo.91196; Maris JM, 2008, PEDIATR BLOOD CANCER, V51, P42, DOI 10.1002/pbc.21535; Maris JM, 2008, PEDIATR BLOOD CANCER, V50, P581, DOI 10.1002/pbc.21232; MEYER WH, 1990, CANCER RES, V50, P2781; Neale G, 2008, CLIN CANCER RES, V14, P4572, DOI 10.1158/1078-0432.CCR-07-5090; Niu GL, 2002, ONCOGENE, V21, P2000, DOI 10.1038/sj.onc.1205260; Osugi T, 2002, J BIOL CHEM, V277, P6676, DOI 10.1074/jbc.M108246200; Scehnet JS, 2009, BLOOD, V113, P254, DOI 10.1182/blood-2008-02-140020; Song H, 2005, P NATL ACAD SCI USA, V102, P4700, DOI 10.1073/pnas.0409894102; Teng TS, 2009, J CELL SCI, V122, P4150, DOI 10.1242/jcs.057109; Thaloor D, 1998, CELL GROWTH DIFFER, V9, P305; Verma NK, 2009, J BIOL CHEM, V284, P12349, DOI 10.1074/jbc.M807761200; Wei DY, 2003, ONCOGENE, V22, P319, DOI 10.1038/sj.onc.1206122; Yahata Y, 2003, J BIOL CHEM, V278, P40026, DOI 10.1074/jbc.M301866200	26	39	42	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2012	7	4							e35513	10.1371/journal.pone.0035513	http://dx.doi.org/10.1371/journal.pone.0035513			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WC	22530037	Green Submitted, gold, Green Published			2022-12-25	WOS:000305347400056
J	Armenteras, D; Retana, J				Armenteras, Dolors; Retana, Javier			Dynamics, Patterns and Causes of Fires in Northwestern Amazonia	PLOS ONE			English	Article							CLIMATE-CHANGE; INTERANNUAL VARIABILITY; SOUTH-AMERICA; DEFORESTATION; RAINFALL; FOREST; TRENDS; BRAZIL	According to recent studies, two widespread droughts occurred in the Amazon basin, one during 2005 and one during 2010. The drought increased the prevalence of climate-driven fires over most of the basin. Given the importance of human-atmosphere-vegetation interactions in tropical rainforests, these events have generated concerns over the vulnerability of this area to climate change. This paper focuses on one of the wettest areas of the basin, Northwestern Amazonia, where the interactions between the climate and fires are much weaker and where little is known about the anthropogenic drivers of fires. We have assessed the response of fires to climate over a ten-year period, and analysed the socio-economic and demographic determinants of fire occurrence. The patterns of fires and climate and their linkages in Northwestern Amazonia differ from the enhanced fire response to climate variation observed in the rest of Amazonia. The highest number of recorded fires in Northwestern Amazonia occurred in 2004 and 2007, and this did not coincide with the periods of extreme drought experienced in Amazonia in 2005 and 2010. Rather, during those years, Northwestern Amazonia experienced a relatively small numbers of fire hotspots. We have shown that fire occurrence correlated well with deforestation and was determined by anthropogenic drivers, mainly small-scale agriculture, cattle ranching (i.e., pastures) and active agricultural frontiers (including illegal crops). Thus, the particular climatic conditions for air convergence and rainfall created by proximity to the Andes, coupled with the presence of one of the most active colonisation fronts in the region, make this region differently affected by the general drought-induced fire patterns experienced by the rest of the Amazon. Moreover, the results suggest that, even in this wet region, humans are able to modify the frequency of fires and impact these historically well preserved forests.	[Armenteras, Dolors] Univ Nacl Colombia, Fac Sci, Dept Biol, Landscape Ecol & Ecosyst Modelling Lab, Bogota, Colombia; [Retana, Javier] Univ Autonoma Barcelona, CREAF, E-08193 Barcelona, Spain; [Retana, Javier] Univ Autonoma Barcelona, Unitat Ecol, E-08193 Barcelona, Spain	Universidad Nacional de Colombia; Autonomous University of Barcelona; Centro de Investigacion Ecologica y Aplicaciones Forestales (CREAF); University of Barcelona; Autonomous University of Barcelona	Armenteras, D (corresponding author), Univ Nacl Colombia, Fac Sci, Dept Biol, Landscape Ecol & Ecosyst Modelling Lab, Bogota, Colombia.	darmenterasp@unal.edu.co	Armenteras, Dolors/A-4000-2010; Retana, Javier/L-1214-2014	Armenteras, Dolors/0000-0003-0922-7298; Retana, Javier/0000-0002-7505-9467				Alencar AAC, 2004, ECOL APPL, V14, pS139; [Anonymous], 2006, EOS T AM GEOPHYS UNI, DOI DOI 10.1029/2006EO260001; [Anonymous], 1985, NAT CENS POP 1985 19; [Anonymous], 2005, NAT CENS POP 1985 19; [Anonymous], 1993, NAT CENS POP 1985 19; Aragao LEOC, 2008, PHILOS T R SOC B, V363, P1779, DOI 10.1098/rstb.2007.0026; Aragao LEOC, 2007, GEOPHYS RES LETT, V34, DOI [10.1029/2006GL028946., 10.1029/2006GL028946]; Armenteras D, 2006, ECOL INDIC, V6, P353, DOI 10.1016/j.ecolind.2005.03.014; Armenteras-Pascual D, 2011, AGR FOREST METEOROL, V151, P279, DOI 10.1016/j.agrformet.2010.11.002; Asner GP, 2010, NEW PHYTOL, V187, P569, DOI 10.1111/j.1469-8137.2010.03310.x; Bowman DMJS, 2009, SCIENCE, V324, P481, DOI 10.1126/science.1163886; Cochrane MA, 2003, NATURE, V421, P913, DOI 10.1038/nature01437; Davalos LM, 2011, ENVIRON SCI TECHNOL, V45, P1219, DOI 10.1021/es102373d; Etter A, 2005, FOREST ECOL MANAG, V208, P249, DOI 10.1016/j.foreco.2004.12.008; Giglio L, 2003, REMOTE SENS ENVIRON, V87, P273, DOI 10.1016/S0034-4257(03)00184-6; Giles J, 2006, NATURE, V442, P726, DOI 10.1038/442726c; IDEAM IGAC IAvH INVEMAR SINCHI IIAP, 2007, EC CONT COST MAR COL; Instituto de Hidrologia Meteorologia y Estudios Ambientales-IDEAM, 2011, MEM TECN CU IN PRESS; Kummerow C, 1998, J ATMOS OCEAN TECH, V15, P809, DOI 10.1175/1520-0426(1998)015<0809:TTRMMT>2.0.CO;2; Lewis SL, 2011, SCIENCE, V331, P554, DOI 10.1126/science.1200807; Li WH, 2008, PHILOS T R SOC B, V363, P1767, DOI 10.1098/rstb.2007.0022; Malhi Y, 2004, PHILOS T R SOC B, V359, P311, DOI 10.1098/rstb.2003.1433; Malhi Y, 2008, SCIENCE, V319, P169, DOI 10.1126/science.1146961; Malhi Y, 2009, P NATL ACAD SCI USA, V106, P20610, DOI 10.1073/pnas.0804619106; Marengo JA, 2008, PHILOS T R SOC B, V363, P1773, DOI 10.1098/rstb.2007.0015; Marengo JA, 1998, J GEOPHYS RES-ATMOS, V103, P1775, DOI 10.1029/97JD02551; MARENGO JA, 1992, INT J CLIMATOL, V12, P853, DOI 10.1002/joc.3370120808; Metzger JP, 2002, LANDSCAPE ECOL, V17, P419, DOI 10.1023/A:1021250306481; Morton DC, 2008, GLOBAL CHANGE BIOL, V14, P2262, DOI 10.1111/j.1365-2486.2008.01652.x; National Aeronautics and Space Administration, 2009, MONTHL 0 25 0 25 TRM; Poveda G, 2006, PALAEOGEOGR PALAEOCL, V234, P3, DOI 10.1016/j.palaeo.2005.10.031; Ray D, 2005, ECOL APPL, V15, P1664, DOI 10.1890/05-0404; Rodriguez N, 2012, BIOTROPICA, V44, P123, DOI 10.1111/j.1744-7429.2011.00770.x; Rudel TK, 2009, CONSERV BIOL, V23, P1396, DOI 10.1111/j.1523-1739.2009.01332.x; Silvestrini RA, 2011, ECOL APPL, V21, P1573, DOI 10.1890/10-0827.1; United Nations Office on Drugs and Crime, 2010, INT SYST ILL CROPS M; van der Werf GR, 2008, GLOBAL BIOGEOCHEM CY, V22, DOI 10.1029/2007GB003122; Villar JCE, 2009, INT J CLIMATOL, V29, P1574, DOI 10.1002/joc.1791; Wassenaar T, 2007, GLOBAL ENVIRON CHANG, V17, P86, DOI 10.1016/j.gloenvcha.2006.03.007	40	21	22	2	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2012	7	4							e35288	10.1371/journal.pone.0035288	http://dx.doi.org/10.1371/journal.pone.0035288			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VO	22523580	gold, Green Published			2022-12-25	WOS:000305345000052
J	Wineinger, NE; Tiwari, HK				Wineinger, Nathan E.; Tiwari, Hemant K.			The Impact of Errors in Copy Number Variation Detection Algorithms on Association Results	PLOS ONE			English	Article							MISSING HERITABILITY; GENOME-WIDE	The inaccuracy of copy number variation (CNV) detection on single nucleotide polymorphism (SNP) arrays has recently been brought to attention. Such high error rates will undoubtedly have ramifications on downstream association testing. We examined this effect for a wide range of scenarios and found a noticeable decrease in power for error rates typical of CNV calling algorithms. We compared power using CNV calls to the log relative ratio and found the latter to be superior when error rates are moderate to large or when the CNV size is small. It is our recommendation that CNV researchers use intensity measurements as an alternative to CNV calls in these scenarios.	[Wineinger, Nathan E.; Tiwari, Hemant K.] Univ Alabama Birmingham, Dept Biostat, Sect Stat Genet, Birmingham, AL 35294 USA; [Wineinger, Nathan E.] Scripps Hlth, Scripps Translat Sci Inst, La Jolla, CA USA	University of Alabama System; University of Alabama Birmingham; Scripps Research Institute	Wineinger, NE (corresponding author), Univ Alabama Birmingham, Dept Biostat, Sect Stat Genet, Birmingham, AL 35294 USA.	wineinger.nathan@scrippshealth.org			Marie and Emmett Carmichael Scholarship; Scripps Health; National Institutes of Health (NIH) [T32HL079888]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL079888] Funding Source: NIH RePORTER	Marie and Emmett Carmichael Scholarship; Scripps Health; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported in part by the Marie and Emmett Carmichael Scholarship, Scripps Health, and by National Institutes of Health (NIH) grant T32HL079888 (Dr. Tiwari). The opinions expressed herein are those of the authors and not necessarily those of the NIH or any organization with which the authors are affiliated. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aitman TJ, 2006, NATURE, V439, P851, DOI 10.1038/nature04489; Baross A, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-368; Craddock N, 2010, NATURE, V464, P713, DOI 10.1038/nature08979; Eichler EE, 2010, NAT REV GENET, V11, P446, DOI 10.1038/nrg2809; Glessner JT, 2010, AM J HUM GENET, V87, P661, DOI 10.1016/j.ajhg.2010.09.014; Gonzalez E, 2005, SCIENCE, V307, P1434, DOI 10.1126/science.1101160; Gordon D, 2005, J CLIN INVEST, V115, P1408, DOI 10.1172/JCI24756; Kang SJ, 2004, GENET EPIDEMIOL, V26, P132, DOI 10.1002/gepi.10301; Korn JM, 2008, NAT GENET, V40, P1253, DOI 10.1038/ng.237; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Sebat J, 2007, SCIENCE, V316, P445, DOI 10.1126/science.1138659; Stefansson H, 2008, NATURE, V455, P232, DOI 10.1038/nature07229; Stone JL, 2008, NATURE, V455, P237, DOI 10.1038/nature07239; Wang K, 2007, GENOME RES, V17, P1665, DOI 10.1101/gr.6861907; Winchester Laura, 2009, Briefings in Functional Genomics & Proteomics, V8, P353, DOI 10.1093/bfgp/elp017; Zhang DD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014511	16	9	10	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2012	7	4							e32396	10.1371/journal.pone.0032396	http://dx.doi.org/10.1371/journal.pone.0032396			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VO	22523537	Green Published, Green Submitted, gold			2022-12-25	WOS:000305345000006
J	Ruan, JB; Ouyang, H; Amaya, MF; Ravichandran, M; Loppnau, P; Min, JR; Zang, JY				Ruan, Jianbin; Ouyang, Hui; Amaya, Maria F.; Ravichandran, Mani; Loppnau, Peter; Min, Jinrong; Zang, Jianye			Structural Basis of the Chromodomain of Cbx3 Bound to Methylated Peptides from Histone H1 and G9a	PLOS ONE			English	Article							HETEROCHROMATIN PROTEIN-1; DNA METHYLATION; HP1; COMPLEX; RECOGNITION; BINDING; H3; SPECIFICITY; METHYLTRANSFERASE; TRANSCRIPTION	Background: HP1 proteins are highly conserved heterochromatin proteins, which have been identified to be structural adapters assembling a variety of macromolecular complexes involved in regulation of gene expression, chromatin remodeling and heterochromatin formation. Much evidence shows that HP1 proteins interact with numerous proteins including methylated histones, histone methyltransferases and so on. Cbx3 is one of the paralogues of HP1 proteins, which has been reported to specifically recognize trimethylated histone H3K9 mark, and a consensus binding motif has been defined for the Cbx3 chromodomain. Methodology/Principal Findings: Here, we found that the Cbx3 chromodomain can bind to H1K26me2 and G9aK185me3 with comparable binding affinities compared to H3K9me3. We also determined the crystal structures of the human Cbx3 chromodomain in complex with dimethylated histone H1K26 and trimethylated G9aK185 peptides, respectively. The complex structures unveil that the Cbx3 chromodomain specifically bind methylated histone H1K26 and G9aK185 through a conserved mechanism. Conclusions/Significance: The Cbx3 chromodomain binds with comparable affinities to all of the methylated H3K9, H1K26 and G9aK185 peptides. It is suggested that Cbx3 may regulate gene expression via recognizing both histones and nonhistone proteins.	[Ruan, Jianbin; Zang, Jianye] Univ Sci & Technol China, Hefei Natl Lab Phys Sci, Hefei 230026, Anhui, Peoples R China; [Ruan, Jianbin; Zang, Jianye] Univ Sci & Technol China, Sch Life Sci, Hefei 230026, Anhui, Peoples R China; [Ruan, Jianbin; Zang, Jianye] Chinese Acad Sci, Key Lab Struct Biol, Hefei, Anhui, Peoples R China; [Ouyang, Hui; Amaya, Maria F.; Ravichandran, Mani; Loppnau, Peter; Min, Jinrong] Univ Toronto, Struct Genom Consortium, Toronto, ON, Canada; [Min, Jinrong] Univ Toronto, Dept Physiol, Toronto, ON, Canada	Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; University of Toronto; Structural Genomics Consortium; University of Toronto	Ruan, JB (corresponding author), Univ Sci & Technol China, Hefei Natl Lab Phys Sci, Hefei 230026, Anhui, Peoples R China.	jr.min@utoronto.ca; zangjy@ustc.edu.cn	Zang, Jianye/E-5228-2013; Min, Jinrong/G-3449-2011	Min, Jinrong/0000-0001-5210-3130; Ruan, Jianbin/0000-0001-5843-8273	Chinese Ministry of Science and Technology [2009CB825502]; National Natural Science Foundation of China [31171241, 30970576]; "100 Talents Program'' of the Chinese Academy of Sciences; Structural Genomics Consortium [1097737]; Canadian Institutes for Health Research; Canadian Foundation for Innovation; Genome Canada through the Ontario Genomics Institute; GlaxoSmithKline; Karolinska Institute; Knut and Alice Wallenberg Foundation; Ontario Innovation Trust; Ontario Ministry for Research and Innovation; Merck Co., Inc.; Novartis Research Foundation; Swedish Agency for Innovation Systems; Swedish Foundation for Strategic Research; Wellcome Trust	Chinese Ministry of Science and Technology(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); "100 Talents Program'' of the Chinese Academy of Sciences(Chinese Academy of Sciences); Structural Genomics Consortium(University of Toronto); Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Foundation for Innovation(Canada Foundation for Innovation); Genome Canada through the Ontario Genomics Institute(Genome Canada); GlaxoSmithKline(GlaxoSmithKline); Karolinska Institute(Karolinska Institutet); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Ontario Innovation Trust; Ontario Ministry for Research and Innovation(Ministry of Research and Innovation, Ontario); Merck Co., Inc.(Merck & Company); Novartis Research Foundation; Swedish Agency for Innovation Systems(Vinnova); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Wellcome Trust(Wellcome Trust)	This work was supported by the grant from the Chinese Ministry of Science and Technology (No. 2009CB825502), the grants from National Natural Science Foundation of China (Nos. 31171241 and 30970576) and "100 Talents Program'' of the Chinese Academy of Sciences to JZ. This research was also supported by the Structural Genomics Consortium, a registered charity (number 1097737) [that receives funds from the Canadian Institutes for Health Research, the Canadian Foundation for Innovation, Genome Canada through the Ontario Genomics Institute, GlaxoSmithKline, Karolinska Institute, the Knut and Alice Wallenberg Foundation, the Ontario Innovation Trust, the Ontario Ministry for Research and Innovation, Merck & Co., Inc., the Novartis Research Foundation, the Swedish Agency for Innovation Systems, the Swedish Foundation for Strategic Research] and the Wellcome Trust to JM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainsztein AM, 1998, J CELL BIOL, V143, P1763, DOI 10.1083/jcb.143.7.1763; Bannister AJ, 2001, NATURE, V410, P120, DOI 10.1038/35065138; Bian CB, 2011, EMBO J, V30, P2829, DOI 10.1038/emboj.2011.193; Canzio D, 2011, MOL CELL, V41, P67, DOI 10.1016/j.molcel.2010.12.016; Chin HG, 2007, NUCLEIC ACIDS RES, V35, P7313, DOI 10.1093/nar/gkm726; Cowell IG, 2002, CHROMOSOMA, V111, P22, DOI 10.1007/s00412-002-0182-8; Daujat S, 2005, J BIOL CHEM, V280, P38090, DOI 10.1074/jbc.C500229200; Davis IW, 2004, NUCLEIC ACIDS RES, V32, pW615, DOI 10.1093/nar/gkh398; Eissenberg JC, 2000, CURR OPIN GENET DEV, V10, P204, DOI 10.1016/S0959-437X(00)00058-7; El Gazzar M, 2008, J BIOL CHEM, V283, P32198, DOI 10.1074/jbc.M803446200; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fanti L, 2008, CURR OPIN GENET DEV, V18, P169, DOI 10.1016/j.gde.2008.01.009; Fujita N, 2003, J BIOL CHEM, V278, P24132, DOI 10.1074/jbc.M302283200; Garcia BA, 2004, J PROTEOME RES, V3, P1219, DOI 10.1021/pr0498887; Haldar S, 2011, J BIOL CHEM, V286, P9308, DOI 10.1074/jbc.M110.143198; Happel N, 2009, GENE, V431, P1, DOI 10.1016/j.gene.2008.11.003; Honda S, 2008, MOL CELL BIOL, V28, P6044, DOI 10.1128/MCB.00823-08; Huang Y, 2006, STRUCTURE, V14, P703, DOI 10.1016/j.str.2006.01.007; Inoue A, 2008, MUTAT RES-GEN TOX EN, V657, P48, DOI 10.1016/j.mrgentox.2008.08.010; Izzo A, 2008, BIOL CHEM, V389, P333, DOI 10.1515/BC.2008.037; Jones DO, 2000, BIOESSAYS, V22, P124, DOI 10.1002/(SICI)1521-1878(200002)22:2&lt;124::AID-BIES4&gt;3.0.CO;2-E; Kaustov L, 2011, J BIOL CHEM, V286, P521, DOI 10.1074/jbc.M110.191411; Kim H, 2011, NUCLEIC ACIDS RES, V39, P8329, DOI 10.1093/nar/gkr529; Kiyomitsu T, 2010, J CELL BIOL, V188, P791, DOI 10.1083/jcb.200908096; Kourmouli N, 2000, EMBO J, V19, P6558, DOI 10.1093/emboj/19.23.6558; Kuzmichev A, 2004, MOL CELL, V14, P183, DOI 10.1016/S1097-2765(04)00185-6; Kwon SH, 2011, BIOESSAYS, V33, P280, DOI 10.1002/bies.201000138; Li J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025104; Lu AP, 2009, J PROTEOME RES, V8, P4207, DOI 10.1021/pr9000652; Maison C, 2004, NAT REV MOL CELL BIO, V5, P296, DOI 10.1038/nrm1355; Min JR, 2007, NAT STRUCT MOL BIOL, V14, P1229, DOI 10.1038/nsmb1340; Min JR, 2003, GENE DEV, V17, P1823, DOI 10.1101/gad.269603; Nakayam J, 2001, SCIENCE, V292, P110, DOI 10.1126/science.1060118; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; Nielsen AL, 2001, MOL CELL, V7, P729, DOI 10.1016/S1097-2765(01)00218-0; Nielsen PR, 2002, NATURE, V416, P103, DOI 10.1038/nature722; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PARO R, 1991, P NATL ACAD SCI USA, V88, P263, DOI 10.1073/pnas.88.1.263; Perrakis A, 2001, ACTA CRYSTALLOGR D, V57, P1445, DOI 10.1107/S0907444901014007; Piacentini L, 2010, FLY, V4, P299, DOI 10.4161/fly.4.4.13261; Shareef MM, 2001, MOL BIOL CELL, V12, P1671, DOI 10.1091/mbc.12.6.1671; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; Xu C, 2008, STRUCTURE, V16, P1740, DOI 10.1016/j.str.2008.08.008; Xu C, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1237; Xu C, 2010, P NATL ACAD SCI USA, V107, P19266, DOI 10.1073/pnas.1008937107; Yamamoto K, 2003, BIOCHEM BIOPH RES CO, V301, P287, DOI 10.1016/S0006-291X(02)03021-8; Yap KL, 2011, BIOCHEMISTRY-US, V50, P1966, DOI 10.1021/bi101885m; Ye QA, 1997, J BIOL CHEM, V272, P14983, DOI 10.1074/jbc.272.23.14983	48	25	25	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2012	7	4							e35376	10.1371/journal.pone.0035376	http://dx.doi.org/10.1371/journal.pone.0035376			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UT	22514736	gold, Green Published, Green Submitted			2022-12-25	WOS:000305341600141
J	Wang, Q; Feng, H; Zheng, PL; Shen, BR; Chen, L; Liu, L; Liu, X; Hao, QS; Wang, SC; Chen, JG; Teng, JL				Wang, Qiao; Feng, Hui; Zheng, Pengli; Shen, Birong; Chen, Liang; Liu, Lin; Liu, Xiao; Hao, Qingsong; Wang, Shunchang; Chen, Jianguo; Teng, Junlin			The Intracellular Transport and Secretion of Calumenin-1/2 in Living Cells	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM; CYTOPLASMIC DYNEIN; SARCOPLASMIC-RETICULUM; CA2+-BINDING PROTEIN; GOLGI TRANSPORT; COATED VESICLES; BULK FLOW; KINESIN; ER; MEMBRANE	Calumenin isoforms 1 and 2 (calu-1/2), encoded by the CALU gene, belong to the CREC protein family. Calu-1/2 proteins are secreted into the extracellular space, but the secretory process and regulatory mechanism are largely unknown. Here, using a time-lapse imaging system, we visualized the intracellular transport and secretory process of calu-1/2-EGFP after their translocation into the ER lumen. Interestingly, we observed that an abundance of calu-1/2-EGFP accumulated in cellular processes before being released into the extracellular space, while only part of calu-1/2-EGFP proteins were secreted directly after attaching to the cell periphery. Moreover, we found the secretion of calu-1/2-EGFP required microtubule integrity, and that calu-1/2-EGFP-containing vesicles were transported by the motor proteins Kif5b and cytoplasmic dynein. Finally, we determined the export signal of calu-1/2-EGFP (amino acid positions 20-46) and provided evidence that the asparagine at site 131 was indispensable for calu-1/2-EGFP stabilization. Taken together, we provide a detailed picture of the intracellular transport of calu-1/2-EGFP, which facilitates our understanding of the secretory mechanism of calu-1/2.	[Wang, Qiao; Feng, Hui; Zheng, Pengli; Shen, Birong; Chen, Liang; Liu, Lin; Liu, Xiao; Hao, Qingsong; Wang, Shunchang; Chen, Jianguo; Teng, Junlin] Peking Univ, State Key Lab Biomembrane & Membrane Bioengn, Minist Educ, Coll Life Sci, Beijing 100871, Peoples R China; [Wang, Qiao; Feng, Hui; Zheng, Pengli; Shen, Birong; Chen, Liang; Liu, Lin; Liu, Xiao; Hao, Qingsong; Wang, Shunchang; Chen, Jianguo; Teng, Junlin] Peking Univ, Key Lab Cell Proliferat & Differentiat, Minist Educ, Coll Life Sci, Beijing 100871, Peoples R China; [Chen, Jianguo] Peking Univ, Ctr Theoret Biol, Beijing 100871, Peoples R China	Peking University; Peking University; Peking University	Wang, Q (corresponding author), Peking Univ, State Key Lab Biomembrane & Membrane Bioengn, Minist Educ, Coll Life Sci, Beijing 100871, Peoples R China.	junlinteng@pku.edu.cn	Chen, Liangyi/F-1352-2010	Chen, Liangyi/0000-0003-1270-7321; Wang, Qiao/0000-0001-6416-1733; Zheng, Pengli/0000-0002-3797-4023	Major State Basic Research Development Program of China (973 Program) [2010CB833705]; National Natural Science Foundation of China [30971433, 31071177]	Major State Basic Research Development Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Major State Basic Research Development Program of China (973 Program)(2010CB833705) and the National Natural Science Foundation of China (30971433, 31071177). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araki Y, 2007, EMBO J, V26, P1475, DOI 10.1038/sj.emboj.7601609; Belden WJ, 2001, SCIENCE, V294, P1528, DOI 10.1126/science.1065224; BURGOYNE RD, 1987, BIOSCIENCE REP, V7, P281, DOI 10.1007/BF01121449; Burkhardt JK, 1997, J CELL BIOL, V139, P469, DOI 10.1083/jcb.139.2.469; COOPER JA, 1987, J CELL BIOL, V105, P1473, DOI 10.1083/jcb.105.4.1473; Ding C, 2009, J CELL SCI, V122, P2820, DOI 10.1242/jcs.048777; Fu W, J CELL SCI, V123, P3645; Grigoriev I, 2008, CURR BIOL, V18, P177, DOI 10.1016/j.cub.2007.12.050; Grigoriev I, 2007, DEV CELL, V13, P305, DOI 10.1016/j.devcel.2007.06.010; Hansen GAW, 2009, MOL CELL BIOCHEM, V320, P25, DOI 10.1007/s11010-008-9895-1; HENDRICKS AG, 2010, CURR BIOL; Hirokawa N, 2005, NAT REV NEUROSCI, V6, P201, DOI 10.1038/nrn1624; Hirokawa N, 2009, NAT REV MOL CELL BIO, V10, P682, DOI 10.1038/nrm2774; Hirschberg K, 1998, J CELL BIOL, V143, P1485, DOI 10.1083/jcb.143.6.1485; Honore B, 2000, FEBS LETT, V466, P11, DOI 10.1016/S0014-5793(99)01780-9; Honore B, 2009, BIOESSAYS, V31, P262, DOI 10.1002/bies.200800186; Hseu MJ, 1999, FEBS LETT, V445, P440, DOI 10.1016/S0014-5793(99)00177-5; Jaulin F, 2007, DEV CELL, V13, P511, DOI 10.1016/j.devcel.2007.08.001; Jung DH, 2006, BIOCHEM BIOPH RES CO, V343, P34, DOI 10.1016/j.bbrc.2006.02.115; Kanai Y, 2004, NEURON, V43, P513, DOI 10.1016/j.neuron.2004.07.022; Kapitein LC, 2010, CURR BIOL, V20, P290, DOI 10.1016/j.cub.2009.12.052; Kardon JR, 2009, NAT REV MOL CELL BIO, V10, P854, DOI 10.1038/nrm2804; KELLY RB, 1985, SCIENCE, V230, P25, DOI 10.1126/science.2994224; Kreitzer G, 2000, NAT CELL BIOL, V2, P125, DOI 10.1038/35000081; Kuehn MJ, 1998, NATURE, V391, P187, DOI 10.1038/34438; Kural C, 2005, SCIENCE, V308, P1469, DOI 10.1126/science.1108408; Lansbergen G, 2006, DEV CELL, V11, P21, DOI 10.1016/j.devcel.2006.05.012; Li HH, 2006, J CELL SCI, V119, P4452, DOI 10.1242/jcs.03219; Malkus P, 2002, J CELL BIOL, V159, P915, DOI 10.1083/jcb.200208074; Martinez-Menarguez JA, 1999, CELL, V98, P81, DOI 10.1016/S0092-8674(00)80608-X; MEYER DI, 1979, FEBS LETT, V101, P129, DOI 10.1016/0014-5793(79)81310-1; Mili S, 2008, NATURE, V453, P115, DOI 10.1038/nature06888; Ostergaard M, 2006, PROTEOMICS, V6, P3509, DOI 10.1002/pmic.200500686; Polishchuk EV, 2003, MOL BIOL CELL, V14, P4470, DOI 10.1091/mbc.E03-01-0033; Presley JF, 1997, NATURE, V389, P81, DOI 10.1038/38001; Sahoo SK, 2008, MOL CELLS, V26, P265; Saito K, 2009, CELL, V136, P891, DOI 10.1016/j.cell.2008.12.025; SAMSON F, 1979, J PHARMACOL EXP THER, V208, P411; Setou M, 2002, NATURE, V417, P83, DOI 10.1038/nature743; Tsukumo Y, 2009, J BIOL CHEM, V284, P27500, DOI 10.1074/jbc.M109.021592; van der Voet M, 2009, NAT CELL BIOL, V11, P269, DOI 10.1038/ncb1834; Vorum H, 2000, FEBS LETT, V465, P129, DOI 10.1016/S0014-5793(99)01734-2; Vorum H, 1999, EXP CELL RES, V248, P473, DOI 10.1006/excr.1999.4431; Vorum H, 1998, BBA-PROTEIN STRUCT M, V1386, P121, DOI 10.1016/S0167-4838(98)00089-2; Wajih N, 2004, J BIOL CHEM, V279, P25276, DOI 10.1074/jbc.M401645200; Wang Q, 2010, CELL RES; Wang QA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013252; Wang QA, 2010, CELL RES, V20, P713, DOI 10.1038/cr.2010.47; Wang XF, 2009, P NATL ACAD SCI USA, V106, P21288, DOI 10.1073/pnas.0908151106; Watson P, 2005, NAT CELL BIOL, V7, P48, DOI 10.1038/ncb1206; WIELAND FT, 1987, CELL, V50, P289, DOI 10.1016/0092-8674(87)90224-8; Wozniak MJ, 2006, EMBO J, V25, P5457, DOI 10.1038/sj.emboj.7601427; Wozniak MJ, 2009, J CELL SCI, V122, P1979, DOI 10.1242/jcs.041962; Yabe D, 1998, GENOMICS, V49, P331, DOI 10.1006/geno.1998.5245; Yabe D, 1997, J BIOL CHEM, V272, P18232, DOI 10.1074/jbc.272.29.18232	55	9	9	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2012	7	4							e35344	10.1371/journal.pone.0035344	http://dx.doi.org/10.1371/journal.pone.0035344			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UT	22514732	Green Published, gold, Green Submitted			2022-12-25	WOS:000305341600137
J	Wu, YF; Qi, XM; Gong, LK; Xing, GZ; Chen, M; Miao, LL; Yao, J; Suzuki, T; Furihata, C; Luan, Y; Ren, J				Wu, Yuanfeng; Qi, Xinming; Gong, Likun; Xing, Guozhen; Chen, Min; Miao, Lingling; Yao, Jun; Suzuki, Takayoshi; Furihata, Chie; Luan, Yang; Ren, Jin			Identification of BC005512 as a DNA Damage Responsive Murine Endogenous Retrovirus of GLN Family Involved in Cell Growth Regulation	PLOS ONE			English	Article							MUTATION ASSAY; MOLECULAR-MECHANISMS; ORGAN VARIATION; HEPG2 CELLS; RAT-LIVER; GENOTOXICITY; EXPRESSION; MICE; CANCER; P53	Genotoxicity assessment is of great significance in drug safety evaluation, and microarray is a useful tool widely used to identify genotoxic stress responsive genes. In the present work, by using oligonucleotide microarray in an in vivo model, we identified an unknown gene BC005512 (abbreviated as BC, official full name: cDNA sequence BC005512), whose expression in mouse liver was specifically induced by seven well-known genotoxins (GTXs), but not by non-genotoxins (NGTXs). Bioinformatics revealed that BC was a member of the GLN family of murine endogenous retrovirus (ERV). However, the relationship to genotoxicity and the cellular function of GLN are largely unknown. Using NIH/3T3 cells as an in vitro model system and quantitative real-time PCR, BC expression was specifically induced by another seven GTXs, covering diverse genotoxicity mechanisms. Additionally, dose-response and linear regression analysis showed that expression level of BC in NIH/3T3 cells strongly correlated with DNA damage, measured using the alkaline comet assay,. While in p53 deficient L5178Y cells, GTXs could not induce BC expression. Further functional studies using RNA interference revealed that down-regulation of BC expression induced G1/S phase arrest, inhibited cell proliferation and thus suppressed cell growth in NIH/3T3 cells. Together, our results provide the first evidence that BC005512, a member from GLN family of murine ERV, was responsive to DNA damage and involved in cell growth regulation. These findings could be of great value in genotoxicity predictions and contribute to a deeper understanding of GLN biological functions.	[Wu, Yuanfeng; Qi, Xinming; Gong, Likun; Xing, Guozhen; Chen, Min; Miao, Lingling; Yao, Jun; Luan, Yang; Ren, Jin] Chinese Acad Sci, Shanghai Inst Mat Med, State Key Lab New Drug Res, Ctr Drug Safety Evaluat & Res, Shanghai 200031, Peoples R China; [Suzuki, Takayoshi] Natl Inst Hlth Sci, Div Cellular & Gene Therapy Prod, Tokyo, Japan; [Furihata, Chie] Aoyama Gakuin Univ, Sch Sci & Engn, Dept Chem & Biol Sci, Tokyo, Kanagawa 150, Japan	Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS; National Institute of Health Sciences - Japan; Aoyama Gakuin University	Wu, YF (corresponding author), Chinese Acad Sci, Shanghai Inst Mat Med, State Key Lab New Drug Res, Ctr Drug Safety Evaluat & Res, Shanghai 200031, Peoples R China.	yluan@cdser.simm.ac.cn; jren@cdser.simm.ac.cn	Miao, Lingling/X-6143-2019; wu, yuanfeng/GVU-6762-2022; Wu, Yuanfeng/O-2920-2014; SUZUKI, TAKAYOSHI/ABA-2386-2020	Miao, Lingling/0000-0003-3674-2885; Wu, Yuanfeng/0000-0001-6390-3635; SUZUKI, TAKAYOSHI/0000-0002-2261-5263	National Natural Science Foundation of China [20807045/B070701]; National Science and Technology Major Project "Key New Drug Creation and Manufacturing Program", China [2009ZX09301-001, 2008ZX09305-007, 2009ZX09501-033]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science and Technology Major Project "Key New Drug Creation and Manufacturing Program", China	This work was supported by National Natural Science Foundation of China (No. 20807045/B070701), and National Science and Technology Major Project "Key New Drug Creation and Manufacturing Program", China (No. 2009ZX09301-001, 2008ZX09305-007 and 2009ZX09501-033). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas T, 2009, NAT REV CANCER, V9, P400, DOI 10.1038/nrc2657; [Anonymous], 1996, ENV MOL MUTAGEN, V28, P363; ANTOCCIA A, 1993, MUTAT RES, V287, P93, DOI 10.1016/0027-5107(93)90148-9; Balada E, 2009, REV MED VIROL, V19, P273, DOI 10.1002/rmv.622; Baldwin E. L., 2005, Current Medicinal Chemistry - Anti-Cancer Agents, V5, P363, DOI 10.2174/1568011054222364; Bates S, 1996, ONCOGENE, V13, P1103; BERANEK DT, 1990, MUTAT RES, V231, P11, DOI 10.1016/0027-5107(90)90173-2; Boeke J. D., 1997, P343; Choy W.N., 2001, GENETIC TOXICOLOGY C, P93; DRAGANI TA, 1987, CANCER RES, V47, P795; Dupressoir A, 2009, P NATL ACAD SCI USA, V106, P12127, DOI 10.1073/pnas.0902925106; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Ellinger-Ziegelbauer H, 2005, MUTAT RES-FUND MOL M, V575, P61, DOI 10.1016/j.mrfmmm.2005.02.004; Ellinger-Ziegelbauer H, 2009, TOXICOL LETT, V186, P36, DOI 10.1016/j.toxlet.2008.08.017; Fenech M, 2000, MUTAT RES-FUND MOL M, V455, P81, DOI 10.1016/S0027-5107(00)00065-8; Fenech M, 2007, NAT PROTOC, V2, P1084, DOI 10.1038/nprot.2007.77; Goodsell DS, 2006, ONCOLOGIST, V11, P316, DOI 10.1634/theoncologist.11-3-316; Hastwell PW, 2006, MUTAT RES-GEN TOX EN, V607, P160, DOI 10.1016/j.mrgentox.2006.04.011; Hendriks G, 2012, TOXICOL SCI, V125, P285, DOI 10.1093/toxsci/kfr281; Hendriks G, 2011, MUTAT RES-FUND MOL M, V709-10, P49, DOI 10.1016/j.mrfmmm.2011.02.013; Hohenadl C, 1999, J INVEST DERMATOL, V113, P587, DOI 10.1046/j.1523-1747.1999.00728.x; Honma M, 1999, MUTAGENESIS, V14, P23, DOI 10.1093/mutage/14.1.23; HSIEH LL, 1987, CANCER RES, V47, P3421; ITIN A, 1986, J VIROL, V59, P301, DOI 10.1128/JVI.59.2.301-307.1986; Kirkland D, 2008, MUTAT RES-GEN TOX EN, V654, P114, DOI 10.1016/j.mrgentox.2008.05.002; Kohany O, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-474; Komarov PG, 1999, SCIENCE, V285, P1733, DOI 10.1126/science.285.5434.1733; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; LATOUR I, 1995, FEBS LETT, V373, P299, DOI 10.1016/0014-5793(95)01065-M; Leavitt SA, 2008, MUTAGENESIS, V23, P445, DOI 10.1093/mutage/gen033; LI JP, 1990, NATURE, V343, P762, DOI 10.1038/343762a0; Magkoufopoulou C, 2011, MUTAGENESIS, V26, P593, DOI 10.1093/mutage/ger021; OBATA MM, 1988, J VIROL, V62, P4381, DOI 10.1128/JVI.62.11.4381-4386.1988; Ohsawa K, 2000, MUTAT RES-GEN TOX EN, V471, P113, DOI 10.1016/S1383-5718(00)00120-0; Okada N, 1997, MUTAGENESIS, V12, P179, DOI 10.1093/mutage/12.3.179; Olive PL, 2006, NAT PROTOC, V1, P23, DOI 10.1038/nprot.2006.5; Pommier Y, 2006, NAT REV CANCER, V6, P789, DOI 10.1038/nrc1977; Ponferrada VG, 2003, ARCH VIROL, V148, P659, DOI 10.1007/s00705-002-0960-x; Ribet D, 2008, J VIROL, V82, P4413, DOI 10.1128/JVI.02141-07; Rink SM, 1996, CHEM RES TOXICOL, V9, P382, DOI 10.1021/tx950156q; Ruprecht K, 2008, CELL MOL LIFE SCI, V65, P3366, DOI 10.1007/s00018-008-8496-1; SACKETT DL, 1993, BIOCHEMISTRY-US, V32, P13560, DOI 10.1021/bi00212a023; SALMON ED, 1984, CELL MOTIL CYTOSKEL, V4, P155, DOI 10.1002/cm.970040302; Sancar A, 2004, ANNU REV BIOCHEM, V73, P39, DOI 10.1146/annurev.biochem.73.011303.073723; Scott DJ, 2011, TOXICOLOGY, V290, P50, DOI 10.1016/j.tox.2011.08.015; Storer RD, 1997, MUTAT RES-FUND MOL M, V373, P157, DOI 10.1016/S0027-5107(96)00227-8; Suzuki T, 1999, MUTAT RES-GEN TOX EN, V444, P259, DOI 10.1016/S1383-5718(99)00104-7; Suzuki T, 1996, ENVIRON MOL MUTAGEN, V28, P348; Thomas RS, 2007, TOXICOL SCI, V96, P40, DOI 10.1093/toxsci/kfl171; TSICHLIS PN, 1991, P NATL ACAD SCI USA, V88, P4611, DOI 10.1073/pnas.88.11.4611; Van Hummelen P, 2010, MUTAT RES-REV MUTAT, V705, P165, DOI 10.1016/j.mrrev.2010.04.007; Wang T, 2007, P NATL ACAD SCI USA, V104, P18613, DOI 10.1073/pnas.0703637104; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; Westerink WMA, 2010, MUTAT RES-GEN TOX EN, V696, P21, DOI 10.1016/j.mrgentox.2009.12.007; Yelamos J, 2006, EMBO J, V25, P4350, DOI 10.1038/sj.emboj.7601301	55	8	12	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2012	7	4							e35010	10.1371/journal.pone.0035010	http://dx.doi.org/10.1371/journal.pone.0035010			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UT	22514700	Green Submitted, Green Published, gold			2022-12-25	WOS:000305341600106
J	Petrie, JR; Vanhercke, T; Shrestha, P; El Tahchy, A; White, A; Zhou, XR; Liu, Q; Mansour, MP; Nichols, PD; Singh, SP				Petrie, James R.; Vanhercke, Thomas; Shrestha, Pushkar; El Tahchy, Anna; White, Adam; Zhou, Xue-Rong; Liu, Qing; Mansour, Maged P.; Nichols, Peter D.; Singh, Surinder P.			Recruiting a New Substrate for Triacylglycerol Synthesis in Plants: The Monoacylglycerol Acyltransferase Pathway	PLOS ONE			English	Article							LYSOPHOSPHATIDIC ACID-PHOSPHATASE; DIACYLGLYCEROL ACYLTRANSFERASE; FUNCTIONAL-CHARACTERIZATION; ARABIDOPSIS-THALIANA; GENE; IDENTIFICATION; MGAT2; YEAST; SEEDS; BIOSYNTHESIS	Background: Monoacylglycerol acyltransferases (MGATs) are predominantly associated with lipid absorption and resynthesis in the animal intestine where they catalyse the first step in the monoacylglycerol (MAG) pathway by acylating MAG to form diacylglycerol (DAG). Typical plant triacylglycerol (TAG) biosynthesis routes such as the Kennedy pathway do not include an MGAT step. Rather, DAG and TAG are synthesised de novo from glycerol-3-phosphate (G-3-P) by a series of three subsequent acylation reactions although a complex interplay with membrane lipids exists. Methodology/Principal Findings: We demonstrate that heterologous expression of a mouse MGAT acyltransferase in Nicotiana benthamiana significantly increases TAG accumulation in vegetative tissues despite the low levels of endogenous MAG substrate available. In addition, DAG produced by this acyltransferase can serve as a substrate for both native and coexpressed diacylglycerol acyltransferases (DGAT). Finally, we show that the Arabidopsis thaliana GPAT4 acyltransferase can produce MAG in Saccharomyces cerevisiae using oleoyl-CoA as the acyl-donor. Conclusions/Significance: This study demonstrates the concept of a new method of increasing oil content in vegetative tissues by using MAG as a substrate for TAG biosynthesis. Based on in vitro yeast assays and expression results in N. benthamiana, we propose that co-expression of a MAG synthesising enzyme such as A. thaliana GPAT4 and a MGAT or bifunctional M/DGAT can result in DAG and TAG synthesis from G-3-P via a route that is independent and complementary to the endogenous Kennedy pathway and other TAG synthesis routes.	[Petrie, James R.; Shrestha, Pushkar; El Tahchy, Anna; White, Adam; Liu, Qing; Mansour, Maged P.; Nichols, Peter D.; Singh, Surinder P.] CSIRO Food Futures Natl Res Flagship, Canberra, ACT, Australia; [Vanhercke, Thomas; Zhou, Xue-Rong] CSIRO Plant Ind, Canberra, ACT, Australia; [Mansour, Maged P.; Nichols, Peter D.] CSIRO Marine & Atmospher Res, Hobart, Tas, Australia	Commonwealth Scientific & Industrial Research Organisation (CSIRO); Commonwealth Scientific & Industrial Research Organisation (CSIRO); Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Petrie, JR (corresponding author), CSIRO Food Futures Natl Res Flagship, Canberra, ACT, Australia.	surinder.singh@csiro.au	Zhou, Xue-Rong/D-4706-2009; singh, surinder/C-9528-2009; El Tahchy, Anna/AAE-8701-2022; Nichols, Peter D/C-5128-2011; Petrie, James R/D-4598-2009; Vanhercke, Thomas/B-6647-2011; tahchy, Anna El/B-6997-2012; Shrestha, Pushkar/A-2728-2010; Liu, Qing/A-1395-2010	Zhou, Xue-Rong/0000-0003-3717-2984; singh, surinder/0000-0003-4488-8147; Petrie, James R/0000-0002-5892-798X; Vanhercke, Thomas/0000-0003-1397-7622; Shrestha, Pushkar/0000-0001-9642-6636; Liu, Qing/0000-0001-6617-6859; Belide, Srinivas/0000-0001-9536-8200; , Maged/0000-0002-4646-8472	CSIRO	CSIRO(Commonwealth Scientific & Industrial Research Organisation (CSIRO))	The authors are all employees of the funder of the study, CSIRO. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Athenstaedt K, 2011, EUR J LIPID SCI TECH, V113, P1188, DOI 10.1002/ejlt.201100051; Bates PD, 2007, J BIOL CHEM, V282, P31206, DOI 10.1074/jbc.M705447200; Bates PD, 2009, PLANT PHYSIOL, V150, P55, DOI 10.1104/pp.109.137737; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Bouvier-Nave P, 2000, EUR J BIOCHEM, V267, P85, DOI 10.1046/j.1432-1327.2000.00961.x; Cao JS, 2007, J LIPID RES, V48, P583, DOI 10.1194/jlr.M600331-JLR200; Cao JS, 2003, J BIOL CHEM, V278, P25657, DOI 10.1074/jbc.M302835200; Cao JS, 2003, J BIOL CHEM, V278, P13860, DOI 10.1074/jbc.M300139200; Carrasco S, 2007, TRENDS BIOCHEM SCI, V32, P27, DOI 10.1016/j.tibs.2006.11.004; Chibalin AV, 2008, CELL, V132, P375, DOI 10.1016/j.cell.2007.12.035; Heier C, 2010, BBA-MOL CELL BIOL L, V1801, P1063, DOI 10.1016/j.bbalip.2010.06.001; HIRAYAMA O, 1965, AGR BIOL CHEM TOKYO, V29, P1; Igal RA, 2001, J LIPID RES, V42, P88; James CN, 2010, P NATL ACAD SCI USA, V107, P17833, DOI 10.1073/pnas.0911359107; KENNEDY EP, 1961, FED PROC, V20, P934; LAKSHMINARAYANA G, 1984, J AM OIL CHEM SOC, V61, P1249, DOI 10.1007/BF02636264; Lu CF, 2009, P NATL ACAD SCI USA, V106, P18837, DOI 10.1073/pnas.0908848106; PANEKINA T V, 1978, Chemistry of Natural Compounds (English Translation of Khimiya Prirodnykh Soedinenii), V14, P33, DOI 10.1007/BF00565871; Parthibane V, 2012, J BIOL CHEM, V287, P1946, DOI 10.1074/jbc.M111.309955; PERRY HJ, 1993, PHYTOCHEMISTRY, V33, P329, DOI 10.1016/0031-9422(93)85512-P; Rani SH, 2010, J BIOL CHEM, V285, P38337, DOI 10.1074/jbc.M110.133116; Reddy VS, 2008, J BIOL CHEM, V283, P8846, DOI 10.1074/jbc.M706752200; Reddy VS, 2010, BBA-MOL CELL BIOL L, V1801, P455, DOI 10.1016/j.bbalip.2009.12.005; Sandager L, 2002, J BIOL CHEM, V277, P6478, DOI 10.1074/jbc.M109109200; Stobart K, 1997, PLANTA, V203, P58, DOI 10.1007/s004250050165; Tumaney AW, 2001, J BIOL CHEM, V276, P10847, DOI 10.1074/jbc.M100005200; Vega-Sanchez ME, 2010, CURR OPIN BIOTECH, V21, P218, DOI 10.1016/j.copbio.2010.02.002; Vogel G, 1996, PLANT PHYSIOL, V110, P923, DOI 10.1104/pp.110.3.923; Voinnet O, 2003, PLANT J, V33, P949, DOI 10.1046/j.1365-313X.2003.01676.x; Weselake RJ, 2009, BIOTECHNOL ADV, V27, P866, DOI 10.1016/j.biotechadv.2009.07.001; Wood CC, 2009, PLANT BIOTECHNOL J, V7, P914, DOI 10.1111/j.1467-7652.2009.00453.x; Yang WL, 2010, P NATL ACAD SCI USA, V107, P12040, DOI 10.1073/pnas.0914149107; Yen CLE, 2003, J BIOL CHEM, V278, P18532, DOI 10.1074/jbc.M301633200; Yen CLE, 2002, P NATL ACAD SCI USA, V99, P8512, DOI 10.1073/pnas.132274899; Zheng ZF, 2001, J BIOL CHEM, V276, P41710, DOI 10.1074/jbc.M104749200; Zhou XR, 2011, J BIOL CHEM, V286, P43644, DOI 10.1074/jbc.M111.266114	36	122	160	1	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2012	7	4							e35214	10.1371/journal.pone.0035214	http://dx.doi.org/10.1371/journal.pone.0035214			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VO	23145108	Green Published, gold, Green Submitted			2022-12-25	WOS:000305345000048
J	Lo, PK; Kanojia, D; Liu, X; Singh, UP; Berger, FG; Wang, Q; Chen, H				Lo, P-K; Kanojia, D.; Liu, X.; Singh, U. P.; Berger, F. G.; Wang, Q.; Chen, H.			CD49f and CD61 identify Her2/neu-induced mammary tumor-initiating cells that are potentially derived from luminal progenitors and maintained by the integrin-TGF beta signaling	ONCOGENE			English	Article						tumor-initiating cells; Her2/neu; mammary tumor; CD49f; CD61; ESA	EPITHELIAL-MESENCHYMAL TRANSITION; BREAST-CANCER CELLS; STEM-CELLS; II RECEPTOR; EXPRESSION; MOUSE; GLAND; TUMORIGENESIS; POPULATION; TGF-BETA-1	Human epidermal growth factor receptor 2 (HER2)/Neu is overexpressed in 20-30% of breast cancers and associated with aggressive phenotypes and poor prognosis. For deciphering the role of HER2/Neu in breast cancer, mouse mammary tumor virus (MMTV)-Her2/neu transgenic mice that develop mammary tumors resembling human HER2-subtype breast cancer have been established. Several recent studies have revealed that HER2/Neu is overexpressed in and regulates self renewal of breast tumor-initiating cells (TICs). However, in the MMTV-Her2/neu transgenic mouse model, the identity of TICs remains elusive, despite previous studies showing supportive evidence for existence of TICs in Her2/neu-induced mammary tumors. Through systematic screening and characterization, we identified that surface markers CD49f, CD61 and ESA were aberrantly overexpressed in Her2-overexpressing mammary tumor cells. Analysis of these markers and CD24 detected anomalous expansion of the luminal progenitor population in preneoplastic mammary glands of Her2/neu transgenic mice, indicating that aberrant luminal progenitors originated in Her2-induced mammary tumors. The combined markers, CD49f and CD61, further delineated the CD49f(high)CD61(high)-sorted fraction as a TIC-enriched population, which displayed increased tumorsphere formation ability, enhanced tumorigenicity both in vitro and in vivo and drug resistance to pacitaxel and doxorubicin. Moreover, the TIC-enriched population manifested increased transforming growth factor-beta (TGF beta) signaling and exhibited gene expression signatures of stemness, TGF beta signaling and epithelial-to-mesenchymal transition. Our findings that self-renewal and clonogenicity of TICs were suppressed by pharmacologically inhibiting the TGF beta signaling further indicate that the TGF beta pathway is vital for maintenance of the TIC population. Finally, we showed that the integrin-beta 3 (CD61) signaling pathway was required for sustaining active TGF beta signaling and self-renewal of TICs. We for the first time developed a technique to highly enrich TICs from mammary tumors of Her2/neu transgenic mice, unraveled their properties and identified the cooperative integrin-beta 3-TGF beta signaling axis as a potential therapeutic target for HER2-induced TICs. Oncogene (2012) 31, 2614-2626; doi:10.1038/onc.2011.439; published online 26 September 2011	[Lo, P-K; Kanojia, D.; Berger, F. G.; Chen, H.] Univ S Carolina, Dept Biol Sci, Columbia, SC 29208 USA; [Lo, P-K; Kanojia, D.; Berger, F. G.; Wang, Q.; Chen, H.] Univ S Carolina, Ctr Colon Canc Res, Columbia, SC 29208 USA; [Liu, X.] Univ S Carolina, Dept Math, Columbia, SC 29208 USA; [Singh, U. P.] Univ S Carolina, Sch Med, Dept Pathol Microbiol & Immunol, Columbia, SC 29208 USA; [Wang, Q.] Univ S Carolina, Dept Chem & Biochem, Columbia, SC 29208 USA	University of South Carolina; University of South Carolina System; University of South Carolina Columbia; University of South Carolina; University of South Carolina System; University of South Carolina Columbia; University of South Carolina; University of South Carolina System; University of South Carolina Columbia; University of South Carolina; University of South Carolina System; University of South Carolina Columbia; University of South Carolina; University of South Carolina System; University of South Carolina Columbia	Chen, H (corresponding author), Univ S Carolina, Dept Biol Sci, 715 Sumter St,PSC621, Columbia, SC 29208 USA.	hchen@biol.sc.edu	Kanojia, Deepak/G-5120-2014; chen, hexin/F-1714-2011	Kanojia, Deepak/0000-0003-4295-4972; Wang, Qian/0000-0002-2149-384X; Singh, Udai/0000-0002-7048-4325	Elsa U Pardee Cancer Foundation [B94AFFAA]; American Cancer Society [RSG-10-067-01-TBE]; NIH [3P20RR017698-08]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR017698] Funding Source: NIH RePORTER	Elsa U Pardee Cancer Foundation; American Cancer Society(American Cancer Society); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	We thank Dr Marai M Pena, Celestia Davis, Sara Johnson and Andrea Daamen for experimental assistance. This work was supported by the Elsa U Pardee Cancer Foundation grant (B94AFFAA), the American Cancer Society Research Award (RSG-10-067-01-TBE) to HC and NIH grant (3P20RR017698-08) to HC and QW.	Asselin-Labat ML, 2007, NAT CELL BIOL, V9, P201, DOI 10.1038/ncb1530; Biswas S, 2006, CLIN CANCER RES, V12, P4142, DOI 10.1158/1078-0432.CCR-06-0952; Chen HX, 2010, PROTEOMICS, V10, P3800, DOI 10.1002/pmic.201000297; Cicalese A, 2009, CELL, V138, P1083, DOI 10.1016/j.cell.2009.06.048; Clarke Michael F, 2006, Cancer Res, V66, P9339, DOI 10.1158/0008-5472.CAN-06-3126; Desgrosellier JS, 2010, NAT REV CANCER, V10, P9, DOI 10.1038/nrc2748; Galliher AJ, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1524; Galliher AJ, 2007, CANCER RES, V67, P3752, DOI 10.1158/0008-5472.CAN-06-3851; Ginestier C, 2007, CELL STEM CELL, V1, P555, DOI 10.1016/j.stem.2007.08.014; Gu Y.B., 2011, J BIOTECH RES, V3, P7; GUY CT, 1992, P NATL ACAD SCI USA, V89, P10578, DOI 10.1073/pnas.89.22.10578; Hanker L, 2010, BREAST CANCER RES TR, V122, P765, DOI 10.1007/s10549-009-0608-6; HYNES NE, 1985, MOL CELL BIOL, V5, P268, DOI 10.1128/MCB.5.1.268; Ishikawa Toshihisa, 2009, J Exp Ther Oncol, V8, P5; James D, 2005, DEVELOPMENT, V132, P1273, DOI 10.1242/dev.01706; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Korkaya H, 2008, ONCOGENE, V27, P6120, DOI 10.1038/onc.2008.207; Kveiborg M., 2001, Journal of Endocrinology, V169, P549, DOI 10.1677/joe.0.1690549; Li XX, 2008, JNCI-J NATL CANCER I, V100, P672, DOI 10.1093/jnci/djn123; Lim E, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2560; Lim E, 2009, NAT MED, V15, P907, DOI 10.1038/nm.2000; Liu JC, 2007, CANCER RES, V67, P8671, DOI 10.1158/0008-5472.CAN-07-1486; Liu SL, 2006, CANCER RES, V66, P6063, DOI 10.1158/0008-5472.CAN-06-0054; Magnifico A, 2009, CLIN CANCER RES, V15, P2010, DOI 10.1158/1078-0432.CCR-08-1327; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Mani SA, 2007, P NATL ACAD SCI USA, V104, P10069, DOI 10.1073/pnas.0703900104; Margadant C, 2010, EMBO REP, V11, P97, DOI 10.1038/embor.2009.276; Park JI, 2003, ONCOGENE, V22, P4314, DOI 10.1038/sj.onc.1206478; Scaffidi AK, 2004, J BIOL CHEM, V279, P37726, DOI 10.1074/jbc.M403010200; Shackleton M, 2006, NATURE, V439, P84, DOI 10.1038/nature04372; Shipitsin M, 2007, CANCER CELL, V11, P259, DOI 10.1016/j.ccr.2007.01.013; Stingl J, 2006, NATURE, V439, P993, DOI 10.1038/nature04496; Vaillant F, 2008, CANCER RES, V68, P7711, DOI 10.1158/0008-5472.CAN-08-1949; Visvader JE, 2011, NATURE, V469, P314, DOI 10.1038/nature09781; Welm B, 2003, CELL PROLIFERAT, V36, P17, DOI 10.1046/j.1365-2184.36.s.1.3.x; Wipff PJ, 2007, J CELL BIOL, V179, P1311, DOI 10.1083/jcb.200704042; Wright MH, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr1855; Yang C, 2007, EXP CELL RES, V313, P1240, DOI 10.1016/j.yexcr.2007.01.011	38	149	155	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY	2012	31	21					2614	2626		10.1038/onc.2011.439	http://dx.doi.org/10.1038/onc.2011.439			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	948SS	21996747	Green Accepted			2022-12-25	WOS:000304523500002
J	Kim, M; Yoon, S; Lee, S; Ha, SA; Kim, HK; Kim, JW; Chung, J				Kim, Minsoo; Yoon, Soomin; Lee, Sukmook; Ha, Seon Ah; Kim, Hyun Kee; Kim, Jin Woo; Chung, Junho			Gremlin-1 Induces BMP-Independent Tumor Cell Proliferation, Migration, and Invasion	PLOS ONE			English	Article							BONE MORPHOGENETIC PROTEIN; ANTAGONIST GREMLIN-1; DRM/GREMLIN; CANCER; EXPRESSION; CARCINOMA; DAN	Gremlin-1, a bone morphogenetic protein (BMP) antagonist, is overexpressed in various cancerous tissues but its role in carcinogenesis has not been established. Here, we report that gremlin-1 binds various cancer cell lines and this interaction is inhibited by our newly developed gremlin-1 antibody, GRE1. Gremlin-1 binding to cancer cells was unaffected by the presence of BMP-2, BMP-4, and BMP-7. In addition, the binding was independent of vascular endothelial growth factor receptor-2 (VEGFR2) expression on the cell surface. Addition of gremlin-1 to A549 cells induced a fibroblast-like morphology and decreased E-cadherin expression. In a scratch wound healing assay, A549 cells incubated with gremlin-1 or transfected with gremlin-1 showed increased migration, which was inhibited in the presence of the GRE1 antibody. Gremlin-1 transfected A549 cells also exhibited increased invasiveness as well as an increased growth rate. These effects were also inhibited by the addition of the GRE1 antibody. In conclusion, this study demonstrates that gremlin-1 directly interacts with cancer cells in a BMP- and VEGFR2-independent manner and can induce cell migration, invasion, and proliferation.	[Kim, Minsoo; Yoon, Soomin; Chung, Junho] Seoul Natl Univ, Coll Med, Dept Biochem & Mol Biol, Seoul, South Korea; [Kim, Minsoo] Seoul Natl Univ, Coll Med, Dept Canc Biol, Seoul, South Korea; [Kim, Minsoo; Chung, Junho] Seoul Natl Univ, Coll Med, Canc Res Inst, Seoul, South Korea; [Lee, Sukmook] Scripps Korea Antibody Inst, Chuncheon Si, Gangwon Do, South Korea; [Ha, Seon Ah; Kim, Jin Woo] Catholic Univ Korea, Coll Med, Mol Genet Lab, Seoul, South Korea; [Kim, Hyun Kee; Kim, Jin Woo] Catholic Univ Korea, Coll Med, Dept Obstet & Gynecol, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Catholic University of Korea; Catholic University of Korea	Kim, M (corresponding author), Seoul Natl Univ, Coll Med, Dept Biochem & Mol Biol, Seoul, South Korea.	jjhchung@snu.ac.kr	Chung, Junho/J-2792-2012		Korea Biotech R&D Group of Next-generation growth engine project of the Ministry of Education, Science and Technology, Republic of Korea [2011K000737]	Korea Biotech R&D Group of Next-generation growth engine project of the Ministry of Education, Science and Technology, Republic of Korea	This research was supported by a grant (2011K000737) from Korea Biotech R&D Group of Next-generation growth engine project of the Ministry of Education, Science and Technology, Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bobinac D, 2005, CROAT MED J, V46, P389; Chen B, 2004, J IMMUNOL, V173, P5914, DOI 10.4049/jimmunol.173.10.5914; Chen D, 2004, GROWTH FACTORS, V22, P233, DOI 10.1080/08977190412331279890; Chung L, 2004, FASEB J, V18, pA345, DOI 10.1096/fj.03-0586fje; Gupta GP, 2006, CELL, V127, P679, DOI 10.1016/j.cell.2006.11.001; Kim K, 2007, BIOCHEM BIOPH RES CO, V354, P115, DOI 10.1016/j.bbrc.2006.12.164; Koli K, 2006, AM J PATHOL, V169, P61, DOI 10.2353/ajpath.2006.051263; Lappin DWP, 2000, CURR OPIN NEPHROL HY, V9, P469, DOI 10.1097/00041552-200009000-00002; Lee MS, 2008, HYBRIDOMA, V27, P18, DOI 10.1089/hyb.2007.0532; Li XL, 2009, CANCER CHEMOTH PHARM, V64, P1097, DOI 10.1007/s00280-009-0966-0; Lu MM, 2001, DEV DYNAM, V222, P667, DOI 10.1002/dvdy.1231; Merino R, 1999, DEVELOPMENT, V126, P5515; Mitola S, 2010, BLOOD, V116, P3677, DOI 10.1182/blood-2010-06-291930; Namkoong H, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-74; Park S, 2010, CLIN CHIM ACTA, V411, P1238, DOI 10.1016/j.cca.2010.04.027; Perl AK, 1998, NATURE, V392, P190, DOI 10.1038/32433; Rosso O, 2007, MOL CANCER RES, V5, P1246, DOI 10.1158/1541-7786.MCR-07-0060; Sha GH, 2009, FERTIL STERIL, V91, P350, DOI 10.1016/j.fertnstert.2007.12.007; Shi W, 2001, AM J PHYSIOL-LUNG C, V280, pL1030, DOI 10.1152/ajplung.2001.280.5.L1030; Singh A, 2010, CYTOKINE GROWTH F R, V21, P299, DOI 10.1016/j.cytogfr.2010.06.003; Sneddon JB, 2006, P NATL ACAD SCI USA, V103, P14842, DOI 10.1073/pnas.0606857103; Stanley E, 1998, MECH DEVELOP, V77, P173, DOI 10.1016/S0925-4773(98)00139-7; Sun JP, 2006, J BIOL CHEM, V281, P29349, DOI 10.1074/jbc.M603833200; TOMAYKO MM, 1989, CANCER CHEMOTH PHARM, V24, P148, DOI 10.1007/BF00300234; Topol LZ, 2000, J BIOL CHEM, V275, P8785, DOI 10.1074/jbc.275.12.8785; Topol LZ, 2000, CYTOGENET CELL GENET, V89, P79, DOI 10.1159/000015568; Topol LZ, 1997, MOL CELL BIOL, V17, P4801, DOI 10.1128/MCB.17.8.4801	27	102	114	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2012	7	4							e35100	10.1371/journal.pone.0035100	http://dx.doi.org/10.1371/journal.pone.0035100			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UT	23118971	gold, Green Submitted, Green Published			2022-12-25	WOS:000305341600118
J	Chen, L; Huang, LZ; Min, DH; Phillips, A; Wang, SQ; Madgwick, PJ; Parry, MAJ; Hu, YG				Chen, Liang; Huang, Linzhou; Min, Donghong; Phillips, Andy; Wang, Shiqiang; Madgwick, Pippa J.; Parry, Martin A. J.; Hu, Yin-Gang			Development and Characterization of a New TILLING Population of Common Bread Wheat (Triticum aestivum L.)	PLOS ONE			English	Article							CHEMICALLY-INDUCED MUTATIONS; DETECT INDUCED MUTATIONS; GENE-FUNCTION; INSERTIONAL MUTAGENESIS; FUNCTIONAL GENOMICS; POINT MUTATIONS; INDUCED MUTANTS; DISCOVERY; RESOURCE; RICE	Mutagenesis is an important tool in crop improvement. However, the hexaploid genome of wheat (Triticum aestivum L.) presents problems in identifying desirable genetic changes based on phenotypic screening due to gene redundancy. TILLING (Targeting Induced Local Lesions IN Genomes), a powerful reverse genetic strategy that allows the detection of induced point mutations in individuals of the mutagenized populations, can address the major challenge of linking sequence information to the biological function of genes and can also identify novel variation for crop breeding. Wheat is especially well-suited for TILLING due to the high mutation densities tolerated by polyploids. However, only a few wheat TILLING populations are currently available in the world, which is far from satisfying the requirement of researchers and breeders in different growing environments. In addition, current TILLING screening protocols require costly fluorescence detection systems, limiting their use, especially in developing countries. We developed a new TILLING resource comprising 2610 M-2 mutants in a common wheat cultivar 'Jinmai 47'. Numerous phenotypes with altered morphological and agronomic traits were observed from the M-2 and M-3 lines in the field. To simplify the procedure and decrease costs, we use unlabeled primers and either non-denaturing polyacrylamide gels or agarose gels for mutation detection. The value of this new resource was tested using PCR with RAPD and Intron-spliced junction (ISJ) primers, and also TILLING in three selected candidate genes, in 300 and 512 mutant lines, revealing high mutation densities of 1/34 kb by RAPD/ISJ analysis and 1/47 kb by TILLING. In total, 31 novel alleles were identified in the 3 targeted genes and confirmed by sequencing. The results indicate that this mutant population represents a useful resource for the wheat research community. We hope that the use of this reverse genetics resource will provide novel allelic diversity for wheat improvement and functional genomics.	[Chen, Liang; Huang, Linzhou; Min, Donghong; Wang, Shiqiang; Hu, Yin-Gang] NW A&F Univ, Coll Agron, State Key Lab Crop Stress Biol Arid Areas, Yangling, Shaanxi, Peoples R China; [Phillips, Andy; Madgwick, Pippa J.; Parry, Martin A. J.] Rothamsted Res, Dept Plant Sci, Ctr Crop Genet Improvement, Harpenden, Herts, England; NW A&F Univ, Inst Water Saving Agr Arid Reg China, Yangling, Shaanxi, Peoples R China	Northwest A&F University - China; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Rothamsted Research; Northwest A&F University - China	Hu, YG (corresponding author), NW A&F Univ, Coll Agron, State Key Lab Crop Stress Biol Arid Areas, Yangling, Shaanxi, Peoples R China.	huyingang@nwsuaf.edu.cn	Chen, Lei/A-2275-2011	Chen, Lei/0000-0003-3068-1583; Parry, Martin/0000-0002-4477-672X; cai, yudong/0000-0001-5664-7979	Ministry of Science and Technology [2006AA100201, 2006AA100223, 2006CB708208]; 111 Program of Introducing Talents of Discipline to Universities P. R. China [111-2-16]; ACIAR Project of Australia [CIM/2005/111]; Biotechnology and Biological Sciences Research Council [BBS/E/C/00004820, BBS/E/C/00005202, BBS/E/C/00004952, BB/E025161/1, BB/I000607/1] Funding Source: researchfish	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); 111 Program of Introducing Talents of Discipline to Universities P. R. China; ACIAR Project of Australia(Australian Ctr Intl Agr Res); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the sub-project of the 863 Program (2006AA100201, 2006AA100223), the pre-phase project of the 973 Program (2006CB708208) of the Ministry of Science and Technology, and the 111 Program of Introducing Talents of Discipline to Universities (111-2-16), P. R. China, as well as the ACIAR Project (CIM/2005/111) of Australia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldrich C, 1993, PLANT MOL BIOL REP, V11, P128, DOI DOI 10.1007/BF02670471; Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391; BASSAM BJ, 1991, ANAL BIOCHEM, V196, P80, DOI 10.1016/0003-2697(91)90120-I; Bentley A, 2000, GENETICS, V156, P1169; Bibi S, 2009, PAK J BOT, V41, P1022; Caldwell DG, 2004, PLANT J, V40, P143, DOI 10.1111/j.1365-313X.2004.02190.x; Chawade A, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-86; Chen LA, 2011, AUST J CROP SCI, V5, P318; Chua NH, 2006, CURR OPIN BIOTECH, V17, P103, DOI 10.1016/j.copbio.2006.03.002; Cooper JL, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-9; Dahmani-Mardas F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015776; Dong CM, 2009, PLANT GENOME-US, V2, P39, DOI 10.3835/plantgenome2008.10.0012; Eversole K, 2009, ANN WHEAT N IN PRESS, P55; Fox JL, 2004, NAT BIOTECHNOL, V22, P1062, DOI 10.1038/nbt0904-1062; Fu DL, 2007, TRANSGENIC RES, V16, P689, DOI 10.1007/s11248-007-9150-7; Gonzalez FG, 2005, EUPHYTICA, V146, P253, DOI 10.1007/s10681-005-9021-3; Gottwald Sven, 2009, BMC Res Notes, V2, P258, DOI 10.1186/1756-0500-2-258; Greene EA, 2003, GENETICS, V164, P731; HALLORAN GM, 1982, ANN BOT-LONDON, V49, P115, DOI 10.1093/oxfordjournals.aob.a086220; Henikoff S, 2004, PLANT PHYSIOL, V135, P630, DOI 10.1104/pp.104.041061; Hirochika H, 2001, CURR OPIN PLANT BIOL, V4, P118, DOI 10.1016/S1369-5266(00)00146-1; Jaillon O, 2007, NATURE, V449, P463, DOI 10.1038/nature06148; Jeon JS, 2000, PLANT J, V22, P561, DOI 10.1046/j.1365-313x.2000.00767.x; Knoll JE, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-81; Matsumoto T, 2005, NATURE, V436, P793, DOI 10.1038/nature03895; McCallum CM, 2000, PLANT PHYSIOL, V123, P439, DOI 10.1104/pp.123.2.439; MERRIL CR, 1984, ELECTROPHORESIS, V5, P289, DOI 10.1002/elps.1150050509; Minoia Silvia, 2010, BMC Res Notes, V3, P69, DOI 10.1186/1756-0500-3-69; Muth J, 2008, PLANT BIOTECHNOL J, V6, P576, DOI 10.1111/j.1467-7652.2008.00340.x; Naghavi Mohammad Reza, 2004, Iranian Journal of Biotechnology, V2, P195; Nomura T, 2005, P NATL ACAD SCI USA, V102, P16490, DOI 10.1073/pnas.0505156102; Oleykowski CA, 1998, NUCLEIC ACIDS RES, V26, P4597, DOI 10.1093/nar/26.20.4597; Parry MAJ, 2009, J EXP BOT, V60, P2817, DOI 10.1093/jxb/erp189; Piron F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011313; Przetakiewicz J, 2002, CELL MOL BIOL LETT, V7, P671; Raghavan C, 2007, MOL BREEDING, V19, P87, DOI 10.1007/s11032-006-9046-x; Rothe N, 2010, THESIS KANSASS STATE; Sabetta W, 2011, PLANT METHODS, V7, DOI 10.1186/1746-4811-7-20; Slade AJ, 2005, NAT BIOTECHNOL, V23, P75, DOI 10.1038/nbt1043; Slafer GA, 1996, FIELD CROP RES, V46, P1, DOI 10.1016/0378-4290(95)00081-X; SONG WN, 1995, GENET RESOUR CROP EV, V42, P273, DOI 10.1007/BF02431262; Stephenson P, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-62; Suzuki T, 2008, MOL GENET GENOMICS, V279, P213, DOI 10.1007/s00438-007-0293-2; Talame V, 2008, PLANT BIOTECHNOL J, V6, P477, DOI 10.1111/j.1467-7652.2008.00341.x; Till B. J., 2007, GENOMICS ASSISTED CR, P333; Till BJ, 2003, METH MOL B, V236, P205; Till BJ, 2007, BMC PLANT BIOL, V7, DOI 10.1186/1471-2229-7-19; Till Bradley J., 2004, BMC Plant Biology, V4, P12, DOI 10.1186/1471-2229-4-12; Uauy C, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-115; Wang N, 2008, NEW PHYTOL, V180, P751, DOI 10.1111/j.1469-8137.2008.02619.x; Weigel D, 2000, PLANT PHYSIOL, V122, P1003, DOI 10.1104/pp.122.4.1003; Wu JL, 2005, PLANT MOL BIOL, V59, P85, DOI 10.1007/s11103-004-5112-0; Xin ZG, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-103	53	254	259	6	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2012	7	7							e41570	10.1371/journal.pone.0041570	http://dx.doi.org/10.1371/journal.pone.0041570			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977TM	22844501	Green Published, gold, Green Submitted			2022-12-25	WOS:000306687700113
J	Chen, L; Ma, YL; Kim, EY; Yu, W; Schwartz, RJ; Qian, L; Wang, J				Chen, Li; Ma, Yanlin; Kim, Eun Young; Yu, Wei; Schwartz, Robert J.; Qian, Ling; Wang, Jun			Conditional Ablation of Ezh2 in Murine Hearts Reveals Its Essential Roles in Endocardial Cushion Formation, Cardiomyocyte Proliferation and Survival	PLOS ONE			English	Article							HISTONE METHYLTRANSFERASE ACTIVITY; CARDIAC DEVELOPMENT; TRANSCRIPTION FACTOR; MOUSE DEVELOPMENT; NOTCH ACTIVATION; GENE-EXPRESSION; OUTFLOW-TRACT; BHLH FACTORS; CELL FATE; METHYLATION	Ezh2 is a histone trimethyltransferase that silences genes mainly via catalyzing trimethylation of histone 3 lysine 27 (H3K27Me3). The role of Ezh2 as a regulator of gene silencing and cell proliferation in cancer development has been extensively investigated; however, its function in heart development during embryonic cardiogenesis has not been well studied. In the present study, we used a genetically modified mouse system in which Ezh2 was specifically ablated in the mouse heart. We identified a wide spectrum of cardiovascular malformations in the Ezh2 mutant mice, which collectively led to perinatal death. In the Ezh2 mutant heart, the endocardial cushions (ECs) were hypoplastic and the endothelial-to-mesenchymal transition (EMT) process was impaired. The hearts of Ezh2 mutant mice also exhibited decreased cardiomyocyte proliferation and increased apoptosis. We further identified that the Hey2 gene, which is important for cardiomyocyte proliferation and cardiac morphogenesis, is a downstream target of Ezh2. The regulation of Hey2 expression by Ezh2 may be independent of Notch signaling activity. Our work defines an indispensible role of the chromatin remodeling factor Ezh2 in normal cardiovascular development.	[Chen, Li; Kim, Eun Young; Qian, Ling; Wang, Jun] Texas Heart Inst, Basic Res Labs, Dept Stem Cell Engn, Houston, TX 77025 USA; [Ma, Yanlin] Texas A&M Hlth Sci Ctr, Inst Biosci & Technol, Houston, TX USA; [Kim, Eun Young] Univ Texas Hlth Sci Ctr Houston, Program Genes & Dev, Houston, TX USA; [Yu, Wei; Schwartz, Robert J.] Univ Houston, Dept Biochem & Mol Biol, Houston, TX USA	Texas Heart Institute; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; University of Texas System; University of Texas Health Science Center Houston; University of Houston System; University of Houston	Chen, L (corresponding author), Texas Heart Inst, Basic Res Labs, Dept Stem Cell Engn, Houston, TX 77025 USA.	junwang@heart.thi.tmc.edu	Chen, Lei/A-2275-2011	Chen, Lei/0000-0003-3068-1583; Parry, Martin/0000-0002-4477-672X; cai, yudong/0000-0001-5664-7979	American Heart Association; National Health Institute; American Heart Association Southern Central Affiliate; Biotechnology and Biological Sciences Research Council [BBS/E/C/00004820, BBS/E/C/00005202, BBS/E/C/00004952, BB/E025161/1, BB/I000607/1] Funding Source: researchfish	American Heart Association(American Heart Association); National Health Institute; American Heart Association Southern Central Affiliate; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported in part by grants from the American Heart Association to JW. JW is also supported by a P30 grant from the National Health Institute as a Newly Independent Investigator (NII). LC is supported by a Postdoctoral Fellowship from the American Heart Association Southern Central Affiliate. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama H, 2004, P NATL ACAD SCI USA, V101, P6502, DOI 10.1073/pnas.0401711101; Bracken AP, 2003, EMBO J, V22, P5323, DOI 10.1093/emboj/cdg542; Brutsaert DL, 2003, PHYSIOL REV, V83, P59, DOI 10.1152/physrev.00017.2002; Cao R, 2004, MOL CELL, V15, P57, DOI 10.1016/j.molcel.2004.06.020; Caretti G, 2004, GENE DEV, V18, P2627, DOI 10.1101/gad.1241904; Cha TL, 2005, SCIENCE, V310, P306, DOI 10.1126/science.1118947; Chase A, 2011, CLIN CANCER RES, V17, P2613, DOI 10.1158/1078-0432.CCR-10-2156; Conerly ML, 2011, GENE DEV, V25, P997, DOI 10.1101/gad.2054311; Curry CL, 2005, ONCOGENE, V24, P6333, DOI 10.1038/sj.onc.1208783; Danielian PS, 1998, CURR BIOL, V8, P1323, DOI 10.1016/S0960-9822(07)00562-3; de la Pompa JL, 1998, NATURE, V392, P182, DOI 10.1038/32419; Diez H, 2007, EXP CELL RES, V313, P1, DOI 10.1016/j.yexcr.2006.09.009; Doetzlhofer A, 2009, DEV CELL, V16, P58, DOI 10.1016/j.devcel.2008.11.008; Donovan J, 2002, CURR BIOL, V12, P1605, DOI 10.1016/S0960-9822(02)01149-1; Esteller M, 2007, HUM MOL GENET, V16, pR50, DOI 10.1093/hmg/ddm018; Ezhkova E, 2011, GENE DEV, V25, P485, DOI 10.1101/gad.2019811; Fischer A, 2007, NUCLEIC ACIDS RES, V35, P4583, DOI 10.1093/nar/gkm477; Fouse SD, 2008, CELL STEM CELL, V2, P160, DOI 10.1016/j.stem.2007.12.011; Fussbroich B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021651; Gessler M, 2002, CURR BIOL, V12, P1601, DOI 10.1016/S0960-9822(02)01150-8; Gordadze AV, 2001, J VIROL, V75, P5899, DOI 10.1128/JVI.75.13.5899-5912.2001; Han P, 2011, CIRC RES, V108, P378, DOI 10.1161/CIRCRESAHA.110.224287; Harrelson Z, 2004, DEVELOPMENT, V131, P5041, DOI 10.1242/dev.01378; High FA, 2008, NAT REV GENET, V9, P49, DOI 10.1038/nrg2279; Iso T, 2003, J CELL PHYSIOL, V194, P237, DOI 10.1002/jcp.10208; Jiang XB, 2000, DEVELOPMENT, V127, P1607; Kim EY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020803; Lee ST, 2011, MOL CELL, V43, P798, DOI 10.1016/j.molcel.2011.08.011; Leimeister C, 2000, DEV BIOL, V227, P91, DOI 10.1006/dbio.2000.9884; Leimeister C, 1999, MECH DEVELOP, V85, P173, DOI 10.1016/S0925-4773(99)00080-5; Li X, 2009, AM J PATHOL, V175, P1246, DOI 10.2353/ajpath.2009.090042; Liu W, 2004, P NATL ACAD SCI USA, V101, P4489, DOI 10.1073/pnas.0308466101; Liu YG, 2010, AM J PHYSIOL-HEART C, V298, pH2082, DOI 10.1152/ajpheart.00747.2009; Ma Q, 2008, DEV BIOL, V323, P98, DOI 10.1016/j.ydbio.2008.08.013; Moses Kelvin A., 2001, Genesis The Journal of Genetics and Development, V31, P176, DOI 10.1002/gene.10022; Niessen K, 2008, CIRC RES, V102, P1169, DOI 10.1161/CIRCRESAHA.108.174318; Niessen K, 2008, J CELL BIOL, V182, P315, DOI 10.1083/jcb.200710067; Noseda M, 2004, CIRC RES, V94, P910, DOI 10.1161/01.RES.0000124300.76171.C9; O'Carroll D, 2001, MOL CELL BIOL, V21, P4330, DOI 10.1128/MCB.21.13.4330-4336.2001; Olson EN, 2004, NAT MED, V10, P467, DOI 10.1038/nm0504-467; Pasini D, 2004, EMBO J, V23, P4061, DOI 10.1038/sj.emboj.7600402; Person AD, 2005, INT REV CYTOL, V243, P287, DOI 10.1016/S0074-7696(05)43005-3; Riising EM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002704; Rutenberg JB, 2006, DEVELOPMENT, V133, P4381, DOI 10.1242/dev.02607; Sakata Y, 2006, J MOL CELL CARDIOL, V40, P267, DOI 10.1016/j.yjmcc.2005.09.006; Shen XH, 2008, MOL CELL, V32, P491, DOI 10.1016/j.molcel.2008.10.016; Shi B, 2007, MOL CELL BIOL, V27, P5105, DOI 10.1128/MCB.00162-07; Shirai M, 2009, P NATL ACAD SCI USA, V106, P18604, DOI 10.1073/pnas.0900635106; Su IH, 2003, NAT IMMUNOL, V4, P124, DOI 10.1038/ni876; Tanay A, 2007, P NATL ACAD SCI USA, V104, P5521, DOI 10.1073/pnas.0609746104; Timmerman LA, 2004, GENE DEV, V18, P99, DOI 10.1101/gad.276304; van Weerd JH, 2011, CARDIOVASC RES, V91, P203, DOI 10.1093/cvr/cvr138; Wang J, 2008, J BIOL CHEM, V283, P23235, DOI 10.1074/jbc.M709748200; Wang J, 2007, MOL CELL BIOL, V27, P622, DOI 10.1128/MCB.01160-06; Wang J, 2011, WIRES SYST BIOL MED, V3, P446, DOI 10.1002/wsbm.130; Wang J, 2011, BIRTH DEFECTS RES A, V91, P468, DOI 10.1002/bdra.20816; Wilkinson FH, 2006, P NATL ACAD SCI USA, V103, P19296, DOI 10.1073/pnas.0603564103; Wu JC, 2004, CURR PROB CARDIOLOGY, V29, P641, DOI 10.1016/j.cpcardiol.2004.04.003; Wu SC, 2011, J BIOL CHEM, V286, P28511, DOI 10.1074/jbc.M111.240515; Wu ZL, 2010, CELL DEATH DIFFER, V17, P801, DOI 10.1038/cdd.2009.162; Wyngaarden LA, 2011, DEVELOPMENT, V138, P3759, DOI 10.1242/dev.063180	61	254	259	6	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2012	7	2							e31005	10.1371/journal.pone.0031005	http://dx.doi.org/10.1371/journal.pone.0031005			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	914UG	22844501	Green Published, Green Submitted, gold			2022-12-25	WOS:000301977500025
J	Chen, LC; Hsu, C; Chiueh, CC; Lee, WS				Chen, Li-Ching; Hsu, Chin; Chiueh, Chuang Chin; Lee, Wen-Sen			Ferrous Citrate Up-Regulates the NOS2 through Nuclear Translocation of NF kappa B Induced by Free Radicals Generation in Mouse Cerebral Endothelial Cells	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; TRANSIENT FOREBRAIN ISCHEMIA; SUBARACHNOID HEMORRHAGE; OXIDATIVE STRESS; BRAIN-INJURY; PUTATIVE ROLE; IRON; ACTIVATION; EXPRESSION; FERRITIN	Previous studies indicate that the inducible nitric oxide synthase 2 (NOS2) of the brain vascular tissue in experimental subarachnoid hemorrhage (SAH) rats is a critical factor for inducing cerebral vasospasm. However, the underlying molecular mechanisms remain to be elucidated. Here, we applied ferrous citrate (FC) complexes to the primary cultured mouse cerebral endothelial cell (CEC) to mimic the SAH conditions and to address the issue how SAH-induced NOS2 up-regulation. Using immunocytochemical staining technique, we demonstrated that NOS2 was expressed in the cultured CEC. Treatment of the CEC with FC induced increases of the intracellular level of ROS, nuclear factor kappa-light-chain-enhancer of activated B cells (NF kappa B) nuclear translocation as well as NF kappa B binding onto the NOS promoter, and the levels of NOS2 mRNA and protein. These effects were abolished by pre-treatment of the cell with N-Acetyl-Cysteine (NAC), a reactive oxygen species (ROS) scavenger. In the present study, two previously predicted NFkB binding sites were confirmed in the NOS2 promoter within the range of -1529 bp to -1516 bp and -1224 bp to -1210 bp. Interestingly, both NF kappa B binding sites are involved in the FC-activated NOS2 transcriptional activity; the binding site located at -1529 bp to -1516 bp played a greater role than the other binding site located at -1224 bp to -1210 bp in the mouse CEC. These findings highlight the molecular mechanism underlying FC-induced up-regulation of NOS2 in the mouse CEC.	[Chen, Li-Ching; Lee, Wen-Sen] Taipei Med Univ, Grad Inst Med Sci, Sch Med, Taipei, Taiwan; [Hsu, Chin] Kaohsiung Med Univ, Dept Physiol, Kaohsiung, Taiwan; [Chiueh, Chuang Chin] Taipei Med Univ, Shuang Ho Hosp, Taipei, Taiwan; [Lee, Wen-Sen] Taipei Med Univ, Dept Physiol, Sch Med, Taipei, Taiwan; [Lee, Wen-Sen] Taipei Med Univ Hosp, Canc Res Ctr, Taipei, Taiwan	Taipei Medical University; Kaohsiung Medical University; Taipei Medical University; Shuang Ho Hospital; Taipei Medical University; Taipei Medical University; Taipei Medical University Hospital	Lee, WS (corresponding author), Taipei Med Univ, Grad Inst Med Sci, Sch Med, Taipei, Taiwan.	wslee@tmu.edu.tw	Chen, Lei/A-2275-2011	Chen, Lei/0000-0003-3068-1583; Parry, Martin/0000-0002-4477-672X; cai, yudong/0000-0001-5664-7979	National Science Council of Taiwan [NSC-101-2320-B-038-005, NSC-101-2629-B-037-001, NSC-95-2320-B-037-032-MY2, NSC97-2314-B-037-039-MY2, NSC-95-2320-B-038-027-MY2]; Biotechnology and Biological Sciences Research Council [BBS/E/C/00004820, BBS/E/C/00005202, BBS/E/C/00004952, BB/E025161/1, BB/I000607/1] Funding Source: researchfish	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by research grants from the National Science Council of Taiwan (NSC-101-2320-B-038-005 and NSC-101-2629-B-037-001 to W. S. L.; NSC-95-2320-B-037-032-MY2 and NSC97-2314-B-037-039-MY2 to C. H.; NSC-95-2320-B-038-027-MY2 to C. C. C.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aladag MA, 2009, NEUROCHEM RES, V34, P1935, DOI 10.1007/s11064-009-9979-7; ALLEN DR, 1994, ARCH BIOCHEM BIOPHYS, V315, P235, DOI 10.1006/abbi.1994.1495; Amberg GC, 2010, CIRC RES, V107, P1002, DOI 10.1161/CIRCRESAHA.110.217018; Asehnoune K, 2004, J IMMUNOL, V172, P2522, DOI 10.4049/jimmunol.172.4.2522; Ayer RE, 2008, ACTA NEUROCHIR SUPPL, V104, P33; Berra L V, 2007, J Neurosurg Sci, V51, P1; BIEMOND P, 1988, FREE RADICAL BIO MED, V4, P185, DOI 10.1016/0891-5849(88)90026-3; Bishop GM, 2001, BRAIN RES, V907, P175, DOI 10.1016/S0006-8993(01)02303-4; Chen LC, 2009, J AGR FOOD CHEM, V57, P7331, DOI 10.1021/jf901477g; Chen TY, 2010, STROKE, V41, P160, DOI 10.1161/STROKEAHA.109.562850; Chiueh CC, 2001, PEDIATR NEUROL, V25, P138, DOI 10.1016/S0887-8994(01)00266-1; Chiueh CC, 2000, NEUROTOX RES, V2, P293, DOI 10.1007/BF03033799; Defrere S, 2008, MOL HUM REPROD, V14, P377, DOI 10.1093/molehr/gan033; del Zoppo G, 2000, BRAIN PATHOL, V10, P95; Du WL, 2005, CHEST, V128, p556S, DOI 10.1378/chest.128.6_suppl.556S; Dumont AS, 2003, NEUROSURGERY, V53, P123, DOI 10.1227/01.NEU.0000068863.37133.9E; Gaasch JA, 2007, NEUROCHEM RES, V32, P1196, DOI 10.1007/s11064-007-9290-4; Hanggi D, 2006, ACTA NEUROCHIR, V148, P605, DOI 10.1007/s00701-005-0721-1; Ho PY, 2006, MOL CANCER THER, V5, P3130, DOI 10.1158/1535-7163.MCT-06-0457; Horky LL, 1998, J NEUROSURG, V88, P298, DOI 10.3171/jns.1998.88.2.0298; Hua Y, 2007, STROKE, V38, P759, DOI 10.1161/01.STR.0000247868.97078.10; Ishimaru H, 1996, BRAIN RES, V726, P23, DOI 10.1016/0006-8993(96)00294-6; Janjua Nazli, 2003, Curr Opin Crit Care, V9, P113, DOI 10.1097/00075198-200304000-00006; Jaramillo M, 2003, J IMMUNOL, V171, P4243, DOI 10.4049/jimmunol.171.8.4243; KONDO Y, 1995, J CEREBR BLOOD F MET, V15, P216, DOI 10.1038/jcbfm.1995.27; Lin CL, 2006, J NEUROSURG, V104, P298, DOI 10.3171/jns.2006.104.2.298; Lopez-Ongil S, 1998, BRIT J PHARMACOL, V124, P447, DOI 10.1038/sj.bjp.0701847; Mills E, 2010, FUTURE MED CHEM, V2, P51, DOI 10.4155/FMC.09.140; MOHANAKUMAR KP, 1994, ANN NY ACAD SCI, V738, P392; MORRIS SM, 1994, AM J PHYSIOL, V266, pE829, DOI 10.1152/ajpendo.1994.266.6.E829; Ong WY, 2005, REPROD NUTR DEV, V45, P647, DOI 10.1051/rnd:2005051; Ortego M, 2005, J CARDIOVASC PHARM, V45, P468, DOI 10.1097/01.fjc.0000159042.50488.e5; Osuka K, 2009, J NEUROTRAUM, V26, P1157, DOI 10.1089/neu.2008-0836; Otani H, 2009, ANTIOXID REDOX SIGN, V11, P1913, DOI [10.1089/ars.2009.2453, 10.1089/ARS.2009.2453]; Palmer C, 1999, J NEUROSCI RES, V56, P60, DOI 10.1002/(SICI)1097-4547(19990401)56:1<60::AID-JNR8>3.0.CO;2-A; Ql WN, 2004, MICROSURG, V24, P316, DOI 10.1002/micr.20030; Rauhala P, 1998, FREE RADICAL BIO MED, V24, P1065, DOI 10.1016/S0891-5849(97)00386-9; Regunathan S, 2003, ANN NY ACAD SCI, V1009, P20, DOI 10.1196/annals.1304.002; Shih HC, 2006, STROKE, V37, P3025, DOI 10.1161/01.STR.0000249008.18669.5a; Sorond FA, 2000, ANTIOXID REDOX SIGN, V2, P421, DOI 10.1089/15230860050192206; Taylor BS, 2001, PROG INFLAM RES, P1; Taylor BS, 2000, SHOCK, V13, P413, DOI 10.1097/00024382-200006000-00001; Van Bergen P, 1999, FREE RADICAL RES, V31, P631, DOI 10.1080/10715769900301201; Vijay A, 2006, NEUROL RES, V28, P759, DOI 10.1179/016164106X152034; West KA, 2003, J CLIN INVEST, V111, P81, DOI 10.1172/JCI200316147; Wilkinson DS, 2005, MOL CELL BIOL, V25, P1200, DOI 10.1128/MCB.25.3.1200-1212.2005; Won SM, 2011, EXP MOL MED, V43, P121, DOI 10.3858/emm.2011.43.2.020; Wong J M, 1995, Adv Pharmacol, V34, P155; Xu J, 2000, STROKE, V31, P1744, DOI 10.1161/01.STR.31.7.1744; Young HM, 1997, HISTOCHEM CELL BIOL, V107, P19, DOI 10.1007/s004180050085; Zhen JH, 2008, AM J HYPERTENS, V21, P28, DOI 10.1038/ajh.2007.14	51	254	259	6	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2012	7	9							e46239	10.1371/journal.pone.0046239	http://dx.doi.org/10.1371/journal.pone.0046239			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022PZ	22844501	Green Submitted, gold, Green Published			2022-12-25	WOS:000309973900115
